id|nct_id|result_group_id|ctgov_group_code|period|reason|count
5781881|NCT04646109|19897182|P2|Overall Study|Mutation disrupting ivermectin metabolism was found in 6 patients|6
5781882|NCT04646109|19897183|P1|Overall Study|Mutation disrupting ivermectin metabolism was found in 6 patients|0
5781883|NCT04608500|19897244|P2|Overall Study|Other|2
5781884|NCT04608500|19897245|P1|Overall Study|Other|6
5781885|NCT04608500|19897244|P2|Overall Study|Protocol Violation|0
5781886|NCT04608500|19897245|P1|Overall Study|Protocol Violation|1
5781887|NCT04608500|19897244|P2|Overall Study|Participant request|7
5781888|NCT04608500|19897245|P1|Overall Study|Participant request|11
5781889|NCT04608500|19897244|P2|Overall Study|Lost to Follow-up|9
5781890|NCT04608500|19897245|P1|Overall Study|Lost to Follow-up|15
5781891|NCT04608500|19897244|P2|Overall Study|Adverse Event|0
5781892|NCT04608500|19897245|P1|Overall Study|Adverse Event|2
5781893|NCT04574999|19897270|P2|Overall Study|Previous planned surgery|0
5781894|NCT04574999|19897271|P1|Overall Study|Previous planned surgery|1
5781895|NCT04574999|19897270|P2|Overall Study|Personal problems|0
5781896|NCT04574999|19897271|P1|Overall Study|Personal problems|1
5781897|NCT04574999|19897270|P2|Overall Study|Lost to Follow-up|0
5781898|NCT04574999|19897271|P1|Overall Study|Lost to Follow-up|1
5781899|NCT04574999|19897270|P2|Overall Study|Withdrawal by Subject|2
5781900|NCT04574999|19897271|P1|Overall Study|Withdrawal by Subject|2
5781901|NCT04574999|19897270|P2|Overall Study|Protocol Violation|0
5781902|NCT04574999|19897271|P1|Overall Study|Protocol Violation|1
5781903|NCT04574999|19897270|P2|Overall Study|Lack of Efficacy|3
5781904|NCT04574999|19897271|P1|Overall Study|Lack of Efficacy|2
5781905|NCT04574999|19897270|P2|Overall Study|Adverse Event|0
5781906|NCT04574999|19897271|P1|Overall Study|Adverse Event|1
5781907|NCT04542694|19897327|P2|Overall Study|Protocol Violation|0
5781908|NCT04542694|19897328|P1|Overall Study|Protocol Violation|1
5781909|NCT04542694|19897327|P2|Overall Study|Adverse Event|0
5781910|NCT04542694|19897328|P1|Overall Study|Adverse Event|1
5781911|NCT04542694|19897327|P2|Overall Study|The need for prohibited therapy|0
5781912|NCT04542694|19897328|P1|Overall Study|The need for prohibited therapy|2
5781913|NCT04534491|19897368|P1|Overall Study|Non-verifiable users|58
5781914|NCT04534491|19897368|P1|Overall Study|Non-users|70
5781915|NCT04534491|19897368|P1|Overall Study|Not completed end-of-study interview|24
5781916|NCT04532164|19897463|P1|Overall Study|Withdrawal by Subject|14
5781917|NCT04532164|19897463|P1|Overall Study|Found to be Ineligible|3
5781918|NCT04532164|19897463|P1|Overall Study|Lost to Follow-up|1
5781919|NCT04532164|19897463|P1|Overall Study|Protocol Violation|5
5781920|NCT04532164|19897463|P1|Overall Study|Adverse Event|1
5781921|NCT04531813|19897474|P1|Overall Study|Withdrawal by Subject|1
5781922|NCT04531813|19897474|P1|Overall Study|Protocol Violation|1
5781923|NCT04531540|19897478|P1|Overall Study|Found to be Ineligible|1
5781924|NCT04531540|19897478|P1|Overall Study|Withdrawal by Subject|4
5781925|NCT04531540|19897478|P1|Overall Study|Protocol Violation|3
5781926|NCT04531540|19897478|P1|Overall Study|Adverse Event|1
5781927|NCT04531527|19897485|P1|Overall Study|Found to be Ineligible|3
5781928|NCT04523831|19897492|P2|Overall Study|Adverse Event|0
5781929|NCT04523831|19897493|P1|Overall Study|Adverse Event|2
5781930|NCT04523831|19897492|P2|Overall Study|Death|3
5781931|NCT04523831|19897493|P1|Overall Study|Death|0
5781932|NCT04523831|19897492|P2|Overall Study|Lost to Follow-up|17
5781933|NCT04523831|19897493|P1|Overall Study|Lost to Follow-up|15
5781934|NCT04521777|19897505|P1|Overall Study|Withdrawal by Subject|2
5781935|NCT04521777|19897505|P1|Overall Study|Death|2
5781936|NCT04512482|19897516|P2|Second Intervention (1 Day)|Protocol Violation|1
5781937|NCT04512482|19897517|P1|Second Intervention (1 Day)|Protocol Violation|2
5781938|NCT04502979|19897525|P2|Overall Study|Withdrawal by Subject|1
5781939|NCT04502979|19897526|P1|Overall Study|Withdrawal by Subject|2
5781940|NCT04502979|19897525|P2|Overall Study|Lost to Follow-up|3
5781941|NCT04502979|19897526|P1|Overall Study|Lost to Follow-up|1
5781942|NCT04491994|19897555|P2|Overall Study|Lost to Follow-up|3
5781943|NCT04491994|19897556|P1|Overall Study|Lost to Follow-up|4
5781944|NCT04491994|19897555|P2|Overall Study|Protocol Violation|2
5781945|NCT04491994|19897556|P1|Overall Study|Protocol Violation|11
5781946|NCT04491994|19897555|P2|Overall Study|developed fever > 3 days|1
5781947|NCT04491994|19897556|P1|Overall Study|developed fever > 3 days|4
5781948|NCT04491994|19897555|P2|Overall Study|Withdrawal by Subject|5
5781949|NCT04491994|19897556|P1|Overall Study|Withdrawal by Subject|10
5781950|NCT04483011|19897592|P2|Washout (7 Days)|Withdrawal by Subject|1
5781951|NCT04483011|19897593|P1|Washout (7 Days)|Withdrawal by Subject|0
5781952|NCT04474405|19897627|P6|Overall Study|Other|0
5781953|NCT04474405|19897628|P5|Overall Study|Other|3
5781954|NCT04474405|19897629|P4|Overall Study|Other|0
5781955|NCT04474405|19897630|P3|Overall Study|Other|0
5781956|NCT04474405|19897631|P2|Overall Study|Other|0
5781957|NCT04474405|19897632|P1|Overall Study|Other|0
5781958|NCT04474405|19897627|P6|Overall Study|Withdrawal by Subject|0
5781959|NCT04474405|19897628|P5|Overall Study|Withdrawal by Subject|1
5781960|NCT04474405|19897629|P4|Overall Study|Withdrawal by Subject|0
5781961|NCT04474405|19897630|P3|Overall Study|Withdrawal by Subject|1
5781962|NCT04474405|19897631|P2|Overall Study|Withdrawal by Subject|0
5781963|NCT04474405|19897632|P1|Overall Study|Withdrawal by Subject|0
5781964|NCT04468347|19897659|P4|Overall Study|Protocol Violation|0
5781965|NCT04468347|19897660|P3|Overall Study|Protocol Violation|0
5781966|NCT04468347|19897661|P2|Overall Study|Protocol Violation|0
5781967|NCT04468347|19897662|P1|Overall Study|Protocol Violation|1
5781968|NCT04468347|19897659|P4|Overall Study|Physician Decision|0
5781969|NCT04468347|19897660|P3|Overall Study|Physician Decision|2
5781970|NCT04468347|19897661|P2|Overall Study|Physician Decision|0
5781971|NCT04468347|19897662|P1|Overall Study|Physician Decision|1
5781972|NCT04468347|19897659|P4|Overall Study|Lost to Follow-up|1
5781973|NCT04468347|19897660|P3|Overall Study|Lost to Follow-up|1
5781974|NCT04468347|19897661|P2|Overall Study|Lost to Follow-up|0
5781975|NCT04468347|19897662|P1|Overall Study|Lost to Follow-up|0
5781976|NCT04468347|19897659|P4|Overall Study|Withdrawal by Subject|3
5781977|NCT04468347|19897660|P3|Overall Study|Withdrawal by Subject|3
5781978|NCT04468347|19897661|P2|Overall Study|Withdrawal by Subject|1
5781979|NCT04468347|19897662|P1|Overall Study|Withdrawal by Subject|0
5781982|NCT04435808|19897789|P2|Overall Study|Study stopped by DSMB|1
5781983|NCT04435808|19897790|P1|Overall Study|Study stopped by DSMB|0
5781984|NCT04425863|19897799|P3|Overall Study|Death|1
5781985|NCT04425863|19897800|P2|Overall Study|Death|0
5781986|NCT04425863|19897801|P1|Overall Study|Death|0
5781987|NCT04422561|19897834|P2|Overall Study|Lost to Follow-up|11
5781988|NCT04422561|19897835|P1|Overall Study|Lost to Follow-up|25
5781989|NCT04406194|19897876|P2|Period 1|Withdrawal by Subject|1
5781990|NCT04406194|19897877|P1|Period 1|Withdrawal by Subject|0
5781991|NCT04403399|19897900|P2|Period 2|Physician Decision|1
5781992|NCT04403399|19897901|P1|Period 2|Physician Decision|0
5781993|NCT04400682|19897934|P2|Period 1|Withdrawal by Subject|4
5781994|NCT04400682|19897935|P1|Period 1|Withdrawal by Subject|1
5781995|NCT04399161|19897950|P3|Overall Study|Protocol Violation|0
5781996|NCT04399161|19897951|P2|Overall Study|Protocol Violation|2
5781997|NCT04399161|19897952|P1|Overall Study|Protocol Violation|1
5781998|NCT04399161|19897950|P3|Overall Study|Withdrawal by Subject|2
5781999|NCT04399161|19897951|P2|Overall Study|Withdrawal by Subject|0
5782000|NCT04399161|19897952|P1|Overall Study|Withdrawal by Subject|1
5782001|NCT04393493|19897973|P2|First 4 Days of Intervention|Early improvement|7
5782002|NCT04393493|19897974|P1|First 4 Days of Intervention|Early improvement|5
5782003|NCT04376060|19898075|P1|Overall Study|Physician Decision|1
5782005|NCT04359771|19898143|P2|Overall Study|Lack of Efficacy|2
5782006|NCT04359771|19898144|P1|Overall Study|Lack of Efficacy|2
5782007|NCT04355663|19898159|P3|Overall Study|Withdrawal by Subject|3
5782008|NCT04355663|19898160|P2|Overall Study|Withdrawal by Subject|8
5782009|NCT04355663|19898161|P1|Overall Study|Withdrawal by Subject|0
5782010|NCT04355663|19898159|P3|Overall Study|Adverse Event|1
5782011|NCT04355663|19898160|P2|Overall Study|Adverse Event|0
5782012|NCT04355663|19898161|P1|Overall Study|Adverse Event|0
5782013|NCT04355663|19898159|P3|Overall Study|Physician Decision|0
5782014|NCT04355663|19898160|P2|Overall Study|Physician Decision|7
5782015|NCT04355663|19898161|P1|Overall Study|Physician Decision|2
5782016|NCT04350788|19898204|P2|Overall Study|Protocol Violation|0
5782017|NCT04350788|19898205|P1|Overall Study|Protocol Violation|4
5782018|NCT04350788|19898204|P2|Overall Study|Withdrawal by Subject|4
5782019|NCT04350788|19898205|P1|Overall Study|Withdrawal by Subject|2
5782020|NCT04350788|19898204|P2|Overall Study|Lost to Follow-up|2
5782021|NCT04350788|19898205|P1|Overall Study|Lost to Follow-up|6
5782022|NCT04349917|19898259|P2|First Intervention (2-4 Hours)|Unable to Swallow Pill|1
5782023|NCT04349917|19898260|P1|First Intervention (2-4 Hours)|Unable to Swallow Pill|0
5782024|NCT04349917|19898259|P2|First Intervention (2-4 Hours)|Withdrawal by Subject|1
5782025|NCT04349917|19898260|P1|First Intervention (2-4 Hours)|Withdrawal by Subject|0
5782026|NCT04348851|19898281|P4|Post-Test 2|Stroke survivor death|1
5782027|NCT04348851|19898282|P3|Post-Test 2|Stroke survivor death|0
5782028|NCT04348851|19898283|P2|Post-Test 2|Stroke survivor death|1
5782029|NCT04348851|19898284|P1|Post-Test 2|Stroke survivor death|0
5782030|NCT04348851|19898281|P4|Post-Test 1|Lost to Follow-up|0
5782031|NCT04348851|19898282|P3|Post-Test 1|Lost to Follow-up|0
5782032|NCT04348851|19898283|P2|Post-Test 1|Lost to Follow-up|1
5782033|NCT04348851|19898284|P1|Post-Test 1|Lost to Follow-up|0
5782034|NCT04348851|19898281|P4|Post-Test 1|Withdrawal by Subject|0
5782035|NCT04348851|19898282|P3|Post-Test 1|Withdrawal by Subject|0
5782036|NCT04348851|19898283|P2|Post-Test 1|Withdrawal by Subject|1
5782037|NCT04348851|19898284|P1|Post-Test 1|Withdrawal by Subject|0
5782038|NCT04343261|19898391|P1|Overall Study|received inadequate amount of antibodies|7
5782039|NCT04343261|19898391|P1|Overall Study|Adverse Event|1
5782040|NCT04339296|19898432|P2|Overall Study|Discontinued intervention|3
5782041|NCT04339296|19898433|P1|Overall Study|Discontinued intervention|5
5782042|NCT04339296|19898432|P2|Overall Study|Lost to Follow-up|4
5782043|NCT04339296|19898433|P1|Overall Study|Lost to Follow-up|0
5782044|NCT04339296|19898432|P2|Overall Study|Withdrew after completion of baseline|1
5782045|NCT04339296|19898433|P1|Overall Study|Withdrew after completion of baseline|2
5782046|NCT04339296|19898432|P2|Overall Study|Refuse to participate after allocation|1
5782047|NCT04339296|19898433|P1|Overall Study|Refuse to participate after allocation|1
5782048|NCT04336475|19898443|P2|Overall Study|Lost to Follow-up|2
5782049|NCT04336475|19898444|P1|Overall Study|Lost to Follow-up|0
5782050|NCT04336475|19898443|P2|Overall Study|upper respiratory infection|0
5782051|NCT04336475|19898444|P1|Overall Study|upper respiratory infection|1
5782052|NCT04336475|19898443|P2|Overall Study|pain|0
5782053|NCT04336475|19898444|P1|Overall Study|pain|1
5782054|NCT04329923|19898465|P6|Overall Study|positive SARS-COV2 PCR at baseline|2
5782136|NCT04292899|19899174|P4|Overall Study|Investigator's Discretion|3
5782055|NCT04329923|19898466|P5|Overall Study|positive SARS-COV2 PCR at baseline|0
5782056|NCT04329923|19898467|P4|Overall Study|positive SARS-COV2 PCR at baseline|0
5782057|NCT04329923|19898468|P3|Overall Study|positive SARS-COV2 PCR at baseline|0
5782058|NCT04329923|19898469|P2|Overall Study|positive SARS-COV2 PCR at baseline|0
5782059|NCT04329923|19898470|P1|Overall Study|positive SARS-COV2 PCR at baseline|0
5782060|NCT04329923|19898465|P6|Overall Study|early termination of study|2
5782061|NCT04329923|19898466|P5|Overall Study|early termination of study|1
5782062|NCT04329923|19898467|P4|Overall Study|early termination of study|0
5782063|NCT04329923|19898468|P3|Overall Study|early termination of study|0
5782064|NCT04329923|19898469|P2|Overall Study|early termination of study|0
5782065|NCT04329923|19898470|P1|Overall Study|early termination of study|0
5782066|NCT04329923|19898465|P6|Overall Study|Withdrawal by Subject|1
5782067|NCT04329923|19898466|P5|Overall Study|Withdrawal by Subject|1
5782068|NCT04329923|19898467|P4|Overall Study|Withdrawal by Subject|1
5782069|NCT04329923|19898468|P3|Overall Study|Withdrawal by Subject|1
5782070|NCT04329923|19898469|P2|Overall Study|Withdrawal by Subject|4
5782071|NCT04329923|19898470|P1|Overall Study|Withdrawal by Subject|1
5782075|NCT04322526|19898587|P2|Washout (1 Week)|Lost to Follow-up|2
5782076|NCT04322526|19898588|P1|Washout (1 Week)|Lost to Follow-up|1
5782077|NCT04322526|19898587|P2|First Intervention (1 Day)|Withdrawal by Subject|1
5782078|NCT04322526|19898588|P1|First Intervention (1 Day)|Withdrawal by Subject|1
5782079|NCT04032613|19898607|P2|Overall Study|Did not complete post-program assessment|2
5782080|NCT04032613|19898608|P1|Overall Study|Did not complete post-program assessment|5
5782081|NCT04025684|19898620|P4|Overall Study|Multiple reasons|1
5782082|NCT04025684|19898621|P3|Overall Study|Multiple reasons|0
5782083|NCT04025684|19898622|P2|Overall Study|Multiple reasons|3
5782084|NCT04025684|19898623|P1|Overall Study|Multiple reasons|1
5782085|NCT04025684|19898620|P4|Overall Study|Withdrawal by Subject|0
5782086|NCT04025684|19898621|P3|Overall Study|Withdrawal by Subject|0
5782087|NCT04025684|19898622|P2|Overall Study|Withdrawal by Subject|1
5782088|NCT04025684|19898623|P1|Overall Study|Withdrawal by Subject|1
5782089|NCT04318535|19898697|P3|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|0
5782090|NCT04318535|19898698|P2|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|1
5782091|NCT04318535|19898699|P1|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|0
5782092|NCT04308239|19898883|P2|Post-intervention Evaluation (1 Week)|testing error during evaluation|2
5782093|NCT04308239|19898884|P1|Post-intervention Evaluation (1 Week)|testing error during evaluation|0
5782094|NCT04308239|19898883|P2|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|2
5782095|NCT04308239|19898884|P1|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|1
5782096|NCT04308239|19898883|P2|Pre-intervention Evaluation (1 Week)|testing error during evaluation|2
5782097|NCT04308239|19898884|P1|Pre-intervention Evaluation (1 Week)|testing error during evaluation|1
5782098|NCT04308239|19898883|P2|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|1
5782099|NCT04308239|19898884|P1|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|2
5782100|NCT03615404|19898962|P1|Overall Study|vaccine did not pass quality assurance|1
5782101|NCT03615404|19898962|P1|Overall Study|Death|1
5782104|NCT04295356|19899068|P2|Overall Study|Protocol Violation|1
5782105|NCT04295356|19899069|P1|Overall Study|Protocol Violation|0
5782106|NCT04295356|19899068|P2|Overall Study|Lost to Follow-up|3
5782107|NCT04295356|19899069|P1|Overall Study|Lost to Follow-up|0
5782108|NCT04295356|19899068|P2|Overall Study|Physician Decision|0
5782109|NCT04295356|19899069|P1|Overall Study|Physician Decision|1
5782110|NCT03466099|19899159|P3|Overall Study|Worsening disease|1
5782111|NCT03466099|19899160|P2|Overall Study|Worsening disease|0
5782112|NCT03466099|19899161|P1|Overall Study|Worsening disease|0
5782113|NCT03466099|19899159|P3|Overall Study|Subject compliance|0
5782114|NCT03466099|19899160|P2|Overall Study|Subject compliance|0
5782115|NCT03466099|19899161|P1|Overall Study|Subject compliance|2
5782116|NCT03466099|19899159|P3|Overall Study|Rescued without meeting criteria|1
5782117|NCT03466099|19899160|P2|Overall Study|Rescued without meeting criteria|1
5782118|NCT03466099|19899161|P1|Overall Study|Rescued without meeting criteria|4
5782119|NCT03466099|19899159|P3|Overall Study|Use of rescue medication|13
5782120|NCT03466099|19899160|P2|Overall Study|Use of rescue medication|9
5782121|NCT03466099|19899161|P1|Overall Study|Use of rescue medication|8
5782122|NCT03466099|19899159|P3|Overall Study|Withdrawal by Subject|1
5782123|NCT03466099|19899160|P2|Overall Study|Withdrawal by Subject|3
5782124|NCT03466099|19899161|P1|Overall Study|Withdrawal by Subject|2
5782125|NCT03466099|19899159|P3|Overall Study|Adverse Event|1
5782126|NCT03466099|19899160|P2|Overall Study|Adverse Event|1
5782127|NCT03466099|19899161|P1|Overall Study|Adverse Event|1
5782128|NCT04292899|19899174|P4|Overall Study|Protocol Violation|1
5782129|NCT04292899|19899175|P3|Overall Study|Protocol Violation|0
5782130|NCT04292899|19899176|P2|Overall Study|Protocol Violation|0
5782131|NCT04292899|19899177|P1|Overall Study|Protocol Violation|0
5782132|NCT04292899|19899174|P4|Overall Study|Non-compliance With Study Drug|1
5782133|NCT04292899|19899175|P3|Overall Study|Non-compliance With Study Drug|0
5782134|NCT04292899|19899176|P2|Overall Study|Non-compliance With Study Drug|0
5782135|NCT04292899|19899177|P1|Overall Study|Non-compliance With Study Drug|0
5782137|NCT04292899|19899175|P3|Overall Study|Investigator's Discretion|0
5782138|NCT04292899|19899176|P2|Overall Study|Investigator's Discretion|0
5782139|NCT04292899|19899177|P1|Overall Study|Investigator's Discretion|0
5782140|NCT04292899|19899174|P4|Overall Study|Adverse Event|2
5782141|NCT04292899|19899175|P3|Overall Study|Adverse Event|2
5782142|NCT04292899|19899176|P2|Overall Study|Adverse Event|1
5782143|NCT04292899|19899177|P1|Overall Study|Adverse Event|2
5782144|NCT04292899|19899174|P4|Overall Study|Withdrew consent|32
5782145|NCT04292899|19899175|P3|Overall Study|Withdrew consent|11
5782146|NCT04292899|19899176|P2|Overall Study|Withdrew consent|0
5782147|NCT04292899|19899177|P1|Overall Study|Withdrew consent|1
5782148|NCT04292899|19899174|P4|Overall Study|Lost to Follow-up|235
5782149|NCT04292899|19899175|P3|Overall Study|Lost to Follow-up|22
5782150|NCT04292899|19899176|P2|Overall Study|Lost to Follow-up|4
5782151|NCT04292899|19899177|P1|Overall Study|Lost to Follow-up|8
5782152|NCT04292899|19899174|P4|Overall Study|Death|371
5782153|NCT04292899|19899175|P3|Overall Study|Death|188
5782154|NCT04292899|19899176|P2|Overall Study|Death|28
5782155|NCT04292899|19899177|P1|Overall Study|Death|21
5782156|NCT04292730|19899191|P4|Overall Study|Randomized but not Treated|14
5782157|NCT04292730|19899192|P3|Overall Study|Randomized but not Treated|0
5782158|NCT04292730|19899193|P2|Overall Study|Randomized but not Treated|4
5782159|NCT04292730|19899194|P1|Overall Study|Randomized but not Treated|8
5782160|NCT04292730|19899191|P4|Overall Study|Protocol Violation|0
5782161|NCT04292730|19899192|P3|Overall Study|Protocol Violation|1
5782162|NCT04292730|19899193|P2|Overall Study|Protocol Violation|0
5782163|NCT04292730|19899194|P1|Overall Study|Protocol Violation|0
5782164|NCT04292730|19899191|P4|Overall Study|Non-Compliance with Study Drug|0
5782165|NCT04292730|19899192|P3|Overall Study|Non-Compliance with Study Drug|0
5782166|NCT04292730|19899193|P2|Overall Study|Non-Compliance with Study Drug|1
5782167|NCT04292730|19899194|P1|Overall Study|Non-Compliance with Study Drug|0
5782168|NCT04292730|19899191|P4|Overall Study|Withdrew Consent|6
5782169|NCT04292730|19899192|P3|Overall Study|Withdrew Consent|5
5782170|NCT04292730|19899193|P2|Overall Study|Withdrew Consent|2
5782171|NCT04292730|19899194|P1|Overall Study|Withdrew Consent|2
5782172|NCT04292730|19899191|P4|Overall Study|Death|12
5782173|NCT04292730|19899192|P3|Overall Study|Death|4
5782174|NCT04292730|19899193|P2|Overall Study|Death|2
5782175|NCT04292730|19899194|P1|Overall Study|Death|2
5782176|NCT04292730|19899191|P4|Overall Study|Lost to Follow-up|48
5782177|NCT04292730|19899192|P3|Overall Study|Lost to Follow-up|12
5782178|NCT04292730|19899193|P2|Overall Study|Lost to Follow-up|12
5782179|NCT04292730|19899194|P1|Overall Study|Lost to Follow-up|8
5782180|NCT04292171|19899220|P2|Overall Study|Delivered prior to procedure|1
5782181|NCT04292171|19899221|P1|Overall Study|Delivered prior to procedure|0
5782182|NCT04292171|19899220|P2|Overall Study|Pharmacy error|0
5782183|NCT04292171|19899221|P1|Overall Study|Pharmacy error|2
5782184|NCT03417141|19899235|P1|Overall Study|Protocol Violation|3
5782185|NCT03417141|19899235|P1|Overall Study|Withdrawal by Subject|1
5782190|NCT03357952|19899311|P2|Overall Study|Sponsor Decision|0
5782191|NCT03357952|19899312|P1|Overall Study|Sponsor Decision|9
5782192|NCT03357952|19899311|P2|Overall Study|Withdrawal by Subject|1
5782193|NCT03357952|19899312|P1|Overall Study|Withdrawal by Subject|0
5782194|NCT03346070|19899343|P5|Overall Study|Screen Failure|1
5782195|NCT03346070|19899344|P4|Overall Study|Screen Failure|1
5782196|NCT03346070|19899345|P3|Overall Study|Screen Failure|0
5782197|NCT03346070|19899346|P2|Overall Study|Screen Failure|0
5782198|NCT03346070|19899347|P1|Overall Study|Screen Failure|0
5782199|NCT03346070|19899343|P5|Overall Study|Study medication not received as planned|2
5782200|NCT03346070|19899344|P4|Overall Study|Study medication not received as planned|3
5782201|NCT03346070|19899345|P3|Overall Study|Study medication not received as planned|2
5782202|NCT03346070|19899346|P2|Overall Study|Study medication not received as planned|3
5782203|NCT03346070|19899347|P1|Overall Study|Study medication not received as planned|2
5782204|NCT03346070|19899343|P5|Overall Study|Withdrawal by Subject|0
5782205|NCT03346070|19899344|P4|Overall Study|Withdrawal by Subject|1
5782206|NCT03346070|19899345|P3|Overall Study|Withdrawal by Subject|0
5782207|NCT03346070|19899346|P2|Overall Study|Withdrawal by Subject|0
5782208|NCT03346070|19899347|P1|Overall Study|Withdrawal by Subject|1
5782209|NCT03346070|19899343|P5|Overall Study|Physician Decision|1
5782210|NCT03346070|19899344|P4|Overall Study|Physician Decision|1
5782211|NCT03346070|19899345|P3|Overall Study|Physician Decision|0
5782212|NCT03346070|19899346|P2|Overall Study|Physician Decision|0
5782213|NCT03346070|19899347|P1|Overall Study|Physician Decision|0
5782214|NCT03346070|19899343|P5|Overall Study|Lost to Follow-up|0
5782215|NCT03346070|19899344|P4|Overall Study|Lost to Follow-up|0
5782216|NCT03346070|19899345|P3|Overall Study|Lost to Follow-up|2
5782217|NCT03346070|19899346|P2|Overall Study|Lost to Follow-up|1
5782218|NCT03346070|19899347|P1|Overall Study|Lost to Follow-up|0
5782219|NCT03346070|19899343|P5|Overall Study|Death|1
5782220|NCT03346070|19899344|P4|Overall Study|Death|0
5782221|NCT03346070|19899345|P3|Overall Study|Death|0
5782222|NCT03346070|19899346|P2|Overall Study|Death|0
5782223|NCT03346070|19899347|P1|Overall Study|Death|0
5782228|NCT03287635|19899456|P1|Overall Study|Physician Decision|1
5782229|NCT03287635|19899456|P1|Overall Study|Withdrawal by Subject|1
5782230|NCT03287635|19899456|P1|Overall Study|Lost to Follow-up|5
5782231|NCT03287219|19899464|P2|Overall Study|Protocol Violation|2
5782232|NCT03287219|19899465|P1|Overall Study|Protocol Violation|0
5782233|NCT04287517|19899539|P2|Overall Study|Withdrawal by Subject|1
5782234|NCT04287517|19899540|P1|Overall Study|Withdrawal by Subject|1
5782236|NCT03198715|19899634|P5|Overall Study|Other|0
5782237|NCT03198715|19899635|P4|Overall Study|Other|0
5782238|NCT03198715|19899636|P3|Overall Study|Other|1
5782239|NCT03198715|19899637|P2|Overall Study|Other|1
5782240|NCT03198715|19899638|P1|Overall Study|Other|0
5782241|NCT03198715|19899634|P5|Overall Study|Death|2
5782242|NCT03198715|19899635|P4|Overall Study|Death|0
5782243|NCT03198715|19899636|P3|Overall Study|Death|1
5782244|NCT03198715|19899637|P2|Overall Study|Death|0
5782245|NCT03198715|19899638|P1|Overall Study|Death|0
5782291|NCT04280705|19899871|P2|Overall Study|Transferred to another hospital|1
5782317|NCT02798211|19900142|P6|Period 2|Withdrawal of Informed Consent|3
5782318|NCT02798211|19900143|P5|Period 2|Withdrawal of Informed Consent|2
5782319|NCT02798211|19900144|P4|Period 2|Withdrawal of Informed Consent|2
5782320|NCT02798211|19900145|P3|Period 2|Withdrawal of Informed Consent|0
5782321|NCT02798211|19900146|P2|Period 2|Withdrawal of Informed Consent|0
5782322|NCT02798211|19900147|P1|Period 2|Withdrawal of Informed Consent|1
5782323|NCT02798211|19900142|P6|Period 2|Technical problems|0
5782324|NCT02798211|19900143|P5|Period 2|Technical problems|0
5782325|NCT02798211|19900144|P4|Period 2|Technical problems|1
5782326|NCT02798211|19900145|P3|Period 2|Technical problems|0
5782327|NCT02798211|19900146|P2|Period 2|Technical problems|0
5782328|NCT02798211|19900147|P1|Period 2|Technical problems|1
5782329|NCT02798211|19900142|P6|Period 2|Pregnancy|0
5782330|NCT02798211|19900143|P5|Period 2|Pregnancy|0
5782331|NCT02798211|19900144|P4|Period 2|Pregnancy|2
5782332|NCT02798211|19900145|P3|Period 2|Pregnancy|0
5782333|NCT02798211|19900146|P2|Period 2|Pregnancy|0
5782334|NCT02798211|19900147|P1|Period 2|Pregnancy|0
5782335|NCT02798211|19900142|P6|Period 2|Physician Decision|0
5782336|NCT02798211|19900143|P5|Period 2|Physician Decision|1
5782337|NCT02798211|19900144|P4|Period 2|Physician Decision|1
5782338|NCT02798211|19900145|P3|Period 2|Physician Decision|0
5782339|NCT02798211|19900146|P2|Period 2|Physician Decision|0
5782340|NCT02798211|19900147|P1|Period 2|Physician Decision|1
5782341|NCT02798211|19900142|P6|Period 2|Lost to Follow-up|0
5782342|NCT02798211|19900143|P5|Period 2|Lost to Follow-up|2
5782343|NCT02798211|19900144|P4|Period 2|Lost to Follow-up|0
5782344|NCT02798211|19900145|P3|Period 2|Lost to Follow-up|0
5782345|NCT02798211|19900146|P2|Period 2|Lost to Follow-up|0
5782346|NCT02798211|19900147|P1|Period 2|Lost to Follow-up|3
5782347|NCT02798211|19900142|P6|Period 2|Lack of Efficacy|1
5782348|NCT02798211|19900143|P5|Period 2|Lack of Efficacy|0
5782349|NCT02798211|19900144|P4|Period 2|Lack of Efficacy|1
5782350|NCT02798211|19900145|P3|Period 2|Lack of Efficacy|0
5782351|NCT02798211|19900146|P2|Period 2|Lack of Efficacy|0
5782352|NCT02798211|19900147|P1|Period 2|Lack of Efficacy|1
5782353|NCT02798211|19900142|P6|Period 2|Adverse Event|0
5782354|NCT02798211|19900143|P5|Period 2|Adverse Event|1
5782355|NCT02798211|19900144|P4|Period 2|Adverse Event|0
5782356|NCT02798211|19900145|P3|Period 2|Adverse Event|0
5782357|NCT02798211|19900146|P2|Period 2|Adverse Event|0
5782358|NCT02798211|19900147|P1|Period 2|Adverse Event|5
5782292|NCT04280705|19899872|P1|Overall Study|Transferred to another hospital|1
5782293|NCT04280705|19899871|P2|Overall Study|Adverse Event|4
5782294|NCT04280705|19899872|P1|Overall Study|Adverse Event|0
5782295|NCT04280705|19899871|P2|Overall Study|Withdrawal by Subject|9
5782296|NCT04280705|19899872|P1|Overall Study|Withdrawal by Subject|7
5782297|NCT04280705|19899871|P2|Overall Study|Physician Decision|0
5782298|NCT04280705|19899872|P1|Overall Study|Physician Decision|1
5782299|NCT04280705|19899871|P2|Overall Study|Enrolled but not treated|10
5782300|NCT04280705|19899872|P1|Overall Study|Enrolled but not treated|4
5782415|NCT04272775|19900341|P2|Overall Study|Progressive Disease|1
5782416|NCT04272775|19900342|P1|Overall Study|Progressive Disease|3
5782417|NCT04272775|19900341|P2|Overall Study|Adverse Event|2
5782418|NCT04272775|19900342|P1|Overall Study|Adverse Event|1
5782419|NCT04272775|19900341|P2|Overall Study|Withdrawal by Subject|2
5782420|NCT04272775|19900342|P1|Overall Study|Withdrawal by Subject|1
5782421|NCT04272775|19900341|P2|Overall Study|Symptomatic Deterioration|1
5782422|NCT04272775|19900342|P1|Overall Study|Symptomatic Deterioration|1
5782423|NCT04272775|19900341|P2|Overall Study|Protocol Violation|1
5782424|NCT04272775|19900342|P1|Overall Study|Protocol Violation|0
5782425|NCT04272775|19900341|P2|Overall Study|Study Terminated by Sponsor|0
5782426|NCT04272775|19900342|P1|Overall Study|Study Terminated by Sponsor|1
5782359|NCT02798211|19900142|P6|Period 2|Withdrawal by Subject|2
5782360|NCT02798211|19900143|P5|Period 2|Withdrawal by Subject|2
5782361|NCT02798211|19900144|P4|Period 2|Withdrawal by Subject|0
5782362|NCT02798211|19900145|P3|Period 2|Withdrawal by Subject|0
5782363|NCT02798211|19900146|P2|Period 2|Withdrawal by Subject|0
5782364|NCT02798211|19900147|P1|Period 2|Withdrawal by Subject|2
5782365|NCT02798211|19900142|P6|Period 1|Withdrawal of Informed Consent|0
5782366|NCT02798211|19900143|P5|Period 1|Withdrawal of Informed Consent|0
5782367|NCT02798211|19900144|P4|Period 1|Withdrawal of Informed Consent|0
5782368|NCT02798211|19900145|P3|Period 1|Withdrawal of Informed Consent|3
5782369|NCT02798211|19900146|P2|Period 1|Withdrawal of Informed Consent|7
5782370|NCT02798211|19900147|P1|Period 1|Withdrawal of Informed Consent|2
5782371|NCT02798211|19900142|P6|Period 1|Death|0
5782372|NCT02798211|19900143|P5|Period 1|Death|0
5782373|NCT02798211|19900144|P4|Period 1|Death|0
5782374|NCT02798211|19900145|P3|Period 1|Death|1
5782375|NCT02798211|19900146|P2|Period 1|Death|0
5782376|NCT02798211|19900147|P1|Period 1|Death|0
5782377|NCT02798211|19900142|P6|Period 1|Withdrawal by Subject|0
5782378|NCT02798211|19900143|P5|Period 1|Withdrawal by Subject|0
5782379|NCT02798211|19900144|P4|Period 1|Withdrawal by Subject|0
5782380|NCT02798211|19900145|P3|Period 1|Withdrawal by Subject|0
5782381|NCT02798211|19900146|P2|Period 1|Withdrawal by Subject|1
5782382|NCT02798211|19900147|P1|Period 1|Withdrawal by Subject|1
5782383|NCT02798211|19900142|P6|Period 1|Protocol Violation|0
5782384|NCT02798211|19900143|P5|Period 1|Protocol Violation|0
5782385|NCT02798211|19900144|P4|Period 1|Protocol Violation|0
5782386|NCT02798211|19900145|P3|Period 1|Protocol Violation|2
5782387|NCT02798211|19900146|P2|Period 1|Protocol Violation|0
5782388|NCT02798211|19900147|P1|Period 1|Protocol Violation|0
5782389|NCT02798211|19900142|P6|Period 1|Lost to Follow-up|0
5782390|NCT02798211|19900143|P5|Period 1|Lost to Follow-up|0
5782391|NCT02798211|19900144|P4|Period 1|Lost to Follow-up|0
5782392|NCT02798211|19900145|P3|Period 1|Lost to Follow-up|0
5782393|NCT02798211|19900146|P2|Period 1|Lost to Follow-up|1
5782394|NCT02798211|19900147|P1|Period 1|Lost to Follow-up|2
5782395|NCT02798211|19900142|P6|Period 1|Adverse Event|0
5782396|NCT02798211|19900143|P5|Period 1|Adverse Event|0
5782397|NCT02798211|19900144|P4|Period 1|Adverse Event|0
5782398|NCT02798211|19900145|P3|Period 1|Adverse Event|0
5782399|NCT02798211|19900146|P2|Period 1|Adverse Event|1
5782400|NCT02798211|19900147|P1|Period 1|Adverse Event|1
5782401|NCT02730793|19900264|P2|Overall Study|Withdrawal by Subject|1
5782402|NCT02730793|19900265|P1|Overall Study|Withdrawal by Subject|0
5782403|NCT02730793|19900264|P2|Overall Study|Physician Decision|1
5782404|NCT02730793|19900265|P1|Overall Study|Physician Decision|0
5782405|NCT02721355|19900316|P2|Overall Study|Lost to Follow-up|1
5782406|NCT02721355|19900317|P1|Overall Study|Lost to Follow-up|6
5782472|NCT02617628|19900531|P2|Overall Study|Withdr, Transfers-other prisons, dropout|61
5782473|NCT02617628|19900532|P1|Overall Study|Withdr, Transfers-other prisons, dropout|62
5782474|NCT02476916|19900580|P2|Extension Period|On Treatment|17
5782475|NCT02476916|19900581|P1|Extension Period|On Treatment|12
5782476|NCT02476916|19900580|P2|Extension Period|Prematurely Discontinued Treatment|1
5782477|NCT02476916|19900581|P1|Extension Period|Prematurely Discontinued Treatment|6
5782478|NCT02476916|19900580|P2|Core Period|Withdrawal by Subject|0
5782479|NCT02476916|19900581|P1|Core Period|Withdrawal by Subject|3
5782480|NCT02476916|19900580|P2|Core Period|Investigator decision|1
5782481|NCT02476916|19900581|P1|Core Period|Investigator decision|1
5782482|NCT02476916|19900580|P2|Core Period|Adverse Event|2
5782483|NCT02476916|19900581|P1|Core Period|Adverse Event|2
5782484|NCT02371369|19900654|P2|Part 2|Death|1
5782485|NCT02371369|19900655|P1|Part 2|Death|0
5782486|NCT02371369|19900654|P2|Part 2|Physician Decision|0
5782487|NCT02371369|19900655|P1|Part 2|Physician Decision|1
5782488|NCT02371369|19900654|P2|Part 2|Withdrawal by Subject|1
5782489|NCT02371369|19900655|P1|Part 2|Withdrawal by Subject|5
5782490|NCT02371369|19900654|P2|Part 2|Adverse Event|2
5782491|NCT02371369|19900655|P1|Part 2|Adverse Event|3
5782492|NCT02371369|19900654|P2|Part 1|Protocol Violation|1
5782493|NCT02371369|19900655|P1|Part 1|Protocol Violation|0
5782494|NCT02371369|19900654|P2|Part 1|Disease progression|1
5782495|NCT02371369|19900655|P1|Part 1|Disease progression|0
5782496|NCT02371369|19900654|P2|Part 1|Withdrawal by Subject|6
5782497|NCT02371369|19900655|P1|Part 1|Withdrawal by Subject|1
5782498|NCT02371369|19900654|P2|Part 1|Adverse Event|0
5782499|NCT02371369|19900655|P1|Part 1|Adverse Event|8
5782500|NCT02371369|19900654|P2|Part 1|Physician Decision|3
5782501|NCT02371369|19900655|P1|Part 1|Physician Decision|0
5782502|NCT02357979|19900711|P2|Overall Study|Lost to Follow-up|5
5782503|NCT02357979|19900712|P1|Overall Study|Lost to Follow-up|5
5782516|NCT02213380|19900928|P2|Per-protocol Analysis|Protocol Violation|36
5782517|NCT02213380|19900929|P1|Per-protocol Analysis|Protocol Violation|32
5782518|NCT02213380|19900928|P2|Underwent Randomization|Not treated|3
5782519|NCT02213380|19900929|P1|Underwent Randomization|Not treated|3
5782520|NCT02213380|19900928|P2|Underwent Randomization|Withdrawal by Subject|0
5782521|NCT02213380|19900929|P1|Underwent Randomization|Withdrawal by Subject|2
5782522|NCT02180867|19900958|P7|Overall Study|Refusal of further protocol therapy|0
5782523|NCT02180867|19900959|P6|Overall Study|Refusal of further protocol therapy|0
5782524|NCT02180867|19900960|P5|Overall Study|Refusal of further protocol therapy|4
5782525|NCT02180867|19900961|P4|Overall Study|Refusal of further protocol therapy|6
5782526|NCT02180867|19900962|P3|Overall Study|Refusal of further protocol therapy|2
5782527|NCT02180867|19900963|P2|Overall Study|Refusal of further protocol therapy|0
5782528|NCT02180867|19900964|P1|Overall Study|Refusal of further protocol therapy|1
5782529|NCT02180867|19900958|P7|Overall Study|Repeat Eligibility Studies|0
5782530|NCT02180867|19900959|P6|Overall Study|Repeat Eligibility Studies|0
5782531|NCT02180867|19900960|P5|Overall Study|Repeat Eligibility Studies|1
5782532|NCT02180867|19900961|P4|Overall Study|Repeat Eligibility Studies|0
5782533|NCT02180867|19900962|P3|Overall Study|Repeat Eligibility Studies|0
5782534|NCT02180867|19900963|P2|Overall Study|Repeat Eligibility Studies|0
5782535|NCT02180867|19900964|P1|Overall Study|Repeat Eligibility Studies|0
5782536|NCT02180867|19900958|P7|Overall Study|Ineligible|0
5782537|NCT02180867|19900959|P6|Overall Study|Ineligible|0
5782538|NCT02180867|19900960|P5|Overall Study|Ineligible|5
5782539|NCT02180867|19900961|P4|Overall Study|Ineligible|3
5782540|NCT02180867|19900962|P3|Overall Study|Ineligible|0
5782541|NCT02180867|19900963|P2|Overall Study|Ineligible|2
5782542|NCT02180867|19900964|P1|Overall Study|Ineligible|1
5782543|NCT02180867|19900958|P7|Overall Study|Withdrawal by Subject|0
5782544|NCT02180867|19900959|P6|Overall Study|Withdrawal by Subject|0
5782545|NCT02180867|19900960|P5|Overall Study|Withdrawal by Subject|1
5782546|NCT02180867|19900961|P4|Overall Study|Withdrawal by Subject|1
5782547|NCT02180867|19900962|P3|Overall Study|Withdrawal by Subject|0
5782548|NCT02180867|19900963|P2|Overall Study|Withdrawal by Subject|0
5782549|NCT02180867|19900964|P1|Overall Study|Withdrawal by Subject|0
5782550|NCT02180867|19900958|P7|Overall Study|Physician Decision|4
5782551|NCT02180867|19900959|P6|Overall Study|Physician Decision|3
5782552|NCT02180867|19900960|P5|Overall Study|Physician Decision|9
5782553|NCT02180867|19900961|P4|Overall Study|Physician Decision|10
5782554|NCT02180867|19900962|P3|Overall Study|Physician Decision|1
5782555|NCT02180867|19900963|P2|Overall Study|Physician Decision|3
5782556|NCT02180867|19900964|P1|Overall Study|Physician Decision|1
5782557|NCT02180867|19900958|P7|Overall Study|Lack of Efficacy|1
5782558|NCT02180867|19900959|P6|Overall Study|Lack of Efficacy|0
5782559|NCT02180867|19900960|P5|Overall Study|Lack of Efficacy|6
5782560|NCT02180867|19900961|P4|Overall Study|Lack of Efficacy|1
5782561|NCT02180867|19900962|P3|Overall Study|Lack of Efficacy|0
5782562|NCT02180867|19900963|P2|Overall Study|Lack of Efficacy|2
5782563|NCT02180867|19900964|P1|Overall Study|Lack of Efficacy|0
5782564|NCT02180867|19900958|P7|Overall Study|Death|0
5782565|NCT02180867|19900959|P6|Overall Study|Death|0
5782566|NCT02180867|19900960|P5|Overall Study|Death|1
5782567|NCT02180867|19900961|P4|Overall Study|Death|0
5782568|NCT02180867|19900962|P3|Overall Study|Death|0
5782569|NCT02180867|19900963|P2|Overall Study|Death|0
5782570|NCT02180867|19900964|P1|Overall Study|Death|0
5782571|NCT02180867|19900958|P7|Overall Study|Adverse Event|0
5782572|NCT02180867|19900959|P6|Overall Study|Adverse Event|0
5782573|NCT02180867|19900960|P5|Overall Study|Adverse Event|0
5782574|NCT02180867|19900961|P4|Overall Study|Adverse Event|5
5782575|NCT02180867|19900962|P3|Overall Study|Adverse Event|1
5782576|NCT02180867|19900963|P2|Overall Study|Adverse Event|4
5782577|NCT02180867|19900964|P1|Overall Study|Adverse Event|3
5782578|NCT02180165|19900997|P4|Overall Study|Withdrawal by Subject|1
5782579|NCT02180165|19900998|P3|Overall Study|Withdrawal by Subject|2
5782580|NCT02180165|19900999|P2|Overall Study|Withdrawal by Subject|0
5782581|NCT02180165|19901000|P1|Overall Study|Withdrawal by Subject|3
5782582|NCT02180165|19900997|P4|Overall Study|Physician Decision|0
5782583|NCT02180165|19900998|P3|Overall Study|Physician Decision|5
5782584|NCT02180165|19900999|P2|Overall Study|Physician Decision|0
5782585|NCT02180165|19901000|P1|Overall Study|Physician Decision|1
5782586|NCT02180165|19900997|P4|Overall Study|Lack of Efficacy|2
5782587|NCT02180165|19900998|P3|Overall Study|Lack of Efficacy|3
5782588|NCT02180165|19900999|P2|Overall Study|Lack of Efficacy|1
5782589|NCT02180165|19901000|P1|Overall Study|Lack of Efficacy|0
5782590|NCT02180165|19900997|P4|Overall Study|Adverse Event|3
5782591|NCT02180165|19900998|P3|Overall Study|Adverse Event|18
5782592|NCT02180165|19900999|P2|Overall Study|Adverse Event|0
5782593|NCT02180165|19901000|P1|Overall Study|Adverse Event|7
5782594|NCT02180165|19900997|P4|Overall Study|Not Treated|0
5782595|NCT02180165|19900998|P3|Overall Study|Not Treated|1
5782596|NCT02180165|19900999|P2|Overall Study|Not Treated|0
5782597|NCT02180165|19901000|P1|Overall Study|Not Treated|0
5782604|NCT02137837|19901147|P3|Overall Study|Not protocol specified|3
5782605|NCT02137837|19901148|P2|Overall Study|Not protocol specified|1
5782606|NCT02137837|19901149|P1|Overall Study|Not protocol specified|2
5782607|NCT02137837|19901147|P3|Overall Study|Progression/relapse|7
5782608|NCT02137837|19901148|P2|Overall Study|Progression/relapse|7
5782609|NCT02137837|19901149|P1|Overall Study|Progression/relapse|9
5782610|NCT02137837|19901147|P3|Overall Study|Refusal unrelated to adverse event|1
5782611|NCT02137837|19901148|P2|Overall Study|Refusal unrelated to adverse event|2
5782612|NCT02137837|19901149|P1|Overall Study|Refusal unrelated to adverse event|2
5782613|NCT02137837|19901147|P3|Overall Study|Adverse Event|1
5782614|NCT02137837|19901148|P2|Overall Study|Adverse Event|2
5782615|NCT02137837|19901149|P1|Overall Study|Adverse Event|0
5782616|NCT02132754|19901209|P34|Overall Study|Withdrawal by Subject|2
5782617|NCT02132754|19901210|P33|Overall Study|Withdrawal by Subject|0
5782618|NCT02132754|19901211|P32|Overall Study|Withdrawal by Subject|1
5782619|NCT02132754|19901212|P31|Overall Study|Withdrawal by Subject|0
5782620|NCT02132754|19901213|P30|Overall Study|Withdrawal by Subject|0
5782621|NCT02132754|19901214|P29|Overall Study|Withdrawal by Subject|0
5782622|NCT02132754|19901215|P28|Overall Study|Withdrawal by Subject|1
5782623|NCT02132754|19901216|P27|Overall Study|Withdrawal by Subject|0
5782624|NCT02132754|19901217|P26|Overall Study|Withdrawal by Subject|0
5782625|NCT02132754|19901218|P25|Overall Study|Withdrawal by Subject|1
5782626|NCT02132754|19901219|P24|Overall Study|Withdrawal by Subject|0
5782627|NCT02132754|19901220|P23|Overall Study|Withdrawal by Subject|0
5782628|NCT02132754|19901221|P22|Overall Study|Withdrawal by Subject|0
5782629|NCT02132754|19901222|P21|Overall Study|Withdrawal by Subject|1
5782630|NCT02132754|19901223|P20|Overall Study|Withdrawal by Subject|0
5782631|NCT02132754|19901224|P19|Overall Study|Withdrawal by Subject|0
5782632|NCT02132754|19901225|P18|Overall Study|Withdrawal by Subject|0
5782633|NCT02132754|19901226|P17|Overall Study|Withdrawal by Subject|1
5782634|NCT02132754|19901227|P16|Overall Study|Withdrawal by Subject|2
5782635|NCT02132754|19901228|P15|Overall Study|Withdrawal by Subject|1
5782636|NCT02132754|19901229|P14|Overall Study|Withdrawal by Subject|0
5782637|NCT02132754|19901230|P13|Overall Study|Withdrawal by Subject|1
5782638|NCT02132754|19901231|P12|Overall Study|Withdrawal by Subject|0
5782639|NCT02132754|19901232|P11|Overall Study|Withdrawal by Subject|0
5782640|NCT02132754|19901233|P10|Overall Study|Withdrawal by Subject|1
5782641|NCT02132754|19901234|P9|Overall Study|Withdrawal by Subject|0
5782642|NCT02132754|19901235|P8|Overall Study|Withdrawal by Subject|0
5782643|NCT02132754|19901236|P7|Overall Study|Withdrawal by Subject|0
5782644|NCT02132754|19901237|P6|Overall Study|Withdrawal by Subject|0
5782645|NCT02132754|19901238|P5|Overall Study|Withdrawal by Subject|0
5782646|NCT02132754|19901239|P4|Overall Study|Withdrawal by Subject|0
5782647|NCT02132754|19901240|P3|Overall Study|Withdrawal by Subject|0
5782648|NCT02132754|19901241|P2|Overall Study|Withdrawal by Subject|0
5782649|NCT02132754|19901242|P1|Overall Study|Withdrawal by Subject|0
5782650|NCT02132754|19901209|P34|Overall Study|Transferred to Extension Study|6
5782651|NCT02132754|19901210|P33|Overall Study|Transferred to Extension Study|0
5782652|NCT02132754|19901211|P32|Overall Study|Transferred to Extension Study|0
5782653|NCT02132754|19901212|P31|Overall Study|Transferred to Extension Study|0
5782654|NCT02132754|19901213|P30|Overall Study|Transferred to Extension Study|0
5782655|NCT02132754|19901214|P29|Overall Study|Transferred to Extension Study|0
5782656|NCT02132754|19901215|P28|Overall Study|Transferred to Extension Study|0
5782657|NCT02132754|19901216|P27|Overall Study|Transferred to Extension Study|0
5782658|NCT02132754|19901217|P26|Overall Study|Transferred to Extension Study|0
5782659|NCT02132754|19901218|P25|Overall Study|Transferred to Extension Study|0
5782660|NCT02132754|19901219|P24|Overall Study|Transferred to Extension Study|0
5782661|NCT02132754|19901220|P23|Overall Study|Transferred to Extension Study|0
5782662|NCT02132754|19901221|P22|Overall Study|Transferred to Extension Study|0
5782663|NCT02132754|19901222|P21|Overall Study|Transferred to Extension Study|0
5782664|NCT02132754|19901223|P20|Overall Study|Transferred to Extension Study|0
5782665|NCT02132754|19901224|P19|Overall Study|Transferred to Extension Study|0
5782666|NCT02132754|19901225|P18|Overall Study|Transferred to Extension Study|0
5782667|NCT02132754|19901226|P17|Overall Study|Transferred to Extension Study|0
5782668|NCT02132754|19901227|P16|Overall Study|Transferred to Extension Study|0
5782669|NCT02132754|19901228|P15|Overall Study|Transferred to Extension Study|0
5782670|NCT02132754|19901229|P14|Overall Study|Transferred to Extension Study|0
5782671|NCT02132754|19901230|P13|Overall Study|Transferred to Extension Study|0
5782672|NCT02132754|19901231|P12|Overall Study|Transferred to Extension Study|0
5782673|NCT02132754|19901232|P11|Overall Study|Transferred to Extension Study|0
5782674|NCT02132754|19901233|P10|Overall Study|Transferred to Extension Study|0
5782675|NCT02132754|19901234|P9|Overall Study|Transferred to Extension Study|0
5782676|NCT02132754|19901235|P8|Overall Study|Transferred to Extension Study|0
5782677|NCT02132754|19901236|P7|Overall Study|Transferred to Extension Study|0
5782678|NCT02132754|19901237|P6|Overall Study|Transferred to Extension Study|0
5782679|NCT02132754|19901238|P5|Overall Study|Transferred to Extension Study|0
5782680|NCT02132754|19901239|P4|Overall Study|Transferred to Extension Study|0
5782681|NCT02132754|19901240|P3|Overall Study|Transferred to Extension Study|0
5782682|NCT02132754|19901241|P2|Overall Study|Transferred to Extension Study|0
5782683|NCT02132754|19901242|P1|Overall Study|Transferred to Extension Study|0
5782684|NCT02132754|19901209|P34|Overall Study|Screen Failure|0
5782685|NCT02132754|19901210|P33|Overall Study|Screen Failure|0
5782686|NCT02132754|19901211|P32|Overall Study|Screen Failure|0
5782687|NCT02132754|19901212|P31|Overall Study|Screen Failure|0
5782688|NCT02132754|19901213|P30|Overall Study|Screen Failure|0
5782689|NCT02132754|19901214|P29|Overall Study|Screen Failure|0
5782690|NCT02132754|19901215|P28|Overall Study|Screen Failure|0
5782691|NCT02132754|19901216|P27|Overall Study|Screen Failure|0
5782692|NCT02132754|19901217|P26|Overall Study|Screen Failure|0
5782693|NCT02132754|19901218|P25|Overall Study|Screen Failure|0
5782694|NCT02132754|19901219|P24|Overall Study|Screen Failure|0
5782695|NCT02132754|19901220|P23|Overall Study|Screen Failure|0
5782696|NCT02132754|19901221|P22|Overall Study|Screen Failure|1
5782697|NCT02132754|19901222|P21|Overall Study|Screen Failure|0
5782698|NCT02132754|19901223|P20|Overall Study|Screen Failure|1
5782699|NCT02132754|19901224|P19|Overall Study|Screen Failure|0
5782700|NCT02132754|19901225|P18|Overall Study|Screen Failure|0
5782701|NCT02132754|19901226|P17|Overall Study|Screen Failure|0
5782702|NCT02132754|19901227|P16|Overall Study|Screen Failure|0
5782703|NCT02132754|19901228|P15|Overall Study|Screen Failure|0
5782704|NCT02132754|19901229|P14|Overall Study|Screen Failure|0
5782705|NCT02132754|19901230|P13|Overall Study|Screen Failure|0
5782706|NCT02132754|19901231|P12|Overall Study|Screen Failure|0
5782707|NCT02132754|19901232|P11|Overall Study|Screen Failure|0
5782708|NCT02132754|19901233|P10|Overall Study|Screen Failure|0
5782709|NCT02132754|19901234|P9|Overall Study|Screen Failure|0
5782710|NCT02132754|19901235|P8|Overall Study|Screen Failure|0
5782711|NCT02132754|19901236|P7|Overall Study|Screen Failure|0
5782712|NCT02132754|19901237|P6|Overall Study|Screen Failure|0
5782713|NCT02132754|19901238|P5|Overall Study|Screen Failure|0
5782714|NCT02132754|19901239|P4|Overall Study|Screen Failure|0
5782715|NCT02132754|19901240|P3|Overall Study|Screen Failure|0
5782716|NCT02132754|19901241|P2|Overall Study|Screen Failure|0
5782717|NCT02132754|19901242|P1|Overall Study|Screen Failure|0
5782718|NCT02132754|19901209|P34|Overall Study|Progressive Disease|6
5782719|NCT02132754|19901210|P33|Overall Study|Progressive Disease|3
5782720|NCT02132754|19901211|P32|Overall Study|Progressive Disease|1
5782721|NCT02132754|19901212|P31|Overall Study|Progressive Disease|1
5782722|NCT02132754|19901213|P30|Overall Study|Progressive Disease|3
5782723|NCT02132754|19901214|P29|Overall Study|Progressive Disease|2
5782724|NCT02132754|19901215|P28|Overall Study|Progressive Disease|1
5782725|NCT02132754|19901216|P27|Overall Study|Progressive Disease|2
5782726|NCT02132754|19901217|P26|Overall Study|Progressive Disease|1
5782727|NCT02132754|19901218|P25|Overall Study|Progressive Disease|0
5782728|NCT02132754|19901219|P24|Overall Study|Progressive Disease|3
5782729|NCT02132754|19901220|P23|Overall Study|Progressive Disease|2
5782730|NCT02132754|19901221|P22|Overall Study|Progressive Disease|3
5782731|NCT02132754|19901222|P21|Overall Study|Progressive Disease|1
5782732|NCT02132754|19901223|P20|Overall Study|Progressive Disease|1
5782733|NCT02132754|19901224|P19|Overall Study|Progressive Disease|3
5782734|NCT02132754|19901225|P18|Overall Study|Progressive Disease|1
5782735|NCT02132754|19901226|P17|Overall Study|Progressive Disease|2
5782736|NCT02132754|19901227|P16|Overall Study|Progressive Disease|1
5782737|NCT02132754|19901228|P15|Overall Study|Progressive Disease|2
5782738|NCT02132754|19901229|P14|Overall Study|Progressive Disease|3
5782739|NCT02132754|19901230|P13|Overall Study|Progressive Disease|2
5782740|NCT02132754|19901231|P12|Overall Study|Progressive Disease|2
5782741|NCT02132754|19901232|P11|Overall Study|Progressive Disease|3
5782742|NCT02132754|19901233|P10|Overall Study|Progressive Disease|3
5782743|NCT02132754|19901234|P9|Overall Study|Progressive Disease|1
5782744|NCT02132754|19901235|P8|Overall Study|Progressive Disease|1
5782745|NCT02132754|19901236|P7|Overall Study|Progressive Disease|1
5782746|NCT02132754|19901237|P6|Overall Study|Progressive Disease|1
5782747|NCT02132754|19901238|P5|Overall Study|Progressive Disease|1
5782748|NCT02132754|19901239|P4|Overall Study|Progressive Disease|1
5782749|NCT02132754|19901240|P3|Overall Study|Progressive Disease|1
5782750|NCT02132754|19901241|P2|Overall Study|Progressive Disease|1
5782751|NCT02132754|19901242|P1|Overall Study|Progressive Disease|1
5782752|NCT02132754|19901209|P34|Overall Study|Physician Decision|3
5782753|NCT02132754|19901210|P33|Overall Study|Physician Decision|0
5782754|NCT02132754|19901211|P32|Overall Study|Physician Decision|1
5782755|NCT02132754|19901212|P31|Overall Study|Physician Decision|0
5782756|NCT02132754|19901213|P30|Overall Study|Physician Decision|0
5782757|NCT02132754|19901214|P29|Overall Study|Physician Decision|0
5782758|NCT02132754|19901215|P28|Overall Study|Physician Decision|0
5782759|NCT02132754|19901216|P27|Overall Study|Physician Decision|0
5782760|NCT02132754|19901217|P26|Overall Study|Physician Decision|0
5782761|NCT02132754|19901218|P25|Overall Study|Physician Decision|1
5782762|NCT02132754|19901219|P24|Overall Study|Physician Decision|0
5782763|NCT02132754|19901220|P23|Overall Study|Physician Decision|0
5782764|NCT02132754|19901221|P22|Overall Study|Physician Decision|0
5782765|NCT02132754|19901222|P21|Overall Study|Physician Decision|0
5782766|NCT02132754|19901223|P20|Overall Study|Physician Decision|0
5782767|NCT02132754|19901224|P19|Overall Study|Physician Decision|0
5782768|NCT02132754|19901225|P18|Overall Study|Physician Decision|0
5782769|NCT02132754|19901226|P17|Overall Study|Physician Decision|0
5782770|NCT02132754|19901227|P16|Overall Study|Physician Decision|1
5782771|NCT02132754|19901228|P15|Overall Study|Physician Decision|0
5782772|NCT02132754|19901229|P14|Overall Study|Physician Decision|0
5782773|NCT02132754|19901230|P13|Overall Study|Physician Decision|1
5782774|NCT02132754|19901231|P12|Overall Study|Physician Decision|1
5782775|NCT02132754|19901232|P11|Overall Study|Physician Decision|0
5782776|NCT02132754|19901233|P10|Overall Study|Physician Decision|1
5782777|NCT02132754|19901234|P9|Overall Study|Physician Decision|0
5782778|NCT02132754|19901235|P8|Overall Study|Physician Decision|0
5782779|NCT02132754|19901236|P7|Overall Study|Physician Decision|0
5782780|NCT02132754|19901237|P6|Overall Study|Physician Decision|0
5782781|NCT02132754|19901238|P5|Overall Study|Physician Decision|0
5782782|NCT02132754|19901239|P4|Overall Study|Physician Decision|0
5782783|NCT02132754|19901240|P3|Overall Study|Physician Decision|0
5782784|NCT02132754|19901241|P2|Overall Study|Physician Decision|0
5782785|NCT02132754|19901242|P1|Overall Study|Physician Decision|0
5782786|NCT02132754|19901209|P34|Overall Study|Excluded Medication|1
5782787|NCT02132754|19901210|P33|Overall Study|Excluded Medication|0
5782788|NCT02132754|19901211|P32|Overall Study|Excluded Medication|0
5782789|NCT02132754|19901212|P31|Overall Study|Excluded Medication|0
5782790|NCT02132754|19901213|P30|Overall Study|Excluded Medication|0
5782791|NCT02132754|19901214|P29|Overall Study|Excluded Medication|0
5782792|NCT02132754|19901215|P28|Overall Study|Excluded Medication|0
5782793|NCT02132754|19901216|P27|Overall Study|Excluded Medication|0
5782794|NCT02132754|19901217|P26|Overall Study|Excluded Medication|0
5782795|NCT02132754|19901218|P25|Overall Study|Excluded Medication|0
5782796|NCT02132754|19901219|P24|Overall Study|Excluded Medication|0
5782797|NCT02132754|19901220|P23|Overall Study|Excluded Medication|0
5782798|NCT02132754|19901221|P22|Overall Study|Excluded Medication|0
5782799|NCT02132754|19901222|P21|Overall Study|Excluded Medication|1
5782800|NCT02132754|19901223|P20|Overall Study|Excluded Medication|0
5782801|NCT02132754|19901224|P19|Overall Study|Excluded Medication|0
5782802|NCT02132754|19901225|P18|Overall Study|Excluded Medication|0
5782803|NCT02132754|19901226|P17|Overall Study|Excluded Medication|0
5782804|NCT02132754|19901227|P16|Overall Study|Excluded Medication|0
5782805|NCT02132754|19901228|P15|Overall Study|Excluded Medication|0
5782806|NCT02132754|19901229|P14|Overall Study|Excluded Medication|0
5782807|NCT02132754|19901230|P13|Overall Study|Excluded Medication|0
5782808|NCT02132754|19901231|P12|Overall Study|Excluded Medication|0
5782809|NCT02132754|19901232|P11|Overall Study|Excluded Medication|0
5782810|NCT02132754|19901233|P10|Overall Study|Excluded Medication|0
5782811|NCT02132754|19901234|P9|Overall Study|Excluded Medication|0
5782812|NCT02132754|19901235|P8|Overall Study|Excluded Medication|0
5782813|NCT02132754|19901236|P7|Overall Study|Excluded Medication|0
5782814|NCT02132754|19901237|P6|Overall Study|Excluded Medication|0
5782815|NCT02132754|19901238|P5|Overall Study|Excluded Medication|0
5782816|NCT02132754|19901239|P4|Overall Study|Excluded Medication|0
5782817|NCT02132754|19901240|P3|Overall Study|Excluded Medication|0
5782818|NCT02132754|19901241|P2|Overall Study|Excluded Medication|0
5782819|NCT02132754|19901242|P1|Overall Study|Excluded Medication|0
5782820|NCT02132754|19901209|P34|Overall Study|Death|2
5782821|NCT02132754|19901210|P33|Overall Study|Death|0
5782822|NCT02132754|19901211|P32|Overall Study|Death|0
5782823|NCT02132754|19901212|P31|Overall Study|Death|0
5782824|NCT02132754|19901213|P30|Overall Study|Death|0
5782825|NCT02132754|19901214|P29|Overall Study|Death|0
5782826|NCT02132754|19901215|P28|Overall Study|Death|0
5782827|NCT02132754|19901216|P27|Overall Study|Death|1
5782828|NCT02132754|19901217|P26|Overall Study|Death|0
5782829|NCT02132754|19901218|P25|Overall Study|Death|0
5782830|NCT02132754|19901219|P24|Overall Study|Death|0
5782831|NCT02132754|19901220|P23|Overall Study|Death|0
5782832|NCT02132754|19901221|P22|Overall Study|Death|1
5782833|NCT02132754|19901222|P21|Overall Study|Death|0
5782834|NCT02132754|19901223|P20|Overall Study|Death|1
5782835|NCT02132754|19901224|P19|Overall Study|Death|0
5782836|NCT02132754|19901225|P18|Overall Study|Death|0
5782837|NCT02132754|19901226|P17|Overall Study|Death|0
5782838|NCT02132754|19901227|P16|Overall Study|Death|1
5782839|NCT02132754|19901228|P15|Overall Study|Death|0
5782840|NCT02132754|19901229|P14|Overall Study|Death|0
5782841|NCT02132754|19901230|P13|Overall Study|Death|0
5782842|NCT02132754|19901231|P12|Overall Study|Death|0
5782843|NCT02132754|19901232|P11|Overall Study|Death|0
5782844|NCT02132754|19901233|P10|Overall Study|Death|0
5782845|NCT02132754|19901234|P9|Overall Study|Death|0
5782846|NCT02132754|19901235|P8|Overall Study|Death|0
5782847|NCT02132754|19901236|P7|Overall Study|Death|0
5782848|NCT02132754|19901237|P6|Overall Study|Death|0
5782849|NCT02132754|19901238|P5|Overall Study|Death|0
5782850|NCT02132754|19901239|P4|Overall Study|Death|0
5782851|NCT02132754|19901240|P3|Overall Study|Death|0
5782852|NCT02132754|19901241|P2|Overall Study|Death|0
5782853|NCT02132754|19901242|P1|Overall Study|Death|0
5782854|NCT02132754|19901209|P34|Overall Study|Clinical Progression|2
5782855|NCT02132754|19901210|P33|Overall Study|Clinical Progression|0
5782856|NCT02132754|19901211|P32|Overall Study|Clinical Progression|0
5782857|NCT02132754|19901212|P31|Overall Study|Clinical Progression|1
5782858|NCT02132754|19901213|P30|Overall Study|Clinical Progression|0
5782859|NCT02132754|19901214|P29|Overall Study|Clinical Progression|1
5782860|NCT02132754|19901215|P28|Overall Study|Clinical Progression|1
5782861|NCT02132754|19901216|P27|Overall Study|Clinical Progression|0
5782862|NCT02132754|19901217|P26|Overall Study|Clinical Progression|1
5782863|NCT02132754|19901218|P25|Overall Study|Clinical Progression|1
5782864|NCT02132754|19901219|P24|Overall Study|Clinical Progression|0
5782865|NCT02132754|19901220|P23|Overall Study|Clinical Progression|1
5782866|NCT02132754|19901221|P22|Overall Study|Clinical Progression|0
5782867|NCT02132754|19901222|P21|Overall Study|Clinical Progression|0
5782868|NCT02132754|19901223|P20|Overall Study|Clinical Progression|1
5782869|NCT02132754|19901224|P19|Overall Study|Clinical Progression|0
5782870|NCT02132754|19901225|P18|Overall Study|Clinical Progression|1
5782871|NCT02132754|19901226|P17|Overall Study|Clinical Progression|1
5782872|NCT02132754|19901227|P16|Overall Study|Clinical Progression|0
5782873|NCT02132754|19901228|P15|Overall Study|Clinical Progression|0
5782874|NCT02132754|19901229|P14|Overall Study|Clinical Progression|0
5782875|NCT02132754|19901230|P13|Overall Study|Clinical Progression|0
5782876|NCT02132754|19901231|P12|Overall Study|Clinical Progression|0
5782877|NCT02132754|19901232|P11|Overall Study|Clinical Progression|0
5782878|NCT02132754|19901233|P10|Overall Study|Clinical Progression|1
5782879|NCT02132754|19901234|P9|Overall Study|Clinical Progression|0
5782880|NCT02132754|19901235|P8|Overall Study|Clinical Progression|0
5782881|NCT02132754|19901236|P7|Overall Study|Clinical Progression|0
5782882|NCT02132754|19901237|P6|Overall Study|Clinical Progression|0
5782883|NCT02132754|19901238|P5|Overall Study|Clinical Progression|0
5782884|NCT02132754|19901239|P4|Overall Study|Clinical Progression|0
5782885|NCT02132754|19901240|P3|Overall Study|Clinical Progression|0
5782886|NCT02132754|19901241|P2|Overall Study|Clinical Progression|0
5782887|NCT02132754|19901242|P1|Overall Study|Clinical Progression|0
5782888|NCT02132754|19901209|P34|Overall Study|Adverse Event|1
5782889|NCT02132754|19901210|P33|Overall Study|Adverse Event|1
5782890|NCT02132754|19901211|P32|Overall Study|Adverse Event|0
5782891|NCT02132754|19901212|P31|Overall Study|Adverse Event|1
5782892|NCT02132754|19901213|P30|Overall Study|Adverse Event|0
5782893|NCT02132754|19901214|P29|Overall Study|Adverse Event|0
5782894|NCT02132754|19901215|P28|Overall Study|Adverse Event|0
5782895|NCT02132754|19901216|P27|Overall Study|Adverse Event|1
5782896|NCT02132754|19901217|P26|Overall Study|Adverse Event|1
5782897|NCT02132754|19901218|P25|Overall Study|Adverse Event|0
5782898|NCT02132754|19901219|P24|Overall Study|Adverse Event|0
5782899|NCT02132754|19901220|P23|Overall Study|Adverse Event|0
5782900|NCT02132754|19901221|P22|Overall Study|Adverse Event|0
5782901|NCT02132754|19901222|P21|Overall Study|Adverse Event|0
5782902|NCT02132754|19901223|P20|Overall Study|Adverse Event|0
5782903|NCT02132754|19901224|P19|Overall Study|Adverse Event|0
5782904|NCT02132754|19901225|P18|Overall Study|Adverse Event|1
5782905|NCT02132754|19901226|P17|Overall Study|Adverse Event|0
5782906|NCT02132754|19901227|P16|Overall Study|Adverse Event|0
5782907|NCT02132754|19901228|P15|Overall Study|Adverse Event|0
5782908|NCT02132754|19901229|P14|Overall Study|Adverse Event|0
5782909|NCT02132754|19901230|P13|Overall Study|Adverse Event|0
5782910|NCT02132754|19901231|P12|Overall Study|Adverse Event|0
5782911|NCT02132754|19901232|P11|Overall Study|Adverse Event|0
5782912|NCT02132754|19901233|P10|Overall Study|Adverse Event|0
5782913|NCT02132754|19901234|P9|Overall Study|Adverse Event|0
5782914|NCT02132754|19901235|P8|Overall Study|Adverse Event|0
5782915|NCT02132754|19901236|P7|Overall Study|Adverse Event|0
5782916|NCT02132754|19901237|P6|Overall Study|Adverse Event|0
5782917|NCT02132754|19901238|P5|Overall Study|Adverse Event|0
5782918|NCT02132754|19901239|P4|Overall Study|Adverse Event|0
5782919|NCT02132754|19901240|P3|Overall Study|Adverse Event|0
5782920|NCT02132754|19901241|P2|Overall Study|Adverse Event|0
5782921|NCT02132754|19901242|P1|Overall Study|Adverse Event|0
5782922|NCT02036853|19901966|P2|Overall Study|Withdrawal by Subject|1
5782923|NCT02036853|19901967|P1|Overall Study|Withdrawal by Subject|0
5782924|NCT02036853|19901966|P2|Overall Study|Physician Decision|1
5782925|NCT02036853|19901967|P1|Overall Study|Physician Decision|0
5782926|NCT02036853|19901966|P2|Overall Study|Lack of Efficacy|2
5782927|NCT02036853|19901967|P1|Overall Study|Lack of Efficacy|0
5782928|NCT02036853|19901966|P2|Overall Study|Adverse Event|2
5782929|NCT02036853|19901967|P1|Overall Study|Adverse Event|0
5782955|NCT01838044|19902071|P2|Overall Study|Lost to Follow-up|2
5782956|NCT01838044|19902072|P1|Overall Study|Lost to Follow-up|0
5782957|NCT01838044|19902071|P2|Overall Study|Medication error without associated AE|1
5782958|NCT01838044|19902072|P1|Overall Study|Medication error without associated AE|0
5782959|NCT01838044|19902071|P2|Overall Study|Insufficient clinical response|2
5782960|NCT01838044|19902072|P1|Overall Study|Insufficient clinical response|1
5782961|NCT01838044|19902071|P2|Overall Study|Withdrawal by Subject|2
5782962|NCT01838044|19902072|P1|Overall Study|Withdrawal by Subject|0
5782963|NCT01838044|19902071|P2|Overall Study|Protocol Violation|3
5782964|NCT01838044|19902072|P1|Overall Study|Protocol Violation|3
5782965|NCT01838044|19902071|P2|Overall Study|Adverse Event|6
5782966|NCT01838044|19902072|P1|Overall Study|Adverse Event|4
5782969|NCT01806623|19902107|P1|Overall Study|Did not meet the inclusion criteria|56
5782970|NCT01806623|19902107|P1|Overall Study|Adverse Event|1
5782971|NCT01806623|19902107|P1|Overall Study|Withdrawal by Subject|1
5782976|NCT01701362|19902178|P2|Overall Study|Reasons other than those mentioned above|5
5782977|NCT01701362|19902179|P1|Overall Study|Reasons other than those mentioned above|3
5782978|NCT01701362|19902178|P2|Overall Study|Randomized but not treated|2
5782979|NCT01701362|19902179|P1|Overall Study|Randomized but not treated|1
5782980|NCT01701362|19902178|P2|Overall Study|Death|1
5782981|NCT01701362|19902179|P1|Overall Study|Death|0
5782982|NCT01701362|19902178|P2|Overall Study|Insufficient clinical response|6
5782983|NCT01701362|19902179|P1|Overall Study|Insufficient clinical response|6
5782984|NCT01701362|19902178|P2|Overall Study|Lost to Follow-up|9
5782985|NCT01701362|19902179|P1|Overall Study|Lost to Follow-up|6
5782986|NCT01701362|19902178|P2|Overall Study|No longer willing to participate|14
5782987|NCT01701362|19902179|P1|Overall Study|No longer willing to participate|8
5782988|NCT01701362|19902178|P2|Overall Study|Protocol Violation|3
5782989|NCT01701362|19902179|P1|Overall Study|Protocol Violation|5
5782990|NCT01701362|19902178|P2|Overall Study|Adverse events related to study drug|10
5782991|NCT01701362|19902179|P1|Overall Study|Adverse events related to study drug|12
5782992|NCT01701362|19902178|P2|Overall Study|Adverse events not related to study drug|6
5782993|NCT01701362|19902179|P1|Overall Study|Adverse events not related to study drug|1
5782994|NCT01680458|19902207|P1|Overall Study|Protocol Violation|3
5782995|NCT01659255|19902233|P17|Overall Study|Participant Went on to Have an Allograft|0
5782996|NCT01659255|19902234|P16|Overall Study|Participant Went on to Have an Allograft|0
5782997|NCT01659255|19902235|P15|Overall Study|Participant Went on to Have an Allograft|0
5782998|NCT01659255|19902236|P14|Overall Study|Participant Went on to Have an Allograft|0
5782999|NCT01659255|19902237|P13|Overall Study|Participant Went on to Have an Allograft|1
5783000|NCT01659255|19902238|P12|Overall Study|Participant Went on to Have an Allograft|0
5783001|NCT01659255|19902239|P11|Overall Study|Participant Went on to Have an Allograft|0
5783002|NCT01659255|19902240|P10|Overall Study|Participant Went on to Have an Allograft|0
5783003|NCT01659255|19902241|P9|Overall Study|Participant Went on to Have an Allograft|0
5783004|NCT01659255|19902242|P8|Overall Study|Participant Went on to Have an Allograft|0
5783005|NCT01659255|19902243|P7|Overall Study|Participant Went on to Have an Allograft|0
5783006|NCT01659255|19902244|P6|Overall Study|Participant Went on to Have an Allograft|0
5783007|NCT01659255|19902245|P5|Overall Study|Participant Went on to Have an Allograft|0
5783008|NCT01659255|19902246|P4|Overall Study|Participant Went on to Have an Allograft|0
5783009|NCT01659255|19902247|P3|Overall Study|Participant Went on to Have an Allograft|0
5783010|NCT01659255|19902248|P2|Overall Study|Participant Went on to Have an Allograft|0
5783011|NCT01659255|19902249|P1|Overall Study|Participant Went on to Have an Allograft|0
5783012|NCT01659255|19902233|P17|Overall Study|Completed Treatment Per Protocol at the Time|0
5783013|NCT01659255|19902234|P16|Overall Study|Completed Treatment Per Protocol at the Time|1
5783014|NCT01659255|19902235|P15|Overall Study|Completed Treatment Per Protocol at the Time|0
5783015|NCT01659255|19902236|P14|Overall Study|Completed Treatment Per Protocol at the Time|0
5783016|NCT01659255|19902237|P13|Overall Study|Completed Treatment Per Protocol at the Time|0
5783017|NCT01659255|19902238|P12|Overall Study|Completed Treatment Per Protocol at the Time|0
5783018|NCT01659255|19902239|P11|Overall Study|Completed Treatment Per Protocol at the Time|0
5783019|NCT01659255|19902240|P10|Overall Study|Completed Treatment Per Protocol at the Time|0
5783020|NCT01659255|19902241|P9|Overall Study|Completed Treatment Per Protocol at the Time|0
5783021|NCT01659255|19902242|P8|Overall Study|Completed Treatment Per Protocol at the Time|0
5783022|NCT01659255|19902243|P7|Overall Study|Completed Treatment Per Protocol at the Time|0
5783023|NCT01659255|19902244|P6|Overall Study|Completed Treatment Per Protocol at the Time|0
5783024|NCT01659255|19902245|P5|Overall Study|Completed Treatment Per Protocol at the Time|0
5783025|NCT01659255|19902246|P4|Overall Study|Completed Treatment Per Protocol at the Time|0
5783026|NCT01659255|19902247|P3|Overall Study|Completed Treatment Per Protocol at the Time|0
5783027|NCT01659255|19902248|P2|Overall Study|Completed Treatment Per Protocol at the Time|0
5783028|NCT01659255|19902249|P1|Overall Study|Completed Treatment Per Protocol at the Time|0
5783029|NCT01659255|19902233|P17|Overall Study|Sponsor's Decision|0
5783030|NCT01659255|19902234|P16|Overall Study|Sponsor's Decision|0
5783031|NCT01659255|19902235|P15|Overall Study|Sponsor's Decision|0
5783032|NCT01659255|19902236|P14|Overall Study|Sponsor's Decision|0
5783033|NCT01659255|19902237|P13|Overall Study|Sponsor's Decision|0
5783034|NCT01659255|19902238|P12|Overall Study|Sponsor's Decision|0
5783035|NCT01659255|19902239|P11|Overall Study|Sponsor's Decision|0
5783036|NCT01659255|19902240|P10|Overall Study|Sponsor's Decision|0
5783037|NCT01659255|19902241|P9|Overall Study|Sponsor's Decision|0
5783038|NCT01659255|19902242|P8|Overall Study|Sponsor's Decision|0
5783039|NCT01659255|19902243|P7|Overall Study|Sponsor's Decision|1
5783040|NCT01659255|19902244|P6|Overall Study|Sponsor's Decision|0
5783041|NCT01659255|19902245|P5|Overall Study|Sponsor's Decision|0
5783042|NCT01659255|19902246|P4|Overall Study|Sponsor's Decision|0
5783043|NCT01659255|19902247|P3|Overall Study|Sponsor's Decision|0
5783044|NCT01659255|19902248|P2|Overall Study|Sponsor's Decision|0
5783045|NCT01659255|19902249|P1|Overall Study|Sponsor's Decision|0
5783046|NCT01659255|19902233|P17|Overall Study|Investigator Decision|0
5783047|NCT01659255|19902234|P16|Overall Study|Investigator Decision|0
5783048|NCT01659255|19902235|P15|Overall Study|Investigator Decision|0
5783049|NCT01659255|19902236|P14|Overall Study|Investigator Decision|1
5783050|NCT01659255|19902237|P13|Overall Study|Investigator Decision|1
5783051|NCT01659255|19902238|P12|Overall Study|Investigator Decision|0
5783052|NCT01659255|19902239|P11|Overall Study|Investigator Decision|0
5783053|NCT01659255|19902240|P10|Overall Study|Investigator Decision|0
5783054|NCT01659255|19902241|P9|Overall Study|Investigator Decision|0
5783055|NCT01659255|19902242|P8|Overall Study|Investigator Decision|0
5783056|NCT01659255|19902243|P7|Overall Study|Investigator Decision|0
5783057|NCT01659255|19902244|P6|Overall Study|Investigator Decision|0
5783058|NCT01659255|19902245|P5|Overall Study|Investigator Decision|0
5783059|NCT01659255|19902246|P4|Overall Study|Investigator Decision|0
5783060|NCT01659255|19902247|P3|Overall Study|Investigator Decision|0
5783061|NCT01659255|19902248|P2|Overall Study|Investigator Decision|0
5783062|NCT01659255|19902249|P1|Overall Study|Investigator Decision|0
5783063|NCT01659255|19902233|P17|Overall Study|Withdrew Consent|0
5783064|NCT01659255|19902234|P16|Overall Study|Withdrew Consent|0
5783065|NCT01659255|19902235|P15|Overall Study|Withdrew Consent|0
5783066|NCT01659255|19902236|P14|Overall Study|Withdrew Consent|1
5783067|NCT01659255|19902237|P13|Overall Study|Withdrew Consent|0
5783068|NCT01659255|19902238|P12|Overall Study|Withdrew Consent|0
5783069|NCT01659255|19902239|P11|Overall Study|Withdrew Consent|1
5783070|NCT01659255|19902240|P10|Overall Study|Withdrew Consent|0
5783071|NCT01659255|19902241|P9|Overall Study|Withdrew Consent|0
5783072|NCT01659255|19902242|P8|Overall Study|Withdrew Consent|0
5783073|NCT01659255|19902243|P7|Overall Study|Withdrew Consent|0
5783074|NCT01659255|19902244|P6|Overall Study|Withdrew Consent|0
5783075|NCT01659255|19902245|P5|Overall Study|Withdrew Consent|0
5783076|NCT01659255|19902246|P4|Overall Study|Withdrew Consent|0
5783077|NCT01659255|19902247|P3|Overall Study|Withdrew Consent|0
5783078|NCT01659255|19902248|P2|Overall Study|Withdrew Consent|0
5783079|NCT01659255|19902249|P1|Overall Study|Withdrew Consent|0
5783080|NCT01659255|19902233|P17|Overall Study|Progressive Disease|3
5783081|NCT01659255|19902234|P16|Overall Study|Progressive Disease|2
5783082|NCT01659255|19902235|P15|Overall Study|Progressive Disease|6
5783083|NCT01659255|19902236|P14|Overall Study|Progressive Disease|13
5783084|NCT01659255|19902237|P13|Overall Study|Progressive Disease|5
5783085|NCT01659255|19902238|P12|Overall Study|Progressive Disease|3
5783086|NCT01659255|19902239|P11|Overall Study|Progressive Disease|2
5783087|NCT01659255|19902240|P10|Overall Study|Progressive Disease|2
5783088|NCT01659255|19902241|P9|Overall Study|Progressive Disease|0
5783089|NCT01659255|19902242|P8|Overall Study|Progressive Disease|1
5783090|NCT01659255|19902243|P7|Overall Study|Progressive Disease|0
5783091|NCT01659255|19902244|P6|Overall Study|Progressive Disease|0
5783092|NCT01659255|19902245|P5|Overall Study|Progressive Disease|0
5783093|NCT01659255|19902246|P4|Overall Study|Progressive Disease|0
5783094|NCT01659255|19902247|P3|Overall Study|Progressive Disease|0
5783095|NCT01659255|19902248|P2|Overall Study|Progressive Disease|0
5783096|NCT01659255|19902249|P1|Overall Study|Progressive Disease|2
5783097|NCT01659255|19902233|P17|Overall Study|Death|0
5783098|NCT01659255|19902234|P16|Overall Study|Death|1
5783099|NCT01659255|19902235|P15|Overall Study|Death|2
5783100|NCT01659255|19902236|P14|Overall Study|Death|1
5783101|NCT01659255|19902237|P13|Overall Study|Death|1
5783102|NCT01659255|19902238|P12|Overall Study|Death|0
5783103|NCT01659255|19902239|P11|Overall Study|Death|0
5783104|NCT01659255|19902240|P10|Overall Study|Death|0
5783105|NCT01659255|19902241|P9|Overall Study|Death|1
5783106|NCT01659255|19902242|P8|Overall Study|Death|1
5783107|NCT01659255|19902243|P7|Overall Study|Death|0
5783108|NCT01659255|19902244|P6|Overall Study|Death|0
5783109|NCT01659255|19902245|P5|Overall Study|Death|0
5783110|NCT01659255|19902246|P4|Overall Study|Death|0
5783111|NCT01659255|19902247|P3|Overall Study|Death|0
5783112|NCT01659255|19902248|P2|Overall Study|Death|1
5783113|NCT01659255|19902249|P1|Overall Study|Death|0
5783114|NCT01659255|19902233|P17|Overall Study|Adverse Event|0
5783115|NCT01659255|19902234|P16|Overall Study|Adverse Event|1
5783116|NCT01659255|19902235|P15|Overall Study|Adverse Event|0
5783117|NCT01659255|19902236|P14|Overall Study|Adverse Event|2
5783118|NCT01659255|19902237|P13|Overall Study|Adverse Event|0
5783119|NCT01659255|19902238|P12|Overall Study|Adverse Event|1
5783120|NCT01659255|19902239|P11|Overall Study|Adverse Event|0
5783121|NCT01659255|19902240|P10|Overall Study|Adverse Event|1
5783122|NCT01659255|19902241|P9|Overall Study|Adverse Event|0
5783123|NCT01659255|19902242|P8|Overall Study|Adverse Event|0
5783124|NCT01659255|19902243|P7|Overall Study|Adverse Event|1
5783125|NCT01659255|19902244|P6|Overall Study|Adverse Event|1
5783126|NCT01659255|19902245|P5|Overall Study|Adverse Event|0
5783127|NCT01659255|19902246|P4|Overall Study|Adverse Event|0
5783128|NCT01659255|19902247|P3|Overall Study|Adverse Event|0
5783129|NCT01659255|19902248|P2|Overall Study|Adverse Event|0
5783130|NCT01659255|19902249|P1|Overall Study|Adverse Event|0
5783131|NCT01545934|19902329|P2|Overall Study|Lost to Follow-up|0
5783132|NCT01545934|19902330|P1|Overall Study|Lost to Follow-up|1
5783133|NCT01545934|19902329|P2|Overall Study|Withdrawal by Subject|3
5783134|NCT01545934|19902330|P1|Overall Study|Withdrawal by Subject|4
5783135|NCT01524796|19902344|P1|Overall Study|Adverse Event and Lack of Efficacy|1
5783136|NCT01524796|19902344|P1|Overall Study|Switch to carbamazapine|1
5783137|NCT01524796|19902344|P1|Overall Study|Nervous about confidentiality|1
5783138|NCT01524796|19902344|P1|Overall Study|Gall stone surgery|1
5783139|NCT01524796|19902344|P1|Overall Study|Deterioration of pains|1
5783140|NCT01524796|19902344|P1|Overall Study|Move|1
5783141|NCT01524796|19902344|P1|Overall Study|Withdrawal by Subject|4
5783142|NCT01524796|19902344|P1|Overall Study|The price|1
5783143|NCT01524796|19902344|P1|Overall Study|Lost to Follow-up|1
5783144|NCT01524796|19902344|P1|Overall Study|Lack of Efficacy|3
5783145|NCT01524796|19902344|P1|Overall Study|Adverse Event|13
5783146|NCT01488578|19902357|P1|Overall Study|Protocol Violation|1836
5783147|NCT01485887|19902391|P1|Overall Study|Primary disease markedly improved|1
5783148|NCT01485887|19902391|P1|Overall Study|Deterioration of primary disease|1
5783149|NCT01485887|19902391|P1|Overall Study|Adverse Event|8
5783150|NCT01485887|19902391|P1|Overall Study|Withdrawal by Subject|2
5783151|NCT01474772|19902405|P2|Follow-up|AE not Related to Study Drug|1
5783152|NCT01474772|19902406|P1|Follow-up|AE not Related to Study Drug|0
5783153|NCT01474772|19902405|P2|Period 2|Reason not Specified|2
5783154|NCT01474772|19902406|P1|Period 2|Reason not Specified|0
5783155|NCT01474772|19902405|P2|Period 2|Lost to Follow-up|1
5783156|NCT01474772|19902406|P1|Period 2|Lost to Follow-up|1
5783157|NCT01474772|19902405|P2|Period 2|Withdrawal by Subject|4
5783158|NCT01474772|19902406|P1|Period 2|Withdrawal by Subject|3
5783159|NCT01474772|19902405|P2|Period 2|Lack of Efficacy|0
5783160|NCT01474772|19902406|P1|Period 2|Lack of Efficacy|1
5783161|NCT01474772|19902405|P2|Period 2|AE not Related to Study Drug|1
5783162|NCT01474772|19902406|P1|Period 2|AE not Related to Study Drug|4
5783163|NCT01474772|19902405|P2|Period 2|AE Related to Study Drug|1
5783164|NCT01474772|19902406|P1|Period 2|AE Related to Study Drug|0
5783165|NCT01474772|19902405|P2|Period 2|Death|1
5783166|NCT01474772|19902406|P1|Period 2|Death|0
5783167|NCT01474772|19902405|P2|Washout|Reason not Specified|1
5783168|NCT01474772|19902406|P1|Washout|Reason not Specified|0
5783169|NCT01474772|19902405|P2|Washout|Lost to Follow-up|1
5783170|NCT01474772|19902406|P1|Washout|Lost to Follow-up|0
5783171|NCT01474772|19902405|P2|Washout|Withdrawal by Subject|0
5783172|NCT01474772|19902406|P1|Washout|Withdrawal by Subject|1
5783173|NCT01474772|19902405|P2|Washout|AE not Related to Study Drug|0
5783174|NCT01474772|19902406|P1|Washout|AE not Related to Study Drug|2
5783175|NCT01474772|19902405|P2|Period 1|Reason not Specified|1
5783176|NCT01474772|19902406|P1|Period 1|Reason not Specified|1
5783177|NCT01474772|19902405|P2|Period 1|Lost to Follow-up|0
5783178|NCT01474772|19902406|P1|Period 1|Lost to Follow-up|1
5783179|NCT01474772|19902405|P2|Period 1|Withdrawal by Subject|1
5783180|NCT01474772|19902406|P1|Period 1|Withdrawal by Subject|3
5783181|NCT01474772|19902405|P2|Period 1|AE not Related to Study Drug|0
5783182|NCT01474772|19902406|P1|Period 1|AE not Related to Study Drug|1
5783183|NCT01474772|19902405|P2|Period 1|Adverse Event (AE) Related to Study Drug|1
5783184|NCT01474772|19902406|P1|Period 1|Adverse Event (AE) Related to Study Drug|6
5783185|NCT01455428|19902465|P2|Overall Study|Other|4
5783186|NCT01455428|19902466|P1|Overall Study|Other|2
5783187|NCT01455428|19902465|P2|Overall Study|Did not receive treatment|1
5783188|NCT01455428|19902466|P1|Overall Study|Did not receive treatment|1
5783189|NCT01455428|19902465|P2|Overall Study|Insufficient clinical response|2
5783190|NCT01455428|19902466|P1|Overall Study|Insufficient clinical response|0
5783191|NCT01455428|19902465|P2|Overall Study|Did not meet entrance criteria|2
5783192|NCT01455428|19902466|P1|Overall Study|Did not meet entrance criteria|0
5783193|NCT01455428|19902465|P2|Overall Study|Withdrawal by Subject|5
5783194|NCT01455428|19902466|P1|Overall Study|Withdrawal by Subject|2
5783195|NCT01455428|19902465|P2|Overall Study|Lost to Follow-up|1
5783196|NCT01455428|19902466|P1|Overall Study|Lost to Follow-up|1
5783197|NCT01455428|19902465|P2|Overall Study|Adverse Event|2
5783198|NCT01455428|19902466|P1|Overall Study|Adverse Event|6
5783199|NCT01455428|19902465|P2|Overall Study|Protocol Violation|1
5783200|NCT01455428|19902466|P1|Overall Study|Protocol Violation|2
5783201|NCT01455415|19902522|P2|Follow-up|Unspecified Reason|0
5783202|NCT01455415|19902523|P1|Follow-up|Unspecified Reason|1
5783203|NCT01455415|19902522|P2|Follow-up|Withdrawal by Subject|0
5783204|NCT01455415|19902523|P1|Follow-up|Withdrawal by Subject|2
5783205|NCT01455415|19902522|P2|Follow-up|Lack of Efficacy|1
5783206|NCT01455415|19902523|P1|Follow-up|Lack of Efficacy|0
5783207|NCT01455415|19902522|P2|Follow-up|AE Related to Study Drug|1
5783208|NCT01455415|19902523|P1|Follow-up|AE Related to Study Drug|0
5783209|NCT01455415|19902522|P2|Period 2|Protocol Violation|0
5783210|NCT01455415|19902523|P1|Period 2|Protocol Violation|2
5783211|NCT01455415|19902522|P2|Period 2|Unspecified Reason|3
5783212|NCT01455415|19902523|P1|Period 2|Unspecified Reason|2
5783213|NCT01455415|19902522|P2|Period 2|Withdrawal by Subject|3
5783214|NCT01455415|19902523|P1|Period 2|Withdrawal by Subject|2
5783215|NCT01455415|19902522|P2|Period 2|Lack of Efficacy|0
5783216|NCT01455415|19902523|P1|Period 2|Lack of Efficacy|2
5783217|NCT01455415|19902522|P2|Period 2|AE Not Related to Study Drug|1
5783218|NCT01455415|19902523|P1|Period 2|AE Not Related to Study Drug|2
5783219|NCT01455415|19902522|P2|Period 2|Lost to Follow-up|1
5783220|NCT01455415|19902523|P1|Period 2|Lost to Follow-up|2
5783221|NCT01455415|19902522|P2|Period 2|AE Related to Study Drug|2
5783222|NCT01455415|19902523|P1|Period 2|AE Related to Study Drug|1
5783223|NCT01455415|19902522|P2|Washout|Protocol Violation|1
5783224|NCT01455415|19902523|P1|Washout|Protocol Violation|0
5783225|NCT01455415|19902522|P2|Washout|Unspecified Reason|2
5783226|NCT01455415|19902523|P1|Washout|Unspecified Reason|1
5783227|NCT01455415|19902522|P2|Washout|AE Not Related to Study Drug|3
5783228|NCT01455415|19902523|P1|Washout|AE Not Related to Study Drug|2
5783229|NCT01455415|19902522|P2|Washout|Drug Error not Associated to AE|1
5783230|NCT01455415|19902523|P1|Washout|Drug Error not Associated to AE|2
5783231|NCT01455415|19902522|P2|Washout|Lost to Follow-up|0
5783232|NCT01455415|19902523|P1|Washout|Lost to Follow-up|1
5783233|NCT01455415|19902522|P2|Washout|AE Related to Study Drug|0
5783234|NCT01455415|19902523|P1|Washout|AE Related to Study Drug|2
5783235|NCT01455415|19902522|P2|Period 1|Protocol Violation|2
5783236|NCT01455415|19902523|P1|Period 1|Protocol Violation|0
5783237|NCT01455415|19902522|P2|Period 1|Unspecified Reason|1
5783238|NCT01455415|19902523|P1|Period 1|Unspecified Reason|1
5783239|NCT01455415|19902522|P2|Period 1|Withdrawal by Subject|5
5783240|NCT01455415|19902523|P1|Period 1|Withdrawal by Subject|4
5783241|NCT01455415|19902522|P2|Period 1|AE Not Related to Study Drug|6
5783242|NCT01455415|19902523|P1|Period 1|AE Not Related to Study Drug|2
5783243|NCT01455415|19902522|P2|Period 1|Drug Error not Associated to AE|1
5783244|NCT01455415|19902523|P1|Period 1|Drug Error not Associated to AE|0
5783245|NCT01455415|19902522|P2|Period 1|Lost To Follow-up Related to Study Drug|3
5783246|NCT01455415|19902523|P1|Period 1|Lost To Follow-up Related to Study Drug|3
5783247|NCT01455415|19902522|P2|Period 1|Adverse Event (AE) Related to Study Drug|6
5783248|NCT01455415|19902523|P1|Period 1|Adverse Event (AE) Related to Study Drug|9
5783249|NCT01441440|19902576|P3|Overall Study|Difficllty in keeping the schedule|0
5783250|NCT01441440|19902577|P2|Overall Study|Difficllty in keeping the schedule|1
5783251|NCT01441440|19902578|P1|Overall Study|Difficllty in keeping the schedule|1
5783252|NCT01441440|19902576|P3|Overall Study|Work-related matter|0
5783253|NCT01441440|19902577|P2|Overall Study|Work-related matter|1
5783254|NCT01441440|19902578|P1|Overall Study|Work-related matter|0
5783255|NCT01441440|19902576|P3|Overall Study|Moving|1
5783256|NCT01441440|19902577|P2|Overall Study|Moving|1
5783257|NCT01441440|19902578|P1|Overall Study|Moving|0
5783258|NCT01441440|19902576|P3|Overall Study|Lack of Efficacy|1
5783259|NCT01441440|19902577|P2|Overall Study|Lack of Efficacy|0
5783260|NCT01441440|19902578|P1|Overall Study|Lack of Efficacy|1
5783261|NCT01441440|19902576|P3|Overall Study|Pregnancy|0
5783262|NCT01441440|19902577|P2|Overall Study|Pregnancy|0
5783263|NCT01441440|19902578|P1|Overall Study|Pregnancy|1
5783264|NCT01441440|19902576|P3|Overall Study|Withdrawal by Subject|9
5783265|NCT01441440|19902577|P2|Overall Study|Withdrawal by Subject|9
5783266|NCT01441440|19902578|P1|Overall Study|Withdrawal by Subject|11
5783267|NCT01441440|19902576|P3|Overall Study|Lost to Follow-up|1
5783268|NCT01441440|19902577|P2|Overall Study|Lost to Follow-up|2
5783269|NCT01441440|19902578|P1|Overall Study|Lost to Follow-up|0
5783270|NCT01441440|19902576|P3|Overall Study|Adverse Event|9
5783271|NCT01441440|19902577|P2|Overall Study|Adverse Event|9
5783272|NCT01441440|19902578|P1|Overall Study|Adverse Event|2
5783273|NCT01441440|19902576|P3|Overall Study|Death|1
5783274|NCT01441440|19902577|P2|Overall Study|Death|0
5783275|NCT01441440|19902578|P1|Overall Study|Death|1
5783276|NCT01424722|19902601|P1|Overall Study|Sponsor terminated investigation|2258
5783277|NCT01387607|19902607|P2|Overall Study|Randomized, not treated|6
5783278|NCT01387607|19902608|P1|Overall Study|Randomized, not treated|3
5783279|NCT01387607|19902607|P2|Overall Study|Other|1
5783280|NCT01387607|19902608|P1|Overall Study|Other|1
5783281|NCT01387607|19902607|P2|Overall Study|Withdrawal by Subject|14
5783282|NCT01387607|19902608|P1|Overall Study|Withdrawal by Subject|13
5783283|NCT01387607|19902607|P2|Overall Study|Protocol Violation|5
5783284|NCT01387607|19902608|P1|Overall Study|Protocol Violation|1
5783285|NCT01387607|19902607|P2|Overall Study|No longer meets eligibility criteria|1
5783286|NCT01387607|19902608|P1|Overall Study|No longer meets eligibility criteria|0
5783287|NCT01387607|19902607|P2|Overall Study|Lost to Follow-up|1
5783288|NCT01387607|19902608|P1|Overall Study|Lost to Follow-up|2
5783289|NCT01387607|19902607|P2|Overall Study|Lack of Efficacy|6
5783290|NCT01387607|19902608|P1|Overall Study|Lack of Efficacy|8
5783291|NCT01387607|19902607|P2|Overall Study|Adverse Event|11
5783292|NCT01387607|19902608|P1|Overall Study|Adverse Event|23
5783305|NCT01366092|19902699|P1|Overall Study|Withdrawal by Subject|1
5783306|NCT01366092|19902699|P1|Overall Study|Physician Decision|1
5783307|NCT01366092|19902699|P1|Overall Study|Progressive cGVHD|2
5783308|NCT01355068|19902708|P2|First Intervention Period|Withdrawal by Subject|1
5783309|NCT01355068|19902709|P1|First Intervention Period|Withdrawal by Subject|0
5783310|NCT01355068|19902708|P2|First Intervention Period|Adverse Event|1
5783311|NCT01355068|19902709|P1|First Intervention Period|Adverse Event|0
5783312|NCT01336634|19902728|P3|Overall Study|Ongoing|24
5783313|NCT01336634|19902729|P2|Overall Study|Ongoing|22
5783314|NCT01336634|19902730|P1|Overall Study|Ongoing|15
5783315|NCT01336634|19902728|P3|Overall Study|Physician Decision|0
5783316|NCT01336634|19902729|P2|Overall Study|Physician Decision|1
5783317|NCT01336634|19902730|P1|Overall Study|Physician Decision|1
5783318|NCT01336634|19902728|P3|Overall Study|Withdrawal by Subject|1
5783319|NCT01336634|19902729|P2|Overall Study|Withdrawal by Subject|0
5783320|NCT01336634|19902730|P1|Overall Study|Withdrawal by Subject|6
5783321|NCT01336634|19902728|P3|Overall Study|Lost to Follow-up|1
5783322|NCT01336634|19902729|P2|Overall Study|Lost to Follow-up|1
5783323|NCT01336634|19902730|P1|Overall Study|Lost to Follow-up|2
5783324|NCT01336634|19902728|P3|Overall Study|Death|10
5783325|NCT01336634|19902729|P2|Overall Study|Death|33
5783326|NCT01336634|19902730|P1|Overall Study|Death|60
5783327|NCT01332149|19902773|P2|Overall Study|Randomized but not treated|2
5783328|NCT01332149|19902774|P1|Overall Study|Randomized but not treated|1
5783329|NCT01332149|19902773|P2|Overall Study|Did not meet entrance criteria|4
5783330|NCT01332149|19902774|P1|Overall Study|Did not meet entrance criteria|3
5783331|NCT01332149|19902773|P2|Overall Study|Insufficient clinical response|7
5783332|NCT01332149|19902774|P1|Overall Study|Insufficient clinical response|4
5783333|NCT01332149|19902773|P2|Overall Study|Lost to Follow-up|1
5783334|NCT01332149|19902774|P1|Overall Study|Lost to Follow-up|1
5783335|NCT01332149|19902773|P2|Overall Study|Withdrawal by Subject|5
5783336|NCT01332149|19902774|P1|Overall Study|Withdrawal by Subject|4
5783337|NCT01332149|19902773|P2|Overall Study|Protocol Violation|3
5783338|NCT01332149|19902774|P1|Overall Study|Protocol Violation|1
5783339|NCT01332149|19902773|P2|Overall Study|Other unspecified|7
5783340|NCT01332149|19902774|P1|Overall Study|Other unspecified|5
5783341|NCT01332149|19902773|P2|Overall Study|Adverse Event|9
5783342|NCT01332149|19902774|P1|Overall Study|Adverse Event|11
5783343|NCT01302938|19902830|P2|Overall Study|Adverse Event|0
5783344|NCT01302938|19902831|P1|Overall Study|Adverse Event|1
5783345|NCT01302938|19902830|P2|Overall Study|Withdrawal by Subject|0
5783346|NCT01302938|19902831|P1|Overall Study|Withdrawal by Subject|1
5783393|NCT01270828|19902900|P3|Double Blind Phase|Adverse event related to study drug|0
5783394|NCT01270828|19902901|P2|Double Blind Phase|Adverse event related to study drug|7
5783395|NCT01270828|19902902|P1|Double Blind Phase|Adverse event related to study drug|5
5783396|NCT01270828|19902900|P3|Double Blind Phase|Adverse event not related to study drug|0
5783397|NCT01270828|19902901|P2|Double Blind Phase|Adverse event not related to study drug|1
5783398|NCT01270828|19902902|P1|Double Blind Phase|Adverse event not related to study drug|1
5783399|NCT01270828|19902900|P3|Double Blind Phase|Lack of Efficacy|0
5783400|NCT01270828|19902901|P2|Double Blind Phase|Lack of Efficacy|11
5783401|NCT01270828|19902902|P1|Double Blind Phase|Lack of Efficacy|2
5783402|NCT01270828|19902900|P3|Double Blind Phase|Lost to Follow-up|0
5783403|NCT01270828|19902901|P2|Double Blind Phase|Lost to Follow-up|2
5783404|NCT01270828|19902902|P1|Double Blind Phase|Lost to Follow-up|1
5783405|NCT01270828|19902900|P3|Double Blind Phase|Withdrawal by Subject|0
5783406|NCT01270828|19902901|P2|Double Blind Phase|Withdrawal by Subject|15
5783407|NCT01270828|19902902|P1|Double Blind Phase|Withdrawal by Subject|6
5783408|NCT01270828|19902900|P3|Double Blind Phase|Reason Unspecified|0
5783409|NCT01270828|19902901|P2|Double Blind Phase|Reason Unspecified|4
5783410|NCT01270828|19902902|P1|Double Blind Phase|Reason Unspecified|7
5783411|NCT01270828|19902900|P3|Double Blind Phase|Protocol and GCP non-compliance|0
5783412|NCT01270828|19902901|P2|Double Blind Phase|Protocol and GCP non-compliance|3
5783413|NCT01270828|19902902|P1|Double Blind Phase|Protocol and GCP non-compliance|4
5783414|NCT01270828|19902900|P3|Double Blind Phase|Protocol Violation|0
5783415|NCT01270828|19902901|P2|Double Blind Phase|Protocol Violation|1
5783416|NCT01270828|19902902|P1|Double Blind Phase|Protocol Violation|0
5783417|NCT01270828|19902900|P3|Double Blind Phase|Death|0
5783418|NCT01270828|19902901|P2|Double Blind Phase|Death|1
5783419|NCT01270828|19902902|P1|Double Blind Phase|Death|0
5783420|NCT01270828|19902900|P3|Pregabalin CR SB|Protocol Violation|8
5783421|NCT01270828|19902901|P2|Pregabalin CR SB|Protocol Violation|0
5783422|NCT01270828|19902902|P1|Pregabalin CR SB|Protocol Violation|0
5783423|NCT01270828|19902900|P3|Pregabalin CR SB|Unrelated AE|8
5783424|NCT01270828|19902901|P2|Pregabalin CR SB|Unrelated AE|0
5783425|NCT01270828|19902902|P1|Pregabalin CR SB|Unrelated AE|0
5783426|NCT01270828|19902900|P3|Pregabalin CR SB|Lost to Follow-up|10
5783427|NCT01270828|19902901|P2|Pregabalin CR SB|Lost to Follow-up|0
5783428|NCT01270828|19902902|P1|Pregabalin CR SB|Lost to Follow-up|0
5783429|NCT01270828|19902900|P3|Pregabalin CR SB|Withdrawal by Subject|29
5783430|NCT01270828|19902901|P2|Pregabalin CR SB|Withdrawal by Subject|0
5783431|NCT01270828|19902902|P1|Pregabalin CR SB|Withdrawal by Subject|0
5783432|NCT01270828|19902900|P3|Pregabalin CR SB|Lack of Efficacy|32
5783433|NCT01270828|19902901|P2|Pregabalin CR SB|Lack of Efficacy|0
5783434|NCT01270828|19902902|P1|Pregabalin CR SB|Lack of Efficacy|0
5783435|NCT01270828|19902900|P3|Pregabalin CR SB|Related adverse event|46
5783436|NCT01270828|19902901|P2|Pregabalin CR SB|Related adverse event|0
5783437|NCT01270828|19902902|P1|Pregabalin CR SB|Related adverse event|0
5783438|NCT01270828|19902900|P3|Pregabalin CR SB|Enrolled but not treated|5
5783439|NCT01270828|19902901|P2|Pregabalin CR SB|Enrolled but not treated|0
5783440|NCT01270828|19902902|P1|Pregabalin CR SB|Enrolled but not treated|0
5783441|NCT01270828|19902900|P3|Pregabalin CR SB|Reason Unspecified|8
5783442|NCT01270828|19902901|P2|Pregabalin CR SB|Reason Unspecified|0
5783443|NCT01270828|19902902|P1|Pregabalin CR SB|Reason Unspecified|0
5783444|NCT01252563|19902942|P1|Overall Study|No drug administration|6
5783445|NCT01252563|19902942|P1|Overall Study|No visit after first day of treatment|194
5783446|NCT01252563|19902942|P1|Overall Study|Lost to Follow-up|161
5783447|NCT01252563|19902942|P1|Overall Study|Centralized Registration Deviation|30
5783448|NCT01252563|19902942|P1|Overall Study|Contract Deviation|41
5783449|NCT01202227|19902979|P1|Overall Study|Lack of Efficacy|1
5783450|NCT01202227|19902979|P1|Overall Study|Withdrawal by Subject|2
5783451|NCT01202227|19902979|P1|Overall Study|Adverse Event|16
5783452|NCT01190007|19902998|P1|Overall Study|Participant was arrested|1
5783453|NCT01190007|19902998|P1|Overall Study|Difficulty of visit for complications|1
5783454|NCT01190007|19902998|P1|Overall Study|Adverse Event|8
5783455|NCT01190007|19902998|P1|Overall Study|Withdrawal by Subject|4
5783456|NCT01177293|19903013|P2|Washout Period (of 14 Days)|Lost to Follow-up|1
5783457|NCT01177293|19903014|P1|Washout Period (of 14 Days)|Lost to Follow-up|0
5783458|NCT01145417|19903030|P2|Overall Study|Other|0
5783459|NCT01145417|19903031|P1|Overall Study|Other|1
5783460|NCT01145417|19903030|P2|Overall Study|Study terminated by sponsor|43
5783461|NCT01145417|19903031|P1|Overall Study|Study terminated by sponsor|35
5783462|NCT01145417|19903030|P2|Overall Study|Adverse Event|1
5783463|NCT01145417|19903031|P1|Overall Study|Adverse Event|0
5783464|NCT01145417|19903030|P2|Overall Study|Pregnancy|0
5783465|NCT01145417|19903031|P1|Overall Study|Pregnancy|1
5783466|NCT01145417|19903030|P2|Overall Study|Withdrawal by Subject|2
5783467|NCT01145417|19903031|P1|Overall Study|Withdrawal by Subject|1
5783468|NCT01145417|19903030|P2|Overall Study|Lost to Follow-up|1
5783469|NCT01145417|19903031|P1|Overall Study|Lost to Follow-up|2
5783470|NCT01145417|19903030|P2|Overall Study|Death|0
5783471|NCT01145417|19903031|P1|Overall Study|Death|1
5783472|NCT01138826|19903082|P6|Washout Period I (of 16 Days)|Lost to Follow-up|0
5783473|NCT01138826|19903083|P5|Washout Period I (of 16 Days)|Lost to Follow-up|1
5783474|NCT01138826|19903084|P4|Washout Period I (of 16 Days)|Lost to Follow-up|0
5783475|NCT01138826|19903085|P3|Washout Period I (of 16 Days)|Lost to Follow-up|0
5783476|NCT01138826|19903086|P2|Washout Period I (of 16 Days)|Lost to Follow-up|1
5783477|NCT01138826|19903087|P1|Washout Period I (of 16 Days)|Lost to Follow-up|1
5783478|NCT01107743|19903107|P1|Overall Study|Protocol Violation|46
5783479|NCT01049217|19903195|P2|Overall Study|Randomized but not Treated|2
5783480|NCT01049217|19903196|P1|Overall Study|Randomized but not Treated|0
5783481|NCT01049217|19903195|P2|Overall Study|Other|2
5783482|NCT01049217|19903196|P1|Overall Study|Other|1
5783483|NCT01049217|19903195|P2|Overall Study|Study Terminated by Sponsor|43
5783484|NCT01049217|19903196|P1|Overall Study|Study Terminated by Sponsor|43
5783485|NCT01049217|19903195|P2|Overall Study|Pregnancy|0
5783486|NCT01049217|19903196|P1|Overall Study|Pregnancy|1
5783487|NCT01049217|19903195|P2|Overall Study|Protocol Violation|3
5783488|NCT01049217|19903196|P1|Overall Study|Protocol Violation|1
5783489|NCT01049217|19903195|P2|Overall Study|Withdrawal by Subject|3
5783490|NCT01049217|19903196|P1|Overall Study|Withdrawal by Subject|4
5783491|NCT01049217|19903195|P2|Overall Study|Lost to Follow-up|8
5783492|NCT01049217|19903196|P1|Overall Study|Lost to Follow-up|3
5783493|NCT01049217|19903195|P2|Overall Study|Lack of Efficacy|1
5783494|NCT01049217|19903196|P1|Overall Study|Lack of Efficacy|1
5783495|NCT01049217|19903195|P2|Overall Study|Adverse Event|1
5783496|NCT01049217|19903196|P1|Overall Study|Adverse Event|2
5783497|NCT01020526|19903266|P1|Overall Study|Adverse Event|2
5783498|NCT01020526|19903266|P1|Overall Study|Lost to Follow-up|1
5783499|NCT01020526|19903266|P1|Overall Study|Insufficient clinical response|3
5783500|NCT01020526|19903266|P1|Overall Study|Other reasons|3
5783501|NCT01020526|19903266|P1|Overall Study|Withdrawal by Subject|5
5783502|NCT01020474|19903272|P2|Overall Study|Insufficient Clinical Response|3
5783503|NCT01020474|19903273|P1|Overall Study|Insufficient Clinical Response|0
5783504|NCT01020474|19903272|P2|Overall Study|Other Reasons|1
5783505|NCT01020474|19903273|P1|Overall Study|Other Reasons|1
5783506|NCT01020474|19903272|P2|Overall Study|Withdrawal by Subject|7
5783507|NCT01020474|19903273|P1|Overall Study|Withdrawal by Subject|5
5783508|NCT01020474|19903272|P2|Overall Study|Protocol Violation|2
5783509|NCT01020474|19903273|P1|Overall Study|Protocol Violation|0
5783510|NCT01020474|19903272|P2|Overall Study|Adverse Event|4
5783511|NCT01020474|19903273|P1|Overall Study|Adverse Event|4
5783512|NCT01004614|19903297|P4|Washout|Withdrawal by Subject|0
5783513|NCT01004614|19903298|P3|Washout|Withdrawal by Subject|0
5783514|NCT01004614|19903299|P2|Washout|Withdrawal by Subject|1
5783515|NCT01004614|19903300|P1|Washout|Withdrawal by Subject|0
5783516|NCT01003886|19903355|P1|Overall Study|Adverse Event|3
5783517|NCT01003886|19903355|P1|Overall Study|Other|14
5783518|NCT01003886|19903355|P1|Overall Study|Withdrawal by Subject|39
5783519|NCT01003886|19903355|P1|Overall Study|Lost to Follow-up|169
5783520|NCT01003886|19903355|P1|Overall Study|Lack of Efficacy|5
5783521|NCT00936611|19903364|P1|Overall Study|Ineligible for Study Drug|3
5783522|NCT00936611|19903364|P1|Overall Study|Still on Active Therapy|7
5783523|NCT00936611|19903364|P1|Overall Study|Still on Follow-up|1
5783524|NCT00936611|19903364|P1|Overall Study|Withdrawal by Subject|2
5783525|NCT00936611|19903364|P1|Overall Study|Lost to Follow-up|1
5783526|NCT00936611|19903364|P1|Overall Study|New Systemic Therapy|22
5783527|NCT00936611|19903364|P1|Overall Study|Progressive Disease|3
5783530|NCT00920621|19903438|P4|Overall Study|Blood sample not collected|0
5783531|NCT00920621|19903439|P3|Overall Study|Blood sample not collected|0
5783532|NCT00920621|19903440|P2|Overall Study|Blood sample not collected|14
5783533|NCT00920621|19903441|P1|Overall Study|Blood sample not collected|22
5783534|NCT00920621|19903438|P4|Overall Study|Fetal/neonatal deaths|14
5783535|NCT00920621|19903439|P3|Overall Study|Fetal/neonatal deaths|16
5783536|NCT00920621|19903440|P2|Overall Study|Fetal/neonatal deaths|14
5783537|NCT00920621|19903441|P1|Overall Study|Fetal/neonatal deaths|16
5783538|NCT00920621|19903438|P4|Overall Study|Lost to Follow-up|21
5783539|NCT00920621|19903439|P3|Overall Study|Lost to Follow-up|19
5783540|NCT00920621|19903440|P2|Overall Study|Lost to Follow-up|17
5783541|NCT00920621|19903441|P1|Overall Study|Lost to Follow-up|16
5783542|NCT00905437|19903473|P2|Overall Study|Other|6
5783543|NCT00905437|19903474|P1|Overall Study|Other|5
5783544|NCT00905437|19903473|P2|Overall Study|Withdrawal by Subject|1
5783545|NCT00905437|19903474|P1|Overall Study|Withdrawal by Subject|0
5783546|NCT00905437|19903473|P2|Overall Study|Lost to Follow-up|1
5783547|NCT00905437|19903474|P1|Overall Study|Lost to Follow-up|0
5783548|NCT00905437|19903473|P2|Overall Study|Adverse Event|2
5783549|NCT00905437|19903474|P1|Overall Study|Adverse Event|3
5783555|NCT00698828|19903551|P3|Overall Study|Withdrew consent (not treated)|0
5783556|NCT00698828|19903552|P2|Overall Study|Withdrew consent (not treated)|0
5783557|NCT00698828|19903553|P1|Overall Study|Withdrew consent (not treated)|2
5783558|NCT00698828|19903551|P3|Overall Study|Withdrew consent|4
5783559|NCT00698828|19903552|P2|Overall Study|Withdrew consent|7
5783560|NCT00698828|19903553|P1|Overall Study|Withdrew consent|0
5783561|NCT00698828|19903551|P3|Overall Study|Lost to Follow-up|0
5783562|NCT00698828|19903552|P2|Overall Study|Lost to Follow-up|1
5783563|NCT00698828|19903553|P1|Overall Study|Lost to Follow-up|1
5783564|NCT00698828|19903551|P3|Overall Study|Investigator/Sponsor decision|2
5783565|NCT00698828|19903552|P2|Overall Study|Investigator/Sponsor decision|0
5783566|NCT00698828|19903553|P1|Overall Study|Investigator/Sponsor decision|1
5783567|NCT00698828|19903551|P3|Overall Study|Exacerbation of COPD (Not treated)|0
5783568|NCT00698828|19903552|P2|Overall Study|Exacerbation of COPD (Not treated)|0
5783569|NCT00698828|19903553|P1|Overall Study|Exacerbation of COPD (Not treated)|1
5783570|NCT00698828|19903551|P3|Overall Study|Exacerbation of COPD|0
5783571|NCT00698828|19903552|P2|Overall Study|Exacerbation of COPD|3
5783572|NCT00698828|19903553|P1|Overall Study|Exacerbation of COPD|1
5783573|NCT00698828|19903551|P3|Overall Study|Death|1
5783574|NCT00698828|19903552|P2|Overall Study|Death|0
5783575|NCT00698828|19903553|P1|Overall Study|Death|0
5783576|NCT00698828|19903551|P3|Overall Study|Adverse Event|4
5783577|NCT00698828|19903552|P2|Overall Study|Adverse Event|4
5783578|NCT00698828|19903553|P1|Overall Study|Adverse Event|3
5783586|NCT00624780|19903610|P6|Follow-up (Week 26)|Other|0
5783587|NCT00624780|19903611|P5|Follow-up (Week 26)|Other|0
5783588|NCT00624780|19903612|P4|Follow-up (Week 26)|Other|0
5783589|NCT00624780|19903613|P3|Follow-up (Week 26)|Other|0
5783590|NCT00624780|19903614|P2|Follow-up (Week 26)|Other|1
5783591|NCT00624780|19903615|P1|Follow-up (Week 26)|Other|1
5783592|NCT00624780|19903610|P6|Follow-up (Week 26)|Withdrawal by Subject|0
5783593|NCT00624780|19903611|P5|Follow-up (Week 26)|Withdrawal by Subject|0
5783594|NCT00624780|19903612|P4|Follow-up (Week 26)|Withdrawal by Subject|0
5783595|NCT00624780|19903613|P3|Follow-up (Week 26)|Withdrawal by Subject|0
5783596|NCT00624780|19903614|P2|Follow-up (Week 26)|Withdrawal by Subject|0
5783597|NCT00624780|19903615|P1|Follow-up (Week 26)|Withdrawal by Subject|1
5783598|NCT00624780|19903610|P6|Follow-up (Week 26)|Lost to Follow-up|0
5783599|NCT00624780|19903611|P5|Follow-up (Week 26)|Lost to Follow-up|1
5783600|NCT00624780|19903612|P4|Follow-up (Week 26)|Lost to Follow-up|0
5783601|NCT00624780|19903613|P3|Follow-up (Week 26)|Lost to Follow-up|1
5783602|NCT00624780|19903614|P2|Follow-up (Week 26)|Lost to Follow-up|0
5783603|NCT00624780|19903615|P1|Follow-up (Week 26)|Lost to Follow-up|0
5783604|NCT00624780|19903610|P6|Follow-up (Week 26)|Adverse Event|0
5783605|NCT00624780|19903611|P5|Follow-up (Week 26)|Adverse Event|1
5783606|NCT00624780|19903612|P4|Follow-up (Week 26)|Adverse Event|0
5783607|NCT00624780|19903613|P3|Follow-up (Week 26)|Adverse Event|0
5783608|NCT00624780|19903614|P2|Follow-up (Week 26)|Adverse Event|0
5783609|NCT00624780|19903615|P1|Follow-up (Week 26)|Adverse Event|0
5783610|NCT00624780|19903610|P6|Follow-up (Week 26)|Death|0
5783611|NCT00624780|19903611|P5|Follow-up (Week 26)|Death|0
5783612|NCT00624780|19903612|P4|Follow-up (Week 26)|Death|0
5783613|NCT00624780|19903613|P3|Follow-up (Week 26)|Death|1
5783614|NCT00624780|19903614|P2|Follow-up (Week 26)|Death|0
5783615|NCT00624780|19903615|P1|Follow-up (Week 26)|Death|0
5783616|NCT00624780|19903610|P6|Treatment Discontinuation (Week 25)|Lost to Follow-up|0
5783617|NCT00624780|19903611|P5|Treatment Discontinuation (Week 25)|Lost to Follow-up|0
5783618|NCT00624780|19903612|P4|Treatment Discontinuation (Week 25)|Lost to Follow-up|0
5783619|NCT00624780|19903613|P3|Treatment Discontinuation (Week 25)|Lost to Follow-up|1
5783620|NCT00624780|19903614|P2|Treatment Discontinuation (Week 25)|Lost to Follow-up|0
5783621|NCT00624780|19903615|P1|Treatment Discontinuation (Week 25)|Lost to Follow-up|0
5783622|NCT00624780|19903610|P6|Treatment Discontinuation (Week 25)|Lack of Efficacy|0
5783623|NCT00624780|19903611|P5|Treatment Discontinuation (Week 25)|Lack of Efficacy|0
5783624|NCT00624780|19903612|P4|Treatment Discontinuation (Week 25)|Lack of Efficacy|0
5783625|NCT00624780|19903613|P3|Treatment Discontinuation (Week 25)|Lack of Efficacy|0
5783626|NCT00624780|19903614|P2|Treatment Discontinuation (Week 25)|Lack of Efficacy|0
5783627|NCT00624780|19903615|P1|Treatment Discontinuation (Week 25)|Lack of Efficacy|1
5783628|NCT00624780|19903610|P6|Treatment Discontinuation (Week 25)|Adverse Event|1
5783629|NCT00624780|19903611|P5|Treatment Discontinuation (Week 25)|Adverse Event|0
5783630|NCT00624780|19903612|P4|Treatment Discontinuation (Week 25)|Adverse Event|1
5783631|NCT00624780|19903613|P3|Treatment Discontinuation (Week 25)|Adverse Event|2
5783632|NCT00624780|19903614|P2|Treatment Discontinuation (Week 25)|Adverse Event|0
5783633|NCT00624780|19903615|P1|Treatment Discontinuation (Week 25)|Adverse Event|1
5783634|NCT00624780|19903610|P6|Fixed Dosing (Week 13 to Week 24)|Other|3
5783635|NCT00624780|19903611|P5|Fixed Dosing (Week 13 to Week 24)|Other|4
5783636|NCT00624780|19903612|P4|Fixed Dosing (Week 13 to Week 24)|Other|1
5783637|NCT00624780|19903613|P3|Fixed Dosing (Week 13 to Week 24)|Other|4
5783638|NCT00624780|19903614|P2|Fixed Dosing (Week 13 to Week 24)|Other|3
5783639|NCT00624780|19903615|P1|Fixed Dosing (Week 13 to Week 24)|Other|5
5783640|NCT00624780|19903610|P6|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2
5783641|NCT00624780|19903611|P5|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6
5783642|NCT00624780|19903612|P4|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3
5783643|NCT00624780|19903613|P3|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6
5783644|NCT00624780|19903614|P2|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3
5783645|NCT00624780|19903615|P1|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2
5783646|NCT00624780|19903610|P6|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1
5783647|NCT00624780|19903611|P5|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1
5783648|NCT00624780|19903612|P4|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0
5783649|NCT00624780|19903613|P3|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1
5783650|NCT00624780|19903614|P2|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0
5783651|NCT00624780|19903615|P1|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1
5783652|NCT00624780|19903610|P6|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2
5783653|NCT00624780|19903611|P5|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5
5783654|NCT00624780|19903612|P4|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5
5783655|NCT00624780|19903613|P3|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2
5783656|NCT00624780|19903614|P2|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|1
5783657|NCT00624780|19903615|P1|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2
5783658|NCT00624780|19903610|P6|Fixed Dosing (Week 13 to Week 24)|Adverse Event|1
5783659|NCT00624780|19903611|P5|Fixed Dosing (Week 13 to Week 24)|Adverse Event|3
5783660|NCT00624780|19903612|P4|Fixed Dosing (Week 13 to Week 24)|Adverse Event|2
5783661|NCT00624780|19903613|P3|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5
5783662|NCT00624780|19903614|P2|Fixed Dosing (Week 13 to Week 24)|Adverse Event|4
5783663|NCT00624780|19903615|P1|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5
5783664|NCT00624780|19903610|P6|Treatment Optimization (Up to Week 12)|Other|0
5783665|NCT00624780|19903611|P5|Treatment Optimization (Up to Week 12)|Other|9
5783666|NCT00624780|19903612|P4|Treatment Optimization (Up to Week 12)|Other|2
5783667|NCT00624780|19903613|P3|Treatment Optimization (Up to Week 12)|Other|8
5783668|NCT00624780|19903614|P2|Treatment Optimization (Up to Week 12)|Other|4
5783669|NCT00624780|19903615|P1|Treatment Optimization (Up to Week 12)|Other|10
5783670|NCT00624780|19903610|P6|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4
5783671|NCT00624780|19903611|P5|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10
5783672|NCT00624780|19903612|P4|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4
5783673|NCT00624780|19903613|P3|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|7
5783674|NCT00624780|19903614|P2|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|2
5783675|NCT00624780|19903615|P1|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10
5783676|NCT00624780|19903610|P6|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1
5783677|NCT00624780|19903611|P5|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2
5783678|NCT00624780|19903612|P4|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0
5783679|NCT00624780|19903613|P3|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2
5783680|NCT00624780|19903614|P2|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0
5783681|NCT00624780|19903615|P1|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1
5783682|NCT00624780|19903610|P6|Treatment Optimization (Up to Week 12)|Lack of Efficacy|1
5783683|NCT00624780|19903611|P5|Treatment Optimization (Up to Week 12)|Lack of Efficacy|9
5783684|NCT00624780|19903612|P4|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5
5783685|NCT00624780|19903613|P3|Treatment Optimization (Up to Week 12)|Lack of Efficacy|10
5783686|NCT00624780|19903614|P2|Treatment Optimization (Up to Week 12)|Lack of Efficacy|2
5783687|NCT00624780|19903615|P1|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5
5783688|NCT00624780|19903610|P6|Treatment Optimization (Up to Week 12)|Adverse Event|5
5783689|NCT00624780|19903611|P5|Treatment Optimization (Up to Week 12)|Adverse Event|9
5783690|NCT00624780|19903612|P4|Treatment Optimization (Up to Week 12)|Adverse Event|3
5783691|NCT00624780|19903613|P3|Treatment Optimization (Up to Week 12)|Adverse Event|15
5783692|NCT00624780|19903614|P2|Treatment Optimization (Up to Week 12)|Adverse Event|5
5783693|NCT00624780|19903615|P1|Treatment Optimization (Up to Week 12)|Adverse Event|7
5783694|NCT00605917|19903822|P1|Overall Study|Protocol Violation|79
5783695|NCT00605865|19903861|P1|Overall Study|Protocol Violation|115
5783696|NCT00605813|19903900|P1|Overall Study|Protocol Violation|25
5783697|NCT00579254|19903913|P1|Overall Study|Discontinued when study terminated|73
5783698|NCT00579254|19903913|P1|Overall Study|Lost to Follow-up|39
5783715|NCT00537238|19903968|P2|Overall Study|Other|52
5783716|NCT00537238|19903969|P1|Overall Study|Other|44
5783717|NCT00537238|19903968|P2|Overall Study|Does not meet entrance criteria|2
5783718|NCT00537238|19903969|P1|Overall Study|Does not meet entrance criteria|0
5783719|NCT00537238|19903968|P2|Overall Study|Protocol Violation|19
5783720|NCT00537238|19903969|P1|Overall Study|Protocol Violation|15
5783721|NCT00537238|19903968|P2|Overall Study|Withdrawal by Subject|47
5783722|NCT00537238|19903969|P1|Overall Study|Withdrawal by Subject|51
5783723|NCT00537238|19903968|P2|Overall Study|Lost to Follow-up|8
5783724|NCT00537238|19903969|P1|Overall Study|Lost to Follow-up|12
5783725|NCT00537238|19903968|P2|Overall Study|Lack of Efficacy|21
5783726|NCT00537238|19903969|P1|Overall Study|Lack of Efficacy|20
5783727|NCT00537238|19903968|P2|Overall Study|Adverse Event|22
5783728|NCT00537238|19903969|P1|Overall Study|Adverse Event|31
5783729|NCT00537238|19903968|P2|Overall Study|Death|2
5783730|NCT00537238|19903969|P1|Overall Study|Death|1
5783731|NCT00530946|19903993|P4|Overall Study|Noncompliance|0
5783732|NCT00530946|19903994|P3|Overall Study|Noncompliance|0
5783733|NCT00530946|19903995|P2|Overall Study|Noncompliance|0
5783734|NCT00530946|19903996|P1|Overall Study|Noncompliance|1
5783735|NCT00530946|19903993|P4|Overall Study|Protocol Violation|1
5783736|NCT00530946|19903994|P3|Overall Study|Protocol Violation|0
5783737|NCT00530946|19903995|P2|Overall Study|Protocol Violation|0
5783738|NCT00530946|19903996|P1|Overall Study|Protocol Violation|0
5783739|NCT00530946|19903993|P4|Overall Study|Adverse Event|1
5783740|NCT00530946|19903994|P3|Overall Study|Adverse Event|1
5783741|NCT00530946|19903995|P2|Overall Study|Adverse Event|2
5783742|NCT00530946|19903996|P1|Overall Study|Adverse Event|1
5783752|NCT00407537|19904062|P2|Overall Study|Withdrawal by Subject|16
5783753|NCT00407537|19904063|P1|Overall Study|Withdrawal by Subject|34
5783754|NCT00407537|19904062|P2|Overall Study|Other|7
5783755|NCT00407537|19904063|P1|Overall Study|Other|6
5783756|NCT00407537|19904062|P2|Overall Study|Lost to Follow-up|19
5783757|NCT00407537|19904063|P1|Overall Study|Lost to Follow-up|12
5783758|NCT00407537|19904062|P2|Overall Study|Adverse Event|0
5783759|NCT00407537|19904063|P1|Overall Study|Adverse Event|36
5783760|NCT00407537|19904062|P2|Overall Study|Death|2
5783761|NCT00407537|19904063|P1|Overall Study|Death|5
5783762|NCT00381940|19904111|P1|Overall Study|Ineligible|1
5783763|NCT00381940|19904111|P1|Overall Study|Protocol Violation|1
5783764|NCT00381940|19904111|P1|Overall Study|Lack of Efficacy|3
5783765|NCT00280059|19904122|P2|Efficacy Assessment Phase|Withdrawal by Subject|25
5783766|NCT00280059|19904123|P1|Efficacy Assessment Phase|Withdrawal by Subject|26
5783767|NCT00280059|19904122|P2|Efficacy Assessment Phase|Other|8
5783768|NCT00280059|19904123|P1|Efficacy Assessment Phase|Other|7
5783769|NCT00280059|19904122|P2|Efficacy Assessment Phase|Lost to Follow-up|13
5783770|NCT00280059|19904123|P1|Efficacy Assessment Phase|Lost to Follow-up|6
5783771|NCT00280059|19904122|P2|Efficacy Assessment Phase|Lack of Efficacy|3
5783772|NCT00280059|19904123|P1|Efficacy Assessment Phase|Lack of Efficacy|19
5783773|NCT00280059|19904122|P2|Efficacy Assessment Phase|Laboratory abnormaility|0
5783774|NCT00280059|19904123|P1|Efficacy Assessment Phase|Laboratory abnormaility|1
5783775|NCT00280059|19904122|P2|Efficacy Assessment Phase|Adverse Event|31
5783776|NCT00280059|19904123|P1|Efficacy Assessment Phase|Adverse Event|33
5783777|NCT00280059|19904122|P2|Efficacy Assessment Phase|Death|0
5783778|NCT00280059|19904123|P1|Efficacy Assessment Phase|Death|2
5783780|NCT04223232|19904304|P1|Overall Study|Withdrawal by Subject|1
5783781|NCT04222699|19904333|P1|Overall Study|Lost to Follow-up|2
5783782|NCT04214600|19904368|P2|Overall Study|Lost to Follow-up|14
5783783|NCT04214600|19904369|P1|Overall Study|Lost to Follow-up|9
5783784|NCT04195893|19904445|P2|Second Intervention|Withdrawal by Subject|0
5783785|NCT04195893|19904446|P1|Second Intervention|Withdrawal by Subject|1
5783786|NCT04194151|19904505|P6|Overall Study|Monitorization problem|0
5783787|NCT04194151|19904506|P5|Overall Study|Monitorization problem|0
5783788|NCT04194151|19904507|P4|Overall Study|Monitorization problem|0
5783789|NCT04194151|19904508|P3|Overall Study|Monitorization problem|0
5783790|NCT04194151|19904509|P2|Overall Study|Monitorization problem|1
5783791|NCT04194151|19904510|P1|Overall Study|Monitorization problem|0
5783792|NCT04194151|19904505|P6|Overall Study|Physician Decision|1
5783793|NCT04194151|19904506|P5|Overall Study|Physician Decision|0
5783794|NCT04194151|19904507|P4|Overall Study|Physician Decision|1
5783795|NCT04194151|19904508|P3|Overall Study|Physician Decision|1
5783796|NCT04194151|19904509|P2|Overall Study|Physician Decision|1
5783797|NCT04194151|19904510|P1|Overall Study|Physician Decision|1
5783798|NCT04186806|19904550|P2|Period 1: 7 Days|Adverse Event|0
5783799|NCT04186806|19904551|P1|Period 1: 7 Days|Adverse Event|1
5783800|NCT04179838|19904707|P2|Second Intervention (1 Day)|Protocol Violation|1
5783801|NCT04179838|19904708|P1|Second Intervention (1 Day)|Protocol Violation|0
5783802|NCT04179838|19904707|P2|First Intervention (1 Day)|Withdrawal by Subject|3
5783803|NCT04179838|19904708|P1|First Intervention (1 Day)|Withdrawal by Subject|0
5783804|NCT04178590|19904726|P1|Overall Study|Lost to Follow-up|1
5783805|NCT04178590|19904726|P1|Overall Study|Pregnancy|1
5783806|NCT04173741|19904850|P2|Overall Study|IVC measurement cannot be done|1
5783807|NCT04173741|19904851|P1|Overall Study|IVC measurement cannot be done|1
5783812|NCT04161079|19904940|P1|Clinical Investigation 2010-040|Adverse Event|1
5783813|NCT04149353|19905178|P1|Overall Study|Study terminated|1
5783814|NCT04148651|19905183|P1|Overall Study|Lost to Follow-up|2
5783815|NCT04142216|19905222|P2|Overall Study|Use of clove|1
5783816|NCT04142216|19905223|P1|Overall Study|Use of clove|0
5783817|NCT04142216|19905222|P2|Overall Study|Referral to another hemodialysis unit|2
5783818|NCT04142216|19905223|P1|Overall Study|Referral to another hemodialysis unit|3
5783819|NCT04142216|19905222|P2|Overall Study|Death|1
5783820|NCT04142216|19905223|P1|Overall Study|Death|3
5783821|NCT04142216|19905222|P2|Overall Study|Hospitalization|2
5783822|NCT04142216|19905223|P1|Overall Study|Hospitalization|0
5783823|NCT04140890|19905245|P2|Overall Study|Withdrawal by Subject|1
5783824|NCT04140890|19905246|P1|Overall Study|Withdrawal by Subject|0
5783825|NCT04138810|19905274|P2|Overall Study|Subject cancelled surgery|0
5783826|NCT04138810|19905275|P1|Overall Study|Subject cancelled surgery|1
5783827|NCT04138810|19905274|P2|Overall Study|Withdrawal by Subject|1
5783828|NCT04138810|19905275|P1|Overall Study|Withdrawal by Subject|0
5783829|NCT04131556|19905340|P1|Overall Study|Withdrawal by Subject|1
5783830|NCT04131556|19905340|P1|Overall Study|Adverse Event|1
5783831|NCT04128293|19905386|P4|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4
5783832|NCT04128293|19905387|P3|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4
5783833|NCT04128293|19905388|P2|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4
5783834|NCT04128293|19905389|P1|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4
5783835|NCT04123665|19905589|P2|Overall Study|Lost to Follow-up|0
5783836|NCT04123665|19905590|P1|Overall Study|Lost to Follow-up|1
5783837|NCT04123665|19905589|P2|Overall Study|Withdrawal by Subject|0
5783838|NCT04123665|19905590|P1|Overall Study|Withdrawal by Subject|7
5783839|NCT04122534|19905612|P1|Overall Study|Lost to Follow-up|4
5783840|NCT04109222|19905699|P3|Overall Study|Adverse Event|0
5783841|NCT04109222|19905700|P2|Overall Study|Adverse Event|0
5783842|NCT04109222|19905701|P1|Overall Study|Adverse Event|1
5783843|NCT04106817|19905712|P3|Overall Study|Lost to Follow-up|0
5783844|NCT04106817|19905713|P2|Overall Study|Lost to Follow-up|0
5783845|NCT04106817|19905714|P1|Overall Study|Lost to Follow-up|1
5783846|NCT04098809|19905730|P2|Overall Study|Physician Decision|1
5783847|NCT04098809|19905731|P1|Overall Study|Physician Decision|2
5783848|NCT04098809|19905730|P2|Overall Study|Withdrawal by Subject|3
5783849|NCT04098809|19905731|P1|Overall Study|Withdrawal by Subject|1
5783850|NCT04095286|19905757|P6|Period 2 (4 Days) + Washout (7days)|Adverse Event|0
5783851|NCT04095286|19905758|P5|Period 2 (4 Days) + Washout (7days)|Adverse Event|1
5783852|NCT04095286|19905759|P4|Period 2 (4 Days) + Washout (7days)|Adverse Event|0
5783853|NCT04095286|19905760|P3|Period 2 (4 Days) + Washout (7days)|Adverse Event|0
5783854|NCT04095286|19905761|P2|Period 2 (4 Days) + Washout (7days)|Adverse Event|0
5783855|NCT04095286|19905762|P1|Period 2 (4 Days) + Washout (7days)|Adverse Event|0
5783856|NCT04095286|19905757|P6|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0
5783857|NCT04095286|19905758|P5|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0
5783858|NCT04095286|19905759|P4|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0
5783859|NCT04095286|19905760|P3|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|2
5783860|NCT04095286|19905761|P2|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0
5783861|NCT04095286|19905762|P1|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0
5783862|NCT04095286|19905757|P6|Period 1 (4 Days) + Washout (7days)|Adverse Event|0
5783863|NCT04095286|19905758|P5|Period 1 (4 Days) + Washout (7days)|Adverse Event|0
5783864|NCT04095286|19905759|P4|Period 1 (4 Days) + Washout (7days)|Adverse Event|0
5783865|NCT04095286|19905760|P3|Period 1 (4 Days) + Washout (7days)|Adverse Event|1
5783866|NCT04095286|19905761|P2|Period 1 (4 Days) + Washout (7days)|Adverse Event|0
5783867|NCT04095286|19905762|P1|Period 1 (4 Days) + Washout (7days)|Adverse Event|0
5783868|NCT04095286|19905757|P6|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0
5783869|NCT04095286|19905758|P5|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0
5783870|NCT04095286|19905759|P4|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0
5783871|NCT04095286|19905760|P3|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0
5783872|NCT04095286|19905761|P2|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0
5783873|NCT04095286|19905762|P1|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|1
5783874|NCT04095286|19905757|P6|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0
5783875|NCT04095286|19905758|P5|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0
5783876|NCT04095286|19905759|P4|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0
5783877|NCT04095286|19905760|P3|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0
5783878|NCT04095286|19905761|P2|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|1
5783879|NCT04095286|19905762|P1|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0
5783880|NCT04091659|19905805|P2|Overall Study|Lost to Follow-up|1
5783881|NCT04091659|19905806|P1|Overall Study|Lost to Follow-up|0
5783882|NCT04091659|19905805|P2|Overall Study|Protocol Violation|0
5783883|NCT04091659|19905806|P1|Overall Study|Protocol Violation|3
5783884|NCT04090164|19905816|P2|Overall Study|incomplete data on file|0
5783885|NCT04090164|19905817|P1|Overall Study|incomplete data on file|245
5783886|NCT04086641|19905826|P2|Foot 1 (Two Week Utilization)|COVID-19|2
5783887|NCT04086641|19905827|P1|Foot 1 (Two Week Utilization)|COVID-19|1
5783888|NCT04080297|19905936|P2|Overall Study|concurrent illness|0
5783889|NCT04080297|19905937|P1|Overall Study|concurrent illness|1
5783890|NCT04080297|19905936|P2|Overall Study|Adverse Event|3
5783891|NCT04080297|19905937|P1|Overall Study|Adverse Event|1
5783892|NCT04079790|19905959|P4|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0
5783893|NCT04079790|19905960|P3|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|2
5783894|NCT04079790|19905961|P2|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0
5783895|NCT04079790|19905962|P1|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0
5783896|NCT04079790|19905959|P4|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0
5783897|NCT04079790|19905960|P3|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|1
5783898|NCT04079790|19905961|P2|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0
5783899|NCT04079790|19905962|P1|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0
5783900|NCT04079790|19905959|P4|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0
5783901|NCT04079790|19905960|P3|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0
5783902|NCT04079790|19905961|P2|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0
5783903|NCT04079790|19905962|P1|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|1
5783904|NCT04079114|19906106|P1|Overall Study|Study prematuely terminated.|166
5783905|NCT04069715|19906167|P2|Overall Study|Withdrawal by Subject|3
5783906|NCT04069715|19906168|P1|Overall Study|Withdrawal by Subject|3
5783907|NCT04069715|19906167|P2|Overall Study|Physician Decision|1
5783908|NCT04069715|19906168|P1|Overall Study|Physician Decision|1
5783909|NCT04069715|19906167|P2|Overall Study|Lost to Follow-up|1
5783910|NCT04069715|19906168|P1|Overall Study|Lost to Follow-up|1
5783911|NCT04067401|19906222|P2|Overall Study|no data provided|0
5783912|NCT04067401|19906223|P1|Overall Study|no data provided|1
5783913|NCT04067401|19906222|P2|Overall Study|Withdrawal by Subject|0
5783914|NCT04067401|19906223|P1|Overall Study|Withdrawal by Subject|7
5783915|NCT04067141|19906243|P2|Second Intervention|Adverse Event|2
5783916|NCT04067141|19906244|P1|Second Intervention|Adverse Event|0
5783917|NCT04067141|19906243|P2|First Intervention|Withdrawal by Subject|1
5783918|NCT04067141|19906244|P1|First Intervention|Withdrawal by Subject|0
5783919|NCT04065074|19906294|P1|Overall Study|Protocol Non-Compliance after injection|1
5783920|NCT04065074|19906294|P1|Overall Study|Adverse Event|1
5783923|NCT04054011|19906335|P1|Overall Study|COVID|3
5783924|NCT04053465|19906345|P2|Overall Study|Withdrawal by Subject|4
5783925|NCT04053465|19906346|P1|Overall Study|Withdrawal by Subject|4
5783926|NCT04053023|19906375|P2|Part A: Period 2 (Day 20 to Day 38)|Adverse Event|0
5783927|NCT04053023|19906376|P1|Part A: Period 2 (Day 20 to Day 38)|Adverse Event|1
5783928|NCT04050722|19906568|P2|Overall Study|Withdrawal by Subject|0
5783929|NCT04050722|19906569|P1|Overall Study|Withdrawal by Subject|1
5783930|NCT04050618|19906587|P2|Second Intervention|Withdrawal by Subject|0
5783931|NCT04050618|19906588|P1|Second Intervention|Withdrawal by Subject|1
5783932|NCT04050618|19906587|P2|First Intervention|Withdrawal by Subject|0
5783933|NCT04050618|19906588|P1|First Intervention|Withdrawal by Subject|2
5783934|NCT04049578|19906756|P1|Overall Study|Physician Decision|1
5783935|NCT04049552|19906766|P1|Overall Study|Lost to Follow-up|1
5783936|NCT04048681|19906774|P5|Overall Study|family emergency|0
5783937|NCT04048681|19906775|P4|Overall Study|family emergency|1
5783938|NCT04048681|19906776|P3|Overall Study|family emergency|0
5783939|NCT04048681|19906777|P2|Overall Study|family emergency|0
5783940|NCT04048681|19906778|P1|Overall Study|family emergency|0
5783941|NCT04043416|19907105|P2|Washout|Change in health condition|1
5783942|NCT04043416|19907106|P1|Washout|Change in health condition|0
5783943|NCT04037748|19907222|P2|Treatment Period 2|Protocol Violation|0
5783944|NCT04037748|19907223|P1|Treatment Period 2|Protocol Violation|2
5783945|NCT04037748|19907222|P2|Treatment Period 2|Adverse Event|1
5783946|NCT04037748|19907223|P1|Treatment Period 2|Adverse Event|0
5783947|NCT04037748|19907222|P2|Treatment Period 1|Protocol Violation|5
5783948|NCT04037748|19907223|P1|Treatment Period 1|Protocol Violation|4
5783949|NCT04037748|19907222|P2|Treatment Period 1|Adverse Event|1
5783950|NCT04037748|19907223|P1|Treatment Period 1|Adverse Event|1
5783951|NCT04037748|19907222|P2|Treatment Period 1|Withdrawal by Subject|0
5783952|NCT04037748|19907223|P1|Treatment Period 1|Withdrawal by Subject|3
5783953|NCT04036110|19907244|P3|Overall Study|Study Suspended|1
5783954|NCT04036110|19907245|P2|Overall Study|Study Suspended|5
5783955|NCT04036110|19907246|P1|Overall Study|Study Suspended|4
5783956|NCT04036110|19907244|P3|Overall Study|Lost to Follow-up|1
5783957|NCT04036110|19907245|P2|Overall Study|Lost to Follow-up|2
5783958|NCT04036110|19907246|P1|Overall Study|Lost to Follow-up|3
5783959|NCT04035577|19907269|P1|Overall Study|Withdrawal by Subject|1
5783960|NCT04035577|19907269|P1|Overall Study|Lost to Follow-up|1
5783961|NCT04035564|19907289|P2|Overall Study|Guardian declined consent|2
5783962|NCT04035564|19907290|P1|Overall Study|Guardian declined consent|1
5783963|NCT04035564|19907289|P2|Overall Study|No laboratory available|2
5783964|NCT04035564|19907290|P1|Overall Study|No laboratory available|2
5783965|NCT04035564|19907289|P2|Overall Study|Protocol Violation|2
5783966|NCT04035564|19907290|P1|Overall Study|Protocol Violation|1
5783967|NCT04032652|19907321|P2|Overall Study|The study was terminated and the PI has|1
5783968|NCT04032652|19907322|P1|Overall Study|The study was terminated and the PI has|1
5783969|NCT04024228|19907475|P2|Overall Study|Withdrawal by Subject|4
5783970|NCT04024228|19907476|P1|Overall Study|Withdrawal by Subject|3
5783971|NCT04024228|19907475|P2|Overall Study|Protocol Deviation|2
5783972|NCT04024228|19907476|P1|Overall Study|Protocol Deviation|0
5783973|NCT04024228|19907475|P2|Overall Study|Adverse Event|0
5783974|NCT04024228|19907476|P1|Overall Study|Adverse Event|1
5783975|NCT04017611|19907630|P1|Overall Study|Withdrawn prior to completion|1
5783976|NCT04015232|19907729|P2|Overall Study|Medical Grounds|3
5783977|NCT04015232|19907730|P1|Overall Study|Medical Grounds|3
5783978|NCT04015232|19907729|P2|Overall Study|Protocol Violation|0
5783979|NCT04015232|19907730|P1|Overall Study|Protocol Violation|1
5783980|NCT04015232|19907729|P2|Overall Study|Withdrawal by Subject|4
5783981|NCT04015232|19907730|P1|Overall Study|Withdrawal by Subject|7
5783982|NCT04014062|19907802|P2|Period I: Dosing|Withdrawal by Subject|1
5783983|NCT04014062|19907803|P1|Period I: Dosing|Withdrawal by Subject|3
5783984|NCT04014062|19907802|P2|Period I: Dosing|Medical Grounds|5
5783985|NCT04014062|19907803|P1|Period I: Dosing|Medical Grounds|4
5783986|NCT04007159|19907904|P1|Challenge Phase|missed study visits|3
5783987|NCT04007159|19907904|P1|Induction Phase|Adverse Event|2
5783988|NCT04007159|19907904|P1|Induction Phase|Withdrawal by Subject|4
5783989|NCT04007159|19907904|P1|Induction Phase|(missed study visits)|16
5783990|NCT04007107|19907919|P4|Treatment Period 2 (Day 1)|Withdrawal by Subject|0
5783991|NCT04007107|19907920|P3|Treatment Period 2 (Day 1)|Withdrawal by Subject|0
5783992|NCT04007107|19907921|P2|Treatment Period 2 (Day 1)|Withdrawal by Subject|1
5783993|NCT04007107|19907922|P1|Treatment Period 2 (Day 1)|Withdrawal by Subject|0
5783994|NCT04006366|19907950|P1|Overall Study|Withdrawal by Subject|1
5783995|NCT04005885|19907956|P2|Second Intervention|Withdrawal by Subject|2
5783996|NCT04005885|19907957|P1|Second Intervention|Withdrawal by Subject|0
5783997|NCT04005885|19907956|P2|First Intervention|Withdrawal by Subject|1
5783998|NCT04005885|19907957|P1|First Intervention|Withdrawal by Subject|1
5783999|NCT04002960|19908016|P1|Overall Study|Withdrawn prior to Completion|2
5784000|NCT04002648|19908033|P2|Overall Study|Lost to Follow-up|0
5784001|NCT04002648|19908034|P1|Overall Study|Lost to Follow-up|2
5784002|NCT04000815|19908045|P3|Overall Study|Hypertension occured on follow up|2
5784003|NCT04000815|19908046|P2|Overall Study|Hypertension occured on follow up|0
5784004|NCT04000815|19908047|P1|Overall Study|Hypertension occured on follow up|0
5784005|NCT04000815|19908045|P3|Overall Study|Right ovarian cyst occured|0
5784006|NCT04000815|19908046|P2|Overall Study|Right ovarian cyst occured|0
5784007|NCT04000815|19908047|P1|Overall Study|Right ovarian cyst occured|1
5784008|NCT04000815|19908045|P3|Overall Study|Withdrawal by Subject|2
5784009|NCT04000815|19908046|P2|Overall Study|Withdrawal by Subject|3
5784010|NCT04000815|19908047|P1|Overall Study|Withdrawal by Subject|4
5784011|NCT04000815|19908045|P3|Overall Study|Lost to Follow-up|3
5784012|NCT04000815|19908046|P2|Overall Study|Lost to Follow-up|2
5784013|NCT04000815|19908047|P1|Overall Study|Lost to Follow-up|9
5784014|NCT03997825|19908067|P1|Overall Study|Refused participation|1
5784015|NCT03997825|19908067|P1|Overall Study|Withdrawal by Subject|3
5784016|NCT03997825|19908067|P1|Overall Study|Lost to Follow-up|10
5784017|NCT03997825|19908067|P1|Overall Study|Death|3
5784018|NCT03993392|19908101|P1|Overall Study|Did not meet Day 1 check-in criteria|1
5784019|NCT03993392|19908101|P1|Overall Study|Lost to Follow-up|2
5784020|NCT03993392|19908101|P1|Overall Study|Withdrawal by Subject|3
5784021|NCT03988907|19908249|P2|Overall Study|Unable to complete visit|1
5784022|NCT03988907|19908250|P1|Overall Study|Unable to complete visit|0
5784023|NCT03988088|19908306|P4|Open-Label Addendum|Lost to Follow-up|0
5784024|NCT03988088|19908307|P3|Open-Label Addendum|Lost to Follow-up|1
5784025|NCT03988088|19908308|P2|Open-Label Addendum|Lost to Follow-up|0
5784026|NCT03988088|19908309|P1|Open-Label Addendum|Lost to Follow-up|0
5784027|NCT03988088|19908306|P4|Single-Dose Pharmacokinetic Study|Adverse Event|0
5784028|NCT03988088|19908307|P3|Single-Dose Pharmacokinetic Study|Adverse Event|0
5784029|NCT03988088|19908308|P2|Single-Dose Pharmacokinetic Study|Adverse Event|1
5784030|NCT03988088|19908309|P1|Single-Dose Pharmacokinetic Study|Adverse Event|0
5784031|NCT03984825|19908392|P1|Treatment Period 2 (Day 11 to 21)|Adverse Event|3
5784032|NCT03984825|19908392|P1|Treatment Period 2 (Day 11 to 21)|Physician Decision|1
5784033|NCT03984825|19908392|P1|Treatment Period 1 (Day 1 to 10)|Sponsor decision|2
5784034|NCT03983317|19908506|P1|Overall Study|Physician Decision|5
5784035|NCT03982433|19908513|P1|Overall Study|Lost to Follow-up|1
5784036|NCT03977727|19908591|P2|Second Treatment|Lost to Follow-up|3
5784037|NCT03977727|19908592|P1|Second Treatment|Lost to Follow-up|0
5784038|NCT03976466|19908649|P2|Overall Study|Lost to Follow-up|3
5784039|NCT03976466|19908650|P1|Overall Study|Lost to Follow-up|1
5784040|NCT03972137|19908926|P1|Overall Study|Withdrawal by Subject|4
5784041|NCT03972137|19908926|P1|Overall Study|Lost to Follow-up|2
5784042|NCT03970824|19908951|P3|Overall Study|Adverse Event|0
5784043|NCT03970824|19908952|P2|Overall Study|Adverse Event|0
5784044|NCT03970824|19908953|P1|Overall Study|Adverse Event|1
5784045|NCT03970824|19908951|P3|Overall Study|Lost to Follow-up|1
5784046|NCT03970824|19908952|P2|Overall Study|Lost to Follow-up|2
5784047|NCT03970824|19908953|P1|Overall Study|Lost to Follow-up|0
5784048|NCT03970824|19908951|P3|Overall Study|Withdrawal by Subject|3
5784049|NCT03970824|19908952|P2|Overall Study|Withdrawal by Subject|1
5784050|NCT03970824|19908953|P1|Overall Study|Withdrawal by Subject|1
5784055|NCT03966365|19908994|P2|Overall Study|Protocol Violation|0
5784056|NCT03966365|19908995|P1|Overall Study|Protocol Violation|1
5784057|NCT03965403|19909130|P1|Overall Study|Subject not meeting eligibility criteria|1
5784058|NCT03965052|19909143|P2|Overall Study|Protocol Violation|0
5784059|NCT03965052|19909144|P1|Overall Study|Protocol Violation|1
5784060|NCT03962790|19909240|P2|Period 1|Withdrawal by Subject|0
5784061|NCT03962790|19909241|P1|Period 1|Withdrawal by Subject|1
5784062|NCT03962790|19909240|P2|Period 1|No Longer Meets Eligibility Criteria|0
5784063|NCT03962790|19909241|P1|Period 1|No Longer Meets Eligibility Criteria|1
5784064|NCT03962790|19909240|P2|Period 1|Failed to meet all eligibility criteria|1
5784065|NCT03962790|19909241|P1|Period 1|Failed to meet all eligibility criteria|1
5784066|NCT03962790|19909240|P2|Period 1|Adverse Event|1
5784067|NCT03962790|19909241|P1|Period 1|Adverse Event|0
5784068|NCT03961308|19909276|P2|Overall Study|Adverse Event|1
5784069|NCT03961308|19909277|P1|Overall Study|Adverse Event|0
5784070|NCT03961308|19909276|P2|Overall Study|Lost to Follow-up|1
5784071|NCT03961308|19909277|P1|Overall Study|Lost to Follow-up|0
5784072|NCT03961308|19909276|P2|Overall Study|Other|0
5784073|NCT03961308|19909277|P1|Overall Study|Other|1
5784074|NCT03961308|19909276|P2|Overall Study|Withdrawal by Subject|0
5784075|NCT03961308|19909277|P1|Overall Study|Withdrawal by Subject|1
5784076|NCT03953820|19909470|P3|Two-Sequence, Two-Way Crossover|Physician Decision|0
5784077|NCT03953820|19909471|P2|Two-Sequence, Two-Way Crossover|Physician Decision|0
5784078|NCT03953820|19909472|P1|Two-Sequence, Two-Way Crossover|Physician Decision|1
5784079|NCT03953820|19909470|P3|Two-Sequence, Two-Way Crossover|Adverse Event|0
5784080|NCT03953820|19909471|P2|Two-Sequence, Two-Way Crossover|Adverse Event|0
5784081|NCT03953820|19909472|P1|Two-Sequence, Two-Way Crossover|Adverse Event|1
5784082|NCT03953183|19909488|P2|Overall Study|Withdrawal by Subject|1
5784083|NCT03953183|19909489|P1|Overall Study|Withdrawal by Subject|0
5784084|NCT03953183|19909488|P2|Overall Study|Physician Decision|1
5784085|NCT03953183|19909489|P1|Overall Study|Physician Decision|0
5784086|NCT03951805|19909529|P4|Overall Study|Adverse Event|0
5784087|NCT03951805|19909530|P3|Overall Study|Adverse Event|0
5784088|NCT03951805|19909531|P2|Overall Study|Adverse Event|0
5784089|NCT03951805|19909532|P1|Overall Study|Adverse Event|1
5784090|NCT03950674|19909613|P2|Overall Study|Ongoing in Study|8
5784091|NCT03950674|19909614|P1|Overall Study|Ongoing in Study|22
5784092|NCT03950674|19909613|P2|Overall Study|Death|7
5784093|NCT03950674|19909614|P1|Overall Study|Death|3
5784094|NCT03948581|19909648|P2|Overall Study|Lost to Follow-up|1
5784095|NCT03948581|19909649|P1|Overall Study|Lost to Follow-up|0
5784096|NCT03946124|19909659|P1|Overall Study|Withdrawal by Subject|19
5784097|NCT03943095|19909665|P2|Overall Study|Withdrawal by Subject|0
5784098|NCT03943095|19909666|P1|Overall Study|Withdrawal by Subject|1
5784099|NCT03943095|19909665|P2|Overall Study|Incorrectly dispensed wrong box kit|1
5784100|NCT03943095|19909666|P1|Overall Study|Incorrectly dispensed wrong box kit|0
5784101|NCT03937479|19909715|P5|Overall Study|Physician Decision|1
5784102|NCT03937479|19909716|P4|Overall Study|Physician Decision|0
5784103|NCT03937479|19909717|P3|Overall Study|Physician Decision|1
5784104|NCT03937479|19909718|P2|Overall Study|Physician Decision|0
5784105|NCT03937479|19909719|P1|Overall Study|Physician Decision|0
5784106|NCT03937479|19909715|P5|Overall Study|Lost to Follow-up|0
5784107|NCT03937479|19909716|P4|Overall Study|Lost to Follow-up|1
5784108|NCT03937479|19909717|P3|Overall Study|Lost to Follow-up|0
5784109|NCT03937479|19909718|P2|Overall Study|Lost to Follow-up|1
5784110|NCT03937479|19909719|P1|Overall Study|Lost to Follow-up|0
5784111|NCT03937479|19909715|P5|Overall Study|Protocol Violation|2
5784112|NCT03937479|19909716|P4|Overall Study|Protocol Violation|3
5784113|NCT03937479|19909717|P3|Overall Study|Protocol Violation|4
5784114|NCT03937479|19909718|P2|Overall Study|Protocol Violation|6
5784115|NCT03937479|19909719|P1|Overall Study|Protocol Violation|5
5784116|NCT03937479|19909715|P5|Overall Study|Withdrawal by Subject|1
5784117|NCT03937479|19909716|P4|Overall Study|Withdrawal by Subject|2
5784118|NCT03937479|19909717|P3|Overall Study|Withdrawal by Subject|2
5784119|NCT03937479|19909718|P2|Overall Study|Withdrawal by Subject|5
5784120|NCT03937479|19909719|P1|Overall Study|Withdrawal by Subject|3
5784121|NCT03937479|19909715|P5|Overall Study|Adverse Event|1
5784122|NCT03937479|19909716|P4|Overall Study|Adverse Event|0
5784123|NCT03937479|19909717|P3|Overall Study|Adverse Event|0
5784124|NCT03937479|19909718|P2|Overall Study|Adverse Event|3
5784125|NCT03937479|19909719|P1|Overall Study|Adverse Event|2
5784126|NCT03936244|19909822|P2|Overall Study|Physician Decision|3
5784127|NCT03936244|19909823|P1|Overall Study|Physician Decision|7
5784128|NCT03936244|19909822|P2|Overall Study|Lost to Follow-up|1
5784129|NCT03936244|19909823|P1|Overall Study|Lost to Follow-up|5
5784130|NCT03933462|19910159|P2|Overall Study|Adverse Event|0
5784131|NCT03933462|19910160|P1|Overall Study|Adverse Event|2
5784132|NCT03933449|19910184|P2|Overall Study|Ongoing in Study|6
5784133|NCT03933449|19910185|P1|Overall Study|Ongoing in Study|20
5784134|NCT03933449|19910184|P2|Overall Study|Death|51
5784135|NCT03933449|19910185|P1|Overall Study|Death|36
5784136|NCT03933449|19910184|P2|Overall Study|Adverse Event|4
5784137|NCT03933449|19910185|P1|Overall Study|Adverse Event|6
5784138|NCT03927950|19910261|P1|Overall Study|Adverse Event|9
5784139|NCT03923933|19910294|P2|Overall Study|Withdrawal by Subject|1
5784140|NCT03923933|19910295|P1|Overall Study|Withdrawal by Subject|0
5784141|NCT03923933|19910294|P2|Overall Study|Lost to Follow-up|0
5784142|NCT03923933|19910295|P1|Overall Study|Lost to Follow-up|1
5784143|NCT03923530|19910313|P1|Overall Study|screen failure|3
5784144|NCT03923530|19910313|P1|Overall Study|Withdrawal by Subject|1
5784145|NCT03922750|19910326|P3|Overall Study|Adverse Event|0
5784146|NCT03922750|19910327|P2|Overall Study|Adverse Event|1
5784147|NCT03922750|19910328|P1|Overall Study|Adverse Event|0
5784148|NCT03922750|19910326|P3|Overall Study|Unclassified|1
5784149|NCT03922750|19910327|P2|Overall Study|Unclassified|0
5784150|NCT03922750|19910328|P1|Overall Study|Unclassified|0
5784151|NCT03921723|19910360|P1|Period 3 (4 Days)|Withdrawal by Subject|1
5784152|NCT03921723|19910360|P1|Period 2 (4 Days)|Withdrawal by Subject|3
5784153|NCT03918239|19910466|P2|Overall Study|positive urine drug screening results|1
5784154|NCT03918239|19910467|P1|Overall Study|positive urine drug screening results|4
5784155|NCT03918239|19910466|P2|Overall Study|Withdrawal by Subject|3
5784156|NCT03918239|19910467|P1|Overall Study|Withdrawal by Subject|3
5784157|NCT03918239|19910466|P2|Overall Study|Pregnancy|2
5784158|NCT03918239|19910467|P1|Overall Study|Pregnancy|0
5784159|NCT03918239|19910466|P2|Overall Study|Lost to Follow-up|1
5784160|NCT03918239|19910467|P1|Overall Study|Lost to Follow-up|3
5784161|NCT03914950|19910491|P1|Overall Study|Physician Decision|54
5784162|NCT03914417|19910501|P1|Overall Study|Withdrawal by Subject|2
5784169|NCT03911960|19910527|P2|Overall Study|Lost to Follow-up|3
5784170|NCT03911960|19910528|P1|Overall Study|Lost to Follow-up|5
5784171|NCT03911401|19910572|P3|Overall Study|Withdrawal by parent/guardian|11
5784172|NCT03911401|19910573|P2|Overall Study|Withdrawal by parent/guardian|4
5784173|NCT03911401|19910574|P1|Overall Study|Withdrawal by parent/guardian|4
5784174|NCT03911401|19910572|P3|Overall Study|Withdrawal by Subject|0
5784175|NCT03911401|19910573|P2|Overall Study|Withdrawal by Subject|2
5784176|NCT03911401|19910574|P1|Overall Study|Withdrawal by Subject|1
5784177|NCT03911401|19910572|P3|Overall Study|Physician Decision|1
5784178|NCT03911401|19910573|P2|Overall Study|Physician Decision|0
5784179|NCT03911401|19910574|P1|Overall Study|Physician Decision|0
5784180|NCT03911401|19910572|P3|Overall Study|Lack of Efficacy|8
5784181|NCT03911401|19910573|P2|Overall Study|Lack of Efficacy|1
5784182|NCT03911401|19910574|P1|Overall Study|Lack of Efficacy|1
5784183|NCT03911401|19910572|P3|Overall Study|Adverse Event|5
5784184|NCT03911401|19910573|P2|Overall Study|Adverse Event|2
5784185|NCT03911401|19910574|P1|Overall Study|Adverse Event|1
5784186|NCT03909295|19910595|P1|Overall Study|Study terminated by sponsor|50
5784187|NCT03909295|19910595|P1|Overall Study|Adverse Event|2
5784188|NCT03908970|19910624|P2|Overall Study|Withdrawal by Subject|22
5784189|NCT03908970|19910625|P1|Overall Study|Withdrawal by Subject|9
5784190|NCT03908970|19910624|P2|Overall Study|Physician Decision|4
5784191|NCT03908970|19910625|P1|Overall Study|Physician Decision|1
5784192|NCT03908970|19910624|P2|Overall Study|Adverse Event|21
5784193|NCT03908970|19910625|P1|Overall Study|Adverse Event|7
5784194|NCT03905642|19910763|P1|Overall Study|Completed study but not 24 of 28 days|2
5784195|NCT03905642|19910763|P1|Overall Study|Lack of Efficacy|1
5784196|NCT03905642|19910763|P1|Overall Study|Adverse Event|1
5784197|NCT03905642|19910763|P1|Overall Study|Pregnancy|1
5784198|NCT03905642|19910763|P1|Overall Study|Withdrawal by Subject|3
5784199|NCT03904420|19910774|P2|Overall Study|Study terminated|2
5784200|NCT03904420|19910775|P1|Overall Study|Study terminated|2
5784201|NCT03902613|19910781|P1|Overall Study|Physician Decision|1
5784202|NCT03902392|19910787|P2|Overall Study|Lost to Follow-up|7
5784203|NCT03902392|19910788|P1|Overall Study|Lost to Follow-up|7
5784204|NCT03899064|19910854|P1|Overall Study|Other|2
5784205|NCT03899064|19910854|P1|Overall Study|Withdrawal by Subject|2
5784206|NCT03899064|19910854|P1|Overall Study|Protocol Violation|2
5784207|NCT03899064|19910854|P1|Overall Study|Lost to Follow-up|1
5784208|NCT03897179|19910869|P1|Overall Study|Withdrawal by Subject|1
5784215|NCT03892564|19911112|P1|Overall Study|Withdrawal by Subject|2
5784216|NCT03891641|19911120|P2|Overall Study|Study Stoppage Due to COVID-19|2
5784217|NCT03891641|19911121|P1|Overall Study|Study Stoppage Due to COVID-19|2
5784218|NCT03888482|19911182|P2|Second Wear (8 -1/+2 Days)|Other|0
5784219|NCT03888482|19911183|P1|Second Wear (8 -1/+2 Days)|Other|1
5784220|NCT03888482|19911182|P2|Second Wear (8 -1/+2 Days)|Adverse Event|1
5784221|NCT03888482|19911183|P1|Second Wear (8 -1/+2 Days)|Adverse Event|0
5784222|NCT03888391|19911202|P1|Overall Study|Lost to Follow-up|15
5784223|NCT03887442|19911220|P2|Overall Study|Adverse Event|0
5784224|NCT03887442|19911221|P1|Overall Study|Adverse Event|1
5784225|NCT03885726|19911283|P1|Overall Study|Early discharge from hospital|3
5784226|NCT03885726|19911283|P1|Overall Study|Staffing issues/lost interest|1
5784227|NCT03883386|19911349|P2|First Assignment|Withdrawal by Subject|1
5784228|NCT03883386|19911350|P1|First Assignment|Withdrawal by Subject|1
5784229|NCT03883386|19911349|P2|First Assignment|Lost to Follow-up|0
5784230|NCT03883386|19911350|P1|First Assignment|Lost to Follow-up|1
5784231|NCT03882801|19911360|P2|Period 2|Non-compliance with study drug|1
5784232|NCT03882801|19911361|P1|Period 2|Non-compliance with study drug|0
5784233|NCT03882801|19911360|P2|Washout Period|Physician Decision|1
5784234|NCT03882801|19911361|P1|Washout Period|Physician Decision|0
5784235|NCT03882801|19911360|P2|Period 1|Never treated with study drug|0
5784236|NCT03882801|19911361|P1|Period 1|Never treated with study drug|1
5784237|NCT03882801|19911360|P2|Period 1|Non-compliance with study drug|1
5784238|NCT03882801|19911361|P1|Period 1|Non-compliance with study drug|1
5784239|NCT03882801|19911360|P2|Period 1|Adverse Event|1
5784240|NCT03882801|19911361|P1|Period 1|Adverse Event|0
5784241|NCT03882424|19911376|P3|Overall Study|schedule conflict|0
5784242|NCT03882424|19911377|P2|Overall Study|schedule conflict|0
5784243|NCT03882424|19911378|P1|Overall Study|schedule conflict|1
5784244|NCT03882424|19911376|P3|Overall Study|Lost to Follow-up|0
5784245|NCT03882424|19911377|P2|Overall Study|Lost to Follow-up|0
5784246|NCT03882424|19911378|P1|Overall Study|Lost to Follow-up|3
5784247|NCT03882047|19911401|P3|Overall Study|Did Not Meet Eligibility|1
5784248|NCT03882047|19911402|P2|Overall Study|Did Not Meet Eligibility|0
5784249|NCT03882047|19911403|P1|Overall Study|Did Not Meet Eligibility|0
5784250|NCT03882047|19911401|P3|Overall Study|Noncompliance With Protocol|0
5784251|NCT03882047|19911402|P2|Overall Study|Noncompliance With Protocol|0
5784252|NCT03882047|19911403|P1|Overall Study|Noncompliance With Protocol|2
5784253|NCT03882047|19911401|P3|Overall Study|Did Not Wish to Continue|1
5784254|NCT03882047|19911402|P2|Overall Study|Did Not Wish to Continue|4
5784255|NCT03882047|19911403|P1|Overall Study|Did Not Wish to Continue|1
5784256|NCT03882047|19911401|P3|Overall Study|Lost to Follow-up|0
5784257|NCT03882047|19911402|P2|Overall Study|Lost to Follow-up|1
5784258|NCT03882047|19911403|P1|Overall Study|Lost to Follow-up|0
5784259|NCT03882047|19911401|P3|Overall Study|Treatment Failure|12
5784260|NCT03882047|19911402|P2|Overall Study|Treatment Failure|3
5784261|NCT03882047|19911403|P1|Overall Study|Treatment Failure|3
5784262|NCT03882047|19911401|P3|Overall Study|Adverse Event|2
5784263|NCT03882047|19911402|P2|Overall Study|Adverse Event|2
5784264|NCT03882047|19911403|P1|Overall Study|Adverse Event|0
5784265|NCT03879772|19911480|P5|Overall Study|Did Not Meet Entry Requirements|0
5784266|NCT03879772|19911481|P4|Overall Study|Did Not Meet Entry Requirements|0
5784267|NCT03879772|19911482|P3|Overall Study|Did Not Meet Entry Requirements|1
5784268|NCT03879772|19911483|P2|Overall Study|Did Not Meet Entry Requirements|0
5784269|NCT03879772|19911484|P1|Overall Study|Did Not Meet Entry Requirements|1
5784270|NCT03879772|19911480|P5|Overall Study|Protocol Violation|2
5784271|NCT03879772|19911481|P4|Overall Study|Protocol Violation|1
5784272|NCT03879772|19911482|P3|Overall Study|Protocol Violation|3
5784273|NCT03879772|19911483|P2|Overall Study|Protocol Violation|0
5784274|NCT03879772|19911484|P1|Overall Study|Protocol Violation|0
5784275|NCT03879772|19911480|P5|Overall Study|Withdrawal by Subject|1
5784276|NCT03879772|19911481|P4|Overall Study|Withdrawal by Subject|1
5784277|NCT03879772|19911482|P3|Overall Study|Withdrawal by Subject|3
5784278|NCT03879772|19911483|P2|Overall Study|Withdrawal by Subject|1
5784279|NCT03879772|19911484|P1|Overall Study|Withdrawal by Subject|0
5784280|NCT03879772|19911480|P5|Overall Study|Lost to Follow-up|1
5784281|NCT03879772|19911481|P4|Overall Study|Lost to Follow-up|0
5784282|NCT03879772|19911482|P3|Overall Study|Lost to Follow-up|0
5784283|NCT03879772|19911483|P2|Overall Study|Lost to Follow-up|0
5784284|NCT03879772|19911484|P1|Overall Study|Lost to Follow-up|0
5784285|NCT03879772|19911480|P5|Overall Study|Treatment Failure|1
5784286|NCT03879772|19911481|P4|Overall Study|Treatment Failure|2
5784287|NCT03879772|19911482|P3|Overall Study|Treatment Failure|0
5784288|NCT03879772|19911483|P2|Overall Study|Treatment Failure|0
5784289|NCT03879772|19911484|P1|Overall Study|Treatment Failure|1
5784290|NCT03879772|19911480|P5|Overall Study|Adverse Event|3
5784291|NCT03879772|19911481|P4|Overall Study|Adverse Event|4
5784292|NCT03879772|19911482|P3|Overall Study|Adverse Event|3
5784293|NCT03879772|19911483|P2|Overall Study|Adverse Event|2
5784294|NCT03879772|19911484|P1|Overall Study|Adverse Event|2
5784295|NCT03878758|19911521|P1|Overall Study|Improper consent documentation|1
5784296|NCT03878758|19911521|P1|Overall Study|Protocol defined|2
5784297|NCT03878758|19911521|P1|Overall Study|Withdrawal by Subject|1
5784298|NCT03876743|19911570|P4|Overall Study|Lost to Follow-up|7
5784299|NCT03876743|19911571|P3|Overall Study|Lost to Follow-up|4
5784300|NCT03876743|19911572|P2|Overall Study|Lost to Follow-up|4
5784301|NCT03876743|19911573|P1|Overall Study|Lost to Follow-up|6
5784302|NCT03870997|19911668|P6|Overall Study|Did not complete mid-study/final survey|10531
5784303|NCT03870997|19911669|P5|Overall Study|Did not complete mid-study/final survey|10588
5784304|NCT03870997|19911670|P4|Overall Study|Did not complete mid-study/final survey|10947
5784305|NCT03870997|19911671|P3|Overall Study|Did not complete mid-study/final survey|10978
5784306|NCT03870997|19911672|P2|Overall Study|Did not complete mid-study/final survey|10431
5784307|NCT03870997|19911673|P1|Overall Study|Did not complete mid-study/final survey|10544
5784308|NCT03870555|19911740|P3|Period 3 (2 Days)|Adverse Event|0
5784309|NCT03870555|19911741|P2|Period 3 (2 Days)|Adverse Event|0
5784310|NCT03870555|19911742|P1|Period 3 (2 Days)|Adverse Event|1
5784311|NCT03868631|19911828|P2|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1
5784312|NCT03868631|19911829|P1|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1
5784313|NCT03868631|19911828|P2|Week 6 to Week 12 (Study Completion)|Protocol Violation|0
5784314|NCT03868631|19911829|P1|Week 6 to Week 12 (Study Completion)|Protocol Violation|1
5784315|NCT03868631|19911828|P2|Week 6 to Week 12 (Study Completion)|Adverse Event|0
5784316|NCT03868631|19911829|P1|Week 6 to Week 12 (Study Completion)|Adverse Event|2
5784317|NCT03868631|19911828|P2|Baseline to Week 6|Withdrawal by Subject|0
5784318|NCT03868631|19911829|P1|Baseline to Week 6|Withdrawal by Subject|3
5784319|NCT03868631|19911828|P2|Baseline to Week 6|Protocol Violation|1
5784320|NCT03868631|19911829|P1|Baseline to Week 6|Protocol Violation|1
5784321|NCT03868631|19911828|P2|Baseline to Week 6|Adverse Event|3
5784322|NCT03868631|19911829|P1|Baseline to Week 6|Adverse Event|0
5784323|NCT03864653|19911917|P1|Overall Study|Withdrawal by Subject|1
5784324|NCT03864627|19911924|P2|Overall Study|Study terminated by sponsor|1
5784325|NCT03864627|19911925|P1|Overall Study|Study terminated by sponsor|0
5784326|NCT03864627|19911924|P2|Overall Study|Withdrawal by Subject|8
5784327|NCT03864627|19911925|P1|Overall Study|Withdrawal by Subject|4
5784328|NCT03864627|19911924|P2|Overall Study|Lost to Follow-up|1
5784329|NCT03864627|19911925|P1|Overall Study|Lost to Follow-up|0
5784330|NCT03864627|19911924|P2|Overall Study|Lack of Efficacy|1
5784331|NCT03864627|19911925|P1|Overall Study|Lack of Efficacy|0
5784332|NCT03864627|19911924|P2|Overall Study|Adverse Event|1
5784333|NCT03864627|19911925|P1|Overall Study|Adverse Event|0
5784334|NCT03861559|19911969|P2|Overall Study|Did not meet eligibility requirements|0
5784335|NCT03861559|19911970|P1|Overall Study|Did not meet eligibility requirements|1
5784336|NCT03861559|19911969|P2|Overall Study|Noncompliance|1
5784337|NCT03861559|19911970|P1|Overall Study|Noncompliance|1
5784338|NCT03861559|19911969|P2|Overall Study|Treatment failure|2
5784339|NCT03861559|19911970|P1|Overall Study|Treatment failure|0
5784340|NCT03861559|19911969|P2|Overall Study|Adverse Event|2
5784341|NCT03861559|19911970|P1|Overall Study|Adverse Event|0
5784342|NCT03855228|19912174|P4|Overall Study|Did Not Meet Entry Requirements|1
5784343|NCT03855228|19912175|P3|Overall Study|Did Not Meet Entry Requirements|1
5784344|NCT03855228|19912176|P2|Overall Study|Did Not Meet Entry Requirements|2
5784345|NCT03855228|19912177|P1|Overall Study|Did Not Meet Entry Requirements|0
5784346|NCT03855228|19912174|P4|Overall Study|Protocol Violation|1
5784347|NCT03855228|19912175|P3|Overall Study|Protocol Violation|2
5784348|NCT03855228|19912176|P2|Overall Study|Protocol Violation|1
5784349|NCT03855228|19912177|P1|Overall Study|Protocol Violation|0
5784350|NCT03855228|19912174|P4|Overall Study|Lost to Follow-up|1
5784351|NCT03855228|19912175|P3|Overall Study|Lost to Follow-up|0
5784352|NCT03855228|19912176|P2|Overall Study|Lost to Follow-up|0
5784353|NCT03855228|19912177|P1|Overall Study|Lost to Follow-up|0
5784354|NCT03855228|19912174|P4|Overall Study|Treatment Failure|8
5784355|NCT03855228|19912175|P3|Overall Study|Treatment Failure|1
5784356|NCT03855228|19912176|P2|Overall Study|Treatment Failure|2
5784357|NCT03855228|19912177|P1|Overall Study|Treatment Failure|1
5784358|NCT03855228|19912174|P4|Overall Study|Adverse Event|8
5784359|NCT03855228|19912175|P3|Overall Study|Adverse Event|4
5784360|NCT03855228|19912176|P2|Overall Study|Adverse Event|4
5784361|NCT03855228|19912177|P1|Overall Study|Adverse Event|2
5784362|NCT03855189|19912226|P3|Overall Study|Did Not Return|0
5784363|NCT03855189|19912227|P2|Overall Study|Did Not Return|3
5784364|NCT03855189|19912228|P1|Overall Study|Did Not Return|4
5784365|NCT03855189|19912226|P3|Overall Study|Noncompliance with Protocol|0
5784366|NCT03855189|19912227|P2|Overall Study|Noncompliance with Protocol|1
5784367|NCT03855189|19912228|P1|Overall Study|Noncompliance with Protocol|0
5784368|NCT03855189|19912226|P3|Overall Study|Treatment Failure|2
5784369|NCT03855189|19912227|P2|Overall Study|Treatment Failure|1
5784370|NCT03855189|19912228|P1|Overall Study|Treatment Failure|1
5784371|NCT03855189|19912226|P3|Overall Study|Adverse Event|4
5784372|NCT03855189|19912227|P2|Overall Study|Adverse Event|2
5784373|NCT03855189|19912228|P1|Overall Study|Adverse Event|5
5784374|NCT03851016|19912346|P2|First Intervention (3 Weeks)|Withdrawal by Subject|2
5784375|NCT03851016|19912347|P1|First Intervention (3 Weeks)|Withdrawal by Subject|1
5784376|NCT03850496|19912360|P3|Overall Study|Lost to Follow-up|4
5784377|NCT03850496|19912361|P2|Overall Study|Lost to Follow-up|1
5784378|NCT03850496|19912362|P1|Overall Study|Lost to Follow-up|0
5784379|NCT03850496|19912360|P3|Overall Study|Withdrawal by Subject|0
5784380|NCT03850496|19912361|P2|Overall Study|Withdrawal by Subject|0
5784381|NCT03850496|19912362|P1|Overall Study|Withdrawal by Subject|1
5784382|NCT03850444|19912384|P2|Overall Study|Ongoing in Study|59
5784383|NCT03850444|19912385|P1|Overall Study|Ongoing in Study|78
5784384|NCT03850444|19912384|P2|Overall Study|Withdrawal by Subject|1
5784385|NCT03850444|19912385|P1|Overall Study|Withdrawal by Subject|0
5784386|NCT03850444|19912384|P2|Overall Study|Lost to Follow-up|1
5784387|NCT03850444|19912385|P1|Overall Study|Lost to Follow-up|0
5784388|NCT03850444|19912384|P2|Overall Study|Death|64
5784389|NCT03850444|19912385|P1|Overall Study|Death|38
5784390|NCT03850444|19912384|P2|Overall Study|Adverse Event|9
5784391|NCT03850444|19912385|P1|Overall Study|Adverse Event|12
5784392|NCT03850093|19912414|P3|Overall Study|Withdrawal by Subject|2
5784393|NCT03850093|19912415|P2|Overall Study|Withdrawal by Subject|0
5784394|NCT03850093|19912416|P1|Overall Study|Withdrawal by Subject|1
5784395|NCT03849300|19912478|P4|Overall Study|scheduling/transportation conflict|2
5784396|NCT03849300|19912479|P3|Overall Study|scheduling/transportation conflict|3
5784397|NCT03849300|19912480|P2|Overall Study|scheduling/transportation conflict|4
5784398|NCT03849300|19912481|P1|Overall Study|scheduling/transportation conflict|4
5784399|NCT03849300|19912478|P4|Overall Study|move out to different area|4
5784400|NCT03849300|19912479|P3|Overall Study|move out to different area|1
5784401|NCT03849300|19912480|P2|Overall Study|move out to different area|3
5784402|NCT03849300|19912481|P1|Overall Study|move out to different area|1
5784403|NCT03848416|19912583|P3|Overall Study|Death|1
5784404|NCT03848416|19912584|P2|Overall Study|Death|0
5784405|NCT03848416|19912585|P1|Overall Study|Death|0
5784406|NCT03848416|19912583|P3|Overall Study|Withdrawal by Subject|0
5784407|NCT03848416|19912584|P2|Overall Study|Withdrawal by Subject|0
5784408|NCT03848416|19912585|P1|Overall Study|Withdrawal by Subject|1
5784409|NCT03848403|19912599|P3|Period 2 (Day 8)|Sponsor Decision|5
5784410|NCT03848403|19912600|P2|Period 2 (Day 8)|Sponsor Decision|6
5784411|NCT03848403|19912601|P1|Period 2 (Day 8)|Sponsor Decision|8
5784412|NCT03848403|19912599|P3|Period 2 (Day 8)|Physician Decision|0
5784413|NCT03848403|19912600|P2|Period 2 (Day 8)|Physician Decision|1
5784414|NCT03848403|19912601|P1|Period 2 (Day 8)|Physician Decision|0
5784415|NCT03848403|19912599|P3|Period 2 (Day 8)|Adverse Event|2
5784416|NCT03848403|19912600|P2|Period 2 (Day 8)|Adverse Event|2
5784417|NCT03848403|19912601|P1|Period 2 (Day 8)|Adverse Event|1
5784418|NCT03847987|19912686|P2|Overall Study|Adverse Event|0
5784419|NCT03847987|19912687|P1|Overall Study|Adverse Event|2
5784420|NCT03847987|19912686|P2|Overall Study|Lost to Follow-up|0
5784421|NCT03847987|19912687|P1|Overall Study|Lost to Follow-up|1
5784422|NCT03847610|19912710|P1|Overall Study|Withdrawal by Subject|1
5784423|NCT03844945|19912734|P4|Overall Study|Lack of Efficacy|1
5784424|NCT03844945|19912735|P3|Overall Study|Lack of Efficacy|0
5784425|NCT03844945|19912736|P2|Overall Study|Lack of Efficacy|0
5784426|NCT03844945|19912737|P1|Overall Study|Lack of Efficacy|0
5784427|NCT03844945|19912734|P4|Overall Study|Withdrawal by Subject|0
5784428|NCT03844945|19912735|P3|Overall Study|Withdrawal by Subject|1
5784429|NCT03844945|19912736|P2|Overall Study|Withdrawal by Subject|0
5784430|NCT03844945|19912737|P1|Overall Study|Withdrawal by Subject|0
5784431|NCT03844945|19912734|P4|Overall Study|Adverse Event|0
5784432|NCT03844945|19912735|P3|Overall Study|Adverse Event|4
5784433|NCT03844945|19912736|P2|Overall Study|Adverse Event|1
5784434|NCT03844945|19912737|P1|Overall Study|Adverse Event|1
5784435|NCT03841331|19912769|P2|Overall Study|Lost to Follow-up|1
5784436|NCT03841331|19912770|P1|Overall Study|Lost to Follow-up|5
5784437|NCT03841331|19912769|P2|Overall Study|Withdrawal by Subject|9
5784438|NCT03841331|19912770|P1|Overall Study|Withdrawal by Subject|4
5784439|NCT03840135|19912811|P2|Overall Study|Withdrawal by Subject|0
5784440|NCT03840135|19912812|P1|Overall Study|Withdrawal by Subject|1
5784441|NCT03840135|19912811|P2|Overall Study|Protocol Violation|1
5784442|NCT03840135|19912812|P1|Overall Study|Protocol Violation|6
5784443|NCT03837028|19912842|P4|Overall Study|Withdrawal by Subject|7
5784444|NCT03837028|19912843|P3|Overall Study|Withdrawal by Subject|11
5784445|NCT03837028|19912844|P2|Overall Study|Withdrawal by Subject|11
5784446|NCT03837028|19912845|P1|Overall Study|Withdrawal by Subject|12
5784447|NCT03837028|19912842|P4|Overall Study|Lost to Follow-up|0
5784448|NCT03837028|19912843|P3|Overall Study|Lost to Follow-up|2
5784449|NCT03837028|19912844|P2|Overall Study|Lost to Follow-up|0
5784450|NCT03837028|19912845|P1|Overall Study|Lost to Follow-up|4
5784451|NCT03836729|19912898|P1|Treatment Period 2 (Up to Day 7)|Adverse Event|1
5784452|NCT03836664|19913012|P2|Overall Study|Didn't complete forms and lost drug|3
5784453|NCT03836664|19913013|P1|Overall Study|Didn't complete forms and lost drug|3
5784454|NCT03835221|19913054|P1|Methafilcon A|Withdrawal by Subject|1
5784455|NCT03832387|19913136|P2|Overall Study|EXCLUSION CRITERIA|1
5784456|NCT03832387|19913137|P1|Overall Study|EXCLUSION CRITERIA|3
5784457|NCT03832387|19913136|P2|Overall Study|Protocol Violation|6
5784458|NCT03832387|19913137|P1|Overall Study|Protocol Violation|2
5784459|NCT03832322|19913167|P2|Overall Study|Failed cecal intubation in 2nd exam|1
5784460|NCT03832322|19913168|P1|Overall Study|Failed cecal intubation in 2nd exam|3
5784461|NCT03831282|19913204|P1|Overall Study|Could not place sensor|1
5784462|NCT03830281|19913231|P2|Treatment Period (16 Weeks)|Withdrawal by Subject|6
5784463|NCT03830281|19913232|P1|Treatment Period (16 Weeks)|Withdrawal by Subject|5
5784464|NCT03830281|19913231|P2|Treatment Period (16 Weeks)|Physician Decision|0
5784465|NCT03830281|19913232|P1|Treatment Period (16 Weeks)|Physician Decision|1
5784466|NCT03830281|19913231|P2|Treatment Period (16 Weeks)|Sponsor Decision|1
5784467|NCT03830281|19913232|P1|Treatment Period (16 Weeks)|Sponsor Decision|1
5784468|NCT03830281|19913231|P2|Treatment Period (16 Weeks)|Lost to Follow-up|3
5784469|NCT03830281|19913232|P1|Treatment Period (16 Weeks)|Lost to Follow-up|4
5784470|NCT03830281|19913231|P2|Treatment Period (16 Weeks)|Adverse Event|7
5784471|NCT03830281|19913232|P1|Treatment Period (16 Weeks)|Adverse Event|1
5784472|NCT03830281|19913231|P2|Lead-in Period (2 Weeks)|Withdrawal by Subject|0
5784473|NCT03830281|19913232|P1|Lead-in Period (2 Weeks)|Withdrawal by Subject|29
5784474|NCT03830281|19913231|P2|Lead-in Period (2 Weeks)|Physician Decision|0
5784475|NCT03830281|19913232|P1|Lead-in Period (2 Weeks)|Physician Decision|2
5784476|NCT03830281|19913231|P2|Lead-in Period (2 Weeks)|Not Met Eligibility Criteria|0
5784477|NCT03830281|19913232|P1|Lead-in Period (2 Weeks)|Not Met Eligibility Criteria|6
5784478|NCT03830281|19913231|P2|Lead-in Period (2 Weeks)|Adverse Event|0
5784479|NCT03830281|19913232|P1|Lead-in Period (2 Weeks)|Adverse Event|2
5784480|NCT03828617|19913278|P4|Overall Study|Withdrawal by Subject|0
5784481|NCT03828617|19913279|P3|Overall Study|Withdrawal by Subject|2
5784482|NCT03828617|19913280|P2|Overall Study|Withdrawal by Subject|0
5784483|NCT03828617|19913281|P1|Overall Study|Withdrawal by Subject|2
5784484|NCT03828617|19913278|P4|Overall Study|Protocol Violation|0
5784485|NCT03828617|19913279|P3|Overall Study|Protocol Violation|0
5784486|NCT03828617|19913280|P2|Overall Study|Protocol Violation|2
5784487|NCT03828617|19913281|P1|Overall Study|Protocol Violation|0
5784488|NCT03828617|19913278|P4|Overall Study|No longer met eligibility criteria|3
5784489|NCT03828617|19913279|P3|Overall Study|No longer met eligibility criteria|1
5784490|NCT03828617|19913280|P2|Overall Study|No longer met eligibility criteria|1
5784491|NCT03828617|19913281|P1|Overall Study|No longer met eligibility criteria|0
5784492|NCT03828617|19913278|P4|Overall Study|Lost to Follow-up|7
5784493|NCT03828617|19913279|P3|Overall Study|Lost to Follow-up|23
5784494|NCT03828617|19913280|P2|Overall Study|Lost to Follow-up|12
5784495|NCT03828617|19913281|P1|Overall Study|Lost to Follow-up|22
5784496|NCT03827473|19913318|P2|Overall Study|Withdrawal by Subject|0
5784497|NCT03827473|19913319|P1|Overall Study|Withdrawal by Subject|1
5784498|NCT03826914|19913335|P2|Overall Study|Withdrawal by Subject|1
5784499|NCT03826914|19913336|P1|Overall Study|Withdrawal by Subject|1
5784500|NCT03825042|19913359|P2|Overall Study|Withdrawal by Subject|0
5784501|NCT03825042|19913360|P1|Overall Study|Withdrawal by Subject|1
5784502|NCT03825042|19913359|P2|Overall Study|Adverse Event|0
5784503|NCT03825042|19913360|P1|Overall Study|Adverse Event|1
5784504|NCT03824912|19913373|P3|Overall Study|Participation in another study|0
5784505|NCT03824912|19913374|P2|Overall Study|Participation in another study|1
5784506|NCT03824912|19913375|P1|Overall Study|Participation in another study|0
5784507|NCT03824912|19913373|P3|Overall Study|Withdrawal by Subject|1
5784508|NCT03824912|19913374|P2|Overall Study|Withdrawal by Subject|2
5784509|NCT03824912|19913375|P1|Overall Study|Withdrawal by Subject|3
5784510|NCT03824912|19913373|P3|Overall Study|Protocol Violation|1
5784511|NCT03824912|19913374|P2|Overall Study|Protocol Violation|4
5784512|NCT03824912|19913375|P1|Overall Study|Protocol Violation|1
5784513|NCT03824912|19913373|P3|Overall Study|Non-Compliance with Study Drug|1
5784514|NCT03824912|19913374|P2|Overall Study|Non-Compliance with Study Drug|0
5784515|NCT03824912|19913375|P1|Overall Study|Non-Compliance with Study Drug|0
5784516|NCT03824912|19913373|P3|Overall Study|Negative Baseline Culture Result|57
5784517|NCT03824912|19913374|P2|Overall Study|Negative Baseline Culture Result|112
5784518|NCT03824912|19913375|P1|Overall Study|Negative Baseline Culture Result|118
5784519|NCT03824912|19913373|P3|Overall Study|Lost to Follow-up|8
5784520|NCT03824912|19913374|P2|Overall Study|Lost to Follow-up|15
5784521|NCT03824912|19913375|P1|Overall Study|Lost to Follow-up|18
5784522|NCT03824236|19913398|P3|Overall Study|Lost to Follow-up|1
5784523|NCT03824236|19913399|P2|Overall Study|Lost to Follow-up|0
5784524|NCT03824236|19913400|P1|Overall Study|Lost to Follow-up|0
5784525|NCT03822884|19913458|P6|Overall Study|Withdrawal by Subject|0
5784526|NCT03822884|19913459|P5|Overall Study|Withdrawal by Subject|1
5784527|NCT03822884|19913460|P4|Overall Study|Withdrawal by Subject|0
5784528|NCT03822884|19913461|P3|Overall Study|Withdrawal by Subject|0
5784529|NCT03822884|19913462|P2|Overall Study|Withdrawal by Subject|0
5784530|NCT03822884|19913463|P1|Overall Study|Withdrawal by Subject|0
5784531|NCT03822182|19913495|P3|Overall Study|Protocol Violation|1
5784532|NCT03822182|19913496|P2|Overall Study|Protocol Violation|1
5784533|NCT03822182|19913497|P1|Overall Study|Protocol Violation|0
5784534|NCT03817879|19913652|P2|Overall Study|Withdrawal by Subject|1
5784535|NCT03817879|19913653|P1|Overall Study|Withdrawal by Subject|0
5784536|NCT03817879|19913652|P2|Overall Study|Drop out|12
5784537|NCT03817879|19913653|P1|Overall Study|Drop out|5
5784538|NCT03816761|19913689|P6|Second Treatment Period (7 Days)|Unclassified|0
5784539|NCT03816761|19913690|P5|Second Treatment Period (7 Days)|Unclassified|0
5784540|NCT03816761|19913691|P4|Second Treatment Period (7 Days)|Unclassified|1
5784541|NCT03816761|19913692|P3|Second Treatment Period (7 Days)|Unclassified|0
5784542|NCT03816761|19913693|P2|Second Treatment Period (7 Days)|Unclassified|0
5784543|NCT03816761|19913694|P1|Second Treatment Period (7 Days)|Unclassified|0
5784544|NCT03816761|19913689|P6|First Treatment Period (7 Days)|Withdrawal by Subject|1
5784545|NCT03816761|19913690|P5|First Treatment Period (7 Days)|Withdrawal by Subject|0
5784546|NCT03816761|19913691|P4|First Treatment Period (7 Days)|Withdrawal by Subject|0
5784547|NCT03816761|19913692|P3|First Treatment Period (7 Days)|Withdrawal by Subject|0
5784548|NCT03816761|19913693|P2|First Treatment Period (7 Days)|Withdrawal by Subject|0
5784549|NCT03816761|19913694|P1|First Treatment Period (7 Days)|Withdrawal by Subject|0
5784550|NCT03812510|19913997|P1|Overall Study|Adverse Event|5
5784551|NCT03812510|19913997|P1|Overall Study|Did Not Start Study Medication|55
5784552|NCT03812510|19913997|P1|Overall Study|Study Terminated by Sponsor|9
5784553|NCT03812510|19913997|P1|Overall Study|Physician Decision|2
5784554|NCT03812510|19913997|P1|Overall Study|Withdrawal by Subject|42
5784555|NCT03812510|19913997|P1|Overall Study|Lost to Follow-up|39
5784556|NCT03811093|19914044|P2|Overall Study|Unable to measure body fat percentage|0
5784557|NCT03811093|19914045|P1|Overall Study|Unable to measure body fat percentage|2
5784558|NCT03811093|19914044|P2|Overall Study|Lack of Efficacy, Withdrawal by Subject|4
5784559|NCT03811093|19914045|P1|Overall Study|Lack of Efficacy, Withdrawal by Subject|0
5784560|NCT03810235|19914057|P2|Overall Study|Withdrawal by Subject|0
5784561|NCT03810235|19914058|P1|Overall Study|Withdrawal by Subject|2
5784562|NCT03810183|19914088|P2|Overall Study|Study terminated by Sponsor|1
5784563|NCT03810183|19914089|P1|Overall Study|Study terminated by Sponsor|2
5784564|NCT03810014|19914100|P4|Overall Study|Pregnancy|2
5784565|NCT03810014|19914101|P3|Overall Study|Pregnancy|0
5784566|NCT03810014|19914102|P2|Overall Study|Pregnancy|2
5784567|NCT03810014|19914103|P1|Overall Study|Pregnancy|2
5784568|NCT03809611|19914160|P2|Overall Study|Withdrawal by Subject|1
5784569|NCT03809611|19914161|P1|Overall Study|Withdrawal by Subject|1
5784570|NCT03809104|19914193|P1|Overall Study|Withdrawal by Subject|3
5784571|NCT03808688|19914204|P2|Overall Study|Medication Non-Compliance|1
5784572|NCT03808688|19914205|P1|Overall Study|Medication Non-Compliance|0
5784573|NCT03808688|19914204|P2|Overall Study|Visit Out of Window|1
5784574|NCT03808688|19914205|P1|Overall Study|Visit Out of Window|0
5784575|NCT03808688|19914204|P2|Overall Study|IOP Too High, Nerve/Visual Field Changes|1
5784576|NCT03808688|19914205|P1|Overall Study|IOP Too High, Nerve/Visual Field Changes|0
5784577|NCT03808688|19914204|P2|Overall Study|IOP Too High|1
5784578|NCT03808688|19914205|P1|Overall Study|IOP Too High|1
5784579|NCT03808688|19914204|P2|Overall Study|Intolerance to Conjunctival Hyperemia|0
5784580|NCT03808688|19914205|P1|Overall Study|Intolerance to Conjunctival Hyperemia|1
5784581|NCT03808688|19914204|P2|Overall Study|Withdrawal by Subject|0
5784582|NCT03808688|19914205|P1|Overall Study|Withdrawal by Subject|1
5784583|NCT03808688|19914204|P2|Overall Study|Lost to Follow-up|2
5784584|NCT03808688|19914205|P1|Overall Study|Lost to Follow-up|0
5784585|NCT03808688|19914204|P2|Overall Study|Lack of Efficacy|0
5784586|NCT03808688|19914205|P1|Overall Study|Lack of Efficacy|2
5784587|NCT03808688|19914204|P2|Overall Study|Adverse Event|17
5784588|NCT03808688|19914205|P1|Overall Study|Adverse Event|13
5784589|NCT03808298|19914250|P1|Overall Study|Positive Urine Drug Screen at Check-in|3
5784590|NCT03808298|19914250|P1|Overall Study|Withdrawal by Subject|1
5784591|NCT03808298|19914250|P1|Overall Study|Physician Decision|1
5784592|NCT03808298|19914250|P1|Overall Study|Adverse Event|3
5784593|NCT03807739|19914327|P4|Overall Study|Withdrawal by Subject|0
5784594|NCT03807739|19914328|P3|Overall Study|Withdrawal by Subject|0
5784595|NCT03807739|19914329|P2|Overall Study|Withdrawal by Subject|0
5784596|NCT03807739|19914330|P1|Overall Study|Withdrawal by Subject|1
5784597|NCT03807739|19914327|P4|Overall Study|Adverse Event|0
5784598|NCT03807739|19914328|P3|Overall Study|Adverse Event|0
5784599|NCT03807739|19914329|P2|Overall Study|Adverse Event|0
5784600|NCT03807739|19914330|P1|Overall Study|Adverse Event|1
5784601|NCT03807700|19914346|P2|Overall Study|Withdrawal by Subject|1
5784602|NCT03807700|19914347|P1|Overall Study|Withdrawal by Subject|2
5784603|NCT03805971|19914463|P1|Overall Study|Protocol Violation|2
5784604|NCT03805971|19914463|P1|Overall Study|Withdrawal by Subject|1
5784605|NCT03804918|19914485|P1|Overall Study|Participant did not use the app|1
5784606|NCT03804710|19914492|P2|Overall Study|Other|1
5784607|NCT03804710|19914493|P1|Overall Study|Other|0
5784608|NCT03804710|19914492|P2|Overall Study|Withdrawal by Subject|1
5784609|NCT03804710|19914493|P1|Overall Study|Withdrawal by Subject|2
5784610|NCT03804710|19914492|P2|Overall Study|Adverse Event|3
5784611|NCT03804710|19914493|P1|Overall Study|Adverse Event|0
5784612|NCT03802565|19914587|P5|Overall Study|Elevated Enzymes|2
5784613|NCT03802565|19914588|P4|Overall Study|Elevated Enzymes|0
5784614|NCT03802565|19914589|P3|Overall Study|Elevated Enzymes|0
5784615|NCT03802565|19914590|P2|Overall Study|Elevated Enzymes|0
5784616|NCT03802565|19914591|P1|Overall Study|Elevated Enzymes|0
5784617|NCT03802565|19914587|P5|Overall Study|Subjects Related to Each Other|1
5784618|NCT03802565|19914588|P4|Overall Study|Subjects Related to Each Other|2
5784619|NCT03802565|19914589|P3|Overall Study|Subjects Related to Each Other|0
5784620|NCT03802565|19914590|P2|Overall Study|Subjects Related to Each Other|0
5784621|NCT03802565|19914591|P1|Overall Study|Subjects Related to Each Other|1
5784622|NCT03802565|19914587|P5|Overall Study|Lost to Follow-up|0
5784623|NCT03802565|19914588|P4|Overall Study|Lost to Follow-up|0
5784624|NCT03802565|19914589|P3|Overall Study|Lost to Follow-up|1
5784625|NCT03802565|19914590|P2|Overall Study|Lost to Follow-up|0
5784626|NCT03802565|19914591|P1|Overall Study|Lost to Follow-up|0
5784627|NCT03802565|19914587|P5|Overall Study|Protocol Violation|1
5784628|NCT03802565|19914588|P4|Overall Study|Protocol Violation|5
5784629|NCT03802565|19914589|P3|Overall Study|Protocol Violation|4
5784630|NCT03802565|19914590|P2|Overall Study|Protocol Violation|1
5784631|NCT03802565|19914591|P1|Overall Study|Protocol Violation|2
5784632|NCT03802565|19914587|P5|Overall Study|Withdrawal by Subject|1
5784633|NCT03802565|19914588|P4|Overall Study|Withdrawal by Subject|0
5784634|NCT03802565|19914589|P3|Overall Study|Withdrawal by Subject|2
5784635|NCT03802565|19914590|P2|Overall Study|Withdrawal by Subject|2
5784636|NCT03802565|19914591|P1|Overall Study|Withdrawal by Subject|2
5784637|NCT03802565|19914587|P5|Overall Study|Adverse Event|1
5784638|NCT03802565|19914588|P4|Overall Study|Adverse Event|1
5784639|NCT03802565|19914589|P3|Overall Study|Adverse Event|2
5784640|NCT03802565|19914590|P2|Overall Study|Adverse Event|1
5784641|NCT03802565|19914591|P1|Overall Study|Adverse Event|0
5784642|NCT03801148|19914623|P4|Follow-Up (12 Days)|Lost to Follow-up|0
5784643|NCT03801148|19914624|P3|Follow-Up (12 Days)|Lost to Follow-up|1
5784644|NCT03801148|19914625|P2|Follow-Up (12 Days)|Lost to Follow-up|1
5784645|NCT03801148|19914626|P1|Follow-Up (12 Days)|Lost to Follow-up|0
5784646|NCT03801148|19914623|P4|Washout Period (at Least 5 Days)|Withdrawal by Subject|0
5784647|NCT03801148|19914624|P3|Washout Period (at Least 5 Days)|Withdrawal by Subject|1
5784648|NCT03801148|19914625|P2|Washout Period (at Least 5 Days)|Withdrawal by Subject|0
5784649|NCT03801148|19914626|P1|Washout Period (at Least 5 Days)|Withdrawal by Subject|0
5784650|NCT03801148|19914623|P4|Washout Period (at Least 5 Days)|Lost to Follow-up|1
5784651|NCT03801148|19914624|P3|Washout Period (at Least 5 Days)|Lost to Follow-up|0
5784652|NCT03801148|19914625|P2|Washout Period (at Least 5 Days)|Lost to Follow-up|0
5784653|NCT03801148|19914626|P1|Washout Period (at Least 5 Days)|Lost to Follow-up|0
5784654|NCT03801148|19914623|P4|Period 1 (2 Days)|Adverse Event|0
5784655|NCT03801148|19914624|P3|Period 1 (2 Days)|Adverse Event|0
5784656|NCT03801148|19914625|P2|Period 1 (2 Days)|Adverse Event|1
5784657|NCT03801148|19914626|P1|Period 1 (2 Days)|Adverse Event|1
5784658|NCT03799211|19914745|P2|Overall Study|Withdrawal by Subject|0
5784659|NCT03799211|19914746|P1|Overall Study|Withdrawal by Subject|2
5784660|NCT03799211|19914745|P2|Overall Study|Lost to Follow-up|13
5784661|NCT03799211|19914746|P1|Overall Study|Lost to Follow-up|2
5784662|NCT03793556|19914888|P2|Overall Study|Lost to Follow-up|1
5784663|NCT03793556|19914889|P1|Overall Study|Lost to Follow-up|1
5784664|NCT03793556|19914888|P2|Overall Study|Withdrawal by Subject|1
5784665|NCT03793556|19914889|P1|Overall Study|Withdrawal by Subject|12
5784666|NCT03793010|19914933|P2|Overall Study|Did not meet eligibility criteria|0
5784667|NCT03793010|19914934|P1|Overall Study|Did not meet eligibility criteria|1
5784668|NCT03793010|19914933|P2|Overall Study|Withdrew to pursue other treatment|0
5784669|NCT03793010|19914934|P1|Overall Study|Withdrew to pursue other treatment|1
5784670|NCT03793010|19914933|P2|Overall Study|Patient couldn't sit still for injection|0
5784671|NCT03793010|19914934|P1|Overall Study|Patient couldn't sit still for injection|1
5784672|NCT03793010|19914933|P2|Overall Study|Lost to Follow-up|2
5784673|NCT03793010|19914934|P1|Overall Study|Lost to Follow-up|1
5784674|NCT03793010|19914933|P2|Overall Study|Withdrawn by Investigator or Sponsor|18
5784675|NCT03793010|19914934|P1|Overall Study|Withdrawn by Investigator or Sponsor|19
5784676|NCT03793010|19914933|P2|Overall Study|Withdrawal by Subject|7
5784677|NCT03793010|19914934|P1|Overall Study|Withdrawal by Subject|5
5784678|NCT03792672|19914944|P6|Treatment Period 4 (2 Days)|Other|0
5784679|NCT03792672|19914945|P5|Treatment Period 4 (2 Days)|Other|0
5784680|NCT03792672|19914946|P4|Treatment Period 4 (2 Days)|Other|0
5784681|NCT03792672|19914947|P3|Treatment Period 4 (2 Days)|Other|0
5784682|NCT03792672|19914948|P2|Treatment Period 4 (2 Days)|Other|0
5784683|NCT03792672|19914949|P1|Treatment Period 4 (2 Days)|Other|1
5784684|NCT03792672|19914944|P6|Washout Period 3 (10 Days)|Physician Decision|0
5784685|NCT03792672|19914945|P5|Washout Period 3 (10 Days)|Physician Decision|0
5784686|NCT03792672|19914946|P4|Washout Period 3 (10 Days)|Physician Decision|0
5784687|NCT03792672|19914947|P3|Washout Period 3 (10 Days)|Physician Decision|1
5784688|NCT03792672|19914948|P2|Washout Period 3 (10 Days)|Physician Decision|0
5784689|NCT03792672|19914949|P1|Washout Period 3 (10 Days)|Physician Decision|0
5784690|NCT03792672|19914944|P6|Washout Period 3 (10 Days)|Withdrawal by Subject|0
5784691|NCT03792672|19914945|P5|Washout Period 3 (10 Days)|Withdrawal by Subject|0
5784692|NCT03792672|19914946|P4|Washout Period 3 (10 Days)|Withdrawal by Subject|2
5784693|NCT03792672|19914947|P3|Washout Period 3 (10 Days)|Withdrawal by Subject|0
5784694|NCT03792672|19914948|P2|Washout Period 3 (10 Days)|Withdrawal by Subject|0
5784695|NCT03792672|19914949|P1|Washout Period 3 (10 Days)|Withdrawal by Subject|1
5784696|NCT03790917|19914976|P1|Overall Study|Death|1
5784697|NCT03787212|19915113|P2|Period 1|Study Termination|2
5784698|NCT03787212|19915114|P1|Period 1|Study Termination|2
5784699|NCT03786718|19915134|P1|Overall Study|diagnosis changed from type 2 to type 1|1
5784700|NCT03786718|19915134|P1|Overall Study|Did not use the intervention|2
5784701|NCT03786718|19915134|P1|Overall Study|Withdrawal by Subject|1
5784702|NCT03786718|19915134|P1|Overall Study|Lost to Follow-up|3
5784703|NCT03785548|19915151|P2|Overall Study|no Postop queries|0
5784704|NCT03785548|19915152|P1|Overall Study|no Postop queries|1
5784705|NCT03785548|19915151|P2|Overall Study|age > 80|0
5784706|NCT03785548|19915152|P1|Overall Study|age > 80|1
5784707|NCT03783780|19915201|P1|Overall Study|Withdrawn prior to completion|1
5784708|NCT03782571|19915215|P4|Period 3|Adverse Event|0
5784709|NCT03782571|19915216|P3|Period 3|Adverse Event|0
5784710|NCT03782571|19915217|P2|Period 3|Adverse Event|0
5784711|NCT03782571|19915218|P1|Period 3|Adverse Event|1
5784712|NCT03782571|19915215|P4|Period 3|Subject Unable to Attend V5|0
5784713|NCT03782571|19915216|P3|Period 3|Subject Unable to Attend V5|0
5784714|NCT03782571|19915217|P2|Period 3|Subject Unable to Attend V5|0
5784715|NCT03782571|19915218|P1|Period 3|Subject Unable to Attend V5|1
5784716|NCT03782571|19915215|P4|Period 1|Withdrawal by Subject|0
5784717|NCT03782571|19915216|P3|Period 1|Withdrawal by Subject|0
5784718|NCT03782571|19915217|P2|Period 1|Withdrawal by Subject|0
5784719|NCT03782571|19915218|P1|Period 1|Withdrawal by Subject|1
5784720|NCT03781375|19915316|P2|Open-label Phase|Other|2
5784721|NCT03781375|19915317|P1|Open-label Phase|Other|2
5784722|NCT03781375|19915316|P2|Open-label Phase|Suboptimal Clinical Response|0
5784723|NCT03781375|19915317|P1|Open-label Phase|Suboptimal Clinical Response|1
5784724|NCT03781375|19915316|P2|Open-label Phase|Protocol Issues|1
5784725|NCT03781375|19915317|P1|Open-label Phase|Protocol Issues|0
5784726|NCT03781375|19915316|P2|Double-blind Phase|Other|3
5784727|NCT03781375|19915317|P1|Double-blind Phase|Other|1
5784728|NCT03781375|19915316|P2|Double-blind Phase|Lack of Response|2
5784729|NCT03781375|19915317|P1|Double-blind Phase|Lack of Response|6
5784730|NCT03781375|19915316|P2|Double-blind Phase|Adverse Event|1
5784731|NCT03781375|19915317|P1|Double-blind Phase|Adverse Event|0
5784732|NCT03780959|19915331|P3|Part 2|Response Status|6
5784733|NCT03780959|19915332|P2|Part 2|Response Status|18
5784734|NCT03780959|19915333|P1|Part 2|Response Status|0
5784735|NCT03780959|19915331|P3|Part 2|Withdrawal by Parent/Guardian|0
5784736|NCT03780959|19915332|P2|Part 2|Withdrawal by Parent/Guardian|1
5784737|NCT03780959|19915333|P1|Part 2|Withdrawal by Parent/Guardian|0
5784738|NCT03780959|19915331|P3|Part 1|Response Status|0
5784739|NCT03780959|19915332|P2|Part 1|Response Status|0
5784740|NCT03780959|19915333|P1|Part 1|Response Status|2
5784741|NCT03780959|19915331|P3|Part 1|Withdrawal by Parent/Guardian|0
5784742|NCT03780959|19915332|P2|Part 1|Withdrawal by Parent/Guardian|0
5784743|NCT03780959|19915333|P1|Part 1|Withdrawal by Parent/Guardian|1
5784744|NCT03780959|19915331|P3|Part 1|Withdrawal by Subject|0
5784745|NCT03780959|19915332|P2|Part 1|Withdrawal by Subject|0
5784746|NCT03780959|19915333|P1|Part 1|Withdrawal by Subject|1
5784747|NCT03780959|19915331|P3|Part 1|Adverse Event|0
5784748|NCT03780959|19915332|P2|Part 1|Adverse Event|0
5784749|NCT03780959|19915333|P1|Part 1|Adverse Event|1
5784750|NCT03780400|19915345|P1|Overall Study|Withdrawal by Subject|2
5784751|NCT03780400|19915345|P1|Overall Study|Lost to Follow-up|5
5784752|NCT03779503|19915408|P2|First Intervention|Withdrawal by Subject|0
5784753|NCT03779503|19915409|P1|First Intervention|Withdrawal by Subject|1
5784754|NCT03779503|19915408|P2|First Intervention|Adverse Event|1
5784755|NCT03779503|19915409|P1|First Intervention|Adverse Event|0
5784756|NCT03776175|19915448|P4|Follow-Up Period (35 Days)|Lost to Follow-up|2
5784757|NCT03776175|19915449|P3|Follow-Up Period (35 Days)|Lost to Follow-up|0
5784758|NCT03776175|19915450|P2|Follow-Up Period (35 Days)|Lost to Follow-up|0
5784759|NCT03776175|19915451|P1|Follow-Up Period (35 Days)|Lost to Follow-up|0
5784760|NCT03776175|19915448|P4|Treatment Period (42 Days)|Unable to attend study visits|0
5784761|NCT03776175|19915449|P3|Treatment Period (42 Days)|Unable to attend study visits|0
5784762|NCT03776175|19915450|P2|Treatment Period (42 Days)|Unable to attend study visits|2
5784763|NCT03776175|19915451|P1|Treatment Period (42 Days)|Unable to attend study visits|0
5784764|NCT03776175|19915448|P4|Treatment Period (42 Days)|Withdrawal by Subject|0
5784765|NCT03776175|19915449|P3|Treatment Period (42 Days)|Withdrawal by Subject|3
5784766|NCT03776175|19915450|P2|Treatment Period (42 Days)|Withdrawal by Subject|2
5784767|NCT03776175|19915451|P1|Treatment Period (42 Days)|Withdrawal by Subject|1
5784768|NCT03776175|19915448|P4|Treatment Period (42 Days)|Participants screened at other site|0
5784769|NCT03776175|19915449|P3|Treatment Period (42 Days)|Participants screened at other site|0
5784770|NCT03776175|19915450|P2|Treatment Period (42 Days)|Participants screened at other site|2
5784771|NCT03776175|19915451|P1|Treatment Period (42 Days)|Participants screened at other site|0
5784772|NCT03776175|19915448|P4|Treatment Period (42 Days)|Lost to Follow-up|2
5784773|NCT03776175|19915449|P3|Treatment Period (42 Days)|Lost to Follow-up|0
5784774|NCT03776175|19915450|P2|Treatment Period (42 Days)|Lost to Follow-up|0
5784775|NCT03776175|19915451|P1|Treatment Period (42 Days)|Lost to Follow-up|0
5784776|NCT03776175|19915448|P4|Treatment Period (42 Days)|Adverse Event|0
5784777|NCT03776175|19915449|P3|Treatment Period (42 Days)|Adverse Event|1
5784778|NCT03776175|19915450|P2|Treatment Period (42 Days)|Adverse Event|1
5784779|NCT03776175|19915451|P1|Treatment Period (42 Days)|Adverse Event|0
5784780|NCT03774823|19915483|P2|Overall Study|Withdrawal by Subject|1
5784781|NCT03774823|19915484|P1|Overall Study|Withdrawal by Subject|1
5784782|NCT03774576|19915527|P1|Period 2|Adverse Event|1
5784783|NCT03773133|19915540|P1|Overall Study|Screen Failure|8
5784784|NCT03772522|19915547|P2|Post-intervention Follow-up|Lost to Follow-up|0
5784785|NCT03772522|19915548|P1|Post-intervention Follow-up|Lost to Follow-up|1
5784786|NCT03772522|19915547|P2|Intervention|Withdrawal by Subject|0
5784787|NCT03772522|19915548|P1|Intervention|Withdrawal by Subject|1
5784788|NCT03772522|19915547|P2|Pre-intervention|Withdrawal by Subject|4
5784789|NCT03772522|19915548|P1|Pre-intervention|Withdrawal by Subject|3
5784790|NCT03772327|19915571|P2|Overall Study|Withdrawal by Subject|3
5784791|NCT03772327|19915572|P1|Overall Study|Withdrawal by Subject|2
5784792|NCT03772327|19915571|P2|Overall Study|Lost to Follow-up|4
5784793|NCT03772327|19915572|P1|Overall Study|Lost to Follow-up|3
5784794|NCT03767894|19915618|P1|Overall Study|Withdrawal by Subject|1
5784795|NCT03766646|19915640|P2|Overall Study|Protocol Violation|3
5784796|NCT03766646|19915641|P1|Overall Study|Protocol Violation|0
5784797|NCT03766646|19915640|P2|Overall Study|Withdrawal by Subject|0
5784798|NCT03766646|19915641|P1|Overall Study|Withdrawal by Subject|1
5784799|NCT03765164|19915744|P2|Pre-intervention|Withdrawal by Subject|6
5784800|NCT03765164|19915745|P1|Pre-intervention|Withdrawal by Subject|5
5784801|NCT03765138|19915755|P1|Overall Study|Lost to Follow-up|1
5784802|NCT03764813|19915765|P4|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0
5784803|NCT03764813|19915766|P3|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1
5784804|NCT03764813|19915767|P2|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1
5784805|NCT03764813|19915768|P1|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0
5784806|NCT03762668|19915889|P2|Period 1, First Week of Wear|Withdrawal by Subject|1
5784807|NCT03762668|19915890|P1|Period 1, First Week of Wear|Withdrawal by Subject|0
5784808|NCT03760510|19915949|P2|Overall Study|Not ventilated for 24 hours|97
5784809|NCT03760510|19915950|P1|Overall Study|Not ventilated for 24 hours|105
5784810|NCT03760250|19915962|P1|Overall Study|Physician Decision|1
5784811|NCT03760250|19915962|P1|Overall Study|Withdrawal by Subject|1
5784812|NCT03760146|19915973|P6|Overall Study|Withdrawal by Subject|0
5784813|NCT03760146|19915974|P5|Overall Study|Withdrawal by Subject|1
5784814|NCT03760146|19915975|P4|Overall Study|Withdrawal by Subject|0
5784815|NCT03760146|19915976|P3|Overall Study|Withdrawal by Subject|1
5784816|NCT03760146|19915977|P2|Overall Study|Withdrawal by Subject|20
5784817|NCT03760146|19915978|P1|Overall Study|Withdrawal by Subject|19
5784818|NCT03760146|19915973|P6|Overall Study|Protocol Violation|0
5784819|NCT03760146|19915974|P5|Overall Study|Protocol Violation|1
5784820|NCT03760146|19915975|P4|Overall Study|Protocol Violation|0
5784821|NCT03760146|19915976|P3|Overall Study|Protocol Violation|1
5784822|NCT03760146|19915977|P2|Overall Study|Protocol Violation|13
5784823|NCT03760146|19915978|P1|Overall Study|Protocol Violation|21
5784824|NCT03760146|19915973|P6|Overall Study|No longer met eligibility criteria|0
5784825|NCT03760146|19915974|P5|Overall Study|No longer met eligibility criteria|1
5784826|NCT03760146|19915975|P4|Overall Study|No longer met eligibility criteria|0
5784827|NCT03760146|19915976|P3|Overall Study|No longer met eligibility criteria|0
5784828|NCT03760146|19915977|P2|Overall Study|No longer met eligibility criteria|9
5784829|NCT03760146|19915978|P1|Overall Study|No longer met eligibility criteria|3
5784830|NCT03760146|19915973|P6|Overall Study|Lost to Follow-up|8
5784831|NCT03760146|19915974|P5|Overall Study|Lost to Follow-up|14
5784832|NCT03760146|19915975|P4|Overall Study|Lost to Follow-up|2
5784833|NCT03760146|19915976|P3|Overall Study|Lost to Follow-up|9
5784834|NCT03760146|19915977|P2|Overall Study|Lost to Follow-up|28
5784835|NCT03760146|19915978|P1|Overall Study|Lost to Follow-up|41
5784836|NCT03760146|19915973|P6|Overall Study|Death|0
5784837|NCT03760146|19915974|P5|Overall Study|Death|0
5784838|NCT03760146|19915975|P4|Overall Study|Death|0
5784839|NCT03760146|19915976|P3|Overall Study|Death|0
5784840|NCT03760146|19915977|P2|Overall Study|Death|0
5784841|NCT03760146|19915978|P1|Overall Study|Death|1
5784842|NCT03760146|19915973|P6|Overall Study|Adverse Event|0
5784843|NCT03760146|19915974|P5|Overall Study|Adverse Event|0
5784844|NCT03760146|19915975|P4|Overall Study|Adverse Event|0
5784845|NCT03760146|19915976|P3|Overall Study|Adverse Event|0
5784846|NCT03760146|19915977|P2|Overall Study|Adverse Event|8
5784847|NCT03760146|19915978|P1|Overall Study|Adverse Event|11
5784860|NCT03759600|19916063|P1|Overall Study|Progressive Disease|3
5784861|NCT03759600|19916063|P1|Overall Study|Adverse Event|1
5784862|NCT03759600|19916063|P1|Overall Study|Ongoing at Data Cut-off|16
5784863|NCT03759587|19916077|P1|Overall Study|Ongoing|19
5784864|NCT03759340|19916090|P1|Overall Study|Study Terminated by Sponsor|38
5784865|NCT03759340|19916090|P1|Overall Study|Withdrawal by Subject|15
5784866|NCT03759340|19916090|P1|Overall Study|Lost to Follow-up|1
5784867|NCT03759340|19916090|P1|Overall Study|Adverse Event|2
5784868|NCT03757988|19916110|P1|Overall Study|Withdrawal by Subject|1
5784869|NCT03757234|19916133|P5|Overall Study|Other|0
5784870|NCT03757234|19916134|P4|Overall Study|Other|0
5784871|NCT03757234|19916135|P3|Overall Study|Other|0
5784872|NCT03757234|19916136|P2|Overall Study|Other|1
5784873|NCT03757234|19916137|P1|Overall Study|Other|1
5784874|NCT03757234|19916133|P5|Overall Study|Withdrawal by Subject|2
5784875|NCT03757234|19916134|P4|Overall Study|Withdrawal by Subject|1
5784876|NCT03757234|19916135|P3|Overall Study|Withdrawal by Subject|0
5784877|NCT03757234|19916136|P2|Overall Study|Withdrawal by Subject|1
5784878|NCT03757234|19916137|P1|Overall Study|Withdrawal by Subject|1
5784879|NCT03757234|19916133|P5|Overall Study|Lost to Follow-up|1
5784880|NCT03757234|19916134|P4|Overall Study|Lost to Follow-up|0
5784881|NCT03757234|19916135|P3|Overall Study|Lost to Follow-up|0
5784882|NCT03757234|19916136|P2|Overall Study|Lost to Follow-up|0
5784883|NCT03757234|19916137|P1|Overall Study|Lost to Follow-up|1
5784884|NCT03757234|19916133|P5|Overall Study|Adverse Event|1
5784885|NCT03757234|19916134|P4|Overall Study|Adverse Event|0
5784886|NCT03757234|19916135|P3|Overall Study|Adverse Event|0
5784887|NCT03757234|19916136|P2|Overall Study|Adverse Event|0
5784888|NCT03757234|19916137|P1|Overall Study|Adverse Event|0
5784889|NCT03755882|19916204|P2|Period 1|Unsatisfactory Lens Fitting Test Article|0
5784890|NCT03755882|19916205|P1|Period 1|Unsatisfactory Lens Fitting Test Article|3
5784891|NCT03755882|19916204|P2|Period 1|Protocol Violation|0
5784892|NCT03755882|19916205|P1|Period 1|Protocol Violation|1
5784893|NCT03754582|19916211|P3|Follow-up Phase|Other|1
5784894|NCT03754582|19916212|P2|Follow-up Phase|Other|0
5784895|NCT03754582|19916213|P1|Follow-up Phase|Other|0
5784896|NCT03754582|19916211|P3|Treatment Phase|Adverse Event|0
5784897|NCT03754582|19916212|P2|Treatment Phase|Adverse Event|1
5784898|NCT03754582|19916213|P1|Treatment Phase|Adverse Event|0
5784899|NCT03752528|19916305|P1|Part B|Study terminated by sponsor|3
5784900|NCT03752528|19916305|P1|Part B|Protocol Violation|1
5784901|NCT03752528|19916305|P1|Part A|Protocol Violation|1
5784902|NCT03752528|19916305|P1|Part A|Lost to Follow-up|1
5784903|NCT03752151|19916324|P1|Overall Study|Protocol Violation|1
5784904|NCT03752151|19916324|P1|Overall Study|Withdrawal by Subject|1
5784905|NCT03751280|19916332|P2|Overall Study|Withdrawal by Subject|2
5784906|NCT03751280|19916333|P1|Overall Study|Withdrawal by Subject|5
5784907|NCT03751280|19916332|P2|Overall Study|Protocol Violation|2
5784908|NCT03751280|19916333|P1|Overall Study|Protocol Violation|0
5784909|NCT03751280|19916332|P2|Overall Study|Physician Decision|2
5784910|NCT03751280|19916333|P1|Overall Study|Physician Decision|0
5784911|NCT03751280|19916332|P2|Overall Study|Lost to Follow-up|5
5784912|NCT03751280|19916333|P1|Overall Study|Lost to Follow-up|3
5784913|NCT03751280|19916332|P2|Overall Study|Adverse Event|1
5784914|NCT03751280|19916333|P1|Overall Study|Adverse Event|0
5784915|NCT03751020|19916369|P3|Overall Study|Lost to Follow-up|10
5784916|NCT03751020|19916370|P2|Overall Study|Lost to Follow-up|4
5784917|NCT03751020|19916371|P1|Overall Study|Lost to Follow-up|7
5784918|NCT03751020|19916369|P3|Overall Study|Withdrawal by Subject|0
5784919|NCT03751020|19916370|P2|Overall Study|Withdrawal by Subject|0
5784920|NCT03751020|19916371|P1|Overall Study|Withdrawal by Subject|2
5784921|NCT03746405|19916597|P2|Overall Study|technical difficulties|2
5784922|NCT03746405|19916598|P1|Overall Study|technical difficulties|0
5784923|NCT03746405|19916597|P2|Overall Study|Withdrawal by Subject|0
5784924|NCT03746405|19916598|P1|Overall Study|Withdrawal by Subject|3
5784925|NCT03745937|19916608|P4|Overall Study|Not-specifed|1
5784926|NCT03745937|19916609|P3|Overall Study|Not-specifed|0
5784927|NCT03745937|19916610|P2|Overall Study|Not-specifed|1
5784928|NCT03745937|19916611|P1|Overall Study|Not-specifed|0
5784929|NCT03745937|19916608|P4|Overall Study|Withdrawal by Subject|1
5784930|NCT03745937|19916609|P3|Overall Study|Withdrawal by Subject|0
5784931|NCT03745937|19916610|P2|Overall Study|Withdrawal by Subject|0
5784932|NCT03745937|19916611|P1|Overall Study|Withdrawal by Subject|0
5784933|NCT03745222|19916725|P3|Overall Study|Withdrawal by Subject|0
5784934|NCT03745222|19916726|P2|Overall Study|Withdrawal by Subject|1
5784935|NCT03745222|19916727|P1|Overall Study|Withdrawal by Subject|0
5784936|NCT03742271|19916822|P1|Overall Study|Protocol Violation|1
5784937|NCT03742271|19916822|P1|Overall Study|Failed Insertion & removal|3
5784938|NCT03742271|19916822|P1|Overall Study|Lost to Follow-up|4
5784939|NCT03742271|19916822|P1|Overall Study|Withdrawal by Subject|3
5784940|NCT03742271|19916822|P1|Overall Study|Unsatisfactory Visual Response|1
5784941|NCT03741062|19916872|P2|Overall Study|Protocol Violation|0
5784942|NCT03741062|19916873|P1|Overall Study|Protocol Violation|1
5784943|NCT03739866|19916916|P8|Overall Study|Enrolled but not treated|0
5784944|NCT03739866|19916917|P7|Overall Study|Enrolled but not treated|0
5784945|NCT03739866|19916918|P6|Overall Study|Enrolled but not treated|0
5784946|NCT03739866|19916919|P5|Overall Study|Enrolled but not treated|1
5784947|NCT03739866|19916920|P4|Overall Study|Enrolled but not treated|0
5784948|NCT03739866|19916921|P3|Overall Study|Enrolled but not treated|1
5784949|NCT03739866|19916922|P2|Overall Study|Enrolled but not treated|0
5784950|NCT03739866|19916923|P1|Overall Study|Enrolled but not treated|0
5784951|NCT03739866|19916916|P8|Overall Study|Lost to Follow-up|0
5784952|NCT03739866|19916917|P7|Overall Study|Lost to Follow-up|0
5784953|NCT03739866|19916918|P6|Overall Study|Lost to Follow-up|0
5784954|NCT03739866|19916919|P5|Overall Study|Lost to Follow-up|0
5784955|NCT03739866|19916920|P4|Overall Study|Lost to Follow-up|1
5784956|NCT03739866|19916921|P3|Overall Study|Lost to Follow-up|0
5784957|NCT03739866|19916922|P2|Overall Study|Lost to Follow-up|0
5784958|NCT03739866|19916923|P1|Overall Study|Lost to Follow-up|0
5784959|NCT03739528|19916992|P2|Overall Study|Treatment discontinued + study completed|3
5784960|NCT03739528|19916993|P1|Overall Study|Treatment discontinued + study completed|1
5784961|NCT03739528|19916992|P2|Overall Study|Treatment and study discontinued|2
5784962|NCT03739528|19916993|P1|Overall Study|Treatment and study discontinued|6
5784963|NCT03739528|19916992|P2|Overall Study|Not treated|12
5784964|NCT03739528|19916993|P1|Overall Study|Not treated|8
5784965|NCT03739242|19917025|P2|Overall Study|Protocol Violation|1
5784966|NCT03739242|19917026|P1|Overall Study|Protocol Violation|0
5784967|NCT03739242|19917025|P2|Overall Study|Withdrawal by Subject|1
5784968|NCT03739242|19917026|P1|Overall Study|Withdrawal by Subject|1
5784969|NCT03738865|19917064|P2|Overall Study|Physician Decision|1
5784970|NCT03738865|19917065|P1|Overall Study|Physician Decision|0
5784971|NCT03738865|19917064|P2|Overall Study|Adverse Event|0
5784972|NCT03738865|19917065|P1|Overall Study|Adverse Event|2
5784973|NCT03738865|19917064|P2|Overall Study|Withdrawal by Subject|3
5784974|NCT03738865|19917065|P1|Overall Study|Withdrawal by Subject|3
5784975|NCT03738475|19917081|P2|Overall Study|Participant Non-Compliance|0
5784976|NCT03738475|19917082|P1|Overall Study|Participant Non-Compliance|1
5784977|NCT03736031|19917128|P2|Overall Study|Withdrawal by Subject|0
5784978|NCT03736031|19917129|P1|Overall Study|Withdrawal by Subject|9
5784979|NCT03736031|19917128|P2|Overall Study|Lost to Follow-up|2
5784980|NCT03736031|19917129|P1|Overall Study|Lost to Follow-up|21
5784981|NCT03736031|19917128|P2|Overall Study|Death|4
5784982|NCT03736031|19917129|P1|Overall Study|Death|2
5784983|NCT03733899|19917153|P6|Period 3|Withdrawal by Subject|0
5784984|NCT03733899|19917154|P5|Period 3|Withdrawal by Subject|0
5784985|NCT03733899|19917155|P4|Period 3|Withdrawal by Subject|0
5784986|NCT03733899|19917156|P3|Period 3|Withdrawal by Subject|0
5784987|NCT03733899|19917157|P2|Period 3|Withdrawal by Subject|0
5784988|NCT03733899|19917158|P1|Period 3|Withdrawal by Subject|1
5784989|NCT03733899|19917153|P6|Period 2|Unscuccessful Treatment|0
5784990|NCT03733899|19917154|P5|Period 2|Unscuccessful Treatment|0
5784991|NCT03733899|19917155|P4|Period 2|Unscuccessful Treatment|0
5784992|NCT03733899|19917156|P3|Period 2|Unscuccessful Treatment|0
5784993|NCT03733899|19917157|P2|Period 2|Unscuccessful Treatment|1
5784994|NCT03733899|19917158|P1|Period 2|Unscuccessful Treatment|0
5784995|NCT03733899|19917153|P6|Period 1|Protocol Violation|1
5784996|NCT03733899|19917154|P5|Period 1|Protocol Violation|0
5784997|NCT03733899|19917155|P4|Period 1|Protocol Violation|0
5784998|NCT03733899|19917156|P3|Period 1|Protocol Violation|0
5784999|NCT03733899|19917157|P2|Period 1|Protocol Violation|0
5785000|NCT03733899|19917158|P1|Period 1|Protocol Violation|0
5785001|NCT03733470|19917186|P2|Overall Study|PI Decision|1
5785002|NCT03733470|19917187|P1|Overall Study|PI Decision|1
5785003|NCT03733301|19917196|P3|Overall Study|Withdrawal by Subject|1
5785004|NCT03733301|19917197|P2|Overall Study|Withdrawal by Subject|5
5785005|NCT03733301|19917198|P1|Overall Study|Withdrawal by Subject|3
5785006|NCT03733301|19917196|P3|Overall Study|Adverse Event|3
5785007|NCT03733301|19917197|P2|Overall Study|Adverse Event|1
5785008|NCT03733301|19917198|P1|Overall Study|Adverse Event|0
5785009|NCT03733301|19917196|P3|Overall Study|Lack of Efficacy|0
5785010|NCT03733301|19917197|P2|Overall Study|Lack of Efficacy|3
5785011|NCT03733301|19917198|P1|Overall Study|Lack of Efficacy|2
5785012|NCT03733301|19917196|P3|Overall Study|Non-compliance|0
5785013|NCT03733301|19917197|P2|Overall Study|Non-compliance|0
5785014|NCT03733301|19917198|P1|Overall Study|Non-compliance|1
5785015|NCT03733301|19917196|P3|Overall Study|Screen Fail|0
5785016|NCT03733301|19917197|P2|Overall Study|Screen Fail|0
5785017|NCT03733301|19917198|P1|Overall Study|Screen Fail|1
5785018|NCT03732248|19917280|P2|Overall Study|Withdrawal by Subject|0
5785019|NCT03732248|19917281|P1|Overall Study|Withdrawal by Subject|1
5785022|NCT03730103|19917347|P2|Overall Study|Did not meet inclusion criteria|5
5785023|NCT03730103|19917348|P1|Overall Study|Did not meet inclusion criteria|0
5785024|NCT03728140|19917396|P2|Overall Study|Abnormal embryo transfer operation|7
5785025|NCT03728140|19917397|P1|Overall Study|Abnormal embryo transfer operation|10
5785026|NCT03726996|19917450|P1|Overall Study|Study early termination|2
5785027|NCT03726996|19917450|P1|Overall Study|Parent's decision|2
5785028|NCT03725982|19917469|P2|First Intervention|Physician Decision|1
5785029|NCT03725982|19917470|P1|First Intervention|Physician Decision|1
5785030|NCT03725982|19917469|P2|First Intervention|Withdrawal by Subject|1
5785031|NCT03725982|19917470|P1|First Intervention|Withdrawal by Subject|0
5785032|NCT03725085|19917503|P1|Overall Study|Lost to Follow-up|2
5785033|NCT03724981|19917526|P2|First Device|Protocol Violation|1
5785034|NCT03724981|19917527|P1|First Device|Protocol Violation|1
5785035|NCT03723915|19917649|P1|Survival Follow-up|Still in follow-up|2
5785036|NCT03723915|19917649|P1|On Treatment|Failed to meet treatment requirements|2
5785037|NCT03723915|19917649|P1|Screening|Failed to meet screening requirements.|2
5785038|NCT03722784|19917677|P2|Overall Study|Protocol Violation|1
5785039|NCT03722784|19917678|P1|Overall Study|Protocol Violation|0
5785040|NCT03722784|19917677|P2|Overall Study|Physician Decision|1
5785041|NCT03722784|19917678|P1|Overall Study|Physician Decision|1
5785042|NCT03722784|19917677|P2|Overall Study|Withdrawal by Subject|0
5785043|NCT03722784|19917678|P1|Overall Study|Withdrawal by Subject|1
5785044|NCT03722446|19917722|P2|Overall Study|Protocol Violation|2
5785045|NCT03722446|19917723|P1|Overall Study|Protocol Violation|15
5785046|NCT03722264|19917739|P1|Overall Study|Physician Decision|3
5785047|NCT03722030|19917751|P2|Overall Study|Withdrawal by Subject|0
5785048|NCT03722030|19917752|P1|Overall Study|Withdrawal by Subject|1
5785049|NCT03720847|19917822|P2|Washout|Physician Decision|2
5785050|NCT03720847|19917823|P1|Washout|Physician Decision|1
5785051|NCT03720470|19917845|P6|Treatment Period: Final 4 Weeks|Other|0
5785052|NCT03720470|19917846|P5|Treatment Period: Final 4 Weeks|Other|1
5785053|NCT03720470|19917847|P4|Treatment Period: Final 4 Weeks|Other|2
5785054|NCT03720470|19917848|P3|Treatment Period: Final 4 Weeks|Other|0
5785055|NCT03720470|19917849|P2|Treatment Period: Final 4 Weeks|Other|1
5785056|NCT03720470|19917850|P1|Treatment Period: Final 4 Weeks|Other|0
5785057|NCT03720470|19917845|P6|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2
5785058|NCT03720470|19917846|P5|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2
5785059|NCT03720470|19917847|P4|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2
5785060|NCT03720470|19917848|P3|Treatment Period: Final 4 Weeks|Withdrawal by Subject|0
5785061|NCT03720470|19917849|P2|Treatment Period: Final 4 Weeks|Withdrawal by Subject|1
5785062|NCT03720470|19917850|P1|Treatment Period: Final 4 Weeks|Withdrawal by Subject|0
5785063|NCT03720470|19917845|P6|Treatment Period: Final 4 Weeks|Protocol Deviation|0
5785064|NCT03720470|19917846|P5|Treatment Period: Final 4 Weeks|Protocol Deviation|0
5785065|NCT03720470|19917847|P4|Treatment Period: Final 4 Weeks|Protocol Deviation|0
5785066|NCT03720470|19917848|P3|Treatment Period: Final 4 Weeks|Protocol Deviation|1
5785067|NCT03720470|19917849|P2|Treatment Period: Final 4 Weeks|Protocol Deviation|0
5785068|NCT03720470|19917850|P1|Treatment Period: Final 4 Weeks|Protocol Deviation|0
5785069|NCT03720470|19917845|P6|Treatment Period: Final 4 Weeks|Pregnancy|1
5785070|NCT03720470|19917846|P5|Treatment Period: Final 4 Weeks|Pregnancy|0
5785071|NCT03720470|19917847|P4|Treatment Period: Final 4 Weeks|Pregnancy|0
5785072|NCT03720470|19917848|P3|Treatment Period: Final 4 Weeks|Pregnancy|0
5785073|NCT03720470|19917849|P2|Treatment Period: Final 4 Weeks|Pregnancy|0
5785074|NCT03720470|19917850|P1|Treatment Period: Final 4 Weeks|Pregnancy|0
5785075|NCT03720470|19917845|P6|Treatment Period: Final 4 Weeks|Lost to Follow-up|1
5785076|NCT03720470|19917846|P5|Treatment Period: Final 4 Weeks|Lost to Follow-up|0
5785077|NCT03720470|19917847|P4|Treatment Period: Final 4 Weeks|Lost to Follow-up|1
5785078|NCT03720470|19917848|P3|Treatment Period: Final 4 Weeks|Lost to Follow-up|0
5785079|NCT03720470|19917849|P2|Treatment Period: Final 4 Weeks|Lost to Follow-up|0
5785080|NCT03720470|19917850|P1|Treatment Period: Final 4 Weeks|Lost to Follow-up|0
5785081|NCT03720470|19917845|P6|Treatment Period: Final 4 Weeks|Lack of Efficacy|0
5785082|NCT03720470|19917846|P5|Treatment Period: Final 4 Weeks|Lack of Efficacy|0
5785083|NCT03720470|19917847|P4|Treatment Period: Final 4 Weeks|Lack of Efficacy|0
5785084|NCT03720470|19917848|P3|Treatment Period: Final 4 Weeks|Lack of Efficacy|1
5785085|NCT03720470|19917849|P2|Treatment Period: Final 4 Weeks|Lack of Efficacy|0
5785086|NCT03720470|19917850|P1|Treatment Period: Final 4 Weeks|Lack of Efficacy|0
5785087|NCT03720470|19917845|P6|Treatment Period: Final 4 Weeks|Adverse Event|1
5785088|NCT03720470|19917846|P5|Treatment Period: Final 4 Weeks|Adverse Event|1
5785089|NCT03720470|19917847|P4|Treatment Period: Final 4 Weeks|Adverse Event|2
5785090|NCT03720470|19917848|P3|Treatment Period: Final 4 Weeks|Adverse Event|0
5785091|NCT03720470|19917849|P2|Treatment Period: Final 4 Weeks|Adverse Event|0
5785092|NCT03720470|19917850|P1|Treatment Period: Final 4 Weeks|Adverse Event|0
5785093|NCT03720470|19917845|P6|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|1
5785094|NCT03720470|19917846|P5|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0
5785095|NCT03720470|19917847|P4|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0
5785096|NCT03720470|19917848|P3|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0
5785097|NCT03720470|19917849|P2|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0
5785098|NCT03720470|19917850|P1|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0
5785099|NCT03720470|19917845|P6|Treatment Period: First Part 16 Weeks|Other|2
5785100|NCT03720470|19917846|P5|Treatment Period: First Part 16 Weeks|Other|2
5785101|NCT03720470|19917847|P4|Treatment Period: First Part 16 Weeks|Other|1
5785102|NCT03720470|19917848|P3|Treatment Period: First Part 16 Weeks|Other|0
5785103|NCT03720470|19917849|P2|Treatment Period: First Part 16 Weeks|Other|0
5785104|NCT03720470|19917850|P1|Treatment Period: First Part 16 Weeks|Other|1
5785105|NCT03720470|19917845|P6|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0
5785106|NCT03720470|19917846|P5|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|1
5785107|NCT03720470|19917847|P4|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|1
5785108|NCT03720470|19917848|P3|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0
5785109|NCT03720470|19917849|P2|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0
5785110|NCT03720470|19917850|P1|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0
5785111|NCT03720470|19917845|P6|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|6
5785112|NCT03720470|19917846|P5|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|3
5785113|NCT03720470|19917847|P4|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|9
5785196|NCT03716024|19918163|P1|Overall Study|Randomized, not Treated|7
5785114|NCT03720470|19917848|P3|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|0
5785115|NCT03720470|19917849|P2|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|0
5785116|NCT03720470|19917850|P1|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|5
5785117|NCT03720470|19917845|P6|Treatment Period: First Part 16 Weeks|Protocol deviation|1
5785118|NCT03720470|19917846|P5|Treatment Period: First Part 16 Weeks|Protocol deviation|2
5785119|NCT03720470|19917847|P4|Treatment Period: First Part 16 Weeks|Protocol deviation|2
5785120|NCT03720470|19917848|P3|Treatment Period: First Part 16 Weeks|Protocol deviation|0
5785121|NCT03720470|19917849|P2|Treatment Period: First Part 16 Weeks|Protocol deviation|0
5785122|NCT03720470|19917850|P1|Treatment Period: First Part 16 Weeks|Protocol deviation|2
5785123|NCT03720470|19917845|P6|Treatment Period: First Part 16 Weeks|Pregnancy|1
5785124|NCT03720470|19917846|P5|Treatment Period: First Part 16 Weeks|Pregnancy|1
5785125|NCT03720470|19917847|P4|Treatment Period: First Part 16 Weeks|Pregnancy|0
5785126|NCT03720470|19917848|P3|Treatment Period: First Part 16 Weeks|Pregnancy|0
5785127|NCT03720470|19917849|P2|Treatment Period: First Part 16 Weeks|Pregnancy|0
5785128|NCT03720470|19917850|P1|Treatment Period: First Part 16 Weeks|Pregnancy|0
5785129|NCT03720470|19917845|P6|Treatment Period: First Part 16 Weeks|Lost to Follow-up|2
5785130|NCT03720470|19917846|P5|Treatment Period: First Part 16 Weeks|Lost to Follow-up|1
5785131|NCT03720470|19917847|P4|Treatment Period: First Part 16 Weeks|Lost to Follow-up|2
5785132|NCT03720470|19917848|P3|Treatment Period: First Part 16 Weeks|Lost to Follow-up|0
5785133|NCT03720470|19917849|P2|Treatment Period: First Part 16 Weeks|Lost to Follow-up|0
5785134|NCT03720470|19917850|P1|Treatment Period: First Part 16 Weeks|Lost to Follow-up|1
5785135|NCT03720470|19917845|P6|Treatment Period: First Part 16 Weeks|Lack of Efficacy|1
5785136|NCT03720470|19917846|P5|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0
5785137|NCT03720470|19917847|P4|Treatment Period: First Part 16 Weeks|Lack of Efficacy|1
5785138|NCT03720470|19917848|P3|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0
5785139|NCT03720470|19917849|P2|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0
5785140|NCT03720470|19917850|P1|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0
5785141|NCT03720470|19917845|P6|Treatment Period: First Part 16 Weeks|Adverse Event|6
5785142|NCT03720470|19917846|P5|Treatment Period: First Part 16 Weeks|Adverse Event|8
5785143|NCT03720470|19917847|P4|Treatment Period: First Part 16 Weeks|Adverse Event|5
5785144|NCT03720470|19917848|P3|Treatment Period: First Part 16 Weeks|Adverse Event|0
5785145|NCT03720470|19917849|P2|Treatment Period: First Part 16 Weeks|Adverse Event|0
5785146|NCT03720470|19917850|P1|Treatment Period: First Part 16 Weeks|Adverse Event|5
5785147|NCT03718143|19918028|P3|Overall Study|Withdrawal of Informed Consent|1
5785148|NCT03718143|19918029|P2|Overall Study|Withdrawal of Informed Consent|2
5785149|NCT03718143|19918030|P1|Overall Study|Withdrawal of Informed Consent|1
5785150|NCT03718143|19918028|P3|Overall Study|Progression of Disease|0
5785151|NCT03718143|19918029|P2|Overall Study|Progression of Disease|0
5785152|NCT03718143|19918030|P1|Overall Study|Progression of Disease|1
5785153|NCT03718143|19918028|P3|Overall Study|Death|0
5785154|NCT03718143|19918029|P2|Overall Study|Death|0
5785155|NCT03718143|19918030|P1|Overall Study|Death|1
5785156|NCT03718000|19918046|P2|Overall Study|Pregnancy|1
5785157|NCT03718000|19918047|P1|Overall Study|Pregnancy|0
5785158|NCT03718000|19918046|P2|Overall Study|Relocation|4
5785159|NCT03718000|19918047|P1|Overall Study|Relocation|2
5785160|NCT03717064|19918069|P1|Period 2|Adverse Event|1
5785161|NCT03716050|19918101|P8|Overall Study|Protocol Violation|2
5785162|NCT03716050|19918102|P7|Overall Study|Protocol Violation|0
5785163|NCT03716050|19918103|P6|Overall Study|Protocol Violation|0
5785164|NCT03716050|19918104|P5|Overall Study|Protocol Violation|0
5785165|NCT03716050|19918105|P4|Overall Study|Protocol Violation|1
5785166|NCT03716050|19918106|P3|Overall Study|Protocol Violation|0
5785167|NCT03716050|19918107|P2|Overall Study|Protocol Violation|0
5785168|NCT03716050|19918108|P1|Overall Study|Protocol Violation|0
5785169|NCT03716050|19918101|P8|Overall Study|Physician Decision|0
5785170|NCT03716050|19918102|P7|Overall Study|Physician Decision|0
5785171|NCT03716050|19918103|P6|Overall Study|Physician Decision|0
5785172|NCT03716050|19918104|P5|Overall Study|Physician Decision|0
5785173|NCT03716050|19918105|P4|Overall Study|Physician Decision|1
5785174|NCT03716050|19918106|P3|Overall Study|Physician Decision|0
5785175|NCT03716050|19918107|P2|Overall Study|Physician Decision|0
5785176|NCT03716050|19918108|P1|Overall Study|Physician Decision|0
5785177|NCT03716050|19918101|P8|Overall Study|Lost to Follow-up|0
5785178|NCT03716050|19918102|P7|Overall Study|Lost to Follow-up|0
5785179|NCT03716050|19918103|P6|Overall Study|Lost to Follow-up|0
5785180|NCT03716050|19918104|P5|Overall Study|Lost to Follow-up|0
5785181|NCT03716050|19918105|P4|Overall Study|Lost to Follow-up|0
5785182|NCT03716050|19918106|P3|Overall Study|Lost to Follow-up|1
5785183|NCT03716050|19918107|P2|Overall Study|Lost to Follow-up|0
5785184|NCT03716050|19918108|P1|Overall Study|Lost to Follow-up|0
5785185|NCT03716024|19918162|P2|Overall Study|Missing Reason|1
5785186|NCT03716024|19918163|P1|Overall Study|Missing Reason|0
5785187|NCT03716024|19918162|P2|Overall Study|Withdrawal by Subject|1
5785188|NCT03716024|19918163|P1|Overall Study|Withdrawal by Subject|0
5785189|NCT03716024|19918162|P2|Overall Study|Lost to Follow-up|6
5785190|NCT03716024|19918163|P1|Overall Study|Lost to Follow-up|2
5785191|NCT03716024|19918162|P2|Overall Study|Treatment Failure|0
5785192|NCT03716024|19918163|P1|Overall Study|Treatment Failure|1
5785193|NCT03716024|19918162|P2|Overall Study|Adverse Event|2
5785194|NCT03716024|19918163|P1|Overall Study|Adverse Event|1
5785195|NCT03716024|19918162|P2|Overall Study|Randomized, not Treated|8
5785197|NCT03715530|19918197|P3|Overall Study|Lost to Follow-up|2
5785198|NCT03715530|19918198|P2|Overall Study|Lost to Follow-up|1
5785199|NCT03715530|19918199|P1|Overall Study|Lost to Follow-up|3
5785200|NCT03714672|19918259|P4|Overall Study|Lost to Follow-up|0
5785201|NCT03714672|19918260|P3|Overall Study|Lost to Follow-up|0
5785202|NCT03714672|19918261|P2|Overall Study|Lost to Follow-up|1
5785203|NCT03714672|19918262|P1|Overall Study|Lost to Follow-up|1
5785204|NCT03714672|19918259|P4|Overall Study|Other Reason|1
5785205|NCT03714672|19918260|P3|Overall Study|Other Reason|1
5785206|NCT03714672|19918261|P2|Overall Study|Other Reason|2
5785207|NCT03714672|19918262|P1|Overall Study|Other Reason|1
5785208|NCT03714672|19918259|P4|Overall Study|Physician Decision|0
5785209|NCT03714672|19918260|P3|Overall Study|Physician Decision|0
5785210|NCT03714672|19918261|P2|Overall Study|Physician Decision|1
5785211|NCT03714672|19918262|P1|Overall Study|Physician Decision|0
5785212|NCT03714672|19918259|P4|Overall Study|Adverse Event|0
5785213|NCT03714672|19918260|P3|Overall Study|Adverse Event|3
5785214|NCT03714672|19918261|P2|Overall Study|Adverse Event|0
5785215|NCT03714672|19918262|P1|Overall Study|Adverse Event|0
5785216|NCT03714022|19918324|P2|Overall Study|Lost to Follow-up|2
5785217|NCT03714022|19918325|P1|Overall Study|Lost to Follow-up|3
5785218|NCT03714022|19918324|P2|Overall Study|Consent withdrawal|1
5785219|NCT03714022|19918325|P1|Overall Study|Consent withdrawal|0
5785220|NCT03714022|19918324|P2|Overall Study|Adverse Event|0
5785221|NCT03714022|19918325|P1|Overall Study|Adverse Event|1
5785222|NCT03712917|19918378|P3|Overall Study|Lost to Follow-up|5
5785223|NCT03712917|19918379|P2|Overall Study|Lost to Follow-up|4
5785224|NCT03712917|19918380|P1|Overall Study|Lost to Follow-up|9
5785225|NCT03712917|19918378|P3|Overall Study|Adverse Event|3
5785226|NCT03712917|19918379|P2|Overall Study|Adverse Event|4
5785227|NCT03712917|19918380|P1|Overall Study|Adverse Event|0
5785228|NCT03712917|19918378|P3|Overall Study|Pregnancy|1
5785229|NCT03712917|19918379|P2|Overall Study|Pregnancy|0
5785230|NCT03712917|19918380|P1|Overall Study|Pregnancy|0
5785231|NCT03710083|19918408|P1|Overall Study|Unsuccessful Procedure|1
5785232|NCT03710083|19918408|P1|Overall Study|Withdrawal by Subject|2
5785233|NCT03709823|19918421|P6|Overall Study|Other, Not Specified|0
5785234|NCT03709823|19918422|P5|Overall Study|Other, Not Specified|0
5785235|NCT03709823|19918423|P4|Overall Study|Other, Not Specified|1
5785236|NCT03709823|19918424|P3|Overall Study|Other, Not Specified|0
5785237|NCT03709823|19918425|P2|Overall Study|Other, Not Specified|0
5785238|NCT03709823|19918426|P1|Overall Study|Other, Not Specified|0
5785239|NCT03709823|19918421|P6|Overall Study|Withdrawal by Subject|0
5785240|NCT03709823|19918422|P5|Overall Study|Withdrawal by Subject|0
5785241|NCT03709823|19918423|P4|Overall Study|Withdrawal by Subject|0
5785242|NCT03709823|19918424|P3|Overall Study|Withdrawal by Subject|0
5785243|NCT03709823|19918425|P2|Overall Study|Withdrawal by Subject|3
5785244|NCT03709823|19918426|P1|Overall Study|Withdrawal by Subject|1
5785245|NCT03709823|19918421|P6|Overall Study|Lost to Follow-up|0
5785246|NCT03709823|19918422|P5|Overall Study|Lost to Follow-up|1
5785247|NCT03709823|19918423|P4|Overall Study|Lost to Follow-up|1
5785248|NCT03709823|19918424|P3|Overall Study|Lost to Follow-up|2
5785249|NCT03709823|19918425|P2|Overall Study|Lost to Follow-up|2
5785250|NCT03709823|19918426|P1|Overall Study|Lost to Follow-up|2
5785251|NCT03709823|19918421|P6|Overall Study|Adverse Event|0
5785252|NCT03709823|19918422|P5|Overall Study|Adverse Event|0
5785253|NCT03709823|19918423|P4|Overall Study|Adverse Event|0
5785254|NCT03709823|19918424|P3|Overall Study|Adverse Event|1
5785255|NCT03709823|19918425|P2|Overall Study|Adverse Event|0
5785256|NCT03709823|19918426|P1|Overall Study|Adverse Event|0
5785257|NCT03709654|19918463|P2|Overall Study|Adverse Event|0
5785258|NCT03709654|19918464|P1|Overall Study|Adverse Event|1
5785259|NCT03709654|19918463|P2|Overall Study|Withdrawal by Subject|1
5785260|NCT03709654|19918464|P1|Overall Study|Withdrawal by Subject|1
5785261|NCT03709654|19918463|P2|Overall Study|Lost to Follow-up|1
5785262|NCT03709654|19918464|P1|Overall Study|Lost to Follow-up|1
5785263|NCT03709576|19918501|P1|Overall Study|progression prior to enrollment|1
5785264|NCT03708744|19918524|P4|Overall Study|Withdrawal by Subject|0
5785265|NCT03708744|19918525|P3|Overall Study|Withdrawal by Subject|1
5785266|NCT03708744|19918526|P2|Overall Study|Withdrawal by Subject|0
5785267|NCT03708744|19918527|P1|Overall Study|Withdrawal by Subject|0
5785268|NCT03708211|19918561|P2|Overall Study|Other|0
5785269|NCT03708211|19918562|P1|Overall Study|Other|2
5785270|NCT03708211|19918561|P2|Overall Study|Withdrawal by Subject|1
5785271|NCT03708211|19918562|P1|Overall Study|Withdrawal by Subject|0
5785272|NCT03708211|19918561|P2|Overall Study|Progressive Disease|7
5785273|NCT03708211|19918562|P1|Overall Study|Progressive Disease|10
5785274|NCT03707912|19918594|P2|Overall Study|Violation of inclusion criteria|0
5785275|NCT03707912|19918595|P1|Overall Study|Violation of inclusion criteria|1
5785276|NCT03707821|19918615|P2|Overall Study|Unsatisfactory Lens Fitting|0
5785277|NCT03707821|19918616|P1|Overall Study|Unsatisfactory Lens Fitting|1
5785278|NCT03707821|19918615|P2|Overall Study|Unsatisfactory Visual Response|0
5785279|NCT03707821|19918616|P1|Overall Study|Unsatisfactory Visual Response|1
5785280|NCT03707821|19918615|P2|Overall Study|Protocol Violation|1
5785281|NCT03707821|19918616|P1|Overall Study|Protocol Violation|0
5785282|NCT03707587|19918636|P2|Overall Study|Death|1
5785283|NCT03707587|19918637|P1|Overall Study|Death|0
5785284|NCT03707522|19918653|P4|Overall Study|Lost to Follow-up|36
5785285|NCT03707522|19918654|P3|Overall Study|Lost to Follow-up|41
5785286|NCT03707522|19918655|P2|Overall Study|Lost to Follow-up|27
5785287|NCT03707522|19918656|P1|Overall Study|Lost to Follow-up|24
5785288|NCT03705793|19918745|P2|Overall Study|Withdrawal by Subject|1
5785289|NCT03705793|19918746|P1|Overall Study|Withdrawal by Subject|2
5785290|NCT03705793|19918745|P2|Overall Study|Lost to Follow-up|4
5785291|NCT03705793|19918746|P1|Overall Study|Lost to Follow-up|3
5785292|NCT03705494|19918758|P2|Overall Study|Withdrawal by Subject|2
5785293|NCT03705494|19918759|P1|Overall Study|Withdrawal by Subject|5
5785294|NCT03705494|19918758|P2|Overall Study|Lost to Follow-up|1
5785295|NCT03705494|19918759|P1|Overall Study|Lost to Follow-up|2
5785296|NCT03704194|19918845|P2|Overall Study|Withdrawal by Subject|1
5785297|NCT03704194|19918846|P1|Overall Study|Withdrawal by Subject|0
5785298|NCT03703466|19918874|P3|Overall Study|Completed < 3 Cycles As Of Data Cut-Off|2
5785299|NCT03703466|19918875|P2|Overall Study|Completed < 3 Cycles As Of Data Cut-Off|2
5785300|NCT03703466|19918876|P1|Overall Study|Completed < 3 Cycles As Of Data Cut-Off|1
5785301|NCT03703466|19918874|P3|Overall Study|Withdrawal by Subject|0
5785302|NCT03703466|19918875|P2|Overall Study|Withdrawal by Subject|3
5785303|NCT03703466|19918876|P1|Overall Study|Withdrawal by Subject|0
5785304|NCT03703466|19918874|P3|Overall Study|Protocol Violation|0
5785305|NCT03703466|19918875|P2|Overall Study|Protocol Violation|0
5785306|NCT03703466|19918876|P1|Overall Study|Protocol Violation|1
5785307|NCT03703466|19918874|P3|Overall Study|Death|0
5785308|NCT03703466|19918875|P2|Overall Study|Death|1
5785309|NCT03703466|19918876|P1|Overall Study|Death|2
5785310|NCT03703336|19918910|P2|Overall Study|Lost to Follow-up|0
5785311|NCT03703336|19918911|P1|Overall Study|Lost to Follow-up|1
5785312|NCT03703336|19918910|P2|Overall Study|Adverse Event|2
5785313|NCT03703336|19918911|P1|Overall Study|Adverse Event|0
5785314|NCT03703336|19918910|P2|Overall Study|Physician Decision|0
5785315|NCT03703336|19918911|P1|Overall Study|Physician Decision|2
5785316|NCT03703336|19918910|P2|Overall Study|Protocol Violation|1
5785317|NCT03703336|19918911|P1|Overall Study|Protocol Violation|3
5785318|NCT03703336|19918910|P2|Overall Study|Migration|3
5785319|NCT03703336|19918911|P1|Overall Study|Migration|3
5785320|NCT03703336|19918910|P2|Overall Study|Parent withdrew consent|8
5785321|NCT03703336|19918911|P1|Overall Study|Parent withdrew consent|29
5785322|NCT03702166|19918934|P1|Overall Study|Withdrawal by Subject|1
5785323|NCT03702166|19918934|P1|Overall Study|Lost to Follow-up|1
5785324|NCT03700671|19918960|P2|Overall Study|Lack of Efficacy|2
5785325|NCT03700671|19918961|P1|Overall Study|Lack of Efficacy|1
5785326|NCT03700385|19918973|P1|Overall Study|Lost to Follow-up|1
5785327|NCT03698591|19918980|P2|Overall Study|Could not establish TMS dosage|1
5785328|NCT03698591|19918981|P1|Overall Study|Could not establish TMS dosage|0
5785329|NCT03698591|19918980|P2|Overall Study|Equipment Error|0
5785330|NCT03698591|19918981|P1|Overall Study|Equipment Error|1
5785331|NCT03698591|19918980|P2|Overall Study|Ineligible for financial compensation|0
5785332|NCT03698591|19918981|P1|Overall Study|Ineligible for financial compensation|1
5785333|NCT03698591|19918980|P2|Overall Study|Failed health screen|1
5785334|NCT03698591|19918981|P1|Overall Study|Failed health screen|0
5785335|NCT03698591|19918980|P2|Overall Study|Failed drug screen|1
5785336|NCT03698591|19918981|P1|Overall Study|Failed drug screen|1
5785337|NCT03698591|19918980|P2|Overall Study|Withdrawal by Subject|2
5785338|NCT03698591|19918981|P1|Overall Study|Withdrawal by Subject|2
5785339|NCT03698331|19918995|P2|Overall Study|Non-compliance with study drug|0
5785340|NCT03698331|19918996|P1|Overall Study|Non-compliance with study drug|1
5785341|NCT03698331|19918995|P2|Overall Study|Lost to Follow-up|2
5785342|NCT03698331|19918996|P1|Overall Study|Lost to Follow-up|0
5785343|NCT03698331|19918995|P2|Overall Study|Withdrawal by Subject|1
5785344|NCT03698331|19918996|P1|Overall Study|Withdrawal by Subject|1
5785345|NCT03698331|19918995|P2|Overall Study|Adverse Event|3
5785346|NCT03698331|19918996|P1|Overall Study|Adverse Event|2
5785347|NCT03698279|19919018|P6|Overall Study|Lost to Follow-up|0
5785348|NCT03698279|19919019|P5|Overall Study|Lost to Follow-up|0
5785349|NCT03698279|19919020|P4|Overall Study|Lost to Follow-up|5
5785350|NCT03698279|19919021|P3|Overall Study|Lost to Follow-up|4
5785351|NCT03698279|19919022|P2|Overall Study|Lost to Follow-up|1
5785352|NCT03698279|19919023|P1|Overall Study|Lost to Follow-up|3
5785353|NCT03698279|19919018|P6|Overall Study|Withdrawal by Subject|0
5785354|NCT03698279|19919019|P5|Overall Study|Withdrawal by Subject|0
5785355|NCT03698279|19919020|P4|Overall Study|Withdrawal by Subject|0
5785356|NCT03698279|19919021|P3|Overall Study|Withdrawal by Subject|1
5785357|NCT03698279|19919022|P2|Overall Study|Withdrawal by Subject|0
5785358|NCT03698279|19919023|P1|Overall Study|Withdrawal by Subject|0
5785359|NCT03698279|19919018|P6|Overall Study|Protocol deviation|0
5785360|NCT03698279|19919019|P5|Overall Study|Protocol deviation|0
5785361|NCT03698279|19919020|P4|Overall Study|Protocol deviation|0
5785362|NCT03698279|19919021|P3|Overall Study|Protocol deviation|1
5785363|NCT03698279|19919022|P2|Overall Study|Protocol deviation|0
5785364|NCT03698279|19919023|P1|Overall Study|Protocol deviation|1
5785365|NCT03698279|19919018|P6|Overall Study|Withdrawal by parent/guardian|0
5785366|NCT03698279|19919019|P5|Overall Study|Withdrawal by parent/guardian|0
5785367|NCT03698279|19919020|P4|Overall Study|Withdrawal by parent/guardian|1
5785368|NCT03698279|19919021|P3|Overall Study|Withdrawal by parent/guardian|1
5785369|NCT03698279|19919022|P2|Overall Study|Withdrawal by parent/guardian|1
5785370|NCT03698279|19919023|P1|Overall Study|Withdrawal by parent/guardian|1
5785371|NCT03697993|19919119|P2|Overall Study|Initial Urine Culture Negative|1
5785372|NCT03697993|19919120|P1|Overall Study|Initial Urine Culture Negative|0
5785373|NCT03697993|19919119|P2|Overall Study|Physician Decision|0
5785374|NCT03697993|19919120|P1|Overall Study|Physician Decision|4
5785375|NCT03697993|19919119|P2|Overall Study|Lost to Follow-up|0
5785376|NCT03697993|19919120|P1|Overall Study|Lost to Follow-up|3
5785377|NCT03697993|19919119|P2|Overall Study|Enrolled but Treatment not Administered|1
5785378|NCT03697993|19919120|P1|Overall Study|Enrolled but Treatment not Administered|2
5785379|NCT03697993|19919119|P2|Overall Study|Became Ineligible after Enrollment|3
5785380|NCT03697993|19919120|P1|Overall Study|Became Ineligible after Enrollment|1
5785381|NCT03697252|19919146|P2|Overall Study|Other|1
5785382|NCT03697252|19919147|P1|Overall Study|Other|0
5785383|NCT03697252|19919146|P2|Overall Study|Physician Decision|1
5785384|NCT03697252|19919147|P1|Overall Study|Physician Decision|1
5785385|NCT03697252|19919146|P2|Overall Study|Lost to Follow-up|1
5785386|NCT03697252|19919147|P1|Overall Study|Lost to Follow-up|0
5785387|NCT03697252|19919146|P2|Overall Study|Withdrawal by Subject|14
5785388|NCT03697252|19919147|P1|Overall Study|Withdrawal by Subject|14
5785389|NCT03697252|19919146|P2|Overall Study|Adverse Event|2
5785390|NCT03697252|19919147|P1|Overall Study|Adverse Event|3
5785391|NCT03695094|19919228|P2|Overall Study|Withdrawal by Subject|0
5785392|NCT03695094|19919229|P1|Overall Study|Withdrawal by Subject|1
5785393|NCT03695094|19919228|P2|Overall Study|Adverse Event|1
5785394|NCT03695094|19919229|P1|Overall Study|Adverse Event|1
5785395|NCT03694925|19919265|P3|Overall Study|Inadequate laboratory testing|0
5785396|NCT03694925|19919266|P2|Overall Study|Inadequate laboratory testing|3
5785397|NCT03694925|19919267|P1|Overall Study|Inadequate laboratory testing|0
5785398|NCT03694821|19919283|P3|Overall Study|Study terminated|4
5785399|NCT03694821|19919284|P2|Overall Study|Study terminated|8
5785400|NCT03694821|19919285|P1|Overall Study|Study terminated|4
5785401|NCT03693989|19919316|P2|Overall Study|Protocol Violation|4
5785402|NCT03693989|19919317|P1|Overall Study|Protocol Violation|3
5785403|NCT03693950|19919341|P2|Overall Study|Withdrawal by Subject|0
5785404|NCT03693950|19919342|P1|Overall Study|Withdrawal by Subject|1
5785405|NCT03693625|19919366|P2|Overall Study|Withdrawal by Subject|1
5785406|NCT03693625|19919367|P1|Overall Study|Withdrawal by Subject|1
5785407|NCT03693625|19919366|P2|Overall Study|Study Terminated By Sponsor|7
5785408|NCT03693625|19919367|P1|Overall Study|Study Terminated By Sponsor|20
5785409|NCT03693625|19919366|P2|Overall Study|Adverse Event|0
5785410|NCT03693625|19919367|P1|Overall Study|Adverse Event|2
5785411|NCT03692676|19919379|P4|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|3
5785412|NCT03692676|19919380|P3|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0
5785413|NCT03692676|19919381|P2|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0
5785414|NCT03692676|19919382|P1|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0
5785415|NCT03692676|19919379|P4|Overall Study|Other|277
5785416|NCT03692676|19919380|P3|Overall Study|Other|758
5785417|NCT03692676|19919381|P2|Overall Study|Other|805
5785418|NCT03692676|19919382|P1|Overall Study|Other|0
5785419|NCT03692676|19919379|P4|Overall Study|exclude patients with different substance(s)/device at preceding prescription|223
5785420|NCT03692676|19919380|P3|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0
5785421|NCT03692676|19919381|P2|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0
5785422|NCT03692676|19919382|P1|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0
5785423|NCT03692676|19919379|P4|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|1198
5785424|NCT03692676|19919380|P3|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|14965
5785425|NCT03692676|19919381|P2|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|0
5785426|NCT03692676|19919382|P1|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|0
5785427|NCT03692676|19919379|P4|Overall Study|exclude patients with prior use of same substances and device|0
5785428|NCT03692676|19919380|P3|Overall Study|exclude patients with prior use of same substances and device|3700
5785429|NCT03692676|19919381|P2|Overall Study|exclude patients with prior use of same substances and device|0
5785430|NCT03692676|19919382|P1|Overall Study|exclude patients with prior use of same substances and device|0
5785431|NCT03692676|19919379|P4|Overall Study|exclude patients with multiple FDC prescriptions on index date|4
5785432|NCT03692676|19919380|P3|Overall Study|exclude patients with multiple FDC prescriptions on index date|1147
5785433|NCT03692676|19919381|P2|Overall Study|exclude patients with multiple FDC prescriptions on index date|0
5785434|NCT03692676|19919382|P1|Overall Study|exclude patients with multiple FDC prescriptions on index date|0
5785435|NCT03692676|19919379|P4|Overall Study|exclude patients with prior recorded COPD diagnosis|173
5785436|NCT03692676|19919380|P3|Overall Study|exclude patients with prior recorded COPD diagnosis|1515
5785437|NCT03692676|19919381|P2|Overall Study|exclude patients with prior recorded COPD diagnosis|218
5785438|NCT03692676|19919382|P1|Overall Study|exclude patients with prior recorded COPD diagnosis|275
5785439|NCT03692676|19919379|P4|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|684
5785440|NCT03692676|19919380|P3|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|7419
5785441|NCT03692676|19919381|P2|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|759
5785442|NCT03692676|19919382|P1|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|1208
5785443|NCT03692676|19919379|P4|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|273
5785444|NCT03692676|19919380|P3|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|1723
5785445|NCT03692676|19919381|P2|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|717
5785446|NCT03692676|19919382|P1|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|149
5785447|NCT03692676|19919379|P4|Overall Study|exclude patients less than 18 years of age on index date|193
5785448|NCT03692676|19919380|P3|Overall Study|exclude patients less than 18 years of age on index date|836
5785449|NCT03692676|19919381|P2|Overall Study|exclude patients less than 18 years of age on index date|613
5785450|NCT03692676|19919382|P1|Overall Study|exclude patients less than 18 years of age on index date|8
5785451|NCT03692676|19919379|P4|Overall Study|exclude patients without prior recorded asthma diagnosis|558
5785452|NCT03692676|19919380|P3|Overall Study|exclude patients without prior recorded asthma diagnosis|6281
5785453|NCT03692676|19919381|P2|Overall Study|exclude patients without prior recorded asthma diagnosis|563
5785454|NCT03692676|19919382|P1|Overall Study|exclude patients without prior recorded asthma diagnosis|881
5785455|NCT03692676|19919379|P4|Overall Study|exclude patients without concurrent ICS/LABA FDC use|0
5785456|NCT03692676|19919380|P3|Overall Study|exclude patients without concurrent ICS/LABA FDC use|0
5785457|NCT03692676|19919381|P2|Overall Study|exclude patients without concurrent ICS/LABA FDC use|19037
5785458|NCT03692676|19919382|P1|Overall Study|exclude patients without concurrent ICS/LABA FDC use|2480
5785459|NCT03692676|19919379|P4|Overall Study|exclude patients with prior use|0
5785460|NCT03692676|19919380|P3|Overall Study|exclude patients with prior use|0
5785461|NCT03692676|19919381|P2|Overall Study|exclude patients with prior use|24726
5785462|NCT03692676|19919382|P1|Overall Study|exclude patients with prior use|4424
5785463|NCT03691948|19919398|P2|Overall Study|Lost to Follow-up|3
5785464|NCT03691948|19919399|P1|Overall Study|Lost to Follow-up|1
5785465|NCT03691831|19919486|P2|Overall Study|Investigator Decision|2
5785466|NCT03691831|19919487|P1|Overall Study|Investigator Decision|2
5785467|NCT03691831|19919486|P2|Overall Study|Withdrawal by Subject|17
5785468|NCT03691831|19919487|P1|Overall Study|Withdrawal by Subject|9
5785469|NCT03691831|19919486|P2|Overall Study|Lost to Follow-up|12
5785470|NCT03691831|19919487|P1|Overall Study|Lost to Follow-up|16
5785471|NCT03689452|19919512|P2|Overall Study|Lost to Follow-up|1
5785472|NCT03689452|19919513|P1|Overall Study|Lost to Follow-up|1
5785473|NCT03688880|19919531|P2|Overall Study|Other|16
5785474|NCT03688880|19919532|P1|Overall Study|Other|10
5785475|NCT03688880|19919531|P2|Overall Study|Device deficiencies|2
5785476|NCT03688880|19919532|P1|Overall Study|Device deficiencies|0
5785477|NCT03688880|19919531|P2|Overall Study|Adverse Event|2
5785478|NCT03688880|19919532|P1|Overall Study|Adverse Event|0
5785479|NCT03688880|19919531|P2|Overall Study|Lost to Follow-up|7
5785480|NCT03688880|19919532|P1|Overall Study|Lost to Follow-up|4
5785481|NCT03688880|19919531|P2|Overall Study|Use of non-permitted concurrent therapy|2
5785482|NCT03688880|19919532|P1|Overall Study|Use of non-permitted concurrent therapy|0
5785483|NCT03688880|19919531|P2|Overall Study|Withdrawal by Subject|2
5785484|NCT03688880|19919532|P1|Overall Study|Withdrawal by Subject|0
5785485|NCT03688620|19919559|P3|Overall Study|Withdrawal by Subject|6
5785486|NCT03688620|19919560|P2|Overall Study|Withdrawal by Subject|0
5785487|NCT03688620|19919561|P1|Overall Study|Withdrawal by Subject|0
5785488|NCT03688620|19919559|P3|Overall Study|Lost to Follow-up|1
5785489|NCT03688620|19919560|P2|Overall Study|Lost to Follow-up|0
5785490|NCT03688620|19919561|P1|Overall Study|Lost to Follow-up|16
5785491|NCT03688620|19919559|P3|Overall Study|Unwilling to attend the scheduled visit|0
5785492|NCT03688620|19919560|P2|Overall Study|Unwilling to attend the scheduled visit|1
5785493|NCT03688620|19919561|P1|Overall Study|Unwilling to attend the scheduled visit|0
5785494|NCT03688620|19919559|P3|Overall Study|Other|1
5785495|NCT03688620|19919560|P2|Overall Study|Other|0
5785496|NCT03688620|19919561|P1|Overall Study|Other|0
5785497|NCT03687970|19920044|P2|Overall Study|visit scheduling conflicts|0
5785498|NCT03687970|19920045|P1|Overall Study|visit scheduling conflicts|2
5785499|NCT03687827|19920055|P2|Treatment Period 2|Withdrawal by Subject|2
5785500|NCT03687827|19920056|P1|Treatment Period 2|Withdrawal by Subject|1
5785501|NCT03687827|19920055|P2|Treatment Period 2|Physician Decision|1
5785502|NCT03687827|19920056|P1|Treatment Period 2|Physician Decision|4
5785503|NCT03687827|19920055|P2|Treatment Period 1|Withdrawal by Subject|3
5785504|NCT03687827|19920056|P1|Treatment Period 1|Withdrawal by Subject|7
5785505|NCT03687827|19920055|P2|Treatment Period 1|Physician Decision|2
5785506|NCT03687827|19920056|P1|Treatment Period 1|Physician Decision|5
5785507|NCT03687827|19920055|P2|Treatment Period 1|Lost to Follow-up|2
5785508|NCT03687827|19920056|P1|Treatment Period 1|Lost to Follow-up|2
5785509|NCT03687827|19920055|P2|Treatment Period 1|Death|1
5785510|NCT03687827|19920056|P1|Treatment Period 1|Death|0
5785511|NCT03687736|19920072|P1|Overall Study|Withdrawal by Subject|3
5785512|NCT03687736|19920072|P1|Overall Study|Lost to Follow-up|7
5785513|NCT03687372|19920218|P2|Overall Study|Investigator Decision|1
5785514|NCT03687372|19920219|P1|Overall Study|Investigator Decision|1
5785515|NCT03687372|19920218|P2|Overall Study|Withdrawal by Subject|17
5785516|NCT03687372|19920219|P1|Overall Study|Withdrawal by Subject|4
5785517|NCT03687372|19920218|P2|Overall Study|Lost to Follow-up|21
5785518|NCT03687372|19920219|P1|Overall Study|Lost to Follow-up|12
5785519|NCT03686176|19920236|P3|Overall Study|VR Malfunction|0
5785520|NCT03686176|19920237|P2|Overall Study|VR Malfunction|0
5785521|NCT03686176|19920238|P1|Overall Study|VR Malfunction|1
5785522|NCT03686176|19920236|P3|Overall Study|Procedure cancelled|0
5785523|NCT03686176|19920237|P2|Overall Study|Procedure cancelled|0
5785524|NCT03686176|19920238|P1|Overall Study|Procedure cancelled|1
5785525|NCT03686033|19920277|P6|Treatment Period 2 (1 Day)|Adverse Event|0
5785526|NCT03686033|19920278|P5|Treatment Period 2 (1 Day)|Adverse Event|1
5785527|NCT03686033|19920279|P4|Treatment Period 2 (1 Day)|Adverse Event|0
5785528|NCT03686033|19920280|P3|Treatment Period 2 (1 Day)|Adverse Event|0
5785529|NCT03686033|19920281|P2|Treatment Period 2 (1 Day)|Adverse Event|0
5785530|NCT03686033|19920282|P1|Treatment Period 2 (1 Day)|Adverse Event|0
5785531|NCT03685643|19920358|P2|Overall Study|Lost to Follow-up|22
5785532|NCT03685643|19920359|P1|Overall Study|Lost to Follow-up|14
5785533|NCT03684928|19920384|P2|Second Intervention|Soft Tissue Injury|0
5785534|NCT03684928|19920385|P1|Second Intervention|Soft Tissue Injury|1
5785535|NCT03684928|19920384|P2|First Intervention|Withdrawal by Subject|2
5785536|NCT03684928|19920385|P1|First Intervention|Withdrawal by Subject|0
5785537|NCT03684928|19920384|P2|First Intervention|Lost to Follow-up|1
5785538|NCT03684928|19920385|P1|First Intervention|Lost to Follow-up|0
5785539|NCT03684044|19920414|P2|Overall Study|Withdrawal by Subject|9
5785540|NCT03684044|19920415|P1|Overall Study|Withdrawal by Subject|11
5785541|NCT03684044|19920414|P2|Overall Study|Physician Decision|0
5785542|NCT03684044|19920415|P1|Overall Study|Physician Decision|1
5785543|NCT03684044|19920414|P2|Overall Study|Patient Not Available|2
5785544|NCT03684044|19920415|P1|Overall Study|Patient Not Available|0
5785545|NCT03684044|19920414|P2|Overall Study|Lost to Follow-up|2
5785546|NCT03684044|19920415|P1|Overall Study|Lost to Follow-up|3
5785547|NCT03684044|19920414|P2|Overall Study|Death|7
5785548|NCT03684044|19920415|P1|Overall Study|Death|4
5785549|NCT03684044|19920414|P2|Overall Study|Adverse Event|0
5785550|NCT03684044|19920415|P1|Overall Study|Adverse Event|3
5785551|NCT03683758|19920483|P2|Overall Study|Adverse Event|0
5785552|NCT03683758|19920484|P1|Overall Study|Adverse Event|1
5785553|NCT03683758|19920483|P2|Overall Study|Illness preventing participation|0
5785554|NCT03683758|19920484|P1|Overall Study|Illness preventing participation|1
5785555|NCT03683758|19920483|P2|Overall Study|Non-study commitment conflict|3
5785556|NCT03683758|19920484|P1|Overall Study|Non-study commitment conflict|1
5785557|NCT03682302|19920517|P4|Overall Study|Study drug was not administered|1
5785558|NCT03682302|19920518|P3|Overall Study|Study drug was not administered|1
5785559|NCT03682302|19920519|P2|Overall Study|Study drug was not administered|0
5785560|NCT03682302|19920520|P1|Overall Study|Study drug was not administered|0
5785561|NCT03682302|19920517|P4|Overall Study|Lost to Follow-up|1
5785562|NCT03682302|19920518|P3|Overall Study|Lost to Follow-up|0
5785563|NCT03682302|19920519|P2|Overall Study|Lost to Follow-up|2
5785564|NCT03682302|19920520|P1|Overall Study|Lost to Follow-up|1
5785565|NCT03681951|19920558|P8|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0
5785566|NCT03681951|19920559|P7|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0
5785567|NCT03681951|19920560|P6|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0
5785568|NCT03681951|19920561|P5|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0
5785569|NCT03681951|19920562|P4|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0
5785570|NCT03681951|19920563|P3|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0
5785571|NCT03681951|19920564|P2|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0
5785572|NCT03681951|19920565|P1|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|3
5785573|NCT03681951|19920558|P8|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0
5785574|NCT03681951|19920559|P7|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0
5785575|NCT03681951|19920560|P6|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0
5785576|NCT03681951|19920561|P5|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0
5785577|NCT03681951|19920562|P4|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0
5785578|NCT03681951|19920563|P3|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0
5785579|NCT03681951|19920564|P2|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0
5785580|NCT03681951|19920565|P1|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|4
5785581|NCT03681951|19920558|P8|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0
5785582|NCT03681951|19920559|P7|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0
5785583|NCT03681951|19920560|P6|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0
5785584|NCT03681951|19920561|P5|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0
5785585|NCT03681951|19920562|P4|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0
5785586|NCT03681951|19920563|P3|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0
5785587|NCT03681951|19920564|P2|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0
5785588|NCT03681951|19920565|P1|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|1
5785595|NCT03681119|19920833|P2|Overall Study|Sickness|0
5785596|NCT03681119|19920834|P1|Overall Study|Sickness|2
5785597|NCT03681119|19920833|P2|Overall Study|No specific reason|0
5785598|NCT03681119|19920834|P1|Overall Study|No specific reason|4
5785599|NCT03681093|19920841|P3|Overall Study|Subject decision|1
5785600|NCT03681093|19920842|P2|Overall Study|Subject decision|2
5785601|NCT03681093|19920843|P1|Overall Study|Subject decision|0
5785602|NCT03679741|19920927|P2|Period 2|Withdrawal by Subject|1
5785603|NCT03679741|19920928|P1|Period 2|Withdrawal by Subject|1
5785604|NCT03679741|19920927|P2|Period 2|Adverse Event|1
5785605|NCT03679741|19920928|P1|Period 2|Adverse Event|2
5785606|NCT03679741|19920927|P2|Period 1|Withdrawal by Subject|1
5785607|NCT03679741|19920928|P1|Period 1|Withdrawal by Subject|0
5785608|NCT03679741|19920927|P2|Period 1|Adverse Event|1
5785609|NCT03679741|19920928|P1|Period 1|Adverse Event|1
5785610|NCT03679741|19920927|P2|Period 1|Lost to Follow-up|1
5785611|NCT03679741|19920928|P1|Period 1|Lost to Follow-up|0
5785612|NCT03679741|19920927|P2|Period 1|No longer meet eligibility criteria|0
5785613|NCT03679741|19920928|P1|Period 1|No longer meet eligibility criteria|1
5785614|NCT03678870|19920971|P2|Overall Study|Lost to Follow-up|2
5785615|NCT03678870|19920972|P1|Overall Study|Lost to Follow-up|3
5785616|NCT03678870|19920971|P2|Overall Study|prescribed non- protocol medications|6
5785617|NCT03678870|19920972|P1|Overall Study|prescribed non- protocol medications|10
5785618|NCT03677401|19920992|P2|Overall Study|Reason Unspecified|0
5785619|NCT03677401|19920993|P1|Overall Study|Reason Unspecified|1
5785620|NCT03677401|19920992|P2|Overall Study|Sponsor decision|1
5785621|NCT03677401|19920993|P1|Overall Study|Sponsor decision|0
5785622|NCT03677401|19920992|P2|Overall Study|Withdrawal by Subject|2
5785623|NCT03677401|19920993|P1|Overall Study|Withdrawal by Subject|2
5785624|NCT03677401|19920992|P2|Overall Study|Lack of Efficacy|1
5785625|NCT03677401|19920993|P1|Overall Study|Lack of Efficacy|3
5785626|NCT03677401|19920992|P2|Overall Study|Adverse Event|14
5785627|NCT03677401|19920993|P1|Overall Study|Adverse Event|4
5785628|NCT03677375|19921017|P1|Overall Study|Physician Decision|1
5785629|NCT03677375|19921017|P1|Overall Study|Adverse Event|3
5785630|NCT03677375|19921017|P1|Overall Study|Incomplete procedure|8
5785631|NCT03675776|19921075|P3|Double Blind Treatment Period|Lack of Efficacy|0
5785632|NCT03675776|19921076|P2|Double Blind Treatment Period|Lack of Efficacy|0
5785633|NCT03675776|19921077|P1|Double Blind Treatment Period|Lack of Efficacy|1
5785634|NCT03675776|19921075|P3|Double Blind Treatment Period|Study Terminated by Sponsor|8
5785635|NCT03675776|19921076|P2|Double Blind Treatment Period|Study Terminated by Sponsor|6
5785636|NCT03675776|19921077|P1|Double Blind Treatment Period|Study Terminated by Sponsor|5
5785637|NCT03674281|19921170|P3|Overall Study|Withdrawal by Subject|3
5785638|NCT03674281|19921171|P2|Overall Study|Withdrawal by Subject|3
5785639|NCT03674281|19921172|P1|Overall Study|Withdrawal by Subject|1
5785640|NCT03674281|19921170|P3|Overall Study|screen failure|0
5785641|NCT03674281|19921171|P2|Overall Study|screen failure|0
5785642|NCT03674281|19921172|P1|Overall Study|screen failure|2
5785643|NCT03674177|19921196|P4|Overall Study|Lost to Follow-up|2
5785644|NCT03674177|19921197|P3|Overall Study|Lost to Follow-up|0
5785645|NCT03674177|19921198|P2|Overall Study|Lost to Follow-up|1
5785646|NCT03674177|19921199|P1|Overall Study|Lost to Follow-up|2
5785647|NCT03673670|19921271|P6|Treatment Period 3 (3 Days)|Adverse Event|0
5785648|NCT03673670|19921272|P5|Treatment Period 3 (3 Days)|Adverse Event|1
5785649|NCT03673670|19921273|P4|Treatment Period 3 (3 Days)|Adverse Event|0
5785650|NCT03673670|19921274|P3|Treatment Period 3 (3 Days)|Adverse Event|0
5785651|NCT03673670|19921275|P2|Treatment Period 3 (3 Days)|Adverse Event|0
5785652|NCT03673670|19921276|P1|Treatment Period 3 (3 Days)|Adverse Event|0
5785653|NCT03673670|19921271|P6|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0
5785654|NCT03673670|19921272|P5|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|1
5785655|NCT03673670|19921273|P4|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0
5785656|NCT03673670|19921274|P3|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0
5785657|NCT03673670|19921275|P2|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0
5785658|NCT03673670|19921276|P1|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0
5785659|NCT03673670|19921271|P6|Treatment Period 2 (3 Days)|Adverse Event|0
5785660|NCT03673670|19921272|P5|Treatment Period 2 (3 Days)|Adverse Event|1
5785661|NCT03673670|19921273|P4|Treatment Period 2 (3 Days)|Adverse Event|0
5785662|NCT03673670|19921274|P3|Treatment Period 2 (3 Days)|Adverse Event|1
5785663|NCT03673670|19921275|P2|Treatment Period 2 (3 Days)|Adverse Event|0
5785664|NCT03673670|19921276|P1|Treatment Period 2 (3 Days)|Adverse Event|0
5785665|NCT03673670|19921271|P6|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|1
5785666|NCT03673670|19921272|P5|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0
5785667|NCT03673670|19921273|P4|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0
5785668|NCT03673670|19921274|P3|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0
5785669|NCT03673670|19921275|P2|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0
5785670|NCT03673670|19921276|P1|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0
5785671|NCT03673670|19921271|P6|Treatment Period 1 (3 Days)|Adverse Event|1
5785672|NCT03673670|19921272|P5|Treatment Period 1 (3 Days)|Adverse Event|0
5785673|NCT03673670|19921273|P4|Treatment Period 1 (3 Days)|Adverse Event|0
5785674|NCT03673670|19921274|P3|Treatment Period 1 (3 Days)|Adverse Event|0
5785675|NCT03673670|19921275|P2|Treatment Period 1 (3 Days)|Adverse Event|0
5785676|NCT03673670|19921276|P1|Treatment Period 1 (3 Days)|Adverse Event|0
5785677|NCT03673670|19921271|P6|Treatment Period 1 (3 Days)|Physician Decision|0
5785678|NCT03673670|19921272|P5|Treatment Period 1 (3 Days)|Physician Decision|0
5785679|NCT03673670|19921273|P4|Treatment Period 1 (3 Days)|Physician Decision|0
5785680|NCT03673670|19921274|P3|Treatment Period 1 (3 Days)|Physician Decision|1
5785681|NCT03673670|19921275|P2|Treatment Period 1 (3 Days)|Physician Decision|0
5785682|NCT03673670|19921276|P1|Treatment Period 1 (3 Days)|Physician Decision|0
5785683|NCT03673670|19921271|P6|Treatment Period 1 (3 Days)|Withdrawal by Subject|0
5785684|NCT03673670|19921272|P5|Treatment Period 1 (3 Days)|Withdrawal by Subject|0
5785685|NCT03673670|19921273|P4|Treatment Period 1 (3 Days)|Withdrawal by Subject|0
5785686|NCT03673670|19921274|P3|Treatment Period 1 (3 Days)|Withdrawal by Subject|0
5785687|NCT03673670|19921275|P2|Treatment Period 1 (3 Days)|Withdrawal by Subject|0
5785688|NCT03673670|19921276|P1|Treatment Period 1 (3 Days)|Withdrawal by Subject|1
5785689|NCT03672396|19921323|P1|Overall Study|Adverse Event|1
5785690|NCT03672396|19921323|P1|Overall Study|Physician Decision|1
5785691|NCT03672396|19921323|P1|Overall Study|Withdrawal by Subject|4
5785692|NCT03670537|19921353|P1|Overall Study|Protocol Violation|1
5785693|NCT03669081|19921359|P2|Overall Study|Data could not be validated|1
5785694|NCT03669081|19921360|P1|Overall Study|Data could not be validated|1
5785695|NCT03668600|19921376|P1|Overall Study|Adverse Event|1
5785696|NCT03668600|19921376|P1|Overall Study|Lack of Efficacy|7
5785697|NCT03668600|19921376|P1|Overall Study|Withdrawal by Subject|56
5785698|NCT03668600|19921376|P1|Overall Study|Lost to Follow-up|7
5785699|NCT03668600|19921376|P1|Overall Study|Pregnancy|1
5785700|NCT03668600|19921376|P1|Overall Study|Protocol Violation|1
5785701|NCT03668600|19921376|P1|Overall Study|Study Terminated by the Sponsor|157
5785702|NCT03663582|19921434|P1|Overall Study|Physician Decision|1
5785703|NCT03663569|19921466|P1|Overall Study|Serious adverse event|1
5785704|NCT03663569|19921466|P1|Overall Study|Not meet inclusion / exclusion criterion|3
5785705|NCT03663569|19921466|P1|Overall Study|Not come to second visit|3
5785706|NCT03663569|19921466|P1|Overall Study|Adverse Event|4
5785707|NCT03663569|19921466|P1|Overall Study|Patient's request|11
5785708|NCT03663569|19921466|P1|Overall Study|Withdrawal of consent|5
5785709|NCT03663569|19921466|P1|Overall Study|Lost to Follow-up|18
5785710|NCT03663569|19921466|P1|Overall Study|Deceased patient|6
5785711|NCT03663569|19921466|P1|Overall Study|Never taken Spiolto® Respimat®|1
5785712|NCT03663569|19921466|P1|Overall Study|Discontinuation of study|11
5785713|NCT03663179|19921500|P2|Overall Study|Revealed exclusionary condition|0
5785714|NCT03663179|19921501|P1|Overall Study|Revealed exclusionary condition|1
5785715|NCT03663179|19921500|P2|Overall Study|Lost to Follow-up|1
5785716|NCT03663179|19921501|P1|Overall Study|Lost to Follow-up|1
5785717|NCT03663179|19921500|P2|Overall Study|Withdrawal by Subject|0
5785718|NCT03663179|19921501|P1|Overall Study|Withdrawal by Subject|2
5785719|NCT03662334|19921548|P2|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|0
5785720|NCT03662334|19921549|P1|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|1
5785721|NCT03661983|19921608|P4|Double-blind Randomized Phase|Study Terminated by Sponsor|1
5785722|NCT03661983|19921609|P3|Double-blind Randomized Phase|Study Terminated by Sponsor|1
5785723|NCT03661983|19921610|P2|Double-blind Randomized Phase|Study Terminated by Sponsor|1
5785724|NCT03661983|19921611|P1|Double-blind Randomized Phase|Study Terminated by Sponsor|0
5785725|NCT03661983|19921608|P4|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|1
5785726|NCT03661983|19921609|P3|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0
5785727|NCT03661983|19921610|P2|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0
5785728|NCT03661983|19921611|P1|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0
5785729|NCT03661983|19921608|P4|Double-blind Randomized Phase|Disease Relapse|6
5785730|NCT03661983|19921609|P3|Double-blind Randomized Phase|Disease Relapse|0
5785731|NCT03661983|19921610|P2|Double-blind Randomized Phase|Disease Relapse|0
5785732|NCT03661983|19921611|P1|Double-blind Randomized Phase|Disease Relapse|0
5785733|NCT03661983|19921608|P4|Double-blind Randomized Phase|Adverse Event|0
5785734|NCT03661983|19921609|P3|Double-blind Randomized Phase|Adverse Event|0
5785735|NCT03661983|19921610|P2|Double-blind Randomized Phase|Adverse Event|1
5785736|NCT03661983|19921611|P1|Double-blind Randomized Phase|Adverse Event|0
5785737|NCT03661983|19921608|P4|Open Label Stabilization Phase|Study Terminated by Sponsor|0
5785738|NCT03661983|19921609|P3|Open Label Stabilization Phase|Study Terminated by Sponsor|0
5785739|NCT03661983|19921610|P2|Open Label Stabilization Phase|Study Terminated by Sponsor|0
5785740|NCT03661983|19921611|P1|Open Label Stabilization Phase|Study Terminated by Sponsor|3
5785741|NCT03661983|19921608|P4|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0
5785742|NCT03661983|19921609|P3|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0
5785743|NCT03661983|19921610|P2|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0
5785744|NCT03661983|19921611|P1|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|2
5785745|NCT03661983|19921608|P4|Open Label Stabilization Phase|Lack of Efficacy|0
5785746|NCT03661983|19921609|P3|Open Label Stabilization Phase|Lack of Efficacy|0
5785747|NCT03661983|19921610|P2|Open Label Stabilization Phase|Lack of Efficacy|0
5785748|NCT03661983|19921611|P1|Open Label Stabilization Phase|Lack of Efficacy|1
5785749|NCT03661983|19921608|P4|Open Label Stabilization Phase|Adverse Event|0
5785750|NCT03661983|19921609|P3|Open Label Stabilization Phase|Adverse Event|0
5785751|NCT03661983|19921610|P2|Open Label Stabilization Phase|Adverse Event|0
5785752|NCT03661983|19921611|P1|Open Label Stabilization Phase|Adverse Event|5
5785753|NCT03658889|19921852|P2|Overall Study|Protocol Violation|0
5785754|NCT03658889|19921853|P1|Overall Study|Protocol Violation|2
5785755|NCT03658876|19921884|P2|Overall Study|Transplantation/other operation|5
5785756|NCT03658876|19921885|P1|Overall Study|Transplantation/other operation|1
5785757|NCT03658876|19921884|P2|Overall Study|Intercurrent illness|4
5785758|NCT03658876|19921885|P1|Overall Study|Intercurrent illness|6
5785759|NCT03658876|19921884|P2|Overall Study|Death|1
5785760|NCT03658876|19921885|P1|Overall Study|Death|0
5785761|NCT03658876|19921884|P2|Overall Study|Withdrawal by Subject|0
5785762|NCT03658876|19921885|P1|Overall Study|Withdrawal by Subject|2
5785763|NCT03658876|19921884|P2|Overall Study|Protocol Violation|2
5785764|NCT03658876|19921885|P1|Overall Study|Protocol Violation|3
5785765|NCT03658811|19921891|P1|Overall Study|Lost to Follow-up|3
5785766|NCT03657095|19921935|P2|Overall Study|Study Terminated by Sponsor|49
5785767|NCT03657095|19921936|P1|Overall Study|Study Terminated by Sponsor|58
5785768|NCT03657095|19921935|P2|Overall Study|Adverse Event|3
5785769|NCT03657095|19921936|P1|Overall Study|Adverse Event|0
5785770|NCT03657095|19921935|P2|Overall Study|Withdrawal by Subject|1
5785771|NCT03657095|19921936|P1|Overall Study|Withdrawal by Subject|1
5785772|NCT03655951|19921952|P2|Overall Study|Withdrawal by Subject|1
5785773|NCT03655951|19921953|P1|Overall Study|Withdrawal by Subject|0
5785774|NCT03655951|19921952|P2|Overall Study|Lost to Follow-up|20
5785775|NCT03655951|19921953|P1|Overall Study|Lost to Follow-up|39
5785776|NCT03655106|19922142|P2|Overall Study|Protocol Violation|0
5785777|NCT03655106|19922143|P1|Overall Study|Protocol Violation|3
5785778|NCT03655106|19922142|P2|Overall Study|Duplicate Enrollment|1
5785779|NCT03655106|19922143|P1|Overall Study|Duplicate Enrollment|1
5785780|NCT03655106|19922142|P2|Overall Study|Lost to Follow-up|1
5785781|NCT03655106|19922143|P1|Overall Study|Lost to Follow-up|2
5785782|NCT03655106|19922142|P2|Overall Study|Withdrawal by Subject|2
5785783|NCT03655106|19922143|P1|Overall Study|Withdrawal by Subject|3
5785784|NCT03654560|19922155|P2|Overall Study|Lost to Follow-up|0
5785785|NCT03654560|19922156|P1|Overall Study|Lost to Follow-up|1
5785786|NCT03654560|19922155|P2|Overall Study|Death|1
5785787|NCT03654560|19922156|P1|Overall Study|Death|3
5785788|NCT03653429|19922197|P2|Overall Study|Physician Decision|10
5785789|NCT03653429|19922198|P1|Overall Study|Physician Decision|4
5785790|NCT03653416|19922212|P2|Overall Study|Protocol Violation|1
5785791|NCT03653416|19922213|P1|Overall Study|Protocol Violation|6
5785792|NCT03650400|19922263|P2|Overall Study|Study terminated by sponsor|5
5785793|NCT03650400|19922264|P1|Overall Study|Study terminated by sponsor|0
5785794|NCT03649412|19922331|P2|Part B, Washout Period 5 (7 Days)|Adverse Event|1
5785795|NCT03649412|19922332|P1|Part B, Washout Period 5 (7 Days)|Adverse Event|0
5785796|NCT03649412|19922331|P2|Part B, Washout Period 1 (7 Days)|Adverse Event|1
5785797|NCT03649412|19922332|P1|Part B, Washout Period 1 (7 Days)|Adverse Event|0
5785798|NCT03649412|19922331|P2|Part A, Washout Period 5 (7 Days)|Adverse Event|0
5785799|NCT03649412|19922332|P1|Part A, Washout Period 5 (7 Days)|Adverse Event|1
5785800|NCT03649412|19922331|P2|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|0
5785801|NCT03649412|19922332|P1|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|1
5785802|NCT03649412|19922331|P2|Part A, Washout Period 4 (7 Days)|Adverse Event|0
5785803|NCT03649412|19922332|P1|Part A, Washout Period 4 (7 Days)|Adverse Event|1
5785804|NCT03649412|19922331|P2|Part A, Washout Period 1 (7 Days)|Physician Decision|0
5785805|NCT03649412|19922332|P1|Part A, Washout Period 1 (7 Days)|Physician Decision|1
5785806|NCT03648983|19922490|P1|Overall Study|Study was terminated due to PI departure|95
5785807|NCT03647709|19922500|P1|Overall Study|Withdrawal by Subject|3
5785808|NCT03647709|19922500|P1|Overall Study|Physician Decision|6
5785809|NCT03647709|19922500|P1|Overall Study|Lost to Follow-up|5
5785810|NCT03646656|19922533|P2|Overall Study|Withdrawal by Subject|0
5785811|NCT03646656|19922534|P1|Overall Study|Withdrawal by Subject|2
5785812|NCT03646656|19922533|P2|Overall Study|Lost to Follow-up|0
5785813|NCT03646656|19922534|P1|Overall Study|Lost to Follow-up|1
5785814|NCT03645434|19922583|P6|Period 1|COPD exacerbation|0
5785815|NCT03645434|19922584|P5|Period 1|COPD exacerbation|1
5785816|NCT03645434|19922585|P4|Period 1|COPD exacerbation|0
5785817|NCT03645434|19922586|P3|Period 1|COPD exacerbation|0
5785818|NCT03645434|19922587|P2|Period 1|COPD exacerbation|0
5785819|NCT03645434|19922588|P1|Period 1|COPD exacerbation|0
5785820|NCT03645434|19922583|P6|Period 1|Adverse Event|0
5785821|NCT03645434|19922584|P5|Period 1|Adverse Event|0
5785822|NCT03645434|19922585|P4|Period 1|Adverse Event|1
5785823|NCT03645434|19922586|P3|Period 1|Adverse Event|0
5785824|NCT03645434|19922587|P2|Period 1|Adverse Event|0
5785825|NCT03645434|19922588|P1|Period 1|Adverse Event|0
5785826|NCT03645421|19922639|P4|Overall Study|Study specific withdrawal criteria|0
5785827|NCT03645421|19922640|P3|Overall Study|Study specific withdrawal criteria|1
5785828|NCT03645421|19922641|P2|Overall Study|Study specific withdrawal criteria|0
5785829|NCT03645421|19922642|P1|Overall Study|Study specific withdrawal criteria|0
5785830|NCT03645421|19922639|P4|Overall Study|Withdrawal by patient|3
5785831|NCT03645421|19922640|P3|Overall Study|Withdrawal by patient|0
5785832|NCT03645421|19922641|P2|Overall Study|Withdrawal by patient|0
5785833|NCT03645421|19922642|P1|Overall Study|Withdrawal by patient|0
5785834|NCT03645421|19922639|P4|Overall Study|Adverse Event|1
5785835|NCT03645421|19922640|P3|Overall Study|Adverse Event|4
5785836|NCT03645421|19922641|P2|Overall Study|Adverse Event|0
5785837|NCT03645421|19922642|P1|Overall Study|Adverse Event|0
5785838|NCT03643575|19922751|P6|Washout: 7 Days|Non compliance check in|0
5785839|NCT03643575|19922752|P5|Washout: 7 Days|Non compliance check in|0
5785840|NCT03643575|19922753|P4|Washout: 7 Days|Non compliance check in|0
5785841|NCT03643575|19922754|P3|Washout: 7 Days|Non compliance check in|0
5785842|NCT03643575|19922755|P2|Washout: 7 Days|Non compliance check in|1
5785843|NCT03643575|19922756|P1|Washout: 7 Days|Non compliance check in|0
5785844|NCT03643575|19922751|P6|Washout: 7 Days|Adverse Event|0
5785845|NCT03643575|19922752|P5|Washout: 7 Days|Adverse Event|0
5785846|NCT03643575|19922753|P4|Washout: 7 Days|Adverse Event|0
5785847|NCT03643575|19922754|P3|Washout: 7 Days|Adverse Event|0
5785848|NCT03643575|19922755|P2|Washout: 7 Days|Adverse Event|0
5785849|NCT03643575|19922756|P1|Washout: 7 Days|Adverse Event|1
5785850|NCT03643575|19922751|P6|Washout: 7 Days|Withdrew consent due to illness|0
5785851|NCT03643575|19922752|P5|Washout: 7 Days|Withdrew consent due to illness|0
5785852|NCT03643575|19922753|P4|Washout: 7 Days|Withdrew consent due to illness|1
5785853|NCT03643575|19922754|P3|Washout: 7 Days|Withdrew consent due to illness|0
5785854|NCT03643575|19922755|P2|Washout: 7 Days|Withdrew consent due to illness|0
5785855|NCT03643575|19922756|P1|Washout: 7 Days|Withdrew consent due to illness|0
5785856|NCT03643432|19922814|P2|Overall Study|Lost to Follow-up|0
5785857|NCT03643432|19922815|P1|Overall Study|Lost to Follow-up|1
5785858|NCT03643159|19922839|P1|Overall Study|Withdrawal by Subject|1
5785859|NCT03643159|19922839|P1|Overall Study|Adverse Event|1
5785860|NCT03642873|19922846|P6|Third Intervention (1 Day)|Screen failure|0
5785861|NCT03642873|19922847|P5|Third Intervention (1 Day)|Screen failure|1
5785862|NCT03642873|19922848|P4|Third Intervention (1 Day)|Screen failure|0
5785863|NCT03642873|19922849|P3|Third Intervention (1 Day)|Screen failure|0
5785864|NCT03642873|19922850|P2|Third Intervention (1 Day)|Screen failure|0
5785865|NCT03642873|19922851|P1|Third Intervention (1 Day)|Screen failure|0
5785866|NCT03642262|19922902|P2|Period 1|Adverse Event|1
5785867|NCT03642262|19922903|P1|Period 1|Adverse Event|0
5785868|NCT03642262|19922902|P2|Period 1|Withdrawal by Subject|1
5785869|NCT03642262|19922903|P1|Period 1|Withdrawal by Subject|1
5785870|NCT03641508|19922924|P2|First Injection|Lost to Follow-up|0
5785871|NCT03641508|19922925|P1|First Injection|Lost to Follow-up|2
5785872|NCT03640559|19922952|P2|Overall Study|Withdrawal by Subject|0
5785873|NCT03640559|19922953|P1|Overall Study|Withdrawal by Subject|1
5785874|NCT03640559|19922952|P2|Overall Study|Physician Decision|1
5785875|NCT03640559|19922953|P1|Overall Study|Physician Decision|1
5785876|NCT03640507|19922962|P3|Overall Study|Withdrawal by Subject|1
5785877|NCT03640507|19922963|P2|Overall Study|Withdrawal by Subject|0
5785878|NCT03640507|19922964|P1|Overall Study|Withdrawal by Subject|0
5785879|NCT03640052|19922984|P5|Overall Study|Lost to Follow-up|0
5785880|NCT03640052|19922985|P4|Overall Study|Lost to Follow-up|0
5785881|NCT03640052|19922986|P3|Overall Study|Lost to Follow-up|0
5785882|NCT03640052|19922987|P2|Overall Study|Lost to Follow-up|1
5785883|NCT03640052|19922988|P1|Overall Study|Lost to Follow-up|0
5785884|NCT03639675|19923005|P1|Overall Study|Withdrawal by Subject|1
5785885|NCT03639311|19923012|P2|Overall Study|Adverse Event|0
5785886|NCT03639311|19923013|P1|Overall Study|Adverse Event|1
5785887|NCT03639311|19923012|P2|Overall Study|Lost to Follow-up|0
5785888|NCT03639311|19923013|P1|Overall Study|Lost to Follow-up|1
5785889|NCT03639311|19923012|P2|Overall Study|Ongoing at the time of analysis|0
5785890|NCT03639311|19923013|P1|Overall Study|Ongoing at the time of analysis|88
5785891|NCT03638635|19923112|P2|Follow-Up (30 Days After Discharge)|Study terminated prematurely|22
5785892|NCT03638635|19923113|P1|Follow-Up (30 Days After Discharge)|Study terminated prematurely|39
5785893|NCT03638635|19923112|P2|Initial Hospitalization|Withdrawal by study personnel|1
5785894|NCT03638635|19923113|P1|Initial Hospitalization|Withdrawal by study personnel|0
5785895|NCT03638635|19923112|P2|Initial Hospitalization|Study terminated prematurely|1
5785896|NCT03638635|19923113|P1|Initial Hospitalization|Study terminated prematurely|0
5785897|NCT03636893|19923202|P2|Overall Study|Adverse Event|1
5785898|NCT03636893|19923203|P1|Overall Study|Adverse Event|1
5785899|NCT03636893|19923202|P2|Overall Study|Early surgery (for acute bleeding)|0
5785900|NCT03636893|19923203|P1|Overall Study|Early surgery (for acute bleeding)|3
5785901|NCT03636893|19923202|P2|Overall Study|Refusal to surgery|3
5785902|NCT03636893|19923203|P1|Overall Study|Refusal to surgery|4
5785903|NCT03636893|19923202|P2|Overall Study|Withdrawal by Subject|2
5785904|NCT03636893|19923203|P1|Overall Study|Withdrawal by Subject|1
5785905|NCT03636893|19923202|P2|Overall Study|Protocol Violation|3
5785906|NCT03636893|19923203|P1|Overall Study|Protocol Violation|0
5785907|NCT03636893|19923202|P2|Overall Study|Death|1
5785908|NCT03636893|19923203|P1|Overall Study|Death|0
5785909|NCT03635957|19923220|P1|Pegloticase + IMM Period|Lack of Efficacy|3
5785910|NCT03635957|19923220|P1|Run-In Period|Lost to Follow-up|1
5785911|NCT03635424|19923231|P1|Overall Study|Device not implanted|1
5785912|NCT03635424|19923231|P1|Overall Study|Death|1
5785913|NCT03635424|19923231|P1|Overall Study|Adverse Event|1
5785914|NCT03634579|19923252|P1|Overall Study|study termination|9
5785915|NCT03634085|19923350|P2|Overall Study|Withdrawal by Subject|2
5785916|NCT03634085|19923351|P1|Overall Study|Withdrawal by Subject|0
5785917|NCT03634085|19923350|P2|Overall Study|Adverse Event|0
5785918|NCT03634085|19923351|P1|Overall Study|Adverse Event|1
5785919|NCT03633825|19923366|P2|Follow up|Lost to Follow-up|450
5785920|NCT03633825|19923367|P1|Follow up|Lost to Follow-up|478
5785921|NCT03633825|19923366|P2|Enrollment|Post not classified as crisis|13757
5785922|NCT03633825|19923367|P1|Enrollment|Post not classified as crisis|13967
5785923|NCT03633825|19923366|P2|Enrollment|Did not post on network|5080
5785924|NCT03633825|19923367|P1|Enrollment|Did not post on network|5066
5785925|NCT03631732|19923571|P2|Overall Study|Lost to Follow-up|1
5785926|NCT03631732|19923572|P1|Overall Study|Lost to Follow-up|5
5785927|NCT03631732|19923571|P2|Overall Study|Withdrew consent|4
5785928|NCT03631732|19923572|P1|Overall Study|Withdrew consent|3
5785929|NCT03631732|19923571|P2|Overall Study|Investigator's Discretion|0
5785930|NCT03631732|19923572|P1|Overall Study|Investigator's Discretion|1
5785931|NCT03631732|19923571|P2|Overall Study|Lack of Efficacy|0
5785932|NCT03631732|19923572|P1|Overall Study|Lack of Efficacy|1
5785933|NCT03631732|19923571|P2|Overall Study|Death|0
5785934|NCT03631732|19923572|P1|Overall Study|Death|1
5785935|NCT03631732|19923571|P2|Overall Study|Adverse Event|0
5785936|NCT03631732|19923572|P1|Overall Study|Adverse Event|3
5785937|NCT03631732|19923571|P2|Overall Study|Still in Study|148
5785938|NCT03631732|19923572|P1|Overall Study|Still in Study|285
5785939|NCT03631732|19923571|P2|Overall Study|Randomized and Never Treated|0
5785940|NCT03631732|19923572|P1|Overall Study|Randomized and Never Treated|1
5785945|NCT03630016|19923695|P1|Overall Study|Poor Sensor Placement|1
5785946|NCT03629886|19923701|P2|Overall Study|Refused vaccination step of the study|44
5785947|NCT03629886|19923702|P1|Overall Study|Refused vaccination step of the study|0
5785948|NCT03629886|19923701|P2|Overall Study|Didn't meet inclusion/exclusion criteria|28
5785949|NCT03629886|19923702|P1|Overall Study|Didn't meet inclusion/exclusion criteria|0
5785950|NCT03629886|19923701|P2|Overall Study|Study vaccine not administrated|3
5785951|NCT03629886|19923702|P1|Overall Study|Study vaccine not administrated|0
5785952|NCT03629886|19923701|P2|Overall Study|Consent withdrawal, not due to an AE|50
5785953|NCT03629886|19923702|P1|Overall Study|Consent withdrawal, not due to an AE|0
5785954|NCT03629886|19923701|P2|Overall Study|Migrated / moved from the study area|55
5785955|NCT03629886|19923702|P1|Overall Study|Migrated / moved from the study area|0
5785956|NCT03629184|19923721|P2|Overall Study|Physician Decision|0
5785957|NCT03629184|19923722|P1|Overall Study|Physician Decision|1
5785958|NCT03629184|19923721|P2|Overall Study|Withdrawal by Subject|1
5785959|NCT03629184|19923722|P1|Overall Study|Withdrawal by Subject|2
5785960|NCT03629054|19923772|P2|Period 2 (4 Days)|Not treated|1
5785961|NCT03629054|19923773|P1|Period 2 (4 Days)|Not treated|0
5785962|NCT03629041|19923797|P4|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0
5785963|NCT03629041|19923798|P3|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0
5785964|NCT03629041|19923799|P2|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|1
5785965|NCT03629041|19923800|P1|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0
5785966|NCT03629028|19923828|P2|Overall Study|intolerance to examination|0
5785967|NCT03629028|19923829|P1|Overall Study|intolerance to examination|2
5785968|NCT03629028|19923828|P2|Overall Study|Pregnancy|2
5785969|NCT03629028|19923829|P1|Overall Study|Pregnancy|4
5785970|NCT03629028|19923828|P2|Overall Study|Lost to Follow-up|23
5785971|NCT03629028|19923829|P1|Overall Study|Lost to Follow-up|26
5785972|NCT03628599|19923860|P2|Overall Study|Adverse Event|1
5785973|NCT03628599|19923861|P1|Overall Study|Adverse Event|0
5785974|NCT03628417|19923891|P2|Overall Study|Death|1
5785975|NCT03628417|19923892|P1|Overall Study|Death|1
5785976|NCT03627832|19923904|P2|Overall Study|Withdrawal by Subject|1
5785977|NCT03627832|19923905|P1|Overall Study|Withdrawal by Subject|10
5785978|NCT03627494|19923939|P12|Part C Washout 1 (7 Days)|Adverse Event|1
5785979|NCT03627494|19923940|P11|Part C Washout 1 (7 Days)|Adverse Event|1
5785980|NCT03627494|19923941|P10|Part C Washout 1 (7 Days)|Adverse Event|0
5785981|NCT03627494|19923942|P9|Part C Washout 1 (7 Days)|Adverse Event|0
5785982|NCT03627494|19923943|P8|Part C Washout 1 (7 Days)|Adverse Event|0
5785983|NCT03627494|19923944|P7|Part C Washout 1 (7 Days)|Adverse Event|0
5785984|NCT03627494|19923945|P6|Part C Washout 1 (7 Days)|Adverse Event|0
5785985|NCT03627494|19923946|P5|Part C Washout 1 (7 Days)|Adverse Event|0
5785986|NCT03627494|19923947|P4|Part C Washout 1 (7 Days)|Adverse Event|0
5785987|NCT03627494|19923948|P3|Part C Washout 1 (7 Days)|Adverse Event|0
5785988|NCT03627494|19923949|P2|Part C Washout 1 (7 Days)|Adverse Event|0
5785989|NCT03627494|19923950|P1|Part C Washout 1 (7 Days)|Adverse Event|0
5785990|NCT03627494|19923939|P12|Part B (Maximum of 34 Days)|Adverse Event|0
5785991|NCT03627494|19923940|P11|Part B (Maximum of 34 Days)|Adverse Event|0
5785992|NCT03627494|19923941|P10|Part B (Maximum of 34 Days)|Adverse Event|0
5785993|NCT03627494|19923942|P9|Part B (Maximum of 34 Days)|Adverse Event|2
5785994|NCT03627494|19923943|P8|Part B (Maximum of 34 Days)|Adverse Event|0
5785995|NCT03627494|19923944|P7|Part B (Maximum of 34 Days)|Adverse Event|0
5785996|NCT03627494|19923945|P6|Part B (Maximum of 34 Days)|Adverse Event|0
5785997|NCT03627494|19923946|P5|Part B (Maximum of 34 Days)|Adverse Event|0
5785998|NCT03627494|19923947|P4|Part B (Maximum of 34 Days)|Adverse Event|0
5785999|NCT03627494|19923948|P3|Part B (Maximum of 34 Days)|Adverse Event|0
5786000|NCT03627494|19923949|P2|Part B (Maximum of 34 Days)|Adverse Event|0
5786001|NCT03627494|19923950|P1|Part B (Maximum of 34 Days)|Adverse Event|0
5786002|NCT03627494|19923939|P12|Part A Washout 2 (7 Days)|Adverse Event|0
5786003|NCT03627494|19923940|P11|Part A Washout 2 (7 Days)|Adverse Event|0
5786004|NCT03627494|19923941|P10|Part A Washout 2 (7 Days)|Adverse Event|0
5786005|NCT03627494|19923942|P9|Part A Washout 2 (7 Days)|Adverse Event|0
5786006|NCT03627494|19923943|P8|Part A Washout 2 (7 Days)|Adverse Event|0
5786007|NCT03627494|19923944|P7|Part A Washout 2 (7 Days)|Adverse Event|0
5786008|NCT03627494|19923945|P6|Part A Washout 2 (7 Days)|Adverse Event|0
5786009|NCT03627494|19923946|P5|Part A Washout 2 (7 Days)|Adverse Event|0
5786010|NCT03627494|19923947|P4|Part A Washout 2 (7 Days)|Adverse Event|0
5786011|NCT03627494|19923948|P3|Part A Washout 2 (7 Days)|Adverse Event|1
5786012|NCT03627494|19923949|P2|Part A Washout 2 (7 Days)|Adverse Event|0
5786013|NCT03627494|19923950|P1|Part A Washout 2 (7 Days)|Adverse Event|1
5786014|NCT03627195|19924164|P6|Overall Study|OTHER (LACK OF EFFICACY)|0
5786015|NCT03627195|19924165|P5|Overall Study|OTHER (LACK OF EFFICACY)|0
5786016|NCT03627195|19924166|P4|Overall Study|OTHER (LACK OF EFFICACY)|0
5786017|NCT03627195|19924167|P3|Overall Study|OTHER (LACK OF EFFICACY)|0
5786018|NCT03627195|19924168|P2|Overall Study|OTHER (LACK OF EFFICACY)|0
5786019|NCT03627195|19924169|P1|Overall Study|OTHER (LACK OF EFFICACY)|1
5786020|NCT03624946|19924240|P2|Overall Study|Lost to Follow-up|1
5786021|NCT03624946|19924241|P1|Overall Study|Lost to Follow-up|0
5786022|NCT03624504|19924295|P1|Overall Study|Unsuccessful Implant|1
5786023|NCT03622112|19924362|P7|Overall Study|Reason not specified|1
5786024|NCT03622112|19924363|P6|Overall Study|Reason not specified|2
5786025|NCT03622112|19924364|P5|Overall Study|Reason not specified|1
5786026|NCT03622112|19924365|P4|Overall Study|Reason not specified|1
5786027|NCT03622112|19924366|P3|Overall Study|Reason not specified|0
5786028|NCT03622112|19924367|P2|Overall Study|Reason not specified|1
5786029|NCT03622112|19924368|P1|Overall Study|Reason not specified|0
5786030|NCT03622112|19924362|P7|Overall Study|Adverse Event|2
5786031|NCT03622112|19924363|P6|Overall Study|Adverse Event|20
5786032|NCT03622112|19924364|P5|Overall Study|Adverse Event|4
5786033|NCT03622112|19924365|P4|Overall Study|Adverse Event|11
5786034|NCT03622112|19924366|P3|Overall Study|Adverse Event|4
5786035|NCT03622112|19924367|P2|Overall Study|Adverse Event|8
5786036|NCT03622112|19924368|P1|Overall Study|Adverse Event|6
5786037|NCT03622112|19924362|P7|Overall Study|Protocol Violation|0
5786038|NCT03622112|19924363|P6|Overall Study|Protocol Violation|0
5786039|NCT03622112|19924364|P5|Overall Study|Protocol Violation|0
5786040|NCT03622112|19924365|P4|Overall Study|Protocol Violation|1
5786041|NCT03622112|19924366|P3|Overall Study|Protocol Violation|1
5786042|NCT03622112|19924367|P2|Overall Study|Protocol Violation|0
5786043|NCT03622112|19924368|P1|Overall Study|Protocol Violation|2
5786044|NCT03622112|19924362|P7|Overall Study|Study-specific withdrawal criteria|4
5786045|NCT03622112|19924363|P6|Overall Study|Study-specific withdrawal criteria|18
5786046|NCT03622112|19924364|P5|Overall Study|Study-specific withdrawal criteria|4
5786047|NCT03622112|19924365|P4|Overall Study|Study-specific withdrawal criteria|6
5786048|NCT03622112|19924366|P3|Overall Study|Study-specific withdrawal criteria|7
5786049|NCT03622112|19924367|P2|Overall Study|Study-specific withdrawal criteria|8
5786050|NCT03622112|19924368|P1|Overall Study|Study-specific withdrawal criteria|10
5786051|NCT03622112|19924362|P7|Overall Study|Lost to Follow-up|0
5786052|NCT03622112|19924363|P6|Overall Study|Lost to Follow-up|0
5786053|NCT03622112|19924364|P5|Overall Study|Lost to Follow-up|0
5786054|NCT03622112|19924365|P4|Overall Study|Lost to Follow-up|0
5786055|NCT03622112|19924366|P3|Overall Study|Lost to Follow-up|0
5786056|NCT03622112|19924367|P2|Overall Study|Lost to Follow-up|1
5786057|NCT03622112|19924368|P1|Overall Study|Lost to Follow-up|1
5786058|NCT03622112|19924362|P7|Overall Study|Death|0
5786059|NCT03622112|19924363|P6|Overall Study|Death|0
5786060|NCT03622112|19924364|P5|Overall Study|Death|0
5786061|NCT03622112|19924365|P4|Overall Study|Death|1
5786062|NCT03622112|19924366|P3|Overall Study|Death|0
5786063|NCT03622112|19924367|P2|Overall Study|Death|0
5786064|NCT03622112|19924368|P1|Overall Study|Death|0
5786065|NCT03622112|19924362|P7|Overall Study|Withdrawal by Subject|2
5786066|NCT03622112|19924363|P6|Overall Study|Withdrawal by Subject|2
5786067|NCT03622112|19924364|P5|Overall Study|Withdrawal by Subject|1
5786068|NCT03622112|19924365|P4|Overall Study|Withdrawal by Subject|2
5786069|NCT03622112|19924366|P3|Overall Study|Withdrawal by Subject|4
5786070|NCT03622112|19924367|P2|Overall Study|Withdrawal by Subject|2
5786071|NCT03622112|19924368|P1|Overall Study|Withdrawal by Subject|6
5786072|NCT03620708|19924597|P3|Overall Study|Withdrawal by Subject|1
5786073|NCT03620708|19924598|P2|Overall Study|Withdrawal by Subject|0
5786074|NCT03620708|19924599|P1|Overall Study|Withdrawal by Subject|0
5786075|NCT03620708|19924597|P3|Overall Study|Lost to Follow-up|2
5786076|NCT03620708|19924598|P2|Overall Study|Lost to Follow-up|1
5786077|NCT03620708|19924599|P1|Overall Study|Lost to Follow-up|1
5786078|NCT03618628|19924680|P1|Overall Study|Lost to Follow-up|1
5786079|NCT03618628|19924680|P1|Overall Study|Death|1
5786080|NCT03617861|19924710|P4|Second Intervention (1 Day)|Adverse Event|0
5786081|NCT03617861|19924711|P3|Second Intervention (1 Day)|Adverse Event|1
5786082|NCT03617861|19924712|P2|Second Intervention (1 Day)|Adverse Event|0
5786083|NCT03617861|19924713|P1|Second Intervention (1 Day)|Adverse Event|0
5786084|NCT03617588|19924745|P2|Overall Study|Withdrawal by Subject|0
5786085|NCT03617588|19924746|P1|Overall Study|Withdrawal by Subject|1
5786086|NCT03616977|19924807|P2|Period 3|Adverse Event|1
5786087|NCT03616977|19924808|P1|Period 3|Adverse Event|1
5786088|NCT03616977|19924807|P2|Period 1|Physician Decision|1
5786089|NCT03616977|19924808|P1|Period 1|Physician Decision|0
5786092|NCT03616106|19924853|P2|Overall Study|Lost to Follow-up|0
5786093|NCT03616106|19924854|P1|Overall Study|Lost to Follow-up|7
5786094|NCT03616106|19924853|P2|Overall Study|Withdrawal by Subject|1
5786095|NCT03616106|19924854|P1|Overall Study|Withdrawal by Subject|1
5786096|NCT03616106|19924853|P2|Overall Study|Removed by PI|0
5786097|NCT03616106|19924854|P1|Overall Study|Removed by PI|6
5786098|NCT03615482|19924974|P2|Overall Study|Withdrawal by Subject|7
5786099|NCT03615482|19924975|P1|Overall Study|Withdrawal by Subject|7
5786100|NCT03615482|19924974|P2|Overall Study|Physician Decision|3
5786101|NCT03615482|19924975|P1|Overall Study|Physician Decision|2
5786102|NCT03615482|19924974|P2|Overall Study|Lost to Follow-up|7
5786103|NCT03615482|19924975|P1|Overall Study|Lost to Follow-up|7
5786104|NCT03615482|19924974|P2|Overall Study|Death|0
5786105|NCT03615482|19924975|P1|Overall Study|Death|1
5786106|NCT03615066|19925073|P3|Overall Study|Still on Study|6
5786107|NCT03615066|19925074|P2|Overall Study|Still on Study|19
5786108|NCT03615066|19925075|P1|Overall Study|Still on Study|18
5786109|NCT03615066|19925073|P3|Overall Study|Lost to Follow-up|1
5786110|NCT03615066|19925074|P2|Overall Study|Lost to Follow-up|0
5786111|NCT03615066|19925075|P1|Overall Study|Lost to Follow-up|0
5786112|NCT03615066|19925073|P3|Overall Study|Withdrew Consent|1
5786113|NCT03615066|19925074|P2|Overall Study|Withdrew Consent|1
5786114|NCT03615066|19925075|P1|Overall Study|Withdrew Consent|0
5786115|NCT03615066|19925073|P3|Overall Study|Protocol Violation|0
5786116|NCT03615066|19925074|P2|Overall Study|Protocol Violation|0
5786117|NCT03615066|19925075|P1|Overall Study|Protocol Violation|1
5786118|NCT03614975|19925132|P2|Overall Study|Specimens not in lab batch shipment|1
5786119|NCT03614975|19925133|P1|Overall Study|Specimens not in lab batch shipment|1
5786120|NCT03614975|19925132|P2|Overall Study|Withdrawal by Subject|2
5786121|NCT03614975|19925133|P1|Overall Study|Withdrawal by Subject|2
5786122|NCT03614975|19925132|P2|Overall Study|Physician Decision|5
5786123|NCT03614975|19925133|P1|Overall Study|Physician Decision|7
5786124|NCT03614156|19925155|P4|Safety Follow-Up Period|Lost to Follow-up|1
5786125|NCT03614156|19925156|P3|Safety Follow-Up Period|Lost to Follow-up|0
5786126|NCT03614156|19925157|P2|Safety Follow-Up Period|Lost to Follow-up|0
5786127|NCT03614156|19925158|P1|Safety Follow-Up Period|Lost to Follow-up|1
5786128|NCT03614156|19925155|P4|Safety Follow-Up Period|Withdrawal by Subject|0
5786129|NCT03614156|19925156|P3|Safety Follow-Up Period|Withdrawal by Subject|1
5786130|NCT03614156|19925157|P2|Safety Follow-Up Period|Withdrawal by Subject|0
5786131|NCT03614156|19925158|P1|Safety Follow-Up Period|Withdrawal by Subject|0
5786132|NCT03614156|19925155|P4|Safety Follow-Up Period|Miscellaneous Reasons|0
5786133|NCT03614156|19925156|P3|Safety Follow-Up Period|Miscellaneous Reasons|0
5786134|NCT03614156|19925157|P2|Safety Follow-Up Period|Miscellaneous Reasons|0
5786135|NCT03614156|19925158|P1|Safety Follow-Up Period|Miscellaneous Reasons|2
5786136|NCT03614156|19925155|P4|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0
5786137|NCT03614156|19925156|P3|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0
5786138|NCT03614156|19925157|P2|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|1
5786139|NCT03614156|19925158|P1|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0
5786140|NCT03614156|19925155|P4|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|38
5786141|NCT03614156|19925156|P3|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|26
5786142|NCT03614156|19925157|P2|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|22
5786143|NCT03614156|19925158|P1|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|0
5786144|NCT03614156|19925155|P4|Double-Blind Treatment Period (DBTP)|Protocol Violation|1
5786145|NCT03614156|19925156|P3|Double-Blind Treatment Period (DBTP)|Protocol Violation|1
5786146|NCT03614156|19925157|P2|Double-Blind Treatment Period (DBTP)|Protocol Violation|1
5786147|NCT03614156|19925158|P1|Double-Blind Treatment Period (DBTP)|Protocol Violation|0
5786148|NCT03614156|19925155|P4|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|4
5786149|NCT03614156|19925156|P3|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|3
5786150|NCT03614156|19925157|P2|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|0
5786151|NCT03614156|19925158|P1|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|0
5786152|NCT03614156|19925155|P4|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|1
5786153|NCT03614156|19925156|P3|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|1
5786154|NCT03614156|19925157|P2|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|4
5786155|NCT03614156|19925158|P1|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|0
5786156|NCT03614156|19925155|P4|Double-Blind Treatment Period (DBTP)|Adverse Event|1
5786157|NCT03614156|19925156|P3|Double-Blind Treatment Period (DBTP)|Adverse Event|0
5786158|NCT03614156|19925157|P2|Double-Blind Treatment Period (DBTP)|Adverse Event|2
5786159|NCT03614156|19925158|P1|Double-Blind Treatment Period (DBTP)|Adverse Event|0
5786160|NCT03614156|19925155|P4|Open-Label Treatment Period|Study terminated by sponsor|0
5786161|NCT03614156|19925156|P3|Open-Label Treatment Period|Study terminated by sponsor|0
5786162|NCT03614156|19925157|P2|Open-Label Treatment Period|Study terminated by sponsor|0
5786163|NCT03614156|19925158|P1|Open-Label Treatment Period|Study terminated by sponsor|74
5786164|NCT03614156|19925155|P4|Open-Label Treatment Period|Non-compliance with study drug|0
5786165|NCT03614156|19925156|P3|Open-Label Treatment Period|Non-compliance with study drug|0
5786166|NCT03614156|19925157|P2|Open-Label Treatment Period|Non-compliance with study drug|0
5786167|NCT03614156|19925158|P1|Open-Label Treatment Period|Non-compliance with study drug|1
5786168|NCT03614156|19925155|P4|Open-Label Treatment Period|Protocol Violation|0
5786169|NCT03614156|19925156|P3|Open-Label Treatment Period|Protocol Violation|0
5786170|NCT03614156|19925157|P2|Open-Label Treatment Period|Protocol Violation|0
5786171|NCT03614156|19925158|P1|Open-Label Treatment Period|Protocol Violation|2
5786172|NCT03614156|19925155|P4|Open-Label Treatment Period|Lost to Follow-up|0
5786173|NCT03614156|19925156|P3|Open-Label Treatment Period|Lost to Follow-up|0
5786174|NCT03614156|19925157|P2|Open-Label Treatment Period|Lost to Follow-up|0
5786175|NCT03614156|19925158|P1|Open-Label Treatment Period|Lost to Follow-up|10
5786176|NCT03614156|19925155|P4|Open-Label Treatment Period|Withdrawal by Subject|0
5786177|NCT03614156|19925156|P3|Open-Label Treatment Period|Withdrawal by Subject|0
5786178|NCT03614156|19925157|P2|Open-Label Treatment Period|Withdrawal by Subject|0
5786179|NCT03614156|19925158|P1|Open-Label Treatment Period|Withdrawal by Subject|36
5786180|NCT03614156|19925155|P4|Open-Label Treatment Period|Lack of Efficacy|0
5786181|NCT03614156|19925156|P3|Open-Label Treatment Period|Lack of Efficacy|0
5786182|NCT03614156|19925157|P2|Open-Label Treatment Period|Lack of Efficacy|0
5786183|NCT03614156|19925158|P1|Open-Label Treatment Period|Lack of Efficacy|18
5786184|NCT03614156|19925155|P4|Open-Label Treatment Period|Adverse Event|0
5786185|NCT03614156|19925156|P3|Open-Label Treatment Period|Adverse Event|0
5786186|NCT03614156|19925157|P2|Open-Label Treatment Period|Adverse Event|0
5786187|NCT03614156|19925158|P1|Open-Label Treatment Period|Adverse Event|7
5786188|NCT03614156|19925155|P4|Open-Label Treatment Period|Protocol-specified withdrawal met|0
5786189|NCT03614156|19925156|P3|Open-Label Treatment Period|Protocol-specified withdrawal met|0
5786190|NCT03614156|19925157|P2|Open-Label Treatment Period|Protocol-specified withdrawal met|0
5786191|NCT03614156|19925158|P1|Open-Label Treatment Period|Protocol-specified withdrawal met|6
5786192|NCT03614078|19925170|P3|Overall Study|Dizziness and Rash|0
5786193|NCT03614078|19925171|P2|Overall Study|Dizziness and Rash|1
5786194|NCT03614078|19925172|P1|Overall Study|Dizziness and Rash|0
5786195|NCT03614078|19925170|P3|Overall Study|Adverse Event|0
5786196|NCT03614078|19925171|P2|Overall Study|Adverse Event|2
5786197|NCT03614078|19925172|P1|Overall Study|Adverse Event|0
5786198|NCT03614078|19925170|P3|Overall Study|Exacerbation of Psoriasis|0
5786199|NCT03614078|19925171|P2|Overall Study|Exacerbation of Psoriasis|1
5786200|NCT03614078|19925172|P1|Overall Study|Exacerbation of Psoriasis|0
5786201|NCT03614078|19925170|P3|Overall Study|Patient Did Not Meet Eligibility|0
5786202|NCT03614078|19925171|P2|Overall Study|Patient Did Not Meet Eligibility|0
5786203|NCT03614078|19925172|P1|Overall Study|Patient Did Not Meet Eligibility|1
5786204|NCT03614078|19925170|P3|Overall Study|High Neutrophils|2
5786205|NCT03614078|19925171|P2|Overall Study|High Neutrophils|0
5786206|NCT03614078|19925172|P1|Overall Study|High Neutrophils|0
5786207|NCT03614078|19925170|P3|Overall Study|Participant Did Not Return for Visit|0
5786208|NCT03614078|19925171|P2|Overall Study|Participant Did Not Return for Visit|1
5786209|NCT03614078|19925172|P1|Overall Study|Participant Did Not Return for Visit|0
5786210|NCT03614078|19925170|P3|Overall Study|Withdrawal by Subject|3
5786211|NCT03614078|19925171|P2|Overall Study|Withdrawal by Subject|2
5786212|NCT03614078|19925172|P1|Overall Study|Withdrawal by Subject|2
5786213|NCT03613649|19925201|P12|Fourth Treatment|Physician Decision|0
5786214|NCT03613649|19925202|P11|Fourth Treatment|Physician Decision|0
5786215|NCT03613649|19925203|P10|Fourth Treatment|Physician Decision|0
5786216|NCT03613649|19925204|P9|Fourth Treatment|Physician Decision|0
5786217|NCT03613649|19925205|P8|Fourth Treatment|Physician Decision|0
5786218|NCT03613649|19925206|P7|Fourth Treatment|Physician Decision|1
5786219|NCT03613649|19925207|P6|Fourth Treatment|Physician Decision|0
5786220|NCT03613649|19925208|P5|Fourth Treatment|Physician Decision|0
5786221|NCT03613649|19925209|P4|Fourth Treatment|Physician Decision|0
5786222|NCT03613649|19925210|P3|Fourth Treatment|Physician Decision|0
5786223|NCT03613649|19925211|P2|Fourth Treatment|Physician Decision|0
5786224|NCT03613649|19925212|P1|Fourth Treatment|Physician Decision|0
5786225|NCT03613649|19925201|P12|Fourth Treatment|Protocol Violation|0
5786226|NCT03613649|19925202|P11|Fourth Treatment|Protocol Violation|0
5786227|NCT03613649|19925203|P10|Fourth Treatment|Protocol Violation|0
5786228|NCT03613649|19925204|P9|Fourth Treatment|Protocol Violation|0
5786229|NCT03613649|19925205|P8|Fourth Treatment|Protocol Violation|0
5786230|NCT03613649|19925206|P7|Fourth Treatment|Protocol Violation|0
5786231|NCT03613649|19925207|P6|Fourth Treatment|Protocol Violation|0
5786232|NCT03613649|19925208|P5|Fourth Treatment|Protocol Violation|1
5786233|NCT03613649|19925209|P4|Fourth Treatment|Protocol Violation|0
5786234|NCT03613649|19925210|P3|Fourth Treatment|Protocol Violation|0
5786235|NCT03613649|19925211|P2|Fourth Treatment|Protocol Violation|0
5786236|NCT03613649|19925212|P1|Fourth Treatment|Protocol Violation|1
5786237|NCT03613649|19925201|P12|Third Treatment|Protocol Violation|1
5786238|NCT03613649|19925202|P11|Third Treatment|Protocol Violation|0
5786239|NCT03613649|19925203|P10|Third Treatment|Protocol Violation|0
5786240|NCT03613649|19925204|P9|Third Treatment|Protocol Violation|0
5786241|NCT03613649|19925205|P8|Third Treatment|Protocol Violation|0
5786242|NCT03613649|19925206|P7|Third Treatment|Protocol Violation|1
5786243|NCT03613649|19925207|P6|Third Treatment|Protocol Violation|0
5786244|NCT03613649|19925208|P5|Third Treatment|Protocol Violation|0
5786245|NCT03613649|19925209|P4|Third Treatment|Protocol Violation|0
5786246|NCT03613649|19925210|P3|Third Treatment|Protocol Violation|0
5786247|NCT03613649|19925211|P2|Third Treatment|Protocol Violation|0
5786248|NCT03613649|19925212|P1|Third Treatment|Protocol Violation|0
5786249|NCT03613649|19925201|P12|Third Treatment|Lost to Follow-up|1
5786250|NCT03613649|19925202|P11|Third Treatment|Lost to Follow-up|0
5786251|NCT03613649|19925203|P10|Third Treatment|Lost to Follow-up|0
5786252|NCT03613649|19925204|P9|Third Treatment|Lost to Follow-up|0
5786253|NCT03613649|19925205|P8|Third Treatment|Lost to Follow-up|0
5786254|NCT03613649|19925206|P7|Third Treatment|Lost to Follow-up|0
5786255|NCT03613649|19925207|P6|Third Treatment|Lost to Follow-up|0
5786256|NCT03613649|19925208|P5|Third Treatment|Lost to Follow-up|1
5786257|NCT03613649|19925209|P4|Third Treatment|Lost to Follow-up|0
5786258|NCT03613649|19925210|P3|Third Treatment|Lost to Follow-up|0
5786259|NCT03613649|19925211|P2|Third Treatment|Lost to Follow-up|0
5786260|NCT03613649|19925212|P1|Third Treatment|Lost to Follow-up|0
5786261|NCT03613649|19925201|P12|Second Treatment|Withdrawal by Subject|0
5786262|NCT03613649|19925202|P11|Second Treatment|Withdrawal by Subject|0
5786263|NCT03613649|19925203|P10|Second Treatment|Withdrawal by Subject|0
5786264|NCT03613649|19925204|P9|Second Treatment|Withdrawal by Subject|0
5786265|NCT03613649|19925205|P8|Second Treatment|Withdrawal by Subject|0
5786266|NCT03613649|19925206|P7|Second Treatment|Withdrawal by Subject|0
5786267|NCT03613649|19925207|P6|Second Treatment|Withdrawal by Subject|0
5786268|NCT03613649|19925208|P5|Second Treatment|Withdrawal by Subject|1
5786269|NCT03613649|19925209|P4|Second Treatment|Withdrawal by Subject|0
5786270|NCT03613649|19925210|P3|Second Treatment|Withdrawal by Subject|0
5786271|NCT03613649|19925211|P2|Second Treatment|Withdrawal by Subject|0
5786272|NCT03613649|19925212|P1|Second Treatment|Withdrawal by Subject|0
5786273|NCT03613649|19925201|P12|Second Treatment|Lost to Follow-up|0
5786274|NCT03613649|19925202|P11|Second Treatment|Lost to Follow-up|0
5786275|NCT03613649|19925203|P10|Second Treatment|Lost to Follow-up|0
5786276|NCT03613649|19925204|P9|Second Treatment|Lost to Follow-up|0
5786277|NCT03613649|19925205|P8|Second Treatment|Lost to Follow-up|0
5786278|NCT03613649|19925206|P7|Second Treatment|Lost to Follow-up|0
5786279|NCT03613649|19925207|P6|Second Treatment|Lost to Follow-up|0
5786280|NCT03613649|19925208|P5|Second Treatment|Lost to Follow-up|0
5786281|NCT03613649|19925209|P4|Second Treatment|Lost to Follow-up|0
5786282|NCT03613649|19925210|P3|Second Treatment|Lost to Follow-up|1
5786283|NCT03613649|19925211|P2|Second Treatment|Lost to Follow-up|0
5786284|NCT03613649|19925212|P1|Second Treatment|Lost to Follow-up|0
5786285|NCT03613129|19925357|P5|Pre-treatment Assessment|Withdrawal by Subject|0
5786286|NCT03613129|19925358|P4|Pre-treatment Assessment|Withdrawal by Subject|0
5786287|NCT03613129|19925359|P3|Pre-treatment Assessment|Withdrawal by Subject|0
5786288|NCT03613129|19925360|P2|Pre-treatment Assessment|Withdrawal by Subject|0
5786289|NCT03613129|19925361|P1|Pre-treatment Assessment|Withdrawal by Subject|1
5786290|NCT03613129|19925357|P5|Pre-treatment Assessment|Protocol Violation|0
5786291|NCT03613129|19925358|P4|Pre-treatment Assessment|Protocol Violation|0
5786292|NCT03613129|19925359|P3|Pre-treatment Assessment|Protocol Violation|0
5786293|NCT03613129|19925360|P2|Pre-treatment Assessment|Protocol Violation|0
5786294|NCT03613129|19925361|P1|Pre-treatment Assessment|Protocol Violation|2
5786295|NCT03612856|19925386|P3|Pre-dose Period|Withdrawal by Subject|0
5786296|NCT03612856|19925387|P2|Pre-dose Period|Withdrawal by Subject|1
5786297|NCT03612856|19925388|P1|Pre-dose Period|Withdrawal by Subject|0
5786298|NCT03612856|19925386|P3|Pre-dose Period|Physician Decision|1
5786299|NCT03612856|19925387|P2|Pre-dose Period|Physician Decision|1
5786300|NCT03612856|19925388|P1|Pre-dose Period|Physician Decision|0
5786301|NCT03610269|19925588|P1|Overall Study|Screen fail|4
5786302|NCT03610269|19925588|P1|Overall Study|Unable to draw blood|1
5786303|NCT03610269|19925588|P1|Overall Study|Protocol Violation|1
5786304|NCT03610269|19925588|P1|Overall Study|Physician Decision|10
5786305|NCT03609619|19925594|P2|Overall Study|Lost to Follow-up|1
5786306|NCT03609619|19925595|P1|Overall Study|Lost to Follow-up|1
5786307|NCT03609619|19925594|P2|Overall Study|Withdrawal by Subject|3
5786308|NCT03609619|19925595|P1|Overall Study|Withdrawal by Subject|2
5786309|NCT03609619|19925594|P2|Overall Study|Protocol Violation|0
5786310|NCT03609619|19925595|P1|Overall Study|Protocol Violation|5
5786311|NCT03609619|19925594|P2|Overall Study|Lack of Efficacy|2
5786312|NCT03609619|19925595|P1|Overall Study|Lack of Efficacy|1
5786313|NCT03609619|19925594|P2|Overall Study|Adverse Event|0
5786314|NCT03609619|19925595|P1|Overall Study|Adverse Event|1
5786315|NCT03608774|19925633|P2|Overall Study|Health related event|1
5786316|NCT03608774|19925634|P1|Overall Study|Health related event|0
5786317|NCT03608774|19925633|P2|Overall Study|Not eligible at enrollment|1
5786318|NCT03608774|19925634|P1|Overall Study|Not eligible at enrollment|0
5786319|NCT03608774|19925633|P2|Overall Study|Protocol Violation|0
5786320|NCT03608774|19925634|P1|Overall Study|Protocol Violation|1
5786321|NCT03608774|19925633|P2|Overall Study|Withdrawal by Subject|0
5786322|NCT03608774|19925634|P1|Overall Study|Withdrawal by Subject|1
5786323|NCT03608774|19925633|P2|Overall Study|Lost to Follow-up|5
5786324|NCT03608774|19925634|P1|Overall Study|Lost to Follow-up|5
5786325|NCT03607682|19925695|P1|Overall Study|Disease progression|1
5786326|NCT03607682|19925695|P1|Overall Study|Withdrawal by Subject|1
5786327|NCT03607487|19925711|P4|Overall Study|Withdrawal by Subject|1
5786328|NCT03607487|19925712|P3|Overall Study|Withdrawal by Subject|0
5786329|NCT03607487|19925713|P2|Overall Study|Withdrawal by Subject|0
5786330|NCT03607487|19925714|P1|Overall Study|Withdrawal by Subject|2
5786331|NCT03606460|19925765|P2|Overall Study|Lost to Follow-up|8
5786332|NCT03606460|19925766|P1|Overall Study|Lost to Follow-up|1
5786333|NCT03605693|19925786|P2|Overall Study|Physician Decision|0
5786334|NCT03605693|19925787|P1|Overall Study|Physician Decision|1
5786335|NCT03605693|19925786|P2|Overall Study|Lost to Follow-up|0
5786336|NCT03605693|19925787|P1|Overall Study|Lost to Follow-up|4
5786337|NCT03605303|19925801|P2|Period 1|Study Terminated|1
5786338|NCT03605303|19925802|P1|Period 1|Study Terminated|2
5786339|NCT03604497|19925810|P1|Overall Study|Protocol Violation|52
5786340|NCT03604341|19925820|P2|Overall Study|Protocol Violation|1
5786341|NCT03604341|19925821|P1|Overall Study|Protocol Violation|0
5786342|NCT03604341|19925820|P2|Overall Study|Adverse Event|0
5786343|NCT03604341|19925821|P1|Overall Study|Adverse Event|1
5786344|NCT03604341|19925820|P2|Overall Study|Withdrawal by Subject|1
5786345|NCT03604341|19925821|P1|Overall Study|Withdrawal by Subject|1
5786346|NCT03603652|19925831|P1|Overall Study|Death|2
5786347|NCT03603028|19925917|P1|Overall Study|Withdrawal by Subject|1
5786348|NCT03602053|19925925|P3|Overall Study|Other|0
5786349|NCT03602053|19925926|P2|Overall Study|Other|0
5786350|NCT03602053|19925927|P1|Overall Study|Other|1
5786351|NCT03602053|19925925|P3|Overall Study|migration|0
5786352|NCT03602053|19925926|P2|Overall Study|migration|3
5786353|NCT03602053|19925927|P1|Overall Study|migration|2
5786354|NCT03602053|19925925|P3|Overall Study|Physician Decision|0
5786355|NCT03602053|19925926|P2|Overall Study|Physician Decision|0
5786356|NCT03602053|19925927|P1|Overall Study|Physician Decision|1
5786357|NCT03602053|19925925|P3|Overall Study|Protocol Violation|4
5786358|NCT03602053|19925926|P2|Overall Study|Protocol Violation|0
5786359|NCT03602053|19925927|P1|Overall Study|Protocol Violation|3
5786360|NCT03602053|19925925|P3|Overall Study|Lost to Follow-up|0
5786361|NCT03602053|19925926|P2|Overall Study|Lost to Follow-up|6
5786362|NCT03602053|19925927|P1|Overall Study|Lost to Follow-up|5
5786363|NCT03602053|19925925|P3|Overall Study|Withdrawal by Subject|7
5786364|NCT03602053|19925926|P2|Overall Study|Withdrawal by Subject|9
5786365|NCT03602053|19925927|P1|Overall Study|Withdrawal by Subject|7
5786366|NCT03601715|19925973|P3|Second Intervention|Lost to Follow-up|0
5786367|NCT03601715|19925974|P2|Second Intervention|Lost to Follow-up|1
5786368|NCT03601715|19925975|P1|Second Intervention|Lost to Follow-up|1
5786369|NCT03599349|19926008|P1|Overall Study|Lost to Follow-up|1
5786378|NCT03598140|19926037|P2|Overall Study|enrolled but didn't start|0
5786379|NCT03598140|19926038|P1|Overall Study|enrolled but didn't start|1
5786380|NCT03597022|19926057|P3|Overall Study|Serious adverse event|0
5786381|NCT03597022|19926058|P2|Overall Study|Serious adverse event|1
5786382|NCT03597022|19926059|P1|Overall Study|Serious adverse event|1
5786383|NCT03597022|19926057|P3|Overall Study|Premature termination of the study|8
5786384|NCT03597022|19926058|P2|Overall Study|Premature termination of the study|7
5786385|NCT03597022|19926059|P1|Overall Study|Premature termination of the study|7
5786386|NCT03596177|19926089|P2|Double Blind Period|Death during safety follow-up|1
5786387|NCT03596177|19926090|P1|Double Blind Period|Death during safety follow-up|0
5786388|NCT03596177|19926089|P2|Double Blind Period|Other|4
5786389|NCT03596177|19926090|P1|Double Blind Period|Other|0
5786390|NCT03596177|19926089|P2|Double Blind Period|Withdrawal by Subject|1
5786391|NCT03596177|19926090|P1|Double Blind Period|Withdrawal by Subject|0
5786392|NCT03596177|19926089|P2|Single Blind Period|Other|0
5786393|NCT03596177|19926090|P1|Single Blind Period|Other|1
5786394|NCT03596177|19926089|P2|Single Blind Period|Withdrawal by Subject|1
5786395|NCT03596177|19926090|P1|Single Blind Period|Withdrawal by Subject|1
5786396|NCT03594227|19926148|P4|Overall Study|Programmatic Analysis Non-completer|1
5786397|NCT03594227|19926149|P3|Overall Study|Programmatic Analysis Non-completer|1
5786398|NCT03594227|19926150|P2|Overall Study|Programmatic Analysis Non-completer|0
5786399|NCT03594227|19926151|P1|Overall Study|Programmatic Analysis Non-completer|1
5786400|NCT03594227|19926148|P4|Overall Study|Sponsor Decision|1
5786401|NCT03594227|19926149|P3|Overall Study|Sponsor Decision|0
5786402|NCT03594227|19926150|P2|Overall Study|Sponsor Decision|0
5786403|NCT03594227|19926151|P1|Overall Study|Sponsor Decision|0
5786404|NCT03594227|19926148|P4|Overall Study|Pregnancy|0
5786405|NCT03594227|19926149|P3|Overall Study|Pregnancy|0
5786406|NCT03594227|19926150|P2|Overall Study|Pregnancy|1
5786407|NCT03594227|19926151|P1|Overall Study|Pregnancy|0
5786408|NCT03594227|19926148|P4|Overall Study|Withdrawal by Subject|1
5786409|NCT03594227|19926149|P3|Overall Study|Withdrawal by Subject|1
5786410|NCT03594227|19926150|P2|Overall Study|Withdrawal by Subject|1
5786411|NCT03594227|19926151|P1|Overall Study|Withdrawal by Subject|1
5786412|NCT03594227|19926148|P4|Overall Study|Lost to Follow-up|0
5786413|NCT03594227|19926149|P3|Overall Study|Lost to Follow-up|1
5786414|NCT03594227|19926150|P2|Overall Study|Lost to Follow-up|1
5786415|NCT03594227|19926151|P1|Overall Study|Lost to Follow-up|1
5786416|NCT03594227|19926148|P4|Overall Study|Adverse Event|2
5786417|NCT03594227|19926149|P3|Overall Study|Adverse Event|0
5786418|NCT03594227|19926150|P2|Overall Study|Adverse Event|1
5786419|NCT03594227|19926151|P1|Overall Study|Adverse Event|2
5786420|NCT03593681|19926313|P1|Overall Study|Physician Decision|1
5786421|NCT03593681|19926313|P1|Overall Study|Adverse Event|2
5786422|NCT03593681|19926313|P1|Overall Study|Procedure not attempted|3
5786423|NCT03593681|19926313|P1|Overall Study|Withdrawal by Subject|3
5786424|NCT03593681|19926313|P1|Overall Study|Protocol Violation|3
5786425|NCT03593681|19926313|P1|Overall Study|Hysteroscope attempted but unable to find ostia|11
5786426|NCT03593681|19926313|P1|Overall Study|Inadequate sample collected|12
5786427|NCT03592186|19926353|P2|Overall Study|Lost to Follow-up|11
5786428|NCT03592186|19926354|P1|Overall Study|Lost to Follow-up|16
5786429|NCT03592186|19926353|P2|Overall Study|Withdrawal by Subject|0
5786430|NCT03592186|19926354|P1|Overall Study|Withdrawal by Subject|1
5786431|NCT03591406|19926402|P2|Overall Study|Withdrawal by Subject|5
5786432|NCT03591406|19926403|P1|Overall Study|Withdrawal by Subject|0
5786433|NCT03591406|19926402|P2|Overall Study|Protocol Violation|1
5786434|NCT03591406|19926403|P1|Overall Study|Protocol Violation|2
5786435|NCT03591406|19926402|P2|Overall Study|Adverse Event|3
5786436|NCT03591406|19926403|P1|Overall Study|Adverse Event|5
5786437|NCT03590743|19926449|P2|Overall Study|Withdrawal by Subject|1
5786438|NCT03590743|19926450|P1|Overall Study|Withdrawal by Subject|0
5786439|NCT03590613|19926462|P4|Period 2, 4 Days|Physician Decision|1
5786440|NCT03590613|19926463|P3|Period 2, 4 Days|Physician Decision|0
5786441|NCT03590613|19926464|P2|Period 2, 4 Days|Physician Decision|0
5786442|NCT03590613|19926465|P1|Period 2, 4 Days|Physician Decision|0
5786443|NCT03588741|19926594|P1|Overall Study|Withdrawal by Subject|1
5786444|NCT03588572|19926601|P2|Visitation 3|Withdrawal by Subject|0
5786445|NCT03588572|19926602|P1|Visitation 3|Withdrawal by Subject|1
5786446|NCT03588572|19926601|P2|Visitation 3|Physician Decision|1
5786447|NCT03588572|19926602|P1|Visitation 3|Physician Decision|1
5786448|NCT03588572|19926601|P2|Visitation 3|Lost to Follow-up|1
5786449|NCT03588572|19926602|P1|Visitation 3|Lost to Follow-up|1
5786450|NCT03588572|19926601|P2|Visitation 2|Withdrawal by Subject|0
5786451|NCT03588572|19926602|P1|Visitation 2|Withdrawal by Subject|1
5786452|NCT03588572|19926601|P2|Visitation 2|Lack of Efficacy|1
5786453|NCT03588572|19926602|P1|Visitation 2|Lack of Efficacy|0
5786454|NCT03588572|19926601|P2|Visitation 2|Lost to Follow-up|1
5786455|NCT03588572|19926602|P1|Visitation 2|Lost to Follow-up|1
5786456|NCT03588572|19926601|P2|Visitation 1|Lack of Efficacy|1
5786457|NCT03588572|19926602|P1|Visitation 1|Lack of Efficacy|1
5786458|NCT03587974|19926620|P2|Overall Study|Withdrawal by Subject|1
5786459|NCT03587974|19926621|P1|Overall Study|Withdrawal by Subject|2
5786460|NCT03587974|19926620|P2|Overall Study|caregiver demented, care recipient died|3
5786461|NCT03587974|19926621|P1|Overall Study|caregiver demented, care recipient died|3
5786462|NCT03586830|19926737|P4|Overall Study|Withdrawal by Subject|1
5786463|NCT03586830|19926738|P3|Overall Study|Withdrawal by Subject|3
5786464|NCT03586830|19926739|P2|Overall Study|Withdrawal by Subject|0
5786465|NCT03586830|19926740|P1|Overall Study|Withdrawal by Subject|1
5786466|NCT03586830|19926737|P4|Overall Study|Lost to Follow-up|1
5786467|NCT03586830|19926738|P3|Overall Study|Lost to Follow-up|2
5786468|NCT03586830|19926739|P2|Overall Study|Lost to Follow-up|2
5786469|NCT03586830|19926740|P1|Overall Study|Lost to Follow-up|0
5786470|NCT03586830|19926737|P4|Overall Study|Site terminated by Sponsor|3
5786471|NCT03586830|19926738|P3|Overall Study|Site terminated by Sponsor|3
5786472|NCT03586830|19926739|P2|Overall Study|Site terminated by Sponsor|4
5786473|NCT03586830|19926740|P1|Overall Study|Site terminated by Sponsor|1
5786474|NCT03586726|19926762|P1|Overall Study|Withdrawal by Subject|1
5786475|NCT03586648|19926779|P2|Period 2|Adverse Event|0
5786476|NCT03586648|19926780|P1|Period 2|Adverse Event|1
5786477|NCT03586648|19926779|P2|Period 1|Physician Decision|1
5786478|NCT03586648|19926780|P1|Period 1|Physician Decision|0
5786479|NCT03586648|19926779|P2|Period 1|Study related symptoms or complaints|1
5786480|NCT03586648|19926780|P1|Period 1|Study related symptoms or complaints|2
5786481|NCT03586648|19926779|P2|Period 1|Adverse Event|0
5786482|NCT03586648|19926780|P1|Period 1|Adverse Event|1
5786483|NCT03586648|19926779|P2|Period 1|Lost to Follow-up|1
5786484|NCT03586648|19926780|P1|Period 1|Lost to Follow-up|1
5786485|NCT03586648|19926779|P2|Period 1|Withdrawal by Subject|1
5786486|NCT03586648|19926780|P1|Period 1|Withdrawal by Subject|0
5786487|NCT03585959|19926793|P1|Overall Study|Unsuccessful Procedure|2
5786488|NCT03585959|19926793|P1|Overall Study|Physician Decision|1
5786489|NCT03585504|19926844|P2|Overall Study|Lost to Follow-up|29
5786490|NCT03585504|19926845|P1|Overall Study|Lost to Follow-up|26
5786491|NCT03585296|19926855|P1|Overall Study|Withdrawal by Subject|2
5786492|NCT03585296|19926855|P1|Overall Study|Lost to Follow-up|2
5786493|NCT03585296|19926855|P1|Overall Study|Adverse Event|1
5786494|NCT03585244|19926859|P1|Overall Study|Withdrawal by Subject|15
5786495|NCT03583450|19926866|P2|Overall Study|hardware malfunction (battery depletion)|0
5786496|NCT03583450|19926867|P1|Overall Study|hardware malfunction (battery depletion)|1
5786497|NCT03583385|19926889|P2|Treatment Period 2|Adverse Event|0
5786498|NCT03583385|19926890|P1|Treatment Period 2|Adverse Event|1
5786499|NCT03583385|19926889|P2|Treatment Period 1|Withdrawal by Subject|1
5786500|NCT03583385|19926890|P1|Treatment Period 1|Withdrawal by Subject|1
5786501|NCT03582943|19926908|P2|Analyzed|Protocol Violation|1
5786502|NCT03582943|19926909|P1|Analyzed|Protocol Violation|4
5786503|NCT03582943|19926908|P2|Intervention and Follow up|Withdrawal by Subject|2
5786504|NCT03582943|19926909|P1|Intervention and Follow up|Withdrawal by Subject|4
5786505|NCT03582943|19926908|P2|Allocated to Groups|Withdrawal by Subject|1
5786506|NCT03582943|19926909|P1|Allocated to Groups|Withdrawal by Subject|1
5786507|NCT03582826|19926917|P2|Overall Study|Withdrawal by Subject|0
5786508|NCT03582826|19926918|P1|Overall Study|Withdrawal by Subject|2
5786509|NCT03582826|19926917|P2|Overall Study|Lost to Follow-up|0
5786510|NCT03582826|19926918|P1|Overall Study|Lost to Follow-up|39
5786511|NCT03582813|19926935|P2|Overall Study|Withdrawal by Subject|0
5786512|NCT03582813|19926936|P1|Overall Study|Withdrawal by Subject|1
5786513|NCT03582813|19926935|P2|Overall Study|Lost to Follow-up|21
5786514|NCT03582813|19926936|P1|Overall Study|Lost to Follow-up|18
5786515|NCT03582215|19927003|P8|Overall Study|Adverse Event|2
5786516|NCT03582215|19927004|P7|Overall Study|Adverse Event|2
5786517|NCT03582215|19927005|P6|Overall Study|Adverse Event|0
5786518|NCT03582215|19927006|P5|Overall Study|Adverse Event|0
5786519|NCT03582215|19927007|P4|Overall Study|Adverse Event|0
5786520|NCT03582215|19927008|P3|Overall Study|Adverse Event|0
5786521|NCT03582215|19927009|P2|Overall Study|Adverse Event|0
5786522|NCT03582215|19927010|P1|Overall Study|Adverse Event|1
5786523|NCT03581825|19927051|P2|Period 2|Unsatisfactory Vision to Test|1
5786524|NCT03581825|19927052|P1|Period 2|Unsatisfactory Vision to Test|0
5786525|NCT03581825|19927051|P2|Period 1|Lens Discomfort|0
5786526|NCT03581825|19927052|P1|Period 1|Lens Discomfort|1
5786527|NCT03580382|19927088|P2|Overall Study|Early Termination of Study|3
5786528|NCT03580382|19927089|P1|Overall Study|Early Termination of Study|0
5786529|NCT03579940|19927107|P11|Period 2|Withdrawal by Subject|0
5786530|NCT03579940|19927108|P10|Period 2|Withdrawal by Subject|0
5786531|NCT03579940|19927109|P9|Period 2|Withdrawal by Subject|0
5786532|NCT03579940|19927110|P8|Period 2|Withdrawal by Subject|0
5786533|NCT03579940|19927111|P7|Period 2|Withdrawal by Subject|0
5786534|NCT03579940|19927112|P6|Period 2|Withdrawal by Subject|0
5786535|NCT03579940|19927113|P5|Period 2|Withdrawal by Subject|0
5786536|NCT03579940|19927114|P4|Period 2|Withdrawal by Subject|0
5786537|NCT03579940|19927115|P3|Period 2|Withdrawal by Subject|1
5786538|NCT03579940|19927116|P2|Period 2|Withdrawal by Subject|0
5786539|NCT03579940|19927117|P1|Period 2|Withdrawal by Subject|0
5786540|NCT03579719|19927157|P1|Overall Study|Protocol deviation, pre-existent disease|1
5786541|NCT03578146|19927214|P6|Overall Study|Lost to Follow-up|1
5786542|NCT03578146|19927215|P5|Overall Study|Lost to Follow-up|0
5786543|NCT03578146|19927216|P4|Overall Study|Lost to Follow-up|0
5786544|NCT03578146|19927217|P3|Overall Study|Lost to Follow-up|1
5786545|NCT03578146|19927218|P2|Overall Study|Lost to Follow-up|1
5786546|NCT03578146|19927219|P1|Overall Study|Lost to Follow-up|0
5786547|NCT03578146|19927214|P6|Overall Study|Did Not Receive Treatment|2
5786548|NCT03578146|19927215|P5|Overall Study|Did Not Receive Treatment|0
5786549|NCT03578146|19927216|P4|Overall Study|Did Not Receive Treatment|0
5786550|NCT03578146|19927217|P3|Overall Study|Did Not Receive Treatment|0
5786551|NCT03578146|19927218|P2|Overall Study|Did Not Receive Treatment|0
5786552|NCT03578146|19927219|P1|Overall Study|Did Not Receive Treatment|1
5786553|NCT03575871|19927360|P3|Overall Study|Other than specified|0
5786554|NCT03575871|19927361|P2|Overall Study|Other than specified|2
5786555|NCT03575871|19927362|P1|Overall Study|Other than specified|2
5786556|NCT03575871|19927360|P3|Overall Study|Withdrawal by Subject|9
5786557|NCT03575871|19927361|P2|Overall Study|Withdrawal by Subject|1
5786558|NCT03575871|19927362|P1|Overall Study|Withdrawal by Subject|6
5786559|NCT03575871|19927360|P3|Overall Study|Protocol Deviation|1
5786560|NCT03575871|19927361|P2|Overall Study|Protocol Deviation|1
5786561|NCT03575871|19927362|P1|Overall Study|Protocol Deviation|1
5786562|NCT03575871|19927360|P3|Overall Study|Lost to Follow-up|1
5786563|NCT03575871|19927361|P2|Overall Study|Lost to Follow-up|1
5786564|NCT03575871|19927362|P1|Overall Study|Lost to Follow-up|1
5786565|NCT03575871|19927360|P3|Overall Study|Lack of Efficacy|7
5786566|NCT03575871|19927361|P2|Overall Study|Lack of Efficacy|4
5786567|NCT03575871|19927362|P1|Overall Study|Lack of Efficacy|5
5786568|NCT03575871|19927360|P3|Overall Study|Death|0
5786569|NCT03575871|19927361|P2|Overall Study|Death|0
5786570|NCT03575871|19927362|P1|Overall Study|Death|1
5786571|NCT03575871|19927360|P3|Overall Study|Adverse Event|8
5786572|NCT03575871|19927361|P2|Overall Study|Adverse Event|5
5786573|NCT03575871|19927362|P1|Overall Study|Adverse Event|5
5786574|NCT03575806|19927426|P2|Overall Study|Protocol Violation|2
5786575|NCT03575806|19927427|P1|Overall Study|Protocol Violation|0
5786576|NCT03575806|19927426|P2|Overall Study|Withdrawal by Subject|2
5786577|NCT03575806|19927427|P1|Overall Study|Withdrawal by Subject|0
5786578|NCT03575702|19927452|P2|Overall Study|Patient non compliance|0
5786579|NCT03575702|19927453|P1|Overall Study|Patient non compliance|4
5786580|NCT03575702|19927452|P2|Overall Study|Protocol Violation|1
5786581|NCT03575702|19927453|P1|Overall Study|Protocol Violation|0
5786582|NCT03575702|19927452|P2|Overall Study|Lost to Follow-up|2
5786583|NCT03575702|19927453|P1|Overall Study|Lost to Follow-up|1
5786584|NCT03575702|19927452|P2|Overall Study|Withdrawal by Subject|1
5786585|NCT03575702|19927453|P1|Overall Study|Withdrawal by Subject|1
5786586|NCT03573908|19927509|P5|Randomized Withdrawal Period|Other, Not Specified|0
5786587|NCT03573908|19927510|P4|Randomized Withdrawal Period|Other, Not Specified|2
5786588|NCT03573908|19927511|P3|Randomized Withdrawal Period|Other, Not Specified|4
5786589|NCT03573908|19927512|P2|Randomized Withdrawal Period|Other, Not Specified|0
5786590|NCT03573908|19927513|P1|Randomized Withdrawal Period|Other, Not Specified|0
5786591|NCT03573908|19927509|P5|Randomized Withdrawal Period|Lost to Follow-up|0
5786592|NCT03573908|19927510|P4|Randomized Withdrawal Period|Lost to Follow-up|0
5786593|NCT03573908|19927511|P3|Randomized Withdrawal Period|Lost to Follow-up|1
5786594|NCT03573908|19927512|P2|Randomized Withdrawal Period|Lost to Follow-up|0
5786595|NCT03573908|19927513|P1|Randomized Withdrawal Period|Lost to Follow-up|0
5786596|NCT03573908|19927509|P5|Randomized Withdrawal Period|Withdrawal by Subject|2
5786597|NCT03573908|19927510|P4|Randomized Withdrawal Period|Withdrawal by Subject|0
5786598|NCT03573908|19927511|P3|Randomized Withdrawal Period|Withdrawal by Subject|0
5786599|NCT03573908|19927512|P2|Randomized Withdrawal Period|Withdrawal by Subject|0
5786600|NCT03573908|19927513|P1|Randomized Withdrawal Period|Withdrawal by Subject|0
5786601|NCT03573908|19927509|P5|Randomized Withdrawal Period|Adverse Event|0
5786602|NCT03573908|19927510|P4|Randomized Withdrawal Period|Adverse Event|0
5786603|NCT03573908|19927511|P3|Randomized Withdrawal Period|Adverse Event|3
5786604|NCT03573908|19927512|P2|Randomized Withdrawal Period|Adverse Event|0
5786605|NCT03573908|19927513|P1|Randomized Withdrawal Period|Adverse Event|0
5786606|NCT03573908|19927509|P5|Treatment Period|Other, Not Specified|0
5786607|NCT03573908|19927510|P4|Treatment Period|Other, Not Specified|0
5786608|NCT03573908|19927511|P3|Treatment Period|Other, Not Specified|0
5786609|NCT03573908|19927512|P2|Treatment Period|Other, Not Specified|6
5786610|NCT03573908|19927513|P1|Treatment Period|Other, Not Specified|4
5786611|NCT03573908|19927509|P5|Treatment Period|Pregnancy|0
5786612|NCT03573908|19927510|P4|Treatment Period|Pregnancy|0
5786613|NCT03573908|19927511|P3|Treatment Period|Pregnancy|0
5786614|NCT03573908|19927512|P2|Treatment Period|Pregnancy|0
5786615|NCT03573908|19927513|P1|Treatment Period|Pregnancy|1
5786616|NCT03573908|19927509|P5|Treatment Period|Lost to Follow-up|0
5786617|NCT03573908|19927510|P4|Treatment Period|Lost to Follow-up|0
5786618|NCT03573908|19927511|P3|Treatment Period|Lost to Follow-up|0
5786619|NCT03573908|19927512|P2|Treatment Period|Lost to Follow-up|6
5786620|NCT03573908|19927513|P1|Treatment Period|Lost to Follow-up|7
5786621|NCT03573908|19927509|P5|Treatment Period|Withdrawal by Subject|0
5786622|NCT03573908|19927510|P4|Treatment Period|Withdrawal by Subject|0
5786623|NCT03573908|19927511|P3|Treatment Period|Withdrawal by Subject|0
5786624|NCT03573908|19927512|P2|Treatment Period|Withdrawal by Subject|5
5786625|NCT03573908|19927513|P1|Treatment Period|Withdrawal by Subject|7
5786626|NCT03573908|19927509|P5|Treatment Period|Protocol Violation|0
5786627|NCT03573908|19927510|P4|Treatment Period|Protocol Violation|0
5786628|NCT03573908|19927511|P3|Treatment Period|Protocol Violation|0
5786629|NCT03573908|19927512|P2|Treatment Period|Protocol Violation|0
5786630|NCT03573908|19927513|P1|Treatment Period|Protocol Violation|1
5786631|NCT03573908|19927509|P5|Treatment Period|Adverse Event|0
5786632|NCT03573908|19927510|P4|Treatment Period|Adverse Event|0
5786633|NCT03573908|19927511|P3|Treatment Period|Adverse Event|0
5786634|NCT03573908|19927512|P2|Treatment Period|Adverse Event|9
5786635|NCT03573908|19927513|P1|Treatment Period|Adverse Event|4
5786636|NCT03573830|19927530|P2|Overall Study|Lost to Follow-up|0
5786637|NCT03573830|19927531|P1|Overall Study|Lost to Follow-up|4
5786638|NCT03573830|19927530|P2|Overall Study|Dropped without completing treatment|7
5786639|NCT03573830|19927531|P1|Overall Study|Dropped without completing treatment|0
5786640|NCT03573817|19927554|P2|Overall Study|Withdrawal by Subject|1
5786641|NCT03573817|19927555|P1|Overall Study|Withdrawal by Subject|1
5786642|NCT03573817|19927554|P2|Overall Study|Protocol Violation|1
5786643|NCT03573817|19927555|P1|Overall Study|Protocol Violation|0
5786644|NCT03573817|19927554|P2|Overall Study|Adverse Event|2
5786645|NCT03573817|19927555|P1|Overall Study|Adverse Event|0
5786646|NCT03573505|19927583|P2|Overall Study|Death|4
5786647|NCT03573505|19927584|P1|Overall Study|Death|0
5786648|NCT03573505|19927583|P2|Overall Study|Reason not specified|1
5786649|NCT03573505|19927584|P1|Overall Study|Reason not specified|0
5786650|NCT03573505|19927583|P2|Overall Study|Study terminated by sponsor|45
5786651|NCT03573505|19927584|P1|Overall Study|Study terminated by sponsor|50
5786652|NCT03573505|19927583|P2|Overall Study|Site Terminated by Sponsor|1
5786653|NCT03573505|19927584|P1|Overall Study|Site Terminated by Sponsor|1
5786654|NCT03573505|19927583|P2|Overall Study|Disease progression|1
5786655|NCT03573505|19927584|P1|Overall Study|Disease progression|0
5786656|NCT03573505|19927583|P2|Overall Study|Consent withdrawn|1
5786657|NCT03573505|19927584|P1|Overall Study|Consent withdrawn|0
5786658|NCT03573505|19927583|P2|Overall Study|Adverse Event|1
5786659|NCT03573505|19927584|P1|Overall Study|Adverse Event|1
5786660|NCT03573336|19927630|P3|Overall Study|Study terminated|2
5786661|NCT03573336|19927631|P2|Overall Study|Study terminated|4
5786662|NCT03573336|19927632|P1|Overall Study|Study terminated|2
5786663|NCT03573323|19927651|P2|Post-Treatment Follow Up (Weeks 25-36)|Repeat Infections|1
5786664|NCT03573323|19927652|P1|Post-Treatment Follow Up (Weeks 25-36)|Repeat Infections|0
5786665|NCT03573323|19927651|P2|Post-Treatment Follow Up (Weeks 25-36)|Sponsor Decision|1
5786666|NCT03573323|19927652|P1|Post-Treatment Follow Up (Weeks 25-36)|Sponsor Decision|0
5786667|NCT03573323|19927651|P2|Post-Treatment Follow Up (Weeks 25-36)|Not Compliant to Protocol Procedures|11
5786668|NCT03573323|19927652|P1|Post-Treatment Follow Up (Weeks 25-36)|Not Compliant to Protocol Procedures|8
5786669|NCT03573323|19927651|P2|Post-Treatment Follow Up (Weeks 25-36)|Discontinued Trt and Completed Follow Up|8
5786670|NCT03573323|19927652|P1|Post-Treatment Follow Up (Weeks 25-36)|Discontinued Trt and Completed Follow Up|14
5786671|NCT03573323|19927651|P2|Post-Treatment Follow Up (Weeks 25-36)|Did not wish to return to study|2
5786672|NCT03573323|19927652|P1|Post-Treatment Follow Up (Weeks 25-36)|Did not wish to return to study|3
5786673|NCT03573323|19927651|P2|Post-Treatment Follow Up (Weeks 25-36)|Physician Decision|3
5786674|NCT03573323|19927652|P1|Post-Treatment Follow Up (Weeks 25-36)|Physician Decision|4
5786675|NCT03573323|19927651|P2|Post-Treatment Follow Up (Weeks 25-36)|Lack of Efficacy|19
5786676|NCT03573323|19927652|P1|Post-Treatment Follow Up (Weeks 25-36)|Lack of Efficacy|8
5786677|NCT03573323|19927651|P2|Post-Treatment Follow Up (Weeks 25-36)|Withdrawal by Subject|12
5786678|NCT03573323|19927652|P1|Post-Treatment Follow Up (Weeks 25-36)|Withdrawal by Subject|22
5786679|NCT03573323|19927651|P2|Blinded Treatment Period (Weeks 0-24)|Noncompliant to protocol procedures|2
5786680|NCT03573323|19927652|P1|Blinded Treatment Period (Weeks 0-24)|Noncompliant to protocol procedures|1
5786681|NCT03573323|19927651|P2|Blinded Treatment Period (Weeks 0-24)|Alkaline Phosphatase (ALP) level reached|1
5786682|NCT03573323|19927652|P1|Blinded Treatment Period (Weeks 0-24)|Alkaline Phosphatase (ALP) level reached|0
5786683|NCT03573323|19927651|P2|Blinded Treatment Period (Weeks 0-24)|Sponsor Decision|1
5786684|NCT03573323|19927652|P1|Blinded Treatment Period (Weeks 0-24)|Sponsor Decision|0
5786685|NCT03573323|19927651|P2|Blinded Treatment Period (Weeks 0-24)|Lost to Follow-up|13
5786686|NCT03573323|19927652|P1|Blinded Treatment Period (Weeks 0-24)|Lost to Follow-up|14
5786687|NCT03573323|19927651|P2|Blinded Treatment Period (Weeks 0-24)|Physician Decision|0
5786688|NCT03573323|19927652|P1|Blinded Treatment Period (Weeks 0-24)|Physician Decision|1
5786689|NCT03573323|19927651|P2|Blinded Treatment Period (Weeks 0-24)|Pregnancy|2
5786690|NCT03573323|19927652|P1|Blinded Treatment Period (Weeks 0-24)|Pregnancy|1
5786691|NCT03573323|19927651|P2|Blinded Treatment Period (Weeks 0-24)|Lack of Efficacy|3
5786692|NCT03573323|19927652|P1|Blinded Treatment Period (Weeks 0-24)|Lack of Efficacy|2
5786693|NCT03573323|19927651|P2|Blinded Treatment Period (Weeks 0-24)|Withdrawal by Subject|9
5786694|NCT03573323|19927652|P1|Blinded Treatment Period (Weeks 0-24)|Withdrawal by Subject|17
5786695|NCT03573323|19927651|P2|Blinded Treatment Period (Weeks 0-24)|Protocol Violation|8
5786696|NCT03573323|19927652|P1|Blinded Treatment Period (Weeks 0-24)|Protocol Violation|3
5786697|NCT03573323|19927651|P2|Blinded Treatment Period (Weeks 0-24)|Adverse Event|8
5786698|NCT03573323|19927652|P1|Blinded Treatment Period (Weeks 0-24)|Adverse Event|15
5786699|NCT03573323|19927651|P2|Blinded Treatment Period (Weeks 0-24)|Screen Failure|1
5786700|NCT03573323|19927652|P1|Blinded Treatment Period (Weeks 0-24)|Screen Failure|1
5786701|NCT03572218|19927800|P2|Overall Study|No longer interested|2
5786702|NCT03572218|19927801|P1|Overall Study|No longer interested|1
5786703|NCT03572218|19927800|P2|Overall Study|No longer available for study visits|1
5786704|NCT03572218|19927801|P1|Overall Study|No longer available for study visits|2
5786705|NCT03572218|19927800|P2|Overall Study|Lost to Follow-up|2
5786706|NCT03572218|19927801|P1|Overall Study|Lost to Follow-up|3
5786707|NCT03571256|19928072|P3|Overall Study|Protocol Violation|1
5786708|NCT03571256|19928073|P2|Overall Study|Protocol Violation|1
5786709|NCT03571256|19928074|P1|Overall Study|Protocol Violation|0
5786710|NCT03571256|19928072|P3|Overall Study|Other than specified|1
5786711|NCT03571256|19928073|P2|Overall Study|Other than specified|1
5786712|NCT03571256|19928074|P1|Overall Study|Other than specified|0
5786713|NCT03571256|19928072|P3|Overall Study|Withdrawal by Subject|1
5786714|NCT03571256|19928073|P2|Overall Study|Withdrawal by Subject|1
5786715|NCT03571256|19928074|P1|Overall Study|Withdrawal by Subject|3
5786716|NCT03571256|19928072|P3|Overall Study|Adverse Event|1
5786717|NCT03571256|19928073|P2|Overall Study|Adverse Event|0
5786718|NCT03571256|19928074|P1|Overall Study|Adverse Event|3
5786719|NCT03570554|19928162|P4|Overall Study|Adverse Event|1
5786720|NCT03570554|19928163|P3|Overall Study|Adverse Event|0
5786721|NCT03570554|19928164|P2|Overall Study|Adverse Event|0
5786722|NCT03570554|19928165|P1|Overall Study|Adverse Event|0
5786723|NCT03570554|19928162|P4|Overall Study|Non-compliance with study drug|0
5786724|NCT03570554|19928163|P3|Overall Study|Non-compliance with study drug|1
5786725|NCT03570554|19928164|P2|Overall Study|Non-compliance with study drug|0
5786726|NCT03570554|19928165|P1|Overall Study|Non-compliance with study drug|0
5786727|NCT03569371|19928279|P1|Overall Study|Adverse Event|1
5786728|NCT03569371|19928279|P1|Overall Study|Lost to Follow-up|1
5786729|NCT03569371|19928279|P1|Overall Study|Lack of Efficacy|1
5786730|NCT03569202|19928300|P2|Part 3|Other|1
5786731|NCT03569202|19928301|P1|Part 3|Other|1
5786732|NCT03569202|19928300|P2|Part 3|Physician Decision|0
5786733|NCT03569202|19928301|P1|Part 3|Physician Decision|1
5786734|NCT03568942|19928350|P1|Overall Study|Lost to Follow-up|1
5786735|NCT03568942|19928350|P1|Overall Study|Family emergency|1
5786736|NCT03568500|19928388|P3|Overall Study|Participant Noncompliance|0
5786737|NCT03568500|19928389|P2|Overall Study|Participant Noncompliance|1
5786738|NCT03568500|19928390|P1|Overall Study|Participant Noncompliance|1
5786739|NCT03568500|19928388|P3|Overall Study|Technical Problems|0
5786740|NCT03568500|19928389|P2|Overall Study|Technical Problems|1
5786741|NCT03568500|19928390|P1|Overall Study|Technical Problems|2
5786742|NCT03568500|19928388|P3|Overall Study|Withdrawal by Subject|0
5786743|NCT03568500|19928389|P2|Overall Study|Withdrawal by Subject|2
5786744|NCT03568500|19928390|P1|Overall Study|Withdrawal by Subject|4
5786745|NCT03568500|19928388|P3|Overall Study|Physician Decision|0
5786746|NCT03568500|19928389|P2|Overall Study|Physician Decision|0
5786747|NCT03568500|19928390|P1|Overall Study|Physician Decision|1
5786748|NCT03568500|19928388|P3|Overall Study|Adverse Event|2
5786749|NCT03568500|19928389|P2|Overall Study|Adverse Event|1
5786750|NCT03568500|19928390|P1|Overall Study|Adverse Event|1
5786751|NCT03568500|19928388|P3|Overall Study|Lost to Follow-up|2
5786752|NCT03568500|19928389|P2|Overall Study|Lost to Follow-up|1
5786753|NCT03568500|19928390|P1|Overall Study|Lost to Follow-up|1
5786754|NCT03566979|19928417|P4|Overall Study|Adverse Event|0
5786755|NCT03566979|19928418|P3|Overall Study|Adverse Event|0
5786756|NCT03566979|19928419|P2|Overall Study|Adverse Event|0
5786757|NCT03566979|19928420|P1|Overall Study|Adverse Event|1
5786758|NCT03566979|19928417|P4|Overall Study|Lost to Follow-up|5
5786759|NCT03566979|19928418|P3|Overall Study|Lost to Follow-up|9
5786760|NCT03566979|19928419|P2|Overall Study|Lost to Follow-up|7
5786761|NCT03566979|19928420|P1|Overall Study|Lost to Follow-up|2
5786762|NCT03566979|19928417|P4|Overall Study|Withdrawal by Subject|1
5786763|NCT03566979|19928418|P3|Overall Study|Withdrawal by Subject|1
5786764|NCT03566979|19928419|P2|Overall Study|Withdrawal by Subject|0
5786765|NCT03566979|19928420|P1|Overall Study|Withdrawal by Subject|2
5786766|NCT03566810|19928436|P4|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0
5786767|NCT03566810|19928437|P3|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0
5786768|NCT03566810|19928438|P2|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|1
5786769|NCT03566810|19928439|P1|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0
5786770|NCT03566680|19928501|P1|Overall Study|Withdrawal by Subject|3
5786771|NCT03566680|19928501|P1|Overall Study|Lost to Follow-up|13
5786772|NCT03566680|19928501|P1|Overall Study|Pregnancy|1
5786773|NCT03565887|19928512|P2|Overall Study|Withdrawal by Subject|2
5786774|NCT03565887|19928513|P1|Overall Study|Withdrawal by Subject|0
5786775|NCT03565887|19928512|P2|Overall Study|Adverse Event|0
5786776|NCT03565887|19928513|P1|Overall Study|Adverse Event|1
5786777|NCT03565315|19928592|P4|Overall Study|IND Sponsor/PI Voluntary Study Pause|1
5786778|NCT03565315|19928593|P3|Overall Study|IND Sponsor/PI Voluntary Study Pause|0
5786779|NCT03565315|19928594|P2|Overall Study|IND Sponsor/PI Voluntary Study Pause|0
5786780|NCT03565315|19928595|P1|Overall Study|IND Sponsor/PI Voluntary Study Pause|0
5786781|NCT03565211|19928632|P1|Overall Study|Personal issues|1
5786782|NCT03565211|19928632|P1|Overall Study|Adverse Event|44
5786783|NCT03565211|19928632|P1|Overall Study|Lost to Follow-up|1
5786784|NCT03565211|19928632|P1|Overall Study|Withdrawal by Subject|2
5786785|NCT03563716|19928706|P2|Overall Study|Still on Study|50
5786786|NCT03563716|19928707|P1|Overall Study|Still on Study|45
5786787|NCT03563716|19928706|P2|Overall Study|Withdrawal by Subject|3
5786788|NCT03563716|19928707|P1|Overall Study|Withdrawal by Subject|3
5786789|NCT03563716|19928706|P2|Overall Study|Death|14
5786790|NCT03563716|19928707|P1|Overall Study|Death|20
5786791|NCT03562481|19928948|P2|First Intervention|Lost to Follow-up|0
5786792|NCT03562481|19928949|P1|First Intervention|Lost to Follow-up|1
5786793|NCT03562117|19928974|P3|Part 1, Up to 3 Days|Adverse Event|0
5786794|NCT03562117|19928975|P2|Part 1, Up to 3 Days|Adverse Event|0
5786795|NCT03562117|19928976|P1|Part 1, Up to 3 Days|Adverse Event|1
5786796|NCT03560986|19929064|P2|Treatment Period B/Follow-up Period 2|Disc. before end of Follow-up Period 2|7
5786797|NCT03560986|19929065|P1|Treatment Period B/Follow-up Period 2|Disc. before end of Follow-up Period 2|7
5786798|NCT03560986|19929064|P2|Treatment Period B/Follow-up Period 2|Withdrawal by Subject|1
5786799|NCT03560986|19929065|P1|Treatment Period B/Follow-up Period 2|Withdrawal by Subject|0
5786800|NCT03560986|19929064|P2|Treatment Period B/Follow-up Period 2|Adverse Event|0
5786801|NCT03560986|19929065|P1|Treatment Period B/Follow-up Period 2|Adverse Event|1
5786802|NCT03560986|19929064|P2|Treatment Period A/Follow-up Period 1|Disc. before end of Follow-up Period 1|35
5786803|NCT03560986|19929065|P1|Treatment Period A/Follow-up Period 1|Disc. before end of Follow-up Period 1|32
5786804|NCT03560986|19929064|P2|Treatment Period A/Follow-up Period 1|Protocol Violation|1
5786805|NCT03560986|19929065|P1|Treatment Period A/Follow-up Period 1|Protocol Violation|0
5786806|NCT03560986|19929064|P2|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1
5786807|NCT03560986|19929065|P1|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1
5786808|NCT03560986|19929064|P2|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|1
5786809|NCT03560986|19929065|P1|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|3
5786810|NCT03560869|19929087|P2|Overall Study|Withdrawal by PI|1
5786811|NCT03560869|19929088|P1|Overall Study|Withdrawal by PI|0
5786812|NCT03560869|19929087|P2|Overall Study|Screening failure|4
5786813|NCT03560869|19929088|P1|Overall Study|Screening failure|4
5786814|NCT03560869|19929087|P2|Overall Study|Withdrawal by Subject|4
5786815|NCT03560869|19929088|P1|Overall Study|Withdrawal by Subject|3
5786816|NCT03560739|19929100|P4|Overall Study|Adverse Event|0
5786817|NCT03560739|19929101|P3|Overall Study|Adverse Event|0
5786818|NCT03560739|19929102|P2|Overall Study|Adverse Event|1
5786819|NCT03560739|19929103|P1|Overall Study|Adverse Event|0
5786820|NCT03560518|19929132|P3|Double Blind Treatment Period|Adverse Event|1
5786821|NCT03560518|19929133|P2|Double Blind Treatment Period|Adverse Event|3
5786822|NCT03560518|19929134|P1|Double Blind Treatment Period|Adverse Event|0
5786823|NCT03560518|19929132|P3|Double Blind Treatment Period|Lack of Efficacy|1
5786824|NCT03560518|19929133|P2|Double Blind Treatment Period|Lack of Efficacy|1
5786825|NCT03560518|19929134|P1|Double Blind Treatment Period|Lack of Efficacy|2
5786826|NCT03560518|19929132|P3|Double Blind Treatment Period|Withdrawal by Subject|5
5786827|NCT03560518|19929133|P2|Double Blind Treatment Period|Withdrawal by Subject|6
5786828|NCT03560518|19929134|P1|Double Blind Treatment Period|Withdrawal by Subject|10
5786829|NCT03560518|19929132|P3|Double Blind Treatment Period|Lost to Follow-up|6
5786830|NCT03560518|19929133|P2|Double Blind Treatment Period|Lost to Follow-up|6
5786831|NCT03560518|19929134|P1|Double Blind Treatment Period|Lost to Follow-up|5
5786832|NCT03560518|19929132|P3|Double Blind Treatment Period|Pregnancy|0
5786833|NCT03560518|19929133|P2|Double Blind Treatment Period|Pregnancy|2
5786834|NCT03560518|19929134|P1|Double Blind Treatment Period|Pregnancy|0
5786835|NCT03560518|19929132|P3|Double Blind Treatment Period|Protocol Violation|0
5786836|NCT03560518|19929133|P2|Double Blind Treatment Period|Protocol Violation|2
5786837|NCT03560518|19929134|P1|Double Blind Treatment Period|Protocol Violation|1
5786838|NCT03560518|19929132|P3|Double Blind Treatment Period|Study Terminated by the Sponsor|10
5786839|NCT03560518|19929133|P2|Double Blind Treatment Period|Study Terminated by the Sponsor|9
5786840|NCT03560518|19929134|P1|Double Blind Treatment Period|Study Terminated by the Sponsor|6
5786841|NCT03560518|19929132|P3|Double Blind Treatment Period|Miscellaneous Reasons|0
5786842|NCT03560518|19929133|P2|Double Blind Treatment Period|Miscellaneous Reasons|0
5786843|NCT03560518|19929134|P1|Double Blind Treatment Period|Miscellaneous Reasons|1
5786844|NCT03560245|19929147|P2|Overall Study|Other|1
5786845|NCT03560245|19929148|P1|Overall Study|Other|0
5786846|NCT03560245|19929147|P2|Overall Study|Physician Decision|1
5786847|NCT03560245|19929148|P1|Overall Study|Physician Decision|0
5786848|NCT03560245|19929147|P2|Overall Study|Lost to Follow-up|1
5786849|NCT03560245|19929148|P1|Overall Study|Lost to Follow-up|0
5786850|NCT03560245|19929147|P2|Overall Study|Death|1
5786851|NCT03560245|19929148|P1|Overall Study|Death|0
5786852|NCT03560245|19929147|P2|Overall Study|Protocol Violation|0
5786853|NCT03560245|19929148|P1|Overall Study|Protocol Violation|1
5786854|NCT03560245|19929147|P2|Overall Study|Adverse Event|1
5786855|NCT03560245|19929148|P1|Overall Study|Adverse Event|1
5786856|NCT03560245|19929147|P2|Overall Study|Withdrawal by Subject|2
5786857|NCT03560245|19929148|P1|Overall Study|Withdrawal by Subject|3
5786858|NCT03559257|19929202|P2|Open-label Treatment Period|Physician Decision|1
5786859|NCT03559257|19929203|P1|Open-label Treatment Period|Physician Decision|0
5786860|NCT03559257|19929202|P2|Open-label Treatment Period|Lost to Follow-up|0
5786861|NCT03559257|19929203|P1|Open-label Treatment Period|Lost to Follow-up|1
5786862|NCT03559257|19929202|P2|Open-label Treatment Period|Protocol Violation|0
5786863|NCT03559257|19929203|P1|Open-label Treatment Period|Protocol Violation|2
5786864|NCT03559257|19929202|P2|Open-label Treatment Period|Withdrawal by Subject|0
5786865|NCT03559257|19929203|P1|Open-label Treatment Period|Withdrawal by Subject|3
5786866|NCT03559257|19929202|P2|Open-label Treatment Period|Lack of Efficacy|2
5786867|NCT03559257|19929203|P1|Open-label Treatment Period|Lack of Efficacy|3
5786868|NCT03559257|19929202|P2|Open-label Treatment Period|Adverse Event|4
5786869|NCT03559257|19929203|P1|Open-label Treatment Period|Adverse Event|1
5786870|NCT03559257|19929202|P2|Double Blind Treatment Period|Screen Failure|1
5786871|NCT03559257|19929203|P1|Double Blind Treatment Period|Screen Failure|0
5786872|NCT03559257|19929202|P2|Double Blind Treatment Period|Adverse Event|1
5786873|NCT03559257|19929203|P1|Double Blind Treatment Period|Adverse Event|0
5786874|NCT03559257|19929202|P2|Double Blind Treatment Period|Lack of Efficacy|1
5786875|NCT03559257|19929203|P1|Double Blind Treatment Period|Lack of Efficacy|1
5786876|NCT03559257|19929202|P2|Double Blind Treatment Period|Protocol Violation|4
5786877|NCT03559257|19929203|P1|Double Blind Treatment Period|Protocol Violation|1
5786878|NCT03559257|19929202|P2|Double Blind Treatment Period|Withdrawal by Subject|1
5786879|NCT03559257|19929203|P1|Double Blind Treatment Period|Withdrawal by Subject|2
5786880|NCT03559062|19929273|P3|Overall Study|Other|0
5786881|NCT03559062|19929274|P2|Overall Study|Other|1
5786882|NCT03559062|19929275|P1|Overall Study|Other|0
5786883|NCT03558997|19929290|P4|Overall Study|Lost to Follow-up|0
5786884|NCT03558997|19929291|P3|Overall Study|Lost to Follow-up|1
5786885|NCT03558997|19929292|P2|Overall Study|Lost to Follow-up|0
5786886|NCT03558997|19929293|P1|Overall Study|Lost to Follow-up|0
5786887|NCT03558997|19929290|P4|Overall Study|Withdrawal by Subject|1
5786888|NCT03558997|19929291|P3|Overall Study|Withdrawal by Subject|1
5786889|NCT03558997|19929292|P2|Overall Study|Withdrawal by Subject|0
5786890|NCT03558997|19929293|P1|Overall Study|Withdrawal by Subject|1
5786891|NCT03558997|19929290|P4|Overall Study|Physician Decision|0
5786892|NCT03558997|19929291|P3|Overall Study|Physician Decision|1
5786893|NCT03558997|19929292|P2|Overall Study|Physician Decision|0
5786894|NCT03558997|19929293|P1|Overall Study|Physician Decision|0
5786895|NCT03558997|19929290|P4|Overall Study|Adverse Event|1
5786896|NCT03558997|19929291|P3|Overall Study|Adverse Event|5
5786897|NCT03558997|19929292|P2|Overall Study|Adverse Event|2
5786898|NCT03558997|19929293|P1|Overall Study|Adverse Event|0
5786899|NCT03558672|19929325|P1|Overall Study|Study Early Termination|10
5786900|NCT03558555|19929337|P2|Overall Study|Lost to Follow-up|1
5786901|NCT03558555|19929338|P1|Overall Study|Lost to Follow-up|2
5786902|NCT03558516|19929356|P2|Overall Study|Protocol Violation|2
5786903|NCT03558516|19929357|P1|Overall Study|Protocol Violation|2
5786904|NCT03557931|19929397|P3|Overall Study|Miscellaneous|3
5786905|NCT03557931|19929398|P2|Overall Study|Miscellaneous|5
5786906|NCT03557931|19929399|P1|Overall Study|Miscellaneous|8
5786907|NCT03557931|19929397|P3|Overall Study|Withdrawal by Subject|7
5786908|NCT03557931|19929398|P2|Overall Study|Withdrawal by Subject|0
5786909|NCT03557931|19929399|P1|Overall Study|Withdrawal by Subject|14
5786910|NCT03557931|19929397|P3|Overall Study|Protocol Violation|1
5786911|NCT03557931|19929398|P2|Overall Study|Protocol Violation|4
5786912|NCT03557931|19929399|P1|Overall Study|Protocol Violation|1
5786913|NCT03557931|19929397|P3|Overall Study|Lost to Follow-up|1
5786914|NCT03557931|19929398|P2|Overall Study|Lost to Follow-up|4
5786915|NCT03557931|19929399|P1|Overall Study|Lost to Follow-up|4
5786916|NCT03557931|19929397|P3|Overall Study|Adverse Event|1
5786917|NCT03557931|19929398|P2|Overall Study|Adverse Event|6
5786918|NCT03557931|19929399|P1|Overall Study|Adverse Event|4
5786919|NCT03557801|19929430|P3|Overall Study|Lost to Follow-up|0
5786920|NCT03557801|19929431|P2|Overall Study|Lost to Follow-up|1
5786921|NCT03557801|19929432|P1|Overall Study|Lost to Follow-up|0
5786922|NCT03557801|19929430|P3|Overall Study|Withdrawal by Subject|3
5786923|NCT03557801|19929431|P2|Overall Study|Withdrawal by Subject|0
5786924|NCT03557801|19929432|P1|Overall Study|Withdrawal by Subject|1
5786925|NCT03557801|19929430|P3|Overall Study|Protocol Violation|0
5786926|NCT03557801|19929431|P2|Overall Study|Protocol Violation|0
5786927|NCT03557801|19929432|P1|Overall Study|Protocol Violation|1
5786928|NCT03557775|19929449|P3|Overall Study|Physician Decision|0
5786929|NCT03557775|19929450|P2|Overall Study|Physician Decision|1
5786930|NCT03557775|19929451|P1|Overall Study|Physician Decision|0
5786931|NCT03557775|19929449|P3|Overall Study|Withdrawal by Subject|4
5786932|NCT03557775|19929450|P2|Overall Study|Withdrawal by Subject|2
5786933|NCT03557775|19929451|P1|Overall Study|Withdrawal by Subject|1
5786934|NCT03555890|19929582|P4|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|1
5786935|NCT03555890|19929583|P3|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0
5786936|NCT03555890|19929584|P2|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0
5786937|NCT03555890|19929585|P1|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0
5786938|NCT03555565|19929719|P1|Overall Study|Protocol Deviation|13
5786939|NCT03555565|19929719|P1|Overall Study|Case Report Forms Uncollected|2
5786940|NCT03555435|19929729|P3|Overall Study|Lost to Follow-up|8
5786941|NCT03555435|19929730|P2|Overall Study|Lost to Follow-up|19
5786942|NCT03555435|19929731|P1|Overall Study|Lost to Follow-up|17
5786943|NCT03555305|19929742|P2|Period 1|Adverse Event|1
5786944|NCT03555305|19929743|P1|Period 1|Adverse Event|0
5786945|NCT03555305|19929742|P2|Period 1|Physician Decision|1
5786946|NCT03555305|19929743|P1|Period 1|Physician Decision|0
5786947|NCT03554772|19929810|P4|Overall Study|Lost to Follow-up|2
5786948|NCT03554772|19929811|P3|Overall Study|Lost to Follow-up|0
5786949|NCT03554772|19929812|P2|Overall Study|Lost to Follow-up|0
5786950|NCT03554772|19929813|P1|Overall Study|Lost to Follow-up|0
5786951|NCT03554629|19929842|P1|Overall Study|Inadequate data|6
5786952|NCT03554005|19929876|P6|Overall Study|Other|1
5786953|NCT03554005|19929877|P5|Overall Study|Other|0
5786954|NCT03554005|19929878|P4|Overall Study|Other|0
5786955|NCT03554005|19929879|P3|Overall Study|Other|0
5786956|NCT03554005|19929880|P2|Overall Study|Other|0
5786957|NCT03554005|19929881|P1|Overall Study|Other|0
5786958|NCT03554005|19929876|P6|Overall Study|Physician Decision|0
5786959|NCT03554005|19929877|P5|Overall Study|Physician Decision|1
5786960|NCT03554005|19929878|P4|Overall Study|Physician Decision|0
5786961|NCT03554005|19929879|P3|Overall Study|Physician Decision|0
5786962|NCT03554005|19929880|P2|Overall Study|Physician Decision|0
5786963|NCT03554005|19929881|P1|Overall Study|Physician Decision|0
5786964|NCT03554005|19929876|P6|Overall Study|Adverse Event|3
5786965|NCT03554005|19929877|P5|Overall Study|Adverse Event|0
5786966|NCT03554005|19929878|P4|Overall Study|Adverse Event|0
5786967|NCT03554005|19929879|P3|Overall Study|Adverse Event|0
5786968|NCT03554005|19929880|P2|Overall Study|Adverse Event|0
5786969|NCT03554005|19929881|P1|Overall Study|Adverse Event|0
5786970|NCT03554005|19929876|P6|Overall Study|Disease Progression|6
5786971|NCT03554005|19929877|P5|Overall Study|Disease Progression|5
5786972|NCT03554005|19929878|P4|Overall Study|Disease Progression|1
5786973|NCT03554005|19929879|P3|Overall Study|Disease Progression|1
5786974|NCT03554005|19929880|P2|Overall Study|Disease Progression|1
5786975|NCT03554005|19929881|P1|Overall Study|Disease Progression|1
5786976|NCT03554005|19929876|P6|Overall Study|Not in participant's best interest|1
5786977|NCT03554005|19929877|P5|Overall Study|Not in participant's best interest|0
5786978|NCT03554005|19929878|P4|Overall Study|Not in participant's best interest|0
5786979|NCT03554005|19929879|P3|Overall Study|Not in participant's best interest|0
5786980|NCT03554005|19929880|P2|Overall Study|Not in participant's best interest|0
5786981|NCT03554005|19929881|P1|Overall Study|Not in participant's best interest|0
5786982|NCT03553758|19929907|P1|Overall Study|Lost to Follow-up|1
5786983|NCT03552549|19929915|P2|Overall Study|Administrative|14
5786984|NCT03552549|19929916|P1|Overall Study|Administrative|0
5786985|NCT03552549|19929915|P2|Overall Study|Did not meet eligibility criteria|0
5786986|NCT03552549|19929916|P1|Overall Study|Did not meet eligibility criteria|1
5786987|NCT03552549|19929915|P2|Overall Study|Did not complete study treatment|3
5786988|NCT03552549|19929916|P1|Overall Study|Did not complete study treatment|2
5786989|NCT03552549|19929915|P2|Overall Study|Not in participant's best interest|1
5786990|NCT03552549|19929916|P1|Overall Study|Not in participant's best interest|2
5786991|NCT03552549|19929915|P2|Overall Study|Unknown (no reason provided)|2
5786992|NCT03552549|19929916|P1|Overall Study|Unknown (no reason provided)|4
5786993|NCT03552549|19929915|P2|Overall Study|Withdrawal by Subject|7
5786994|NCT03552549|19929916|P1|Overall Study|Withdrawal by Subject|7
5786995|NCT03552549|19929915|P2|Overall Study|Adverse event in first 12 months|8
5786996|NCT03552549|19929916|P1|Overall Study|Adverse event in first 12 months|12
5786997|NCT03552549|19929915|P2|Overall Study|Disease progression|17
5786998|NCT03552549|19929916|P1|Overall Study|Disease progression|25
5786999|NCT03552523|19929954|P2|Overall Study|Withdrawal by Subject|1
5787000|NCT03552523|19929955|P1|Overall Study|Withdrawal by Subject|1
5787001|NCT03551743|19929981|P4|Overall Study|Withdrawal by Subject|0
5787002|NCT03551743|19929982|P3|Overall Study|Withdrawal by Subject|0
5787003|NCT03551743|19929983|P2|Overall Study|Withdrawal by Subject|0
5787004|NCT03551743|19929984|P1|Overall Study|Withdrawal by Subject|1
5787005|NCT03551743|19929981|P4|Overall Study|Adverse Event|0
5787006|NCT03551743|19929982|P3|Overall Study|Adverse Event|0
5787007|NCT03551743|19929983|P2|Overall Study|Adverse Event|0
5787008|NCT03551743|19929984|P1|Overall Study|Adverse Event|1
5787009|NCT03551730|19930030|P4|Overall Study|Adverse Event|0
5787010|NCT03551730|19930031|P3|Overall Study|Adverse Event|0
5787011|NCT03551730|19930032|P2|Overall Study|Adverse Event|0
5787012|NCT03551730|19930033|P1|Overall Study|Adverse Event|1
5787013|NCT03550378|19930155|P2|Overall Study|Death|1
5787014|NCT03550378|19930156|P1|Overall Study|Death|0
5787015|NCT03549429|19930219|P2|Overall Study|Protocol Violation|3
5787016|NCT03549429|19930220|P1|Overall Study|Protocol Violation|5
5787017|NCT03549338|19930233|P3|Overall Study|Clinical Progression|0
5787018|NCT03549338|19930234|P2|Overall Study|Clinical Progression|1
5787019|NCT03549338|19930235|P1|Overall Study|Clinical Progression|0
5787020|NCT03549338|19930233|P3|Overall Study|Progressive Disease|0
5787021|NCT03549338|19930234|P2|Overall Study|Progressive Disease|0
5787022|NCT03549338|19930235|P1|Overall Study|Progressive Disease|1
5787023|NCT03549130|19930262|P2|Overall Study|Lost to Follow-up|1
5787024|NCT03549130|19930263|P1|Overall Study|Lost to Follow-up|0
5787025|NCT03549130|19930262|P2|Overall Study|Adverse Event|1
5787026|NCT03549130|19930263|P1|Overall Study|Adverse Event|0
5787027|NCT03549117|19930281|P2|Overall Study|Withdrawal by Subject|0
5787028|NCT03549117|19930282|P1|Overall Study|Withdrawal by Subject|1
5787029|NCT03548337|19930310|P2|Toddler Dose|Withdrawal by parent/guardian|1
5787030|NCT03548337|19930311|P1|Toddler Dose|Withdrawal by parent/guardian|1
5787031|NCT03548337|19930310|P2|Infant Series|Randomized but Not Vaccinated|0
5787032|NCT03548337|19930311|P1|Infant Series|Randomized but Not Vaccinated|1
5787033|NCT03548337|19930310|P2|Infant Series|Adverse Event|2
5787034|NCT03548337|19930311|P1|Infant Series|Adverse Event|0
5787035|NCT03548337|19930310|P2|Infant Series|Lost to Follow-up|1
5787036|NCT03548337|19930311|P1|Infant Series|Lost to Follow-up|2
5787037|NCT03548337|19930310|P2|Infant Series|No Longer Met Eligibility Criteria|0
5787038|NCT03548337|19930311|P1|Infant Series|No Longer Met Eligibility Criteria|1
5787039|NCT03548337|19930310|P2|Infant Series|Withdrawal by Parent/Guardian|8
5787040|NCT03548337|19930311|P1|Infant Series|Withdrawal by Parent/Guardian|8
5787041|NCT03547635|19930362|P3|Overall Study|Withdrawal by Subject|0
5787042|NCT03547635|19930363|P2|Overall Study|Withdrawal by Subject|0
5787043|NCT03547635|19930364|P1|Overall Study|Withdrawal by Subject|1
5787044|NCT03547635|19930362|P3|Overall Study|Errant Randomization before Treatment|0
5787045|NCT03547635|19930363|P2|Overall Study|Errant Randomization before Treatment|1
5787046|NCT03547635|19930364|P1|Overall Study|Errant Randomization before Treatment|0
5787047|NCT03547635|19930362|P3|Overall Study|Withdrawal by Sponsor|1
5787048|NCT03547635|19930363|P2|Overall Study|Withdrawal by Sponsor|0
5787049|NCT03547635|19930364|P1|Overall Study|Withdrawal by Sponsor|0
5787050|NCT03547635|19930362|P3|Overall Study|Withdrawal By PI|0
5787051|NCT03547635|19930363|P2|Overall Study|Withdrawal By PI|1
5787052|NCT03547635|19930364|P1|Overall Study|Withdrawal By PI|0
5787053|NCT03547635|19930362|P3|Overall Study|Withdrawal by Subject|0
5787054|NCT03547635|19930363|P2|Overall Study|Withdrawal by Subject|0
5787055|NCT03547635|19930364|P1|Overall Study|Withdrawal by Subject|1
5787056|NCT03547635|19930362|P3|Overall Study|Lost to Follow-up|4
5787057|NCT03547635|19930363|P2|Overall Study|Lost to Follow-up|3
5787058|NCT03547635|19930364|P1|Overall Study|Lost to Follow-up|1
5787059|NCT03547635|19930362|P3|Overall Study|Adverse Event|3
5787060|NCT03547635|19930363|P2|Overall Study|Adverse Event|2
5787061|NCT03547635|19930364|P1|Overall Study|Adverse Event|5
5787062|NCT03547583|19930375|P3|Overall Study|Other|3
5787063|NCT03547583|19930376|P2|Overall Study|Other|2
5787064|NCT03547583|19930377|P1|Overall Study|Other|2
5787065|NCT03547583|19930375|P3|Overall Study|Withdrawal by Subject|10
5787066|NCT03547583|19930376|P2|Overall Study|Withdrawal by Subject|19
5787067|NCT03547583|19930377|P1|Overall Study|Withdrawal by Subject|12
5787068|NCT03547583|19930375|P3|Overall Study|Protocol Violation|1
5787069|NCT03547583|19930376|P2|Overall Study|Protocol Violation|1
5787070|NCT03547583|19930377|P1|Overall Study|Protocol Violation|2
5787071|NCT03547583|19930375|P3|Overall Study|Physician Decision|3
5787072|NCT03547583|19930376|P2|Overall Study|Physician Decision|0
5787073|NCT03547583|19930377|P1|Overall Study|Physician Decision|1
5787074|NCT03547583|19930375|P3|Overall Study|Non-compliance with study drug|1
5787075|NCT03547583|19930376|P2|Overall Study|Non-compliance with study drug|0
5787076|NCT03547583|19930377|P1|Overall Study|Non-compliance with study drug|0
5787077|NCT03547583|19930375|P3|Overall Study|Lost to Follow-up|0
5787078|NCT03547583|19930376|P2|Overall Study|Lost to Follow-up|0
5787079|NCT03547583|19930377|P1|Overall Study|Lost to Follow-up|1
5787080|NCT03547583|19930375|P3|Overall Study|Death|4
5787081|NCT03547583|19930376|P2|Overall Study|Death|7
5787082|NCT03547583|19930377|P1|Overall Study|Death|11
5787083|NCT03547583|19930375|P3|Overall Study|Adverse Event|10
5787084|NCT03547583|19930376|P2|Overall Study|Adverse Event|11
5787085|NCT03547583|19930377|P1|Overall Study|Adverse Event|16
5787086|NCT03547531|19930393|P2|Overall Study|having family occasion|2
5787087|NCT03547531|19930394|P1|Overall Study|having family occasion|0
5787088|NCT03547531|19930393|P2|Overall Study|not coming in data collection : sick|2
5787089|NCT03547531|19930394|P1|Overall Study|not coming in data collection : sick|2
5787090|NCT03547167|19930408|P2|Overall Study|Death|2
5787091|NCT03547167|19930409|P1|Overall Study|Death|4
5787092|NCT03547167|19930408|P2|Overall Study|Lost to Follow-up|15
5787093|NCT03547167|19930409|P1|Overall Study|Lost to Follow-up|59
5787094|NCT03547167|19930408|P2|Overall Study|Screen Failure|1
5787095|NCT03547167|19930409|P1|Overall Study|Screen Failure|0
5787096|NCT03547167|19930408|P2|Overall Study|Withdrawal by Subject|12
5787097|NCT03547167|19930409|P1|Overall Study|Withdrawal by Subject|34
5787098|NCT03547154|19930461|P2|Overall Study|Continued treatment beyond 12 mo.|50
5787099|NCT03547154|19930462|P1|Overall Study|Continued treatment beyond 12 mo.|58
5787100|NCT03547154|19930461|P2|Overall Study|Not Selected|1
5787101|NCT03547154|19930462|P1|Overall Study|Not Selected|0
5787102|NCT03547154|19930461|P2|Overall Study|Withdrawal by Subject|6
5787103|NCT03547154|19930462|P1|Overall Study|Withdrawal by Subject|10
5787104|NCT03547154|19930461|P2|Overall Study|Insufficient Therapeutic Response|10
5787105|NCT03547154|19930462|P1|Overall Study|Insufficient Therapeutic Response|13
5787106|NCT03547154|19930461|P2|Overall Study|Physician Decision|3
5787107|NCT03547154|19930462|P1|Overall Study|Physician Decision|4
5787108|NCT03547154|19930461|P2|Overall Study|Protocol Violation|1
5787109|NCT03547154|19930462|P1|Overall Study|Protocol Violation|6
5787110|NCT03547154|19930461|P2|Overall Study|Adverse Event|31
5787111|NCT03547154|19930462|P1|Overall Study|Adverse Event|26
5787112|NCT03547154|19930461|P2|Overall Study|Disease Progression/Recurrence|14
5787113|NCT03547154|19930462|P1|Overall Study|Disease Progression/Recurrence|6
5787114|NCT03546842|19930474|P1|Overall Study|Withdrawal by Subject|2
5787115|NCT03546842|19930474|P1|Overall Study|Protocol Violation|1
5787116|NCT03546816|19930485|P2|Overall Study|Lost to Follow-up|2
5787117|NCT03546816|19930486|P1|Overall Study|Lost to Follow-up|3
5787118|NCT03546816|19930485|P2|Overall Study|Withdrawal by Subject|10
5787119|NCT03546816|19930486|P1|Overall Study|Withdrawal by Subject|8
5787120|NCT03546816|19930485|P2|Overall Study|Physician Decision|0
5787121|NCT03546816|19930486|P1|Overall Study|Physician Decision|2
5787122|NCT03546816|19930485|P2|Overall Study|Pregnancy|0
5787123|NCT03546816|19930486|P1|Overall Study|Pregnancy|1
5787124|NCT03546816|19930485|P2|Overall Study|Lack of Efficacy|4
5787125|NCT03546816|19930486|P1|Overall Study|Lack of Efficacy|2
5787126|NCT03546816|19930485|P2|Overall Study|Adverse Event|3
5787127|NCT03546816|19930486|P1|Overall Study|Adverse Event|5
5787128|NCT03546621|19930514|P4|Overall Study|Progressive disease|1
5787129|NCT03546621|19930515|P3|Overall Study|Progressive disease|0
5787130|NCT03546621|19930516|P2|Overall Study|Progressive disease|0
5787131|NCT03546621|19930517|P1|Overall Study|Progressive disease|0
5787132|NCT03546621|19930514|P4|Overall Study|Adverse Event|1
5787133|NCT03546621|19930515|P3|Overall Study|Adverse Event|0
5787134|NCT03546621|19930516|P2|Overall Study|Adverse Event|1
5787135|NCT03546621|19930517|P1|Overall Study|Adverse Event|0
5787136|NCT03546621|19930514|P4|Overall Study|Lost to Follow-up|0
5787137|NCT03546621|19930515|P3|Overall Study|Lost to Follow-up|0
5787138|NCT03546621|19930516|P2|Overall Study|Lost to Follow-up|1
5787139|NCT03546621|19930517|P1|Overall Study|Lost to Follow-up|0
5787140|NCT03546621|19930514|P4|Overall Study|Withdrawal by Subject|1
5787141|NCT03546621|19930515|P3|Overall Study|Withdrawal by Subject|2
5787142|NCT03546621|19930516|P2|Overall Study|Withdrawal by Subject|1
5787143|NCT03546621|19930517|P1|Overall Study|Withdrawal by Subject|0
5787144|NCT03545984|19930607|P2|Overall Study|CSF cases not present during rotation|9
5787145|NCT03545984|19930608|P1|Overall Study|CSF cases not present during rotation|11
5787146|NCT03543358|19930727|P2|Overall Study|Parent Study Closure|0
5787147|NCT03543358|19930728|P1|Overall Study|Parent Study Closure|1
5787148|NCT03543358|19930727|P2|Overall Study|Disease Progression|0
5787149|NCT03543358|19930728|P1|Overall Study|Disease Progression|1
5787150|NCT03543358|19930727|P2|Overall Study|Death|0
5787151|NCT03543358|19930728|P1|Overall Study|Death|1
5787152|NCT03543137|19930777|P2|Study Period 2: Up to Day 8|Adverse Event|1
5787153|NCT03543137|19930778|P1|Study Period 2: Up to Day 8|Adverse Event|0
5787154|NCT03543137|19930777|P2|Study Period 2: Up to Day 8|Protocol Violation|0
5787155|NCT03543137|19930778|P1|Study Period 2: Up to Day 8|Protocol Violation|1
5787156|NCT03543137|19930777|P2|Study Period 2: Up to Day 8|Withdrawal by Subject|0
5787157|NCT03543137|19930778|P1|Study Period 2: Up to Day 8|Withdrawal by Subject|1
5787158|NCT03541044|19930879|P2|Study Period 2: Up to Day 8|Withdrawal by Subject|0
5787159|NCT03541044|19930880|P1|Study Period 2: Up to Day 8|Withdrawal by Subject|1
5787160|NCT03541044|19930879|P2|Study Period 2: Up to Day 8|Protocol Violation|0
5787161|NCT03541044|19930880|P1|Study Period 2: Up to Day 8|Protocol Violation|1
5787162|NCT03540160|19930900|P1|Overall Study|Sponsor decision|191
5787163|NCT03540160|19930900|P1|Overall Study|Lost to Follow-up|18
5787164|NCT03540160|19930900|P1|Overall Study|Study Closure|10
5787165|NCT03540160|19930900|P1|Overall Study|COVID-19|2
5787166|NCT03540160|19930900|P1|Overall Study|Withdrawal by Subject|68
5787167|NCT03540160|19930900|P1|Overall Study|Adverse Event|20
5787168|NCT03540160|19930900|P1|Overall Study|Pregnancy|1
5787169|NCT03540160|19930900|P1|Overall Study|Lack of Efficacy|60
5787170|NCT03540160|19930900|P1|Overall Study|Physician Decision|8
5787171|NCT03540160|19930900|P1|Overall Study|Protocol Violation|1
5787172|NCT03540030|19930906|P2|Overall Study|never had surgery after signing consent|1
5787173|NCT03540030|19930907|P1|Overall Study|never had surgery after signing consent|9
5787174|NCT03540030|19930906|P2|Overall Study|screen fail|1
5787175|NCT03540030|19930907|P1|Overall Study|screen fail|7
5787176|NCT03540030|19930906|P2|Overall Study|Withdrawal by Subject|1
5787177|NCT03540030|19930907|P1|Overall Study|Withdrawal by Subject|2
5787178|NCT03539549|19930943|P1|Overall Study|Reason not Specified|1
5787179|NCT03539549|19930943|P1|Overall Study|Progressive Disease|1
5787180|NCT03539549|19930943|P1|Overall Study|Death|2
5787181|NCT03539549|19930943|P1|Overall Study|Lost to Follow-up|1
5787182|NCT03539549|19930943|P1|Overall Study|Adverse Event|12
5787183|NCT03539484|19930958|P7|Overall Study|Study Terminated by Sponsor|1
5787184|NCT03539484|19930959|P6|Overall Study|Study Terminated by Sponsor|2
5787185|NCT03539484|19930960|P5|Overall Study|Study Terminated by Sponsor|2
5787186|NCT03539484|19930961|P4|Overall Study|Study Terminated by Sponsor|1
5787187|NCT03539484|19930962|P3|Overall Study|Study Terminated by Sponsor|1
5787188|NCT03539484|19930963|P2|Overall Study|Study Terminated by Sponsor|0
5787189|NCT03539484|19930964|P1|Overall Study|Study Terminated by Sponsor|0
5787190|NCT03539484|19930958|P7|Overall Study|Withdrawal by Subject|1
5787191|NCT03539484|19930959|P6|Overall Study|Withdrawal by Subject|0
5787192|NCT03539484|19930960|P5|Overall Study|Withdrawal by Subject|2
5787193|NCT03539484|19930961|P4|Overall Study|Withdrawal by Subject|0
5787194|NCT03539484|19930962|P3|Overall Study|Withdrawal by Subject|0
5787195|NCT03539484|19930963|P2|Overall Study|Withdrawal by Subject|0
5787196|NCT03539484|19930964|P1|Overall Study|Withdrawal by Subject|0
5787197|NCT03539484|19930958|P7|Overall Study|Lost to Follow-up|0
5787198|NCT03539484|19930959|P6|Overall Study|Lost to Follow-up|0
5787199|NCT03539484|19930960|P5|Overall Study|Lost to Follow-up|1
5787200|NCT03539484|19930961|P4|Overall Study|Lost to Follow-up|0
5787201|NCT03539484|19930962|P3|Overall Study|Lost to Follow-up|0
5787202|NCT03539484|19930963|P2|Overall Study|Lost to Follow-up|1
5787203|NCT03539484|19930964|P1|Overall Study|Lost to Follow-up|0
5787204|NCT03539484|19930958|P7|Overall Study|Death|0
5787205|NCT03539484|19930959|P6|Overall Study|Death|3
5787206|NCT03539484|19930960|P5|Overall Study|Death|8
5787207|NCT03539484|19930961|P4|Overall Study|Death|2
5787208|NCT03539484|19930962|P3|Overall Study|Death|0
5787209|NCT03539484|19930963|P2|Overall Study|Death|0
5787210|NCT03539484|19930964|P1|Overall Study|Death|1
5787211|NCT03539458|19931098|P1|Overall Study|Death|1
5787212|NCT03538743|19931153|P9|Overall Study|Withdrawal by Subject|0
5787213|NCT03538743|19931154|P8|Overall Study|Withdrawal by Subject|0
5787214|NCT03538743|19931155|P7|Overall Study|Withdrawal by Subject|0
5787215|NCT03538743|19931156|P6|Overall Study|Withdrawal by Subject|0
5787216|NCT03538743|19931157|P5|Overall Study|Withdrawal by Subject|0
5787217|NCT03538743|19931158|P4|Overall Study|Withdrawal by Subject|1
5787218|NCT03538743|19931159|P3|Overall Study|Withdrawal by Subject|0
5787219|NCT03538743|19931160|P2|Overall Study|Withdrawal by Subject|0
5787220|NCT03538743|19931161|P1|Overall Study|Withdrawal by Subject|0
5787221|NCT03538743|19931153|P9|Overall Study|Non-Treatment-Related Reasons|3
5787222|NCT03538743|19931154|P8|Overall Study|Non-Treatment-Related Reasons|0
5787223|NCT03538743|19931155|P7|Overall Study|Non-Treatment-Related Reasons|0
5787224|NCT03538743|19931156|P6|Overall Study|Non-Treatment-Related Reasons|0
5787225|NCT03538743|19931157|P5|Overall Study|Non-Treatment-Related Reasons|0
5787226|NCT03538743|19931158|P4|Overall Study|Non-Treatment-Related Reasons|0
5787227|NCT03538743|19931159|P3|Overall Study|Non-Treatment-Related Reasons|0
5787228|NCT03538743|19931160|P2|Overall Study|Non-Treatment-Related Reasons|0
5787229|NCT03538743|19931161|P1|Overall Study|Non-Treatment-Related Reasons|0
5787230|NCT03538743|19931153|P9|Overall Study|Adverse Event|0
5787231|NCT03538743|19931154|P8|Overall Study|Adverse Event|0
5787232|NCT03538743|19931155|P7|Overall Study|Adverse Event|0
5787233|NCT03538743|19931156|P6|Overall Study|Adverse Event|0
5787234|NCT03538743|19931157|P5|Overall Study|Adverse Event|0
5787235|NCT03538743|19931158|P4|Overall Study|Adverse Event|1
5787236|NCT03538743|19931159|P3|Overall Study|Adverse Event|1
5787237|NCT03538743|19931160|P2|Overall Study|Adverse Event|0
5787238|NCT03538743|19931161|P1|Overall Study|Adverse Event|0
5787239|NCT03536949|19931441|P2|Overall Study|Non-compliance|1
5787240|NCT03536949|19931442|P1|Overall Study|Non-compliance|2
5787241|NCT03536949|19931441|P2|Overall Study|Withdrawal by Subject|0
5787242|NCT03536949|19931442|P1|Overall Study|Withdrawal by Subject|6
5787243|NCT03536949|19931441|P2|Overall Study|Lost to Follow-up|1
5787244|NCT03536949|19931442|P1|Overall Study|Lost to Follow-up|2
5787245|NCT03536949|19931441|P2|Overall Study|Adverse Event|0
5787246|NCT03536949|19931442|P1|Overall Study|Adverse Event|4
5787247|NCT03536663|19931505|P1|Endexo|Protocol Violation|1
5787248|NCT03535974|19931523|P3|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|0
5787249|NCT03535974|19931524|P2|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|1
5787250|NCT03535974|19931525|P1|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|2
5787251|NCT03535974|19931523|P3|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0
5787252|NCT03535974|19931524|P2|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|1
5787253|NCT03535974|19931525|P1|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0
5787254|NCT03535844|19931535|P2|Overall Study|Withdrawal by Subject|1
5787255|NCT03535844|19931536|P1|Overall Study|Withdrawal by Subject|0
5787256|NCT03532048|19931824|P2|Overall Study|Withdrawal by Subject|0
5787257|NCT03532048|19931825|P1|Overall Study|Withdrawal by Subject|7
5787258|NCT03532048|19931824|P2|Overall Study|Lost to Follow-up|17
5787259|NCT03532048|19931825|P1|Overall Study|Lost to Follow-up|12
5787260|NCT03531905|19931842|P3|Overall Study|Could not speak with the participant|0
5787261|NCT03531905|19931843|P2|Overall Study|Could not speak with the participant|0
5787262|NCT03531905|19931844|P1|Overall Study|Could not speak with the participant|1
5787263|NCT03531905|19931842|P3|Overall Study|Participant was out of town|0
5787264|NCT03531905|19931843|P2|Overall Study|Participant was out of town|0
5787265|NCT03531905|19931844|P1|Overall Study|Participant was out of town|1
5787266|NCT03531905|19931842|P3|Overall Study|Lost to Follow-up|1
5787267|NCT03531905|19931843|P2|Overall Study|Lost to Follow-up|2
5787268|NCT03531905|19931844|P1|Overall Study|Lost to Follow-up|2
5787269|NCT03531905|19931842|P3|Overall Study|Withdrawal by Subject|2
5787270|NCT03531905|19931843|P2|Overall Study|Withdrawal by Subject|3
5787271|NCT03531905|19931844|P1|Overall Study|Withdrawal by Subject|3
5787272|NCT03530345|19932056|P2|Treatment Period B/Follow-up Period 2|Other reasons for discontinuation|7
5787273|NCT03530345|19932057|P1|Treatment Period B/Follow-up Period 2|Other reasons for discontinuation|5
5787274|NCT03530345|19932056|P2|Treatment Period A/Follow-up Period 1|Other reasons for discontinuation|21
5787275|NCT03530345|19932057|P1|Treatment Period A/Follow-up Period 1|Other reasons for discontinuation|17
5787276|NCT03530345|19932056|P2|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|1
5787277|NCT03530345|19932057|P1|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|3
5787278|NCT03530345|19932056|P2|Treatment Period A/Follow-up Period 1|Lost to Follow-up|0
5787279|NCT03530345|19932057|P1|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1
5787280|NCT03529942|19932090|P1|Overall Study|Personal reasons|1
5787281|NCT03529942|19932090|P1|Overall Study|Needle inserted but no drug administered|1
5787282|NCT03529942|19932090|P1|Overall Study|Lost to Follow-up|7
5787283|NCT03529942|19932090|P1|Overall Study|Physician Decision|1
5787284|NCT03529942|19932090|P1|Overall Study|Withdrawal by Subject|13
5787285|NCT03528577|19932114|P1|Sequence 4|Adverse Event|1
5787286|NCT03528577|19932114|P1|Sequence 4|Failed Spirometry|2
5787287|NCT03528577|19932114|P1|Sequence 3|Failed Spirometry|1
5787288|NCT03528577|19932114|P1|Sequence 2|Failed Spirometry|1
5787289|NCT03528577|19932114|P1|Sequence 2|Withdrawal by Subject|1
5787290|NCT03528577|19932114|P1|Sequence 2|Adverse Event|1
5787291|NCT03528577|19932114|P1|Sequence 1|Restricted medication|1
5787292|NCT03528577|19932114|P1|Sequence 1|Failed Spirometry|1
5787293|NCT03528369|19932124|P3|Overall Study|Adverse Event|0
5787294|NCT03528369|19932125|P2|Overall Study|Adverse Event|1
5787295|NCT03528369|19932126|P1|Overall Study|Adverse Event|0
5787296|NCT03528369|19932124|P3|Overall Study|Lost to Follow-up|0
5787297|NCT03528369|19932125|P2|Overall Study|Lost to Follow-up|0
5787298|NCT03528369|19932126|P1|Overall Study|Lost to Follow-up|1
5787299|NCT03528369|19932124|P3|Overall Study|Withdrawal by Subject|0
5787300|NCT03528369|19932125|P2|Overall Study|Withdrawal by Subject|0
5787301|NCT03528369|19932126|P1|Overall Study|Withdrawal by Subject|2
5787302|NCT03528174|19932155|P1|Overall Study|sensors dislodged|1
5787303|NCT03528174|19932155|P1|Overall Study|Adverse Event|1
5787304|NCT03527966|19932175|P2|Overall Study|Lost to Follow-up|0
5787305|NCT03527966|19932176|P1|Overall Study|Lost to Follow-up|3
5787306|NCT03527745|19932214|P26|Overall Study|Lost to Follow-up|3
5787307|NCT03527745|19932215|P25|Overall Study|Lost to Follow-up|1
5787308|NCT03527745|19932216|P24|Overall Study|Lost to Follow-up|8
5787309|NCT03527745|19932217|P23|Overall Study|Lost to Follow-up|6
5787310|NCT03527745|19932218|P22|Overall Study|Lost to Follow-up|5
5787311|NCT03527745|19932219|P21|Overall Study|Lost to Follow-up|1
5787312|NCT03527745|19932220|P20|Overall Study|Lost to Follow-up|1
5787313|NCT03527745|19932221|P19|Overall Study|Lost to Follow-up|0
5787314|NCT03527745|19932222|P18|Overall Study|Lost to Follow-up|0
5787315|NCT03527745|19932223|P17|Overall Study|Lost to Follow-up|1
5787316|NCT03527745|19932224|P16|Overall Study|Lost to Follow-up|0
5787317|NCT03527745|19932225|P15|Overall Study|Lost to Follow-up|0
5787318|NCT03527745|19932226|P14|Overall Study|Lost to Follow-up|0
5787319|NCT03527745|19932227|P13|Overall Study|Lost to Follow-up|0
5787320|NCT03527745|19932228|P12|Overall Study|Lost to Follow-up|1
5787321|NCT03527745|19932229|P11|Overall Study|Lost to Follow-up|1
5787322|NCT03527745|19932230|P10|Overall Study|Lost to Follow-up|2
5787323|NCT03527745|19932231|P9|Overall Study|Lost to Follow-up|3
5787324|NCT03527745|19932232|P8|Overall Study|Lost to Follow-up|2
5787325|NCT03527745|19932233|P7|Overall Study|Lost to Follow-up|3
5787326|NCT03527745|19932234|P6|Overall Study|Lost to Follow-up|2
5787327|NCT03527745|19932235|P5|Overall Study|Lost to Follow-up|0
5787328|NCT03527745|19932236|P4|Overall Study|Lost to Follow-up|9
5787329|NCT03527745|19932237|P3|Overall Study|Lost to Follow-up|7
5787330|NCT03527745|19932238|P2|Overall Study|Lost to Follow-up|6
5787331|NCT03527745|19932239|P1|Overall Study|Lost to Follow-up|3
5787332|NCT03527173|19932321|P2|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0
5787333|NCT03527173|19932322|P1|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1
5787334|NCT03527173|19932321|P2|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|5
5787335|NCT03527173|19932322|P1|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1
5787336|NCT03527173|19932321|P2|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|0
5787337|NCT03527173|19932322|P1|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|1
5787338|NCT03527173|19932321|P2|Overall Study|Lost to Follow-up|2
5787339|NCT03527173|19932322|P1|Overall Study|Lost to Follow-up|4
5787340|NCT03525678|19932382|P3|Overall Study|Death|4
5787341|NCT03525678|19932383|P2|Overall Study|Death|31
5787342|NCT03525678|19932384|P1|Overall Study|Death|32
5787343|NCT03525678|19932382|P3|Overall Study|Lost to Follow-up|0
5787344|NCT03525678|19932383|P2|Overall Study|Lost to Follow-up|0
5787345|NCT03525678|19932384|P1|Overall Study|Lost to Follow-up|1
5787346|NCT03525678|19932382|P3|Overall Study|Physician Decision|0
5787347|NCT03525678|19932383|P2|Overall Study|Physician Decision|2
5787348|NCT03525678|19932384|P1|Overall Study|Physician Decision|1
5787349|NCT03525678|19932382|P3|Overall Study|Withdrawal by Subject|0
5787350|NCT03525678|19932383|P2|Overall Study|Withdrawal by Subject|1
5787351|NCT03525678|19932384|P1|Overall Study|Withdrawal by Subject|3
5787352|NCT03525678|19932382|P3|Overall Study|Ongoing at the time of interim analysis|21
5787353|NCT03525678|19932383|P2|Overall Study|Ongoing at the time of interim analysis|65
5787354|NCT03525678|19932384|P1|Overall Study|Ongoing at the time of interim analysis|60
5787355|NCT03525444|19932586|P2|Overall Study|Other|1
5787356|NCT03525444|19932587|P1|Overall Study|Other|0
5787357|NCT03525444|19932586|P2|Overall Study|Withdrawal of consent (not due to AE)|1
5787358|NCT03525444|19932587|P1|Overall Study|Withdrawal of consent (not due to AE)|0
5787359|NCT03525444|19932586|P2|Overall Study|Adverse Event|1
5787360|NCT03525444|19932587|P1|Overall Study|Adverse Event|0
5787361|NCT03525119|19932630|P3|Overall Study|Randomized but not Vaccinated|2
5787362|NCT03525119|19932631|P2|Overall Study|Randomized but not Vaccinated|0
5787363|NCT03525119|19932632|P1|Overall Study|Randomized but not Vaccinated|1
5787364|NCT03525119|19932630|P3|Overall Study|Reason not Specified|2
5787365|NCT03525119|19932631|P2|Overall Study|Reason not Specified|1
5787366|NCT03525119|19932632|P1|Overall Study|Reason not Specified|2
5787367|NCT03525119|19932630|P3|Overall Study|Withdrawal by Subject|2
5787368|NCT03525119|19932631|P2|Overall Study|Withdrawal by Subject|4
5787369|NCT03525119|19932632|P1|Overall Study|Withdrawal by Subject|5
5787370|NCT03525119|19932630|P3|Overall Study|Lost to Follow-up|37
5787371|NCT03525119|19932631|P2|Overall Study|Lost to Follow-up|33
5787372|NCT03525119|19932632|P1|Overall Study|Lost to Follow-up|32
5787373|NCT03525119|19932630|P3|Overall Study|Adverse Event|0
5787374|NCT03525119|19932631|P2|Overall Study|Adverse Event|1
5787375|NCT03525119|19932632|P1|Overall Study|Adverse Event|0
5787376|NCT03524157|19932667|P3|Overall Study|cytology not readable|1
5787377|NCT03524157|19932668|P2|Overall Study|cytology not readable|0
5787378|NCT03524157|19932669|P1|Overall Study|cytology not readable|0
5787379|NCT03522675|19932723|P1|Overall Study|Non-reactive to histamine|1
5787380|NCT03522675|19932723|P1|Overall Study|Screen fail|1
5787381|NCT03522506|19932741|P4|Washout Period 2 (7 Days)|Withdrawal by Subject|1
5787382|NCT03522506|19932742|P3|Washout Period 2 (7 Days)|Withdrawal by Subject|0
5787383|NCT03522506|19932743|P2|Washout Period 2 (7 Days)|Withdrawal by Subject|0
5787384|NCT03522506|19932744|P1|Washout Period 2 (7 Days)|Withdrawal by Subject|0
5787385|NCT03522506|19932741|P4|Washout Period 1 (7 Days)|Withdrawal by Subject|1
5787386|NCT03522506|19932742|P3|Washout Period 1 (7 Days)|Withdrawal by Subject|0
5787387|NCT03522506|19932743|P2|Washout Period 1 (7 Days)|Withdrawal by Subject|0
5787388|NCT03522506|19932744|P1|Washout Period 1 (7 Days)|Withdrawal by Subject|0
5787389|NCT03521817|19932822|P2|Overall Study|Protocol Violation|1
5787390|NCT03521817|19932823|P1|Overall Study|Protocol Violation|0
5787391|NCT03521791|19932831|P2|Overall Study|Protocol Violation|17
5787392|NCT03521791|19932832|P1|Overall Study|Protocol Violation|7
5787393|NCT03521141|19932859|P3|Overall Study|Death|1
5787394|NCT03521141|19932860|P2|Overall Study|Death|0
5787395|NCT03521141|19932861|P1|Overall Study|Death|1
5787396|NCT03520959|19932907|P2|Overall Study|Study terminated by Sponsor|1
5787397|NCT03520959|19932908|P1|Overall Study|Study terminated by Sponsor|0
5787398|NCT03519932|19932955|P2|First Intervention|Adverse Event|3
5787399|NCT03519932|19932956|P1|First Intervention|Adverse Event|1
5787400|NCT03519919|19932982|P1|Overall Study|Screen Failure|1
5787401|NCT03519919|19932982|P1|Overall Study|Lack of Efficacy|1
5787402|NCT03519919|19932982|P1|Overall Study|Withdrawal by Subject|1
5787403|NCT03519867|19933034|P10|Overall Study|Reason not provided|0
5787404|NCT03519867|19933035|P9|Overall Study|Reason not provided|1
5787405|NCT03519867|19933036|P8|Overall Study|Reason not provided|1
5787406|NCT03519867|19933037|P7|Overall Study|Reason not provided|0
5787407|NCT03519867|19933038|P6|Overall Study|Reason not provided|1
5787408|NCT03519867|19933039|P5|Overall Study|Reason not provided|0
5787409|NCT03519867|19933040|P4|Overall Study|Reason not provided|1
5787410|NCT03519867|19933041|P3|Overall Study|Reason not provided|1
5787411|NCT03519867|19933042|P2|Overall Study|Reason not provided|1
5787412|NCT03519867|19933043|P1|Overall Study|Reason not provided|1
5787413|NCT03519867|19933034|P10|Overall Study|Admin. of other reversal agent|0
5787414|NCT03519867|19933035|P9|Overall Study|Admin. of other reversal agent|0
5787415|NCT03519867|19933036|P8|Overall Study|Admin. of other reversal agent|0
5787416|NCT03519867|19933037|P7|Overall Study|Admin. of other reversal agent|0
5787417|NCT03519867|19933038|P6|Overall Study|Admin. of other reversal agent|1
5787418|NCT03519867|19933039|P5|Overall Study|Admin. of other reversal agent|0
5787419|NCT03519867|19933040|P4|Overall Study|Admin. of other reversal agent|0
5787420|NCT03519867|19933041|P3|Overall Study|Admin. of other reversal agent|0
5787421|NCT03519867|19933042|P2|Overall Study|Admin. of other reversal agent|1
5787422|NCT03519867|19933043|P1|Overall Study|Admin. of other reversal agent|1
5787423|NCT03519867|19933034|P10|Overall Study|Admin. of relaxant other than Zemuron®|0
5787424|NCT03519867|19933035|P9|Overall Study|Admin. of relaxant other than Zemuron®|0
5787425|NCT03519867|19933036|P8|Overall Study|Admin. of relaxant other than Zemuron®|0
5787426|NCT03519867|19933037|P7|Overall Study|Admin. of relaxant other than Zemuron®|1
5787427|NCT03519867|19933038|P6|Overall Study|Admin. of relaxant other than Zemuron®|0
5787428|NCT03519867|19933039|P5|Overall Study|Admin. of relaxant other than Zemuron®|0
5787429|NCT03519867|19933040|P4|Overall Study|Admin. of relaxant other than Zemuron®|0
5787430|NCT03519867|19933041|P3|Overall Study|Admin. of relaxant other than Zemuron®|0
5787431|NCT03519867|19933042|P2|Overall Study|Admin. of relaxant other than Zemuron®|0
5787432|NCT03519867|19933043|P1|Overall Study|Admin. of relaxant other than Zemuron®|0
5787433|NCT03519867|19933034|P10|Overall Study|Protocol Violation|0
5787434|NCT03519867|19933035|P9|Overall Study|Protocol Violation|0
5787435|NCT03519867|19933036|P8|Overall Study|Protocol Violation|0
5787436|NCT03519867|19933037|P7|Overall Study|Protocol Violation|0
5787437|NCT03519867|19933038|P6|Overall Study|Protocol Violation|1
5787438|NCT03519867|19933039|P5|Overall Study|Protocol Violation|0
5787439|NCT03519867|19933040|P4|Overall Study|Protocol Violation|0
5787440|NCT03519867|19933041|P3|Overall Study|Protocol Violation|0
5787441|NCT03519867|19933042|P2|Overall Study|Protocol Violation|0
5787442|NCT03519867|19933043|P1|Overall Study|Protocol Violation|0
5787443|NCT03519867|19933034|P10|Overall Study|Adverse Event|0
5787444|NCT03519867|19933035|P9|Overall Study|Adverse Event|0
5787445|NCT03519867|19933036|P8|Overall Study|Adverse Event|0
5787446|NCT03519867|19933037|P7|Overall Study|Adverse Event|0
5787447|NCT03519867|19933038|P6|Overall Study|Adverse Event|0
5787448|NCT03519867|19933039|P5|Overall Study|Adverse Event|0
5787449|NCT03519867|19933040|P4|Overall Study|Adverse Event|0
5787450|NCT03519867|19933041|P3|Overall Study|Adverse Event|0
5787451|NCT03519867|19933042|P2|Overall Study|Adverse Event|1
5787452|NCT03519867|19933043|P1|Overall Study|Adverse Event|1
5787453|NCT03519854|19933093|P18|Overall Study|Technical Error|0
5787454|NCT03519854|19933094|P17|Overall Study|Technical Error|0
5787455|NCT03519854|19933095|P16|Overall Study|Technical Error|0
5787456|NCT03519854|19933096|P15|Overall Study|Technical Error|0
5787457|NCT03519854|19933097|P14|Overall Study|Technical Error|0
5787458|NCT03519854|19933098|P13|Overall Study|Technical Error|0
5787459|NCT03519854|19933099|P12|Overall Study|Technical Error|0
5787460|NCT03519854|19933100|P11|Overall Study|Technical Error|0
5787461|NCT03519854|19933101|P10|Overall Study|Technical Error|0
5787462|NCT03519854|19933102|P9|Overall Study|Technical Error|0
5787463|NCT03519854|19933103|P8|Overall Study|Technical Error|0
5787464|NCT03519854|19933104|P7|Overall Study|Technical Error|0
5787465|NCT03519854|19933105|P6|Overall Study|Technical Error|0
5787466|NCT03519854|19933106|P5|Overall Study|Technical Error|0
5787467|NCT03519854|19933107|P4|Overall Study|Technical Error|0
5787468|NCT03519854|19933108|P3|Overall Study|Technical Error|1
5787469|NCT03519854|19933109|P2|Overall Study|Technical Error|0
5787470|NCT03519854|19933110|P1|Overall Study|Technical Error|0
5787471|NCT03519516|19933276|P2|Overall Study|Adverse Event|1
5787472|NCT03519516|19933277|P1|Overall Study|Adverse Event|0
5787473|NCT03519204|19933351|P2|Overall Study|Other Miscellaneous Reasons|0
5787474|NCT03519204|19933352|P1|Overall Study|Other Miscellaneous Reasons|1
5787475|NCT03519204|19933351|P2|Overall Study|Withdrawal by Subject|7
5787476|NCT03519204|19933352|P1|Overall Study|Withdrawal by Subject|9
5787477|NCT03519204|19933351|P2|Overall Study|Lost to Follow-up|8
5787478|NCT03519204|19933352|P1|Overall Study|Lost to Follow-up|3
5787479|NCT03519087|19933371|P5|Laboratory Testing|Protocol Violation|0
5787480|NCT03519087|19933372|P4|Laboratory Testing|Protocol Violation|1
5787481|NCT03519087|19933373|P3|Laboratory Testing|Protocol Violation|0
5787482|NCT03519087|19933374|P2|Laboratory Testing|Protocol Violation|0
5787483|NCT03519087|19933375|P1|Laboratory Testing|Protocol Violation|0
5787484|NCT03519087|19933371|P5|Laboratory Testing|Lost to Follow-up|6
5787485|NCT03519087|19933372|P4|Laboratory Testing|Lost to Follow-up|3
5787486|NCT03519087|19933373|P3|Laboratory Testing|Lost to Follow-up|2
5787487|NCT03519087|19933374|P2|Laboratory Testing|Lost to Follow-up|0
5787488|NCT03519087|19933375|P1|Laboratory Testing|Lost to Follow-up|0
5787489|NCT03519087|19933371|P5|Re-randomization for Treatment|Not appropriate|0
5787490|NCT03519087|19933372|P4|Re-randomization for Treatment|Not appropriate|0
5787491|NCT03519087|19933373|P3|Re-randomization for Treatment|Not appropriate|0
5787492|NCT03519087|19933374|P2|Re-randomization for Treatment|Not appropriate|3
5787493|NCT03519087|19933375|P1|Re-randomization for Treatment|Not appropriate|2
5787494|NCT03519087|19933371|P5|Re-randomization for Treatment|Withdrawal by Subject|0
5787495|NCT03519087|19933372|P4|Re-randomization for Treatment|Withdrawal by Subject|0
5787496|NCT03519087|19933373|P3|Re-randomization for Treatment|Withdrawal by Subject|0
5787497|NCT03519087|19933374|P2|Re-randomization for Treatment|Withdrawal by Subject|29
5787498|NCT03519087|19933375|P1|Re-randomization for Treatment|Withdrawal by Subject|25
5787499|NCT03519087|19933371|P5|Clinic Evaluation|Protocol Violation|0
5787500|NCT03519087|19933372|P4|Clinic Evaluation|Protocol Violation|0
5787501|NCT03519087|19933373|P3|Clinic Evaluation|Protocol Violation|0
5787502|NCT03519087|19933374|P2|Clinic Evaluation|Protocol Violation|0
5787503|NCT03519087|19933375|P1|Clinic Evaluation|Protocol Violation|1
5787504|NCT03519087|19933371|P5|Clinic Evaluation|Physician Decision|0
5787505|NCT03519087|19933372|P4|Clinic Evaluation|Physician Decision|0
5787506|NCT03519087|19933373|P3|Clinic Evaluation|Physician Decision|0
5787507|NCT03519087|19933374|P2|Clinic Evaluation|Physician Decision|18
5787508|NCT03519087|19933375|P1|Clinic Evaluation|Physician Decision|15
5787509|NCT03518840|19933411|P1|Overall Study|Lost to Follow-up|6
5787510|NCT03518125|19933424|P6|Overall Study|Missed Day 394 Visit|0
5787511|NCT03518125|19933425|P5|Overall Study|Missed Day 394 Visit|0
5787512|NCT03518125|19933426|P4|Overall Study|Missed Day 394 Visit|0
5787513|NCT03518125|19933427|P3|Overall Study|Missed Day 394 Visit|0
5787514|NCT03518125|19933428|P2|Overall Study|Missed Day 394 Visit|0
5787515|NCT03518125|19933429|P1|Overall Study|Missed Day 394 Visit|1
5787516|NCT03518125|19933424|P6|Overall Study|Withdrawal by Subject|3
5787517|NCT03518125|19933425|P5|Overall Study|Withdrawal by Subject|1
5787518|NCT03518125|19933426|P4|Overall Study|Withdrawal by Subject|1
5787519|NCT03518125|19933427|P3|Overall Study|Withdrawal by Subject|0
5787520|NCT03518125|19933428|P2|Overall Study|Withdrawal by Subject|1
5787521|NCT03518125|19933429|P1|Overall Study|Withdrawal by Subject|1
5787522|NCT03518125|19933424|P6|Overall Study|Physician Decision|0
5787523|NCT03518125|19933425|P5|Overall Study|Physician Decision|0
5787524|NCT03518125|19933426|P4|Overall Study|Physician Decision|0
5787525|NCT03518125|19933427|P3|Overall Study|Physician Decision|0
5787526|NCT03518125|19933428|P2|Overall Study|Physician Decision|1
5787527|NCT03518125|19933429|P1|Overall Study|Physician Decision|0
5787528|NCT03518125|19933424|P6|Overall Study|Lost to Follow-up|5
5787529|NCT03518125|19933425|P5|Overall Study|Lost to Follow-up|3
5787530|NCT03518125|19933426|P4|Overall Study|Lost to Follow-up|0
5787531|NCT03518125|19933427|P3|Overall Study|Lost to Follow-up|0
5787532|NCT03518125|19933428|P2|Overall Study|Lost to Follow-up|2
5787533|NCT03518125|19933429|P1|Overall Study|Lost to Follow-up|0
5787534|NCT03518008|19933527|P2|Period 2, Second Week of Wear|Family emergency|1
5787535|NCT03518008|19933528|P1|Period 2, Second Week of Wear|Family emergency|0
5787536|NCT03515941|19933553|P2|Overall Study|Adverse Event|0
5787537|NCT03515941|19933554|P1|Overall Study|Adverse Event|1
5787538|NCT03513588|19933665|P3|Overall Study|Death|1
5787539|NCT03513588|19933666|P2|Overall Study|Death|0
5787540|NCT03513588|19933667|P1|Overall Study|Death|0
5787541|NCT03513588|19933665|P3|Overall Study|Study dosing paused by sponsor|0
5787542|NCT03513588|19933666|P2|Overall Study|Study dosing paused by sponsor|1
5787543|NCT03513588|19933667|P1|Overall Study|Study dosing paused by sponsor|1
5787544|NCT03513588|19933665|P3|Overall Study|Lost to Follow-up|1
5787545|NCT03513588|19933666|P2|Overall Study|Lost to Follow-up|1
5787546|NCT03513588|19933667|P1|Overall Study|Lost to Follow-up|0
5787547|NCT03512353|19933710|P1|Overall Study|Death|1
5787548|NCT03512353|19933710|P1|Overall Study|Sponsor Decision|3
5787549|NCT03512028|19933768|P2|Overall Study|Protocol Violation|0
5787550|NCT03512028|19933769|P1|Overall Study|Protocol Violation|2
5787551|NCT03512028|19933768|P2|Overall Study|Withdrawal by Subject|0
5787552|NCT03512028|19933769|P1|Overall Study|Withdrawal by Subject|2
5787554|NCT03511105|19933795|P2|Overall Study|Withdrew consent|0
5787555|NCT03511105|19933796|P1|Overall Study|Withdrew consent|1
5787556|NCT03511105|19933795|P2|Overall Study|Adverse Event|0
5787557|NCT03511105|19933796|P1|Overall Study|Adverse Event|1
5787558|NCT03510910|19933852|P2|Overall Study|Incomplete Survey|3
5787559|NCT03510910|19933853|P1|Overall Study|Incomplete Survey|2
5787560|NCT03510715|19933869|P2|Overall Study|Adverse Event|0
5787561|NCT03510715|19933870|P1|Overall Study|Adverse Event|1
5787562|NCT03510273|19933888|P1|Overall Study|Moved away from study area|4
5787563|NCT03510273|19933888|P1|Overall Study|Care outside study, ineligible to cont.|3
5787564|NCT03510273|19933888|P1|Overall Study|Withdrawal by Subject|2
5787565|NCT03509948|19933911|P2|Overall Study|Protocol Violation|1
5787566|NCT03509948|19933912|P1|Overall Study|Protocol Violation|0
5787567|NCT03509675|19933980|P2|Second Intervention )7 Days)|Lost Rinse B|0
5787568|NCT03509675|19933981|P1|Second Intervention )7 Days)|Lost Rinse B|1
5787569|NCT03509675|19933980|P2|Second Intervention )7 Days)|Withdrawal by Subject|0
5787570|NCT03509675|19933981|P1|Second Intervention )7 Days)|Withdrawal by Subject|1
5787571|NCT03509675|19933980|P2|First Intervention (7 Days)|Lack of Efficacy|1
5787572|NCT03509675|19933981|P1|First Intervention (7 Days)|Lack of Efficacy|2
5787573|NCT03509675|19933980|P2|First Intervention (7 Days)|Lost to Follow-up|3
5787574|NCT03509675|19933981|P1|First Intervention (7 Days)|Lost to Follow-up|3
5787575|NCT03509350|19933989|P2|Overall Study|Withdrawal by Subject|2
5787576|NCT03509350|19933990|P1|Overall Study|Withdrawal by Subject|0
5787577|NCT03509207|19933996|P1|Overall Study|Death|2
5787578|NCT03508843|19934001|P1|Overall Study|technical difficulties|2
5787579|NCT03508843|19934001|P1|Overall Study|Withdrawal by Subject|1
5787580|NCT03508609|19934066|P1|Overall Study|Withdrawal by Subject|1
5787581|NCT03508050|19934078|P2|Overall Study|Sustained desaturation|1
5787582|NCT03508050|19934079|P1|Overall Study|Sustained desaturation|0
5787583|NCT03508050|19934078|P2|Overall Study|Negative biopsy, surgery cancelled|1
5787584|NCT03508050|19934079|P1|Overall Study|Negative biopsy, surgery cancelled|3
5787585|NCT03508050|19934078|P2|Overall Study|Mucus plug|0
5787586|NCT03508050|19934079|P1|Overall Study|Mucus plug|1
5787587|NCT03508050|19934078|P2|Overall Study|Pleural adhesions|0
5787588|NCT03508050|19934079|P1|Overall Study|Pleural adhesions|1
5787589|NCT03506477|19934154|P2|Overall Study|Withdrawal by Subject|0
5787590|NCT03506477|19934155|P1|Overall Study|Withdrawal by Subject|1
5787591|NCT03506425|19934184|P3|Overall Study|Withdrawal by Subject|1
5787592|NCT03506425|19934185|P2|Overall Study|Withdrawal by Subject|0
5787593|NCT03506425|19934186|P1|Overall Study|Withdrawal by Subject|0
5787594|NCT03506425|19934184|P3|Overall Study|Death|0
5787595|NCT03506425|19934185|P2|Overall Study|Death|0
5787596|NCT03506425|19934186|P1|Overall Study|Death|1
5787597|NCT03506425|19934184|P3|Overall Study|Adverse Event|0
5787598|NCT03506425|19934185|P2|Overall Study|Adverse Event|3
5787599|NCT03506425|19934186|P1|Overall Study|Adverse Event|1
5787600|NCT03505593|19934221|P1|Overall Study|Obstruction by Endotracheal tube|1
5787601|NCT03505593|19934221|P1|Overall Study|Unable to pass through esophagus|1
5787602|NCT03505593|19934221|P1|Overall Study|Anatomical abnormality|1
5787603|NCT03505593|19934221|P1|Overall Study|Died before procedure|1
5787604|NCT03505593|19934221|P1|Overall Study|Withdrawal by Subject|1
5787605|NCT03504189|19934318|P1|Overall Study|Device Failure|2
5787606|NCT03504189|19934318|P1|Overall Study|Screening Failure|1
5787607|NCT03504189|19934318|P1|Overall Study|Withdrawal by Subject|1
5787608|NCT03503188|19934344|P2|Overall Study|Non eligible in the sub study|1
5787609|NCT03503188|19934345|P1|Overall Study|Non eligible in the sub study|0
5787610|NCT03502681|19934380|P2|Overall Study|Disease Progression|1
5787611|NCT03502681|19934381|P1|Overall Study|Disease Progression|2
5787612|NCT03502681|19934380|P2|Overall Study|Adverse Event|1
5787613|NCT03502681|19934381|P1|Overall Study|Adverse Event|1
5787614|NCT03502616|19934402|P2|Week 16 to Week 48|Withdrawal by Subject|3
5787615|NCT03502616|19934403|P1|Week 16 to Week 48|Withdrawal by Subject|6
5787616|NCT03502616|19934402|P2|Up to Week 16|Randomized, but not treated|0
5787617|NCT03502616|19934403|P1|Up to Week 16|Randomized, but not treated|1
5787618|NCT03502616|19934402|P2|Up to Week 16|Lost to Follow-up|1
5787619|NCT03502616|19934403|P1|Up to Week 16|Lost to Follow-up|0
5787620|NCT03502616|19934402|P2|Up to Week 16|Withdrawal by Subject|2
5787621|NCT03502616|19934403|P1|Up to Week 16|Withdrawal by Subject|1
5787622|NCT03502070|19934497|P1|Overall Study|Screen Failure|1
5787623|NCT03502070|19934497|P1|Overall Study|Withdrawal by Subject|1
5787624|NCT03501277|19934518|P4|Intervention Period 3 (4 Days)|Adverse Event|1
5787625|NCT03501277|19934519|P3|Intervention Period 3 (4 Days)|Adverse Event|0
5787626|NCT03501277|19934520|P2|Intervention Period 3 (4 Days)|Adverse Event|0
5787627|NCT03501277|19934521|P1|Intervention Period 3 (4 Days)|Adverse Event|0
5787628|NCT03501277|19934518|P4|Intervention Period 2 (4 Days)|Adverse Event|1
5787629|NCT03501277|19934519|P3|Intervention Period 2 (4 Days)|Adverse Event|0
5787630|NCT03501277|19934520|P2|Intervention Period 2 (4 Days)|Adverse Event|0
5787631|NCT03501277|19934521|P1|Intervention Period 2 (4 Days)|Adverse Event|0
5787632|NCT03501277|19934518|P4|Intervention Period 1 (4 Days)|Adverse Event|1
5787633|NCT03501277|19934519|P3|Intervention Period 1 (4 Days)|Adverse Event|0
5787634|NCT03501277|19934520|P2|Intervention Period 1 (4 Days)|Adverse Event|0
5787635|NCT03501277|19934521|P1|Intervention Period 1 (4 Days)|Adverse Event|0
5787636|NCT03501277|19934518|P4|Intervention Period 1 (4 Days)|Other|0
5787637|NCT03501277|19934519|P3|Intervention Period 1 (4 Days)|Other|1
5787638|NCT03501277|19934520|P2|Intervention Period 1 (4 Days)|Other|0
5787639|NCT03501277|19934521|P1|Intervention Period 1 (4 Days)|Other|0
5787640|NCT03500679|19934648|P2|Overall Study|Withdrawal by Subject|0
5787641|NCT03500679|19934649|P1|Overall Study|Withdrawal by Subject|3
5787642|NCT03500679|19934648|P2|Overall Study|Lost to Follow-up|3
5787643|NCT03500679|19934649|P1|Overall Study|Lost to Follow-up|6
5787644|NCT03500224|19934740|P1|Overall Study|Withdrawal by Subject|2
5787645|NCT03500211|19934779|P2|Overall Study|Withdrawal by Subject|1
5787646|NCT03500211|19934780|P1|Overall Study|Withdrawal by Subject|1
5787647|NCT03500198|19934796|P2|Overall Study|Lost to Follow-up|1
5787648|NCT03500198|19934797|P1|Overall Study|Lost to Follow-up|0
5787649|NCT03500159|19934813|P2|Overall Study|Study Terminated|1
5787650|NCT03500159|19934814|P1|Overall Study|Study Terminated|2
5787651|NCT03499067|19934820|P2|First Intervention|Withdrawal by Subject|6
5787652|NCT03499067|19934821|P1|First Intervention|Withdrawal by Subject|3
5787653|NCT03499067|19934820|P2|First Intervention|Physician Decision|1
5787654|NCT03499067|19934821|P1|First Intervention|Physician Decision|2
5787655|NCT03498560|19934861|P1|Overall Study|Death|1
5787656|NCT03498560|19934861|P1|Overall Study|Lost to Follow-up|4
5787657|NCT03498560|19934861|P1|Overall Study|Withdrawal by Subject|14
5787658|NCT03498560|19934861|P1|Overall Study|Found Ineligible|2
5787659|NCT03498287|19934878|P2|Overall Study|Adverse Event|1
5787660|NCT03498287|19934879|P1|Overall Study|Adverse Event|0
5787661|NCT03498287|19934878|P2|Overall Study|Protocol Violation|4
5787662|NCT03498287|19934879|P1|Overall Study|Protocol Violation|0
5787663|NCT03498287|19934878|P2|Overall Study|Withdrawal by Subject|0
5787664|NCT03498287|19934879|P1|Overall Study|Withdrawal by Subject|3
5787665|NCT03497130|19935004|P2|Overall Study|Lost to Follow-up|1
5787666|NCT03497130|19935005|P1|Overall Study|Lost to Follow-up|1
5787667|NCT03497039|19935017|P2|Overall Study|Protocol Violation|1
5787668|NCT03497039|19935018|P1|Overall Study|Protocol Violation|0
5787669|NCT03497039|19935017|P2|Overall Study|Withdrawal by Subject|0
5787670|NCT03497039|19935018|P1|Overall Study|Withdrawal by Subject|1
5787671|NCT03495908|19935146|P2|Overall Study|No documented reason|2
5787672|NCT03495908|19935147|P1|Overall Study|No documented reason|0
5787673|NCT03495908|19935146|P2|Overall Study|Physician Decision|4
5787674|NCT03495908|19935147|P1|Overall Study|Physician Decision|5
5787675|NCT03495908|19935146|P2|Overall Study|Death|0
5787676|NCT03495908|19935147|P1|Overall Study|Death|1
5787677|NCT03495908|19935146|P2|Overall Study|Adverse Event|2
5787678|NCT03495908|19935147|P1|Overall Study|Adverse Event|0
5787679|NCT03495908|19935146|P2|Overall Study|Lost to Follow-up|4
5787680|NCT03495908|19935147|P1|Overall Study|Lost to Follow-up|1
5787681|NCT03495908|19935146|P2|Overall Study|Withdrawal by Subject|1
5787682|NCT03495908|19935147|P1|Overall Study|Withdrawal by Subject|3
5787683|NCT03495817|19935183|P1|26 Week Extension|Lost to Follow-up|2
5787684|NCT03495817|19935183|P1|26 Week Open Label|Lost to Follow-up|1
5787685|NCT03495817|19935183|P1|26 Week Open Label|Withdrawal by Subject|4
5787686|NCT03495817|19935183|P1|26 Week Open Label|Adverse Event|3
5787687|NCT03495102|19935201|P3|Overall Study|Participant was in Rehabilitation|0
5787688|NCT03495102|19935202|P2|Overall Study|Participant was in Rehabilitation|0
5787689|NCT03495102|19935203|P1|Overall Study|Participant was in Rehabilitation|1
5787690|NCT03495102|19935201|P3|Overall Study|Relocated to Another Country|0
5787691|NCT03495102|19935202|P2|Overall Study|Relocated to Another Country|1
5787692|NCT03495102|19935203|P1|Overall Study|Relocated to Another Country|0
5787693|NCT03495102|19935201|P3|Overall Study|Primary Care Physician Recommendation|0
5787694|NCT03495102|19935202|P2|Overall Study|Primary Care Physician Recommendation|1
5787695|NCT03495102|19935203|P1|Overall Study|Primary Care Physician Recommendation|0
5787696|NCT03495102|19935201|P3|Overall Study|Participant Duplicated at Another Site|1
5787697|NCT03495102|19935202|P2|Overall Study|Participant Duplicated at Another Site|0
5787698|NCT03495102|19935203|P1|Overall Study|Participant Duplicated at Another Site|0
5787699|NCT03495102|19935201|P3|Overall Study|Non-compliance|0
5787700|NCT03495102|19935202|P2|Overall Study|Non-compliance|0
5787701|NCT03495102|19935203|P1|Overall Study|Non-compliance|1
5787702|NCT03495102|19935201|P3|Overall Study|Site Closure|2
5787703|NCT03495102|19935202|P2|Overall Study|Site Closure|1
5787704|NCT03495102|19935203|P1|Overall Study|Site Closure|3
5787705|NCT03495102|19935201|P3|Overall Study|Protocol Violation|0
5787706|NCT03495102|19935202|P2|Overall Study|Protocol Violation|1
5787707|NCT03495102|19935203|P1|Overall Study|Protocol Violation|1
5787708|NCT03495102|19935201|P3|Overall Study|Withdrawal by Subject|18
5787709|NCT03495102|19935202|P2|Overall Study|Withdrawal by Subject|36
5787710|NCT03495102|19935203|P1|Overall Study|Withdrawal by Subject|25
5787711|NCT03495102|19935201|P3|Overall Study|Physician Decision|2
5787712|NCT03495102|19935202|P2|Overall Study|Physician Decision|0
5787713|NCT03495102|19935203|P1|Overall Study|Physician Decision|2
5787714|NCT03495102|19935201|P3|Overall Study|Lost to Follow-up|17
5787715|NCT03495102|19935202|P2|Overall Study|Lost to Follow-up|16
5787716|NCT03495102|19935203|P1|Overall Study|Lost to Follow-up|15
5787717|NCT03495102|19935201|P3|Overall Study|Death|4
5787718|NCT03495102|19935202|P2|Overall Study|Death|4
5787719|NCT03495102|19935203|P1|Overall Study|Death|3
5787720|NCT03495102|19935201|P3|Overall Study|Adverse Event|10
5787721|NCT03495102|19935202|P2|Overall Study|Adverse Event|7
5787722|NCT03495102|19935203|P1|Overall Study|Adverse Event|5
5787723|NCT03494985|19935233|P4|Overall Study|Other (Not specified)|0
5787724|NCT03494985|19935234|P3|Overall Study|Other (Not specified)|1
5787725|NCT03494985|19935235|P2|Overall Study|Other (Not specified)|1
5787726|NCT03494985|19935236|P1|Overall Study|Other (Not specified)|0
5787727|NCT03494985|19935233|P4|Overall Study|Other (Withdrawal of consent)|5
5787728|NCT03494985|19935234|P3|Overall Study|Other (Withdrawal of consent)|2
5787729|NCT03494985|19935235|P2|Overall Study|Other (Withdrawal of consent)|3
5787730|NCT03494985|19935236|P1|Overall Study|Other (Withdrawal of consent)|2
5787731|NCT03494985|19935233|P4|Overall Study|Adverse Event|0
5787732|NCT03494985|19935234|P3|Overall Study|Adverse Event|3
5787733|NCT03494985|19935235|P2|Overall Study|Adverse Event|2
5787734|NCT03494985|19935236|P1|Overall Study|Adverse Event|3
5787735|NCT03493854|19935272|P2|Treatment-Free Follow-Up (up to 3 Years)|Ongoing in Follow-Up|16
5787736|NCT03493854|19935273|P1|Treatment-Free Follow-Up (up to 3 Years)|Ongoing in Follow-Up|18
5787737|NCT03493854|19935272|P2|Treatment-Free Follow-Up (up to 3 Years)|Withdrawal by Subject|1
5787738|NCT03493854|19935273|P1|Treatment-Free Follow-Up (up to 3 Years)|Withdrawal by Subject|1
5787739|NCT03493854|19935272|P2|Surgery & Adjuvant Treatment (42 Weeks)|Other|3
5787740|NCT03493854|19935273|P1|Surgery & Adjuvant Treatment (42 Weeks)|Other|5
5787741|NCT03493854|19935272|P2|Surgery & Adjuvant Treatment (42 Weeks)|Withdrawal by Subject|0
5787742|NCT03493854|19935273|P1|Surgery & Adjuvant Treatment (42 Weeks)|Withdrawal by Subject|2
5787743|NCT03493854|19935272|P2|Surgery & Adjuvant Treatment (42 Weeks)|Protocol Violation|0
5787744|NCT03493854|19935273|P1|Surgery & Adjuvant Treatment (42 Weeks)|Protocol Violation|1
5787745|NCT03493854|19935272|P2|Surgery & Adjuvant Treatment (42 Weeks)|Progressive Disease|0
5787746|NCT03493854|19935273|P1|Surgery & Adjuvant Treatment (42 Weeks)|Progressive Disease|3
5787747|NCT03493854|19935272|P2|Surgery & Adjuvant Treatment (42 Weeks)|Lack of Efficacy|1
5787748|NCT03493854|19935273|P1|Surgery & Adjuvant Treatment (42 Weeks)|Lack of Efficacy|0
5787749|NCT03493854|19935272|P2|Surgery & Adjuvant Treatment (42 Weeks)|Adverse Event|2
5787750|NCT03493854|19935273|P1|Surgery & Adjuvant Treatment (42 Weeks)|Adverse Event|2
5787751|NCT03493854|19935272|P2|Surgery & Adjuvant Treatment (42 Weeks)|Ongoing Adjuvant Treatment|228
5787752|NCT03493854|19935273|P1|Surgery & Adjuvant Treatment (42 Weeks)|Ongoing Adjuvant Treatment|229
5787753|NCT03493854|19935272|P2|Neoadjuvant Treatment Phase (24 Weeks)|Other|0
5787754|NCT03493854|19935273|P1|Neoadjuvant Treatment Phase (24 Weeks)|Other|1
5787755|NCT03493854|19935272|P2|Neoadjuvant Treatment Phase (24 Weeks)|Other|2
5787756|NCT03493854|19935273|P1|Neoadjuvant Treatment Phase (24 Weeks)|Other|1
5787757|NCT03493854|19935272|P2|Neoadjuvant Treatment Phase (24 Weeks)|Progressive Disease|3
5787758|NCT03493854|19935273|P1|Neoadjuvant Treatment Phase (24 Weeks)|Progressive Disease|3
5787759|NCT03493854|19935272|P2|Neoadjuvant Treatment Phase (24 Weeks)|Withdrawal by Subject|2
5787760|NCT03493854|19935273|P1|Neoadjuvant Treatment Phase (24 Weeks)|Withdrawal by Subject|1
5787761|NCT03493854|19935272|P2|Neoadjuvant Treatment Phase (24 Weeks)|Protocol Violation|1
5787762|NCT03493854|19935273|P1|Neoadjuvant Treatment Phase (24 Weeks)|Protocol Violation|0
5787763|NCT03493854|19935272|P2|Neoadjuvant Treatment Phase (24 Weeks)|Death|1
5787764|NCT03493854|19935273|P1|Neoadjuvant Treatment Phase (24 Weeks)|Death|1
5787765|NCT03493854|19935272|P2|Neoadjuvant Treatment Phase (24 Weeks)|Adverse Event|5
5787766|NCT03493854|19935273|P1|Neoadjuvant Treatment Phase (24 Weeks)|Adverse Event|3
5787767|NCT03493698|19935319|P1|Treatment Period C|Withdrawal by Subject|1
5787768|NCT03493698|19935319|P1|Treatment Period C|Adverse Event|1
5787769|NCT03493542|19935344|P2|Overall Study|Withdrawal by Subject|6
5787770|NCT03493542|19935345|P1|Overall Study|Withdrawal by Subject|2
5787771|NCT03493542|19935344|P2|Overall Study|Withdrawal by parent or guardian|0
5787772|NCT03493542|19935345|P1|Overall Study|Withdrawal by parent or guardian|3
5787773|NCT03493542|19935344|P2|Overall Study|Ongoing|3
5787774|NCT03493542|19935345|P1|Overall Study|Ongoing|2
5787775|NCT03493386|19935369|P4|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0
5787776|NCT03493386|19935370|P3|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0
5787777|NCT03493386|19935371|P2|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|1
5787778|NCT03493386|19935372|P1|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0
5787779|NCT03492554|19935492|P2|Overall Study|Protocol Violation|14
5787780|NCT03492554|19935493|P1|Overall Study|Protocol Violation|0
5787781|NCT03491553|19935569|P6|Overall Study|Withdrew Consent|0
5787782|NCT03491553|19935570|P5|Overall Study|Withdrew Consent|0
5787783|NCT03491553|19935571|P4|Overall Study|Withdrew Consent|0
5787784|NCT03491553|19935572|P3|Overall Study|Withdrew Consent|0
5787785|NCT03491553|19935573|P2|Overall Study|Withdrew Consent|1
5787786|NCT03491553|19935574|P1|Overall Study|Withdrew Consent|1
5787787|NCT03491553|19935569|P6|Overall Study|Adverse Event|0
5787788|NCT03491553|19935570|P5|Overall Study|Adverse Event|0
5787789|NCT03491553|19935571|P4|Overall Study|Adverse Event|1
5787790|NCT03491553|19935572|P3|Overall Study|Adverse Event|0
5787791|NCT03491553|19935573|P2|Overall Study|Adverse Event|0
5787792|NCT03491553|19935574|P1|Overall Study|Adverse Event|0
5787793|NCT03491150|19935689|P2|Overall Study|Withdrawal by Subject|2
5787794|NCT03491150|19935690|P1|Overall Study|Withdrawal by Subject|1
5787795|NCT03491150|19935689|P2|Overall Study|Other|1
5787796|NCT03491150|19935690|P1|Overall Study|Other|0
5787797|NCT03491150|19935689|P2|Overall Study|Study Terminated by Sponsor|70
5787798|NCT03491150|19935690|P1|Overall Study|Study Terminated by Sponsor|74
5787799|NCT03491150|19935689|P2|Overall Study|Adverse Event|0
5787800|NCT03491150|19935690|P1|Overall Study|Adverse Event|1
5787801|NCT03490032|19935729|P3|Overall Study|family issue (child custody)|0
5787802|NCT03490032|19935730|P2|Overall Study|family issue (child custody)|0
5787803|NCT03490032|19935731|P1|Overall Study|family issue (child custody)|1
5787804|NCT03489863|19935771|P2|Overall Study|Withdrawal by Subject|1
5787805|NCT03489863|19935772|P1|Overall Study|Withdrawal by Subject|0
5787806|NCT03489720|19935780|P2|Overall Study|Withdrawal by Subject|0
5787807|NCT03489720|19935781|P1|Overall Study|Withdrawal by Subject|2
5787808|NCT03489551|19935806|P1|Overall Study|Withdrawal by Subject|2
5787809|NCT03489304|19935810|P1|Overall Study|Lost to Follow-up|4
5787810|NCT03488927|19935819|P3|Overall Study|Withdrawal by Subject|217
5787811|NCT03488927|19935820|P2|Overall Study|Withdrawal by Subject|118
5787812|NCT03488927|19935821|P1|Overall Study|Withdrawal by Subject|44
5787813|NCT03488108|19935834|P2|Second Intervention (12 Weeks)|Withdrawal by Subject|0
5787814|NCT03488108|19935835|P1|Second Intervention (12 Weeks)|Withdrawal by Subject|1
5787815|NCT03488108|19935834|P2|First Intervention (12 Weeks)|Withdrawal by Subject|1
5787816|NCT03488108|19935835|P1|First Intervention (12 Weeks)|Withdrawal by Subject|0
5787817|NCT03486392|19936104|P5|Overall Study|Death|1
5787818|NCT03486392|19936105|P4|Overall Study|Death|0
5787819|NCT03486392|19936106|P3|Overall Study|Death|0
5787820|NCT03486392|19936107|P2|Overall Study|Death|0
5787821|NCT03486392|19936108|P1|Overall Study|Death|0
5787822|NCT03486392|19936104|P5|Overall Study|Withdrawal by Subject|1
5787823|NCT03486392|19936105|P4|Overall Study|Withdrawal by Subject|4
5787824|NCT03486392|19936106|P3|Overall Study|Withdrawal by Subject|6
5787825|NCT03486392|19936107|P2|Overall Study|Withdrawal by Subject|0
5787826|NCT03486392|19936108|P1|Overall Study|Withdrawal by Subject|3
5787827|NCT03486392|19936104|P5|Overall Study|Lost to Follow-up|2
5787828|NCT03486392|19936105|P4|Overall Study|Lost to Follow-up|5
5787829|NCT03486392|19936106|P3|Overall Study|Lost to Follow-up|8
5787830|NCT03486392|19936107|P2|Overall Study|Lost to Follow-up|0
5787831|NCT03486392|19936108|P1|Overall Study|Lost to Follow-up|0
5787832|NCT03483623|19936157|P1|Overall Study|43 complete sets achieved|1
5787833|NCT03482882|19936206|P1|Overall Study|Not further specified|1
5787834|NCT03482882|19936206|P1|Overall Study|Protocol Violation|2
5787835|NCT03482882|19936206|P1|Overall Study|Lost to Follow-up|1
5787836|NCT03482882|19936206|P1|Overall Study|Adverse Event|3
5787837|NCT03482453|19936267|P12|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
5787838|NCT03482453|19936268|P11|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|1
5787839|NCT03482453|19936269|P10|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
5787840|NCT03482453|19936270|P9|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
5787841|NCT03482453|19936271|P8|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
5787842|NCT03482453|19936272|P7|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
5787843|NCT03482453|19936273|P6|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
5787844|NCT03482453|19936274|P5|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
5787845|NCT03482453|19936275|P4|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
5787846|NCT03482453|19936276|P3|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
5787847|NCT03482453|19936277|P2|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
5787848|NCT03482453|19936278|P1|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
5787849|NCT03482011|19936397|P8|Follow-up Period (12 Weeks)|Lost to Follow-up|1
5787850|NCT03482011|19936398|P7|Follow-up Period (12 Weeks)|Lost to Follow-up|0
5787851|NCT03482011|19936399|P6|Follow-up Period (12 Weeks)|Lost to Follow-up|0
5787852|NCT03482011|19936400|P5|Follow-up Period (12 Weeks)|Lost to Follow-up|0
5787853|NCT03482011|19936401|P4|Follow-up Period (12 Weeks)|Lost to Follow-up|0
5787854|NCT03482011|19936402|P3|Follow-up Period (12 Weeks)|Lost to Follow-up|0
5787855|NCT03482011|19936403|P2|Follow-up Period (12 Weeks)|Lost to Follow-up|0
5787856|NCT03482011|19936404|P1|Follow-up Period (12 Weeks)|Lost to Follow-up|0
5787857|NCT03482011|19936397|P8|Follow-up Period (12 Weeks)|Physician Decision|1
5787858|NCT03482011|19936398|P7|Follow-up Period (12 Weeks)|Physician Decision|0
5787859|NCT03482011|19936399|P6|Follow-up Period (12 Weeks)|Physician Decision|0
5787860|NCT03482011|19936400|P5|Follow-up Period (12 Weeks)|Physician Decision|0
5787861|NCT03482011|19936401|P4|Follow-up Period (12 Weeks)|Physician Decision|0
5787862|NCT03482011|19936402|P3|Follow-up Period (12 Weeks)|Physician Decision|0
5787863|NCT03482011|19936403|P2|Follow-up Period (12 Weeks)|Physician Decision|0
5787864|NCT03482011|19936404|P1|Follow-up Period (12 Weeks)|Physician Decision|0
5787865|NCT03482011|19936397|P8|Follow-up Period (12 Weeks)|Lack of Efficacy|6
5787866|NCT03482011|19936398|P7|Follow-up Period (12 Weeks)|Lack of Efficacy|0
5787867|NCT03482011|19936399|P6|Follow-up Period (12 Weeks)|Lack of Efficacy|0
5787868|NCT03482011|19936400|P5|Follow-up Period (12 Weeks)|Lack of Efficacy|0
5787869|NCT03482011|19936401|P4|Follow-up Period (12 Weeks)|Lack of Efficacy|3
5787870|NCT03482011|19936402|P3|Follow-up Period (12 Weeks)|Lack of Efficacy|1
5787871|NCT03482011|19936403|P2|Follow-up Period (12 Weeks)|Lack of Efficacy|0
5787872|NCT03482011|19936404|P1|Follow-up Period (12 Weeks)|Lack of Efficacy|0
5787873|NCT03482011|19936397|P8|Follow-up Period (12 Weeks)|Adverse Event|4
5787874|NCT03482011|19936398|P7|Follow-up Period (12 Weeks)|Adverse Event|1
5787875|NCT03482011|19936399|P6|Follow-up Period (12 Weeks)|Adverse Event|0
5787876|NCT03482011|19936400|P5|Follow-up Period (12 Weeks)|Adverse Event|0
5787877|NCT03482011|19936401|P4|Follow-up Period (12 Weeks)|Adverse Event|0
5787878|NCT03482011|19936402|P3|Follow-up Period (12 Weeks)|Adverse Event|0
5787879|NCT03482011|19936403|P2|Follow-up Period (12 Weeks)|Adverse Event|0
5787880|NCT03482011|19936404|P1|Follow-up Period (12 Weeks)|Adverse Event|0
5787881|NCT03482011|19936397|P8|Follow-up Period (12 Weeks)|Withdrawal by Subject|5
5787882|NCT03482011|19936398|P7|Follow-up Period (12 Weeks)|Withdrawal by Subject|1
5787883|NCT03482011|19936399|P6|Follow-up Period (12 Weeks)|Withdrawal by Subject|1
5787884|NCT03482011|19936400|P5|Follow-up Period (12 Weeks)|Withdrawal by Subject|0
5787885|NCT03482011|19936401|P4|Follow-up Period (12 Weeks)|Withdrawal by Subject|2
5787886|NCT03482011|19936402|P3|Follow-up Period (12 Weeks)|Withdrawal by Subject|0
5787887|NCT03482011|19936403|P2|Follow-up Period (12 Weeks)|Withdrawal by Subject|0
5787888|NCT03482011|19936404|P1|Follow-up Period (12 Weeks)|Withdrawal by Subject|0
5787889|NCT03482011|19936397|P8|Maintenance Period (36 Weeks)|Withdrawal by Subject|2
5787890|NCT03482011|19936398|P7|Maintenance Period (36 Weeks)|Withdrawal by Subject|2
5787891|NCT03482011|19936399|P6|Maintenance Period (36 Weeks)|Withdrawal by Subject|1
5787892|NCT03482011|19936400|P5|Maintenance Period (36 Weeks)|Withdrawal by Subject|2
5787893|NCT03482011|19936401|P4|Maintenance Period (36 Weeks)|Withdrawal by Subject|1
5787894|NCT03482011|19936402|P3|Maintenance Period (36 Weeks)|Withdrawal by Subject|0
5787895|NCT03482011|19936403|P2|Maintenance Period (36 Weeks)|Withdrawal by Subject|0
5787896|NCT03482011|19936404|P1|Maintenance Period (36 Weeks)|Withdrawal by Subject|0
5787897|NCT03482011|19936397|P8|Maintenance Period (36 Weeks)|Physician Decision|1
5787898|NCT03482011|19936398|P7|Maintenance Period (36 Weeks)|Physician Decision|1
5787899|NCT03482011|19936399|P6|Maintenance Period (36 Weeks)|Physician Decision|1
5787900|NCT03482011|19936400|P5|Maintenance Period (36 Weeks)|Physician Decision|0
5787901|NCT03482011|19936401|P4|Maintenance Period (36 Weeks)|Physician Decision|1
5787902|NCT03482011|19936402|P3|Maintenance Period (36 Weeks)|Physician Decision|0
5787903|NCT03482011|19936403|P2|Maintenance Period (36 Weeks)|Physician Decision|0
5787904|NCT03482011|19936404|P1|Maintenance Period (36 Weeks)|Physician Decision|0
5787905|NCT03482011|19936397|P8|Maintenance Period (36 Weeks)|Lost to Follow-up|1
5787906|NCT03482011|19936398|P7|Maintenance Period (36 Weeks)|Lost to Follow-up|0
5787907|NCT03482011|19936399|P6|Maintenance Period (36 Weeks)|Lost to Follow-up|0
5787908|NCT03482011|19936400|P5|Maintenance Period (36 Weeks)|Lost to Follow-up|2
5787909|NCT03482011|19936401|P4|Maintenance Period (36 Weeks)|Lost to Follow-up|0
5787910|NCT03482011|19936402|P3|Maintenance Period (36 Weeks)|Lost to Follow-up|0
5787911|NCT03482011|19936403|P2|Maintenance Period (36 Weeks)|Lost to Follow-up|0
5787912|NCT03482011|19936404|P1|Maintenance Period (36 Weeks)|Lost to Follow-up|0
5787913|NCT03482011|19936397|P8|Maintenance Period (36 Weeks)|Lack of Efficacy|9
5787914|NCT03482011|19936398|P7|Maintenance Period (36 Weeks)|Lack of Efficacy|0
5787915|NCT03482011|19936399|P6|Maintenance Period (36 Weeks)|Lack of Efficacy|1
5787916|NCT03482011|19936400|P5|Maintenance Period (36 Weeks)|Lack of Efficacy|1
5787917|NCT03482011|19936401|P4|Maintenance Period (36 Weeks)|Lack of Efficacy|2
5787918|NCT03482011|19936402|P3|Maintenance Period (36 Weeks)|Lack of Efficacy|1
5787919|NCT03482011|19936403|P2|Maintenance Period (36 Weeks)|Lack of Efficacy|0
5787920|NCT03482011|19936404|P1|Maintenance Period (36 Weeks)|Lack of Efficacy|0
5787921|NCT03482011|19936397|P8|Maintenance Period (36 Weeks)|Adverse Event|4
5787922|NCT03482011|19936398|P7|Maintenance Period (36 Weeks)|Adverse Event|1
5787923|NCT03482011|19936399|P6|Maintenance Period (36 Weeks)|Adverse Event|1
5787924|NCT03482011|19936400|P5|Maintenance Period (36 Weeks)|Adverse Event|0
5787925|NCT03482011|19936401|P4|Maintenance Period (36 Weeks)|Adverse Event|0
5787926|NCT03482011|19936402|P3|Maintenance Period (36 Weeks)|Adverse Event|0
5787927|NCT03482011|19936403|P2|Maintenance Period (36 Weeks)|Adverse Event|0
5787928|NCT03482011|19936404|P1|Maintenance Period (36 Weeks)|Adverse Event|0
5787929|NCT03482011|19936397|P8|Induction Period (16 Weeks)|Withdrawal by Subject|0
5787930|NCT03482011|19936398|P7|Induction Period (16 Weeks)|Withdrawal by Subject|0
5787931|NCT03482011|19936399|P6|Induction Period (16 Weeks)|Withdrawal by Subject|0
5787932|NCT03482011|19936400|P5|Induction Period (16 Weeks)|Withdrawal by Subject|0
5787933|NCT03482011|19936401|P4|Induction Period (16 Weeks)|Withdrawal by Subject|0
5787934|NCT03482011|19936402|P3|Induction Period (16 Weeks)|Withdrawal by Subject|0
5787935|NCT03482011|19936403|P2|Induction Period (16 Weeks)|Withdrawal by Subject|5
5787936|NCT03482011|19936404|P1|Induction Period (16 Weeks)|Withdrawal by Subject|2
5787937|NCT03482011|19936397|P8|Induction Period (16 Weeks)|Screen Failure|0
5787938|NCT03482011|19936398|P7|Induction Period (16 Weeks)|Screen Failure|0
5787939|NCT03482011|19936399|P6|Induction Period (16 Weeks)|Screen Failure|0
5787940|NCT03482011|19936400|P5|Induction Period (16 Weeks)|Screen Failure|0
5787941|NCT03482011|19936401|P4|Induction Period (16 Weeks)|Screen Failure|0
5787942|NCT03482011|19936402|P3|Induction Period (16 Weeks)|Screen Failure|0
5787943|NCT03482011|19936403|P2|Induction Period (16 Weeks)|Screen Failure|1
5787944|NCT03482011|19936404|P1|Induction Period (16 Weeks)|Screen Failure|0
5787945|NCT03482011|19936397|P8|Induction Period (16 Weeks)|Lost to Follow-up|0
5787946|NCT03482011|19936398|P7|Induction Period (16 Weeks)|Lost to Follow-up|0
5787947|NCT03482011|19936399|P6|Induction Period (16 Weeks)|Lost to Follow-up|0
5787948|NCT03482011|19936400|P5|Induction Period (16 Weeks)|Lost to Follow-up|0
5787949|NCT03482011|19936401|P4|Induction Period (16 Weeks)|Lost to Follow-up|0
5787950|NCT03482011|19936402|P3|Induction Period (16 Weeks)|Lost to Follow-up|0
5787951|NCT03482011|19936403|P2|Induction Period (16 Weeks)|Lost to Follow-up|1
5787952|NCT03482011|19936404|P1|Induction Period (16 Weeks)|Lost to Follow-up|0
5787953|NCT03482011|19936397|P8|Induction Period (16 Weeks)|Lack of Efficacy|0
5787954|NCT03482011|19936398|P7|Induction Period (16 Weeks)|Lack of Efficacy|0
5787955|NCT03482011|19936399|P6|Induction Period (16 Weeks)|Lack of Efficacy|0
5787956|NCT03482011|19936400|P5|Induction Period (16 Weeks)|Lack of Efficacy|0
5787957|NCT03482011|19936401|P4|Induction Period (16 Weeks)|Lack of Efficacy|0
5787958|NCT03482011|19936402|P3|Induction Period (16 Weeks)|Lack of Efficacy|0
5787959|NCT03482011|19936403|P2|Induction Period (16 Weeks)|Lack of Efficacy|1
5787960|NCT03482011|19936404|P1|Induction Period (16 Weeks)|Lack of Efficacy|3
5787961|NCT03482011|19936397|P8|Induction Period (16 Weeks)|Adverse Event|0
5787962|NCT03482011|19936398|P7|Induction Period (16 Weeks)|Adverse Event|0
5787963|NCT03482011|19936399|P6|Induction Period (16 Weeks)|Adverse Event|0
5787964|NCT03482011|19936400|P5|Induction Period (16 Weeks)|Adverse Event|0
5787965|NCT03482011|19936401|P4|Induction Period (16 Weeks)|Adverse Event|0
5787966|NCT03482011|19936402|P3|Induction Period (16 Weeks)|Adverse Event|0
5787967|NCT03482011|19936403|P2|Induction Period (16 Weeks)|Adverse Event|3
5787968|NCT03482011|19936404|P1|Induction Period (16 Weeks)|Adverse Event|1
5787969|NCT03481816|19936463|P2|Dose Expansion|Physician Decision|5
5787970|NCT03481816|19936464|P1|Dose Expansion|Physician Decision|0
5787971|NCT03481816|19936463|P2|Dose Expansion|Withdrawal by Subject|2
5787972|NCT03481816|19936464|P1|Dose Expansion|Withdrawal by Subject|0
5787973|NCT03481816|19936463|P2|Dose Expansion|Off treatment due to progressive disease|5
5787974|NCT03481816|19936464|P1|Dose Expansion|Off treatment due to progressive disease|0
5787975|NCT03481816|19936463|P2|Starting Dose|Refused further vaccines after 1 dose|0
5787976|NCT03481816|19936464|P1|Starting Dose|Refused further vaccines after 1 dose|1
5787977|NCT03481309|19936491|P6|Washout (at Least 3 Days)|Withdrawal by Subject|0
5787978|NCT03481309|19936492|P5|Washout (at Least 3 Days)|Withdrawal by Subject|0
5787979|NCT03481309|19936493|P4|Washout (at Least 3 Days)|Withdrawal by Subject|0
5787980|NCT03481309|19936494|P3|Washout (at Least 3 Days)|Withdrawal by Subject|0
5787981|NCT03481309|19936495|P2|Washout (at Least 3 Days)|Withdrawal by Subject|0
5787982|NCT03481309|19936496|P1|Washout (at Least 3 Days)|Withdrawal by Subject|1
5787983|NCT03480841|19936538|P1|Overall Study|Lost to Follow-up|2
5787984|NCT03480802|19936549|P2|Overall Study|Relocated|1
5787985|NCT03480802|19936550|P1|Overall Study|Relocated|0
5787986|NCT03480802|19936549|P2|Overall Study|Withdrawal by Subject|1
5787987|NCT03480802|19936550|P1|Overall Study|Withdrawal by Subject|2
5787988|NCT03480802|19936549|P2|Overall Study|Lost to Follow-up|1
5787989|NCT03480802|19936550|P1|Overall Study|Lost to Follow-up|5
5787990|NCT03480763|19936578|P2|Overall Study|pain with vaccination|0
5787991|NCT03480763|19936579|P1|Overall Study|pain with vaccination|1
5787992|NCT03480763|19936578|P2|Overall Study|oncological treatment|2
5787993|NCT03480763|19936579|P1|Overall Study|oncological treatment|0
5787994|NCT03480763|19936578|P2|Overall Study|non-study pneumococcal vaccine|0
5787995|NCT03480763|19936579|P1|Overall Study|non-study pneumococcal vaccine|1
5787996|NCT03480763|19936578|P2|Overall Study|Lost to Follow-up|7
5787997|NCT03480763|19936579|P1|Overall Study|Lost to Follow-up|4
5787998|NCT03480763|19936578|P2|Overall Study|Withdrawal by Subject|10
5787999|NCT03480763|19936579|P1|Overall Study|Withdrawal by Subject|18
5788000|NCT03480750|19936647|P6|Overall Study|The interruption in Trientine shippment|1
5788001|NCT03480750|19936648|P5|Overall Study|The interruption in Trientine shippment|0
5788002|NCT03480750|19936649|P4|Overall Study|The interruption in Trientine shippment|0
5788003|NCT03480750|19936650|P3|Overall Study|The interruption in Trientine shippment|0
5788004|NCT03480750|19936651|P2|Overall Study|The interruption in Trientine shippment|0
5788005|NCT03480750|19936652|P1|Overall Study|The interruption in Trientine shippment|0
5788006|NCT03480750|19936647|P6|Overall Study|Withdrawal by Subject|0
5788007|NCT03480750|19936648|P5|Overall Study|Withdrawal by Subject|0
5788008|NCT03480750|19936649|P4|Overall Study|Withdrawal by Subject|0
5788009|NCT03480750|19936650|P3|Overall Study|Withdrawal by Subject|0
5788010|NCT03480750|19936651|P2|Overall Study|Withdrawal by Subject|1
5788011|NCT03480750|19936652|P1|Overall Study|Withdrawal by Subject|0
5788012|NCT03480425|19936676|P1|Overall Study|Force transducer technical failure|1
5788013|NCT03480152|19936682|P3|Phase I|Signed consent. Died before treatment.|0
5788014|NCT03480152|19936683|P2|Phase I|Signed consent. Died before treatment.|0
5788015|NCT03480152|19936684|P1|Phase I|Signed consent. Died before treatment.|1
5788016|NCT03480009|19936714|P4|Overall Study|Lost to Follow-up|0
5788017|NCT03480009|19936715|P3|Overall Study|Lost to Follow-up|4
5788018|NCT03480009|19936716|P2|Overall Study|Lost to Follow-up|5
5788019|NCT03480009|19936717|P1|Overall Study|Lost to Follow-up|4
5788020|NCT03479216|19936752|P2|Overall Study|Physician Decision|3
5788021|NCT03479216|19936753|P1|Overall Study|Physician Decision|2
5788022|NCT03479216|19936752|P2|Overall Study|Withdrawal by Subject|2
5788023|NCT03479216|19936753|P1|Overall Study|Withdrawal by Subject|3
5788030|NCT03478891|19936803|P3|Overall Study|Lost to Follow-up|1
5788031|NCT03478891|19936804|P2|Overall Study|Lost to Follow-up|0
5788032|NCT03478891|19936805|P1|Overall Study|Lost to Follow-up|1
5788033|NCT03478891|19936803|P3|Overall Study|Moved from area|1
5788034|NCT03478891|19936804|P2|Overall Study|Moved from area|0
5788035|NCT03478891|19936805|P1|Overall Study|Moved from area|0
5788036|NCT03478891|19936803|P3|Overall Study|Enrolled, but product never administered|1
5788037|NCT03478891|19936804|P2|Overall Study|Enrolled, but product never administered|0
5788038|NCT03478891|19936805|P1|Overall Study|Enrolled, but product never administered|0
5788039|NCT03478696|19936856|P2|Overall Study|Withdrawal by Subject|4
5788040|NCT03478696|19936857|P1|Overall Study|Withdrawal by Subject|9
5788041|NCT03478696|19936856|P2|Overall Study|Physician Decision|3
5788042|NCT03478696|19936857|P1|Overall Study|Physician Decision|6
5788043|NCT03478696|19936856|P2|Overall Study|Lost to Follow-up|0
5788044|NCT03478696|19936857|P1|Overall Study|Lost to Follow-up|1
5788045|NCT03478696|19936856|P2|Overall Study|Adverse Event|5
5788046|NCT03478696|19936857|P1|Overall Study|Adverse Event|1
5788047|NCT03478683|19936871|P2|Overall Study|Withdrawal by Subject|7
5788048|NCT03478683|19936872|P1|Overall Study|Withdrawal by Subject|7
5788049|NCT03478683|19936871|P2|Overall Study|Physician Decision|3
5788050|NCT03478683|19936872|P1|Overall Study|Physician Decision|1
5788051|NCT03478683|19936871|P2|Overall Study|Lost to Follow-up|5
5788052|NCT03478683|19936872|P1|Overall Study|Lost to Follow-up|0
5788053|NCT03478683|19936871|P2|Overall Study|Adverse Event|3
5788054|NCT03478683|19936872|P1|Overall Study|Adverse Event|5
5788055|NCT03478657|19936886|P2|Overall Study|Withdrawal by Subject|1
5788056|NCT03478657|19936887|P1|Overall Study|Withdrawal by Subject|0
5788057|NCT03478644|19936902|P2|Phase 2|Lost to Follow-up|0
5788058|NCT03478644|19936903|P1|Phase 2|Lost to Follow-up|1
5788059|NCT03478644|19936902|P2|Phase 2|Withdrawal by Subject|1
5788060|NCT03478644|19936903|P1|Phase 2|Withdrawal by Subject|2
5788061|NCT03478371|19936915|P1|Overall Study|Lost to Follow-up|4
5788062|NCT03478371|19936915|P1|Overall Study|non-compliance|1
5788063|NCT03477903|19936943|P1|Overall Study|Study Terminated by Sponsor|1
5788064|NCT03476239|19937019|P1|Overall Study|Did not receive study drug|1
5788065|NCT03476239|19937019|P1|Overall Study|Data Not Available|15
5788066|NCT03476239|19937019|P1|Overall Study|Lost to Follow-up|2
5788067|NCT03476239|19937019|P1|Overall Study|Death|39
5788068|NCT03476239|19937019|P1|Overall Study|Withdrawal by Subject|6
5788069|NCT03476239|19937019|P1|Overall Study|Continuing study|43
5788070|NCT03475875|19937069|P2|Period 2|Protocol Violation|1
5788071|NCT03475875|19937070|P1|Period 2|Protocol Violation|0
5788072|NCT03475875|19937069|P2|Period 2|Adverse Event|0
5788073|NCT03475875|19937070|P1|Period 2|Adverse Event|3
5788074|NCT03475875|19937069|P2|Period 1|Adverse Event|1
5788075|NCT03475875|19937070|P1|Period 1|Adverse Event|2
5788076|NCT03475875|19937069|P2|Period 1|Lost to Follow-up|0
5788077|NCT03475875|19937070|P1|Period 1|Lost to Follow-up|1
5788082|NCT03474081|19937145|P2|Overall Study|Investigator site closed|0
5788083|NCT03474081|19937146|P1|Overall Study|Investigator site closed|1
5788084|NCT03474081|19937145|P2|Overall Study|Withdrawal by Subject|7
5788085|NCT03474081|19937146|P1|Overall Study|Withdrawal by Subject|5
5788086|NCT03474081|19937145|P2|Overall Study|Physician Decision|2
5788087|NCT03474081|19937146|P1|Overall Study|Physician Decision|3
5788088|NCT03474081|19937145|P2|Overall Study|Lost to Follow-up|1
5788089|NCT03474081|19937146|P1|Overall Study|Lost to Follow-up|2
5788090|NCT03474081|19937145|P2|Overall Study|Adverse Event|3
5788091|NCT03474081|19937146|P1|Overall Study|Adverse Event|6
5788092|NCT03473808|19937187|P1|Overall Study|Withdrawal by Subject|1
5788093|NCT03473236|19937219|P10|Overall Study|Withdrawal by Subject|0
5788094|NCT03473236|19937220|P9|Overall Study|Withdrawal by Subject|1
5788095|NCT03473236|19937221|P8|Overall Study|Withdrawal by Subject|0
5788096|NCT03473236|19937222|P7|Overall Study|Withdrawal by Subject|0
5788097|NCT03473236|19937223|P6|Overall Study|Withdrawal by Subject|1
5788098|NCT03473236|19937224|P5|Overall Study|Withdrawal by Subject|0
5788099|NCT03473236|19937225|P4|Overall Study|Withdrawal by Subject|0
5788100|NCT03473236|19937226|P3|Overall Study|Withdrawal by Subject|0
5788101|NCT03473236|19937227|P2|Overall Study|Withdrawal by Subject|0
5788102|NCT03473236|19937228|P1|Overall Study|Withdrawal by Subject|0
5788103|NCT03473197|19937395|P1|Overall Study|Withdrawal by Subject|5
5788104|NCT03473197|19937395|P1|Overall Study|Lost to Follow-up|1
5788105|NCT03473197|19937395|P1|Overall Study|Adverse Event|4
5788106|NCT03472547|19937407|P1|Overall Study|Withdrawal by Subject|30
5788107|NCT03472534|19937411|P1|Overall Study|Adverse Event|2
5788108|NCT03472534|19937411|P1|Overall Study|Withdrawal by Subject|9
5788109|NCT03472326|19937417|P4|Part 2: Combination Therapy|Pregnancy|1
5788110|NCT03472326|19937418|P3|Part 2: Combination Therapy|Pregnancy|0
5788111|NCT03472326|19937419|P2|Part 2: Combination Therapy|Pregnancy|0
5788112|NCT03472326|19937420|P1|Part 2: Combination Therapy|Pregnancy|0
5788113|NCT03472326|19937417|P4|Part 2: Combination Therapy|Study Terminated by Sponsor|2
5788114|NCT03472326|19937418|P3|Part 2: Combination Therapy|Study Terminated by Sponsor|1
5788115|NCT03472326|19937419|P2|Part 2: Combination Therapy|Study Terminated by Sponsor|0
5788116|NCT03472326|19937420|P1|Part 2: Combination Therapy|Study Terminated by Sponsor|0
5788117|NCT03472014|19937449|P1|Overall Study|Lost to Follow-up|4
5788118|NCT03471871|19937471|P5|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0
5788119|NCT03471871|19937472|P4|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|1
5788120|NCT03471871|19937473|P3|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0
5788121|NCT03471871|19937474|P2|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0
5788122|NCT03471871|19937475|P1|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0
5788123|NCT03471871|19937471|P5|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|1
5788124|NCT03471871|19937472|P4|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0
5788125|NCT03471871|19937473|P3|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0
5788126|NCT03471871|19937474|P2|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0
5788127|NCT03471871|19937475|P1|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0
5788128|NCT03471871|19937471|P5|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|1
5788129|NCT03471871|19937472|P4|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0
5788130|NCT03471871|19937473|P3|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0
5788131|NCT03471871|19937474|P2|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0
5788132|NCT03471871|19937475|P1|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0
5788133|NCT03471871|19937471|P5|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1
5788134|NCT03471871|19937472|P4|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1
5788135|NCT03471871|19937473|P3|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0
5788136|NCT03471871|19937474|P2|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0
5788137|NCT03471871|19937475|P1|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0
5788138|NCT03471871|19937471|P5|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0
5788139|NCT03471871|19937472|P4|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0
5788140|NCT03471871|19937473|P3|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|1
5788141|NCT03471871|19937474|P2|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0
5788142|NCT03471871|19937475|P1|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0
5788143|NCT03469349|19937595|P2|Overall Study|Adverse Event|4
5788144|NCT03469349|19937596|P1|Overall Study|Adverse Event|2
5788145|NCT03469349|19937595|P2|Overall Study|Lost to Follow-up|2
5788146|NCT03469349|19937596|P1|Overall Study|Lost to Follow-up|2
5788147|NCT03469349|19937595|P2|Overall Study|Progressive Disease|1
5788148|NCT03469349|19937596|P1|Overall Study|Progressive Disease|0
5788149|NCT03469349|19937595|P2|Overall Study|Withdrawal by Subject|3
5788150|NCT03469349|19937596|P1|Overall Study|Withdrawal by Subject|1
5788151|NCT03469336|19937612|P1|Overall Study|Adverse Event|1
5788152|NCT03469258|19937635|P1|Overall Study|Upon surgery, did not meet criteria|4
5788153|NCT03468855|19937664|P1|Overall Study|Inclusion/Exclusion Enrollment Violator|1
5788154|NCT03468855|19937664|P1|Overall Study|Withdrawal by Subject|3
5788155|NCT03468855|19937664|P1|Overall Study|Lost to Follow-up|5
5788156|NCT03468855|19937664|P1|Overall Study|Adverse Event|2
5788157|NCT03468543|19937718|P1|Overall Study|Protocol stopping rules met|3
5788158|NCT03467971|19937737|P2|Treatment Period 2|Withdrawal by Subject|1
5788159|NCT03467971|19937738|P1|Treatment Period 2|Withdrawal by Subject|0
5788160|NCT03467945|19937762|P4|Treatment Period 3|Withdrawal by Subject|1
5788161|NCT03467945|19937763|P3|Treatment Period 3|Withdrawal by Subject|2
5788162|NCT03467945|19937764|P2|Treatment Period 3|Withdrawal by Subject|0
5788163|NCT03467945|19937765|P1|Treatment Period 3|Withdrawal by Subject|1
5788164|NCT03467945|19937762|P4|Treatment Period 2|Withdrawal by Subject|0
5788165|NCT03467945|19937763|P3|Treatment Period 2|Withdrawal by Subject|0
5788166|NCT03467945|19937764|P2|Treatment Period 2|Withdrawal by Subject|1
5788167|NCT03467945|19937765|P1|Treatment Period 2|Withdrawal by Subject|0
5788168|NCT03467763|19937817|P1|Overall Study|Protocol Violation|2
5788169|NCT03467763|19937817|P1|Overall Study|Lost to Follow-up|1
5788170|NCT03467425|19937847|P2|Overall Study|Withdrawal by Subject|17
5788171|NCT03467425|19937848|P1|Overall Study|Withdrawal by Subject|15
5788172|NCT03467425|19937847|P2|Overall Study|Physician Decision|1
5788173|NCT03467425|19937848|P1|Overall Study|Physician Decision|2
5788174|NCT03467425|19937847|P2|Overall Study|Lost to Follow-up|25
5788175|NCT03467425|19937848|P1|Overall Study|Lost to Follow-up|18
5788176|NCT03467425|19937847|P2|Overall Study|Protocol Violation|1
5788177|NCT03467425|19937848|P1|Overall Study|Protocol Violation|0
5788178|NCT03467425|19937847|P2|Overall Study|Lack of Efficacy|1
5788179|NCT03467425|19937848|P1|Overall Study|Lack of Efficacy|3
5788180|NCT03467425|19937847|P2|Overall Study|Adverse Event|9
5788181|NCT03467425|19937848|P1|Overall Study|Adverse Event|9
5788182|NCT03466658|19937915|P1|Overall Study|Withdrawal by Subject|3
5788183|NCT03466086|19937921|P2|Period 1|Withdrawal by Subject|0
5788184|NCT03466086|19937922|P1|Period 1|Withdrawal by Subject|1
5788185|NCT03466086|19937921|P2|Period 1|Sponsor decision due to study timeline|0
5788186|NCT03466086|19937922|P1|Period 1|Sponsor decision due to study timeline|1
5788187|NCT03466073|19937936|P6|Overall Study|Death|1
5788188|NCT03466073|19937937|P5|Overall Study|Death|0
5788189|NCT03466073|19937938|P4|Overall Study|Death|0
5788190|NCT03466073|19937939|P3|Overall Study|Death|0
5788191|NCT03466073|19937940|P2|Overall Study|Death|0
5788192|NCT03466073|19937941|P1|Overall Study|Death|1
5788193|NCT03466060|19937974|P6|Period 2|Lens Handling Difficulties|0
5788194|NCT03466060|19937975|P5|Period 2|Lens Handling Difficulties|0
5788195|NCT03466060|19937976|P4|Period 2|Lens Handling Difficulties|0
5788196|NCT03466060|19937977|P3|Period 2|Lens Handling Difficulties|1
5788197|NCT03466060|19937978|P2|Period 2|Lens Handling Difficulties|0
5788198|NCT03466060|19937979|P1|Period 2|Lens Handling Difficulties|0
5788199|NCT03466060|19937974|P6|Period 1|Grade 2 Conjunctivitis|0
5788200|NCT03466060|19937975|P5|Period 1|Grade 2 Conjunctivitis|0
5788201|NCT03466060|19937976|P4|Period 1|Grade 2 Conjunctivitis|0
5788202|NCT03466060|19937977|P3|Period 1|Grade 2 Conjunctivitis|1
5788203|NCT03466060|19937978|P2|Period 1|Grade 2 Conjunctivitis|0
5788204|NCT03466060|19937979|P1|Period 1|Grade 2 Conjunctivitis|0
5788205|NCT03466060|19937974|P6|Period 1|Lost to Follow-up|0
5788206|NCT03466060|19937975|P5|Period 1|Lost to Follow-up|0
5788207|NCT03466060|19937976|P4|Period 1|Lost to Follow-up|1
5788208|NCT03466060|19937977|P3|Period 1|Lost to Follow-up|0
5788209|NCT03466060|19937978|P2|Period 1|Lost to Follow-up|0
5788210|NCT03466060|19937979|P1|Period 1|Lost to Follow-up|0
5788211|NCT03466060|19937974|P6|Period 1|Withdrawal by Subject|0
5788212|NCT03466060|19937975|P5|Period 1|Withdrawal by Subject|0
5788213|NCT03466060|19937976|P4|Period 1|Withdrawal by Subject|0
5788214|NCT03466060|19937977|P3|Period 1|Withdrawal by Subject|2
5788215|NCT03466060|19937978|P2|Period 1|Withdrawal by Subject|0
5788216|NCT03466060|19937979|P1|Period 1|Withdrawal by Subject|0
5788217|NCT03466060|19937974|P6|Period 1|Test Lens Damage|0
5788218|NCT03466060|19937975|P5|Period 1|Test Lens Damage|0
5788219|NCT03466060|19937976|P4|Period 1|Test Lens Damage|0
5788220|NCT03466060|19937977|P3|Period 1|Test Lens Damage|0
5788221|NCT03466060|19937978|P2|Period 1|Test Lens Damage|2
5788222|NCT03466060|19937979|P1|Period 1|Test Lens Damage|0
5788223|NCT03465904|19938021|P2|Overall Study|Ineligible for mITT analysis|47
5788224|NCT03465904|19938022|P1|Overall Study|Ineligible for mITT analysis|62
5788225|NCT03465904|19938021|P2|Overall Study|Protocol Violation|5
5788226|NCT03465904|19938022|P1|Overall Study|Protocol Violation|8
5788227|NCT03465904|19938021|P2|Overall Study|Lost to Follow-up|9
5788228|NCT03465904|19938022|P1|Overall Study|Lost to Follow-up|10
5788229|NCT03465904|19938021|P2|Overall Study|Withdrawal by Subject|5
5788230|NCT03465904|19938022|P1|Overall Study|Withdrawal by Subject|9
5788231|NCT03465891|19938042|P2|Overall Study|Disease progression|0
5788232|NCT03465891|19938043|P1|Overall Study|Disease progression|1
5788233|NCT03465891|19938042|P2|Overall Study|Withdrawal by Subject|1
5788234|NCT03465891|19938043|P1|Overall Study|Withdrawal by Subject|0
5788235|NCT03465878|19938051|P4|Period 1-Part B First Intervention Day 1|Physician Decision|1
5788236|NCT03465878|19938052|P3|Period 1-Part B First Intervention Day 1|Physician Decision|0
5788237|NCT03465878|19938053|P2|Period 1-Part B First Intervention Day 1|Physician Decision|0
5788238|NCT03465878|19938054|P1|Period 1-Part B First Intervention Day 1|Physician Decision|0
5788239|NCT03465878|19938051|P4|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|1
5788240|NCT03465878|19938052|P3|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0
5788241|NCT03465878|19938053|P2|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0
5788242|NCT03465878|19938054|P1|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0
5788243|NCT03465878|19938051|P4|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0
5788244|NCT03465878|19938052|P3|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0
5788245|NCT03465878|19938053|P2|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|1
5788246|NCT03465878|19938054|P1|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0
5788247|NCT03465709|19938101|P1|Overall Study|Withdrawal by Subject|3
5788248|NCT03465709|19938101|P1|Overall Study|Study/Site Terminated by Sponsor|14
5788249|NCT03465436|19938113|P4|Period 4|Protocol Violation|0
5788250|NCT03465436|19938114|P3|Period 4|Protocol Violation|1
5788251|NCT03465436|19938115|P2|Period 4|Protocol Violation|0
5788252|NCT03465436|19938116|P1|Period 4|Protocol Violation|0
5788253|NCT03465436|19938113|P4|Period 3|Protocol Violation|0
5788254|NCT03465436|19938114|P3|Period 3|Protocol Violation|0
5788255|NCT03465436|19938115|P2|Period 3|Protocol Violation|1
5788256|NCT03465436|19938116|P1|Period 3|Protocol Violation|1
5788257|NCT03465436|19938113|P4|Period 2|Protocol Violation|0
5788258|NCT03465436|19938114|P3|Period 2|Protocol Violation|0
5788259|NCT03465436|19938115|P2|Period 2|Protocol Violation|1
5788260|NCT03465436|19938116|P1|Period 2|Protocol Violation|0
5788261|NCT03465436|19938113|P4|Period 1|Protocol Violation|0
5788262|NCT03465436|19938114|P3|Period 1|Protocol Violation|1
5788263|NCT03465436|19938115|P2|Period 1|Protocol Violation|0
5788264|NCT03465436|19938116|P1|Period 1|Protocol Violation|0
5788265|NCT03464383|19938153|P3|Overall Study|Withdrawal by Subject|0
5788266|NCT03464383|19938154|P2|Overall Study|Withdrawal by Subject|1
5788267|NCT03464383|19938155|P1|Overall Study|Withdrawal by Subject|0
5788268|NCT03464383|19938153|P3|Overall Study|Lost to Follow-up|0
5788269|NCT03464383|19938154|P2|Overall Study|Lost to Follow-up|0
5788270|NCT03464383|19938155|P1|Overall Study|Lost to Follow-up|1
5788271|NCT03463031|19938212|P2|Overall Study|Use of prohibited medication by subject|0
5788272|NCT03463031|19938213|P1|Overall Study|Use of prohibited medication by subject|1
5788273|NCT03463031|19938212|P2|Overall Study|Adverse Event|1
5788274|NCT03463031|19938213|P1|Overall Study|Adverse Event|4
5788275|NCT03463031|19938212|P2|Overall Study|Lost to Follow-up|1
5788276|NCT03463031|19938213|P1|Overall Study|Lost to Follow-up|1
5788277|NCT03463031|19938212|P2|Overall Study|Investigator/Sponsor Decision|1
5788278|NCT03463031|19938213|P1|Overall Study|Investigator/Sponsor Decision|0
5788279|NCT03463031|19938212|P2|Overall Study|Withdrawal by Subject|2
5788280|NCT03463031|19938213|P1|Overall Study|Withdrawal by Subject|4
5788281|NCT03462082|19938261|P8|Open Label Phase|Symptom worsening (Treatment failure)|2
5788282|NCT03462082|19938262|P7|Open Label Phase|Symptom worsening (Treatment failure)|1
5788283|NCT03462082|19938263|P6|Open Label Phase|Symptom worsening (Treatment failure)|0
5788284|NCT03462082|19938264|P5|Open Label Phase|Symptom worsening (Treatment failure)|0
5788285|NCT03462082|19938265|P4|Open Label Phase|Symptom worsening (Treatment failure)|0
5788286|NCT03462082|19938266|P3|Open Label Phase|Symptom worsening (Treatment failure)|0
5788287|NCT03462082|19938267|P2|Open Label Phase|Symptom worsening (Treatment failure)|0
5788288|NCT03462082|19938268|P1|Open Label Phase|Symptom worsening (Treatment failure)|0
5788289|NCT03461757|19938319|P2|Overall Study|Other Reasons|4
5788290|NCT03461757|19938320|P1|Overall Study|Other Reasons|1
5788291|NCT03461757|19938319|P2|Overall Study|Withdrawal by Subject|7
5788292|NCT03461757|19938320|P1|Overall Study|Withdrawal by Subject|7
5788293|NCT03461757|19938319|P2|Overall Study|Protocol Violation|1
5788294|NCT03461757|19938320|P1|Overall Study|Protocol Violation|1
5788295|NCT03461757|19938319|P2|Overall Study|Pregnancy|0
5788296|NCT03461757|19938320|P1|Overall Study|Pregnancy|2
5788297|NCT03461757|19938319|P2|Overall Study|Non-compliance with study treatment|1
5788298|NCT03461757|19938320|P1|Overall Study|Non-compliance with study treatment|0
5788299|NCT03461757|19938319|P2|Overall Study|Not Experienced Moderate/Severe Migraine|25
5788300|NCT03461757|19938320|P1|Overall Study|Not Experienced Moderate/Severe Migraine|28
5788301|NCT03461757|19938319|P2|Overall Study|Lost to Follow-up|7
5788302|NCT03461757|19938320|P1|Overall Study|Lost to Follow-up|13
5788303|NCT03461757|19938319|P2|Overall Study|Adverse Event|0
5788304|NCT03461757|19938320|P1|Overall Study|Adverse Event|1
5788305|NCT03459196|19938494|P1|Overall Study|Subject didn't receive study catheter|2
5788306|NCT03458702|19938538|P2|Study Condition B (Yoga or Rest)|Lost to Follow-up|2
5788307|NCT03458702|19938539|P1|Study Condition B (Yoga or Rest)|Lost to Follow-up|4
5788308|NCT03458702|19938538|P2|Study Condition A (Yoga or Rest)|Lost to Follow-up|6
5788309|NCT03458702|19938539|P1|Study Condition A (Yoga or Rest)|Lost to Follow-up|4
5788310|NCT03457727|19938568|P4|Part 2, Washout Period 1 (5 Days)|Adverse Event|1
5788311|NCT03457727|19938569|P3|Part 2, Washout Period 1 (5 Days)|Adverse Event|0
5788312|NCT03457727|19938570|P2|Part 2, Washout Period 1 (5 Days)|Adverse Event|0
5788313|NCT03457727|19938571|P1|Part 2, Washout Period 1 (5 Days)|Adverse Event|0
5788314|NCT03457636|19938768|P1|Overall Study|Lost to Follow-up|2
5788315|NCT03456960|19938781|P6|Period 2 (1 Day)|Adverse Event|0
5788316|NCT03456960|19938782|P5|Period 2 (1 Day)|Adverse Event|0
5788317|NCT03456960|19938783|P4|Period 2 (1 Day)|Adverse Event|1
5788318|NCT03456960|19938784|P3|Period 2 (1 Day)|Adverse Event|0
5788319|NCT03456960|19938785|P2|Period 2 (1 Day)|Adverse Event|0
5788320|NCT03456960|19938786|P1|Period 2 (1 Day)|Adverse Event|1
5788321|NCT03456960|19938781|P6|Washout Period (at Least 14 Days)|Withdrawal by Subject|0
5788322|NCT03456960|19938782|P5|Washout Period (at Least 14 Days)|Withdrawal by Subject|0
5788323|NCT03456960|19938783|P4|Washout Period (at Least 14 Days)|Withdrawal by Subject|2
5788324|NCT03456960|19938784|P3|Washout Period (at Least 14 Days)|Withdrawal by Subject|1
5788325|NCT03456960|19938785|P2|Washout Period (at Least 14 Days)|Withdrawal by Subject|0
5788326|NCT03456960|19938786|P1|Washout Period (at Least 14 Days)|Withdrawal by Subject|0
5788327|NCT03456856|19938878|P1|Overall Study|Withdrawal by Subject|1
5788328|NCT03456856|19938878|P1|Overall Study|Lost to Follow-up|2
5788329|NCT03456700|19938882|P1|Overall Study|Withdrawal by Subject|1
5788330|NCT03455543|19938914|P3|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|1
5788331|NCT03455543|19938915|P2|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|0
5788332|NCT03455543|19938916|P1|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|0
5788333|NCT03455543|19938914|P3|Part B: Open-label Extension (24 Weeks)|Out of window for visits|2
5788334|NCT03455543|19938915|P2|Part B: Open-label Extension (24 Weeks)|Out of window for visits|0
5788335|NCT03455543|19938916|P1|Part B: Open-label Extension (24 Weeks)|Out of window for visits|0
5788336|NCT03455543|19938914|P3|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|4
5788337|NCT03455543|19938915|P2|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|0
5788338|NCT03455543|19938916|P1|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|0
5788339|NCT03455543|19938914|P3|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|7
5788340|NCT03455543|19938915|P2|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|0
5788341|NCT03455543|19938916|P1|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|0
5788342|NCT03455543|19938914|P3|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|20
5788343|NCT03455543|19938915|P2|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|0
5788344|NCT03455543|19938916|P1|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|0
5788345|NCT03455543|19938914|P3|Part B: Open-label Extension (24 Weeks)|Adverse Event|3
5788346|NCT03455543|19938915|P2|Part B: Open-label Extension (24 Weeks)|Adverse Event|0
5788347|NCT03455543|19938916|P1|Part B: Open-label Extension (24 Weeks)|Adverse Event|0
5788348|NCT03455543|19938914|P3|Part A: Randomized Treatment (17 Weeks)|Physician Decision|0
5788349|NCT03455543|19938915|P2|Part A: Randomized Treatment (17 Weeks)|Physician Decision|0
5788350|NCT03455543|19938916|P1|Part A: Randomized Treatment (17 Weeks)|Physician Decision|2
5788351|NCT03455543|19938914|P3|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|0
5788352|NCT03455543|19938915|P2|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|2
5788353|NCT03455543|19938916|P1|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|7
5788354|NCT03455543|19938914|P3|Part A: Randomized Treatment (17 Weeks)|Adverse Event|0
5788355|NCT03455543|19938915|P2|Part A: Randomized Treatment (17 Weeks)|Adverse Event|5
5788356|NCT03455543|19938916|P1|Part A: Randomized Treatment (17 Weeks)|Adverse Event|2
5788357|NCT03453151|19939105|P1|Overall Study|Physician Decision|3
5788358|NCT03453151|19939105|P1|Overall Study|Withdrawal by Subject|1
5788359|NCT03452943|19939342|P2|Maintenance Period (5 Weeks)|Withdrawal by Subject|0
5788360|NCT03452943|19939343|P1|Maintenance Period (5 Weeks)|Withdrawal by Subject|2
5788361|NCT03452943|19939342|P2|Maintenance Period (5 Weeks)|Adverse Event|0
5788362|NCT03452943|19939343|P1|Maintenance Period (5 Weeks)|Adverse Event|1
5788363|NCT03452943|19939342|P2|Titration Period (7 Weeks)|Lost to Follow-up|0
5788364|NCT03452943|19939343|P1|Titration Period (7 Weeks)|Lost to Follow-up|1
5788365|NCT03452943|19939342|P2|Titration Period (7 Weeks)|Withdrawal by Subject|2
5788366|NCT03452943|19939343|P1|Titration Period (7 Weeks)|Withdrawal by Subject|3
5788367|NCT03452943|19939342|P2|Titration Period (7 Weeks)|Protocol Violation|1
5788368|NCT03452943|19939343|P1|Titration Period (7 Weeks)|Protocol Violation|0
5788369|NCT03452943|19939342|P2|Titration Period (7 Weeks)|Adverse Event|1
5788370|NCT03452943|19939343|P1|Titration Period (7 Weeks)|Adverse Event|1
5788371|NCT03451721|19939395|P1|Overall Study|Death|1
5788372|NCT03450070|19939458|P1|Overall Study|Withdrawal by Subject|8
5788373|NCT03449979|19939466|P4|Overall Study|Technical difficulty|1
5788374|NCT03449979|19939467|P3|Overall Study|Technical difficulty|0
5788375|NCT03449979|19939468|P2|Overall Study|Technical difficulty|0
5788376|NCT03449979|19939469|P1|Overall Study|Technical difficulty|0
5788377|NCT03449758|19939479|P1|Overall Study|Other unspecified reason|3
5788378|NCT03449758|19939479|P1|Overall Study|Consent withdrawal|1
5788379|NCT03449758|19939479|P1|Overall Study|Adverse Event|9
5788380|NCT03449758|19939479|P1|Overall Study|Treatment inefficacy|5
5788381|NCT03449758|19939479|P1|Overall Study|Major protocol deviation|1
5788382|NCT03449446|19939519|P7|Overall Study|Death|0
5788383|NCT03449446|19939520|P6|Overall Study|Death|0
5788384|NCT03449446|19939521|P5|Overall Study|Death|1
5788385|NCT03449446|19939522|P4|Overall Study|Death|0
5788386|NCT03449446|19939523|P3|Overall Study|Death|0
5788387|NCT03449446|19939524|P2|Overall Study|Death|0
5788388|NCT03449446|19939525|P1|Overall Study|Death|0
5788389|NCT03449446|19939519|P7|Overall Study|Protocol Violation|0
5788390|NCT03449446|19939520|P6|Overall Study|Protocol Violation|1
5788391|NCT03449446|19939521|P5|Overall Study|Protocol Violation|1
5788392|NCT03449446|19939522|P4|Overall Study|Protocol Violation|0
5788393|NCT03449446|19939523|P3|Overall Study|Protocol Violation|0
5788394|NCT03449446|19939524|P2|Overall Study|Protocol Violation|0
5788395|NCT03449446|19939525|P1|Overall Study|Protocol Violation|0
5788396|NCT03449446|19939519|P7|Overall Study|Non Compliance with Study Drug|0
5788397|NCT03449446|19939520|P6|Overall Study|Non Compliance with Study Drug|0
5788398|NCT03449446|19939521|P5|Overall Study|Non Compliance with Study Drug|0
5788399|NCT03449446|19939522|P4|Overall Study|Non Compliance with Study Drug|0
5788400|NCT03449446|19939523|P3|Overall Study|Non Compliance with Study Drug|0
5788401|NCT03449446|19939524|P2|Overall Study|Non Compliance with Study Drug|0
5788402|NCT03449446|19939525|P1|Overall Study|Non Compliance with Study Drug|1
5788403|NCT03449446|19939519|P7|Overall Study|Investigator's Discretion|0
5788404|NCT03449446|19939520|P6|Overall Study|Investigator's Discretion|0
5788405|NCT03449446|19939521|P5|Overall Study|Investigator's Discretion|0
5788406|NCT03449446|19939522|P4|Overall Study|Investigator's Discretion|2
5788407|NCT03449446|19939523|P3|Overall Study|Investigator's Discretion|1
5788408|NCT03449446|19939524|P2|Overall Study|Investigator's Discretion|1
5788409|NCT03449446|19939525|P1|Overall Study|Investigator's Discretion|0
5788410|NCT03449446|19939519|P7|Overall Study|Lost to Follow-up|0
5788411|NCT03449446|19939520|P6|Overall Study|Lost to Follow-up|0
5788412|NCT03449446|19939521|P5|Overall Study|Lost to Follow-up|3
5788413|NCT03449446|19939522|P4|Overall Study|Lost to Follow-up|1
5788414|NCT03449446|19939523|P3|Overall Study|Lost to Follow-up|2
5788415|NCT03449446|19939524|P2|Overall Study|Lost to Follow-up|0
5788416|NCT03449446|19939525|P1|Overall Study|Lost to Follow-up|0
5788417|NCT03449446|19939519|P7|Overall Study|Adverse Event|0
5788418|NCT03449446|19939520|P6|Overall Study|Adverse Event|2
5788419|NCT03449446|19939521|P5|Overall Study|Adverse Event|0
5788420|NCT03449446|19939522|P4|Overall Study|Adverse Event|0
5788421|NCT03449446|19939523|P3|Overall Study|Adverse Event|1
5788422|NCT03449446|19939524|P2|Overall Study|Adverse Event|2
5788423|NCT03449446|19939525|P1|Overall Study|Adverse Event|1
5788424|NCT03449446|19939519|P7|Overall Study|Withdrew Consent|1
5788425|NCT03449446|19939520|P6|Overall Study|Withdrew Consent|4
5788426|NCT03449446|19939521|P5|Overall Study|Withdrew Consent|4
5788427|NCT03449446|19939522|P4|Overall Study|Withdrew Consent|4
5788428|NCT03449446|19939523|P3|Overall Study|Withdrew Consent|1
5788429|NCT03449446|19939524|P2|Overall Study|Withdrew Consent|3
5788430|NCT03449446|19939525|P1|Overall Study|Withdrew Consent|1
5788431|NCT03449446|19939519|P7|Overall Study|Unknown Reason|0
5788432|NCT03449446|19939520|P6|Overall Study|Unknown Reason|2
5788433|NCT03449446|19939521|P5|Overall Study|Unknown Reason|2
5788434|NCT03449446|19939522|P4|Overall Study|Unknown Reason|1
5788435|NCT03449446|19939523|P3|Overall Study|Unknown Reason|1
5788436|NCT03449446|19939524|P2|Overall Study|Unknown Reason|1
5788437|NCT03449446|19939525|P1|Overall Study|Unknown Reason|33
5788438|NCT03449446|19939519|P7|Overall Study|Randomized but Never Treated|0
5788439|NCT03449446|19939520|P6|Overall Study|Randomized but Never Treated|0
5788440|NCT03449446|19939521|P5|Overall Study|Randomized but Never Treated|1
5788441|NCT03449446|19939522|P4|Overall Study|Randomized but Never Treated|1
5788442|NCT03449446|19939523|P3|Overall Study|Randomized but Never Treated|1
5788443|NCT03449446|19939524|P2|Overall Study|Randomized but Never Treated|0
5788444|NCT03449446|19939525|P1|Overall Study|Randomized but Never Treated|0
5788445|NCT03448536|19939596|P2|Overall Study|Physician Decision|0
5788446|NCT03448536|19939597|P1|Overall Study|Physician Decision|1
5788447|NCT03448536|19939596|P2|Overall Study|Other|0
5788448|NCT03448536|19939597|P1|Overall Study|Other|3
5788449|NCT03448536|19939596|P2|Overall Study|Inadequate pain reporter|0
5788450|NCT03448536|19939597|P1|Overall Study|Inadequate pain reporter|1
5788451|NCT03448536|19939596|P2|Overall Study|Lost to Follow-up|2
5788452|NCT03448536|19939597|P1|Overall Study|Lost to Follow-up|3
5788453|NCT03448536|19939596|P2|Overall Study|Withdrawal by Subject|2
5788454|NCT03448536|19939597|P1|Overall Study|Withdrawal by Subject|1
5788455|NCT03448536|19939596|P2|Overall Study|Pregnancy|0
5788456|NCT03448536|19939597|P1|Overall Study|Pregnancy|1
5788457|NCT03448536|19939596|P2|Overall Study|Protocol Violation|0
5788458|NCT03448536|19939597|P1|Overall Study|Protocol Violation|2
5788459|NCT03448419|19939623|P2|Overall Study|Withdrawn by Sponsor|1
5788460|NCT03448419|19939624|P1|Overall Study|Withdrawn by Sponsor|0
5788461|NCT03448419|19939623|P2|Overall Study|Patient did not attend all visits|2
5788462|NCT03448419|19939624|P1|Overall Study|Patient did not attend all visits|0
5788463|NCT03448419|19939623|P2|Overall Study|Not treated|1
5788464|NCT03448419|19939624|P1|Overall Study|Not treated|0
5788465|NCT03448419|19939623|P2|Overall Study|Withdrawal by Subject|1
5788466|NCT03448419|19939624|P1|Overall Study|Withdrawal by Subject|3
5788467|NCT03448419|19939623|P2|Overall Study|Lost to Follow-up|2
5788468|NCT03448419|19939624|P1|Overall Study|Lost to Follow-up|0
5788469|NCT03448419|19939623|P2|Overall Study|Adverse Event|9
5788470|NCT03448419|19939624|P1|Overall Study|Adverse Event|10
5788471|NCT03448406|19939650|P2|Overall Study|Adverse Event|9
5788472|NCT03448406|19939651|P1|Overall Study|Adverse Event|8
5788473|NCT03448406|19939650|P2|Overall Study|Protocol Violation|0
5788474|NCT03448406|19939651|P1|Overall Study|Protocol Violation|1
5788475|NCT03448406|19939650|P2|Overall Study|Withdrawal by Subject|2
5788476|NCT03448406|19939651|P1|Overall Study|Withdrawal by Subject|1
5788477|NCT03448406|19939650|P2|Overall Study|Noncompliance of scheduled visits|2
5788478|NCT03448406|19939651|P1|Overall Study|Noncompliance of scheduled visits|1
5788479|NCT03448224|19939677|P2|Overall Study|Provided same answer to every question|0
5788480|NCT03448224|19939678|P1|Overall Study|Provided same answer to every question|1
5788481|NCT03447821|19939695|P3|Overall Study|Lost to Follow-up|1
5788482|NCT03447821|19939696|P2|Overall Study|Lost to Follow-up|0
5788483|NCT03447821|19939697|P1|Overall Study|Lost to Follow-up|0
5788484|NCT03447821|19939695|P3|Overall Study|Withdrawal by Subject|0
5788485|NCT03447821|19939696|P2|Overall Study|Withdrawal by Subject|1
5788486|NCT03447821|19939697|P1|Overall Study|Withdrawal by Subject|1
5788487|NCT03447730|19939723|P3|Overall Study|Adverse Event|0
5788488|NCT03447730|19939724|P2|Overall Study|Adverse Event|2
5788489|NCT03447730|19939725|P1|Overall Study|Adverse Event|0
5788490|NCT03447353|19939752|P1|Overall Study|Withdrew - Nausea Study V1, Sim Drive|1
5788491|NCT03447353|19939752|P1|Overall Study|Scheduling Conflicts|3
5788492|NCT03447353|19939752|P1|Overall Study|Lost to Follow-up|4
5788493|NCT03447353|19939752|P1|Overall Study|Failure at Screening Visit|2
5788494|NCT03447249|19939768|P2|Overall Study|Other|0
5788495|NCT03447249|19939769|P1|Overall Study|Other|3
5788496|NCT03447249|19939768|P2|Overall Study|Withdrawal of consent (not due to AE)|0
5788497|NCT03447249|19939769|P1|Overall Study|Withdrawal of consent (not due to AE)|1
5788498|NCT03447249|19939768|P2|Overall Study|Adverse Event|0
5788499|NCT03447249|19939769|P1|Overall Study|Adverse Event|1
5788500|NCT03446781|19939841|P2|Overall Study|Protocol Violation|3
5788501|NCT03446781|19939842|P1|Overall Study|Protocol Violation|0
5788502|NCT03446781|19939841|P2|Overall Study|Adverse Event|2
5788503|NCT03446781|19939842|P1|Overall Study|Adverse Event|8
5788504|NCT03446781|19939841|P2|Overall Study|Withdrawal by Subject|7
5788505|NCT03446781|19939842|P1|Overall Study|Withdrawal by Subject|9
5788506|NCT03446781|19939841|P2|Overall Study|Lost to Follow-up|5
5788507|NCT03446781|19939842|P1|Overall Study|Lost to Follow-up|11
5788508|NCT03446573|19939900|P2|Overall Study|Ongoing at the time of interim analysis|343
5788509|NCT03446573|19939901|P1|Overall Study|Ongoing at the time of interim analysis|342
5788510|NCT03446573|19939900|P2|Overall Study|Adverse Event|2
5788511|NCT03446573|19939901|P1|Overall Study|Adverse Event|13
5788512|NCT03446573|19939900|P2|Overall Study|Lack of Efficacy|3
5788513|NCT03446573|19939901|P1|Overall Study|Lack of Efficacy|0
5788514|NCT03446573|19939900|P2|Overall Study|Protocol Violation|2
5788515|NCT03446573|19939901|P1|Overall Study|Protocol Violation|3
5788516|NCT03446573|19939900|P2|Overall Study|Lost to Follow-up|5
5788517|NCT03446573|19939901|P1|Overall Study|Lost to Follow-up|3
5788518|NCT03446573|19939900|P2|Overall Study|Physician Decision|1
5788519|NCT03446573|19939901|P1|Overall Study|Physician Decision|1
5788520|NCT03446573|19939900|P2|Overall Study|Withdrawal by Subject|16
5788521|NCT03446573|19939901|P1|Overall Study|Withdrawal by Subject|7
5788522|NCT03444766|19940021|P1|Overall Study|Disease Progression|49
5788523|NCT03444766|19940021|P1|Overall Study|Adverse Event Unrelated to Study Drug|6
5788524|NCT03444766|19940021|P1|Overall Study|Death|2
5788525|NCT03444766|19940021|P1|Overall Study|Lost to Follow-up|2
5788526|NCT03444766|19940021|P1|Overall Study|Participant Withdrew Consent|5
5788527|NCT03444766|19940021|P1|Overall Study|Other Reasons|2
5788528|NCT03444584|19940030|P2|Overall Study|Other|1
5788529|NCT03444584|19940031|P1|Overall Study|Other|0
5788530|NCT03444584|19940030|P2|Overall Study|Withdrawal by Subject|1
5788531|NCT03444584|19940031|P1|Overall Study|Withdrawal by Subject|0
5788532|NCT03443713|19940101|P3|First at Home Period (9-14 Days)|Withdrawal by Subject|1
5788533|NCT03443713|19940102|P2|First at Home Period (9-14 Days)|Withdrawal by Subject|0
5788534|NCT03443713|19940103|P1|First at Home Period (9-14 Days)|Withdrawal by Subject|0
5788535|NCT03443427|19940134|P2|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2
5788536|NCT03443427|19940135|P1|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|6
5788537|NCT03443427|19940134|P2|Overall Study|Adverse Event|3
5788538|NCT03443427|19940135|P1|Overall Study|Adverse Event|2
5788539|NCT03443414|19940172|P5|Overall Study|Reason not specified|1
5788540|NCT03443414|19940173|P4|Overall Study|Reason not specified|0
5788541|NCT03443414|19940174|P3|Overall Study|Reason not specified|0
5788542|NCT03443414|19940175|P2|Overall Study|Reason not specified|0
5788543|NCT03443414|19940176|P1|Overall Study|Reason not specified|2
5788544|NCT03443414|19940172|P5|Overall Study|Death|0
5788545|NCT03443414|19940173|P4|Overall Study|Death|1
5788546|NCT03443414|19940174|P3|Overall Study|Death|0
5788547|NCT03443414|19940175|P2|Overall Study|Death|1
5788548|NCT03443414|19940176|P1|Overall Study|Death|0
5788549|NCT03443414|19940172|P5|Overall Study|Withdrawal by Subject|1
5788550|NCT03443414|19940173|P4|Overall Study|Withdrawal by Subject|2
5788551|NCT03443414|19940174|P3|Overall Study|Withdrawal by Subject|2
5788552|NCT03443414|19940175|P2|Overall Study|Withdrawal by Subject|2
5788553|NCT03443414|19940176|P1|Overall Study|Withdrawal by Subject|3
5788554|NCT03443414|19940172|P5|Overall Study|Adverse Event|3
5788555|NCT03443414|19940173|P4|Overall Study|Adverse Event|2
5788556|NCT03443414|19940174|P3|Overall Study|Adverse Event|4
5788557|NCT03443414|19940175|P2|Overall Study|Adverse Event|0
5788558|NCT03443414|19940176|P1|Overall Study|Adverse Event|6
5788559|NCT03442829|19940287|P2|Overall Study|Illness unrelated to study|1
5788560|NCT03442829|19940288|P1|Overall Study|Illness unrelated to study|1
5788561|NCT03442829|19940287|P2|Overall Study|Scheduling clash|1
5788562|NCT03442829|19940288|P1|Overall Study|Scheduling clash|3
5788563|NCT03442595|19940347|P2|Overall Study|Lost to Follow-up|0
5788564|NCT03442595|19940348|P1|Overall Study|Lost to Follow-up|94
5788565|NCT03441984|19940380|P12|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
5788566|NCT03441984|19940381|P11|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
5788567|NCT03441984|19940382|P10|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
5788568|NCT03441984|19940383|P9|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
5788569|NCT03441984|19940384|P8|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
5788570|NCT03441984|19940385|P7|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
5788571|NCT03441984|19940386|P6|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
5788572|NCT03441984|19940387|P5|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
5788573|NCT03441984|19940388|P4|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
5788574|NCT03441984|19940389|P3|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|1
5788575|NCT03441984|19940390|P2|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
5788576|NCT03441984|19940391|P1|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
5788577|NCT03441789|19940752|P2|Overall Study|Lost to Follow-up|1
5788578|NCT03441789|19940753|P1|Overall Study|Lost to Follow-up|0
5788579|NCT03441789|19940752|P2|Overall Study|Protocol Violation|1
5788580|NCT03441789|19940753|P1|Overall Study|Protocol Violation|0
5788581|NCT03441789|19940752|P2|Overall Study|Adverse Event|1
5788582|NCT03441789|19940753|P1|Overall Study|Adverse Event|0
5788583|NCT03441789|19940752|P2|Overall Study|Withdrawal by Subject|1
5788584|NCT03441789|19940753|P1|Overall Study|Withdrawal by Subject|1
5788585|NCT03440918|19940974|P2|Overall Study|Protocol Violation|16
5788586|NCT03440918|19940975|P1|Overall Study|Protocol Violation|0
5788587|NCT03439124|19941073|P2|Overall Study|Other reasons|0
5788588|NCT03439124|19941074|P1|Overall Study|Other reasons|1
5788589|NCT03439124|19941073|P2|Overall Study|Lost to Follow-up|0
5788590|NCT03439124|19941074|P1|Overall Study|Lost to Follow-up|1
5788591|NCT03439124|19941073|P2|Overall Study|Adverse Event|0
5788592|NCT03439124|19941074|P1|Overall Study|Adverse Event|2
5788593|NCT03439072|19941088|P2|Overall Study|Physician Decision|1
5788594|NCT03439072|19941089|P1|Overall Study|Physician Decision|0
5788595|NCT03439072|19941088|P2|Overall Study|Withdrawal by Subject|3
5788596|NCT03439072|19941089|P1|Overall Study|Withdrawal by Subject|2
5788597|NCT03438539|19941140|P6|Overall Study|Lost to Follow-up|8
5788598|NCT03438539|19941141|P5|Overall Study|Lost to Follow-up|3
5788599|NCT03438539|19941142|P4|Overall Study|Lost to Follow-up|9
5788600|NCT03438539|19941143|P3|Overall Study|Lost to Follow-up|10
5788601|NCT03438539|19941144|P2|Overall Study|Lost to Follow-up|4
5788602|NCT03438539|19941145|P1|Overall Study|Lost to Follow-up|8
5788603|NCT03438383|19941173|P2|Overall Study|Protocol Violation|3
5788604|NCT03438383|19941174|P1|Overall Study|Protocol Violation|9
5788605|NCT03437733|19941205|P2|Overall Study|Eligibility criteria not met|3
5788606|NCT03437733|19941206|P1|Overall Study|Eligibility criteria not met|0
5788607|NCT03437447|19941261|P3|Treatment Period 1|Withdrawal by Subject|1
5788608|NCT03437447|19941262|P2|Treatment Period 1|Withdrawal by Subject|0
5788609|NCT03437447|19941263|P1|Treatment Period 1|Withdrawal by Subject|0
5788610|NCT03436732|19941318|P2|Overall Study|Death|1
5788611|NCT03436732|19941319|P1|Overall Study|Death|0
5788612|NCT03436732|19941318|P2|Overall Study|Adverse Event|0
5788613|NCT03436732|19941319|P1|Overall Study|Adverse Event|2
5788614|NCT03436732|19941318|P2|Overall Study|Off study after cycle 1|0
5788615|NCT03436732|19941319|P1|Overall Study|Off study after cycle 1|1
5788616|NCT03436732|19941318|P2|Overall Study|Not treated-enrolled in different study|0
5788617|NCT03436732|19941319|P1|Overall Study|Not treated-enrolled in different study|1
5788618|NCT03436420|19941332|P1|Overall Study|Lack of Efficacy|3
5788619|NCT03435497|19941485|P2|Overall Study|Wrong survey administered|2
5788620|NCT03435497|19941486|P1|Overall Study|Wrong survey administered|0
5788621|NCT03435497|19941485|P2|Overall Study|Withdrawal by Subject|4
5788622|NCT03435497|19941486|P1|Overall Study|Withdrawal by Subject|0
5788623|NCT03435497|19941485|P2|Overall Study|Death|0
5788624|NCT03435497|19941486|P1|Overall Study|Death|1
5788625|NCT03435497|19941485|P2|Overall Study|Lost to Follow-up|0
5788626|NCT03435497|19941486|P1|Overall Study|Lost to Follow-up|1
5788627|NCT03435081|19941514|P3|Overall Study|Withdrawal Due to Caregiver Circumstance|1
5788628|NCT03435081|19941515|P2|Overall Study|Withdrawal Due to Caregiver Circumstance|0
5788629|NCT03435081|19941516|P1|Overall Study|Withdrawal Due to Caregiver Circumstance|0
5788630|NCT03435081|19941514|P3|Overall Study|Inadequate Response|0
5788631|NCT03435081|19941515|P2|Overall Study|Inadequate Response|1
5788632|NCT03435081|19941516|P1|Overall Study|Inadequate Response|0
5788633|NCT03435081|19941514|P3|Overall Study|Non-compliance|2
5788634|NCT03435081|19941515|P2|Overall Study|Non-compliance|0
5788635|NCT03435081|19941516|P1|Overall Study|Non-compliance|1
5788636|NCT03435081|19941514|P3|Overall Study|Pregnancy|0
5788637|NCT03435081|19941515|P2|Overall Study|Pregnancy|0
5788638|NCT03435081|19941516|P1|Overall Study|Pregnancy|1
5788639|NCT03435081|19941514|P3|Overall Study|Lost to Follow-up|4
5788640|NCT03435081|19941515|P2|Overall Study|Lost to Follow-up|1
5788641|NCT03435081|19941516|P1|Overall Study|Lost to Follow-up|3
5788642|NCT03435081|19941514|P3|Overall Study|Withdrawal by Subject|10
5788643|NCT03435081|19941515|P2|Overall Study|Withdrawal by Subject|7
5788644|NCT03435081|19941516|P1|Overall Study|Withdrawal by Subject|8
5788645|NCT03435081|19941514|P3|Overall Study|Adverse Event|2
5788646|NCT03435081|19941515|P2|Overall Study|Adverse Event|2
5788647|NCT03435081|19941516|P1|Overall Study|Adverse Event|2
5788648|NCT03435081|19941514|P3|Overall Study|Lack of Efficacy|0
5788649|NCT03435081|19941515|P2|Overall Study|Lack of Efficacy|5
5788650|NCT03435081|19941516|P1|Overall Study|Lack of Efficacy|6
5788651|NCT03434977|19941593|P2|Washout Period (at Least 6 Days)|Adverse Event|1
5788652|NCT03434977|19941594|P1|Washout Period (at Least 6 Days)|Adverse Event|0
5788653|NCT03434249|19941661|P2|Overall Study|Difficulties in completing daily diary|1
5788654|NCT03434249|19941662|P1|Overall Study|Difficulties in completing daily diary|2
5788655|NCT03434249|19941661|P2|Overall Study|Non-compliance of family|1
5788656|NCT03434249|19941662|P1|Overall Study|Non-compliance of family|2
5788657|NCT03434249|19941661|P2|Overall Study|Lost to Follow-up|1
5788658|NCT03434249|19941662|P1|Overall Study|Lost to Follow-up|0
5788659|NCT03434249|19941661|P2|Overall Study|Adverse Event|0
5788660|NCT03434249|19941662|P1|Overall Study|Adverse Event|1
5788661|NCT03434119|19941696|P2|Overall Study|Other than specified|5
5788662|NCT03434119|19941697|P1|Overall Study|Other than specified|7
5788663|NCT03434119|19941696|P2|Overall Study|Withdrawal by Subject|5
5788664|NCT03434119|19941697|P1|Overall Study|Withdrawal by Subject|7
5788665|NCT03434119|19941696|P2|Overall Study|Study Terminated by Sponsor|102
5788666|NCT03434119|19941697|P1|Overall Study|Study Terminated by Sponsor|91
5788667|NCT03434119|19941696|P2|Overall Study|Poor Compliance to Protocol|1
5788668|NCT03434119|19941697|P1|Overall Study|Poor Compliance to Protocol|0
5788669|NCT03434119|19941696|P2|Overall Study|Adverse Event|0
5788670|NCT03434119|19941697|P1|Overall Study|Adverse Event|1
5788671|NCT03434119|19941696|P2|Overall Study|Randomized but not treated|0
5788672|NCT03434119|19941697|P1|Overall Study|Randomized but not treated|1
5788673|NCT03433703|19941731|P1|Overall Study|Study terminated by Sponsor|2
5788674|NCT03433677|19941740|P2|Period 2|Withdrawal by Subject|1
5788675|NCT03433677|19941741|P1|Period 2|Withdrawal by Subject|1
5788676|NCT03433677|19941740|P2|Period 1|Protocol Violation|0
5788677|NCT03433677|19941741|P1|Period 1|Protocol Violation|1
5788678|NCT03432533|19941761|P2|Overall Study|Withdrawal by Subject|9
5788679|NCT03432533|19941762|P1|Overall Study|Withdrawal by Subject|14
5788680|NCT03432533|19941761|P2|Overall Study|Lost to Follow-up|2
5788681|NCT03432533|19941762|P1|Overall Study|Lost to Follow-up|1
5788682|NCT03432390|19941778|P2|Apnea Period|Protocol Violation|2
5788683|NCT03432390|19941779|P1|Apnea Period|Protocol Violation|2
5788684|NCT03431441|19941789|P1|Overall Study|Dispensed Incorrect Replacement Lens|1
5788685|NCT03431441|19941789|P1|Overall Study|Adverse Event|2
5788686|NCT03431441|19941789|P1|Overall Study|Withdrawal by Subject|2
5788687|NCT03430986|19941824|P2|24-week Post-Control Period|Withdrawal by Participant|1
5788688|NCT03430986|19941825|P1|24-week Post-Control Period|Withdrawal by Participant|0
5788689|NCT03430986|19941824|P2|24-week Post-Control Period|Lost to Follow-up|1
5788690|NCT03430986|19941825|P1|24-week Post-Control Period|Lost to Follow-up|1
5788691|NCT03430986|19941824|P2|24-week Control Period|Protocol Deviation|2
5788692|NCT03430986|19941825|P1|24-week Control Period|Protocol Deviation|0
5788693|NCT03430986|19941824|P2|24-week Control Period|Withdrawal by Participant|0
5788694|NCT03430986|19941825|P1|24-week Control Period|Withdrawal by Participant|5
5788695|NCT03430986|19941824|P2|24-week Control Period|Lost to Follow-up|2
5788696|NCT03430986|19941825|P1|24-week Control Period|Lost to Follow-up|2
5788697|NCT03430986|19941824|P2|24-week Control Period|Adverse Event|0
5788698|NCT03430986|19941825|P1|24-week Control Period|Adverse Event|1
5788699|NCT03430856|19941842|P3|Overall Study|Voluntary withdrawal of consent|1
5788700|NCT03430856|19941843|P2|Overall Study|Voluntary withdrawal of consent|1
5788701|NCT03430856|19941844|P1|Overall Study|Voluntary withdrawal of consent|1
5788702|NCT03430856|19941842|P3|Overall Study|Rescue criteria|0
5788703|NCT03430856|19941843|P2|Overall Study|Rescue criteria|1
5788704|NCT03430856|19941844|P1|Overall Study|Rescue criteria|1
5788705|NCT03430856|19941842|P3|Overall Study|Adverse Event|0
5788706|NCT03430856|19941843|P2|Overall Study|Adverse Event|1
5788707|NCT03430856|19941844|P1|Overall Study|Adverse Event|0
5788708|NCT03430245|19941882|P1|Overall Study|Lost to Follow-up|1
5788709|NCT03430245|19941882|P1|Overall Study|Withdrawal by Subject|6
5788710|NCT03429556|19941929|P4|Overall Study|Lost to Follow-up|0
5788711|NCT03429556|19941930|P3|Overall Study|Lost to Follow-up|0
5788712|NCT03429556|19941931|P2|Overall Study|Lost to Follow-up|1
5788713|NCT03429556|19941932|P1|Overall Study|Lost to Follow-up|0
5788714|NCT03428997|19941983|P1|Overall Study|Lost to Follow-up|4
5788715|NCT03428997|19941983|P1|Overall Study|Withdrawal by Subject|3
5788716|NCT03428997|19941983|P1|Overall Study|Sponsor decision.|1
5788717|NCT03428750|19941991|P2|Overall Study|Administrative|1
5788718|NCT03428750|19941992|P1|Overall Study|Administrative|0
5788719|NCT03428750|19941991|P2|Overall Study|Protocol Violation|0
5788720|NCT03428750|19941992|P1|Overall Study|Protocol Violation|1
5788721|NCT03428750|19941991|P2|Overall Study|Adverse Event|1
5788722|NCT03428750|19941992|P1|Overall Study|Adverse Event|9
5788723|NCT03428750|19941991|P2|Overall Study|Lost to Follow-up|9
5788724|NCT03428750|19941992|P1|Overall Study|Lost to Follow-up|3
5788725|NCT03428750|19941991|P2|Overall Study|Withdrawal by Subject|10
5788726|NCT03428750|19941992|P1|Overall Study|Withdrawal by Subject|11
5788727|NCT03428152|19942041|P2|Overall Study|Lack of Efficacy|4
5788728|NCT03428152|19942042|P1|Overall Study|Lack of Efficacy|0
5788729|NCT03428152|19942041|P2|Overall Study|Protocol Violation|5
5788730|NCT03428152|19942042|P1|Overall Study|Protocol Violation|3
5788731|NCT03428152|19942041|P2|Overall Study|Physician Decision|2
5788732|NCT03428152|19942042|P1|Overall Study|Physician Decision|4
5788733|NCT03428100|19942062|P4|Overall Study|Physician Decision|0
5788734|NCT03428100|19942063|P3|Overall Study|Physician Decision|0
5788735|NCT03428100|19942064|P2|Overall Study|Physician Decision|1
5788736|NCT03428100|19942065|P1|Overall Study|Physician Decision|0
5788737|NCT03428100|19942062|P4|Overall Study|Withdrawal by Subject|0
5788738|NCT03428100|19942063|P3|Overall Study|Withdrawal by Subject|0
5788739|NCT03428100|19942064|P2|Overall Study|Withdrawal by Subject|0
5788740|NCT03428100|19942065|P1|Overall Study|Withdrawal by Subject|4
5788741|NCT03428100|19942062|P4|Overall Study|Protocol Deviation|0
5788742|NCT03428100|19942063|P3|Overall Study|Protocol Deviation|2
5788743|NCT03428100|19942064|P2|Overall Study|Protocol Deviation|2
5788744|NCT03428100|19942065|P1|Overall Study|Protocol Deviation|0
5788745|NCT03428100|19942062|P4|Overall Study|Lack of Efficacy|6
5788746|NCT03428100|19942063|P3|Overall Study|Lack of Efficacy|7
5788747|NCT03428100|19942064|P2|Overall Study|Lack of Efficacy|10
5788748|NCT03428100|19942065|P1|Overall Study|Lack of Efficacy|16
5788749|NCT03428100|19942062|P4|Overall Study|Adverse Event|1
5788750|NCT03428100|19942063|P3|Overall Study|Adverse Event|3
5788751|NCT03428100|19942064|P2|Overall Study|Adverse Event|0
5788752|NCT03428100|19942065|P1|Overall Study|Adverse Event|1
5788753|NCT03427892|19942185|P1|Overall Study|Lost to Follow-up|2
5788754|NCT03427073|19942226|P8|Overall Study|Physician Decision|1
5788755|NCT03427073|19942227|P7|Overall Study|Physician Decision|1
5788756|NCT03427073|19942228|P6|Overall Study|Physician Decision|0
5788757|NCT03427073|19942229|P5|Overall Study|Physician Decision|0
5788758|NCT03427073|19942230|P4|Overall Study|Physician Decision|0
5788759|NCT03427073|19942231|P3|Overall Study|Physician Decision|0
5788760|NCT03427073|19942232|P2|Overall Study|Physician Decision|0
5788761|NCT03427073|19942233|P1|Overall Study|Physician Decision|0
5788762|NCT03427073|19942226|P8|Overall Study|Disease Progression|3
5788763|NCT03427073|19942227|P7|Overall Study|Disease Progression|2
5788764|NCT03427073|19942228|P6|Overall Study|Disease Progression|4
5788765|NCT03427073|19942229|P5|Overall Study|Disease Progression|3
5788766|NCT03427073|19942230|P4|Overall Study|Disease Progression|3
5788767|NCT03427073|19942231|P3|Overall Study|Disease Progression|1
5788768|NCT03427073|19942232|P2|Overall Study|Disease Progression|1
5788769|NCT03427073|19942233|P1|Overall Study|Disease Progression|1
5788770|NCT03426995|19942302|P19|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
5788771|NCT03426995|19942303|P18|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
5788772|NCT03426995|19942304|P17|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
5788773|NCT03426995|19942305|P16|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|3
5788774|NCT03426995|19942306|P15|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|1
5788775|NCT03426995|19942307|P14|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
5788776|NCT03426995|19942308|P13|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
5788777|NCT03426995|19942309|P12|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
5788778|NCT03426995|19942310|P11|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
5788779|NCT03426995|19942311|P10|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
5788780|NCT03426995|19942312|P9|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
5788781|NCT03426995|19942313|P8|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
5788782|NCT03426995|19942314|P7|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
5788783|NCT03426995|19942315|P6|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
5788784|NCT03426995|19942316|P5|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
5788785|NCT03426995|19942317|P4|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
5788786|NCT03426995|19942318|P3|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
5788787|NCT03426995|19942319|P2|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
5788788|NCT03426995|19942320|P1|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
5788789|NCT03426995|19942302|P19|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
5788790|NCT03426995|19942303|P18|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
5788791|NCT03426995|19942304|P17|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
5788792|NCT03426995|19942305|P16|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|9
5788793|NCT03426995|19942306|P15|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|8
5788794|NCT03426995|19942307|P14|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
5788795|NCT03426995|19942308|P13|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
5788796|NCT03426995|19942309|P12|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
5788797|NCT03426995|19942310|P11|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
5788798|NCT03426995|19942311|P10|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
5788799|NCT03426995|19942312|P9|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
5788800|NCT03426995|19942313|P8|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
5788801|NCT03426995|19942314|P7|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
5788802|NCT03426995|19942315|P6|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
5788803|NCT03426995|19942316|P5|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
5788804|NCT03426995|19942317|P4|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
5788805|NCT03426995|19942318|P3|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
5788806|NCT03426995|19942319|P2|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
5788807|NCT03426995|19942320|P1|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
5788808|NCT03426995|19942302|P19|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
5788809|NCT03426995|19942303|P18|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
5788810|NCT03426995|19942304|P17|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
5788811|NCT03426995|19942305|P16|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
5788812|NCT03426995|19942306|P15|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
5788813|NCT03426995|19942307|P14|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
5788814|NCT03426995|19942308|P13|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
5788815|NCT03426995|19942309|P12|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
5788816|NCT03426995|19942310|P11|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
5788817|NCT03426995|19942311|P10|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
5788818|NCT03426995|19942312|P9|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
5788819|NCT03426995|19942313|P8|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|1
5788820|NCT03426995|19942314|P7|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
5788821|NCT03426995|19942315|P6|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
5788822|NCT03426995|19942316|P5|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
5788823|NCT03426995|19942317|P4|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
5788824|NCT03426995|19942318|P3|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
5788825|NCT03426995|19942319|P2|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
5788826|NCT03426995|19942320|P1|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
5788827|NCT03426995|19942302|P19|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
5788828|NCT03426995|19942303|P18|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
5788829|NCT03426995|19942304|P17|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
5788830|NCT03426995|19942305|P16|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
5788831|NCT03426995|19942306|P15|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
5788832|NCT03426995|19942307|P14|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
5788833|NCT03426995|19942308|P13|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
5788834|NCT03426995|19942309|P12|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
5788835|NCT03426995|19942310|P11|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|1
5788836|NCT03426995|19942311|P10|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
5788837|NCT03426995|19942312|P9|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
5788838|NCT03426995|19942313|P8|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
5788839|NCT03426995|19942314|P7|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
5788840|NCT03426995|19942315|P6|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
5788841|NCT03426995|19942316|P5|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
5788842|NCT03426995|19942317|P4|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
5788843|NCT03426995|19942318|P3|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
5788844|NCT03426995|19942319|P2|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
5788845|NCT03426995|19942320|P1|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
5788846|NCT03426995|19942302|P19|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
5788847|NCT03426995|19942303|P18|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
5788848|NCT03426995|19942304|P17|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
5788849|NCT03426995|19942305|P16|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
5788850|NCT03426995|19942306|P15|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
5788851|NCT03426995|19942307|P14|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
5788852|NCT03426995|19942308|P13|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
5788853|NCT03426995|19942309|P12|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
5788854|NCT03426995|19942310|P11|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
5788855|NCT03426995|19942311|P10|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
5788856|NCT03426995|19942312|P9|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
5788857|NCT03426995|19942313|P8|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
5788858|NCT03426995|19942314|P7|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
5788859|NCT03426995|19942315|P6|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|1
5788860|NCT03426995|19942316|P5|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|1
5788861|NCT03426995|19942317|P4|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
5788862|NCT03426995|19942318|P3|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
5788863|NCT03426995|19942319|P2|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
5788864|NCT03426995|19942320|P1|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
5788865|NCT03426995|19942302|P19|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
5788866|NCT03426995|19942303|P18|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
5788867|NCT03426995|19942304|P17|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
5788868|NCT03426995|19942305|P16|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
5788869|NCT03426995|19942306|P15|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
5788870|NCT03426995|19942307|P14|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
5788871|NCT03426995|19942308|P13|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
5788872|NCT03426995|19942309|P12|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
5788873|NCT03426995|19942310|P11|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
5788874|NCT03426995|19942311|P10|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
5788875|NCT03426995|19942312|P9|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
5788876|NCT03426995|19942313|P8|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
5788877|NCT03426995|19942314|P7|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
5788878|NCT03426995|19942315|P6|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|1
5788879|NCT03426995|19942316|P5|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
5788880|NCT03426995|19942317|P4|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
5788881|NCT03426995|19942318|P3|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
5788882|NCT03426995|19942319|P2|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
5788883|NCT03426995|19942320|P1|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
5788884|NCT03426995|19942302|P19|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
5788885|NCT03426995|19942303|P18|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
5788886|NCT03426995|19942304|P17|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
5788887|NCT03426995|19942305|P16|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
5788888|NCT03426995|19942306|P15|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
5788889|NCT03426995|19942307|P14|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
5788890|NCT03426995|19942308|P13|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
5788891|NCT03426995|19942309|P12|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
5788892|NCT03426995|19942310|P11|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
5788893|NCT03426995|19942311|P10|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
5788894|NCT03426995|19942312|P9|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
5788895|NCT03426995|19942313|P8|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
5788896|NCT03426995|19942314|P7|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
5788897|NCT03426995|19942315|P6|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
5788898|NCT03426995|19942316|P5|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
5788899|NCT03426995|19942317|P4|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
5788900|NCT03426995|19942318|P3|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|1
5788901|NCT03426995|19942319|P2|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
5788902|NCT03426995|19942320|P1|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
5788903|NCT03426787|19942667|P1|Overall Study|Unrelated to intervention death|1
5788904|NCT03426787|19942667|P1|Overall Study|Lost to Follow-up|7
5788905|NCT03426787|19942667|P1|Overall Study|Withdrawal by Subject|6
5788906|NCT03426631|19942677|P2|Overall Study|Lost to Follow-up|1
5788907|NCT03426631|19942678|P1|Overall Study|Lost to Follow-up|0
5788908|NCT03426436|19942690|P1|Overall Study|ECGs not saved|4
5788909|NCT03426436|19942690|P1|Overall Study|Consent issue|1
5788910|NCT03426436|19942690|P1|Overall Study|Withdrawal by Subject|2
5788911|NCT03426436|19942690|P1|Overall Study|Incorrect lead placement|12
5788912|NCT03426137|19942698|P3|Overall Study|Withdrawal by Subject|0
5788913|NCT03426137|19942699|P2|Overall Study|Withdrawal by Subject|0
5788914|NCT03426137|19942700|P1|Overall Study|Withdrawal by Subject|3
5788915|NCT03425396|19942713|P5|Overall Study|Other|1
5788916|NCT03425396|19942714|P4|Overall Study|Other|0
5788917|NCT03425396|19942715|P3|Overall Study|Other|1
5788918|NCT03425396|19942716|P2|Overall Study|Other|1
5788919|NCT03425396|19942717|P1|Overall Study|Other|0
5788920|NCT03425396|19942713|P5|Overall Study|Withdrawal by Subject|0
5788921|NCT03425396|19942714|P4|Overall Study|Withdrawal by Subject|1
5788922|NCT03425396|19942715|P3|Overall Study|Withdrawal by Subject|0
5788923|NCT03425396|19942716|P2|Overall Study|Withdrawal by Subject|1
5788924|NCT03425396|19942717|P1|Overall Study|Withdrawal by Subject|0
5788925|NCT03425396|19942713|P5|Overall Study|Lost to Follow-up|0
5788926|NCT03425396|19942714|P4|Overall Study|Lost to Follow-up|0
5788927|NCT03425396|19942715|P3|Overall Study|Lost to Follow-up|2
5788928|NCT03425396|19942716|P2|Overall Study|Lost to Follow-up|5
5788929|NCT03425396|19942717|P1|Overall Study|Lost to Follow-up|2
5788930|NCT03425253|19942799|P1|Overall Study|Did not Meet all Eligibility Criteria Defined in the Protocol|5
5788931|NCT03425253|19942799|P1|Overall Study|Withdrew Consent|6
5788932|NCT03425253|19942799|P1|Overall Study|Lost to Follow-up|3
5788933|NCT03425253|19942799|P1|Overall Study|Adverse Event|2
5788934|NCT03424265|19942828|P2|Overall Study|Withdrawal by Subject|2
5788935|NCT03424265|19942829|P1|Overall Study|Withdrawal by Subject|0
5788936|NCT03424265|19942828|P2|Overall Study|screening failure|0
5788937|NCT03424265|19942829|P1|Overall Study|screening failure|1
5788938|NCT03424044|19942835|P9|Third Intervention (76 Hours)|Withdrawal by Subject|0
5788939|NCT03424044|19942836|P8|Third Intervention (76 Hours)|Withdrawal by Subject|0
5788940|NCT03424044|19942837|P7|Third Intervention (76 Hours)|Withdrawal by Subject|0
5788941|NCT03424044|19942838|P6|Third Intervention (76 Hours)|Withdrawal by Subject|0
5788942|NCT03424044|19942839|P5|Third Intervention (76 Hours)|Withdrawal by Subject|0
5788943|NCT03424044|19942840|P4|Third Intervention (76 Hours)|Withdrawal by Subject|1
5788944|NCT03424044|19942841|P3|Third Intervention (76 Hours)|Withdrawal by Subject|0
5788945|NCT03424044|19942842|P2|Third Intervention (76 Hours)|Withdrawal by Subject|0
5788946|NCT03424044|19942843|P1|Third Intervention (76 Hours)|Withdrawal by Subject|0
5788947|NCT03424044|19942835|P9|Third Intervention (76 Hours)|Adverse Event|0
5788948|NCT03424044|19942836|P8|Third Intervention (76 Hours)|Adverse Event|0
5788949|NCT03424044|19942837|P7|Third Intervention (76 Hours)|Adverse Event|1
5788950|NCT03424044|19942838|P6|Third Intervention (76 Hours)|Adverse Event|0
5788951|NCT03424044|19942839|P5|Third Intervention (76 Hours)|Adverse Event|0
5788952|NCT03424044|19942840|P4|Third Intervention (76 Hours)|Adverse Event|0
5788953|NCT03424044|19942841|P3|Third Intervention (76 Hours)|Adverse Event|0
5788954|NCT03424044|19942842|P2|Third Intervention (76 Hours)|Adverse Event|0
5788955|NCT03424044|19942843|P1|Third Intervention (76 Hours)|Adverse Event|1
5788956|NCT03424044|19942835|P9|First Intervention (76 Hours)|device issues|1
5788957|NCT03424044|19942836|P8|First Intervention (76 Hours)|device issues|1
5788958|NCT03424044|19942837|P7|First Intervention (76 Hours)|device issues|1
5788959|NCT03424044|19942838|P6|First Intervention (76 Hours)|device issues|0
5788960|NCT03424044|19942839|P5|First Intervention (76 Hours)|device issues|0
5788961|NCT03424044|19942840|P4|First Intervention (76 Hours)|device issues|0
5788962|NCT03424044|19942841|P3|First Intervention (76 Hours)|device issues|0
5788963|NCT03424044|19942842|P2|First Intervention (76 Hours)|device issues|0
5788964|NCT03424044|19942843|P1|First Intervention (76 Hours)|device issues|0
5788965|NCT03424044|19942835|P9|First Intervention (76 Hours)|Adverse Event|0
5788966|NCT03424044|19942836|P8|First Intervention (76 Hours)|Adverse Event|0
5788967|NCT03424044|19942837|P7|First Intervention (76 Hours)|Adverse Event|0
5788968|NCT03424044|19942838|P6|First Intervention (76 Hours)|Adverse Event|0
5788969|NCT03424044|19942839|P5|First Intervention (76 Hours)|Adverse Event|1
5788970|NCT03424044|19942840|P4|First Intervention (76 Hours)|Adverse Event|0
5788971|NCT03424044|19942841|P3|First Intervention (76 Hours)|Adverse Event|0
5788972|NCT03424044|19942842|P2|First Intervention (76 Hours)|Adverse Event|0
5788973|NCT03424044|19942843|P1|First Intervention (76 Hours)|Adverse Event|0
5788974|NCT03424044|19942835|P9|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0
5788975|NCT03424044|19942836|P8|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0
5788976|NCT03424044|19942837|P7|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0
5788977|NCT03424044|19942838|P6|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0
5788978|NCT03424044|19942839|P5|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0
5788979|NCT03424044|19942840|P4|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0
5788980|NCT03424044|19942841|P3|First Rest Period (1-12 Weeks)|Withdrawal by Subject|1
5788981|NCT03424044|19942842|P2|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0
5788982|NCT03424044|19942843|P1|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0
5788983|NCT03423173|19942915|P4|Overall Study|Reason not Specified|1
5788984|NCT03423173|19942916|P3|Overall Study|Reason not Specified|3
5788985|NCT03423173|19942917|P2|Overall Study|Reason not Specified|5
5788986|NCT03423173|19942918|P1|Overall Study|Reason not Specified|2
5788987|NCT03423173|19942915|P4|Overall Study|Death|0
5788988|NCT03423173|19942916|P3|Overall Study|Death|0
5788989|NCT03423173|19942917|P2|Overall Study|Death|0
5788990|NCT03423173|19942918|P1|Overall Study|Death|1
5788991|NCT03423173|19942915|P4|Overall Study|Withdrawal of consent|5
5788992|NCT03423173|19942916|P3|Overall Study|Withdrawal of consent|4
5788993|NCT03423173|19942917|P2|Overall Study|Withdrawal of consent|10
5788994|NCT03423173|19942918|P1|Overall Study|Withdrawal of consent|4
5788995|NCT03423173|19942915|P4|Overall Study|Lost to Follow-up|22
5788996|NCT03423173|19942916|P3|Overall Study|Lost to Follow-up|17
5788997|NCT03423173|19942917|P2|Overall Study|Lost to Follow-up|19
5788998|NCT03423173|19942918|P1|Overall Study|Lost to Follow-up|10
5788999|NCT03423173|19942915|P4|Overall Study|Adverse Event|1
5789000|NCT03423173|19942916|P3|Overall Study|Adverse Event|1
5789001|NCT03423173|19942917|P2|Overall Study|Adverse Event|1
5789002|NCT03423173|19942918|P1|Overall Study|Adverse Event|1
5789003|NCT03423173|19942915|P4|Overall Study|Randomized but not vaccinated|1
5789004|NCT03423173|19942916|P3|Overall Study|Randomized but not vaccinated|2
5789005|NCT03423173|19942917|P2|Overall Study|Randomized but not vaccinated|0
5789006|NCT03423173|19942918|P1|Overall Study|Randomized but not vaccinated|1
5789007|NCT03421730|19942972|P12|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
5789008|NCT03421730|19942973|P11|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
5789009|NCT03421730|19942974|P10|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
5789010|NCT03421730|19942975|P9|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
5789011|NCT03421730|19942976|P8|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
5789012|NCT03421730|19942977|P7|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
5789013|NCT03421730|19942978|P6|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
5789014|NCT03421730|19942979|P5|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|2
5789015|NCT03421730|19942980|P4|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
5789016|NCT03421730|19942981|P3|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
5789017|NCT03421730|19942982|P2|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
5789018|NCT03421730|19942983|P1|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
5789019|NCT03421730|19942972|P12|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
5789020|NCT03421730|19942973|P11|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
5789021|NCT03421730|19942974|P10|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
5789022|NCT03421730|19942975|P9|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
5789023|NCT03421730|19942976|P8|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
5789024|NCT03421730|19942977|P7|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
5789025|NCT03421730|19942978|P6|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
5789026|NCT03421730|19942979|P5|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
5789027|NCT03421730|19942980|P4|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
5789028|NCT03421730|19942981|P3|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
5789029|NCT03421730|19942982|P2|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|2
5789030|NCT03421730|19942983|P1|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
5789031|NCT03421379|19943056|P2|Period 1|Did not receive treatment|2
5789032|NCT03421379|19943057|P1|Period 1|Did not receive treatment|1
5789033|NCT03421379|19943056|P2|Period 1|Physician Decision|1
5789034|NCT03421379|19943057|P1|Period 1|Physician Decision|1
5789035|NCT03421379|19943056|P2|Period 1|Withdrawal by Subject|1
5789036|NCT03421379|19943057|P1|Period 1|Withdrawal by Subject|0
5789037|NCT03420300|19943109|P1|Overall Study|Death|2
5789038|NCT03419962|19943118|P1|Overall Study|Missing completion data|31
5789039|NCT03419962|19943118|P1|Overall Study|Difficulty in inhaling the doses|1
5789040|NCT03419962|19943118|P1|Overall Study|Lost to Follow-up|3
5789041|NCT03419962|19943118|P1|Overall Study|Refusal of continuing with trial drug|1
5789042|NCT03419962|19943118|P1|Overall Study|Change to other medication|1
5789043|NCT03419598|19943149|P1|Overall Study|Poor quality CT scans could not be adequately segmented to create virtual patient tibial geometry|2
5789044|NCT03418571|19943205|P2|Overall Study|Consent withdrawn by legal guardian|0
5789045|NCT03418571|19943206|P1|Overall Study|Consent withdrawn by legal guardian|1
5789046|NCT03418376|19943218|P4|Overall Study|Exacerbation|0
5789047|NCT03418376|19943219|P3|Overall Study|Exacerbation|0
5789048|NCT03418376|19943220|P2|Overall Study|Exacerbation|1
5789049|NCT03418376|19943221|P1|Overall Study|Exacerbation|0
5789050|NCT03418376|19943218|P4|Overall Study|Personal reasons|1
5789051|NCT03418376|19943219|P3|Overall Study|Personal reasons|2
5789052|NCT03418376|19943220|P2|Overall Study|Personal reasons|2
5789053|NCT03418376|19943221|P1|Overall Study|Personal reasons|0
5789054|NCT03418376|19943218|P4|Overall Study|Musculoskeletal injury|0
5789055|NCT03418376|19943219|P3|Overall Study|Musculoskeletal injury|1
5789056|NCT03418376|19943220|P2|Overall Study|Musculoskeletal injury|2
5789057|NCT03418376|19943221|P1|Overall Study|Musculoskeletal injury|1
5789058|NCT03418324|19943249|P2|Overall Study|Physician Decision|1
5789059|NCT03418324|19943250|P1|Overall Study|Physician Decision|1
5789060|NCT03418324|19943249|P2|Overall Study|Death|1
5789061|NCT03418324|19943250|P1|Overall Study|Death|0
5789062|NCT03417830|19943300|P2|Part A (up to 26 Days)|Study Closed/Terminated|0
5789063|NCT03417830|19943301|P1|Part A (up to 26 Days)|Study Closed/Terminated|1
5789064|NCT03417505|19943458|P2|First Lens Type (30 Days)|Lost to Follow-up|1
5789065|NCT03417505|19943459|P1|First Lens Type (30 Days)|Lost to Follow-up|1
5789066|NCT03417219|19943490|P2|Overall Study|Lost to Follow-up|3
5789067|NCT03417219|19943491|P1|Overall Study|Lost to Follow-up|0
5789068|NCT03417024|19943501|P1|Overall Study|Physician Decision|2
5789069|NCT03417024|19943501|P1|Overall Study|Study Termination prior to follow-up|11
5789070|NCT03416127|19943526|P3|Overall Study|Withdrawal by Subject|1
5789071|NCT03416127|19943527|P2|Overall Study|Withdrawal by Subject|1
5789072|NCT03416127|19943528|P1|Overall Study|Withdrawal by Subject|0
5789073|NCT03415178|19943672|P2|Single Arm Period (up to Week 16)|Adverse Event|1
5789074|NCT03415178|19943673|P1|Single Arm Period (up to Week 16)|Adverse Event|0
5789075|NCT03415178|19943672|P2|Parallel-Arm Period (up to Week 4)|Randomized but not treated|2
5789076|NCT03415178|19943673|P1|Parallel-Arm Period (up to Week 4)|Randomized but not treated|0
5789083|NCT03414359|19943738|P2|Overall Study|Protocol Violation|1
5789084|NCT03414359|19943739|P1|Overall Study|Protocol Violation|0
5789085|NCT03414359|19943738|P2|Overall Study|Lack of Efficacy|1
5789086|NCT03414359|19943739|P1|Overall Study|Lack of Efficacy|1
5789087|NCT03414047|19943751|P4|Overall Study|Withdrawal by Subject|2
5789088|NCT03414047|19943752|P3|Overall Study|Withdrawal by Subject|0
5789089|NCT03414047|19943753|P2|Overall Study|Withdrawal by Subject|0
5789090|NCT03414047|19943754|P1|Overall Study|Withdrawal by Subject|1
5789091|NCT03414047|19943751|P4|Overall Study|Adverse Event|1
5789092|NCT03414047|19943752|P3|Overall Study|Adverse Event|0
5789093|NCT03414047|19943753|P2|Overall Study|Adverse Event|0
5789094|NCT03414047|19943754|P1|Overall Study|Adverse Event|0
5789095|NCT03412929|19943814|P1|Overall Study|Protocol Violation|3
5789096|NCT03412734|19943825|P2|Overall Study|Exclusion criteria - patient receiving Flagyl for treatment|0
5789097|NCT03412734|19943826|P1|Overall Study|Exclusion criteria - patient receiving Flagyl for treatment|1
5789098|NCT03412734|19943825|P2|Overall Study|Incorrect labeling of samples|0
5789099|NCT03412734|19943826|P1|Overall Study|Incorrect labeling of samples|2
5789100|NCT03412084|19943834|P2|Overall Study|Lost to Follow-up|1
5789101|NCT03412084|19943835|P1|Overall Study|Lost to Follow-up|1
5789102|NCT03412084|19943834|P2|Overall Study|Participant moved|0
5789103|NCT03412084|19943835|P1|Overall Study|Participant moved|1
5789104|NCT03412084|19943834|P2|Overall Study|Withdrawal by Subject|0
5789105|NCT03412084|19943835|P1|Overall Study|Withdrawal by Subject|2
5789106|NCT03412019|19943845|P2|Overall Study|Withdrawal by Subject|1
5789107|NCT03412019|19943846|P1|Overall Study|Withdrawal by Subject|1
5789110|NCT03409796|19943904|P2|Overall Study|Other|1
5789111|NCT03409796|19943905|P1|Overall Study|Other|0
5789112|NCT03409796|19943904|P2|Overall Study|Adverse Event|0
5789113|NCT03409796|19943905|P1|Overall Study|Adverse Event|2
5789114|NCT03409731|19943917|P1|Overall Study|Death|2
5789115|NCT03409731|19943917|P1|Overall Study|Withdrawal by Subject|1
5789116|NCT03408639|19944011|P2|Overall Study|Physician Decision|6
5789117|NCT03408639|19944012|P1|Overall Study|Physician Decision|3
5789118|NCT03408639|19944011|P2|Overall Study|Withdrawal by Subject|7
5789119|NCT03408639|19944012|P1|Overall Study|Withdrawal by Subject|2
5789120|NCT03408639|19944011|P2|Overall Study|Lost to Follow-up|4
5789121|NCT03408639|19944012|P1|Overall Study|Lost to Follow-up|1
5789122|NCT03408639|19944011|P2|Overall Study|Death|5
5789123|NCT03408639|19944012|P1|Overall Study|Death|5
5789124|NCT03408483|19944042|P2|Overall Study|Lost to Follow-up|0
5789125|NCT03408483|19944043|P1|Overall Study|Lost to Follow-up|3
5789126|NCT03408483|19944042|P2|Overall Study|Physician Decision|3
5789127|NCT03408483|19944043|P1|Overall Study|Physician Decision|3
5789128|NCT03407482|19944219|P1|Overall Study|Data Entry Error|1
5789129|NCT03407482|19944219|P1|Overall Study|Withdrawal by Subject|6
5789130|NCT03407482|19944219|P1|Overall Study|Study Terminated By Sponsor|106
5789131|NCT03407482|19944219|P1|Overall Study|Protocol Violation|1
5789132|NCT03407482|19944219|P1|Overall Study|Pregnancy|2
5789133|NCT03407482|19944219|P1|Overall Study|Non-Compliance With Study Drug|1
5789134|NCT03407482|19944219|P1|Overall Study|Lost to Follow-up|1
5789135|NCT03407482|19944219|P1|Overall Study|Disease Relapse|1
5789136|NCT03407482|19944219|P1|Overall Study|Adverse Event|12
5789137|NCT03407430|19944230|P2|Washout|Protocol Violation|0
5789138|NCT03407430|19944231|P1|Washout|Protocol Violation|1
5789139|NCT03407170|19944263|P1|Overall Study|Adverse Event|1
5789140|NCT03407118|19944276|P2|Period 2|Withdrawal by Subject|0
5789141|NCT03407118|19944277|P1|Period 2|Withdrawal by Subject|1
5789142|NCT03406260|19944354|P6|Period 1|Adverse Event|0
5789143|NCT03406260|19944355|P5|Period 1|Adverse Event|1
5789144|NCT03406260|19944356|P4|Period 1|Adverse Event|0
5789145|NCT03406260|19944357|P3|Period 1|Adverse Event|0
5789146|NCT03406260|19944358|P2|Period 1|Adverse Event|0
5789147|NCT03406260|19944359|P1|Period 1|Adverse Event|0
5789148|NCT03405935|19944371|P1|Overall Study|Lost to Follow-up|2
5789149|NCT03405935|19944371|P1|Overall Study|Withdrawal by Subject|1
5789150|NCT03405935|19944371|P1|Overall Study|Death|2
5789151|NCT03405935|19944371|P1|Overall Study|Adverse Event|3
5789152|NCT03405818|19944398|P1|Overall Study|Lost to Follow-up|4
5789153|NCT03405818|19944398|P1|Overall Study|Withdrawal by Subject|4
5789154|NCT03404843|19944452|P2|Overall Study|Study difficulties unrelated to Tx|1
5789155|NCT03404843|19944453|P1|Overall Study|Study difficulties unrelated to Tx|4
5789156|NCT03404674|19944485|P6|Overall Study|Started a Medication that Precluded Eligibility|1
5789157|NCT03404674|19944486|P5|Overall Study|Started a Medication that Precluded Eligibility|0
5789158|NCT03404674|19944487|P4|Overall Study|Started a Medication that Precluded Eligibility|1
5789159|NCT03404674|19944488|P3|Overall Study|Started a Medication that Precluded Eligibility|0
5789160|NCT03404674|19944489|P2|Overall Study|Started a Medication that Precluded Eligibility|0
5789161|NCT03404674|19944490|P1|Overall Study|Started a Medication that Precluded Eligibility|0
5789162|NCT03404674|19944485|P6|Overall Study|Behavioral Problems|0
5789163|NCT03404674|19944486|P5|Overall Study|Behavioral Problems|0
5789164|NCT03404674|19944487|P4|Overall Study|Behavioral Problems|0
5789165|NCT03404674|19944488|P3|Overall Study|Behavioral Problems|1
5789166|NCT03404674|19944489|P2|Overall Study|Behavioral Problems|0
5789167|NCT03404674|19944490|P1|Overall Study|Behavioral Problems|0
5789168|NCT03404674|19944485|P6|Overall Study|Inability to Attend Future Visits|0
5789169|NCT03404674|19944486|P5|Overall Study|Inability to Attend Future Visits|0
5789170|NCT03404674|19944487|P4|Overall Study|Inability to Attend Future Visits|0
5789171|NCT03404674|19944488|P3|Overall Study|Inability to Attend Future Visits|1
5789172|NCT03404674|19944489|P2|Overall Study|Inability to Attend Future Visits|1
5789173|NCT03404674|19944490|P1|Overall Study|Inability to Attend Future Visits|0
5789174|NCT03404206|19944585|P3|Overall Study|Lost to Follow-up|0
5789175|NCT03404206|19944586|P2|Overall Study|Lost to Follow-up|1
5789176|NCT03404206|19944587|P1|Overall Study|Lost to Follow-up|3
5789177|NCT03404206|19944585|P3|Overall Study|Withdrawal by Subject|0
5789178|NCT03404206|19944586|P2|Overall Study|Withdrawal by Subject|1
5789179|NCT03404206|19944587|P1|Overall Study|Withdrawal by Subject|1
5789180|NCT03403426|19944732|P1|Overall Study|Lost to Follow-up|2
5789181|NCT03403426|19944732|P1|Overall Study|Death|1
5789182|NCT03403413|19944745|P1|Overall Study|Lack of Efficacy|2
5789183|NCT03403400|19944763|P3|Overall Study|Benign Paroxysmal Positional Vertigo|1
5789184|NCT03403400|19944764|P2|Overall Study|Benign Paroxysmal Positional Vertigo|0
5789185|NCT03403400|19944765|P1|Overall Study|Benign Paroxysmal Positional Vertigo|0
5789186|NCT03403400|19944763|P3|Overall Study|Hospitalization|0
5789187|NCT03403400|19944764|P2|Overall Study|Hospitalization|0
5789188|NCT03403400|19944765|P1|Overall Study|Hospitalization|1
5789189|NCT03403400|19944763|P3|Overall Study|Lost to Follow-up|1
5789190|NCT03403400|19944764|P2|Overall Study|Lost to Follow-up|0
5789191|NCT03403400|19944765|P1|Overall Study|Lost to Follow-up|1
5789192|NCT03403374|19944797|P1|Overall Study|Lost to Follow-up|1
5789193|NCT03403036|19944804|P1|Overall Study|Lack of Efficacy|5
5789194|NCT03402893|19944831|P1|Overall Study|Withdrawal by Subject|1
5789195|NCT03402750|19944842|P2|Overall Study|Lost to Follow-up|1
5789196|NCT03402750|19944843|P1|Overall Study|Lost to Follow-up|2
5789197|NCT03401450|19944908|P2|Overall Study|Cancelled surgery|2
5789198|NCT03401450|19944909|P1|Overall Study|Cancelled surgery|0
5789199|NCT03401450|19944908|P2|Overall Study|post surgery medication change|1
5789200|NCT03401450|19944909|P1|Overall Study|post surgery medication change|2
5789201|NCT03401450|19944908|P2|Overall Study|Did not complete medication diary|2
5789202|NCT03401450|19944909|P1|Overall Study|Did not complete medication diary|4
5789203|NCT03401450|19944908|P2|Overall Study|Anesthesia plan changed|2
5789204|NCT03401450|19944909|P1|Overall Study|Anesthesia plan changed|2
5789205|NCT03401450|19944908|P2|Overall Study|Lost to Follow-up|6
5789206|NCT03401450|19944909|P1|Overall Study|Lost to Follow-up|4
5789215|NCT03398356|19945208|P3|After 6 Weeks of Treatment|Physician Decision|0
5789216|NCT03398356|19945209|P2|After 6 Weeks of Treatment|Physician Decision|2
5789217|NCT03398356|19945210|P1|After 6 Weeks of Treatment|Physician Decision|0
5789218|NCT03398356|19945208|P3|Before Treatment|Physician Decision|11
5789219|NCT03398356|19945209|P2|Before Treatment|Physician Decision|0
5789220|NCT03398356|19945210|P1|Before Treatment|Physician Decision|0
5789221|NCT03398356|19945208|P3|Before Treatment|Withdrawal by Subject|0
5789222|NCT03398356|19945209|P2|Before Treatment|Withdrawal by Subject|5
5789223|NCT03398356|19945210|P1|Before Treatment|Withdrawal by Subject|0
5789224|NCT03398356|19945208|P3|Before Treatment|drug intolerance|0
5789225|NCT03398356|19945209|P2|Before Treatment|drug intolerance|1
5789226|NCT03398356|19945210|P1|Before Treatment|drug intolerance|2
5789227|NCT03398356|19945208|P3|Before Treatment|Lost to Follow-up|0
5789228|NCT03398356|19945209|P2|Before Treatment|Lost to Follow-up|2
5789229|NCT03398356|19945210|P1|Before Treatment|Lost to Follow-up|1
5789230|NCT03397771|19945315|P2|Overall Study|Adverse Event|1
5789231|NCT03397771|19945316|P1|Overall Study|Adverse Event|2
5789232|NCT03397771|19945315|P2|Overall Study|Protocol Violation|2
5789233|NCT03397771|19945316|P1|Overall Study|Protocol Violation|2
5789234|NCT03397771|19945315|P2|Overall Study|Withdrawal by Subject|3
5789235|NCT03397771|19945316|P1|Overall Study|Withdrawal by Subject|1
5789236|NCT03397771|19945315|P2|Overall Study|2 erroneously randomized, never treated|1
5789237|NCT03397771|19945316|P1|Overall Study|2 erroneously randomized, never treated|3
5789238|NCT03396913|19945376|P2|Overall Study|Lost to Follow-up|6
5789239|NCT03396913|19945377|P1|Overall Study|Lost to Follow-up|0
5789240|NCT03396835|19945387|P1|Overall Study|Did not meet criteria for data analysis|1
5789241|NCT03396835|19945387|P1|Overall Study|Withdrawn prior to completion|1
5789242|NCT03394508|19945422|P2|Overall Study|Lost to Follow-up|0
5789243|NCT03394508|19945423|P1|Overall Study|Lost to Follow-up|1
5789244|NCT03394508|19945422|P2|Overall Study|Protocol Violation|3
5789245|NCT03394508|19945423|P1|Overall Study|Protocol Violation|0
5789246|NCT03394391|19945449|P2|Overall Study|Lost to Follow-up|2
5789247|NCT03394391|19945450|P1|Overall Study|Lost to Follow-up|1
5789248|NCT03393806|19945468|P2|Overall Study|Physician Decision|0
5789249|NCT03393806|19945469|P1|Overall Study|Physician Decision|1
5789250|NCT03392194|19945611|P2|Overall Study|Conflicts with personal schedule|0
5789251|NCT03392194|19945612|P1|Overall Study|Conflicts with personal schedule|1
5789252|NCT03392194|19945611|P2|Overall Study|Withdrawal by Subject|2
5789253|NCT03392194|19945612|P1|Overall Study|Withdrawal by Subject|1
5789254|NCT03390426|19945647|P2|Overall Study|Protocol Violation|1
5789255|NCT03390426|19945648|P1|Overall Study|Protocol Violation|0
5789256|NCT03390166|19945668|P2|Overall Study|Move to work oversea|1
5789257|NCT03390166|19945669|P1|Overall Study|Move to work oversea|0
5789258|NCT03390166|19945668|P2|Overall Study|To drug therapy course|1
5789259|NCT03390166|19945669|P1|Overall Study|To drug therapy course|0
5789260|NCT03390166|19945668|P2|Overall Study|To militarycamp for conscript|0
5789261|NCT03390166|19945669|P1|Overall Study|To militarycamp for conscript|1
5789262|NCT03390166|19945668|P2|Overall Study|Move from study area|2
5789263|NCT03390166|19945669|P1|Overall Study|Move from study area|3
5789264|NCT03390166|19945668|P2|Overall Study|Physician Decision|1
5789265|NCT03390166|19945669|P1|Overall Study|Physician Decision|2
5789266|NCT03390166|19945668|P2|Overall Study|Lost to Follow-up|4
5789267|NCT03390166|19945669|P1|Overall Study|Lost to Follow-up|6
5789268|NCT03390166|19945668|P2|Overall Study|Death|1
5789269|NCT03390166|19945669|P1|Overall Study|Death|0
5789270|NCT03389308|19945723|P1|Overall Study|Sponsor Request|2
5789271|NCT03389308|19945723|P1|Overall Study|Adverse Event|2
5789272|NCT03389308|19945723|P1|Overall Study|Lost to Follow-up|3
5789273|NCT03389308|19945723|P1|Overall Study|Withdrawal by Subject|5
5789274|NCT03387683|19945748|P2|Overall Study|Did not receive treatment|0
5789275|NCT03387683|19945749|P1|Overall Study|Did not receive treatment|1
5789276|NCT03387683|19945748|P2|Overall Study|In receipt of disallowed medication|0
5789277|NCT03387683|19945749|P1|Overall Study|In receipt of disallowed medication|1
5789278|NCT03387462|19945757|P1|Overall Study|Lost to Follow-up|1
5789279|NCT03387059|19945787|P2|Overall Study|Study termination|4
5789280|NCT03387059|19945788|P1|Overall Study|Study termination|5
5789281|NCT03387046|19945802|P2|Overall Study|Adverse Event|1
5789282|NCT03387046|19945803|P1|Overall Study|Adverse Event|1
5789283|NCT03386994|19945830|P1|Overall Study|Death|16
5789284|NCT03386994|19945830|P1|Overall Study|Withdrawal by Subject|3
5789285|NCT03386994|19945830|P1|Overall Study|Lost to Follow-up|4
5789286|NCT03386994|19945830|P1|Overall Study|Adverse Event|14
5789287|NCT03386994|19945830|P1|Overall Study|Lung transplant|1
5789288|NCT03386474|19945890|P2|Overall Study|Adverse Event|1
5789289|NCT03386474|19945891|P1|Overall Study|Adverse Event|0
5789290|NCT03386474|19945890|P2|Overall Study|Death|0
5789291|NCT03386474|19945891|P1|Overall Study|Death|1
5789292|NCT03386448|19945913|P2|Overall Study|Adverse Event|2
5789293|NCT03386448|19945914|P1|Overall Study|Adverse Event|0
5789294|NCT03386435|19945922|P2|Overall Study|Protocol Violation|7
5789295|NCT03386435|19945923|P1|Overall Study|Protocol Violation|5
5789296|NCT03386032|19945938|P3|Overall Study|Lost to Follow-up|0
5789297|NCT03386032|19945939|P2|Overall Study|Lost to Follow-up|3
5789298|NCT03386032|19945940|P1|Overall Study|Lost to Follow-up|9
5789299|NCT03386032|19945938|P3|Overall Study|Withdrawal by Subject|0
5789300|NCT03386032|19945939|P2|Overall Study|Withdrawal by Subject|0
5789301|NCT03386032|19945940|P1|Overall Study|Withdrawal by Subject|1
5789302|NCT03386032|19945938|P3|Overall Study|Adverse Event|0
5789303|NCT03386032|19945939|P2|Overall Study|Adverse Event|2
5789304|NCT03386032|19945940|P1|Overall Study|Adverse Event|2
5789305|NCT03386032|19945938|P3|Overall Study|Lack of Efficacy|0
5789306|NCT03386032|19945939|P2|Overall Study|Lack of Efficacy|2
5789307|NCT03386032|19945940|P1|Overall Study|Lack of Efficacy|6
5789308|NCT03384316|19945975|P2|Overall Study|Screen failure|1
5789309|NCT03384316|19945976|P1|Overall Study|Screen failure|0
5789310|NCT03383887|19946015|P2|Overall Study|Lost to Follow-up|1
5789311|NCT03383887|19946016|P1|Overall Study|Lost to Follow-up|0
5789312|NCT03383783|19946024|P1|Overall Study|Withdrawal by Subject|2
5789313|NCT03383614|19946108|P4|Overall Study|Withdrawal by Subject|0
5789314|NCT03383614|19946109|P3|Overall Study|Withdrawal by Subject|0
5789315|NCT03383614|19946110|P2|Overall Study|Withdrawal by Subject|1
5789316|NCT03383614|19946111|P1|Overall Study|Withdrawal by Subject|0
5789317|NCT03382912|19946379|P2|Overall Study|Withdrawal by Subject|5
5789318|NCT03382912|19946380|P1|Overall Study|Withdrawal by Subject|0
5789319|NCT03382912|19946379|P2|Overall Study|Sponsor Decision|6
5789320|NCT03382912|19946380|P1|Overall Study|Sponsor Decision|6
5789321|NCT03382912|19946379|P2|Overall Study|Physician Decision|1
5789322|NCT03382912|19946380|P1|Overall Study|Physician Decision|0
5789323|NCT03382899|19946396|P2|Overall Study|Withdrawal by Subject|5
5789324|NCT03382899|19946397|P1|Overall Study|Withdrawal by Subject|0
5789325|NCT03382899|19946396|P2|Overall Study|Sponsor's decision|28
5789326|NCT03382899|19946397|P1|Overall Study|Sponsor's decision|31
5789327|NCT03382899|19946396|P2|Overall Study|Lost to Follow-up|1
5789328|NCT03382899|19946397|P1|Overall Study|Lost to Follow-up|0
5789329|NCT03382899|19946396|P2|Overall Study|Ineligibility Determined|1
5789330|NCT03382899|19946397|P1|Overall Study|Ineligibility Determined|0
5789331|NCT03382834|19946413|P2|Overall Study|Withdrawal by Subject|1
5789332|NCT03382834|19946414|P1|Overall Study|Withdrawal by Subject|0
5789333|NCT03382834|19946413|P2|Overall Study|Lost to Follow-up|0
5789334|NCT03382834|19946414|P1|Overall Study|Lost to Follow-up|1
5789335|NCT03382262|19946438|P4|Overall Study|Withdrawal by Subject|1
5789336|NCT03382262|19946439|P3|Overall Study|Withdrawal by Subject|0
5789337|NCT03382262|19946440|P2|Overall Study|Withdrawal by Subject|0
5789338|NCT03382262|19946441|P1|Overall Study|Withdrawal by Subject|0
5789339|NCT03382262|19946438|P4|Overall Study|Physician Decision|0
5789340|NCT03382262|19946439|P3|Overall Study|Physician Decision|1
5789341|NCT03382262|19946440|P2|Overall Study|Physician Decision|0
5789342|NCT03382262|19946441|P1|Overall Study|Physician Decision|0
5789343|NCT03381248|19946499|P2|Overall Study|Protocol Violation|1
5789344|NCT03381248|19946500|P1|Overall Study|Protocol Violation|2
5789345|NCT03381248|19946499|P2|Overall Study|Adverse Event|0
5789346|NCT03381248|19946500|P1|Overall Study|Adverse Event|2
5789347|NCT03381248|19946499|P2|Overall Study|Lack of Efficacy|0
5789348|NCT03381248|19946500|P1|Overall Study|Lack of Efficacy|1
5789349|NCT03381248|19946499|P2|Overall Study|Lost to Follow-up|2
5789350|NCT03381248|19946500|P1|Overall Study|Lost to Follow-up|3
5789351|NCT03381248|19946499|P2|Overall Study|Withdrawal by Subject|3
5789352|NCT03381248|19946500|P1|Overall Study|Withdrawal by Subject|5
5789353|NCT03380429|19946607|P5|Overall Study|Adverse Event|0
5789354|NCT03380429|19946608|P4|Overall Study|Adverse Event|2
5789355|NCT03380429|19946609|P3|Overall Study|Adverse Event|1
5789356|NCT03380429|19946610|P2|Overall Study|Adverse Event|1
5789357|NCT03380429|19946611|P1|Overall Study|Adverse Event|1
5789358|NCT03380429|19946607|P5|Overall Study|Lack of Efficacy|1
5789359|NCT03380429|19946608|P4|Overall Study|Lack of Efficacy|2
5789360|NCT03380429|19946609|P3|Overall Study|Lack of Efficacy|0
5789361|NCT03380429|19946610|P2|Overall Study|Lack of Efficacy|0
5789362|NCT03380429|19946611|P1|Overall Study|Lack of Efficacy|0
5789363|NCT03380429|19946607|P5|Overall Study|Protocol Violation|1
5789364|NCT03380429|19946608|P4|Overall Study|Protocol Violation|0
5789365|NCT03380429|19946609|P3|Overall Study|Protocol Violation|1
5789366|NCT03380429|19946610|P2|Overall Study|Protocol Violation|0
5789367|NCT03380429|19946611|P1|Overall Study|Protocol Violation|1
5789368|NCT03380429|19946607|P5|Overall Study|Lost to Follow-up|1
5789369|NCT03380429|19946608|P4|Overall Study|Lost to Follow-up|3
5789370|NCT03380429|19946609|P3|Overall Study|Lost to Follow-up|4
5789371|NCT03380429|19946610|P2|Overall Study|Lost to Follow-up|2
5789372|NCT03380429|19946611|P1|Overall Study|Lost to Follow-up|0
5789373|NCT03380429|19946607|P5|Overall Study|Withdrawal by Subject|1
5789374|NCT03380429|19946608|P4|Overall Study|Withdrawal by Subject|2
5789375|NCT03380429|19946609|P3|Overall Study|Withdrawal by Subject|5
5789376|NCT03380429|19946610|P2|Overall Study|Withdrawal by Subject|3
5789377|NCT03380429|19946611|P1|Overall Study|Withdrawal by Subject|3
5789378|NCT03380429|19946607|P5|Overall Study|Physician Decision|1
5789379|NCT03380429|19946608|P4|Overall Study|Physician Decision|1
5789380|NCT03380429|19946609|P3|Overall Study|Physician Decision|0
5789381|NCT03380429|19946610|P2|Overall Study|Physician Decision|1
5789382|NCT03380429|19946611|P1|Overall Study|Physician Decision|0
5789383|NCT03380390|19946664|P1|Overall Study|Adverse Event|3
5789384|NCT03379753|19946672|P2|Overall Study|No primary outcome|22
5789385|NCT03379753|19946673|P1|Overall Study|No primary outcome|12
5789386|NCT03379753|19946672|P2|Overall Study|not having correct procedure|2
5789387|NCT03379753|19946673|P1|Overall Study|not having correct procedure|1
5789388|NCT03379753|19946672|P2|Overall Study|Withdrawal by Subject|1
5789389|NCT03379753|19946673|P1|Overall Study|Withdrawal by Subject|2
5789390|NCT03379506|19946769|P4|Overall Study|Ongoing in study|11
5789391|NCT03379506|19946770|P3|Overall Study|Ongoing in study|0
5789392|NCT03379506|19946771|P2|Overall Study|Ongoing in study|9
5789393|NCT03379506|19946772|P1|Overall Study|Ongoing in study|0
5789394|NCT03379376|19946822|P1|Overall Study|Death|1
5789395|NCT03379376|19946822|P1|Overall Study|Overwhelmed, didn't want to continue|1
5789396|NCT03379376|19946822|P1|Overall Study|Did not wish to complete follow up|1
5789397|NCT03379376|19946822|P1|Overall Study|Lost to Follow-up|2
5789398|NCT03379233|19946832|P2|Overall Study|Technical issues with Concept 2 inhalers|6
5789399|NCT03379233|19946833|P1|Overall Study|Technical issues with Concept 2 inhalers|1
5789400|NCT03377634|19946867|P2|Study Period|Withdrawal by Subject|0
5789401|NCT03377634|19946868|P1|Study Period|Withdrawal by Subject|1
5789402|NCT03377634|19946867|P2|Study Period|Adverse Event|0
5789403|NCT03377634|19946868|P1|Study Period|Adverse Event|1
5789404|NCT03376516|19946890|P1|Overall Study|Consent withdrawn|1
5789405|NCT03376516|19946890|P1|Overall Study|Not treated|1
5789406|NCT03374995|19946971|P2|Overall Study|Withdrawal by Subject|1
5789407|NCT03374995|19946972|P1|Overall Study|Withdrawal by Subject|0
5789408|NCT03374488|19946986|P2|Overall Study|On-going at clinical cut off date|28
5789409|NCT03374488|19946987|P1|Overall Study|On-going at clinical cut off date|30
5789410|NCT03374488|19946986|P2|Overall Study|Withdrawal by Subject|1
5789411|NCT03374488|19946987|P1|Overall Study|Withdrawal by Subject|1
5789412|NCT03374488|19946986|P2|Overall Study|Death|8
5789413|NCT03374488|19946987|P1|Overall Study|Death|10
5789414|NCT03374189|19946999|P2|Overall Study|Lost to Follow-up|0
5789415|NCT03374189|19947000|P1|Overall Study|Lost to Follow-up|1
5789416|NCT03372603|19947140|P2|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|0
5789417|NCT03372603|19947141|P1|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|1
5789418|NCT03372603|19947140|P2|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|0
5789419|NCT03372603|19947141|P1|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|1
5789420|NCT03372551|19947183|P2|First Intervention (1 Week)|Withdrawal by Subject|0
5789421|NCT03372551|19947184|P1|First Intervention (1 Week)|Withdrawal by Subject|1
5789422|NCT03372369|19947214|P2|Intervention and Follow-Up Period|Withdrawal by Subject|3
5789423|NCT03372369|19947215|P1|Intervention and Follow-Up Period|Withdrawal by Subject|3
5789424|NCT03372369|19947214|P2|Qualification Period|Inconsistent Eligibility Results|9
5789425|NCT03372369|19947215|P1|Qualification Period|Inconsistent Eligibility Results|10
5789426|NCT03372369|19947214|P2|Qualification Period|Withdrawal by Subject|13
5789427|NCT03372369|19947215|P1|Qualification Period|Withdrawal by Subject|16
5789428|NCT03372083|19947227|P1|Overall Study|Withdrawal by Subject|1
5789429|NCT03372083|19947227|P1|Overall Study|Physician Decision|1
5789430|NCT03372083|19947227|P1|Overall Study|Adverse Event|3
5789431|NCT03371459|19947259|P2|Washout|Lost to Follow-up|1
5789432|NCT03371459|19947260|P1|Washout|Lost to Follow-up|0
5789433|NCT03371381|19947268|P1|Overall Study|Other|4
5789434|NCT03371381|19947268|P1|Overall Study|Study terminated by sponsor|3
5789435|NCT03371381|19947268|P1|Overall Study|Death|5
5789436|NCT03370770|19947280|P1|Overall Study|Death|5
5789437|NCT03370770|19947280|P1|Overall Study|Adverse Event|2
5789438|NCT03370770|19947280|P1|Overall Study|Progressive Disease|98
5789439|NCT03370770|19947280|P1|Overall Study|Patient was followed in another hospital center|1
5789440|NCT03370419|19947294|P1|Overall Study|Lost to Follow-up|16
5789441|NCT03370302|19947304|P6|Dose Expansion Phase|Progressive Disease|0
5789442|NCT03370302|19947305|P5|Dose Expansion Phase|Progressive Disease|0
5789443|NCT03370302|19947306|P4|Dose Expansion Phase|Progressive Disease|6
5789444|NCT03370302|19947307|P3|Dose Expansion Phase|Progressive Disease|0
5789445|NCT03370302|19947308|P2|Dose Expansion Phase|Progressive Disease|0
5789446|NCT03370302|19947309|P1|Dose Expansion Phase|Progressive Disease|0
5789447|NCT03370302|19947304|P6|Dose Escalation Phase|Progressive Disease|1
5789448|NCT03370302|19947305|P5|Dose Escalation Phase|Progressive Disease|3
5789449|NCT03370302|19947306|P4|Dose Escalation Phase|Progressive Disease|0
5789450|NCT03370302|19947307|P3|Dose Escalation Phase|Progressive Disease|2
5789451|NCT03370302|19947308|P2|Dose Escalation Phase|Progressive Disease|4
5789452|NCT03370302|19947309|P1|Dose Escalation Phase|Progressive Disease|2
5789453|NCT03370302|19947304|P6|Dose Escalation Phase|Adverse Event|0
5789454|NCT03370302|19947305|P5|Dose Escalation Phase|Adverse Event|0
5789455|NCT03370302|19947306|P4|Dose Escalation Phase|Adverse Event|0
5789456|NCT03370302|19947307|P3|Dose Escalation Phase|Adverse Event|2
5789457|NCT03370302|19947308|P2|Dose Escalation Phase|Adverse Event|0
5789458|NCT03370302|19947309|P1|Dose Escalation Phase|Adverse Event|1
5789459|NCT03370302|19947304|P6|Dose Escalation Phase|Withdrawal by Subject|2
5789460|NCT03370302|19947305|P5|Dose Escalation Phase|Withdrawal by Subject|0
5789461|NCT03370302|19947306|P4|Dose Escalation Phase|Withdrawal by Subject|0
5789462|NCT03370302|19947307|P3|Dose Escalation Phase|Withdrawal by Subject|2
5789463|NCT03370302|19947308|P2|Dose Escalation Phase|Withdrawal by Subject|1
5789464|NCT03370302|19947309|P1|Dose Escalation Phase|Withdrawal by Subject|0
5789465|NCT03370302|19947304|P6|Dose Escalation Phase|Other|0
5789466|NCT03370302|19947305|P5|Dose Escalation Phase|Other|0
5789467|NCT03370302|19947306|P4|Dose Escalation Phase|Other|0
5789468|NCT03370302|19947307|P3|Dose Escalation Phase|Other|1
5789469|NCT03370302|19947308|P2|Dose Escalation Phase|Other|1
5789470|NCT03370302|19947309|P1|Dose Escalation Phase|Other|0
5789471|NCT03370289|19947406|P1|Overall Study|Sample Size Sufficient|4
5789472|NCT03370289|19947406|P1|Overall Study|Screen Failure|1
5789473|NCT03369951|19947440|P1|Overall Study|Protocol Violation|1
5789474|NCT03369951|19947440|P1|Overall Study|Lost to Follow-up|1
5789475|NCT03369951|19947440|P1|Overall Study|Death|1
5789476|NCT03369951|19947440|P1|Overall Study|Withdrawal by Subject|3
5789477|NCT03369704|19947475|P2|Follow-up Epoch|Lost to Follow-up|0
5789478|NCT03369704|19947476|P1|Follow-up Epoch|Lost to Follow-up|1
5789479|NCT03369704|19947475|P2|Treatment Epoch|Adverse Event|0
5789480|NCT03369704|19947476|P1|Treatment Epoch|Adverse Event|2
5789481|NCT03369704|19947475|P2|Treatment Epoch|Lack of Efficacy|2
5789482|NCT03369704|19947476|P1|Treatment Epoch|Lack of Efficacy|0
5789483|NCT03369704|19947475|P2|Treatment Epoch|Lost to Follow-up|1
5789484|NCT03369704|19947476|P1|Treatment Epoch|Lost to Follow-up|0
5789485|NCT03369704|19947475|P2|Treatment Epoch|Protocol Violation|0
5789486|NCT03369704|19947476|P1|Treatment Epoch|Protocol Violation|1
5789487|NCT03369704|19947475|P2|Treatment Epoch|technical problems|0
5789488|NCT03369704|19947476|P1|Treatment Epoch|technical problems|1
5789489|NCT03369418|19947511|P2|Overall Study|Withdrawal by Subject|3
5789490|NCT03369418|19947512|P1|Overall Study|Withdrawal by Subject|3
5789491|NCT03368807|19947668|P1|Period 1 (Blinded CGM)|Lost to Follow-up|1
5789492|NCT03368807|19947668|P1|Period 1 (Blinded CGM)|Sponsor Decision|1
5789493|NCT03368807|19947668|P1|Period 1 (Blinded CGM)|Protocol Violation|1
5789494|NCT03368807|19947668|P1|Period 1 (Blinded CGM)|Withdrawal by Subject|3
5789495|NCT03368170|19947718|P2|Overall Study|Adverse Event|1
5789496|NCT03368170|19947719|P1|Overall Study|Adverse Event|2
5789497|NCT03365934|19947751|P1|Overall Study|Withdrawal by Subject|1
5789498|NCT03365934|19947751|P1|Overall Study|Adverse Event|1
5789499|NCT03365011|19948041|P2|Overall Study|Withdrawal by Subject|2
5789500|NCT03365011|19948042|P1|Overall Study|Withdrawal by Subject|1
5789501|NCT03364608|19948052|P1|Overall Study|Lost to Follow-up|2
5789502|NCT03364608|19948052|P1|Overall Study|Protocol Violation|2
5789503|NCT03364608|19948052|P1|Overall Study|Withdrawal by Subject|4
5789504|NCT03364335|19948079|P5|Overall Study|Lost to Follow-up|11
5789505|NCT03364335|19948080|P4|Overall Study|Lost to Follow-up|11
5789506|NCT03364335|19948081|P3|Overall Study|Lost to Follow-up|10
5789507|NCT03364335|19948082|P2|Overall Study|Lost to Follow-up|7
5789508|NCT03364335|19948083|P1|Overall Study|Lost to Follow-up|7
5789509|NCT03364335|19948079|P5|Overall Study|Adverse Event|0
5789510|NCT03364335|19948080|P4|Overall Study|Adverse Event|2
5789511|NCT03364335|19948081|P3|Overall Study|Adverse Event|1
5789512|NCT03364335|19948082|P2|Overall Study|Adverse Event|4
5789513|NCT03364335|19948083|P1|Overall Study|Adverse Event|3
5789514|NCT03364192|19948155|P1|Overall Study|Lost to Follow-up|1
5789515|NCT03364192|19948155|P1|Overall Study|Withdrawal by Subject|5
5789516|NCT03364192|19948155|P1|Overall Study|Ineligible|10
5789517|NCT03364023|19948162|P1|Overall Study|Death|14
5789518|NCT03364023|19948162|P1|Overall Study|Lost to Follow-up|3
5789519|NCT03363906|19948169|P2|Period 2 (Test or Reference)|Lost to Follow-up|0
5789520|NCT03363906|19948170|P1|Period 2 (Test or Reference)|Lost to Follow-up|1
5789521|NCT03363906|19948169|P2|Period 2 (Test or Reference)|Withdrawal by Subject|1
5789522|NCT03363906|19948170|P1|Period 2 (Test or Reference)|Withdrawal by Subject|1
5789523|NCT03363906|19948169|P2|Period 2 (Test or Reference)|Adverse Event|0
5789524|NCT03363906|19948170|P1|Period 2 (Test or Reference)|Adverse Event|2
5789525|NCT03363906|19948169|P2|Period 1 (Reference or Test)|Adverse Event|2
5789526|NCT03363906|19948170|P1|Period 1 (Reference or Test)|Adverse Event|1
5789527|NCT03363776|19948243|P3|Overall Study|Death|0
5789528|NCT03363776|19948244|P2|Overall Study|Death|0
5789529|NCT03363776|19948245|P1|Overall Study|Death|1
5789530|NCT03363776|19948243|P3|Overall Study|Study drug toxicity|1
5789531|NCT03363776|19948244|P2|Overall Study|Study drug toxicity|0
5789532|NCT03363776|19948245|P1|Overall Study|Study drug toxicity|0
5789533|NCT03363776|19948243|P3|Overall Study|Progressive disease|1
5789534|NCT03363776|19948244|P2|Overall Study|Progressive disease|3
5789535|NCT03363776|19948245|P1|Overall Study|Progressive disease|2
5789536|NCT03361865|19948399|P2|Overall Study|On-going at clinical cut off date|39
5789537|NCT03361865|19948400|P1|Overall Study|On-going at clinical cut off date|29
5789538|NCT03361865|19948399|P2|Overall Study|Physician Decision|0
5789539|NCT03361865|19948400|P1|Overall Study|Physician Decision|1
5789540|NCT03361865|19948399|P2|Overall Study|Death|10
5789541|NCT03361865|19948400|P1|Overall Study|Death|13
5789542|NCT03361605|19948410|P1|Overall Study|Analyzable data not available|3
5789543|NCT03361228|19948417|P2|Overall Study|Death|0
5789544|NCT03361228|19948418|P1|Overall Study|Death|3
5789545|NCT03361228|19948417|P2|Overall Study|Other|1
5789546|NCT03361228|19948418|P1|Overall Study|Other|1
5789547|NCT03361176|19948440|P2|Overall Study|Withdrawal by Subject|1
5789548|NCT03361176|19948441|P1|Overall Study|Withdrawal by Subject|0
5789549|NCT03361176|19948440|P2|Overall Study|Adverse Event|2
5789550|NCT03361176|19948441|P1|Overall Study|Adverse Event|0
5789551|NCT03361176|19948440|P2|Overall Study|Lost to Follow-up|2
5789552|NCT03361176|19948441|P1|Overall Study|Lost to Follow-up|1
5789553|NCT03360747|19948472|P1|Overall Study|Voluntary Withdrawal|1
5789554|NCT03360344|19948488|P3|Overall Study|Withdrawal by Subject|1
5789555|NCT03360344|19948489|P2|Overall Study|Withdrawal by Subject|1
5789556|NCT03360344|19948490|P1|Overall Study|Withdrawal by Subject|0
5789557|NCT03360071|19948553|P2|Overall Study|Lost to Follow-up|0
5789558|NCT03360071|19948554|P1|Overall Study|Lost to Follow-up|1
5789559|NCT03359850|19948568|P2|Extension Phase (Up to 18 Months)|Ongoing in the study|1
5789560|NCT03359850|19948569|P1|Extension Phase (Up to 18 Months)|Ongoing in the study|1
5789561|NCT03359850|19948568|P2|Extension Phase (Up to 18 Months)|Disease Progression|0
5789562|NCT03359850|19948569|P1|Extension Phase (Up to 18 Months)|Disease Progression|5
5789563|NCT03359850|19948568|P2|Extension Phase (Up to 18 Months)|Withdrawal by Subject|2
5789564|NCT03359850|19948569|P1|Extension Phase (Up to 18 Months)|Withdrawal by Subject|0
5789565|NCT03359850|19948568|P2|Extension Phase (Up to 18 Months)|Death|4
5789566|NCT03359850|19948569|P1|Extension Phase (Up to 18 Months)|Death|2
5789567|NCT03359850|19948568|P2|PK Phase (Up to Day 8)|Adverse Event|0
5789568|NCT03359850|19948569|P1|PK Phase (Up to Day 8)|Adverse Event|1
5789569|NCT03359850|19948568|P2|PK Phase (Up to Day 8)|Physician Decision|1
5789570|NCT03359850|19948569|P1|PK Phase (Up to Day 8)|Physician Decision|0
5789571|NCT03359473|19948652|P4|Overall Study|Protocol-defined stopping criteria|1
5789572|NCT03359473|19948653|P3|Overall Study|Protocol-defined stopping criteria|0
5789573|NCT03359473|19948654|P2|Overall Study|Protocol-defined stopping criteria|0
5789574|NCT03359473|19948655|P1|Overall Study|Protocol-defined stopping criteria|1
5789575|NCT03359473|19948652|P4|Overall Study|Withdrawal by Subject|0
5789576|NCT03359473|19948653|P3|Overall Study|Withdrawal by Subject|1
5789577|NCT03359473|19948654|P2|Overall Study|Withdrawal by Subject|2
5789578|NCT03359473|19948655|P1|Overall Study|Withdrawal by Subject|1
5789579|NCT03359473|19948652|P4|Overall Study|Physician Decision|1
5789580|NCT03359473|19948653|P3|Overall Study|Physician Decision|0
5789581|NCT03359473|19948654|P2|Overall Study|Physician Decision|1
5789582|NCT03359473|19948655|P1|Overall Study|Physician Decision|0
5789583|NCT03359473|19948652|P4|Overall Study|Lost to Follow-up|0
5789584|NCT03359473|19948653|P3|Overall Study|Lost to Follow-up|0
5789585|NCT03359473|19948654|P2|Overall Study|Lost to Follow-up|1
5789586|NCT03359473|19948655|P1|Overall Study|Lost to Follow-up|0
5789587|NCT03359473|19948652|P4|Overall Study|Adverse Event|3
5789588|NCT03359473|19948653|P3|Overall Study|Adverse Event|5
5789589|NCT03359473|19948654|P2|Overall Study|Adverse Event|2
5789590|NCT03359473|19948655|P1|Overall Study|Adverse Event|0
5789591|NCT03358472|19948879|P3|Overall Study|On-going at clinical cut off date|5
5789592|NCT03358472|19948880|P2|Overall Study|On-going at clinical cut off date|6
5789593|NCT03358472|19948881|P1|Overall Study|On-going at clinical cut off date|9
5789594|NCT03358472|19948879|P3|Overall Study|Withdrawal by Subject|1
5789595|NCT03358472|19948880|P2|Overall Study|Withdrawal by Subject|0
5789596|NCT03358472|19948881|P1|Overall Study|Withdrawal by Subject|0
5789597|NCT03358472|19948879|P3|Overall Study|Physician Decision|0
5789598|NCT03358472|19948880|P2|Overall Study|Physician Decision|1
5789599|NCT03358472|19948881|P1|Overall Study|Physician Decision|0
5789600|NCT03358472|19948879|P3|Overall Study|Death|10
5789601|NCT03358472|19948880|P2|Overall Study|Death|3
5789602|NCT03358472|19948881|P1|Overall Study|Death|6
5789603|NCT03358407|19948905|P10|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0
5789604|NCT03358407|19948906|P9|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0
5789605|NCT03358407|19948907|P8|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|6
5789606|NCT03358407|19948908|P7|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|3
5789607|NCT03358407|19948909|P6|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|3
5789608|NCT03358407|19948910|P5|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0
5789609|NCT03358407|19948911|P4|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0
5789610|NCT03358407|19948912|P3|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0
5789611|NCT03358407|19948913|P2|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0
5789612|NCT03358407|19948914|P1|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0
5789613|NCT03358407|19948905|P10|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0
5789614|NCT03358407|19948906|P9|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0
5789615|NCT03358407|19948907|P8|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0
5789616|NCT03358407|19948908|P7|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|1
5789617|NCT03358407|19948909|P6|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|1
5789618|NCT03358407|19948910|P5|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0
5789619|NCT03358407|19948911|P4|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0
5789620|NCT03358407|19948912|P3|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0
5789621|NCT03358407|19948913|P2|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0
5789622|NCT03358407|19948914|P1|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0
5789623|NCT03358407|19948905|P10|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0
5789624|NCT03358407|19948906|P9|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0
5789625|NCT03358407|19948907|P8|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|1
5789626|NCT03358407|19948908|P7|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0
5789627|NCT03358407|19948909|P6|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|1
5789628|NCT03358407|19948910|P5|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0
5789629|NCT03358407|19948911|P4|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0
5789630|NCT03358407|19948912|P3|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0
5789631|NCT03358407|19948913|P2|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0
5789632|NCT03358407|19948914|P1|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0
5789633|NCT03358407|19948905|P10|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0
5789634|NCT03358407|19948906|P9|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0
5789635|NCT03358407|19948907|P8|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|2
5789636|NCT03358407|19948908|P7|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0
5789637|NCT03358407|19948909|P6|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|1
5789638|NCT03358407|19948910|P5|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0
5789639|NCT03358407|19948911|P4|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0
5789640|NCT03358407|19948912|P3|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0
5789641|NCT03358407|19948913|P2|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0
5789642|NCT03358407|19948914|P1|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0
5789643|NCT03358407|19948905|P10|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0
5789644|NCT03358407|19948906|P9|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0
5789645|NCT03358407|19948907|P8|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0
5789646|NCT03358407|19948908|P7|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0
5789647|NCT03358407|19948909|P6|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0
5789648|NCT03358407|19948910|P5|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|1
5789649|NCT03358407|19948911|P4|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0
5789650|NCT03358407|19948912|P3|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0
5789651|NCT03358407|19948913|P2|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0
5789652|NCT03358407|19948914|P1|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0
5789653|NCT03358407|19948905|P10|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0
5789654|NCT03358407|19948906|P9|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0
5789655|NCT03358407|19948907|P8|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0
5789656|NCT03358407|19948908|P7|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0
5789657|NCT03358407|19948909|P6|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0
5789658|NCT03358407|19948910|P5|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0
5789659|NCT03358407|19948911|P4|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0
5789660|NCT03358407|19948912|P3|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|1
5789661|NCT03358407|19948913|P2|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0
5789662|NCT03358407|19948914|P1|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0
5789663|NCT03358329|19949191|P1|Overall Study|Withdrawal by Subject|2
5789664|NCT03358329|19949191|P1|Overall Study|Lost to Follow-up|2
5789665|NCT03358238|19949222|P2|Overall Study|Withdrawal by Subject|1
5789666|NCT03358238|19949223|P1|Overall Study|Withdrawal by Subject|0
5789667|NCT03358147|19949243|P5|Overall Study|Lack of Efficacy|0
5789668|NCT03358147|19949244|P4|Overall Study|Lack of Efficacy|0
5789669|NCT03358147|19949245|P3|Overall Study|Lack of Efficacy|1
5789670|NCT03358147|19949246|P2|Overall Study|Lack of Efficacy|1
5789671|NCT03358147|19949247|P1|Overall Study|Lack of Efficacy|0
5789672|NCT03358147|19949243|P5|Overall Study|Administrative reasons|0
5789673|NCT03358147|19949244|P4|Overall Study|Administrative reasons|3
5789674|NCT03358147|19949245|P3|Overall Study|Administrative reasons|0
5789675|NCT03358147|19949246|P2|Overall Study|Administrative reasons|1
5789676|NCT03358147|19949247|P1|Overall Study|Administrative reasons|0
5789677|NCT03358147|19949243|P5|Overall Study|Physician Decision|1
5789678|NCT03358147|19949244|P4|Overall Study|Physician Decision|6
5789679|NCT03358147|19949245|P3|Overall Study|Physician Decision|1
5789680|NCT03358147|19949246|P2|Overall Study|Physician Decision|0
5789681|NCT03358147|19949247|P1|Overall Study|Physician Decision|1
5789682|NCT03358147|19949243|P5|Overall Study|Protocol specified criteria|1
5789683|NCT03358147|19949244|P4|Overall Study|Protocol specified criteria|3
5789684|NCT03358147|19949245|P3|Overall Study|Protocol specified criteria|0
5789685|NCT03358147|19949246|P2|Overall Study|Protocol specified criteria|3
5789686|NCT03358147|19949247|P1|Overall Study|Protocol specified criteria|2
5789687|NCT03358147|19949243|P5|Overall Study|Major Protocol Deviation|1
5789688|NCT03358147|19949244|P4|Overall Study|Major Protocol Deviation|3
5789689|NCT03358147|19949245|P3|Overall Study|Major Protocol Deviation|2
5789690|NCT03358147|19949246|P2|Overall Study|Major Protocol Deviation|3
5789691|NCT03358147|19949247|P1|Overall Study|Major Protocol Deviation|11
5789692|NCT03358147|19949243|P5|Overall Study|Lost to Follow-up|4
5789693|NCT03358147|19949244|P4|Overall Study|Lost to Follow-up|6
5789694|NCT03358147|19949245|P3|Overall Study|Lost to Follow-up|7
5789695|NCT03358147|19949246|P2|Overall Study|Lost to Follow-up|3
5789696|NCT03358147|19949247|P1|Overall Study|Lost to Follow-up|4
5789697|NCT03358147|19949243|P5|Overall Study|Adverse Event|2
5789698|NCT03358147|19949244|P4|Overall Study|Adverse Event|5
5789699|NCT03358147|19949245|P3|Overall Study|Adverse Event|7
5789700|NCT03358147|19949246|P2|Overall Study|Adverse Event|9
5789701|NCT03358147|19949247|P1|Overall Study|Adverse Event|3
5789702|NCT03358147|19949243|P5|Overall Study|Withdrawal by Subject|5
5789703|NCT03358147|19949244|P4|Overall Study|Withdrawal by Subject|10
5789704|NCT03358147|19949245|P3|Overall Study|Withdrawal by Subject|16
5789705|NCT03358147|19949246|P2|Overall Study|Withdrawal by Subject|19
5789706|NCT03358147|19949247|P1|Overall Study|Withdrawal by Subject|13
5789707|NCT03357731|19949284|P6|Overall Study|Lost to Follow-up|0
5789708|NCT03357731|19949285|P5|Overall Study|Lost to Follow-up|0
5789709|NCT03357731|19949286|P4|Overall Study|Lost to Follow-up|1
5789710|NCT03357731|19949287|P3|Overall Study|Lost to Follow-up|0
5789711|NCT03357731|19949288|P2|Overall Study|Lost to Follow-up|0
5789712|NCT03357731|19949289|P1|Overall Study|Lost to Follow-up|0
5789713|NCT03357731|19949284|P6|Overall Study|Hypotension|0
5789714|NCT03357731|19949285|P5|Overall Study|Hypotension|0
5789715|NCT03357731|19949286|P4|Overall Study|Hypotension|1
5789716|NCT03357731|19949287|P3|Overall Study|Hypotension|1
5789717|NCT03357731|19949288|P2|Overall Study|Hypotension|0
5789718|NCT03357731|19949289|P1|Overall Study|Hypotension|0
5789719|NCT03357731|19949284|P6|Overall Study|Adverse Event|1
5789720|NCT03357731|19949285|P5|Overall Study|Adverse Event|0
5789721|NCT03357731|19949286|P4|Overall Study|Adverse Event|0
5789722|NCT03357731|19949287|P3|Overall Study|Adverse Event|0
5789723|NCT03357731|19949288|P2|Overall Study|Adverse Event|0
5789724|NCT03357731|19949289|P1|Overall Study|Adverse Event|0
5789725|NCT03357731|19949284|P6|Overall Study|Acute bradycardia and hypotension|0
5789726|NCT03357731|19949285|P5|Overall Study|Acute bradycardia and hypotension|0
5789727|NCT03357731|19949286|P4|Overall Study|Acute bradycardia and hypotension|1
5789728|NCT03357731|19949287|P3|Overall Study|Acute bradycardia and hypotension|0
5789729|NCT03357731|19949288|P2|Overall Study|Acute bradycardia and hypotension|0
5789730|NCT03357731|19949289|P1|Overall Study|Acute bradycardia and hypotension|0
5789731|NCT03357731|19949284|P6|Overall Study|Withdrew consent due to personal reasons|0
5789732|NCT03357731|19949285|P5|Overall Study|Withdrew consent due to personal reasons|1
5789733|NCT03357731|19949286|P4|Overall Study|Withdrew consent due to personal reasons|0
5789734|NCT03357731|19949287|P3|Overall Study|Withdrew consent due to personal reasons|0
5789735|NCT03357731|19949288|P2|Overall Study|Withdrew consent due to personal reasons|0
5789736|NCT03357731|19949289|P1|Overall Study|Withdrew consent due to personal reasons|0
5789737|NCT03357471|19949328|P2|Overall Study|Lost to Follow-up|0
5789738|NCT03357471|19949329|P1|Overall Study|Lost to Follow-up|1
5789739|NCT03357471|19949328|P2|Overall Study|Adverse Event|0
5789740|NCT03357471|19949329|P1|Overall Study|Adverse Event|1
5789741|NCT03357341|19949386|P2|Overall Study|Death|1
5789742|NCT03357341|19949387|P1|Overall Study|Death|0
5789743|NCT03357341|19949386|P2|Overall Study|Lost to Follow-up|5
5789744|NCT03357341|19949387|P1|Overall Study|Lost to Follow-up|4
5789745|NCT03357341|19949386|P2|Overall Study|Withdrawal by Subject|6
5789746|NCT03357341|19949387|P1|Overall Study|Withdrawal by Subject|3
5789747|NCT03356977|19949427|P1|Overall Study|Withdrawal by parent/guardian|2
5789748|NCT03356977|19949427|P1|Overall Study|Lost to Follow-up|3
5789749|NCT03354663|19949475|P1|Completed 30-day Visit|Missed Visit|1
5789750|NCT03354663|19949475|P1|Completed 30-day Visit|Withdrawal by Subject|1
5789751|NCT03354663|19949475|P1|Enrollment to Catheter Insertion|Adverse Event|1
5789752|NCT03354663|19949475|P1|Enrollment to Catheter Insertion|Did not meet inc/exc criteria|4
5789753|NCT03354637|19949502|P3|Open Label Extension|Physician Decision|1
5789754|NCT03354637|19949503|P2|Open Label Extension|Physician Decision|0
5789755|NCT03354637|19949504|P1|Open Label Extension|Physician Decision|0
5789756|NCT03354637|19949502|P3|Open Label Extension|Lack of Efficacy|1
5789757|NCT03354637|19949503|P2|Open Label Extension|Lack of Efficacy|0
5789758|NCT03354637|19949504|P1|Open Label Extension|Lack of Efficacy|0
5789759|NCT03354637|19949502|P3|Open Label Extension|Subject Noncompliance|1
5789760|NCT03354637|19949503|P2|Open Label Extension|Subject Noncompliance|0
5789761|NCT03354637|19949504|P1|Open Label Extension|Subject Noncompliance|0
5789762|NCT03354637|19949502|P3|Open Label Extension|Study Terminated by Sponsor|17
5789763|NCT03354637|19949503|P2|Open Label Extension|Study Terminated by Sponsor|0
5789764|NCT03354637|19949504|P1|Open Label Extension|Study Terminated by Sponsor|0
5789765|NCT03354637|19949502|P3|Open Label Extension|Withdrawal by Subject|5
5789766|NCT03354637|19949503|P2|Open Label Extension|Withdrawal by Subject|0
5789767|NCT03354637|19949504|P1|Open Label Extension|Withdrawal by Subject|0
5789768|NCT03354637|19949502|P3|Open Label Extension|Lost to Follow-up|2
5789769|NCT03354637|19949503|P2|Open Label Extension|Lost to Follow-up|0
5789770|NCT03354637|19949504|P1|Open Label Extension|Lost to Follow-up|0
5789771|NCT03354637|19949502|P3|Open Label Extension|Adverse Event|1
5789772|NCT03354637|19949503|P2|Open Label Extension|Adverse Event|0
5789773|NCT03354637|19949504|P1|Open Label Extension|Adverse Event|0
5789774|NCT03354637|19949502|P3|Double-blind Period|Incomplete Efficacy Data Collection|0
5789775|NCT03354637|19949503|P2|Double-blind Period|Incomplete Efficacy Data Collection|1
5789776|NCT03354637|19949504|P1|Double-blind Period|Incomplete Efficacy Data Collection|1
5789777|NCT03354637|19949502|P3|Double-blind Period|Withdrawal by Subject|4
5789778|NCT03354637|19949503|P2|Double-blind Period|Withdrawal by Subject|6
5789779|NCT03354637|19949504|P1|Double-blind Period|Withdrawal by Subject|10
5789780|NCT03354637|19949502|P3|Double-blind Period|Lost to Follow-up|3
5789781|NCT03354637|19949503|P2|Double-blind Period|Lost to Follow-up|4
5789782|NCT03354637|19949504|P1|Double-blind Period|Lost to Follow-up|3
5789783|NCT03354637|19949502|P3|Double-blind Period|Adverse Event|0
5789784|NCT03354637|19949503|P2|Double-blind Period|Adverse Event|2
5789785|NCT03354637|19949504|P1|Double-blind Period|Adverse Event|1
5789786|NCT03354637|19949502|P3|Double-blind Period|Protocol Violation|0
5789787|NCT03354637|19949503|P2|Double-blind Period|Protocol Violation|0
5789788|NCT03354637|19949504|P1|Double-blind Period|Protocol Violation|2
5789789|NCT03354429|19949578|P2|Overall Study|Lost to Follow-up|0
5789790|NCT03354429|19949579|P1|Overall Study|Lost to Follow-up|1
5789791|NCT03354429|19949578|P2|Overall Study|Withdrawal by Subject|7
5789792|NCT03354429|19949579|P1|Overall Study|Withdrawal by Subject|8
5789793|NCT03353922|19949630|P6|Overall Study|Adverse Event|0
5789794|NCT03353922|19949631|P5|Overall Study|Adverse Event|0
5789795|NCT03353922|19949632|P4|Overall Study|Adverse Event|0
5789796|NCT03353922|19949633|P3|Overall Study|Adverse Event|0
5789797|NCT03353922|19949634|P2|Overall Study|Adverse Event|1
5789798|NCT03353922|19949635|P1|Overall Study|Adverse Event|0
5789799|NCT03353922|19949630|P6|Overall Study|Withdrawal by Subject|0
5789800|NCT03353922|19949631|P5|Overall Study|Withdrawal by Subject|0
5789801|NCT03353922|19949632|P4|Overall Study|Withdrawal by Subject|1
5789802|NCT03353922|19949633|P3|Overall Study|Withdrawal by Subject|1
5789803|NCT03353922|19949634|P2|Overall Study|Withdrawal by Subject|0
5789804|NCT03353922|19949635|P1|Overall Study|Withdrawal by Subject|1
5789805|NCT03352713|19949677|P1|Overall Study|Device incompatible/stolen|5
5789806|NCT03352713|19949677|P1|Overall Study|Completed 0 EMAs|8
5789807|NCT03352713|19949677|P1|Overall Study|Withdrawn by investigator|5
5789808|NCT03352713|19949677|P1|Overall Study|Lost to Follow-up|8
5789809|NCT03352453|19949698|P2|Overall Study|Adverse Event|9
5789810|NCT03352453|19949699|P1|Overall Study|Adverse Event|2
5789811|NCT03352453|19949698|P2|Overall Study|Lost to Follow-up|6
5789812|NCT03352453|19949699|P1|Overall Study|Lost to Follow-up|7
5789813|NCT03352453|19949698|P2|Overall Study|Protocol Deviation|0
5789814|NCT03352453|19949699|P1|Overall Study|Protocol Deviation|1
5789815|NCT03352453|19949698|P2|Overall Study|Study Terminated by Sponsor|1
5789816|NCT03352453|19949699|P1|Overall Study|Study Terminated by Sponsor|2
5789817|NCT03352453|19949698|P2|Overall Study|Withdrawal by Subject|14
5789818|NCT03352453|19949699|P1|Overall Study|Withdrawal by Subject|8
5789819|NCT03352453|19949698|P2|Overall Study|Lack of Efficacy|0
5789820|NCT03352453|19949699|P1|Overall Study|Lack of Efficacy|1
5789821|NCT03352453|19949698|P2|Overall Study|Miscellaneous Reasons|2
5789822|NCT03352453|19949699|P1|Overall Study|Miscellaneous Reasons|1
5789823|NCT03351738|19949725|P6|Overall Study|Withdrawal by Subject|0
5789824|NCT03351738|19949726|P5|Overall Study|Withdrawal by Subject|0
5789825|NCT03351738|19949727|P4|Overall Study|Withdrawal by Subject|1
5789826|NCT03351738|19949728|P3|Overall Study|Withdrawal by Subject|0
5789827|NCT03351738|19949729|P2|Overall Study|Withdrawal by Subject|1
5789828|NCT03351738|19949730|P1|Overall Study|Withdrawal by Subject|0
5789829|NCT03351335|19949882|P3|Overall Study|Failure to maintain inclusion/exclusion|4
5789830|NCT03351335|19949883|P2|Overall Study|Failure to maintain inclusion/exclusion|0
5789831|NCT03351335|19949884|P1|Overall Study|Failure to maintain inclusion/exclusion|0
5789832|NCT03351231|19949904|P1|Safety Follow-Up Period|Other reason|2
5789833|NCT03351231|19949904|P1|Safety Follow-Up Period|Participant withdrew consent|1
5789834|NCT03351231|19949904|P1|Combination Therapy Period|Adverse Event unrelated to study drug|1
5789835|NCT03351231|19949904|P1|Combination Therapy Period|Study drug toxicity|1
5789836|NCT03351231|19949904|P1|Combination Therapy Period|Disease progression|2
5789837|NCT03351231|19949904|P1|Combination Therapy Period|Administrative reason by the Sponsor|1
5789838|NCT03350984|19949939|P2|Overall Study|Physician Decision|0
5789839|NCT03350984|19949940|P1|Overall Study|Physician Decision|1
5789840|NCT03350984|19949939|P2|Overall Study|Protocol Violation|2
5789841|NCT03350984|19949940|P1|Overall Study|Protocol Violation|1
5789842|NCT03350984|19949939|P2|Overall Study|Lost to Follow-up|6
5789843|NCT03350984|19949940|P1|Overall Study|Lost to Follow-up|5
5789844|NCT03350984|19949939|P2|Overall Study|Death|0
5789845|NCT03350984|19949940|P1|Overall Study|Death|1
5789846|NCT03350503|19950018|P1|Overall Study|Subject Wishes|2
5789847|NCT03350503|19950018|P1|Overall Study|Hospital Transfer or Removal|2
5789848|NCT03350503|19950018|P1|Overall Study|Adverse Event|1
5789849|NCT03350256|19950022|P1|Overall Study|Lack of Efficacy|2
5789850|NCT03350256|19950022|P1|Overall Study|Lost to Follow-up|1
5789851|NCT03350256|19950022|P1|Overall Study|Subject moving out of state|1
5789852|NCT03350256|19950022|P1|Overall Study|Withdrawal by Subject|3
5789853|NCT03350256|19950022|P1|Overall Study|Did not proceed to permanent implant|3
5789854|NCT03350256|19950022|P1|Overall Study|Trial failure|12
5789855|NCT03350256|19950022|P1|Overall Study|Adverse Event|2
5789856|NCT03350256|19950022|P1|Overall Study|Denial by insurance|1
5789857|NCT03350256|19950022|P1|Overall Study|Non compliance|2
5789858|NCT03350256|19950022|P1|Overall Study|Protocol Violation|3
5789859|NCT03350256|19950022|P1|Overall Study|Recommended for other therapies|2
5789860|NCT03350256|19950022|P1|Overall Study|Inclusion/exclusion violation|4
5789861|NCT03349515|19950096|P2|Overall Study|Physician Decision|1
5789862|NCT03349515|19950097|P1|Overall Study|Physician Decision|3
5789863|NCT03349515|19950096|P2|Overall Study|Lack of Efficacy|0
5789864|NCT03349515|19950097|P1|Overall Study|Lack of Efficacy|2
5789865|NCT03349437|19950103|P3|Screening|Withdrawn|0
5789866|NCT03349437|19950104|P2|Screening|Withdrawn|0
5789867|NCT03349437|19950105|P1|Screening|Withdrawn|1
5789868|NCT03349437|19950103|P3|Screening|Screen Fail|0
5789869|NCT03349437|19950104|P2|Screening|Screen Fail|0
5789870|NCT03349437|19950105|P1|Screening|Screen Fail|4
5789871|NCT03349333|19950112|P1|Overall Study|Patients in treatment less than 24 month|8
5789872|NCT03349333|19950112|P1|Overall Study|3-week lapse between pralatrexate doses|1
5789873|NCT03349333|19950112|P1|Overall Study|Physician Decision|2
5789874|NCT03349333|19950112|P1|Overall Study|Conditions interfere with participation|2
5789875|NCT03349333|19950112|P1|Overall Study|Withdrawal by Subject|5
5789876|NCT03349333|19950112|P1|Overall Study|Other|6
5789877|NCT03349333|19950112|P1|Overall Study|Adverse Event|11
5789878|NCT03349333|19950112|P1|Overall Study|Progression of Disease|36
5789879|NCT03349099|19950135|P2|Overall Study|Stone migrated from the kidney|0
5789880|NCT03349099|19950136|P1|Overall Study|Stone migrated from the kidney|1
5789881|NCT03349099|19950135|P2|Overall Study|Physician Decision|4
5789882|NCT03349099|19950136|P1|Overall Study|Physician Decision|3
5789883|NCT03349060|19950149|P3|Overall Study|Other|0
5789884|NCT03349060|19950150|P2|Overall Study|Other|1
5789885|NCT03349060|19950151|P1|Overall Study|Other|2
5789886|NCT03349060|19950149|P3|Overall Study|Withdrawal By Parent/Guardian|0
5789887|NCT03349060|19950150|P2|Overall Study|Withdrawal By Parent/Guardian|1
5789888|NCT03349060|19950151|P1|Overall Study|Withdrawal By Parent/Guardian|0
5789889|NCT03349060|19950149|P3|Overall Study|Medication error,no linked adverse event|1
5789890|NCT03349060|19950150|P2|Overall Study|Medication error,no linked adverse event|0
5789891|NCT03349060|19950151|P1|Overall Study|Medication error,no linked adverse event|0
5789892|NCT03349060|19950149|P3|Overall Study|Withdrawal by Subject|4
5789893|NCT03349060|19950150|P2|Overall Study|Withdrawal by Subject|3
5789894|NCT03349060|19950151|P1|Overall Study|Withdrawal by Subject|5
5789895|NCT03349060|19950149|P3|Overall Study|Protocol Violation|1
5789896|NCT03349060|19950150|P2|Overall Study|Protocol Violation|2
5789897|NCT03349060|19950151|P1|Overall Study|Protocol Violation|2
5789898|NCT03349060|19950149|P3|Overall Study|Lost to Follow-up|1
5789899|NCT03349060|19950150|P2|Overall Study|Lost to Follow-up|1
5789900|NCT03349060|19950151|P1|Overall Study|Lost to Follow-up|2
5789901|NCT03349060|19950149|P3|Overall Study|Lack of Efficacy|2
5789902|NCT03349060|19950150|P2|Overall Study|Lack of Efficacy|0
5789903|NCT03349060|19950151|P1|Overall Study|Lack of Efficacy|1
5789904|NCT03349060|19950149|P3|Overall Study|Adverse Event|7
5789905|NCT03349060|19950150|P2|Overall Study|Adverse Event|9
5789906|NCT03349060|19950151|P1|Overall Study|Adverse Event|9
5789907|NCT03349034|19950292|P2|Overall Study|Other|1
5789908|NCT03349034|19950293|P1|Overall Study|Other|0
5789909|NCT03349034|19950292|P2|Overall Study|soft tissue flap used|0
5789910|NCT03349034|19950293|P1|Overall Study|soft tissue flap used|1
5789911|NCT03349034|19950292|P2|Overall Study|intubated for >48 hrs following surgery|1
5789912|NCT03349034|19950293|P1|Overall Study|intubated for >48 hrs following surgery|1
5789913|NCT03349034|19950292|P2|Overall Study|catheters dislodged during transport|0
5789914|NCT03349034|19950293|P1|Overall Study|catheters dislodged during transport|2
5789915|NCT03348904|19950314|P3|Overall Study|Administrative reason by the sponsor|0
5789916|NCT03348904|19950315|P2|Overall Study|Administrative reason by the sponsor|1
5789917|NCT03348904|19950316|P1|Overall Study|Administrative reason by the sponsor|0
5789918|NCT03346759|19950392|P2|Second Menstrual Cycle|Lost to Follow-up|0
5789919|NCT03346759|19950393|P1|Second Menstrual Cycle|Lost to Follow-up|1
5789920|NCT03346759|19950392|P2|First Menstrual Cycle|Withdrawal by Subject|0
5789921|NCT03346759|19950393|P1|First Menstrual Cycle|Withdrawal by Subject|1
5789922|NCT03346759|19950392|P2|Enrollment to Baseline Data Collected|Lost to Follow-up|3
5789923|NCT03346759|19950393|P1|Enrollment to Baseline Data Collected|Lost to Follow-up|2
5789924|NCT03346057|19950437|P4|Overall Study|Withdrawal by Subject|0
5789925|NCT03346057|19950438|P3|Overall Study|Withdrawal by Subject|0
5789926|NCT03346057|19950439|P2|Overall Study|Withdrawal by Subject|0
5789927|NCT03346057|19950440|P1|Overall Study|Withdrawal by Subject|1
5789928|NCT03346057|19950437|P4|Overall Study|Randomization Mistake - Not Treated|0
5789929|NCT03346057|19950438|P3|Overall Study|Randomization Mistake - Not Treated|0
5789930|NCT03346057|19950439|P2|Overall Study|Randomization Mistake - Not Treated|1
5789931|NCT03346057|19950440|P1|Overall Study|Randomization Mistake - Not Treated|1
5789932|NCT03346057|19950437|P4|Overall Study|Physician Decision|2
5789933|NCT03346057|19950438|P3|Overall Study|Physician Decision|0
5789934|NCT03346057|19950439|P2|Overall Study|Physician Decision|2
5789935|NCT03346057|19950440|P1|Overall Study|Physician Decision|3
5789936|NCT03346057|19950437|P4|Overall Study|Renal Insufficiency - Not Treated|0
5789937|NCT03346057|19950438|P3|Overall Study|Renal Insufficiency - Not Treated|0
5789938|NCT03346057|19950439|P2|Overall Study|Renal Insufficiency - Not Treated|0
5789939|NCT03346057|19950440|P1|Overall Study|Renal Insufficiency - Not Treated|1
5789940|NCT03346057|19950437|P4|Overall Study|Ineligible For Study - Not Treated|0
5789941|NCT03346057|19950438|P3|Overall Study|Ineligible For Study - Not Treated|0
5789942|NCT03346057|19950439|P2|Overall Study|Ineligible For Study - Not Treated|1
5789943|NCT03346057|19950440|P1|Overall Study|Ineligible For Study - Not Treated|0
5789944|NCT03346057|19950437|P4|Overall Study|Lost to Follow-up|0
5789945|NCT03346057|19950438|P3|Overall Study|Lost to Follow-up|1
5789946|NCT03346057|19950439|P2|Overall Study|Lost to Follow-up|2
5789947|NCT03346057|19950440|P1|Overall Study|Lost to Follow-up|0
5789948|NCT03346057|19950437|P4|Overall Study|Death|0
5789949|NCT03346057|19950438|P3|Overall Study|Death|0
5789950|NCT03346057|19950439|P2|Overall Study|Death|2
5789951|NCT03346057|19950440|P1|Overall Study|Death|1
5789952|NCT03345979|19950472|P2|Overall Study|Physician Decision|2
5789953|NCT03345979|19950473|P1|Overall Study|Physician Decision|0
5789954|NCT03345979|19950472|P2|Overall Study|Protocol Violation|3
5789955|NCT03345979|19950473|P1|Overall Study|Protocol Violation|1
5789956|NCT03345979|19950472|P2|Overall Study|Lack of Efficacy|2
5789957|NCT03345979|19950473|P1|Overall Study|Lack of Efficacy|4
5789958|NCT03345979|19950472|P2|Overall Study|Lost to Follow-up|9
5789959|NCT03345979|19950473|P1|Overall Study|Lost to Follow-up|8
5789960|NCT03345979|19950472|P2|Overall Study|Adverse Event|11
5789961|NCT03345979|19950473|P1|Overall Study|Adverse Event|10
5789962|NCT03345979|19950472|P2|Overall Study|Withdrawal by Subject|31
5789963|NCT03345979|19950473|P1|Overall Study|Withdrawal by Subject|20
5789964|NCT03345914|19950494|P3|Overall Study|Ongoing|1
5789965|NCT03345914|19950495|P2|Overall Study|Ongoing|0
5789966|NCT03345914|19950496|P1|Overall Study|Ongoing|0
5789967|NCT03345914|19950494|P3|Overall Study|Other|1
5789968|NCT03345914|19950495|P2|Overall Study|Other|1
5789969|NCT03345914|19950496|P1|Overall Study|Other|1
5789970|NCT03345914|19950494|P3|Overall Study|Withdrawal by Subject|2
5789971|NCT03345914|19950495|P2|Overall Study|Withdrawal by Subject|1
5789972|NCT03345914|19950496|P1|Overall Study|Withdrawal by Subject|5
5789973|NCT03345914|19950494|P3|Overall Study|Physician Decision|1
5789974|NCT03345914|19950495|P2|Overall Study|Physician Decision|1
5789975|NCT03345914|19950496|P1|Overall Study|Physician Decision|0
5789976|NCT03345914|19950494|P3|Overall Study|Transition to OLE during follow-up|39
5789977|NCT03345914|19950495|P2|Overall Study|Transition to OLE during follow-up|33
5789978|NCT03345914|19950496|P1|Overall Study|Transition to OLE during follow-up|37
5789979|NCT03345914|19950494|P3|Overall Study|Transition to another study at week 16|78
5789980|NCT03345914|19950495|P2|Overall Study|Transition to another study at week 16|86
5789981|NCT03345914|19950496|P1|Overall Study|Transition to another study at week 16|80
5789982|NCT03345901|19950567|P1|Overall Study|The study was terminated|18
5789983|NCT03345472|19950572|P1|3 Months to 12 Months|Death|1
5789984|NCT03345472|19950572|P1|3 Months to 12 Months|Adverse Event|1
5789985|NCT03345472|19950572|P1|3 Months to 12 Months|Withdrawal by Subject|1
5789986|NCT03345472|19950572|P1|3 Months to 12 Months|Lost to Follow-up|2
5789987|NCT03345472|19950572|P1|3 Months to 12 Months|Physician Decision|3
5789988|NCT03345472|19950572|P1|Implant to 3 Months|Adverse Event|1
5789989|NCT03345472|19950572|P1|Implant to 3 Months|Physician Decision|1
5789990|NCT03345472|19950572|P1|Implant to 3 Months|Withdrawal by Subject|2
5789991|NCT03345407|19950586|P7|Overall Study|Adverse Event|16
5789992|NCT03345407|19950587|P6|Overall Study|Adverse Event|5
5789993|NCT03345407|19950588|P5|Overall Study|Adverse Event|6
5789994|NCT03345407|19950589|P4|Overall Study|Adverse Event|4
5789995|NCT03345407|19950590|P3|Overall Study|Adverse Event|5
5789996|NCT03345407|19950591|P2|Overall Study|Adverse Event|0
5789997|NCT03345407|19950592|P1|Overall Study|Adverse Event|4
5789998|NCT03345407|19950586|P7|Overall Study|Lack of Efficacy|3
5789999|NCT03345407|19950587|P6|Overall Study|Lack of Efficacy|0
5790000|NCT03345407|19950588|P5|Overall Study|Lack of Efficacy|1
5790001|NCT03345407|19950589|P4|Overall Study|Lack of Efficacy|1
5790002|NCT03345407|19950590|P3|Overall Study|Lack of Efficacy|1
5790003|NCT03345407|19950591|P2|Overall Study|Lack of Efficacy|1
5790004|NCT03345407|19950592|P1|Overall Study|Lack of Efficacy|1
5790005|NCT03345407|19950586|P7|Overall Study|Protocol Violation|3
5790006|NCT03345407|19950587|P6|Overall Study|Protocol Violation|0
5790007|NCT03345407|19950588|P5|Overall Study|Protocol Violation|1
5790008|NCT03345407|19950589|P4|Overall Study|Protocol Violation|0
5790009|NCT03345407|19950590|P3|Overall Study|Protocol Violation|0
5790010|NCT03345407|19950591|P2|Overall Study|Protocol Violation|0
5790011|NCT03345407|19950592|P1|Overall Study|Protocol Violation|2
5790012|NCT03345407|19950586|P7|Overall Study|Protocol-defined stopping criteria|1
5790013|NCT03345407|19950587|P6|Overall Study|Protocol-defined stopping criteria|1
5790014|NCT03345407|19950588|P5|Overall Study|Protocol-defined stopping criteria|2
5790015|NCT03345407|19950589|P4|Overall Study|Protocol-defined stopping criteria|0
5790016|NCT03345407|19950590|P3|Overall Study|Protocol-defined stopping criteria|0
5790017|NCT03345407|19950591|P2|Overall Study|Protocol-defined stopping criteria|0
5790018|NCT03345407|19950592|P1|Overall Study|Protocol-defined stopping criteria|9
5790019|NCT03345407|19950586|P7|Overall Study|Lost to Follow-up|3
5790020|NCT03345407|19950587|P6|Overall Study|Lost to Follow-up|2
5790021|NCT03345407|19950588|P5|Overall Study|Lost to Follow-up|1
5790022|NCT03345407|19950589|P4|Overall Study|Lost to Follow-up|0
5790023|NCT03345407|19950590|P3|Overall Study|Lost to Follow-up|1
5790024|NCT03345407|19950591|P2|Overall Study|Lost to Follow-up|0
5790025|NCT03345407|19950592|P1|Overall Study|Lost to Follow-up|2
5790026|NCT03345407|19950586|P7|Overall Study|Physician Decision|3
5790027|NCT03345407|19950587|P6|Overall Study|Physician Decision|2
5790028|NCT03345407|19950588|P5|Overall Study|Physician Decision|1
5790029|NCT03345407|19950589|P4|Overall Study|Physician Decision|0
5790030|NCT03345407|19950590|P3|Overall Study|Physician Decision|0
5790031|NCT03345407|19950591|P2|Overall Study|Physician Decision|1
5790032|NCT03345407|19950592|P1|Overall Study|Physician Decision|3
5790033|NCT03345407|19950586|P7|Overall Study|Withdrawal by Subject|16
5790034|NCT03345407|19950587|P6|Overall Study|Withdrawal by Subject|6
5790035|NCT03345407|19950588|P5|Overall Study|Withdrawal by Subject|3
5790036|NCT03345407|19950589|P4|Overall Study|Withdrawal by Subject|6
5790037|NCT03345407|19950590|P3|Overall Study|Withdrawal by Subject|5
5790038|NCT03345407|19950591|P2|Overall Study|Withdrawal by Subject|1
5790039|NCT03345407|19950592|P1|Overall Study|Withdrawal by Subject|11
5790040|NCT03344640|19950821|P2|Follow-up Epoch|Withdrawal by Subject|2
5790041|NCT03344640|19950822|P1|Follow-up Epoch|Withdrawal by Subject|0
5790042|NCT03344640|19950821|P2|Overall Study|Withdrawal by Subject|2
5790043|NCT03344640|19950822|P1|Overall Study|Withdrawal by Subject|1
5790044|NCT03344640|19950821|P2|Overall Study|Physician Decision|1
5790045|NCT03344640|19950822|P1|Overall Study|Physician Decision|1
5790046|NCT03344640|19950821|P2|Overall Study|Adverse Event|0
5790047|NCT03344640|19950822|P1|Overall Study|Adverse Event|1
5790048|NCT03344562|19950851|P2|Overall Study|Withdrawal by Subject|0
5790049|NCT03344562|19950852|P1|Overall Study|Withdrawal by Subject|2
5790050|NCT03344172|19950872|P2|Overall Study|Received <1 dose of treatment|0
5790051|NCT03344172|19950873|P1|Overall Study|Received <1 dose of treatment|1
5790052|NCT03343639|19950891|P2|Overall Study|Protocol Violation|1
5790053|NCT03343639|19950892|P1|Overall Study|Protocol Violation|0
5790054|NCT03343639|19950891|P2|Overall Study|Lost to Follow-up|5
5790055|NCT03343639|19950892|P1|Overall Study|Lost to Follow-up|4
5790056|NCT03343639|19950891|P2|Overall Study|Withdrawal by Subject|6
5790057|NCT03343639|19950892|P1|Overall Study|Withdrawal by Subject|10
5790058|NCT03343067|19950920|P3|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|1
5790059|NCT03343067|19950921|P2|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|3
5790060|NCT03343067|19950922|P1|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|0
5790061|NCT03342898|19951050|P3|Overall Study|Reason not Specified|0
5790062|NCT03342898|19951051|P2|Overall Study|Reason not Specified|2
5790063|NCT03342898|19951052|P1|Overall Study|Reason not Specified|2
5790064|NCT03342898|19951050|P3|Overall Study|Death|1
5790065|NCT03342898|19951051|P2|Overall Study|Death|1
5790066|NCT03342898|19951052|P1|Overall Study|Death|0
5790067|NCT03342898|19951050|P3|Overall Study|Withdrawal of Consent|11
5790068|NCT03342898|19951051|P2|Overall Study|Withdrawal of Consent|9
5790069|NCT03342898|19951052|P1|Overall Study|Withdrawal of Consent|5
5790070|NCT03342898|19951050|P3|Overall Study|Lost to Follow-up|42
5790071|NCT03342898|19951051|P2|Overall Study|Lost to Follow-up|40
5790072|NCT03342898|19951052|P1|Overall Study|Lost to Follow-up|44
5790073|NCT03342898|19951050|P3|Overall Study|Adverse Event|0
5790074|NCT03342898|19951051|P2|Overall Study|Adverse Event|1
5790075|NCT03342898|19951052|P1|Overall Study|Adverse Event|3
5790076|NCT03342638|19951095|P2|Overall Study|Physician Decision|1
5790077|NCT03342638|19951096|P1|Overall Study|Physician Decision|0
5790078|NCT03342638|19951095|P2|Overall Study|Withdrawal by Subject|0
5790079|NCT03342638|19951096|P1|Overall Study|Withdrawal by Subject|1
5790080|NCT03342560|19951102|P1|Overall Study|Lost to Follow-up|2
5790081|NCT03342469|19951112|P4|Overall Study|Withdrawal by Subject|0
5790082|NCT03342469|19951113|P3|Overall Study|Withdrawal by Subject|0
5790083|NCT03342469|19951114|P2|Overall Study|Withdrawal by Subject|1
5790084|NCT03342469|19951115|P1|Overall Study|Withdrawal by Subject|0
5790085|NCT03342053|19951146|P2|Overall Study|Withdrawal by Subject|1
5790086|NCT03342053|19951147|P1|Overall Study|Withdrawal by Subject|0
5790087|NCT03342053|19951146|P2|Overall Study|Adverse Event|0
5790088|NCT03342053|19951147|P1|Overall Study|Adverse Event|2
5790089|NCT03341923|19951165|P2|Period 2, Second 14 Days of Wear|Adverse Event|1
5790090|NCT03341923|19951166|P1|Period 2, Second 14 Days of Wear|Adverse Event|0
5790091|NCT03341637|19951210|P2|Overall Study|Reason not Specified|1
5790092|NCT03341637|19951211|P1|Overall Study|Reason not Specified|1
5790093|NCT03341637|19951210|P2|Overall Study|Withdrawal by Subject|3
5790094|NCT03341637|19951211|P1|Overall Study|Withdrawal by Subject|3
5790095|NCT03341637|19951210|P2|Overall Study|Lost to Follow-up|0
5790096|NCT03341637|19951211|P1|Overall Study|Lost to Follow-up|1
5790097|NCT03341533|19951239|P2|Overall Study|Not eligible after randomization|1
5790098|NCT03341533|19951240|P1|Overall Study|Not eligible after randomization|2
5790099|NCT03341533|19951239|P2|Overall Study|Withdrawal by Subject|1
5790100|NCT03341533|19951240|P1|Overall Study|Withdrawal by Subject|1
5790101|NCT03341312|19951252|P4|Period 1|Withdrawal by Subject|0
5790102|NCT03341312|19951253|P3|Period 1|Withdrawal by Subject|0
5790103|NCT03341312|19951254|P2|Period 1|Withdrawal by Subject|1
5790104|NCT03341312|19951255|P1|Period 1|Withdrawal by Subject|0
5790105|NCT03341299|19951267|P4|Washout (A Minimum of 21 Hours)|Adverse Event|0
5790106|NCT03341299|19951268|P3|Washout (A Minimum of 21 Hours)|Adverse Event|1
5790107|NCT03341299|19951269|P2|Washout (A Minimum of 21 Hours)|Adverse Event|0
5790108|NCT03341299|19951270|P1|Washout (A Minimum of 21 Hours)|Adverse Event|0
5790145|NCT03339726|19951410|P3|Overall Study|Lost to Follow-up|0
5790146|NCT03339726|19951411|P2|Overall Study|Lost to Follow-up|1
5790147|NCT03339726|19951412|P1|Overall Study|Lost to Follow-up|0
5790148|NCT03339726|19951410|P3|Overall Study|Withdrawal by Subject|0
5790149|NCT03339726|19951411|P2|Overall Study|Withdrawal by Subject|0
5790150|NCT03339726|19951412|P1|Overall Study|Withdrawal by Subject|1
5790151|NCT03339583|19951470|P2|Follow-up (14 Days)|Physician Decision|3
5790152|NCT03339583|19951471|P1|Follow-up (14 Days)|Physician Decision|6
5790153|NCT03339583|19951470|P2|Second Intervention (14 Days)|Adverse Event|1
5790154|NCT03339583|19951471|P1|Second Intervention (14 Days)|Adverse Event|0
5790155|NCT03339583|19951470|P2|Second Intervention (14 Days)|unrelated acute exacerbation|1
5790156|NCT03339583|19951471|P1|Second Intervention (14 Days)|unrelated acute exacerbation|0
5790157|NCT03339583|19951470|P2|First Intervention (14 Days)|Adverse Event|0
5790158|NCT03339583|19951471|P1|First Intervention (14 Days)|Adverse Event|1
5790159|NCT03339453|19951509|P2|First Visit of Glucagon Treatment|Adverse Event|1
5790160|NCT03339453|19951510|P1|First Visit of Glucagon Treatment|Adverse Event|0
5790161|NCT03339401|19951528|P2|Overall Study|Investigator Decision|0
5790162|NCT03339401|19951529|P1|Overall Study|Investigator Decision|1
5790163|NCT03339401|19951528|P2|Overall Study|Study terminated|3
5790164|NCT03339401|19951529|P1|Overall Study|Study terminated|4
5790165|NCT03339401|19951528|P2|Overall Study|Withdrawal by Subject|0
5790166|NCT03339401|19951529|P1|Overall Study|Withdrawal by Subject|2
5790167|NCT03339401|19951528|P2|Overall Study|Death|1
5790168|NCT03339401|19951529|P1|Overall Study|Death|2
5790169|NCT03338855|19951583|P2|Overall Study|Withdrawn as birth control pill stopped|0
5790170|NCT03338855|19951584|P1|Overall Study|Withdrawn as birth control pill stopped|1
5790175|NCT03338673|19951644|P2|Overall Study|Lost to Follow-up|1
5790176|NCT03338673|19951645|P1|Overall Study|Lost to Follow-up|1
5790177|NCT03338400|19951680|P2|Overall Study|Lost to Follow-up|2
5790178|NCT03338400|19951681|P1|Overall Study|Lost to Follow-up|1
5790179|NCT03337490|19951717|P3|Overall Study|Lost to Follow-up|0
5790180|NCT03337490|19951718|P2|Overall Study|Lost to Follow-up|1
5790181|NCT03337490|19951719|P1|Overall Study|Lost to Follow-up|0
5790182|NCT03337490|19951717|P3|Overall Study|Physician Decision|0
5790183|NCT03337490|19951718|P2|Overall Study|Physician Decision|1
5790184|NCT03337490|19951719|P1|Overall Study|Physician Decision|0
5790185|NCT03337490|19951717|P3|Overall Study|Lack of Efficacy|35
5790186|NCT03337490|19951718|P2|Overall Study|Lack of Efficacy|12
5790187|NCT03337490|19951719|P1|Overall Study|Lack of Efficacy|10
5790188|NCT03337490|19951717|P3|Overall Study|Withdrawal by Subject|0
5790189|NCT03337490|19951718|P2|Overall Study|Withdrawal by Subject|0
5790190|NCT03337490|19951719|P1|Overall Study|Withdrawal by Subject|1
5790191|NCT03337477|19951732|P2|Overall Study|Lost to Follow-up|2
5790192|NCT03337477|19951733|P1|Overall Study|Lost to Follow-up|0
5790193|NCT03337477|19951732|P2|Overall Study|Death|1
5790194|NCT03337477|19951733|P1|Overall Study|Death|0
5790195|NCT03337477|19951732|P2|Overall Study|Withdrawal by Subject|1
5790196|NCT03337477|19951733|P1|Overall Study|Withdrawal by Subject|0
5790197|NCT03337477|19951732|P2|Overall Study|not categorized into the listed ones|9
5790198|NCT03337477|19951733|P1|Overall Study|not categorized into the listed ones|11
5790199|NCT03337308|19951757|P4|Overall Study|Protocol Violation|0
5790200|NCT03337308|19951758|P3|Overall Study|Protocol Violation|0
5790201|NCT03337308|19951759|P2|Overall Study|Protocol Violation|1
5790202|NCT03337308|19951760|P1|Overall Study|Protocol Violation|0
5790203|NCT03337308|19951757|P4|Overall Study|Withdrawal by Subject|1
5790204|NCT03337308|19951758|P3|Overall Study|Withdrawal by Subject|2
5790205|NCT03337308|19951759|P2|Overall Study|Withdrawal by Subject|1
5790206|NCT03337308|19951760|P1|Overall Study|Withdrawal by Subject|2
5790207|NCT03337308|19951757|P4|Overall Study|Lost to Follow-up|0
5790208|NCT03337308|19951758|P3|Overall Study|Lost to Follow-up|0
5790209|NCT03337308|19951759|P2|Overall Study|Lost to Follow-up|2
5790210|NCT03337308|19951760|P1|Overall Study|Lost to Follow-up|1
5790211|NCT03337308|19951757|P4|Overall Study|Adverse Event|1
5790212|NCT03337308|19951758|P3|Overall Study|Adverse Event|3
5790213|NCT03337308|19951759|P2|Overall Study|Adverse Event|3
5790214|NCT03337308|19951760|P1|Overall Study|Adverse Event|2
5790215|NCT03337139|19951796|P2|Phase I|Withdrawal by Subject|0
5790216|NCT03337139|19951797|P1|Phase I|Withdrawal by Subject|10
5790217|NCT03336502|19951848|P2|Overall Study|Adverse Event|5
5790218|NCT03336502|19951849|P1|Overall Study|Adverse Event|2
5790219|NCT03336502|19951848|P2|Overall Study|Death|2
5790220|NCT03336502|19951849|P1|Overall Study|Death|1
5790221|NCT03336502|19951848|P2|Overall Study|Prohibited Drugs|1
5790222|NCT03336502|19951849|P1|Overall Study|Prohibited Drugs|1
5790223|NCT03336502|19951848|P2|Overall Study|Physician Decision|1
5790224|NCT03336502|19951849|P1|Overall Study|Physician Decision|0
5790225|NCT03335566|19951901|P2|Overall Study|Other than specified above|2
5790226|NCT03335566|19951902|P1|Overall Study|Other than specified above|1
5790227|NCT03335566|19951901|P2|Overall Study|Protocol Violation|0
5790228|NCT03335566|19951902|P1|Overall Study|Protocol Violation|1
5790229|NCT03335566|19951901|P2|Overall Study|Technical Problems|0
5790230|NCT03335566|19951902|P1|Overall Study|Technical Problems|1
5790231|NCT03335566|19951901|P2|Overall Study|Lost to Follow-up|0
5790232|NCT03335566|19951902|P1|Overall Study|Lost to Follow-up|1
5790233|NCT03335566|19951901|P2|Overall Study|Adverse Event|1
5790234|NCT03335566|19951902|P1|Overall Study|Adverse Event|0
5790235|NCT03334747|19952031|P9|Follow-Up Phase|Subject/guardian decision|1
5790236|NCT03334747|19952032|P8|Follow-Up Phase|Subject/guardian decision|0
5790237|NCT03334747|19952033|P7|Follow-Up Phase|Subject/guardian decision|1
5790238|NCT03334747|19952034|P6|Follow-Up Phase|Subject/guardian decision|0
5790239|NCT03334747|19952035|P5|Follow-Up Phase|Subject/guardian decision|0
5790240|NCT03334747|19952036|P4|Follow-Up Phase|Subject/guardian decision|0
5790241|NCT03334747|19952037|P3|Follow-Up Phase|Subject/guardian decision|0
5790242|NCT03334747|19952038|P2|Follow-Up Phase|Subject/guardian decision|0
5790243|NCT03334747|19952039|P1|Follow-Up Phase|Subject/guardian decision|0
5790244|NCT03334747|19952031|P9|Treatment Phase|Subject/guardian decision|0
5790245|NCT03334747|19952032|P8|Treatment Phase|Subject/guardian decision|0
5790246|NCT03334747|19952033|P7|Treatment Phase|Subject/guardian decision|0
5790247|NCT03334747|19952034|P6|Treatment Phase|Subject/guardian decision|1
5790248|NCT03334747|19952035|P5|Treatment Phase|Subject/guardian decision|0
5790249|NCT03334747|19952036|P4|Treatment Phase|Subject/guardian decision|0
5790250|NCT03334747|19952037|P3|Treatment Phase|Subject/guardian decision|0
5790251|NCT03334747|19952038|P2|Treatment Phase|Subject/guardian decision|0
5790252|NCT03334747|19952039|P1|Treatment Phase|Subject/guardian decision|1
5790253|NCT03334747|19952031|P9|Treatment Phase|Technical problems|0
5790254|NCT03334747|19952032|P8|Treatment Phase|Technical problems|0
5790255|NCT03334747|19952033|P7|Treatment Phase|Technical problems|0
5790256|NCT03334747|19952034|P6|Treatment Phase|Technical problems|0
5790257|NCT03334747|19952035|P5|Treatment Phase|Technical problems|1
5790258|NCT03334747|19952036|P4|Treatment Phase|Technical problems|0
5790259|NCT03334747|19952037|P3|Treatment Phase|Technical problems|0
5790260|NCT03334747|19952038|P2|Treatment Phase|Technical problems|0
5790261|NCT03334747|19952039|P1|Treatment Phase|Technical problems|0
5790262|NCT03334721|19952229|P2|Overall Study|No longer met inclusion/exclusion criter|0
5790263|NCT03334721|19952230|P1|Overall Study|No longer met inclusion/exclusion criter|1
5790264|NCT03334721|19952229|P2|Overall Study|Withdrawal by Subject|0
5790265|NCT03334721|19952230|P1|Overall Study|Withdrawal by Subject|1
5790280|NCT03334448|19952281|P4|Washout|Protocol Violation|1
5790281|NCT03334448|19952282|P3|Washout|Protocol Violation|0
5790282|NCT03334448|19952283|P2|Washout|Protocol Violation|0
5790283|NCT03334448|19952284|P1|Washout|Protocol Violation|0
5790284|NCT03334448|19952281|P4|Washout|Personal Reason|0
5790285|NCT03334448|19952282|P3|Washout|Personal Reason|0
5790286|NCT03334448|19952283|P2|Washout|Personal Reason|1
5790287|NCT03334448|19952284|P1|Washout|Personal Reason|0
5790288|NCT03334422|19952296|P4|Overall Study|Pregnancy|0
5790289|NCT03334422|19952297|P3|Overall Study|Pregnancy|0
5790290|NCT03334422|19952298|P2|Overall Study|Pregnancy|1
5790291|NCT03334422|19952299|P1|Overall Study|Pregnancy|0
5790292|NCT03334422|19952296|P4|Overall Study|Inability to obtain laboratory samples|0
5790293|NCT03334422|19952297|P3|Overall Study|Inability to obtain laboratory samples|0
5790294|NCT03334422|19952298|P2|Overall Study|Inability to obtain laboratory samples|1
5790295|NCT03334422|19952299|P1|Overall Study|Inability to obtain laboratory samples|0
5790296|NCT03334422|19952296|P4|Overall Study|Lost to Follow-up|1
5790297|NCT03334422|19952297|P3|Overall Study|Lost to Follow-up|0
5790298|NCT03334422|19952298|P2|Overall Study|Lost to Follow-up|0
5790299|NCT03334422|19952299|P1|Overall Study|Lost to Follow-up|0
5790300|NCT03334422|19952296|P4|Overall Study|Withdrawal by Subject|0
5790301|NCT03334422|19952297|P3|Overall Study|Withdrawal by Subject|1
5790302|NCT03334422|19952298|P2|Overall Study|Withdrawal by Subject|3
5790303|NCT03334422|19952299|P1|Overall Study|Withdrawal by Subject|8
5790304|NCT03334422|19952296|P4|Overall Study|Lack of Efficacy|3
5790305|NCT03334422|19952297|P3|Overall Study|Lack of Efficacy|7
5790306|NCT03334422|19952298|P2|Overall Study|Lack of Efficacy|2
5790307|NCT03334422|19952299|P1|Overall Study|Lack of Efficacy|10
5790308|NCT03334422|19952296|P4|Overall Study|Adverse Event|2
5790309|NCT03334422|19952297|P3|Overall Study|Adverse Event|2
5790310|NCT03334422|19952298|P2|Overall Study|Adverse Event|3
5790311|NCT03334422|19952299|P1|Overall Study|Adverse Event|1
5790312|NCT03334396|19952406|P8|Overall Study|Started New Job|0
5790313|NCT03334396|19952407|P7|Overall Study|Started New Job|0
5790314|NCT03334396|19952408|P6|Overall Study|Started New Job|0
5790315|NCT03334396|19952409|P5|Overall Study|Started New Job|0
5790316|NCT03334396|19952410|P4|Overall Study|Started New Job|0
5790317|NCT03334396|19952411|P3|Overall Study|Started New Job|0
5790318|NCT03334396|19952412|P2|Overall Study|Started New Job|0
5790319|NCT03334396|19952413|P1|Overall Study|Started New Job|1
5790320|NCT03334396|19952406|P8|Overall Study|Ineligible|0
5790321|NCT03334396|19952407|P7|Overall Study|Ineligible|0
5790322|NCT03334396|19952408|P6|Overall Study|Ineligible|0
5790323|NCT03334396|19952409|P5|Overall Study|Ineligible|0
5790324|NCT03334396|19952410|P4|Overall Study|Ineligible|0
5790325|NCT03334396|19952411|P3|Overall Study|Ineligible|0
5790326|NCT03334396|19952412|P2|Overall Study|Ineligible|1
5790327|NCT03334396|19952413|P1|Overall Study|Ineligible|0
5790328|NCT03334396|19952406|P8|Overall Study|Pregnancy|0
5790329|NCT03334396|19952407|P7|Overall Study|Pregnancy|0
5790330|NCT03334396|19952408|P6|Overall Study|Pregnancy|0
5790331|NCT03334396|19952409|P5|Overall Study|Pregnancy|0
5790332|NCT03334396|19952410|P4|Overall Study|Pregnancy|0
5790333|NCT03334396|19952411|P3|Overall Study|Pregnancy|0
5790334|NCT03334396|19952412|P2|Overall Study|Pregnancy|1
5790335|NCT03334396|19952413|P1|Overall Study|Pregnancy|0
5790336|NCT03334396|19952406|P8|Overall Study|Withdrawal by Subject|0
5790337|NCT03334396|19952407|P7|Overall Study|Withdrawal by Subject|2
5790338|NCT03334396|19952408|P6|Overall Study|Withdrawal by Subject|1
5790339|NCT03334396|19952409|P5|Overall Study|Withdrawal by Subject|2
5790340|NCT03334396|19952410|P4|Overall Study|Withdrawal by Subject|2
5790341|NCT03334396|19952411|P3|Overall Study|Withdrawal by Subject|7
5790342|NCT03334396|19952412|P2|Overall Study|Withdrawal by Subject|5
5790343|NCT03334396|19952413|P1|Overall Study|Withdrawal by Subject|10
5790344|NCT03334396|19952406|P8|Overall Study|Physician Decision|0
5790345|NCT03334396|19952407|P7|Overall Study|Physician Decision|0
5790346|NCT03334396|19952408|P6|Overall Study|Physician Decision|0
5790347|NCT03334396|19952409|P5|Overall Study|Physician Decision|0
5790348|NCT03334396|19952410|P4|Overall Study|Physician Decision|0
5790349|NCT03334396|19952411|P3|Overall Study|Physician Decision|0
5790350|NCT03334396|19952412|P2|Overall Study|Physician Decision|0
5790351|NCT03334396|19952413|P1|Overall Study|Physician Decision|1
5790352|NCT03334396|19952406|P8|Overall Study|Lost to Follow-up|0
5790353|NCT03334396|19952407|P7|Overall Study|Lost to Follow-up|1
5790354|NCT03334396|19952408|P6|Overall Study|Lost to Follow-up|0
5790355|NCT03334396|19952409|P5|Overall Study|Lost to Follow-up|0
5790356|NCT03334396|19952410|P4|Overall Study|Lost to Follow-up|0
5790357|NCT03334396|19952411|P3|Overall Study|Lost to Follow-up|1
5790358|NCT03334396|19952412|P2|Overall Study|Lost to Follow-up|0
5790359|NCT03334396|19952413|P1|Overall Study|Lost to Follow-up|0
5790360|NCT03334396|19952406|P8|Overall Study|Lack of Efficacy|1
5790361|NCT03334396|19952407|P7|Overall Study|Lack of Efficacy|0
5790362|NCT03334396|19952408|P6|Overall Study|Lack of Efficacy|0
5790363|NCT03334396|19952409|P5|Overall Study|Lack of Efficacy|1
5790364|NCT03334396|19952410|P4|Overall Study|Lack of Efficacy|3
5790365|NCT03334396|19952411|P3|Overall Study|Lack of Efficacy|1
5790366|NCT03334396|19952412|P2|Overall Study|Lack of Efficacy|4
5790367|NCT03334396|19952413|P1|Overall Study|Lack of Efficacy|10
5790368|NCT03334396|19952406|P8|Overall Study|Adverse Event|0
5790369|NCT03334396|19952407|P7|Overall Study|Adverse Event|0
5790370|NCT03334396|19952408|P6|Overall Study|Adverse Event|0
5790371|NCT03334396|19952409|P5|Overall Study|Adverse Event|0
5790372|NCT03334396|19952410|P4|Overall Study|Adverse Event|0
5790373|NCT03334396|19952411|P3|Overall Study|Adverse Event|1
5790374|NCT03334396|19952412|P2|Overall Study|Adverse Event|0
5790375|NCT03334396|19952413|P1|Overall Study|Adverse Event|1
5790376|NCT03334214|19952518|P2|Overall Study|Other|0
5790377|NCT03334214|19952519|P1|Overall Study|Other|1
5790378|NCT03334214|19952518|P2|Overall Study|Withdrawal by Subject|1
5790379|NCT03334214|19952519|P1|Overall Study|Withdrawal by Subject|0
5790380|NCT03334214|19952518|P2|Overall Study|Adverse Event or Serious Adverse Event|1
5790381|NCT03334214|19952519|P1|Overall Study|Adverse Event or Serious Adverse Event|0
5790382|NCT03334175|19952545|P2|Overall Study|Lost to Follow-up|1
5790383|NCT03334175|19952546|P1|Overall Study|Lost to Follow-up|0
5790384|NCT03333876|19952568|P1|Mandibular Advancement|Product Damage|2
5790385|NCT03333876|19952568|P1|Mandibular Advancement|Adverse Event|2
5790386|NCT03333876|19952568|P1|Nasal Dilator|Bed Partner Lost to follow up|6
5790387|NCT03333876|19952568|P1|Screening Period|Screen Failure|4
5790388|NCT03332784|19952759|P20|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
5790389|NCT03332784|19952760|P19|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
5790390|NCT03332784|19952761|P18|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
5790391|NCT03332784|19952762|P17|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
5790392|NCT03332784|19952763|P16|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
5790393|NCT03332784|19952764|P15|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|1
5790394|NCT03332784|19952765|P14|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
5790395|NCT03332784|19952766|P13|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
5790396|NCT03332784|19952767|P12|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
5790397|NCT03332784|19952768|P11|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
5790398|NCT03332784|19952769|P10|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
5790399|NCT03332784|19952770|P9|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
5790400|NCT03332784|19952771|P8|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
5790401|NCT03332784|19952772|P7|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
5790402|NCT03332784|19952773|P6|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
5790403|NCT03332784|19952774|P5|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
5790404|NCT03332784|19952775|P4|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
5790405|NCT03332784|19952776|P3|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
5790406|NCT03332784|19952777|P2|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|1
5790407|NCT03332784|19952778|P1|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
5790411|NCT03332160|19953048|P2|Overall Study|Non-adherence to treatment|2
5790412|NCT03332160|19953049|P1|Overall Study|Non-adherence to treatment|0
5790413|NCT03332160|19953048|P2|Overall Study|Developed Exclusion Criteria|1
5790414|NCT03332160|19953049|P1|Overall Study|Developed Exclusion Criteria|0
5790415|NCT03332160|19953048|P2|Overall Study|Adverse Event|1
5790416|NCT03332160|19953049|P1|Overall Study|Adverse Event|0
5790417|NCT03332160|19953048|P2|Overall Study|Withdrawal by Subject|1
5790418|NCT03332160|19953049|P1|Overall Study|Withdrawal by Subject|1
5790419|NCT03331315|19953133|P2|Overall Study|Physician Decision|14
5790420|NCT03331315|19953134|P1|Overall Study|Physician Decision|18
5790421|NCT03331042|19953171|P4|Overall Study|Lost to Follow-up|1
5790422|NCT03331042|19953172|P3|Overall Study|Lost to Follow-up|0
5790423|NCT03331042|19953173|P2|Overall Study|Lost to Follow-up|0
5790424|NCT03331042|19953174|P1|Overall Study|Lost to Follow-up|0
5790425|NCT03331042|19953171|P4|Overall Study|Physician Decision|0
5790426|NCT03331042|19953172|P3|Overall Study|Physician Decision|1
5790427|NCT03331042|19953173|P2|Overall Study|Physician Decision|0
5790428|NCT03331042|19953174|P1|Overall Study|Physician Decision|0
5790429|NCT03331042|19953171|P4|Overall Study|Protocol Violation|0
5790430|NCT03331042|19953172|P3|Overall Study|Protocol Violation|0
5790431|NCT03331042|19953173|P2|Overall Study|Protocol Violation|0
5790432|NCT03331042|19953174|P1|Overall Study|Protocol Violation|1
5790433|NCT03330236|19953284|P2|Overall Study|Surgery aborted/converted to open|52
5790434|NCT03330236|19953285|P1|Overall Study|Surgery aborted/converted to open|60
5790435|NCT03330236|19953284|P2|Overall Study|Volatile anesthetics used|8
5790436|NCT03330236|19953285|P1|Overall Study|Volatile anesthetics used|11
5790437|NCT03330236|19953284|P2|Overall Study|SedLine malfunction/blinding|14
5790438|NCT03330236|19953285|P1|Overall Study|SedLine malfunction/blinding|19
5790439|NCT03330236|19953284|P2|Overall Study|Protocol Violation|3
5790440|NCT03330236|19953285|P1|Overall Study|Protocol Violation|4
5790441|NCT03330236|19953284|P2|Overall Study|Physician Decision|0
5790442|NCT03330236|19953285|P1|Overall Study|Physician Decision|2
5790443|NCT03330236|19953284|P2|Overall Study|Lost to Follow-up|2
5790444|NCT03330236|19953285|P1|Overall Study|Lost to Follow-up|0
5790445|NCT03330236|19953284|P2|Overall Study|Withdrawal by Subject|4
5790446|NCT03330236|19953285|P1|Overall Study|Withdrawal by Subject|2
5790447|NCT03330236|19953284|P2|Overall Study|Death|1
5790448|NCT03330236|19953285|P1|Overall Study|Death|2
5790449|NCT03329989|19953319|P1|Overall Study|Protocol Violation|1
5790450|NCT03329989|19953319|P1|Overall Study|Adverse Event|5
5790451|NCT03329989|19953319|P1|Overall Study|Lost to Follow-up|8
5790452|NCT03329989|19953319|P1|Overall Study|Withdrawal by Subject|9
5790453|NCT03329885|19953346|P9|Overall Study|Sponsor discontinued the study early|0
5790454|NCT03329885|19953347|P8|Overall Study|Sponsor discontinued the study early|1
5790455|NCT03329885|19953348|P7|Overall Study|Sponsor discontinued the study early|1
5790456|NCT03329885|19953349|P6|Overall Study|Sponsor discontinued the study early|0
5790457|NCT03329885|19953350|P5|Overall Study|Sponsor discontinued the study early|0
5790458|NCT03329885|19953351|P4|Overall Study|Sponsor discontinued the study early|0
5790459|NCT03329885|19953352|P3|Overall Study|Sponsor discontinued the study early|0
5790460|NCT03329885|19953353|P2|Overall Study|Sponsor discontinued the study early|0
5790461|NCT03329885|19953354|P1|Overall Study|Sponsor discontinued the study early|0
5790497|NCT03329573|19953609|P4|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0
5790498|NCT03329573|19953610|P3|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0
5790499|NCT03329573|19953611|P2|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|1
5790500|NCT03329573|19953612|P1|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0
5790501|NCT03329573|19953609|P4|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0
5790502|NCT03329573|19953610|P3|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0
5790503|NCT03329573|19953611|P2|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0
5790504|NCT03329573|19953612|P1|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|1
5790505|NCT03329573|19953609|P4|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0
5790506|NCT03329573|19953610|P3|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0
5790507|NCT03329573|19953611|P2|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|2
5790508|NCT03329573|19953612|P1|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|1
5790509|NCT03329573|19953609|P4|Treatment Period 1 (Up to 5 Days)|Adverse Event|0
5790510|NCT03329573|19953610|P3|Treatment Period 1 (Up to 5 Days)|Adverse Event|0
5790511|NCT03329573|19953611|P2|Treatment Period 1 (Up to 5 Days)|Adverse Event|1
5790512|NCT03329573|19953612|P1|Treatment Period 1 (Up to 5 Days)|Adverse Event|0
5790513|NCT03328897|19953696|P3|Follow-up Epoch|Patient/guardian decision|0
5790514|NCT03328897|19953697|P2|Follow-up Epoch|Patient/guardian decision|1
5790515|NCT03328897|19953698|P1|Follow-up Epoch|Patient/guardian decision|2
5790516|NCT03328897|19953696|P3|Follow-up Epoch|Pregnancy|0
5790517|NCT03328897|19953697|P2|Follow-up Epoch|Pregnancy|0
5790518|NCT03328897|19953698|P1|Follow-up Epoch|Pregnancy|1
5790519|NCT03328897|19953696|P3|Follow-up Epoch|Lost to Follow-up|0
5790520|NCT03328897|19953697|P2|Follow-up Epoch|Lost to Follow-up|1
5790521|NCT03328897|19953698|P1|Follow-up Epoch|Lost to Follow-up|0
5790522|NCT03328897|19953696|P3|Follow-up Epoch|Lack of Efficacy|1
5790523|NCT03328897|19953697|P2|Follow-up Epoch|Lack of Efficacy|1
5790524|NCT03328897|19953698|P1|Follow-up Epoch|Lack of Efficacy|1
5790525|NCT03328897|19953696|P3|Follow-up Epoch|Adverse Event|1
5790526|NCT03328897|19953697|P2|Follow-up Epoch|Adverse Event|0
5790527|NCT03328897|19953698|P1|Follow-up Epoch|Adverse Event|4
5790528|NCT03328897|19953696|P3|Randomized-treatment Epoch|Lack of Efficacy|0
5790529|NCT03328897|19953697|P2|Randomized-treatment Epoch|Lack of Efficacy|0
5790530|NCT03328897|19953698|P1|Randomized-treatment Epoch|Lack of Efficacy|1
5790531|NCT03328897|19953696|P3|Randomized-treatment Epoch|Patient/guardian decision|1
5790532|NCT03328897|19953697|P2|Randomized-treatment Epoch|Patient/guardian decision|3
5790533|NCT03328897|19953698|P1|Randomized-treatment Epoch|Patient/guardian decision|8
5790534|NCT03328897|19953696|P3|Randomized-treatment Epoch|Pregnancy|0
5790535|NCT03328897|19953697|P2|Randomized-treatment Epoch|Pregnancy|0
5790536|NCT03328897|19953698|P1|Randomized-treatment Epoch|Pregnancy|3
5790537|NCT03328897|19953696|P3|Randomized-treatment Epoch|Lost to Follow-up|0
5790538|NCT03328897|19953697|P2|Randomized-treatment Epoch|Lost to Follow-up|1
5790539|NCT03328897|19953698|P1|Randomized-treatment Epoch|Lost to Follow-up|0
5790540|NCT03328897|19953696|P3|Randomized-treatment Epoch|Adverse Event|1
5790541|NCT03328897|19953697|P2|Randomized-treatment Epoch|Adverse Event|1
5790542|NCT03328897|19953698|P1|Randomized-treatment Epoch|Adverse Event|4
5790543|NCT03328182|19953760|P1|Overall Study|No Product Evaluated|1
5790544|NCT03328182|19953760|P1|Overall Study|Protocol Violation|2
5790545|NCT03328182|19953760|P1|Overall Study|Withdrawal by Subject|1
5790546|NCT03327402|19953765|P1|Overall Study|Other (Visit Out-Of-Window)|1
5790547|NCT03327402|19953765|P1|Overall Study|Withdrawal by Subject|1
5790548|NCT03326869|19954084|P2|Overall Study|Study data has been lost to natural disa|1
5790549|NCT03326869|19954085|P1|Overall Study|Study data has been lost to natural disa|1
5790550|NCT03326518|19954101|P3|Overall Study|Lost to Follow-up|1
5790551|NCT03326518|19954102|P2|Overall Study|Lost to Follow-up|0
5790552|NCT03326518|19954103|P1|Overall Study|Lost to Follow-up|1
5790553|NCT03326518|19954101|P3|Overall Study|Withdrawal by Subject|0
5790554|NCT03326518|19954102|P2|Overall Study|Withdrawal by Subject|0
5790555|NCT03326518|19954103|P1|Overall Study|Withdrawal by Subject|1
5790556|NCT03326518|19954101|P3|Overall Study|Protocol Violation|0
5790557|NCT03326518|19954102|P2|Overall Study|Protocol Violation|0
5790558|NCT03326518|19954103|P1|Overall Study|Protocol Violation|1
5790559|NCT03326323|19954138|P1|Overall Study|Unable to receive ANH protocol|3
5790560|NCT03325894|19954145|P2|Overall Study|Other (Not received Treatment)|0
5790561|NCT03325894|19954146|P1|Overall Study|Other (Not received Treatment)|1
5790562|NCT03325894|19954145|P2|Overall Study|Study Terminated by Sponsor|43
5790563|NCT03325894|19954146|P1|Overall Study|Study Terminated by Sponsor|38
5790564|NCT03325894|19954145|P2|Overall Study|Lack of Efficacy|14
5790565|NCT03325894|19954146|P1|Overall Study|Lack of Efficacy|8
5790566|NCT03325894|19954145|P2|Overall Study|Lost to Follow-up|9
5790567|NCT03325894|19954146|P1|Overall Study|Lost to Follow-up|4
5790568|NCT03325894|19954145|P2|Overall Study|Withdrawal by Subject|6
5790569|NCT03325894|19954146|P1|Overall Study|Withdrawal by Subject|10
5790570|NCT03325894|19954145|P2|Overall Study|Protocol Violation|2
5790571|NCT03325894|19954146|P1|Overall Study|Protocol Violation|1
5790572|NCT03325894|19954145|P2|Overall Study|Adverse Event|3
5790573|NCT03325894|19954146|P1|Overall Study|Adverse Event|2
5790574|NCT03325881|19954214|P2|Overall Study|Not treated|0
5790575|NCT03325881|19954215|P1|Overall Study|Not treated|1
5790576|NCT03325881|19954214|P2|Overall Study|Lack of Efficacy|0
5790577|NCT03325881|19954215|P1|Overall Study|Lack of Efficacy|2
5790578|NCT03325881|19954214|P2|Overall Study|Withdrawal by Subject|2
5790579|NCT03325881|19954215|P1|Overall Study|Withdrawal by Subject|0
5790580|NCT03325881|19954214|P2|Overall Study|Protocol Violation|1
5790581|NCT03325881|19954215|P1|Overall Study|Protocol Violation|0
5790582|NCT03325673|19954243|P2|Overall Study|Adverse Event|0
5790583|NCT03325673|19954244|P1|Overall Study|Adverse Event|4
5790584|NCT03323736|19954298|P3|Overall Study|Iontophoresis fill/no iontophoresis|0
5790585|NCT03323736|19954299|P2|Overall Study|Iontophoresis fill/no iontophoresis|2
5790586|NCT03323736|19954300|P1|Overall Study|Iontophoresis fill/no iontophoresis|2
5790587|NCT03323736|19954298|P3|Overall Study|Withdrawal Before Treatment|1
5790588|NCT03323736|19954299|P2|Overall Study|Withdrawal Before Treatment|1
5790589|NCT03323736|19954300|P1|Overall Study|Withdrawal Before Treatment|3
5790590|NCT03323736|19954298|P3|Overall Study|Screen Failure|1
5790591|NCT03323736|19954299|P2|Overall Study|Screen Failure|9
5790592|NCT03323736|19954300|P1|Overall Study|Screen Failure|14
5790593|NCT03323164|19954327|P2|Overall Study|Poor quality imaging/scans|2
5790594|NCT03323164|19954328|P1|Overall Study|Poor quality imaging/scans|2
5790595|NCT03323086|19954354|P2|Overall Study|Lost to Follow-up|2
5790596|NCT03323086|19954355|P1|Overall Study|Lost to Follow-up|3
5790597|NCT03322566|19954383|P3|Overall Study|On-going at clinical cut off date|36
5790598|NCT03322566|19954384|P2|Overall Study|On-going at clinical cut off date|74
5790599|NCT03322566|19954385|P1|Overall Study|On-going at clinical cut off date|68
5790600|NCT03322566|19954383|P3|Overall Study|Withdrawal by Subject|5
5790601|NCT03322566|19954384|P2|Overall Study|Withdrawal by Subject|1
5790602|NCT03322566|19954385|P1|Overall Study|Withdrawal by Subject|3
5790603|NCT03322566|19954383|P3|Overall Study|Physician Decision|1
5790604|NCT03322566|19954384|P2|Overall Study|Physician Decision|0
5790605|NCT03322566|19954385|P1|Overall Study|Physician Decision|0
5790606|NCT03322566|19954383|P3|Overall Study|Death|13
5790607|NCT03322566|19954384|P2|Overall Study|Death|12
5790608|NCT03322566|19954385|P1|Overall Study|Death|20
5790609|NCT03322540|19954404|P2|Overall Study|Participants Ongoing|59
5790610|NCT03322540|19954405|P1|Overall Study|Participants Ongoing|63
5790611|NCT03322540|19954404|P2|Overall Study|Withdrawal by Subject|1
5790612|NCT03322540|19954405|P1|Overall Study|Withdrawal by Subject|2
5790613|NCT03322540|19954404|P2|Overall Study|Physician Decision|1
5790614|NCT03322540|19954405|P1|Overall Study|Physician Decision|0
5790615|NCT03322540|19954404|P2|Overall Study|Lost to Follow-up|1
5790616|NCT03322540|19954405|P1|Overall Study|Lost to Follow-up|0
5790617|NCT03322540|19954404|P2|Overall Study|Death|15
5790618|NCT03322540|19954405|P1|Overall Study|Death|12
5790619|NCT03322514|19954413|P2|Overall Study|Withdrawal by Subject|1
5790620|NCT03322514|19954414|P1|Overall Study|Withdrawal by Subject|1
5790621|NCT03322462|19954424|P1|Overall Study|Other|1
5790622|NCT03322462|19954424|P1|Overall Study|Technical difficulties|2
5790623|NCT03322423|19954433|P2|Period 2|Subject not eligible for Pytergiumectomy|1
5790624|NCT03322423|19954434|P1|Period 2|Subject not eligible for Pytergiumectomy|0
5790625|NCT03322423|19954433|P2|Period 2|Protocol Violation|0
5790626|NCT03322423|19954434|P1|Period 2|Protocol Violation|1
5790627|NCT03322423|19954433|P2|Period 2|Dispensed incorrect lens in left eye|1
5790628|NCT03322423|19954434|P1|Period 2|Dispensed incorrect lens in left eye|0
5790629|NCT03322423|19954433|P2|Period 1|Unsatisfactory Lens Fitting|0
5790630|NCT03322423|19954434|P1|Period 1|Unsatisfactory Lens Fitting|1
5790631|NCT03322423|19954433|P2|Period 1|Incorrect Lens Dispensed|0
5790632|NCT03322423|19954434|P1|Period 1|Incorrect Lens Dispensed|1
5790633|NCT03322423|19954433|P2|Period 1|Withdrawal by Subject|1
5790634|NCT03322423|19954434|P1|Period 1|Withdrawal by Subject|0
5790635|NCT03322423|19954433|P2|Period 1|Subject no longer eligible|1
5790636|NCT03322423|19954434|P1|Period 1|Subject no longer eligible|0
5790637|NCT03322293|19954447|P3|Overall Study|Lost to Follow-up|1
5790638|NCT03322293|19954448|P2|Overall Study|Lost to Follow-up|0
5790639|NCT03322293|19954449|P1|Overall Study|Lost to Follow-up|0
5790640|NCT03321721|19954472|P3|Overall Study|Lost to Follow-up|11
5790641|NCT03321721|19954473|P2|Overall Study|Lost to Follow-up|8
5790642|NCT03321721|19954474|P1|Overall Study|Lost to Follow-up|4
5790643|NCT03321396|19954491|P1|Overall Study|Physician Decision|1
5790644|NCT03320941|19954529|P5|Overall Study|subject/guardian decision|0
5790645|NCT03320941|19954530|P4|Overall Study|subject/guardian decision|1
5790646|NCT03320941|19954531|P3|Overall Study|subject/guardian decision|0
5790647|NCT03320941|19954532|P2|Overall Study|subject/guardian decision|0
5790648|NCT03320941|19954533|P1|Overall Study|subject/guardian decision|0
5790649|NCT03320824|19954636|P2|Overall Study|could not complete final visit|1
5790650|NCT03320824|19954637|P1|Overall Study|could not complete final visit|0
5790651|NCT03320824|19954636|P2|Overall Study|moved out of state|1
5790652|NCT03320824|19954637|P1|Overall Study|moved out of state|0
5790653|NCT03320824|19954636|P2|Overall Study|Lost to Follow-up|1
5790654|NCT03320824|19954637|P1|Overall Study|Lost to Follow-up|10
5790655|NCT03320824|19954636|P2|Overall Study|Withdrawal by Subject|1
5790656|NCT03320824|19954637|P1|Overall Study|Withdrawal by Subject|8
5790657|NCT03320564|19954653|P1|Overall Study|Protocol Violation|1
5790658|NCT03320369|19954657|P1|Overall Study|Withdrawal by Subject|2
5790659|NCT03320369|19954657|P1|Overall Study|Adverse Event|1
5790660|NCT03319719|19954678|P1|Overall Study|Lost to Follow-up|1
5790661|NCT03319212|19954711|P2|Overall Study|Physician Decision|0
5790662|NCT03319212|19954712|P1|Overall Study|Physician Decision|1
5790663|NCT03319212|19954711|P2|Overall Study|Lost to Follow-up|1
5790664|NCT03319212|19954712|P1|Overall Study|Lost to Follow-up|0
5790665|NCT03319212|19954711|P2|Overall Study|Withdrawal by Subject|1
5790666|NCT03319212|19954712|P1|Overall Study|Withdrawal by Subject|0
5790667|NCT03319212|19954711|P2|Overall Study|Adverse Event|2
5790668|NCT03319212|19954712|P1|Overall Study|Adverse Event|2
5790669|NCT03319212|19954711|P2|Overall Study|Discontinued as moving out of local area|1
5790670|NCT03319212|19954712|P1|Overall Study|Discontinued as moving out of local area|0
5790671|NCT03318861|19954794|P5|Overall Study|Enrolled But Did Not Initiate KITE-585|1
5790672|NCT03318861|19954795|P4|Overall Study|Enrolled But Did Not Initiate KITE-585|1
5790673|NCT03318861|19954796|P3|Overall Study|Enrolled But Did Not Initiate KITE-585|0
5790674|NCT03318861|19954797|P2|Overall Study|Enrolled But Did Not Initiate KITE-585|1
5790675|NCT03318861|19954798|P1|Overall Study|Enrolled But Did Not Initiate KITE-585|0
5790676|NCT03318861|19954794|P5|Overall Study|Still on Study|1
5790677|NCT03318861|19954795|P4|Overall Study|Still on Study|2
5790678|NCT03318861|19954796|P3|Overall Study|Still on Study|1
5790679|NCT03318861|19954797|P2|Overall Study|Still on Study|1
5790680|NCT03318861|19954798|P1|Overall Study|Still on Study|2
5790681|NCT03318861|19954794|P5|Overall Study|Death|1
5790682|NCT03318861|19954795|P4|Overall Study|Death|1
5790683|NCT03318861|19954796|P3|Overall Study|Death|2
5790684|NCT03318861|19954797|P2|Overall Study|Death|2
5790685|NCT03318861|19954798|P1|Overall Study|Death|1
5790686|NCT03318783|19954865|P2|Overall Study|Death|1
5790687|NCT03318783|19954866|P1|Overall Study|Death|0
5790688|NCT03318783|19954865|P2|Overall Study|Withdrawal by Subject|1
5790689|NCT03318783|19954866|P1|Overall Study|Withdrawal by Subject|0
5790690|NCT03318315|19954906|P3|Overall Study|Withdrawal by Subject|2
5790691|NCT03318315|19954907|P2|Overall Study|Withdrawal by Subject|0
5790692|NCT03318315|19954908|P1|Overall Study|Withdrawal by Subject|0
5790693|NCT03318315|19954906|P3|Overall Study|Protocol Violation|1
5790694|NCT03318315|19954907|P2|Overall Study|Protocol Violation|1
5790695|NCT03318315|19954908|P1|Overall Study|Protocol Violation|1
5790696|NCT03318315|19954906|P3|Overall Study|Lost to Follow-up|1
5790697|NCT03318315|19954907|P2|Overall Study|Lost to Follow-up|2
5790698|NCT03318315|19954908|P1|Overall Study|Lost to Follow-up|3
5790699|NCT03316911|19955022|P2|Overall Study|Lost to Follow-up|29
5790700|NCT03316911|19955023|P1|Overall Study|Lost to Follow-up|33
5790701|NCT03316131|19955101|P2|Treatment Period 2|Protocol deviation|0
5790702|NCT03316131|19955102|P1|Treatment Period 2|Protocol deviation|1
5790703|NCT03315793|19955140|P2|Overall Study|Difficult for regular visit|1
5790704|NCT03315793|19955141|P1|Overall Study|Difficult for regular visit|0
5790705|NCT03315793|19955140|P2|Overall Study|Protocol Deviation|0
5790706|NCT03315793|19955141|P1|Overall Study|Protocol Deviation|1
5790707|NCT03315793|19955140|P2|Overall Study|Adverse Event|2
5790708|NCT03315793|19955141|P1|Overall Study|Adverse Event|4
5790709|NCT03315689|19955185|P2|Open Label Extension = 52 Weeks|Lost to Follow-up|1
5790710|NCT03315689|19955186|P1|Open Label Extension = 52 Weeks|Lost to Follow-up|0
5790711|NCT03315689|19955185|P2|Open Label Extension = 52 Weeks|Withdrawal by Subject|2
5790712|NCT03315689|19955186|P1|Open Label Extension = 52 Weeks|Withdrawal by Subject|0
5790713|NCT03315689|19955185|P2|Double-blind Period = 28 Days|Withdrawal by Subject|0
5790714|NCT03315689|19955186|P1|Double-blind Period = 28 Days|Withdrawal by Subject|1
5790715|NCT03315286|19955280|P2|Overall Study|Protocol Violation|1
5790716|NCT03315286|19955281|P1|Overall Study|Protocol Violation|0
5790717|NCT03315286|19955280|P2|Overall Study|Withdrawal by Subject|0
5790718|NCT03315286|19955281|P1|Overall Study|Withdrawal by Subject|1
5790719|NCT03315286|19955280|P2|Overall Study|Lost to Follow-up|3
5790720|NCT03315286|19955281|P1|Overall Study|Lost to Follow-up|0
5790721|NCT03314857|19955322|P1|Overall Study|Physician Decision|1
5790722|NCT03314857|19955322|P1|Overall Study|Death|4
5790723|NCT03314662|19955356|P3|Overall Study|Death|0
5790724|NCT03314662|19955357|P2|Overall Study|Death|0
5790725|NCT03314662|19955358|P1|Overall Study|Death|2
5790726|NCT03314662|19955356|P3|Overall Study|Lost to Follow-up|4
5790727|NCT03314662|19955357|P2|Overall Study|Lost to Follow-up|4
5790728|NCT03314662|19955358|P1|Overall Study|Lost to Follow-up|5
5790729|NCT03314662|19955356|P3|Overall Study|Withdrawal by Subject|1
5790730|NCT03314662|19955357|P2|Overall Study|Withdrawal by Subject|1
5790731|NCT03314662|19955358|P1|Overall Study|Withdrawal by Subject|1
5790732|NCT03314519|19955403|P2|Overall Study|Protocol Violation|2
5790733|NCT03314519|19955404|P1|Overall Study|Protocol Violation|3
5790734|NCT03314233|19955414|P1|Overall Study|No longer eligible at time of delivery|1
5790735|NCT03313310|19955427|P2|Phase 3|Lost to Follow-up|1
5790736|NCT03313310|19955428|P1|Phase 3|Lost to Follow-up|0
5790737|NCT03313310|19955427|P2|Phase 2|Lost to Follow-up|0
5790738|NCT03313310|19955428|P1|Phase 2|Lost to Follow-up|4
5790739|NCT03313050|19955470|P4|Stage 2: 12 Months|Other|1
5790740|NCT03313050|19955471|P3|Stage 2: 12 Months|Other|0
5790741|NCT03313050|19955472|P2|Stage 2: 12 Months|Other|0
5790742|NCT03313050|19955473|P1|Stage 2: 12 Months|Other|0
5790743|NCT03313050|19955470|P4|Stage 2: 12 Months|Withdrawal by Subject|3
5790744|NCT03313050|19955471|P3|Stage 2: 12 Months|Withdrawal by Subject|0
5790745|NCT03313050|19955472|P2|Stage 2: 12 Months|Withdrawal by Subject|0
5790746|NCT03313050|19955473|P1|Stage 2: 12 Months|Withdrawal by Subject|0
5790747|NCT03313050|19955470|P4|Stage 2: 12 Months|Protocol deviation|7
5790748|NCT03313050|19955471|P3|Stage 2: 12 Months|Protocol deviation|7
5790749|NCT03313050|19955472|P2|Stage 2: 12 Months|Protocol deviation|0
5790750|NCT03313050|19955473|P1|Stage 2: 12 Months|Protocol deviation|0
5790751|NCT03313050|19955470|P4|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|3
5790752|NCT03313050|19955471|P3|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0
5790753|NCT03313050|19955472|P2|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0
5790754|NCT03313050|19955473|P1|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0
5790755|NCT03313050|19955470|P4|Stage 2: 12 Months|Lost to Follow-up|5
5790756|NCT03313050|19955471|P3|Stage 2: 12 Months|Lost to Follow-up|1
5790757|NCT03313050|19955472|P2|Stage 2: 12 Months|Lost to Follow-up|0
5790758|NCT03313050|19955473|P1|Stage 2: 12 Months|Lost to Follow-up|0
5790759|NCT03313050|19955470|P4|Stage 2: 12 Months|Death|0
5790760|NCT03313050|19955471|P3|Stage 2: 12 Months|Death|3
5790761|NCT03313050|19955472|P2|Stage 2: 12 Months|Death|0
5790762|NCT03313050|19955473|P1|Stage 2: 12 Months|Death|0
5790763|NCT03313050|19955470|P4|Stage 2: 12 Months|Adverse Event|1
5790764|NCT03313050|19955471|P3|Stage 2: 12 Months|Adverse Event|0
5790765|NCT03313050|19955472|P2|Stage 2: 12 Months|Adverse Event|0
5790766|NCT03313050|19955473|P1|Stage 2: 12 Months|Adverse Event|0
5790767|NCT03313037|19955513|P2|Overall Study|Randomized but not treated|0
5790768|NCT03313037|19955514|P1|Overall Study|Randomized but not treated|1
5790769|NCT03313037|19955513|P2|Overall Study|Lost to Follow-up|8
5790770|NCT03313037|19955514|P1|Overall Study|Lost to Follow-up|9
5790771|NCT03313037|19955513|P2|Overall Study|No longer meets eligibility criteria|7
5790772|NCT03313037|19955514|P1|Overall Study|No longer meets eligibility criteria|1
5790773|NCT03313037|19955513|P2|Overall Study|Withdrawal by Subject|3
5790774|NCT03313037|19955514|P1|Overall Study|Withdrawal by Subject|4
5790775|NCT03313037|19955513|P2|Overall Study|Other|1
5790776|NCT03313037|19955514|P1|Overall Study|Other|1
5790777|NCT03313037|19955513|P2|Overall Study|Protocol Violation|1
5790778|NCT03313037|19955514|P1|Overall Study|Protocol Violation|4
5790779|NCT03312933|19955536|P1|Overall Study|Withdrawal by Subject|3
5790780|NCT03312933|19955536|P1|Overall Study|Lost to Follow-up|36
5790781|NCT03312933|19955536|P1|Overall Study|Protocol Violation|15
5790782|NCT03312543|19955542|P2|Regression (Week 12 to Week 24)|Death|1
5790783|NCT03312543|19955543|P1|Regression (Week 12 to Week 24)|Death|0
5790784|NCT03312543|19955542|P2|Regression (Week 12 to Week 24)|Protocol Violation|1
5790785|NCT03312543|19955543|P1|Regression (Week 12 to Week 24)|Protocol Violation|1
5790786|NCT03312543|19955542|P2|Treatment (Baseline to Week 12)|Protocol Violation|1
5790787|NCT03312543|19955543|P1|Treatment (Baseline to Week 12)|Protocol Violation|1
5790788|NCT03312543|19955542|P2|Treatment (Baseline to Week 12)|Withdrawal by Subject|4
5790789|NCT03312543|19955543|P1|Treatment (Baseline to Week 12)|Withdrawal by Subject|3
5790790|NCT03312543|19955542|P2|Before Treatment (Screening to Baseline)|Withdrawal by Subject|2
5790791|NCT03312543|19955543|P1|Before Treatment (Screening to Baseline)|Withdrawal by Subject|1
5790792|NCT03312543|19955542|P2|Before Treatment (Screening to Baseline)|Lost to Follow-up|2
5790793|NCT03312543|19955543|P1|Before Treatment (Screening to Baseline)|Lost to Follow-up|0
5790794|NCT03312231|19955639|P5|Overall Study|Study Vaccination not Received|0
5790795|NCT03312231|19955640|P4|Overall Study|Study Vaccination not Received|0
5790796|NCT03312231|19955641|P3|Overall Study|Study Vaccination not Received|1
5790797|NCT03312231|19955642|P2|Overall Study|Study Vaccination not Received|1
5790798|NCT03312231|19955643|P1|Overall Study|Study Vaccination not Received|1
5790799|NCT03312231|19955639|P5|Overall Study|Death|0
5790800|NCT03312231|19955640|P4|Overall Study|Death|0
5790801|NCT03312231|19955641|P3|Overall Study|Death|1
5790802|NCT03312231|19955642|P2|Overall Study|Death|1
5790803|NCT03312231|19955643|P1|Overall Study|Death|0
5790804|NCT03312231|19955639|P5|Overall Study|Withdrawal by Subject|0
5790805|NCT03312231|19955640|P4|Overall Study|Withdrawal by Subject|0
5790806|NCT03312231|19955641|P3|Overall Study|Withdrawal by Subject|1
5790807|NCT03312231|19955642|P2|Overall Study|Withdrawal by Subject|3
5790808|NCT03312231|19955643|P1|Overall Study|Withdrawal by Subject|0
5790809|NCT03312231|19955639|P5|Overall Study|Lost to Follow-up|1
5790810|NCT03312231|19955640|P4|Overall Study|Lost to Follow-up|3
5790811|NCT03312231|19955641|P3|Overall Study|Lost to Follow-up|1
5790812|NCT03312231|19955642|P2|Overall Study|Lost to Follow-up|6
5790813|NCT03312231|19955643|P1|Overall Study|Lost to Follow-up|2
5790814|NCT03312114|19955845|P1|Overall Study|All the five enrolled dropped out of the|5
5790815|NCT03311841|19955855|P5|14-day Wash-out|Non-Compliance With Study Drug|0
5790816|NCT03311841|19955856|P4|14-day Wash-out|Non-Compliance With Study Drug|1
5790817|NCT03311841|19955857|P3|14-day Wash-out|Non-Compliance With Study Drug|0
5790818|NCT03311841|19955858|P2|14-day Wash-out|Non-Compliance With Study Drug|0
5790819|NCT03311841|19955859|P1|14-day Wash-out|Non-Compliance With Study Drug|0
5790820|NCT03311841|19955855|P5|14-day Wash-out|Adverse Event|0
5790821|NCT03311841|19955856|P4|14-day Wash-out|Adverse Event|0
5790822|NCT03311841|19955857|P3|14-day Wash-out|Adverse Event|0
5790823|NCT03311841|19955858|P2|14-day Wash-out|Adverse Event|1
5790824|NCT03311841|19955859|P1|14-day Wash-out|Adverse Event|0
5790825|NCT03311659|19955960|P1|Overall Study|Protocol Violation|1
5790826|NCT03311646|19955975|P1|Overall Study|PI Withdrawal for Positive Drug Screen|4
5790827|NCT03311646|19955975|P1|Overall Study|Lost to Follow-up|5
5790828|NCT03311646|19955975|P1|Overall Study|Withdrawal by Subject|5
5790829|NCT03311646|19955975|P1|Overall Study|Physician Decision|1
5790830|NCT03311373|19955982|P1|Overall Study|Withdrawal by Subject|3
5790831|NCT03311373|19955982|P1|Overall Study|Physician Decision|1
5790832|NCT03311373|19955982|P1|Overall Study|Lost to Follow-up|1
5790833|NCT03311373|19955982|P1|Overall Study|Protocol Discontinuation Criteria|3
5790834|NCT03311373|19955982|P1|Overall Study|Adverse Event|1
5790835|NCT03311230|19956040|P4|Overall Study|Unrelated injury|0
5790836|NCT03311230|19956041|P3|Overall Study|Unrelated injury|0
5790837|NCT03311230|19956042|P2|Overall Study|Unrelated injury|1
5790838|NCT03311230|19956043|P1|Overall Study|Unrelated injury|0
5790839|NCT03311230|19956040|P4|Overall Study|Withdrawal by Subject|7
5790840|NCT03311230|19956041|P3|Overall Study|Withdrawal by Subject|2
5790841|NCT03311230|19956042|P2|Overall Study|Withdrawal by Subject|4
5790842|NCT03311230|19956043|P1|Overall Study|Withdrawal by Subject|1
5790843|NCT03310775|19956067|P2|Overall Study|aggravation of depression|1
5790844|NCT03310775|19956068|P1|Overall Study|aggravation of depression|0
5790845|NCT03310775|19956067|P2|Overall Study|Lost to Follow-up|3
5790846|NCT03310775|19956068|P1|Overall Study|Lost to Follow-up|2
5790847|NCT03310723|19956086|P2|Overall Study|Protocol Violation|2
5790848|NCT03310723|19956087|P1|Overall Study|Protocol Violation|0
5790849|NCT03310723|19956086|P2|Overall Study|Withdrawal by Subject|1
5790850|NCT03310723|19956087|P1|Overall Study|Withdrawal by Subject|0
5790851|NCT03310580|19956098|P3|Overall Study|Adverse Event|0
5790852|NCT03310580|19956099|P2|Overall Study|Adverse Event|1
5790853|NCT03310580|19956100|P1|Overall Study|Adverse Event|0
5790854|NCT03310411|19956133|P4|Period 1|Adverse Event|1
5790855|NCT03310411|19956134|P3|Period 1|Adverse Event|0
5790856|NCT03310411|19956135|P2|Period 1|Adverse Event|0
5790857|NCT03310411|19956136|P1|Period 1|Adverse Event|0
5790858|NCT03310268|19956157|P3|Overall Study|(Not specified)|0
5790859|NCT03310268|19956158|P2|Overall Study|(Not specified)|5
5790860|NCT03310268|19956159|P1|Overall Study|(Not specified)|1
5790861|NCT03310021|19956190|P20|Overall Study|Lost to Follow-up|0
5790862|NCT03310021|19956191|P19|Overall Study|Lost to Follow-up|0
5790863|NCT03310021|19956192|P18|Overall Study|Lost to Follow-up|0
5790864|NCT03310021|19956193|P17|Overall Study|Lost to Follow-up|0
5790865|NCT03310021|19956194|P16|Overall Study|Lost to Follow-up|0
5790866|NCT03310021|19956195|P15|Overall Study|Lost to Follow-up|0
5790867|NCT03310021|19956196|P14|Overall Study|Lost to Follow-up|0
5790868|NCT03310021|19956197|P13|Overall Study|Lost to Follow-up|0
5790869|NCT03310021|19956198|P12|Overall Study|Lost to Follow-up|0
5790870|NCT03310021|19956199|P11|Overall Study|Lost to Follow-up|1
5790871|NCT03310021|19956200|P10|Overall Study|Lost to Follow-up|0
5790872|NCT03310021|19956201|P9|Overall Study|Lost to Follow-up|0
5790873|NCT03310021|19956202|P8|Overall Study|Lost to Follow-up|0
5790874|NCT03310021|19956203|P7|Overall Study|Lost to Follow-up|0
5790875|NCT03310021|19956204|P6|Overall Study|Lost to Follow-up|0
5790876|NCT03310021|19956205|P5|Overall Study|Lost to Follow-up|0
5790877|NCT03310021|19956206|P4|Overall Study|Lost to Follow-up|0
5790878|NCT03310021|19956207|P3|Overall Study|Lost to Follow-up|0
5790879|NCT03310021|19956208|P2|Overall Study|Lost to Follow-up|0
5790880|NCT03310021|19956209|P1|Overall Study|Lost to Follow-up|0
5790881|NCT03310021|19956190|P20|Overall Study|Withdrawal by Subject|0
5790882|NCT03310021|19956191|P19|Overall Study|Withdrawal by Subject|0
5790883|NCT03310021|19956192|P18|Overall Study|Withdrawal by Subject|0
5790884|NCT03310021|19956193|P17|Overall Study|Withdrawal by Subject|0
5790885|NCT03310021|19956194|P16|Overall Study|Withdrawal by Subject|0
5790886|NCT03310021|19956195|P15|Overall Study|Withdrawal by Subject|0
5790887|NCT03310021|19956196|P14|Overall Study|Withdrawal by Subject|0
5790888|NCT03310021|19956197|P13|Overall Study|Withdrawal by Subject|0
5790889|NCT03310021|19956198|P12|Overall Study|Withdrawal by Subject|0
5790890|NCT03310021|19956199|P11|Overall Study|Withdrawal by Subject|0
5790891|NCT03310021|19956200|P10|Overall Study|Withdrawal by Subject|0
5790892|NCT03310021|19956201|P9|Overall Study|Withdrawal by Subject|0
5790893|NCT03310021|19956202|P8|Overall Study|Withdrawal by Subject|0
5790894|NCT03310021|19956203|P7|Overall Study|Withdrawal by Subject|1
5790895|NCT03310021|19956204|P6|Overall Study|Withdrawal by Subject|0
5790896|NCT03310021|19956205|P5|Overall Study|Withdrawal by Subject|0
5790897|NCT03310021|19956206|P4|Overall Study|Withdrawal by Subject|0
5790898|NCT03310021|19956207|P3|Overall Study|Withdrawal by Subject|0
5790899|NCT03310021|19956208|P2|Overall Study|Withdrawal by Subject|0
5790900|NCT03310021|19956209|P1|Overall Study|Withdrawal by Subject|0
5790901|NCT03309943|19956353|P2|Overall Study|Inappropriate behavior towards staff|1
5790902|NCT03309943|19956354|P1|Overall Study|Inappropriate behavior towards staff|0
5790903|NCT03309943|19956353|P2|Overall Study|Withdrawal by Subject|1
5790904|NCT03309943|19956354|P1|Overall Study|Withdrawal by Subject|0
5790905|NCT03309696|19956417|P4|Overall Study|Analysis of TEP data could not be completed|0
5790906|NCT03309696|19956418|P3|Overall Study|Analysis of TEP data could not be completed|0
5790907|NCT03309696|19956419|P2|Overall Study|Analysis of TEP data could not be completed|5
5790908|NCT03309696|19956420|P1|Overall Study|Analysis of TEP data could not be completed|0
5790909|NCT03309202|19956439|P4|Overall Study|Lost to Follow-up|0
5790910|NCT03309202|19956440|P3|Overall Study|Lost to Follow-up|0
5790911|NCT03309202|19956441|P2|Overall Study|Lost to Follow-up|0
5790912|NCT03309202|19956442|P1|Overall Study|Lost to Follow-up|1
5790913|NCT03308968|19956536|P3|Open-Label Period (12 Weeks)|Lack of Efficacy|0
5790914|NCT03308968|19956537|P2|Open-Label Period (12 Weeks)|Lack of Efficacy|2
5790915|NCT03308968|19956538|P1|Open-Label Period (12 Weeks)|Lack of Efficacy|1
5790916|NCT03308968|19956536|P3|Open-Label Period (12 Weeks)|Lost to Follow-up|1
5790917|NCT03308968|19956537|P2|Open-Label Period (12 Weeks)|Lost to Follow-up|1
5790918|NCT03308968|19956538|P1|Open-Label Period (12 Weeks)|Lost to Follow-up|0
5790919|NCT03308968|19956536|P3|Open-Label Period (12 Weeks)|Non-compliance to study procedures|1
5790920|NCT03308968|19956537|P2|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0
5790921|NCT03308968|19956538|P1|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0
5790922|NCT03308968|19956536|P3|Open-Label Period (12 Weeks)|Protocol Violation|1
5790923|NCT03308968|19956537|P2|Open-Label Period (12 Weeks)|Protocol Violation|1
5790924|NCT03308968|19956538|P1|Open-Label Period (12 Weeks)|Protocol Violation|0
5790925|NCT03308968|19956536|P3|Open-Label Period (12 Weeks)|Withdrawal by Subject|7
5790926|NCT03308968|19956537|P2|Open-Label Period (12 Weeks)|Withdrawal by Subject|5
5790927|NCT03308968|19956538|P1|Open-Label Period (12 Weeks)|Withdrawal by Subject|5
5790928|NCT03308968|19956536|P3|Open-Label Period (12 Weeks)|Adverse Event|1
5790929|NCT03308968|19956537|P2|Open-Label Period (12 Weeks)|Adverse Event|1
5790930|NCT03308968|19956538|P1|Open-Label Period (12 Weeks)|Adverse Event|4
5790931|NCT03308968|19956536|P3|Open-Label Period (12 Weeks)|Other than specified|1
5790932|NCT03308968|19956537|P2|Open-Label Period (12 Weeks)|Other than specified|2
5790933|NCT03308968|19956538|P1|Open-Label Period (12 Weeks)|Other than specified|1
5790934|NCT03308968|19956536|P3|Double-Blind Period (12 Weeks)|Other than specified|2
5790935|NCT03308968|19956537|P2|Double-Blind Period (12 Weeks)|Other than specified|0
5790936|NCT03308968|19956538|P1|Double-Blind Period (12 Weeks)|Other than specified|1
5790937|NCT03308968|19956536|P3|Double-Blind Period (12 Weeks)|Lack of Efficacy|0
5790938|NCT03308968|19956537|P2|Double-Blind Period (12 Weeks)|Lack of Efficacy|1
5790939|NCT03308968|19956538|P1|Double-Blind Period (12 Weeks)|Lack of Efficacy|1
5790940|NCT03308968|19956536|P3|Double-Blind Period (12 Weeks)|Lost to Follow-up|0
5790941|NCT03308968|19956537|P2|Double-Blind Period (12 Weeks)|Lost to Follow-up|0
5790942|NCT03308968|19956538|P1|Double-Blind Period (12 Weeks)|Lost to Follow-up|1
5790943|NCT03308968|19956536|P3|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|0
5790944|NCT03308968|19956537|P2|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1
5790945|NCT03308968|19956538|P1|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1
5790946|NCT03308968|19956536|P3|Double-Blind Period (12 Weeks)|Protocol Violation|2
5790947|NCT03308968|19956537|P2|Double-Blind Period (12 Weeks)|Protocol Violation|0
5790948|NCT03308968|19956538|P1|Double-Blind Period (12 Weeks)|Protocol Violation|6
5790949|NCT03308968|19956536|P3|Double-Blind Period (12 Weeks)|Withdrawal by Subject|3
5790950|NCT03308968|19956537|P2|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2
5790951|NCT03308968|19956538|P1|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2
5790952|NCT03308968|19956536|P3|Double-Blind Period (12 Weeks)|Adverse Event|4
5790953|NCT03308968|19956537|P2|Double-Blind Period (12 Weeks)|Adverse Event|1
5790954|NCT03308968|19956538|P1|Double-Blind Period (12 Weeks)|Adverse Event|3
5790955|NCT03308825|19956616|P4|Overall Study|Protocol Violation|0
5790956|NCT03308825|19956617|P3|Overall Study|Protocol Violation|0
5790957|NCT03308825|19956618|P2|Overall Study|Protocol Violation|2
5790958|NCT03308825|19956619|P1|Overall Study|Protocol Violation|0
5790959|NCT03308825|19956616|P4|Overall Study|Lost to Follow-up|0
5790960|NCT03308825|19956617|P3|Overall Study|Lost to Follow-up|1
5790961|NCT03308825|19956618|P2|Overall Study|Lost to Follow-up|2
5790962|NCT03308825|19956619|P1|Overall Study|Lost to Follow-up|2
5790963|NCT03307252|19956707|P11|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|1
5790964|NCT03307252|19956708|P10|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
5790965|NCT03307252|19956709|P9|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
5790966|NCT03307252|19956710|P8|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
5790967|NCT03307252|19956711|P7|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
5790968|NCT03307252|19956712|P6|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
5790969|NCT03307252|19956713|P5|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
5790970|NCT03307252|19956714|P4|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
5790971|NCT03307252|19956715|P3|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
5790972|NCT03307252|19956716|P2|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
5790973|NCT03307252|19956717|P1|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
5790974|NCT03307252|19956707|P11|Part 2, Period 4|Other than listed|0
5790975|NCT03307252|19956708|P10|Part 2, Period 4|Other than listed|0
5790976|NCT03307252|19956709|P9|Part 2, Period 4|Other than listed|0
5790977|NCT03307252|19956710|P8|Part 2, Period 4|Other than listed|0
5790978|NCT03307252|19956711|P7|Part 2, Period 4|Other than listed|1
5790979|NCT03307252|19956712|P6|Part 2, Period 4|Other than listed|0
5790980|NCT03307252|19956713|P5|Part 2, Period 4|Other than listed|0
5790981|NCT03307252|19956714|P4|Part 2, Period 4|Other than listed|0
5790982|NCT03307252|19956715|P3|Part 2, Period 4|Other than listed|0
5790983|NCT03307252|19956716|P2|Part 2, Period 4|Other than listed|0
5790984|NCT03307252|19956717|P1|Part 2, Period 4|Other than listed|0
5790985|NCT03307252|19956707|P11|Part 2, Period 3|Other than listed|0
5790986|NCT03307252|19956708|P10|Part 2, Period 3|Other than listed|0
5790987|NCT03307252|19956709|P9|Part 2, Period 3|Other than listed|0
5790988|NCT03307252|19956710|P8|Part 2, Period 3|Other than listed|0
5790989|NCT03307252|19956711|P7|Part 2, Period 3|Other than listed|0
5790990|NCT03307252|19956712|P6|Part 2, Period 3|Other than listed|0
5790991|NCT03307252|19956713|P5|Part 2, Period 3|Other than listed|1
5790992|NCT03307252|19956714|P4|Part 2, Period 3|Other than listed|0
5790993|NCT03307252|19956715|P3|Part 2, Period 3|Other than listed|0
5790994|NCT03307252|19956716|P2|Part 2, Period 3|Other than listed|0
5790995|NCT03307252|19956717|P1|Part 2, Period 3|Other than listed|0
5790996|NCT03307252|19956707|P11|Part 2, Period 1|Treatment not received|0
5790997|NCT03307252|19956708|P10|Part 2, Period 1|Treatment not received|0
5790998|NCT03307252|19956709|P9|Part 2, Period 1|Treatment not received|0
5790999|NCT03307252|19956710|P8|Part 2, Period 1|Treatment not received|0
5791000|NCT03307252|19956711|P7|Part 2, Period 1|Treatment not received|0
5791001|NCT03307252|19956712|P6|Part 2, Period 1|Treatment not received|1
5791002|NCT03307252|19956713|P5|Part 2, Period 1|Treatment not received|0
5791003|NCT03307252|19956714|P4|Part 2, Period 1|Treatment not received|0
5791004|NCT03307252|19956715|P3|Part 2, Period 1|Treatment not received|0
5791005|NCT03307252|19956716|P2|Part 2, Period 1|Treatment not received|0
5791006|NCT03307252|19956717|P1|Part 2, Period 1|Treatment not received|0
5791007|NCT03307174|19956754|P2|Overall Study|Intrathecal catheter placement|1
5791008|NCT03307174|19956755|P1|Overall Study|Intrathecal catheter placement|0
5791009|NCT03307174|19956754|P2|Overall Study|Planned epidural removal|0
5791010|NCT03307174|19956755|P1|Overall Study|Planned epidural removal|1
5791011|NCT03307174|19956754|P2|Overall Study|Nonfunctional epidural|1
5791012|NCT03307174|19956755|P1|Overall Study|Nonfunctional epidural|1
5791013|NCT03307174|19956754|P2|Overall Study|Hypotension|0
5791014|NCT03307174|19956755|P1|Overall Study|Hypotension|6
5791015|NCT03307174|19956754|P2|Overall Study|Aborted Surgery|2
5791016|NCT03307174|19956755|P1|Overall Study|Aborted Surgery|1
5791017|NCT03307174|19956754|P2|Overall Study|Unplanned ICU Administrion|3
5791018|NCT03307174|19956755|P1|Overall Study|Unplanned ICU Administrion|5
5791019|NCT03306277|19957036|P1|Overall Study|Withdrawal by Subject|1
5791020|NCT03306277|19957036|P1|Overall Study|Adverse Event|1
5791021|NCT03306277|19957036|P1|Overall Study|Death|1
5791022|NCT03306043|19957047|P1|Overall Study|Withdrawal by Subject|2
5791023|NCT03306043|19957047|P1|Overall Study|Lost to Follow-up|1
5791024|NCT03306043|19957047|P1|Overall Study|Adverse Event|1
5791025|NCT03305770|19957073|P2|Overall Study|Subject moved|0
5791026|NCT03305770|19957074|P1|Overall Study|Subject moved|1
5791027|NCT03305770|19957073|P2|Overall Study|Physician Decision - prior to dispense|1
5791028|NCT03305770|19957074|P1|Overall Study|Physician Decision - prior to dispense|0
5791029|NCT03305731|19957082|P1|Overall Study|Protocol Violation|1
5791030|NCT03305575|19957093|P2|Overall Study|Physician Decision|0
5791031|NCT03305575|19957094|P1|Overall Study|Physician Decision|1
5791032|NCT03305419|19957114|P8|Part B (14 Days)|Physician Decision|0
5791033|NCT03305419|19957115|P7|Part B (14 Days)|Physician Decision|1
5791034|NCT03305419|19957116|P6|Part B (14 Days)|Physician Decision|8
5791035|NCT03305419|19957117|P5|Part B (14 Days)|Physician Decision|2
5791036|NCT03305419|19957118|P4|Part B (14 Days)|Physician Decision|0
5791037|NCT03305419|19957119|P3|Part B (14 Days)|Physician Decision|0
5791038|NCT03305419|19957120|P2|Part B (14 Days)|Physician Decision|0
5791039|NCT03305419|19957121|P1|Part B (14 Days)|Physician Decision|0
5791040|NCT03305419|19957114|P8|Part B (14 Days)|Adverse Event|0
5791041|NCT03305419|19957115|P7|Part B (14 Days)|Adverse Event|4
5791042|NCT03305419|19957116|P6|Part B (14 Days)|Adverse Event|2
5791043|NCT03305419|19957117|P5|Part B (14 Days)|Adverse Event|1
5791044|NCT03305419|19957118|P4|Part B (14 Days)|Adverse Event|0
5791045|NCT03305419|19957119|P3|Part B (14 Days)|Adverse Event|0
5791046|NCT03305419|19957120|P2|Part B (14 Days)|Adverse Event|0
5791047|NCT03305419|19957121|P1|Part B (14 Days)|Adverse Event|0
5791048|NCT03305419|19957114|P8|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0
5791049|NCT03305419|19957115|P7|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0
5791050|NCT03305419|19957116|P6|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0
5791051|NCT03305419|19957117|P5|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0
5791052|NCT03305419|19957118|P4|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0
5791053|NCT03305419|19957119|P3|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0
5791054|NCT03305419|19957120|P2|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0
5791055|NCT03305419|19957121|P1|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|1
5791056|NCT03305419|19957114|P8|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0
5791057|NCT03305419|19957115|P7|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0
5791058|NCT03305419|19957116|P6|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0
5791059|NCT03305419|19957117|P5|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0
5791060|NCT03305419|19957118|P4|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0
5791061|NCT03305419|19957119|P3|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0
5791062|NCT03305419|19957120|P2|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0
5791063|NCT03305419|19957121|P1|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|1
5791064|NCT03305419|19957114|P8|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0
5791065|NCT03305419|19957115|P7|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0
5791066|NCT03305419|19957116|P6|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0
5791067|NCT03305419|19957117|P5|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0
5791068|NCT03305419|19957118|P4|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0
5791069|NCT03305419|19957119|P3|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0
5791070|NCT03305419|19957120|P2|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|1
5791071|NCT03305419|19957121|P1|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0
5791072|NCT03305081|19957262|P2|Overall Study|Lost to Follow-up|15
5791073|NCT03305081|19957263|P1|Overall Study|Lost to Follow-up|10
5791074|NCT03305055|19957273|P2|Overall Study|Adverse Event|1
5791075|NCT03305055|19957274|P1|Overall Study|Adverse Event|1
5791076|NCT03305055|19957273|P2|Overall Study|Withdrawal by Subject|1
5791077|NCT03305055|19957274|P1|Overall Study|Withdrawal by Subject|0
5791078|NCT03304873|19957292|P2|Overall Study|Lost to Follow-up|8
5791079|NCT03304873|19957293|P1|Overall Study|Lost to Follow-up|1
5791080|NCT03303521|19957399|P2|Overall Study|Adverse Event|0
5791081|NCT03303521|19957400|P1|Overall Study|Adverse Event|1
5791082|NCT03303521|19957399|P2|Overall Study|Non-comliance to study protocol|1
5791083|NCT03303521|19957400|P1|Overall Study|Non-comliance to study protocol|0
5791084|NCT03303521|19957399|P2|Overall Study|Transferred to non-study dialysis center|0
5791085|NCT03303521|19957400|P1|Overall Study|Transferred to non-study dialysis center|1
5791086|NCT03303521|19957399|P2|Overall Study|Investigational product discontinuation|1
5791087|NCT03303521|19957400|P1|Overall Study|Investigational product discontinuation|0
5791088|NCT03303521|19957399|P2|Overall Study|Kidney transplantation|1
5791089|NCT03303521|19957400|P1|Overall Study|Kidney transplantation|0
5791090|NCT03303521|19957399|P2|Overall Study|Death|0
5791091|NCT03303521|19957400|P1|Overall Study|Death|1
5791092|NCT03303521|19957399|P2|Overall Study|Withdrawal by Subject|0
5791093|NCT03303521|19957400|P1|Overall Study|Withdrawal by Subject|2
5791094|NCT03303417|19957410|P2|Overall Study|Withdrawal by Subject|1
5791095|NCT03303417|19957411|P1|Overall Study|Withdrawal by Subject|1
5791096|NCT03302975|19957452|P1|Overall Study|Lost to Follow-up|4
5791097|NCT03302936|19957460|P2|Overall Study|Protocol Violation|4
5791098|NCT03302936|19957461|P1|Overall Study|Protocol Violation|3
5791099|NCT03302559|19957510|P1|Overall Study|Withdrew Consent|3
5791100|NCT03302559|19957510|P1|Overall Study|Lost to Follow-up|1
5791101|NCT03302559|19957510|P1|Overall Study|Adverse Event|2
5791102|NCT03302247|19957528|P1|Overall Study|Death|1
5791103|NCT03302247|19957528|P1|Overall Study|the study has closed prematurely|2
5791104|NCT03301844|19957535|P2|Overall Study|suspected colon cancer|1
5791105|NCT03301844|19957536|P1|Overall Study|suspected colon cancer|1
5791106|NCT03301740|19957563|P2|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|0
5791107|NCT03301740|19957564|P1|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|1
5791108|NCT03301740|19957563|P2|Phase 2 Intervention (3 Weeks)|Kidney Transplant|0
5791109|NCT03301740|19957564|P1|Phase 2 Intervention (3 Weeks)|Kidney Transplant|1
5791110|NCT03301714|19957607|P3|Overall Study|Did not receive allocated intervention|3
5791111|NCT03301714|19957608|P2|Overall Study|Did not receive allocated intervention|2
5791112|NCT03301714|19957609|P1|Overall Study|Did not receive allocated intervention|0
5791113|NCT03301714|19957607|P3|Overall Study|Lost to Follow-up|4
5791114|NCT03301714|19957608|P2|Overall Study|Lost to Follow-up|4
5791115|NCT03301714|19957609|P1|Overall Study|Lost to Follow-up|10
5791116|NCT03301649|19957626|P3|Overall Study|Other than specified|0
5791117|NCT03301649|19957627|P2|Overall Study|Other than specified|3
5791118|NCT03301649|19957628|P1|Overall Study|Other than specified|5
5791119|NCT03301649|19957626|P3|Overall Study|Withdrawal by Subject|0
5791120|NCT03301649|19957627|P2|Overall Study|Withdrawal by Subject|4
5791121|NCT03301649|19957628|P1|Overall Study|Withdrawal by Subject|10
5791122|NCT03301649|19957626|P3|Overall Study|Protocol Violation|1
5791123|NCT03301649|19957627|P2|Overall Study|Protocol Violation|1
5791124|NCT03301649|19957628|P1|Overall Study|Protocol Violation|0
5791125|NCT03301649|19957626|P3|Overall Study|Lost to Follow-up|3
5791126|NCT03301649|19957627|P2|Overall Study|Lost to Follow-up|11
5791127|NCT03301649|19957628|P1|Overall Study|Lost to Follow-up|11
5791128|NCT03301649|19957626|P3|Overall Study|Need alternate therapy due to live lice|81
5791129|NCT03301649|19957627|P2|Overall Study|Need alternate therapy due to live lice|25
5791130|NCT03301649|19957628|P1|Overall Study|Need alternate therapy due to live lice|17
5791131|NCT03301155|19957711|P2|Overall Study|Сompliance with exclusion criteria|7
5791132|NCT03301155|19957712|P1|Overall Study|Сompliance with exclusion criteria|8
5791139|NCT03300024|19957771|P2|Overall Study|Physician Decision|6
5791140|NCT03300024|19957772|P1|Overall Study|Physician Decision|4
5791141|NCT03299686|19957826|P2|Follow-up Epoch|Subject/Guardian Decision|1
5791142|NCT03299686|19957827|P1|Follow-up Epoch|Subject/Guardian Decision|0
5791143|NCT03299686|19957826|P2|Treatment Epoch|Adverse Event|4
5791144|NCT03299686|19957827|P1|Treatment Epoch|Adverse Event|8
5791145|NCT03299686|19957826|P2|Treatment Epoch|Physician Decision|0
5791146|NCT03299686|19957827|P1|Treatment Epoch|Physician Decision|1
5791147|NCT03299686|19957826|P2|Treatment Epoch|Subject/Guardian Decision|0
5791148|NCT03299686|19957827|P1|Treatment Epoch|Subject/Guardian Decision|2
5791149|NCT03299101|19957843|P1|Overall Study|Not enough time to complete prehab|1
5791150|NCT03299101|19957843|P1|Overall Study|Surgery was changed|3
5791151|NCT03299101|19957843|P1|Overall Study|Withdrawal by Subject|5
5791152|NCT03299101|19957843|P1|Overall Study|Lost to Follow-up|1
5791153|NCT03299049|19957866|P2|Overall Study|Adverse Event|13
5791154|NCT03299049|19957867|P1|Overall Study|Adverse Event|12
5791155|NCT03299049|19957866|P2|Overall Study|Lack of Efficacy|3
5791156|NCT03299049|19957867|P1|Overall Study|Lack of Efficacy|9
5791157|NCT03299049|19957866|P2|Overall Study|Protocol Violation|1
5791158|NCT03299049|19957867|P1|Overall Study|Protocol Violation|1
5791159|NCT03299049|19957866|P2|Overall Study|Pregnancy|3
5791160|NCT03299049|19957867|P1|Overall Study|Pregnancy|1
5791161|NCT03299049|19957866|P2|Overall Study|Lost to Follow-up|0
5791162|NCT03299049|19957867|P1|Overall Study|Lost to Follow-up|2
5791163|NCT03299049|19957866|P2|Overall Study|Physician Decision|1
5791164|NCT03299049|19957867|P1|Overall Study|Physician Decision|5
5791165|NCT03299049|19957866|P2|Overall Study|Withdrawal by Subject|21
5791166|NCT03299049|19957867|P1|Overall Study|Withdrawal by Subject|6
5791167|NCT03299049|19957866|P2|Overall Study|On-going|481
5791168|NCT03299049|19957867|P1|Overall Study|On-going|486
5791169|NCT03298867|19957966|P2|Overall Study|Continued in the Follow-Up Period|1
5791170|NCT03298867|19957967|P1|Overall Study|Continued in the Follow-Up Period|0
5791171|NCT03298867|19957966|P2|Overall Study|Did not Continue in the Follow-Up Period|1
5791172|NCT03298867|19957967|P1|Overall Study|Did not Continue in the Follow-Up Period|2
5791173|NCT03298412|19957983|P1|Run-in Period|Decision by Sponsor|6
5791174|NCT03298412|19957983|P1|Run-in Period|Ineligibility Determined|1
5791175|NCT03298412|19957983|P1|Run-in Period|Disease Progression|1
5791176|NCT03298412|19957983|P1|Run-in Period|Other, Not Specified|1
5791177|NCT03297294|19958094|P5|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0
5791178|NCT03297294|19958095|P4|Treatment Withdrawal Period (TW)|Study terminated by sponsor|1
5791179|NCT03297294|19958096|P3|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0
5791180|NCT03297294|19958097|P2|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0
5791181|NCT03297294|19958098|P1|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0
5791182|NCT03297294|19958094|P5|Double-Blind Treatment Period (DB)|Physician Decision|0
5791183|NCT03297294|19958095|P4|Double-Blind Treatment Period (DB)|Physician Decision|0
5791184|NCT03297294|19958096|P3|Double-Blind Treatment Period (DB)|Physician Decision|0
5791185|NCT03297294|19958097|P2|Double-Blind Treatment Period (DB)|Physician Decision|1
5791186|NCT03297294|19958098|P1|Double-Blind Treatment Period (DB)|Physician Decision|1
5791187|NCT03297294|19958094|P5|Double-Blind Treatment Period (DB)|Adverse Event|0
5791188|NCT03297294|19958095|P4|Double-Blind Treatment Period (DB)|Adverse Event|0
5791189|NCT03297294|19958096|P3|Double-Blind Treatment Period (DB)|Adverse Event|0
5791190|NCT03297294|19958097|P2|Double-Blind Treatment Period (DB)|Adverse Event|1
5791191|NCT03297294|19958098|P1|Double-Blind Treatment Period (DB)|Adverse Event|3
5791192|NCT03297294|19958094|P5|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0
5791193|NCT03297294|19958095|P4|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0
5791194|NCT03297294|19958096|P3|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0
5791195|NCT03297294|19958097|P2|Double-Blind Treatment Period (DB)|Withdrawal by Subject|4
5791196|NCT03297294|19958098|P1|Double-Blind Treatment Period (DB)|Withdrawal by Subject|4
5791197|NCT03297294|19958094|P5|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0
5791198|NCT03297294|19958095|P4|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0
5791199|NCT03297294|19958096|P3|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0
5791200|NCT03297294|19958097|P2|Double-Blind Treatment Period (DB)|Study terminated by sponsor|31
5791201|NCT03297294|19958098|P1|Double-Blind Treatment Period (DB)|Study terminated by sponsor|30
5791202|NCT03297021|19958140|P3|Overall Study|Missing Post-Op Data|1
5791203|NCT03297021|19958141|P2|Overall Study|Missing Post-Op Data|2
5791204|NCT03297021|19958142|P1|Overall Study|Missing Post-Op Data|1
5791205|NCT03297021|19958140|P3|Overall Study|Incomplete/illegible data sheet|3
5791206|NCT03297021|19958141|P2|Overall Study|Incomplete/illegible data sheet|2
5791207|NCT03297021|19958142|P1|Overall Study|Incomplete/illegible data sheet|4
5791208|NCT03296566|19958206|P2|Overall Study|Withdrawal by Subject|3
5791209|NCT03296566|19958207|P1|Overall Study|Withdrawal by Subject|0
5791210|NCT03296566|19958206|P2|Overall Study|Lost to Follow-up|46
5791211|NCT03296566|19958207|P1|Overall Study|Lost to Follow-up|19
5791212|NCT03295201|19958304|P2|Overall Study|Hospital admission|1
5791213|NCT03295201|19958305|P1|Overall Study|Hospital admission|0
5791214|NCT03295201|19958304|P2|Overall Study|Lost to Follow-up|1
5791215|NCT03295201|19958305|P1|Overall Study|Lost to Follow-up|1
5791216|NCT03294681|19958357|P1|Overall Study|Withdrawal by Subject|1
5791217|NCT03294538|19958395|P3|Overall Study|Outside of Visit Window|1
5791218|NCT03294538|19958396|P2|Overall Study|Outside of Visit Window|4
5791219|NCT03294538|19958397|P1|Overall Study|Outside of Visit Window|4
5791220|NCT03294538|19958395|P3|Overall Study|Lost to Follow-up|0
5791221|NCT03294538|19958396|P2|Overall Study|Lost to Follow-up|0
5791222|NCT03294538|19958397|P1|Overall Study|Lost to Follow-up|1
5791223|NCT03294538|19958395|P3|Overall Study|Adverse Event|1
5791224|NCT03294538|19958396|P2|Overall Study|Adverse Event|1
5791225|NCT03294538|19958397|P1|Overall Study|Adverse Event|0
5791226|NCT03293654|19958415|P3|Overall Study|Lost to Follow-up|0
5791227|NCT03293654|19958416|P2|Overall Study|Lost to Follow-up|1
5791228|NCT03293654|19958417|P1|Overall Study|Lost to Follow-up|0
5791232|NCT03293394|19958466|P2|Follow-up (6 Months)|Adverse Event|2
5791233|NCT03293394|19958467|P1|Follow-up (6 Months)|Adverse Event|4
5791240|NCT03292432|19958569|P2|Overall Study|Site closed before any data collected|0
5791241|NCT03292432|19958570|P1|Overall Study|Site closed before any data collected|1
5791242|NCT03292432|19958569|P2|Overall Study|Withdrawal by Subject|2
5791243|NCT03292432|19958570|P1|Overall Study|Withdrawal by Subject|1
5791244|NCT03292432|19958569|P2|Overall Study|Death|1
5791245|NCT03292432|19958570|P1|Overall Study|Death|2
5791246|NCT03292432|19958569|P2|Overall Study|Lost to Follow-up|5
5791247|NCT03292432|19958570|P1|Overall Study|Lost to Follow-up|9
5791248|NCT03292432|19958569|P2|Overall Study|In follow-up as of March 20, 2020|13
5791249|NCT03292432|19958570|P1|Overall Study|In follow-up as of March 20, 2020|16
5791250|NCT03292016|19958596|P6|Second Washout|Adverse Event|0
5791251|NCT03292016|19958597|P5|Second Washout|Adverse Event|0
5791252|NCT03292016|19958598|P4|Second Washout|Adverse Event|0
5791253|NCT03292016|19958599|P3|Second Washout|Adverse Event|0
5791254|NCT03292016|19958600|P2|Second Washout|Adverse Event|1
5791255|NCT03292016|19958601|P1|Second Washout|Adverse Event|0
5791256|NCT03291288|19958643|P2|Pexidartinib Only|Ongoing|13
5791257|NCT03291288|19958644|P1|Pexidartinib Only|Ongoing|0
5791258|NCT03291288|19958643|P2|Pexidartinib Only|Other|2
5791259|NCT03291288|19958644|P1|Pexidartinib Only|Other|0
5791260|NCT03291288|19958643|P2|Pexidartinib Only|Patient request|1
5791261|NCT03291288|19958644|P1|Pexidartinib Only|Patient request|0
5791262|NCT03291288|19958643|P2|Pexidartinib Only|Disease progression|8
5791263|NCT03291288|19958644|P1|Pexidartinib Only|Disease progression|0
5791264|NCT03291288|19958643|P2|Pexidartinib Only|Adverse Event|1
5791265|NCT03291288|19958644|P1|Pexidartinib Only|Adverse Event|0
5791266|NCT03291288|19958643|P2|Drug-drug Interaction Phase|Did not receive treatment|0
5791267|NCT03291288|19958644|P1|Drug-drug Interaction Phase|Did not receive treatment|2
5791268|NCT03291288|19958643|P2|Drug-drug Interaction Phase|Disease progression|0
5791269|NCT03291288|19958644|P1|Drug-drug Interaction Phase|Disease progression|2
5791270|NCT03291288|19958643|P2|Drug-drug Interaction Phase|Adverse Event|0
5791271|NCT03291288|19958644|P1|Drug-drug Interaction Phase|Adverse Event|3
5791272|NCT03290300|19958718|P1|Overall Study|Lost to Follow-up|3
5791273|NCT03289676|19958751|P2|Overall Study|Lost to Follow-up|1
5791274|NCT03289676|19958752|P1|Overall Study|Lost to Follow-up|0
5791275|NCT03289676|19958751|P2|Overall Study|Protocol Violation|0
5791276|NCT03289676|19958752|P1|Overall Study|Protocol Violation|2
5791277|NCT03289676|19958751|P2|Overall Study|Withdrawal by Subject|0
5791278|NCT03289676|19958752|P1|Overall Study|Withdrawal by Subject|2
5791279|NCT03289533|19958762|P1|Overall Study|Terminated from study by sponsor|10
5791280|NCT03289533|19958762|P1|Overall Study|Death|12
5791281|NCT03289208|19958823|P3|Overall Study|Adverse Event|0
5791282|NCT03289208|19958824|P2|Overall Study|Adverse Event|0
5791283|NCT03289208|19958825|P1|Overall Study|Adverse Event|1
5791284|NCT03288987|19958844|P2|Overall Study|Protocol Violation|4
5791285|NCT03288987|19958845|P1|Overall Study|Protocol Violation|10
5791286|NCT03288779|19958861|P1|Overall Study|Withdrawal by Subject|3
5791287|NCT03287869|19958868|P2|Overall Study|Reason not Specified|3
5791288|NCT03287869|19958869|P1|Overall Study|Reason not Specified|6
5791289|NCT03287869|19958868|P2|Overall Study|Physician Decision|5
5791290|NCT03287869|19958869|P1|Overall Study|Physician Decision|5
5791291|NCT03287869|19958868|P2|Overall Study|Early Closure of the Site|1
5791292|NCT03287869|19958869|P1|Overall Study|Early Closure of the Site|0
5791293|NCT03287869|19958868|P2|Overall Study|Withdrawal by Subject|43
5791294|NCT03287869|19958869|P1|Overall Study|Withdrawal by Subject|36
5791295|NCT03287869|19958868|P2|Overall Study|Protocol Deviation|1
5791296|NCT03287869|19958869|P1|Overall Study|Protocol Deviation|2
5791297|NCT03287869|19958868|P2|Overall Study|Progressive Disease|0
5791298|NCT03287869|19958869|P1|Overall Study|Progressive Disease|1
5791299|NCT03287869|19958868|P2|Overall Study|Non-Compliance With Study Drug|9
5791300|NCT03287869|19958869|P1|Overall Study|Non-Compliance With Study Drug|5
5791301|NCT03287869|19958868|P2|Overall Study|Lost to Follow-up|19
5791302|NCT03287869|19958869|P1|Overall Study|Lost to Follow-up|13
5791303|NCT03287869|19958868|P2|Overall Study|Lack of Efficacy|0
5791304|NCT03287869|19958869|P1|Overall Study|Lack of Efficacy|1
5791305|NCT03287869|19958868|P2|Overall Study|Adverse Event|12
5791306|NCT03287869|19958869|P1|Overall Study|Adverse Event|14
5791307|NCT03287804|19958890|P1|Overall Study|Progressive disease|8
5791308|NCT03287804|19958890|P1|Overall Study|Physician Decision|2
5791309|NCT03287804|19958890|P1|Overall Study|Death|1
5791310|NCT03287791|19958906|P3|Overall Study|Did not meet inclusion criteria|0
5791311|NCT03287791|19958907|P2|Overall Study|Did not meet inclusion criteria|0
5791312|NCT03287791|19958908|P1|Overall Study|Did not meet inclusion criteria|1
5791313|NCT03287791|19958906|P3|Overall Study|Non-compliance|0
5791314|NCT03287791|19958907|P2|Overall Study|Non-compliance|1
5791315|NCT03287791|19958908|P1|Overall Study|Non-compliance|0
5791316|NCT03287791|19958906|P3|Overall Study|Too much time between 2 visits|0
5791317|NCT03287791|19958907|P2|Overall Study|Too much time between 2 visits|1
5791318|NCT03287791|19958908|P1|Overall Study|Too much time between 2 visits|0
5791319|NCT03287791|19958906|P3|Overall Study|Participant was enrolled at 2 sites|1
5791320|NCT03287791|19958907|P2|Overall Study|Participant was enrolled at 2 sites|0
5791321|NCT03287791|19958908|P1|Overall Study|Participant was enrolled at 2 sites|1
5791322|NCT03287791|19958906|P3|Overall Study|Protocol Violation|1
5791323|NCT03287791|19958907|P2|Overall Study|Protocol Violation|2
5791324|NCT03287791|19958908|P1|Overall Study|Protocol Violation|7
5791325|NCT03287791|19958906|P3|Overall Study|Lost to Follow-up|11
5791326|NCT03287791|19958907|P2|Overall Study|Lost to Follow-up|14
5791327|NCT03287791|19958908|P1|Overall Study|Lost to Follow-up|8
5791328|NCT03287791|19958906|P3|Overall Study|Missed more than 6 consecutive doses|2
5791329|NCT03287791|19958907|P2|Overall Study|Missed more than 6 consecutive doses|2
5791330|NCT03287791|19958908|P1|Overall Study|Missed more than 6 consecutive doses|3
5791331|NCT03287791|19958906|P3|Overall Study|Withdrawal by Subject|17
5791332|NCT03287791|19958907|P2|Overall Study|Withdrawal by Subject|12
5791333|NCT03287791|19958908|P1|Overall Study|Withdrawal by Subject|12
5791334|NCT03287791|19958906|P3|Overall Study|Adverse Event|3
5791335|NCT03287791|19958907|P2|Overall Study|Adverse Event|4
5791336|NCT03287791|19958908|P1|Overall Study|Adverse Event|0
5791337|NCT03287791|19958906|P3|Overall Study|Insufficient Therapeutic Response|1
5791338|NCT03287791|19958907|P2|Overall Study|Insufficient Therapeutic Response|0
5791339|NCT03287791|19958908|P1|Overall Study|Insufficient Therapeutic Response|0
5791340|NCT03287622|19958921|P2|Overall Study|surgery related|2
5791341|NCT03287622|19958922|P1|Overall Study|surgery related|0
5791342|NCT03287622|19958921|P2|Overall Study|prolonged Length of stay|0
5791343|NCT03287622|19958922|P1|Overall Study|prolonged Length of stay|2
5791344|NCT03287622|19958921|P2|Overall Study|No prescripion after surgery|31
5791345|NCT03287622|19958922|P1|Overall Study|No prescripion after surgery|28
5791346|NCT03287622|19958921|P2|Overall Study|Lost to Follow-up|15
5791347|NCT03287622|19958922|P1|Overall Study|Lost to Follow-up|27
5791348|NCT03287622|19958921|P2|Overall Study|Withdrawal by Subject|0
5791349|NCT03287622|19958922|P1|Overall Study|Withdrawal by Subject|1
5791350|NCT03287089|19958944|P2|Overall Study|Withdrawal by Subject|2
5791351|NCT03287089|19958945|P1|Overall Study|Withdrawal by Subject|0
5791352|NCT03287089|19958944|P2|Overall Study|Physician Decision|2
5791353|NCT03287089|19958945|P1|Overall Study|Physician Decision|0
5791354|NCT03287089|19958944|P2|Overall Study|Lost to Follow-up|2
5791355|NCT03287089|19958945|P1|Overall Study|Lost to Follow-up|0
5791356|NCT03286751|19958980|P6|Washout Period 5|Adverse Event|0
5791357|NCT03286751|19958981|P5|Washout Period 5|Adverse Event|1
5791358|NCT03286751|19958982|P4|Washout Period 5|Adverse Event|0
5791359|NCT03286751|19958983|P3|Washout Period 5|Adverse Event|0
5791360|NCT03286751|19958984|P2|Washout Period 5|Adverse Event|0
5791361|NCT03286751|19958985|P1|Washout Period 5|Adverse Event|0
5791362|NCT03286751|19958980|P6|Washout Period 2|Personal Reasons|0
5791363|NCT03286751|19958981|P5|Washout Period 2|Personal Reasons|0
5791364|NCT03286751|19958982|P4|Washout Period 2|Personal Reasons|0
5791365|NCT03286751|19958983|P3|Washout Period 2|Personal Reasons|0
5791366|NCT03286751|19958984|P2|Washout Period 2|Personal Reasons|1
5791367|NCT03286751|19958985|P1|Washout Period 2|Personal Reasons|0
5791368|NCT03286751|19958980|P6|Washout Period 1|Withdrawal by Subject|0
5791369|NCT03286751|19958981|P5|Washout Period 1|Withdrawal by Subject|1
5791370|NCT03286751|19958982|P4|Washout Period 1|Withdrawal by Subject|0
5791371|NCT03286751|19958983|P3|Washout Period 1|Withdrawal by Subject|0
5791372|NCT03286751|19958984|P2|Washout Period 1|Withdrawal by Subject|0
5791373|NCT03286751|19958985|P1|Washout Period 1|Withdrawal by Subject|0
5791374|NCT03286400|19959005|P1|Overall Study|Scheduling difficulty|4
5791375|NCT03286400|19959005|P1|Overall Study|Physician Decision|1
5791376|NCT03286400|19959005|P1|Overall Study|Lost to Follow-up|10
5791377|NCT03286400|19959005|P1|Overall Study|Death|10
5791378|NCT03286218|19959034|P12|Treatment Phase Period 4|Withdrawal by Subject|1
5791379|NCT03286218|19959035|P11|Treatment Phase Period 4|Withdrawal by Subject|0
5791380|NCT03286218|19959036|P10|Treatment Phase Period 4|Withdrawal by Subject|0
5791381|NCT03286218|19959037|P9|Treatment Phase Period 4|Withdrawal by Subject|0
5791382|NCT03286218|19959038|P8|Treatment Phase Period 4|Withdrawal by Subject|0
5791383|NCT03286218|19959039|P7|Treatment Phase Period 4|Withdrawal by Subject|0
5791384|NCT03286218|19959040|P6|Treatment Phase Period 4|Withdrawal by Subject|0
5791385|NCT03286218|19959041|P5|Treatment Phase Period 4|Withdrawal by Subject|0
5791386|NCT03286218|19959042|P4|Treatment Phase Period 4|Withdrawal by Subject|0
5791387|NCT03286218|19959043|P3|Treatment Phase Period 4|Withdrawal by Subject|0
5791388|NCT03286218|19959044|P2|Treatment Phase Period 4|Withdrawal by Subject|0
5791389|NCT03286218|19959045|P1|Treatment Phase Period 4|Withdrawal by Subject|0
5791390|NCT03286218|19959034|P12|Treatment Phase Period 1|Withdrawal by Subject|1
5791391|NCT03286218|19959035|P11|Treatment Phase Period 1|Withdrawal by Subject|0
5791392|NCT03286218|19959036|P10|Treatment Phase Period 1|Withdrawal by Subject|0
5791393|NCT03286218|19959037|P9|Treatment Phase Period 1|Withdrawal by Subject|0
5791394|NCT03286218|19959038|P8|Treatment Phase Period 1|Withdrawal by Subject|0
5791395|NCT03286218|19959039|P7|Treatment Phase Period 1|Withdrawal by Subject|0
5791396|NCT03286218|19959040|P6|Treatment Phase Period 1|Withdrawal by Subject|1
5791397|NCT03286218|19959041|P5|Treatment Phase Period 1|Withdrawal by Subject|0
5791398|NCT03286218|19959042|P4|Treatment Phase Period 1|Withdrawal by Subject|1
5791399|NCT03286218|19959043|P3|Treatment Phase Period 1|Withdrawal by Subject|1
5791400|NCT03286218|19959044|P2|Treatment Phase Period 1|Withdrawal by Subject|0
5791401|NCT03286218|19959045|P1|Treatment Phase Period 1|Withdrawal by Subject|0
5791402|NCT03286218|19959034|P12|Qualification Phase Period 2|Withdrawal by Subject|0
5791403|NCT03286218|19959035|P11|Qualification Phase Period 2|Withdrawal by Subject|0
5791404|NCT03286218|19959036|P10|Qualification Phase Period 2|Withdrawal by Subject|0
5791405|NCT03286218|19959037|P9|Qualification Phase Period 2|Withdrawal by Subject|0
5791406|NCT03286218|19959038|P8|Qualification Phase Period 2|Withdrawal by Subject|0
5791407|NCT03286218|19959039|P7|Qualification Phase Period 2|Withdrawal by Subject|0
5791408|NCT03286218|19959040|P6|Qualification Phase Period 2|Withdrawal by Subject|0
5791409|NCT03286218|19959041|P5|Qualification Phase Period 2|Withdrawal by Subject|0
5791410|NCT03286218|19959042|P4|Qualification Phase Period 2|Withdrawal by Subject|0
5791411|NCT03286218|19959043|P3|Qualification Phase Period 2|Withdrawal by Subject|0
5791412|NCT03286218|19959044|P2|Qualification Phase Period 2|Withdrawal by Subject|2
5791413|NCT03286218|19959045|P1|Qualification Phase Period 2|Withdrawal by Subject|1
5791414|NCT03286218|19959034|P12|Qualification Phase Period 2|Protocol Violation|0
5791415|NCT03286218|19959035|P11|Qualification Phase Period 2|Protocol Violation|0
5791416|NCT03286218|19959036|P10|Qualification Phase Period 2|Protocol Violation|0
5791417|NCT03286218|19959037|P9|Qualification Phase Period 2|Protocol Violation|0
5791418|NCT03286218|19959038|P8|Qualification Phase Period 2|Protocol Violation|0
5791419|NCT03286218|19959039|P7|Qualification Phase Period 2|Protocol Violation|0
5791420|NCT03286218|19959040|P6|Qualification Phase Period 2|Protocol Violation|0
5791421|NCT03286218|19959041|P5|Qualification Phase Period 2|Protocol Violation|0
5791422|NCT03286218|19959042|P4|Qualification Phase Period 2|Protocol Violation|0
5791423|NCT03286218|19959043|P3|Qualification Phase Period 2|Protocol Violation|0
5791424|NCT03286218|19959044|P2|Qualification Phase Period 2|Protocol Violation|0
5791425|NCT03286218|19959045|P1|Qualification Phase Period 2|Protocol Violation|2
5791426|NCT03286218|19959034|P12|Qualification Phase Period 2|Lost to Follow-up|0
5791427|NCT03286218|19959035|P11|Qualification Phase Period 2|Lost to Follow-up|0
5791428|NCT03286218|19959036|P10|Qualification Phase Period 2|Lost to Follow-up|0
5791429|NCT03286218|19959037|P9|Qualification Phase Period 2|Lost to Follow-up|0
5791430|NCT03286218|19959038|P8|Qualification Phase Period 2|Lost to Follow-up|0
5791431|NCT03286218|19959039|P7|Qualification Phase Period 2|Lost to Follow-up|0
5791432|NCT03286218|19959040|P6|Qualification Phase Period 2|Lost to Follow-up|0
5791433|NCT03286218|19959041|P5|Qualification Phase Period 2|Lost to Follow-up|0
5791434|NCT03286218|19959042|P4|Qualification Phase Period 2|Lost to Follow-up|0
5791435|NCT03286218|19959043|P3|Qualification Phase Period 2|Lost to Follow-up|0
5791436|NCT03286218|19959044|P2|Qualification Phase Period 2|Lost to Follow-up|1
5791437|NCT03286218|19959045|P1|Qualification Phase Period 2|Lost to Follow-up|0
5791438|NCT03286218|19959034|P12|Qualification Phase Period 2|Failure to meet randomization criteria|0
5791439|NCT03286218|19959035|P11|Qualification Phase Period 2|Failure to meet randomization criteria|0
5791440|NCT03286218|19959036|P10|Qualification Phase Period 2|Failure to meet randomization criteria|0
5791441|NCT03286218|19959037|P9|Qualification Phase Period 2|Failure to meet randomization criteria|0
5791442|NCT03286218|19959038|P8|Qualification Phase Period 2|Failure to meet randomization criteria|0
5791443|NCT03286218|19959039|P7|Qualification Phase Period 2|Failure to meet randomization criteria|0
5791444|NCT03286218|19959040|P6|Qualification Phase Period 2|Failure to meet randomization criteria|0
5791445|NCT03286218|19959041|P5|Qualification Phase Period 2|Failure to meet randomization criteria|0
5791446|NCT03286218|19959042|P4|Qualification Phase Period 2|Failure to meet randomization criteria|0
5791447|NCT03286218|19959043|P3|Qualification Phase Period 2|Failure to meet randomization criteria|0
5791448|NCT03286218|19959044|P2|Qualification Phase Period 2|Failure to meet randomization criteria|15
5791449|NCT03286218|19959045|P1|Qualification Phase Period 2|Failure to meet randomization criteria|14
5791450|NCT03286218|19959034|P12|Qualification Phase Period 2|Adverse Event|0
5791451|NCT03286218|19959035|P11|Qualification Phase Period 2|Adverse Event|0
5791452|NCT03286218|19959036|P10|Qualification Phase Period 2|Adverse Event|0
5791453|NCT03286218|19959037|P9|Qualification Phase Period 2|Adverse Event|0
5791454|NCT03286218|19959038|P8|Qualification Phase Period 2|Adverse Event|0
5791455|NCT03286218|19959039|P7|Qualification Phase Period 2|Adverse Event|0
5791456|NCT03286218|19959040|P6|Qualification Phase Period 2|Adverse Event|0
5791457|NCT03286218|19959041|P5|Qualification Phase Period 2|Adverse Event|0
5791458|NCT03286218|19959042|P4|Qualification Phase Period 2|Adverse Event|0
5791459|NCT03286218|19959043|P3|Qualification Phase Period 2|Adverse Event|0
5791460|NCT03286218|19959044|P2|Qualification Phase Period 2|Adverse Event|1
5791461|NCT03286218|19959045|P1|Qualification Phase Period 2|Adverse Event|0
5791462|NCT03286218|19959034|P12|Qualification Phase Period 1|Withdrawal by Subject|0
5791463|NCT03286218|19959035|P11|Qualification Phase Period 1|Withdrawal by Subject|0
5791464|NCT03286218|19959036|P10|Qualification Phase Period 1|Withdrawal by Subject|0
5791465|NCT03286218|19959037|P9|Qualification Phase Period 1|Withdrawal by Subject|0
5791466|NCT03286218|19959038|P8|Qualification Phase Period 1|Withdrawal by Subject|0
5791467|NCT03286218|19959039|P7|Qualification Phase Period 1|Withdrawal by Subject|0
5791468|NCT03286218|19959040|P6|Qualification Phase Period 1|Withdrawal by Subject|0
5791469|NCT03286218|19959041|P5|Qualification Phase Period 1|Withdrawal by Subject|0
5791470|NCT03286218|19959042|P4|Qualification Phase Period 1|Withdrawal by Subject|0
5791471|NCT03286218|19959043|P3|Qualification Phase Period 1|Withdrawal by Subject|0
5791472|NCT03286218|19959044|P2|Qualification Phase Period 1|Withdrawal by Subject|1
5791473|NCT03286218|19959045|P1|Qualification Phase Period 1|Withdrawal by Subject|0
5791474|NCT03286218|19959034|P12|Qualification Phase Period 1|Adverse Event|0
5791475|NCT03286218|19959035|P11|Qualification Phase Period 1|Adverse Event|0
5791476|NCT03286218|19959036|P10|Qualification Phase Period 1|Adverse Event|0
5791477|NCT03286218|19959037|P9|Qualification Phase Period 1|Adverse Event|0
5791478|NCT03286218|19959038|P8|Qualification Phase Period 1|Adverse Event|0
5791479|NCT03286218|19959039|P7|Qualification Phase Period 1|Adverse Event|0
5791480|NCT03286218|19959040|P6|Qualification Phase Period 1|Adverse Event|0
5791481|NCT03286218|19959041|P5|Qualification Phase Period 1|Adverse Event|0
5791482|NCT03286218|19959042|P4|Qualification Phase Period 1|Adverse Event|0
5791483|NCT03286218|19959043|P3|Qualification Phase Period 1|Adverse Event|0
5791484|NCT03286218|19959044|P2|Qualification Phase Period 1|Adverse Event|0
5791485|NCT03286218|19959045|P1|Qualification Phase Period 1|Adverse Event|1
5791486|NCT03285711|19959108|P4|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0
5791487|NCT03285711|19959109|P3|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0
5791488|NCT03285711|19959110|P2|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|1
5791489|NCT03285711|19959111|P1|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0
5791490|NCT03285711|19959108|P4|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0
5791491|NCT03285711|19959109|P3|Blinded Phase (Week 16 to 32)|Lack of Efficacy|1
5791492|NCT03285711|19959110|P2|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0
5791493|NCT03285711|19959111|P1|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0
5791494|NCT03285711|19959108|P4|Blinded Phase (Up to Week 16)|Protocol Violation|0
5791495|NCT03285711|19959109|P3|Blinded Phase (Up to Week 16)|Protocol Violation|0
5791496|NCT03285711|19959110|P2|Blinded Phase (Up to Week 16)|Protocol Violation|0
5791497|NCT03285711|19959111|P1|Blinded Phase (Up to Week 16)|Protocol Violation|1
5791498|NCT03285711|19959108|P4|Blinded Phase (Up to Week 16)|Adverse Event|0
5791499|NCT03285711|19959109|P3|Blinded Phase (Up to Week 16)|Adverse Event|0
5791500|NCT03285711|19959110|P2|Blinded Phase (Up to Week 16)|Adverse Event|1
5791501|NCT03285711|19959111|P1|Blinded Phase (Up to Week 16)|Adverse Event|2
5791502|NCT03285295|19959219|P5|Alinity s Chagas Follow-Up|Lost to Follow-up|0
5791503|NCT03285295|19959220|P4|Alinity s Chagas Follow-Up|Lost to Follow-up|0
5791504|NCT03285295|19959221|P3|Alinity s Chagas Follow-Up|Lost to Follow-up|0
5791505|NCT03285295|19959222|P2|Alinity s Chagas Follow-Up|Lost to Follow-up|0
5791506|NCT03285295|19959223|P1|Alinity s Chagas Follow-Up|Lost to Follow-up|13
5791507|NCT03285295|19959219|P5|Alinity s Chagas|No Results Generated|0
5791508|NCT03285295|19959220|P4|Alinity s Chagas|No Results Generated|0
5791509|NCT03285295|19959221|P3|Alinity s Chagas|No Results Generated|0
5791510|NCT03285295|19959222|P2|Alinity s Chagas|No Results Generated|0
5791511|NCT03285295|19959223|P1|Alinity s Chagas|No Results Generated|105
5791512|NCT03285295|19959219|P5|Alinity s Chagas|No Results on Comparator Assay|0
5791513|NCT03285295|19959220|P4|Alinity s Chagas|No Results on Comparator Assay|0
5791514|NCT03285295|19959221|P3|Alinity s Chagas|No Results on Comparator Assay|0
5791515|NCT03285295|19959222|P2|Alinity s Chagas|No Results on Comparator Assay|0
5791516|NCT03285295|19959223|P1|Alinity s Chagas|No Results on Comparator Assay|38
5791517|NCT03285295|19959219|P5|Alinity s Chagas|Protocol Violation|0
5791518|NCT03285295|19959220|P4|Alinity s Chagas|Protocol Violation|0
5791519|NCT03285295|19959221|P3|Alinity s Chagas|Protocol Violation|0
5791520|NCT03285295|19959222|P2|Alinity s Chagas|Protocol Violation|0
5791521|NCT03285295|19959223|P1|Alinity s Chagas|Protocol Violation|76
5791522|NCT03285295|19959219|P5|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0
5791523|NCT03285295|19959220|P4|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0
5791524|NCT03285295|19959221|P3|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0
5791525|NCT03285295|19959222|P2|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0
5791526|NCT03285295|19959223|P1|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|14
5791527|NCT03285295|19959219|P5|Alinity s Anti-HBc|No Results Generated|0
5791528|NCT03285295|19959220|P4|Alinity s Anti-HBc|No Results Generated|0
5791529|NCT03285295|19959221|P3|Alinity s Anti-HBc|No Results Generated|0
5791530|NCT03285295|19959222|P2|Alinity s Anti-HBc|No Results Generated|0
5791531|NCT03285295|19959223|P1|Alinity s Anti-HBc|No Results Generated|70
5791532|NCT03285295|19959219|P5|Alinity s Anti-HBc|No Results on Comparator Assay|0
5791533|NCT03285295|19959220|P4|Alinity s Anti-HBc|No Results on Comparator Assay|0
5791534|NCT03285295|19959221|P3|Alinity s Anti-HBc|No Results on Comparator Assay|0
5791535|NCT03285295|19959222|P2|Alinity s Anti-HBc|No Results on Comparator Assay|1
5791536|NCT03285295|19959223|P1|Alinity s Anti-HBc|No Results on Comparator Assay|13
5791537|NCT03285295|19959219|P5|Alinity s Anti-HBc|Protocol Violation|0
5791538|NCT03285295|19959220|P4|Alinity s Anti-HBc|Protocol Violation|0
5791539|NCT03285295|19959221|P3|Alinity s Anti-HBc|Protocol Violation|0
5791540|NCT03285295|19959222|P2|Alinity s Anti-HBc|Protocol Violation|0
5791541|NCT03285295|19959223|P1|Alinity s Anti-HBc|Protocol Violation|8
5791542|NCT03285295|19959219|P5|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0
5791543|NCT03285295|19959220|P4|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0
5791544|NCT03285295|19959221|P3|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0
5791545|NCT03285295|19959222|P2|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0
5791546|NCT03285295|19959223|P1|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|11
5791547|NCT03285295|19959219|P5|Alinity s HIV Ag/Ab Combo|No Results Generated|0
5791548|NCT03285295|19959220|P4|Alinity s HIV Ag/Ab Combo|No Results Generated|0
5791549|NCT03285295|19959221|P3|Alinity s HIV Ag/Ab Combo|No Results Generated|0
5791550|NCT03285295|19959222|P2|Alinity s HIV Ag/Ab Combo|No Results Generated|0
5791551|NCT03285295|19959223|P1|Alinity s HIV Ag/Ab Combo|No Results Generated|72
5791552|NCT03285295|19959219|P5|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0
5791553|NCT03285295|19959220|P4|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0
5791554|NCT03285295|19959221|P3|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0
5791555|NCT03285295|19959222|P2|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0
5791556|NCT03285295|19959223|P1|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|16
5791557|NCT03285295|19959219|P5|Alinity s HIV Ag/Ab Combo|Protocol Violation|0
5791558|NCT03285295|19959220|P4|Alinity s HIV Ag/Ab Combo|Protocol Violation|0
5791559|NCT03285295|19959221|P3|Alinity s HIV Ag/Ab Combo|Protocol Violation|0
5791560|NCT03285295|19959222|P2|Alinity s HIV Ag/Ab Combo|Protocol Violation|0
5791561|NCT03285295|19959223|P1|Alinity s HIV Ag/Ab Combo|Protocol Violation|11
5791562|NCT03285295|19959219|P5|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0
5791563|NCT03285295|19959220|P4|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0
5791564|NCT03285295|19959221|P3|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0
5791565|NCT03285295|19959222|P2|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0
5791566|NCT03285295|19959223|P1|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|18
5791567|NCT03285295|19959219|P5|Alinity s Anti-HCV|No Results Generated|0
5791568|NCT03285295|19959220|P4|Alinity s Anti-HCV|No Results Generated|0
5791569|NCT03285295|19959221|P3|Alinity s Anti-HCV|No Results Generated|0
5791570|NCT03285295|19959222|P2|Alinity s Anti-HCV|No Results Generated|0
5791571|NCT03285295|19959223|P1|Alinity s Anti-HCV|No Results Generated|71
5791572|NCT03285295|19959219|P5|Alinity s Anti-HCV|No Results on Comparator Assay|0
5791573|NCT03285295|19959220|P4|Alinity s Anti-HCV|No Results on Comparator Assay|0
5791574|NCT03285295|19959221|P3|Alinity s Anti-HCV|No Results on Comparator Assay|0
5791575|NCT03285295|19959222|P2|Alinity s Anti-HCV|No Results on Comparator Assay|0
5791576|NCT03285295|19959223|P1|Alinity s Anti-HCV|No Results on Comparator Assay|13
5791577|NCT03285295|19959219|P5|Alinity s Anti-HCV|Protocol Violation|0
5791578|NCT03285295|19959220|P4|Alinity s Anti-HCV|Protocol Violation|0
5791579|NCT03285295|19959221|P3|Alinity s Anti-HCV|Protocol Violation|0
5791580|NCT03285295|19959222|P2|Alinity s Anti-HCV|Protocol Violation|0
5791581|NCT03285295|19959223|P1|Alinity s Anti-HCV|Protocol Violation|12
5791582|NCT03285295|19959219|P5|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0
5791583|NCT03285295|19959220|P4|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0
5791584|NCT03285295|19959221|P3|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0
5791585|NCT03285295|19959222|P2|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0
5791586|NCT03285295|19959223|P1|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|4
5791587|NCT03285295|19959219|P5|Alinity s HTLV I/II|No Results Generated|0
5791588|NCT03285295|19959220|P4|Alinity s HTLV I/II|No Results Generated|0
5791589|NCT03285295|19959221|P3|Alinity s HTLV I/II|No Results Generated|0
5791590|NCT03285295|19959222|P2|Alinity s HTLV I/II|No Results Generated|0
5791591|NCT03285295|19959223|P1|Alinity s HTLV I/II|No Results Generated|70
5791592|NCT03285295|19959219|P5|Alinity s HTLV I/II|No Result on Comparator Assay|0
5791593|NCT03285295|19959220|P4|Alinity s HTLV I/II|No Result on Comparator Assay|0
5791594|NCT03285295|19959221|P3|Alinity s HTLV I/II|No Result on Comparator Assay|0
5791595|NCT03285295|19959222|P2|Alinity s HTLV I/II|No Result on Comparator Assay|0
5791596|NCT03285295|19959223|P1|Alinity s HTLV I/II|No Result on Comparator Assay|15
5791597|NCT03285295|19959219|P5|Alinity s HTLV I/II|Protocol Violation|0
5791598|NCT03285295|19959220|P4|Alinity s HTLV I/II|Protocol Violation|0
5791599|NCT03285295|19959221|P3|Alinity s HTLV I/II|Protocol Violation|0
5791600|NCT03285295|19959222|P2|Alinity s HTLV I/II|Protocol Violation|0
5791601|NCT03285295|19959223|P1|Alinity s HTLV I/II|Protocol Violation|6
5791602|NCT03285295|19959219|P5|Alinity s HBsAg|No Results Generated|0
5791603|NCT03285295|19959220|P4|Alinity s HBsAg|No Results Generated|0
5791604|NCT03285295|19959221|P3|Alinity s HBsAg|No Results Generated|0
5791605|NCT03285295|19959222|P2|Alinity s HBsAg|No Results Generated|6
5791606|NCT03285295|19959223|P1|Alinity s HBsAg|No Results Generated|74
5791607|NCT03285295|19959219|P5|Alinity s HBsAg|No Result on Comparator Assay|0
5791608|NCT03285295|19959220|P4|Alinity s HBsAg|No Result on Comparator Assay|0
5791609|NCT03285295|19959221|P3|Alinity s HBsAg|No Result on Comparator Assay|0
5791610|NCT03285295|19959222|P2|Alinity s HBsAg|No Result on Comparator Assay|0
5791611|NCT03285295|19959223|P1|Alinity s HBsAg|No Result on Comparator Assay|17
5791612|NCT03285295|19959219|P5|Alinity s HBsAg|Protocol Violation|0
5791613|NCT03285295|19959220|P4|Alinity s HBsAg|Protocol Violation|0
5791614|NCT03285295|19959221|P3|Alinity s HBsAg|Protocol Violation|0
5791615|NCT03285295|19959222|P2|Alinity s HBsAg|Protocol Violation|0
5791616|NCT03285295|19959223|P1|Alinity s HBsAg|Protocol Violation|11
5791617|NCT03285113|19959252|P1|Overall Study|Unable to implant leads|2
5791618|NCT03284229|19959273|P1|Overall Study|Lost to Follow-up|3
5791619|NCT03283709|19959307|P2|Overall Study|trial terminated|1
5791620|NCT03283709|19959308|P1|Overall Study|trial terminated|0
5791621|NCT03283696|19959340|P2|Overall Study|Withdrawal by Subject|0
5791622|NCT03283696|19959341|P1|Overall Study|Withdrawal by Subject|2
5791623|NCT03283696|19959340|P2|Overall Study|Physician Decision|6
5791624|NCT03283696|19959341|P1|Overall Study|Physician Decision|5
5791625|NCT03283319|19959386|P6|Overall Study|BARDA regulatory agency or IRB decision|0
5791626|NCT03283319|19959387|P5|Overall Study|BARDA regulatory agency or IRB decision|0
5791627|NCT03283319|19959388|P4|Overall Study|BARDA regulatory agency or IRB decision|1
5791628|NCT03283319|19959389|P3|Overall Study|BARDA regulatory agency or IRB decision|0
5791629|NCT03283319|19959390|P2|Overall Study|BARDA regulatory agency or IRB decision|0
5791630|NCT03283319|19959391|P1|Overall Study|BARDA regulatory agency or IRB decision|0
5791631|NCT03283319|19959386|P6|Overall Study|Withdrawal by Subject|1
5791632|NCT03283319|19959387|P5|Overall Study|Withdrawal by Subject|0
5791633|NCT03283319|19959388|P4|Overall Study|Withdrawal by Subject|1
5791634|NCT03283319|19959389|P3|Overall Study|Withdrawal by Subject|2
5791635|NCT03283319|19959390|P2|Overall Study|Withdrawal by Subject|2
5791636|NCT03283319|19959391|P1|Overall Study|Withdrawal by Subject|2
5791637|NCT03283319|19959386|P6|Overall Study|Lost to Follow-up|3
5791638|NCT03283319|19959387|P5|Overall Study|Lost to Follow-up|4
5791639|NCT03283319|19959388|P4|Overall Study|Lost to Follow-up|5
5791640|NCT03283319|19959389|P3|Overall Study|Lost to Follow-up|5
5791641|NCT03283319|19959390|P2|Overall Study|Lost to Follow-up|4
5791642|NCT03283319|19959391|P1|Overall Study|Lost to Follow-up|5
5791643|NCT03283098|19959533|P2|Overall Study|Withdrawal by Subject|1
5791644|NCT03283098|19959534|P1|Overall Study|Withdrawal by Subject|0
5791645|NCT03282240|19959654|P3|Overall Study|Withdrawal by Subject|1
5791646|NCT03282240|19959655|P2|Overall Study|Withdrawal by Subject|0
5791647|NCT03282240|19959656|P1|Overall Study|Withdrawal by Subject|1
5791648|NCT03282240|19959654|P3|Overall Study|Protocol Deviation|2
5791649|NCT03282240|19959655|P2|Overall Study|Protocol Deviation|1
5791650|NCT03282240|19959656|P1|Overall Study|Protocol Deviation|4
5791651|NCT03282240|19959654|P3|Overall Study|Lost to Follow-up|0
5791652|NCT03282240|19959655|P2|Overall Study|Lost to Follow-up|0
5791653|NCT03282240|19959656|P1|Overall Study|Lost to Follow-up|3
5791654|NCT03282240|19959654|P3|Overall Study|Adverse Event|0
5791655|NCT03282240|19959655|P2|Overall Study|Adverse Event|2
5791656|NCT03282240|19959656|P1|Overall Study|Adverse Event|2
5791657|NCT03282227|19959708|P1|Overall Study|Other|1
5791658|NCT03282227|19959708|P1|Overall Study|Pregnancy|2
5791659|NCT03282227|19959708|P1|Overall Study|Physician Decision|2
5791660|NCT03282227|19959708|P1|Overall Study|Sponsor decision|3
5791661|NCT03282227|19959708|P1|Overall Study|Lack of Efficacy|12
5791662|NCT03282227|19959708|P1|Overall Study|Withdrawal by Subject|20
5791663|NCT03282227|19959708|P1|Overall Study|Lost to Follow-up|21
5791664|NCT03282227|19959708|P1|Overall Study|Adverse Event|15
5791665|NCT03282227|19959708|P1|Overall Study|Non-compliance w/ protocol requirements|79
5791666|NCT03282227|19959708|P1|Overall Study|Exposure Goals Achieved|60
5791667|NCT03281876|19959744|P2|Overall Study|OTHER|5
5791668|NCT03281876|19959745|P1|Overall Study|OTHER|5
5791669|NCT03281876|19959744|P2|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
5791670|NCT03281876|19959745|P1|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2
5791671|NCT03281876|19959744|P2|Overall Study|Withdrawal by Subject|15
5791672|NCT03281876|19959745|P1|Overall Study|Withdrawal by Subject|11
5791673|NCT03281876|19959744|P2|Overall Study|Lost to Follow-up|4
5791674|NCT03281876|19959745|P1|Overall Study|Lost to Follow-up|1
5791675|NCT03281876|19959744|P2|Overall Study|Adverse Event|15
5791676|NCT03281876|19959745|P1|Overall Study|Adverse Event|4
5791677|NCT03281668|19959815|P1|Overall Study|Lost to Follow-up|1
5791678|NCT03281668|19959815|P1|Overall Study|Withdrawal by Subject|4
5791679|NCT03281668|19959815|P1|Overall Study|scheduling conflict, family circumstance|2
5791680|NCT03281668|19959815|P1|Overall Study|Physician Decision|1
5791681|NCT03281577|19959843|P4|Overall Study|Withdrawal by Subject|0
5791682|NCT03281577|19959844|P3|Overall Study|Withdrawal by Subject|0
5791683|NCT03281577|19959845|P2|Overall Study|Withdrawal by Subject|0
5791684|NCT03281577|19959846|P1|Overall Study|Withdrawal by Subject|1
5791685|NCT03281577|19959843|P4|Overall Study|Adverse Event|1
5791686|NCT03281577|19959844|P3|Overall Study|Adverse Event|0
5791687|NCT03281577|19959845|P2|Overall Study|Adverse Event|0
5791688|NCT03281577|19959846|P1|Overall Study|Adverse Event|0
5791689|NCT03280615|19959901|P2|Overall Study|Withdrawal by Subject|2
5791690|NCT03280615|19959902|P1|Overall Study|Withdrawal by Subject|2
5791691|NCT03280615|19959901|P2|Overall Study|Adverse Event|1
5791692|NCT03280615|19959902|P1|Overall Study|Adverse Event|1
5791693|NCT03280615|19959901|P2|Overall Study|Lost to Follow-up|2
5791694|NCT03280615|19959902|P1|Overall Study|Lost to Follow-up|1
5791695|NCT03280550|19959914|P2|Overall Study|Physician Decision|1
5791696|NCT03280550|19959915|P1|Overall Study|Physician Decision|0
5791697|NCT03280550|19959914|P2|Overall Study|Withdrawal by Subject|2
5791698|NCT03280550|19959915|P1|Overall Study|Withdrawal by Subject|2
5791699|NCT03280537|19959967|P2|Overall Study|Withdrawal by Subject|4
5791700|NCT03280537|19959968|P1|Overall Study|Withdrawal by Subject|2
5791701|NCT03280381|19960020|P2|Overall Study|Physician Decision|2
5791702|NCT03280381|19960021|P1|Overall Study|Physician Decision|0
5791706|NCT03280108|19960037|P2|Overall Study|Lost to Follow-up|0
5791707|NCT03280108|19960038|P1|Overall Study|Lost to Follow-up|2
5791708|NCT03278106|19960120|P1|Overall Study|No protocol treatment|1
5791709|NCT03278028|19960536|P2|Overall Study|Pregnancy|1
5791710|NCT03278028|19960537|P1|Overall Study|Pregnancy|0
5791711|NCT03278028|19960536|P2|Overall Study|Withdrawal by Subject|1
5791712|NCT03278028|19960537|P1|Overall Study|Withdrawal by Subject|3
5791713|NCT03278028|19960536|P2|Overall Study|Lost to Follow-up|0
5791714|NCT03278028|19960537|P1|Overall Study|Lost to Follow-up|1
5791715|NCT03277846|19960545|P2|Overall Study|Inpatient stay too brief|11
5791716|NCT03277846|19960546|P1|Overall Study|Inpatient stay too brief|12
5791727|NCT03276936|19960687|P2|Overall Study|Not mentioned|3
5791728|NCT03276936|19960688|P1|Overall Study|Not mentioned|6
5791729|NCT03276936|19960687|P2|Overall Study|Withdrawal by Subject|20
5791730|NCT03276936|19960688|P1|Overall Study|Withdrawal by Subject|30
5791731|NCT03276936|19960687|P2|Overall Study|Lost to Follow-up|13
5791732|NCT03276936|19960688|P1|Overall Study|Lost to Follow-up|16
5791733|NCT03276936|19960687|P2|Overall Study|Adverse Event|2
5791734|NCT03276936|19960688|P1|Overall Study|Adverse Event|4
5791735|NCT03276078|19960726|P1|Overall Study|Adverse Event|1
5791736|NCT03276026|19960755|P2|Overall Study|Protocol Violation|0
5791737|NCT03276026|19960756|P1|Overall Study|Protocol Violation|1
5791738|NCT03274986|19960784|P2|Overall Study|Lost to Follow-up|1
5791739|NCT03274986|19960785|P1|Overall Study|Lost to Follow-up|0
5791740|NCT03274986|19960784|P2|Overall Study|Withdrawal by Subject|1
5791741|NCT03274986|19960785|P1|Overall Study|Withdrawal by Subject|0
5791742|NCT03274453|19960852|P4|Overall Study|Surgery Cancelled|0
5791743|NCT03274453|19960853|P3|Overall Study|Surgery Cancelled|0
5791744|NCT03274453|19960854|P2|Overall Study|Surgery Cancelled|1
5791745|NCT03274453|19960855|P1|Overall Study|Surgery Cancelled|0
5791746|NCT03274453|19960852|P4|Overall Study|Physician Decision|3
5791747|NCT03274453|19960853|P3|Overall Study|Physician Decision|0
5791748|NCT03274453|19960854|P2|Overall Study|Physician Decision|0
5791749|NCT03274453|19960855|P1|Overall Study|Physician Decision|2
5791750|NCT03274453|19960852|P4|Overall Study|Lost to Follow-up|1
5791751|NCT03274453|19960853|P3|Overall Study|Lost to Follow-up|4
5791752|NCT03274453|19960854|P2|Overall Study|Lost to Follow-up|5
5791753|NCT03274453|19960855|P1|Overall Study|Lost to Follow-up|2
5791754|NCT03274440|19960865|P6|Overall Study|Time commitment too great|0
5791755|NCT03274440|19960866|P5|Overall Study|Time commitment too great|0
5791756|NCT03274440|19960867|P4|Overall Study|Time commitment too great|1
5791757|NCT03274440|19960868|P3|Overall Study|Time commitment too great|0
5791758|NCT03274440|19960869|P2|Overall Study|Time commitment too great|0
5791759|NCT03274440|19960870|P1|Overall Study|Time commitment too great|1
5791760|NCT03274076|19960883|P4|24 Weeks Open Label|Withdrawal by Subject|1
5791761|NCT03274076|19960884|P3|24 Weeks Open Label|Withdrawal by Subject|0
5791762|NCT03274076|19960885|P2|24 Weeks Open Label|Withdrawal by Subject|0
5791763|NCT03274076|19960886|P1|24 Weeks Open Label|Withdrawal by Subject|0
5791764|NCT03274076|19960883|P4|24 Weeks Open Label|Adverse Event|0
5791765|NCT03274076|19960884|P3|24 Weeks Open Label|Adverse Event|2
5791766|NCT03274076|19960885|P2|24 Weeks Open Label|Adverse Event|0
5791767|NCT03274076|19960886|P1|24 Weeks Open Label|Adverse Event|0
5791768|NCT03274076|19960883|P4|24 Weeks Double Blind|Withdrawal by Subject|0
5791769|NCT03274076|19960884|P3|24 Weeks Double Blind|Withdrawal by Subject|0
5791770|NCT03274076|19960885|P2|24 Weeks Double Blind|Withdrawal by Subject|1
5791771|NCT03274076|19960886|P1|24 Weeks Double Blind|Withdrawal by Subject|0
5791772|NCT03273946|19960914|P1|Overall Study|Participant relative refused to use drug|1
5791773|NCT03273946|19960914|P1|Overall Study|Participant refused to use the drug|2
5791774|NCT03273946|19960914|P1|Overall Study|Unwillingness of the guardian|1
5791775|NCT03273946|19960914|P1|Overall Study|Withdrawal by Subject|5
5791776|NCT03273387|19960962|P2|Overall Study|Withdrawal by Subject|1
5791777|NCT03273387|19960963|P1|Overall Study|Withdrawal by Subject|1
5791778|NCT03273387|19960962|P2|Overall Study|Death|2
5791779|NCT03273387|19960963|P1|Overall Study|Death|2
5791780|NCT03273166|19960984|P1|Overall Study|Withdrawn prior to Completion|31
5791795|NCT03271307|19961058|P5|Overall Study|Lost to Follow-up|91
5791796|NCT03271307|19961059|P4|Overall Study|Lost to Follow-up|28
5791797|NCT03271307|19961060|P3|Overall Study|Lost to Follow-up|0
5791798|NCT03271307|19961061|P2|Overall Study|Lost to Follow-up|0
5791799|NCT03271307|19961062|P1|Overall Study|Lost to Follow-up|0
5791800|NCT03271021|19961118|P2|Overall Study|Miscellaneous|8
5791801|NCT03271021|19961119|P1|Overall Study|Miscellaneous|9
5791802|NCT03271021|19961118|P2|Overall Study|Abnormal Lab Results|0
5791803|NCT03271021|19961119|P1|Overall Study|Abnormal Lab Results|1
5791804|NCT03271021|19961118|P2|Overall Study|Protocol Violation|4
5791805|NCT03271021|19961119|P1|Overall Study|Protocol Violation|6
5791806|NCT03271021|19961118|P2|Overall Study|Lost to Follow-up|39
5791807|NCT03271021|19961119|P1|Overall Study|Lost to Follow-up|34
5791808|NCT03271021|19961118|P2|Overall Study|Withdrawal by Subject|53
5791809|NCT03271021|19961119|P1|Overall Study|Withdrawal by Subject|36
5791810|NCT03271021|19961118|P2|Overall Study|Adverse Event|2
5791811|NCT03271021|19961119|P1|Overall Study|Adverse Event|3
5791812|NCT03270657|19961137|P1|Overall Study|Withdrawal by Subject|1
5791813|NCT03270644|19961143|P1|Day 4 - 10 Propranolol Reference|Adverse Event|1
5791814|NCT03270644|19961143|P1|Day 1 Lasmiditan Reference|Physician Decision|1
5791815|NCT03270085|19961193|P2|Overall Study|Withdrawal by Subject|0
5791816|NCT03270085|19961194|P1|Overall Study|Withdrawal by Subject|1
5791817|NCT03269552|19961215|P1|Overall Study|Adverse Event|2
5791818|NCT03268941|19961226|P7|Part 2: Days 17 to 25|Withdrawal by Subject|1
5791819|NCT03268941|19961227|P6|Part 2: Days 17 to 25|Withdrawal by Subject|0
5791820|NCT03268941|19961228|P5|Part 2: Days 17 to 25|Withdrawal by Subject|0
5791821|NCT03268941|19961229|P4|Part 2: Days 17 to 25|Withdrawal by Subject|0
5791822|NCT03268941|19961230|P3|Part 2: Days 17 to 25|Withdrawal by Subject|0
5791823|NCT03268941|19961231|P2|Part 2: Days 17 to 25|Withdrawal by Subject|0
5791824|NCT03268941|19961232|P1|Part 2: Days 17 to 25|Withdrawal by Subject|0
5791825|NCT03268941|19961226|P7|Part 2: Days 17 to 25|Reason not specified|1
5791826|NCT03268941|19961227|P6|Part 2: Days 17 to 25|Reason not specified|0
5791827|NCT03268941|19961228|P5|Part 2: Days 17 to 25|Reason not specified|0
5791828|NCT03268941|19961229|P4|Part 2: Days 17 to 25|Reason not specified|0
5791829|NCT03268941|19961230|P3|Part 2: Days 17 to 25|Reason not specified|0
5791830|NCT03268941|19961231|P2|Part 2: Days 17 to 25|Reason not specified|0
5791831|NCT03268941|19961232|P1|Part 2: Days 17 to 25|Reason not specified|0
5791832|NCT03268941|19961226|P7|Part 1 (Days 1 to 9)|Protocol Deviation|0
5791833|NCT03268941|19961227|P6|Part 1 (Days 1 to 9)|Protocol Deviation|0
5791834|NCT03268941|19961228|P5|Part 1 (Days 1 to 9)|Protocol Deviation|0
5791835|NCT03268941|19961229|P4|Part 1 (Days 1 to 9)|Protocol Deviation|0
5791836|NCT03268941|19961230|P3|Part 1 (Days 1 to 9)|Protocol Deviation|0
5791837|NCT03268941|19961231|P2|Part 1 (Days 1 to 9)|Protocol Deviation|0
5791838|NCT03268941|19961232|P1|Part 1 (Days 1 to 9)|Protocol Deviation|1
5791839|NCT03268941|19961226|P7|Part 1 (Days 1 to 9)|Adverse Event|0
5791840|NCT03268941|19961227|P6|Part 1 (Days 1 to 9)|Adverse Event|0
5791841|NCT03268941|19961228|P5|Part 1 (Days 1 to 9)|Adverse Event|0
5791842|NCT03268941|19961229|P4|Part 1 (Days 1 to 9)|Adverse Event|1
5791843|NCT03268941|19961230|P3|Part 1 (Days 1 to 9)|Adverse Event|0
5791844|NCT03268941|19961231|P2|Part 1 (Days 1 to 9)|Adverse Event|0
5791845|NCT03268941|19961232|P1|Part 1 (Days 1 to 9)|Adverse Event|0
5791846|NCT03268941|19961226|P7|Part 1 (Days 1 to 9)|Withdrawal by Subject|0
5791847|NCT03268941|19961227|P6|Part 1 (Days 1 to 9)|Withdrawal by Subject|0
5791848|NCT03268941|19961228|P5|Part 1 (Days 1 to 9)|Withdrawal by Subject|0
5791849|NCT03268941|19961229|P4|Part 1 (Days 1 to 9)|Withdrawal by Subject|1
5791850|NCT03268941|19961230|P3|Part 1 (Days 1 to 9)|Withdrawal by Subject|0
5791851|NCT03268941|19961231|P2|Part 1 (Days 1 to 9)|Withdrawal by Subject|0
5791852|NCT03268941|19961232|P1|Part 1 (Days 1 to 9)|Withdrawal by Subject|0
5791853|NCT03268746|19961294|P1|Overall Study|Withdrawal by Subject|1
5791854|NCT03268590|19961316|P1|Overall Study|Previously unknown exclusion criteria|1
5791855|NCT03268005|19961351|P2|Overall Study|Withdrawal by Subject|11
5791856|NCT03268005|19961352|P1|Overall Study|Withdrawal by Subject|11
5791857|NCT03268005|19961351|P2|Overall Study|Lost to Follow-up|2
5791858|NCT03268005|19961352|P1|Overall Study|Lost to Follow-up|2
5791859|NCT03268005|19961351|P2|Overall Study|Death|1
5791860|NCT03268005|19961352|P1|Overall Study|Death|2
5791861|NCT03267940|19961466|P6|Expansion (Maximum Exposure: 421 Days)|Death|6
5791862|NCT03267940|19961467|P5|Expansion (Maximum Exposure: 421 Days)|Death|0
5791863|NCT03267940|19961468|P4|Expansion (Maximum Exposure: 421 Days)|Death|13
5791864|NCT03267940|19961469|P3|Expansion (Maximum Exposure: 421 Days)|Death|10
5791865|NCT03267940|19961470|P2|Expansion (Maximum Exposure: 421 Days)|Death|0
5791866|NCT03267940|19961471|P1|Expansion (Maximum Exposure: 421 Days)|Death|0
5791867|NCT03267940|19961466|P6|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|3
5791868|NCT03267940|19961467|P5|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|5
5791869|NCT03267940|19961468|P4|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|4
5791870|NCT03267940|19961469|P3|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|7
5791871|NCT03267940|19961470|P2|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0
5791872|NCT03267940|19961471|P1|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0
5791873|NCT03267940|19961466|P6|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1
5791874|NCT03267940|19961467|P5|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1
5791875|NCT03267940|19961468|P4|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1
5791876|NCT03267940|19961469|P3|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|2
5791877|NCT03267940|19961470|P2|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0
5791878|NCT03267940|19961471|P1|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0
5791879|NCT03267940|19961466|P6|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0
5791880|NCT03267940|19961467|P5|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2
5791881|NCT03267940|19961468|P4|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|1
5791882|NCT03267940|19961469|P3|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2
5791883|NCT03267940|19961470|P2|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0
5791884|NCT03267940|19961471|P1|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0
5791885|NCT03267940|19961466|P6|Expansion (Maximum Exposure: 421 Days)|Other than specified|0
5791886|NCT03267940|19961467|P5|Expansion (Maximum Exposure: 421 Days)|Other than specified|2
5791887|NCT03267940|19961468|P4|Expansion (Maximum Exposure: 421 Days)|Other than specified|3
5791888|NCT03267940|19961469|P3|Expansion (Maximum Exposure: 421 Days)|Other than specified|0
5791889|NCT03267940|19961470|P2|Expansion (Maximum Exposure: 421 Days)|Other than specified|0
5791890|NCT03267940|19961471|P1|Expansion (Maximum Exposure: 421 Days)|Other than specified|0
5791891|NCT03267940|19961466|P6|Run-in Portion (Max. Exposure: 508 Days)|Death|0
5791892|NCT03267940|19961467|P5|Run-in Portion (Max. Exposure: 508 Days)|Death|0
5791893|NCT03267940|19961468|P4|Run-in Portion (Max. Exposure: 508 Days)|Death|0
5791894|NCT03267940|19961469|P3|Run-in Portion (Max. Exposure: 508 Days)|Death|0
5791895|NCT03267940|19961470|P2|Run-in Portion (Max. Exposure: 508 Days)|Death|3
5791896|NCT03267940|19961471|P1|Run-in Portion (Max. Exposure: 508 Days)|Death|7
5791897|NCT03267940|19961466|P6|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0
5791898|NCT03267940|19961467|P5|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0
5791899|NCT03267940|19961468|P4|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0
5791900|NCT03267940|19961469|P3|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0
5791901|NCT03267940|19961470|P2|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|1
5791902|NCT03267940|19961471|P1|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0
5791903|NCT03267940|19961466|P6|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0
5791904|NCT03267940|19961467|P5|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0
5791905|NCT03267940|19961468|P4|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0
5791906|NCT03267940|19961469|P3|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0
5791907|NCT03267940|19961470|P2|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|1
5791908|NCT03267940|19961471|P1|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0
5791909|NCT03267940|19961466|P6|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0
5791910|NCT03267940|19961467|P5|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0
5791911|NCT03267940|19961468|P4|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0
5791912|NCT03267940|19961469|P3|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0
5791913|NCT03267940|19961470|P2|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|2
5791914|NCT03267940|19961471|P1|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|1
5791915|NCT03267576|19961573|P2|Period 2: Day 44 to 71|Withdrawal by Subject|1
5791916|NCT03267576|19961574|P1|Period 2: Day 44 to 71|Withdrawal by Subject|1
5791917|NCT03267576|19961573|P2|Period 2: Day 44 to 71|Lost to Follow-up|1
5791918|NCT03267576|19961574|P1|Period 2: Day 44 to 71|Lost to Follow-up|0
5791919|NCT03267511|19961612|P4|Overall Study|Lost to Follow-up|1
5791920|NCT03267511|19961613|P3|Overall Study|Lost to Follow-up|0
5791921|NCT03267511|19961614|P2|Overall Study|Lost to Follow-up|0
5791922|NCT03267511|19961615|P1|Overall Study|Lost to Follow-up|0
5791923|NCT03267264|19961631|P4|Overall Study|Withdrawal by Subject|4
5791924|NCT03267264|19961632|P3|Overall Study|Withdrawal by Subject|2
5791925|NCT03267264|19961633|P2|Overall Study|Withdrawal by Subject|0
5791926|NCT03267264|19961634|P1|Overall Study|Withdrawal by Subject|1
5791927|NCT03267212|19961651|P2|Washout (Min 2 Days / Max 7 Days)|Physician Decision|0
5791928|NCT03267212|19961652|P1|Washout (Min 2 Days / Max 7 Days)|Physician Decision|1
5791929|NCT03267212|19961651|P2|First Intervention|Withdrawal by Subject|1
5791930|NCT03267212|19961652|P1|First Intervention|Withdrawal by Subject|1
5791931|NCT03267212|19961651|P2|First Intervention|Lost to Follow-up|2
5791932|NCT03267212|19961652|P1|First Intervention|Lost to Follow-up|0
5791933|NCT03266588|19961667|P3|Long-term Treatment Period|Positive Sheehan-STS Score > 0|0
5791934|NCT03266588|19961668|P2|Long-term Treatment Period|Positive Sheehan-STS Score > 0|1
5791935|NCT03266588|19961669|P1|Long-term Treatment Period|Positive Sheehan-STS Score > 0|0
5791936|NCT03266588|19961667|P3|Long-term Treatment Period|Other Reasons|0
5791937|NCT03266588|19961668|P2|Long-term Treatment Period|Other Reasons|0
5791938|NCT03266588|19961669|P1|Long-term Treatment Period|Other Reasons|5
5791939|NCT03266588|19961667|P3|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|0
5791940|NCT03266588|19961668|P2|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|2
5791941|NCT03266588|19961669|P1|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|1
5791942|NCT03266588|19961667|P3|Long-term Treatment Period|Withdrawal by Subject|16
5791943|NCT03266588|19961668|P2|Long-term Treatment Period|Withdrawal by Subject|63
5791944|NCT03266588|19961669|P1|Long-term Treatment Period|Withdrawal by Subject|100
5791945|NCT03266588|19961667|P3|Long-term Treatment Period|Screen Failure: Eligibility Criteria|17
5791946|NCT03266588|19961668|P2|Long-term Treatment Period|Screen Failure: Eligibility Criteria|17
5791947|NCT03266588|19961669|P1|Long-term Treatment Period|Screen Failure: Eligibility Criteria|33
5791948|NCT03266588|19961667|P3|Long-term Treatment Period|Protocol Deviation|4
5791949|NCT03266588|19961668|P2|Long-term Treatment Period|Protocol Deviation|10
5791950|NCT03266588|19961669|P1|Long-term Treatment Period|Protocol Deviation|17
5791951|NCT03266588|19961667|P3|Long-term Treatment Period|Pregnancy|0
5791952|NCT03266588|19961668|P2|Long-term Treatment Period|Pregnancy|5
5791953|NCT03266588|19961669|P1|Long-term Treatment Period|Pregnancy|11
5791954|NCT03266588|19961667|P3|Long-term Treatment Period|Non-Compliance|7
5791955|NCT03266588|19961668|P2|Long-term Treatment Period|Non-Compliance|57
5791956|NCT03266588|19961669|P1|Long-term Treatment Period|Non-Compliance|126
5791957|NCT03266588|19961667|P3|Long-term Treatment Period|Lost to Follow-up|8
5791958|NCT03266588|19961668|P2|Long-term Treatment Period|Lost to Follow-up|37
5791959|NCT03266588|19961669|P1|Long-term Treatment Period|Lost to Follow-up|39
5791960|NCT03266588|19961667|P3|Long-term Treatment Period|Lack of Efficacy|5
5791961|NCT03266588|19961668|P2|Long-term Treatment Period|Lack of Efficacy|31
5791962|NCT03266588|19961669|P1|Long-term Treatment Period|Lack of Efficacy|41
5791963|NCT03266588|19961667|P3|Long-term Treatment Period|Adverse Event|8
5791964|NCT03266588|19961668|P2|Long-term Treatment Period|Adverse Event|17
5791965|NCT03266588|19961669|P1|Long-term Treatment Period|Adverse Event|33
5791966|NCT03266588|19961667|P3|Observational Period|Other Reasons|1
5791967|NCT03266588|19961668|P2|Observational Period|Other Reasons|0
5791968|NCT03266588|19961669|P1|Observational Period|Other Reasons|3
5791969|NCT03266588|19961667|P3|Observational Period|Protocol Deviation|0
5791970|NCT03266588|19961668|P2|Observational Period|Protocol Deviation|0
5791971|NCT03266588|19961669|P1|Observational Period|Protocol Deviation|1
5791972|NCT03266588|19961667|P3|Observational Period|Eligibility Failure- Baseline Lab Values|0
5791973|NCT03266588|19961668|P2|Observational Period|Eligibility Failure- Baseline Lab Values|1
5791974|NCT03266588|19961669|P1|Observational Period|Eligibility Failure- Baseline Lab Values|3
5791975|NCT03266588|19961667|P3|Observational Period|Lost to Follow-up|4
5791976|NCT03266588|19961668|P2|Observational Period|Lost to Follow-up|12
5791977|NCT03266588|19961669|P1|Observational Period|Lost to Follow-up|8
5791978|NCT03266588|19961667|P3|Observational Period|Non-compliance|10
5791979|NCT03266588|19961668|P2|Observational Period|Non-compliance|12
5791980|NCT03266588|19961669|P1|Observational Period|Non-compliance|18
5791981|NCT03266588|19961667|P3|Observational Period|Withdrawal by Subject|13
5791982|NCT03266588|19961668|P2|Observational Period|Withdrawal by Subject|22
5791983|NCT03266588|19961669|P1|Observational Period|Withdrawal by Subject|44
5791984|NCT03266588|19961667|P3|Observational Period|Screen Failure: Eligibility Criteria|140
5791985|NCT03266588|19961668|P2|Observational Period|Screen Failure: Eligibility Criteria|228
5791986|NCT03266588|19961669|P1|Observational Period|Screen Failure: Eligibility Criteria|439
5791987|NCT03266172|19961700|P3|Part C Washout Period (7 Days)|Withdrawal by Subject|1
5791988|NCT03266172|19961701|P2|Part C Washout Period (7 Days)|Withdrawal by Subject|0
5791989|NCT03266172|19961702|P1|Part C Washout Period (7 Days)|Withdrawal by Subject|0
5791990|NCT03266172|19961700|P3|Part C Washout Period (7 Days)|Withdrawal by Subject|1
5791991|NCT03266172|19961701|P2|Part C Washout Period (7 Days)|Withdrawal by Subject|0
5791992|NCT03266172|19961702|P1|Part C Washout Period (7 Days)|Withdrawal by Subject|0
5791993|NCT03266172|19961700|P3|Part B: Washout (7 Days)|Withdrawal by Subject|0
5791994|NCT03266172|19961701|P2|Part B: Washout (7 Days)|Withdrawal by Subject|2
5791995|NCT03266172|19961702|P1|Part B: Washout (7 Days)|Withdrawal by Subject|0
5791996|NCT03266172|19961700|P3|Part A: Washout Period (7 Days)|Withdrawal by Subject|0
5791997|NCT03266172|19961701|P2|Part A: Washout Period (7 Days)|Withdrawal by Subject|0
5791998|NCT03266172|19961702|P1|Part A: Washout Period (7 Days)|Withdrawal by Subject|1
5791999|NCT03266172|19961700|P3|Part A: Washout Period (7 Days)|Adverse Event|0
5792000|NCT03266172|19961701|P2|Part A: Washout Period (7 Days)|Adverse Event|0
5792001|NCT03266172|19961702|P1|Part A: Washout Period (7 Days)|Adverse Event|1
5792002|NCT03266172|19961700|P3|Part A: Period 1(2 Days)|Withdrawal by Subject|0
5792003|NCT03266172|19961701|P2|Part A: Period 1(2 Days)|Withdrawal by Subject|0
5792004|NCT03266172|19961702|P1|Part A: Period 1(2 Days)|Withdrawal by Subject|1
5792005|NCT03266107|19961947|P1|12-Month Follow-up Visit|Lost to Follow-up|1
5792006|NCT03266107|19961947|P1|3-Month Follow-up Visit|Lost to Follow-up|1
5792007|NCT03266107|19961947|P1|Enrollment to Procedure|Study stopped prior to Procedure|2
5792008|NCT03266107|19961947|P1|Enrollment to Procedure|Failure to Access Due to Hardened Bone|1
5792009|NCT03266094|19961959|P1|Overall Study|Withdrawal by Subject|1
5792010|NCT03266094|19961959|P1|Overall Study|Lost to Follow-up|1
5792011|NCT03265938|19961977|P1|Overall Study|friable mass|6
5792012|NCT03265938|19961977|P1|Overall Study|Physician Decision|1
5792013|NCT03265938|19961977|P1|Overall Study|Withdrawal by Subject|1
5792014|NCT03265600|19961990|P2|Overall Study|Partially completed 8 wk or 24 wk survey|5
5792015|NCT03265600|19961991|P1|Overall Study|Partially completed 8 wk or 24 wk survey|3
5792016|NCT03265600|19961990|P2|Overall Study|Withdrawal by Subject|2
5792017|NCT03265600|19961991|P1|Overall Study|Withdrawal by Subject|4
5792018|NCT03265600|19961990|P2|Overall Study|Lost to Follow-up|5
5792019|NCT03265600|19961991|P1|Overall Study|Lost to Follow-up|17
5792020|NCT03265132|19962017|P2|Overall Study|Withdrawal by Subject|1
5792021|NCT03265132|19962018|P1|Overall Study|Withdrawal by Subject|0
5792022|NCT03265132|19962017|P2|Overall Study|Progressive disease|2
5792023|NCT03265132|19962018|P1|Overall Study|Progressive disease|0
5792024|NCT03265132|19962017|P2|Overall Study|Lack of Efficacy|2
5792025|NCT03265132|19962018|P1|Overall Study|Lack of Efficacy|0
5792026|NCT03265132|19962017|P2|Overall Study|Adverse Event|1
5792027|NCT03265132|19962018|P1|Overall Study|Adverse Event|0
5792028|NCT03265119|19962116|P2|Overall Study|Lack of Compliance|0
5792029|NCT03265119|19962117|P1|Overall Study|Lack of Compliance|1
5792030|NCT03265119|19962116|P2|Overall Study|Lost to Follow-up|0
5792031|NCT03265119|19962117|P1|Overall Study|Lost to Follow-up|1
5792032|NCT03265119|19962116|P2|Overall Study|Withdrawal by Subject|4
5792033|NCT03265119|19962117|P1|Overall Study|Withdrawal by Subject|2
5792034|NCT03265119|19962116|P2|Overall Study|Protocol Violation|2
5792035|NCT03265119|19962117|P1|Overall Study|Protocol Violation|1
5792036|NCT03265119|19962116|P2|Overall Study|Lack of Efficacy|0
5792037|NCT03265119|19962117|P1|Overall Study|Lack of Efficacy|3
5792038|NCT03265119|19962116|P2|Overall Study|Adverse Event|1
5792039|NCT03265119|19962117|P1|Overall Study|Adverse Event|2
5792040|NCT03264456|19962125|P1|Overall Study|Lost to Follow-up|1
5792041|NCT03264456|19962125|P1|Overall Study|Withdrawal by Subject|3
5792042|NCT03263806|19962160|P2|Overall Study|Study Termination|6
5792043|NCT03263806|19962161|P1|Overall Study|Study Termination|5
5792044|NCT03263806|19962160|P2|Overall Study|Withdrawal by Subject|1
5792045|NCT03263806|19962161|P1|Overall Study|Withdrawal by Subject|0
5792046|NCT03263806|19962160|P2|Overall Study|Elevated Troponin (failed screen)|0
5792047|NCT03263806|19962161|P1|Overall Study|Elevated Troponin (failed screen)|1
5792048|NCT03263702|19962175|P2|Overall Study|Withdrawal by Subject|2
5792049|NCT03263702|19962176|P1|Overall Study|Withdrawal by Subject|1
5792050|NCT03263702|19962175|P2|Overall Study|Lost to Follow-up|2
5792051|NCT03263702|19962176|P1|Overall Study|Lost to Follow-up|2
5792052|NCT03262441|19962202|P1|Overall Study|Withdrawal by Subject|1
5792053|NCT03262233|19962214|P4|Overall Study|data collection artifact|0
5792054|NCT03262233|19962215|P3|Overall Study|data collection artifact|0
5792055|NCT03262233|19962216|P2|Overall Study|data collection artifact|1
5792056|NCT03262233|19962217|P1|Overall Study|data collection artifact|0
5792057|NCT03262233|19962214|P4|Overall Study|Protocol Violation|13
5792058|NCT03262233|19962215|P3|Overall Study|Protocol Violation|2
5792059|NCT03262233|19962216|P2|Overall Study|Protocol Violation|10
5792060|NCT03262233|19962217|P1|Overall Study|Protocol Violation|5
5792061|NCT03262233|19962214|P4|Overall Study|Declined due to shock|3
5792062|NCT03262233|19962215|P3|Overall Study|Declined due to shock|2
5792063|NCT03262233|19962216|P2|Overall Study|Declined due to shock|2
5792064|NCT03262233|19962217|P1|Overall Study|Declined due to shock|1
5792065|NCT03262233|19962214|P4|Overall Study|Withdrawal by Subject|13
5792066|NCT03262233|19962215|P3|Overall Study|Withdrawal by Subject|21
5792067|NCT03262233|19962216|P2|Overall Study|Withdrawal by Subject|8
5792068|NCT03262233|19962217|P1|Overall Study|Withdrawal by Subject|12
5792069|NCT03262038|19962241|P2|Overall Study|Withdrawal by Subject|1
5792070|NCT03262038|19962242|P1|Overall Study|Withdrawal by Subject|0
5792071|NCT03262012|19962258|P4|Overall Study|Protocol Discontinuation Criteria|0
5792072|NCT03262012|19962259|P3|Overall Study|Protocol Discontinuation Criteria|0
5792073|NCT03262012|19962260|P2|Overall Study|Protocol Discontinuation Criteria|1
5792074|NCT03262012|19962261|P1|Overall Study|Protocol Discontinuation Criteria|0
5792075|NCT03262012|19962258|P4|Overall Study|Lack of Efficacy|2
5792076|NCT03262012|19962259|P3|Overall Study|Lack of Efficacy|1
5792077|NCT03262012|19962260|P2|Overall Study|Lack of Efficacy|5
5792078|NCT03262012|19962261|P1|Overall Study|Lack of Efficacy|0
5792079|NCT03262012|19962258|P4|Overall Study|Physician Decision|0
5792080|NCT03262012|19962259|P3|Overall Study|Physician Decision|1
5792081|NCT03262012|19962260|P2|Overall Study|Physician Decision|5
5792082|NCT03262012|19962261|P1|Overall Study|Physician Decision|2
5792083|NCT03262012|19962258|P4|Overall Study|Adverse Event|6
5792084|NCT03262012|19962259|P3|Overall Study|Adverse Event|4
5792085|NCT03262012|19962260|P2|Overall Study|Adverse Event|12
5792086|NCT03262012|19962261|P1|Overall Study|Adverse Event|10
5792087|NCT03262012|19962258|P4|Overall Study|Withdrawal by Subject|7
5792088|NCT03262012|19962259|P3|Overall Study|Withdrawal by Subject|8
5792089|NCT03262012|19962260|P2|Overall Study|Withdrawal by Subject|13
5792090|NCT03262012|19962261|P1|Overall Study|Withdrawal by Subject|15
5792091|NCT03261531|19962284|P1|Overall Study|Withdrawal by Subject|4
5792092|NCT03261167|19962302|P2|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1
5792093|NCT03261167|19962303|P1|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1
5792094|NCT03261167|19962302|P2|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|0
5792095|NCT03261167|19962303|P1|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|1
5792096|NCT03261167|19962302|P2|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|0
5792097|NCT03261167|19962303|P1|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|1
5792098|NCT03261167|19962302|P2|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|1
5792099|NCT03261167|19962303|P1|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|3
5792100|NCT03261167|19962302|P2|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|3
5792101|NCT03261167|19962303|P1|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|0
5792102|NCT03260894|19962341|P2|Overall Study|On-going at clinical cut off date|31
5792103|NCT03260894|19962342|P1|Overall Study|On-going at clinical cut off date|36
5792104|NCT03260894|19962341|P2|Overall Study|Withdrawal by Subject|11
5792105|NCT03260894|19962342|P1|Overall Study|Withdrawal by Subject|4
5792106|NCT03260894|19962341|P2|Overall Study|Death|8
5792107|NCT03260894|19962342|P1|Overall Study|Death|6
5792108|NCT03260868|19962354|P2|Overall Study|Other than specified above|0
5792109|NCT03260868|19962355|P1|Overall Study|Other than specified above|1
5792110|NCT03260868|19962354|P2|Overall Study|Study Terminated By Sponsor|1
5792111|NCT03260868|19962355|P1|Overall Study|Study Terminated By Sponsor|2
5792112|NCT03260868|19962354|P2|Overall Study|Poor Compliance to Protocol|2
5792113|NCT03260868|19962355|P1|Overall Study|Poor Compliance to Protocol|0
5792114|NCT03260205|19962477|P5|Overall Study|Participant Who Did Not Received AnyDose|1
5792115|NCT03260205|19962478|P4|Overall Study|Participant Who Did Not Received AnyDose|3
5792116|NCT03260205|19962479|P3|Overall Study|Participant Who Did Not Received AnyDose|2
5792117|NCT03260205|19962480|P2|Overall Study|Participant Who Did Not Received AnyDose|1
5792118|NCT03260205|19962481|P1|Overall Study|Participant Who Did Not Received AnyDose|1
5792119|NCT03260205|19962477|P5|Overall Study|Other: Unspecified|1
5792120|NCT03260205|19962478|P4|Overall Study|Other: Unspecified|1
5792121|NCT03260205|19962479|P3|Overall Study|Other: Unspecified|3
5792122|NCT03260205|19962480|P2|Overall Study|Other: Unspecified|0
5792123|NCT03260205|19962481|P1|Overall Study|Other: Unspecified|0
5792124|NCT03260205|19962477|P5|Overall Study|Withdrawal by Participant or Parent/LAR|2
5792125|NCT03260205|19962478|P4|Overall Study|Withdrawal by Participant or Parent/LAR|0
5792126|NCT03260205|19962479|P3|Overall Study|Withdrawal by Participant or Parent/LAR|1
5792127|NCT03260205|19962480|P2|Overall Study|Withdrawal by Participant or Parent/LAR|5
5792128|NCT03260205|19962481|P1|Overall Study|Withdrawal by Participant or Parent/LAR|4
5792129|NCT03260205|19962477|P5|Overall Study|Protocol Violation|1
5792130|NCT03260205|19962478|P4|Overall Study|Protocol Violation|0
5792131|NCT03260205|19962479|P3|Overall Study|Protocol Violation|2
5792132|NCT03260205|19962480|P2|Overall Study|Protocol Violation|0
5792133|NCT03260205|19962481|P1|Overall Study|Protocol Violation|0
5792134|NCT03260205|19962477|P5|Overall Study|Lost to Follow-up|5
5792135|NCT03260205|19962478|P4|Overall Study|Lost to Follow-up|1
5792136|NCT03260205|19962479|P3|Overall Study|Lost to Follow-up|1
5792137|NCT03260205|19962480|P2|Overall Study|Lost to Follow-up|2
5792138|NCT03260205|19962481|P1|Overall Study|Lost to Follow-up|2
5792139|NCT03260205|19962477|P5|Overall Study|Adverse Event|4
5792140|NCT03260205|19962478|P4|Overall Study|Adverse Event|2
5792141|NCT03260205|19962479|P3|Overall Study|Adverse Event|2
5792142|NCT03260205|19962480|P2|Overall Study|Adverse Event|0
5792143|NCT03260205|19962481|P1|Overall Study|Adverse Event|2
5792144|NCT03259555|19962544|P2|Overall Study|Other|0
5792145|NCT03259555|19962545|P1|Overall Study|Other|1
5792146|NCT03259555|19962544|P2|Overall Study|Physician Decision|2
5792147|NCT03259555|19962545|P1|Overall Study|Physician Decision|1
5792148|NCT03259555|19962544|P2|Overall Study|Withdrawal by Subject|16
5792149|NCT03259555|19962545|P1|Overall Study|Withdrawal by Subject|19
5792150|NCT03259555|19962544|P2|Overall Study|Progressive Disease|2
5792151|NCT03259555|19962545|P1|Overall Study|Progressive Disease|0
5792152|NCT03259555|19962544|P2|Overall Study|Non-Compliance With Study Drug|0
5792153|NCT03259555|19962545|P1|Overall Study|Non-Compliance With Study Drug|1
5792154|NCT03259555|19962544|P2|Overall Study|Lost to Follow-up|2
5792155|NCT03259555|19962545|P1|Overall Study|Lost to Follow-up|0
5792156|NCT03259555|19962544|P2|Overall Study|Lack of Efficacy|4
5792157|NCT03259555|19962545|P1|Overall Study|Lack of Efficacy|6
5792158|NCT03259555|19962544|P2|Overall Study|Adverse Event|4
5792159|NCT03259555|19962545|P1|Overall Study|Adverse Event|6
5792160|NCT03259490|19962555|P2|Period 2|Protocol Violation|0
5792161|NCT03259490|19962556|P1|Period 2|Protocol Violation|1
5792162|NCT03259490|19962555|P2|Period 1|Withdrawal by Subject|1
5792163|NCT03259490|19962556|P1|Period 1|Withdrawal by Subject|0
5792164|NCT03259087|19962624|P5|Period 2 of Part 2|Adverse Event|1
5792165|NCT03259087|19962625|P4|Period 2 of Part 2|Adverse Event|0
5792166|NCT03259087|19962626|P3|Period 2 of Part 2|Adverse Event|0
5792167|NCT03259087|19962627|P2|Period 2 of Part 2|Adverse Event|0
5792168|NCT03259087|19962628|P1|Period 2 of Part 2|Adverse Event|0
5792169|NCT03259087|19962624|P5|Part 1 and Period 1 of Part 2|Adverse Event|1
5792170|NCT03259087|19962625|P4|Part 1 and Period 1 of Part 2|Adverse Event|0
5792171|NCT03259087|19962626|P3|Part 1 and Period 1 of Part 2|Adverse Event|0
5792172|NCT03259087|19962627|P2|Part 1 and Period 1 of Part 2|Adverse Event|0
5792173|NCT03259087|19962628|P1|Part 1 and Period 1 of Part 2|Adverse Event|0
5792174|NCT03258814|19962756|P3|Overall Study|Early Termination|10
5792175|NCT03258814|19962757|P2|Overall Study|Early Termination|3
5792176|NCT03258814|19962758|P1|Overall Study|Early Termination|4
5792177|NCT03258762|19962813|P2|Overall Study|Lost to Follow-up|1
5792178|NCT03258762|19962814|P1|Overall Study|Lost to Follow-up|0
5792179|NCT03258710|19962874|P1|Overall Study|Physician Decision|1
5792180|NCT03258710|19962874|P1|Overall Study|Protocol-defined stopping criteria|1
5792181|NCT03258710|19962874|P1|Overall Study|Adverse Event|1
5792182|NCT03257995|19962968|P6|Overall Study|Protocol deviation|2
5792183|NCT03257995|19962969|P5|Overall Study|Protocol deviation|0
5792184|NCT03257995|19962970|P4|Overall Study|Protocol deviation|0
5792185|NCT03257995|19962971|P3|Overall Study|Protocol deviation|0
5792186|NCT03257995|19962972|P2|Overall Study|Protocol deviation|0
5792187|NCT03257995|19962973|P1|Overall Study|Protocol deviation|0
5792188|NCT03257995|19962968|P6|Overall Study|Adverse Event|0
5792189|NCT03257995|19962969|P5|Overall Study|Adverse Event|0
5792190|NCT03257995|19962970|P4|Overall Study|Adverse Event|0
5792191|NCT03257995|19962971|P3|Overall Study|Adverse Event|0
5792192|NCT03257995|19962972|P2|Overall Study|Adverse Event|1
5792193|NCT03257995|19962973|P1|Overall Study|Adverse Event|0
5792194|NCT03257865|19963023|P2|Overall Study|Lost to Follow-up|4
5792195|NCT03257865|19963024|P1|Overall Study|Lost to Follow-up|4
5792196|NCT03257865|19963023|P2|Overall Study|Other|1
5792197|NCT03257865|19963024|P1|Overall Study|Other|0
5792198|NCT03257865|19963023|P2|Overall Study|Physician Decision|1
5792199|NCT03257865|19963024|P1|Overall Study|Physician Decision|3
5792200|NCT03257865|19963023|P2|Overall Study|Withdrawal by Subject|17
5792201|NCT03257865|19963024|P1|Overall Study|Withdrawal by Subject|23
5792202|NCT03257865|19963023|P2|Overall Study|Non-compliance with Study Drug|2
5792203|NCT03257865|19963024|P1|Overall Study|Non-compliance with Study Drug|0
5792204|NCT03257865|19963023|P2|Overall Study|Lack of Efficacy|2
5792205|NCT03257865|19963024|P1|Overall Study|Lack of Efficacy|1
5792206|NCT03257865|19963023|P2|Overall Study|Adverse Event|8
5792207|NCT03257865|19963024|P1|Overall Study|Adverse Event|4
5792208|NCT03257813|19963034|P2|Overall Study|Protocol Violation|3
5792209|NCT03257813|19963035|P1|Overall Study|Protocol Violation|6
5792210|NCT03257657|19963057|P2|Overall Study|Noted not eligible right after enrolled|1
5792211|NCT03257657|19963058|P1|Overall Study|Noted not eligible right after enrolled|0
5792212|NCT03257657|19963057|P2|Overall Study|Withdrawn|1
5792213|NCT03257657|19963058|P1|Overall Study|Withdrawn|0
5792214|NCT03257657|19963057|P2|Overall Study|Lost to Follow-up|3
5792215|NCT03257657|19963058|P1|Overall Study|Lost to Follow-up|0
5792216|NCT03257631|19963089|P4|Overall Study|Still on Study|4
5792217|NCT03257631|19963090|P3|Overall Study|Still on Study|4
5792218|NCT03257631|19963091|P2|Overall Study|Still on Study|2
5792219|NCT03257631|19963092|P1|Overall Study|Still on Study|3
5792220|NCT03257631|19963089|P4|Overall Study|Lost to Follow-up|0
5792221|NCT03257631|19963090|P3|Overall Study|Lost to Follow-up|1
5792222|NCT03257631|19963091|P2|Overall Study|Lost to Follow-up|0
5792223|NCT03257631|19963092|P1|Overall Study|Lost to Follow-up|0
5792224|NCT03257631|19963089|P4|Overall Study|Withdrawal by Parent/Guardian|1
5792225|NCT03257631|19963090|P3|Overall Study|Withdrawal by Parent/Guardian|4
5792226|NCT03257631|19963091|P2|Overall Study|Withdrawal by Parent/Guardian|2
5792227|NCT03257631|19963092|P1|Overall Study|Withdrawal by Parent/Guardian|0
5792228|NCT03257631|19963089|P4|Overall Study|Progressive Disease|0
5792229|NCT03257631|19963090|P3|Overall Study|Progressive Disease|1
5792230|NCT03257631|19963091|P2|Overall Study|Progressive Disease|0
5792231|NCT03257631|19963092|P1|Overall Study|Progressive Disease|0
5792232|NCT03257631|19963089|P4|Overall Study|Death|5
5792233|NCT03257631|19963090|P3|Overall Study|Death|13
5792234|NCT03257631|19963091|P2|Overall Study|Death|5
5792235|NCT03257631|19963092|P1|Overall Study|Death|8
5792236|NCT03257410|19963128|P2|Overall Study|Other|1
5792237|NCT03257410|19963129|P1|Overall Study|Other|0
5792238|NCT03257410|19963128|P2|Overall Study|Miscellaneous|2
5792239|NCT03257410|19963129|P1|Overall Study|Miscellaneous|2
5792240|NCT03257410|19963128|P2|Overall Study|Missing 3 consecutive study treatments|6
5792241|NCT03257410|19963129|P1|Overall Study|Missing 3 consecutive study treatments|5
5792242|NCT03257410|19963128|P2|Overall Study|Change to another dialysis center|2
5792243|NCT03257410|19963129|P1|Overall Study|Change to another dialysis center|2
5792244|NCT03257410|19963128|P2|Overall Study|Death|2
5792245|NCT03257410|19963129|P1|Overall Study|Death|3
5792246|NCT03257410|19963128|P2|Overall Study|Switch to peritoneal dialysis|0
5792247|NCT03257410|19963129|P1|Overall Study|Switch to peritoneal dialysis|1
5792248|NCT03257410|19963128|P2|Overall Study|Renal transplantation|0
5792249|NCT03257410|19963129|P1|Overall Study|Renal transplantation|2
5792250|NCT03257410|19963128|P2|Overall Study|Physician Decision|1
5792251|NCT03257410|19963129|P1|Overall Study|Physician Decision|1
5792252|NCT03257410|19963128|P2|Overall Study|Withdrawal by Subject|2
5792253|NCT03257410|19963129|P1|Overall Study|Withdrawal by Subject|1
5792254|NCT03257410|19963128|P2|Overall Study|Lost to Follow-up|0
5792255|NCT03257410|19963129|P1|Overall Study|Lost to Follow-up|1
5792256|NCT03257410|19963128|P2|Overall Study|Protocol Violation|2
5792257|NCT03257410|19963129|P1|Overall Study|Protocol Violation|1
5792258|NCT03257410|19963128|P2|Overall Study|Adverse Event|3
5792259|NCT03257410|19963129|P1|Overall Study|Adverse Event|2
5792260|NCT03257371|19963269|P1|Overall Study|Lost to Follow-up|1
5792261|NCT03257358|19963278|P2|Overall Study|No longer requires treatment|1
5792262|NCT03257358|19963279|P1|Overall Study|No longer requires treatment|0
5792263|NCT03257358|19963278|P2|Overall Study|New therapy for study indication|0
5792264|NCT03257358|19963279|P1|Overall Study|New therapy for study indication|1
5792265|NCT03257358|19963278|P2|Overall Study|Withdrawal of informed consent|5
5792266|NCT03257358|19963279|P1|Overall Study|Withdrawal of informed consent|9
5792267|NCT03257358|19963278|P2|Overall Study|Withdrawal by Subject|3
5792268|NCT03257358|19963279|P1|Overall Study|Withdrawal by Subject|8
5792269|NCT03257358|19963278|P2|Overall Study|Technical problems|1
5792270|NCT03257358|19963279|P1|Overall Study|Technical problems|4
5792271|NCT03257358|19963278|P2|Overall Study|Protocol Violation|3
5792272|NCT03257358|19963279|P1|Overall Study|Protocol Violation|5
5792273|NCT03257358|19963278|P2|Overall Study|Physician Decision|2
5792274|NCT03257358|19963279|P1|Overall Study|Physician Decision|2
5792275|NCT03257358|19963278|P2|Overall Study|Non-compliance with fingolimod treatment|2
5792276|NCT03257358|19963279|P1|Overall Study|Non-compliance with fingolimod treatment|4
5792277|NCT03257358|19963278|P2|Overall Study|Lost to Follow-up|4
5792278|NCT03257358|19963279|P1|Overall Study|Lost to Follow-up|12
5792279|NCT03257358|19963278|P2|Overall Study|Lack of Efficacy|1
5792280|NCT03257358|19963279|P1|Overall Study|Lack of Efficacy|1
5792281|NCT03257358|19963278|P2|Overall Study|Adverse Event|12
5792282|NCT03257358|19963279|P1|Overall Study|Adverse Event|25
5792283|NCT03256851|19963407|P2|Overall Study|Withdrawal by Subject|0
5792284|NCT03256851|19963408|P1|Overall Study|Withdrawal by Subject|1
5792285|NCT03256695|19963420|P1|Overall Study|Other than specified|3
5792286|NCT03256695|19963420|P1|Overall Study|Protocol Violation|5
5792287|NCT03256695|19963420|P1|Overall Study|Lack of Efficacy|3
5792288|NCT03256695|19963420|P1|Overall Study|Lost to Follow-up|3
5792289|NCT03256695|19963420|P1|Overall Study|Non-compliance with study drug|1
5792290|NCT03256695|19963420|P1|Overall Study|Withdrawal by Subject|14
5792291|NCT03256695|19963420|P1|Overall Study|Death|2
5792292|NCT03256695|19963420|P1|Overall Study|Adverse Event|8
5792293|NCT03256578|19963430|P2|Overall Study|Excluded Post Randomization|56
5792294|NCT03256578|19963431|P1|Overall Study|Excluded Post Randomization|66
5792295|NCT03256552|19963481|P1|Overall Study|Withdrawal by Subject|2
5792296|NCT03256552|19963481|P1|Overall Study|Adverse Event|1
5792297|NCT03256552|19963481|P1|Overall Study|Physician Decision|1
5792298|NCT03256552|19963481|P1|Overall Study|Protocol Violation|1
5792299|NCT03256526|19963506|P3|Overall Study|Lost to Follow-up|2
5792300|NCT03256526|19963507|P2|Overall Study|Lost to Follow-up|0
5792301|NCT03256526|19963508|P1|Overall Study|Lost to Follow-up|1
5792302|NCT03256526|19963506|P3|Overall Study|Adverse Event|1
5792303|NCT03256526|19963507|P2|Overall Study|Adverse Event|0
5792304|NCT03256526|19963508|P1|Overall Study|Adverse Event|1
5792305|NCT03255980|19963590|P4|Overall Study|Withdrawal by Subject|3
5792306|NCT03255980|19963591|P3|Overall Study|Withdrawal by Subject|0
5792307|NCT03255980|19963592|P2|Overall Study|Withdrawal by Subject|1
5792308|NCT03255980|19963593|P1|Overall Study|Withdrawal by Subject|0
5792309|NCT03255980|19963590|P4|Overall Study|Lost to Follow-up|3
5792310|NCT03255980|19963591|P3|Overall Study|Lost to Follow-up|0
5792311|NCT03255980|19963592|P2|Overall Study|Lost to Follow-up|1
5792312|NCT03255980|19963593|P1|Overall Study|Lost to Follow-up|1
5792313|NCT03255980|19963590|P4|Overall Study|Lack of compliance to study or assessmen|0
5792314|NCT03255980|19963591|P3|Overall Study|Lack of compliance to study or assessmen|0
5792315|NCT03255980|19963592|P2|Overall Study|Lack of compliance to study or assessmen|1
5792316|NCT03255980|19963593|P1|Overall Study|Lack of compliance to study or assessmen|0
5792317|NCT03255980|19963590|P4|Overall Study|Adverse Event|1
5792318|NCT03255980|19963591|P3|Overall Study|Adverse Event|0
5792319|NCT03255980|19963592|P2|Overall Study|Adverse Event|1
5792320|NCT03255980|19963593|P1|Overall Study|Adverse Event|1
5792321|NCT03255980|19963590|P4|Overall Study|Grade =>3 Skin Toxicity|5
5792322|NCT03255980|19963591|P3|Overall Study|Grade =>3 Skin Toxicity|6
5792323|NCT03255980|19963592|P2|Overall Study|Grade =>3 Skin Toxicity|4
5792324|NCT03255980|19963593|P1|Overall Study|Grade =>3 Skin Toxicity|1
5792325|NCT03255824|19963610|P2|Overall Study|Under-sedation|1
5792326|NCT03255824|19963611|P1|Overall Study|Under-sedation|2
5792327|NCT03255733|19963639|P1|Overall Study|Lost to Follow-up|4
5792328|NCT03255655|19963646|P2|Overall Study|Lost to Follow-up|4
5792329|NCT03255655|19963647|P1|Overall Study|Lost to Follow-up|7
5792330|NCT03255382|19963657|P2|Overall Study|Other|0
5792331|NCT03255382|19963658|P1|Overall Study|Other|6
5792332|NCT03255382|19963657|P2|Overall Study|Withdrawal by Subject|0
5792333|NCT03255382|19963658|P1|Overall Study|Withdrawal by Subject|2
5792334|NCT03255382|19963657|P2|Overall Study|Lost to Follow-up|0
5792335|NCT03255382|19963658|P1|Overall Study|Lost to Follow-up|2
5792336|NCT03255382|19963657|P2|Overall Study|Adverse Event|0
5792337|NCT03255382|19963658|P1|Overall Study|Adverse Event|3
5792338|NCT03255291|19963832|P6|Overall Study|Baseline data collection issues|0
5792339|NCT03255291|19963833|P5|Overall Study|Baseline data collection issues|2
5792340|NCT03255291|19963834|P4|Overall Study|Baseline data collection issues|0
5792341|NCT03255291|19963835|P3|Overall Study|Baseline data collection issues|0
5792342|NCT03255291|19963836|P2|Overall Study|Baseline data collection issues|0
5792343|NCT03255291|19963837|P1|Overall Study|Baseline data collection issues|3
5792344|NCT03255291|19963832|P6|Overall Study|Determined to be ineligible|10
5792345|NCT03255291|19963833|P5|Overall Study|Determined to be ineligible|5
5792346|NCT03255291|19963834|P4|Overall Study|Determined to be ineligible|6
5792347|NCT03255291|19963835|P3|Overall Study|Determined to be ineligible|6
5792348|NCT03255291|19963836|P2|Overall Study|Determined to be ineligible|12
5792349|NCT03255291|19963837|P1|Overall Study|Determined to be ineligible|10
5792350|NCT03255187|19963870|P2|Period From First to Second Follow-up|Withdrawal by Subject|1
5792351|NCT03255187|19963871|P1|Period From First to Second Follow-up|Withdrawal by Subject|0
5792352|NCT03255187|19963870|P2|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|3
5792353|NCT03255187|19963871|P1|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|1
5792354|NCT03254602|19963930|P1|Overall Study|Lost to Follow-up|4
5792355|NCT03254459|19963938|P2|Overall Study|Miscellaneous|1
5792356|NCT03254459|19963939|P1|Overall Study|Miscellaneous|0
5792357|NCT03254459|19963938|P2|Overall Study|Lost to Follow-up|1
5792358|NCT03254459|19963939|P1|Overall Study|Lost to Follow-up|0
5792359|NCT03254459|19963938|P2|Overall Study|Withdrawal by Subject Consent|1
5792360|NCT03254459|19963939|P1|Overall Study|Withdrawal by Subject Consent|3
5792361|NCT03254459|19963938|P2|Overall Study|Adverse Event|20
5792362|NCT03254459|19963939|P1|Overall Study|Adverse Event|7
5792363|NCT03254134|19963964|P2|Overall Study|Not eligible patients|3630
5792364|NCT03254134|19963965|P1|Overall Study|Not eligible patients|599
5792365|NCT03252145|19964002|P2|Overall Study|Complicating Disease|2
5792366|NCT03252145|19964003|P1|Overall Study|Complicating Disease|1
5792367|NCT03252145|19964002|P2|Overall Study|Withdrawal by Subject|0
5792368|NCT03252145|19964003|P1|Overall Study|Withdrawal by Subject|1
5792369|NCT03252015|19964071|P4|Overall Study|Adverse Event|1
5792370|NCT03252015|19964072|P3|Overall Study|Adverse Event|0
5792371|NCT03252015|19964073|P2|Overall Study|Adverse Event|0
5792372|NCT03252015|19964074|P1|Overall Study|Adverse Event|1
5792373|NCT03252015|19964071|P4|Overall Study|Withdrawal by Subject|0
5792374|NCT03252015|19964072|P3|Overall Study|Withdrawal by Subject|1
5792375|NCT03252015|19964073|P2|Overall Study|Withdrawal by Subject|1
5792376|NCT03252015|19964074|P1|Overall Study|Withdrawal by Subject|0
5792377|NCT03251963|19964112|P2|Overall Study|bled prior to Xa level|2
5792378|NCT03251963|19964113|P1|Overall Study|bled prior to Xa level|1
5792379|NCT03251963|19964112|P2|Overall Study|no peak Xa level drawn|0
5792380|NCT03251963|19964113|P1|Overall Study|no peak Xa level drawn|2
5792381|NCT03251963|19964112|P2|Overall Study|inappropriate Xa level timing|3
5792382|NCT03251963|19964113|P1|Overall Study|inappropriate Xa level timing|6
5792383|NCT03251482|19964132|P5|Overall Study|Withdrawal by Subject|0
5792384|NCT03251482|19964133|P4|Overall Study|Withdrawal by Subject|0
5792385|NCT03251482|19964134|P3|Overall Study|Withdrawal by Subject|0
5792386|NCT03251482|19964135|P2|Overall Study|Withdrawal by Subject|1
5792387|NCT03251482|19964136|P1|Overall Study|Withdrawal by Subject|0
5792388|NCT03249935|19964293|P1|Overall Study|Protocol Violation|5
5792389|NCT03249935|19964293|P1|Overall Study|Negative for chlamydia at enrollment|4
5792390|NCT03249935|19964293|P1|Overall Study|Discharged from facility early|36
5792391|NCT03249909|19964302|P3|Overall Study|Lost to Follow-up|0
5792392|NCT03249909|19964303|P2|Overall Study|Lost to Follow-up|1
5792393|NCT03249909|19964304|P1|Overall Study|Lost to Follow-up|0
5792394|NCT03249909|19964302|P3|Overall Study|Adverse Event|0
5792395|NCT03249909|19964303|P2|Overall Study|Adverse Event|0
5792396|NCT03249909|19964304|P1|Overall Study|Adverse Event|3
5792397|NCT03249909|19964302|P3|Overall Study|Withdrawal by Subject|0
5792398|NCT03249909|19964303|P2|Overall Study|Withdrawal by Subject|0
5792399|NCT03249909|19964304|P1|Overall Study|Withdrawal by Subject|3
5792400|NCT03249454|19964348|P11|Overall Study|Withdrawal by Subject|1
5792401|NCT03249454|19964349|P10|Overall Study|Withdrawal by Subject|1
5792402|NCT03249454|19964350|P9|Overall Study|Withdrawal by Subject|0
5792403|NCT03249454|19964351|P8|Overall Study|Withdrawal by Subject|0
5792404|NCT03249454|19964352|P7|Overall Study|Withdrawal by Subject|0
5792405|NCT03249454|19964353|P6|Overall Study|Withdrawal by Subject|0
5792406|NCT03249454|19964354|P5|Overall Study|Withdrawal by Subject|0
5792407|NCT03249454|19964355|P4|Overall Study|Withdrawal by Subject|0
5792408|NCT03249454|19964356|P3|Overall Study|Withdrawal by Subject|0
5792409|NCT03249454|19964357|P2|Overall Study|Withdrawal by Subject|0
5792410|NCT03249454|19964358|P1|Overall Study|Withdrawal by Subject|0
5792411|NCT03248882|19964446|P5|Overall Study|Withdrawal by Subject|2
5792412|NCT03248882|19964447|P4|Overall Study|Withdrawal by Subject|4
5792413|NCT03248882|19964448|P3|Overall Study|Withdrawal by Subject|3
5792414|NCT03248882|19964449|P2|Overall Study|Withdrawal by Subject|2
5792415|NCT03248882|19964450|P1|Overall Study|Withdrawal by Subject|2
5792416|NCT03248882|19964446|P5|Overall Study|Protocol Violation|1
5792417|NCT03248882|19964447|P4|Overall Study|Protocol Violation|0
5792418|NCT03248882|19964448|P3|Overall Study|Protocol Violation|2
5792419|NCT03248882|19964449|P2|Overall Study|Protocol Violation|0
5792420|NCT03248882|19964450|P1|Overall Study|Protocol Violation|2
5792421|NCT03248882|19964446|P5|Overall Study|Lost to Follow-up|1
5792422|NCT03248882|19964447|P4|Overall Study|Lost to Follow-up|0
5792423|NCT03248882|19964448|P3|Overall Study|Lost to Follow-up|0
5792424|NCT03248882|19964449|P2|Overall Study|Lost to Follow-up|0
5792425|NCT03248882|19964450|P1|Overall Study|Lost to Follow-up|0
5792426|NCT03248882|19964446|P5|Overall Study|Adverse Event|9
5792427|NCT03248882|19964447|P4|Overall Study|Adverse Event|6
5792428|NCT03248882|19964448|P3|Overall Study|Adverse Event|2
5792429|NCT03248882|19964449|P2|Overall Study|Adverse Event|3
5792430|NCT03248882|19964450|P1|Overall Study|Adverse Event|3
5792431|NCT03248492|19964492|P5|Overall Study|Other|0
5792432|NCT03248492|19964493|P4|Overall Study|Other|4
5792433|NCT03248492|19964494|P3|Overall Study|Other|0
5792434|NCT03248492|19964495|P2|Overall Study|Other|1
5792435|NCT03248492|19964496|P1|Overall Study|Other|0
5792436|NCT03248492|19964492|P5|Overall Study|Death|0
5792437|NCT03248492|19964493|P4|Overall Study|Death|6
5792438|NCT03248492|19964494|P3|Overall Study|Death|0
5792439|NCT03248492|19964495|P2|Overall Study|Death|0
5792440|NCT03248492|19964496|P1|Overall Study|Death|1
5792441|NCT03248492|19964492|P5|Overall Study|Physician Decision|0
5792442|NCT03248492|19964493|P4|Overall Study|Physician Decision|2
5792443|NCT03248492|19964494|P3|Overall Study|Physician Decision|1
5792444|NCT03248492|19964495|P2|Overall Study|Physician Decision|0
5792445|NCT03248492|19964496|P1|Overall Study|Physician Decision|1
5792446|NCT03248492|19964492|P5|Overall Study|Withdrawal by Subject|1
5792447|NCT03248492|19964493|P4|Overall Study|Withdrawal by Subject|3
5792448|NCT03248492|19964494|P3|Overall Study|Withdrawal by Subject|0
5792449|NCT03248492|19964495|P2|Overall Study|Withdrawal by Subject|3
5792450|NCT03248492|19964496|P1|Overall Study|Withdrawal by Subject|3
5792451|NCT03248492|19964492|P5|Overall Study|Adverse Event|1
5792452|NCT03248492|19964493|P4|Overall Study|Adverse Event|8
5792453|NCT03248492|19964494|P3|Overall Study|Adverse Event|8
5792454|NCT03248492|19964495|P2|Overall Study|Adverse Event|6
5792455|NCT03248492|19964496|P1|Overall Study|Adverse Event|6
5792456|NCT03248492|19964492|P5|Overall Study|Progressive disease per RECIST v1.1|0
5792457|NCT03248492|19964493|P4|Overall Study|Progressive disease per RECIST v1.1|22
5792458|NCT03248492|19964494|P3|Overall Study|Progressive disease per RECIST v1.1|9
5792459|NCT03248492|19964495|P2|Overall Study|Progressive disease per RECIST v1.1|12
5792460|NCT03248492|19964496|P1|Overall Study|Progressive disease per RECIST v1.1|16
5792461|NCT03248492|19964492|P5|Overall Study|Ongoing|2
5792462|NCT03248492|19964493|P4|Overall Study|Ongoing|85
5792463|NCT03248492|19964494|P3|Overall Study|Ongoing|3
5792464|NCT03248492|19964495|P2|Overall Study|Ongoing|26
5792465|NCT03248492|19964496|P1|Overall Study|Ongoing|23
5792466|NCT03247816|19964562|P1|Overall Study|Missing Feraccru stop date|3
5792467|NCT03247816|19964562|P1|Overall Study|Lost to Follow-up|10
5792468|NCT03247816|19964562|P1|Overall Study|Lack of Efficacy|1
5792469|NCT03247816|19964562|P1|Overall Study|Physician Decision|3
5792470|NCT03247816|19964562|P1|Overall Study|Adverse Event|12
5792471|NCT03247673|19964618|P3|Overall Study|Lost to Follow-up|1
5792472|NCT03247673|19964619|P2|Overall Study|Lost to Follow-up|0
5792473|NCT03247673|19964620|P1|Overall Study|Lost to Follow-up|0
5792474|NCT03247673|19964618|P3|Overall Study|Withdrawal by Subject|3
5792475|NCT03247673|19964619|P2|Overall Study|Withdrawal by Subject|0
5792476|NCT03247673|19964620|P1|Overall Study|Withdrawal by Subject|1
5792477|NCT03246724|19964644|P4|Overall Study|Re-consented to participate|1
5792478|NCT03246724|19964645|P3|Overall Study|Re-consented to participate|0
5792479|NCT03246724|19964646|P2|Overall Study|Re-consented to participate|0
5792480|NCT03246724|19964647|P1|Overall Study|Re-consented to participate|0
5792481|NCT03246724|19964644|P4|Overall Study|Unable to obtain medication timely|1
5792482|NCT03246724|19964645|P3|Overall Study|Unable to obtain medication timely|2
5792483|NCT03246724|19964646|P2|Overall Study|Unable to obtain medication timely|2
5792484|NCT03246724|19964647|P1|Overall Study|Unable to obtain medication timely|0
5792485|NCT03246724|19964644|P4|Overall Study|Transferred to other arm|0
5792486|NCT03246724|19964645|P3|Overall Study|Transferred to other arm|1
5792487|NCT03246724|19964646|P2|Overall Study|Transferred to other arm|0
5792488|NCT03246724|19964647|P1|Overall Study|Transferred to other arm|0
5792489|NCT03246724|19964644|P4|Overall Study|Study completed before surgical date|1
5792490|NCT03246724|19964645|P3|Overall Study|Study completed before surgical date|8
5792491|NCT03246724|19964646|P2|Overall Study|Study completed before surgical date|1
5792492|NCT03246724|19964647|P1|Overall Study|Study completed before surgical date|2
5792493|NCT03246724|19964644|P4|Overall Study|Ineligible on day of surgery|3
5792494|NCT03246724|19964645|P3|Overall Study|Ineligible on day of surgery|0
5792495|NCT03246724|19964646|P2|Overall Study|Ineligible on day of surgery|2
5792496|NCT03246724|19964647|P1|Overall Study|Ineligible on day of surgery|7
5792497|NCT03246724|19964644|P4|Overall Study|Withdrawal by Subject|2
5792498|NCT03246724|19964645|P3|Overall Study|Withdrawal by Subject|4
5792499|NCT03246724|19964646|P2|Overall Study|Withdrawal by Subject|2
5792500|NCT03246724|19964647|P1|Overall Study|Withdrawal by Subject|5
5792501|NCT03246672|19964673|P1|Overall Study|Lost to Follow-up|2
5792502|NCT03246152|19964679|P1|Overall Study|Protocol Violation|1
5792503|NCT03246152|19964679|P1|Overall Study|Lost to Follow-up|2
5792504|NCT03246061|19964687|P2|Overall Study|Still in follow-up|21
5792505|NCT03246061|19964688|P1|Overall Study|Still in follow-up|15
5792506|NCT03245619|19964722|P17|Part A (Up to Day 22)|Physician Decision|0
5792507|NCT03245619|19964723|P16|Part A (Up to Day 22)|Physician Decision|0
5792508|NCT03245619|19964724|P15|Part A (Up to Day 22)|Physician Decision|0
5792509|NCT03245619|19964725|P14|Part A (Up to Day 22)|Physician Decision|0
5792510|NCT03245619|19964726|P13|Part A (Up to Day 22)|Physician Decision|0
5792511|NCT03245619|19964727|P12|Part A (Up to Day 22)|Physician Decision|0
5792512|NCT03245619|19964728|P11|Part A (Up to Day 22)|Physician Decision|0
5792513|NCT03245619|19964729|P10|Part A (Up to Day 22)|Physician Decision|0
5792514|NCT03245619|19964730|P9|Part A (Up to Day 22)|Physician Decision|0
5792515|NCT03245619|19964731|P8|Part A (Up to Day 22)|Physician Decision|0
5792516|NCT03245619|19964732|P7|Part A (Up to Day 22)|Physician Decision|0
5792517|NCT03245619|19964733|P6|Part A (Up to Day 22)|Physician Decision|0
5792518|NCT03245619|19964734|P5|Part A (Up to Day 22)|Physician Decision|0
5792519|NCT03245619|19964735|P4|Part A (Up to Day 22)|Physician Decision|0
5792520|NCT03245619|19964736|P3|Part A (Up to Day 22)|Physician Decision|6
5792521|NCT03245619|19964737|P2|Part A (Up to Day 22)|Physician Decision|6
5792522|NCT03245619|19964738|P1|Part A (Up to Day 22)|Physician Decision|4
5792523|NCT03245398|19965012|P2|Overall Study|Travelled to another island|0
5792524|NCT03245398|19965013|P1|Overall Study|Travelled to another island|1
5792525|NCT03244800|19965043|P4|Overall Study|Withdrew treatment|1
5792526|NCT03244800|19965044|P3|Overall Study|Withdrew treatment|0
5792527|NCT03244800|19965045|P2|Overall Study|Withdrew treatment|0
5792528|NCT03244800|19965046|P1|Overall Study|Withdrew treatment|0
5792529|NCT03244800|19965043|P4|Overall Study|Adverse Event|1
5792530|NCT03244800|19965044|P3|Overall Study|Adverse Event|0
5792531|NCT03244800|19965045|P2|Overall Study|Adverse Event|1
5792532|NCT03244800|19965046|P1|Overall Study|Adverse Event|0
5792533|NCT03244618|19965106|P2|Overall Study|Withdrawal by Subject|2
5792534|NCT03244618|19965107|P1|Overall Study|Withdrawal by Subject|0
5792535|NCT03244618|19965106|P2|Overall Study|Protocol Violation|3
5792536|NCT03244618|19965107|P1|Overall Study|Protocol Violation|4
5792537|NCT03244618|19965106|P2|Overall Study|Lost to Follow-up|4
5792538|NCT03244618|19965107|P1|Overall Study|Lost to Follow-up|3
5792539|NCT03243630|19965142|P1|Overall Study|Physician Decision|1
5792540|NCT03243630|19965142|P1|Overall Study|Protocol Violation|1
5792541|NCT03243305|19965150|P1|Overall Study|Early terminations|267
5792542|NCT03243305|19965150|P1|Overall Study|Study Terminated by Sponsor|1
5792543|NCT03243305|19965150|P1|Overall Study|Study method no longer primary method|12
5792544|NCT03243305|19965150|P1|Overall Study|Protocol Violation|22
5792545|NCT03243305|19965150|P1|Overall Study|Physician Decision|22
5792546|NCT03243305|19965150|P1|Overall Study|No sexually active|26
5792547|NCT03243305|19965150|P1|Overall Study|Adverse Event|23
5792548|NCT03243305|19965150|P1|Overall Study|Non-Compliance with Study Drug|38
5792549|NCT03243305|19965150|P1|Overall Study|Pregnancy|104
5792550|NCT03243305|19965150|P1|Overall Study|Withdrawal by Subject|170
5792551|NCT03243305|19965150|P1|Overall Study|Lost to Follow-up|250
5792552|NCT03243084|19965157|P2|Washout (1-3 Weeks)|Lost to Follow-up|0
5792553|NCT03243084|19965158|P1|Washout (1-3 Weeks)|Lost to Follow-up|1
5792554|NCT03242863|19965174|P6|Study Week 1|Withdrawal by Subject|0
5792555|NCT03242863|19965175|P5|Study Week 1|Withdrawal by Subject|3
5792556|NCT03242863|19965176|P4|Study Week 1|Withdrawal by Subject|0
5792557|NCT03242863|19965177|P3|Study Week 1|Withdrawal by Subject|0
5792558|NCT03242863|19965178|P2|Study Week 1|Withdrawal by Subject|1
5792559|NCT03242863|19965179|P1|Study Week 1|Withdrawal by Subject|0
5792560|NCT03242434|19965202|P2|Overall Study|Death|2
5792561|NCT03242434|19965203|P1|Overall Study|Death|0
5792562|NCT03241927|19965215|P2|Overall Study|study terminated|0
5792563|NCT03241927|19965216|P1|Overall Study|study terminated|1
5792564|NCT03241368|19965262|P1|Overall Study|Protocol Violation|1
5792565|NCT03241368|19965262|P1|Overall Study|Withdrawal by Subject|6
5792566|NCT03241368|19965262|P1|Overall Study|Physician Decision|6
5792567|NCT03241368|19965262|P1|Overall Study|Lost to Follow-up|1
5792568|NCT03241368|19965262|P1|Overall Study|MRE Stricture or Patency Capsule Failure|25
5792584|NCT03240575|19965286|P4|Overall Study|Other|0
5792585|NCT03240575|19965287|P3|Overall Study|Other|0
5792586|NCT03240575|19965288|P2|Overall Study|Other|1
5792587|NCT03240575|19965289|P1|Overall Study|Other|0
5792588|NCT03240575|19965286|P4|Overall Study|Withdrawal by Subject|1
5792589|NCT03240575|19965287|P3|Overall Study|Withdrawal by Subject|0
5792590|NCT03240575|19965288|P2|Overall Study|Withdrawal by Subject|11
5792591|NCT03240575|19965289|P1|Overall Study|Withdrawal by Subject|2
5792592|NCT03240575|19965286|P4|Overall Study|Adverse Event|1
5792593|NCT03240575|19965287|P3|Overall Study|Adverse Event|0
5792594|NCT03240575|19965288|P2|Overall Study|Adverse Event|2
5792595|NCT03240575|19965289|P1|Overall Study|Adverse Event|0
5792596|NCT03240081|19965311|P2|Overall Study|Lost to Follow-up|1
5792597|NCT03240081|19965312|P1|Overall Study|Lost to Follow-up|0
5792598|NCT03240081|19965311|P2|Overall Study|Withdrawal by Subject|2
5792599|NCT03240081|19965312|P1|Overall Study|Withdrawal by Subject|0
5792600|NCT03239873|19965322|P2|Overall Study|Protocol Violation|0
5792601|NCT03239873|19965323|P1|Overall Study|Protocol Violation|1
5792602|NCT03239873|19965322|P2|Overall Study|Contraindication to study medication|0
5792603|NCT03239873|19965323|P1|Overall Study|Contraindication to study medication|1
5792604|NCT03239873|19965322|P2|Overall Study|Withdrawal by Subject|0
5792605|NCT03239873|19965323|P1|Overall Study|Withdrawal by Subject|2
5792606|NCT03239873|19965322|P2|Overall Study|Withdrawal by Parent/Guardian|11
5792607|NCT03239873|19965323|P1|Overall Study|Withdrawal by Parent/Guardian|12
5792608|NCT03239873|19965322|P2|Overall Study|Physician Decision|0
5792609|NCT03239873|19965323|P1|Overall Study|Physician Decision|1
5792610|NCT03239873|19965322|P2|Overall Study|Lost to Follow-up|16
5792611|NCT03239873|19965323|P1|Overall Study|Lost to Follow-up|15
5792612|NCT03239483|19965515|P2|Overall Study|Withdrawal by Subject|0
5792613|NCT03239483|19965516|P1|Overall Study|Withdrawal by Subject|1
5792614|NCT03239483|19965515|P2|Overall Study|Lost to Follow-up|0
5792615|NCT03239483|19965516|P1|Overall Study|Lost to Follow-up|1
5792616|NCT03238924|19965537|P2|Overall Study|Withdrawal by Subject|2
5792617|NCT03238924|19965538|P1|Overall Study|Withdrawal by Subject|2
5792618|NCT03238911|19965550|P2|Overall Study|Lost to Follow-up|1
5792619|NCT03238911|19965551|P1|Overall Study|Lost to Follow-up|2
5792620|NCT03238911|19965550|P2|Overall Study|Withdrawal by Subject|2
5792621|NCT03238911|19965551|P1|Overall Study|Withdrawal by Subject|1
5792622|NCT03238781|19965594|P3|Overall Study|Decision by sponsor|0
5792623|NCT03238781|19965595|P2|Overall Study|Decision by sponsor|1
5792624|NCT03238781|19965596|P1|Overall Study|Decision by sponsor|0
5792625|NCT03238781|19965594|P3|Overall Study|Withdrawal by Subject|16
5792626|NCT03238781|19965595|P2|Overall Study|Withdrawal by Subject|14
5792627|NCT03238781|19965596|P1|Overall Study|Withdrawal by Subject|23
5792628|NCT03238781|19965594|P3|Overall Study|Lost to Follow-up|2
5792629|NCT03238781|19965595|P2|Overall Study|Lost to Follow-up|1
5792630|NCT03238781|19965596|P1|Overall Study|Lost to Follow-up|2
5792631|NCT03238781|19965594|P3|Overall Study|Adverse Event|2
5792632|NCT03238781|19965595|P2|Overall Study|Adverse Event|1
5792633|NCT03238781|19965596|P1|Overall Study|Adverse Event|1
5792634|NCT03238352|19965646|P3|Overall Study|Withdrawal by Subject|0
5792635|NCT03238352|19965647|P2|Overall Study|Withdrawal by Subject|1
5792636|NCT03238352|19965648|P1|Overall Study|Withdrawal by Subject|0
5792637|NCT03238352|19965646|P3|Overall Study|Lost to Follow-up|1
5792638|NCT03238352|19965647|P2|Overall Study|Lost to Follow-up|2
5792639|NCT03238352|19965648|P1|Overall Study|Lost to Follow-up|0
5792640|NCT03238001|19965659|P1|Visit 2 (Secondary Endpoint Cohort)|Protocol Violation|4
5792641|NCT03238001|19965659|P1|Visit 2 (Secondary Endpoint Cohort)|Study completion|1
5792642|NCT03238001|19965659|P1|Visit 2 (Secondary Endpoint Cohort)|Met exclusion criteria at visit 2|3
5792643|NCT03238001|19965659|P1|Visit 2 (Secondary Endpoint Cohort)|Withdrawal by Subject|3
5792644|NCT03238001|19965659|P1|Visit 2 (Secondary Endpoint Cohort)|Unanalyzable test result|2
5792645|NCT03238001|19965659|P1|Visit 2 (Secondary Endpoint Cohort)|Lost to Follow-up|16
5792646|NCT03238001|19965659|P1|Visit 1 (Primary Endpoint Cohort)|Unanalyzable test result|2
5792647|NCT03238001|19965659|P1|Visit 1 (Primary Endpoint Cohort)|Protocol Violation|2
5792648|NCT03237845|19965690|P2|Overall Study|Other Reasons|0
5792649|NCT03237845|19965691|P1|Overall Study|Other Reasons|4
5792650|NCT03237845|19965690|P2|Overall Study|Withdrawal by Subject|3
5792651|NCT03237845|19965691|P1|Overall Study|Withdrawal by Subject|3
5792652|NCT03237845|19965690|P2|Overall Study|Technical Problems|1
5792653|NCT03237845|19965691|P1|Overall Study|Technical Problems|8
5792654|NCT03237845|19965690|P2|Overall Study|Protocol Deviation|1
5792655|NCT03237845|19965691|P1|Overall Study|Protocol Deviation|0
5792656|NCT03237845|19965690|P2|Overall Study|Pregnancy|0
5792657|NCT03237845|19965691|P1|Overall Study|Pregnancy|1
5792658|NCT03237845|19965690|P2|Overall Study|Physician Decision|2
5792659|NCT03237845|19965691|P1|Overall Study|Physician Decision|1
5792660|NCT03237845|19965690|P2|Overall Study|Non-Compliance With Study Treatment|1
5792661|NCT03237845|19965691|P1|Overall Study|Non-Compliance With Study Treatment|0
5792662|NCT03237845|19965690|P2|Overall Study|Not Experienced Moderate/Severe Migraine|31
5792663|NCT03237845|19965691|P1|Overall Study|Not Experienced Moderate/Severe Migraine|26
5792664|NCT03237845|19965690|P2|Overall Study|Lost to Follow-up|10
5792665|NCT03237845|19965691|P1|Overall Study|Lost to Follow-up|13
5792666|NCT03237845|19965690|P2|Overall Study|Adverse Event|1
5792667|NCT03237845|19965691|P1|Overall Study|Adverse Event|0
5792668|NCT03237065|19965821|P2|Overall Study|Unable to obtain venous access|1
5792669|NCT03237065|19965822|P1|Overall Study|Unable to obtain venous access|0
5792670|NCT03237065|19965821|P2|Overall Study|Lost to Follow-up|0
5792671|NCT03237065|19965822|P1|Overall Study|Lost to Follow-up|1
5792672|NCT03237065|19965821|P2|Overall Study|Withdrawal by Subject|0
5792673|NCT03237065|19965822|P1|Overall Study|Withdrawal by Subject|3
5792674|NCT03237065|19965821|P2|Overall Study|Protocol Violation|1
5792675|NCT03237065|19965822|P1|Overall Study|Protocol Violation|0
5792676|NCT03237065|19965821|P2|Overall Study|Adverse Event|2
5792677|NCT03237065|19965822|P1|Overall Study|Adverse Event|0
5792678|NCT03237013|19965865|P3|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|37
5792679|NCT03237013|19965866|P2|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|30
5792680|NCT03237013|19965867|P1|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|43
5792681|NCT03236779|19965916|P2|Overall Study|Lost to Follow-up|21
5792682|NCT03236779|19965917|P1|Overall Study|Lost to Follow-up|13
5792683|NCT03236311|19965931|P2|Overall Study|Adverse Event|1
5792684|NCT03236311|19965932|P1|Overall Study|Adverse Event|0
5792685|NCT03236311|19965931|P2|Overall Study|Study terminated by sponsor|2
5792686|NCT03236311|19965932|P1|Overall Study|Study terminated by sponsor|0
5792687|NCT03235726|19965976|P10|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
5792688|NCT03235726|19965977|P9|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
5792689|NCT03235726|19965978|P8|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
5792690|NCT03235726|19965979|P7|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
5792691|NCT03235726|19965980|P6|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
5792692|NCT03235726|19965981|P5|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|1
5792693|NCT03235726|19965982|P4|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
5792694|NCT03235726|19965983|P3|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
5792695|NCT03235726|19965984|P2|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
5792696|NCT03235726|19965985|P1|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
5792697|NCT03235726|19965976|P10|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
5792698|NCT03235726|19965977|P9|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
5792699|NCT03235726|19965978|P8|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
5792700|NCT03235726|19965979|P7|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
5792701|NCT03235726|19965980|P6|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
5792702|NCT03235726|19965981|P5|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|1
5792703|NCT03235726|19965982|P4|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
5792704|NCT03235726|19965983|P3|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
5792705|NCT03235726|19965984|P2|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
5792706|NCT03235726|19965985|P1|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
5792707|NCT03235479|19966139|P2|Overall Study|Other Reasons|5
5792708|NCT03235479|19966140|P1|Overall Study|Other Reasons|3
5792709|NCT03235479|19966139|P2|Overall Study|Withdrawal by Subject|2
5792710|NCT03235479|19966140|P1|Overall Study|Withdrawal by Subject|2
5792711|NCT03235479|19966139|P2|Overall Study|Technical Problems|2
5792712|NCT03235479|19966140|P1|Overall Study|Technical Problems|3
5792713|NCT03235479|19966139|P2|Overall Study|Protocol Deviation|3
5792714|NCT03235479|19966140|P1|Overall Study|Protocol Deviation|1
5792715|NCT03235479|19966139|P2|Overall Study|Pregnancy|0
5792716|NCT03235479|19966140|P1|Overall Study|Pregnancy|1
5792717|NCT03235479|19966139|P2|Overall Study|Not Experienced Moderate/Severe Migraine|17
5792718|NCT03235479|19966140|P1|Overall Study|Not Experienced Moderate/Severe Migraine|23
5792719|NCT03235479|19966139|P2|Overall Study|Lost to Follow-up|11
5792720|NCT03235479|19966140|P1|Overall Study|Lost to Follow-up|8
5792721|NCT03235349|19966177|P1|Overall Study|Other|1
5792722|NCT03235349|19966177|P1|Overall Study|Adverse Event|1
5792723|NCT03235284|19966187|P3|Overall Study|Adverse Event|1
5792724|NCT03235284|19966188|P2|Overall Study|Adverse Event|2
5792725|NCT03235284|19966189|P1|Overall Study|Adverse Event|1
5792726|NCT03235115|19966206|P6|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|1
5792727|NCT03235115|19966207|P5|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0
5792728|NCT03235115|19966208|P4|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0
5792729|NCT03235115|19966209|P3|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0
5792730|NCT03235115|19966210|P2|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0
5792731|NCT03235115|19966211|P1|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0
5792732|NCT03235089|19966231|P2|Overall Study|Physician Decision|2
5792733|NCT03235089|19966232|P1|Overall Study|Physician Decision|2
5792734|NCT03235089|19966231|P2|Overall Study|Lost to Follow-up|1
5792735|NCT03235089|19966232|P1|Overall Study|Lost to Follow-up|1
5792736|NCT03235050|19966273|P5|Overall Study|Other reasons|2
5792737|NCT03235050|19966274|P4|Overall Study|Other reasons|1
5792738|NCT03235050|19966275|P3|Overall Study|Other reasons|0
5792739|NCT03235050|19966276|P2|Overall Study|Other reasons|1
5792740|NCT03235050|19966277|P1|Overall Study|Other reasons|0
5792741|NCT03235050|19966273|P5|Overall Study|Withdrawal by Subject|7
5792742|NCT03235050|19966274|P4|Overall Study|Withdrawal by Subject|5
5792743|NCT03235050|19966275|P3|Overall Study|Withdrawal by Subject|2
5792744|NCT03235050|19966276|P2|Overall Study|Withdrawal by Subject|2
5792745|NCT03235050|19966277|P1|Overall Study|Withdrawal by Subject|3
5792746|NCT03235050|19966273|P5|Overall Study|Lost to Follow-up|0
5792747|NCT03235050|19966274|P4|Overall Study|Lost to Follow-up|2
5792748|NCT03235050|19966275|P3|Overall Study|Lost to Follow-up|1
5792749|NCT03235050|19966276|P2|Overall Study|Lost to Follow-up|2
5792750|NCT03235050|19966277|P1|Overall Study|Lost to Follow-up|1
5792751|NCT03235050|19966273|P5|Overall Study|Death|1
5792752|NCT03235050|19966274|P4|Overall Study|Death|2
5792753|NCT03235050|19966275|P3|Overall Study|Death|0
5792754|NCT03235050|19966276|P2|Overall Study|Death|0
5792755|NCT03235050|19966277|P1|Overall Study|Death|0
5792756|NCT03235050|19966273|P5|Overall Study|Adverse Event|1
5792757|NCT03235050|19966274|P4|Overall Study|Adverse Event|4
5792758|NCT03235050|19966275|P3|Overall Study|Adverse Event|1
5792759|NCT03235050|19966276|P2|Overall Study|Adverse Event|0
5792760|NCT03235050|19966277|P1|Overall Study|Adverse Event|0
5792761|NCT03234465|19966338|P2|Overall Study|Other|8
5792762|NCT03234465|19966339|P1|Overall Study|Other|14
5792763|NCT03234465|19966338|P2|Overall Study|Non-compliance|0
5792764|NCT03234465|19966339|P1|Overall Study|Non-compliance|2
5792765|NCT03234465|19966338|P2|Overall Study|Symptomatic deterioration|1
5792766|NCT03234465|19966339|P1|Overall Study|Symptomatic deterioration|0
5792767|NCT03234465|19966338|P2|Overall Study|Withdrawal by Subject|27
5792768|NCT03234465|19966339|P1|Overall Study|Withdrawal by Subject|12
5792769|NCT03234465|19966338|P2|Overall Study|Lost to Follow-up|1
5792770|NCT03234465|19966339|P1|Overall Study|Lost to Follow-up|1
5792771|NCT03234465|19966338|P2|Overall Study|Death|1
5792772|NCT03234465|19966339|P1|Overall Study|Death|0
5792773|NCT03234465|19966338|P2|Overall Study|Adverse Event|2
5792774|NCT03234465|19966339|P1|Overall Study|Adverse Event|4
5792775|NCT03234036|19966369|P4|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0
5792776|NCT03234036|19966370|P3|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0
5792777|NCT03234036|19966371|P2|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1
5792778|NCT03234036|19966372|P1|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1
5792779|NCT03233529|19966543|P1|Open-Label Period (Day 15 to Day 71)|Adverse Event|1
5792780|NCT03233529|19966543|P1|Double-Blind Period (Day 1 to Day 15)|Adverse Event|1
5792781|NCT03233438|19966587|P2|Overall Study|No recording of dalbavancin|1
5792782|NCT03233438|19966588|P1|Overall Study|No recording of dalbavancin|0
5792783|NCT03233438|19966587|P2|Overall Study|Withdrawal by Subject|1
5792784|NCT03233438|19966588|P1|Overall Study|Withdrawal by Subject|2
5792785|NCT03233438|19966587|P2|Overall Study|Lost to Follow-up|9
5792786|NCT03233438|19966588|P1|Overall Study|Lost to Follow-up|4
5792787|NCT03233308|19966654|P1|Overall Study|Protocol Violation|1
5792788|NCT03233308|19966654|P1|Overall Study|Adverse Event|1
5792789|NCT03233230|19966670|P4|Overall Study|Lost to Follow-up|0
5792790|NCT03233230|19966671|P3|Overall Study|Lost to Follow-up|0
5792791|NCT03233230|19966672|P2|Overall Study|Lost to Follow-up|3
5792792|NCT03233230|19966673|P1|Overall Study|Lost to Follow-up|0
5792793|NCT03233230|19966670|P4|Overall Study|Withdrawal by Subject|1
5792794|NCT03233230|19966671|P3|Overall Study|Withdrawal by Subject|0
5792795|NCT03233230|19966672|P2|Overall Study|Withdrawal by Subject|2
5792796|NCT03233230|19966673|P1|Overall Study|Withdrawal by Subject|2
5792797|NCT03233230|19966670|P4|Overall Study|Other|3
5792798|NCT03233230|19966671|P3|Overall Study|Other|5
5792799|NCT03233230|19966672|P2|Overall Study|Other|5
5792800|NCT03233230|19966673|P1|Overall Study|Other|5
5792801|NCT03233230|19966670|P4|Overall Study|Lack of Efficacy|0
5792802|NCT03233230|19966671|P3|Overall Study|Lack of Efficacy|0
5792803|NCT03233230|19966672|P2|Overall Study|Lack of Efficacy|0
5792804|NCT03233230|19966673|P1|Overall Study|Lack of Efficacy|1
5792805|NCT03233230|19966670|P4|Overall Study|Protocol Violation|1
5792806|NCT03233230|19966671|P3|Overall Study|Protocol Violation|1
5792807|NCT03233230|19966672|P2|Overall Study|Protocol Violation|2
5792808|NCT03233230|19966673|P1|Overall Study|Protocol Violation|1
5792809|NCT03233230|19966670|P4|Overall Study|Adverse Event|3
5792810|NCT03233230|19966671|P3|Overall Study|Adverse Event|6
5792811|NCT03233230|19966672|P2|Overall Study|Adverse Event|3
5792812|NCT03233230|19966673|P1|Overall Study|Adverse Event|6
5792813|NCT03233009|19966865|P1|Overall Study|Lost to Follow-up|1
5792814|NCT03232983|19966908|P4|Period 4|Withdrawal by Subject|0
5792815|NCT03232983|19966909|P3|Period 4|Withdrawal by Subject|0
5792816|NCT03232983|19966910|P2|Period 4|Withdrawal by Subject|0
5792817|NCT03232983|19966911|P1|Period 4|Withdrawal by Subject|1
5792818|NCT03232983|19966908|P4|Washout Period 2|Withdrawal by Subject|1
5792819|NCT03232983|19966909|P3|Washout Period 2|Withdrawal by Subject|0
5792820|NCT03232983|19966910|P2|Washout Period 2|Withdrawal by Subject|0
5792821|NCT03232983|19966911|P1|Washout Period 2|Withdrawal by Subject|0
5792822|NCT03232983|19966908|P4|Washout Period 2|Physician Decision|0
5792823|NCT03232983|19966909|P3|Washout Period 2|Physician Decision|1
5792824|NCT03232983|19966910|P2|Washout Period 2|Physician Decision|0
5792825|NCT03232983|19966911|P1|Washout Period 2|Physician Decision|0
5792826|NCT03232983|19966908|P4|Period 1|Physician Decision|0
5792827|NCT03232983|19966909|P3|Period 1|Physician Decision|1
5792828|NCT03232983|19966910|P2|Period 1|Physician Decision|0
5792829|NCT03232983|19966911|P1|Period 1|Physician Decision|0
5792830|NCT03232567|19966955|P4|Overall Study|Withdrawal by Subject|0
5792831|NCT03232567|19966956|P3|Overall Study|Withdrawal by Subject|0
5792832|NCT03232567|19966957|P2|Overall Study|Withdrawal by Subject|1
5792833|NCT03232567|19966958|P1|Overall Study|Withdrawal by Subject|0
5792834|NCT03232333|19966980|P1|Overall Study|Withdrawal by Subject|2
5792835|NCT03232333|19966980|P1|Overall Study|Lost to Follow-up|4
5792836|NCT03232333|19966980|P1|Overall Study|Infection or Osteomyelitis|9
5792837|NCT03231943|19966997|P13|Part 2|Withdrawal by Subject|0
5792838|NCT03231943|19966998|P12|Part 2|Withdrawal by Subject|1
5792839|NCT03231943|19966999|P11|Part 2|Withdrawal by Subject|0
5792840|NCT03231943|19967000|P10|Part 2|Withdrawal by Subject|0
5792841|NCT03231943|19967001|P9|Part 2|Withdrawal by Subject|0
5792842|NCT03231943|19967002|P8|Part 2|Withdrawal by Subject|0
5792843|NCT03231943|19967003|P7|Part 2|Withdrawal by Subject|0
5792844|NCT03231943|19967004|P6|Part 2|Withdrawal by Subject|0
5792845|NCT03231943|19967005|P5|Part 2|Withdrawal by Subject|0
5792846|NCT03231943|19967006|P4|Part 2|Withdrawal by Subject|0
5792847|NCT03231943|19967007|P3|Part 2|Withdrawal by Subject|0
5792848|NCT03231943|19967008|P2|Part 2|Withdrawal by Subject|0
5792849|NCT03231943|19967009|P1|Part 2|Withdrawal by Subject|0
5792850|NCT03231943|19966997|P13|Part 2|Adverse Event|0
5792851|NCT03231943|19966998|P12|Part 2|Adverse Event|0
5792852|NCT03231943|19966999|P11|Part 2|Adverse Event|1
5792853|NCT03231943|19967000|P10|Part 2|Adverse Event|0
5792854|NCT03231943|19967001|P9|Part 2|Adverse Event|0
5792855|NCT03231943|19967002|P8|Part 2|Adverse Event|0
5792856|NCT03231943|19967003|P7|Part 2|Adverse Event|0
5792857|NCT03231943|19967004|P6|Part 2|Adverse Event|0
5792858|NCT03231943|19967005|P5|Part 2|Adverse Event|0
5792859|NCT03231943|19967006|P4|Part 2|Adverse Event|0
5792860|NCT03231943|19967007|P3|Part 2|Adverse Event|0
5792861|NCT03231943|19967008|P2|Part 2|Adverse Event|0
5792862|NCT03231943|19967009|P1|Part 2|Adverse Event|0
5792863|NCT03231943|19966997|P13|Part 1, Period 3 (up to Day 45)|Adverse Event|0
5792864|NCT03231943|19966998|P12|Part 1, Period 3 (up to Day 45)|Adverse Event|0
5792865|NCT03231943|19966999|P11|Part 1, Period 3 (up to Day 45)|Adverse Event|0
5792866|NCT03231943|19967000|P10|Part 1, Period 3 (up to Day 45)|Adverse Event|0
5792867|NCT03231943|19967001|P9|Part 1, Period 3 (up to Day 45)|Adverse Event|0
5792868|NCT03231943|19967002|P8|Part 1, Period 3 (up to Day 45)|Adverse Event|0
5792869|NCT03231943|19967003|P7|Part 1, Period 3 (up to Day 45)|Adverse Event|0
5792870|NCT03231943|19967004|P6|Part 1, Period 3 (up to Day 45)|Adverse Event|0
5792871|NCT03231943|19967005|P5|Part 1, Period 3 (up to Day 45)|Adverse Event|0
5792872|NCT03231943|19967006|P4|Part 1, Period 3 (up to Day 45)|Adverse Event|0
5792873|NCT03231943|19967007|P3|Part 1, Period 3 (up to Day 45)|Adverse Event|0
5792874|NCT03231943|19967008|P2|Part 1, Period 3 (up to Day 45)|Adverse Event|0
5792875|NCT03231943|19967009|P1|Part 1, Period 3 (up to Day 45)|Adverse Event|1
5792876|NCT03231943|19966997|P13|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
5792877|NCT03231943|19966998|P12|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
5792878|NCT03231943|19966999|P11|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
5792879|NCT03231943|19967000|P10|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
5792880|NCT03231943|19967001|P9|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
5792881|NCT03231943|19967002|P8|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
5792882|NCT03231943|19967003|P7|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
5792883|NCT03231943|19967004|P6|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
5792884|NCT03231943|19967005|P5|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
5792885|NCT03231943|19967006|P4|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
5792886|NCT03231943|19967007|P3|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
5792887|NCT03231943|19967008|P2|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|1
5792888|NCT03231943|19967009|P1|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
5792889|NCT03231943|19966997|P13|Part 1, Period 2 (up to Day 30)|Adverse Event|0
5792890|NCT03231943|19966998|P12|Part 1, Period 2 (up to Day 30)|Adverse Event|0
5792891|NCT03231943|19966999|P11|Part 1, Period 2 (up to Day 30)|Adverse Event|0
5792892|NCT03231943|19967000|P10|Part 1, Period 2 (up to Day 30)|Adverse Event|0
5792893|NCT03231943|19967001|P9|Part 1, Period 2 (up to Day 30)|Adverse Event|0
5792894|NCT03231943|19967002|P8|Part 1, Period 2 (up to Day 30)|Adverse Event|0
5792895|NCT03231943|19967003|P7|Part 1, Period 2 (up to Day 30)|Adverse Event|0
5792896|NCT03231943|19967004|P6|Part 1, Period 2 (up to Day 30)|Adverse Event|0
5792897|NCT03231943|19967005|P5|Part 1, Period 2 (up to Day 30)|Adverse Event|0
5792898|NCT03231943|19967006|P4|Part 1, Period 2 (up to Day 30)|Adverse Event|0
5792899|NCT03231943|19967007|P3|Part 1, Period 2 (up to Day 30)|Adverse Event|1
5792900|NCT03231943|19967008|P2|Part 1, Period 2 (up to Day 30)|Adverse Event|1
5792901|NCT03231943|19967009|P1|Part 1, Period 2 (up to Day 30)|Adverse Event|0
5792902|NCT03231800|19967472|P2|Overall Study|reason not provided|0
5792903|NCT03231800|19967473|P1|Overall Study|reason not provided|2
5792904|NCT03231800|19967472|P2|Overall Study|Protocol Violation|1
5792905|NCT03231800|19967473|P1|Overall Study|Protocol Violation|1
5792906|NCT03231800|19967472|P2|Overall Study|Lost to Follow-up|2
5792907|NCT03231800|19967473|P1|Overall Study|Lost to Follow-up|0
5792908|NCT03231709|19967489|P2|Treatment Period 2|Pretreatment Event/Adverse Event|1
5792909|NCT03231709|19967490|P1|Treatment Period 2|Pretreatment Event/Adverse Event|0
5792910|NCT03231709|19967489|P2|Treatment Period 1|Reason not Specified|1
5792911|NCT03231709|19967490|P1|Treatment Period 1|Reason not Specified|0
5792912|NCT03231371|19967508|P1|Overall Study|chose or were ineligible to have MRI|12
5792913|NCT03231371|19967508|P1|Overall Study|Withdrawal by Subject|1
5792914|NCT03231228|19967521|P2|Overall Study|Physician Decision|0
5792915|NCT03231228|19967522|P1|Overall Study|Physician Decision|1
5792916|NCT03231228|19967521|P2|Overall Study|Lost to Follow-up|0
5792917|NCT03231228|19967522|P1|Overall Study|Lost to Follow-up|2
5792918|NCT03230864|19967533|P4|Double Blind Treatment (DBT) Period|Sponsor Decision|0
5792919|NCT03230864|19967534|P3|Double Blind Treatment (DBT) Period|Sponsor Decision|2
5792920|NCT03230864|19967535|P2|Double Blind Treatment (DBT) Period|Sponsor Decision|0
5792921|NCT03230864|19967536|P1|Double Blind Treatment (DBT) Period|Sponsor Decision|0
5792922|NCT03230864|19967533|P4|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1
5792923|NCT03230864|19967534|P3|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1
5792924|NCT03230864|19967535|P2|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0
5792925|NCT03230864|19967536|P1|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0
5792926|NCT03230864|19967533|P4|Double Blind Treatment (DBT) Period|Adverse Event|1
5792927|NCT03230864|19967534|P3|Double Blind Treatment (DBT) Period|Adverse Event|5
5792928|NCT03230864|19967535|P2|Double Blind Treatment (DBT) Period|Adverse Event|0
5792929|NCT03230864|19967536|P1|Double Blind Treatment (DBT) Period|Adverse Event|0
5792930|NCT03230864|19967533|P4|Prospective Confirmation (PC) Period|Study Personnel Decision|0
5792931|NCT03230864|19967534|P3|Prospective Confirmation (PC) Period|Study Personnel Decision|0
5792932|NCT03230864|19967535|P2|Prospective Confirmation (PC) Period|Study Personnel Decision|0
5792933|NCT03230864|19967536|P1|Prospective Confirmation (PC) Period|Study Personnel Decision|1
5792934|NCT03230864|19967533|P4|Prospective Confirmation (PC) Period|Sponsor Decision|0
5792935|NCT03230864|19967534|P3|Prospective Confirmation (PC) Period|Sponsor Decision|0
5792936|NCT03230864|19967535|P2|Prospective Confirmation (PC) Period|Sponsor Decision|9
5792937|NCT03230864|19967536|P1|Prospective Confirmation (PC) Period|Sponsor Decision|9
5792938|NCT03230864|19967533|P4|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0
5792939|NCT03230864|19967534|P3|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0
5792940|NCT03230864|19967535|P2|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|5
5792941|NCT03230864|19967536|P1|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|14
5792942|NCT03230864|19967533|P4|Prospective Confirmation (PC) Period|Withdrawal by Subject|0
5792943|NCT03230864|19967534|P3|Prospective Confirmation (PC) Period|Withdrawal by Subject|0
5792944|NCT03230864|19967535|P2|Prospective Confirmation (PC) Period|Withdrawal by Subject|1
5792945|NCT03230864|19967536|P1|Prospective Confirmation (PC) Period|Withdrawal by Subject|4
5792946|NCT03230864|19967533|P4|Prospective Confirmation (PC) Period|Protocol Violation|0
5792947|NCT03230864|19967534|P3|Prospective Confirmation (PC) Period|Protocol Violation|0
5792948|NCT03230864|19967535|P2|Prospective Confirmation (PC) Period|Protocol Violation|2
5792949|NCT03230864|19967536|P1|Prospective Confirmation (PC) Period|Protocol Violation|1
5792950|NCT03230864|19967533|P4|Prospective Confirmation (PC) Period|Lack of Efficacy|0
5792951|NCT03230864|19967534|P3|Prospective Confirmation (PC) Period|Lack of Efficacy|0
5792952|NCT03230864|19967535|P2|Prospective Confirmation (PC) Period|Lack of Efficacy|2
5792953|NCT03230864|19967536|P1|Prospective Confirmation (PC) Period|Lack of Efficacy|0
5792954|NCT03230864|19967533|P4|Prospective Confirmation (PC) Period|Adverse Event|0
5792955|NCT03230864|19967534|P3|Prospective Confirmation (PC) Period|Adverse Event|0
5792956|NCT03230864|19967535|P2|Prospective Confirmation (PC) Period|Adverse Event|0
5792957|NCT03230864|19967536|P1|Prospective Confirmation (PC) Period|Adverse Event|3
5792958|NCT03229486|19967554|P2|Overall Study|Protocol Violation|1
5792959|NCT03229486|19967555|P1|Overall Study|Protocol Violation|0
5792960|NCT03229109|19967596|P4|Overall Study|Withdrawal by Subject|1
5792961|NCT03229109|19967597|P3|Overall Study|Withdrawal by Subject|0
5792962|NCT03229109|19967598|P2|Overall Study|Withdrawal by Subject|0
5792963|NCT03229109|19967599|P1|Overall Study|Withdrawal by Subject|0
5792964|NCT03228836|19967618|P1|Overall Study|Other|4
5792965|NCT03228836|19967618|P1|Overall Study|Disease Progression|7
5792966|NCT03228836|19967618|P1|Overall Study|Physician Decision|1
5792967|NCT03228836|19967618|P1|Overall Study|Death|1
5792968|NCT03228836|19967618|P1|Overall Study|Withdrawal by Subject|1
5792969|NCT03228836|19967618|P1|Overall Study|Adverse Event|3
5792970|NCT03228433|19967630|P6|Overall Study|Positive alcohol test|0
5792971|NCT03228433|19967631|P5|Overall Study|Positive alcohol test|0
5792972|NCT03228433|19967632|P4|Overall Study|Positive alcohol test|1
5792973|NCT03228433|19967633|P3|Overall Study|Positive alcohol test|0
5792974|NCT03228433|19967634|P2|Overall Study|Positive alcohol test|0
5792975|NCT03228433|19967635|P1|Overall Study|Positive alcohol test|0
5792976|NCT03228433|19967630|P6|Overall Study|Lost to Follow-up|0
5792977|NCT03228433|19967631|P5|Overall Study|Lost to Follow-up|0
5792978|NCT03228433|19967632|P4|Overall Study|Lost to Follow-up|0
5792979|NCT03228433|19967633|P3|Overall Study|Lost to Follow-up|0
5792980|NCT03228433|19967634|P2|Overall Study|Lost to Follow-up|0
5792981|NCT03228433|19967635|P1|Overall Study|Lost to Follow-up|1
5792982|NCT03228212|19967710|P2|Period 2|Lost to Follow-up|0
5792983|NCT03228212|19967711|P1|Period 2|Lost to Follow-up|1
5792984|NCT03228212|19967710|P2|Period 1|no longer meets eligibility criteria|1
5792985|NCT03228212|19967711|P1|Period 1|no longer meets eligibility criteria|0
5792986|NCT03228212|19967710|P2|Period 1|Adverse Event|0
5792987|NCT03228212|19967711|P1|Period 1|Adverse Event|1
5792988|NCT03227861|19967727|P1|Extension Period (Week 48 to Week 96)|Other|2
5792989|NCT03227861|19967727|P1|Extension Period (Week 48 to Week 96)|Adverse Event|1
5792990|NCT03227861|19967727|P1|Extension Period (Week 48 to Week 96)|Lost to Follow-up|6
5792991|NCT03227861|19967727|P1|Extension Period (Week 48 to Week 96)|Transition to Other ARV Treatment|16
5792992|NCT03227861|19967727|P1|Extension Period (Week 48 to Week 96)|Transition to Commercial D/C/F/TAF|55
5792993|NCT03227861|19967727|P1|Main Study Period (Week 0 to Week 48)|Other|5
5792994|NCT03227861|19967727|P1|Main Study Period (Week 0 to Week 48)|Protocol Violation|1
5792995|NCT03227861|19967727|P1|Main Study Period (Week 0 to Week 48)|Adverse Event|1
5792996|NCT03227861|19967727|P1|Main Study Period (Week 0 to Week 48)|Withdrawal by Subject|1
5792997|NCT03227861|19967727|P1|Main Study Period (Week 0 to Week 48)|Lost to Follow-up|4
5792998|NCT03227692|19967759|P2|Overall Study|Adverse Event|2
5792999|NCT03227692|19967760|P1|Overall Study|Adverse Event|0
5793000|NCT03227692|19967759|P2|Overall Study|Lost to Follow-up|2
5793001|NCT03227692|19967760|P1|Overall Study|Lost to Follow-up|4
5793002|NCT03227692|19967759|P2|Overall Study|Protocol Violation|1
5793003|NCT03227692|19967760|P1|Overall Study|Protocol Violation|1
5793004|NCT03227445|19967788|P4|Period 2 (28 Days)|Withdrawal by Subject|1
5793005|NCT03227445|19967789|P3|Period 2 (28 Days)|Withdrawal by Subject|0
5793006|NCT03227445|19967790|P2|Period 2 (28 Days)|Withdrawal by Subject|1
5793007|NCT03227445|19967791|P1|Period 2 (28 Days)|Withdrawal by Subject|0
5793008|NCT03227445|19967788|P4|Period 2 (28 Days)|Protocol Violation|1
5793009|NCT03227445|19967789|P3|Period 2 (28 Days)|Protocol Violation|0
5793010|NCT03227445|19967790|P2|Period 2 (28 Days)|Protocol Violation|0
5793011|NCT03227445|19967791|P1|Period 2 (28 Days)|Protocol Violation|0
5793012|NCT03227445|19967788|P4|Period 2 (28 Days)|Adverse Event|1
5793013|NCT03227445|19967789|P3|Period 2 (28 Days)|Adverse Event|2
5793014|NCT03227445|19967790|P2|Period 2 (28 Days)|Adverse Event|0
5793015|NCT03227445|19967791|P1|Period 2 (28 Days)|Adverse Event|1
5793016|NCT03227445|19967788|P4|Period 1 (28 Days)|Withdrawal by Subject|1
5793017|NCT03227445|19967789|P3|Period 1 (28 Days)|Withdrawal by Subject|1
5793018|NCT03227445|19967790|P2|Period 1 (28 Days)|Withdrawal by Subject|0
5793019|NCT03227445|19967791|P1|Period 1 (28 Days)|Withdrawal by Subject|0
5793020|NCT03227445|19967788|P4|Period 1 (28 Days)|Protocol Violation|0
5793021|NCT03227445|19967789|P3|Period 1 (28 Days)|Protocol Violation|0
5793022|NCT03227445|19967790|P2|Period 1 (28 Days)|Protocol Violation|0
5793023|NCT03227445|19967791|P1|Period 1 (28 Days)|Protocol Violation|1
5793024|NCT03227445|19967788|P4|Period 1 (28 Days)|Adverse Event|1
5793025|NCT03227445|19967789|P3|Period 1 (28 Days)|Adverse Event|0
5793026|NCT03227445|19967790|P2|Period 1 (28 Days)|Adverse Event|2
5793027|NCT03227445|19967791|P1|Period 1 (28 Days)|Adverse Event|1
5793043|NCT03226769|19967863|P2|Overall Study|Withdrawal by Subject|1
5793044|NCT03226769|19967864|P1|Overall Study|Withdrawal by Subject|0
5793045|NCT03226392|19967878|P2|Overall Study|Subject/Guardian Decision|6
5793046|NCT03226392|19967879|P1|Overall Study|Subject/Guardian Decision|7
5793047|NCT03226392|19967878|P2|Overall Study|Technical Problems|2
5793048|NCT03226392|19967879|P1|Overall Study|Technical Problems|0
5793049|NCT03226392|19967878|P2|Overall Study|Adverse Event|0
5793050|NCT03226392|19967879|P1|Overall Study|Adverse Event|1
5793051|NCT03226392|19967878|P2|Overall Study|Lost to Follow-up|0
5793052|NCT03226392|19967879|P1|Overall Study|Lost to Follow-up|1
5793053|NCT03226392|19967878|P2|Overall Study|Physician Decision|0
5793054|NCT03226392|19967879|P1|Overall Study|Physician Decision|1
5793055|NCT03226392|19967878|P2|Overall Study|Protocol Deviation|0
5793056|NCT03226392|19967879|P1|Overall Study|Protocol Deviation|1
5793057|NCT03226353|19967920|P1|Overall Study|Screen Failure|5
5793058|NCT03226353|19967920|P1|Overall Study|Withdrawal by Subject|1
5793059|NCT03226275|19967944|P4|Treatment Period 1 (8 Days)|Protocol non-compliance|1
5793060|NCT03226275|19967945|P3|Treatment Period 1 (8 Days)|Protocol non-compliance|0
5793061|NCT03226275|19967946|P2|Treatment Period 1 (8 Days)|Protocol non-compliance|0
5793062|NCT03226275|19967947|P1|Treatment Period 1 (8 Days)|Protocol non-compliance|0
5793063|NCT03226275|19967944|P4|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0
5793064|NCT03226275|19967945|P3|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|1
5793065|NCT03226275|19967946|P2|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0
5793066|NCT03226275|19967947|P1|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0
5793067|NCT03226249|19967993|P1|Survival Follow-up|Patients still in follow-up.|30
5793068|NCT03226249|19967993|P1|PEM Consolidation (1-2 Years)|Per Protocol not eligible|29
5793069|NCT03226249|19967993|P1|2-4 Cycles of AVD +/- Chemo & RT, PET#4|Transferred to another state|1
5793070|NCT03224598|19968063|P3|Overall Study|Other|0
5793071|NCT03224598|19968064|P2|Overall Study|Other|1
5793072|NCT03224598|19968065|P1|Overall Study|Other|0
5793073|NCT03224598|19968063|P3|Overall Study|Lost to Follow-up|0
5793074|NCT03224598|19968064|P2|Overall Study|Lost to Follow-up|2
5793075|NCT03224598|19968065|P1|Overall Study|Lost to Follow-up|0
5793076|NCT03224325|19968091|P7|Overall Study|Withdrawal by Subject|0
5793077|NCT03224325|19968092|P6|Overall Study|Withdrawal by Subject|0
5793078|NCT03224325|19968093|P5|Overall Study|Withdrawal by Subject|0
5793079|NCT03224325|19968094|P4|Overall Study|Withdrawal by Subject|1
5793080|NCT03224325|19968095|P3|Overall Study|Withdrawal by Subject|0
5793081|NCT03224325|19968096|P2|Overall Study|Withdrawal by Subject|0
5793082|NCT03224325|19968097|P1|Overall Study|Withdrawal by Subject|0
5793083|NCT03224325|19968091|P7|Overall Study|Adverse Event|1
5793084|NCT03224325|19968092|P6|Overall Study|Adverse Event|0
5793085|NCT03224325|19968093|P5|Overall Study|Adverse Event|0
5793086|NCT03224325|19968094|P4|Overall Study|Adverse Event|0
5793087|NCT03224325|19968095|P3|Overall Study|Adverse Event|0
5793088|NCT03224325|19968096|P2|Overall Study|Adverse Event|0
5793089|NCT03224325|19968097|P1|Overall Study|Adverse Event|1
5793090|NCT03224234|19968162|P2|Main Study|Lost to Follow-up|5
5793091|NCT03224234|19968163|P1|Main Study|Lost to Follow-up|5
5793092|NCT03224130|19968211|P2|Overall Study|consent issue|1
5793093|NCT03224130|19968212|P1|Overall Study|consent issue|0
5793094|NCT03223909|19968233|P3|Overall Study|Protocol Violation|16
5793095|NCT03223909|19968234|P2|Overall Study|Protocol Violation|45
5793096|NCT03223909|19968235|P1|Overall Study|Protocol Violation|48
5793097|NCT03223662|19968264|P1|Overall Study|Study closure|1
5793098|NCT03223662|19968264|P1|Overall Study|Physician Decision|1
5793099|NCT03222583|19968368|P2|Overall Study|Other|3
5793100|NCT03222583|19968369|P1|Overall Study|Other|1
5793101|NCT03222583|19968368|P2|Overall Study|Lost to Follow-up|0
5793102|NCT03222583|19968369|P1|Overall Study|Lost to Follow-up|1
5793103|NCT03222583|19968368|P2|Overall Study|Withdrawal by Subject|3
5793104|NCT03222583|19968369|P1|Overall Study|Withdrawal by Subject|3
5793105|NCT03222141|19968419|P1|Overall Study|Lost to Follow-up|3
5793106|NCT03222141|19968419|P1|Overall Study|Death|15
5793107|NCT03220737|19968533|P7|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0
5793108|NCT03220737|19968534|P6|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0
5793109|NCT03220737|19968535|P5|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0
5793110|NCT03220737|19968536|P4|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0
5793111|NCT03220737|19968537|P3|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0
5793112|NCT03220737|19968538|P2|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0
5793113|NCT03220737|19968539|P1|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|1
5793114|NCT03220737|19968533|P7|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0
5793115|NCT03220737|19968534|P6|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0
5793116|NCT03220737|19968535|P5|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0
5793117|NCT03220737|19968536|P4|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0
5793118|NCT03220737|19968537|P3|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0
5793119|NCT03220737|19968538|P2|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0
5793120|NCT03220737|19968539|P1|Long-term Follow-up (Day 365-730)|Lost to Follow-up|9
5793121|NCT03220737|19968533|P7|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0
5793122|NCT03220737|19968534|P6|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0
5793123|NCT03220737|19968535|P5|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0
5793124|NCT03220737|19968536|P4|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0
5793125|NCT03220737|19968537|P3|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0
5793126|NCT03220737|19968538|P2|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0
5793127|NCT03220737|19968539|P1|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|1
5793128|NCT03220737|19968533|P7|Placebo Crossover (Day 181-365)|Lost to Follow-up|0
5793129|NCT03220737|19968534|P6|Placebo Crossover (Day 181-365)|Lost to Follow-up|0
5793130|NCT03220737|19968535|P5|Placebo Crossover (Day 181-365)|Lost to Follow-up|2
5793131|NCT03220737|19968536|P4|Placebo Crossover (Day 181-365)|Lost to Follow-up|0
5793132|NCT03220737|19968537|P3|Placebo Crossover (Day 181-365)|Lost to Follow-up|0
5793133|NCT03220737|19968538|P2|Placebo Crossover (Day 181-365)|Lost to Follow-up|0
5793134|NCT03220737|19968539|P1|Placebo Crossover (Day 181-365)|Lost to Follow-up|0
5793135|NCT03220737|19968533|P7|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0
5793136|NCT03220737|19968534|P6|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0
5793137|NCT03220737|19968535|P5|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0
5793138|NCT03220737|19968536|P4|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0
5793139|NCT03220737|19968537|P3|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|1
5793140|NCT03220737|19968538|P2|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0
5793141|NCT03220737|19968539|P1|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0
5793142|NCT03220737|19968533|P7|Main Study (Day 1 - 181)|Protocol Violation|1
5793143|NCT03220737|19968534|P6|Main Study (Day 1 - 181)|Protocol Violation|0
5793144|NCT03220737|19968535|P5|Main Study (Day 1 - 181)|Protocol Violation|3
5793145|NCT03220737|19968536|P4|Main Study (Day 1 - 181)|Protocol Violation|1
5793146|NCT03220737|19968537|P3|Main Study (Day 1 - 181)|Protocol Violation|1
5793147|NCT03220737|19968538|P2|Main Study (Day 1 - 181)|Protocol Violation|0
5793148|NCT03220737|19968539|P1|Main Study (Day 1 - 181)|Protocol Violation|0
5793149|NCT03220737|19968533|P7|Main Study (Day 1 - 181)|Lost to Follow-up|0
5793150|NCT03220737|19968534|P6|Main Study (Day 1 - 181)|Lost to Follow-up|1
5793151|NCT03220737|19968535|P5|Main Study (Day 1 - 181)|Lost to Follow-up|13
5793152|NCT03220737|19968536|P4|Main Study (Day 1 - 181)|Lost to Follow-up|1
5793153|NCT03220737|19968537|P3|Main Study (Day 1 - 181)|Lost to Follow-up|6
5793154|NCT03220737|19968538|P2|Main Study (Day 1 - 181)|Lost to Follow-up|1
5793155|NCT03220737|19968539|P1|Main Study (Day 1 - 181)|Lost to Follow-up|2
5793156|NCT03220737|19968533|P7|Main Study (Day 1 - 181)|Withdrawal by Subject|0
5793157|NCT03220737|19968534|P6|Main Study (Day 1 - 181)|Withdrawal by Subject|0
5793158|NCT03220737|19968535|P5|Main Study (Day 1 - 181)|Withdrawal by Subject|4
5793159|NCT03220737|19968536|P4|Main Study (Day 1 - 181)|Withdrawal by Subject|1
5793160|NCT03220737|19968537|P3|Main Study (Day 1 - 181)|Withdrawal by Subject|4
5793161|NCT03220737|19968538|P2|Main Study (Day 1 - 181)|Withdrawal by Subject|1
5793162|NCT03220737|19968539|P1|Main Study (Day 1 - 181)|Withdrawal by Subject|4
5793163|NCT03220217|19968602|P3|Overall Study|Subject Missed Procedure|1
5793164|NCT03220217|19968603|P2|Overall Study|Subject Missed Procedure|0
5793165|NCT03220217|19968604|P1|Overall Study|Subject Missed Procedure|0
5793166|NCT03220217|19968602|P3|Overall Study|Withdrawal by Subject|0
5793167|NCT03220217|19968603|P2|Overall Study|Withdrawal by Subject|1
5793168|NCT03220217|19968604|P1|Overall Study|Withdrawal by Subject|0
5793169|NCT03219723|19968751|P1|Overall Study|Protocol Deviation|4
5793170|NCT03219723|19968751|P1|Overall Study|Case Report Forms Uncollected|6
5793171|NCT03219372|19968758|P2|Overall Study|Withdrawal by Subject|0
5793172|NCT03219372|19968759|P1|Overall Study|Withdrawal by Subject|1
5793173|NCT03219216|19968817|P2|Overall Study|Lost to Follow-up|1
5793174|NCT03219216|19968818|P1|Overall Study|Lost to Follow-up|0
5793175|NCT03218397|19968864|P2|Overall Study|Randomized during laboratory off hours|1
5793176|NCT03218397|19968865|P1|Overall Study|Randomized during laboratory off hours|2
5793177|NCT03218397|19968864|P2|Overall Study|No gram-negative bacilli (GNB)|2
5793178|NCT03218397|19968865|P1|Overall Study|No gram-negative bacilli (GNB)|0
5793179|NCT03218397|19968864|P2|Overall Study|Inaccessible hospital records|5
5793180|NCT03218397|19968865|P1|Overall Study|Inaccessible hospital records|2
5793181|NCT03218397|19968864|P2|Overall Study|Mixed culture|2
5793182|NCT03218397|19968865|P1|Overall Study|Mixed culture|2
5793183|NCT03218397|19968864|P2|Overall Study|Comfort care and mixed culture|1
5793184|NCT03218397|19968865|P1|Overall Study|Comfort care and mixed culture|0
5793185|NCT03218397|19968864|P2|Overall Study|Comfort care and positive blood culture|0
5793186|NCT03218397|19968865|P1|Overall Study|Comfort care and positive blood culture|1
5793187|NCT03218397|19968864|P2|Overall Study|Comfort care|5
5793188|NCT03218397|19968865|P1|Overall Study|Comfort care|8
5793189|NCT03218397|19968864|P2|Overall Study|Prior positive blood culture|13
5793190|NCT03218397|19968865|P1|Overall Study|Prior positive blood culture|8
5793191|NCT03217968|19968897|P1|Overall Study|Protocol Violation|6
5793192|NCT03217968|19968897|P1|Overall Study|Lost to Follow-up|1
5793193|NCT03217968|19968897|P1|Overall Study|Withdrawal by Subject|4
5793194|NCT03217175|19968906|P2|Overall Study|Physician Decision|1
5793195|NCT03217175|19968907|P1|Overall Study|Physician Decision|4
5793196|NCT03216954|19968921|P5|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0
5793197|NCT03216954|19968922|P4|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0
5793198|NCT03216954|19968923|P3|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0
5793199|NCT03216954|19968924|P2|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|1
5793200|NCT03216954|19968925|P1|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0
5793201|NCT03216954|19968921|P5|Overall Study|Withdrawal by Subject|0
5793202|NCT03216954|19968922|P4|Overall Study|Withdrawal by Subject|0
5793203|NCT03216954|19968923|P3|Overall Study|Withdrawal by Subject|0
5793204|NCT03216954|19968924|P2|Overall Study|Withdrawal by Subject|0
5793205|NCT03216954|19968925|P1|Overall Study|Withdrawal by Subject|2
5793206|NCT03216954|19968921|P5|Overall Study|Adverse Event|1
5793207|NCT03216954|19968922|P4|Overall Study|Adverse Event|0
5793208|NCT03216954|19968923|P3|Overall Study|Adverse Event|1
5793209|NCT03216954|19968924|P2|Overall Study|Adverse Event|0
5793210|NCT03216954|19968925|P1|Overall Study|Adverse Event|0
5793211|NCT03216850|19969014|P1|Overall Study|Pre-analytical error|6
5793212|NCT03216746|19969022|P4|Overall Study|Lost to Follow-up|6
5793213|NCT03216746|19969023|P3|Overall Study|Lost to Follow-up|5
5793214|NCT03216746|19969024|P2|Overall Study|Lost to Follow-up|8
5793215|NCT03216746|19969025|P1|Overall Study|Lost to Follow-up|6
5793216|NCT03216265|19969066|P3|Overall Study|Withdrawal by Subject|1
5793217|NCT03216265|19969067|P2|Overall Study|Withdrawal by Subject|0
5793218|NCT03216265|19969068|P1|Overall Study|Withdrawal by Subject|0
5793219|NCT03216265|19969066|P3|Overall Study|Lost to Follow-up|0
5793220|NCT03216265|19969067|P2|Overall Study|Lost to Follow-up|1
5793221|NCT03216265|19969068|P1|Overall Study|Lost to Follow-up|0
5793222|NCT03216265|19969066|P3|Overall Study|Adverse Event|2
5793223|NCT03216265|19969067|P2|Overall Study|Adverse Event|0
5793224|NCT03216265|19969068|P1|Overall Study|Adverse Event|2
5793225|NCT03215758|19969159|P2|Overall Study|Subject/Guardian Decision|3
5793226|NCT03215758|19969160|P1|Overall Study|Subject/Guardian Decision|3
5793227|NCT03215758|19969159|P2|Overall Study|Adverse Event|2
5793228|NCT03215758|19969160|P1|Overall Study|Adverse Event|1
5793229|NCT03215758|19969159|P2|Overall Study|Death|1
5793230|NCT03215758|19969160|P1|Overall Study|Death|0
5793231|NCT03215758|19969159|P2|Overall Study|Physician Decision|1
5793232|NCT03215758|19969160|P1|Overall Study|Physician Decision|0
5793233|NCT03215758|19969159|P2|Overall Study|Protocol deviation|1
5793234|NCT03215758|19969160|P1|Overall Study|Protocol deviation|0
5793235|NCT03215758|19969159|P2|Overall Study|Technical Problems|0
5793236|NCT03215758|19969160|P1|Overall Study|Technical Problems|1
5793237|NCT03215706|19969174|P2|Treatment Period|Ongoing in the treatment period|43
5793238|NCT03215706|19969175|P1|Treatment Period|Ongoing in the treatment period|105
5793239|NCT03215706|19969174|P2|Treatment Period|Other Reasons|5
5793240|NCT03215706|19969175|P1|Treatment Period|Other Reasons|4
5793241|NCT03215706|19969174|P2|Treatment Period|Lost to Follow-up|1
5793242|NCT03215706|19969175|P1|Treatment Period|Lost to Follow-up|0
5793243|NCT03215706|19969174|P2|Treatment Period|Participant withdrew consent|4
5793244|NCT03215706|19969175|P1|Treatment Period|Participant withdrew consent|3
5793245|NCT03215706|19969174|P2|Treatment Period|Request to D/C treatment|6
5793246|NCT03215706|19969175|P1|Treatment Period|Request to D/C treatment|1
5793247|NCT03215706|19969174|P2|Treatment Period|Adverse event unrelated to study drug|23
5793248|NCT03215706|19969175|P1|Treatment Period|Adverse event unrelated to study drug|24
5793249|NCT03215706|19969174|P2|Treatment Period|Death|1
5793250|NCT03215706|19969175|P1|Treatment Period|Death|2
5793251|NCT03215706|19969174|P2|Treatment Period|Study Drug Toxicity|21
5793252|NCT03215706|19969175|P1|Treatment Period|Study Drug Toxicity|53
5793253|NCT03215706|19969174|P2|Treatment Period|Disease Progression|142
5793254|NCT03215706|19969175|P1|Treatment Period|Disease Progression|150
5793255|NCT03215706|19969174|P2|Randomization|other reasons|2
5793256|NCT03215706|19969175|P1|Randomization|other reasons|0
5793257|NCT03215706|19969174|P2|Randomization|no longer meets study criteria|4
5793258|NCT03215706|19969175|P1|Randomization|no longer meets study criteria|1
5793259|NCT03215706|19969174|P2|Randomization|participant withdrew consent|3
5793260|NCT03215706|19969175|P1|Randomization|participant withdrew consent|1
5793261|NCT03215706|19969174|P2|Randomization|Adverse Event unrelated to study drug|0
5793262|NCT03215706|19969175|P1|Randomization|Adverse Event unrelated to study drug|1
5793263|NCT03215667|19969195|P1|Overall Study|Physician Decision|4
5793264|NCT03214952|19969200|P1|Overall Study|Case Report Forms Uncollected|13
5793265|NCT03214952|19969200|P1|Overall Study|Protocol Deviation|45
5793266|NCT03214588|19969215|P3|Overall Study|Reason Not Specified|0
5793267|NCT03214588|19969216|P2|Overall Study|Reason Not Specified|1
5793268|NCT03214588|19969217|P1|Overall Study|Reason Not Specified|0
5793269|NCT03214588|19969215|P3|Overall Study|Adverse Event|2
5793270|NCT03214588|19969216|P2|Overall Study|Adverse Event|0
5793271|NCT03214588|19969217|P1|Overall Study|Adverse Event|1
5793272|NCT03214406|19969284|P2|Overall Study|Lost to Follow-up|2
5793273|NCT03214406|19969285|P1|Overall Study|Lost to Follow-up|0
5793274|NCT03214406|19969284|P2|Overall Study|Withdrawal by Subject|0
5793275|NCT03214406|19969285|P1|Overall Study|Withdrawal by Subject|1
5793276|NCT03214406|19969284|P2|Overall Study|did not meet enrollment criteria|13
5793277|NCT03214406|19969285|P1|Overall Study|did not meet enrollment criteria|9
5793278|NCT03214380|19969299|P6|Treatment Period|Treatment Interruption|0
5793279|NCT03214380|19969300|P5|Treatment Period|Treatment Interruption|0
5793280|NCT03214380|19969301|P4|Treatment Period|Treatment Interruption|0
5793281|NCT03214380|19969302|P3|Treatment Period|Treatment Interruption|1
5793282|NCT03214380|19969303|P2|Treatment Period|Treatment Interruption|0
5793283|NCT03214380|19969304|P1|Treatment Period|Treatment Interruption|0
5793284|NCT03214380|19969299|P6|Treatment Period|Participant schedule|0
5793285|NCT03214380|19969300|P5|Treatment Period|Participant schedule|0
5793286|NCT03214380|19969301|P4|Treatment Period|Participant schedule|0
5793287|NCT03214380|19969302|P3|Treatment Period|Participant schedule|1
5793288|NCT03214380|19969303|P2|Treatment Period|Participant schedule|0
5793289|NCT03214380|19969304|P1|Treatment Period|Participant schedule|0
5793290|NCT03214380|19969299|P6|Treatment Period|Lost to Follow-up|0
5793291|NCT03214380|19969300|P5|Treatment Period|Lost to Follow-up|0
5793292|NCT03214380|19969301|P4|Treatment Period|Lost to Follow-up|0
5793293|NCT03214380|19969302|P3|Treatment Period|Lost to Follow-up|3
5793294|NCT03214380|19969303|P2|Treatment Period|Lost to Follow-up|6
5793295|NCT03214380|19969304|P1|Treatment Period|Lost to Follow-up|0
5793296|NCT03214380|19969299|P6|Treatment Period|Death|0
5793297|NCT03214380|19969300|P5|Treatment Period|Death|0
5793298|NCT03214380|19969301|P4|Treatment Period|Death|0
5793299|NCT03214380|19969302|P3|Treatment Period|Death|2
5793300|NCT03214380|19969303|P2|Treatment Period|Death|1
5793301|NCT03214380|19969304|P1|Treatment Period|Death|0
5793302|NCT03214380|19969299|P6|Treatment Period|Withdrawal by Subject|11
5793303|NCT03214380|19969300|P5|Treatment Period|Withdrawal by Subject|7
5793304|NCT03214380|19969301|P4|Treatment Period|Withdrawal by Subject|0
5793305|NCT03214380|19969302|P3|Treatment Period|Withdrawal by Subject|8
5793306|NCT03214380|19969303|P2|Treatment Period|Withdrawal by Subject|10
5793307|NCT03214380|19969304|P1|Treatment Period|Withdrawal by Subject|0
5793308|NCT03214380|19969299|P6|Treatment Period|Non-Compliance with Study Drug|0
5793309|NCT03214380|19969300|P5|Treatment Period|Non-Compliance with Study Drug|1
5793310|NCT03214380|19969301|P4|Treatment Period|Non-Compliance with Study Drug|0
5793311|NCT03214380|19969302|P3|Treatment Period|Non-Compliance with Study Drug|0
5793312|NCT03214380|19969303|P2|Treatment Period|Non-Compliance with Study Drug|0
5793313|NCT03214380|19969304|P1|Treatment Period|Non-Compliance with Study Drug|0
5793314|NCT03214380|19969299|P6|Treatment Period|Adverse Event|0
5793315|NCT03214380|19969300|P5|Treatment Period|Adverse Event|1
5793316|NCT03214380|19969301|P4|Treatment Period|Adverse Event|0
5793317|NCT03214380|19969302|P3|Treatment Period|Adverse Event|1
5793318|NCT03214380|19969303|P2|Treatment Period|Adverse Event|1
5793319|NCT03214380|19969304|P1|Treatment Period|Adverse Event|0
5793320|NCT03214380|19969299|P6|Lead-in|Participant Schedule|0
5793321|NCT03214380|19969300|P5|Lead-in|Participant Schedule|0
5793322|NCT03214380|19969301|P4|Lead-in|Participant Schedule|0
5793323|NCT03214380|19969302|P3|Lead-in|Participant Schedule|0
5793324|NCT03214380|19969303|P2|Lead-in|Participant Schedule|0
5793325|NCT03214380|19969304|P1|Lead-in|Participant Schedule|2
5793326|NCT03214380|19969299|P6|Lead-in|Non Compliance|0
5793327|NCT03214380|19969300|P5|Lead-in|Non Compliance|0
5793328|NCT03214380|19969301|P4|Lead-in|Non Compliance|0
5793329|NCT03214380|19969302|P3|Lead-in|Non Compliance|0
5793330|NCT03214380|19969303|P2|Lead-in|Non Compliance|0
5793331|NCT03214380|19969304|P1|Lead-in|Non Compliance|1
5793332|NCT03214380|19969299|P6|Lead-in|Natural Disaster|0
5793333|NCT03214380|19969300|P5|Lead-in|Natural Disaster|0
5793334|NCT03214380|19969301|P4|Lead-in|Natural Disaster|0
5793335|NCT03214380|19969302|P3|Lead-in|Natural Disaster|0
5793336|NCT03214380|19969303|P2|Lead-in|Natural Disaster|0
5793337|NCT03214380|19969304|P1|Lead-in|Natural Disaster|9
5793338|NCT03214380|19969299|P6|Lead-in|Family Emergency|0
5793339|NCT03214380|19969300|P5|Lead-in|Family Emergency|0
5793340|NCT03214380|19969301|P4|Lead-in|Family Emergency|0
5793341|NCT03214380|19969302|P3|Lead-in|Family Emergency|0
5793342|NCT03214380|19969303|P2|Lead-in|Family Emergency|0
5793343|NCT03214380|19969304|P1|Lead-in|Family Emergency|1
5793344|NCT03214380|19969299|P6|Lead-in|Withdrawal by Subject|0
5793345|NCT03214380|19969300|P5|Lead-in|Withdrawal by Subject|0
5793346|NCT03214380|19969301|P4|Lead-in|Withdrawal by Subject|14
5793347|NCT03214380|19969302|P3|Lead-in|Withdrawal by Subject|0
5793348|NCT03214380|19969303|P2|Lead-in|Withdrawal by Subject|0
5793349|NCT03214380|19969304|P1|Lead-in|Withdrawal by Subject|41
5793350|NCT03214380|19969299|P6|Lead-in|Protocol Deviation|0
5793351|NCT03214380|19969300|P5|Lead-in|Protocol Deviation|0
5793352|NCT03214380|19969301|P4|Lead-in|Protocol Deviation|3
5793353|NCT03214380|19969302|P3|Lead-in|Protocol Deviation|0
5793354|NCT03214380|19969303|P2|Lead-in|Protocol Deviation|0
5793355|NCT03214380|19969304|P1|Lead-in|Protocol Deviation|7
5793356|NCT03214380|19969299|P6|Lead-in|Physician Decision|0
5793357|NCT03214380|19969300|P5|Lead-in|Physician Decision|0
5793358|NCT03214380|19969301|P4|Lead-in|Physician Decision|0
5793359|NCT03214380|19969302|P3|Lead-in|Physician Decision|0
5793360|NCT03214380|19969303|P2|Lead-in|Physician Decision|0
5793361|NCT03214380|19969304|P1|Lead-in|Physician Decision|6
5793362|NCT03214380|19969299|P6|Lead-in|Eligibility Criteria|0
5793363|NCT03214380|19969300|P5|Lead-in|Eligibility Criteria|0
5793364|NCT03214380|19969301|P4|Lead-in|Eligibility Criteria|0
5793365|NCT03214380|19969302|P3|Lead-in|Eligibility Criteria|0
5793366|NCT03214380|19969303|P2|Lead-in|Eligibility Criteria|0
5793367|NCT03214380|19969304|P1|Lead-in|Eligibility Criteria|3
5793368|NCT03214380|19969299|P6|Lead-in|Lost to Follow-up|0
5793369|NCT03214380|19969300|P5|Lead-in|Lost to Follow-up|0
5793370|NCT03214380|19969301|P4|Lead-in|Lost to Follow-up|1
5793371|NCT03214380|19969302|P3|Lead-in|Lost to Follow-up|0
5793372|NCT03214380|19969303|P2|Lead-in|Lost to Follow-up|0
5793373|NCT03214380|19969304|P1|Lead-in|Lost to Follow-up|4
5793374|NCT03214380|19969299|P6|Lead-in|Adverse Event|0
5793375|NCT03214380|19969300|P5|Lead-in|Adverse Event|0
5793376|NCT03214380|19969301|P4|Lead-in|Adverse Event|1
5793377|NCT03214380|19969302|P3|Lead-in|Adverse Event|0
5793378|NCT03214380|19969303|P2|Lead-in|Adverse Event|0
5793379|NCT03214380|19969304|P1|Lead-in|Adverse Event|3
5793380|NCT03214367|19969340|P8|Treatment Period|Withdrawal by Subject|1
5793381|NCT03214367|19969341|P7|Treatment Period|Withdrawal by Subject|1
5793382|NCT03214367|19969342|P6|Treatment Period|Withdrawal by Subject|1
5793383|NCT03214367|19969343|P5|Treatment Period|Withdrawal by Subject|0
5793384|NCT03214367|19969344|P4|Treatment Period|Withdrawal by Subject|14
5793385|NCT03214367|19969345|P3|Treatment Period|Withdrawal by Subject|23
5793386|NCT03214367|19969346|P2|Treatment Period|Withdrawal by Subject|20
5793387|NCT03214367|19969347|P1|Treatment Period|Withdrawal by Subject|0
5793388|NCT03214367|19969340|P8|Treatment Period|Protocol Violation|0
5793389|NCT03214367|19969341|P7|Treatment Period|Protocol Violation|0
5793390|NCT03214367|19969342|P6|Treatment Period|Protocol Violation|0
5793391|NCT03214367|19969343|P5|Treatment Period|Protocol Violation|0
5793392|NCT03214367|19969344|P4|Treatment Period|Protocol Violation|0
5793393|NCT03214367|19969345|P3|Treatment Period|Protocol Violation|0
5793394|NCT03214367|19969346|P2|Treatment Period|Protocol Violation|3
5793395|NCT03214367|19969347|P1|Treatment Period|Protocol Violation|0
5793396|NCT03214367|19969340|P8|Treatment Period|Physician Decision|0
5793397|NCT03214367|19969341|P7|Treatment Period|Physician Decision|0
5793398|NCT03214367|19969342|P6|Treatment Period|Physician Decision|0
5793399|NCT03214367|19969343|P5|Treatment Period|Physician Decision|0
5793400|NCT03214367|19969344|P4|Treatment Period|Physician Decision|0
5793401|NCT03214367|19969345|P3|Treatment Period|Physician Decision|2
5793402|NCT03214367|19969346|P2|Treatment Period|Physician Decision|1
5793403|NCT03214367|19969347|P1|Treatment Period|Physician Decision|0
5793404|NCT03214367|19969340|P8|Treatment Period|Sponsor Decision|0
5793405|NCT03214367|19969341|P7|Treatment Period|Sponsor Decision|0
5793406|NCT03214367|19969342|P6|Treatment Period|Sponsor Decision|0
5793407|NCT03214367|19969343|P5|Treatment Period|Sponsor Decision|0
5793408|NCT03214367|19969344|P4|Treatment Period|Sponsor Decision|0
5793409|NCT03214367|19969345|P3|Treatment Period|Sponsor Decision|0
5793410|NCT03214367|19969346|P2|Treatment Period|Sponsor Decision|3
5793411|NCT03214367|19969347|P1|Treatment Period|Sponsor Decision|0
5793412|NCT03214367|19969340|P8|Treatment Period|Lost to Follow-up|0
5793413|NCT03214367|19969341|P7|Treatment Period|Lost to Follow-up|1
5793414|NCT03214367|19969342|P6|Treatment Period|Lost to Follow-up|2
5793415|NCT03214367|19969343|P5|Treatment Period|Lost to Follow-up|0
5793416|NCT03214367|19969344|P4|Treatment Period|Lost to Follow-up|2
5793417|NCT03214367|19969345|P3|Treatment Period|Lost to Follow-up|3
5793418|NCT03214367|19969346|P2|Treatment Period|Lost to Follow-up|5
5793419|NCT03214367|19969347|P1|Treatment Period|Lost to Follow-up|0
5793420|NCT03214367|19969340|P8|Treatment Period|Death|0
5793421|NCT03214367|19969341|P7|Treatment Period|Death|0
5793422|NCT03214367|19969342|P6|Treatment Period|Death|0
5793423|NCT03214367|19969343|P5|Treatment Period|Death|0
5793424|NCT03214367|19969344|P4|Treatment Period|Death|1
5793425|NCT03214367|19969345|P3|Treatment Period|Death|1
5793426|NCT03214367|19969346|P2|Treatment Period|Death|1
5793427|NCT03214367|19969347|P1|Treatment Period|Death|0
5793428|NCT03214367|19969340|P8|Treatment Period|Adverse Event|0
5793429|NCT03214367|19969341|P7|Treatment Period|Adverse Event|0
5793430|NCT03214367|19969342|P6|Treatment Period|Adverse Event|0
5793431|NCT03214367|19969343|P5|Treatment Period|Adverse Event|0
5793432|NCT03214367|19969344|P4|Treatment Period|Adverse Event|2
5793433|NCT03214367|19969345|P3|Treatment Period|Adverse Event|4
5793434|NCT03214367|19969346|P2|Treatment Period|Adverse Event|1
5793435|NCT03214367|19969347|P1|Treatment Period|Adverse Event|0
5793436|NCT03214367|19969340|P8|Lead-in Period|Treatment Interruption|0
5793437|NCT03214367|19969341|P7|Lead-in Period|Treatment Interruption|0
5793438|NCT03214367|19969342|P6|Lead-in Period|Treatment Interruption|0
5793439|NCT03214367|19969343|P5|Lead-in Period|Treatment Interruption|0
5793440|NCT03214367|19969344|P4|Lead-in Period|Treatment Interruption|0
5793441|NCT03214367|19969345|P3|Lead-in Period|Treatment Interruption|0
5793442|NCT03214367|19969346|P2|Lead-in Period|Treatment Interruption|0
5793443|NCT03214367|19969347|P1|Lead-in Period|Treatment Interruption|1
5793444|NCT03214367|19969340|P8|Lead-in Period|Protocol Violation|0
5793445|NCT03214367|19969341|P7|Lead-in Period|Protocol Violation|0
5793446|NCT03214367|19969342|P6|Lead-in Period|Protocol Violation|0
5793447|NCT03214367|19969343|P5|Lead-in Period|Protocol Violation|0
5793448|NCT03214367|19969344|P4|Lead-in Period|Protocol Violation|0
5793449|NCT03214367|19969345|P3|Lead-in Period|Protocol Violation|0
5793450|NCT03214367|19969346|P2|Lead-in Period|Protocol Violation|0
5793451|NCT03214367|19969347|P1|Lead-in Period|Protocol Violation|5
5793452|NCT03214367|19969340|P8|Lead-in Period|Physician Decision|0
5793453|NCT03214367|19969341|P7|Lead-in Period|Physician Decision|0
5793454|NCT03214367|19969342|P6|Lead-in Period|Physician Decision|0
5793455|NCT03214367|19969343|P5|Lead-in Period|Physician Decision|0
5793456|NCT03214367|19969344|P4|Lead-in Period|Physician Decision|0
5793457|NCT03214367|19969345|P3|Lead-in Period|Physician Decision|0
5793458|NCT03214367|19969346|P2|Lead-in Period|Physician Decision|0
5793459|NCT03214367|19969347|P1|Lead-in Period|Physician Decision|12
5793460|NCT03214367|19969340|P8|Lead-in Period|Sponsor Decision|0
5793461|NCT03214367|19969341|P7|Lead-in Period|Sponsor Decision|0
5793462|NCT03214367|19969342|P6|Lead-in Period|Sponsor Decision|0
5793463|NCT03214367|19969343|P5|Lead-in Period|Sponsor Decision|0
5793464|NCT03214367|19969344|P4|Lead-in Period|Sponsor Decision|0
5793465|NCT03214367|19969345|P3|Lead-in Period|Sponsor Decision|0
5793466|NCT03214367|19969346|P2|Lead-in Period|Sponsor Decision|0
5793467|NCT03214367|19969347|P1|Lead-in Period|Sponsor Decision|11
5793468|NCT03214367|19969340|P8|Lead-in Period|Lost to Follow-up|0
5793469|NCT03214367|19969341|P7|Lead-in Period|Lost to Follow-up|0
5793470|NCT03214367|19969342|P6|Lead-in Period|Lost to Follow-up|0
5793471|NCT03214367|19969343|P5|Lead-in Period|Lost to Follow-up|0
5793472|NCT03214367|19969344|P4|Lead-in Period|Lost to Follow-up|0
5793473|NCT03214367|19969345|P3|Lead-in Period|Lost to Follow-up|0
5793474|NCT03214367|19969346|P2|Lead-in Period|Lost to Follow-up|0
5793475|NCT03214367|19969347|P1|Lead-in Period|Lost to Follow-up|12
5793476|NCT03214367|19969340|P8|Lead-in Period|Adverse Event|0
5793477|NCT03214367|19969341|P7|Lead-in Period|Adverse Event|0
5793478|NCT03214367|19969342|P6|Lead-in Period|Adverse Event|0
5793479|NCT03214367|19969343|P5|Lead-in Period|Adverse Event|0
5793480|NCT03214367|19969344|P4|Lead-in Period|Adverse Event|0
5793481|NCT03214367|19969345|P3|Lead-in Period|Adverse Event|0
5793482|NCT03214367|19969346|P2|Lead-in Period|Adverse Event|0
5793483|NCT03214367|19969347|P1|Lead-in Period|Adverse Event|3
5793484|NCT03214367|19969340|P8|Lead-in Period|Withdrawal by Subject|0
5793485|NCT03214367|19969341|P7|Lead-in Period|Withdrawal by Subject|0
5793486|NCT03214367|19969342|P6|Lead-in Period|Withdrawal by Subject|0
5793487|NCT03214367|19969343|P5|Lead-in Period|Withdrawal by Subject|2
5793488|NCT03214367|19969344|P4|Lead-in Period|Withdrawal by Subject|0
5793489|NCT03214367|19969345|P3|Lead-in Period|Withdrawal by Subject|0
5793490|NCT03214367|19969346|P2|Lead-in Period|Withdrawal by Subject|0
5793491|NCT03214367|19969347|P1|Lead-in Period|Withdrawal by Subject|50
5793492|NCT03214224|19969392|P1|Overall Study|Practice controls or therapists|6
5793493|NCT03214224|19969392|P1|Overall Study|Withdrawal by Subject|2
5793494|NCT03214224|19969392|P1|Overall Study|Protocol Violation|1
5793495|NCT03214094|19969401|P1|Overall Study|Protocol Deviation|46
5793496|NCT03214094|19969401|P1|Overall Study|Case Report Forms Uncollected|14
5793497|NCT03214081|19969409|P1|Overall Study|Protocol Deviation|54
5793498|NCT03214081|19969409|P1|Overall Study|Case Report Forms Uncollected|9
5793499|NCT03213626|19969424|P1|Overall Study|Progressive Disease|6
5793500|NCT03213626|19969424|P1|Overall Study|Adverse Event|1
5793501|NCT03213509|19969434|P2|Overall Study|Did not consent for verbal autopsy|5
5793502|NCT03213509|19969435|P1|Overall Study|Did not consent for verbal autopsy|4
5793503|NCT03213366|19969465|P2|Overall Study|Lost to Follow-up|4
5793504|NCT03213366|19969466|P1|Overall Study|Lost to Follow-up|9
5793505|NCT03212690|19969492|P1|Overall Study|Protocol Violation|1
5793506|NCT03212521|19969540|P1|Overall Study|Other|1
5793507|NCT03212521|19969540|P1|Overall Study|Withdrawal by Subject|1
5793508|NCT03212521|19969540|P1|Overall Study|Lost to Follow-up|4
5793509|NCT03212521|19969540|P1|Overall Study|Adverse Event|1
5793510|NCT03212365|19969549|P2|Overall Study|developed acute renal failure|1
5793511|NCT03212365|19969550|P1|Overall Study|developed acute renal failure|0
5793512|NCT03212365|19969549|P2|Overall Study|Withdrawal by Subject|1
5793513|NCT03212365|19969550|P1|Overall Study|Withdrawal by Subject|0
5793514|NCT03212365|19969549|P2|Overall Study|Required epidural placement|0
5793515|NCT03212365|19969550|P1|Overall Study|Required epidural placement|1
5793516|NCT03212365|19969549|P2|Overall Study|Medication distribution error|0
5793517|NCT03212365|19969550|P1|Overall Study|Medication distribution error|1
5793518|NCT03212365|19969549|P2|Overall Study|Unexpected return to OR|1
5793519|NCT03212365|19969550|P1|Overall Study|Unexpected return to OR|1
5793520|NCT03212365|19969549|P2|Overall Study|Initiated heparin infusion on floor|1
5793521|NCT03212365|19969550|P1|Overall Study|Initiated heparin infusion on floor|1
5793522|NCT03212365|19969549|P2|Overall Study|Refused study medication|0
5793523|NCT03212365|19969550|P1|Overall Study|Refused study medication|3
5793524|NCT03212365|19969549|P2|Overall Study|Bled requiring enoxaparin cessation|2
5793525|NCT03212365|19969550|P1|Overall Study|Bled requiring enoxaparin cessation|4
5793526|NCT03212365|19969549|P2|Overall Study|Discharged prior to Xa level|8
5793527|NCT03212365|19969550|P1|Overall Study|Discharged prior to Xa level|12
5793528|NCT03212326|19969562|P1|Overall Study|Physician Decision|4
5793529|NCT03212261|19969567|P1|Overall Study|Too busy/ No time|5
5793530|NCT03212261|19969567|P1|Overall Study|Family Emergency|1
5793531|NCT03212261|19969567|P1|Overall Study|Lost to Follow-up|7
5793532|NCT03212261|19969567|P1|Overall Study|Tech Trouble- No first study visit|1
5793533|NCT03212261|19969567|P1|Overall Study|Became ineligible d/t tech|2
5793534|NCT03212144|19969575|P2|Second Sequence (4 Weeks)|Lost to Follow-up|1
5793535|NCT03212144|19969576|P1|Second Sequence (4 Weeks)|Lost to Follow-up|1
5793536|NCT03212144|19969575|P2|First Sequence (4 Weeks)|Lost to Follow-up|0
5793537|NCT03212144|19969576|P1|First Sequence (4 Weeks)|Lost to Follow-up|1
5793538|NCT03211858|19969584|P2|Overall Study|Other than specified above|21
5793539|NCT03211858|19969585|P1|Overall Study|Other than specified above|22
5793540|NCT03211858|19969584|P2|Overall Study|Non-serious Hypoglycemia|0
5793541|NCT03211858|19969585|P1|Overall Study|Non-serious Hypoglycemia|1
5793542|NCT03211858|19969584|P2|Overall Study|Poor compliance to protocol|2
5793543|NCT03211858|19969585|P1|Overall Study|Poor compliance to protocol|6
5793544|NCT03211858|19969584|P2|Overall Study|Lack of Efficacy|4
5793545|NCT03211858|19969585|P1|Overall Study|Lack of Efficacy|0
5793546|NCT03211858|19969584|P2|Overall Study|Adverse Event|6
5793547|NCT03211858|19969585|P1|Overall Study|Adverse Event|8
5793548|NCT03211156|19969637|P2|Overall Study|Adverse Event|0
5793549|NCT03211156|19969638|P1|Overall Study|Adverse Event|1
5793550|NCT03211156|19969637|P2|Overall Study|Lost to Follow-up|1
5793551|NCT03211156|19969638|P1|Overall Study|Lost to Follow-up|1
5793552|NCT03211156|19969637|P2|Overall Study|Withdrawal by Subject|2
5793553|NCT03211156|19969638|P1|Overall Study|Withdrawal by Subject|0
5793554|NCT03210961|19969669|P15|Overall Study|Other|0
5793555|NCT03210961|19969670|P14|Overall Study|Other|2
5793556|NCT03210961|19969671|P13|Overall Study|Other|2
5793557|NCT03210961|19969672|P12|Overall Study|Other|0
5793558|NCT03210961|19969673|P11|Overall Study|Other|1
5793559|NCT03210961|19969674|P10|Overall Study|Other|0
5793560|NCT03210961|19969675|P9|Overall Study|Other|0
5793561|NCT03210961|19969676|P8|Overall Study|Other|0
5793562|NCT03210961|19969677|P7|Overall Study|Other|1
5793563|NCT03210961|19969678|P6|Overall Study|Other|0
5793564|NCT03210961|19969679|P5|Overall Study|Other|0
5793565|NCT03210961|19969680|P4|Overall Study|Other|1
5793566|NCT03210961|19969681|P3|Overall Study|Other|0
5793567|NCT03210961|19969682|P2|Overall Study|Other|0
5793568|NCT03210961|19969683|P1|Overall Study|Other|0
5793569|NCT03210961|19969669|P15|Overall Study|No Longer Meets Eligibility Criteria|0
5793570|NCT03210961|19969670|P14|Overall Study|No Longer Meets Eligibility Criteria|1
5793571|NCT03210961|19969671|P13|Overall Study|No Longer Meets Eligibility Criteria|0
5793572|NCT03210961|19969672|P12|Overall Study|No Longer Meets Eligibility Criteria|0
5793573|NCT03210961|19969673|P11|Overall Study|No Longer Meets Eligibility Criteria|0
5793574|NCT03210961|19969674|P10|Overall Study|No Longer Meets Eligibility Criteria|0
5793575|NCT03210961|19969675|P9|Overall Study|No Longer Meets Eligibility Criteria|0
5793576|NCT03210961|19969676|P8|Overall Study|No Longer Meets Eligibility Criteria|0
5793577|NCT03210961|19969677|P7|Overall Study|No Longer Meets Eligibility Criteria|0
5793578|NCT03210961|19969678|P6|Overall Study|No Longer Meets Eligibility Criteria|0
5793579|NCT03210961|19969679|P5|Overall Study|No Longer Meets Eligibility Criteria|0
5793580|NCT03210961|19969680|P4|Overall Study|No Longer Meets Eligibility Criteria|0
5793581|NCT03210961|19969681|P3|Overall Study|No Longer Meets Eligibility Criteria|0
5793582|NCT03210961|19969682|P2|Overall Study|No Longer Meets Eligibility Criteria|0
5793583|NCT03210961|19969683|P1|Overall Study|No Longer Meets Eligibility Criteria|0
5793584|NCT03210961|19969669|P15|Overall Study|Withdrawal by Subject|1
5793585|NCT03210961|19969670|P14|Overall Study|Withdrawal by Subject|0
5793586|NCT03210961|19969671|P13|Overall Study|Withdrawal by Subject|0
5793587|NCT03210961|19969672|P12|Overall Study|Withdrawal by Subject|0
5793588|NCT03210961|19969673|P11|Overall Study|Withdrawal by Subject|0
5793589|NCT03210961|19969674|P10|Overall Study|Withdrawal by Subject|0
5793590|NCT03210961|19969675|P9|Overall Study|Withdrawal by Subject|0
5793591|NCT03210961|19969676|P8|Overall Study|Withdrawal by Subject|0
5793592|NCT03210961|19969677|P7|Overall Study|Withdrawal by Subject|0
5793593|NCT03210961|19969678|P6|Overall Study|Withdrawal by Subject|0
5793594|NCT03210961|19969679|P5|Overall Study|Withdrawal by Subject|0
5793595|NCT03210961|19969680|P4|Overall Study|Withdrawal by Subject|0
5793596|NCT03210961|19969681|P3|Overall Study|Withdrawal by Subject|0
5793597|NCT03210961|19969682|P2|Overall Study|Withdrawal by Subject|0
5793598|NCT03210961|19969683|P1|Overall Study|Withdrawal by Subject|0
5793599|NCT03210961|19969669|P15|Overall Study|Lost to Follow-up|1
5793600|NCT03210961|19969670|P14|Overall Study|Lost to Follow-up|0
5793601|NCT03210961|19969671|P13|Overall Study|Lost to Follow-up|0
5793602|NCT03210961|19969672|P12|Overall Study|Lost to Follow-up|0
5793603|NCT03210961|19969673|P11|Overall Study|Lost to Follow-up|0
5793604|NCT03210961|19969674|P10|Overall Study|Lost to Follow-up|0
5793605|NCT03210961|19969675|P9|Overall Study|Lost to Follow-up|0
5793606|NCT03210961|19969676|P8|Overall Study|Lost to Follow-up|0
5793607|NCT03210961|19969677|P7|Overall Study|Lost to Follow-up|0
5793608|NCT03210961|19969678|P6|Overall Study|Lost to Follow-up|0
5793609|NCT03210961|19969679|P5|Overall Study|Lost to Follow-up|0
5793610|NCT03210961|19969680|P4|Overall Study|Lost to Follow-up|0
5793611|NCT03210961|19969681|P3|Overall Study|Lost to Follow-up|0
5793612|NCT03210961|19969682|P2|Overall Study|Lost to Follow-up|0
5793613|NCT03210961|19969683|P1|Overall Study|Lost to Follow-up|0
5793614|NCT03210961|19969669|P15|Overall Study|Adverse Event|0
5793615|NCT03210961|19969670|P14|Overall Study|Adverse Event|1
5793616|NCT03210961|19969671|P13|Overall Study|Adverse Event|0
5793617|NCT03210961|19969672|P12|Overall Study|Adverse Event|0
5793618|NCT03210961|19969673|P11|Overall Study|Adverse Event|0
5793619|NCT03210961|19969674|P10|Overall Study|Adverse Event|0
5793620|NCT03210961|19969675|P9|Overall Study|Adverse Event|0
5793621|NCT03210961|19969676|P8|Overall Study|Adverse Event|0
5793622|NCT03210961|19969677|P7|Overall Study|Adverse Event|0
5793623|NCT03210961|19969678|P6|Overall Study|Adverse Event|0
5793624|NCT03210961|19969679|P5|Overall Study|Adverse Event|0
5793625|NCT03210961|19969680|P4|Overall Study|Adverse Event|0
5793626|NCT03210961|19969681|P3|Overall Study|Adverse Event|0
5793627|NCT03210961|19969682|P2|Overall Study|Adverse Event|0
5793628|NCT03210961|19969683|P1|Overall Study|Adverse Event|0
5793629|NCT03210519|19970042|P2|Overall Study|Adverse Event|0
5793630|NCT03210519|19970043|P1|Overall Study|Adverse Event|2
5793631|NCT03210220|19970099|P2|Overall Study|Physician Decision|0
5793632|NCT03210220|19970100|P1|Overall Study|Physician Decision|1
5793633|NCT03209973|19970123|P1|Overall Study|Death|1
5793634|NCT03209973|19970123|P1|Overall Study|Patient withdrew consent|3
5793635|NCT03209570|19970129|P2|Overall Study|Withdrawal by Subject|3
5793636|NCT03209570|19970130|P1|Overall Study|Withdrawal by Subject|0
5793637|NCT03209570|19970129|P2|Overall Study|Protocol Violation|0
5793638|NCT03209570|19970130|P1|Overall Study|Protocol Violation|1
5793639|NCT03209570|19970129|P2|Overall Study|Incomplete Data|10
5793640|NCT03209570|19970130|P1|Overall Study|Incomplete Data|8
5793641|NCT03209570|19970129|P2|Overall Study|Death|0
5793642|NCT03209570|19970130|P1|Overall Study|Death|1
5793643|NCT03209518|19970140|P1|Overall Study|Protocol Deviation|1
5793644|NCT03209518|19970140|P1|Overall Study|Case Report Forms Uncollected|1
5793645|NCT03209492|19970145|P1|Overall Study|Case Report Forms Uncollected|5
5793646|NCT03208933|19970150|P1|Overall Study|Protocol Violation|1
5793647|NCT03208933|19970150|P1|Overall Study|Physician Decision|3
5793648|NCT03208933|19970150|P1|Overall Study|Lost to Follow-up|2
5793649|NCT03208933|19970150|P1|Overall Study|Adverse Event|1
5793650|NCT03208933|19970150|P1|Overall Study|Withdrawal by Subject|3
5793651|NCT03208933|19970150|P1|Overall Study|Death|3
5793652|NCT03208088|19970197|P10|Period 4|Unsatisfactory Test Article|0
5793653|NCT03208088|19970198|P9|Period 4|Unsatisfactory Test Article|0
5793654|NCT03208088|19970199|P8|Period 4|Unsatisfactory Test Article|0
5793655|NCT03208088|19970200|P7|Period 4|Unsatisfactory Test Article|0
5793656|NCT03208088|19970201|P6|Period 4|Unsatisfactory Test Article|0
5793657|NCT03208088|19970202|P5|Period 4|Unsatisfactory Test Article|0
5793658|NCT03208088|19970203|P4|Period 4|Unsatisfactory Test Article|1
5793659|NCT03208088|19970204|P3|Period 4|Unsatisfactory Test Article|0
5793660|NCT03208088|19970205|P2|Period 4|Unsatisfactory Test Article|0
5793661|NCT03208088|19970206|P1|Period 4|Unsatisfactory Test Article|0
5793662|NCT03208088|19970197|P10|Period 3|Unsatisfactory Test Article|0
5793663|NCT03208088|19970198|P9|Period 3|Unsatisfactory Test Article|0
5793664|NCT03208088|19970199|P8|Period 3|Unsatisfactory Test Article|0
5793665|NCT03208088|19970200|P7|Period 3|Unsatisfactory Test Article|0
5793666|NCT03208088|19970201|P6|Period 3|Unsatisfactory Test Article|0
5793667|NCT03208088|19970202|P5|Period 3|Unsatisfactory Test Article|0
5793668|NCT03208088|19970203|P4|Period 3|Unsatisfactory Test Article|1
5793669|NCT03208088|19970204|P3|Period 3|Unsatisfactory Test Article|0
5793670|NCT03208088|19970205|P2|Period 3|Unsatisfactory Test Article|0
5793671|NCT03208088|19970206|P1|Period 3|Unsatisfactory Test Article|0
5793672|NCT03208088|19970197|P10|Period 2|Withdrawal by Subject|0
5793673|NCT03208088|19970198|P9|Period 2|Withdrawal by Subject|1
5793674|NCT03208088|19970199|P8|Period 2|Withdrawal by Subject|0
5793675|NCT03208088|19970200|P7|Period 2|Withdrawal by Subject|0
5793676|NCT03208088|19970201|P6|Period 2|Withdrawal by Subject|0
5793677|NCT03208088|19970202|P5|Period 2|Withdrawal by Subject|0
5793678|NCT03208088|19970203|P4|Period 2|Withdrawal by Subject|0
5793679|NCT03208088|19970204|P3|Period 2|Withdrawal by Subject|0
5793680|NCT03208088|19970205|P2|Period 2|Withdrawal by Subject|0
5793681|NCT03208088|19970206|P1|Period 2|Withdrawal by Subject|0
5793682|NCT03207763|19970236|P2|Overall Study|Lost to Follow-up|0
5793683|NCT03207763|19970237|P1|Overall Study|Lost to Follow-up|1
5793684|NCT03207750|19970263|P2|Overall Study|OTHER, NOT SPECIFIED|4
5793685|NCT03207750|19970264|P1|Overall Study|OTHER, NOT SPECIFIED|5
5793686|NCT03207750|19970263|P2|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|2
5793687|NCT03207750|19970264|P1|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|1
5793688|NCT03207750|19970263|P2|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|5
5793689|NCT03207750|19970264|P1|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|10
5793690|NCT03207750|19970263|P2|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|10
5793691|NCT03207750|19970264|P1|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|7
5793692|NCT03207750|19970263|P2|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|13
5793693|NCT03207750|19970264|P1|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|11
5793694|NCT03207750|19970263|P2|Overall Study|Protocol Violation|1
5793695|NCT03207750|19970264|P1|Overall Study|Protocol Violation|0
5793696|NCT03207750|19970263|P2|Overall Study|Lost to Follow-up|29
5793697|NCT03207750|19970264|P1|Overall Study|Lost to Follow-up|21
5793698|NCT03207750|19970263|P2|Overall Study|Adverse Event|2
5793699|NCT03207750|19970264|P1|Overall Study|Adverse Event|3
5793700|NCT03207243|19970344|P2|Overall Study|Protocol Violation|3
5793701|NCT03207243|19970345|P1|Overall Study|Protocol Violation|0
5793702|NCT03207243|19970344|P2|Overall Study|Protocol Specified Withdrawal Criteria|2
5793703|NCT03207243|19970345|P1|Overall Study|Protocol Specified Withdrawal Criteria|7
5793704|NCT03207243|19970344|P2|Overall Study|Lost to Follow-up|1
5793705|NCT03207243|19970345|P1|Overall Study|Lost to Follow-up|0
5793706|NCT03207243|19970344|P2|Overall Study|Physician Decision|1
5793707|NCT03207243|19970345|P1|Overall Study|Physician Decision|1
5793708|NCT03207243|19970344|P2|Overall Study|Withdrawal by Subject|4
5793709|NCT03207243|19970345|P1|Overall Study|Withdrawal by Subject|2
5793710|NCT03207243|19970344|P2|Overall Study|Loss of Asthma Control|31
5793711|NCT03207243|19970345|P1|Overall Study|Loss of Asthma Control|47
5793712|NCT03207243|19970344|P2|Overall Study|Adverse Event|2
5793713|NCT03207243|19970345|P1|Overall Study|Adverse Event|2
5793714|NCT03206970|19970456|P1|Overall Study|Lost to Follow-up|3
5793715|NCT03206970|19970456|P1|Overall Study|Withdrawal by Subject|9
5793716|NCT03206970|19970456|P1|Overall Study|Death|14
5793717|NCT03206918|19970460|P1|Overall Study|Withdrawal by Subject|2
5793718|NCT03206918|19970460|P1|Overall Study|Death|4
5793719|NCT03206788|19970466|P2|Overall Study|Physician Decision|1
5793720|NCT03206788|19970467|P1|Overall Study|Physician Decision|0
5793721|NCT03206788|19970466|P2|Overall Study|Adverse Event|1
5793722|NCT03206788|19970467|P1|Overall Study|Adverse Event|0
5793723|NCT03206788|19970466|P2|Overall Study|Withdrawal by Subject|1
5793724|NCT03206788|19970467|P1|Overall Study|Withdrawal by Subject|0
5793725|NCT03206216|19970505|P2|Overall Study|Withdrawal by Subject|1
5793726|NCT03206216|19970506|P1|Overall Study|Withdrawal by Subject|0
5793727|NCT03205488|19970517|P3|Overall Study|Protocol Violation|1
5793728|NCT03205488|19970518|P2|Overall Study|Protocol Violation|0
5793729|NCT03205488|19970519|P1|Overall Study|Protocol Violation|0
5793730|NCT03205488|19970517|P3|Overall Study|Adverse Event|4
5793731|NCT03205488|19970518|P2|Overall Study|Adverse Event|2
5793732|NCT03205488|19970519|P1|Overall Study|Adverse Event|1
5793733|NCT03205371|19970545|P12|Overall Study|Adverse Event|0
5793734|NCT03205371|19970546|P11|Overall Study|Adverse Event|0
5793735|NCT03205371|19970547|P10|Overall Study|Adverse Event|0
5793736|NCT03205371|19970548|P9|Overall Study|Adverse Event|0
5793737|NCT03205371|19970549|P8|Overall Study|Adverse Event|1
5793738|NCT03205371|19970550|P7|Overall Study|Adverse Event|0
5793739|NCT03205371|19970551|P6|Overall Study|Adverse Event|0
5793740|NCT03205371|19970552|P5|Overall Study|Adverse Event|0
5793741|NCT03205371|19970553|P4|Overall Study|Adverse Event|0
5793742|NCT03205371|19970554|P3|Overall Study|Adverse Event|0
5793743|NCT03205371|19970555|P2|Overall Study|Adverse Event|0
5793744|NCT03205371|19970556|P1|Overall Study|Adverse Event|0
5793745|NCT03205371|19970545|P12|Overall Study|Protocol Violation|0
5793746|NCT03205371|19970546|P11|Overall Study|Protocol Violation|0
5793747|NCT03205371|19970547|P10|Overall Study|Protocol Violation|0
5793748|NCT03205371|19970548|P9|Overall Study|Protocol Violation|0
5793749|NCT03205371|19970549|P8|Overall Study|Protocol Violation|0
5793750|NCT03205371|19970550|P7|Overall Study|Protocol Violation|1
5793751|NCT03205371|19970551|P6|Overall Study|Protocol Violation|0
5793752|NCT03205371|19970552|P5|Overall Study|Protocol Violation|0
5793753|NCT03205371|19970553|P4|Overall Study|Protocol Violation|0
5793754|NCT03205371|19970554|P3|Overall Study|Protocol Violation|0
5793755|NCT03205371|19970555|P2|Overall Study|Protocol Violation|0
5793756|NCT03205371|19970556|P1|Overall Study|Protocol Violation|0
5793757|NCT03205371|19970545|P12|Overall Study|Lost to Follow-up|0
5793758|NCT03205371|19970546|P11|Overall Study|Lost to Follow-up|0
5793759|NCT03205371|19970547|P10|Overall Study|Lost to Follow-up|0
5793760|NCT03205371|19970548|P9|Overall Study|Lost to Follow-up|3
5793761|NCT03205371|19970549|P8|Overall Study|Lost to Follow-up|2
5793762|NCT03205371|19970550|P7|Overall Study|Lost to Follow-up|5
5793763|NCT03205371|19970551|P6|Overall Study|Lost to Follow-up|0
5793764|NCT03205371|19970552|P5|Overall Study|Lost to Follow-up|0
5793765|NCT03205371|19970553|P4|Overall Study|Lost to Follow-up|0
5793766|NCT03205371|19970554|P3|Overall Study|Lost to Follow-up|0
5793767|NCT03205371|19970555|P2|Overall Study|Lost to Follow-up|0
5793768|NCT03205371|19970556|P1|Overall Study|Lost to Follow-up|0
5793769|NCT03205371|19970545|P12|Overall Study|Withdrawal by Subject|1
5793770|NCT03205371|19970546|P11|Overall Study|Withdrawal by Subject|0
5793771|NCT03205371|19970547|P10|Overall Study|Withdrawal by Subject|0
5793772|NCT03205371|19970548|P9|Overall Study|Withdrawal by Subject|2
5793773|NCT03205371|19970549|P8|Overall Study|Withdrawal by Subject|0
5793774|NCT03205371|19970550|P7|Overall Study|Withdrawal by Subject|4
5793775|NCT03205371|19970551|P6|Overall Study|Withdrawal by Subject|0
5793776|NCT03205371|19970552|P5|Overall Study|Withdrawal by Subject|0
5793777|NCT03205371|19970553|P4|Overall Study|Withdrawal by Subject|0
5793778|NCT03205371|19970554|P3|Overall Study|Withdrawal by Subject|0
5793779|NCT03205371|19970555|P2|Overall Study|Withdrawal by Subject|1
5793780|NCT03205371|19970556|P1|Overall Study|Withdrawal by Subject|4
5793781|NCT03205163|19970645|P2|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|0
5793782|NCT03205163|19970646|P1|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|1
5793783|NCT03205150|19970697|P3|Overall Study|Lost to Follow-up|1
5793784|NCT03205150|19970698|P2|Overall Study|Lost to Follow-up|0
5793785|NCT03205150|19970699|P1|Overall Study|Lost to Follow-up|0
5793786|NCT03205150|19970697|P3|Overall Study|Adverse Event|1
5793787|NCT03205150|19970698|P2|Overall Study|Adverse Event|1
5793788|NCT03205150|19970699|P1|Overall Study|Adverse Event|1
5793789|NCT03205150|19970697|P3|Overall Study|Patient/guardian decision|0
5793790|NCT03205150|19970698|P2|Overall Study|Patient/guardian decision|3
5793791|NCT03205150|19970699|P1|Overall Study|Patient/guardian decision|0
5793792|NCT03205150|19970697|P3|Overall Study|Protocol deviation|0
5793793|NCT03205150|19970698|P2|Overall Study|Protocol deviation|3
5793794|NCT03205150|19970699|P1|Overall Study|Protocol deviation|1
5793795|NCT03205046|19970737|P2|Overall Study|Study terminated by sponsor|1
5793796|NCT03205046|19970738|P1|Overall Study|Study terminated by sponsor|2
5793797|NCT03205046|19970737|P2|Overall Study|Lost to Follow-up|1
5793798|NCT03205046|19970738|P1|Overall Study|Lost to Follow-up|0
5793799|NCT03205046|19970737|P2|Overall Study|Withdrawal by Subject|2
5793800|NCT03205046|19970738|P1|Overall Study|Withdrawal by Subject|1
5793801|NCT03205046|19970737|P2|Overall Study|Death|6
5793802|NCT03205046|19970738|P1|Overall Study|Death|10
5793803|NCT03204539|19970792|P2|Overall Study|Loss of funding|1
5793804|NCT03204539|19970793|P1|Overall Study|Loss of funding|0
5793805|NCT03204279|19970817|P2|Overall Study|Withdrawal by Subject|1
5793806|NCT03204279|19970818|P1|Overall Study|Withdrawal by Subject|0
5793807|NCT03203291|19970945|P1|Overall Study|Withdrawal by Subject|1
5793808|NCT03201900|19970993|P1|Extension Phase (Up to 124 Weeks)|Ongoing|41
5793809|NCT03201900|19970993|P1|Extension Phase (Up to 124 Weeks)|Withdrawal of consent|1
5793810|NCT03201900|19970993|P1|Extension Phase (Up to 124 Weeks)|Lost to Follow-up|1
5793811|NCT03201900|19970993|P1|Extension Phase (Up to 124 Weeks)|Inadequate therapeutic effect|1
5793812|NCT03201900|19970993|P1|Extension Phase (Up to 124 Weeks)|Pregnancy|1
5793813|NCT03201900|19970993|P1|Extension Phase (Up to 124 Weeks)|Subject choice|1
5793814|NCT03201900|19970993|P1|Treatment Phase (Up to 62 Weeks)|Not treated|2
5793815|NCT03201900|19970993|P1|Treatment Phase (Up to 62 Weeks)|Other than specified|11
5793816|NCT03201900|19970993|P1|Treatment Phase (Up to 62 Weeks)|Withdrawal of consent|6
5793817|NCT03201900|19970993|P1|Treatment Phase (Up to 62 Weeks)|Lost to Follow-up|2
5793818|NCT03201900|19970993|P1|Treatment Phase (Up to 62 Weeks)|Inadequate therapeutic effect|6
5793819|NCT03201900|19970993|P1|Treatment Phase (Up to 62 Weeks)|Subject Choice|1
5793820|NCT03201900|19970993|P1|Treatment Phase (Up to 62 Weeks)|Adverse Event|9
5793821|NCT03201419|19971008|P9|Overall Study|Other|0
5793822|NCT03201419|19971009|P8|Overall Study|Other|0
5793823|NCT03201419|19971010|P7|Overall Study|Other|0
5793824|NCT03201419|19971011|P6|Overall Study|Other|0
5793825|NCT03201419|19971012|P5|Overall Study|Other|0
5793826|NCT03201419|19971013|P4|Overall Study|Other|0
5793827|NCT03201419|19971014|P3|Overall Study|Other|1
5793828|NCT03201419|19971015|P2|Overall Study|Other|0
5793829|NCT03201419|19971016|P1|Overall Study|Other|0
5793830|NCT03201419|19971008|P9|Overall Study|Withdrawal by Subject|2
5793831|NCT03201419|19971009|P8|Overall Study|Withdrawal by Subject|1
5793832|NCT03201419|19971010|P7|Overall Study|Withdrawal by Subject|0
5793833|NCT03201419|19971011|P6|Overall Study|Withdrawal by Subject|0
5793834|NCT03201419|19971012|P5|Overall Study|Withdrawal by Subject|0
5793835|NCT03201419|19971013|P4|Overall Study|Withdrawal by Subject|0
5793836|NCT03201419|19971014|P3|Overall Study|Withdrawal by Subject|1
5793837|NCT03201419|19971015|P2|Overall Study|Withdrawal by Subject|2
5793838|NCT03201419|19971016|P1|Overall Study|Withdrawal by Subject|4
5793839|NCT03201419|19971008|P9|Overall Study|Protocol Deviation|0
5793840|NCT03201419|19971009|P8|Overall Study|Protocol Deviation|0
5793841|NCT03201419|19971010|P7|Overall Study|Protocol Deviation|1
5793842|NCT03201419|19971011|P6|Overall Study|Protocol Deviation|0
5793843|NCT03201419|19971012|P5|Overall Study|Protocol Deviation|0
5793844|NCT03201419|19971013|P4|Overall Study|Protocol Deviation|0
5793845|NCT03201419|19971014|P3|Overall Study|Protocol Deviation|0
5793846|NCT03201419|19971015|P2|Overall Study|Protocol Deviation|0
5793847|NCT03201419|19971016|P1|Overall Study|Protocol Deviation|0
5793848|NCT03201419|19971008|P9|Overall Study|Lost to Follow-up|0
5793849|NCT03201419|19971009|P8|Overall Study|Lost to Follow-up|0
5793850|NCT03201419|19971010|P7|Overall Study|Lost to Follow-up|0
5793851|NCT03201419|19971011|P6|Overall Study|Lost to Follow-up|0
5793852|NCT03201419|19971012|P5|Overall Study|Lost to Follow-up|0
5793853|NCT03201419|19971013|P4|Overall Study|Lost to Follow-up|0
5793854|NCT03201419|19971014|P3|Overall Study|Lost to Follow-up|0
5793855|NCT03201419|19971015|P2|Overall Study|Lost to Follow-up|0
5793856|NCT03201419|19971016|P1|Overall Study|Lost to Follow-up|1
5793857|NCT03201419|19971008|P9|Overall Study|Adverse Event|0
5793858|NCT03201419|19971009|P8|Overall Study|Adverse Event|0
5793859|NCT03201419|19971010|P7|Overall Study|Adverse Event|5
5793860|NCT03201419|19971011|P6|Overall Study|Adverse Event|1
5793861|NCT03201419|19971012|P5|Overall Study|Adverse Event|1
5793862|NCT03201419|19971013|P4|Overall Study|Adverse Event|0
5793863|NCT03201419|19971014|P3|Overall Study|Adverse Event|0
5793864|NCT03201419|19971015|P2|Overall Study|Adverse Event|1
5793865|NCT03201419|19971016|P1|Overall Study|Adverse Event|3
5793866|NCT03200912|19971366|P3|Overall Study|Non-compliance with study drug|0
5793867|NCT03200912|19971367|P2|Overall Study|Non-compliance with study drug|1
5793868|NCT03200912|19971368|P1|Overall Study|Non-compliance with study drug|0
5793869|NCT03200912|19971366|P3|Overall Study|Withdrawal by Subject|4
5793870|NCT03200912|19971367|P2|Overall Study|Withdrawal by Subject|2
5793871|NCT03200912|19971368|P1|Overall Study|Withdrawal by Subject|1
5793872|NCT03200912|19971366|P3|Overall Study|Adverse Event|0
5793873|NCT03200912|19971367|P2|Overall Study|Adverse Event|0
5793874|NCT03200912|19971368|P1|Overall Study|Adverse Event|3
5793875|NCT03200860|19971378|P2|Overall Study|Withdrawal by Subject|0
5793876|NCT03200860|19971379|P1|Overall Study|Withdrawal by Subject|1
5793877|NCT03199911|19971422|P2|Overall Study|Did not proceed with surgery|1
5793878|NCT03199911|19971423|P1|Overall Study|Did not proceed with surgery|2
5793879|NCT03199911|19971422|P2|Overall Study|Lost to Follow-up|5
5793880|NCT03199911|19971423|P1|Overall Study|Lost to Follow-up|5
5793881|NCT03198767|19971474|P7|Overall Study|Protocol Violation|0
5793882|NCT03198767|19971475|P6|Overall Study|Protocol Violation|0
5793883|NCT03198767|19971476|P5|Overall Study|Protocol Violation|0
5793884|NCT03198767|19971477|P4|Overall Study|Protocol Violation|6
5793885|NCT03198767|19971478|P3|Overall Study|Protocol Violation|0
5793886|NCT03198767|19971479|P2|Overall Study|Protocol Violation|0
5793887|NCT03198767|19971480|P1|Overall Study|Protocol Violation|0
5793888|NCT03198754|19971521|P2|Overall Study|Ineligible|1
5793889|NCT03198754|19971522|P1|Overall Study|Ineligible|2
5793890|NCT03198754|19971521|P2|Overall Study|Lost to Follow-up|3
5793891|NCT03198754|19971522|P1|Overall Study|Lost to Follow-up|4
5793892|NCT03198754|19971521|P2|Overall Study|Withdrawal by Subject|4
5793893|NCT03198754|19971522|P1|Overall Study|Withdrawal by Subject|5
5793894|NCT03198520|19971560|P1|Overall Study|Study Ended|1
5793895|NCT03198520|19971560|P1|Overall Study|Withdrawal by Subject|1
5793896|NCT03198520|19971560|P1|Overall Study|Protocol Violation|2
5793897|NCT03198520|19971560|P1|Overall Study|Physician Decision|2
5793898|NCT03198507|19971583|P2|Overall Study|Withdrawal by Subject|0
5793899|NCT03198507|19971584|P1|Overall Study|Withdrawal by Subject|1
5793900|NCT03197883|19971710|P2|Overall Study|Other (Not Specified)|5
5793901|NCT03197883|19971711|P1|Overall Study|Other (Not Specified)|0
5793902|NCT03197883|19971710|P2|Overall Study|Protocol Violation|0
5793903|NCT03197883|19971711|P1|Overall Study|Protocol Violation|1
5793904|NCT03197883|19971710|P2|Overall Study|Lost to Follow-up|0
5793905|NCT03197883|19971711|P1|Overall Study|Lost to Follow-up|1
5793906|NCT03197883|19971710|P2|Overall Study|Adverse Event|1
5793907|NCT03197883|19971711|P1|Overall Study|Adverse Event|1
5793908|NCT03197558|19971741|P1|Overall Study|Tubes not placed|1
5793909|NCT03197376|19971749|P4|Immune Persistence Phase|Not vaccine related|1
5793910|NCT03197376|19971750|P3|Immune Persistence Phase|Not vaccine related|1
5793911|NCT03197376|19971751|P2|Immune Persistence Phase|Not vaccine related|0
5793912|NCT03197376|19971752|P1|Immune Persistence Phase|Not vaccine related|1
5793913|NCT03197376|19971749|P4|Immune Persistence Phase|Withdrawal by subject's parents|3
5793914|NCT03197376|19971750|P3|Immune Persistence Phase|Withdrawal by subject's parents|2
5793915|NCT03197376|19971751|P2|Immune Persistence Phase|Withdrawal by subject's parents|4
5793916|NCT03197376|19971752|P1|Immune Persistence Phase|Withdrawal by subject's parents|4
5793917|NCT03197376|19971749|P4|Immune Persistence Phase|Lost to Follow-up|1
5793918|NCT03197376|19971750|P3|Immune Persistence Phase|Lost to Follow-up|2
5793919|NCT03197376|19971751|P2|Immune Persistence Phase|Lost to Follow-up|0
5793920|NCT03197376|19971752|P1|Immune Persistence Phase|Lost to Follow-up|0
5793921|NCT03197376|19971749|P4|Primary and Booster Phase|Not vaccine related|6
5793922|NCT03197376|19971750|P3|Primary and Booster Phase|Not vaccine related|0
5793923|NCT03197376|19971751|P2|Primary and Booster Phase|Not vaccine related|2
5793924|NCT03197376|19971752|P1|Primary and Booster Phase|Not vaccine related|1
5793925|NCT03197376|19971749|P4|Primary and Booster Phase|Ineligibility criteria|2
5793926|NCT03197376|19971750|P3|Primary and Booster Phase|Ineligibility criteria|4
5793927|NCT03197376|19971751|P2|Primary and Booster Phase|Ineligibility criteria|1
5793928|NCT03197376|19971752|P1|Primary and Booster Phase|Ineligibility criteria|1
5793929|NCT03197376|19971749|P4|Primary and Booster Phase|Withdrawal by subject's parents|11
5793930|NCT03197376|19971750|P3|Primary and Booster Phase|Withdrawal by subject's parents|14
5793931|NCT03197376|19971751|P2|Primary and Booster Phase|Withdrawal by subject's parents|10
5793932|NCT03197376|19971752|P1|Primary and Booster Phase|Withdrawal by subject's parents|11
5793933|NCT03197376|19971749|P4|Primary and Booster Phase|Physician Decision|3
5793934|NCT03197376|19971750|P3|Primary and Booster Phase|Physician Decision|1
5793935|NCT03197376|19971751|P2|Primary and Booster Phase|Physician Decision|0
5793936|NCT03197376|19971752|P1|Primary and Booster Phase|Physician Decision|1
5793937|NCT03197376|19971749|P4|Primary and Booster Phase|Lost to Follow-up|0
5793938|NCT03197376|19971750|P3|Primary and Booster Phase|Lost to Follow-up|1
5793939|NCT03197376|19971751|P2|Primary and Booster Phase|Lost to Follow-up|0
5793940|NCT03197376|19971752|P1|Primary and Booster Phase|Lost to Follow-up|0
5793941|NCT03197376|19971749|P4|Primary and Booster Phase|Death|2
5793942|NCT03197376|19971750|P3|Primary and Booster Phase|Death|0
5793943|NCT03197376|19971751|P2|Primary and Booster Phase|Death|0
5793944|NCT03197376|19971752|P1|Primary and Booster Phase|Death|1
5793945|NCT03197376|19971749|P4|Primary and Booster Phase|Adverse Event|1
5793946|NCT03197376|19971750|P3|Primary and Booster Phase|Adverse Event|0
5793947|NCT03197376|19971751|P2|Primary and Booster Phase|Adverse Event|0
5793948|NCT03197376|19971752|P1|Primary and Booster Phase|Adverse Event|0
5793949|NCT03196635|19971826|P1|Overall Study|Withdrawal by Subject|1
5793950|NCT03196505|19971846|P2|Overall Study|Physician Decision|26
5793951|NCT03196505|19971847|P1|Overall Study|Physician Decision|26
5793952|NCT03196349|19971858|P3|Overall Study|Study Terminated early|11
5793953|NCT03196349|19971859|P2|Overall Study|Study Terminated early|9
5793954|NCT03196349|19971860|P1|Overall Study|Study Terminated early|15
5793955|NCT03196349|19971858|P3|Overall Study|No data entered|0
5793956|NCT03196349|19971859|P2|Overall Study|No data entered|4
5793957|NCT03196349|19971860|P1|Overall Study|No data entered|2
5793958|NCT03196349|19971858|P3|Overall Study|Did not receive study drug|2
5793959|NCT03196349|19971859|P2|Overall Study|Did not receive study drug|1
5793960|NCT03196349|19971860|P1|Overall Study|Did not receive study drug|0
5793961|NCT03196193|19971897|P2|Overall Study|Computed Tomography (CT) data missing|0
5793962|NCT03196193|19971898|P1|Overall Study|Computed Tomography (CT) data missing|2
5793963|NCT03196193|19971897|P2|Overall Study|Adverse Event|0
5793964|NCT03196193|19971898|P1|Overall Study|Adverse Event|1
5793965|NCT03194490|19971996|P2|Overall Study|participant developed specific neck pain|0
5793966|NCT03194490|19971997|P1|Overall Study|participant developed specific neck pain|1
5793967|NCT03194490|19971996|P2|Overall Study|Lost to Follow-up|3
5793968|NCT03194490|19971997|P1|Overall Study|Lost to Follow-up|1
5793969|NCT03194464|19972039|P1|Overall Study|data not usable|2
5793970|NCT03194217|19972130|P4|Overall Study|Other|0
5793971|NCT03194217|19972131|P3|Overall Study|Other|1
5793972|NCT03194217|19972132|P2|Overall Study|Other|1
5793973|NCT03194217|19972133|P1|Overall Study|Other|0
5793974|NCT03194217|19972130|P4|Overall Study|Failure to meet randomisation criteria|1
5793975|NCT03194217|19972131|P3|Overall Study|Failure to meet randomisation criteria|0
5793976|NCT03194217|19972132|P2|Overall Study|Failure to meet randomisation criteria|0
5793977|NCT03194217|19972133|P1|Overall Study|Failure to meet randomisation criteria|0
5793978|NCT03194217|19972130|P4|Overall Study|Adverse Event|3
5793979|NCT03194217|19972131|P3|Overall Study|Adverse Event|3
5793980|NCT03194217|19972132|P2|Overall Study|Adverse Event|2
5793981|NCT03194217|19972133|P1|Overall Study|Adverse Event|0
5793982|NCT03193047|19972174|P2|Overall Study|Participant Left State|0
5793983|NCT03193047|19972175|P1|Overall Study|Participant Left State|1
5793984|NCT03193047|19972174|P2|Overall Study|Physician Decision|0
5793985|NCT03193047|19972175|P1|Overall Study|Physician Decision|1
5793986|NCT03193021|19972195|P2|Overall Study|Lost to Follow-up|1
5793987|NCT03193021|19972196|P1|Overall Study|Lost to Follow-up|1
5793988|NCT03192904|19972221|P2|Overall Study|Lost to Follow-up|1
5793989|NCT03192904|19972222|P1|Overall Study|Lost to Follow-up|0
5793990|NCT03192904|19972221|P2|Overall Study|Physician Decision|1
5793991|NCT03192904|19972222|P1|Overall Study|Physician Decision|3
5793992|NCT03192488|19972278|P6|Third Intervention (d1)|Adverse Event|0
5793993|NCT03192488|19972279|P5|Third Intervention (d1)|Adverse Event|1
5793994|NCT03192488|19972280|P4|Third Intervention (d1)|Adverse Event|0
5793995|NCT03192488|19972281|P3|Third Intervention (d1)|Adverse Event|0
5793996|NCT03192488|19972282|P2|Third Intervention (d1)|Adverse Event|0
5793997|NCT03192488|19972283|P1|Third Intervention (d1)|Adverse Event|0
5793998|NCT03192488|19972278|P6|First Washout (>6d)|Withdrawal by Subject|1
5793999|NCT03192488|19972279|P5|First Washout (>6d)|Withdrawal by Subject|0
5794000|NCT03192488|19972280|P4|First Washout (>6d)|Withdrawal by Subject|0
5794001|NCT03192488|19972281|P3|First Washout (>6d)|Withdrawal by Subject|1
5794002|NCT03192488|19972282|P2|First Washout (>6d)|Withdrawal by Subject|0
5794003|NCT03192488|19972283|P1|First Washout (>6d)|Withdrawal by Subject|0
5794004|NCT03192475|19972299|P2|Overall Study|Lost to Follow-up|8
5794005|NCT03192475|19972300|P1|Overall Study|Lost to Follow-up|13
5794006|NCT03192475|19972299|P2|Overall Study|Death|1
5794007|NCT03192475|19972300|P1|Overall Study|Death|0
5794008|NCT03192306|19972336|P2|Overall Study|Protocol Violation|1
5794009|NCT03192306|19972337|P1|Overall Study|Protocol Violation|1
5794010|NCT03192306|19972336|P2|Overall Study|Lost to Follow-up|0
5794011|NCT03192306|19972337|P1|Overall Study|Lost to Follow-up|1
5794012|NCT03192306|19972336|P2|Overall Study|Withdrawal by Subject|1
5794013|NCT03192306|19972337|P1|Overall Study|Withdrawal by Subject|1
5794014|NCT03192306|19972336|P2|Overall Study|Did not treat cold sore during study|143
5794015|NCT03192306|19972337|P1|Overall Study|Did not treat cold sore during study|149
5794016|NCT03192150|19972357|P2|Overall Study|Other-Various Administrative Reasons|5
5794017|NCT03192150|19972358|P1|Overall Study|Other-Various Administrative Reasons|2
5794018|NCT03192150|19972357|P2|Overall Study|Surgery Canceled|2
5794019|NCT03192150|19972358|P1|Overall Study|Surgery Canceled|6
5794020|NCT03192150|19972357|P2|Overall Study|Protocol Violation|2
5794021|NCT03192150|19972358|P1|Overall Study|Protocol Violation|5
5794022|NCT03192150|19972357|P2|Overall Study|Withdrawal by Subject|2
5794023|NCT03192150|19972358|P1|Overall Study|Withdrawal by Subject|4
5794024|NCT03192150|19972357|P2|Overall Study|Lost to Follow-up|1
5794025|NCT03192150|19972358|P1|Overall Study|Lost to Follow-up|1
5794026|NCT03192150|19972357|P2|Overall Study|Lack of Efficacy|30
5794027|NCT03192150|19972358|P1|Overall Study|Lack of Efficacy|23
5794028|NCT03192150|19972357|P2|Overall Study|Adverse Event|12
5794029|NCT03192150|19972358|P1|Overall Study|Adverse Event|14
5794030|NCT03192137|19972368|P2|Overall Study|Other - Various Administrative Reasons|3
5794031|NCT03192137|19972369|P1|Overall Study|Other - Various Administrative Reasons|8
5794032|NCT03192137|19972368|P2|Overall Study|Surgery Cancelled|1
5794033|NCT03192137|19972369|P1|Overall Study|Surgery Cancelled|4
5794034|NCT03192137|19972368|P2|Overall Study|Protocol Violation|3
5794035|NCT03192137|19972369|P1|Overall Study|Protocol Violation|4
5794036|NCT03192137|19972368|P2|Overall Study|Withdrawal by Subject|3
5794037|NCT03192137|19972369|P1|Overall Study|Withdrawal by Subject|3
5794038|NCT03192137|19972368|P2|Overall Study|Lack of Efficacy|37
5794039|NCT03192137|19972369|P1|Overall Study|Lack of Efficacy|20
5794040|NCT03192137|19972368|P2|Overall Study|Physician Decision|0
5794041|NCT03192137|19972369|P1|Overall Study|Physician Decision|1
5794042|NCT03192137|19972368|P2|Overall Study|Adverse Event|11
5794043|NCT03192137|19972369|P1|Overall Study|Adverse Event|10
5794044|NCT03191552|19972380|P3|Overall Study|Undergone surgery (Progressive hip dyspl|0
5794045|NCT03191552|19972381|P2|Overall Study|Undergone surgery (Progressive hip dyspl|1
5794046|NCT03191552|19972382|P1|Overall Study|Undergone surgery (Progressive hip dyspl|0
5794047|NCT03191552|19972380|P3|Overall Study|Lost to Follow-up|0
5794048|NCT03191552|19972381|P2|Overall Study|Lost to Follow-up|0
5794049|NCT03191552|19972382|P1|Overall Study|Lost to Follow-up|1
5794050|NCT03191396|19972435|P2|Overall Study|Withdrawal by Subject|2
5794051|NCT03191396|19972436|P1|Overall Study|Withdrawal by Subject|3
5794052|NCT03191396|19972435|P2|Overall Study|Lost to Follow-up|3
5794053|NCT03191396|19972436|P1|Overall Study|Lost to Follow-up|0
5794054|NCT03190369|19972542|P2|Overall Study|Randomized but not treated|2
5794055|NCT03190369|19972543|P1|Overall Study|Randomized but not treated|0
5794056|NCT03190369|19972542|P2|Overall Study|Withdraw before treatment|5
5794057|NCT03190369|19972543|P1|Overall Study|Withdraw before treatment|1
5794058|NCT03190369|19972542|P2|Overall Study|Poor compliance to protocol|1
5794059|NCT03190369|19972543|P1|Overall Study|Poor compliance to protocol|0
5794060|NCT03189745|19972604|P2|Overall Study|Conflict in work schedule of participant|1
5794061|NCT03189745|19972605|P1|Overall Study|Conflict in work schedule of participant|1
5794062|NCT03189446|19972658|P1|Overall Study|Physician Decision|1
5794063|NCT03189446|19972658|P1|Overall Study|Withdrawal by Subject|2
5794064|NCT03189446|19972658|P1|Overall Study|Adverse Event|2
5794065|NCT03188536|19972669|P1|Overall Study|Not participated/met inclusion criteria|1
5794066|NCT03188536|19972669|P1|Overall Study|No relapse/refractoriness(last 6 months)|5
5794067|NCT03188263|19972738|P2|Overall Study|Physician Decision|0
5794068|NCT03188263|19972739|P1|Overall Study|Physician Decision|1
5794069|NCT03188263|19972738|P2|Overall Study|Withdrawal by Subject|0
5794070|NCT03188263|19972739|P1|Overall Study|Withdrawal by Subject|3
5794071|NCT03188120|19972747|P1|Overall Study|No visit after the first visit|13
5794072|NCT03188120|19972747|P1|Overall Study|Other than specified|3
5794073|NCT03188120|19972747|P1|Overall Study|Lost to Follow-up|7
5794074|NCT03188120|19972747|P1|Overall Study|Improved|12
5794075|NCT03188120|19972747|P1|Overall Study|Insufficient Effectiveness|8
5794076|NCT03188120|19972747|P1|Overall Study|Adverse Event|4
5794077|NCT03188055|19972754|P6|Overall Study|Withdrawal by Subject|0
5794078|NCT03188055|19972755|P5|Overall Study|Withdrawal by Subject|0
5794079|NCT03188055|19972756|P4|Overall Study|Withdrawal by Subject|1
5794080|NCT03188055|19972757|P3|Overall Study|Withdrawal by Subject|0
5794081|NCT03188055|19972758|P2|Overall Study|Withdrawal by Subject|1
5794082|NCT03188055|19972759|P1|Overall Study|Withdrawal by Subject|0
5794083|NCT03188055|19972754|P6|Overall Study|Lost to Follow-up|0
5794084|NCT03188055|19972755|P5|Overall Study|Lost to Follow-up|0
5794085|NCT03188055|19972756|P4|Overall Study|Lost to Follow-up|11
5794086|NCT03188055|19972757|P3|Overall Study|Lost to Follow-up|0
5794087|NCT03188055|19972758|P2|Overall Study|Lost to Follow-up|18
5794088|NCT03188055|19972759|P1|Overall Study|Lost to Follow-up|0
5794089|NCT03188055|19972754|P6|Overall Study|Unavailable for training|0
5794090|NCT03188055|19972755|P5|Overall Study|Unavailable for training|0
5794091|NCT03188055|19972756|P4|Overall Study|Unavailable for training|0
5794092|NCT03188055|19972757|P3|Overall Study|Unavailable for training|19
5794093|NCT03188055|19972758|P2|Overall Study|Unavailable for training|0
5794094|NCT03188055|19972759|P1|Overall Study|Unavailable for training|0
5794095|NCT03187756|19972785|P1|Overall Study|Termination of study|4
5794096|NCT03187301|19972803|P7|Pre-Intervention|Withdrawal by Subject|0
5794097|NCT03187301|19972804|P6|Pre-Intervention|Withdrawal by Subject|0
5794098|NCT03187301|19972805|P5|Pre-Intervention|Withdrawal by Subject|0
5794099|NCT03187301|19972806|P4|Pre-Intervention|Withdrawal by Subject|0
5794100|NCT03187301|19972807|P3|Pre-Intervention|Withdrawal by Subject|0
5794101|NCT03187301|19972808|P2|Pre-Intervention|Withdrawal by Subject|0
5794102|NCT03187301|19972809|P1|Pre-Intervention|Withdrawal by Subject|1
5794103|NCT03187301|19972803|P7|Titration Period|Exclusion Criteria Met|1
5794104|NCT03187301|19972804|P6|Titration Period|Exclusion Criteria Met|0
5794105|NCT03187301|19972805|P5|Titration Period|Exclusion Criteria Met|0
5794106|NCT03187301|19972806|P4|Titration Period|Exclusion Criteria Met|0
5794107|NCT03187301|19972807|P3|Titration Period|Exclusion Criteria Met|0
5794108|NCT03187301|19972808|P2|Titration Period|Exclusion Criteria Met|0
5794109|NCT03187301|19972809|P1|Titration Period|Exclusion Criteria Met|0
5794110|NCT03187301|19972803|P7|Titration Period|Withdrawal by Subject|1
5794111|NCT03187301|19972804|P6|Titration Period|Withdrawal by Subject|0
5794112|NCT03187301|19972805|P5|Titration Period|Withdrawal by Subject|0
5794113|NCT03187301|19972806|P4|Titration Period|Withdrawal by Subject|0
5794114|NCT03187301|19972807|P3|Titration Period|Withdrawal by Subject|0
5794115|NCT03187301|19972808|P2|Titration Period|Withdrawal by Subject|0
5794116|NCT03187301|19972809|P1|Titration Period|Withdrawal by Subject|0
5794117|NCT03187301|19972803|P7|Titration Period|Adverse Event|5
5794118|NCT03187301|19972804|P6|Titration Period|Adverse Event|0
5794119|NCT03187301|19972805|P5|Titration Period|Adverse Event|0
5794120|NCT03187301|19972806|P4|Titration Period|Adverse Event|0
5794121|NCT03187301|19972807|P3|Titration Period|Adverse Event|0
5794122|NCT03187301|19972808|P2|Titration Period|Adverse Event|0
5794123|NCT03187301|19972809|P1|Titration Period|Adverse Event|0
5794124|NCT03187197|19972861|P3|Overall Study|NA in incl/excl criteria, not analyzed.|1
5794125|NCT03187197|19972862|P2|Overall Study|NA in incl/excl criteria, not analyzed.|45
5794126|NCT03187197|19972863|P1|Overall Study|NA in incl/excl criteria, not analyzed.|14
5794127|NCT03187197|19972861|P3|Overall Study|Status missing|3
5794128|NCT03187197|19972862|P2|Overall Study|Status missing|33
5794129|NCT03187197|19972863|P1|Overall Study|Status missing|2
5794130|NCT03187197|19972861|P3|Overall Study|Missing|3
5794131|NCT03187197|19972862|P2|Overall Study|Missing|32
5794132|NCT03187197|19972863|P1|Overall Study|Missing|1
5794133|NCT03187197|19972861|P3|Overall Study|Reason not listed|1
5794134|NCT03187197|19972862|P2|Overall Study|Reason not listed|54
5794135|NCT03187197|19972863|P1|Overall Study|Reason not listed|2
5794136|NCT03187197|19972861|P3|Overall Study|Administrative problem|0
5794137|NCT03187197|19972862|P2|Overall Study|Administrative problem|1
5794138|NCT03187197|19972863|P1|Overall Study|Administrative problem|1
5794139|NCT03187197|19972861|P3|Overall Study|Death|0
5794140|NCT03187197|19972862|P2|Overall Study|Death|11
5794141|NCT03187197|19972863|P1|Overall Study|Death|0
5794142|NCT03187197|19972861|P3|Overall Study|Adverse Event|0
5794143|NCT03187197|19972862|P2|Overall Study|Adverse Event|29
5794144|NCT03187197|19972863|P1|Overall Study|Adverse Event|6
5794145|NCT03187197|19972861|P3|Overall Study|Lost to Follow-up|7
5794146|NCT03187197|19972862|P2|Overall Study|Lost to Follow-up|60
5794147|NCT03187197|19972863|P1|Overall Study|Lost to Follow-up|1
5794148|NCT03187197|19972861|P3|Overall Study|Withdrawal by Subject|4
5794149|NCT03187197|19972862|P2|Overall Study|Withdrawal by Subject|63
5794150|NCT03187197|19972863|P1|Overall Study|Withdrawal by Subject|8
5794151|NCT03187197|19972861|P3|Overall Study|Stopped Pradaxa®/VKA|4
5794152|NCT03187197|19972862|P2|Overall Study|Stopped Pradaxa®/VKA|65
5794153|NCT03187197|19972863|P1|Overall Study|Stopped Pradaxa®/VKA|11
5794154|NCT03186781|19972901|P6|Overall Study|Withdrawal by Subject|0
5794155|NCT03186781|19972902|P5|Overall Study|Withdrawal by Subject|1
5794156|NCT03186781|19972903|P4|Overall Study|Withdrawal by Subject|0
5794157|NCT03186781|19972904|P3|Overall Study|Withdrawal by Subject|0
5794158|NCT03186781|19972905|P2|Overall Study|Withdrawal by Subject|0
5794159|NCT03186781|19972906|P1|Overall Study|Withdrawal by Subject|0
5794160|NCT03186781|19972901|P6|Overall Study|Moved from Area|0
5794161|NCT03186781|19972902|P5|Overall Study|Moved from Area|1
5794162|NCT03186781|19972903|P4|Overall Study|Moved from Area|0
5794163|NCT03186781|19972904|P3|Overall Study|Moved from Area|0
5794164|NCT03186781|19972905|P2|Overall Study|Moved from Area|0
5794165|NCT03186781|19972906|P1|Overall Study|Moved from Area|0
5794166|NCT03186781|19972901|P6|Overall Study|Lost to Follow-up|0
5794167|NCT03186781|19972902|P5|Overall Study|Lost to Follow-up|1
5794168|NCT03186781|19972903|P4|Overall Study|Lost to Follow-up|0
5794169|NCT03186781|19972904|P3|Overall Study|Lost to Follow-up|1
5794170|NCT03186781|19972905|P2|Overall Study|Lost to Follow-up|0
5794171|NCT03186781|19972906|P1|Overall Study|Lost to Follow-up|0
5794172|NCT03185481|19973003|P1|Overall Study|Study Terminated by Sponsor|4
5794173|NCT03185481|19973003|P1|Overall Study|Adverse Event|1
5794174|NCT03184987|19973074|P3|Overall Study|Adverse Event|1
5794175|NCT03184987|19973075|P2|Overall Study|Adverse Event|0
5794176|NCT03184987|19973076|P1|Overall Study|Adverse Event|1
5794177|NCT03184987|19973074|P3|Overall Study|Physician Decision|1
5794178|NCT03184987|19973075|P2|Overall Study|Physician Decision|0
5794179|NCT03184987|19973076|P1|Overall Study|Physician Decision|0
5794180|NCT03184987|19973074|P3|Overall Study|Withdrawal by Subject|2
5794181|NCT03184987|19973075|P2|Overall Study|Withdrawal by Subject|1
5794182|NCT03184987|19973076|P1|Overall Study|Withdrawal by Subject|0
5794183|NCT03184701|19973141|P1|Overall Study|Lost to Follow-up|5
5794184|NCT03184701|19973141|P1|Overall Study|Withdrawal by Subject|6
5794185|NCT03184701|19973141|P1|Overall Study|Physician Decision|3
5794186|NCT03184701|19973141|P1|Overall Study|Death|3
5794187|NCT03184519|19973145|P1|Overall Study|Physician Decision|21
5794188|NCT03184519|19973145|P1|Overall Study|Lost to Follow-up|6
5794189|NCT03184441|19973149|P1|Overall Study|Withdrawal by Subject|1
5794190|NCT03184077|19973175|P2|Overall Study|Lost to Follow-up|21
5794191|NCT03184077|19973176|P1|Overall Study|Lost to Follow-up|21
5794192|NCT03183518|19973195|P1|Overall Study|Other (Withdrawal of consent)|1
5794193|NCT03183518|19973195|P1|Overall Study|Other (Not specified)|2
5794194|NCT03183063|19973229|P3|Overall Study|Physician Decision|4
5794195|NCT03183063|19973230|P2|Overall Study|Physician Decision|4
5794196|NCT03183063|19973231|P1|Overall Study|Physician Decision|3
5794197|NCT03183063|19973229|P3|Overall Study|Withdrawal by Subject|0
5794198|NCT03183063|19973230|P2|Overall Study|Withdrawal by Subject|0
5794199|NCT03183063|19973231|P1|Overall Study|Withdrawal by Subject|2
5794200|NCT03182738|19973286|P2|Overall Study|Withdrawal by Subject|1
5794201|NCT03182738|19973287|P1|Overall Study|Withdrawal by Subject|0
5794202|NCT03182738|19973286|P2|Overall Study|Pregnancy|1
5794203|NCT03182738|19973287|P1|Overall Study|Pregnancy|0
5794204|NCT03182738|19973286|P2|Overall Study|Lost to Follow-up|3
5794205|NCT03182738|19973287|P1|Overall Study|Lost to Follow-up|9
5794206|NCT03181594|19973336|P1|Overall Study|Physician Decision|1
5794207|NCT03181594|19973336|P1|Overall Study|Lost to Follow-up|1
5794208|NCT03181503|19973344|P2|Overall Study|Lost to Follow-up|1
5794209|NCT03181503|19973345|P1|Overall Study|Lost to Follow-up|1
5794210|NCT03181503|19973344|P2|Overall Study|Withdrawal by Subject|0
5794211|NCT03181503|19973345|P1|Overall Study|Withdrawal by Subject|3
5794212|NCT03181503|19973344|P2|Overall Study|Protocol Violation|0
5794213|NCT03181503|19973345|P1|Overall Study|Protocol Violation|1
5794214|NCT03181503|19973344|P2|Overall Study|Adverse Event|2
5794215|NCT03181503|19973345|P1|Overall Study|Adverse Event|2
5794216|NCT03181451|19973384|P3|Overall Study|Withdrawal by Subject|0
5794217|NCT03181451|19973385|P2|Overall Study|Withdrawal by Subject|1
5794218|NCT03181451|19973386|P1|Overall Study|Withdrawal by Subject|0
5794219|NCT03181451|19973384|P3|Overall Study|Adverse Event|0
5794220|NCT03181451|19973385|P2|Overall Study|Adverse Event|1
5794221|NCT03181451|19973386|P1|Overall Study|Adverse Event|0
5794222|NCT03180801|19973573|P3|Overall Study|Lost to Follow-up|3
5794223|NCT03180801|19973574|P2|Overall Study|Lost to Follow-up|2
5794224|NCT03180801|19973575|P1|Overall Study|Lost to Follow-up|0
5794225|NCT03180801|19973573|P3|Overall Study|Withdrawal by Subject|1
5794226|NCT03180801|19973574|P2|Overall Study|Withdrawal by Subject|2
5794227|NCT03180801|19973575|P1|Overall Study|Withdrawal by Subject|2
5794228|NCT03180801|19973573|P3|Overall Study|Adverse Event|2
5794229|NCT03180801|19973574|P2|Overall Study|Adverse Event|0
5794230|NCT03180801|19973575|P1|Overall Study|Adverse Event|1
5794231|NCT03180801|19973573|P3|Overall Study|Inoculation Target Reached|3
5794232|NCT03180801|19973574|P2|Overall Study|Inoculation Target Reached|1
5794233|NCT03180801|19973575|P1|Overall Study|Inoculation Target Reached|1
5794234|NCT03180801|19973573|P3|Overall Study|Non-compliance|0
5794235|NCT03180801|19973574|P2|Overall Study|Non-compliance|4
5794236|NCT03180801|19973575|P1|Overall Study|Non-compliance|1
5794237|NCT03180801|19973573|P3|Overall Study|Physician Decision|1
5794238|NCT03180801|19973574|P2|Overall Study|Physician Decision|3
5794239|NCT03180801|19973575|P1|Overall Study|Physician Decision|3
5794240|NCT03180645|19973619|P3|Overall Study|Adverse Event|2
5794241|NCT03180645|19973620|P2|Overall Study|Adverse Event|1
5794242|NCT03180645|19973621|P1|Overall Study|Adverse Event|0
5794243|NCT03180619|19973663|P3|Overall Study|Investigator's discretion|1
5794244|NCT03180619|19973664|P2|Overall Study|Investigator's discretion|0
5794245|NCT03180619|19973665|P1|Overall Study|Investigator's discretion|1
5794246|NCT03180619|19973663|P3|Overall Study|Adverse Event|1
5794247|NCT03180619|19973664|P2|Overall Study|Adverse Event|0
5794248|NCT03180619|19973665|P1|Overall Study|Adverse Event|2
5794249|NCT03180619|19973663|P3|Overall Study|Still on Study|25
5794250|NCT03180619|19973664|P2|Overall Study|Still on Study|14
5794251|NCT03180619|19973665|P1|Overall Study|Still on Study|64
5794252|NCT03180619|19973663|P3|Overall Study|Death|0
5794253|NCT03180619|19973664|P2|Overall Study|Death|1
5794254|NCT03180619|19973665|P1|Overall Study|Death|1
5794255|NCT03180619|19973663|P3|Overall Study|Withdrew Consent|1
5794256|NCT03180619|19973664|P2|Overall Study|Withdrew Consent|0
5794257|NCT03180619|19973665|P1|Overall Study|Withdrew Consent|5
5794258|NCT03180528|19973762|P1|Overall Study|Eligible and enrolled, but did not receive treatment due to abnormal baseline laboratory values.|1
5794259|NCT03180528|19973762|P1|Overall Study|Withdrawal by Subject|1
5794260|NCT03180528|19973762|P1|Overall Study|Adverse Event|1
5794261|NCT03180138|19973872|P3|Overall Study|Found to be >24 mon after randomization|3
5794262|NCT03180138|19973873|P2|Overall Study|Found to be >24 mon after randomization|0
5794263|NCT03180138|19973874|P1|Overall Study|Found to be >24 mon after randomization|3
5794264|NCT03180138|19973872|P3|Overall Study|No prior immunization records|6
5794265|NCT03180138|19973873|P2|Overall Study|No prior immunization records|0
5794266|NCT03180138|19973874|P1|Overall Study|No prior immunization records|17
5794267|NCT03180138|19973872|P3|Overall Study|Mobile-phone could not be verified|15
5794268|NCT03180138|19973873|P2|Overall Study|Mobile-phone could not be verified|13
5794269|NCT03180138|19973874|P1|Overall Study|Mobile-phone could not be verified|2
5794270|NCT03179891|19973885|P2|First Intervention|Protocol Violation|1
5794271|NCT03179891|19973886|P1|First Intervention|Protocol Violation|0
5794272|NCT03179891|19973885|P2|First Intervention|Unspecified reason|0
5794273|NCT03179891|19973886|P1|First Intervention|Unspecified reason|1
5794274|NCT03179891|19973885|P2|First Intervention|Withdrawal by Subject|1
5794275|NCT03179891|19973886|P1|First Intervention|Withdrawal by Subject|1
5794276|NCT03179319|19973965|P2|Overall Study|Lost to Follow-up|0
5794277|NCT03179319|19973966|P1|Overall Study|Lost to Follow-up|6
5794278|NCT03178942|19973981|P2|Overall Study|Lost to Follow-up|2
5794279|NCT03178942|19973982|P1|Overall Study|Lost to Follow-up|1
5794280|NCT03178942|19973981|P2|Overall Study|Withdrawal by Subject|0
5794281|NCT03178942|19973982|P1|Overall Study|Withdrawal by Subject|2
5794282|NCT03178851|19973997|P3|Overall Study|Lost to Follow-up|0
5794283|NCT03178851|19973998|P2|Overall Study|Lost to Follow-up|1
5794284|NCT03178851|19973999|P1|Overall Study|Lost to Follow-up|2
5794285|NCT03178851|19973997|P3|Overall Study|Withdrawal by Subject|0
5794286|NCT03178851|19973998|P2|Overall Study|Withdrawal by Subject|0
5794287|NCT03178851|19973999|P1|Overall Study|Withdrawal by Subject|8
5794288|NCT03178851|19973997|P3|Overall Study|Death|10
5794289|NCT03178851|19973998|P2|Overall Study|Death|1
5794290|NCT03178851|19973999|P1|Overall Study|Death|35
5794291|NCT03178851|19973997|P3|Overall Study|Continuing on Study|42
5794292|NCT03178851|19973998|P2|Overall Study|Continuing on Study|9
5794293|NCT03178851|19973999|P1|Overall Study|Continuing on Study|47
5794294|NCT03178266|19974046|P2|Overall Study|Withdrawal by Subject|2
5794295|NCT03178266|19974047|P1|Overall Study|Withdrawal by Subject|0
5794296|NCT03178266|19974046|P2|Overall Study|Disont. Early|1
5794297|NCT03178266|19974047|P1|Overall Study|Disont. Early|0
5794298|NCT03178266|19974046|P2|Overall Study|Death|1
5794299|NCT03178266|19974047|P1|Overall Study|Death|0
5794300|NCT03178045|19974057|P2|Overall Study|Procedure Ineligible Post-Operatively/Pr|46
5794301|NCT03178045|19974058|P1|Overall Study|Procedure Ineligible Post-Operatively/Pr|47
5794302|NCT03178045|19974057|P2|Overall Study|Surgery Cancelled/Relocated|30
5794303|NCT03178045|19974058|P1|Overall Study|Surgery Cancelled/Relocated|34
5794304|NCT03178045|19974057|P2|Overall Study|Withdrawal by Subject|7
5794305|NCT03178045|19974058|P1|Overall Study|Withdrawal by Subject|5
5794306|NCT03176459|19974401|P2|Overall Study|Lost to Follow-up|7
5794307|NCT03176459|19974402|P1|Overall Study|Lost to Follow-up|5
5794308|NCT03176407|19974424|P1|Overall Study|EGD showed esophageal varices=excl. crit|1
5794309|NCT03176407|19974424|P1|Overall Study|human failure|1
5794310|NCT03176407|19974424|P1|Overall Study|Protocol Violation|1
5794311|NCT03176238|19974434|P2|Overall Study|Everolimus dose interrupt > 4 wks|0
5794312|NCT03176238|19974435|P1|Overall Study|Everolimus dose interrupt > 4 wks|9
5794313|NCT03176238|19974434|P2|Overall Study|Changes in the patient's condition|1
5794314|NCT03176238|19974435|P1|Overall Study|Changes in the patient's condition|2
5794315|NCT03176238|19974434|P2|Overall Study|Protocol Violation|0
5794316|NCT03176238|19974435|P1|Overall Study|Protocol Violation|1
5794317|NCT03176238|19974434|P2|Overall Study|Patient is switched to commercial drug|1
5794318|NCT03176238|19974435|P1|Overall Study|Patient is switched to commercial drug|16
5794319|NCT03176238|19974434|P2|Overall Study|Tx duration completed per EAP|1
5794320|NCT03176238|19974435|P1|Overall Study|Tx duration completed per EAP|0
5794321|NCT03176238|19974434|P2|Overall Study|Disease Progression|22
5794322|NCT03176238|19974435|P1|Overall Study|Disease Progression|133
5794323|NCT03176238|19974434|P2|Overall Study|Death|0
5794324|NCT03176238|19974435|P1|Overall Study|Death|3
5794325|NCT03176238|19974434|P2|Overall Study|Administrative problems|0
5794326|NCT03176238|19974435|P1|Overall Study|Administrative problems|1
5794327|NCT03176238|19974434|P2|Overall Study|Lost to Follow-up|0
5794328|NCT03176238|19974435|P1|Overall Study|Lost to Follow-up|3
5794329|NCT03176238|19974434|P2|Overall Study|Consent withdrawal|2
5794330|NCT03176238|19974435|P1|Overall Study|Consent withdrawal|14
5794331|NCT03176238|19974434|P2|Overall Study|Inter-current illness|1
5794332|NCT03176238|19974435|P1|Overall Study|Inter-current illness|0
5794333|NCT03176238|19974434|P2|Overall Study|Abnormal lab value(s)|0
5794334|NCT03176238|19974435|P1|Overall Study|Abnormal lab value(s)|2
5794335|NCT03176238|19974434|P2|Overall Study|Unacceptable AEs|8
5794336|NCT03176238|19974435|P1|Overall Study|Unacceptable AEs|15
5794337|NCT03175562|19974454|P1|Overall Study|Other (Not Specified)|5
5794338|NCT03175562|19974454|P1|Overall Study|Withdrawal by Subject|7
5794339|NCT03175562|19974454|P1|Overall Study|Lost to Follow-up|3
5794340|NCT03175562|19974454|P1|Overall Study|Adverse Event|1
5794341|NCT03175172|19974479|P1|Overall Study|Study Terminated by Sponsor|3
5794342|NCT03175172|19974479|P1|Overall Study|Lost to Follow-up|1
5794343|NCT03175172|19974479|P1|Overall Study|Withdrawal by Subject|3
5794344|NCT03175172|19974479|P1|Overall Study|Death|3
5794345|NCT03175120|19974489|P2|Overall Study|Other|3
5794346|NCT03175120|19974490|P1|Overall Study|Other|2
5794347|NCT03175120|19974489|P2|Overall Study|Withdrawal by Subject|5
5794348|NCT03175120|19974490|P1|Overall Study|Withdrawal by Subject|2
5794349|NCT03175120|19974489|P2|Overall Study|Lost to Follow-up|0
5794350|NCT03175120|19974490|P1|Overall Study|Lost to Follow-up|1
5794351|NCT03175120|19974489|P2|Overall Study|Protocol Violation|2
5794352|NCT03175120|19974490|P1|Overall Study|Protocol Violation|5
5794353|NCT03175120|19974489|P2|Overall Study|Adverse Event|2
5794354|NCT03175120|19974490|P1|Overall Study|Adverse Event|2
5794355|NCT03172702|19974674|P1|Overall Study|Other|2
5794356|NCT03172702|19974674|P1|Overall Study|Withdrawal by Subject|5
5794357|NCT03172702|19974674|P1|Overall Study|Study-specific Withdrawal Criteria|10
5794358|NCT03172702|19974674|P1|Overall Study|Death|2
5794359|NCT03172702|19974674|P1|Overall Study|Adverse Event|9
5794360|NCT03172494|19974702|P3|Overall Study|Non-compliance towards treatment|0
5794361|NCT03172494|19974703|P2|Overall Study|Non-compliance towards treatment|0
5794362|NCT03172494|19974704|P1|Overall Study|Non-compliance towards treatment|2
5794363|NCT03172494|19974702|P3|Overall Study|Severe hypoglycaemic episode|1
5794364|NCT03172494|19974703|P2|Overall Study|Severe hypoglycaemic episode|0
5794365|NCT03172494|19974704|P1|Overall Study|Severe hypoglycaemic episode|0
5794366|NCT03172494|19974702|P3|Overall Study|Withdrawal by Subject|8
5794367|NCT03172494|19974703|P2|Overall Study|Withdrawal by Subject|8
5794368|NCT03172494|19974704|P1|Overall Study|Withdrawal by Subject|10
5794369|NCT03172494|19974702|P3|Overall Study|Pregnancy|0
5794370|NCT03172494|19974703|P2|Overall Study|Pregnancy|1
5794371|NCT03172494|19974704|P1|Overall Study|Pregnancy|0
5794372|NCT03172494|19974702|P3|Overall Study|Lack of Efficacy|4
5794373|NCT03172494|19974703|P2|Overall Study|Lack of Efficacy|0
5794374|NCT03172494|19974704|P1|Overall Study|Lack of Efficacy|0
5794375|NCT03172494|19974702|P3|Overall Study|Protocol Violation|1
5794376|NCT03172494|19974703|P2|Overall Study|Protocol Violation|2
5794377|NCT03172494|19974704|P1|Overall Study|Protocol Violation|3
5794378|NCT03172494|19974702|P3|Overall Study|Adverse Event|15
5794379|NCT03172494|19974703|P2|Overall Study|Adverse Event|1
5794380|NCT03172494|19974704|P1|Overall Study|Adverse Event|5
5794381|NCT03172481|19974887|P2|Double-blind|Withdrawal by Subject|0
5794382|NCT03172481|19974888|P1|Double-blind|Withdrawal by Subject|1
5794383|NCT03172364|19974896|P2|Overall Study|Protocol Violation|0
5794384|NCT03172364|19974897|P1|Overall Study|Protocol Violation|1
5794385|NCT03172364|19974896|P2|Overall Study|Adverse Event|1
5794386|NCT03172364|19974897|P1|Overall Study|Adverse Event|1
5794387|NCT03172130|19974915|P2|Overall Study|Failure to tolerate CPAP/Sham CPAP|1
5794388|NCT03172130|19974916|P1|Overall Study|Failure to tolerate CPAP/Sham CPAP|3
5794389|NCT03171415|19974941|P5|Overall Study|Lost to Follow-up|2
5794390|NCT03171415|19974942|P4|Overall Study|Lost to Follow-up|0
5794391|NCT03171415|19974943|P3|Overall Study|Lost to Follow-up|0
5794392|NCT03171415|19974944|P2|Overall Study|Lost to Follow-up|0
5794393|NCT03171415|19974945|P1|Overall Study|Lost to Follow-up|0
5794394|NCT03170609|19975018|P7|Overall Study|Other|0
5794395|NCT03170609|19975019|P6|Overall Study|Other|1
5794396|NCT03170609|19975020|P5|Overall Study|Other|0
5794397|NCT03170609|19975021|P4|Overall Study|Other|0
5794398|NCT03170609|19975022|P3|Overall Study|Other|0
5794399|NCT03170609|19975023|P2|Overall Study|Other|0
5794400|NCT03170609|19975024|P1|Overall Study|Other|1
5794401|NCT03170609|19975018|P7|Overall Study|Lost to Follow-up|0
5794402|NCT03170609|19975019|P6|Overall Study|Lost to Follow-up|1
5794403|NCT03170609|19975020|P5|Overall Study|Lost to Follow-up|1
5794404|NCT03170609|19975021|P4|Overall Study|Lost to Follow-up|2
5794405|NCT03170609|19975022|P3|Overall Study|Lost to Follow-up|5
5794406|NCT03170609|19975023|P2|Overall Study|Lost to Follow-up|0
5794407|NCT03170609|19975024|P1|Overall Study|Lost to Follow-up|1
5794408|NCT03170609|19975018|P7|Overall Study|Withdrawal by Subject|1
5794409|NCT03170609|19975019|P6|Overall Study|Withdrawal by Subject|0
5794410|NCT03170609|19975020|P5|Overall Study|Withdrawal by Subject|0
5794411|NCT03170609|19975021|P4|Overall Study|Withdrawal by Subject|0
5794412|NCT03170609|19975022|P3|Overall Study|Withdrawal by Subject|0
5794413|NCT03170609|19975023|P2|Overall Study|Withdrawal by Subject|2
5794414|NCT03170609|19975024|P1|Overall Study|Withdrawal by Subject|1
5794415|NCT03170609|19975018|P7|Overall Study|Death|0
5794416|NCT03170609|19975019|P6|Overall Study|Death|0
5794417|NCT03170609|19975020|P5|Overall Study|Death|0
5794418|NCT03170609|19975021|P4|Overall Study|Death|0
5794419|NCT03170609|19975022|P3|Overall Study|Death|1
5794420|NCT03170609|19975023|P2|Overall Study|Death|0
5794421|NCT03170609|19975024|P1|Overall Study|Death|0
5794422|NCT03170544|19975094|P12|Part 1|Not treated|0
5794423|NCT03170544|19975095|P11|Part 1|Not treated|0
5794424|NCT03170544|19975096|P10|Part 1|Not treated|0
5794425|NCT03170544|19975097|P9|Part 1|Not treated|0
5794426|NCT03170544|19975098|P8|Part 1|Not treated|0
5794427|NCT03170544|19975099|P7|Part 1|Not treated|0
5794428|NCT03170544|19975100|P6|Part 1|Not treated|0
5794429|NCT03170544|19975101|P5|Part 1|Not treated|0
5794430|NCT03170544|19975102|P4|Part 1|Not treated|1
5794431|NCT03170544|19975103|P3|Part 1|Not treated|0
5794432|NCT03170544|19975104|P2|Part 1|Not treated|0
5794433|NCT03170544|19975105|P1|Part 1|Not treated|0
5794434|NCT03170544|19975094|P12|Part 1|Lost to Follow-up|0
5794435|NCT03170544|19975095|P11|Part 1|Lost to Follow-up|0
5794436|NCT03170544|19975096|P10|Part 1|Lost to Follow-up|0
5794437|NCT03170544|19975097|P9|Part 1|Lost to Follow-up|0
5794438|NCT03170544|19975098|P8|Part 1|Lost to Follow-up|0
5794439|NCT03170544|19975099|P7|Part 1|Lost to Follow-up|0
5794440|NCT03170544|19975100|P6|Part 1|Lost to Follow-up|0
5794441|NCT03170544|19975101|P5|Part 1|Lost to Follow-up|0
5794442|NCT03170544|19975102|P4|Part 1|Lost to Follow-up|0
5794443|NCT03170544|19975103|P3|Part 1|Lost to Follow-up|0
5794444|NCT03170544|19975104|P2|Part 1|Lost to Follow-up|0
5794445|NCT03170544|19975105|P1|Part 1|Lost to Follow-up|1
5794446|NCT03170271|19975269|P2|Overall Study|Randomized in error|0
5794447|NCT03170271|19975270|P1|Overall Study|Randomized in error|4
5794448|NCT03170271|19975269|P2|Overall Study|Other|2
5794449|NCT03170271|19975270|P1|Overall Study|Other|2
5794450|NCT03170271|19975269|P2|Overall Study|Withdrawal by Subject|5
5794451|NCT03170271|19975270|P1|Overall Study|Withdrawal by Subject|17
5794452|NCT03170271|19975269|P2|Overall Study|Protocol-specified withdrawal criterion|1
5794453|NCT03170271|19975270|P1|Overall Study|Protocol-specified withdrawal criterion|2
5794454|NCT03170271|19975269|P2|Overall Study|Physician Decision|0
5794455|NCT03170271|19975270|P1|Overall Study|Physician Decision|1
5794456|NCT03170271|19975269|P2|Overall Study|Lost to Follow-up|1
5794457|NCT03170271|19975270|P1|Overall Study|Lost to Follow-up|0
5794458|NCT03170271|19975269|P2|Overall Study|Adverse Event|2
5794459|NCT03170271|19975270|P1|Overall Study|Adverse Event|7
5794460|NCT03170232|19975298|P2|Overall Study|Withdrawal by Subject|1
5794461|NCT03170232|19975299|P1|Overall Study|Withdrawal by Subject|0
5794462|NCT03170232|19975298|P2|Overall Study|Lost to Follow-up|0
5794463|NCT03170232|19975299|P1|Overall Study|Lost to Follow-up|1
5794464|NCT03170232|19975298|P2|Overall Study|Study closed/terminated|23
5794465|NCT03170232|19975299|P1|Overall Study|Study closed/terminated|26
5794466|NCT03170232|19975298|P2|Overall Study|Lack of Efficacy|1
5794467|NCT03170232|19975299|P1|Overall Study|Lack of Efficacy|0
5794468|NCT03170232|19975298|P2|Overall Study|Protocol Violation|1
5794469|NCT03170232|19975299|P1|Overall Study|Protocol Violation|0
5794470|NCT03170232|19975298|P2|Overall Study|Adverse Event|1
5794471|NCT03170232|19975299|P1|Overall Study|Adverse Event|0
5794472|NCT03170193|19975377|P7|Overall Study|Lost to Follow-up|0
5794473|NCT03170193|19975378|P6|Overall Study|Lost to Follow-up|0
5794474|NCT03170193|19975379|P5|Overall Study|Lost to Follow-up|0
5794475|NCT03170193|19975380|P4|Overall Study|Lost to Follow-up|0
5794476|NCT03170193|19975381|P3|Overall Study|Lost to Follow-up|0
5794477|NCT03170193|19975382|P2|Overall Study|Lost to Follow-up|1
5794478|NCT03170193|19975383|P1|Overall Study|Lost to Follow-up|1
5794479|NCT03170193|19975377|P7|Overall Study|Withdrawal by Subject|0
5794480|NCT03170193|19975378|P6|Overall Study|Withdrawal by Subject|0
5794481|NCT03170193|19975379|P5|Overall Study|Withdrawal by Subject|0
5794482|NCT03170193|19975380|P4|Overall Study|Withdrawal by Subject|1
5794483|NCT03170193|19975381|P3|Overall Study|Withdrawal by Subject|0
5794484|NCT03170193|19975382|P2|Overall Study|Withdrawal by Subject|0
5794485|NCT03170193|19975383|P1|Overall Study|Withdrawal by Subject|0
5794486|NCT03170154|19975452|P1|Overall Study|Withdrawal by Subject|2
5794487|NCT03170154|19975452|P1|Overall Study|Death|2
5794488|NCT03170154|19975452|P1|Overall Study|Lost to Follow-up|4
5794489|NCT03169530|19975476|P2|Overall Study|Study ended by NIH|17
5794490|NCT03169530|19975477|P1|Overall Study|Study ended by NIH|15
5794491|NCT03169244|19975497|P2|Overall Study|Physician Decision|0
5794492|NCT03169244|19975498|P1|Overall Study|Physician Decision|1
5794493|NCT03169244|19975497|P2|Overall Study|Withdrawal by Subject|2
5794494|NCT03169244|19975498|P1|Overall Study|Withdrawal by Subject|2
5794495|NCT03169244|19975497|P2|Overall Study|Adverse Event|0
5794496|NCT03169244|19975498|P1|Overall Study|Adverse Event|1
5794497|NCT03169244|19975497|P2|Overall Study|Lost to Follow-up|2
5794498|NCT03169244|19975498|P1|Overall Study|Lost to Follow-up|1
5794499|NCT03169153|19975508|P2|Period 2, Second 30 Days of Wear|Could not attend visit|0
5794500|NCT03169153|19975509|P1|Period 2, Second 30 Days of Wear|Could not attend visit|1
5794501|NCT03169153|19975508|P2|Period 2, Second 30 Days of Wear|Adverse Event|2
5794502|NCT03169153|19975509|P1|Period 2, Second 30 Days of Wear|Adverse Event|1
5794503|NCT03169153|19975508|P2|Period 1, First 30 Days of Wear|Withdrawal by Subject|3
5794504|NCT03169153|19975509|P1|Period 1, First 30 Days of Wear|Withdrawal by Subject|2
5794505|NCT03169153|19975508|P2|Period 1, First 30 Days of Wear|Lost to Follow-up|1
5794506|NCT03169153|19975509|P1|Period 1, First 30 Days of Wear|Lost to Follow-up|1
5794507|NCT03168919|19975520|P1|Overall Study|Withdrawal by Subject|2
5794508|NCT03168906|19975530|P2|Overall Study|Lack of Efficacy|6
5794509|NCT03168906|19975531|P1|Overall Study|Lack of Efficacy|6
5794510|NCT03168425|19975577|P2|Overall Study|unable to confirm post op opioids|3
5794511|NCT03168425|19975578|P1|Overall Study|unable to confirm post op opioids|2
5794512|NCT03168425|19975577|P2|Overall Study|Lost to Follow-up|8
5794513|NCT03168425|19975578|P1|Overall Study|Lost to Follow-up|5
5794514|NCT03167151|19975655|P3|Overall Study|No evidence of tumour at surgery|1
5794515|NCT03167151|19975656|P2|Overall Study|No evidence of tumour at surgery|1
5794516|NCT03167151|19975657|P1|Overall Study|No evidence of tumour at surgery|0
5794517|NCT03167151|19975655|P3|Overall Study|Withdrawal by Subject|0
5794518|NCT03167151|19975656|P2|Overall Study|Withdrawal by Subject|0
5794519|NCT03167151|19975657|P1|Overall Study|Withdrawal by Subject|1
5794520|NCT03166735|19975670|P5|Overall Study|Lost to Follow-up|1
5794521|NCT03166735|19975671|P4|Overall Study|Lost to Follow-up|0
5794522|NCT03166735|19975672|P3|Overall Study|Lost to Follow-up|1
5794523|NCT03166735|19975673|P2|Overall Study|Lost to Follow-up|2
5794524|NCT03166735|19975674|P1|Overall Study|Lost to Follow-up|0
5794525|NCT03166735|19975670|P5|Overall Study|Withdrawal by Subject|2
5794526|NCT03166735|19975671|P4|Overall Study|Withdrawal by Subject|1
5794527|NCT03166735|19975672|P3|Overall Study|Withdrawal by Subject|1
5794528|NCT03166735|19975673|P2|Overall Study|Withdrawal by Subject|0
5794529|NCT03166735|19975674|P1|Overall Study|Withdrawal by Subject|0
5794530|NCT03166735|19975670|P5|Overall Study|follow-up not completed as planned|1
5794531|NCT03166735|19975671|P4|Overall Study|follow-up not completed as planned|0
5794532|NCT03166735|19975672|P3|Overall Study|follow-up not completed as planned|1
5794533|NCT03166735|19975673|P2|Overall Study|follow-up not completed as planned|1
5794534|NCT03166735|19975674|P1|Overall Study|follow-up not completed as planned|0
5794535|NCT03166735|19975670|P5|Overall Study|Not Treated|0
5794536|NCT03166735|19975671|P4|Overall Study|Not Treated|0
5794537|NCT03166735|19975672|P3|Overall Study|Not Treated|0
5794538|NCT03166735|19975673|P2|Overall Study|Not Treated|0
5794539|NCT03166735|19975674|P1|Overall Study|Not Treated|1
5794540|NCT03166618|19975724|P2|Overall Study|Study was Terminated|1
5794541|NCT03166618|19975725|P1|Overall Study|Study was Terminated|0
5794542|NCT03166215|19975737|P3|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|2
5794543|NCT03166215|19975738|P2|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0
5794544|NCT03166215|19975739|P1|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0
5794545|NCT03166215|19975737|P3|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0
5794546|NCT03166215|19975738|P2|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|2
5794547|NCT03166215|19975739|P1|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0
5794548|NCT03166124|19975779|P4|Wash-out Period|Adverse Event|0
5794549|NCT03166124|19975780|P3|Wash-out Period|Adverse Event|1
5794550|NCT03166124|19975781|P2|Wash-out Period|Adverse Event|1
5794551|NCT03166124|19975782|P1|Wash-out Period|Adverse Event|0
5794552|NCT03166124|19975779|P4|Wash-out Period|Withdrawal by Subject|1
5794553|NCT03166124|19975780|P3|Wash-out Period|Withdrawal by Subject|0
5794554|NCT03166124|19975781|P2|Wash-out Period|Withdrawal by Subject|1
5794555|NCT03166124|19975782|P1|Wash-out Period|Withdrawal by Subject|0
5794556|NCT03166124|19975779|P4|Treatment Period 1|Adverse Event|0
5794557|NCT03166124|19975780|P3|Treatment Period 1|Adverse Event|1
5794558|NCT03166124|19975781|P2|Treatment Period 1|Adverse Event|0
5794559|NCT03166124|19975782|P1|Treatment Period 1|Adverse Event|0
5794560|NCT03165955|19975827|P1|Treatment|Progressive disease|3
5794561|NCT03165955|19975827|P1|Treatment|Adverse Event|1
5794562|NCT03165955|19975827|P1|Treatment|Death|1
5794563|NCT03165955|19975827|P1|Treatment|Withdrawal by Subject|3
5794564|NCT03165110|19975966|P1|Overall Study|Anroid phone software incompatibility|1
5794565|NCT03165045|19975988|P1|Visit 2|Available total CCQ score at vist 2 only|44
5794566|NCT03165045|19975988|P1|Visit 2|No available total CCQ score at all|29
5794567|NCT03165045|19975988|P1|Visit 2|Available CCQ score at visit 1 only|109
5794568|NCT03165045|19975988|P1|Visit 1|No visit 1|10
5794569|NCT03165045|19975988|P1|Visit 1|No treatment documented|10
5794570|NCT03165045|19975988|P1|Visit 1|No registration after visit 1|9
5794571|NCT03164551|19976008|P2|Overall Study|Other|2
5794572|NCT03164551|19976009|P1|Overall Study|Other|8
5794573|NCT03164551|19976008|P2|Overall Study|Cancellation of Fresh Embryo Transfer|14
5794574|NCT03164551|19976009|P1|Overall Study|Cancellation of Fresh Embryo Transfer|12
5794575|NCT03164551|19976008|P2|Overall Study|Participant was non-compliant|0
5794576|NCT03164551|19976009|P1|Overall Study|Participant was non-compliant|1
5794577|NCT03164551|19976008|P2|Overall Study|Imaging discontinued prior completion|0
5794578|NCT03164551|19976009|P1|Overall Study|Imaging discontinued prior completion|8
5794612|NCT03162614|19976432|P6|Overall Study|Missed vaccination, exclusion criteria|0
5794613|NCT03162614|19976433|P5|Overall Study|Missed vaccination, exclusion criteria|3
5794614|NCT03162614|19976434|P4|Overall Study|Missed vaccination, exclusion criteria|4
5794615|NCT03162614|19976435|P3|Overall Study|Missed vaccination, exclusion criteria|2
5794616|NCT03162614|19976436|P2|Overall Study|Missed vaccination, exclusion criteria|2
5794617|NCT03162614|19976437|P1|Overall Study|Missed vaccination, exclusion criteria|2
5794618|NCT03162614|19976432|P6|Overall Study|Withdrawal by Subject|0
5794619|NCT03162614|19976433|P5|Overall Study|Withdrawal by Subject|0
5794620|NCT03162614|19976434|P4|Overall Study|Withdrawal by Subject|1
5794621|NCT03162614|19976435|P3|Overall Study|Withdrawal by Subject|1
5794622|NCT03162614|19976436|P2|Overall Study|Withdrawal by Subject|1
5794623|NCT03162614|19976437|P1|Overall Study|Withdrawal by Subject|2
5794624|NCT03162614|19976432|P6|Overall Study|Protocol Violation|0
5794625|NCT03162614|19976433|P5|Overall Study|Protocol Violation|0
5794626|NCT03162614|19976434|P4|Overall Study|Protocol Violation|1
5794627|NCT03162614|19976435|P3|Overall Study|Protocol Violation|0
5794628|NCT03162614|19976436|P2|Overall Study|Protocol Violation|1
5794629|NCT03162614|19976437|P1|Overall Study|Protocol Violation|0
5794630|NCT03162614|19976432|P6|Overall Study|Lost to Follow-up|0
5794631|NCT03162614|19976433|P5|Overall Study|Lost to Follow-up|2
5794632|NCT03162614|19976434|P4|Overall Study|Lost to Follow-up|1
5794633|NCT03162614|19976435|P3|Overall Study|Lost to Follow-up|1
5794634|NCT03162614|19976436|P2|Overall Study|Lost to Follow-up|1
5794635|NCT03162614|19976437|P1|Overall Study|Lost to Follow-up|2
5794636|NCT03162328|19976590|P3|Study Period|Withdrawal by Subject|1
5794637|NCT03162328|19976591|P2|Study Period|Withdrawal by Subject|0
5794638|NCT03162328|19976592|P1|Study Period|Withdrawal by Subject|0
5794639|NCT03162328|19976590|P3|Screening Period|Withdrawal by Subject|0
5794640|NCT03162328|19976591|P2|Screening Period|Withdrawal by Subject|0
5794641|NCT03162328|19976592|P1|Screening Period|Withdrawal by Subject|1
5794642|NCT03162328|19976590|P3|Screening Period|Did not meet inclusion/exclusion|0
5794643|NCT03162328|19976591|P2|Screening Period|Did not meet inclusion/exclusion|0
5794644|NCT03162328|19976592|P1|Screening Period|Did not meet inclusion/exclusion|21
5794645|NCT03162055|19976621|P2|Overall Study|Other|15
5794646|NCT03162055|19976622|P1|Overall Study|Other|8
5794647|NCT03162055|19976621|P2|Overall Study|Incorrect randomization|3
5794648|NCT03162055|19976622|P1|Overall Study|Incorrect randomization|4
5794649|NCT03162055|19976621|P2|Overall Study|Did not receive treatment|0
5794650|NCT03162055|19976622|P1|Overall Study|Did not receive treatment|2
5794651|NCT03162055|19976621|P2|Overall Study|Withdrawal by Subject|2
5794652|NCT03162055|19976622|P1|Overall Study|Withdrawal by Subject|17
5794653|NCT03162055|19976621|P2|Overall Study|Study-specific withdrawal criteria|14
5794654|NCT03162055|19976622|P1|Overall Study|Study-specific withdrawal criteria|22
5794655|NCT03162055|19976621|P2|Overall Study|Lost to Follow-up|1
5794656|NCT03162055|19976622|P1|Overall Study|Lost to Follow-up|0
5794657|NCT03162055|19976621|P2|Overall Study|Death|3
5794658|NCT03162055|19976622|P1|Overall Study|Death|3
5794659|NCT03162055|19976621|P2|Overall Study|Adverse Event|5
5794660|NCT03162055|19976622|P1|Overall Study|Adverse Event|6
5794661|NCT03161405|19976714|P1|Second Intervention Period (6 Days)|Positive urine drug screen|1
5794662|NCT03160898|19976734|P4|Overall Study|Other|2
5794663|NCT03160898|19976735|P3|Overall Study|Other|2
5794664|NCT03160898|19976736|P2|Overall Study|Other|0
5794665|NCT03160898|19976737|P1|Overall Study|Other|2
5794666|NCT03160898|19976734|P4|Overall Study|Withdrawal by Subject|1
5794667|NCT03160898|19976735|P3|Overall Study|Withdrawal by Subject|2
5794668|NCT03160898|19976736|P2|Overall Study|Withdrawal by Subject|3
5794669|NCT03160898|19976737|P1|Overall Study|Withdrawal by Subject|1
5794670|NCT03160898|19976734|P4|Overall Study|Sponsor Discretion|0
5794671|NCT03160898|19976735|P3|Overall Study|Sponsor Discretion|0
5794672|NCT03160898|19976736|P2|Overall Study|Sponsor Discretion|0
5794673|NCT03160898|19976737|P1|Overall Study|Sponsor Discretion|2
5794674|NCT03160898|19976734|P4|Overall Study|Protocol Violation|0
5794675|NCT03160898|19976735|P3|Overall Study|Protocol Violation|2
5794676|NCT03160898|19976736|P2|Overall Study|Protocol Violation|0
5794677|NCT03160898|19976737|P1|Overall Study|Protocol Violation|1
5794678|NCT03160898|19976734|P4|Overall Study|Progressive Disease|1
5794679|NCT03160898|19976735|P3|Overall Study|Progressive Disease|2
5794680|NCT03160898|19976736|P2|Overall Study|Progressive Disease|1
5794681|NCT03160898|19976737|P1|Overall Study|Progressive Disease|4
5794682|NCT03160898|19976734|P4|Overall Study|Physician Decision|1
5794683|NCT03160898|19976735|P3|Overall Study|Physician Decision|0
5794684|NCT03160898|19976736|P2|Overall Study|Physician Decision|0
5794685|NCT03160898|19976737|P1|Overall Study|Physician Decision|1
5794686|NCT03160898|19976734|P4|Overall Study|Lost to Follow-up|2
5794687|NCT03160898|19976735|P3|Overall Study|Lost to Follow-up|1
5794688|NCT03160898|19976736|P2|Overall Study|Lost to Follow-up|1
5794689|NCT03160898|19976737|P1|Overall Study|Lost to Follow-up|1
5794690|NCT03160898|19976734|P4|Overall Study|Difficulty Traveling to Clinic Visits|1
5794691|NCT03160898|19976735|P3|Overall Study|Difficulty Traveling to Clinic Visits|0
5794692|NCT03160898|19976736|P2|Overall Study|Difficulty Traveling to Clinic Visits|0
5794693|NCT03160898|19976737|P1|Overall Study|Difficulty Traveling to Clinic Visits|3
5794694|NCT03160898|19976734|P4|Overall Study|Death|1
5794695|NCT03160898|19976735|P3|Overall Study|Death|0
5794696|NCT03160898|19976736|P2|Overall Study|Death|0
5794697|NCT03160898|19976737|P1|Overall Study|Death|1
5794698|NCT03160898|19976734|P4|Overall Study|Adverse Event|10
5794699|NCT03160898|19976735|P3|Overall Study|Adverse Event|7
5794700|NCT03160898|19976736|P2|Overall Study|Adverse Event|8
5794701|NCT03160898|19976737|P1|Overall Study|Adverse Event|4
5794702|NCT03160885|19976760|P7|Maintenance Treatment Period|Completed Week 50|0
5794703|NCT03160885|19976761|P6|Maintenance Treatment Period|Completed Week 50|0
5794704|NCT03160885|19976762|P5|Maintenance Treatment Period|Completed Week 50|0
5794705|NCT03160885|19976763|P4|Maintenance Treatment Period|Completed Week 50|0
5794706|NCT03160885|19976764|P3|Maintenance Treatment Period|Completed Week 50|1
5794707|NCT03160885|19976765|P2|Maintenance Treatment Period|Completed Week 50|0
5794708|NCT03160885|19976766|P1|Maintenance Treatment Period|Completed Week 50|0
5794709|NCT03160885|19976760|P7|Maintenance Treatment Period|Transfer to open-label treatment|0
5794710|NCT03160885|19976761|P6|Maintenance Treatment Period|Transfer to open-label treatment|8
5794711|NCT03160885|19976762|P5|Maintenance Treatment Period|Transfer to open-label treatment|26
5794712|NCT03160885|19976763|P4|Maintenance Treatment Period|Transfer to open-label treatment|26
5794713|NCT03160885|19976764|P3|Maintenance Treatment Period|Transfer to open-label treatment|29
5794714|NCT03160885|19976765|P2|Maintenance Treatment Period|Transfer to open-label treatment|0
5794715|NCT03160885|19976766|P1|Maintenance Treatment Period|Transfer to open-label treatment|0
5794716|NCT03160885|19976760|P7|Maintenance Treatment Period|Discontinued IMP|0
5794717|NCT03160885|19976761|P6|Maintenance Treatment Period|Discontinued IMP|7
5794718|NCT03160885|19976762|P5|Maintenance Treatment Period|Discontinued IMP|5
5794719|NCT03160885|19976763|P4|Maintenance Treatment Period|Discontinued IMP|13
5794720|NCT03160885|19976764|P3|Maintenance Treatment Period|Discontinued IMP|9
5794721|NCT03160885|19976765|P2|Maintenance Treatment Period|Discontinued IMP|0
5794722|NCT03160885|19976766|P1|Maintenance Treatment Period|Discontinued IMP|0
5794723|NCT03160885|19976760|P7|Maintenance Treatment Period|Not dosed - transfer to open-label|0
5794724|NCT03160885|19976761|P6|Maintenance Treatment Period|Not dosed - transfer to open-label|0
5794725|NCT03160885|19976762|P5|Maintenance Treatment Period|Not dosed - transfer to open-label|0
5794726|NCT03160885|19976763|P4|Maintenance Treatment Period|Not dosed - transfer to open-label|1
5794727|NCT03160885|19976764|P3|Maintenance Treatment Period|Not dosed - transfer to open-label|0
5794728|NCT03160885|19976765|P2|Maintenance Treatment Period|Not dosed - transfer to open-label|0
5794729|NCT03160885|19976766|P1|Maintenance Treatment Period|Not dosed - transfer to open-label|0
5794730|NCT03160885|19976760|P7|Open-label Treatment|Completed Week 50|4
5794731|NCT03160885|19976761|P6|Open-label Treatment|Completed Week 50|0
5794732|NCT03160885|19976762|P5|Open-label Treatment|Completed Week 50|0
5794733|NCT03160885|19976763|P4|Open-label Treatment|Completed Week 50|0
5794734|NCT03160885|19976764|P3|Open-label Treatment|Completed Week 50|0
5794735|NCT03160885|19976765|P2|Open-label Treatment|Completed Week 50|0
5794736|NCT03160885|19976766|P1|Open-label Treatment|Completed Week 50|0
5794737|NCT03160885|19976760|P7|Open-label Treatment|Discontinued IMP|131
5794738|NCT03160885|19976761|P6|Open-label Treatment|Discontinued IMP|0
5794739|NCT03160885|19976762|P5|Open-label Treatment|Discontinued IMP|0
5794740|NCT03160885|19976763|P4|Open-label Treatment|Discontinued IMP|0
5794741|NCT03160885|19976764|P3|Open-label Treatment|Discontinued IMP|0
5794742|NCT03160885|19976765|P2|Open-label Treatment|Discontinued IMP|0
5794743|NCT03160885|19976766|P1|Open-label Treatment|Discontinued IMP|0
5794744|NCT03160885|19976760|P7|Open-label Treatment|Not dosed|2
5794745|NCT03160885|19976761|P6|Open-label Treatment|Not dosed|0
5794746|NCT03160885|19976762|P5|Open-label Treatment|Not dosed|0
5794747|NCT03160885|19976763|P4|Open-label Treatment|Not dosed|0
5794748|NCT03160885|19976764|P3|Open-label Treatment|Not dosed|0
5794749|NCT03160885|19976765|P2|Open-label Treatment|Not dosed|0
5794750|NCT03160885|19976766|P1|Open-label Treatment|Not dosed|0
5794751|NCT03160885|19976760|P7|Initial Treatment Period|Discontinued IMP before Week 16|0
5794752|NCT03160885|19976761|P6|Initial Treatment Period|Discontinued IMP before Week 16|0
5794753|NCT03160885|19976762|P5|Initial Treatment Period|Discontinued IMP before Week 16|0
5794754|NCT03160885|19976763|P4|Initial Treatment Period|Discontinued IMP before Week 16|0
5794755|NCT03160885|19976764|P3|Initial Treatment Period|Discontinued IMP before Week 16|0
5794756|NCT03160885|19976765|P2|Initial Treatment Period|Discontinued IMP before Week 16|22
5794757|NCT03160885|19976766|P1|Initial Treatment Period|Discontinued IMP before Week 16|33
5794758|NCT03160885|19976760|P7|Initial Treatment Period|Not dosed|0
5794759|NCT03160885|19976761|P6|Initial Treatment Period|Not dosed|0
5794760|NCT03160885|19976762|P5|Initial Treatment Period|Not dosed|0
5794761|NCT03160885|19976763|P4|Initial Treatment Period|Not dosed|0
5794762|NCT03160885|19976764|P3|Initial Treatment Period|Not dosed|0
5794763|NCT03160885|19976765|P2|Initial Treatment Period|Not dosed|0
5794764|NCT03160885|19976766|P1|Initial Treatment Period|Not dosed|2
5794765|NCT03160716|19976812|P1|Overall Study|Lost to Follow-up|1
5794766|NCT03160703|19976823|P4|Overall Study|Withdrawal by Subject|1
5794767|NCT03160703|19976824|P3|Overall Study|Withdrawal by Subject|0
5794768|NCT03160703|19976825|P2|Overall Study|Withdrawal by Subject|0
5794769|NCT03160703|19976826|P1|Overall Study|Withdrawal by Subject|0
5794770|NCT03160573|19976840|P4|First Sequence (3 Weeks)|Withdrawal by Subject|2
5794771|NCT03160573|19976841|P3|First Sequence (3 Weeks)|Withdrawal by Subject|2
5794772|NCT03160573|19976842|P2|First Sequence (3 Weeks)|Withdrawal by Subject|3
5794773|NCT03160573|19976843|P1|First Sequence (3 Weeks)|Withdrawal by Subject|1
5794774|NCT03160560|19976857|P4|Second Intervention (3 Weeks)|Withdrawal by Subject|0
5794775|NCT03160560|19976858|P3|Second Intervention (3 Weeks)|Withdrawal by Subject|0
5794776|NCT03160560|19976859|P2|Second Intervention (3 Weeks)|Withdrawal by Subject|0
5794777|NCT03160560|19976860|P1|Second Intervention (3 Weeks)|Withdrawal by Subject|1
5794778|NCT03160560|19976857|P4|First Intervention (3 Weeks)|Withdrawal by Subject|0
5794779|NCT03160560|19976858|P3|First Intervention (3 Weeks)|Withdrawal by Subject|1
5794780|NCT03160560|19976859|P2|First Intervention (3 Weeks)|Withdrawal by Subject|1
5794781|NCT03160560|19976860|P1|First Intervention (3 Weeks)|Withdrawal by Subject|2
5794782|NCT03159611|19976938|P2|Overall Study|Inability to perform procedures|0
5794783|NCT03159611|19976939|P1|Overall Study|Inability to perform procedures|1
5794784|NCT03159611|19976938|P2|Overall Study|Non-compliance with protocol requirement|2
5794785|NCT03159611|19976939|P1|Overall Study|Non-compliance with protocol requirement|3
5794786|NCT03159611|19976938|P2|Overall Study|Withdrawal by Subject|1
5794787|NCT03159611|19976939|P1|Overall Study|Withdrawal by Subject|1
5794788|NCT03159611|19976938|P2|Overall Study|Adverse Event|0
5794789|NCT03159611|19976939|P1|Overall Study|Adverse Event|1
5794790|NCT03159611|19976938|P2|Overall Study|Protocol Violation|4
5794791|NCT03159611|19976939|P1|Overall Study|Protocol Violation|7
5794792|NCT03159611|19976938|P2|Overall Study|Did Not Meet Exclusion Criteria|3
5794793|NCT03159611|19976939|P1|Overall Study|Did Not Meet Exclusion Criteria|1
5794794|NCT03159611|19976938|P2|Overall Study|Did Not Meet Inclusion Criteria|5
5794795|NCT03159611|19976939|P1|Overall Study|Did Not Meet Inclusion Criteria|9
5794796|NCT03159468|19976959|P6|Overall Study|Withdrawal by Subject|0
5794797|NCT03159468|19976960|P5|Overall Study|Withdrawal by Subject|0
5794798|NCT03159468|19976961|P4|Overall Study|Withdrawal by Subject|0
5794799|NCT03159468|19976962|P3|Overall Study|Withdrawal by Subject|3
5794800|NCT03159468|19976963|P2|Overall Study|Withdrawal by Subject|0
5794801|NCT03159468|19976964|P1|Overall Study|Withdrawal by Subject|0
5794802|NCT03159091|19977013|P2|Overall Study|Patient has taken no dose of study drug|1
5794803|NCT03159091|19977014|P1|Overall Study|Patient has taken no dose of study drug|0
5794804|NCT03159091|19977013|P2|Overall Study|Incorrect inclusion ineligible patient|3
5794805|NCT03159091|19977014|P1|Overall Study|Incorrect inclusion ineligible patient|5
5794806|NCT03158688|19977030|P2|Overall Study|Lost to Follow-up|3
5794807|NCT03158688|19977031|P1|Overall Study|Lost to Follow-up|0
5794808|NCT03158688|19977030|P2|Overall Study|Decision by sponsor|3
5794809|NCT03158688|19977031|P1|Overall Study|Decision by sponsor|2
5794810|NCT03158688|19977030|P2|Overall Study|Withdrawal by Subject|14
5794811|NCT03158688|19977031|P1|Overall Study|Withdrawal by Subject|9
5794812|NCT03158688|19977030|P2|Overall Study|Death|59
5794813|NCT03158688|19977031|P1|Overall Study|Death|36
5794814|NCT03158688|19977030|P2|Overall Study|Continuing in study|233
5794815|NCT03158688|19977031|P1|Overall Study|Continuing in study|107
5794816|NCT03158311|19977064|P3|Overall Study|Randomized in error|1
5794817|NCT03158311|19977065|P2|Overall Study|Randomized in error|0
5794818|NCT03158311|19977066|P1|Overall Study|Randomized in error|0
5794819|NCT03158311|19977064|P3|Overall Study|Pregnancy|0
5794820|NCT03158311|19977065|P2|Overall Study|Pregnancy|2
5794821|NCT03158311|19977066|P1|Overall Study|Pregnancy|0
5794822|NCT03158311|19977064|P3|Overall Study|Sponsor decision|0
5794823|NCT03158311|19977065|P2|Overall Study|Sponsor decision|0
5794824|NCT03158311|19977066|P1|Overall Study|Sponsor decision|1
5794825|NCT03158311|19977064|P3|Overall Study|Lost to Follow-up|1
5794826|NCT03158311|19977065|P2|Overall Study|Lost to Follow-up|1
5794827|NCT03158311|19977066|P1|Overall Study|Lost to Follow-up|1
5794828|NCT03158311|19977064|P3|Overall Study|Physician Decision|7
5794829|NCT03158311|19977065|P2|Overall Study|Physician Decision|3
5794830|NCT03158311|19977066|P1|Overall Study|Physician Decision|2
5794831|NCT03158311|19977064|P3|Overall Study|Techinical Problems|5
5794832|NCT03158311|19977065|P2|Overall Study|Techinical Problems|1
5794833|NCT03158311|19977066|P1|Overall Study|Techinical Problems|3
5794834|NCT03158311|19977064|P3|Overall Study|Adverse Event|3
5794835|NCT03158311|19977065|P2|Overall Study|Adverse Event|3
5794836|NCT03158311|19977066|P1|Overall Study|Adverse Event|5
5794837|NCT03158311|19977064|P3|Overall Study|Subject/Guardian Decision|11
5794838|NCT03158311|19977065|P2|Overall Study|Subject/Guardian Decision|6
5794839|NCT03158311|19977066|P1|Overall Study|Subject/Guardian Decision|10
5794840|NCT03158285|19977098|P3|Active Treatment Period: Week 24 - 52|Other|0
5794841|NCT03158285|19977099|P2|Active Treatment Period: Week 24 - 52|Other|1
5794842|NCT03158285|19977100|P1|Active Treatment Period: Week 24 - 52|Other|1
5794843|NCT03158285|19977098|P3|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|1
5794844|NCT03158285|19977099|P2|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|2
5794845|NCT03158285|19977100|P1|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|1
5794846|NCT03158285|19977098|P3|Active Treatment Period: Week 24 - 52|Pregnancy|1
5794847|NCT03158285|19977099|P2|Active Treatment Period: Week 24 - 52|Pregnancy|0
5794848|NCT03158285|19977100|P1|Active Treatment Period: Week 24 - 52|Pregnancy|0
5794849|NCT03158285|19977098|P3|Active Treatment Period: Week 24 - 52|Lack of Efficacy|4
5794850|NCT03158285|19977099|P2|Active Treatment Period: Week 24 - 52|Lack of Efficacy|3
5794851|NCT03158285|19977100|P1|Active Treatment Period: Week 24 - 52|Lack of Efficacy|5
5794852|NCT03158285|19977098|P3|Active Treatment Period: Week 24 - 52|Adverse Event|1
5794853|NCT03158285|19977099|P2|Active Treatment Period: Week 24 - 52|Adverse Event|0
5794854|NCT03158285|19977100|P1|Active Treatment Period: Week 24 - 52|Adverse Event|3
5794855|NCT03158285|19977098|P3|Placebo-controlled Period: Week 0 - 24|Other|0
5794856|NCT03158285|19977099|P2|Placebo-controlled Period: Week 0 - 24|Other|1
5794857|NCT03158285|19977100|P1|Placebo-controlled Period: Week 0 - 24|Other|1
5794858|NCT03158285|19977098|P3|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|0
5794859|NCT03158285|19977099|P2|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|1
5794860|NCT03158285|19977100|P1|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|1
5794861|NCT03158285|19977098|P3|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|0
5794862|NCT03158285|19977099|P2|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|1
5794863|NCT03158285|19977100|P1|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|0
5794864|NCT03158285|19977098|P3|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|3
5794865|NCT03158285|19977099|P2|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|3
5794866|NCT03158285|19977100|P1|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|0
5794867|NCT03158285|19977098|P3|Placebo-controlled Period: Week 0 - 24|Adverse Event|6
5794868|NCT03158285|19977099|P2|Placebo-controlled Period: Week 0 - 24|Adverse Event|2
5794869|NCT03158285|19977100|P1|Placebo-controlled Period: Week 0 - 24|Adverse Event|4
5794870|NCT03158272|19977316|P4|Overall Study|Adverse event unrelated to the drug|0
5794871|NCT03158272|19977317|P3|Overall Study|Adverse event unrelated to the drug|0
5794872|NCT03158272|19977318|P2|Overall Study|Adverse event unrelated to the drug|1
5794873|NCT03158272|19977319|P1|Overall Study|Adverse event unrelated to the drug|0
5794874|NCT03158272|19977316|P4|Overall Study|Other reasons|0
5794875|NCT03158272|19977317|P3|Overall Study|Other reasons|1
5794876|NCT03158272|19977318|P2|Overall Study|Other reasons|0
5794877|NCT03158272|19977319|P1|Overall Study|Other reasons|0
5794878|NCT03158272|19977316|P4|Overall Study|Death|0
5794879|NCT03158272|19977317|P3|Overall Study|Death|1
5794880|NCT03158272|19977318|P2|Overall Study|Death|0
5794881|NCT03158272|19977319|P1|Overall Study|Death|0
5794882|NCT03158272|19977316|P4|Overall Study|Disease progression|6
5794883|NCT03158272|19977317|P3|Overall Study|Disease progression|4
5794884|NCT03158272|19977318|P2|Overall Study|Disease progression|3
5794885|NCT03158272|19977319|P1|Overall Study|Disease progression|3
5794886|NCT03158220|19977389|P2|Overall Study|Physician Decision|0
5794887|NCT03158220|19977390|P1|Overall Study|Physician Decision|1
5794888|NCT03158220|19977389|P2|Overall Study|Lost to Follow-up|5
5794889|NCT03158220|19977390|P1|Overall Study|Lost to Follow-up|8
5794890|NCT03158220|19977389|P2|Overall Study|Status unknown|1
5794891|NCT03158220|19977390|P1|Overall Study|Status unknown|0
5794892|NCT03158220|19977389|P2|Overall Study|Withdrawal by Subject|9
5794893|NCT03158220|19977390|P1|Overall Study|Withdrawal by Subject|8
5794894|NCT03158220|19977389|P2|Overall Study|Screen Failure|1
5794895|NCT03158220|19977390|P1|Overall Study|Screen Failure|0
5794896|NCT03158012|19977427|P2|Overall Study|Withdrawal by Subject|1
5794897|NCT03158012|19977428|P1|Overall Study|Withdrawal by Subject|0
5794898|NCT03157583|19977434|P1|Overall Study|Other (did not meet study criteria)|1
5794899|NCT03157531|19977452|P1|Overall Study|Lost to Follow-up|4
5794900|NCT03157531|19977452|P1|Overall Study|Death|2
5794901|NCT03156543|19977473|P2|Overall Study|Withdrawal by Subject|0
5794902|NCT03156543|19977474|P1|Overall Study|Withdrawal by Subject|1
5794903|NCT03155269|19977484|P2|Overall Study|Lost to Follow-up|2
5794904|NCT03155269|19977485|P1|Overall Study|Lost to Follow-up|1
5794905|NCT03155269|19977484|P2|Overall Study|Withdrawal by Subject|5
5794906|NCT03155269|19977485|P1|Overall Study|Withdrawal by Subject|4
5794907|NCT03155178|19977531|P4|Overall Study|Did not meet treatment day baseline|7
5794908|NCT03155178|19977532|P3|Overall Study|Did not meet treatment day baseline|7
5794909|NCT03155178|19977533|P2|Overall Study|Did not meet treatment day baseline|7
5794910|NCT03155178|19977534|P1|Overall Study|Did not meet treatment day baseline|7
5794911|NCT03154086|19977578|P15|Part B (Up to 25 Days)|Adverse Event|0
5794912|NCT03154086|19977579|P14|Part B (Up to 25 Days)|Adverse Event|0
5794913|NCT03154086|19977580|P13|Part B (Up to 25 Days)|Adverse Event|0
5794914|NCT03154086|19977581|P12|Part B (Up to 25 Days)|Adverse Event|0
5794915|NCT03154086|19977582|P11|Part B (Up to 25 Days)|Adverse Event|1
5794916|NCT03154086|19977583|P10|Part B (Up to 25 Days)|Adverse Event|0
5794917|NCT03154086|19977584|P9|Part B (Up to 25 Days)|Adverse Event|0
5794918|NCT03154086|19977585|P8|Part B (Up to 25 Days)|Adverse Event|0
5794919|NCT03154086|19977586|P7|Part B (Up to 25 Days)|Adverse Event|0
5794920|NCT03154086|19977587|P6|Part B (Up to 25 Days)|Adverse Event|0
5794921|NCT03154086|19977588|P5|Part B (Up to 25 Days)|Adverse Event|0
5794922|NCT03154086|19977589|P4|Part B (Up to 25 Days)|Adverse Event|0
5794923|NCT03154086|19977590|P3|Part B (Up to 25 Days)|Adverse Event|0
5794924|NCT03154086|19977591|P2|Part B (Up to 25 Days)|Adverse Event|0
5794925|NCT03154086|19977592|P1|Part B (Up to 25 Days)|Adverse Event|0
5794926|NCT03154086|19977578|P15|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
5794927|NCT03154086|19977579|P14|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
5794928|NCT03154086|19977580|P13|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
5794929|NCT03154086|19977581|P12|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
5794930|NCT03154086|19977582|P11|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
5794931|NCT03154086|19977583|P10|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
5794932|NCT03154086|19977584|P9|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
5794933|NCT03154086|19977585|P8|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|1
5794934|NCT03154086|19977586|P7|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
5794935|NCT03154086|19977587|P6|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
5794936|NCT03154086|19977588|P5|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
5794937|NCT03154086|19977589|P4|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
5794938|NCT03154086|19977590|P3|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
5794939|NCT03154086|19977591|P2|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
5794940|NCT03154086|19977592|P1|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
5794941|NCT03154086|19977578|P15|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
5794942|NCT03154086|19977579|P14|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
5794943|NCT03154086|19977580|P13|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
5794944|NCT03154086|19977581|P12|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
5794945|NCT03154086|19977582|P11|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
5794946|NCT03154086|19977583|P10|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
5794947|NCT03154086|19977584|P9|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|1
5794948|NCT03154086|19977585|P8|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
5794949|NCT03154086|19977586|P7|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
5794950|NCT03154086|19977587|P6|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
5794951|NCT03154086|19977588|P5|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
5794952|NCT03154086|19977589|P4|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
5794953|NCT03154086|19977590|P3|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
5794954|NCT03154086|19977591|P2|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
5794955|NCT03154086|19977592|P1|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
5794956|NCT03154086|19977578|P15|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
5794957|NCT03154086|19977579|P14|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
5794958|NCT03154086|19977580|P13|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
5794959|NCT03154086|19977581|P12|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
5794960|NCT03154086|19977582|P11|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
5794961|NCT03154086|19977583|P10|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
5794962|NCT03154086|19977584|P9|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
5794963|NCT03154086|19977585|P8|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
5794964|NCT03154086|19977586|P7|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
5794965|NCT03154086|19977587|P6|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
5794966|NCT03154086|19977588|P5|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
5794967|NCT03154086|19977589|P4|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
5794968|NCT03154086|19977590|P3|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
5794969|NCT03154086|19977591|P2|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
5794970|NCT03154086|19977592|P1|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|1
5794971|NCT03154086|19977578|P15|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
5794972|NCT03154086|19977579|P14|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
5794973|NCT03154086|19977580|P13|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
5794974|NCT03154086|19977581|P12|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
5794975|NCT03154086|19977582|P11|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
5794976|NCT03154086|19977583|P10|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
5794977|NCT03154086|19977584|P9|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
5794978|NCT03154086|19977585|P8|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
5794979|NCT03154086|19977586|P7|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
5794980|NCT03154086|19977587|P6|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
5794981|NCT03154086|19977588|P5|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
5794982|NCT03154086|19977589|P4|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
5794983|NCT03154086|19977590|P3|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|1
5794984|NCT03154086|19977591|P2|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
5794985|NCT03154086|19977592|P1|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
5794986|NCT03154086|19977578|P15|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
5794987|NCT03154086|19977579|P14|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
5794988|NCT03154086|19977580|P13|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
5794989|NCT03154086|19977581|P12|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
5794990|NCT03154086|19977582|P11|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
5794991|NCT03154086|19977583|P10|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
5794992|NCT03154086|19977584|P9|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
5794993|NCT03154086|19977585|P8|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
5794994|NCT03154086|19977586|P7|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
5794995|NCT03154086|19977587|P6|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
5794996|NCT03154086|19977588|P5|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
5794997|NCT03154086|19977589|P4|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
5794998|NCT03154086|19977590|P3|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
5794999|NCT03154086|19977591|P2|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|1
5795000|NCT03154086|19977592|P1|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
5795001|NCT03154086|19977578|P15|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
5795002|NCT03154086|19977579|P14|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
5795003|NCT03154086|19977580|P13|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
5795004|NCT03154086|19977581|P12|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
5795005|NCT03154086|19977582|P11|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
5795006|NCT03154086|19977583|P10|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
5795007|NCT03154086|19977584|P9|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
5795008|NCT03154086|19977585|P8|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
5795009|NCT03154086|19977586|P7|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
5795010|NCT03154086|19977587|P6|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
5795011|NCT03154086|19977588|P5|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
5795012|NCT03154086|19977589|P4|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|1
5795013|NCT03154086|19977590|P3|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
5795014|NCT03154086|19977591|P2|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
5795015|NCT03154086|19977592|P1|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
5795016|NCT03154047|19977992|P1|Overall Study|Withdrawal by Subject|3
5795017|NCT03154047|19977992|P1|Overall Study|Study terminated by sponsor|76
5795018|NCT03154047|19977992|P1|Overall Study|Death|1
5795019|NCT03152552|19978039|P5|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|11
5795020|NCT03152552|19978040|P4|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9
5795021|NCT03152552|19978041|P3|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9
5795022|NCT03152552|19978042|P2|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|5
5795023|NCT03152552|19978043|P1|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|6
5795024|NCT03152552|19978039|P5|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0
5795025|NCT03152552|19978040|P4|Treatment Period 1 (12 Weeks)|Subject/guardian decision|1
5795026|NCT03152552|19978041|P3|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0
5795027|NCT03152552|19978042|P2|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0
5795028|NCT03152552|19978043|P1|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0
5795029|NCT03152552|19978039|P5|Treatment Period 1 (12 Weeks)|Technical problems|0
5795030|NCT03152552|19978040|P4|Treatment Period 1 (12 Weeks)|Technical problems|0
5795031|NCT03152552|19978041|P3|Treatment Period 1 (12 Weeks)|Technical problems|1
5795032|NCT03152552|19978042|P2|Treatment Period 1 (12 Weeks)|Technical problems|0
5795033|NCT03152552|19978043|P1|Treatment Period 1 (12 Weeks)|Technical problems|0
5795034|NCT03152552|19978039|P5|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
5795035|NCT03152552|19978040|P4|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
5795036|NCT03152552|19978041|P3|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
5795037|NCT03152552|19978042|P2|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
5795038|NCT03152552|19978043|P1|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
5795039|NCT03152552|19978039|P5|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|20
5795040|NCT03152552|19978040|P4|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19
5795041|NCT03152552|19978041|P3|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19
5795042|NCT03152552|19978042|P2|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|9
5795043|NCT03152552|19978043|P1|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|8
5795044|NCT03152552|19978039|P5|Treatment Period 1 (12 Weeks)|Protocol deviation|0
5795045|NCT03152552|19978040|P4|Treatment Period 1 (12 Weeks)|Protocol deviation|0
5795046|NCT03152552|19978041|P3|Treatment Period 1 (12 Weeks)|Protocol deviation|0
5795047|NCT03152552|19978042|P2|Treatment Period 1 (12 Weeks)|Protocol deviation|1
5795048|NCT03152552|19978043|P1|Treatment Period 1 (12 Weeks)|Protocol deviation|0
5795049|NCT03152552|19978039|P5|Treatment Period 1 (12 Weeks)|Death|1
5795050|NCT03152552|19978040|P4|Treatment Period 1 (12 Weeks)|Death|0
5795051|NCT03152552|19978041|P3|Treatment Period 1 (12 Weeks)|Death|0
5795052|NCT03152552|19978042|P2|Treatment Period 1 (12 Weeks)|Death|1
5795053|NCT03152552|19978043|P1|Treatment Period 1 (12 Weeks)|Death|0
5795054|NCT03152526|19978176|P2|Overall Study|Withdrawal by Subject|1
5795055|NCT03152526|19978177|P1|Overall Study|Withdrawal by Subject|0
5795056|NCT03152110|19978197|P1|Overall Study|Withdrawal by Subject|3
5795057|NCT03152019|19978212|P2|Overall Study|Adverse Event|1
5795058|NCT03152019|19978213|P1|Overall Study|Adverse Event|0
5795059|NCT03151551|19978221|P2|Post-Treatment Follow-Up Period|Physician Decision|1
5795060|NCT03151551|19978222|P1|Post-Treatment Follow-Up Period|Physician Decision|0
5795061|NCT03151551|19978221|P2|Post-Treatment Follow-Up Period|Withdrawal by Subject|22
5795062|NCT03151551|19978222|P1|Post-Treatment Follow-Up Period|Withdrawal by Subject|20
5795063|NCT03151551|19978221|P2|Post-Treatment Follow-Up Period|Lost to Follow-up|2
5795064|NCT03151551|19978222|P1|Post-Treatment Follow-Up Period|Lost to Follow-up|4
5795065|NCT03151551|19978221|P2|Post-Treatment Follow-Up Period|Adverse Event|3
5795066|NCT03151551|19978222|P1|Post-Treatment Follow-Up Period|Adverse Event|1
5795067|NCT03151551|19978221|P2|Open-Label Treatment Period|Protocol Deviation|2
5795068|NCT03151551|19978222|P1|Open-Label Treatment Period|Protocol Deviation|1
5795069|NCT03151551|19978221|P2|Open-Label Treatment Period|Physician Decision|0
5795070|NCT03151551|19978222|P1|Open-Label Treatment Period|Physician Decision|3
5795071|NCT03151551|19978221|P2|Open-Label Treatment Period|Lack of Efficacy|1
5795072|NCT03151551|19978222|P1|Open-Label Treatment Period|Lack of Efficacy|1
5795073|NCT03151551|19978221|P2|Open-Label Treatment Period|Withdrawal by Subject|18
5795074|NCT03151551|19978222|P1|Open-Label Treatment Period|Withdrawal by Subject|12
5795075|NCT03151551|19978221|P2|Open-Label Treatment Period|Lost to Follow-up|1
5795076|NCT03151551|19978222|P1|Open-Label Treatment Period|Lost to Follow-up|1
5795077|NCT03151551|19978221|P2|Open-Label Treatment Period|Adverse Event|2
5795078|NCT03151551|19978222|P1|Open-Label Treatment Period|Adverse Event|0
5795079|NCT03151226|19978342|P1|Overall Study|not wear device correctly|1
5795080|NCT03151226|19978342|P1|Overall Study|Withdrawal by Subject|2
5795081|NCT03151148|19978348|P2|Overall Study|Withdrawal by Subject|0
5795082|NCT03151148|19978349|P1|Overall Study|Withdrawal by Subject|1
5795083|NCT03151148|19978348|P2|Overall Study|Lost to Follow-up|0
5795084|NCT03151148|19978349|P1|Overall Study|Lost to Follow-up|1
5795085|NCT03150719|19978423|P2|Overall Study|Other|0
5795086|NCT03150719|19978424|P1|Overall Study|Other|1
5795087|NCT03150719|19978423|P2|Overall Study|Death|1
5795088|NCT03150719|19978424|P1|Overall Study|Death|0
5795089|NCT03150719|19978423|P2|Overall Study|Adverse Event|1
5795090|NCT03150719|19978424|P1|Overall Study|Adverse Event|0
5795091|NCT03150485|19978440|P6|Overall Study|Unsatisfactory Lens Fitting|0
5795092|NCT03150485|19978441|P5|Overall Study|Unsatisfactory Lens Fitting|0
5795093|NCT03150485|19978442|P4|Overall Study|Unsatisfactory Lens Fitting|0
5795094|NCT03150485|19978443|P3|Overall Study|Unsatisfactory Lens Fitting|0
5795095|NCT03150485|19978444|P2|Overall Study|Unsatisfactory Lens Fitting|1
5795096|NCT03150485|19978445|P1|Overall Study|Unsatisfactory Lens Fitting|0
5795097|NCT03150082|19978622|P2|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0
5795098|NCT03150082|19978623|P1|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|1
5795099|NCT03149848|19978729|P1|Period 2 (Day 15 to Day 28)|Adverse Event|2
5795100|NCT03149848|19978729|P1|Period 1 (Day 1 to Day 14)|Protocol-Defined Stopping criteria|1
5795101|NCT03149055|19978782|P1|Overall Study|Not treated|4
5795102|NCT03149042|19978787|P1|Overall Study|Invasive FFR Measurement cancelled|1
5795103|NCT03149042|19978787|P1|Overall Study|Poor CT Image Quality|1
5795104|NCT03149042|19978787|P1|Overall Study|Invasive FFR not performed|21
5795105|NCT03148756|19978801|P2|Overall Study|Study Terminated|1
5795106|NCT03148756|19978802|P1|Overall Study|Study Terminated|0
5795107|NCT03148691|19978835|P3|Overall Study|Withdrawal by Subject|0
5795108|NCT03148691|19978836|P2|Overall Study|Withdrawal by Subject|0
5795109|NCT03148691|19978837|P1|Overall Study|Withdrawal by Subject|1
5795110|NCT03148691|19978835|P3|Overall Study|Other|0
5795111|NCT03148691|19978836|P2|Overall Study|Other|0
5795112|NCT03148691|19978837|P1|Overall Study|Other|1
5795113|NCT03148691|19978835|P3|Overall Study|Lost to Follow-up|1
5795114|NCT03148691|19978836|P2|Overall Study|Lost to Follow-up|0
5795115|NCT03148691|19978837|P1|Overall Study|Lost to Follow-up|0
5795116|NCT03148691|19978835|P3|Overall Study|Protocol Violation|7
5795117|NCT03148691|19978836|P2|Overall Study|Protocol Violation|2
5795118|NCT03148691|19978837|P1|Overall Study|Protocol Violation|1
5795119|NCT03148067|19978900|P1|Overall Study|Death|1
5795120|NCT03148067|19978900|P1|Overall Study|Lost to Follow-up|3
5795121|NCT03147495|19978929|P2|Overall Study|Physician Decision|6
5795122|NCT03147495|19978930|P1|Overall Study|Physician Decision|0
5795123|NCT03147248|19978952|P6|Overall Study|Prolonged Dosing Interval|1
5795124|NCT03147248|19978953|P5|Overall Study|Prolonged Dosing Interval|1
5795125|NCT03147248|19978954|P4|Overall Study|Prolonged Dosing Interval|0
5795126|NCT03147248|19978955|P3|Overall Study|Prolonged Dosing Interval|0
5795127|NCT03147248|19978956|P2|Overall Study|Prolonged Dosing Interval|0
5795128|NCT03147248|19978957|P1|Overall Study|Prolonged Dosing Interval|0
5795129|NCT03147248|19978952|P6|Overall Study|Physician Decision|4
5795130|NCT03147248|19978953|P5|Overall Study|Physician Decision|2
5795131|NCT03147248|19978954|P4|Overall Study|Physician Decision|0
5795132|NCT03147248|19978955|P3|Overall Study|Physician Decision|0
5795133|NCT03147248|19978956|P2|Overall Study|Physician Decision|0
5795134|NCT03147248|19978957|P1|Overall Study|Physician Decision|0
5795135|NCT03147248|19978952|P6|Overall Study|Death|4
5795136|NCT03147248|19978953|P5|Overall Study|Death|0
5795137|NCT03147248|19978954|P4|Overall Study|Death|0
5795138|NCT03147248|19978955|P3|Overall Study|Death|0
5795139|NCT03147248|19978956|P2|Overall Study|Death|0
5795140|NCT03147248|19978957|P1|Overall Study|Death|0
5795141|NCT03147248|19978952|P6|Overall Study|Pregnancy|0
5795142|NCT03147248|19978953|P5|Overall Study|Pregnancy|1
5795143|NCT03147248|19978954|P4|Overall Study|Pregnancy|0
5795144|NCT03147248|19978955|P3|Overall Study|Pregnancy|0
5795145|NCT03147248|19978956|P2|Overall Study|Pregnancy|0
5795146|NCT03147248|19978957|P1|Overall Study|Pregnancy|0
5795147|NCT03147248|19978952|P6|Overall Study|Lost to Follow-up|0
5795148|NCT03147248|19978953|P5|Overall Study|Lost to Follow-up|2
5795149|NCT03147248|19978954|P4|Overall Study|Lost to Follow-up|0
5795150|NCT03147248|19978955|P3|Overall Study|Lost to Follow-up|0
5795151|NCT03147248|19978956|P2|Overall Study|Lost to Follow-up|0
5795152|NCT03147248|19978957|P1|Overall Study|Lost to Follow-up|0
5795153|NCT03147248|19978952|P6|Overall Study|Protocol Violation|0
5795154|NCT03147248|19978953|P5|Overall Study|Protocol Violation|2
5795155|NCT03147248|19978954|P4|Overall Study|Protocol Violation|0
5795156|NCT03147248|19978955|P3|Overall Study|Protocol Violation|0
5795157|NCT03147248|19978956|P2|Overall Study|Protocol Violation|0
5795158|NCT03147248|19978957|P1|Overall Study|Protocol Violation|0
5795159|NCT03147248|19978952|P6|Overall Study|Withdrawal by Subject|9
5795160|NCT03147248|19978953|P5|Overall Study|Withdrawal by Subject|12
5795161|NCT03147248|19978954|P4|Overall Study|Withdrawal by Subject|0
5795162|NCT03147248|19978955|P3|Overall Study|Withdrawal by Subject|0
5795163|NCT03147248|19978956|P2|Overall Study|Withdrawal by Subject|0
5795164|NCT03147248|19978957|P1|Overall Study|Withdrawal by Subject|0
5795165|NCT03147248|19978952|P6|Overall Study|Disease progression|2
5795166|NCT03147248|19978953|P5|Overall Study|Disease progression|0
5795167|NCT03147248|19978954|P4|Overall Study|Disease progression|0
5795168|NCT03147248|19978955|P3|Overall Study|Disease progression|0
5795169|NCT03147248|19978956|P2|Overall Study|Disease progression|0
5795170|NCT03147248|19978957|P1|Overall Study|Disease progression|1
5795171|NCT03147248|19978952|P6|Overall Study|Adverse Event|11
5795172|NCT03147248|19978953|P5|Overall Study|Adverse Event|6
5795173|NCT03147248|19978954|P4|Overall Study|Adverse Event|2
5795174|NCT03147248|19978955|P3|Overall Study|Adverse Event|2
5795175|NCT03147248|19978956|P2|Overall Study|Adverse Event|2
5795176|NCT03147248|19978957|P1|Overall Study|Adverse Event|0
5795177|NCT03146741|19978979|P1|Overall Study|Awaiting txp|2
5795178|NCT03146741|19978979|P1|Overall Study|Physician Decision|2
5795179|NCT03146741|19978979|P1|Overall Study|Listeted for MOT|2
5795180|NCT03146741|19978979|P1|Overall Study|Txp with non-HCV+ heart|4
5795181|NCT03146403|19978999|P2|Overall Study|Lost to Follow-up|0
5795182|NCT03146403|19979000|P1|Overall Study|Lost to Follow-up|2
5795183|NCT03146403|19978999|P2|Overall Study|Withdrawal by Subject|3
5795184|NCT03146403|19979000|P1|Overall Study|Withdrawal by Subject|0
5795185|NCT03145207|19979036|P1|Overall Study|baseline blood pressure high|1
5795186|NCT03145207|19979036|P1|Overall Study|volunteer started taking allergy shots|1
5795187|NCT03144180|19979081|P2|Overall Study|Scrub tech removed tube cap|1
5795188|NCT03144180|19979082|P1|Overall Study|Scrub tech removed tube cap|0
5795189|NCT03144180|19979081|P2|Overall Study|Provider forgot to use the Q-cup|1
5795190|NCT03144180|19979082|P1|Overall Study|Provider forgot to use the Q-cup|0
5795191|NCT03144180|19979081|P2|Overall Study|Provider forgot to fill out forms|3
5795192|NCT03144180|19979082|P1|Overall Study|Provider forgot to fill out forms|1
5795193|NCT03144180|19979081|P2|Overall Study|STAT Delivery|1
5795194|NCT03144180|19979082|P1|Overall Study|STAT Delivery|1
5795195|NCT03143855|19979094|P2|Overall Study|Participant experienced withdrawal|1
5795196|NCT03143855|19979095|P1|Overall Study|Participant experienced withdrawal|0
5795197|NCT03143855|19979094|P2|Overall Study|Protocol Violation|0
5795198|NCT03143855|19979095|P1|Overall Study|Protocol Violation|1
5795199|NCT03143855|19979094|P2|Overall Study|Withdrawal by Subject|3
5795200|NCT03143855|19979095|P1|Overall Study|Withdrawal by Subject|4
5795201|NCT03143166|19979126|P1|Period 2 (Washout of at Least 4 Days)|Withdrawal by Subject|1
5795202|NCT03143101|19979145|P3|Overall Study|Lost to Follow-up|0
5795203|NCT03143101|19979146|P2|Overall Study|Lost to Follow-up|2
5795204|NCT03143101|19979147|P1|Overall Study|Lost to Follow-up|2
5795205|NCT03143101|19979145|P3|Overall Study|Withdrawal by Subject|0
5795206|NCT03143101|19979146|P2|Overall Study|Withdrawal by Subject|1
5795207|NCT03143101|19979147|P1|Overall Study|Withdrawal by Subject|0
5795208|NCT03142932|19979202|P2|Overall Study|Lost to Follow-up|11
5795209|NCT03142932|19979203|P1|Overall Study|Lost to Follow-up|2
5795210|NCT03142750|19979219|P2|Overall Study|Lost to Follow-up|1
5795211|NCT03142750|19979220|P1|Overall Study|Lost to Follow-up|4
5795212|NCT03141788|19979254|P1|Overall Study|Withdrawal by Subject|4
5795213|NCT03141788|19979254|P1|Overall Study|Protocol Violation|3
5795214|NCT03141788|19979254|P1|Overall Study|Lost to Follow-up|1
5795215|NCT03141307|19979335|P2|Follow-Up|Lost to Follow-up|54
5795216|NCT03141307|19979336|P1|Follow-Up|Lost to Follow-up|97
5795217|NCT03141307|19979335|P2|In-Hospital|Protocol Violation|0
5795218|NCT03141307|19979336|P1|In-Hospital|Protocol Violation|4
5795219|NCT03141307|19979335|P2|In-Hospital|Withdrawal by Subject|2
5795220|NCT03141307|19979336|P1|In-Hospital|Withdrawal by Subject|0
5795221|NCT03141151|19979354|P2|Overall Study|Withdrawal by Subject|2
5795222|NCT03141151|19979355|P1|Overall Study|Withdrawal by Subject|3
5795223|NCT03141151|19979354|P2|Overall Study|Lost to Follow-up|2
5795224|NCT03141151|19979355|P1|Overall Study|Lost to Follow-up|3
5795225|NCT03141086|19979373|P2|Overall Study|Adverse Event|2
5795226|NCT03141086|19979374|P1|Overall Study|Adverse Event|0
5795227|NCT03141086|19979373|P2|Overall Study|Protocol Violation|1
5795228|NCT03141086|19979374|P1|Overall Study|Protocol Violation|0
5795229|NCT03141086|19979373|P2|Overall Study|Withdrawal by Subject|1
5795230|NCT03141086|19979374|P1|Overall Study|Withdrawal by Subject|0
5795231|NCT03141086|19979373|P2|Overall Study|Study Terminated By Sponsor|1
5795232|NCT03141086|19979374|P1|Overall Study|Study Terminated By Sponsor|1
5795233|NCT03139604|19979414|P2|Overall Study|Continuing on Study|136
5795234|NCT03139604|19979415|P1|Overall Study|Continuing on Study|134
5795235|NCT03139604|19979414|P2|Overall Study|Death|64
5795236|NCT03139604|19979415|P1|Overall Study|Death|60
5795237|NCT03139604|19979414|P2|Overall Study|Lost to Follow-up|1
5795238|NCT03139604|19979415|P1|Overall Study|Lost to Follow-up|1
5795239|NCT03139604|19979414|P2|Overall Study|Physician Decision|2
5795240|NCT03139604|19979415|P1|Overall Study|Physician Decision|1
5795241|NCT03139604|19979414|P2|Overall Study|Withdrawal by Subject|15
5795242|NCT03139604|19979415|P1|Overall Study|Withdrawal by Subject|16
5795243|NCT03139604|19979414|P2|Overall Study|Other|2
5795244|NCT03139604|19979415|P1|Overall Study|Other|7
5795245|NCT03139552|19979464|P1|Overall Study|unable to attend tasting due to schedule|3
5795246|NCT03139448|19979507|P2|Overall Study|Physician Decision|2
5795247|NCT03139448|19979508|P1|Overall Study|Physician Decision|0
5795248|NCT03139448|19979507|P2|Overall Study|Screen fail|3
5795249|NCT03139448|19979508|P1|Overall Study|Screen fail|1
5795250|NCT03139448|19979507|P2|Overall Study|Withdrawal by Subject|6
5795251|NCT03139448|19979508|P1|Overall Study|Withdrawal by Subject|3
5795252|NCT03139448|19979507|P2|Overall Study|Location of procedure changed|8
5795253|NCT03139448|19979508|P1|Overall Study|Location of procedure changed|2
5795254|NCT03139448|19979507|P2|Overall Study|Lack of Efficacy|7
5795255|NCT03139448|19979508|P1|Overall Study|Lack of Efficacy|6
5795256|NCT03139279|19979532|P2|Overall Study|Withdrawal by Subject|2
5795257|NCT03139279|19979533|P1|Overall Study|Withdrawal by Subject|0
5795258|NCT03139279|19979532|P2|Overall Study|Protocol Violation|4
5795259|NCT03139279|19979533|P1|Overall Study|Protocol Violation|5
5795260|NCT03139279|19979532|P2|Overall Study|Physician Decision|0
5795261|NCT03139279|19979533|P1|Overall Study|Physician Decision|2
5795262|NCT03139240|19979551|P4|Overall Study|Lost to Follow-up|0
5795263|NCT03139240|19979552|P3|Overall Study|Lost to Follow-up|1
5795264|NCT03139240|19979553|P2|Overall Study|Lost to Follow-up|1
5795265|NCT03139240|19979554|P1|Overall Study|Lost to Follow-up|0
5795266|NCT03138967|19979586|P2|Overall Study|Physician Decision|3
5795267|NCT03138967|19979587|P1|Overall Study|Physician Decision|1
5795268|NCT03138967|19979586|P2|Overall Study|Death|1
5795269|NCT03138967|19979587|P1|Overall Study|Death|0
5795270|NCT03138655|19979638|P8|Overall Study|Reason not Specified|0
5795271|NCT03138655|19979639|P7|Overall Study|Reason not Specified|0
5795272|NCT03138655|19979640|P6|Overall Study|Reason not Specified|1
5795273|NCT03138655|19979641|P5|Overall Study|Reason not Specified|1
5795274|NCT03138655|19979642|P4|Overall Study|Reason not Specified|2
5795275|NCT03138655|19979643|P3|Overall Study|Reason not Specified|0
5795276|NCT03138655|19979644|P2|Overall Study|Reason not Specified|0
5795277|NCT03138655|19979645|P1|Overall Study|Reason not Specified|1
5795278|NCT03138655|19979638|P8|Overall Study|Withdrawal by Subject|0
5795279|NCT03138655|19979639|P7|Overall Study|Withdrawal by Subject|1
5795280|NCT03138655|19979640|P6|Overall Study|Withdrawal by Subject|0
5795281|NCT03138655|19979641|P5|Overall Study|Withdrawal by Subject|0
5795282|NCT03138655|19979642|P4|Overall Study|Withdrawal by Subject|0
5795283|NCT03138655|19979643|P3|Overall Study|Withdrawal by Subject|0
5795284|NCT03138655|19979644|P2|Overall Study|Withdrawal by Subject|1
5795285|NCT03138655|19979645|P1|Overall Study|Withdrawal by Subject|0
5795286|NCT03138655|19979638|P8|Overall Study|Adverse Event|2
5795287|NCT03138655|19979639|P7|Overall Study|Adverse Event|2
5795288|NCT03138655|19979640|P6|Overall Study|Adverse Event|4
5795289|NCT03138655|19979641|P5|Overall Study|Adverse Event|1
5795290|NCT03138655|19979642|P4|Overall Study|Adverse Event|1
5795291|NCT03138655|19979643|P3|Overall Study|Adverse Event|2
5795292|NCT03138655|19979644|P2|Overall Study|Adverse Event|1
5795293|NCT03138655|19979645|P1|Overall Study|Adverse Event|2
5795294|NCT03137784|19979766|P6|Overall Study|Non-compliance with study treatment|0
5795295|NCT03137784|19979767|P5|Overall Study|Non-compliance with study treatment|1
5795296|NCT03137784|19979768|P4|Overall Study|Non-compliance with study treatment|0
5795297|NCT03137784|19979769|P3|Overall Study|Non-compliance with study treatment|0
5795298|NCT03137784|19979770|P2|Overall Study|Non-compliance with study treatment|0
5795299|NCT03137784|19979771|P1|Overall Study|Non-compliance with study treatment|0
5795300|NCT03137784|19979766|P6|Overall Study|Subject/guardian decision|0
5795301|NCT03137784|19979767|P5|Overall Study|Subject/guardian decision|0
5795302|NCT03137784|19979768|P4|Overall Study|Subject/guardian decision|0
5795303|NCT03137784|19979769|P3|Overall Study|Subject/guardian decision|0
5795304|NCT03137784|19979770|P2|Overall Study|Subject/guardian decision|0
5795305|NCT03137784|19979771|P1|Overall Study|Subject/guardian decision|1
5795306|NCT03137784|19979766|P6|Overall Study|Adverse Event|0
5795307|NCT03137784|19979767|P5|Overall Study|Adverse Event|0
5795308|NCT03137784|19979768|P4|Overall Study|Adverse Event|0
5795309|NCT03137784|19979769|P3|Overall Study|Adverse Event|0
5795310|NCT03137784|19979770|P2|Overall Study|Adverse Event|1
5795311|NCT03137784|19979771|P1|Overall Study|Adverse Event|1
5795312|NCT03137173|19979827|P2|Overall Study|Other reasons|2
5795313|NCT03137173|19979828|P1|Overall Study|Other reasons|3
5795314|NCT03137173|19979827|P2|Overall Study|Lost to Follow-up|18
5795315|NCT03137173|19979828|P1|Overall Study|Lost to Follow-up|13
5795316|NCT03137173|19979827|P2|Overall Study|Physician Decision|0
5795317|NCT03137173|19979828|P1|Overall Study|Physician Decision|1
5795318|NCT03137173|19979827|P2|Overall Study|Death|3
5795319|NCT03137173|19979828|P1|Overall Study|Death|1
5795320|NCT03137173|19979827|P2|Overall Study|Withdrawal by Subject|13
5795321|NCT03137173|19979828|P1|Overall Study|Withdrawal by Subject|8
5795322|NCT03137069|19979844|P6|Overall Study|Data Entry Error|0
5795323|NCT03137069|19979845|P5|Overall Study|Data Entry Error|0
5795324|NCT03137069|19979846|P4|Overall Study|Data Entry Error|1
5795325|NCT03137069|19979847|P3|Overall Study|Data Entry Error|0
5795326|NCT03137069|19979848|P2|Overall Study|Data Entry Error|0
5795327|NCT03137069|19979849|P1|Overall Study|Data Entry Error|0
5795328|NCT03137069|19979844|P6|Overall Study|Study Terminated by Sponsor|0
5795329|NCT03137069|19979845|P5|Overall Study|Study Terminated by Sponsor|1
5795330|NCT03137069|19979846|P4|Overall Study|Study Terminated by Sponsor|0
5795331|NCT03137069|19979847|P3|Overall Study|Study Terminated by Sponsor|0
5795332|NCT03137069|19979848|P2|Overall Study|Study Terminated by Sponsor|0
5795333|NCT03137069|19979849|P1|Overall Study|Study Terminated by Sponsor|0
5795334|NCT03137069|19979844|P6|Overall Study|Physician Decision|0
5795335|NCT03137069|19979845|P5|Overall Study|Physician Decision|0
5795336|NCT03137069|19979846|P4|Overall Study|Physician Decision|1
5795337|NCT03137069|19979847|P3|Overall Study|Physician Decision|0
5795338|NCT03137069|19979848|P2|Overall Study|Physician Decision|0
5795339|NCT03137069|19979849|P1|Overall Study|Physician Decision|0
5795340|NCT03137069|19979844|P6|Overall Study|Protocol Violation|1
5795341|NCT03137069|19979845|P5|Overall Study|Protocol Violation|1
5795342|NCT03137069|19979846|P4|Overall Study|Protocol Violation|1
5795343|NCT03137069|19979847|P3|Overall Study|Protocol Violation|0
5795344|NCT03137069|19979848|P2|Overall Study|Protocol Violation|1
5795345|NCT03137069|19979849|P1|Overall Study|Protocol Violation|0
5795346|NCT03137069|19979844|P6|Overall Study|Adverse Event|1
5795347|NCT03137069|19979845|P5|Overall Study|Adverse Event|0
5795348|NCT03137069|19979846|P4|Overall Study|Adverse Event|1
5795349|NCT03137069|19979847|P3|Overall Study|Adverse Event|1
5795350|NCT03137069|19979848|P2|Overall Study|Adverse Event|3
5795351|NCT03137069|19979849|P1|Overall Study|Adverse Event|0
5795352|NCT03137069|19979844|P6|Overall Study|Withdrawal by Subject|0
5795353|NCT03137069|19979845|P5|Overall Study|Withdrawal by Subject|0
5795354|NCT03137069|19979846|P4|Overall Study|Withdrawal by Subject|2
5795355|NCT03137069|19979847|P3|Overall Study|Withdrawal by Subject|2
5795356|NCT03137069|19979848|P2|Overall Study|Withdrawal by Subject|2
5795357|NCT03137069|19979849|P1|Overall Study|Withdrawal by Subject|1
5795358|NCT03136861|19979892|P7|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0
5795359|NCT03136861|19979893|P6|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0
5795360|NCT03136861|19979894|P5|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0
5795361|NCT03136861|19979895|P4|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0
5795362|NCT03136861|19979896|P3|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|1
5795363|NCT03136861|19979897|P2|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0
5795364|NCT03136861|19979898|P1|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0
5795365|NCT03136861|19979892|P7|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0
5795366|NCT03136861|19979893|P6|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0
5795367|NCT03136861|19979894|P5|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0
5795368|NCT03136861|19979895|P4|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0
5795369|NCT03136861|19979896|P3|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|1
5795370|NCT03136861|19979897|P2|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0
5795371|NCT03136861|19979898|P1|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0
5795372|NCT03136861|19979892|P7|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1
5795373|NCT03136861|19979893|P6|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0
5795374|NCT03136861|19979894|P5|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|2
5795375|NCT03136861|19979895|P4|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1
5795376|NCT03136861|19979896|P3|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0
5795377|NCT03136861|19979897|P2|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0
5795378|NCT03136861|19979898|P1|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0
5795379|NCT03136861|19979892|P7|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0
5795380|NCT03136861|19979893|P6|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0
5795381|NCT03136861|19979894|P5|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0
5795382|NCT03136861|19979895|P4|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0
5795383|NCT03136861|19979896|P3|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0
5795384|NCT03136861|19979897|P2|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1
5795385|NCT03136861|19979898|P1|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1
5795386|NCT03136861|19979892|P7|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0
5795387|NCT03136861|19979893|P6|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0
5795388|NCT03136861|19979894|P5|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0
5795389|NCT03136861|19979895|P4|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0
5795390|NCT03136861|19979896|P3|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0
5795391|NCT03136861|19979897|P2|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|1
5795392|NCT03136861|19979898|P1|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0
5795393|NCT03136861|19979892|P7|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0
5795394|NCT03136861|19979893|P6|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0
5795395|NCT03136861|19979894|P5|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0
5795396|NCT03136861|19979895|P4|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0
5795397|NCT03136861|19979896|P3|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0
5795398|NCT03136861|19979897|P2|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|1
5795399|NCT03136861|19979898|P1|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|2
5795400|NCT03136861|19979892|P7|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0
5795401|NCT03136861|19979893|P6|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0
5795402|NCT03136861|19979894|P5|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0
5795403|NCT03136861|19979895|P4|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0
5795404|NCT03136861|19979896|P3|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0
5795405|NCT03136861|19979897|P2|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1
5795406|NCT03136861|19979898|P1|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1
5795407|NCT03136861|19979892|P7|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0
5795408|NCT03136861|19979893|P6|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0
5795409|NCT03136861|19979894|P5|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0
5795410|NCT03136861|19979895|P4|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0
5795411|NCT03136861|19979896|P3|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0
5795412|NCT03136861|19979897|P2|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|2
5795413|NCT03136861|19979898|P1|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|3
5795414|NCT03136484|19979913|P2|Overall Study|Death|0
5795415|NCT03136484|19979914|P1|Overall Study|Death|1
5795416|NCT03136484|19979913|P2|Overall Study|Lost to Follow-up|8
5795417|NCT03136484|19979914|P1|Overall Study|Lost to Follow-up|7
5795418|NCT03136484|19979913|P2|Overall Study|Withdrawal by Subject|14
5795419|NCT03136484|19979914|P1|Overall Study|Withdrawal by Subject|19
5795420|NCT03136380|19980042|P5|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0
5795421|NCT03136380|19980043|P4|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0
5795422|NCT03136380|19980044|P3|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0
5795423|NCT03136380|19980045|P2|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|1
5795424|NCT03136380|19980046|P1|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0
5795425|NCT03136367|19980222|P3|T5 1 Year After Surgery|logistical issues prevented contact|2
5795426|NCT03136367|19980223|P2|T5 1 Year After Surgery|logistical issues prevented contact|4
5795427|NCT03136367|19980224|P1|T5 1 Year After Surgery|logistical issues prevented contact|0
5795428|NCT03136367|19980222|P3|T5 1 Year After Surgery|study ended before due|110
5795429|NCT03136367|19980223|P2|T5 1 Year After Surgery|study ended before due|103
5795430|NCT03136367|19980224|P1|T5 1 Year After Surgery|study ended before due|31
5795431|NCT03136367|19980222|P3|T5 1 Year After Surgery|Lost to Follow-up|15
5795432|NCT03136367|19980223|P2|T5 1 Year After Surgery|Lost to Follow-up|22
5795433|NCT03136367|19980224|P1|T5 1 Year After Surgery|Lost to Follow-up|2
5795434|NCT03136367|19980222|P3|T5 1 Year After Surgery|Discontinued lost contact|0
5795435|NCT03136367|19980223|P2|T5 1 Year After Surgery|Discontinued lost contact|6
5795436|NCT03136367|19980224|P1|T5 1 Year After Surgery|Discontinued lost contact|1
5795437|NCT03136367|19980222|P3|T5 1 Year After Surgery|Death|1
5795438|NCT03136367|19980223|P2|T5 1 Year After Surgery|Death|0
5795439|NCT03136367|19980224|P1|T5 1 Year After Surgery|Death|0
5795440|NCT03136367|19980222|P3|T5 1 Year After Surgery|Withdrawal by Subject|0
5795441|NCT03136367|19980223|P2|T5 1 Year After Surgery|Withdrawal by Subject|0
5795442|NCT03136367|19980224|P1|T5 1 Year After Surgery|Withdrawal by Subject|1
5795443|NCT03136367|19980222|P3|T5 1 Year After Surgery|discontinued mistakenly included|1
5795444|NCT03136367|19980223|P2|T5 1 Year After Surgery|discontinued mistakenly included|1
5795445|NCT03136367|19980224|P1|T5 1 Year After Surgery|discontinued mistakenly included|1
5795446|NCT03136367|19980222|P3|T4 12 Weeks After Surgery|discontinued mistakenly included|1
5795447|NCT03136367|19980223|P2|T4 12 Weeks After Surgery|discontinued mistakenly included|0
5795448|NCT03136367|19980224|P1|T4 12 Weeks After Surgery|discontinued mistakenly included|0
5795449|NCT03136367|19980222|P3|T4 12 Weeks After Surgery|discontinued transferred care|5
5795450|NCT03136367|19980223|P2|T4 12 Weeks After Surgery|discontinued transferred care|1
5795451|NCT03136367|19980224|P1|T4 12 Weeks After Surgery|discontinued transferred care|0
5795452|NCT03136367|19980222|P3|T4 12 Weeks After Surgery|discontinued lost contact|0
5795453|NCT03136367|19980223|P2|T4 12 Weeks After Surgery|discontinued lost contact|0
5795454|NCT03136367|19980224|P1|T4 12 Weeks After Surgery|discontinued lost contact|1
5795455|NCT03136367|19980222|P3|T4 12 Weeks After Surgery|Death|3
5795456|NCT03136367|19980223|P2|T4 12 Weeks After Surgery|Death|1
5795457|NCT03136367|19980224|P1|T4 12 Weeks After Surgery|Death|0
5795458|NCT03136367|19980222|P3|T4 12 Weeks After Surgery|Withdrawal by Subject|0
5795459|NCT03136367|19980223|P2|T4 12 Weeks After Surgery|Withdrawal by Subject|3
5795460|NCT03136367|19980224|P1|T4 12 Weeks After Surgery|Withdrawal by Subject|1
5795461|NCT03136367|19980222|P3|T3 1 Week After Surgery|Discontinued lost contact|4
5795462|NCT03136367|19980223|P2|T3 1 Week After Surgery|Discontinued lost contact|2
5795463|NCT03136367|19980224|P1|T3 1 Week After Surgery|Discontinued lost contact|1
5795464|NCT03136367|19980222|P3|T3 1 Week After Surgery|Withdrawal by Subject|2
5795465|NCT03136367|19980223|P2|T3 1 Week After Surgery|Withdrawal by Subject|6
5795466|NCT03136367|19980224|P1|T3 1 Week After Surgery|Withdrawal by Subject|0
5795467|NCT03136367|19980222|P3|T3 1 Week After Surgery|other discontinued|3
5795468|NCT03136367|19980223|P2|T3 1 Week After Surgery|other discontinued|4
5795469|NCT03136367|19980224|P1|T3 1 Week After Surgery|other discontinued|2
5795470|NCT03136367|19980222|P3|T3 1 Week After Surgery|Discontinued transferred care|14
5795471|NCT03136367|19980223|P2|T3 1 Week After Surgery|Discontinued transferred care|11
5795472|NCT03136367|19980224|P1|T3 1 Week After Surgery|Discontinued transferred care|2
5795473|NCT03136367|19980222|P3|T3 1 Week After Surgery|Discontinued mistakenly included|8
5795474|NCT03136367|19980223|P2|T3 1 Week After Surgery|Discontinued mistakenly included|9
5795475|NCT03136367|19980224|P1|T3 1 Week After Surgery|Discontinued mistakenly included|5
5795476|NCT03136367|19980222|P3|T2 Post-consultation|Discontinued lost contact|0
5795477|NCT03136367|19980223|P2|T2 Post-consultation|Discontinued lost contact|1
5795478|NCT03136367|19980224|P1|T2 Post-consultation|Discontinued lost contact|0
5795479|NCT03136367|19980222|P3|T2 Post-consultation|Discontinued transferred care|3
5795480|NCT03136367|19980223|P2|T2 Post-consultation|Discontinued transferred care|0
5795481|NCT03136367|19980224|P1|T2 Post-consultation|Discontinued transferred care|0
5795482|NCT03136367|19980222|P3|T2 Post-consultation|Discontinued other|6
5795483|NCT03136367|19980223|P2|T2 Post-consultation|Discontinued other|2
5795484|NCT03136367|19980224|P1|T2 Post-consultation|Discontinued other|0
5795485|NCT03136367|19980222|P3|T2 Post-consultation|discontinued mistakenly included|17
5795486|NCT03136367|19980223|P2|T2 Post-consultation|discontinued mistakenly included|2
5795487|NCT03136367|19980224|P1|T2 Post-consultation|discontinued mistakenly included|2
5795488|NCT03136367|19980222|P3|T2 Post-consultation|Withdrawal by Subject|5
5795489|NCT03136367|19980223|P2|T2 Post-consultation|Withdrawal by Subject|1
5795490|NCT03136367|19980224|P1|T2 Post-consultation|Withdrawal by Subject|1
5795491|NCT03136367|19980222|P3|T1 Consultation|Discontinued other|0
5795492|NCT03136367|19980223|P2|T1 Consultation|Discontinued other|1
5795493|NCT03136367|19980224|P1|T1 Consultation|Discontinued other|0
5795494|NCT03136367|19980222|P3|T1 Consultation|discontinued mistakenly included|1
5795495|NCT03136367|19980223|P2|T1 Consultation|discontinued mistakenly included|6
5795496|NCT03136367|19980224|P1|T1 Consultation|discontinued mistakenly included|2
5795497|NCT03136198|19980269|P2|Overall Study|Withdrawal by Subject|1
5795498|NCT03136198|19980270|P1|Overall Study|Withdrawal by Subject|0
5795499|NCT03136159|19980278|P2|Overall Study|never got dressing placed|0
5795500|NCT03136159|19980279|P1|Overall Study|never got dressing placed|1
5795501|NCT03136159|19980278|P2|Overall Study|additional dressing|0
5795502|NCT03136159|19980279|P1|Overall Study|additional dressing|1
5795503|NCT03136159|19980278|P2|Overall Study|vertical skin incision|0
5795504|NCT03136159|19980279|P1|Overall Study|vertical skin incision|1
5795505|NCT03136159|19980278|P2|Overall Study|chorioamnionitis|0
5795506|NCT03136159|19980279|P1|Overall Study|chorioamnionitis|2
5795507|NCT03136107|19980285|P1|Overall Study|Other (Not specified)|1
5795508|NCT03136068|19980295|P2|Overall Study|Protocol Violation|0
5795509|NCT03136068|19980296|P1|Overall Study|Protocol Violation|1
5795510|NCT03136068|19980295|P2|Overall Study|Lost to Follow-up|1
5795511|NCT03136068|19980296|P1|Overall Study|Lost to Follow-up|1
5795512|NCT03135899|19980318|P8|Overall Study|Withdrawal by Subject|0
5795513|NCT03135899|19980319|P7|Overall Study|Withdrawal by Subject|0
5795514|NCT03135899|19980320|P6|Overall Study|Withdrawal by Subject|2
5795515|NCT03135899|19980321|P5|Overall Study|Withdrawal by Subject|0
5795516|NCT03135899|19980322|P4|Overall Study|Withdrawal by Subject|0
5795517|NCT03135899|19980323|P3|Overall Study|Withdrawal by Subject|0
5795518|NCT03135899|19980324|P2|Overall Study|Withdrawal by Subject|0
5795519|NCT03135899|19980325|P1|Overall Study|Withdrawal by Subject|0
5795520|NCT03135899|19980318|P8|Overall Study|Failed spirometry,unable to repeat visit|0
5795521|NCT03135899|19980319|P7|Overall Study|Failed spirometry,unable to repeat visit|1
5795522|NCT03135899|19980320|P6|Overall Study|Failed spirometry,unable to repeat visit|0
5795523|NCT03135899|19980321|P5|Overall Study|Failed spirometry,unable to repeat visit|0
5795524|NCT03135899|19980322|P4|Overall Study|Failed spirometry,unable to repeat visit|0
5795525|NCT03135899|19980323|P3|Overall Study|Failed spirometry,unable to repeat visit|0
5795526|NCT03135899|19980324|P2|Overall Study|Failed spirometry,unable to repeat visit|0
5795527|NCT03135899|19980325|P1|Overall Study|Failed spirometry,unable to repeat visit|0
5795528|NCT03135548|19980358|P3|Overall Study|Other than listed|2
5795529|NCT03135548|19980359|P2|Overall Study|Other than listed|2
5795530|NCT03135548|19980360|P1|Overall Study|Other than listed|0
5795531|NCT03135548|19980358|P3|Overall Study|Withdrawal by Subject|1
5795532|NCT03135548|19980359|P2|Overall Study|Withdrawal by Subject|2
5795533|NCT03135548|19980360|P1|Overall Study|Withdrawal by Subject|2
5795534|NCT03135548|19980358|P3|Overall Study|Lost to Follow-up|0
5795535|NCT03135548|19980359|P2|Overall Study|Lost to Follow-up|0
5795536|NCT03135548|19980360|P1|Overall Study|Lost to Follow-up|3
5795537|NCT03135522|19980390|P2|Overall Study|Adverse Event|0
5795538|NCT03135522|19980391|P1|Overall Study|Adverse Event|1
5795539|NCT03135431|19980405|P2|Overall Study|Study Surgeon not available|0
5795540|NCT03135431|19980406|P1|Overall Study|Study Surgeon not available|2
5795541|NCT03135028|19980427|P1|Overall Study|Withdrew Consent|1
5795542|NCT03135028|19980427|P1|Overall Study|Study Terminated by Sponsor|2
5795543|NCT03135028|19980427|P1|Overall Study|Death|6
5795544|NCT03134911|19980573|P1|Overall Study|Not meeting inclusion/exclusion criteria|3
5795545|NCT03134911|19980573|P1|Overall Study|Screen failure|31
5795546|NCT03134599|19980635|P6|Week 3|Lost to Follow-up|1
5795547|NCT03134599|19980636|P5|Week 3|Lost to Follow-up|0
5795548|NCT03134599|19980637|P4|Week 3|Lost to Follow-up|1
5795549|NCT03134599|19980638|P3|Week 3|Lost to Follow-up|0
5795550|NCT03134599|19980639|P2|Week 3|Lost to Follow-up|0
5795551|NCT03134599|19980640|P1|Week 3|Lost to Follow-up|0
5795552|NCT03134599|19980635|P6|Week 2|Lost to Follow-up|0
5795553|NCT03134599|19980636|P5|Week 2|Lost to Follow-up|1
5795554|NCT03134599|19980637|P4|Week 2|Lost to Follow-up|1
5795555|NCT03134599|19980638|P3|Week 2|Lost to Follow-up|0
5795556|NCT03134599|19980639|P2|Week 2|Lost to Follow-up|0
5795557|NCT03134599|19980640|P1|Week 2|Lost to Follow-up|1
5795558|NCT03134599|19980635|P6|Week 1|Lost to Follow-up|0
5795559|NCT03134599|19980636|P5|Week 1|Lost to Follow-up|1
5795560|NCT03134599|19980637|P4|Week 1|Lost to Follow-up|0
5795561|NCT03134599|19980638|P3|Week 1|Lost to Follow-up|0
5795562|NCT03134599|19980639|P2|Week 1|Lost to Follow-up|0
5795563|NCT03134599|19980640|P1|Week 1|Lost to Follow-up|0
5795564|NCT03134222|19980680|P5|Treatment Period (Week 12 to 48)|Lost to Follow-up|0
5795565|NCT03134222|19980681|P4|Treatment Period (Week 12 to 48)|Lost to Follow-up|0
5795566|NCT03134222|19980682|P3|Treatment Period (Week 12 to 48)|Lost to Follow-up|0
5795567|NCT03134222|19980683|P2|Treatment Period (Week 12 to 48)|Lost to Follow-up|1
5795568|NCT03134222|19980684|P1|Treatment Period (Week 12 to 48)|Lost to Follow-up|0
5795569|NCT03134222|19980680|P5|Treatment Period (Week 12 to 48)|Investigator's Discretion|0
5795570|NCT03134222|19980681|P4|Treatment Period (Week 12 to 48)|Investigator's Discretion|1
5795571|NCT03134222|19980682|P3|Treatment Period (Week 12 to 48)|Investigator's Discretion|0
5795572|NCT03134222|19980683|P2|Treatment Period (Week 12 to 48)|Investigator's Discretion|0
5795573|NCT03134222|19980684|P1|Treatment Period (Week 12 to 48)|Investigator's Discretion|0
5795574|NCT03134222|19980680|P5|Treatment Period (Week 12 to 48)|Lack of Efficacy|0
5795575|NCT03134222|19980681|P4|Treatment Period (Week 12 to 48)|Lack of Efficacy|0
5795576|NCT03134222|19980682|P3|Treatment Period (Week 12 to 48)|Lack of Efficacy|0
5795577|NCT03134222|19980683|P2|Treatment Period (Week 12 to 48)|Lack of Efficacy|0
5795578|NCT03134222|19980684|P1|Treatment Period (Week 12 to 48)|Lack of Efficacy|2
5795579|NCT03134222|19980680|P5|Treatment Period (Week 12 to 48)|Withdrew Consent|1
5795580|NCT03134222|19980681|P4|Treatment Period (Week 12 to 48)|Withdrew Consent|0
5795581|NCT03134222|19980682|P3|Treatment Period (Week 12 to 48)|Withdrew Consent|0
5795582|NCT03134222|19980683|P2|Treatment Period (Week 12 to 48)|Withdrew Consent|2
5795583|NCT03134222|19980684|P1|Treatment Period (Week 12 to 48)|Withdrew Consent|0
5795584|NCT03134222|19980680|P5|Treatment Period (Up to Week 12)|Randomized but not treated|0
5795585|NCT03134222|19980681|P4|Treatment Period (Up to Week 12)|Randomized but not treated|0
5795586|NCT03134222|19980682|P3|Treatment Period (Up to Week 12)|Randomized but not treated|1
5795587|NCT03134222|19980683|P2|Treatment Period (Up to Week 12)|Randomized but not treated|1
5795588|NCT03134222|19980684|P1|Treatment Period (Up to Week 12)|Randomized but not treated|0
5795589|NCT03134222|19980680|P5|Treatment Period (Up to Week 12)|Withdrew Consent|0
5795590|NCT03134222|19980681|P4|Treatment Period (Up to Week 12)|Withdrew Consent|0
5795591|NCT03134222|19980682|P3|Treatment Period (Up to Week 12)|Withdrew Consent|0
5795592|NCT03134222|19980683|P2|Treatment Period (Up to Week 12)|Withdrew Consent|1
5795593|NCT03134222|19980684|P1|Treatment Period (Up to Week 12)|Withdrew Consent|0
5795594|NCT03134222|19980680|P5|Treatment Period (Up to Week 12)|Lost to Follow-up|0
5795595|NCT03134222|19980681|P4|Treatment Period (Up to Week 12)|Lost to Follow-up|0
5795596|NCT03134222|19980682|P3|Treatment Period (Up to Week 12)|Lost to Follow-up|1
5795597|NCT03134222|19980683|P2|Treatment Period (Up to Week 12)|Lost to Follow-up|1
5795598|NCT03134222|19980684|P1|Treatment Period (Up to Week 12)|Lost to Follow-up|1
5795599|NCT03134222|19980680|P5|Treatment Period (Up to Week 12)|Adverse Event|0
5795600|NCT03134222|19980681|P4|Treatment Period (Up to Week 12)|Adverse Event|0
5795601|NCT03134222|19980682|P3|Treatment Period (Up to Week 12)|Adverse Event|0
5795602|NCT03134222|19980683|P2|Treatment Period (Up to Week 12)|Adverse Event|1
5795603|NCT03134222|19980684|P1|Treatment Period (Up to Week 12)|Adverse Event|4
5795604|NCT03134183|19980706|P2|Overall Study|Withdrawal by Subject|1
5795605|NCT03134183|19980707|P1|Overall Study|Withdrawal by Subject|1
5795606|NCT03133767|19980758|P2|Overall Study|Protocol Violation|1
5795607|NCT03133767|19980759|P1|Overall Study|Protocol Violation|0
5795608|NCT03133767|19980758|P2|Overall Study|Lost to Follow-up|24
5795609|NCT03133767|19980759|P1|Overall Study|Lost to Follow-up|38
5795610|NCT03133481|19980775|P2|Overall Study|FC Catheter fell out post operative day1|4
5795611|NCT03133481|19980776|P1|Overall Study|FC Catheter fell out post operative day1|0
5795612|NCT03132753|19980806|P2|6 Month Follow-Up - 12 Month Follow-Up|Lost to Follow-up|2
5795613|NCT03132753|19980807|P1|6 Month Follow-Up - 12 Month Follow-Up|Lost to Follow-up|6
5795614|NCT03132753|19980806|P2|Baseline - 6 Month Follow-Up|Lost to Follow-up|32
5795615|NCT03132753|19980807|P1|Baseline - 6 Month Follow-Up|Lost to Follow-up|27
5795616|NCT03132220|19980952|P2|Overall Study|Withdrawal by Subject|4
5795617|NCT03132220|19980953|P1|Overall Study|Withdrawal by Subject|1
5795618|NCT03132220|19980952|P2|Overall Study|Lost to Follow-up|8
5795619|NCT03132220|19980953|P1|Overall Study|Lost to Follow-up|17
5795620|NCT03131999|19980981|P2|Overall Study|Withdrawal by Subject|1
5795621|NCT03131999|19980982|P1|Overall Study|Withdrawal by Subject|0
5795622|NCT03131895|19980994|P4|Intervention Period 2 (2 Days)|Withdrawal by Subject|0
5795623|NCT03131895|19980995|P3|Intervention Period 2 (2 Days)|Withdrawal by Subject|0
5795624|NCT03131895|19980996|P2|Intervention Period 2 (2 Days)|Withdrawal by Subject|0
5795625|NCT03131895|19980997|P1|Intervention Period 2 (2 Days)|Withdrawal by Subject|1
5795626|NCT03131895|19980994|P4|Intervention Period 2 (2 Days)|Lost to Follow-up|0
5795627|NCT03131895|19980995|P3|Intervention Period 2 (2 Days)|Lost to Follow-up|0
5795628|NCT03131895|19980996|P2|Intervention Period 2 (2 Days)|Lost to Follow-up|1
5795629|NCT03131895|19980997|P1|Intervention Period 2 (2 Days)|Lost to Follow-up|0
5795630|NCT03131895|19980994|P4|Washout Period (at Least 5 Days)|Other|0
5795631|NCT03131895|19980995|P3|Washout Period (at Least 5 Days)|Other|2
5795632|NCT03131895|19980996|P2|Washout Period (at Least 5 Days)|Other|0
5795633|NCT03131895|19980997|P1|Washout Period (at Least 5 Days)|Other|0
5795634|NCT03131895|19980994|P4|Washout Period (at Least 5 Days)|Withdrawal by Subject|1
5795635|NCT03131895|19980995|P3|Washout Period (at Least 5 Days)|Withdrawal by Subject|0
5795636|NCT03131895|19980996|P2|Washout Period (at Least 5 Days)|Withdrawal by Subject|2
5795637|NCT03131895|19980997|P1|Washout Period (at Least 5 Days)|Withdrawal by Subject|0
5795638|NCT03131895|19980994|P4|Washout Period (at Least 5 Days)|Lost to Follow-up|3
5795639|NCT03131895|19980995|P3|Washout Period (at Least 5 Days)|Lost to Follow-up|2
5795640|NCT03131895|19980996|P2|Washout Period (at Least 5 Days)|Lost to Follow-up|3
5795641|NCT03131895|19980997|P1|Washout Period (at Least 5 Days)|Lost to Follow-up|0
5795642|NCT03131895|19980994|P4|Washout Period (at Least 5 Days)|Adverse Event|1
5795643|NCT03131895|19980995|P3|Washout Period (at Least 5 Days)|Adverse Event|0
5795644|NCT03131895|19980996|P2|Washout Period (at Least 5 Days)|Adverse Event|0
5795645|NCT03131895|19980997|P1|Washout Period (at Least 5 Days)|Adverse Event|1
5795646|NCT03131713|19981017|P2|Overall Study|Lost to Follow-up|0
5795647|NCT03131713|19981018|P1|Overall Study|Lost to Follow-up|5
5795648|NCT03131687|19981042|P6|Overall Study|Inadvertent Enrollment|0
5795649|NCT03131687|19981043|P5|Overall Study|Inadvertent Enrollment|0
5795650|NCT03131687|19981044|P4|Overall Study|Inadvertent Enrollment|1
5795651|NCT03131687|19981045|P3|Overall Study|Inadvertent Enrollment|0
5795652|NCT03131687|19981046|P2|Overall Study|Inadvertent Enrollment|0
5795653|NCT03131687|19981047|P1|Overall Study|Inadvertent Enrollment|0
5795654|NCT03131687|19981042|P6|Overall Study|Principle Investigator Decision|0
5795655|NCT03131687|19981043|P5|Overall Study|Principle Investigator Decision|0
5795656|NCT03131687|19981044|P4|Overall Study|Principle Investigator Decision|0
5795657|NCT03131687|19981045|P3|Overall Study|Principle Investigator Decision|0
5795658|NCT03131687|19981046|P2|Overall Study|Principle Investigator Decision|1
5795659|NCT03131687|19981047|P1|Overall Study|Principle Investigator Decision|0
5795660|NCT03131687|19981042|P6|Overall Study|Participant Started New Diabetic Drug|0
5795661|NCT03131687|19981043|P5|Overall Study|Participant Started New Diabetic Drug|0
5795662|NCT03131687|19981044|P4|Overall Study|Participant Started New Diabetic Drug|0
5795663|NCT03131687|19981045|P3|Overall Study|Participant Started New Diabetic Drug|0
5795664|NCT03131687|19981046|P2|Overall Study|Participant Started New Diabetic Drug|0
5795665|NCT03131687|19981047|P1|Overall Study|Participant Started New Diabetic Drug|1
5795666|NCT03131687|19981042|P6|Overall Study|Lost to Follow-up|2
5795667|NCT03131687|19981043|P5|Overall Study|Lost to Follow-up|4
5795668|NCT03131687|19981044|P4|Overall Study|Lost to Follow-up|1
5795669|NCT03131687|19981045|P3|Overall Study|Lost to Follow-up|0
5795670|NCT03131687|19981046|P2|Overall Study|Lost to Follow-up|4
5795671|NCT03131687|19981047|P1|Overall Study|Lost to Follow-up|1
5795672|NCT03131687|19981042|P6|Overall Study|Withdrawal by Subject|1
5795673|NCT03131687|19981043|P5|Overall Study|Withdrawal by Subject|2
5795674|NCT03131687|19981044|P4|Overall Study|Withdrawal by Subject|1
5795675|NCT03131687|19981045|P3|Overall Study|Withdrawal by Subject|3
5795676|NCT03131687|19981046|P2|Overall Study|Withdrawal by Subject|3
5795677|NCT03131687|19981047|P1|Overall Study|Withdrawal by Subject|3
5795678|NCT03131687|19981042|P6|Overall Study|Death|0
5795679|NCT03131687|19981043|P5|Overall Study|Death|0
5795680|NCT03131687|19981044|P4|Overall Study|Death|0
5795681|NCT03131687|19981045|P3|Overall Study|Death|0
5795682|NCT03131687|19981046|P2|Overall Study|Death|0
5795683|NCT03131687|19981047|P1|Overall Study|Death|1
5795684|NCT03131687|19981042|P6|Overall Study|Adverse Event|2
5795685|NCT03131687|19981043|P5|Overall Study|Adverse Event|2
5795686|NCT03131687|19981044|P4|Overall Study|Adverse Event|1
5795687|NCT03131687|19981045|P3|Overall Study|Adverse Event|0
5795688|NCT03131687|19981046|P2|Overall Study|Adverse Event|1
5795689|NCT03131687|19981047|P1|Overall Study|Adverse Event|0
5795690|NCT03131648|19981157|P8|Open-label (Short Term Extension)|Discontinued IMP|3
5795691|NCT03131648|19981158|P7|Open-label (Short Term Extension)|Discontinued IMP|0
5795692|NCT03131648|19981159|P6|Open-label (Short Term Extension)|Discontinued IMP|0
5795693|NCT03131648|19981160|P5|Open-label (Short Term Extension)|Discontinued IMP|0
5795694|NCT03131648|19981161|P4|Open-label (Short Term Extension)|Discontinued IMP|0
5795695|NCT03131648|19981162|P3|Open-label (Short Term Extension)|Discontinued IMP|0
5795696|NCT03131648|19981163|P2|Open-label (Short Term Extension)|Discontinued IMP|0
5795697|NCT03131648|19981164|P1|Open-label (Short Term Extension)|Discontinued IMP|0
5795698|NCT03131648|19981157|P8|Maintenance Treatment Period|Completed Week 50|0
5795699|NCT03131648|19981158|P7|Maintenance Treatment Period|Completed Week 50|0
5795700|NCT03131648|19981159|P6|Maintenance Treatment Period|Completed Week 50|0
5795701|NCT03131648|19981160|P5|Maintenance Treatment Period|Completed Week 50|1
5795702|NCT03131648|19981161|P4|Maintenance Treatment Period|Completed Week 50|0
5795703|NCT03131648|19981162|P3|Maintenance Treatment Period|Completed Week 50|0
5795704|NCT03131648|19981163|P2|Maintenance Treatment Period|Completed Week 50|0
5795705|NCT03131648|19981164|P1|Maintenance Treatment Period|Completed Week 50|0
5795706|NCT03131648|19981157|P8|Maintenance Treatment Period|Transfer to open-label treatment|0
5795707|NCT03131648|19981158|P7|Maintenance Treatment Period|Transfer to open-label treatment|0
5795708|NCT03131648|19981159|P6|Maintenance Treatment Period|Transfer to open-label treatment|10
5795709|NCT03131648|19981160|P5|Maintenance Treatment Period|Transfer to open-label treatment|9
5795710|NCT03131648|19981161|P4|Maintenance Treatment Period|Transfer to open-label treatment|18
5795711|NCT03131648|19981162|P3|Maintenance Treatment Period|Transfer to open-label treatment|21
5795712|NCT03131648|19981163|P2|Maintenance Treatment Period|Transfer to open-label treatment|0
5795713|NCT03131648|19981164|P1|Maintenance Treatment Period|Transfer to open-label treatment|0
5795714|NCT03131648|19981157|P8|Maintenance Treatment Period|Discontinued IMP|0
5795715|NCT03131648|19981158|P7|Maintenance Treatment Period|Discontinued IMP|0
5795716|NCT03131648|19981159|P6|Maintenance Treatment Period|Discontinued IMP|4
5795717|NCT03131648|19981160|P5|Maintenance Treatment Period|Discontinued IMP|4
5795718|NCT03131648|19981161|P4|Maintenance Treatment Period|Discontinued IMP|5
5795719|NCT03131648|19981162|P3|Maintenance Treatment Period|Discontinued IMP|3
5795720|NCT03131648|19981163|P2|Maintenance Treatment Period|Discontinued IMP|0
5795721|NCT03131648|19981164|P1|Maintenance Treatment Period|Discontinued IMP|0
5795722|NCT03131648|19981157|P8|Maintenance Treatment Period|Not dosed|0
5795723|NCT03131648|19981158|P7|Maintenance Treatment Period|Not dosed|0
5795724|NCT03131648|19981159|P6|Maintenance Treatment Period|Not dosed|0
5795725|NCT03131648|19981160|P5|Maintenance Treatment Period|Not dosed|1
5795726|NCT03131648|19981161|P4|Maintenance Treatment Period|Not dosed|2
5795727|NCT03131648|19981162|P3|Maintenance Treatment Period|Not dosed|3
5795728|NCT03131648|19981163|P2|Maintenance Treatment Period|Not dosed|0
5795729|NCT03131648|19981164|P1|Maintenance Treatment Period|Not dosed|0
5795730|NCT03131648|19981157|P8|Open-label Treatment|Completed Week 50|0
5795731|NCT03131648|19981158|P7|Open-label Treatment|Completed Week 50|6
5795732|NCT03131648|19981159|P6|Open-label Treatment|Completed Week 50|0
5795733|NCT03131648|19981160|P5|Open-label Treatment|Completed Week 50|0
5795734|NCT03131648|19981161|P4|Open-label Treatment|Completed Week 50|0
5795735|NCT03131648|19981162|P3|Open-label Treatment|Completed Week 50|0
5795736|NCT03131648|19981163|P2|Open-label Treatment|Completed Week 50|0
5795737|NCT03131648|19981164|P1|Open-label Treatment|Completed Week 50|0
5795738|NCT03131648|19981157|P8|Open-label Treatment|Discontinued IMP|0
5795739|NCT03131648|19981158|P7|Open-label Treatment|Discontinued IMP|112
5795740|NCT03131648|19981159|P6|Open-label Treatment|Discontinued IMP|0
5795741|NCT03131648|19981160|P5|Open-label Treatment|Discontinued IMP|0
5795742|NCT03131648|19981161|P4|Open-label Treatment|Discontinued IMP|0
5795743|NCT03131648|19981162|P3|Open-label Treatment|Discontinued IMP|0
5795744|NCT03131648|19981163|P2|Open-label Treatment|Discontinued IMP|0
5795745|NCT03131648|19981164|P1|Open-label Treatment|Discontinued IMP|0
5795746|NCT03131648|19981157|P8|Initial Treatment Period|Discontinued IMP before Week 16|0
5795747|NCT03131648|19981158|P7|Initial Treatment Period|Discontinued IMP before Week 16|0
5795748|NCT03131648|19981159|P6|Initial Treatment Period|Discontinued IMP before Week 16|0
5795749|NCT03131648|19981160|P5|Initial Treatment Period|Discontinued IMP before Week 16|0
5795750|NCT03131648|19981161|P4|Initial Treatment Period|Discontinued IMP before Week 16|0
5795751|NCT03131648|19981162|P3|Initial Treatment Period|Discontinued IMP before Week 16|0
5795752|NCT03131648|19981163|P2|Initial Treatment Period|Discontinued IMP before Week 16|18
5795753|NCT03131648|19981164|P1|Initial Treatment Period|Discontinued IMP before Week 16|51
5795754|NCT03131648|19981157|P8|Initial Treatment Period|Not dosed|0
5795755|NCT03131648|19981158|P7|Initial Treatment Period|Not dosed|0
5795756|NCT03131648|19981159|P6|Initial Treatment Period|Not dosed|0
5795757|NCT03131648|19981160|P5|Initial Treatment Period|Not dosed|0
5795758|NCT03131648|19981161|P4|Initial Treatment Period|Not dosed|0
5795759|NCT03131648|19981162|P3|Initial Treatment Period|Not dosed|0
5795760|NCT03131648|19981163|P2|Initial Treatment Period|Not dosed|2
5795761|NCT03131648|19981164|P1|Initial Treatment Period|Not dosed|2
5795762|NCT03131596|19981212|P2|Overall Study|Lost to Follow-up|0
5795763|NCT03131596|19981213|P1|Overall Study|Lost to Follow-up|3
5795764|NCT03131596|19981212|P2|Overall Study|Protocol Violation|3
5795765|NCT03131596|19981213|P1|Overall Study|Protocol Violation|3
5795766|NCT03131479|19981230|P5|Overall Study|Subject/Guardian Decision|0
5795767|NCT03131479|19981231|P4|Overall Study|Subject/Guardian Decision|1
5795768|NCT03131479|19981232|P3|Overall Study|Subject/Guardian Decision|0
5795769|NCT03131479|19981233|P2|Overall Study|Subject/Guardian Decision|0
5795770|NCT03131479|19981234|P1|Overall Study|Subject/Guardian Decision|0
5795771|NCT03131479|19981230|P5|Overall Study|Adverse Event|0
5795772|NCT03131479|19981231|P4|Overall Study|Adverse Event|1
5795773|NCT03131479|19981232|P3|Overall Study|Adverse Event|1
5795774|NCT03131479|19981233|P2|Overall Study|Adverse Event|0
5795775|NCT03131479|19981234|P1|Overall Study|Adverse Event|0
5795776|NCT03131219|19981293|P2|Initial Evaluation Period|Deemed ineligible post treatment|0
5795777|NCT03131219|19981294|P1|Initial Evaluation Period|Deemed ineligible post treatment|2
5795778|NCT03131219|19981293|P2|Initial Evaluation Period|Protocol Violation|0
5795779|NCT03131219|19981294|P1|Initial Evaluation Period|Protocol Violation|1
5795780|NCT03131219|19981293|P2|Initial Evaluation Period|Adverse Event|0
5795781|NCT03131219|19981294|P1|Initial Evaluation Period|Adverse Event|1
5795782|NCT03131167|19981354|P13|Overall Study|Other (Unspecified)|0
5795783|NCT03131167|19981355|P12|Overall Study|Other (Unspecified)|0
5795784|NCT03131167|19981356|P11|Overall Study|Other (Unspecified)|0
5795785|NCT03131167|19981357|P10|Overall Study|Other (Unspecified)|0
5795786|NCT03131167|19981358|P9|Overall Study|Other (Unspecified)|0
5795787|NCT03131167|19981359|P8|Overall Study|Other (Unspecified)|0
5795788|NCT03131167|19981360|P7|Overall Study|Other (Unspecified)|0
5795789|NCT03131167|19981361|P6|Overall Study|Other (Unspecified)|1
5795790|NCT03131167|19981362|P5|Overall Study|Other (Unspecified)|0
5795791|NCT03131167|19981363|P4|Overall Study|Other (Unspecified)|0
5795792|NCT03131167|19981364|P3|Overall Study|Other (Unspecified)|0
5795793|NCT03131167|19981365|P2|Overall Study|Other (Unspecified)|0
5795794|NCT03131167|19981366|P1|Overall Study|Other (Unspecified)|0
5795795|NCT03130257|19981426|P3|Overall Study|Withdrawal by Subject|2
5795796|NCT03130257|19981427|P2|Overall Study|Withdrawal by Subject|0
5795797|NCT03130257|19981428|P1|Overall Study|Withdrawal by Subject|1
5795798|NCT03128931|19981482|P1|Overall Study|Equipment Issues|3
5795799|NCT03128931|19981482|P1|Overall Study|Physician Decision|1
5795802|NCT03128723|19981492|P1|Overall Study|Withdrawal by Subject|2
5795803|NCT03128411|19981507|P1|Long Term Follow-up Phase|Ongoing|18
5795804|NCT03128411|19981507|P1|Long Term Follow-up Phase|Death|1
5795805|NCT03128411|19981507|P1|Treatment Phase|Ongoing|41
5795806|NCT03128411|19981507|P1|Treatment Phase|Physician Decision|1
5795807|NCT03128411|19981507|P1|Treatment Phase|Adverse Event|18
5795808|NCT03128307|19981550|P1|Overall Study|Withdrawal by Subject|5
5795809|NCT03128307|19981550|P1|Overall Study|Lost to Follow-up|29
5795810|NCT03128099|19981558|P3|Overall Study|Did not complete all the assessments|1
5795811|NCT03128099|19981559|P2|Overall Study|Did not complete all the assessments|0
5795812|NCT03128099|19981560|P1|Overall Study|Did not complete all the assessments|0
5795813|NCT03128099|19981558|P3|Overall Study|Became homeless and lost contact|0
5795814|NCT03128099|19981559|P2|Overall Study|Became homeless and lost contact|0
5795815|NCT03128099|19981560|P1|Overall Study|Became homeless and lost contact|1
5795816|NCT03128099|19981558|P3|Overall Study|Participant got a full time job.|0
5795817|NCT03128099|19981559|P2|Overall Study|Participant got a full time job.|0
5795818|NCT03128099|19981560|P1|Overall Study|Participant got a full time job.|1
5795819|NCT03128099|19981558|P3|Overall Study|High dose task was too long|0
5795820|NCT03128099|19981559|P2|Overall Study|High dose task was too long|4
5795821|NCT03128099|19981560|P1|Overall Study|High dose task was too long|0
5795822|NCT03127644|19981610|P3|Overall Study|Study-specific withdrawal criteria|2
5795823|NCT03127644|19981611|P2|Overall Study|Study-specific withdrawal criteria|0
5795824|NCT03127644|19981612|P1|Overall Study|Study-specific withdrawal criteria|0
5795825|NCT03127384|19981644|P1|Overall Study|Subject request|2
5795826|NCT03127384|19981644|P1|Overall Study|Lost to Follow-up|4
5795827|NCT03126539|19981680|P5|Overall Study|Lost to Follow-up|0
5795828|NCT03126539|19981681|P4|Overall Study|Lost to Follow-up|0
5795829|NCT03126539|19981682|P3|Overall Study|Lost to Follow-up|1
5795830|NCT03126539|19981683|P2|Overall Study|Lost to Follow-up|1
5795831|NCT03126539|19981684|P1|Overall Study|Lost to Follow-up|1
5795832|NCT03126344|19981713|P3|Overall Study|Lost to Follow-up|5
5795833|NCT03126344|19981714|P2|Overall Study|Lost to Follow-up|0
5795834|NCT03126344|19981715|P1|Overall Study|Lost to Follow-up|0
5795835|NCT03125941|19981731|P2|Overall Study|did not receive intervention|2
5795836|NCT03125941|19981732|P1|Overall Study|did not receive intervention|1
5795837|NCT03125915|19981768|P4|6 Month Follow-up|Lost to Follow-up|3
5795838|NCT03125915|19981769|P3|6 Month Follow-up|Lost to Follow-up|6
5795839|NCT03125915|19981770|P2|6 Month Follow-up|Lost to Follow-up|3
5795840|NCT03125915|19981771|P1|6 Month Follow-up|Lost to Follow-up|7
5795841|NCT03125915|19981768|P4|3 Month Follow-up|Lost to Follow-up|2
5795842|NCT03125915|19981769|P3|3 Month Follow-up|Lost to Follow-up|4
5795843|NCT03125915|19981770|P2|3 Month Follow-up|Lost to Follow-up|4
5795844|NCT03125915|19981771|P1|3 Month Follow-up|Lost to Follow-up|6
5795845|NCT03125915|19981768|P4|1 Month Follow up|Lost to Follow-up|3
5795846|NCT03125915|19981769|P3|1 Month Follow up|Lost to Follow-up|2
5795847|NCT03125915|19981770|P2|1 Month Follow up|Lost to Follow-up|3
5795848|NCT03125915|19981771|P1|1 Month Follow up|Lost to Follow-up|3
5795861|NCT03125395|19981837|P1|Overall Study|Commercial drug is available|5
5795862|NCT03125395|19981837|P1|Overall Study|Physician Decision|2
5795863|NCT03125395|19981837|P1|Overall Study|Withdrawal of consent (not due to AE)|1
5795864|NCT03125395|19981837|P1|Overall Study|Adverse Event|2
5795907|NCT03124784|19982109|P1|Overall Study|Computer/Equip Malfunction|1
5795908|NCT03124784|19982109|P1|Overall Study|Adverse Event|1
5795909|NCT03124563|19982131|P2|Overall Study|Withdrawal by Subject|1
5795910|NCT03124563|19982132|P1|Overall Study|Withdrawal by Subject|1
5795911|NCT03124563|19982131|P2|Overall Study|Lost to Follow-up|1
5795912|NCT03124563|19982132|P1|Overall Study|Lost to Follow-up|1
5795913|NCT03124537|19982157|P2|Overall Study|App Crash, Incomplete Data|8
5795914|NCT03124537|19982158|P1|Overall Study|App Crash, Incomplete Data|7
5795915|NCT03124537|19982157|P2|Overall Study|Lost to Follow-up|5
5795916|NCT03124537|19982158|P1|Overall Study|Lost to Follow-up|3
5795917|NCT03124407|19982182|P4|Overall Study|Adverse Event|0
5795918|NCT03124407|19982183|P3|Overall Study|Adverse Event|1
5795919|NCT03124407|19982184|P2|Overall Study|Adverse Event|0
5795920|NCT03124407|19982185|P1|Overall Study|Adverse Event|0
5795921|NCT03124407|19982182|P4|Overall Study|Lost to Follow-up|0
5795922|NCT03124407|19982183|P3|Overall Study|Lost to Follow-up|0
5795923|NCT03124407|19982184|P2|Overall Study|Lost to Follow-up|0
5795924|NCT03124407|19982185|P1|Overall Study|Lost to Follow-up|1
5795925|NCT03124381|19982205|P2|Overall Study|Non-Compliance with Study Treatment|0
5796012|NCT03120520|19982873|P2|Overall Study|Lost to Follow-up|1
5795926|NCT03124381|19982206|P1|Overall Study|Non-Compliance with Study Treatment|1
5795927|NCT03124381|19982205|P2|Overall Study|Adverse Event|1
5795928|NCT03124381|19982206|P1|Overall Study|Adverse Event|1
5795929|NCT03124381|19982205|P2|Overall Study|Protocol Violation|1
5795930|NCT03124381|19982206|P1|Overall Study|Protocol Violation|0
5795931|NCT03124381|19982205|P2|Overall Study|Withdrawal by Subject|3
5795932|NCT03124381|19982206|P1|Overall Study|Withdrawal by Subject|6
5795933|NCT03124381|19982205|P2|Overall Study|Lost to Follow-up|1
5795934|NCT03124381|19982206|P1|Overall Study|Lost to Follow-up|1
5795935|NCT03124199|19982313|P1|Overall Study|Lost to Follow-up|4
5795936|NCT03124108|19982322|P3|Overall Study|Adverse Event|0
5795937|NCT03124108|19982323|P2|Overall Study|Adverse Event|1
5795938|NCT03124108|19982324|P1|Overall Study|Adverse Event|0
5795939|NCT03123861|19982470|P2|Overall Study|Withdrawal by Subject|2
5795940|NCT03123861|19982471|P1|Overall Study|Withdrawal by Subject|2
5795941|NCT03123861|19982470|P2|Overall Study|Protocol Violation|1
5795942|NCT03123861|19982471|P1|Overall Study|Protocol Violation|1
5795943|NCT03123471|19982522|P2|Apremilast Extension Phase|Withdrawal by Subject|7
5795944|NCT03123471|19982523|P1|Apremilast Extension Phase|Withdrawal by Subject|3
5795945|NCT03123471|19982522|P2|Apremilast Extension Phase|Lack of Efficacy|8
5795946|NCT03123471|19982523|P1|Apremilast Extension Phase|Lack of Efficacy|2
5795947|NCT03123471|19982522|P2|Apremilast Extension Phase|Adverse Event|5
5795948|NCT03123471|19982523|P1|Apremilast Extension Phase|Adverse Event|1
5795949|NCT03123471|19982522|P2|Apremilast Extension Phase|Lost to Follow-up|5
5795950|NCT03123471|19982523|P1|Apremilast Extension Phase|Lost to Follow-up|2
5795951|NCT03123471|19982522|P2|Placebo-controlled Phase|Miscellaneous|1
5795952|NCT03123471|19982523|P1|Placebo-controlled Phase|Miscellaneous|0
5795953|NCT03123471|19982522|P2|Placebo-controlled Phase|Protocol Deviation|1
5795954|NCT03123471|19982523|P1|Placebo-controlled Phase|Protocol Deviation|2
5795955|NCT03123471|19982522|P2|Placebo-controlled Phase|Lost to Follow-up|3
5795956|NCT03123471|19982523|P1|Placebo-controlled Phase|Lost to Follow-up|1
5795957|NCT03123471|19982522|P2|Placebo-controlled Phase|Non-compliance with Study Drug|0
5795958|NCT03123471|19982523|P1|Placebo-controlled Phase|Non-compliance with Study Drug|3
5795959|NCT03123471|19982522|P2|Placebo-controlled Phase|Withdrawal by Subject|16
5795960|NCT03123471|19982523|P1|Placebo-controlled Phase|Withdrawal by Subject|6
5795961|NCT03123471|19982522|P2|Placebo-controlled Phase|Lack of Efficacy|4
5795962|NCT03123471|19982523|P1|Placebo-controlled Phase|Lack of Efficacy|3
5795963|NCT03123471|19982522|P2|Placebo-controlled Phase|Adverse Event|8
5795964|NCT03123471|19982523|P1|Placebo-controlled Phase|Adverse Event|3
5795965|NCT03123393|19982550|P2|Overall Study|Reason not Specified|13
5795966|NCT03123393|19982551|P1|Overall Study|Reason not Specified|13
5795967|NCT03123393|19982550|P2|Overall Study|Withdrawal by Subject|1
5795968|NCT03123393|19982551|P1|Overall Study|Withdrawal by Subject|2
5795969|NCT03123393|19982550|P2|Overall Study|Study Terminated by Sponsor|9
5795970|NCT03123393|19982551|P1|Overall Study|Study Terminated by Sponsor|6
5795971|NCT03123354|19982579|P1|Overall Study|Physician Decision|6
5795972|NCT03122886|19982604|P2|Overall Study|Withdrawal by Subject|2
5795973|NCT03122886|19982605|P1|Overall Study|Withdrawal by Subject|1
5795974|NCT03122548|19982627|P1|Overall Study|Study Terminated by Sponsor|2
5795975|NCT03122548|19982627|P1|Overall Study|Progression - subject went into hospice|1
5795976|NCT03122548|19982627|P1|Overall Study|Death|2
5795977|NCT03122457|19982635|P1|Overall Study|Withdrawal by Subject|6
5795978|NCT03122223|19982644|P4|Overall Study|Participant unable to adhere|0
5795979|NCT03122223|19982645|P3|Overall Study|Participant unable to adhere|1
5795980|NCT03122223|19982646|P2|Overall Study|Participant unable to adhere|1
5795981|NCT03122223|19982647|P1|Overall Study|Participant unable to adhere|1
5795982|NCT03122223|19982644|P4|Overall Study|Lost to Follow-up|0
5795983|NCT03122223|19982645|P3|Overall Study|Lost to Follow-up|2
5795984|NCT03122223|19982646|P2|Overall Study|Lost to Follow-up|2
5795985|NCT03122223|19982647|P1|Overall Study|Lost to Follow-up|0
5795986|NCT03122223|19982644|P4|Overall Study|Withdrawal by Subject|0
5795987|NCT03122223|19982645|P3|Overall Study|Withdrawal by Subject|1
5795988|NCT03122223|19982646|P2|Overall Study|Withdrawal by Subject|2
5795989|NCT03122223|19982647|P1|Overall Study|Withdrawal by Subject|2
5795990|NCT03122184|19982703|P2|Overall Study|Terminated due to cognitive problem|0
5795991|NCT03122184|19982704|P1|Overall Study|Terminated due to cognitive problem|1
5795992|NCT03122184|19982703|P2|Overall Study|Withdrawal by Subject|0
5795993|NCT03122184|19982704|P1|Overall Study|Withdrawal by Subject|3
5795994|NCT03122184|19982703|P2|Overall Study|Lost to Follow-up|6
5795995|NCT03122184|19982704|P1|Overall Study|Lost to Follow-up|4
5795996|NCT03122171|19982741|P1|Overall Study|Withdrawal by Subject|1
5795997|NCT03122145|19982750|P2|Overall Study|Concurrent respiratory disease|0
5795998|NCT03122145|19982751|P1|Overall Study|Concurrent respiratory disease|3
5795999|NCT03121950|19982761|P2|Overall Study|Withdrawal by Subject|2
5796000|NCT03121950|19982762|P1|Overall Study|Withdrawal by Subject|11
5796001|NCT03120676|19982863|P1|Overall Study|Not treated|1
5796002|NCT03120520|19982871|P4|Overall Study|Other|0
5796003|NCT03120520|19982872|P3|Overall Study|Other|0
5796004|NCT03120520|19982873|P2|Overall Study|Other|1
5796005|NCT03120520|19982874|P1|Overall Study|Other|0
5796006|NCT03120520|19982871|P4|Overall Study|Withdrawal by Subject|2
5796007|NCT03120520|19982872|P3|Overall Study|Withdrawal by Subject|3
5796008|NCT03120520|19982873|P2|Overall Study|Withdrawal by Subject|2
5796009|NCT03120520|19982874|P1|Overall Study|Withdrawal by Subject|3
5796010|NCT03120520|19982871|P4|Overall Study|Lost to Follow-up|1
5796011|NCT03120520|19982872|P3|Overall Study|Lost to Follow-up|1
5796013|NCT03120520|19982874|P1|Overall Study|Lost to Follow-up|1
5796014|NCT03120351|19982898|P2|Overall Study|Physician Decision|1
5796015|NCT03120351|19982899|P1|Overall Study|Physician Decision|1
5796016|NCT03120013|19982905|P2|First Intervention (2 Weeks)|Withdrawal by Subject|1
5796017|NCT03120013|19982906|P1|First Intervention (2 Weeks)|Withdrawal by Subject|0
5796018|NCT03119701|19982950|P2|Mid-term (Final) Follow-up at D90|Death|1
5796019|NCT03119701|19982951|P1|Mid-term (Final) Follow-up at D90|Death|3
5796020|NCT03119701|19982950|P2|6-day Dosing|Withdrawal by Subject|1
5796021|NCT03119701|19982951|P1|6-day Dosing|Withdrawal by Subject|0
5796022|NCT03119701|19982950|P2|6-day Dosing|Physician Decision|1
5796023|NCT03119701|19982951|P1|6-day Dosing|Physician Decision|0
5796024|NCT03119701|19982950|P2|6-day Dosing|Adverse Event|0
5796025|NCT03119701|19982951|P1|6-day Dosing|Adverse Event|3
5796026|NCT03119701|19982950|P2|6-day Dosing|Death|1
5796027|NCT03119701|19982951|P1|6-day Dosing|Death|4
5796028|NCT03119688|19982983|P1|Overall Study|Adverse Event|4
5796029|NCT03119662|19983016|P2|Overall Study|Withdrawal by Subject|1
5796030|NCT03119662|19983017|P1|Overall Study|Withdrawal by Subject|0
5796031|NCT03119610|19983087|P2|Overall Study|Lost to Follow-up|1
5796032|NCT03119610|19983088|P1|Overall Study|Lost to Follow-up|0
5796033|NCT03119610|19983087|P2|Overall Study|Adverse Event|0
5796034|NCT03119610|19983088|P1|Overall Study|Adverse Event|1
5796035|NCT03118947|19983175|P1|Overall Study|Lost to Follow-up|2
5796036|NCT03118947|19983175|P1|Overall Study|Change in patient's living situation|4
5796037|NCT03118947|19983175|P1|Overall Study|Withdrawal by caregiver|3
5796038|NCT03118947|19983175|P1|Overall Study|Withdrawal by Subject|3
5796039|NCT03118947|19983175|P1|Overall Study|Protocol Violation|2
5796040|NCT03118947|19983175|P1|Overall Study|Non-compliance with study drug|1
5796041|NCT03118947|19983175|P1|Overall Study|Lack of Efficacy|4
5796042|NCT03118947|19983175|P1|Overall Study|Death|3
5796043|NCT03118947|19983175|P1|Overall Study|Adverse Event|7
5796044|NCT03118934|19983182|P6|Overall Study|Discontinued prior to exposure|0
5796045|NCT03118934|19983183|P5|Overall Study|Discontinued prior to exposure|2
5796046|NCT03118934|19983184|P4|Overall Study|Discontinued prior to exposure|1
5796047|NCT03118934|19983185|P3|Overall Study|Discontinued prior to exposure|1
5796048|NCT03118934|19983186|P2|Overall Study|Discontinued prior to exposure|1
5796049|NCT03118934|19983187|P1|Overall Study|Discontinued prior to exposure|0
5796050|NCT03118934|19983182|P6|Overall Study|Physician Decision|1
5796051|NCT03118934|19983183|P5|Overall Study|Physician Decision|0
5796052|NCT03118934|19983184|P4|Overall Study|Physician Decision|0
5796053|NCT03118934|19983185|P3|Overall Study|Physician Decision|0
5796054|NCT03118934|19983186|P2|Overall Study|Physician Decision|0
5796055|NCT03118934|19983187|P1|Overall Study|Physician Decision|0
5796056|NCT03118934|19983182|P6|Overall Study|Adverse Event|1
5796057|NCT03118934|19983183|P5|Overall Study|Adverse Event|0
5796058|NCT03118934|19983184|P4|Overall Study|Adverse Event|0
5796059|NCT03118934|19983185|P3|Overall Study|Adverse Event|0
5796060|NCT03118934|19983186|P2|Overall Study|Adverse Event|0
5796061|NCT03118934|19983187|P1|Overall Study|Adverse Event|0
5796062|NCT03118765|19983211|P5|Overall Study|Sponsor Decision|1
5796063|NCT03118765|19983212|P4|Overall Study|Sponsor Decision|0
5796064|NCT03118765|19983213|P3|Overall Study|Sponsor Decision|1
5796065|NCT03118765|19983214|P2|Overall Study|Sponsor Decision|0
5796066|NCT03118765|19983215|P1|Overall Study|Sponsor Decision|1
5796067|NCT03118765|19983211|P5|Overall Study|Lost to Follow-up|0
5796068|NCT03118765|19983212|P4|Overall Study|Lost to Follow-up|0
5796069|NCT03118765|19983213|P3|Overall Study|Lost to Follow-up|1
5796070|NCT03118765|19983214|P2|Overall Study|Lost to Follow-up|0
5796071|NCT03118765|19983215|P1|Overall Study|Lost to Follow-up|1
5796072|NCT03118765|19983211|P5|Overall Study|COPD Exacerbation|0
5796073|NCT03118765|19983212|P4|Overall Study|COPD Exacerbation|1
5796074|NCT03118765|19983213|P3|Overall Study|COPD Exacerbation|0
5796075|NCT03118765|19983214|P2|Overall Study|COPD Exacerbation|0
5796076|NCT03118765|19983215|P1|Overall Study|COPD Exacerbation|1
5796077|NCT03118765|19983211|P5|Overall Study|Violation of Inclusion/ExclusionCriteria|0
5796078|NCT03118765|19983212|P4|Overall Study|Violation of Inclusion/ExclusionCriteria|0
5796079|NCT03118765|19983213|P3|Overall Study|Violation of Inclusion/ExclusionCriteria|1
5796080|NCT03118765|19983214|P2|Overall Study|Violation of Inclusion/ExclusionCriteria|1
5796081|NCT03118765|19983215|P1|Overall Study|Violation of Inclusion/ExclusionCriteria|0
5796082|NCT03118765|19983211|P5|Overall Study|Non compliance with Study Procedures|0
5796083|NCT03118765|19983212|P4|Overall Study|Non compliance with Study Procedures|1
5796084|NCT03118765|19983213|P3|Overall Study|Non compliance with Study Procedures|0
5796085|NCT03118765|19983214|P2|Overall Study|Non compliance with Study Procedures|0
5796086|NCT03118765|19983215|P1|Overall Study|Non compliance with Study Procedures|0
5796087|NCT03118765|19983211|P5|Overall Study|Adverse Event|1
5796088|NCT03118765|19983212|P4|Overall Study|Adverse Event|1
5796089|NCT03118765|19983213|P3|Overall Study|Adverse Event|1
5796090|NCT03118765|19983214|P2|Overall Study|Adverse Event|1
5796091|NCT03118765|19983215|P1|Overall Study|Adverse Event|1
5796092|NCT03118765|19983211|P5|Overall Study|Withdrawal by Subject|0
5796093|NCT03118765|19983212|P4|Overall Study|Withdrawal by Subject|0
5796094|NCT03118765|19983213|P3|Overall Study|Withdrawal by Subject|1
5796095|NCT03118765|19983214|P2|Overall Study|Withdrawal by Subject|0
5796096|NCT03118765|19983215|P1|Overall Study|Withdrawal by Subject|0
5796097|NCT03118739|19983311|P2|Overall Study|Lost to Follow-up|0
5796098|NCT03118739|19983312|P1|Overall Study|Lost to Follow-up|2
5796099|NCT03118739|19983311|P2|Overall Study|Withdrawal by Subject|3
5796100|NCT03118739|19983312|P1|Overall Study|Withdrawal by Subject|5
5796101|NCT03118739|19983311|P2|Overall Study|Physician Decision|1
5796102|NCT03118739|19983312|P1|Overall Study|Physician Decision|0
5796103|NCT03118297|19983425|P2|Overall Study|Lost to Follow-up|2
5796104|NCT03118297|19983426|P1|Overall Study|Lost to Follow-up|0
5796105|NCT03117361|19983478|P1|Overall Study|Treatment-related adverse event|1
5796106|NCT03117361|19983478|P1|Overall Study|On study treatment at the end of study|1
5796107|NCT03117361|19983478|P1|Overall Study|Physician Decision|2
5796108|NCT03117361|19983478|P1|Overall Study|Death|1
5796109|NCT03117361|19983478|P1|Overall Study|Progressive disease|5
5796110|NCT03116828|19983593|P2|Overall Study|OTHER|3
5796111|NCT03116828|19983594|P1|Overall Study|OTHER|3
5796112|NCT03116828|19983593|P2|Overall Study|Withdrawal by Subject|8
5796113|NCT03116828|19983594|P1|Overall Study|Withdrawal by Subject|4
5796114|NCT03116828|19983593|P2|Overall Study|Adverse Event|10
5796115|NCT03116828|19983594|P1|Overall Study|Adverse Event|1
5796116|NCT03116698|19983604|P4|Overall Study|Death|0
5796117|NCT03116698|19983605|P3|Overall Study|Death|2
5796118|NCT03116698|19983606|P2|Overall Study|Death|0
5796119|NCT03116698|19983607|P1|Overall Study|Death|0
5796120|NCT03116698|19983604|P4|Overall Study|Protocol Violation|0
5796121|NCT03116698|19983605|P3|Overall Study|Protocol Violation|0
5796122|NCT03116698|19983606|P2|Overall Study|Protocol Violation|0
5796123|NCT03116698|19983607|P1|Overall Study|Protocol Violation|1
5796124|NCT03116698|19983604|P4|Overall Study|Physician Decision|0
5796125|NCT03116698|19983605|P3|Overall Study|Physician Decision|0
5796126|NCT03116698|19983606|P2|Overall Study|Physician Decision|1
5796127|NCT03116698|19983607|P1|Overall Study|Physician Decision|1
5796128|NCT03116698|19983604|P4|Overall Study|Lost to Follow-up|0
5796129|NCT03116698|19983605|P3|Overall Study|Lost to Follow-up|0
5796130|NCT03116698|19983606|P2|Overall Study|Lost to Follow-up|0
5796131|NCT03116698|19983607|P1|Overall Study|Lost to Follow-up|2
5796132|NCT03116698|19983604|P4|Overall Study|Withdrawal by Subject|2
5796133|NCT03116698|19983605|P3|Overall Study|Withdrawal by Subject|5
5796134|NCT03116698|19983606|P2|Overall Study|Withdrawal by Subject|4
5796135|NCT03116698|19983607|P1|Overall Study|Withdrawal by Subject|1
5796136|NCT03116698|19983604|P4|Overall Study|Adverse Event|0
5796137|NCT03116698|19983605|P3|Overall Study|Adverse Event|1
5796138|NCT03116698|19983606|P2|Overall Study|Adverse Event|1
5796139|NCT03116698|19983607|P1|Overall Study|Adverse Event|1
5796154|NCT03115476|19983684|P3|LP0084-1369|Trial terminated by Sponsor|160
5796155|NCT03115476|19983685|P2|LP0084-1369|Trial terminated by Sponsor|210
5796156|NCT03115476|19983686|P1|LP0084-1369|Trial terminated by Sponsor|190
5796157|NCT03115476|19983684|P3|LP0084-1369|Death|2
5796158|NCT03115476|19983685|P2|LP0084-1369|Death|0
5796159|NCT03115476|19983686|P1|LP0084-1369|Death|1
5796160|NCT03114969|19983735|P9|Overall Study|Adverse Event|2
5796161|NCT03114969|19983736|P8|Overall Study|Adverse Event|0
5796162|NCT03114969|19983737|P7|Overall Study|Adverse Event|1
5796163|NCT03114969|19983738|P6|Overall Study|Adverse Event|1
5796164|NCT03114969|19983739|P5|Overall Study|Adverse Event|0
5796165|NCT03114969|19983740|P4|Overall Study|Adverse Event|0
5796166|NCT03114969|19983741|P3|Overall Study|Adverse Event|1
5796167|NCT03114969|19983742|P2|Overall Study|Adverse Event|0
5796168|NCT03114969|19983743|P1|Overall Study|Adverse Event|0
5796169|NCT03114969|19983735|P9|Overall Study|Lost to Follow-up|0
5796170|NCT03114969|19983736|P8|Overall Study|Lost to Follow-up|0
5796171|NCT03114969|19983737|P7|Overall Study|Lost to Follow-up|0
5796172|NCT03114969|19983738|P6|Overall Study|Lost to Follow-up|0
5796173|NCT03114969|19983739|P5|Overall Study|Lost to Follow-up|0
5796174|NCT03114969|19983740|P4|Overall Study|Lost to Follow-up|2
5796175|NCT03114969|19983741|P3|Overall Study|Lost to Follow-up|3
5796176|NCT03114969|19983742|P2|Overall Study|Lost to Follow-up|0
5796177|NCT03114969|19983743|P1|Overall Study|Lost to Follow-up|0
5796178|NCT03114657|19983844|P2|Overall Study|Withdrawal by Subject|22
5796179|NCT03114657|19983845|P1|Overall Study|Withdrawal by Subject|28
5796180|NCT03114657|19983844|P2|Overall Study|Symptomatic Deterioration|1
5796181|NCT03114657|19983845|P1|Overall Study|Symptomatic Deterioration|0
5796182|NCT03114657|19983844|P2|Overall Study|Study Terminated By Sponsor|374
5796183|NCT03114657|19983845|P1|Overall Study|Study Terminated By Sponsor|355
5796184|NCT03114657|19983844|P2|Overall Study|Physician Decision|2
5796185|NCT03114657|19983845|P1|Overall Study|Physician Decision|2
5796186|NCT03114657|19983844|P2|Overall Study|Multiple Reasons|2
5796187|NCT03114657|19983845|P1|Overall Study|Multiple Reasons|1
5796188|NCT03114657|19983844|P2|Overall Study|Death|0
5796189|NCT03114657|19983845|P1|Overall Study|Death|4
5796190|NCT03114657|19983844|P2|Overall Study|Adverse Event|6
5796191|NCT03114657|19983845|P1|Overall Study|Adverse Event|9
5796192|NCT03114488|19983890|P2|Time Period 2|Withdrawal by Subject|3
5796193|NCT03114488|19983891|P1|Time Period 2|Withdrawal by Subject|1
5796194|NCT03113916|19983903|P2|Overall Study|Lost to Follow-up|2
5796195|NCT03113916|19983904|P1|Overall Study|Lost to Follow-up|1
5796196|NCT03113916|19983903|P2|Overall Study|Pregnancy|3
5796197|NCT03113916|19983904|P1|Overall Study|Pregnancy|1
5796198|NCT03113916|19983903|P2|Overall Study|Withdrawal by Subject|7
5796199|NCT03113916|19983904|P1|Overall Study|Withdrawal by Subject|9
5796200|NCT03111108|19984001|P2|Overall Study|Withdrawal by Subject|0
5796201|NCT03111108|19984002|P1|Overall Study|Withdrawal by Subject|1
5796202|NCT03111108|19984001|P2|Overall Study|Death|1
5796203|NCT03111108|19984002|P1|Overall Study|Death|0
5796204|NCT03110900|19984020|P2|Overall Study|Sponsor withdrew|1
5796205|NCT03110900|19984021|P1|Overall Study|Sponsor withdrew|1
5796206|NCT03110770|19984032|P5|Overall Study|Illness/Injury unrelated to product|1
5796207|NCT03110770|19984033|P4|Overall Study|Illness/Injury unrelated to product|0
5796208|NCT03110770|19984034|P3|Overall Study|Illness/Injury unrelated to product|0
5796209|NCT03110770|19984035|P2|Overall Study|Illness/Injury unrelated to product|0
5796210|NCT03110770|19984036|P1|Overall Study|Illness/Injury unrelated to product|0
5796211|NCT03110770|19984032|P5|Overall Study|Moved from area|43
5796212|NCT03110770|19984033|P4|Overall Study|Moved from area|42
5796213|NCT03110770|19984034|P3|Overall Study|Moved from area|2
5796214|NCT03110770|19984035|P2|Overall Study|Moved from area|0
5796215|NCT03110770|19984036|P1|Overall Study|Moved from area|5
5796216|NCT03110770|19984032|P5|Overall Study|Withdrawal by Subject|24
5796217|NCT03110770|19984033|P4|Overall Study|Withdrawal by Subject|24
5796218|NCT03110770|19984034|P3|Overall Study|Withdrawal by Subject|0
5796219|NCT03110770|19984035|P2|Overall Study|Withdrawal by Subject|0
5796220|NCT03110770|19984036|P1|Overall Study|Withdrawal by Subject|0
5796221|NCT03110770|19984032|P5|Overall Study|Investigator Decision|3
5796222|NCT03110770|19984033|P4|Overall Study|Investigator Decision|5
5796223|NCT03110770|19984034|P3|Overall Study|Investigator Decision|0
5796224|NCT03110770|19984035|P2|Overall Study|Investigator Decision|0
5796225|NCT03110770|19984036|P1|Overall Study|Investigator Decision|0
5796226|NCT03110770|19984032|P5|Overall Study|Lost to Follow-up|45
5796227|NCT03110770|19984033|P4|Overall Study|Lost to Follow-up|53
5796228|NCT03110770|19984034|P3|Overall Study|Lost to Follow-up|0
5796229|NCT03110770|19984035|P2|Overall Study|Lost to Follow-up|0
5796230|NCT03110770|19984036|P1|Overall Study|Lost to Follow-up|0
5796231|NCT03110770|19984032|P5|Overall Study|Enrolled but did not receive product|7
5796232|NCT03110770|19984033|P4|Overall Study|Enrolled but did not receive product|8
5796233|NCT03110770|19984034|P3|Overall Study|Enrolled but did not receive product|0
5796234|NCT03110770|19984035|P2|Overall Study|Enrolled but did not receive product|0
5796235|NCT03110770|19984036|P1|Overall Study|Enrolled but did not receive product|0
5796236|NCT03110770|19984032|P5|Overall Study|Death|0
5796237|NCT03110770|19984033|P4|Overall Study|Death|1
5796238|NCT03110770|19984034|P3|Overall Study|Death|0
5796239|NCT03110770|19984035|P2|Overall Study|Death|0
5796240|NCT03110770|19984036|P1|Overall Study|Death|1
5796241|NCT03110380|19984140|P2|Overall Study|Lost to Follow-up|1
5796242|NCT03110380|19984141|P1|Overall Study|Lost to Follow-up|4
5796243|NCT03110380|19984140|P2|Overall Study|Withdrew Consent|16
5796244|NCT03110380|19984141|P1|Overall Study|Withdrew Consent|9
5796245|NCT03110380|19984140|P2|Overall Study|Protocol Violation|1
5796246|NCT03110380|19984141|P1|Overall Study|Protocol Violation|0
5796247|NCT03110380|19984140|P2|Overall Study|Non-Compliance with Study Drug|1
5796248|NCT03110380|19984141|P1|Overall Study|Non-Compliance with Study Drug|1
5796249|NCT03110380|19984140|P2|Overall Study|Investigator's Discretion|2
5796250|NCT03110380|19984141|P1|Overall Study|Investigator's Discretion|1
5796251|NCT03110380|19984140|P2|Overall Study|Death|1
5796252|NCT03110380|19984141|P1|Overall Study|Death|2
5796253|NCT03110380|19984140|P2|Overall Study|Adverse Event|3
5796254|NCT03110380|19984141|P1|Overall Study|Adverse Event|3
5796255|NCT03110380|19984140|P2|Overall Study|Still in Study|256
5796256|NCT03110380|19984141|P1|Overall Study|Still in Study|264
5796257|NCT03110380|19984140|P2|Overall Study|Randomized and Never Treated|2
5796258|NCT03110380|19984141|P1|Overall Study|Randomized and Never Treated|0
5796259|NCT03110185|19984153|P2|Overall Study|Patient Refusal|1
5796260|NCT03110185|19984154|P1|Overall Study|Patient Refusal|0
5796261|NCT03110185|19984153|P2|Overall Study|MRI Incompatible|0
5796262|NCT03110185|19984154|P1|Overall Study|MRI Incompatible|2
5796263|NCT03110185|19984153|P2|Overall Study|Protocol Violation|4
5796264|NCT03110185|19984154|P1|Overall Study|Protocol Violation|1
5796265|NCT03110185|19984153|P2|Overall Study|Conflict with care|12
5796266|NCT03110185|19984154|P1|Overall Study|Conflict with care|5
5796267|NCT03110185|19984153|P2|Overall Study|Time Constraints|6
5796268|NCT03110185|19984154|P1|Overall Study|Time Constraints|0
5796269|NCT03110185|19984153|P2|Overall Study|Withdrawal by Subject|7
5796270|NCT03110185|19984154|P1|Overall Study|Withdrawal by Subject|2
5796271|NCT03110185|19984153|P2|Overall Study|Death|1
5796272|NCT03110185|19984154|P1|Overall Study|Death|0
5796273|NCT03110159|19984164|P1|Overall Study|Study termination|1
5796274|NCT03110029|19984175|P2|Overall Study|Withdrawal by Subject|1
5796275|NCT03110029|19984176|P1|Overall Study|Withdrawal by Subject|1
5796276|NCT03109184|19984250|P2|Overall Study|Withdrawal by Subject|1
5796277|NCT03109184|19984251|P1|Overall Study|Withdrawal by Subject|1
5796278|NCT03109184|19984250|P2|Overall Study|Lost to Follow-up|6
5796279|NCT03109184|19984251|P1|Overall Study|Lost to Follow-up|6
5796280|NCT03108521|19984405|P2|Overall Study|Adverse Event|0
5796281|NCT03108521|19984406|P1|Overall Study|Adverse Event|3
5796282|NCT03108521|19984405|P2|Overall Study|Physician Decision|0
5796283|NCT03108521|19984406|P1|Overall Study|Physician Decision|4
5796284|NCT03108521|19984405|P2|Overall Study|Lack of Efficacy|0
5796285|NCT03108521|19984406|P1|Overall Study|Lack of Efficacy|2
5796286|NCT03108521|19984405|P2|Overall Study|Lost to Follow-up|0
5796287|NCT03108521|19984406|P1|Overall Study|Lost to Follow-up|3
5796288|NCT03108157|19984458|P2|Overall Study|Protocol Violation|4
5796289|NCT03108157|19984459|P1|Overall Study|Protocol Violation|15
5796290|NCT03108027|19984469|P6|Period 3|Adverse Event|0
5796291|NCT03108027|19984470|P5|Period 3|Adverse Event|0
5796292|NCT03108027|19984471|P4|Period 3|Adverse Event|0
5796293|NCT03108027|19984472|P3|Period 3|Adverse Event|0
5796294|NCT03108027|19984473|P2|Period 3|Adverse Event|1
5796295|NCT03108027|19984474|P1|Period 3|Adverse Event|0
5796296|NCT03108027|19984469|P6|Period 1|Subject/Guardian Decision|0
5796297|NCT03108027|19984470|P5|Period 1|Subject/Guardian Decision|0
5796298|NCT03108027|19984471|P4|Period 1|Subject/Guardian Decision|2
5796299|NCT03108027|19984472|P3|Period 1|Subject/Guardian Decision|0
5796300|NCT03108027|19984473|P2|Period 1|Subject/Guardian Decision|0
5796301|NCT03108027|19984474|P1|Period 1|Subject/Guardian Decision|0
5796302|NCT03107715|19984501|P2|Overall Study|infant stillborn|1
5796303|NCT03107715|19984502|P1|Overall Study|infant stillborn|0
5796304|NCT03107715|19984501|P2|Overall Study|did not deliver at the home hospital|6
5796305|NCT03107715|19984502|P1|Overall Study|did not deliver at the home hospital|4
5796306|NCT03107611|19984517|P3|Overall Study|Worsening signs/symptoms|2
5796307|NCT03107611|19984518|P2|Overall Study|Worsening signs/symptoms|1
5796308|NCT03107611|19984519|P1|Overall Study|Worsening signs/symptoms|2
5796309|NCT03107611|19984517|P3|Overall Study|Withdrawal by Subject|1
5796310|NCT03107611|19984518|P2|Overall Study|Withdrawal by Subject|0
5796311|NCT03107611|19984519|P1|Overall Study|Withdrawal by Subject|1
5796312|NCT03107611|19984517|P3|Overall Study|Protocol Violation|1
5796313|NCT03107611|19984518|P2|Overall Study|Protocol Violation|0
5796314|NCT03107611|19984519|P1|Overall Study|Protocol Violation|0
5796315|NCT03107611|19984517|P3|Overall Study|Lost to Follow-up|3
5796316|NCT03107611|19984518|P2|Overall Study|Lost to Follow-up|3
5796317|NCT03107611|19984519|P1|Overall Study|Lost to Follow-up|3
5796318|NCT03107611|19984517|P3|Overall Study|Adverse Event|2
5796319|NCT03107611|19984518|P2|Overall Study|Adverse Event|0
5796320|NCT03107611|19984519|P1|Overall Study|Adverse Event|1
5796321|NCT03107377|19984538|P2|Overall Study|Other reason not specified|15
5796322|NCT03107377|19984539|P1|Overall Study|Other reason not specified|16
5796323|NCT03107377|19984538|P2|Overall Study|Lost to Follow-up|34
5796324|NCT03107377|19984539|P1|Overall Study|Lost to Follow-up|37
5796325|NCT03107377|19984538|P2|Overall Study|Withdrawal by Subject|22
5796326|NCT03107377|19984539|P1|Overall Study|Withdrawal by Subject|16
5796327|NCT03107377|19984538|P2|Overall Study|Pregnancy|7
5796328|NCT03107377|19984539|P1|Overall Study|Pregnancy|7
5796329|NCT03107377|19984538|P2|Overall Study|Physician Decision|6
5796330|NCT03107377|19984539|P1|Overall Study|Physician Decision|3
5796331|NCT03107377|19984538|P2|Overall Study|Protocol Violation|12
5796332|NCT03107377|19984539|P1|Overall Study|Protocol Violation|9
5796333|NCT03107377|19984538|P2|Overall Study|Adverse Event|3
5796334|NCT03107377|19984539|P1|Overall Study|Adverse Event|3
5796335|NCT03107052|19984564|P3|Overall Study|Study terminated due to futility|23
5796336|NCT03107052|19984565|P2|Overall Study|Study terminated due to futility|31
5796337|NCT03107052|19984566|P1|Overall Study|Study terminated due to futility|67
5796338|NCT03107052|19984564|P3|Overall Study|Other than specified|0
5796339|NCT03107052|19984565|P2|Overall Study|Other than specified|2
5796340|NCT03107052|19984566|P1|Overall Study|Other than specified|4
5796341|NCT03107052|19984564|P3|Overall Study|Lack of Efficacy|4
5796342|NCT03107052|19984565|P2|Overall Study|Lack of Efficacy|7
5796343|NCT03107052|19984566|P1|Overall Study|Lack of Efficacy|23
5796344|NCT03107052|19984564|P3|Overall Study|Lost to Follow-up|1
5796345|NCT03107052|19984565|P2|Overall Study|Lost to Follow-up|0
5796346|NCT03107052|19984566|P1|Overall Study|Lost to Follow-up|4
5796347|NCT03107052|19984564|P3|Overall Study|Protocol Violation|3
5796348|NCT03107052|19984565|P2|Overall Study|Protocol Violation|0
5796349|NCT03107052|19984566|P1|Overall Study|Protocol Violation|6
5796350|NCT03107052|19984564|P3|Overall Study|Withdrawal by Subject|8
5796351|NCT03107052|19984565|P2|Overall Study|Withdrawal by Subject|5
5796352|NCT03107052|19984566|P1|Overall Study|Withdrawal by Subject|9
5796353|NCT03107052|19984564|P3|Overall Study|Adverse Event|2
5796354|NCT03107052|19984565|P2|Overall Study|Adverse Event|1
5796355|NCT03107052|19984566|P1|Overall Study|Adverse Event|6
5796356|NCT03107026|19984610|P3|Overall Study|Physician Decision|0
5796357|NCT03107026|19984611|P2|Overall Study|Physician Decision|1
5796358|NCT03107026|19984612|P1|Overall Study|Physician Decision|0
5796359|NCT03107026|19984610|P3|Overall Study|non-compliance with study drug|3
5796360|NCT03107026|19984611|P2|Overall Study|non-compliance with study drug|2
5796361|NCT03107026|19984612|P1|Overall Study|non-compliance with study drug|2
5796362|NCT03107026|19984610|P3|Overall Study|non compliance with study visits|0
5796363|NCT03107026|19984611|P2|Overall Study|non compliance with study visits|2
5796364|NCT03107026|19984612|P1|Overall Study|non compliance with study visits|1
5796365|NCT03107026|19984610|P3|Overall Study|Withdrawal by Subject|17
5796366|NCT03107026|19984611|P2|Overall Study|Withdrawal by Subject|5
5796367|NCT03107026|19984612|P1|Overall Study|Withdrawal by Subject|13
5796368|NCT03107026|19984610|P3|Overall Study|Pregnancy|0
5796369|NCT03107026|19984611|P2|Overall Study|Pregnancy|0
5796370|NCT03107026|19984612|P1|Overall Study|Pregnancy|1
5796371|NCT03107026|19984610|P3|Overall Study|Protocol Violation|0
5796372|NCT03107026|19984611|P2|Overall Study|Protocol Violation|2
5796373|NCT03107026|19984612|P1|Overall Study|Protocol Violation|1
5796374|NCT03107026|19984610|P3|Overall Study|Lost to Follow-up|13
5796375|NCT03107026|19984611|P2|Overall Study|Lost to Follow-up|12
5796376|NCT03107026|19984612|P1|Overall Study|Lost to Follow-up|12
5796377|NCT03107026|19984610|P3|Overall Study|Adverse Event|23
5796378|NCT03107026|19984611|P2|Overall Study|Adverse Event|14
5796379|NCT03107026|19984612|P1|Overall Study|Adverse Event|2
5796380|NCT03106753|19984679|P2|Overall Study|Withdrawal by Subject|1
5796381|NCT03106753|19984680|P1|Overall Study|Withdrawal by Subject|0
5796382|NCT03106077|19984746|P2|Overall Study|Screen Failure|0
5796383|NCT03106077|19984747|P1|Overall Study|Screen Failure|94
5796384|NCT03105362|19984791|P1|Overall Study|Lost to Follow-up|1
5796385|NCT03105362|19984791|P1|Overall Study|Withdrawal by Subject|1
5796386|NCT03105297|19984798|P1|Nasal Resistance Phase (Day 30, 31)|Withdrawal by Subject|7
5796387|NCT03105297|19984798|P1|Nasal Resistance Phase (Day 30, 31)|Adverse Event|1
5796388|NCT03105297|19984798|P1|Baseline Phase (Day 1)|Other|21
5796389|NCT03104816|19984842|P3|Overall Study|Protocol Violation|2
5796390|NCT03104816|19984843|P2|Overall Study|Protocol Violation|0
5796391|NCT03104816|19984844|P1|Overall Study|Protocol Violation|2
5796392|NCT03104816|19984842|P3|Overall Study|Lack of Efficacy|0
5796393|NCT03104816|19984843|P2|Overall Study|Lack of Efficacy|2
5796394|NCT03104816|19984844|P1|Overall Study|Lack of Efficacy|0
5796395|NCT03103919|19984952|P2|Overall Study|Adverse Event|2
5796396|NCT03103919|19984953|P1|Overall Study|Adverse Event|2
5796397|NCT03103906|19984989|P2|Overall Study|Other|0
5796398|NCT03103906|19984990|P1|Overall Study|Other|2
5796399|NCT03103906|19984989|P2|Overall Study|Adverse Event|3
5796400|NCT03103906|19984990|P1|Overall Study|Adverse Event|2
5796401|NCT03103763|19985013|P3|Overall Study|Withdrawal by Subject|2
5796402|NCT03103763|19985014|P2|Overall Study|Withdrawal by Subject|3
5796403|NCT03103763|19985015|P1|Overall Study|Withdrawal by Subject|0
5796404|NCT03103763|19985013|P3|Overall Study|Death|5
5796405|NCT03103763|19985014|P2|Overall Study|Death|5
5796406|NCT03103763|19985015|P1|Overall Study|Death|15
5796407|NCT03103503|19985044|P1|Overall Study|Study Closure|757
5796408|NCT03103503|19985044|P1|Overall Study|Lost to Follow-up|3
5796409|NCT03103503|19985044|P1|Overall Study|Plexa Lead or Pulse Generator Extraction|10
5796410|NCT03103503|19985044|P1|Overall Study|Withdrawal by Subject|10
5796411|NCT03103503|19985044|P1|Overall Study|Physician Decision|57
5796412|NCT03103503|19985044|P1|Overall Study|Death|64
5796413|NCT03103100|19985069|P3|Overall Study|Physician Decision|2
5796414|NCT03103100|19985070|P2|Overall Study|Physician Decision|0
5796415|NCT03103100|19985071|P1|Overall Study|Physician Decision|1
5796416|NCT03103100|19985069|P3|Overall Study|Adverse Event|0
5796417|NCT03103100|19985070|P2|Overall Study|Adverse Event|0
5796418|NCT03103100|19985071|P1|Overall Study|Adverse Event|1
5796419|NCT03102918|19985095|P2|Overall Study|Protocol Violation|0
5796420|NCT03102918|19985096|P1|Overall Study|Protocol Violation|1
5796421|NCT03102762|19985122|P2|Overall Study|Lost to Follow-up|0
5796422|NCT03102762|19985123|P1|Overall Study|Lost to Follow-up|1
5796423|NCT03102710|19985167|P3|Overall Study|Subject unable to attend final session|0
5796424|NCT03102710|19985168|P2|Overall Study|Subject unable to attend final session|1
5796425|NCT03102710|19985169|P1|Overall Study|Subject unable to attend final session|0
5796426|NCT03102710|19985167|P3|Overall Study|Nausea during MRI scan|0
5796427|NCT03102710|19985168|P2|Overall Study|Nausea during MRI scan|1
5796428|NCT03102710|19985169|P1|Overall Study|Nausea during MRI scan|0
5796429|NCT03102710|19985167|P3|Overall Study|Technical issues during final MRI scan|0
5796430|NCT03102710|19985168|P2|Overall Study|Technical issues during final MRI scan|1
5796431|NCT03102710|19985169|P1|Overall Study|Technical issues during final MRI scan|0
5796432|NCT03102710|19985167|P3|Overall Study|Dental metal affected MRI scan quality|0
5796433|NCT03102710|19985168|P2|Overall Study|Dental metal affected MRI scan quality|0
5796434|NCT03102710|19985169|P1|Overall Study|Dental metal affected MRI scan quality|1
5796435|NCT03102034|19985194|P2|Overall Study|Withdrawal by Subject|0
5796436|NCT03102034|19985195|P1|Overall Study|Withdrawal by Subject|1
5796437|NCT03101592|19985224|P3|Overall Study|participant files could not be located|118
5796438|NCT03101592|19985225|P2|Overall Study|participant files could not be located|170
5796439|NCT03101592|19985226|P1|Overall Study|participant files could not be located|111
5796440|NCT03101462|19985245|P2|Overall Study|Missed Visit 02 and/or Visit 03|1
5796441|NCT03101462|19985246|P1|Overall Study|Missed Visit 02 and/or Visit 03|1
5796442|NCT03101371|19985262|P2|Overall Study|Did not meet eligibility criteria|1
5796443|NCT03101371|19985263|P1|Overall Study|Did not meet eligibility criteria|2
5796444|NCT03101371|19985262|P2|Overall Study|Lost to Follow-up|4
5796445|NCT03101371|19985263|P1|Overall Study|Lost to Follow-up|1
5796446|NCT03101371|19985262|P2|Overall Study|Physician Decision|1
5796447|NCT03101371|19985263|P1|Overall Study|Physician Decision|0
5796448|NCT03101293|19985283|P2|Washout Period (at Least 7 Days)|Positive drug urine screen|0
5796449|NCT03101293|19985284|P1|Washout Period (at Least 7 Days)|Positive drug urine screen|1
5796450|NCT03101267|19985299|P3|Primary Study Period|Miscellaneous|0
5796451|NCT03101267|19985300|P2|Primary Study Period|Miscellaneous|0
5796452|NCT03101267|19985301|P1|Primary Study Period|Miscellaneous|2
5796453|NCT03101267|19985299|P3|Primary Study Period|Withdrawal by Subject|3
5796454|NCT03101267|19985300|P2|Primary Study Period|Withdrawal by Subject|2
5796455|NCT03101267|19985301|P1|Primary Study Period|Withdrawal by Subject|1
5796456|NCT03101150|19985356|P2|Overall Study|Miscarriage|6
5796457|NCT03101150|19985357|P1|Overall Study|Miscarriage|3
5796458|NCT03101150|19985356|P2|Overall Study|Lost to Follow-up|4
5796459|NCT03101150|19985357|P1|Overall Study|Lost to Follow-up|2
5796460|NCT03101020|19985392|P2|Overall Study|Withdrawal by Subject|2
5796461|NCT03101020|19985393|P1|Overall Study|Withdrawal by Subject|0
5796462|NCT03101020|19985392|P2|Overall Study|Ran over by a car|1
5796463|NCT03101020|19985393|P1|Overall Study|Ran over by a car|0
5796464|NCT03101020|19985392|P2|Overall Study|Lack of time to participate|0
5796465|NCT03101020|19985393|P1|Overall Study|Lack of time to participate|1
5796466|NCT03100942|19985428|P7|Placebo Arm Re-Randomized|Withdrew Consent|1
5796467|NCT03100942|19985429|P6|Placebo Arm Re-Randomized|Withdrew Consent|0
5796468|NCT03100942|19985430|P5|Placebo Arm Re-Randomized|Withdrew Consent|0
5796469|NCT03100942|19985431|P4|Placebo Arm Re-Randomized|Withdrew Consent|0
5796470|NCT03100942|19985432|P3|Placebo Arm Re-Randomized|Withdrew Consent|0
5796471|NCT03100942|19985433|P2|Placebo Arm Re-Randomized|Withdrew Consent|0
5796472|NCT03100942|19985434|P1|Placebo Arm Re-Randomized|Withdrew Consent|0
5796473|NCT03100942|19985428|P7|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0
5796474|NCT03100942|19985429|P6|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0
5796475|NCT03100942|19985430|P5|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0
5796476|NCT03100942|19985431|P4|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|1
5796477|NCT03100942|19985432|P3|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0
5796478|NCT03100942|19985433|P2|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0
5796479|NCT03100942|19985434|P1|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|1
5796480|NCT03100942|19985428|P7|Randomized Treatment Period|Lost to Follow-up|0
5796481|NCT03100942|19985429|P6|Randomized Treatment Period|Lost to Follow-up|0
5796482|NCT03100942|19985430|P5|Randomized Treatment Period|Lost to Follow-up|0
5796483|NCT03100942|19985431|P4|Randomized Treatment Period|Lost to Follow-up|0
5796484|NCT03100942|19985432|P3|Randomized Treatment Period|Lost to Follow-up|1
5796485|NCT03100942|19985433|P2|Randomized Treatment Period|Lost to Follow-up|0
5796486|NCT03100942|19985434|P1|Randomized Treatment Period|Lost to Follow-up|0
5796487|NCT03100942|19985428|P7|Randomized Treatment Period|Protocol Violation|0
5796488|NCT03100942|19985429|P6|Randomized Treatment Period|Protocol Violation|0
5796489|NCT03100942|19985430|P5|Randomized Treatment Period|Protocol Violation|0
5796490|NCT03100942|19985431|P4|Randomized Treatment Period|Protocol Violation|1
5796491|NCT03100942|19985432|P3|Randomized Treatment Period|Protocol Violation|1
5796492|NCT03100942|19985433|P2|Randomized Treatment Period|Protocol Violation|1
5796493|NCT03100942|19985434|P1|Randomized Treatment Period|Protocol Violation|0
5796494|NCT03100942|19985428|P7|Randomized Treatment Period|Investigator's Discretion|0
5796495|NCT03100942|19985429|P6|Randomized Treatment Period|Investigator's Discretion|0
5796496|NCT03100942|19985430|P5|Randomized Treatment Period|Investigator's Discretion|0
5796497|NCT03100942|19985431|P4|Randomized Treatment Period|Investigator's Discretion|0
5796498|NCT03100942|19985432|P3|Randomized Treatment Period|Investigator's Discretion|0
5796499|NCT03100942|19985433|P2|Randomized Treatment Period|Investigator's Discretion|1
5796500|NCT03100942|19985434|P1|Randomized Treatment Period|Investigator's Discretion|2
5796501|NCT03100942|19985428|P7|Randomized Treatment Period|Adverse Event|0
5796502|NCT03100942|19985429|P6|Randomized Treatment Period|Adverse Event|0
5796503|NCT03100942|19985430|P5|Randomized Treatment Period|Adverse Event|0
5796504|NCT03100942|19985431|P4|Randomized Treatment Period|Adverse Event|0
5796505|NCT03100942|19985432|P3|Randomized Treatment Period|Adverse Event|1
5796506|NCT03100942|19985433|P2|Randomized Treatment Period|Adverse Event|2
5796507|NCT03100942|19985434|P1|Randomized Treatment Period|Adverse Event|5
5796508|NCT03100942|19985428|P7|Randomized Treatment Period|Withdrew Consent|0
5796509|NCT03100942|19985429|P6|Randomized Treatment Period|Withdrew Consent|0
5796510|NCT03100942|19985430|P5|Randomized Treatment Period|Withdrew Consent|0
5796511|NCT03100942|19985431|P4|Randomized Treatment Period|Withdrew Consent|3
5796512|NCT03100942|19985432|P3|Randomized Treatment Period|Withdrew Consent|3
5796513|NCT03100942|19985433|P2|Randomized Treatment Period|Withdrew Consent|5
5796514|NCT03100942|19985434|P1|Randomized Treatment Period|Withdrew Consent|4
5796515|NCT03100838|19985472|P4|Overall Study|Lost to Follow-up|0
5796516|NCT03100838|19985473|P3|Overall Study|Lost to Follow-up|1
5796517|NCT03100838|19985474|P2|Overall Study|Lost to Follow-up|0
5796518|NCT03100838|19985475|P1|Overall Study|Lost to Follow-up|0
5796519|NCT03100838|19985472|P4|Overall Study|Pregnancy|0
5796520|NCT03100838|19985473|P3|Overall Study|Pregnancy|0
5796521|NCT03100838|19985474|P2|Overall Study|Pregnancy|1
5796522|NCT03100838|19985475|P1|Overall Study|Pregnancy|0
5796523|NCT03100838|19985472|P4|Overall Study|Physician Decision|1
5796524|NCT03100838|19985473|P3|Overall Study|Physician Decision|1
5796525|NCT03100838|19985474|P2|Overall Study|Physician Decision|1
5796526|NCT03100838|19985475|P1|Overall Study|Physician Decision|1
5796527|NCT03100838|19985472|P4|Overall Study|Adverse Event|0
5796528|NCT03100838|19985473|P3|Overall Study|Adverse Event|0
5796529|NCT03100838|19985474|P2|Overall Study|Adverse Event|0
5796530|NCT03100838|19985475|P1|Overall Study|Adverse Event|1
5796531|NCT03100825|19985501|P1|Overall Study|Physician Decision|1
5796532|NCT03100825|19985501|P1|Overall Study|Participant/Guardian Decision|7
5796533|NCT03100344|19985528|P4|Overall Study|Lost to Follow-up|1
5796534|NCT03100344|19985529|P3|Overall Study|Lost to Follow-up|1
5796535|NCT03100344|19985530|P2|Overall Study|Lost to Follow-up|1
5796536|NCT03100344|19985531|P1|Overall Study|Lost to Follow-up|1
5796537|NCT03100344|19985528|P4|Overall Study|Withdrawal by Subject|8
5796538|NCT03100344|19985529|P3|Overall Study|Withdrawal by Subject|4
5796539|NCT03100344|19985530|P2|Overall Study|Withdrawal by Subject|7
5796540|NCT03100344|19985531|P1|Overall Study|Withdrawal by Subject|10
5796541|NCT03100344|19985528|P4|Overall Study|Protocol Violation|0
5796542|NCT03100344|19985529|P3|Overall Study|Protocol Violation|0
5796543|NCT03100344|19985530|P2|Overall Study|Protocol Violation|0
5796544|NCT03100344|19985531|P1|Overall Study|Protocol Violation|1
5796545|NCT03100344|19985528|P4|Overall Study|Lack of Efficacy|0
5796546|NCT03100344|19985529|P3|Overall Study|Lack of Efficacy|0
5796547|NCT03100344|19985530|P2|Overall Study|Lack of Efficacy|0
5796548|NCT03100344|19985531|P1|Overall Study|Lack of Efficacy|2
5796549|NCT03100344|19985528|P4|Overall Study|Adverse Event|3
5796550|NCT03100344|19985529|P3|Overall Study|Adverse Event|2
5796551|NCT03100344|19985530|P2|Overall Study|Adverse Event|3
5796552|NCT03100344|19985531|P1|Overall Study|Adverse Event|0
5796553|NCT03100058|19985634|P13|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
5796554|NCT03100058|19985635|P12|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
5796555|NCT03100058|19985636|P11|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
5796556|NCT03100058|19985637|P10|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|1
5796557|NCT03100058|19985638|P9|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
5796558|NCT03100058|19985639|P8|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
5796559|NCT03100058|19985640|P7|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
5796560|NCT03100058|19985641|P6|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
5796561|NCT03100058|19985642|P5|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
5796562|NCT03100058|19985643|P4|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
5796563|NCT03100058|19985644|P3|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
5796564|NCT03100058|19985645|P2|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
5796565|NCT03100058|19985646|P1|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
5796566|NCT03100058|19985634|P13|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|1
5796567|NCT03100058|19985635|P12|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
5796568|NCT03100058|19985636|P11|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
5796569|NCT03100058|19985637|P10|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
5796570|NCT03100058|19985638|P9|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
5796571|NCT03100058|19985639|P8|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
5796572|NCT03100058|19985640|P7|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
5796573|NCT03100058|19985641|P6|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
5796574|NCT03100058|19985642|P5|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
5796575|NCT03100058|19985643|P4|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
5796576|NCT03100058|19985644|P3|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
5796577|NCT03100058|19985645|P2|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
5796578|NCT03100058|19985646|P1|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
5796579|NCT03100058|19985634|P13|Epoch 4 (Last 24 Weeks of the Study)|Death|0
5796580|NCT03100058|19985635|P12|Epoch 4 (Last 24 Weeks of the Study)|Death|0
5796581|NCT03100058|19985636|P11|Epoch 4 (Last 24 Weeks of the Study)|Death|1
5796582|NCT03100058|19985637|P10|Epoch 4 (Last 24 Weeks of the Study)|Death|0
5796583|NCT03100058|19985638|P9|Epoch 4 (Last 24 Weeks of the Study)|Death|0
5796584|NCT03100058|19985639|P8|Epoch 4 (Last 24 Weeks of the Study)|Death|0
5796585|NCT03100058|19985640|P7|Epoch 4 (Last 24 Weeks of the Study)|Death|0
5796586|NCT03100058|19985641|P6|Epoch 4 (Last 24 Weeks of the Study)|Death|0
5796587|NCT03100058|19985642|P5|Epoch 4 (Last 24 Weeks of the Study)|Death|0
5796588|NCT03100058|19985643|P4|Epoch 4 (Last 24 Weeks of the Study)|Death|0
5796589|NCT03100058|19985644|P3|Epoch 4 (Last 24 Weeks of the Study)|Death|0
5796590|NCT03100058|19985645|P2|Epoch 4 (Last 24 Weeks of the Study)|Death|0
5796591|NCT03100058|19985646|P1|Epoch 4 (Last 24 Weeks of the Study)|Death|0
5796592|NCT03100058|19985634|P13|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|2
5796593|NCT03100058|19985635|P12|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
5796594|NCT03100058|19985636|P11|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|7
5796595|NCT03100058|19985637|P10|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|4
5796596|NCT03100058|19985638|P9|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
5796597|NCT03100058|19985639|P8|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
5796598|NCT03100058|19985640|P7|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
5796599|NCT03100058|19985641|P6|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
5796600|NCT03100058|19985642|P5|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
5796601|NCT03100058|19985643|P4|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
5796602|NCT03100058|19985644|P3|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
5796603|NCT03100058|19985645|P2|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
5796604|NCT03100058|19985646|P1|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
5796605|NCT03100058|19985634|P13|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
5796606|NCT03100058|19985635|P12|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|1
5796607|NCT03100058|19985636|P11|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|3
5796608|NCT03100058|19985637|P10|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
5796609|NCT03100058|19985638|P9|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
5796610|NCT03100058|19985639|P8|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
5796611|NCT03100058|19985640|P7|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
5796612|NCT03100058|19985641|P6|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
5796613|NCT03100058|19985642|P5|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
5796614|NCT03100058|19985643|P4|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
5796615|NCT03100058|19985644|P3|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
5796616|NCT03100058|19985645|P2|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
5796617|NCT03100058|19985646|P1|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
5796618|NCT03100058|19985634|P13|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|1
5796619|NCT03100058|19985635|P12|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|2
5796620|NCT03100058|19985636|P11|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|4
5796621|NCT03100058|19985637|P10|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
5796622|NCT03100058|19985638|P9|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
5796623|NCT03100058|19985639|P8|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
5796624|NCT03100058|19985640|P7|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
5796625|NCT03100058|19985641|P6|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
5796626|NCT03100058|19985642|P5|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
5796627|NCT03100058|19985643|P4|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
5796628|NCT03100058|19985644|P3|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
5796629|NCT03100058|19985645|P2|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
5796630|NCT03100058|19985646|P1|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
5796631|NCT03100058|19985634|P13|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
5796632|NCT03100058|19985635|P12|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
5796633|NCT03100058|19985636|P11|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
5796634|NCT03100058|19985637|P10|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
5796635|NCT03100058|19985638|P9|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
5796636|NCT03100058|19985639|P8|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
5796637|NCT03100058|19985640|P7|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|1
5796638|NCT03100058|19985641|P6|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
5796639|NCT03100058|19985642|P5|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
5796640|NCT03100058|19985643|P4|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
5796641|NCT03100058|19985644|P3|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
5796642|NCT03100058|19985645|P2|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
5796643|NCT03100058|19985646|P1|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
5796644|NCT03100058|19985634|P13|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
5796645|NCT03100058|19985635|P12|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
5796646|NCT03100058|19985636|P11|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
5796647|NCT03100058|19985637|P10|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
5796648|NCT03100058|19985638|P9|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
5796649|NCT03100058|19985639|P8|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
5796650|NCT03100058|19985640|P7|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
5796651|NCT03100058|19985641|P6|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
5796652|NCT03100058|19985642|P5|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
5796653|NCT03100058|19985643|P4|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
5796654|NCT03100058|19985644|P3|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
5796655|NCT03100058|19985645|P2|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
5796656|NCT03100058|19985646|P1|Epoch 3 (24 Weeks of Treatment)|Pregnancy|1
5796657|NCT03100058|19985634|P13|Epoch 3 (24 Weeks of Treatment)|Death|0
5796658|NCT03100058|19985635|P12|Epoch 3 (24 Weeks of Treatment)|Death|0
5796659|NCT03100058|19985636|P11|Epoch 3 (24 Weeks of Treatment)|Death|0
5796660|NCT03100058|19985637|P10|Epoch 3 (24 Weeks of Treatment)|Death|0
5796661|NCT03100058|19985638|P9|Epoch 3 (24 Weeks of Treatment)|Death|0
5796662|NCT03100058|19985639|P8|Epoch 3 (24 Weeks of Treatment)|Death|0
5796663|NCT03100058|19985640|P7|Epoch 3 (24 Weeks of Treatment)|Death|0
5796664|NCT03100058|19985641|P6|Epoch 3 (24 Weeks of Treatment)|Death|0
5796665|NCT03100058|19985642|P5|Epoch 3 (24 Weeks of Treatment)|Death|0
5796666|NCT03100058|19985643|P4|Epoch 3 (24 Weeks of Treatment)|Death|0
5796667|NCT03100058|19985644|P3|Epoch 3 (24 Weeks of Treatment)|Death|0
5796668|NCT03100058|19985645|P2|Epoch 3 (24 Weeks of Treatment)|Death|1
5796669|NCT03100058|19985646|P1|Epoch 3 (24 Weeks of Treatment)|Death|0
5796670|NCT03100058|19985634|P13|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
5796671|NCT03100058|19985635|P12|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
5796672|NCT03100058|19985636|P11|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
5796673|NCT03100058|19985637|P10|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
5796674|NCT03100058|19985638|P9|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
5796675|NCT03100058|19985639|P8|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
5796676|NCT03100058|19985640|P7|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1
5796677|NCT03100058|19985641|P6|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
5796678|NCT03100058|19985642|P5|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
5796679|NCT03100058|19985643|P4|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1
5796680|NCT03100058|19985644|P3|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
5796681|NCT03100058|19985645|P2|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
5796682|NCT03100058|19985646|P1|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
5796683|NCT03100058|19985634|P13|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
5796684|NCT03100058|19985635|P12|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
5796685|NCT03100058|19985636|P11|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
5796686|NCT03100058|19985637|P10|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
5796687|NCT03100058|19985638|P9|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
5796688|NCT03100058|19985639|P8|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1
5796689|NCT03100058|19985640|P7|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
5796690|NCT03100058|19985641|P6|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
5796691|NCT03100058|19985642|P5|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
5796692|NCT03100058|19985643|P4|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1
5796693|NCT03100058|19985644|P3|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
5796694|NCT03100058|19985645|P2|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
5796695|NCT03100058|19985646|P1|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
5796696|NCT03100058|19985634|P13|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0
5796697|NCT03100058|19985635|P12|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0
5796698|NCT03100058|19985636|P11|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0
5796699|NCT03100058|19985637|P10|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0
5796700|NCT03100058|19985638|P9|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1
5796701|NCT03100058|19985639|P8|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0
5796702|NCT03100058|19985640|P7|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1
5796703|NCT03100058|19985641|P6|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0
5796704|NCT03100058|19985642|P5|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0
5796705|NCT03100058|19985643|P4|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0
5796706|NCT03100058|19985644|P3|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1
5796707|NCT03100058|19985645|P2|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1
5796708|NCT03100058|19985646|P1|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0
5796709|NCT03100058|19985634|P13|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0
5796710|NCT03100058|19985635|P12|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0
5796711|NCT03100058|19985636|P11|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0
5796712|NCT03100058|19985637|P10|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0
5796713|NCT03100058|19985638|P9|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0
5796714|NCT03100058|19985639|P8|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0
5796715|NCT03100058|19985640|P7|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1
5796716|NCT03100058|19985641|P6|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1
5796717|NCT03100058|19985642|P5|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0
5796718|NCT03100058|19985643|P4|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0
5796719|NCT03100058|19985644|P3|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1
5796720|NCT03100058|19985645|P2|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1
5796721|NCT03100058|19985646|P1|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0
5796722|NCT03100058|19985634|P13|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0
5796723|NCT03100058|19985635|P12|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0
5796724|NCT03100058|19985636|P11|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0
5796725|NCT03100058|19985637|P10|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0
5796726|NCT03100058|19985638|P9|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2
5796727|NCT03100058|19985639|P8|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4
5796728|NCT03100058|19985640|P7|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1
5796729|NCT03100058|19985641|P6|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1
5796730|NCT03100058|19985642|P5|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1
5796731|NCT03100058|19985643|P4|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4
5796732|NCT03100058|19985644|P3|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|3
5796733|NCT03100058|19985645|P2|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4
5796734|NCT03100058|19985646|P1|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2
5796735|NCT03100058|19985634|P13|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0
5796736|NCT03100058|19985635|P12|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0
5796737|NCT03100058|19985636|P11|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0
5796738|NCT03100058|19985637|P10|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0
5796739|NCT03100058|19985638|P9|Epoch 3 (24 Weeks of Treatment)|Adverse Event|2
5796740|NCT03100058|19985639|P8|Epoch 3 (24 Weeks of Treatment)|Adverse Event|11
5796741|NCT03100058|19985640|P7|Epoch 3 (24 Weeks of Treatment)|Adverse Event|3
5796742|NCT03100058|19985641|P6|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0
5796743|NCT03100058|19985642|P5|Epoch 3 (24 Weeks of Treatment)|Adverse Event|1
5796744|NCT03100058|19985643|P4|Epoch 3 (24 Weeks of Treatment)|Adverse Event|8
5796745|NCT03100058|19985644|P3|Epoch 3 (24 Weeks of Treatment)|Adverse Event|4
5796746|NCT03100058|19985645|P2|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0
5796747|NCT03100058|19985646|P1|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0
5796748|NCT03099694|19985853|P2|Overall Study|Lost to Follow-up|5
5796749|NCT03099694|19985854|P1|Overall Study|Lost to Follow-up|9
5796750|NCT03099694|19985853|P2|Overall Study|Withdrawal by Subject|13
5796751|NCT03099694|19985854|P1|Overall Study|Withdrawal by Subject|11
5796752|NCT03099538|19985893|P1|Overall Study|Lack of Efficacy|3
5796753|NCT03099187|19985918|P4|12-month Safety Follow-up|Due to hospitalization|1
5796754|NCT03099187|19985919|P3|12-month Safety Follow-up|Due to hospitalization|0
5796755|NCT03099187|19985920|P2|12-month Safety Follow-up|Due to hospitalization|0
5796756|NCT03099187|19985921|P1|12-month Safety Follow-up|Due to hospitalization|0
5796757|NCT03099187|19985918|P4|12-month Safety Follow-up|Withdrawal by Subject|2
5796758|NCT03099187|19985919|P3|12-month Safety Follow-up|Withdrawal by Subject|3
5796759|NCT03099187|19985920|P2|12-month Safety Follow-up|Withdrawal by Subject|0
5796760|NCT03099187|19985921|P1|12-month Safety Follow-up|Withdrawal by Subject|0
5796761|NCT03099187|19985918|P4|12-month Safety Follow-up|Symptomatic deterioration|1
5796762|NCT03099187|19985919|P3|12-month Safety Follow-up|Symptomatic deterioration|1
5796763|NCT03099187|19985920|P2|12-month Safety Follow-up|Symptomatic deterioration|0
5796764|NCT03099187|19985921|P1|12-month Safety Follow-up|Symptomatic deterioration|0
5796765|NCT03099187|19985918|P4|12-month Safety Follow-up|Lost to Follow-up|0
5796766|NCT03099187|19985919|P3|12-month Safety Follow-up|Lost to Follow-up|1
5796767|NCT03099187|19985920|P2|12-month Safety Follow-up|Lost to Follow-up|0
5796768|NCT03099187|19985921|P1|12-month Safety Follow-up|Lost to Follow-up|0
5796769|NCT03099187|19985918|P4|12-month Safety Follow-up|Lung transplantation|1
5796770|NCT03099187|19985919|P3|12-month Safety Follow-up|Lung transplantation|2
5796771|NCT03099187|19985920|P2|12-month Safety Follow-up|Lung transplantation|0
5796772|NCT03099187|19985921|P1|12-month Safety Follow-up|Lung transplantation|0
5796773|NCT03099187|19985918|P4|12-month Safety Follow-up|Death|9
5796774|NCT03099187|19985919|P3|12-month Safety Follow-up|Death|7
5796775|NCT03099187|19985920|P2|12-month Safety Follow-up|Death|0
5796776|NCT03099187|19985921|P1|12-month Safety Follow-up|Death|0
5796777|NCT03099187|19985918|P4|12-month Safety Follow-up|Adverse Event|12
5796778|NCT03099187|19985919|P3|12-month Safety Follow-up|Adverse Event|5
5796779|NCT03099187|19985920|P2|12-month Safety Follow-up|Adverse Event|0
5796780|NCT03099187|19985921|P1|12-month Safety Follow-up|Adverse Event|0
5796781|NCT03099187|19985918|P4|Double-blind Treatment|Non-compliance with Protocol procedure|0
5796782|NCT03099187|19985919|P3|Double-blind Treatment|Non-compliance with Protocol procedure|0
5796783|NCT03099187|19985920|P2|Double-blind Treatment|Non-compliance with Protocol procedure|1
5796784|NCT03099187|19985921|P1|Double-blind Treatment|Non-compliance with Protocol procedure|1
5796785|NCT03099187|19985918|P4|Double-blind Treatment|Randomization error|0
5796786|NCT03099187|19985919|P3|Double-blind Treatment|Randomization error|0
5796787|NCT03099187|19985920|P2|Double-blind Treatment|Randomization error|2
5796788|NCT03099187|19985921|P1|Double-blind Treatment|Randomization error|0
5796789|NCT03099187|19985918|P4|Double-blind Treatment|Disease progression|0
5796790|NCT03099187|19985919|P3|Double-blind Treatment|Disease progression|0
5796791|NCT03099187|19985920|P2|Double-blind Treatment|Disease progression|1
5796792|NCT03099187|19985921|P1|Double-blind Treatment|Disease progression|0
5796793|NCT03099187|19985918|P4|Double-blind Treatment|Non-compliance with study drug|0
5796794|NCT03099187|19985919|P3|Double-blind Treatment|Non-compliance with study drug|0
5796795|NCT03099187|19985920|P2|Double-blind Treatment|Non-compliance with study drug|2
5796796|NCT03099187|19985921|P1|Double-blind Treatment|Non-compliance with study drug|0
5796797|NCT03099187|19985918|P4|Double-blind Treatment|Lung transplantation|0
5796798|NCT03099187|19985919|P3|Double-blind Treatment|Lung transplantation|0
5796799|NCT03099187|19985920|P2|Double-blind Treatment|Lung transplantation|1
5796800|NCT03099187|19985921|P1|Double-blind Treatment|Lung transplantation|0
5796801|NCT03099187|19985918|P4|Double-blind Treatment|Withdrawal by Subject|0
5796802|NCT03099187|19985919|P3|Double-blind Treatment|Withdrawal by Subject|0
5796803|NCT03099187|19985920|P2|Double-blind Treatment|Withdrawal by Subject|4
5796804|NCT03099187|19985921|P1|Double-blind Treatment|Withdrawal by Subject|9
5796805|NCT03099187|19985918|P4|Double-blind Treatment|Physician Decision|0
5796806|NCT03099187|19985919|P3|Double-blind Treatment|Physician Decision|0
5796807|NCT03099187|19985920|P2|Double-blind Treatment|Physician Decision|1
5796808|NCT03099187|19985921|P1|Double-blind Treatment|Physician Decision|2
5796809|NCT03099187|19985918|P4|Double-blind Treatment|Lack of Efficacy|0
5796810|NCT03099187|19985919|P3|Double-blind Treatment|Lack of Efficacy|0
5796811|NCT03099187|19985920|P2|Double-blind Treatment|Lack of Efficacy|0
5796812|NCT03099187|19985921|P1|Double-blind Treatment|Lack of Efficacy|1
5796813|NCT03099187|19985918|P4|Double-blind Treatment|Death|0
5796814|NCT03099187|19985919|P3|Double-blind Treatment|Death|0
5796815|NCT03099187|19985920|P2|Double-blind Treatment|Death|3
5796816|NCT03099187|19985921|P1|Double-blind Treatment|Death|1
5796817|NCT03099187|19985918|P4|Double-blind Treatment|Adverse Event|0
5796818|NCT03099187|19985919|P3|Double-blind Treatment|Adverse Event|0
5796819|NCT03099187|19985920|P2|Double-blind Treatment|Adverse Event|1
5796820|NCT03099187|19985921|P1|Double-blind Treatment|Adverse Event|19
5796821|NCT03099161|19985976|P3|Overall Study|Progressive Disease|1
5796822|NCT03099161|19985977|P2|Overall Study|Progressive Disease|4
5796823|NCT03099161|19985978|P1|Overall Study|Progressive Disease|1
5796824|NCT03099161|19985976|P3|Overall Study|Physician Decision|0
5796825|NCT03099161|19985977|P2|Overall Study|Physician Decision|0
5796826|NCT03099161|19985978|P1|Overall Study|Physician Decision|2
5796827|NCT03099161|19985976|P3|Overall Study|Adverse Event|2
5796828|NCT03099161|19985977|P2|Overall Study|Adverse Event|0
5796829|NCT03099161|19985978|P1|Overall Study|Adverse Event|0
5796830|NCT03099096|19985995|P1|Overall Study|Physician Decision|1
5796831|NCT03099096|19985995|P1|Overall Study|Adverse Event|1
5796832|NCT03098979|19986008|P6|Overall Study|Protocol Violation|1
5796833|NCT03098979|19986009|P5|Overall Study|Protocol Violation|0
5796834|NCT03098979|19986010|P4|Overall Study|Protocol Violation|0
5796835|NCT03098979|19986011|P3|Overall Study|Protocol Violation|0
5796836|NCT03098979|19986012|P2|Overall Study|Protocol Violation|0
5796837|NCT03098979|19986013|P1|Overall Study|Protocol Violation|0
5796838|NCT03098979|19986008|P6|Overall Study|Non-compliance|1
5796839|NCT03098979|19986009|P5|Overall Study|Non-compliance|0
5796840|NCT03098979|19986010|P4|Overall Study|Non-compliance|0
5796841|NCT03098979|19986011|P3|Overall Study|Non-compliance|0
5796842|NCT03098979|19986012|P2|Overall Study|Non-compliance|0
5796843|NCT03098979|19986013|P1|Overall Study|Non-compliance|0
5796844|NCT03098979|19986008|P6|Overall Study|Physician Decision|0
5796845|NCT03098979|19986009|P5|Overall Study|Physician Decision|0
5796846|NCT03098979|19986010|P4|Overall Study|Physician Decision|0
5796847|NCT03098979|19986011|P3|Overall Study|Physician Decision|0
5796848|NCT03098979|19986012|P2|Overall Study|Physician Decision|1
5796849|NCT03098979|19986013|P1|Overall Study|Physician Decision|2
5796850|NCT03098979|19986008|P6|Overall Study|Death|0
5796851|NCT03098979|19986009|P5|Overall Study|Death|1
5796852|NCT03098979|19986010|P4|Overall Study|Death|0
5796853|NCT03098979|19986011|P3|Overall Study|Death|2
5796854|NCT03098979|19986012|P2|Overall Study|Death|0
5796855|NCT03098979|19986013|P1|Overall Study|Death|1
5796856|NCT03098979|19986008|P6|Overall Study|Withdrawal by Subject|1
5796857|NCT03098979|19986009|P5|Overall Study|Withdrawal by Subject|2
5796858|NCT03098979|19986010|P4|Overall Study|Withdrawal by Subject|1
5796859|NCT03098979|19986011|P3|Overall Study|Withdrawal by Subject|1
5796860|NCT03098979|19986012|P2|Overall Study|Withdrawal by Subject|1
5796861|NCT03098979|19986013|P1|Overall Study|Withdrawal by Subject|2
5796862|NCT03098979|19986008|P6|Overall Study|Adverse Event|1
5796863|NCT03098979|19986009|P5|Overall Study|Adverse Event|6
5796864|NCT03098979|19986010|P4|Overall Study|Adverse Event|4
5796865|NCT03098979|19986011|P3|Overall Study|Adverse Event|1
5796866|NCT03098979|19986012|P2|Overall Study|Adverse Event|0
5796867|NCT03098979|19986013|P1|Overall Study|Adverse Event|1
5796868|NCT03098030|19986156|P4|Overall Study|Lost to Follow-up|1
5796869|NCT03098030|19986157|P3|Overall Study|Lost to Follow-up|2
5796870|NCT03098030|19986158|P2|Overall Study|Lost to Follow-up|0
5796871|NCT03098030|19986159|P1|Overall Study|Lost to Follow-up|0
5796872|NCT03098030|19986156|P4|Overall Study|Withdrawal by Subject|2
5796873|NCT03098030|19986157|P3|Overall Study|Withdrawal by Subject|8
5796874|NCT03098030|19986158|P2|Overall Study|Withdrawal by Subject|7
5796875|NCT03098030|19986159|P1|Overall Study|Withdrawal by Subject|0
5796876|NCT03098030|19986156|P4|Overall Study|Death|82
5796877|NCT03098030|19986157|P3|Overall Study|Death|156
5796878|NCT03098030|19986158|P2|Overall Study|Death|156
5796879|NCT03098030|19986159|P1|Overall Study|Death|10
5796880|NCT03097861|19986180|P3|Overall Study|Reason not provided|1
5796881|NCT03097861|19986181|P2|Overall Study|Reason not provided|1
5796882|NCT03097861|19986182|P1|Overall Study|Reason not provided|3
5796883|NCT03097861|19986180|P3|Overall Study|Withdrawal by Subject|3
5796884|NCT03097861|19986181|P2|Overall Study|Withdrawal by Subject|5
5796885|NCT03097861|19986182|P1|Overall Study|Withdrawal by Subject|1
5796886|NCT03097861|19986180|P3|Overall Study|Lost to Follow-up|1
5796887|NCT03097861|19986181|P2|Overall Study|Lost to Follow-up|7
5796888|NCT03097861|19986182|P1|Overall Study|Lost to Follow-up|0
5796889|NCT03097861|19986180|P3|Overall Study|Investigator Decision|0
5796890|NCT03097861|19986181|P2|Overall Study|Investigator Decision|1
5796891|NCT03097861|19986182|P1|Overall Study|Investigator Decision|0
5796892|NCT03097861|19986180|P3|Overall Study|Adverse Event|4
5796893|NCT03097861|19986181|P2|Overall Study|Adverse Event|8
5796894|NCT03097861|19986182|P1|Overall Study|Adverse Event|3
5796895|NCT03097614|19986199|P1|Overall Study|Adverse Event|3
5796896|NCT03097289|19986301|P1|Overall Study|Collected platelet product unusable|3
5796897|NCT03097289|19986301|P1|Overall Study|Equipment failure|2
5796898|NCT03097289|19986301|P1|Overall Study|Adverse Event|1
5796899|NCT03097133|19986310|P2|Overall Study|Adverse Event|0
5796900|NCT03097133|19986311|P1|Overall Study|Adverse Event|1
5796901|NCT03097133|19986310|P2|Overall Study|Other|2
5796902|NCT03097133|19986311|P1|Overall Study|Other|3
5796903|NCT03097133|19986310|P2|Overall Study|Discontinued DB, not entered FU Phase|25
5796904|NCT03097133|19986311|P1|Overall Study|Discontinued DB, not entered FU Phase|21
5796905|NCT03097133|19986310|P2|Overall Study|Withdrawal by Subject|5
5796906|NCT03097133|19986311|P1|Overall Study|Withdrawal by Subject|2
5796907|NCT03097133|19986310|P2|Overall Study|Lost to Follow-up|2
5796908|NCT03097133|19986311|P1|Overall Study|Lost to Follow-up|3
5796909|NCT03097029|19986361|P1|Overall Study|Withdrawal by Subject|1
5796910|NCT03096483|19986405|P1|Overall Study|Withdrawal by site|1
5796911|NCT03096314|19986434|P2|Screened Vitamin D Deficient|Lost to Follow-up|12
5796912|NCT03096314|19986435|P1|Screened Vitamin D Deficient|Lost to Follow-up|9
5796913|NCT03095651|19986497|P8|Overall Study|Withdrawal by Subject|0
5796914|NCT03095651|19986498|P7|Overall Study|Withdrawal by Subject|0
5796915|NCT03095651|19986499|P6|Overall Study|Withdrawal by Subject|1
5796916|NCT03095651|19986500|P5|Overall Study|Withdrawal by Subject|0
5796917|NCT03095651|19986501|P4|Overall Study|Withdrawal by Subject|0
5796918|NCT03095651|19986502|P3|Overall Study|Withdrawal by Subject|0
5796919|NCT03095651|19986503|P2|Overall Study|Withdrawal by Subject|0
5796920|NCT03095651|19986504|P1|Overall Study|Withdrawal by Subject|0
5796921|NCT03095651|19986497|P8|Overall Study|Lost to Follow-up|0
5796922|NCT03095651|19986498|P7|Overall Study|Lost to Follow-up|0
5796923|NCT03095651|19986499|P6|Overall Study|Lost to Follow-up|0
5796924|NCT03095651|19986500|P5|Overall Study|Lost to Follow-up|0
5796925|NCT03095651|19986501|P4|Overall Study|Lost to Follow-up|1
5796926|NCT03095651|19986502|P3|Overall Study|Lost to Follow-up|0
5796927|NCT03095651|19986503|P2|Overall Study|Lost to Follow-up|1
5796928|NCT03095651|19986504|P1|Overall Study|Lost to Follow-up|1
5796929|NCT03095599|19986783|P2|Overall Study|Withdrawal prior to vaccination|0
5796930|NCT03095599|19986784|P1|Overall Study|Withdrawal prior to vaccination|1
5796931|NCT03095599|19986783|P2|Overall Study|Lost to Follow-up|0
5796932|NCT03095599|19986784|P1|Overall Study|Lost to Follow-up|1
5796933|NCT03095599|19986783|P2|Overall Study|Withdrawal by Subject|0
5796934|NCT03095599|19986784|P1|Overall Study|Withdrawal by Subject|1
5796935|NCT03095521|19986820|P2|Overall Study|Lost to Follow-up|1
5796936|NCT03095521|19986821|P1|Overall Study|Lost to Follow-up|0
5796937|NCT03095521|19986820|P2|Overall Study|Withdrawal by Subject|1
5796938|NCT03095521|19986821|P1|Overall Study|Withdrawal by Subject|0
5796939|NCT03095508|19986839|P2|Overall Study|Adverse Event|1
5796940|NCT03095508|19986840|P1|Overall Study|Adverse Event|0
5796941|NCT03095027|19986888|P2|Period 2, Second Week of Wear|Adverse Event|0
5796942|NCT03095027|19986889|P1|Period 2, Second Week of Wear|Adverse Event|1
5796943|NCT03094195|19986925|P8|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0
5796944|NCT03094195|19986926|P7|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0
5796945|NCT03094195|19986927|P6|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0
5796946|NCT03094195|19986928|P5|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0
5796947|NCT03094195|19986929|P4|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0
5796948|NCT03094195|19986930|P3|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1
5796949|NCT03094195|19986931|P2|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1
5796950|NCT03094195|19986932|P1|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0
5796951|NCT03094195|19986925|P8|Double-Blind Treatment Period (DB)|Physician Decision|0
5796952|NCT03094195|19986926|P7|Double-Blind Treatment Period (DB)|Physician Decision|0
5796953|NCT03094195|19986927|P6|Double-Blind Treatment Period (DB)|Physician Decision|0
5796954|NCT03094195|19986928|P5|Double-Blind Treatment Period (DB)|Physician Decision|0
5796955|NCT03094195|19986929|P4|Double-Blind Treatment Period (DB)|Physician Decision|0
5796956|NCT03094195|19986930|P3|Double-Blind Treatment Period (DB)|Physician Decision|1
5796957|NCT03094195|19986931|P2|Double-Blind Treatment Period (DB)|Physician Decision|0
5796958|NCT03094195|19986932|P1|Double-Blind Treatment Period (DB)|Physician Decision|0
5796959|NCT03094195|19986925|P8|Double-Blind Treatment Period (DB)|Adverse Event|0
5796960|NCT03094195|19986926|P7|Double-Blind Treatment Period (DB)|Adverse Event|0
5796961|NCT03094195|19986927|P6|Double-Blind Treatment Period (DB)|Adverse Event|0
5796962|NCT03094195|19986928|P5|Double-Blind Treatment Period (DB)|Adverse Event|0
5796963|NCT03094195|19986929|P4|Double-Blind Treatment Period (DB)|Adverse Event|0
5796964|NCT03094195|19986930|P3|Double-Blind Treatment Period (DB)|Adverse Event|1
5796965|NCT03094195|19986931|P2|Double-Blind Treatment Period (DB)|Adverse Event|2
5796966|NCT03094195|19986932|P1|Double-Blind Treatment Period (DB)|Adverse Event|3
5796967|NCT03094195|19986925|P8|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0
5796968|NCT03094195|19986926|P7|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0
5796969|NCT03094195|19986927|P6|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0
5796970|NCT03094195|19986928|P5|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0
5796971|NCT03094195|19986929|P4|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0
5796972|NCT03094195|19986930|P3|Double-Blind Treatment Period (DB)|Study terminated by sponsor|11
5796973|NCT03094195|19986931|P2|Double-Blind Treatment Period (DB)|Study terminated by sponsor|10
5796974|NCT03094195|19986932|P1|Double-Blind Treatment Period (DB)|Study terminated by sponsor|12
5796975|NCT03093415|19986990|P3|Enrollment to SVR12 Results|Lost to Follow-up|3
5796976|NCT03093415|19986991|P2|Enrollment to SVR12 Results|Lost to Follow-up|8
5796977|NCT03093415|19986992|P1|Enrollment to SVR12 Results|Lost to Follow-up|1
5796978|NCT03093415|19986990|P3|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|0
5796979|NCT03093415|19986991|P2|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|3
5796980|NCT03093415|19986992|P1|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|9
5796981|NCT03093415|19986990|P3|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|0
5796982|NCT03093415|19986991|P2|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|2
5796983|NCT03093415|19986992|P1|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|4
5796984|NCT03093415|19986990|P3|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|0
5796985|NCT03093415|19986991|P2|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|3
5796986|NCT03093415|19986992|P1|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|5
5796987|NCT03093415|19986990|P3|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|0
5796988|NCT03093415|19986991|P2|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|32
5796989|NCT03093415|19986992|P1|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|15
5796990|NCT03093415|19986990|P3|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|0
5796991|NCT03093415|19986991|P2|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|4
5796992|NCT03093415|19986992|P1|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|4
5796993|NCT03093415|19986990|P3|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|0
5796994|NCT03093415|19986991|P2|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|12
5796995|NCT03093415|19986992|P1|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|18
5796996|NCT03093415|19986990|P3|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|0
5796997|NCT03093415|19986991|P2|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|12
5796998|NCT03093415|19986992|P1|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|0
5796999|NCT03093415|19986990|P3|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|0
5797000|NCT03093415|19986991|P2|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|6
5797001|NCT03093415|19986992|P1|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|28
5797002|NCT03093415|19986990|P3|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|0
5797003|NCT03093415|19986991|P2|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|0
5797004|NCT03093415|19986992|P1|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|40
5797005|NCT03093415|19986990|P3|Assessed for Eligibility --> Enrollment|Lost to Follow-up|0
5797006|NCT03093415|19986991|P2|Assessed for Eligibility --> Enrollment|Lost to Follow-up|36
5797007|NCT03093415|19986992|P1|Assessed for Eligibility --> Enrollment|Lost to Follow-up|17
5797008|NCT03093350|19987015|P1|Overall Study|Signed consent, never began treartment|1
5797009|NCT03093350|19987015|P1|Overall Study|Death|1
5797010|NCT03093324|19987023|P2|Overall Study|Withdrawal by Subject|2
5797011|NCT03093324|19987024|P1|Overall Study|Withdrawal by Subject|2
5797012|NCT03093324|19987023|P2|Overall Study|Protocol Deviation|2
5797013|NCT03093324|19987024|P1|Overall Study|Protocol Deviation|2
5797014|NCT03093324|19987023|P2|Overall Study|Lost to Follow-up|0
5797015|NCT03093324|19987024|P1|Overall Study|Lost to Follow-up|1
5797016|NCT03093324|19987023|P2|Overall Study|Adverse Event|15
5797017|NCT03093324|19987024|P1|Overall Study|Adverse Event|4
5797018|NCT03093181|19987071|P3|Overall Study|Other (Protocol violation)|1
5797019|NCT03093181|19987072|P2|Overall Study|Other (Protocol violation)|0
5797020|NCT03093181|19987073|P1|Overall Study|Other (Protocol violation)|0
5797021|NCT03093181|19987071|P3|Overall Study|Adverse Event|0
5797022|NCT03093181|19987072|P2|Overall Study|Adverse Event|1
5797023|NCT03093181|19987073|P1|Overall Study|Adverse Event|0
5797024|NCT03093181|19987071|P3|Overall Study|Other (Not specified)|0
5797025|NCT03093181|19987072|P2|Overall Study|Other (Not specified)|0
5797026|NCT03093181|19987073|P1|Overall Study|Other (Not specified)|1
5797027|NCT03093181|19987071|P3|Overall Study|Withdrawal by Subject|2
5797028|NCT03093181|19987072|P2|Overall Study|Withdrawal by Subject|1
5797029|NCT03093181|19987073|P1|Overall Study|Withdrawal by Subject|2
5797030|NCT03092791|19987135|P8|Overall Study|Reason Not Specified|0
5797031|NCT03092791|19987136|P7|Overall Study|Reason Not Specified|0
5797032|NCT03092791|19987137|P6|Overall Study|Reason Not Specified|1
5797033|NCT03092791|19987138|P5|Overall Study|Reason Not Specified|1
5797034|NCT03092791|19987139|P4|Overall Study|Reason Not Specified|0
5797035|NCT03092791|19987140|P3|Overall Study|Reason Not Specified|0
5797036|NCT03092791|19987141|P2|Overall Study|Reason Not Specified|0
5797037|NCT03092791|19987142|P1|Overall Study|Reason Not Specified|0
5797038|NCT03092791|19987135|P8|Overall Study|Death|1
5797039|NCT03092791|19987136|P7|Overall Study|Death|0
5797040|NCT03092791|19987137|P6|Overall Study|Death|1
5797041|NCT03092791|19987138|P5|Overall Study|Death|0
5797042|NCT03092791|19987139|P4|Overall Study|Death|0
5797043|NCT03092791|19987140|P3|Overall Study|Death|0
5797044|NCT03092791|19987141|P2|Overall Study|Death|0
5797045|NCT03092791|19987142|P1|Overall Study|Death|0
5797046|NCT03092791|19987135|P8|Overall Study|Study Termination|55
5797047|NCT03092791|19987136|P7|Overall Study|Study Termination|53
5797048|NCT03092791|19987137|P6|Overall Study|Study Termination|46
5797049|NCT03092791|19987138|P5|Overall Study|Study Termination|55
5797050|NCT03092791|19987139|P4|Overall Study|Study Termination|0
5797051|NCT03092791|19987140|P3|Overall Study|Study Termination|0
5797052|NCT03092791|19987141|P2|Overall Study|Study Termination|0
5797053|NCT03092791|19987142|P1|Overall Study|Study Termination|0
5797054|NCT03092791|19987135|P8|Overall Study|Withdrawal of Consent|4
5797055|NCT03092791|19987136|P7|Overall Study|Withdrawal of Consent|6
5797056|NCT03092791|19987137|P6|Overall Study|Withdrawal of Consent|12
5797057|NCT03092791|19987138|P5|Overall Study|Withdrawal of Consent|4
5797058|NCT03092791|19987139|P4|Overall Study|Withdrawal of Consent|0
5797059|NCT03092791|19987140|P3|Overall Study|Withdrawal of Consent|0
5797060|NCT03092791|19987141|P2|Overall Study|Withdrawal of Consent|0
5797061|NCT03092791|19987142|P1|Overall Study|Withdrawal of Consent|0
5797062|NCT03092791|19987135|P8|Overall Study|Lost to Follow-up|0
5797063|NCT03092791|19987136|P7|Overall Study|Lost to Follow-up|1
5797064|NCT03092791|19987137|P6|Overall Study|Lost to Follow-up|0
5797065|NCT03092791|19987138|P5|Overall Study|Lost to Follow-up|0
5797066|NCT03092791|19987139|P4|Overall Study|Lost to Follow-up|0
5797067|NCT03092791|19987140|P3|Overall Study|Lost to Follow-up|0
5797068|NCT03092791|19987141|P2|Overall Study|Lost to Follow-up|0
5797069|NCT03092791|19987142|P1|Overall Study|Lost to Follow-up|0
5797070|NCT03092752|19987257|P1|Overall Study|<6 month history|245900
5797071|NCT03092752|19987257|P1|Overall Study|Average hospital visit interval >92 days|10779
5797072|NCT03092752|19987257|P1|Overall Study|Having no claim of study drugs|29282
5797073|NCT03092752|19987257|P1|Overall Study|At least one claim with T2DM|61299
5797074|NCT03092752|19987257|P1|Overall Study|Aged <40 years|14209
5797075|NCT03092726|19987322|P2|Overall Study|Withdrawal by Subject|3
5797076|NCT03092726|19987323|P1|Overall Study|Withdrawal by Subject|5
5797077|NCT03092726|19987322|P2|Overall Study|Lost to Follow-up|0
5797078|NCT03092726|19987323|P1|Overall Study|Lost to Follow-up|1
5797079|NCT03092726|19987322|P2|Overall Study|Lack of Efficacy|1
5797080|NCT03092726|19987323|P1|Overall Study|Lack of Efficacy|0
5797081|NCT03092726|19987322|P2|Overall Study|Adverse Event|10
5797082|NCT03092726|19987323|P1|Overall Study|Adverse Event|3
5797083|NCT03092479|19987349|P2|Overall Study|Withdrawal by Subject|0
5797084|NCT03092479|19987350|P1|Overall Study|Withdrawal by Subject|4
5797085|NCT03092479|19987349|P2|Overall Study|Lost to Follow-up|2
5797086|NCT03092479|19987350|P1|Overall Study|Lost to Follow-up|3
5797087|NCT03092375|19987372|P4|Overall Study|Lack of Efficacy|0
5797088|NCT03092375|19987373|P3|Overall Study|Lack of Efficacy|1
5797089|NCT03092375|19987374|P2|Overall Study|Lack of Efficacy|1
5797090|NCT03092375|19987375|P1|Overall Study|Lack of Efficacy|0
5797091|NCT03092219|19987403|P2|Overall Study|Protocol Violation|4
5797092|NCT03092219|19987404|P1|Overall Study|Protocol Violation|7
5797093|NCT03091920|19987448|P3|Overall Study|Adverse Event|0
5797094|NCT03091920|19987449|P2|Overall Study|Adverse Event|1
5797095|NCT03091920|19987450|P1|Overall Study|Adverse Event|0
5797096|NCT03091777|19987597|P3|Overall Study|Abnormal Laboratory Value|12
5797097|NCT03091777|19987598|P2|Overall Study|Abnormal Laboratory Value|11
5797098|NCT03091777|19987599|P1|Overall Study|Abnormal Laboratory Value|7
5797099|NCT03091777|19987597|P3|Overall Study|Physician Decision|1
5797100|NCT03091777|19987598|P2|Overall Study|Physician Decision|0
5797101|NCT03091777|19987599|P1|Overall Study|Physician Decision|1
5797102|NCT03091777|19987597|P3|Overall Study|Noncompliance with study drug|1
5797103|NCT03091777|19987598|P2|Overall Study|Noncompliance with study drug|3
5797104|NCT03091777|19987599|P1|Overall Study|Noncompliance with study drug|2
5797105|NCT03091777|19987597|P3|Overall Study|Lack of Efficacy|5
5797106|NCT03091777|19987598|P2|Overall Study|Lack of Efficacy|0
5797107|NCT03091777|19987599|P1|Overall Study|Lack of Efficacy|0
5797108|NCT03091777|19987597|P3|Overall Study|Lost to Follow-up|7
5797109|NCT03091777|19987598|P2|Overall Study|Lost to Follow-up|14
5797110|NCT03091777|19987599|P1|Overall Study|Lost to Follow-up|12
5797111|NCT03091777|19987597|P3|Overall Study|Protocol Violation|1
5797112|NCT03091777|19987598|P2|Overall Study|Protocol Violation|1
5797113|NCT03091777|19987599|P1|Overall Study|Protocol Violation|2
5797114|NCT03091777|19987597|P3|Overall Study|Withdrawal by Subject|6
5797115|NCT03091777|19987598|P2|Overall Study|Withdrawal by Subject|2
5797116|NCT03091777|19987599|P1|Overall Study|Withdrawal by Subject|4
5797117|NCT03091777|19987597|P3|Overall Study|Adverse Event|4
5797118|NCT03091777|19987598|P2|Overall Study|Adverse Event|1
5797119|NCT03091777|19987599|P1|Overall Study|Adverse Event|2
5797120|NCT03091777|19987597|P3|Overall Study|Pregnancy|0
5797121|NCT03091777|19987598|P2|Overall Study|Pregnancy|1
5797122|NCT03091777|19987599|P1|Overall Study|Pregnancy|2
5797123|NCT03091439|19987647|P2|Overall Study|Study Terminated by the Sponsor|0
5797124|NCT03091439|19987648|P1|Overall Study|Study Terminated by the Sponsor|1
5797125|NCT03091400|19987672|P2|Washout - 2 Weeks|Withdrawal by Subject|0
5797126|NCT03091400|19987673|P1|Washout - 2 Weeks|Withdrawal by Subject|1
5797127|NCT03091348|19987695|P2|Overall Study|Lost to Follow-up|1
5797128|NCT03091348|19987696|P1|Overall Study|Lost to Follow-up|2
5797129|NCT03091192|19987722|P2|Overall Study|Lost to Follow-up|0
5797130|NCT03091192|19987723|P1|Overall Study|Lost to Follow-up|1
5797131|NCT03091192|19987722|P2|Overall Study|Withdrawal by Subject|0
5797132|NCT03091192|19987723|P1|Overall Study|Withdrawal by Subject|2
5797133|NCT03091192|19987722|P2|Overall Study|Death|13
5797134|NCT03091192|19987723|P1|Overall Study|Death|9
5797135|NCT03091192|19987722|P2|Overall Study|Study terminated by sponsor|14
5797136|NCT03091192|19987723|P1|Overall Study|Study terminated by sponsor|21
5797137|NCT03090100|19987791|P2|Overall Study|Other|2
5797138|NCT03090100|19987792|P1|Overall Study|Other|2
5797139|NCT03090100|19987791|P2|Overall Study|Non-compliance|0
5797140|NCT03090100|19987792|P1|Overall Study|Non-compliance|2
5797141|NCT03090100|19987791|P2|Overall Study|Protocol Violation|6
5797142|NCT03090100|19987792|P1|Overall Study|Protocol Violation|2
5797143|NCT03090100|19987791|P2|Overall Study|Withdrawal by Subject|19
5797144|NCT03090100|19987792|P1|Overall Study|Withdrawal by Subject|7
5797145|NCT03090100|19987791|P2|Overall Study|Lost to Follow-up|2
5797146|NCT03090100|19987792|P1|Overall Study|Lost to Follow-up|2
5797147|NCT03090100|19987791|P2|Overall Study|Lack of Efficacy|7
5797148|NCT03090100|19987792|P1|Overall Study|Lack of Efficacy|2
5797149|NCT03090100|19987791|P2|Overall Study|Pregnancy|1
5797150|NCT03090100|19987792|P1|Overall Study|Pregnancy|1
5797151|NCT03090100|19987791|P2|Overall Study|Adverse Event|11
5797152|NCT03090100|19987792|P1|Overall Study|Adverse Event|9
5797153|NCT03089944|19987832|P1|Overall Study|Other|1
5797154|NCT03089944|19987832|P1|Overall Study|Adverse Event|1
5797155|NCT03089944|19987832|P1|Overall Study|Withdrew Consent|2
5797156|NCT03089944|19987832|P1|Overall Study|Lost to Follow-up|8
5797157|NCT03089853|19987879|P2|Overall Study|Lost to Follow-up|1
5797158|NCT03089853|19987880|P1|Overall Study|Lost to Follow-up|2
5797159|NCT03089580|19987902|P1|Overall Study|Lost to Follow-up|2
5797160|NCT03089216|19987913|P4|Overall Study|Adverse Event|1
5797161|NCT03089216|19987914|P3|Overall Study|Adverse Event|0
5797162|NCT03089216|19987915|P2|Overall Study|Adverse Event|0
5797163|NCT03089216|19987916|P1|Overall Study|Adverse Event|0
5797164|NCT03089047|19987932|P2|Overall Study|Lost to Follow-up|0
5797165|NCT03089047|19987933|P1|Overall Study|Lost to Follow-up|1
5797166|NCT03088917|19987943|P1|Overall Study|Moved outside study region|50
5797167|NCT03088917|19987943|P1|Overall Study|Severe comorbidity/short life expectancy|5
5797168|NCT03088917|19987943|P1|Overall Study|Contact not established|13
5797169|NCT03088917|19987943|P1|Overall Study|Refuse re-evaluation|13
5797170|NCT03088917|19987943|P1|Overall Study|In care/cured elsewhere|15
5797174|NCT03087786|19988026|P2|Overall Study|Withdrawal by Subject|0
5797175|NCT03087786|19988027|P1|Overall Study|Withdrawal by Subject|2
5797176|NCT03087643|19988063|P2|Overall Study|Death|2
5797177|NCT03087643|19988064|P1|Overall Study|Death|2
5797178|NCT03087643|19988063|P2|Overall Study|Withdrawal by Subject|4
5797179|NCT03087643|19988064|P1|Overall Study|Withdrawal by Subject|2
5797180|NCT03087513|19988091|P1|Second Intervention After 3 hr Washout|Equipment malfunction|2
5797181|NCT03086551|19988138|P2|Washout|Withdrawal by Subject|1
5797182|NCT03086551|19988139|P1|Washout|Withdrawal by Subject|2
5797183|NCT03086551|19988138|P2|Washout|Lost to Follow-up|2
5797184|NCT03086551|19988139|P1|Washout|Lost to Follow-up|1
5797185|NCT03086551|19988138|P2|First Intervention|Lost to Follow-up|1
5797186|NCT03086551|19988139|P1|First Intervention|Lost to Follow-up|0
5797187|NCT03086551|19988138|P2|First Intervention|Failure to meet inclusion criterion|0
5797188|NCT03086551|19988139|P1|First Intervention|Failure to meet inclusion criterion|1
5797189|NCT03086447|19988155|P2|Overall Study|Lens Discomfort|1
5797190|NCT03086447|19988156|P1|Overall Study|Lens Discomfort|2
5797191|NCT03086447|19988155|P2|Overall Study|Adverse Event|0
5797192|NCT03086447|19988156|P1|Overall Study|Adverse Event|3
5797193|NCT03086447|19988155|P2|Overall Study|Lost to Follow-up|1
5797194|NCT03086447|19988156|P1|Overall Study|Lost to Follow-up|0
5797195|NCT03086447|19988155|P2|Overall Study|Protocol Violation|4
5797196|NCT03086447|19988156|P1|Overall Study|Protocol Violation|2
5797197|NCT03086447|19988155|P2|Overall Study|Test Article No Longer Available|0
5797198|NCT03086447|19988156|P1|Overall Study|Test Article No Longer Available|1
5797199|NCT03086447|19988155|P2|Overall Study|Unsatisfactory Lens Fitting|1
5797200|NCT03086447|19988156|P1|Overall Study|Unsatisfactory Lens Fitting|0
5797201|NCT03086447|19988155|P2|Overall Study|Lens Damage|6
5797202|NCT03086447|19988156|P1|Overall Study|Lens Damage|1
5797203|NCT03086447|19988155|P2|Overall Study|Product quality complaint|1
5797204|NCT03086447|19988156|P1|Overall Study|Product quality complaint|0
5797205|NCT03086447|19988155|P2|Overall Study|Lost Lens|5
5797206|NCT03086447|19988156|P1|Overall Study|Lost Lens|2
5797207|NCT03086447|19988155|P2|Overall Study|No Longer Meets Eligibility Criteria|1
5797208|NCT03086447|19988156|P1|Overall Study|No Longer Meets Eligibility Criteria|0
5797209|NCT03086343|19988214|P2|Overall Study|Missing|1
5797210|NCT03086343|19988215|P1|Overall Study|Missing|0
5797211|NCT03086343|19988214|P2|Overall Study|Other, not specified|4
5797212|NCT03086343|19988215|P1|Overall Study|Other, not specified|8
5797213|NCT03086343|19988214|P2|Overall Study|Lack of Efficacy|6
5797214|NCT03086343|19988215|P1|Overall Study|Lack of Efficacy|4
5797215|NCT03086343|19988214|P2|Overall Study|Lost to Follow-up|1
5797216|NCT03086343|19988215|P1|Overall Study|Lost to Follow-up|3
5797217|NCT03086343|19988214|P2|Overall Study|Withdrawal by Subject|6
5797218|NCT03086343|19988215|P1|Overall Study|Withdrawal by Subject|10
5797219|NCT03086343|19988214|P2|Overall Study|Adverse Event|7
5797220|NCT03086343|19988215|P1|Overall Study|Adverse Event|7
5797221|NCT03086330|19988227|P2|Overall Study|Lost to Follow-up|2
5797222|NCT03086330|19988228|P1|Overall Study|Lost to Follow-up|1
5797223|NCT03086330|19988227|P2|Overall Study|Withdrawal by Subject|2
5797224|NCT03086330|19988228|P1|Overall Study|Withdrawal by Subject|3
5797225|NCT03086135|19988425|P1|Overall Study|Lost to Follow-up|2
5797226|NCT03086135|19988425|P1|Overall Study|Adverse Event|1
5797227|NCT03086018|19988452|P1|Final Testing for End of Trial|Withdrawal by Subject|1
5797228|NCT03086018|19988452|P1|Final Testing for End of Trial|Adverse Event|1
5797229|NCT03085914|19988467|P7|Overall Study|Ongoing in Trial|3
5797230|NCT03085914|19988468|P6|Overall Study|Ongoing in Trial|3
5797231|NCT03085914|19988469|P5|Overall Study|Ongoing in Trial|4
5797232|NCT03085914|19988470|P4|Overall Study|Ongoing in Trial|3
5797233|NCT03085914|19988471|P3|Overall Study|Ongoing in Trial|5
5797234|NCT03085914|19988472|P2|Overall Study|Ongoing in Trial|0
5797235|NCT03085914|19988473|P1|Overall Study|Ongoing in Trial|1
5797236|NCT03085914|19988467|P7|Overall Study|Other Unspecified|4
5797237|NCT03085914|19988468|P6|Overall Study|Other Unspecified|2
5797238|NCT03085914|19988469|P5|Overall Study|Other Unspecified|2
5797239|NCT03085914|19988470|P4|Overall Study|Other Unspecified|3
5797240|NCT03085914|19988471|P3|Overall Study|Other Unspecified|1
5797241|NCT03085914|19988472|P2|Overall Study|Other Unspecified|2
5797242|NCT03085914|19988473|P1|Overall Study|Other Unspecified|2
5797243|NCT03085914|19988467|P7|Overall Study|Withdrawal by Subject|1
5797244|NCT03085914|19988468|P6|Overall Study|Withdrawal by Subject|0
5797245|NCT03085914|19988469|P5|Overall Study|Withdrawal by Subject|2
5797246|NCT03085914|19988470|P4|Overall Study|Withdrawal by Subject|2
5797247|NCT03085914|19988471|P3|Overall Study|Withdrawal by Subject|0
5797248|NCT03085914|19988472|P2|Overall Study|Withdrawal by Subject|1
5797249|NCT03085914|19988473|P1|Overall Study|Withdrawal by Subject|1
5797250|NCT03085914|19988467|P7|Overall Study|Lost to Follow-up|1
5797251|NCT03085914|19988468|P6|Overall Study|Lost to Follow-up|1
5797252|NCT03085914|19988469|P5|Overall Study|Lost to Follow-up|0
5797253|NCT03085914|19988470|P4|Overall Study|Lost to Follow-up|0
5797254|NCT03085914|19988471|P3|Overall Study|Lost to Follow-up|1
5797255|NCT03085914|19988472|P2|Overall Study|Lost to Follow-up|0
5797256|NCT03085914|19988473|P1|Overall Study|Lost to Follow-up|1
5797257|NCT03085914|19988467|P7|Overall Study|Death|2
5797258|NCT03085914|19988468|P6|Overall Study|Death|2
5797259|NCT03085914|19988469|P5|Overall Study|Death|5
5797260|NCT03085914|19988470|P4|Overall Study|Death|1
5797261|NCT03085914|19988471|P3|Overall Study|Death|4
5797262|NCT03085914|19988472|P2|Overall Study|Death|6
5797263|NCT03085914|19988473|P1|Overall Study|Death|4
5797264|NCT03085797|19988557|P2|No-treatment Follow-up Period (6 Months)|Withdrawal by Subject|1
5797265|NCT03085797|19988558|P1|No-treatment Follow-up Period (6 Months)|Withdrawal by Subject|0
5797266|NCT03085797|19988557|P2|Treatment Period (TP) (52 Weeks)|Withdrawal by Subject|17
5797267|NCT03085797|19988558|P1|Treatment Period (TP) (52 Weeks)|Withdrawal by Subject|16
5797268|NCT03085797|19988557|P2|Treatment Period (TP) (52 Weeks)|Lost to Follow-up|0
5797269|NCT03085797|19988558|P1|Treatment Period (TP) (52 Weeks)|Lost to Follow-up|1
5797270|NCT03085238|19988580|P1|Overall Study|Death|2
5797271|NCT03085238|19988580|P1|Overall Study|Adverse Event|2
5797272|NCT03085017|19988607|P2|Overall Study|Death|3
5797273|NCT03085017|19988608|P1|Overall Study|Death|0
5797274|NCT03084315|19988634|P2|Overall Study|Withdrawal by Subject|2
5797275|NCT03084315|19988635|P1|Overall Study|Withdrawal by Subject|2
5797276|NCT03084315|19988634|P2|Overall Study|Lost to Follow-up|7
5797277|NCT03084315|19988635|P1|Overall Study|Lost to Follow-up|8
5797278|NCT03083990|19988645|P2|Overall Study|Adverse Event|0
5797279|NCT03083990|19988646|P1|Overall Study|Adverse Event|1
5797280|NCT03083639|19988728|P2|Washout Period (at Least 6 Days)|Lost to Follow-up|0
5797281|NCT03083639|19988729|P1|Washout Period (at Least 6 Days)|Lost to Follow-up|1
5797282|NCT03083639|19988728|P2|Washout Period (at Least 6 Days)|Pregnancy|1
5797283|NCT03083639|19988729|P1|Washout Period (at Least 6 Days)|Pregnancy|0
5797284|NCT03083483|19988742|P3|Overall Study|technological issues|1
5797285|NCT03083483|19988743|P2|Overall Study|technological issues|0
5797286|NCT03083483|19988744|P1|Overall Study|technological issues|1
5797287|NCT03083483|19988742|P3|Overall Study|Lost to Follow-up|1
5797288|NCT03083483|19988743|P2|Overall Study|Lost to Follow-up|1
5797289|NCT03083483|19988744|P1|Overall Study|Lost to Follow-up|2
5797290|NCT03083483|19988742|P3|Overall Study|Adverse Event|1
5797291|NCT03083483|19988743|P2|Overall Study|Adverse Event|1
5797292|NCT03083483|19988744|P1|Overall Study|Adverse Event|1
5797293|NCT03083470|19988763|P5|Overall Study|Withdrawal by Subject|1
5797294|NCT03083470|19988764|P4|Overall Study|Withdrawal by Subject|0
5797295|NCT03083470|19988765|P3|Overall Study|Withdrawal by Subject|0
5797296|NCT03083470|19988766|P2|Overall Study|Withdrawal by Subject|0
5797297|NCT03083470|19988767|P1|Overall Study|Withdrawal by Subject|0
5797298|NCT03083470|19988763|P5|Overall Study|Lost to Follow-up|1
5797299|NCT03083470|19988764|P4|Overall Study|Lost to Follow-up|0
5797300|NCT03083470|19988765|P3|Overall Study|Lost to Follow-up|0
5797301|NCT03083470|19988766|P2|Overall Study|Lost to Follow-up|0
5797302|NCT03083470|19988767|P1|Overall Study|Lost to Follow-up|0
5797303|NCT03082599|19988815|P2|Overall Study|Lost to Follow-up|0
5797304|NCT03082599|19988816|P1|Overall Study|Lost to Follow-up|1
5797305|NCT03081884|19988888|P1|Overall Study|metastasis managed with systemic therapy|3
5797306|NCT03081884|19988888|P1|Overall Study|deferred prostate cancer treatment|1
5797307|NCT03080961|19988894|P1|Overall Study|Withdrawal by Subject|3
5797308|NCT03080493|19988905|P2|Overall Study|Randomization error (parity group)|1
5797309|NCT03080493|19988906|P1|Overall Study|Randomization error (parity group)|0
5797310|NCT03080493|19988905|P2|Overall Study|Adverse Event|1
5797311|NCT03080493|19988906|P1|Overall Study|Adverse Event|0
5797312|NCT03080493|19988905|P2|Overall Study|Did not provide NRS pain results|0
5797313|NCT03080493|19988906|P1|Overall Study|Did not provide NRS pain results|1
5797314|NCT03080454|19988922|P1|Anodal FU (7 Days)|Lost to Follow-up|4
5797315|NCT03080454|19988922|P1|Anodal Doublestim (5 Days)|Adverse Event|1
5797316|NCT03080454|19988922|P1|Baseline|Adverse Event|2
5797317|NCT03078816|19988989|P1|Overall Study|Withdrawal by Subject|1
5797328|NCT03078582|19989050|P2|Overall Study|Adverse Event|8
5797329|NCT03078582|19989051|P1|Overall Study|Adverse Event|0
5797330|NCT03078556|19989071|P4|Washout Period 1 (7 Days)|Physician Decision|0
5797331|NCT03078556|19989072|P3|Washout Period 1 (7 Days)|Physician Decision|0
5797332|NCT03078556|19989073|P2|Washout Period 1 (7 Days)|Physician Decision|1
5797333|NCT03078556|19989074|P1|Washout Period 1 (7 Days)|Physician Decision|0
5797334|NCT03078556|19989071|P4|Washout Period 1 (7 Days)|Adverse Event|1
5797335|NCT03078556|19989072|P3|Washout Period 1 (7 Days)|Adverse Event|0
5797336|NCT03078556|19989073|P2|Washout Period 1 (7 Days)|Adverse Event|1
5797337|NCT03078556|19989074|P1|Washout Period 1 (7 Days)|Adverse Event|0
5797338|NCT03078556|19989071|P4|Washout Period 1 (7 Days)|Lost to Follow-up|0
5797339|NCT03078556|19989072|P3|Washout Period 1 (7 Days)|Lost to Follow-up|1
5797340|NCT03078556|19989073|P2|Washout Period 1 (7 Days)|Lost to Follow-up|0
5797341|NCT03078556|19989074|P1|Washout Period 1 (7 Days)|Lost to Follow-up|2
5797342|NCT03078556|19989071|P4|Treatment Period 1 (4 Days)|Adverse Event|0
5797343|NCT03078556|19989072|P3|Treatment Period 1 (4 Days)|Adverse Event|0
5797344|NCT03078556|19989073|P2|Treatment Period 1 (4 Days)|Adverse Event|1
5797345|NCT03078556|19989074|P1|Treatment Period 1 (4 Days)|Adverse Event|0
5797346|NCT03078478|19989218|P2|Maintencance Period 2 (36 Weeks)|Not reconsenting|2
5797347|NCT03078478|19989219|P1|Maintencance Period 2 (36 Weeks)|Not reconsenting|0
5797348|NCT03078478|19989218|P2|Maintencance Period 2 (36 Weeks)|Death|6
5797349|NCT03078478|19989219|P1|Maintencance Period 2 (36 Weeks)|Death|4
5797350|NCT03078478|19989218|P2|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|6
5797351|NCT03078478|19989219|P1|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|3
5797352|NCT03078478|19989218|P2|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|13
5797353|NCT03078478|19989219|P1|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|18
5797354|NCT03078478|19989218|P2|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|0
5797355|NCT03078478|19989219|P1|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|1
5797356|NCT03078478|19989218|P2|Maintenance Period 1 (36 Weeks)|Death|3
5797357|NCT03078478|19989219|P1|Maintenance Period 1 (36 Weeks)|Death|3
5797358|NCT03078478|19989218|P2|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|4
5797359|NCT03078478|19989219|P1|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|7
5797360|NCT03078478|19989218|P2|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36
5797361|NCT03078478|19989219|P1|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36
5797362|NCT03077919|19989305|P2|Overall Study|Lost to Follow-up|1
5797363|NCT03077919|19989306|P1|Overall Study|Lost to Follow-up|4
5797364|NCT03077724|19989366|P2|Overall Study|Withdrawal by Subject|1
5797365|NCT03077724|19989367|P1|Overall Study|Withdrawal by Subject|3
5797366|NCT03077724|19989366|P2|Overall Study|Lost to Follow-up|1
5797367|NCT03077724|19989367|P1|Overall Study|Lost to Follow-up|5
5797368|NCT03077711|19989379|P2|Overall Study|noncompliant taking medication|0
5797369|NCT03077711|19989380|P1|Overall Study|noncompliant taking medication|2
5797370|NCT03077711|19989379|P2|Overall Study|Lost to Follow-up|2
5797371|NCT03077711|19989380|P1|Overall Study|Lost to Follow-up|2
5797372|NCT03077659|19989399|P3|Overall Study|Withdrawal by Subject|1
5797373|NCT03077659|19989400|P2|Overall Study|Withdrawal by Subject|0
5797374|NCT03077659|19989401|P1|Overall Study|Withdrawal by Subject|0
5797375|NCT03077607|19989432|P2|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2
5797376|NCT03077607|19989433|P1|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2
5797377|NCT03077607|19989432|P2|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|0
5797378|NCT03077607|19989433|P1|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|1
5797379|NCT03077607|19989432|P2|Period 1 (15 Days)|Death|0
5797380|NCT03077607|19989433|P1|Period 1 (15 Days)|Death|1
5797381|NCT03077607|19989432|P2|Period 1 (15 Days)|Adverse Event|0
5797382|NCT03077607|19989433|P1|Period 1 (15 Days)|Adverse Event|1
5797383|NCT03077438|19989501|P2|Overall Study|Lost to Follow-up|3
5797384|NCT03077438|19989502|P1|Overall Study|Lost to Follow-up|6
5797385|NCT03077438|19989501|P2|Overall Study|Withdrawal by Subject|6
5797386|NCT03077438|19989502|P1|Overall Study|Withdrawal by Subject|3
5797387|NCT03077438|19989501|P2|Overall Study|Protocol Violation|5
5797388|NCT03077438|19989502|P1|Overall Study|Protocol Violation|3
5797389|NCT03076996|19989543|P1|Overall Study|Literacy precluded participation|1
5797390|NCT03076996|19989543|P1|Overall Study|Lost to Follow-up|3
5797391|NCT03076996|19989543|P1|Overall Study|Withdrawal by Subject|2
5797392|NCT03076970|19989569|P6|Period 3|Failure to meet I/E criteria|0
5797393|NCT03076970|19989570|P5|Period 3|Failure to meet I/E criteria|1
5797394|NCT03076970|19989571|P4|Period 3|Failure to meet I/E criteria|0
5797395|NCT03076970|19989572|P3|Period 3|Failure to meet I/E criteria|0
5797396|NCT03076970|19989573|P2|Period 3|Failure to meet I/E criteria|0
5797397|NCT03076970|19989574|P1|Period 3|Failure to meet I/E criteria|0
5797398|NCT03076970|19989569|P6|Period 3|Withdrawal by Subject|1
5797399|NCT03076970|19989570|P5|Period 3|Withdrawal by Subject|0
5797400|NCT03076970|19989571|P4|Period 3|Withdrawal by Subject|0
5797401|NCT03076970|19989572|P3|Period 3|Withdrawal by Subject|0
5797402|NCT03076970|19989573|P2|Period 3|Withdrawal by Subject|0
5797403|NCT03076970|19989574|P1|Period 3|Withdrawal by Subject|0
5797404|NCT03076970|19989569|P6|Washout Period 2|Adverse Event|0
5797405|NCT03076970|19989570|P5|Washout Period 2|Adverse Event|1
5797406|NCT03076970|19989571|P4|Washout Period 2|Adverse Event|0
5797407|NCT03076970|19989572|P3|Washout Period 2|Adverse Event|0
5797408|NCT03076970|19989573|P2|Washout Period 2|Adverse Event|0
5797409|NCT03076970|19989574|P1|Washout Period 2|Adverse Event|0
5797410|NCT03076515|19989626|P2|Overall Study|DMC decision based on interim analysis|29
5797411|NCT03076515|19989627|P1|Overall Study|DMC decision based on interim analysis|25
5797412|NCT03076190|19989646|P2|Overall Study|Excluded from Analysis (zero duration ev|7
5797413|NCT03076190|19989647|P1|Overall Study|Excluded from Analysis (zero duration ev|9
5797414|NCT03076190|19989646|P2|Overall Study|Lost to Follow-up|34
5797415|NCT03076190|19989647|P1|Overall Study|Lost to Follow-up|9
5797416|NCT03075904|19989660|P1|Overall Study|Need for Medication not Permitted|1
5797417|NCT03075904|19989660|P1|Overall Study|Physician Decision|3
5797418|NCT03075891|19989670|P2|Overall Study|Drug abuse relapse issue|1
5797419|NCT03075891|19989671|P1|Overall Study|Drug abuse relapse issue|0
5797420|NCT03075891|19989670|P2|Overall Study|Patient requiring study withdrawal|1
5797421|NCT03075891|19989671|P1|Overall Study|Patient requiring study withdrawal|0
5797422|NCT03075891|19989670|P2|Overall Study|Other visits not performed (no time)|0
5797423|NCT03075891|19989671|P1|Overall Study|Other visits not performed (no time)|1
5797424|NCT03075891|19989670|P2|Overall Study|Pregnancy|1
5797425|NCT03075891|19989671|P1|Overall Study|Pregnancy|3
5797426|NCT03075891|19989670|P2|Overall Study|Lost to Follow-up|0
5797427|NCT03075891|19989671|P1|Overall Study|Lost to Follow-up|1
5797428|NCT03075891|19989670|P2|Overall Study|Withdrawal by Subject|6
5797429|NCT03075891|19989671|P1|Overall Study|Withdrawal by Subject|3
5797430|NCT03075891|19989670|P2|Overall Study|Adverse Event|4
5797431|NCT03075891|19989671|P1|Overall Study|Adverse Event|1
5797432|NCT03075878|19989677|P1|Overall Study|Physician Decision|1
5797433|NCT03075839|19989685|P1|Overall Study|Lost to Follow-up|4
5797434|NCT03075644|19989693|P2|Overall Study|Withdrawal by Subject|1
5797435|NCT03075644|19989694|P1|Overall Study|Withdrawal by Subject|1
5797436|NCT03075527|19989764|P1|Overall Study|Ongoing treatment|2
5797437|NCT03075410|19989788|P9|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0
5797438|NCT03075410|19989789|P8|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0
5797439|NCT03075410|19989790|P7|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0
5797440|NCT03075410|19989791|P6|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0
5797441|NCT03075410|19989792|P5|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0
5797442|NCT03075410|19989793|P4|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0
5797443|NCT03075410|19989794|P3|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0
5797444|NCT03075410|19989795|P2|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0
5797445|NCT03075410|19989796|P1|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|1
5797446|NCT03075410|19989788|P9|Part A-Period 2 (14 Days)|Personal reasons|0
5797447|NCT03075410|19989789|P8|Part A-Period 2 (14 Days)|Personal reasons|0
5797448|NCT03075410|19989790|P7|Part A-Period 2 (14 Days)|Personal reasons|0
5797449|NCT03075410|19989791|P6|Part A-Period 2 (14 Days)|Personal reasons|0
5797450|NCT03075410|19989792|P5|Part A-Period 2 (14 Days)|Personal reasons|0
5797451|NCT03075410|19989793|P4|Part A-Period 2 (14 Days)|Personal reasons|0
5797452|NCT03075410|19989794|P3|Part A-Period 2 (14 Days)|Personal reasons|1
5797453|NCT03075410|19989795|P2|Part A-Period 2 (14 Days)|Personal reasons|0
5797454|NCT03075410|19989796|P1|Part A-Period 2 (14 Days)|Personal reasons|1
5797455|NCT03075267|19989963|P3|Overall Study|Protocol Violation|0
5797456|NCT03075267|19989964|P2|Overall Study|Protocol Violation|0
5797457|NCT03075267|19989965|P1|Overall Study|Protocol Violation|1
5797458|NCT03075163|19990099|P2|Overall Study|not eligible for treatment limb|138
5797459|NCT03075163|19990100|P1|Overall Study|not eligible for treatment limb|138
5797460|NCT03074500|19990147|P3|Overall Study|Adverse Event|1
5797461|NCT03074500|19990148|P2|Overall Study|Adverse Event|0
5797462|NCT03074500|19990149|P1|Overall Study|Adverse Event|0
5797463|NCT03074500|19990147|P3|Overall Study|Lack of Efficacy|0
5797464|NCT03074500|19990148|P2|Overall Study|Lack of Efficacy|1
5797465|NCT03074500|19990149|P1|Overall Study|Lack of Efficacy|0
5797466|NCT03074500|19990147|P3|Overall Study|Lost to Follow-up|0
5797467|NCT03074500|19990148|P2|Overall Study|Lost to Follow-up|0
5797468|NCT03074500|19990149|P1|Overall Study|Lost to Follow-up|1
5797469|NCT03074331|19990186|P1|Overall Study|Withdrew Consent|1
5797470|NCT03074331|19990186|P1|Overall Study|Lost to Follow-up|5
5797471|NCT03074331|19990186|P1|Overall Study|Enrolled but Not Treated|1
5797472|NCT03074162|19990198|P6|Period 3|Withdrawal by Subject|0
5797473|NCT03074162|19990199|P5|Period 3|Withdrawal by Subject|1
5797474|NCT03074162|19990200|P4|Period 3|Withdrawal by Subject|0
5797475|NCT03074162|19990201|P3|Period 3|Withdrawal by Subject|0
5797476|NCT03074162|19990202|P2|Period 3|Withdrawal by Subject|0
5797477|NCT03074162|19990203|P1|Period 3|Withdrawal by Subject|1
5797478|NCT03074162|19990198|P6|Period 2 Including Washout 2|Withdrawal by Subject|1
5797479|NCT03074162|19990199|P5|Period 2 Including Washout 2|Withdrawal by Subject|0
5797480|NCT03074162|19990200|P4|Period 2 Including Washout 2|Withdrawal by Subject|0
5797481|NCT03074162|19990201|P3|Period 2 Including Washout 2|Withdrawal by Subject|1
5797482|NCT03074162|19990202|P2|Period 2 Including Washout 2|Withdrawal by Subject|0
5797483|NCT03074162|19990203|P1|Period 2 Including Washout 2|Withdrawal by Subject|0
5797484|NCT03074162|19990198|P6|Period 1 Including Washout 1|Withdrawal by Subject|0
5797485|NCT03074162|19990199|P5|Period 1 Including Washout 1|Withdrawal by Subject|0
5797486|NCT03074162|19990200|P4|Period 1 Including Washout 1|Withdrawal by Subject|0
5797487|NCT03074162|19990201|P3|Period 1 Including Washout 1|Withdrawal by Subject|1
5797488|NCT03074162|19990202|P2|Period 1 Including Washout 1|Withdrawal by Subject|0
5797489|NCT03074162|19990203|P1|Period 1 Including Washout 1|Withdrawal by Subject|0
5797490|NCT03073798|19990265|P1|Overall Study|Withdrawal by Subject|1
5797491|NCT03073798|19990265|P1|Overall Study|Adverse Event|1
5797492|NCT03073213|19990303|P3|Multiple Dose Period|Protocol Violation|1
5797493|NCT03073213|19990304|P2|Multiple Dose Period|Protocol Violation|0
5797494|NCT03073213|19990305|P1|Multiple Dose Period|Protocol Violation|0
5797495|NCT03073200|19990320|P3|Overall Study|Lack of Efficacy|0
5797496|NCT03073200|19990321|P2|Overall Study|Lack of Efficacy|0
5797497|NCT03073200|19990322|P1|Overall Study|Lack of Efficacy|1
5797498|NCT03073200|19990320|P3|Overall Study|Protocol Violation|0
5797499|NCT03073200|19990321|P2|Overall Study|Protocol Violation|0
5797500|NCT03073200|19990322|P1|Overall Study|Protocol Violation|2
5797501|NCT03073200|19990320|P3|Overall Study|Site closed by sponsor|1
5797502|NCT03073200|19990321|P2|Overall Study|Site closed by sponsor|0
5797503|NCT03073200|19990322|P1|Overall Study|Site closed by sponsor|0
5797504|NCT03073200|19990320|P3|Overall Study|Withdrawal by parent/guardian|1
5797505|NCT03073200|19990321|P2|Overall Study|Withdrawal by parent/guardian|1
5797506|NCT03073200|19990322|P1|Overall Study|Withdrawal by parent/guardian|0
5797507|NCT03073200|19990320|P3|Overall Study|Continuing treatment (Ongoing)|28
5797508|NCT03073200|19990321|P2|Overall Study|Continuing treatment (Ongoing)|106
5797509|NCT03073200|19990322|P1|Overall Study|Continuing treatment (Ongoing)|48
5797510|NCT03073200|19990320|P3|Overall Study|Withdrawal by Subject|0
5797511|NCT03073200|19990321|P2|Overall Study|Withdrawal by Subject|3
5797512|NCT03073200|19990322|P1|Overall Study|Withdrawal by Subject|3
5797513|NCT03073200|19990320|P3|Overall Study|Participant had Crohns disease|0
5797514|NCT03073200|19990321|P2|Overall Study|Participant had Crohns disease|1
5797515|NCT03073200|19990322|P1|Overall Study|Participant had Crohns disease|0
5797516|NCT03073200|19990320|P3|Overall Study|Lost to Follow-up|0
5797517|NCT03073200|19990321|P2|Overall Study|Lost to Follow-up|2
5797518|NCT03073200|19990322|P1|Overall Study|Lost to Follow-up|1
5797519|NCT03073200|19990320|P3|Overall Study|Adverse Event|0
5797520|NCT03073200|19990321|P2|Overall Study|Adverse Event|2
5797521|NCT03073200|19990322|P1|Overall Study|Adverse Event|0
5797522|NCT03073109|19990384|P2|Overall Study|Lost to Follow-up|1
5797523|NCT03073109|19990385|P1|Overall Study|Lost to Follow-up|8
5797524|NCT03073109|19990384|P2|Overall Study|Other|0
5797525|NCT03073109|19990385|P1|Overall Study|Other|2
5797526|NCT03073109|19990384|P2|Overall Study|Adverse Event|1
5797527|NCT03073109|19990385|P1|Overall Study|Adverse Event|0
5797528|NCT03072875|19990413|P1|Overall Study|Lost to Follow-up|1
5797529|NCT03072719|19990429|P2|Overall Study|Adverse Event|1
5797530|NCT03072719|19990430|P1|Overall Study|Adverse Event|1
5797531|NCT03071276|19990455|P1|Overall Study|Lack of Efficacy|14
5797532|NCT03071276|19990455|P1|Overall Study|Adverse Event|1
5797533|NCT03071263|19990463|P2|Overall Study|Participant moved to another city|1
5797534|NCT03071263|19990464|P1|Overall Study|Participant moved to another city|0
5797535|NCT03071263|19990463|P2|Overall Study|Physician Decision|0
5797536|NCT03071263|19990464|P1|Overall Study|Physician Decision|1
5797537|NCT03071263|19990463|P2|Overall Study|Withdrawal by Subject|3
5797538|NCT03071263|19990464|P1|Overall Study|Withdrawal by Subject|1
5797539|NCT03071263|19990463|P2|Overall Study|Adverse Event|3
5797540|NCT03071263|19990464|P1|Overall Study|Adverse Event|1
5797541|NCT03070964|19990488|P1|Overall Study|Adverse Event|1
5797542|NCT03070964|19990488|P1|Overall Study|Withdrawal by Subject|1
5797543|NCT03070964|19990488|P1|Overall Study|Physician Decision|1
5797544|NCT03070964|19990488|P1|Overall Study|Never treated|1
5797545|NCT03070964|19990488|P1|Overall Study|Treatment-unrelated adverse event|2
5797546|NCT03070964|19990488|P1|Overall Study|Progressive disease|8
5797547|NCT03070782|19990499|P6|Overall Study|Investigator Judgement|0
5797548|NCT03070782|19990500|P5|Overall Study|Investigator Judgement|0
5797549|NCT03070782|19990501|P4|Overall Study|Investigator Judgement|1
5797550|NCT03070782|19990502|P3|Overall Study|Investigator Judgement|0
5797551|NCT03070782|19990503|P2|Overall Study|Investigator Judgement|0
5797552|NCT03070782|19990504|P1|Overall Study|Investigator Judgement|0
5797553|NCT03070782|19990499|P6|Overall Study|Pregnancy|0
5797554|NCT03070782|19990500|P5|Overall Study|Pregnancy|0
5797555|NCT03070782|19990501|P4|Overall Study|Pregnancy|1
5797556|NCT03070782|19990502|P3|Overall Study|Pregnancy|0
5797557|NCT03070782|19990503|P2|Overall Study|Pregnancy|0
5797558|NCT03070782|19990504|P1|Overall Study|Pregnancy|0
5797559|NCT03070782|19990499|P6|Overall Study|Ineligibility|1
5797560|NCT03070782|19990500|P5|Overall Study|Ineligibility|0
5797561|NCT03070782|19990501|P4|Overall Study|Ineligibility|1
5797562|NCT03070782|19990502|P3|Overall Study|Ineligibility|0
5797563|NCT03070782|19990503|P2|Overall Study|Ineligibility|0
5797564|NCT03070782|19990504|P1|Overall Study|Ineligibility|0
5797565|NCT03070782|19990499|P6|Overall Study|Reason Not Specified|1
5797566|NCT03070782|19990500|P5|Overall Study|Reason Not Specified|2
5797567|NCT03070782|19990501|P4|Overall Study|Reason Not Specified|1
5797568|NCT03070782|19990502|P3|Overall Study|Reason Not Specified|0
5797569|NCT03070782|19990503|P2|Overall Study|Reason Not Specified|0
5797570|NCT03070782|19990504|P1|Overall Study|Reason Not Specified|2
5797571|NCT03070782|19990499|P6|Overall Study|Withdrawal by Subject|3
5797572|NCT03070782|19990500|P5|Overall Study|Withdrawal by Subject|4
5797573|NCT03070782|19990501|P4|Overall Study|Withdrawal by Subject|0
5797574|NCT03070782|19990502|P3|Overall Study|Withdrawal by Subject|1
5797575|NCT03070782|19990503|P2|Overall Study|Withdrawal by Subject|1
5797576|NCT03070782|19990504|P1|Overall Study|Withdrawal by Subject|2
5797577|NCT03070782|19990499|P6|Overall Study|Adverse Event|2
5797578|NCT03070782|19990500|P5|Overall Study|Adverse Event|6
5797579|NCT03070782|19990501|P4|Overall Study|Adverse Event|1
5797580|NCT03070782|19990502|P3|Overall Study|Adverse Event|3
5797581|NCT03070782|19990503|P2|Overall Study|Adverse Event|0
5797582|NCT03070782|19990504|P1|Overall Study|Adverse Event|3
5797583|NCT03070483|19990744|P1|Overall Study|Lost to Follow-up|2
5797584|NCT03070431|19990791|P1|Overall Study|Lost to Follow-up|2
5797585|NCT03070431|19990791|P1|Overall Study|Withdrawal by Subject|2
5797586|NCT03070171|19990813|P2|Treatment Period 4 + Washout|Withdrawal by Subject|1
5797587|NCT03070171|19990814|P1|Treatment Period 4 + Washout|Withdrawal by Subject|0
5797588|NCT03070171|19990813|P2|Treatment Period 2 + Washout|Other Adverse Event|1
5797589|NCT03070171|19990814|P1|Treatment Period 2 + Washout|Other Adverse Event|0
5797590|NCT03070002|19990830|P1|Follow up for 2 Years|Death|1
5797591|NCT03069989|19990838|P2|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|0
5797592|NCT03069989|19990839|P1|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|1
5797593|NCT03069482|19990946|P2|Overall Study|Physician Decision|0
5797594|NCT03069482|19990947|P1|Overall Study|Physician Decision|1
5797595|NCT03069482|19990946|P2|Overall Study|Lost to Follow-up|1
5797596|NCT03069482|19990947|P1|Overall Study|Lost to Follow-up|0
5797597|NCT03069365|19991057|P1|Overall Study|Adverse Event|1
5797598|NCT03069352|19991065|P2|Overall Study|Ongoing|40
5797599|NCT03069352|19991066|P1|Overall Study|Ongoing|12
5797600|NCT03069313|19991108|P1|Overall Study|Adverse Event|5
5797601|NCT03068767|19991146|P2|Overall Study|Protocol Violation|0
5797602|NCT03068767|19991147|P1|Overall Study|Protocol Violation|3
5797603|NCT03068767|19991146|P2|Overall Study|Lost to Follow-up|3
5797604|NCT03068767|19991147|P1|Overall Study|Lost to Follow-up|7
5797758|NCT03066609|19991403|P1|OVERALL STUDY|discontinued follow up|0
5797605|NCT03068754|19991157|P4|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|3
5797606|NCT03068754|19991158|P3|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|12
5797607|NCT03068754|19991159|P2|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|0
5797608|NCT03068754|19991160|P1|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|0
5797609|NCT03068754|19991157|P4|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0
5797610|NCT03068754|19991158|P3|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|1
5797611|NCT03068754|19991159|P2|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0
5797612|NCT03068754|19991160|P1|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0
5797613|NCT03068754|19991157|P4|Open Label Extension Period (OLE)|Withdrawal by Subject|0
5797614|NCT03068754|19991158|P3|Open Label Extension Period (OLE)|Withdrawal by Subject|5
5797615|NCT03068754|19991159|P2|Open Label Extension Period (OLE)|Withdrawal by Subject|0
5797616|NCT03068754|19991160|P1|Open Label Extension Period (OLE)|Withdrawal by Subject|0
5797617|NCT03068754|19991157|P4|Open Label Extension Period (OLE)|Disease progression|1
5797618|NCT03068754|19991158|P3|Open Label Extension Period (OLE)|Disease progression|3
5797619|NCT03068754|19991159|P2|Open Label Extension Period (OLE)|Disease progression|0
5797620|NCT03068754|19991160|P1|Open Label Extension Period (OLE)|Disease progression|0
5797621|NCT03068754|19991157|P4|Open Label Extension Period (OLE)|Death|1
5797622|NCT03068754|19991158|P3|Open Label Extension Period (OLE)|Death|0
5797623|NCT03068754|19991159|P2|Open Label Extension Period (OLE)|Death|0
5797624|NCT03068754|19991160|P1|Open Label Extension Period (OLE)|Death|0
5797625|NCT03068754|19991157|P4|Open Label Extension Period (OLE)|Adverse Event|1
5797626|NCT03068754|19991158|P3|Open Label Extension Period (OLE)|Adverse Event|0
5797627|NCT03068754|19991159|P2|Open Label Extension Period (OLE)|Adverse Event|0
5797628|NCT03068754|19991160|P1|Open Label Extension Period (OLE)|Adverse Event|0
5797629|NCT03068754|19991157|P4|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|0
5797630|NCT03068754|19991158|P3|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|0
5797631|NCT03068754|19991159|P2|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|29
5797632|NCT03068754|19991160|P1|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|55
5797633|NCT03068754|19991157|P4|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0
5797634|NCT03068754|19991158|P3|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0
5797635|NCT03068754|19991159|P2|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|1
5797636|NCT03068754|19991160|P1|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0
5797637|NCT03068754|19991157|P4|Randomized Treatment Period (RTP)|Discontinued by Physician|0
5797638|NCT03068754|19991158|P3|Randomized Treatment Period (RTP)|Discontinued by Physician|0
5797639|NCT03068754|19991159|P2|Randomized Treatment Period (RTP)|Discontinued by Physician|0
5797640|NCT03068754|19991160|P1|Randomized Treatment Period (RTP)|Discontinued by Physician|1
5797641|NCT03068754|19991157|P4|Randomized Treatment Period (RTP)|Withdrawal by Subject|0
5797642|NCT03068754|19991158|P3|Randomized Treatment Period (RTP)|Withdrawal by Subject|0
5797643|NCT03068754|19991159|P2|Randomized Treatment Period (RTP)|Withdrawal by Subject|2
5797644|NCT03068754|19991160|P1|Randomized Treatment Period (RTP)|Withdrawal by Subject|6
5797645|NCT03068754|19991157|P4|Randomized Treatment Period (RTP)|Lost to Follow-up|0
5797646|NCT03068754|19991158|P3|Randomized Treatment Period (RTP)|Lost to Follow-up|0
5797647|NCT03068754|19991159|P2|Randomized Treatment Period (RTP)|Lost to Follow-up|0
5797648|NCT03068754|19991160|P1|Randomized Treatment Period (RTP)|Lost to Follow-up|1
5797649|NCT03068754|19991157|P4|Randomized Treatment Period (RTP)|Disease progression|0
5797650|NCT03068754|19991158|P3|Randomized Treatment Period (RTP)|Disease progression|0
5797651|NCT03068754|19991159|P2|Randomized Treatment Period (RTP)|Disease progression|2
5797652|NCT03068754|19991160|P1|Randomized Treatment Period (RTP)|Disease progression|1
5797653|NCT03068754|19991157|P4|Randomized Treatment Period (RTP)|Death|0
5797654|NCT03068754|19991158|P3|Randomized Treatment Period (RTP)|Death|0
5797655|NCT03068754|19991159|P2|Randomized Treatment Period (RTP)|Death|2
5797656|NCT03068754|19991160|P1|Randomized Treatment Period (RTP)|Death|2
5797657|NCT03068754|19991157|P4|Randomized Treatment Period (RTP)|Adverse Event|0
5797658|NCT03068754|19991158|P3|Randomized Treatment Period (RTP)|Adverse Event|0
5797659|NCT03068754|19991159|P2|Randomized Treatment Period (RTP)|Adverse Event|3
5797660|NCT03068754|19991160|P1|Randomized Treatment Period (RTP)|Adverse Event|1
5797661|NCT03068468|19991195|P4|Open-Label Extension Period|Reason not Specified|4
5797662|NCT03068468|19991196|P3|Open-Label Extension Period|Reason not Specified|1
5797663|NCT03068468|19991197|P2|Open-Label Extension Period|Reason not Specified|0
5797664|NCT03068468|19991198|P1|Open-Label Extension Period|Reason not Specified|0
5797665|NCT03068468|19991195|P4|Open-Label Extension Period|Withdrawal by Parent/Guardian|4
5797666|NCT03068468|19991196|P3|Open-Label Extension Period|Withdrawal by Parent/Guardian|0
5797667|NCT03068468|19991197|P2|Open-Label Extension Period|Withdrawal by Parent/Guardian|0
5797668|NCT03068468|19991198|P1|Open-Label Extension Period|Withdrawal by Parent/Guardian|0
5797669|NCT03068468|19991195|P4|Open-Label Extension Period|Withdrawal by Sponsor|228
5797670|NCT03068468|19991196|P3|Open-Label Extension Period|Withdrawal by Sponsor|115
5797671|NCT03068468|19991197|P2|Open-Label Extension Period|Withdrawal by Sponsor|0
5797672|NCT03068468|19991198|P1|Open-Label Extension Period|Withdrawal by Sponsor|0
5797673|NCT03068468|19991195|P4|Open-Label Extension Period|Failure to Meet Randomization Criteria|0
5797674|NCT03068468|19991196|P3|Open-Label Extension Period|Failure to Meet Randomization Criteria|2
5797675|NCT03068468|19991197|P2|Open-Label Extension Period|Failure to Meet Randomization Criteria|0
5797676|NCT03068468|19991198|P1|Open-Label Extension Period|Failure to Meet Randomization Criteria|0
5797677|NCT03068468|19991195|P4|Open-Label Extension Period|Lost to Follow-up|0
5797678|NCT03068468|19991196|P3|Open-Label Extension Period|Lost to Follow-up|1
5797679|NCT03068468|19991197|P2|Open-Label Extension Period|Lost to Follow-up|0
5797680|NCT03068468|19991198|P1|Open-Label Extension Period|Lost to Follow-up|0
5797681|NCT03068468|19991195|P4|Open-Label Extension Period|Death|1
5797682|NCT03068468|19991196|P3|Open-Label Extension Period|Death|0
5797683|NCT03068468|19991197|P2|Open-Label Extension Period|Death|0
5797684|NCT03068468|19991198|P1|Open-Label Extension Period|Death|0
5797685|NCT03068468|19991195|P4|Open-Label Extension Period|Withdrawal by Subject|20
5797686|NCT03068468|19991196|P3|Open-Label Extension Period|Withdrawal by Subject|7
5797687|NCT03068468|19991197|P2|Open-Label Extension Period|Withdrawal by Subject|0
5797688|NCT03068468|19991198|P1|Open-Label Extension Period|Withdrawal by Subject|0
5797689|NCT03068468|19991195|P4|Open-Label Extension Period|Adverse Event|17
5797690|NCT03068468|19991196|P3|Open-Label Extension Period|Adverse Event|13
5797691|NCT03068468|19991197|P2|Open-Label Extension Period|Adverse Event|0
5797692|NCT03068468|19991198|P1|Open-Label Extension Period|Adverse Event|0
5797693|NCT03068468|19991195|P4|Open-Label Extension Period|Lack of Efficacy|2
5797694|NCT03068468|19991196|P3|Open-Label Extension Period|Lack of Efficacy|1
5797695|NCT03068468|19991197|P2|Open-Label Extension Period|Lack of Efficacy|0
5797696|NCT03068468|19991198|P1|Open-Label Extension Period|Lack of Efficacy|0
5797697|NCT03068468|19991195|P4|Placebo-Controlled Period|Death|0
5797698|NCT03068468|19991196|P3|Placebo-Controlled Period|Death|0
5797699|NCT03068468|19991197|P2|Placebo-Controlled Period|Death|1
5797700|NCT03068468|19991198|P1|Placebo-Controlled Period|Death|0
5797701|NCT03068468|19991195|P4|Placebo-Controlled Period|Reason Not Specified|0
5797702|NCT03068468|19991196|P3|Placebo-Controlled Period|Reason Not Specified|0
5797703|NCT03068468|19991197|P2|Placebo-Controlled Period|Reason Not Specified|6
5797704|NCT03068468|19991198|P1|Placebo-Controlled Period|Reason Not Specified|1
5797705|NCT03068468|19991195|P4|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0
5797706|NCT03068468|19991196|P3|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0
5797707|NCT03068468|19991197|P2|Placebo-Controlled Period|Withdrawal by Parent/Guardian|2
5797708|NCT03068468|19991198|P1|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1
5797709|NCT03068468|19991195|P4|Placebo-Controlled Period|Withdrawal by Subject|0
5797710|NCT03068468|19991196|P3|Placebo-Controlled Period|Withdrawal by Subject|0
5797711|NCT03068468|19991197|P2|Placebo-Controlled Period|Withdrawal by Subject|11
5797712|NCT03068468|19991198|P1|Placebo-Controlled Period|Withdrawal by Subject|3
5797713|NCT03068468|19991195|P4|Placebo-Controlled Period|Adverse Event|0
5797714|NCT03068468|19991196|P3|Placebo-Controlled Period|Adverse Event|0
5797715|NCT03068468|19991197|P2|Placebo-Controlled Period|Adverse Event|21
5797716|NCT03068468|19991198|P1|Placebo-Controlled Period|Adverse Event|16
5797717|NCT03068468|19991195|P4|Placebo-Controlled Period|Lack of Efficacy|0
5797718|NCT03068468|19991196|P3|Placebo-Controlled Period|Lack of Efficacy|0
5797719|NCT03068468|19991197|P2|Placebo-Controlled Period|Lack of Efficacy|1
5797720|NCT03068468|19991198|P1|Placebo-Controlled Period|Lack of Efficacy|0
5797721|NCT03068468|19991195|P4|Placebo-Controlled Period|Randomized but not Treated|0
5797722|NCT03068468|19991196|P3|Placebo-Controlled Period|Randomized but not Treated|0
5797723|NCT03068468|19991197|P2|Placebo-Controlled Period|Randomized but not Treated|3
5797724|NCT03068468|19991198|P1|Placebo-Controlled Period|Randomized but not Treated|1
5797725|NCT03067987|19991250|P2|Overall Study|Withdrawal by Subject|1
5797726|NCT03067987|19991251|P1|Overall Study|Withdrawal by Subject|2
5797727|NCT03067987|19991250|P2|Overall Study|Protocol Violation|2
5797728|NCT03067987|19991251|P1|Overall Study|Protocol Violation|1
5797729|NCT03067987|19991250|P2|Overall Study|Lost to Follow-up|10
5797730|NCT03067987|19991251|P1|Overall Study|Lost to Follow-up|7
5797743|NCT03066999|19991336|P2|Overall Study|abnormal urethraBladder neck contracture|2
5797744|NCT03066999|19991337|P1|Overall Study|abnormal urethraBladder neck contracture|0
5797745|NCT03066778|19991357|P2|Overall Study|Ongoing in Study|37
5797746|NCT03066778|19991358|P1|Overall Study|Ongoing in Study|57
5797747|NCT03066778|19991357|P2|Overall Study|Withdrawal by Subject|5
5797748|NCT03066778|19991358|P1|Overall Study|Withdrawal by Subject|4
5797749|NCT03066778|19991357|P2|Overall Study|Death|183
5797750|NCT03066778|19991358|P1|Overall Study|Death|167
5797751|NCT03066622|19991386|P2|Overall Study|Withdrawal by Subject|1
5797752|NCT03066622|19991387|P1|Overall Study|Withdrawal by Subject|2
5797753|NCT03066622|19991386|P2|Overall Study|Lost to Follow-up|25
5797754|NCT03066622|19991387|P1|Overall Study|Lost to Follow-up|24
5797755|NCT03066609|19991400|P4|OVERALL STUDY|discontinued follow up|0
5797756|NCT03066609|19991401|P3|OVERALL STUDY|discontinued follow up|0
5797757|NCT03066609|19991402|P2|OVERALL STUDY|discontinued follow up|2
5797759|NCT03066609|19991400|P4|OVERALL STUDY|Lack of Efficacy|1
5797760|NCT03066609|19991401|P3|OVERALL STUDY|Lack of Efficacy|1
5797761|NCT03066609|19991402|P2|OVERALL STUDY|Lack of Efficacy|1
5797762|NCT03066609|19991403|P1|OVERALL STUDY|Lack of Efficacy|2
5797763|NCT03066609|19991400|P4|OVERALL STUDY|Pregnancy|0
5797764|NCT03066609|19991401|P3|OVERALL STUDY|Pregnancy|1
5797765|NCT03066609|19991402|P2|OVERALL STUDY|Pregnancy|0
5797766|NCT03066609|19991403|P1|OVERALL STUDY|Pregnancy|1
5797767|NCT03066609|19991400|P4|OVERALL STUDY|Lost to Follow-up|1
5797768|NCT03066609|19991401|P3|OVERALL STUDY|Lost to Follow-up|1
5797769|NCT03066609|19991402|P2|OVERALL STUDY|Lost to Follow-up|1
5797770|NCT03066609|19991403|P1|OVERALL STUDY|Lost to Follow-up|1
5797771|NCT03066609|19991400|P4|OVERALL STUDY|Withdrawal by Subject|2
5797772|NCT03066609|19991401|P3|OVERALL STUDY|Withdrawal by Subject|1
5797773|NCT03066609|19991402|P2|OVERALL STUDY|Withdrawal by Subject|2
5797774|NCT03066609|19991403|P1|OVERALL STUDY|Withdrawal by Subject|4
5797775|NCT03066609|19991400|P4|OVERALL STUDY|Adverse Event|1
5797776|NCT03066609|19991401|P3|OVERALL STUDY|Adverse Event|0
5797777|NCT03066609|19991402|P2|OVERALL STUDY|Adverse Event|2
5797778|NCT03066609|19991403|P1|OVERALL STUDY|Adverse Event|2
5797779|NCT03066609|19991400|P4|MAINTENANCE|Lack of Efficacy|1
5797780|NCT03066609|19991401|P3|MAINTENANCE|Lack of Efficacy|0
5797781|NCT03066609|19991402|P2|MAINTENANCE|Lack of Efficacy|1
5797782|NCT03066609|19991403|P1|MAINTENANCE|Lack of Efficacy|2
5797783|NCT03066609|19991400|P4|MAINTENANCE|Pregnancy|0
5797784|NCT03066609|19991401|P3|MAINTENANCE|Pregnancy|0
5797785|NCT03066609|19991402|P2|MAINTENANCE|Pregnancy|0
5797786|NCT03066609|19991403|P1|MAINTENANCE|Pregnancy|1
5797787|NCT03066609|19991400|P4|MAINTENANCE|Lost to Follow-up|0
5797788|NCT03066609|19991401|P3|MAINTENANCE|Lost to Follow-up|1
5797789|NCT03066609|19991402|P2|MAINTENANCE|Lost to Follow-up|1
5797790|NCT03066609|19991403|P1|MAINTENANCE|Lost to Follow-up|0
5797791|NCT03066609|19991400|P4|MAINTENANCE|Withdrawal by Subject|1
5797792|NCT03066609|19991401|P3|MAINTENANCE|Withdrawal by Subject|1
5797793|NCT03066609|19991402|P2|MAINTENANCE|Withdrawal by Subject|2
5797794|NCT03066609|19991403|P1|MAINTENANCE|Withdrawal by Subject|4
5797795|NCT03066609|19991400|P4|MAINTENANCE|Adverse Event|1
5797796|NCT03066609|19991401|P3|MAINTENANCE|Adverse Event|0
5797797|NCT03066609|19991402|P2|MAINTENANCE|Adverse Event|0
5797798|NCT03066609|19991403|P1|MAINTENANCE|Adverse Event|0
5797799|NCT03066609|19991400|P4|INDUCTION|Adverse Event|0
5797800|NCT03066609|19991401|P3|INDUCTION|Adverse Event|0
5797801|NCT03066609|19991402|P2|INDUCTION|Adverse Event|2
5797802|NCT03066609|19991403|P1|INDUCTION|Adverse Event|2
5797803|NCT03066609|19991400|P4|INDUCTION|Lack of Efficacy|0
5797804|NCT03066609|19991401|P3|INDUCTION|Lack of Efficacy|1
5797805|NCT03066609|19991402|P2|INDUCTION|Lack of Efficacy|0
5797806|NCT03066609|19991403|P1|INDUCTION|Lack of Efficacy|0
5797807|NCT03066609|19991400|P4|INDUCTION|Pregnancy|0
5797808|NCT03066609|19991401|P3|INDUCTION|Pregnancy|1
5797809|NCT03066609|19991402|P2|INDUCTION|Pregnancy|0
5797810|NCT03066609|19991403|P1|INDUCTION|Pregnancy|0
5797811|NCT03066193|19991433|P1|Overall Study|Withdrawal by Subject|1
5797812|NCT03065933|19991446|P1|Overall Study|study terminated|5
5797813|NCT03065530|19991454|P4|Overall Study|Protocol Violation|1
5797814|NCT03065530|19991455|P3|Overall Study|Protocol Violation|1
5797815|NCT03065530|19991456|P2|Overall Study|Protocol Violation|0
5797816|NCT03065530|19991457|P1|Overall Study|Protocol Violation|1
5797817|NCT03065530|19991454|P4|Overall Study|Lack of Efficacy|1
5797818|NCT03065530|19991455|P3|Overall Study|Lack of Efficacy|0
5797819|NCT03065530|19991456|P2|Overall Study|Lack of Efficacy|1
5797820|NCT03065530|19991457|P1|Overall Study|Lack of Efficacy|1
5797821|NCT03065023|19991565|P5|Overall Study|Withdrawal by Subject|0
5797822|NCT03065023|19991566|P4|Overall Study|Withdrawal by Subject|1
5797823|NCT03065023|19991567|P3|Overall Study|Withdrawal by Subject|0
5797824|NCT03065023|19991568|P2|Overall Study|Withdrawal by Subject|0
5797825|NCT03065023|19991569|P1|Overall Study|Withdrawal by Subject|0
5797826|NCT03065023|19991565|P5|Overall Study|Participant Decision|0
5797827|NCT03065023|19991566|P4|Overall Study|Participant Decision|1
5797828|NCT03065023|19991567|P3|Overall Study|Participant Decision|0
5797829|NCT03065023|19991568|P2|Overall Study|Participant Decision|0
5797830|NCT03065023|19991569|P1|Overall Study|Participant Decision|0
5797831|NCT03065023|19991565|P5|Overall Study|Lost to Follow-up|0
5797832|NCT03065023|19991566|P4|Overall Study|Lost to Follow-up|0
5797833|NCT03065023|19991567|P3|Overall Study|Lost to Follow-up|0
5797834|NCT03065023|19991568|P2|Overall Study|Lost to Follow-up|1
5797835|NCT03065023|19991569|P1|Overall Study|Lost to Follow-up|0
5797836|NCT03065023|19991565|P5|Overall Study|Death|0
5797837|NCT03065023|19991566|P4|Overall Study|Death|1
5797838|NCT03065023|19991567|P3|Overall Study|Death|1
5797839|NCT03065023|19991568|P2|Overall Study|Death|0
5797840|NCT03065023|19991569|P1|Overall Study|Death|2
5797841|NCT03065023|19991565|P5|Overall Study|Progressive Disease|0
5797842|NCT03065023|19991566|P4|Overall Study|Progressive Disease|0
5797843|NCT03065023|19991567|P3|Overall Study|Progressive Disease|0
5797844|NCT03065023|19991568|P2|Overall Study|Progressive Disease|1
5797845|NCT03065023|19991569|P1|Overall Study|Progressive Disease|0
5797846|NCT03064841|19991635|P1|Overall Study|Screen failure|2
5797847|NCT03064841|19991635|P1|Overall Study|No glycated haemoglobinA1c measurement|11
5797848|NCT03064841|19991635|P1|Overall Study|Inclusion/exclusion criteria violation|4
5797849|NCT03064451|19991650|P1|Overall Study|Withdrew consent: 3-month FU visit|1
5797850|NCT03064451|19991650|P1|Overall Study|Exited prior to procedure|8
5797851|NCT03064451|19991650|P1|Overall Study|Mapping Failure|4
5797852|NCT03064451|19991650|P1|Overall Study|Lost to Follow-up|1
5797853|NCT03064126|19991668|P4|Overall Study|Protocol Violation|0
5797854|NCT03064126|19991669|P3|Overall Study|Protocol Violation|1
5797855|NCT03064126|19991670|P2|Overall Study|Protocol Violation|1
5797856|NCT03064126|19991671|P1|Overall Study|Protocol Violation|11
5797857|NCT03064126|19991668|P4|Overall Study|Subject moved|0
5797858|NCT03064126|19991669|P3|Overall Study|Subject moved|0
5797859|NCT03064126|19991670|P2|Overall Study|Subject moved|0
5797860|NCT03064126|19991671|P1|Overall Study|Subject moved|1
5797861|NCT03064126|19991668|P4|Overall Study|Withdrawal by Subject|0
5797862|NCT03064126|19991669|P3|Overall Study|Withdrawal by Subject|0
5797863|NCT03064126|19991670|P2|Overall Study|Withdrawal by Subject|4
5797864|NCT03064126|19991671|P1|Overall Study|Withdrawal by Subject|7
5797865|NCT03064126|19991668|P4|Overall Study|Investigator Discretion|0
5797866|NCT03064126|19991669|P3|Overall Study|Investigator Discretion|0
5797867|NCT03064126|19991670|P2|Overall Study|Investigator Discretion|0
5797868|NCT03064126|19991671|P1|Overall Study|Investigator Discretion|1
5797869|NCT03064126|19991668|P4|Overall Study|Death|1
5797870|NCT03064126|19991669|P3|Overall Study|Death|2
5797871|NCT03064126|19991670|P2|Overall Study|Death|2
5797872|NCT03064126|19991671|P1|Overall Study|Death|6
5797873|NCT03063086|19991813|P6|Overall Study|Physician Decision|0
5797874|NCT03063086|19991814|P5|Overall Study|Physician Decision|0
5797875|NCT03063086|19991815|P4|Overall Study|Physician Decision|1
5797876|NCT03063086|19991816|P3|Overall Study|Physician Decision|0
5797877|NCT03063086|19991817|P2|Overall Study|Physician Decision|0
5797878|NCT03063086|19991818|P1|Overall Study|Physician Decision|0
5797879|NCT03063086|19991813|P6|Overall Study|Non-compliance with study treatment|1
5797880|NCT03063086|19991814|P5|Overall Study|Non-compliance with study treatment|0
5797881|NCT03063086|19991815|P4|Overall Study|Non-compliance with study treatment|1
5797882|NCT03063086|19991816|P3|Overall Study|Non-compliance with study treatment|0
5797883|NCT03063086|19991817|P2|Overall Study|Non-compliance with study treatment|0
5797884|NCT03063086|19991818|P1|Overall Study|Non-compliance with study treatment|0
5797885|NCT03063086|19991813|P6|Overall Study|subject/guardian decision|0
5797886|NCT03063086|19991814|P5|Overall Study|subject/guardian decision|0
5797887|NCT03063086|19991815|P4|Overall Study|subject/guardian decision|0
5797888|NCT03063086|19991816|P3|Overall Study|subject/guardian decision|0
5797889|NCT03063086|19991817|P2|Overall Study|subject/guardian decision|0
5797890|NCT03063086|19991818|P1|Overall Study|subject/guardian decision|1
5797891|NCT03063086|19991813|P6|Overall Study|Adverse Event|0
5797892|NCT03063086|19991814|P5|Overall Study|Adverse Event|0
5797893|NCT03063086|19991815|P4|Overall Study|Adverse Event|1
5797894|NCT03063086|19991816|P3|Overall Study|Adverse Event|1
5797895|NCT03063086|19991817|P2|Overall Study|Adverse Event|1
5797896|NCT03063086|19991818|P1|Overall Study|Adverse Event|1
5797897|NCT03063086|19991813|P6|Overall Study|technical problems|0
5797898|NCT03063086|19991814|P5|Overall Study|technical problems|0
5797899|NCT03063086|19991815|P4|Overall Study|technical problems|0
5797900|NCT03063086|19991816|P3|Overall Study|technical problems|0
5797901|NCT03063086|19991817|P2|Overall Study|technical problems|0
5797902|NCT03063086|19991818|P1|Overall Study|technical problems|1
5797903|NCT03062891|19991864|P2|Overall Study|Lost to Follow-up|38
5797904|NCT03062891|19991865|P1|Overall Study|Lost to Follow-up|50
5797905|NCT03062891|19991864|P2|Overall Study|Withdrawal by Subject|0
5797906|NCT03062891|19991865|P1|Overall Study|Withdrawal by Subject|2
5797907|NCT03061331|19991975|P2|Washout Period (8 Weeks)|Adverse Event|1
5797908|NCT03061331|19991976|P1|Washout Period (8 Weeks)|Adverse Event|2
5797909|NCT03061214|19992006|P3|Overall Study|Death|0
5797910|NCT03061214|19992007|P2|Overall Study|Death|1
5797911|NCT03061214|19992008|P1|Overall Study|Death|1
5797912|NCT03061214|19992006|P3|Overall Study|Lost to Follow-up|1
5797913|NCT03061214|19992007|P2|Overall Study|Lost to Follow-up|1
5797914|NCT03061214|19992008|P1|Overall Study|Lost to Follow-up|3
5797915|NCT03061214|19992006|P3|Overall Study|Withdrawal by Subject|9
5797916|NCT03061214|19992007|P2|Overall Study|Withdrawal by Subject|26
5797917|NCT03061214|19992008|P1|Overall Study|Withdrawal by Subject|21
5797918|NCT03061188|19992234|P4|On Follow-up for 3 Years|Still in follow-up|3
5797919|NCT03061188|19992235|P3|On Follow-up for 3 Years|Still in follow-up|0
5797920|NCT03061188|19992236|P2|On Follow-up for 3 Years|Still in follow-up|0
5797921|NCT03061188|19992237|P1|On Follow-up for 3 Years|Still in follow-up|0
5797922|NCT03061188|19992234|P4|On Follow-up for 3 Years|Death|2
5797923|NCT03061188|19992235|P3|On Follow-up for 3 Years|Death|5
5797924|NCT03061188|19992236|P2|On Follow-up for 3 Years|Death|3
5797925|NCT03061188|19992237|P1|On Follow-up for 3 Years|Death|0
5797926|NCT03061188|19992234|P4|Went on to Cycle 2 and Beyond|Adverse Event|1
5797927|NCT03061188|19992235|P3|Went on to Cycle 2 and Beyond|Adverse Event|1
5797928|NCT03061188|19992236|P2|Went on to Cycle 2 and Beyond|Adverse Event|0
5797929|NCT03061188|19992237|P1|Went on to Cycle 2 and Beyond|Adverse Event|0
5797930|NCT03061175|19992259|P2|Followup 2 at 6 Months|Lost to Follow-up|7
5797931|NCT03061175|19992260|P1|Followup 2 at 6 Months|Lost to Follow-up|4
5797932|NCT03061175|19992259|P2|Followup 1 at 2-4 Weeks Post-surgery|Withdrawal by Subject|1
5797933|NCT03061175|19992260|P1|Followup 1 at 2-4 Weeks Post-surgery|Withdrawal by Subject|0
5797934|NCT03061175|19992259|P2|Followup 1 at 2-4 Weeks Post-surgery|Skipped assessment|2
5797935|NCT03061175|19992260|P1|Followup 1 at 2-4 Weeks Post-surgery|Skipped assessment|6
5797936|NCT03061175|19992259|P2|Baseline|Participant was deemed ineligible|0
5797937|NCT03061175|19992260|P1|Baseline|Participant was deemed ineligible|1
5797938|NCT03061097|19992284|P2|Overall Study|Withdrawal by Subject|3
5797939|NCT03061097|19992285|P1|Overall Study|Withdrawal by Subject|0
5797940|NCT03060551|19992306|P1|Overall Study|Adverse Event|1
5797941|NCT03060551|19992306|P1|Overall Study|Withdrawal by Subject|1
5797942|NCT03060512|19992327|P2|Overall Study|Non-compliance with study medication|2
5797943|NCT03060512|19992328|P1|Overall Study|Non-compliance with study medication|1
5797944|NCT03060512|19992327|P2|Overall Study|Withdrawal by Subject|0
5797945|NCT03060512|19992328|P1|Overall Study|Withdrawal by Subject|1
5797946|NCT03060512|19992327|P2|Overall Study|Lost to Follow-up|1
5797947|NCT03060512|19992328|P1|Overall Study|Lost to Follow-up|1
5797948|NCT03060512|19992327|P2|Overall Study|Adverse Event|6
5797949|NCT03060512|19992328|P1|Overall Study|Adverse Event|4
5797950|NCT03058991|19992365|P3|Overall Study|Withdrawal by Subject|0
5797951|NCT03058991|19992366|P2|Overall Study|Withdrawal by Subject|0
5797952|NCT03058991|19992367|P1|Overall Study|Withdrawal by Subject|1
5797953|NCT03058991|19992365|P3|Overall Study|Lost to Follow-up|12
5797954|NCT03058991|19992366|P2|Overall Study|Lost to Follow-up|12
5797955|NCT03058991|19992367|P1|Overall Study|Lost to Follow-up|17
5797956|NCT03058705|19992393|P1|Overall Study|Physician Decision|2
5797957|NCT03058705|19992393|P1|Overall Study|Withdrawal by Subject|2
5797958|NCT03058692|19992399|P2|Overall Study|Withdrawal by Subject|1
5797959|NCT03058692|19992400|P1|Overall Study|Withdrawal by Subject|1
5797960|NCT03058692|19992399|P2|Overall Study|Lost to Follow-up|1
5797961|NCT03058692|19992400|P1|Overall Study|Lost to Follow-up|2
5797966|NCT03056573|19992569|P2|Overall Study|Lost to Follow-up|1
5797967|NCT03056573|19992570|P1|Overall Study|Lost to Follow-up|1
5797968|NCT03056573|19992569|P2|Overall Study|Withdrawal by Subject|0
5797969|NCT03056573|19992570|P1|Overall Study|Withdrawal by Subject|2
5797970|NCT03056573|19992569|P2|Overall Study|Death|4
5797971|NCT03056573|19992570|P1|Overall Study|Death|2
5797972|NCT03056352|19992630|P1|Overall Study|Lost to Follow-up|1
5797973|NCT03056300|19992636|P1|Overall Study|Surgical reason per study protocol|3
5797974|NCT03056040|19992653|P2|Primary Evaluation Period|Pregnancy|1
5797975|NCT03056040|19992654|P1|Primary Evaluation Period|Pregnancy|0
5797976|NCT03056040|19992653|P2|Primary Evaluation Period|Lack of Efficacy|1
5797977|NCT03056040|19992654|P1|Primary Evaluation Period|Lack of Efficacy|0
5797978|NCT03056040|19992653|P2|Primary Evaluation Period|Withdrawal by Subject|1
5797979|NCT03056040|19992654|P1|Primary Evaluation Period|Withdrawal by Subject|1
5797980|NCT03055988|19992668|P2|Period 2|Other than listed|1
5797981|NCT03055988|19992669|P1|Period 2|Other than listed|1
5797982|NCT03055988|19992668|P2|Period 2|Adverse Event|1
5797983|NCT03055988|19992669|P1|Period 2|Adverse Event|0
5797984|NCT03055988|19992668|P2|Period 1|Withdrawal by Subject|4
5797985|NCT03055988|19992669|P1|Period 1|Withdrawal by Subject|0
5797986|NCT03055988|19992668|P2|Period 1|Lost to Follow-up|0
5797987|NCT03055988|19992669|P1|Period 1|Lost to Follow-up|1
5797988|NCT03055988|19992668|P2|Period 1|Adverse Event|1
5797989|NCT03055988|19992669|P1|Period 1|Adverse Event|0
5797990|NCT03055858|19992695|P1|Overall Study|Adverse Event|1
5797991|NCT03055858|19992695|P1|Overall Study|Death|5
5797992|NCT03055832|19992703|P2|Week 2|Withdrawal by Subject|0
5797993|NCT03055832|19992704|P1|Week 2|Withdrawal by Subject|1
5797994|NCT03055806|19992764|P4|Overall Study|Partner not willing to try intercourse|0
5797995|NCT03055806|19992765|P3|Overall Study|Partner not willing to try intercourse|0
5797996|NCT03055806|19992766|P2|Overall Study|Partner not willing to try intercourse|0
5797997|NCT03055806|19992767|P1|Overall Study|Partner not willing to try intercourse|1
5797998|NCT03055806|19992764|P4|Overall Study|Withdrawal of consent to continue study|6
5797999|NCT03055806|19992765|P3|Overall Study|Withdrawal of consent to continue study|4
5798000|NCT03055806|19992766|P2|Overall Study|Withdrawal of consent to continue study|3
5798001|NCT03055806|19992767|P1|Overall Study|Withdrawal of consent to continue study|2
5798002|NCT03055806|19992764|P4|Overall Study|Withdrawal of consent to continue drug|0
5798003|NCT03055806|19992765|P3|Overall Study|Withdrawal of consent to continue drug|2
5798004|NCT03055806|19992766|P2|Overall Study|Withdrawal of consent to continue drug|1
5798005|NCT03055806|19992767|P1|Overall Study|Withdrawal of consent to continue drug|1
5798006|NCT03055806|19992764|P4|Overall Study|Protocol Violation|0
5798007|NCT03055806|19992765|P3|Overall Study|Protocol Violation|0
5798008|NCT03055806|19992766|P2|Overall Study|Protocol Violation|0
5798009|NCT03055806|19992767|P1|Overall Study|Protocol Violation|1
5798010|NCT03055806|19992764|P4|Overall Study|Physician Decision|1
5798011|NCT03055806|19992765|P3|Overall Study|Physician Decision|0
5798012|NCT03055806|19992766|P2|Overall Study|Physician Decision|0
5798013|NCT03055806|19992767|P1|Overall Study|Physician Decision|1
5798014|NCT03055806|19992764|P4|Overall Study|Lost to Follow-up|7
5798015|NCT03055806|19992765|P3|Overall Study|Lost to Follow-up|6
5798016|NCT03055806|19992766|P2|Overall Study|Lost to Follow-up|3
5798017|NCT03055806|19992767|P1|Overall Study|Lost to Follow-up|0
5798018|NCT03055806|19992764|P4|Overall Study|Adverse Event|1
5798019|NCT03055806|19992765|P3|Overall Study|Adverse Event|1
5798020|NCT03055806|19992766|P2|Overall Study|Adverse Event|0
5798021|NCT03055806|19992767|P1|Overall Study|Adverse Event|0
5798022|NCT03055624|19992816|P1|Overall Study|Study closed|9
5798023|NCT03055494|19992827|P2|Overall Study|Non-compliance with study treatment|0
5798024|NCT03055494|19992828|P1|Overall Study|Non-compliance with study treatment|1
5798025|NCT03055494|19992827|P2|Overall Study|Adverse Event|1
5798026|NCT03055494|19992828|P1|Overall Study|Adverse Event|0
5798027|NCT03055494|19992827|P2|Overall Study|Withdrawal by Subject|0
5798028|NCT03055494|19992828|P1|Overall Study|Withdrawal by Subject|1
5798029|NCT03055494|19992827|P2|Overall Study|Physician Decision|0
5798030|NCT03055494|19992828|P1|Overall Study|Physician Decision|2
5798031|NCT03055494|19992827|P2|Overall Study|Lost to Follow-up|0
5798032|NCT03055494|19992828|P1|Overall Study|Lost to Follow-up|6
5798033|NCT03055338|19992859|P3|Overall Study|Withdrawal by Subject|7
5798034|NCT03055338|19992860|P2|Overall Study|Withdrawal by Subject|8
5798035|NCT03055338|19992861|P1|Overall Study|Withdrawal by Subject|9
5798036|NCT03055338|19992859|P3|Overall Study|Physician Decision|2
5798037|NCT03055338|19992860|P2|Overall Study|Physician Decision|0
5798038|NCT03055338|19992861|P1|Overall Study|Physician Decision|0
5798039|NCT03055338|19992859|P3|Overall Study|No Post-treatment Protocol Contact|0
5798040|NCT03055338|19992860|P2|Overall Study|No Post-treatment Protocol Contact|1
5798041|NCT03055338|19992861|P1|Overall Study|No Post-treatment Protocol Contact|0
5798042|NCT03055338|19992859|P3|Overall Study|Lost to Follow-up|3
5798043|NCT03055338|19992860|P2|Overall Study|Lost to Follow-up|2
5798044|NCT03055338|19992861|P1|Overall Study|Lost to Follow-up|9
5798045|NCT03055260|19992880|P2|Overall Study|Withdrawal by Subject|0
5798046|NCT03055260|19992881|P1|Overall Study|Withdrawal by Subject|1
5798047|NCT03055221|19992889|P1|Overall Study|Study terminated by Sponsor|3
5798048|NCT03055221|19992889|P1|Overall Study|Physician Decision|1
5798049|NCT03055221|19992889|P1|Overall Study|Death|6
5798050|NCT03055221|19992889|P1|Overall Study|Withdrawal by Subject|4
5798051|NCT03055221|19992889|P1|Overall Study|Adverse Event|2
5798052|NCT03055195|19992896|P2|Overall Study|Physician Decision|0
5798053|NCT03055195|19992897|P1|Overall Study|Physician Decision|1
5798054|NCT03055195|19992896|P2|Overall Study|Protocol Violation|1
5798055|NCT03055195|19992897|P1|Overall Study|Protocol Violation|2
5798056|NCT03055195|19992896|P2|Overall Study|Study Terminated by Sponsor|6
5798057|NCT03055195|19992897|P1|Overall Study|Study Terminated by Sponsor|2
5798058|NCT03055195|19992896|P2|Overall Study|Withdrawal by Subject|7
5798059|NCT03055195|19992897|P1|Overall Study|Withdrawal by Subject|6
5798060|NCT03055195|19992896|P2|Overall Study|Lack of Efficacy|0
5798061|NCT03055195|19992897|P1|Overall Study|Lack of Efficacy|1
5798062|NCT03054428|19993269|P3|Overall Study|Lost to Follow-up|1
5798063|NCT03054428|19993270|P2|Overall Study|Lost to Follow-up|0
5798064|NCT03054428|19993271|P1|Overall Study|Lost to Follow-up|0
5798065|NCT03054428|19993269|P3|Overall Study|Withdrawal by Subject|3
5798066|NCT03054428|19993270|P2|Overall Study|Withdrawal by Subject|2
5798067|NCT03054428|19993271|P1|Overall Study|Withdrawal by Subject|3
5798068|NCT03054428|19993269|P3|Overall Study|Transitioned to OLE study|73
5798069|NCT03054428|19993270|P2|Overall Study|Transitioned to OLE study|76
5798070|NCT03054428|19993271|P1|Overall Study|Transitioned to OLE study|76
5798071|NCT03054428|19993269|P3|Overall Study|Discont'd to enroll in OLE: not enrolled|0
5798072|NCT03054428|19993270|P2|Overall Study|Discont'd to enroll in OLE: not enrolled|0
5798073|NCT03054428|19993271|P1|Overall Study|Discont'd to enroll in OLE: not enrolled|1
5798074|NCT03054428|19993269|P3|Overall Study|Discontinued to enroll in OLE: enrolled|1
5798075|NCT03054428|19993270|P2|Overall Study|Discontinued to enroll in OLE: enrolled|0
5798076|NCT03054428|19993271|P1|Overall Study|Discontinued to enroll in OLE: enrolled|0
5798077|NCT03054428|19993269|P3|Overall Study|Lack of Efficacy|0
5798078|NCT03054428|19993270|P2|Overall Study|Lack of Efficacy|1
5798079|NCT03054428|19993271|P1|Overall Study|Lack of Efficacy|3
5798080|NCT03054428|19993269|P3|Overall Study|Physician Decision|1
5798081|NCT03054428|19993270|P2|Overall Study|Physician Decision|1
5798082|NCT03054428|19993271|P1|Overall Study|Physician Decision|0
5798083|NCT03054064|19993367|P1|Overall Study|Change in Status|1
5798084|NCT03054064|19993367|P1|Overall Study|High Blood Pressure|1
5798085|NCT03054064|19993367|P1|Overall Study|Bladder Issue|1
5798086|NCT03054064|19993367|P1|Overall Study|Investigator Decision|2
5798087|NCT03054064|19993367|P1|Overall Study|Lower Extremity Deep Vein Thrombosis|1
5798088|NCT03053518|19993412|P1|Overall Study|Ineligible|5
5798089|NCT03053518|19993412|P1|Overall Study|Lost to Follow-up|2
5798090|NCT03053518|19993412|P1|Overall Study|Withdrawal by Subject|3
5798091|NCT03053492|19993418|P2|Overall Study|Withdrawal by Subject|5
5798092|NCT03053492|19993419|P1|Overall Study|Withdrawal by Subject|7
5798093|NCT03053492|19993418|P2|Overall Study|Adverse Event|1
5798094|NCT03053492|19993419|P1|Overall Study|Adverse Event|1
5798095|NCT03053427|19993433|P2|Overall Study|Miscellaneous|1
5798096|NCT03053427|19993434|P1|Overall Study|Miscellaneous|0
5798097|NCT03053427|19993433|P2|Overall Study|Withdrawal by Subject|2
5798098|NCT03053427|19993434|P1|Overall Study|Withdrawal by Subject|3
5798099|NCT03053427|19993433|P2|Overall Study|Protocol Deviation|3
5798100|NCT03053427|19993434|P1|Overall Study|Protocol Deviation|3
5798101|NCT03053427|19993433|P2|Overall Study|Worsening of the target disease|1
5798102|NCT03053427|19993434|P1|Overall Study|Worsening of the target disease|0
5798103|NCT03053427|19993433|P2|Overall Study|Lost to Follow-up|2
5798104|NCT03053427|19993434|P1|Overall Study|Lost to Follow-up|2
5798105|NCT03053427|19993433|P2|Overall Study|Lack of Efficacy|3
5798106|NCT03053427|19993434|P1|Overall Study|Lack of Efficacy|1
5798107|NCT03053427|19993433|P2|Overall Study|Adverse Event|4
5798108|NCT03053427|19993434|P1|Overall Study|Adverse Event|4
5798109|NCT03053180|19993469|P1|Overall Study|Failure to Return|1
5798110|NCT03053063|19993481|P4|Open-Label Phase|Investigator's discretion|2
5798111|NCT03053063|19993482|P3|Open-Label Phase|Investigator's discretion|0
5798112|NCT03053063|19993483|P2|Open-Label Phase|Investigator's discretion|0
5798113|NCT03053063|19993484|P1|Open-Label Phase|Investigator's discretion|0
5798114|NCT03053063|19993481|P4|Open-Label Phase|Death|2
5798115|NCT03053063|19993482|P3|Open-Label Phase|Death|0
5798116|NCT03053063|19993483|P2|Open-Label Phase|Death|0
5798117|NCT03053063|19993484|P1|Open-Label Phase|Death|0
5798118|NCT03053063|19993481|P4|Open-Label Phase|Study Terminated by Sponsor|19
5798119|NCT03053063|19993482|P3|Open-Label Phase|Study Terminated by Sponsor|0
5798120|NCT03053063|19993483|P2|Open-Label Phase|Study Terminated by Sponsor|0
5798121|NCT03053063|19993484|P1|Open-Label Phase|Study Terminated by Sponsor|0
5798122|NCT03053063|19993481|P4|Randomized Phase|Entered the Open-Label Phase|0
5798123|NCT03053063|19993482|P3|Randomized Phase|Entered the Open-Label Phase|3
5798124|NCT03053063|19993483|P2|Randomized Phase|Entered the Open-Label Phase|11
5798125|NCT03053063|19993484|P1|Randomized Phase|Entered the Open-Label Phase|9
5798126|NCT03053063|19993481|P4|Randomized Phase|Randomized but Never Treated|0
5798127|NCT03053063|19993482|P3|Randomized Phase|Randomized but Never Treated|2
5798128|NCT03053063|19993483|P2|Randomized Phase|Randomized but Never Treated|3
5798129|NCT03053063|19993484|P1|Randomized Phase|Randomized but Never Treated|1
5798130|NCT03053063|19993481|P4|Randomized Phase|Adverse Event|0
5798131|NCT03053063|19993482|P3|Randomized Phase|Adverse Event|0
5798132|NCT03053063|19993483|P2|Randomized Phase|Adverse Event|1
5798133|NCT03053063|19993484|P1|Randomized Phase|Adverse Event|0
5798134|NCT03053063|19993481|P4|Randomized Phase|Lost to Follow-up|0
5798135|NCT03053063|19993482|P3|Randomized Phase|Lost to Follow-up|1
5798136|NCT03053063|19993483|P2|Randomized Phase|Lost to Follow-up|5
5798137|NCT03053063|19993484|P1|Randomized Phase|Lost to Follow-up|3
5798138|NCT03053063|19993481|P4|Randomized Phase|Investigator's Discretion|0
5798139|NCT03053063|19993482|P3|Randomized Phase|Investigator's Discretion|2
5798140|NCT03053063|19993483|P2|Randomized Phase|Investigator's Discretion|6
5798141|NCT03053063|19993484|P1|Randomized Phase|Investigator's Discretion|8
5798142|NCT03053063|19993481|P4|Randomized Phase|Withdrew consent|0
5798143|NCT03053063|19993482|P3|Randomized Phase|Withdrew consent|5
5798144|NCT03053063|19993483|P2|Randomized Phase|Withdrew consent|11
5798145|NCT03053063|19993484|P1|Randomized Phase|Withdrew consent|8
5798146|NCT03053063|19993481|P4|Randomized Phase|Study Terminated by Sponsor|0
5798147|NCT03053063|19993482|P3|Randomized Phase|Study Terminated by Sponsor|161
5798148|NCT03053063|19993483|P2|Randomized Phase|Study Terminated by Sponsor|317
5798149|NCT03053063|19993484|P1|Randomized Phase|Study Terminated by Sponsor|326
5798150|NCT03053050|19993514|P4|Open-label Phase|Investigator's Discretion|4
5798151|NCT03053050|19993515|P3|Open-label Phase|Investigator's Discretion|0
5798152|NCT03053050|19993516|P2|Open-label Phase|Investigator's Discretion|0
5798153|NCT03053050|19993517|P1|Open-label Phase|Investigator's Discretion|0
5798154|NCT03053050|19993514|P4|Open-label Phase|Withdrew Consent|6
5798155|NCT03053050|19993515|P3|Open-label Phase|Withdrew Consent|0
5798156|NCT03053050|19993516|P2|Open-label Phase|Withdrew Consent|0
5798157|NCT03053050|19993517|P1|Open-label Phase|Withdrew Consent|0
5798158|NCT03053050|19993514|P4|Open-label Phase|Study Terminated by Sponsor|89
5798159|NCT03053050|19993515|P3|Open-label Phase|Study Terminated by Sponsor|0
5798160|NCT03053050|19993516|P2|Open-label Phase|Study Terminated by Sponsor|0
5798161|NCT03053050|19993517|P1|Open-label Phase|Study Terminated by Sponsor|0
5798162|NCT03053050|19993514|P4|Randomized Phase|Entered the Open-Label Phase|0
5798163|NCT03053050|19993515|P3|Randomized Phase|Entered the Open-Label Phase|18
5798164|NCT03053050|19993516|P2|Randomized Phase|Entered the Open-Label Phase|45
5798165|NCT03053050|19993517|P1|Randomized Phase|Entered the Open-Label Phase|36
5798166|NCT03053050|19993514|P4|Randomized Phase|Randomized but Never Treated|0
5798167|NCT03053050|19993515|P3|Randomized Phase|Randomized but Never Treated|2
5798168|NCT03053050|19993516|P2|Randomized Phase|Randomized but Never Treated|2
5798169|NCT03053050|19993517|P1|Randomized Phase|Randomized but Never Treated|2
5798170|NCT03053050|19993514|P4|Randomized Phase|Adverse Event|0
5798171|NCT03053050|19993515|P3|Randomized Phase|Adverse Event|0
5798172|NCT03053050|19993516|P2|Randomized Phase|Adverse Event|1
5798173|NCT03053050|19993517|P1|Randomized Phase|Adverse Event|0
5798174|NCT03053050|19993514|P4|Randomized Phase|Lost to Follow-up|0
5798175|NCT03053050|19993515|P3|Randomized Phase|Lost to Follow-up|1
5798176|NCT03053050|19993516|P2|Randomized Phase|Lost to Follow-up|1
5798177|NCT03053050|19993517|P1|Randomized Phase|Lost to Follow-up|5
5798178|NCT03053050|19993514|P4|Randomized Phase|Investigator's Discretion|0
5798179|NCT03053050|19993515|P3|Randomized Phase|Investigator's Discretion|3
5798180|NCT03053050|19993516|P2|Randomized Phase|Investigator's Discretion|6
5798181|NCT03053050|19993517|P1|Randomized Phase|Investigator's Discretion|6
5798182|NCT03053050|19993514|P4|Randomized Phase|Withdrew Consent|0
5798183|NCT03053050|19993515|P3|Randomized Phase|Withdrew Consent|9
5798184|NCT03053050|19993516|P2|Randomized Phase|Withdrew Consent|8
5798185|NCT03053050|19993517|P1|Randomized Phase|Withdrew Consent|16
5798186|NCT03053050|19993514|P4|Randomized Phase|Study Terminated by Sponsor|0
5798187|NCT03053050|19993515|P3|Randomized Phase|Study Terminated by Sponsor|128
5798188|NCT03053050|19993516|P2|Randomized Phase|Study Terminated by Sponsor|260
5798189|NCT03053050|19993517|P1|Randomized Phase|Study Terminated by Sponsor|259
5798190|NCT03052764|19993561|P2|Double-Blind Treatment Period|Reason not Specified|1
5798191|NCT03052764|19993562|P1|Double-Blind Treatment Period|Reason not Specified|2
5798192|NCT03052764|19993561|P2|Double-Blind Treatment Period|Withdrawal by Subject|1
5798193|NCT03052764|19993562|P1|Double-Blind Treatment Period|Withdrawal by Subject|3
5798194|NCT03052764|19993561|P2|Double-Blind Treatment Period|Protocol Violation|1
5798195|NCT03052764|19993562|P1|Double-Blind Treatment Period|Protocol Violation|2
5798196|NCT03052764|19993561|P2|Double-Blind Treatment Period|Lack of Efficacy|0
5798197|NCT03052764|19993562|P1|Double-Blind Treatment Period|Lack of Efficacy|1
5798198|NCT03052764|19993561|P2|Double-Blind Treatment Period|Adverse Event|0
5798199|NCT03052764|19993562|P1|Double-Blind Treatment Period|Adverse Event|2
5798200|NCT03052725|19993582|P2|Overall Study|Study terminated by sponsor|144
5798201|NCT03052725|19993583|P1|Overall Study|Study terminated by sponsor|143
5798202|NCT03052725|19993582|P2|Overall Study|Site closure|1
5798203|NCT03052725|19993583|P1|Overall Study|Site closure|0
5798204|NCT03052725|19993582|P2|Overall Study|Pregnancy|1
5798205|NCT03052725|19993583|P1|Overall Study|Pregnancy|0
5798206|NCT03052725|19993582|P2|Overall Study|Withdrawal by Subject|4
5798207|NCT03052725|19993583|P1|Overall Study|Withdrawal by Subject|3
5798208|NCT03052725|19993582|P2|Overall Study|Adverse Event|0
5798209|NCT03052725|19993583|P1|Overall Study|Adverse Event|2
5798210|NCT03052517|19993630|P3|Overall Study|Technical Problems|0
5798211|NCT03052517|19993631|P2|Overall Study|Technical Problems|1
5798212|NCT03052517|19993632|P1|Overall Study|Technical Problems|0
5798213|NCT03052517|19993630|P3|Overall Study|Non-Compliance With Study Treatment|0
5798214|NCT03052517|19993631|P2|Overall Study|Non-Compliance With Study Treatment|2
5798215|NCT03052517|19993632|P1|Overall Study|Non-Compliance With Study Treatment|0
5798216|NCT03052517|19993630|P3|Overall Study|Pregnancy|1
5798217|NCT03052517|19993631|P2|Overall Study|Pregnancy|0
5798218|NCT03052517|19993632|P1|Overall Study|Pregnancy|1
5798219|NCT03052517|19993630|P3|Overall Study|Lost to Follow-up|0
5798220|NCT03052517|19993631|P2|Overall Study|Lost to Follow-up|4
5798221|NCT03052517|19993632|P1|Overall Study|Lost to Follow-up|2
5798222|NCT03052517|19993630|P3|Overall Study|Death|1
5798223|NCT03052517|19993631|P2|Overall Study|Death|0
5798224|NCT03052517|19993632|P1|Overall Study|Death|3
5798225|NCT03052517|19993630|P3|Overall Study|Physician Decision|1
5798226|NCT03052517|19993631|P2|Overall Study|Physician Decision|5
5798227|NCT03052517|19993632|P1|Overall Study|Physician Decision|4
5798228|NCT03052517|19993630|P3|Overall Study|Adverse Event|0
5798229|NCT03052517|19993631|P2|Overall Study|Adverse Event|5
5798230|NCT03052517|19993632|P1|Overall Study|Adverse Event|6
5798231|NCT03052517|19993630|P3|Overall Study|Lack of Efficacy|7
5798232|NCT03052517|19993631|P2|Overall Study|Lack of Efficacy|14
5798233|NCT03052517|19993632|P1|Overall Study|Lack of Efficacy|23
5798234|NCT03052517|19993630|P3|Overall Study|Subject/Guardian Decision|22
5798235|NCT03052517|19993631|P2|Overall Study|Subject/Guardian Decision|45
5798236|NCT03052517|19993632|P1|Overall Study|Subject/Guardian Decision|50
5798237|NCT03052517|19993630|P3|Overall Study|Study Terminated By Sponsor|296
5798238|NCT03052517|19993631|P2|Overall Study|Study Terminated By Sponsor|938
5798239|NCT03052517|19993632|P1|Overall Study|Study Terminated By Sponsor|928
5798240|NCT03052426|19993676|P3|Overall Study|Lost to Follow-up|1
5798241|NCT03052426|19993677|P2|Overall Study|Lost to Follow-up|0
5798242|NCT03052426|19993678|P1|Overall Study|Lost to Follow-up|2
5798243|NCT03052426|19993676|P3|Overall Study|Withdrawal by Subject|0
5798244|NCT03052426|19993677|P2|Overall Study|Withdrawal by Subject|1
5798245|NCT03052426|19993678|P1|Overall Study|Withdrawal by Subject|0
5798246|NCT03052322|19993693|P2|Overall Study|Adverse Event|13
5798247|NCT03052322|19993694|P1|Overall Study|Adverse Event|6
5798248|NCT03052322|19993693|P2|Overall Study|Lost to Follow-up|4
5798249|NCT03052322|19993694|P1|Overall Study|Lost to Follow-up|2
5798250|NCT03052322|19993693|P2|Overall Study|Protocol Violation|0
5798251|NCT03052322|19993694|P1|Overall Study|Protocol Violation|1
5798252|NCT03052322|19993693|P2|Overall Study|Lack of Efficacy|2
5798253|NCT03052322|19993694|P1|Overall Study|Lack of Efficacy|1
5798254|NCT03052322|19993693|P2|Overall Study|Death|2
5798255|NCT03052322|19993694|P1|Overall Study|Death|0
5798256|NCT03052322|19993693|P2|Overall Study|Withdrawal by Subject|9
5798257|NCT03052322|19993694|P1|Overall Study|Withdrawal by Subject|10
5798258|NCT03052322|19993693|P2|Overall Study|Other un-specified|2
5798259|NCT03052322|19993694|P1|Overall Study|Other un-specified|1
5798260|NCT03051607|19993777|P1|Overall Study|Adverse Event|66
5798261|NCT03051217|19993787|P7|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0
5798262|NCT03051217|19993788|P6|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|1
5798263|NCT03051217|19993789|P5|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0
5798264|NCT03051217|19993790|P4|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0
5798265|NCT03051217|19993791|P3|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0
5798266|NCT03051217|19993792|P2|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0
5798267|NCT03051217|19993793|P1|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0
5798268|NCT03051217|19993787|P7|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0
5798269|NCT03051217|19993788|P6|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0
5798270|NCT03051217|19993789|P5|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|1
5798271|NCT03051217|19993790|P4|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0
5798272|NCT03051217|19993791|P3|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0
5798273|NCT03051217|19993792|P2|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0
5798274|NCT03051217|19993793|P1|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0
5798351|NCT03049748|19994227|P2|Overall Study|Lost to Follow-up|0
5798275|NCT03051217|19993787|P7|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0
5798276|NCT03051217|19993788|P6|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0
5798277|NCT03051217|19993789|P5|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0
5798278|NCT03051217|19993790|P4|Maintenance Period (Week 16 to Week 52)|Protocol Violation|1
5798279|NCT03051217|19993791|P3|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0
5798280|NCT03051217|19993792|P2|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0
5798281|NCT03051217|19993793|P1|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0
5798282|NCT03051217|19993787|P7|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0
5798283|NCT03051217|19993788|P6|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0
5798284|NCT03051217|19993789|P5|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0
5798285|NCT03051217|19993790|P4|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|1
5798286|NCT03051217|19993791|P3|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0
5798287|NCT03051217|19993792|P2|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0
5798288|NCT03051217|19993793|P1|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0
5798289|NCT03051217|19993787|P7|Maintenance Period (Week 16 to Week 52)|Adverse Event|1
5798290|NCT03051217|19993788|P6|Maintenance Period (Week 16 to Week 52)|Adverse Event|1
5798291|NCT03051217|19993789|P5|Maintenance Period (Week 16 to Week 52)|Adverse Event|2
5798292|NCT03051217|19993790|P4|Maintenance Period (Week 16 to Week 52)|Adverse Event|1
5798293|NCT03051217|19993791|P3|Maintenance Period (Week 16 to Week 52)|Adverse Event|0
5798294|NCT03051217|19993792|P2|Maintenance Period (Week 16 to Week 52)|Adverse Event|0
5798295|NCT03051217|19993793|P1|Maintenance Period (Week 16 to Week 52)|Adverse Event|0
5798296|NCT03051217|19993787|P7|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
5798297|NCT03051217|19993788|P6|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
5798298|NCT03051217|19993789|P5|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
5798299|NCT03051217|19993790|P4|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
5798300|NCT03051217|19993791|P3|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1
5798301|NCT03051217|19993792|P2|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1
5798302|NCT03051217|19993793|P1|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1
5798303|NCT03051217|19993787|P7|Initial Period (Week 0 to Week 16)|Protocol Violation|0
5798304|NCT03051217|19993788|P6|Initial Period (Week 0 to Week 16)|Protocol Violation|0
5798305|NCT03051217|19993789|P5|Initial Period (Week 0 to Week 16)|Protocol Violation|0
5798306|NCT03051217|19993790|P4|Initial Period (Week 0 to Week 16)|Protocol Violation|0
5798307|NCT03051217|19993791|P3|Initial Period (Week 0 to Week 16)|Protocol Violation|0
5798308|NCT03051217|19993792|P2|Initial Period (Week 0 to Week 16)|Protocol Violation|1
5798309|NCT03051217|19993793|P1|Initial Period (Week 0 to Week 16)|Protocol Violation|0
5798310|NCT03051217|19993787|P7|Initial Period (Week 0 to Week 16)|Adverse Event|0
5798311|NCT03051217|19993788|P6|Initial Period (Week 0 to Week 16)|Adverse Event|0
5798312|NCT03051217|19993789|P5|Initial Period (Week 0 to Week 16)|Adverse Event|0
5798313|NCT03051217|19993790|P4|Initial Period (Week 0 to Week 16)|Adverse Event|0
5798314|NCT03051217|19993791|P3|Initial Period (Week 0 to Week 16)|Adverse Event|1
5798315|NCT03051217|19993792|P2|Initial Period (Week 0 to Week 16)|Adverse Event|0
5798316|NCT03051217|19993793|P1|Initial Period (Week 0 to Week 16)|Adverse Event|2
5798317|NCT03051165|19993822|P1|Overall Study|Early termination of study|12
5798318|NCT03051165|19993822|P1|Overall Study|Withdrawal by Subject|1
5798319|NCT03051100|19993836|P2|Overall Study|Withdrawal by Subject|0
5798320|NCT03051100|19993837|P1|Overall Study|Withdrawal by Subject|1
5798321|NCT03050398|19994087|P1|Overall Study|Study terminated by sponsor|8
5798322|NCT03050372|19994092|P2|Second Intervention (Nights #4 and #5)|Lost to Follow-up|1
5798323|NCT03050372|19994093|P1|Second Intervention (Nights #4 and #5)|Lost to Follow-up|0
5798324|NCT03050372|19994092|P2|Adaptation Night (Night #1 PSG)|Adverse Event|0
5798325|NCT03050372|19994093|P1|Adaptation Night (Night #1 PSG)|Adverse Event|1
5798326|NCT03050359|19994116|P2|Overall Study|Reason Not Specified|0
5798327|NCT03050359|19994117|P1|Overall Study|Reason Not Specified|1
5798328|NCT03050359|19994116|P2|Overall Study|Pregnancy|0
5798329|NCT03050359|19994117|P1|Overall Study|Pregnancy|1
5798330|NCT03050359|19994116|P2|Overall Study|Voluntary Withdrawal|6
5798331|NCT03050359|19994117|P1|Overall Study|Voluntary Withdrawal|4
5798332|NCT03050359|19994116|P2|Overall Study|Lost to Follow-up|1
5798333|NCT03050359|19994117|P1|Overall Study|Lost to Follow-up|2
5798334|NCT03050359|19994116|P2|Overall Study|Significant Protocol Deviation|3
5798335|NCT03050359|19994117|P1|Overall Study|Significant Protocol Deviation|2
5798336|NCT03050359|19994116|P2|Overall Study|Pretreatment Event/Adverse Event|10
5798337|NCT03050359|19994117|P1|Overall Study|Pretreatment Event/Adverse Event|5
5798338|NCT03050359|19994116|P2|Overall Study|Randomized But Not Treated|0
5798339|NCT03050359|19994117|P1|Overall Study|Randomized But Not Treated|2
5798340|NCT03049852|19994213|P3|Overall Study|Lost to Follow-up|0
5798341|NCT03049852|19994214|P2|Overall Study|Lost to Follow-up|1
5798342|NCT03049852|19994215|P1|Overall Study|Lost to Follow-up|0
5798343|NCT03049748|19994227|P2|Overall Study|Moved out of state (relocation)|1
5798344|NCT03049748|19994228|P1|Overall Study|Moved out of state (relocation)|0
5798345|NCT03049748|19994227|P2|Overall Study|Protocol Violation|2
5798346|NCT03049748|19994228|P1|Overall Study|Protocol Violation|0
5798347|NCT03049748|19994227|P2|Overall Study|Withdrawal by Subject|3
5798348|NCT03049748|19994228|P1|Overall Study|Withdrawal by Subject|0
5798349|NCT03049748|19994227|P2|Overall Study|Death|0
5798350|NCT03049748|19994228|P1|Overall Study|Death|3
5798352|NCT03049748|19994228|P1|Overall Study|Lost to Follow-up|1
5798353|NCT03049488|19994269|P6|Overall Study|Withdrawal by Subject|0
5798354|NCT03049488|19994270|P5|Overall Study|Withdrawal by Subject|1
5798355|NCT03049488|19994271|P4|Overall Study|Withdrawal by Subject|1
5798356|NCT03049488|19994272|P3|Overall Study|Withdrawal by Subject|0
5798357|NCT03049488|19994273|P2|Overall Study|Withdrawal by Subject|0
5798358|NCT03049488|19994274|P1|Overall Study|Withdrawal by Subject|0
5798359|NCT03049488|19994269|P6|Overall Study|Physician Decision|0
5798360|NCT03049488|19994270|P5|Overall Study|Physician Decision|0
5798361|NCT03049488|19994271|P4|Overall Study|Physician Decision|0
5798362|NCT03049488|19994272|P3|Overall Study|Physician Decision|0
5798363|NCT03049488|19994273|P2|Overall Study|Physician Decision|1
5798364|NCT03049488|19994274|P1|Overall Study|Physician Decision|0
5798365|NCT03049488|19994269|P6|Overall Study|Moved from Area|0
5798366|NCT03049488|19994270|P5|Overall Study|Moved from Area|1
5798367|NCT03049488|19994271|P4|Overall Study|Moved from Area|1
5798368|NCT03049488|19994272|P3|Overall Study|Moved from Area|0
5798369|NCT03049488|19994273|P2|Overall Study|Moved from Area|0
5798370|NCT03049488|19994274|P1|Overall Study|Moved from Area|1
5798371|NCT03049488|19994269|P6|Overall Study|Lost to Follow-up|0
5798372|NCT03049488|19994270|P5|Overall Study|Lost to Follow-up|0
5798373|NCT03049488|19994271|P4|Overall Study|Lost to Follow-up|0
5798374|NCT03049488|19994272|P3|Overall Study|Lost to Follow-up|0
5798375|NCT03049488|19994273|P2|Overall Study|Lost to Follow-up|1
5798376|NCT03049488|19994274|P1|Overall Study|Lost to Follow-up|1
5798377|NCT03049280|19994357|P1|Overall Study|Physician Decision|1
5798378|NCT03048747|19994363|P1|Overall Study|Physician Decision|1
5798379|NCT03048747|19994363|P1|Overall Study|Participant Met Withdrawal Criteria|2
5798380|NCT03048747|19994363|P1|Overall Study|Adverse Event|2
5798381|NCT03048500|19994368|P1|Follow up for 3 Years|Death|12
5798382|NCT03048500|19994368|P1|Follow up for 3 Years|Currently in Follow-up|4
5798383|NCT03048500|19994368|P1|Reached 1st Response/Continued Treatment|Physician decision, Patient PS declining|1
5798384|NCT03048500|19994368|P1|Reached 1st Response/Continued Treatment|Withdrawal by Subject|1
5798385|NCT03048500|19994368|P1|Reached 1st Response/Continued Treatment|Death|1
5798386|NCT03048500|19994368|P1|Reached 1st Response/Continued Treatment|Progressive Disease|4
5798387|NCT03048500|19994368|P1|2 Cycles of Treatment|Withdrawal by Subject|1
5798388|NCT03048058|19994391|P2|Overall Study|Withdrawal by Subject|4
5798389|NCT03048058|19994392|P1|Overall Study|Withdrawal by Subject|0
5798390|NCT03048058|19994391|P2|Overall Study|Lost to Follow-up|0
5798391|NCT03048058|19994392|P1|Overall Study|Lost to Follow-up|4
5798392|NCT03047720|19994418|P2|First Intervention (6weeks)|Participant data entry insufficient|0
5798393|NCT03047720|19994419|P1|First Intervention (6weeks)|Participant data entry insufficient|7
5798394|NCT03047551|19994433|P2|Overall Study|Ineligible|1
5798395|NCT03047551|19994434|P1|Overall Study|Ineligible|0
5798396|NCT03047551|19994433|P2|Overall Study|Probe malfunction|1
5798397|NCT03047551|19994434|P1|Overall Study|Probe malfunction|0
5798398|NCT03047551|19994433|P2|Overall Study|Withdrawal by Subject|1
5798399|NCT03047551|19994434|P1|Overall Study|Withdrawal by Subject|0
5798400|NCT03047551|19994433|P2|Overall Study|Physician Decision|0
5798401|NCT03047551|19994434|P1|Overall Study|Physician Decision|1
5798402|NCT03047551|19994433|P2|Overall Study|Did not receive TAS|0
5798403|NCT03047551|19994434|P1|Overall Study|Did not receive TAS|1
5798404|NCT03046446|19994511|P1|Overall Study|Non OA related knee surgery|1
5798405|NCT03046446|19994511|P1|Overall Study|Disease Progression (see caveats)|25
5798406|NCT03046446|19994511|P1|Overall Study|Withdrawn by Investigator/Sponsor|3
5798407|NCT03046446|19994511|P1|Overall Study|Withdrawal by Subject|14
5798408|NCT03046446|19994511|P1|Overall Study|Lost to Follow-up|3
5798409|NCT03046446|19994511|P1|Overall Study|Adverse Event|6
5798410|NCT03046446|19994511|P1|Overall Study|Lack of Efficacy|7
5798411|NCT03045887|19994574|P10|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0
5798412|NCT03045887|19994575|P9|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0
5798413|NCT03045887|19994576|P8|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0
5798414|NCT03045887|19994577|P7|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0
5798415|NCT03045887|19994578|P6|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0
5798416|NCT03045887|19994579|P5|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0
5798417|NCT03045887|19994580|P4|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|1
5798418|NCT03045887|19994581|P3|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0
5798419|NCT03045887|19994582|P2|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0
5798420|NCT03045887|19994583|P1|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0
5798421|NCT03045887|19994574|P10|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0
5798422|NCT03045887|19994575|P9|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0
5798423|NCT03045887|19994576|P8|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0
5798424|NCT03045887|19994577|P7|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0
5798425|NCT03045887|19994578|P6|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0
5798426|NCT03045887|19994579|P5|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0
5798427|NCT03045887|19994580|P4|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1
5798428|NCT03045887|19994581|P3|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1
5798429|NCT03045887|19994582|P2|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0
5798430|NCT03045887|19994583|P1|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0
5798431|NCT03045887|19994574|P10|Part A, Period 2 (1 Day)|Adverse Event|0
5798432|NCT03045887|19994575|P9|Part A, Period 2 (1 Day)|Adverse Event|0
5798433|NCT03045887|19994576|P8|Part A, Period 2 (1 Day)|Adverse Event|0
5798434|NCT03045887|19994577|P7|Part A, Period 2 (1 Day)|Adverse Event|0
5798435|NCT03045887|19994578|P6|Part A, Period 2 (1 Day)|Adverse Event|0
5798436|NCT03045887|19994579|P5|Part A, Period 2 (1 Day)|Adverse Event|0
5798437|NCT03045887|19994580|P4|Part A, Period 2 (1 Day)|Adverse Event|0
5798438|NCT03045887|19994581|P3|Part A, Period 2 (1 Day)|Adverse Event|0
5798439|NCT03045887|19994582|P2|Part A, Period 2 (1 Day)|Adverse Event|0
5798440|NCT03045887|19994583|P1|Part A, Period 2 (1 Day)|Adverse Event|1
5798441|NCT03045887|19994574|P10|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0
5798442|NCT03045887|19994575|P9|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0
5798443|NCT03045887|19994576|P8|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0
5798444|NCT03045887|19994577|P7|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0
5798445|NCT03045887|19994578|P6|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0
5798446|NCT03045887|19994579|P5|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0
5798447|NCT03045887|19994580|P4|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|1
5798448|NCT03045887|19994581|P3|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0
5798449|NCT03045887|19994582|P2|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0
5798450|NCT03045887|19994583|P1|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0
5798451|NCT03045887|19994574|P10|Part A,Washout Period 1(4 Weeks)|Physician Decision|0
5798452|NCT03045887|19994575|P9|Part A,Washout Period 1(4 Weeks)|Physician Decision|0
5798453|NCT03045887|19994576|P8|Part A,Washout Period 1(4 Weeks)|Physician Decision|0
5798454|NCT03045887|19994577|P7|Part A,Washout Period 1(4 Weeks)|Physician Decision|0
5798455|NCT03045887|19994578|P6|Part A,Washout Period 1(4 Weeks)|Physician Decision|0
5798456|NCT03045887|19994579|P5|Part A,Washout Period 1(4 Weeks)|Physician Decision|0
5798457|NCT03045887|19994580|P4|Part A,Washout Period 1(4 Weeks)|Physician Decision|0
5798458|NCT03045887|19994581|P3|Part A,Washout Period 1(4 Weeks)|Physician Decision|0
5798459|NCT03045887|19994582|P2|Part A,Washout Period 1(4 Weeks)|Physician Decision|0
5798460|NCT03045887|19994583|P1|Part A,Washout Period 1(4 Weeks)|Physician Decision|3
5798461|NCT03045302|19994865|P1|Overall Study|Pre-treatment adverse event|1
5798462|NCT03045081|19994871|P2|Overall Study|Withdrawal by Subject|11
5798463|NCT03045081|19994872|P1|Overall Study|Withdrawal by Subject|6
5798464|NCT03044886|19994891|P3|Overall Study|Lost to Follow-up|12
5798465|NCT03044886|19994892|P2|Overall Study|Lost to Follow-up|10
5798466|NCT03044886|19994893|P1|Overall Study|Lost to Follow-up|15
5798467|NCT03044730|19994934|P1|On Follow-up for 2 Years|Death|17
5798468|NCT03044730|19994934|P1|On Follow-up for 2 Years|Lost to Follow-up|1
5798469|NCT03044730|19994934|P1|On Follow-up for 2 Years|Still in follow-up|7
5798470|NCT03044730|19994934|P1|Cycles 4 and Beyond|Adverse Event|1
5798471|NCT03044730|19994934|P1|Cycles 4 and Beyond|Progressive Disease|9
5798472|NCT03044730|19994934|P1|3 Cycles of Pembro + Capecitab|Adverse Event|1
5798473|NCT03044730|19994934|P1|3 Cycles of Pembro + Capecitab|Death|1
5798474|NCT03044730|19994934|P1|3 Cycles of Pembro + Capecitab|Patient non-compliant with capecitabine|1
5798475|NCT03044730|19994934|P1|3 Cycles of Pembro + Capecitab|Progressive Disease|1
5798478|NCT03044431|19994981|P1|Overall Study|Lost to Follow-up|59
5798479|NCT03044353|19994994|P3|Overall Study|Adverse Event|0
5798480|NCT03044353|19994995|P2|Overall Study|Adverse Event|1
5798481|NCT03044353|19994996|P1|Overall Study|Adverse Event|0
5798482|NCT03044197|19995079|P2|Overall Study|Withdrawal by Subject|1
5798483|NCT03044197|19995080|P1|Overall Study|Withdrawal by Subject|3
5798484|NCT03044106|19995090|P2|Washout (1 Week)|Withdrawal by Subject|2
5798485|NCT03044106|19995091|P1|Washout (1 Week)|Withdrawal by Subject|0
5798486|NCT03043651|19995163|P1|Overall Study|Study Terminated by Sponsor|39
5798487|NCT03043651|19995163|P1|Overall Study|Withdrawal by Subject|4
5798488|NCT03043651|19995163|P1|Overall Study|Adverse Event|2
5798489|NCT03043651|19995163|P1|Overall Study|Progressive Disease|2
5798490|NCT03043651|19995163|P1|Overall Study|Death|1
5798491|NCT03043560|19995175|P2|Overall Study|Lost to Follow-up|1
5798492|NCT03043560|19995176|P1|Overall Study|Lost to Follow-up|0
5798493|NCT03043560|19995175|P2|Overall Study|Discontinued Intervention|2
5798494|NCT03043560|19995176|P1|Overall Study|Discontinued Intervention|1
5798495|NCT03043365|19995217|P2|Week 8 to Week 16 - Washout Period|Lost to Follow-up|0
5798496|NCT03043365|19995218|P1|Week 8 to Week 16 - Washout Period|Lost to Follow-up|1
5798497|NCT03043365|19995217|P2|Weeks 0 to Week 8|Lost to Follow-up|0
5798498|NCT03043365|19995218|P1|Weeks 0 to Week 8|Lost to Follow-up|2
5798499|NCT03043365|19995217|P2|Weeks 0 to Week 8|Adverse Event|3
5798500|NCT03043365|19995218|P1|Weeks 0 to Week 8|Adverse Event|1
5798501|NCT03042910|19995272|P1|Overall Study|Enrolled but not treated|1
5798502|NCT03042910|19995272|P1|Overall Study|Withdrawal by Subject|3
5798503|NCT03042910|19995272|P1|Overall Study|Disease Progression|2
5798504|NCT03042910|19995272|P1|Overall Study|Adverse Event|1
5798505|NCT03042767|19995303|P2|Overall Study|Lost to Follow-up|2
5798506|NCT03042767|19995304|P1|Overall Study|Lost to Follow-up|1
5798507|NCT03042559|19995345|P2|Overall Study|drop out|1
5798508|NCT03042559|19995346|P1|Overall Study|drop out|1
5798509|NCT03041792|19995481|P2|Overall Study|Randomized but not treated|1
5798510|NCT03041792|19995482|P1|Overall Study|Randomized but not treated|0
5798511|NCT03041792|19995481|P2|Overall Study|Death in the family|2
5798512|NCT03041792|19995482|P1|Overall Study|Death in the family|0
5798513|NCT03041792|19995481|P2|Overall Study|Adverse Event|0
5798514|NCT03041792|19995482|P1|Overall Study|Adverse Event|4
5798515|NCT03041181|19995555|P2|Overall Study|Disease Progression|2
5798516|NCT03041181|19995556|P1|Overall Study|Disease Progression|1
5798517|NCT03041116|19995572|P2|Open-label|Withdrawal by Subject|0
5798518|NCT03041116|19995573|P1|Open-label|Withdrawal by Subject|1
5798519|NCT03041116|19995572|P2|Open-label|Termination of the study by Sponsor|37
5798520|NCT03041116|19995573|P1|Open-label|Termination of the study by Sponsor|39
5798521|NCT03041116|19995572|P2|Open-label|Death|0
5798522|NCT03041116|19995573|P1|Open-label|Death|1
5798523|NCT03041116|19995572|P2|Double-blind|Withdrawal by Subject|4
5798524|NCT03041116|19995573|P1|Double-blind|Withdrawal by Subject|0
5798525|NCT03041116|19995572|P2|Double-blind|Death|2
5798526|NCT03041116|19995573|P1|Double-blind|Death|0
5798527|NCT03041090|19995589|P2|Overall Study|technical error|3
5798528|NCT03041090|19995590|P1|Overall Study|technical error|0
5798535|NCT03040713|19995642|P1|Overall Study|Positive amyloid scan|3
5798536|NCT03040687|19995650|P3|Overall Study|Withdrawal by Subject|0
5798537|NCT03040687|19995651|P2|Overall Study|Withdrawal by Subject|0
5798538|NCT03040687|19995652|P1|Overall Study|Withdrawal by Subject|1
5798539|NCT03040336|19995721|P2|Overall Study|Withdrawal by Subject|3
5798540|NCT03040336|19995722|P1|Overall Study|Withdrawal by Subject|2
5798541|NCT03040336|19995721|P2|Overall Study|Death|0
5798542|NCT03040336|19995722|P1|Overall Study|Death|1
5798543|NCT03039738|19995835|P2|Overall Study|Incomplete data sets|0
5798544|NCT03039738|19995836|P1|Overall Study|Incomplete data sets|54
5798545|NCT03039699|19995858|P2|Overall Study|Bacterial infection|28
5798546|NCT03039699|19995859|P1|Overall Study|Bacterial infection|12
5798547|NCT03039699|19995858|P2|Overall Study|Lack of data to assess study endpoint|3
5798548|NCT03039699|19995859|P1|Overall Study|Lack of data to assess study endpoint|5
5798549|NCT03039699|19995858|P2|Overall Study|Incorrect inclusion|4
5798550|NCT03039699|19995859|P1|Overall Study|Incorrect inclusion|5
5798551|NCT03039686|19995882|P3|Open Label Period|Withdrawal by Subject|1
5798552|NCT03039686|19995883|P2|Open Label Period|Withdrawal by Subject|3
5798553|NCT03039686|19995884|P1|Open Label Period|Withdrawal by Subject|0
5798554|NCT03039686|19995882|P3|Open Label Period|Subject Request to Discontinue Study Treatment|0
5798555|NCT03039686|19995883|P2|Open Label Period|Subject Request to Discontinue Study Treatment|1
5798556|NCT03039686|19995884|P1|Open Label Period|Subject Request to Discontinue Study Treatment|0
5798557|NCT03039686|19995882|P3|Open Label Period|Administrative Reason by Sponsor|41
5798558|NCT03039686|19995883|P2|Open Label Period|Administrative Reason by Sponsor|34
5798559|NCT03039686|19995884|P1|Open Label Period|Administrative Reason by Sponsor|0
5798560|NCT03039686|19995882|P3|Double-blind Period|Death|1
5798561|NCT03039686|19995883|P2|Double-blind Period|Death|0
5798562|NCT03039686|19995884|P1|Double-blind Period|Death|0
5798563|NCT03039686|19995882|P3|Double-blind Period|Withdrawal by Subject|1
5798564|NCT03039686|19995883|P2|Double-blind Period|Withdrawal by Subject|2
5798565|NCT03039686|19995884|P1|Double-blind Period|Withdrawal by Subject|2
5798566|NCT03039686|19995882|P3|Double-blind Period|Subject Request to Discontinue Study Treatment|0
5798567|NCT03039686|19995883|P2|Double-blind Period|Subject Request to Discontinue Study Treatment|2
5798568|NCT03039686|19995884|P1|Double-blind Period|Subject Request to Discontinue Study Treatment|1
5798569|NCT03039686|19995882|P3|Double-blind Period|Administrative Reason by Sponsor|21
5798570|NCT03039686|19995883|P2|Double-blind Period|Administrative Reason by Sponsor|25
5798571|NCT03039686|19995884|P1|Double-blind Period|Administrative Reason by Sponsor|24
5798572|NCT03039621|19995950|P2|Overall Study|Violation of non-inclusion criteria|2
5798573|NCT03039621|19995951|P1|Overall Study|Violation of non-inclusion criteria|1
5798574|NCT03039621|19995950|P2|Overall Study|Necessity to use drugs forbidden by pro|7
5798575|NCT03039621|19995951|P1|Overall Study|Necessity to use drugs forbidden by pro|4
5798576|NCT03039621|19995950|P2|Overall Study|Non-compliance with protocol requirement|5
5798577|NCT03039621|19995951|P1|Overall Study|Non-compliance with protocol requirement|4
5798578|NCT03039621|19995950|P2|Overall Study|Violation of inclusion criteria|2
5798579|NCT03039621|19995951|P1|Overall Study|Violation of inclusion criteria|3
5798580|NCT03039569|19995975|P2|Overall Study|Lost to Follow-up|4
5798581|NCT03039569|19995976|P1|Overall Study|Lost to Follow-up|5
5798582|NCT03039283|19996021|P1|Overall Study|Protocol Violation|2
5798583|NCT03039192|19996032|P2|Overall Study|Other|2
5798584|NCT03039192|19996033|P1|Overall Study|Other|3
5798585|NCT03039192|19996032|P2|Overall Study|Discontinued from treatment phase|12
5798586|NCT03039192|19996033|P1|Overall Study|Discontinued from treatment phase|19
5798587|NCT03039192|19996032|P2|Overall Study|Withdrawal by Subject|9
5798588|NCT03039192|19996033|P1|Overall Study|Withdrawal by Subject|6
5798589|NCT03039192|19996032|P2|Overall Study|Adverse event, non-fatal|2
5798590|NCT03039192|19996033|P1|Overall Study|Adverse event, non-fatal|0
5798591|NCT03039192|19996032|P2|Overall Study|Adverse event, serious fatal|1
5798592|NCT03039192|19996033|P1|Overall Study|Adverse event, serious fatal|0
5798593|NCT03039192|19996032|P2|Overall Study|Lost to Follow-up|4
5798594|NCT03039192|19996033|P1|Overall Study|Lost to Follow-up|4
5798595|NCT03038880|19996106|P3|Overall Study|Physician Decision|0
5798596|NCT03038880|19996107|P2|Overall Study|Physician Decision|1
5798597|NCT03038880|19996108|P1|Overall Study|Physician Decision|2
5798598|NCT03038880|19996106|P3|Overall Study|Death|0
5798599|NCT03038880|19996107|P2|Overall Study|Death|2
5798600|NCT03038880|19996108|P1|Overall Study|Death|1
5798601|NCT03038126|19996301|P2|Overall Study|Too Ill to Participate|2
5798602|NCT03038126|19996302|P1|Overall Study|Too Ill to Participate|1
5798603|NCT03038126|19996301|P2|Overall Study|Long Term Hospitalization|0
5798604|NCT03038126|19996302|P1|Overall Study|Long Term Hospitalization|2
5798605|NCT03038126|19996301|P2|Overall Study|Lost to Follow-up|1
5798606|NCT03038126|19996302|P1|Overall Study|Lost to Follow-up|0
5798607|NCT03038126|19996301|P2|Overall Study|Withdrawal by Subject|0
5798608|NCT03038126|19996302|P1|Overall Study|Withdrawal by Subject|5
5798609|NCT03038126|19996301|P2|Overall Study|Death|1
5798610|NCT03038126|19996302|P1|Overall Study|Death|1
5798611|NCT03038113|19996326|P14|Overall Study|Lost to Follow-up|0
5798612|NCT03038113|19996327|P13|Overall Study|Lost to Follow-up|0
5798613|NCT03038113|19996328|P12|Overall Study|Lost to Follow-up|0
5798614|NCT03038113|19996329|P11|Overall Study|Lost to Follow-up|0
5798615|NCT03038113|19996330|P10|Overall Study|Lost to Follow-up|0
5798616|NCT03038113|19996331|P9|Overall Study|Lost to Follow-up|0
5798617|NCT03038113|19996332|P8|Overall Study|Lost to Follow-up|0
5798618|NCT03038113|19996333|P7|Overall Study|Lost to Follow-up|1
5798619|NCT03038113|19996334|P6|Overall Study|Lost to Follow-up|0
5798620|NCT03038113|19996335|P5|Overall Study|Lost to Follow-up|0
5798621|NCT03038113|19996336|P4|Overall Study|Lost to Follow-up|0
5798622|NCT03038113|19996337|P3|Overall Study|Lost to Follow-up|0
5798623|NCT03038113|19996338|P2|Overall Study|Lost to Follow-up|0
5798624|NCT03038113|19996339|P1|Overall Study|Lost to Follow-up|0
5798625|NCT03038113|19996326|P14|Overall Study|Withdrawal by Subject|1
5798626|NCT03038113|19996327|P13|Overall Study|Withdrawal by Subject|0
5798627|NCT03038113|19996328|P12|Overall Study|Withdrawal by Subject|0
5798628|NCT03038113|19996329|P11|Overall Study|Withdrawal by Subject|0
5798629|NCT03038113|19996330|P10|Overall Study|Withdrawal by Subject|0
5798630|NCT03038113|19996331|P9|Overall Study|Withdrawal by Subject|0
5798631|NCT03038113|19996332|P8|Overall Study|Withdrawal by Subject|0
5798632|NCT03038113|19996333|P7|Overall Study|Withdrawal by Subject|0
5798633|NCT03038113|19996334|P6|Overall Study|Withdrawal by Subject|0
5798634|NCT03038113|19996335|P5|Overall Study|Withdrawal by Subject|0
5798635|NCT03038113|19996336|P4|Overall Study|Withdrawal by Subject|0
5798636|NCT03038113|19996337|P3|Overall Study|Withdrawal by Subject|1
5798637|NCT03038113|19996338|P2|Overall Study|Withdrawal by Subject|0
5798638|NCT03038113|19996339|P1|Overall Study|Withdrawal by Subject|0
5798639|NCT03037619|19996580|P2|Overall Study|Lost to Follow-up|1
5798640|NCT03037619|19996581|P1|Overall Study|Lost to Follow-up|0
5798641|NCT03037580|19996595|P2|Overall Study|Death|1
5798642|NCT03037580|19996596|P1|Overall Study|Death|0
5798643|NCT03037580|19996595|P2|Overall Study|Study Terminated by Sponsor|15
5798644|NCT03037580|19996596|P1|Overall Study|Study Terminated by Sponsor|12
5798645|NCT03037580|19996595|P2|Overall Study|Adverse Event|0
5798646|NCT03037580|19996596|P1|Overall Study|Adverse Event|1
5798647|NCT03037580|19996595|P2|Overall Study|Withdrawal by Subject|0
5798648|NCT03037580|19996596|P1|Overall Study|Withdrawal by Subject|3
5798649|NCT03037489|19996621|P2|Overall Study|Withdrawal by Subject|0
5798650|NCT03037489|19996622|P1|Overall Study|Withdrawal by Subject|3
5798651|NCT03037489|19996621|P2|Overall Study|Adverse Event|0
5798652|NCT03037489|19996622|P1|Overall Study|Adverse Event|4
5798653|NCT03037307|19996628|P6|Period 1|Did Not Meet Study Criteria|0
5798654|NCT03037307|19996629|P5|Period 1|Did Not Meet Study Criteria|0
5798655|NCT03037307|19996630|P4|Period 1|Did Not Meet Study Criteria|1
5798656|NCT03037307|19996631|P3|Period 1|Did Not Meet Study Criteria|0
5798657|NCT03037307|19996632|P2|Period 1|Did Not Meet Study Criteria|0
5798658|NCT03037307|19996633|P1|Period 1|Did Not Meet Study Criteria|0
5798659|NCT03036852|19996693|P1|Overall Study|Lost to Follow-up|1
5798660|NCT03036852|19996693|P1|Overall Study|Adverse Event|1
5798661|NCT03036852|19996693|P1|Overall Study|Lack of Efficacy|2
5798662|NCT03036852|19996693|P1|Overall Study|Death|2
5798663|NCT03036839|19996750|P3|Overall Study|Withdrew Consent|1
5798664|NCT03036839|19996751|P2|Overall Study|Withdrew Consent|0
5798665|NCT03036839|19996752|P1|Overall Study|Withdrew Consent|0
5798666|NCT03036839|19996750|P3|Overall Study|Death|3
5798667|NCT03036839|19996751|P2|Overall Study|Death|0
5798668|NCT03036839|19996752|P1|Overall Study|Death|3
5798669|NCT03036839|19996750|P3|Overall Study|Adverse Event|1
5798670|NCT03036839|19996751|P2|Overall Study|Adverse Event|0
5798671|NCT03036839|19996752|P1|Overall Study|Adverse Event|0
5798672|NCT03036813|19996805|P3|Overall Study|Other|5
5798673|NCT03036813|19996806|P2|Overall Study|Other|3
5798674|NCT03036813|19996807|P1|Overall Study|Other|0
5798675|NCT03036813|19996805|P3|Overall Study|Pregnancy|1
5798676|NCT03036813|19996806|P2|Overall Study|Pregnancy|0
5798677|NCT03036813|19996807|P1|Overall Study|Pregnancy|0
5798678|NCT03036813|19996805|P3|Overall Study|Non-Compliance|3
5798679|NCT03036813|19996806|P2|Overall Study|Non-Compliance|5
5798680|NCT03036813|19996807|P1|Overall Study|Non-Compliance|1
5798681|NCT03036813|19996805|P3|Overall Study|Physician Decision|1
5798682|NCT03036813|19996806|P2|Overall Study|Physician Decision|1
5798683|NCT03036813|19996807|P1|Overall Study|Physician Decision|2
5798684|NCT03036813|19996805|P3|Overall Study|Lost to Follow-up|0
5798685|NCT03036813|19996806|P2|Overall Study|Lost to Follow-up|1
5798686|NCT03036813|19996807|P1|Overall Study|Lost to Follow-up|1
5798687|NCT03036813|19996805|P3|Overall Study|Withdrawal by Subject|10
5798688|NCT03036813|19996806|P2|Overall Study|Withdrawal by Subject|6
5798689|NCT03036813|19996807|P1|Overall Study|Withdrawal by Subject|12
5798690|NCT03036813|19996805|P3|Overall Study|Adverse Event|6
5798691|NCT03036813|19996806|P2|Overall Study|Adverse Event|11
5798692|NCT03036813|19996807|P1|Overall Study|Adverse Event|6
5798693|NCT03036124|19997039|P2|Overall Study|Withdrawal by Subject|4
5798694|NCT03036124|19997040|P1|Overall Study|Withdrawal by Subject|5
5798695|NCT03036124|19997039|P2|Overall Study|Lost to Follow-up|2
5798696|NCT03036124|19997040|P1|Overall Study|Lost to Follow-up|0
5798697|NCT03036072|19997058|P2|Overall Study|Physician Decision|1
5798698|NCT03036072|19997059|P1|Overall Study|Physician Decision|0
5798699|NCT03036072|19997058|P2|Overall Study|Withdrawal by Subject|1
5798700|NCT03036072|19997059|P1|Overall Study|Withdrawal by Subject|0
5798701|NCT03036072|19997058|P2|Overall Study|Death|1
5798702|NCT03036072|19997059|P1|Overall Study|Death|0
5798703|NCT03035942|19997079|P3|Overall Study|Adverse Event|5
5798704|NCT03035942|19997080|P2|Overall Study|Adverse Event|4
5798705|NCT03035942|19997081|P1|Overall Study|Adverse Event|8
5798706|NCT03035916|19997110|P3|Overall Study|Puncture failed|0
5798707|NCT03035916|19997111|P2|Overall Study|Puncture failed|2
5798708|NCT03035916|19997112|P1|Overall Study|Puncture failed|0
5798709|NCT03035864|19997161|P2|Follow-up Period|Other|2
5798710|NCT03035864|19997162|P1|Follow-up Period|Other|3
5798711|NCT03035864|19997161|P2|Follow-up Period|Physician Decision|0
5798712|NCT03035864|19997162|P1|Follow-up Period|Physician Decision|1
5798713|NCT03035864|19997161|P2|Follow-up Period|Lost to Follow-up|2
5798714|NCT03035864|19997162|P1|Follow-up Period|Lost to Follow-up|6
5798715|NCT03035864|19997161|P2|Follow-up Period|Adverse Event|0
5798716|NCT03035864|19997162|P1|Follow-up Period|Adverse Event|1
5798717|NCT03035864|19997161|P2|Treatment Period|Other|1
5798718|NCT03035864|19997162|P1|Treatment Period|Other|3
5798719|NCT03035864|19997161|P2|Treatment Period|Adverse Event|0
5798720|NCT03035864|19997162|P1|Treatment Period|Adverse Event|1
5798721|NCT03035032|19997236|P1|Overall Study|Physician Decision|5
5798722|NCT03035032|19997236|P1|Overall Study|Withdrawal by Subject|2
5798723|NCT03035032|19997236|P1|Overall Study|Protocol Violation|2
5798724|NCT03035032|19997236|P1|Overall Study|Progressive Disease|22
5798725|NCT03035032|19997236|P1|Overall Study|Lost to Follow-up|1
5798726|NCT03035032|19997236|P1|Overall Study|Death|9
5798727|NCT03035032|19997236|P1|Overall Study|Adverse Event|2
5798728|NCT03034967|19997257|P6|Overall Study|Adverse Event, Serious Fatal|1
5798729|NCT03034967|19997258|P5|Overall Study|Adverse Event, Serious Fatal|1
5798730|NCT03034967|19997259|P4|Overall Study|Adverse Event, Serious Fatal|2
5798731|NCT03034967|19997260|P3|Overall Study|Adverse Event, Serious Fatal|1
5798732|NCT03034967|19997261|P2|Overall Study|Adverse Event, Serious Fatal|1
5798733|NCT03034967|19997262|P1|Overall Study|Adverse Event, Serious Fatal|0
5798734|NCT03034967|19997257|P6|Overall Study|Adverse Event, non-fatal|8
5798735|NCT03034967|19997258|P5|Overall Study|Adverse Event, non-fatal|2
5798736|NCT03034967|19997259|P4|Overall Study|Adverse Event, non-fatal|0
5798737|NCT03034967|19997260|P3|Overall Study|Adverse Event, non-fatal|2
5798738|NCT03034967|19997261|P2|Overall Study|Adverse Event, non-fatal|1
5798739|NCT03034967|19997262|P1|Overall Study|Adverse Event, non-fatal|3
5798740|NCT03034967|19997257|P6|Overall Study|Lack of Efficacy|0
5798741|NCT03034967|19997258|P5|Overall Study|Lack of Efficacy|1
5798742|NCT03034967|19997259|P4|Overall Study|Lack of Efficacy|1
5798743|NCT03034967|19997260|P3|Overall Study|Lack of Efficacy|2
5798744|NCT03034967|19997261|P2|Overall Study|Lack of Efficacy|1
5798745|NCT03034967|19997262|P1|Overall Study|Lack of Efficacy|0
5798746|NCT03034967|19997257|P6|Overall Study|Protocol Violation|2
5798747|NCT03034967|19997258|P5|Overall Study|Protocol Violation|0
5798748|NCT03034967|19997259|P4|Overall Study|Protocol Violation|0
5798749|NCT03034967|19997260|P3|Overall Study|Protocol Violation|0
5798750|NCT03034967|19997261|P2|Overall Study|Protocol Violation|0
5798751|NCT03034967|19997262|P1|Overall Study|Protocol Violation|1
5798752|NCT03034967|19997257|P6|Overall Study|Liver function test abnormality|0
5798753|NCT03034967|19997258|P5|Overall Study|Liver function test abnormality|0
5798754|NCT03034967|19997259|P4|Overall Study|Liver function test abnormality|0
5798755|NCT03034967|19997260|P3|Overall Study|Liver function test abnormality|1
5798756|NCT03034967|19997261|P2|Overall Study|Liver function test abnormality|0
5798757|NCT03034967|19997262|P1|Overall Study|Liver function test abnormality|0
5798758|NCT03034967|19997257|P6|Overall Study|Lost to Follow-up|2
5798759|NCT03034967|19997258|P5|Overall Study|Lost to Follow-up|0
5798760|NCT03034967|19997259|P4|Overall Study|Lost to Follow-up|1
5798761|NCT03034967|19997260|P3|Overall Study|Lost to Follow-up|0
5798762|NCT03034967|19997261|P2|Overall Study|Lost to Follow-up|0
5798763|NCT03034967|19997262|P1|Overall Study|Lost to Follow-up|0
5798764|NCT03034967|19997257|P6|Overall Study|Physician Decision|0
5798765|NCT03034967|19997258|P5|Overall Study|Physician Decision|1
5798766|NCT03034967|19997259|P4|Overall Study|Physician Decision|1
5798767|NCT03034967|19997260|P3|Overall Study|Physician Decision|1
5798768|NCT03034967|19997261|P2|Overall Study|Physician Decision|0
5798769|NCT03034967|19997262|P1|Overall Study|Physician Decision|1
5798770|NCT03034967|19997257|P6|Overall Study|Withdrawal by Subject|2
5798771|NCT03034967|19997258|P5|Overall Study|Withdrawal by Subject|9
5798772|NCT03034967|19997259|P4|Overall Study|Withdrawal by Subject|6
5798773|NCT03034967|19997260|P3|Overall Study|Withdrawal by Subject|6
5798774|NCT03034967|19997261|P2|Overall Study|Withdrawal by Subject|2
5798775|NCT03034967|19997262|P1|Overall Study|Withdrawal by Subject|9
5798776|NCT03034954|19997460|P2|Overall Study|Machine malfunction; did not reach 3 mA|0
5798777|NCT03034954|19997461|P1|Overall Study|Machine malfunction; did not reach 3 mA|1
5798778|NCT03034915|19997528|P3|Overall Study|Physician Decision|2
5798779|NCT03034915|19997529|P2|Overall Study|Physician Decision|5
5798780|NCT03034915|19997530|P1|Overall Study|Physician Decision|1
5798781|NCT03034915|19997528|P3|Overall Study|Protocol-defined withdrawal criteria met|29
5798782|NCT03034915|19997529|P2|Overall Study|Protocol-defined withdrawal criteria met|26
5798783|NCT03034915|19997530|P1|Overall Study|Protocol-defined withdrawal criteria met|19
5798784|NCT03034915|19997528|P3|Overall Study|Site closed|4
5798785|NCT03034915|19997529|P2|Overall Study|Site closed|2
5798786|NCT03034915|19997530|P1|Overall Study|Site closed|2
5798787|NCT03034915|19997528|P3|Overall Study|Lack of Efficacy|18
5798788|NCT03034915|19997529|P2|Overall Study|Lack of Efficacy|16
5798789|NCT03034915|19997530|P1|Overall Study|Lack of Efficacy|8
5798790|NCT03034915|19997528|P3|Overall Study|Protocol Deviation|7
5798791|NCT03034915|19997529|P2|Overall Study|Protocol Deviation|14
5798792|NCT03034915|19997530|P1|Overall Study|Protocol Deviation|2
5798793|NCT03034915|19997528|P3|Overall Study|Withdrawal by Subject|41
5798794|NCT03034915|19997529|P2|Overall Study|Withdrawal by Subject|46
5798795|NCT03034915|19997530|P1|Overall Study|Withdrawal by Subject|29
5798796|NCT03034915|19997528|P3|Overall Study|Lost to Follow-up|3
5798797|NCT03034915|19997529|P2|Overall Study|Lost to Follow-up|13
5798798|NCT03034915|19997530|P1|Overall Study|Lost to Follow-up|5
5798799|NCT03034915|19997528|P3|Overall Study|Adverse Event|22
5798800|NCT03034915|19997529|P2|Overall Study|Adverse Event|32
5798801|NCT03034915|19997530|P1|Overall Study|Adverse Event|29
5798802|NCT03034772|19997570|P2|Overall Study|Withdrawal by Subject|1
5798803|NCT03034772|19997571|P1|Overall Study|Withdrawal by Subject|0
5798804|NCT03034772|19997570|P2|Overall Study|Adverse Event|1
5798805|NCT03034772|19997571|P1|Overall Study|Adverse Event|0
5798806|NCT03034577|19997587|P2|Overall Study|Lost to Follow-up|26
5798807|NCT03034577|19997588|P1|Overall Study|Lost to Follow-up|25
5798808|NCT03034577|19997587|P2|Overall Study|Withdrawal by Subject|9
5798809|NCT03034577|19997588|P1|Overall Study|Withdrawal by Subject|6
5798810|NCT03034460|19997606|P2|Overall Study|Personal Reasons|0
5798811|NCT03034460|19997607|P1|Overall Study|Personal Reasons|1
5798812|NCT03034460|19997606|P2|Overall Study|Withdrawal by Subject|2
5798813|NCT03034460|19997607|P1|Overall Study|Withdrawal by Subject|2
5798814|NCT03034460|19997606|P2|Overall Study|Adverse Event|1
5798815|NCT03034460|19997607|P1|Overall Study|Adverse Event|0
5798816|NCT03034057|19997649|P1|Overall Study|Medication error without associated AE|1
5798817|NCT03034057|19997649|P1|Overall Study|Adverse Event|22
5798818|NCT03034057|19997649|P1|Overall Study|Lost to Follow-up|19
5798819|NCT03034057|19997649|P1|Overall Study|Not defined|2
5798820|NCT03034057|19997649|P1|Overall Study|Protocol Violation|1
5798821|NCT03034057|19997649|P1|Overall Study|Withdrawal by Subject|10
5798822|NCT03034044|19997655|P1|Overall Study|Enrolled, but not received Xyntha|1
5798823|NCT03033784|19997677|P13|Overall Study|Withdrawal by Subject|2
5798824|NCT03033784|19997678|P12|Overall Study|Withdrawal by Subject|0
5798825|NCT03033784|19997679|P11|Overall Study|Withdrawal by Subject|0
5798826|NCT03033784|19997680|P10|Overall Study|Withdrawal by Subject|0
5798827|NCT03033784|19997681|P9|Overall Study|Withdrawal by Subject|0
5798828|NCT03033784|19997682|P8|Overall Study|Withdrawal by Subject|0
5798829|NCT03033784|19997683|P7|Overall Study|Withdrawal by Subject|0
5798830|NCT03033784|19997684|P6|Overall Study|Withdrawal by Subject|0
5798831|NCT03033784|19997685|P5|Overall Study|Withdrawal by Subject|0
5798832|NCT03033784|19997686|P4|Overall Study|Withdrawal by Subject|0
5798833|NCT03033784|19997687|P3|Overall Study|Withdrawal by Subject|0
5798834|NCT03033784|19997688|P2|Overall Study|Withdrawal by Subject|0
5798835|NCT03033784|19997689|P1|Overall Study|Withdrawal by Subject|0
5798836|NCT03033784|19997677|P13|Overall Study|Anxiety related to MRI scanner|0
5798837|NCT03033784|19997678|P12|Overall Study|Anxiety related to MRI scanner|0
5798838|NCT03033784|19997679|P11|Overall Study|Anxiety related to MRI scanner|0
5798839|NCT03033784|19997680|P10|Overall Study|Anxiety related to MRI scanner|0
5798840|NCT03033784|19997681|P9|Overall Study|Anxiety related to MRI scanner|0
5798841|NCT03033784|19997682|P8|Overall Study|Anxiety related to MRI scanner|0
5798842|NCT03033784|19997683|P7|Overall Study|Anxiety related to MRI scanner|0
5798843|NCT03033784|19997684|P6|Overall Study|Anxiety related to MRI scanner|0
5798844|NCT03033784|19997685|P5|Overall Study|Anxiety related to MRI scanner|0
5798845|NCT03033784|19997686|P4|Overall Study|Anxiety related to MRI scanner|0
5798846|NCT03033784|19997687|P3|Overall Study|Anxiety related to MRI scanner|0
5798847|NCT03033784|19997688|P2|Overall Study|Anxiety related to MRI scanner|1
5798848|NCT03033784|19997689|P1|Overall Study|Anxiety related to MRI scanner|0
5798849|NCT03033745|19997730|P3|Overall Study|Withdrawal by Subject|0
5798850|NCT03033745|19997731|P2|Overall Study|Withdrawal by Subject|1
5798851|NCT03033745|19997732|P1|Overall Study|Withdrawal by Subject|0
5798852|NCT03033745|19997730|P3|Overall Study|Adverse Event|1
5798853|NCT03033745|19997731|P2|Overall Study|Adverse Event|0
5798854|NCT03033745|19997732|P1|Overall Study|Adverse Event|1
5798855|NCT03033745|19997730|P3|Overall Study|Protocol Violation|1
5798856|NCT03033745|19997731|P2|Overall Study|Protocol Violation|0
5798857|NCT03033745|19997732|P1|Overall Study|Protocol Violation|0
5798858|NCT03032523|19997828|P2|Overall Study|Physician Decision|0
5798859|NCT03032523|19997829|P1|Overall Study|Physician Decision|1
5798860|NCT03032523|19997828|P2|Overall Study|Withdrawal by Subject|2
5798861|NCT03032523|19997829|P1|Overall Study|Withdrawal by Subject|2
5798862|NCT03032510|19997841|P2|Overall Study|Physician Decision|0
5798863|NCT03032510|19997842|P1|Overall Study|Physician Decision|2
5798864|NCT03032510|19997841|P2|Overall Study|Subject noncompliance|2
5798865|NCT03032510|19997842|P1|Overall Study|Subject noncompliance|4
5798866|NCT03032510|19997841|P2|Overall Study|Withdrawal by Subject|7
5798867|NCT03032510|19997842|P1|Overall Study|Withdrawal by Subject|8
5798868|NCT03032510|19997841|P2|Overall Study|Lost to Follow-up|7
5798869|NCT03032510|19997842|P1|Overall Study|Lost to Follow-up|8
5798870|NCT03032510|19997841|P2|Overall Study|Adverse Event|2
5798871|NCT03032510|19997842|P1|Overall Study|Adverse Event|5
5798872|NCT03032380|19997863|P2|Overall Study|Other - Miscellaneous|1
5798873|NCT03032380|19997864|P1|Overall Study|Other - Miscellaneous|0
5798874|NCT03032380|19997863|P2|Overall Study|Death|34
5798875|NCT03032380|19997864|P1|Overall Study|Death|39
5798876|NCT03032380|19997863|P2|Overall Study|Recovery|1
5798877|NCT03032380|19997864|P1|Overall Study|Recovery|0
5798878|NCT03032380|19997863|P2|Overall Study|Withdrawal by Subject|3
5798879|NCT03032380|19997864|P1|Overall Study|Withdrawal by Subject|2
5798880|NCT03032380|19997863|P2|Overall Study|Lack of Efficacy|0
5798881|NCT03032380|19997864|P1|Overall Study|Lack of Efficacy|1
5798882|NCT03032380|19997863|P2|Overall Study|Adverse Event|1
5798883|NCT03032380|19997864|P1|Overall Study|Adverse Event|0
5798884|NCT03031899|19997911|P1|Overall Study|lesion disappeared after stopping habit|1
5798885|NCT03031899|19997911|P1|Overall Study|Protocol Violation|1
5798886|NCT03031678|19997928|P1|Overall Study|Study closed prior to completion|1
5798887|NCT03031496|19997937|P2|Period 1|Withdrawal by Subject|2
5798888|NCT03031496|19997938|P1|Period 1|Withdrawal by Subject|0
5798889|NCT03031496|19997937|P2|Period 1|Adverse Event|0
5798890|NCT03031496|19997938|P1|Period 1|Adverse Event|2
5798891|NCT03031431|19997974|P1|Overall Study|Infant removed by maternal request|1
5798892|NCT03030989|19998002|P2|Overall Study|No longer interested|3
5798893|NCT03030989|19998003|P1|Overall Study|No longer interested|5
5798894|NCT03030989|19998002|P2|Overall Study|Line Removed|2
5798895|NCT03030989|19998003|P1|Overall Study|Line Removed|0
5798896|NCT03030989|19998002|P2|Overall Study|Positive Blood Cultures|1
5798897|NCT03030989|19998003|P1|Overall Study|Positive Blood Cultures|2
5798898|NCT03030989|19998002|P2|Overall Study|Fatigue/Overwhelmed|5
5798899|NCT03030989|19998003|P1|Overall Study|Fatigue/Overwhelmed|1
5798900|NCT03030989|19998002|P2|Overall Study|Rash|1
5798901|NCT03030989|19998003|P1|Overall Study|Rash|2
5798902|NCT03030989|19998002|P2|Overall Study|Fever|2
5798903|NCT03030989|19998003|P1|Overall Study|Fever|2
5798904|NCT03030599|19998056|P3|Open-label Extension|Other Reason|0
5798905|NCT03030599|19998057|P2|Open-label Extension|Other Reason|0
5798906|NCT03030599|19998058|P1|Open-label Extension|Other Reason|1
5798907|NCT03030599|19998056|P3|Open-label Extension|Lack of Efficacy|0
5798908|NCT03030599|19998057|P2|Open-label Extension|Lack of Efficacy|0
5798909|NCT03030599|19998058|P1|Open-label Extension|Lack of Efficacy|1
5798910|NCT03030599|19998056|P3|Open-label Extension|Lost to Follow-up|0
5798911|NCT03030599|19998057|P2|Open-label Extension|Lost to Follow-up|0
5798912|NCT03030599|19998058|P1|Open-label Extension|Lost to Follow-up|2
5798913|NCT03030599|19998056|P3|Open-label Extension|Adverse Event|0
5798914|NCT03030599|19998057|P2|Open-label Extension|Adverse Event|0
5798915|NCT03030599|19998058|P1|Open-label Extension|Adverse Event|3
5798916|NCT03030599|19998056|P3|Double Blind Randomized Withdrawal|Withdrawal by Subject|1
5798917|NCT03030599|19998057|P2|Double Blind Randomized Withdrawal|Withdrawal by Subject|0
5798918|NCT03030599|19998058|P1|Double Blind Randomized Withdrawal|Withdrawal by Subject|0
5798919|NCT03030599|19998056|P3|Double Blind Randomized Withdrawal|Randomized in error|2
5798920|NCT03030599|19998057|P2|Double Blind Randomized Withdrawal|Randomized in error|0
5798921|NCT03030599|19998058|P1|Double Blind Randomized Withdrawal|Randomized in error|0
5798922|NCT03030599|19998056|P3|Double Blind Randomized Withdrawal|Adverse Event|3
5798923|NCT03030599|19998057|P2|Double Blind Randomized Withdrawal|Adverse Event|0
5798924|NCT03030599|19998058|P1|Double Blind Randomized Withdrawal|Adverse Event|0
5798925|NCT03030599|19998056|P3|Double Blind Randomized Withdrawal|Lack of Efficacy|2
5798926|NCT03030599|19998057|P2|Double Blind Randomized Withdrawal|Lack of Efficacy|0
5798927|NCT03030599|19998058|P1|Double Blind Randomized Withdrawal|Lack of Efficacy|0
5798928|NCT03030599|19998056|P3|Stable Dose|Lost to Follow-up|0
5798929|NCT03030599|19998057|P2|Stable Dose|Lost to Follow-up|0
5798930|NCT03030599|19998058|P1|Stable Dose|Lost to Follow-up|1
5798931|NCT03030599|19998056|P3|Stable Dose|Adverse Event|0
5798932|NCT03030599|19998057|P2|Stable Dose|Adverse Event|0
5798933|NCT03030599|19998058|P1|Stable Dose|Adverse Event|1
5798934|NCT03030599|19998056|P3|Stable Dose|Protocol deviation|0
5798935|NCT03030599|19998057|P2|Stable Dose|Protocol deviation|0
5798936|NCT03030599|19998058|P1|Stable Dose|Protocol deviation|3
5798937|NCT03030599|19998056|P3|Open Label Treatment and Titration|Lost to Follow-up|0
5798938|NCT03030599|19998057|P2|Open Label Treatment and Titration|Lost to Follow-up|0
5798939|NCT03030599|19998058|P1|Open Label Treatment and Titration|Lost to Follow-up|3
5798940|NCT03030599|19998056|P3|Open Label Treatment and Titration|Sponsor decision|0
5798941|NCT03030599|19998057|P2|Open Label Treatment and Titration|Sponsor decision|0
5798942|NCT03030599|19998058|P1|Open Label Treatment and Titration|Sponsor decision|2
5798943|NCT03030599|19998056|P3|Open Label Treatment and Titration|Withdrawal by Subject|0
5798944|NCT03030599|19998057|P2|Open Label Treatment and Titration|Withdrawal by Subject|0
5798945|NCT03030599|19998058|P1|Open Label Treatment and Titration|Withdrawal by Subject|6
5798946|NCT03030599|19998056|P3|Open Label Treatment and Titration|Adverse Event|0
5798947|NCT03030599|19998057|P2|Open Label Treatment and Titration|Adverse Event|0
5798948|NCT03030599|19998058|P1|Open Label Treatment and Titration|Adverse Event|18
5798949|NCT03030599|19998056|P3|Open Label Treatment and Titration|Non-Compliance with Study Drug|0
5798950|NCT03030599|19998057|P2|Open Label Treatment and Titration|Non-Compliance with Study Drug|0
5798951|NCT03030599|19998058|P1|Open Label Treatment and Titration|Non-Compliance with Study Drug|4
5798952|NCT03030599|19998056|P3|Open Label Treatment and Titration|Lack of Efficacy|0
5798953|NCT03030599|19998057|P2|Open Label Treatment and Titration|Lack of Efficacy|0
5798954|NCT03030599|19998058|P1|Open Label Treatment and Titration|Lack of Efficacy|1
5798955|NCT03030599|19998056|P3|Open Label Treatment and Titration|Physician Decision|0
5798956|NCT03030599|19998057|P2|Open Label Treatment and Titration|Physician Decision|0
5798957|NCT03030599|19998058|P1|Open Label Treatment and Titration|Physician Decision|3
5798958|NCT03030599|19998056|P3|Open Label Treatment and Titration|Other|0
5798959|NCT03030599|19998057|P2|Open Label Treatment and Titration|Other|0
5798960|NCT03030599|19998058|P1|Open Label Treatment and Titration|Other|1
5798961|NCT03030599|19998056|P3|Open Label Treatment and Titration|Protocol deviation|0
5798962|NCT03030599|19998057|P2|Open Label Treatment and Titration|Protocol deviation|0
5798963|NCT03030599|19998058|P1|Open Label Treatment and Titration|Protocol deviation|8
5798964|NCT03029832|19998091|P2|Overall Study|Study Terminated By Sponsor|1
5798965|NCT03029832|19998092|P1|Overall Study|Study Terminated By Sponsor|1
5798966|NCT03029832|19998091|P2|Overall Study|Death due to Disease Progression|0
5798967|NCT03029832|19998092|P1|Overall Study|Death due to Disease Progression|1
5798968|NCT03029832|19998091|P2|Overall Study|Safety Follow-Up Completed|0
5798969|NCT03029832|19998092|P1|Overall Study|Safety Follow-Up Completed|2
5798970|NCT03029819|19998122|P2|Overall Study|Removed due to disruptive behavior|1
5798971|NCT03029819|19998123|P1|Overall Study|Removed due to disruptive behavior|0
5798972|NCT03029819|19998122|P2|Overall Study|Lost to Follow-up|5
5798973|NCT03029819|19998123|P1|Overall Study|Lost to Follow-up|3
5798974|NCT03029780|19998137|P2|Overall Study|Adverse Event Unrelated to Study Drug|3
5798975|NCT03029780|19998138|P1|Overall Study|Adverse Event Unrelated to Study Drug|0
5798976|NCT03029780|19998137|P2|Overall Study|Study Drug Toxicity|5
5798977|NCT03029780|19998138|P1|Overall Study|Study Drug Toxicity|5
5798978|NCT03029780|19998137|P2|Overall Study|Disease Progression|3
5798979|NCT03029780|19998138|P1|Overall Study|Disease Progression|1
5798980|NCT03029650|19998161|P2|Washout (1 Week)|Physician Decision|1
5798981|NCT03029650|19998162|P1|Washout (1 Week)|Physician Decision|0
5798982|NCT03029650|19998161|P2|Washout (1 Week)|Withdrawal by Subject|1
5798983|NCT03029650|19998162|P1|Washout (1 Week)|Withdrawal by Subject|1
5798984|NCT03029624|19998177|P1|Overall Study|MRI need|2
5798985|NCT03029624|19998177|P1|Overall Study|Lack of Efficacy|1
5798986|NCT03029624|19998177|P1|Overall Study|Withdrawal by Subject|1
5798987|NCT03029624|19998177|P1|Overall Study|Adverse Event|1
5798988|NCT03029234|19998184|P1|Overall Study|Death|61
5798989|NCT03029234|19998184|P1|Overall Study|Withdrawal by Subject|5
5798990|NCT03029234|19998184|P1|Overall Study|Sponsor Decision|1
5798991|NCT03028870|19998307|P4|Overall Study|Administrative|4
5798992|NCT03028870|19998308|P3|Overall Study|Administrative|12
5798993|NCT03028870|19998309|P2|Overall Study|Administrative|5
5798994|NCT03028870|19998310|P1|Overall Study|Administrative|5
5798995|NCT03028870|19998307|P4|Overall Study|Lack of Efficacy|0
5798996|NCT03028870|19998308|P3|Overall Study|Lack of Efficacy|0
5798997|NCT03028870|19998309|P2|Overall Study|Lack of Efficacy|0
5798998|NCT03028870|19998310|P1|Overall Study|Lack of Efficacy|3
5798999|NCT03028870|19998307|P4|Overall Study|Lost to Follow-up|0
5799000|NCT03028870|19998308|P3|Overall Study|Lost to Follow-up|0
5799001|NCT03028870|19998309|P2|Overall Study|Lost to Follow-up|0
5799002|NCT03028870|19998310|P1|Overall Study|Lost to Follow-up|1
5799003|NCT03028870|19998307|P4|Overall Study|Withdrawal by Subject|2
5799004|NCT03028870|19998308|P3|Overall Study|Withdrawal by Subject|1
5799005|NCT03028870|19998309|P2|Overall Study|Withdrawal by Subject|1
5799006|NCT03028870|19998310|P1|Overall Study|Withdrawal by Subject|1
5799007|NCT03028870|19998307|P4|Overall Study|Adverse Event|3
5799008|NCT03028870|19998308|P3|Overall Study|Adverse Event|3
5799009|NCT03028870|19998309|P2|Overall Study|Adverse Event|4
5799010|NCT03028870|19998310|P1|Overall Study|Adverse Event|7
5799011|NCT03028142|19998515|P6|Overall Study|Withdrawal by Subject|0
5799012|NCT03028142|19998516|P5|Overall Study|Withdrawal by Subject|1
5799013|NCT03028142|19998517|P4|Overall Study|Withdrawal by Subject|0
5799014|NCT03028142|19998518|P3|Overall Study|Withdrawal by Subject|0
5799015|NCT03028142|19998519|P2|Overall Study|Withdrawal by Subject|0
5799016|NCT03028142|19998520|P1|Overall Study|Withdrawal by Subject|0
5799017|NCT03028142|19998515|P6|Overall Study|Adverse Event|1
5799018|NCT03028142|19998516|P5|Overall Study|Adverse Event|0
5799019|NCT03028142|19998517|P4|Overall Study|Adverse Event|0
5799020|NCT03028142|19998518|P3|Overall Study|Adverse Event|0
5799021|NCT03028142|19998519|P2|Overall Study|Adverse Event|1
5799022|NCT03028142|19998520|P1|Overall Study|Adverse Event|1
5799023|NCT03028129|19998539|P2|Overall Study|Withdrawal by Subject|45
5799024|NCT03028129|19998540|P1|Overall Study|Withdrawal by Subject|62
5799025|NCT03028129|19998539|P2|Overall Study|Protocol Violation|1
5799026|NCT03028129|19998540|P1|Overall Study|Protocol Violation|1
5799027|NCT03028129|19998539|P2|Overall Study|Physician Decision|1
5799028|NCT03028129|19998540|P1|Overall Study|Physician Decision|0
5799029|NCT03028129|19998539|P2|Overall Study|Lost to Follow-up|38
5799030|NCT03028129|19998540|P1|Overall Study|Lost to Follow-up|50
5799031|NCT03028129|19998539|P2|Overall Study|Adverse Event|2
5799032|NCT03028129|19998540|P1|Overall Study|Adverse Event|13
5799033|NCT03028012|19998560|P3|Overall Study|Lost to Follow-up|3
5799034|NCT03028012|19998561|P2|Overall Study|Lost to Follow-up|3
5799035|NCT03028012|19998562|P1|Overall Study|Lost to Follow-up|2
5799036|NCT03026530|19998676|P2|Overall Study|Protocol Violation|5
5799037|NCT03026530|19998677|P1|Overall Study|Protocol Violation|2
5799038|NCT03026530|19998676|P2|Overall Study|Lost to Follow-up|24
5799039|NCT03026530|19998677|P1|Overall Study|Lost to Follow-up|19
5799040|NCT03026283|19998685|P8|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0
5799041|NCT03026283|19998686|P7|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0
5799042|NCT03026283|19998687|P6|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|19
5799043|NCT03026283|19998688|P5|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|25
5799044|NCT03026283|19998689|P4|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0
5799045|NCT03026283|19998690|P3|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0
5799046|NCT03026283|19998691|P2|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0
5799047|NCT03026283|19998692|P1|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0
5799048|NCT03026283|19998685|P8|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0
5799049|NCT03026283|19998686|P7|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0
5799050|NCT03026283|19998687|P6|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0
5799051|NCT03026283|19998688|P5|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0
5799052|NCT03026283|19998689|P4|Optimal Care/Stress Test/ICA|Withdrawal by Subject|1
5799053|NCT03026283|19998690|P3|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0
5799054|NCT03026283|19998691|P2|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0
5799055|NCT03026283|19998692|P1|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0
5799056|NCT03026283|19998685|P8|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0
5799057|NCT03026283|19998686|P7|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0
5799058|NCT03026283|19998687|P6|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|7
5799059|NCT03026283|19998688|P5|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0
5799060|NCT03026283|19998689|P4|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|2
5799061|NCT03026283|19998690|P3|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0
5799062|NCT03026283|19998691|P2|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0
5799063|NCT03026283|19998692|P1|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0
5799064|NCT03026283|19998685|P8|Optimal Care/Stress Test/ICA|Lost to Follow-up|0
5799065|NCT03026283|19998686|P7|Optimal Care/Stress Test/ICA|Lost to Follow-up|0
5799066|NCT03026283|19998687|P6|Optimal Care/Stress Test/ICA|Lost to Follow-up|2
5799067|NCT03026283|19998688|P5|Optimal Care/Stress Test/ICA|Lost to Follow-up|2
5799068|NCT03026283|19998689|P4|Optimal Care/Stress Test/ICA|Lost to Follow-up|9
5799069|NCT03026283|19998690|P3|Optimal Care/Stress Test/ICA|Lost to Follow-up|0
5799070|NCT03026283|19998691|P2|Optimal Care/Stress Test/ICA|Lost to Follow-up|0
5799071|NCT03026283|19998692|P1|Optimal Care/Stress Test/ICA|Lost to Follow-up|0
5799072|NCT03026283|19998685|P8|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0
5799073|NCT03026283|19998686|P7|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0
5799074|NCT03026283|19998687|P6|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0
5799075|NCT03026283|19998688|P5|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|11
5799076|NCT03026283|19998689|P4|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|8
5799077|NCT03026283|19998690|P3|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0
5799078|NCT03026283|19998691|P2|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0
5799079|NCT03026283|19998692|P1|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0
5799080|NCT03026283|19998685|P8|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0
5799081|NCT03026283|19998686|P7|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0
5799082|NCT03026283|19998687|P6|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0
5799083|NCT03026283|19998688|P5|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0
5799084|NCT03026283|19998689|P4|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0
5799085|NCT03026283|19998690|P3|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|15
5799086|NCT03026283|19998691|P2|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0
5799087|NCT03026283|19998692|P1|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0
5799088|NCT03026283|19998685|P8|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0
5799089|NCT03026283|19998686|P7|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0
5799090|NCT03026283|19998687|P6|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0
5799091|NCT03026283|19998688|P5|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0
5799092|NCT03026283|19998689|P4|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0
5799093|NCT03026283|19998690|P3|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0
5799094|NCT03026283|19998691|P2|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|3
5799095|NCT03026283|19998692|P1|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0
5799096|NCT03026283|19998685|P8|CCTA Diagnosis|Withdrawal by Subject|0
5799097|NCT03026283|19998686|P7|CCTA Diagnosis|Withdrawal by Subject|0
5799098|NCT03026283|19998687|P6|CCTA Diagnosis|Withdrawal by Subject|0
5799099|NCT03026283|19998688|P5|CCTA Diagnosis|Withdrawal by Subject|0
5799100|NCT03026283|19998689|P4|CCTA Diagnosis|Withdrawal by Subject|0
5799101|NCT03026283|19998690|P3|CCTA Diagnosis|Withdrawal by Subject|0
5799102|NCT03026283|19998691|P2|CCTA Diagnosis|Withdrawal by Subject|0
5799103|NCT03026283|19998692|P1|CCTA Diagnosis|Withdrawal by Subject|5
5799104|NCT03026283|19998685|P8|CCTA Diagnosis|CCTA not performed as planned|0
5799105|NCT03026283|19998686|P7|CCTA Diagnosis|CCTA not performed as planned|0
5799106|NCT03026283|19998687|P6|CCTA Diagnosis|CCTA not performed as planned|0
5799107|NCT03026283|19998688|P5|CCTA Diagnosis|CCTA not performed as planned|0
5799108|NCT03026283|19998689|P4|CCTA Diagnosis|CCTA not performed as planned|0
5799109|NCT03026283|19998690|P3|CCTA Diagnosis|CCTA not performed as planned|0
5799110|NCT03026283|19998691|P2|CCTA Diagnosis|CCTA not performed as planned|0
5799111|NCT03026283|19998692|P1|CCTA Diagnosis|CCTA not performed as planned|9
5799112|NCT03026257|19998713|P6|Overall Study|Withdrawal by Subject|0
5799113|NCT03026257|19998714|P5|Overall Study|Withdrawal by Subject|0
5799114|NCT03026257|19998715|P4|Overall Study|Withdrawal by Subject|0
5799115|NCT03026257|19998716|P3|Overall Study|Withdrawal by Subject|0
5799116|NCT03026257|19998717|P2|Overall Study|Withdrawal by Subject|1
5799117|NCT03026257|19998718|P1|Overall Study|Withdrawal by Subject|1
5799118|NCT03026257|19998713|P6|Overall Study|Protocol Violation|0
5799119|NCT03026257|19998714|P5|Overall Study|Protocol Violation|1
5799120|NCT03026257|19998715|P4|Overall Study|Protocol Violation|1
5799121|NCT03026257|19998716|P3|Overall Study|Protocol Violation|0
5799122|NCT03026257|19998717|P2|Overall Study|Protocol Violation|0
5799123|NCT03026257|19998718|P1|Overall Study|Protocol Violation|1
5799124|NCT03026257|19998713|P6|Overall Study|Lost to Follow-up|0
5799125|NCT03026257|19998714|P5|Overall Study|Lost to Follow-up|0
5799126|NCT03026257|19998715|P4|Overall Study|Lost to Follow-up|0
5799127|NCT03026257|19998716|P3|Overall Study|Lost to Follow-up|0
5799128|NCT03026257|19998717|P2|Overall Study|Lost to Follow-up|0
5799129|NCT03026257|19998718|P1|Overall Study|Lost to Follow-up|1
5799130|NCT03026257|19998713|P6|Overall Study|Adverse Event|0
5799131|NCT03026257|19998714|P5|Overall Study|Adverse Event|0
5799132|NCT03026257|19998715|P4|Overall Study|Adverse Event|0
5799133|NCT03026257|19998716|P3|Overall Study|Adverse Event|0
5799134|NCT03026257|19998717|P2|Overall Study|Adverse Event|0
5799135|NCT03026257|19998718|P1|Overall Study|Adverse Event|3
5799136|NCT03026166|19998734|P2|Overall Study|Other|0
5799137|NCT03026166|19998735|P1|Overall Study|Other|1
5799138|NCT03026166|19998734|P2|Overall Study|Study Terminated by Sponsor|3
5799139|NCT03026166|19998735|P1|Overall Study|Study Terminated by Sponsor|3
5799140|NCT03026166|19998734|P2|Overall Study|Lost to Follow-up|0
5799141|NCT03026166|19998735|P1|Overall Study|Lost to Follow-up|1
5799142|NCT03026166|19998734|P2|Overall Study|Withdrawal by Subject|2
5799143|NCT03026166|19998735|P1|Overall Study|Withdrawal by Subject|1
5799144|NCT03026166|19998734|P2|Overall Study|Physician Decision|0
5799145|NCT03026166|19998735|P1|Overall Study|Physician Decision|2
5799146|NCT03026166|19998734|P2|Overall Study|Death|7
5799147|NCT03026166|19998735|P1|Overall Study|Death|22
5799148|NCT03026088|19998751|P1|Overall Study|Study termination|20
5799149|NCT03026075|19998775|P1|Overall Study|Physician Decision|1
5799150|NCT03025542|19998790|P2|Overall Study|Withdrawal by Subject|0
5799151|NCT03025542|19998791|P1|Overall Study|Withdrawal by Subject|1
5799152|NCT03025542|19998790|P2|Overall Study|Lost to Follow-up|0
5799153|NCT03025542|19998791|P1|Overall Study|Lost to Follow-up|1
5799154|NCT03025542|19998790|P2|Overall Study|Adverse Event|2
5799155|NCT03025542|19998791|P1|Overall Study|Adverse Event|0
5799156|NCT03025217|19998831|P1|Overall Study|Not eligible, poor English|2
5799157|NCT03025217|19998831|P1|Overall Study|Lost to Follow-up|1
5799158|NCT03025217|19998831|P1|Overall Study|Pregnancy|1
5799159|NCT03024970|19998836|P2|Second Intervention|Lost to Follow-up|0
5799160|NCT03024970|19998837|P1|Second Intervention|Lost to Follow-up|1
5799161|NCT03024970|19998836|P2|First Intervention|Adverse Event|0
5799162|NCT03024970|19998837|P1|First Intervention|Adverse Event|1
5799163|NCT03024606|19998915|P2|Overall Study|Withdrawal by Subject|10
5799164|NCT03024606|19998916|P1|Overall Study|Withdrawal by Subject|9
5799165|NCT03023878|19998944|P1|Long Term Follow-Up Period|Death|2
5799166|NCT03023878|19998944|P1|Treatment Period|Adverse Event|1
5799167|NCT03023878|19998944|P1|Treatment Period|Withdrawal by Subject|1
5799168|NCT03023878|19998944|P1|Treatment Period|Disease Progression|1
5799169|NCT03023878|19998944|P1|Between Run-In and Treatment Periods|Protocol-specified criteria|2
5799170|NCT03023878|19998944|P1|Pre-Study Run-In Period|Withdrawal by Subject|5
5799171|NCT03023878|19998944|P1|Pre-Study Run-In Period|Death|1
5799172|NCT03023878|19998944|P1|Pre-Study Run-In Period|Protocol-specified criteria|11
5799173|NCT03023722|19998957|P1|Overall Study|No follow-up assessment|4
5799174|NCT03023423|19999012|P3|Overall Study|Ongoing|24
5799175|NCT03023423|19999013|P2|Overall Study|Ongoing|32
5799176|NCT03023423|19999014|P1|Overall Study|Ongoing|2
5799177|NCT03023423|19999012|P3|Overall Study|Other|2
5799178|NCT03023423|19999013|P2|Overall Study|Other|2
5799179|NCT03023423|19999014|P1|Overall Study|Other|0
5799180|NCT03023423|19999012|P3|Overall Study|Death|20
5799181|NCT03023423|19999013|P2|Overall Study|Death|12
5799182|NCT03023423|19999014|P1|Overall Study|Death|5
5799183|NCT03023137|19999051|P2|Overall Study|Lost the baby in a car accident|0
5799184|NCT03023137|19999052|P1|Overall Study|Lost the baby in a car accident|1
5799185|NCT03023137|19999051|P2|Overall Study|Protocol Violation|4
5799186|NCT03023137|19999052|P1|Overall Study|Protocol Violation|0
5799187|NCT03023137|19999051|P2|Overall Study|Lost to Follow-up|1
5799188|NCT03023137|19999052|P1|Overall Study|Lost to Follow-up|1
5799189|NCT03023137|19999051|P2|Overall Study|Multiple pregnancy|4
5799190|NCT03023137|19999052|P1|Overall Study|Multiple pregnancy|2
5799191|NCT03022981|19999081|P3|Overall Study|Withdrew Assent By Parent/Guardian|1
5799192|NCT03022981|19999082|P2|Overall Study|Withdrew Assent By Parent/Guardian|0
5799193|NCT03022981|19999083|P1|Overall Study|Withdrew Assent By Parent/Guardian|0
5799194|NCT03022981|19999081|P3|Overall Study|Non-Compliance With Study Drug|2
5799195|NCT03022981|19999082|P2|Overall Study|Non-Compliance With Study Drug|0
5799196|NCT03022981|19999083|P1|Overall Study|Non-Compliance With Study Drug|0
5799197|NCT03022981|19999081|P3|Overall Study|Lost to Follow-up|1
5799198|NCT03022981|19999082|P2|Overall Study|Lost to Follow-up|2
5799199|NCT03022981|19999083|P1|Overall Study|Lost to Follow-up|6
5799200|NCT03022981|19999081|P3|Overall Study|Investigator's Discretion|2
5799201|NCT03022981|19999082|P2|Overall Study|Investigator's Discretion|1
5799202|NCT03022981|19999083|P1|Overall Study|Investigator's Discretion|0
5799203|NCT03022981|19999081|P3|Overall Study|Adverse Event|0
5799204|NCT03022981|19999082|P2|Overall Study|Adverse Event|1
5799205|NCT03022981|19999083|P1|Overall Study|Adverse Event|0
5799206|NCT03022799|19999182|P13|Overall Study|Adverse Event|0
5799207|NCT03022799|19999183|P12|Overall Study|Adverse Event|0
5799208|NCT03022799|19999184|P11|Overall Study|Adverse Event|1
5799209|NCT03022799|19999185|P10|Overall Study|Adverse Event|1
5799210|NCT03022799|19999186|P9|Overall Study|Adverse Event|0
5799211|NCT03022799|19999187|P8|Overall Study|Adverse Event|0
5799212|NCT03022799|19999188|P7|Overall Study|Adverse Event|0
5799213|NCT03022799|19999189|P6|Overall Study|Adverse Event|0
5799214|NCT03022799|19999190|P5|Overall Study|Adverse Event|0
5799215|NCT03022799|19999191|P4|Overall Study|Adverse Event|0
5799216|NCT03022799|19999192|P3|Overall Study|Adverse Event|0
5799217|NCT03022799|19999193|P2|Overall Study|Adverse Event|0
5799218|NCT03022799|19999194|P1|Overall Study|Adverse Event|0
5799219|NCT03022630|19999391|P2|Overall Study|Withdrawal by Subject|5
5799220|NCT03022630|19999392|P1|Overall Study|Withdrawal by Subject|0
5799221|NCT03022630|19999391|P2|Overall Study|Death|7
5799222|NCT03022630|19999392|P1|Overall Study|Death|9
5799223|NCT03022422|19999509|P6|Overall Study|3 subjects consented but not vaccinated|0
5799224|NCT03022422|19999510|P5|Overall Study|3 subjects consented but not vaccinated|0
5799225|NCT03022422|19999511|P4|Overall Study|3 subjects consented but not vaccinated|0
5799226|NCT03022422|19999512|P3|Overall Study|3 subjects consented but not vaccinated|3
5799227|NCT03022422|19999513|P2|Overall Study|3 subjects consented but not vaccinated|0
5799228|NCT03022422|19999514|P1|Overall Study|3 subjects consented but not vaccinated|0
5799229|NCT03022370|19999569|P2|Overall Study|Lost to Follow-up|109
5799230|NCT03022370|19999570|P1|Overall Study|Lost to Follow-up|174
5799231|NCT03022370|19999569|P2|Overall Study|Death|12
5799232|NCT03022370|19999570|P1|Overall Study|Death|6
5799233|NCT03022084|19999646|P2|Overall Study|Lost to Follow-up|3
5799234|NCT03022084|19999647|P1|Overall Study|Lost to Follow-up|2
5799235|NCT03022045|19999655|P2|Overall Study|Withdrawal by Subject|1
5799236|NCT03022045|19999656|P1|Overall Study|Withdrawal by Subject|1
5799237|NCT03022045|19999655|P2|Overall Study|Adverse Event|1
5799238|NCT03022045|19999656|P1|Overall Study|Adverse Event|0
5799239|NCT03021668|19999685|P2|Overall Study|Physician Decision|1
5799240|NCT03021668|19999686|P1|Overall Study|Physician Decision|0
5799241|NCT03021642|19999698|P2|Washout Period (21 Days)|Adverse Event|1
5799242|NCT03021642|19999699|P1|Washout Period (21 Days)|Adverse Event|1
5799243|NCT03021564|19999739|P2|Overall Study|Lost to Follow-up|2
5799244|NCT03021564|19999740|P1|Overall Study|Lost to Follow-up|0
5799245|NCT03021564|19999739|P2|Overall Study|Death|466
5799246|NCT03021564|19999740|P1|Overall Study|Death|84
5799247|NCT03021304|19999784|P1|Overall Study|Lack of Efficacy|1
5799248|NCT03021265|19999789|P1|Overall Study|No visit since the first visit|4
5799249|NCT03021265|19999789|P1|Overall Study|No reason given|2
5799250|NCT03021265|19999789|P1|Overall Study|Lost to Follow-up|67
5799251|NCT03021265|19999789|P1|Overall Study|Improved|17
5799252|NCT03021265|19999789|P1|Overall Study|Lack of Efficacy|3
5799253|NCT03021265|19999789|P1|Overall Study|Adverse Event|29
5799254|NCT03021187|19999799|P4|Overall Study|Lost to Follow-up|4
5799255|NCT03021187|19999800|P3|Overall Study|Lost to Follow-up|1
5799256|NCT03021187|19999801|P2|Overall Study|Lost to Follow-up|3
5799257|NCT03021187|19999802|P1|Overall Study|Lost to Follow-up|10
5799258|NCT03021187|19999799|P4|Overall Study|Withdrawal by Subject|5
5799259|NCT03021187|19999800|P3|Overall Study|Withdrawal by Subject|2
5799260|NCT03021187|19999801|P2|Overall Study|Withdrawal by Subject|6
5799261|NCT03021187|19999802|P1|Overall Study|Withdrawal by Subject|0
5799262|NCT03021187|19999799|P4|Overall Study|Death|0
5799263|NCT03021187|19999800|P3|Overall Study|Death|3
5799264|NCT03021187|19999801|P2|Overall Study|Death|0
5799265|NCT03021187|19999802|P1|Overall Study|Death|0
5799266|NCT03021018|19999958|P3|Overall Study|Fall with subsequent nasal fracture|0
5799267|NCT03021018|19999959|P2|Overall Study|Fall with subsequent nasal fracture|0
5799268|NCT03021018|19999960|P1|Overall Study|Fall with subsequent nasal fracture|1
5799269|NCT03021018|19999958|P3|Overall Study|Adverse Event|0
5799270|NCT03021018|19999959|P2|Overall Study|Adverse Event|0
5799271|NCT03021018|19999960|P1|Overall Study|Adverse Event|1
5799272|NCT03021005|19999991|P2|Overall Study|Lost to Follow-up|26
5799273|NCT03021005|19999992|P1|Overall Study|Lost to Follow-up|39
5799280|NCT03020745|20000052|P10|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0
5799281|NCT03020745|20000053|P9|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|2
5799282|NCT03020745|20000054|P8|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0
5799283|NCT03020745|20000055|P7|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0
5799284|NCT03020745|20000056|P6|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0
5799285|NCT03020745|20000057|P5|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0
5799286|NCT03020745|20000058|P4|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0
5799287|NCT03020745|20000059|P3|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0
5799288|NCT03020745|20000060|P2|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0
5799289|NCT03020745|20000061|P1|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0
5799290|NCT03020745|20000052|P10|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0
5799291|NCT03020745|20000053|P9|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|1
5799292|NCT03020745|20000054|P8|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0
5799293|NCT03020745|20000055|P7|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0
5799294|NCT03020745|20000056|P6|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|1
5799295|NCT03020745|20000057|P5|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0
5799296|NCT03020745|20000058|P4|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0
5799297|NCT03020745|20000059|P3|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0
5799298|NCT03020745|20000060|P2|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0
5799299|NCT03020745|20000061|P1|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0
5799300|NCT03020745|20000052|P10|Part 2 (Up to 169 Days)|Withdrawal by Subject|0
5799301|NCT03020745|20000053|P9|Part 2 (Up to 169 Days)|Withdrawal by Subject|0
5799302|NCT03020745|20000054|P8|Part 2 (Up to 169 Days)|Withdrawal by Subject|1
5799303|NCT03020745|20000055|P7|Part 2 (Up to 169 Days)|Withdrawal by Subject|0
5799304|NCT03020745|20000056|P6|Part 2 (Up to 169 Days)|Withdrawal by Subject|0
5799305|NCT03020745|20000057|P5|Part 2 (Up to 169 Days)|Withdrawal by Subject|0
5799306|NCT03020745|20000058|P4|Part 2 (Up to 169 Days)|Withdrawal by Subject|0
5799307|NCT03020745|20000059|P3|Part 2 (Up to 169 Days)|Withdrawal by Subject|0
5799308|NCT03020745|20000060|P2|Part 2 (Up to 169 Days)|Withdrawal by Subject|0
5799309|NCT03020745|20000061|P1|Part 2 (Up to 169 Days)|Withdrawal by Subject|0
5799310|NCT03020745|20000052|P10|Part 2 (Up to 169 Days)|Adverse Event|0
5799311|NCT03020745|20000053|P9|Part 2 (Up to 169 Days)|Adverse Event|1
5799312|NCT03020745|20000054|P8|Part 2 (Up to 169 Days)|Adverse Event|0
5799313|NCT03020745|20000055|P7|Part 2 (Up to 169 Days)|Adverse Event|0
5799314|NCT03020745|20000056|P6|Part 2 (Up to 169 Days)|Adverse Event|0
5799315|NCT03020745|20000057|P5|Part 2 (Up to 169 Days)|Adverse Event|0
5799316|NCT03020745|20000058|P4|Part 2 (Up to 169 Days)|Adverse Event|0
5799317|NCT03020745|20000059|P3|Part 2 (Up to 169 Days)|Adverse Event|0
5799318|NCT03020745|20000060|P2|Part 2 (Up to 169 Days)|Adverse Event|0
5799319|NCT03020745|20000061|P1|Part 2 (Up to 169 Days)|Adverse Event|0
5799320|NCT03020576|20000422|P2|Overall Study|Withdrawal by Subject|2
5799321|NCT03020576|20000423|P1|Overall Study|Withdrawal by Subject|1
5799322|NCT03020160|20000514|P2|Overall Study|Continuing to receive emicizumab|41
5799323|NCT03020160|20000515|P1|Overall Study|Continuing to receive emicizumab|7
5799324|NCT03020069|20000574|P2|Overall Study|Lost to Follow-up|1
5799325|NCT03020069|20000575|P1|Overall Study|Lost to Follow-up|0
5799326|NCT03019627|20000621|P2|Overall Study|Other|2
5799327|NCT03019627|20000622|P1|Overall Study|Other|2
5799328|NCT03019627|20000621|P2|Overall Study|not compliance|2
5799329|NCT03019627|20000622|P1|Overall Study|not compliance|2
5799330|NCT03019627|20000621|P2|Overall Study|Lost to Follow-up|1
5799331|NCT03019627|20000622|P1|Overall Study|Lost to Follow-up|2
5799332|NCT03019627|20000621|P2|Overall Study|Unrelated to adverse event|3
5799333|NCT03019627|20000622|P1|Overall Study|Unrelated to adverse event|1
5799334|NCT03019627|20000621|P2|Overall Study|Adverse Event|0
5799335|NCT03019627|20000622|P1|Overall Study|Adverse Event|8
5799336|NCT03019549|20000638|P1|Period 2|Withdrawal by Subject|1
5799337|NCT03019549|20000638|P1|Period 2|Physician Decision|2
5799338|NCT03019549|20000638|P1|Period 2|Adverse Event|2
5799339|NCT03019549|20000638|P1|Washout|DId not meet genotype criteria|11
5799340|NCT03019458|20000651|P2|Overall Study|Death|1
5799341|NCT03019458|20000652|P1|Overall Study|Death|0
5799342|NCT03018938|20000666|P2|Overall Study|Not recorded|2
5799343|NCT03018938|20000667|P1|Overall Study|Not recorded|0
5799344|NCT03018938|20000666|P2|Overall Study|Screen failure-After randomization|2
5799345|NCT03018938|20000667|P1|Overall Study|Screen failure-After randomization|4
5799346|NCT03018938|20000666|P2|Overall Study|Sponsor Decision|1
5799347|NCT03018938|20000667|P1|Overall Study|Sponsor Decision|0
5799348|NCT03018938|20000666|P2|Overall Study|Physician Decision|2
5799349|NCT03018938|20000667|P1|Overall Study|Physician Decision|3
5799350|NCT03018938|20000666|P2|Overall Study|Withdrawal by Subject|45
5799351|NCT03018938|20000667|P1|Overall Study|Withdrawal by Subject|38
5799352|NCT03018938|20000666|P2|Overall Study|Lost to Follow-up|32
5799353|NCT03018938|20000667|P1|Overall Study|Lost to Follow-up|21
5799354|NCT03018938|20000666|P2|Overall Study|Death|1
5799355|NCT03018938|20000667|P1|Overall Study|Death|0
5799356|NCT03018691|20000706|P3|Overall Study|Withdrawal by parent/guardian|1
5799357|NCT03018691|20000707|P2|Overall Study|Withdrawal by parent/guardian|0
5799358|NCT03018691|20000708|P1|Overall Study|Withdrawal by parent/guardian|1
5799359|NCT03018691|20000706|P3|Overall Study|Withdrawal by Subject|1
5799360|NCT03018691|20000707|P2|Overall Study|Withdrawal by Subject|0
5799361|NCT03018691|20000708|P1|Overall Study|Withdrawal by Subject|0
5799362|NCT03018691|20000706|P3|Overall Study|Lack of Efficacy|1
5799363|NCT03018691|20000707|P2|Overall Study|Lack of Efficacy|0
5799364|NCT03018691|20000708|P1|Overall Study|Lack of Efficacy|0
5799365|NCT03018691|20000706|P3|Overall Study|Adverse Event|4
5799366|NCT03018691|20000707|P2|Overall Study|Adverse Event|1
5799367|NCT03018691|20000708|P1|Overall Study|Adverse Event|1
5799368|NCT03018340|20000744|P2|Overall Study|Not further specified|1
5799369|NCT03018340|20000745|P1|Overall Study|Not further specified|0
5799370|NCT03018340|20000744|P2|Overall Study|Protocol Violation|7
5799371|NCT03018340|20000745|P1|Overall Study|Protocol Violation|3
5799372|NCT03018340|20000744|P2|Overall Study|Lost to Follow-up|7
5799373|NCT03018340|20000745|P1|Overall Study|Lost to Follow-up|1
5799374|NCT03018340|20000744|P2|Overall Study|Non-compliance with study drug/procedure|4
5799375|NCT03018340|20000745|P1|Overall Study|Non-compliance with study drug/procedure|3
5799376|NCT03018340|20000744|P2|Overall Study|Lack of Efficacy|1
5799377|NCT03018340|20000745|P1|Overall Study|Lack of Efficacy|0
5799378|NCT03018340|20000744|P2|Overall Study|Withdrawal by Subject|8
5799379|NCT03018340|20000745|P1|Overall Study|Withdrawal by Subject|0
5799380|NCT03018340|20000744|P2|Overall Study|Adverse Event|2
5799381|NCT03018340|20000745|P1|Overall Study|Adverse Event|1
5799382|NCT03018106|20000804|P2|Overall Study|Lost to Follow-up|1
5799383|NCT03018106|20000805|P1|Overall Study|Lost to Follow-up|0
5799384|NCT03018028|20000818|P5|Overall Study|Withdrawal by Subject|0
5799385|NCT03018028|20000819|P4|Overall Study|Withdrawal by Subject|2
5799386|NCT03018028|20000820|P3|Overall Study|Withdrawal by Subject|1
5799387|NCT03018028|20000821|P2|Overall Study|Withdrawal by Subject|0
5799388|NCT03018028|20000822|P1|Overall Study|Withdrawal by Subject|3
5799389|NCT03017846|20001072|P1|Overall Study|Adverse Event|2
5799390|NCT03017846|20001072|P1|Overall Study|Lost to Follow-up|3
5799391|NCT03017612|20001080|P1|Overall Study|Adverse Event|2
5799392|NCT03017235|20001125|P2|Overall Study|Cancer, emergency, allergy, active UTI|2
5799393|NCT03017235|20001126|P1|Overall Study|Cancer, emergency, allergy, active UTI|4
5799394|NCT03017235|20001125|P2|Overall Study|Protocol Violation|1
5799395|NCT03017235|20001126|P1|Overall Study|Protocol Violation|2
5799396|NCT03017235|20001125|P2|Overall Study|Adverse Event|1
5799397|NCT03017235|20001126|P1|Overall Study|Adverse Event|0
5799398|NCT03017235|20001125|P2|Overall Study|Lost to Follow-up|7
5799399|NCT03017235|20001126|P1|Overall Study|Lost to Follow-up|2
5799400|NCT03017235|20001125|P2|Overall Study|Withdrawal by Subject|3
5799401|NCT03017235|20001126|P1|Overall Study|Withdrawal by Subject|4
5799402|NCT03016325|20001195|P8|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|4
5799403|NCT03016325|20001196|P7|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|3
5799404|NCT03016325|20001197|P6|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|5
5799405|NCT03016325|20001198|P5|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0
5799406|NCT03016325|20001199|P4|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0
5799407|NCT03016325|20001200|P3|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0
5799408|NCT03016325|20001201|P2|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0
5799409|NCT03016325|20001202|P1|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0
5799410|NCT03016325|20001195|P8|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0
5799411|NCT03016325|20001196|P7|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0
5799412|NCT03016325|20001197|P6|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0
5799413|NCT03016325|20001198|P5|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0
5799414|NCT03016325|20001199|P4|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0
5799415|NCT03016325|20001200|P3|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0
5799416|NCT03016325|20001201|P2|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|1
5799417|NCT03016325|20001202|P1|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0
5799418|NCT03016325|20001195|P8|182-Day Follow-Up Period|Vital status collected via EMR|0
5799419|NCT03016325|20001196|P7|182-Day Follow-Up Period|Vital status collected via EMR|0
5799420|NCT03016325|20001197|P6|182-Day Follow-Up Period|Vital status collected via EMR|0
5799421|NCT03016325|20001198|P5|182-Day Follow-Up Period|Vital status collected via EMR|0
5799422|NCT03016325|20001199|P4|182-Day Follow-Up Period|Vital status collected via EMR|1
5799423|NCT03016325|20001200|P3|182-Day Follow-Up Period|Vital status collected via EMR|0
5799424|NCT03016325|20001201|P2|182-Day Follow-Up Period|Vital status collected via EMR|0
5799425|NCT03016325|20001202|P1|182-Day Follow-Up Period|Vital status collected via EMR|0
5799426|NCT03016325|20001195|P8|182-Day Follow-Up Period|Alive, per civil unit|0
5799427|NCT03016325|20001196|P7|182-Day Follow-Up Period|Alive, per civil unit|0
5799428|NCT03016325|20001197|P6|182-Day Follow-Up Period|Alive, per civil unit|0
5799429|NCT03016325|20001198|P5|182-Day Follow-Up Period|Alive, per civil unit|1
5799430|NCT03016325|20001199|P4|182-Day Follow-Up Period|Alive, per civil unit|0
5799431|NCT03016325|20001200|P3|182-Day Follow-Up Period|Alive, per civil unit|0
5799432|NCT03016325|20001201|P2|182-Day Follow-Up Period|Alive, per civil unit|0
5799433|NCT03016325|20001202|P1|182-Day Follow-Up Period|Alive, per civil unit|0
5799434|NCT03016325|20001195|P8|182-Day Follow-Up Period|Alive, per Family doctor|0
5799435|NCT03016325|20001196|P7|182-Day Follow-Up Period|Alive, per Family doctor|0
5799436|NCT03016325|20001197|P6|182-Day Follow-Up Period|Alive, per Family doctor|0
5799437|NCT03016325|20001198|P5|182-Day Follow-Up Period|Alive, per Family doctor|1
5799438|NCT03016325|20001199|P4|182-Day Follow-Up Period|Alive, per Family doctor|0
5799439|NCT03016325|20001200|P3|182-Day Follow-Up Period|Alive, per Family doctor|0
5799440|NCT03016325|20001201|P2|182-Day Follow-Up Period|Alive, per Family doctor|0
5799441|NCT03016325|20001202|P1|182-Day Follow-Up Period|Alive, per Family doctor|0
5799442|NCT03016325|20001195|P8|182-Day Follow-Up Period|Participant withdrew consent|0
5799443|NCT03016325|20001196|P7|182-Day Follow-Up Period|Participant withdrew consent|1
5799444|NCT03016325|20001197|P6|182-Day Follow-Up Period|Participant withdrew consent|0
5799445|NCT03016325|20001198|P5|182-Day Follow-Up Period|Participant withdrew consent|1
5799446|NCT03016325|20001199|P4|182-Day Follow-Up Period|Participant withdrew consent|0
5799447|NCT03016325|20001200|P3|182-Day Follow-Up Period|Participant withdrew consent|0
5799448|NCT03016325|20001201|P2|182-Day Follow-Up Period|Participant withdrew consent|0
5799449|NCT03016325|20001202|P1|182-Day Follow-Up Period|Participant withdrew consent|0
5799450|NCT03016325|20001195|P8|182-Day Follow-Up Period|Alive, per national insurance system|0
5799451|NCT03016325|20001196|P7|182-Day Follow-Up Period|Alive, per national insurance system|0
5799452|NCT03016325|20001197|P6|182-Day Follow-Up Period|Alive, per national insurance system|0
5799453|NCT03016325|20001198|P5|182-Day Follow-Up Period|Alive, per national insurance system|0
5799454|NCT03016325|20001199|P4|182-Day Follow-Up Period|Alive, per national insurance system|0
5799455|NCT03016325|20001200|P3|182-Day Follow-Up Period|Alive, per national insurance system|0
5799456|NCT03016325|20001201|P2|182-Day Follow-Up Period|Alive, per national insurance system|0
5799457|NCT03016325|20001202|P1|182-Day Follow-Up Period|Alive, per national insurance system|1
5799458|NCT03016325|20001195|P8|182-Day Follow-Up Period|Death|1
5799459|NCT03016325|20001196|P7|182-Day Follow-Up Period|Death|0
5799460|NCT03016325|20001197|P6|182-Day Follow-Up Period|Death|0
5799461|NCT03016325|20001198|P5|182-Day Follow-Up Period|Death|9
5799462|NCT03016325|20001199|P4|182-Day Follow-Up Period|Death|12
5799463|NCT03016325|20001200|P3|182-Day Follow-Up Period|Death|11
5799464|NCT03016325|20001201|P2|182-Day Follow-Up Period|Death|3
5799465|NCT03016325|20001202|P1|182-Day Follow-Up Period|Death|3
5799466|NCT03016325|20001195|P8|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0
5799467|NCT03016325|20001196|P7|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0
5799468|NCT03016325|20001197|P6|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0
5799469|NCT03016325|20001198|P5|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0
5799470|NCT03016325|20001199|P4|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0
5799471|NCT03016325|20001200|P3|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0
5799472|NCT03016325|20001201|P2|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|1
5799473|NCT03016325|20001202|P1|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0
5799474|NCT03016325|20001195|P8|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0
5799475|NCT03016325|20001196|P7|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0
5799476|NCT03016325|20001197|P6|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0
5799477|NCT03016325|20001198|P5|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0
5799478|NCT03016325|20001199|P4|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0
5799479|NCT03016325|20001200|P3|32-Day Follow-Up Period|Family doctor OK'd participant, per call|1
5799480|NCT03016325|20001201|P2|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0
5799481|NCT03016325|20001202|P1|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0
5799482|NCT03016325|20001195|P8|32-Day Follow-Up Period|Participant withdrew consent|0
5799483|NCT03016325|20001196|P7|32-Day Follow-Up Period|Participant withdrew consent|1
5799484|NCT03016325|20001197|P6|32-Day Follow-Up Period|Participant withdrew consent|0
5799485|NCT03016325|20001198|P5|32-Day Follow-Up Period|Participant withdrew consent|2
5799486|NCT03016325|20001199|P4|32-Day Follow-Up Period|Participant withdrew consent|0
5799487|NCT03016325|20001200|P3|32-Day Follow-Up Period|Participant withdrew consent|0
5799488|NCT03016325|20001201|P2|32-Day Follow-Up Period|Participant withdrew consent|0
5799489|NCT03016325|20001202|P1|32-Day Follow-Up Period|Participant withdrew consent|0
5799490|NCT03016325|20001195|P8|32-Day Follow-Up Period|Participant refused to visit|0
5799491|NCT03016325|20001196|P7|32-Day Follow-Up Period|Participant refused to visit|0
5799492|NCT03016325|20001197|P6|32-Day Follow-Up Period|Participant refused to visit|0
5799493|NCT03016325|20001198|P5|32-Day Follow-Up Period|Participant refused to visit|2
5799494|NCT03016325|20001199|P4|32-Day Follow-Up Period|Participant refused to visit|0
5799495|NCT03016325|20001200|P3|32-Day Follow-Up Period|Participant refused to visit|2
5799496|NCT03016325|20001201|P2|32-Day Follow-Up Period|Participant refused to visit|1
5799497|NCT03016325|20001202|P1|32-Day Follow-Up Period|Participant refused to visit|0
5799498|NCT03016325|20001195|P8|32-Day Follow-Up Period|Poor/non-compliance|0
5799499|NCT03016325|20001196|P7|32-Day Follow-Up Period|Poor/non-compliance|0
5799500|NCT03016325|20001197|P6|32-Day Follow-Up Period|Poor/non-compliance|0
5799501|NCT03016325|20001198|P5|32-Day Follow-Up Period|Poor/non-compliance|1
5799502|NCT03016325|20001199|P4|32-Day Follow-Up Period|Poor/non-compliance|1
5799503|NCT03016325|20001200|P3|32-Day Follow-Up Period|Poor/non-compliance|0
5799504|NCT03016325|20001201|P2|32-Day Follow-Up Period|Poor/non-compliance|0
5799505|NCT03016325|20001202|P1|32-Day Follow-Up Period|Poor/non-compliance|1
5799506|NCT03016325|20001195|P8|32-Day Follow-Up Period|Lost to Follow-up|0
5799507|NCT03016325|20001196|P7|32-Day Follow-Up Period|Lost to Follow-up|0
5799508|NCT03016325|20001197|P6|32-Day Follow-Up Period|Lost to Follow-up|0
5799509|NCT03016325|20001198|P5|32-Day Follow-Up Period|Lost to Follow-up|0
5799510|NCT03016325|20001199|P4|32-Day Follow-Up Period|Lost to Follow-up|1
5799511|NCT03016325|20001200|P3|32-Day Follow-Up Period|Lost to Follow-up|1
5799512|NCT03016325|20001201|P2|32-Day Follow-Up Period|Lost to Follow-up|0
5799513|NCT03016325|20001202|P1|32-Day Follow-Up Period|Lost to Follow-up|1
5799514|NCT03016325|20001195|P8|32-Day Follow-Up Period|Death|0
5799515|NCT03016325|20001196|P7|32-Day Follow-Up Period|Death|0
5799516|NCT03016325|20001197|P6|32-Day Follow-Up Period|Death|0
5799517|NCT03016325|20001198|P5|32-Day Follow-Up Period|Death|3
5799518|NCT03016325|20001199|P4|32-Day Follow-Up Period|Death|6
5799519|NCT03016325|20001200|P3|32-Day Follow-Up Period|Death|5
5799520|NCT03016325|20001201|P2|32-Day Follow-Up Period|Death|0
5799521|NCT03016325|20001202|P1|32-Day Follow-Up Period|Death|2
5799522|NCT03016325|20001195|P8|Treatment Period|Participant refuses assessments|0
5799523|NCT03016325|20001196|P7|Treatment Period|Participant refuses assessments|0
5799524|NCT03016325|20001197|P6|Treatment Period|Participant refuses assessments|0
5799525|NCT03016325|20001198|P5|Treatment Period|Participant refuses assessments|0
5799526|NCT03016325|20001199|P4|Treatment Period|Participant refuses assessments|0
5799527|NCT03016325|20001200|P3|Treatment Period|Participant refuses assessments|1
5799528|NCT03016325|20001201|P2|Treatment Period|Participant refuses assessments|0
5799529|NCT03016325|20001202|P1|Treatment Period|Participant refuses assessments|0
5799530|NCT03016325|20001195|P8|Treatment Period|Death|0
5799531|NCT03016325|20001196|P7|Treatment Period|Death|0
5799532|NCT03016325|20001197|P6|Treatment Period|Death|0
5799533|NCT03016325|20001198|P5|Treatment Period|Death|2
5799534|NCT03016325|20001199|P4|Treatment Period|Death|0
5799535|NCT03016325|20001200|P3|Treatment Period|Death|0
5799536|NCT03016325|20001201|P2|Treatment Period|Death|0
5799537|NCT03016325|20001202|P1|Treatment Period|Death|0
5799538|NCT03016325|20001195|P8|Treatment Period|Participant withdrew consent|0
5799539|NCT03016325|20001196|P7|Treatment Period|Participant withdrew consent|0
5799540|NCT03016325|20001197|P6|Treatment Period|Participant withdrew consent|0
5799541|NCT03016325|20001198|P5|Treatment Period|Participant withdrew consent|0
5799542|NCT03016325|20001199|P4|Treatment Period|Participant withdrew consent|0
5799543|NCT03016325|20001200|P3|Treatment Period|Participant withdrew consent|0
5799544|NCT03016325|20001201|P2|Treatment Period|Participant withdrew consent|1
5799545|NCT03016325|20001202|P1|Treatment Period|Participant withdrew consent|0
5799546|NCT03016078|20001425|P1|Overall Study|Protocol Violation|1
5799547|NCT03016078|20001425|P1|Overall Study|Protocol Violation|1
5799548|NCT03015220|20001444|P4|Overall Study|Lost to Follow-up|0
5799549|NCT03015220|20001445|P3|Overall Study|Lost to Follow-up|1
5799550|NCT03015220|20001446|P2|Overall Study|Lost to Follow-up|0
5799551|NCT03015220|20001447|P1|Overall Study|Lost to Follow-up|0
5799552|NCT03015220|20001444|P4|Overall Study|Withdrawal by Subject|2
5799553|NCT03015220|20001445|P3|Overall Study|Withdrawal by Subject|2
5799554|NCT03015220|20001446|P2|Overall Study|Withdrawal by Subject|2
5799555|NCT03015220|20001447|P1|Overall Study|Withdrawal by Subject|3
5799556|NCT03015181|20001592|P7|Overall Study|Physician Decision|1
5799557|NCT03015181|20001593|P6|Overall Study|Physician Decision|0
5799558|NCT03015181|20001594|P5|Overall Study|Physician Decision|0
5799559|NCT03015181|20001595|P4|Overall Study|Physician Decision|0
5799560|NCT03015181|20001596|P3|Overall Study|Physician Decision|0
5799561|NCT03015181|20001597|P2|Overall Study|Physician Decision|0
5799562|NCT03015181|20001598|P1|Overall Study|Physician Decision|0
5799563|NCT03015181|20001592|P7|Overall Study|Withdrawal by Subject|0
5799564|NCT03015181|20001593|P6|Overall Study|Withdrawal by Subject|1
5799565|NCT03015181|20001594|P5|Overall Study|Withdrawal by Subject|0
5799566|NCT03015181|20001595|P4|Overall Study|Withdrawal by Subject|0
5799567|NCT03015181|20001596|P3|Overall Study|Withdrawal by Subject|0
5799568|NCT03015181|20001597|P2|Overall Study|Withdrawal by Subject|0
5799569|NCT03015181|20001598|P1|Overall Study|Withdrawal by Subject|0
5799570|NCT03015181|20001592|P7|Overall Study|Enrolled, but product never administered|0
5799571|NCT03015181|20001593|P6|Overall Study|Enrolled, but product never administered|0
5799572|NCT03015181|20001594|P5|Overall Study|Enrolled, but product never administered|0
5799573|NCT03015181|20001595|P4|Overall Study|Enrolled, but product never administered|0
5799574|NCT03015181|20001596|P3|Overall Study|Enrolled, but product never administered|0
5799575|NCT03015181|20001597|P2|Overall Study|Enrolled, but product never administered|0
5799576|NCT03015181|20001598|P1|Overall Study|Enrolled, but product never administered|1
5799577|NCT03014674|20001744|P3|Overall Study|Withdrawal by Subject|0
5799578|NCT03014674|20001745|P2|Overall Study|Withdrawal by Subject|0
5799579|NCT03014674|20001746|P1|Overall Study|Withdrawal by Subject|1
5799580|NCT03014479|20001821|P2|Overall Study|Unacceptable Inability of Site Visit|1
5799581|NCT03014479|20001822|P1|Overall Study|Unacceptable Inability of Site Visit|0
5799582|NCT03014479|20001821|P2|Overall Study|Voluntary Withdrawal|2
5799583|NCT03014479|20001822|P1|Overall Study|Voluntary Withdrawal|0
5799584|NCT03014479|20001821|P2|Overall Study|Adverse Event|1
5799585|NCT03014479|20001822|P1|Overall Study|Adverse Event|0
5799586|NCT03014453|20001868|P1|Overall Study|Refused to take part in|37
5799587|NCT03014453|20001868|P1|Overall Study|Excluded|19
5799588|NCT03014453|20001868|P1|Overall Study|Discontinued GER|3
5799589|NCT03014453|20001868|P1|Overall Study|Lost to Follow-up|12
5799590|NCT03014206|20001872|P1|Overall Study|Registration Violation|12
5799591|NCT03014180|20001876|P1|Overall Study|Protocol Violation|2
5799592|NCT03014011|20001885|P2|Washout|Withdrawal by Subject|0
5799593|NCT03014011|20001886|P1|Washout|Withdrawal by Subject|1
5799594|NCT03014011|20001885|P2|First Intervention|Withdrawal by Subject|0
5799595|NCT03014011|20001886|P1|First Intervention|Withdrawal by Subject|1
5799596|NCT03013985|20001894|P2|Overall Study|Withdrawal by Subject|17
5799597|NCT03013985|20001895|P1|Overall Study|Withdrawal by Subject|14
5799598|NCT03013985|20001894|P2|Overall Study|Protocol Violation|2
5799599|NCT03013985|20001895|P1|Overall Study|Protocol Violation|2
5799600|NCT03012841|20001927|P2|Overall Study|Insurance change|1
5799601|NCT03012841|20001928|P1|Overall Study|Insurance change|0
5799602|NCT03012841|20001927|P2|Overall Study|Study reached n=165 treated subject cap|5
5799603|NCT03012841|20001928|P1|Overall Study|Study reached n=165 treated subject cap|0
5799604|NCT03012841|20001927|P2|Overall Study|No ablation performed|2
5799605|NCT03012841|20001928|P1|Overall Study|No ablation performed|0
5799606|NCT03012841|20001927|P2|Overall Study|Physician Decision|2
5799607|NCT03012841|20001928|P1|Overall Study|Physician Decision|0
5799608|NCT03012841|20001927|P2|Overall Study|Seasonal winter travel|0
5799609|NCT03012841|20001928|P1|Overall Study|Seasonal winter travel|1
5799610|NCT03012841|20001927|P2|Overall Study|Subject relocation|0
5799611|NCT03012841|20001928|P1|Overall Study|Subject relocation|1
5799612|NCT03012841|20001927|P2|Overall Study|Unable to complete 12 month visit|0
5799613|NCT03012841|20001928|P1|Overall Study|Unable to complete 12 month visit|6
5799614|NCT03012841|20001927|P2|Overall Study|Withdrawal by Subject|0
5799615|NCT03012841|20001928|P1|Overall Study|Withdrawal by Subject|6
5799616|NCT03012841|20001927|P2|Overall Study|Lost to Follow-up|1
5799617|NCT03012841|20001928|P1|Overall Study|Lost to Follow-up|6
5799618|NCT03012841|20001927|P2|Overall Study|Protocol Violation|10
5799619|NCT03012841|20001928|P1|Overall Study|Protocol Violation|0
5799620|NCT03012828|20001942|P6|Overall Study|Delay to last visit would delay DBL|1
5799621|NCT03012828|20001943|P5|Overall Study|Delay to last visit would delay DBL|0
5799622|NCT03012828|20001944|P4|Overall Study|Delay to last visit would delay DBL|0
5799623|NCT03012828|20001945|P3|Overall Study|Delay to last visit would delay DBL|0
5799624|NCT03012828|20001946|P2|Overall Study|Delay to last visit would delay DBL|0
5799625|NCT03012828|20001947|P1|Overall Study|Delay to last visit would delay DBL|0
5799626|NCT03012828|20001942|P6|Overall Study|Non-compliance with protocol|0
5799627|NCT03012828|20001943|P5|Overall Study|Non-compliance with protocol|1
5799628|NCT03012828|20001944|P4|Overall Study|Non-compliance with protocol|0
5799629|NCT03012828|20001945|P3|Overall Study|Non-compliance with protocol|0
5799630|NCT03012828|20001946|P2|Overall Study|Non-compliance with protocol|0
5799631|NCT03012828|20001947|P1|Overall Study|Non-compliance with protocol|0
5799632|NCT03012828|20001942|P6|Overall Study|Withdrawal by Subject|1
5799633|NCT03012828|20001943|P5|Overall Study|Withdrawal by Subject|0
5799634|NCT03012828|20001944|P4|Overall Study|Withdrawal by Subject|0
5799635|NCT03012828|20001945|P3|Overall Study|Withdrawal by Subject|1
5799636|NCT03012828|20001946|P2|Overall Study|Withdrawal by Subject|0
5799637|NCT03012828|20001947|P1|Overall Study|Withdrawal by Subject|0
5799638|NCT03012828|20001942|P6|Overall Study|Lost to Follow-up|0
5799639|NCT03012828|20001943|P5|Overall Study|Lost to Follow-up|1
5799640|NCT03012828|20001944|P4|Overall Study|Lost to Follow-up|0
5799641|NCT03012828|20001945|P3|Overall Study|Lost to Follow-up|1
5799642|NCT03012828|20001946|P2|Overall Study|Lost to Follow-up|0
5799643|NCT03012828|20001947|P1|Overall Study|Lost to Follow-up|1
5799644|NCT03012334|20001995|P10|Period 4|Adverse Event|0
5799645|NCT03012334|20001996|P9|Period 4|Adverse Event|1
5799646|NCT03012334|20001997|P8|Period 4|Adverse Event|0
5799647|NCT03012334|20001998|P7|Period 4|Adverse Event|0
5799648|NCT03012334|20001999|P6|Period 4|Adverse Event|0
5799649|NCT03012334|20002000|P5|Period 4|Adverse Event|0
5799650|NCT03012334|20002001|P4|Period 4|Adverse Event|0
5799651|NCT03012334|20002002|P3|Period 4|Adverse Event|0
5799652|NCT03012334|20002003|P2|Period 4|Adverse Event|0
5799653|NCT03012334|20002004|P1|Period 4|Adverse Event|0
5799654|NCT03012334|20001995|P10|Period 4|Non-Compliance|0
5799655|NCT03012334|20001996|P9|Period 4|Non-Compliance|0
5799656|NCT03012334|20001997|P8|Period 4|Non-Compliance|0
5799657|NCT03012334|20001998|P7|Period 4|Non-Compliance|1
5799658|NCT03012334|20001999|P6|Period 4|Non-Compliance|0
5799659|NCT03012334|20002000|P5|Period 4|Non-Compliance|0
5799660|NCT03012334|20002001|P4|Period 4|Non-Compliance|0
5799661|NCT03012334|20002002|P3|Period 4|Non-Compliance|0
5799662|NCT03012334|20002003|P2|Period 4|Non-Compliance|0
5799663|NCT03012334|20002004|P1|Period 4|Non-Compliance|0
5799664|NCT03012334|20001995|P10|Period 2|Protocol Violation|0
5799665|NCT03012334|20001996|P9|Period 2|Protocol Violation|0
5799666|NCT03012334|20001997|P8|Period 2|Protocol Violation|1
5799667|NCT03012334|20001998|P7|Period 2|Protocol Violation|0
5799668|NCT03012334|20001999|P6|Period 2|Protocol Violation|0
5799669|NCT03012334|20002000|P5|Period 2|Protocol Violation|0
5799670|NCT03012334|20002001|P4|Period 2|Protocol Violation|0
5799671|NCT03012334|20002002|P3|Period 2|Protocol Violation|1
5799672|NCT03012334|20002003|P2|Period 2|Protocol Violation|0
5799673|NCT03012334|20002004|P1|Period 2|Protocol Violation|0
5799674|NCT03012334|20001995|P10|Period 2|Withdrawal by Subject|0
5799675|NCT03012334|20001996|P9|Period 2|Withdrawal by Subject|0
5799676|NCT03012334|20001997|P8|Period 2|Withdrawal by Subject|0
5799677|NCT03012334|20001998|P7|Period 2|Withdrawal by Subject|0
5799678|NCT03012334|20001999|P6|Period 2|Withdrawal by Subject|0
5799679|NCT03012334|20002000|P5|Period 2|Withdrawal by Subject|0
5799680|NCT03012334|20002001|P4|Period 2|Withdrawal by Subject|0
5799681|NCT03012334|20002002|P3|Period 2|Withdrawal by Subject|0
5799682|NCT03012334|20002003|P2|Period 2|Withdrawal by Subject|1
5799683|NCT03012334|20002004|P1|Period 2|Withdrawal by Subject|0
5799684|NCT03012334|20001995|P10|Period 1|Withdrawal by Subject|1
5799685|NCT03012334|20001996|P9|Period 1|Withdrawal by Subject|0
5799686|NCT03012334|20001997|P8|Period 1|Withdrawal by Subject|0
5799687|NCT03012334|20001998|P7|Period 1|Withdrawal by Subject|0
5799688|NCT03012334|20001999|P6|Period 1|Withdrawal by Subject|0
5799689|NCT03012334|20002000|P5|Period 1|Withdrawal by Subject|0
5799690|NCT03012334|20002001|P4|Period 1|Withdrawal by Subject|0
5799691|NCT03012334|20002002|P3|Period 1|Withdrawal by Subject|0
5799692|NCT03012334|20002003|P2|Period 1|Withdrawal by Subject|0
5799693|NCT03012334|20002004|P1|Period 1|Withdrawal by Subject|0
5799694|NCT03012061|20002074|P3|Overall Study|Adverse Event|0
5799695|NCT03012061|20002075|P2|Overall Study|Adverse Event|0
5799696|NCT03012061|20002076|P1|Overall Study|Adverse Event|2
5799697|NCT03012061|20002074|P3|Overall Study|Lack of Efficacy|0
5799698|NCT03012061|20002075|P2|Overall Study|Lack of Efficacy|1
5799699|NCT03012061|20002076|P1|Overall Study|Lack of Efficacy|0
5799700|NCT03012061|20002074|P3|Overall Study|Protocol Violation|2
5799701|NCT03012061|20002075|P2|Overall Study|Protocol Violation|0
5799702|NCT03012061|20002076|P1|Overall Study|Protocol Violation|0
5799703|NCT03012061|20002074|P3|Overall Study|Met Protocol Withdrawal Criterion|1
5799704|NCT03012061|20002075|P2|Overall Study|Met Protocol Withdrawal Criterion|0
5799705|NCT03012061|20002076|P1|Overall Study|Met Protocol Withdrawal Criterion|0
5799706|NCT03012061|20002074|P3|Overall Study|Study closed/ Terminated|1
5799707|NCT03012061|20002075|P2|Overall Study|Study closed/ Terminated|0
5799708|NCT03012061|20002076|P1|Overall Study|Study closed/ Terminated|0
5799709|NCT03012061|20002074|P3|Overall Study|Lost to Follow-up|0
5799710|NCT03012061|20002075|P2|Overall Study|Lost to Follow-up|1
5799711|NCT03012061|20002076|P1|Overall Study|Lost to Follow-up|2
5799712|NCT03012061|20002074|P3|Overall Study|Investigator Site Closed|0
5799713|NCT03012061|20002075|P2|Overall Study|Investigator Site Closed|2
5799714|NCT03012061|20002076|P1|Overall Study|Investigator Site Closed|1
5799715|NCT03012061|20002074|P3|Overall Study|Withdrawal by Subject|4
5799716|NCT03012061|20002075|P2|Overall Study|Withdrawal by Subject|5
5799717|NCT03012061|20002076|P1|Overall Study|Withdrawal by Subject|1
5799718|NCT03011840|20002101|P2|Overall Study|Not received PIL in post PIL phase|21
5799719|NCT03011840|20002102|P1|Overall Study|Not received PIL in post PIL phase|0
5799720|NCT03011099|20002112|P2|Overall Study|Withdrawal by Subject|2
5799721|NCT03011099|20002113|P1|Overall Study|Withdrawal by Subject|0
5799722|NCT03011034|20002139|P2|Overall Study|Adverse Event|0
5799723|NCT03011034|20002140|P1|Overall Study|Adverse Event|1
5799724|NCT03010501|20002202|P6|Study Week 3|Withdrawal by Subject|0
5799725|NCT03010501|20002203|P5|Study Week 3|Withdrawal by Subject|0
5799726|NCT03010501|20002204|P4|Study Week 3|Withdrawal by Subject|1
5799727|NCT03010501|20002205|P3|Study Week 3|Withdrawal by Subject|0
5799728|NCT03010501|20002206|P2|Study Week 3|Withdrawal by Subject|0
5799729|NCT03010501|20002207|P1|Study Week 3|Withdrawal by Subject|0
5799730|NCT03010501|20002202|P6|Study Week 1|Withdrawal by Subject|0
5799731|NCT03010501|20002203|P5|Study Week 1|Withdrawal by Subject|0
5799732|NCT03010501|20002204|P4|Study Week 1|Withdrawal by Subject|2
5799733|NCT03010501|20002205|P3|Study Week 1|Withdrawal by Subject|0
5799734|NCT03010501|20002206|P2|Study Week 1|Withdrawal by Subject|1
5799735|NCT03010501|20002207|P1|Study Week 1|Withdrawal by Subject|2
5799736|NCT03010423|20002221|P1|Overall Study|Study termination|8
5799737|NCT03010254|20002234|P2|Overall Study|Other|3
5799738|NCT03010254|20002235|P1|Overall Study|Other|2
5799739|NCT03010254|20002234|P2|Overall Study|Withdrawal by Subject|1
5799740|NCT03010254|20002235|P1|Overall Study|Withdrawal by Subject|1
5799741|NCT03010254|20002234|P2|Overall Study|Lost to Follow-up|0
5799742|NCT03010254|20002235|P1|Overall Study|Lost to Follow-up|4
5799743|NCT03010254|20002234|P2|Overall Study|Adverse Event|1
5799744|NCT03010254|20002235|P1|Overall Study|Adverse Event|0
5799745|NCT03007966|20002403|P2|Overall Study|Did not meeting inclusion/exclusion|0
5799746|NCT03007966|20002404|P1|Overall Study|Did not meeting inclusion/exclusion|1
5799747|NCT03007472|20002445|P1|Overall Study|Loss to Follow Up|1
5799748|NCT03007472|20002445|P1|Overall Study|Death|2
5799749|NCT03007472|20002445|P1|Overall Study|Did not have aidable contralateral thresholds at the time|2
5799750|NCT03006926|20002473|P2|Overall Study|Withdrawal by Subject|2
5799751|NCT03006926|20002474|P1|Overall Study|Withdrawal by Subject|0
5799752|NCT03006926|20002473|P2|Overall Study|Lost to Follow-up|1
5799753|NCT03006926|20002474|P1|Overall Study|Lost to Follow-up|0
5799754|NCT03006926|20002473|P2|Overall Study|Ongoing-on Treatment|36
5799755|NCT03006926|20002474|P1|Overall Study|Ongoing-on Treatment|0
5799756|NCT03006926|20002473|P2|Overall Study|Ongoing Survival Follow-up|26
5799757|NCT03006926|20002474|P1|Overall Study|Ongoing Survival Follow-up|0
5799758|NCT03006926|20002473|P2|Overall Study|Death|33
5799759|NCT03006926|20002474|P1|Overall Study|Death|0
5799760|NCT03006562|20002494|P2|Overall Study|Lost to Follow-up|1
5799761|NCT03006562|20002495|P1|Overall Study|Lost to Follow-up|0
5799762|NCT03006458|20002586|P2|First Intervention|Unsatisfied Vision|3
5799763|NCT03006458|20002587|P1|First Intervention|Unsatisfied Vision|0
5799764|NCT03006341|20002629|P4|Overall Study|Not linked in the EMR|10685
5799765|NCT03006341|20002630|P3|Overall Study|Not linked in the EMR|30993
5799766|NCT03006341|20002631|P2|Overall Study|Not linked in the EMR|67505
5799767|NCT03006341|20002632|P1|Overall Study|Not linked in the EMR|25069
5799768|NCT03005288|20002676|P2|Overall Study|Physician Decision|1
5799769|NCT03005288|20002677|P1|Overall Study|Physician Decision|0
5799770|NCT03005288|20002676|P2|Overall Study|Protocol deviation|1
5799771|NCT03005288|20002677|P1|Overall Study|Protocol deviation|0
5799772|NCT03005288|20002676|P2|Overall Study|Adverse Event|0
5799773|NCT03005288|20002677|P1|Overall Study|Adverse Event|5
5799774|NCT03005288|20002676|P2|Overall Study|Lost to Follow-up|1
5799775|NCT03005288|20002677|P1|Overall Study|Lost to Follow-up|0
5799776|NCT03005288|20002676|P2|Overall Study|Withdrawal by Subject|5
5799777|NCT03005288|20002677|P1|Overall Study|Withdrawal by Subject|7
5799778|NCT03005067|20002709|P2|Overall Study|Protocol Violation|1
5799779|NCT03005067|20002710|P1|Overall Study|Protocol Violation|0
5799780|NCT03005067|20002709|P2|Overall Study|Other (reason not specified)|1
5799781|NCT03005067|20002710|P1|Overall Study|Other (reason not specified)|3
5799782|NCT03005067|20002709|P2|Overall Study|Adverse Event|3
5799783|NCT03005067|20002710|P1|Overall Study|Adverse Event|4
5799784|NCT03005067|20002709|P2|Overall Study|Withdrawal by Subject|2
5799785|NCT03005067|20002710|P1|Overall Study|Withdrawal by Subject|3
5799786|NCT03004924|20002738|P3|Overall Study|HSV1 Positive|0
5799787|NCT03004924|20002739|P2|Overall Study|HSV1 Positive|0
5799788|NCT03004924|20002740|P1|Overall Study|HSV1 Positive|1
5799789|NCT03004924|20002738|P3|Overall Study|Missed Study Visit|2
5799790|NCT03004924|20002739|P2|Overall Study|Missed Study Visit|0
5799791|NCT03004924|20002740|P1|Overall Study|Missed Study Visit|0
5799792|NCT03004924|20002738|P3|Overall Study|Terminated by Sponsor|1
5799793|NCT03004924|20002739|P2|Overall Study|Terminated by Sponsor|0
5799794|NCT03004924|20002740|P1|Overall Study|Terminated by Sponsor|0
5799795|NCT03004924|20002738|P3|Overall Study|Pregnancy|0
5799796|NCT03004924|20002739|P2|Overall Study|Pregnancy|1
5799797|NCT03004924|20002740|P1|Overall Study|Pregnancy|0
5799798|NCT03004924|20002738|P3|Overall Study|Screen Failure|0
5799799|NCT03004924|20002739|P2|Overall Study|Screen Failure|0
5799800|NCT03004924|20002740|P1|Overall Study|Screen Failure|1
5799801|NCT03004924|20002738|P3|Overall Study|Withdrawal by parent/guardian|2
5799802|NCT03004924|20002739|P2|Overall Study|Withdrawal by parent/guardian|0
5799803|NCT03004924|20002740|P1|Overall Study|Withdrawal by parent/guardian|1
5799804|NCT03004924|20002738|P3|Overall Study|Physician Decision|1
5799805|NCT03004924|20002739|P2|Overall Study|Physician Decision|0
5799806|NCT03004924|20002740|P1|Overall Study|Physician Decision|1
5799807|NCT03004924|20002738|P3|Overall Study|Lack of Efficacy|2
5799808|NCT03004924|20002739|P2|Overall Study|Lack of Efficacy|4
5799809|NCT03004924|20002740|P1|Overall Study|Lack of Efficacy|2
5799810|NCT03004924|20002738|P3|Overall Study|Lost to Follow-up|4
5799811|NCT03004924|20002739|P2|Overall Study|Lost to Follow-up|1
5799812|NCT03004924|20002740|P1|Overall Study|Lost to Follow-up|6
5799813|NCT03004924|20002738|P3|Overall Study|Withdrawal by Subject|5
5799814|NCT03004924|20002739|P2|Overall Study|Withdrawal by Subject|3
5799815|NCT03004924|20002740|P1|Overall Study|Withdrawal by Subject|5
5799816|NCT03004924|20002738|P3|Overall Study|Protocol Violation|1
5799817|NCT03004924|20002739|P2|Overall Study|Protocol Violation|0
5799818|NCT03004924|20002740|P1|Overall Study|Protocol Violation|4
5799819|NCT03004924|20002738|P3|Overall Study|Adverse Event|10
5799820|NCT03004924|20002739|P2|Overall Study|Adverse Event|5
5799821|NCT03004924|20002740|P1|Overall Study|Adverse Event|6
5799822|NCT03004469|20002984|P3|Overall Study|Other unspecified reason|1
5799823|NCT03004469|20002985|P2|Overall Study|Other unspecified reason|4
5799824|NCT03004469|20002986|P1|Overall Study|Other unspecified reason|0
5799825|NCT03004469|20002984|P3|Overall Study|Withdrawal by Subject|10
5799826|NCT03004469|20002985|P2|Overall Study|Withdrawal by Subject|27
5799827|NCT03004469|20002986|P1|Overall Study|Withdrawal by Subject|29
5799828|NCT03004469|20002984|P3|Overall Study|Protocol Violation|1
5799829|NCT03004469|20002985|P2|Overall Study|Protocol Violation|0
5799830|NCT03004469|20002986|P1|Overall Study|Protocol Violation|0
5799831|NCT03004469|20002984|P3|Overall Study|Non-Compliance with Study Drug|0
5799832|NCT03004469|20002985|P2|Overall Study|Non-Compliance with Study Drug|0
5799833|NCT03004469|20002986|P1|Overall Study|Non-Compliance with Study Drug|2
5799834|NCT03004469|20002984|P3|Overall Study|Lost to Follow-up|6
5799835|NCT03004469|20002985|P2|Overall Study|Lost to Follow-up|14
5799836|NCT03004469|20002986|P1|Overall Study|Lost to Follow-up|23
5799837|NCT03004469|20002984|P3|Overall Study|Lack of Efficacy|1
5799838|NCT03004469|20002985|P2|Overall Study|Lack of Efficacy|0
5799839|NCT03004469|20002986|P1|Overall Study|Lack of Efficacy|1
5799840|NCT03004469|20002984|P3|Overall Study|Adverse Event|6
5799841|NCT03004469|20002985|P2|Overall Study|Adverse Event|4
5799842|NCT03004469|20002986|P1|Overall Study|Adverse Event|6
5799843|NCT03003520|20003029|P2|Follow-up|Withdrawal by Subject|0
5799844|NCT03003520|20003030|P1|Follow-up|Withdrawal by Subject|1
5799845|NCT03003520|20003029|P2|Follow-up|Ongoing|2
5799846|NCT03003520|20003030|P1|Follow-up|Ongoing|12
5799847|NCT03003520|20003029|P2|Follow-up|Death|1
5799848|NCT03003520|20003030|P1|Follow-up|Death|1
5799849|NCT03003520|20003029|P2|Consolidation|Withdrawal by Subject|0
5799850|NCT03003520|20003030|P1|Consolidation|Withdrawal by Subject|1
5799851|NCT03003520|20003029|P2|Consolidation|Progressive disease|1
5799852|NCT03003520|20003030|P1|Consolidation|Progressive disease|3
5799853|NCT03003520|20003029|P2|Consolidation|Adverse Event|0
5799854|NCT03003520|20003030|P1|Consolidation|Adverse Event|2
5799855|NCT03003520|20003029|P2|Consolidation|Ongoing|0
5799856|NCT03003520|20003030|P1|Consolidation|Ongoing|18
5799857|NCT03003520|20003029|P2|Induction|Progressive disease|0
5799858|NCT03003520|20003030|P1|Induction|Progressive disease|1
5799859|NCT03003520|20003029|P2|Induction|Withdrawal by Subject|0
5799860|NCT03003520|20003030|P1|Induction|Withdrawal by Subject|3
5799861|NCT03003520|20003029|P2|Induction|Physician Decision|0
5799862|NCT03003520|20003030|P1|Induction|Physician Decision|2
5799863|NCT03003520|20003029|P2|Induction|Palliative care|0
5799864|NCT03003520|20003030|P1|Induction|Palliative care|1
5799865|NCT03003520|20003029|P2|Induction|Death|0
5799866|NCT03003520|20003030|P1|Induction|Death|1
5799867|NCT03003520|20003029|P2|Induction|Adverse Event|0
5799868|NCT03003520|20003030|P1|Induction|Adverse Event|4
5799869|NCT03003520|20003029|P2|Induction|Ongoing|0
5799870|NCT03003520|20003030|P1|Induction|Ongoing|1
5799871|NCT03003494|20003048|P1|Overall Study|Evaluable PF10 questionnaire at visit1|28
5799872|NCT03003390|20003059|P2|Overall Study|Parent refused intervention|0
5799873|NCT03003390|20003060|P1|Overall Study|Parent refused intervention|2
5799874|NCT03003390|20003059|P2|Overall Study|Physician Decision|0
5799875|NCT03003390|20003060|P1|Overall Study|Physician Decision|2
5799876|NCT03003000|20003088|P3|Overall Study|Other than listed|1
5799877|NCT03003000|20003089|P2|Overall Study|Other than listed|1
5799878|NCT03003000|20003090|P1|Overall Study|Other than listed|1
5799879|NCT03003000|20003088|P3|Overall Study|Refused to continue medication|0
5799880|NCT03003000|20003089|P2|Overall Study|Refused to continue medication|0
5799881|NCT03003000|20003090|P1|Overall Study|Refused to continue medication|2
5799882|NCT03003000|20003088|P3|Overall Study|Non-compliant with protocol|1
5799883|NCT03003000|20003089|P2|Overall Study|Non-compliant with protocol|1
5799884|NCT03003000|20003090|P1|Overall Study|Non-compliant with protocol|0
5799885|NCT03003000|20003088|P3|Overall Study|Lack of Efficacy|0
5799886|NCT03003000|20003089|P2|Overall Study|Lack of Efficacy|0
5799887|NCT03003000|20003090|P1|Overall Study|Lack of Efficacy|1
5799888|NCT03003000|20003088|P3|Overall Study|Adverse Event|3
5799889|NCT03003000|20003089|P2|Overall Study|Adverse Event|2
5799890|NCT03003000|20003090|P1|Overall Study|Adverse Event|1
5799891|NCT03002818|20003192|P1|Overall Study|Decision of the investigator|1
5799892|NCT03002623|20003218|P2|Overall Study|Physician Decision|1
5799893|NCT03002623|20003219|P1|Overall Study|Physician Decision|1
5799894|NCT03002623|20003218|P2|Overall Study|Lost to Follow-up|0
5799895|NCT03002623|20003219|P1|Overall Study|Lost to Follow-up|1
5799896|NCT03002610|20003236|P3|Overall Study|Withdrawal by Subject|13
5799897|NCT03002610|20003237|P2|Overall Study|Withdrawal by Subject|25
5799898|NCT03002610|20003238|P1|Overall Study|Withdrawal by Subject|6
5799899|NCT03002311|20003262|P2|Overall Study|Physician Decision|1
5799900|NCT03002311|20003263|P1|Overall Study|Physician Decision|3
5799901|NCT03002311|20003262|P2|Overall Study|Referral provider called to schedule app|3
5799902|NCT03002311|20003263|P1|Overall Study|Referral provider called to schedule app|3
5799903|NCT03002311|20003262|P2|Overall Study|Lost to Follow-up|26
5799904|NCT03002311|20003263|P1|Overall Study|Lost to Follow-up|13
5799905|NCT03002194|20003271|P1|Overall Study|Withdrawal by Subject|2
5799906|NCT03002194|20003271|P1|Overall Study|Lack of Efficacy|1
5799907|NCT03002194|20003271|P1|Overall Study|Adverse Event|1
5799908|NCT03002194|20003271|P1|Overall Study|Lost to Follow-up|6
5799909|NCT03002077|20003277|P1|Overall Study|Protocol Violation|21
5799910|NCT03002077|20003277|P1|Overall Study|Pregnancy|4
5799911|NCT03002077|20003277|P1|Overall Study|Lost to Follow-up|21
5799912|NCT03002077|20003277|P1|Overall Study|Withdrawal by Subject|72
5799913|NCT03002077|20003277|P1|Overall Study|Lack of Efficacy|20
5799914|NCT03002077|20003277|P1|Overall Study|Adverse Event|23
5799915|NCT03002077|20003277|P1|Overall Study|Miscellaneous Reasons|10
5799916|NCT03002077|20003277|P1|Overall Study|Site Terminated by Sponsor|5
5799917|NCT03002077|20003277|P1|Overall Study|Study Terminated by Sponsor|257
5799918|NCT03002077|20003277|P1|Overall Study|Non-compliance w/Background ADT|1
5799919|NCT03002077|20003277|P1|Overall Study|Non-compliance with Study Drug|4
5799920|NCT03002038|20003285|P2|Overall Study|Immigration to another region|2
5799921|NCT03002038|20003286|P1|Overall Study|Immigration to another region|0
5799922|NCT03002038|20003285|P2|Overall Study|Withdrawal by Subject|4
5799923|NCT03002038|20003286|P1|Overall Study|Withdrawal by Subject|8
5799924|NCT03002038|20003285|P2|Overall Study|Adverse Event|1
5799925|NCT03002038|20003286|P1|Overall Study|Adverse Event|3
5799926|NCT03001557|20003342|P5|Overall Study|Randomized but not treated|0
5799927|NCT03001557|20003343|P4|Overall Study|Randomized but not treated|0
5799928|NCT03001557|20003344|P3|Overall Study|Randomized but not treated|1
5799929|NCT03001557|20003345|P2|Overall Study|Randomized but not treated|0
5799930|NCT03001557|20003346|P1|Overall Study|Randomized but not treated|0
5799931|NCT03001219|20003645|P2|Extension Period Analysis|Withdrawal by Subject|5
5799932|NCT03001219|20003646|P1|Extension Period Analysis|Withdrawal by Subject|4
5799933|NCT03001219|20003645|P2|Extension Period Analysis|Protocol Deviation|1
5799934|NCT03001219|20003646|P1|Extension Period Analysis|Protocol Deviation|0
5799935|NCT03001219|20003645|P2|Extension Period Analysis|Adverse Event|1
5799936|NCT03001219|20003646|P1|Extension Period Analysis|Adverse Event|1
5799937|NCT03001219|20003645|P2|Extension Period Analysis|Physician Decision|1
5799938|NCT03001219|20003646|P1|Extension Period Analysis|Physician Decision|0
5799939|NCT03001219|20003645|P2|Extension Period Analysis|Participant Non-Compliance|1
5799940|NCT03001219|20003646|P1|Extension Period Analysis|Participant Non-Compliance|0
5799941|NCT03001219|20003645|P2|Extension Period Analysis|Study Termination by Sponsor|36
5799942|NCT03001219|20003646|P1|Extension Period Analysis|Study Termination by Sponsor|0
5799943|NCT03001219|20003645|P2|Proof of Concept|Physician Decision|0
5799944|NCT03001219|20003646|P1|Proof of Concept|Physician Decision|1
5799945|NCT03001219|20003645|P2|Proof of Concept|Adverse Event|1
5799946|NCT03001219|20003646|P1|Proof of Concept|Adverse Event|1
5799947|NCT03001219|20003645|P2|Proof of Concept|Protocol Deviation|1
5799948|NCT03001219|20003646|P1|Proof of Concept|Protocol Deviation|0
5799949|NCT03001219|20003645|P2|Proof of Concept|Withdrawal by Subject|4
5799950|NCT03001219|20003646|P1|Proof of Concept|Withdrawal by Subject|0
5799951|NCT03001219|20003645|P2|Proof of Concept|Study Termination by Sponsor|1
5799952|NCT03001219|20003646|P1|Proof of Concept|Study Termination by Sponsor|0
5799953|NCT03001076|20003707|P2|Overall Study|Lost to Follow-up|2
5799954|NCT03001076|20003708|P1|Overall Study|Lost to Follow-up|0
5799955|NCT03001076|20003707|P2|Overall Study|Sponsor decision|0
5799956|NCT03001076|20003708|P1|Overall Study|Sponsor decision|1
5799957|NCT03001076|20003707|P2|Overall Study|Adverse Event|3
5799958|NCT03001076|20003708|P1|Overall Study|Adverse Event|3
5799959|NCT03001076|20003707|P2|Overall Study|Other|0
5799960|NCT03001076|20003708|P1|Overall Study|Other|1
5799961|NCT03001076|20003707|P2|Overall Study|Withdrawal by patient|0
5799962|NCT03001076|20003708|P1|Overall Study|Withdrawal by patient|2
5799963|NCT03001011|20003742|P2|Overall Study|Other than specified above|8
5799964|NCT03001011|20003743|P1|Overall Study|Other than specified above|3
5799965|NCT03001011|20003742|P2|Overall Study|Chronic kidney disease lead to dialysis|10
5799966|NCT03001011|20003743|P1|Overall Study|Chronic kidney disease lead to dialysis|15
5799967|NCT03001011|20003742|P2|Overall Study|Adverse Event|3
5799968|NCT03001011|20003743|P1|Overall Study|Adverse Event|9
5799969|NCT03000686|20003777|P4|Part 1, Period 1 (1 Day)|Adverse Event|0
5799970|NCT03000686|20003778|P3|Part 1, Period 1 (1 Day)|Adverse Event|0
5799971|NCT03000686|20003779|P2|Part 1, Period 1 (1 Day)|Adverse Event|1
5799972|NCT03000686|20003780|P1|Part 1, Period 1 (1 Day)|Adverse Event|0
5799973|NCT03000673|20003850|P4|Overall Study|Withdrawal by Subject|0
5799974|NCT03000673|20003851|P3|Overall Study|Withdrawal by Subject|0
5799975|NCT03000673|20003852|P2|Overall Study|Withdrawal by Subject|0
5799976|NCT03000673|20003853|P1|Overall Study|Withdrawal by Subject|1
5799977|NCT03000569|20003946|P2|Overall Study|Withdrawal by Subject|0
5799978|NCT03000569|20003947|P1|Overall Study|Withdrawal by Subject|1
5799979|NCT03000530|20004082|P3|Overall Study|Withdrawal by Subject|1
5799980|NCT03000530|20004083|P2|Overall Study|Withdrawal by Subject|2
5799981|NCT03000530|20004084|P1|Overall Study|Withdrawal by Subject|0
5799982|NCT03000530|20004082|P3|Overall Study|Lost to Follow-up|1
5799983|NCT03000530|20004083|P2|Overall Study|Lost to Follow-up|3
5799984|NCT03000530|20004084|P1|Overall Study|Lost to Follow-up|0
5799985|NCT03000530|20004082|P3|Overall Study|Adverse Event|2
5799986|NCT03000530|20004083|P2|Overall Study|Adverse Event|0
5799987|NCT03000530|20004084|P1|Overall Study|Adverse Event|0
5799988|NCT03000452|20004282|P1|Follow-Up Period|Withdrawal by Subject|3
5799989|NCT03000452|20004282|P1|Follow-Up Period|Death|3
5799990|NCT03000452|20004282|P1|Follow-Up Period|Study Terminated by Sponsor|1
5799991|NCT03000452|20004282|P1|Treatment Period|Miscellaneous|2
5799992|NCT03000452|20004282|P1|Treatment Period|Physician Decision|1
5799993|NCT03000452|20004282|P1|Treatment Period|Progressive Disease (PD)|14
5799994|NCT03000452|20004282|P1|Treatment Period|Death|1
5799995|NCT03000075|20004339|P7|Part B|Adverse Event|0
5799996|NCT03000075|20004340|P6|Part B|Adverse Event|0
5799997|NCT03000075|20004341|P5|Part B|Adverse Event|1
5799998|NCT03000075|20004342|P4|Part B|Adverse Event|0
5799999|NCT03000075|20004343|P3|Part B|Adverse Event|0
5800000|NCT03000075|20004344|P2|Part B|Adverse Event|0
5800001|NCT03000075|20004345|P1|Part B|Adverse Event|0
5800002|NCT03000075|20004339|P7|Part B|Not dosed due to AE|1
5800003|NCT03000075|20004340|P6|Part B|Not dosed due to AE|2
5800004|NCT03000075|20004341|P5|Part B|Not dosed due to AE|0
5800005|NCT03000075|20004342|P4|Part B|Not dosed due to AE|0
5800006|NCT03000075|20004343|P3|Part B|Not dosed due to AE|0
5800007|NCT03000075|20004344|P2|Part B|Not dosed due to AE|0
5800008|NCT03000075|20004345|P1|Part B|Not dosed due to AE|0
5800009|NCT03000075|20004339|P7|Part A|Adverse Event|0
5800010|NCT03000075|20004340|P6|Part A|Adverse Event|0
5800011|NCT03000075|20004341|P5|Part A|Adverse Event|0
5800012|NCT03000075|20004342|P4|Part A|Adverse Event|0
5800013|NCT03000075|20004343|P3|Part A|Adverse Event|0
5800014|NCT03000075|20004344|P2|Part A|Adverse Event|0
5800015|NCT03000075|20004345|P1|Part A|Adverse Event|4
5800016|NCT02999672|20004398|P2|Overall Study|Adverse Event|0
5800017|NCT02999672|20004399|P1|Overall Study|Adverse Event|4
5800018|NCT02999672|20004398|P2|Overall Study|Progressive Disease|5
5800019|NCT02999672|20004399|P1|Overall Study|Progressive Disease|9
5800020|NCT02999672|20004398|P2|Overall Study|Study Terminated by Sponsor|1
5800021|NCT02999672|20004399|P1|Overall Study|Study Terminated by Sponsor|0
5800022|NCT02999672|20004398|P2|Overall Study|Death|1
5800023|NCT02999672|20004399|P1|Overall Study|Death|0
5800024|NCT02999633|20004415|P1|Overall Study|Progressive disease|12
5800025|NCT02999633|20004415|P1|Overall Study|Adverse Event|2
5800026|NCT02999178|20004425|P2|Overall Study|Other reason not defined above|13
5800027|NCT02999178|20004426|P1|Overall Study|Other reason not defined above|7
5800028|NCT02999178|20004425|P2|Overall Study|Withdrawal by Subject|21
5800029|NCT02999178|20004426|P1|Overall Study|Withdrawal by Subject|21
5800030|NCT02999178|20004425|P2|Overall Study|Lost to Follow-up|2
5800031|NCT02999178|20004426|P1|Overall Study|Lost to Follow-up|0
5800032|NCT02999178|20004425|P2|Overall Study|Protocol Violation|2
5800033|NCT02999178|20004426|P1|Overall Study|Protocol Violation|1
5800034|NCT02999178|20004425|P2|Overall Study|Adverse Event|62
5800035|NCT02999178|20004426|P1|Overall Study|Adverse Event|85
5800036|NCT02999100|20004476|P6|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0
5800037|NCT02999100|20004477|P5|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0
5800038|NCT02999100|20004478|P4|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0
5800039|NCT02999100|20004479|P3|Part 2 (Day 1): Dosing Session 1|Protocol Violation|1
5800040|NCT02999100|20004480|P2|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0
5800041|NCT02999100|20004481|P1|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0
5800042|NCT02999100|20004476|P6|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|1
5800043|NCT02999100|20004477|P5|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0
5800044|NCT02999100|20004478|P4|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0
5800045|NCT02999100|20004479|P3|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0
5800046|NCT02999100|20004480|P2|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0
5800047|NCT02999100|20004481|P1|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0
5800048|NCT02999100|20004476|P6|Part 1 (up to 15 Days)|Adverse Event|0
5800049|NCT02999100|20004477|P5|Part 1 (up to 15 Days)|Adverse Event|0
5800050|NCT02999100|20004478|P4|Part 1 (up to 15 Days)|Adverse Event|0
5800051|NCT02999100|20004479|P3|Part 1 (up to 15 Days)|Adverse Event|0
5800052|NCT02999100|20004480|P2|Part 1 (up to 15 Days)|Adverse Event|1
5800053|NCT02999100|20004481|P1|Part 1 (up to 15 Days)|Adverse Event|0
5800054|NCT02998996|20004649|P6|Overall Study|Family reasons|0
5800055|NCT02998996|20004650|P5|Overall Study|Family reasons|1
5800056|NCT02998996|20004651|P4|Overall Study|Family reasons|0
5800057|NCT02998996|20004652|P3|Overall Study|Family reasons|0
5800058|NCT02998996|20004653|P2|Overall Study|Family reasons|0
5800059|NCT02998996|20004654|P1|Overall Study|Family reasons|0
5800060|NCT02998996|20004649|P6|Overall Study|Pregnancy|0
5800061|NCT02998996|20004650|P5|Overall Study|Pregnancy|0
5800062|NCT02998996|20004651|P4|Overall Study|Pregnancy|0
5800063|NCT02998996|20004652|P3|Overall Study|Pregnancy|0
5800064|NCT02998996|20004653|P2|Overall Study|Pregnancy|1
5800065|NCT02998996|20004654|P1|Overall Study|Pregnancy|0
5800066|NCT02998996|20004649|P6|Overall Study|Lost to Follow-up|0
5800067|NCT02998996|20004650|P5|Overall Study|Lost to Follow-up|0
5800068|NCT02998996|20004651|P4|Overall Study|Lost to Follow-up|0
5800069|NCT02998996|20004652|P3|Overall Study|Lost to Follow-up|1
5800070|NCT02998996|20004653|P2|Overall Study|Lost to Follow-up|0
5800071|NCT02998996|20004654|P1|Overall Study|Lost to Follow-up|0
5800072|NCT02998671|20004688|P5|Period 2|Lost to Follow-up|0
5800073|NCT02998671|20004689|P4|Period 2|Lost to Follow-up|1
5800074|NCT02998671|20004690|P3|Period 2|Lost to Follow-up|0
5800075|NCT02998671|20004691|P2|Period 2|Lost to Follow-up|0
5800076|NCT02998671|20004692|P1|Period 2|Lost to Follow-up|0
5800077|NCT02998671|20004688|P5|Period 2|Withdrawal by Subject|0
5800078|NCT02998671|20004689|P4|Period 2|Withdrawal by Subject|0
5800079|NCT02998671|20004690|P3|Period 2|Withdrawal by Subject|0
5800080|NCT02998671|20004691|P2|Period 2|Withdrawal by Subject|1
5800081|NCT02998671|20004692|P1|Period 2|Withdrawal by Subject|0
5800082|NCT02998671|20004688|P5|Period 2|Study Terminated By Sponsor|0
5800083|NCT02998671|20004689|P4|Period 2|Study Terminated By Sponsor|3
5800084|NCT02998671|20004690|P3|Period 2|Study Terminated By Sponsor|1
5800085|NCT02998671|20004691|P2|Period 2|Study Terminated By Sponsor|5
5800086|NCT02998671|20004692|P1|Period 2|Study Terminated By Sponsor|3
5800087|NCT02998671|20004688|P5|Period 2|Adverse Event|0
5800088|NCT02998671|20004689|P4|Period 2|Adverse Event|0
5800089|NCT02998671|20004690|P3|Period 2|Adverse Event|0
5800090|NCT02998671|20004691|P2|Period 2|Adverse Event|1
5800091|NCT02998671|20004692|P1|Period 2|Adverse Event|0
5800092|NCT02998671|20004688|P5|Period 1|Adverse Event|1
5800093|NCT02998671|20004689|P4|Period 1|Adverse Event|0
5800094|NCT02998671|20004690|P3|Period 1|Adverse Event|0
5800095|NCT02998671|20004691|P2|Period 1|Adverse Event|0
5800096|NCT02998671|20004692|P1|Period 1|Adverse Event|0
5800097|NCT02998671|20004688|P5|Period 1|Pregnancy|0
5800098|NCT02998671|20004689|P4|Period 1|Pregnancy|0
5800099|NCT02998671|20004690|P3|Period 1|Pregnancy|0
5800100|NCT02998671|20004691|P2|Period 1|Pregnancy|0
5800101|NCT02998671|20004692|P1|Period 1|Pregnancy|1
5800102|NCT02998671|20004688|P5|Period 1|Withdrawal by Subject|2
5800103|NCT02998671|20004689|P4|Period 1|Withdrawal by Subject|0
5800104|NCT02998671|20004690|P3|Period 1|Withdrawal by Subject|0
5800105|NCT02998671|20004691|P2|Period 1|Withdrawal by Subject|2
5800106|NCT02998671|20004692|P1|Period 1|Withdrawal by Subject|1
5800107|NCT02998671|20004688|P5|Period 1|Study Terminated By Sponsor|1
5800108|NCT02998671|20004689|P4|Period 1|Study Terminated By Sponsor|0
5800109|NCT02998671|20004690|P3|Period 1|Study Terminated By Sponsor|0
5800110|NCT02998671|20004691|P2|Period 1|Study Terminated By Sponsor|1
5800111|NCT02998671|20004692|P1|Period 1|Study Terminated By Sponsor|2
5800112|NCT02998554|20004737|P2|Overall Study|Lack of Efficacy|1
5800113|NCT02998554|20004738|P1|Overall Study|Lack of Efficacy|0
5800114|NCT02998554|20004737|P2|Overall Study|Lost to Follow-up|1
5800115|NCT02998554|20004738|P1|Overall Study|Lost to Follow-up|0
5800116|NCT02998554|20004737|P2|Overall Study|Withdrawal by Subject|6
5800117|NCT02998554|20004738|P1|Overall Study|Withdrawal by Subject|2
5800118|NCT02998554|20004737|P2|Overall Study|Protocol deviation|0
5800119|NCT02998554|20004738|P1|Overall Study|Protocol deviation|1
5800120|NCT02998554|20004737|P2|Overall Study|Adverse Event|3
5800121|NCT02998554|20004738|P1|Overall Study|Adverse Event|8
5800122|NCT02998541|20004769|P3|Overall Study|Withdrawal by Parent/Guardian|1
5800123|NCT02998541|20004770|P2|Overall Study|Withdrawal by Parent/Guardian|0
5800124|NCT02998541|20004771|P1|Overall Study|Withdrawal by Parent/Guardian|0
5800125|NCT02998541|20004769|P3|Overall Study|Physician Decision|3
5800126|NCT02998541|20004770|P2|Overall Study|Physician Decision|0
5800127|NCT02998541|20004771|P1|Overall Study|Physician Decision|0
5800128|NCT02998541|20004769|P3|Overall Study|Lost to Follow-up|1
5800129|NCT02998541|20004770|P2|Overall Study|Lost to Follow-up|3
5800130|NCT02998541|20004771|P1|Overall Study|Lost to Follow-up|0
5800131|NCT02998541|20004769|P3|Overall Study|Withdrawal by Subject|0
5800132|NCT02998541|20004770|P2|Overall Study|Withdrawal by Subject|1
5800133|NCT02998541|20004771|P1|Overall Study|Withdrawal by Subject|3
5800134|NCT02998541|20004769|P3|Overall Study|Protocol Violation|0
5800135|NCT02998541|20004770|P2|Overall Study|Protocol Violation|0
5800136|NCT02998541|20004771|P1|Overall Study|Protocol Violation|1
5800137|NCT02998541|20004769|P3|Overall Study|Adverse Event|1
5800138|NCT02998541|20004770|P2|Overall Study|Adverse Event|5
5800139|NCT02998541|20004771|P1|Overall Study|Adverse Event|4
5800140|NCT02998476|20004826|P2|Overall Study|Death|2
5800141|NCT02998476|20004827|P1|Overall Study|Death|32
5800142|NCT02998476|20004826|P2|Overall Study|Withdrawal by Subject|2
5800143|NCT02998476|20004827|P1|Overall Study|Withdrawal by Subject|1
5800144|NCT02998476|20004826|P2|Overall Study|Disease Progression|0
5800145|NCT02998476|20004827|P1|Overall Study|Disease Progression|1
5800146|NCT02998476|20004826|P2|Overall Study|Ongoing in study|1
5800147|NCT02998476|20004827|P1|Overall Study|Ongoing in study|21
5800148|NCT02998021|20004837|P2|Overall Study|unsafe home|1
5800149|NCT02998021|20004838|P1|Overall Study|unsafe home|0
5800150|NCT02998021|20004837|P2|Overall Study|Withdrawal by Subject|1
5800151|NCT02998021|20004838|P1|Overall Study|Withdrawal by Subject|3
5800152|NCT02997163|20004913|P4|Overall Study|Adverse Event|1
5800153|NCT02997163|20004914|P3|Overall Study|Adverse Event|0
5800154|NCT02997163|20004915|P2|Overall Study|Adverse Event|0
5800155|NCT02997163|20004916|P1|Overall Study|Adverse Event|1
5800156|NCT02996968|20005048|P2|Overall Study|Withdrawal by Subject|0
5800157|NCT02996968|20005049|P1|Overall Study|Withdrawal by Subject|1
5800158|NCT02996682|20005057|P2|Overall Study|Death|3
5800159|NCT02996682|20005058|P1|Overall Study|Death|0
5800160|NCT02996500|20005137|P6|Overall Study|Withdrawal by Subject|0
5800161|NCT02996500|20005138|P5|Overall Study|Withdrawal by Subject|2
5800162|NCT02996500|20005139|P4|Overall Study|Withdrawal by Subject|0
5800163|NCT02996500|20005140|P3|Overall Study|Withdrawal by Subject|3
5800164|NCT02996500|20005141|P2|Overall Study|Withdrawal by Subject|0
5800165|NCT02996500|20005142|P1|Overall Study|Withdrawal by Subject|3
5800166|NCT02996500|20005137|P6|Overall Study|Protocol Violation|0
5800167|NCT02996500|20005138|P5|Overall Study|Protocol Violation|0
5800168|NCT02996500|20005139|P4|Overall Study|Protocol Violation|1
5800169|NCT02996500|20005140|P3|Overall Study|Protocol Violation|0
5800170|NCT02996500|20005141|P2|Overall Study|Protocol Violation|0
5800171|NCT02996500|20005142|P1|Overall Study|Protocol Violation|0
5800172|NCT02996500|20005137|P6|Overall Study|Other|0
5800173|NCT02996500|20005138|P5|Overall Study|Other|0
5800174|NCT02996500|20005139|P4|Overall Study|Other|0
5800175|NCT02996500|20005140|P3|Overall Study|Other|2
5800176|NCT02996500|20005141|P2|Overall Study|Other|0
5800177|NCT02996500|20005142|P1|Overall Study|Other|2
5800178|NCT02996500|20005137|P6|Overall Study|Progressive Disease|0
5800179|NCT02996500|20005138|P5|Overall Study|Progressive Disease|0
5800180|NCT02996500|20005139|P4|Overall Study|Progressive Disease|0
5800181|NCT02996500|20005140|P3|Overall Study|Progressive Disease|0
5800182|NCT02996500|20005141|P2|Overall Study|Progressive Disease|0
5800183|NCT02996500|20005142|P1|Overall Study|Progressive Disease|1
5800184|NCT02996500|20005137|P6|Overall Study|Non-Compliance With Study Drug|1
5800185|NCT02996500|20005138|P5|Overall Study|Non-Compliance With Study Drug|0
5800186|NCT02996500|20005139|P4|Overall Study|Non-Compliance With Study Drug|0
5800187|NCT02996500|20005140|P3|Overall Study|Non-Compliance With Study Drug|0
5800188|NCT02996500|20005141|P2|Overall Study|Non-Compliance With Study Drug|0
5800189|NCT02996500|20005142|P1|Overall Study|Non-Compliance With Study Drug|0
5800190|NCT02996500|20005137|P6|Overall Study|No Longer Meets Eligibility Criteria|0
5800191|NCT02996500|20005138|P5|Overall Study|No Longer Meets Eligibility Criteria|0
5800192|NCT02996500|20005139|P4|Overall Study|No Longer Meets Eligibility Criteria|0
5800193|NCT02996500|20005140|P3|Overall Study|No Longer Meets Eligibility Criteria|1
5800194|NCT02996500|20005141|P2|Overall Study|No Longer Meets Eligibility Criteria|0
5800195|NCT02996500|20005142|P1|Overall Study|No Longer Meets Eligibility Criteria|0
5800196|NCT02996500|20005137|P6|Overall Study|Lost to Follow-up|1
5800197|NCT02996500|20005138|P5|Overall Study|Lost to Follow-up|0
5800198|NCT02996500|20005139|P4|Overall Study|Lost to Follow-up|0
5800199|NCT02996500|20005140|P3|Overall Study|Lost to Follow-up|0
5800200|NCT02996500|20005141|P2|Overall Study|Lost to Follow-up|0
5800201|NCT02996500|20005142|P1|Overall Study|Lost to Follow-up|1
5800202|NCT02996500|20005137|P6|Overall Study|Lack of Efficacy|0
5800203|NCT02996500|20005138|P5|Overall Study|Lack of Efficacy|2
5800204|NCT02996500|20005139|P4|Overall Study|Lack of Efficacy|0
5800205|NCT02996500|20005140|P3|Overall Study|Lack of Efficacy|0
5800206|NCT02996500|20005141|P2|Overall Study|Lack of Efficacy|0
5800207|NCT02996500|20005142|P1|Overall Study|Lack of Efficacy|0
5800208|NCT02996500|20005137|P6|Overall Study|Adverse Event|2
5800209|NCT02996500|20005138|P5|Overall Study|Adverse Event|1
5800210|NCT02996500|20005139|P4|Overall Study|Adverse Event|3
5800211|NCT02996500|20005140|P3|Overall Study|Adverse Event|4
5800212|NCT02996500|20005141|P2|Overall Study|Adverse Event|1
5800213|NCT02996500|20005142|P1|Overall Study|Adverse Event|1
5800214|NCT02996474|20005325|P1|Overall Study|Physician Decision|5
5800215|NCT02996448|20005329|P1|Overall Study|Study terminated due to adverse effects|3
5800216|NCT02996097|20005335|P2|Overall Study|Lost to Follow-up|11
5800217|NCT02996097|20005336|P1|Overall Study|Lost to Follow-up|11
5800218|NCT02995980|20005343|P1|Overall Study|Lost to Follow-up|14
5800219|NCT02994108|20005420|P2|Phase 2 Assessment|Withdrawal by Subject|0
5800220|NCT02994108|20005421|P1|Phase 2 Assessment|Withdrawal by Subject|1
5800221|NCT02994108|20005420|P2|Phase 2 Assessment|Lost to Follow-up|7
5800222|NCT02994108|20005421|P1|Phase 2 Assessment|Lost to Follow-up|8
5800223|NCT02994108|20005420|P2|Phase 1 Assessment|Lost to Follow-up|3
5800224|NCT02994108|20005421|P1|Phase 1 Assessment|Lost to Follow-up|5
5800225|NCT02994108|20005420|P2|Intervention Messages|Withdrawal by Subject|0
5800226|NCT02994108|20005421|P1|Intervention Messages|Withdrawal by Subject|2
5800227|NCT02994056|20005453|P1|Overall Study|Withdrew Consent|1
5800228|NCT02994056|20005453|P1|Overall Study|Death|8
5800229|NCT02993926|20005487|P3|Enantone Treatment Phase|Reason Not Specified|0
5800230|NCT02993926|20005488|P2|Enantone Treatment Phase|Reason Not Specified|0
5800231|NCT02993926|20005489|P1|Enantone Treatment Phase|Reason Not Specified|4
5800232|NCT02993926|20005487|P3|Enantone Treatment Phase|Investigator Judgment|0
5800233|NCT02993926|20005488|P2|Enantone Treatment Phase|Investigator Judgment|0
5800234|NCT02993926|20005489|P1|Enantone Treatment Phase|Investigator Judgment|1
5800235|NCT02993926|20005487|P3|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0
5800236|NCT02993926|20005488|P2|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0
5800237|NCT02993926|20005489|P1|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|26
5800238|NCT02993926|20005487|P3|Enantone Treatment Phase|Adverse Event|0
5800239|NCT02993926|20005488|P2|Enantone Treatment Phase|Adverse Event|0
5800240|NCT02993926|20005489|P1|Enantone Treatment Phase|Adverse Event|1
5800241|NCT02993783|20005521|P2|Overall Study|Reason not Specified|9
5800242|NCT02993783|20005522|P1|Overall Study|Reason not Specified|6
5800243|NCT02993757|20005554|P2|Overall Study|Voluntary withdraw not due adverse event|8
5800244|NCT02993757|20005555|P1|Overall Study|Voluntary withdraw not due adverse event|8
5800245|NCT02993757|20005554|P2|Overall Study|Lost to Follow-up|0
5800246|NCT02993757|20005555|P1|Overall Study|Lost to Follow-up|1
5800247|NCT02993757|20005554|P2|Overall Study|Non compliance with the protocol|170
5800248|NCT02993757|20005555|P1|Overall Study|Non compliance with the protocol|155
5800249|NCT02993471|20005587|P1|Period 2 (Drug Cocktail + Ixekizumab)|Withdrawal by Subject|1
5800250|NCT02993471|20005587|P1|Period 2 (Drug Cocktail + Ixekizumab)|Protocol Violation|1
5800251|NCT02993250|20005649|P2|Overall Study|Lost to Follow-up|1
5800252|NCT02993250|20005650|P1|Overall Study|Lost to Follow-up|0
5800253|NCT02992691|20005670|P1|Overall Study|Withdrawal by Subject|1
5800254|NCT02992691|20005670|P1|Overall Study|Adverse Event|2
5800255|NCT02992418|20005689|P2|Overall Study|Lost to Follow-up|22
5800256|NCT02992418|20005690|P1|Overall Study|Lost to Follow-up|27
5800257|NCT02992418|20005689|P2|Overall Study|Non-compliance with the protocol|308
5800258|NCT02992418|20005690|P1|Overall Study|Non-compliance with the protocol|308
5800259|NCT02992418|20005689|P2|Overall Study|Withdrawal by Subject|12
5800260|NCT02992418|20005690|P1|Overall Study|Withdrawal by Subject|11
5800261|NCT02992288|20005730|P6|Overall Study|Withdrawal by Subject|4
5800262|NCT02992288|20005731|P5|Overall Study|Withdrawal by Subject|3
5800263|NCT02992288|20005732|P4|Overall Study|Withdrawal by Subject|5
5800264|NCT02992288|20005733|P3|Overall Study|Withdrawal by Subject|1
5800265|NCT02992288|20005734|P2|Overall Study|Withdrawal by Subject|2
5800266|NCT02992288|20005735|P1|Overall Study|Withdrawal by Subject|4
5800267|NCT02992288|20005730|P6|Overall Study|Protocol Violation|1
5800268|NCT02992288|20005731|P5|Overall Study|Protocol Violation|0
5800269|NCT02992288|20005732|P4|Overall Study|Protocol Violation|0
5800270|NCT02992288|20005733|P3|Overall Study|Protocol Violation|0
5800271|NCT02992288|20005734|P2|Overall Study|Protocol Violation|0
5800272|NCT02992288|20005735|P1|Overall Study|Protocol Violation|0
5800273|NCT02992288|20005730|P6|Overall Study|Lost to Follow-up|0
5800274|NCT02992288|20005731|P5|Overall Study|Lost to Follow-up|0
5800275|NCT02992288|20005732|P4|Overall Study|Lost to Follow-up|1
5800276|NCT02992288|20005733|P3|Overall Study|Lost to Follow-up|0
5800277|NCT02992288|20005734|P2|Overall Study|Lost to Follow-up|0
5800278|NCT02992288|20005735|P1|Overall Study|Lost to Follow-up|0
5800279|NCT02992288|20005730|P6|Overall Study|Death|0
5800280|NCT02992288|20005731|P5|Overall Study|Death|2
5800281|NCT02992288|20005732|P4|Overall Study|Death|1
5800282|NCT02992288|20005733|P3|Overall Study|Death|2
5800283|NCT02992288|20005734|P2|Overall Study|Death|0
5800284|NCT02992288|20005735|P1|Overall Study|Death|2
5800285|NCT02992288|20005730|P6|Overall Study|Physician Decision|1
5800286|NCT02992288|20005731|P5|Overall Study|Physician Decision|0
5800287|NCT02992288|20005732|P4|Overall Study|Physician Decision|0
5800288|NCT02992288|20005733|P3|Overall Study|Physician Decision|1
5800289|NCT02992288|20005734|P2|Overall Study|Physician Decision|0
5800290|NCT02992288|20005735|P1|Overall Study|Physician Decision|3
5800291|NCT02992288|20005730|P6|Overall Study|Non-compliance with study drug|0
5800292|NCT02992288|20005731|P5|Overall Study|Non-compliance with study drug|1
5800293|NCT02992288|20005732|P4|Overall Study|Non-compliance with study drug|0
5800294|NCT02992288|20005733|P3|Overall Study|Non-compliance with study drug|1
5800295|NCT02992288|20005734|P2|Overall Study|Non-compliance with study drug|1
5800296|NCT02992288|20005735|P1|Overall Study|Non-compliance with study drug|0
5800297|NCT02992288|20005730|P6|Overall Study|Adverse Event|7
5800298|NCT02992288|20005731|P5|Overall Study|Adverse Event|2
5800299|NCT02992288|20005732|P4|Overall Study|Adverse Event|2
5800300|NCT02992288|20005733|P3|Overall Study|Adverse Event|2
5800301|NCT02992288|20005734|P2|Overall Study|Adverse Event|2
5800302|NCT02992288|20005735|P1|Overall Study|Adverse Event|8
5800303|NCT02992132|20005820|P3|Overall Study|Physician Decision|1
5800304|NCT02992132|20005821|P2|Overall Study|Physician Decision|0
5800305|NCT02992132|20005822|P1|Overall Study|Physician Decision|0
5800306|NCT02992132|20005820|P3|Overall Study|Withdrawal by Subject|1
5800307|NCT02992132|20005821|P2|Overall Study|Withdrawal by Subject|2
5800308|NCT02992132|20005822|P1|Overall Study|Withdrawal by Subject|0
5800309|NCT02992132|20005820|P3|Overall Study|Caregiver withdrew consent|2
5800310|NCT02992132|20005821|P2|Overall Study|Caregiver withdrew consent|3
5800311|NCT02992132|20005822|P1|Overall Study|Caregiver withdrew consent|2
5800312|NCT02992132|20005820|P3|Overall Study|Protocol Violation|0
5800313|NCT02992132|20005821|P2|Overall Study|Protocol Violation|2
5800314|NCT02992132|20005822|P1|Overall Study|Protocol Violation|2
5800315|NCT02992132|20005820|P3|Overall Study|Progressive disease|0
5800316|NCT02992132|20005821|P2|Overall Study|Progressive disease|0
5800317|NCT02992132|20005822|P1|Overall Study|Progressive disease|1
5800318|NCT02992132|20005820|P3|Overall Study|Non-compliance with study drug|0
5800319|NCT02992132|20005821|P2|Overall Study|Non-compliance with study drug|0
5800320|NCT02992132|20005822|P1|Overall Study|Non-compliance with study drug|2
5800321|NCT02992132|20005820|P3|Overall Study|Lack of Efficacy|0
5800322|NCT02992132|20005821|P2|Overall Study|Lack of Efficacy|0
5800323|NCT02992132|20005822|P1|Overall Study|Lack of Efficacy|2
5800324|NCT02992132|20005820|P3|Overall Study|Adverse Event|3
5800325|NCT02992132|20005821|P2|Overall Study|Adverse Event|1
5800326|NCT02992132|20005822|P1|Overall Study|Adverse Event|4
5800327|NCT02991859|20005935|P17|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
5800328|NCT02991859|20005936|P16|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
5800329|NCT02991859|20005937|P15|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
5800330|NCT02991859|20005938|P14|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
5800331|NCT02991859|20005939|P13|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
5800332|NCT02991859|20005940|P12|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
5800333|NCT02991859|20005941|P11|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
5800334|NCT02991859|20005942|P10|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
5800335|NCT02991859|20005943|P9|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|1
5800336|NCT02991859|20005944|P8|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
5800337|NCT02991859|20005945|P7|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
5800338|NCT02991859|20005946|P6|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
5800339|NCT02991859|20005947|P5|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
5800340|NCT02991859|20005948|P4|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
5800341|NCT02991859|20005949|P3|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
5800342|NCT02991859|20005950|P2|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
5800343|NCT02991859|20005951|P1|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
5800344|NCT02991859|20005935|P17|Wash Out, Up to Day 77|Lost to Follow-up|0
5800345|NCT02991859|20005936|P16|Wash Out, Up to Day 77|Lost to Follow-up|0
5800346|NCT02991859|20005937|P15|Wash Out, Up to Day 77|Lost to Follow-up|0
5800347|NCT02991859|20005938|P14|Wash Out, Up to Day 77|Lost to Follow-up|0
5800348|NCT02991859|20005939|P13|Wash Out, Up to Day 77|Lost to Follow-up|0
5800349|NCT02991859|20005940|P12|Wash Out, Up to Day 77|Lost to Follow-up|0
5800350|NCT02991859|20005941|P11|Wash Out, Up to Day 77|Lost to Follow-up|0
5800351|NCT02991859|20005942|P10|Wash Out, Up to Day 77|Lost to Follow-up|1
5800352|NCT02991859|20005943|P9|Wash Out, Up to Day 77|Lost to Follow-up|0
5800353|NCT02991859|20005944|P8|Wash Out, Up to Day 77|Lost to Follow-up|0
5800354|NCT02991859|20005945|P7|Wash Out, Up to Day 77|Lost to Follow-up|0
5800355|NCT02991859|20005946|P6|Wash Out, Up to Day 77|Lost to Follow-up|0
5800356|NCT02991859|20005947|P5|Wash Out, Up to Day 77|Lost to Follow-up|0
5800357|NCT02991859|20005948|P4|Wash Out, Up to Day 77|Lost to Follow-up|0
5800358|NCT02991859|20005949|P3|Wash Out, Up to Day 77|Lost to Follow-up|0
5800359|NCT02991859|20005950|P2|Wash Out, Up to Day 77|Lost to Follow-up|0
5800360|NCT02991859|20005951|P1|Wash Out, Up to Day 77|Lost to Follow-up|0
5800361|NCT02991859|20005935|P17|Wash Out, Up to Day 77|Withdrawal by Subject|0
5800362|NCT02991859|20005936|P16|Wash Out, Up to Day 77|Withdrawal by Subject|0
5800363|NCT02991859|20005937|P15|Wash Out, Up to Day 77|Withdrawal by Subject|0
5800364|NCT02991859|20005938|P14|Wash Out, Up to Day 77|Withdrawal by Subject|0
5800365|NCT02991859|20005939|P13|Wash Out, Up to Day 77|Withdrawal by Subject|0
5800366|NCT02991859|20005940|P12|Wash Out, Up to Day 77|Withdrawal by Subject|0
5800367|NCT02991859|20005941|P11|Wash Out, Up to Day 77|Withdrawal by Subject|0
5800368|NCT02991859|20005942|P10|Wash Out, Up to Day 77|Withdrawal by Subject|0
5800369|NCT02991859|20005943|P9|Wash Out, Up to Day 77|Withdrawal by Subject|0
5800370|NCT02991859|20005944|P8|Wash Out, Up to Day 77|Withdrawal by Subject|0
5800371|NCT02991859|20005945|P7|Wash Out, Up to Day 77|Withdrawal by Subject|0
5800372|NCT02991859|20005946|P6|Wash Out, Up to Day 77|Withdrawal by Subject|1
5800373|NCT02991859|20005947|P5|Wash Out, Up to Day 77|Withdrawal by Subject|0
5800374|NCT02991859|20005948|P4|Wash Out, Up to Day 77|Withdrawal by Subject|0
5800375|NCT02991859|20005949|P3|Wash Out, Up to Day 77|Withdrawal by Subject|0
5800376|NCT02991859|20005950|P2|Wash Out, Up to Day 77|Withdrawal by Subject|0
5800377|NCT02991859|20005951|P1|Wash Out, Up to Day 77|Withdrawal by Subject|0
5800378|NCT02991859|20005935|P17|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
5800379|NCT02991859|20005936|P16|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
5800380|NCT02991859|20005937|P15|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
5800381|NCT02991859|20005938|P14|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1
5800382|NCT02991859|20005939|P13|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1
5800383|NCT02991859|20005940|P12|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
5800384|NCT02991859|20005941|P11|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
5800385|NCT02991859|20005942|P10|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
5800386|NCT02991859|20005943|P9|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
5800387|NCT02991859|20005944|P8|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
5800388|NCT02991859|20005945|P7|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
5800389|NCT02991859|20005946|P6|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
5800390|NCT02991859|20005947|P5|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
5800391|NCT02991859|20005948|P4|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
5800392|NCT02991859|20005949|P3|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
5800393|NCT02991859|20005950|P2|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
5800394|NCT02991859|20005951|P1|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
5800395|NCT02991859|20005935|P17|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
5800396|NCT02991859|20005936|P16|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
5800397|NCT02991859|20005937|P15|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
5800398|NCT02991859|20005938|P14|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
5800399|NCT02991859|20005939|P13|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
5800400|NCT02991859|20005940|P12|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
5800401|NCT02991859|20005941|P11|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
5800402|NCT02991859|20005942|P10|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
5800403|NCT02991859|20005943|P9|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
5800404|NCT02991859|20005944|P8|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
5800405|NCT02991859|20005945|P7|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
5800406|NCT02991859|20005946|P6|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
5800407|NCT02991859|20005947|P5|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1
5800408|NCT02991859|20005948|P4|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
5800409|NCT02991859|20005949|P3|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
5800410|NCT02991859|20005950|P2|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1
5800411|NCT02991859|20005951|P1|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
5800412|NCT02991430|20006246|P3|Post-treatment Observation Period|Study Termination|5
5800413|NCT02991430|20006247|P2|Post-treatment Observation Period|Study Termination|6
5800414|NCT02991430|20006248|P1|Post-treatment Observation Period|Study Termination|3
5800415|NCT02991430|20006246|P3|Treatment Period 2|Lost to Follow-up|1
5800416|NCT02991430|20006247|P2|Treatment Period 2|Lost to Follow-up|0
5800417|NCT02991430|20006248|P1|Treatment Period 2|Lost to Follow-up|0
5800418|NCT02991430|20006246|P3|Treatment Period 2|Study Termination|3
5800419|NCT02991430|20006247|P2|Treatment Period 2|Study Termination|3
5800420|NCT02991430|20006248|P1|Treatment Period 2|Study Termination|6
5800421|NCT02991430|20006246|P3|Treatment Period 1|Withdrawal by Subject|0
5800422|NCT02991430|20006247|P2|Treatment Period 1|Withdrawal by Subject|4
5800423|NCT02991430|20006248|P1|Treatment Period 1|Withdrawal by Subject|0
5800424|NCT02991430|20006246|P3|Treatment Period 1|Adverse Event|2
5800425|NCT02991430|20006247|P2|Treatment Period 1|Adverse Event|0
5800426|NCT02991430|20006248|P1|Treatment Period 1|Adverse Event|1
5800427|NCT02991118|20006285|P2|Overall Study|Lost to Follow-up|9
5800428|NCT02991118|20006286|P1|Overall Study|Lost to Follow-up|1
5800429|NCT02991118|20006285|P2|Overall Study|Could not attend study visits|1
5800430|NCT02991118|20006286|P1|Overall Study|Could not attend study visits|0
5800431|NCT02991118|20006285|P2|Overall Study|Withdrawal by Subject|7
5800432|NCT02991118|20006286|P1|Overall Study|Withdrawal by Subject|1
5800433|NCT02991118|20006285|P2|Overall Study|Adverse Event|2
5800434|NCT02991118|20006286|P1|Overall Study|Adverse Event|2
5800435|NCT02991118|20006285|P2|Overall Study|Moved out of the country|1
5800436|NCT02991118|20006286|P1|Overall Study|Moved out of the country|0
5800437|NCT02991118|20006285|P2|Overall Study|Physician Decision|1
5800438|NCT02991118|20006286|P1|Overall Study|Physician Decision|0
5800439|NCT02991118|20006285|P2|Overall Study|Protocol Violation|3
5800440|NCT02991118|20006286|P1|Overall Study|Protocol Violation|0
5800441|NCT02991118|20006285|P2|Overall Study|Death|8
5800442|NCT02991118|20006286|P1|Overall Study|Death|3
5800443|NCT02991040|20006330|P1|Overall Study|Lost to Follow-up|2
5800444|NCT02991040|20006330|P1|Overall Study|Withdrawal by Subject|2
5800445|NCT02990910|20006345|P2|Overall Study|Lack of Efficacy|10
5800446|NCT02990910|20006346|P1|Overall Study|Lack of Efficacy|6
5800459|NCT02990000|20006405|P2|Overall Study|Failed to provide data beyond baseline|34
5800460|NCT02990000|20006406|P1|Overall Study|Failed to provide data beyond baseline|36
5800461|NCT02989805|20006426|P2|Overall Study|invalid consent|4
5800462|NCT02989805|20006427|P1|Overall Study|invalid consent|6
5800463|NCT02989649|20006528|P1|Overall Study|Reason Not Specified|13
5800464|NCT02989649|20006528|P1|Overall Study|Lost For Observation During Study|3
5800465|NCT02989649|20006528|P1|Overall Study|Adverse Event/Adverse Drug Reaction|1
5800466|NCT02989649|20006528|P1|Overall Study|Patient/Investigator's Decision to Stop|403
5800467|NCT02989610|20006540|P1|Overall Study|Withdrawal/Other reasons|39
5800468|NCT02989389|20006570|P10|Period 1|Physician Decision|0
5800469|NCT02989389|20006571|P9|Period 1|Physician Decision|1
5800470|NCT02989389|20006572|P8|Period 1|Physician Decision|0
5800471|NCT02989389|20006573|P7|Period 1|Physician Decision|0
5800472|NCT02989389|20006574|P6|Period 1|Physician Decision|0
5800473|NCT02989389|20006575|P5|Period 1|Physician Decision|0
5800474|NCT02989389|20006576|P4|Period 1|Physician Decision|0
5800475|NCT02989389|20006577|P3|Period 1|Physician Decision|0
5800476|NCT02989389|20006578|P2|Period 1|Physician Decision|0
5800477|NCT02989389|20006579|P1|Period 1|Physician Decision|0
5800478|NCT02989389|20006570|P10|Period 1|Lost to Follow-up|0
5800479|NCT02989389|20006571|P9|Period 1|Lost to Follow-up|0
5800480|NCT02989389|20006572|P8|Period 1|Lost to Follow-up|0
5800481|NCT02989389|20006573|P7|Period 1|Lost to Follow-up|0
5800482|NCT02989389|20006574|P6|Period 1|Lost to Follow-up|0
5800483|NCT02989389|20006575|P5|Period 1|Lost to Follow-up|0
5800484|NCT02989389|20006576|P4|Period 1|Lost to Follow-up|0
5800485|NCT02989389|20006577|P3|Period 1|Lost to Follow-up|0
5800486|NCT02989389|20006578|P2|Period 1|Lost to Follow-up|1
5800487|NCT02989389|20006579|P1|Period 1|Lost to Follow-up|0
5800488|NCT02989168|20006645|P2|Overall Study|Sponsor stopped study.|0
5800489|NCT02989168|20006646|P1|Overall Study|Sponsor stopped study.|1
5800490|NCT02989168|20006645|P2|Overall Study|Adverse Event|2
5800491|NCT02989168|20006646|P1|Overall Study|Adverse Event|1
5800492|NCT02989168|20006645|P2|Overall Study|Physician Decision|1
5800493|NCT02989168|20006646|P1|Overall Study|Physician Decision|0
5800494|NCT02989168|20006645|P2|Overall Study|Withdrawal by Subject|0
5800495|NCT02989168|20006646|P1|Overall Study|Withdrawal by Subject|2
5800496|NCT02988622|20006692|P1|Overall Study|Lost to Follow-up|17
5800497|NCT02988219|20006727|P2|Overall Study|Withdrawal by Subject|2
5800498|NCT02988219|20006728|P1|Overall Study|Withdrawal by Subject|0
5800499|NCT02988219|20006727|P2|Overall Study|Lack of Efficacy|1
5800500|NCT02988219|20006728|P1|Overall Study|Lack of Efficacy|1
5800501|NCT02988115|20006747|P2|Overall Study|Lost to Follow-up|0
5800502|NCT02988115|20006748|P1|Overall Study|Lost to Follow-up|1
5800503|NCT02988115|20006747|P2|Overall Study|Withdrawn by Mistake|0
5800504|NCT02988115|20006748|P1|Overall Study|Withdrawn by Mistake|1
5800505|NCT02988115|20006747|P2|Overall Study|Withdrawal by Subject|1
5800506|NCT02988115|20006748|P1|Overall Study|Withdrawal by Subject|1
5800507|NCT02988115|20006747|P2|Overall Study|Sponsor Decision|2
5800508|NCT02988115|20006748|P1|Overall Study|Sponsor Decision|5
5800509|NCT02988115|20006747|P2|Overall Study|Adverse Event|1
5800510|NCT02988115|20006748|P1|Overall Study|Adverse Event|6
5800511|NCT02987972|20006774|P3|Overall Study|Withdrawal by Subject|21
5800512|NCT02987972|20006775|P2|Overall Study|Withdrawal by Subject|17
5800513|NCT02987972|20006776|P1|Overall Study|Withdrawal by Subject|22
5800514|NCT02987972|20006774|P3|Overall Study|Protocol Violation|5
5800515|NCT02987972|20006775|P2|Overall Study|Protocol Violation|1
5800516|NCT02987972|20006776|P1|Overall Study|Protocol Violation|2
5800517|NCT02987972|20006774|P3|Overall Study|Physician Decision|0
5800518|NCT02987972|20006775|P2|Overall Study|Physician Decision|6
5800519|NCT02987972|20006776|P1|Overall Study|Physician Decision|1
5800520|NCT02987972|20006774|P3|Overall Study|Lost to Follow-up|4
5800521|NCT02987972|20006775|P2|Overall Study|Lost to Follow-up|8
5800522|NCT02987972|20006776|P1|Overall Study|Lost to Follow-up|7
5800523|NCT02987972|20006774|P3|Overall Study|Lack of Efficacy|12
5800524|NCT02987972|20006775|P2|Overall Study|Lack of Efficacy|12
5800525|NCT02987972|20006776|P1|Overall Study|Lack of Efficacy|9
5800526|NCT02987972|20006774|P3|Overall Study|Death|0
5800527|NCT02987972|20006775|P2|Overall Study|Death|0
5800528|NCT02987972|20006776|P1|Overall Study|Death|1
5800529|NCT02987972|20006774|P3|Overall Study|Adverse Event|0
5800530|NCT02987972|20006775|P2|Overall Study|Adverse Event|1
5800531|NCT02987972|20006776|P1|Overall Study|Adverse Event|1
5800532|NCT02987660|20006814|P2|Overall Study|Study terminated by sponsor|10
5800533|NCT02987660|20006815|P1|Overall Study|Study terminated by sponsor|10
5800566|NCT02987205|20006872|P1|Overall Study|Withdrawal by Subject|3
5800567|NCT02987205|20006872|P1|Overall Study|Adverse Event|1
5800568|NCT02986854|20006906|P3|Overall Study|Lost to Follow-up|2
5800569|NCT02986854|20006907|P2|Overall Study|Lost to Follow-up|11
5800570|NCT02986854|20006908|P1|Overall Study|Lost to Follow-up|3
5800571|NCT02986854|20006906|P3|Overall Study|Withdrawal by Subject|1
5800572|NCT02986854|20006907|P2|Overall Study|Withdrawal by Subject|1
5800573|NCT02986854|20006908|P1|Overall Study|Withdrawal by Subject|0
5800574|NCT02986373|20006992|P1|Overall Study|Other|24
5800575|NCT02986373|20006992|P1|Overall Study|Withdrawal by Subject|10
5800576|NCT02986373|20006992|P1|Overall Study|Lost to Follow-up|1
5800577|NCT02986373|20006992|P1|Overall Study|Adverse Event|4
5800578|NCT02986139|20007034|P2|Overall Study|Lost to Follow-up|1
5800579|NCT02986139|20007035|P1|Overall Study|Lost to Follow-up|0
5800580|NCT02986139|20007034|P2|Overall Study|Withdrawal by Subject|1
5800581|NCT02986139|20007035|P1|Overall Study|Withdrawal by Subject|0
5800582|NCT02986139|20007034|P2|Overall Study|Sponsor Decision|2
5800583|NCT02986139|20007035|P1|Overall Study|Sponsor Decision|1
5800584|NCT02985996|20007052|P5|Overall Study|Protocol Violation|0
5800585|NCT02985996|20007053|P4|Overall Study|Protocol Violation|0
5800586|NCT02985996|20007054|P3|Overall Study|Protocol Violation|0
5800587|NCT02985996|20007055|P2|Overall Study|Protocol Violation|1
5800588|NCT02985996|20007056|P1|Overall Study|Protocol Violation|0
5800589|NCT02985996|20007052|P5|Overall Study|Withdrawal by Subject|0
5800590|NCT02985996|20007053|P4|Overall Study|Withdrawal by Subject|0
5800591|NCT02985996|20007054|P3|Overall Study|Withdrawal by Subject|1
5800592|NCT02985996|20007055|P2|Overall Study|Withdrawal by Subject|0
5800593|NCT02985996|20007056|P1|Overall Study|Withdrawal by Subject|0
5800594|NCT02985684|20007190|P1|6-Month Closure Success Evaluation|Device Removal|3
5800595|NCT02985684|20007190|P1|6-Month Closure Success Evaluation|Technical Failure (No Device)|5
5800596|NCT02985684|20007190|P1|6-Month Clinical Success Evaluation|Missed Echocardiograph|5
5800597|NCT02985398|20007201|P1|Overall Study|Study Burden|9
5800598|NCT02985398|20007201|P1|Overall Study|Withdrawal by Subject|8
5800599|NCT02985398|20007201|P1|Overall Study|Lost to Follow-up|4
5800600|NCT02985398|20007201|P1|Overall Study|Adverse Event|1
5800601|NCT02984995|20007219|P2|Overall Study|Adverse Event|0
5800602|NCT02984995|20007220|P1|Overall Study|Adverse Event|1
5800603|NCT02984995|20007219|P2|Overall Study|Progressive disease|1
5800604|NCT02984995|20007220|P1|Overall Study|Progressive disease|11
5800605|NCT02984995|20007219|P2|Overall Study|Required stem cell transplant|2
5800606|NCT02984995|20007220|P1|Overall Study|Required stem cell transplant|13
5800607|NCT02984982|20007267|P2|Overall Study|Randomized but not treated|1
5800608|NCT02984982|20007268|P1|Overall Study|Randomized but not treated|0
5800609|NCT02984982|20007267|P2|Overall Study|Withdrawal by Subject|0
5800610|NCT02984982|20007268|P1|Overall Study|Withdrawal by Subject|2
5800611|NCT02984982|20007267|P2|Overall Study|Poor Compliance to Protocol|4
5800612|NCT02984982|20007268|P1|Overall Study|Poor Compliance to Protocol|4
5800613|NCT02984982|20007267|P2|Overall Study|Adverse Event|5
5800614|NCT02984982|20007268|P1|Overall Study|Adverse Event|2
5800615|NCT02984943|20007320|P1|Overall Study|Physician Decision|1
5800616|NCT02984943|20007320|P1|Overall Study|Withdrawal by Subject|3
5800617|NCT02984267|20007434|P2|Overall Study|Withdrawal by Subject|1
5800618|NCT02984267|20007435|P1|Overall Study|Withdrawal by Subject|0
5800619|NCT02984267|20007434|P2|Overall Study|Protocol Violation|0
5800620|NCT02984267|20007435|P1|Overall Study|Protocol Violation|1
5800621|NCT02983617|20007480|P2|Overall Study|Still on Study|28
5800622|NCT02983617|20007481|P1|Overall Study|Still on Study|6
5800623|NCT02983617|20007480|P2|Overall Study|Death|1
5800624|NCT02983617|20007481|P1|Overall Study|Death|0
5800625|NCT02983617|20007480|P2|Overall Study|Adverse Event|1
5800626|NCT02983617|20007481|P1|Overall Study|Adverse Event|0
5800627|NCT02983604|20007499|P4|Overall Study|Enrolled but not Treated|0
5800628|NCT02983604|20007500|P3|Overall Study|Enrolled but not Treated|1
5800629|NCT02983604|20007501|P2|Overall Study|Enrolled but not Treated|0
5800630|NCT02983604|20007502|P1|Overall Study|Enrolled but not Treated|0
5800631|NCT02983305|20007551|P2|Overall Study|incomplete data|0
5800632|NCT02983305|20007552|P1|Overall Study|incomplete data|2
5800633|NCT02983227|20007562|P2|Overall Study|Withdrawal by Subject|8
5800634|NCT02983227|20007563|P1|Overall Study|Withdrawal by Subject|19
5800635|NCT02983227|20007562|P2|Overall Study|Physician Decision|1
5800636|NCT02983227|20007563|P1|Overall Study|Physician Decision|3
5800637|NCT02983227|20007562|P2|Overall Study|Multiple Reasons|1
5800638|NCT02983227|20007563|P1|Overall Study|Multiple Reasons|2
5800639|NCT02983227|20007562|P2|Overall Study|Lost to Follow-up|0
5800640|NCT02983227|20007563|P1|Overall Study|Lost to Follow-up|3
5800641|NCT02983227|20007562|P2|Overall Study|Lack of Efficacy|1
5800642|NCT02983227|20007563|P1|Overall Study|Lack of Efficacy|8
5800643|NCT02983227|20007562|P2|Overall Study|Death|0
5800644|NCT02983227|20007563|P1|Overall Study|Death|3
5800645|NCT02983227|20007562|P2|Overall Study|Adverse Event|3
5800646|NCT02983227|20007563|P1|Overall Study|Adverse Event|21
5800647|NCT02982863|20007643|P5|Overall Study|Not eligible patients|492
5800648|NCT02982863|20007644|P4|Overall Study|Not eligible patients|1400
5800649|NCT02982863|20007645|P3|Overall Study|Not eligible patients|1852
5800650|NCT02982863|20007646|P2|Overall Study|Not eligible patients|4261
5800651|NCT02982863|20007647|P1|Overall Study|Not eligible patients|809
5800652|NCT02982720|20007704|P1|Overall Study|Death|1
5800653|NCT02982720|20007704|P1|Overall Study|Adverse Event|3
5800654|NCT02982239|20007714|P2|Overall Study|Lost to Follow-up|2
5800655|NCT02982239|20007715|P1|Overall Study|Lost to Follow-up|3
5800656|NCT02982213|20007731|P2|Overall Study|Did not complete follow up questionnaire|1
5800657|NCT02982213|20007732|P1|Overall Study|Did not complete follow up questionnaire|5
5800658|NCT02982187|20007748|P8|Overall Study|Withdrawal by Subject|0
5800659|NCT02982187|20007749|P7|Overall Study|Withdrawal by Subject|1
5800660|NCT02982187|20007750|P6|Overall Study|Withdrawal by Subject|0
5800661|NCT02982187|20007751|P5|Overall Study|Withdrawal by Subject|0
5800662|NCT02982187|20007752|P4|Overall Study|Withdrawal by Subject|0
5800663|NCT02982187|20007753|P3|Overall Study|Withdrawal by Subject|0
5800664|NCT02982187|20007754|P2|Overall Study|Withdrawal by Subject|0
5800665|NCT02982187|20007755|P1|Overall Study|Withdrawal by Subject|0
5800666|NCT02982018|20007805|P2|Overall Study|Withdrawal by Subject|1
5800667|NCT02982018|20007806|P1|Overall Study|Withdrawal by Subject|0
5800668|NCT02982018|20007805|P2|Overall Study|Lens Discomfort|0
5800669|NCT02982018|20007806|P1|Overall Study|Lens Discomfort|2
5800670|NCT02982018|20007805|P2|Overall Study|Adverse Event|1
5800671|NCT02982018|20007806|P1|Overall Study|Adverse Event|1
5800672|NCT02982018|20007805|P2|Overall Study|Protocol Violation|1
5800673|NCT02982018|20007806|P1|Overall Study|Protocol Violation|1
5800674|NCT02982018|20007805|P2|Overall Study|Incorrect Lens Dispensed|0
5800675|NCT02982018|20007806|P1|Overall Study|Incorrect Lens Dispensed|1
5800676|NCT02981602|20007825|P5|Overall Study|Adverse Event|0
5800677|NCT02981602|20007826|P4|Overall Study|Adverse Event|1
5800678|NCT02981602|20007827|P3|Overall Study|Adverse Event|0
5800679|NCT02981602|20007828|P2|Overall Study|Adverse Event|0
5800680|NCT02981602|20007829|P1|Overall Study|Adverse Event|0
5800685|NCT02981342|20008021|P4|Overall Study|Lost to Follow-up|0
5800686|NCT02981342|20008022|P3|Overall Study|Lost to Follow-up|0
5800687|NCT02981342|20008023|P2|Overall Study|Lost to Follow-up|1
5800688|NCT02981342|20008024|P1|Overall Study|Lost to Follow-up|0
5800689|NCT02981342|20008021|P4|Overall Study|Randomized, Never Treated|7
5800690|NCT02981342|20008022|P3|Overall Study|Randomized, Never Treated|0
5800691|NCT02981342|20008023|P2|Overall Study|Randomized, Never Treated|1
5800692|NCT02981342|20008024|P1|Overall Study|Randomized, Never Treated|0
5800693|NCT02981342|20008021|P4|Overall Study|Study closed by sponsor|1
5800694|NCT02981342|20008022|P3|Overall Study|Study closed by sponsor|1
5800695|NCT02981342|20008023|P2|Overall Study|Study closed by sponsor|0
5800696|NCT02981342|20008024|P1|Overall Study|Study closed by sponsor|0
5800697|NCT02981342|20008021|P4|Overall Study|Withdrawal by Subject|1
5800698|NCT02981342|20008022|P3|Overall Study|Withdrawal by Subject|3
5800699|NCT02981342|20008023|P2|Overall Study|Withdrawal by Subject|0
5800700|NCT02981342|20008024|P1|Overall Study|Withdrawal by Subject|0
5800701|NCT02981342|20008021|P4|Overall Study|Death|4
5800702|NCT02981342|20008022|P3|Overall Study|Death|9
5800703|NCT02981342|20008023|P2|Overall Study|Death|9
5800704|NCT02981342|20008024|P1|Overall Study|Death|0
5800705|NCT02981342|20008021|P4|Overall Study|Adverse Event|1
5800706|NCT02981342|20008022|P3|Overall Study|Adverse Event|0
5800707|NCT02981342|20008023|P2|Overall Study|Adverse Event|0
5800708|NCT02981342|20008024|P1|Overall Study|Adverse Event|0
5800709|NCT02980783|20008082|P1|Overall Study|Lost to Follow-up|1
5800710|NCT02980601|20008095|P2|Overall Study|Failed to sign consent|0
5800711|NCT02980601|20008096|P1|Overall Study|Failed to sign consent|2
5800712|NCT02980601|20008095|P2|Overall Study|Graft loss|0
5800713|NCT02980601|20008096|P1|Overall Study|Graft loss|1
5800714|NCT02980601|20008095|P2|Overall Study|Death|1
5800715|NCT02980601|20008096|P1|Overall Study|Death|0
5800716|NCT02980601|20008095|P2|Overall Study|Lost to Follow-up|2
5800717|NCT02980601|20008096|P1|Overall Study|Lost to Follow-up|2
5800718|NCT02980523|20008189|P5|Overall Study|Did not receive intervention|0
5800719|NCT02980523|20008190|P4|Overall Study|Did not receive intervention|1
5800720|NCT02980523|20008191|P3|Overall Study|Did not receive intervention|0
5800721|NCT02980523|20008192|P2|Overall Study|Did not receive intervention|0
5800722|NCT02980523|20008193|P1|Overall Study|Did not receive intervention|0
5800723|NCT02980523|20008189|P5|Overall Study|Lack of Efficacy|8
5800724|NCT02980523|20008190|P4|Overall Study|Lack of Efficacy|5
5800725|NCT02980523|20008191|P3|Overall Study|Lack of Efficacy|4
5800726|NCT02980523|20008192|P2|Overall Study|Lack of Efficacy|4
5800727|NCT02980523|20008193|P1|Overall Study|Lack of Efficacy|1
5800728|NCT02980523|20008189|P5|Overall Study|Excluded from analysis|1
5800729|NCT02980523|20008190|P4|Overall Study|Excluded from analysis|1
5800730|NCT02980523|20008191|P3|Overall Study|Excluded from analysis|1
5800731|NCT02980523|20008192|P2|Overall Study|Excluded from analysis|3
5800732|NCT02980523|20008193|P1|Overall Study|Excluded from analysis|1
5800733|NCT02980523|20008189|P5|Overall Study|Lost to Follow-up|1
5800734|NCT02980523|20008190|P4|Overall Study|Lost to Follow-up|2
5800735|NCT02980523|20008191|P3|Overall Study|Lost to Follow-up|1
5800736|NCT02980523|20008192|P2|Overall Study|Lost to Follow-up|4
5800737|NCT02980523|20008193|P1|Overall Study|Lost to Follow-up|1
5800738|NCT02980224|20008237|P2|Overall Study|Withdrawal by Subject|2
5800739|NCT02980224|20008238|P1|Overall Study|Withdrawal by Subject|0
5800740|NCT02980224|20008237|P2|Overall Study|Adverse Event|1
5800741|NCT02980224|20008238|P1|Overall Study|Adverse Event|4
5800742|NCT02980133|20008256|P4|Overall Study|Withdrawal by Subject|0
5800743|NCT02980133|20008257|P3|Overall Study|Withdrawal by Subject|1
5800744|NCT02980133|20008258|P2|Overall Study|Withdrawal by Subject|0
5800745|NCT02980133|20008259|P1|Overall Study|Withdrawal by Subject|0
5800746|NCT02980133|20008256|P4|Overall Study|Withdrawal by parent/guardian|1
5800747|NCT02980133|20008257|P3|Overall Study|Withdrawal by parent/guardian|3
5800748|NCT02980133|20008258|P2|Overall Study|Withdrawal by parent/guardian|3
5800749|NCT02980133|20008259|P1|Overall Study|Withdrawal by parent/guardian|6
5800750|NCT02980133|20008256|P4|Overall Study|Protocol Violation|0
5800751|NCT02980133|20008257|P3|Overall Study|Protocol Violation|0
5800752|NCT02980133|20008258|P2|Overall Study|Protocol Violation|1
5800753|NCT02980133|20008259|P1|Overall Study|Protocol Violation|0
5800754|NCT02980133|20008256|P4|Overall Study|Lost to Follow-up|3
5800755|NCT02980133|20008257|P3|Overall Study|Lost to Follow-up|1
5800756|NCT02980133|20008258|P2|Overall Study|Lost to Follow-up|0
5800757|NCT02980133|20008259|P1|Overall Study|Lost to Follow-up|0
5800758|NCT02980133|20008256|P4|Overall Study|Other than specified|2
5800759|NCT02980133|20008257|P3|Overall Study|Other than specified|2
5800760|NCT02980133|20008258|P2|Overall Study|Other than specified|1
5800761|NCT02980133|20008259|P1|Overall Study|Other than specified|1
5800762|NCT02980107|20008297|P2|Overall Study|Withdrawal by Subject|62
5800763|NCT02980107|20008298|P1|Overall Study|Withdrawal by Subject|51
5800764|NCT02980042|20008312|P2|Overall Study|Insurance issues/treatment plan changes|0
5800765|NCT02980042|20008313|P1|Overall Study|Insurance issues/treatment plan changes|2
5800766|NCT02980042|20008312|P2|Overall Study|Lost to Follow-up|0
5800767|NCT02980042|20008313|P1|Overall Study|Lost to Follow-up|5
5800768|NCT02979639|20008345|P1|Overall Study|Adverse Event|2
5800769|NCT02979639|20008345|P1|Overall Study|Withdrawal by Subject|3
5800770|NCT02979639|20008345|P1|Overall Study|Lost to Follow-up|8
5800771|NCT02979639|20008345|P1|Overall Study|Withdrawal based on medical judgement|1
5800772|NCT02979613|20008377|P2|Open-Label Extension (OLE) Phase|Investigator's Discretion|1
5800773|NCT02979613|20008378|P1|Open-Label Extension (OLE) Phase|Investigator's Discretion|0
5800774|NCT02979613|20008377|P2|Open-Label Extension (OLE) Phase|Death|1
5800775|NCT02979613|20008378|P1|Open-Label Extension (OLE) Phase|Death|0
5800776|NCT02979613|20008377|P2|Open-Label Extension (OLE) Phase|Adverse Event|0
5800777|NCT02979613|20008378|P1|Open-Label Extension (OLE) Phase|Adverse Event|1
5800778|NCT02979613|20008377|P2|Open-Label Extension (OLE) Phase|Withdrew Consent|4
5800779|NCT02979613|20008378|P1|Open-Label Extension (OLE) Phase|Withdrew Consent|2
5800780|NCT02979613|20008377|P2|Double-Blind Phase|Randomized but Never Treated|0
5800781|NCT02979613|20008378|P1|Double-Blind Phase|Randomized but Never Treated|2
5800782|NCT02979613|20008377|P2|Double-Blind Phase|Protocol Violation|1
5800783|NCT02979613|20008378|P1|Double-Blind Phase|Protocol Violation|1
5800784|NCT02979613|20008377|P2|Double-Blind Phase|Lost to Follow-up|1
5800785|NCT02979613|20008378|P1|Double-Blind Phase|Lost to Follow-up|1
5800786|NCT02979613|20008377|P2|Double-Blind Phase|Adverse Event|0
5800787|NCT02979613|20008378|P1|Double-Blind Phase|Adverse Event|2
5800788|NCT02979613|20008377|P2|Double-Blind Phase|Pregnancy|2
5800789|NCT02979613|20008378|P1|Double-Blind Phase|Pregnancy|2
5800790|NCT02979613|20008377|P2|Double-Blind Phase|Withdrew Consent|4
5800791|NCT02979613|20008378|P1|Double-Blind Phase|Withdrew Consent|2
5800792|NCT02979535|20008438|P2|Overall Study|Lost to Follow-up|1
5800793|NCT02979535|20008439|P1|Overall Study|Lost to Follow-up|6
5800794|NCT02979535|20008438|P2|Overall Study|Consent withdrawn by participant|18
5800795|NCT02979535|20008439|P1|Overall Study|Consent withdrawn by participant|11
5800796|NCT02979535|20008438|P2|Overall Study|Non compliance with the protocol|82
5800797|NCT02979535|20008439|P1|Overall Study|Non compliance with the protocol|78
5800798|NCT02979431|20008502|P4|Overall Study|Subject left country after Day14|0
5800799|NCT02979431|20008503|P3|Overall Study|Subject left country after Day14|0
5800800|NCT02979431|20008504|P2|Overall Study|Subject left country after Day14|0
5800801|NCT02979431|20008505|P1|Overall Study|Subject left country after Day14|1
5800802|NCT02979431|20008502|P4|Overall Study|Adverse Event|0
5800803|NCT02979431|20008503|P3|Overall Study|Adverse Event|1
5800804|NCT02979431|20008504|P2|Overall Study|Adverse Event|0
5800805|NCT02979431|20008505|P1|Overall Study|Adverse Event|0
5800806|NCT02979431|20008502|P4|Overall Study|Randomized but received no study drug|0
5800807|NCT02979431|20008503|P3|Overall Study|Randomized but received no study drug|0
5800808|NCT02979431|20008504|P2|Overall Study|Randomized but received no study drug|1
5800809|NCT02979431|20008505|P1|Overall Study|Randomized but received no study drug|1
5800810|NCT02979431|20008502|P4|Overall Study|Parent/guardian withdrew consent|1
5800811|NCT02979431|20008503|P3|Overall Study|Parent/guardian withdrew consent|1
5800812|NCT02979431|20008504|P2|Overall Study|Parent/guardian withdrew consent|1
5800813|NCT02979431|20008505|P1|Overall Study|Parent/guardian withdrew consent|2
5800814|NCT02979249|20008583|P1|Overall Study|Withdrawal by Subject|4
5800815|NCT02979249|20008583|P1|Overall Study|Lost to Follow-up|2
5800816|NCT02979197|20008591|P3|Overall Study|Subject unable to commit to study dates|0
5800817|NCT02979197|20008592|P2|Overall Study|Subject unable to commit to study dates|1
5800818|NCT02979197|20008593|P1|Overall Study|Subject unable to commit to study dates|0
5800819|NCT02979197|20008591|P3|Overall Study|Protocol Violation|0
5800820|NCT02979197|20008592|P2|Overall Study|Protocol Violation|1
5800821|NCT02979197|20008593|P1|Overall Study|Protocol Violation|0
5800822|NCT02979197|20008591|P3|Overall Study|Adverse Event|0
5800823|NCT02979197|20008592|P2|Overall Study|Adverse Event|2
5800824|NCT02979197|20008593|P1|Overall Study|Adverse Event|4
5800825|NCT02978833|20008636|P2|Overall Study|Study terminated|1
5800826|NCT02978833|20008637|P1|Overall Study|Study terminated|1
5800827|NCT02978417|20008666|P2|Overall Study|Lost to Follow-up|2
5800828|NCT02978417|20008667|P1|Overall Study|Lost to Follow-up|2
5800829|NCT02977572|20008722|P2|Overall Study|Exclusion criterion|2
5800830|NCT02977572|20008723|P1|Overall Study|Exclusion criterion|2
5800831|NCT02977507|20008745|P2|Overall Study|Lost to Follow-up|0
5800832|NCT02977507|20008746|P1|Overall Study|Lost to Follow-up|1
5800833|NCT02977507|20008745|P2|Overall Study|Protocol Deviation|0
5800834|NCT02977507|20008746|P1|Overall Study|Protocol Deviation|1
5800835|NCT02976519|20008776|P7|Treatment Period 2 (Part 2 Only)|Adverse Event|1
5800836|NCT02976519|20008777|P6|Treatment Period 2 (Part 2 Only)|Adverse Event|0
5800837|NCT02976519|20008778|P5|Treatment Period 2 (Part 2 Only)|Adverse Event|0
5800838|NCT02976519|20008779|P4|Treatment Period 2 (Part 2 Only)|Adverse Event|0
5800839|NCT02976519|20008780|P3|Treatment Period 2 (Part 2 Only)|Adverse Event|0
5800840|NCT02976519|20008781|P2|Treatment Period 2 (Part 2 Only)|Adverse Event|0
5800841|NCT02976519|20008782|P1|Treatment Period 2 (Part 2 Only)|Adverse Event|0
5800842|NCT02976519|20008776|P7|Wash-out Period (Part 2 Only)|Withdrawal by Subject|1
5800843|NCT02976519|20008777|P6|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0
5800844|NCT02976519|20008778|P5|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0
5800845|NCT02976519|20008779|P4|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0
5800846|NCT02976519|20008780|P3|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0
5800847|NCT02976519|20008781|P2|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0
5800848|NCT02976519|20008782|P1|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0
5800849|NCT02976519|20008776|P7|Wash-out Period (Part 2 Only)|Reason not listed|1
5800850|NCT02976519|20008777|P6|Wash-out Period (Part 2 Only)|Reason not listed|0
5800851|NCT02976519|20008778|P5|Wash-out Period (Part 2 Only)|Reason not listed|0
5800852|NCT02976519|20008779|P4|Wash-out Period (Part 2 Only)|Reason not listed|0
5800853|NCT02976519|20008780|P3|Wash-out Period (Part 2 Only)|Reason not listed|0
5800854|NCT02976519|20008781|P2|Wash-out Period (Part 2 Only)|Reason not listed|0
5800855|NCT02976519|20008782|P1|Wash-out Period (Part 2 Only)|Reason not listed|0
5800856|NCT02976519|20008776|P7|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0
5800857|NCT02976519|20008777|P6|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0
5800858|NCT02976519|20008778|P5|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0
5800859|NCT02976519|20008779|P4|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|1
5800860|NCT02976519|20008780|P3|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0
5800861|NCT02976519|20008781|P2|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0
5800862|NCT02976519|20008782|P1|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0
5800863|NCT02976519|20008776|P7|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0
5800864|NCT02976519|20008777|P6|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0
5800865|NCT02976519|20008778|P5|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0
5800866|NCT02976519|20008779|P4|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0
5800867|NCT02976519|20008780|P3|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0
5800868|NCT02976519|20008781|P2|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|1
5800869|NCT02976519|20008782|P1|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0
5800870|NCT02976103|20008813|P2|Overall Study|Lost to Follow-up|8
5800871|NCT02976103|20008814|P1|Overall Study|Lost to Follow-up|12
5800872|NCT02976103|20008813|P2|Overall Study|Withdrawal by Subject|0
5800873|NCT02976103|20008814|P1|Overall Study|Withdrawal by Subject|1
5800874|NCT02975973|20008869|P4|Overall Study|Adverse Event|0
5800875|NCT02975973|20008870|P3|Overall Study|Adverse Event|1
5800876|NCT02975973|20008871|P2|Overall Study|Adverse Event|1
5800877|NCT02975973|20008872|P1|Overall Study|Adverse Event|1
5800881|NCT02975336|20008970|P4|Overall Study|Other|4
5800882|NCT02975336|20008971|P3|Overall Study|Other|6
5800883|NCT02975336|20008972|P2|Overall Study|Other|6
5800884|NCT02975336|20008973|P1|Overall Study|Other|5
5800885|NCT02975336|20008970|P4|Overall Study|Withdrawal by Subject|3
5800886|NCT02975336|20008971|P3|Overall Study|Withdrawal by Subject|1
5800887|NCT02975336|20008972|P2|Overall Study|Withdrawal by Subject|0
5800888|NCT02975336|20008973|P1|Overall Study|Withdrawal by Subject|1
5800889|NCT02975336|20008970|P4|Overall Study|Lack of Efficacy|3
5800890|NCT02975336|20008971|P3|Overall Study|Lack of Efficacy|2
5800891|NCT02975336|20008972|P2|Overall Study|Lack of Efficacy|4
5800892|NCT02975336|20008973|P1|Overall Study|Lack of Efficacy|4
5800893|NCT02975336|20008970|P4|Overall Study|Protocol Violation|1
5800894|NCT02975336|20008971|P3|Overall Study|Protocol Violation|3
5800895|NCT02975336|20008972|P2|Overall Study|Protocol Violation|1
5800896|NCT02975336|20008973|P1|Overall Study|Protocol Violation|4
5800897|NCT02975336|20008970|P4|Overall Study|Lost to Follow-up|4
5800898|NCT02975336|20008971|P3|Overall Study|Lost to Follow-up|2
5800899|NCT02975336|20008972|P2|Overall Study|Lost to Follow-up|1
5800900|NCT02975336|20008973|P1|Overall Study|Lost to Follow-up|2
5800901|NCT02975336|20008970|P4|Overall Study|Adverse Event|18
5800902|NCT02975336|20008971|P3|Overall Study|Adverse Event|13
5800903|NCT02975336|20008972|P2|Overall Study|Adverse Event|17
5800904|NCT02975336|20008973|P1|Overall Study|Adverse Event|16
5800905|NCT02975206|20009206|P3|Overall Study|Other (e.g., lost to follow up)|6
5800906|NCT02975206|20009207|P2|Overall Study|Other (e.g., lost to follow up)|6
5800907|NCT02975206|20009208|P1|Overall Study|Other (e.g., lost to follow up)|13
5800908|NCT02975206|20009206|P3|Overall Study|Withdrawal by Subject|11
5800909|NCT02975206|20009207|P2|Overall Study|Withdrawal by Subject|11
5800910|NCT02975206|20009208|P1|Overall Study|Withdrawal by Subject|14
5800911|NCT02974868|20009225|P4|Cross-Over Extension (COE) Period|Withdrawal by Subject|0
5800912|NCT02974868|20009226|P3|Cross-Over Extension (COE) Period|Withdrawal by Subject|3
5800913|NCT02974868|20009227|P2|Cross-Over Extension (COE) Period|Withdrawal by Subject|1
5800914|NCT02974868|20009228|P1|Cross-Over Extension (COE) Period|Withdrawal by Subject|2
5800915|NCT02974868|20009225|P4|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|6
5800916|NCT02974868|20009226|P3|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|11
5800917|NCT02974868|20009227|P2|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|1
5800918|NCT02974868|20009228|P1|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|2
5800919|NCT02974868|20009225|P4|Initial 24-Week Treatment Period (TP)|others|8
5800920|NCT02974868|20009226|P3|Initial 24-Week Treatment Period (TP)|others|1
5800921|NCT02974868|20009227|P2|Initial 24-Week Treatment Period (TP)|others|8
5800922|NCT02974868|20009228|P1|Initial 24-Week Treatment Period (TP)|others|3
5800923|NCT02974868|20009225|P4|Initial 24-Week Treatment Period (TP)|Adverse Event|4
5800924|NCT02974868|20009226|P3|Initial 24-Week Treatment Period (TP)|Adverse Event|2
5800925|NCT02974868|20009227|P2|Initial 24-Week Treatment Period (TP)|Adverse Event|1
5800926|NCT02974868|20009228|P1|Initial 24-Week Treatment Period (TP)|Adverse Event|1
5800927|NCT02974855|20009350|P4|Overall Study|Adverse Event|1
5800928|NCT02974855|20009351|P3|Overall Study|Adverse Event|0
5800929|NCT02974855|20009352|P2|Overall Study|Adverse Event|1
5800930|NCT02974855|20009353|P1|Overall Study|Adverse Event|0
5800931|NCT02974842|20009539|P1|Overall Study|Screen failures|4
5800932|NCT02974842|20009539|P1|Overall Study|Withdrawal by Subject|4
5800933|NCT02974634|20009558|P2|Overall Study|Death|11
5800934|NCT02974634|20009559|P1|Overall Study|Death|8
5800935|NCT02974634|20009558|P2|Overall Study|intervention technology related issues|0
5800936|NCT02974634|20009559|P1|Overall Study|intervention technology related issues|5
5800937|NCT02974634|20009558|P2|Overall Study|Noncompliance|7
5800938|NCT02974634|20009559|P1|Overall Study|Noncompliance|3
5800939|NCT02974634|20009558|P2|Overall Study|Advanced disease|3
5800940|NCT02974634|20009559|P1|Overall Study|Advanced disease|12
5800941|NCT02974543|20009569|P2|Overall Study|Withdrawal by Subject|0
5800942|NCT02974543|20009570|P1|Overall Study|Withdrawal by Subject|1
5800943|NCT02974153|20009604|P3|Overall Study|Other|7
5800944|NCT02974153|20009605|P2|Overall Study|Other|8
5800945|NCT02974153|20009606|P1|Overall Study|Other|14
5800946|NCT02974153|20009604|P3|Overall Study|Study Burden|3
5800947|NCT02974153|20009605|P2|Overall Study|Study Burden|7
5800948|NCT02974153|20009606|P1|Overall Study|Study Burden|8
5800949|NCT02974153|20009604|P3|Overall Study|Withdrawal by Subject|11
5800950|NCT02974153|20009605|P2|Overall Study|Withdrawal by Subject|16
5800951|NCT02974153|20009606|P1|Overall Study|Withdrawal by Subject|9
5800952|NCT02974153|20009604|P3|Overall Study|Physician Decision|1
5800953|NCT02974153|20009605|P2|Overall Study|Physician Decision|2
5800954|NCT02974153|20009606|P1|Overall Study|Physician Decision|0
5800955|NCT02974153|20009604|P3|Overall Study|Lost to Follow-up|17
5800956|NCT02974153|20009605|P2|Overall Study|Lost to Follow-up|10
5800957|NCT02974153|20009606|P1|Overall Study|Lost to Follow-up|9
5800958|NCT02974153|20009604|P3|Overall Study|Lack of Efficacy|10
5800959|NCT02974153|20009605|P2|Overall Study|Lack of Efficacy|5
5800960|NCT02974153|20009606|P1|Overall Study|Lack of Efficacy|6
5800961|NCT02974153|20009604|P3|Overall Study|Adverse Event|1
5800962|NCT02974153|20009605|P2|Overall Study|Adverse Event|0
5800963|NCT02974153|20009606|P1|Overall Study|Adverse Event|6
5800964|NCT02974140|20009692|P1|Overall Study|Study Terminated by Sponsor|36
5800965|NCT02974140|20009692|P1|Overall Study|Lost to Follow-up|1
5800966|NCT02974140|20009692|P1|Overall Study|Adverse Event|2
5800967|NCT02974114|20009708|P3|Overall Study|Other (Not specified)|2
5800968|NCT02974114|20009709|P2|Overall Study|Other (Not specified)|1
5800969|NCT02974114|20009710|P1|Overall Study|Other (Not specified)|0
5800970|NCT02974088|20009753|P2|Overall Study|Adverse Event|1
5800971|NCT02974088|20009754|P1|Overall Study|Adverse Event|0
5800972|NCT02974088|20009753|P2|Overall Study|Lost to Follow-up|2
5800973|NCT02974088|20009754|P1|Overall Study|Lost to Follow-up|0
5800974|NCT02973802|20009760|P1|Overall Study|Withdrawal by Subject|1
5800975|NCT02973802|20009760|P1|Overall Study|Lost to Follow-up|1
5800976|NCT02973477|20009787|P2|Second Intervention|Lost to Follow-up|0
5800977|NCT02973477|20009788|P1|Second Intervention|Lost to Follow-up|1
5800978|NCT02973477|20009787|P2|Washout|Withdrawal by Subject|0
5800979|NCT02973477|20009788|P1|Washout|Withdrawal by Subject|1
5800980|NCT02973477|20009787|P2|First Intervention|Lost to Follow-up|2
5800981|NCT02973477|20009788|P1|First Intervention|Lost to Follow-up|0
5800982|NCT02973100|20009826|P4|Overall Study|Failed to attend Safety followup period|0
5800983|NCT02973100|20009827|P3|Overall Study|Failed to attend Safety followup period|1
5800984|NCT02973100|20009828|P2|Overall Study|Failed to attend Safety followup period|0
5800985|NCT02973100|20009829|P1|Overall Study|Failed to attend Safety followup period|0
5800986|NCT02973100|20009826|P4|Overall Study|Notification of change in address|1
5800987|NCT02973100|20009827|P3|Overall Study|Notification of change in address|0
5800988|NCT02973100|20009828|P2|Overall Study|Notification of change in address|0
5800989|NCT02973100|20009829|P1|Overall Study|Notification of change in address|0
5800990|NCT02973100|20009826|P4|Overall Study|Withdrawal by Subject|4
5800991|NCT02973100|20009827|P3|Overall Study|Withdrawal by Subject|1
5800992|NCT02973100|20009828|P2|Overall Study|Withdrawal by Subject|5
5800993|NCT02973100|20009829|P1|Overall Study|Withdrawal by Subject|3
5800994|NCT02973100|20009826|P4|Overall Study|Lost to Follow-up|0
5800995|NCT02973100|20009827|P3|Overall Study|Lost to Follow-up|1
5800996|NCT02973100|20009828|P2|Overall Study|Lost to Follow-up|1
5800997|NCT02973100|20009829|P1|Overall Study|Lost to Follow-up|3
5800998|NCT02973100|20009826|P4|Overall Study|Adverse Event|2
5800999|NCT02973100|20009827|P3|Overall Study|Adverse Event|1
5801000|NCT02973100|20009828|P2|Overall Study|Adverse Event|2
5801001|NCT02973100|20009829|P1|Overall Study|Adverse Event|1
5801002|NCT02973048|20009867|P2|Overall Study|Withdrawal by Subject|3
5801003|NCT02973048|20009868|P1|Overall Study|Withdrawal by Subject|0
5801004|NCT02973048|20009867|P2|Overall Study|Epidural catheter insertion failure|0
5801005|NCT02973048|20009868|P1|Overall Study|Epidural catheter insertion failure|1
5801006|NCT02972658|20009920|P4|Overall Study|Sponsor Decision|119
5801007|NCT02972658|20009921|P3|Overall Study|Sponsor Decision|72
5801008|NCT02972658|20009922|P2|Overall Study|Sponsor Decision|127
5801009|NCT02972658|20009923|P1|Overall Study|Sponsor Decision|70
5801010|NCT02972658|20009920|P4|Overall Study|Withdrawal due to Caregiver Circumstance|0
5801011|NCT02972658|20009921|P3|Overall Study|Withdrawal due to Caregiver Circumstance|1
5801012|NCT02972658|20009922|P2|Overall Study|Withdrawal due to Caregiver Circumstance|1
5801013|NCT02972658|20009923|P1|Overall Study|Withdrawal due to Caregiver Circumstance|1
5801014|NCT02972658|20009920|P4|Overall Study|Withdrawal by Subject|6
5801015|NCT02972658|20009921|P3|Overall Study|Withdrawal by Subject|1
5801016|NCT02972658|20009922|P2|Overall Study|Withdrawal by Subject|4
5801017|NCT02972658|20009923|P1|Overall Study|Withdrawal by Subject|4
5801018|NCT02972658|20009920|P4|Overall Study|Progressive Disease|1
5801019|NCT02972658|20009921|P3|Overall Study|Progressive Disease|0
5801020|NCT02972658|20009922|P2|Overall Study|Progressive Disease|1
5801021|NCT02972658|20009923|P1|Overall Study|Progressive Disease|0
5801022|NCT02972658|20009920|P4|Overall Study|Lost to Follow-up|2
5801023|NCT02972658|20009921|P3|Overall Study|Lost to Follow-up|1
5801024|NCT02972658|20009922|P2|Overall Study|Lost to Follow-up|1
5801025|NCT02972658|20009923|P1|Overall Study|Lost to Follow-up|0
5801026|NCT02972658|20009920|P4|Overall Study|Death|1
5801027|NCT02972658|20009921|P3|Overall Study|Death|0
5801028|NCT02972658|20009922|P2|Overall Study|Death|0
5801029|NCT02972658|20009923|P1|Overall Study|Death|0
5801030|NCT02972658|20009920|P4|Overall Study|Other-determined by Investigator|0
5801031|NCT02972658|20009921|P3|Overall Study|Other-determined by Investigator|0
5801032|NCT02972658|20009922|P2|Overall Study|Other-determined by Investigator|1
5801033|NCT02972658|20009923|P1|Overall Study|Other-determined by Investigator|1
5801034|NCT02972658|20009920|P4|Overall Study|Adverse Event|2
5801035|NCT02972658|20009921|P3|Overall Study|Adverse Event|0
5801036|NCT02972658|20009922|P2|Overall Study|Adverse Event|3
5801037|NCT02972658|20009923|P1|Overall Study|Adverse Event|0
5801038|NCT02972632|20009953|P1|Overall Study|Voluntary Withdrawal|10
5801039|NCT02972632|20009953|P1|Overall Study|Lost to Follow-up|4
5801040|NCT02972632|20009953|P1|Overall Study|Pretreatment Event/Adverse Event|3
5801041|NCT02972515|20009983|P1|Overall Study|Lost to Follow-up|78
5801042|NCT02972502|20009992|P2|Overall Study|Withdrawal by Subject|1
5801043|NCT02972502|20009993|P1|Overall Study|Withdrawal by Subject|1
5801044|NCT02972502|20009992|P2|Overall Study|Lost to Follow-up|1
5801045|NCT02972502|20009993|P1|Overall Study|Lost to Follow-up|3
5801046|NCT02972359|20010003|P1|Overall Study|Missing|1
5801047|NCT02972359|20010003|P1|Overall Study|Other reasons|5
5801048|NCT02972359|20010003|P1|Overall Study|Lost to Follow-up|26
5801049|NCT02972359|20010003|P1|Overall Study|Protocol Violation|1
5801050|NCT02972359|20010003|P1|Overall Study|Withdrawal by Subject|30
5801051|NCT02972359|20010003|P1|Overall Study|Death|1
5801052|NCT02972359|20010003|P1|Overall Study|Adverse Event|4
5801053|NCT02972359|20010003|P1|Overall Study|Lack of Efficacy|1
5801054|NCT02972359|20010003|P1|Overall Study|Incl. criteria not met/Exclusion met|2
5801055|NCT02972242|20010016|P2|Overall Study|Withdrawal by Subject|0
5801056|NCT02972242|20010017|P1|Overall Study|Withdrawal by Subject|1
5801057|NCT02971670|20010074|P4|Overall Study|Withdrawal by Subject|2
5801058|NCT02971670|20010075|P3|Overall Study|Withdrawal by Subject|1
5801059|NCT02971670|20010076|P2|Overall Study|Withdrawal by Subject|1
5801060|NCT02971670|20010077|P1|Overall Study|Withdrawal by Subject|4
5801061|NCT02971605|20010116|P1|Overall Study|Withdrawal by Subject|1
5801062|NCT02971202|20010230|P3|Overall Study|screen fail after consent|1
5801063|NCT02971202|20010231|P2|Overall Study|screen fail after consent|0
5801064|NCT02971202|20010232|P1|Overall Study|screen fail after consent|1
5801065|NCT02971202|20010230|P3|Overall Study|Pregnancy|0
5801066|NCT02971202|20010231|P2|Overall Study|Pregnancy|0
5801067|NCT02971202|20010232|P1|Overall Study|Pregnancy|1
5801068|NCT02971163|20010248|P2|Overall Study|Lost to Follow-up|2
5801069|NCT02971163|20010249|P1|Overall Study|Lost to Follow-up|4
5801070|NCT02971007|20010272|P3|Overall Study|Patient discontinued study drug|0
5801071|NCT02971007|20010273|P2|Overall Study|Patient discontinued study drug|1
5801072|NCT02971007|20010274|P1|Overall Study|Patient discontinued study drug|0
5801073|NCT02971007|20010272|P3|Overall Study|Patient had yeast at Day 5 visit|0
5801074|NCT02971007|20010273|P2|Overall Study|Patient had yeast at Day 5 visit|0
5801075|NCT02971007|20010274|P1|Overall Study|Patient had yeast at Day 5 visit|1
5801076|NCT02971007|20010272|P3|Overall Study|Withdrawal by Subject|0
5801077|NCT02971007|20010273|P2|Overall Study|Withdrawal by Subject|1
5801078|NCT02971007|20010274|P1|Overall Study|Withdrawal by Subject|0
5801079|NCT02971007|20010272|P3|Overall Study|Lost to Follow-up|1
5801080|NCT02971007|20010273|P2|Overall Study|Lost to Follow-up|1
5801081|NCT02971007|20010274|P1|Overall Study|Lost to Follow-up|0
5801082|NCT02971007|20010272|P3|Overall Study|Adverse Event|0
5801083|NCT02971007|20010273|P2|Overall Study|Adverse Event|0
5801084|NCT02971007|20010274|P1|Overall Study|Adverse Event|1
5801085|NCT02970669|20010306|P2|Open-label Period|Physician Decision|0
5801086|NCT02970669|20010307|P1|Open-label Period|Physician Decision|1
5801087|NCT02970669|20010306|P2|Open-label Period|Adverse Event|0
5801088|NCT02970669|20010307|P1|Open-label Period|Adverse Event|1
5801089|NCT02970669|20010306|P2|Open-label Period|Withdrawal by Subject|2
5801090|NCT02970669|20010307|P1|Open-label Period|Withdrawal by Subject|2
5801091|NCT02970669|20010306|P2|Double-blind Period|Withdrawal by Subject|2
5801092|NCT02970669|20010307|P1|Double-blind Period|Withdrawal by Subject|2
5801093|NCT02970669|20010306|P2|Double-blind Period|Physician Decision|2
5801094|NCT02970669|20010307|P1|Double-blind Period|Physician Decision|0
5801095|NCT02970669|20010306|P2|Double-blind Period|Study terminated by sponsor|2
5801096|NCT02970669|20010307|P1|Double-blind Period|Study terminated by sponsor|1
5801097|NCT02970669|20010306|P2|Double-blind Period|Death|0
5801098|NCT02970669|20010307|P1|Double-blind Period|Death|1
5801099|NCT02970669|20010306|P2|Double-blind Period|Adverse Event|0
5801100|NCT02970669|20010307|P1|Double-blind Period|Adverse Event|4
5801101|NCT02970305|20010461|P2|Overall Study|Lost to Follow-up|2
5801102|NCT02970305|20010462|P1|Overall Study|Lost to Follow-up|1
5801103|NCT02970305|20010461|P2|Overall Study|Not further specified|2
5801104|NCT02970305|20010462|P1|Overall Study|Not further specified|1
5801105|NCT02970305|20010461|P2|Overall Study|Withdrawal by Subject|11
5801106|NCT02970305|20010462|P1|Overall Study|Withdrawal by Subject|12
5801107|NCT02970305|20010461|P2|Overall Study|Protocol Violation|2
5801108|NCT02970305|20010462|P1|Overall Study|Protocol Violation|2
5801109|NCT02970305|20010461|P2|Overall Study|Noncompliance with study drug|4
5801110|NCT02970305|20010462|P1|Overall Study|Noncompliance with study drug|2
5801111|NCT02970305|20010461|P2|Overall Study|Lack of Efficacy|1
5801112|NCT02970305|20010462|P1|Overall Study|Lack of Efficacy|1
5801113|NCT02970305|20010461|P2|Overall Study|Adverse Event|6
5801114|NCT02970305|20010462|P1|Overall Study|Adverse Event|10
5801115|NCT02970292|20010494|P2|Overall Study|Other|0
5801116|NCT02970292|20010495|P1|Overall Study|Other|1
5801117|NCT02970292|20010494|P2|Overall Study|Protocol Violation|0
5801118|NCT02970292|20010495|P1|Overall Study|Protocol Violation|2
5801119|NCT02970292|20010494|P2|Overall Study|Lost to Follow-up|0
5801120|NCT02970292|20010495|P1|Overall Study|Lost to Follow-up|1
5801121|NCT02970292|20010494|P2|Overall Study|Lack of Efficacy|0
5801122|NCT02970292|20010495|P1|Overall Study|Lack of Efficacy|1
5801123|NCT02970292|20010494|P2|Overall Study|Adverse Event|0
5801124|NCT02970292|20010495|P1|Overall Study|Adverse Event|5
5801125|NCT02970292|20010494|P2|Overall Study|Noncompliance with study drug|2
5801126|NCT02970292|20010495|P1|Overall Study|Noncompliance with study drug|2
5801127|NCT02970292|20010494|P2|Overall Study|Withdrawal by Subject|5
5801128|NCT02970292|20010495|P1|Overall Study|Withdrawal by Subject|11
5801129|NCT02970292|20010494|P2|Overall Study|Physician Decision|1
5801130|NCT02970292|20010495|P1|Overall Study|Physician Decision|1
5801131|NCT02969863|20010561|P6|Overall Study|Physician Decision|0
5801132|NCT02969863|20010562|P5|Overall Study|Physician Decision|0
5801133|NCT02969863|20010563|P4|Overall Study|Physician Decision|0
5801134|NCT02969863|20010564|P3|Overall Study|Physician Decision|0
5801135|NCT02969863|20010565|P2|Overall Study|Physician Decision|0
5801136|NCT02969863|20010566|P1|Overall Study|Physician Decision|1
5801137|NCT02969655|20010582|P2|Overall Study|Adverse Event|8
5801138|NCT02969655|20010583|P1|Overall Study|Adverse Event|10
5801139|NCT02969655|20010582|P2|Overall Study|Protocol-specified withdrawal criteria|2
5801140|NCT02969655|20010583|P1|Overall Study|Protocol-specified withdrawal criteria|4
5801141|NCT02969655|20010582|P2|Overall Study|Physician Decision|3
5801142|NCT02969655|20010583|P1|Overall Study|Physician Decision|4
5801143|NCT02969655|20010582|P2|Overall Study|Withdrawal by Subject|2
5801144|NCT02969655|20010583|P1|Overall Study|Withdrawal by Subject|3
5801145|NCT02969590|20010618|P3|Screening Period|Hormones not suppressed post Lupron|0
5801146|NCT02969590|20010619|P2|Screening Period|Hormones not suppressed post Lupron|0
5801147|NCT02969590|20010620|P1|Screening Period|Hormones not suppressed post Lupron|1
5801148|NCT02969525|20010643|P12|Dose-Blind Period|Withdrew before Safety Follow-up visit|0
5801149|NCT02969525|20010644|P11|Dose-Blind Period|Withdrew before Safety Follow-up visit|1
5801150|NCT02969525|20010645|P10|Dose-Blind Period|Withdrew before Safety Follow-up visit|0
5801151|NCT02969525|20010646|P9|Dose-Blind Period|Withdrew before Safety Follow-up visit|0
5801152|NCT02969525|20010647|P8|Dose-Blind Period|Withdrew before Safety Follow-up visit|0
5801153|NCT02969525|20010648|P7|Dose-Blind Period|Withdrew before Safety Follow-up visit|0
5801154|NCT02969525|20010649|P6|Dose-Blind Period|Withdrew before Safety Follow-up visit|0
5801155|NCT02969525|20010650|P5|Dose-Blind Period|Withdrew before Safety Follow-up visit|0
5801156|NCT02969525|20010651|P4|Dose-Blind Period|Withdrew before Safety Follow-up visit|0
5801157|NCT02969525|20010652|P3|Dose-Blind Period|Withdrew before Safety Follow-up visit|0
5801158|NCT02969525|20010653|P2|Dose-Blind Period|Withdrew before Safety Follow-up visit|0
5801159|NCT02969525|20010654|P1|Dose-Blind Period|Withdrew before Safety Follow-up visit|0
5801160|NCT02969525|20010643|P12|Dose-Blind Period|Non-cooperating patient|1
5801161|NCT02969525|20010644|P11|Dose-Blind Period|Non-cooperating patient|0
5801162|NCT02969525|20010645|P10|Dose-Blind Period|Non-cooperating patient|0
5801163|NCT02969525|20010646|P9|Dose-Blind Period|Non-cooperating patient|0
5801164|NCT02969525|20010647|P8|Dose-Blind Period|Non-cooperating patient|0
5801165|NCT02969525|20010648|P7|Dose-Blind Period|Non-cooperating patient|0
5801166|NCT02969525|20010649|P6|Dose-Blind Period|Non-cooperating patient|0
5801167|NCT02969525|20010650|P5|Dose-Blind Period|Non-cooperating patient|0
5801168|NCT02969525|20010651|P4|Dose-Blind Period|Non-cooperating patient|0
5801169|NCT02969525|20010652|P3|Dose-Blind Period|Non-cooperating patient|0
5801170|NCT02969525|20010653|P2|Dose-Blind Period|Non-cooperating patient|0
5801171|NCT02969525|20010654|P1|Dose-Blind Period|Non-cooperating patient|0
5801172|NCT02969525|20010643|P12|Dose-Blind Period|Withdrawal by Subject|0
5801173|NCT02969525|20010644|P11|Dose-Blind Period|Withdrawal by Subject|0
5801174|NCT02969525|20010645|P10|Dose-Blind Period|Withdrawal by Subject|2
5801175|NCT02969525|20010646|P9|Dose-Blind Period|Withdrawal by Subject|1
5801176|NCT02969525|20010647|P8|Dose-Blind Period|Withdrawal by Subject|0
5801177|NCT02969525|20010648|P7|Dose-Blind Period|Withdrawal by Subject|2
5801178|NCT02969525|20010649|P6|Dose-Blind Period|Withdrawal by Subject|0
5801179|NCT02969525|20010650|P5|Dose-Blind Period|Withdrawal by Subject|0
5801180|NCT02969525|20010651|P4|Dose-Blind Period|Withdrawal by Subject|0
5801181|NCT02969525|20010652|P3|Dose-Blind Period|Withdrawal by Subject|0
5801182|NCT02969525|20010653|P2|Dose-Blind Period|Withdrawal by Subject|0
5801183|NCT02969525|20010654|P1|Dose-Blind Period|Withdrawal by Subject|0
5801184|NCT02969525|20010643|P12|Dose-Blind Period|Adverse Event|1
5801185|NCT02969525|20010644|P11|Dose-Blind Period|Adverse Event|1
5801186|NCT02969525|20010645|P10|Dose-Blind Period|Adverse Event|1
5801187|NCT02969525|20010646|P9|Dose-Blind Period|Adverse Event|0
5801188|NCT02969525|20010647|P8|Dose-Blind Period|Adverse Event|0
5801189|NCT02969525|20010648|P7|Dose-Blind Period|Adverse Event|0
5801190|NCT02969525|20010649|P6|Dose-Blind Period|Adverse Event|0
5801191|NCT02969525|20010650|P5|Dose-Blind Period|Adverse Event|0
5801192|NCT02969525|20010651|P4|Dose-Blind Period|Adverse Event|0
5801193|NCT02969525|20010652|P3|Dose-Blind Period|Adverse Event|0
5801194|NCT02969525|20010653|P2|Dose-Blind Period|Adverse Event|0
5801195|NCT02969525|20010654|P1|Dose-Blind Period|Adverse Event|0
5801196|NCT02969525|20010643|P12|Double-Blind Period|Study medication discontinued prior Wk12|0
5801197|NCT02969525|20010644|P11|Double-Blind Period|Study medication discontinued prior Wk12|0
5801198|NCT02969525|20010645|P10|Double-Blind Period|Study medication discontinued prior Wk12|0
5801199|NCT02969525|20010646|P9|Double-Blind Period|Study medication discontinued prior Wk12|0
5801200|NCT02969525|20010647|P8|Double-Blind Period|Study medication discontinued prior Wk12|0
5801201|NCT02969525|20010648|P7|Double-Blind Period|Study medication discontinued prior Wk12|0
5801202|NCT02969525|20010649|P6|Double-Blind Period|Study medication discontinued prior Wk12|0
5801203|NCT02969525|20010650|P5|Double-Blind Period|Study medication discontinued prior Wk12|0
5801204|NCT02969525|20010651|P4|Double-Blind Period|Study medication discontinued prior Wk12|2
5801205|NCT02969525|20010652|P3|Double-Blind Period|Study medication discontinued prior Wk12|0
5801206|NCT02969525|20010653|P2|Double-Blind Period|Study medication discontinued prior Wk12|0
5801207|NCT02969525|20010654|P1|Double-Blind Period|Study medication discontinued prior Wk12|2
5801208|NCT02969525|20010643|P12|Double-Blind Period|LOW EGFR|0
5801209|NCT02969525|20010644|P11|Double-Blind Period|LOW EGFR|0
5801210|NCT02969525|20010645|P10|Double-Blind Period|LOW EGFR|0
5801211|NCT02969525|20010646|P9|Double-Blind Period|LOW EGFR|0
5801212|NCT02969525|20010647|P8|Double-Blind Period|LOW EGFR|0
5801213|NCT02969525|20010648|P7|Double-Blind Period|LOW EGFR|0
5801214|NCT02969525|20010649|P6|Double-Blind Period|LOW EGFR|0
5801215|NCT02969525|20010650|P5|Double-Blind Period|LOW EGFR|0
5801216|NCT02969525|20010651|P4|Double-Blind Period|LOW EGFR|1
5801217|NCT02969525|20010652|P3|Double-Blind Period|LOW EGFR|0
5801218|NCT02969525|20010653|P2|Double-Blind Period|LOW EGFR|0
5801219|NCT02969525|20010654|P1|Double-Blind Period|LOW EGFR|0
5801220|NCT02969525|20010643|P12|Double-Blind Period|Adverse Event|0
5801221|NCT02969525|20010644|P11|Double-Blind Period|Adverse Event|0
5801222|NCT02969525|20010645|P10|Double-Blind Period|Adverse Event|0
5801223|NCT02969525|20010646|P9|Double-Blind Period|Adverse Event|0
5801224|NCT02969525|20010647|P8|Double-Blind Period|Adverse Event|0
5801225|NCT02969525|20010648|P7|Double-Blind Period|Adverse Event|0
5801226|NCT02969525|20010649|P6|Double-Blind Period|Adverse Event|0
5801227|NCT02969525|20010650|P5|Double-Blind Period|Adverse Event|0
5801228|NCT02969525|20010651|P4|Double-Blind Period|Adverse Event|1
5801229|NCT02969525|20010652|P3|Double-Blind Period|Adverse Event|1
5801230|NCT02969525|20010653|P2|Double-Blind Period|Adverse Event|0
5801231|NCT02969525|20010654|P1|Double-Blind Period|Adverse Event|0
5801232|NCT02969408|20010805|P1|Overall Study|Other than specified|1
5801233|NCT02969408|20010805|P1|Overall Study|Protocol Violation|1
5801234|NCT02969408|20010805|P1|Overall Study|Lost to Follow-up|4
5801235|NCT02969408|20010805|P1|Overall Study|Withdrawal by Subject|8
5801236|NCT02969408|20010805|P1|Overall Study|Adverse Event|2
5801237|NCT02969356|20010813|P1|Overall Study|Personal reasons|5
5801238|NCT02969356|20010813|P1|Overall Study|Did not need to be reinjected|6
5801239|NCT02969356|20010813|P1|Overall Study|Lost to Follow-up|3
5801240|NCT02969356|20010813|P1|Overall Study|Consent withdrawn|2
5801241|NCT02969356|20010813|P1|Overall Study|Adverse Event|7
5801242|NCT02969187|20010856|P2|Overall Study|Physician Decision|13
5801243|NCT02969187|20010857|P1|Overall Study|Physician Decision|12
5801244|NCT02969044|20010869|P2|Overall Study|Adverse Event|0
5801245|NCT02969044|20010870|P1|Overall Study|Adverse Event|3
5801246|NCT02969044|20010869|P2|Overall Study|Withdrawal by Subject|6
5801247|NCT02969044|20010870|P1|Overall Study|Withdrawal by Subject|2
5801248|NCT02969018|20010929|P8|Overall Study|Withdrawal by Subject|3
5801249|NCT02969018|20010930|P7|Overall Study|Withdrawal by Subject|4
5801250|NCT02969018|20010931|P6|Overall Study|Withdrawal by Subject|4
5801251|NCT02969018|20010932|P5|Overall Study|Withdrawal by Subject|0
5801252|NCT02969018|20010933|P4|Overall Study|Withdrawal by Subject|1
5801253|NCT02969018|20010934|P3|Overall Study|Withdrawal by Subject|2
5801254|NCT02969018|20010935|P2|Overall Study|Withdrawal by Subject|1
5801255|NCT02969018|20010936|P1|Overall Study|Withdrawal by Subject|0
5801256|NCT02969018|20010929|P8|Overall Study|Protocol Violation|0
5801257|NCT02969018|20010930|P7|Overall Study|Protocol Violation|0
5801258|NCT02969018|20010931|P6|Overall Study|Protocol Violation|0
5801259|NCT02969018|20010932|P5|Overall Study|Protocol Violation|0
5801260|NCT02969018|20010933|P4|Overall Study|Protocol Violation|1
5801261|NCT02969018|20010934|P3|Overall Study|Protocol Violation|1
5801262|NCT02969018|20010935|P2|Overall Study|Protocol Violation|0
5801263|NCT02969018|20010936|P1|Overall Study|Protocol Violation|0
5801264|NCT02969018|20010929|P8|Overall Study|Pregnancy|0
5801265|NCT02969018|20010930|P7|Overall Study|Pregnancy|0
5801266|NCT02969018|20010931|P6|Overall Study|Pregnancy|1
5801267|NCT02969018|20010932|P5|Overall Study|Pregnancy|0
5801268|NCT02969018|20010933|P4|Overall Study|Pregnancy|0
5801269|NCT02969018|20010934|P3|Overall Study|Pregnancy|0
5801270|NCT02969018|20010935|P2|Overall Study|Pregnancy|0
5801271|NCT02969018|20010936|P1|Overall Study|Pregnancy|0
5801272|NCT02969018|20010929|P8|Overall Study|Other|2
5801273|NCT02969018|20010930|P7|Overall Study|Other|0
5801274|NCT02969018|20010931|P6|Overall Study|Other|0
5801275|NCT02969018|20010932|P5|Overall Study|Other|0
5801276|NCT02969018|20010933|P4|Overall Study|Other|1
5801277|NCT02969018|20010934|P3|Overall Study|Other|0
5801278|NCT02969018|20010935|P2|Overall Study|Other|0
5801279|NCT02969018|20010936|P1|Overall Study|Other|0
5801280|NCT02969018|20010929|P8|Overall Study|Non-Compliance With Study Drug|0
5801281|NCT02969018|20010930|P7|Overall Study|Non-Compliance With Study Drug|0
5801282|NCT02969018|20010931|P6|Overall Study|Non-Compliance With Study Drug|0
5801283|NCT02969018|20010932|P5|Overall Study|Non-Compliance With Study Drug|0
5801284|NCT02969018|20010933|P4|Overall Study|Non-Compliance With Study Drug|0
5801285|NCT02969018|20010934|P3|Overall Study|Non-Compliance With Study Drug|0
5801286|NCT02969018|20010935|P2|Overall Study|Non-Compliance With Study Drug|0
5801287|NCT02969018|20010936|P1|Overall Study|Non-Compliance With Study Drug|1
5801288|NCT02969018|20010929|P8|Overall Study|No Longer Meets Eligibility Criteria|0
5801289|NCT02969018|20010930|P7|Overall Study|No Longer Meets Eligibility Criteria|1
5801290|NCT02969018|20010931|P6|Overall Study|No Longer Meets Eligibility Criteria|0
5801291|NCT02969018|20010932|P5|Overall Study|No Longer Meets Eligibility Criteria|0
5801292|NCT02969018|20010933|P4|Overall Study|No Longer Meets Eligibility Criteria|0
5801293|NCT02969018|20010934|P3|Overall Study|No Longer Meets Eligibility Criteria|0
5801294|NCT02969018|20010935|P2|Overall Study|No Longer Meets Eligibility Criteria|0
5801295|NCT02969018|20010936|P1|Overall Study|No Longer Meets Eligibility Criteria|0
5801296|NCT02969018|20010929|P8|Overall Study|Lost to Follow-up|1
5801297|NCT02969018|20010930|P7|Overall Study|Lost to Follow-up|0
5801298|NCT02969018|20010931|P6|Overall Study|Lost to Follow-up|1
5801299|NCT02969018|20010932|P5|Overall Study|Lost to Follow-up|1
5801300|NCT02969018|20010933|P4|Overall Study|Lost to Follow-up|0
5801301|NCT02969018|20010934|P3|Overall Study|Lost to Follow-up|2
5801302|NCT02969018|20010935|P2|Overall Study|Lost to Follow-up|2
5801303|NCT02969018|20010936|P1|Overall Study|Lost to Follow-up|1
5801304|NCT02969018|20010929|P8|Overall Study|Lack of Efficacy|1
5801305|NCT02969018|20010930|P7|Overall Study|Lack of Efficacy|1
5801306|NCT02969018|20010931|P6|Overall Study|Lack of Efficacy|1
5801307|NCT02969018|20010932|P5|Overall Study|Lack of Efficacy|1
5801308|NCT02969018|20010933|P4|Overall Study|Lack of Efficacy|0
5801309|NCT02969018|20010934|P3|Overall Study|Lack of Efficacy|0
5801310|NCT02969018|20010935|P2|Overall Study|Lack of Efficacy|1
5801311|NCT02969018|20010936|P1|Overall Study|Lack of Efficacy|0
5801312|NCT02969018|20010929|P8|Overall Study|Adverse Event|0
5801313|NCT02969018|20010930|P7|Overall Study|Adverse Event|2
5801314|NCT02969018|20010931|P6|Overall Study|Adverse Event|1
5801315|NCT02969018|20010932|P5|Overall Study|Adverse Event|0
5801316|NCT02969018|20010933|P4|Overall Study|Adverse Event|2
5801317|NCT02969018|20010934|P3|Overall Study|Adverse Event|1
5801318|NCT02969018|20010935|P2|Overall Study|Adverse Event|4
5801319|NCT02969018|20010936|P1|Overall Study|Adverse Event|2
5801320|NCT02968979|20011076|P1|Overall Study|Withdrawal by Subject|1
5801321|NCT02968979|20011076|P1|Overall Study|Protocol Violation|7
5801322|NCT02968576|20011201|P2|Overall Study|Pregnancy|1
5801323|NCT02968576|20011202|P1|Overall Study|Pregnancy|0
5801330|NCT02968433|20011224|P1|Overall Study|Withdrawal by Subject|1
5801331|NCT02968173|20011318|P1|Overall Study|Withdrawal by Subject|1
5801332|NCT02967679|20011355|P1|Overall Study|Adverse Event|1
5801333|NCT02967562|20011376|P2|Overall Study|High leak precluding analysis|1
5801334|NCT02967562|20011377|P1|Overall Study|High leak precluding analysis|1
5801335|NCT02967562|20011376|P2|Overall Study|Consent not obtained|0
5801336|NCT02967562|20011377|P1|Overall Study|Consent not obtained|1
5801337|NCT02967055|20011603|P1|Overall Study|Stopped due to drug cost|1
5801338|NCT02967055|20011603|P1|Overall Study|Stopped due to side effects|3
5801339|NCT02967055|20011603|P1|Overall Study|Lost to Follow-up|2
5801340|NCT02967055|20011603|P1|Overall Study|Screen fail|3
5801341|NCT02967055|20011603|P1|Overall Study|Excluded|40
5801342|NCT02966795|20011624|P2|Overall Study|Patient Left the Country|1
5801343|NCT02966795|20011625|P1|Overall Study|Patient Left the Country|0
5801344|NCT02966509|20011636|P2|End of Life Utilization and Cost 15month|Patient Still Alive|48
5801345|NCT02966509|20011637|P1|End of Life Utilization and Cost 15month|Patient Still Alive|45
5801346|NCT02966509|20011636|P2|End of Life Utilization and Cost 6 Month|Patient Still Alive|75
5801347|NCT02966509|20011637|P1|End of Life Utilization and Cost 6 Month|Patient Still Alive|69
5801348|NCT02966509|20011636|P2|6 Month Satisfaction Survey|Refused to Answer|11
5801349|NCT02966509|20011637|P1|6 Month Satisfaction Survey|Refused to Answer|8
5801350|NCT02966509|20011636|P2|6 Month Satisfaction Survey|Lost to Follow-up|1
5801351|NCT02966509|20011637|P1|6 Month Satisfaction Survey|Lost to Follow-up|1
5801352|NCT02966509|20011636|P2|6 Month Satisfaction Survey|Withdrawal by Subject|3
5801353|NCT02966509|20011637|P1|6 Month Satisfaction Survey|Withdrawal by Subject|2
5801354|NCT02966509|20011636|P2|6 Month Satisfaction Survey|Death|33
5801355|NCT02966509|20011637|P1|6 Month Satisfaction Survey|Death|36
5801356|NCT02966509|20011636|P2|6 Month Satisfaction Decision Survey|Refused to Answer|2
5801357|NCT02966509|20011637|P1|6 Month Satisfaction Decision Survey|Refused to Answer|0
5801358|NCT02966509|20011636|P2|6 Month Satisfaction Decision Survey|Lost to Follow-up|1
5801359|NCT02966509|20011637|P1|6 Month Satisfaction Decision Survey|Lost to Follow-up|1
5801360|NCT02966509|20011636|P2|6 Month Satisfaction Decision Survey|Withdrawal by Subject|3
5801361|NCT02966509|20011637|P1|6 Month Satisfaction Decision Survey|Withdrawal by Subject|2
5801362|NCT02966509|20011636|P2|6 Month Satisfaction Decision Survey|Death|25
5801363|NCT02966509|20011637|P1|6 Month Satisfaction Decision Survey|Death|22
5801364|NCT02966509|20011636|P2|Baseline Satisfaction Survey|Refused to Answer|2
5801365|NCT02966509|20011637|P1|Baseline Satisfaction Survey|Refused to Answer|1
5801366|NCT02966509|20011636|P2|Baseline Satisfaction Survey|Lost to Follow-up|1
5801367|NCT02966509|20011637|P1|Baseline Satisfaction Survey|Lost to Follow-up|1
5801368|NCT02966509|20011636|P2|Baseline Satisfaction Survey|Death|1
5801369|NCT02966509|20011637|P1|Baseline Satisfaction Survey|Death|0
5801370|NCT02966509|20011636|P2|Baseline Satisfaction Survey|Withdrawal by Subject|3
5801371|NCT02966509|20011637|P1|Baseline Satisfaction Survey|Withdrawal by Subject|2
5801372|NCT02966353|20011661|P1|Overall Study|Protocol deviation|2
5801373|NCT02966353|20011661|P1|Overall Study|Progressive disease|2
5801374|NCT02966353|20011661|P1|Overall Study|Physician Decision|3
5801375|NCT02966353|20011661|P1|Overall Study|Death|4
5801376|NCT02966353|20011661|P1|Overall Study|Adverse Event|4
5801377|NCT02966353|20011661|P1|Overall Study|Withdrawal by Subject|7
5801378|NCT02966340|20011670|P2|Overall Study|startle non-responder|1
5801379|NCT02966340|20011671|P1|Overall Study|startle non-responder|1
5801380|NCT02966340|20011670|P2|Overall Study|data acquisition error|0
5801381|NCT02966340|20011671|P1|Overall Study|data acquisition error|1
5801382|NCT02966340|20011670|P2|Overall Study|Withdrawal by Subject|0
5801383|NCT02966340|20011671|P1|Overall Study|Withdrawal by Subject|1
5801384|NCT02966340|20011670|P2|Overall Study|Lost to Follow-up|1
5801385|NCT02966340|20011671|P1|Overall Study|Lost to Follow-up|0
5801386|NCT02966340|20011670|P2|Overall Study|Adverse Event|1
5801387|NCT02966340|20011671|P1|Overall Study|Adverse Event|0
5801388|NCT02966223|20011714|P1|Overall Study|Lost to Follow-up|1
5801389|NCT02966223|20011714|P1|Overall Study|Withdrawal by Subject|11
5801390|NCT02966223|20011714|P1|Overall Study|Physician Decision|3
5801391|NCT02966015|20011722|P2|Inclusion Visit|did not answer questionnaire|3
5801392|NCT02966015|20011723|P1|Inclusion Visit|did not answer questionnaire|8
5801393|NCT02966002|20011729|P1|Overall Study|Lost to Follow-up|1
5801394|NCT02966002|20011729|P1|Overall Study|Adverse Event|1
5801395|NCT02966002|20011729|P1|Overall Study|Withdrawal by Subject|2
5801396|NCT02965846|20011744|P3|Overall Study|Participants not randomized|33
5801397|NCT02965846|20011745|P2|Overall Study|Participants not randomized|0
5801398|NCT02965846|20011746|P1|Overall Study|Participants not randomized|0
5801399|NCT02965846|20011744|P3|Overall Study|Study Terminated By Sponsor|0
5801400|NCT02965846|20011745|P2|Overall Study|Study Terminated By Sponsor|4
5801401|NCT02965846|20011746|P1|Overall Study|Study Terminated By Sponsor|4
5801402|NCT02965846|20011744|P3|Overall Study|Withdrawal by Subject|0
5801403|NCT02965846|20011745|P2|Overall Study|Withdrawal by Subject|1
5801404|NCT02965846|20011746|P1|Overall Study|Withdrawal by Subject|0
5801405|NCT02965846|20011744|P3|Overall Study|Lost to Follow-up|0
5801406|NCT02965846|20011745|P2|Overall Study|Lost to Follow-up|0
5801407|NCT02965846|20011746|P1|Overall Study|Lost to Follow-up|1
5801408|NCT02965833|20011754|P2|Period 2, Second 30 Days of Wear|Protocol Violation|0
5801409|NCT02965833|20011755|P1|Period 2, Second 30 Days of Wear|Protocol Violation|2
5801410|NCT02965833|20011754|P2|Period 1, First 30 Days of Wear|Withdrawal by Subject|0
5801411|NCT02965833|20011755|P1|Period 1, First 30 Days of Wear|Withdrawal by Subject|1
5801412|NCT02965833|20011754|P2|Period 1, First 30 Days of Wear|Protocol Violation|0
5801413|NCT02965833|20011755|P1|Period 1, First 30 Days of Wear|Protocol Violation|1
5801414|NCT02965833|20011754|P2|Period 1, First 30 Days of Wear|Lost to Follow-up|1
5801415|NCT02965833|20011755|P1|Period 1, First 30 Days of Wear|Lost to Follow-up|1
5801416|NCT02965833|20011754|P2|Period 1, First 30 Days of Wear|Adverse Event|1
5801417|NCT02965833|20011755|P1|Period 1, First 30 Days of Wear|Adverse Event|0
5801418|NCT02965820|20011761|P2|Period 2, Second 30 Days|Adverse Event|1
5801419|NCT02965820|20011762|P1|Period 2, Second 30 Days|Adverse Event|1
5801420|NCT02965599|20011801|P2|Overall Study|Protocol-defined stop criteria reached|0
5801421|NCT02965599|20011802|P1|Overall Study|Protocol-defined stop criteria reached|1
5801422|NCT02965573|20011866|P2|Overall Study|Lack of Efficacy|0
5801423|NCT02965573|20011867|P1|Overall Study|Lack of Efficacy|1
5801424|NCT02965456|20011928|P2|Overall Study|Participant ran out of study drug|1
5801425|NCT02965456|20011929|P1|Overall Study|Participant ran out of study drug|0
5801426|NCT02965456|20011928|P2|Overall Study|Protocol Violation|1
5801427|NCT02965456|20011929|P1|Overall Study|Protocol Violation|0
5801428|NCT02965456|20011928|P2|Overall Study|Pregnancy|0
5801429|NCT02965456|20011929|P1|Overall Study|Pregnancy|1
5801430|NCT02965456|20011928|P2|Overall Study|Physician Decision|1
5801431|NCT02965456|20011929|P1|Overall Study|Physician Decision|0
5801432|NCT02965456|20011928|P2|Overall Study|Lack of Efficacy|0
5801433|NCT02965456|20011929|P1|Overall Study|Lack of Efficacy|1
5801434|NCT02965456|20011928|P2|Overall Study|Worsening Condition|2
5801435|NCT02965456|20011929|P1|Overall Study|Worsening Condition|0
5801436|NCT02965456|20011928|P2|Overall Study|Noncompliance with Study Drug|1
5801437|NCT02965456|20011929|P1|Overall Study|Noncompliance with Study Drug|1
5801438|NCT02965456|20011928|P2|Overall Study|Adverse Event|0
5801439|NCT02965456|20011929|P1|Overall Study|Adverse Event|3
5801440|NCT02965456|20011928|P2|Overall Study|Withdrawal by Parent or Guardian|6
5801441|NCT02965456|20011929|P1|Overall Study|Withdrawal by Parent or Guardian|3
5801442|NCT02965456|20011928|P2|Overall Study|Subject Request|13
5801443|NCT02965456|20011929|P1|Overall Study|Subject Request|22
5801444|NCT02965456|20011928|P2|Overall Study|Lost to Follow-up|18
5801445|NCT02965456|20011929|P1|Overall Study|Lost to Follow-up|40
5801470|NCT02964312|20012066|P1|Overall Study|Death|1
5801471|NCT02964312|20012066|P1|Overall Study|Did not consent to long-term FU|14
5801472|NCT02964312|20012066|P1|Overall Study|Lack of Efficacy|10
5801473|NCT02964312|20012066|P1|Overall Study|Withdrawal by Subject|11
5801474|NCT02964312|20012066|P1|Overall Study|Lost to Follow-up|28
5801475|NCT02964247|20012077|P2|Overall Study|Withdrawal by Subject|2
5801476|NCT02964247|20012078|P1|Overall Study|Withdrawal by Subject|1
5801477|NCT02964247|20012077|P2|Overall Study|Lost to Follow-up|0
5801478|NCT02964247|20012078|P1|Overall Study|Lost to Follow-up|2
5801479|NCT02964234|20012136|P2|Overall Study|Lost to Follow-up|13
5801480|NCT02964234|20012137|P1|Overall Study|Lost to Follow-up|22
5801481|NCT02963935|20012166|P2|Overall Study|Unclassified|22
5801482|NCT02963935|20012167|P1|Overall Study|Unclassified|13
5801483|NCT02963935|20012166|P2|Overall Study|Lost to Follow-up|6
5801484|NCT02963935|20012167|P1|Overall Study|Lost to Follow-up|1
5801485|NCT02963935|20012166|P2|Overall Study|Lack of Efficacy|2
5801486|NCT02963935|20012167|P1|Overall Study|Lack of Efficacy|0
5801487|NCT02963935|20012166|P2|Overall Study|Protocol Violation|1
5801488|NCT02963935|20012167|P1|Overall Study|Protocol Violation|2
5801489|NCT02963935|20012166|P2|Overall Study|Adverse Event|6
5801490|NCT02963935|20012167|P1|Overall Study|Adverse Event|12
5801491|NCT02963922|20012275|P2|Overall Study|Other|14
5801492|NCT02963922|20012276|P1|Overall Study|Other|8
5801493|NCT02963922|20012275|P2|Overall Study|Lost to Follow-up|3
5801494|NCT02963922|20012276|P1|Overall Study|Lost to Follow-up|2
5801495|NCT02963922|20012275|P2|Overall Study|Lack of Efficacy|1
5801496|NCT02963922|20012276|P1|Overall Study|Lack of Efficacy|1
5801497|NCT02963922|20012275|P2|Overall Study|Protocol deviation|6
5801498|NCT02963922|20012276|P1|Overall Study|Protocol deviation|6
5801499|NCT02963922|20012275|P2|Overall Study|Adverse Event|6
5801500|NCT02963922|20012276|P1|Overall Study|Adverse Event|15
5801501|NCT02963701|20012374|P2|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|0
5801502|NCT02963701|20012375|P1|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|1
5801503|NCT02963506|20012435|P13|Dose-Blind Period|Meeting exclusion criteria 9|1
5801504|NCT02963506|20012436|P12|Dose-Blind Period|Meeting exclusion criteria 9|0
5801505|NCT02963506|20012437|P11|Dose-Blind Period|Meeting exclusion criteria 9|0
5801506|NCT02963506|20012438|P10|Dose-Blind Period|Meeting exclusion criteria 9|0
5801507|NCT02963506|20012439|P9|Dose-Blind Period|Meeting exclusion criteria 9|0
5801508|NCT02963506|20012440|P8|Dose-Blind Period|Meeting exclusion criteria 9|0
5801509|NCT02963506|20012441|P7|Dose-Blind Period|Meeting exclusion criteria 9|0
5801510|NCT02963506|20012442|P6|Dose-Blind Period|Meeting exclusion criteria 9|0
5801511|NCT02963506|20012443|P5|Dose-Blind Period|Meeting exclusion criteria 9|0
5801512|NCT02963506|20012444|P4|Dose-Blind Period|Meeting exclusion criteria 9|0
5801513|NCT02963506|20012445|P3|Dose-Blind Period|Meeting exclusion criteria 9|0
5801514|NCT02963506|20012446|P2|Dose-Blind Period|Meeting exclusion criteria 9|0
5801515|NCT02963506|20012447|P1|Dose-Blind Period|Meeting exclusion criteria 9|0
5801516|NCT02963506|20012435|P13|Dose-Blind Period|Sponsor decision|0
5801517|NCT02963506|20012436|P12|Dose-Blind Period|Sponsor decision|0
5801518|NCT02963506|20012437|P11|Dose-Blind Period|Sponsor decision|0
5801519|NCT02963506|20012438|P10|Dose-Blind Period|Sponsor decision|0
5801520|NCT02963506|20012439|P9|Dose-Blind Period|Sponsor decision|0
5801521|NCT02963506|20012440|P8|Dose-Blind Period|Sponsor decision|0
5801522|NCT02963506|20012441|P7|Dose-Blind Period|Sponsor decision|0
5801523|NCT02963506|20012442|P6|Dose-Blind Period|Sponsor decision|1
5801524|NCT02963506|20012443|P5|Dose-Blind Period|Sponsor decision|0
5801525|NCT02963506|20012444|P4|Dose-Blind Period|Sponsor decision|0
5801526|NCT02963506|20012445|P3|Dose-Blind Period|Sponsor decision|0
5801527|NCT02963506|20012446|P2|Dose-Blind Period|Sponsor decision|0
5801528|NCT02963506|20012447|P1|Dose-Blind Period|Sponsor decision|0
5801529|NCT02963506|20012435|P13|Dose-Blind Period|Withdrawal by Subject|0
5801530|NCT02963506|20012436|P12|Dose-Blind Period|Withdrawal by Subject|0
5801531|NCT02963506|20012437|P11|Dose-Blind Period|Withdrawal by Subject|0
5801532|NCT02963506|20012438|P10|Dose-Blind Period|Withdrawal by Subject|1
5801533|NCT02963506|20012439|P9|Dose-Blind Period|Withdrawal by Subject|0
5801534|NCT02963506|20012440|P8|Dose-Blind Period|Withdrawal by Subject|2
5801535|NCT02963506|20012441|P7|Dose-Blind Period|Withdrawal by Subject|2
5801536|NCT02963506|20012442|P6|Dose-Blind Period|Withdrawal by Subject|1
5801537|NCT02963506|20012443|P5|Dose-Blind Period|Withdrawal by Subject|0
5801538|NCT02963506|20012444|P4|Dose-Blind Period|Withdrawal by Subject|0
5801539|NCT02963506|20012445|P3|Dose-Blind Period|Withdrawal by Subject|0
5801540|NCT02963506|20012446|P2|Dose-Blind Period|Withdrawal by Subject|0
5801541|NCT02963506|20012447|P1|Dose-Blind Period|Withdrawal by Subject|0
5801542|NCT02963506|20012435|P13|Dose-Blind Period|Lost to Follow-up|0
5801543|NCT02963506|20012436|P12|Dose-Blind Period|Lost to Follow-up|1
5801544|NCT02963506|20012437|P11|Dose-Blind Period|Lost to Follow-up|0
5801545|NCT02963506|20012438|P10|Dose-Blind Period|Lost to Follow-up|0
5801546|NCT02963506|20012439|P9|Dose-Blind Period|Lost to Follow-up|1
5801547|NCT02963506|20012440|P8|Dose-Blind Period|Lost to Follow-up|0
5801548|NCT02963506|20012441|P7|Dose-Blind Period|Lost to Follow-up|0
5801549|NCT02963506|20012442|P6|Dose-Blind Period|Lost to Follow-up|1
5801550|NCT02963506|20012443|P5|Dose-Blind Period|Lost to Follow-up|0
5801551|NCT02963506|20012444|P4|Dose-Blind Period|Lost to Follow-up|0
5801552|NCT02963506|20012445|P3|Dose-Blind Period|Lost to Follow-up|0
5801553|NCT02963506|20012446|P2|Dose-Blind Period|Lost to Follow-up|0
5801554|NCT02963506|20012447|P1|Dose-Blind Period|Lost to Follow-up|0
5801555|NCT02963506|20012435|P13|Dose-Blind Period|Lack of Efficacy|0
5801556|NCT02963506|20012436|P12|Dose-Blind Period|Lack of Efficacy|0
5801557|NCT02963506|20012437|P11|Dose-Blind Period|Lack of Efficacy|0
5801558|NCT02963506|20012438|P10|Dose-Blind Period|Lack of Efficacy|1
5801559|NCT02963506|20012439|P9|Dose-Blind Period|Lack of Efficacy|0
5801560|NCT02963506|20012440|P8|Dose-Blind Period|Lack of Efficacy|1
5801561|NCT02963506|20012441|P7|Dose-Blind Period|Lack of Efficacy|0
5801562|NCT02963506|20012442|P6|Dose-Blind Period|Lack of Efficacy|0
5801563|NCT02963506|20012443|P5|Dose-Blind Period|Lack of Efficacy|0
5801564|NCT02963506|20012444|P4|Dose-Blind Period|Lack of Efficacy|0
5801565|NCT02963506|20012445|P3|Dose-Blind Period|Lack of Efficacy|0
5801566|NCT02963506|20012446|P2|Dose-Blind Period|Lack of Efficacy|0
5801567|NCT02963506|20012447|P1|Dose-Blind Period|Lack of Efficacy|0
5801568|NCT02963506|20012435|P13|Dose-Blind Period|Adverse Event|6
5801569|NCT02963506|20012436|P12|Dose-Blind Period|Adverse Event|1
5801570|NCT02963506|20012437|P11|Dose-Blind Period|Adverse Event|1
5801571|NCT02963506|20012438|P10|Dose-Blind Period|Adverse Event|2
5801572|NCT02963506|20012439|P9|Dose-Blind Period|Adverse Event|2
5801573|NCT02963506|20012440|P8|Dose-Blind Period|Adverse Event|2
5801574|NCT02963506|20012441|P7|Dose-Blind Period|Adverse Event|3
5801575|NCT02963506|20012442|P6|Dose-Blind Period|Adverse Event|1
5801576|NCT02963506|20012443|P5|Dose-Blind Period|Adverse Event|0
5801577|NCT02963506|20012444|P4|Dose-Blind Period|Adverse Event|0
5801578|NCT02963506|20012445|P3|Dose-Blind Period|Adverse Event|0
5801579|NCT02963506|20012446|P2|Dose-Blind Period|Adverse Event|0
5801580|NCT02963506|20012447|P1|Dose-Blind Period|Adverse Event|0
5801581|NCT02963506|20012435|P13|Double-Blind Period|Adverse event, non fatal after Wk12|0
5801582|NCT02963506|20012436|P12|Double-Blind Period|Adverse event, non fatal after Wk12|0
5801583|NCT02963506|20012437|P11|Double-Blind Period|Adverse event, non fatal after Wk12|0
5801584|NCT02963506|20012438|P10|Double-Blind Period|Adverse event, non fatal after Wk12|0
5801585|NCT02963506|20012439|P9|Double-Blind Period|Adverse event, non fatal after Wk12|0
5801586|NCT02963506|20012440|P8|Double-Blind Period|Adverse event, non fatal after Wk12|0
5801587|NCT02963506|20012441|P7|Double-Blind Period|Adverse event, non fatal after Wk12|0
5801588|NCT02963506|20012442|P6|Double-Blind Period|Adverse event, non fatal after Wk12|0
5801589|NCT02963506|20012443|P5|Double-Blind Period|Adverse event, non fatal after Wk12|0
5801590|NCT02963506|20012444|P4|Double-Blind Period|Adverse event, non fatal after Wk12|0
5801591|NCT02963506|20012445|P3|Double-Blind Period|Adverse event, non fatal after Wk12|0
5801592|NCT02963506|20012446|P2|Double-Blind Period|Adverse event, non fatal after Wk12|1
5801593|NCT02963506|20012447|P1|Double-Blind Period|Adverse event, non fatal after Wk12|0
5801594|NCT02963506|20012435|P13|Double-Blind Period|No compliance|0
5801595|NCT02963506|20012436|P12|Double-Blind Period|No compliance|0
5801596|NCT02963506|20012437|P11|Double-Blind Period|No compliance|0
5801597|NCT02963506|20012438|P10|Double-Blind Period|No compliance|0
5801598|NCT02963506|20012439|P9|Double-Blind Period|No compliance|0
5801599|NCT02963506|20012440|P8|Double-Blind Period|No compliance|0
5801600|NCT02963506|20012441|P7|Double-Blind Period|No compliance|0
5801601|NCT02963506|20012442|P6|Double-Blind Period|No compliance|0
5801602|NCT02963506|20012443|P5|Double-Blind Period|No compliance|0
5801603|NCT02963506|20012444|P4|Double-Blind Period|No compliance|0
5801604|NCT02963506|20012445|P3|Double-Blind Period|No compliance|0
5801605|NCT02963506|20012446|P2|Double-Blind Period|No compliance|1
5801606|NCT02963506|20012447|P1|Double-Blind Period|No compliance|0
5801607|NCT02963506|20012435|P13|Double-Blind Period|Withdrawal by Subject|0
5801608|NCT02963506|20012436|P12|Double-Blind Period|Withdrawal by Subject|0
5801609|NCT02963506|20012437|P11|Double-Blind Period|Withdrawal by Subject|0
5801610|NCT02963506|20012438|P10|Double-Blind Period|Withdrawal by Subject|0
5801611|NCT02963506|20012439|P9|Double-Blind Period|Withdrawal by Subject|0
5801612|NCT02963506|20012440|P8|Double-Blind Period|Withdrawal by Subject|0
5801613|NCT02963506|20012441|P7|Double-Blind Period|Withdrawal by Subject|0
5801614|NCT02963506|20012442|P6|Double-Blind Period|Withdrawal by Subject|0
5801615|NCT02963506|20012443|P5|Double-Blind Period|Withdrawal by Subject|0
5801616|NCT02963506|20012444|P4|Double-Blind Period|Withdrawal by Subject|1
5801617|NCT02963506|20012445|P3|Double-Blind Period|Withdrawal by Subject|1
5801618|NCT02963506|20012446|P2|Double-Blind Period|Withdrawal by Subject|0
5801619|NCT02963506|20012447|P1|Double-Blind Period|Withdrawal by Subject|0
5801620|NCT02963506|20012435|P13|Double-Blind Period|Lost to Follow-up|0
5801621|NCT02963506|20012436|P12|Double-Blind Period|Lost to Follow-up|0
5801622|NCT02963506|20012437|P11|Double-Blind Period|Lost to Follow-up|0
5801623|NCT02963506|20012438|P10|Double-Blind Period|Lost to Follow-up|0
5801624|NCT02963506|20012439|P9|Double-Blind Period|Lost to Follow-up|0
5801625|NCT02963506|20012440|P8|Double-Blind Period|Lost to Follow-up|0
5801626|NCT02963506|20012441|P7|Double-Blind Period|Lost to Follow-up|0
5801627|NCT02963506|20012442|P6|Double-Blind Period|Lost to Follow-up|0
5801628|NCT02963506|20012443|P5|Double-Blind Period|Lost to Follow-up|0
5801629|NCT02963506|20012444|P4|Double-Blind Period|Lost to Follow-up|0
5801630|NCT02963506|20012445|P3|Double-Blind Period|Lost to Follow-up|0
5801631|NCT02963506|20012446|P2|Double-Blind Period|Lost to Follow-up|1
5801632|NCT02963506|20012447|P1|Double-Blind Period|Lost to Follow-up|0
5801633|NCT02963506|20012435|P13|Double-Blind Period|Death|0
5801634|NCT02963506|20012436|P12|Double-Blind Period|Death|0
5801635|NCT02963506|20012437|P11|Double-Blind Period|Death|0
5801636|NCT02963506|20012438|P10|Double-Blind Period|Death|0
5801637|NCT02963506|20012439|P9|Double-Blind Period|Death|0
5801638|NCT02963506|20012440|P8|Double-Blind Period|Death|0
5801639|NCT02963506|20012441|P7|Double-Blind Period|Death|0
5801640|NCT02963506|20012442|P6|Double-Blind Period|Death|0
5801641|NCT02963506|20012443|P5|Double-Blind Period|Death|0
5801642|NCT02963506|20012444|P4|Double-Blind Period|Death|1
5801643|NCT02963506|20012445|P3|Double-Blind Period|Death|0
5801644|NCT02963506|20012446|P2|Double-Blind Period|Death|0
5801645|NCT02963506|20012447|P1|Double-Blind Period|Death|0
5801646|NCT02963506|20012435|P13|Double-Blind Period|Adverse Event|0
5801647|NCT02963506|20012436|P12|Double-Blind Period|Adverse Event|0
5801648|NCT02963506|20012437|P11|Double-Blind Period|Adverse Event|0
5801649|NCT02963506|20012438|P10|Double-Blind Period|Adverse Event|0
5801650|NCT02963506|20012439|P9|Double-Blind Period|Adverse Event|0
5801651|NCT02963506|20012440|P8|Double-Blind Period|Adverse Event|0
5801652|NCT02963506|20012441|P7|Double-Blind Period|Adverse Event|0
5801653|NCT02963506|20012442|P6|Double-Blind Period|Adverse Event|0
5801654|NCT02963506|20012443|P5|Double-Blind Period|Adverse Event|0
5801655|NCT02963506|20012444|P4|Double-Blind Period|Adverse Event|0
5801656|NCT02963506|20012445|P3|Double-Blind Period|Adverse Event|1
5801657|NCT02963506|20012446|P2|Double-Blind Period|Adverse Event|0
5801658|NCT02963506|20012447|P1|Double-Blind Period|Adverse Event|0
5801659|NCT02963311|20012499|P1|Overall Study|Screen Failure|4
5801660|NCT02963311|20012499|P1|Overall Study|Withdrawal by Subject|1
5801661|NCT02962960|20012526|P3|Overall Study|Protocol Violation|0
5801662|NCT02962960|20012527|P2|Overall Study|Protocol Violation|0
5801663|NCT02962960|20012528|P1|Overall Study|Protocol Violation|1
5801664|NCT02962960|20012526|P3|Overall Study|Adverse Event|0
5801665|NCT02962960|20012527|P2|Overall Study|Adverse Event|1
5801666|NCT02962960|20012528|P1|Overall Study|Adverse Event|1
5801667|NCT02962960|20012526|P3|Overall Study|Withdrawal by Subject|0
5801668|NCT02962960|20012527|P2|Overall Study|Withdrawal by Subject|1
5801669|NCT02962960|20012528|P1|Overall Study|Withdrawal by Subject|1
5801670|NCT02962908|20012612|P4|Overall Study|Physician Decision|0
5801671|NCT02962908|20012613|P3|Overall Study|Physician Decision|0
5801672|NCT02962908|20012614|P2|Overall Study|Physician Decision|1
5801673|NCT02962908|20012615|P1|Overall Study|Physician Decision|0
5801674|NCT02962908|20012612|P4|Overall Study|Protocol Violation|0
5801675|NCT02962908|20012613|P3|Overall Study|Protocol Violation|0
5801676|NCT02962908|20012614|P2|Overall Study|Protocol Violation|1
5801677|NCT02962908|20012615|P1|Overall Study|Protocol Violation|0
5801678|NCT02962908|20012612|P4|Overall Study|Withdrawal by Subject|2
5801679|NCT02962908|20012613|P3|Overall Study|Withdrawal by Subject|0
5801680|NCT02962908|20012614|P2|Overall Study|Withdrawal by Subject|3
5801681|NCT02962908|20012615|P1|Overall Study|Withdrawal by Subject|0
5801682|NCT02962908|20012612|P4|Overall Study|Lost to Follow-up|1
5801683|NCT02962908|20012613|P3|Overall Study|Lost to Follow-up|0
5801684|NCT02962908|20012614|P2|Overall Study|Lost to Follow-up|3
5801685|NCT02962908|20012615|P1|Overall Study|Lost to Follow-up|0
5801686|NCT02962882|20012679|P1|Overall Study|Transfer from ICU|32
5801687|NCT02962882|20012679|P1|Overall Study|Withdrawal by Subject|2
5801688|NCT02962882|20012679|P1|Overall Study|Adverse Event|2
5801689|NCT02962739|20012688|P6|Overall Study|Protocol Violation|0
5801690|NCT02962739|20012689|P5|Overall Study|Protocol Violation|1
5801691|NCT02962739|20012690|P4|Overall Study|Protocol Violation|0
5801692|NCT02962739|20012691|P3|Overall Study|Protocol Violation|1
5801693|NCT02962739|20012692|P2|Overall Study|Protocol Violation|0
5801694|NCT02962739|20012693|P1|Overall Study|Protocol Violation|0
5801695|NCT02962739|20012688|P6|Overall Study|Withdrawal by Subject|0
5801696|NCT02962739|20012689|P5|Overall Study|Withdrawal by Subject|0
5801697|NCT02962739|20012690|P4|Overall Study|Withdrawal by Subject|0
5801698|NCT02962739|20012691|P3|Overall Study|Withdrawal by Subject|0
5801699|NCT02962739|20012692|P2|Overall Study|Withdrawal by Subject|1
5801700|NCT02962739|20012693|P1|Overall Study|Withdrawal by Subject|0
5801701|NCT02962648|20012726|P1|Overall Study|Subject had problems with transportation|2
5801702|NCT02962648|20012726|P1|Overall Study|Physician Decision|1
5801703|NCT02962648|20012726|P1|Overall Study|Lost to Follow-up|3
5801704|NCT02962648|20012726|P1|Overall Study|Withdrawal by Subject|3
5801705|NCT02962284|20012764|P2|Overall Study|Withdrawal by Subject|0
5801706|NCT02962284|20012765|P1|Overall Study|Withdrawal by Subject|1
5801707|NCT02962284|20012764|P2|Overall Study|Progressive disease|3
5801708|NCT02962284|20012765|P1|Overall Study|Progressive disease|2
5801709|NCT02962284|20012764|P2|Overall Study|Death|0
5801710|NCT02962284|20012765|P1|Overall Study|Death|2
5801711|NCT02961920|20012796|P2|Overall Study|did not achive stydy protocol schedule|1
5801712|NCT02961920|20012797|P1|Overall Study|did not achive stydy protocol schedule|1
5801713|NCT02961790|20012825|P4|Overall Study|without post baseline data|1
5801714|NCT02961790|20012826|P3|Overall Study|without post baseline data|4
5801715|NCT02961790|20012827|P2|Overall Study|without post baseline data|6
5801716|NCT02961790|20012828|P1|Overall Study|without post baseline data|7
5801717|NCT02961790|20012825|P4|Overall Study|without baseline data|0
5801718|NCT02961790|20012826|P3|Overall Study|without baseline data|1
5801719|NCT02961790|20012827|P2|Overall Study|without baseline data|0
5801720|NCT02961790|20012828|P1|Overall Study|without baseline data|4
5801721|NCT02961790|20012825|P4|Overall Study|Canceled|4
5801722|NCT02961790|20012826|P3|Overall Study|Canceled|1
5801723|NCT02961790|20012827|P2|Overall Study|Canceled|5
5801724|NCT02961790|20012828|P1|Overall Study|Canceled|4
5801725|NCT02961764|20012851|P2|Overall Study|Withdrawal by Subject|0
5801726|NCT02961764|20012852|P1|Overall Study|Withdrawal by Subject|2
5801727|NCT02961764|20012851|P2|Overall Study|Lost to Follow-up|24
5801728|NCT02961764|20012852|P1|Overall Study|Lost to Follow-up|35
5801729|NCT02961764|20012851|P2|Overall Study|Death|0
5801730|NCT02961764|20012852|P1|Overall Study|Death|2
5801731|NCT02961764|20012851|P2|Overall Study|Protocol Violation|1
5801732|NCT02961764|20012852|P1|Overall Study|Protocol Violation|0
5801733|NCT02961751|20012926|P1|Overall Study|Protocol Violation|1
5801734|NCT02961751|20012926|P1|Overall Study|Not Eligible at Enrollment|1
5801735|NCT02961751|20012926|P1|Overall Study|Physician Decision|2
5801736|NCT02961751|20012926|P1|Overall Study|Lost to Follow-up|11
5801737|NCT02961244|20012939|P2|Overall Study|İnadequate data|2
5801738|NCT02961244|20012940|P1|Overall Study|İnadequate data|0
5801739|NCT02961244|20012939|P2|Overall Study|Lost to Follow-up|2
5801740|NCT02961244|20012940|P1|Overall Study|Lost to Follow-up|0
5801741|NCT02961244|20012939|P2|Overall Study|Surgery plan change after study approval|2
5801742|NCT02961244|20012940|P1|Overall Study|Surgery plan change after study approval|0
5801743|NCT02961244|20012939|P2|Overall Study|Withdrawal by Subject|2
5801744|NCT02961244|20012940|P1|Overall Study|Withdrawal by Subject|1
5801745|NCT02961244|20012939|P2|Overall Study|Protocol Violation|1
5801746|NCT02961244|20012940|P1|Overall Study|Protocol Violation|0
5801747|NCT02961218|20012950|P2|Overall Study|Subject/Guardian Decision|1
5801748|NCT02961218|20012951|P1|Overall Study|Subject/Guardian Decision|3
5801749|NCT02961218|20012950|P2|Overall Study|Physician Decision|2
5801750|NCT02961218|20012951|P1|Overall Study|Physician Decision|0
5801751|NCT02961218|20012950|P2|Overall Study|Lost to Follow-up|2
5801752|NCT02961218|20012951|P1|Overall Study|Lost to Follow-up|0
5801753|NCT02960893|20013031|P2|Extension Phase (48-week)|Sponsors Decision|0
5801754|NCT02960893|20013032|P1|Extension Phase (48-week)|Sponsors Decision|1
5801755|NCT02960893|20013031|P2|Extension Phase (48-week)|Lost to Follow-up|1
5801756|NCT02960893|20013032|P1|Extension Phase (48-week)|Lost to Follow-up|1
5801757|NCT02960893|20013031|P2|Extension Phase (48-week)|Other Reason|1
5801758|NCT02960893|20013032|P1|Extension Phase (48-week)|Other Reason|2
5801759|NCT02960893|20013031|P2|Extension Phase (48-week)|Withdrawal by Subject|8
5801760|NCT02960893|20013032|P1|Extension Phase (48-week)|Withdrawal by Subject|8
5801761|NCT02960893|20013031|P2|Extension Phase (48-week)|Adverse Event|3
5801762|NCT02960893|20013032|P1|Extension Phase (48-week)|Adverse Event|2
5801763|NCT02960893|20013031|P2|Randomization Phase (8-week)|Reason Not Specified|1
5801764|NCT02960893|20013032|P1|Randomization Phase (8-week)|Reason Not Specified|0
5801765|NCT02960893|20013031|P2|Randomization Phase (8-week)|Withdrawal by Subject|1
5801766|NCT02960893|20013032|P1|Randomization Phase (8-week)|Withdrawal by Subject|2
5801767|NCT02960893|20013031|P2|Randomization Phase (8-week)|Adverse Event|0
5801768|NCT02960893|20013032|P1|Randomization Phase (8-week)|Adverse Event|5
5801769|NCT02960854|20013050|P2|Overall Study|Death|6
5801770|NCT02960854|20013051|P1|Overall Study|Death|4
5801771|NCT02960854|20013050|P2|Overall Study|Subject Withdrew Consent|1
5801772|NCT02960854|20013051|P1|Overall Study|Subject Withdrew Consent|0
5801773|NCT02960854|20013050|P2|Overall Study|Subject No Longer Meets Study Criteria|0
5801774|NCT02960854|20013051|P1|Overall Study|Subject No Longer Meets Study Criteria|1
5801775|NCT02960854|20013050|P2|Overall Study|Not Disclosed|2
5801776|NCT02960854|20013051|P1|Overall Study|Not Disclosed|2
5801777|NCT02960217|20013090|P2|Open-Label Extension Phase|Other, Not Specified|1
5801778|NCT02960217|20013091|P1|Open-Label Extension Phase|Other, Not Specified|0
5801779|NCT02960217|20013090|P2|Open-Label Extension Phase|Lack of Efficacy|1
5801780|NCT02960217|20013091|P1|Open-Label Extension Phase|Lack of Efficacy|1
5801781|NCT02960217|20013090|P2|Open-Label Extension Phase|Sponsor Decision|11
5801782|NCT02960217|20013091|P1|Open-Label Extension Phase|Sponsor Decision|18
5801783|NCT02960217|20013090|P2|Open-Label Extension Phase|Adverse Event|0
5801784|NCT02960217|20013091|P1|Open-Label Extension Phase|Adverse Event|1
5801785|NCT02960217|20013090|P2|Maintenance Phase: Treatment Period 2|Other, Not Specified|1
5801786|NCT02960217|20013091|P1|Maintenance Phase: Treatment Period 2|Other, Not Specified|0
5801787|NCT02960217|20013090|P2|Maintenance Phase: Treatment Period 2|Lack of Efficacy|0
5801788|NCT02960217|20013091|P1|Maintenance Phase: Treatment Period 2|Lack of Efficacy|1
5801789|NCT02960217|20013090|P2|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|1
5801790|NCT02960217|20013091|P1|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|0
5801791|NCT02960217|20013090|P2|Maintenance Phase: Treatment Period 2|Adverse Event|1
5801792|NCT02960217|20013091|P1|Maintenance Phase: Treatment Period 2|Adverse Event|0
5801793|NCT02960217|20013090|P2|Maintenance Phase: Treatment Period 1|Adverse Event|0
5801794|NCT02960217|20013091|P1|Maintenance Phase: Treatment Period 1|Adverse Event|1
5801795|NCT02959983|20013170|P2|Overall Study|Withdrawal by Subject|12
5801796|NCT02959983|20013171|P1|Overall Study|Withdrawal by Subject|7
5801797|NCT02959983|20013170|P2|Overall Study|Adverse Event|1
5801798|NCT02959983|20013171|P1|Overall Study|Adverse Event|5
5801799|NCT02959983|20013170|P2|Overall Study|Physician Decision|0
5801800|NCT02959983|20013171|P1|Overall Study|Physician Decision|1
5801801|NCT02959983|20013170|P2|Overall Study|Other|1
5801802|NCT02959983|20013171|P1|Overall Study|Other|1
5801803|NCT02959983|20013170|P2|Overall Study|Lost to Follow-up|9
5801804|NCT02959983|20013171|P1|Overall Study|Lost to Follow-up|12
5801805|NCT02959983|20013170|P2|Overall Study|Lack of Efficacy|1
5801806|NCT02959983|20013171|P1|Overall Study|Lack of Efficacy|0
5801807|NCT02959983|20013170|P2|Overall Study|Protocol Violation|1
5801808|NCT02959983|20013171|P1|Overall Study|Protocol Violation|0
5801809|NCT02959970|20013185|P2|Overall Study|Lost to Follow-up|5
5801810|NCT02959970|20013186|P1|Overall Study|Lost to Follow-up|1
5801811|NCT02959970|20013185|P2|Overall Study|Withdrawal by Subject|2
5801812|NCT02959970|20013186|P1|Overall Study|Withdrawal by Subject|0
5801813|NCT02959970|20013185|P2|Overall Study|Adverse Event|0
5801814|NCT02959970|20013186|P1|Overall Study|Adverse Event|1
5801815|NCT02959892|20013220|P2|Overall Study|Study termination|1
5801816|NCT02959892|20013221|P1|Overall Study|Study termination|0
5801817|NCT02959892|20013220|P2|Overall Study|PET tracer synthesis failure|0
5801818|NCT02959892|20013221|P1|Overall Study|PET tracer synthesis failure|1
5801819|NCT02959866|20013229|P1|Overall Study|Withdrawal by Subject|1
5801820|NCT02959814|20013318|P1|Overall Study|Excluded by FFR core-lab|24
5801821|NCT02959814|20013318|P1|Overall Study|In-procedure QFR not computed|6
5801822|NCT02959814|20013318|P1|Overall Study|FFR not measured|2
5801823|NCT02959814|20013318|P1|Overall Study|Protocol Violation|7
5801824|NCT02959814|20013318|P1|Overall Study|Excluded based on anatomical criteria|2
5801825|NCT02959814|20013318|P1|Overall Study|Excluded based on diagnostic angiography|16
5801826|NCT02959671|20013337|P1|Overall Study|Participants signed a consent; however enrollment was complete before they started study activity.|3
5801827|NCT02959671|20013337|P1|Overall Study|Adverse Event|2
5801828|NCT02959437|20013349|P4|Overall Study|Participants Ongoing in Study|0
5801829|NCT02959437|20013350|P3|Overall Study|Participants Ongoing in Study|0
5801830|NCT02959437|20013351|P2|Overall Study|Participants Ongoing in Study|0
5801831|NCT02959437|20013352|P1|Overall Study|Participants Ongoing in Study|7
5801832|NCT02959437|20013349|P4|Overall Study|Other Unspecified|0
5801833|NCT02959437|20013350|P3|Overall Study|Other Unspecified|0
5801834|NCT02959437|20013351|P2|Overall Study|Other Unspecified|0
5801835|NCT02959437|20013352|P1|Overall Study|Other Unspecified|2
5801836|NCT02959437|20013349|P4|Overall Study|Study Terminated by Sponsor|0
5801837|NCT02959437|20013350|P3|Overall Study|Study Terminated by Sponsor|0
5801838|NCT02959437|20013351|P2|Overall Study|Study Terminated by Sponsor|0
5801839|NCT02959437|20013352|P1|Overall Study|Study Terminated by Sponsor|2
5801840|NCT02959437|20013349|P4|Overall Study|Progressive Disease|0
5801841|NCT02959437|20013350|P3|Overall Study|Progressive Disease|0
5801842|NCT02959437|20013351|P2|Overall Study|Progressive Disease|1
5801843|NCT02959437|20013352|P1|Overall Study|Progressive Disease|8
5801844|NCT02959437|20013349|P4|Overall Study|Withdrawal by Subject|0
5801845|NCT02959437|20013350|P3|Overall Study|Withdrawal by Subject|0
5801846|NCT02959437|20013351|P2|Overall Study|Withdrawal by Subject|3
5801847|NCT02959437|20013352|P1|Overall Study|Withdrawal by Subject|10
5801848|NCT02959437|20013349|P4|Overall Study|Lost to Follow-up|0
5801849|NCT02959437|20013350|P3|Overall Study|Lost to Follow-up|0
5801850|NCT02959437|20013351|P2|Overall Study|Lost to Follow-up|1
5801851|NCT02959437|20013352|P1|Overall Study|Lost to Follow-up|2
5801852|NCT02959437|20013349|P4|Overall Study|Death|0
5801853|NCT02959437|20013350|P3|Overall Study|Death|0
5801854|NCT02959437|20013351|P2|Overall Study|Death|3
5801855|NCT02959437|20013352|P1|Overall Study|Death|31
5801856|NCT02959190|20013385|P4|Post Treatment Follow Up|Withdrawal by Subject|0
5801857|NCT02959190|20013386|P3|Post Treatment Follow Up|Withdrawal by Subject|1
5801858|NCT02959190|20013387|P2|Post Treatment Follow Up|Withdrawal by Subject|0
5801859|NCT02959190|20013388|P1|Post Treatment Follow Up|Withdrawal by Subject|2
5801860|NCT02959190|20013385|P4|Post Treatment Follow Up|Adverse Event|0
5801861|NCT02959190|20013386|P3|Post Treatment Follow Up|Adverse Event|0
5801862|NCT02959190|20013387|P2|Post Treatment Follow Up|Adverse Event|1
5801863|NCT02959190|20013388|P1|Post Treatment Follow Up|Adverse Event|1
5801864|NCT02959190|20013385|P4|Open Label|Protocol Violation|2
5801865|NCT02959190|20013386|P3|Open Label|Protocol Violation|0
5801866|NCT02959190|20013387|P2|Open Label|Protocol Violation|0
5801867|NCT02959190|20013388|P1|Open Label|Protocol Violation|0
5801868|NCT02959190|20013385|P4|Open Label|Physician Decision|0
5801869|NCT02959190|20013386|P3|Open Label|Physician Decision|1
5801870|NCT02959190|20013387|P2|Open Label|Physician Decision|0
5801871|NCT02959190|20013388|P1|Open Label|Physician Decision|0
5801872|NCT02959190|20013385|P4|Open Label|Withdrawal by Subject|0
5801873|NCT02959190|20013386|P3|Open Label|Withdrawal by Subject|0
5801874|NCT02959190|20013387|P2|Open Label|Withdrawal by Subject|8
5801875|NCT02959190|20013388|P1|Open Label|Withdrawal by Subject|2
5801876|NCT02959190|20013385|P4|Open Label|Pregnancy|0
5801877|NCT02959190|20013386|P3|Open Label|Pregnancy|0
5801878|NCT02959190|20013387|P2|Open Label|Pregnancy|1
5801879|NCT02959190|20013388|P1|Open Label|Pregnancy|0
5801880|NCT02959190|20013385|P4|Open Label|Adverse Event|4
5801881|NCT02959190|20013386|P3|Open Label|Adverse Event|3
5801882|NCT02959190|20013387|P2|Open Label|Adverse Event|7
5801883|NCT02959190|20013388|P1|Open Label|Adverse Event|5
5801884|NCT02959177|20013481|P3|Follow-up Post Treatment Phase|Withdrawal by Subject|2
5801885|NCT02959177|20013482|P2|Follow-up Post Treatment Phase|Withdrawal by Subject|0
5801886|NCT02959177|20013483|P1|Follow-up Post Treatment Phase|Withdrawal by Subject|0
5801887|NCT02959177|20013481|P3|Follow-up Post Treatment Phase|Adverse Event|0
5801888|NCT02959177|20013482|P2|Follow-up Post Treatment Phase|Adverse Event|1
5801889|NCT02959177|20013483|P1|Follow-up Post Treatment Phase|Adverse Event|0
5801890|NCT02959177|20013481|P3|Follow-up Post Treatment Phase|Lost to Follow-up|0
5801891|NCT02959177|20013482|P2|Follow-up Post Treatment Phase|Lost to Follow-up|0
5801892|NCT02959177|20013483|P1|Follow-up Post Treatment Phase|Lost to Follow-up|1
5801893|NCT02959177|20013481|P3|Double-Blind Treatment Phase|Withdrawal by Subject|5
5801894|NCT02959177|20013482|P2|Double-Blind Treatment Phase|Withdrawal by Subject|0
5801895|NCT02959177|20013483|P1|Double-Blind Treatment Phase|Withdrawal by Subject|5
5801896|NCT02959177|20013481|P3|Double-Blind Treatment Phase|Protocol Violation|0
5801897|NCT02959177|20013482|P2|Double-Blind Treatment Phase|Protocol Violation|1
5801898|NCT02959177|20013483|P1|Double-Blind Treatment Phase|Protocol Violation|0
5801899|NCT02959177|20013481|P3|Double-Blind Treatment Phase|Physician Decision|0
5801900|NCT02959177|20013482|P2|Double-Blind Treatment Phase|Physician Decision|0
5801901|NCT02959177|20013483|P1|Double-Blind Treatment Phase|Physician Decision|1
5801902|NCT02959177|20013481|P3|Double-Blind Treatment Phase|Adverse Event|0
5801903|NCT02959177|20013482|P2|Double-Blind Treatment Phase|Adverse Event|2
5801904|NCT02959177|20013483|P1|Double-Blind Treatment Phase|Adverse Event|5
5801905|NCT02959138|20013538|P3|Overall Study|Enrolled but Never Treated|0
5801906|NCT02959138|20013539|P2|Overall Study|Enrolled but Never Treated|1
5801907|NCT02959138|20013540|P1|Overall Study|Enrolled but Never Treated|0
5801908|NCT02958553|20013681|P1|Phase II, 6th Visit -6 Month emPOWER FU|Adverse Event|2
5801909|NCT02958553|20013681|P1|Phase I, 3rd Visit -2 Week emPOWER FU|Withdrawal by Subject|1
5801910|NCT02958267|20013715|P2|Follow-up Visits|Additional treatment pursued|1
5801911|NCT02958267|20013716|P1|Follow-up Visits|Additional treatment pursued|2
5801912|NCT02958267|20013715|P2|Enrollment to Actual Treatment Complete|Physician Decision|0
5801913|NCT02958267|20013716|P1|Enrollment to Actual Treatment Complete|Physician Decision|1
5801914|NCT02958267|20013715|P2|Enrollment to Actual Treatment Complete|Withdrawal by Subject|0
5801915|NCT02958267|20013716|P1|Enrollment to Actual Treatment Complete|Withdrawal by Subject|1
5801916|NCT02957942|20013728|P2|Overall Study|Practicing experiment protocol|6
5801917|NCT02957942|20013729|P1|Overall Study|Practicing experiment protocol|0
5801918|NCT02957942|20013728|P2|Overall Study|Withdrawal by Subject|1
5801919|NCT02957942|20013729|P1|Overall Study|Withdrawal by Subject|0
5801920|NCT02957747|20013745|P2|Overall Study|Lost to Follow-up|5
5801921|NCT02957747|20013746|P1|Overall Study|Lost to Follow-up|10
5801922|NCT02957747|20013745|P2|Overall Study|Withdrawal by Subject|3
5801923|NCT02957747|20013746|P1|Overall Study|Withdrawal by Subject|0
5801924|NCT02957331|20013782|P2|Overall Study|Protocol Violation|0
5801925|NCT02957331|20013783|P1|Overall Study|Protocol Violation|1
5801926|NCT02956967|20013802|P1|Overall Study|Termination of Nivestim administration|29
5801927|NCT02956967|20013802|P1|Overall Study|Missing|1
5801928|NCT02956967|20013802|P1|Overall Study|Lost to Follow-up|5
5801929|NCT02956967|20013802|P1|Overall Study|Reason non-related to neutropenia|10
5801930|NCT02956967|20013802|P1|Overall Study|Adverse Event|3
5801931|NCT02956837|20013829|P4|Overall Study|Lost to Follow-up|0
5801932|NCT02956837|20013830|P3|Overall Study|Lost to Follow-up|2
5801933|NCT02956837|20013831|P2|Overall Study|Lost to Follow-up|1
5801934|NCT02956837|20013832|P1|Overall Study|Lost to Follow-up|0
5801935|NCT02956837|20013829|P4|Overall Study|Withdrawal by Subject|3
5801936|NCT02956837|20013830|P3|Overall Study|Withdrawal by Subject|0
5801937|NCT02956837|20013831|P2|Overall Study|Withdrawal by Subject|1
5801938|NCT02956837|20013832|P1|Overall Study|Withdrawal by Subject|0
5801939|NCT02956837|20013829|P4|Overall Study|Serious Adverse Events|0
5801940|NCT02956837|20013830|P3|Overall Study|Serious Adverse Events|0
5801941|NCT02956837|20013831|P2|Overall Study|Serious Adverse Events|1
5801942|NCT02956837|20013832|P1|Overall Study|Serious Adverse Events|0
5801961|NCT02956460|20014051|P2|Lens 1|Lost to Follow-up|0
5801962|NCT02956460|20014052|P1|Lens 1|Lost to Follow-up|1
5801963|NCT02956278|20014081|P3|Overall Study|Withdrawal by Subject|0
5801964|NCT02956278|20014082|P2|Overall Study|Withdrawal by Subject|2
5801965|NCT02956278|20014083|P1|Overall Study|Withdrawal by Subject|6
5801966|NCT02956057|20014167|P6|Overall Study|Lost to Follow-up|0
5801967|NCT02956057|20014168|P5|Overall Study|Lost to Follow-up|1
5801968|NCT02956057|20014169|P4|Overall Study|Lost to Follow-up|1
5801969|NCT02956057|20014170|P3|Overall Study|Lost to Follow-up|1
5801970|NCT02956057|20014171|P2|Overall Study|Lost to Follow-up|2
5801971|NCT02956057|20014172|P1|Overall Study|Lost to Follow-up|0
5801972|NCT02956057|20014167|P6|Overall Study|Discontinued intervention|17
5801973|NCT02956057|20014168|P5|Overall Study|Discontinued intervention|4
5801974|NCT02956057|20014169|P4|Overall Study|Discontinued intervention|14
5801975|NCT02956057|20014170|P3|Overall Study|Discontinued intervention|7
5801976|NCT02956057|20014171|P2|Overall Study|Discontinued intervention|10
5801977|NCT02956057|20014172|P1|Overall Study|Discontinued intervention|14
5801978|NCT02956005|20014192|P1|Overall Study|Physician Decision|12
5801979|NCT02956005|20014192|P1|Overall Study|Withdrawal by Subject|3
5801980|NCT02956005|20014192|P1|Overall Study|Not eligible|1
5801981|NCT02955797|20014201|P4|Overall Study|Lost to Follow-up|0
5801982|NCT02955797|20014202|P3|Overall Study|Lost to Follow-up|0
5801983|NCT02955797|20014203|P2|Overall Study|Lost to Follow-up|1
5801984|NCT02955797|20014204|P1|Overall Study|Lost to Follow-up|0
5801985|NCT02955797|20014201|P4|Overall Study|Withdrawal by Subject|1
5801986|NCT02955797|20014202|P3|Overall Study|Withdrawal by Subject|0
5801987|NCT02955797|20014203|P2|Overall Study|Withdrawal by Subject|2
5801988|NCT02955797|20014204|P1|Overall Study|Withdrawal by Subject|2
5801989|NCT02955797|20014201|P4|Overall Study|Protocol Violation|1
5801990|NCT02955797|20014202|P3|Overall Study|Protocol Violation|0
5801991|NCT02955797|20014203|P2|Overall Study|Protocol Violation|0
5801992|NCT02955797|20014204|P1|Overall Study|Protocol Violation|1
5801993|NCT02955212|20014222|P2|Overall Study|Other|2
5801994|NCT02955212|20014223|P1|Overall Study|Other|3
5801995|NCT02955212|20014222|P2|Overall Study|Lost to Follow-up|0
5801996|NCT02955212|20014223|P1|Overall Study|Lost to Follow-up|1
5801997|NCT02955212|20014222|P2|Overall Study|Withdrawal by Subject|3
5801998|NCT02955212|20014223|P1|Overall Study|Withdrawal by Subject|8
5801999|NCT02955212|20014222|P2|Overall Study|Adverse Event|7
5802000|NCT02955212|20014223|P1|Overall Study|Adverse Event|4
5802001|NCT02955186|20014249|P2|Overall Study|Protocol Violation|0
5802002|NCT02955186|20014250|P1|Overall Study|Protocol Violation|1
5802003|NCT02955186|20014249|P2|Overall Study|Withdrawal by Subject|2
5802004|NCT02955186|20014250|P1|Overall Study|Withdrawal by Subject|6
5802005|NCT02954952|20014272|P3|Overall Study|No data collected|0
5802006|NCT02954952|20014273|P2|Overall Study|No data collected|1
5802007|NCT02954952|20014274|P1|Overall Study|No data collected|0
5802008|NCT02954952|20014272|P3|Overall Study|Withdrawal by Subject|0
5802009|NCT02954952|20014273|P2|Overall Study|Withdrawal by Subject|0
5802010|NCT02954952|20014274|P1|Overall Study|Withdrawal by Subject|1
5802011|NCT02954887|20014282|P1|Overall Study|Other|1
5802012|NCT02954887|20014282|P1|Overall Study|Lack of Efficacy|3
5802013|NCT02954887|20014282|P1|Overall Study|Withdrawal by Subject|3
5802014|NCT02954848|20014311|P2|Overall Study|Withdrawal by Participant|1
5802015|NCT02954848|20014312|P1|Overall Study|Withdrawal by Participant|0
5802016|NCT02954848|20014311|P2|Overall Study|Adverse Event|3
5802017|NCT02954848|20014312|P1|Overall Study|Adverse Event|2
5802018|NCT02954848|20014311|P2|Overall Study|Randomized but Not Treated|1
5802019|NCT02954848|20014312|P1|Overall Study|Randomized but Not Treated|0
5802020|NCT02954653|20014372|P9|Overall Study|Treatment failure and consent withdrawal|0
5802021|NCT02954653|20014373|P8|Overall Study|Treatment failure and consent withdrawal|0
5802022|NCT02954653|20014374|P7|Overall Study|Treatment failure and consent withdrawal|0
5802023|NCT02954653|20014375|P6|Overall Study|Treatment failure and consent withdrawal|0
5802024|NCT02954653|20014376|P5|Overall Study|Treatment failure and consent withdrawal|0
5802025|NCT02954653|20014377|P4|Overall Study|Treatment failure and consent withdrawal|0
5802026|NCT02954653|20014378|P3|Overall Study|Treatment failure and consent withdrawal|0
5802027|NCT02954653|20014379|P2|Overall Study|Treatment failure and consent withdrawal|1
5802028|NCT02954653|20014380|P1|Overall Study|Treatment failure and consent withdrawal|0
5802029|NCT02954653|20014372|P9|Overall Study|Started another anti-cancer therapy|0
5802030|NCT02954653|20014373|P8|Overall Study|Started another anti-cancer therapy|0
5802031|NCT02954653|20014374|P7|Overall Study|Started another anti-cancer therapy|0
5802032|NCT02954653|20014375|P6|Overall Study|Started another anti-cancer therapy|0
5802033|NCT02954653|20014376|P5|Overall Study|Started another anti-cancer therapy|0
5802034|NCT02954653|20014377|P4|Overall Study|Started another anti-cancer therapy|0
5802035|NCT02954653|20014378|P3|Overall Study|Started another anti-cancer therapy|0
5802036|NCT02954653|20014379|P2|Overall Study|Started another anti-cancer therapy|1
5802037|NCT02954653|20014380|P1|Overall Study|Started another anti-cancer therapy|0
5802038|NCT02954653|20014372|P9|Overall Study|Randomized but did not receive treatment|0
5802039|NCT02954653|20014373|P8|Overall Study|Randomized but did not receive treatment|0
5802040|NCT02954653|20014374|P7|Overall Study|Randomized but did not receive treatment|0
5802041|NCT02954653|20014375|P6|Overall Study|Randomized but did not receive treatment|0
5802042|NCT02954653|20014376|P5|Overall Study|Randomized but did not receive treatment|0
5802043|NCT02954653|20014377|P4|Overall Study|Randomized but did not receive treatment|0
5802044|NCT02954653|20014378|P3|Overall Study|Randomized but did not receive treatment|0
5802045|NCT02954653|20014379|P2|Overall Study|Randomized but did not receive treatment|0
5802046|NCT02954653|20014380|P1|Overall Study|Randomized but did not receive treatment|1
5802047|NCT02954653|20014372|P9|Overall Study|Death|0
5802048|NCT02954653|20014373|P8|Overall Study|Death|0
5802049|NCT02954653|20014374|P7|Overall Study|Death|0
5802050|NCT02954653|20014375|P6|Overall Study|Death|0
5802051|NCT02954653|20014376|P5|Overall Study|Death|0
5802052|NCT02954653|20014377|P4|Overall Study|Death|0
5802053|NCT02954653|20014378|P3|Overall Study|Death|0
5802054|NCT02954653|20014379|P2|Overall Study|Death|1
5802055|NCT02954653|20014380|P1|Overall Study|Death|3
5802056|NCT02954601|20014499|P4|First Intervention (Five Days)|Withdrawal by Subject|0
5802057|NCT02954601|20014500|P3|First Intervention (Five Days)|Withdrawal by Subject|1
5802058|NCT02954601|20014501|P2|First Intervention (Five Days)|Withdrawal by Subject|0
5802059|NCT02954601|20014502|P1|First Intervention (Five Days)|Withdrawal by Subject|0
5802060|NCT02954575|20014524|P1|Overall Study|Adverse Event|1
5802061|NCT02954575|20014524|P1|Overall Study|Withdrawal by Subject|2
5802062|NCT02954354|20014544|P3|Overall Study|Miscellaneous|1
5802063|NCT02954354|20014545|P2|Overall Study|Miscellaneous|2
5802064|NCT02954354|20014546|P1|Overall Study|Miscellaneous|2
5802065|NCT02954354|20014544|P3|Overall Study|Lost to Follow-up|0
5802066|NCT02954354|20014545|P2|Overall Study|Lost to Follow-up|5
5802067|NCT02954354|20014546|P1|Overall Study|Lost to Follow-up|12
5802068|NCT02954354|20014544|P3|Overall Study|Withdrawal by Subject|11
5802069|NCT02954354|20014545|P2|Overall Study|Withdrawal by Subject|9
5802070|NCT02954354|20014546|P1|Overall Study|Withdrawal by Subject|17
5802071|NCT02954354|20014544|P3|Overall Study|Lack of Efficacy|0
5802072|NCT02954354|20014545|P2|Overall Study|Lack of Efficacy|2
5802073|NCT02954354|20014546|P1|Overall Study|Lack of Efficacy|0
5802074|NCT02954354|20014544|P3|Overall Study|Failure to Meet Eligibility Criteria|0
5802075|NCT02954354|20014545|P2|Overall Study|Failure to Meet Eligibility Criteria|0
5802076|NCT02954354|20014546|P1|Overall Study|Failure to Meet Eligibility Criteria|1
5802077|NCT02954354|20014544|P3|Overall Study|Adverse Event|4
5802078|NCT02954354|20014545|P2|Overall Study|Adverse Event|2
5802079|NCT02954354|20014546|P1|Overall Study|Adverse Event|2
5802080|NCT02954172|20014647|P2|Overall Study|non-measurable lesions at baseline|2
5802081|NCT02954172|20014648|P1|Overall Study|non-measurable lesions at baseline|1
5802082|NCT02954172|20014647|P2|Overall Study|allergic reaction|1
5802083|NCT02954172|20014648|P1|Overall Study|allergic reaction|2
5802084|NCT02954172|20014647|P2|Overall Study|Protocol Violation|0
5802085|NCT02954172|20014648|P1|Overall Study|Protocol Violation|3
5802086|NCT02954159|20014660|P2|Overall Study|Withdrawal by Subject|1
5802087|NCT02954159|20014661|P1|Overall Study|Withdrawal by Subject|0
5802088|NCT02954159|20014660|P2|Overall Study|Study ended prematurely due to low enrol|0
5802089|NCT02954159|20014661|P1|Overall Study|Study ended prematurely due to low enrol|1
5802090|NCT02953938|20014675|P2|Overall Study|Withdrawal by Subject|1
5802091|NCT02953938|20014676|P1|Overall Study|Withdrawal by Subject|1
5802092|NCT02953938|20014675|P2|Overall Study|Adverse Event|1
5802093|NCT02953938|20014676|P1|Overall Study|Adverse Event|0
5802094|NCT02953821|20014707|P2|Overall Study|Refused follow-up visit|1
5802095|NCT02953821|20014708|P1|Overall Study|Refused follow-up visit|2
5802096|NCT02953821|20014707|P2|Overall Study|No improvement|1
5802097|NCT02953821|20014708|P1|Overall Study|No improvement|0
5802098|NCT02953821|20014707|P2|Overall Study|Out of state for indeterminate time|1
5802099|NCT02953821|20014708|P1|Overall Study|Out of state for indeterminate time|0
5802100|NCT02953821|20014707|P2|Overall Study|Lack of Efficacy|0
5802101|NCT02953821|20014708|P1|Overall Study|Lack of Efficacy|1
5802102|NCT02953821|20014707|P2|Overall Study|Change of address|1
5802103|NCT02953821|20014708|P1|Overall Study|Change of address|0
5802104|NCT02953821|20014707|P2|Overall Study|Withdrawal by Subject|3
5802105|NCT02953821|20014708|P1|Overall Study|Withdrawal by Subject|3
5802106|NCT02953821|20014707|P2|Overall Study|Physician Decision|1
5802107|NCT02953821|20014708|P1|Overall Study|Physician Decision|1
5802108|NCT02953821|20014707|P2|Overall Study|Lost to Follow-up|0
5802109|NCT02953821|20014708|P1|Overall Study|Lost to Follow-up|2
5802110|NCT02953821|20014707|P2|Overall Study|Progressive Disease|1
5802111|NCT02953821|20014708|P1|Overall Study|Progressive Disease|5
5802112|NCT02953821|20014707|P2|Overall Study|Death|0
5802113|NCT02953821|20014708|P1|Overall Study|Death|1
5802114|NCT02953821|20014707|P2|Overall Study|Adverse Event|4
5802115|NCT02953821|20014708|P1|Overall Study|Adverse Event|0
5802116|NCT02953678|20014726|P1|Overall Study|Reason unspecified|2
5802117|NCT02953678|20014726|P1|Overall Study|Withdrawal by Subject|3
5802118|NCT02953678|20014726|P1|Overall Study|Relapse of Underlying Malignancy|2
5802119|NCT02953678|20014726|P1|Overall Study|Progressive Disease of GVHD|6
5802120|NCT02953678|20014726|P1|Overall Study|Physician Decision|20
5802121|NCT02953678|20014726|P1|Overall Study|Death|7
5802122|NCT02953678|20014726|P1|Overall Study|Adverse Event|20
5802123|NCT02953314|20014774|P2|Overall Study|Withdrawal of consent (not due to AE)|2
5802124|NCT02953314|20014775|P1|Overall Study|Withdrawal of consent (not due to AE)|0
5802125|NCT02953314|20014774|P2|Overall Study|Adverse Event|1
5802126|NCT02953314|20014775|P1|Overall Study|Adverse Event|0
5802127|NCT02952898|20014801|P3|Overall Study|Non-compliance with study drug|2
5802128|NCT02952898|20014802|P2|Overall Study|Non-compliance with study drug|1
5802129|NCT02952898|20014803|P1|Overall Study|Non-compliance with study drug|1
5802130|NCT02952898|20014801|P3|Overall Study|Lost to Follow-up|2
5802131|NCT02952898|20014802|P2|Overall Study|Lost to Follow-up|2
5802132|NCT02952898|20014803|P1|Overall Study|Lost to Follow-up|3
5802133|NCT02952898|20014801|P3|Overall Study|Adverse Event|3
5802134|NCT02952898|20014802|P2|Overall Study|Adverse Event|8
5802135|NCT02952898|20014803|P1|Overall Study|Adverse Event|8
5802136|NCT02952898|20014801|P3|Overall Study|Withdrawal by Subject|8
5802137|NCT02952898|20014802|P2|Overall Study|Withdrawal by Subject|8
5802138|NCT02952898|20014803|P1|Overall Study|Withdrawal by Subject|10
5802139|NCT02952820|20014927|P3|Active Treatment Period (6 Months)|Not treated|1
5802140|NCT02952820|20014928|P2|Active Treatment Period (6 Months)|Not treated|0
5802141|NCT02952820|20014929|P1|Active Treatment Period (6 Months)|Not treated|0
5802142|NCT02952820|20014927|P3|Active Treatment Period (6 Months)|Other than specified|2
5802143|NCT02952820|20014928|P2|Active Treatment Period (6 Months)|Other than specified|6
5802144|NCT02952820|20014929|P1|Active Treatment Period (6 Months)|Other than specified|0
5802145|NCT02952820|20014927|P3|Active Treatment Period (6 Months)|Withdrawal of consent|8
5802146|NCT02952820|20014928|P2|Active Treatment Period (6 Months)|Withdrawal of consent|6
5802147|NCT02952820|20014929|P1|Active Treatment Period (6 Months)|Withdrawal of consent|0
5802148|NCT02952820|20014927|P3|Active Treatment Period (6 Months)|Inadequate therapeutic effect|2
5802149|NCT02952820|20014928|P2|Active Treatment Period (6 Months)|Inadequate therapeutic effect|6
5802150|NCT02952820|20014929|P1|Active Treatment Period (6 Months)|Inadequate therapeutic effect|0
5802151|NCT02952820|20014927|P3|Active Treatment Period (6 Months)|Subject choice|7
5802152|NCT02952820|20014928|P2|Active Treatment Period (6 Months)|Subject choice|10
5802153|NCT02952820|20014929|P1|Active Treatment Period (6 Months)|Subject choice|0
5802154|NCT02952820|20014927|P3|Active Treatment Period (6 Months)|Lost to Follow-up|6
5802155|NCT02952820|20014928|P2|Active Treatment Period (6 Months)|Lost to Follow-up|4
5802156|NCT02952820|20014929|P1|Active Treatment Period (6 Months)|Lost to Follow-up|0
5802157|NCT02952820|20014927|P3|Active Treatment Period (6 Months)|Adverse Event|5
5802158|NCT02952820|20014928|P2|Active Treatment Period (6 Months)|Adverse Event|6
5802159|NCT02952820|20014929|P1|Active Treatment Period (6 Months)|Adverse Event|0
5802160|NCT02952820|20014927|P3|Placebo-Controlled Treatment (6 Months)|Not treated|4
5802161|NCT02952820|20014928|P2|Placebo-Controlled Treatment (6 Months)|Not treated|4
5802162|NCT02952820|20014929|P1|Placebo-Controlled Treatment (6 Months)|Not treated|4
5802163|NCT02952820|20014927|P3|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|21
5802164|NCT02952820|20014928|P2|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|11
5802165|NCT02952820|20014929|P1|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|13
5802166|NCT02952820|20014927|P3|Placebo-Controlled Treatment (6 Months)|Other than specified|13
5802167|NCT02952820|20014928|P2|Placebo-Controlled Treatment (6 Months)|Other than specified|14
5802168|NCT02952820|20014929|P1|Placebo-Controlled Treatment (6 Months)|Other than specified|0
5802169|NCT02952820|20014927|P3|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|11
5802170|NCT02952820|20014928|P2|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|12
5802171|NCT02952820|20014929|P1|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|17
5802172|NCT02952820|20014927|P3|Placebo-Controlled Treatment (6 Months)|Subject choice|17
5802173|NCT02952820|20014928|P2|Placebo-Controlled Treatment (6 Months)|Subject choice|12
5802174|NCT02952820|20014929|P1|Placebo-Controlled Treatment (6 Months)|Subject choice|15
5802175|NCT02952820|20014927|P3|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|6
5802176|NCT02952820|20014928|P2|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7
5802177|NCT02952820|20014929|P1|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7
5802178|NCT02952820|20014927|P3|Placebo-Controlled Treatment (6 Months)|Adverse Event|16
5802179|NCT02952820|20014928|P2|Placebo-Controlled Treatment (6 Months)|Adverse Event|9
5802180|NCT02952820|20014929|P1|Placebo-Controlled Treatment (6 Months)|Adverse Event|8
5802181|NCT02952313|20014989|P1|Long-term Follow-up|Death|1
5802182|NCT02952313|20014989|P1|Long-term Follow-up|Physician Decision|1
5802183|NCT02952313|20014989|P1|Long-term Follow-up|Withdrawal by Subject|5
5802184|NCT02952313|20014989|P1|Long-term Follow-up|Lack of Efficacy|6
5802185|NCT02952313|20014989|P1|Long-term Follow-up|Did not reconsent for long-term FU|7
5802186|NCT02952313|20014989|P1|Long-term Follow-up|Lost to Follow-up|12
5802187|NCT02952313|20014989|P1|Primary Endpoint|Missed visit|1
5802188|NCT02952313|20014989|P1|Primary Endpoint|Lack of Efficacy|1
5802189|NCT02952313|20014989|P1|Primary Endpoint|Withdrawal by Subject|1
5802190|NCT02952313|20014989|P1|Primary Endpoint|Lost to Follow-up|4
5802191|NCT02952261|20015000|P2|Overall Study|Protocol Violation|0
5802192|NCT02952261|20015001|P1|Overall Study|Protocol Violation|1
5802193|NCT02952261|20015000|P2|Overall Study|Withdrawal by Subject|5
5802194|NCT02952261|20015001|P1|Overall Study|Withdrawal by Subject|4
5802195|NCT02951988|20015016|P4|Double-Blind Treatment Period|Miscellaneous Reasons|0
5802196|NCT02951988|20015017|P3|Double-Blind Treatment Period|Miscellaneous Reasons|1
5802197|NCT02951988|20015018|P2|Double-Blind Treatment Period|Miscellaneous Reasons|2
5802198|NCT02951988|20015019|P1|Double-Blind Treatment Period|Miscellaneous Reasons|0
5802199|NCT02951988|20015016|P4|Double-Blind Treatment Period|Adverse Event|6
5802200|NCT02951988|20015017|P3|Double-Blind Treatment Period|Adverse Event|3
5802201|NCT02951988|20015018|P2|Double-Blind Treatment Period|Adverse Event|8
5802202|NCT02951988|20015019|P1|Double-Blind Treatment Period|Adverse Event|0
5802203|NCT02951988|20015016|P4|Double-Blind Treatment Period|Withdrawal by Subject|28
5802204|NCT02951988|20015017|P3|Double-Blind Treatment Period|Withdrawal by Subject|22
5802205|NCT02951988|20015018|P2|Double-Blind Treatment Period|Withdrawal by Subject|23
5802206|NCT02951988|20015019|P1|Double-Blind Treatment Period|Withdrawal by Subject|0
5802207|NCT02951988|20015016|P4|Double-Blind Treatment Period|Lost to Follow-up|3
5802208|NCT02951988|20015017|P3|Double-Blind Treatment Period|Lost to Follow-up|12
5802209|NCT02951988|20015018|P2|Double-Blind Treatment Period|Lost to Follow-up|4
5802210|NCT02951988|20015019|P1|Double-Blind Treatment Period|Lost to Follow-up|0
5802211|NCT02951988|20015016|P4|Double-Blind Treatment Period|Pregnancy|0
5802212|NCT02951988|20015017|P3|Double-Blind Treatment Period|Pregnancy|1
5802213|NCT02951988|20015018|P2|Double-Blind Treatment Period|Pregnancy|1
5802214|NCT02951988|20015019|P1|Double-Blind Treatment Period|Pregnancy|0
5802215|NCT02951988|20015016|P4|Double-Blind Treatment Period|Protocol Violation|8
5802216|NCT02951988|20015017|P3|Double-Blind Treatment Period|Protocol Violation|4
5802217|NCT02951988|20015018|P2|Double-Blind Treatment Period|Protocol Violation|4
5802218|NCT02951988|20015019|P1|Double-Blind Treatment Period|Protocol Violation|0
5802219|NCT02951988|20015016|P4|Double-Blind Treatment Period|Non-compliance with study drug|0
5802220|NCT02951988|20015017|P3|Double-Blind Treatment Period|Non-compliance with study drug|3
5802221|NCT02951988|20015018|P2|Double-Blind Treatment Period|Non-compliance with study drug|1
5802222|NCT02951988|20015019|P1|Double-Blind Treatment Period|Non-compliance with study drug|0
5802223|NCT02951988|20015016|P4|Double-Blind Treatment Period|Study terminated by sponsor|69
5802224|NCT02951988|20015017|P3|Double-Blind Treatment Period|Study terminated by sponsor|54
5802225|NCT02951988|20015018|P2|Double-Blind Treatment Period|Study terminated by sponsor|58
5802226|NCT02951988|20015019|P1|Double-Blind Treatment Period|Study terminated by sponsor|0
5802227|NCT02951988|20015016|P4|Double-Blind Treatment Period|Site terminated by sponsor|1
5802228|NCT02951988|20015017|P3|Double-Blind Treatment Period|Site terminated by sponsor|1
5802229|NCT02951988|20015018|P2|Double-Blind Treatment Period|Site terminated by sponsor|0
5802230|NCT02951988|20015019|P1|Double-Blind Treatment Period|Site terminated by sponsor|0
5802231|NCT02951988|20015016|P4|Open-Label Treatment Period|Adverse Event|0
5802232|NCT02951988|20015017|P3|Open-Label Treatment Period|Adverse Event|0
5802233|NCT02951988|20015018|P2|Open-Label Treatment Period|Adverse Event|0
5802234|NCT02951988|20015019|P1|Open-Label Treatment Period|Adverse Event|45
5802235|NCT02951988|20015016|P4|Open-Label Treatment Period|Lack of Efficacy|0
5802236|NCT02951988|20015017|P3|Open-Label Treatment Period|Lack of Efficacy|0
5802237|NCT02951988|20015018|P2|Open-Label Treatment Period|Lack of Efficacy|0
5802238|NCT02951988|20015019|P1|Open-Label Treatment Period|Lack of Efficacy|49
5802239|NCT02951988|20015016|P4|Open-Label Treatment Period|Withdrawal by Subject|0
5802240|NCT02951988|20015017|P3|Open-Label Treatment Period|Withdrawal by Subject|0
5802241|NCT02951988|20015018|P2|Open-Label Treatment Period|Withdrawal by Subject|0
5802242|NCT02951988|20015019|P1|Open-Label Treatment Period|Withdrawal by Subject|78
5802243|NCT02951988|20015016|P4|Open-Label Treatment Period|Lost to Follow-up|0
5802244|NCT02951988|20015017|P3|Open-Label Treatment Period|Lost to Follow-up|0
5802245|NCT02951988|20015018|P2|Open-Label Treatment Period|Lost to Follow-up|0
5802246|NCT02951988|20015019|P1|Open-Label Treatment Period|Lost to Follow-up|28
5802247|NCT02951988|20015016|P4|Open-Label Treatment Period|Pregnancy|0
5802248|NCT02951988|20015017|P3|Open-Label Treatment Period|Pregnancy|0
5802249|NCT02951988|20015018|P2|Open-Label Treatment Period|Pregnancy|0
5802250|NCT02951988|20015019|P1|Open-Label Treatment Period|Pregnancy|2
5802251|NCT02951988|20015016|P4|Open-Label Treatment Period|Protocol Violation|0
5802252|NCT02951988|20015017|P3|Open-Label Treatment Period|Protocol Violation|0
5802253|NCT02951988|20015018|P2|Open-Label Treatment Period|Protocol Violation|0
5802254|NCT02951988|20015019|P1|Open-Label Treatment Period|Protocol Violation|22
5802255|NCT02951988|20015016|P4|Open-Label Treatment Period|Non-compliance with study drug|0
5802256|NCT02951988|20015017|P3|Open-Label Treatment Period|Non-compliance with study drug|0
5802257|NCT02951988|20015018|P2|Open-Label Treatment Period|Non-compliance with study drug|0
5802258|NCT02951988|20015019|P1|Open-Label Treatment Period|Non-compliance with study drug|5
5802259|NCT02951988|20015016|P4|Open-Label Treatment Period|Non-compliance with background ADT|0
5802260|NCT02951988|20015017|P3|Open-Label Treatment Period|Non-compliance with background ADT|0
5802261|NCT02951988|20015018|P2|Open-Label Treatment Period|Non-compliance with background ADT|0
5802262|NCT02951988|20015019|P1|Open-Label Treatment Period|Non-compliance with background ADT|2
5802263|NCT02951988|20015016|P4|Open-Label Treatment Period|Study terminated by sponsor|0
5802264|NCT02951988|20015017|P3|Open-Label Treatment Period|Study terminated by sponsor|0
5802265|NCT02951988|20015018|P2|Open-Label Treatment Period|Study terminated by sponsor|0
5802266|NCT02951988|20015019|P1|Open-Label Treatment Period|Study terminated by sponsor|9
5802267|NCT02951988|20015016|P4|Open-Label Treatment Period|Miscellaneous Reasons|0
5802268|NCT02951988|20015017|P3|Open-Label Treatment Period|Miscellaneous Reasons|0
5802269|NCT02951988|20015018|P2|Open-Label Treatment Period|Miscellaneous Reasons|0
5802270|NCT02951988|20015019|P1|Open-Label Treatment Period|Miscellaneous Reasons|8
5802271|NCT02951819|20015052|P2|Overall Study|Ongoing|11
5802272|NCT02951819|20015053|P1|Overall Study|Ongoing|83
5802273|NCT02951819|20015052|P2|Overall Study|Other|0
5802274|NCT02951819|20015053|P1|Overall Study|Other|1
5802275|NCT02951819|20015052|P2|Overall Study|Progressive Disease|0
5802276|NCT02951819|20015053|P1|Overall Study|Progressive Disease|1
5802277|NCT02951819|20015052|P2|Overall Study|Withdrawal by Subject|0
5802278|NCT02951819|20015053|P1|Overall Study|Withdrawal by Subject|1
5802279|NCT02951819|20015052|P2|Overall Study|Death|3
5802280|NCT02951819|20015053|P1|Overall Study|Death|1
5802281|NCT02951780|20015084|P9|Period 2|Scheduling Conflicts|0
5802282|NCT02951780|20015085|P8|Period 2|Scheduling Conflicts|1
5802283|NCT02951780|20015086|P7|Period 2|Scheduling Conflicts|0
5802284|NCT02951780|20015087|P6|Period 2|Scheduling Conflicts|0
5802285|NCT02951780|20015088|P5|Period 2|Scheduling Conflicts|0
5802286|NCT02951780|20015089|P4|Period 2|Scheduling Conflicts|0
5802287|NCT02951780|20015090|P3|Period 2|Scheduling Conflicts|0
5802288|NCT02951780|20015091|P2|Period 2|Scheduling Conflicts|0
5802289|NCT02951780|20015092|P1|Period 2|Scheduling Conflicts|0
5802290|NCT02951780|20015084|P9|Period 1|Scheduling Conflicts|0
5802291|NCT02951780|20015085|P8|Period 1|Scheduling Conflicts|1
5802292|NCT02951780|20015086|P7|Period 1|Scheduling Conflicts|0
5802293|NCT02951780|20015087|P6|Period 1|Scheduling Conflicts|0
5802294|NCT02951780|20015088|P5|Period 1|Scheduling Conflicts|0
5802295|NCT02951780|20015089|P4|Period 1|Scheduling Conflicts|0
5802296|NCT02951780|20015090|P3|Period 1|Scheduling Conflicts|0
5802297|NCT02951780|20015091|P2|Period 1|Scheduling Conflicts|0
5802298|NCT02951780|20015092|P1|Period 1|Scheduling Conflicts|0
5802299|NCT02951780|20015084|P9|Period 1|Adverse Event|0
5802300|NCT02951780|20015085|P8|Period 1|Adverse Event|0
5802301|NCT02951780|20015086|P7|Period 1|Adverse Event|0
5802302|NCT02951780|20015087|P6|Period 1|Adverse Event|0
5802303|NCT02951780|20015088|P5|Period 1|Adverse Event|0
5802304|NCT02951780|20015089|P4|Period 1|Adverse Event|1
5802305|NCT02951780|20015090|P3|Period 1|Adverse Event|0
5802306|NCT02951780|20015091|P2|Period 1|Adverse Event|0
5802307|NCT02951780|20015092|P1|Period 1|Adverse Event|0
5802308|NCT02951767|20015157|P1|Overall Study|Lost to Follow-up|1
5802309|NCT02951767|20015157|P1|Overall Study|Death|59
5802310|NCT02951767|20015157|P1|Overall Study|Withdrawal by Subject|5
5802311|NCT02951767|20015157|P1|Overall Study|Ongoing at data cutoff 04 July 2016|54
5802312|NCT02951533|20015189|P3|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2
5802313|NCT02951533|20015190|P2|Part III (Week 64 Through Week 100)|Withdrawal by Subject|0
5802314|NCT02951533|20015191|P1|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2
5802315|NCT02951533|20015189|P3|Part III (Week 64 Through Week 100)|Lost to Follow-up|0
5802316|NCT02951533|20015190|P2|Part III (Week 64 Through Week 100)|Lost to Follow-up|0
5802317|NCT02951533|20015191|P1|Part III (Week 64 Through Week 100)|Lost to Follow-up|1
5802318|NCT02951533|20015189|P3|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0
5802319|NCT02951533|20015190|P2|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0
5802320|NCT02951533|20015191|P1|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|1
5802321|NCT02951533|20015189|P3|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|0
5802322|NCT02951533|20015190|P2|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|2
5802323|NCT02951533|20015191|P1|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|1
5802324|NCT02951533|20015189|P3|Part IIb (Week 32 Through Week 56)|Adverse Event|0
5802325|NCT02951533|20015190|P2|Part IIb (Week 32 Through Week 56)|Adverse Event|2
5802326|NCT02951533|20015191|P1|Part IIb (Week 32 Through Week 56)|Adverse Event|0
5802327|NCT02951533|20015189|P3|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0
5802328|NCT02951533|20015190|P2|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0
5802329|NCT02951533|20015191|P1|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|1
5802330|NCT02951533|20015189|P3|Part IIa (Week 24 Through Week 32)|Adverse Event|0
5802331|NCT02951533|20015190|P2|Part IIa (Week 24 Through Week 32)|Adverse Event|1
5802332|NCT02951533|20015191|P1|Part IIa (Week 24 Through Week 32)|Adverse Event|0
5802333|NCT02951533|20015189|P3|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0
5802334|NCT02951533|20015190|P2|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|1
5802335|NCT02951533|20015191|P1|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0
5802336|NCT02951533|20015189|P3|Part I (Week 0 Through Week 24)|Withdrawal by Subject|0
5802337|NCT02951533|20015190|P2|Part I (Week 0 Through Week 24)|Withdrawal by Subject|4
5802338|NCT02951533|20015191|P1|Part I (Week 0 Through Week 24)|Withdrawal by Subject|2
5802339|NCT02951533|20015189|P3|Part I (Week 0 Through Week 24)|Lost to Follow-up|0
5802340|NCT02951533|20015190|P2|Part I (Week 0 Through Week 24)|Lost to Follow-up|2
5802341|NCT02951533|20015191|P1|Part I (Week 0 Through Week 24)|Lost to Follow-up|2
5802342|NCT02951533|20015189|P3|Part I (Week 0 Through Week 24)|Adverse Event|0
5802343|NCT02951533|20015190|P2|Part I (Week 0 Through Week 24)|Adverse Event|16
5802344|NCT02951533|20015191|P1|Part I (Week 0 Through Week 24)|Adverse Event|0
5802345|NCT02951429|20015313|P2|Overall Study|Participant ongoing in the study|17
5802346|NCT02951429|20015314|P1|Overall Study|Participant ongoing in the study|23
5802347|NCT02951429|20015313|P2|Overall Study|Withdrawal by Subject|11
5802348|NCT02951429|20015314|P1|Overall Study|Withdrawal by Subject|7
5802349|NCT02951429|20015313|P2|Overall Study|Progressive Disease|1
5802350|NCT02951429|20015314|P1|Overall Study|Progressive Disease|1
5802351|NCT02951429|20015313|P2|Overall Study|Other|3
5802352|NCT02951429|20015314|P1|Overall Study|Other|1
5802353|NCT02951429|20015313|P2|Overall Study|Lung Transplantation|6
5802354|NCT02951429|20015314|P1|Overall Study|Lung Transplantation|9
5802355|NCT02951429|20015313|P2|Overall Study|Lost to Follow-up|1
5802356|NCT02951429|20015314|P1|Overall Study|Lost to Follow-up|0
5802357|NCT02951429|20015313|P2|Overall Study|Lack of Efficacy|1
5802358|NCT02951429|20015314|P1|Overall Study|Lack of Efficacy|0
5802359|NCT02951429|20015313|P2|Overall Study|Death|36
5802360|NCT02951429|20015314|P1|Overall Study|Death|28
5802361|NCT02951429|20015313|P2|Overall Study|Adverse Event|7
5802362|NCT02951429|20015314|P1|Overall Study|Adverse Event|3
5802363|NCT02951156|20015590|P3|Overall Study|Other|2
5802364|NCT02951156|20015591|P2|Overall Study|Other|1
5802365|NCT02951156|20015592|P1|Overall Study|Other|5
5802366|NCT02951156|20015590|P3|Overall Study|Study terminated by sponsor|1
5802367|NCT02951156|20015591|P2|Overall Study|Study terminated by sponsor|0
5802368|NCT02951156|20015592|P1|Overall Study|Study terminated by sponsor|0
5802369|NCT02951156|20015590|P3|Overall Study|Withdrawal by Subject|1
5802370|NCT02951156|20015591|P2|Overall Study|Withdrawal by Subject|0
5802371|NCT02951156|20015592|P1|Overall Study|Withdrawal by Subject|0
5802372|NCT02951156|20015590|P3|Overall Study|Progressive disease|1
5802373|NCT02951156|20015591|P2|Overall Study|Progressive disease|0
5802374|NCT02951156|20015592|P1|Overall Study|Progressive disease|1
5802375|NCT02951156|20015590|P3|Overall Study|Death|5
5802376|NCT02951156|20015591|P2|Overall Study|Death|8
5802377|NCT02951156|20015592|P1|Overall Study|Death|3
5802378|NCT02951052|20015652|P2|Overall Study|Ongoing|0
5802379|NCT02951052|20015653|P1|Overall Study|Ongoing|1
5802380|NCT02951052|20015652|P2|Overall Study|Lack of Efficacy|4
5802381|NCT02951052|20015653|P1|Overall Study|Lack of Efficacy|3
5802382|NCT02951052|20015652|P2|Overall Study|Protocol Violation|3
5802383|NCT02951052|20015653|P1|Overall Study|Protocol Violation|5
5802384|NCT02951052|20015652|P2|Overall Study|Protocol-specified withdrawal criterion|0
5802385|NCT02951052|20015653|P1|Overall Study|Protocol-specified withdrawal criterion|1
5802386|NCT02951052|20015652|P2|Overall Study|Lost to Follow-up|1
5802387|NCT02951052|20015653|P1|Overall Study|Lost to Follow-up|1
5802388|NCT02951052|20015652|P2|Overall Study|Physician Decision|0
5802389|NCT02951052|20015653|P1|Overall Study|Physician Decision|2
5802390|NCT02951052|20015652|P2|Overall Study|Withdrawal by Subject|5
5802391|NCT02951052|20015653|P1|Overall Study|Withdrawal by Subject|1
5802392|NCT02951052|20015652|P2|Overall Study|Adverse Event|5
5802393|NCT02951052|20015653|P1|Overall Study|Adverse Event|13
5802394|NCT02950831|20015821|P1|Overall Study|stimulation trail failure|5
5802395|NCT02950831|20015821|P1|Overall Study|Withdrawal by Subject|3
5802396|NCT02950831|20015821|P1|Overall Study|Lost to Follow-up|1
5802397|NCT02950545|20015863|P6|Session 3 (70 Minutes)|Withdrawal by Subject|1
5802398|NCT02950545|20015864|P5|Session 3 (70 Minutes)|Withdrawal by Subject|0
5802399|NCT02950545|20015865|P4|Session 3 (70 Minutes)|Withdrawal by Subject|0
5802400|NCT02950545|20015866|P3|Session 3 (70 Minutes)|Withdrawal by Subject|0
5802401|NCT02950545|20015867|P2|Session 3 (70 Minutes)|Withdrawal by Subject|0
5802402|NCT02950545|20015868|P1|Session 3 (70 Minutes)|Withdrawal by Subject|0
5802403|NCT02950545|20015863|P6|Washout 2 (5 Minutes)|Withdrawal by Subject|0
5802404|NCT02950545|20015864|P5|Washout 2 (5 Minutes)|Withdrawal by Subject|0
5802405|NCT02950545|20015865|P4|Washout 2 (5 Minutes)|Withdrawal by Subject|0
5802406|NCT02950545|20015866|P3|Washout 2 (5 Minutes)|Withdrawal by Subject|0
5802407|NCT02950545|20015867|P2|Washout 2 (5 Minutes)|Withdrawal by Subject|0
5802408|NCT02950545|20015868|P1|Washout 2 (5 Minutes)|Withdrawal by Subject|1
5802409|NCT02950545|20015863|P6|Session 2 (70 Minutes)|Withdrawal by Subject|0
5802410|NCT02950545|20015864|P5|Session 2 (70 Minutes)|Withdrawal by Subject|1
5802411|NCT02950545|20015865|P4|Session 2 (70 Minutes)|Withdrawal by Subject|0
5802412|NCT02950545|20015866|P3|Session 2 (70 Minutes)|Withdrawal by Subject|0
5802413|NCT02950545|20015867|P2|Session 2 (70 Minutes)|Withdrawal by Subject|0
5802414|NCT02950545|20015868|P1|Session 2 (70 Minutes)|Withdrawal by Subject|0
5802415|NCT02950545|20015863|P6|Washout 1 (5 Minutes)|Withdrawal by Subject|1
5802416|NCT02950545|20015864|P5|Washout 1 (5 Minutes)|Withdrawal by Subject|0
5802417|NCT02950545|20015865|P4|Washout 1 (5 Minutes)|Withdrawal by Subject|1
5802418|NCT02950545|20015866|P3|Washout 1 (5 Minutes)|Withdrawal by Subject|0
5802419|NCT02950545|20015867|P2|Washout 1 (5 Minutes)|Withdrawal by Subject|0
5802420|NCT02950545|20015868|P1|Washout 1 (5 Minutes)|Withdrawal by Subject|1
5802421|NCT02950545|20015863|P6|Session 1 (70 Minutes)|Withdrawal by Subject|1
5802422|NCT02950545|20015864|P5|Session 1 (70 Minutes)|Withdrawal by Subject|0
5802423|NCT02950545|20015865|P4|Session 1 (70 Minutes)|Withdrawal by Subject|0
5802424|NCT02950545|20015866|P3|Session 1 (70 Minutes)|Withdrawal by Subject|0
5802425|NCT02950545|20015867|P2|Session 1 (70 Minutes)|Withdrawal by Subject|0
5802426|NCT02950545|20015868|P1|Session 1 (70 Minutes)|Withdrawal by Subject|0
5802427|NCT02950480|20015877|P2|Overall Study|Withdrawal by Subject|0
5802428|NCT02950480|20015878|P1|Overall Study|Withdrawal by Subject|1
5802429|NCT02949947|20015939|P2|Overall Study|Insurance change|0
5802430|NCT02949947|20015940|P1|Overall Study|Insurance change|1
5802431|NCT02949947|20015939|P2|Overall Study|Non Compliance|1
5802432|NCT02949947|20015940|P1|Overall Study|Non Compliance|0
5802433|NCT02949908|20015973|P1|Overall Study|Study termination|2
5802434|NCT02949271|20016037|P2|Overall Study|Outside the window for cervical dilation|3
5802435|NCT02949271|20016038|P1|Overall Study|Outside the window for cervical dilation|2
5802436|NCT02949271|20016037|P2|Overall Study|Delivered prior to intervention|9
5802437|NCT02949271|20016038|P1|Overall Study|Delivered prior to intervention|7
5802438|NCT02949271|20016037|P2|Overall Study|Withdrawal by Subject|0
5802439|NCT02949271|20016038|P1|Overall Study|Withdrawal by Subject|1
5802440|NCT02949271|20016037|P2|Overall Study|Protocol Violation|3
5802441|NCT02949271|20016038|P1|Overall Study|Protocol Violation|6
5802442|NCT02949271|20016037|P2|Overall Study|Physician Decision|5
5802443|NCT02949271|20016038|P1|Overall Study|Physician Decision|5
5802444|NCT02949271|20016037|P2|Overall Study|Lost to Follow-up|6
5802445|NCT02949271|20016038|P1|Overall Study|Lost to Follow-up|3
5802446|NCT02949271|20016037|P2|Overall Study|Lack of Efficacy|4
5802447|NCT02949271|20016038|P1|Overall Study|Lack of Efficacy|5
5802449|NCT02949128|20016078|P1|Extension Period|Withdrawal by Subject|1
5802450|NCT02949128|20016078|P1|Extension Period|Physician Decision|1
5802451|NCT02949128|20016078|P1|Initial Evaluation Period|Protocol Violation|1
5802452|NCT02949128|20016078|P1|Initial Evaluation Period|Physician Decision|1
5802453|NCT02949128|20016078|P1|Initial Evaluation Period|Death|2
5802454|NCT02949128|20016078|P1|Initial Evaluation Period|Adverse Event|3
5802455|NCT02949128|20016078|P1|Initial Evaluation Period|Failed to Meet Eligibility Criteria|2
5802456|NCT02949011|20016095|P3|Overall Study|Miscellaneous|6
5802457|NCT02949011|20016096|P2|Overall Study|Miscellaneous|4
5802458|NCT02949011|20016097|P1|Overall Study|Miscellaneous|2
5802459|NCT02949011|20016095|P3|Overall Study|Death|1
5802460|NCT02949011|20016096|P2|Overall Study|Death|0
5802461|NCT02949011|20016097|P1|Overall Study|Death|0
5802462|NCT02949011|20016095|P3|Overall Study|Lost to Follow-up|5
5802463|NCT02949011|20016096|P2|Overall Study|Lost to Follow-up|5
5802464|NCT02949011|20016097|P1|Overall Study|Lost to Follow-up|7
5802465|NCT02949011|20016095|P3|Overall Study|Withdrawal by Subject|21
5802466|NCT02949011|20016096|P2|Overall Study|Withdrawal by Subject|13
5802467|NCT02949011|20016097|P1|Overall Study|Withdrawal by Subject|13
5802468|NCT02949011|20016095|P3|Overall Study|Lack of Efficacy|0
5802469|NCT02949011|20016096|P2|Overall Study|Lack of Efficacy|2
5802470|NCT02949011|20016097|P1|Overall Study|Lack of Efficacy|0
5802471|NCT02949011|20016095|P3|Overall Study|Protocol Deviation|3
5802472|NCT02949011|20016096|P2|Overall Study|Protocol Deviation|3
5802473|NCT02949011|20016097|P1|Overall Study|Protocol Deviation|5
5802474|NCT02949011|20016095|P3|Overall Study|Failed Inclusion/Exclusion Criteria|3
5802475|NCT02949011|20016096|P2|Overall Study|Failed Inclusion/Exclusion Criteria|0
5802476|NCT02949011|20016097|P1|Overall Study|Failed Inclusion/Exclusion Criteria|0
5802477|NCT02949011|20016095|P3|Overall Study|Adverse Event|3
5802478|NCT02949011|20016096|P2|Overall Study|Adverse Event|7
5802479|NCT02949011|20016097|P1|Overall Study|Adverse Event|6
5802480|NCT02948634|20016167|P2|Overall Study|Lack of efficacy and study suspended|2
5802481|NCT02948634|20016168|P1|Overall Study|Lack of efficacy and study suspended|10
5802482|NCT02948582|20016178|P6|Washout Period 4|Adverse Event|0
5802483|NCT02948582|20016179|P5|Washout Period 4|Adverse Event|0
5802484|NCT02948582|20016180|P4|Washout Period 4|Adverse Event|0
5802485|NCT02948582|20016181|P3|Washout Period 4|Adverse Event|1
5802486|NCT02948582|20016182|P2|Washout Period 4|Adverse Event|0
5802487|NCT02948582|20016183|P1|Washout Period 4|Adverse Event|1
5802488|NCT02948582|20016178|P6|Washout Period 2|personal reasons|0
5802489|NCT02948582|20016179|P5|Washout Period 2|personal reasons|0
5802490|NCT02948582|20016180|P4|Washout Period 2|personal reasons|1
5802491|NCT02948582|20016181|P3|Washout Period 2|personal reasons|0
5802492|NCT02948582|20016182|P2|Washout Period 2|personal reasons|0
5802493|NCT02948582|20016183|P1|Washout Period 2|personal reasons|0
5802494|NCT02948582|20016178|P6|Washout Period 2|Adverse Event|0
5802495|NCT02948582|20016179|P5|Washout Period 2|Adverse Event|0
5802496|NCT02948582|20016180|P4|Washout Period 2|Adverse Event|0
5802497|NCT02948582|20016181|P3|Washout Period 2|Adverse Event|0
5802498|NCT02948582|20016182|P2|Washout Period 2|Adverse Event|1
5802499|NCT02948582|20016183|P1|Washout Period 2|Adverse Event|0
5802500|NCT02948582|20016178|P6|Washout Period 1|Protocol Violation|1
5802501|NCT02948582|20016179|P5|Washout Period 1|Protocol Violation|0
5802502|NCT02948582|20016180|P4|Washout Period 1|Protocol Violation|0
5802503|NCT02948582|20016181|P3|Washout Period 1|Protocol Violation|0
5802504|NCT02948582|20016182|P2|Washout Period 1|Protocol Violation|0
5802505|NCT02948582|20016183|P1|Washout Period 1|Protocol Violation|0
5802506|NCT02948582|20016178|P6|Washout Period 1|Adverse Event|0
5802507|NCT02948582|20016179|P5|Washout Period 1|Adverse Event|0
5802508|NCT02948582|20016180|P4|Washout Period 1|Adverse Event|0
5802509|NCT02948582|20016181|P3|Washout Period 1|Adverse Event|0
5802510|NCT02948582|20016182|P2|Washout Period 1|Adverse Event|2
5802511|NCT02948582|20016183|P1|Washout Period 1|Adverse Event|0
5802512|NCT02947100|20016305|P1|Overall Study|did not meet inclusion criteria|1
5802513|NCT02947100|20016305|P1|Overall Study|study terminated early|3
5802514|NCT02947022|20016313|P1|Overall Study|Study Stopped|1
5802515|NCT02946918|20016334|P2|Overall Study|Ran out of study medication|1
5802516|NCT02946918|20016335|P1|Overall Study|Ran out of study medication|0
5802517|NCT02946918|20016334|P2|Overall Study|Physician Decision|2
5802518|NCT02946918|20016335|P1|Overall Study|Physician Decision|0
5802519|NCT02946918|20016334|P2|Overall Study|Patient unblinded himself|0
5802520|NCT02946918|20016335|P1|Overall Study|Patient unblinded himself|1
5802521|NCT02946580|20016360|P2|Overall Study|Did not undergo posterior spinal fusion|1
5802522|NCT02946580|20016361|P1|Overall Study|Did not undergo posterior spinal fusion|0
5802523|NCT02946580|20016360|P2|Overall Study|Adverse Event|2
5802524|NCT02946580|20016361|P1|Overall Study|Adverse Event|0
5802525|NCT02946580|20016360|P2|Overall Study|Withdrawal by Subject|2
5802526|NCT02946580|20016361|P1|Overall Study|Withdrawal by Subject|1
5802527|NCT02946515|20016379|P2|Overall Study|Lost to Follow-up|1
5802528|NCT02946515|20016380|P1|Overall Study|Lost to Follow-up|2
5802529|NCT02946463|20016393|P2|Primary Evaluation Period|Withdrawal by Subject|1
5802530|NCT02946463|20016394|P1|Primary Evaluation Period|Withdrawal by Subject|0
5802531|NCT02946463|20016393|P2|Primary Evaluation Period|Physician Decision|1
5802532|NCT02946463|20016394|P1|Primary Evaluation Period|Physician Decision|0
5802533|NCT02946385|20016416|P6|Overall Study|Lost to Follow-up|1
5802534|NCT02946385|20016417|P5|Overall Study|Lost to Follow-up|2
5802535|NCT02946385|20016418|P4|Overall Study|Lost to Follow-up|0
5802536|NCT02946385|20016419|P3|Overall Study|Lost to Follow-up|3
5802537|NCT02946385|20016420|P2|Overall Study|Lost to Follow-up|0
5802538|NCT02946385|20016421|P1|Overall Study|Lost to Follow-up|0
5802539|NCT02945657|20016524|P1|Overall Study|Withdrawal by Parent/Guardian|3
5802540|NCT02945657|20016524|P1|Overall Study|Adverse Event|1
5802541|NCT02945410|20016566|P6|Washout 1 (14 Days)|Withdrawal by Subject|0
5802542|NCT02945410|20016567|P5|Washout 1 (14 Days)|Withdrawal by Subject|1
5802543|NCT02945410|20016568|P4|Washout 1 (14 Days)|Withdrawal by Subject|0
5802544|NCT02945410|20016569|P3|Washout 1 (14 Days)|Withdrawal by Subject|2
5802545|NCT02945410|20016570|P2|Washout 1 (14 Days)|Withdrawal by Subject|0
5802546|NCT02945410|20016571|P1|Washout 1 (14 Days)|Withdrawal by Subject|0
5802547|NCT02945410|20016566|P6|Intervention 1 (5 Days)|Adverse Event|1
5802548|NCT02945410|20016567|P5|Intervention 1 (5 Days)|Adverse Event|0
5802549|NCT02945410|20016568|P4|Intervention 1 (5 Days)|Adverse Event|0
5802550|NCT02945410|20016569|P3|Intervention 1 (5 Days)|Adverse Event|0
5802551|NCT02945410|20016570|P2|Intervention 1 (5 Days)|Adverse Event|0
5802552|NCT02945410|20016571|P1|Intervention 1 (5 Days)|Adverse Event|1
5802553|NCT02945410|20016566|P6|Intervention 1 (5 Days)|Withdrawal by Subject|0
5802554|NCT02945410|20016567|P5|Intervention 1 (5 Days)|Withdrawal by Subject|0
5802555|NCT02945410|20016568|P4|Intervention 1 (5 Days)|Withdrawal by Subject|0
5802556|NCT02945410|20016569|P3|Intervention 1 (5 Days)|Withdrawal by Subject|0
5802557|NCT02945410|20016570|P2|Intervention 1 (5 Days)|Withdrawal by Subject|3
5802558|NCT02945410|20016571|P1|Intervention 1 (5 Days)|Withdrawal by Subject|0
5802559|NCT02945254|20016602|P2|Overall Study|Withdrawal by Subject|0
5802560|NCT02945254|20016603|P1|Overall Study|Withdrawal by Subject|1
5802561|NCT02945254|20016602|P2|Overall Study|Lost to Follow-up|0
5802562|NCT02945254|20016603|P1|Overall Study|Lost to Follow-up|1
5802563|NCT02945046|20016619|P3|Overall Study|Other than specified|7
5802564|NCT02945046|20016620|P2|Overall Study|Other than specified|4
5802565|NCT02945046|20016621|P1|Overall Study|Other than specified|5
5802566|NCT02945046|20016619|P3|Overall Study|Lack of Efficacy|1
5802567|NCT02945046|20016620|P2|Overall Study|Lack of Efficacy|2
5802568|NCT02945046|20016621|P1|Overall Study|Lack of Efficacy|1
5802569|NCT02945046|20016619|P3|Overall Study|Lost to Follow-up|0
5802570|NCT02945046|20016620|P2|Overall Study|Lost to Follow-up|1
5802571|NCT02945046|20016621|P1|Overall Study|Lost to Follow-up|1
5802572|NCT02945046|20016619|P3|Overall Study|Protocol Violation|2
5802573|NCT02945046|20016620|P2|Overall Study|Protocol Violation|3
5802574|NCT02945046|20016621|P1|Overall Study|Protocol Violation|2
5802575|NCT02945046|20016619|P3|Overall Study|Withdrawal by Subject|3
5802576|NCT02945046|20016620|P2|Overall Study|Withdrawal by Subject|3
5802577|NCT02945046|20016621|P1|Overall Study|Withdrawal by Subject|3
5802578|NCT02945046|20016619|P3|Overall Study|Adverse Event|2
5802579|NCT02945046|20016620|P2|Overall Study|Adverse Event|0
5802580|NCT02945046|20016621|P1|Overall Study|Adverse Event|1
5802581|NCT02944968|20016674|P1|Overall Study|Subject didn't meet eligibility criteria|2
5802582|NCT02944968|20016674|P1|Overall Study|Subject excluded before study procedure|1
5802583|NCT02944656|20016681|P2|Overall Study|Lost to Follow-up|10
5802584|NCT02944656|20016682|P1|Overall Study|Lost to Follow-up|7
5802585|NCT02944656|20016681|P2|Overall Study|No longer eligible|0
5802586|NCT02944656|20016682|P1|Overall Study|No longer eligible|3
5802587|NCT02944513|20016718|P2|Overall Study|Withdrawal by Subject|1
5802588|NCT02944513|20016719|P1|Overall Study|Withdrawal by Subject|4
5802589|NCT02944448|20016744|P2|Overall Study|Abnormal laboratory values|0
5802590|NCT02944448|20016745|P1|Overall Study|Abnormal laboratory values|1
5802591|NCT02944448|20016744|P2|Overall Study|Noncompliant with dosing|0
5802592|NCT02944448|20016745|P1|Overall Study|Noncompliant with dosing|1
5802593|NCT02944448|20016744|P2|Overall Study|Sponsor did not supply drug in time|1
5802594|NCT02944448|20016745|P1|Overall Study|Sponsor did not supply drug in time|0
5802595|NCT02944448|20016744|P2|Overall Study|Withdrawal by Subject|4
5802596|NCT02944448|20016745|P1|Overall Study|Withdrawal by Subject|14
5802597|NCT02944448|20016744|P2|Overall Study|Protocol Violation|7
5802598|NCT02944448|20016745|P1|Overall Study|Protocol Violation|25
5802599|NCT02944448|20016744|P2|Overall Study|Lost to Follow-up|1
5802600|NCT02944448|20016745|P1|Overall Study|Lost to Follow-up|3
5802601|NCT02944448|20016744|P2|Overall Study|Lack of Efficacy|5
5802602|NCT02944448|20016745|P1|Overall Study|Lack of Efficacy|8
5802603|NCT02944448|20016744|P2|Overall Study|Adverse Event|6
5802604|NCT02944448|20016745|P1|Overall Study|Adverse Event|37
5802605|NCT02944383|20016772|P3|Overall Study|Withdrawal by Subject|0
5802606|NCT02944383|20016773|P2|Overall Study|Withdrawal by Subject|0
5802607|NCT02944383|20016774|P1|Overall Study|Withdrawal by Subject|1
5802608|NCT02944383|20016772|P3|Overall Study|Lost to Follow-up|1
5802609|NCT02944383|20016773|P2|Overall Study|Lost to Follow-up|0
5802610|NCT02944383|20016774|P1|Overall Study|Lost to Follow-up|0
5802611|NCT02943668|20016935|P1|Overall Study|Disease Progression|1
5802612|NCT02943577|20016946|P2|Overall Study|Pregnancy|0
5802613|NCT02943577|20016947|P1|Overall Study|Pregnancy|1
5802614|NCT02943577|20016946|P2|Overall Study|Withdrawal by Subject|1
5802615|NCT02943577|20016947|P1|Overall Study|Withdrawal by Subject|1
5802616|NCT02943577|20016946|P2|Overall Study|Lost to Follow-up|1
5802617|NCT02943577|20016947|P1|Overall Study|Lost to Follow-up|0
5802618|NCT02943577|20016946|P2|Overall Study|Adverse Event|2
5802619|NCT02943577|20016947|P1|Overall Study|Adverse Event|3
5802620|NCT02943577|20016946|P2|Overall Study|Protocol Violation|1
5802621|NCT02943577|20016947|P1|Overall Study|Protocol Violation|0
5802622|NCT02943564|20016962|P3|Overall Study|Lack of Efficacy|0
5802623|NCT02943564|20016963|P2|Overall Study|Lack of Efficacy|1
5802624|NCT02943564|20016964|P1|Overall Study|Lack of Efficacy|0
5802625|NCT02943564|20016962|P3|Overall Study|Adverse Event|1
5802626|NCT02943564|20016963|P2|Overall Study|Adverse Event|2
5802627|NCT02943564|20016964|P1|Overall Study|Adverse Event|1
5802628|NCT02943564|20016962|P3|Overall Study|Withdrawal by Subject|2
5802629|NCT02943564|20016963|P2|Overall Study|Withdrawal by Subject|5
5802630|NCT02943564|20016964|P1|Overall Study|Withdrawal by Subject|6
5802631|NCT02943564|20016962|P3|Overall Study|Lost to Follow-up|0
5802632|NCT02943564|20016963|P2|Overall Study|Lost to Follow-up|0
5802633|NCT02943564|20016964|P1|Overall Study|Lost to Follow-up|1
5802634|NCT02943564|20016962|P3|Overall Study|Protocol Violation|2
5802635|NCT02943564|20016963|P2|Overall Study|Protocol Violation|2
5802636|NCT02943564|20016964|P1|Overall Study|Protocol Violation|2
5802637|NCT02943564|20016962|P3|Overall Study|Pregnancy|1
5802638|NCT02943564|20016963|P2|Overall Study|Pregnancy|1
5802639|NCT02943564|20016964|P1|Overall Study|Pregnancy|0
5802640|NCT02943564|20016962|P3|Overall Study|Non-compliance with study drug|0
5802641|NCT02943564|20016963|P2|Overall Study|Non-compliance with study drug|1
5802642|NCT02943564|20016964|P1|Overall Study|Non-compliance with study drug|0
5802643|NCT02943564|20016962|P3|Overall Study|Site terminated by sponsor|0
5802644|NCT02943564|20016963|P2|Overall Study|Site terminated by sponsor|1
5802645|NCT02943564|20016964|P1|Overall Study|Site terminated by sponsor|0
5802646|NCT02943564|20016962|P3|Overall Study|Miscellaneous Reasons|3
5802647|NCT02943564|20016963|P2|Overall Study|Miscellaneous Reasons|0
5802648|NCT02943564|20016964|P1|Overall Study|Miscellaneous Reasons|0
5802649|NCT02943473|20016984|P1|Overall Study|Physician Decision|4
5802650|NCT02943473|20016984|P1|Overall Study|screen failure|1
5802651|NCT02943473|20016984|P1|Overall Study|enrolled but not dosed|1
5802652|NCT02943460|20016991|P3|Open Label Extension (OLE)|Still in Open Label Extension Phase|8
5802653|NCT02943460|20016992|P2|Open Label Extension (OLE)|Still in Open Label Extension Phase|14
5802654|NCT02943460|20016993|P1|Open Label Extension (OLE)|Still in Open Label Extension Phase|18
5802655|NCT02943460|20016991|P3|Open Label Extension (OLE)|Investigator's Discretion|0
5802656|NCT02943460|20016992|P2|Open Label Extension (OLE)|Investigator's Discretion|1
5802657|NCT02943460|20016993|P1|Open Label Extension (OLE)|Investigator's Discretion|0
5802658|NCT02943460|20016991|P3|Open Label Extension (OLE)|Withdrew Consent|0
5802659|NCT02943460|20016992|P2|Open Label Extension (OLE)|Withdrew Consent|1
5802660|NCT02943460|20016993|P1|Open Label Extension (OLE)|Withdrew Consent|1
5802661|NCT02943460|20016991|P3|Open Label Extension (OLE)|Adverse Event|1
5802662|NCT02943460|20016992|P2|Open Label Extension (OLE)|Adverse Event|2
5802663|NCT02943460|20016993|P1|Open Label Extension (OLE)|Adverse Event|0
5802664|NCT02943460|20016991|P3|Blinded Study|Withdrew Consent|0
5802665|NCT02943460|20016992|P2|Blinded Study|Withdrew Consent|1
5802666|NCT02943460|20016993|P1|Blinded Study|Withdrew Consent|0
5802667|NCT02943460|20016991|P3|Blinded Study|Adverse Event|0
5802668|NCT02943460|20016992|P2|Blinded Study|Adverse Event|0
5802669|NCT02943460|20016993|P1|Blinded Study|Adverse Event|3
5802670|NCT02943447|20017011|P3|Open-Label Extension Phase|Lost to Follow-up|0
5802671|NCT02943447|20017012|P2|Open-Label Extension Phase|Lost to Follow-up|1
5802672|NCT02943447|20017013|P1|Open-Label Extension Phase|Lost to Follow-up|0
5802673|NCT02943447|20017011|P3|Open-Label Extension Phase|Withdrew consent|1
5802674|NCT02943447|20017012|P2|Open-Label Extension Phase|Withdrew consent|1
5802675|NCT02943447|20017013|P1|Open-Label Extension Phase|Withdrew consent|1
5802676|NCT02943447|20017011|P3|Open-Label Extension Phase|Lack of Efficacy|0
5802677|NCT02943447|20017012|P2|Open-Label Extension Phase|Lack of Efficacy|4
5802678|NCT02943447|20017013|P1|Open-Label Extension Phase|Lack of Efficacy|3
5802679|NCT02943447|20017011|P3|Open-Label Extension Phase|Adverse Event|3
5802680|NCT02943447|20017012|P2|Open-Label Extension Phase|Adverse Event|7
5802681|NCT02943447|20017013|P1|Open-Label Extension Phase|Adverse Event|4
5802682|NCT02943447|20017011|P3|Open-Label Extension Phase|Study terminated by sponsor|6
5802683|NCT02943447|20017012|P2|Open-Label Extension Phase|Study terminated by sponsor|12
5802684|NCT02943447|20017013|P1|Open-Label Extension Phase|Study terminated by sponsor|10
5802685|NCT02943447|20017011|P3|Blinded Study Phase|Investigator's discretion|0
5802686|NCT02943447|20017012|P2|Blinded Study Phase|Investigator's discretion|0
5802687|NCT02943447|20017013|P1|Blinded Study Phase|Investigator's discretion|1
5802688|NCT02943447|20017011|P3|Blinded Study Phase|Adverse Event|0
5802689|NCT02943447|20017012|P2|Blinded Study Phase|Adverse Event|0
5802690|NCT02943447|20017013|P1|Blinded Study Phase|Adverse Event|3
5802691|NCT02943447|20017011|P3|Blinded Study Phase|Withdrew Consent|1
5802692|NCT02943447|20017012|P2|Blinded Study Phase|Withdrew Consent|2
5802693|NCT02943447|20017013|P1|Blinded Study Phase|Withdrew Consent|1
5802694|NCT02943096|20017082|P2|Overall Study|Lack of Efficacy|1
5802695|NCT02943096|20017083|P1|Overall Study|Lack of Efficacy|0
5802696|NCT02942771|20017102|P5|Overall Study|Withdrawal by Subject|2
5802697|NCT02942771|20017103|P4|Overall Study|Withdrawal by Subject|0
5802698|NCT02942771|20017104|P3|Overall Study|Withdrawal by Subject|0
5802699|NCT02942771|20017105|P2|Overall Study|Withdrawal by Subject|0
5802700|NCT02942771|20017106|P1|Overall Study|Withdrawal by Subject|1
5802701|NCT02942771|20017102|P5|Overall Study|Lost to Follow-up|0
5802702|NCT02942771|20017103|P4|Overall Study|Lost to Follow-up|0
5802703|NCT02942771|20017104|P3|Overall Study|Lost to Follow-up|0
5802704|NCT02942771|20017105|P2|Overall Study|Lost to Follow-up|0
5802705|NCT02942771|20017106|P1|Overall Study|Lost to Follow-up|1
5802706|NCT02942771|20017102|P5|Overall Study|Adverse Event|2
5802707|NCT02942771|20017103|P4|Overall Study|Adverse Event|0
5802708|NCT02942771|20017104|P3|Overall Study|Adverse Event|0
5802709|NCT02942771|20017105|P2|Overall Study|Adverse Event|0
5802710|NCT02942771|20017106|P1|Overall Study|Adverse Event|1
5802711|NCT02942576|20017159|P2|Overall Study|Other|8
5802712|NCT02942576|20017160|P1|Overall Study|Other|10
5802713|NCT02942576|20017159|P2|Overall Study|Physician Decision|4
5802714|NCT02942576|20017160|P1|Overall Study|Physician Decision|1
5802715|NCT02942576|20017159|P2|Overall Study|Withdrawal by Subject|5
5802716|NCT02942576|20017160|P1|Overall Study|Withdrawal by Subject|7
5802717|NCT02942576|20017159|P2|Overall Study|Adverse Event|6
5802718|NCT02942576|20017160|P1|Overall Study|Adverse Event|28
5802719|NCT02942485|20017174|P2|Overall Study|Lost to Follow-up|0
5802720|NCT02942485|20017175|P1|Overall Study|Lost to Follow-up|1
5802721|NCT02942407|20017187|P2|Overall Study|Death|13
5802722|NCT02942407|20017188|P1|Overall Study|Death|16
5802723|NCT02942407|20017187|P2|Overall Study|Withdrawal by Subject|9
5802724|NCT02942407|20017188|P1|Overall Study|Withdrawal by Subject|7
5802725|NCT02942407|20017187|P2|Overall Study|Lost to Follow-up|2
5802726|NCT02942407|20017188|P1|Overall Study|Lost to Follow-up|3
5802727|NCT02942017|20017250|P2|Overall Study|Randomized but not dosed|3
5802728|NCT02942017|20017251|P1|Overall Study|Randomized but not dosed|1
5802729|NCT02942017|20017250|P2|Overall Study|Lost to Follow-up|1
5802730|NCT02942017|20017251|P1|Overall Study|Lost to Follow-up|1
5802731|NCT02942017|20017250|P2|Overall Study|Withdrawal by Subject|1
5802732|NCT02942017|20017251|P1|Overall Study|Withdrawal by Subject|0
5802733|NCT02942017|20017250|P2|Overall Study|Adverse Event|1
5802734|NCT02942017|20017251|P1|Overall Study|Adverse Event|0
5802735|NCT02942004|20017282|P3|Overall Study|Randomized but not dosed|4
5802736|NCT02942004|20017283|P2|Overall Study|Randomized but not dosed|9
5802737|NCT02942004|20017284|P1|Overall Study|Randomized but not dosed|3
5802738|NCT02942004|20017282|P3|Overall Study|Lost to Follow-up|2
5802739|NCT02942004|20017283|P2|Overall Study|Lost to Follow-up|1
5802740|NCT02942004|20017284|P1|Overall Study|Lost to Follow-up|1
5802741|NCT02942004|20017282|P3|Overall Study|Withdrawal by Subject|3
5802742|NCT02942004|20017283|P2|Overall Study|Withdrawal by Subject|2
5802743|NCT02942004|20017284|P1|Overall Study|Withdrawal by Subject|0
5802744|NCT02940886|20017404|P2|Overall Study|Enrolment error|1
5802745|NCT02940886|20017405|P1|Overall Study|Enrolment error|0
5802746|NCT02940886|20017404|P2|Overall Study|No treatment|2
5802747|NCT02940886|20017405|P1|Overall Study|No treatment|7
5802748|NCT02940886|20017404|P2|Overall Study|Sponsor decision|1
5802749|NCT02940886|20017405|P1|Overall Study|Sponsor decision|0
5802750|NCT02940886|20017404|P2|Overall Study|Physician Decision|4
5802751|NCT02940886|20017405|P1|Overall Study|Physician Decision|9
5802752|NCT02940886|20017404|P2|Overall Study|Lost to Follow-up|21
5802753|NCT02940886|20017405|P1|Overall Study|Lost to Follow-up|49
5802754|NCT02940886|20017404|P2|Overall Study|Lack of Efficacy|0
5802755|NCT02940886|20017405|P1|Overall Study|Lack of Efficacy|1
5802756|NCT02940886|20017404|P2|Overall Study|Death|0
5802757|NCT02940886|20017405|P1|Overall Study|Death|1
5802758|NCT02940886|20017404|P2|Overall Study|Withdrawal by Subject|20
5802759|NCT02940886|20017405|P1|Overall Study|Withdrawal by Subject|28
5802760|NCT02940886|20017404|P2|Overall Study|Protocol Violation|2
5802761|NCT02940886|20017405|P1|Overall Study|Protocol Violation|0
5802762|NCT02940886|20017404|P2|Overall Study|Adverse Event|3
5802763|NCT02940886|20017405|P1|Overall Study|Adverse Event|7
5802764|NCT02940860|20017451|P2|Overall Study|Not treated|2
5802765|NCT02940860|20017452|P1|Overall Study|Not treated|2
5802766|NCT02940860|20017451|P2|Overall Study|Moved, poor venous access, transport|4
5802767|NCT02940860|20017452|P1|Overall Study|Moved, poor venous access, transport|6
5802768|NCT02940860|20017451|P2|Overall Study|Death|2
5802769|NCT02940860|20017452|P1|Overall Study|Death|3
5802770|NCT02940860|20017451|P2|Overall Study|Protocol Violation|2
5802771|NCT02940860|20017452|P1|Overall Study|Protocol Violation|0
5802772|NCT02940860|20017451|P2|Overall Study|Sponsor Decision|1
5802773|NCT02940860|20017452|P1|Overall Study|Sponsor Decision|0
5802774|NCT02940860|20017451|P2|Overall Study|Physician Decision|3
5802775|NCT02940860|20017452|P1|Overall Study|Physician Decision|5
5802776|NCT02940860|20017451|P2|Overall Study|Lost to Follow-up|7
5802777|NCT02940860|20017452|P1|Overall Study|Lost to Follow-up|13
5802778|NCT02940860|20017451|P2|Overall Study|Withdrawal by Subject|9
5802779|NCT02940860|20017452|P1|Overall Study|Withdrawal by Subject|19
5802780|NCT02940860|20017451|P2|Overall Study|Serious AE|3
5802781|NCT02940860|20017452|P1|Overall Study|Serious AE|7
5802782|NCT02940860|20017451|P2|Overall Study|Non-serious AE|2
5802783|NCT02940860|20017452|P1|Overall Study|Non-serious AE|1
5802784|NCT02940691|20017496|P1|Overall Study|Incarceration|1
5802785|NCT02940691|20017496|P1|Overall Study|Lost to Follow-up|5
5802786|NCT02940626|20017505|P2|Overall Study|Prohibited Concomitant Medication|1
5802787|NCT02940626|20017506|P1|Overall Study|Prohibited Concomitant Medication|0
5802788|NCT02940626|20017505|P2|Overall Study|Transfer to Hospice Care|0
5802789|NCT02940626|20017506|P1|Overall Study|Transfer to Hospice Care|1
5802790|NCT02940626|20017505|P2|Overall Study|Withdrawal by Subject|0
5802791|NCT02940626|20017506|P1|Overall Study|Withdrawal by Subject|1
5802792|NCT02940626|20017505|P2|Overall Study|Lost to Follow-up|2
5802793|NCT02940626|20017506|P1|Overall Study|Lost to Follow-up|5
5802794|NCT02940626|20017505|P2|Overall Study|Death|32
5802795|NCT02940626|20017506|P1|Overall Study|Death|40
5802800|NCT02940522|20017567|P2|Overall Study|Withdrawal by Subject|0
5802801|NCT02940522|20017568|P1|Overall Study|Withdrawal by Subject|1
5802802|NCT02940522|20017567|P2|Overall Study|Lost to Follow-up|2
5802803|NCT02940522|20017568|P1|Overall Study|Lost to Follow-up|1
5802804|NCT02939950|20017659|P2|Overall Study|Ineligible at Baseline|8
5802805|NCT02939950|20017660|P1|Overall Study|Ineligible at Baseline|2
5802806|NCT02939950|20017659|P2|Overall Study|Randomized, not dispensed|0
5802807|NCT02939950|20017660|P1|Overall Study|Randomized, not dispensed|1
5802808|NCT02939950|20017659|P2|Overall Study|Adverse Event|3
5802809|NCT02939950|20017660|P1|Overall Study|Adverse Event|7
5802810|NCT02939950|20017659|P2|Overall Study|Withdrawal by Subject|28
5802811|NCT02939950|20017660|P1|Overall Study|Withdrawal by Subject|12
5802812|NCT02939950|20017659|P2|Overall Study|Pregnancy|7
5802813|NCT02939950|20017660|P1|Overall Study|Pregnancy|6
5802814|NCT02939950|20017659|P2|Overall Study|Physician Decision|0
5802815|NCT02939950|20017660|P1|Overall Study|Physician Decision|2
5802816|NCT02939950|20017659|P2|Overall Study|Protocol Violation|3
5802817|NCT02939950|20017660|P1|Overall Study|Protocol Violation|6
5802818|NCT02939950|20017659|P2|Overall Study|Unacceptable lens movement|0
5802819|NCT02939950|20017660|P1|Overall Study|Unacceptable lens movement|2
5802820|NCT02939950|20017659|P2|Overall Study|Study related symptoms|8
5802821|NCT02939950|20017660|P1|Overall Study|Study related symptoms|8
5802822|NCT02939950|20017659|P2|Overall Study|Participant Relocated|3
5802823|NCT02939950|20017660|P1|Overall Study|Participant Relocated|5
5802824|NCT02939950|20017659|P2|Overall Study|Military orders|0
5802825|NCT02939950|20017660|P1|Overall Study|Military orders|1
5802826|NCT02939950|20017659|P2|Overall Study|Unacceptable distance lens visual acuity|1
5802827|NCT02939950|20017660|P1|Overall Study|Unacceptable distance lens visual acuity|1
5802828|NCT02939950|20017659|P2|Overall Study|Lack of motivation|2
5802829|NCT02939950|20017660|P1|Overall Study|Lack of motivation|0
5802830|NCT02939950|20017659|P2|Overall Study|Chalazion upper lid|1
5802831|NCT02939950|20017660|P1|Overall Study|Chalazion upper lid|0
5802832|NCT02939950|20017659|P2|Overall Study|Positive slit lamp findings|1
5802833|NCT02939950|20017660|P1|Overall Study|Positive slit lamp findings|0
5802834|NCT02939950|20017659|P2|Overall Study|Lost to Follow-up|16
5802835|NCT02939950|20017660|P1|Overall Study|Lost to Follow-up|13
5802836|NCT02939937|20017670|P2|Overall Study|Lost to Follow-up|3
5802837|NCT02939937|20017671|P1|Overall Study|Lost to Follow-up|1
5802838|NCT02939937|20017670|P2|Overall Study|Adverse Event|0
5802839|NCT02939937|20017671|P1|Overall Study|Adverse Event|5
5802840|NCT02939716|20017685|P6|Overall Study|scanner failure|1
5802841|NCT02939716|20017686|P5|Overall Study|scanner failure|1
5802842|NCT02939716|20017687|P4|Overall Study|scanner failure|1
5802843|NCT02939716|20017688|P3|Overall Study|scanner failure|0
5802844|NCT02939716|20017689|P2|Overall Study|scanner failure|0
5802845|NCT02939716|20017690|P1|Overall Study|scanner failure|0
5802846|NCT02939599|20017715|P2|Overall Study|Study Terminated By Sponsor|2
5802847|NCT02939599|20017716|P1|Overall Study|Study Terminated By Sponsor|2
5802848|NCT02939599|20017715|P2|Overall Study|Adverse Event|0
5802849|NCT02939599|20017716|P1|Overall Study|Adverse Event|1
5802850|NCT02939560|20017730|P1|Overall Study|Protocol Violation|1
5802851|NCT02939560|20017730|P1|Overall Study|Withdrawal by Subject|2
5802852|NCT02939131|20017788|P2|Overall Study|not willing to adhere to protocol|0
5802853|NCT02939131|20017789|P1|Overall Study|not willing to adhere to protocol|2
5802854|NCT02939131|20017788|P2|Overall Study|Other|1
5802855|NCT02939131|20017789|P1|Overall Study|Other|0
5802856|NCT02939131|20017788|P2|Overall Study|severe debilitation|0
5802857|NCT02939131|20017789|P1|Overall Study|severe debilitation|1
5802858|NCT02939131|20017788|P2|Overall Study|Lost to Follow-up|4
5802859|NCT02939131|20017789|P1|Overall Study|Lost to Follow-up|2
5802860|NCT02939131|20017788|P2|Overall Study|Unable to get to clinic|4
5802861|NCT02939131|20017789|P1|Overall Study|Unable to get to clinic|6
5802862|NCT02939079|20017807|P2|Overall Study|relapse during the study|1
5802863|NCT02939079|20017808|P1|Overall Study|relapse during the study|1
5802864|NCT02939079|20017807|P2|Overall Study|Withdrawal by Subject|1
5802865|NCT02939079|20017808|P1|Overall Study|Withdrawal by Subject|0
5802866|NCT02939079|20017807|P2|Overall Study|Protocol Violation|0
5802867|NCT02939079|20017808|P1|Overall Study|Protocol Violation|1
5802868|NCT02939079|20017807|P2|Overall Study|Lost to Follow-up|2
5802869|NCT02939079|20017808|P1|Overall Study|Lost to Follow-up|0
5802870|NCT02939079|20017807|P2|Overall Study|Adverse Event|1
5802871|NCT02939079|20017808|P1|Overall Study|Adverse Event|2
5802878|NCT02938585|20017883|P4|Overall Study|Withdrawal by Subject|5
5802879|NCT02938585|20017884|P3|Overall Study|Withdrawal by Subject|0
5802880|NCT02938585|20017885|P2|Overall Study|Withdrawal by Subject|0
5802881|NCT02938585|20017886|P1|Overall Study|Withdrawal by Subject|0
5802882|NCT02938585|20017883|P4|Overall Study|Withdrawal by parent or guardian|0
5802883|NCT02938585|20017884|P3|Overall Study|Withdrawal by parent or guardian|0
5802884|NCT02938585|20017885|P2|Overall Study|Withdrawal by parent or guardian|1
5802885|NCT02938585|20017886|P1|Overall Study|Withdrawal by parent or guardian|0
5802886|NCT02938520|20018050|P2|Overall Study|Adverse Event|4
5802887|NCT02938520|20018051|P1|Overall Study|Adverse Event|9
5802888|NCT02938520|20018050|P2|Overall Study|Lack of Efficacy|3
5802889|NCT02938520|20018051|P1|Overall Study|Lack of Efficacy|5
5802890|NCT02938520|20018050|P2|Overall Study|Protocol Violation|1
5802891|NCT02938520|20018051|P1|Overall Study|Protocol Violation|0
5802892|NCT02938520|20018050|P2|Overall Study|Withdrawal by Subject|7
5802893|NCT02938520|20018051|P1|Overall Study|Withdrawal by Subject|7
5802894|NCT02938520|20018050|P2|Overall Study|Lost to Follow-up|2
5802895|NCT02938520|20018051|P1|Overall Study|Lost to Follow-up|2
5802896|NCT02938520|20018050|P2|Overall Study|Physician Decision|5
5802897|NCT02938520|20018051|P1|Overall Study|Physician Decision|2
5802898|NCT02938520|20018050|P2|Overall Study|On-going at the time of analysis|261
5802899|NCT02938520|20018051|P1|Overall Study|On-going at the time of analysis|258
5802900|NCT02937870|20018273|P1|Overall Study|Protocol Deviation|2
5802901|NCT02937870|20018273|P1|Overall Study|Adverse Event|1
5802902|NCT02937740|20018304|P2|Uptitrated to TID on Day 90 for 30 Days|Missed visits|1
5802903|NCT02937740|20018305|P1|Uptitrated to TID on Day 90 for 30 Days|Missed visits|0
5802904|NCT02937740|20018304|P2|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|1
5802905|NCT02937740|20018305|P1|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|0
5802906|NCT02937740|20018304|P2|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|0
5802907|NCT02937740|20018305|P1|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|1
5802908|NCT02937740|20018304|P2|BID for 90 Days, 22 mg/Day|Lost to Follow-up|7
5802909|NCT02937740|20018305|P1|BID for 90 Days, 22 mg/Day|Lost to Follow-up|2
5802910|NCT02937740|20018304|P2|BID for 90 Days, 22 mg/Day|Adverse Event|10
5802911|NCT02937740|20018305|P1|BID for 90 Days, 22 mg/Day|Adverse Event|0
5802912|NCT02937740|20018304|P2|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|14
5802913|NCT02937740|20018305|P1|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|3
5802914|NCT02937701|20018321|P5|Week 22 to Week 50|Other|1
5802915|NCT02937701|20018322|P4|Week 22 to Week 50|Other|0
5802916|NCT02937701|20018323|P3|Week 22 to Week 50|Other|0
5802917|NCT02937701|20018324|P2|Week 22 to Week 50|Other|0
5802918|NCT02937701|20018325|P1|Week 22 to Week 50|Other|0
5802919|NCT02937701|20018321|P5|Week 22 to Week 50|Physician Decision|1
5802920|NCT02937701|20018322|P4|Week 22 to Week 50|Physician Decision|0
5802921|NCT02937701|20018323|P3|Week 22 to Week 50|Physician Decision|2
5802922|NCT02937701|20018324|P2|Week 22 to Week 50|Physician Decision|0
5802923|NCT02937701|20018325|P1|Week 22 to Week 50|Physician Decision|0
5802924|NCT02937701|20018321|P5|Week 22 to Week 50|Lost to Follow-up|1
5802925|NCT02937701|20018322|P4|Week 22 to Week 50|Lost to Follow-up|0
5802926|NCT02937701|20018323|P3|Week 22 to Week 50|Lost to Follow-up|2
5802927|NCT02937701|20018324|P2|Week 22 to Week 50|Lost to Follow-up|0
5802928|NCT02937701|20018325|P1|Week 22 to Week 50|Lost to Follow-up|0
5802929|NCT02937701|20018321|P5|Week 22 to Week 50|Withdrawal by Subject|1
5802930|NCT02937701|20018322|P4|Week 22 to Week 50|Withdrawal by Subject|2
5802931|NCT02937701|20018323|P3|Week 22 to Week 50|Withdrawal by Subject|8
5802932|NCT02937701|20018324|P2|Week 22 to Week 50|Withdrawal by Subject|0
5802933|NCT02937701|20018325|P1|Week 22 to Week 50|Withdrawal by Subject|0
5802934|NCT02937701|20018321|P5|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|2
5802935|NCT02937701|20018322|P4|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|3
5802936|NCT02937701|20018323|P3|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|10
5802937|NCT02937701|20018324|P2|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0
5802938|NCT02937701|20018325|P1|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0
5802939|NCT02937701|20018321|P5|Week 22 to Week 50|Adverse Event|3
5802940|NCT02937701|20018322|P4|Week 22 to Week 50|Adverse Event|3
5802941|NCT02937701|20018323|P3|Week 22 to Week 50|Adverse Event|10
5802942|NCT02937701|20018324|P2|Week 22 to Week 50|Adverse Event|0
5802943|NCT02937701|20018325|P1|Week 22 to Week 50|Adverse Event|0
5802944|NCT02937701|20018321|P5|Day 1 to Week 22|Other|0
5802945|NCT02937701|20018322|P4|Day 1 to Week 22|Other|0
5802946|NCT02937701|20018323|P3|Day 1 to Week 22|Other|0
5802947|NCT02937701|20018324|P2|Day 1 to Week 22|Other|0
5802948|NCT02937701|20018325|P1|Day 1 to Week 22|Other|1
5802949|NCT02937701|20018321|P5|Day 1 to Week 22|Physician Decision|0
5802950|NCT02937701|20018322|P4|Day 1 to Week 22|Physician Decision|0
5802951|NCT02937701|20018323|P3|Day 1 to Week 22|Physician Decision|0
5802952|NCT02937701|20018324|P2|Day 1 to Week 22|Physician Decision|0
5802953|NCT02937701|20018325|P1|Day 1 to Week 22|Physician Decision|2
5802954|NCT02937701|20018321|P5|Day 1 to Week 22|Lost to Follow-up|0
5802955|NCT02937701|20018322|P4|Day 1 to Week 22|Lost to Follow-up|0
5802956|NCT02937701|20018323|P3|Day 1 to Week 22|Lost to Follow-up|0
5802957|NCT02937701|20018324|P2|Day 1 to Week 22|Lost to Follow-up|1
5802958|NCT02937701|20018325|P1|Day 1 to Week 22|Lost to Follow-up|1
5802959|NCT02937701|20018321|P5|Day 1 to Week 22|Protocol Violation|0
5802960|NCT02937701|20018322|P4|Day 1 to Week 22|Protocol Violation|0
5802961|NCT02937701|20018323|P3|Day 1 to Week 22|Protocol Violation|0
5802962|NCT02937701|20018324|P2|Day 1 to Week 22|Protocol Violation|1
5802963|NCT02937701|20018325|P1|Day 1 to Week 22|Protocol Violation|1
5802964|NCT02937701|20018321|P5|Day 1 to Week 22|Death|0
5802965|NCT02937701|20018322|P4|Day 1 to Week 22|Death|0
5802966|NCT02937701|20018323|P3|Day 1 to Week 22|Death|0
5802967|NCT02937701|20018324|P2|Day 1 to Week 22|Death|1
5802968|NCT02937701|20018325|P1|Day 1 to Week 22|Death|1
5802969|NCT02937701|20018321|P5|Day 1 to Week 22|Withdrawal by Subject|0
5802970|NCT02937701|20018322|P4|Day 1 to Week 22|Withdrawal by Subject|0
5802971|NCT02937701|20018323|P3|Day 1 to Week 22|Withdrawal by Subject|0
5802972|NCT02937701|20018324|P2|Day 1 to Week 22|Withdrawal by Subject|6
5802973|NCT02937701|20018325|P1|Day 1 to Week 22|Withdrawal by Subject|6
5802974|NCT02937701|20018321|P5|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0
5802975|NCT02937701|20018322|P4|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0
5802976|NCT02937701|20018323|P3|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0
5802977|NCT02937701|20018324|P2|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|9
5802978|NCT02937701|20018325|P1|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|5
5802979|NCT02937701|20018321|P5|Day 1 to Week 22|Protocol Specified Criteria|0
5802980|NCT02937701|20018322|P4|Day 1 to Week 22|Protocol Specified Criteria|0
5802981|NCT02937701|20018323|P3|Day 1 to Week 22|Protocol Specified Criteria|0
5802982|NCT02937701|20018324|P2|Day 1 to Week 22|Protocol Specified Criteria|7
5802983|NCT02937701|20018325|P1|Day 1 to Week 22|Protocol Specified Criteria|7
5802984|NCT02937701|20018321|P5|Day 1 to Week 22|Adverse Event|0
5802985|NCT02937701|20018322|P4|Day 1 to Week 22|Adverse Event|0
5802986|NCT02937701|20018323|P3|Day 1 to Week 22|Adverse Event|0
5802987|NCT02937701|20018324|P2|Day 1 to Week 22|Adverse Event|14
5802988|NCT02937701|20018325|P1|Day 1 to Week 22|Adverse Event|11
5802989|NCT02937636|20018356|P2|Overall Study|Other (Not specified)|2
5802990|NCT02937636|20018357|P1|Overall Study|Other (Not specified)|3
5802991|NCT02937584|20018384|P2|Washout|Adverse Event|1
5802992|NCT02937584|20018385|P1|Washout|Adverse Event|0
5802993|NCT02937584|20018384|P2|Period 1|Adverse Event|2
5802994|NCT02937584|20018385|P1|Period 1|Adverse Event|1
5802995|NCT02936869|20018456|P2|Overall Study|Protocol Violation|0
5802996|NCT02936869|20018457|P1|Overall Study|Protocol Violation|1
5802997|NCT02936869|20018456|P2|Overall Study|Legal Case|1
5802998|NCT02936869|20018457|P1|Overall Study|Legal Case|0
5802999|NCT02936869|20018456|P2|Overall Study|Death|1
5803000|NCT02936869|20018457|P1|Overall Study|Death|0
5803001|NCT02936869|20018456|P2|Overall Study|Lost to Follow-up|3
5803002|NCT02936869|20018457|P1|Overall Study|Lost to Follow-up|1
5803003|NCT02936037|20018490|P2|Open Label Extension|Withdrawal by Subject|4
5803004|NCT02936037|20018491|P1|Open Label Extension|Withdrawal by Subject|0
5803005|NCT02936037|20018490|P2|Open Label Extension|Other|3
5803006|NCT02936037|20018491|P1|Open Label Extension|Other|0
5803007|NCT02936037|20018490|P2|Open Label Extension|Adverse Event|3
5803008|NCT02936037|20018491|P1|Open Label Extension|Adverse Event|0
5803009|NCT02936037|20018490|P2|Double-Blind Treatment Period|Lost to Follow-up|1
5803010|NCT02936037|20018491|P1|Double-Blind Treatment Period|Lost to Follow-up|0
5803011|NCT02936037|20018490|P2|Double-Blind Treatment Period|Withdrawal by Subject|28
5803012|NCT02936037|20018491|P1|Double-Blind Treatment Period|Withdrawal by Subject|31
5803013|NCT02936037|20018490|P2|Double-Blind Treatment Period|Adverse Event|11
5803014|NCT02936037|20018491|P1|Double-Blind Treatment Period|Adverse Event|11
5803015|NCT02936037|20018490|P2|Double-Blind Treatment Period|Death|1
5803016|NCT02936037|20018491|P1|Double-Blind Treatment Period|Death|0
5803017|NCT02936037|20018490|P2|Double-Blind Treatment Period|Lack of Efficacy|12
5803018|NCT02936037|20018491|P1|Double-Blind Treatment Period|Lack of Efficacy|4
5803019|NCT02936037|20018490|P2|Double-Blind Treatment Period|Suicidal risk, etc.|8
5803020|NCT02936037|20018491|P1|Double-Blind Treatment Period|Suicidal risk, etc.|2
5803021|NCT02936037|20018490|P2|Double-Blind Treatment Period|Protocol Violation|4
5803022|NCT02936037|20018491|P1|Double-Blind Treatment Period|Protocol Violation|1
5803023|NCT02935894|20018497|P1|Overall Study|Subject dismissed|1
5803024|NCT02935842|20018512|P4|Testing and Therapy Period 3|Withdrawal by Subject|0
5803025|NCT02935842|20018513|P3|Testing and Therapy Period 3|Withdrawal by Subject|3
5803026|NCT02935842|20018514|P2|Testing and Therapy Period 3|Withdrawal by Subject|0
5803027|NCT02935842|20018515|P1|Testing and Therapy Period 3|Withdrawal by Subject|0
5803028|NCT02935842|20018512|P4|Testing and Therapy Period 3|Lost to Follow-up|1
5803029|NCT02935842|20018513|P3|Testing and Therapy Period 3|Lost to Follow-up|0
5803030|NCT02935842|20018514|P2|Testing and Therapy Period 3|Lost to Follow-up|0
5803031|NCT02935842|20018515|P1|Testing and Therapy Period 3|Lost to Follow-up|0
5803032|NCT02935842|20018512|P4|Testing and Therapy Period 3|Accident prior to treatment|0
5803033|NCT02935842|20018513|P3|Testing and Therapy Period 3|Accident prior to treatment|0
5803034|NCT02935842|20018514|P2|Testing and Therapy Period 3|Accident prior to treatment|2
5803035|NCT02935842|20018515|P1|Testing and Therapy Period 3|Accident prior to treatment|2
5803036|NCT02935842|20018512|P4|Testing and Therapy Period 3|Required other therapy (dysphagia)|0
5803037|NCT02935842|20018513|P3|Testing and Therapy Period 3|Required other therapy (dysphagia)|2
5803038|NCT02935842|20018514|P2|Testing and Therapy Period 3|Required other therapy (dysphagia)|2
5803039|NCT02935842|20018515|P1|Testing and Therapy Period 3|Required other therapy (dysphagia)|1
5803040|NCT02935842|20018512|P4|Testing and Therapy Period 2|Withdrawal by Subject|0
5803041|NCT02935842|20018513|P3|Testing and Therapy Period 2|Withdrawal by Subject|0
5803042|NCT02935842|20018514|P2|Testing and Therapy Period 2|Withdrawal by Subject|0
5803043|NCT02935842|20018515|P1|Testing and Therapy Period 2|Withdrawal by Subject|2
5803044|NCT02935673|20018584|P3|Overall Study|Withdrawal by Subject|0
5803045|NCT02935673|20018585|P2|Overall Study|Withdrawal by Subject|2
5803046|NCT02935673|20018586|P1|Overall Study|Withdrawal by Subject|1
5803047|NCT02935673|20018584|P3|Overall Study|Adverse Event|0
5803048|NCT02935673|20018585|P2|Overall Study|Adverse Event|1
5803049|NCT02935673|20018586|P1|Overall Study|Adverse Event|0
5803050|NCT02935192|20018731|P2|Overall Study|Withdrawal by Subject|4
5803051|NCT02935192|20018732|P1|Overall Study|Withdrawal by Subject|8
5803052|NCT02934178|20018849|P2|Received Vaccination 3|Withdrawal by Subject|0
5803053|NCT02934178|20018850|P1|Received Vaccination 3|Withdrawal by Subject|1
5803054|NCT02934178|20018849|P2|Received Vaccination 2|Death|1
5803055|NCT02934178|20018850|P1|Received Vaccination 2|Death|0
5803056|NCT02933528|20018990|P1|Overall Study|Lost to Follow-up|2
5803057|NCT02933060|20019018|P2|Overall Study|Withdrawal by Subject|1
5803058|NCT02933060|20019019|P1|Overall Study|Withdrawal by Subject|0
5803059|NCT02932943|20019060|P2|Overall Study|Withdrawal by Subject|3
5803060|NCT02932943|20019061|P1|Overall Study|Withdrawal by Subject|3
5803061|NCT02932943|20019060|P2|Overall Study|Adverse Event|2
5803062|NCT02932943|20019061|P1|Overall Study|Adverse Event|2
5803063|NCT02932943|20019060|P2|Overall Study|Lost to Follow-up|2
5803064|NCT02932943|20019061|P1|Overall Study|Lost to Follow-up|0
5803065|NCT02932904|20019077|P4|Overall Study|Randomized But Not Treated|2
5803066|NCT02932904|20019078|P3|Overall Study|Randomized But Not Treated|0
5803067|NCT02932904|20019079|P2|Overall Study|Randomized But Not Treated|1
5803068|NCT02932904|20019080|P1|Overall Study|Randomized But Not Treated|1
5803069|NCT02932904|20019077|P4|Overall Study|Pretreatment Event/Adverse Event|3
5803070|NCT02932904|20019078|P3|Overall Study|Pretreatment Event/Adverse Event|1
5803071|NCT02932904|20019079|P2|Overall Study|Pretreatment Event/Adverse Event|5
5803072|NCT02932904|20019080|P1|Overall Study|Pretreatment Event/Adverse Event|3
5803073|NCT02932904|20019077|P4|Overall Study|Significant Protocol Deviation|1
5803074|NCT02932904|20019078|P3|Overall Study|Significant Protocol Deviation|6
5803075|NCT02932904|20019079|P2|Overall Study|Significant Protocol Deviation|3
5803076|NCT02932904|20019080|P1|Overall Study|Significant Protocol Deviation|2
5803077|NCT02932904|20019077|P4|Overall Study|Lost to Follow-up|0
5803078|NCT02932904|20019078|P3|Overall Study|Lost to Follow-up|6
5803079|NCT02932904|20019079|P2|Overall Study|Lost to Follow-up|3
5803080|NCT02932904|20019080|P1|Overall Study|Lost to Follow-up|5
5803081|NCT02932904|20019077|P4|Overall Study|Voluntary Withdrawal|2
5803082|NCT02932904|20019078|P3|Overall Study|Voluntary Withdrawal|4
5803083|NCT02932904|20019079|P2|Overall Study|Voluntary Withdrawal|1
5803084|NCT02932904|20019080|P1|Overall Study|Voluntary Withdrawal|2
5803085|NCT02932904|20019077|P4|Overall Study|Study Termination|0
5803086|NCT02932904|20019078|P3|Overall Study|Study Termination|0
5803087|NCT02932904|20019079|P2|Overall Study|Study Termination|1
5803088|NCT02932904|20019080|P1|Overall Study|Study Termination|0
5803089|NCT02932904|20019077|P4|Overall Study|Pregnancy|0
5803090|NCT02932904|20019078|P3|Overall Study|Pregnancy|1
5803091|NCT02932904|20019079|P2|Overall Study|Pregnancy|1
5803092|NCT02932904|20019080|P1|Overall Study|Pregnancy|0
5803093|NCT02932904|20019077|P4|Overall Study|Noncompliance with Study Drug|4
5803094|NCT02932904|20019078|P3|Overall Study|Noncompliance with Study Drug|3
5803095|NCT02932904|20019079|P2|Overall Study|Noncompliance with Study Drug|3
5803096|NCT02932904|20019080|P1|Overall Study|Noncompliance with Study Drug|2
5803097|NCT02932904|20019077|P4|Overall Study|Reason not Specified|2
5803098|NCT02932904|20019078|P3|Overall Study|Reason not Specified|2
5803099|NCT02932904|20019079|P2|Overall Study|Reason not Specified|0
5803100|NCT02932904|20019080|P1|Overall Study|Reason not Specified|1
5803101|NCT02932891|20019115|P1|Overall Study|HPA Suppress|2
5803102|NCT02932891|20019115|P1|Overall Study|Lost to Follow-up|2
5803103|NCT02932878|20019121|P2|Overall Study|Due to Lab Results|1
5803104|NCT02932878|20019122|P1|Overall Study|Due to Lab Results|2
5803105|NCT02932462|20019143|P2|Overall Study|Progressive Disease|0
5803106|NCT02932462|20019144|P1|Overall Study|Progressive Disease|1
5803107|NCT02932462|20019143|P2|Overall Study|Non-Compliance With Study Drug|1
5803108|NCT02932462|20019144|P1|Overall Study|Non-Compliance With Study Drug|0
5803109|NCT02932462|20019143|P2|Overall Study|Withdrawal by Subject|4
5803110|NCT02932462|20019144|P1|Overall Study|Withdrawal by Subject|1
5803111|NCT02932462|20019143|P2|Overall Study|Protocol Violation|5
5803112|NCT02932462|20019144|P1|Overall Study|Protocol Violation|0
5803113|NCT02932462|20019143|P2|Overall Study|Lost to Follow-up|1
5803114|NCT02932462|20019144|P1|Overall Study|Lost to Follow-up|4
5803115|NCT02932462|20019143|P2|Overall Study|Adverse Event|2
5803116|NCT02932462|20019144|P1|Overall Study|Adverse Event|1
5803117|NCT02932306|20019156|P2|Overall Study|Withdrew due to burning,itching,stinging|0
5803118|NCT02932306|20019157|P1|Overall Study|Withdrew due to burning,itching,stinging|1
5803119|NCT02932306|20019156|P2|Overall Study|Worsening condition|0
5803120|NCT02932306|20019157|P1|Overall Study|Worsening condition|2
5803121|NCT02932306|20019156|P2|Overall Study|Lack of Efficacy|2
5803122|NCT02932306|20019157|P1|Overall Study|Lack of Efficacy|0
5803123|NCT02932306|20019156|P2|Overall Study|Withdrawal by Parent or Guardian|8
5803124|NCT02932306|20019157|P1|Overall Study|Withdrawal by Parent or Guardian|6
5803125|NCT02932306|20019156|P2|Overall Study|Lost to Follow-up|40
5803126|NCT02932306|20019157|P1|Overall Study|Lost to Follow-up|36
5803127|NCT02932306|20019156|P2|Overall Study|Noncompliance with Study Drug|1
5803128|NCT02932306|20019157|P1|Overall Study|Noncompliance with Study Drug|1
5803129|NCT02932306|20019156|P2|Overall Study|Protocol Violation|1
5803130|NCT02932306|20019157|P1|Overall Study|Protocol Violation|1
5803131|NCT02932306|20019156|P2|Overall Study|Pregnancy|0
5803132|NCT02932306|20019157|P1|Overall Study|Pregnancy|2
5803133|NCT02932306|20019156|P2|Overall Study|Adverse Event|0
5803134|NCT02932306|20019157|P1|Overall Study|Adverse Event|3
5803135|NCT02932306|20019156|P2|Overall Study|Withdrawal by Subject|25
5803136|NCT02932306|20019157|P1|Overall Study|Withdrawal by Subject|16
5803140|NCT02932228|20019177|P2|Overall Study|not eligible upon chart review|5
5803141|NCT02932228|20019178|P1|Overall Study|not eligible upon chart review|2
5803142|NCT02932228|20019177|P2|Overall Study|Death|23
5803143|NCT02932228|20019178|P1|Overall Study|Death|8
5803144|NCT02931838|20019203|P6|Overall Study|Adverse Event|1
5803145|NCT02931838|20019204|P5|Overall Study|Adverse Event|3
5803146|NCT02931838|20019205|P4|Overall Study|Adverse Event|1
5803147|NCT02931838|20019206|P3|Overall Study|Adverse Event|2
5803148|NCT02931838|20019207|P2|Overall Study|Adverse Event|1
5803149|NCT02931838|20019208|P1|Overall Study|Adverse Event|2
5803150|NCT02931838|20019203|P6|Overall Study|Withdrawal by Subject|0
5803151|NCT02931838|20019204|P5|Overall Study|Withdrawal by Subject|0
5803152|NCT02931838|20019205|P4|Overall Study|Withdrawal by Subject|1
5803153|NCT02931838|20019206|P3|Overall Study|Withdrawal by Subject|0
5803154|NCT02931838|20019207|P2|Overall Study|Withdrawal by Subject|2
5803155|NCT02931838|20019208|P1|Overall Study|Withdrawal by Subject|1
5803156|NCT02931838|20019203|P6|Overall Study|Subject request to discontinue treatment|0
5803157|NCT02931838|20019204|P5|Overall Study|Subject request to discontinue treatment|1
5803158|NCT02931838|20019205|P4|Overall Study|Subject request to discontinue treatment|0
5803159|NCT02931838|20019206|P3|Overall Study|Subject request to discontinue treatment|3
5803160|NCT02931838|20019207|P2|Overall Study|Subject request to discontinue treatment|3
5803161|NCT02931838|20019208|P1|Overall Study|Subject request to discontinue treatment|4
5803162|NCT02931838|20019203|P6|Overall Study|Lost to Follow-up|0
5803163|NCT02931838|20019204|P5|Overall Study|Lost to Follow-up|2
5803164|NCT02931838|20019205|P4|Overall Study|Lost to Follow-up|1
5803165|NCT02931838|20019206|P3|Overall Study|Lost to Follow-up|1
5803166|NCT02931838|20019207|P2|Overall Study|Lost to Follow-up|0
5803167|NCT02931838|20019208|P1|Overall Study|Lost to Follow-up|1
5803168|NCT02931838|20019203|P6|Overall Study|Lack of Efficacy|1
5803169|NCT02931838|20019204|P5|Overall Study|Lack of Efficacy|0
5803170|NCT02931838|20019205|P4|Overall Study|Lack of Efficacy|0
5803171|NCT02931838|20019206|P3|Overall Study|Lack of Efficacy|0
5803172|NCT02931838|20019207|P2|Overall Study|Lack of Efficacy|4
5803173|NCT02931838|20019208|P1|Overall Study|Lack of Efficacy|5
5803174|NCT02931838|20019203|P6|Overall Study|Poor/non-compliance|0
5803175|NCT02931838|20019204|P5|Overall Study|Poor/non-compliance|0
5803176|NCT02931838|20019205|P4|Overall Study|Poor/non-compliance|0
5803177|NCT02931838|20019206|P3|Overall Study|Poor/non-compliance|1
5803178|NCT02931838|20019207|P2|Overall Study|Poor/non-compliance|0
5803179|NCT02931838|20019208|P1|Overall Study|Poor/non-compliance|0
5803180|NCT02931838|20019203|P6|Overall Study|Reason not provided by investigator|0
5803181|NCT02931838|20019204|P5|Overall Study|Reason not provided by investigator|0
5803182|NCT02931838|20019205|P4|Overall Study|Reason not provided by investigator|0
5803183|NCT02931838|20019206|P3|Overall Study|Reason not provided by investigator|1
5803184|NCT02931838|20019207|P2|Overall Study|Reason not provided by investigator|0
5803185|NCT02931838|20019208|P1|Overall Study|Reason not provided by investigator|1
5803186|NCT02931396|20019259|P2|Overall Study|Withdrawal by Subject|0
5803187|NCT02931396|20019260|P1|Overall Study|Withdrawal by Subject|2
5803188|NCT02931396|20019259|P2|Overall Study|Lost to Follow-up|0
5803189|NCT02931396|20019260|P1|Overall Study|Lost to Follow-up|3
5803190|NCT02930837|20019306|P1|Overall Study|Withdrawal by Subject|1
5803191|NCT02930837|20019306|P1|Overall Study|Lost to Follow-up|5
5803192|NCT02930837|20019306|P1|Overall Study|Adverse Event|6
5803199|NCT02930018|20019661|P2|Overall Study|Withdrawal by Subject|2
5803200|NCT02930018|20019662|P1|Overall Study|Withdrawal by Subject|5
5803201|NCT02930018|20019661|P2|Overall Study|Lost to Follow-up|1
5803202|NCT02930018|20019662|P1|Overall Study|Lost to Follow-up|1
5803203|NCT02930005|20019686|P2|Overall Study|Lost to Follow-up|5
5803204|NCT02930005|20019687|P1|Overall Study|Lost to Follow-up|1
5803205|NCT02929498|20019727|P3|Part 1: Dose Confirmation (Upto 2 Years)|Death|0
5803206|NCT02929498|20019728|P2|Part 1: Dose Confirmation (Upto 2 Years)|Death|0
5803207|NCT02929498|20019729|P1|Part 1: Dose Confirmation (Upto 2 Years)|Death|2
5803208|NCT02929498|20019727|P3|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0
5803209|NCT02929498|20019728|P2|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0
5803210|NCT02929498|20019729|P1|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|3
5803211|NCT02929407|20019823|P1|Overall Study|Adverse Event|1
5803212|NCT02928770|20019838|P1|Overall Study|Withdrawal by Subject|2
5803257|NCT02928029|20019985|P2|Overall Study|AE not related to clinical progression|1
5803258|NCT02928029|20019986|P1|Overall Study|AE not related to clinical progression|1
5803259|NCT02928029|20019985|P2|Overall Study|Clinical progression|2
5803260|NCT02928029|20019986|P1|Overall Study|Clinical progression|1
5803261|NCT02928029|20019985|P2|Overall Study|Radiological progression|0
5803262|NCT02928029|20019986|P1|Overall Study|Radiological progression|1
5803263|NCT02928029|20019985|P2|Overall Study|Withdrawal by Subject|1
5803264|NCT02928029|20019986|P1|Overall Study|Withdrawal by Subject|0
5803265|NCT02927938|20020000|P4|Overall Study|Early Study Termination|3
5803266|NCT02927938|20020001|P3|Overall Study|Early Study Termination|4
5803267|NCT02927938|20020002|P2|Overall Study|Early Study Termination|5
5803268|NCT02927938|20020003|P1|Overall Study|Early Study Termination|1
5803269|NCT02927938|20020000|P4|Overall Study|Death|4
5803270|NCT02927938|20020001|P3|Overall Study|Death|0
5803271|NCT02927938|20020002|P2|Overall Study|Death|1
5803272|NCT02927938|20020003|P1|Overall Study|Death|0
5803273|NCT02927925|20020011|P1|Overall Study|Disease progression at clinical cutoff|1
5803274|NCT02927925|20020011|P1|Overall Study|Other|3
5803275|NCT02927925|20020011|P1|Overall Study|Withdrawal by Subject|11
5803276|NCT02927925|20020011|P1|Overall Study|Physician Decision|1
5803277|NCT02927925|20020011|P1|Overall Study|Death|16
5803278|NCT02927834|20020028|P3|Overall Study|Lost to Follow-up|2
5803279|NCT02927834|20020029|P2|Overall Study|Lost to Follow-up|2
5803280|NCT02927834|20020030|P1|Overall Study|Lost to Follow-up|1
5803281|NCT02927795|20020044|P1|Overall Study|Not Treated|4
5803282|NCT02927795|20020044|P1|Overall Study|Non-evaluable PF10 quest. at visit 2|19
5803283|NCT02927431|20020100|P3|Overall Study|Withdrawal by Subject|1
5803284|NCT02927431|20020101|P2|Overall Study|Withdrawal by Subject|0
5803285|NCT02927431|20020102|P1|Overall Study|Withdrawal by Subject|0
5803286|NCT02927366|20020180|P2|Overall Study|Patient schedule|0
5803287|NCT02927366|20020181|P1|Overall Study|Patient schedule|1
5803288|NCT02927366|20020180|P2|Overall Study|Adverse Event|0
5803289|NCT02927366|20020181|P1|Overall Study|Adverse Event|1
5803290|NCT02927171|20020236|P2|Overall Study|Lost to Follow-up|1
5803291|NCT02927171|20020237|P1|Overall Study|Lost to Follow-up|0
5803292|NCT02926833|20020251|P4|Overall Study|Adverse Event|0
5803293|NCT02926833|20020252|P3|Overall Study|Adverse Event|1
5803294|NCT02926833|20020253|P2|Overall Study|Adverse Event|0
5803295|NCT02926833|20020254|P1|Overall Study|Adverse Event|0
5803296|NCT02926833|20020251|P4|Overall Study|Still on study|14
5803297|NCT02926833|20020252|P3|Overall Study|Still on study|5
5803298|NCT02926833|20020253|P2|Overall Study|Still on study|3
5803299|NCT02926833|20020254|P1|Overall Study|Still on study|2
5803300|NCT02926833|20020251|P4|Overall Study|Death|7
5803301|NCT02926833|20020252|P3|Overall Study|Death|1
5803302|NCT02926833|20020253|P2|Overall Study|Death|1
5803303|NCT02926833|20020254|P1|Overall Study|Death|1
5803304|NCT02926833|20020251|P4|Overall Study|Full Consent Withdrawal|2
5803305|NCT02926833|20020252|P3|Overall Study|Full Consent Withdrawal|0
5803306|NCT02926833|20020253|P2|Overall Study|Full Consent Withdrawal|0
5803307|NCT02926833|20020254|P1|Overall Study|Full Consent Withdrawal|0
5803308|NCT02926638|20020310|P2|Overall Study|Not protocol specified|0
5803309|NCT02926638|20020311|P1|Overall Study|Not protocol specified|1
5803310|NCT02926638|20020310|P2|Overall Study|Ineligible|0
5803311|NCT02926638|20020311|P1|Overall Study|Ineligible|1
5803312|NCT02926638|20020310|P2|Overall Study|Progression|5
5803313|NCT02926638|20020311|P1|Overall Study|Progression|2
5803314|NCT02926573|20020325|P2|Overall Study|Delirium|1
5803315|NCT02926573|20020326|P1|Overall Study|Delirium|0
5803316|NCT02926573|20020325|P2|Overall Study|Return to operating room|2
5803317|NCT02926573|20020326|P1|Overall Study|Return to operating room|0
5803318|NCT02926573|20020325|P2|Overall Study|Withdrawal by Subject|2
5803319|NCT02926573|20020326|P1|Overall Study|Withdrawal by Subject|0
5803320|NCT02926573|20020325|P2|Overall Study|Change to outpatient status|1
5803321|NCT02926573|20020326|P1|Overall Study|Change to outpatient status|5
5803322|NCT02926573|20020325|P2|Overall Study|Change in surgery plan|1
5803323|NCT02926573|20020326|P1|Overall Study|Change in surgery plan|3
5803324|NCT02926573|20020325|P2|Overall Study|Remain intubated|2
5803325|NCT02926573|20020326|P1|Overall Study|Remain intubated|2
5803326|NCT02926573|20020325|P2|Overall Study|Nausea|0
5803327|NCT02926573|20020326|P1|Overall Study|Nausea|1
5803328|NCT02926209|20020344|P2|Study Cohort|Poor Bowel Preparation|0
5803329|NCT02926209|20020345|P1|Study Cohort|Poor Bowel Preparation|1
5803330|NCT02925923|20020358|P2|Overall Study|blood samples hemolyzed|2
5803331|NCT02925923|20020359|P1|Overall Study|blood samples hemolyzed|0
5803332|NCT02925741|20020416|P2|Overall Study|Withdrawal by Subject|0
5803333|NCT02925741|20020417|P1|Overall Study|Withdrawal by Subject|11
5803334|NCT02925494|20020450|P4|Post-Treatment Follow-Up Period|Adverse Event|1
5803335|NCT02925494|20020451|P3|Post-Treatment Follow-Up Period|Adverse Event|0
5803336|NCT02925494|20020452|P2|Post-Treatment Follow-Up Period|Adverse Event|0
5803337|NCT02925494|20020453|P1|Post-Treatment Follow-Up Period|Adverse Event|0
5803338|NCT02925494|20020450|P4|Post-Treatment Follow-Up Period|Non-Compliance|2
5803339|NCT02925494|20020451|P3|Post-Treatment Follow-Up Period|Non-Compliance|1
5803340|NCT02925494|20020452|P2|Post-Treatment Follow-Up Period|Non-Compliance|0
5803341|NCT02925494|20020453|P1|Post-Treatment Follow-Up Period|Non-Compliance|0
5803342|NCT02925494|20020450|P4|Post-Treatment Follow-Up Period|Pregnancy|2
5803343|NCT02925494|20020451|P3|Post-Treatment Follow-Up Period|Pregnancy|1
5803344|NCT02925494|20020452|P2|Post-Treatment Follow-Up Period|Pregnancy|0
5803345|NCT02925494|20020453|P1|Post-Treatment Follow-Up Period|Pregnancy|1
5803346|NCT02925494|20020450|P4|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|6
5803347|NCT02925494|20020451|P3|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|2
5803348|NCT02925494|20020452|P2|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|2
5803349|NCT02925494|20020453|P1|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|1
5803350|NCT02925494|20020450|P4|Post-Treatment Follow-Up Period|Other|6
5803351|NCT02925494|20020451|P3|Post-Treatment Follow-Up Period|Other|3
5803352|NCT02925494|20020452|P2|Post-Treatment Follow-Up Period|Other|4
5803353|NCT02925494|20020453|P1|Post-Treatment Follow-Up Period|Other|1
5803354|NCT02925494|20020450|P4|Post-Treatment Follow-Up Period|Lost to Follow-up|10
5803355|NCT02925494|20020451|P3|Post-Treatment Follow-Up Period|Lost to Follow-up|9
5803356|NCT02925494|20020452|P2|Post-Treatment Follow-Up Period|Lost to Follow-up|2
5803357|NCT02925494|20020453|P1|Post-Treatment Follow-Up Period|Lost to Follow-up|3
5803358|NCT02925494|20020450|P4|Post-Treatment Follow-Up Period|Withdrawal by Subject|23
5803359|NCT02925494|20020451|P3|Post-Treatment Follow-Up Period|Withdrawal by Subject|8
5803360|NCT02925494|20020452|P2|Post-Treatment Follow-Up Period|Withdrawal by Subject|2
5803361|NCT02925494|20020453|P1|Post-Treatment Follow-Up Period|Withdrawal by Subject|8
5803362|NCT02925403|20020481|P2|Overall Study|Lost to Follow-up|1
5803363|NCT02925403|20020482|P1|Overall Study|Lost to Follow-up|0
5803364|NCT02925312|20020496|P2|Overall Study|Adverse Event|0
5803365|NCT02925312|20020497|P1|Overall Study|Adverse Event|2
5803366|NCT02925312|20020496|P2|Overall Study|Lost to Follow-up|0
5803367|NCT02925312|20020497|P1|Overall Study|Lost to Follow-up|25
5803368|NCT02925117|20020513|P12|Period 2 (Weeks 16 - 88)|Other|0
5803369|NCT02925117|20020514|P11|Period 2 (Weeks 16 - 88)|Other|3
5803370|NCT02925117|20020515|P10|Period 2 (Weeks 16 - 88)|Other|4
5803371|NCT02925117|20020516|P9|Period 2 (Weeks 16 - 88)|Other|3
5803372|NCT02925117|20020517|P8|Period 2 (Weeks 16 - 88)|Other|1
5803373|NCT02925117|20020518|P7|Period 2 (Weeks 16 - 88)|Other|1
5803374|NCT02925117|20020519|P6|Period 2 (Weeks 16 - 88)|Other|1
5803375|NCT02925117|20020520|P5|Period 2 (Weeks 16 - 88)|Other|1
5803376|NCT02925117|20020521|P4|Period 2 (Weeks 16 - 88)|Other|0
5803377|NCT02925117|20020522|P3|Period 2 (Weeks 16 - 88)|Other|0
5803378|NCT02925117|20020523|P2|Period 2 (Weeks 16 - 88)|Other|0
5803379|NCT02925117|20020524|P1|Period 2 (Weeks 16 - 88)|Other|0
5803380|NCT02925117|20020513|P12|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1
5803381|NCT02925117|20020514|P11|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0
5803382|NCT02925117|20020515|P10|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0
5803383|NCT02925117|20020516|P9|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1
5803384|NCT02925117|20020517|P8|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1
5803385|NCT02925117|20020518|P7|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1
5803386|NCT02925117|20020519|P6|Period 2 (Weeks 16 - 88)|Lost to Follow-up|2
5803387|NCT02925117|20020520|P5|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1
5803388|NCT02925117|20020521|P4|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0
5803389|NCT02925117|20020522|P3|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0
5803390|NCT02925117|20020523|P2|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0
5803391|NCT02925117|20020524|P1|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0
5803392|NCT02925117|20020513|P12|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2
5803393|NCT02925117|20020514|P11|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2
5803394|NCT02925117|20020515|P10|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2
5803395|NCT02925117|20020516|P9|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2
5803396|NCT02925117|20020517|P8|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|3
5803397|NCT02925117|20020518|P7|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|4
5803398|NCT02925117|20020519|P6|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|1
5803399|NCT02925117|20020520|P5|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0
5803400|NCT02925117|20020521|P4|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0
5803401|NCT02925117|20020522|P3|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0
5803402|NCT02925117|20020523|P2|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0
5803403|NCT02925117|20020524|P1|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0
5803404|NCT02925117|20020513|P12|Period 2 (Weeks 16 - 88)|Adverse Event|2
5803405|NCT02925117|20020514|P11|Period 2 (Weeks 16 - 88)|Adverse Event|3
5803406|NCT02925117|20020515|P10|Period 2 (Weeks 16 - 88)|Adverse Event|0
5803407|NCT02925117|20020516|P9|Period 2 (Weeks 16 - 88)|Adverse Event|0
5803408|NCT02925117|20020517|P8|Period 2 (Weeks 16 - 88)|Adverse Event|0
5803409|NCT02925117|20020518|P7|Period 2 (Weeks 16 - 88)|Adverse Event|0
5803410|NCT02925117|20020519|P6|Period 2 (Weeks 16 - 88)|Adverse Event|1
5803411|NCT02925117|20020520|P5|Period 2 (Weeks 16 - 88)|Adverse Event|0
5803412|NCT02925117|20020521|P4|Period 2 (Weeks 16 - 88)|Adverse Event|0
5803413|NCT02925117|20020522|P3|Period 2 (Weeks 16 - 88)|Adverse Event|0
5803414|NCT02925117|20020523|P2|Period 2 (Weeks 16 - 88)|Adverse Event|0
5803415|NCT02925117|20020524|P1|Period 2 (Weeks 16 - 88)|Adverse Event|0
5803416|NCT02925117|20020513|P12|Period 1 (Weeks 0 - 16)|Other|0
5803417|NCT02925117|20020514|P11|Period 1 (Weeks 0 - 16)|Other|0
5803418|NCT02925117|20020515|P10|Period 1 (Weeks 0 - 16)|Other|0
5803419|NCT02925117|20020516|P9|Period 1 (Weeks 0 - 16)|Other|0
5803420|NCT02925117|20020517|P8|Period 1 (Weeks 0 - 16)|Other|0
5803421|NCT02925117|20020518|P7|Period 1 (Weeks 0 - 16)|Other|0
5803422|NCT02925117|20020519|P6|Period 1 (Weeks 0 - 16)|Other|0
5803423|NCT02925117|20020520|P5|Period 1 (Weeks 0 - 16)|Other|0
5803424|NCT02925117|20020521|P4|Period 1 (Weeks 0 - 16)|Other|1
5803425|NCT02925117|20020522|P3|Period 1 (Weeks 0 - 16)|Other|1
5803426|NCT02925117|20020523|P2|Period 1 (Weeks 0 - 16)|Other|4
5803427|NCT02925117|20020524|P1|Period 1 (Weeks 0 - 16)|Other|5
5803428|NCT02925117|20020513|P12|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0
5803429|NCT02925117|20020514|P11|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0
5803430|NCT02925117|20020515|P10|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0
5803431|NCT02925117|20020516|P9|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0
5803432|NCT02925117|20020517|P8|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0
5803433|NCT02925117|20020518|P7|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0
5803434|NCT02925117|20020519|P6|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0
5803435|NCT02925117|20020520|P5|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0
5803436|NCT02925117|20020521|P4|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0
5803437|NCT02925117|20020522|P3|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0
5803438|NCT02925117|20020523|P2|Period 1 (Weeks 0 - 16)|Lost to Follow-up|1
5803439|NCT02925117|20020524|P1|Period 1 (Weeks 0 - 16)|Lost to Follow-up|2
5803440|NCT02925117|20020513|P12|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0
5803441|NCT02925117|20020514|P11|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0
5803442|NCT02925117|20020515|P10|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0
5803443|NCT02925117|20020516|P9|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0
5803444|NCT02925117|20020517|P8|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0
5803445|NCT02925117|20020518|P7|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0
5803446|NCT02925117|20020519|P6|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0
5803447|NCT02925117|20020520|P5|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0
5803448|NCT02925117|20020521|P4|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0
5803449|NCT02925117|20020522|P3|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|3
5803450|NCT02925117|20020523|P2|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|3
5803451|NCT02925117|20020524|P1|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|10
5803452|NCT02925117|20020513|P12|Period 1 (Weeks 0 - 16)|Adverse Event|0
5803453|NCT02925117|20020514|P11|Period 1 (Weeks 0 - 16)|Adverse Event|0
5803454|NCT02925117|20020515|P10|Period 1 (Weeks 0 - 16)|Adverse Event|0
5803455|NCT02925117|20020516|P9|Period 1 (Weeks 0 - 16)|Adverse Event|0
5803456|NCT02925117|20020517|P8|Period 1 (Weeks 0 - 16)|Adverse Event|0
5803457|NCT02925117|20020518|P7|Period 1 (Weeks 0 - 16)|Adverse Event|0
5803458|NCT02925117|20020519|P6|Period 1 (Weeks 0 - 16)|Adverse Event|0
5803459|NCT02925117|20020520|P5|Period 1 (Weeks 0 - 16)|Adverse Event|0
5803460|NCT02925117|20020521|P4|Period 1 (Weeks 0 - 16)|Adverse Event|2
5803461|NCT02925117|20020522|P3|Period 1 (Weeks 0 - 16)|Adverse Event|1
5803462|NCT02925117|20020523|P2|Period 1 (Weeks 0 - 16)|Adverse Event|3
5803463|NCT02925117|20020524|P1|Period 1 (Weeks 0 - 16)|Adverse Event|1
5803472|NCT02924688|20020661|P6|Overall Study|Withdrawal by Subject|14
5803473|NCT02924688|20020662|P5|Overall Study|Withdrawal by Subject|13
5803474|NCT02924688|20020663|P4|Overall Study|Withdrawal by Subject|12
5803475|NCT02924688|20020664|P3|Overall Study|Withdrawal by Subject|9
5803476|NCT02924688|20020665|P2|Overall Study|Withdrawal by Subject|13
5803477|NCT02924688|20020666|P1|Overall Study|Withdrawal by Subject|14
5803478|NCT02924688|20020661|P6|Overall Study|Physician Decision|1
5803479|NCT02924688|20020662|P5|Overall Study|Physician Decision|1
5803480|NCT02924688|20020663|P4|Overall Study|Physician Decision|1
5803481|NCT02924688|20020664|P3|Overall Study|Physician Decision|0
5803482|NCT02924688|20020665|P2|Overall Study|Physician Decision|1
5803483|NCT02924688|20020666|P1|Overall Study|Physician Decision|2
5803484|NCT02924688|20020661|P6|Overall Study|Lost to Follow-up|4
5803485|NCT02924688|20020662|P5|Overall Study|Lost to Follow-up|2
5803486|NCT02924688|20020663|P4|Overall Study|Lost to Follow-up|4
5803487|NCT02924688|20020664|P3|Overall Study|Lost to Follow-up|2
5803488|NCT02924688|20020665|P2|Overall Study|Lost to Follow-up|4
5803489|NCT02924688|20020666|P1|Overall Study|Lost to Follow-up|2
5803490|NCT02924688|20020661|P6|Overall Study|Protocol defined withdrawal criteria met|0
5803491|NCT02924688|20020662|P5|Overall Study|Protocol defined withdrawal criteria met|1
5803492|NCT02924688|20020663|P4|Overall Study|Protocol defined withdrawal criteria met|1
5803493|NCT02924688|20020664|P3|Overall Study|Protocol defined withdrawal criteria met|1
5803494|NCT02924688|20020665|P2|Overall Study|Protocol defined withdrawal criteria met|0
5803495|NCT02924688|20020666|P1|Overall Study|Protocol defined withdrawal criteria met|1
5803496|NCT02924688|20020661|P6|Overall Study|Protocol Violation|2
5803497|NCT02924688|20020662|P5|Overall Study|Protocol Violation|2
5803498|NCT02924688|20020663|P4|Overall Study|Protocol Violation|6
5803499|NCT02924688|20020664|P3|Overall Study|Protocol Violation|5
5803500|NCT02924688|20020665|P2|Overall Study|Protocol Violation|7
5803501|NCT02924688|20020666|P1|Overall Study|Protocol Violation|3
5803502|NCT02924688|20020661|P6|Overall Study|Lack of Efficacy|1
5803503|NCT02924688|20020662|P5|Overall Study|Lack of Efficacy|1
5803504|NCT02924688|20020663|P4|Overall Study|Lack of Efficacy|2
5803505|NCT02924688|20020664|P3|Overall Study|Lack of Efficacy|4
5803506|NCT02924688|20020665|P2|Overall Study|Lack of Efficacy|3
5803507|NCT02924688|20020666|P1|Overall Study|Lack of Efficacy|2
5803508|NCT02924688|20020661|P6|Overall Study|Adverse Event|2
5803509|NCT02924688|20020662|P5|Overall Study|Adverse Event|3
5803510|NCT02924688|20020663|P4|Overall Study|Adverse Event|2
5803511|NCT02924688|20020664|P3|Overall Study|Adverse Event|2
5803512|NCT02924688|20020665|P2|Overall Study|Adverse Event|3
5803513|NCT02924688|20020666|P1|Overall Study|Adverse Event|9
5803514|NCT02924428|20020736|P2|Overall Study|Pregnancy|1
5803515|NCT02924428|20020737|P1|Overall Study|Pregnancy|0
5803516|NCT02924428|20020736|P2|Overall Study|Lost to Follow-up|4
5803517|NCT02924428|20020737|P1|Overall Study|Lost to Follow-up|2
5803518|NCT02924428|20020736|P2|Overall Study|Physician Decision|0
5803519|NCT02924428|20020737|P1|Overall Study|Physician Decision|1
5803520|NCT02924428|20020736|P2|Overall Study|Adverse Event|0
5803521|NCT02924428|20020737|P1|Overall Study|Adverse Event|1
5803522|NCT02924051|20020772|P2|Overall Study|Withdrawal by Subject|9
5803523|NCT02924051|20020773|P1|Overall Study|Withdrawal by Subject|1
5803524|NCT02923921|20020785|P2|Overall Study|Unknown, Not Collected|6
5803525|NCT02923921|20020786|P1|Overall Study|Unknown, Not Collected|7
5803526|NCT02923921|20020785|P2|Overall Study|Withdrawal by Subject|13
5803527|NCT02923921|20020786|P1|Overall Study|Withdrawal by Subject|6
5803528|NCT02923921|20020785|P2|Overall Study|Lost to Follow-up|0
5803529|NCT02923921|20020786|P1|Overall Study|Lost to Follow-up|1
5803530|NCT02923921|20020785|P2|Overall Study|Sponsor Decision|38
5803531|NCT02923921|20020786|P1|Overall Study|Sponsor Decision|39
5803532|NCT02923830|20020819|P2|Overall Study|Physician Decision|15
5803533|NCT02923830|20020820|P1|Overall Study|Physician Decision|13
5803534|NCT02923427|20020840|P2|Overall Study|can not replace LMA|0
5803535|NCT02923427|20020841|P1|Overall Study|can not replace LMA|1
5803536|NCT02923427|20020840|P2|Overall Study|destaturation|0
5803537|NCT02923427|20020841|P1|Overall Study|destaturation|1
5803538|NCT02923427|20020840|P2|Overall Study|convert to laparatomy|2
5803539|NCT02923427|20020841|P1|Overall Study|convert to laparatomy|2
5803540|NCT02923349|20020868|P7|Overall Study|Death|0
5803541|NCT02923349|20020869|P6|Overall Study|Death|3
5803542|NCT02923349|20020870|P5|Overall Study|Death|2
5803543|NCT02923349|20020871|P4|Overall Study|Death|4
5803544|NCT02923349|20020872|P3|Overall Study|Death|2
5803545|NCT02923349|20020873|P2|Overall Study|Death|0
5803546|NCT02923349|20020874|P1|Overall Study|Death|1
5803547|NCT02923349|20020868|P7|Overall Study|Lost to Follow-up|0
5803548|NCT02923349|20020869|P6|Overall Study|Lost to Follow-up|1
5803549|NCT02923349|20020870|P5|Overall Study|Lost to Follow-up|1
5803550|NCT02923349|20020871|P4|Overall Study|Lost to Follow-up|0
5803551|NCT02923349|20020872|P3|Overall Study|Lost to Follow-up|3
5803552|NCT02923349|20020873|P2|Overall Study|Lost to Follow-up|0
5803553|NCT02923349|20020874|P1|Overall Study|Lost to Follow-up|0
5803554|NCT02923349|20020868|P7|Overall Study|Physician Decision|2
5803555|NCT02923349|20020869|P6|Overall Study|Physician Decision|0
5803556|NCT02923349|20020870|P5|Overall Study|Physician Decision|1
5803557|NCT02923349|20020871|P4|Overall Study|Physician Decision|1
5803558|NCT02923349|20020872|P3|Overall Study|Physician Decision|0
5803559|NCT02923349|20020873|P2|Overall Study|Physician Decision|0
5803560|NCT02923349|20020874|P1|Overall Study|Physician Decision|0
5803561|NCT02923349|20020868|P7|Overall Study|Withdrawal by Subject|0
5803562|NCT02923349|20020869|P6|Overall Study|Withdrawal by Subject|3
5803563|NCT02923349|20020870|P5|Overall Study|Withdrawal by Subject|12
5803564|NCT02923349|20020871|P4|Overall Study|Withdrawal by Subject|10
5803565|NCT02923349|20020872|P3|Overall Study|Withdrawal by Subject|8
5803566|NCT02923349|20020873|P2|Overall Study|Withdrawal by Subject|2
5803567|NCT02923349|20020874|P1|Overall Study|Withdrawal by Subject|2
5803568|NCT02923349|20020868|P7|Overall Study|Other|1
5803569|NCT02923349|20020869|P6|Overall Study|Other|0
5803570|NCT02923349|20020870|P5|Overall Study|Other|3
5803571|NCT02923349|20020871|P4|Overall Study|Other|1
5803572|NCT02923349|20020872|P3|Overall Study|Other|4
5803573|NCT02923349|20020873|P2|Overall Study|Other|2
5803574|NCT02923349|20020874|P1|Overall Study|Other|1
5803575|NCT02923245|20020959|P2|Overall Study|ultrasound order was cancelled|1
5803576|NCT02923245|20020960|P1|Overall Study|ultrasound order was cancelled|2
5803577|NCT02923115|20020983|P6|Overall Study|Randomized, but not dosed|0
5803578|NCT02923115|20020984|P5|Overall Study|Randomized, but not dosed|5
5803579|NCT02923115|20020985|P4|Overall Study|Randomized, but not dosed|1
5803580|NCT02923115|20020986|P3|Overall Study|Randomized, but not dosed|3
5803581|NCT02923115|20020987|P2|Overall Study|Randomized, but not dosed|0
5803582|NCT02923115|20020988|P1|Overall Study|Randomized, but not dosed|0
5803583|NCT02923115|20020983|P6|Overall Study|Withdrawal by Subject|0
5803584|NCT02923115|20020984|P5|Overall Study|Withdrawal by Subject|0
5803585|NCT02923115|20020985|P4|Overall Study|Withdrawal by Subject|0
5803586|NCT02923115|20020986|P3|Overall Study|Withdrawal by Subject|0
5803587|NCT02923115|20020987|P2|Overall Study|Withdrawal by Subject|1
5803588|NCT02923115|20020988|P1|Overall Study|Withdrawal by Subject|0
5803589|NCT02923115|20020983|P6|Overall Study|Lost to Follow-up|0
5803590|NCT02923115|20020984|P5|Overall Study|Lost to Follow-up|0
5803591|NCT02923115|20020985|P4|Overall Study|Lost to Follow-up|1
5803592|NCT02923115|20020986|P3|Overall Study|Lost to Follow-up|0
5803593|NCT02923115|20020987|P2|Overall Study|Lost to Follow-up|0
5803594|NCT02923115|20020988|P1|Overall Study|Lost to Follow-up|0
5803595|NCT02922153|20021170|P2|Overall Study|Physician Decision|1
5803596|NCT02922153|20021171|P1|Overall Study|Physician Decision|1
5803597|NCT02922153|20021170|P2|Overall Study|Lost to Follow-up|0
5803598|NCT02922153|20021171|P1|Overall Study|Lost to Follow-up|1
5803599|NCT02922153|20021170|P2|Overall Study|Death|1
5803600|NCT02922153|20021171|P1|Overall Study|Death|8
5803601|NCT02921750|20021230|P2|Overall Study|Serious Adverse Event|2
5803602|NCT02921750|20021231|P1|Overall Study|Serious Adverse Event|1
5803603|NCT02921750|20021230|P2|Overall Study|Wound healed|3
5803604|NCT02921750|20021231|P1|Overall Study|Wound healed|3
5803605|NCT02921750|20021230|P2|Overall Study|Lost to Follow-up|3
5803606|NCT02921750|20021231|P1|Overall Study|Lost to Follow-up|3
5803607|NCT02921750|20021230|P2|Overall Study|Withdrawal by Subject|1
5803608|NCT02921750|20021231|P1|Overall Study|Withdrawal by Subject|1
5803609|NCT02921750|20021230|P2|Overall Study|Adverse Event|2
5803610|NCT02921750|20021231|P1|Overall Study|Adverse Event|1
5803611|NCT02921425|20021262|P1|Overall Study|Protocol Violation|9
5803612|NCT02921087|20021334|P2|Overall Study|Withdrawal by Subject|1
5803613|NCT02921087|20021335|P1|Overall Study|Withdrawal by Subject|0
5803614|NCT02920983|20021364|P6|Dispense 3|Unacceptable Lens Fit|0
5803615|NCT02920983|20021365|P5|Dispense 3|Unacceptable Lens Fit|1
5803616|NCT02920983|20021366|P4|Dispense 3|Unacceptable Lens Fit|0
5803617|NCT02920983|20021367|P3|Dispense 3|Unacceptable Lens Fit|0
5803618|NCT02920983|20021368|P2|Dispense 3|Unacceptable Lens Fit|1
5803619|NCT02920983|20021369|P1|Dispense 3|Unacceptable Lens Fit|1
5803620|NCT02920983|20021364|P6|Dispense 2|Unscceptable lens fit|0
5803621|NCT02920983|20021365|P5|Dispense 2|Unscceptable lens fit|1
5803622|NCT02920983|20021366|P4|Dispense 2|Unscceptable lens fit|0
5803623|NCT02920983|20021367|P3|Dispense 2|Unscceptable lens fit|0
5803624|NCT02920983|20021368|P2|Dispense 2|Unscceptable lens fit|0
5803625|NCT02920983|20021369|P1|Dispense 2|Unscceptable lens fit|1
5803626|NCT02920983|20021364|P6|Dispense 1|Unacceptable Lens Fit|0
5803627|NCT02920983|20021365|P5|Dispense 1|Unacceptable Lens Fit|1
5803628|NCT02920983|20021366|P4|Dispense 1|Unacceptable Lens Fit|0
5803629|NCT02920983|20021367|P3|Dispense 1|Unacceptable Lens Fit|0
5803630|NCT02920983|20021368|P2|Dispense 1|Unacceptable Lens Fit|0
5803631|NCT02920983|20021369|P1|Dispense 1|Unacceptable Lens Fit|0
5803632|NCT02920970|20021398|P2|Second Intervention|Poor Lens Fit|0
5803633|NCT02920970|20021399|P1|Second Intervention|Poor Lens Fit|1
5803634|NCT02920970|20021398|P2|First Intervention|Adverse Event|1
5803635|NCT02920970|20021399|P1|First Intervention|Adverse Event|0
5803636|NCT02920970|20021398|P2|First Intervention|Protocol Violation|1
5803637|NCT02920970|20021399|P1|First Intervention|Protocol Violation|0
5803638|NCT02920957|20021425|P2|Second Intervention: 1 Month|Lost to Follow-up|1
5803639|NCT02920957|20021426|P1|Second Intervention: 1 Month|Lost to Follow-up|0
5803640|NCT02920957|20021425|P2|First Intervention : 1 Month|Adverse Event|0
5803641|NCT02920957|20021426|P1|First Intervention : 1 Month|Adverse Event|1
5803642|NCT02920957|20021425|P2|First Intervention : 1 Month|Lost to Follow-up|0
5803643|NCT02920957|20021426|P1|First Intervention : 1 Month|Lost to Follow-up|1
5803644|NCT02920957|20021425|P2|First Intervention : 1 Month|Withdrawal by Subject|0
5803645|NCT02920957|20021426|P1|First Intervention : 1 Month|Withdrawal by Subject|2
5803646|NCT02920450|20021515|P4|Overall Study|Withdrawal by Subject|0
5803647|NCT02920450|20021516|P3|Overall Study|Withdrawal by Subject|0
5803648|NCT02920450|20021517|P2|Overall Study|Withdrawal by Subject|0
5803649|NCT02920450|20021518|P1|Overall Study|Withdrawal by Subject|1
5803650|NCT02920450|20021515|P4|Overall Study|Death|0
5803651|NCT02920450|20021516|P3|Overall Study|Death|0
5803652|NCT02920450|20021517|P2|Overall Study|Death|0
5803653|NCT02920450|20021518|P1|Overall Study|Death|1
5803654|NCT02920242|20021529|P3|Overall Study|Did not meet inc./exc. criteria|0
5803655|NCT02920242|20021530|P2|Overall Study|Did not meet inc./exc. criteria|0
5803656|NCT02920242|20021531|P1|Overall Study|Did not meet inc./exc. criteria|1
5803657|NCT02920242|20021529|P3|Overall Study|Withdrawal by Subject|1
5803658|NCT02920242|20021530|P2|Overall Study|Withdrawal by Subject|0
5803659|NCT02920242|20021531|P1|Overall Study|Withdrawal by Subject|1
5803660|NCT02920177|20021559|P2|Overall Study|Lost to Follow-up|1
5803661|NCT02920177|20021560|P1|Overall Study|Lost to Follow-up|0
5803662|NCT02920177|20021559|P2|Overall Study|Physician Decision|0
5803663|NCT02920177|20021560|P1|Overall Study|Physician Decision|1
5803664|NCT02920177|20021559|P2|Overall Study|Withdrawal by Subject|1
5803665|NCT02920177|20021560|P1|Overall Study|Withdrawal by Subject|1
5803666|NCT02919995|20021580|P6|Overall Study|Adverse Event|1
5803667|NCT02919995|20021581|P5|Overall Study|Adverse Event|0
5803668|NCT02919995|20021582|P4|Overall Study|Adverse Event|0
5803669|NCT02919995|20021583|P3|Overall Study|Adverse Event|0
5803670|NCT02919995|20021584|P2|Overall Study|Adverse Event|0
5803671|NCT02919995|20021585|P1|Overall Study|Adverse Event|0
5803672|NCT02919761|20021648|P3|Part 2: Double-blind|Discontinued exclusion 16|2
5803673|NCT02919761|20021649|P2|Part 2: Double-blind|Discontinued exclusion 16|0
5803674|NCT02919761|20021650|P1|Part 2: Double-blind|Discontinued exclusion 16|0
5803675|NCT02919761|20021648|P3|Part 2: Double-blind|Did not meet LDA at Week 20|1
5803676|NCT02919761|20021649|P2|Part 2: Double-blind|Did not meet LDA at Week 20|0
5803677|NCT02919761|20021650|P1|Part 2: Double-blind|Did not meet LDA at Week 20|0
5803678|NCT02919761|20021648|P3|Part 2: Double-blind|Did not meet LDA at Week 16|1
5803679|NCT02919761|20021649|P2|Part 2: Double-blind|Did not meet LDA at Week 16|0
5803680|NCT02919761|20021650|P1|Part 2: Double-blind|Did not meet LDA at Week 16|0
5803681|NCT02919761|20021648|P3|Part 2: Double-blind|Worsening of disease activity|10
5803682|NCT02919761|20021649|P2|Part 2: Double-blind|Worsening of disease activity|4
5803683|NCT02919761|20021650|P1|Part 2: Double-blind|Worsening of disease activity|0
5803684|NCT02919761|20021648|P3|Part 2: Double-blind|Met withdrawal criteria|2
5803685|NCT02919761|20021649|P2|Part 2: Double-blind|Met withdrawal criteria|1
5803686|NCT02919761|20021650|P1|Part 2: Double-blind|Met withdrawal criteria|0
5803687|NCT02919761|20021648|P3|Part 2: Double-blind|Lost to Follow-up|3
5803688|NCT02919761|20021649|P2|Part 2: Double-blind|Lost to Follow-up|0
5803689|NCT02919761|20021650|P1|Part 2: Double-blind|Lost to Follow-up|0
5803690|NCT02919761|20021648|P3|Part 2: Double-blind|Adverse Event|0
5803691|NCT02919761|20021649|P2|Part 2: Double-blind|Adverse Event|1
5803692|NCT02919761|20021650|P1|Part 2: Double-blind|Adverse Event|0
5803693|NCT02919761|20021648|P3|Part 2: Double-blind|Withdrawal by Subject|2
5803694|NCT02919761|20021649|P2|Part 2: Double-blind|Withdrawal by Subject|0
5803695|NCT02919761|20021650|P1|Part 2: Double-blind|Withdrawal by Subject|0
5803696|NCT02919761|20021648|P3|Part 1: Open Label|Termination by Sponsor|0
5803697|NCT02919761|20021649|P2|Part 1: Open Label|Termination by Sponsor|0
5803698|NCT02919761|20021650|P1|Part 1: Open Label|Termination by Sponsor|1
5803699|NCT02919761|20021648|P3|Part 1: Open Label|did not meet inclusion criteria 8|0
5803700|NCT02919761|20021649|P2|Part 1: Open Label|did not meet inclusion criteria 8|0
5803701|NCT02919761|20021650|P1|Part 1: Open Label|did not meet inclusion criteria 8|1
5803702|NCT02919761|20021648|P3|Part 1: Open Label|Dose Greater Than 20mg/Week|0
5803703|NCT02919761|20021649|P2|Part 1: Open Label|Dose Greater Than 20mg/Week|0
5803704|NCT02919761|20021650|P1|Part 1: Open Label|Dose Greater Than 20mg/Week|1
5803705|NCT02919761|20021648|P3|Part 1: Open Label|Did Not Achieve Lda At Week 12|0
5803706|NCT02919761|20021649|P2|Part 1: Open Label|Did Not Achieve Lda At Week 12|0
5803707|NCT02919761|20021650|P1|Part 1: Open Label|Did Not Achieve Lda At Week 12|2
5803708|NCT02919761|20021648|P3|Part 1: Open Label|Met withdrawal criteria|0
5803709|NCT02919761|20021649|P2|Part 1: Open Label|Met withdrawal criteria|0
5803710|NCT02919761|20021650|P1|Part 1: Open Label|Met withdrawal criteria|5
5803711|NCT02919761|20021648|P3|Part 1: Open Label|Lost to Follow-up|0
5803712|NCT02919761|20021649|P2|Part 1: Open Label|Lost to Follow-up|0
5803713|NCT02919761|20021650|P1|Part 1: Open Label|Lost to Follow-up|1
5803714|NCT02919761|20021648|P3|Part 1: Open Label|Adverse Event|0
5803715|NCT02919761|20021649|P2|Part 1: Open Label|Adverse Event|0
5803716|NCT02919761|20021650|P1|Part 1: Open Label|Adverse Event|1
5803717|NCT02919761|20021648|P3|Part 1: Open Label|Withdrawal by Subject|0
5803718|NCT02919761|20021649|P2|Part 1: Open Label|Withdrawal by Subject|0
5803719|NCT02919761|20021650|P1|Part 1: Open Label|Withdrawal by Subject|12
5803720|NCT02919696|20021678|P2|Overall Study|Never Treated|1
5803721|NCT02919696|20021679|P1|Overall Study|Never Treated|0
5803722|NCT02919696|20021678|P2|Overall Study|Sponsor Decision|1
5803723|NCT02919696|20021679|P1|Overall Study|Sponsor Decision|1
5803724|NCT02919696|20021678|P2|Overall Study|Withdrawal by Subject|1
5803725|NCT02919696|20021679|P1|Overall Study|Withdrawal by Subject|2
5803726|NCT02919696|20021678|P2|Overall Study|Adverse Event|2
5803727|NCT02919696|20021679|P1|Overall Study|Adverse Event|1
5803728|NCT02919683|20021701|P2|Post-Surgery Follow-Up|Patient is still completing follow-ups|0
5803729|NCT02919683|20021702|P1|Post-Surgery Follow-Up|Patient is still completing follow-ups|1
5803730|NCT02919683|20021701|P2|Post-Surgery Follow-Up|Death|2
5803731|NCT02919683|20021702|P1|Post-Surgery Follow-Up|Death|2
5803732|NCT02919618|20021715|P1|Overall Study|Death|1
5803733|NCT02919267|20021745|P4|Overall Study|Protocol Violation|4
5803734|NCT02919267|20021746|P3|Overall Study|Protocol Violation|3
5803735|NCT02919267|20021747|P2|Overall Study|Protocol Violation|3
5803736|NCT02919267|20021748|P1|Overall Study|Protocol Violation|0
5803737|NCT02918552|20021913|P2|Overall Study|Lost to Follow-up|1
5803738|NCT02918552|20021914|P1|Overall Study|Lost to Follow-up|0
5803739|NCT02918552|20021913|P2|Overall Study|Withdrawal by Subject|1
5803740|NCT02918552|20021914|P1|Overall Study|Withdrawal by Subject|0
5803741|NCT02918552|20021913|P2|Overall Study|Failed Pharmacokinetics|0
5803742|NCT02918552|20021914|P1|Overall Study|Failed Pharmacokinetics|1
5803743|NCT02918318|20021990|P5|Open Label Follow-up Phase: 4 Weeks|Adverse Event|1
5803744|NCT02918318|20021991|P4|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0
5803745|NCT02918318|20021992|P3|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0
5803746|NCT02918318|20021993|P2|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0
5803747|NCT02918318|20021994|P1|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0
5803748|NCT02918318|20021990|P5|Open Label Treatment Phase: 4 Weeks|Adverse Event|1
5803749|NCT02918318|20021991|P4|Open Label Treatment Phase: 4 Weeks|Adverse Event|0
5803750|NCT02918318|20021992|P3|Open Label Treatment Phase: 4 Weeks|Adverse Event|0
5803751|NCT02918318|20021993|P2|Open Label Treatment Phase: 4 Weeks|Adverse Event|0
5803752|NCT02918318|20021994|P1|Open Label Treatment Phase: 4 Weeks|Adverse Event|0
5803753|NCT02918318|20021990|P5|Posttreatment Phase: Up to 24 Weeks|Other|0
5803754|NCT02918318|20021991|P4|Posttreatment Phase: Up to 24 Weeks|Other|1
5803755|NCT02918318|20021992|P3|Posttreatment Phase: Up to 24 Weeks|Other|1
5803756|NCT02918318|20021993|P2|Posttreatment Phase: Up to 24 Weeks|Other|3
5803757|NCT02918318|20021994|P1|Posttreatment Phase: Up to 24 Weeks|Other|0
5803758|NCT02918318|20021990|P5|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0
5803759|NCT02918318|20021991|P4|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|1
5803760|NCT02918318|20021992|P3|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0
5803761|NCT02918318|20021993|P2|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0
5803762|NCT02918318|20021994|P1|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|1
5803763|NCT02918318|20021990|P5|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|0
5803764|NCT02918318|20021991|P4|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1
5803765|NCT02918318|20021992|P3|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1
5803766|NCT02918318|20021993|P2|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|0
5803767|NCT02918318|20021994|P1|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1
5803768|NCT02918318|20021990|P5|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0
5803769|NCT02918318|20021991|P4|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|2
5803770|NCT02918318|20021992|P3|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0
5803771|NCT02918318|20021993|P2|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0
5803772|NCT02918318|20021994|P1|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0
5803773|NCT02918318|20021990|P5|Double-blind Induction Phase: 4 Weeks|Other|0
5803774|NCT02918318|20021991|P4|Double-blind Induction Phase: 4 Weeks|Other|1
5803775|NCT02918318|20021992|P3|Double-blind Induction Phase: 4 Weeks|Other|0
5803776|NCT02918318|20021993|P2|Double-blind Induction Phase: 4 Weeks|Other|2
5803777|NCT02918318|20021994|P1|Double-blind Induction Phase: 4 Weeks|Other|0
5803778|NCT02918318|20021990|P5|Double-blind Induction Phase: 4 Weeks|Non-compliance|0
5803779|NCT02918318|20021991|P4|Double-blind Induction Phase: 4 Weeks|Non-compliance|1
5803780|NCT02918318|20021992|P3|Double-blind Induction Phase: 4 Weeks|Non-compliance|0
5803781|NCT02918318|20021993|P2|Double-blind Induction Phase: 4 Weeks|Non-compliance|0
5803782|NCT02918318|20021994|P1|Double-blind Induction Phase: 4 Weeks|Non-compliance|0
5803783|NCT02918318|20021990|P5|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0
5803784|NCT02918318|20021991|P4|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0
5803785|NCT02918318|20021992|P3|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0
5803786|NCT02918318|20021993|P2|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|1
5803787|NCT02918318|20021994|P1|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|1
5803788|NCT02918318|20021990|P5|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0
5803789|NCT02918318|20021991|P4|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|1
5803790|NCT02918318|20021992|P3|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0
5803791|NCT02918318|20021993|P2|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0
5803792|NCT02918318|20021994|P1|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0
5803793|NCT02918318|20021990|P5|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0
5803794|NCT02918318|20021991|P4|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|2
5803795|NCT02918318|20021992|P3|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0
5803796|NCT02918318|20021993|P2|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0
5803797|NCT02918318|20021994|P1|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0
5803798|NCT02918318|20021990|P5|Double-blind Induction Phase: 4 Weeks|Adverse Event|0
5803799|NCT02918318|20021991|P4|Double-blind Induction Phase: 4 Weeks|Adverse Event|3
5803800|NCT02918318|20021992|P3|Double-blind Induction Phase: 4 Weeks|Adverse Event|2
5803801|NCT02918318|20021993|P2|Double-blind Induction Phase: 4 Weeks|Adverse Event|4
5803802|NCT02918318|20021994|P1|Double-blind Induction Phase: 4 Weeks|Adverse Event|1
5803803|NCT02918279|20022055|P2|Overall Study|Other|1
5803804|NCT02918279|20022056|P1|Overall Study|Other|3
5803805|NCT02918279|20022055|P2|Overall Study|Withdrawal by parent/guardian|1
5803806|NCT02918279|20022056|P1|Overall Study|Withdrawal by parent/guardian|2
5803807|NCT02918279|20022055|P2|Overall Study|Withdrawal by Subject|15
5803808|NCT02918279|20022056|P1|Overall Study|Withdrawal by Subject|5
5803809|NCT02918279|20022055|P2|Overall Study|Lost to Follow-up|6
5803810|NCT02918279|20022056|P1|Overall Study|Lost to Follow-up|3
5803811|NCT02918266|20022192|P11|Part 2: Intervention Period 1 (2 Days)|Study termination|1
5803812|NCT02918266|20022193|P10|Part 2: Intervention Period 1 (2 Days)|Study termination|1
5803813|NCT02918266|20022194|P9|Part 2: Intervention Period 1 (2 Days)|Study termination|2
5803814|NCT02918266|20022195|P8|Part 2: Intervention Period 1 (2 Days)|Study termination|1
5803815|NCT02918266|20022196|P7|Part 2: Intervention Period 1 (2 Days)|Study termination|2
5803816|NCT02918266|20022197|P6|Part 2: Intervention Period 1 (2 Days)|Study termination|1
5803817|NCT02918266|20022198|P5|Part 2: Intervention Period 1 (2 Days)|Study termination|1
5803818|NCT02918266|20022199|P4|Part 2: Intervention Period 1 (2 Days)|Study termination|1
5803819|NCT02918266|20022200|P3|Part 2: Intervention Period 1 (2 Days)|Study termination|1
5803820|NCT02918266|20022201|P2|Part 2: Intervention Period 1 (2 Days)|Study termination|1
5803821|NCT02918266|20022202|P1|Part 2: Intervention Period 1 (2 Days)|Study termination|0
5803822|NCT02918071|20022307|P1|Overall Study|Lost to Follow-up|1
5803823|NCT02918071|20022307|P1|Overall Study|Withdrawal by Subject|2
5803824|NCT02917941|20022317|P1|Survival Follow-up Period|Withdrawal by Subject|4
5803825|NCT02917941|20022317|P1|Survival Follow-up Period|Lost to Follow-up|1
5803826|NCT02917941|20022317|P1|Treatment Period|Reason not Specified|2
5803827|NCT02917941|20022317|P1|Treatment Period|Progressive Disease|11
5803828|NCT02917941|20022317|P1|Treatment Period|Adverse Event|11
5803829|NCT02917265|20022370|P2|Overall Study|Withdrawal by Subject|0
5803830|NCT02917265|20022371|P1|Overall Study|Withdrawal by Subject|1
5803831|NCT02917265|20022370|P2|Overall Study|Physician Decision|0
5803832|NCT02917265|20022371|P1|Overall Study|Physician Decision|1
5803833|NCT02916927|20022387|P2|Overall Study|Withdrawal before first time point|0
5803834|NCT02916927|20022388|P1|Overall Study|Withdrawal before first time point|1
5803835|NCT02916927|20022387|P2|Overall Study|At radiology for 45 & 60 min time points|1
5803836|NCT02916927|20022388|P1|Overall Study|At radiology for 45 & 60 min time points|0
5803837|NCT02916927|20022387|P2|Overall Study|Discharged prior to study drug receipt|2
5803838|NCT02916927|20022388|P1|Overall Study|Discharged prior to study drug receipt|0
5803839|NCT02916693|20022432|P1|Overall Study|Lost to Follow-up|7
5803840|NCT02916433|20022451|P2|Overall Study|Physician Decision|0
5803841|NCT02916433|20022452|P1|Overall Study|Physician Decision|1
5803842|NCT02916433|20022451|P2|Overall Study|Withdrawal by Subject|0
5803843|NCT02916433|20022452|P1|Overall Study|Withdrawal by Subject|1
5803844|NCT02915978|20022475|P3|Overall Study|Adverse Event|0
5803845|NCT02915978|20022476|P2|Overall Study|Adverse Event|1
5803846|NCT02915978|20022477|P1|Overall Study|Adverse Event|2
5803847|NCT02915874|20022529|P2|Overall Study|Started New Anxiety Medication|1
5803848|NCT02915874|20022530|P1|Overall Study|Started New Anxiety Medication|0
5803849|NCT02915874|20022529|P2|Overall Study|Withdrawal by Subject|1
5803850|NCT02915874|20022530|P1|Overall Study|Withdrawal by Subject|1
5803851|NCT02915874|20022529|P2|Overall Study|Lost to Follow-up|4
5803852|NCT02915874|20022530|P1|Overall Study|Lost to Follow-up|5
5803853|NCT02915835|20022550|P2|Overall Study|Withdrawal by Subject|1
5803854|NCT02915835|20022551|P1|Overall Study|Withdrawal by Subject|0
5803855|NCT02915835|20022550|P2|Overall Study|Physician Decision|0
5803856|NCT02915835|20022551|P1|Overall Study|Physician Decision|1
5803857|NCT02915783|20022675|P1|Overall Study|Ongoing: In Survival Follow Up|8
5803858|NCT02915783|20022675|P1|Overall Study|Ongoing: Receiving Treatment|6
5803859|NCT02915302|20022757|P2|Overall Study|Other|0
5803860|NCT02915302|20022758|P1|Overall Study|Other|1
5803861|NCT02915302|20022757|P2|Overall Study|Withdrawal by Subject|29
5803862|NCT02915302|20022758|P1|Overall Study|Withdrawal by Subject|22
5803863|NCT02915302|20022757|P2|Overall Study|Lost to Follow-up|22
5803864|NCT02915302|20022758|P1|Overall Study|Lost to Follow-up|19
5803865|NCT02915302|20022757|P2|Overall Study|Protocol Violation|27
5803866|NCT02915302|20022758|P1|Overall Study|Protocol Violation|20
5803867|NCT02915302|20022757|P2|Overall Study|Adverse Event|0
5803868|NCT02915302|20022758|P1|Overall Study|Adverse Event|3
5803869|NCT02915159|20022770|P2|Overall Study|Lack of Efficacy|3
5803870|NCT02915159|20022771|P1|Overall Study|Lack of Efficacy|0
5803871|NCT02915159|20022770|P2|Overall Study|Adverse Event|2
5803872|NCT02915159|20022771|P1|Overall Study|Adverse Event|2
5803873|NCT02915159|20022770|P2|Overall Study|Request to discontinue treatment|2
5803874|NCT02915159|20022771|P1|Overall Study|Request to discontinue treatment|1
5803875|NCT02915159|20022770|P2|Overall Study|Participant withdrew consent|1
5803876|NCT02915159|20022771|P1|Overall Study|Participant withdrew consent|5
5803877|NCT02915159|20022770|P2|Overall Study|poor/non-compliance|0
5803878|NCT02915159|20022771|P1|Overall Study|poor/non-compliance|1
5803879|NCT02915159|20022770|P2|Overall Study|Participant no longer meets criteria|0
5803880|NCT02915159|20022771|P1|Overall Study|Participant no longer meets criteria|2
5803881|NCT02915016|20022910|P8|Overall Study|Participant unable to adhere|1
5803882|NCT02915016|20022911|P7|Overall Study|Participant unable to adhere|0
5803883|NCT02915016|20022912|P6|Overall Study|Participant unable to adhere|0
5803884|NCT02915016|20022913|P5|Overall Study|Participant unable to adhere|0
5803885|NCT02915016|20022914|P4|Overall Study|Participant unable to adhere|0
5803886|NCT02915016|20022915|P3|Overall Study|Participant unable to adhere|0
5803887|NCT02915016|20022916|P2|Overall Study|Participant unable to adhere|0
5803888|NCT02915016|20022917|P1|Overall Study|Participant unable to adhere|0
5803889|NCT02915016|20022910|P8|Overall Study|HIV infection|0
5803890|NCT02915016|20022911|P7|Overall Study|HIV infection|0
5803891|NCT02915016|20022912|P6|Overall Study|HIV infection|0
5803892|NCT02915016|20022913|P5|Overall Study|HIV infection|1
5803893|NCT02915016|20022914|P4|Overall Study|HIV infection|0
5803894|NCT02915016|20022915|P3|Overall Study|HIV infection|1
5803895|NCT02915016|20022916|P2|Overall Study|HIV infection|1
5803896|NCT02915016|20022917|P1|Overall Study|HIV infection|1
5803897|NCT02915016|20022910|P8|Overall Study|Elected not to continue|0
5803898|NCT02915016|20022911|P7|Overall Study|Elected not to continue|1
5803899|NCT02915016|20022912|P6|Overall Study|Elected not to continue|0
5803900|NCT02915016|20022913|P5|Overall Study|Elected not to continue|0
5803901|NCT02915016|20022914|P4|Overall Study|Elected not to continue|1
5803902|NCT02915016|20022915|P3|Overall Study|Elected not to continue|0
5803903|NCT02915016|20022916|P2|Overall Study|Elected not to continue|0
5803904|NCT02915016|20022917|P1|Overall Study|Elected not to continue|0
5803905|NCT02915016|20022910|P8|Overall Study|Withdrawal by Subject|1
5803906|NCT02915016|20022911|P7|Overall Study|Withdrawal by Subject|1
5803907|NCT02915016|20022912|P6|Overall Study|Withdrawal by Subject|3
5803908|NCT02915016|20022913|P5|Overall Study|Withdrawal by Subject|1
5803909|NCT02915016|20022914|P4|Overall Study|Withdrawal by Subject|0
5803910|NCT02915016|20022915|P3|Overall Study|Withdrawal by Subject|1
5803911|NCT02915016|20022916|P2|Overall Study|Withdrawal by Subject|0
5803912|NCT02915016|20022917|P1|Overall Study|Withdrawal by Subject|2
5803913|NCT02915016|20022910|P8|Overall Study|Physician Decision|0
5803914|NCT02915016|20022911|P7|Overall Study|Physician Decision|2
5803915|NCT02915016|20022912|P6|Overall Study|Physician Decision|1
5803916|NCT02915016|20022913|P5|Overall Study|Physician Decision|0
5803917|NCT02915016|20022914|P4|Overall Study|Physician Decision|0
5803918|NCT02915016|20022915|P3|Overall Study|Physician Decision|1
5803919|NCT02915016|20022916|P2|Overall Study|Physician Decision|0
5803920|NCT02915016|20022917|P1|Overall Study|Physician Decision|0
5803921|NCT02915016|20022910|P8|Overall Study|Lost to Follow-up|2
5803922|NCT02915016|20022911|P7|Overall Study|Lost to Follow-up|8
5803923|NCT02915016|20022912|P6|Overall Study|Lost to Follow-up|2
5803924|NCT02915016|20022913|P5|Overall Study|Lost to Follow-up|5
5803925|NCT02915016|20022914|P4|Overall Study|Lost to Follow-up|3
5803926|NCT02915016|20022915|P3|Overall Study|Lost to Follow-up|5
5803927|NCT02915016|20022916|P2|Overall Study|Lost to Follow-up|2
5803928|NCT02915016|20022917|P1|Overall Study|Lost to Follow-up|4
5803929|NCT02914548|20023141|P3|Overall Study|>40% of body surface area|1
5803930|NCT02914548|20023142|P2|Overall Study|>40% of body surface area|1
5803931|NCT02914548|20023143|P1|Overall Study|>40% of body surface area|0
5803932|NCT02914548|20023141|P3|Overall Study|Withdrawal by Subject|4
5803933|NCT02914548|20023142|P2|Overall Study|Withdrawal by Subject|4
5803934|NCT02914548|20023143|P1|Overall Study|Withdrawal by Subject|3
5803935|NCT02914548|20023141|P3|Overall Study|Protocol Violation|0
5803936|NCT02914548|20023142|P2|Overall Study|Protocol Violation|0
5803937|NCT02914548|20023143|P1|Overall Study|Protocol Violation|1
5803938|NCT02914548|20023141|P3|Overall Study|Physician Decision|0
5803939|NCT02914548|20023142|P2|Overall Study|Physician Decision|2
5803940|NCT02914548|20023143|P1|Overall Study|Physician Decision|2
5803941|NCT02914548|20023141|P3|Overall Study|Adverse Event|15
5803942|NCT02914548|20023142|P2|Overall Study|Adverse Event|7
5803943|NCT02914548|20023143|P1|Overall Study|Adverse Event|15
5803944|NCT02914457|20023174|P1|Overall Study|Protocol Violation|1
5803945|NCT02914457|20023174|P1|Overall Study|ECG acquisition error due to sweating|1
5803946|NCT02914457|20023174|P1|Overall Study|Electrical instability of patient|1
5803947|NCT02914457|20023174|P1|Overall Study|No veins available for lead placement|1
5803948|NCT02914457|20023174|P1|Overall Study|Physician Decision|1
5803949|NCT02914457|20023174|P1|Overall Study|Withdrawal by Subject|1
5803950|NCT02914275|20023184|P2|Overall Study|Excluded due to invalid informed consent|0
5803951|NCT02914275|20023185|P1|Overall Study|Excluded due to invalid informed consent|3
5803952|NCT02914275|20023184|P2|Overall Study|Other|1
5803953|NCT02914275|20023185|P1|Overall Study|Other|4
5803954|NCT02914275|20023184|P2|Overall Study|Physician Decision|1
5803955|NCT02914275|20023185|P1|Overall Study|Physician Decision|3
5803956|NCT02914275|20023184|P2|Overall Study|Protocol Violation|1
5803957|NCT02914275|20023185|P1|Overall Study|Protocol Violation|1
5803958|NCT02914275|20023184|P2|Overall Study|Withdrawal by Subject|10
5803959|NCT02914275|20023185|P1|Overall Study|Withdrawal by Subject|26
5803960|NCT02914275|20023184|P2|Overall Study|Lost to Follow-up|29
5803961|NCT02914275|20023185|P1|Overall Study|Lost to Follow-up|84
5803962|NCT02914236|20023217|P1|Overall Study|Lost to Follow-up|1
5803963|NCT02914184|20023263|P4|Overall Study|Migrated/moved from the study area|1
5803964|NCT02914184|20023264|P3|Overall Study|Migrated/moved from the study area|2
5803965|NCT02914184|20023265|P2|Overall Study|Migrated/moved from the study area|1
5803966|NCT02914184|20023266|P1|Overall Study|Migrated/moved from the study area|2
5803967|NCT02914184|20023263|P4|Overall Study|Other|0
5803968|NCT02914184|20023264|P3|Overall Study|Other|0
5803969|NCT02914184|20023265|P2|Overall Study|Other|0
5803970|NCT02914184|20023266|P1|Overall Study|Other|1
5803971|NCT02914184|20023263|P4|Overall Study|Withdrawal by Subject|3
5803972|NCT02914184|20023264|P3|Overall Study|Withdrawal by Subject|7
5803973|NCT02914184|20023265|P2|Overall Study|Withdrawal by Subject|2
5803974|NCT02914184|20023266|P1|Overall Study|Withdrawal by Subject|4
5803975|NCT02914184|20023263|P4|Overall Study|Lost to Follow-up|7
5803976|NCT02914184|20023264|P3|Overall Study|Lost to Follow-up|8
5803977|NCT02914184|20023265|P2|Overall Study|Lost to Follow-up|10
5803978|NCT02914184|20023266|P1|Overall Study|Lost to Follow-up|7
5803979|NCT02913482|20023324|P3|Overall Study|Progressive Disease|1
5803980|NCT02913482|20023325|P2|Overall Study|Progressive Disease|1
5803981|NCT02913482|20023326|P1|Overall Study|Progressive Disease|0
5803982|NCT02913482|20023324|P3|Overall Study|Death|2
5803983|NCT02913482|20023325|P2|Overall Study|Death|1
5803984|NCT02913482|20023326|P1|Overall Study|Death|1
5803985|NCT02913326|20023359|P2|Overall Study|Adverse Event|0
5803986|NCT02913326|20023360|P1|Overall Study|Adverse Event|1
5803987|NCT02913326|20023359|P2|Overall Study|Lost to Follow-up|1
5803988|NCT02913326|20023360|P1|Overall Study|Lost to Follow-up|0
5803989|NCT02913326|20023359|P2|Overall Study|Reason not listed|1
5803990|NCT02913326|20023360|P1|Overall Study|Reason not listed|0
5803991|NCT02913105|20023383|P3|Overall Study|Withdrawal by Subject|1
5803992|NCT02913105|20023384|P2|Overall Study|Withdrawal by Subject|3
5803993|NCT02913105|20023385|P1|Overall Study|Withdrawal by Subject|0
5803994|NCT02913105|20023383|P3|Overall Study|Physician Decision|0
5803995|NCT02913105|20023384|P2|Overall Study|Physician Decision|1
5803996|NCT02913105|20023385|P1|Overall Study|Physician Decision|1
5803997|NCT02913105|20023383|P3|Overall Study|Reason Not Specified|1
5803998|NCT02913105|20023384|P2|Overall Study|Reason Not Specified|1
5803999|NCT02913105|20023385|P1|Overall Study|Reason Not Specified|3
5804000|NCT02913105|20023383|P3|Overall Study|Non-Compliance With Study Drug|1
5804001|NCT02913105|20023384|P2|Overall Study|Non-Compliance With Study Drug|0
5804002|NCT02913105|20023385|P1|Overall Study|Non-Compliance With Study Drug|0
5804003|NCT02913105|20023383|P3|Overall Study|Adverse Event|4
5804004|NCT02913105|20023384|P2|Overall Study|Adverse Event|0
5804005|NCT02913105|20023385|P1|Overall Study|Adverse Event|11
5804006|NCT02912650|20023438|P4|Overall Study|Adverse Event|0
5804007|NCT02912650|20023439|P3|Overall Study|Adverse Event|1
5804008|NCT02912650|20023440|P2|Overall Study|Adverse Event|0
5804009|NCT02912650|20023441|P1|Overall Study|Adverse Event|0
5804010|NCT02912650|20023438|P4|Overall Study|Withdrawal by Subject|5
5804011|NCT02912650|20023439|P3|Overall Study|Withdrawal by Subject|1
5804012|NCT02912650|20023440|P2|Overall Study|Withdrawal by Subject|0
5804013|NCT02912650|20023441|P1|Overall Study|Withdrawal by Subject|1
5804014|NCT02912468|20023525|P2|Overall Study|Randomized and not treated|1
5804015|NCT02912468|20023526|P1|Overall Study|Randomized and not treated|0
5804016|NCT02912468|20023525|P2|Overall Study|Withdrawal by Subject|2
5804017|NCT02912468|20023526|P1|Overall Study|Withdrawal by Subject|6
5804018|NCT02912468|20023525|P2|Overall Study|Adverse Event|2
5804019|NCT02912468|20023526|P1|Overall Study|Adverse Event|3
5804020|NCT02912455|20023605|P2|Overall Study|Lost to Follow-up|1
5804021|NCT02912455|20023606|P1|Overall Study|Lost to Follow-up|2
5804022|NCT02912455|20023605|P2|Overall Study|Lack of Efficacy|1
5804023|NCT02912455|20023606|P1|Overall Study|Lack of Efficacy|0
5804024|NCT02912455|20023605|P2|Overall Study|Withdrawal by Subject|1
5804025|NCT02912455|20023606|P1|Overall Study|Withdrawal by Subject|0
5804026|NCT02911948|20023701|P2|Overall Study|Unclassified|3
5804027|NCT02911948|20023702|P1|Overall Study|Unclassified|0
5804028|NCT02911948|20023701|P2|Overall Study|Lack of Efficacy|1
5804029|NCT02911948|20023702|P1|Overall Study|Lack of Efficacy|0
5804030|NCT02911948|20023701|P2|Overall Study|Withdrawal by Subject|2
5804031|NCT02911948|20023702|P1|Overall Study|Withdrawal by Subject|0
5804032|NCT02911948|20023701|P2|Overall Study|Protocol Violation|1
5804033|NCT02911948|20023702|P1|Overall Study|Protocol Violation|0
5804034|NCT02911688|20023964|P2|Washout|Withdrawal by Subject|1
5804035|NCT02911688|20023965|P1|Washout|Withdrawal by Subject|0
5804036|NCT02911688|20023964|P2|Washout|Lost to Follow-up|1
5804037|NCT02911688|20023965|P1|Washout|Lost to Follow-up|1
5804038|NCT02911519|20023989|P2|Overall Study|Death|2
5804039|NCT02911519|20023990|P1|Overall Study|Death|0
5804040|NCT02911519|20023989|P2|Overall Study|Lost to Follow-up|2
5804041|NCT02911519|20023990|P1|Overall Study|Lost to Follow-up|2
5804042|NCT02910739|20024022|P4|Overall Study|Adverse Event|0
5804043|NCT02910739|20024023|P3|Overall Study|Adverse Event|0
5804044|NCT02910739|20024024|P2|Overall Study|Adverse Event|0
5804045|NCT02910739|20024025|P1|Overall Study|Adverse Event|1
5804046|NCT02910713|20024051|P1|Overall Study|Investigator Discretion|1
5804047|NCT02910713|20024051|P1|Overall Study|Enrollment cap|7
5804048|NCT02910713|20024051|P1|Overall Study|Received Neither Application|18
5804049|NCT02910713|20024051|P1|Overall Study|Received One Application|10
5804050|NCT02910713|20024051|P1|Overall Study|Subject Choice|4
5804051|NCT02910713|20024051|P1|Overall Study|Protocol Violation|2
5804052|NCT02910167|20024067|P1|Overall Study|Lost to Follow-up|18
5804053|NCT02910167|20024067|P1|Overall Study|Adverse Event|1
5804054|NCT02910089|20024092|P2|Overall Study|Lost insurance eligibility|16
5804055|NCT02910089|20024093|P1|Overall Study|Lost insurance eligibility|22
5804056|NCT02910063|20024105|P3|Phase 2|Death|0
5804057|NCT02910063|20024106|P2|Phase 2|Death|0
5804058|NCT02910063|20024107|P1|Phase 2|Death|24
5804059|NCT02910063|20024105|P3|Phase 2|Lost to Follow-up|0
5804060|NCT02910063|20024106|P2|Phase 2|Lost to Follow-up|0
5804061|NCT02910063|20024107|P1|Phase 2|Lost to Follow-up|1
5804062|NCT02910063|20024105|P3|Phase 2|Withdrawal by Subject|0
5804063|NCT02910063|20024106|P2|Phase 2|Withdrawal by Subject|0
5804064|NCT02910063|20024107|P1|Phase 2|Withdrawal by Subject|3
5804065|NCT02910011|20024148|P1|Overall Study|Physician Decision|2
5804066|NCT02909907|20024257|P2|Overall Study|Withdrawal by Subject|1
5804067|NCT02909907|20024258|P1|Overall Study|Withdrawal by Subject|0
5804068|NCT02909504|20024299|P1|Overall Study|Lost to Follow-up|1
5804069|NCT02909504|20024299|P1|Overall Study|Subject moved|1
5804070|NCT02909504|20024299|P1|Overall Study|Pregnancy|1
5804071|NCT02909504|20024299|P1|Overall Study|Withdrawal by Subject|4
5804072|NCT02909504|20024299|P1|Overall Study|Lack of Efficacy|3
5804073|NCT02909504|20024299|P1|Overall Study|Adverse Event|2
5804074|NCT02909153|20024336|P5|Overall Study|Withdrawal by Subject|0
5804075|NCT02909153|20024337|P4|Overall Study|Withdrawal by Subject|0
5804076|NCT02909153|20024338|P3|Overall Study|Withdrawal by Subject|0
5804077|NCT02909153|20024339|P2|Overall Study|Withdrawal by Subject|1
5804078|NCT02909153|20024340|P1|Overall Study|Withdrawal by Subject|0
5804079|NCT02909101|20024430|P2|Overall Study|Lost to Follow-up|1
5804080|NCT02909101|20024431|P1|Overall Study|Lost to Follow-up|1
5804081|NCT02908880|20024449|P1|Overall Study|Death|5
5804082|NCT02908880|20024449|P1|Overall Study|Withdrawal by Subject|17
5804083|NCT02908880|20024449|P1|Overall Study|Explantation of the device|1
5804084|NCT02908880|20024449|P1|Overall Study|Lost to Follow-up|4
5804085|NCT02908841|20024459|P2|Overall Study|Physician Decision|0
5804086|NCT02908841|20024460|P1|Overall Study|Physician Decision|4
5804087|NCT02908672|20024478|P2|Overall Study|Discontinued the study during run-in|0
5804088|NCT02908672|20024479|P1|Overall Study|Discontinued the study during run-in|3
5804089|NCT02908672|20024478|P2|Overall Study|Study is ongoing|141
5804090|NCT02908672|20024479|P1|Overall Study|Study is ongoing|124
5804091|NCT02908672|20024478|P2|Overall Study|Withdrawal by Subject|18
5804092|NCT02908672|20024479|P1|Overall Study|Withdrawal by Subject|13
5804093|NCT02908672|20024478|P2|Overall Study|Protocol Violation|1
5804094|NCT02908672|20024479|P1|Overall Study|Protocol Violation|1
5804095|NCT02908672|20024478|P2|Overall Study|Other|0
5804096|NCT02908672|20024479|P1|Overall Study|Other|2
5804097|NCT02908672|20024478|P2|Overall Study|Lost to Follow-up|3
5804098|NCT02908672|20024479|P1|Overall Study|Lost to Follow-up|3
5804099|NCT02908672|20024478|P2|Overall Study|Death|93
5804100|NCT02908672|20024479|P1|Overall Study|Death|112
5804101|NCT02908529|20024552|P2|Overall Study|Lost to Follow-up|2
5804102|NCT02908529|20024553|P1|Overall Study|Lost to Follow-up|0
5804103|NCT02908516|20024563|P2|Overall Study|Study Terminated|3
5804104|NCT02908516|20024564|P1|Overall Study|Study Terminated|3
5804105|NCT02908464|20024580|P2|Overall Study|Found ineligible after randomization|2
5804106|NCT02908464|20024581|P1|Overall Study|Found ineligible after randomization|0
5804107|NCT02908464|20024580|P2|Overall Study|Withdrawal by Subject|1
5804108|NCT02908464|20024581|P1|Overall Study|Withdrawal by Subject|2
5804109|NCT02908347|20024602|P2|Overall Study|Lost to Follow-up|0
5804110|NCT02908347|20024603|P1|Overall Study|Lost to Follow-up|1
5804111|NCT02908347|20024602|P2|Overall Study|Adverse Event|1
5804112|NCT02908347|20024603|P1|Overall Study|Adverse Event|0
5804113|NCT02908100|20024699|P3|Overall Study|Randomised in Error|0
5804114|NCT02908100|20024700|P2|Overall Study|Randomised in Error|0
5804115|NCT02908100|20024701|P1|Overall Study|Randomised in Error|1
5804116|NCT02908100|20024699|P3|Overall Study|Withdrawal by Subject|5
5804117|NCT02908100|20024700|P2|Overall Study|Withdrawal by Subject|7
5804118|NCT02908100|20024701|P1|Overall Study|Withdrawal by Subject|8
5804119|NCT02908100|20024699|P3|Overall Study|Pregnancy|0
5804120|NCT02908100|20024700|P2|Overall Study|Pregnancy|2
5804121|NCT02908100|20024701|P1|Overall Study|Pregnancy|1
5804122|NCT02908100|20024699|P3|Overall Study|Physician Decision|0
5804123|NCT02908100|20024700|P2|Overall Study|Physician Decision|1
5804124|NCT02908100|20024701|P1|Overall Study|Physician Decision|0
5804125|NCT02908100|20024699|P3|Overall Study|Non-Compliance With Contraceptive Method|0
5804126|NCT02908100|20024700|P2|Overall Study|Non-Compliance With Contraceptive Method|0
5804127|NCT02908100|20024701|P1|Overall Study|Non-Compliance With Contraceptive Method|1
5804128|NCT02908100|20024699|P3|Overall Study|Non-Compliance With Study Drug|2
5804129|NCT02908100|20024700|P2|Overall Study|Non-Compliance With Study Drug|1
5804130|NCT02908100|20024701|P1|Overall Study|Non-Compliance With Study Drug|1
5804131|NCT02908100|20024699|P3|Overall Study|Lost to Follow-up|2
5804132|NCT02908100|20024700|P2|Overall Study|Lost to Follow-up|1
5804133|NCT02908100|20024701|P1|Overall Study|Lost to Follow-up|0
5804134|NCT02908100|20024699|P3|Overall Study|Lack of Efficacy|3
5804135|NCT02908100|20024700|P2|Overall Study|Lack of Efficacy|3
5804136|NCT02908100|20024701|P1|Overall Study|Lack of Efficacy|2
5804137|NCT02908100|20024699|P3|Overall Study|Death|0
5804138|NCT02908100|20024700|P2|Overall Study|Death|0
5804139|NCT02908100|20024701|P1|Overall Study|Death|2
5804140|NCT02908100|20024699|P3|Overall Study|Adverse Event|9
5804141|NCT02908100|20024700|P2|Overall Study|Adverse Event|6
5804142|NCT02908100|20024701|P1|Overall Study|Adverse Event|7
5804143|NCT02907892|20024737|P2|Overall Study|Lost to Follow-up|40
5804144|NCT02907892|20024738|P1|Overall Study|Lost to Follow-up|27
5804145|NCT02907619|20024758|P3|Overall Study|Other|0
5804146|NCT02907619|20024759|P2|Overall Study|Other|1
5804147|NCT02907619|20024760|P1|Overall Study|Other|0
5804148|NCT02907619|20024758|P3|Overall Study|Withdrawal by Subject|0
5804149|NCT02907619|20024759|P2|Overall Study|Withdrawal by Subject|1
5804150|NCT02907619|20024760|P1|Overall Study|Withdrawal by Subject|1
5804151|NCT02907619|20024758|P3|Overall Study|Death|1
5804152|NCT02907619|20024759|P2|Overall Study|Death|0
5804153|NCT02907619|20024760|P1|Overall Study|Death|0
5804154|NCT02907619|20024758|P3|Overall Study|Study terminated by sponsor|19
5804155|NCT02907619|20024759|P2|Overall Study|Study terminated by sponsor|18
5804156|NCT02907619|20024760|P1|Overall Study|Study terminated by sponsor|18
5804157|NCT02907463|20024976|P1|Overall Study|Missing Exit Form|1
5804158|NCT02907463|20024976|P1|Overall Study|Device Explanted|1
5804159|NCT02907463|20024976|P1|Overall Study|Not Implanted with Study Device|2
5804160|NCT02907463|20024976|P1|Overall Study|MIS Approach was not used|2
5804161|NCT02907463|20024976|P1|Overall Study|Withdrawal by Subject|4
5804162|NCT02907463|20024976|P1|Overall Study|Death|10
5804163|NCT02907463|20024976|P1|Overall Study|Lost to Follow-up|17
5804164|NCT02907216|20025058|P2|Overall Study|Withdrawal by Subject|0
5804165|NCT02907216|20025059|P1|Overall Study|Withdrawal by Subject|1
5804166|NCT02907216|20025058|P2|Overall Study|No benefit to be obtained by continuing|1
5804167|NCT02907216|20025059|P1|Overall Study|No benefit to be obtained by continuing|0
5804168|NCT02906930|20025111|P4|Overall Study|Other|2
5804169|NCT02906930|20025112|P3|Overall Study|Other|1
5804170|NCT02906930|20025113|P2|Overall Study|Other|2
5804171|NCT02906930|20025114|P1|Overall Study|Other|1
5804172|NCT02906930|20025111|P4|Overall Study|Death|0
5804173|NCT02906930|20025112|P3|Overall Study|Death|1
5804174|NCT02906930|20025113|P2|Overall Study|Death|0
5804175|NCT02906930|20025114|P1|Overall Study|Death|0
5804176|NCT02906930|20025111|P4|Overall Study|Lost to Follow-up|2
5804177|NCT02906930|20025112|P3|Overall Study|Lost to Follow-up|5
5804178|NCT02906930|20025113|P2|Overall Study|Lost to Follow-up|7
5804179|NCT02906930|20025114|P1|Overall Study|Lost to Follow-up|5
5804180|NCT02906930|20025111|P4|Overall Study|Withdrawal by Subject|4
5804181|NCT02906930|20025112|P3|Overall Study|Withdrawal by Subject|5
5804182|NCT02906930|20025113|P2|Overall Study|Withdrawal by Subject|5
5804183|NCT02906930|20025114|P1|Overall Study|Withdrawal by Subject|0
5804184|NCT02906917|20025307|P2|Intensification Period (Week 26-38)|Withdrawal by Subject|2
5804185|NCT02906917|20025308|P1|Intensification Period (Week 26-38)|Withdrawal by Subject|3
5804186|NCT02906917|20025307|P2|Intensification Period (Week 26-38)|Lost to Follow-up|1
5804187|NCT02906917|20025308|P1|Intensification Period (Week 26-38)|Lost to Follow-up|3
5804188|NCT02906917|20025307|P2|Intensification Period (Week 26-38)|Adverse Event|2
5804189|NCT02906917|20025308|P1|Intensification Period (Week 26-38)|Adverse Event|0
5804190|NCT02906917|20025307|P2|Intensification Period (Week 26-38)|Unclassified|2
5804191|NCT02906917|20025308|P1|Intensification Period (Week 26-38)|Unclassified|3
5804192|NCT02906917|20025307|P2|Initiation Period (Week 0-26)|Withdrawal by Subject|4
5804193|NCT02906917|20025308|P1|Initiation Period (Week 0-26)|Withdrawal by Subject|3
5804194|NCT02906917|20025307|P2|Initiation Period (Week 0-26)|Lost to Follow-up|4
5804195|NCT02906917|20025308|P1|Initiation Period (Week 0-26)|Lost to Follow-up|1
5804196|NCT02906917|20025307|P2|Initiation Period (Week 0-26)|Adverse Event|0
5804197|NCT02906917|20025308|P1|Initiation Period (Week 0-26)|Adverse Event|1
5804198|NCT02906917|20025307|P2|Initiation Period (Week 0-26)|Unclassified|3
5804199|NCT02906917|20025308|P1|Initiation Period (Week 0-26)|Unclassified|1
5804200|NCT02906709|20025369|P2|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|0
5804285|NCT02906670|20025431|P3|Cohort 5P, Q2W|Adverse Event|0
5804201|NCT02906709|20025370|P1|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|2
5804202|NCT02906709|20025369|P2|Phase B (Extension, Week 17 to Week 52)|Adverse Event|0
5804203|NCT02906709|20025370|P1|Phase B (Extension, Week 17 to Week 52)|Adverse Event|3
5804204|NCT02906709|20025369|P2|Phase A (Week 0 to Week 16)|Death|1
5804205|NCT02906709|20025370|P1|Phase A (Week 0 to Week 16)|Death|0
5804206|NCT02906709|20025369|P2|Phase A (Week 0 to Week 16)|Adverse Event|2
5804207|NCT02906709|20025370|P1|Phase A (Week 0 to Week 16)|Adverse Event|1
5804208|NCT02906670|20025424|P10|Cohort 5P, QW|Radiological Progression|0
5804209|NCT02906670|20025425|P9|Cohort 5P, QW|Radiological Progression|0
5804210|NCT02906670|20025426|P8|Cohort 5P, QW|Radiological Progression|0
5804211|NCT02906670|20025427|P7|Cohort 5P, QW|Radiological Progression|0
5804212|NCT02906670|20025428|P6|Cohort 5P, QW|Radiological Progression|0
5804213|NCT02906670|20025429|P5|Cohort 5P, QW|Radiological Progression|3
5804214|NCT02906670|20025430|P4|Cohort 5P, QW|Radiological Progression|0
5804215|NCT02906670|20025431|P3|Cohort 5P, QW|Radiological Progression|0
5804216|NCT02906670|20025432|P2|Cohort 5P, QW|Radiological Progression|0
5804217|NCT02906670|20025433|P1|Cohort 5P, QW|Radiological Progression|0
5804218|NCT02906670|20025424|P10|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|1
5804219|NCT02906670|20025425|P9|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0
5804220|NCT02906670|20025426|P8|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0
5804221|NCT02906670|20025427|P7|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0
5804222|NCT02906670|20025428|P6|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0
5804223|NCT02906670|20025429|P5|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0
5804224|NCT02906670|20025430|P4|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0
5804225|NCT02906670|20025431|P3|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0
5804226|NCT02906670|20025432|P2|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0
5804227|NCT02906670|20025433|P1|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0
5804228|NCT02906670|20025424|P10|Cohort 7P, Q2W|Physician Decision|1
5804229|NCT02906670|20025425|P9|Cohort 7P, Q2W|Physician Decision|0
5804230|NCT02906670|20025426|P8|Cohort 7P, Q2W|Physician Decision|0
5804231|NCT02906670|20025427|P7|Cohort 7P, Q2W|Physician Decision|0
5804232|NCT02906670|20025428|P6|Cohort 7P, Q2W|Physician Decision|0
5804233|NCT02906670|20025429|P5|Cohort 7P, Q2W|Physician Decision|0
5804234|NCT02906670|20025430|P4|Cohort 7P, Q2W|Physician Decision|0
5804235|NCT02906670|20025431|P3|Cohort 7P, Q2W|Physician Decision|0
5804236|NCT02906670|20025432|P2|Cohort 7P, Q2W|Physician Decision|0
5804237|NCT02906670|20025433|P1|Cohort 7P, Q2W|Physician Decision|0
5804238|NCT02906670|20025424|P10|Cohort 7P, Q2W|Adverse Event|1
5804239|NCT02906670|20025425|P9|Cohort 7P, Q2W|Adverse Event|0
5804240|NCT02906670|20025426|P8|Cohort 7P, Q2W|Adverse Event|0
5804241|NCT02906670|20025427|P7|Cohort 7P, Q2W|Adverse Event|0
5804242|NCT02906670|20025428|P6|Cohort 7P, Q2W|Adverse Event|0
5804243|NCT02906670|20025429|P5|Cohort 7P, Q2W|Adverse Event|0
5804244|NCT02906670|20025430|P4|Cohort 7P, Q2W|Adverse Event|0
5804245|NCT02906670|20025431|P3|Cohort 7P, Q2W|Adverse Event|0
5804246|NCT02906670|20025432|P2|Cohort 7P, Q2W|Adverse Event|0
5804247|NCT02906670|20025433|P1|Cohort 7P, Q2W|Adverse Event|0
5804248|NCT02906670|20025424|P10|Cohort 4P, QW|Radiological Progression|0
5804249|NCT02906670|20025425|P9|Cohort 4P, QW|Radiological Progression|0
5804250|NCT02906670|20025426|P8|Cohort 4P, QW|Radiological Progression|0
5804251|NCT02906670|20025427|P7|Cohort 4P, QW|Radiological Progression|0
5804252|NCT02906670|20025428|P6|Cohort 4P, QW|Radiological Progression|0
5804253|NCT02906670|20025429|P5|Cohort 4P, QW|Radiological Progression|0
5804254|NCT02906670|20025430|P4|Cohort 4P, QW|Radiological Progression|3
5804255|NCT02906670|20025431|P3|Cohort 4P, QW|Radiological Progression|0
5804256|NCT02906670|20025432|P2|Cohort 4P, QW|Radiological Progression|0
5804257|NCT02906670|20025433|P1|Cohort 4P, QW|Radiological Progression|0
5804258|NCT02906670|20025424|P10|Cohort 6P, Q2W|Clinical Progression|0
5804259|NCT02906670|20025425|P9|Cohort 6P, Q2W|Clinical Progression|3
5804260|NCT02906670|20025426|P8|Cohort 6P, Q2W|Clinical Progression|0
5804261|NCT02906670|20025427|P7|Cohort 6P, Q2W|Clinical Progression|0
5804262|NCT02906670|20025428|P6|Cohort 6P, Q2W|Clinical Progression|0
5804263|NCT02906670|20025429|P5|Cohort 6P, Q2W|Clinical Progression|0
5804264|NCT02906670|20025430|P4|Cohort 6P, Q2W|Clinical Progression|0
5804265|NCT02906670|20025431|P3|Cohort 6P, Q2W|Clinical Progression|0
5804266|NCT02906670|20025432|P2|Cohort 6P, Q2W|Clinical Progression|0
5804267|NCT02906670|20025433|P1|Cohort 6P, Q2W|Clinical Progression|0
5804268|NCT02906670|20025424|P10|Cohort 6P, Q2W|Radiological Progression|0
5804269|NCT02906670|20025425|P9|Cohort 6P, Q2W|Radiological Progression|1
5804270|NCT02906670|20025426|P8|Cohort 6P, Q2W|Radiological Progression|0
5804271|NCT02906670|20025427|P7|Cohort 6P, Q2W|Radiological Progression|0
5804272|NCT02906670|20025428|P6|Cohort 6P, Q2W|Radiological Progression|0
5804273|NCT02906670|20025429|P5|Cohort 6P, Q2W|Radiological Progression|0
5804274|NCT02906670|20025430|P4|Cohort 6P, Q2W|Radiological Progression|0
5804275|NCT02906670|20025431|P3|Cohort 6P, Q2W|Radiological Progression|0
5804276|NCT02906670|20025432|P2|Cohort 6P, Q2W|Radiological Progression|0
5804277|NCT02906670|20025433|P1|Cohort 6P, Q2W|Radiological Progression|0
5804278|NCT02906670|20025424|P10|Cohort 5P, Q2W|Adverse Event|0
5804279|NCT02906670|20025425|P9|Cohort 5P, Q2W|Adverse Event|0
5804280|NCT02906670|20025426|P8|Cohort 5P, Q2W|Adverse Event|1
5804281|NCT02906670|20025427|P7|Cohort 5P, Q2W|Adverse Event|0
5804282|NCT02906670|20025428|P6|Cohort 5P, Q2W|Adverse Event|0
5804283|NCT02906670|20025429|P5|Cohort 5P, Q2W|Adverse Event|0
5804284|NCT02906670|20025430|P4|Cohort 5P, Q2W|Adverse Event|0
5804286|NCT02906670|20025432|P2|Cohort 5P, Q2W|Adverse Event|0
5804287|NCT02906670|20025433|P1|Cohort 5P, Q2W|Adverse Event|0
5804288|NCT02906670|20025424|P10|Cohort 5P, Q2W|Radiological Progression|0
5804289|NCT02906670|20025425|P9|Cohort 5P, Q2W|Radiological Progression|0
5804290|NCT02906670|20025426|P8|Cohort 5P, Q2W|Radiological Progression|2
5804291|NCT02906670|20025427|P7|Cohort 5P, Q2W|Radiological Progression|0
5804292|NCT02906670|20025428|P6|Cohort 5P, Q2W|Radiological Progression|0
5804293|NCT02906670|20025429|P5|Cohort 5P, Q2W|Radiological Progression|0
5804294|NCT02906670|20025430|P4|Cohort 5P, Q2W|Radiological Progression|0
5804295|NCT02906670|20025431|P3|Cohort 5P, Q2W|Radiological Progression|0
5804296|NCT02906670|20025432|P2|Cohort 5P, Q2W|Radiological Progression|0
5804297|NCT02906670|20025433|P1|Cohort 5P, Q2W|Radiological Progression|0
5804298|NCT02906670|20025424|P10|Cohort 5, Q2W|Lack of Clinical Benefit|0
5804299|NCT02906670|20025425|P9|Cohort 5, Q2W|Lack of Clinical Benefit|0
5804300|NCT02906670|20025426|P8|Cohort 5, Q2W|Lack of Clinical Benefit|0
5804301|NCT02906670|20025427|P7|Cohort 5, Q2W|Lack of Clinical Benefit|1
5804302|NCT02906670|20025428|P6|Cohort 5, Q2W|Lack of Clinical Benefit|0
5804303|NCT02906670|20025429|P5|Cohort 5, Q2W|Lack of Clinical Benefit|0
5804304|NCT02906670|20025430|P4|Cohort 5, Q2W|Lack of Clinical Benefit|0
5804305|NCT02906670|20025431|P3|Cohort 5, Q2W|Lack of Clinical Benefit|0
5804306|NCT02906670|20025432|P2|Cohort 5, Q2W|Lack of Clinical Benefit|0
5804307|NCT02906670|20025433|P1|Cohort 5, Q2W|Lack of Clinical Benefit|0
5804308|NCT02906670|20025424|P10|Cohort 5, Q2W|Adverse Event|0
5804309|NCT02906670|20025425|P9|Cohort 5, Q2W|Adverse Event|0
5804310|NCT02906670|20025426|P8|Cohort 5, Q2W|Adverse Event|0
5804311|NCT02906670|20025427|P7|Cohort 5, Q2W|Adverse Event|1
5804312|NCT02906670|20025428|P6|Cohort 5, Q2W|Adverse Event|0
5804313|NCT02906670|20025429|P5|Cohort 5, Q2W|Adverse Event|0
5804314|NCT02906670|20025430|P4|Cohort 5, Q2W|Adverse Event|0
5804315|NCT02906670|20025431|P3|Cohort 5, Q2W|Adverse Event|0
5804316|NCT02906670|20025432|P2|Cohort 5, Q2W|Adverse Event|0
5804317|NCT02906670|20025433|P1|Cohort 5, Q2W|Adverse Event|0
5804318|NCT02906670|20025424|P10|Cohort 5, Q2W|Clinical Progression|0
5804319|NCT02906670|20025425|P9|Cohort 5, Q2W|Clinical Progression|0
5804320|NCT02906670|20025426|P8|Cohort 5, Q2W|Clinical Progression|0
5804321|NCT02906670|20025427|P7|Cohort 5, Q2W|Clinical Progression|1
5804322|NCT02906670|20025428|P6|Cohort 5, Q2W|Clinical Progression|0
5804323|NCT02906670|20025429|P5|Cohort 5, Q2W|Clinical Progression|0
5804324|NCT02906670|20025430|P4|Cohort 5, Q2W|Clinical Progression|0
5804325|NCT02906670|20025431|P3|Cohort 5, Q2W|Clinical Progression|0
5804326|NCT02906670|20025432|P2|Cohort 5, Q2W|Clinical Progression|0
5804327|NCT02906670|20025433|P1|Cohort 5, Q2W|Clinical Progression|0
5804328|NCT02906670|20025424|P10|Cohort 5, Q2W|Radiological Progression|0
5804329|NCT02906670|20025425|P9|Cohort 5, Q2W|Radiological Progression|0
5804330|NCT02906670|20025426|P8|Cohort 5, Q2W|Radiological Progression|0
5804331|NCT02906670|20025427|P7|Cohort 5, Q2W|Radiological Progression|4
5804332|NCT02906670|20025428|P6|Cohort 5, Q2W|Radiological Progression|0
5804333|NCT02906670|20025429|P5|Cohort 5, Q2W|Radiological Progression|0
5804334|NCT02906670|20025430|P4|Cohort 5, Q2W|Radiological Progression|0
5804335|NCT02906670|20025431|P3|Cohort 5, Q2W|Radiological Progression|0
5804336|NCT02906670|20025432|P2|Cohort 5, Q2W|Radiological Progression|0
5804337|NCT02906670|20025433|P1|Cohort 5, Q2W|Radiological Progression|0
5804338|NCT02906670|20025424|P10|Cohort 4, Q2W|Clinical Progression|0
5804339|NCT02906670|20025425|P9|Cohort 4, Q2W|Clinical Progression|0
5804340|NCT02906670|20025426|P8|Cohort 4, Q2W|Clinical Progression|0
5804341|NCT02906670|20025427|P7|Cohort 4, Q2W|Clinical Progression|0
5804342|NCT02906670|20025428|P6|Cohort 4, Q2W|Clinical Progression|2
5804343|NCT02906670|20025429|P5|Cohort 4, Q2W|Clinical Progression|0
5804344|NCT02906670|20025430|P4|Cohort 4, Q2W|Clinical Progression|0
5804345|NCT02906670|20025431|P3|Cohort 4, Q2W|Clinical Progression|0
5804346|NCT02906670|20025432|P2|Cohort 4, Q2W|Clinical Progression|0
5804347|NCT02906670|20025433|P1|Cohort 4, Q2W|Clinical Progression|0
5804348|NCT02906670|20025424|P10|Cohort 4, Q2W|Radiological Progression|0
5804349|NCT02906670|20025425|P9|Cohort 4, Q2W|Radiological Progression|0
5804350|NCT02906670|20025426|P8|Cohort 4, Q2W|Radiological Progression|0
5804351|NCT02906670|20025427|P7|Cohort 4, Q2W|Radiological Progression|0
5804352|NCT02906670|20025428|P6|Cohort 4, Q2W|Radiological Progression|1
5804353|NCT02906670|20025429|P5|Cohort 4, Q2W|Radiological Progression|0
5804354|NCT02906670|20025430|P4|Cohort 4, Q2W|Radiological Progression|0
5804355|NCT02906670|20025431|P3|Cohort 4, Q2W|Radiological Progression|0
5804356|NCT02906670|20025432|P2|Cohort 4, Q2W|Radiological Progression|0
5804357|NCT02906670|20025433|P1|Cohort 4, Q2W|Radiological Progression|0
5804358|NCT02906670|20025424|P10|Cohort 3, QW|Lack of Clinical Benefit|0
5804359|NCT02906670|20025425|P9|Cohort 3, QW|Lack of Clinical Benefit|0
5804360|NCT02906670|20025426|P8|Cohort 3, QW|Lack of Clinical Benefit|0
5804361|NCT02906670|20025427|P7|Cohort 3, QW|Lack of Clinical Benefit|0
5804362|NCT02906670|20025428|P6|Cohort 3, QW|Lack of Clinical Benefit|0
5804363|NCT02906670|20025429|P5|Cohort 3, QW|Lack of Clinical Benefit|0
5804364|NCT02906670|20025430|P4|Cohort 3, QW|Lack of Clinical Benefit|0
5804365|NCT02906670|20025431|P3|Cohort 3, QW|Lack of Clinical Benefit|2
5804366|NCT02906670|20025432|P2|Cohort 3, QW|Lack of Clinical Benefit|0
5804367|NCT02906670|20025433|P1|Cohort 3, QW|Lack of Clinical Benefit|0
5804368|NCT02906670|20025424|P10|Cohort 3, QW|Radiological Progression|0
5804369|NCT02906670|20025425|P9|Cohort 3, QW|Radiological Progression|0
5804370|NCT02906670|20025426|P8|Cohort 3, QW|Radiological Progression|0
5804371|NCT02906670|20025427|P7|Cohort 3, QW|Radiological Progression|0
5804372|NCT02906670|20025428|P6|Cohort 3, QW|Radiological Progression|0
5804373|NCT02906670|20025429|P5|Cohort 3, QW|Radiological Progression|0
5804374|NCT02906670|20025430|P4|Cohort 3, QW|Radiological Progression|0
5804375|NCT02906670|20025431|P3|Cohort 3, QW|Radiological Progression|2
5804376|NCT02906670|20025432|P2|Cohort 3, QW|Radiological Progression|0
5804377|NCT02906670|20025433|P1|Cohort 3, QW|Radiological Progression|0
5804378|NCT02906670|20025424|P10|Cohort 2, QW|Radiological Progression|0
5804379|NCT02906670|20025425|P9|Cohort 2, QW|Radiological Progression|0
5804380|NCT02906670|20025426|P8|Cohort 2, QW|Radiological Progression|0
5804381|NCT02906670|20025427|P7|Cohort 2, QW|Radiological Progression|0
5804382|NCT02906670|20025428|P6|Cohort 2, QW|Radiological Progression|0
5804383|NCT02906670|20025429|P5|Cohort 2, QW|Radiological Progression|0
5804384|NCT02906670|20025430|P4|Cohort 2, QW|Radiological Progression|0
5804385|NCT02906670|20025431|P3|Cohort 2, QW|Radiological Progression|0
5804386|NCT02906670|20025432|P2|Cohort 2, QW|Radiological Progression|1
5804387|NCT02906670|20025433|P1|Cohort 2, QW|Radiological Progression|0
5804388|NCT02906670|20025424|P10|Cohort 1, QW|Radiological Progression|0
5804389|NCT02906670|20025425|P9|Cohort 1, QW|Radiological Progression|0
5804390|NCT02906670|20025426|P8|Cohort 1, QW|Radiological Progression|0
5804391|NCT02906670|20025427|P7|Cohort 1, QW|Radiological Progression|0
5804392|NCT02906670|20025428|P6|Cohort 1, QW|Radiological Progression|0
5804393|NCT02906670|20025429|P5|Cohort 1, QW|Radiological Progression|0
5804394|NCT02906670|20025430|P4|Cohort 1, QW|Radiological Progression|0
5804395|NCT02906670|20025431|P3|Cohort 1, QW|Radiological Progression|0
5804396|NCT02906670|20025432|P2|Cohort 1, QW|Radiological Progression|0
5804397|NCT02906670|20025433|P1|Cohort 1, QW|Radiological Progression|1
5804398|NCT02906644|20025550|P2|Weeks 3 to 14|Lost to Follow-up|4
5804399|NCT02906644|20025551|P1|Weeks 3 to 14|Lost to Follow-up|3
5804400|NCT02906644|20025550|P2|Weeks 3 to 14|Withdrawal by Subject|7
5804401|NCT02906644|20025551|P1|Weeks 3 to 14|Withdrawal by Subject|13
5804402|NCT02906644|20025550|P2|First 2 Weeks|Physician Decision|1
5804403|NCT02906644|20025551|P1|First 2 Weeks|Physician Decision|1
5804404|NCT02906644|20025550|P2|First 2 Weeks|Withdrawal by Subject|2
5804405|NCT02906644|20025551|P1|First 2 Weeks|Withdrawal by Subject|0
5804406|NCT02906579|20025567|P1|Overall Study|Physician Decision|1
5804407|NCT02906579|20025567|P1|Overall Study|Adverse Event|1
5804408|NCT02906358|20025771|P2|Overall Study|Lost to Follow-up|15
5804409|NCT02906358|20025772|P1|Overall Study|Lost to Follow-up|12
5804410|NCT02906358|20025771|P2|Overall Study|Withdrawal by Subject|7
5804411|NCT02906358|20025772|P1|Overall Study|Withdrawal by Subject|10
5804412|NCT02905825|20025806|P1|Overall Study|Device Malfunction|1
5804413|NCT02905825|20025806|P1|Overall Study|Protocol Violation|11
5804414|NCT02905331|20025814|P3|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0
5804415|NCT02905331|20025815|P2|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|2
5804416|NCT02905331|20025816|P1|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0
5804417|NCT02905331|20025814|P3|Active Treatment and Follow up (wk16-40)|Other|0
5804418|NCT02905331|20025815|P2|Active Treatment and Follow up (wk16-40)|Other|6
5804419|NCT02905331|20025816|P1|Active Treatment and Follow up (wk16-40)|Other|0
5804420|NCT02905331|20025814|P3|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0
5804421|NCT02905331|20025815|P2|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|1
5804422|NCT02905331|20025816|P1|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0
5804423|NCT02905331|20025814|P3|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0
5804424|NCT02905331|20025815|P2|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0
5804425|NCT02905331|20025816|P1|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|2
5804426|NCT02905331|20025814|P3|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0
5804427|NCT02905331|20025815|P2|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0
5804428|NCT02905331|20025816|P1|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|1
5804429|NCT02905266|20025844|P2|Maintenance Phase Part 2|Maximum Clinical Benefit|2
5804430|NCT02905266|20025845|P1|Maintenance Phase Part 2|Maximum Clinical Benefit|0
5804431|NCT02905266|20025844|P2|Maintenance Phase Part 2|Study Drug Toxicity|4
5804432|NCT02905266|20025845|P1|Maintenance Phase Part 2|Study Drug Toxicity|3
5804433|NCT02905266|20025844|P2|Maintenance Phase Part 2|Disease Progression|2
5804434|NCT02905266|20025845|P1|Maintenance Phase Part 2|Disease Progression|9
5804435|NCT02905266|20025844|P2|Transition From Part 1 to Part 2|Adverse Event|1
5804436|NCT02905266|20025845|P1|Transition From Part 1 to Part 2|Adverse Event|1
5804437|NCT02905266|20025844|P2|Transition From Part 1 to Part 2|Participant withdrew consent|1
5804438|NCT02905266|20025845|P1|Transition From Part 1 to Part 2|Participant withdrew consent|0
5804439|NCT02905266|20025844|P2|Transition From Part 1 to Part 2|Death|1
5804440|NCT02905266|20025845|P1|Transition From Part 1 to Part 2|Death|0
5804441|NCT02905266|20025844|P2|Transition From Part 1 to Part 2|Study drug toxicity|4
5804442|NCT02905266|20025845|P1|Transition From Part 1 to Part 2|Study drug toxicity|0
5804443|NCT02905266|20025844|P2|Transition From Part 1 to Part 2|Disease progression|1
5804444|NCT02905266|20025845|P1|Transition From Part 1 to Part 2|Disease progression|2
5804445|NCT02905266|20025844|P2|Transition From Part 1 to Part 2|Adverse event unrelated to study drug|0
5804446|NCT02905266|20025845|P1|Transition From Part 1 to Part 2|Adverse event unrelated to study drug|1
5804447|NCT02905266|20025844|P2|Treatment Phase Part 1|Study Drug Toxicity|16
5804448|NCT02905266|20025845|P1|Treatment Phase Part 1|Study Drug Toxicity|22
5804449|NCT02905266|20025844|P2|Treatment Phase Part 1|Disease Progression|7
5804450|NCT02905266|20025845|P1|Treatment Phase Part 1|Disease Progression|6
5804451|NCT02905266|20025844|P2|Treatment Phase Part 1|Participant Withdrew Consent|0
5804452|NCT02905266|20025845|P1|Treatment Phase Part 1|Participant Withdrew Consent|1
5804453|NCT02905149|20025873|P2|Overall Study|Lost to Follow-up|0
5804454|NCT02905149|20025874|P1|Overall Study|Lost to Follow-up|2
5804455|NCT02905006|20025892|P6|Overall Study|Patient randomized by mistake|1
5804456|NCT02905006|20025893|P5|Overall Study|Patient randomized by mistake|0
5804457|NCT02905006|20025894|P4|Overall Study|Patient randomized by mistake|0
5804458|NCT02905006|20025895|P3|Overall Study|Patient randomized by mistake|0
5804459|NCT02905006|20025896|P2|Overall Study|Patient randomized by mistake|0
5804460|NCT02905006|20025897|P1|Overall Study|Patient randomized by mistake|0
5804461|NCT02905006|20025892|P6|Overall Study|Patient moved abroad|0
5804462|NCT02905006|20025893|P5|Overall Study|Patient moved abroad|0
5804463|NCT02905006|20025894|P4|Overall Study|Patient moved abroad|1
5804464|NCT02905006|20025895|P3|Overall Study|Patient moved abroad|0
5804465|NCT02905006|20025896|P2|Overall Study|Patient moved abroad|0
5804466|NCT02905006|20025897|P1|Overall Study|Patient moved abroad|0
5804467|NCT02905006|20025892|P6|Overall Study|Subject positive for Hep B|0
5804468|NCT02905006|20025893|P5|Overall Study|Subject positive for Hep B|0
5804469|NCT02905006|20025894|P4|Overall Study|Subject positive for Hep B|0
5804470|NCT02905006|20025895|P3|Overall Study|Subject positive for Hep B|1
5804471|NCT02905006|20025896|P2|Overall Study|Subject positive for Hep B|0
5804472|NCT02905006|20025897|P1|Overall Study|Subject positive for Hep B|0
5804473|NCT02905006|20025892|P6|Overall Study|Positive for Tuberculosis|0
5804474|NCT02905006|20025893|P5|Overall Study|Positive for Tuberculosis|0
5804475|NCT02905006|20025894|P4|Overall Study|Positive for Tuberculosis|0
5804476|NCT02905006|20025895|P3|Overall Study|Positive for Tuberculosis|0
5804477|NCT02905006|20025896|P2|Overall Study|Positive for Tuberculosis|1
5804478|NCT02905006|20025897|P1|Overall Study|Positive for Tuberculosis|0
5804479|NCT02905006|20025892|P6|Overall Study|Lab withdrawal criterion met|1
5804480|NCT02905006|20025893|P5|Overall Study|Lab withdrawal criterion met|2
5804481|NCT02905006|20025894|P4|Overall Study|Lab withdrawal criterion met|2
5804482|NCT02905006|20025895|P3|Overall Study|Lab withdrawal criterion met|2
5804483|NCT02905006|20025896|P2|Overall Study|Lab withdrawal criterion met|1
5804484|NCT02905006|20025897|P1|Overall Study|Lab withdrawal criterion met|0
5804485|NCT02905006|20025892|P6|Overall Study|Screening exclusion criteria met|0
5804486|NCT02905006|20025893|P5|Overall Study|Screening exclusion criteria met|0
5804487|NCT02905006|20025894|P4|Overall Study|Screening exclusion criteria met|0
5804488|NCT02905006|20025895|P3|Overall Study|Screening exclusion criteria met|0
5804489|NCT02905006|20025896|P2|Overall Study|Screening exclusion criteria met|0
5804490|NCT02905006|20025897|P1|Overall Study|Screening exclusion criteria met|1
5804491|NCT02905006|20025892|P6|Overall Study|Withdrawal by Subject|1
5804492|NCT02905006|20025893|P5|Overall Study|Withdrawal by Subject|0
5804493|NCT02905006|20025894|P4|Overall Study|Withdrawal by Subject|1
5804494|NCT02905006|20025895|P3|Overall Study|Withdrawal by Subject|1
5804495|NCT02905006|20025896|P2|Overall Study|Withdrawal by Subject|0
5804496|NCT02905006|20025897|P1|Overall Study|Withdrawal by Subject|0
5804497|NCT02905006|20025892|P6|Overall Study|Lost to Follow-up|0
5804498|NCT02905006|20025893|P5|Overall Study|Lost to Follow-up|1
5804499|NCT02905006|20025894|P4|Overall Study|Lost to Follow-up|1
5804500|NCT02905006|20025895|P3|Overall Study|Lost to Follow-up|0
5804501|NCT02905006|20025896|P2|Overall Study|Lost to Follow-up|0
5804502|NCT02905006|20025897|P1|Overall Study|Lost to Follow-up|0
5804503|NCT02905006|20025892|P6|Overall Study|Protocol Violation|0
5804504|NCT02905006|20025893|P5|Overall Study|Protocol Violation|0
5804505|NCT02905006|20025894|P4|Overall Study|Protocol Violation|0
5804506|NCT02905006|20025895|P3|Overall Study|Protocol Violation|0
5804507|NCT02905006|20025896|P2|Overall Study|Protocol Violation|0
5804508|NCT02905006|20025897|P1|Overall Study|Protocol Violation|2
5804509|NCT02905006|20025892|P6|Overall Study|Lack of Efficacy|0
5804510|NCT02905006|20025893|P5|Overall Study|Lack of Efficacy|0
5804511|NCT02905006|20025894|P4|Overall Study|Lack of Efficacy|0
5804512|NCT02905006|20025895|P3|Overall Study|Lack of Efficacy|0
5804513|NCT02905006|20025896|P2|Overall Study|Lack of Efficacy|0
5804514|NCT02905006|20025897|P1|Overall Study|Lack of Efficacy|1
5804515|NCT02905006|20025892|P6|Overall Study|Adverse Event|1
5804516|NCT02905006|20025893|P5|Overall Study|Adverse Event|0
5804517|NCT02905006|20025894|P4|Overall Study|Adverse Event|1
5804518|NCT02905006|20025895|P3|Overall Study|Adverse Event|1
5804519|NCT02905006|20025896|P2|Overall Study|Adverse Event|1
5804520|NCT02905006|20025897|P1|Overall Study|Adverse Event|1
5804521|NCT02904902|20026124|P1|Overall Study|Withdrawal by Subject|1
5804522|NCT02904265|20026137|P2|Overall Study|Physician Decision|2
5804523|NCT02904265|20026138|P1|Overall Study|Physician Decision|1
5804524|NCT02904096|20026146|P2|Overall Study|Sponsor instructed|0
5804525|NCT02904096|20026147|P1|Overall Study|Sponsor instructed|1
5804526|NCT02904096|20026146|P2|Overall Study|Non-compliant|1
5804527|NCT02904096|20026147|P1|Overall Study|Non-compliant|3
5804528|NCT02904096|20026146|P2|Overall Study|Lost to Follow-up|17
5804529|NCT02904096|20026147|P1|Overall Study|Lost to Follow-up|10
5804530|NCT02904096|20026146|P2|Overall Study|Withdrawal by Subject|3
5804531|NCT02904096|20026147|P1|Overall Study|Withdrawal by Subject|4
5804532|NCT02904096|20026146|P2|Overall Study|Adverse Event|0
5804533|NCT02904096|20026147|P1|Overall Study|Adverse Event|1
5804534|NCT02903966|20026183|P2|Part B (Day 44 to 112)|Withdrawal by Subject|1
5804535|NCT02903966|20026184|P1|Part B (Day 44 to 112)|Withdrawal by Subject|0
5804536|NCT02903966|20026183|P2|Part B (Day 44 to 112)|Lack of Efficacy|1
5804537|NCT02903966|20026184|P1|Part B (Day 44 to 112)|Lack of Efficacy|0
5804538|NCT02903966|20026183|P2|Part A (Day 1 to 43)|Adverse Event|0
5804539|NCT02903966|20026184|P1|Part A (Day 1 to 43)|Adverse Event|1
5804540|NCT02903420|20026266|P1|Overall Study|Death|3
5804541|NCT02903238|20026318|P1|Overall Study|Lost to Follow-up|4
5804542|NCT02903030|20026344|P2|First Intervention (8 Weeks)|Withdrawal by Subject|1
5804543|NCT02903030|20026345|P1|First Intervention (8 Weeks)|Withdrawal by Subject|2
5804544|NCT02902965|20026363|P1|Overall Study|Withdrawal by Subject|10
5804545|NCT02902809|20026381|P1|Overall Study|Discontinuation of asthma program|28
5804546|NCT02901054|20026473|P1|Overall Study|Withdrawal by Subject|3
5804547|NCT02901054|20026473|P1|Overall Study|Physician Decision|1
5804548|NCT02900378|20026488|P2|Randomization (Visit 2)|Withdrawal of Informed Consent|2
5804549|NCT02900378|20026489|P1|Randomization (Visit 2)|Withdrawal of Informed Consent|0
5804550|NCT02900378|20026488|P2|Randomization (Visit 2)|Withdrawal by Parent/Guardian|3
5804551|NCT02900378|20026489|P1|Randomization (Visit 2)|Withdrawal by Parent/Guardian|5
5804552|NCT02900378|20026488|P2|Randomization (Visit 2)|Protocol Deviation|7
5804553|NCT02900378|20026489|P1|Randomization (Visit 2)|Protocol Deviation|1
5804554|NCT02900378|20026488|P2|Randomization (Visit 2)|Non-compliance with Study Drug|1
5804555|NCT02900378|20026489|P1|Randomization (Visit 2)|Non-compliance with Study Drug|1
5804556|NCT02900378|20026488|P2|Randomization (Visit 2)|Lost to Follow-up|0
5804557|NCT02900378|20026489|P1|Randomization (Visit 2)|Lost to Follow-up|1
5804558|NCT02900378|20026488|P2|Randomization (Visit 2)|Death|4
5804559|NCT02900378|20026489|P1|Randomization (Visit 2)|Death|1
5804560|NCT02900378|20026488|P2|Randomization (Visit 2)|Adverse Event|11
5804561|NCT02900378|20026489|P1|Randomization (Visit 2)|Adverse Event|14
5804562|NCT02900170|20026533|P1|Overall Study|Lost to Follow-up|8
5804563|NCT02900092|20026537|P1|Overall Study|Adverse Event|1
5804564|NCT02899988|20026545|P11|Maintenance Period (88 Weeks)|Withdrawal by Subject|1
5804565|NCT02899988|20026546|P10|Maintenance Period (88 Weeks)|Withdrawal by Subject|0
5804566|NCT02899988|20026547|P9|Maintenance Period (88 Weeks)|Withdrawal by Subject|2
5804567|NCT02899988|20026548|P8|Maintenance Period (88 Weeks)|Withdrawal by Subject|2
5804568|NCT02899988|20026549|P7|Maintenance Period (88 Weeks)|Withdrawal by Subject|3
5804569|NCT02899988|20026550|P6|Maintenance Period (88 Weeks)|Withdrawal by Subject|0
5804570|NCT02899988|20026551|P5|Maintenance Period (88 Weeks)|Withdrawal by Subject|1
5804571|NCT02899988|20026552|P4|Maintenance Period (88 Weeks)|Withdrawal by Subject|0
5804572|NCT02899988|20026553|P3|Maintenance Period (88 Weeks)|Withdrawal by Subject|0
5804573|NCT02899988|20026554|P2|Maintenance Period (88 Weeks)|Withdrawal by Subject|0
5804574|NCT02899988|20026555|P1|Maintenance Period (88 Weeks)|Withdrawal by Subject|0
5804575|NCT02899988|20026545|P11|Maintenance Period (88 Weeks)|Lost to Follow-up|0
5804576|NCT02899988|20026546|P10|Maintenance Period (88 Weeks)|Lost to Follow-up|0
5804577|NCT02899988|20026547|P9|Maintenance Period (88 Weeks)|Lost to Follow-up|0
5804578|NCT02899988|20026548|P8|Maintenance Period (88 Weeks)|Lost to Follow-up|1
5804579|NCT02899988|20026549|P7|Maintenance Period (88 Weeks)|Lost to Follow-up|0
5804580|NCT02899988|20026550|P6|Maintenance Period (88 Weeks)|Lost to Follow-up|1
5804581|NCT02899988|20026551|P5|Maintenance Period (88 Weeks)|Lost to Follow-up|0
5804582|NCT02899988|20026552|P4|Maintenance Period (88 Weeks)|Lost to Follow-up|0
5804583|NCT02899988|20026553|P3|Maintenance Period (88 Weeks)|Lost to Follow-up|0
5804584|NCT02899988|20026554|P2|Maintenance Period (88 Weeks)|Lost to Follow-up|0
5804585|NCT02899988|20026555|P1|Maintenance Period (88 Weeks)|Lost to Follow-up|0
5804586|NCT02899988|20026545|P11|Maintenance Period (88 Weeks)|Adverse Event|1
5804587|NCT02899988|20026546|P10|Maintenance Period (88 Weeks)|Adverse Event|2
5804588|NCT02899988|20026547|P9|Maintenance Period (88 Weeks)|Adverse Event|2
5804589|NCT02899988|20026548|P8|Maintenance Period (88 Weeks)|Adverse Event|2
5804590|NCT02899988|20026549|P7|Maintenance Period (88 Weeks)|Adverse Event|1
5804591|NCT02899988|20026550|P6|Maintenance Period (88 Weeks)|Adverse Event|2
5804592|NCT02899988|20026551|P5|Maintenance Period (88 Weeks)|Adverse Event|1
5804593|NCT02899988|20026552|P4|Maintenance Period (88 Weeks)|Adverse Event|0
5804594|NCT02899988|20026553|P3|Maintenance Period (88 Weeks)|Adverse Event|0
5804595|NCT02899988|20026554|P2|Maintenance Period (88 Weeks)|Adverse Event|0
5804596|NCT02899988|20026555|P1|Maintenance Period (88 Weeks)|Adverse Event|0
5804597|NCT02899988|20026545|P11|Induction Period (16 Weeks)|Physician Decision|0
5804598|NCT02899988|20026546|P10|Induction Period (16 Weeks)|Physician Decision|0
5804599|NCT02899988|20026547|P9|Induction Period (16 Weeks)|Physician Decision|0
5804600|NCT02899988|20026548|P8|Induction Period (16 Weeks)|Physician Decision|0
5804601|NCT02899988|20026549|P7|Induction Period (16 Weeks)|Physician Decision|0
5804602|NCT02899988|20026550|P6|Induction Period (16 Weeks)|Physician Decision|0
5804603|NCT02899988|20026551|P5|Induction Period (16 Weeks)|Physician Decision|0
5804604|NCT02899988|20026552|P4|Induction Period (16 Weeks)|Physician Decision|0
5804605|NCT02899988|20026553|P3|Induction Period (16 Weeks)|Physician Decision|0
5804606|NCT02899988|20026554|P2|Induction Period (16 Weeks)|Physician Decision|1
5804607|NCT02899988|20026555|P1|Induction Period (16 Weeks)|Physician Decision|0
5804608|NCT02899988|20026545|P11|Induction Period (16 Weeks)|Adverse Event|0
5804609|NCT02899988|20026546|P10|Induction Period (16 Weeks)|Adverse Event|0
5804610|NCT02899988|20026547|P9|Induction Period (16 Weeks)|Adverse Event|0
5804611|NCT02899988|20026548|P8|Induction Period (16 Weeks)|Adverse Event|0
5804612|NCT02899988|20026549|P7|Induction Period (16 Weeks)|Adverse Event|0
5804613|NCT02899988|20026550|P6|Induction Period (16 Weeks)|Adverse Event|0
5804614|NCT02899988|20026551|P5|Induction Period (16 Weeks)|Adverse Event|0
5804615|NCT02899988|20026552|P4|Induction Period (16 Weeks)|Adverse Event|2
5804616|NCT02899988|20026553|P3|Induction Period (16 Weeks)|Adverse Event|0
5804617|NCT02899988|20026554|P2|Induction Period (16 Weeks)|Adverse Event|0
5804618|NCT02899988|20026555|P1|Induction Period (16 Weeks)|Adverse Event|0
5804619|NCT02899988|20026545|P11|Induction Period (16 Weeks)|Withdrawal by Subject|0
5804620|NCT02899988|20026546|P10|Induction Period (16 Weeks)|Withdrawal by Subject|0
5804621|NCT02899988|20026547|P9|Induction Period (16 Weeks)|Withdrawal by Subject|0
5804622|NCT02899988|20026548|P8|Induction Period (16 Weeks)|Withdrawal by Subject|0
5804623|NCT02899988|20026549|P7|Induction Period (16 Weeks)|Withdrawal by Subject|0
5804624|NCT02899988|20026550|P6|Induction Period (16 Weeks)|Withdrawal by Subject|0
5804625|NCT02899988|20026551|P5|Induction Period (16 Weeks)|Withdrawal by Subject|0
5804626|NCT02899988|20026552|P4|Induction Period (16 Weeks)|Withdrawal by Subject|0
5804627|NCT02899988|20026553|P3|Induction Period (16 Weeks)|Withdrawal by Subject|0
5804628|NCT02899988|20026554|P2|Induction Period (16 Weeks)|Withdrawal by Subject|1
5804629|NCT02899988|20026555|P1|Induction Period (16 Weeks)|Withdrawal by Subject|2
5804630|NCT02899962|20026614|P3|Maintenance Phase|Withdrawal by Subject|36
5804631|NCT02899962|20026615|P2|Maintenance Phase|Withdrawal by Subject|30
5804632|NCT02899962|20026616|P1|Maintenance Phase|Withdrawal by Subject|0
5804633|NCT02899962|20026614|P3|Maintenance Phase|Not clear/almost clear after rescue med|70
5804634|NCT02899962|20026615|P2|Maintenance Phase|Not clear/almost clear after rescue med|65
5804635|NCT02899962|20026616|P1|Maintenance Phase|Not clear/almost clear after rescue med|0
5804636|NCT02899962|20026614|P3|Maintenance Phase|Not achieve treatment success after Wk 4|2
5804637|NCT02899962|20026615|P2|Maintenance Phase|Not achieve treatment success after Wk 4|3
5804638|NCT02899962|20026616|P1|Maintenance Phase|Not achieve treatment success after Wk 4|0
5804639|NCT02899962|20026614|P3|Maintenance Phase|Other reasons|13
5804640|NCT02899962|20026615|P2|Maintenance Phase|Other reasons|9
5804641|NCT02899962|20026616|P1|Maintenance Phase|Other reasons|0
5804642|NCT02899962|20026614|P3|Maintenance Phase|Lost to Follow-up|14
5804643|NCT02899962|20026615|P2|Maintenance Phase|Lost to Follow-up|12
5804644|NCT02899962|20026616|P1|Maintenance Phase|Lost to Follow-up|0
5804645|NCT02899962|20026614|P3|Maintenance Phase|Lack of Efficacy|16
5804646|NCT02899962|20026615|P2|Maintenance Phase|Lack of Efficacy|20
5804647|NCT02899962|20026616|P1|Maintenance Phase|Lack of Efficacy|0
5804648|NCT02899962|20026614|P3|Maintenance Phase|Death|1
5804649|NCT02899962|20026615|P2|Maintenance Phase|Death|0
5804650|NCT02899962|20026616|P1|Maintenance Phase|Death|0
5804651|NCT02899962|20026614|P3|Maintenance Phase|Adverse Event|1
5804652|NCT02899962|20026615|P2|Maintenance Phase|Adverse Event|2
5804653|NCT02899962|20026616|P1|Maintenance Phase|Adverse Event|0
5804654|NCT02899962|20026614|P3|Open-label Phase|Withdrawal by Subject|0
5804655|NCT02899962|20026615|P2|Open-label Phase|Withdrawal by Subject|0
5804656|NCT02899962|20026616|P1|Open-label Phase|Withdrawal by Subject|7
5804657|NCT02899962|20026614|P3|Open-label Phase|Other reasons|0
5804658|NCT02899962|20026615|P2|Open-label Phase|Other reasons|0
5804659|NCT02899962|20026616|P1|Open-label Phase|Other reasons|9
5804660|NCT02899962|20026614|P3|Open-label Phase|Lost to Follow-up|0
5804661|NCT02899962|20026615|P2|Open-label Phase|Lost to Follow-up|0
5804662|NCT02899962|20026616|P1|Open-label Phase|Lost to Follow-up|9
5804663|NCT02899962|20026614|P3|Open-label Phase|Adverse Event|0
5804664|NCT02899962|20026615|P2|Open-label Phase|Adverse Event|0
5804665|NCT02899962|20026616|P1|Open-label Phase|Adverse Event|2
5804666|NCT02899377|20026684|P2|Overall Study|Adverse Event|0
5804667|NCT02899377|20026685|P1|Overall Study|Adverse Event|1
5804668|NCT02899338|20026718|P2|Overall Study|Withdrawal by Subject|0
5804669|NCT02899338|20026719|P1|Overall Study|Withdrawal by Subject|2
5804670|NCT02899338|20026718|P2|Overall Study|Adverse Event|2
5804671|NCT02899338|20026719|P1|Overall Study|Adverse Event|1
5804672|NCT02899156|20026733|P2|Overall Study|Physician Decision|1
5804673|NCT02899156|20026734|P1|Overall Study|Physician Decision|0
5804674|NCT02899156|20026733|P2|Overall Study|Death|0
5804675|NCT02899156|20026734|P1|Overall Study|Death|1
5804676|NCT02898662|20026776|P2|Overall Study|Other|1
5804677|NCT02898662|20026777|P1|Overall Study|Other|0
5804678|NCT02898662|20026776|P2|Overall Study|Subject decision|0
5804679|NCT02898662|20026777|P1|Overall Study|Subject decision|1
5804680|NCT02898662|20026776|P2|Overall Study|Randomized in error|1
5804681|NCT02898662|20026777|P1|Overall Study|Randomized in error|0
5804682|NCT02898662|20026776|P2|Overall Study|Technical issue|1
5804683|NCT02898662|20026777|P1|Overall Study|Technical issue|0
5804684|NCT02898662|20026776|P2|Overall Study|Withdrawal by Subject|1
5804685|NCT02898662|20026777|P1|Overall Study|Withdrawal by Subject|4
5804686|NCT02898662|20026776|P2|Overall Study|Loss of asthma control|24
5804687|NCT02898662|20026777|P1|Overall Study|Loss of asthma control|23
5804688|NCT02898662|20026776|P2|Overall Study|Adverse Event|0
5804689|NCT02898662|20026777|P1|Overall Study|Adverse Event|1
5804690|NCT02898597|20026801|P2|Overall Study|Death|1
5804691|NCT02898597|20026802|P1|Overall Study|Death|0
5804692|NCT02898597|20026801|P2|Overall Study|Lost to Follow-up|9
5804693|NCT02898597|20026802|P1|Overall Study|Lost to Follow-up|0
5804694|NCT02898597|20026801|P2|Overall Study|Protocol Violation|2
5804695|NCT02898597|20026802|P1|Overall Study|Protocol Violation|4
5804696|NCT02898454|20026811|P3|Overall Study|Did Not Met Eligibility Criteria|0
5804697|NCT02898454|20026812|P2|Overall Study|Did Not Met Eligibility Criteria|0
5804698|NCT02898454|20026813|P1|Overall Study|Did Not Met Eligibility Criteria|1
5804699|NCT02898454|20026811|P3|Overall Study|Lost to Follow-up|0
5804700|NCT02898454|20026812|P2|Overall Study|Lost to Follow-up|0
5804701|NCT02898454|20026813|P1|Overall Study|Lost to Follow-up|1
5804702|NCT02898454|20026811|P3|Overall Study|Withdrawal by Subject|3
5804703|NCT02898454|20026812|P2|Overall Study|Withdrawal by Subject|3
5804704|NCT02898454|20026813|P1|Overall Study|Withdrawal by Subject|6
5804705|NCT02898454|20026811|P3|Overall Study|Lack of Efficacy|0
5804706|NCT02898454|20026812|P2|Overall Study|Lack of Efficacy|1
5804707|NCT02898454|20026813|P1|Overall Study|Lack of Efficacy|4
5804708|NCT02898454|20026811|P3|Overall Study|Protocol Violation|1
5804709|NCT02898454|20026812|P2|Overall Study|Protocol Violation|0
5804710|NCT02898454|20026813|P1|Overall Study|Protocol Violation|1
5804711|NCT02898454|20026811|P3|Overall Study|Adverse Event|2
5804712|NCT02898454|20026812|P2|Overall Study|Adverse Event|1
5804713|NCT02898454|20026813|P1|Overall Study|Adverse Event|4
5804714|NCT02898259|20026931|P5|Overall Study|Transformation before study began|0
5804715|NCT02898259|20026932|P4|Overall Study|Transformation before study began|1
5804716|NCT02898259|20026933|P3|Overall Study|Transformation before study began|0
5804717|NCT02898259|20026934|P2|Overall Study|Transformation before study began|0
5804718|NCT02898259|20026935|P1|Overall Study|Transformation before study began|0
5804719|NCT02898259|20026931|P5|Overall Study|Lost to Follow-up|0
5804720|NCT02898259|20026932|P4|Overall Study|Lost to Follow-up|0
5804721|NCT02898259|20026933|P3|Overall Study|Lost to Follow-up|1
5804722|NCT02898259|20026934|P2|Overall Study|Lost to Follow-up|0
5804723|NCT02898259|20026935|P1|Overall Study|Lost to Follow-up|0
5804724|NCT02898259|20026931|P5|Overall Study|Lack of Efficacy|0
5804725|NCT02898259|20026932|P4|Overall Study|Lack of Efficacy|0
5804726|NCT02898259|20026933|P3|Overall Study|Lack of Efficacy|3
5804727|NCT02898259|20026934|P2|Overall Study|Lack of Efficacy|1
5804728|NCT02898259|20026935|P1|Overall Study|Lack of Efficacy|1
5804729|NCT02898259|20026931|P5|Overall Study|Adverse Event|0
5804730|NCT02898259|20026932|P4|Overall Study|Adverse Event|0
5804731|NCT02898259|20026933|P3|Overall Study|Adverse Event|1
5804732|NCT02898259|20026934|P2|Overall Study|Adverse Event|0
5804733|NCT02898259|20026935|P1|Overall Study|Adverse Event|0
5804734|NCT02898116|20026943|P1|Overall Study|Progressive disease|1
5804735|NCT02898116|20026943|P1|Overall Study|Adverse Event|1
5804736|NCT02897349|20026951|P2|Overall Study|Other than listed above|1
5804737|NCT02897349|20026952|P1|Overall Study|Other than listed above|0
5804738|NCT02897349|20026951|P2|Overall Study|Adverse Event|3
5804739|NCT02897349|20026952|P1|Overall Study|Adverse Event|3
5804740|NCT02897349|20026951|P2|Overall Study|Lost to Follow-up|2
5804741|NCT02897349|20026952|P1|Overall Study|Lost to Follow-up|2
5804742|NCT02897115|20026994|P2|Overall Study|Early termination of study by sponsor|8
5804743|NCT02897115|20026995|P1|Overall Study|Early termination of study by sponsor|11
5804744|NCT02896855|20027072|P2|Overall Study|Withdrawal by Subject|1
5804745|NCT02896855|20027073|P1|Overall Study|Withdrawal by Subject|1
5804746|NCT02896855|20027072|P2|Overall Study|Lost to Follow-up|0
5804747|NCT02896855|20027073|P1|Overall Study|Lost to Follow-up|5
5804748|NCT02896855|20027072|P2|Overall Study|Death|12
5804749|NCT02896855|20027073|P1|Overall Study|Death|13
5804750|NCT02896855|20027072|P2|Overall Study|In Follow-Up|49
5804751|NCT02896855|20027073|P1|Overall Study|In Follow-Up|61
5804752|NCT02896855|20027072|P2|Overall Study|On Study Treatment|60
5804753|NCT02896855|20027073|P1|Overall Study|On Study Treatment|41
5804754|NCT02896569|20027156|P2|Overall Study|Withdrawal by Subject|0
5804755|NCT02896569|20027157|P1|Overall Study|Withdrawal by Subject|1
5804756|NCT02896569|20027156|P2|Overall Study|Adverse Event|1
5804757|NCT02896569|20027157|P1|Overall Study|Adverse Event|0
5804758|NCT02896569|20027156|P2|Overall Study|Physician Decision|3
5804759|NCT02896569|20027157|P1|Overall Study|Physician Decision|1
5804760|NCT02896569|20027156|P2|Overall Study|Lost to Follow-up|1
5804761|NCT02896569|20027157|P1|Overall Study|Lost to Follow-up|2
5804762|NCT02896400|20027191|P16|Biochemical Verification at 3 Months|participant was not eligible for biochem|56
5804763|NCT02896400|20027192|P15|Biochemical Verification at 3 Months|participant was not eligible for biochem|52
5804764|NCT02896400|20027193|P14|Biochemical Verification at 3 Months|participant was not eligible for biochem|48
5804765|NCT02896400|20027194|P13|Biochemical Verification at 3 Months|participant was not eligible for biochem|52
5804766|NCT02896400|20027195|P12|Biochemical Verification at 3 Months|participant was not eligible for biochem|41
5804767|NCT02896400|20027196|P11|Biochemical Verification at 3 Months|participant was not eligible for biochem|55
5804768|NCT02896400|20027197|P10|Biochemical Verification at 3 Months|participant was not eligible for biochem|52
5804769|NCT02896400|20027198|P9|Biochemical Verification at 3 Months|participant was not eligible for biochem|44
5804770|NCT02896400|20027199|P8|Biochemical Verification at 3 Months|participant was not eligible for biochem|47
5804771|NCT02896400|20027200|P7|Biochemical Verification at 3 Months|participant was not eligible for biochem|48
5804772|NCT02896400|20027201|P6|Biochemical Verification at 3 Months|participant was not eligible for biochem|48
5804773|NCT02896400|20027202|P5|Biochemical Verification at 3 Months|participant was not eligible for biochem|45
5804774|NCT02896400|20027203|P4|Biochemical Verification at 3 Months|participant was not eligible for biochem|40
5804775|NCT02896400|20027204|P3|Biochemical Verification at 3 Months|participant was not eligible for biochem|46
5804776|NCT02896400|20027205|P2|Biochemical Verification at 3 Months|participant was not eligible for biochem|48
5804777|NCT02896400|20027206|P1|Biochemical Verification at 3 Months|participant was not eligible for biochem|45
5804778|NCT02896400|20027191|P16|Biochemical Verification at 3 Months|Lost to Follow-up|1
5804779|NCT02896400|20027192|P15|Biochemical Verification at 3 Months|Lost to Follow-up|3
5804780|NCT02896400|20027193|P14|Biochemical Verification at 3 Months|Lost to Follow-up|0
5804781|NCT02896400|20027194|P13|Biochemical Verification at 3 Months|Lost to Follow-up|1
5804782|NCT02896400|20027195|P12|Biochemical Verification at 3 Months|Lost to Follow-up|0
5804783|NCT02896400|20027196|P11|Biochemical Verification at 3 Months|Lost to Follow-up|0
5804784|NCT02896400|20027197|P10|Biochemical Verification at 3 Months|Lost to Follow-up|1
5804785|NCT02896400|20027198|P9|Biochemical Verification at 3 Months|Lost to Follow-up|1
5804786|NCT02896400|20027199|P8|Biochemical Verification at 3 Months|Lost to Follow-up|2
5804787|NCT02896400|20027200|P7|Biochemical Verification at 3 Months|Lost to Follow-up|3
5804788|NCT02896400|20027201|P6|Biochemical Verification at 3 Months|Lost to Follow-up|1
5804789|NCT02896400|20027202|P5|Biochemical Verification at 3 Months|Lost to Follow-up|0
5804790|NCT02896400|20027203|P4|Biochemical Verification at 3 Months|Lost to Follow-up|1
5804791|NCT02896400|20027204|P3|Biochemical Verification at 3 Months|Lost to Follow-up|1
5804792|NCT02896400|20027205|P2|Biochemical Verification at 3 Months|Lost to Follow-up|0
5804793|NCT02896400|20027206|P1|Biochemical Verification at 3 Months|Lost to Follow-up|1
5804794|NCT02896400|20027191|P16|3 Month Follow-up|Death|0
5804795|NCT02896400|20027192|P15|3 Month Follow-up|Death|1
5804796|NCT02896400|20027193|P14|3 Month Follow-up|Death|1
5804797|NCT02896400|20027194|P13|3 Month Follow-up|Death|0
5804798|NCT02896400|20027195|P12|3 Month Follow-up|Death|0
5804799|NCT02896400|20027196|P11|3 Month Follow-up|Death|0
5804800|NCT02896400|20027197|P10|3 Month Follow-up|Death|0
5804801|NCT02896400|20027198|P9|3 Month Follow-up|Death|0
5804802|NCT02896400|20027199|P8|3 Month Follow-up|Death|0
5804803|NCT02896400|20027200|P7|3 Month Follow-up|Death|0
5804804|NCT02896400|20027201|P6|3 Month Follow-up|Death|0
5804805|NCT02896400|20027202|P5|3 Month Follow-up|Death|0
5804806|NCT02896400|20027203|P4|3 Month Follow-up|Death|0
5804807|NCT02896400|20027204|P3|3 Month Follow-up|Death|0
5804808|NCT02896400|20027205|P2|3 Month Follow-up|Death|0
5804809|NCT02896400|20027206|P1|3 Month Follow-up|Death|0
5804810|NCT02896400|20027191|P16|3 Month Follow-up|Lost to Follow-up|2
5804811|NCT02896400|20027192|P15|3 Month Follow-up|Lost to Follow-up|3
5804812|NCT02896400|20027193|P14|3 Month Follow-up|Lost to Follow-up|5
5804813|NCT02896400|20027194|P13|3 Month Follow-up|Lost to Follow-up|3
5804814|NCT02896400|20027195|P12|3 Month Follow-up|Lost to Follow-up|6
5804815|NCT02896400|20027196|P11|3 Month Follow-up|Lost to Follow-up|6
5804816|NCT02896400|20027197|P10|3 Month Follow-up|Lost to Follow-up|5
5804817|NCT02896400|20027198|P9|3 Month Follow-up|Lost to Follow-up|6
5804818|NCT02896400|20027199|P8|3 Month Follow-up|Lost to Follow-up|3
5804819|NCT02896400|20027200|P7|3 Month Follow-up|Lost to Follow-up|4
5804820|NCT02896400|20027201|P6|3 Month Follow-up|Lost to Follow-up|6
5804821|NCT02896400|20027202|P5|3 Month Follow-up|Lost to Follow-up|12
5804822|NCT02896400|20027203|P4|3 Month Follow-up|Lost to Follow-up|11
5804823|NCT02896400|20027204|P3|3 Month Follow-up|Lost to Follow-up|6
5804824|NCT02896400|20027205|P2|3 Month Follow-up|Lost to Follow-up|3
5804825|NCT02896400|20027206|P1|3 Month Follow-up|Lost to Follow-up|6
5804826|NCT02896400|20027191|P16|1 Month Follow-up|Death|1
5804827|NCT02896400|20027192|P15|1 Month Follow-up|Death|0
5804828|NCT02896400|20027193|P14|1 Month Follow-up|Death|0
5804829|NCT02896400|20027194|P13|1 Month Follow-up|Death|0
5804830|NCT02896400|20027195|P12|1 Month Follow-up|Death|0
5804831|NCT02896400|20027196|P11|1 Month Follow-up|Death|0
5804832|NCT02896400|20027197|P10|1 Month Follow-up|Death|0
5804833|NCT02896400|20027198|P9|1 Month Follow-up|Death|0
5804834|NCT02896400|20027199|P8|1 Month Follow-up|Death|0
5804835|NCT02896400|20027200|P7|1 Month Follow-up|Death|0
5804836|NCT02896400|20027201|P6|1 Month Follow-up|Death|0
5804837|NCT02896400|20027202|P5|1 Month Follow-up|Death|0
5804838|NCT02896400|20027203|P4|1 Month Follow-up|Death|0
5804839|NCT02896400|20027204|P3|1 Month Follow-up|Death|0
5804840|NCT02896400|20027205|P2|1 Month Follow-up|Death|0
5804841|NCT02896400|20027206|P1|1 Month Follow-up|Death|0
5804842|NCT02896400|20027191|P16|1 Month Follow-up|Lost to Follow-up|2
5804843|NCT02896400|20027192|P15|1 Month Follow-up|Lost to Follow-up|1
5804844|NCT02896400|20027193|P14|1 Month Follow-up|Lost to Follow-up|4
5804845|NCT02896400|20027194|P13|1 Month Follow-up|Lost to Follow-up|3
5804846|NCT02896400|20027195|P12|1 Month Follow-up|Lost to Follow-up|5
5804847|NCT02896400|20027196|P11|1 Month Follow-up|Lost to Follow-up|5
5804848|NCT02896400|20027197|P10|1 Month Follow-up|Lost to Follow-up|7
5804849|NCT02896400|20027198|P9|1 Month Follow-up|Lost to Follow-up|4
5804850|NCT02896400|20027199|P8|1 Month Follow-up|Lost to Follow-up|6
5804851|NCT02896400|20027200|P7|1 Month Follow-up|Lost to Follow-up|5
5804852|NCT02896400|20027201|P6|1 Month Follow-up|Lost to Follow-up|6
5804853|NCT02896400|20027202|P5|1 Month Follow-up|Lost to Follow-up|9
5804854|NCT02896400|20027203|P4|1 Month Follow-up|Lost to Follow-up|8
5804855|NCT02896400|20027204|P3|1 Month Follow-up|Lost to Follow-up|5
5804856|NCT02896400|20027205|P2|1 Month Follow-up|Lost to Follow-up|7
5804857|NCT02896400|20027206|P1|1 Month Follow-up|Lost to Follow-up|7
5804858|NCT02896361|20027232|P3|Third Intervention (2 Weeks)|emergenge of several new painful regions|0
5804859|NCT02896361|20027233|P2|Third Intervention (2 Weeks)|emergenge of several new painful regions|1
5804860|NCT02896361|20027234|P1|Third Intervention (2 Weeks)|emergenge of several new painful regions|0
5804861|NCT02896361|20027232|P3|Third Intervention (2 Weeks)|Protocol Violation|0
5804862|NCT02896361|20027233|P2|Third Intervention (2 Weeks)|Protocol Violation|0
5804863|NCT02896361|20027234|P1|Third Intervention (2 Weeks)|Protocol Violation|1
5804864|NCT02896296|20027252|P1|Overall Study|Relocation|1
5804865|NCT02896296|20027252|P1|Overall Study|Incarceration|1
5804866|NCT02896296|20027252|P1|Overall Study|Site closing|7
5804867|NCT02896296|20027252|P1|Overall Study|Withdrawal by Subject|10
5804868|NCT02896296|20027252|P1|Overall Study|Physician Decision|2
5804869|NCT02896296|20027252|P1|Overall Study|Pregnancy|1
5804870|NCT02896296|20027252|P1|Overall Study|Lost to Follow-up|19
5804871|NCT02896296|20027252|P1|Overall Study|Adverse Event|1
5804872|NCT02896127|20027260|P2|COMPLETED POST-TREATMENT FOLLOW UP|Protocol Violation|1
5804873|NCT02896127|20027261|P1|COMPLETED POST-TREATMENT FOLLOW UP|Protocol Violation|0
5804874|NCT02896127|20027260|P2|COMPLETED POST-TREATMENT FOLLOW UP|Pregnancy|0
5804875|NCT02896127|20027261|P1|COMPLETED POST-TREATMENT FOLLOW UP|Pregnancy|1
5804876|NCT02896127|20027260|P2|COMPLETED POST-TREATMENT FOLLOW UP|Physician Decision|0
5804877|NCT02896127|20027261|P1|COMPLETED POST-TREATMENT FOLLOW UP|Physician Decision|1
5804878|NCT02896127|20027260|P2|COMPLETED POST-TREATMENT FOLLOW UP|Lost to Follow-up|1
5804879|NCT02896127|20027261|P1|COMPLETED POST-TREATMENT FOLLOW UP|Lost to Follow-up|0
5804880|NCT02896127|20027260|P2|COMPLETED POST-TREATMENT FOLLOW UP|Withdrawal by Subject|3
5804881|NCT02896127|20027261|P1|COMPLETED POST-TREATMENT FOLLOW UP|Withdrawal by Subject|2
5804882|NCT02896127|20027260|P2|COMPLETED WEEK 52|Technical problems|0
5804883|NCT02896127|20027261|P1|COMPLETED WEEK 52|Technical problems|1
5804884|NCT02896127|20027260|P2|COMPLETED WEEK 52|Withdrawal by Subject|4
5804885|NCT02896127|20027261|P1|COMPLETED WEEK 52|Withdrawal by Subject|12
5804886|NCT02896127|20027260|P2|COMPLETED WEEK 52|Pregnancy|0
5804887|NCT02896127|20027261|P1|COMPLETED WEEK 52|Pregnancy|2
5804888|NCT02896127|20027260|P2|COMPLETED WEEK 52|Physician Decision|1
5804889|NCT02896127|20027261|P1|COMPLETED WEEK 52|Physician Decision|1
5804890|NCT02896127|20027260|P2|COMPLETED WEEK 52|Lost to Follow-up|1
5804891|NCT02896127|20027261|P1|COMPLETED WEEK 52|Lost to Follow-up|0
5804892|NCT02896127|20027260|P2|COMPLETED WEEK 52|Lack of Efficacy|3
5804893|NCT02896127|20027261|P1|COMPLETED WEEK 52|Lack of Efficacy|2
5804894|NCT02896127|20027260|P2|COMPLETED WEEK 52|Adverse Event|2
5804895|NCT02896127|20027261|P1|COMPLETED WEEK 52|Adverse Event|9
5804896|NCT02895347|20027283|P2|Overall Study|Withdrawal by Subject|1
5804897|NCT02895347|20027284|P1|Overall Study|Withdrawal by Subject|3
5804898|NCT02895295|20027296|P3|Overall Study|Survey Non-response|92
5804899|NCT02895295|20027297|P2|Overall Study|Survey Non-response|94
5804900|NCT02895295|20027298|P1|Overall Study|Survey Non-response|71
5804901|NCT02894840|20027332|P4|Overall Study|Lost to Follow-up|0
5804902|NCT02894840|20027333|P3|Overall Study|Lost to Follow-up|3
5804903|NCT02894840|20027334|P2|Overall Study|Lost to Follow-up|0
5804904|NCT02894840|20027335|P1|Overall Study|Lost to Follow-up|1
5804905|NCT02892734|20027607|P1|Follow up for 2 Years|Study closed early|1
5804906|NCT02892734|20027607|P1|Follow up for 2 Years|Death|2
5804907|NCT02892734|20027607|P1|Treatment on Study|Progressive Disease|2
5804908|NCT02892513|20027617|P2|Overall Study|Withdrawal by Subject|1
5804909|NCT02892513|20027618|P1|Overall Study|Withdrawal by Subject|0
5804910|NCT02892448|20027638|P3|Overall Study|Screening failure|1
5804911|NCT02892448|20027639|P2|Overall Study|Screening failure|2
5804912|NCT02892448|20027640|P1|Overall Study|Screening failure|2
5804913|NCT02892422|20027660|P1|Overall Study|Investigator decision|1
5804914|NCT02892422|20027660|P1|Overall Study|patient decision|7
5804915|NCT02892422|20027660|P1|Overall Study|patient legally incapable|1
5804916|NCT02892422|20027660|P1|Overall Study|non-compliance|10
5804917|NCT02892422|20027660|P1|Overall Study|moving elsewhere|4
5804918|NCT02892422|20027660|P1|Overall Study|exclusion criteria met|3
5804919|NCT02892422|20027660|P1|Overall Study|withdrawal of consent|13
5804920|NCT02892422|20027660|P1|Overall Study|sponsor information 16159A results|21
5804921|NCT02892422|20027660|P1|Overall Study|Lost to Follow-up|5
5804922|NCT02892422|20027660|P1|Overall Study|Withdrawal by Subject|56
5804923|NCT02892422|20027660|P1|Overall Study|Protocol Violation|4
5804924|NCT02892422|20027660|P1|Overall Study|Non-compliance with study drug|11
5804925|NCT02892422|20027660|P1|Overall Study|Lack of Efficacy|32
5804926|NCT02892422|20027660|P1|Overall Study|Adverse Event|38
5804927|NCT02892422|20027660|P1|Overall Study|Enrolled not treated|4
5804928|NCT02892409|20027666|P2|Overall Study|Withdrawal by Subject|1
5804929|NCT02892409|20027667|P1|Overall Study|Withdrawal by Subject|2
5804930|NCT02892409|20027666|P2|Overall Study|Adverse Event|0
5804931|NCT02892409|20027667|P1|Overall Study|Adverse Event|1
5804932|NCT02892344|20027689|P2|Overall Study|Technical problems|1
5804933|NCT02892344|20027690|P1|Overall Study|Technical problems|0
5804934|NCT02892344|20027689|P2|Overall Study|Subject/guardian decision|4
5804935|NCT02892344|20027690|P1|Overall Study|Subject/guardian decision|0
5804936|NCT02892344|20027689|P2|Overall Study|Physician Decision|2
5804937|NCT02892344|20027690|P1|Overall Study|Physician Decision|0
5804938|NCT02892344|20027689|P2|Overall Study|Non-compliance with study treatment|1
5804939|NCT02892344|20027690|P1|Overall Study|Non-compliance with study treatment|0
5804940|NCT02892344|20027689|P2|Overall Study|Lost to Follow-up|1
5804941|NCT02892344|20027690|P1|Overall Study|Lost to Follow-up|0
5804942|NCT02892344|20027689|P2|Overall Study|Adverse Event|8
5804943|NCT02892344|20027690|P1|Overall Study|Adverse Event|1
5804944|NCT02892344|20027689|P2|Overall Study|Protocol deviation|4
5804945|NCT02892344|20027690|P1|Overall Study|Protocol deviation|3
5804946|NCT02892019|20027739|P2|Overall Study|Adverse Event|1
5804947|NCT02892019|20027740|P1|Overall Study|Adverse Event|1
5804948|NCT02892019|20027739|P2|Overall Study|Withdrawal by Subject|1
5804949|NCT02892019|20027740|P1|Overall Study|Withdrawal by Subject|0
5804950|NCT02892019|20027739|P2|Overall Study|randomized but not treated|1
5804951|NCT02892019|20027740|P1|Overall Study|randomized but not treated|0
5804962|NCT02891408|20027802|P7|Overall Study|Lost to Follow-up|0
5804963|NCT02891408|20027803|P6|Overall Study|Lost to Follow-up|0
5804964|NCT02891408|20027804|P5|Overall Study|Lost to Follow-up|0
5804965|NCT02891408|20027805|P4|Overall Study|Lost to Follow-up|0
5804966|NCT02891408|20027806|P3|Overall Study|Lost to Follow-up|1
5804967|NCT02891408|20027807|P2|Overall Study|Lost to Follow-up|0
5804968|NCT02891408|20027808|P1|Overall Study|Lost to Follow-up|0
5804969|NCT02891200|20027921|P2|Overall Study|Withdrawal by Subject|4
5804970|NCT02891200|20027922|P1|Overall Study|Withdrawal by Subject|1
5804971|NCT02891200|20027921|P2|Overall Study|Death|9
5804972|NCT02891200|20027922|P1|Overall Study|Death|10
5804973|NCT02891200|20027921|P2|Overall Study|Lost to Follow-up|36
5804974|NCT02891200|20027922|P1|Overall Study|Lost to Follow-up|31
5804975|NCT02891174|20027950|P2|Second Intervention (24 Hours)|Protocol Violation|1
5804976|NCT02891174|20027951|P1|Second Intervention (24 Hours)|Protocol Violation|0
5804977|NCT02891174|20027950|P2|Second Intervention (24 Hours)|Withdrew after receiving study drug|1
5804978|NCT02891174|20027951|P1|Second Intervention (24 Hours)|Withdrew after receiving study drug|2
5804979|NCT02891174|20027950|P2|Second Intervention (24 Hours)|Discharged during second intervention|5
5804980|NCT02891174|20027951|P1|Second Intervention (24 Hours)|Discharged during second intervention|3
5804981|NCT02891174|20027950|P2|Second Intervention (24 Hours)|No blood pressure after cross-over|0
5804982|NCT02891174|20027951|P1|Second Intervention (24 Hours)|No blood pressure after cross-over|1
5804983|NCT02891174|20027950|P2|First Intervention (24 Hours)|Withdrew after receiving study drug|6
5804984|NCT02891174|20027951|P1|First Intervention (24 Hours)|Withdrew after receiving study drug|2
5804985|NCT02891174|20027950|P2|First Intervention (24 Hours)|Discharged prior to cross-over|2
5804986|NCT02891174|20027951|P1|First Intervention (24 Hours)|Discharged prior to cross-over|0
5804987|NCT02891174|20027950|P2|First Intervention (24 Hours)|Declined any study medication|5
5804988|NCT02891174|20027951|P1|First Intervention (24 Hours)|Declined any study medication|1
5804989|NCT02891070|20027965|P2|Overall Study|Death|0
5804990|NCT02891070|20027966|P1|Overall Study|Death|3
5804991|NCT02891070|20027965|P2|Overall Study|Withdrawal by Subject|2
5804992|NCT02891070|20027966|P1|Overall Study|Withdrawal by Subject|1
5804993|NCT02891070|20027965|P2|Overall Study|Protocol Violation|1
5804994|NCT02891070|20027966|P1|Overall Study|Protocol Violation|0
5804995|NCT02891070|20027965|P2|Overall Study|Other|0
5804996|NCT02891070|20027966|P1|Overall Study|Other|1
5804997|NCT02891070|20027965|P2|Overall Study|Lost to Follow-up|4
5804998|NCT02891070|20027966|P1|Overall Study|Lost to Follow-up|4
5804999|NCT02891070|20027965|P2|Overall Study|Physician Decision|1
5805000|NCT02891070|20027966|P1|Overall Study|Physician Decision|0
5805001|NCT02891070|20027965|P2|Overall Study|Adverse Event|0
5805002|NCT02891070|20027966|P1|Overall Study|Adverse Event|1
5805003|NCT02890992|20027992|P8|130 Weeks Open-Label Extension Period|Other than specified|0
5805004|NCT02890992|20027993|P7|130 Weeks Open-Label Extension Period|Other than specified|0
5805005|NCT02890992|20027994|P6|130 Weeks Open-Label Extension Period|Other than specified|0
5805006|NCT02890992|20027995|P5|130 Weeks Open-Label Extension Period|Other than specified|0
5805007|NCT02890992|20027996|P4|130 Weeks Open-Label Extension Period|Other than specified|0
5805008|NCT02890992|20027997|P3|130 Weeks Open-Label Extension Period|Other than specified|0
5805009|NCT02890992|20027998|P2|130 Weeks Open-Label Extension Period|Other than specified|2
5805010|NCT02890992|20027999|P1|130 Weeks Open-Label Extension Period|Other than specified|0
5805011|NCT02890992|20027992|P8|130 Weeks Open-Label Extension Period|Included but not treated|1
5805012|NCT02890992|20027993|P7|130 Weeks Open-Label Extension Period|Included but not treated|1
5805013|NCT02890992|20027994|P6|130 Weeks Open-Label Extension Period|Included but not treated|0
5805014|NCT02890992|20027995|P5|130 Weeks Open-Label Extension Period|Included but not treated|0
5805015|NCT02890992|20027996|P4|130 Weeks Open-Label Extension Period|Included but not treated|0
5805016|NCT02890992|20027997|P3|130 Weeks Open-Label Extension Period|Included but not treated|0
5805017|NCT02890992|20027998|P2|130 Weeks Open-Label Extension Period|Included but not treated|0
5805018|NCT02890992|20027999|P1|130 Weeks Open-Label Extension Period|Included but not treated|0
5805019|NCT02890992|20027992|P8|130 Weeks Open-Label Extension Period|Adverse Event|0
5805020|NCT02890992|20027993|P7|130 Weeks Open-Label Extension Period|Adverse Event|0
5805021|NCT02890992|20027994|P6|130 Weeks Open-Label Extension Period|Adverse Event|0
5805022|NCT02890992|20027995|P5|130 Weeks Open-Label Extension Period|Adverse Event|0
5805023|NCT02890992|20027996|P4|130 Weeks Open-Label Extension Period|Adverse Event|0
5805024|NCT02890992|20027997|P3|130 Weeks Open-Label Extension Period|Adverse Event|0
5805025|NCT02890992|20027998|P2|130 Weeks Open-Label Extension Period|Adverse Event|1
5805026|NCT02890992|20027999|P1|130 Weeks Open-Label Extension Period|Adverse Event|0
5805040|NCT02889861|20028229|P1|Overall Study|Ongoing in Survival Follow-up|2
5805041|NCT02889796|20028254|P6|Overall Study|Randomized but not Dosed|2
5805042|NCT02889796|20028255|P5|Overall Study|Randomized but not Dosed|0
5805043|NCT02889796|20028256|P4|Overall Study|Randomized but not Dosed|0
5805044|NCT02889796|20028257|P3|Overall Study|Randomized but not Dosed|0
5805045|NCT02889796|20028258|P2|Overall Study|Randomized but not Dosed|0
5805046|NCT02889796|20028259|P1|Overall Study|Randomized but not Dosed|2
5805047|NCT02889796|20028254|P6|Overall Study|Pregnancy|0
5805048|NCT02889796|20028255|P5|Overall Study|Pregnancy|0
5805049|NCT02889796|20028256|P4|Overall Study|Pregnancy|0
5805050|NCT02889796|20028257|P3|Overall Study|Pregnancy|1
5805051|NCT02889796|20028258|P2|Overall Study|Pregnancy|1
5805052|NCT02889796|20028259|P1|Overall Study|Pregnancy|0
5805053|NCT02889796|20028254|P6|Overall Study|Death|1
5805054|NCT02889796|20028255|P5|Overall Study|Death|0
5805055|NCT02889796|20028256|P4|Overall Study|Death|1
5805056|NCT02889796|20028257|P3|Overall Study|Death|0
5805057|NCT02889796|20028258|P2|Overall Study|Death|1
5805058|NCT02889796|20028259|P1|Overall Study|Death|1
5805059|NCT02889796|20028254|P6|Overall Study|Non-compliance With Study Drug|2
5805060|NCT02889796|20028255|P5|Overall Study|Non-compliance With Study Drug|1
5805061|NCT02889796|20028256|P4|Overall Study|Non-compliance With Study Drug|0
5805062|NCT02889796|20028257|P3|Overall Study|Non-compliance With Study Drug|0
5805063|NCT02889796|20028258|P2|Overall Study|Non-compliance With Study Drug|2
5805064|NCT02889796|20028259|P1|Overall Study|Non-compliance With Study Drug|0
5805065|NCT02889796|20028254|P6|Overall Study|Protocol Violation|4
5805066|NCT02889796|20028255|P5|Overall Study|Protocol Violation|0
5805067|NCT02889796|20028256|P4|Overall Study|Protocol Violation|0
5805068|NCT02889796|20028257|P3|Overall Study|Protocol Violation|3
5805069|NCT02889796|20028258|P2|Overall Study|Protocol Violation|1
5805070|NCT02889796|20028259|P1|Overall Study|Protocol Violation|0
5805071|NCT02889796|20028254|P6|Overall Study|Lost to Follow-up|6
5805072|NCT02889796|20028255|P5|Overall Study|Lost to Follow-up|2
5805073|NCT02889796|20028256|P4|Overall Study|Lost to Follow-up|0
5805074|NCT02889796|20028257|P3|Overall Study|Lost to Follow-up|2
5805075|NCT02889796|20028258|P2|Overall Study|Lost to Follow-up|7
5805076|NCT02889796|20028259|P1|Overall Study|Lost to Follow-up|5
5805077|NCT02889796|20028254|P6|Overall Study|Adverse Event|7
5805078|NCT02889796|20028255|P5|Overall Study|Adverse Event|1
5805079|NCT02889796|20028256|P4|Overall Study|Adverse Event|4
5805080|NCT02889796|20028257|P3|Overall Study|Adverse Event|8
5805081|NCT02889796|20028258|P2|Overall Study|Adverse Event|8
5805082|NCT02889796|20028259|P1|Overall Study|Adverse Event|17
5805083|NCT02889796|20028254|P6|Overall Study|Investigator's Discretion|15
5805084|NCT02889796|20028255|P5|Overall Study|Investigator's Discretion|0
5805085|NCT02889796|20028256|P4|Overall Study|Investigator's Discretion|3
5805086|NCT02889796|20028257|P3|Overall Study|Investigator's Discretion|10
5805087|NCT02889796|20028258|P2|Overall Study|Investigator's Discretion|9
5805088|NCT02889796|20028259|P1|Overall Study|Investigator's Discretion|10
5805089|NCT02889796|20028254|P6|Overall Study|Withdrew Consent|35
5805090|NCT02889796|20028255|P5|Overall Study|Withdrew Consent|2
5805091|NCT02889796|20028256|P4|Overall Study|Withdrew Consent|1
5805092|NCT02889796|20028257|P3|Overall Study|Withdrew Consent|20
5805093|NCT02889796|20028258|P2|Overall Study|Withdrew Consent|29
5805094|NCT02889796|20028259|P1|Overall Study|Withdrew Consent|18
5805095|NCT02889562|20028626|P2|Overall Study|Withdrawal by Subject|1
5805096|NCT02889562|20028627|P1|Overall Study|Withdrawal by Subject|0
5805097|NCT02889562|20028626|P2|Overall Study|Physician Decision|1
5805098|NCT02889562|20028627|P1|Overall Study|Physician Decision|0
5805099|NCT02888756|20028653|P3|Analytical Treatment Interruption|Physician Decision|5
5805100|NCT02888756|20028654|P2|Analytical Treatment Interruption|Physician Decision|6
5805101|NCT02888756|20028655|P1|Analytical Treatment Interruption|Physician Decision|10
5805102|NCT02888171|20028795|P2|Overall Study|Adverse Event|1
5805103|NCT02888171|20028796|P1|Overall Study|Adverse Event|0
5805104|NCT02888171|20028795|P2|Overall Study|Withdrawal by Subject|2
5805105|NCT02888171|20028796|P1|Overall Study|Withdrawal by Subject|3
5805106|NCT02888171|20028795|P2|Overall Study|Lost to Follow-up|1
5805107|NCT02888171|20028796|P1|Overall Study|Lost to Follow-up|2
5805108|NCT02888080|20028825|P2|Overall Study|Adverse Event|1
5805109|NCT02888080|20028826|P1|Overall Study|Adverse Event|0
5805110|NCT02888080|20028825|P2|Overall Study|Lack of Efficacy|1
5805111|NCT02888080|20028826|P1|Overall Study|Lack of Efficacy|0
5805112|NCT02888080|20028825|P2|Overall Study|New Therapy for study indication|0
5805113|NCT02888080|20028826|P1|Overall Study|New Therapy for study indication|1
5805114|NCT02888080|20028825|P2|Overall Study|Subject / Guardian decision|3
5805115|NCT02888080|20028826|P1|Overall Study|Subject / Guardian decision|1
5805116|NCT02887989|20028852|P2|Overall Study|Death|0
5805117|NCT02887989|20028853|P1|Overall Study|Death|1
5805118|NCT02887989|20028852|P2|Overall Study|Withdrawal by Subject|11
5805119|NCT02887989|20028853|P1|Overall Study|Withdrawal by Subject|8
5805120|NCT02887521|20028865|P2|Overall Study|Withdrawal by Subject|3
5805121|NCT02887521|20028866|P1|Overall Study|Withdrawal by Subject|0
5805122|NCT02887183|20028929|P1|Overall Study|Withdrawal by Subject|35
5805123|NCT02887183|20028929|P1|Overall Study|Physician Decision|10
5805124|NCT02887183|20028929|P1|Overall Study|Lost to Follow-up|13
5805125|NCT02887183|20028929|P1|Overall Study|Technical Problems|2
5805126|NCT02887183|20028929|P1|Overall Study|Protocol Violation|6
5805127|NCT02887183|20028929|P1|Overall Study|Pregnancy|1
5805128|NCT02887183|20028929|P1|Overall Study|Death|30
5805129|NCT02887183|20028929|P1|Overall Study|Adverse Event|44
5805130|NCT02886728|20028957|P4|Overall Study|Randomized but Not Dosed|2
5805131|NCT02886728|20028958|P3|Overall Study|Randomized but Not Dosed|0
5805132|NCT02886728|20028959|P2|Overall Study|Randomized but Not Dosed|0
5805133|NCT02886728|20028960|P1|Overall Study|Randomized but Not Dosed|1
5805134|NCT02886728|20028957|P4|Overall Study|Pregnancy|0
5805135|NCT02886728|20028958|P3|Overall Study|Pregnancy|1
5805136|NCT02886728|20028959|P2|Overall Study|Pregnancy|0
5805137|NCT02886728|20028960|P1|Overall Study|Pregnancy|0
5805138|NCT02886728|20028957|P4|Overall Study|Non-Compliance with Study Drug|0
5805139|NCT02886728|20028958|P3|Overall Study|Non-Compliance with Study Drug|1
5805140|NCT02886728|20028959|P2|Overall Study|Non-Compliance with Study Drug|0
5805141|NCT02886728|20028960|P1|Overall Study|Non-Compliance with Study Drug|1
5805142|NCT02886728|20028957|P4|Overall Study|Protocol Violation|4
5805143|NCT02886728|20028958|P3|Overall Study|Protocol Violation|0
5805144|NCT02886728|20028959|P2|Overall Study|Protocol Violation|0
5805145|NCT02886728|20028960|P1|Overall Study|Protocol Violation|0
5805146|NCT02886728|20028957|P4|Overall Study|Death|0
5805147|NCT02886728|20028958|P3|Overall Study|Death|0
5805148|NCT02886728|20028959|P2|Overall Study|Death|1
5805149|NCT02886728|20028960|P1|Overall Study|Death|3
5805150|NCT02886728|20028957|P4|Overall Study|Investigator's Discretion|11
5805151|NCT02886728|20028958|P3|Overall Study|Investigator's Discretion|5
5805152|NCT02886728|20028959|P2|Overall Study|Investigator's Discretion|7
5805153|NCT02886728|20028960|P1|Overall Study|Investigator's Discretion|11
5805154|NCT02886728|20028957|P4|Overall Study|Adverse Event|11
5805155|NCT02886728|20028958|P3|Overall Study|Adverse Event|5
5805156|NCT02886728|20028959|P2|Overall Study|Adverse Event|5
5805157|NCT02886728|20028960|P1|Overall Study|Adverse Event|13
5805158|NCT02886728|20028957|P4|Overall Study|Lost to Follow-up|12
5805159|NCT02886728|20028958|P3|Overall Study|Lost to Follow-up|13
5805160|NCT02886728|20028959|P2|Overall Study|Lost to Follow-up|6
5805161|NCT02886728|20028960|P1|Overall Study|Lost to Follow-up|12
5805162|NCT02886728|20028957|P4|Overall Study|Withdrew Consent|47
5805163|NCT02886728|20028958|P3|Overall Study|Withdrew Consent|11
5805164|NCT02886728|20028959|P2|Overall Study|Withdrew Consent|13
5805165|NCT02886728|20028960|P1|Overall Study|Withdrew Consent|31
5805166|NCT02886715|20029141|P3|Overall Study|missing|2
5805167|NCT02886715|20029142|P2|Overall Study|missing|2
5805168|NCT02886715|20029143|P1|Overall Study|missing|7
5805169|NCT02886715|20029141|P3|Overall Study|Withdrawal by Subject|5
5805170|NCT02886715|20029142|P2|Overall Study|Withdrawal by Subject|18
5805171|NCT02886715|20029143|P1|Overall Study|Withdrawal by Subject|20
5805172|NCT02886715|20029141|P3|Overall Study|Protocol Violation|1
5805173|NCT02886715|20029142|P2|Overall Study|Protocol Violation|2
5805174|NCT02886715|20029143|P1|Overall Study|Protocol Violation|3
5805175|NCT02886715|20029141|P3|Overall Study|Pregnancy|1
5805176|NCT02886715|20029142|P2|Overall Study|Pregnancy|1
5805177|NCT02886715|20029143|P1|Overall Study|Pregnancy|1
5805178|NCT02886715|20029141|P3|Overall Study|Lost to Follow-up|10
5805179|NCT02886715|20029142|P2|Overall Study|Lost to Follow-up|26
5805180|NCT02886715|20029143|P1|Overall Study|Lost to Follow-up|29
5805181|NCT02886715|20029141|P3|Overall Study|Lack of Efficacy|1
5805182|NCT02886715|20029142|P2|Overall Study|Lack of Efficacy|2
5805183|NCT02886715|20029143|P1|Overall Study|Lack of Efficacy|0
5805184|NCT02886715|20029141|P3|Overall Study|Adverse Event|0
5805185|NCT02886715|20029142|P2|Overall Study|Adverse Event|2
5805186|NCT02886715|20029143|P1|Overall Study|Adverse Event|4
5805187|NCT02886715|20029141|P3|Overall Study|Non-Compliance With Study Drug|0
5805188|NCT02886715|20029142|P2|Overall Study|Non-Compliance With Study Drug|2
5805189|NCT02886715|20029143|P1|Overall Study|Non-Compliance With Study Drug|0
5805190|NCT02886702|20029160|P3|Overall Study|Administrative Reasons|1
5805191|NCT02886702|20029161|P2|Overall Study|Administrative Reasons|0
5805192|NCT02886702|20029162|P1|Overall Study|Administrative Reasons|0
5805193|NCT02886702|20029160|P3|Overall Study|Adverse Event|3
5805194|NCT02886702|20029161|P2|Overall Study|Adverse Event|9
5805195|NCT02886702|20029162|P1|Overall Study|Adverse Event|4
5805196|NCT02886702|20029160|P3|Overall Study|Lack of Efficacy|5
5805197|NCT02886702|20029161|P2|Overall Study|Lack of Efficacy|4
5805198|NCT02886702|20029162|P1|Overall Study|Lack of Efficacy|3
5805199|NCT02886702|20029160|P3|Overall Study|Lost to Follow-up|8
5805200|NCT02886702|20029161|P2|Overall Study|Lost to Follow-up|13
5805201|NCT02886702|20029162|P1|Overall Study|Lost to Follow-up|11
5805202|NCT02886702|20029160|P3|Overall Study|Non-Compliance With Study Drug|4
5805203|NCT02886702|20029161|P2|Overall Study|Non-Compliance With Study Drug|1
5805204|NCT02886702|20029162|P1|Overall Study|Non-Compliance With Study Drug|0
5805205|NCT02886702|20029160|P3|Overall Study|Protocol Violation|1
5805206|NCT02886702|20029161|P2|Overall Study|Protocol Violation|2
5805207|NCT02886702|20029162|P1|Overall Study|Protocol Violation|2
5805208|NCT02886702|20029160|P3|Overall Study|Significant Worsening of Condition|0
5805209|NCT02886702|20029161|P2|Overall Study|Significant Worsening of Condition|1
5805210|NCT02886702|20029162|P1|Overall Study|Significant Worsening of Condition|0
5805211|NCT02886702|20029160|P3|Overall Study|Withdrawal by Subject|22
5805212|NCT02886702|20029161|P2|Overall Study|Withdrawal by Subject|18
5805213|NCT02886702|20029162|P1|Overall Study|Withdrawal by Subject|24
5805214|NCT02886702|20029160|P3|Overall Study|Other|9
5805215|NCT02886702|20029161|P2|Overall Study|Other|3
5805216|NCT02886702|20029162|P1|Overall Study|Other|4
5805217|NCT02886624|20029176|P1|48-week Post Treatment Follow-up|Lost to Follow-up|1
5805218|NCT02886624|20029176|P1|12-week Post Treatment Follow-up|Death|1
5805219|NCT02886338|20029185|P1|Overall Study|Withdrawal by Subject|1
5805220|NCT02885181|20029374|P4|Overall Study|Withdrawal by Subject|1
5805221|NCT02885181|20029375|P3|Overall Study|Withdrawal by Subject|0
5805222|NCT02885181|20029376|P2|Overall Study|Withdrawal by Subject|0
5805223|NCT02885181|20029377|P1|Overall Study|Withdrawal by Subject|0
5805224|NCT02885181|20029374|P4|Overall Study|Adverse Event|1
5805225|NCT02885181|20029375|P3|Overall Study|Adverse Event|0
5805226|NCT02885181|20029376|P2|Overall Study|Adverse Event|0
5805227|NCT02885181|20029377|P1|Overall Study|Adverse Event|0
5805228|NCT02885181|20029374|P4|Overall Study|Investigator's Discretion|1
5805229|NCT02885181|20029375|P3|Overall Study|Investigator's Discretion|0
5805230|NCT02885181|20029376|P2|Overall Study|Investigator's Discretion|1
5805231|NCT02885181|20029377|P1|Overall Study|Investigator's Discretion|0
5805232|NCT02884089|20029493|P4|Follow-up Visit|Withdrawal by Subject|1
5805233|NCT02884089|20029494|P3|Follow-up Visit|Withdrawal by Subject|0
5805234|NCT02884089|20029495|P2|Follow-up Visit|Withdrawal by Subject|0
5805235|NCT02884089|20029496|P1|Follow-up Visit|Withdrawal by Subject|1
5805236|NCT02884089|20029493|P4|Period 4|Lost to Follow-up|0
5805237|NCT02884089|20029494|P3|Period 4|Lost to Follow-up|0
5805238|NCT02884089|20029495|P2|Period 4|Lost to Follow-up|0
5805239|NCT02884089|20029496|P1|Period 4|Lost to Follow-up|1
5805240|NCT02884089|20029493|P4|Period 4|Withdrawal by Subject|0
5805241|NCT02884089|20029494|P3|Period 4|Withdrawal by Subject|0
5805242|NCT02884089|20029495|P2|Period 4|Withdrawal by Subject|1
5805243|NCT02884089|20029496|P1|Period 4|Withdrawal by Subject|0
5805244|NCT02884089|20029493|P4|Washout Period 3|Lost to Follow-up|1
5805245|NCT02884089|20029494|P3|Washout Period 3|Lost to Follow-up|0
5805246|NCT02884089|20029495|P2|Washout Period 3|Lost to Follow-up|0
5805247|NCT02884089|20029496|P1|Washout Period 3|Lost to Follow-up|0
5805248|NCT02884089|20029493|P4|Washout Period 3|Withdrawal by Subject|0
5805249|NCT02884089|20029494|P3|Washout Period 3|Withdrawal by Subject|1
5805250|NCT02884089|20029495|P2|Washout Period 3|Withdrawal by Subject|0
5805251|NCT02884089|20029496|P1|Washout Period 3|Withdrawal by Subject|0
5805252|NCT02884089|20029493|P4|Period 3|Withdrawal by Subject|0
5805253|NCT02884089|20029494|P3|Period 3|Withdrawal by Subject|1
5805254|NCT02884089|20029495|P2|Period 3|Withdrawal by Subject|0
5805255|NCT02884089|20029496|P1|Period 3|Withdrawal by Subject|0
5805256|NCT02884089|20029493|P4|Period 2|Adverse Event|0
5805257|NCT02884089|20029494|P3|Period 2|Adverse Event|0
5805258|NCT02884089|20029495|P2|Period 2|Adverse Event|0
5805259|NCT02884089|20029496|P1|Period 2|Adverse Event|1
5805260|NCT02884089|20029493|P4|Washout Period 1|Withdrawal by Subject|0
5805261|NCT02884089|20029494|P3|Washout Period 1|Withdrawal by Subject|0
5805262|NCT02884089|20029495|P2|Washout Period 1|Withdrawal by Subject|1
5805263|NCT02884089|20029496|P1|Washout Period 1|Withdrawal by Subject|0
5805264|NCT02884089|20029493|P4|Washout Period 1|Lost to Follow-up|1
5805265|NCT02884089|20029494|P3|Washout Period 1|Lost to Follow-up|0
5805266|NCT02884089|20029495|P2|Washout Period 1|Lost to Follow-up|1
5805267|NCT02884089|20029496|P1|Washout Period 1|Lost to Follow-up|0
5805268|NCT02884089|20029493|P4|Period 1|Dosing error|0
5805269|NCT02884089|20029494|P3|Period 1|Dosing error|0
5805270|NCT02884089|20029495|P2|Period 1|Dosing error|2
5805271|NCT02884089|20029496|P1|Period 1|Dosing error|2
5805272|NCT02883452|20029516|P6|Overall Study|Other|1
5805273|NCT02883452|20029517|P5|Overall Study|Other|0
5805274|NCT02883452|20029518|P4|Overall Study|Other|0
5805275|NCT02883452|20029519|P3|Overall Study|Other|0
5805276|NCT02883452|20029520|P2|Overall Study|Other|0
5805277|NCT02883452|20029521|P1|Overall Study|Other|0
5805278|NCT02883452|20029516|P6|Overall Study|Death|0
5805279|NCT02883452|20029517|P5|Overall Study|Death|0
5805280|NCT02883452|20029518|P4|Overall Study|Death|0
5805281|NCT02883452|20029519|P3|Overall Study|Death|1
5805282|NCT02883452|20029520|P2|Overall Study|Death|0
5805283|NCT02883452|20029521|P1|Overall Study|Death|1
5805284|NCT02883452|20029516|P6|Overall Study|Physician Decision|1
5805285|NCT02883452|20029517|P5|Overall Study|Physician Decision|4
5805286|NCT02883452|20029518|P4|Overall Study|Physician Decision|0
5805287|NCT02883452|20029519|P3|Overall Study|Physician Decision|0
5805288|NCT02883452|20029520|P2|Overall Study|Physician Decision|0
5805289|NCT02883452|20029521|P1|Overall Study|Physician Decision|0
5805290|NCT02883452|20029516|P6|Overall Study|Adverse Event|3
5805291|NCT02883452|20029517|P5|Overall Study|Adverse Event|1
5805292|NCT02883452|20029518|P4|Overall Study|Adverse Event|1
5805293|NCT02883452|20029519|P3|Overall Study|Adverse Event|1
5805294|NCT02883452|20029520|P2|Overall Study|Adverse Event|1
5805295|NCT02883452|20029521|P1|Overall Study|Adverse Event|2
5805296|NCT02883452|20029516|P6|Overall Study|Disease progression|5
5805297|NCT02883452|20029517|P5|Overall Study|Disease progression|4
5805298|NCT02883452|20029518|P4|Overall Study|Disease progression|1
5805299|NCT02883452|20029519|P3|Overall Study|Disease progression|0
5805300|NCT02883452|20029520|P2|Overall Study|Disease progression|0
5805301|NCT02883452|20029521|P1|Overall Study|Disease progression|1
5805302|NCT02883452|20029516|P6|Overall Study|Withdrawal by Subject|5
5805303|NCT02883452|20029517|P5|Overall Study|Withdrawal by Subject|2
5805304|NCT02883452|20029518|P4|Overall Study|Withdrawal by Subject|0
5805305|NCT02883452|20029519|P3|Overall Study|Withdrawal by Subject|3
5805306|NCT02883452|20029520|P2|Overall Study|Withdrawal by Subject|1
5805307|NCT02883452|20029521|P1|Overall Study|Withdrawal by Subject|1
5805308|NCT02883244|20029549|P2|Overall Study|Lost to Follow-up|1
5805309|NCT02883244|20029550|P1|Overall Study|Lost to Follow-up|0
5805310|NCT02882854|20029568|P2|Overall Study|Physician Decision|1
5805311|NCT02882854|20029569|P1|Overall Study|Physician Decision|0
5805312|NCT02882854|20029568|P2|Overall Study|Lost to Follow-up|2
5805313|NCT02882854|20029569|P1|Overall Study|Lost to Follow-up|1
5805314|NCT02882152|20029616|P2|Overall Study|Lost to Follow-up|0
5805315|NCT02882152|20029617|P1|Overall Study|Lost to Follow-up|1
5805316|NCT02881957|20029638|P2|Overall Study|Protocol Violation|0
5805317|NCT02881957|20029639|P1|Overall Study|Protocol Violation|1
5805318|NCT02881957|20029638|P2|Overall Study|Withdrawal by Subject|1
5805319|NCT02881957|20029639|P1|Overall Study|Withdrawal by Subject|2
5805320|NCT02881957|20029638|P2|Overall Study|Discharged within 48 hours|1
5805321|NCT02881957|20029639|P1|Overall Study|Discharged within 48 hours|0
5805322|NCT02881957|20029638|P2|Overall Study|Concurrent trial enrollment|1
5805323|NCT02881957|20029639|P1|Overall Study|Concurrent trial enrollment|0
5805324|NCT02881957|20029638|P2|Overall Study|Comfort care|1
5805325|NCT02881957|20029639|P1|Overall Study|Comfort care|0
5805326|NCT02881567|20029725|P1|Overall Study|Reason not Specified|3
5805327|NCT02881567|20029725|P1|Overall Study|Study terminated by sponsor|9
5805328|NCT02881567|20029725|P1|Overall Study|Investigator decision|1
5805329|NCT02881567|20029725|P1|Overall Study|Consent withdrawn|1
5805330|NCT02881567|20029725|P1|Overall Study|Lost to Follow-up|3
5805331|NCT02881567|20029725|P1|Overall Study|Adverse Event|1
5805332|NCT02881047|20029741|P1|Overall Study|Withdrawal by Subject|1
5805333|NCT02881047|20029741|P1|Overall Study|Adverse Event|1
5805334|NCT02880865|20029793|P2|Overall Study|Physician Decision|1
5805335|NCT02880865|20029794|P1|Overall Study|Physician Decision|0
5805336|NCT02880865|20029793|P2|Overall Study|Withdrawal by Subject|2
5805337|NCT02880865|20029794|P1|Overall Study|Withdrawal by Subject|0
5805338|NCT02880865|20029793|P2|Overall Study|Adverse Event|0
5805339|NCT02880865|20029794|P1|Overall Study|Adverse Event|1
5805340|NCT02880761|20029877|P2|Overall Study|Lost to Follow-up|4
5805341|NCT02880761|20029878|P1|Overall Study|Lost to Follow-up|3
5805342|NCT02880761|20029877|P2|Overall Study|Protocol Violation|3
5805343|NCT02880761|20029878|P1|Overall Study|Protocol Violation|4
5805344|NCT02880761|20029877|P2|Overall Study|Withdrawal by Subject|6
5805345|NCT02880761|20029878|P1|Overall Study|Withdrawal by Subject|3
5805346|NCT02880761|20029877|P2|Overall Study|Death|8
5805347|NCT02880761|20029878|P1|Overall Study|Death|6
5805348|NCT02878590|20030106|P1|Overall Study|Withdrawal by Subject|2
5805349|NCT02878330|20030144|P2|Overall Study|Other|7
5805350|NCT02878330|20030145|P1|Overall Study|Other|4
5805351|NCT02878330|20030144|P2|Overall Study|Withdrawal by Subject|21
5805352|NCT02878330|20030145|P1|Overall Study|Withdrawal by Subject|11
5805353|NCT02878330|20030144|P2|Overall Study|Lost to Follow-up|26
5805354|NCT02878330|20030145|P1|Overall Study|Lost to Follow-up|11
5805355|NCT02878330|20030144|P2|Overall Study|Death|2
5805356|NCT02878330|20030145|P1|Overall Study|Death|3
5805357|NCT02878213|20030161|P1|Overall Study|Adverse Event|1
5805358|NCT02878213|20030161|P1|Overall Study|Withdrawal by Subject|2
5805359|NCT02877927|20030176|P2|Overall Study|Missed EOT/PTE Visit|6
5805360|NCT02877927|20030177|P1|Overall Study|Missed EOT/PTE Visit|5
5805361|NCT02877927|20030176|P2|Overall Study|Physician Decision|1
5805362|NCT02877927|20030177|P1|Overall Study|Physician Decision|0
5805363|NCT02877927|20030176|P2|Overall Study|Withdrawal by Subject|12
5805364|NCT02877927|20030177|P1|Overall Study|Withdrawal by Subject|11
5805365|NCT02877927|20030176|P2|Overall Study|Lost to Follow-up|38
5805366|NCT02877927|20030177|P1|Overall Study|Lost to Follow-up|37
5805367|NCT02877927|20030176|P2|Overall Study|Adverse Event|0
5805368|NCT02877927|20030177|P1|Overall Study|Adverse Event|1
5805369|NCT02877680|20030208|P2|Overall Study|Lost to Follow-up|1
5805370|NCT02877680|20030209|P1|Overall Study|Lost to Follow-up|1
5805371|NCT02877082|20030267|P1|Overall Study|Trial was closed early|5
5805372|NCT02877004|20030278|P3|Overall Study|Pregnancy|1
5805373|NCT02877004|20030279|P2|Overall Study|Pregnancy|0
5805374|NCT02877004|20030280|P1|Overall Study|Pregnancy|0
5805375|NCT02876601|20030364|P4|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0
5805376|NCT02876601|20030365|P3|Washout (Minimum of 6 Weeks)|unforeseen unavailability|1
5805377|NCT02876601|20030366|P2|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0
5805378|NCT02876601|20030367|P1|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0
5805379|NCT02875977|20030465|P2|Overall Study|Lost to Follow-up|29
5805380|NCT02875977|20030466|P1|Overall Study|Lost to Follow-up|42
5805381|NCT02875834|20030484|P4|Randomized Treatment Phase|(Not collected)|9
5805382|NCT02875834|20030485|P3|Randomized Treatment Phase|(Not collected)|10
5805383|NCT02875834|20030486|P2|Randomized Treatment Phase|(Not collected)|9
5805384|NCT02875834|20030487|P1|Randomized Treatment Phase|(Not collected)|0
5805385|NCT02875834|20030484|P4|Randomized Treatment Phase|Protocol Violation|0
5805386|NCT02875834|20030485|P3|Randomized Treatment Phase|Protocol Violation|0
5805387|NCT02875834|20030486|P2|Randomized Treatment Phase|Protocol Violation|2
5805388|NCT02875834|20030487|P1|Randomized Treatment Phase|Protocol Violation|0
5805389|NCT02875834|20030484|P4|Randomized Treatment Phase|Withdrawal by Subject|0
5805390|NCT02875834|20030485|P3|Randomized Treatment Phase|Withdrawal by Subject|1
5805391|NCT02875834|20030486|P2|Randomized Treatment Phase|Withdrawal by Subject|3
5805392|NCT02875834|20030487|P1|Randomized Treatment Phase|Withdrawal by Subject|0
5805393|NCT02875834|20030484|P4|Open-label Phase|(Not collected)|0
5805394|NCT02875834|20030485|P3|Open-label Phase|(Not collected)|0
5805395|NCT02875834|20030486|P2|Open-label Phase|(Not collected)|0
5805396|NCT02875834|20030487|P1|Open-label Phase|(Not collected)|4
5805397|NCT02875834|20030484|P4|Open-label Phase|Withdrawal by Subject|0
5805398|NCT02875834|20030485|P3|Open-label Phase|Withdrawal by Subject|0
5805399|NCT02875834|20030486|P2|Open-label Phase|Withdrawal by Subject|0
5805400|NCT02875834|20030487|P1|Open-label Phase|Withdrawal by Subject|3
5805401|NCT02875613|20030545|P1|Overall Study|Withdrawal by Subject|1
5805402|NCT02875366|20030551|P2|Overall Study|Noncompliance|1
5805403|NCT02875366|20030552|P1|Overall Study|Noncompliance|0
5805404|NCT02875366|20030551|P2|Overall Study|Adverse Event|2
5805405|NCT02875366|20030552|P1|Overall Study|Adverse Event|0
5805406|NCT02875340|20030604|P1|Overall Study|Adverse Event|1
5805407|NCT02875340|20030604|P1|Overall Study|Physician Decision|3
5805408|NCT02875340|20030604|P1|Overall Study|Withdrawal by Subject|2
5805409|NCT02875340|20030604|P1|Overall Study|Death|2
5805410|NCT02875067|20030626|P1|Overall Study|Withdrawal by Termination of Study|5
5805411|NCT02875067|20030626|P1|Overall Study|Withdrawal by Subject|1
5805412|NCT02875028|20030641|P2|Washout Period|Withdrawal by Subject|1
5805413|NCT02875028|20030642|P1|Washout Period|Withdrawal by Subject|0
5805414|NCT02874924|20030673|P3|Overall Study|Withdrawal by Subject|0
5805415|NCT02874924|20030674|P2|Overall Study|Withdrawal by Subject|0
5805416|NCT02874924|20030675|P1|Overall Study|Withdrawal by Subject|1
5805417|NCT02874924|20030673|P3|Overall Study|Adverse Event|0
5805418|NCT02874924|20030674|P2|Overall Study|Adverse Event|0
5805419|NCT02874924|20030675|P1|Overall Study|Adverse Event|2
5805420|NCT02874794|20030708|P2|Overall Study|Death|1
5805421|NCT02874794|20030709|P1|Overall Study|Death|2
5805422|NCT02874794|20030708|P2|Overall Study|Withdrawal by Subject|8
5805423|NCT02874794|20030709|P1|Overall Study|Withdrawal by Subject|2
5805424|NCT02874794|20030708|P2|Overall Study|Physician Decision|2
5805425|NCT02874794|20030709|P1|Overall Study|Physician Decision|3
5805441|NCT02874534|20030797|P2|Overall Study|Ongoing in study|1
5805442|NCT02874534|20030798|P1|Overall Study|Ongoing in study|1
5805443|NCT02874534|20030797|P2|Overall Study|Lost to Follow-up|2
5805444|NCT02874534|20030798|P1|Overall Study|Lost to Follow-up|2
5805445|NCT02874534|20030797|P2|Overall Study|Withdrawal by Subject|8
5805446|NCT02874534|20030798|P1|Overall Study|Withdrawal by Subject|5
5805447|NCT02873936|20030823|P3|Overall Study|Randomized but not Dosed|0
5805448|NCT02873936|20030824|P2|Overall Study|Randomized but not Dosed|0
5805449|NCT02873936|20030825|P1|Overall Study|Randomized but not Dosed|1
5805450|NCT02873936|20030823|P3|Overall Study|Non-compliance With Study Drug|1
5805451|NCT02873936|20030824|P2|Overall Study|Non-compliance With Study Drug|0
5805452|NCT02873936|20030825|P1|Overall Study|Non-compliance With Study Drug|1
5805453|NCT02873936|20030823|P3|Overall Study|Lost to Follow-up|1
5805454|NCT02873936|20030824|P2|Overall Study|Lost to Follow-up|1
5805455|NCT02873936|20030825|P1|Overall Study|Lost to Follow-up|1
5805456|NCT02873936|20030823|P3|Overall Study|Protocol Violation|3
5805457|NCT02873936|20030824|P2|Overall Study|Protocol Violation|1
5805458|NCT02873936|20030825|P1|Overall Study|Protocol Violation|0
5805459|NCT02873936|20030823|P3|Overall Study|Adverse Event|3
5805460|NCT02873936|20030824|P2|Overall Study|Adverse Event|5
5805461|NCT02873936|20030825|P1|Overall Study|Adverse Event|3
5805462|NCT02873936|20030823|P3|Overall Study|Investigator's Discretion|4
5805463|NCT02873936|20030824|P2|Overall Study|Investigator's Discretion|5
5805464|NCT02873936|20030825|P1|Overall Study|Investigator's Discretion|3
5805465|NCT02873936|20030823|P3|Overall Study|Withdrew Consent|20
5805466|NCT02873936|20030824|P2|Overall Study|Withdrew Consent|11
5805467|NCT02873936|20030825|P1|Overall Study|Withdrew Consent|4
5805468|NCT02873754|20030960|P1|Overall Study|Couldn't complete study procedures|1
5805469|NCT02873754|20030960|P1|Overall Study|Lost to Follow-up|5
5805470|NCT02873702|20030977|P4|Maintenance Period (up to Month 6)|Withdrawal by Subject|1
5805471|NCT02873702|20030978|P3|Maintenance Period (up to Month 6)|Withdrawal by Subject|2
5805554|NCT02872311|20031390|P4|Overall Study|Protocol Violation|0
5805472|NCT02873702|20030979|P2|Maintenance Period (up to Month 6)|Withdrawal by Subject|0
5805473|NCT02873702|20030980|P1|Maintenance Period (up to Month 6)|Withdrawal by Subject|0
5805474|NCT02873702|20030977|P4|Maintenance Period (up to Month 6)|Relapse of EE|1
5805475|NCT02873702|20030978|P3|Maintenance Period (up to Month 6)|Relapse of EE|4
5805476|NCT02873702|20030979|P2|Maintenance Period (up to Month 6)|Relapse of EE|0
5805477|NCT02873702|20030980|P1|Maintenance Period (up to Month 6)|Relapse of EE|0
5805478|NCT02873702|20030977|P4|Maintenance Period (up to Month 6)|Adverse Event|0
5805479|NCT02873702|20030978|P3|Maintenance Period (up to Month 6)|Adverse Event|1
5805480|NCT02873702|20030979|P2|Maintenance Period (up to Month 6)|Adverse Event|0
5805481|NCT02873702|20030980|P1|Maintenance Period (up to Month 6)|Adverse Event|0
5805482|NCT02873702|20030977|P4|Healing Period (up to Week 8)|Withdrawal by Subject|0
5805483|NCT02873702|20030978|P3|Healing Period (up to Week 8)|Withdrawal by Subject|0
5805484|NCT02873702|20030979|P2|Healing Period (up to Week 8)|Withdrawal by Subject|1
5805485|NCT02873702|20030980|P1|Healing Period (up to Week 8)|Withdrawal by Subject|0
5805486|NCT02873702|20030977|P4|Healing Period (up to Week 8)|Adverse Event|0
5805487|NCT02873702|20030978|P3|Healing Period (up to Week 8)|Adverse Event|0
5805488|NCT02873702|20030979|P2|Healing Period (up to Week 8)|Adverse Event|0
5805489|NCT02873702|20030980|P1|Healing Period (up to Week 8)|Adverse Event|1
5805490|NCT02873689|20030992|P2|Overall Study|Randomized but not Treated|1
5805491|NCT02873689|20030993|P1|Overall Study|Randomized but not Treated|1
5805492|NCT02873689|20030992|P2|Overall Study|Adverse Event|2
5805493|NCT02873689|20030993|P1|Overall Study|Adverse Event|2
5805494|NCT02873689|20030992|P2|Overall Study|Protocol Violation|0
5805495|NCT02873689|20030993|P1|Overall Study|Protocol Violation|1
5805496|NCT02873689|20030992|P2|Overall Study|Withdrawal by Subject|2
5805497|NCT02873689|20030993|P1|Overall Study|Withdrawal by Subject|2
5805498|NCT02873689|20030992|P2|Overall Study|Lack of Efficacy|0
5805499|NCT02873689|20030993|P1|Overall Study|Lack of Efficacy|1
5805500|NCT02873429|20031034|P2|16 Weeks|Lost to Follow-up|0
5805501|NCT02873429|20031035|P1|16 Weeks|Lost to Follow-up|3
5805502|NCT02873429|20031034|P2|16 Weeks|Completed 6-8 week, missed 16 week|2
5805503|NCT02873429|20031035|P1|16 Weeks|Completed 6-8 week, missed 16 week|2
5805504|NCT02873429|20031034|P2|6-8 Weeks|Missed 6-8 week, eligible for 16 week|1
5805505|NCT02873429|20031035|P1|6-8 Weeks|Missed 6-8 week, eligible for 16 week|10
5805506|NCT02873377|20031047|P2|Period Title 3: 6 Months Follow up|Lost to Follow-up|23
5805507|NCT02873377|20031048|P1|Period Title 3: 6 Months Follow up|Lost to Follow-up|15
5805508|NCT02873377|20031047|P2|Period Title 2: 3 Months Follow up|Lost to Follow-up|22
5805509|NCT02873377|20031048|P1|Period Title 2: 3 Months Follow up|Lost to Follow-up|22
5805510|NCT02873221|20031306|P3|Safety Follow-up Period|Withdrawal of Consent|8
5805511|NCT02873221|20031307|P2|Safety Follow-up Period|Withdrawal of Consent|10
5805512|NCT02873221|20031308|P1|Safety Follow-up Period|Withdrawal of Consent|4
5805513|NCT02873221|20031306|P3|Safety Follow-up Period|Lost to Follow-up|5
5805514|NCT02873221|20031307|P2|Safety Follow-up Period|Lost to Follow-up|5
5805515|NCT02873221|20031308|P1|Safety Follow-up Period|Lost to Follow-up|3
5805516|NCT02873221|20031306|P3|Safety Follow-up Period|Protocol Violation|1
5805517|NCT02873221|20031307|P2|Safety Follow-up Period|Protocol Violation|0
5805518|NCT02873221|20031308|P1|Safety Follow-up Period|Protocol Violation|0
5805519|NCT02873221|20031306|P3|Safety Follow-up Period|Other Miscellaneous Reasons|0
5805520|NCT02873221|20031307|P2|Safety Follow-up Period|Other Miscellaneous Reasons|2
5805521|NCT02873221|20031308|P1|Safety Follow-up Period|Other Miscellaneous Reasons|0
5805522|NCT02873221|20031306|P3|Treatment Period|Lost to Follow-up|26
5805523|NCT02873221|20031307|P2|Treatment Period|Lost to Follow-up|30
5805524|NCT02873221|20031308|P1|Treatment Period|Lost to Follow-up|26
5805525|NCT02873221|20031306|P3|Treatment Period|Adverse Event|11
5805526|NCT02873221|20031307|P2|Treatment Period|Adverse Event|9
5805527|NCT02873221|20031308|P1|Treatment Period|Adverse Event|4
5805528|NCT02873221|20031306|P3|Treatment Period|Lack of Efficacy|12
5805529|NCT02873221|20031307|P2|Treatment Period|Lack of Efficacy|17
5805530|NCT02873221|20031308|P1|Treatment Period|Lack of Efficacy|0
5805531|NCT02873221|20031306|P3|Treatment Period|Withdrawal of Consent|41
5805532|NCT02873221|20031307|P2|Treatment Period|Withdrawal of Consent|51
5805533|NCT02873221|20031308|P1|Treatment Period|Withdrawal of Consent|52
5805534|NCT02873221|20031306|P3|Treatment Period|Lack of Qualifying Event|1
5805535|NCT02873221|20031307|P2|Treatment Period|Lack of Qualifying Event|3
5805536|NCT02873221|20031308|P1|Treatment Period|Lack of Qualifying Event|0
5805537|NCT02873221|20031306|P3|Treatment Period|Pregnancy|3
5805538|NCT02873221|20031307|P2|Treatment Period|Pregnancy|6
5805539|NCT02873221|20031308|P1|Treatment Period|Pregnancy|4
5805540|NCT02873221|20031306|P3|Treatment Period|Protocol Violation|8
5805541|NCT02873221|20031307|P2|Treatment Period|Protocol Violation|5
5805542|NCT02873221|20031308|P1|Treatment Period|Protocol Violation|2
5805543|NCT02873221|20031306|P3|Treatment Period|Non-Compliance with Study Drug|2
5805544|NCT02873221|20031307|P2|Treatment Period|Non-Compliance with Study Drug|3
5805545|NCT02873221|20031308|P1|Treatment Period|Non-Compliance with Study Drug|0
5805546|NCT02873221|20031306|P3|Treatment Period|Other Miscellaneous Reasons|1
5805547|NCT02873221|20031307|P2|Treatment Period|Other Miscellaneous Reasons|2
5805548|NCT02873221|20031308|P1|Treatment Period|Other Miscellaneous Reasons|0
5805551|NCT02872935|20031360|P2|Overall Study|Other|1
5805552|NCT02872935|20031361|P1|Overall Study|Other|0
5805553|NCT02872311|20031389|P5|Overall Study|Protocol Violation|0
5805555|NCT02872311|20031391|P3|Overall Study|Protocol Violation|1
5805556|NCT02872311|20031392|P2|Overall Study|Protocol Violation|2
5805557|NCT02872311|20031393|P1|Overall Study|Protocol Violation|0
5805558|NCT02872311|20031389|P5|Overall Study|Lost to Follow-up|0
5805559|NCT02872311|20031390|P4|Overall Study|Lost to Follow-up|0
5805560|NCT02872311|20031391|P3|Overall Study|Lost to Follow-up|0
5805561|NCT02872311|20031392|P2|Overall Study|Lost to Follow-up|0
5805562|NCT02872311|20031393|P1|Overall Study|Lost to Follow-up|2
5805563|NCT02872311|20031389|P5|Overall Study|Death|0
5805564|NCT02872311|20031390|P4|Overall Study|Death|0
5805565|NCT02872311|20031391|P3|Overall Study|Death|0
5805566|NCT02872311|20031392|P2|Overall Study|Death|0
5805567|NCT02872311|20031393|P1|Overall Study|Death|2
5805568|NCT02872285|20031454|P2|Overall Study|Discontinued due to back surgery|0
5805569|NCT02872285|20031455|P1|Overall Study|Discontinued due to back surgery|1
5805570|NCT02872285|20031454|P2|Overall Study|Lost to Follow-up|2
5805571|NCT02872285|20031455|P1|Overall Study|Lost to Follow-up|2
5805572|NCT02872285|20031454|P2|Overall Study|Withdrawal by Subject|0
5805573|NCT02872285|20031455|P1|Overall Study|Withdrawal by Subject|2
5805574|NCT02872012|20031501|P5|Overall Study|Withdrawal by Subject|0
5805575|NCT02872012|20031502|P4|Overall Study|Withdrawal by Subject|0
5805576|NCT02872012|20031503|P3|Overall Study|Withdrawal by Subject|0
5805577|NCT02872012|20031504|P2|Overall Study|Withdrawal by Subject|0
5805578|NCT02872012|20031505|P1|Overall Study|Withdrawal by Subject|1
5805579|NCT02871739|20031523|P4|Overall Study|Lost to Follow-up|2
5805580|NCT02871739|20031524|P3|Overall Study|Lost to Follow-up|0
5805581|NCT02871739|20031525|P2|Overall Study|Lost to Follow-up|2
5805582|NCT02871739|20031526|P1|Overall Study|Lost to Follow-up|3
5805583|NCT02871635|20031538|P2|Overall Study|Secondary lack of efficacy|1
5805584|NCT02871635|20031539|P1|Overall Study|Secondary lack of efficacy|2
5805585|NCT02871635|20031538|P2|Overall Study|Adverse Event|4
5805586|NCT02871635|20031539|P1|Overall Study|Adverse Event|4
5805587|NCT02871635|20031538|P2|Overall Study|Withdrawal by Subject|4
5805588|NCT02871635|20031539|P1|Overall Study|Withdrawal by Subject|3
5805589|NCT02871635|20031538|P2|Overall Study|Physician Decision|1
5805590|NCT02871635|20031539|P1|Overall Study|Physician Decision|1
5805591|NCT02871635|20031538|P2|Overall Study|Pregnancy|2
5805592|NCT02871635|20031539|P1|Overall Study|Pregnancy|0
5805593|NCT02871635|20031538|P2|Overall Study|Lost to Follow-up|2
5805594|NCT02871635|20031539|P1|Overall Study|Lost to Follow-up|1
5805595|NCT02871635|20031538|P2|Overall Study|Protocol Violation|1
5805596|NCT02871635|20031539|P1|Overall Study|Protocol Violation|3
5805597|NCT02871635|20031538|P2|Overall Study|Primary lack of efficacy|4
5805598|NCT02871635|20031539|P1|Overall Study|Primary lack of efficacy|4
5805599|NCT02871375|20031629|P2|Period 1, First 14 Days of Wear|Inclusion criteria not met|1
5805600|NCT02871375|20031630|P1|Period 1, First 14 Days of Wear|Inclusion criteria not met|0
5805601|NCT02870933|20031676|P2|Overall Study|Withdrawal by Subject|1
5805602|NCT02870933|20031677|P1|Overall Study|Withdrawal by Subject|0
5805603|NCT02870933|20031676|P2|Overall Study|Death|1
5805604|NCT02870933|20031677|P1|Overall Study|Death|2
5805605|NCT02869893|20031763|P1|Overall Study|participant fear of MRI scanner|2
5805606|NCT02869893|20031763|P1|Overall Study|participant aversion to IV|5
5805607|NCT02869438|20031793|P2|Overall Study|Withdrawal by Subject|2
5805608|NCT02869438|20031794|P1|Overall Study|Withdrawal by Subject|1
5805609|NCT02869438|20031793|P2|Overall Study|Adverse Event|0
5805610|NCT02869438|20031794|P1|Overall Study|Adverse Event|1
5805611|NCT02869438|20031793|P2|Overall Study|Lost to Follow-up|0
5805612|NCT02869438|20031794|P1|Overall Study|Lost to Follow-up|1
5805613|NCT02868892|20031842|P1|Overall Study|Investigator left site and no follow-up|6
5805614|NCT02868554|20031851|P3|Overall Study|Lost to Follow-up|1
5805615|NCT02868554|20031852|P2|Overall Study|Lost to Follow-up|0
5805616|NCT02868554|20031853|P1|Overall Study|Lost to Follow-up|3
5805617|NCT02868281|20031878|P2|Overall Study|Long journey/moving away|1
5805618|NCT02868281|20031879|P1|Overall Study|Long journey/moving away|1
5805619|NCT02868281|20031878|P2|Overall Study|Inclusion/exclusion criteria violation|2
5805620|NCT02868281|20031879|P1|Overall Study|Inclusion/exclusion criteria violation|3
5805621|NCT02868281|20031878|P2|Overall Study|Had protocol-defined asthma exacerbation|8
5805622|NCT02868281|20031879|P1|Overall Study|Had protocol-defined asthma exacerbation|8
5805623|NCT02868281|20031878|P2|Overall Study|Physician Decision|0
5805624|NCT02868281|20031879|P1|Overall Study|Physician Decision|2
5805625|NCT02868281|20031878|P2|Overall Study|Withdrawal by Subject|15
5805626|NCT02868281|20031879|P1|Overall Study|Withdrawal by Subject|11
5805627|NCT02868281|20031878|P2|Overall Study|Lost to Follow-up|6
5805628|NCT02868281|20031879|P1|Overall Study|Lost to Follow-up|3
5805629|NCT02868281|20031878|P2|Overall Study|Protocol Violation|10
5805630|NCT02868281|20031879|P1|Overall Study|Protocol Violation|13
5805631|NCT02868281|20031878|P2|Overall Study|Adverse Event|2
5805632|NCT02868281|20031879|P1|Overall Study|Adverse Event|2
5805633|NCT02868216|20031913|P2|Overall Study|Withdrawal by Subject|5
5805634|NCT02868216|20031914|P1|Overall Study|Withdrawal by Subject|7
5805635|NCT02868216|20031913|P2|Overall Study|coronary artery bypass|0
5805636|NCT02868216|20031914|P1|Overall Study|coronary artery bypass|1
5805637|NCT02868216|20031913|P2|Overall Study|Death|1
5805638|NCT02868216|20031914|P1|Overall Study|Death|0
5805639|NCT02867995|20031922|P2|Overall Study|Lost to Follow-up|2
5805640|NCT02867995|20031923|P1|Overall Study|Lost to Follow-up|0
5805641|NCT02867995|20031922|P2|Overall Study|Withdrawal by Subject|1
5805642|NCT02867995|20031923|P1|Overall Study|Withdrawal by Subject|0
5805643|NCT02867709|20031942|P3|Safety Follow-up Period|Protocol Violation|1
5805644|NCT02867709|20031943|P2|Safety Follow-up Period|Protocol Violation|1
5805645|NCT02867709|20031944|P1|Safety Follow-up Period|Protocol Violation|0
5805646|NCT02867709|20031942|P3|Safety Follow-up Period|Pregnancy|0
5805647|NCT02867709|20031943|P2|Safety Follow-up Period|Pregnancy|1
5805648|NCT02867709|20031944|P1|Safety Follow-up Period|Pregnancy|0
5805649|NCT02867709|20031942|P3|Safety Follow-up Period|Lost to Follow-up|7
5805650|NCT02867709|20031943|P2|Safety Follow-up Period|Lost to Follow-up|5
5805651|NCT02867709|20031944|P1|Safety Follow-up Period|Lost to Follow-up|10
5805652|NCT02867709|20031942|P3|Safety Follow-up Period|Withdrawal of Consent|6
5805653|NCT02867709|20031943|P2|Safety Follow-up Period|Withdrawal of Consent|8
5805654|NCT02867709|20031944|P1|Safety Follow-up Period|Withdrawal of Consent|1
5805655|NCT02867709|20031942|P3|Treatment Period|Protocol Violation|3
5805656|NCT02867709|20031943|P2|Treatment Period|Protocol Violation|2
5805657|NCT02867709|20031944|P1|Treatment Period|Protocol Violation|3
5805658|NCT02867709|20031942|P3|Treatment Period|Lack of Qualifying Event|42
5805659|NCT02867709|20031943|P2|Treatment Period|Lack of Qualifying Event|55
5805660|NCT02867709|20031944|P1|Treatment Period|Lack of Qualifying Event|42
5805661|NCT02867709|20031942|P3|Treatment Period|Lost to Follow-up|20
5805662|NCT02867709|20031943|P2|Treatment Period|Lost to Follow-up|20
5805663|NCT02867709|20031944|P1|Treatment Period|Lost to Follow-up|17
5805664|NCT02867709|20031942|P3|Treatment Period|Withdrawal of Consent|8
5805665|NCT02867709|20031943|P2|Treatment Period|Withdrawal of Consent|9
5805666|NCT02867709|20031944|P1|Treatment Period|Withdrawal of Consent|7
5805667|NCT02867709|20031942|P3|Treatment Period|Adverse Event|2
5805668|NCT02867709|20031943|P2|Treatment Period|Adverse Event|1
5805669|NCT02867709|20031944|P1|Treatment Period|Adverse Event|1
5805670|NCT02866942|20032051|P1|Overall Study|Invalid consent|1
5805671|NCT02866695|20032056|P1|Overall Study|Lost to Follow-up|1
5805672|NCT02866695|20032056|P1|Overall Study|Adverse Event|1
5805673|NCT02866175|20032073|P2|Overall Study|Did not receive treatment|15
5805674|NCT02866175|20032074|P1|Overall Study|Did not receive treatment|5
5805675|NCT02866175|20032073|P2|Overall Study|Physician Decision|15
5805676|NCT02866175|20032074|P1|Overall Study|Physician Decision|3
5805677|NCT02866175|20032073|P2|Overall Study|Lack of Efficacy|1
5805678|NCT02866175|20032074|P1|Overall Study|Lack of Efficacy|0
5805679|NCT02866175|20032073|P2|Overall Study|Lost to Follow-up|0
5805680|NCT02866175|20032074|P1|Overall Study|Lost to Follow-up|2
5805681|NCT02866175|20032073|P2|Overall Study|Progressive disease|1
5805682|NCT02866175|20032074|P1|Overall Study|Progressive disease|1
5805683|NCT02866175|20032073|P2|Overall Study|Other|14
5805684|NCT02866175|20032074|P1|Overall Study|Other|7
5805685|NCT02866175|20032073|P2|Overall Study|Death|23
5805686|NCT02866175|20032074|P1|Overall Study|Death|30
5805687|NCT02866175|20032073|P2|Overall Study|Withdrawal by Subject|52
5805688|NCT02866175|20032074|P1|Overall Study|Withdrawal by Subject|31
5805689|NCT02866175|20032073|P2|Overall Study|Adverse Event|54
5805690|NCT02866175|20032074|P1|Overall Study|Adverse Event|56
5805705|NCT02865499|20032138|P1|Baseline|Withdrawal by Subject|1
5805706|NCT02865499|20032138|P1|Baseline|Adverse Event|1
5805707|NCT02865395|20032145|P3|Overall Study|Physician Decision|7
5805708|NCT02865395|20032146|P2|Overall Study|Physician Decision|10
5805709|NCT02865395|20032147|P1|Overall Study|Physician Decision|6
5805710|NCT02865083|20032173|P2|Overall Study|Early Termination|1
5805711|NCT02865083|20032174|P1|Overall Study|Early Termination|3
5805712|NCT02864394|20032235|P2|Overall Study|Ongoing In Study|53
5805713|NCT02864394|20032236|P1|Overall Study|Ongoing In Study|77
5805714|NCT02864394|20032235|P2|Overall Study|Withdrawal by Subject|9
5805715|NCT02864394|20032236|P1|Overall Study|Withdrawal by Subject|1
5805716|NCT02864394|20032235|P2|Overall Study|Death|150
5805717|NCT02864394|20032236|P1|Overall Study|Death|135
5805718|NCT02864381|20032262|P2|Overall Study|Protocol Violation|1
5805719|NCT02864381|20032263|P1|Overall Study|Protocol Violation|0
5805720|NCT02864381|20032262|P2|Overall Study|Investigator's Discretion|0
5805721|NCT02864381|20032263|P1|Overall Study|Investigator's Discretion|1
5805722|NCT02864381|20032262|P2|Overall Study|Lost to Follow-up|1
5805723|NCT02864381|20032263|P1|Overall Study|Lost to Follow-up|1
5805724|NCT02864381|20032262|P2|Overall Study|Reason Unknown|3
5805725|NCT02864381|20032263|P1|Overall Study|Reason Unknown|7
5805726|NCT02864381|20032262|P2|Overall Study|Withdrew Consent|6
5805727|NCT02864381|20032263|P1|Overall Study|Withdrew Consent|5
5805728|NCT02864381|20032262|P2|Overall Study|Death|61
5805729|NCT02864381|20032263|P1|Overall Study|Death|58
5805730|NCT02864342|20032281|P2|Overall Study|Adverse Event|0
5805731|NCT02864342|20032282|P1|Overall Study|Adverse Event|1
5805732|NCT02864342|20032281|P2|Overall Study|Lost Device|0
5805733|NCT02864342|20032282|P1|Overall Study|Lost Device|1
5805734|NCT02864342|20032281|P2|Overall Study|Lost to Follow-up|5
5805735|NCT02864342|20032282|P1|Overall Study|Lost to Follow-up|1
5805736|NCT02864342|20032281|P2|Overall Study|Did Not Start Treatment with Symbicort|1
5805737|NCT02864342|20032282|P1|Overall Study|Did Not Start Treatment with Symbicort|0
5805738|NCT02864342|20032281|P2|Overall Study|Death|1
5805739|NCT02864342|20032282|P1|Overall Study|Death|0
5805740|NCT02864342|20032281|P2|Overall Study|Device Technology Issue|7
5805741|NCT02864342|20032282|P1|Overall Study|Device Technology Issue|6
5805742|NCT02864342|20032281|P2|Overall Study|Withdrawal by Subject|2
5805743|NCT02864342|20032282|P1|Overall Study|Withdrawal by Subject|4
5805744|NCT02864342|20032281|P2|Overall Study|Eligibility Criteria Deviation|3
5805745|NCT02864342|20032282|P1|Overall Study|Eligibility Criteria Deviation|2
5805746|NCT02864316|20032299|P2|Overall Study|Adverse Event|1
5805747|NCT02864316|20032300|P1|Overall Study|Adverse Event|0
5805748|NCT02864316|20032299|P2|Overall Study|Progressive Disease|1
5805749|NCT02864316|20032300|P1|Overall Study|Progressive Disease|2
5805750|NCT02863575|20032338|P3|Overall Study|Adverse Event|0
5805751|NCT02863575|20032339|P2|Overall Study|Adverse Event|1
5805752|NCT02863575|20032340|P1|Overall Study|Adverse Event|0
5805753|NCT02863575|20032338|P3|Overall Study|Withdrawal by Subject|1
5805754|NCT02863575|20032339|P2|Overall Study|Withdrawal by Subject|1
5805755|NCT02863575|20032340|P1|Overall Study|Withdrawal by Subject|0
5805756|NCT02863575|20032338|P3|Overall Study|Participants Unable To Swallow Capsule|0
5805757|NCT02863575|20032339|P2|Overall Study|Participants Unable To Swallow Capsule|0
5805758|NCT02863575|20032340|P1|Overall Study|Participants Unable To Swallow Capsule|1
5805759|NCT02863419|20032392|P3|Overall Study|Died|1
5805760|NCT02863419|20032393|P2|Overall Study|Died|4
5805761|NCT02863419|20032394|P1|Overall Study|Died|3
5805762|NCT02863419|20032392|P3|Overall Study|Withdrawal by Subject|3
5805763|NCT02863419|20032393|P2|Overall Study|Withdrawal by Subject|5
5805764|NCT02863419|20032394|P1|Overall Study|Withdrawal by Subject|5
5805765|NCT02863419|20032392|P3|Overall Study|Lost to Follow-up|4
5805766|NCT02863419|20032393|P2|Overall Study|Lost to Follow-up|1
5805767|NCT02863419|20032394|P1|Overall Study|Lost to Follow-up|0
5805768|NCT02863328|20032511|P2|Overall Study|Died|1
5805769|NCT02863328|20032512|P1|Overall Study|Died|0
5805770|NCT02863328|20032511|P2|Overall Study|Withdrawal by Subject|12
5805771|NCT02863328|20032512|P1|Overall Study|Withdrawal by Subject|7
5805772|NCT02863328|20032511|P2|Overall Study|Lost to Follow-up|10
5805773|NCT02863328|20032512|P1|Overall Study|Lost to Follow-up|4
5805774|NCT02862730|20032669|P7|Third Intervention (84 Hours)|diagnosis of gastroparesis|0
5805775|NCT02862730|20032670|P6|Third Intervention (84 Hours)|diagnosis of gastroparesis|0
5805776|NCT02862730|20032671|P5|Third Intervention (84 Hours)|diagnosis of gastroparesis|0
5805777|NCT02862730|20032672|P4|Third Intervention (84 Hours)|diagnosis of gastroparesis|1
5805778|NCT02862730|20032673|P3|Third Intervention (84 Hours)|diagnosis of gastroparesis|0
5805779|NCT02862730|20032674|P2|Third Intervention (84 Hours)|diagnosis of gastroparesis|0
5805780|NCT02862730|20032675|P1|Third Intervention (84 Hours)|diagnosis of gastroparesis|0
5805781|NCT02862730|20032669|P7|Third Rest Period (7-45 Days)|Withdrawal by Subject|0
5805782|NCT02862730|20032670|P6|Third Rest Period (7-45 Days)|Withdrawal by Subject|0
5805783|NCT02862730|20032671|P5|Third Rest Period (7-45 Days)|Withdrawal by Subject|1
5805784|NCT02862730|20032672|P4|Third Rest Period (7-45 Days)|Withdrawal by Subject|0
5805785|NCT02862730|20032673|P3|Third Rest Period (7-45 Days)|Withdrawal by Subject|1
5805786|NCT02862730|20032674|P2|Third Rest Period (7-45 Days)|Withdrawal by Subject|0
5805787|NCT02862730|20032675|P1|Third Rest Period (7-45 Days)|Withdrawal by Subject|0
5805788|NCT02862730|20032669|P7|Second Intervention (84 Hours)|Withdrawal by Subject|0
5805789|NCT02862730|20032670|P6|Second Intervention (84 Hours)|Withdrawal by Subject|0
5805790|NCT02862730|20032671|P5|Second Intervention (84 Hours)|Withdrawal by Subject|0
5805791|NCT02862730|20032672|P4|Second Intervention (84 Hours)|Withdrawal by Subject|0
5805792|NCT02862730|20032673|P3|Second Intervention (84 Hours)|Withdrawal by Subject|0
5805793|NCT02862730|20032674|P2|Second Intervention (84 Hours)|Withdrawal by Subject|0
5805794|NCT02862730|20032675|P1|Second Intervention (84 Hours)|Withdrawal by Subject|1
5805795|NCT02862730|20032669|P7|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0
5805796|NCT02862730|20032670|P6|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0
5805797|NCT02862730|20032671|P5|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0
5805798|NCT02862730|20032672|P4|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0
5805799|NCT02862730|20032673|P3|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|1
5805800|NCT02862730|20032674|P2|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0
5805801|NCT02862730|20032675|P1|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0
5805802|NCT02862600|20032730|P1|Period 2--Perhexiline-high Target Range|Lack of Efficacy|7
5805803|NCT02862600|20032730|P1|Period 1--Perhexiline-low Target Range|Withdrawal by Subject|1
5805804|NCT02862600|20032730|P1|Period 1--Perhexiline-low Target Range|Protocol Violation|3
5805805|NCT02862600|20032730|P1|Period 1--Perhexiline-low Target Range|Lack of Efficacy|9
5805806|NCT02862574|20032740|P3|Open-Label Treatment Period|Study Terminated by Sponsor|1
5805807|NCT02862574|20032741|P2|Open-Label Treatment Period|Study Terminated by Sponsor|3
5805808|NCT02862574|20032742|P1|Open-Label Treatment Period|Study Terminated by Sponsor|2
5805809|NCT02862574|20032740|P3|Double-Blind Treatment Period|Study Terminated by Sponsor|4
5805810|NCT02862574|20032741|P2|Double-Blind Treatment Period|Study Terminated by Sponsor|1
5805811|NCT02862574|20032742|P1|Double-Blind Treatment Period|Study Terminated by Sponsor|3
5805812|NCT02862574|20032740|P3|Double-Blind Treatment Period|Adverse Event|0
5805813|NCT02862574|20032741|P2|Double-Blind Treatment Period|Adverse Event|1
5805814|NCT02862574|20032742|P1|Double-Blind Treatment Period|Adverse Event|0
5805815|NCT02862548|20032762|P2|Open-Label Extension Phase|Still on Study|24
5805816|NCT02862548|20032763|P1|Open-Label Extension Phase|Still on Study|26
5805817|NCT02862548|20032762|P2|Open-Label Phase|Death|1
5805818|NCT02862548|20032763|P1|Open-Label Phase|Death|0
5805819|NCT02862535|20032791|P4|Overall Study|Enrolled, not Treated|1
5805820|NCT02862535|20032792|P3|Overall Study|Enrolled, not Treated|0
5805821|NCT02862535|20032793|P2|Overall Study|Enrolled, not Treated|0
5805822|NCT02862535|20032794|P1|Overall Study|Enrolled, not Treated|1
5805823|NCT02862535|20032791|P4|Overall Study|Study Terminated by Sponsor|5
5805824|NCT02862535|20032792|P3|Overall Study|Study Terminated by Sponsor|8
5805825|NCT02862535|20032793|P2|Overall Study|Study Terminated by Sponsor|3
5805826|NCT02862535|20032794|P1|Overall Study|Study Terminated by Sponsor|1
5805827|NCT02862535|20032791|P4|Overall Study|Death|5
5805828|NCT02862535|20032792|P3|Overall Study|Death|2
5805829|NCT02862535|20032793|P2|Overall Study|Death|3
5805830|NCT02862535|20032794|P1|Overall Study|Death|7
5805831|NCT02862106|20032822|P2|Overall Study|Subjects moved to other city|0
5805832|NCT02862106|20032823|P1|Overall Study|Subjects moved to other city|1
5805833|NCT02862106|20032822|P2|Overall Study|Withdrawal by Subject|0
5805834|NCT02862106|20032823|P1|Overall Study|Withdrawal by Subject|2
5805835|NCT02862106|20032822|P2|Overall Study|Lost to Follow-up|5
5805836|NCT02862106|20032823|P1|Overall Study|Lost to Follow-up|15
5805837|NCT02862106|20032822|P2|Overall Study|Protocol Violation|1
5805838|NCT02862106|20032823|P1|Overall Study|Protocol Violation|16
5805839|NCT02862106|20032822|P2|Overall Study|Adverse Event|0
5805840|NCT02862106|20032823|P1|Overall Study|Adverse Event|4
5805841|NCT02861807|20032944|P2|Overall Study|Withdrawal by Subject|8
5805842|NCT02861807|20032945|P1|Overall Study|Withdrawal by Subject|5
5805843|NCT02861807|20032944|P2|Overall Study|Lost to Follow-up|6
5805844|NCT02861807|20032945|P1|Overall Study|Lost to Follow-up|7
5805845|NCT02861664|20032961|P2|Overall Study|Withdrawal of Consent|1
5805846|NCT02861664|20032962|P1|Overall Study|Withdrawal of Consent|0
5805847|NCT02861534|20032974|P2|Overall Study|Withdrawal by Subject|18
5805848|NCT02861534|20032975|P1|Overall Study|Withdrawal by Subject|15
5805849|NCT02861534|20032974|P2|Overall Study|Site Terminated by Sponsor|3
5805850|NCT02861534|20032975|P1|Overall Study|Site Terminated by Sponsor|4
5805851|NCT02861534|20032974|P2|Overall Study|Lost to Follow-up|14
5805852|NCT02861534|20032975|P1|Overall Study|Lost to Follow-up|14
5805853|NCT02861534|20032974|P2|Overall Study|Death|552
5805854|NCT02861534|20032975|P1|Overall Study|Death|541
5805855|NCT02860169|20033063|P1|Part C|Other (Screening failure)|1
5805856|NCT02860169|20033063|P1|Part B|Withdrawal by Subject|1
5805857|NCT02860169|20033063|P1|Part B|Other (Screening failure)|10
5805858|NCT02860169|20033063|P1|Part A|Other (did not completed consent)|1
5805859|NCT02860169|20033063|P1|Part A|Other (Survey not completed)|3
5805860|NCT02860169|20033063|P1|Part A|Other (Screening failure)|6
5805861|NCT02860169|20033063|P1|Part A|Withdrawal by Subject|1
5805862|NCT02860130|20033081|P2|Overall Study|Other|1
5805863|NCT02860130|20033082|P1|Overall Study|Other|2
5805864|NCT02860130|20033081|P2|Overall Study|Physician Decision|2
5805865|NCT02860130|20033082|P1|Overall Study|Physician Decision|2
5805866|NCT02860130|20033081|P2|Overall Study|Withdrawal by Subject|2
5805867|NCT02860130|20033082|P1|Overall Study|Withdrawal by Subject|0
5805868|NCT02860130|20033081|P2|Overall Study|Protocol Violation|1
5805869|NCT02860130|20033082|P1|Overall Study|Protocol Violation|1
5805870|NCT02860130|20033081|P2|Overall Study|Adverse Event|3
5805871|NCT02860130|20033082|P1|Overall Study|Adverse Event|2
5805873|NCT02859246|20033203|P1|Overall Study|Withdrawal by Subject|1
5805874|NCT02859246|20033203|P1|Overall Study|Adverse Event|1
5805875|NCT02859246|20033203|P1|Overall Study|Screen fails|3
5805876|NCT02858726|20033212|P4|Overall Study|Noncompliance|0
5805877|NCT02858726|20033213|P3|Overall Study|Noncompliance|0
5805878|NCT02858726|20033214|P2|Overall Study|Noncompliance|1
5805879|NCT02858726|20033215|P1|Overall Study|Noncompliance|0
5805880|NCT02858726|20033212|P4|Overall Study|Withdrawal by Subject|0
5805881|NCT02858726|20033213|P3|Overall Study|Withdrawal by Subject|1
5805882|NCT02858726|20033214|P2|Overall Study|Withdrawal by Subject|2
5805883|NCT02858726|20033215|P1|Overall Study|Withdrawal by Subject|1
5805884|NCT02858726|20033212|P4|Overall Study|Study Terminated by Sponsor|1
5805885|NCT02858726|20033213|P3|Overall Study|Study Terminated by Sponsor|0
5805886|NCT02858726|20033214|P2|Overall Study|Study Terminated by Sponsor|0
5805887|NCT02858726|20033215|P1|Overall Study|Study Terminated by Sponsor|0
5805888|NCT02858726|20033212|P4|Overall Study|Protocol Violation|1
5805889|NCT02858726|20033213|P3|Overall Study|Protocol Violation|0
5805890|NCT02858726|20033214|P2|Overall Study|Protocol Violation|0
5805891|NCT02858726|20033215|P1|Overall Study|Protocol Violation|0
5805892|NCT02858726|20033212|P4|Overall Study|Physician Decision|0
5805893|NCT02858726|20033213|P3|Overall Study|Physician Decision|1
5805894|NCT02858726|20033214|P2|Overall Study|Physician Decision|0
5805895|NCT02858726|20033215|P1|Overall Study|Physician Decision|0
5805896|NCT02858726|20033212|P4|Overall Study|Adverse Event|1
5805897|NCT02858726|20033213|P3|Overall Study|Adverse Event|9
5805898|NCT02858726|20033214|P2|Overall Study|Adverse Event|4
5805899|NCT02858726|20033215|P1|Overall Study|Adverse Event|4
5805900|NCT02858492|20033246|P4|Overall Study|Protocol defined stopping criteria|1
5805901|NCT02858492|20033247|P3|Overall Study|Protocol defined stopping criteria|0
5805902|NCT02858492|20033248|P2|Overall Study|Protocol defined stopping criteria|0
5805903|NCT02858492|20033249|P1|Overall Study|Protocol defined stopping criteria|0
5805904|NCT02858492|20033246|P4|Overall Study|Lack of Efficacy|1
5805905|NCT02858492|20033247|P3|Overall Study|Lack of Efficacy|0
5805906|NCT02858492|20033248|P2|Overall Study|Lack of Efficacy|0
5805907|NCT02858492|20033249|P1|Overall Study|Lack of Efficacy|0
5805908|NCT02858492|20033246|P4|Overall Study|Adverse Event|3
5805909|NCT02858492|20033247|P3|Overall Study|Adverse Event|0
5805910|NCT02858492|20033248|P2|Overall Study|Adverse Event|0
5805911|NCT02858492|20033249|P1|Overall Study|Adverse Event|0
5805912|NCT02858492|20033246|P4|Overall Study|Withdrawal by Subject|1
5805913|NCT02858492|20033247|P3|Overall Study|Withdrawal by Subject|0
5805914|NCT02858492|20033248|P2|Overall Study|Withdrawal by Subject|1
5805915|NCT02858492|20033249|P1|Overall Study|Withdrawal by Subject|0
5805916|NCT02858440|20033425|P1|Overall Study|Migrated/moved from study area|4
5805917|NCT02858440|20033425|P1|Overall Study|Consent withdrawal|3
5805918|NCT02858440|20033425|P1|Overall Study|Protocol Violation|2
5805919|NCT02858440|20033425|P1|Overall Study|Lost to Follow-up|3
5805920|NCT02858401|20033458|P7|Overall Study|Lost to Follow-up|0
5805921|NCT02858401|20033459|P6|Overall Study|Lost to Follow-up|0
5805922|NCT02858401|20033460|P5|Overall Study|Lost to Follow-up|0
5805923|NCT02858401|20033461|P4|Overall Study|Lost to Follow-up|0
5805924|NCT02858401|20033462|P3|Overall Study|Lost to Follow-up|0
5805925|NCT02858401|20033463|P2|Overall Study|Lost to Follow-up|1
5805926|NCT02858401|20033464|P1|Overall Study|Lost to Follow-up|0
5805927|NCT02858401|20033458|P7|Overall Study|Withdrew Consent|0
5805928|NCT02858401|20033459|P6|Overall Study|Withdrew Consent|1
5805929|NCT02858401|20033460|P5|Overall Study|Withdrew Consent|0
5805930|NCT02858401|20033461|P4|Overall Study|Withdrew Consent|0
5805931|NCT02858401|20033462|P3|Overall Study|Withdrew Consent|0
5805932|NCT02858401|20033463|P2|Overall Study|Withdrew Consent|0
5805933|NCT02858401|20033464|P1|Overall Study|Withdrew Consent|0
5805934|NCT02858362|20033875|P3|Overall Study|Lost to Follow-up|0
5805935|NCT02858362|20033876|P2|Overall Study|Lost to Follow-up|0
5805936|NCT02858362|20033877|P1|Overall Study|Lost to Follow-up|1
5805937|NCT02858362|20033875|P3|Overall Study|Early Study Termination|3
5805938|NCT02858362|20033876|P2|Overall Study|Early Study Termination|0
5805939|NCT02858362|20033877|P1|Overall Study|Early Study Termination|0
5805940|NCT02858362|20033875|P3|Overall Study|Withdrawal by Subject|0
5805941|NCT02858362|20033876|P2|Overall Study|Withdrawal by Subject|0
5805942|NCT02858362|20033877|P1|Overall Study|Withdrawal by Subject|1
5805943|NCT02858362|20033875|P3|Overall Study|Protocol Violation|0
5805944|NCT02858362|20033876|P2|Overall Study|Protocol Violation|1
5805945|NCT02858362|20033877|P1|Overall Study|Protocol Violation|0
5805946|NCT02858180|20033918|P2|Overall Study|Lost to Follow-up|2
5805947|NCT02858180|20033919|P1|Overall Study|Lost to Follow-up|0
5805948|NCT02858076|20033933|P2|Overall Study|Completed Out of Window|3
5805949|NCT02858076|20033934|P1|Overall Study|Completed Out of Window|1
5805950|NCT02858076|20033933|P2|Overall Study|Lost to Follow-up|7
5805951|NCT02858076|20033934|P1|Overall Study|Lost to Follow-up|2
5805952|NCT02858076|20033933|P2|Overall Study|Withdrawal by Subject|5
5805953|NCT02858076|20033934|P1|Overall Study|Withdrawal by Subject|1
5805954|NCT02858076|20033933|P2|Overall Study|Death|3
5805955|NCT02858076|20033934|P1|Overall Study|Death|6
5805956|NCT02857816|20033979|P1|Overall Study|Lost to Follow-up|1
5805957|NCT02857816|20033979|P1|Overall Study|Withdrawal by Subject|4
5805958|NCT02857816|20033979|P1|Overall Study|Screen Failure|33
5805959|NCT02857426|20033987|P2|Follow-up|other reason|0
5805960|NCT02857426|20033988|P1|Follow-up|other reason|1
5805961|NCT02857426|20033987|P2|Follow-up|Participant withdrew consent|4
5805962|NCT02857426|20033988|P1|Follow-up|Participant withdrew consent|3
5805963|NCT02857426|20033987|P2|Follow-up|Death|2
5805964|NCT02857426|20033988|P1|Follow-up|Death|6
5805965|NCT02857426|20033987|P2|Treatment|Maximum clinical benefit|0
5805966|NCT02857426|20033988|P1|Treatment|Maximum clinical benefit|1
5805967|NCT02857426|20033987|P2|Treatment|Participant withdrew consent|1
5805968|NCT02857426|20033988|P1|Treatment|Participant withdrew consent|1
5805969|NCT02857426|20033987|P2|Treatment|Adverse event unrelated to study drug|2
5805970|NCT02857426|20033988|P1|Treatment|Adverse event unrelated to study drug|6
5805971|NCT02857426|20033987|P2|Treatment|Death|0
5805972|NCT02857426|20033988|P1|Treatment|Death|1
5805973|NCT02857426|20033987|P2|Treatment|Study drug toxicity|1
5805974|NCT02857426|20033988|P1|Treatment|Study drug toxicity|4
5805975|NCT02857426|20033987|P2|Treatment|Disease progression|13
5805976|NCT02857426|20033988|P1|Treatment|Disease progression|33
5805977|NCT02857283|20034004|P2|First Exposure|Withdrawal by Subject|0
5805978|NCT02857283|20034005|P1|First Exposure|Withdrawal by Subject|1
5805979|NCT02856880|20034039|P1|Overall Study|Withdrawal of consent|1
5805980|NCT02856555|20034083|P3|Overall Study|Randomized but Never Treated|0
5805981|NCT02856555|20034084|P2|Overall Study|Randomized but Never Treated|1
5805982|NCT02856555|20034085|P1|Overall Study|Randomized but Never Treated|0
5805983|NCT02856555|20034083|P3|Overall Study|Withdrawal by Subject|0
5805984|NCT02856555|20034084|P2|Overall Study|Withdrawal by Subject|0
5805985|NCT02856555|20034085|P1|Overall Study|Withdrawal by Subject|3
5805986|NCT02856555|20034083|P3|Overall Study|Lost to Follow-up|0
5805987|NCT02856555|20034084|P2|Overall Study|Lost to Follow-up|3
5805988|NCT02856555|20034085|P1|Overall Study|Lost to Follow-up|1
5805989|NCT02856555|20034083|P3|Overall Study|Adverse Event|0
5805990|NCT02856555|20034084|P2|Overall Study|Adverse Event|0
5805991|NCT02856555|20034085|P1|Overall Study|Adverse Event|1
5805992|NCT02856282|20034093|P1|Overall Study|Withdrawal by Subject|1
5805993|NCT02855541|20034125|P1|Overall Study|Withdrawal by Subject|2
5805994|NCT02855541|20034125|P1|Overall Study|Change in health status|2
5805995|NCT02855450|20034138|P2|Overall Study|Lost to Follow-up|0
5805996|NCT02855450|20034139|P1|Overall Study|Lost to Follow-up|4
5805997|NCT02855450|20034138|P2|Overall Study|Adverse Event|0
5805998|NCT02855450|20034139|P1|Overall Study|Adverse Event|1
5805999|NCT02855411|20034156|P1|Overall Study|Does not meet entrance criteria|14
5806000|NCT02855411|20034156|P1|Overall Study|Study terminated by sponsor|21
5806001|NCT02855359|20034178|P4|Overall Study|Study Termination by Sponsor|0
5806002|NCT02855359|20034179|P3|Overall Study|Study Termination by Sponsor|0
5806003|NCT02855359|20034180|P2|Overall Study|Study Termination by Sponsor|11
5806004|NCT02855359|20034181|P1|Overall Study|Study Termination by Sponsor|9
5806005|NCT02855359|20034178|P4|Overall Study|Death|0
5806006|NCT02855359|20034179|P3|Overall Study|Death|0
5806007|NCT02855359|20034180|P2|Overall Study|Death|2
5806008|NCT02855359|20034181|P1|Overall Study|Death|2
5806009|NCT02854800|20034227|P3|Overall Study|Withdrawal by Subject|3
5806010|NCT02854800|20034228|P2|Overall Study|Withdrawal by Subject|2
5806011|NCT02854800|20034229|P1|Overall Study|Withdrawal by Subject|4
5806012|NCT02854800|20034227|P3|Overall Study|Protocol Violation|3
5806013|NCT02854800|20034228|P2|Overall Study|Protocol Violation|11
5806014|NCT02854800|20034229|P1|Overall Study|Protocol Violation|16
5806015|NCT02854631|20034269|P2|Overall Study|Lost to Follow-up|2
5806016|NCT02854631|20034270|P1|Overall Study|Lost to Follow-up|4
5806017|NCT02854631|20034269|P2|Overall Study|Subjects Randomized but Never Treated|0
5806018|NCT02854631|20034270|P1|Overall Study|Subjects Randomized but Never Treated|2
5806019|NCT02854631|20034269|P2|Overall Study|Protocol Violation|1
5806020|NCT02854631|20034270|P1|Overall Study|Protocol Violation|0
5806021|NCT02854631|20034269|P2|Overall Study|Liver Biopsy Inconsistent With Diagnosis|0
5806022|NCT02854631|20034270|P1|Overall Study|Liver Biopsy Inconsistent With Diagnosis|2
5806023|NCT02854631|20034269|P2|Overall Study|Death|8
5806024|NCT02854631|20034270|P1|Overall Study|Death|12
5806025|NCT02854631|20034269|P2|Overall Study|Investigator's Discretion|0
5806026|NCT02854631|20034270|P1|Overall Study|Investigator's Discretion|2
5806027|NCT02854631|20034269|P2|Overall Study|Withdrew Consent|2
5806028|NCT02854631|20034270|P1|Overall Study|Withdrew Consent|3
5806029|NCT02854631|20034269|P2|Overall Study|Adverse Event|2
5806030|NCT02854631|20034270|P1|Overall Study|Adverse Event|1
5806031|NCT02854605|20034331|P3|Overall Study|Protocol Violation|1
5806032|NCT02854605|20034332|P2|Overall Study|Protocol Violation|0
5806033|NCT02854605|20034333|P1|Overall Study|Protocol Violation|0
5806034|NCT02854605|20034331|P3|Overall Study|Investigator's Discretion|0
5806035|NCT02854605|20034332|P2|Overall Study|Investigator's Discretion|0
5806036|NCT02854605|20034333|P1|Overall Study|Investigator's Discretion|1
5806037|NCT02854605|20034331|P3|Overall Study|Withdrew Consent|1
5806038|NCT02854605|20034332|P2|Overall Study|Withdrew Consent|0
5806039|NCT02854605|20034333|P1|Overall Study|Withdrew Consent|1
5806040|NCT02854605|20034331|P3|Overall Study|Lost to Follow-up|0
5806041|NCT02854605|20034332|P2|Overall Study|Lost to Follow-up|2
5806042|NCT02854605|20034333|P1|Overall Study|Lost to Follow-up|0
5806043|NCT02854605|20034331|P3|Overall Study|Adverse Event|2
5806044|NCT02854605|20034332|P2|Overall Study|Adverse Event|5
5806045|NCT02854605|20034333|P1|Overall Study|Adverse Event|1
5806046|NCT02854527|20034363|P10|Overall Study|Lost to Follow-up|0
5806047|NCT02854527|20034364|P9|Overall Study|Lost to Follow-up|0
5806048|NCT02854527|20034365|P8|Overall Study|Lost to Follow-up|0
5806049|NCT02854527|20034366|P7|Overall Study|Lost to Follow-up|0
5806050|NCT02854527|20034367|P6|Overall Study|Lost to Follow-up|0
5806051|NCT02854527|20034368|P5|Overall Study|Lost to Follow-up|0
5806052|NCT02854527|20034369|P4|Overall Study|Lost to Follow-up|1
5806053|NCT02854527|20034370|P3|Overall Study|Lost to Follow-up|0
5806054|NCT02854527|20034371|P2|Overall Study|Lost to Follow-up|0
5806055|NCT02854527|20034372|P1|Overall Study|Lost to Follow-up|0
5806056|NCT02854527|20034363|P10|Overall Study|Adverse Event|0
5806057|NCT02854527|20034364|P9|Overall Study|Adverse Event|0
5806058|NCT02854527|20034365|P8|Overall Study|Adverse Event|0
5806059|NCT02854527|20034366|P7|Overall Study|Adverse Event|0
5806060|NCT02854527|20034367|P6|Overall Study|Adverse Event|0
5806061|NCT02854527|20034368|P5|Overall Study|Adverse Event|1
5806062|NCT02854527|20034369|P4|Overall Study|Adverse Event|0
5806063|NCT02854527|20034370|P3|Overall Study|Adverse Event|0
5806064|NCT02854527|20034371|P2|Overall Study|Adverse Event|0
5806065|NCT02854527|20034372|P1|Overall Study|Adverse Event|0
5806066|NCT02853929|20034430|P2|Overall Study|Subjects enrolled but not vaccinated|4
5806067|NCT02853929|20034431|P1|Overall Study|Subjects enrolled but not vaccinated|7
5806068|NCT02853929|20034430|P2|Overall Study|Withdrawal by Subject|0
5806069|NCT02853929|20034431|P1|Overall Study|Withdrawal by Subject|1
5806070|NCT02853929|20034430|P2|Overall Study|Lost to Follow-up|0
5806071|NCT02853929|20034431|P1|Overall Study|Lost to Follow-up|3
5806072|NCT02853760|20034469|P6|Washout (1 Week)|acute illness (not connected with the study)|2
5806073|NCT02853760|20034470|P5|Washout (1 Week)|acute illness (not connected with the study)|0
5806074|NCT02853760|20034471|P4|Washout (1 Week)|acute illness (not connected with the study)|2
5806075|NCT02853760|20034472|P3|Washout (1 Week)|acute illness (not connected with the study)|1
5806076|NCT02853760|20034473|P2|Washout (1 Week)|acute illness (not connected with the study)|0
5806077|NCT02853760|20034474|P1|Washout (1 Week)|acute illness (not connected with the study)|0
5806078|NCT02853435|20034500|P6|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0
5806079|NCT02853435|20034501|P5|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|1
5806080|NCT02853435|20034502|P4|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0
5806081|NCT02853435|20034503|P3|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0
5806082|NCT02853435|20034504|P2|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0
5806083|NCT02853435|20034505|P1|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0
5806084|NCT02853331|20034815|P2|Overall Study|Ongoing in study|325
5806085|NCT02853331|20034816|P1|Overall Study|Ongoing in study|368
5806086|NCT02853331|20034815|P2|Overall Study|Withdrawal by Subject|9
5806087|NCT02853331|20034816|P1|Overall Study|Withdrawal by Subject|5
5806088|NCT02853331|20034815|P2|Overall Study|Death|95
5806089|NCT02853331|20034816|P1|Overall Study|Death|59
5806090|NCT02853318|20034848|P1|Overall Study|Withdrawal by Subject|1
5806091|NCT02853123|20034856|P2|Washout Period|Adverse Event|0
5806092|NCT02853123|20034857|P1|Washout Period|Adverse Event|1
5806093|NCT02853123|20034856|P2|Washout Period|Worsening of COPD|3
5806094|NCT02853123|20034857|P1|Washout Period|Worsening of COPD|0
5806095|NCT02853123|20034856|P2|Treatment Period 1|Adverse Event|3
5806096|NCT02853123|20034857|P1|Treatment Period 1|Adverse Event|0
5806097|NCT02853032|20034880|P2|Overall Study|Requested to withdraw from all treatment|2
5806098|NCT02853032|20034881|P1|Overall Study|Requested to withdraw from all treatment|2
5806099|NCT02853032|20034880|P2|Overall Study|Withdrawal by Subject|1
5806100|NCT02853032|20034881|P1|Overall Study|Withdrawal by Subject|3
5806101|NCT02853032|20034880|P2|Overall Study|Adverse Event|0
5806102|NCT02853032|20034881|P1|Overall Study|Adverse Event|4
5806103|NCT02852434|20034957|P2|Overall Study|Unsuccessful Dilator Procedure|0
5806104|NCT02852434|20034958|P1|Overall Study|Unsuccessful Dilator Procedure|2
5806105|NCT02852434|20034957|P2|Overall Study|Withdrawal by Subject|1
5806106|NCT02852434|20034958|P1|Overall Study|Withdrawal by Subject|0
5806107|NCT02852265|20034974|P2|3-month Follow-up|Lost to Follow-up|1
5806108|NCT02852265|20034975|P1|3-month Follow-up|Lost to Follow-up|1
5806109|NCT02851069|20035008|P1|Overall Study|Other|3
5806110|NCT02851069|20035008|P1|Overall Study|Failure to Return|3
5806111|NCT02850978|20035030|P1|Overall Study|Reason not listed|88
5806112|NCT02850978|20035030|P1|Overall Study|Lost to Follow-up|121
5806113|NCT02850978|20035030|P1|Overall Study|Improvement in condition|34
5806114|NCT02850978|20035030|P1|Overall Study|Lack of Efficacy|40
5806115|NCT02850978|20035030|P1|Overall Study|Adverse Event|81
5806116|NCT02850978|20035030|P1|Overall Study|No visit since the first visit|35
5806117|NCT02850978|20035030|P1|Overall Study|Uncollectable CRF|27
5806118|NCT02850965|20035037|P2|Overall Study|Randomized but not treated|1
5806119|NCT02850965|20035038|P1|Overall Study|Randomized but not treated|0
5806120|NCT02850965|20035037|P2|Overall Study|Physician Decision|1
5806121|NCT02850965|20035038|P1|Overall Study|Physician Decision|0
5806122|NCT02850965|20035037|P2|Overall Study|Withdrawal by Subject|4
5806123|NCT02850965|20035038|P1|Overall Study|Withdrawal by Subject|3
5806124|NCT02850965|20035037|P2|Overall Study|Adverse Event|2
5806125|NCT02850965|20035038|P1|Overall Study|Adverse Event|3
5806126|NCT02850965|20035037|P2|Overall Study|Lack of Efficacy|8
5806127|NCT02850965|20035038|P1|Overall Study|Lack of Efficacy|4
5806128|NCT02850965|20035037|P2|Overall Study|Lost to Follow-up|3
5806129|NCT02850965|20035038|P1|Overall Study|Lost to Follow-up|5
5806130|NCT02850965|20035037|P2|Overall Study|Protocol Violation|2
5806131|NCT02850965|20035038|P1|Overall Study|Protocol Violation|0
5806132|NCT02850965|20035037|P2|Overall Study|Other than listed|4
5806133|NCT02850965|20035038|P1|Overall Study|Other than listed|3
5806134|NCT02850276|20035054|P1|Overall Study|Lost to Follow-up|2
5806135|NCT02850276|20035054|P1|Overall Study|Physician Decision|2
5806136|NCT02850276|20035054|P1|Overall Study|Withdrawal by Subject|14
5806137|NCT02850276|20035054|P1|Overall Study|screen failure|43
5806138|NCT02849990|20035081|P1|Overall Study|Withdrawal by Subject|1
5806139|NCT02849990|20035081|P1|Overall Study|Adverse Event|1
5806140|NCT02849704|20035106|P2|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|0
5806141|NCT02849704|20035107|P1|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|1
5806142|NCT02849704|20035106|P2|Assessment on PERT - CP Subj - 16 Days|Adverse Event|0
5806143|NCT02849704|20035107|P1|Assessment on PERT - CP Subj - 16 Days|Adverse Event|1
5806144|NCT02849704|20035106|P2|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|0
5806145|NCT02849704|20035107|P1|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|1
5806146|NCT02849678|20035122|P2|Overall Study|Protocol Violation|6
5806147|NCT02849678|20035123|P1|Overall Study|Protocol Violation|3
5806148|NCT02849626|20035143|P2|Extension Phase A (up to 29 Weeks)|Non-specified|0
5806149|NCT02849626|20035144|P1|Extension Phase A (up to 29 Weeks)|Non-specified|1
5806150|NCT02849626|20035143|P2|Extension Phase A (up to 29 Weeks)|Inadequate therapeutic effect|1
5806151|NCT02849626|20035144|P1|Extension Phase A (up to 29 Weeks)|Inadequate therapeutic effect|3
5806152|NCT02849626|20035143|P2|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0
5806153|NCT02849626|20035144|P1|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|4
5806154|NCT02849626|20035143|P2|Extension Phase A (up to 29 Weeks)|Adverse Event|2
5806155|NCT02849626|20035144|P1|Extension Phase A (up to 29 Weeks)|Adverse Event|3
5806156|NCT02849626|20035143|P2|Core Phase (up to 23 Weeks)|Non-specified|0
5806157|NCT02849626|20035144|P1|Core Phase (up to 23 Weeks)|Non-specified|3
5806158|NCT02849626|20035143|P2|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|2
5806159|NCT02849626|20035144|P1|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|6
5806160|NCT02849626|20035143|P2|Core Phase (up to 23 Weeks)|Withdrawal by Subject|2
5806161|NCT02849626|20035144|P1|Core Phase (up to 23 Weeks)|Withdrawal by Subject|7
5806162|NCT02849626|20035143|P2|Core Phase (up to 23 Weeks)|Adverse Event|3
5806163|NCT02849626|20035144|P1|Core Phase (up to 23 Weeks)|Adverse Event|11
5806164|NCT02849509|20035207|P3|Overall Study|No inform. on termination of Pradaxa/VKA|1
5806165|NCT02849509|20035208|P2|Overall Study|No inform. on termination of Pradaxa/VKA|10
5806166|NCT02849509|20035209|P1|Overall Study|No inform. on termination of Pradaxa/VKA|6
5806167|NCT02849509|20035207|P3|Overall Study|Other, reason not specified|25
5806168|NCT02849509|20035208|P2|Overall Study|Other, reason not specified|29
5806169|NCT02849509|20035209|P1|Overall Study|Other, reason not specified|14
5806170|NCT02849509|20035207|P3|Overall Study|Lost to Follow-up|36
5806171|NCT02849509|20035208|P2|Overall Study|Lost to Follow-up|67
5806172|NCT02849509|20035209|P1|Overall Study|Lost to Follow-up|27
5806173|NCT02849509|20035207|P3|Overall Study|Withdrawal by Subject|12
5806174|NCT02849509|20035208|P2|Overall Study|Withdrawal by Subject|17
5806175|NCT02849509|20035209|P1|Overall Study|Withdrawal by Subject|6
5806176|NCT02849509|20035207|P3|Overall Study|Other adverse event|8
5806177|NCT02849509|20035208|P2|Overall Study|Other adverse event|41
5806178|NCT02849509|20035209|P1|Overall Study|Other adverse event|36
5806179|NCT02849509|20035207|P3|Overall Study|Worsening of other pre-existing disease|2
5806180|NCT02849509|20035208|P2|Overall Study|Worsening of other pre-existing disease|1
5806181|NCT02849509|20035209|P1|Overall Study|Worsening of other pre-existing disease|0
5806182|NCT02849509|20035207|P3|Overall Study|Worsening of disease under study|1
5806183|NCT02849509|20035208|P2|Overall Study|Worsening of disease under study|1
5806184|NCT02849509|20035209|P1|Overall Study|Worsening of disease under study|1
5806185|NCT02849080|20035416|P4|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0
5806186|NCT02849080|20035417|P3|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0
5806187|NCT02849080|20035418|P2|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0
5806188|NCT02849080|20035419|P1|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|1
5806189|NCT02849080|20035416|P4|Extension Phase: 53 - 104 Weeks|Other|0
5806190|NCT02849080|20035417|P3|Extension Phase: 53 - 104 Weeks|Other|1
5806191|NCT02849080|20035418|P2|Extension Phase: 53 - 104 Weeks|Other|0
5806192|NCT02849080|20035419|P1|Extension Phase: 53 - 104 Weeks|Other|0
5806193|NCT02849080|20035416|P4|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0
5806194|NCT02849080|20035417|P3|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0
5806195|NCT02849080|20035418|P2|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0
5806196|NCT02849080|20035419|P1|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|2
5806197|NCT02849080|20035416|P4|Main Phase: 0 - 52 Weeks|Death|0
5806198|NCT02849080|20035417|P3|Main Phase: 0 - 52 Weeks|Death|0
5806199|NCT02849080|20035418|P2|Main Phase: 0 - 52 Weeks|Death|2
5806200|NCT02849080|20035419|P1|Main Phase: 0 - 52 Weeks|Death|0
5806201|NCT02849080|20035416|P4|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0
5806202|NCT02849080|20035417|P3|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0
5806203|NCT02849080|20035418|P2|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|1
5806204|NCT02849080|20035419|P1|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|5
5806205|NCT02849080|20035416|P4|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0
5806206|NCT02849080|20035417|P3|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0
5806207|NCT02849080|20035418|P2|Main Phase: 0 - 52 Weeks|Lost to Follow-up|4
5806208|NCT02849080|20035419|P1|Main Phase: 0 - 52 Weeks|Lost to Follow-up|7
5806209|NCT02848729|20035546|P2|Overall Study|Emesis|11
5806210|NCT02848729|20035547|P1|Overall Study|Emesis|15
5806211|NCT02848729|20035546|P2|Overall Study|Withdrawal by Subject|0
5806212|NCT02848729|20035547|P1|Overall Study|Withdrawal by Subject|1
5806213|NCT02848664|20035564|P1|Overall Study|no assistance for device training|1
5806214|NCT02848664|20035564|P1|Overall Study|Adverse Event|1
5806215|NCT02848664|20035564|P1|Overall Study|Withdrawal by Subject|2
5806216|NCT02848651|20035572|P1|Overall Study|Withdrawal by Subject|14
5806217|NCT02848651|20035572|P1|Overall Study|Physician Decision|4
5806218|NCT02848651|20035572|P1|Overall Study|Symptomatic Deterioration|1
5806219|NCT02848651|20035572|P1|Overall Study|Non-Compliance|1
5806220|NCT02848651|20035572|P1|Overall Study|Lost to Follow-up|1
5806221|NCT02848651|20035572|P1|Overall Study|Death|85
5806222|NCT02848599|20035601|P2|Overall Study|Protocol Violation|9
5806223|NCT02848599|20035602|P1|Overall Study|Protocol Violation|7
5806224|NCT02848326|20035624|P6|Safety Follow-up Period|Lost to Follow-up|3
5806225|NCT02848326|20035625|P5|Safety Follow-up Period|Lost to Follow-up|1
5806226|NCT02848326|20035626|P4|Safety Follow-up Period|Lost to Follow-up|0
5806227|NCT02848326|20035627|P3|Safety Follow-up Period|Lost to Follow-up|2
5806228|NCT02848326|20035628|P2|Safety Follow-up Period|Lost to Follow-up|0
5806229|NCT02848326|20035629|P1|Safety Follow-up Period|Lost to Follow-up|4
5806230|NCT02848326|20035624|P6|Safety Follow-up Period|Withdrawal of Consent|2
5806231|NCT02848326|20035625|P5|Safety Follow-up Period|Withdrawal of Consent|0
5806232|NCT02848326|20035626|P4|Safety Follow-up Period|Withdrawal of Consent|0
5806233|NCT02848326|20035627|P3|Safety Follow-up Period|Withdrawal of Consent|1
5806234|NCT02848326|20035628|P2|Safety Follow-up Period|Withdrawal of Consent|1
5806235|NCT02848326|20035629|P1|Safety Follow-up Period|Withdrawal of Consent|0
5806236|NCT02848326|20035624|P6|Treatment Period|Non-compliance with Study Drug|0
5806237|NCT02848326|20035625|P5|Treatment Period|Non-compliance with Study Drug|0
5806238|NCT02848326|20035626|P4|Treatment Period|Non-compliance with Study Drug|1
5806239|NCT02848326|20035627|P3|Treatment Period|Non-compliance with Study Drug|0
5806240|NCT02848326|20035628|P2|Treatment Period|Non-compliance with Study Drug|0
5806241|NCT02848326|20035629|P1|Treatment Period|Non-compliance with Study Drug|4
5806242|NCT02848326|20035624|P6|Treatment Period|Protocol Violation|3
5806243|NCT02848326|20035625|P5|Treatment Period|Protocol Violation|3
5806244|NCT02848326|20035626|P4|Treatment Period|Protocol Violation|2
5806245|NCT02848326|20035627|P3|Treatment Period|Protocol Violation|4
5806246|NCT02848326|20035628|P2|Treatment Period|Protocol Violation|3
5806247|NCT02848326|20035629|P1|Treatment Period|Protocol Violation|4
5806248|NCT02848326|20035624|P6|Treatment Period|Pregnancy|1
5806249|NCT02848326|20035625|P5|Treatment Period|Pregnancy|0
5806250|NCT02848326|20035626|P4|Treatment Period|Pregnancy|1
5806251|NCT02848326|20035627|P3|Treatment Period|Pregnancy|1
5806252|NCT02848326|20035628|P2|Treatment Period|Pregnancy|0
5806253|NCT02848326|20035629|P1|Treatment Period|Pregnancy|0
5806254|NCT02848326|20035624|P6|Treatment Period|Lost to Follow-up|3
5806255|NCT02848326|20035625|P5|Treatment Period|Lost to Follow-up|2
5806256|NCT02848326|20035626|P4|Treatment Period|Lost to Follow-up|7
5806257|NCT02848326|20035627|P3|Treatment Period|Lost to Follow-up|11
5806258|NCT02848326|20035628|P2|Treatment Period|Lost to Follow-up|1
5806259|NCT02848326|20035629|P1|Treatment Period|Lost to Follow-up|5
5806260|NCT02848326|20035624|P6|Treatment Period|Withdrawal of Consent|6
5806261|NCT02848326|20035625|P5|Treatment Period|Withdrawal of Consent|9
5806262|NCT02848326|20035626|P4|Treatment Period|Withdrawal of Consent|6
5806263|NCT02848326|20035627|P3|Treatment Period|Withdrawal of Consent|9
5806264|NCT02848326|20035628|P2|Treatment Period|Withdrawal of Consent|6
5806265|NCT02848326|20035629|P1|Treatment Period|Withdrawal of Consent|20
5806266|NCT02848326|20035624|P6|Treatment Period|Adverse Event|7
5806267|NCT02848326|20035625|P5|Treatment Period|Adverse Event|5
5806268|NCT02848326|20035626|P4|Treatment Period|Adverse Event|6
5806269|NCT02848326|20035627|P3|Treatment Period|Adverse Event|11
5806270|NCT02848326|20035628|P2|Treatment Period|Adverse Event|4
5806271|NCT02848326|20035629|P1|Treatment Period|Adverse Event|5
5806272|NCT02848313|20035663|P2|Overall Study|Lost to follow up|0
5806273|NCT02848313|20035664|P1|Overall Study|Lost to follow up|1
5806274|NCT02848313|20035663|P2|Overall Study|Withdrawal by Subject|1
5806275|NCT02848313|20035664|P1|Overall Study|Withdrawal by Subject|1
5806276|NCT02848313|20035663|P2|Overall Study|Lack of Efficacy|1
5806277|NCT02848313|20035664|P1|Overall Study|Lack of Efficacy|0
5806278|NCT02848313|20035663|P2|Overall Study|Adverse Event|2
5806279|NCT02848313|20035664|P1|Overall Study|Adverse Event|1
5806280|NCT02847858|20035711|P2|Overall Study|Lost to Follow-up|269
5806281|NCT02847858|20035712|P1|Overall Study|Lost to Follow-up|401
5806282|NCT02847650|20035738|P2|Overall Study|Withdrawal by Subject|1
5806283|NCT02847650|20035739|P1|Overall Study|Withdrawal by Subject|1
5806284|NCT02847650|20035738|P2|Overall Study|Protocol Violation|1
5806285|NCT02847650|20035739|P1|Overall Study|Protocol Violation|0
5806286|NCT02847650|20035738|P2|Overall Study|Lost to Follow-up|0
5806287|NCT02847650|20035739|P1|Overall Study|Lost to Follow-up|1
5806288|NCT02847650|20035738|P2|Overall Study|Adverse Event|4
5806289|NCT02847650|20035739|P1|Overall Study|Adverse Event|2
5806290|NCT02847637|20035763|P4|Overall Study|First emicizumab dose delayed|0
5806291|NCT02847637|20035764|P3|Overall Study|First emicizumab dose delayed|0
5806292|NCT02847637|20035765|P2|Overall Study|First emicizumab dose delayed|0
5806293|NCT02847637|20035766|P1|Overall Study|First emicizumab dose delayed|1
5806294|NCT02847637|20035763|P4|Overall Study|Ongoing treatment with emicizumab|63
5806295|NCT02847637|20035764|P3|Overall Study|Ongoing treatment with emicizumab|34
5806296|NCT02847637|20035765|P2|Overall Study|Ongoing treatment with emicizumab|35
5806297|NCT02847637|20035766|P1|Overall Study|Ongoing treatment with emicizumab|16
5806298|NCT02847637|20035763|P4|Overall Study|Withdrew from treatment due to AE|0
5806299|NCT02847637|20035764|P3|Overall Study|Withdrew from treatment due to AE|1
5806300|NCT02847637|20035765|P2|Overall Study|Withdrew from treatment due to AE|0
5806301|NCT02847637|20035766|P1|Overall Study|Withdrew from treatment due to AE|0
5806302|NCT02847494|20035880|P2|Overall Study|Lost to Follow-up|5
5806303|NCT02847494|20035881|P1|Overall Study|Lost to Follow-up|8
5806304|NCT02847260|20035891|P1|Overall Study|Physician Decision|1
5806305|NCT02847260|20035891|P1|Overall Study|Clinical Deterioration|1
5806306|NCT02847260|20035891|P1|Overall Study|Withdrawal by Subject|2
5806307|NCT02847260|20035891|P1|Overall Study|Adverse Event|3
5806308|NCT02847182|20035905|P2|Overall Study|Withdrawal by Subject|1
5806309|NCT02847182|20035906|P1|Overall Study|Withdrawal by Subject|0
5806310|NCT02846779|20036030|P3|Overall Study|Less than 31 days of follow-up|52
5806311|NCT02846779|20036031|P2|Overall Study|Less than 31 days of follow-up|45
5806312|NCT02846779|20036032|P1|Overall Study|Less than 31 days of follow-up|56
5806313|NCT02846779|20036030|P3|Overall Study|Lost Enrollment|86
5806314|NCT02846779|20036031|P2|Overall Study|Lost Enrollment|82
5806315|NCT02846779|20036032|P1|Overall Study|Lost Enrollment|83
5806316|NCT02846558|20036088|P4|Overall Study|Lost to Follow-up|0
5806317|NCT02846558|20036089|P3|Overall Study|Lost to Follow-up|0
5806318|NCT02846558|20036090|P2|Overall Study|Lost to Follow-up|0
5806319|NCT02846558|20036091|P1|Overall Study|Lost to Follow-up|2
5806320|NCT02846558|20036088|P4|Overall Study|Withdrawal by Subject|2
5806321|NCT02846558|20036089|P3|Overall Study|Withdrawal by Subject|2
5806322|NCT02846558|20036090|P2|Overall Study|Withdrawal by Subject|4
5806323|NCT02846558|20036091|P1|Overall Study|Withdrawal by Subject|5
5806324|NCT02846558|20036088|P4|Overall Study|Adverse Event|0
5806325|NCT02846558|20036089|P3|Overall Study|Adverse Event|0
5806326|NCT02846558|20036090|P2|Overall Study|Adverse Event|0
5806327|NCT02846558|20036091|P1|Overall Study|Adverse Event|1
5806328|NCT02846415|20036129|P2|Overall Study|Withdrawal by Subject|1
5806329|NCT02846415|20036130|P1|Overall Study|Withdrawal by Subject|1
5806330|NCT02846415|20036129|P2|Overall Study|Lost to Follow-up|0
5806331|NCT02846415|20036130|P1|Overall Study|Lost to Follow-up|2
5806332|NCT02846324|20036144|P4|Overall Study|Withdrawal by Subject|0
5806333|NCT02846324|20036145|P3|Overall Study|Withdrawal by Subject|4
5806334|NCT02846324|20036146|P2|Overall Study|Withdrawal by Subject|0
5806335|NCT02846324|20036147|P1|Overall Study|Withdrawal by Subject|1
5806336|NCT02846324|20036144|P4|Overall Study|Other|0
5806337|NCT02846324|20036145|P3|Overall Study|Other|0
5806338|NCT02846324|20036146|P2|Overall Study|Other|0
5806339|NCT02846324|20036147|P1|Overall Study|Other|1
5806340|NCT02845375|20036264|P3|Overall Study|upper airway obstruction|1
5806341|NCT02845375|20036265|P2|Overall Study|upper airway obstruction|2
5806342|NCT02845375|20036266|P1|Overall Study|upper airway obstruction|1
5806343|NCT02845336|20036279|P2|Overall Study|Inability to get medication|0
5806344|NCT02845336|20036280|P1|Overall Study|Inability to get medication|2
5806345|NCT02845336|20036279|P2|Overall Study|Lost to Follow-up|1
5806346|NCT02845336|20036280|P1|Overall Study|Lost to Follow-up|3
5806347|NCT02844946|20036322|P2|Overall Study|Lost to Follow-up|0
5806348|NCT02844946|20036323|P1|Overall Study|Lost to Follow-up|7
5806349|NCT02844920|20036341|P1|Overall Study|Lost to Follow-up|2
5806350|NCT02844543|20036367|P1|Overall Study|Did not meet eligibility criteria|1
5806351|NCT02844543|20036367|P1|Overall Study|Withdrawal by Subject|4
5806352|NCT02843659|20036377|P3|Overall Study|Adverse Event|0
5806353|NCT02843659|20036378|P2|Overall Study|Adverse Event|1
5806354|NCT02843659|20036379|P1|Overall Study|Adverse Event|0
5806355|NCT02843659|20036377|P3|Overall Study|Administrative Reason by Sponsor|4
5806356|NCT02843659|20036378|P2|Overall Study|Administrative Reason by Sponsor|5
5806357|NCT02843659|20036379|P1|Overall Study|Administrative Reason by Sponsor|4
5806358|NCT02843659|20036377|P3|Overall Study|Subject Withdrew Consent|1
5806359|NCT02843659|20036378|P2|Overall Study|Subject Withdrew Consent|0
5806360|NCT02843659|20036379|P1|Overall Study|Subject Withdrew Consent|0
5806361|NCT02843178|20036457|P4|Overall Study|Withdrawal by Subject|1
5806362|NCT02843178|20036458|P3|Overall Study|Withdrawal by Subject|1
5806363|NCT02843178|20036459|P2|Overall Study|Withdrawal by Subject|0
5806364|NCT02843178|20036460|P1|Overall Study|Withdrawal by Subject|0
5806365|NCT02843178|20036457|P4|Overall Study|Lost to Follow-up|3
5806366|NCT02843178|20036458|P3|Overall Study|Lost to Follow-up|6
5806367|NCT02843178|20036459|P2|Overall Study|Lost to Follow-up|8
5806368|NCT02843178|20036460|P1|Overall Study|Lost to Follow-up|8
5806369|NCT02842866|20036500|P2|Overall Study|Withdrawal by Subject|0
5806370|NCT02842866|20036501|P1|Overall Study|Withdrawal by Subject|1
5806371|NCT02842866|20036500|P2|Overall Study|Lost to Follow-up|0
5806372|NCT02842866|20036501|P1|Overall Study|Lost to Follow-up|2
5806373|NCT02842866|20036500|P2|Overall Study|Protocol Violation|2
5806374|NCT02842866|20036501|P1|Overall Study|Protocol Violation|4
5806375|NCT02842866|20036500|P2|Overall Study|Serious Adverse Event|1
5806376|NCT02842866|20036501|P1|Overall Study|Serious Adverse Event|0
5806377|NCT02842853|20036513|P4|Overall Study|Lost to Follow-up|11
5806378|NCT02842853|20036514|P3|Overall Study|Lost to Follow-up|10
5806379|NCT02842853|20036515|P2|Overall Study|Lost to Follow-up|13
5806380|NCT02842853|20036516|P1|Overall Study|Lost to Follow-up|9
5806381|NCT02842853|20036513|P4|Overall Study|Withdrawal by Subject|8
5806382|NCT02842853|20036514|P3|Overall Study|Withdrawal by Subject|9
5806383|NCT02842853|20036515|P2|Overall Study|Withdrawal by Subject|13
5806384|NCT02842853|20036516|P1|Overall Study|Withdrawal by Subject|11
5806385|NCT02842853|20036513|P4|Overall Study|Subject met exclusion criteria|0
5806386|NCT02842853|20036514|P3|Overall Study|Subject met exclusion criteria|0
5806387|NCT02842853|20036515|P2|Overall Study|Subject met exclusion criteria|1
5806388|NCT02842853|20036516|P1|Overall Study|Subject met exclusion criteria|0
5806389|NCT02842853|20036513|P4|Overall Study|Non-compliance with the protocol|5
5806390|NCT02842853|20036514|P3|Overall Study|Non-compliance with the protocol|2
5806391|NCT02842853|20036515|P2|Overall Study|Non-compliance with the protocol|7
5806392|NCT02842853|20036516|P1|Overall Study|Non-compliance with the protocol|3
5806393|NCT02842736|20036536|P1|Overall Study|IUD: Mirena|1
5806394|NCT02842736|20036536|P1|Overall Study|Hysterectomy for uterine prolapse|1
5806395|NCT02842736|20036536|P1|Overall Study|Hysterectomy for fibroids|2
5806396|NCT02842736|20036536|P1|Overall Study|Pregnancy|3
5806397|NCT02842736|20036536|P1|Overall Study|Withdrawal by Subject|4
5806398|NCT02842736|20036536|P1|Overall Study|Intervention for menstrual bleeding|17
5806399|NCT02842736|20036536|P1|Overall Study|Lost to Follow-up|13
5806400|NCT02842151|20036579|P1|Overall Study|Subject moved too far away|1
5806401|NCT02842151|20036579|P1|Overall Study|Adverse Event|1
5806402|NCT02842086|20036587|P2|Overall Study|HIV-1 Infection|6
5806403|NCT02842086|20036588|P1|Overall Study|HIV-1 Infection|5
5806404|NCT02842086|20036587|P2|Overall Study|Lost to Follow-up|236
5806405|NCT02842086|20036588|P1|Overall Study|Lost to Follow-up|274
5806406|NCT02842086|20036587|P2|Overall Study|Withdrew Consent|194
5806407|NCT02842086|20036588|P1|Overall Study|Withdrew Consent|205
5806408|NCT02842086|20036587|P2|Overall Study|Protocol Violation|4
5806409|NCT02842086|20036588|P1|Overall Study|Protocol Violation|8
5806410|NCT02842086|20036587|P2|Overall Study|Non-Compliance with Study Drug|8
5806411|NCT02842086|20036588|P1|Overall Study|Non-Compliance with Study Drug|9
5806412|NCT02842086|20036587|P2|Overall Study|Investigator's Discretion|13
5806413|NCT02842086|20036588|P1|Overall Study|Investigator's Discretion|9
5806414|NCT02842086|20036587|P2|Overall Study|Death|3
5806415|NCT02842086|20036588|P1|Overall Study|Death|3
5806416|NCT02842086|20036587|P2|Overall Study|Adverse Event|20
5806417|NCT02842086|20036588|P1|Overall Study|Adverse Event|18
5806418|NCT02842086|20036587|P2|Overall Study|Still in Double-Blind Phase|3
5806419|NCT02842086|20036588|P1|Overall Study|Still in Double-Blind Phase|7
5806420|NCT02842086|20036587|P2|Overall Study|Randomized but Never Treated|6
5806421|NCT02842086|20036588|P1|Overall Study|Randomized but Never Treated|6
5806422|NCT02842073|20036624|P1|Overall Study|Withdrawal by Subject|1
5806423|NCT02841787|20036650|P3|Overall Study|Withdrawal by Subject|0
5806424|NCT02841787|20036651|P2|Overall Study|Withdrawal by Subject|4
5806425|NCT02841787|20036652|P1|Overall Study|Withdrawal by Subject|1
5806426|NCT02841787|20036650|P3|Overall Study|Symptoms dropped below threshold|0
5806427|NCT02841787|20036651|P2|Overall Study|Symptoms dropped below threshold|0
5806428|NCT02841787|20036652|P1|Overall Study|Symptoms dropped below threshold|1
5806429|NCT02841787|20036650|P3|Overall Study|Lost to Follow-up|0
5806430|NCT02841787|20036651|P2|Overall Study|Lost to Follow-up|0
5806431|NCT02841787|20036652|P1|Overall Study|Lost to Follow-up|1
5806432|NCT02841709|20036666|P5|5th Intervention|Adverse Event|2
5806433|NCT02841709|20036667|P4|5th Intervention|Adverse Event|0
5806434|NCT02841709|20036668|P3|5th Intervention|Adverse Event|0
5806435|NCT02841709|20036669|P2|5th Intervention|Adverse Event|0
5806436|NCT02841709|20036670|P1|5th Intervention|Adverse Event|2
5806437|NCT02840721|20036800|P1|Follow-Up|Withdrawal of Consent|2
5806438|NCT02840721|20036800|P1|Follow-Up|Withdrawal by Subject|4
5806439|NCT02840721|20036800|P1|Follow-Up|Lack of Efficacy|1
5806440|NCT02840721|20036800|P1|Treatment Period|Adverse Event|1
5806441|NCT02840461|20036822|P3|Overall Study|Worsening of Symptom & Kit Error|2
5806442|NCT02840461|20036823|P2|Overall Study|Worsening of Symptom & Kit Error|0
5806443|NCT02840461|20036824|P1|Overall Study|Worsening of Symptom & Kit Error|0
5806444|NCT02840461|20036822|P3|Overall Study|Withdrawal by Subject|2
5806445|NCT02840461|20036823|P2|Overall Study|Withdrawal by Subject|6
5806446|NCT02840461|20036824|P1|Overall Study|Withdrawal by Subject|10
5806447|NCT02840461|20036822|P3|Overall Study|Protocol Violation|1
5806448|NCT02840461|20036823|P2|Overall Study|Protocol Violation|3
5806449|NCT02840461|20036824|P1|Overall Study|Protocol Violation|2
5806450|NCT02840461|20036822|P3|Overall Study|Non-Comliance with Dosing Requirements|0
5806451|NCT02840461|20036823|P2|Overall Study|Non-Comliance with Dosing Requirements|1
5806452|NCT02840461|20036824|P1|Overall Study|Non-Comliance with Dosing Requirements|0
5806453|NCT02840461|20036822|P3|Overall Study|Lost to Follow-up|6
5806454|NCT02840461|20036823|P2|Overall Study|Lost to Follow-up|7
5806455|NCT02840461|20036824|P1|Overall Study|Lost to Follow-up|10
5806456|NCT02840461|20036822|P3|Overall Study|Adverse Event|3
5806457|NCT02840461|20036823|P2|Overall Study|Adverse Event|5
5806458|NCT02840461|20036824|P1|Overall Study|Adverse Event|1
5806459|NCT02840253|20036835|P1|Overall Study|Unsuccessful block|4
5806460|NCT02839876|20036920|P2|Overall Study|Protocol Violation|11
5806461|NCT02839876|20036921|P1|Overall Study|Protocol Violation|10
5806462|NCT02839798|20036983|P1|Overall Study|Withdrawal by Subject|2
5806463|NCT02839746|20037029|P1|Overall Study|Not met selection criteria|12
5806464|NCT02839681|20037043|P1|Overall Study|Death|2
5806465|NCT02839330|20037056|P4|Overall Study|Other reason, not specified|6
5806466|NCT02839330|20037057|P3|Overall Study|Other reason, not specified|3
5806467|NCT02839330|20037058|P2|Overall Study|Other reason, not specified|3
5806468|NCT02839330|20037059|P1|Overall Study|Other reason, not specified|4
5806469|NCT02839330|20037056|P4|Overall Study|Protocol Violation|3
5806470|NCT02839330|20037057|P3|Overall Study|Protocol Violation|2
5806471|NCT02839330|20037058|P2|Overall Study|Protocol Violation|2
5806472|NCT02839330|20037059|P1|Overall Study|Protocol Violation|1
5806473|NCT02839330|20037056|P4|Overall Study|Administrative Reason|1
5806474|NCT02839330|20037057|P3|Overall Study|Administrative Reason|0
5806475|NCT02839330|20037058|P2|Overall Study|Administrative Reason|0
5806476|NCT02839330|20037059|P1|Overall Study|Administrative Reason|0
5806477|NCT02839330|20037056|P4|Overall Study|Lost to Follow-up|25
5806478|NCT02839330|20037057|P3|Overall Study|Lost to Follow-up|29
5806479|NCT02839330|20037058|P2|Overall Study|Lost to Follow-up|27
5806480|NCT02839330|20037059|P1|Overall Study|Lost to Follow-up|22
5806481|NCT02839330|20037056|P4|Overall Study|Withdrawal by Subject|13
5806482|NCT02839330|20037057|P3|Overall Study|Withdrawal by Subject|11
5806483|NCT02839330|20037058|P2|Overall Study|Withdrawal by Subject|19
5806484|NCT02839330|20037059|P1|Overall Study|Withdrawal by Subject|27
5806485|NCT02839330|20037056|P4|Overall Study|Death|1
5806486|NCT02839330|20037057|P3|Overall Study|Death|1
5806487|NCT02839330|20037058|P2|Overall Study|Death|6
5806488|NCT02839330|20037059|P1|Overall Study|Death|4
5806489|NCT02839330|20037056|P4|Overall Study|Adverse Event|2
5806490|NCT02839330|20037057|P3|Overall Study|Adverse Event|2
5806491|NCT02839330|20037058|P2|Overall Study|Adverse Event|1
5806492|NCT02839330|20037059|P1|Overall Study|Adverse Event|0
5806493|NCT02839200|20037094|P6|Overall Study|Randomized in error|0
5806494|NCT02839200|20037095|P5|Overall Study|Randomized in error|0
5806495|NCT02839200|20037096|P4|Overall Study|Randomized in error|0
5806496|NCT02839200|20037097|P3|Overall Study|Randomized in error|0
5806497|NCT02839200|20037098|P2|Overall Study|Randomized in error|1
5806498|NCT02839200|20037099|P1|Overall Study|Randomized in error|0
5806499|NCT02839200|20037094|P6|Overall Study|Adverse Event|0
5806500|NCT02839200|20037095|P5|Overall Study|Adverse Event|1
5806501|NCT02839200|20037096|P4|Overall Study|Adverse Event|0
5806502|NCT02839200|20037097|P3|Overall Study|Adverse Event|0
5806503|NCT02839200|20037098|P2|Overall Study|Adverse Event|0
5806504|NCT02839200|20037099|P1|Overall Study|Adverse Event|0
5806505|NCT02839200|20037094|P6|Overall Study|Lost to Follow-up|0
5806506|NCT02839200|20037095|P5|Overall Study|Lost to Follow-up|1
5806507|NCT02839200|20037096|P4|Overall Study|Lost to Follow-up|0
5806508|NCT02839200|20037097|P3|Overall Study|Lost to Follow-up|0
5806509|NCT02839200|20037098|P2|Overall Study|Lost to Follow-up|0
5806510|NCT02839200|20037099|P1|Overall Study|Lost to Follow-up|2
5806511|NCT02839200|20037094|P6|Overall Study|Withdrawal by Subject|1
5806512|NCT02839200|20037095|P5|Overall Study|Withdrawal by Subject|0
5806513|NCT02839200|20037096|P4|Overall Study|Withdrawal by Subject|0
5806514|NCT02839200|20037097|P3|Overall Study|Withdrawal by Subject|1
5806515|NCT02839200|20037098|P2|Overall Study|Withdrawal by Subject|0
5806516|NCT02839200|20037099|P1|Overall Study|Withdrawal by Subject|2
5806517|NCT02838901|20037133|P2|Overall Study|Lost to Follow-up|1
5806518|NCT02838901|20037134|P1|Overall Study|Lost to Follow-up|1
5806519|NCT02838901|20037133|P2|Overall Study|Withdrawal by Subject|1
5806520|NCT02838901|20037134|P1|Overall Study|Withdrawal by Subject|1
5806521|NCT02838420|20037164|P2|Overall Study|Death|13
5806522|NCT02838420|20037165|P1|Overall Study|Death|8
5806523|NCT02838420|20037164|P2|Overall Study|Withdrawal by Subject|4
5806524|NCT02838420|20037165|P1|Overall Study|Withdrawal by Subject|3
5806525|NCT02838420|20037164|P2|Overall Study|Lost to Follow-up|0
5806526|NCT02838420|20037165|P1|Overall Study|Lost to Follow-up|1
5806527|NCT02838420|20037164|P2|Overall Study|Ongoing in Study|45
5806528|NCT02838420|20037165|P1|Overall Study|Ongoing in Study|113
5806529|NCT02838134|20037228|P2|Overall Study|logistic problems|1
5806530|NCT02838134|20037229|P1|Overall Study|logistic problems|1
5806531|NCT02838134|20037228|P2|Overall Study|Lost to Follow-up|2
5806532|NCT02838134|20037229|P1|Overall Study|Lost to Follow-up|1
5806533|NCT02838017|20037261|P2|Overall Study|Lost to Follow-up|11
5806534|NCT02838017|20037262|P1|Overall Study|Lost to Follow-up|14
5806535|NCT02837952|20037280|P2|Overall Study|Medication Error|0
5806536|NCT02837952|20037281|P1|Overall Study|Medication Error|1
5806537|NCT02837952|20037280|P2|Overall Study|Withdrawal by Subject|5
5806538|NCT02837952|20037281|P1|Overall Study|Withdrawal by Subject|4
5806539|NCT02837952|20037280|P2|Overall Study|Adverse Event|1
5806540|NCT02837952|20037281|P1|Overall Study|Adverse Event|0
5806541|NCT02837731|20037318|P2|Allocation|Known aortic abnormalities|1
5806542|NCT02837731|20037319|P1|Allocation|Known aortic abnormalities|0
5806543|NCT02837731|20037318|P2|Allocation|Did not meet sepsis criteria|2
5806544|NCT02837731|20037319|P1|Allocation|Did not meet sepsis criteria|1
5806545|NCT02837731|20037318|P2|Allocation|Moribund/Do not resuscitate|0
5806546|NCT02837731|20037319|P1|Allocation|Moribund/Do not resuscitate|2
5806547|NCT02837731|20037318|P2|Allocation|Protocol not implemented|0
5806548|NCT02837731|20037319|P1|Allocation|Protocol not implemented|7
5806549|NCT02837731|20037318|P2|Allocation|Device not available|0
5806550|NCT02837731|20037319|P1|Allocation|Device not available|1
5806551|NCT02837731|20037318|P2|Allocation|Withdrawal by Subject|0
5806552|NCT02837731|20037319|P1|Allocation|Withdrawal by Subject|2
5806553|NCT02837731|20037318|P2|Allocation|Diabetic Ketoacidosis/withdrew|0
5806554|NCT02837731|20037319|P1|Allocation|Diabetic Ketoacidosis/withdrew|1
5806555|NCT02837731|20037318|P2|Allocation|Immediate surgery/withdrew|0
5806556|NCT02837731|20037319|P1|Allocation|Immediate surgery/withdrew|2
5806557|NCT02837731|20037318|P2|Allocation|Admitted to General Floor|4
5806558|NCT02837731|20037319|P1|Allocation|Admitted to General Floor|3
5806559|NCT02837029|20037367|P3|2 Year Follow-up|Still in follow-up|0
5806560|NCT02837029|20037368|P2|2 Year Follow-up|Still in follow-up|1
5806561|NCT02837029|20037369|P1|2 Year Follow-up|Still in follow-up|0
5806562|NCT02837029|20037367|P3|2 Year Follow-up|Death|0
5806563|NCT02837029|20037368|P2|2 Year Follow-up|Death|6
5806564|NCT02837029|20037369|P1|2 Year Follow-up|Death|6
5806565|NCT02837029|20037367|P3|Cycle 2 and Beyond|Adverse Event|0
5806566|NCT02837029|20037368|P2|Cycle 2 and Beyond|Adverse Event|0
5806567|NCT02837029|20037369|P1|Cycle 2 and Beyond|Adverse Event|1
5806568|NCT02837029|20037367|P3|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|0
5806569|NCT02837029|20037368|P2|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|1
5806570|NCT02837029|20037369|P1|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|0
5806571|NCT02837029|20037367|P3|Cycle 1 (DLT Monitoring Period)|Adverse Event|0
5806572|NCT02837029|20037368|P2|Cycle 1 (DLT Monitoring Period)|Adverse Event|2
5806573|NCT02837029|20037369|P1|Cycle 1 (DLT Monitoring Period)|Adverse Event|0
5806574|NCT02837029|20037367|P3|Cycle 1 (DLT Monitoring Period)|Progressive Disease|0
5806575|NCT02837029|20037368|P2|Cycle 1 (DLT Monitoring Period)|Progressive Disease|0
5806576|NCT02837029|20037369|P1|Cycle 1 (DLT Monitoring Period)|Progressive Disease|2
5806577|NCT02837029|20037367|P3|Screening|Failed to meet screening requirements.|0
5806578|NCT02837029|20037368|P2|Screening|Failed to meet screening requirements.|3
5806579|NCT02837029|20037369|P1|Screening|Failed to meet screening requirements.|7
5806580|NCT02836652|20037391|P2|Overall Study|Not on treatment regimen post-op day 15|3
5806581|NCT02836652|20037392|P1|Overall Study|Not on treatment regimen post-op day 15|3
5806582|NCT02836652|20037391|P2|Overall Study|Withdrawn|9
5806583|NCT02836652|20037392|P1|Overall Study|Withdrawn|9
5806584|NCT02836652|20037391|P2|Overall Study|Transplant/Explant|4
5806585|NCT02836652|20037392|P1|Overall Study|Transplant/Explant|3
5806586|NCT02836652|20037391|P2|Overall Study|Death|3
5806587|NCT02836652|20037392|P1|Overall Study|Death|3
5806588|NCT02836613|20037406|P2|Overall Study|Withdrawal by Subject|2
5806589|NCT02836613|20037407|P1|Overall Study|Withdrawal by Subject|0
5806590|NCT02836613|20037406|P2|Overall Study|Lost to Follow-up|1
5806591|NCT02836613|20037407|P1|Overall Study|Lost to Follow-up|0
5806592|NCT02836613|20037406|P2|Overall Study|Accidental drowning|0
5806593|NCT02836613|20037407|P1|Overall Study|Accidental drowning|1
5806594|NCT02836496|20037421|P2|Overall Study|Withdrawal by Subject|1
5806595|NCT02836496|20037422|P1|Overall Study|Withdrawal by Subject|0
5806596|NCT02836496|20037421|P2|Overall Study|Adverse Event|1
5806597|NCT02836496|20037422|P1|Overall Study|Adverse Event|2
5806608|NCT02836236|20037457|P2|Overall Study|Still on Study|49
5806609|NCT02836236|20037458|P1|Overall Study|Still on Study|101
5806610|NCT02836236|20037457|P2|Overall Study|Investigator's Discretion|0
5806611|NCT02836236|20037458|P1|Overall Study|Investigator's Discretion|1
5806612|NCT02836236|20037457|P2|Overall Study|Adverse Event|1
5806613|NCT02836236|20037458|P1|Overall Study|Adverse Event|0
5806614|NCT02836236|20037457|P2|Overall Study|Withdrew Consent|0
5806615|NCT02836236|20037458|P1|Overall Study|Withdrew Consent|2
5806616|NCT02836236|20037457|P2|Overall Study|Randomized but Never Treated|0
5806617|NCT02836236|20037458|P1|Overall Study|Randomized but Never Treated|1
5806618|NCT02835820|20037474|P2|Overall Study|Baseline Screen Failure|3
5806619|NCT02835820|20037475|P1|Overall Study|Baseline Screen Failure|0
5806620|NCT02835690|20037522|P3|Overall Study|Not Treated|0
5806621|NCT02835690|20037523|P2|Overall Study|Not Treated|2
5806622|NCT02835690|20037524|P1|Overall Study|Not Treated|0
5806623|NCT02835690|20037522|P3|Overall Study|Ongoing in Study (Follow-up)|9
5806624|NCT02835690|20037523|P2|Overall Study|Ongoing in Study (Follow-up)|7
5806625|NCT02835690|20037524|P1|Overall Study|Ongoing in Study (Follow-up)|10
5806626|NCT02835690|20037522|P3|Overall Study|Death|6
5806627|NCT02835690|20037523|P2|Overall Study|Death|6
5806628|NCT02835690|20037524|P1|Overall Study|Death|4
5806629|NCT02835495|20037607|P2|Overall Study|Declined in-person follow-up visit|2
5806630|NCT02835495|20037608|P1|Overall Study|Declined in-person follow-up visit|4
5806631|NCT02835495|20037607|P2|Overall Study|Cancer diagnosis prior intervention|0
5806632|NCT02835495|20037608|P1|Overall Study|Cancer diagnosis prior intervention|1
5806633|NCT02835339|20037634|P2|Overall Study|Did not receive allocated intervention|16
5806634|NCT02835339|20037635|P1|Overall Study|Did not receive allocated intervention|13
5806635|NCT02835092|20037657|P3|Overall Study|Lost to Follow-up|0
5806636|NCT02835092|20037658|P2|Overall Study|Lost to Follow-up|2
5806637|NCT02835092|20037659|P1|Overall Study|Lost to Follow-up|0
5806638|NCT02835092|20037657|P3|Overall Study|Withdrawal by Subject|3
5806639|NCT02835092|20037658|P2|Overall Study|Withdrawal by Subject|6
5806640|NCT02835092|20037659|P1|Overall Study|Withdrawal by Subject|3
5806641|NCT02834819|20037669|P2|Overall Study|Did not complete 7 day follow up call.|0
5806642|NCT02834819|20037670|P1|Overall Study|Did not complete 7 day follow up call.|5
5806643|NCT02834247|20037729|P4|Dose Expansion Phase|Withdrawal by Subject|1
5806644|NCT02834247|20037730|P3|Dose Expansion Phase|Withdrawal by Subject|0
5806645|NCT02834247|20037731|P2|Dose Expansion Phase|Withdrawal by Subject|0
5806646|NCT02834247|20037732|P1|Dose Expansion Phase|Withdrawal by Subject|0
5806647|NCT02834247|20037729|P4|Dose Expansion Phase|Lost to Follow-up|1
5806648|NCT02834247|20037730|P3|Dose Expansion Phase|Lost to Follow-up|0
5806649|NCT02834247|20037731|P2|Dose Expansion Phase|Lost to Follow-up|0
5806650|NCT02834247|20037732|P1|Dose Expansion Phase|Lost to Follow-up|0
5806651|NCT02834247|20037729|P4|Dose Expansion Phase|Death|8
5806652|NCT02834247|20037730|P3|Dose Expansion Phase|Death|0
5806653|NCT02834247|20037731|P2|Dose Expansion Phase|Death|0
5806654|NCT02834247|20037732|P1|Dose Expansion Phase|Death|0
5806655|NCT02834247|20037729|P4|Dose Expansion Phase|Study Terminated by Sponsor|7
5806656|NCT02834247|20037730|P3|Dose Expansion Phase|Study Terminated by Sponsor|0
5806657|NCT02834247|20037731|P2|Dose Expansion Phase|Study Terminated by Sponsor|0
5806658|NCT02834247|20037732|P1|Dose Expansion Phase|Study Terminated by Sponsor|0
5806659|NCT02834247|20037729|P4|Dose Escalation Phase|Withdrawal by Subject|0
5806660|NCT02834247|20037730|P3|Dose Escalation Phase|Withdrawal by Subject|0
5806661|NCT02834247|20037731|P2|Dose Escalation Phase|Withdrawal by Subject|2
5806662|NCT02834247|20037732|P1|Dose Escalation Phase|Withdrawal by Subject|2
5806663|NCT02834247|20037729|P4|Dose Escalation Phase|Lost to Follow-up|0
5806664|NCT02834247|20037730|P3|Dose Escalation Phase|Lost to Follow-up|0
5806665|NCT02834247|20037731|P2|Dose Escalation Phase|Lost to Follow-up|1
5806666|NCT02834247|20037732|P1|Dose Escalation Phase|Lost to Follow-up|0
5806667|NCT02834247|20037729|P4|Dose Escalation Phase|Death|0
5806668|NCT02834247|20037730|P3|Dose Escalation Phase|Death|5
5806669|NCT02834247|20037731|P2|Dose Escalation Phase|Death|6
5806670|NCT02834247|20037732|P1|Dose Escalation Phase|Death|5
5806671|NCT02834247|20037729|P4|Dose Escalation Phase|Study Terminated by Sponsor|0
5806672|NCT02834247|20037730|P3|Dose Escalation Phase|Study Terminated by Sponsor|0
5806673|NCT02834247|20037731|P2|Dose Escalation Phase|Study Terminated by Sponsor|2
5806674|NCT02834247|20037732|P1|Dose Escalation Phase|Study Terminated by Sponsor|1
5806675|NCT02833974|20037761|P2|Overall Study|Adverse Event|3
5806676|NCT02833974|20037762|P1|Overall Study|Adverse Event|0
5806677|NCT02833974|20037761|P2|Overall Study|Lost to Follow-up|0
5806678|NCT02833974|20037762|P1|Overall Study|Lost to Follow-up|1
5806679|NCT02833948|20037788|P2|Overall Study|scans could not be evaluated|2
5806680|NCT02833948|20037789|P1|Overall Study|scans could not be evaluated|5
5806681|NCT02833948|20037788|P2|Overall Study|were not scanned|13
5806682|NCT02833948|20037789|P1|Overall Study|were not scanned|8
5806683|NCT02833948|20037788|P2|Overall Study|Death|3
5806684|NCT02833948|20037789|P1|Overall Study|Death|2
5806685|NCT02833350|20037862|P7|Overall Study|Withdrawal by Subject|2
5806686|NCT02833350|20037863|P6|Overall Study|Withdrawal by Subject|0
5806687|NCT02833350|20037864|P5|Overall Study|Withdrawal by Subject|2
5806688|NCT02833350|20037865|P4|Overall Study|Withdrawal by Subject|0
5806689|NCT02833350|20037866|P3|Overall Study|Withdrawal by Subject|2
5806690|NCT02833350|20037867|P2|Overall Study|Withdrawal by Subject|3
5806691|NCT02833350|20037868|P1|Overall Study|Withdrawal by Subject|3
5806692|NCT02833350|20037862|P7|Overall Study|Lost to Follow-up|1
5806693|NCT02833350|20037863|P6|Overall Study|Lost to Follow-up|0
5806694|NCT02833350|20037864|P5|Overall Study|Lost to Follow-up|0
5806695|NCT02833350|20037865|P4|Overall Study|Lost to Follow-up|0
5806696|NCT02833350|20037866|P3|Overall Study|Lost to Follow-up|0
5806697|NCT02833350|20037867|P2|Overall Study|Lost to Follow-up|1
5806698|NCT02833350|20037868|P1|Overall Study|Lost to Follow-up|0
5806699|NCT02833350|20037862|P7|Overall Study|Lack of Efficacy|1
5806700|NCT02833350|20037863|P6|Overall Study|Lack of Efficacy|1
5806701|NCT02833350|20037864|P5|Overall Study|Lack of Efficacy|0
5806702|NCT02833350|20037865|P4|Overall Study|Lack of Efficacy|4
5806703|NCT02833350|20037866|P3|Overall Study|Lack of Efficacy|1
5806704|NCT02833350|20037867|P2|Overall Study|Lack of Efficacy|2
5806705|NCT02833350|20037868|P1|Overall Study|Lack of Efficacy|0
5806706|NCT02833350|20037862|P7|Overall Study|Death|0
5806707|NCT02833350|20037863|P6|Overall Study|Death|0
5806708|NCT02833350|20037864|P5|Overall Study|Death|0
5806709|NCT02833350|20037865|P4|Overall Study|Death|0
5806710|NCT02833350|20037866|P3|Overall Study|Death|1
5806711|NCT02833350|20037867|P2|Overall Study|Death|0
5806712|NCT02833350|20037868|P1|Overall Study|Death|0
5806713|NCT02833350|20037862|P7|Overall Study|Adverse Event|1
5806714|NCT02833350|20037863|P6|Overall Study|Adverse Event|0
5806715|NCT02833350|20037864|P5|Overall Study|Adverse Event|1
5806716|NCT02833350|20037865|P4|Overall Study|Adverse Event|4
5806717|NCT02833350|20037866|P3|Overall Study|Adverse Event|4
5806718|NCT02833350|20037867|P2|Overall Study|Adverse Event|3
5806719|NCT02833350|20037868|P1|Overall Study|Adverse Event|0
5806720|NCT02833077|20038075|P2|Overall Study|Protocol Deviation|1
5806721|NCT02833077|20038076|P1|Overall Study|Protocol Deviation|0
5806722|NCT02833077|20038075|P2|Overall Study|Personal Reasons|4
5806723|NCT02833077|20038076|P1|Overall Study|Personal Reasons|6
5806724|NCT02833077|20038075|P2|Overall Study|Lost to Follow-up|1
5806725|NCT02833077|20038076|P1|Overall Study|Lost to Follow-up|10
5806726|NCT02833077|20038075|P2|Overall Study|Adverse Event|2
5806727|NCT02833077|20038076|P1|Overall Study|Adverse Event|1
5806728|NCT02832375|20038099|P2|Overall Study|Withdrawal of Consent|0
5806729|NCT02832375|20038100|P1|Overall Study|Withdrawal of Consent|1
5806730|NCT02832375|20038099|P2|Overall Study|Lost to Follow-up|0
5806731|NCT02832375|20038100|P1|Overall Study|Lost to Follow-up|1
5806732|NCT02832167|20038118|P1|Treatment Period 2|Other reasons|3
5806733|NCT02832167|20038118|P1|Treatment Period 2|Participant withdrew consent|3
5806734|NCT02832167|20038118|P1|Treatment Period 2|Participant request to discontinue|2
5806735|NCT02832167|20038118|P1|Treatment Period 2|Study Drug Toxicity|5
5806736|NCT02832167|20038118|P1|Treatment Period 2|Maximum clinical benefit|1
5806737|NCT02832167|20038118|P1|Treatment Period 2|Adverse event unrelated to study drug|1
5806738|NCT02832167|20038118|P1|Treatment Period 2|Disease progression|68
5806739|NCT02832167|20038118|P1|Transition From Period 1 to Period 2|Lost to Follow-up|3
5806740|NCT02832167|20038118|P1|Transition From Period 1 to Period 2|Death|2
5806741|NCT02832167|20038118|P1|Transition From Period 1 to Period 2|Participant withdrew consent|1
5806742|NCT02832167|20038118|P1|Transition From Period 1 to Period 2|Other reasons|1
5806743|NCT02832167|20038118|P1|Treatment Period 1|Other reasons|6
5806744|NCT02832167|20038118|P1|Treatment Period 1|Participant withdrew consent|3
5806745|NCT02832167|20038118|P1|Treatment Period 1|No longer meet study criteria|1
5806746|NCT02832167|20038118|P1|Treatment Period 1|Participant request to discontinue|9
5806747|NCT02832167|20038118|P1|Treatment Period 1|Study Drug Toxicity|6
5806748|NCT02832167|20038118|P1|Treatment Period 1|Death|1
5806749|NCT02832167|20038118|P1|Treatment Period 1|Adverse event unrelated to study drug|11
5806750|NCT02832167|20038118|P1|Treatment Period 1|Disease progression|92
5806751|NCT02831855|20038159|P3|Double Blind Phase (24 Weeks)|Randomized but not Treated|0
5806752|NCT02831855|20038160|P2|Double Blind Phase (24 Weeks)|Randomized but not Treated|3
5806753|NCT02831855|20038161|P1|Double Blind Phase (24 Weeks)|Randomized but not Treated|0
5806754|NCT02831855|20038159|P3|Double Blind Phase (24 Weeks)|Protocol Violation|2
5806755|NCT02831855|20038160|P2|Double Blind Phase (24 Weeks)|Protocol Violation|5
5806756|NCT02831855|20038161|P1|Double Blind Phase (24 Weeks)|Protocol Violation|0
5806757|NCT02831855|20038159|P3|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|1
5806758|NCT02831855|20038160|P2|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|6
5806759|NCT02831855|20038161|P1|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|0
5806760|NCT02831855|20038159|P3|Double Blind Phase (24 Weeks)|Other|5
5806761|NCT02831855|20038160|P2|Double Blind Phase (24 Weeks)|Other|2
5806762|NCT02831855|20038161|P1|Double Blind Phase (24 Weeks)|Other|0
5806763|NCT02831855|20038159|P3|Double Blind Phase (24 Weeks)|Withdrawal by Subject|2
5806764|NCT02831855|20038160|P2|Double Blind Phase (24 Weeks)|Withdrawal by Subject|5
5806765|NCT02831855|20038161|P1|Double Blind Phase (24 Weeks)|Withdrawal by Subject|0
5806766|NCT02831855|20038159|P3|Double Blind Phase (24 Weeks)|Screen Failure|0
5806767|NCT02831855|20038160|P2|Double Blind Phase (24 Weeks)|Screen Failure|1
5806768|NCT02831855|20038161|P1|Double Blind Phase (24 Weeks)|Screen Failure|0
5806769|NCT02831855|20038159|P3|Double Blind Phase (24 Weeks)|Lost to Follow-up|1
5806770|NCT02831855|20038160|P2|Double Blind Phase (24 Weeks)|Lost to Follow-up|1
5806771|NCT02831855|20038161|P1|Double Blind Phase (24 Weeks)|Lost to Follow-up|0
5806772|NCT02831855|20038159|P3|Double Blind Phase (24 Weeks)|Death|2
5806773|NCT02831855|20038160|P2|Double Blind Phase (24 Weeks)|Death|0
5806774|NCT02831855|20038161|P1|Double Blind Phase (24 Weeks)|Death|0
5806775|NCT02831855|20038159|P3|Double Blind Phase (24 Weeks)|Adverse Event|6
5806776|NCT02831855|20038160|P2|Double Blind Phase (24 Weeks)|Adverse Event|6
5806777|NCT02831855|20038161|P1|Double Blind Phase (24 Weeks)|Adverse Event|0
5806778|NCT02831855|20038159|P3|Open Label Phase (24 Weeks)|Other|0
5806779|NCT02831855|20038160|P2|Open Label Phase (24 Weeks)|Other|0
5806780|NCT02831855|20038161|P1|Open Label Phase (24 Weeks)|Other|4
5806781|NCT02831855|20038159|P3|Open Label Phase (24 Weeks)|Withdrawal by Subject|0
5806782|NCT02831855|20038160|P2|Open Label Phase (24 Weeks)|Withdrawal by Subject|0
5806783|NCT02831855|20038161|P1|Open Label Phase (24 Weeks)|Withdrawal by Subject|6
5806784|NCT02831855|20038159|P3|Open Label Phase (24 Weeks)|Protocol Violation|0
5806785|NCT02831855|20038160|P2|Open Label Phase (24 Weeks)|Protocol Violation|0
5806786|NCT02831855|20038161|P1|Open Label Phase (24 Weeks)|Protocol Violation|5
5806787|NCT02831855|20038159|P3|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0
5806788|NCT02831855|20038160|P2|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0
5806789|NCT02831855|20038161|P1|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|2
5806790|NCT02831855|20038159|P3|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0
5806791|NCT02831855|20038160|P2|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0
5806792|NCT02831855|20038161|P1|Open Label Phase (24 Weeks)|Insufficient Clinical Response|7
5806793|NCT02831855|20038159|P3|Open Label Phase (24 Weeks)|Lost to Follow-up|0
5806794|NCT02831855|20038160|P2|Open Label Phase (24 Weeks)|Lost to Follow-up|0
5806795|NCT02831855|20038161|P1|Open Label Phase (24 Weeks)|Lost to Follow-up|8
5806796|NCT02831855|20038159|P3|Open Label Phase (24 Weeks)|Adverse Event|0
5806797|NCT02831855|20038160|P2|Open Label Phase (24 Weeks)|Adverse Event|0
5806798|NCT02831855|20038161|P1|Open Label Phase (24 Weeks)|Adverse Event|39
5806799|NCT02831764|20038222|P2|Overall Study|Ongoing at the time of the analysis|335
5806800|NCT02831764|20038223|P1|Overall Study|Ongoing at the time of the analysis|330
5806801|NCT02831764|20038222|P2|Overall Study|Protocol Violation|2
5806802|NCT02831764|20038223|P1|Overall Study|Protocol Violation|5
5806803|NCT02831764|20038222|P2|Overall Study|Lack of Efficacy|2
5806804|NCT02831764|20038223|P1|Overall Study|Lack of Efficacy|2
5806805|NCT02831764|20038222|P2|Overall Study|Adverse Event|5
5806806|NCT02831764|20038223|P1|Overall Study|Adverse Event|8
5806807|NCT02831764|20038222|P2|Overall Study|Lost to Follow-up|5
5806808|NCT02831764|20038223|P1|Overall Study|Lost to Follow-up|6
5806809|NCT02831764|20038222|P2|Overall Study|Physician Decision|2
5806810|NCT02831764|20038223|P1|Overall Study|Physician Decision|2
5806811|NCT02831764|20038222|P2|Overall Study|Withdrawal by Subject|6
5806812|NCT02831764|20038223|P1|Overall Study|Withdrawal by Subject|7
5806813|NCT02831764|20038222|P2|Overall Study|Protocol specific withdrawal criteria|2
5806814|NCT02831764|20038223|P1|Overall Study|Protocol specific withdrawal criteria|0
5806815|NCT02831673|20038287|P2|Overall Study|Ongoing at Week 48 primary analysis.|330
5806816|NCT02831673|20038288|P1|Overall Study|Ongoing at Week 48 primary analysis.|320
5806817|NCT02831673|20038287|P2|Overall Study|Withdrawal by Subject|4
5806818|NCT02831673|20038288|P1|Overall Study|Withdrawal by Subject|6
5806819|NCT02831673|20038287|P2|Overall Study|Physician Decision|3
5806820|NCT02831673|20038288|P1|Overall Study|Physician Decision|6
5806821|NCT02831673|20038287|P2|Overall Study|Lost to Follow-up|6
5806822|NCT02831673|20038288|P1|Overall Study|Lost to Follow-up|9
5806823|NCT02831673|20038287|P2|Overall Study|Protocol Withdrawal Criterion Met|6
5806824|NCT02831673|20038288|P1|Overall Study|Protocol Withdrawal Criterion Met|1
5806825|NCT02831673|20038287|P2|Overall Study|Protocol Violation|4
5806826|NCT02831673|20038288|P1|Overall Study|Protocol Violation|5
5806827|NCT02831673|20038287|P2|Overall Study|Lack of Efficacy|1
5806828|NCT02831673|20038288|P1|Overall Study|Lack of Efficacy|3
5806829|NCT02831673|20038287|P2|Overall Study|Adverse Event|4
5806830|NCT02831673|20038288|P1|Overall Study|Adverse Event|6
5806831|NCT02831387|20038361|P2|Overall Study|Discontinued due to stock recovery|1
5806832|NCT02831387|20038362|P1|Overall Study|Discontinued due to stock recovery|0
5806833|NCT02831387|20038361|P2|Overall Study|Withdrawal by Subject|1
5806834|NCT02831387|20038362|P1|Overall Study|Withdrawal by Subject|1
5806835|NCT02831257|20038380|P1|Overall Study|Withdrawal by Subject|6
5806836|NCT02831257|20038380|P1|Overall Study|Physician Decision|1
5806837|NCT02831257|20038380|P1|Overall Study|Adverse Event|2
5806838|NCT02831257|20038380|P1|Overall Study|Lack of Efficacy|3
5806839|NCT02830893|20038394|P2|Overall Study|Discharged to SNF, no transportation.|1
5806840|NCT02830893|20038395|P1|Overall Study|Discharged to SNF, no transportation.|0
5806841|NCT02830893|20038394|P2|Overall Study|Lost to Follow-up|2
5806842|NCT02830893|20038395|P1|Overall Study|Lost to Follow-up|0
5806843|NCT02830893|20038394|P2|Overall Study|Relocation to out of the country|0
5806844|NCT02830893|20038395|P1|Overall Study|Relocation to out of the country|1
5806845|NCT02830880|20038407|P1|Overall Study|Physician Decision|1
5806846|NCT02830880|20038407|P1|Overall Study|Death|1
5806847|NCT02830880|20038407|P1|Overall Study|Adverse reaction to chemotherapy|1
5806848|NCT02830087|20038426|P6|Overall Study|No study staff to follow-up patients|3
5806849|NCT02830087|20038427|P5|Overall Study|No study staff to follow-up patients|3
5806850|NCT02830087|20038428|P4|Overall Study|No study staff to follow-up patients|3
5806851|NCT02830087|20038429|P3|Overall Study|No study staff to follow-up patients|4
5806852|NCT02830087|20038430|P2|Overall Study|No study staff to follow-up patients|4
5806853|NCT02830087|20038431|P1|Overall Study|No study staff to follow-up patients|4
5806854|NCT02829996|20038498|P5|Overall Study|Withdrawal by Subject|0
5806855|NCT02829996|20038499|P4|Overall Study|Withdrawal by Subject|0
5806856|NCT02829996|20038500|P3|Overall Study|Withdrawal by Subject|0
5806857|NCT02829996|20038501|P2|Overall Study|Withdrawal by Subject|0
5806858|NCT02829996|20038502|P1|Overall Study|Withdrawal by Subject|1
5806859|NCT02829944|20038527|P2|Overall Study|Staff unavailable|1
5806860|NCT02829944|20038528|P1|Overall Study|Staff unavailable|0
5806861|NCT02829944|20038527|P2|Overall Study|Catheter broke|1
5806862|NCT02829944|20038528|P1|Overall Study|Catheter broke|0
5806863|NCT02829944|20038527|P2|Overall Study|Catheter Displacement|0
5806864|NCT02829944|20038528|P1|Overall Study|Catheter Displacement|1
5806865|NCT02829944|20038527|P2|Overall Study|Withdrawal by Subject|1
5806866|NCT02829944|20038528|P1|Overall Study|Withdrawal by Subject|2
5806867|NCT02829944|20038527|P2|Overall Study|Inadequate Neuraxial Block|1
5806868|NCT02829944|20038528|P1|Overall Study|Inadequate Neuraxial Block|1
5806869|NCT02829944|20038527|P2|Overall Study|Screen Failure|2
5806870|NCT02829944|20038528|P1|Overall Study|Screen Failure|2
5806871|NCT02829944|20038527|P2|Overall Study|Physician Decision|1
5806872|NCT02829944|20038528|P1|Overall Study|Physician Decision|0
5806873|NCT02829918|20038578|P1|Overall Study|Progression|1
5806874|NCT02829918|20038578|P1|Overall Study|Adverse Event|1
5806875|NCT02829918|20038578|P1|Overall Study|Withdrawal by Subject|4
5806876|NCT02829918|20038578|P1|Overall Study|Death|2
5806877|NCT02829775|20038583|P1|Overall Study|Disease remission|1
5806878|NCT02829775|20038583|P1|Overall Study|Withdrawal by Subject|3
5806879|NCT02829775|20038583|P1|Overall Study|Death|1
5806880|NCT02829138|20038665|P2|Overall Study|Withdrawal by Subject|0
5806881|NCT02829138|20038666|P1|Overall Study|Withdrawal by Subject|1
5806882|NCT02828982|20038689|P2|First Intervention (3 Weeks)|Withdrawal by Subject|1
5806883|NCT02828982|20038690|P1|First Intervention (3 Weeks)|Withdrawal by Subject|1
5806884|NCT02828644|20038712|P2|Overall Study|Lost to Follow-up|22
5806885|NCT02828644|20038713|P1|Overall Study|Lost to Follow-up|23
5806886|NCT02828436|20038720|P2|Period 2|Lost to Follow-up|0
5806887|NCT02828436|20038721|P1|Period 2|Lost to Follow-up|1
5806888|NCT02828436|20038720|P2|Period 2|Did Not Meet Inclusion Criteria|0
5806889|NCT02828436|20038721|P1|Period 2|Did Not Meet Inclusion Criteria|3
5806890|NCT02828436|20038720|P2|Period 2|Withdrawal by Subject|0
5806891|NCT02828436|20038721|P1|Period 2|Withdrawal by Subject|4
5806892|NCT02828436|20038720|P2|Period 1|Lost to Follow-up|1
5806893|NCT02828436|20038721|P1|Period 1|Lost to Follow-up|0
5806894|NCT02828436|20038720|P2|Period 1|Did Not Meet Inclusion Criteria|3
5806895|NCT02828436|20038721|P1|Period 1|Did Not Meet Inclusion Criteria|0
5806896|NCT02828241|20038729|P2|Overall Study|Protocol Violation|0
5806897|NCT02828241|20038730|P1|Overall Study|Protocol Violation|1
5806898|NCT02828241|20038729|P2|Overall Study|Adverse Event|2
5806899|NCT02828241|20038730|P1|Overall Study|Adverse Event|7
5806900|NCT02828124|20038757|P4|Overall Study|Subject Withdrew Consent|1
5806901|NCT02828124|20038758|P3|Overall Study|Subject Withdrew Consent|0
5806902|NCT02828124|20038759|P2|Overall Study|Subject Withdrew Consent|0
5806903|NCT02828124|20038760|P1|Overall Study|Subject Withdrew Consent|0
5806904|NCT02828124|20038757|P4|Overall Study|AE Unrelated to Study Drug|1
5806905|NCT02828124|20038758|P3|Overall Study|AE Unrelated to Study Drug|0
5806906|NCT02828124|20038759|P2|Overall Study|AE Unrelated to Study Drug|0
5806907|NCT02828124|20038760|P1|Overall Study|AE Unrelated to Study Drug|0
5806908|NCT02828124|20038757|P4|Overall Study|Disease Progression|4
5806909|NCT02828124|20038758|P3|Overall Study|Disease Progression|1
5806910|NCT02828124|20038759|P2|Overall Study|Disease Progression|2
5806911|NCT02828124|20038760|P1|Overall Study|Disease Progression|1
5806912|NCT02828111|20038875|P5|Overall Study|Lost to Follow-up|1
5806913|NCT02828111|20038876|P4|Overall Study|Lost to Follow-up|1
5806914|NCT02828111|20038877|P3|Overall Study|Lost to Follow-up|0
5806915|NCT02828111|20038878|P2|Overall Study|Lost to Follow-up|0
5806916|NCT02828111|20038879|P1|Overall Study|Lost to Follow-up|0
5806917|NCT02828111|20038875|P5|Overall Study|Withdrawal by Subject|0
5806918|NCT02828111|20038876|P4|Overall Study|Withdrawal by Subject|0
5806919|NCT02828111|20038877|P3|Overall Study|Withdrawal by Subject|2
5806920|NCT02828111|20038878|P2|Overall Study|Withdrawal by Subject|0
5806921|NCT02828111|20038879|P1|Overall Study|Withdrawal by Subject|0
5806922|NCT02828020|20038940|P3|Safety Follow-up Period|Other Miscellaneous Reasons|0
5806923|NCT02828020|20038941|P2|Safety Follow-up Period|Other Miscellaneous Reasons|0
5806924|NCT02828020|20038942|P1|Safety Follow-up Period|Other Miscellaneous Reasons|1
5806925|NCT02828020|20038940|P3|Safety Follow-up Period|Protocol Violation|1
5806926|NCT02828020|20038941|P2|Safety Follow-up Period|Protocol Violation|2
5806927|NCT02828020|20038942|P1|Safety Follow-up Period|Protocol Violation|0
5806928|NCT02828020|20038940|P3|Safety Follow-up Period|Lost to Follow-up|11
5806929|NCT02828020|20038941|P2|Safety Follow-up Period|Lost to Follow-up|8
5806930|NCT02828020|20038942|P1|Safety Follow-up Period|Lost to Follow-up|9
5806931|NCT02828020|20038940|P3|Safety Follow-up Period|Withdrawal of Consent|7
5806932|NCT02828020|20038941|P2|Safety Follow-up Period|Withdrawal of Consent|8
5806933|NCT02828020|20038942|P1|Safety Follow-up Period|Withdrawal of Consent|10
5806934|NCT02828020|20038940|P3|Treatment Period|Other Miscellaneous Reasons|0
5806935|NCT02828020|20038941|P2|Treatment Period|Other Miscellaneous Reasons|1
5806936|NCT02828020|20038942|P1|Treatment Period|Other Miscellaneous Reasons|0
5806937|NCT02828020|20038940|P3|Treatment Period|Protocol Violation|7
5806938|NCT02828020|20038941|P2|Treatment Period|Protocol Violation|4
5806939|NCT02828020|20038942|P1|Treatment Period|Protocol Violation|2
5806940|NCT02828020|20038940|P3|Treatment Period|Pregnancy|0
5806941|NCT02828020|20038941|P2|Treatment Period|Pregnancy|2
5806942|NCT02828020|20038942|P1|Treatment Period|Pregnancy|0
5806943|NCT02828020|20038940|P3|Treatment Period|Lack of Qualifying Event|43
5806944|NCT02828020|20038941|P2|Treatment Period|Lack of Qualifying Event|53
5806945|NCT02828020|20038942|P1|Treatment Period|Lack of Qualifying Event|44
5806946|NCT02828020|20038940|P3|Treatment Period|Lost to Follow-up|18
5806947|NCT02828020|20038941|P2|Treatment Period|Lost to Follow-up|24
5806948|NCT02828020|20038942|P1|Treatment Period|Lost to Follow-up|21
5806949|NCT02828020|20038940|P3|Treatment Period|Withdrawal of Consent|9
5806950|NCT02828020|20038941|P2|Treatment Period|Withdrawal of Consent|14
5806951|NCT02828020|20038942|P1|Treatment Period|Withdrawal of Consent|10
5806952|NCT02828020|20038940|P3|Treatment Period|Adverse Event|1
5806953|NCT02828020|20038941|P2|Treatment Period|Adverse Event|1
5806954|NCT02828020|20038942|P1|Treatment Period|Adverse Event|3
5806955|NCT02827708|20038973|P2|Overall Study|Death|2
5806956|NCT02827708|20038974|P1|Overall Study|Death|1
5806957|NCT02827708|20038973|P2|Overall Study|Withdrawal by Subject|2
5806958|NCT02827708|20038974|P1|Overall Study|Withdrawal by Subject|1
5806959|NCT02827708|20038973|P2|Overall Study|Lost to Follow-up|1
5806960|NCT02827708|20038974|P1|Overall Study|Lost to Follow-up|3
5806961|NCT02827500|20039053|P2|Overall Study|Other|1
5806962|NCT02827500|20039054|P1|Overall Study|Other|5
5806963|NCT02827500|20039053|P2|Overall Study|Missing primary endpoint data|1
5806964|NCT02827500|20039054|P1|Overall Study|Missing primary endpoint data|3
5806965|NCT02827500|20039053|P2|Overall Study|Withdrawal by Subject|1
5806966|NCT02827500|20039054|P1|Overall Study|Withdrawal by Subject|3
5806967|NCT02827500|20039053|P2|Overall Study|Lost to Follow-up|1
5806968|NCT02827500|20039054|P1|Overall Study|Lost to Follow-up|1
5806969|NCT02827500|20039053|P2|Overall Study|Death|3
5806970|NCT02827500|20039054|P1|Overall Study|Death|7
5806971|NCT02826798|20039075|P5|Overall Study|Withdrawal by Subject|0
5806972|NCT02826798|20039076|P4|Overall Study|Withdrawal by Subject|1
5806973|NCT02826798|20039077|P3|Overall Study|Withdrawal by Subject|0
5806974|NCT02826798|20039078|P2|Overall Study|Withdrawal by Subject|1
5806975|NCT02826798|20039079|P1|Overall Study|Withdrawal by Subject|0
5806976|NCT02826603|20039141|P2|Overall Study|New therapy for study indication|1
5806977|NCT02826603|20039142|P1|Overall Study|New therapy for study indication|0
5806978|NCT02826603|20039141|P2|Overall Study|Death|0
5806979|NCT02826603|20039142|P1|Overall Study|Death|2
5806980|NCT02826603|20039141|P2|Overall Study|Withdrawal by Subject|19
5806981|NCT02826603|20039142|P1|Overall Study|Withdrawal by Subject|20
5806982|NCT02826603|20039141|P2|Overall Study|Protocol Violation|3
5806983|NCT02826603|20039142|P1|Overall Study|Protocol Violation|3
5806984|NCT02826603|20039141|P2|Overall Study|Pregnancy|2
5806985|NCT02826603|20039142|P1|Overall Study|Pregnancy|1
5806986|NCT02826603|20039141|P2|Overall Study|Physician Decision|7
5806987|NCT02826603|20039142|P1|Overall Study|Physician Decision|1
5806988|NCT02826603|20039141|P2|Overall Study|Noncompliance with treatment|2
5806989|NCT02826603|20039142|P1|Overall Study|Noncompliance with treatment|0
5806990|NCT02826603|20039141|P2|Overall Study|Lost to Follow-up|12
5806991|NCT02826603|20039142|P1|Overall Study|Lost to Follow-up|13
5806992|NCT02826603|20039141|P2|Overall Study|Lack of Efficacy|9
5806993|NCT02826603|20039142|P1|Overall Study|Lack of Efficacy|4
5806994|NCT02826603|20039141|P2|Overall Study|Adverse Event|9
5806995|NCT02826603|20039142|P1|Overall Study|Adverse Event|17
5806996|NCT02826421|20039182|P4|Overall Study|Reason not given|0
5806997|NCT02826421|20039183|P3|Overall Study|Reason not given|1
5806998|NCT02826421|20039184|P2|Overall Study|Reason not given|0
5806999|NCT02826421|20039185|P1|Overall Study|Reason not given|1
5807000|NCT02826421|20039182|P4|Overall Study|Withdrawal by Subject|1
5807001|NCT02826421|20039183|P3|Overall Study|Withdrawal by Subject|1
5807002|NCT02826421|20039184|P2|Overall Study|Withdrawal by Subject|3
5807003|NCT02826421|20039185|P1|Overall Study|Withdrawal by Subject|1
5807004|NCT02826421|20039182|P4|Overall Study|Adverse Event|1
5807005|NCT02826421|20039183|P3|Overall Study|Adverse Event|0
5807006|NCT02826421|20039184|P2|Overall Study|Adverse Event|0
5807007|NCT02826421|20039185|P1|Overall Study|Adverse Event|1
5807008|NCT02825992|20039197|P1|Overall Study|Procedure terminated|2
5807009|NCT02825992|20039197|P1|Overall Study|Lost to Follow-up|2
5807010|NCT02825992|20039197|P1|Overall Study|Withdrawal by Subject|4
5807011|NCT02825550|20039225|P1|Overall Study|Physician Decision|1
5807012|NCT02825251|20039233|P2|Overall Study|Unclassified|0
5807013|NCT02825251|20039234|P1|Overall Study|Unclassified|2
5807014|NCT02825251|20039233|P2|Overall Study|Withdrawal by Subject|4
5807015|NCT02825251|20039234|P1|Overall Study|Withdrawal by Subject|1
5807016|NCT02825251|20039233|P2|Overall Study|Lost to Follow-up|1
5807017|NCT02825251|20039234|P1|Overall Study|Lost to Follow-up|0
5807018|NCT02825251|20039233|P2|Overall Study|Adverse Event|1
5807019|NCT02825251|20039234|P1|Overall Study|Adverse Event|0
5807020|NCT02825043|20039425|P1|Overall Study|Lost to Follow-up|4
5807021|NCT02824562|20039447|P2|Overall Study|Death|1
5807022|NCT02824562|20039448|P1|Overall Study|Death|0
5807023|NCT02824562|20039447|P2|Overall Study|Lost to Follow-up|4
5807024|NCT02824562|20039448|P1|Overall Study|Lost to Follow-up|3
5807025|NCT02824432|20039457|P2|Overall Study|Major Protocol Deviation|0
5807026|NCT02824432|20039458|P1|Overall Study|Major Protocol Deviation|1
5807027|NCT02824224|20039534|P2|Overall Study|Did not show up for allocation visit|0
5807028|NCT02824224|20039535|P1|Overall Study|Did not show up for allocation visit|2
5807029|NCT02824224|20039534|P2|Overall Study|Discontinued, IUS expulsion|1
5807030|NCT02824224|20039535|P1|Overall Study|Discontinued, IUS expulsion|0
5807031|NCT02824198|20039555|P2|Overall Study|Withdrawal by Subject|0
5807032|NCT02824198|20039556|P1|Overall Study|Withdrawal by Subject|5
5807033|NCT02824198|20039555|P2|Overall Study|Lost to Follow-up|2
5807034|NCT02824198|20039556|P1|Overall Study|Lost to Follow-up|5
5807035|NCT02824198|20039555|P2|Overall Study|Non-compliance with the protocol|1
5807036|NCT02824198|20039556|P1|Overall Study|Non-compliance with the protocol|5
5807037|NCT02823964|20039586|P1|Overall Study|Withdrawal by Subject|1
5807038|NCT02823964|20039586|P1|Overall Study|Lack of Efficacy|1
5807039|NCT02823964|20039586|P1|Overall Study|Physician Decision|1
5807040|NCT02823964|20039586|P1|Overall Study|Adverse Event|2
5807041|NCT02823470|20039600|P2|Overall Study|Study terminated by sponsor|15
5807042|NCT02823470|20039601|P1|Overall Study|Study terminated by sponsor|8
5807043|NCT02823470|20039600|P2|Overall Study|Adverse Event|0
5807044|NCT02823470|20039601|P1|Overall Study|Adverse Event|1
5807045|NCT02822794|20039674|P2|Overall Study|Withdrew Consent|0
5807046|NCT02822794|20039675|P1|Overall Study|Withdrew Consent|1
5807047|NCT02822235|20039776|P2|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|1
5807048|NCT02822235|20039777|P1|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|6
5807049|NCT02822235|20039776|P2|Prospective Phase (Day 1 up to Month 12)|Death|0
5807050|NCT02822235|20039777|P1|Prospective Phase (Day 1 up to Month 12)|Death|1
5807051|NCT02822235|20039776|P2|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|0
5807052|NCT02822235|20039777|P1|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|4
5807053|NCT02822235|20039776|P2|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|1
5807054|NCT02822235|20039777|P1|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|0
5807055|NCT02822235|20039776|P2|Cross-sectional Phase (Day 1)|Reason Not Specified|0
5807056|NCT02822235|20039777|P1|Cross-sectional Phase (Day 1)|Reason Not Specified|2
5807057|NCT02822235|20039776|P2|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|107
5807058|NCT02822235|20039777|P1|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|144
5807059|NCT02822222|20039832|P2|Overall Study|Protocol requirement SBP<110 mmHg|0
5807060|NCT02822222|20039833|P1|Overall Study|Protocol requirement SBP<110 mmHg|1
5807061|NCT02821962|20039883|P2|Overall Study|Lost to Follow-up|0
5807062|NCT02821962|20039884|P1|Overall Study|Lost to Follow-up|2
5807063|NCT02821910|20039928|P6|Overall Study|Other than specified|0
5807064|NCT02821910|20039929|P5|Overall Study|Other than specified|0
5807065|NCT02821910|20039930|P4|Overall Study|Other than specified|0
5807066|NCT02821910|20039931|P3|Overall Study|Other than specified|1
5807067|NCT02821910|20039932|P2|Overall Study|Other than specified|0
5807068|NCT02821910|20039933|P1|Overall Study|Other than specified|1
5807069|NCT02821910|20039928|P6|Overall Study|Withdrawal by Subject|1
5807070|NCT02821910|20039929|P5|Overall Study|Withdrawal by Subject|0
5807071|NCT02821910|20039930|P4|Overall Study|Withdrawal by Subject|0
5807072|NCT02821910|20039931|P3|Overall Study|Withdrawal by Subject|1
5807073|NCT02821910|20039932|P2|Overall Study|Withdrawal by Subject|0
5807074|NCT02821910|20039933|P1|Overall Study|Withdrawal by Subject|0
5807075|NCT02821819|20039995|P1|Overall Study|Protocol Violation|1
5807076|NCT02821715|20040000|P6|Overall Study|Protocol Violation|0
5807077|NCT02821715|20040001|P5|Overall Study|Protocol Violation|0
5807078|NCT02821715|20040002|P4|Overall Study|Protocol Violation|0
5807079|NCT02821715|20040003|P3|Overall Study|Protocol Violation|0
5807080|NCT02821715|20040004|P2|Overall Study|Protocol Violation|0
5807081|NCT02821715|20040005|P1|Overall Study|Protocol Violation|1
5807082|NCT02821416|20040056|P2|Overall Study|Lost to Follow-up|0
5807083|NCT02821416|20040057|P1|Overall Study|Lost to Follow-up|1
5807084|NCT02821416|20040056|P2|Overall Study|Withdrawal by Subject|0
5807085|NCT02821416|20040057|P1|Overall Study|Withdrawal by Subject|2
5807086|NCT02821416|20040056|P2|Overall Study|Adverse Event|1
5807087|NCT02821416|20040057|P1|Overall Study|Adverse Event|0
5807088|NCT02821000|20040103|P1|Overall Study|Ongoing in Study|58
5807089|NCT02821000|20040103|P1|Overall Study|Withdrawal by Subject|1
5807090|NCT02821000|20040103|P1|Overall Study|Death|44
5807091|NCT02820844|20040141|P6|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|1
5807092|NCT02820844|20040142|P5|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
5807093|NCT02820844|20040143|P4|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
5807094|NCT02820844|20040144|P3|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
5807095|NCT02820844|20040145|P2|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
5807096|NCT02820844|20040146|P1|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
5807097|NCT02820844|20040141|P6|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0
5807098|NCT02820844|20040142|P5|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|2
5807099|NCT02820844|20040143|P4|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0
5807100|NCT02820844|20040144|P3|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0
5807101|NCT02820844|20040145|P2|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0
5807102|NCT02820844|20040146|P1|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0
5807103|NCT02820844|20040141|P6|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
5807104|NCT02820844|20040142|P5|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
5807105|NCT02820844|20040143|P4|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|2
5807106|NCT02820844|20040144|P3|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|7
5807107|NCT02820844|20040145|P2|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
5807108|NCT02820844|20040146|P1|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
5807109|NCT02820844|20040141|P6|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0
5807110|NCT02820844|20040142|P5|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0
5807111|NCT02820844|20040143|P4|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0
5807112|NCT02820844|20040144|P3|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|1
5807113|NCT02820844|20040145|P2|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0
5807114|NCT02820844|20040146|P1|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0
5807115|NCT02820844|20040141|P6|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0
5807116|NCT02820844|20040142|P5|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0
5807117|NCT02820844|20040143|P4|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|2
5807118|NCT02820844|20040144|P3|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|1
5807119|NCT02820844|20040145|P2|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0
5807120|NCT02820844|20040146|P1|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0
5807121|NCT02820844|20040141|P6|Double-blinded (Up to 48 Weeks)|Investigator discretion|0
5807122|NCT02820844|20040142|P5|Double-blinded (Up to 48 Weeks)|Investigator discretion|0
5807123|NCT02820844|20040143|P4|Double-blinded (Up to 48 Weeks)|Investigator discretion|0
5807124|NCT02820844|20040144|P3|Double-blinded (Up to 48 Weeks)|Investigator discretion|0
5807125|NCT02820844|20040145|P2|Double-blinded (Up to 48 Weeks)|Investigator discretion|0
5807126|NCT02820844|20040146|P1|Double-blinded (Up to 48 Weeks)|Investigator discretion|1
5807127|NCT02820844|20040141|P6|Double-blinded (Up to 48 Weeks)|Adverse Event|0
5807128|NCT02820844|20040142|P5|Double-blinded (Up to 48 Weeks)|Adverse Event|0
5807129|NCT02820844|20040143|P4|Double-blinded (Up to 48 Weeks)|Adverse Event|0
5807130|NCT02820844|20040144|P3|Double-blinded (Up to 48 Weeks)|Adverse Event|0
5807131|NCT02820844|20040145|P2|Double-blinded (Up to 48 Weeks)|Adverse Event|1
5807132|NCT02820844|20040146|P1|Double-blinded (Up to 48 Weeks)|Adverse Event|2
5807133|NCT02820844|20040141|P6|Double-blinded (Up to 48 Weeks)|Protocol Violation|0
5807134|NCT02820844|20040142|P5|Double-blinded (Up to 48 Weeks)|Protocol Violation|0
5807135|NCT02820844|20040143|P4|Double-blinded (Up to 48 Weeks)|Protocol Violation|0
5807136|NCT02820844|20040144|P3|Double-blinded (Up to 48 Weeks)|Protocol Violation|0
5807137|NCT02820844|20040145|P2|Double-blinded (Up to 48 Weeks)|Protocol Violation|3
5807138|NCT02820844|20040146|P1|Double-blinded (Up to 48 Weeks)|Protocol Violation|0
5807139|NCT02820844|20040141|P6|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0
5807140|NCT02820844|20040142|P5|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0
5807141|NCT02820844|20040143|P4|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0
5807142|NCT02820844|20040144|P3|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0
5807143|NCT02820844|20040145|P2|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|2
5807144|NCT02820844|20040146|P1|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|1
5807145|NCT02820844|20040141|P6|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0
5807146|NCT02820844|20040142|P5|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0
5807147|NCT02820844|20040143|P4|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0
5807148|NCT02820844|20040144|P3|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0
5807149|NCT02820844|20040145|P2|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|3
5807150|NCT02820844|20040146|P1|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|1
5807151|NCT02820597|20040360|P1|Overall Study|Lost to Follow-up|12
5807152|NCT02820038|20040411|P4|Overall Study|Withdrawal by Subject|13
5807153|NCT02820038|20040412|P3|Overall Study|Withdrawal by Subject|3
5807154|NCT02820038|20040413|P2|Overall Study|Withdrawal by Subject|14
5807155|NCT02820038|20040414|P1|Overall Study|Withdrawal by Subject|3
5807156|NCT02820038|20040411|P4|Overall Study|Lost to Follow-up|9
5807157|NCT02820038|20040412|P3|Overall Study|Lost to Follow-up|2
5807158|NCT02820038|20040413|P2|Overall Study|Lost to Follow-up|11
5807159|NCT02820038|20040414|P1|Overall Study|Lost to Follow-up|7
5807160|NCT02819804|20040541|P1|Complete Cycle 1 (28 Days)|Progressive disease/no response|1
5807161|NCT02819726|20040548|P4|Part B (All Participants)|Protocol non-compliance|0
5807162|NCT02819726|20040549|P3|Part B (All Participants)|Protocol non-compliance|1
5807163|NCT02819726|20040550|P2|Part B (All Participants)|Protocol non-compliance|0
5807164|NCT02819726|20040551|P1|Part B (All Participants)|Protocol non-compliance|0
5807165|NCT02819726|20040548|P4|Part B (All Participants)|Withdrawal by Subject|0
5807166|NCT02819726|20040549|P3|Part B (All Participants)|Withdrawal by Subject|1
5807167|NCT02819726|20040550|P2|Part B (All Participants)|Withdrawal by Subject|1
5807168|NCT02819726|20040551|P1|Part B (All Participants)|Withdrawal by Subject|2
5807169|NCT02819726|20040548|P4|Part B (All Participants)|Lost to Follow-up|2
5807170|NCT02819726|20040549|P3|Part B (All Participants)|Lost to Follow-up|2
5807171|NCT02819726|20040550|P2|Part B (All Participants)|Lost to Follow-up|1
5807172|NCT02819726|20040551|P1|Part B (All Participants)|Lost to Follow-up|1
5807173|NCT02819726|20040548|P4|Part A (All Participants)|Protocol non-compliance|0
5807174|NCT02819726|20040549|P3|Part A (All Participants)|Protocol non-compliance|5
5807175|NCT02819726|20040550|P2|Part A (All Participants)|Protocol non-compliance|4
5807176|NCT02819726|20040551|P1|Part A (All Participants)|Protocol non-compliance|3
5807177|NCT02819726|20040548|P4|Part A (All Participants)|Withdrawal by Subject|0
5807178|NCT02819726|20040549|P3|Part A (All Participants)|Withdrawal by Subject|6
5807179|NCT02819726|20040550|P2|Part A (All Participants)|Withdrawal by Subject|5
5807180|NCT02819726|20040551|P1|Part A (All Participants)|Withdrawal by Subject|3
5807181|NCT02819726|20040548|P4|Part A (All Participants)|Lost to Follow-up|0
5807182|NCT02819726|20040549|P3|Part A (All Participants)|Lost to Follow-up|0
5807183|NCT02819726|20040550|P2|Part A (All Participants)|Lost to Follow-up|1
5807184|NCT02819726|20040551|P1|Part A (All Participants)|Lost to Follow-up|0
5807185|NCT02819310|20040678|P1|Overall Study|Protocol Violation|30
5807186|NCT02819310|20040678|P1|Overall Study|Physician Decision|8
5807187|NCT02819310|20040678|P1|Overall Study|Lack of Efficacy|5
5807188|NCT02819310|20040678|P1|Overall Study|Adverse Event|13
5807189|NCT02819310|20040678|P1|Overall Study|Lost to Follow-up|16
5807190|NCT02819310|20040678|P1|Overall Study|Withdrawal by Subject|37
5807191|NCT02819297|20040684|P2|Overall Study|Protocol Violation|2
5807192|NCT02819297|20040685|P1|Overall Study|Protocol Violation|1
5807193|NCT02819297|20040684|P2|Overall Study|Lack of Efficacy|8
5807194|NCT02819297|20040685|P1|Overall Study|Lack of Efficacy|5
5807195|NCT02819297|20040684|P2|Overall Study|Physician Decision|5
5807196|NCT02819297|20040685|P1|Overall Study|Physician Decision|5
5807197|NCT02819297|20040684|P2|Overall Study|Adverse Event|10
5807198|NCT02819297|20040685|P1|Overall Study|Adverse Event|12
5807199|NCT02819297|20040684|P2|Overall Study|Lost to Follow-up|14
5807200|NCT02819297|20040685|P1|Overall Study|Lost to Follow-up|12
5807201|NCT02819297|20040684|P2|Overall Study|Withdrawal by Subject|13
5807202|NCT02819297|20040685|P1|Overall Study|Withdrawal by Subject|25
5807203|NCT02818998|20040759|P3|Overall Study|Physician Decision|0
5807204|NCT02818998|20040760|P2|Overall Study|Physician Decision|0
5807205|NCT02818998|20040761|P1|Overall Study|Physician Decision|1
5807206|NCT02818998|20040759|P3|Overall Study|Withdrawal by Subject|6
5807207|NCT02818998|20040760|P2|Overall Study|Withdrawal by Subject|6
5807208|NCT02818998|20040761|P1|Overall Study|Withdrawal by Subject|7
5807209|NCT02818998|20040759|P3|Overall Study|Death|8
5807210|NCT02818998|20040760|P2|Overall Study|Death|6
5807211|NCT02818998|20040761|P1|Overall Study|Death|3
5807212|NCT02818998|20040759|P3|Overall Study|Withdrawal by sponsor|1
5807213|NCT02818998|20040760|P2|Overall Study|Withdrawal by sponsor|1
5807214|NCT02818998|20040761|P1|Overall Study|Withdrawal by sponsor|0
5807215|NCT02818998|20040759|P3|Overall Study|Lost to Follow-up|2
5807216|NCT02818998|20040760|P2|Overall Study|Lost to Follow-up|1
5807217|NCT02818998|20040761|P1|Overall Study|Lost to Follow-up|4
5807218|NCT02818998|20040759|P3|Overall Study|Adverse Event|1
5807219|NCT02818998|20040760|P2|Overall Study|Adverse Event|2
5807220|NCT02818998|20040761|P1|Overall Study|Adverse Event|3
5807221|NCT02818920|20040794|P1|Overall Study|Refused Further Treatment|1
5807222|NCT02818920|20040794|P1|Overall Study|Developed Other Disease|1
5807223|NCT02818920|20040794|P1|Overall Study|Adverse Event|3
5807224|NCT02818920|20040794|P1|Overall Study|Went Off Study Prior to Adjuvant Therapy|8
5807225|NCT02818920|20040794|P1|Overall Study|Progressed After Neoadjuvant Therapy|1
5807226|NCT02818920|20040794|P1|Overall Study|Unresectable|4
5807227|NCT02818777|20040798|P1|Overall Study|Adverse Event|3
5807228|NCT02818036|20040865|P2|Overall Study|Withdrawal by Subject|0
5807229|NCT02818036|20040866|P1|Overall Study|Withdrawal by Subject|1
5807230|NCT02818036|20040865|P2|Overall Study|head did not fit in fMRI scanner headres|0
5807231|NCT02818036|20040866|P1|Overall Study|head did not fit in fMRI scanner headres|1
5807232|NCT02817841|20040874|P1|Overall Study|Protocol Violation|94
5807233|NCT02817841|20040874|P1|Overall Study|Other reasons|53
5807234|NCT02817841|20040874|P1|Overall Study|Pregnancy wish|17
5807235|NCT02817841|20040874|P1|Overall Study|Pregnancy|32
5807236|NCT02817841|20040874|P1|Overall Study|Adverse event related to bleeding|51
5807237|NCT02817841|20040874|P1|Overall Study|Adverse event not related to bleeding|131
5807238|NCT02817841|20040874|P1|Overall Study|Withdrawal by Subject|183
5807239|NCT02817841|20040874|P1|Overall Study|Lost to Follow-up|287
5807240|NCT02817828|20040901|P1|Overall Study|Other|26
5807241|NCT02817828|20040901|P1|Overall Study|Withdrawal by Subject|78
5807242|NCT02817828|20040901|P1|Overall Study|Pregnancy wish|15
5807243|NCT02817828|20040901|P1|Overall Study|Pregnancy|7
5807244|NCT02817828|20040901|P1|Overall Study|Protocol Violation|11
5807245|NCT02817828|20040901|P1|Overall Study|Adverse event related to bleeding|53
5807246|NCT02817828|20040901|P1|Overall Study|Adverse event not related to bleeding|104
5807247|NCT02817828|20040901|P1|Overall Study|Lost to Follow-up|41
5807248|NCT02817776|20040925|P1|Overall Study|Death|2
5807249|NCT02817776|20040925|P1|Overall Study|Withdrawal by Subject|33
5807250|NCT02817776|20040925|P1|Overall Study|Lost to Follow-up|20
5807251|NCT02817776|20040925|P1|Overall Study|Excluded|33
5807252|NCT02817594|20040946|P1|Overall Study|Did Not Receive Treatment|1
5807253|NCT02817594|20040946|P1|Overall Study|Other|1
5807254|NCT02817594|20040946|P1|Overall Study|Withdrawal by Subject|1
5807255|NCT02817555|20040967|P2|Overall Study|changed to Peritoneal Dialysis|1
5807256|NCT02817555|20040968|P1|Overall Study|changed to Peritoneal Dialysis|0
5807257|NCT02817555|20040967|P2|Overall Study|transplant|1
5807258|NCT02817555|20040968|P1|Overall Study|transplant|1
5807259|NCT02817555|20040967|P2|Overall Study|moved away|0
5807260|NCT02817555|20040968|P1|Overall Study|moved away|1
5807261|NCT02817555|20040967|P2|Overall Study|Death|3
5807262|NCT02817555|20040968|P1|Overall Study|Death|1
5807263|NCT02817516|20040988|P4|Overall Study|Other|0
5807264|NCT02817516|20040989|P3|Overall Study|Other|1
5807265|NCT02817516|20040990|P2|Overall Study|Other|0
5807266|NCT02817516|20040991|P1|Overall Study|Other|0
5807267|NCT02817087|20041028|P2|Overall Study|Withdrawal by Subject|0
5807268|NCT02817087|20041029|P1|Overall Study|Withdrawal by Subject|2
5807272|NCT02816138|20041158|P1|Overall Study|Adverse Event|1
5807273|NCT02815735|20041204|P2|Second Intervention (4 Weeks)|Protocol Violation|0
5807274|NCT02815735|20041205|P1|Second Intervention (4 Weeks)|Protocol Violation|1
5807275|NCT02815735|20041204|P2|First Intervention (4 Weeks)|Poor fitting characteristics|1
5807276|NCT02815735|20041205|P1|First Intervention (4 Weeks)|Poor fitting characteristics|0
5807277|NCT02815735|20041204|P2|First Intervention (4 Weeks)|Lost to Follow-up|0
5807278|NCT02815735|20041205|P1|First Intervention (4 Weeks)|Lost to Follow-up|1
5807279|NCT02815735|20041204|P2|First Intervention (4 Weeks)|Discomfort|0
5807280|NCT02815735|20041205|P1|First Intervention (4 Weeks)|Discomfort|1
5807281|NCT02815670|20041259|P1|Overall Study|Prematurely discontinued of the trial|1
5807282|NCT02815397|20041291|P1|Overall Study|Physician Decision|2
5807283|NCT02815293|20041301|P3|Overall Study|Adverse Event|0
5807284|NCT02815293|20041302|P2|Overall Study|Adverse Event|1
5807285|NCT02815293|20041303|P1|Overall Study|Adverse Event|0
5807286|NCT02815293|20041301|P3|Overall Study|Participants not randomized|18
5807287|NCT02815293|20041302|P2|Overall Study|Participants not randomized|0
5807288|NCT02815293|20041303|P1|Overall Study|Participants not randomized|0
5807289|NCT02815293|20041301|P3|Overall Study|Study termination by sponsor|0
5807290|NCT02815293|20041302|P2|Overall Study|Study termination by sponsor|7
5807291|NCT02815293|20041303|P1|Overall Study|Study termination by sponsor|10
5807292|NCT02815280|20041313|P2|Open-Label Phase|Positive pregnancy test; subject- noncompliance; withdrew consent; lack of efficacy etc.|2
5807293|NCT02815280|20041314|P1|Open-Label Phase|Positive pregnancy test; subject- noncompliance; withdrew consent; lack of efficacy etc.|5
5807294|NCT02815280|20041313|P2|Open-Label Phase|Administrative|12
5807295|NCT02815280|20041314|P1|Open-Label Phase|Administrative|26
5807296|NCT02815280|20041313|P2|Open-Label Phase|Protocol Violation|0
5807297|NCT02815280|20041314|P1|Open-Label Phase|Protocol Violation|3
5807298|NCT02815280|20041313|P2|Open-Label Phase|Withdrawal by Subject|18
5807299|NCT02815280|20041314|P1|Open-Label Phase|Withdrawal by Subject|33
5807300|NCT02815280|20041313|P2|Open-Label Phase|Lost to Follow-up|9
5807301|NCT02815280|20041314|P1|Open-Label Phase|Lost to Follow-up|18
5807302|NCT02815280|20041313|P2|Open-Label Phase|Adverse Event|3
5807303|NCT02815280|20041314|P1|Open-Label Phase|Adverse Event|2
5807304|NCT02815280|20041313|P2|Double-Blind Phase|Subject: withdrew consent; non-compliant with visits; moved;lack of efficacy;positive pregnancy test|2
5807305|NCT02815280|20041314|P1|Double-Blind Phase|Subject: withdrew consent; non-compliant with visits; moved;lack of efficacy;positive pregnancy test|3
5807306|NCT02815280|20041313|P2|Double-Blind Phase|Protocol Violation|2
5807307|NCT02815280|20041314|P1|Double-Blind Phase|Protocol Violation|2
5807308|NCT02815280|20041313|P2|Double-Blind Phase|Withdrawal by Subject|11
5807309|NCT02815280|20041314|P1|Double-Blind Phase|Withdrawal by Subject|20
5807310|NCT02815280|20041313|P2|Double-Blind Phase|Lost to Follow-up|9
5807311|NCT02815280|20041314|P1|Double-Blind Phase|Lost to Follow-up|10
5807312|NCT02815280|20041313|P2|Double-Blind Phase|Adverse Event|1
5807313|NCT02815280|20041314|P1|Double-Blind Phase|Adverse Event|1
5807314|NCT02815267|20041334|P2|Open-Label Phase|Other|5
5807315|NCT02815267|20041335|P1|Open-Label Phase|Other|2
5807316|NCT02815267|20041334|P2|Open-Label Phase|Administrative|12
5807317|NCT02815267|20041335|P1|Open-Label Phase|Administrative|21
5807318|NCT02815267|20041334|P2|Open-Label Phase|Protocol Violation|1
5807319|NCT02815267|20041335|P1|Open-Label Phase|Protocol Violation|0
5807320|NCT02815267|20041334|P2|Open-Label Phase|Withdrawal by Subject|13
5807321|NCT02815267|20041335|P1|Open-Label Phase|Withdrawal by Subject|24
5807322|NCT02815267|20041334|P2|Open-Label Phase|Lost to Follow-up|9
5807323|NCT02815267|20041335|P1|Open-Label Phase|Lost to Follow-up|23
5807324|NCT02815267|20041334|P2|Open-Label Phase|Adverse Event|1
5807325|NCT02815267|20041335|P1|Open-Label Phase|Adverse Event|1
5807326|NCT02815267|20041334|P2|Double-Blind Phase|Received a disallowed medication|1
5807327|NCT02815267|20041335|P1|Double-Blind Phase|Received a disallowed medication|1
5807328|NCT02815267|20041334|P2|Double-Blind Phase|Site withdrawal|6
5807329|NCT02815267|20041335|P1|Double-Blind Phase|Site withdrawal|1
5807330|NCT02815267|20041334|P2|Double-Blind Phase|Protocol Violation|2
5807331|NCT02815267|20041335|P1|Double-Blind Phase|Protocol Violation|3
5807332|NCT02815267|20041334|P2|Double-Blind Phase|Withdrawal by Subject|10
5807333|NCT02815267|20041335|P1|Double-Blind Phase|Withdrawal by Subject|11
5807334|NCT02815267|20041334|P2|Double-Blind Phase|Lost to Follow-up|9
5807335|NCT02815267|20041335|P1|Double-Blind Phase|Lost to Follow-up|17
5807336|NCT02815267|20041334|P2|Double-Blind Phase|Adverse Event|3
5807337|NCT02815267|20041335|P1|Double-Blind Phase|Adverse Event|0
5807338|NCT02814838|20041370|P2|Overall Study|Consent withdrawal|1
5807339|NCT02814838|20041371|P1|Overall Study|Consent withdrawal|1
5807340|NCT02814838|20041370|P2|Overall Study|3 agreed dates for the final visit missed|0
5807341|NCT02814838|20041371|P1|Overall Study|3 agreed dates for the final visit missed|1
5807342|NCT02814643|20041510|P2|Overall Study|Withdrawal by Subject|2
5807343|NCT02814643|20041511|P1|Overall Study|Withdrawal by Subject|1
5807344|NCT02814643|20041510|P2|Overall Study|Lost to Follow-up|1
5807345|NCT02814643|20041511|P1|Overall Study|Lost to Follow-up|0
5807346|NCT02814565|20041535|P2|Overall Study|Subject decision, caused by AE Influenza|1
5807347|NCT02814565|20041536|P1|Overall Study|Subject decision, caused by AE Influenza|1
5807348|NCT02814565|20041535|P2|Overall Study|Lack of Efficacy|1
5807349|NCT02814565|20041536|P1|Overall Study|Lack of Efficacy|0
5807350|NCT02814175|20041606|P6|Part 2|Lack of Efficacy|3
5807351|NCT02814175|20041607|P5|Part 2|Lack of Efficacy|0
5807352|NCT02814175|20041608|P4|Part 2|Lack of Efficacy|0
5807353|NCT02814175|20041609|P3|Part 2|Lack of Efficacy|0
5807354|NCT02814175|20041610|P2|Part 2|Lack of Efficacy|0
5807355|NCT02814175|20041611|P1|Part 2|Lack of Efficacy|0
5807356|NCT02814175|20041606|P6|Part 2|Lost to Follow-up|0
5807357|NCT02814175|20041607|P5|Part 2|Lost to Follow-up|0
5807358|NCT02814175|20041608|P4|Part 2|Lost to Follow-up|1
5807359|NCT02814175|20041609|P3|Part 2|Lost to Follow-up|0
5807360|NCT02814175|20041610|P2|Part 2|Lost to Follow-up|0
5807361|NCT02814175|20041611|P1|Part 2|Lost to Follow-up|0
5807362|NCT02814175|20041606|P6|Part 2|Withdrawal Consent|1
5807363|NCT02814175|20041607|P5|Part 2|Withdrawal Consent|1
5807364|NCT02814175|20041608|P4|Part 2|Withdrawal Consent|2
5807365|NCT02814175|20041609|P3|Part 2|Withdrawal Consent|0
5807366|NCT02814175|20041610|P2|Part 2|Withdrawal Consent|0
5807367|NCT02814175|20041611|P1|Part 2|Withdrawal Consent|0
5807368|NCT02814175|20041606|P6|Part 2|Adverse Event|2
5807369|NCT02814175|20041607|P5|Part 2|Adverse Event|1
5807370|NCT02814175|20041608|P4|Part 2|Adverse Event|1
5807371|NCT02814175|20041609|P3|Part 2|Adverse Event|0
5807372|NCT02814175|20041610|P2|Part 2|Adverse Event|0
5807373|NCT02814175|20041611|P1|Part 2|Adverse Event|0
5807374|NCT02814175|20041606|P6|Part 1|Lack of Efficacy|0
5807375|NCT02814175|20041607|P5|Part 1|Lack of Efficacy|0
5807376|NCT02814175|20041608|P4|Part 1|Lack of Efficacy|0
5807377|NCT02814175|20041609|P3|Part 1|Lack of Efficacy|0
5807378|NCT02814175|20041610|P2|Part 1|Lack of Efficacy|2
5807379|NCT02814175|20041611|P1|Part 1|Lack of Efficacy|1
5807380|NCT02814175|20041606|P6|Part 1|Lost to Follow-up|0
5807381|NCT02814175|20041607|P5|Part 1|Lost to Follow-up|0
5807382|NCT02814175|20041608|P4|Part 1|Lost to Follow-up|0
5807383|NCT02814175|20041609|P3|Part 1|Lost to Follow-up|0
5807384|NCT02814175|20041610|P2|Part 1|Lost to Follow-up|0
5807385|NCT02814175|20041611|P1|Part 1|Lost to Follow-up|1
5807386|NCT02814175|20041606|P6|Part 1|Withdrawal Consent|0
5807387|NCT02814175|20041607|P5|Part 1|Withdrawal Consent|0
5807388|NCT02814175|20041608|P4|Part 1|Withdrawal Consent|0
5807389|NCT02814175|20041609|P3|Part 1|Withdrawal Consent|0
5807390|NCT02814175|20041610|P2|Part 1|Withdrawal Consent|1
5807391|NCT02814175|20041611|P1|Part 1|Withdrawal Consent|8
5807392|NCT02814175|20041606|P6|Part 1|Adverse Event|0
5807393|NCT02814175|20041607|P5|Part 1|Adverse Event|0
5807394|NCT02814175|20041608|P4|Part 1|Adverse Event|0
5807395|NCT02814175|20041609|P3|Part 1|Adverse Event|0
5807396|NCT02814175|20041610|P2|Part 1|Adverse Event|3
5807397|NCT02814175|20041611|P1|Part 1|Adverse Event|2
5807398|NCT02813694|20041649|P2|Overall Study|Patient hospitalized|0
5807399|NCT02813694|20041650|P1|Overall Study|Patient hospitalized|1
5807400|NCT02813694|20041649|P2|Overall Study|Randomized- did not receive study drug|0
5807401|NCT02813694|20041650|P1|Overall Study|Randomized- did not receive study drug|2
5807402|NCT02813694|20041649|P2|Overall Study|Death|3
5807403|NCT02813694|20041650|P1|Overall Study|Death|3
5807404|NCT02813694|20041649|P2|Overall Study|Lost to Follow-up|1
5807405|NCT02813694|20041650|P1|Overall Study|Lost to Follow-up|1
5807406|NCT02813694|20041649|P2|Overall Study|Withdrawal by Subject|9
5807407|NCT02813694|20041650|P1|Overall Study|Withdrawal by Subject|10
5807408|NCT02813694|20041649|P2|Overall Study|Physician Decision|1
5807409|NCT02813694|20041650|P1|Overall Study|Physician Decision|0
5807410|NCT02813681|20041663|P3|Overall Study|Lost to Follow-up|0
5807411|NCT02813681|20041664|P2|Overall Study|Lost to Follow-up|1
5807412|NCT02813681|20041665|P1|Overall Study|Lost to Follow-up|0
5807413|NCT02813681|20041663|P3|Overall Study|Physician Decision|0
5807414|NCT02813681|20041664|P2|Overall Study|Physician Decision|5
5807415|NCT02813681|20041665|P1|Overall Study|Physician Decision|5
5807416|NCT02813577|20041686|P1|Overall Study|Study terminated|4
5807417|NCT02812186|20041796|P2|Period 1|nonevaluable data sets|6
5807418|NCT02812186|20041797|P1|Period 1|nonevaluable data sets|6
5807419|NCT02812186|20041796|P2|Period 1|Post randomization screen failure|9
5807420|NCT02812186|20041797|P1|Period 1|Post randomization screen failure|5
5807421|NCT02811640|20041841|P1|Overall Study|Technology malfunction|2
5807422|NCT02811159|20041876|P1|Treatment Course 1|Lost to Follow-up|1
5807423|NCT02810457|20041915|P2|Overall Study|Physician Decision|1
5807424|NCT02810457|20041916|P1|Overall Study|Physician Decision|0
5807425|NCT02810457|20041915|P2|Overall Study|Miscalculated PD|0
5807426|NCT02810457|20041916|P1|Overall Study|Miscalculated PD|1
5807427|NCT02810457|20041915|P2|Overall Study|Patient ineligibility|0
5807428|NCT02810457|20041916|P1|Overall Study|Patient ineligibility|3
5807429|NCT02810457|20041915|P2|Overall Study|Investigator decision|2
5807430|NCT02810457|20041916|P1|Overall Study|Investigator decision|3
5807431|NCT02810457|20041915|P2|Overall Study|Clinical progression|16
5807432|NCT02810457|20041916|P1|Overall Study|Clinical progression|15
5807433|NCT02810457|20041915|P2|Overall Study|Ongoing at data cutoff and discontinued|2
5807434|NCT02810457|20041916|P1|Overall Study|Ongoing at data cutoff and discontinued|3
5807435|NCT02810457|20041915|P2|Overall Study|Death|28
5807436|NCT02810457|20041916|P1|Overall Study|Death|39
5807437|NCT02810457|20041915|P2|Overall Study|Patient lost to follow-up|2
5807438|NCT02810457|20041916|P1|Overall Study|Patient lost to follow-up|2
5807439|NCT02810457|20041915|P2|Overall Study|Patient decision|35
5807440|NCT02810457|20041916|P1|Overall Study|Patient decision|31
5807441|NCT02810457|20041915|P2|Overall Study|Adverse Event|43
5807442|NCT02810457|20041916|P1|Overall Study|Adverse Event|37
5807443|NCT02810457|20041915|P2|Overall Study|Objective PD assessed by RECIST v1.1|199
5807444|NCT02810457|20041916|P1|Overall Study|Objective PD assessed by RECIST v1.1|191
5807445|NCT02810457|20041915|P2|Overall Study|Randomised but no treatment received|1
5807446|NCT02810457|20041916|P1|Overall Study|Randomised but no treatment received|2
5807447|NCT02809976|20041945|P1|Overall Study|Withdrawal by Subject|1
5807448|NCT02809976|20041945|P1|Overall Study|Lost to Follow-up|1
5807449|NCT02809833|20041983|P1|Overall Study|Missing Information|52
5807450|NCT02809833|20041983|P1|Overall Study|Other|5
5807451|NCT02809833|20041983|P1|Overall Study|Adverse Event (AE)|24
5807452|NCT02809833|20041983|P1|Overall Study|Lost to Follow-up|35
5807453|NCT02809833|20041983|P1|Overall Study|Withdrawal by Subject|34
5807454|NCT02809833|20041983|P1|Overall Study|Noncompliance|1
5807455|NCT02809833|20041983|P1|Overall Study|Remission/Treatment No Longer Needed|3
5807456|NCT02809833|20041983|P1|Overall Study|Lack of Efficacy|89
5807457|NCT02809833|20041983|P1|Overall Study|Intolerance|54
5807458|NCT02809833|20041983|P1|Overall Study|Death|3
5807459|NCT02809118|20042115|P3|Overall Study|Withdrawal by Subject|1
5807460|NCT02809118|20042116|P2|Overall Study|Withdrawal by Subject|1
5807461|NCT02809118|20042117|P1|Overall Study|Withdrawal by Subject|0
5807462|NCT02809053|20042130|P2|Overall Study|Disease Progression|1
5807463|NCT02809053|20042131|P1|Overall Study|Disease Progression|2
5807464|NCT02809053|20042130|P2|Overall Study|Withdrawal by Subject|3
5807465|NCT02809053|20042131|P1|Overall Study|Withdrawal by Subject|2
5807466|NCT02809053|20042130|P2|Overall Study|Lost to Follow-up|1
5807467|NCT02809053|20042131|P1|Overall Study|Lost to Follow-up|3
5807468|NCT02809053|20042130|P2|Overall Study|Death|1
5807469|NCT02809053|20042131|P1|Overall Study|Death|0
5807470|NCT02808975|20042177|P2|Overall Study|Other, not specified|1
5807471|NCT02808975|20042178|P1|Overall Study|Other, not specified|5
5807472|NCT02808975|20042177|P2|Overall Study|Planned HS surgery performed prior Wk 13|0
5807473|NCT02808975|20042178|P1|Overall Study|Planned HS surgery performed prior Wk 13|1
5807474|NCT02808975|20042177|P2|Overall Study|Lost to Follow-up|6
5807475|NCT02808975|20042178|P1|Overall Study|Lost to Follow-up|4
5807476|NCT02808975|20042177|P2|Overall Study|Withdrew consent|8
5807477|NCT02808975|20042178|P1|Overall Study|Withdrew consent|9
5807478|NCT02808975|20042177|P2|Overall Study|Adverse Event|4
5807479|NCT02808975|20042178|P1|Overall Study|Adverse Event|3
5807480|NCT02808338|20042205|P1|Overnight In-lab Polysomonography|Reason not given|1
5807481|NCT02808338|20042205|P1|Overnight In-lab Polysomonography|Withdrawal by Subject|1
5807482|NCT02808338|20042205|P1|Screening|Screen Failure|10
5807483|NCT02808312|20042221|P5|Overall Study|Enrolled but Never Treated|0
5807484|NCT02808312|20042222|P4|Overall Study|Enrolled but Never Treated|0
5807485|NCT02808312|20042223|P3|Overall Study|Enrolled but Never Treated|1
5807486|NCT02808312|20042224|P2|Overall Study|Enrolled but Never Treated|0
5807487|NCT02808312|20042225|P1|Overall Study|Enrolled but Never Treated|0
5807488|NCT02807948|20042382|P2|Overall Study|Physician Decision|0
5807489|NCT02807948|20042383|P1|Overall Study|Physician Decision|1
5807498|NCT02807623|20042437|P3|Overall Study|incomplete blood draw|1
5807499|NCT02807623|20042438|P2|Overall Study|incomplete blood draw|2
5807500|NCT02807623|20042439|P1|Overall Study|incomplete blood draw|0
5807501|NCT02807623|20042437|P3|Overall Study|Drug intolerance|0
5807502|NCT02807623|20042438|P2|Overall Study|Drug intolerance|1
5807503|NCT02807623|20042439|P1|Overall Study|Drug intolerance|0
5807504|NCT02807623|20042437|P3|Overall Study|Lost to Follow-up|22
5807505|NCT02807623|20042438|P2|Overall Study|Lost to Follow-up|18
5807506|NCT02807623|20042439|P1|Overall Study|Lost to Follow-up|23
5807507|NCT02807402|20042466|P1|Overall Study|Other|2
5807508|NCT02807402|20042466|P1|Overall Study|Death|3
5807509|NCT02807402|20042466|P1|Overall Study|Failure to Return|1
5807510|NCT02807376|20042504|P2|Overall Study|Lost to Follow-up|1
5807511|NCT02807376|20042505|P1|Overall Study|Lost to Follow-up|0
5807512|NCT02807376|20042504|P2|Overall Study|Intra-operative exclusion criteria|0
5807513|NCT02807376|20042505|P1|Overall Study|Intra-operative exclusion criteria|3
5807514|NCT02807259|20042515|P2|Endline (3 Months)|migration, refusal, not available|87
5807515|NCT02807259|20042516|P1|Endline (3 Months)|migration, refusal, not available|35
5807516|NCT02807259|20042515|P2|Midline (3 Months)|migration, refusal, not available|34
5807517|NCT02807259|20042516|P1|Midline (3 Months)|migration, refusal, not available|30
5807518|NCT02807259|20042515|P2|Baseline (3 Months)|migration, refusal, not available|112
5807519|NCT02807259|20042516|P1|Baseline (3 Months)|migration, refusal, not available|77
5807520|NCT02806986|20042534|P1|Treatment Stage 2|Withdrawal by Subject|2
5807521|NCT02806986|20042534|P1|Treatment Stage 2|Adverse Event|3
5807522|NCT02806986|20042534|P1|Treatment Stage 1|Adverse Event|1
5807523|NCT02806973|20042554|P4|Period 3|Adverse Event|0
5807524|NCT02806973|20042555|P3|Period 3|Adverse Event|1
5807525|NCT02806973|20042556|P2|Period 3|Adverse Event|0
5807526|NCT02806973|20042557|P1|Period 3|Adverse Event|0
5807527|NCT02806973|20042554|P4|Period 3|Withdrawal by Subject|3
5807528|NCT02806973|20042555|P3|Period 3|Withdrawal by Subject|0
5807529|NCT02806973|20042556|P2|Period 3|Withdrawal by Subject|0
5807530|NCT02806973|20042557|P1|Period 3|Withdrawal by Subject|0
5807531|NCT02806973|20042554|P4|Period 1|Adverse Event|1
5807532|NCT02806973|20042555|P3|Period 1|Adverse Event|0
5807533|NCT02806973|20042556|P2|Period 1|Adverse Event|0
5807534|NCT02806973|20042557|P1|Period 1|Adverse Event|0
5807535|NCT02806973|20042554|P4|Period 1|Withdrawal by Subject|1
5807536|NCT02806973|20042555|P3|Period 1|Withdrawal by Subject|1
5807537|NCT02806973|20042556|P2|Period 1|Withdrawal by Subject|2
5807538|NCT02806973|20042557|P1|Period 1|Withdrawal by Subject|0
5807539|NCT02806960|20042591|P4|Period 1|Study Terminated (withdrawn by sponsor)|3
5807540|NCT02806960|20042592|P3|Period 1|Study Terminated (withdrawn by sponsor)|3
5807541|NCT02806960|20042593|P2|Period 1|Study Terminated (withdrawn by sponsor)|3
5807542|NCT02806960|20042594|P1|Period 1|Study Terminated (withdrawn by sponsor)|3
5807543|NCT02806947|20042630|P2|Overall Study|Withdrawal by Subject|1
5807544|NCT02806947|20042631|P1|Overall Study|Withdrawal by Subject|5
5807545|NCT02806726|20042770|P1|Overall Study|Lost to Follow-up|1
5807546|NCT02806713|20042779|P2|Overall Study|cancelled surgery|2
5807547|NCT02806713|20042780|P1|Overall Study|cancelled surgery|1
5807548|NCT02806713|20042779|P2|Overall Study|Urethral injury during procedure|0
5807549|NCT02806713|20042780|P1|Overall Study|Urethral injury during procedure|1
5807550|NCT02806505|20042799|P2|Overall Study|Insufficient therapeutic response|4
5807551|NCT02806505|20042800|P1|Overall Study|Insufficient therapeutic response|2
5807552|NCT02806505|20042799|P2|Overall Study|Failure to return|1
5807553|NCT02806505|20042800|P1|Overall Study|Failure to return|0
5807554|NCT02806505|20042799|P2|Overall Study|Did not cooperate/refused treatment|3
5807555|NCT02806505|20042800|P1|Overall Study|Did not cooperate/refused treatment|3
5807556|NCT02806505|20042799|P2|Overall Study|Death|0
5807557|NCT02806505|20042800|P1|Overall Study|Death|4
5807558|NCT02806505|20042799|P2|Overall Study|Adverse event/intercurrent illness|3
5807559|NCT02806505|20042800|P1|Overall Study|Adverse event/intercurrent illness|1
5807560|NCT02806414|20042810|P1|Overall Study|Lost to Follow-up|2
5807561|NCT02806232|20042824|P9|Overall Study|Withdrawal by Subject|0
5807562|NCT02806232|20042825|P8|Overall Study|Withdrawal by Subject|0
5807563|NCT02806232|20042826|P7|Overall Study|Withdrawal by Subject|0
5807564|NCT02806232|20042827|P6|Overall Study|Withdrawal by Subject|1
5807565|NCT02806232|20042828|P5|Overall Study|Withdrawal by Subject|2
5807566|NCT02806232|20042829|P4|Overall Study|Withdrawal by Subject|0
5807567|NCT02806232|20042830|P3|Overall Study|Withdrawal by Subject|0
5807568|NCT02806232|20042831|P2|Overall Study|Withdrawal by Subject|2
5807569|NCT02806232|20042832|P1|Overall Study|Withdrawal by Subject|0
5807570|NCT02806232|20042824|P9|Overall Study|Lost to Follow-up|0
5807571|NCT02806232|20042825|P8|Overall Study|Lost to Follow-up|0
5807572|NCT02806232|20042826|P7|Overall Study|Lost to Follow-up|0
5807573|NCT02806232|20042827|P6|Overall Study|Lost to Follow-up|1
5807574|NCT02806232|20042828|P5|Overall Study|Lost to Follow-up|0
5807575|NCT02806232|20042829|P4|Overall Study|Lost to Follow-up|0
5807576|NCT02806232|20042830|P3|Overall Study|Lost to Follow-up|1
5807577|NCT02806232|20042831|P2|Overall Study|Lost to Follow-up|2
5807578|NCT02806232|20042832|P1|Overall Study|Lost to Follow-up|1
5807579|NCT02806024|20042872|P2|Overall Study|DVT during antepartum admission|1
5807580|NCT02806024|20042873|P1|Overall Study|DVT during antepartum admission|0
5807581|NCT02806024|20042872|P2|Overall Study|Night Delivery|1
5807582|NCT02806024|20042873|P1|Overall Study|Night Delivery|1
5807583|NCT02805907|20042883|P2|Overall Study|Lost to Follow-up|3
5807584|NCT02805907|20042884|P1|Overall Study|Lost to Follow-up|3
5807585|NCT02805790|20042898|P2|Second Intervention (4 Weeks)|Physician Decision|1
5807586|NCT02805790|20042899|P1|Second Intervention (4 Weeks)|Physician Decision|0
5807587|NCT02804750|20042934|P2|Period 4|Adverse Event|5
5807588|NCT02804750|20042935|P1|Period 4|Adverse Event|0
5807589|NCT02804750|20042934|P2|Period 3|Adverse Event|2
5807590|NCT02804750|20042935|P1|Period 3|Adverse Event|0
5807591|NCT02804750|20042934|P2|Period 2|Adverse Event|0
5807592|NCT02804750|20042935|P1|Period 2|Adverse Event|1
5807593|NCT02804750|20042934|P2|Period 1|Withdrawal by Subject|1
5807594|NCT02804750|20042935|P1|Period 1|Withdrawal by Subject|0
5807595|NCT02804750|20042934|P2|Period 1|Adverse Event|2
5807596|NCT02804750|20042935|P1|Period 1|Adverse Event|0
5807597|NCT02804399|20042962|P2|Period 2|Adverse Event|1
5807598|NCT02804399|20042963|P1|Period 2|Adverse Event|0
5807599|NCT02803580|20043035|P1|Overall Study|Inclusion in clinical trial|1
5807600|NCT02803580|20043035|P1|Overall Study|Withdrawal by Subject|3
5807601|NCT02803580|20043035|P1|Overall Study|Lost to Follow-up|19
5807602|NCT02803580|20043035|P1|Overall Study|Death|13
5807603|NCT02803138|20043074|P1|Overall Study|Other, not specified|28
5807604|NCT02803138|20043074|P1|Overall Study|Death|1
5807605|NCT02803138|20043074|P1|Overall Study|Withdrawn consent|1
5807606|NCT02803138|20043074|P1|Overall Study|Insufficient virological response|2
5807607|NCT02803138|20043074|P1|Overall Study|Failure to return|38
5807608|NCT02802878|20043090|P2|Overall Study|Protocol Violation|0
5807609|NCT02802878|20043091|P1|Overall Study|Protocol Violation|1
5807610|NCT02802878|20043090|P2|Overall Study|Withdrawal by Subject|3
5807611|NCT02802878|20043091|P1|Overall Study|Withdrawal by Subject|3
5807612|NCT02802865|20043107|P2|Overall Study|Ineliegible due to tuberculosis|1
5807613|NCT02802865|20043108|P1|Overall Study|Ineliegible due to tuberculosis|0
5807614|NCT02802865|20043107|P2|Overall Study|Pregnancy|1
5807615|NCT02802865|20043108|P1|Overall Study|Pregnancy|1
5807616|NCT02802592|20043130|P1|Overall Study|Study terminated due to loss of funding|4
5807617|NCT02802345|20043307|P2|Overall Study|Other than listed|5
5807618|NCT02802345|20043308|P1|Overall Study|Other than listed|1
5807619|NCT02802345|20043307|P2|Overall Study|Protocol Violation|1
5807620|NCT02802345|20043308|P1|Overall Study|Protocol Violation|0
5807621|NCT02802345|20043307|P2|Overall Study|Withdrawal by Subject|3
5807622|NCT02802345|20043308|P1|Overall Study|Withdrawal by Subject|3
5807623|NCT02802345|20043307|P2|Overall Study|Adverse Event|20
5807624|NCT02802345|20043308|P1|Overall Study|Adverse Event|28
5807625|NCT02802345|20043307|P2|Overall Study|Not Treated|1
5807626|NCT02802345|20043308|P1|Overall Study|Not Treated|0
5807627|NCT02802319|20043324|P2|Overall Study|Lost to Follow-up|4
5807628|NCT02802319|20043325|P1|Overall Study|Lost to Follow-up|0
5807629|NCT02802319|20043324|P2|Overall Study|Physician Decision|1
5807630|NCT02802319|20043325|P1|Overall Study|Physician Decision|2
5807631|NCT02801877|20043488|P4|Overall Study|Never Started Treatment|0
5807632|NCT02801877|20043489|P3|Overall Study|Never Started Treatment|4
5807633|NCT02801877|20043490|P2|Overall Study|Never Started Treatment|0
5807634|NCT02801877|20043491|P1|Overall Study|Never Started Treatment|2
5807635|NCT02801877|20043488|P4|Overall Study|Lost to Follow-up|0
5807636|NCT02801877|20043489|P3|Overall Study|Lost to Follow-up|2
5807637|NCT02801877|20043490|P2|Overall Study|Lost to Follow-up|1
5807638|NCT02801877|20043491|P1|Overall Study|Lost to Follow-up|1
5807639|NCT02801669|20043511|P2|Overall Study|Other|6
5807640|NCT02801669|20043512|P1|Overall Study|Other|4
5807641|NCT02801669|20043511|P2|Overall Study|Withdrawal by Subject|77
5807642|NCT02801669|20043512|P1|Overall Study|Withdrawal by Subject|81
5807643|NCT02801669|20043511|P2|Overall Study|Death|69
5807644|NCT02801669|20043512|P1|Overall Study|Death|66
5807645|NCT02801617|20043539|P2|Overall Study|Protocol Violation|6
5807646|NCT02801617|20043540|P1|Overall Study|Protocol Violation|2
5807647|NCT02801578|20043558|P1|Overall Study|Adverse Event|2
5807648|NCT02801396|20043562|P6|Period 1|Withdrawal by Subject|0
5807649|NCT02801396|20043563|P5|Period 1|Withdrawal by Subject|1
5807650|NCT02801396|20043564|P4|Period 1|Withdrawal by Subject|0
5807651|NCT02801396|20043565|P3|Period 1|Withdrawal by Subject|0
5807652|NCT02801396|20043566|P2|Period 1|Withdrawal by Subject|0
5807653|NCT02801396|20043567|P1|Period 1|Withdrawal by Subject|0
5807654|NCT02800928|20043612|P2|Overall Study|Protocol Violation|1
5807655|NCT02800928|20043613|P1|Overall Study|Protocol Violation|1
5807656|NCT02800928|20043612|P2|Overall Study|Withdrawal by Subject|1
5807657|NCT02800928|20043613|P1|Overall Study|Withdrawal by Subject|1
5807658|NCT02800642|20043621|P1|Overall Study|Lost to Follow-up|1
5807659|NCT02800642|20043621|P1|Overall Study|Withdrawal by Subject|3
5807660|NCT02800642|20043621|P1|Overall Study|Adverse Event|6
5807661|NCT02800642|20043621|P1|Overall Study|Physician Decision|2
5807662|NCT02800642|20043621|P1|Overall Study|Other|10
5807663|NCT02800642|20043621|P1|Overall Study|Death|3
5807664|NCT02799784|20043665|P2|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|1
5807665|NCT02799784|20043666|P1|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|0
5807666|NCT02799784|20043665|P2|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|1
5807667|NCT02799784|20043666|P1|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|0
5807668|NCT02799784|20043665|P2|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|0
5807669|NCT02799784|20043666|P1|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|1
5807670|NCT02799784|20043665|P2|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|1
5807671|NCT02799784|20043666|P1|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|0
5807672|NCT02799784|20043665|P2|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|0
5807673|NCT02799784|20043666|P1|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|5
5807674|NCT02799784|20043665|P2|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1
5807675|NCT02799784|20043666|P1|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1
5807676|NCT02799472|20043674|P2|Overall Study|Lost to Follow-up|1
5807677|NCT02799472|20043675|P1|Overall Study|Lost to Follow-up|0
5807678|NCT02799472|20043674|P2|Overall Study|Lack of Efficacy|0
5807679|NCT02799472|20043675|P1|Overall Study|Lack of Efficacy|2
5807680|NCT02799472|20043674|P2|Overall Study|Withdrawal by Subject|4
5807681|NCT02799472|20043675|P1|Overall Study|Withdrawal by Subject|2
5807682|NCT02799381|20043735|P2|Overall Study|Participant did not take any study drug|0
5807683|NCT02799381|20043736|P1|Overall Study|Participant did not take any study drug|1
5807684|NCT02799381|20043735|P2|Overall Study|Adverse Event|1
5807685|NCT02799381|20043736|P1|Overall Study|Adverse Event|0
5807686|NCT02799381|20043735|P2|Overall Study|Withdrew consent|2
5807687|NCT02799381|20043736|P1|Overall Study|Withdrew consent|3
5807688|NCT02799082|20043781|P2|Overall Study|Protocol Violation|1
5807689|NCT02799082|20043782|P1|Overall Study|Protocol Violation|0
5807690|NCT02799082|20043781|P2|Overall Study|Refused second PDT or withdraw consent|3
5807691|NCT02799082|20043782|P1|Overall Study|Refused second PDT or withdraw consent|4
5807692|NCT02799069|20043819|P3|Overall Study|Protocol Violation|2
5807693|NCT02799069|20043820|P2|Overall Study|Protocol Violation|0
5807694|NCT02799069|20043821|P1|Overall Study|Protocol Violation|1
5807695|NCT02799069|20043819|P3|Overall Study|Withdrawal by Subject|3
5807696|NCT02799069|20043820|P2|Overall Study|Withdrawal by Subject|4
5807697|NCT02799069|20043821|P1|Overall Study|Withdrawal by Subject|4
5807698|NCT02799069|20043819|P3|Overall Study|Lost to Follow-up|0
5807699|NCT02799069|20043820|P2|Overall Study|Lost to Follow-up|1
5807700|NCT02799069|20043821|P1|Overall Study|Lost to Follow-up|1
5807701|NCT02799069|20043819|P3|Overall Study|Lack of Efficacy|0
5807702|NCT02799069|20043820|P2|Overall Study|Lack of Efficacy|0
5807703|NCT02799069|20043821|P1|Overall Study|Lack of Efficacy|2
5807704|NCT02799069|20043819|P3|Overall Study|Adverse Event|2
5807705|NCT02799069|20043820|P2|Overall Study|Adverse Event|2
5807706|NCT02799069|20043821|P1|Overall Study|Adverse Event|0
5807707|NCT02798861|20044159|P1|Overall Study|Withdrawal by Subject|1
5807708|NCT02798861|20044159|P1|Overall Study|Lost to Follow-up|22
5807709|NCT02798835|20044167|P3|Overall Study|Protocol Violation|3
5807710|NCT02798835|20044168|P2|Overall Study|Protocol Violation|0
5807711|NCT02798835|20044169|P1|Overall Study|Protocol Violation|0
5807712|NCT02798315|20044235|P1|Overall Study|Failure to return|1
5807713|NCT02797808|20044271|P2|Overall Study|Physician Decision|2
5807714|NCT02797808|20044272|P1|Overall Study|Physician Decision|6
5807715|NCT02797808|20044271|P2|Overall Study|Withdrawal by Subject|1
5807716|NCT02797808|20044272|P1|Overall Study|Withdrawal by Subject|1
5807717|NCT02797678|20044280|P4|Second Intervention (5 Nights)|study/device use non-compliance|0
5807718|NCT02797678|20044281|P3|Second Intervention (5 Nights)|study/device use non-compliance|1
5807719|NCT02797678|20044282|P2|Second Intervention (5 Nights)|study/device use non-compliance|0
5807720|NCT02797678|20044283|P1|Second Intervention (5 Nights)|study/device use non-compliance|0
5807721|NCT02797678|20044280|P4|First Intervention (5 Nights)|study/device use non-compliance|0
5807722|NCT02797678|20044281|P3|First Intervention (5 Nights)|study/device use non-compliance|0
5807723|NCT02797678|20044282|P2|First Intervention (5 Nights)|study/device use non-compliance|1
5807724|NCT02797678|20044283|P1|First Intervention (5 Nights)|study/device use non-compliance|0
5807725|NCT02797678|20044280|P4|Screening Phase|Meeting Inclusion/Exclusion criteria|0
5807726|NCT02797678|20044281|P3|Screening Phase|Meeting Inclusion/Exclusion criteria|0
5807727|NCT02797678|20044282|P2|Screening Phase|Meeting Inclusion/Exclusion criteria|0
5807728|NCT02797678|20044283|P1|Screening Phase|Meeting Inclusion/Exclusion criteria|25
5807729|NCT02797522|20044318|P11|Overall Study|Study Terminated by Sponsor|1
5807730|NCT02797522|20044319|P10|Overall Study|Study Terminated by Sponsor|4
5807731|NCT02797522|20044320|P9|Overall Study|Study Terminated by Sponsor|2
5807732|NCT02797522|20044321|P8|Overall Study|Study Terminated by Sponsor|4
5807733|NCT02797522|20044322|P7|Overall Study|Study Terminated by Sponsor|0
5807734|NCT02797522|20044323|P6|Overall Study|Study Terminated by Sponsor|0
5807735|NCT02797522|20044324|P5|Overall Study|Study Terminated by Sponsor|0
5807736|NCT02797522|20044325|P4|Overall Study|Study Terminated by Sponsor|0
5807737|NCT02797522|20044326|P3|Overall Study|Study Terminated by Sponsor|0
5807738|NCT02797522|20044327|P2|Overall Study|Study Terminated by Sponsor|0
5807739|NCT02797522|20044328|P1|Overall Study|Study Terminated by Sponsor|0
5807740|NCT02797171|20044440|P6|Overall Study|Not Randomized|1
5807741|NCT02797171|20044441|P5|Overall Study|Not Randomized|0
5807742|NCT02797171|20044442|P4|Overall Study|Not Randomized|0
5807743|NCT02797171|20044443|P3|Overall Study|Not Randomized|0
5807744|NCT02797171|20044444|P2|Overall Study|Not Randomized|0
5807745|NCT02797171|20044445|P1|Overall Study|Not Randomized|0
5807746|NCT02797171|20044440|P6|Overall Study|Participant unable to adhere|0
5807747|NCT02797171|20044441|P5|Overall Study|Participant unable to adhere|0
5807748|NCT02797171|20044442|P4|Overall Study|Participant unable to adhere|0
5807749|NCT02797171|20044443|P3|Overall Study|Participant unable to adhere|0
5807750|NCT02797171|20044444|P2|Overall Study|Participant unable to adhere|1
5807751|NCT02797171|20044445|P1|Overall Study|Participant unable to adhere|0
5807752|NCT02797171|20044440|P6|Overall Study|Protocol Violation|0
5807753|NCT02797171|20044441|P5|Overall Study|Protocol Violation|0
5807754|NCT02797171|20044442|P4|Overall Study|Protocol Violation|0
5807755|NCT02797171|20044443|P3|Overall Study|Protocol Violation|0
5807756|NCT02797171|20044444|P2|Overall Study|Protocol Violation|0
5807757|NCT02797171|20044445|P1|Overall Study|Protocol Violation|1
5807758|NCT02797171|20044440|P6|Overall Study|Withdrawal by Subject|0
5807759|NCT02797171|20044441|P5|Overall Study|Withdrawal by Subject|0
5807760|NCT02797171|20044442|P4|Overall Study|Withdrawal by Subject|0
5807761|NCT02797171|20044443|P3|Overall Study|Withdrawal by Subject|0
5807762|NCT02797171|20044444|P2|Overall Study|Withdrawal by Subject|1
5807763|NCT02797171|20044445|P1|Overall Study|Withdrawal by Subject|1
5807764|NCT02797171|20044440|P6|Overall Study|Lost to Follow-up|0
5807765|NCT02797171|20044441|P5|Overall Study|Lost to Follow-up|2
5807766|NCT02797171|20044442|P4|Overall Study|Lost to Follow-up|1
5807767|NCT02797171|20044443|P3|Overall Study|Lost to Follow-up|2
5807768|NCT02797171|20044444|P2|Overall Study|Lost to Follow-up|0
5807769|NCT02797171|20044445|P1|Overall Study|Lost to Follow-up|2
5807770|NCT02797132|20044507|P1|Part B (24 Weeks)|Adverse Event|3
5807771|NCT02797132|20044507|P1|Part A (15 Days)|Adverse Event|1
5807772|NCT02797080|20044559|P1|Overall Study|Withdrawal by Subject|1
5807773|NCT02797080|20044559|P1|Overall Study|Lost to Follow-up|1
5807774|NCT02796963|20044601|P4|Overall Study|Lost to Follow-up|72
5807775|NCT02796963|20044602|P3|Overall Study|Lost to Follow-up|69
5807776|NCT02796963|20044603|P2|Overall Study|Lost to Follow-up|76
5807777|NCT02796963|20044604|P1|Overall Study|Lost to Follow-up|89
5807778|NCT02796677|20044674|P4|Overall Study|Reason not mentioned|5
5807779|NCT02796677|20044675|P3|Overall Study|Reason not mentioned|0
5807780|NCT02796677|20044676|P2|Overall Study|Reason not mentioned|3
5807781|NCT02796677|20044677|P1|Overall Study|Reason not mentioned|2
5807782|NCT02796677|20044674|P4|Overall Study|Progressive disease|18
5807783|NCT02796677|20044675|P3|Overall Study|Progressive disease|13
5807784|NCT02796677|20044676|P2|Overall Study|Progressive disease|15
5807785|NCT02796677|20044677|P1|Overall Study|Progressive disease|6
5807786|NCT02796677|20044674|P4|Overall Study|Withdrawal by Subject|7
5807787|NCT02796677|20044675|P3|Overall Study|Withdrawal by Subject|6
5807788|NCT02796677|20044676|P2|Overall Study|Withdrawal by Subject|14
5807789|NCT02796677|20044677|P1|Overall Study|Withdrawal by Subject|4
5807790|NCT02796677|20044674|P4|Overall Study|Lack of Efficacy|20
5807791|NCT02796677|20044675|P3|Overall Study|Lack of Efficacy|14
5807792|NCT02796677|20044676|P2|Overall Study|Lack of Efficacy|9
5807793|NCT02796677|20044677|P1|Overall Study|Lack of Efficacy|7
5807794|NCT02796677|20044674|P4|Overall Study|Lost to Follow-up|2
5807795|NCT02796677|20044675|P3|Overall Study|Lost to Follow-up|2
5807796|NCT02796677|20044676|P2|Overall Study|Lost to Follow-up|5
5807797|NCT02796677|20044677|P1|Overall Study|Lost to Follow-up|1
5807798|NCT02796677|20044674|P4|Overall Study|Protocol Violation|8
5807799|NCT02796677|20044675|P3|Overall Study|Protocol Violation|4
5807800|NCT02796677|20044676|P2|Overall Study|Protocol Violation|5
5807801|NCT02796677|20044677|P1|Overall Study|Protocol Violation|7
5807802|NCT02796677|20044674|P4|Overall Study|Adverse Event|14
5807803|NCT02796677|20044675|P3|Overall Study|Adverse Event|14
5807804|NCT02796677|20044676|P2|Overall Study|Adverse Event|22
5807805|NCT02796677|20044677|P1|Overall Study|Adverse Event|11
5807806|NCT02796651|20044701|P1|Overall Study|Other|10
5807807|NCT02796651|20044701|P1|Overall Study|Lack of Efficacy|1
5807808|NCT02796651|20044701|P1|Overall Study|Protocol Violation|4
5807809|NCT02796651|20044701|P1|Overall Study|Withdrawal by Subject|4
5807810|NCT02796651|20044701|P1|Overall Study|Lost to Follow-up|1
5807811|NCT02796651|20044701|P1|Overall Study|Adverse Event|6
5807812|NCT02796560|20044732|P2|Overall Study|Withdrawal by Subject|2
5807813|NCT02796560|20044733|P1|Overall Study|Withdrawal by Subject|2
5807814|NCT02796560|20044732|P2|Overall Study|Adverse Event|0
5807815|NCT02796560|20044733|P1|Overall Study|Adverse Event|2
5807816|NCT02795832|20044808|P6|Overall Study|Adverse Event|3
5807817|NCT02795832|20044809|P5|Overall Study|Adverse Event|0
5807818|NCT02795832|20044810|P4|Overall Study|Adverse Event|0
5807819|NCT02795832|20044811|P3|Overall Study|Adverse Event|0
5807820|NCT02795832|20044812|P2|Overall Study|Adverse Event|0
5807821|NCT02795832|20044813|P1|Overall Study|Adverse Event|0
5807822|NCT02795767|20044891|P3|Overall Study|Lack of Efficacy|1
5807823|NCT02795767|20044892|P2|Overall Study|Lack of Efficacy|0
5807824|NCT02795767|20044893|P1|Overall Study|Lack of Efficacy|0
5807825|NCT02795767|20044891|P3|Overall Study|Ongoing Study Treatment|9
5807826|NCT02795767|20044892|P2|Overall Study|Ongoing Study Treatment|10
5807827|NCT02795767|20044893|P1|Overall Study|Ongoing Study Treatment|66
5807828|NCT02795767|20044891|P3|Overall Study|Received Commercial Emicizumab|0
5807829|NCT02795767|20044892|P2|Overall Study|Received Commercial Emicizumab|0
5807830|NCT02795767|20044893|P1|Overall Study|Received Commercial Emicizumab|2
5807831|NCT02794974|20045030|P2|Overall Study|Physician Decision|1
5807832|NCT02794974|20045031|P1|Overall Study|Physician Decision|0
5807833|NCT02794870|20045047|P2|Overall Study|Withdrawal by Subject|0
5807834|NCT02794870|20045048|P1|Overall Study|Withdrawal by Subject|2
5807835|NCT02794480|20045145|P4|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1
5807836|NCT02794480|20045146|P3|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0
5807837|NCT02794480|20045147|P2|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0
5807838|NCT02794480|20045148|P1|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1
5807839|NCT02794480|20045145|P4|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|1
5807840|NCT02794480|20045146|P3|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0
5807841|NCT02794480|20045147|P2|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|2
5807842|NCT02794480|20045148|P1|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0
5807843|NCT02794480|20045145|P4|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|2
5807844|NCT02794480|20045146|P3|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0
5807845|NCT02794480|20045147|P2|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0
5807846|NCT02794480|20045148|P1|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0
5807847|NCT02794480|20045145|P4|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0
5807848|NCT02794480|20045146|P3|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|1
5807849|NCT02794480|20045147|P2|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0
5807850|NCT02794480|20045148|P1|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0
5807851|NCT02794480|20045145|P4|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0
5807852|NCT02794480|20045146|P3|Period 1: Treatment Period 1 (28 Days)|Adverse Event|1
5807853|NCT02794480|20045147|P2|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0
5807854|NCT02794480|20045148|P1|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0
5807855|NCT02794246|20045191|P1|Overall Study|Physician Decision|4
5807856|NCT02794246|20045191|P1|Overall Study|Withdrawal by Subject|2
5807857|NCT02794103|20045203|P1|Overall Study|Loss to follow up due to high sedation|3
5807858|NCT02793947|20045214|P2|Overall Study|Physician Decision|5
5807859|NCT02793947|20045215|P1|Overall Study|Physician Decision|1
5807860|NCT02793947|20045214|P2|Overall Study|Death|0
5807861|NCT02793947|20045215|P1|Overall Study|Death|1
5807862|NCT02793232|20045319|P9|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0
5807863|NCT02793232|20045320|P8|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0
5807864|NCT02793232|20045321|P7|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1
5807865|NCT02793232|20045322|P6|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0
5807866|NCT02793232|20045323|P5|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1
5807867|NCT02793232|20045324|P4|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0
5807868|NCT02793232|20045325|P3|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0
5807869|NCT02793232|20045326|P2|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0
5807870|NCT02793232|20045327|P1|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0
5807871|NCT02793128|20045580|P1|Overall Study|Patient elected nephroureterectomy|1
5807872|NCT02793128|20045580|P1|Overall Study|Comorbid conditions and noncompliance|1
5807873|NCT02793128|20045580|P1|Overall Study|Physician Decision|1
5807874|NCT02793128|20045580|P1|Overall Study|Withdrawal by Subject|2
5807875|NCT02793128|20045580|P1|Overall Study|Death|4
5807876|NCT02792829|20045602|P8|Treatment Period 2|Use of proscribed medications|1
5807877|NCT02792829|20045603|P7|Treatment Period 2|Use of proscribed medications|0
5807878|NCT02792829|20045604|P6|Treatment Period 2|Use of proscribed medications|0
5807879|NCT02792829|20045605|P5|Treatment Period 2|Use of proscribed medications|0
5807880|NCT02792829|20045606|P4|Treatment Period 2|Use of proscribed medications|0
5807881|NCT02792829|20045607|P3|Treatment Period 2|Use of proscribed medications|0
5807882|NCT02792829|20045608|P2|Treatment Period 2|Use of proscribed medications|0
5807883|NCT02792829|20045609|P1|Treatment Period 2|Use of proscribed medications|0
5807884|NCT02792829|20045602|P8|Treatment Period 2|Adverse Event|1
5807885|NCT02792829|20045603|P7|Treatment Period 2|Adverse Event|1
5807886|NCT02792829|20045604|P6|Treatment Period 2|Adverse Event|0
5807887|NCT02792829|20045605|P5|Treatment Period 2|Adverse Event|1
5807888|NCT02792829|20045606|P4|Treatment Period 2|Adverse Event|0
5807889|NCT02792829|20045607|P3|Treatment Period 2|Adverse Event|0
5807890|NCT02792829|20045608|P2|Treatment Period 2|Adverse Event|0
5807891|NCT02792829|20045609|P1|Treatment Period 2|Adverse Event|0
5807892|NCT02792829|20045602|P8|Treatment Period 2|Non compliance with alcohol prohibition|0
5807893|NCT02792829|20045603|P7|Treatment Period 2|Non compliance with alcohol prohibition|0
5807894|NCT02792829|20045604|P6|Treatment Period 2|Non compliance with alcohol prohibition|0
5807895|NCT02792829|20045605|P5|Treatment Period 2|Non compliance with alcohol prohibition|0
5807896|NCT02792829|20045606|P4|Treatment Period 2|Non compliance with alcohol prohibition|0
5807897|NCT02792829|20045607|P3|Treatment Period 2|Non compliance with alcohol prohibition|0
5807898|NCT02792829|20045608|P2|Treatment Period 2|Non compliance with alcohol prohibition|1
5807899|NCT02792829|20045609|P1|Treatment Period 2|Non compliance with alcohol prohibition|0
5807900|NCT02792777|20045717|P2|Overall Study|Participant interviewed twice|0
5807901|NCT02792777|20045718|P1|Overall Study|Participant interviewed twice|1
5807902|NCT02792777|20045717|P2|Overall Study|Later determined to be ineligible|0
5807903|NCT02792777|20045718|P1|Overall Study|Later determined to be ineligible|2
5807904|NCT02792777|20045717|P2|Overall Study|Recording malfunction|0
5807905|NCT02792777|20045718|P1|Overall Study|Recording malfunction|2
5807906|NCT02792777|20045717|P2|Overall Study|Withdrawal by Subject|0
5807907|NCT02792777|20045718|P1|Overall Study|Withdrawal by Subject|2
5807908|NCT02792699|20045734|P3|Overall Study|Other|0
5807909|NCT02792699|20045735|P2|Overall Study|Other|0
5807910|NCT02792699|20045736|P1|Overall Study|Other|1
5807911|NCT02792699|20045734|P3|Overall Study|Dissatisfaction with Treatment Efficacy|1
5807912|NCT02792699|20045735|P2|Overall Study|Dissatisfaction with Treatment Efficacy|3
5807913|NCT02792699|20045736|P1|Overall Study|Dissatisfaction with Treatment Efficacy|1
5807914|NCT02792699|20045734|P3|Overall Study|Physician Decision|0
5807915|NCT02792699|20045735|P2|Overall Study|Physician Decision|0
5807916|NCT02792699|20045736|P1|Overall Study|Physician Decision|2
5807917|NCT02792699|20045734|P3|Overall Study|Lost to Follow-up|2
5807918|NCT02792699|20045735|P2|Overall Study|Lost to Follow-up|1
5807919|NCT02792699|20045736|P1|Overall Study|Lost to Follow-up|0
5807920|NCT02792699|20045734|P3|Overall Study|Withdrawal by Subject|3
5807921|NCT02792699|20045735|P2|Overall Study|Withdrawal by Subject|4
5807922|NCT02792699|20045736|P1|Overall Study|Withdrawal by Subject|4
5807923|NCT02792699|20045734|P3|Overall Study|Adverse Event|4
5807924|NCT02792699|20045735|P2|Overall Study|Adverse Event|2
5807925|NCT02792699|20045736|P1|Overall Study|Adverse Event|1
5807926|NCT02792517|20045817|P1|Overall Study|Lost to Follow-up|3
5807927|NCT02792517|20045817|P1|Overall Study|Decision by Sponsor|7
5807928|NCT02792517|20045817|P1|Overall Study|Withdrawal by Subject|10
5807929|NCT02792231|20045833|P2|Overall Study|Ongoing at interim data cutoff|1
5807930|NCT02792231|20045834|P1|Overall Study|Ongoing at interim data cutoff|1
5807931|NCT02792231|20045833|P2|Overall Study|Technical problems|1
5807932|NCT02792231|20045834|P1|Overall Study|Technical problems|0
5807933|NCT02792231|20045833|P2|Overall Study|Protocol deviation|0
5807934|NCT02792231|20045834|P1|Overall Study|Protocol deviation|2
5807935|NCT02792231|20045833|P2|Overall Study|Non-compliance with study treatment|1
5808021|NCT02790073|20046287|P1|Overall Study|Death|1
5807936|NCT02792231|20045834|P1|Overall Study|Non-compliance with study treatment|2
5807937|NCT02792231|20045833|P2|Overall Study|Pregnancy|3
5807938|NCT02792231|20045834|P1|Overall Study|Pregnancy|1
5807939|NCT02792231|20045833|P2|Overall Study|Lost to Follow-up|5
5807940|NCT02792231|20045834|P1|Overall Study|Lost to Follow-up|9
5807941|NCT02792231|20045833|P2|Overall Study|Lack of Efficacy|9
5807942|NCT02792231|20045834|P1|Overall Study|Lack of Efficacy|7
5807943|NCT02792231|20045833|P2|Overall Study|Physician Decision|11
5807944|NCT02792231|20045834|P1|Overall Study|Physician Decision|14
5807945|NCT02792231|20045833|P2|Overall Study|Adverse Event|13
5807946|NCT02792231|20045834|P1|Overall Study|Adverse Event|16
5807947|NCT02792231|20045833|P2|Overall Study|Patient/guardian decision|41
5807948|NCT02792231|20045834|P1|Overall Study|Patient/guardian decision|32
5807949|NCT02792218|20045856|P2|Overall Study|Ongoing at interim cutoff|5
5807950|NCT02792218|20045857|P1|Overall Study|Ongoing at interim cutoff|1
5807951|NCT02792218|20045856|P2|Overall Study|Pregnancy|0
5807952|NCT02792218|20045857|P1|Overall Study|Pregnancy|1
5807953|NCT02792218|20045856|P2|Overall Study|Non-compliance with study treatment|1
5807954|NCT02792218|20045857|P1|Overall Study|Non-compliance with study treatment|0
5807955|NCT02792218|20045856|P2|Overall Study|New therapy for study indication|1
5807956|NCT02792218|20045857|P1|Overall Study|New therapy for study indication|0
5807957|NCT02792218|20045856|P2|Overall Study|Protocol deviation|2
5807958|NCT02792218|20045857|P1|Overall Study|Protocol deviation|3
5807959|NCT02792218|20045856|P2|Overall Study|Physician Decision|4
5807960|NCT02792218|20045857|P1|Overall Study|Physician Decision|3
5807961|NCT02792218|20045856|P2|Overall Study|Lack of Efficacy|12
5807962|NCT02792218|20045857|P1|Overall Study|Lack of Efficacy|1
5807963|NCT02792218|20045856|P2|Overall Study|Lost to Follow-up|5
5807964|NCT02792218|20045857|P1|Overall Study|Lost to Follow-up|10
5807965|NCT02792218|20045856|P2|Overall Study|Adverse Event|14
5807966|NCT02792218|20045857|P1|Overall Study|Adverse Event|14
5807967|NCT02792218|20045856|P2|Overall Study|Patient/guardian decision|42
5807968|NCT02792218|20045857|P1|Overall Study|Patient/guardian decision|16
5807969|NCT02792062|20045883|P6|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0
5807970|NCT02792062|20045884|P5|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0
5807971|NCT02792062|20045885|P4|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0
5807972|NCT02792062|20045886|P3|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0
5807973|NCT02792062|20045887|P2|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0
5807974|NCT02792062|20045888|P1|Washout Period (at Least 14 Days)|Voluntary Withdrawal|1
5807975|NCT02791763|20045970|P3|Overall Study|Adverse Event|7
5807976|NCT02791763|20045971|P2|Overall Study|Adverse Event|13
5807977|NCT02791763|20045972|P1|Overall Study|Adverse Event|12
5807978|NCT02791763|20045970|P3|Overall Study|Met hemoglobin stopping criteria|0
5807979|NCT02791763|20045971|P2|Overall Study|Met hemoglobin stopping criteria|0
5807980|NCT02791763|20045972|P1|Overall Study|Met hemoglobin stopping criteria|1
5807981|NCT02791763|20045970|P3|Overall Study|Participant had renal transplant|0
5807982|NCT02791763|20045971|P2|Overall Study|Participant had renal transplant|0
5807983|NCT02791763|20045972|P1|Overall Study|Participant had renal transplant|3
5807984|NCT02791763|20045970|P3|Overall Study|Cancer event|0
5807985|NCT02791763|20045971|P2|Overall Study|Cancer event|3
5807986|NCT02791763|20045972|P1|Overall Study|Cancer event|1
5807987|NCT02791763|20045970|P3|Overall Study|Needs maintenance/changes in dialysis|5
5807988|NCT02791763|20045971|P2|Overall Study|Needs maintenance/changes in dialysis|19
5807989|NCT02791763|20045972|P1|Overall Study|Needs maintenance/changes in dialysis|16
5807990|NCT02791763|20045970|P3|Overall Study|Physician Decision|0
5807991|NCT02791763|20045971|P2|Overall Study|Physician Decision|1
5807992|NCT02791763|20045972|P1|Overall Study|Physician Decision|0
5807993|NCT02791763|20045970|P3|Overall Study|Withdrawal by Subject|0
5807994|NCT02791763|20045971|P2|Overall Study|Withdrawal by Subject|1
5807995|NCT02791763|20045972|P1|Overall Study|Withdrawal by Subject|5
5807996|NCT02791763|20045970|P3|Overall Study|Protocol Violation|1
5807997|NCT02791763|20045971|P2|Overall Study|Protocol Violation|0
5807998|NCT02791763|20045972|P1|Overall Study|Protocol Violation|0
5807999|NCT02791659|20046091|P2|Overall Study|Protocol Violation|1
5808000|NCT02791659|20046092|P1|Overall Study|Protocol Violation|0
5808001|NCT02791516|20046100|P2|Overall Study|Withdrawal by Subject|1
5808002|NCT02791516|20046101|P1|Overall Study|Withdrawal by Subject|1
5808003|NCT02791490|20046113|P2|Overall Study|Withdrawal by Subject|6
5808004|NCT02791490|20046114|P1|Overall Study|Withdrawal by Subject|2
5808005|NCT02791490|20046113|P2|Overall Study|Lost to Follow-up|2
5808006|NCT02791490|20046114|P1|Overall Study|Lost to Follow-up|1
5808007|NCT02791438|20046134|P2|Treatment Period|Withdrawal by Parent/Guardian|0
5808008|NCT02791438|20046135|P1|Treatment Period|Withdrawal by Parent/Guardian|2
5808009|NCT02791438|20046134|P2|Treatment Period|Withdrawal by Subject|1
5808010|NCT02791438|20046135|P1|Treatment Period|Withdrawal by Subject|0
5808011|NCT02791438|20046134|P2|Treatment Period|Adverse Event|0
5808012|NCT02791438|20046135|P1|Treatment Period|Adverse Event|1
5808013|NCT02791269|20046176|P2|Overall Study|Lost to Follow-up|1
5808014|NCT02791269|20046177|P1|Overall Study|Lost to Follow-up|0
5808015|NCT02790606|20046255|P1|Overall Study|Withdrawal by Subject|1
5808016|NCT02790606|20046255|P1|Overall Study|Physician Decision|3
5808017|NCT02790606|20046255|P1|Overall Study|Lost to Follow-up|4
5808018|NCT02790606|20046255|P1|Overall Study|Death|27
5808019|NCT02790073|20046287|P1|Overall Study|Withdrawal by Subject|1
5808020|NCT02790073|20046287|P1|Overall Study|Withdrawal from HD|1
5808022|NCT02789176|20046310|P4|Overall Study|Lost to Follow-up|1
5808023|NCT02789176|20046311|P3|Overall Study|Lost to Follow-up|6
5808024|NCT02789176|20046312|P2|Overall Study|Lost to Follow-up|2
5808025|NCT02789176|20046313|P1|Overall Study|Lost to Follow-up|8
5808026|NCT02789176|20046310|P4|Overall Study|Withdrawal by Subject|0
5808027|NCT02789176|20046311|P3|Overall Study|Withdrawal by Subject|1
5808028|NCT02789176|20046312|P2|Overall Study|Withdrawal by Subject|0
5808029|NCT02789176|20046313|P1|Overall Study|Withdrawal by Subject|0
5808030|NCT02789176|20046310|P4|Overall Study|Death|0
5808031|NCT02789176|20046311|P3|Overall Study|Death|3
5808032|NCT02789176|20046312|P2|Overall Study|Death|0
5808033|NCT02789176|20046313|P1|Overall Study|Death|0
5808034|NCT02789111|20046337|P2|Overall Study|Withdrawal by Subject|4
5808035|NCT02789111|20046338|P1|Overall Study|Withdrawal by Subject|1
5808036|NCT02788747|20046366|P3|Overall Study|Adverse Event|0
5808037|NCT02788747|20046367|P2|Overall Study|Adverse Event|0
5808038|NCT02788747|20046368|P1|Overall Study|Adverse Event|1
5808039|NCT02788656|20046438|P2|Overall Study|Withdrawal by Subject|0
5808040|NCT02788656|20046439|P1|Overall Study|Withdrawal by Subject|1
5808041|NCT02788513|20046464|P5|Overall Study|Decision by the study team|1
5808042|NCT02788513|20046465|P4|Overall Study|Decision by the study team|0
5808043|NCT02788513|20046466|P3|Overall Study|Decision by the study team|0
5808044|NCT02788513|20046467|P2|Overall Study|Decision by the study team|0
5808045|NCT02788513|20046468|P1|Overall Study|Decision by the study team|0
5808046|NCT02788513|20046464|P5|Overall Study|Subject decided to stop taking treatment|0
5808047|NCT02788513|20046465|P4|Overall Study|Subject decided to stop taking treatment|0
5808048|NCT02788513|20046466|P3|Overall Study|Subject decided to stop taking treatment|1
5808049|NCT02788513|20046467|P2|Overall Study|Subject decided to stop taking treatment|0
5808050|NCT02788513|20046468|P1|Overall Study|Subject decided to stop taking treatment|0
5808051|NCT02788513|20046464|P5|Overall Study|Protocol Violation|0
5808052|NCT02788513|20046465|P4|Overall Study|Protocol Violation|1
5808053|NCT02788513|20046466|P3|Overall Study|Protocol Violation|1
5808054|NCT02788513|20046467|P2|Overall Study|Protocol Violation|0
5808055|NCT02788513|20046468|P1|Overall Study|Protocol Violation|0
5808056|NCT02788513|20046464|P5|Overall Study|Adverse Event|2
5808057|NCT02788513|20046465|P4|Overall Study|Adverse Event|2
5808058|NCT02788513|20046466|P3|Overall Study|Adverse Event|4
5808059|NCT02788513|20046467|P2|Overall Study|Adverse Event|8
5808060|NCT02788513|20046468|P1|Overall Study|Adverse Event|5
5808061|NCT02788513|20046464|P5|Overall Study|Lost to Follow-up|1
5808062|NCT02788513|20046465|P4|Overall Study|Lost to Follow-up|0
5808063|NCT02788513|20046466|P3|Overall Study|Lost to Follow-up|0
5808064|NCT02788513|20046467|P2|Overall Study|Lost to Follow-up|0
5808065|NCT02788513|20046468|P1|Overall Study|Lost to Follow-up|1
5808066|NCT02788513|20046464|P5|Overall Study|Withdrawal by Subject|1
5808067|NCT02788513|20046465|P4|Overall Study|Withdrawal by Subject|3
5808068|NCT02788513|20046466|P3|Overall Study|Withdrawal by Subject|2
5808069|NCT02788513|20046467|P2|Overall Study|Withdrawal by Subject|0
5808070|NCT02788513|20046468|P1|Overall Study|Withdrawal by Subject|3
5808071|NCT02788474|20046492|P2|Open Label Treatment Period|Non-compliance|0
5808072|NCT02788474|20046493|P1|Open Label Treatment Period|Non-compliance|1
5808073|NCT02788474|20046492|P2|Open Label Treatment Period|Patient's refusal|3
5808074|NCT02788474|20046493|P1|Open Label Treatment Period|Patient's refusal|1
5808075|NCT02788474|20046492|P2|Open Label Treatment Period|Other than reason specified|0
5808076|NCT02788474|20046493|P1|Open Label Treatment Period|Other than reason specified|1
5808077|NCT02788474|20046492|P2|Open Label Treatment Period|Adverse Event|9
5808078|NCT02788474|20046493|P1|Open Label Treatment Period|Adverse Event|29
5808079|NCT02788474|20046492|P2|Double Blind Treatment Period|Adverse Event|4
5808080|NCT02788474|20046493|P1|Double Blind Treatment Period|Adverse Event|6
5808081|NCT02788474|20046492|P2|Double Blind Treatment Period|Patient's refusal|0
5808082|NCT02788474|20046493|P1|Double Blind Treatment Period|Patient's refusal|3
5808083|NCT02788474|20046492|P2|Double Blind Treatment Period|Not treated|0
5808084|NCT02788474|20046493|P1|Double Blind Treatment Period|Not treated|1
5808085|NCT02788357|20046508|P2|Overall Study|Lost to Follow-up|0
5808086|NCT02788357|20046509|P1|Overall Study|Lost to Follow-up|3
5808087|NCT02788279|20046524|P3|Overall Study|Sponsor decision|11
5808088|NCT02788279|20046525|P2|Overall Study|Sponsor decision|29
5808089|NCT02788279|20046526|P1|Overall Study|Sponsor decision|18
5808090|NCT02788279|20046524|P3|Overall Study|Lost to Follow-up|2
5808091|NCT02788279|20046525|P2|Overall Study|Lost to Follow-up|3
5808092|NCT02788279|20046526|P1|Overall Study|Lost to Follow-up|0
5808093|NCT02788279|20046524|P3|Overall Study|Withdrawal by Subject|5
5808094|NCT02788279|20046525|P2|Overall Study|Withdrawal by Subject|15
5808095|NCT02788279|20046526|P1|Overall Study|Withdrawal by Subject|10
5808096|NCT02788279|20046524|P3|Overall Study|Death|72
5808097|NCT02788279|20046525|P2|Overall Study|Death|136
5808098|NCT02788279|20046526|P1|Overall Study|Death|62
5808099|NCT02788201|20046563|P6|Overall Study|Withdrawal by Subject|1
5808100|NCT02788201|20046564|P5|Overall Study|Withdrawal by Subject|0
5808101|NCT02788201|20046565|P4|Overall Study|Withdrawal by Subject|0
5808102|NCT02788201|20046566|P3|Overall Study|Withdrawal by Subject|0
5808103|NCT02788201|20046567|P2|Overall Study|Withdrawal by Subject|0
5808104|NCT02788201|20046568|P1|Overall Study|Withdrawal by Subject|0
5808105|NCT02788201|20046563|P6|Overall Study|Ineligible|1
5808106|NCT02788201|20046564|P5|Overall Study|Ineligible|0
5808107|NCT02788201|20046565|P4|Overall Study|Ineligible|0
5808108|NCT02788201|20046566|P3|Overall Study|Ineligible|0
5808109|NCT02788201|20046567|P2|Overall Study|Ineligible|0
5808110|NCT02788201|20046568|P1|Overall Study|Ineligible|0
5808111|NCT02788201|20046563|P6|Overall Study|Death|1
5808112|NCT02788201|20046564|P5|Overall Study|Death|0
5808113|NCT02788201|20046565|P4|Overall Study|Death|1
5808114|NCT02788201|20046566|P3|Overall Study|Death|1
5808115|NCT02788201|20046567|P2|Overall Study|Death|1
5808116|NCT02788201|20046568|P1|Overall Study|Death|1
5808117|NCT02788175|20046621|P1|Overall Study|Ineligible prior to study agent|6
5808118|NCT02788175|20046621|P1|Overall Study|Withdrawal by Subject|4
5808119|NCT02788175|20046621|P1|Overall Study|Protocol Violation|3
5808120|NCT02787863|20046643|P8|Overall Study|Withdrawal by Subject|0
5808121|NCT02787863|20046644|P7|Overall Study|Withdrawal by Subject|0
5808122|NCT02787863|20046645|P6|Overall Study|Withdrawal by Subject|0
5808123|NCT02787863|20046646|P5|Overall Study|Withdrawal by Subject|0
5808124|NCT02787863|20046647|P4|Overall Study|Withdrawal by Subject|0
5808125|NCT02787863|20046648|P3|Overall Study|Withdrawal by Subject|1
5808126|NCT02787863|20046649|P2|Overall Study|Withdrawal by Subject|1
5808127|NCT02787863|20046650|P1|Overall Study|Withdrawal by Subject|0
5808128|NCT02787863|20046643|P8|Overall Study|Death|0
5808129|NCT02787863|20046644|P7|Overall Study|Death|0
5808130|NCT02787863|20046645|P6|Overall Study|Death|0
5808131|NCT02787863|20046646|P5|Overall Study|Death|0
5808132|NCT02787863|20046647|P4|Overall Study|Death|0
5808133|NCT02787863|20046648|P3|Overall Study|Death|1
5808134|NCT02787863|20046649|P2|Overall Study|Death|0
5808135|NCT02787863|20046650|P1|Overall Study|Death|1
5808136|NCT02787551|20046748|P2|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|0
5808137|NCT02787551|20046749|P1|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|5
5808138|NCT02787551|20046748|P2|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|0
5808139|NCT02787551|20046749|P1|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|3
5808140|NCT02787551|20046748|P2|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|0
5808141|NCT02787551|20046749|P1|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|1
5808142|NCT02787551|20046748|P2|Core Period: 26 Weeks|Other than specified|1
5808143|NCT02787551|20046749|P1|Core Period: 26 Weeks|Other than specified|3
5808144|NCT02787551|20046748|P2|Core Period: 26 Weeks|Randomized but not treated|1
5808145|NCT02787551|20046749|P1|Core Period: 26 Weeks|Randomized but not treated|2
5808146|NCT02787551|20046748|P2|Core Period: 26 Weeks|Withdrawal by Subject|9
5808147|NCT02787551|20046749|P1|Core Period: 26 Weeks|Withdrawal by Subject|9
5808148|NCT02787551|20046748|P2|Core Period: 26 Weeks|Poor compliance to protocol|0
5808149|NCT02787551|20046749|P1|Core Period: 26 Weeks|Poor compliance to protocol|2
5808150|NCT02787551|20046748|P2|Core Period: 26 Weeks|Lack of Efficacy|0
5808151|NCT02787551|20046749|P1|Core Period: 26 Weeks|Lack of Efficacy|1
5808152|NCT02787551|20046748|P2|Core Period: 26 Weeks|Adverse Event|0
5808153|NCT02787551|20046749|P1|Core Period: 26 Weeks|Adverse Event|10
5808154|NCT02787304|20046785|P4|Overall Study|Study terminated by sponsor|32
5808155|NCT02787304|20046786|P3|Overall Study|Study terminated by sponsor|31
5808156|NCT02787304|20046787|P2|Overall Study|Study terminated by sponsor|31
5808157|NCT02787304|20046788|P1|Overall Study|Study terminated by sponsor|25
5808158|NCT02787304|20046785|P4|Overall Study|Physician Decision|0
5808159|NCT02787304|20046786|P3|Overall Study|Physician Decision|1
5808160|NCT02787304|20046787|P2|Overall Study|Physician Decision|0
5808161|NCT02787304|20046788|P1|Overall Study|Physician Decision|0
5808162|NCT02787304|20046785|P4|Overall Study|Noncompliance with study drug|0
5808163|NCT02787304|20046786|P3|Overall Study|Noncompliance with study drug|1
5808164|NCT02787304|20046787|P2|Overall Study|Noncompliance with study drug|0
5808165|NCT02787304|20046788|P1|Overall Study|Noncompliance with study drug|0
5808166|NCT02787304|20046785|P4|Overall Study|Lost to Follow-up|1
5808167|NCT02787304|20046786|P3|Overall Study|Lost to Follow-up|0
5808168|NCT02787304|20046787|P2|Overall Study|Lost to Follow-up|0
5808169|NCT02787304|20046788|P1|Overall Study|Lost to Follow-up|1
5808170|NCT02787304|20046785|P4|Overall Study|Withdrawal by Subject|0
5808171|NCT02787304|20046786|P3|Overall Study|Withdrawal by Subject|0
5808172|NCT02787304|20046787|P2|Overall Study|Withdrawal by Subject|4
5808173|NCT02787304|20046788|P1|Overall Study|Withdrawal by Subject|1
5808174|NCT02787304|20046785|P4|Overall Study|Adverse Event|1
5808175|NCT02787304|20046786|P3|Overall Study|Adverse Event|8
5808176|NCT02787304|20046787|P2|Overall Study|Adverse Event|3
5808177|NCT02787304|20046788|P1|Overall Study|Adverse Event|9
5808178|NCT02787083|20046842|P2|Overall Study|Withdrawal by Subject|2
5808179|NCT02787083|20046843|P1|Overall Study|Withdrawal by Subject|2
5808180|NCT02787083|20046842|P2|Overall Study|Adverse Event|0
5808181|NCT02787083|20046843|P1|Overall Study|Adverse Event|1
5808182|NCT02786953|20046868|P2|Overall Study|Physician Decision|1
5808183|NCT02786953|20046869|P1|Overall Study|Physician Decision|0
5808184|NCT02786953|20046868|P2|Overall Study|Withdrawal by Subject|0
5808185|NCT02786953|20046869|P1|Overall Study|Withdrawal by Subject|3
5808186|NCT02786927|20046891|P1|Overall Study|Protocol Violation|4
5808187|NCT02786927|20046891|P1|Overall Study|Adverse Event|1
5808188|NCT02786901|20046901|P3|Overall Study|Randomized in error|1
5808189|NCT02786901|20046902|P2|Overall Study|Randomized in error|0
5808190|NCT02786901|20046903|P1|Overall Study|Randomized in error|2
5808191|NCT02786901|20046901|P3|Overall Study|Disallowed medication|0
5808192|NCT02786901|20046902|P2|Overall Study|Disallowed medication|1
5808193|NCT02786901|20046903|P1|Overall Study|Disallowed medication|1
5808194|NCT02786901|20046901|P3|Overall Study|Subject Request/Lost to Follow up|5
5808195|NCT02786901|20046902|P2|Overall Study|Subject Request/Lost to Follow up|5
5808196|NCT02786901|20046903|P1|Overall Study|Subject Request/Lost to Follow up|1
5808197|NCT02786901|20046901|P3|Overall Study|Rescue Therapy Use|33
5808198|NCT02786901|20046902|P2|Overall Study|Rescue Therapy Use|49
5808199|NCT02786901|20046903|P1|Overall Study|Rescue Therapy Use|71
5808200|NCT02786901|20046901|P3|Overall Study|Physician Decision|0
5808201|NCT02786901|20046902|P2|Overall Study|Physician Decision|0
5808202|NCT02786901|20046903|P1|Overall Study|Physician Decision|1
5808203|NCT02786901|20046901|P3|Overall Study|Adverse Event|2
5808204|NCT02786901|20046902|P2|Overall Study|Adverse Event|1
5808205|NCT02786901|20046903|P1|Overall Study|Adverse Event|1
5808206|NCT02786836|20046932|P1|Overall Study|Device or Pharmacy Issues|3
5808207|NCT02786836|20046932|P1|Overall Study|Liver Transplantation|2
5808208|NCT02786836|20046932|P1|Overall Study|Withdrawal by Subject|3
5808209|NCT02786836|20046932|P1|Overall Study|Protocol Violation|3
5808210|NCT02786836|20046932|P1|Overall Study|Lack of Efficacy|2
5808211|NCT02786836|20046932|P1|Overall Study|Death|1
5808212|NCT02786537|20046964|P6|As Treated|Advised to stop tx after loss of meds|0
5808213|NCT02786537|20046965|P5|As Treated|Advised to stop tx after loss of meds|0
5808214|NCT02786537|20046966|P4|As Treated|Advised to stop tx after loss of meds|0
5808215|NCT02786537|20046967|P3|As Treated|Advised to stop tx after loss of meds|0
5808216|NCT02786537|20046968|P2|As Treated|Advised to stop tx after loss of meds|1
5808217|NCT02786537|20046969|P1|As Treated|Advised to stop tx after loss of meds|0
5808218|NCT02786537|20046964|P6|As Treated|Drugs stolen from patient|0
5808219|NCT02786537|20046965|P5|As Treated|Drugs stolen from patient|0
5808220|NCT02786537|20046966|P4|As Treated|Drugs stolen from patient|0
5808221|NCT02786537|20046967|P3|As Treated|Drugs stolen from patient|0
5808222|NCT02786537|20046968|P2|As Treated|Drugs stolen from patient|1
5808223|NCT02786537|20046969|P1|As Treated|Drugs stolen from patient|0
5808224|NCT02786537|20046964|P6|As Treated|Opiate dependency relapse|0
5808225|NCT02786537|20046965|P5|As Treated|Opiate dependency relapse|0
5808226|NCT02786537|20046966|P4|As Treated|Opiate dependency relapse|0
5808227|NCT02786537|20046967|P3|As Treated|Opiate dependency relapse|0
5808228|NCT02786537|20046968|P2|As Treated|Opiate dependency relapse|1
5808229|NCT02786537|20046969|P1|As Treated|Opiate dependency relapse|0
5808230|NCT02786537|20046964|P6|As Treated|Incarceration|0
5808231|NCT02786537|20046965|P5|As Treated|Incarceration|0
5808232|NCT02786537|20046966|P4|As Treated|Incarceration|0
5808233|NCT02786537|20046967|P3|As Treated|Incarceration|0
5808234|NCT02786537|20046968|P2|As Treated|Incarceration|1
5808235|NCT02786537|20046969|P1|As Treated|Incarceration|0
5808236|NCT02786537|20046964|P6|As Treated|Withdrawal by Subject|0
5808237|NCT02786537|20046965|P5|As Treated|Withdrawal by Subject|1
5808238|NCT02786537|20046966|P4|As Treated|Withdrawal by Subject|0
5808239|NCT02786537|20046967|P3|As Treated|Withdrawal by Subject|0
5808240|NCT02786537|20046968|P2|As Treated|Withdrawal by Subject|2
5808241|NCT02786537|20046969|P1|As Treated|Withdrawal by Subject|1
5808242|NCT02786537|20046964|P6|As Treated|Lost insurance|0
5808243|NCT02786537|20046965|P5|As Treated|Lost insurance|0
5808244|NCT02786537|20046966|P4|As Treated|Lost insurance|1
5808245|NCT02786537|20046967|P3|As Treated|Lost insurance|0
5808246|NCT02786537|20046968|P2|As Treated|Lost insurance|0
5808247|NCT02786537|20046969|P1|As Treated|Lost insurance|0
5808248|NCT02786537|20046964|P6|As Treated|Non-compliance with study drug|1
5808249|NCT02786537|20046965|P5|As Treated|Non-compliance with study drug|0
5808250|NCT02786537|20046966|P4|As Treated|Non-compliance with study drug|1
5808251|NCT02786537|20046967|P3|As Treated|Non-compliance with study drug|0
5808252|NCT02786537|20046968|P2|As Treated|Non-compliance with study drug|11
5808253|NCT02786537|20046969|P1|As Treated|Non-compliance with study drug|1
5808254|NCT02786537|20046964|P6|As Treated|Lost to Follow-up|4
5808255|NCT02786537|20046965|P5|As Treated|Lost to Follow-up|4
5808256|NCT02786537|20046966|P4|As Treated|Lost to Follow-up|25
5808257|NCT02786537|20046967|P3|As Treated|Lost to Follow-up|0
5808258|NCT02786537|20046968|P2|As Treated|Lost to Follow-up|32
5808259|NCT02786537|20046969|P1|As Treated|Lost to Follow-up|4
5808260|NCT02786537|20046964|P6|As Treated|Lack of Efficacy|0
5808261|NCT02786537|20046965|P5|As Treated|Lack of Efficacy|0
5808262|NCT02786537|20046966|P4|As Treated|Lack of Efficacy|1
5808263|NCT02786537|20046967|P3|As Treated|Lack of Efficacy|0
5808264|NCT02786537|20046968|P2|As Treated|Lack of Efficacy|0
5808265|NCT02786537|20046969|P1|As Treated|Lack of Efficacy|0
5808266|NCT02786537|20046964|P6|As Treated|Death|0
5808267|NCT02786537|20046965|P5|As Treated|Death|1
5808268|NCT02786537|20046966|P4|As Treated|Death|3
5808269|NCT02786537|20046967|P3|As Treated|Death|0
5808270|NCT02786537|20046968|P2|As Treated|Death|2
5808271|NCT02786537|20046969|P1|As Treated|Death|0
5808272|NCT02786537|20046964|P6|As Treated|Adverse Event|2
5808273|NCT02786537|20046965|P5|As Treated|Adverse Event|6
5808274|NCT02786537|20046966|P4|As Treated|Adverse Event|4
5808275|NCT02786537|20046967|P3|As Treated|Adverse Event|0
5808276|NCT02786537|20046968|P2|As Treated|Adverse Event|11
5808277|NCT02786537|20046969|P1|As Treated|Adverse Event|0
5808278|NCT02786537|20046964|P6|As Randomized|Subject lost insurance|0
5808279|NCT02786537|20046965|P5|As Randomized|Subject lost insurance|0
5808280|NCT02786537|20046966|P4|As Randomized|Subject lost insurance|1
5808281|NCT02786537|20046967|P3|As Randomized|Subject lost insurance|0
5808282|NCT02786537|20046968|P2|As Randomized|Subject lost insurance|0
5808283|NCT02786537|20046969|P1|As Randomized|Subject lost insurance|0
5808284|NCT02786537|20046964|P6|As Randomized|Advised to stop after lapse in dosing|0
5808285|NCT02786537|20046965|P5|As Randomized|Advised to stop after lapse in dosing|0
5808286|NCT02786537|20046966|P4|As Randomized|Advised to stop after lapse in dosing|0
5808287|NCT02786537|20046967|P3|As Randomized|Advised to stop after lapse in dosing|0
5808288|NCT02786537|20046968|P2|As Randomized|Advised to stop after lapse in dosing|1
5808289|NCT02786537|20046969|P1|As Randomized|Advised to stop after lapse in dosing|0
5808290|NCT02786537|20046964|P6|As Randomized|HCV drugs stolen from pt|0
5808291|NCT02786537|20046965|P5|As Randomized|HCV drugs stolen from pt|0
5808292|NCT02786537|20046966|P4|As Randomized|HCV drugs stolen from pt|0
5808293|NCT02786537|20046967|P3|As Randomized|HCV drugs stolen from pt|0
5808294|NCT02786537|20046968|P2|As Randomized|HCV drugs stolen from pt|1
5808295|NCT02786537|20046969|P1|As Randomized|HCV drugs stolen from pt|0
5808296|NCT02786537|20046964|P6|As Randomized|Opiate Dependency Relapse|0
5808297|NCT02786537|20046965|P5|As Randomized|Opiate Dependency Relapse|0
5808298|NCT02786537|20046966|P4|As Randomized|Opiate Dependency Relapse|0
5808299|NCT02786537|20046967|P3|As Randomized|Opiate Dependency Relapse|0
5808300|NCT02786537|20046968|P2|As Randomized|Opiate Dependency Relapse|1
5808301|NCT02786537|20046969|P1|As Randomized|Opiate Dependency Relapse|0
5808302|NCT02786537|20046964|P6|As Randomized|Incarceration|0
5808303|NCT02786537|20046965|P5|As Randomized|Incarceration|0
5808304|NCT02786537|20046966|P4|As Randomized|Incarceration|0
5808305|NCT02786537|20046967|P3|As Randomized|Incarceration|0
5808306|NCT02786537|20046968|P2|As Randomized|Incarceration|1
5808307|NCT02786537|20046969|P1|As Randomized|Incarceration|0
5808308|NCT02786537|20046964|P6|As Randomized|Lost to treatment follow-up|4
5808309|NCT02786537|20046965|P5|As Randomized|Lost to treatment follow-up|4
5808310|NCT02786537|20046966|P4|As Randomized|Lost to treatment follow-up|24
5808311|NCT02786537|20046967|P3|As Randomized|Lost to treatment follow-up|0
5808312|NCT02786537|20046968|P2|As Randomized|Lost to treatment follow-up|32
5808313|NCT02786537|20046969|P1|As Randomized|Lost to treatment follow-up|4
5808314|NCT02786537|20046964|P6|As Randomized|Non-compliance with study drug|1
5808315|NCT02786537|20046965|P5|As Randomized|Non-compliance with study drug|0
5808316|NCT02786537|20046966|P4|As Randomized|Non-compliance with study drug|1
5808317|NCT02786537|20046967|P3|As Randomized|Non-compliance with study drug|0
5808318|NCT02786537|20046968|P2|As Randomized|Non-compliance with study drug|11
5808319|NCT02786537|20046969|P1|As Randomized|Non-compliance with study drug|1
5808320|NCT02786537|20046964|P6|As Randomized|Death|0
5808321|NCT02786537|20046965|P5|As Randomized|Death|1
5808322|NCT02786537|20046966|P4|As Randomized|Death|3
5808323|NCT02786537|20046967|P3|As Randomized|Death|0
5808324|NCT02786537|20046968|P2|As Randomized|Death|2
5808325|NCT02786537|20046969|P1|As Randomized|Death|0
5808326|NCT02786537|20046964|P6|As Randomized|Withdrawal by Subject|0
5808327|NCT02786537|20046965|P5|As Randomized|Withdrawal by Subject|1
5808328|NCT02786537|20046966|P4|As Randomized|Withdrawal by Subject|1
5808329|NCT02786537|20046967|P3|As Randomized|Withdrawal by Subject|0
5808330|NCT02786537|20046968|P2|As Randomized|Withdrawal by Subject|2
5808331|NCT02786537|20046969|P1|As Randomized|Withdrawal by Subject|1
5808332|NCT02786537|20046964|P6|As Randomized|Lack of Efficacy|0
5808333|NCT02786537|20046965|P5|As Randomized|Lack of Efficacy|0
5808334|NCT02786537|20046966|P4|As Randomized|Lack of Efficacy|1
5808335|NCT02786537|20046967|P3|As Randomized|Lack of Efficacy|0
5808336|NCT02786537|20046968|P2|As Randomized|Lack of Efficacy|0
5808337|NCT02786537|20046969|P1|As Randomized|Lack of Efficacy|0
5808338|NCT02786537|20046964|P6|As Randomized|Adverse Event|2
5808339|NCT02786537|20046965|P5|As Randomized|Adverse Event|6
5808340|NCT02786537|20046966|P4|As Randomized|Adverse Event|4
5808341|NCT02786537|20046967|P3|As Randomized|Adverse Event|0
5808342|NCT02786537|20046968|P2|As Randomized|Adverse Event|11
5808343|NCT02786537|20046969|P1|As Randomized|Adverse Event|0
5808344|NCT02786004|20047035|P2|Overall Study|Withdrawal by Subject|1
5808345|NCT02786004|20047036|P1|Overall Study|Withdrawal by Subject|0
5808346|NCT02785913|20047044|P1|Overall Study|Not protocol specified|1
5808347|NCT02785913|20047044|P1|Overall Study|Progression|18
5808348|NCT02785913|20047044|P1|Overall Study|Death|2
5808349|NCT02785913|20047044|P1|Overall Study|Adverse Event|5
5808350|NCT02785900|20047055|P2|Overall Study|Physician Decision|2
5808351|NCT02785900|20047056|P1|Overall Study|Physician Decision|3
5808352|NCT02785900|20047055|P2|Overall Study|Withdrawal by Subject|8
5808353|NCT02785900|20047056|P1|Overall Study|Withdrawal by Subject|4
5808354|NCT02785900|20047055|P2|Overall Study|Death|32
5808355|NCT02785900|20047056|P1|Overall Study|Death|46
5808356|NCT02785900|20047055|P2|Overall Study|Study Termination by Sponsor|81
5808357|NCT02785900|20047056|P1|Overall Study|Study Termination by Sponsor|64
5808358|NCT02785770|20047080|P4|Intervention Period 3 (1 Day)|Adverse Event|1
5808359|NCT02785770|20047081|P3|Intervention Period 3 (1 Day)|Adverse Event|0
5808360|NCT02785770|20047082|P2|Intervention Period 3 (1 Day)|Adverse Event|0
5808361|NCT02785770|20047083|P1|Intervention Period 3 (1 Day)|Adverse Event|0
5808362|NCT02785770|20047080|P4|Intervention Period 2 (1 Day)|Family related obligations|0
5808363|NCT02785770|20047081|P3|Intervention Period 2 (1 Day)|Family related obligations|1
5808364|NCT02785770|20047082|P2|Intervention Period 2 (1 Day)|Family related obligations|0
5808365|NCT02785770|20047083|P1|Intervention Period 2 (1 Day)|Family related obligations|0
5808366|NCT02785770|20047080|P4|Intervention Period 2 (1 Day)|Adverse Event|0
5808367|NCT02785770|20047081|P3|Intervention Period 2 (1 Day)|Adverse Event|0
5808368|NCT02785770|20047082|P2|Intervention Period 2 (1 Day)|Adverse Event|1
5808369|NCT02785770|20047083|P1|Intervention Period 2 (1 Day)|Adverse Event|0
5808370|NCT02785588|20047150|P1|Phase 1: Initial Feasibility Assessment|Withdrawal by Subject|1
5808371|NCT02785588|20047150|P1|Phase 1: Initial Feasibility Assessment|Breakdown of investigational device|1
5808372|NCT02785458|20047166|P2|3 Months|Completed Evaluation at 1 Month|89
5808373|NCT02785458|20047167|P1|3 Months|Completed Evaluation at 1 Month|100
5808374|NCT02785458|20047166|P2|3 Months|Lost to Follow-up|21
5808375|NCT02785458|20047167|P1|3 Months|Lost to Follow-up|25
5808376|NCT02785458|20047166|P2|3 Months|Withdrawal by Subject|1
5808377|NCT02785458|20047167|P1|3 Months|Withdrawal by Subject|3
5808378|NCT02785458|20047166|P2|1 Month|Partial Interview|4
5808379|NCT02785458|20047167|P1|1 Month|Partial Interview|0
5808380|NCT02785458|20047166|P2|1 Month|Completed Evaluation by Baseline|39
5808381|NCT02785458|20047167|P1|1 Month|Completed Evaluation by Baseline|42
5808382|NCT02785458|20047166|P2|1 Month|Deemed Ineligible|0
5808383|NCT02785458|20047167|P1|1 Month|Deemed Ineligible|1
5808384|NCT02785458|20047166|P2|1 Month|Lost to Follow-up|31
5808385|NCT02785458|20047167|P1|1 Month|Lost to Follow-up|38
5808386|NCT02785458|20047166|P2|1 Month|Withdrawal by Subject|1
5808387|NCT02785458|20047167|P1|1 Month|Withdrawal by Subject|2
5808388|NCT02784834|20047354|P1|Overall Study|Lack of Efficacy|1
5808389|NCT02784704|20047360|P2|Overall Study|Subject Non Compliance|0
5808390|NCT02784704|20047361|P1|Overall Study|Subject Non Compliance|2
5808391|NCT02784704|20047360|P2|Overall Study|Withdrawal by Subject|3
5808392|NCT02784704|20047361|P1|Overall Study|Withdrawal by Subject|1
5808393|NCT02784704|20047360|P2|Overall Study|Lost to Follow-up|4
5808394|NCT02784704|20047361|P1|Overall Study|Lost to Follow-up|6
5808395|NCT02784704|20047360|P2|Overall Study|Adverse Event|2
5808396|NCT02784704|20047361|P1|Overall Study|Adverse Event|4
5808397|NCT02784106|20047482|P4|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1
5808398|NCT02784106|20047483|P3|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1
5808399|NCT02784106|20047484|P2|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0
5808400|NCT02784106|20047485|P1|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0
5808401|NCT02784106|20047482|P4|Open-Label Extension Period (26 Weeks)|Adverse Event|1
5808402|NCT02784106|20047483|P3|Open-Label Extension Period (26 Weeks)|Adverse Event|2
5808403|NCT02784106|20047484|P2|Open-Label Extension Period (26 Weeks)|Adverse Event|0
5808404|NCT02784106|20047485|P1|Open-Label Extension Period (26 Weeks)|Adverse Event|0
5808405|NCT02784106|20047482|P4|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0
5808406|NCT02784106|20047483|P3|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0
5808407|NCT02784106|20047484|P2|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0
5808408|NCT02784106|20047485|P1|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1
5808409|NCT02784106|20047482|P4|Double-Blind Treatment Period (12 Weeks)|Other|0
5808410|NCT02784106|20047483|P3|Double-Blind Treatment Period (12 Weeks)|Other|0
5808411|NCT02784106|20047484|P2|Double-Blind Treatment Period (12 Weeks)|Other|0
5808412|NCT02784106|20047485|P1|Double-Blind Treatment Period (12 Weeks)|Other|2
5808413|NCT02784106|20047482|P4|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0
5808414|NCT02784106|20047483|P3|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0
5808415|NCT02784106|20047484|P2|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|1
5808416|NCT02784106|20047485|P1|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|2
5808417|NCT02784106|20047482|P4|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0
5808418|NCT02784106|20047483|P3|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0
5808419|NCT02784106|20047484|P2|Double-Blind Treatment Period (12 Weeks)|Adverse Event|5
5808420|NCT02784106|20047485|P1|Double-Blind Treatment Period (12 Weeks)|Adverse Event|3
5808421|NCT02783768|20047586|P2|Overall Study|Lost to Follow-up|0
5808422|NCT02783768|20047587|P1|Overall Study|Lost to Follow-up|1
5808423|NCT02783729|20047609|P4|Overall Study|Lost to Follow-up|0
5808424|NCT02783729|20047610|P3|Overall Study|Lost to Follow-up|1
5808425|NCT02783729|20047611|P2|Overall Study|Lost to Follow-up|1
5808426|NCT02783729|20047612|P1|Overall Study|Lost to Follow-up|2
5808427|NCT02783729|20047609|P4|Overall Study|Participant's choice|1
5808428|NCT02783729|20047610|P3|Overall Study|Participant's choice|2
5808429|NCT02783729|20047611|P2|Overall Study|Participant's choice|1
5808430|NCT02783729|20047612|P1|Overall Study|Participant's choice|2
5808431|NCT02783729|20047609|P4|Overall Study|Withdrawal by Subject|2
5808432|NCT02783729|20047610|P3|Overall Study|Withdrawal by Subject|1
5808433|NCT02783729|20047611|P2|Overall Study|Withdrawal by Subject|3
5808434|NCT02783729|20047612|P1|Overall Study|Withdrawal by Subject|2
5808435|NCT02783729|20047609|P4|Overall Study|Other|3
5808436|NCT02783729|20047610|P3|Overall Study|Other|2
5808437|NCT02783729|20047611|P2|Overall Study|Other|6
5808438|NCT02783729|20047612|P1|Overall Study|Other|1
5808439|NCT02783729|20047609|P4|Overall Study|Adverse Event|3
5808440|NCT02783729|20047610|P3|Overall Study|Adverse Event|2
5808441|NCT02783729|20047611|P2|Overall Study|Adverse Event|6
5808442|NCT02783729|20047612|P1|Overall Study|Adverse Event|2
5808443|NCT02783729|20047609|P4|Overall Study|Lack of Efficacy|0
5808444|NCT02783729|20047610|P3|Overall Study|Lack of Efficacy|0
5808445|NCT02783729|20047611|P2|Overall Study|Lack of Efficacy|0
5808446|NCT02783729|20047612|P1|Overall Study|Lack of Efficacy|1
5808447|NCT02783599|20047678|P1|Overall Study|Death|1
5808448|NCT02783599|20047678|P1|Overall Study|Physician Decision|2
5808449|NCT02783599|20047678|P1|Overall Study|Adverse Event|4
5808450|NCT02783599|20047678|P1|Overall Study|Surgical Resection|10
5808451|NCT02783599|20047678|P1|Overall Study|Progressive disease|23
5808452|NCT02783573|20047694|P3|Delayed-Start Period|Sponsor Decision|12
5808453|NCT02783573|20047695|P2|Delayed-Start Period|Sponsor Decision|17
5808454|NCT02783573|20047696|P1|Delayed-Start Period|Sponsor Decision|0
5808455|NCT02783573|20047694|P3|Placebo-Controlled Treatment Period|Sponsor Decision|492
5808456|NCT02783573|20047695|P2|Placebo-Controlled Treatment Period|Sponsor Decision|512
5808457|NCT02783573|20047696|P1|Placebo-Controlled Treatment Period|Sponsor Decision|494
5808458|NCT02783573|20047694|P3|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|9
5808459|NCT02783573|20047695|P2|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3
5808460|NCT02783573|20047696|P1|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3
5808461|NCT02783573|20047694|P3|Placebo-Controlled Treatment Period|Withdrawal by Subject|23
5808462|NCT02783573|20047695|P2|Placebo-Controlled Treatment Period|Withdrawal by Subject|20
5808463|NCT02783573|20047696|P1|Placebo-Controlled Treatment Period|Withdrawal by Subject|15
5808464|NCT02783573|20047694|P3|Placebo-Controlled Treatment Period|Protocol Violation|0
5808465|NCT02783573|20047695|P2|Placebo-Controlled Treatment Period|Protocol Violation|2
5808466|NCT02783573|20047696|P1|Placebo-Controlled Treatment Period|Protocol Violation|1
5808467|NCT02783573|20047694|P3|Placebo-Controlled Treatment Period|Physician Decision|3
5808468|NCT02783573|20047695|P2|Placebo-Controlled Treatment Period|Physician Decision|1
5808469|NCT02783573|20047696|P1|Placebo-Controlled Treatment Period|Physician Decision|3
5808470|NCT02783573|20047694|P3|Placebo-Controlled Treatment Period|Other-determined by Investigator|2
5808471|NCT02783573|20047695|P2|Placebo-Controlled Treatment Period|Other-determined by Investigator|1
5808472|NCT02783573|20047696|P1|Placebo-Controlled Treatment Period|Other-determined by Investigator|0
5808473|NCT02783573|20047694|P3|Placebo-Controlled Treatment Period|Non-Compliance|0
5808474|NCT02783573|20047695|P2|Placebo-Controlled Treatment Period|Non-Compliance|1
5808475|NCT02783573|20047696|P1|Placebo-Controlled Treatment Period|Non-Compliance|0
5808476|NCT02783573|20047694|P3|Placebo-Controlled Treatment Period|Lost to Follow-up|1
5808477|NCT02783573|20047695|P2|Placebo-Controlled Treatment Period|Lost to Follow-up|3
5808478|NCT02783573|20047696|P1|Placebo-Controlled Treatment Period|Lost to Follow-up|3
5808479|NCT02783573|20047694|P3|Placebo-Controlled Treatment Period|Lack of Efficacy|2
5808480|NCT02783573|20047695|P2|Placebo-Controlled Treatment Period|Lack of Efficacy|0
5808481|NCT02783573|20047696|P1|Placebo-Controlled Treatment Period|Lack of Efficacy|0
5808482|NCT02783573|20047694|P3|Placebo-Controlled Treatment Period|Death|3
5808483|NCT02783573|20047695|P2|Placebo-Controlled Treatment Period|Death|2
5808484|NCT02783573|20047696|P1|Placebo-Controlled Treatment Period|Death|4
5808485|NCT02783573|20047694|P3|Placebo-Controlled Treatment Period|Adverse Event|13
5808486|NCT02783573|20047695|P2|Placebo-Controlled Treatment Period|Adverse Event|17
5808487|NCT02783573|20047696|P1|Placebo-Controlled Treatment Period|Adverse Event|13
5808488|NCT02783170|20047761|P2|Overall Study|Randomized but not Vaccinated|0
5808489|NCT02783170|20047762|P1|Overall Study|Randomized but not Vaccinated|1
5808490|NCT02783066|20047803|P1|Overall Study|Withdrawal by Subject|13
5808491|NCT02782923|20047834|P1|Overall Study|Lost to Follow-up|15
5808496|NCT02782676|20047871|P2|Overall Study|Lost to Follow-up|1
5808497|NCT02782676|20047872|P1|Overall Study|Lost to Follow-up|0
5808498|NCT02782377|20047900|P1|Overall Study|Physician Decision|5
5808499|NCT02782325|20047935|P3|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|4
5808500|NCT02782325|20047936|P2|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0
5808501|NCT02782325|20047937|P1|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0
5808502|NCT02782325|20047935|P3|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|0
5808503|NCT02782325|20047936|P2|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|2
5808504|NCT02782325|20047937|P1|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|4
5808505|NCT02782169|20047965|P2|Overall Study|Lost to Follow-up|2
5808506|NCT02782169|20047966|P1|Overall Study|Lost to Follow-up|1
5808507|NCT02781844|20047984|P8|Treatment Period 1|Adverse Event|0
5808508|NCT02781844|20047985|P7|Treatment Period 1|Adverse Event|0
5808509|NCT02781844|20047986|P6|Treatment Period 1|Adverse Event|1
5808510|NCT02781844|20047987|P5|Treatment Period 1|Adverse Event|0
5808511|NCT02781844|20047988|P4|Treatment Period 1|Adverse Event|0
5808512|NCT02781844|20047989|P3|Treatment Period 1|Adverse Event|0
5808513|NCT02781844|20047990|P2|Treatment Period 1|Adverse Event|0
5808514|NCT02781844|20047991|P1|Treatment Period 1|Adverse Event|0
5808515|NCT02781818|20048124|P3|Overall Study|Lost to Follow-up|1
5808516|NCT02781818|20048125|P2|Overall Study|Lost to Follow-up|2
5808517|NCT02781818|20048126|P1|Overall Study|Lost to Follow-up|4
5808518|NCT02781558|20048192|P2|Overall Study|Adverse Event|0
5808519|NCT02781558|20048193|P1|Overall Study|Adverse Event|1
5808520|NCT02781558|20048192|P2|Overall Study|Lost to Follow-up|2
5808521|NCT02781558|20048193|P1|Overall Study|Lost to Follow-up|2
5808522|NCT02781324|20048280|P2|Overall Study|Physician Decision|2
5808523|NCT02781324|20048281|P1|Overall Study|Physician Decision|1
5808524|NCT02781324|20048280|P2|Overall Study|Withdrawal by Subject|0
5808525|NCT02781324|20048281|P1|Overall Study|Withdrawal by Subject|1
5808526|NCT02781311|20048310|P3|Overall Study|Non-Compliance with Study Drug|0
5808527|NCT02781311|20048311|P2|Overall Study|Non-Compliance with Study Drug|0
5808528|NCT02781311|20048312|P1|Overall Study|Non-Compliance with Study Drug|2
5808529|NCT02781311|20048310|P3|Overall Study|Lost to Follow-up|1
5808530|NCT02781311|20048311|P2|Overall Study|Lost to Follow-up|8
5808531|NCT02781311|20048312|P1|Overall Study|Lost to Follow-up|11
5808532|NCT02781311|20048310|P3|Overall Study|Withdrawal of Consent|2
5808533|NCT02781311|20048311|P2|Overall Study|Withdrawal of Consent|12
5808534|NCT02781311|20048312|P1|Overall Study|Withdrawal of Consent|11
5808535|NCT02781311|20048310|P3|Overall Study|Adverse Event|1
5808536|NCT02781311|20048311|P2|Overall Study|Adverse Event|6
5808537|NCT02781311|20048312|P1|Overall Study|Adverse Event|2
5808538|NCT02780856|20048339|P1|Overall Study|Lost to Follow-up|1
5808539|NCT02780700|20048358|P1|Overall Study|Progressive disease|1
5808540|NCT02780687|20048368|P2|Overall Study|progressive disease|6
5808541|NCT02780687|20048369|P1|Overall Study|progressive disease|29
5808542|NCT02780687|20048368|P2|Overall Study|Switched to commercial program (in CTP)|0
5808543|NCT02780687|20048369|P1|Overall Study|Switched to commercial program (in CTP)|2
5808544|NCT02780687|20048368|P2|Overall Study|Withdrawal by Subject|1
5808545|NCT02780687|20048369|P1|Overall Study|Withdrawal by Subject|2
5808546|NCT02780687|20048368|P2|Overall Study|Adverse Event|1
5808547|NCT02780687|20048369|P1|Overall Study|Adverse Event|1
5808548|NCT02780388|20048441|P5|Overall Study|Withdrawal by Subject|0
5808549|NCT02780388|20048442|P4|Overall Study|Withdrawal by Subject|0
5808550|NCT02780388|20048443|P3|Overall Study|Withdrawal by Subject|0
5808551|NCT02780388|20048444|P2|Overall Study|Withdrawal by Subject|1
5808552|NCT02780388|20048445|P1|Overall Study|Withdrawal by Subject|1
5808553|NCT02780388|20048441|P5|Overall Study|Lost to Follow-up|0
5808554|NCT02780388|20048442|P4|Overall Study|Lost to Follow-up|0
5808555|NCT02780388|20048443|P3|Overall Study|Lost to Follow-up|0
5808556|NCT02780388|20048444|P2|Overall Study|Lost to Follow-up|1
5808557|NCT02780388|20048445|P1|Overall Study|Lost to Follow-up|0
5808558|NCT02780167|20048511|P5|Overall Study|Other|2
5808559|NCT02780167|20048512|P4|Overall Study|Other|1
5808560|NCT02780167|20048513|P3|Overall Study|Other|3
5808561|NCT02780167|20048514|P2|Overall Study|Other|0
5808562|NCT02780167|20048515|P1|Overall Study|Other|0
5808563|NCT02780167|20048511|P5|Overall Study|Withdrawal by Subject|4
5808564|NCT02780167|20048512|P4|Overall Study|Withdrawal by Subject|3
5808565|NCT02780167|20048513|P3|Overall Study|Withdrawal by Subject|4
5808566|NCT02780167|20048514|P2|Overall Study|Withdrawal by Subject|4
5808567|NCT02780167|20048515|P1|Overall Study|Withdrawal by Subject|6
5808568|NCT02780167|20048511|P5|Overall Study|Protocol Violation|2
5808569|NCT02780167|20048512|P4|Overall Study|Protocol Violation|1
5808570|NCT02780167|20048513|P3|Overall Study|Protocol Violation|1
5808571|NCT02780167|20048514|P2|Overall Study|Protocol Violation|5
5808572|NCT02780167|20048515|P1|Overall Study|Protocol Violation|5
5808573|NCT02780167|20048511|P5|Overall Study|No longer meets eligibility criteria|1
5808574|NCT02780167|20048512|P4|Overall Study|No longer meets eligibility criteria|1
5808575|NCT02780167|20048513|P3|Overall Study|No longer meets eligibility criteria|0
5808576|NCT02780167|20048514|P2|Overall Study|No longer meets eligibility criteria|0
5808577|NCT02780167|20048515|P1|Overall Study|No longer meets eligibility criteria|0
5808578|NCT02780167|20048511|P5|Overall Study|Does not meet entrance criteria|0
5808579|NCT02780167|20048512|P4|Overall Study|Does not meet entrance criteria|0
5808580|NCT02780167|20048513|P3|Overall Study|Does not meet entrance criteria|1
5808581|NCT02780167|20048514|P2|Overall Study|Does not meet entrance criteria|0
5808582|NCT02780167|20048515|P1|Overall Study|Does not meet entrance criteria|0
5808583|NCT02780167|20048511|P5|Overall Study|Lost to Follow-up|0
5808584|NCT02780167|20048512|P4|Overall Study|Lost to Follow-up|0
5808585|NCT02780167|20048513|P3|Overall Study|Lost to Follow-up|1
5808586|NCT02780167|20048514|P2|Overall Study|Lost to Follow-up|0
5808587|NCT02780167|20048515|P1|Overall Study|Lost to Follow-up|2
5808588|NCT02780167|20048511|P5|Overall Study|Lack of Efficacy|0
5808589|NCT02780167|20048512|P4|Overall Study|Lack of Efficacy|1
5808590|NCT02780167|20048513|P3|Overall Study|Lack of Efficacy|6
5808591|NCT02780167|20048514|P2|Overall Study|Lack of Efficacy|5
5808592|NCT02780167|20048515|P1|Overall Study|Lack of Efficacy|6
5808593|NCT02780167|20048511|P5|Overall Study|Adverse Event|8
5808594|NCT02780167|20048512|P4|Overall Study|Adverse Event|12
5808595|NCT02780167|20048513|P3|Overall Study|Adverse Event|8
5808596|NCT02780167|20048514|P2|Overall Study|Adverse Event|8
5808597|NCT02780167|20048515|P1|Overall Study|Adverse Event|9
5808598|NCT02780115|20048652|P5|Overall Study|Adverse Event|1
5808599|NCT02780115|20048653|P4|Overall Study|Adverse Event|1
5808600|NCT02780115|20048654|P3|Overall Study|Adverse Event|0
5808601|NCT02780115|20048655|P2|Overall Study|Adverse Event|0
5808602|NCT02780115|20048656|P1|Overall Study|Adverse Event|0
5808603|NCT02780115|20048652|P5|Overall Study|Withdrawal by Subject|0
5808604|NCT02780115|20048653|P4|Overall Study|Withdrawal by Subject|0
5808605|NCT02780115|20048654|P3|Overall Study|Withdrawal by Subject|1
5808606|NCT02780115|20048655|P2|Overall Study|Withdrawal by Subject|1
5808607|NCT02780115|20048656|P1|Overall Study|Withdrawal by Subject|0
5808608|NCT02779075|20048726|P2|Overall Study|IV lost during 2nd study|0
5808609|NCT02779075|20048727|P1|Overall Study|IV lost during 2nd study|1
5808610|NCT02779075|20048726|P2|Overall Study|Withdrawal by Subject|3
5808611|NCT02779075|20048727|P1|Overall Study|Withdrawal by Subject|1
5808612|NCT02778867|20048790|P4|Phase 2|Adverse Event|1
5808613|NCT02778867|20048791|P3|Phase 2|Adverse Event|0
5808614|NCT02778867|20048792|P2|Phase 2|Adverse Event|0
5808615|NCT02778867|20048793|P1|Phase 2|Adverse Event|0
5808616|NCT02778867|20048790|P4|Phase 2|Physician Decision|1
5808617|NCT02778867|20048791|P3|Phase 2|Physician Decision|0
5808618|NCT02778867|20048792|P2|Phase 2|Physician Decision|0
5808619|NCT02778867|20048793|P1|Phase 2|Physician Decision|0
5808620|NCT02778867|20048790|P4|Phase 2|Withdrawal by Subject|0
5808621|NCT02778867|20048791|P3|Phase 2|Withdrawal by Subject|1
5808622|NCT02778867|20048792|P2|Phase 2|Withdrawal by Subject|0
5808623|NCT02778867|20048793|P1|Phase 2|Withdrawal by Subject|0
5808624|NCT02778867|20048790|P4|Phase 1|Withdrawal by Subject|0
5808625|NCT02778867|20048791|P3|Phase 1|Withdrawal by Subject|0
5808626|NCT02778867|20048792|P2|Phase 1|Withdrawal by Subject|3
5808627|NCT02778867|20048793|P1|Phase 1|Withdrawal by Subject|2
5808628|NCT02778555|20048814|P3|Overall Study|Withdrawal by Subject|107
5808629|NCT02778555|20048815|P2|Overall Study|Withdrawal by Subject|32
5808630|NCT02778555|20048816|P1|Overall Study|Withdrawal by Subject|55
5808631|NCT02778204|20048828|P4|Overall Study|Eligibility Violation|1
5808632|NCT02778204|20048829|P3|Overall Study|Eligibility Violation|0
5808633|NCT02778204|20048830|P2|Overall Study|Eligibility Violation|0
5808634|NCT02778204|20048831|P1|Overall Study|Eligibility Violation|0
5808635|NCT02778204|20048828|P4|Overall Study|Protocol Violation|0
5808636|NCT02778204|20048829|P3|Overall Study|Protocol Violation|1
5808637|NCT02778204|20048830|P2|Overall Study|Protocol Violation|0
5808638|NCT02778204|20048831|P1|Overall Study|Protocol Violation|0
5808639|NCT02778204|20048828|P4|Overall Study|Lost to Follow-up|1
5808640|NCT02778204|20048829|P3|Overall Study|Lost to Follow-up|2
5808641|NCT02778204|20048830|P2|Overall Study|Lost to Follow-up|0
5808642|NCT02778204|20048831|P1|Overall Study|Lost to Follow-up|1
5808643|NCT02778204|20048828|P4|Overall Study|Withdrawal by Subject|2
5808644|NCT02778204|20048829|P3|Overall Study|Withdrawal by Subject|1
5808645|NCT02778204|20048830|P2|Overall Study|Withdrawal by Subject|0
5808646|NCT02778204|20048831|P1|Overall Study|Withdrawal by Subject|0
5808647|NCT02778204|20048828|P4|Overall Study|Adverse Event|0
5808648|NCT02778204|20048829|P3|Overall Study|Adverse Event|0
5808649|NCT02778204|20048830|P2|Overall Study|Adverse Event|0
5808650|NCT02778204|20048831|P1|Overall Study|Adverse Event|1
5808651|NCT02778100|20048923|P2|Period 1 (Common Cold)|Withdrawal by Subject|0
5808652|NCT02778100|20048924|P1|Period 1 (Common Cold)|Withdrawal by Subject|1
5808653|NCT02778074|20048955|P2|Overall Study|Lost to Follow-up|10
5808654|NCT02778074|20048956|P1|Overall Study|Lost to Follow-up|7
5808655|NCT02777918|20048988|P2|Overall Study|Withdrawal by Subject|1
5808656|NCT02777918|20048989|P1|Overall Study|Withdrawal by Subject|1
5808657|NCT02777918|20048988|P2|Overall Study|Too busy / stressed|1
5808658|NCT02777918|20048989|P1|Overall Study|Too busy / stressed|1
5808659|NCT02777918|20048988|P2|Overall Study|Medical reasons|2
5808660|NCT02777918|20048989|P1|Overall Study|Medical reasons|1
5808661|NCT02777827|20049007|P6|Washout Between Periods 3 and 4|Protocol Violation|0
5808662|NCT02777827|20049008|P5|Washout Between Periods 3 and 4|Protocol Violation|0
5808663|NCT02777827|20049009|P4|Washout Between Periods 3 and 4|Protocol Violation|0
5808664|NCT02777827|20049010|P3|Washout Between Periods 3 and 4|Protocol Violation|1
5808665|NCT02777827|20049011|P2|Washout Between Periods 3 and 4|Protocol Violation|0
5808666|NCT02777827|20049012|P1|Washout Between Periods 3 and 4|Protocol Violation|0
5808667|NCT02777242|20049215|P1|Overall Study|Withdrawal by Subject|1
5808668|NCT02777242|20049215|P1|Overall Study|Sponsor's request|1
5808669|NCT02777242|20049215|P1|Overall Study|Multiple|1
5808670|NCT02777242|20049215|P1|Overall Study|Lost to Follow-up|1
5808671|NCT02777242|20049215|P1|Overall Study|Other|2
5808672|NCT02777125|20049221|P2|Overall Study|Protocol Violation|12
5808673|NCT02777125|20049222|P1|Overall Study|Protocol Violation|8
5808674|NCT02777125|20049221|P2|Overall Study|Assent form violation|23
5808675|NCT02777125|20049222|P1|Overall Study|Assent form violation|21
5808676|NCT02777125|20049221|P2|Overall Study|Consent form violation|12
5808677|NCT02777125|20049222|P1|Overall Study|Consent form violation|14
5808678|NCT02777086|20049238|P2|Overall Study|Lost to Follow-up|99
5808679|NCT02777086|20049239|P1|Overall Study|Lost to Follow-up|96
5808680|NCT02776683|20049282|P2|Post-switch Period|Other than listed|15
5808681|NCT02776683|20049283|P1|Post-switch Period|Other than listed|0
5808682|NCT02776683|20049282|P2|Post-switch Period|Progressive disease|20
5808683|NCT02776683|20049283|P1|Post-switch Period|Progressive disease|0
5808684|NCT02776683|20049282|P2|Post-switch Period|Physician Decision|3
5808685|NCT02776683|20049283|P1|Post-switch Period|Physician Decision|0
5808686|NCT02776683|20049282|P2|Post-switch Period|Withdrawal by Subject|2
5808687|NCT02776683|20049283|P1|Post-switch Period|Withdrawal by Subject|0
5808688|NCT02776683|20049282|P2|Post-switch Period|Adverse Event|3
5808689|NCT02776683|20049283|P1|Post-switch Period|Adverse Event|0
5808690|NCT02776683|20049282|P2|Pre-switch Period|Other than listed|0
5808691|NCT02776683|20049283|P1|Pre-switch Period|Other than listed|3
5808692|NCT02776683|20049282|P2|Pre-switch Period|Progressive disease|0
5808693|NCT02776683|20049283|P1|Pre-switch Period|Progressive disease|39
5808694|NCT02776683|20049282|P2|Pre-switch Period|Physician Decision|0
5808695|NCT02776683|20049283|P1|Pre-switch Period|Physician Decision|7
5808696|NCT02776683|20049282|P2|Pre-switch Period|Withdrawal by Subject|0
5808697|NCT02776683|20049283|P1|Pre-switch Period|Withdrawal by Subject|9
5808698|NCT02776683|20049282|P2|Pre-switch Period|Adverse Event|0
5808699|NCT02776683|20049283|P1|Pre-switch Period|Adverse Event|21
5808700|NCT02776683|20049282|P2|Pre-switch Period|Protocol Violation|0
5808701|NCT02776683|20049283|P1|Pre-switch Period|Protocol Violation|1
5808702|NCT02776670|20049294|P2|Overall Study|Other - Reason not given|1
5808703|NCT02776670|20049295|P1|Overall Study|Other - Reason not given|0
5808704|NCT02776670|20049294|P2|Overall Study|Withdrawal by Subject|1
5808705|NCT02776670|20049295|P1|Overall Study|Withdrawal by Subject|0
5808706|NCT02776670|20049294|P2|Overall Study|Protocol Violation|2
5808707|NCT02776670|20049295|P1|Overall Study|Protocol Violation|0
5808708|NCT02776670|20049294|P2|Overall Study|Adverse Event|2
5808709|NCT02776670|20049295|P1|Overall Study|Adverse Event|0
5808710|NCT02776553|20049352|P2|Overall Study|Protocol Violation|1
5808711|NCT02776553|20049353|P1|Overall Study|Protocol Violation|0
5808712|NCT02776553|20049352|P2|Overall Study|had other surgery|0
5808713|NCT02776553|20049353|P1|Overall Study|had other surgery|1
5808714|NCT02776553|20049352|P2|Overall Study|got liver transplant|2
5808715|NCT02776553|20049353|P1|Overall Study|got liver transplant|1
5808716|NCT02776553|20049352|P2|Overall Study|Lost to Follow-up|0
5808717|NCT02776553|20049353|P1|Overall Study|Lost to Follow-up|1
5808718|NCT02776033|20049366|P3|Overall Study|Adverse Event|0
5808719|NCT02776033|20049367|P2|Overall Study|Adverse Event|2
5808720|NCT02776033|20049368|P1|Overall Study|Adverse Event|1
5808721|NCT02776033|20049366|P3|Overall Study|Lost to Follow-up|0
5808722|NCT02776033|20049367|P2|Overall Study|Lost to Follow-up|0
5808723|NCT02776033|20049368|P1|Overall Study|Lost to Follow-up|1
5808724|NCT02776033|20049366|P3|Overall Study|Physician Decision|0
5808725|NCT02776033|20049367|P2|Overall Study|Physician Decision|0
5808726|NCT02776033|20049368|P1|Overall Study|Physician Decision|2
5808727|NCT02776033|20049366|P3|Overall Study|Withdrawal by Subject|2
5808728|NCT02776033|20049367|P2|Overall Study|Withdrawal by Subject|0
5808729|NCT02776033|20049368|P1|Overall Study|Withdrawal by Subject|0
5808730|NCT02775916|20049433|P2|Overall Study|Subject/Guardian Decision|0
5808731|NCT02775916|20049434|P1|Overall Study|Subject/Guardian Decision|2
5808732|NCT02775916|20049433|P2|Overall Study|Adverse Event|0
5808733|NCT02775916|20049434|P1|Overall Study|Adverse Event|1
5808734|NCT02775903|20049456|P4|Overall Study|Other-Miscellaneous|5
5808735|NCT02775903|20049457|P3|Overall Study|Other-Miscellaneous|4
5808736|NCT02775903|20049458|P2|Overall Study|Other-Miscellaneous|3
5808737|NCT02775903|20049459|P1|Overall Study|Other-Miscellaneous|4
5808738|NCT02775903|20049456|P4|Overall Study|Lost to Follow-up|1
5808739|NCT02775903|20049457|P3|Overall Study|Lost to Follow-up|1
5808740|NCT02775903|20049458|P2|Overall Study|Lost to Follow-up|0
5808741|NCT02775903|20049459|P1|Overall Study|Lost to Follow-up|0
5808742|NCT02775903|20049456|P4|Overall Study|Adverse Event|1
5808743|NCT02775903|20049457|P3|Overall Study|Adverse Event|1
5808744|NCT02775903|20049458|P2|Overall Study|Adverse Event|0
5808745|NCT02775903|20049459|P1|Overall Study|Adverse Event|0
5808746|NCT02775903|20049456|P4|Overall Study|Withdrawal by Subject|4
5808747|NCT02775903|20049457|P3|Overall Study|Withdrawal by Subject|5
5808748|NCT02775903|20049458|P2|Overall Study|Withdrawal by Subject|5
5808749|NCT02775903|20049459|P1|Overall Study|Withdrawal by Subject|5
5808750|NCT02775903|20049456|P4|Overall Study|Death|35
5808751|NCT02775903|20049457|P3|Overall Study|Death|38
5808752|NCT02775903|20049458|P2|Overall Study|Death|18
5808753|NCT02775903|20049459|P1|Overall Study|Death|19
5808754|NCT02775903|20049456|P4|Overall Study|Ongoing|19
5808755|NCT02775903|20049457|P3|Overall Study|Ongoing|15
5808756|NCT02775903|20049458|P2|Overall Study|Ongoing|15
5808757|NCT02775903|20049459|P1|Overall Study|Ongoing|14
5808758|NCT02775864|20049511|P4|Overall Study|Medicaid eligibility discontinued|890
5808759|NCT02775864|20049512|P3|Overall Study|Medicaid eligibility discontinued|720
5808760|NCT02775864|20049513|P2|Overall Study|Medicaid eligibility discontinued|2019
5808761|NCT02775864|20049514|P1|Overall Study|Medicaid eligibility discontinued|1478
5808762|NCT02775864|20049511|P4|Overall Study|Data ended end of 2010|1194
5808763|NCT02775864|20049512|P3|Overall Study|Data ended end of 2010|1140
5808764|NCT02775864|20049513|P2|Overall Study|Data ended end of 2010|2880
5808765|NCT02775864|20049514|P1|Overall Study|Data ended end of 2010|1764
5808766|NCT02775435|20049547|P2|Overall Study|Not Treated|1
5808767|NCT02775435|20049548|P1|Overall Study|Not Treated|0
5808768|NCT02775435|20049547|P2|Overall Study|Ongoing in Study|72
5808769|NCT02775435|20049548|P1|Overall Study|Ongoing in Study|121
5808770|NCT02775435|20049547|P2|Overall Study|Clinical Progression|26
5808771|NCT02775435|20049548|P1|Overall Study|Clinical Progression|13
5808772|NCT02775435|20049547|P2|Overall Study|Progressive Disease|140
5808773|NCT02775435|20049548|P1|Overall Study|Progressive Disease|86
5808774|NCT02775435|20049547|P2|Overall Study|Withdrawal by Subject|9
5808775|NCT02775435|20049548|P1|Overall Study|Withdrawal by Subject|5
5808776|NCT02775435|20049547|P2|Overall Study|Physician Decision|6
5808777|NCT02775435|20049548|P1|Overall Study|Physician Decision|5
5808778|NCT02775435|20049547|P2|Overall Study|Lost to Follow-up|2
5808779|NCT02775435|20049548|P1|Overall Study|Lost to Follow-up|0
5808780|NCT02775435|20049547|P2|Overall Study|Adverse Event|25
5808781|NCT02775435|20049548|P1|Overall Study|Adverse Event|48
5808782|NCT02775344|20049566|P2|Overall Study|No ovarian cyst identified|2
5808783|NCT02775344|20049567|P1|Overall Study|No ovarian cyst identified|3
5808784|NCT02774681|20049700|P1|Follow-Up for 3 Years|Withdrawal by Subject|1
5808785|NCT02774681|20049700|P1|Follow-Up for 3 Years|Death|11
5808786|NCT02774681|20049700|P1|Treatment on Study|Progressive Disease|7
5808787|NCT02774278|20049764|P1|Overall Study|Protocol Violation|2
5808788|NCT02774278|20049764|P1|Overall Study|Withdrawal by Subject|3
5808789|NCT02774278|20049764|P1|Overall Study|Administrative reasons|6
5808790|NCT02774278|20049764|P1|Overall Study|Refused treatment/did not cooperate|9
5808791|NCT02774278|20049764|P1|Overall Study|Adverse event/intercurrent illness|16
5808792|NCT02774278|20049764|P1|Overall Study|Death|29
5808793|NCT02774278|20049764|P1|Overall Study|Lack of Efficacy|199
5808794|NCT02773537|20049939|P3|Overall Study|Lost to Follow-up|4
5808795|NCT02773537|20049940|P2|Overall Study|Lost to Follow-up|1
5808796|NCT02773537|20049941|P1|Overall Study|Lost to Follow-up|0
5808797|NCT02773446|20049976|P6|First Admission|Lost to Follow-up|0
5808798|NCT02773446|20049977|P5|First Admission|Lost to Follow-up|0
5808799|NCT02773446|20049978|P4|First Admission|Lost to Follow-up|0
5808800|NCT02773446|20049979|P3|First Admission|Lost to Follow-up|0
5808801|NCT02773446|20049980|P2|First Admission|Lost to Follow-up|0
5808802|NCT02773446|20049981|P1|First Admission|Lost to Follow-up|1
5808803|NCT02773446|20049976|P6|First Admission|Withdrawal by Subject|0
5808804|NCT02773446|20049977|P5|First Admission|Withdrawal by Subject|0
5808805|NCT02773446|20049978|P4|First Admission|Withdrawal by Subject|1
5808806|NCT02773446|20049979|P3|First Admission|Withdrawal by Subject|0
5808807|NCT02773446|20049980|P2|First Admission|Withdrawal by Subject|0
5808808|NCT02773446|20049981|P1|First Admission|Withdrawal by Subject|0
5808809|NCT02773368|20050022|P2|Overall Study|Missing|1
5808810|NCT02773368|20050023|P1|Overall Study|Missing|0
5808811|NCT02773368|20050022|P2|Overall Study|Unclassified|1
5808812|NCT02773368|20050023|P1|Overall Study|Unclassified|1
5808813|NCT02773368|20050022|P2|Overall Study|Withdrawal by Subject|1
5808814|NCT02773368|20050023|P1|Overall Study|Withdrawal by Subject|5
5808815|NCT02773368|20050022|P2|Overall Study|Lost to Follow-up|1
5808816|NCT02773368|20050023|P1|Overall Study|Lost to Follow-up|4
5808817|NCT02772809|20050093|P1|Overall Study|not completed some tasks|6
5808818|NCT02772757|20050105|P3|Overall Study|Physician Decision|3
5808819|NCT02772757|20050106|P2|Overall Study|Physician Decision|3
5808820|NCT02772757|20050107|P1|Overall Study|Physician Decision|0
5808821|NCT02772757|20050105|P3|Overall Study|Protocol Violation|1
5808822|NCT02772757|20050106|P2|Overall Study|Protocol Violation|0
5808823|NCT02772757|20050107|P1|Overall Study|Protocol Violation|0
5808824|NCT02772757|20050105|P3|Overall Study|Withdrawal by Subject|1
5808825|NCT02772757|20050106|P2|Overall Study|Withdrawal by Subject|0
5808826|NCT02772757|20050107|P1|Overall Study|Withdrawal by Subject|1
5808827|NCT02771522|20050190|P1|Overall Study|No white spot lesions|3
5808828|NCT02771522|20050190|P1|Overall Study|Withdrawal by Subject|2
5808829|NCT02771522|20050190|P1|Overall Study|Lost to Follow-up|3
5808830|NCT02771366|20050201|P2|Period 2 (Crossover)|Withdrawal by Subject|0
5808831|NCT02771366|20050202|P1|Period 2 (Crossover)|Withdrawal by Subject|2
5808832|NCT02771366|20050201|P2|Period 1|Withdrawal by Subject|2
5808833|NCT02771366|20050202|P1|Period 1|Withdrawal by Subject|0
5808834|NCT02771275|20050228|P1|Overall Study|On Study|11
5808835|NCT02771275|20050228|P1|Overall Study|Reoperation|2
5808836|NCT02771210|20050238|P2|Period 2|Withdrawal of informed consent|2
5808837|NCT02771210|20050239|P1|Period 2|Withdrawal of informed consent|0
5808838|NCT02771210|20050238|P2|Period 2|Withdrawal by Subject|0
5808839|NCT02771210|20050239|P1|Period 2|Withdrawal by Subject|1
5808840|NCT02771210|20050238|P2|Period 2|Lack of Efficacy|1
5808841|NCT02771210|20050239|P1|Period 2|Lack of Efficacy|0
5808842|NCT02771210|20050238|P2|Period 2|Adverse Event|0
5808843|NCT02771210|20050239|P1|Period 2|Adverse Event|1
5808844|NCT02771210|20050238|P2|Period 1|Withdrawal of informed consent|5
5808845|NCT02771210|20050239|P1|Period 1|Withdrawal of informed consent|1
5808846|NCT02771210|20050238|P2|Period 1|Withdrawal by Subject|3
5808847|NCT02771210|20050239|P1|Period 1|Withdrawal by Subject|0
5808848|NCT02771210|20050238|P2|Period 1|Physician Decision|1
5808849|NCT02771210|20050239|P1|Period 1|Physician Decision|0
5808850|NCT02771210|20050238|P2|Period 1|Lost to Follow-up|0
5808851|NCT02771210|20050239|P1|Period 1|Lost to Follow-up|2
5808852|NCT02771210|20050238|P2|Period 1|Lack of Efficacy|6
5808853|NCT02771210|20050239|P1|Period 1|Lack of Efficacy|3
5808854|NCT02771210|20050238|P2|Period 1|Adverse Event|3
5808855|NCT02771210|20050239|P1|Period 1|Adverse Event|5
5808856|NCT02771145|20050265|P1|Overall Study|Lost to Follow-up|1
5808857|NCT02771145|20050265|P1|Overall Study|Adverse Event|3
5808858|NCT02770612|20050399|P1|Overall Study|Met exclusion criteria (postop LOS>7d)|1
5808859|NCT02770547|20050405|P2|Overall Study|Adverse Event|1
5808860|NCT02770547|20050406|P1|Overall Study|Adverse Event|0
5808861|NCT02770547|20050405|P2|Overall Study|Patient non-compliant|0
5808862|NCT02770547|20050406|P1|Overall Study|Patient non-compliant|1
5808863|NCT02770248|20050479|P2|Overall Study|Randomized in error, prior to treatment|1
5808864|NCT02770248|20050480|P1|Overall Study|Randomized in error, prior to treatment|0
5808865|NCT02770248|20050479|P2|Overall Study|Adverse Event|1
5808866|NCT02770248|20050480|P1|Overall Study|Adverse Event|0
5808867|NCT02769858|20050498|P1|Overall Study|Withdrawal by Subject|2
5808868|NCT02769624|20050509|P2|Overall Study|Lost to Follow-up|1
5808869|NCT02769624|20050510|P1|Overall Study|Lost to Follow-up|0
5808870|NCT02769312|20050539|P2|Follow-up|Lost to Follow-up|1
5808871|NCT02769312|20050540|P1|Follow-up|Lost to Follow-up|1
5808872|NCT02769312|20050539|P2|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|1
5808873|NCT02769312|20050540|P1|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|0
5808874|NCT02769312|20050539|P2|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|0
5808875|NCT02769312|20050540|P1|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|1
5808876|NCT02769312|20050539|P2|Double-Blind (0-2 Weeks)|Adverse Event|0
5808877|NCT02769312|20050540|P1|Double-Blind (0-2 Weeks)|Adverse Event|1
5808878|NCT02769312|20050539|P2|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1
5808879|NCT02769312|20050540|P1|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1
5808880|NCT02769247|20050557|P4|Overall Study|Physician Decision|0
5808881|NCT02769247|20050558|P3|Overall Study|Physician Decision|0
5808882|NCT02769247|20050559|P2|Overall Study|Physician Decision|0
5808883|NCT02769247|20050560|P1|Overall Study|Physician Decision|1
5808884|NCT02769247|20050557|P4|Overall Study|Protocol Violation|0
5808885|NCT02769247|20050558|P3|Overall Study|Protocol Violation|1
5808886|NCT02769247|20050559|P2|Overall Study|Protocol Violation|0
5808887|NCT02769247|20050560|P1|Overall Study|Protocol Violation|0
5808888|NCT02769247|20050557|P4|Overall Study|Withdrawal by Subject|1
5808889|NCT02769247|20050558|P3|Overall Study|Withdrawal by Subject|0
5808890|NCT02769247|20050559|P2|Overall Study|Withdrawal by Subject|0
5808891|NCT02769247|20050560|P1|Overall Study|Withdrawal by Subject|1
5808892|NCT02769065|20050628|P30|Overall Study|Pre-treatment Event/Adverse Event|0
5808893|NCT02769065|20050629|P29|Overall Study|Pre-treatment Event/Adverse Event|0
5808894|NCT02769065|20050630|P28|Overall Study|Pre-treatment Event/Adverse Event|0
5808895|NCT02769065|20050631|P27|Overall Study|Pre-treatment Event/Adverse Event|0
5808896|NCT02769065|20050632|P26|Overall Study|Pre-treatment Event/Adverse Event|0
5808897|NCT02769065|20050633|P25|Overall Study|Pre-treatment Event/Adverse Event|0
5808898|NCT02769065|20050634|P24|Overall Study|Pre-treatment Event/Adverse Event|0
5808899|NCT02769065|20050635|P23|Overall Study|Pre-treatment Event/Adverse Event|0
5808900|NCT02769065|20050636|P22|Overall Study|Pre-treatment Event/Adverse Event|0
5808901|NCT02769065|20050637|P21|Overall Study|Pre-treatment Event/Adverse Event|0
5808902|NCT02769065|20050638|P20|Overall Study|Pre-treatment Event/Adverse Event|0
5808903|NCT02769065|20050639|P19|Overall Study|Pre-treatment Event/Adverse Event|0
5808904|NCT02769065|20050640|P18|Overall Study|Pre-treatment Event/Adverse Event|0
5808905|NCT02769065|20050641|P17|Overall Study|Pre-treatment Event/Adverse Event|0
5808906|NCT02769065|20050642|P16|Overall Study|Pre-treatment Event/Adverse Event|0
5808907|NCT02769065|20050643|P15|Overall Study|Pre-treatment Event/Adverse Event|0
5808908|NCT02769065|20050644|P14|Overall Study|Pre-treatment Event/Adverse Event|0
5808909|NCT02769065|20050645|P13|Overall Study|Pre-treatment Event/Adverse Event|0
5808910|NCT02769065|20050646|P12|Overall Study|Pre-treatment Event/Adverse Event|0
5808911|NCT02769065|20050647|P11|Overall Study|Pre-treatment Event/Adverse Event|1
5808912|NCT02769065|20050648|P10|Overall Study|Pre-treatment Event/Adverse Event|0
5808913|NCT02769065|20050649|P9|Overall Study|Pre-treatment Event/Adverse Event|0
5808914|NCT02769065|20050650|P8|Overall Study|Pre-treatment Event/Adverse Event|0
5808915|NCT02769065|20050651|P7|Overall Study|Pre-treatment Event/Adverse Event|0
5808916|NCT02769065|20050652|P6|Overall Study|Pre-treatment Event/Adverse Event|0
5808917|NCT02769065|20050653|P5|Overall Study|Pre-treatment Event/Adverse Event|0
5808918|NCT02769065|20050654|P4|Overall Study|Pre-treatment Event/Adverse Event|0
5808919|NCT02769065|20050655|P3|Overall Study|Pre-treatment Event/Adverse Event|0
5808920|NCT02769065|20050656|P2|Overall Study|Pre-treatment Event/Adverse Event|0
5808921|NCT02769065|20050657|P1|Overall Study|Pre-treatment Event/Adverse Event|0
5808922|NCT02769065|20050628|P30|Overall Study|Reason Not Specified|0
5808923|NCT02769065|20050629|P29|Overall Study|Reason Not Specified|0
5808924|NCT02769065|20050630|P28|Overall Study|Reason Not Specified|0
5808925|NCT02769065|20050631|P27|Overall Study|Reason Not Specified|0
5808926|NCT02769065|20050632|P26|Overall Study|Reason Not Specified|0
5808927|NCT02769065|20050633|P25|Overall Study|Reason Not Specified|0
5808928|NCT02769065|20050634|P24|Overall Study|Reason Not Specified|0
5808929|NCT02769065|20050635|P23|Overall Study|Reason Not Specified|0
5808930|NCT02769065|20050636|P22|Overall Study|Reason Not Specified|0
5808931|NCT02769065|20050637|P21|Overall Study|Reason Not Specified|0
5808932|NCT02769065|20050638|P20|Overall Study|Reason Not Specified|0
5808933|NCT02769065|20050639|P19|Overall Study|Reason Not Specified|0
5808934|NCT02769065|20050640|P18|Overall Study|Reason Not Specified|0
5808935|NCT02769065|20050641|P17|Overall Study|Reason Not Specified|0
5808936|NCT02769065|20050642|P16|Overall Study|Reason Not Specified|0
5808937|NCT02769065|20050643|P15|Overall Study|Reason Not Specified|0
5808938|NCT02769065|20050644|P14|Overall Study|Reason Not Specified|0
5808939|NCT02769065|20050645|P13|Overall Study|Reason Not Specified|0
5808940|NCT02769065|20050646|P12|Overall Study|Reason Not Specified|0
5808941|NCT02769065|20050647|P11|Overall Study|Reason Not Specified|0
5808942|NCT02769065|20050648|P10|Overall Study|Reason Not Specified|0
5808943|NCT02769065|20050649|P9|Overall Study|Reason Not Specified|0
5808944|NCT02769065|20050650|P8|Overall Study|Reason Not Specified|0
5808945|NCT02769065|20050651|P7|Overall Study|Reason Not Specified|1
5808946|NCT02769065|20050652|P6|Overall Study|Reason Not Specified|0
5808947|NCT02769065|20050653|P5|Overall Study|Reason Not Specified|0
5808948|NCT02769065|20050654|P4|Overall Study|Reason Not Specified|0
5808949|NCT02769065|20050655|P3|Overall Study|Reason Not Specified|0
5808950|NCT02769065|20050656|P2|Overall Study|Reason Not Specified|0
5808951|NCT02769065|20050657|P1|Overall Study|Reason Not Specified|0
5808952|NCT02769065|20050628|P30|Overall Study|Voluntary Withdrawal|0
5808953|NCT02769065|20050629|P29|Overall Study|Voluntary Withdrawal|0
5808954|NCT02769065|20050630|P28|Overall Study|Voluntary Withdrawal|0
5808955|NCT02769065|20050631|P27|Overall Study|Voluntary Withdrawal|0
5808956|NCT02769065|20050632|P26|Overall Study|Voluntary Withdrawal|0
5808957|NCT02769065|20050633|P25|Overall Study|Voluntary Withdrawal|0
5808958|NCT02769065|20050634|P24|Overall Study|Voluntary Withdrawal|0
5808959|NCT02769065|20050635|P23|Overall Study|Voluntary Withdrawal|0
5808960|NCT02769065|20050636|P22|Overall Study|Voluntary Withdrawal|0
5808961|NCT02769065|20050637|P21|Overall Study|Voluntary Withdrawal|0
5808962|NCT02769065|20050638|P20|Overall Study|Voluntary Withdrawal|0
5808963|NCT02769065|20050639|P19|Overall Study|Voluntary Withdrawal|0
5808964|NCT02769065|20050640|P18|Overall Study|Voluntary Withdrawal|0
5808965|NCT02769065|20050641|P17|Overall Study|Voluntary Withdrawal|0
5808966|NCT02769065|20050642|P16|Overall Study|Voluntary Withdrawal|0
5808967|NCT02769065|20050643|P15|Overall Study|Voluntary Withdrawal|0
5808968|NCT02769065|20050644|P14|Overall Study|Voluntary Withdrawal|0
5808969|NCT02769065|20050645|P13|Overall Study|Voluntary Withdrawal|0
5808970|NCT02769065|20050646|P12|Overall Study|Voluntary Withdrawal|0
5808971|NCT02769065|20050647|P11|Overall Study|Voluntary Withdrawal|0
5808972|NCT02769065|20050648|P10|Overall Study|Voluntary Withdrawal|0
5808973|NCT02769065|20050649|P9|Overall Study|Voluntary Withdrawal|0
5808974|NCT02769065|20050650|P8|Overall Study|Voluntary Withdrawal|0
5808975|NCT02769065|20050651|P7|Overall Study|Voluntary Withdrawal|0
5808976|NCT02769065|20050652|P6|Overall Study|Voluntary Withdrawal|0
5808977|NCT02769065|20050653|P5|Overall Study|Voluntary Withdrawal|0
5808978|NCT02769065|20050654|P4|Overall Study|Voluntary Withdrawal|0
5808979|NCT02769065|20050655|P3|Overall Study|Voluntary Withdrawal|0
5808980|NCT02769065|20050656|P2|Overall Study|Voluntary Withdrawal|0
5808981|NCT02769065|20050657|P1|Overall Study|Voluntary Withdrawal|1
5808982|NCT02768870|20051067|P1|Overall Study|On Study|19
5808983|NCT02768870|20051067|P1|Overall Study|Reoperation|4
5808984|NCT02768870|20051067|P1|Overall Study|Death|1
5808985|NCT02768870|20051067|P1|Overall Study|Not Implanted with Device|2
5808986|NCT02768298|20051111|P2|Overall Study|Withdrawal of informed consent|1
5808987|NCT02768298|20051112|P1|Overall Study|Withdrawal of informed consent|0
5808988|NCT02768298|20051111|P2|Overall Study|Subject/guardian decision|0
5808989|NCT02768298|20051112|P1|Overall Study|Subject/guardian decision|1
5808990|NCT02768298|20051111|P2|Overall Study|Non-compliance with study treatment|1
5808991|NCT02768298|20051112|P1|Overall Study|Non-compliance with study treatment|0
5808992|NCT02768298|20051111|P2|Overall Study|Death|1
5808993|NCT02768298|20051112|P1|Overall Study|Death|2
5808994|NCT02768298|20051111|P2|Overall Study|Adverse Event|4
5808995|NCT02768298|20051112|P1|Overall Study|Adverse Event|1
5808996|NCT02768194|20051126|P6|Period 3|Other (Reason not specified)|0
5808997|NCT02768194|20051127|P5|Period 3|Other (Reason not specified)|0
5808998|NCT02768194|20051128|P4|Period 3|Other (Reason not specified)|0
5808999|NCT02768194|20051129|P3|Period 3|Other (Reason not specified)|0
5809000|NCT02768194|20051130|P2|Period 3|Other (Reason not specified)|1
5809001|NCT02768194|20051131|P1|Period 3|Other (Reason not specified)|0
5809002|NCT02768194|20051126|P6|Period 2|Other (Reason not specified)|0
5809003|NCT02768194|20051127|P5|Period 2|Other (Reason not specified)|0
5809004|NCT02768194|20051128|P4|Period 2|Other (Reason not specified)|0
5809005|NCT02768194|20051129|P3|Period 2|Other (Reason not specified)|0
5809006|NCT02768194|20051130|P2|Period 2|Other (Reason not specified)|0
5809007|NCT02768194|20051131|P1|Period 2|Other (Reason not specified)|1
5809008|NCT02768194|20051126|P6|Period 1|Adverse Event|0
5809009|NCT02768194|20051127|P5|Period 1|Adverse Event|0
5809010|NCT02768194|20051128|P4|Period 1|Adverse Event|1
5809011|NCT02768194|20051129|P3|Period 1|Adverse Event|0
5809012|NCT02768194|20051130|P2|Period 1|Adverse Event|0
5809013|NCT02768194|20051131|P1|Period 1|Adverse Event|0
5809014|NCT02768103|20051153|P1|Overall Study|1 participant did not fit in the fMRI|1
5809015|NCT02767765|20051214|P1|Overall Study|Withdrawal by Subject|1
5809016|NCT02767765|20051214|P1|Overall Study|Non-Compliance|1
5809017|NCT02767765|20051214|P1|Overall Study|Investigator decision|1
5809018|NCT02767765|20051214|P1|Overall Study|Lost to Follow-up|2
5809019|NCT02767765|20051214|P1|Overall Study|Insufficient response|1
5809020|NCT02767765|20051214|P1|Overall Study|Death|1
5809021|NCT02767765|20051214|P1|Overall Study|Adverse Event|4
5809022|NCT02766777|20051340|P1|Overall Study|Withdrawal by Subject|4
5809023|NCT02766777|20051340|P1|Overall Study|Protocol Violation|1
5809024|NCT02766777|20051340|P1|Overall Study|Non-Compliance With Study Drug|1
5809025|NCT02766777|20051340|P1|Overall Study|Lost to Follow-up|16
5809026|NCT02766777|20051340|P1|Overall Study|Adverse Event|12
5809027|NCT02766608|20051365|P5|Overall Study|Administrative Reasons|0
5809028|NCT02766608|20051366|P4|Overall Study|Administrative Reasons|0
5809029|NCT02766608|20051367|P3|Overall Study|Administrative Reasons|1
5809030|NCT02766608|20051368|P2|Overall Study|Administrative Reasons|1
5809031|NCT02766608|20051369|P1|Overall Study|Administrative Reasons|3
5809032|NCT02766608|20051365|P5|Overall Study|Protocol Violation|1
5809033|NCT02766608|20051366|P4|Overall Study|Protocol Violation|0
5809034|NCT02766608|20051367|P3|Overall Study|Protocol Violation|4
5809035|NCT02766608|20051368|P2|Overall Study|Protocol Violation|4
5809036|NCT02766608|20051369|P1|Overall Study|Protocol Violation|0
5809037|NCT02766608|20051365|P5|Overall Study|Protocol disc criteria|0
5809038|NCT02766608|20051366|P4|Overall Study|Protocol disc criteria|0
5809039|NCT02766608|20051367|P3|Overall Study|Protocol disc criteria|4
5809040|NCT02766608|20051368|P2|Overall Study|Protocol disc criteria|3
5809041|NCT02766608|20051369|P1|Overall Study|Protocol disc criteria|3
5809042|NCT02766608|20051365|P5|Overall Study|Physician Decision|2
5809043|NCT02766608|20051366|P4|Overall Study|Physician Decision|1
5809044|NCT02766608|20051367|P3|Overall Study|Physician Decision|3
5809045|NCT02766608|20051368|P2|Overall Study|Physician Decision|2
5809046|NCT02766608|20051369|P1|Overall Study|Physician Decision|3
5809047|NCT02766608|20051365|P5|Overall Study|Lost to Follow-up|2
5809048|NCT02766608|20051366|P4|Overall Study|Lost to Follow-up|2
5809049|NCT02766608|20051367|P3|Overall Study|Lost to Follow-up|5
5809050|NCT02766608|20051368|P2|Overall Study|Lost to Follow-up|3
5809051|NCT02766608|20051369|P1|Overall Study|Lost to Follow-up|6
5809052|NCT02766608|20051365|P5|Overall Study|Lack of Efficacy|2
5809053|NCT02766608|20051366|P4|Overall Study|Lack of Efficacy|8
5809054|NCT02766608|20051367|P3|Overall Study|Lack of Efficacy|32
5809055|NCT02766608|20051368|P2|Overall Study|Lack of Efficacy|15
5809056|NCT02766608|20051369|P1|Overall Study|Lack of Efficacy|16
5809057|NCT02766608|20051365|P5|Overall Study|Withdrawal by Subject|10
5809058|NCT02766608|20051366|P4|Overall Study|Withdrawal by Subject|13
5809059|NCT02766608|20051367|P3|Overall Study|Withdrawal by Subject|24
5809060|NCT02766608|20051368|P2|Overall Study|Withdrawal by Subject|20
5809061|NCT02766608|20051369|P1|Overall Study|Withdrawal by Subject|21
5809062|NCT02766608|20051365|P5|Overall Study|Adverse Event|12
5809063|NCT02766608|20051366|P4|Overall Study|Adverse Event|13
5809064|NCT02766608|20051367|P3|Overall Study|Adverse Event|17
5809065|NCT02766608|20051368|P2|Overall Study|Adverse Event|22
5809066|NCT02766608|20051369|P1|Overall Study|Adverse Event|27
5809067|NCT02766400|20051461|P2|Overall Study|Withdrawal by Subject|0
5809068|NCT02766400|20051462|P1|Overall Study|Withdrawal by Subject|1
5809069|NCT02766400|20051461|P2|Overall Study|Death|2
5809070|NCT02766400|20051462|P1|Overall Study|Death|1
5809071|NCT02766283|20051477|P1|Overall Study|Lost to Follow-up|27
5809072|NCT02766088|20051510|P1|Overall Study|Death|1
5809073|NCT02766088|20051510|P1|Overall Study|Other|1
5809074|NCT02766088|20051510|P1|Overall Study|Lost to Follow-up|5
5809075|NCT02766088|20051510|P1|Overall Study|Migrated/moved from the study area|1
5809076|NCT02766088|20051510|P1|Overall Study|Sponsor study termination|498
5809077|NCT02766023|20051525|P2|Overall Study|Not Eligible at Enrollment|1
5809078|NCT02766023|20051526|P1|Overall Study|Not Eligible at Enrollment|0
5809079|NCT02766023|20051525|P2|Overall Study|Physician Decision|0
5809080|NCT02766023|20051526|P1|Overall Study|Physician Decision|1
5809081|NCT02766023|20051525|P2|Overall Study|Withdrawal by Subject|5
5809082|NCT02766023|20051526|P1|Overall Study|Withdrawal by Subject|4
5809083|NCT02766023|20051525|P2|Overall Study|Adverse Event|0
5809084|NCT02766023|20051526|P1|Overall Study|Adverse Event|1
5809085|NCT02766023|20051525|P2|Overall Study|Pregnancy|0
5809086|NCT02766023|20051526|P1|Overall Study|Pregnancy|1
5809087|NCT02766023|20051525|P2|Overall Study|Lost to Follow-up|11
5809088|NCT02766023|20051526|P1|Overall Study|Lost to Follow-up|23
5809089|NCT02765490|20051576|P2|Overall Study|Death|1
5809090|NCT02765490|20051577|P1|Overall Study|Death|0
5809091|NCT02765490|20051576|P2|Overall Study|Other|1
5809092|NCT02765490|20051577|P1|Overall Study|Other|0
5809093|NCT02765490|20051576|P2|Overall Study|Lost to Follow-up|1
5809094|NCT02765490|20051577|P1|Overall Study|Lost to Follow-up|1
5809095|NCT02765100|20051610|P2|Overall Study|Lost to Follow-up|1
5809096|NCT02765100|20051611|P1|Overall Study|Lost to Follow-up|0
5809097|NCT02765100|20051610|P2|Overall Study|subject found ineligible after baseline|1
5809098|NCT02765100|20051611|P1|Overall Study|subject found ineligible after baseline|1
5809099|NCT02764775|20051632|P1|Overall Study|Withdrawal by Subject|3
5809100|NCT02764775|20051632|P1|Overall Study|Lost to Follow-up|2
5809101|NCT02764775|20051632|P1|Overall Study|Death|1
5809102|NCT02764697|20051636|P1|Overall Study|Lack of Efficacy|3
5809103|NCT02764229|20051641|P1|Overall Study|Study Stopped by Sponsor|69
5809104|NCT02764229|20051641|P1|Overall Study|Lack of Efficacy|1
5809105|NCT02764229|20051641|P1|Overall Study|Lost to Follow-up|3
5809106|NCT02764229|20051641|P1|Overall Study|Physician Decision|5
5809107|NCT02764229|20051641|P1|Overall Study|Adverse Event|9
5809108|NCT02764229|20051641|P1|Overall Study|Withdrawal by Subject|15
5809109|NCT02764190|20051647|P2|Overall Study|Lost to Follow-up|13
5809110|NCT02764190|20051648|P1|Overall Study|Lost to Follow-up|17
5809111|NCT02764151|20051702|P4|Overall Study|Other|2
5809112|NCT02764151|20051703|P3|Overall Study|Other|0
5809113|NCT02764151|20051704|P2|Overall Study|Other|0
5809114|NCT02764151|20051705|P1|Overall Study|Other|0
5809115|NCT02764151|20051702|P4|Overall Study|Subject refused further follow-up|1
5809116|NCT02764151|20051703|P3|Overall Study|Subject refused further follow-up|0
5809117|NCT02764151|20051704|P2|Overall Study|Subject refused further follow-up|0
5809118|NCT02764151|20051705|P1|Overall Study|Subject refused further follow-up|0
5809119|NCT02763644|20051844|P2|Overall Study|Adverse Event|1
5809120|NCT02763644|20051845|P1|Overall Study|Adverse Event|1
5809121|NCT02763644|20051844|P2|Overall Study|Death|1
5809122|NCT02763644|20051845|P1|Overall Study|Death|1
5809123|NCT02763644|20051844|P2|Overall Study|Patient/guardian decision|0
5809124|NCT02763644|20051845|P1|Overall Study|Patient/guardian decision|1
5809125|NCT02763579|20051865|P2|Overall Study|On-going in study|60
5809126|NCT02763579|20051866|P1|Overall Study|On-going in study|77
5809127|NCT02763579|20051865|P2|Overall Study|Physician Decision|0
5809128|NCT02763579|20051866|P1|Overall Study|Physician Decision|2
5809129|NCT02763579|20051865|P2|Overall Study|Withdrawal by Subject|9
5809130|NCT02763579|20051866|P1|Overall Study|Withdrawal by Subject|18
5809131|NCT02763579|20051865|P2|Overall Study|Lost to Follow-up|1
5809132|NCT02763579|20051866|P1|Overall Study|Lost to Follow-up|3
5809133|NCT02763579|20051865|P2|Overall Study|Death|132
5809134|NCT02763579|20051866|P1|Overall Study|Death|101
5809147|NCT02763254|20051909|P1|Overall Study|Adverse Event|1
5809148|NCT02763215|20051914|P1|Overall Study|Lost to Follow-up|1
5809149|NCT02763215|20051914|P1|Overall Study|Death|1
5809150|NCT02763215|20051914|P1|Overall Study|Visit outside visit-window|1
5809151|NCT02763215|20051914|P1|Overall Study|Missed visit|1
5809152|NCT02763215|20051914|P1|Overall Study|Participants withdrew from study|3
5809153|NCT02763189|20051937|P2|Overall Study|Device failure|2
5809154|NCT02763189|20051938|P1|Overall Study|Device failure|0
5809155|NCT02763046|20051956|P3|Overall Study|Subject/guardian decision|4
5809156|NCT02763046|20051957|P2|Overall Study|Subject/guardian decision|0
5809157|NCT02763046|20051958|P1|Overall Study|Subject/guardian decision|2
5809158|NCT02763046|20051956|P3|Overall Study|Physician Decision|1
5809159|NCT02763046|20051957|P2|Overall Study|Physician Decision|0
5809160|NCT02763046|20051958|P1|Overall Study|Physician Decision|1
5809161|NCT02763046|20051956|P3|Overall Study|Lack of Efficacy|3
5809162|NCT02763046|20051957|P2|Overall Study|Lack of Efficacy|1
5809163|NCT02763046|20051958|P1|Overall Study|Lack of Efficacy|1
5809164|NCT02763046|20051956|P3|Overall Study|Adverse Event|0
5809165|NCT02763046|20051957|P2|Overall Study|Adverse Event|4
5809166|NCT02763046|20051958|P1|Overall Study|Adverse Event|5
5809167|NCT02762578|20052074|P2|Overall Study|Unclassified|0
5809168|NCT02762578|20052075|P1|Overall Study|Unclassified|6
5809169|NCT02762578|20052074|P2|Overall Study|Withdrawal by Subject|2
5809170|NCT02762578|20052075|P1|Overall Study|Withdrawal by Subject|4
5809171|NCT02762578|20052074|P2|Overall Study|Protocol Violation|2
5809172|NCT02762578|20052075|P1|Overall Study|Protocol Violation|4
5809173|NCT02762578|20052074|P2|Overall Study|Adverse Event|6
5809174|NCT02762578|20052075|P1|Overall Study|Adverse Event|1
5809175|NCT02762500|20052177|P2|Overall Study|Adverse Event|2
5809176|NCT02762500|20052178|P1|Overall Study|Adverse Event|0
5809177|NCT02762500|20052177|P2|Overall Study|Withdrawal by Subject|1
5809178|NCT02762500|20052178|P1|Overall Study|Withdrawal by Subject|1
5809179|NCT02762500|20052177|P2|Overall Study|Lack of Efficacy|0
5809180|NCT02762500|20052178|P1|Overall Study|Lack of Efficacy|1
5809181|NCT02762370|20052198|P2|Overall Study|Protocol Violation|0
5809182|NCT02762370|20052199|P1|Overall Study|Protocol Violation|1
5809183|NCT02762084|20052239|P3|Overall Study|Adverse Event|1
5809184|NCT02762084|20052240|P2|Overall Study|Adverse Event|0
5809185|NCT02762084|20052241|P1|Overall Study|Adverse Event|0
5809186|NCT02762084|20052239|P3|Overall Study|Withdrawal by Subject|0
5809187|NCT02762084|20052240|P2|Overall Study|Withdrawal by Subject|0
5809188|NCT02762084|20052241|P1|Overall Study|Withdrawal by Subject|1
5809189|NCT02761980|20052302|P4|Overall Study|Other|0
5809190|NCT02761980|20052303|P3|Overall Study|Other|1
5809191|NCT02761980|20052304|P2|Overall Study|Other|0
5809192|NCT02761980|20052305|P1|Overall Study|Other|0
5809193|NCT02761980|20052302|P4|Overall Study|Withdrawal by Subject|0
5809194|NCT02761980|20052303|P3|Overall Study|Withdrawal by Subject|0
5809195|NCT02761980|20052304|P2|Overall Study|Withdrawal by Subject|1
5809196|NCT02761980|20052305|P1|Overall Study|Withdrawal by Subject|0
5809197|NCT02761980|20052302|P4|Overall Study|Adverse Event|6
5809198|NCT02761980|20052303|P3|Overall Study|Adverse Event|5
5809199|NCT02761980|20052304|P2|Overall Study|Adverse Event|6
5809200|NCT02761980|20052305|P1|Overall Study|Adverse Event|4
5809201|NCT02761733|20052352|P4|Overall Study|Cognitive Impairment|0
5809202|NCT02761733|20052353|P3|Overall Study|Cognitive Impairment|1
5809203|NCT02761733|20052354|P2|Overall Study|Cognitive Impairment|0
5809204|NCT02761733|20052355|P1|Overall Study|Cognitive Impairment|5
5809205|NCT02761733|20052352|P4|Overall Study|Discharged from Study Site|11
5809206|NCT02761733|20052353|P3|Overall Study|Discharged from Study Site|25
5809207|NCT02761733|20052354|P2|Overall Study|Discharged from Study Site|9
5809208|NCT02761733|20052355|P1|Overall Study|Discharged from Study Site|10
5809209|NCT02761733|20052352|P4|Overall Study|Withdrawal by Subject|0
5809210|NCT02761733|20052353|P3|Overall Study|Withdrawal by Subject|0
5809211|NCT02761733|20052354|P2|Overall Study|Withdrawal by Subject|0
5809212|NCT02761733|20052355|P1|Overall Study|Withdrawal by Subject|2
5809213|NCT02761733|20052352|P4|Overall Study|Physician Decision|0
5809214|NCT02761733|20052353|P3|Overall Study|Physician Decision|0
5809215|NCT02761733|20052354|P2|Overall Study|Physician Decision|0
5809216|NCT02761733|20052355|P1|Overall Study|Physician Decision|4
5809217|NCT02761733|20052352|P4|Overall Study|Lost to Follow-up|3
5809218|NCT02761733|20052353|P3|Overall Study|Lost to Follow-up|0
5809219|NCT02761733|20052354|P2|Overall Study|Lost to Follow-up|7
5809220|NCT02761733|20052355|P1|Overall Study|Lost to Follow-up|6
5809221|NCT02761733|20052352|P4|Overall Study|Death|1
5809222|NCT02761733|20052353|P3|Overall Study|Death|1
5809223|NCT02761733|20052354|P2|Overall Study|Death|5
5809224|NCT02761733|20052355|P1|Overall Study|Death|3
5809225|NCT02761642|20052385|P1|Overall Study|Reason Unspecified|21
5809226|NCT02761642|20052385|P1|Overall Study|Physician Decision|1
5809227|NCT02761642|20052385|P1|Overall Study|Lack of Efficacy|20
5809228|NCT02761642|20052385|P1|Overall Study|Death|3
5809229|NCT02761642|20052385|P1|Overall Study|Non-compliant|7
5809230|NCT02761642|20052385|P1|Overall Study|Withdrawal by Subject|2
5809231|NCT02761642|20052385|P1|Overall Study|Adverse Event|13
5809232|NCT02761642|20052385|P1|Overall Study|Did not Receive Study Treatment|3
5809233|NCT02761629|20052398|P2|Overall Study|Randomized But Not Treated|4
5809234|NCT02761629|20052399|P1|Overall Study|Randomized But Not Treated|8
5809235|NCT02761629|20052398|P2|Overall Study|Lost to Follow-up|1
5809236|NCT02761629|20052399|P1|Overall Study|Lost to Follow-up|4
5809237|NCT02761629|20052398|P2|Overall Study|Other|2
5809238|NCT02761629|20052399|P1|Overall Study|Other|0
5809239|NCT02761629|20052398|P2|Overall Study|Withdrawal by Subject|3
5809240|NCT02761629|20052399|P1|Overall Study|Withdrawal by Subject|0
5809241|NCT02761629|20052398|P2|Overall Study|Protocol Violation|2
5809242|NCT02761629|20052399|P1|Overall Study|Protocol Violation|2
5809243|NCT02761629|20052398|P2|Overall Study|Did not Cooperate/Refused Treatment|4
5809244|NCT02761629|20052399|P1|Overall Study|Did not Cooperate/Refused Treatment|2
5809245|NCT02761629|20052398|P2|Overall Study|Failure to Return|4
5809246|NCT02761629|20052399|P1|Overall Study|Failure to Return|2
5809247|NCT02761629|20052398|P2|Overall Study|Insufficient Therapeutic Response|7
5809248|NCT02761629|20052399|P1|Overall Study|Insufficient Therapeutic Response|2
5809249|NCT02761629|20052398|P2|Overall Study|Adverse Event/Intercurrent Illness|5
5809250|NCT02761629|20052399|P1|Overall Study|Adverse Event/Intercurrent Illness|7
5809251|NCT02760927|20052446|P1|Overall Study|Tube Slippage from Device|1
5809252|NCT02760810|20052463|P1|Overall Study|Protocol Violation|1
5809253|NCT02760654|20052471|P2|Overall Study|Withdrawal by Subject|3
5809254|NCT02760654|20052472|P1|Overall Study|Withdrawal by Subject|4
5809255|NCT02760654|20052471|P2|Overall Study|Lost to Follow-up|3
5809256|NCT02760654|20052472|P1|Overall Study|Lost to Follow-up|3
5809257|NCT02760602|20052498|P2|Overall Study|Terminated by sponsor|13
5809258|NCT02760602|20052499|P1|Overall Study|Terminated by sponsor|12
5809259|NCT02760602|20052498|P2|Overall Study|Withdrawal by Subject|0
5809260|NCT02760602|20052499|P1|Overall Study|Withdrawal by Subject|1
5809261|NCT02760368|20052540|P3|Overall Study|Withdrawal by Sponsor|1
5809262|NCT02760368|20052541|P2|Overall Study|Withdrawal by Sponsor|0
5809263|NCT02760368|20052542|P1|Overall Study|Withdrawal by Sponsor|0
5809264|NCT02760368|20052540|P3|Overall Study|Death|0
5809265|NCT02760368|20052541|P2|Overall Study|Death|0
5809266|NCT02760368|20052542|P1|Overall Study|Death|1
5809267|NCT02760368|20052540|P3|Overall Study|Screen Failure|1
5809268|NCT02760368|20052541|P2|Overall Study|Screen Failure|0
5809269|NCT02760368|20052542|P1|Overall Study|Screen Failure|0
5809270|NCT02760368|20052540|P3|Overall Study|Withdrawal by Subject|9
5809271|NCT02760368|20052541|P2|Overall Study|Withdrawal by Subject|8
5809272|NCT02760368|20052542|P1|Overall Study|Withdrawal by Subject|12
5809273|NCT02760069|20052724|P3|Overall Study|Withdrawal by Subject|1
5809274|NCT02760069|20052725|P2|Overall Study|Withdrawal by Subject|1
5809275|NCT02760069|20052726|P1|Overall Study|Withdrawal by Subject|0
5809276|NCT02759939|20052752|P4|Overall Study|Lost to Follow-up|650
5809277|NCT02759939|20052753|P3|Overall Study|Lost to Follow-up|783
5809278|NCT02759939|20052754|P2|Overall Study|Lost to Follow-up|791
5809279|NCT02759939|20052755|P1|Overall Study|Lost to Follow-up|735
5809280|NCT02759939|20052752|P4|Overall Study|Ineligible for T2 and T3|391
5809281|NCT02759939|20052753|P3|Overall Study|Ineligible for T2 and T3|366
5809282|NCT02759939|20052754|P2|Overall Study|Ineligible for T2 and T3|179
5809283|NCT02759939|20052755|P1|Overall Study|Ineligible for T2 and T3|310
5809284|NCT02759939|20052752|P4|Overall Study|Missing data on first outcome assessed|2
5809285|NCT02759939|20052753|P3|Overall Study|Missing data on first outcome assessed|5
5809286|NCT02759939|20052754|P2|Overall Study|Missing data on first outcome assessed|2
5809287|NCT02759939|20052755|P1|Overall Study|Missing data on first outcome assessed|11
5809288|NCT02759692|20052765|P2|Period 2|Test article no longer available|1
5809289|NCT02759692|20052766|P1|Period 2|Test article no longer available|0
5809290|NCT02759692|20052765|P2|Period 2|Lost to Follow-up|0
5809291|NCT02759692|20052766|P1|Period 2|Lost to Follow-up|1
5809292|NCT02759692|20052765|P2|Period 1|Miss-Randomized|1
5809293|NCT02759692|20052766|P1|Period 1|Miss-Randomized|1
5809294|NCT02759692|20052765|P2|Period 1|No longer meets eligibility criteria.|0
5809295|NCT02759692|20052766|P1|Period 1|No longer meets eligibility criteria.|1
5809296|NCT02759692|20052765|P2|Period 1|Test article no longer available|1
5809297|NCT02759692|20052766|P1|Period 1|Test article no longer available|1
5809298|NCT02759562|20052784|P2|Open-Label Treatment Period|Study Terminated by Sponsor|2
5809299|NCT02759562|20052785|P1|Open-Label Treatment Period|Study Terminated by Sponsor|1
5809300|NCT02759562|20052784|P2|Open-Label Treatment Period|Withdrew Consent|0
5809301|NCT02759562|20052785|P1|Open-Label Treatment Period|Withdrew Consent|1
5809302|NCT02759471|20052798|P1|Overall Study|discomfort|2
5809303|NCT02759315|20052854|P5|Overall Study|Study terminated prior to completion|1
5809304|NCT02759315|20052855|P4|Overall Study|Study terminated prior to completion|0
5809305|NCT02759315|20052856|P3|Overall Study|Study terminated prior to completion|5
5809306|NCT02759315|20052857|P2|Overall Study|Study terminated prior to completion|0
5809307|NCT02759315|20052858|P1|Overall Study|Study terminated prior to completion|2
5809308|NCT02759315|20052854|P5|Overall Study|Protocol Violation|0
5809309|NCT02759315|20052855|P4|Overall Study|Protocol Violation|0
5809310|NCT02759315|20052856|P3|Overall Study|Protocol Violation|0
5809311|NCT02759315|20052857|P2|Overall Study|Protocol Violation|1
5809312|NCT02759315|20052858|P1|Overall Study|Protocol Violation|0
5809313|NCT02759315|20052854|P5|Overall Study|Lost to Follow-up|0
5809314|NCT02759315|20052855|P4|Overall Study|Lost to Follow-up|0
5809315|NCT02759315|20052856|P3|Overall Study|Lost to Follow-up|4
5809316|NCT02759315|20052857|P2|Overall Study|Lost to Follow-up|0
5809317|NCT02759315|20052858|P1|Overall Study|Lost to Follow-up|2
5809318|NCT02759315|20052854|P5|Overall Study|Death|0
5809319|NCT02759315|20052855|P4|Overall Study|Death|0
5809320|NCT02759315|20052856|P3|Overall Study|Death|1
5809321|NCT02759315|20052857|P2|Overall Study|Death|0
5809322|NCT02759315|20052858|P1|Overall Study|Death|0
5809323|NCT02759315|20052854|P5|Overall Study|Adverse Event|0
5809324|NCT02759315|20052855|P4|Overall Study|Adverse Event|1
5809325|NCT02759315|20052856|P3|Overall Study|Adverse Event|0
5809326|NCT02759315|20052857|P2|Overall Study|Adverse Event|0
5809327|NCT02759315|20052858|P1|Overall Study|Adverse Event|0
5809328|NCT02759016|20052961|P2|Overall Study|Other not defined above|1
5809329|NCT02759016|20052962|P1|Overall Study|Other not defined above|2
5809330|NCT02759016|20052961|P2|Overall Study|SD, PR-MRDpos or PR-L|2
5809331|NCT02759016|20052962|P1|Overall Study|SD, PR-MRDpos or PR-L|0
5809332|NCT02759016|20052961|P2|Overall Study|Progressive disease|0
5809333|NCT02759016|20052962|P1|Overall Study|Progressive disease|1
5809334|NCT02759016|20052961|P2|Overall Study|Not treated with BI 836826|0
5809335|NCT02759016|20052962|P1|Overall Study|Not treated with BI 836826|1
5809336|NCT02758613|20052991|P4|Treatment|Withdrawal by Subject|0
5809337|NCT02758613|20052992|P3|Treatment|Withdrawal by Subject|1
5809338|NCT02758613|20052993|P2|Treatment|Withdrawal by Subject|0
5809339|NCT02758613|20052994|P1|Treatment|Withdrawal by Subject|1
5809340|NCT02758613|20052991|P4|Treatment|Physician and Sponsor Decision|0
5809341|NCT02758613|20052992|P3|Treatment|Physician and Sponsor Decision|0
5809342|NCT02758613|20052993|P2|Treatment|Physician and Sponsor Decision|0
5809343|NCT02758613|20052994|P1|Treatment|Physician and Sponsor Decision|1
5809344|NCT02758301|20053012|P2|Overall Study|Protocol Violation|1
5809345|NCT02758301|20053013|P1|Overall Study|Protocol Violation|0
5809346|NCT02758301|20053012|P2|Overall Study|Lost to Follow-up|0
5809347|NCT02758301|20053013|P1|Overall Study|Lost to Follow-up|7
5809348|NCT02758301|20053012|P2|Overall Study|Withdrawal by Subject|6
5809349|NCT02758301|20053013|P1|Overall Study|Withdrawal by Subject|5
5809350|NCT02758301|20053012|P2|Overall Study|Physician Decision|1
5809351|NCT02758301|20053013|P1|Overall Study|Physician Decision|10
5809352|NCT02758301|20053012|P2|Overall Study|Death|0
5809353|NCT02758301|20053013|P1|Overall Study|Death|12
5809354|NCT02758171|20053032|P2|Wash-out|Other reason|0
5809355|NCT02758171|20053033|P1|Wash-out|Other reason|1
5809356|NCT02758171|20053032|P2|Wash-out|Withdrawal by Subject|0
5809357|NCT02758171|20053033|P1|Wash-out|Withdrawal by Subject|1
5809358|NCT02757963|20053087|P1|Overall Study|Withdrawal by Subject|34
5809359|NCT02757963|20053087|P1|Overall Study|Physician Decision|1
5809360|NCT02757963|20053087|P1|Overall Study|Lost to Follow-up|5
5809361|NCT02757963|20053087|P1|Overall Study|Reached Stopping Criteria|1054
5809362|NCT02757963|20053087|P1|Overall Study|Adverse Event|3
5809363|NCT02757768|20053127|P2|Overall Study|Miscellaneous|2
5809364|NCT02757768|20053128|P1|Overall Study|Miscellaneous|4
5809365|NCT02757768|20053127|P2|Overall Study|Withdrawal by Subject|9
5809366|NCT02757768|20053128|P1|Overall Study|Withdrawal by Subject|16
5809367|NCT02757768|20053127|P2|Overall Study|Protocol Deviation|9
5809368|NCT02757768|20053128|P1|Overall Study|Protocol Deviation|2
5809369|NCT02757768|20053127|P2|Overall Study|Lost to Follow-up|0
5809370|NCT02757768|20053128|P1|Overall Study|Lost to Follow-up|1
5809371|NCT02757768|20053127|P2|Overall Study|Lack of Efficacy|1
5809372|NCT02757768|20053128|P1|Overall Study|Lack of Efficacy|2
5809373|NCT02757768|20053127|P2|Overall Study|Adverse Event|3
5809374|NCT02757768|20053128|P1|Overall Study|Adverse Event|5
5809375|NCT02757768|20053127|P2|Overall Study|Randomized Never Received Study Drug|4
5809376|NCT02757768|20053128|P1|Overall Study|Randomized Never Received Study Drug|3
5809377|NCT02757625|20053178|P4|Overall Study|Adverse Event|0
5809378|NCT02757625|20053179|P3|Overall Study|Adverse Event|1
5809379|NCT02757625|20053180|P2|Overall Study|Adverse Event|0
5809380|NCT02757625|20053181|P1|Overall Study|Adverse Event|0
5809381|NCT02757625|20053178|P4|Overall Study|Investigator's discretion|0
5809382|NCT02757625|20053179|P3|Overall Study|Investigator's discretion|1
5809383|NCT02757625|20053180|P2|Overall Study|Investigator's discretion|0
5809384|NCT02757625|20053181|P1|Overall Study|Investigator's discretion|0
5809385|NCT02757521|20053340|P2|Overall Study|Adverse Event|0
5809386|NCT02757521|20053341|P1|Overall Study|Adverse Event|1
5809387|NCT02757430|20053347|P1|Overall Study|No procedure performed|2
5809388|NCT02757430|20053347|P1|Overall Study|No informed consent|1
5809389|NCT02757430|20053347|P1|Overall Study|Inclusion/Exclusion criteria not met|3
5809390|NCT02757430|20053347|P1|Overall Study|Physician Decision|6
5809391|NCT02757352|20053366|P10|Follow-Up Period|Withdrawal by Subject|2
5809392|NCT02757352|20053367|P9|Follow-Up Period|Withdrawal by Subject|6
5809393|NCT02757352|20053368|P8|Follow-Up Period|Withdrawal by Subject|1
5809394|NCT02757352|20053369|P7|Follow-Up Period|Withdrawal by Subject|0
5809395|NCT02757352|20053370|P6|Follow-Up Period|Withdrawal by Subject|0
5809396|NCT02757352|20053371|P5|Follow-Up Period|Withdrawal by Subject|0
5809397|NCT02757352|20053372|P4|Follow-Up Period|Withdrawal by Subject|0
5809398|NCT02757352|20053373|P3|Follow-Up Period|Withdrawal by Subject|0
5809399|NCT02757352|20053374|P2|Follow-Up Period|Withdrawal by Subject|0
5809400|NCT02757352|20053375|P1|Follow-Up Period|Withdrawal by Subject|0
5809401|NCT02757352|20053366|P10|Follow-Up Period|Lack of Efficacy|1
5809402|NCT02757352|20053367|P9|Follow-Up Period|Lack of Efficacy|1
5809403|NCT02757352|20053368|P8|Follow-Up Period|Lack of Efficacy|0
5809404|NCT02757352|20053369|P7|Follow-Up Period|Lack of Efficacy|0
5809405|NCT02757352|20053370|P6|Follow-Up Period|Lack of Efficacy|0
5809406|NCT02757352|20053371|P5|Follow-Up Period|Lack of Efficacy|0
5809407|NCT02757352|20053372|P4|Follow-Up Period|Lack of Efficacy|0
5809408|NCT02757352|20053373|P3|Follow-Up Period|Lack of Efficacy|0
5809409|NCT02757352|20053374|P2|Follow-Up Period|Lack of Efficacy|0
5809410|NCT02757352|20053375|P1|Follow-Up Period|Lack of Efficacy|0
5809411|NCT02757352|20053366|P10|Follow-Up Period|Lost to Follow-up|0
5809412|NCT02757352|20053367|P9|Follow-Up Period|Lost to Follow-up|1
5809413|NCT02757352|20053368|P8|Follow-Up Period|Lost to Follow-up|0
5809414|NCT02757352|20053369|P7|Follow-Up Period|Lost to Follow-up|0
5809415|NCT02757352|20053370|P6|Follow-Up Period|Lost to Follow-up|0
5809416|NCT02757352|20053371|P5|Follow-Up Period|Lost to Follow-up|0
5809417|NCT02757352|20053372|P4|Follow-Up Period|Lost to Follow-up|0
5809418|NCT02757352|20053373|P3|Follow-Up Period|Lost to Follow-up|0
5809419|NCT02757352|20053374|P2|Follow-Up Period|Lost to Follow-up|0
5809420|NCT02757352|20053375|P1|Follow-Up Period|Lost to Follow-up|0
5809421|NCT02757352|20053366|P10|Follow-Up Period|Adverse Event|0
5809422|NCT02757352|20053367|P9|Follow-Up Period|Adverse Event|2
5809423|NCT02757352|20053368|P8|Follow-Up Period|Adverse Event|0
5809424|NCT02757352|20053369|P7|Follow-Up Period|Adverse Event|1
5809425|NCT02757352|20053370|P6|Follow-Up Period|Adverse Event|0
5809426|NCT02757352|20053371|P5|Follow-Up Period|Adverse Event|0
5809427|NCT02757352|20053372|P4|Follow-Up Period|Adverse Event|0
5809428|NCT02757352|20053373|P3|Follow-Up Period|Adverse Event|0
5809429|NCT02757352|20053374|P2|Follow-Up Period|Adverse Event|0
5809430|NCT02757352|20053375|P1|Follow-Up Period|Adverse Event|0
5809431|NCT02757352|20053366|P10|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0
5809432|NCT02757352|20053367|P9|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0
5809433|NCT02757352|20053368|P8|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0
5809434|NCT02757352|20053369|P7|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0
5809435|NCT02757352|20053370|P6|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1
5809436|NCT02757352|20053371|P5|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1
5809437|NCT02757352|20053372|P4|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|2
5809438|NCT02757352|20053373|P3|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0
5809439|NCT02757352|20053374|P2|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0
5809440|NCT02757352|20053375|P1|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0
5809441|NCT02757352|20053366|P10|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0
5809442|NCT02757352|20053367|P9|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0
5809443|NCT02757352|20053368|P8|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0
5809444|NCT02757352|20053369|P7|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0
5809445|NCT02757352|20053370|P6|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|1
5809446|NCT02757352|20053371|P5|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0
5809447|NCT02757352|20053372|P4|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0
5809448|NCT02757352|20053373|P3|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0
5809449|NCT02757352|20053374|P2|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0
5809450|NCT02757352|20053375|P1|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0
5809451|NCT02757352|20053366|P10|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0
5809452|NCT02757352|20053367|P9|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0
5809453|NCT02757352|20053368|P8|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0
5809454|NCT02757352|20053369|P7|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0
5809455|NCT02757352|20053370|P6|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0
5809456|NCT02757352|20053371|P5|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|1
5809457|NCT02757352|20053372|P4|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0
5809458|NCT02757352|20053373|P3|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0
5809459|NCT02757352|20053374|P2|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0
5809460|NCT02757352|20053375|P1|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0
5809461|NCT02757352|20053366|P10|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0
5809462|NCT02757352|20053367|P9|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0
5809463|NCT02757352|20053368|P8|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0
5809464|NCT02757352|20053369|P7|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0
5809465|NCT02757352|20053370|P6|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|4
5809466|NCT02757352|20053371|P5|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|1
5809467|NCT02757352|20053372|P4|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|2
5809468|NCT02757352|20053373|P3|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0
5809469|NCT02757352|20053374|P2|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0
5809470|NCT02757352|20053375|P1|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0
5809471|NCT02757352|20053366|P10|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0
5809472|NCT02757352|20053367|P9|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0
5809473|NCT02757352|20053368|P8|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0
5809474|NCT02757352|20053369|P7|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0
5809475|NCT02757352|20053370|P6|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|1
5809476|NCT02757352|20053371|P5|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0
5809477|NCT02757352|20053372|P4|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|3
5809478|NCT02757352|20053373|P3|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0
5809479|NCT02757352|20053374|P2|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0
5809480|NCT02757352|20053375|P1|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0
5809481|NCT02757352|20053366|P10|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0
5809482|NCT02757352|20053367|P9|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0
5809483|NCT02757352|20053368|P8|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0
5809484|NCT02757352|20053369|P7|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0
5809485|NCT02757352|20053370|P6|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0
5809486|NCT02757352|20053371|P5|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0
5809487|NCT02757352|20053372|P4|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0
5809488|NCT02757352|20053373|P3|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|42
5809489|NCT02757352|20053374|P2|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|40
5809490|NCT02757352|20053375|P1|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|62
5809491|NCT02757352|20053366|P10|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0
5809492|NCT02757352|20053367|P9|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0
5809493|NCT02757352|20053368|P8|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0
5809494|NCT02757352|20053369|P7|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0
5809495|NCT02757352|20053370|P6|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0
5809496|NCT02757352|20053371|P5|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0
5809497|NCT02757352|20053372|P4|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0
5809498|NCT02757352|20053373|P3|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|4
5809499|NCT02757352|20053374|P2|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1
5809500|NCT02757352|20053375|P1|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1
5809501|NCT02757352|20053366|P10|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0
5809502|NCT02757352|20053367|P9|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0
5809503|NCT02757352|20053368|P8|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0
5809504|NCT02757352|20053369|P7|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0
5809505|NCT02757352|20053370|P6|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0
5809506|NCT02757352|20053371|P5|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0
5809507|NCT02757352|20053372|P4|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0
5809508|NCT02757352|20053373|P3|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0
5809509|NCT02757352|20053374|P2|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|1
5809510|NCT02757352|20053375|P1|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0
5809511|NCT02757352|20053366|P10|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0
5809512|NCT02757352|20053367|P9|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0
5809513|NCT02757352|20053368|P8|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0
5809514|NCT02757352|20053369|P7|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0
5809515|NCT02757352|20053370|P6|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0
5809516|NCT02757352|20053371|P5|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0
5809517|NCT02757352|20053372|P4|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0
5809518|NCT02757352|20053373|P3|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0
5809519|NCT02757352|20053374|P2|Double-Blind Period (Week 16 - Week 52)|Adverse Event|1
5809520|NCT02757352|20053375|P1|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0
5809521|NCT02757352|20053366|P10|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0
5809522|NCT02757352|20053367|P9|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0
5809523|NCT02757352|20053368|P8|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0
5809524|NCT02757352|20053369|P7|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0
5809525|NCT02757352|20053370|P6|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0
5809526|NCT02757352|20053371|P5|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0
5809527|NCT02757352|20053372|P4|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0
5809528|NCT02757352|20053373|P3|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|2
5809529|NCT02757352|20053374|P2|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|1
5809530|NCT02757352|20053375|P1|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|6
5809531|NCT02757352|20053366|P10|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0
5809532|NCT02757352|20053367|P9|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0
5809533|NCT02757352|20053368|P8|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0
5809534|NCT02757352|20053369|P7|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0
5809535|NCT02757352|20053370|P6|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0
5809536|NCT02757352|20053371|P5|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0
5809537|NCT02757352|20053372|P4|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0
5809538|NCT02757352|20053373|P3|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|1
5809539|NCT02757352|20053374|P2|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0
5809540|NCT02757352|20053375|P1|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0
5809541|NCT02757352|20053366|P10|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0
5809542|NCT02757352|20053367|P9|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0
5809543|NCT02757352|20053368|P8|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0
5809544|NCT02757352|20053369|P7|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0
5809545|NCT02757352|20053370|P6|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0
5809546|NCT02757352|20053371|P5|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0
5809547|NCT02757352|20053372|P4|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0
5809548|NCT02757352|20053373|P3|Double-Blind Period (Week 0 - Week 16)|Adverse Event|1
5809549|NCT02757352|20053374|P2|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0
5809550|NCT02757352|20053375|P1|Double-Blind Period (Week 0 - Week 16)|Adverse Event|2
5809551|NCT02756832|20053598|P1|Overall Study|Protocol Deviation|10
5809552|NCT02756832|20053598|P1|Overall Study|Reason not Specified|9
5809553|NCT02756832|20053598|P1|Overall Study|Sponsor Decision/Regulatory Requirement|1
5809554|NCT02756832|20053598|P1|Overall Study|Insufficient Efficacy|2
5809555|NCT02756832|20053598|P1|Overall Study|Patient's Unwillingness|12
5809556|NCT02756832|20053598|P1|Overall Study|Lost for Observation|13
5809557|NCT02756832|20053598|P1|Overall Study|Lost for Observation after Baseline|6
5809558|NCT02756819|20053612|P1|Overall Study|Reason not Specified|9
5809559|NCT02756819|20053612|P1|Overall Study|Adverse Event|2
5809560|NCT02756819|20053612|P1|Overall Study|Insufficient efficacy|2
5809561|NCT02756819|20053612|P1|Overall Study|Patient's unwillingness|16
5809562|NCT02756819|20053612|P1|Overall Study|Lost for observation|23
5809563|NCT02756650|20053711|P1|Overall Study|Adverse Event|1
5809564|NCT02756650|20053711|P1|Overall Study|Physician Decision|1
5809565|NCT02756637|20053734|P2|Overall Study|Did not complete curative therapy|0
5809566|NCT02756637|20053735|P1|Overall Study|Did not complete curative therapy|33
5809567|NCT02756637|20053734|P2|Overall Study|No available NLR value|44
5809568|NCT02756637|20053735|P1|Overall Study|No available NLR value|44
5809569|NCT02756637|20053734|P2|Overall Study|Not eligible for initial SWOG study|10
5809570|NCT02756637|20053735|P1|Overall Study|Not eligible for initial SWOG study|10
5809571|NCT02756611|20053756|P1|Overall Study|Active on Study|205
5809572|NCT02756611|20053756|P1|Overall Study|Missing|2
5809573|NCT02756611|20053756|P1|Overall Study|Other|7
5809574|NCT02756611|20053756|P1|Overall Study|Lost to Follow-up|2
5809575|NCT02756611|20053756|P1|Overall Study|Withdrawal by Subject|1
5809576|NCT02756611|20053756|P1|Overall Study|Death|39
5809577|NCT02756364|20053770|P3|Overall Study|Lost to Follow-up|1
5809578|NCT02756364|20053771|P2|Overall Study|Lost to Follow-up|1
5809579|NCT02756364|20053772|P1|Overall Study|Lost to Follow-up|0
5809580|NCT02756364|20053770|P3|Overall Study|Withdrawal by Patient|8
5809581|NCT02756364|20053771|P2|Overall Study|Withdrawal by Patient|1
5809582|NCT02756364|20053772|P1|Overall Study|Withdrawal by Patient|2
5809583|NCT02756364|20053770|P3|Overall Study|Death|18
5809584|NCT02756364|20053771|P2|Overall Study|Death|15
5809585|NCT02756364|20053772|P1|Overall Study|Death|20
5809586|NCT02756364|20053770|P3|Overall Study|Site Terminated by Sponsor|21
5809587|NCT02756364|20053771|P2|Overall Study|Site Terminated by Sponsor|30
5809588|NCT02756364|20053772|P1|Overall Study|Site Terminated by Sponsor|24
5809589|NCT02756338|20053806|P1|Overall Study|Device Replaced with Pacemaker|4
5809590|NCT02756338|20053806|P1|Overall Study|Withdrawn by Investigator|1
5809591|NCT02756182|20053815|P1|Overall Study|StudyTechnical Difficulties|4
5809592|NCT02756078|20053830|P2|Period 2|Withdrawal by Subject|1
5809593|NCT02756078|20053831|P1|Period 2|Withdrawal by Subject|3
5809594|NCT02756078|20053830|P2|Period 2|Unsatisfactory Lens Fitting|1
5809595|NCT02756078|20053831|P1|Period 2|Unsatisfactory Lens Fitting|0
5809596|NCT02756078|20053830|P2|Period 2|Adverse Event|5
5809597|NCT02756078|20053831|P1|Period 2|Adverse Event|3
5809598|NCT02756078|20053830|P2|Period 1|Lens Discomfort|2
5809599|NCT02756078|20053831|P1|Period 1|Lens Discomfort|2
5809600|NCT02756078|20053830|P2|Period 1|Withdrawal by Subject|6
5809601|NCT02756078|20053831|P1|Period 1|Withdrawal by Subject|6
5809602|NCT02756078|20053830|P2|Period 1|Adverse Event|10
5809603|NCT02756078|20053831|P1|Period 1|Adverse Event|1
5809604|NCT02756078|20053830|P2|Period 1|Protocol Violation|1
5809605|NCT02756078|20053831|P1|Period 1|Protocol Violation|0
5809606|NCT02756078|20053830|P2|Period 1|Lost to Follow-up|2
5809607|NCT02756078|20053831|P1|Period 1|Lost to Follow-up|0
5809608|NCT02756078|20053830|P2|Period 1|Unsatisfactory Lens Fitting|1
5809609|NCT02756078|20053831|P1|Period 1|Unsatisfactory Lens Fitting|0
5809610|NCT02756013|20053849|P1|Overall Study|Hypersensitivity|1
5809611|NCT02756013|20053849|P1|Overall Study|Adverse Event|1
5809612|NCT02755831|20053861|P2|Overall Study|Lost to Follow-up|3
5809613|NCT02755831|20053862|P1|Overall Study|Lost to Follow-up|3
5809622|NCT02755805|20053917|P2|Overall Study|Withdrawal by Subject|2
5809623|NCT02755805|20053918|P1|Overall Study|Withdrawal by Subject|0
5809624|NCT02755805|20053917|P2|Overall Study|Refused assessments|0
5809625|NCT02755805|20053918|P1|Overall Study|Refused assessments|1
5809626|NCT02755805|20053917|P2|Overall Study|Lost to Follow-up|2
5809627|NCT02755805|20053918|P1|Overall Study|Lost to Follow-up|1
5809628|NCT02755649|20053933|P3|Overall Study|Undecided|0
5809629|NCT02755649|20053934|P2|Overall Study|Undecided|0
5809630|NCT02755649|20053935|P1|Overall Study|Undecided|1
5809631|NCT02755649|20053933|P3|Overall Study|Withdrawal by Subject|0
5809632|NCT02755649|20053934|P2|Overall Study|Withdrawal by Subject|1
5809633|NCT02755649|20053935|P1|Overall Study|Withdrawal by Subject|0
5809634|NCT02755649|20053933|P3|Overall Study|Physician Decision|2
5809635|NCT02755649|20053934|P2|Overall Study|Physician Decision|0
5809636|NCT02755649|20053935|P1|Overall Study|Physician Decision|0
5809637|NCT02755649|20053933|P3|Overall Study|Did Not Complete Follow-up Visits|0
5809638|NCT02755649|20053934|P2|Overall Study|Did Not Complete Follow-up Visits|0
5809639|NCT02755649|20053935|P1|Overall Study|Did Not Complete Follow-up Visits|1
5809640|NCT02755649|20053933|P3|Overall Study|Transitioned into OLE study|100
5809641|NCT02755649|20053934|P2|Overall Study|Transitioned into OLE study|98
5809642|NCT02755649|20053935|P1|Overall Study|Transitioned into OLE study|99
5809643|NCT02755116|20054010|P2|Overall Study|surgery converted to open, pt admitted|1
5809644|NCT02755116|20054011|P1|Overall Study|surgery converted to open, pt admitted|3
5809645|NCT02755090|20054027|P2|Overall Study|equipment malfunction|0
5809646|NCT02755090|20054028|P1|Overall Study|equipment malfunction|1
5809647|NCT02754492|20054080|P4|Overall Study|Venous access issues not resulting in AE|4
5809648|NCT02754492|20054081|P3|Overall Study|Venous access issues not resulting in AE|0
5809649|NCT02754492|20054082|P2|Overall Study|Venous access issues not resulting in AE|0
5809650|NCT02754492|20054083|P1|Overall Study|Venous access issues not resulting in AE|0
5809651|NCT02754492|20054080|P4|Overall Study|Adverse Event|13
5809652|NCT02754492|20054081|P3|Overall Study|Adverse Event|0
5809653|NCT02754492|20054082|P2|Overall Study|Adverse Event|0
5809654|NCT02754492|20054083|P1|Overall Study|Adverse Event|0
5809655|NCT02754492|20054080|P4|Overall Study|Equipment malfuntion|5
5809656|NCT02754492|20054081|P3|Overall Study|Equipment malfuntion|2
5809657|NCT02754492|20054082|P2|Overall Study|Equipment malfuntion|0
5809658|NCT02754492|20054083|P1|Overall Study|Equipment malfuntion|0
5809659|NCT02754492|20054080|P4|Overall Study|Withdrawal by Subject|0
5809660|NCT02754492|20054081|P3|Overall Study|Withdrawal by Subject|0
5809661|NCT02754492|20054082|P2|Overall Study|Withdrawal by Subject|0
5809662|NCT02754492|20054083|P1|Overall Study|Withdrawal by Subject|2
5809663|NCT02754492|20054080|P4|Overall Study|Protocol Violation|1
5809664|NCT02754492|20054081|P3|Overall Study|Protocol Violation|0
5809665|NCT02754492|20054082|P2|Overall Study|Protocol Violation|2
5809666|NCT02754492|20054083|P1|Overall Study|Protocol Violation|2
5809667|NCT02754440|20054099|P4|Overall Study|Subject issues not resulting in AE|12
5809668|NCT02754440|20054100|P3|Overall Study|Subject issues not resulting in AE|0
5809669|NCT02754440|20054101|P2|Overall Study|Subject issues not resulting in AE|0
5809670|NCT02754440|20054102|P1|Overall Study|Subject issues not resulting in AE|0
5809671|NCT02754440|20054099|P4|Overall Study|Equipment failure|7
5809672|NCT02754440|20054100|P3|Overall Study|Equipment failure|5
5809673|NCT02754440|20054101|P2|Overall Study|Equipment failure|5
5809674|NCT02754440|20054102|P1|Overall Study|Equipment failure|0
5809675|NCT02754440|20054099|P4|Overall Study|Withdrawal by Subject|1
5809676|NCT02754440|20054100|P3|Overall Study|Withdrawal by Subject|0
5809677|NCT02754440|20054101|P2|Overall Study|Withdrawal by Subject|0
5809678|NCT02754440|20054102|P1|Overall Study|Withdrawal by Subject|0
5809679|NCT02754440|20054099|P4|Overall Study|Adverse Event|9
5809680|NCT02754440|20054100|P3|Overall Study|Adverse Event|0
5809681|NCT02754440|20054101|P2|Overall Study|Adverse Event|1
5809682|NCT02754440|20054102|P1|Overall Study|Adverse Event|3
5809683|NCT02754440|20054099|P4|Overall Study|Protocol Violation|6
5809684|NCT02754440|20054100|P3|Overall Study|Protocol Violation|2
5809685|NCT02754440|20054101|P2|Overall Study|Protocol Violation|2
5809686|NCT02754440|20054102|P1|Overall Study|Protocol Violation|3
5809687|NCT02753946|20054154|P2|Overall Study|Physician Decision|2
5809688|NCT02753946|20054155|P1|Overall Study|Physician Decision|0
5809689|NCT02753946|20054154|P2|Overall Study|Lack of Efficacy|0
5809690|NCT02753946|20054155|P1|Overall Study|Lack of Efficacy|1
5809691|NCT02753946|20054154|P2|Overall Study|Withdrawal by Subject|1
5809692|NCT02753946|20054155|P1|Overall Study|Withdrawal by Subject|6
5809693|NCT02753946|20054154|P2|Overall Study|Adverse Event|6
5809694|NCT02753946|20054155|P1|Overall Study|Adverse Event|7
5809695|NCT02753595|20054256|P2|Overall Study|Sponsor termination|2
5809696|NCT02753595|20054257|P1|Overall Study|Sponsor termination|2
5809697|NCT02753075|20054301|P3|Overall Study|Physician Decision|0
5809698|NCT02753075|20054302|P2|Overall Study|Physician Decision|1
5809699|NCT02753075|20054303|P1|Overall Study|Physician Decision|3
5809700|NCT02753075|20054301|P3|Overall Study|Withdrawal of Consent|3
5809701|NCT02753075|20054302|P2|Overall Study|Withdrawal of Consent|1
5809702|NCT02753075|20054303|P1|Overall Study|Withdrawal of Consent|1
5809703|NCT02753075|20054301|P3|Overall Study|Lost to Follow-up|0
5809704|NCT02753075|20054302|P2|Overall Study|Lost to Follow-up|0
5809705|NCT02753075|20054303|P1|Overall Study|Lost to Follow-up|2
5809706|NCT02753075|20054301|P3|Overall Study|Adverse Event|0
5809707|NCT02753075|20054302|P2|Overall Study|Adverse Event|1
5809708|NCT02753075|20054303|P1|Overall Study|Adverse Event|2
5809709|NCT02752958|20054328|P1|Overall Study|Other (Reason not specified)|2
5809710|NCT02752958|20054328|P1|Overall Study|Withdrawal by Subject|2
5809711|NCT02752958|20054328|P1|Overall Study|Protocol Violation|1
5809712|NCT02752958|20054328|P1|Overall Study|Lost to Follow-up|1
5809713|NCT02752958|20054328|P1|Overall Study|Adverse Event|3
5809714|NCT02752906|20054399|P2|Overall Study|Lost to Follow-up|2
5809715|NCT02752906|20054400|P1|Overall Study|Lost to Follow-up|3
5809716|NCT02752906|20054399|P2|Overall Study|Withdrawal by Subject|2
5809717|NCT02752906|20054400|P1|Overall Study|Withdrawal by Subject|2
5809718|NCT02752906|20054399|P2|Overall Study|Protocol Violation|1
5809719|NCT02752906|20054400|P1|Overall Study|Protocol Violation|2
5809720|NCT02752802|20054425|P2|Overall Study|Contrast Volume Not Collected|0
5809721|NCT02752802|20054426|P1|Overall Study|Contrast Volume Not Collected|1
5809722|NCT02752776|20054438|P3|Overall Study|Withdrawal by Subject|2
5809723|NCT02752776|20054439|P2|Overall Study|Withdrawal by Subject|4
5809724|NCT02752776|20054440|P1|Overall Study|Withdrawal by Subject|3
5809725|NCT02752776|20054438|P3|Overall Study|Death|1
5809726|NCT02752776|20054439|P2|Overall Study|Death|0
5809727|NCT02752776|20054440|P1|Overall Study|Death|0
5809728|NCT02752776|20054438|P3|Overall Study|Subject/guardian decision|4
5809729|NCT02752776|20054439|P2|Overall Study|Subject/guardian decision|6
5809730|NCT02752776|20054440|P1|Overall Study|Subject/guardian decision|8
5809731|NCT02752776|20054438|P3|Overall Study|Protocol Violation|6
5809732|NCT02752776|20054439|P2|Overall Study|Protocol Violation|13
5809733|NCT02752776|20054440|P1|Overall Study|Protocol Violation|10
5809734|NCT02752776|20054438|P3|Overall Study|Pregnancy|3
5809735|NCT02752776|20054439|P2|Overall Study|Pregnancy|6
5809736|NCT02752776|20054440|P1|Overall Study|Pregnancy|1
5809737|NCT02752776|20054438|P3|Overall Study|Physician Decision|2
5809738|NCT02752776|20054439|P2|Overall Study|Physician Decision|6
5809739|NCT02752776|20054440|P1|Overall Study|Physician Decision|2
5809740|NCT02752776|20054438|P3|Overall Study|Non-compliance with study treatment|1
5809741|NCT02752776|20054439|P2|Overall Study|Non-compliance with study treatment|0
5809742|NCT02752776|20054440|P1|Overall Study|Non-compliance with study treatment|0
5809743|NCT02752776|20054438|P3|Overall Study|Lost to Follow-up|4
5809744|NCT02752776|20054439|P2|Overall Study|Lost to Follow-up|12
5809745|NCT02752776|20054440|P1|Overall Study|Lost to Follow-up|11
5809746|NCT02752776|20054438|P3|Overall Study|Lack of Efficacy|14
5809747|NCT02752776|20054439|P2|Overall Study|Lack of Efficacy|6
5809748|NCT02752776|20054440|P1|Overall Study|Lack of Efficacy|2
5809749|NCT02752776|20054438|P3|Overall Study|Adverse Event|11
5809750|NCT02752776|20054439|P2|Overall Study|Adverse Event|23
5809751|NCT02752776|20054440|P1|Overall Study|Adverse Event|15
5809752|NCT02752633|20054486|P1|Overall Study|Withdrawal by Subject|1
5809753|NCT02752087|20054524|P2|Washout|Physician Decision|0
5809754|NCT02752087|20054525|P1|Washout|Physician Decision|1
5809755|NCT02752074|20054535|P2|Overall Study|Withdrawal by Subject|10
5809756|NCT02752074|20054536|P1|Overall Study|Withdrawal by Subject|9
5809757|NCT02752074|20054535|P2|Overall Study|Death|129
5809758|NCT02752074|20054536|P1|Overall Study|Death|146
5809759|NCT02752074|20054535|P2|Overall Study|Lost to Follow-up|4
5809760|NCT02752074|20054536|P1|Overall Study|Lost to Follow-up|1
5809761|NCT02752048|20054561|P3|Overall Study|Withdrawal by Subject|3
5809762|NCT02752048|20054562|P2|Overall Study|Withdrawal by Subject|0
5809763|NCT02752048|20054563|P1|Overall Study|Withdrawal by Subject|0
5809764|NCT02751983|20054582|P2|Three-Month Follow-Up Assessments|Lost to Follow-up|16
5809765|NCT02751983|20054583|P1|Three-Month Follow-Up Assessments|Lost to Follow-up|12
5809766|NCT02751983|20054582|P2|One-Month Follow-Up Assessments|Lost to Follow-up|12
5809767|NCT02751983|20054583|P1|One-Month Follow-Up Assessments|Lost to Follow-up|14
5809768|NCT02751983|20054582|P2|Post-Treatment Assessment|Lost to Follow-up|0
5809769|NCT02751983|20054583|P1|Post-Treatment Assessment|Lost to Follow-up|5
5809770|NCT02751983|20054582|P2|Treatment|Discharged prior to beginning ACT|0
5809771|NCT02751983|20054583|P1|Treatment|Discharged prior to beginning ACT|2
5809772|NCT02751983|20054582|P2|Treatment|Stopped ACT, but Remained in study|0
5809773|NCT02751983|20054583|P1|Treatment|Stopped ACT, but Remained in study|2
5809774|NCT02751931|20054604|P2|Overall Study|Other: Miscelleneous|8
5809775|NCT02751931|20054605|P1|Overall Study|Other: Miscelleneous|10
5809776|NCT02751931|20054604|P2|Overall Study|Adverse Event|0
5809777|NCT02751931|20054605|P1|Overall Study|Adverse Event|3
5809778|NCT02751580|20054693|P1|Overall Study|Death|2
5809779|NCT02751580|20054693|P1|Overall Study|Lost to Follow-up|4
5809780|NCT02751450|20054706|P2|Overall Study|Adverse Event|0
5809781|NCT02751450|20054707|P1|Overall Study|Adverse Event|1
5809782|NCT02751424|20054728|P9|Part 2|Adverse Event|0
5809783|NCT02751424|20054729|P8|Part 2|Adverse Event|5
5809784|NCT02751424|20054730|P7|Part 2|Adverse Event|0
5809785|NCT02751424|20054731|P6|Part 2|Adverse Event|0
5809786|NCT02751424|20054732|P5|Part 2|Adverse Event|0
5809787|NCT02751424|20054733|P4|Part 2|Adverse Event|0
5809788|NCT02751424|20054734|P3|Part 2|Adverse Event|0
5809789|NCT02751424|20054735|P2|Part 2|Adverse Event|0
5809790|NCT02751424|20054736|P1|Part 2|Adverse Event|0
5809791|NCT02751320|20054892|P1|Overall Study|Withdrawal by Subject|1
5809792|NCT02751320|20054892|P1|Overall Study|Adverse Event|2
5809793|NCT02750943|20054930|P2|Overall Study|Withdrawal by Subject|7
5809794|NCT02750943|20054931|P1|Overall Study|Withdrawal by Subject|5
5809795|NCT02750943|20054930|P2|Overall Study|Lost to Follow-up|2
5809796|NCT02750943|20054931|P1|Overall Study|Lost to Follow-up|1
5809797|NCT02750930|20054945|P1|Overall Study|Study closed/terminated|8
5809798|NCT02750813|20054957|P2|Period 1, First 14 Days of Wear|Reason not given|1
5809799|NCT02750813|20054958|P1|Period 1, First 14 Days of Wear|Reason not given|0
5809800|NCT02750813|20054957|P2|Period 1, First 14 Days of Wear|Withdrawal by Subject|0
5809801|NCT02750813|20054958|P1|Period 1, First 14 Days of Wear|Withdrawal by Subject|1
5809802|NCT02750800|20054973|P1|Overall Study|Other, not specified|3
5809803|NCT02750800|20054973|P1|Overall Study|Patient request|12
5809804|NCT02750800|20054973|P1|Overall Study|Investigator decision|53
5809805|NCT02750800|20054973|P1|Overall Study|Lost to Follow-up|12
5809806|NCT02750800|20054973|P1|Overall Study|Adverse Event|18
5809807|NCT02750761|20055078|P6|Overall Study|Lost to Follow-up|0
5809808|NCT02750761|20055079|P5|Overall Study|Lost to Follow-up|0
5809809|NCT02750761|20055080|P4|Overall Study|Lost to Follow-up|0
5809810|NCT02750761|20055081|P3|Overall Study|Lost to Follow-up|1
5809811|NCT02750761|20055082|P2|Overall Study|Lost to Follow-up|0
5809812|NCT02750761|20055083|P1|Overall Study|Lost to Follow-up|0
5809813|NCT02750709|20055179|P6|Treatment Period 1|Adverse Event|1
5809814|NCT02750709|20055180|P5|Treatment Period 1|Adverse Event|0
5809815|NCT02750709|20055181|P4|Treatment Period 1|Adverse Event|0
5809816|NCT02750709|20055182|P3|Treatment Period 1|Adverse Event|0
5809817|NCT02750709|20055183|P2|Treatment Period 1|Adverse Event|0
5809818|NCT02750709|20055184|P1|Treatment Period 1|Adverse Event|0
5809819|NCT02750618|20055210|P1|Overall Study|Withdrawal by Subject|1
5809820|NCT02750592|20055226|P1|Overall Study|Lack of Efficacy|2
5809821|NCT02750592|20055226|P1|Overall Study|Adverse Event|3
5809822|NCT02750501|20055245|P1|Overall Study|Non-compliant use of PERT|1
5809823|NCT02750501|20055245|P1|Overall Study|G-tube came out|1
5809824|NCT02750501|20055245|P1|Overall Study|Protocol Violation|1
5809825|NCT02750501|20055245|P1|Overall Study|Physician Decision|1
5809826|NCT02750501|20055245|P1|Overall Study|Adverse Event|4
5809827|NCT02750410|20055259|P2|Open-Label Extension Period|Withdrawal by Subject|2
5809828|NCT02750410|20055260|P1|Open-Label Extension Period|Withdrawal by Subject|1
5809829|NCT02750410|20055259|P2|Open-Label Extension Period|Protocol Violation|1
5809830|NCT02750410|20055260|P1|Open-Label Extension Period|Protocol Violation|0
5809831|NCT02750410|20055259|P2|Open-Label Extension Period|Adverse Event|3
5809832|NCT02750410|20055260|P1|Open-Label Extension Period|Adverse Event|5
5809833|NCT02750410|20055259|P2|Double-Blind Treatment Period|Withdrawal by Subject|1
5809834|NCT02750410|20055260|P1|Double-Blind Treatment Period|Withdrawal by Subject|0
5809835|NCT02750410|20055259|P2|Double-Blind Treatment Period|Adverse Event|2
5809836|NCT02750410|20055260|P1|Double-Blind Treatment Period|Adverse Event|2
5809837|NCT02750345|20055278|P6|Intervention 1|Adverse Event|0
5809838|NCT02750345|20055279|P5|Intervention 1|Adverse Event|1
5809839|NCT02750345|20055280|P4|Intervention 1|Adverse Event|0
5809840|NCT02750345|20055281|P3|Intervention 1|Adverse Event|0
5809841|NCT02750345|20055282|P2|Intervention 1|Adverse Event|0
5809842|NCT02750345|20055283|P1|Intervention 1|Adverse Event|0
5809843|NCT02750332|20055309|P2|Treatment Period 1|Withdrawal by Subject|1
5809844|NCT02750332|20055310|P1|Treatment Period 1|Withdrawal by Subject|0
5809845|NCT02750306|20055330|P2|Overall Study|Protocol Violation|0
5809846|NCT02750306|20055331|P1|Overall Study|Protocol Violation|1
5809847|NCT02750306|20055330|P2|Overall Study|Withdrawal by Subject|2
5809848|NCT02750306|20055331|P1|Overall Study|Withdrawal by Subject|5
5809853|NCT02749370|20055396|P1|Overall Study|Lost to Follow-up|3
5809854|NCT02749370|20055396|P1|Overall Study|Withdrawal by Subject|11
5809855|NCT02748863|20055446|P5|Treatment Period 2|Pregnancy|1
5809856|NCT02748863|20055447|P4|Treatment Period 2|Pregnancy|0
5809857|NCT02748863|20055448|P3|Treatment Period 2|Pregnancy|0
5809858|NCT02748863|20055449|P2|Treatment Period 2|Pregnancy|0
5809859|NCT02748863|20055450|P1|Treatment Period 2|Pregnancy|0
5809860|NCT02748863|20055446|P5|Treatment Period 2|Lack of Efficacy|0
5809861|NCT02748863|20055447|P4|Treatment Period 2|Lack of Efficacy|0
5809862|NCT02748863|20055448|P3|Treatment Period 2|Lack of Efficacy|0
5809863|NCT02748863|20055449|P2|Treatment Period 2|Lack of Efficacy|1
5809864|NCT02748863|20055450|P1|Treatment Period 2|Lack of Efficacy|0
5809865|NCT02748863|20055446|P5|Treatment Period 2|Adverse Event|0
5809866|NCT02748863|20055447|P4|Treatment Period 2|Adverse Event|2
5809867|NCT02748863|20055448|P3|Treatment Period 2|Adverse Event|0
5809868|NCT02748863|20055449|P2|Treatment Period 2|Adverse Event|2
5809869|NCT02748863|20055450|P1|Treatment Period 2|Adverse Event|3
5809870|NCT02748863|20055446|P5|Treatment Period 2|Lost to Follow-up|0
5809871|NCT02748863|20055447|P4|Treatment Period 2|Lost to Follow-up|0
5809872|NCT02748863|20055448|P3|Treatment Period 2|Lost to Follow-up|0
5809873|NCT02748863|20055449|P2|Treatment Period 2|Lost to Follow-up|0
5809874|NCT02748863|20055450|P1|Treatment Period 2|Lost to Follow-up|2
5809875|NCT02748863|20055446|P5|Treatment Period 1|Withdrawal by Subject|0
5809876|NCT02748863|20055447|P4|Treatment Period 1|Withdrawal by Subject|0
5809877|NCT02748863|20055448|P3|Treatment Period 1|Withdrawal by Subject|1
5809878|NCT02748863|20055449|P2|Treatment Period 1|Withdrawal by Subject|1
5809879|NCT02748863|20055450|P1|Treatment Period 1|Withdrawal by Subject|0
5809880|NCT02748863|20055446|P5|Treatment Period 1|Lack of Efficacy|0
5809881|NCT02748863|20055447|P4|Treatment Period 1|Lack of Efficacy|0
5809882|NCT02748863|20055448|P3|Treatment Period 1|Lack of Efficacy|1
5809883|NCT02748863|20055449|P2|Treatment Period 1|Lack of Efficacy|0
5809884|NCT02748863|20055450|P1|Treatment Period 1|Lack of Efficacy|0
5809885|NCT02748863|20055446|P5|Treatment Period 1|Adverse Event|0
5809886|NCT02748863|20055447|P4|Treatment Period 1|Adverse Event|0
5809887|NCT02748863|20055448|P3|Treatment Period 1|Adverse Event|0
5809888|NCT02748863|20055449|P2|Treatment Period 1|Adverse Event|1
5809889|NCT02748863|20055450|P1|Treatment Period 1|Adverse Event|0
5809890|NCT02748512|20055534|P2|Overall Study|Lost to Follow-up|1
5809891|NCT02748512|20055535|P1|Overall Study|Lost to Follow-up|1
5809892|NCT02748356|20055543|P1|Overall Study|Withdrawal by Subject|1
5809893|NCT02748317|20055548|P1|Overall Study|Death|1
5809894|NCT02748317|20055548|P1|Overall Study|Lost to Follow-up|8
5809895|NCT02748317|20055548|P1|Overall Study|Withdrawal by Subject|14
5809896|NCT02748213|20055555|P2|Overall Study|Other|29
5809897|NCT02748213|20055556|P1|Overall Study|Other|30
5809898|NCT02748213|20055555|P2|Overall Study|Failure to Return|0
5809899|NCT02748213|20055556|P1|Overall Study|Failure to Return|1
5809900|NCT02748213|20055555|P2|Overall Study|Refused Treatment*|6
5809901|NCT02748213|20055556|P1|Overall Study|Refused Treatment*|6
5809902|NCT02748213|20055555|P2|Overall Study|Protocol Violation|4
5809903|NCT02748213|20055556|P1|Overall Study|Protocol Violation|6
5809904|NCT02748213|20055555|P2|Overall Study|Violation of Selection Criteria|0
5809905|NCT02748213|20055556|P1|Overall Study|Violation of Selection Criteria|2
5809906|NCT02748213|20055555|P2|Overall Study|Insufficient Therapeutic Response|57
5809907|NCT02748213|20055556|P1|Overall Study|Insufficient Therapeutic Response|56
5809908|NCT02748213|20055555|P2|Overall Study|Death|3
5809909|NCT02748213|20055556|P1|Overall Study|Death|5
5809910|NCT02748213|20055555|P2|Overall Study|Adverse Event or Intercurrent Illness|11
5809911|NCT02748213|20055556|P1|Overall Study|Adverse Event or Intercurrent Illness|5
5809912|NCT02748213|20055555|P2|Overall Study|Abnormal Laboratory Test|0
5809913|NCT02748213|20055556|P1|Overall Study|Abnormal Laboratory Test|1
5809914|NCT02748213|20055555|P2|Overall Study|Withdrawal Prior to Treatment|2
5809915|NCT02748213|20055556|P1|Overall Study|Withdrawal Prior to Treatment|1
5809916|NCT02748057|20055585|P2|Overall Study|Withdrawal by Subject|0
5809917|NCT02748057|20055586|P1|Overall Study|Withdrawal by Subject|1
5809918|NCT02748057|20055585|P2|Overall Study|Participant Moved|0
5809919|NCT02748057|20055586|P1|Overall Study|Participant Moved|1
5809920|NCT02748057|20055585|P2|Overall Study|Protocol Violation|1
5809921|NCT02748057|20055586|P1|Overall Study|Protocol Violation|2
5809922|NCT02748057|20055585|P2|Overall Study|Physician Decision|1
5809923|NCT02748057|20055586|P1|Overall Study|Physician Decision|0
5809924|NCT02748057|20055585|P2|Overall Study|Adverse Event|0
5809925|NCT02748057|20055586|P1|Overall Study|Adverse Event|1
5809926|NCT02747420|20055655|P2|Overall Study|Withdrawal by Subject|2
5809927|NCT02747420|20055656|P1|Overall Study|Withdrawal by Subject|3
5809928|NCT02747420|20055655|P2|Overall Study|Lost to Follow-up|2
5809929|NCT02747420|20055656|P1|Overall Study|Lost to Follow-up|4
5809930|NCT02747108|20055673|P2|Overall Study|Protocol Violation|0
5809931|NCT02747108|20055674|P1|Overall Study|Protocol Violation|2
5809932|NCT02747108|20055673|P2|Overall Study|Withdrawal by Subject|0
5809933|NCT02747108|20055674|P1|Overall Study|Withdrawal by Subject|1
5809934|NCT02747108|20055673|P2|Overall Study|Death|2
5809935|NCT02747108|20055674|P1|Overall Study|Death|2
5809936|NCT02747043|20055716|P2|Overall Study|Disease progression|0
5809937|NCT02747043|20055717|P1|Overall Study|Disease progression|4
5809938|NCT02747043|20055716|P2|Overall Study|Protocol Violation|1
5809939|NCT02747043|20055717|P1|Overall Study|Protocol Violation|0
5809940|NCT02747043|20055716|P2|Overall Study|Physician Decision|1
5809941|NCT02747043|20055717|P1|Overall Study|Physician Decision|1
5809942|NCT02747043|20055716|P2|Overall Study|Withdrawal by Subject|1
5809943|NCT02747043|20055717|P1|Overall Study|Withdrawal by Subject|1
5809944|NCT02747043|20055716|P2|Overall Study|Adverse Event|1
5809945|NCT02747043|20055717|P1|Overall Study|Adverse Event|3
5809946|NCT02747043|20055716|P2|Overall Study|Other|1
5809947|NCT02747043|20055717|P1|Overall Study|Other|1
5809948|NCT02747004|20055746|P3|Overall Study|on study treatment/follow-up|41
5809949|NCT02747004|20055747|P2|Overall Study|on study treatment/follow-up|42
5809950|NCT02747004|20055748|P1|Overall Study|on study treatment/follow-up|48
5809951|NCT02747004|20055746|P3|Overall Study|Lost to Follow-up|2
5809952|NCT02747004|20055747|P2|Overall Study|Lost to Follow-up|2
5809953|NCT02747004|20055748|P1|Overall Study|Lost to Follow-up|1
5809954|NCT02747004|20055746|P3|Overall Study|Withdrawal by Subject|4
5809955|NCT02747004|20055747|P2|Overall Study|Withdrawal by Subject|5
5809956|NCT02747004|20055748|P1|Overall Study|Withdrawal by Subject|8
5809957|NCT02746705|20055807|P2|Overall Study|outlier scores deemed not valid|1
5809958|NCT02746705|20055808|P1|Overall Study|outlier scores deemed not valid|0
5809959|NCT02746705|20055807|P2|Overall Study|Lost to Follow-up|0
5809960|NCT02746705|20055808|P1|Overall Study|Lost to Follow-up|1
5809961|NCT02746705|20055807|P2|Overall Study|Physician Decision|1
5809962|NCT02746705|20055808|P1|Overall Study|Physician Decision|1
5809963|NCT02746679|20055822|P2|Overall Study|Lost to Follow-up|6
5809964|NCT02746679|20055823|P1|Overall Study|Lost to Follow-up|4
5809965|NCT02746627|20055856|P3|Overall Study|Withdrawal by Subject|1
5809966|NCT02746627|20055857|P2|Overall Study|Withdrawal by Subject|1
5809967|NCT02746627|20055858|P1|Overall Study|Withdrawal by Subject|1
5809968|NCT02746575|20055881|P1|Overall Study|Unknown history of CVA|1
5809969|NCT02746575|20055881|P1|Overall Study|PI unavailable|1
5809970|NCT02746575|20055881|P1|Overall Study|typ of surgery|1
5809971|NCT02746575|20055881|P1|Overall Study|type of surgery|1
5809972|NCT02746575|20055881|P1|Overall Study|put on beta-blocker|3
5809973|NCT02746575|20055881|P1|Overall Study|Study paused|8
5809974|NCT02746575|20055881|P1|Overall Study|Bradycardia/hypotension|9
5809975|NCT02746575|20055881|P1|Overall Study|Withdrawal by Subject|3
5809976|NCT02746575|20055881|P1|Overall Study|Received epidural|10
5809977|NCT02746575|20055881|P1|Overall Study|Surgery cancelled or time chaned|13
5809978|NCT02745535|20055944|P1|Overall Study|Lost to Follow-up|2
5809979|NCT02745535|20055944|P1|Overall Study|Adverse Event|3
5809980|NCT02745535|20055944|P1|Overall Study|Death|1
5809981|NCT02745392|20055956|P4|Overall Study|Lost to Follow-up|0
5809982|NCT02745392|20055957|P3|Overall Study|Lost to Follow-up|0
5809983|NCT02745392|20055958|P2|Overall Study|Lost to Follow-up|1
5809984|NCT02745392|20055959|P1|Overall Study|Lost to Follow-up|0
5809985|NCT02745145|20055992|P3|Overall Study|Study Termination|7
5809986|NCT02745145|20055993|P2|Overall Study|Study Termination|3
5809987|NCT02745145|20055994|P1|Overall Study|Study Termination|8
5809988|NCT02745145|20055992|P3|Overall Study|Withdrew consent|1
5809989|NCT02745145|20055993|P2|Overall Study|Withdrew consent|1
5809990|NCT02745145|20055994|P1|Overall Study|Withdrew consent|1
5809991|NCT02745145|20055992|P3|Overall Study|Progressive disease|1
5809992|NCT02745145|20055993|P2|Overall Study|Progressive disease|0
5809993|NCT02745145|20055994|P1|Overall Study|Progressive disease|0
5809994|NCT02745145|20055992|P3|Overall Study|Death|0
5809995|NCT02745145|20055993|P2|Overall Study|Death|1
5809996|NCT02745145|20055994|P1|Overall Study|Death|0
5809997|NCT02745145|20055992|P3|Overall Study|Adverse Event|0
5809998|NCT02745145|20055993|P2|Overall Study|Adverse Event|0
5809999|NCT02745145|20055994|P1|Overall Study|Adverse Event|1
5810000|NCT02745119|20056033|P4|Overall Study|Reason Not Specified|1
5810001|NCT02745119|20056034|P3|Overall Study|Reason Not Specified|0
5810002|NCT02745119|20056035|P2|Overall Study|Reason Not Specified|2
5810003|NCT02745119|20056036|P1|Overall Study|Reason Not Specified|0
5810004|NCT02745119|20056033|P4|Overall Study|Physician Decision|2
5810005|NCT02745119|20056034|P3|Overall Study|Physician Decision|2
5810006|NCT02745119|20056035|P2|Overall Study|Physician Decision|2
5810007|NCT02745119|20056036|P1|Overall Study|Physician Decision|0
5810008|NCT02745119|20056033|P4|Overall Study|Study Terminated by Sponsor|251
5810009|NCT02745119|20056034|P3|Overall Study|Study Terminated by Sponsor|135
5810010|NCT02745119|20056035|P2|Overall Study|Study Terminated by Sponsor|252
5810011|NCT02745119|20056036|P1|Overall Study|Study Terminated by Sponsor|134
5810012|NCT02745119|20056033|P4|Overall Study|Withdrawal by Subject|14
5810013|NCT02745119|20056034|P3|Overall Study|Withdrawal by Subject|8
5810014|NCT02745119|20056035|P2|Overall Study|Withdrawal by Subject|15
5810015|NCT02745119|20056036|P1|Overall Study|Withdrawal by Subject|7
5810016|NCT02745119|20056033|P4|Overall Study|Protocol Deviation|1
5810017|NCT02745119|20056034|P3|Overall Study|Protocol Deviation|0
5810018|NCT02745119|20056035|P2|Overall Study|Protocol Deviation|0
5810019|NCT02745119|20056036|P1|Overall Study|Protocol Deviation|0
5810020|NCT02745119|20056033|P4|Overall Study|Lost to Follow-up|1
5810021|NCT02745119|20056034|P3|Overall Study|Lost to Follow-up|0
5810022|NCT02745119|20056035|P2|Overall Study|Lost to Follow-up|0
5810023|NCT02745119|20056036|P1|Overall Study|Lost to Follow-up|0
5810024|NCT02745119|20056033|P4|Overall Study|Death|4
5810025|NCT02745119|20056034|P3|Overall Study|Death|0
5810026|NCT02745119|20056035|P2|Overall Study|Death|3
5810027|NCT02745119|20056036|P1|Overall Study|Death|3
5810028|NCT02745119|20056033|P4|Overall Study|Adverse Event|3
5810029|NCT02745119|20056034|P3|Overall Study|Adverse Event|1
5810030|NCT02745119|20056035|P2|Overall Study|Adverse Event|0
5810031|NCT02745119|20056036|P1|Overall Study|Adverse Event|1
5810032|NCT02745080|20056060|P2|Overall Study|Withdrawal by Subject|41
5810033|NCT02745080|20056061|P1|Overall Study|Withdrawal by Subject|22
5810034|NCT02745080|20056060|P2|Overall Study|Protocol Violation|1
5810035|NCT02745080|20056061|P1|Overall Study|Protocol Violation|3
5810036|NCT02745080|20056060|P2|Overall Study|Physician Decision|0
5810037|NCT02745080|20056061|P1|Overall Study|Physician Decision|3
5810038|NCT02745080|20056060|P2|Overall Study|Lost to Follow-up|3
5810039|NCT02745080|20056061|P1|Overall Study|Lost to Follow-up|3
5810040|NCT02745080|20056060|P2|Overall Study|Lack of Efficacy|23
5810041|NCT02745080|20056061|P1|Overall Study|Lack of Efficacy|11
5810042|NCT02745080|20056060|P2|Overall Study|Adverse Event|21
5810043|NCT02745080|20056061|P1|Overall Study|Adverse Event|13
5810044|NCT02744898|20056076|P1|Overall Study|Toxicity|1
5810045|NCT02744898|20056076|P1|Overall Study|Physician Decision|1
5810046|NCT02744898|20056076|P1|Overall Study|Progressive Disease|2
5810047|NCT02744755|20056090|P2|Study Period 2|Lack of Efficacy|2
5810048|NCT02744755|20056091|P1|Study Period 2|Lack of Efficacy|3
5810049|NCT02744755|20056090|P2|Study Period 2|Withdrawal by Subject|2
5810050|NCT02744755|20056091|P1|Study Period 2|Withdrawal by Subject|2
5810051|NCT02744755|20056090|P2|Study Period 2|Lost to Follow-up|2
5810052|NCT02744755|20056091|P1|Study Period 2|Lost to Follow-up|0
5810053|NCT02744755|20056090|P2|Study Period 2|not defined|2
5810054|NCT02744755|20056091|P1|Study Period 2|not defined|3
5810055|NCT02744755|20056090|P2|Study Period 2|Protocol Violation|0
5810056|NCT02744755|20056091|P1|Study Period 2|Protocol Violation|1
5810057|NCT02744755|20056090|P2|Study Period 2|Adverse Event|0
5810058|NCT02744755|20056091|P1|Study Period 2|Adverse Event|5
5810059|NCT02744755|20056090|P2|Study Period 1|Withdrawal by Subject|4
5810060|NCT02744755|20056091|P1|Study Period 1|Withdrawal by Subject|8
5810061|NCT02744755|20056090|P2|Study Period 1|Lack of Efficacy|0
5810062|NCT02744755|20056091|P1|Study Period 1|Lack of Efficacy|1
5810063|NCT02744755|20056090|P2|Study Period 1|Lost to Follow-up|1
5810064|NCT02744755|20056091|P1|Study Period 1|Lost to Follow-up|1
5810065|NCT02744755|20056090|P2|Study Period 1|Adverse Event|1
5810066|NCT02744755|20056091|P1|Study Period 1|Adverse Event|1
5810067|NCT02744755|20056090|P2|Study Period 1|Pregnancy|0
5810068|NCT02744755|20056091|P1|Study Period 1|Pregnancy|1
5810069|NCT02744755|20056090|P2|Study Period 1|not defined|1
5810070|NCT02744755|20056091|P1|Study Period 1|not defined|0
5810071|NCT02744755|20056090|P2|Study Period 1|Protocol Violation|1
5810072|NCT02744755|20056091|P1|Study Period 1|Protocol Violation|2
5810073|NCT02744391|20056151|P1|Overall Study|Withdrawal by Subject|3
5810074|NCT02744391|20056151|P1|Overall Study|Physician Decision|2
5810075|NCT02744391|20056151|P1|Overall Study|Lost to Follow-up|9
5810076|NCT02744066|20056192|P2|Overall Study|Discharged from NICU prior to completion|4
5810077|NCT02744066|20056193|P1|Overall Study|Discharged from NICU prior to completion|0
5810078|NCT02744066|20056192|P2|Overall Study|Withdrawal by parent|1
5810079|NCT02744066|20056193|P1|Overall Study|Withdrawal by parent|0
5810080|NCT02743962|20056203|P2|Overall Study|Atrophic vaginitis diagnosed|0
5810081|NCT02743962|20056204|P1|Overall Study|Atrophic vaginitis diagnosed|1
5810082|NCT02743949|20056226|P3|Overall Study|Voluntary Withdrawal|0
5810083|NCT02743949|20056227|P2|Overall Study|Voluntary Withdrawal|1
5810084|NCT02743949|20056228|P1|Overall Study|Voluntary Withdrawal|2
5810085|NCT02743949|20056226|P3|Overall Study|Significant Protocol Deviation|1
5810086|NCT02743949|20056227|P2|Overall Study|Significant Protocol Deviation|0
5810087|NCT02743949|20056228|P1|Overall Study|Significant Protocol Deviation|2
5810088|NCT02743949|20056226|P3|Overall Study|Adverse Event|2
5810089|NCT02743949|20056227|P2|Overall Study|Adverse Event|0
5810090|NCT02743949|20056228|P1|Overall Study|Adverse Event|0
5810091|NCT02743780|20056255|P5|Part 3 (7 Days)|Adverse Event|0
5810092|NCT02743780|20056256|P4|Part 3 (7 Days)|Adverse Event|0
5810093|NCT02743780|20056257|P3|Part 3 (7 Days)|Adverse Event|1
5810094|NCT02743780|20056258|P2|Part 3 (7 Days)|Adverse Event|0
5810095|NCT02743780|20056259|P1|Part 3 (7 Days)|Adverse Event|0
5810096|NCT02743520|20056313|P1|Overall Study|Withdrawal by Subject|1
5810097|NCT02743221|20056386|P2|Overall Study|Patient not eligible, not treated|1
5810098|NCT02743221|20056387|P1|Overall Study|Patient not eligible, not treated|0
5810099|NCT02743221|20056386|P2|Overall Study|Physician Decision|5
5810100|NCT02743221|20056387|P1|Overall Study|Physician Decision|2
5810101|NCT02743221|20056386|P2|Overall Study|non medical reason|2
5810102|NCT02743221|20056387|P1|Overall Study|non medical reason|8
5810103|NCT02743221|20056386|P2|Overall Study|Adverse Event|14
5810104|NCT02743221|20056387|P1|Overall Study|Adverse Event|17
5810105|NCT02743221|20056386|P2|Overall Study|Progressive disease|38
5810106|NCT02743221|20056387|P1|Overall Study|Progressive disease|29
5810107|NCT02743117|20056403|P2|Overall Study|Other|0
5810108|NCT02743117|20056404|P1|Overall Study|Other|1
5810109|NCT02743117|20056403|P2|Overall Study|Lost to Follow-up|1
5810110|NCT02743117|20056404|P1|Overall Study|Lost to Follow-up|0
5810111|NCT02742818|20056437|P2|Overall Study|Protocol Violation|1
5810112|NCT02742818|20056438|P1|Overall Study|Protocol Violation|0
5810113|NCT02742818|20056437|P2|Overall Study|Adverse Event|1
5810114|NCT02742818|20056438|P1|Overall Study|Adverse Event|0
5810115|NCT02742766|20056471|P19|Part 2 (Up to 22 Days)|Physician Decision|0
5810116|NCT02742766|20056472|P18|Part 2 (Up to 22 Days)|Physician Decision|0
5810117|NCT02742766|20056473|P17|Part 2 (Up to 22 Days)|Physician Decision|0
5810118|NCT02742766|20056474|P16|Part 2 (Up to 22 Days)|Physician Decision|1
5810119|NCT02742766|20056475|P15|Part 2 (Up to 22 Days)|Physician Decision|0
5810120|NCT02742766|20056476|P14|Part 2 (Up to 22 Days)|Physician Decision|5
5810121|NCT02742766|20056477|P13|Part 2 (Up to 22 Days)|Physician Decision|2
5810122|NCT02742766|20056478|P12|Part 2 (Up to 22 Days)|Physician Decision|0
5810123|NCT02742766|20056479|P11|Part 2 (Up to 22 Days)|Physician Decision|0
5810124|NCT02742766|20056480|P10|Part 2 (Up to 22 Days)|Physician Decision|0
5810125|NCT02742766|20056481|P9|Part 2 (Up to 22 Days)|Physician Decision|0
5810126|NCT02742766|20056482|P8|Part 2 (Up to 22 Days)|Physician Decision|0
5810127|NCT02742766|20056483|P7|Part 2 (Up to 22 Days)|Physician Decision|0
5810128|NCT02742766|20056484|P6|Part 2 (Up to 22 Days)|Physician Decision|0
5810129|NCT02742766|20056485|P5|Part 2 (Up to 22 Days)|Physician Decision|0
5810130|NCT02742766|20056486|P4|Part 2 (Up to 22 Days)|Physician Decision|0
5810131|NCT02742766|20056487|P3|Part 2 (Up to 22 Days)|Physician Decision|0
5810132|NCT02742766|20056488|P2|Part 2 (Up to 22 Days)|Physician Decision|0
5810133|NCT02742766|20056489|P1|Part 2 (Up to 22 Days)|Physician Decision|0
5810134|NCT02742766|20056471|P19|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
5810135|NCT02742766|20056472|P18|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
5810136|NCT02742766|20056473|P17|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
5810137|NCT02742766|20056474|P16|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
5810138|NCT02742766|20056475|P15|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
5810139|NCT02742766|20056476|P14|Part 2 (Up to 22 Days)|Withdrawal by Subject|1
5810140|NCT02742766|20056477|P13|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
5810141|NCT02742766|20056478|P12|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
5810142|NCT02742766|20056479|P11|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
5810143|NCT02742766|20056480|P10|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
5810144|NCT02742766|20056481|P9|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
5810145|NCT02742766|20056482|P8|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
5810146|NCT02742766|20056483|P7|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
5810147|NCT02742766|20056484|P6|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
5810148|NCT02742766|20056485|P5|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
5810149|NCT02742766|20056486|P4|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
5810150|NCT02742766|20056487|P3|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
5810151|NCT02742766|20056488|P2|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
5810152|NCT02742766|20056489|P1|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
5810153|NCT02742649|20056749|P5|Open-Label Period|Lost to Follow-up|1
5810154|NCT02742649|20056750|P4|Open-Label Period|Lost to Follow-up|0
5810155|NCT02742649|20056751|P3|Open-Label Period|Lost to Follow-up|0
5810156|NCT02742649|20056752|P2|Open-Label Period|Lost to Follow-up|0
5810157|NCT02742649|20056753|P1|Open-Label Period|Lost to Follow-up|0
5810158|NCT02742649|20056749|P5|Double-Blind Treatment Period|Adverse Event|0
5810159|NCT02742649|20056750|P4|Double-Blind Treatment Period|Adverse Event|0
5810160|NCT02742649|20056751|P3|Double-Blind Treatment Period|Adverse Event|0
5810161|NCT02742649|20056752|P2|Double-Blind Treatment Period|Adverse Event|1
5810162|NCT02742649|20056753|P1|Double-Blind Treatment Period|Adverse Event|0
5810163|NCT02742649|20056749|P5|Pre-Randomization Washout Period|Washout/Randomization Failure|0
5810164|NCT02742649|20056750|P4|Pre-Randomization Washout Period|Washout/Randomization Failure|0
5810165|NCT02742649|20056751|P3|Pre-Randomization Washout Period|Washout/Randomization Failure|0
5810166|NCT02742649|20056752|P2|Pre-Randomization Washout Period|Washout/Randomization Failure|0
5810167|NCT02742649|20056753|P1|Pre-Randomization Washout Period|Washout/Randomization Failure|5
5810168|NCT02742519|20056792|P3|Part 2 Open Label Period (32 Weeks)|Other|1
5810169|NCT02742519|20056793|P2|Part 2 Open Label Period (32 Weeks)|Other|0
5810170|NCT02742519|20056794|P1|Part 2 Open Label Period (32 Weeks)|Other|0
5810171|NCT02742519|20056792|P3|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|9
5810172|NCT02742519|20056793|P2|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0
5810173|NCT02742519|20056794|P1|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0
5810174|NCT02742519|20056792|P3|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|0
5810175|NCT02742519|20056793|P2|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1
5810176|NCT02742519|20056794|P1|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1
5810177|NCT02742441|20056814|P2|Overall Study|Adverse Event|2
5810178|NCT02742441|20056815|P1|Overall Study|Adverse Event|0
5810179|NCT02742441|20056814|P2|Overall Study|Withdrawal by Subject|2
5810180|NCT02742441|20056815|P1|Overall Study|Withdrawal by Subject|2
5810181|NCT02742441|20056814|P2|Overall Study|Lost to Follow-up|4
5810182|NCT02742441|20056815|P1|Overall Study|Lost to Follow-up|4
5810183|NCT02742103|20056862|P2|Overall Study|Withdrawal by Subject|2
5810184|NCT02742103|20056863|P1|Overall Study|Withdrawal by Subject|5
5810185|NCT02742103|20056862|P2|Overall Study|Moved to another town|1
5810186|NCT02742103|20056863|P1|Overall Study|Moved to another town|0
5810187|NCT02742103|20056862|P2|Overall Study|Adverse Event|0
5810188|NCT02742103|20056863|P1|Overall Study|Adverse Event|1
5810189|NCT02742103|20056862|P2|Overall Study|Death|2
5810190|NCT02742103|20056863|P1|Overall Study|Death|2
5810191|NCT02742103|20056862|P2|Overall Study|Protocol Violation|0
5810192|NCT02742103|20056863|P1|Overall Study|Protocol Violation|1
5810193|NCT02741713|20056909|P2|Overall Study|Surgery type changed intra-operatively|1
5810194|NCT02741713|20056910|P1|Overall Study|Surgery type changed intra-operatively|2
5810195|NCT02741635|20056950|P1|Overall Study|Withdrawal by Subject|1
5810196|NCT02741596|20056958|P2|Overall Study|Subject withdrawn-to commercial product|63
5810197|NCT02741596|20056959|P1|Overall Study|Subject withdrawn-to commercial product|54
5810198|NCT02741596|20056958|P2|Overall Study|Subject withdrawn-Other|4
5810199|NCT02741596|20056959|P1|Overall Study|Subject withdrawn-Other|17
5810200|NCT02741596|20056958|P2|Overall Study|Other (Unspecified)|3
5810201|NCT02741596|20056959|P1|Overall Study|Other (Unspecified)|0
5810202|NCT02741596|20056958|P2|Overall Study|Pregnancy|1
5810203|NCT02741596|20056959|P1|Overall Study|Pregnancy|3
5810204|NCT02741596|20056958|P2|Overall Study|Physician Decision|1
5810205|NCT02741596|20056959|P1|Overall Study|Physician Decision|2
5810206|NCT02741596|20056958|P2|Overall Study|Lost to Follow-up|1
5810207|NCT02741596|20056959|P1|Overall Study|Lost to Follow-up|1
5810208|NCT02741596|20056958|P2|Overall Study|Adverse Event|5
5810209|NCT02741596|20056959|P1|Overall Study|Adverse Event|1
5810210|NCT02741518|20056977|P2|Overall Study|Withdrawal by Subject|1
5810211|NCT02741518|20056978|P1|Overall Study|Withdrawal by Subject|1
5810212|NCT02741310|20056988|P2|Overall Study|Sponsor Decision|2
5810213|NCT02741310|20056989|P1|Overall Study|Sponsor Decision|2
5810214|NCT02741271|20057034|P2|Overall Study|Withdrawal by Parent/Guardian|2
5810215|NCT02741271|20057035|P1|Overall Study|Withdrawal by Parent/Guardian|0
5810216|NCT02741271|20057034|P2|Overall Study|Lost to Follow-up|0
5810217|NCT02741271|20057035|P1|Overall Study|Lost to Follow-up|2
5810218|NCT02741245|20057068|P5|Overall Study|Withdrawal by Subject|0
5810219|NCT02741245|20057069|P4|Overall Study|Withdrawal by Subject|1
5810220|NCT02741245|20057070|P3|Overall Study|Withdrawal by Subject|0
5810221|NCT02741245|20057071|P2|Overall Study|Withdrawal by Subject|0
5810222|NCT02741245|20057072|P1|Overall Study|Withdrawal by Subject|0
5810223|NCT02741245|20057068|P5|Overall Study|Protocol Violation|0
5810224|NCT02741245|20057069|P4|Overall Study|Protocol Violation|1
5810225|NCT02741245|20057070|P3|Overall Study|Protocol Violation|0
5810226|NCT02741245|20057071|P2|Overall Study|Protocol Violation|1
5810227|NCT02741245|20057072|P1|Overall Study|Protocol Violation|0
5810228|NCT02741245|20057068|P5|Overall Study|Adverse Event|2
5810229|NCT02741245|20057069|P4|Overall Study|Adverse Event|2
5810230|NCT02741245|20057070|P3|Overall Study|Adverse Event|0
5810231|NCT02741245|20057071|P2|Overall Study|Adverse Event|0
5810232|NCT02741245|20057072|P1|Overall Study|Adverse Event|0
5810233|NCT02741076|20057178|P4|Overall Study|No additional information available|1
5810234|NCT02741076|20057179|P3|Overall Study|No additional information available|1
5810235|NCT02741076|20057180|P2|Overall Study|No additional information available|0
5810236|NCT02741076|20057181|P1|Overall Study|No additional information available|0
5810237|NCT02741076|20057178|P4|Overall Study|Sponsor Request|1
5810238|NCT02741076|20057179|P3|Overall Study|Sponsor Request|0
5810239|NCT02741076|20057180|P2|Overall Study|Sponsor Request|3
5810240|NCT02741076|20057181|P1|Overall Study|Sponsor Request|2
5810241|NCT02741076|20057178|P4|Overall Study|Withdrawal by Subject|0
5810242|NCT02741076|20057179|P3|Overall Study|Withdrawal by Subject|0
5810243|NCT02741076|20057180|P2|Overall Study|Withdrawal by Subject|1
5810244|NCT02741076|20057181|P1|Overall Study|Withdrawal by Subject|0
5810245|NCT02741076|20057178|P4|Overall Study|Lack of Efficacy|0
5810246|NCT02741076|20057179|P3|Overall Study|Lack of Efficacy|0
5810247|NCT02741076|20057180|P2|Overall Study|Lack of Efficacy|0
5810248|NCT02741076|20057181|P1|Overall Study|Lack of Efficacy|1
5810249|NCT02741076|20057178|P4|Overall Study|Adverse Event|0
5810250|NCT02741076|20057179|P3|Overall Study|Adverse Event|1
5810251|NCT02741076|20057180|P2|Overall Study|Adverse Event|1
5810252|NCT02741076|20057181|P1|Overall Study|Adverse Event|0
5810253|NCT02740049|20057319|P1|Overall Study|Isolated cells did not grow sufficiently|1
5810254|NCT02739997|20057325|P1|Overall Study|Withdrawal by Subject|1
5810255|NCT02739997|20057325|P1|Overall Study|Death|1
5810256|NCT02739984|20057339|P2|Overall Study|Lost to Follow-up|0
5810257|NCT02739984|20057340|P1|Overall Study|Lost to Follow-up|3
5810258|NCT02739984|20057339|P2|Overall Study|Death|1
5810259|NCT02739984|20057340|P1|Overall Study|Death|0
5810260|NCT02739984|20057339|P2|Overall Study|Withdrawal by Subject|1
5810261|NCT02739984|20057340|P1|Overall Study|Withdrawal by Subject|1
5810262|NCT02739984|20057339|P2|Overall Study|Sponsor Decision|0
5810263|NCT02739984|20057340|P1|Overall Study|Sponsor Decision|1
5810264|NCT02739828|20057388|P1|Overall Study|Lost to Follow-up|4
5810265|NCT02739828|20057388|P1|Overall Study|Adverse Event|1
5810266|NCT02739594|20057448|P2|Overall Study|Other|2
5810267|NCT02739594|20057449|P1|Overall Study|Other|6
5810268|NCT02739594|20057448|P2|Overall Study|Elevated Serum Creatinine|1
5810269|NCT02739594|20057449|P1|Overall Study|Elevated Serum Creatinine|0
5810270|NCT02739594|20057448|P2|Overall Study|Lost to Follow-up|1
5810271|NCT02739594|20057449|P1|Overall Study|Lost to Follow-up|0
5810272|NCT02739594|20057448|P2|Overall Study|Withdrawal by Subject|1
5810273|NCT02739594|20057449|P1|Overall Study|Withdrawal by Subject|1
5810274|NCT02739594|20057448|P2|Overall Study|Administrative Reasons|3
5810275|NCT02739594|20057449|P1|Overall Study|Administrative Reasons|1
5810276|NCT02739594|20057448|P2|Overall Study|Renal Insufficiency|6
5810277|NCT02739594|20057449|P1|Overall Study|Renal Insufficiency|4
5810278|NCT02739594|20057448|P2|Overall Study|Death|2
5810279|NCT02739594|20057449|P1|Overall Study|Death|4
5810280|NCT02739594|20057448|P2|Overall Study|Protocol Violation|6
5810281|NCT02739594|20057449|P1|Overall Study|Protocol Violation|5
5810282|NCT02739594|20057448|P2|Overall Study|Violation of Eligibility Criteria|2
5810283|NCT02739594|20057449|P1|Overall Study|Violation of Eligibility Criteria|1
5810284|NCT02739594|20057448|P2|Overall Study|Undesired Event|4
5810285|NCT02739594|20057449|P1|Overall Study|Undesired Event|3
5810286|NCT02739360|20057479|P1|Overall Study|Study terminated by Sponsor|2
5810287|NCT02739360|20057479|P1|Overall Study|Adverse Event|1
5810288|NCT02739321|20057485|P2|Overall Study|Withdrawal by Subject|2
5810289|NCT02739321|20057486|P1|Overall Study|Withdrawal by Subject|1
5810290|NCT02739321|20057485|P2|Overall Study|Lost to Follow-up|1
5810291|NCT02739321|20057486|P1|Overall Study|Lost to Follow-up|1
5810292|NCT02739321|20057485|P2|Overall Study|Lack of Efficacy|1
5810293|NCT02739321|20057486|P1|Overall Study|Lack of Efficacy|1
5810294|NCT02739269|20057532|P2|Overall Study|Withdrawal by Subject|2
5810295|NCT02739269|20057533|P1|Overall Study|Withdrawal by Subject|0
5810296|NCT02739269|20057532|P2|Overall Study|Cycle cancellation|2
5810297|NCT02739269|20057533|P1|Overall Study|Cycle cancellation|2
5810298|NCT02739269|20057532|P2|Overall Study|Protocol Violation|0
5810299|NCT02739269|20057533|P1|Overall Study|Protocol Violation|5
5810300|NCT02738879|20057560|P2|Overall Study|Withdrawal by Subject|7
5810301|NCT02738879|20057561|P1|Overall Study|Withdrawal by Subject|5
5810302|NCT02738879|20057560|P2|Overall Study|Site Discontinued Study Participation|0
5810303|NCT02738879|20057561|P1|Overall Study|Site Discontinued Study Participation|1
5810304|NCT02738879|20057560|P2|Overall Study|Screen Failure|2
5810305|NCT02738879|20057561|P1|Overall Study|Screen Failure|1
5810306|NCT02738879|20057560|P2|Overall Study|Pregnancy|1
5810307|NCT02738879|20057561|P1|Overall Study|Pregnancy|0
5810308|NCT02738879|20057560|P2|Overall Study|Physician Decision|4
5810309|NCT02738879|20057561|P1|Overall Study|Physician Decision|3
5810310|NCT02738879|20057560|P2|Overall Study|Protocol Violation|3
5810311|NCT02738879|20057561|P1|Overall Study|Protocol Violation|1
5810312|NCT02738879|20057560|P2|Overall Study|Lost to Follow-up|5
5810313|NCT02738879|20057561|P1|Overall Study|Lost to Follow-up|1
5810314|NCT02738879|20057560|P2|Overall Study|Death|2
5810315|NCT02738879|20057561|P1|Overall Study|Death|0
5810316|NCT02738879|20057560|P2|Overall Study|Adverse Event|1
5810317|NCT02738879|20057561|P1|Overall Study|Adverse Event|1
5810318|NCT02738801|20057613|P2|Overall Study|Withdrawal by Subject|1
5810319|NCT02738801|20057614|P1|Overall Study|Withdrawal by Subject|0
5810320|NCT02738801|20057613|P2|Overall Study|Adverse Event|1
5810321|NCT02738801|20057614|P1|Overall Study|Adverse Event|1
5810322|NCT02738580|20057630|P2|Overall Study|EXCLUDED FROM DONNOR PROGRAM|1
5810323|NCT02738580|20057631|P1|Overall Study|EXCLUDED FROM DONNOR PROGRAM|0
5810324|NCT02738580|20057630|P2|Overall Study|Withdrawal by Subject|1
5810325|NCT02738580|20057631|P1|Overall Study|Withdrawal by Subject|0
5810326|NCT02738580|20057630|P2|Overall Study|Lack of Efficacy|2
5810327|NCT02738580|20057631|P1|Overall Study|Lack of Efficacy|3
5810328|NCT02738580|20057630|P2|Overall Study|Adverse Event|0
5810329|NCT02738580|20057631|P1|Overall Study|Adverse Event|1
5810330|NCT02738333|20057642|P3|Overall Study|Lost to Follow-up|0
5810331|NCT02738333|20057643|P2|Overall Study|Lost to Follow-up|0
5810332|NCT02738333|20057644|P1|Overall Study|Lost to Follow-up|1
5810333|NCT02738333|20057642|P3|Overall Study|Death|0
5810334|NCT02738333|20057643|P2|Overall Study|Death|0
5810335|NCT02738333|20057644|P1|Overall Study|Death|1
5810336|NCT02738203|20057733|P2|Overall Study|Protocol Violation|1
5810337|NCT02738203|20057734|P1|Overall Study|Protocol Violation|0
5810338|NCT02738203|20057733|P2|Overall Study|Failed IUD Insertion|2
5810339|NCT02738203|20057734|P1|Overall Study|Failed IUD Insertion|2
5810340|NCT02738151|20057750|P2|Overall Study|Other than specified above|21
5810341|NCT02738151|20057751|P1|Overall Study|Other than specified above|11
5810342|NCT02738151|20057750|P2|Overall Study|Poor Compliance to Protocol|3
5810343|NCT02738151|20057751|P1|Overall Study|Poor Compliance to Protocol|4
5810344|NCT02738151|20057750|P2|Overall Study|Hypoglycemia|1
5810345|NCT02738151|20057751|P1|Overall Study|Hypoglycemia|0
5810346|NCT02738151|20057750|P2|Overall Study|Adverse Event|5
5810347|NCT02738151|20057751|P1|Overall Study|Adverse Event|4
5810348|NCT02738151|20057750|P2|Overall Study|Randomized but not treated|1
5810349|NCT02738151|20057751|P1|Overall Study|Randomized but not treated|4
5810350|NCT02738138|20057795|P2|Overall Study|Other - not further specified|0
5810351|NCT02738138|20057796|P1|Overall Study|Other - not further specified|1
5810352|NCT02738138|20057795|P2|Overall Study|Lost to Follow-up|0
5810353|NCT02738138|20057796|P1|Overall Study|Lost to Follow-up|2
5810354|NCT02738138|20057795|P2|Overall Study|Adverse Event|1
5810355|NCT02738138|20057796|P1|Overall Study|Adverse Event|0
5810356|NCT02738008|20057833|P3|Overall Study|Adverse Event|2
5810357|NCT02738008|20057834|P2|Overall Study|Adverse Event|1
5810358|NCT02738008|20057835|P1|Overall Study|Adverse Event|0
5810359|NCT02738008|20057833|P3|Overall Study|Study Terminated by Sponsor|3
5810360|NCT02738008|20057834|P2|Overall Study|Study Terminated by Sponsor|5
5810361|NCT02738008|20057835|P1|Overall Study|Study Terminated by Sponsor|1
5810362|NCT02737852|20057873|P1|Overall Study|Withdrawal by Subject|2
5810363|NCT02737722|20057882|P4|Overall Study|Physician Decision|0
5810364|NCT02737722|20057883|P3|Overall Study|Physician Decision|1
5810365|NCT02737722|20057884|P2|Overall Study|Physician Decision|0
5810366|NCT02737722|20057885|P1|Overall Study|Physician Decision|0
5810367|NCT02737618|20057936|P1|Overall Study|Withdrawal by Subject|9
5810368|NCT02737592|20057941|P1|Overall Study|Withdrawal by Subject|1
5810369|NCT02737358|20057962|P2|Overall Study|Lost to Follow-up|3
5810370|NCT02737358|20057963|P1|Overall Study|Lost to Follow-up|2
5810371|NCT02737358|20057962|P2|Overall Study|Withdrawal by Subject|12
5810372|NCT02737358|20057963|P1|Overall Study|Withdrawal by Subject|7
5810373|NCT02736890|20058052|P2|Crossover Next 12 Weeks|Withdrawal by Subject|0
5810374|NCT02736890|20058053|P1|Crossover Next 12 Weeks|Withdrawal by Subject|1
5810375|NCT02736890|20058052|P2|Crossover Next 12 Weeks|Lost to Follow-up|2
5810376|NCT02736890|20058053|P1|Crossover Next 12 Weeks|Lost to Follow-up|1
5810377|NCT02736825|20058075|P2|Overall Study|Early Termination|1
5810378|NCT02736825|20058076|P1|Overall Study|Early Termination|0
5810379|NCT02736825|20058075|P2|Overall Study|Lost to Follow-up|11
5810380|NCT02736825|20058076|P1|Overall Study|Lost to Follow-up|10
5810381|NCT02736721|20058116|P1|Overall Study|Other|5
5810382|NCT02736721|20058116|P1|Overall Study|Lost to Follow-up|3
5810383|NCT02736721|20058116|P1|Overall Study|Adverse Event|8
5810384|NCT02736578|20058127|P2|Overall Study|Adverse Event|0
5810385|NCT02736578|20058128|P1|Overall Study|Adverse Event|1
5810386|NCT02736409|20058150|P4|Overall Study|Physician Decision|2
5810387|NCT02736409|20058151|P3|Overall Study|Physician Decision|0
5810388|NCT02736409|20058152|P2|Overall Study|Physician Decision|0
5810389|NCT02736409|20058153|P1|Overall Study|Physician Decision|0
5810390|NCT02736409|20058150|P4|Overall Study|Lost to Follow-up|1
5810391|NCT02736409|20058151|P3|Overall Study|Lost to Follow-up|2
5810392|NCT02736409|20058152|P2|Overall Study|Lost to Follow-up|0
5810393|NCT02736409|20058153|P1|Overall Study|Lost to Follow-up|0
5810394|NCT02736409|20058150|P4|Overall Study|Pregnancy|0
5810395|NCT02736409|20058151|P3|Overall Study|Pregnancy|1
5810396|NCT02736409|20058152|P2|Overall Study|Pregnancy|0
5810397|NCT02736409|20058153|P1|Overall Study|Pregnancy|0
5810398|NCT02736409|20058150|P4|Overall Study|Other|1
5810399|NCT02736409|20058151|P3|Overall Study|Other|1
5810400|NCT02736409|20058152|P2|Overall Study|Other|0
5810401|NCT02736409|20058153|P1|Overall Study|Other|0
5810402|NCT02736409|20058150|P4|Overall Study|Adverse Event|4
5810403|NCT02736409|20058151|P3|Overall Study|Adverse Event|5
5810404|NCT02736409|20058152|P2|Overall Study|Adverse Event|1
5810405|NCT02736409|20058153|P1|Overall Study|Adverse Event|0
5810406|NCT02736409|20058150|P4|Overall Study|Non-Compliance with Study Drug|1
5810407|NCT02736409|20058151|P3|Overall Study|Non-Compliance with Study Drug|0
5810408|NCT02736409|20058152|P2|Overall Study|Non-Compliance with Study Drug|0
5810409|NCT02736409|20058153|P1|Overall Study|Non-Compliance with Study Drug|0
5810410|NCT02736409|20058150|P4|Overall Study|Withdrawal by Subject|3
5810411|NCT02736409|20058151|P3|Overall Study|Withdrawal by Subject|17
5810412|NCT02736409|20058152|P2|Overall Study|Withdrawal by Subject|2
5810413|NCT02736409|20058153|P1|Overall Study|Withdrawal by Subject|4
5810414|NCT02736188|20058293|P1|Overall Study|Other|6
5810415|NCT02736188|20058293|P1|Overall Study|Withdrawal by Subject|1
5810416|NCT02736188|20058293|P1|Overall Study|Adverse Event|1
5810417|NCT02736188|20058293|P1|Overall Study|Discontinuation of Study by Sponsor|134
5810418|NCT02735980|20058331|P3|Overall Study|Withdrawal by Subject|0
5810419|NCT02735980|20058332|P2|Overall Study|Withdrawal by Subject|2
5810420|NCT02735980|20058333|P1|Overall Study|Withdrawal by Subject|1
5810421|NCT02735980|20058331|P3|Overall Study|Screen failure|0
5810422|NCT02735980|20058332|P2|Overall Study|Screen failure|0
5810423|NCT02735980|20058333|P1|Overall Study|Screen failure|1
5810424|NCT02735980|20058331|P3|Overall Study|Physician Decision|0
5810425|NCT02735980|20058332|P2|Overall Study|Physician Decision|1
5810426|NCT02735980|20058333|P1|Overall Study|Physician Decision|3
5810427|NCT02735980|20058331|P3|Overall Study|Death|0
5810428|NCT02735980|20058332|P2|Overall Study|Death|4
5810429|NCT02735980|20058333|P1|Overall Study|Death|5
5810430|NCT02735980|20058331|P3|Overall Study|Adverse Event|1
5810431|NCT02735980|20058332|P2|Overall Study|Adverse Event|4
5810432|NCT02735980|20058333|P1|Overall Study|Adverse Event|0
5810433|NCT02735915|20058362|P1|Overall Study|Withdrawal by Subject|1
5810434|NCT02735915|20058362|P1|Overall Study|Withdrawal following SAE|2
5810435|NCT02735915|20058362|P1|Overall Study|Not vaccinated but subject ID assigned|8
5810436|NCT02735577|20058394|P1|Optional 28 Days of Disulfiram Treatment|Lost to Follow-up|2
5810437|NCT02735577|20058394|P1|Disulfiram Treatment|Lost to Follow-up|1
5810443|NCT02735200|20058441|P2|Overall Study|Withdrawal by Subject|0
5810444|NCT02735200|20058442|P1|Overall Study|Withdrawal by Subject|8
5810445|NCT02735200|20058441|P2|Overall Study|Lost to Follow-up|5
5810446|NCT02735200|20058442|P1|Overall Study|Lost to Follow-up|0
5810447|NCT02735096|20058485|P1|Overall Study|No symptoms in clinic/personal leave|1
5810448|NCT02735044|20058494|P2|Overall Study|Other, not specified above|11
5810449|NCT02735044|20058495|P1|Overall Study|Other, not specified above|5
5810450|NCT02735044|20058494|P2|Overall Study|Randomized and not treated|2
5810451|NCT02735044|20058495|P1|Overall Study|Randomized and not treated|0
5810452|NCT02735044|20058494|P2|Overall Study|Poor compliance to protocol|7
5810453|NCT02735044|20058495|P1|Overall Study|Poor compliance to protocol|7
5810454|NCT02735044|20058494|P2|Overall Study|Lack of Efficacy|0
5810455|NCT02735044|20058495|P1|Overall Study|Lack of Efficacy|1
5810456|NCT02735044|20058494|P2|Overall Study|Adverse Event|3
5810457|NCT02735044|20058495|P1|Overall Study|Adverse Event|3
5810458|NCT02734862|20058564|P3|Part B|Other|0
5810459|NCT02734862|20058565|P2|Part B|Other|1
5810460|NCT02734862|20058566|P1|Part B|Other|0
5810461|NCT02734862|20058564|P3|Part B|Withdrawal by Subject|0
5810462|NCT02734862|20058565|P2|Part B|Withdrawal by Subject|1
5810463|NCT02734862|20058566|P1|Part B|Withdrawal by Subject|3
5810464|NCT02734862|20058564|P3|Part B|Lost to Follow-up|0
5810465|NCT02734862|20058565|P2|Part B|Lost to Follow-up|2
5810466|NCT02734862|20058566|P1|Part B|Lost to Follow-up|2
5810467|NCT02734862|20058564|P3|Part B|Death|5
5810468|NCT02734862|20058565|P2|Part B|Death|3
5810469|NCT02734862|20058566|P1|Part B|Death|8
5810470|NCT02734862|20058564|P3|Part A|Other|3
5810471|NCT02734862|20058565|P2|Part A|Other|1
5810472|NCT02734862|20058566|P1|Part A|Other|1
5810473|NCT02734862|20058564|P3|Part A|Noncompliance|0
5810474|NCT02734862|20058565|P2|Part A|Noncompliance|1
5810475|NCT02734862|20058566|P1|Part A|Noncompliance|1
5810476|NCT02734862|20058564|P3|Part A|Adverse Event|1
5810477|NCT02734862|20058565|P2|Part A|Adverse Event|0
5810478|NCT02734862|20058566|P1|Part A|Adverse Event|2
5810479|NCT02734862|20058564|P3|Part A|Physician Decision|1
5810480|NCT02734862|20058565|P2|Part A|Physician Decision|0
5810481|NCT02734862|20058566|P1|Part A|Physician Decision|2
5810482|NCT02734862|20058564|P3|Part A|Withdrawal by Subject|2
5810483|NCT02734862|20058565|P2|Part A|Withdrawal by Subject|1
5810484|NCT02734862|20058566|P1|Part A|Withdrawal by Subject|1
5810485|NCT02734862|20058564|P3|Part A|Lost to Follow-up|1
5810486|NCT02734862|20058565|P2|Part A|Lost to Follow-up|1
5810487|NCT02734862|20058566|P1|Part A|Lost to Follow-up|2
5810488|NCT02734862|20058564|P3|Part A|Death|6
5810489|NCT02734862|20058565|P2|Part A|Death|4
5810490|NCT02734862|20058566|P1|Part A|Death|3
5810491|NCT02734810|20058607|P2|Overall Study|Lack of Efficacy|0
5810492|NCT02734810|20058608|P1|Overall Study|Lack of Efficacy|1
5810493|NCT02734810|20058607|P2|Overall Study|Adverse Event|0
5810494|NCT02734810|20058608|P1|Overall Study|Adverse Event|1
5810495|NCT02734693|20058617|P3|Overall Study|Withdrawal by Subject|0
5810496|NCT02734693|20058618|P2|Overall Study|Withdrawal by Subject|0
5810497|NCT02734693|20058619|P1|Overall Study|Withdrawal by Subject|1
5810498|NCT02734693|20058617|P3|Overall Study|Protocol Violation|0
5810499|NCT02734693|20058618|P2|Overall Study|Protocol Violation|0
5810500|NCT02734693|20058619|P1|Overall Study|Protocol Violation|1
5810501|NCT02734693|20058617|P3|Overall Study|Lost to Follow-up|0
5810502|NCT02734693|20058618|P2|Overall Study|Lost to Follow-up|0
5810503|NCT02734693|20058619|P1|Overall Study|Lost to Follow-up|2
5810504|NCT02734693|20058617|P3|Overall Study|Lack of Efficacy|0
5810505|NCT02734693|20058618|P2|Overall Study|Lack of Efficacy|0
5810506|NCT02734693|20058619|P1|Overall Study|Lack of Efficacy|1
5810507|NCT02734693|20058617|P3|Overall Study|Adverse Event|3
5810508|NCT02734693|20058618|P2|Overall Study|Adverse Event|3
5810509|NCT02734693|20058619|P1|Overall Study|Adverse Event|1
5810516|NCT02734212|20058737|P2|Overall Study|Lost to Follow-up|10
5810517|NCT02734212|20058738|P1|Overall Study|Lost to Follow-up|5
5810518|NCT02733991|20058759|P2|Overall Study|Withdrawal by Subject|5
5810519|NCT02733991|20058760|P1|Overall Study|Withdrawal by Subject|0
5810520|NCT02733991|20058759|P2|Overall Study|Adverse Event|0
5810521|NCT02733991|20058760|P1|Overall Study|Adverse Event|1
5810522|NCT02733367|20058800|P1|Overall Study|Withdrawal by Subject|6
5810523|NCT02733042|20058826|P19|Follow-up Period|Withdrawal by Subject|0
5810524|NCT02733042|20058827|P18|Follow-up Period|Withdrawal by Subject|0
5810525|NCT02733042|20058828|P17|Follow-up Period|Withdrawal by Subject|0
5810526|NCT02733042|20058829|P16|Follow-up Period|Withdrawal by Subject|1
5810527|NCT02733042|20058830|P15|Follow-up Period|Withdrawal by Subject|0
5810528|NCT02733042|20058831|P14|Follow-up Period|Withdrawal by Subject|0
5810529|NCT02733042|20058832|P13|Follow-up Period|Withdrawal by Subject|0
5810530|NCT02733042|20058833|P12|Follow-up Period|Withdrawal by Subject|0
5810531|NCT02733042|20058834|P11|Follow-up Period|Withdrawal by Subject|1
5810532|NCT02733042|20058835|P10|Follow-up Period|Withdrawal by Subject|0
5810533|NCT02733042|20058836|P9|Follow-up Period|Withdrawal by Subject|1
5810534|NCT02733042|20058837|P8|Follow-up Period|Withdrawal by Subject|0
5810535|NCT02733042|20058838|P7|Follow-up Period|Withdrawal by Subject|0
5810536|NCT02733042|20058839|P6|Follow-up Period|Withdrawal by Subject|0
5810537|NCT02733042|20058840|P5|Follow-up Period|Withdrawal by Subject|0
5810538|NCT02733042|20058841|P4|Follow-up Period|Withdrawal by Subject|0
5810539|NCT02733042|20058842|P3|Follow-up Period|Withdrawal by Subject|0
5810540|NCT02733042|20058843|P2|Follow-up Period|Withdrawal by Subject|0
5810541|NCT02733042|20058844|P1|Follow-up Period|Withdrawal by Subject|0
5810542|NCT02733042|20058826|P19|Follow-up Period|Other|0
5810543|NCT02733042|20058827|P18|Follow-up Period|Other|0
5810544|NCT02733042|20058828|P17|Follow-up Period|Other|0
5810545|NCT02733042|20058829|P16|Follow-up Period|Other|0
5810546|NCT02733042|20058830|P15|Follow-up Period|Other|0
5810547|NCT02733042|20058831|P14|Follow-up Period|Other|0
5810548|NCT02733042|20058832|P13|Follow-up Period|Other|0
5810549|NCT02733042|20058833|P12|Follow-up Period|Other|0
5810550|NCT02733042|20058834|P11|Follow-up Period|Other|0
5810551|NCT02733042|20058835|P10|Follow-up Period|Other|0
5810552|NCT02733042|20058836|P9|Follow-up Period|Other|0
5810553|NCT02733042|20058837|P8|Follow-up Period|Other|0
5810554|NCT02733042|20058838|P7|Follow-up Period|Other|0
5810555|NCT02733042|20058839|P6|Follow-up Period|Other|0
5810556|NCT02733042|20058840|P5|Follow-up Period|Other|0
5810557|NCT02733042|20058841|P4|Follow-up Period|Other|1
5810558|NCT02733042|20058842|P3|Follow-up Period|Other|0
5810559|NCT02733042|20058843|P2|Follow-up Period|Other|0
5810560|NCT02733042|20058844|P1|Follow-up Period|Other|0
5810561|NCT02733042|20058826|P19|Follow-up Period|Death|2
5810562|NCT02733042|20058827|P18|Follow-up Period|Death|1
5810563|NCT02733042|20058828|P17|Follow-up Period|Death|0
5810564|NCT02733042|20058829|P16|Follow-up Period|Death|4
5810565|NCT02733042|20058830|P15|Follow-up Period|Death|1
5810566|NCT02733042|20058831|P14|Follow-up Period|Death|1
5810567|NCT02733042|20058832|P13|Follow-up Period|Death|8
5810568|NCT02733042|20058833|P12|Follow-up Period|Death|0
5810569|NCT02733042|20058834|P11|Follow-up Period|Death|0
5810570|NCT02733042|20058835|P10|Follow-up Period|Death|0
5810571|NCT02733042|20058836|P9|Follow-up Period|Death|3
5810572|NCT02733042|20058837|P8|Follow-up Period|Death|3
5810573|NCT02733042|20058838|P7|Follow-up Period|Death|0
5810574|NCT02733042|20058839|P6|Follow-up Period|Death|2
5810575|NCT02733042|20058840|P5|Follow-up Period|Death|1
5810576|NCT02733042|20058841|P4|Follow-up Period|Death|0
5810577|NCT02733042|20058842|P3|Follow-up Period|Death|2
5810578|NCT02733042|20058843|P2|Follow-up Period|Death|1
5810579|NCT02733042|20058844|P1|Follow-up Period|Death|1
5810580|NCT02733042|20058826|P19|Follow-up Period|Ongoing on Follow-up|0
5810581|NCT02733042|20058827|P18|Follow-up Period|Ongoing on Follow-up|1
5810582|NCT02733042|20058828|P17|Follow-up Period|Ongoing on Follow-up|0
5810583|NCT02733042|20058829|P16|Follow-up Period|Ongoing on Follow-up|0
5810584|NCT02733042|20058830|P15|Follow-up Period|Ongoing on Follow-up|0
5810585|NCT02733042|20058831|P14|Follow-up Period|Ongoing on Follow-up|3
5810586|NCT02733042|20058832|P13|Follow-up Period|Ongoing on Follow-up|1
5810587|NCT02733042|20058833|P12|Follow-up Period|Ongoing on Follow-up|9
5810588|NCT02733042|20058834|P11|Follow-up Period|Ongoing on Follow-up|4
5810589|NCT02733042|20058835|P10|Follow-up Period|Ongoing on Follow-up|2
5810590|NCT02733042|20058836|P9|Follow-up Period|Ongoing on Follow-up|0
5810591|NCT02733042|20058837|P8|Follow-up Period|Ongoing on Follow-up|1
5810592|NCT02733042|20058838|P7|Follow-up Period|Ongoing on Follow-up|0
5810593|NCT02733042|20058839|P6|Follow-up Period|Ongoing on Follow-up|0
5810594|NCT02733042|20058840|P5|Follow-up Period|Ongoing on Follow-up|0
5810595|NCT02733042|20058841|P4|Follow-up Period|Ongoing on Follow-up|2
5810596|NCT02733042|20058842|P3|Follow-up Period|Ongoing on Follow-up|4
5810597|NCT02733042|20058843|P2|Follow-up Period|Ongoing on Follow-up|2
5810598|NCT02733042|20058844|P1|Follow-up Period|Ongoing on Follow-up|2
5810599|NCT02733042|20058826|P19|Treatment Period|Death|0
5810600|NCT02733042|20058827|P18|Treatment Period|Death|0
5810601|NCT02733042|20058828|P17|Treatment Period|Death|0
5810602|NCT02733042|20058829|P16|Treatment Period|Death|2
5810603|NCT02733042|20058830|P15|Treatment Period|Death|1
5810604|NCT02733042|20058831|P14|Treatment Period|Death|0
5810605|NCT02733042|20058832|P13|Treatment Period|Death|0
5810606|NCT02733042|20058833|P12|Treatment Period|Death|0
5810607|NCT02733042|20058834|P11|Treatment Period|Death|1
5810608|NCT02733042|20058835|P10|Treatment Period|Death|0
5810609|NCT02733042|20058836|P9|Treatment Period|Death|1
5810610|NCT02733042|20058837|P8|Treatment Period|Death|0
5810611|NCT02733042|20058838|P7|Treatment Period|Death|1
5810612|NCT02733042|20058839|P6|Treatment Period|Death|0
5810613|NCT02733042|20058840|P5|Treatment Period|Death|0
5810614|NCT02733042|20058841|P4|Treatment Period|Death|0
5810615|NCT02733042|20058842|P3|Treatment Period|Death|0
5810616|NCT02733042|20058843|P2|Treatment Period|Death|0
5810617|NCT02733042|20058844|P1|Treatment Period|Death|0
5810618|NCT02733042|20058826|P19|Treatment Period|Ongoing on Assigned Treatment|1
5810619|NCT02733042|20058827|P18|Treatment Period|Ongoing on Assigned Treatment|0
5810620|NCT02733042|20058828|P17|Treatment Period|Ongoing on Assigned Treatment|0
5810621|NCT02733042|20058829|P16|Treatment Period|Ongoing on Assigned Treatment|0
5810622|NCT02733042|20058830|P15|Treatment Period|Ongoing on Assigned Treatment|0
5810623|NCT02733042|20058831|P14|Treatment Period|Ongoing on Assigned Treatment|0
5810624|NCT02733042|20058832|P13|Treatment Period|Ongoing on Assigned Treatment|0
5810625|NCT02733042|20058833|P12|Treatment Period|Ongoing on Assigned Treatment|0
5810626|NCT02733042|20058834|P11|Treatment Period|Ongoing on Assigned Treatment|4
5810627|NCT02733042|20058835|P10|Treatment Period|Ongoing on Assigned Treatment|8
5810628|NCT02733042|20058836|P9|Treatment Period|Ongoing on Assigned Treatment|0
5810629|NCT02733042|20058837|P8|Treatment Period|Ongoing on Assigned Treatment|0
5810630|NCT02733042|20058838|P7|Treatment Period|Ongoing on Assigned Treatment|0
5810631|NCT02733042|20058839|P6|Treatment Period|Ongoing on Assigned Treatment|0
5810632|NCT02733042|20058840|P5|Treatment Period|Ongoing on Assigned Treatment|3
5810633|NCT02733042|20058841|P4|Treatment Period|Ongoing on Assigned Treatment|0
5810634|NCT02733042|20058842|P3|Treatment Period|Ongoing on Assigned Treatment|0
5810635|NCT02733042|20058843|P2|Treatment Period|Ongoing on Assigned Treatment|0
5810636|NCT02733042|20058844|P1|Treatment Period|Ongoing on Assigned Treatment|0
5810637|NCT02733042|20058826|P19|Treatment Period|Other|0
5810638|NCT02733042|20058827|P18|Treatment Period|Other|1
5810639|NCT02733042|20058828|P17|Treatment Period|Other|0
5810640|NCT02733042|20058829|P16|Treatment Period|Other|1
5810641|NCT02733042|20058830|P15|Treatment Period|Other|0
5810642|NCT02733042|20058831|P14|Treatment Period|Other|0
5810643|NCT02733042|20058832|P13|Treatment Period|Other|0
5810644|NCT02733042|20058833|P12|Treatment Period|Other|0
5810645|NCT02733042|20058834|P11|Treatment Period|Other|1
5810646|NCT02733042|20058835|P10|Treatment Period|Other|1
5810647|NCT02733042|20058836|P9|Treatment Period|Other|0
5810648|NCT02733042|20058837|P8|Treatment Period|Other|0
5810649|NCT02733042|20058838|P7|Treatment Period|Other|0
5810650|NCT02733042|20058839|P6|Treatment Period|Other|0
5810651|NCT02733042|20058840|P5|Treatment Period|Other|0
5810652|NCT02733042|20058841|P4|Treatment Period|Other|0
5810653|NCT02733042|20058842|P3|Treatment Period|Other|1
5810654|NCT02733042|20058843|P2|Treatment Period|Other|0
5810655|NCT02733042|20058844|P1|Treatment Period|Other|0
5810656|NCT02733042|20058826|P19|Treatment Period|Withdrawal by Subject|0
5810657|NCT02733042|20058827|P18|Treatment Period|Withdrawal by Subject|0
5810658|NCT02733042|20058828|P17|Treatment Period|Withdrawal by Subject|0
5810659|NCT02733042|20058829|P16|Treatment Period|Withdrawal by Subject|0
5810660|NCT02733042|20058830|P15|Treatment Period|Withdrawal by Subject|0
5810661|NCT02733042|20058831|P14|Treatment Period|Withdrawal by Subject|1
5810662|NCT02733042|20058832|P13|Treatment Period|Withdrawal by Subject|1
5810663|NCT02733042|20058833|P12|Treatment Period|Withdrawal by Subject|2
5810664|NCT02733042|20058834|P11|Treatment Period|Withdrawal by Subject|0
5810665|NCT02733042|20058835|P10|Treatment Period|Withdrawal by Subject|1
5810666|NCT02733042|20058836|P9|Treatment Period|Withdrawal by Subject|1
5810667|NCT02733042|20058837|P8|Treatment Period|Withdrawal by Subject|0
5810668|NCT02733042|20058838|P7|Treatment Period|Withdrawal by Subject|0
5810669|NCT02733042|20058839|P6|Treatment Period|Withdrawal by Subject|0
5810670|NCT02733042|20058840|P5|Treatment Period|Withdrawal by Subject|0
5810671|NCT02733042|20058841|P4|Treatment Period|Withdrawal by Subject|1
5810672|NCT02733042|20058842|P3|Treatment Period|Withdrawal by Subject|2
5810673|NCT02733042|20058843|P2|Treatment Period|Withdrawal by Subject|1
5810674|NCT02733042|20058844|P1|Treatment Period|Withdrawal by Subject|0
5810675|NCT02733042|20058826|P19|Treatment Period|Progressive Disease|4
5810676|NCT02733042|20058827|P18|Treatment Period|Progressive Disease|3
5810677|NCT02733042|20058828|P17|Treatment Period|Progressive Disease|2
5810678|NCT02733042|20058829|P16|Treatment Period|Progressive Disease|7
5810679|NCT02733042|20058830|P15|Treatment Period|Progressive Disease|4
5810680|NCT02733042|20058831|P14|Treatment Period|Progressive Disease|1
5810681|NCT02733042|20058832|P13|Treatment Period|Progressive Disease|8
5810682|NCT02733042|20058833|P12|Treatment Period|Progressive Disease|2
5810683|NCT02733042|20058834|P11|Treatment Period|Progressive Disease|2
5810684|NCT02733042|20058835|P10|Treatment Period|Progressive Disease|0
5810685|NCT02733042|20058836|P9|Treatment Period|Progressive Disease|3
5810686|NCT02733042|20058837|P8|Treatment Period|Progressive Disease|3
5810687|NCT02733042|20058838|P7|Treatment Period|Progressive Disease|0
5810688|NCT02733042|20058839|P6|Treatment Period|Progressive Disease|3
5810689|NCT02733042|20058840|P5|Treatment Period|Progressive Disease|1
5810690|NCT02733042|20058841|P4|Treatment Period|Progressive Disease|1
5810691|NCT02733042|20058842|P3|Treatment Period|Progressive Disease|3
5810692|NCT02733042|20058843|P2|Treatment Period|Progressive Disease|1
5810693|NCT02733042|20058844|P1|Treatment Period|Progressive Disease|2
5810694|NCT02733042|20058826|P19|Treatment Period|Adverse Event|0
5810695|NCT02733042|20058827|P18|Treatment Period|Adverse Event|1
5810696|NCT02733042|20058828|P17|Treatment Period|Adverse Event|0
5810697|NCT02733042|20058829|P16|Treatment Period|Adverse Event|0
5810698|NCT02733042|20058830|P15|Treatment Period|Adverse Event|0
5810699|NCT02733042|20058831|P14|Treatment Period|Adverse Event|2
5810700|NCT02733042|20058832|P13|Treatment Period|Adverse Event|0
5810701|NCT02733042|20058833|P12|Treatment Period|Adverse Event|2
5810702|NCT02733042|20058834|P11|Treatment Period|Adverse Event|2
5810703|NCT02733042|20058835|P10|Treatment Period|Adverse Event|0
5810704|NCT02733042|20058836|P9|Treatment Period|Adverse Event|0
5810705|NCT02733042|20058837|P8|Treatment Period|Adverse Event|0
5810706|NCT02733042|20058838|P7|Treatment Period|Adverse Event|0
5810707|NCT02733042|20058839|P6|Treatment Period|Adverse Event|0
5810708|NCT02733042|20058840|P5|Treatment Period|Adverse Event|0
5810709|NCT02733042|20058841|P4|Treatment Period|Adverse Event|1
5810710|NCT02733042|20058842|P3|Treatment Period|Adverse Event|1
5810711|NCT02733042|20058843|P2|Treatment Period|Adverse Event|0
5810712|NCT02733042|20058844|P1|Treatment Period|Adverse Event|1
5810713|NCT02732951|20059049|P2|Overall Study|Protocol Violation|1
5810714|NCT02732951|20059050|P1|Overall Study|Protocol Violation|0
5810715|NCT02732951|20059049|P2|Overall Study|Adverse Event|4
5810716|NCT02732951|20059050|P1|Overall Study|Adverse Event|4
5810717|NCT02732951|20059049|P2|Overall Study|Lost to Follow-up|1
5810718|NCT02732951|20059050|P1|Overall Study|Lost to Follow-up|0
5810719|NCT02732951|20059049|P2|Overall Study|Other than listed|0
5810720|NCT02732951|20059050|P1|Overall Study|Other than listed|1
5810721|NCT02732938|20059060|P3|Overall Study|Study terminated by sponsor|0
5810722|NCT02732938|20059061|P2|Overall Study|Study terminated by sponsor|6
5810723|NCT02732938|20059062|P1|Overall Study|Study terminated by sponsor|3
5810724|NCT02732938|20059060|P3|Overall Study|Refused further follow-up|0
5810725|NCT02732938|20059061|P2|Overall Study|Refused further follow-up|0
5810726|NCT02732938|20059062|P1|Overall Study|Refused further follow-up|1
5810727|NCT02732938|20059060|P3|Overall Study|Randomized but did not receive treatment|0
5810728|NCT02732938|20059061|P2|Overall Study|Randomized but did not receive treatment|1
5810729|NCT02732938|20059062|P1|Overall Study|Randomized but did not receive treatment|0
5810730|NCT02732938|20059060|P3|Overall Study|Death|0
5810731|NCT02732938|20059061|P2|Overall Study|Death|11
5810732|NCT02732938|20059062|P1|Overall Study|Death|0
5810733|NCT02732912|20059108|P2|Overall Study|No outcome; discharged or refused|9
5810734|NCT02732912|20059109|P1|Overall Study|No outcome; discharged or refused|6
5810735|NCT02732912|20059108|P2|Overall Study|Incomplete completion of questionnaire|3
5810736|NCT02732912|20059109|P1|Overall Study|Incomplete completion of questionnaire|2
5810737|NCT02732912|20059108|P2|Overall Study|Discharged before night|6
5810738|NCT02732912|20059109|P1|Overall Study|Discharged before night|2
5810739|NCT02732639|20059134|P1|Overall Study|Lost to Follow-up|1
5810740|NCT02732561|20059160|P2|Overall Study|Withdrawal by Subject|0
5810741|NCT02732561|20059161|P1|Overall Study|Withdrawal by Subject|1
5810742|NCT02732561|20059160|P2|Overall Study|Lost to Follow-up|1
5810743|NCT02732561|20059161|P1|Overall Study|Lost to Follow-up|1
5810744|NCT02732327|20059187|P2|Overall Study|Protocol Violation|1
5810745|NCT02732327|20059188|P1|Overall Study|Protocol Violation|0
5810746|NCT02732210|20059196|P2|Overall Study|Missing|8
5810747|NCT02732210|20059197|P1|Overall Study|Missing|0
5810748|NCT02732210|20059196|P2|Overall Study|Other|103
5810749|NCT02732210|20059197|P1|Overall Study|Other|35
5810750|NCT02732210|20059196|P2|Overall Study|Death|15
5810751|NCT02732210|20059197|P1|Overall Study|Death|4
5810752|NCT02732210|20059196|P2|Overall Study|Lost to Follow-up|57
5810753|NCT02732210|20059197|P1|Overall Study|Lost to Follow-up|5
5810754|NCT02732210|20059196|P2|Overall Study|Withdrawal by Subject|87
5810755|NCT02732210|20059197|P1|Overall Study|Withdrawal by Subject|28
5810756|NCT02732210|20059196|P2|Overall Study|Study Ended|13
5810757|NCT02732210|20059197|P1|Overall Study|Study Ended|13
5810758|NCT02732210|20059196|P2|Overall Study|Site Closed|11
5810759|NCT02732210|20059197|P1|Overall Study|Site Closed|0
5810760|NCT02731755|20059376|P2|First Intervention|Withdrawal by Subject|2
5810761|NCT02731755|20059377|P1|First Intervention|Withdrawal by Subject|0
5810762|NCT02731742|20059401|P4|Overall Study|Study Terminated by Sponsor|1
5810763|NCT02731742|20059402|P3|Overall Study|Study Terminated by Sponsor|1
5810764|NCT02731742|20059403|P2|Overall Study|Study Terminated by Sponsor|1
5810765|NCT02731742|20059404|P1|Overall Study|Study Terminated by Sponsor|2
5810766|NCT02731742|20059401|P4|Overall Study|Physician Decision|1
5810767|NCT02731742|20059402|P3|Overall Study|Physician Decision|0
5810768|NCT02731742|20059403|P2|Overall Study|Physician Decision|0
5810769|NCT02731742|20059404|P1|Overall Study|Physician Decision|0
5810770|NCT02731742|20059401|P4|Overall Study|Death|0
5810771|NCT02731742|20059402|P3|Overall Study|Death|5
5810772|NCT02731742|20059403|P2|Overall Study|Death|2
5810773|NCT02731742|20059404|P1|Overall Study|Death|1
5810774|NCT02731690|20059422|P1|Overall Study|Discontinuation of Study by Sponsor|26
5810775|NCT02731690|20059422|P1|Overall Study|Withdrawal by Subject|3
5810776|NCT02731690|20059422|P1|Overall Study|Adverse Event|1
5810777|NCT02731638|20059442|P2|Overall Study|Lost to Follow-up|9
5810778|NCT02731638|20059443|P1|Overall Study|Lost to Follow-up|6
5810779|NCT02731157|20059686|P1|First Rejuvenated RCE|Withdrawal by Subject|1
5810780|NCT02731131|20059704|P2|Overall Study|Refused Therapy|1
5810781|NCT02731131|20059705|P1|Overall Study|Refused Therapy|0
5810782|NCT02731131|20059704|P2|Overall Study|Psychiatric Disorder|1
5810783|NCT02731131|20059705|P1|Overall Study|Psychiatric Disorder|0
5810784|NCT02730871|20059755|P2|Overall Study|Adverse Event|0
5810785|NCT02730871|20059756|P1|Overall Study|Adverse Event|6
5810786|NCT02730819|20059770|P1|Overall Study|Lost to Follow-up|9
5810787|NCT02730728|20059779|P3|Overall Study|Lack of Efficacy|1
5810788|NCT02730728|20059780|P2|Overall Study|Lack of Efficacy|1
5810789|NCT02730728|20059781|P1|Overall Study|Lack of Efficacy|0
5810790|NCT02730728|20059779|P3|Overall Study|Withdrawal by Subject|0
5810791|NCT02730728|20059780|P2|Overall Study|Withdrawal by Subject|1
5810792|NCT02730728|20059781|P1|Overall Study|Withdrawal by Subject|0
5810793|NCT02730598|20059810|P2|Overall Study|Unrelated Injury affecting outcomes.|0
5810794|NCT02730598|20059811|P1|Overall Study|Unrelated Injury affecting outcomes.|1
5810795|NCT02730598|20059810|P2|Overall Study|Protocol Violation|1
5810796|NCT02730598|20059811|P1|Overall Study|Protocol Violation|0
5810797|NCT02730598|20059810|P2|Overall Study|Withdrawal by Subject|3
5810798|NCT02730598|20059811|P1|Overall Study|Withdrawal by Subject|3
5810799|NCT02730455|20059834|P3|Overall Study|Other|0
5810800|NCT02730455|20059835|P2|Overall Study|Other|2
5810801|NCT02730455|20059836|P1|Overall Study|Other|2
5810802|NCT02730455|20059834|P3|Overall Study|Other|2
5810803|NCT02730455|20059835|P2|Overall Study|Other|1
5810804|NCT02730455|20059836|P1|Overall Study|Other|1
5810805|NCT02730455|20059834|P3|Overall Study|Lost to Follow-up|4
5810806|NCT02730455|20059835|P2|Overall Study|Lost to Follow-up|1
5810807|NCT02730455|20059836|P1|Overall Study|Lost to Follow-up|3
5810808|NCT02730455|20059834|P3|Overall Study|Consent withdrawn|1
5810809|NCT02730455|20059835|P2|Overall Study|Consent withdrawn|4
5810810|NCT02730455|20059836|P1|Overall Study|Consent withdrawn|2
5810811|NCT02730455|20059834|P3|Overall Study|Death|4
5810812|NCT02730455|20059835|P2|Overall Study|Death|6
5810813|NCT02730455|20059836|P1|Overall Study|Death|5
5810814|NCT02730377|20059886|P2|Overall Study|Lost to Follow-up|21
5810815|NCT02730377|20059887|P1|Overall Study|Lost to Follow-up|25
5810816|NCT02730377|20059886|P2|Overall Study|Withdrawal by Subject|42
5810817|NCT02730377|20059887|P1|Overall Study|Withdrawal by Subject|45
5810818|NCT02730377|20059886|P2|Overall Study|Pregnancy|1
5810819|NCT02730377|20059887|P1|Overall Study|Pregnancy|0
5810820|NCT02730377|20059886|P2|Overall Study|Lack of Efficacy|13
5810821|NCT02730377|20059887|P1|Overall Study|Lack of Efficacy|4
5810822|NCT02730377|20059886|P2|Overall Study|Protocol Violation|30
5810823|NCT02730377|20059887|P1|Overall Study|Protocol Violation|23
5810824|NCT02730377|20059886|P2|Overall Study|Adverse Event|41
5810825|NCT02730377|20059887|P1|Overall Study|Adverse Event|79
5810826|NCT02730377|20059886|P2|Overall Study|Inadequate glycaemic control|473
5810827|NCT02730377|20059887|P1|Overall Study|Inadequate glycaemic control|368
5810828|NCT02730377|20059886|P2|Overall Study|Death|8
5810829|NCT02730377|20059887|P1|Overall Study|Death|1
5810830|NCT02730377|20059886|P2|Overall Study|Other|4
5810831|NCT02730377|20059887|P1|Overall Study|Other|5
5810832|NCT02730351|20059937|P2|Treatment Period 2 (2 Weeks)|Lack of Efficacy|0
5810833|NCT02730351|20059938|P1|Treatment Period 2 (2 Weeks)|Lack of Efficacy|1
5810834|NCT02730351|20059937|P2|Treatment Period 2 (2 Weeks)|Adverse Event|0
5810835|NCT02730351|20059938|P1|Treatment Period 2 (2 Weeks)|Adverse Event|1
5810836|NCT02730351|20059937|P2|Wash-out Period (2 Weeks)|Withdrawal by Subject|0
5810837|NCT02730351|20059938|P1|Wash-out Period (2 Weeks)|Withdrawal by Subject|1
5810838|NCT02730351|20059937|P2|Wash-out Period (2 Weeks)|Protocol Violation|1
5810839|NCT02730351|20059938|P1|Wash-out Period (2 Weeks)|Protocol Violation|0
5810840|NCT02730351|20059937|P2|Treatment Period 1 (2 Weeks)|Adverse Event|0
5810841|NCT02730351|20059938|P1|Treatment Period 1 (2 Weeks)|Adverse Event|1
5810842|NCT02730208|20059972|P2|Overall Study|Withdrawal of consent (not due to AE)|1
5810843|NCT02730208|20059973|P1|Overall Study|Withdrawal of consent (not due to AE)|0
5810844|NCT02730195|20059981|P1|Overall Study|Withdrawal by Subject|1
5810845|NCT02730169|20059991|P4|Overall Study|Other|1
5810846|NCT02730169|20059992|P3|Overall Study|Other|1
5810847|NCT02730169|20059993|P2|Overall Study|Other|0
5810848|NCT02730169|20059994|P1|Overall Study|Other|0
5810849|NCT02730169|20059991|P4|Overall Study|Lost to Follow-up|6
5810850|NCT02730169|20059992|P3|Overall Study|Lost to Follow-up|5
5810851|NCT02730169|20059993|P2|Overall Study|Lost to Follow-up|6
5810852|NCT02730169|20059994|P1|Overall Study|Lost to Follow-up|5
5810853|NCT02730169|20059991|P4|Overall Study|Withdrawal by Subject|8
5810854|NCT02730169|20059992|P3|Overall Study|Withdrawal by Subject|6
5810855|NCT02730169|20059993|P2|Overall Study|Withdrawal by Subject|11
5810856|NCT02730169|20059994|P1|Overall Study|Withdrawal by Subject|6
5810857|NCT02730169|20059991|P4|Overall Study|Adverse Event of Special Interest|0
5810858|NCT02730169|20059992|P3|Overall Study|Adverse Event of Special Interest|2
5810859|NCT02730169|20059993|P2|Overall Study|Adverse Event of Special Interest|1
5810860|NCT02730169|20059994|P1|Overall Study|Adverse Event of Special Interest|0
5810861|NCT02730169|20059991|P4|Overall Study|Adverse Event|0
5810862|NCT02730169|20059992|P3|Overall Study|Adverse Event|3
5810863|NCT02730169|20059993|P2|Overall Study|Adverse Event|3
5810864|NCT02730169|20059994|P1|Overall Study|Adverse Event|2
5810865|NCT02730169|20059991|P4|Overall Study|Protocol Violation|1
5810866|NCT02730169|20059992|P3|Overall Study|Protocol Violation|0
5810867|NCT02730169|20059993|P2|Overall Study|Protocol Violation|0
5810868|NCT02730169|20059994|P1|Overall Study|Protocol Violation|1
5810869|NCT02729909|20060062|P2|Overall Study|Voluntary Withdrawal|0
5810870|NCT02729909|20060063|P1|Overall Study|Voluntary Withdrawal|1
5810871|NCT02729909|20060062|P2|Overall Study|Significant Protocol Deviation|2
5810872|NCT02729909|20060063|P1|Overall Study|Significant Protocol Deviation|0
5810873|NCT02729909|20060062|P2|Overall Study|Lack of Efficacy|2
5810874|NCT02729909|20060063|P1|Overall Study|Lack of Efficacy|0
5810875|NCT02729909|20060062|P2|Overall Study|Lost to Follow-up|1
5810876|NCT02729909|20060063|P1|Overall Study|Lost to Follow-up|0
5810877|NCT02729896|20060082|P3|Overall Study|Withdrawal by Subject|3
5810878|NCT02729896|20060083|P2|Overall Study|Withdrawal by Subject|0
5810879|NCT02729896|20060084|P1|Overall Study|Withdrawal by Subject|1
5810880|NCT02729896|20060082|P3|Overall Study|Progressive Disease|0
5810881|NCT02729896|20060083|P2|Overall Study|Progressive Disease|1
5810882|NCT02729896|20060084|P1|Overall Study|Progressive Disease|0
5810883|NCT02729896|20060082|P3|Overall Study|Physician Decision|3
5810884|NCT02729896|20060083|P2|Overall Study|Physician Decision|2
5810885|NCT02729896|20060084|P1|Overall Study|Physician Decision|1
5810886|NCT02729896|20060082|P3|Overall Study|Other|0
5810887|NCT02729896|20060083|P2|Overall Study|Other|2
5810888|NCT02729896|20060084|P1|Overall Study|Other|0
5810889|NCT02729896|20060082|P3|Overall Study|Lost to Follow-up|3
5810890|NCT02729896|20060083|P2|Overall Study|Lost to Follow-up|2
5810891|NCT02729896|20060084|P1|Overall Study|Lost to Follow-up|0
5810892|NCT02729896|20060082|P3|Overall Study|Death|13
5810893|NCT02729896|20060083|P2|Overall Study|Death|2
5810894|NCT02729896|20060084|P1|Overall Study|Death|0
5810895|NCT02729831|20060129|P4|6 Month Follow-up|Death|1
5810896|NCT02729831|20060130|P3|6 Month Follow-up|Death|0
5810897|NCT02729831|20060131|P2|6 Month Follow-up|Death|3
5810898|NCT02729831|20060132|P1|6 Month Follow-up|Death|1
5810899|NCT02729831|20060129|P4|6 Month Follow-up|Lost to Follow-up|42
5810900|NCT02729831|20060130|P3|6 Month Follow-up|Lost to Follow-up|48
5810901|NCT02729831|20060131|P2|6 Month Follow-up|Lost to Follow-up|51
5810902|NCT02729831|20060132|P1|6 Month Follow-up|Lost to Follow-up|54
5810903|NCT02729831|20060129|P4|1 Week Post-visit|Lost to Follow-up|36
5810904|NCT02729831|20060130|P3|1 Week Post-visit|Lost to Follow-up|38
5810905|NCT02729831|20060131|P2|1 Week Post-visit|Lost to Follow-up|40
5810906|NCT02729831|20060132|P1|1 Week Post-visit|Lost to Follow-up|43
5810907|NCT02729831|20060129|P4|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|17
5810908|NCT02729831|20060130|P3|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|18
5810909|NCT02729831|20060131|P2|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|23
5810910|NCT02729831|20060132|P1|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|38
5810911|NCT02729753|20060160|P2|Overall Study|Device Malfunction. No units in stock.|1
5810912|NCT02729753|20060161|P1|Overall Study|Device Malfunction. No units in stock.|0
5810913|NCT02729545|20060175|P2|Overall Study|Withdrawal by Subject|3
5810914|NCT02729545|20060176|P1|Overall Study|Withdrawal by Subject|2
5810915|NCT02729545|20060175|P2|Overall Study|Lost to Follow-up|1
5810916|NCT02729545|20060176|P1|Overall Study|Lost to Follow-up|0
5810917|NCT02729545|20060175|P2|Overall Study|Pregnancy|1
5810918|NCT02729545|20060176|P1|Overall Study|Pregnancy|1
5810919|NCT02729194|20060198|P1|Overall Study|Withdrawal by Subject|3
5810920|NCT02729051|20060210|P2|Overall Study|Withdrawal by Subject|17
5810921|NCT02729051|20060211|P1|Overall Study|Withdrawal by Subject|6
5810922|NCT02729051|20060210|P2|Overall Study|Physician Decision|1
5810923|NCT02729051|20060211|P1|Overall Study|Physician Decision|1
5810924|NCT02729051|20060210|P2|Overall Study|Lost to Follow-up|2
5810925|NCT02729051|20060211|P1|Overall Study|Lost to Follow-up|1
5810926|NCT02729051|20060210|P2|Overall Study|Lack of Efficacy|1
5810927|NCT02729051|20060211|P1|Overall Study|Lack of Efficacy|1
5810928|NCT02729051|20060210|P2|Overall Study|Adverse Event|11
5810929|NCT02729051|20060211|P1|Overall Study|Adverse Event|21
5810930|NCT02729025|20060355|P2|Overall Study|Sponsor Decision|1
5810931|NCT02729025|20060356|P1|Overall Study|Sponsor Decision|0
5810932|NCT02728895|20060370|P2|Overall Study|Withdrawal by Subject|3
5810933|NCT02728895|20060371|P1|Overall Study|Withdrawal by Subject|0
5810934|NCT02728895|20060370|P2|Overall Study|Other|2
5810935|NCT02728895|20060371|P1|Overall Study|Other|1
5810944|NCT02728206|20060398|P1|Overall Study|Death|1
5810945|NCT02728089|20060406|P1|Overall Study|Withdrawal by Subject|1
5810946|NCT02728089|20060406|P1|Overall Study|Physician Decision|2
5810947|NCT02727777|20060494|P3|Overall Study|Progressive disease|0
5810948|NCT02727777|20060495|P2|Overall Study|Progressive disease|0
5810949|NCT02727777|20060496|P1|Overall Study|Progressive disease|2
5810950|NCT02727777|20060494|P3|Overall Study|Screen Failure|0
5810951|NCT02727777|20060495|P2|Overall Study|Screen Failure|0
5810952|NCT02727777|20060496|P1|Overall Study|Screen Failure|2
5810953|NCT02727660|20060517|P3|Overall Study|Administrative Reasons|4
5810954|NCT02727660|20060518|P2|Overall Study|Administrative Reasons|3
5810955|NCT02727660|20060519|P1|Overall Study|Administrative Reasons|2
5810956|NCT02727660|20060517|P3|Overall Study|Protocol Specified Disc. Criteria|2
5810957|NCT02727660|20060518|P2|Overall Study|Protocol Specified Disc. Criteria|5
5810958|NCT02727660|20060519|P1|Overall Study|Protocol Specified Disc. Criteria|5
5810959|NCT02727660|20060517|P3|Overall Study|Protocol Violation|5
5810960|NCT02727660|20060518|P2|Overall Study|Protocol Violation|5
5810961|NCT02727660|20060519|P1|Overall Study|Protocol Violation|7
5810962|NCT02727660|20060517|P3|Overall Study|Lost to Follow-up|8
5810963|NCT02727660|20060518|P2|Overall Study|Lost to Follow-up|9
5810964|NCT02727660|20060519|P1|Overall Study|Lost to Follow-up|5
5810965|NCT02727660|20060517|P3|Overall Study|Physician Decision|14
5810966|NCT02727660|20060518|P2|Overall Study|Physician Decision|8
5810967|NCT02727660|20060519|P1|Overall Study|Physician Decision|3
5810968|NCT02727660|20060517|P3|Overall Study|Withdrawal by Subject|30
5810969|NCT02727660|20060518|P2|Overall Study|Withdrawal by Subject|25
5810970|NCT02727660|20060519|P1|Overall Study|Withdrawal by Subject|26
5810971|NCT02727660|20060517|P3|Overall Study|Adverse Event|32
5810972|NCT02727660|20060518|P2|Overall Study|Adverse Event|21
5810973|NCT02727660|20060519|P1|Overall Study|Adverse Event|28
5810974|NCT02727660|20060517|P3|Overall Study|Lack of Efficacy|70
5810975|NCT02727660|20060518|P2|Overall Study|Lack of Efficacy|40
5810976|NCT02727660|20060519|P1|Overall Study|Lack of Efficacy|40
5810977|NCT02727322|20060538|P2|Overall Study|Protocol Violation|0
5810978|NCT02727322|20060539|P1|Overall Study|Protocol Violation|1
5810979|NCT02727322|20060538|P2|Overall Study|Withdrawal by Subject|1
5810980|NCT02727322|20060539|P1|Overall Study|Withdrawal by Subject|1
5810981|NCT02726945|20060565|P3|Overall Study|Elected to have total knee replacement|0
5810982|NCT02726945|20060566|P2|Overall Study|Elected to have total knee replacement|1
5810983|NCT02726945|20060567|P1|Overall Study|Elected to have total knee replacement|0
5810984|NCT02726945|20060565|P3|Overall Study|Withdrawal by Subject|1
5810985|NCT02726945|20060566|P2|Overall Study|Withdrawal by Subject|0
5810986|NCT02726945|20060567|P1|Overall Study|Withdrawal by Subject|0
5810987|NCT02726399|20060701|P1|Overall Study|Progression of disease|4
5810988|NCT02726399|20060701|P1|Overall Study|Adverse Event|2
5810989|NCT02726399|20060701|P1|Overall Study|Participant Non-Compliance|1
5810990|NCT02726113|20060718|P2|Genomic Analysis|Insurance non-coverage for surgery|1
5810991|NCT02726113|20060719|P1|Genomic Analysis|Insurance non-coverage for surgery|1
5810992|NCT02726113|20060718|P2|Genomic Analysis|Withdrawal by Subject|1
5810993|NCT02726113|20060719|P1|Genomic Analysis|Withdrawal by Subject|2
5810994|NCT02726113|20060718|P2|Genomic Analysis|Protocol Violation|0
5810995|NCT02726113|20060719|P1|Genomic Analysis|Protocol Violation|1
5810996|NCT02726113|20060718|P2|Total Enrollment|Insurance non-coverage for surgery|1
5810997|NCT02726113|20060719|P1|Total Enrollment|Insurance non-coverage for surgery|1
5810998|NCT02726113|20060718|P2|Total Enrollment|Withdrawal by Subject|1
5810999|NCT02726113|20060719|P1|Total Enrollment|Withdrawal by Subject|2
5811000|NCT02726113|20060718|P2|Total Enrollment|Protocol Violation|0
5811001|NCT02726113|20060719|P1|Total Enrollment|Protocol Violation|1
5811002|NCT02726113|20060718|P2|Total Enrollment|Physician Decision|1
5811003|NCT02726113|20060719|P1|Total Enrollment|Physician Decision|0
5811004|NCT02726074|20060726|P1|Overall Study|Others|3
5811005|NCT02726074|20060726|P1|Overall Study|Lost to Follow-up|2
5811006|NCT02726074|20060726|P1|Overall Study|Protocol Violation|3
5811007|NCT02726074|20060726|P1|Overall Study|Adverse Event|14
5811008|NCT02726074|20060726|P1|Overall Study|Withdrawal by Subject|4
5811009|NCT02726022|20060738|P1|Overall Study|Treatment Failure and Poor Compliance|1
5811010|NCT02726022|20060738|P1|Overall Study|Poor Compliance|13
5811011|NCT02726022|20060738|P1|Overall Study|Treatment Failure|8
5811012|NCT02726022|20060738|P1|Overall Study|Adverse Event|14
5811013|NCT02725866|20060747|P1|Overall Study|Other, not specified|4
5811014|NCT02725866|20060747|P1|Overall Study|Insufficient virological response|1
5811015|NCT02725866|20060747|P1|Overall Study|Withdrew consent|3
5811016|NCT02725866|20060747|P1|Overall Study|Failure to return|6
5811017|NCT02725788|20060771|P2|Overall Study|Protocol Violation|1
5811018|NCT02725788|20060772|P1|Overall Study|Protocol Violation|0
5811019|NCT02725788|20060771|P2|Overall Study|Lost to Follow-up|1
5811020|NCT02725788|20060772|P1|Overall Study|Lost to Follow-up|1
5811021|NCT02725710|20060780|P2|Overall Study|Lost to Follow-up|0
5811022|NCT02725710|20060781|P1|Overall Study|Lost to Follow-up|1
5811023|NCT02725671|20060809|P1|Overall Study|Lost to Follow-up|1
5811024|NCT02725593|20060824|P2|Long Term Extension|Withdrawal by Subject|3
5811025|NCT02725593|20060825|P1|Long Term Extension|Withdrawal by Subject|1
5811026|NCT02725593|20060824|P2|Blinded Treatment Period|Lost to Follow-up|1
5811027|NCT02725593|20060825|P1|Blinded Treatment Period|Lost to Follow-up|1
5811028|NCT02725593|20060824|P2|Blinded Treatment Period|Withdrawal by Parent/Guardian|2
5811029|NCT02725593|20060825|P1|Blinded Treatment Period|Withdrawal by Parent/Guardian|0
5811030|NCT02725593|20060824|P2|Blinded Treatment Period|Withdrawal by Subject|3
5811031|NCT02725593|20060825|P1|Blinded Treatment Period|Withdrawal by Subject|4
5811032|NCT02725515|20060839|P2|Overall Study|Lack of Response|1
5811033|NCT02725515|20060840|P1|Overall Study|Lack of Response|0
5811034|NCT02725515|20060839|P2|Overall Study|Completed Study Under Original Protocol|1
5811035|NCT02725515|20060840|P1|Overall Study|Completed Study Under Original Protocol|0
5811036|NCT02725515|20060839|P2|Overall Study|No Documented Disease Improvement|1
5811037|NCT02725515|20060840|P1|Overall Study|No Documented Disease Improvement|0
5811038|NCT02725515|20060839|P2|Overall Study|Adverse Event|2
5811039|NCT02725515|20060840|P1|Overall Study|Adverse Event|7
5811040|NCT02725515|20060839|P2|Overall Study|Lost to Follow-up|1
5811041|NCT02725515|20060840|P1|Overall Study|Lost to Follow-up|1
5811042|NCT02725515|20060839|P2|Overall Study|Non-Compliance With Study Drug|3
5811043|NCT02725515|20060840|P1|Overall Study|Non-Compliance With Study Drug|0
5811044|NCT02725515|20060839|P2|Overall Study|Withdrawal by Subject|1
5811045|NCT02725515|20060840|P1|Overall Study|Withdrawal by Subject|2
5811046|NCT02725515|20060839|P2|Overall Study|Loss of Improvement per Protocol|25
5811047|NCT02725515|20060840|P1|Overall Study|Loss of Improvement per Protocol|14
5811048|NCT02725515|20060839|P2|Overall Study|Refused infusion (no study treatment)|0
5811049|NCT02725515|20060840|P1|Overall Study|Refused infusion (no study treatment)|1
5811050|NCT02725476|20060852|P2|Overall Study|Adverse Event|1
5811051|NCT02725476|20060853|P1|Overall Study|Adverse Event|1
5811052|NCT02725476|20060852|P2|Overall Study|Physician Decision|0
5811053|NCT02725476|20060853|P1|Overall Study|Physician Decision|2
5811054|NCT02725411|20060864|P3|Follow-up Period (24 Weeks)|Withdrawal by Subject|3
5811055|NCT02725411|20060865|P2|Follow-up Period (24 Weeks)|Withdrawal by Subject|3
5811056|NCT02725411|20060866|P1|Follow-up Period (24 Weeks)|Withdrawal by Subject|1
5811057|NCT02725411|20060864|P3|Follow-up Period (24 Weeks)|Other|2
5811058|NCT02725411|20060865|P2|Follow-up Period (24 Weeks)|Other|4
5811059|NCT02725411|20060866|P1|Follow-up Period (24 Weeks)|Other|1
5811060|NCT02725411|20060864|P3|Follow-up Period (24 Weeks)|Lost to Follow-up|0
5811061|NCT02725411|20060865|P2|Follow-up Period (24 Weeks)|Lost to Follow-up|1
5811062|NCT02725411|20060866|P1|Follow-up Period (24 Weeks)|Lost to Follow-up|1
5811063|NCT02725411|20060864|P3|Follow-up Period (24 Weeks)|Lack of Efficacy|0
5811064|NCT02725411|20060865|P2|Follow-up Period (24 Weeks)|Lack of Efficacy|2
5811065|NCT02725411|20060866|P1|Follow-up Period (24 Weeks)|Lack of Efficacy|0
5811066|NCT02725411|20060864|P3|Follow-up Period (24 Weeks)|Adverse Event|0
5811067|NCT02725411|20060865|P2|Follow-up Period (24 Weeks)|Adverse Event|1
5811068|NCT02725411|20060866|P1|Follow-up Period (24 Weeks)|Adverse Event|1
5811069|NCT02725411|20060864|P3|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|35
5811070|NCT02725411|20060865|P2|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|35
5811071|NCT02725411|20060866|P1|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|25
5811072|NCT02725411|20060864|P3|Treatment Period (56 Weeks)|Withdrawal by Subject|4
5811073|NCT02725411|20060865|P2|Treatment Period (56 Weeks)|Withdrawal by Subject|1
5811074|NCT02725411|20060866|P1|Treatment Period (56 Weeks)|Withdrawal by Subject|0
5811075|NCT02725411|20060864|P3|Treatment Period (56 Weeks)|Other|5
5811076|NCT02725411|20060865|P2|Treatment Period (56 Weeks)|Other|4
5811077|NCT02725411|20060866|P1|Treatment Period (56 Weeks)|Other|1
5811078|NCT02725411|20060864|P3|Treatment Period (56 Weeks)|Lost to Follow-up|0
5811079|NCT02725411|20060865|P2|Treatment Period (56 Weeks)|Lost to Follow-up|1
5811080|NCT02725411|20060866|P1|Treatment Period (56 Weeks)|Lost to Follow-up|0
5811081|NCT02725411|20060864|P3|Treatment Period (56 Weeks)|Lack of Efficacy|1
5811082|NCT02725411|20060865|P2|Treatment Period (56 Weeks)|Lack of Efficacy|4
5811083|NCT02725411|20060866|P1|Treatment Period (56 Weeks)|Lack of Efficacy|1
5811084|NCT02725411|20060864|P3|Treatment Period (56 Weeks)|Adverse Event|4
5811085|NCT02725411|20060865|P2|Treatment Period (56 Weeks)|Adverse Event|5
5811086|NCT02725411|20060866|P1|Treatment Period (56 Weeks)|Adverse Event|3
5811087|NCT02725268|20061082|P4|Overall Study|Ongoing|0
5811088|NCT02725268|20061083|P3|Overall Study|Ongoing|0
5811089|NCT02725268|20061084|P2|Overall Study|Ongoing|3
5811090|NCT02725268|20061085|P1|Overall Study|Ongoing|3
5811091|NCT02725268|20061082|P4|Overall Study|Reason not Specified|0
5811092|NCT02725268|20061083|P3|Overall Study|Reason not Specified|0
5811093|NCT02725268|20061084|P2|Overall Study|Reason not Specified|1
5811094|NCT02725268|20061085|P1|Overall Study|Reason not Specified|1
5811095|NCT02725268|20061082|P4|Overall Study|Withdrawal by Subject|1
5811096|NCT02725268|20061083|P3|Overall Study|Withdrawal by Subject|8
5811097|NCT02725268|20061084|P2|Overall Study|Withdrawal by Subject|4
5811098|NCT02725268|20061085|P1|Overall Study|Withdrawal by Subject|8
5811099|NCT02725268|20061082|P4|Overall Study|Lost to Follow-up|0
5811100|NCT02725268|20061083|P3|Overall Study|Lost to Follow-up|0
5811101|NCT02725268|20061084|P2|Overall Study|Lost to Follow-up|3
5811102|NCT02725268|20061085|P1|Overall Study|Lost to Follow-up|2
5811103|NCT02725268|20061082|P4|Overall Study|Death|16
5811104|NCT02725268|20061083|P3|Overall Study|Death|29
5811105|NCT02725268|20061084|P2|Overall Study|Death|48
5811106|NCT02725268|20061085|P1|Overall Study|Death|45
5811107|NCT02725008|20061121|P2|Overall Study|Admitted to hospital|1
5811108|NCT02725008|20061122|P1|Overall Study|Admitted to hospital|0
5811109|NCT02725008|20061121|P2|Overall Study|Withdrawal by Subject|2
5811110|NCT02725008|20061122|P1|Overall Study|Withdrawal by Subject|2
5811111|NCT02725008|20061121|P2|Overall Study|Lost to Follow-up|9
5811112|NCT02725008|20061122|P1|Overall Study|Lost to Follow-up|7
5811113|NCT02724839|20061133|P3|Overall Study|Physician Decision|3
5811114|NCT02724839|20061134|P2|Overall Study|Physician Decision|0
5811115|NCT02724839|20061135|P1|Overall Study|Physician Decision|0
5811116|NCT02724839|20061133|P3|Overall Study|Lost to Follow-up|2
5811117|NCT02724839|20061134|P2|Overall Study|Lost to Follow-up|3
5811118|NCT02724839|20061135|P1|Overall Study|Lost to Follow-up|0
5811119|NCT02724839|20061133|P3|Overall Study|Withdrawal by Subject|0
5811120|NCT02724839|20061134|P2|Overall Study|Withdrawal by Subject|1
5811121|NCT02724839|20061135|P1|Overall Study|Withdrawal by Subject|1
5811122|NCT02724644|20061212|P2|Overall Study|Administrative|0
5811123|NCT02724644|20061213|P1|Overall Study|Administrative|1
5811124|NCT02724644|20061212|P2|Overall Study|Withdrawal by Subject|1
5811125|NCT02724644|20061213|P1|Overall Study|Withdrawal by Subject|7
5811126|NCT02724644|20061212|P2|Overall Study|Lost to Follow-up|2
5811127|NCT02724644|20061213|P1|Overall Study|Lost to Follow-up|6
5811128|NCT02724644|20061212|P2|Overall Study|Adverse Event|1
5811129|NCT02724644|20061213|P1|Overall Study|Adverse Event|7
5811130|NCT02724462|20061243|P2|12 Month Follow-up Survey|Excluded as ineligible after randomization|48
5811131|NCT02724462|20061244|P1|12 Month Follow-up Survey|Excluded as ineligible after randomization|40
5811132|NCT02724462|20061243|P2|12 Month Follow-up Survey|Lost to Follow-up|134
5811133|NCT02724462|20061244|P1|12 Month Follow-up Survey|Lost to Follow-up|174
5811134|NCT02724462|20061243|P2|6 Month Follow-up Survey|Excluded as ineligible after randomization|48
5811135|NCT02724462|20061244|P1|6 Month Follow-up Survey|Excluded as ineligible after randomization|40
5811136|NCT02724462|20061243|P2|6 Month Follow-up Survey|Lost to Follow-up|123
5811137|NCT02724462|20061244|P1|6 Month Follow-up Survey|Lost to Follow-up|156
5811138|NCT02724462|20061243|P2|3 Month Follow-up Survey|Excluded as ineligible after randomization|48
5811139|NCT02724462|20061244|P1|3 Month Follow-up Survey|Excluded as ineligible after randomization|40
5811140|NCT02724462|20061243|P2|3 Month Follow-up Survey|Lost to Follow-up|151
5811141|NCT02724462|20061244|P1|3 Month Follow-up Survey|Lost to Follow-up|171
5811142|NCT02724111|20061258|P2|Overall Study|Protocol Violation|5
5811143|NCT02724111|20061259|P1|Overall Study|Protocol Violation|2
5811144|NCT02723786|20061311|P1|Overall Study|Lost to Follow-up|1
5811145|NCT02723630|20061339|P6|Intervention Period 3|consumption of restricted item|0
5811146|NCT02723630|20061340|P5|Intervention Period 3|consumption of restricted item|0
5811147|NCT02723630|20061341|P4|Intervention Period 3|consumption of restricted item|0
5811148|NCT02723630|20061342|P3|Intervention Period 3|consumption of restricted item|0
5811149|NCT02723630|20061343|P2|Intervention Period 3|consumption of restricted item|1
5811150|NCT02723630|20061344|P1|Intervention Period 3|consumption of restricted item|0
5811151|NCT02723630|20061339|P6|Intervention Period 1|Adverse Event|0
5811152|NCT02723630|20061340|P5|Intervention Period 1|Adverse Event|0
5811153|NCT02723630|20061341|P4|Intervention Period 1|Adverse Event|0
5811154|NCT02723630|20061342|P3|Intervention Period 1|Adverse Event|0
5811155|NCT02723630|20061343|P2|Intervention Period 1|Adverse Event|0
5811156|NCT02723630|20061344|P1|Intervention Period 1|Adverse Event|1
5811157|NCT02723591|20061375|P2|Overall Study|Miscellaneous|6
5811158|NCT02723591|20061376|P1|Overall Study|Miscellaneous|5
5811159|NCT02723591|20061375|P2|Overall Study|Randomized but Never Received StudyDrug|12
5811160|NCT02723591|20061376|P1|Overall Study|Randomized but Never Received StudyDrug|12
5811161|NCT02723591|20061375|P2|Overall Study|Withdrawal by Subject|8
5811162|NCT02723591|20061376|P1|Overall Study|Withdrawal by Subject|4
5811163|NCT02723591|20061375|P2|Overall Study|Protocol Violation|23
5811164|NCT02723591|20061376|P1|Overall Study|Protocol Violation|20
5811165|NCT02723591|20061375|P2|Overall Study|Lost to Follow-up|7
5811166|NCT02723591|20061376|P1|Overall Study|Lost to Follow-up|1
5811167|NCT02723591|20061375|P2|Overall Study|Lack of Efficacy|3
5811168|NCT02723591|20061376|P1|Overall Study|Lack of Efficacy|4
5811169|NCT02723591|20061375|P2|Overall Study|Death|2
5811170|NCT02723591|20061376|P1|Overall Study|Death|2
5811171|NCT02723591|20061375|P2|Overall Study|Adverse Event|40
5811172|NCT02723591|20061376|P1|Overall Study|Adverse Event|48
5811173|NCT02723344|20061504|P2|Overall Study|Lost to Follow-up|4
5811174|NCT02723344|20061505|P1|Overall Study|Lost to Follow-up|0
5811175|NCT02723201|20061528|P3|Second Intervention Period|Adverse Event|0
5811176|NCT02723201|20061529|P2|Second Intervention Period|Adverse Event|0
5811177|NCT02723201|20061530|P1|Second Intervention Period|Adverse Event|1
5811178|NCT02723201|20061528|P3|Second Intervention Period|Protocol Violation|0
5811179|NCT02723201|20061529|P2|Second Intervention Period|Protocol Violation|0
5811180|NCT02723201|20061530|P1|Second Intervention Period|Protocol Violation|1
5811181|NCT02723188|20061589|P3|Overall Study|Withdrawal by Subject|0
5811182|NCT02723188|20061590|P2|Overall Study|Withdrawal by Subject|0
5811183|NCT02723188|20061591|P1|Overall Study|Withdrawal by Subject|1
5811184|NCT02723175|20061604|P2|Overall Study|Lost to 3 Month Follow Up|1
5811185|NCT02723175|20061605|P1|Overall Study|Lost to 3 Month Follow Up|1
5811186|NCT02723175|20061604|P2|Overall Study|Lost to 1 Month Follow Up|2
5811187|NCT02723175|20061605|P1|Overall Study|Lost to 1 Month Follow Up|3
5811188|NCT02723084|20061647|P2|Overall Study|Lost to Follow-up|0
5811189|NCT02723084|20061648|P1|Overall Study|Lost to Follow-up|3
5811190|NCT02723084|20061647|P2|Overall Study|Withdrawal by Subject|1
5811191|NCT02723084|20061648|P1|Overall Study|Withdrawal by Subject|1
5811192|NCT02722967|20061662|P3|Overall Study|Non-adherence of the patch to the skin|2
5811193|NCT02722967|20061663|P2|Overall Study|Non-adherence of the patch to the skin|0
5811194|NCT02722967|20061664|P1|Overall Study|Non-adherence of the patch to the skin|0
5811195|NCT02722967|20061662|P3|Overall Study|Physician Decision|0
5811196|NCT02722967|20061663|P2|Overall Study|Physician Decision|0
5811197|NCT02722967|20061664|P1|Overall Study|Physician Decision|1
5811198|NCT02722967|20061662|P3|Overall Study|Withdrawal by Subject|1
5811199|NCT02722967|20061663|P2|Overall Study|Withdrawal by Subject|0
5811200|NCT02722967|20061664|P1|Overall Study|Withdrawal by Subject|1
5811201|NCT02722967|20061662|P3|Overall Study|Non-compliance with patch wearing|1
5811202|NCT02722967|20061663|P2|Overall Study|Non-compliance with patch wearing|1
5811203|NCT02722967|20061664|P1|Overall Study|Non-compliance with patch wearing|2
5811204|NCT02722967|20061662|P3|Overall Study|Lost to Follow-up|0
5811205|NCT02722967|20061663|P2|Overall Study|Lost to Follow-up|1
5811206|NCT02722967|20061664|P1|Overall Study|Lost to Follow-up|0
5811207|NCT02722967|20061662|P3|Overall Study|Adverse Event|0
5811208|NCT02722967|20061663|P2|Overall Study|Adverse Event|0
5811209|NCT02722967|20061664|P1|Overall Study|Adverse Event|1
5811210|NCT02722928|20061674|P2|Overall Study|Required Intraoperative MRI|7
5811211|NCT02722928|20061675|P1|Overall Study|Required Intraoperative MRI|5
5811212|NCT02722928|20061674|P2|Overall Study|Standard CT was not as required per prot|13
5811213|NCT02722928|20061675|P1|Overall Study|Standard CT was not as required per prot|5
5811214|NCT02722304|20061805|P5|Overall Study|Other|1
5811215|NCT02722304|20061806|P4|Overall Study|Other|1
5811216|NCT02722304|20061807|P3|Overall Study|Other|0
5811217|NCT02722304|20061808|P2|Overall Study|Other|0
5811218|NCT02722304|20061809|P1|Overall Study|Other|0
5811219|NCT02722304|20061805|P5|Overall Study|Study Terminated by Sponsor|1
5811220|NCT02722304|20061806|P4|Overall Study|Study Terminated by Sponsor|1
5811221|NCT02722304|20061807|P3|Overall Study|Study Terminated by Sponsor|2
5811222|NCT02722304|20061808|P2|Overall Study|Study Terminated by Sponsor|0
5811223|NCT02722304|20061809|P1|Overall Study|Study Terminated by Sponsor|1
5811224|NCT02722278|20061861|P2|Overall Study|Site closure not study related|1
5811225|NCT02722278|20061862|P1|Overall Study|Site closure not study related|0
5811226|NCT02722278|20061861|P2|Overall Study|Subject declined after tx assignment|1
5811227|NCT02722278|20061862|P1|Overall Study|Subject declined after tx assignment|0
5811228|NCT02722278|20061861|P2|Overall Study|High PSA pre-study/ not eligible|1
5811229|NCT02722278|20061862|P1|Overall Study|High PSA pre-study/ not eligible|0
5811230|NCT02722278|20061861|P2|Overall Study|Protocol Violation|0
5811231|NCT02722278|20061862|P1|Overall Study|Protocol Violation|1
5811232|NCT02722278|20061861|P2|Overall Study|Lost to Follow-up|0
5811233|NCT02722278|20061862|P1|Overall Study|Lost to Follow-up|2
5811234|NCT02722278|20061861|P2|Overall Study|Adverse Event|1
5811235|NCT02722278|20061862|P1|Overall Study|Adverse Event|4
5811236|NCT02722278|20061861|P2|Overall Study|Withdrawal by Subject|3
5811237|NCT02722278|20061862|P1|Overall Study|Withdrawal by Subject|5
5811238|NCT02722148|20061886|P1|Overall Study|Non compliant with treatment regimen|3
5811239|NCT02722148|20061886|P1|Overall Study|Lost to Follow-up|2
5811240|NCT02722044|20061893|P1|Overall Study|Did Not Meet Criteria at Week 14|1
5811241|NCT02722044|20061893|P1|Overall Study|Withdrawal by Subject|1
5811242|NCT02722044|20061893|P1|Overall Study|Physician Decision|1
5811243|NCT02722044|20061893|P1|Overall Study|Adverse Event|2
5811244|NCT02721966|20061923|P5|Overall Study|Did not continue to period 2|5
5811245|NCT02721966|20061924|P4|Overall Study|Did not continue to period 2|0
5811246|NCT02721966|20061925|P3|Overall Study|Did not continue to period 2|0
5811247|NCT02721966|20061926|P2|Overall Study|Did not continue to period 2|12
5811248|NCT02721966|20061927|P1|Overall Study|Did not continue to period 2|5
5811249|NCT02721966|20061923|P5|Overall Study|Pregnancy|0
5811250|NCT02721966|20061924|P4|Overall Study|Pregnancy|0
5811251|NCT02721966|20061925|P3|Overall Study|Pregnancy|0
5811252|NCT02721966|20061926|P2|Overall Study|Pregnancy|0
5811253|NCT02721966|20061927|P1|Overall Study|Pregnancy|1
5811254|NCT02721966|20061923|P5|Overall Study|Physician Decision|0
5811255|NCT02721966|20061924|P4|Overall Study|Physician Decision|0
5811256|NCT02721966|20061925|P3|Overall Study|Physician Decision|0
5811257|NCT02721966|20061926|P2|Overall Study|Physician Decision|1
5811258|NCT02721966|20061927|P1|Overall Study|Physician Decision|1
5811259|NCT02721966|20061923|P5|Overall Study|Lost to Follow-up|0
5811260|NCT02721966|20061924|P4|Overall Study|Lost to Follow-up|0
5811261|NCT02721966|20061925|P3|Overall Study|Lost to Follow-up|3
5811262|NCT02721966|20061926|P2|Overall Study|Lost to Follow-up|0
5811263|NCT02721966|20061927|P1|Overall Study|Lost to Follow-up|0
5811264|NCT02721966|20061923|P5|Overall Study|Lack of Efficacy|0
5811265|NCT02721966|20061924|P4|Overall Study|Lack of Efficacy|0
5811266|NCT02721966|20061925|P3|Overall Study|Lack of Efficacy|0
5811267|NCT02721966|20061926|P2|Overall Study|Lack of Efficacy|4
5811268|NCT02721966|20061927|P1|Overall Study|Lack of Efficacy|7
5811269|NCT02721966|20061923|P5|Overall Study|Death|0
5811270|NCT02721966|20061924|P4|Overall Study|Death|0
5811271|NCT02721966|20061925|P3|Overall Study|Death|0
5811272|NCT02721966|20061926|P2|Overall Study|Death|0
5811273|NCT02721966|20061927|P1|Overall Study|Death|1
5811274|NCT02721966|20061923|P5|Overall Study|Adverse Event|0
5811275|NCT02721966|20061924|P4|Overall Study|Adverse Event|0
5811276|NCT02721966|20061925|P3|Overall Study|Adverse Event|3
5811277|NCT02721966|20061926|P2|Overall Study|Adverse Event|4
5811278|NCT02721966|20061927|P1|Overall Study|Adverse Event|4
5811279|NCT02721966|20061923|P5|Overall Study|Withdrawal by Subject|0
5811280|NCT02721966|20061924|P4|Overall Study|Withdrawal by Subject|7
5811281|NCT02721966|20061925|P3|Overall Study|Withdrawal by Subject|3
5811282|NCT02721966|20061926|P2|Overall Study|Withdrawal by Subject|2
5811283|NCT02721966|20061927|P1|Overall Study|Withdrawal by Subject|9
5811284|NCT02721966|20061923|P5|Overall Study|Protocol Violation|0
5811285|NCT02721966|20061924|P4|Overall Study|Protocol Violation|0
5811286|NCT02721966|20061925|P3|Overall Study|Protocol Violation|0
5811287|NCT02721966|20061926|P2|Overall Study|Protocol Violation|0
5811288|NCT02721966|20061927|P1|Overall Study|Protocol Violation|1
5811289|NCT02721875|20061967|P2|Overall Study|Progressive disease/relapse|0
5811290|NCT02721875|20061968|P1|Overall Study|Progressive disease/relapse|1
5811291|NCT02721147|20062019|P3|Overall Study|Lost to Follow-up|0
5811292|NCT02721147|20062020|P2|Overall Study|Lost to Follow-up|0
5811293|NCT02721147|20062021|P1|Overall Study|Lost to Follow-up|2
5811294|NCT02720757|20062065|P1|Overall Study|General exclusion|3
5811295|NCT02720757|20062065|P1|Overall Study|Missing|3
5811296|NCT02720757|20062065|P1|Overall Study|Patients wish to withdraw|2
5811297|NCT02720757|20062065|P1|Overall Study|Informed consent withdrawal|1
5811298|NCT02720757|20062065|P1|Overall Study|Loss of contact|4
5811299|NCT02720757|20062065|P1|Overall Study|Other reason|5
5811300|NCT02720536|20062079|P1|Overall Study|PR- unwilling to comply with procedures|1
5811301|NCT02720536|20062079|P1|Overall Study|PR - abnormal lab value(s)|1
5811302|NCT02720536|20062079|P1|Overall Study|PR - adverse event|1
5811303|NCT02720536|20062079|P1|Overall Study|PR - death|1
5811304|NCT02720536|20062079|P1|Overall Study|PR - unsatisfactory therapeutic effect|2
5811305|NCT02720536|20062079|P1|Overall Study|PR - pregnancy|2
5811306|NCT02720536|20062079|P1|Overall Study|Primary reason (PR) - subject withdrawal|11
5811307|NCT02720523|20062114|P7|Period 2: Long-term Extension Period|Other|3
5811308|NCT02720523|20062115|P6|Period 2: Long-term Extension Period|Other|0
5811309|NCT02720523|20062116|P5|Period 2: Long-term Extension Period|Other|2
5811310|NCT02720523|20062117|P4|Period 2: Long-term Extension Period|Other|0
5811311|NCT02720523|20062118|P3|Period 2: Long-term Extension Period|Other|0
5811312|NCT02720523|20062119|P2|Period 2: Long-term Extension Period|Other|0
5811313|NCT02720523|20062120|P1|Period 2: Long-term Extension Period|Other|0
5811314|NCT02720523|20062114|P7|Period 2: Long-term Extension Period|Withdrawal by Subject|1
5811315|NCT02720523|20062115|P6|Period 2: Long-term Extension Period|Withdrawal by Subject|1
5811316|NCT02720523|20062116|P5|Period 2: Long-term Extension Period|Withdrawal by Subject|2
5811317|NCT02720523|20062117|P4|Period 2: Long-term Extension Period|Withdrawal by Subject|0
5811318|NCT02720523|20062118|P3|Period 2: Long-term Extension Period|Withdrawal by Subject|0
5811319|NCT02720523|20062119|P2|Period 2: Long-term Extension Period|Withdrawal by Subject|0
5811320|NCT02720523|20062120|P1|Period 2: Long-term Extension Period|Withdrawal by Subject|0
5811321|NCT02720523|20062114|P7|Period 2: Long-term Extension Period|Adverse Event|11
5811322|NCT02720523|20062115|P6|Period 2: Long-term Extension Period|Adverse Event|7
5811323|NCT02720523|20062116|P5|Period 2: Long-term Extension Period|Adverse Event|4
5811324|NCT02720523|20062117|P4|Period 2: Long-term Extension Period|Adverse Event|0
5811325|NCT02720523|20062118|P3|Period 2: Long-term Extension Period|Adverse Event|0
5811326|NCT02720523|20062119|P2|Period 2: Long-term Extension Period|Adverse Event|0
5811327|NCT02720523|20062120|P1|Period 2: Long-term Extension Period|Adverse Event|0
5811328|NCT02720523|20062114|P7|Period 2: Long-term Extension Period|Ongoing|45
5811329|NCT02720523|20062115|P6|Period 2: Long-term Extension Period|Ongoing|54
5811330|NCT02720523|20062116|P5|Period 2: Long-term Extension Period|Ongoing|57
5811331|NCT02720523|20062117|P4|Period 2: Long-term Extension Period|Ongoing|0
5811332|NCT02720523|20062118|P3|Period 2: Long-term Extension Period|Ongoing|0
5811333|NCT02720523|20062119|P2|Period 2: Long-term Extension Period|Ongoing|0
5811334|NCT02720523|20062120|P1|Period 2: Long-term Extension Period|Ongoing|0
5811335|NCT02720523|20062114|P7|Period 1: Placebo-controlled Period|Other|0
5811336|NCT02720523|20062115|P6|Period 1: Placebo-controlled Period|Other|0
5811337|NCT02720523|20062116|P5|Period 1: Placebo-controlled Period|Other|0
5811338|NCT02720523|20062117|P4|Period 1: Placebo-controlled Period|Other|1
5811339|NCT02720523|20062118|P3|Period 1: Placebo-controlled Period|Other|1
5811340|NCT02720523|20062119|P2|Period 1: Placebo-controlled Period|Other|0
5811341|NCT02720523|20062120|P1|Period 1: Placebo-controlled Period|Other|0
5811342|NCT02720523|20062114|P7|Period 1: Placebo-controlled Period|Lack of Efficacy|0
5811343|NCT02720523|20062115|P6|Period 1: Placebo-controlled Period|Lack of Efficacy|0
5811344|NCT02720523|20062116|P5|Period 1: Placebo-controlled Period|Lack of Efficacy|0
5811345|NCT02720523|20062117|P4|Period 1: Placebo-controlled Period|Lack of Efficacy|0
5811346|NCT02720523|20062118|P3|Period 1: Placebo-controlled Period|Lack of Efficacy|0
5811347|NCT02720523|20062119|P2|Period 1: Placebo-controlled Period|Lack of Efficacy|0
5811348|NCT02720523|20062120|P1|Period 1: Placebo-controlled Period|Lack of Efficacy|1
5811349|NCT02720523|20062114|P7|Period 1: Placebo-controlled Period|Withdrawal by Subject|0
5811350|NCT02720523|20062115|P6|Period 1: Placebo-controlled Period|Withdrawal by Subject|0
5811351|NCT02720523|20062116|P5|Period 1: Placebo-controlled Period|Withdrawal by Subject|0
5811352|NCT02720523|20062117|P4|Period 1: Placebo-controlled Period|Withdrawal by Subject|0
5811353|NCT02720523|20062118|P3|Period 1: Placebo-controlled Period|Withdrawal by Subject|0
5811354|NCT02720523|20062119|P2|Period 1: Placebo-controlled Period|Withdrawal by Subject|0
5811355|NCT02720523|20062120|P1|Period 1: Placebo-controlled Period|Withdrawal by Subject|1
5811356|NCT02720523|20062114|P7|Period 1: Placebo-controlled Period|Adverse Event|0
5811357|NCT02720523|20062115|P6|Period 1: Placebo-controlled Period|Adverse Event|0
5811358|NCT02720523|20062116|P5|Period 1: Placebo-controlled Period|Adverse Event|0
5811359|NCT02720523|20062117|P4|Period 1: Placebo-controlled Period|Adverse Event|5
5811360|NCT02720523|20062118|P3|Period 1: Placebo-controlled Period|Adverse Event|1
5811361|NCT02720523|20062119|P2|Period 1: Placebo-controlled Period|Adverse Event|0
5811362|NCT02720523|20062120|P1|Period 1: Placebo-controlled Period|Adverse Event|0
5811363|NCT02720510|20062179|P2|Overall Study|Physician Decision|2
5811364|NCT02720510|20062180|P1|Overall Study|Physician Decision|1
5811365|NCT02720510|20062179|P2|Overall Study|Adverse Event|1
5811366|NCT02720510|20062180|P1|Overall Study|Adverse Event|0
5811367|NCT02720510|20062179|P2|Overall Study|Study Terminated by the sponsor|0
5811368|NCT02720510|20062180|P1|Overall Study|Study Terminated by the sponsor|2
5811369|NCT02720484|20062198|P1|Follow Up for 2 Years|Lost to Follow-up|2
5811370|NCT02720484|20062198|P1|Follow Up for 2 Years|Death|3
5811371|NCT02720484|20062198|P1|Follow Up for 2 Years|Withdrawal by Subject|1
5811372|NCT02720484|20062198|P1|Treatment on Study|Progressive Disease|4
5811373|NCT02720484|20062198|P1|Treatment on Study|Withdrawal by Subject|1
5811374|NCT02720484|20062198|P1|Treatment on Study|Adverse Event|1
5811375|NCT02720198|20062230|P2|Overall Study|Withdrawal by Subject|1
5811376|NCT02720198|20062231|P1|Overall Study|Withdrawal by Subject|0
5811377|NCT02720081|20062266|P2|Overall Study|Protocol Violation|1
5811378|NCT02720081|20062267|P1|Overall Study|Protocol Violation|4
5811379|NCT02720081|20062266|P2|Overall Study|Adverse Event|3
5811380|NCT02720081|20062267|P1|Overall Study|Adverse Event|0
5811381|NCT02720042|20062323|P1|Overall Study|unable due to non-study-related illness|3
5811382|NCT02720042|20062323|P1|Overall Study|Phasix Mesh explanted|1
5811383|NCT02720042|20062323|P1|Overall Study|Physician Decision|3
5811384|NCT02720042|20062323|P1|Overall Study|Withdrawal by Subject|1
5811385|NCT02720042|20062323|P1|Overall Study|Lost to Follow-up|4
5811386|NCT02720042|20062323|P1|Overall Study|Death|3
5811387|NCT02719743|20062364|P5|Overall Study|Lost to Follow-up|0
5811388|NCT02719743|20062365|P4|Overall Study|Lost to Follow-up|0
5811389|NCT02719743|20062366|P3|Overall Study|Lost to Follow-up|0
5811390|NCT02719743|20062367|P2|Overall Study|Lost to Follow-up|1
5811391|NCT02719743|20062368|P1|Overall Study|Lost to Follow-up|1
5811392|NCT02719743|20062364|P5|Overall Study|Migrated/moved from study area|2
5811393|NCT02719743|20062365|P4|Overall Study|Migrated/moved from study area|0
5811394|NCT02719743|20062366|P3|Overall Study|Migrated/moved from study area|0
5811395|NCT02719743|20062367|P2|Overall Study|Migrated/moved from study area|0
5811396|NCT02719743|20062368|P1|Overall Study|Migrated/moved from study area|0
5811397|NCT02719743|20062364|P5|Overall Study|Consent withdrawal|0
5811398|NCT02719743|20062365|P4|Overall Study|Consent withdrawal|1
5811399|NCT02719743|20062366|P3|Overall Study|Consent withdrawal|0
5811400|NCT02719743|20062367|P2|Overall Study|Consent withdrawal|2
5811401|NCT02719743|20062368|P1|Overall Study|Consent withdrawal|0
5811402|NCT02719522|20062509|P1|Overall Study|Lost to Follow-up|5
5811403|NCT02719522|20062509|P1|Overall Study|Death|2
5811404|NCT02719522|20062509|P1|Overall Study|Implant Failure|4
5811405|NCT02719353|20062551|P2|First Intervention|Physician Decision|1
5811406|NCT02719353|20062552|P1|First Intervention|Physician Decision|0
5811407|NCT02719171|20062591|P5|Overall Study|Other|0
5811408|NCT02719171|20062592|P4|Overall Study|Other|1
5811409|NCT02719171|20062593|P3|Overall Study|Other|0
5811410|NCT02719171|20062594|P2|Overall Study|Other|0
5811411|NCT02719171|20062595|P1|Overall Study|Other|0
5811412|NCT02719171|20062591|P5|Overall Study|Subject Withdrawal|0
5811413|NCT02719171|20062592|P4|Overall Study|Subject Withdrawal|1
5811414|NCT02719171|20062593|P3|Overall Study|Subject Withdrawal|2
5811415|NCT02719171|20062594|P2|Overall Study|Subject Withdrawal|2
5811416|NCT02719171|20062595|P1|Overall Study|Subject Withdrawal|0
5811417|NCT02719171|20062591|P5|Overall Study|Lost to Follow-up|0
5811418|NCT02719171|20062592|P4|Overall Study|Lost to Follow-up|0
5811419|NCT02719171|20062593|P3|Overall Study|Lost to Follow-up|1
5811420|NCT02719171|20062594|P2|Overall Study|Lost to Follow-up|0
5811421|NCT02719171|20062595|P1|Overall Study|Lost to Follow-up|0
5811422|NCT02719171|20062591|P5|Overall Study|Adverse Event|2
5811423|NCT02719171|20062592|P4|Overall Study|Adverse Event|0
5811424|NCT02719171|20062593|P3|Overall Study|Adverse Event|0
5811425|NCT02719171|20062594|P2|Overall Study|Adverse Event|2
5811426|NCT02719171|20062595|P1|Overall Study|Adverse Event|1
5811427|NCT02719028|20062712|P4|Overall Study|Protocol Violation|1
5811428|NCT02719028|20062713|P3|Overall Study|Protocol Violation|0
5811429|NCT02719028|20062714|P2|Overall Study|Protocol Violation|0
5811430|NCT02719028|20062715|P1|Overall Study|Protocol Violation|0
5811431|NCT02719028|20062712|P4|Overall Study|Use of prohibited medication|0
5811432|NCT02719028|20062713|P3|Overall Study|Use of prohibited medication|1
5811433|NCT02719028|20062714|P2|Overall Study|Use of prohibited medication|0
5811434|NCT02719028|20062715|P1|Overall Study|Use of prohibited medication|0
5811435|NCT02719028|20062712|P4|Overall Study|Physician Decision|1
5811436|NCT02719028|20062713|P3|Overall Study|Physician Decision|1
5811437|NCT02719028|20062714|P2|Overall Study|Physician Decision|1
5811438|NCT02719028|20062715|P1|Overall Study|Physician Decision|0
5811439|NCT02719028|20062712|P4|Overall Study|Adverse Event|8
5811440|NCT02719028|20062713|P3|Overall Study|Adverse Event|4
5811441|NCT02719028|20062714|P2|Overall Study|Adverse Event|1
5811442|NCT02719028|20062715|P1|Overall Study|Adverse Event|2
5811443|NCT02718898|20062748|P7|Post Treatment Follow-up Period|Withdrawal by Subject|3
5811444|NCT02718898|20062749|P6|Post Treatment Follow-up Period|Withdrawal by Subject|5
5811445|NCT02718898|20062750|P5|Post Treatment Follow-up Period|Withdrawal by Subject|0
5811446|NCT02718898|20062751|P4|Post Treatment Follow-up Period|Withdrawal by Subject|0
5811447|NCT02718898|20062752|P3|Post Treatment Follow-up Period|Withdrawal by Subject|0
5811448|NCT02718898|20062753|P2|Post Treatment Follow-up Period|Withdrawal by Subject|0
5811449|NCT02718898|20062754|P1|Post Treatment Follow-up Period|Withdrawal by Subject|0
5811450|NCT02718898|20062748|P7|Post Treatment Follow-up Period|Lost to Follow-up|1
5811451|NCT02718898|20062749|P6|Post Treatment Follow-up Period|Lost to Follow-up|5
5811452|NCT02718898|20062750|P5|Post Treatment Follow-up Period|Lost to Follow-up|1
5811453|NCT02718898|20062751|P4|Post Treatment Follow-up Period|Lost to Follow-up|0
5811454|NCT02718898|20062752|P3|Post Treatment Follow-up Period|Lost to Follow-up|0
5811455|NCT02718898|20062753|P2|Post Treatment Follow-up Period|Lost to Follow-up|0
5811456|NCT02718898|20062754|P1|Post Treatment Follow-up Period|Lost to Follow-up|0
5811457|NCT02718898|20062748|P7|Post Treatment Follow-up Period|Adverse Event|1
5811458|NCT02718898|20062749|P6|Post Treatment Follow-up Period|Adverse Event|1
5811459|NCT02718898|20062750|P5|Post Treatment Follow-up Period|Adverse Event|0
5811460|NCT02718898|20062751|P4|Post Treatment Follow-up Period|Adverse Event|0
5811461|NCT02718898|20062752|P3|Post Treatment Follow-up Period|Adverse Event|0
5811462|NCT02718898|20062753|P2|Post Treatment Follow-up Period|Adverse Event|0
5811463|NCT02718898|20062754|P1|Post Treatment Follow-up Period|Adverse Event|0
5811464|NCT02718898|20062748|P7|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0
5811465|NCT02718898|20062749|P6|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0
5811466|NCT02718898|20062750|P5|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0
5811622|NCT02718417|20062809|P3|Maintenance Phase (MP)|Adverse Event|0
5811467|NCT02718898|20062751|P4|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|1
5811468|NCT02718898|20062752|P3|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0
5811469|NCT02718898|20062753|P2|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0
5811470|NCT02718898|20062754|P1|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0
5811471|NCT02718898|20062748|P7|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0
5811472|NCT02718898|20062749|P6|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0
5811473|NCT02718898|20062750|P5|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0
5811474|NCT02718898|20062751|P4|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|1
5811475|NCT02718898|20062752|P3|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0
5811476|NCT02718898|20062753|P2|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0
5811477|NCT02718898|20062754|P1|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0
5811478|NCT02718898|20062748|P7|Open Label Treatment Period (OLTP)|Lack of Efficacy|0
5811479|NCT02718898|20062749|P6|Open Label Treatment Period (OLTP)|Lack of Efficacy|0
5811480|NCT02718898|20062750|P5|Open Label Treatment Period (OLTP)|Lack of Efficacy|0
5811481|NCT02718898|20062751|P4|Open Label Treatment Period (OLTP)|Lack of Efficacy|2
5811482|NCT02718898|20062752|P3|Open Label Treatment Period (OLTP)|Lack of Efficacy|1
5811483|NCT02718898|20062753|P2|Open Label Treatment Period (OLTP)|Lack of Efficacy|0
5811484|NCT02718898|20062754|P1|Open Label Treatment Period (OLTP)|Lack of Efficacy|0
5811485|NCT02718898|20062748|P7|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0
5811486|NCT02718898|20062749|P6|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0
5811487|NCT02718898|20062750|P5|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0
5811488|NCT02718898|20062751|P4|Open Label Treatment Period (OLTP)|Withdrawal by Subject|3
5811489|NCT02718898|20062752|P3|Open Label Treatment Period (OLTP)|Withdrawal by Subject|1
5811490|NCT02718898|20062753|P2|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0
5811491|NCT02718898|20062754|P1|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0
5811492|NCT02718898|20062748|P7|Open Label Treatment Period (OLTP)|Lost to Follow-up|0
5811493|NCT02718898|20062749|P6|Open Label Treatment Period (OLTP)|Lost to Follow-up|0
5811494|NCT02718898|20062750|P5|Open Label Treatment Period (OLTP)|Lost to Follow-up|0
5811495|NCT02718898|20062751|P4|Open Label Treatment Period (OLTP)|Lost to Follow-up|2
5811496|NCT02718898|20062752|P3|Open Label Treatment Period (OLTP)|Lost to Follow-up|0
5811497|NCT02718898|20062753|P2|Open Label Treatment Period (OLTP)|Lost to Follow-up|0
5811498|NCT02718898|20062754|P1|Open Label Treatment Period (OLTP)|Lost to Follow-up|0
5811499|NCT02718898|20062748|P7|Open Label Treatment Period (OLTP)|Adverse Event|0
5811500|NCT02718898|20062749|P6|Open Label Treatment Period (OLTP)|Adverse Event|0
5811501|NCT02718898|20062750|P5|Open Label Treatment Period (OLTP)|Adverse Event|0
5811502|NCT02718898|20062751|P4|Open Label Treatment Period (OLTP)|Adverse Event|1
5811503|NCT02718898|20062752|P3|Open Label Treatment Period (OLTP)|Adverse Event|1
5811504|NCT02718898|20062753|P2|Open Label Treatment Period (OLTP)|Adverse Event|0
5811505|NCT02718898|20062754|P1|Open Label Treatment Period (OLTP)|Adverse Event|0
5811506|NCT02718898|20062748|P7|Blinded Treatment Period|Lost to Follow-up|0
5811507|NCT02718898|20062749|P6|Blinded Treatment Period|Lost to Follow-up|0
5811508|NCT02718898|20062750|P5|Blinded Treatment Period|Lost to Follow-up|0
5811509|NCT02718898|20062751|P4|Blinded Treatment Period|Lost to Follow-up|0
5811510|NCT02718898|20062752|P3|Blinded Treatment Period|Lost to Follow-up|0
5811511|NCT02718898|20062753|P2|Blinded Treatment Period|Lost to Follow-up|0
5811512|NCT02718898|20062754|P1|Blinded Treatment Period|Lost to Follow-up|2
5811513|NCT02718898|20062748|P7|Blinded Treatment Period|Lack of Efficacy|0
5811514|NCT02718898|20062749|P6|Blinded Treatment Period|Lack of Efficacy|0
5811515|NCT02718898|20062750|P5|Blinded Treatment Period|Lack of Efficacy|0
5811516|NCT02718898|20062751|P4|Blinded Treatment Period|Lack of Efficacy|0
5811517|NCT02718898|20062752|P3|Blinded Treatment Period|Lack of Efficacy|0
5811518|NCT02718898|20062753|P2|Blinded Treatment Period|Lack of Efficacy|0
5811519|NCT02718898|20062754|P1|Blinded Treatment Period|Lack of Efficacy|1
5811520|NCT02718898|20062748|P7|Blinded Treatment Period|Physician Decision|0
5811521|NCT02718898|20062749|P6|Blinded Treatment Period|Physician Decision|0
5811522|NCT02718898|20062750|P5|Blinded Treatment Period|Physician Decision|0
5811523|NCT02718898|20062751|P4|Blinded Treatment Period|Physician Decision|0
5811524|NCT02718898|20062752|P3|Blinded Treatment Period|Physician Decision|0
5811525|NCT02718898|20062753|P2|Blinded Treatment Period|Physician Decision|0
5811526|NCT02718898|20062754|P1|Blinded Treatment Period|Physician Decision|1
5811527|NCT02718898|20062748|P7|Blinded Treatment Period|Adverse Event|0
5811528|NCT02718898|20062749|P6|Blinded Treatment Period|Adverse Event|0
5811529|NCT02718898|20062750|P5|Blinded Treatment Period|Adverse Event|0
5811530|NCT02718898|20062751|P4|Blinded Treatment Period|Adverse Event|0
5811531|NCT02718898|20062752|P3|Blinded Treatment Period|Adverse Event|0
5811532|NCT02718898|20062753|P2|Blinded Treatment Period|Adverse Event|1
5811533|NCT02718898|20062754|P1|Blinded Treatment Period|Adverse Event|5
5811534|NCT02718625|20062789|P2|Overall Study|Termination of Study by Sponsor|1
5811535|NCT02718625|20062790|P1|Overall Study|Termination of Study by Sponsor|0
5811536|NCT02718625|20062789|P2|Overall Study|Adverse Event|1
5811537|NCT02718625|20062790|P1|Overall Study|Adverse Event|0
5811538|NCT02718417|20062809|P3|Long-term Follow-up Phase|Other|0
5811539|NCT02718417|20062810|P2|Long-term Follow-up Phase|Other|2
5811540|NCT02718417|20062811|P1|Long-term Follow-up Phase|Other|0
5811541|NCT02718417|20062809|P3|Long-term Follow-up Phase|Withdrawal by Subject|9
5811542|NCT02718417|20062810|P2|Long-term Follow-up Phase|Withdrawal by Subject|9
5811543|NCT02718417|20062811|P1|Long-term Follow-up Phase|Withdrawal by Subject|6
5811544|NCT02718417|20062809|P3|Long-term Follow-up Phase|Study terminated by sponsor|112
5811545|NCT02718417|20062810|P2|Long-term Follow-up Phase|Study terminated by sponsor|80
5811546|NCT02718417|20062811|P1|Long-term Follow-up Phase|Study terminated by sponsor|105
5811547|NCT02718417|20062809|P3|Long-term Follow-up Phase|Lost to Follow-up|3
5811548|NCT02718417|20062810|P2|Long-term Follow-up Phase|Lost to Follow-up|4
5811549|NCT02718417|20062811|P1|Long-term Follow-up Phase|Lost to Follow-up|8
5811550|NCT02718417|20062809|P3|Long-term Follow-up Phase|Death leading to discontinuation|11
5811551|NCT02718417|20062810|P2|Long-term Follow-up Phase|Death leading to discontinuation|17
5811552|NCT02718417|20062811|P1|Long-term Follow-up Phase|Death leading to discontinuation|20
5811553|NCT02718417|20062809|P3|Follow-up Phase|Death leading to discontinuation|3
5811554|NCT02718417|20062810|P2|Follow-up Phase|Death leading to discontinuation|7
5811555|NCT02718417|20062811|P1|Follow-up Phase|Death leading to discontinuation|7
5811556|NCT02718417|20062809|P3|Follow-up Phase|Lost to Follow-up|0
5811557|NCT02718417|20062810|P2|Follow-up Phase|Lost to Follow-up|3
5811558|NCT02718417|20062811|P1|Follow-up Phase|Lost to Follow-up|2
5811559|NCT02718417|20062809|P3|Follow-up Phase|Study terminated by sponsor|6
5811560|NCT02718417|20062810|P2|Follow-up Phase|Study terminated by sponsor|138
5811561|NCT02718417|20062811|P1|Follow-up Phase|Study terminated by sponsor|100
5811562|NCT02718417|20062809|P3|Follow-up Phase|Withdrawal by Subject|5
5811563|NCT02718417|20062810|P2|Follow-up Phase|Withdrawal by Subject|17
5811564|NCT02718417|20062811|P1|Follow-up Phase|Withdrawal by Subject|19
5811565|NCT02718417|20062809|P3|Follow-up Phase|Other|4
5811566|NCT02718417|20062810|P2|Follow-up Phase|Other|6
5811567|NCT02718417|20062811|P1|Follow-up Phase|Other|4
5811568|NCT02718417|20062809|P3|Follow-up Phase|Adverse Event|1
5811569|NCT02718417|20062810|P2|Follow-up Phase|Adverse Event|1
5811570|NCT02718417|20062811|P1|Follow-up Phase|Adverse Event|3
5811571|NCT02718417|20062809|P3|Observation Phase (OP)|Other|7
5811572|NCT02718417|20062810|P2|Observation Phase (OP)|Other|0
5811573|NCT02718417|20062811|P1|Observation Phase (OP)|Other|0
5811574|NCT02718417|20062809|P3|Observation Phase (OP)|Global deterioration of health status|1
5811575|NCT02718417|20062810|P2|Observation Phase (OP)|Global deterioration of health status|0
5811576|NCT02718417|20062811|P1|Observation Phase (OP)|Global deterioration of health status|0
5811577|NCT02718417|20062809|P3|Observation Phase (OP)|Withdrawal by Subject|34
5811578|NCT02718417|20062810|P2|Observation Phase (OP)|Withdrawal by Subject|0
5811579|NCT02718417|20062811|P1|Observation Phase (OP)|Withdrawal by Subject|0
5811580|NCT02718417|20062809|P3|Observation Phase (OP)|Study terminated by sponsor|135
5811581|NCT02718417|20062810|P2|Observation Phase (OP)|Study terminated by sponsor|0
5811582|NCT02718417|20062811|P1|Observation Phase (OP)|Study terminated by sponsor|0
5811583|NCT02718417|20062809|P3|Observation Phase (OP)|Progressive disease|92
5811584|NCT02718417|20062810|P2|Observation Phase (OP)|Progressive disease|0
5811585|NCT02718417|20062811|P1|Observation Phase (OP)|Progressive disease|0
5811586|NCT02718417|20062809|P3|Observation Phase (OP)|Physician Decision|9
5811587|NCT02718417|20062810|P2|Observation Phase (OP)|Physician Decision|0
5811588|NCT02718417|20062811|P1|Observation Phase (OP)|Physician Decision|0
5811589|NCT02718417|20062809|P3|Observation Phase (OP)|Lost to Follow-up|1
5811590|NCT02718417|20062810|P2|Observation Phase (OP)|Lost to Follow-up|0
5811591|NCT02718417|20062811|P1|Observation Phase (OP)|Lost to Follow-up|0
5811592|NCT02718417|20062809|P3|Observation Phase (OP)|Death leading to discontinuation|2
5811593|NCT02718417|20062810|P2|Observation Phase (OP)|Death leading to discontinuation|0
5811594|NCT02718417|20062811|P1|Observation Phase (OP)|Death leading to discontinuation|0
5811595|NCT02718417|20062809|P3|Observation Phase (OP)|Adverse Event|1
5811596|NCT02718417|20062810|P2|Observation Phase (OP)|Adverse Event|0
5811597|NCT02718417|20062811|P1|Observation Phase (OP)|Adverse Event|0
5811598|NCT02718417|20062809|P3|Maintenance Phase (MP)|Study terminated by sponsor|0
5811599|NCT02718417|20062810|P2|Maintenance Phase (MP)|Study terminated by sponsor|140
5811600|NCT02718417|20062811|P1|Maintenance Phase (MP)|Study terminated by sponsor|114
5811601|NCT02718417|20062809|P3|Maintenance Phase (MP)|Withdrawal by Subject|0
5811602|NCT02718417|20062810|P2|Maintenance Phase (MP)|Withdrawal by Subject|20
5811603|NCT02718417|20062811|P1|Maintenance Phase (MP)|Withdrawal by Subject|17
5811604|NCT02718417|20062809|P3|Maintenance Phase (MP)|Other|0
5811605|NCT02718417|20062810|P2|Maintenance Phase (MP)|Other|1
5811606|NCT02718417|20062811|P1|Maintenance Phase (MP)|Other|2
5811607|NCT02718417|20062809|P3|Maintenance Phase (MP)|Progressive disease|0
5811608|NCT02718417|20062810|P2|Maintenance Phase (MP)|Progressive disease|88
5811609|NCT02718417|20062811|P1|Maintenance Phase (MP)|Progressive disease|100
5811610|NCT02718417|20062809|P3|Maintenance Phase (MP)|Physician's decision|0
5811611|NCT02718417|20062810|P2|Maintenance Phase (MP)|Physician's decision|7
5811612|NCT02718417|20062811|P1|Maintenance Phase (MP)|Physician's decision|6
5811613|NCT02718417|20062809|P3|Maintenance Phase (MP)|No longer met eligibility criteria|0
5811614|NCT02718417|20062810|P2|Maintenance Phase (MP)|No longer met eligibility criteria|1
5811615|NCT02718417|20062811|P1|Maintenance Phase (MP)|No longer met eligibility criteria|0
5811616|NCT02718417|20062809|P3|Maintenance Phase (MP)|Global deterioration of health status|0
5811617|NCT02718417|20062810|P2|Maintenance Phase (MP)|Global deterioration of health status|3
5811618|NCT02718417|20062811|P1|Maintenance Phase (MP)|Global deterioration of health status|5
5811619|NCT02718417|20062809|P3|Maintenance Phase (MP)|Death leading to discontinuation|0
5811620|NCT02718417|20062810|P2|Maintenance Phase (MP)|Death leading to discontinuation|1
5811621|NCT02718417|20062811|P1|Maintenance Phase (MP)|Death leading to discontinuation|1
5811623|NCT02718417|20062810|P2|Maintenance Phase (MP)|Adverse Event|26
5811624|NCT02718417|20062811|P1|Maintenance Phase (MP)|Adverse Event|21
5811625|NCT02718417|20062809|P3|Chemotherapy Phase (CP)|Other|1
5811626|NCT02718417|20062810|P2|Chemotherapy Phase (CP)|Other|0
5811627|NCT02718417|20062811|P1|Chemotherapy Phase (CP)|Other|2
5811628|NCT02718417|20062809|P3|Chemotherapy Phase (CP)|Withdrawal by Subject|15
5811629|NCT02718417|20062810|P2|Chemotherapy Phase (CP)|Withdrawal by Subject|8
5811630|NCT02718417|20062811|P1|Chemotherapy Phase (CP)|Withdrawal by Subject|13
5811631|NCT02718417|20062809|P3|Chemotherapy Phase (CP)|Progressive disease|10
5811632|NCT02718417|20062810|P2|Chemotherapy Phase (CP)|Progressive disease|7
5811633|NCT02718417|20062811|P1|Chemotherapy Phase (CP)|Progressive disease|11
5811634|NCT02718417|20062809|P3|Chemotherapy Phase (CP)|Physician's decision|4
5811635|NCT02718417|20062810|P2|Chemotherapy Phase (CP)|Physician's decision|0
5811636|NCT02718417|20062811|P1|Chemotherapy Phase (CP)|Physician's decision|5
5811637|NCT02718417|20062809|P3|Chemotherapy Phase (CP)|No longer met eligibility criteria|1
5811638|NCT02718417|20062810|P2|Chemotherapy Phase (CP)|No longer met eligibility criteria|2
5811639|NCT02718417|20062811|P1|Chemotherapy Phase (CP)|No longer met eligibility criteria|4
5811640|NCT02718417|20062809|P3|Chemotherapy Phase (CP)|Global deterioration of health status|1
5811641|NCT02718417|20062810|P2|Chemotherapy Phase (CP)|Global deterioration of health status|2
5811642|NCT02718417|20062811|P1|Chemotherapy Phase (CP)|Global deterioration of health status|3
5811643|NCT02718417|20062809|P3|Chemotherapy Phase (CP)|Death leading to discontinuation|1
5811644|NCT02718417|20062810|P2|Chemotherapy Phase (CP)|Death leading to discontinuation|4
5811645|NCT02718417|20062811|P1|Chemotherapy Phase (CP)|Death leading to discontinuation|5
5811646|NCT02718417|20062809|P3|Chemotherapy Phase (CP)|Adverse Event|13
5811647|NCT02718417|20062810|P2|Chemotherapy Phase (CP)|Adverse Event|14
5811648|NCT02718417|20062811|P1|Chemotherapy Phase (CP)|Adverse Event|9
5811649|NCT02718326|20062917|P3|Overall Study|Pregnancy|0
5811650|NCT02718326|20062918|P2|Overall Study|Pregnancy|0
5811651|NCT02718326|20062919|P1|Overall Study|Pregnancy|1
5811652|NCT02718326|20062917|P3|Overall Study|Protocol Deviation|0
5811653|NCT02718326|20062918|P2|Overall Study|Protocol Deviation|0
5811654|NCT02718326|20062919|P1|Overall Study|Protocol Deviation|1
5811655|NCT02718326|20062917|P3|Overall Study|Lost to Follow-up|14
5811656|NCT02718326|20062918|P2|Overall Study|Lost to Follow-up|5
5811657|NCT02718326|20062919|P1|Overall Study|Lost to Follow-up|18
5811658|NCT02718326|20062917|P3|Overall Study|Withdrawal by Subject|6
5811659|NCT02718326|20062918|P2|Overall Study|Withdrawal by Subject|9
5811660|NCT02718326|20062919|P1|Overall Study|Withdrawal by Subject|4
5811661|NCT02718326|20062917|P3|Overall Study|Death|2
5811662|NCT02718326|20062918|P2|Overall Study|Death|1
5811663|NCT02718326|20062919|P1|Overall Study|Death|8
5811664|NCT02718326|20062917|P3|Overall Study|Adverse Event|0
5811665|NCT02718326|20062918|P2|Overall Study|Adverse Event|9
5811666|NCT02718326|20062919|P1|Overall Study|Adverse Event|4
5811667|NCT02717754|20063040|P6|Overall Study|Incorrect Infusion Duration|20
5811668|NCT02717754|20063041|P5|Overall Study|Incorrect Infusion Duration|20
5811669|NCT02717754|20063042|P4|Overall Study|Incorrect Infusion Duration|10
5811670|NCT02717754|20063043|P3|Overall Study|Incorrect Infusion Duration|0
5811671|NCT02717754|20063044|P2|Overall Study|Incorrect Infusion Duration|0
5811672|NCT02717754|20063045|P1|Overall Study|Incorrect Infusion Duration|0
5811673|NCT02717494|20063076|P3|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|4
5811674|NCT02717494|20063077|P2|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0
5811675|NCT02717494|20063078|P1|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0
5811676|NCT02717494|20063076|P3|First Intervention (Step 1)|Death|1
5811677|NCT02717494|20063077|P2|First Intervention (Step 1)|Death|0
5811678|NCT02717494|20063078|P1|First Intervention (Step 1)|Death|0
5811679|NCT02717494|20063076|P3|First Intervention (Step 1)|Withdrawal by Subject|1
5811680|NCT02717494|20063077|P2|First Intervention (Step 1)|Withdrawal by Subject|0
5811681|NCT02717494|20063078|P1|First Intervention (Step 1)|Withdrawal by Subject|2
5811682|NCT02717494|20063076|P3|First Intervention (Step 1)|Lost to Follow-up|3
5811683|NCT02717494|20063077|P2|First Intervention (Step 1)|Lost to Follow-up|7
5811684|NCT02717494|20063078|P1|First Intervention (Step 1)|Lost to Follow-up|4
5811685|NCT02717195|20063140|P5|Double-blind Treatment (DBT) Period|Patient missed required visits|1
5811686|NCT02717195|20063141|P4|Double-blind Treatment (DBT) Period|Patient missed required visits|1
5811687|NCT02717195|20063142|P3|Double-blind Treatment (DBT) Period|Patient missed required visits|0
5811688|NCT02717195|20063143|P2|Double-blind Treatment (DBT) Period|Patient missed required visits|0
5811689|NCT02717195|20063144|P1|Double-blind Treatment (DBT) Period|Patient missed required visits|0
5811690|NCT02717195|20063140|P5|Double-blind Treatment (DBT) Period|Psychosocial issues|0
5811691|NCT02717195|20063141|P4|Double-blind Treatment (DBT) Period|Psychosocial issues|0
5811692|NCT02717195|20063142|P3|Double-blind Treatment (DBT) Period|Psychosocial issues|1
5811693|NCT02717195|20063143|P2|Double-blind Treatment (DBT) Period|Psychosocial issues|0
5811694|NCT02717195|20063144|P1|Double-blind Treatment (DBT) Period|Psychosocial issues|0
5811695|NCT02717195|20063140|P5|Double-blind Treatment (DBT) Period|Needed antidepressant medication|1
5811696|NCT02717195|20063141|P4|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0
5811697|NCT02717195|20063142|P3|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0
5811698|NCT02717195|20063143|P2|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0
5811699|NCT02717195|20063144|P1|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0
5811700|NCT02717195|20063140|P5|Double-blind Treatment (DBT) Period|Change of residence|1
5811701|NCT02717195|20063141|P4|Double-blind Treatment (DBT) Period|Change of residence|1
5811702|NCT02717195|20063142|P3|Double-blind Treatment (DBT) Period|Change of residence|0
5811703|NCT02717195|20063143|P2|Double-blind Treatment (DBT) Period|Change of residence|0
5811704|NCT02717195|20063144|P1|Double-blind Treatment (DBT) Period|Change of residence|0
5811705|NCT02717195|20063140|P5|Double-blind Treatment (DBT) Period|Family circumstances|1
5811706|NCT02717195|20063141|P4|Double-blind Treatment (DBT) Period|Family circumstances|0
5811707|NCT02717195|20063142|P3|Double-blind Treatment (DBT) Period|Family circumstances|0
5811708|NCT02717195|20063143|P2|Double-blind Treatment (DBT) Period|Family circumstances|0
5811709|NCT02717195|20063144|P1|Double-blind Treatment (DBT) Period|Family circumstances|0
5811710|NCT02717195|20063140|P5|Double-blind Treatment (DBT) Period|Investigator decision|1
5811711|NCT02717195|20063141|P4|Double-blind Treatment (DBT) Period|Investigator decision|1
5811712|NCT02717195|20063142|P3|Double-blind Treatment (DBT) Period|Investigator decision|0
5811713|NCT02717195|20063143|P2|Double-blind Treatment (DBT) Period|Investigator decision|0
5811714|NCT02717195|20063144|P1|Double-blind Treatment (DBT) Period|Investigator decision|0
5811715|NCT02717195|20063140|P5|Double-blind Treatment (DBT) Period|Patient decision|2
5811716|NCT02717195|20063141|P4|Double-blind Treatment (DBT) Period|Patient decision|2
5811717|NCT02717195|20063142|P3|Double-blind Treatment (DBT) Period|Patient decision|0
5811718|NCT02717195|20063143|P2|Double-blind Treatment (DBT) Period|Patient decision|0
5811719|NCT02717195|20063144|P1|Double-blind Treatment (DBT) Period|Patient decision|0
5811720|NCT02717195|20063140|P5|Double-blind Treatment (DBT) Period|Enrolled but not treated|0
5811721|NCT02717195|20063141|P4|Double-blind Treatment (DBT) Period|Enrolled but not treated|0
5811722|NCT02717195|20063142|P3|Double-blind Treatment (DBT) Period|Enrolled but not treated|1
5811723|NCT02717195|20063143|P2|Double-blind Treatment (DBT) Period|Enrolled but not treated|0
5811724|NCT02717195|20063144|P1|Double-blind Treatment (DBT) Period|Enrolled but not treated|0
5811725|NCT02717195|20063140|P5|Double-blind Treatment (DBT) Period|Lost to Follow-up|2
5811726|NCT02717195|20063141|P4|Double-blind Treatment (DBT) Period|Lost to Follow-up|3
5811727|NCT02717195|20063142|P3|Double-blind Treatment (DBT) Period|Lost to Follow-up|0
5811728|NCT02717195|20063143|P2|Double-blind Treatment (DBT) Period|Lost to Follow-up|0
5811729|NCT02717195|20063144|P1|Double-blind Treatment (DBT) Period|Lost to Follow-up|0
5811730|NCT02717195|20063140|P5|Double-blind Treatment (DBT) Period|Withdrawal by Subject|8
5811731|NCT02717195|20063141|P4|Double-blind Treatment (DBT) Period|Withdrawal by Subject|13
5811732|NCT02717195|20063142|P3|Double-blind Treatment (DBT) Period|Withdrawal by Subject|14
5811733|NCT02717195|20063143|P2|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0
5811734|NCT02717195|20063144|P1|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0
5811735|NCT02717195|20063140|P5|Double-blind Treatment (DBT) Period|Protocol Violation|1
5811736|NCT02717195|20063141|P4|Double-blind Treatment (DBT) Period|Protocol Violation|0
5811737|NCT02717195|20063142|P3|Double-blind Treatment (DBT) Period|Protocol Violation|1
5811738|NCT02717195|20063143|P2|Double-blind Treatment (DBT) Period|Protocol Violation|0
5811739|NCT02717195|20063144|P1|Double-blind Treatment (DBT) Period|Protocol Violation|0
5811740|NCT02717195|20063140|P5|Double-blind Treatment (DBT) Period|Non-compliance with IMP|2
5811741|NCT02717195|20063141|P4|Double-blind Treatment (DBT) Period|Non-compliance with IMP|3
5811742|NCT02717195|20063142|P3|Double-blind Treatment (DBT) Period|Non-compliance with IMP|4
5811743|NCT02717195|20063143|P2|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0
5811744|NCT02717195|20063144|P1|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0
5811745|NCT02717195|20063140|P5|Double-blind Treatment (DBT) Period|Lack of Efficacy|2
5811746|NCT02717195|20063141|P4|Double-blind Treatment (DBT) Period|Lack of Efficacy|9
5811747|NCT02717195|20063142|P3|Double-blind Treatment (DBT) Period|Lack of Efficacy|6
5811748|NCT02717195|20063143|P2|Double-blind Treatment (DBT) Period|Lack of Efficacy|0
5811749|NCT02717195|20063144|P1|Double-blind Treatment (DBT) Period|Lack of Efficacy|0
5811750|NCT02717195|20063140|P5|Double-blind Treatment (DBT) Period|Adverse Event|8
5811751|NCT02717195|20063141|P4|Double-blind Treatment (DBT) Period|Adverse Event|11
5811752|NCT02717195|20063142|P3|Double-blind Treatment (DBT) Period|Adverse Event|10
5811753|NCT02717195|20063143|P2|Double-blind Treatment (DBT) Period|Adverse Event|0
5811754|NCT02717195|20063144|P1|Double-blind Treatment (DBT) Period|Adverse Event|0
5811755|NCT02717195|20063140|P5|Prospective Confirmation (PC) Period|Noncompliance with protocol|0
5811756|NCT02717195|20063141|P4|Prospective Confirmation (PC) Period|Noncompliance with protocol|0
5811757|NCT02717195|20063142|P3|Prospective Confirmation (PC) Period|Noncompliance with protocol|0
5811758|NCT02717195|20063143|P2|Prospective Confirmation (PC) Period|Noncompliance with protocol|0
5811759|NCT02717195|20063144|P1|Prospective Confirmation (PC) Period|Noncompliance with protocol|1
5811760|NCT02717195|20063140|P5|Prospective Confirmation (PC) Period|Patient fraud with payment|0
5811761|NCT02717195|20063141|P4|Prospective Confirmation (PC) Period|Patient fraud with payment|0
5811762|NCT02717195|20063142|P3|Prospective Confirmation (PC) Period|Patient fraud with payment|0
5811763|NCT02717195|20063143|P2|Prospective Confirmation (PC) Period|Patient fraud with payment|0
5811764|NCT02717195|20063144|P1|Prospective Confirmation (PC) Period|Patient fraud with payment|1
5811765|NCT02717195|20063140|P5|Prospective Confirmation (PC) Period|Sponsor requested|0
5811766|NCT02717195|20063141|P4|Prospective Confirmation (PC) Period|Sponsor requested|0
5811767|NCT02717195|20063142|P3|Prospective Confirmation (PC) Period|Sponsor requested|0
5811768|NCT02717195|20063143|P2|Prospective Confirmation (PC) Period|Sponsor requested|1
5811769|NCT02717195|20063144|P1|Prospective Confirmation (PC) Period|Sponsor requested|0
5811770|NCT02717195|20063140|P5|Prospective Confirmation (PC) Period|Duplicate subject|0
5811771|NCT02717195|20063141|P4|Prospective Confirmation (PC) Period|Duplicate subject|0
5811772|NCT02717195|20063142|P3|Prospective Confirmation (PC) Period|Duplicate subject|0
5811773|NCT02717195|20063143|P2|Prospective Confirmation (PC) Period|Duplicate subject|0
5811774|NCT02717195|20063144|P1|Prospective Confirmation (PC) Period|Duplicate subject|1
5811775|NCT02717195|20063140|P5|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0
5811776|NCT02717195|20063141|P4|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0
5811777|NCT02717195|20063142|P3|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0
5811778|NCT02717195|20063143|P2|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|1
5811779|NCT02717195|20063144|P1|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0
5811780|NCT02717195|20063140|P5|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0
5811781|NCT02717195|20063141|P4|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0
5811782|NCT02717195|20063142|P3|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0
5811783|NCT02717195|20063143|P2|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0
5811784|NCT02717195|20063144|P1|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|1
5811785|NCT02717195|20063140|P5|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0
5811786|NCT02717195|20063141|P4|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0
5811787|NCT02717195|20063142|P3|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0
5811788|NCT02717195|20063143|P2|Prospective Confirmation (PC) Period|Subject took exclusionary medication|1
5811789|NCT02717195|20063144|P1|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0
5811790|NCT02717195|20063140|P5|Prospective Confirmation (PC) Period|Investigator decision|0
5811791|NCT02717195|20063141|P4|Prospective Confirmation (PC) Period|Investigator decision|0
5811792|NCT02717195|20063142|P3|Prospective Confirmation (PC) Period|Investigator decision|0
5811793|NCT02717195|20063143|P2|Prospective Confirmation (PC) Period|Investigator decision|1
5811794|NCT02717195|20063144|P1|Prospective Confirmation (PC) Period|Investigator decision|2
5811795|NCT02717195|20063140|P5|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0
5811796|NCT02717195|20063141|P4|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0
5811797|NCT02717195|20063142|P3|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0
5811798|NCT02717195|20063143|P2|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|1
5811799|NCT02717195|20063144|P1|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0
5811800|NCT02717195|20063140|P5|Prospective Confirmation (PC) Period|Change of place of residence|0
5811801|NCT02717195|20063141|P4|Prospective Confirmation (PC) Period|Change of place of residence|0
5811802|NCT02717195|20063142|P3|Prospective Confirmation (PC) Period|Change of place of residence|0
5811803|NCT02717195|20063143|P2|Prospective Confirmation (PC) Period|Change of place of residence|0
5811804|NCT02717195|20063144|P1|Prospective Confirmation (PC) Period|Change of place of residence|1
5811805|NCT02717195|20063140|P5|Prospective Confirmation (PC) Period|Low level of drug in the blood|0
5811806|NCT02717195|20063141|P4|Prospective Confirmation (PC) Period|Low level of drug in the blood|0
5811807|NCT02717195|20063142|P3|Prospective Confirmation (PC) Period|Low level of drug in the blood|0
5811808|NCT02717195|20063143|P2|Prospective Confirmation (PC) Period|Low level of drug in the blood|0
5811809|NCT02717195|20063144|P1|Prospective Confirmation (PC) Period|Low level of drug in the blood|1
5811810|NCT02717195|20063140|P5|Prospective Confirmation (PC) Period|Patient decision|0
5811811|NCT02717195|20063141|P4|Prospective Confirmation (PC) Period|Patient decision|0
5811812|NCT02717195|20063142|P3|Prospective Confirmation (PC) Period|Patient decision|0
5811813|NCT02717195|20063143|P2|Prospective Confirmation (PC) Period|Patient decision|2
5811814|NCT02717195|20063144|P1|Prospective Confirmation (PC) Period|Patient decision|5
5811815|NCT02717195|20063140|P5|Prospective Confirmation (PC) Period|Technical error|0
5811816|NCT02717195|20063141|P4|Prospective Confirmation (PC) Period|Technical error|0
5811817|NCT02717195|20063142|P3|Prospective Confirmation (PC) Period|Technical error|0
5811818|NCT02717195|20063143|P2|Prospective Confirmation (PC) Period|Technical error|0
5811819|NCT02717195|20063144|P1|Prospective Confirmation (PC) Period|Technical error|1
5811820|NCT02717195|20063140|P5|Prospective Confirmation (PC) Period|Lack of results for blood levels|0
5811821|NCT02717195|20063141|P4|Prospective Confirmation (PC) Period|Lack of results for blood levels|0
5811822|NCT02717195|20063142|P3|Prospective Confirmation (PC) Period|Lack of results for blood levels|0
5811823|NCT02717195|20063143|P2|Prospective Confirmation (PC) Period|Lack of results for blood levels|0
5811824|NCT02717195|20063144|P1|Prospective Confirmation (PC) Period|Lack of results for blood levels|1
5811825|NCT02717195|20063140|P5|Prospective Confirmation (PC) Period|Enrolled but not treated|0
5811826|NCT02717195|20063141|P4|Prospective Confirmation (PC) Period|Enrolled but not treated|0
5811827|NCT02717195|20063142|P3|Prospective Confirmation (PC) Period|Enrolled but not treated|0
5811828|NCT02717195|20063143|P2|Prospective Confirmation (PC) Period|Enrolled but not treated|3
5811829|NCT02717195|20063144|P1|Prospective Confirmation (PC) Period|Enrolled but not treated|3
5811830|NCT02717195|20063140|P5|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0
5811831|NCT02717195|20063141|P4|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0
5811832|NCT02717195|20063142|P3|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0
5811833|NCT02717195|20063143|P2|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|75
5811834|NCT02717195|20063144|P1|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|189
5811835|NCT02717195|20063140|P5|Prospective Confirmation (PC) Period|Lost to Follow-up|0
5811836|NCT02717195|20063141|P4|Prospective Confirmation (PC) Period|Lost to Follow-up|0
5811837|NCT02717195|20063142|P3|Prospective Confirmation (PC) Period|Lost to Follow-up|0
5811838|NCT02717195|20063143|P2|Prospective Confirmation (PC) Period|Lost to Follow-up|4
5811839|NCT02717195|20063144|P1|Prospective Confirmation (PC) Period|Lost to Follow-up|9
5811840|NCT02717195|20063140|P5|Prospective Confirmation (PC) Period|Withdrawal by Subject|0
5811841|NCT02717195|20063141|P4|Prospective Confirmation (PC) Period|Withdrawal by Subject|0
5811842|NCT02717195|20063142|P3|Prospective Confirmation (PC) Period|Withdrawal by Subject|0
5811843|NCT02717195|20063143|P2|Prospective Confirmation (PC) Period|Withdrawal by Subject|12
5811844|NCT02717195|20063144|P1|Prospective Confirmation (PC) Period|Withdrawal by Subject|43
5811845|NCT02717195|20063140|P5|Prospective Confirmation (PC) Period|Protocol Violation|0
5811846|NCT02717195|20063141|P4|Prospective Confirmation (PC) Period|Protocol Violation|0
5811847|NCT02717195|20063142|P3|Prospective Confirmation (PC) Period|Protocol Violation|0
5811848|NCT02717195|20063143|P2|Prospective Confirmation (PC) Period|Protocol Violation|1
5811849|NCT02717195|20063144|P1|Prospective Confirmation (PC) Period|Protocol Violation|3
5811850|NCT02717195|20063140|P5|Prospective Confirmation (PC) Period|Non-compliance with IMP|0
5811851|NCT02717195|20063141|P4|Prospective Confirmation (PC) Period|Non-compliance with IMP|0
5811852|NCT02717195|20063142|P3|Prospective Confirmation (PC) Period|Non-compliance with IMP|0
5811853|NCT02717195|20063143|P2|Prospective Confirmation (PC) Period|Non-compliance with IMP|1
5811854|NCT02717195|20063144|P1|Prospective Confirmation (PC) Period|Non-compliance with IMP|7
5811855|NCT02717195|20063140|P5|Prospective Confirmation (PC) Period|Lack of Efficacy|0
5811856|NCT02717195|20063141|P4|Prospective Confirmation (PC) Period|Lack of Efficacy|0
5811857|NCT02717195|20063142|P3|Prospective Confirmation (PC) Period|Lack of Efficacy|0
5811858|NCT02717195|20063143|P2|Prospective Confirmation (PC) Period|Lack of Efficacy|1
5811859|NCT02717195|20063144|P1|Prospective Confirmation (PC) Period|Lack of Efficacy|2
5811860|NCT02717195|20063140|P5|Prospective Confirmation (PC) Period|Adverse Event|0
5811861|NCT02717195|20063141|P4|Prospective Confirmation (PC) Period|Adverse Event|0
5811862|NCT02717195|20063142|P3|Prospective Confirmation (PC) Period|Adverse Event|0
5811863|NCT02717195|20063143|P2|Prospective Confirmation (PC) Period|Adverse Event|7
5811864|NCT02717195|20063144|P1|Prospective Confirmation (PC) Period|Adverse Event|19
5811865|NCT02717130|20063175|P1|Overall Study|Study Closure|4
5811866|NCT02717130|20063175|P1|Overall Study|Physician Decision|1
5811867|NCT02717130|20063175|P1|Overall Study|Adverse Event|1
5811868|NCT02717130|20063175|P1|Overall Study|Withdrawal by Subject|1
5811869|NCT02716987|20063185|P6|Overall Study|Withdrawal by Subject|1
5811870|NCT02716987|20063186|P5|Overall Study|Withdrawal by Subject|1
5811871|NCT02716987|20063187|P4|Overall Study|Withdrawal by Subject|0
5811872|NCT02716987|20063188|P3|Overall Study|Withdrawal by Subject|0
5811873|NCT02716987|20063189|P2|Overall Study|Withdrawal by Subject|0
5811874|NCT02716987|20063190|P1|Overall Study|Withdrawal by Subject|0
5811875|NCT02716987|20063185|P6|Overall Study|Ligand synthesis failure|0
5811876|NCT02716987|20063186|P5|Overall Study|Ligand synthesis failure|0
5811877|NCT02716987|20063187|P4|Overall Study|Ligand synthesis failure|0
5811878|NCT02716987|20063188|P3|Overall Study|Ligand synthesis failure|1
5811879|NCT02716987|20063189|P2|Overall Study|Ligand synthesis failure|0
5811880|NCT02716987|20063190|P1|Overall Study|Ligand synthesis failure|0
5811881|NCT02716896|20063256|P2|Overall Study|Physician Decision|1
5811882|NCT02716896|20063257|P1|Overall Study|Physician Decision|0
5811883|NCT02716805|20063308|P4|Overall Study|Progressive disease|0
5811884|NCT02716805|20063309|P3|Overall Study|Progressive disease|0
5811885|NCT02716805|20063310|P2|Overall Study|Progressive disease|0
5811886|NCT02716805|20063311|P1|Overall Study|Progressive disease|2
5811887|NCT02716779|20063319|P3|Combination Therapy|Adverse Event|1
5811888|NCT02716779|20063320|P2|Combination Therapy|Adverse Event|2
5811889|NCT02716779|20063321|P1|Combination Therapy|Adverse Event|0
5811890|NCT02716779|20063319|P3|Monotherapy|Adverse Event|1
5811891|NCT02716779|20063320|P2|Monotherapy|Adverse Event|1
5811892|NCT02716779|20063321|P1|Monotherapy|Adverse Event|0
5811893|NCT02716584|20063421|P2|Overall Study|Lost to Follow-up|5
5811894|NCT02716584|20063422|P1|Overall Study|Lost to Follow-up|8
5811895|NCT02716298|20063478|P2|First Intervention (1 Month)|Lens discomfort|1
5811896|NCT02716298|20063479|P1|First Intervention (1 Month)|Lens discomfort|1
5811897|NCT02716194|20063497|P3|Period 1 - ADVATE|Withdrawal by Subject|0
5811898|NCT02716194|20063498|P2|Period 1 - ADVATE|Withdrawal by Subject|1
5811899|NCT02716194|20063499|P1|Period 1 - ADVATE|Withdrawal by Subject|1
5811900|NCT02715804|20063579|P2|Overall Study|Other than specified|3
5811901|NCT02715804|20063580|P1|Overall Study|Other than specified|2
5811902|NCT02715804|20063579|P2|Overall Study|Withdrawal by Subject|4
5811903|NCT02715804|20063580|P1|Overall Study|Withdrawal by Subject|5
5811904|NCT02715804|20063579|P2|Overall Study|Death|106
5811905|NCT02715804|20063580|P1|Overall Study|Death|222
5811906|NCT02715765|20063603|P3|Overall Study|Study Termination|0
5811907|NCT02715765|20063604|P2|Overall Study|Study Termination|0
5811908|NCT02715765|20063605|P1|Overall Study|Study Termination|3
5811909|NCT02715726|20063618|P2|Overall Study|Randomized but not treated|2
5811910|NCT02715726|20063619|P1|Overall Study|Randomized but not treated|1
5811911|NCT02715726|20063618|P2|Overall Study|Other than specified above|15
5811912|NCT02715726|20063619|P1|Overall Study|Other than specified above|11
5811913|NCT02715726|20063618|P2|Overall Study|Participant moved|3
5811914|NCT02715726|20063619|P1|Overall Study|Participant moved|1
5811915|NCT02715726|20063618|P2|Overall Study|Death|1
5811916|NCT02715726|20063619|P1|Overall Study|Death|2
5811917|NCT02715726|20063618|P2|Overall Study|Protocol Violation|0
5811918|NCT02715726|20063619|P1|Overall Study|Protocol Violation|1
5811919|NCT02715726|20063618|P2|Overall Study|Adverse Event|6
5811920|NCT02715726|20063619|P1|Overall Study|Adverse Event|2
5811921|NCT02714868|20063699|P2|Overall Study|PI withdraw did not meet inclusion|0
5811922|NCT02714868|20063700|P1|Overall Study|PI withdraw did not meet inclusion|1
5811923|NCT02714868|20063699|P2|Overall Study|PI withdrawal safety risk self/others|0
5811924|NCT02714868|20063700|P1|Overall Study|PI withdrawal safety risk self/others|1
5811925|NCT02714868|20063699|P2|Overall Study|Withdrawal by Subject|0
5811926|NCT02714868|20063700|P1|Overall Study|Withdrawal by Subject|3
5811927|NCT02714595|20063718|P2|Overall Study|Other-Miscellaneous|1
5811928|NCT02714595|20063719|P1|Overall Study|Other-Miscellaneous|0
5811929|NCT02714595|20063718|P2|Overall Study|Death|9
5811930|NCT02714595|20063719|P1|Overall Study|Death|30
5811931|NCT02714595|20063718|P2|Overall Study|Lack of Efficacy|1
5811932|NCT02714595|20063719|P1|Overall Study|Lack of Efficacy|0
5811933|NCT02714595|20063718|P2|Overall Study|Withdrawal by Subject|2
5811934|NCT02714595|20063719|P1|Overall Study|Withdrawal by Subject|1
5811935|NCT02714595|20063718|P2|Overall Study|Lost to Follow-up|0
5811936|NCT02714595|20063719|P1|Overall Study|Lost to Follow-up|1
5811937|NCT02714426|20063976|P2|Overall Study|Withdrawal by Subject|2
5811938|NCT02714426|20063977|P1|Overall Study|Withdrawal by Subject|2
5811939|NCT02714218|20064038|P3|Overall Study|Stop treatment, but will do follow up|0
5811940|NCT02714218|20064039|P2|Overall Study|Stop treatment, but will do follow up|1
5811941|NCT02714218|20064040|P1|Overall Study|Stop treatment, but will do follow up|0
5811942|NCT02714218|20064038|P3|Overall Study|Complete Response|0
5811943|NCT02714218|20064039|P2|Overall Study|Complete Response|0
5811944|NCT02714218|20064040|P1|Overall Study|Complete Response|1
5811945|NCT02714218|20064038|P3|Overall Study|Dose Delayed > 6 weeks|0
5811946|NCT02714218|20064039|P2|Overall Study|Dose Delayed > 6 weeks|0
5811947|NCT02714218|20064040|P1|Overall Study|Dose Delayed > 6 weeks|1
5811948|NCT02714218|20064038|P3|Overall Study|Completed|0
5811949|NCT02714218|20064039|P2|Overall Study|Completed|0
5811950|NCT02714218|20064040|P1|Overall Study|Completed|2
5811951|NCT02714218|20064038|P3|Overall Study|Not Reported|0
5811952|NCT02714218|20064039|P2|Overall Study|Not Reported|5
5811953|NCT02714218|20064040|P1|Overall Study|Not Reported|9
5811954|NCT02714218|20064038|P3|Overall Study|Medical Decision|0
5811955|NCT02714218|20064039|P2|Overall Study|Medical Decision|1
5811956|NCT02714218|20064040|P1|Overall Study|Medical Decision|0
5811957|NCT02714218|20064038|P3|Overall Study|Maximum Clinical Benefit|0
5811958|NCT02714218|20064039|P2|Overall Study|Maximum Clinical Benefit|2
5811959|NCT02714218|20064040|P1|Overall Study|Maximum Clinical Benefit|2
5811960|NCT02714218|20064038|P3|Overall Study|Participant Withdrew Consent|0
5811961|NCT02714218|20064039|P2|Overall Study|Participant Withdrew Consent|3
5811962|NCT02714218|20064040|P1|Overall Study|Participant Withdrew Consent|2
5811963|NCT02714218|20064038|P3|Overall Study|Request to Discontinue Treatment|1
5811964|NCT02714218|20064039|P2|Overall Study|Request to Discontinue Treatment|5
5811965|NCT02714218|20064040|P1|Overall Study|Request to Discontinue Treatment|1
5811966|NCT02714218|20064038|P3|Overall Study|Study Drug Toxicity|4
5811967|NCT02714218|20064039|P2|Overall Study|Study Drug Toxicity|69
5811968|NCT02714218|20064040|P1|Overall Study|Study Drug Toxicity|46
5811969|NCT02714218|20064038|P3|Overall Study|Adverse Event Unrelated to Study Drug|0
5811970|NCT02714218|20064039|P2|Overall Study|Adverse Event Unrelated to Study Drug|6
5811971|NCT02714218|20064040|P1|Overall Study|Adverse Event Unrelated to Study Drug|10
5811972|NCT02714218|20064038|P3|Overall Study|Disease Progression|14
5811973|NCT02714218|20064039|P2|Overall Study|Disease Progression|51
5811974|NCT02714218|20064040|P1|Overall Study|Disease Progression|56
5811975|NCT02714062|20064090|P3|Overall Study|Protocol Violation|0
5811976|NCT02714062|20064091|P2|Overall Study|Protocol Violation|1
5811977|NCT02714062|20064092|P1|Overall Study|Protocol Violation|0
5811978|NCT02714062|20064090|P3|Overall Study|Withdrawal by Subject|1
5811979|NCT02714062|20064091|P2|Overall Study|Withdrawal by Subject|0
5811980|NCT02714062|20064092|P1|Overall Study|Withdrawal by Subject|1
5811981|NCT02714062|20064090|P3|Overall Study|Adverse Event|2
5811982|NCT02714062|20064091|P2|Overall Study|Adverse Event|0
5811983|NCT02714062|20064092|P1|Overall Study|Adverse Event|0
5811984|NCT02713867|20064138|P2|Treatment Period|Disease Progression|78
5811985|NCT02713867|20064139|P1|Treatment Period|Disease Progression|79
5811986|NCT02713867|20064138|P2|Treatment Period|Study Drug Toxicity|20
5811987|NCT02713867|20064139|P1|Treatment Period|Study Drug Toxicity|16
5811988|NCT02713867|20064138|P2|Treatment Period|Death|3
5811989|NCT02713867|20064139|P1|Treatment Period|Death|7
5811990|NCT02713867|20064138|P2|Treatment Period|AE unrelated to Study Drug|9
5811991|NCT02713867|20064139|P1|Treatment Period|AE unrelated to Study Drug|8
5811992|NCT02713867|20064138|P2|Treatment Period|Requested to Discontinue|7
5811993|NCT02713867|20064139|P1|Treatment Period|Requested to Discontinue|8
5811994|NCT02713867|20064138|P2|Treatment Period|Withdrew consent|6
5811995|NCT02713867|20064139|P1|Treatment Period|Withdrew consent|1
5811996|NCT02713867|20064138|P2|Treatment Period|Maximum Clinical Benefit|4
5811997|NCT02713867|20064139|P1|Treatment Period|Maximum Clinical Benefit|3
5811998|NCT02713867|20064138|P2|Treatment Period|Poor/Non Compliance|0
5811999|NCT02713867|20064139|P1|Treatment Period|Poor/Non Compliance|1
5812000|NCT02713867|20064138|P2|Treatment Period|No longer meets study criteria|1
5812001|NCT02713867|20064139|P1|Treatment Period|No longer meets study criteria|2
5812002|NCT02713867|20064138|P2|Treatment Period|Administrative reason by sponsor|4
5812003|NCT02713867|20064139|P1|Treatment Period|Administrative reason by sponsor|9
5812004|NCT02713867|20064138|P2|Treatment Period|Other Reasons|18
5812005|NCT02713867|20064139|P1|Treatment Period|Other Reasons|12
5812006|NCT02713867|20064138|P2|Treatment Period|Not Reported|0
5812007|NCT02713867|20064139|P1|Treatment Period|Not Reported|1
5812008|NCT02713867|20064138|P2|Randomization|Participant Withdrew consent|2
5812009|NCT02713867|20064139|P1|Randomization|Participant Withdrew consent|0
5812010|NCT02713867|20064138|P2|Randomization|Other Reason|1
5812011|NCT02713867|20064139|P1|Randomization|Other Reason|2
5812012|NCT02713828|20064177|P2|Overall Study|study terminated but patient allowed to|0
5812013|NCT02713828|20064178|P1|Overall Study|study terminated but patient allowed to|2
5812014|NCT02713828|20064177|P2|Overall Study|Withdrawal by Subject|0
5812015|NCT02713828|20064178|P1|Overall Study|Withdrawal by Subject|1
5812016|NCT02713828|20064177|P2|Overall Study|Death|0
5812017|NCT02713828|20064178|P1|Overall Study|Death|2
5812018|NCT02713789|20064190|P3|Overall Study|Lost to Follow-up|1
5812019|NCT02713789|20064191|P2|Overall Study|Lost to Follow-up|1
5812020|NCT02713789|20064192|P1|Overall Study|Lost to Follow-up|0
5812021|NCT02713594|20064255|P2|Overall Study|Lost to Follow-up|374
5812022|NCT02713594|20064256|P1|Overall Study|Lost to Follow-up|358
5812023|NCT02713594|20064255|P2|Overall Study|Withdrawal by Subject|22
5812024|NCT02713594|20064256|P1|Overall Study|Withdrawal by Subject|32
5812025|NCT02713542|20064268|P2|Overall Study|Withdrawal by Subject|1
5812026|NCT02713542|20064269|P1|Overall Study|Withdrawal by Subject|4
5812027|NCT02713542|20064268|P2|Overall Study|Use of prohibited medication|5
5812028|NCT02713542|20064269|P1|Overall Study|Use of prohibited medication|14
5812029|NCT02713529|20064282|P7|Overall Study|Death|3
5812030|NCT02713529|20064283|P6|Overall Study|Death|13
5812031|NCT02713529|20064284|P5|Overall Study|Death|3
5812032|NCT02713529|20064285|P4|Overall Study|Death|27
5812033|NCT02713529|20064286|P3|Overall Study|Death|26
5812034|NCT02713529|20064287|P2|Overall Study|Death|3
5812035|NCT02713529|20064288|P1|Overall Study|Death|3
5812036|NCT02713529|20064282|P7|Overall Study|Lost to Follow-up|0
5812037|NCT02713529|20064283|P6|Overall Study|Lost to Follow-up|0
5812038|NCT02713529|20064284|P5|Overall Study|Lost to Follow-up|0
5812039|NCT02713529|20064285|P4|Overall Study|Lost to Follow-up|0
5812040|NCT02713529|20064286|P3|Overall Study|Lost to Follow-up|1
5812041|NCT02713529|20064287|P2|Overall Study|Lost to Follow-up|0
5812042|NCT02713529|20064288|P1|Overall Study|Lost to Follow-up|1
5812043|NCT02713529|20064282|P7|Overall Study|Withdrawal by Subject|1
5812044|NCT02713529|20064283|P6|Overall Study|Withdrawal by Subject|1
5812045|NCT02713529|20064284|P5|Overall Study|Withdrawal by Subject|0
5812046|NCT02713529|20064285|P4|Overall Study|Withdrawal by Subject|2
5812047|NCT02713529|20064286|P3|Overall Study|Withdrawal by Subject|4
5812048|NCT02713529|20064287|P2|Overall Study|Withdrawal by Subject|1
5812049|NCT02713529|20064288|P1|Overall Study|Withdrawal by Subject|3
5812050|NCT02713490|20064370|P2|Overall Study|Met exclusion criteria|1
5812051|NCT02713490|20064371|P1|Overall Study|Met exclusion criteria|0
5812052|NCT02713490|20064370|P2|Overall Study|Did not receive study drug|0
5812053|NCT02713490|20064371|P1|Overall Study|Did not receive study drug|1
5812054|NCT02713490|20064370|P2|Overall Study|Withdrawal by Subject|1
5812055|NCT02713490|20064371|P1|Overall Study|Withdrawal by Subject|2
5812056|NCT02713243|20064398|P2|Overall Study|Protocol deviation|1
5812057|NCT02713243|20064399|P1|Overall Study|Protocol deviation|0
5812058|NCT02713243|20064398|P2|Overall Study|Administrative problems|1
5812059|NCT02713243|20064399|P1|Overall Study|Administrative problems|0
5812060|NCT02713243|20064398|P2|Overall Study|Abnormal laboratory value(s)#|0
5812061|NCT02713243|20064399|P1|Overall Study|Abnormal laboratory value(s)#|1
5812062|NCT02713204|20064435|P8|From Week 12 up to Week 36|Participant Re-located|0
5812063|NCT02713204|20064436|P7|From Week 12 up to Week 36|Participant Re-located|0
5812064|NCT02713204|20064437|P6|From Week 12 up to Week 36|Participant Re-located|0
5812065|NCT02713204|20064438|P5|From Week 12 up to Week 36|Participant Re-located|1
5812066|NCT02713204|20064439|P4|From Week 12 up to Week 36|Participant Re-located|0
5812067|NCT02713204|20064440|P3|From Week 12 up to Week 36|Participant Re-located|0
5812068|NCT02713204|20064441|P2|From Week 12 up to Week 36|Participant Re-located|0
5812069|NCT02713204|20064442|P1|From Week 12 up to Week 36|Participant Re-located|0
5812070|NCT02713204|20064435|P8|From Week 12 up to Week 36|Lost to Follow-up|0
5812071|NCT02713204|20064436|P7|From Week 12 up to Week 36|Lost to Follow-up|0
5812072|NCT02713204|20064437|P6|From Week 12 up to Week 36|Lost to Follow-up|0
5812073|NCT02713204|20064438|P5|From Week 12 up to Week 36|Lost to Follow-up|0
5812074|NCT02713204|20064439|P4|From Week 12 up to Week 36|Lost to Follow-up|2
5812075|NCT02713204|20064440|P3|From Week 12 up to Week 36|Lost to Follow-up|0
5812076|NCT02713204|20064441|P2|From Week 12 up to Week 36|Lost to Follow-up|0
5812077|NCT02713204|20064442|P1|From Week 12 up to Week 36|Lost to Follow-up|0
5812078|NCT02713204|20064435|P8|From Week 12 up to Week 36|Death|3
5812079|NCT02713204|20064436|P7|From Week 12 up to Week 36|Death|0
5812080|NCT02713204|20064437|P6|From Week 12 up to Week 36|Death|1
5812081|NCT02713204|20064438|P5|From Week 12 up to Week 36|Death|0
5812082|NCT02713204|20064439|P4|From Week 12 up to Week 36|Death|1
5812083|NCT02713204|20064440|P3|From Week 12 up to Week 36|Death|0
5812084|NCT02713204|20064441|P2|From Week 12 up to Week 36|Death|0
5812085|NCT02713204|20064442|P1|From Week 12 up to Week 36|Death|0
5812086|NCT02713204|20064435|P8|From Week 12 up to Week 36|Adverse Event|1
5812087|NCT02713204|20064436|P7|From Week 12 up to Week 36|Adverse Event|2
5812088|NCT02713204|20064437|P6|From Week 12 up to Week 36|Adverse Event|0
5812089|NCT02713204|20064438|P5|From Week 12 up to Week 36|Adverse Event|1
5812090|NCT02713204|20064439|P4|From Week 12 up to Week 36|Adverse Event|1
5812091|NCT02713204|20064440|P3|From Week 12 up to Week 36|Adverse Event|0
5812092|NCT02713204|20064441|P2|From Week 12 up to Week 36|Adverse Event|0
5812093|NCT02713204|20064442|P1|From Week 12 up to Week 36|Adverse Event|1
5812094|NCT02713204|20064435|P8|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
5812095|NCT02713204|20064436|P7|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
5812096|NCT02713204|20064437|P6|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
5812097|NCT02713204|20064438|P5|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
5812098|NCT02713204|20064439|P4|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
5812099|NCT02713204|20064440|P3|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
5812100|NCT02713204|20064441|P2|Baseline (Day 1) up to Week 12|Lost to Follow-up|1
5812101|NCT02713204|20064442|P1|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
5812102|NCT02713204|20064435|P8|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
5812103|NCT02713204|20064436|P7|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
5812104|NCT02713204|20064437|P6|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
5812105|NCT02713204|20064438|P5|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
5812106|NCT02713204|20064439|P4|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
5812107|NCT02713204|20064440|P3|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1
5812108|NCT02713204|20064441|P2|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
5812109|NCT02713204|20064442|P1|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
5812110|NCT02713204|20064435|P8|Baseline (Day 1) up to Week 12|Adverse Event|0
5812111|NCT02713204|20064436|P7|Baseline (Day 1) up to Week 12|Adverse Event|0
5812112|NCT02713204|20064437|P6|Baseline (Day 1) up to Week 12|Adverse Event|0
5812113|NCT02713204|20064438|P5|Baseline (Day 1) up to Week 12|Adverse Event|0
5812114|NCT02713204|20064439|P4|Baseline (Day 1) up to Week 12|Adverse Event|0
5812115|NCT02713204|20064440|P3|Baseline (Day 1) up to Week 12|Adverse Event|1
5812116|NCT02713204|20064441|P2|Baseline (Day 1) up to Week 12|Adverse Event|0
5812117|NCT02713204|20064442|P1|Baseline (Day 1) up to Week 12|Adverse Event|1
5812118|NCT02712996|20064523|P2|Second Intervention (Study Days 43-84)|Adverse Event|1
5812119|NCT02712996|20064524|P1|Second Intervention (Study Days 43-84)|Adverse Event|0
5812120|NCT02712983|20064583|P9|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0
5812121|NCT02712983|20064584|P8|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|2
5812122|NCT02712983|20064585|P7|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|1
5812123|NCT02712983|20064586|P6|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|1
5812124|NCT02712983|20064587|P5|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|2
5812125|NCT02712983|20064588|P4|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0
5812126|NCT02712983|20064589|P3|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0
5812127|NCT02712983|20064590|P2|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0
5812128|NCT02712983|20064591|P1|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0
5812129|NCT02712983|20064583|P9|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0
5812130|NCT02712983|20064584|P8|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0
5812131|NCT02712983|20064585|P7|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0
5812132|NCT02712983|20064586|P6|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0
5812133|NCT02712983|20064587|P5|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0
5812134|NCT02712983|20064588|P4|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|1
5812135|NCT02712983|20064589|P3|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0
5812136|NCT02712983|20064590|P2|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0
5812137|NCT02712983|20064591|P1|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0
5812138|NCT02712983|20064583|P9|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0
5812139|NCT02712983|20064584|P8|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1
5812140|NCT02712983|20064585|P7|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1
5812141|NCT02712983|20064586|P6|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0
5812142|NCT02712983|20064587|P5|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0
5812143|NCT02712983|20064588|P4|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0
5812144|NCT02712983|20064589|P3|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0
5812145|NCT02712983|20064590|P2|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1
5812146|NCT02712983|20064591|P1|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0
5812147|NCT02712983|20064583|P9|Treatment Phase|Subject Decision|0
5812148|NCT02712983|20064584|P8|Treatment Phase|Subject Decision|2
5812149|NCT02712983|20064585|P7|Treatment Phase|Subject Decision|1
5812150|NCT02712983|20064586|P6|Treatment Phase|Subject Decision|0
5812151|NCT02712983|20064587|P5|Treatment Phase|Subject Decision|1
5812152|NCT02712983|20064588|P4|Treatment Phase|Subject Decision|2
5812153|NCT02712983|20064589|P3|Treatment Phase|Subject Decision|0
5812154|NCT02712983|20064590|P2|Treatment Phase|Subject Decision|0
5812155|NCT02712983|20064591|P1|Treatment Phase|Subject Decision|2
5812156|NCT02712983|20064583|P9|Treatment Phase|Physician Decision|1
5812157|NCT02712983|20064584|P8|Treatment Phase|Physician Decision|1
5812158|NCT02712983|20064585|P7|Treatment Phase|Physician Decision|0
5812159|NCT02712983|20064586|P6|Treatment Phase|Physician Decision|0
5812160|NCT02712983|20064587|P5|Treatment Phase|Physician Decision|0
5812161|NCT02712983|20064588|P4|Treatment Phase|Physician Decision|0
5812162|NCT02712983|20064589|P3|Treatment Phase|Physician Decision|0
5812163|NCT02712983|20064590|P2|Treatment Phase|Physician Decision|0
5812164|NCT02712983|20064591|P1|Treatment Phase|Physician Decision|0
5812165|NCT02712983|20064583|P9|Treatment Phase|Technical Problems|0
5812166|NCT02712983|20064584|P8|Treatment Phase|Technical Problems|0
5812167|NCT02712983|20064585|P7|Treatment Phase|Technical Problems|1
5812168|NCT02712983|20064586|P6|Treatment Phase|Technical Problems|0
5812169|NCT02712983|20064587|P5|Treatment Phase|Technical Problems|0
5812170|NCT02712983|20064588|P4|Treatment Phase|Technical Problems|0
5812171|NCT02712983|20064589|P3|Treatment Phase|Technical Problems|0
5812172|NCT02712983|20064590|P2|Treatment Phase|Technical Problems|0
5812173|NCT02712983|20064591|P1|Treatment Phase|Technical Problems|0
5812174|NCT02712983|20064583|P9|Treatment Phase|Protocol Deviation|0
5812175|NCT02712983|20064584|P8|Treatment Phase|Protocol Deviation|0
5812176|NCT02712983|20064585|P7|Treatment Phase|Protocol Deviation|1
5812177|NCT02712983|20064586|P6|Treatment Phase|Protocol Deviation|0
5812178|NCT02712983|20064587|P5|Treatment Phase|Protocol Deviation|0
5812179|NCT02712983|20064588|P4|Treatment Phase|Protocol Deviation|2
5812180|NCT02712983|20064589|P3|Treatment Phase|Protocol Deviation|0
5812181|NCT02712983|20064590|P2|Treatment Phase|Protocol Deviation|0
5812182|NCT02712983|20064591|P1|Treatment Phase|Protocol Deviation|0
5812183|NCT02712983|20064583|P9|Treatment Phase|Adverse Event|1
5812184|NCT02712983|20064584|P8|Treatment Phase|Adverse Event|6
5812185|NCT02712983|20064585|P7|Treatment Phase|Adverse Event|6
5812186|NCT02712983|20064586|P6|Treatment Phase|Adverse Event|0
5812187|NCT02712983|20064587|P5|Treatment Phase|Adverse Event|3
5812188|NCT02712983|20064588|P4|Treatment Phase|Adverse Event|4
5812189|NCT02712983|20064589|P3|Treatment Phase|Adverse Event|1
5812190|NCT02712983|20064590|P2|Treatment Phase|Adverse Event|1
5812191|NCT02712983|20064591|P1|Treatment Phase|Adverse Event|3
5812192|NCT02712788|20064823|P2|Overall Study|Protocol Violation|0
5812193|NCT02712788|20064824|P1|Overall Study|Protocol Violation|1
5812194|NCT02712788|20064823|P2|Overall Study|Physician Decision|0
5812195|NCT02712788|20064824|P1|Overall Study|Physician Decision|1
5812196|NCT02712554|20064834|P2|Part B: Treatment Phase|Other|1
5812197|NCT02712554|20064835|P1|Part B: Treatment Phase|Other|0
5812198|NCT02712554|20064834|P2|Part B: Treatment Phase|Withdrawal by Subject|1
5812199|NCT02712554|20064835|P1|Part B: Treatment Phase|Withdrawal by Subject|0
5812200|NCT02712554|20064834|P2|Part B: Treatment Phase|Adverse Event|1
5812201|NCT02712554|20064835|P1|Part B: Treatment Phase|Adverse Event|0
5812202|NCT02712554|20064834|P2|Part B: Qualification Phase|Adverse Event|1
5812203|NCT02712554|20064835|P1|Part B: Qualification Phase|Adverse Event|0
5812204|NCT02712554|20064834|P2|Part B: Qualification Phase|Withdrawal by Subject|3
5812205|NCT02712554|20064835|P1|Part B: Qualification Phase|Withdrawal by Subject|0
5812206|NCT02712554|20064834|P2|Part B: Qualification Phase|Sponsor Decision|4
5812207|NCT02712554|20064835|P1|Part B: Qualification Phase|Sponsor Decision|0
5812208|NCT02712554|20064834|P2|Part B: Qualification Phase|Drug Discrimination Failure|13
5812209|NCT02712554|20064835|P1|Part B: Qualification Phase|Drug Discrimination Failure|0
5812210|NCT02712398|20064953|P1|Overall Study|Re-operation|21
5812211|NCT02712398|20064953|P1|Overall Study|Death|2
5812212|NCT02712398|20064953|P1|Overall Study|Physician Decision|1
5812213|NCT02712398|20064953|P1|Overall Study|Sponsor Decision|1
5812214|NCT02712398|20064953|P1|Overall Study|Lost to Follow-up|6
5812215|NCT02712398|20064953|P1|Overall Study|Withdrawal by Subject|6
5812216|NCT02712333|20064993|P2|First Period|Withdrawal by Subject|2
5812217|NCT02712333|20064994|P1|First Period|Withdrawal by Subject|3
5812218|NCT02712320|20065012|P1|Overall Study|Treating with the prohibited medications|2
5812219|NCT02712320|20065012|P1|Overall Study|Transferred to another facility|1
5812220|NCT02712320|20065012|P1|Overall Study|Withdrawal by Subject|1
5812221|NCT02712320|20065012|P1|Overall Study|Lost to Follow-up|1
5812222|NCT02712008|20065055|P8|From Week 12 up to Week 36|Withdrawal by Subject|2
5812223|NCT02712008|20065056|P7|From Week 12 up to Week 36|Withdrawal by Subject|3
5812224|NCT02712008|20065057|P6|From Week 12 up to Week 36|Withdrawal by Subject|0
5812225|NCT02712008|20065058|P5|From Week 12 up to Week 36|Withdrawal by Subject|0
5812226|NCT02712008|20065059|P4|From Week 12 up to Week 36|Withdrawal by Subject|0
5812227|NCT02712008|20065060|P3|From Week 12 up to Week 36|Withdrawal by Subject|0
5812228|NCT02712008|20065061|P2|From Week 12 up to Week 36|Withdrawal by Subject|0
5812229|NCT02712008|20065062|P1|From Week 12 up to Week 36|Withdrawal by Subject|0
5812230|NCT02712008|20065055|P8|From Week 12 up to Week 36|Physician Decision|0
5812231|NCT02712008|20065056|P7|From Week 12 up to Week 36|Physician Decision|0
5812232|NCT02712008|20065057|P6|From Week 12 up to Week 36|Physician Decision|0
5812233|NCT02712008|20065058|P5|From Week 12 up to Week 36|Physician Decision|1
5812234|NCT02712008|20065059|P4|From Week 12 up to Week 36|Physician Decision|1
5812235|NCT02712008|20065060|P3|From Week 12 up to Week 36|Physician Decision|0
5812236|NCT02712008|20065061|P2|From Week 12 up to Week 36|Physician Decision|0
5812237|NCT02712008|20065062|P1|From Week 12 up to Week 36|Physician Decision|0
5812238|NCT02712008|20065055|P8|From Week 12 up to Week 36|Lost to Follow-up|0
5812239|NCT02712008|20065056|P7|From Week 12 up to Week 36|Lost to Follow-up|1
5812240|NCT02712008|20065057|P6|From Week 12 up to Week 36|Lost to Follow-up|0
5812241|NCT02712008|20065058|P5|From Week 12 up to Week 36|Lost to Follow-up|0
5812242|NCT02712008|20065059|P4|From Week 12 up to Week 36|Lost to Follow-up|1
5812243|NCT02712008|20065060|P3|From Week 12 up to Week 36|Lost to Follow-up|0
5812244|NCT02712008|20065061|P2|From Week 12 up to Week 36|Lost to Follow-up|0
5812245|NCT02712008|20065062|P1|From Week 12 up to Week 36|Lost to Follow-up|0
5812246|NCT02712008|20065055|P8|From Week 12 up to Week 36|Death|0
5812247|NCT02712008|20065056|P7|From Week 12 up to Week 36|Death|1
5812248|NCT02712008|20065057|P6|From Week 12 up to Week 36|Death|0
5812249|NCT02712008|20065058|P5|From Week 12 up to Week 36|Death|0
5812250|NCT02712008|20065059|P4|From Week 12 up to Week 36|Death|0
5812251|NCT02712008|20065060|P3|From Week 12 up to Week 36|Death|0
5812252|NCT02712008|20065061|P2|From Week 12 up to Week 36|Death|0
5812253|NCT02712008|20065062|P1|From Week 12 up to Week 36|Death|1
5812254|NCT02712008|20065055|P8|From Week 12 up to Week 36|Adverse Event|2
5812255|NCT02712008|20065056|P7|From Week 12 up to Week 36|Adverse Event|0
5812256|NCT02712008|20065057|P6|From Week 12 up to Week 36|Adverse Event|0
5812257|NCT02712008|20065058|P5|From Week 12 up to Week 36|Adverse Event|1
5812258|NCT02712008|20065059|P4|From Week 12 up to Week 36|Adverse Event|0
5812259|NCT02712008|20065060|P3|From Week 12 up to Week 36|Adverse Event|0
5812260|NCT02712008|20065061|P2|From Week 12 up to Week 36|Adverse Event|0
5812261|NCT02712008|20065062|P1|From Week 12 up to Week 36|Adverse Event|0
5812262|NCT02712008|20065055|P8|Baseline (Day 1) up to Week 12|Other Unspecified|0
5812263|NCT02712008|20065056|P7|Baseline (Day 1) up to Week 12|Other Unspecified|0
5812264|NCT02712008|20065057|P6|Baseline (Day 1) up to Week 12|Other Unspecified|0
5812265|NCT02712008|20065058|P5|Baseline (Day 1) up to Week 12|Other Unspecified|0
5812266|NCT02712008|20065059|P4|Baseline (Day 1) up to Week 12|Other Unspecified|0
5812267|NCT02712008|20065060|P3|Baseline (Day 1) up to Week 12|Other Unspecified|0
5812268|NCT02712008|20065061|P2|Baseline (Day 1) up to Week 12|Other Unspecified|1
5812269|NCT02712008|20065062|P1|Baseline (Day 1) up to Week 12|Other Unspecified|0
5812270|NCT02712008|20065055|P8|Baseline (Day 1) up to Week 12|Protocol Violation|0
5812271|NCT02712008|20065056|P7|Baseline (Day 1) up to Week 12|Protocol Violation|0
5812272|NCT02712008|20065057|P6|Baseline (Day 1) up to Week 12|Protocol Violation|0
5812273|NCT02712008|20065058|P5|Baseline (Day 1) up to Week 12|Protocol Violation|0
5812274|NCT02712008|20065059|P4|Baseline (Day 1) up to Week 12|Protocol Violation|0
5812275|NCT02712008|20065060|P3|Baseline (Day 1) up to Week 12|Protocol Violation|1
5812276|NCT02712008|20065061|P2|Baseline (Day 1) up to Week 12|Protocol Violation|0
5812277|NCT02712008|20065062|P1|Baseline (Day 1) up to Week 12|Protocol Violation|0
5812278|NCT02712008|20065055|P8|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
5812279|NCT02712008|20065056|P7|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
5812280|NCT02712008|20065057|P6|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
5812281|NCT02712008|20065058|P5|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
5812282|NCT02712008|20065059|P4|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
5812283|NCT02712008|20065060|P3|Baseline (Day 1) up to Week 12|Lost to Follow-up|2
5812284|NCT02712008|20065061|P2|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
5812285|NCT02712008|20065062|P1|Baseline (Day 1) up to Week 12|Lost to Follow-up|1
5812286|NCT02712008|20065055|P8|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
5812287|NCT02712008|20065056|P7|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
5812288|NCT02712008|20065057|P6|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
5812289|NCT02712008|20065058|P5|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
5812290|NCT02712008|20065059|P4|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
5812291|NCT02712008|20065060|P3|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1
5812292|NCT02712008|20065061|P2|Baseline (Day 1) up to Week 12|Withdrawal by Subject|2
5812293|NCT02712008|20065062|P1|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
5812294|NCT02712008|20065055|P8|Baseline (Day 1) up to Week 12|Death|0
5812295|NCT02712008|20065056|P7|Baseline (Day 1) up to Week 12|Death|0
5812296|NCT02712008|20065057|P6|Baseline (Day 1) up to Week 12|Death|0
5812297|NCT02712008|20065058|P5|Baseline (Day 1) up to Week 12|Death|0
5812298|NCT02712008|20065059|P4|Baseline (Day 1) up to Week 12|Death|0
5812299|NCT02712008|20065060|P3|Baseline (Day 1) up to Week 12|Death|0
5812300|NCT02712008|20065061|P2|Baseline (Day 1) up to Week 12|Death|0
5812301|NCT02712008|20065062|P1|Baseline (Day 1) up to Week 12|Death|3
5812302|NCT02711995|20065094|P1|Washout (90 Days)|Conflicting medication|1
5812303|NCT02711800|20065133|P1|Overall Study|Withdrawal by Subject|1
5812304|NCT02711800|20065133|P1|Overall Study|Lost to Follow-up|1
5812305|NCT02711345|20065152|P10|Overall Study|Death|0
5812306|NCT02711345|20065153|P9|Overall Study|Death|0
5812307|NCT02711345|20065154|P8|Overall Study|Death|1
5812308|NCT02711345|20065155|P7|Overall Study|Death|0
5812309|NCT02711345|20065156|P6|Overall Study|Death|0
5812310|NCT02711345|20065157|P5|Overall Study|Death|0
5812311|NCT02711345|20065158|P4|Overall Study|Death|0
5812312|NCT02711345|20065159|P3|Overall Study|Death|0
5812313|NCT02711345|20065160|P2|Overall Study|Death|0
5812314|NCT02711345|20065161|P1|Overall Study|Death|1
5812315|NCT02711345|20065152|P10|Overall Study|Subject/guardian decision|4
5812316|NCT02711345|20065153|P9|Overall Study|Subject/guardian decision|0
5812317|NCT02711345|20065154|P8|Overall Study|Subject/guardian decision|1
5812318|NCT02711345|20065155|P7|Overall Study|Subject/guardian decision|3
5812319|NCT02711345|20065156|P6|Overall Study|Subject/guardian decision|2
5812320|NCT02711345|20065157|P5|Overall Study|Subject/guardian decision|0
5812321|NCT02711345|20065158|P4|Overall Study|Subject/guardian decision|0
5812322|NCT02711345|20065159|P3|Overall Study|Subject/guardian decision|0
5812323|NCT02711345|20065160|P2|Overall Study|Subject/guardian decision|0
5812324|NCT02711345|20065161|P1|Overall Study|Subject/guardian decision|0
5812325|NCT02711345|20065152|P10|Overall Study|Progressive disease|6
5812326|NCT02711345|20065153|P9|Overall Study|Progressive disease|5
5812327|NCT02711345|20065154|P8|Overall Study|Progressive disease|4
5812328|NCT02711345|20065155|P7|Overall Study|Progressive disease|8
5812329|NCT02711345|20065156|P6|Overall Study|Progressive disease|2
5812330|NCT02711345|20065157|P5|Overall Study|Progressive disease|7
5812331|NCT02711345|20065158|P4|Overall Study|Progressive disease|3
5812332|NCT02711345|20065159|P3|Overall Study|Progressive disease|5
5812333|NCT02711345|20065160|P2|Overall Study|Progressive disease|3
5812334|NCT02711345|20065161|P1|Overall Study|Progressive disease|1
5812335|NCT02711345|20065152|P10|Overall Study|Physician Decision|0
5812336|NCT02711345|20065153|P9|Overall Study|Physician Decision|1
5812337|NCT02711345|20065154|P8|Overall Study|Physician Decision|0
5812338|NCT02711345|20065155|P7|Overall Study|Physician Decision|0
5812339|NCT02711345|20065156|P6|Overall Study|Physician Decision|0
5812340|NCT02711345|20065157|P5|Overall Study|Physician Decision|0
5812341|NCT02711345|20065158|P4|Overall Study|Physician Decision|0
5812342|NCT02711345|20065159|P3|Overall Study|Physician Decision|1
5812343|NCT02711345|20065160|P2|Overall Study|Physician Decision|0
5812344|NCT02711345|20065161|P1|Overall Study|Physician Decision|0
5812345|NCT02711345|20065152|P10|Overall Study|Adverse Event|2
5812346|NCT02711345|20065153|P9|Overall Study|Adverse Event|0
5812347|NCT02711345|20065154|P8|Overall Study|Adverse Event|0
5812348|NCT02711345|20065155|P7|Overall Study|Adverse Event|1
5812349|NCT02711345|20065156|P6|Overall Study|Adverse Event|2
5812350|NCT02711345|20065157|P5|Overall Study|Adverse Event|1
5812351|NCT02711345|20065158|P4|Overall Study|Adverse Event|1
5812352|NCT02711345|20065159|P3|Overall Study|Adverse Event|0
5812353|NCT02711345|20065160|P2|Overall Study|Adverse Event|0
5812354|NCT02711345|20065161|P1|Overall Study|Adverse Event|0
5812355|NCT02711306|20065347|P2|Overall Study|Withdrawal by Subject|2
5812356|NCT02711306|20065348|P1|Overall Study|Withdrawal by Subject|2
5812357|NCT02710422|20065541|P2|Overall Study|Termination of study|9
5812358|NCT02710422|20065542|P1|Overall Study|Termination of study|9
5812359|NCT02710292|20065558|P2|Period 1, First 10 Days of Wear|Withdrawal by Subject|2
5812360|NCT02710292|20065559|P1|Period 1, First 10 Days of Wear|Withdrawal by Subject|1
5812361|NCT02710292|20065558|P2|Period 1, First 10 Days of Wear|Adverse Event|1
5812362|NCT02710292|20065559|P1|Period 1, First 10 Days of Wear|Adverse Event|0
5812363|NCT02710214|20065568|P2|Overall Study|Death|1
5812364|NCT02710214|20065569|P1|Overall Study|Death|0
5812365|NCT02710214|20065568|P2|Overall Study|Lack of Efficacy|1
5812366|NCT02710214|20065569|P1|Overall Study|Lack of Efficacy|0
5812367|NCT02710214|20065568|P2|Overall Study|Lost to Follow-up|0
5812368|NCT02710214|20065569|P1|Overall Study|Lost to Follow-up|1
5812369|NCT02710136|20065603|P2|Phase 1a[Refer to Arm/Group Description]|Adverse Event|0
5812370|NCT02710136|20065604|P1|Phase 1a[Refer to Arm/Group Description]|Adverse Event|1
5812371|NCT02710071|20065629|P2|Second Intervention (6 Weeks).|Withdrawal by Subject|2
5812372|NCT02710071|20065630|P1|Second Intervention (6 Weeks).|Withdrawal by Subject|1
5812373|NCT02710071|20065629|P2|First Intervention (6 Weeks).|Withdrawal by Subject|4
5812374|NCT02710071|20065630|P1|First Intervention (6 Weeks).|Withdrawal by Subject|3
5812375|NCT02710045|20065640|P3|Overall Study|Poor Attendance|0
5812376|NCT02710045|20065641|P2|Overall Study|Poor Attendance|1
5812377|NCT02710045|20065642|P1|Overall Study|Poor Attendance|0
5812378|NCT02710045|20065640|P3|Overall Study|Physician Decision|1
5812379|NCT02710045|20065641|P2|Overall Study|Physician Decision|0
5812380|NCT02710045|20065642|P1|Overall Study|Physician Decision|0
5812381|NCT02710045|20065640|P3|Overall Study|Lost to Follow-up|7
5812382|NCT02710045|20065641|P2|Overall Study|Lost to Follow-up|6
5812383|NCT02710045|20065642|P1|Overall Study|Lost to Follow-up|3
5812384|NCT02710045|20065640|P3|Overall Study|Protocol Violation|3
5812385|NCT02710045|20065641|P2|Overall Study|Protocol Violation|2
5812386|NCT02710045|20065642|P1|Overall Study|Protocol Violation|1
5812387|NCT02710045|20065640|P3|Overall Study|Withdrawal by Subject|2
5812388|NCT02710045|20065641|P2|Overall Study|Withdrawal by Subject|6
5812389|NCT02710045|20065642|P1|Overall Study|Withdrawal by Subject|6
5812390|NCT02710045|20065640|P3|Overall Study|Death|0
5812391|NCT02710045|20065641|P2|Overall Study|Death|2
5812392|NCT02710045|20065642|P1|Overall Study|Death|1
5812393|NCT02709889|20065676|P4|Overall Study|Other, Not Specified|6
5812394|NCT02709889|20065677|P3|Overall Study|Other, Not Specified|1
5812395|NCT02709889|20065678|P2|Overall Study|Other, Not Specified|1
5812396|NCT02709889|20065679|P1|Overall Study|Other, Not Specified|0
5812397|NCT02709889|20065676|P4|Overall Study|Study Terminated by Sponsor|17
5812398|NCT02709889|20065677|P3|Overall Study|Study Terminated by Sponsor|2
5812399|NCT02709889|20065678|P2|Overall Study|Study Terminated by Sponsor|6
5812400|NCT02709889|20065679|P1|Overall Study|Study Terminated by Sponsor|4
5812401|NCT02709889|20065676|P4|Overall Study|Lost to Follow-up|4
5812402|NCT02709889|20065677|P3|Overall Study|Lost to Follow-up|0
5812403|NCT02709889|20065678|P2|Overall Study|Lost to Follow-up|0
5812404|NCT02709889|20065679|P1|Overall Study|Lost to Follow-up|2
5812405|NCT02709889|20065676|P4|Overall Study|Physician Decision|5
5812406|NCT02709889|20065677|P3|Overall Study|Physician Decision|3
5812407|NCT02709889|20065678|P2|Overall Study|Physician Decision|2
5812408|NCT02709889|20065679|P1|Overall Study|Physician Decision|1
5812409|NCT02709889|20065676|P4|Overall Study|Death|44
5812410|NCT02709889|20065677|P3|Overall Study|Death|4
5812411|NCT02709889|20065678|P2|Overall Study|Death|38
5812412|NCT02709889|20065679|P1|Overall Study|Death|25
5812413|NCT02709889|20065676|P4|Overall Study|Withdrawal by Subject|12
5812414|NCT02709889|20065677|P3|Overall Study|Withdrawal by Subject|2
5812415|NCT02709889|20065678|P2|Overall Study|Withdrawal by Subject|10
5812416|NCT02709889|20065679|P1|Overall Study|Withdrawal by Subject|11
5812417|NCT02709785|20065760|P3|Overall Study|Withdrawal by Subject|1
5812418|NCT02709785|20065761|P2|Overall Study|Withdrawal by Subject|2
5812419|NCT02709785|20065762|P1|Overall Study|Withdrawal by Subject|1
5812420|NCT02709746|20065787|P5|Phase B (Double-blind Treatment Period)|Lost to Follow-up|2
5812421|NCT02709746|20065788|P4|Phase B (Double-blind Treatment Period)|Lost to Follow-up|0
5812422|NCT02709746|20065789|P3|Phase B (Double-blind Treatment Period)|Lost to Follow-up|2
5812423|NCT02709746|20065790|P2|Phase B (Double-blind Treatment Period)|Lost to Follow-up|4
5812424|NCT02709746|20065791|P1|Phase B (Double-blind Treatment Period)|Lost to Follow-up|0
5812425|NCT02709746|20065787|P5|Phase B (Double-blind Treatment Period)|enrolled not treated|0
5812426|NCT02709746|20065788|P4|Phase B (Double-blind Treatment Period)|enrolled not treated|0
5812427|NCT02709746|20065789|P3|Phase B (Double-blind Treatment Period)|enrolled not treated|1
5812428|NCT02709746|20065790|P2|Phase B (Double-blind Treatment Period)|enrolled not treated|0
5812429|NCT02709746|20065791|P1|Phase B (Double-blind Treatment Period)|enrolled not treated|0
5812430|NCT02709746|20065787|P5|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|1
5812431|NCT02709746|20065788|P4|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2
5812432|NCT02709746|20065789|P3|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2
5812433|NCT02709746|20065790|P2|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2
5812434|NCT02709746|20065791|P1|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|0
5812435|NCT02709746|20065787|P5|Phase B (Double-blind Treatment Period)|Adverse Event|2
5812436|NCT02709746|20065788|P4|Phase B (Double-blind Treatment Period)|Adverse Event|5
5812437|NCT02709746|20065789|P3|Phase B (Double-blind Treatment Period)|Adverse Event|8
5812438|NCT02709746|20065790|P2|Phase B (Double-blind Treatment Period)|Adverse Event|4
5812439|NCT02709746|20065791|P1|Phase B (Double-blind Treatment Period)|Adverse Event|0
5812440|NCT02709746|20065787|P5|Phase B (Double-blind Treatment Period)|Lack of Efficacy|2
5812441|NCT02709746|20065788|P4|Phase B (Double-blind Treatment Period)|Lack of Efficacy|1
5812442|NCT02709746|20065789|P3|Phase B (Double-blind Treatment Period)|Lack of Efficacy|0
5812443|NCT02709746|20065790|P2|Phase B (Double-blind Treatment Period)|Lack of Efficacy|3
5812444|NCT02709746|20065791|P1|Phase B (Double-blind Treatment Period)|Lack of Efficacy|0
5812445|NCT02709746|20065787|P5|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|0
5812446|NCT02709746|20065788|P4|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|1
5812447|NCT02709746|20065789|P3|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|4
5812448|NCT02709746|20065790|P2|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|1
5812449|NCT02709746|20065791|P1|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|0
5812450|NCT02709746|20065787|P5|Phase B (Double-blind Treatment Period)|Other|7
5812451|NCT02709746|20065788|P4|Phase B (Double-blind Treatment Period)|Other|6
5812452|NCT02709746|20065789|P3|Phase B (Double-blind Treatment Period)|Other|5
5812453|NCT02709746|20065790|P2|Phase B (Double-blind Treatment Period)|Other|6
5812454|NCT02709746|20065791|P1|Phase B (Double-blind Treatment Period)|Other|0
5812455|NCT02709746|20065787|P5|Phase B (Double-blind Treatment Period)|Protocol Violation|2
5812456|NCT02709746|20065788|P4|Phase B (Double-blind Treatment Period)|Protocol Violation|0
5812457|NCT02709746|20065789|P3|Phase B (Double-blind Treatment Period)|Protocol Violation|0
5812458|NCT02709746|20065790|P2|Phase B (Double-blind Treatment Period)|Protocol Violation|1
5812459|NCT02709746|20065791|P1|Phase B (Double-blind Treatment Period)|Protocol Violation|0
5812460|NCT02709746|20065787|P5|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0
5812461|NCT02709746|20065788|P4|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0
5812462|NCT02709746|20065789|P3|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0
5812463|NCT02709746|20065790|P2|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0
5812464|NCT02709746|20065791|P1|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|103
5812465|NCT02709746|20065787|P5|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0
5812466|NCT02709746|20065788|P4|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0
5812467|NCT02709746|20065789|P3|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0
5812468|NCT02709746|20065790|P2|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0
5812469|NCT02709746|20065791|P1|Phase A (Single-blind Treatment Period)|Lost to Follow-up|7
5812470|NCT02709746|20065787|P5|Phase A (Single-blind Treatment Period)|Enrolled not treated|0
5812471|NCT02709746|20065788|P4|Phase A (Single-blind Treatment Period)|Enrolled not treated|0
5812472|NCT02709746|20065789|P3|Phase A (Single-blind Treatment Period)|Enrolled not treated|0
5812473|NCT02709746|20065790|P2|Phase A (Single-blind Treatment Period)|Enrolled not treated|0
5812474|NCT02709746|20065791|P1|Phase A (Single-blind Treatment Period)|Enrolled not treated|7
5812475|NCT02709746|20065787|P5|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0
5812476|NCT02709746|20065788|P4|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0
5812477|NCT02709746|20065789|P3|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0
5812478|NCT02709746|20065790|P2|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0
5812479|NCT02709746|20065791|P1|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|12
5812480|NCT02709746|20065787|P5|Phase A (Single-blind Treatment Period)|Adverse Event|0
5812481|NCT02709746|20065788|P4|Phase A (Single-blind Treatment Period)|Adverse Event|0
5812482|NCT02709746|20065789|P3|Phase A (Single-blind Treatment Period)|Adverse Event|0
5812483|NCT02709746|20065790|P2|Phase A (Single-blind Treatment Period)|Adverse Event|0
5812484|NCT02709746|20065791|P1|Phase A (Single-blind Treatment Period)|Adverse Event|2
5812485|NCT02709746|20065787|P5|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0
5812486|NCT02709746|20065788|P4|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0
5812487|NCT02709746|20065789|P3|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0
5812488|NCT02709746|20065790|P2|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0
5812489|NCT02709746|20065791|P1|Phase A (Single-blind Treatment Period)|Lack of Efficacy|7
5812490|NCT02709746|20065787|P5|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0
5812491|NCT02709746|20065788|P4|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0
5812492|NCT02709746|20065789|P3|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0
5812493|NCT02709746|20065790|P2|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0
5812494|NCT02709746|20065791|P1|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|12
5812495|NCT02709746|20065787|P5|Phase A (Single-blind Treatment Period)|Not sepcified|0
5812496|NCT02709746|20065788|P4|Phase A (Single-blind Treatment Period)|Not sepcified|0
5812497|NCT02709746|20065789|P3|Phase A (Single-blind Treatment Period)|Not sepcified|0
5812498|NCT02709746|20065790|P2|Phase A (Single-blind Treatment Period)|Not sepcified|0
5812499|NCT02709746|20065791|P1|Phase A (Single-blind Treatment Period)|Not sepcified|14
5812500|NCT02709746|20065787|P5|Phase A (Single-blind Treatment Period)|Protocol Violation|0
5812501|NCT02709746|20065788|P4|Phase A (Single-blind Treatment Period)|Protocol Violation|0
5812502|NCT02709746|20065789|P3|Phase A (Single-blind Treatment Period)|Protocol Violation|0
5812503|NCT02709746|20065790|P2|Phase A (Single-blind Treatment Period)|Protocol Violation|0
5812504|NCT02709746|20065791|P1|Phase A (Single-blind Treatment Period)|Protocol Violation|4
5812505|NCT02709577|20065913|P4|Overall Study|Withdrawal by Subject|0
5812506|NCT02709577|20065914|P3|Overall Study|Withdrawal by Subject|2
5812507|NCT02709577|20065915|P2|Overall Study|Withdrawal by Subject|3
5812508|NCT02709577|20065916|P1|Overall Study|Withdrawal by Subject|2
5812509|NCT02709577|20065913|P4|Overall Study|procedural complication|0
5812510|NCT02709577|20065914|P3|Overall Study|procedural complication|0
5812511|NCT02709577|20065915|P2|Overall Study|procedural complication|1
5812512|NCT02709577|20065916|P1|Overall Study|procedural complication|0
5812513|NCT02709577|20065913|P4|Overall Study|non-accommodating anatomy|0
5812514|NCT02709577|20065914|P3|Overall Study|non-accommodating anatomy|0
5812515|NCT02709577|20065915|P2|Overall Study|non-accommodating anatomy|1
5812516|NCT02709577|20065916|P1|Overall Study|non-accommodating anatomy|0
5812517|NCT02709538|20065931|P3|Overall Study|Other|5
5812518|NCT02709538|20065932|P2|Overall Study|Other|7
5812519|NCT02709538|20065933|P1|Overall Study|Other|16
5812520|NCT02709538|20065931|P3|Overall Study|Withdrawal by Parent or Legal Guardian|0
5812521|NCT02709538|20065932|P2|Overall Study|Withdrawal by Parent or Legal Guardian|0
5812522|NCT02709538|20065933|P1|Overall Study|Withdrawal by Parent or Legal Guardian|1
5812523|NCT02709538|20065931|P3|Overall Study|Protocol deviation|4
5812524|NCT02709538|20065932|P2|Overall Study|Protocol deviation|4
5812525|NCT02709538|20065933|P1|Overall Study|Protocol deviation|10
5812526|NCT02709538|20065931|P3|Overall Study|Non-compliance with study drug|0
5812527|NCT02709538|20065932|P2|Overall Study|Non-compliance with study drug|0
5812528|NCT02709538|20065933|P1|Overall Study|Non-compliance with study drug|2
5812529|NCT02709538|20065931|P3|Overall Study|Non-compliance with study procedures|0
5812530|NCT02709538|20065932|P2|Overall Study|Non-compliance with study procedures|0
5812531|NCT02709538|20065933|P1|Overall Study|Non-compliance with study procedures|5
5812532|NCT02709538|20065931|P3|Overall Study|Withdrawal by Subject|4
5812533|NCT02709538|20065932|P2|Overall Study|Withdrawal by Subject|7
5812534|NCT02709538|20065933|P1|Overall Study|Withdrawal by Subject|40
5812535|NCT02709538|20065931|P3|Overall Study|Physician Decision|0
5812536|NCT02709538|20065932|P2|Overall Study|Physician Decision|0
5812537|NCT02709538|20065933|P1|Overall Study|Physician Decision|1
5812538|NCT02709538|20065931|P3|Overall Study|Lost to Follow-up|4
5812539|NCT02709538|20065932|P2|Overall Study|Lost to Follow-up|8
5812540|NCT02709538|20065933|P1|Overall Study|Lost to Follow-up|24
5812541|NCT02709538|20065931|P3|Overall Study|Lack of Efficacy|0
5812542|NCT02709538|20065932|P2|Overall Study|Lack of Efficacy|0
5812543|NCT02709538|20065933|P1|Overall Study|Lack of Efficacy|1
5812544|NCT02709538|20065931|P3|Overall Study|Adverse Event|3
5812545|NCT02709538|20065932|P2|Overall Study|Adverse Event|2
5812546|NCT02709538|20065933|P1|Overall Study|Adverse Event|13
5812547|NCT02709486|20065944|P3|Overall Study|Withdrawal by Subject|32
5812548|NCT02709486|20065945|P2|Overall Study|Withdrawal by Subject|22
5812549|NCT02709486|20065946|P1|Overall Study|Withdrawal by Subject|32
5812550|NCT02709486|20065944|P3|Overall Study|Other|3
5812551|NCT02709486|20065945|P2|Overall Study|Other|2
5812552|NCT02709486|20065946|P1|Overall Study|Other|0
5812553|NCT02709486|20065944|P3|Overall Study|Lost to Follow-up|2
5812554|NCT02709486|20065945|P2|Overall Study|Lost to Follow-up|2
5812555|NCT02709486|20065946|P1|Overall Study|Lost to Follow-up|3
5812556|NCT02709486|20065944|P3|Overall Study|Insufficient clinical response|3
5812557|NCT02709486|20065945|P2|Overall Study|Insufficient clinical response|3
5812558|NCT02709486|20065946|P1|Overall Study|Insufficient clinical response|7
5812559|NCT02709486|20065944|P3|Overall Study|Death|2
5812560|NCT02709486|20065945|P2|Overall Study|Death|0
5812561|NCT02709486|20065946|P1|Overall Study|Death|0
5812562|NCT02709486|20065944|P3|Overall Study|Adverse Event|3
5812563|NCT02709486|20065945|P2|Overall Study|Adverse Event|5
5812564|NCT02709486|20065946|P1|Overall Study|Adverse Event|2
5812565|NCT02709369|20066137|P1|Overall Study|Did not received intervention|2
5812566|NCT02709369|20066137|P1|Overall Study|Withdrawal by Subject|10
5812567|NCT02709369|20066137|P1|Overall Study|Lost to Follow-up|15
5812568|NCT02709330|20066171|P2|Overall Study|Withdrawal by Subject|0
5812569|NCT02709330|20066172|P1|Overall Study|Withdrawal by Subject|4
5812570|NCT02709330|20066171|P2|Overall Study|Physician Decision|0
5812571|NCT02709330|20066172|P1|Overall Study|Physician Decision|2
5812572|NCT02709330|20066171|P2|Overall Study|Lost to Follow-up|0
5812573|NCT02709330|20066172|P1|Overall Study|Lost to Follow-up|2
5812574|NCT02709330|20066171|P2|Overall Study|Death|0
5812575|NCT02709330|20066172|P1|Overall Study|Death|5
5812576|NCT02709096|20066186|P2|Overall Study|non-compliance|1
5812577|NCT02709096|20066187|P1|Overall Study|non-compliance|1
5812578|NCT02709083|20066193|P1|Overall Study|Original PI left institution|7
5812579|NCT02709005|20066206|P2|Overall Study|Withdrawal by Subject|0
5812580|NCT02709005|20066207|P1|Overall Study|Withdrawal by Subject|3
5812581|NCT02709005|20066206|P2|Overall Study|Lost to Follow-up|1
5812582|NCT02709005|20066207|P1|Overall Study|Lost to Follow-up|1
5812585|NCT02708524|20066321|P4|Overall Study|Subject lost study lens|0
5812586|NCT02708524|20066322|P3|Overall Study|Subject lost study lens|0
5812587|NCT02708524|20066323|P2|Overall Study|Subject lost study lens|0
5812588|NCT02708524|20066324|P1|Overall Study|Subject lost study lens|1
5812589|NCT02708524|20066321|P4|Overall Study|Did not wear lens at final visit|0
5812590|NCT02708524|20066322|P3|Overall Study|Did not wear lens at final visit|0
5812591|NCT02708524|20066323|P2|Overall Study|Did not wear lens at final visit|1
5812592|NCT02708524|20066324|P1|Overall Study|Did not wear lens at final visit|0
5812593|NCT02708524|20066321|P4|Overall Study|Dispensed incorrect study lens|0
5812594|NCT02708524|20066322|P3|Overall Study|Dispensed incorrect study lens|1
5812595|NCT02708524|20066323|P2|Overall Study|Dispensed incorrect study lens|1
5812596|NCT02708524|20066324|P1|Overall Study|Dispensed incorrect study lens|0
5812597|NCT02708524|20066321|P4|Overall Study|Withdrawal by Subject|0
5812598|NCT02708524|20066322|P3|Overall Study|Withdrawal by Subject|0
5812599|NCT02708524|20066323|P2|Overall Study|Withdrawal by Subject|1
5812600|NCT02708524|20066324|P1|Overall Study|Withdrawal by Subject|1
5812601|NCT02708524|20066321|P4|Overall Study|Protocol Violation|0
5812602|NCT02708524|20066322|P3|Overall Study|Protocol Violation|0
5812603|NCT02708524|20066323|P2|Overall Study|Protocol Violation|1
5812604|NCT02708524|20066324|P1|Overall Study|Protocol Violation|0
5812605|NCT02708524|20066321|P4|Overall Study|Lost to Follow-up|0
5812606|NCT02708524|20066322|P3|Overall Study|Lost to Follow-up|1
5812607|NCT02708524|20066323|P2|Overall Study|Lost to Follow-up|1
5812608|NCT02708524|20066324|P1|Overall Study|Lost to Follow-up|1
5812609|NCT02708524|20066321|P4|Overall Study|Lens Discomfort|0
5812610|NCT02708524|20066322|P3|Overall Study|Lens Discomfort|1
5812611|NCT02708524|20066323|P2|Overall Study|Lens Discomfort|0
5812612|NCT02708524|20066324|P1|Overall Study|Lens Discomfort|1
5812613|NCT02708524|20066321|P4|Overall Study|Adverse Event|0
5812614|NCT02708524|20066322|P3|Overall Study|Adverse Event|0
5812615|NCT02708524|20066323|P2|Overall Study|Adverse Event|1
5812616|NCT02708524|20066324|P1|Overall Study|Adverse Event|0
5812617|NCT02708498|20066378|P8|Overall Study|Unknown reason, missing data|0
5812618|NCT02708498|20066379|P7|Overall Study|Unknown reason, missing data|0
5812619|NCT02708498|20066380|P6|Overall Study|Unknown reason, missing data|132
5812620|NCT02708498|20066381|P5|Overall Study|Unknown reason, missing data|195
5812621|NCT02708498|20066382|P4|Overall Study|Unknown reason, missing data|51
5812622|NCT02708498|20066383|P3|Overall Study|Unknown reason, missing data|62
5812623|NCT02708498|20066384|P2|Overall Study|Unknown reason, missing data|0
5812624|NCT02708498|20066385|P1|Overall Study|Unknown reason, missing data|0
5812625|NCT02708498|20066378|P8|Overall Study|Death|0
5812626|NCT02708498|20066379|P7|Overall Study|Death|0
5812627|NCT02708498|20066380|P6|Overall Study|Death|0
5812628|NCT02708498|20066381|P5|Overall Study|Death|1
5812629|NCT02708498|20066382|P4|Overall Study|Death|0
5812630|NCT02708498|20066383|P3|Overall Study|Death|0
5812631|NCT02708498|20066384|P2|Overall Study|Death|19
5812632|NCT02708498|20066385|P1|Overall Study|Death|20
5812633|NCT02708485|20066413|P2|Overall Study|Withdrawal by Subject|2
5812634|NCT02708485|20066414|P1|Overall Study|Withdrawal by Subject|3
5812635|NCT02708355|20066434|P3|Overall Study|Adverse Event|0
5812636|NCT02708355|20066435|P2|Overall Study|Adverse Event|0
5812637|NCT02708355|20066436|P1|Overall Study|Adverse Event|1
5812638|NCT02708277|20066458|P2|Overall Study|Lost to Follow-up|4
5812639|NCT02708277|20066459|P1|Overall Study|Lost to Follow-up|7
5812640|NCT02708121|20066511|P2|Overall Study|Withdrawal by Subject|4
5812641|NCT02708121|20066512|P1|Overall Study|Withdrawal by Subject|0
5812642|NCT02708121|20066511|P2|Overall Study|Withdrawn by Study Team|1
5812643|NCT02708121|20066512|P1|Overall Study|Withdrawn by Study Team|1
5812644|NCT02708095|20066524|P3|Overall Study|Withdrawal by Subject|4
5812645|NCT02708095|20066525|P2|Overall Study|Withdrawal by Subject|3
5812646|NCT02708095|20066526|P1|Overall Study|Withdrawal by Subject|5
5812647|NCT02708095|20066524|P3|Overall Study|Protocol Violation|1
5812648|NCT02708095|20066525|P2|Overall Study|Protocol Violation|0
5812649|NCT02708095|20066526|P1|Overall Study|Protocol Violation|0
5812650|NCT02708095|20066524|P3|Overall Study|Physician Decision|2
5812651|NCT02708095|20066525|P2|Overall Study|Physician Decision|3
5812652|NCT02708095|20066526|P1|Overall Study|Physician Decision|2
5812653|NCT02708095|20066524|P3|Overall Study|Lost to Follow-up|0
5812654|NCT02708095|20066525|P2|Overall Study|Lost to Follow-up|0
5812655|NCT02708095|20066526|P1|Overall Study|Lost to Follow-up|2
5812656|NCT02708095|20066524|P3|Overall Study|Lack of Efficacy|0
5812657|NCT02708095|20066525|P2|Overall Study|Lack of Efficacy|3
5812658|NCT02708095|20066526|P1|Overall Study|Lack of Efficacy|9
5812659|NCT02708095|20066524|P3|Overall Study|Adverse Event|11
5812660|NCT02708095|20066525|P2|Overall Study|Adverse Event|10
5812661|NCT02708095|20066526|P1|Overall Study|Adverse Event|4
5812662|NCT02707991|20066549|P2|Overall Study|Became ineligible|1
5812663|NCT02707991|20066550|P1|Overall Study|Became ineligible|0
5812664|NCT02707991|20066549|P2|Overall Study|Protocol Violation|0
5812665|NCT02707991|20066550|P1|Overall Study|Protocol Violation|1
5812666|NCT02707965|20066567|P16|Overall Study|Protocol deviation|0
5812667|NCT02707965|20066568|P15|Overall Study|Protocol deviation|0
5812668|NCT02707965|20066569|P14|Overall Study|Protocol deviation|0
5812669|NCT02707965|20066570|P13|Overall Study|Protocol deviation|0
5812670|NCT02707965|20066571|P12|Overall Study|Protocol deviation|0
5812671|NCT02707965|20066572|P11|Overall Study|Protocol deviation|0
5812672|NCT02707965|20066573|P10|Overall Study|Protocol deviation|0
5812673|NCT02707965|20066574|P9|Overall Study|Protocol deviation|0
5812674|NCT02707965|20066575|P8|Overall Study|Protocol deviation|1
5812675|NCT02707965|20066576|P7|Overall Study|Protocol deviation|0
5812676|NCT02707965|20066577|P6|Overall Study|Protocol deviation|0
5812677|NCT02707965|20066578|P5|Overall Study|Protocol deviation|0
5812678|NCT02707965|20066579|P4|Overall Study|Protocol deviation|0
5812679|NCT02707965|20066580|P3|Overall Study|Protocol deviation|0
5812680|NCT02707965|20066581|P2|Overall Study|Protocol deviation|1
5812681|NCT02707965|20066582|P1|Overall Study|Protocol deviation|1
5812682|NCT02707965|20066567|P16|Overall Study|PI decisions|0
5812683|NCT02707965|20066568|P15|Overall Study|PI decisions|2
5812684|NCT02707965|20066569|P14|Overall Study|PI decisions|0
5812685|NCT02707965|20066570|P13|Overall Study|PI decisions|0
5812686|NCT02707965|20066571|P12|Overall Study|PI decisions|0
5812687|NCT02707965|20066572|P11|Overall Study|PI decisions|0
5812688|NCT02707965|20066573|P10|Overall Study|PI decisions|0
5812689|NCT02707965|20066574|P9|Overall Study|PI decisions|0
5812690|NCT02707965|20066575|P8|Overall Study|PI decisions|0
5812691|NCT02707965|20066576|P7|Overall Study|PI decisions|0
5812692|NCT02707965|20066577|P6|Overall Study|PI decisions|0
5812693|NCT02707965|20066578|P5|Overall Study|PI decisions|0
5812694|NCT02707965|20066579|P4|Overall Study|PI decisions|0
5812695|NCT02707965|20066580|P3|Overall Study|PI decisions|0
5812696|NCT02707965|20066581|P2|Overall Study|PI decisions|0
5812697|NCT02707965|20066582|P1|Overall Study|PI decisions|0
5812698|NCT02707965|20066567|P16|Overall Study|Withdrawal by Subject|0
5812699|NCT02707965|20066568|P15|Overall Study|Withdrawal by Subject|0
5812700|NCT02707965|20066569|P14|Overall Study|Withdrawal by Subject|0
5812701|NCT02707965|20066570|P13|Overall Study|Withdrawal by Subject|0
5812702|NCT02707965|20066571|P12|Overall Study|Withdrawal by Subject|0
5812703|NCT02707965|20066572|P11|Overall Study|Withdrawal by Subject|0
5812704|NCT02707965|20066573|P10|Overall Study|Withdrawal by Subject|0
5812705|NCT02707965|20066574|P9|Overall Study|Withdrawal by Subject|0
5812706|NCT02707965|20066575|P8|Overall Study|Withdrawal by Subject|2
5812707|NCT02707965|20066576|P7|Overall Study|Withdrawal by Subject|0
5812708|NCT02707965|20066577|P6|Overall Study|Withdrawal by Subject|0
5812709|NCT02707965|20066578|P5|Overall Study|Withdrawal by Subject|0
5812710|NCT02707965|20066579|P4|Overall Study|Withdrawal by Subject|0
5812711|NCT02707965|20066580|P3|Overall Study|Withdrawal by Subject|1
5812712|NCT02707965|20066581|P2|Overall Study|Withdrawal by Subject|0
5812713|NCT02707965|20066582|P1|Overall Study|Withdrawal by Subject|0
5812714|NCT02707952|20066634|P4|Overall Study|Withdrawal by Subject|0
5812715|NCT02707952|20066635|P3|Overall Study|Withdrawal by Subject|2
5812716|NCT02707952|20066636|P2|Overall Study|Withdrawal by Subject|1
5812717|NCT02707952|20066637|P1|Overall Study|Withdrawal by Subject|0
5812718|NCT02707952|20066634|P4|Overall Study|Lost to Follow-up|0
5812719|NCT02707952|20066635|P3|Overall Study|Lost to Follow-up|0
5812720|NCT02707952|20066636|P2|Overall Study|Lost to Follow-up|0
5812721|NCT02707952|20066637|P1|Overall Study|Lost to Follow-up|1
5812722|NCT02707952|20066634|P4|Overall Study|Adverse Event|0
5812723|NCT02707952|20066635|P3|Overall Study|Adverse Event|0
5812724|NCT02707952|20066636|P2|Overall Study|Adverse Event|0
5812725|NCT02707952|20066637|P1|Overall Study|Adverse Event|1
5812726|NCT02707640|20066658|P2|Overall Study|Sponsor Discretion|0
5812727|NCT02707640|20066659|P1|Overall Study|Sponsor Discretion|1
5812728|NCT02707640|20066658|P2|Overall Study|Participant's Personal Decision|2
5812729|NCT02707640|20066659|P1|Overall Study|Participant's Personal Decision|1
5812730|NCT02707640|20066658|P2|Overall Study|Withdrawal by Subject|1
5812731|NCT02707640|20066659|P1|Overall Study|Withdrawal by Subject|0
5812732|NCT02707640|20066658|P2|Overall Study|Physician Decision|0
5812733|NCT02707640|20066659|P1|Overall Study|Physician Decision|2
5812734|NCT02707640|20066658|P2|Overall Study|Death|2
5812735|NCT02707640|20066659|P1|Overall Study|Death|1
5812736|NCT02707640|20066658|P2|Overall Study|Adverse Event|2
5812737|NCT02707640|20066659|P1|Overall Study|Adverse Event|4
5812738|NCT02707601|20066679|P2|Overall Study|Participants Randomized but Not Treated|0
5812739|NCT02707601|20066680|P1|Overall Study|Participants Randomized but Not Treated|2
5812740|NCT02707601|20066679|P2|Overall Study|Lost to Follow-up|1
5812741|NCT02707601|20066680|P1|Overall Study|Lost to Follow-up|1
5812742|NCT02707601|20066679|P2|Overall Study|Withdrew Consent|1
5812743|NCT02707601|20066680|P1|Overall Study|Withdrew Consent|0
5812744|NCT02707601|20066679|P2|Overall Study|Investigator's Discretion|0
5812745|NCT02707601|20066680|P1|Overall Study|Investigator's Discretion|1
5812746|NCT02707601|20066679|P2|Overall Study|Lack of Efficacy|1
5812747|NCT02707601|20066680|P1|Overall Study|Lack of Efficacy|0
5812748|NCT02707601|20066679|P2|Overall Study|Death|1
5812749|NCT02707601|20066680|P1|Overall Study|Death|0
5812762|NCT02706938|20066805|P2|Second Period, 6 Weeks|Withdrawal by Subject|3
5812763|NCT02706938|20066806|P1|Second Period, 6 Weeks|Withdrawal by Subject|0
5812764|NCT02706938|20066805|P2|Second Period, 6 Weeks|Adverse Event|7
5812765|NCT02706938|20066806|P1|Second Period, 6 Weeks|Adverse Event|0
5812766|NCT02706938|20066805|P2|First Period, 6 Weeks|Withdrawal by Subject|0
5812767|NCT02706938|20066806|P1|First Period, 6 Weeks|Withdrawal by Subject|1
5812768|NCT02706938|20066805|P2|First Period, 6 Weeks|Lost to Follow-up|2
5812769|NCT02706938|20066806|P1|First Period, 6 Weeks|Lost to Follow-up|2
5812770|NCT02706938|20066805|P2|First Period, 6 Weeks|Adverse Event|0
5812771|NCT02706938|20066806|P1|First Period, 6 Weeks|Adverse Event|8
5812772|NCT02706899|20066870|P2|Overall Study|Study Termination by Sponsor|6
5812773|NCT02706899|20066871|P1|Overall Study|Study Termination by Sponsor|4
5812774|NCT02706899|20066870|P2|Overall Study|Death|0
5812775|NCT02706899|20066871|P1|Overall Study|Death|8
5812776|NCT02706899|20066870|P2|Overall Study|Withdrawal by Subject|0
5812777|NCT02706899|20066871|P1|Overall Study|Withdrawal by Subject|1
5812778|NCT02706886|20066902|P9|Part A: SAD Period|Withdrawal by Subject|0
5812779|NCT02706886|20066903|P8|Part A: SAD Period|Withdrawal by Subject|0
5812780|NCT02706886|20066904|P7|Part A: SAD Period|Withdrawal by Subject|0
5812781|NCT02706886|20066905|P6|Part A: SAD Period|Withdrawal by Subject|0
5812782|NCT02706886|20066906|P5|Part A: SAD Period|Withdrawal by Subject|0
5812783|NCT02706886|20066907|P4|Part A: SAD Period|Withdrawal by Subject|2
5812784|NCT02706886|20066908|P3|Part A: SAD Period|Withdrawal by Subject|0
5812785|NCT02706886|20066909|P2|Part A: SAD Period|Withdrawal by Subject|0
5812786|NCT02706886|20066910|P1|Part A: SAD Period|Withdrawal by Subject|0
5812851|NCT02706834|20067175|P11|Overall Study|Other Reason Not Specified|0
5812852|NCT02706834|20067176|P10|Overall Study|Other Reason Not Specified|0
5812853|NCT02706834|20067177|P9|Overall Study|Other Reason Not Specified|0
5812854|NCT02706834|20067178|P8|Overall Study|Other Reason Not Specified|0
5812855|NCT02706834|20067179|P7|Overall Study|Other Reason Not Specified|0
5812856|NCT02706834|20067180|P6|Overall Study|Other Reason Not Specified|0
5812857|NCT02706834|20067181|P5|Overall Study|Other Reason Not Specified|1
5812858|NCT02706834|20067182|P4|Overall Study|Other Reason Not Specified|0
5812859|NCT02706834|20067183|P3|Overall Study|Other Reason Not Specified|0
5812860|NCT02706834|20067184|P2|Overall Study|Other Reason Not Specified|0
5812861|NCT02706834|20067185|P1|Overall Study|Other Reason Not Specified|1
5812862|NCT02706834|20067175|P11|Overall Study|Voluntary Withdrawal|0
5812863|NCT02706834|20067176|P10|Overall Study|Voluntary Withdrawal|1
5812864|NCT02706834|20067177|P9|Overall Study|Voluntary Withdrawal|0
5812865|NCT02706834|20067178|P8|Overall Study|Voluntary Withdrawal|0
5812866|NCT02706834|20067179|P7|Overall Study|Voluntary Withdrawal|0
5812867|NCT02706834|20067180|P6|Overall Study|Voluntary Withdrawal|0
5812868|NCT02706834|20067181|P5|Overall Study|Voluntary Withdrawal|0
5812869|NCT02706834|20067182|P4|Overall Study|Voluntary Withdrawal|0
5812870|NCT02706834|20067183|P3|Overall Study|Voluntary Withdrawal|0
5812871|NCT02706834|20067184|P2|Overall Study|Voluntary Withdrawal|0
5812872|NCT02706834|20067185|P1|Overall Study|Voluntary Withdrawal|1
5812873|NCT02706834|20067175|P11|Overall Study|Lost to Follow-up|0
5812874|NCT02706834|20067176|P10|Overall Study|Lost to Follow-up|0
5812875|NCT02706834|20067177|P9|Overall Study|Lost to Follow-up|0
5812876|NCT02706834|20067178|P8|Overall Study|Lost to Follow-up|0
5812877|NCT02706834|20067179|P7|Overall Study|Lost to Follow-up|0
5812878|NCT02706834|20067180|P6|Overall Study|Lost to Follow-up|0
5812879|NCT02706834|20067181|P5|Overall Study|Lost to Follow-up|0
5812880|NCT02706834|20067182|P4|Overall Study|Lost to Follow-up|0
5812881|NCT02706834|20067183|P3|Overall Study|Lost to Follow-up|1
5812882|NCT02706834|20067184|P2|Overall Study|Lost to Follow-up|0
5812883|NCT02706834|20067185|P1|Overall Study|Lost to Follow-up|0
5812884|NCT02706834|20067175|P11|Overall Study|Pretreatment Event/Adverse Event|1
5812885|NCT02706834|20067176|P10|Overall Study|Pretreatment Event/Adverse Event|0
5812886|NCT02706834|20067177|P9|Overall Study|Pretreatment Event/Adverse Event|0
5812887|NCT02706834|20067178|P8|Overall Study|Pretreatment Event/Adverse Event|0
5812888|NCT02706834|20067179|P7|Overall Study|Pretreatment Event/Adverse Event|0
5812889|NCT02706834|20067180|P6|Overall Study|Pretreatment Event/Adverse Event|0
5812890|NCT02706834|20067181|P5|Overall Study|Pretreatment Event/Adverse Event|0
5812891|NCT02706834|20067182|P4|Overall Study|Pretreatment Event/Adverse Event|0
5812892|NCT02706834|20067183|P3|Overall Study|Pretreatment Event/Adverse Event|0
5812893|NCT02706834|20067184|P2|Overall Study|Pretreatment Event/Adverse Event|1
5812894|NCT02706834|20067185|P1|Overall Study|Pretreatment Event/Adverse Event|0
5812895|NCT02706717|20067329|P2|Overall Study|Death|1
5812896|NCT02706717|20067330|P1|Overall Study|Death|0
5812897|NCT02706717|20067329|P2|Overall Study|Physician Decision|1
5812898|NCT02706717|20067330|P1|Overall Study|Physician Decision|0
5812899|NCT02706717|20067329|P2|Overall Study|Lost to Follow-up|1
5812900|NCT02706717|20067330|P1|Overall Study|Lost to Follow-up|0
5812901|NCT02706717|20067329|P2|Overall Study|Withdrawal by Subject|8
5812902|NCT02706717|20067330|P1|Overall Study|Withdrawal by Subject|1
5812903|NCT02706691|20067394|P1|Overall Study|Adverse Event|1
5812904|NCT02706483|20067401|P1|Overall Study|Subject moved|1
5812905|NCT02706483|20067401|P1|Overall Study|Site closure|4
5812906|NCT02706483|20067401|P1|Overall Study|Non-compliance with visits|6
5812907|NCT02706483|20067401|P1|Overall Study|Withdrawal by Subject|136
5812908|NCT02706483|20067401|P1|Overall Study|Protocol Violation|18
5812909|NCT02706483|20067401|P1|Overall Study|Pregnancy|6
5812910|NCT02706483|20067401|P1|Overall Study|Physician Decision|6
5812911|NCT02706483|20067401|P1|Overall Study|Non-compliance with study drug|15
5812912|NCT02706483|20067401|P1|Overall Study|Lost to Follow-up|101
5812913|NCT02706483|20067401|P1|Overall Study|Lack of Efficacy|39
5812914|NCT02706483|20067401|P1|Overall Study|Death|1
5812915|NCT02706483|20067401|P1|Overall Study|Adverse Event|97
5812916|NCT02706327|20067408|P3|Overall Study|Lost to Follow-up|2
5812917|NCT02706327|20067409|P2|Overall Study|Lost to Follow-up|1
5812918|NCT02706327|20067410|P1|Overall Study|Lost to Follow-up|1
5812919|NCT02705716|20067462|P2|Overall Study|Withdrawal of Consent|1
5812920|NCT02705716|20067463|P1|Overall Study|Withdrawal of Consent|1
5812921|NCT02705716|20067462|P2|Overall Study|Protocol Violation|0
5812922|NCT02705716|20067463|P1|Overall Study|Protocol Violation|3
5812923|NCT02705716|20067462|P2|Overall Study|Adverse Event|1
5812924|NCT02705716|20067463|P1|Overall Study|Adverse Event|0
5812925|NCT02705625|20067476|P3|Overall Study|Overdosing|1
5812926|NCT02705625|20067477|P2|Overall Study|Overdosing|0
5812927|NCT02705625|20067478|P1|Overall Study|Overdosing|0
5812928|NCT02705625|20067476|P3|Overall Study|Non-compliance|1
5812929|NCT02705625|20067477|P2|Overall Study|Non-compliance|1
5812930|NCT02705625|20067478|P1|Overall Study|Non-compliance|0
5812931|NCT02705625|20067476|P3|Overall Study|Lost to Follow-up|1
5812932|NCT02705625|20067477|P2|Overall Study|Lost to Follow-up|0
5812933|NCT02705625|20067478|P1|Overall Study|Lost to Follow-up|0
5812934|NCT02705625|20067476|P3|Overall Study|Withdrawal by Subject|5
5812935|NCT02705625|20067477|P2|Overall Study|Withdrawal by Subject|4
5812936|NCT02705625|20067478|P1|Overall Study|Withdrawal by Subject|1
5812937|NCT02705625|20067476|P3|Overall Study|Death|1
5812938|NCT02705625|20067477|P2|Overall Study|Death|0
5812939|NCT02705625|20067478|P1|Overall Study|Death|0
5812940|NCT02705625|20067476|P3|Overall Study|Adverse Event|2
5812941|NCT02705625|20067477|P2|Overall Study|Adverse Event|5
5812942|NCT02705625|20067478|P1|Overall Study|Adverse Event|6
5812943|NCT02705625|20067476|P3|Overall Study|Protocol Violation|0
5812944|NCT02705625|20067477|P2|Overall Study|Protocol Violation|0
5812945|NCT02705625|20067478|P1|Overall Study|Protocol Violation|1
5812946|NCT02705586|20067507|P1|Overall Study|Vacation/Planned Absence|1
5812947|NCT02705586|20067507|P1|Overall Study|Transportation Difficulties|5
5812948|NCT02705586|20067507|P1|Overall Study|Health Issues|2
5812949|NCT02705105|20067545|P2|Follow-Up|Discontinued per Amendment 3|2
5812950|NCT02705105|20067546|P1|Follow-Up|Discontinued per Amendment 3|0
5812951|NCT02705105|20067545|P2|Follow-Up|Study Terminated|26
5812952|NCT02705105|20067546|P1|Follow-Up|Study Terminated|0
5812953|NCT02705105|20067545|P2|Follow-Up|Withdrawal by Subject|14
5812954|NCT02705105|20067546|P1|Follow-Up|Withdrawal by Subject|1
5812955|NCT02705105|20067545|P2|Follow-Up|Death|68
5812956|NCT02705105|20067546|P1|Follow-Up|Death|3
5812957|NCT02705105|20067545|P2|Treatment|Ongoing w/ Treatment at time of data cut|2
5812958|NCT02705105|20067546|P1|Treatment|Ongoing w/ Treatment at time of data cut|0
5812959|NCT02705105|20067545|P2|Treatment|Physician Decision|3
5812960|NCT02705105|20067546|P1|Treatment|Physician Decision|0
5812961|NCT02705105|20067545|P2|Treatment|Clinical Disease Progression|32
5812962|NCT02705105|20067546|P1|Treatment|Clinical Disease Progression|0
5812963|NCT02705105|20067545|P2|Treatment|Adverse Event|17
5812964|NCT02705105|20067546|P1|Treatment|Adverse Event|0
5812965|NCT02705105|20067545|P2|Treatment|Withdrawal by Subject|5
5812966|NCT02705105|20067546|P1|Treatment|Withdrawal by Subject|3
5812967|NCT02705105|20067545|P2|Treatment|Objective Disease Progression|50
5812968|NCT02705105|20067546|P1|Treatment|Objective Disease Progression|1
5812969|NCT02704689|20067609|P1|Overall Study|Study device not implanted|2
5812970|NCT02704689|20067609|P1|Overall Study|Physician Decision|1
5812971|NCT02704143|20067626|P1|Overall Study|disease progression|10
5812972|NCT02704091|20067651|P2|Overall Study|Other|8
5812973|NCT02704091|20067652|P1|Overall Study|Other|2
5812974|NCT02704091|20067651|P2|Overall Study|Lost to Follow-up|5
5812975|NCT02704091|20067652|P1|Overall Study|Lost to Follow-up|13
5812976|NCT02704091|20067651|P2|Overall Study|Consent withdrawn|4
5812977|NCT02704091|20067652|P1|Overall Study|Consent withdrawn|4
5812978|NCT02704091|20067651|P2|Overall Study|Protocol Violation|3
5812979|NCT02704091|20067652|P1|Overall Study|Protocol Violation|5
5812980|NCT02704091|20067651|P2|Overall Study|Adverse Event|3
5812981|NCT02704091|20067652|P1|Overall Study|Adverse Event|4
5812982|NCT02703636|20067712|P1|Overall Study|Withdrawal by Subject|1
5812983|NCT02703636|20067712|P1|Overall Study|Study stopped by sponsor|1
5812984|NCT02703636|20067712|P1|Overall Study|Adverse Event|14
5812985|NCT02703532|20067727|P4|Overall Study|Lost to Follow-up|0
5812986|NCT02703532|20067728|P3|Overall Study|Lost to Follow-up|2
5812987|NCT02703532|20067729|P2|Overall Study|Lost to Follow-up|0
5812988|NCT02703532|20067730|P1|Overall Study|Lost to Follow-up|2
5812989|NCT02703532|20067727|P4|Overall Study|Withdrawal by Subject|1
5812990|NCT02703532|20067728|P3|Overall Study|Withdrawal by Subject|0
5812991|NCT02703532|20067729|P2|Overall Study|Withdrawal by Subject|1
5812992|NCT02703532|20067730|P1|Overall Study|Withdrawal by Subject|0
5812993|NCT02703454|20067792|P2|Overall Study|Study discontinuation|8
5812994|NCT02703454|20067793|P1|Overall Study|Study discontinuation|5
5812995|NCT02703454|20067792|P2|Overall Study|Lost to Follow-up|2
5812996|NCT02703454|20067793|P1|Overall Study|Lost to Follow-up|1
5812997|NCT02703454|20067792|P2|Overall Study|Withdrawal by Subject|3
5812998|NCT02703454|20067793|P1|Overall Study|Withdrawal by Subject|4
5812999|NCT02703454|20067792|P2|Overall Study|Not treated|3
5813000|NCT02703454|20067793|P1|Overall Study|Not treated|1
5813001|NCT02703337|20067828|P8|Period One (Part A)|Withdrawal by Subject|0
5813002|NCT02703337|20067829|P7|Period One (Part A)|Withdrawal by Subject|0
5813003|NCT02703337|20067830|P6|Period One (Part A)|Withdrawal by Subject|0
5813004|NCT02703337|20067831|P5|Period One (Part A)|Withdrawal by Subject|1
5813005|NCT02703337|20067832|P4|Period One (Part A)|Withdrawal by Subject|0
5813006|NCT02703337|20067833|P3|Period One (Part A)|Withdrawal by Subject|0
5813007|NCT02703337|20067834|P2|Period One (Part A)|Withdrawal by Subject|0
5813008|NCT02703337|20067835|P1|Period One (Part A)|Withdrawal by Subject|0
5813009|NCT02703324|20067855|P6|Period Two|Withdrawal by Subject|0
5813010|NCT02703324|20067856|P5|Period Two|Withdrawal by Subject|0
5813011|NCT02703324|20067857|P4|Period Two|Withdrawal by Subject|0
5813012|NCT02703324|20067858|P3|Period Two|Withdrawal by Subject|1
5813013|NCT02703324|20067859|P2|Period Two|Withdrawal by Subject|0
5813014|NCT02703324|20067860|P1|Period Two|Withdrawal by Subject|0
5813015|NCT02703311|20067869|P1|Overall Study|Withdrawal by Subject|3
5813016|NCT02703311|20067869|P1|Overall Study|Death|5
5813017|NCT02703259|20067887|P2|2 Weeks Postoperative Assessment|Lost to Follow-up|10
5813018|NCT02703259|20067888|P1|2 Weeks Postoperative Assessment|Lost to Follow-up|10
5813019|NCT02703259|20067887|P2|24 Hours Postoperative Assessment|excluded from analysis per protocol|2
5813020|NCT02703259|20067888|P1|24 Hours Postoperative Assessment|excluded from analysis per protocol|1
5813021|NCT02703259|20067887|P2|24 Hours Postoperative Assessment|Lost to Follow-up|4
5813022|NCT02703259|20067888|P1|24 Hours Postoperative Assessment|Lost to Follow-up|1
5813023|NCT02702609|20067936|P2|Overall Study|Physician Decision|0
5813024|NCT02702609|20067937|P1|Overall Study|Physician Decision|1
5813025|NCT02702609|20067936|P2|Overall Study|Lost to Follow-up|4
5813026|NCT02702609|20067937|P1|Overall Study|Lost to Follow-up|8
5813027|NCT02702401|20067955|P2|Overall Study|Ongoing in study|34
5813028|NCT02702401|20067956|P1|Overall Study|Ongoing in study|94
5813029|NCT02702401|20067955|P2|Overall Study|Withdrawal by Subject|0
5813030|NCT02702401|20067956|P1|Overall Study|Withdrawal by Subject|4
5813031|NCT02702401|20067955|P2|Overall Study|Death|101
5813032|NCT02702401|20067956|P1|Overall Study|Death|180
5813033|NCT02702388|20067978|P2|Overall Study|Ongoing: In Survival Follow-up|26
5813034|NCT02702388|20067979|P1|Overall Study|Ongoing: In Survival Follow-up|18
5813035|NCT02702388|20067978|P2|Overall Study|Ongoing: Receiving Treatment|35
5813036|NCT02702388|20067979|P1|Overall Study|Ongoing: Receiving Treatment|43
5813037|NCT02702388|20067978|P2|Overall Study|Withdrawal by Subject|4
5813038|NCT02702388|20067979|P1|Overall Study|Withdrawal by Subject|3
5813039|NCT02702388|20067978|P2|Overall Study|Death|12
5813040|NCT02702388|20067979|P1|Overall Study|Death|11
5813041|NCT02702193|20068001|P2|12 Month Follow up|Lost to Follow-up|18
5813042|NCT02702193|20068002|P1|12 Month Follow up|Lost to Follow-up|16
5813043|NCT02702193|20068001|P2|12 Month Follow up|Withdrawal by Subject|0
5813044|NCT02702193|20068002|P1|12 Month Follow up|Withdrawal by Subject|1
5813045|NCT02702193|20068001|P2|8 Month Follow up|Lost to Follow-up|18
5813046|NCT02702193|20068002|P1|8 Month Follow up|Lost to Follow-up|14
5813047|NCT02702193|20068001|P2|8 Month Follow up|Withdrawal by Subject|0
5813048|NCT02702193|20068002|P1|8 Month Follow up|Withdrawal by Subject|1
5813049|NCT02702193|20068001|P2|4 Month Follow up|Lost to Follow-up|18
5813050|NCT02702193|20068002|P1|4 Month Follow up|Lost to Follow-up|17
5813051|NCT02702193|20068001|P2|4 Month Follow up|Withdrawal by Subject|0
5813052|NCT02702193|20068002|P1|4 Month Follow up|Withdrawal by Subject|1
5813053|NCT02702193|20068001|P2|Baseline Assessment/Randomization|Withdrawal by Subject|0
5813054|NCT02702193|20068002|P1|Baseline Assessment/Randomization|Withdrawal by Subject|1
5813055|NCT02702011|20068030|P4|Overall Study|Withdrawal by Subject|0
5813056|NCT02702011|20068031|P3|Overall Study|Withdrawal by Subject|0
5813057|NCT02702011|20068032|P2|Overall Study|Withdrawal by Subject|1
5813058|NCT02702011|20068033|P1|Overall Study|Withdrawal by Subject|0
5813059|NCT02701985|20068045|P2|Overall Study|Adverse Event|5
5813060|NCT02701985|20068046|P1|Overall Study|Adverse Event|0
5813061|NCT02701985|20068045|P2|Overall Study|Death|0
5813062|NCT02701985|20068046|P1|Overall Study|Death|1
5813063|NCT02701985|20068045|P2|Overall Study|Lost to Follow-up|0
5813064|NCT02701985|20068046|P1|Overall Study|Lost to Follow-up|1
5813065|NCT02701985|20068045|P2|Overall Study|Withdrawal by Subject|1
5813066|NCT02701985|20068046|P1|Overall Study|Withdrawal by Subject|1
5813067|NCT02701777|20068105|P3|Overall Study|Some subjects were unable to commit to the training study.|4
5813068|NCT02701777|20068106|P2|Overall Study|Some subjects were unable to commit to the training study.|3
5813069|NCT02701777|20068107|P1|Overall Study|Some subjects were unable to commit to the training study.|0
5813070|NCT02701777|20068105|P3|Overall Study|Some subjects did not like the stimulation.|0
5813071|NCT02701777|20068106|P2|Overall Study|Some subjects did not like the stimulation.|0
5813072|NCT02701777|20068107|P1|Overall Study|Some subjects did not like the stimulation.|4
5813073|NCT02701764|20068123|P2|Overall Study|Lost to Follow-up|1
5813074|NCT02701764|20068124|P1|Overall Study|Lost to Follow-up|0
5813075|NCT02701634|20068183|P2|Overall Study|Randomized but not treated|0
5813076|NCT02701634|20068184|P1|Overall Study|Randomized but not treated|1
5813077|NCT02701634|20068183|P2|Overall Study|Withdrew Consent|7
5813078|NCT02701634|20068184|P1|Overall Study|Withdrew Consent|6
5813079|NCT02701634|20068183|P2|Overall Study|Study terminated by Sponsor|17
5813080|NCT02701634|20068184|P1|Overall Study|Study terminated by Sponsor|15
5813081|NCT02701634|20068183|P2|Overall Study|Investigator's Discretion|4
5813082|NCT02701634|20068184|P1|Overall Study|Investigator's Discretion|7
5813083|NCT02701634|20068183|P2|Overall Study|Death|0
5813084|NCT02701634|20068184|P1|Overall Study|Death|1
5813085|NCT02701634|20068183|P2|Overall Study|Adverse Event|3
5813086|NCT02701634|20068184|P1|Overall Study|Adverse Event|2
5813087|NCT02701361|20068254|P3|Overall Study|incarceration|1
5813088|NCT02701361|20068255|P2|Overall Study|incarceration|0
5813089|NCT02701361|20068256|P1|Overall Study|incarceration|0
5813090|NCT02701361|20068254|P3|Overall Study|timed out in rehab center|0
5813091|NCT02701361|20068255|P2|Overall Study|timed out in rehab center|1
5813092|NCT02701361|20068256|P1|Overall Study|timed out in rehab center|0
5813093|NCT02701361|20068254|P3|Overall Study|Withdrawal by Subject|0
5813094|NCT02701361|20068255|P2|Overall Study|Withdrawal by Subject|0
5813095|NCT02701361|20068256|P1|Overall Study|Withdrawal by Subject|4
5813096|NCT02701361|20068254|P3|Overall Study|Lost to Follow-up|1
5813097|NCT02701361|20068255|P2|Overall Study|Lost to Follow-up|2
5813098|NCT02701361|20068256|P1|Overall Study|Lost to Follow-up|5
5813099|NCT02701296|20068297|P2|Overall Study|Incomplete Data|2
5813100|NCT02701296|20068298|P1|Overall Study|Incomplete Data|0
5813101|NCT02700997|20068550|P1|Overall Study|No CT measurement - pelvic calcification|1
5813102|NCT02700997|20068550|P1|Overall Study|Did not undergo CT imaging|1
5813103|NCT02700984|20068556|P2|Overall Study|Reason not specified|2
5813104|NCT02700984|20068557|P1|Overall Study|Reason not specified|3
5813105|NCT02700984|20068556|P2|Overall Study|Withdrawal by Subject|9
5813106|NCT02700984|20068557|P1|Overall Study|Withdrawal by Subject|8
5813107|NCT02700984|20068556|P2|Overall Study|Physician Decision|1
5813108|NCT02700984|20068557|P1|Overall Study|Physician Decision|0
5813109|NCT02700984|20068556|P2|Overall Study|Lost to Follow-up|1
5813110|NCT02700984|20068557|P1|Overall Study|Lost to Follow-up|2
5813111|NCT02700984|20068556|P2|Overall Study|Death|1
5813112|NCT02700984|20068557|P1|Overall Study|Death|2
5813113|NCT02700919|20068609|P3|Overall Study|Other|1
5813114|NCT02700919|20068610|P2|Overall Study|Other|1
5813115|NCT02700919|20068611|P1|Overall Study|Other|2
5813116|NCT02700919|20068609|P3|Overall Study|Lost to Follow-up|0
5813117|NCT02700919|20068610|P2|Overall Study|Lost to Follow-up|0
5813118|NCT02700919|20068611|P1|Overall Study|Lost to Follow-up|2
5813119|NCT02700919|20068609|P3|Overall Study|Withdrawal by Subject|2
5813120|NCT02700919|20068610|P2|Overall Study|Withdrawal by Subject|8
5813121|NCT02700919|20068611|P1|Overall Study|Withdrawal by Subject|5
5813122|NCT02700919|20068609|P3|Overall Study|Adverse Event|1
5813123|NCT02700919|20068610|P2|Overall Study|Adverse Event|3
5813124|NCT02700919|20068611|P1|Overall Study|Adverse Event|1
5813125|NCT02700919|20068609|P3|Overall Study|Protocol Violation|0
5813126|NCT02700919|20068610|P2|Overall Study|Protocol Violation|0
5813127|NCT02700919|20068611|P1|Overall Study|Protocol Violation|1
5813128|NCT02700919|20068609|P3|Overall Study|Physician Decision|0
5813129|NCT02700919|20068610|P2|Overall Study|Physician Decision|0
5813130|NCT02700919|20068611|P1|Overall Study|Physician Decision|1
5813131|NCT02700815|20068673|P4|Overall Study|Withdrawal by Subject|0
5813132|NCT02700815|20068674|P3|Overall Study|Withdrawal by Subject|1
5813133|NCT02700815|20068675|P2|Overall Study|Withdrawal by Subject|0
5813134|NCT02700815|20068676|P1|Overall Study|Withdrawal by Subject|0
5813135|NCT02700815|20068673|P4|Overall Study|Refusal to continue medication|1
5813136|NCT02700815|20068674|P3|Overall Study|Refusal to continue medication|0
5813137|NCT02700815|20068675|P2|Overall Study|Refusal to continue medication|1
5813138|NCT02700815|20068676|P1|Overall Study|Refusal to continue medication|0
5813139|NCT02700815|20068673|P4|Overall Study|Lost to Follow-up|1
5813140|NCT02700815|20068674|P3|Overall Study|Lost to Follow-up|0
5813141|NCT02700815|20068675|P2|Overall Study|Lost to Follow-up|0
5813142|NCT02700815|20068676|P1|Overall Study|Lost to Follow-up|1
5813143|NCT02700815|20068673|P4|Overall Study|Lack of Efficacy|2
5813144|NCT02700815|20068674|P3|Overall Study|Lack of Efficacy|1
5813145|NCT02700815|20068675|P2|Overall Study|Lack of Efficacy|0
5813146|NCT02700815|20068676|P1|Overall Study|Lack of Efficacy|0
5813147|NCT02700815|20068673|P4|Overall Study|Adverse Event|3
5813148|NCT02700815|20068674|P3|Overall Study|Adverse Event|2
5813149|NCT02700815|20068675|P2|Overall Study|Adverse Event|6
5813150|NCT02700815|20068676|P1|Overall Study|Adverse Event|0
5813151|NCT02700412|20068714|P1|Overall Study|Withdrawal by Subject|2
5813152|NCT02700412|20068714|P1|Overall Study|Protocol Violation|5
5813153|NCT02700412|20068714|P1|Overall Study|Lack of Efficacy|19
5813154|NCT02700412|20068714|P1|Overall Study|Death|1
5813155|NCT02700412|20068714|P1|Overall Study|Adverse Event|6
5813156|NCT02699996|20068765|P2|Overall Study|Withdrawal by Subject|2
5813157|NCT02699996|20068766|P1|Overall Study|Withdrawal by Subject|5
5813158|NCT02699983|20068784|P2|Overall Study|Withdrawal by Subject|0
5813159|NCT02699983|20068785|P1|Overall Study|Withdrawal by Subject|1
5813160|NCT02699892|20068850|P1|Overall Study|Other|36
5813161|NCT02699866|20068855|P1|Overall Study|Adverse Event|3
5813162|NCT02699866|20068855|P1|Overall Study|Physician Decision|2
5813163|NCT02699866|20068855|P1|Overall Study|Withdrawal by Subject|3
5813164|NCT02699684|20068863|P2|Period 2, Second 30 Days of Wear|Adverse Event|0
5813165|NCT02699684|20068864|P1|Period 2, Second 30 Days of Wear|Adverse Event|1
5813166|NCT02699593|20068881|P2|Period 2|Torn Contact Lens|0
5813167|NCT02699593|20068882|P1|Period 2|Torn Contact Lens|1
5813168|NCT02699593|20068881|P2|Period 2|Lost Contact Lens|1
5813169|NCT02699593|20068882|P1|Period 2|Lost Contact Lens|0
5813170|NCT02699593|20068881|P2|Period 2|Adverse Event|1
5813171|NCT02699593|20068882|P1|Period 2|Adverse Event|1
5813172|NCT02699593|20068881|P2|Period 1|Adverse Event|1
5813173|NCT02699593|20068882|P1|Period 1|Adverse Event|1
5813174|NCT02699593|20068881|P2|Period 1|Withdrawal by Subject|1
5813175|NCT02699593|20068882|P1|Period 1|Withdrawal by Subject|0
5813176|NCT02699593|20068881|P2|Period 1|Protocol Violation|1
5813177|NCT02699593|20068882|P1|Period 1|Protocol Violation|0
5813178|NCT02699593|20068881|P2|Period 1|Torn Contact Len|3
5813179|NCT02699593|20068882|P1|Period 1|Torn Contact Len|4
5813180|NCT02699593|20068881|P2|Period 1|Unsatisfactory Visual Response|1
5813181|NCT02699593|20068882|P1|Period 1|Unsatisfactory Visual Response|0
5813182|NCT02699463|20068892|P2|Overall Study|Withdrawal by Subject|1
5813183|NCT02699463|20068893|P1|Overall Study|Withdrawal by Subject|4
5813184|NCT02699463|20068892|P2|Overall Study|Lost to Follow-up|8
5813185|NCT02699463|20068893|P1|Overall Study|Lost to Follow-up|11
5813186|NCT02699450|20068902|P3|Overall Study|Adverse Event|0
5813187|NCT02699450|20068903|P2|Overall Study|Adverse Event|0
5813188|NCT02699450|20068904|P1|Overall Study|Adverse Event|1
5813189|NCT02699450|20068902|P3|Overall Study|Withdrawal by Subject|2
5813190|NCT02699450|20068903|P2|Overall Study|Withdrawal by Subject|1
5813191|NCT02699450|20068904|P1|Overall Study|Withdrawal by Subject|3
5813192|NCT02699450|20068902|P3|Overall Study|Physician Decision|0
5813193|NCT02699450|20068903|P2|Overall Study|Physician Decision|0
5813194|NCT02699450|20068904|P1|Overall Study|Physician Decision|2
5813195|NCT02699450|20068902|P3|Overall Study|Lost to Follow-up|5
5813196|NCT02699450|20068903|P2|Overall Study|Lost to Follow-up|0
5813197|NCT02699450|20068904|P1|Overall Study|Lost to Follow-up|3
5813198|NCT02699450|20068902|P3|Overall Study|Protocol Violation|5
5813199|NCT02699450|20068903|P2|Overall Study|Protocol Violation|3
5813200|NCT02699450|20068904|P1|Overall Study|Protocol Violation|4
5813201|NCT02699450|20068902|P3|Overall Study|Met Criteria for Study Exit|1
5813202|NCT02699450|20068903|P2|Overall Study|Met Criteria for Study Exit|0
5813203|NCT02699450|20068904|P1|Overall Study|Met Criteria for Study Exit|0
5813204|NCT02699450|20068902|P3|Overall Study|Death|2
5813205|NCT02699450|20068903|P2|Overall Study|Death|1
5813206|NCT02699450|20068904|P1|Overall Study|Death|2
5813207|NCT02699125|20069039|P2|Second Intervention (6 Weeks).|Withdrawal by Subject|2
5813208|NCT02699125|20069040|P1|Second Intervention (6 Weeks).|Withdrawal by Subject|7
5813209|NCT02699125|20069039|P2|Placebo|Withdrawal by Subject|4
5813210|NCT02699125|20069040|P1|Placebo|Withdrawal by Subject|0
5813211|NCT02699125|20069039|P2|Placebo|Protocol Violation|0
5813212|NCT02699125|20069040|P1|Placebo|Protocol Violation|1
5813213|NCT02699125|20069039|P2|Placebo|Lost to Follow-up|0
5813214|NCT02699125|20069040|P1|Placebo|Lost to Follow-up|2
5813215|NCT02699099|20069054|P3|Overall Study|Withdrawal by Subject|2
5813216|NCT02699099|20069055|P2|Overall Study|Withdrawal by Subject|1
5813217|NCT02699099|20069056|P1|Overall Study|Withdrawal by Subject|6
5813218|NCT02699099|20069054|P3|Overall Study|Lost to Follow-up|0
5813219|NCT02699099|20069055|P2|Overall Study|Lost to Follow-up|1
5813220|NCT02699099|20069056|P1|Overall Study|Lost to Follow-up|0
5813221|NCT02699099|20069054|P3|Overall Study|Adverse Event|1
5813222|NCT02699099|20069055|P2|Overall Study|Adverse Event|0
5813223|NCT02699099|20069056|P1|Overall Study|Adverse Event|1
5813224|NCT02698865|20069132|P2|Overall Study|Lost to Follow-up|2
5813225|NCT02698865|20069133|P1|Overall Study|Lost to Follow-up|4
5813226|NCT02698865|20069132|P2|Overall Study|Physician Decision|4
5813227|NCT02698865|20069133|P1|Overall Study|Physician Decision|0
5813228|NCT02698865|20069132|P2|Overall Study|Withdrawal by Subject|16
5813229|NCT02698865|20069133|P1|Overall Study|Withdrawal by Subject|20
5813230|NCT02698865|20069132|P2|Overall Study|Other|11
5813231|NCT02698865|20069133|P1|Overall Study|Other|11
5813232|NCT02698475|20069171|P1|Overall Study|Protocol Violation|1
5813233|NCT02698475|20069171|P1|Overall Study|Withdrawal by Subject|3
5813234|NCT02698475|20069171|P1|Overall Study|Lack of Efficacy|1
5813235|NCT02698436|20069188|P2|Overall Study|Non-compliance with study regimen|0
5813236|NCT02698436|20069189|P1|Overall Study|Non-compliance with study regimen|1
5813237|NCT02698436|20069188|P2|Overall Study|Lost to Follow-up|4
5813238|NCT02698436|20069189|P1|Overall Study|Lost to Follow-up|2
5813239|NCT02698436|20069188|P2|Overall Study|Withdrawal by Subject|3
5813240|NCT02698436|20069189|P1|Overall Study|Withdrawal by Subject|3
5813241|NCT02698436|20069188|P2|Overall Study|Adverse Event|0
5813242|NCT02698436|20069189|P1|Overall Study|Adverse Event|1
5813243|NCT02698423|20069229|P2|Overall Study|Lost to Follow-up|24
5813244|NCT02698423|20069230|P1|Overall Study|Lost to Follow-up|19
5813245|NCT02698410|20069238|P1|Overall Study|Other|1
5813246|NCT02698410|20069238|P1|Overall Study|Withdrawal by Subject|1
5813247|NCT02698410|20069238|P1|Overall Study|Adverse Event|2
5813248|NCT02698371|20069257|P1|ADU-SE (G6) Arm/Group Flow|Lost to Follow-up|2
5813249|NCT02698371|20069257|P1|ADU-ER (G5) Arm/Group Flow|Lost to Follow-up|3
5813250|NCT02698371|20069257|P1|FBU-SE (G4) Arm/Group Flow|Lost to Follow-up|3
5813251|NCT02698371|20069257|P1|FBU-ER (G3) Arm/Group Flow|Lost to Follow-up|3
5813252|NCT02698371|20069257|P1|FBDC-SE-EE (G2; Control ) Arm/Group Flow|Lost to Follow-up|3
5813253|NCT02698371|20069257|P1|FBDC-SE (G1; Control) Arm/Group Flow|Lost to Follow-up|3
5813254|NCT02698371|20069257|P1|All Participants Flow|Lost to Follow-up|3
5813255|NCT02698241|20069379|P1|Overall Study|Death|2
5813256|NCT02698241|20069379|P1|Overall Study|geographic and licensing issue|1
5813257|NCT02698241|20069379|P1|Overall Study|Subject on inodrip not safe to continue|6
5813258|NCT02698241|20069379|P1|Overall Study|Lost to Follow-up|3
5813259|NCT02698241|20069379|P1|Overall Study|Subject underwent system modification|2
5813260|NCT02698241|20069379|P1|Overall Study|Physician Decision|2
5813261|NCT02698241|20069379|P1|Overall Study|Withdrawal by Subject|7
5813262|NCT02698241|20069379|P1|Overall Study|Screening not met|7
5813263|NCT02698241|20069379|P1|Overall Study|Inclusion/exclusion criteria not met|4
5813264|NCT02698189|20069386|P2|Overall Study|Still ongoing in the study|1
5813265|NCT02698189|20069387|P1|Overall Study|Still ongoing in the study|0
5813266|NCT02698189|20069386|P2|Overall Study|Progressive disease|5
5813267|NCT02698189|20069387|P1|Overall Study|Progressive disease|3
5813268|NCT02698176|20069417|P4|Overall Study|Clinical progression|0
5813269|NCT02698176|20069418|P3|Overall Study|Clinical progression|0
5813270|NCT02698176|20069419|P2|Overall Study|Clinical progression|0
5813271|NCT02698176|20069420|P1|Overall Study|Clinical progression|3
5813272|NCT02698176|20069417|P4|Overall Study|Adverse Event|0
5813273|NCT02698176|20069418|P3|Overall Study|Adverse Event|0
5813274|NCT02698176|20069419|P2|Overall Study|Adverse Event|0
5813275|NCT02698176|20069420|P1|Overall Study|Adverse Event|2
5813276|NCT02698176|20069417|P4|Overall Study|Progressive disease|0
5813277|NCT02698176|20069418|P3|Overall Study|Progressive disease|1
5813278|NCT02698176|20069419|P2|Overall Study|Progressive disease|3
5813279|NCT02698176|20069420|P1|Overall Study|Progressive disease|4
5813280|NCT02697773|20069477|P3|Overall Study|Randomized but not treated|0
5813281|NCT02697773|20069478|P2|Overall Study|Randomized but not treated|1
5813282|NCT02697773|20069479|P1|Overall Study|Randomized but not treated|1
5813283|NCT02697773|20069477|P3|Overall Study|Withdrawal by Subject|13
5813284|NCT02697773|20069478|P2|Overall Study|Withdrawal by Subject|13
5813285|NCT02697773|20069479|P1|Overall Study|Withdrawal by Subject|10
5813286|NCT02697773|20069477|P3|Overall Study|Protocol Violation|0
5813287|NCT02697773|20069478|P2|Overall Study|Protocol Violation|1
5813288|NCT02697773|20069479|P1|Overall Study|Protocol Violation|1
5813289|NCT02697773|20069477|P3|Overall Study|Other|10
5813290|NCT02697773|20069478|P2|Overall Study|Other|11
5813291|NCT02697773|20069479|P1|Overall Study|Other|15
5813292|NCT02697773|20069477|P3|Overall Study|Lost to Follow-up|7
5813293|NCT02697773|20069478|P2|Overall Study|Lost to Follow-up|5
5813294|NCT02697773|20069479|P1|Overall Study|Lost to Follow-up|5
5813295|NCT02697773|20069477|P3|Overall Study|Lack of Efficacy|6
5813296|NCT02697773|20069478|P2|Overall Study|Lack of Efficacy|6
5813297|NCT02697773|20069479|P1|Overall Study|Lack of Efficacy|4
5813298|NCT02697773|20069477|P3|Overall Study|Death|2
5813299|NCT02697773|20069478|P2|Overall Study|Death|0
5813300|NCT02697773|20069479|P1|Overall Study|Death|0
5813301|NCT02697773|20069477|P3|Overall Study|Adverse Event|2
5813302|NCT02697773|20069478|P2|Overall Study|Adverse Event|1
5813303|NCT02697773|20069479|P1|Overall Study|Adverse Event|2
5813304|NCT02697617|20069658|P2|Overall Study|Pregnancy|0
5813305|NCT02697617|20069659|P1|Overall Study|Pregnancy|1
5813306|NCT02697617|20069658|P2|Overall Study|Withdrawal by Subject|2
5813307|NCT02697617|20069659|P1|Overall Study|Withdrawal by Subject|0
5813308|NCT02697435|20069679|P2|Overall Study|Physician Decision|4
5813309|NCT02697435|20069680|P1|Overall Study|Physician Decision|0
5813310|NCT02697435|20069679|P2|Overall Study|Withdrawal by Subject|0
5813311|NCT02697435|20069680|P1|Overall Study|Withdrawal by Subject|1
5813336|NCT02696850|20069823|P2|Overall Study|Lost to Follow-up|5
5813337|NCT02696850|20069824|P1|Overall Study|Lost to Follow-up|8
5813338|NCT02696850|20069823|P2|Overall Study|Withdrawal by Subject|3
5813339|NCT02696850|20069824|P1|Overall Study|Withdrawal by Subject|3
5813340|NCT02696798|20069837|P3|Post-treatment Follow-up Period|No progressive improvement|0
5813341|NCT02696798|20069838|P2|Post-treatment Follow-up Period|No progressive improvement|1
5813342|NCT02696798|20069839|P1|Post-treatment Follow-up Period|No progressive improvement|0
5813343|NCT02696798|20069837|P3|Post-treatment Follow-up Period|Physician Decision|0
5813344|NCT02696798|20069838|P2|Post-treatment Follow-up Period|Physician Decision|2
5813345|NCT02696798|20069839|P1|Post-treatment Follow-up Period|Physician Decision|0
5813346|NCT02696798|20069837|P3|Post-treatment Follow-up Period|Withdrawal by Subject|12
5813347|NCT02696798|20069838|P2|Post-treatment Follow-up Period|Withdrawal by Subject|8
5813348|NCT02696798|20069839|P1|Post-treatment Follow-up Period|Withdrawal by Subject|2
5813349|NCT02696798|20069837|P3|Post-treatment Follow-up Period|Lack of Efficacy|0
5813350|NCT02696798|20069838|P2|Post-treatment Follow-up Period|Lack of Efficacy|2
5813351|NCT02696798|20069839|P1|Post-treatment Follow-up Period|Lack of Efficacy|1
5813352|NCT02696798|20069837|P3|Post-treatment Follow-up Period|Lost to Follow-up|1
5813353|NCT02696798|20069838|P2|Post-treatment Follow-up Period|Lost to Follow-up|1
5813354|NCT02696798|20069839|P1|Post-treatment Follow-up Period|Lost to Follow-up|0
5813355|NCT02696798|20069837|P3|Post-treatment Follow-up Period|Adverse Event|6
5813356|NCT02696798|20069838|P2|Post-treatment Follow-up Period|Adverse Event|12
5813357|NCT02696798|20069839|P1|Post-treatment Follow-up Period|Adverse Event|2
5813358|NCT02696798|20069837|P3|Extended Treatment Period|Withdrawal by Subject|3
5813359|NCT02696798|20069838|P2|Extended Treatment Period|Withdrawal by Subject|2
5813360|NCT02696798|20069839|P1|Extended Treatment Period|Withdrawal by Subject|3
5813361|NCT02696798|20069837|P3|Extended Treatment Period|Physician Decision|0
5813362|NCT02696798|20069838|P2|Extended Treatment Period|Physician Decision|1
5813363|NCT02696798|20069839|P1|Extended Treatment Period|Physician Decision|0
5813364|NCT02696798|20069837|P3|Extended Treatment Period|Lost to Follow-up|0
5813365|NCT02696798|20069838|P2|Extended Treatment Period|Lost to Follow-up|0
5813366|NCT02696798|20069839|P1|Extended Treatment Period|Lost to Follow-up|1
5813367|NCT02696798|20069837|P3|Extended Treatment Period|Lack of Efficacy|2
5813368|NCT02696798|20069838|P2|Extended Treatment Period|Lack of Efficacy|2
5813369|NCT02696798|20069839|P1|Extended Treatment Period|Lack of Efficacy|7
5813370|NCT02696798|20069837|P3|Extended Treatment Period|Adverse Event|5
5813371|NCT02696798|20069838|P2|Extended Treatment Period|Adverse Event|4
5813372|NCT02696798|20069839|P1|Extended Treatment Period|Adverse Event|1
5813373|NCT02696798|20069837|P3|Blinded Treatment Dosing Period|Withdrawal by Subject|4
5813374|NCT02696798|20069838|P2|Blinded Treatment Dosing Period|Withdrawal by Subject|3
5813375|NCT02696798|20069839|P1|Blinded Treatment Dosing Period|Withdrawal by Subject|7
5813376|NCT02696798|20069837|P3|Blinded Treatment Dosing Period|Physician Decision|0
5813377|NCT02696798|20069838|P2|Blinded Treatment Dosing Period|Physician Decision|1
5813378|NCT02696798|20069839|P1|Blinded Treatment Dosing Period|Physician Decision|0
5813379|NCT02696798|20069837|P3|Blinded Treatment Dosing Period|Lost to Follow-up|0
5813380|NCT02696798|20069838|P2|Blinded Treatment Dosing Period|Lost to Follow-up|1
5813381|NCT02696798|20069839|P1|Blinded Treatment Dosing Period|Lost to Follow-up|0
5813382|NCT02696798|20069837|P3|Blinded Treatment Dosing Period|Lack of Efficacy|1
5813383|NCT02696798|20069838|P2|Blinded Treatment Dosing Period|Lack of Efficacy|1
5813384|NCT02696798|20069839|P1|Blinded Treatment Dosing Period|Lack of Efficacy|2
5813385|NCT02696798|20069837|P3|Blinded Treatment Dosing Period|Death|1
5813386|NCT02696798|20069838|P2|Blinded Treatment Dosing Period|Death|0
5813387|NCT02696798|20069839|P1|Blinded Treatment Dosing Period|Death|0
5813388|NCT02696798|20069837|P3|Blinded Treatment Dosing Period|Adverse Event|2
5813389|NCT02696798|20069838|P2|Blinded Treatment Dosing Period|Adverse Event|9
5813390|NCT02696798|20069839|P1|Blinded Treatment Dosing Period|Adverse Event|2
5813391|NCT02696785|20069936|P4|Follow-up Period|Withdrawal by Subject|4
5813392|NCT02696785|20069937|P3|Follow-up Period|Withdrawal by Subject|5
5813393|NCT02696785|20069938|P2|Follow-up Period|Withdrawal by Subject|0
5813394|NCT02696785|20069939|P1|Follow-up Period|Withdrawal by Subject|1
5813395|NCT02696785|20069936|P4|Follow-up Period|Lack of Efficacy|1
5813396|NCT02696785|20069937|P3|Follow-up Period|Lack of Efficacy|0
5813397|NCT02696785|20069938|P2|Follow-up Period|Lack of Efficacy|0
5813398|NCT02696785|20069939|P1|Follow-up Period|Lack of Efficacy|0
5813399|NCT02696785|20069936|P4|Follow-up Period|Lost to Follow-up|1
5813400|NCT02696785|20069937|P3|Follow-up Period|Lost to Follow-up|0
5813401|NCT02696785|20069938|P2|Follow-up Period|Lost to Follow-up|0
5813402|NCT02696785|20069939|P1|Follow-up Period|Lost to Follow-up|0
5813403|NCT02696785|20069936|P4|Follow-up Period|Adverse Event|2
5813404|NCT02696785|20069937|P3|Follow-up Period|Adverse Event|8
5813405|NCT02696785|20069938|P2|Follow-up Period|Adverse Event|0
5813406|NCT02696785|20069939|P1|Follow-up Period|Adverse Event|0
5813407|NCT02696785|20069936|P4|Extended Treatment Period|Withdrawal by Subject|5
5813408|NCT02696785|20069937|P3|Extended Treatment Period|Withdrawal by Subject|3
5813409|NCT02696785|20069938|P2|Extended Treatment Period|Withdrawal by Subject|2
5813410|NCT02696785|20069939|P1|Extended Treatment Period|Withdrawal by Subject|1
5813411|NCT02696785|20069936|P4|Extended Treatment Period|Lack of Efficacy|0
5813412|NCT02696785|20069937|P3|Extended Treatment Period|Lack of Efficacy|0
5813413|NCT02696785|20069938|P2|Extended Treatment Period|Lack of Efficacy|1
5813414|NCT02696785|20069939|P1|Extended Treatment Period|Lack of Efficacy|0
5813415|NCT02696785|20069936|P4|Extended Treatment Period|Adverse Event|1
5813416|NCT02696785|20069937|P3|Extended Treatment Period|Adverse Event|2
5813417|NCT02696785|20069938|P2|Extended Treatment Period|Adverse Event|3
5813418|NCT02696785|20069939|P1|Extended Treatment Period|Adverse Event|2
5813419|NCT02696785|20069936|P4|Washout Period|Lack of Efficacy|0
5813420|NCT02696785|20069937|P3|Washout Period|Lack of Efficacy|0
5813421|NCT02696785|20069938|P2|Washout Period|Lack of Efficacy|1
5813422|NCT02696785|20069939|P1|Washout Period|Lack of Efficacy|0
5813423|NCT02696785|20069936|P4|Washout Period|Withdrawal by Subject|0
5813424|NCT02696785|20069937|P3|Washout Period|Withdrawal by Subject|0
5813425|NCT02696785|20069938|P2|Washout Period|Withdrawal by Subject|1
5813426|NCT02696785|20069939|P1|Washout Period|Withdrawal by Subject|0
5813427|NCT02696785|20069936|P4|Blinded Treatment Period|Screen Failure|0
5813428|NCT02696785|20069937|P3|Blinded Treatment Period|Screen Failure|0
5813429|NCT02696785|20069938|P2|Blinded Treatment Period|Screen Failure|0
5813430|NCT02696785|20069939|P1|Blinded Treatment Period|Screen Failure|1
5813431|NCT02696785|20069936|P4|Blinded Treatment Period|Lack of Efficacy|1
5813432|NCT02696785|20069937|P3|Blinded Treatment Period|Lack of Efficacy|0
5813433|NCT02696785|20069938|P2|Blinded Treatment Period|Lack of Efficacy|0
5813434|NCT02696785|20069939|P1|Blinded Treatment Period|Lack of Efficacy|0
5813435|NCT02696785|20069936|P4|Blinded Treatment Period|Withdrawal by Subject|2
5813436|NCT02696785|20069937|P3|Blinded Treatment Period|Withdrawal by Subject|1
5813437|NCT02696785|20069938|P2|Blinded Treatment Period|Withdrawal by Subject|1
5813438|NCT02696785|20069939|P1|Blinded Treatment Period|Withdrawal by Subject|0
5813439|NCT02696785|20069936|P4|Blinded Treatment Period|Adverse Event|0
5813440|NCT02696785|20069937|P3|Blinded Treatment Period|Adverse Event|3
5813441|NCT02696785|20069938|P2|Blinded Treatment Period|Adverse Event|1
5813442|NCT02696785|20069939|P1|Blinded Treatment Period|Adverse Event|0
5813443|NCT02696434|20070059|P2|Overall Study|Physician Decision|1
5813444|NCT02696434|20070060|P1|Overall Study|Physician Decision|0
5813445|NCT02696434|20070059|P2|Overall Study|Withdrawal by Subject|12
5813446|NCT02696434|20070060|P1|Overall Study|Withdrawal by Subject|14
5813447|NCT02696434|20070059|P2|Overall Study|Lost to Follow-up|4
5813448|NCT02696434|20070060|P1|Overall Study|Lost to Follow-up|5
5813449|NCT02696434|20070059|P2|Overall Study|Adverse Event|1
5813450|NCT02696434|20070060|P1|Overall Study|Adverse Event|3
5813451|NCT02696317|20070078|P2|Period 2, 10 Days of Wear|Withdrawal by Subject|0
5813452|NCT02696317|20070079|P1|Period 2, 10 Days of Wear|Withdrawal by Subject|1
5813453|NCT02696317|20070078|P2|Habitual, 10 Days of Wear|Withdrawal by Subject|4
5813454|NCT02696317|20070079|P1|Habitual, 10 Days of Wear|Withdrawal by Subject|2
5813455|NCT02696226|20070123|P4|Overall Study|Study terminated - lack of enrollment|0
5813456|NCT02696226|20070124|P3|Overall Study|Study terminated - lack of enrollment|2
5813457|NCT02696226|20070125|P2|Overall Study|Study terminated - lack of enrollment|0
5813458|NCT02696226|20070126|P1|Overall Study|Study terminated - lack of enrollment|1
5813459|NCT02696031|20070170|P3|Week 52|Withdrawal by Subject|9
5813460|NCT02696031|20070171|P2|Week 52|Withdrawal by Subject|3
5813461|NCT02696031|20070172|P1|Week 52|Withdrawal by Subject|12
5813462|NCT02696031|20070170|P3|Week 52|Protocol Violation|0
5813463|NCT02696031|20070171|P2|Week 52|Protocol Violation|0
5813464|NCT02696031|20070172|P1|Week 52|Protocol Violation|1
5813465|NCT02696031|20070170|P3|Week 52|Pregnancy|0
5813466|NCT02696031|20070171|P2|Week 52|Pregnancy|2
5813467|NCT02696031|20070172|P1|Week 52|Pregnancy|0
5813468|NCT02696031|20070170|P3|Week 52|Physician Decision|2
5813469|NCT02696031|20070171|P2|Week 52|Physician Decision|1
5813470|NCT02696031|20070172|P1|Week 52|Physician Decision|1
5813471|NCT02696031|20070170|P3|Week 52|Lost to Follow-up|1
5813472|NCT02696031|20070171|P2|Week 52|Lost to Follow-up|1
5813473|NCT02696031|20070172|P1|Week 52|Lost to Follow-up|1
5813474|NCT02696031|20070170|P3|Week 52|Lack of Efficacy|11
5813475|NCT02696031|20070171|P2|Week 52|Lack of Efficacy|7
5813476|NCT02696031|20070172|P1|Week 52|Lack of Efficacy|10
5813477|NCT02696031|20070170|P3|Week 52|Adverse Event|3
5813478|NCT02696031|20070171|P2|Week 52|Adverse Event|5
5813479|NCT02696031|20070172|P1|Week 52|Adverse Event|4
5813480|NCT02696031|20070170|P3|Week 24|Withdrawal by Subject|5
5813481|NCT02696031|20070171|P2|Week 24|Withdrawal by Subject|1
5813482|NCT02696031|20070172|P1|Week 24|Withdrawal by Subject|4
5813483|NCT02696031|20070170|P3|Week 24|Protocol Violation|0
5813484|NCT02696031|20070171|P2|Week 24|Protocol Violation|0
5813485|NCT02696031|20070172|P1|Week 24|Protocol Violation|1
5813486|NCT02696031|20070170|P3|Week 24|Physician Decision|1
5813487|NCT02696031|20070171|P2|Week 24|Physician Decision|0
5813488|NCT02696031|20070172|P1|Week 24|Physician Decision|1
5813489|NCT02696031|20070170|P3|Week 24|Lost to Follow-up|1
5813490|NCT02696031|20070171|P2|Week 24|Lost to Follow-up|1
5813491|NCT02696031|20070172|P1|Week 24|Lost to Follow-up|0
5813492|NCT02696031|20070170|P3|Week 24|Lack of Efficacy|2
5813493|NCT02696031|20070171|P2|Week 24|Lack of Efficacy|1
5813494|NCT02696031|20070172|P1|Week 24|Lack of Efficacy|2
5813495|NCT02696031|20070170|P3|Week 24|Adverse Event|2
5813496|NCT02696031|20070171|P2|Week 24|Adverse Event|4
5813497|NCT02696031|20070172|P1|Week 24|Adverse Event|2
5813498|NCT02695719|20070186|P2|Overall Study|Voluntary Withdrawal|0
5813499|NCT02695719|20070187|P1|Overall Study|Voluntary Withdrawal|1
5813500|NCT02695719|20070186|P2|Overall Study|Significant Protocol Deviation|1
5813501|NCT02695719|20070187|P1|Overall Study|Significant Protocol Deviation|0
5813502|NCT02695719|20070186|P2|Overall Study|Pretreatment Event/Adverse Event|9
5813503|NCT02695719|20070187|P1|Overall Study|Pretreatment Event/Adverse Event|2
5813504|NCT02695628|20070205|P1|Overall Study|Withdrawal by Subject|1
5813505|NCT02695537|20070211|P1|Overall Study|Protocol Violation|3
5813506|NCT02695537|20070211|P1|Overall Study|Withdrawal by Subject|4
5813507|NCT02695537|20070211|P1|Overall Study|Lack of Efficacy|28
5813508|NCT02695537|20070211|P1|Overall Study|Adverse Event|3
5813509|NCT02695524|20070221|P2|Overall Study|Death|1
5813510|NCT02695524|20070222|P1|Overall Study|Death|0
5813511|NCT02695524|20070221|P2|Overall Study|Lost to Follow-up|2
5813512|NCT02695524|20070222|P1|Overall Study|Lost to Follow-up|3
5813513|NCT02695420|20070251|P4|Overall Study|Death|0
5813514|NCT02695420|20070252|P3|Overall Study|Death|0
5813515|NCT02695420|20070253|P2|Overall Study|Death|1
5813516|NCT02695420|20070254|P1|Overall Study|Death|0
5813517|NCT02695329|20070276|P2|Overall Study|Poor X-ray quality for measurement|5
5813518|NCT02695329|20070277|P1|Overall Study|Poor X-ray quality for measurement|4
5813519|NCT02695329|20070276|P2|Overall Study|Adverse Event|0
5813520|NCT02695329|20070277|P1|Overall Study|Adverse Event|1
5813521|NCT02694978|20070297|P2|Overall Study|Other-Withdrew prior to dosing|8
5813522|NCT02694978|20070298|P1|Overall Study|Other-Withdrew prior to dosing|9
5813523|NCT02694978|20070297|P2|Overall Study|Other-Personal reasons|3
5813524|NCT02694978|20070298|P1|Overall Study|Other-Personal reasons|3
5813525|NCT02694978|20070297|P2|Overall Study|Other-Protocol noncompliant|1
5813526|NCT02694978|20070298|P1|Overall Study|Other-Protocol noncompliant|2
5813527|NCT02694978|20070297|P2|Overall Study|Other-Unable to be reached|1
5813528|NCT02694978|20070298|P1|Overall Study|Other-Unable to be reached|0
5813529|NCT02694978|20070297|P2|Overall Study|Other-Investigator's decision|0
5813530|NCT02694978|20070298|P1|Overall Study|Other-Investigator's decision|1
5813531|NCT02694978|20070297|P2|Overall Study|Other-Decision of Participant|1
5813532|NCT02694978|20070298|P1|Overall Study|Other-Decision of Participant|6
5813533|NCT02694978|20070297|P2|Overall Study|Death|1
5813534|NCT02694978|20070298|P1|Overall Study|Death|4
5813535|NCT02694978|20070297|P2|Overall Study|Lost to Follow-up|17
5813536|NCT02694978|20070298|P1|Overall Study|Lost to Follow-up|14
5813537|NCT02694978|20070297|P2|Overall Study|Withdrawal by Subject|19
5813538|NCT02694978|20070298|P1|Overall Study|Withdrawal by Subject|22
5813539|NCT02694978|20070297|P2|Overall Study|Adverse Event|9
5813540|NCT02694978|20070298|P1|Overall Study|Adverse Event|10
5813541|NCT02694757|20070319|P1|Overall Study|Lack of Efficacy|3
5813542|NCT02694744|20070325|P2|Overall Study|Taking potassium supplement: exclusion 6|1
5813543|NCT02694744|20070326|P1|Overall Study|Taking potassium supplement: exclusion 6|0
5813544|NCT02694744|20070325|P2|Overall Study|Lost to Follow-up|0
5813545|NCT02694744|20070326|P1|Overall Study|Lost to Follow-up|1
5813546|NCT02694744|20070325|P2|Overall Study|Physician Decision|2
5813547|NCT02694744|20070326|P1|Overall Study|Physician Decision|1
5813548|NCT02694744|20070325|P2|Overall Study|Withdrawal by Subject|1
5813549|NCT02694744|20070326|P1|Overall Study|Withdrawal by Subject|2
5813550|NCT02694744|20070325|P2|Overall Study|Adverse Event|1
5813551|NCT02694744|20070326|P1|Overall Study|Adverse Event|2
5813552|NCT02694718|20070334|P1|Overall Study|Withdrawal by Subject|1
5813553|NCT02694718|20070334|P1|Overall Study|Death|1
5813554|NCT02694562|20070352|P1|Overall Study|Physician Decision|1
5813555|NCT02694562|20070352|P1|Overall Study|Screen Failure|2
5813556|NCT02694562|20070352|P1|Overall Study|Lost to Follow-up|3
5813557|NCT02694562|20070352|P1|Overall Study|Protocol Violation|4
5813558|NCT02694562|20070352|P1|Overall Study|Death|8
5813559|NCT02694549|20070361|P1|Overall Study|screen failures|2
5813560|NCT02694536|20070367|P1|Overall Study|Other|22
5813561|NCT02694536|20070367|P1|Overall Study|Death|8
5813562|NCT02694536|20070367|P1|Overall Study|Withdrawal by Subject|8
5813563|NCT02694536|20070367|P1|Overall Study|Study Drug-Related Adverse Event|1
5813564|NCT02694536|20070367|P1|Overall Study|Lost to Follow-up|1
5813565|NCT02694536|20070367|P1|Overall Study|Progressive Disease|40
5813566|NCT02694523|20070378|P7|Part B|Other|1
5813567|NCT02694523|20070379|P6|Part B|Other|0
5813568|NCT02694523|20070380|P5|Part B|Other|0
5813569|NCT02694523|20070381|P4|Part B|Other|0
5813570|NCT02694523|20070382|P3|Part B|Other|1
5813571|NCT02694523|20070383|P2|Part B|Other|0
5813572|NCT02694523|20070384|P1|Part B|Other|0
5813573|NCT02694523|20070378|P7|Part B|Withdrawal by Subject|0
5813574|NCT02694523|20070379|P6|Part B|Withdrawal by Subject|3
5813575|NCT02694523|20070380|P5|Part B|Withdrawal by Subject|1
5813576|NCT02694523|20070381|P4|Part B|Withdrawal by Subject|0
5813577|NCT02694523|20070382|P3|Part B|Withdrawal by Subject|9
5813578|NCT02694523|20070383|P2|Part B|Withdrawal by Subject|0
5813579|NCT02694523|20070384|P1|Part B|Withdrawal by Subject|0
5813580|NCT02694523|20070378|P7|Part B|Lost to Follow-up|1
5813581|NCT02694523|20070379|P6|Part B|Lost to Follow-up|0
5813582|NCT02694523|20070380|P5|Part B|Lost to Follow-up|2
5813583|NCT02694523|20070381|P4|Part B|Lost to Follow-up|3
5813584|NCT02694523|20070382|P3|Part B|Lost to Follow-up|2
5813585|NCT02694523|20070383|P2|Part B|Lost to Follow-up|0
5813586|NCT02694523|20070384|P1|Part B|Lost to Follow-up|0
5813587|NCT02694523|20070378|P7|Part B|Protocol Violation|0
5813588|NCT02694523|20070379|P6|Part B|Protocol Violation|0
5813589|NCT02694523|20070380|P5|Part B|Protocol Violation|0
5813590|NCT02694523|20070381|P4|Part B|Protocol Violation|0
5813591|NCT02694523|20070382|P3|Part B|Protocol Violation|1
5813592|NCT02694523|20070383|P2|Part B|Protocol Violation|0
5813593|NCT02694523|20070384|P1|Part B|Protocol Violation|0
5813594|NCT02694523|20070378|P7|Part B|Adverse Event|0
5813595|NCT02694523|20070379|P6|Part B|Adverse Event|2
5813596|NCT02694523|20070380|P5|Part B|Adverse Event|1
5813597|NCT02694523|20070381|P4|Part B|Adverse Event|1
5813598|NCT02694523|20070382|P3|Part B|Adverse Event|7
5813599|NCT02694523|20070383|P2|Part B|Adverse Event|0
5813600|NCT02694523|20070384|P1|Part B|Adverse Event|0
5813601|NCT02694523|20070378|P7|Part A|Other|0
5813602|NCT02694523|20070379|P6|Part A|Other|0
5813603|NCT02694523|20070380|P5|Part A|Other|0
5813604|NCT02694523|20070381|P4|Part A|Other|0
5813605|NCT02694523|20070382|P3|Part A|Other|0
5813606|NCT02694523|20070383|P2|Part A|Other|1
5813607|NCT02694523|20070384|P1|Part A|Other|1
5813608|NCT02694523|20070378|P7|Part A|Withdrawal by Subject|0
5813609|NCT02694523|20070379|P6|Part A|Withdrawal by Subject|0
5813610|NCT02694523|20070380|P5|Part A|Withdrawal by Subject|0
5813611|NCT02694523|20070381|P4|Part A|Withdrawal by Subject|0
5813612|NCT02694523|20070382|P3|Part A|Withdrawal by Subject|0
5813613|NCT02694523|20070383|P2|Part A|Withdrawal by Subject|1
5813614|NCT02694523|20070384|P1|Part A|Withdrawal by Subject|3
5813615|NCT02694523|20070378|P7|Part A|Lost to Follow-up|0
5813616|NCT02694523|20070379|P6|Part A|Lost to Follow-up|0
5813617|NCT02694523|20070380|P5|Part A|Lost to Follow-up|0
5813618|NCT02694523|20070381|P4|Part A|Lost to Follow-up|0
5813619|NCT02694523|20070382|P3|Part A|Lost to Follow-up|0
5813620|NCT02694523|20070383|P2|Part A|Lost to Follow-up|2
5813621|NCT02694523|20070384|P1|Part A|Lost to Follow-up|1
5813622|NCT02694523|20070378|P7|Part A|Protocol Violation|0
5813623|NCT02694523|20070379|P6|Part A|Protocol Violation|0
5813624|NCT02694523|20070380|P5|Part A|Protocol Violation|0
5813625|NCT02694523|20070381|P4|Part A|Protocol Violation|0
5813626|NCT02694523|20070382|P3|Part A|Protocol Violation|0
5813627|NCT02694523|20070383|P2|Part A|Protocol Violation|0
5813628|NCT02694523|20070384|P1|Part A|Protocol Violation|1
5813629|NCT02694523|20070378|P7|Part A|Adverse Event|0
5813630|NCT02694523|20070379|P6|Part A|Adverse Event|0
5813631|NCT02694523|20070380|P5|Part A|Adverse Event|0
5813632|NCT02694523|20070381|P4|Part A|Adverse Event|0
5813633|NCT02694523|20070382|P3|Part A|Adverse Event|0
5813634|NCT02694523|20070383|P2|Part A|Adverse Event|3
5813635|NCT02694523|20070384|P1|Part A|Adverse Event|7
5813636|NCT02694328|20070414|P2|Overall Study|Abnormal Laboratory Value|3
5813637|NCT02694328|20070415|P1|Overall Study|Abnormal Laboratory Value|0
5813638|NCT02694328|20070414|P2|Overall Study|Protocol Violation|5
5813639|NCT02694328|20070415|P1|Overall Study|Protocol Violation|6
5813640|NCT02694328|20070414|P2|Overall Study|Pregnancy|1
5813641|NCT02694328|20070415|P1|Overall Study|Pregnancy|1
5813642|NCT02694328|20070414|P2|Overall Study|Lack of Efficacy|2
5813643|NCT02694328|20070415|P1|Overall Study|Lack of Efficacy|1
5813644|NCT02694328|20070414|P2|Overall Study|Incarceration|1
5813645|NCT02694328|20070415|P1|Overall Study|Incarceration|1
5813646|NCT02694328|20070414|P2|Overall Study|Noncompliant with study drug|8
5813647|NCT02694328|20070415|P1|Overall Study|Noncompliant with study drug|11
5813648|NCT02694328|20070414|P2|Overall Study|Lost to Follow-up|22
5813649|NCT02694328|20070415|P1|Overall Study|Lost to Follow-up|26
5813650|NCT02694328|20070414|P2|Overall Study|Withdrawal by Subject|23
5813651|NCT02694328|20070415|P1|Overall Study|Withdrawal by Subject|27
5813652|NCT02694328|20070414|P2|Overall Study|Adverse Event|33
5813653|NCT02694328|20070415|P1|Overall Study|Adverse Event|27
5813654|NCT02693834|20070437|P2|Week 2 Practice|Adverse Event|1
5813655|NCT02693834|20070438|P1|Week 2 Practice|Adverse Event|0
5813656|NCT02693834|20070437|P2|Baseline Measurement|Adverse Event|0
5813657|NCT02693834|20070438|P1|Baseline Measurement|Adverse Event|1
5813658|NCT02693834|20070437|P2|Baseline Measurement|Withdrawal by Subject|0
5813659|NCT02693834|20070438|P1|Baseline Measurement|Withdrawal by Subject|1
5813660|NCT02693743|20070448|P2|Overall Study|Physician Decision|0
5813661|NCT02693743|20070449|P1|Overall Study|Physician Decision|1
5813662|NCT02693691|20070480|P1|Extended Follow-Up (Until Last pt 12M)|Physician Decision|1
5813663|NCT02693691|20070480|P1|Extended Follow-Up (Until Last pt 12M)|Withdrawal by Subject|11
5813664|NCT02693691|20070480|P1|Extended Follow-Up (Until Last pt 12M)|Death|12
5813665|NCT02693691|20070480|P1|Primary Endpoint Analysis (First 12M)|Adverse Event|1
5813666|NCT02693691|20070480|P1|Primary Endpoint Analysis (First 12M)|Physician Decision|7
5813667|NCT02693691|20070480|P1|Primary Endpoint Analysis (First 12M)|Withdrawal by Subject|12
5813668|NCT02693691|20070480|P1|Primary Endpoint Analysis (First 12M)|Death|30
5813669|NCT02693418|20070492|P5|Overall Study|Menses during study period|0
5813670|NCT02693418|20070493|P4|Overall Study|Menses during study period|0
5813671|NCT02693418|20070494|P3|Overall Study|Menses during study period|2
5813672|NCT02693418|20070495|P2|Overall Study|Menses during study period|0
5813673|NCT02693418|20070496|P1|Overall Study|Menses during study period|0
5813674|NCT02693418|20070492|P5|Overall Study|Lost to Follow-up|0
5813675|NCT02693418|20070493|P4|Overall Study|Lost to Follow-up|0
5813676|NCT02693418|20070494|P3|Overall Study|Lost to Follow-up|0
5813677|NCT02693418|20070495|P2|Overall Study|Lost to Follow-up|2
5813678|NCT02693418|20070496|P1|Overall Study|Lost to Follow-up|1
5813679|NCT02693171|20070513|P1|Overall Study|Discontinuation of Study by Sponsor|8
5813680|NCT02693171|20070513|P1|Overall Study|Adverse Event|1
5813681|NCT02693106|20070545|P1|Overall Study|No time|3
5813682|NCT02693002|20070557|P2|Overall Study|Withdrawal by Subject|0
5813683|NCT02693002|20070558|P1|Overall Study|Withdrawal by Subject|1
5813684|NCT02692716|20070581|P2|Overall Study|Withdrawal by Subject|1
5813685|NCT02692716|20070582|P1|Overall Study|Withdrawal by Subject|3
5813686|NCT02692716|20070581|P2|Overall Study|Lost to Follow-up|5
5813687|NCT02692716|20070582|P1|Overall Study|Lost to Follow-up|2
5813688|NCT02692703|20070622|P1|Overall Study|Other|1
5813689|NCT02692703|20070622|P1|Overall Study|Lost to Follow-up|1
5813690|NCT02692560|20070630|P2|Overall Study|Withdrawal by Subject|6
5813691|NCT02692560|20070631|P1|Overall Study|Withdrawal by Subject|0
5813692|NCT02692482|20070671|P2|Overall Study|Withdrawal by Subject|2
5813693|NCT02692482|20070672|P1|Overall Study|Withdrawal by Subject|1
5813694|NCT02692482|20070671|P2|Overall Study|Death|2
5813695|NCT02692482|20070672|P1|Overall Study|Death|2
5813696|NCT02692417|20070686|P2|Overall Study|Adverse Event|0
5813697|NCT02692417|20070687|P1|Overall Study|Adverse Event|1
5813698|NCT02692417|20070686|P2|Overall Study|Withdrawal by Subject|1
5813699|NCT02692417|20070687|P1|Overall Study|Withdrawal by Subject|5
5813700|NCT02692235|20070699|P2|Overall Study|Adverse Event|2
5813701|NCT02692235|20070700|P1|Overall Study|Adverse Event|1
5813702|NCT02692235|20070699|P2|Overall Study|Withdrawal by Subject|1
5813703|NCT02692235|20070700|P1|Overall Study|Withdrawal by Subject|2
5813704|NCT02692040|20070731|P17|Overall Study|Adverse Event|0
5813705|NCT02692040|20070732|P16|Overall Study|Adverse Event|1
5813706|NCT02692040|20070733|P15|Overall Study|Adverse Event|1
5813707|NCT02692040|20070734|P14|Overall Study|Adverse Event|3
5813708|NCT02692040|20070735|P13|Overall Study|Adverse Event|0
5813709|NCT02692040|20070736|P12|Overall Study|Adverse Event|0
5813710|NCT02692040|20070737|P11|Overall Study|Adverse Event|0
5813711|NCT02692040|20070738|P10|Overall Study|Adverse Event|0
5813712|NCT02692040|20070739|P9|Overall Study|Adverse Event|0
5813713|NCT02692040|20070740|P8|Overall Study|Adverse Event|0
5813714|NCT02692040|20070741|P7|Overall Study|Adverse Event|0
5813715|NCT02692040|20070742|P6|Overall Study|Adverse Event|0
5813716|NCT02692040|20070743|P5|Overall Study|Adverse Event|0
5813717|NCT02692040|20070744|P4|Overall Study|Adverse Event|0
5813718|NCT02692040|20070745|P3|Overall Study|Adverse Event|0
5813719|NCT02692040|20070746|P2|Overall Study|Adverse Event|0
5813720|NCT02692040|20070747|P1|Overall Study|Adverse Event|0
5813721|NCT02692040|20070731|P17|Overall Study|Protocol Violation|0
5813722|NCT02692040|20070732|P16|Overall Study|Protocol Violation|0
5813723|NCT02692040|20070733|P15|Overall Study|Protocol Violation|0
5813724|NCT02692040|20070734|P14|Overall Study|Protocol Violation|0
5813725|NCT02692040|20070735|P13|Overall Study|Protocol Violation|1
5813726|NCT02692040|20070736|P12|Overall Study|Protocol Violation|0
5813727|NCT02692040|20070737|P11|Overall Study|Protocol Violation|0
5813728|NCT02692040|20070738|P10|Overall Study|Protocol Violation|0
5813729|NCT02692040|20070739|P9|Overall Study|Protocol Violation|0
5813730|NCT02692040|20070740|P8|Overall Study|Protocol Violation|0
5813731|NCT02692040|20070741|P7|Overall Study|Protocol Violation|0
5813732|NCT02692040|20070742|P6|Overall Study|Protocol Violation|0
5813733|NCT02692040|20070743|P5|Overall Study|Protocol Violation|0
5813734|NCT02692040|20070744|P4|Overall Study|Protocol Violation|0
5813735|NCT02692040|20070745|P3|Overall Study|Protocol Violation|0
5813736|NCT02692040|20070746|P2|Overall Study|Protocol Violation|0
5813737|NCT02692040|20070747|P1|Overall Study|Protocol Violation|0
5813738|NCT02691936|20070839|P2|Overall Study|Withdrawal by Subject|5
5813739|NCT02691936|20070840|P1|Overall Study|Withdrawal by Subject|2
5813740|NCT02691741|20070862|P2|Overall Study|Withdrawal by Subject|4
5813741|NCT02691741|20070863|P1|Overall Study|Withdrawal by Subject|0
5813742|NCT02691741|20070862|P2|Overall Study|Physician Decision|1
5813743|NCT02691741|20070863|P1|Overall Study|Physician Decision|0
5813744|NCT02691741|20070862|P2|Overall Study|Lost to Follow-up|0
5813745|NCT02691741|20070863|P1|Overall Study|Lost to Follow-up|1
5813746|NCT02691741|20070862|P2|Overall Study|Adverse Event|2
5813747|NCT02691741|20070863|P1|Overall Study|Adverse Event|0
5813803|NCT02691572|20071199|P2|Overall Study|Protocol Violation|1
5813804|NCT02691572|20071200|P1|Overall Study|Protocol Violation|0
5813805|NCT02691572|20071199|P2|Overall Study|Withdrawal by Subject|0
5813806|NCT02691572|20071200|P1|Overall Study|Withdrawal by Subject|1
5813807|NCT02691507|20071208|P2|Overall Study|Missed Visit 3|1
5813808|NCT02691507|20071209|P1|Overall Study|Missed Visit 3|0
5813809|NCT02691494|20071342|P3|Post-Treatment Follow-Up Period|Non-Compliance|1
5813810|NCT02691494|20071343|P2|Post-Treatment Follow-Up Period|Non-Compliance|1
5813811|NCT02691494|20071344|P1|Post-Treatment Follow-Up Period|Non-Compliance|0
5813812|NCT02691494|20071342|P3|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|3
5813813|NCT02691494|20071343|P2|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|0
5813814|NCT02691494|20071344|P1|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|0
5813815|NCT02691494|20071342|P3|Post-Treatment Follow-Up Period|Other|1
5813816|NCT02691494|20071343|P2|Post-Treatment Follow-Up Period|Other|1
5813817|NCT02691494|20071344|P1|Post-Treatment Follow-Up Period|Other|2
5813818|NCT02691494|20071342|P3|Post-Treatment Follow-Up Period|Lost to Follow-up|4
5813819|NCT02691494|20071343|P2|Post-Treatment Follow-Up Period|Lost to Follow-up|3
5813820|NCT02691494|20071344|P1|Post-Treatment Follow-Up Period|Lost to Follow-up|2
5813821|NCT02691494|20071342|P3|Post-Treatment Follow-Up Period|Withdrawal by Subject|8
5813822|NCT02691494|20071343|P2|Post-Treatment Follow-Up Period|Withdrawal by Subject|2
5813823|NCT02691494|20071344|P1|Post-Treatment Follow-Up Period|Withdrawal by Subject|1
5813824|NCT02691468|20071372|P2|Overall Study|Failure to advance FOB|0
5813825|NCT02691468|20071373|P1|Overall Study|Failure to advance FOB|2
5813826|NCT02691468|20071372|P2|Overall Study|Lost to Follow-up|1
5813827|NCT02691468|20071373|P1|Overall Study|Lost to Follow-up|2
5813828|NCT02691468|20071372|P2|Overall Study|Bronchial blocker use|1
5813829|NCT02691468|20071373|P1|Overall Study|Bronchial blocker use|2
5813830|NCT02691247|20071424|P3|Overall Study|Lost to Follow-up|1
5813831|NCT02691247|20071425|P2|Overall Study|Lost to Follow-up|0
5813832|NCT02691247|20071426|P1|Overall Study|Lost to Follow-up|2
5813833|NCT02691247|20071424|P3|Overall Study|Withdrawal by Subject|2
5813834|NCT02691247|20071425|P2|Overall Study|Withdrawal by Subject|2
5813835|NCT02691247|20071426|P1|Overall Study|Withdrawal by Subject|1
5813836|NCT02691013|20071456|P2|Overall Study|Withdrawal by Subject|0
5813837|NCT02691013|20071457|P1|Overall Study|Withdrawal by Subject|3
5813838|NCT02690974|20071471|P1|Overall Study|Protocol Deviation|1
5813839|NCT02690974|20071471|P1|Overall Study|Protocol-defined stopping criteria|1
5813840|NCT02690974|20071471|P1|Overall Study|Non-compliance with study treatment|1
5813841|NCT02690974|20071471|P1|Overall Study|Physician Decision|2
5813842|NCT02690974|20071471|P1|Overall Study|Withdrawal of Informed Consent|3
5813843|NCT02690974|20071471|P1|Overall Study|Lost to Follow-up|3
5813844|NCT02690974|20071471|P1|Overall Study|Subject/guardian decision|4
5813845|NCT02690974|20071471|P1|Overall Study|Death|9
5813846|NCT02690974|20071471|P1|Overall Study|Adverse Event|16
5813847|NCT02690727|20071512|P2|Overall Study|Adverse Event|2
5813848|NCT02690727|20071513|P1|Overall Study|Adverse Event|2
5813849|NCT02690701|20071525|P2|Treatment Period 2|Protocol Violation|1
5813850|NCT02690701|20071526|P1|Treatment Period 2|Protocol Violation|0
5813851|NCT02690701|20071525|P2|Treatment Period 2|Withdrawal by Subject|2
5813852|NCT02690701|20071526|P1|Treatment Period 2|Withdrawal by Subject|0
5813853|NCT02690701|20071525|P2|Treatment Period 2|Lost to Follow-up|2
5813854|NCT02690701|20071526|P1|Treatment Period 2|Lost to Follow-up|0
5813855|NCT02690701|20071525|P2|Treatment Period 2|Lack of Efficacy|0
5813856|NCT02690701|20071526|P1|Treatment Period 2|Lack of Efficacy|1
5813857|NCT02690701|20071525|P2|Treatment Period 2|Adverse Event|0
5813858|NCT02690701|20071526|P1|Treatment Period 2|Adverse Event|2
5813859|NCT02690701|20071525|P2|Treatment Period 1|Withdrawal by Subject|1
5813860|NCT02690701|20071526|P1|Treatment Period 1|Withdrawal by Subject|0
5813861|NCT02690701|20071525|P2|Treatment Period 1|Adverse Event|2
5813862|NCT02690701|20071526|P1|Treatment Period 1|Adverse Event|2
5813863|NCT02690207|20071591|P1|Overall Study|Other reasons for withdrawal|23
5813864|NCT02690207|20071591|P1|Overall Study|Suspected HZ Episode|1
5813865|NCT02690207|20071591|P1|Overall Study|Migrated/moved from study area|5
5813866|NCT02690207|20071591|P1|Overall Study|Non-serious Adverse Event|18
5813867|NCT02690207|20071591|P1|Overall Study|Serious adverse event|110
5813868|NCT02690207|20071591|P1|Overall Study|Protocol Violation|2
5813869|NCT02690207|20071591|P1|Overall Study|Withdrawal by Subject|46
5813870|NCT02690207|20071591|P1|Overall Study|Lost to Follow-up|48
5813871|NCT02690194|20071601|P3|Overall Study|Withdrawal by Subject|0
5813872|NCT02690194|20071602|P2|Overall Study|Withdrawal by Subject|4
5813873|NCT02690194|20071603|P1|Overall Study|Withdrawal by Subject|1
5813874|NCT02689804|20071810|P2|Overall Study|Withdrawal by Subject|0
5813875|NCT02689804|20071811|P1|Overall Study|Withdrawal by Subject|2
5813876|NCT02689492|20071837|P1|Overall Study|Other than listed|1
5813877|NCT02689492|20071837|P1|Overall Study|Withdrawal/ Physician's Decision|1
5813878|NCT02689492|20071837|P1|Overall Study|Withdrawal/Loss To Follow-Up|1
5813879|NCT02689492|20071837|P1|Overall Study|Physician Decision|2
5813880|NCT02689492|20071837|P1|Overall Study|Death|9
5813881|NCT02689492|20071837|P1|Overall Study|Withdrawal by Subject|11
5813882|NCT02689492|20071837|P1|Overall Study|Lost to Follow-up|61
5813883|NCT02689219|20071853|P2|Overall Study|Disease Progression|6
5813884|NCT02689219|20071854|P1|Overall Study|Disease Progression|10
5813885|NCT02689219|20071853|P2|Overall Study|Death|1
5813886|NCT02689219|20071854|P1|Overall Study|Death|1
5813887|NCT02689206|20071871|P5|Overall Study|Withdrawal by Subject|0
5813888|NCT02689206|20071872|P4|Overall Study|Withdrawal by Subject|0
5813889|NCT02689206|20071873|P3|Overall Study|Withdrawal by Subject|1
5813890|NCT02689206|20071874|P2|Overall Study|Withdrawal by Subject|0
5813891|NCT02689206|20071875|P1|Overall Study|Withdrawal by Subject|1
5813892|NCT02689206|20071871|P5|Overall Study|Physician Decision|0
5813893|NCT02689206|20071872|P4|Overall Study|Physician Decision|0
5813894|NCT02689206|20071873|P3|Overall Study|Physician Decision|0
5813895|NCT02689206|20071874|P2|Overall Study|Physician Decision|0
5813896|NCT02689206|20071875|P1|Overall Study|Physician Decision|1
5813897|NCT02689206|20071871|P5|Overall Study|Other: Reached stopping criteria|4
5813898|NCT02689206|20071872|P4|Overall Study|Other: Reached stopping criteria|3
5813899|NCT02689206|20071873|P3|Overall Study|Other: Reached stopping criteria|2
5813900|NCT02689206|20071874|P2|Overall Study|Other: Reached stopping criteria|1
5813901|NCT02689206|20071875|P1|Overall Study|Other: Reached stopping criteria|0
5813902|NCT02689206|20071871|P5|Overall Study|Protocol Violation|2
5813903|NCT02689206|20071872|P4|Overall Study|Protocol Violation|1
5813904|NCT02689206|20071873|P3|Overall Study|Protocol Violation|0
5813905|NCT02689206|20071874|P2|Overall Study|Protocol Violation|0
5813906|NCT02689206|20071875|P1|Overall Study|Protocol Violation|1
5813907|NCT02689206|20071871|P5|Overall Study|Adverse Event|2
5813908|NCT02689206|20071872|P4|Overall Study|Adverse Event|0
5813909|NCT02689206|20071873|P3|Overall Study|Adverse Event|1
5813910|NCT02689206|20071874|P2|Overall Study|Adverse Event|0
5813911|NCT02689206|20071875|P1|Overall Study|Adverse Event|0
5813912|NCT02688933|20072088|P2|Overall Study|Lost to Follow-up|5
5813913|NCT02688933|20072089|P1|Overall Study|Lost to Follow-up|1
5813914|NCT02688933|20072088|P2|Overall Study|Other than Specified|25
5813915|NCT02688933|20072089|P1|Overall Study|Other than Specified|14
5813916|NCT02688933|20072088|P2|Overall Study|Hypoglycemia|0
5813917|NCT02688933|20072089|P1|Overall Study|Hypoglycemia|2
5813918|NCT02688933|20072088|P2|Overall Study|Poor compliance to protocol|4
5813919|NCT02688933|20072089|P1|Overall Study|Poor compliance to protocol|7
5813920|NCT02688933|20072088|P2|Overall Study|Lack of Efficacy|2
5813921|NCT02688933|20072089|P1|Overall Study|Lack of Efficacy|2
5813922|NCT02688933|20072088|P2|Overall Study|Adverse Event|1
5813923|NCT02688933|20072089|P1|Overall Study|Adverse Event|3
5813924|NCT02688764|20072149|P2|Overall Study|Withdrawal by parent|0
5813925|NCT02688764|20072150|P1|Overall Study|Withdrawal by parent|3
5813926|NCT02688764|20072149|P2|Overall Study|Subject taken off dialysis|0
5813927|NCT02688764|20072150|P1|Overall Study|Subject taken off dialysis|1
5813928|NCT02688764|20072149|P2|Overall Study|Subject moving out|0
5813929|NCT02688764|20072150|P1|Overall Study|Subject moving out|2
5813930|NCT02688764|20072149|P2|Overall Study|Study drug taste/Withd. parent|0
5813931|NCT02688764|20072150|P1|Overall Study|Study drug taste/Withd. parent|1
5813932|NCT02688764|20072149|P2|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|0
5813933|NCT02688764|20072150|P1|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|1
5813934|NCT02688764|20072149|P2|Overall Study|Phosphorus level outside safe range|1
5813935|NCT02688764|20072150|P1|Overall Study|Phosphorus level outside safe range|0
5813936|NCT02688764|20072149|P2|Overall Study|Non-compl./Withd. subject|2
5813937|NCT02688764|20072150|P1|Overall Study|Non-compl./Withd. subject|0
5813938|NCT02688764|20072149|P2|Overall Study|Non-compl./Ph. decision/Withd. subject|1
5813939|NCT02688764|20072150|P1|Overall Study|Non-compl./Ph. decision/Withd. subject|1
5813940|NCT02688764|20072149|P2|Overall Study|Non-compl./Physician decision|0
5813941|NCT02688764|20072150|P1|Overall Study|Non-compl./Physician decision|2
5813942|NCT02688764|20072149|P2|Overall Study|Non-compliance with study drug|0
5813943|NCT02688764|20072150|P1|Overall Study|Non-compliance with study drug|4
5813944|NCT02688764|20072149|P2|Overall Study|Lack of efficacy/Physician decision|1
5813945|NCT02688764|20072150|P1|Overall Study|Lack of efficacy/Physician decision|0
5813946|NCT02688764|20072149|P2|Overall Study|Lack of Efficacy|2
5813947|NCT02688764|20072150|P1|Overall Study|Lack of Efficacy|3
5813948|NCT02688764|20072149|P2|Overall Study|Kidney transplant|4
5813949|NCT02688764|20072150|P1|Overall Study|Kidney transplant|10
5813950|NCT02688764|20072149|P2|Overall Study|AE/Withd. subject|0
5813951|NCT02688764|20072150|P1|Overall Study|AE/Withd. subject|1
5813952|NCT02688764|20072149|P2|Overall Study|AE/Withd. parent/Withd. subject|1
5813953|NCT02688764|20072150|P1|Overall Study|AE/Withd. parent/Withd. subject|1
5813954|NCT02688764|20072149|P2|Overall Study|AE/Withd. parent|0
5813955|NCT02688764|20072150|P1|Overall Study|AE/Withd. parent|3
5813956|NCT02688764|20072149|P2|Overall Study|AE/Physician decision|0
5813957|NCT02688764|20072150|P1|Overall Study|AE/Physician decision|1
5813958|NCT02688764|20072149|P2|Overall Study|AE/Other|1
5813959|NCT02688764|20072150|P1|Overall Study|AE/Other|0
5813960|NCT02688764|20072149|P2|Overall Study|AE/Non-compl./Withd. parent|1
5813961|NCT02688764|20072150|P1|Overall Study|AE/Non-compl./Withd. parent|0
5813962|NCT02688764|20072149|P2|Overall Study|AE/Non-compl.|0
5813963|NCT02688764|20072150|P1|Overall Study|AE/Non-compl.|1
5813964|NCT02688764|20072149|P2|Overall Study|AE/Lack of efficacy|0
5813965|NCT02688764|20072150|P1|Overall Study|AE/Lack of efficacy|1
5813966|NCT02688764|20072149|P2|Overall Study|AE/Kidney transplant|0
5813967|NCT02688764|20072150|P1|Overall Study|AE/Kidney transplant|1
5813968|NCT02688764|20072149|P2|Overall Study|Adverse Event|3
5813969|NCT02688764|20072150|P1|Overall Study|Adverse Event|3
5813970|NCT02688387|20072217|P22|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
5813971|NCT02688387|20072218|P21|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
5813972|NCT02688387|20072219|P20|Part 3B, Washout Period 3 (10 Days)|Study terminated|1
5813973|NCT02688387|20072220|P19|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
5813974|NCT02688387|20072221|P18|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
5813975|NCT02688387|20072222|P17|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
5813976|NCT02688387|20072223|P16|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
5813977|NCT02688387|20072224|P15|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
5813978|NCT02688387|20072225|P14|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
5813979|NCT02688387|20072226|P13|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
5813980|NCT02688387|20072227|P12|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
5813981|NCT02688387|20072228|P11|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
5813982|NCT02688387|20072229|P10|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
5813983|NCT02688387|20072230|P9|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
5813984|NCT02688387|20072231|P8|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
5813985|NCT02688387|20072232|P7|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
5813986|NCT02688387|20072233|P6|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
5813987|NCT02688387|20072234|P5|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
5813988|NCT02688387|20072235|P4|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
5813989|NCT02688387|20072236|P3|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
5813990|NCT02688387|20072237|P2|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
5813991|NCT02688387|20072238|P1|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
5813992|NCT02688387|20072217|P22|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
5813993|NCT02688387|20072218|P21|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1
5813994|NCT02688387|20072219|P20|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
5813995|NCT02688387|20072220|P19|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1
5813996|NCT02688387|20072221|P18|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
5813997|NCT02688387|20072222|P17|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
5813998|NCT02688387|20072223|P16|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
5813999|NCT02688387|20072224|P15|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
5814000|NCT02688387|20072225|P14|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
5814001|NCT02688387|20072226|P13|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
5814002|NCT02688387|20072227|P12|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
5814003|NCT02688387|20072228|P11|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
5814004|NCT02688387|20072229|P10|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
5814005|NCT02688387|20072230|P9|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
5814006|NCT02688387|20072231|P8|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
5814007|NCT02688387|20072232|P7|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
5814008|NCT02688387|20072233|P6|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
5814009|NCT02688387|20072234|P5|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
5814010|NCT02688387|20072235|P4|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
5814011|NCT02688387|20072236|P3|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
5814012|NCT02688387|20072237|P2|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
5814013|NCT02688387|20072238|P1|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
5814014|NCT02688387|20072217|P22|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
5814015|NCT02688387|20072218|P21|Part 3B, Period 3 (up to 6 Days)|Physician Decision|1
5814016|NCT02688387|20072219|P20|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
5814017|NCT02688387|20072220|P19|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
5814018|NCT02688387|20072221|P18|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
5814019|NCT02688387|20072222|P17|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
5814020|NCT02688387|20072223|P16|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
5814021|NCT02688387|20072224|P15|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
5814022|NCT02688387|20072225|P14|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
5814023|NCT02688387|20072226|P13|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
5814024|NCT02688387|20072227|P12|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
5814025|NCT02688387|20072228|P11|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
5814026|NCT02688387|20072229|P10|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
5814027|NCT02688387|20072230|P9|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
5814028|NCT02688387|20072231|P8|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
5814029|NCT02688387|20072232|P7|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
5814030|NCT02688387|20072233|P6|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
5814031|NCT02688387|20072234|P5|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
5814032|NCT02688387|20072235|P4|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
5814033|NCT02688387|20072236|P3|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
5814034|NCT02688387|20072237|P2|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
5814035|NCT02688387|20072238|P1|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
5814036|NCT02688387|20072217|P22|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
5814037|NCT02688387|20072218|P21|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
5814038|NCT02688387|20072219|P20|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
5814039|NCT02688387|20072220|P19|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
5814040|NCT02688387|20072221|P18|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
5814041|NCT02688387|20072222|P17|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
5814042|NCT02688387|20072223|P16|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
5814043|NCT02688387|20072224|P15|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|1
5814044|NCT02688387|20072225|P14|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
5814045|NCT02688387|20072226|P13|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
5814046|NCT02688387|20072227|P12|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
5814047|NCT02688387|20072228|P11|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
5814048|NCT02688387|20072229|P10|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
5814049|NCT02688387|20072230|P9|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
5814050|NCT02688387|20072231|P8|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
5814051|NCT02688387|20072232|P7|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
5814052|NCT02688387|20072233|P6|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
5814053|NCT02688387|20072234|P5|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
5814054|NCT02688387|20072235|P4|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
5814055|NCT02688387|20072236|P3|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
5814056|NCT02688387|20072237|P2|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
5814057|NCT02688387|20072238|P1|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
5814058|NCT02688387|20072217|P22|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
5814059|NCT02688387|20072218|P21|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
5814060|NCT02688387|20072219|P20|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
5814061|NCT02688387|20072220|P19|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
5814062|NCT02688387|20072221|P18|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
5814063|NCT02688387|20072222|P17|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
5814064|NCT02688387|20072223|P16|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
5814065|NCT02688387|20072224|P15|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
5814066|NCT02688387|20072225|P14|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
5814067|NCT02688387|20072226|P13|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
5814068|NCT02688387|20072227|P12|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
5814069|NCT02688387|20072228|P11|Part 2, Period 1 (up to 6 Days)|Adverse Event|1
5814070|NCT02688387|20072229|P10|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
5814071|NCT02688387|20072230|P9|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
5814072|NCT02688387|20072231|P8|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
5814073|NCT02688387|20072232|P7|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
5814074|NCT02688387|20072233|P6|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
5814075|NCT02688387|20072234|P5|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
5814076|NCT02688387|20072235|P4|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
5814077|NCT02688387|20072236|P3|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
5814078|NCT02688387|20072237|P2|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
5814079|NCT02688387|20072238|P1|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
5814080|NCT02688387|20072217|P22|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
5814081|NCT02688387|20072218|P21|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
5814082|NCT02688387|20072219|P20|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
5814083|NCT02688387|20072220|P19|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
5814084|NCT02688387|20072221|P18|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
5814085|NCT02688387|20072222|P17|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
5814086|NCT02688387|20072223|P16|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
5814087|NCT02688387|20072224|P15|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
5814088|NCT02688387|20072225|P14|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
5814089|NCT02688387|20072226|P13|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
5814090|NCT02688387|20072227|P12|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
5814091|NCT02688387|20072228|P11|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
5814092|NCT02688387|20072229|P10|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
5814093|NCT02688387|20072230|P9|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
5814094|NCT02688387|20072231|P8|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
5814095|NCT02688387|20072232|P7|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
5814096|NCT02688387|20072233|P6|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
5814097|NCT02688387|20072234|P5|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
5814098|NCT02688387|20072235|P4|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
5814099|NCT02688387|20072236|P3|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
5814100|NCT02688387|20072237|P2|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
5814101|NCT02688387|20072238|P1|Part 1, Washout Period 3 (7 Days)|Protocol Violation|1
5814102|NCT02688387|20072217|P22|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
5814103|NCT02688387|20072218|P21|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
5814104|NCT02688387|20072219|P20|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
5814105|NCT02688387|20072220|P19|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
5814106|NCT02688387|20072221|P18|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
5814107|NCT02688387|20072222|P17|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
5814108|NCT02688387|20072223|P16|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
5814109|NCT02688387|20072224|P15|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
5814110|NCT02688387|20072225|P14|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
5814111|NCT02688387|20072226|P13|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
5814112|NCT02688387|20072227|P12|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
5814113|NCT02688387|20072228|P11|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
5814114|NCT02688387|20072229|P10|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
5814115|NCT02688387|20072230|P9|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
5814116|NCT02688387|20072231|P8|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
5814117|NCT02688387|20072232|P7|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
5814118|NCT02688387|20072233|P6|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
5814119|NCT02688387|20072234|P5|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1
5814120|NCT02688387|20072235|P4|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
5814121|NCT02688387|20072236|P3|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1
5814122|NCT02688387|20072237|P2|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
5814123|NCT02688387|20072238|P1|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
5814124|NCT02688387|20072217|P22|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
5814125|NCT02688387|20072218|P21|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
5814126|NCT02688387|20072219|P20|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
5814127|NCT02688387|20072220|P19|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
5814128|NCT02688387|20072221|P18|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
5814129|NCT02688387|20072222|P17|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
5814130|NCT02688387|20072223|P16|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
5814131|NCT02688387|20072224|P15|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
5814132|NCT02688387|20072225|P14|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
5814133|NCT02688387|20072226|P13|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
5814134|NCT02688387|20072227|P12|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
5814135|NCT02688387|20072228|P11|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
5814136|NCT02688387|20072229|P10|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
5814137|NCT02688387|20072230|P9|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
5814138|NCT02688387|20072231|P8|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
5814139|NCT02688387|20072232|P7|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
5814140|NCT02688387|20072233|P6|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
5814141|NCT02688387|20072234|P5|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
5814142|NCT02688387|20072235|P4|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
5814143|NCT02688387|20072236|P3|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
5814144|NCT02688387|20072237|P2|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|1
5814145|NCT02688387|20072238|P1|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
5814146|NCT02688387|20072217|P22|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
5814147|NCT02688387|20072218|P21|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
5814148|NCT02688387|20072219|P20|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
5814149|NCT02688387|20072220|P19|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
5814150|NCT02688387|20072221|P18|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
5814151|NCT02688387|20072222|P17|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
5814152|NCT02688387|20072223|P16|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
5814153|NCT02688387|20072224|P15|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
5814154|NCT02688387|20072225|P14|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
5814155|NCT02688387|20072226|P13|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
5814156|NCT02688387|20072227|P12|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
5814157|NCT02688387|20072228|P11|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
5814158|NCT02688387|20072229|P10|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
5814159|NCT02688387|20072230|P9|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
5814160|NCT02688387|20072231|P8|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
5814161|NCT02688387|20072232|P7|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
5814162|NCT02688387|20072233|P6|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
5814163|NCT02688387|20072234|P5|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
5814164|NCT02688387|20072235|P4|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|1
5814165|NCT02688387|20072236|P3|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
5814166|NCT02688387|20072237|P2|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
5814167|NCT02688387|20072238|P1|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
5814168|NCT02688387|20072217|P22|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
5814169|NCT02688387|20072218|P21|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
5814170|NCT02688387|20072219|P20|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
5814171|NCT02688387|20072220|P19|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
5814172|NCT02688387|20072221|P18|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
5814173|NCT02688387|20072222|P17|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
5814174|NCT02688387|20072223|P16|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
5814175|NCT02688387|20072224|P15|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
5814176|NCT02688387|20072225|P14|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
5814177|NCT02688387|20072226|P13|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
5814178|NCT02688387|20072227|P12|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
5814179|NCT02688387|20072228|P11|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
5814180|NCT02688387|20072229|P10|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
5814181|NCT02688387|20072230|P9|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
5814182|NCT02688387|20072231|P8|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
5814183|NCT02688387|20072232|P7|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
5814184|NCT02688387|20072233|P6|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
5814185|NCT02688387|20072234|P5|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
5814186|NCT02688387|20072235|P4|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
5814187|NCT02688387|20072236|P3|Part 1, Period 1 (up to 6 Days)|Adverse Event|1
5814188|NCT02688387|20072237|P2|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
5814189|NCT02688387|20072238|P1|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
5814190|NCT02688192|20072506|P2|Overall Study|Physician Decision|0
5814191|NCT02688192|20072507|P1|Overall Study|Physician Decision|1
5814192|NCT02688192|20072506|P2|Overall Study|Lost to Follow-up|5
5814193|NCT02688192|20072507|P1|Overall Study|Lost to Follow-up|11
5814194|NCT02688153|20072526|P2|Overall Study|Conversion to Commercial Valve|0
5814195|NCT02688153|20072527|P1|Overall Study|Conversion to Commercial Valve|3
5814196|NCT02688153|20072526|P2|Overall Study|Valve Explant|0
5814197|NCT02688153|20072527|P1|Overall Study|Valve Explant|1
5814198|NCT02688153|20072526|P2|Overall Study|Withdrawal by Subject|2
5814199|NCT02688153|20072527|P1|Overall Study|Withdrawal by Subject|4
5814200|NCT02688153|20072526|P2|Overall Study|Death|5
5814201|NCT02688153|20072527|P1|Overall Study|Death|7
5814202|NCT02687919|20072587|P2|Overall Study|Protocol Violation|0
5814203|NCT02687919|20072588|P1|Overall Study|Protocol Violation|2
5814204|NCT02687919|20072587|P2|Overall Study|Withdrawal by Subject|6
5814205|NCT02687919|20072588|P1|Overall Study|Withdrawal by Subject|6
5814206|NCT02687815|20072618|P2|Overall Study|Withdrawal by Subject|4
5814207|NCT02687815|20072619|P1|Overall Study|Withdrawal by Subject|2
5814208|NCT02687815|20072618|P2|Overall Study|Lost to Follow-up|4
5814209|NCT02687815|20072619|P1|Overall Study|Lost to Follow-up|2
5814210|NCT02687542|20072636|P5|Overall Study|Withdrawal by Subject|4
5814211|NCT02687542|20072637|P4|Overall Study|Withdrawal by Subject|2
5814212|NCT02687542|20072638|P3|Overall Study|Withdrawal by Subject|1
5814213|NCT02687542|20072639|P2|Overall Study|Withdrawal by Subject|1
5814214|NCT02687542|20072640|P1|Overall Study|Withdrawal by Subject|0
5814215|NCT02687542|20072636|P5|Overall Study|Adverse Event|9
5814216|NCT02687542|20072637|P4|Overall Study|Adverse Event|2
5814217|NCT02687542|20072638|P3|Overall Study|Adverse Event|3
5814218|NCT02687542|20072639|P2|Overall Study|Adverse Event|1
5814219|NCT02687542|20072640|P1|Overall Study|Adverse Event|3
5814220|NCT02687542|20072636|P5|Overall Study|Other|5
5814221|NCT02687542|20072637|P4|Overall Study|Other|6
5814222|NCT02687542|20072638|P3|Overall Study|Other|10
5814223|NCT02687542|20072639|P2|Overall Study|Other|9
5814224|NCT02687542|20072640|P1|Overall Study|Other|5
5814225|NCT02687542|20072636|P5|Overall Study|Protocol Violation|0
5814226|NCT02687542|20072637|P4|Overall Study|Protocol Violation|0
5814227|NCT02687542|20072638|P3|Overall Study|Protocol Violation|0
5814228|NCT02687542|20072639|P2|Overall Study|Protocol Violation|1
5814229|NCT02687542|20072640|P1|Overall Study|Protocol Violation|0
5814230|NCT02687542|20072636|P5|Overall Study|Lost to Follow-up|1
5814231|NCT02687542|20072637|P4|Overall Study|Lost to Follow-up|0
5814232|NCT02687542|20072638|P3|Overall Study|Lost to Follow-up|0
5814233|NCT02687542|20072639|P2|Overall Study|Lost to Follow-up|0
5814234|NCT02687542|20072640|P1|Overall Study|Lost to Follow-up|0
5814235|NCT02687542|20072636|P5|Overall Study|Medication error without associated AEs|1
5814236|NCT02687542|20072637|P4|Overall Study|Medication error without associated AEs|0
5814237|NCT02687542|20072638|P3|Overall Study|Medication error without associated AEs|0
5814238|NCT02687542|20072639|P2|Overall Study|Medication error without associated AEs|0
5814239|NCT02687542|20072640|P1|Overall Study|Medication error without associated AEs|0
5814240|NCT02687191|20072769|P6|Overall Study|Withdrawal by Subject|0
5814241|NCT02687191|20072770|P5|Overall Study|Withdrawal by Subject|0
5814242|NCT02687191|20072771|P4|Overall Study|Withdrawal by Subject|1
5814243|NCT02687191|20072772|P3|Overall Study|Withdrawal by Subject|0
5814244|NCT02687191|20072773|P2|Overall Study|Withdrawal by Subject|0
5814245|NCT02687191|20072774|P1|Overall Study|Withdrawal by Subject|0
5814246|NCT02687191|20072769|P6|Overall Study|Death|1
5814247|NCT02687191|20072770|P5|Overall Study|Death|1
5814248|NCT02687191|20072771|P4|Overall Study|Death|0
5814249|NCT02687191|20072772|P3|Overall Study|Death|1
5814250|NCT02687191|20072773|P2|Overall Study|Death|1
5814251|NCT02687191|20072774|P1|Overall Study|Death|0
5814252|NCT02686164|20072938|P1|Overall Study|Clinical progression|1
5814253|NCT02686164|20072938|P1|Overall Study|Withdrawal of consent|1
5814254|NCT02686164|20072938|P1|Overall Study|Adverse Event|1
5814255|NCT02686034|20072975|P2|Open Label Period 3|Lost to Follow-up|1
5814256|NCT02686034|20072976|P1|Open Label Period 3|Lost to Follow-up|0
5814257|NCT02686034|20072975|P2|Randomized Controlled Period 2|Spontaneous reduction in migraines|0
5814258|NCT02686034|20072976|P1|Randomized Controlled Period 2|Spontaneous reduction in migraines|1
5814259|NCT02686034|20072975|P2|Randomized Controlled Period 2|Adverse Event|2
5814260|NCT02686034|20072976|P1|Randomized Controlled Period 2|Adverse Event|0
5814261|NCT02686034|20072975|P2|Randomized Controlled Period 2|Withdrawal by Subject|0
5814262|NCT02686034|20072976|P1|Randomized Controlled Period 2|Withdrawal by Subject|3
5814263|NCT02686034|20072975|P2|Randomized Controlled Period 2|Lost to Follow-up|2
5814264|NCT02686034|20072976|P1|Randomized Controlled Period 2|Lost to Follow-up|1
5814265|NCT02686034|20072975|P2|Run-In Period 1|Lost to Follow-up|4
5814266|NCT02686034|20072976|P1|Run-In Period 1|Lost to Follow-up|4
5814267|NCT02686034|20072975|P2|Run-In Period 1|Withdrawal by Subject|3
5814268|NCT02686034|20072976|P1|Run-In Period 1|Withdrawal by Subject|4
5814269|NCT02686034|20072975|P2|Run-In Period 1|Eligibility|10
5814270|NCT02686034|20072976|P1|Run-In Period 1|Eligibility|12
5814271|NCT02685826|20073026|P3|Overall Study|Full Clinical Hold by FDA|20
5814272|NCT02685826|20073027|P2|Overall Study|Full Clinical Hold by FDA|9
5814273|NCT02685826|20073028|P1|Overall Study|Full Clinical Hold by FDA|19
5814274|NCT02685826|20073026|P3|Overall Study|Withdrawal by Subject|0
5814275|NCT02685826|20073027|P2|Overall Study|Withdrawal by Subject|0
5814276|NCT02685826|20073028|P1|Overall Study|Withdrawal by Subject|2
5814277|NCT02685826|20073026|P3|Overall Study|Progressive Disease|0
5814278|NCT02685826|20073027|P2|Overall Study|Progressive Disease|1
5814279|NCT02685826|20073028|P1|Overall Study|Progressive Disease|2
5814280|NCT02685826|20073026|P3|Overall Study|Adverse Event|1
5814281|NCT02685826|20073027|P2|Overall Study|Adverse Event|0
5814282|NCT02685826|20073028|P1|Overall Study|Adverse Event|2
5814283|NCT02685488|20073122|P2|Overall Study|Withdrawal by Subject|1
5814284|NCT02685488|20073123|P1|Overall Study|Withdrawal by Subject|0
5814285|NCT02685202|20073176|P1|Overall Study|Lost to Follow-up|9
5814286|NCT02685072|20073184|P2|1-Month Follow-Up|Withdrawal by Subject|0
5814287|NCT02685072|20073185|P1|1-Month Follow-Up|Withdrawal by Subject|1
5814288|NCT02685072|20073184|P2|Treatment Period|Withdrawal by Subject|3
5814289|NCT02685072|20073185|P1|Treatment Period|Withdrawal by Subject|1
5814290|NCT02685072|20073184|P2|Treatment Period|Lost to Follow-up|6
5814291|NCT02685072|20073185|P1|Treatment Period|Lost to Follow-up|12
5814292|NCT02685033|20073229|P2|Overall Study|Adverse Event|0
5814293|NCT02685033|20073230|P1|Overall Study|Adverse Event|1
5814294|NCT02685033|20073229|P2|Overall Study|Lost to Follow-up|1
5814295|NCT02685033|20073230|P1|Overall Study|Lost to Follow-up|2
5814296|NCT02685033|20073229|P2|Overall Study|Withdrawal of Consent|1
5814297|NCT02685033|20073230|P1|Overall Study|Withdrawal of Consent|0
5814298|NCT02684981|20073266|P3|Overall Study|Other|17
5814299|NCT02684981|20073267|P2|Overall Study|Other|49
5814300|NCT02684981|20073268|P1|Overall Study|Other|83
5814301|NCT02684981|20073266|P3|Overall Study|Permanently discontinued the treatment|110
5814302|NCT02684981|20073267|P2|Overall Study|Permanently discontinued the treatment|161
5814303|NCT02684981|20073268|P1|Overall Study|Permanently discontinued the treatment|157
5814304|NCT02684370|20073443|P6|Part B|Subject Withdrawal|2
5814305|NCT02684370|20073444|P5|Part B|Subject Withdrawal|1
5814306|NCT02684370|20073445|P4|Part B|Subject Withdrawal|1
5814307|NCT02684370|20073446|P3|Part B|Subject Withdrawal|0
5814308|NCT02684370|20073447|P2|Part B|Subject Withdrawal|0
5814309|NCT02684370|20073448|P1|Part B|Subject Withdrawal|0
5814310|NCT02684370|20073443|P6|Part B|Lost to Follow-up|5
5814311|NCT02684370|20073444|P5|Part B|Lost to Follow-up|2
5814312|NCT02684370|20073445|P4|Part B|Lost to Follow-up|1
5814313|NCT02684370|20073446|P3|Part B|Lost to Follow-up|0
5814314|NCT02684370|20073447|P2|Part B|Lost to Follow-up|0
5814315|NCT02684370|20073448|P1|Part B|Lost to Follow-up|0
5814316|NCT02684370|20073443|P6|Part B|Adverse Event|1
5814317|NCT02684370|20073444|P5|Part B|Adverse Event|2
5814318|NCT02684370|20073445|P4|Part B|Adverse Event|0
5814319|NCT02684370|20073446|P3|Part B|Adverse Event|0
5814320|NCT02684370|20073447|P2|Part B|Adverse Event|0
5814321|NCT02684370|20073448|P1|Part B|Adverse Event|0
5814322|NCT02684370|20073443|P6|Part A|Other|0
5814323|NCT02684370|20073444|P5|Part A|Other|0
5814324|NCT02684370|20073445|P4|Part A|Other|0
5814325|NCT02684370|20073446|P3|Part A|Other|1
5814326|NCT02684370|20073447|P2|Part A|Other|0
5814327|NCT02684370|20073448|P1|Part A|Other|0
5814328|NCT02684370|20073443|P6|Part A|Subject Withdrawal|0
5814329|NCT02684370|20073444|P5|Part A|Subject Withdrawal|0
5814330|NCT02684370|20073445|P4|Part A|Subject Withdrawal|0
5814331|NCT02684370|20073446|P3|Part A|Subject Withdrawal|3
5814332|NCT02684370|20073447|P2|Part A|Subject Withdrawal|0
5814333|NCT02684370|20073448|P1|Part A|Subject Withdrawal|1
5814334|NCT02684370|20073443|P6|Part A|Lost to Follow-up|0
5814335|NCT02684370|20073444|P5|Part A|Lost to Follow-up|0
5814336|NCT02684370|20073445|P4|Part A|Lost to Follow-up|0
5814337|NCT02684370|20073446|P3|Part A|Lost to Follow-up|0
5814338|NCT02684370|20073447|P2|Part A|Lost to Follow-up|1
5814339|NCT02684370|20073448|P1|Part A|Lost to Follow-up|1
5814340|NCT02684370|20073443|P6|Part A|Adverse Event|0
5814341|NCT02684370|20073444|P5|Part A|Adverse Event|0
5814342|NCT02684370|20073445|P4|Part A|Adverse Event|0
5814343|NCT02684370|20073446|P3|Part A|Adverse Event|1
5814344|NCT02684370|20073447|P2|Part A|Adverse Event|0
5814345|NCT02684370|20073448|P1|Part A|Adverse Event|2
5814346|NCT02684357|20073493|P6|Part B|Other|1
5814347|NCT02684357|20073494|P5|Part B|Other|0
5814348|NCT02684357|20073495|P4|Part B|Other|1
5814349|NCT02684357|20073496|P3|Part B|Other|0
5814350|NCT02684357|20073497|P2|Part B|Other|0
5814351|NCT02684357|20073498|P1|Part B|Other|0
5814352|NCT02684357|20073493|P6|Part B|Withdrawal by Subject|4
5814353|NCT02684357|20073494|P5|Part B|Withdrawal by Subject|2
5814354|NCT02684357|20073495|P4|Part B|Withdrawal by Subject|0
5814355|NCT02684357|20073496|P3|Part B|Withdrawal by Subject|0
5814356|NCT02684357|20073497|P2|Part B|Withdrawal by Subject|0
5814357|NCT02684357|20073498|P1|Part B|Withdrawal by Subject|0
5814358|NCT02684357|20073493|P6|Part B|Lost to Follow-up|7
5814359|NCT02684357|20073494|P5|Part B|Lost to Follow-up|1
5814360|NCT02684357|20073495|P4|Part B|Lost to Follow-up|1
5814361|NCT02684357|20073496|P3|Part B|Lost to Follow-up|0
5814362|NCT02684357|20073497|P2|Part B|Lost to Follow-up|0
5814363|NCT02684357|20073498|P1|Part B|Lost to Follow-up|0
5814364|NCT02684357|20073493|P6|Part B|Adverse Event (Other)|1
5814365|NCT02684357|20073494|P5|Part B|Adverse Event (Other)|1
5814366|NCT02684357|20073495|P4|Part B|Adverse Event (Other)|1
5814367|NCT02684357|20073496|P3|Part B|Adverse Event (Other)|0
5814368|NCT02684357|20073497|P2|Part B|Adverse Event (Other)|0
5814369|NCT02684357|20073498|P1|Part B|Adverse Event (Other)|0
5814370|NCT02684357|20073493|P6|Part A|Other|0
5814371|NCT02684357|20073494|P5|Part A|Other|0
5814372|NCT02684357|20073495|P4|Part A|Other|0
5814373|NCT02684357|20073496|P3|Part A|Other|0
5814374|NCT02684357|20073497|P2|Part A|Other|1
5814375|NCT02684357|20073498|P1|Part A|Other|0
5814376|NCT02684357|20073493|P6|Part A|Withdrawal by Subject|0
5814377|NCT02684357|20073494|P5|Part A|Withdrawal by Subject|0
5814378|NCT02684357|20073495|P4|Part A|Withdrawal by Subject|0
5814379|NCT02684357|20073496|P3|Part A|Withdrawal by Subject|0
5814380|NCT02684357|20073497|P2|Part A|Withdrawal by Subject|0
5814381|NCT02684357|20073498|P1|Part A|Withdrawal by Subject|3
5814382|NCT02684357|20073493|P6|Part A|Lost to Follow-up|0
5814383|NCT02684357|20073494|P5|Part A|Lost to Follow-up|0
5814384|NCT02684357|20073495|P4|Part A|Lost to Follow-up|0
5814385|NCT02684357|20073496|P3|Part A|Lost to Follow-up|2
5814386|NCT02684357|20073497|P2|Part A|Lost to Follow-up|2
5814387|NCT02684357|20073498|P1|Part A|Lost to Follow-up|0
5814388|NCT02684357|20073493|P6|Part A|Adverse Event (Worsening of Disease)|0
5814389|NCT02684357|20073494|P5|Part A|Adverse Event (Worsening of Disease)|0
5814390|NCT02684357|20073495|P4|Part A|Adverse Event (Worsening of Disease)|0
5814391|NCT02684357|20073496|P3|Part A|Adverse Event (Worsening of Disease)|0
5814392|NCT02684357|20073497|P2|Part A|Adverse Event (Worsening of Disease)|0
5814393|NCT02684357|20073498|P1|Part A|Adverse Event (Worsening of Disease)|1
5814394|NCT02684344|20073548|P2|Overall Study|Withdrawal by Subject|1
5814395|NCT02684344|20073549|P1|Overall Study|Withdrawal by Subject|0
5814396|NCT02684279|20073555|P1|Overall Study|Physician Decision|1
5814397|NCT02684279|20073555|P1|Overall Study|Site closures|7
5814398|NCT02684279|20073555|P1|Overall Study|family emergency|1
5814399|NCT02684279|20073555|P1|Overall Study|subject to have surgery|1
5814400|NCT02684279|20073555|P1|Overall Study|non compliance with study visits|2
5814401|NCT02684279|20073555|P1|Overall Study|non-compliance with study drug|9
5814402|NCT02684279|20073555|P1|Overall Study|Withdrawal by Subject|92
5814403|NCT02684279|20073555|P1|Overall Study|Pregnancy|8
5814404|NCT02684279|20073555|P1|Overall Study|Protocol Violation|6
5814405|NCT02684279|20073555|P1|Overall Study|Lost to Follow-up|61
5814406|NCT02684279|20073555|P1|Overall Study|Lack of Efficacy|4
5814407|NCT02684279|20073555|P1|Overall Study|Adverse Event|87
5814408|NCT02684097|20073607|P2|Overall Study|Lack of Efficacy|6
5814409|NCT02684097|20073608|P1|Overall Study|Lack of Efficacy|13
5814410|NCT02683876|20073656|P2|Overall Study|samples damaged during shipping|0
5814411|NCT02683876|20073657|P1|Overall Study|samples damaged during shipping|2
5814412|NCT02683785|20073667|P2|Overall Study|Adverse Event|2
5814413|NCT02683785|20073668|P1|Overall Study|Adverse Event|0
5814414|NCT02683785|20073667|P2|Overall Study|Lost to Follow-up|1
5814415|NCT02683785|20073668|P1|Overall Study|Lost to Follow-up|0
5814416|NCT02683785|20073667|P2|Overall Study|Withdrawal by Subject|1
5814417|NCT02683785|20073668|P1|Overall Study|Withdrawal by Subject|1
5814418|NCT02683746|20073725|P2|Overall Study|Physician Decision|1
5814419|NCT02683746|20073726|P1|Overall Study|Physician Decision|2
5814420|NCT02683746|20073725|P2|Overall Study|Withdrawal by Subject|5
5814421|NCT02683746|20073726|P1|Overall Study|Withdrawal by Subject|6
5814422|NCT02683746|20073725|P2|Overall Study|Lost to Follow-up|6
5814423|NCT02683746|20073726|P1|Overall Study|Lost to Follow-up|5
5814424|NCT02683746|20073725|P2|Overall Study|Adverse Event|2
5814425|NCT02683746|20073726|P1|Overall Study|Adverse Event|3
5814426|NCT02683668|20073769|P3|Period 2|Withdrawal by Subject|0
5814427|NCT02683668|20073770|P2|Period 2|Withdrawal by Subject|1
5814428|NCT02683668|20073771|P1|Period 2|Withdrawal by Subject|0
5814429|NCT02683525|20073837|P1|Overall Study|Disease Progression|6
5814430|NCT02683525|20073837|P1|Overall Study|Physician Decision|1
5814431|NCT02683525|20073837|P1|Overall Study|Lost to Follow-up|1
5814432|NCT02683109|20073892|P2|Overall Study|Adverse Event|0
5814433|NCT02683109|20073893|P1|Overall Study|Adverse Event|1
5814434|NCT02682823|20073914|P5|Overall Study|Adverse Event|0
5814435|NCT02682823|20073915|P4|Overall Study|Adverse Event|1
5814436|NCT02682823|20073916|P3|Overall Study|Adverse Event|0
5814437|NCT02682823|20073917|P2|Overall Study|Adverse Event|0
5814438|NCT02682823|20073918|P1|Overall Study|Adverse Event|0
5814439|NCT02682823|20073914|P5|Overall Study|Protocol Deviation|0
5814440|NCT02682823|20073915|P4|Overall Study|Protocol Deviation|0
5814441|NCT02682823|20073916|P3|Overall Study|Protocol Deviation|0
5814442|NCT02682823|20073917|P2|Overall Study|Protocol Deviation|1
5814443|NCT02682823|20073918|P1|Overall Study|Protocol Deviation|0
5814444|NCT02682823|20073914|P5|Overall Study|Withdrawal by Subject|1
5814445|NCT02682823|20073915|P4|Overall Study|Withdrawal by Subject|0
5814446|NCT02682823|20073916|P3|Overall Study|Withdrawal by Subject|1
5814447|NCT02682823|20073917|P2|Overall Study|Withdrawal by Subject|0
5814448|NCT02682823|20073918|P1|Overall Study|Withdrawal by Subject|0
5814449|NCT02682602|20073954|P2|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|0
5814450|NCT02682602|20073955|P1|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|3
5814451|NCT02682602|20073954|P2|Pre-operative Diseased & Normal Hips|Unusable images|0
5814452|NCT02682602|20073955|P1|Pre-operative Diseased & Normal Hips|Unusable images|1
5814453|NCT02682264|20074088|P2|Overall Study|Stopped test article application|1
5814454|NCT02682264|20074089|P1|Overall Study|Stopped test article application|0
5814455|NCT02682264|20074088|P2|Overall Study|Moved abroad and unable to continue|3
5814456|NCT02682264|20074089|P1|Overall Study|Moved abroad and unable to continue|0
5814457|NCT02682264|20074088|P2|Overall Study|Technical Problems|1
5814458|NCT02682264|20074089|P1|Overall Study|Technical Problems|0
5814459|NCT02682264|20074088|P2|Overall Study|Progressive Disease|0
5814460|NCT02682264|20074089|P1|Overall Study|Progressive Disease|1
5814461|NCT02682264|20074088|P2|Overall Study|Recovery|2
5814462|NCT02682264|20074089|P1|Overall Study|Recovery|1
5814463|NCT02682264|20074088|P2|Overall Study|Pregnancy|2
5814464|NCT02682264|20074089|P1|Overall Study|Pregnancy|1
5814465|NCT02682264|20074088|P2|Overall Study|Noncompliance with study drug|4
5814466|NCT02682264|20074089|P1|Overall Study|Noncompliance with study drug|1
5814467|NCT02682264|20074088|P2|Overall Study|Adverse Event|0
5814468|NCT02682264|20074089|P1|Overall Study|Adverse Event|9
5814469|NCT02682264|20074088|P2|Overall Study|Withdrawal by Parent|7
5814470|NCT02682264|20074089|P1|Overall Study|Withdrawal by Parent|6
5814471|NCT02682264|20074088|P2|Overall Study|Lack of Efficacy|16
5814472|NCT02682264|20074089|P1|Overall Study|Lack of Efficacy|14
5814473|NCT02682264|20074088|P2|Overall Study|Lost to Follow-up|41
5814474|NCT02682264|20074089|P1|Overall Study|Lost to Follow-up|49
5814475|NCT02682264|20074088|P2|Overall Study|Withdrawal by Subject|45
5814476|NCT02682264|20074089|P1|Overall Study|Withdrawal by Subject|56
5814477|NCT02681510|20074175|P1|Overall Study|Lost to Follow-up|9
5814478|NCT02681510|20074175|P1|Overall Study|Withdrawal by Subject|1
5814479|NCT02681094|20074205|P3|2 - Enrolled Participants Set|No treatment given|1
5814480|NCT02681094|20074206|P2|2 - Enrolled Participants Set|No treatment given|1
5814481|NCT02681094|20074207|P1|2 - Enrolled Participants Set|No treatment given|0
5814482|NCT02681094|20074205|P3|2 - Enrolled Participants Set|Other|7
5814483|NCT02681094|20074206|P2|2 - Enrolled Participants Set|Other|6
5814484|NCT02681094|20074207|P1|2 - Enrolled Participants Set|Other|6
5814485|NCT02681094|20074205|P3|2 - Enrolled Participants Set|Study specific discontinuation criteria|21
5814486|NCT02681094|20074206|P2|2 - Enrolled Participants Set|Study specific discontinuation criteria|15
5814487|NCT02681094|20074207|P1|2 - Enrolled Participants Set|Study specific discontinuation criteria|14
5814488|NCT02681094|20074205|P3|2 - Enrolled Participants Set|Lack of therapeutic response|14
5814489|NCT02681094|20074206|P2|2 - Enrolled Participants Set|Lack of therapeutic response|5
5814490|NCT02681094|20074207|P1|2 - Enrolled Participants Set|Lack of therapeutic response|1
5814491|NCT02681094|20074205|P3|2 - Enrolled Participants Set|Severe non-compliance to protocol|1
5814492|NCT02681094|20074206|P2|2 - Enrolled Participants Set|Severe non-compliance to protocol|0
5814493|NCT02681094|20074207|P1|2 - Enrolled Participants Set|Severe non-compliance to protocol|2
5814494|NCT02681094|20074205|P3|2 - Enrolled Participants Set|Adverse Event|1
5814495|NCT02681094|20074206|P2|2 - Enrolled Participants Set|Adverse Event|4
5814496|NCT02681094|20074207|P1|2 - Enrolled Participants Set|Adverse Event|10
5814497|NCT02681094|20074205|P3|2 - Enrolled Participants Set|Participant decision|9
5814498|NCT02681094|20074206|P2|2 - Enrolled Participants Set|Participant decision|10
5814499|NCT02681094|20074207|P1|2 - Enrolled Participants Set|Participant decision|7
5814500|NCT02681094|20074205|P3|1 -Modified Enrolled Participants Set|No treatment given|1
5814501|NCT02681094|20074206|P2|1 -Modified Enrolled Participants Set|No treatment given|1
5814502|NCT02681094|20074207|P1|1 -Modified Enrolled Participants Set|No treatment given|0
5814503|NCT02681094|20074205|P3|1 -Modified Enrolled Participants Set|Other|7
5814504|NCT02681094|20074206|P2|1 -Modified Enrolled Participants Set|Other|6
5814505|NCT02681094|20074207|P1|1 -Modified Enrolled Participants Set|Other|6
5814506|NCT02681094|20074205|P3|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|20
5814507|NCT02681094|20074206|P2|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|13
5814508|NCT02681094|20074207|P1|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|11
5814509|NCT02681094|20074205|P3|1 -Modified Enrolled Participants Set|Lack of therapeutic response|14
5814510|NCT02681094|20074206|P2|1 -Modified Enrolled Participants Set|Lack of therapeutic response|5
5814511|NCT02681094|20074207|P1|1 -Modified Enrolled Participants Set|Lack of therapeutic response|1
5814512|NCT02681094|20074205|P3|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|1
5814513|NCT02681094|20074206|P2|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|0
5814514|NCT02681094|20074207|P1|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|2
5814515|NCT02681094|20074205|P3|1 -Modified Enrolled Participants Set|Adverse Event|1
5814516|NCT02681094|20074206|P2|1 -Modified Enrolled Participants Set|Adverse Event|4
5814517|NCT02681094|20074207|P1|1 -Modified Enrolled Participants Set|Adverse Event|10
5814518|NCT02681094|20074205|P3|1 -Modified Enrolled Participants Set|Participant decision|9
5814519|NCT02681094|20074206|P2|1 -Modified Enrolled Participants Set|Participant decision|10
5814520|NCT02681094|20074207|P1|1 -Modified Enrolled Participants Set|Participant decision|7
5814521|NCT02680847|20074226|P3|Overall Study|Adverse Event|1
5814522|NCT02680847|20074227|P2|Overall Study|Adverse Event|0
5814523|NCT02680847|20074228|P1|Overall Study|Adverse Event|0
5814524|NCT02680847|20074226|P3|Overall Study|Lack of Efficacy|2
5814525|NCT02680847|20074227|P2|Overall Study|Lack of Efficacy|0
5814526|NCT02680847|20074228|P1|Overall Study|Lack of Efficacy|0
5814527|NCT02680847|20074226|P3|Overall Study|Unwilling to participate in study|0
5814528|NCT02680847|20074227|P2|Overall Study|Unwilling to participate in study|1
5814529|NCT02680847|20074228|P1|Overall Study|Unwilling to participate in study|1
5814530|NCT02680847|20074226|P3|Overall Study|No longer met eligibility criteria|0
5814531|NCT02680847|20074227|P2|Overall Study|No longer met eligibility criteria|2
5814532|NCT02680847|20074228|P1|Overall Study|No longer met eligibility criteria|2
5814533|NCT02680847|20074226|P3|Overall Study|Other|0
5814534|NCT02680847|20074227|P2|Overall Study|Other|0
5814535|NCT02680847|20074228|P1|Overall Study|Other|2
5814536|NCT02680834|20074265|P2|Overall Study|Lost to Follow-up|1
5814537|NCT02680834|20074266|P1|Overall Study|Lost to Follow-up|0
5814538|NCT02680834|20074265|P2|Overall Study|Withdrawal by Subject|0
5814539|NCT02680834|20074266|P1|Overall Study|Withdrawal by Subject|6
5814540|NCT02680834|20074265|P2|Overall Study|Physician Decision|2
5814541|NCT02680834|20074266|P1|Overall Study|Physician Decision|5
5814542|NCT02680756|20074278|P2|Overall Study|None of above or not recorded|2
5814543|NCT02680756|20074279|P1|Overall Study|None of above or not recorded|3
5814544|NCT02680756|20074278|P2|Overall Study|TSAT above 60% or a ferritin above 800 m|0
5814545|NCT02680756|20074279|P1|Overall Study|TSAT above 60% or a ferritin above 800 m|1
5814546|NCT02680756|20074278|P2|Overall Study|Protocol Violation|0
5814547|NCT02680756|20074279|P1|Overall Study|Protocol Violation|1
5814548|NCT02680756|20074278|P2|Overall Study|Death|0
5814549|NCT02680756|20074279|P1|Overall Study|Death|1
5814550|NCT02680756|20074278|P2|Overall Study|Blood transfusion for any reason|1
5814551|NCT02680756|20074279|P1|Overall Study|Blood transfusion for any reason|0
5814552|NCT02680756|20074278|P2|Overall Study|Hb ≤7.5 g/dL|2
5814553|NCT02680756|20074279|P1|Overall Study|Hb ≤7.5 g/dL|0
5814554|NCT02680756|20074278|P2|Overall Study|Physician Decision|1
5814555|NCT02680756|20074279|P1|Overall Study|Physician Decision|4
5814556|NCT02680756|20074278|P2|Overall Study|Withdrawal by Subject|5
5814557|NCT02680756|20074279|P1|Overall Study|Withdrawal by Subject|5
5814558|NCT02680756|20074278|P2|Overall Study|Lost to Follow-up|6
5814559|NCT02680756|20074279|P1|Overall Study|Lost to Follow-up|7
5814560|NCT02680756|20074278|P2|Overall Study|Adverse Event|2
5814561|NCT02680756|20074279|P1|Overall Study|Adverse Event|10
5814562|NCT02680665|20074327|P1|Overall Study|No visit after the first prescription|5
5814563|NCT02680639|20074333|P3|Screening Period|Screen Failure|0
5814564|NCT02680639|20074334|P2|Screening Period|Screen Failure|0
5814565|NCT02680639|20074335|P1|Screening Period|Screen Failure|7
5814566|NCT02680041|20074417|P1|Overall Study|Lost to Follow-up|2
5814567|NCT02680041|20074417|P1|Overall Study|Withdrawal prior to 18F-fluciclovine PET|8
5814568|NCT02680002|20074432|P6|Overall Study|Adverse Event|2
5814569|NCT02680002|20074433|P5|Overall Study|Adverse Event|1
5814570|NCT02680002|20074434|P4|Overall Study|Adverse Event|0
5814571|NCT02680002|20074435|P3|Overall Study|Adverse Event|0
5814572|NCT02680002|20074436|P2|Overall Study|Adverse Event|0
5814573|NCT02680002|20074437|P1|Overall Study|Adverse Event|0
5814574|NCT02680002|20074432|P6|Overall Study|Other|0
5814575|NCT02680002|20074433|P5|Overall Study|Other|1
5814576|NCT02680002|20074434|P4|Overall Study|Other|0
5814577|NCT02680002|20074435|P3|Overall Study|Other|0
5814578|NCT02680002|20074436|P2|Overall Study|Other|1
5814579|NCT02680002|20074437|P1|Overall Study|Other|0
5814580|NCT02680002|20074432|P6|Overall Study|Missed Visit 8 (Day 201)|0
5814581|NCT02680002|20074433|P5|Overall Study|Missed Visit 8 (Day 201)|5
5814582|NCT02680002|20074434|P4|Overall Study|Missed Visit 8 (Day 201)|1
5814583|NCT02680002|20074435|P3|Overall Study|Missed Visit 8 (Day 201)|3
5814584|NCT02680002|20074436|P2|Overall Study|Missed Visit 8 (Day 201)|1
5814585|NCT02680002|20074437|P1|Overall Study|Missed Visit 8 (Day 201)|2
5814586|NCT02680002|20074432|P6|Overall Study|Withdrawal by Subject|2
5814587|NCT02680002|20074433|P5|Overall Study|Withdrawal by Subject|2
5814588|NCT02680002|20074434|P4|Overall Study|Withdrawal by Subject|0
5814589|NCT02680002|20074435|P3|Overall Study|Withdrawal by Subject|1
5814590|NCT02680002|20074436|P2|Overall Study|Withdrawal by Subject|0
5814591|NCT02680002|20074437|P1|Overall Study|Withdrawal by Subject|0
5814592|NCT02680002|20074432|P6|Overall Study|Protocol Violation|2
5814593|NCT02680002|20074433|P5|Overall Study|Protocol Violation|1
5814594|NCT02680002|20074434|P4|Overall Study|Protocol Violation|0
5814595|NCT02680002|20074435|P3|Overall Study|Protocol Violation|1
5814596|NCT02680002|20074436|P2|Overall Study|Protocol Violation|0
5814597|NCT02680002|20074437|P1|Overall Study|Protocol Violation|1
5814598|NCT02680002|20074432|P6|Overall Study|Physician Decision|1
5814599|NCT02680002|20074433|P5|Overall Study|Physician Decision|1
5814600|NCT02680002|20074434|P4|Overall Study|Physician Decision|1
5814601|NCT02680002|20074435|P3|Overall Study|Physician Decision|1
5814602|NCT02680002|20074436|P2|Overall Study|Physician Decision|1
5814603|NCT02680002|20074437|P1|Overall Study|Physician Decision|5
5814604|NCT02680002|20074432|P6|Overall Study|Lost to Follow-up|2
5814605|NCT02680002|20074433|P5|Overall Study|Lost to Follow-up|0
5814606|NCT02680002|20074434|P4|Overall Study|Lost to Follow-up|2
5814607|NCT02680002|20074435|P3|Overall Study|Lost to Follow-up|4
5814608|NCT02680002|20074436|P2|Overall Study|Lost to Follow-up|1
5814609|NCT02680002|20074437|P1|Overall Study|Lost to Follow-up|5
5814610|NCT02679755|20074580|P2|Overall Study|Adverse events not related to study drug|2
5814611|NCT02679755|20074581|P1|Overall Study|Adverse events not related to study drug|1
5814612|NCT02679755|20074580|P2|Overall Study|Adverse Event|4
5814613|NCT02679755|20074581|P1|Overall Study|Adverse Event|1
5814614|NCT02679755|20074580|P2|Overall Study|Withdrawal by participant|3
5814615|NCT02679755|20074581|P1|Overall Study|Withdrawal by participant|6
5814616|NCT02679755|20074580|P2|Overall Study|Not defined|2
5814617|NCT02679755|20074581|P1|Overall Study|Not defined|0
5814618|NCT02679755|20074580|P2|Overall Study|Objective progression or relapse|83
5814619|NCT02679755|20074581|P1|Overall Study|Objective progression or relapse|24
5814620|NCT02679755|20074580|P2|Overall Study|Lost to Follow-up|0
5814621|NCT02679755|20074581|P1|Overall Study|Lost to Follow-up|1
5814622|NCT02679755|20074580|P2|Overall Study|Global deterioration of health status|8
5814623|NCT02679755|20074581|P1|Overall Study|Global deterioration of health status|1
5814624|NCT02679755|20074580|P2|Overall Study|Death|3
5814625|NCT02679755|20074581|P1|Overall Study|Death|0
5814626|NCT02679729|20074623|P9|Overall Study|Participant decision|0
5814627|NCT02679729|20074624|P8|Overall Study|Participant decision|0
5814628|NCT02679729|20074625|P7|Overall Study|Participant decision|1
5814629|NCT02679729|20074626|P6|Overall Study|Participant decision|0
5814630|NCT02679729|20074627|P5|Overall Study|Participant decision|0
5814631|NCT02679729|20074628|P4|Overall Study|Participant decision|0
5814632|NCT02679729|20074629|P3|Overall Study|Participant decision|0
5814633|NCT02679729|20074630|P2|Overall Study|Participant decision|1
5814634|NCT02679729|20074631|P1|Overall Study|Participant decision|0
5814635|NCT02679729|20074623|P9|Overall Study|Lost to Follow-up|0
5814636|NCT02679729|20074624|P8|Overall Study|Lost to Follow-up|0
5814637|NCT02679729|20074625|P7|Overall Study|Lost to Follow-up|0
5814638|NCT02679729|20074626|P6|Overall Study|Lost to Follow-up|0
5814639|NCT02679729|20074627|P5|Overall Study|Lost to Follow-up|1
5814640|NCT02679729|20074628|P4|Overall Study|Lost to Follow-up|0
5814641|NCT02679729|20074629|P3|Overall Study|Lost to Follow-up|0
5814642|NCT02679729|20074630|P2|Overall Study|Lost to Follow-up|1
5814643|NCT02679729|20074631|P1|Overall Study|Lost to Follow-up|0
5814644|NCT02679573|20074743|P2|Overall Study|Lost to Follow-up|3
5814645|NCT02679573|20074744|P1|Overall Study|Lost to Follow-up|0
5814646|NCT02679573|20074743|P2|Overall Study|Physician Decision|4
5814647|NCT02679573|20074744|P1|Overall Study|Physician Decision|2
5814648|NCT02679573|20074743|P2|Overall Study|Death|0
5814649|NCT02679573|20074744|P1|Overall Study|Death|2
5814650|NCT02679573|20074743|P2|Overall Study|Withdrawal by Subject|9
5814651|NCT02679573|20074744|P1|Overall Study|Withdrawal by Subject|2
5814652|NCT02679573|20074743|P2|Overall Study|Could not complete required study visits|2
5814653|NCT02679573|20074744|P1|Overall Study|Could not complete required study visits|6
5814654|NCT02679573|20074743|P2|Overall Study|Lack of Efficacy|15
5814655|NCT02679573|20074744|P1|Overall Study|Lack of Efficacy|12
5814656|NCT02679573|20074743|P2|Overall Study|Adverse Event|6
5814657|NCT02679573|20074744|P1|Overall Study|Adverse Event|13
5814658|NCT02679287|20074768|P2|Period 3|Work/Scheduling Conflict|1
5814659|NCT02679287|20074769|P1|Period 3|Work/Scheduling Conflict|0
5814660|NCT02679287|20074768|P2|Period 2|Disliked Mobile System|0
5814661|NCT02679287|20074769|P1|Period 2|Disliked Mobile System|2
5814662|NCT02679287|20074768|P2|Period 2|Work/Scheduling Conflict|0
5814663|NCT02679287|20074769|P1|Period 2|Work/Scheduling Conflict|1
5814664|NCT02679287|20074768|P2|Period 1: Randomization-Study Session 1|Adverse Event prior to intervention|1
5814665|NCT02679287|20074769|P1|Period 1: Randomization-Study Session 1|Adverse Event prior to intervention|0
5814666|NCT02679287|20074768|P2|Period 1: Randomization-Study Session 1|Disliked mobile system|1
5814667|NCT02679287|20074769|P1|Period 1: Randomization-Study Session 1|Disliked mobile system|0
5814668|NCT02679287|20074768|P2|Period 1: Randomization-Study Session 1|Work or scheduling conflict|3
5814669|NCT02679287|20074769|P1|Period 1: Randomization-Study Session 1|Work or scheduling conflict|2
5814670|NCT02679287|20074768|P2|Period 1: Randomization-Study Session 1|Regimen not compatible with study|1
5814671|NCT02679287|20074769|P1|Period 1: Randomization-Study Session 1|Regimen not compatible with study|2
5814672|NCT02679274|20074799|P2|Overall Study|Withdrawal by Subject|0
5814673|NCT02679274|20074800|P1|Overall Study|Withdrawal by Subject|1
5814674|NCT02679235|20074830|P1|Overall Study|Adverse Event|1
5814675|NCT02679235|20074830|P1|Overall Study|Withdrawal by Subject|3
5814676|NCT02679222|20074837|P1|Overall Study|No time for project|1
5814677|NCT02679079|20074857|P3|Overall Study|Withdrawal by Subject|0
5814678|NCT02679079|20074858|P2|Overall Study|Withdrawal by Subject|1
5814679|NCT02679079|20074859|P1|Overall Study|Withdrawal by Subject|2
5814680|NCT02679079|20074857|P3|Overall Study|Protocol Violation|0
5814681|NCT02679079|20074858|P2|Overall Study|Protocol Violation|1
5814682|NCT02679079|20074859|P1|Overall Study|Protocol Violation|0
5814683|NCT02679079|20074857|P3|Overall Study|Adverse Event|2
5814684|NCT02679079|20074858|P2|Overall Study|Adverse Event|0
5814685|NCT02679079|20074859|P1|Overall Study|Adverse Event|2
5814686|NCT02678923|20074904|P2|Overall Study|Did Not Return for Study Visits|0
5814687|NCT02678923|20074905|P1|Overall Study|Did Not Return for Study Visits|1
5814688|NCT02678923|20074904|P2|Overall Study|Lost to Follow-up|0
5814689|NCT02678923|20074905|P1|Overall Study|Lost to Follow-up|1
5814690|NCT02678923|20074904|P2|Overall Study|Withdrawal by Subject|2
5814691|NCT02678923|20074905|P1|Overall Study|Withdrawal by Subject|3
5814692|NCT02678923|20074904|P2|Overall Study|Protocol Deviation (Not Dosed)|3
5814693|NCT02678923|20074905|P1|Overall Study|Protocol Deviation (Not Dosed)|1
5814694|NCT02678676|20074921|P2|Overall Study|Unconfirmed for lost to follow-up|67
5814695|NCT02678676|20074922|P1|Overall Study|Unconfirmed for lost to follow-up|85
5814696|NCT02678676|20074921|P2|Overall Study|Lost to Follow-up|151
5814697|NCT02678676|20074922|P1|Overall Study|Lost to Follow-up|171
5814698|NCT02678676|20074921|P2|Overall Study|Withdrawal by Subject|5
5814699|NCT02678676|20074922|P1|Overall Study|Withdrawal by Subject|13
5814700|NCT02678676|20074921|P2|Overall Study|Death|649
5814701|NCT02678676|20074922|P1|Overall Study|Death|619
5814702|NCT02678416|20074953|P1|Part 2|Withdrawal by Subject|1
5814703|NCT02678416|20074953|P1|Part 2|Adverse Event|2
5814704|NCT02678416|20074953|P1|Part 1|Withdrawal by Subject|1
5814705|NCT02678390|20074973|P2|AE (1 Day)|Withdrawal by Subject|1
5814706|NCT02678390|20074974|P1|AE (1 Day)|Withdrawal by Subject|0
5814707|NCT02678286|20074990|P2|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2
5814708|NCT02678286|20074991|P1|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2
5814709|NCT02678286|20074990|P2|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|2
5814710|NCT02678286|20074991|P1|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|3
5814711|NCT02678286|20074990|P2|Study Overall (28 Day Follow-Up)|Lack of Efficacy|0
5814712|NCT02678286|20074991|P1|Study Overall (28 Day Follow-Up)|Lack of Efficacy|1
5814713|NCT02678286|20074990|P2|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|1
5814714|NCT02678286|20074991|P1|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|0
5814715|NCT02678286|20074990|P2|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|1
5814716|NCT02678286|20074991|P1|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|2
5814717|NCT02678000|20075043|P5|PART 2|Withdrawal by Subject|0
5814718|NCT02678000|20075044|P4|PART 2|Withdrawal by Subject|0
5814719|NCT02678000|20075045|P3|PART 2|Withdrawal by Subject|1
5814720|NCT02678000|20075046|P2|PART 2|Withdrawal by Subject|0
5814721|NCT02678000|20075047|P1|PART 2|Withdrawal by Subject|0
5814722|NCT02678000|20075043|P5|PART 2|Adverse Event|0
5814723|NCT02678000|20075044|P4|PART 2|Adverse Event|1
5814724|NCT02678000|20075045|P3|PART 2|Adverse Event|2
5814725|NCT02678000|20075046|P2|PART 2|Adverse Event|0
5814726|NCT02678000|20075047|P1|PART 2|Adverse Event|0
5814727|NCT02677896|20075085|P2|Overall Study|Did not receive study drug|2
5814728|NCT02677896|20075086|P1|Overall Study|Did not receive study drug|2
5814729|NCT02677896|20075085|P2|Overall Study|Miscellaneous|11
5814730|NCT02677896|20075086|P1|Overall Study|Miscellaneous|6
5814731|NCT02677896|20075085|P2|Overall Study|Withdrawal by patient:|30
5814732|NCT02677896|20075086|P1|Overall Study|Withdrawal by patient:|25
5814733|NCT02677896|20075085|P2|Overall Study|Protocol deviation|1
5814734|NCT02677896|20075086|P1|Overall Study|Protocol deviation|2
5814735|NCT02677896|20075085|P2|Overall Study|Progressive disease:|171
5814736|NCT02677896|20075086|P1|Overall Study|Progressive disease:|65
5814737|NCT02677896|20075085|P2|Overall Study|Lost to Follow-up|1
5814738|NCT02677896|20075086|P1|Overall Study|Lost to Follow-up|0
5814739|NCT02677896|20075085|P2|Overall Study|Death|7
5814740|NCT02677896|20075086|P1|Overall Study|Death|9
5814741|NCT02677896|20075085|P2|Overall Study|Adverse Event|21
5814742|NCT02677896|20075086|P1|Overall Study|Adverse Event|28
5814743|NCT02677844|20075114|P7|Period 3|Withdrawal by Subject|0
5814744|NCT02677844|20075115|P6|Period 3|Withdrawal by Subject|0
5814745|NCT02677844|20075116|P5|Period 3|Withdrawal by Subject|0
5814746|NCT02677844|20075117|P4|Period 3|Withdrawal by Subject|1
5814747|NCT02677844|20075118|P3|Period 3|Withdrawal by Subject|0
5814748|NCT02677844|20075119|P2|Period 3|Withdrawal by Subject|0
5814749|NCT02677844|20075120|P1|Period 3|Withdrawal by Subject|0
5814750|NCT02677714|20075200|P2|Overall Study|Withdrawal by Subject|0
5814751|NCT02677714|20075201|P1|Overall Study|Withdrawal by Subject|2
5814752|NCT02677220|20075272|P1|Overall Study|Adverse Event|1
5814753|NCT02677116|20075287|P9|Overall Study|Withdrawal by Subject|0
5814754|NCT02677116|20075288|P8|Overall Study|Withdrawal by Subject|0
5814755|NCT02677116|20075289|P7|Overall Study|Withdrawal by Subject|0
5814756|NCT02677116|20075290|P6|Overall Study|Withdrawal by Subject|0
5814757|NCT02677116|20075291|P5|Overall Study|Withdrawal by Subject|0
5814758|NCT02677116|20075292|P4|Overall Study|Withdrawal by Subject|0
5814759|NCT02677116|20075293|P3|Overall Study|Withdrawal by Subject|0
5814760|NCT02677116|20075294|P2|Overall Study|Withdrawal by Subject|0
5814761|NCT02677116|20075295|P1|Overall Study|Withdrawal by Subject|1
5814762|NCT02677116|20075287|P9|Overall Study|Withdrawal by parent or guardian|0
5814763|NCT02677116|20075288|P8|Overall Study|Withdrawal by parent or guardian|1
5814764|NCT02677116|20075289|P7|Overall Study|Withdrawal by parent or guardian|2
5814765|NCT02677116|20075290|P6|Overall Study|Withdrawal by parent or guardian|0
5814766|NCT02677116|20075291|P5|Overall Study|Withdrawal by parent or guardian|0
5814767|NCT02677116|20075292|P4|Overall Study|Withdrawal by parent or guardian|1
5814768|NCT02677116|20075293|P3|Overall Study|Withdrawal by parent or guardian|0
5814769|NCT02677116|20075294|P2|Overall Study|Withdrawal by parent or guardian|1
5814770|NCT02677116|20075295|P1|Overall Study|Withdrawal by parent or guardian|2
5814771|NCT02677116|20075287|P9|Overall Study|Physician Decision|2
5814772|NCT02677116|20075288|P8|Overall Study|Physician Decision|1
5814773|NCT02677116|20075289|P7|Overall Study|Physician Decision|1
5814774|NCT02677116|20075290|P6|Overall Study|Physician Decision|3
5814775|NCT02677116|20075291|P5|Overall Study|Physician Decision|1
5814776|NCT02677116|20075292|P4|Overall Study|Physician Decision|2
5814777|NCT02677116|20075293|P3|Overall Study|Physician Decision|3
5814778|NCT02677116|20075294|P2|Overall Study|Physician Decision|2
5814779|NCT02677116|20075295|P1|Overall Study|Physician Decision|0
5814780|NCT02677116|20075287|P9|Overall Study|Adverse Event|0
5814781|NCT02677116|20075288|P8|Overall Study|Adverse Event|0
5814782|NCT02677116|20075289|P7|Overall Study|Adverse Event|1
5814783|NCT02677116|20075290|P6|Overall Study|Adverse Event|1
5814784|NCT02677116|20075291|P5|Overall Study|Adverse Event|0
5814785|NCT02677116|20075292|P4|Overall Study|Adverse Event|0
5814786|NCT02677116|20075293|P3|Overall Study|Adverse Event|0
5814787|NCT02677116|20075294|P2|Overall Study|Adverse Event|1
5814788|NCT02677116|20075295|P1|Overall Study|Adverse Event|0
5814789|NCT02676895|20075368|P3|Overall Study|Withdrawal by Subject|1
5814790|NCT02676895|20075369|P2|Overall Study|Withdrawal by Subject|0
5814791|NCT02676895|20075370|P1|Overall Study|Withdrawal by Subject|0
5814792|NCT02676895|20075368|P3|Overall Study|Lost to Follow-up|1
5814793|NCT02676895|20075369|P2|Overall Study|Lost to Follow-up|0
5814794|NCT02676895|20075370|P1|Overall Study|Lost to Follow-up|0
5814795|NCT02676895|20075368|P3|Overall Study|Adverse Event|1
5814796|NCT02676895|20075369|P2|Overall Study|Adverse Event|3
5814797|NCT02676895|20075370|P1|Overall Study|Adverse Event|0
5814798|NCT02676895|20075368|P3|Overall Study|Protocol Violation|0
5814799|NCT02676895|20075369|P2|Overall Study|Protocol Violation|0
5814800|NCT02676895|20075370|P1|Overall Study|Protocol Violation|1
5814801|NCT02676895|20075368|P3|Overall Study|Administrative reason|0
5814802|NCT02676895|20075369|P2|Overall Study|Administrative reason|0
5814803|NCT02676895|20075370|P1|Overall Study|Administrative reason|1
5814804|NCT02676882|20075413|P2|Overall Study|Withdrawal by Subject|2
5814805|NCT02676882|20075414|P1|Overall Study|Withdrawal by Subject|1
5814806|NCT02676882|20075413|P2|Overall Study|Lost to Follow-up|0
5814807|NCT02676882|20075414|P1|Overall Study|Lost to Follow-up|1
5814808|NCT02676882|20075413|P2|Overall Study|Adverse Event|0
5814809|NCT02676882|20075414|P1|Overall Study|Adverse Event|1
5814810|NCT02676466|20075433|P8|Overall Study|Withdrawal by Subject|1
5814811|NCT02676466|20075434|P7|Overall Study|Withdrawal by Subject|1
5814812|NCT02676466|20075435|P6|Overall Study|Withdrawal by Subject|1
5814813|NCT02676466|20075436|P5|Overall Study|Withdrawal by Subject|3
5814814|NCT02676466|20075437|P4|Overall Study|Withdrawal by Subject|0
5814815|NCT02676466|20075438|P3|Overall Study|Withdrawal by Subject|1
5814816|NCT02676466|20075439|P2|Overall Study|Withdrawal by Subject|3
5814817|NCT02676466|20075440|P1|Overall Study|Withdrawal by Subject|4
5814818|NCT02676466|20075433|P8|Overall Study|Death|0
5814819|NCT02676466|20075434|P7|Overall Study|Death|0
5814820|NCT02676466|20075435|P6|Overall Study|Death|0
5814821|NCT02676466|20075436|P5|Overall Study|Death|0
5814822|NCT02676466|20075437|P4|Overall Study|Death|0
5814823|NCT02676466|20075438|P3|Overall Study|Death|1
5814824|NCT02676466|20075439|P2|Overall Study|Death|2
5814825|NCT02676466|20075440|P1|Overall Study|Death|0
5814826|NCT02675998|20075523|P4|4-Week Randomized Withdrawal Period|Withdrawal by Subject|1
5814827|NCT02675998|20075524|P3|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0
5814828|NCT02675998|20075525|P2|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0
5814829|NCT02675998|20075526|P1|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0
5814830|NCT02675998|20075523|P4|4-Week Randomized Withdrawal Period|Physician Decision|0
5814831|NCT02675998|20075524|P3|4-Week Randomized Withdrawal Period|Physician Decision|0
5814832|NCT02675998|20075525|P2|4-Week Randomized Withdrawal Period|Physician Decision|0
5814833|NCT02675998|20075526|P1|4-Week Randomized Withdrawal Period|Physician Decision|1
5814834|NCT02675998|20075523|P4|4-Week Randomized Withdrawal Period|Protocol Violation|1
5814835|NCT02675998|20075524|P3|4-Week Randomized Withdrawal Period|Protocol Violation|0
5814836|NCT02675998|20075525|P2|4-Week Randomized Withdrawal Period|Protocol Violation|0
5814837|NCT02675998|20075526|P1|4-Week Randomized Withdrawal Period|Protocol Violation|0
5814838|NCT02675998|20075523|P4|4-Week Randomized Withdrawal Period|Adverse Event|3
5814839|NCT02675998|20075524|P3|4-Week Randomized Withdrawal Period|Adverse Event|1
5814840|NCT02675998|20075525|P2|4-Week Randomized Withdrawal Period|Adverse Event|0
5814841|NCT02675998|20075526|P1|4-Week Randomized Withdrawal Period|Adverse Event|0
5814842|NCT02675998|20075523|P4|4-Week Randomized Withdrawal Period|Lack of Efficacy|3
5814843|NCT02675998|20075524|P3|4-Week Randomized Withdrawal Period|Lack of Efficacy|1
5814844|NCT02675998|20075525|P2|4-Week Randomized Withdrawal Period|Lack of Efficacy|1
5814845|NCT02675998|20075526|P1|4-Week Randomized Withdrawal Period|Lack of Efficacy|0
5814846|NCT02675998|20075523|P4|8-Week Treatment Period|Other|0
5814847|NCT02675998|20075524|P3|8-Week Treatment Period|Other|2
5814848|NCT02675998|20075525|P2|8-Week Treatment Period|Other|1
5814849|NCT02675998|20075526|P1|8-Week Treatment Period|Other|3
5814850|NCT02675998|20075523|P4|8-Week Treatment Period|Protocol Violation|0
5814851|NCT02675998|20075524|P3|8-Week Treatment Period|Protocol Violation|1
5814852|NCT02675998|20075525|P2|8-Week Treatment Period|Protocol Violation|1
5814853|NCT02675998|20075526|P1|8-Week Treatment Period|Protocol Violation|1
5814854|NCT02675998|20075523|P4|8-Week Treatment Period|GI side Effects|0
5814855|NCT02675998|20075524|P3|8-Week Treatment Period|GI side Effects|2
5814856|NCT02675998|20075525|P2|8-Week Treatment Period|GI side Effects|4
5814857|NCT02675998|20075526|P1|8-Week Treatment Period|GI side Effects|1
5814858|NCT02675998|20075523|P4|8-Week Treatment Period|Physician Decision|0
5814859|NCT02675998|20075524|P3|8-Week Treatment Period|Physician Decision|2
5814860|NCT02675998|20075525|P2|8-Week Treatment Period|Physician Decision|0
5814861|NCT02675998|20075526|P1|8-Week Treatment Period|Physician Decision|1
5814862|NCT02675998|20075523|P4|8-Week Treatment Period|Lack of Efficacy|0
5814863|NCT02675998|20075524|P3|8-Week Treatment Period|Lack of Efficacy|3
5814864|NCT02675998|20075525|P2|8-Week Treatment Period|Lack of Efficacy|5
5814865|NCT02675998|20075526|P1|8-Week Treatment Period|Lack of Efficacy|2
5814866|NCT02675998|20075523|P4|8-Week Treatment Period|Withdrawal by Subject|0
5814867|NCT02675998|20075524|P3|8-Week Treatment Period|Withdrawal by Subject|3
5814868|NCT02675998|20075525|P2|8-Week Treatment Period|Withdrawal by Subject|3
5814869|NCT02675998|20075526|P1|8-Week Treatment Period|Withdrawal by Subject|3
5814870|NCT02675998|20075523|P4|8-Week Treatment Period|Adverse Event|0
5814871|NCT02675998|20075524|P3|8-Week Treatment Period|Adverse Event|6
5814872|NCT02675998|20075525|P2|8-Week Treatment Period|Adverse Event|5
5814873|NCT02675998|20075526|P1|8-Week Treatment Period|Adverse Event|6
5814874|NCT02675907|20075542|P2|Study Overall|Lost to Follow-up|2
5814875|NCT02675907|20075543|P1|Study Overall|Lost to Follow-up|0
5814876|NCT02675907|20075542|P2|Study Overall|Withdrawal by Subject|2
5814877|NCT02675907|20075543|P1|Study Overall|Withdrawal by Subject|2
5814878|NCT02675907|20075542|P2|Study Overall|Lack of Efficacy|0
5814879|NCT02675907|20075543|P1|Study Overall|Lack of Efficacy|1
5814880|NCT02675907|20075542|P2|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1
5814881|NCT02675907|20075543|P1|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1
5814882|NCT02675907|20075542|P2|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4
5814883|NCT02675907|20075543|P1|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4
5814884|NCT02675751|20075588|P1|Overall Study|Lost to Follow-up|16
5814885|NCT02675634|20075592|P6|Test Period 2|Adverse Event|1
5814886|NCT02675634|20075593|P5|Test Period 2|Adverse Event|0
5814887|NCT02675634|20075594|P4|Test Period 2|Adverse Event|0
5814888|NCT02675634|20075595|P3|Test Period 2|Adverse Event|0
5814889|NCT02675634|20075596|P2|Test Period 2|Adverse Event|0
5814890|NCT02675634|20075597|P1|Test Period 2|Adverse Event|0
5814891|NCT02675634|20075592|P6|Test Period 2|Lack of Efficacy|0
5814892|NCT02675634|20075593|P5|Test Period 2|Lack of Efficacy|0
5814893|NCT02675634|20075594|P4|Test Period 2|Lack of Efficacy|0
5814894|NCT02675634|20075595|P3|Test Period 2|Lack of Efficacy|0
5814895|NCT02675634|20075596|P2|Test Period 2|Lack of Efficacy|0
5814896|NCT02675634|20075597|P1|Test Period 2|Lack of Efficacy|1
5814897|NCT02675634|20075592|P6|Test Period 1|Device deficiency that did not lead to A|0
5814898|NCT02675634|20075593|P5|Test Period 1|Device deficiency that did not lead to A|0
5814899|NCT02675634|20075594|P4|Test Period 1|Device deficiency that did not lead to A|0
5814900|NCT02675634|20075595|P3|Test Period 1|Device deficiency that did not lead to A|1
5814901|NCT02675634|20075596|P2|Test Period 1|Device deficiency that did not lead to A|0
5814902|NCT02675634|20075597|P1|Test Period 1|Device deficiency that did not lead to A|0
5814903|NCT02675634|20075592|P6|Test Period 1|Adverse Event|0
5814904|NCT02675634|20075593|P5|Test Period 1|Adverse Event|0
5814905|NCT02675634|20075594|P4|Test Period 1|Adverse Event|1
5814906|NCT02675634|20075595|P3|Test Period 1|Adverse Event|0
5814907|NCT02675634|20075596|P2|Test Period 1|Adverse Event|1
5814908|NCT02675634|20075597|P1|Test Period 1|Adverse Event|0
5814909|NCT02675517|20075614|P1|Overall Study|Evaluable PF-10 questionnaire at visit1|151
5814910|NCT02675517|20075614|P1|Overall Study|No evaluable PF-10 questionnaire at all|8
5814911|NCT02675426|20075626|P3|Overall Study|Other|2
5814912|NCT02675426|20075627|P2|Overall Study|Other|1
5814913|NCT02675426|20075628|P1|Overall Study|Other|3
5814914|NCT02675426|20075626|P3|Overall Study|Lost to Follow-up|2
5814915|NCT02675426|20075627|P2|Overall Study|Lost to Follow-up|0
5814916|NCT02675426|20075628|P1|Overall Study|Lost to Follow-up|1
5814917|NCT02675426|20075626|P3|Overall Study|Withdrawal by Subject|5
5814918|NCT02675426|20075627|P2|Overall Study|Withdrawal by Subject|5
5814919|NCT02675426|20075628|P1|Overall Study|Withdrawal by Subject|3
5814920|NCT02675426|20075626|P3|Overall Study|Adverse Event|9
5814921|NCT02675426|20075627|P2|Overall Study|Adverse Event|2
5814922|NCT02675426|20075628|P1|Overall Study|Adverse Event|6
5814932|NCT02675075|20075710|P2|Overall Study|Lost to Follow-up|0
5814933|NCT02675075|20075711|P1|Overall Study|Lost to Follow-up|3
5814934|NCT02674854|20075723|P3|Overall Study|Subject missed V6.2|0
5814935|NCT02674854|20075724|P2|Overall Study|Subject missed V6.2|0
5814936|NCT02674854|20075725|P1|Overall Study|Subject missed V6.2|1
5814937|NCT02674854|20075723|P3|Overall Study|Death|0
5814938|NCT02674854|20075724|P2|Overall Study|Death|1
5814939|NCT02674854|20075725|P1|Overall Study|Death|0
5814940|NCT02674854|20075723|P3|Overall Study|Protocol Violation|2
5814941|NCT02674854|20075724|P2|Overall Study|Protocol Violation|1
5814942|NCT02674854|20075725|P1|Overall Study|Protocol Violation|1
5814943|NCT02674854|20075723|P3|Overall Study|Disallowed Concurrent Medication|0
5814944|NCT02674854|20075724|P2|Overall Study|Disallowed Concurrent Medication|2
5814945|NCT02674854|20075725|P1|Overall Study|Disallowed Concurrent Medication|2
5814946|NCT02674854|20075723|P3|Overall Study|Lack of Efficacy|0
5814947|NCT02674854|20075724|P2|Overall Study|Lack of Efficacy|3
5814948|NCT02674854|20075725|P1|Overall Study|Lack of Efficacy|0
5814949|NCT02674854|20075723|P3|Overall Study|Lost to Follow-up|2
5814950|NCT02674854|20075724|P2|Overall Study|Lost to Follow-up|0
5814951|NCT02674854|20075725|P1|Overall Study|Lost to Follow-up|1
5814952|NCT02674854|20075723|P3|Overall Study|No-compliant subject|1
5814953|NCT02674854|20075724|P2|Overall Study|No-compliant subject|0
5814954|NCT02674854|20075725|P1|Overall Study|No-compliant subject|1
5814955|NCT02674854|20075723|P3|Overall Study|Withdrawal by Subject|4
5814956|NCT02674854|20075724|P2|Overall Study|Withdrawal by Subject|5
5814957|NCT02674854|20075725|P1|Overall Study|Withdrawal by Subject|1
5814958|NCT02674854|20075723|P3|Overall Study|Adverse Event|5
5814959|NCT02674854|20075724|P2|Overall Study|Adverse Event|15
5814960|NCT02674854|20075725|P1|Overall Study|Adverse Event|17
5814961|NCT02674685|20075733|P1|Overall Study|Protocol Violation|4
5814962|NCT02674633|20075774|P2|Overall Study|Withdrawal by Parent/Guardian|2
5814963|NCT02674633|20075775|P1|Overall Study|Withdrawal by Parent/Guardian|1
5814964|NCT02674633|20075774|P2|Overall Study|Physician Decision|0
5814965|NCT02674633|20075775|P1|Overall Study|Physician Decision|1
5814966|NCT02674633|20075774|P2|Overall Study|Lost to Follow-up|2
5814967|NCT02674633|20075775|P1|Overall Study|Lost to Follow-up|3
5814968|NCT02674568|20075795|P1|Overall Study|Other, Not Specified|20
5814969|NCT02674568|20075795|P1|Overall Study|Lost to Follow-up|9
5814970|NCT02674568|20075795|P1|Overall Study|Physician Decision|2
5814971|NCT02674568|20075795|P1|Overall Study|Death|303
5814972|NCT02674568|20075795|P1|Overall Study|Withdrawal by Subject|5
5814973|NCT02674477|20075820|P2|Overall Study|Protocol Violation|2
5814974|NCT02674477|20075821|P1|Overall Study|Protocol Violation|8
5814975|NCT02674386|20075845|P3|Overall Study|Enrolled but not evaluated|0
5814976|NCT02674386|20075846|P2|Overall Study|Enrolled but not evaluated|4
5814977|NCT02674386|20075847|P1|Overall Study|Enrolled but not evaluated|0
5814978|NCT02674386|20075845|P3|Overall Study|Other|0
5814979|NCT02674386|20075846|P2|Overall Study|Other|1
5814980|NCT02674386|20075847|P1|Overall Study|Other|0
5814981|NCT02674386|20075845|P3|Overall Study|Withdrawal by Subject|0
5814982|NCT02674386|20075846|P2|Overall Study|Withdrawal by Subject|4
5814983|NCT02674386|20075847|P1|Overall Study|Withdrawal by Subject|0
5814984|NCT02674386|20075845|P3|Overall Study|Lost to Follow-up|1
5814985|NCT02674386|20075846|P2|Overall Study|Lost to Follow-up|1
5814986|NCT02674386|20075847|P1|Overall Study|Lost to Follow-up|0
5814987|NCT02674334|20075902|P2|Overall Study|NIRS not recording|0
5814988|NCT02674334|20075903|P1|Overall Study|NIRS not recording|1
5814989|NCT02674334|20075902|P2|Overall Study|participant difficulty breathing|0
5814990|NCT02674334|20075903|P1|Overall Study|participant difficulty breathing|1
5814991|NCT02674334|20075902|P2|Overall Study|Lost to Follow-up|3
5814992|NCT02674334|20075903|P1|Overall Study|Lost to Follow-up|5
5814993|NCT02674204|20075913|P2|Overall Study|Adverse Event|0
5814994|NCT02674204|20075914|P1|Overall Study|Adverse Event|1
5815003|NCT02673684|20076175|P2|Overall Study|Study not completed d/t loss of funding|8
5815004|NCT02673684|20076176|P1|Overall Study|Study not completed d/t loss of funding|9
5815005|NCT02673619|20076192|P4|Overall Study|Lack of Efficacy|0
5815006|NCT02673619|20076193|P3|Overall Study|Lack of Efficacy|1
5815007|NCT02673619|20076194|P2|Overall Study|Lack of Efficacy|0
5815008|NCT02673619|20076195|P1|Overall Study|Lack of Efficacy|0
5815009|NCT02673619|20076192|P4|Overall Study|Adverse Event|0
5815010|NCT02673619|20076193|P3|Overall Study|Adverse Event|1
5815011|NCT02673619|20076194|P2|Overall Study|Adverse Event|0
5815012|NCT02673619|20076195|P1|Overall Study|Adverse Event|0
5815013|NCT02673619|20076192|P4|Overall Study|Withdrawal by Subject|0
5815014|NCT02673619|20076193|P3|Overall Study|Withdrawal by Subject|1
5815015|NCT02673619|20076194|P2|Overall Study|Withdrawal by Subject|1
5815016|NCT02673619|20076195|P1|Overall Study|Withdrawal by Subject|1
5815017|NCT02673619|20076192|P4|Overall Study|Lost to Follow-up|0
5815018|NCT02673619|20076193|P3|Overall Study|Lost to Follow-up|0
5815019|NCT02673619|20076194|P2|Overall Study|Lost to Follow-up|0
5815020|NCT02673619|20076195|P1|Overall Study|Lost to Follow-up|1
5815021|NCT02673515|20076306|P2|Overall Study|Lack of motivation|1
5815022|NCT02673515|20076307|P1|Overall Study|Lack of motivation|2
5815023|NCT02673489|20076323|P2|Follow Up Period|Unable to return for follow-up|1
5815024|NCT02673489|20076324|P1|Follow Up Period|Unable to return for follow-up|0
5815025|NCT02673489|20076323|P2|Follow Up Period|Unable to return for week 24 follow-up|1
5815026|NCT02673489|20076324|P1|Follow Up Period|Unable to return for week 24 follow-up|0
5815027|NCT02673489|20076323|P2|Treatment Period|Adverse Event|1
5815028|NCT02673489|20076324|P1|Treatment Period|Adverse Event|0
5815029|NCT02673489|20076323|P2|Treatment Period|Participant was incarcerated|1
5815030|NCT02673489|20076324|P1|Treatment Period|Participant was incarcerated|0
5815031|NCT02673489|20076323|P2|Treatment Period|Participant moved to another province|0
5815032|NCT02673489|20076324|P1|Treatment Period|Participant moved to another province|1
5815033|NCT02673489|20076323|P2|Treatment Period|Participant request to discontinue|1
5815034|NCT02673489|20076324|P1|Treatment Period|Participant request to discontinue|1
5815035|NCT02673489|20076323|P2|Treatment Period|Lost to Follow-up|0
5815036|NCT02673489|20076324|P1|Treatment Period|Lost to Follow-up|3
5815037|NCT02672852|20076389|P7|Part B|Other|2
5815038|NCT02672852|20076390|P6|Part B|Other|1
5815039|NCT02672852|20076391|P5|Part B|Other|4
5815040|NCT02672852|20076392|P4|Part B|Other|0
5815041|NCT02672852|20076393|P3|Part B|Other|0
5815042|NCT02672852|20076394|P2|Part B|Other|0
5815043|NCT02672852|20076395|P1|Part B|Other|0
5815044|NCT02672852|20076389|P7|Part B|Withdrawal by Subject|7
5815045|NCT02672852|20076390|P6|Part B|Withdrawal by Subject|0
5815046|NCT02672852|20076391|P5|Part B|Withdrawal by Subject|5
5815047|NCT02672852|20076392|P4|Part B|Withdrawal by Subject|0
5815048|NCT02672852|20076393|P3|Part B|Withdrawal by Subject|0
5815049|NCT02672852|20076394|P2|Part B|Withdrawal by Subject|0
5815050|NCT02672852|20076395|P1|Part B|Withdrawal by Subject|0
5815051|NCT02672852|20076389|P7|Part B|Lost to Follow-up|1
5815052|NCT02672852|20076390|P6|Part B|Lost to Follow-up|4
5815053|NCT02672852|20076391|P5|Part B|Lost to Follow-up|3
5815054|NCT02672852|20076392|P4|Part B|Lost to Follow-up|0
5815055|NCT02672852|20076393|P3|Part B|Lost to Follow-up|0
5815056|NCT02672852|20076394|P2|Part B|Lost to Follow-up|0
5815057|NCT02672852|20076395|P1|Part B|Lost to Follow-up|0
5815058|NCT02672852|20076389|P7|Part B|Other adverse event|1
5815059|NCT02672852|20076390|P6|Part B|Other adverse event|5
5815060|NCT02672852|20076391|P5|Part B|Other adverse event|3
5815061|NCT02672852|20076392|P4|Part B|Other adverse event|0
5815062|NCT02672852|20076393|P3|Part B|Other adverse event|0
5815063|NCT02672852|20076394|P2|Part B|Other adverse event|0
5815064|NCT02672852|20076395|P1|Part B|Other adverse event|0
5815065|NCT02672852|20076389|P7|Part B|Worsening pre-existing condition|0
5815066|NCT02672852|20076390|P6|Part B|Worsening pre-existing condition|1
5815067|NCT02672852|20076391|P5|Part B|Worsening pre-existing condition|0
5815068|NCT02672852|20076392|P4|Part B|Worsening pre-existing condition|0
5815069|NCT02672852|20076393|P3|Part B|Worsening pre-existing condition|0
5815070|NCT02672852|20076394|P2|Part B|Worsening pre-existing condition|0
5815071|NCT02672852|20076395|P1|Part B|Worsening pre-existing condition|0
5815072|NCT02672852|20076389|P7|Part B|Disease worsening|1
5815073|NCT02672852|20076390|P6|Part B|Disease worsening|0
5815074|NCT02672852|20076391|P5|Part B|Disease worsening|1
5815075|NCT02672852|20076392|P4|Part B|Disease worsening|0
5815076|NCT02672852|20076393|P3|Part B|Disease worsening|0
5815077|NCT02672852|20076394|P2|Part B|Disease worsening|0
5815078|NCT02672852|20076395|P1|Part B|Disease worsening|0
5815079|NCT02672852|20076389|P7|Part A2|Not entered in Part B|0
5815080|NCT02672852|20076390|P6|Part A2|Not entered in Part B|0
5815081|NCT02672852|20076391|P5|Part A2|Not entered in Part B|0
5815082|NCT02672852|20076392|P4|Part A2|Not entered in Part B|4
5815083|NCT02672852|20076393|P3|Part A2|Not entered in Part B|0
5815084|NCT02672852|20076394|P2|Part A2|Not entered in Part B|0
5815085|NCT02672852|20076395|P1|Part A2|Not entered in Part B|0
5815086|NCT02672852|20076389|P7|Part A2|Other|0
5815087|NCT02672852|20076390|P6|Part A2|Other|0
5815088|NCT02672852|20076391|P5|Part A2|Other|0
5815089|NCT02672852|20076392|P4|Part A2|Other|0
5815090|NCT02672852|20076393|P3|Part A2|Other|3
5815091|NCT02672852|20076394|P2|Part A2|Other|0
5815092|NCT02672852|20076395|P1|Part A2|Other|0
5815093|NCT02672852|20076389|P7|Part A2|Withdrawal by Subject|0
5815094|NCT02672852|20076390|P6|Part A2|Withdrawal by Subject|0
5815095|NCT02672852|20076391|P5|Part A2|Withdrawal by Subject|0
5815096|NCT02672852|20076392|P4|Part A2|Withdrawal by Subject|0
5815097|NCT02672852|20076393|P3|Part A2|Withdrawal by Subject|1
5815098|NCT02672852|20076394|P2|Part A2|Withdrawal by Subject|0
5815099|NCT02672852|20076395|P1|Part A2|Withdrawal by Subject|0
5815100|NCT02672852|20076389|P7|Part A2|Lost to Follow-up|0
5815101|NCT02672852|20076390|P6|Part A2|Lost to Follow-up|0
5815102|NCT02672852|20076391|P5|Part A2|Lost to Follow-up|0
5815103|NCT02672852|20076392|P4|Part A2|Lost to Follow-up|0
5815104|NCT02672852|20076393|P3|Part A2|Lost to Follow-up|2
5815105|NCT02672852|20076394|P2|Part A2|Lost to Follow-up|0
5815106|NCT02672852|20076395|P1|Part A2|Lost to Follow-up|0
5815107|NCT02672852|20076389|P7|Part A2|Adverse Event|0
5815108|NCT02672852|20076390|P6|Part A2|Adverse Event|0
5815109|NCT02672852|20076391|P5|Part A2|Adverse Event|0
5815110|NCT02672852|20076392|P4|Part A2|Adverse Event|0
5815111|NCT02672852|20076393|P3|Part A2|Adverse Event|3
5815112|NCT02672852|20076394|P2|Part A2|Adverse Event|0
5815113|NCT02672852|20076395|P1|Part A2|Adverse Event|0
5815114|NCT02672852|20076389|P7|Part A2|Disease worsening|0
5815115|NCT02672852|20076390|P6|Part A2|Disease worsening|0
5815116|NCT02672852|20076391|P5|Part A2|Disease worsening|0
5815117|NCT02672852|20076392|P4|Part A2|Disease worsening|0
5815118|NCT02672852|20076393|P3|Part A2|Disease worsening|1
5815119|NCT02672852|20076394|P2|Part A2|Disease worsening|0
5815120|NCT02672852|20076395|P1|Part A2|Disease worsening|0
5815121|NCT02672852|20076389|P7|Part A1|Withdrawal by Subject|0
5815122|NCT02672852|20076390|P6|Part A1|Withdrawal by Subject|0
5815123|NCT02672852|20076391|P5|Part A1|Withdrawal by Subject|0
5815124|NCT02672852|20076392|P4|Part A1|Withdrawal by Subject|0
5815125|NCT02672852|20076393|P3|Part A1|Withdrawal by Subject|0
5815126|NCT02672852|20076394|P2|Part A1|Withdrawal by Subject|1
5815127|NCT02672852|20076395|P1|Part A1|Withdrawal by Subject|1
5815128|NCT02672852|20076389|P7|Part A1|Lost to Follow-up|0
5815129|NCT02672852|20076390|P6|Part A1|Lost to Follow-up|0
5815130|NCT02672852|20076391|P5|Part A1|Lost to Follow-up|0
5815131|NCT02672852|20076392|P4|Part A1|Lost to Follow-up|0
5815132|NCT02672852|20076393|P3|Part A1|Lost to Follow-up|0
5815133|NCT02672852|20076394|P2|Part A1|Lost to Follow-up|2
5815134|NCT02672852|20076395|P1|Part A1|Lost to Follow-up|1
5815135|NCT02672852|20076389|P7|Part A1|Adverse Event|0
5815136|NCT02672852|20076390|P6|Part A1|Adverse Event|0
5815137|NCT02672852|20076391|P5|Part A1|Adverse Event|0
5815138|NCT02672852|20076392|P4|Part A1|Adverse Event|0
5815139|NCT02672852|20076393|P3|Part A1|Adverse Event|0
5815140|NCT02672852|20076394|P2|Part A1|Adverse Event|1
5815141|NCT02672852|20076395|P1|Part A1|Adverse Event|0
5815142|NCT02672852|20076389|P7|Part A1|Disease Worsening|0
5815143|NCT02672852|20076390|P6|Part A1|Disease Worsening|0
5815144|NCT02672852|20076391|P5|Part A1|Disease Worsening|0
5815145|NCT02672852|20076392|P4|Part A1|Disease Worsening|0
5815146|NCT02672852|20076393|P3|Part A1|Disease Worsening|0
5815147|NCT02672852|20076394|P2|Part A1|Disease Worsening|0
5815148|NCT02672852|20076395|P1|Part A1|Disease Worsening|1
5815149|NCT02672553|20076426|P2|Overall Study|Intraoperative screen failure|0
5815150|NCT02672553|20076427|P1|Overall Study|Intraoperative screen failure|2
5815151|NCT02672553|20076426|P2|Overall Study|Withdrawal by Subject|3
5815152|NCT02672553|20076427|P1|Overall Study|Withdrawal by Subject|3
5815153|NCT02672553|20076426|P2|Overall Study|Conversion to Commercial Valve|0
5815154|NCT02672553|20076427|P1|Overall Study|Conversion to Commercial Valve|3
5815155|NCT02672553|20076426|P2|Overall Study|Valve Explant|0
5815156|NCT02672553|20076427|P1|Overall Study|Valve Explant|1
5815157|NCT02672553|20076426|P2|Overall Study|Death|5
5815158|NCT02672553|20076427|P1|Overall Study|Death|3
5815159|NCT02672423|20076499|P10|Period 3|Physician Decision|0
5815160|NCT02672423|20076500|P9|Period 3|Physician Decision|0
5815161|NCT02672423|20076501|P8|Period 3|Physician Decision|0
5815162|NCT02672423|20076502|P7|Period 3|Physician Decision|0
5815163|NCT02672423|20076503|P6|Period 3|Physician Decision|1
5815164|NCT02672423|20076504|P5|Period 3|Physician Decision|0
5815165|NCT02672423|20076505|P4|Period 3|Physician Decision|0
5815166|NCT02672423|20076506|P3|Period 3|Physician Decision|0
5815167|NCT02672423|20076507|P2|Period 3|Physician Decision|0
5815168|NCT02672423|20076508|P1|Period 3|Physician Decision|0
5815169|NCT02672423|20076499|P10|Period 3|Withdrawal by Subject|0
5815170|NCT02672423|20076500|P9|Period 3|Withdrawal by Subject|0
5815171|NCT02672423|20076501|P8|Period 3|Withdrawal by Subject|1
5815172|NCT02672423|20076502|P7|Period 3|Withdrawal by Subject|0
5815173|NCT02672423|20076503|P6|Period 3|Withdrawal by Subject|0
5815174|NCT02672423|20076504|P5|Period 3|Withdrawal by Subject|0
5815175|NCT02672423|20076505|P4|Period 3|Withdrawal by Subject|0
5815176|NCT02672423|20076506|P3|Period 3|Withdrawal by Subject|0
5815177|NCT02672423|20076507|P2|Period 3|Withdrawal by Subject|0
5815178|NCT02672423|20076508|P1|Period 3|Withdrawal by Subject|0
5815179|NCT02672423|20076499|P10|Period 2|Withdrawal by Subject|0
5815180|NCT02672423|20076500|P9|Period 2|Withdrawal by Subject|0
5815181|NCT02672423|20076501|P8|Period 2|Withdrawal by Subject|0
5815182|NCT02672423|20076502|P7|Period 2|Withdrawal by Subject|0
5815183|NCT02672423|20076503|P6|Period 2|Withdrawal by Subject|0
5815184|NCT02672423|20076504|P5|Period 2|Withdrawal by Subject|0
5815185|NCT02672423|20076505|P4|Period 2|Withdrawal by Subject|0
5815186|NCT02672423|20076506|P3|Period 2|Withdrawal by Subject|1
5815187|NCT02672423|20076507|P2|Period 2|Withdrawal by Subject|0
5815188|NCT02672423|20076508|P1|Period 2|Withdrawal by Subject|0
5815189|NCT02672423|20076499|P10|Period 1|Adverse Event|0
5815190|NCT02672423|20076500|P9|Period 1|Adverse Event|0
5815191|NCT02672423|20076501|P8|Period 1|Adverse Event|0
5815192|NCT02672423|20076502|P7|Period 1|Adverse Event|0
5815193|NCT02672423|20076503|P6|Period 1|Adverse Event|0
5815194|NCT02672423|20076504|P5|Period 1|Adverse Event|1
5815195|NCT02672423|20076505|P4|Period 1|Adverse Event|0
5815196|NCT02672423|20076506|P3|Period 1|Adverse Event|0
5815197|NCT02672423|20076507|P2|Period 1|Adverse Event|0
5815198|NCT02672423|20076508|P1|Period 1|Adverse Event|0
5815199|NCT02671760|20076603|P3|Overall Study|Lost to Follow-up|0
5815200|NCT02671760|20076604|P2|Overall Study|Lost to Follow-up|1
5815201|NCT02671760|20076605|P1|Overall Study|Lost to Follow-up|0
5815202|NCT02671500|20076631|P1|Overall Study|Lost to Follow-up|2
5815203|NCT02671500|20076631|P1|Overall Study|Lack of Efficacy|12
5815204|NCT02671461|20076646|P3|Follow-up|Administrative Reason by Sponsor|0
5815205|NCT02671461|20076647|P2|Follow-up|Administrative Reason by Sponsor|1
5815206|NCT02671461|20076648|P1|Follow-up|Administrative Reason by Sponsor|0
5815207|NCT02671461|20076646|P3|Follow-up|Lost to Follow-up|1
5815208|NCT02671461|20076647|P2|Follow-up|Lost to Follow-up|0
5815209|NCT02671461|20076648|P1|Follow-up|Lost to Follow-up|0
5815210|NCT02671461|20076646|P3|Follow-up|Withdrawal by Subject|0
5815211|NCT02671461|20076647|P2|Follow-up|Withdrawal by Subject|0
5815212|NCT02671461|20076648|P1|Follow-up|Withdrawal by Subject|1
5815213|NCT02671461|20076646|P3|Treatment|Randomized, not treated|0
5815214|NCT02671461|20076647|P2|Treatment|Randomized, not treated|0
5815215|NCT02671461|20076648|P1|Treatment|Randomized, not treated|1
5815216|NCT02671461|20076646|P3|Treatment|Administrative Reason by Sponsor|4
5815217|NCT02671461|20076647|P2|Treatment|Administrative Reason by Sponsor|3
5815218|NCT02671461|20076648|P1|Treatment|Administrative Reason by Sponsor|1
5815219|NCT02671461|20076646|P3|Treatment|Adverse Event|1
5815220|NCT02671461|20076647|P2|Treatment|Adverse Event|0
5815221|NCT02671461|20076648|P1|Treatment|Adverse Event|0
5815222|NCT02671422|20076671|P1|Overall Study|Other not defined above|3
5815223|NCT02671422|20076671|P1|Overall Study|Not treated with Vargatef®|3
5815224|NCT02671422|20076671|P1|Overall Study|Adverse Event unrelated to Vargatef®|8
5815225|NCT02671422|20076671|P1|Overall Study|Sponsor decision|5
5815226|NCT02671422|20076671|P1|Overall Study|Worsening of Disease|4
5815227|NCT02671422|20076671|P1|Overall Study|Progressive Disease|156
5815228|NCT02671422|20076671|P1|Overall Study|Withdrawal by Subject|7
5815229|NCT02671422|20076671|P1|Overall Study|Lost to Follow-up|4
5815230|NCT02671422|20076671|P1|Overall Study|Lack of Efficacy|1
5815231|NCT02671422|20076671|P1|Overall Study|Adverse Event|68
5815232|NCT02671422|20076671|P1|Overall Study|Lost to Follow-up|1
5815233|NCT02671266|20076677|P2|Overall Study|Withdrawal by Subject|1
5815234|NCT02671266|20076678|P1|Overall Study|Withdrawal by Subject|1
5815235|NCT02670928|20076709|P2|Overall Study|Miss 3 classes in a row in first 12 wks|0
5815236|NCT02670928|20076710|P1|Overall Study|Miss 3 classes in a row in first 12 wks|2
5815237|NCT02670928|20076709|P2|Overall Study|Lost to Follow-up|0
5815238|NCT02670928|20076710|P1|Overall Study|Lost to Follow-up|1
5815239|NCT02670928|20076709|P2|Overall Study|Withdrawal by Subject|0
5815240|NCT02670928|20076710|P1|Overall Study|Withdrawal by Subject|4
5815241|NCT02670928|20076709|P2|Overall Study|Adverse Event|1
5815242|NCT02670928|20076710|P1|Overall Study|Adverse Event|3
5815243|NCT02670915|20076737|P3|Overall Study|Unclassified|0
5815244|NCT02670915|20076738|P2|Overall Study|Unclassified|3
5815245|NCT02670915|20076739|P1|Overall Study|Unclassified|0
5815246|NCT02670915|20076737|P3|Overall Study|Withdrawal by parent/guardian|1
5815247|NCT02670915|20076738|P2|Overall Study|Withdrawal by parent/guardian|4
5815248|NCT02670915|20076739|P1|Overall Study|Withdrawal by parent/guardian|4
5815249|NCT02670915|20076737|P3|Overall Study|Withdrawal by Subject|4
5815250|NCT02670915|20076738|P2|Overall Study|Withdrawal by Subject|1
5815251|NCT02670915|20076739|P1|Overall Study|Withdrawal by Subject|0
5815252|NCT02670551|20077023|P3|Overall Study|Did Not Receive Treatment|0
5815253|NCT02670551|20077024|P2|Overall Study|Did Not Receive Treatment|3
5815254|NCT02670551|20077025|P1|Overall Study|Did Not Receive Treatment|5
5815255|NCT02670551|20077023|P3|Overall Study|Other Miscellaneous Reasons|3
5815256|NCT02670551|20077024|P2|Overall Study|Other Miscellaneous Reasons|3
5815257|NCT02670551|20077025|P1|Overall Study|Other Miscellaneous Reasons|2
5815258|NCT02670551|20077023|P3|Overall Study|Noncompliance with study drug|2
5815259|NCT02670551|20077024|P2|Overall Study|Noncompliance with study drug|3
5815260|NCT02670551|20077025|P1|Overall Study|Noncompliance with study drug|3
5815261|NCT02670551|20077023|P3|Overall Study|Protocol Violation|0
5815262|NCT02670551|20077024|P2|Overall Study|Protocol Violation|0
5815263|NCT02670551|20077025|P1|Overall Study|Protocol Violation|1
5815264|NCT02670551|20077023|P3|Overall Study|Lost to Follow-up|6
5815265|NCT02670551|20077024|P2|Overall Study|Lost to Follow-up|7
5815266|NCT02670551|20077025|P1|Overall Study|Lost to Follow-up|5
5815267|NCT02670551|20077023|P3|Overall Study|Withdrawal of Consent|8
5815268|NCT02670551|20077024|P2|Overall Study|Withdrawal of Consent|3
5815269|NCT02670551|20077025|P1|Overall Study|Withdrawal of Consent|6
5815270|NCT02670551|20077023|P3|Overall Study|Lack of Efficacy|3
5815271|NCT02670551|20077024|P2|Overall Study|Lack of Efficacy|0
5815272|NCT02670551|20077025|P1|Overall Study|Lack of Efficacy|2
5815273|NCT02670551|20077023|P3|Overall Study|Adverse Event|9
5815274|NCT02670551|20077024|P2|Overall Study|Adverse Event|7
5815275|NCT02670551|20077025|P1|Overall Study|Adverse Event|4
5815276|NCT02670538|20077039|P3|Overall Study|Other Miscellaneous Reasons|2
5815277|NCT02670538|20077040|P2|Overall Study|Other Miscellaneous Reasons|1
5815278|NCT02670538|20077041|P1|Overall Study|Other Miscellaneous Reasons|0
5815279|NCT02670538|20077039|P3|Overall Study|Noncompliance with Study Drug|2
5815280|NCT02670538|20077040|P2|Overall Study|Noncompliance with Study Drug|3
5815281|NCT02670538|20077041|P1|Overall Study|Noncompliance with Study Drug|1
5815282|NCT02670538|20077039|P3|Overall Study|Protocol Violation|1
5815283|NCT02670538|20077040|P2|Overall Study|Protocol Violation|4
5815284|NCT02670538|20077041|P1|Overall Study|Protocol Violation|3
5815285|NCT02670538|20077039|P3|Overall Study|Lack of Efficacy|2
5815286|NCT02670538|20077040|P2|Overall Study|Lack of Efficacy|1
5815287|NCT02670538|20077041|P1|Overall Study|Lack of Efficacy|7
5815288|NCT02670538|20077039|P3|Overall Study|Adverse Event|11
5815289|NCT02670538|20077040|P2|Overall Study|Adverse Event|5
5815290|NCT02670538|20077041|P1|Overall Study|Adverse Event|5
5815291|NCT02670538|20077039|P3|Overall Study|Lost to Follow-up|7
5815292|NCT02670538|20077040|P2|Overall Study|Lost to Follow-up|12
5815293|NCT02670538|20077041|P1|Overall Study|Lost to Follow-up|8
5815294|NCT02670538|20077039|P3|Overall Study|Withdrawal of Consent|5
5815295|NCT02670538|20077040|P2|Overall Study|Withdrawal of Consent|6
5815296|NCT02670538|20077041|P1|Overall Study|Withdrawal of Consent|8
5815297|NCT02670473|20077052|P1|Overall Study|Withdrawal by Subject|1
5815298|NCT02670330|20077111|P2|Overall Study|Lost to Follow-up|2
5815299|NCT02670330|20077112|P1|Overall Study|Lost to Follow-up|3
5815300|NCT02670330|20077111|P2|Overall Study|Withdrawal by Subject|29
5815301|NCT02670330|20077112|P1|Overall Study|Withdrawal by Subject|34
5815302|NCT02670330|20077111|P2|Overall Study|Adverse Event|3
5815303|NCT02670330|20077112|P1|Overall Study|Adverse Event|1
5815304|NCT02670330|20077111|P2|Overall Study|Study Terminated By Sponsor|43
5815305|NCT02670330|20077112|P1|Overall Study|Study Terminated By Sponsor|36
5815306|NCT02670330|20077111|P2|Overall Study|Protocol Deviation|0
5815307|NCT02670330|20077112|P1|Overall Study|Protocol Deviation|1
5815308|NCT02670083|20077124|P2|Overall Study|Non-Compliance With Study Drug|0
5815309|NCT02670083|20077125|P1|Overall Study|Non-Compliance With Study Drug|1
5815310|NCT02670083|20077124|P2|Overall Study|Withdrawal by Subject|31
5815311|NCT02670083|20077125|P1|Overall Study|Withdrawal by Subject|32
5815312|NCT02670083|20077124|P2|Overall Study|Symptomatic Deterioration|2
5815313|NCT02670083|20077125|P1|Overall Study|Symptomatic Deterioration|0
5815314|NCT02670083|20077124|P2|Overall Study|Study Terminated By Sponsor|254
5815315|NCT02670083|20077125|P1|Overall Study|Study Terminated By Sponsor|257
5815316|NCT02670083|20077124|P2|Overall Study|Physician Decision|2
5815317|NCT02670083|20077125|P1|Overall Study|Physician Decision|0
5815318|NCT02670083|20077124|P2|Overall Study|Multiple Reasons|9
5815319|NCT02670083|20077125|P1|Overall Study|Multiple Reasons|9
5815320|NCT02670083|20077124|P2|Overall Study|Lost to Follow-up|2
5815321|NCT02670083|20077125|P1|Overall Study|Lost to Follow-up|2
5815322|NCT02670083|20077124|P2|Overall Study|Death|6
5815323|NCT02670083|20077125|P1|Overall Study|Death|4
5815324|NCT02670083|20077124|P2|Overall Study|Adverse Event|13
5815325|NCT02670083|20077125|P1|Overall Study|Adverse Event|16
5815326|NCT02669940|20077170|P2|Overall Study|Insufficient follow-up data|0
5815327|NCT02669940|20077171|P1|Overall Study|Insufficient follow-up data|1
5815328|NCT02669940|20077170|P2|Overall Study|Failure to return|3
5815329|NCT02669940|20077171|P1|Overall Study|Failure to return|0
5815330|NCT02669862|20077273|P3|Overall Study|Protocol Violation|1
5815331|NCT02669862|20077274|P2|Overall Study|Protocol Violation|0
5815332|NCT02669862|20077275|P1|Overall Study|Protocol Violation|0
5815333|NCT02669862|20077273|P3|Overall Study|moved|0
5815334|NCT02669862|20077274|P2|Overall Study|moved|1
5815335|NCT02669862|20077275|P1|Overall Study|moved|0
5815336|NCT02669862|20077273|P3|Overall Study|Withdrawal by Subject|3
5815337|NCT02669862|20077274|P2|Overall Study|Withdrawal by Subject|2
5815338|NCT02669862|20077275|P1|Overall Study|Withdrawal by Subject|2
5815339|NCT02669862|20077273|P3|Overall Study|Lost to Follow-up|1
5815340|NCT02669862|20077274|P2|Overall Study|Lost to Follow-up|2
5815341|NCT02669862|20077275|P1|Overall Study|Lost to Follow-up|0
5815342|NCT02669849|20077291|P3|Overall Study|Other|2
5815343|NCT02669849|20077292|P2|Overall Study|Other|0
5815344|NCT02669849|20077293|P1|Overall Study|Other|0
5815345|NCT02669849|20077291|P3|Overall Study|Study terminated by sponsor|14
5815346|NCT02669849|20077292|P2|Overall Study|Study terminated by sponsor|1
5815347|NCT02669849|20077293|P1|Overall Study|Study terminated by sponsor|16
5815348|NCT02669849|20077291|P3|Overall Study|Death|2
5815349|NCT02669849|20077292|P2|Overall Study|Death|1
5815350|NCT02669849|20077293|P1|Overall Study|Death|1
5815351|NCT02669849|20077291|P3|Overall Study|Lost to Follow-up|3
5815352|NCT02669849|20077292|P2|Overall Study|Lost to Follow-up|0
5815353|NCT02669849|20077293|P1|Overall Study|Lost to Follow-up|1
5815354|NCT02669849|20077291|P3|Overall Study|Withdrawal of Consent (not due to AE)|3
5815355|NCT02669849|20077292|P2|Overall Study|Withdrawal of Consent (not due to AE)|0
5815356|NCT02669849|20077293|P1|Overall Study|Withdrawal of Consent (not due to AE)|0
5815357|NCT02669758|20077336|P1|Overall Study|Protocol Violation|1
5815358|NCT02669758|20077336|P1|Overall Study|Study noncompliance|1
5815359|NCT02669758|20077336|P1|Overall Study|Pregnancy|1
5815360|NCT02669758|20077336|P1|Overall Study|Lack of Efficacy|5
5815361|NCT02669758|20077336|P1|Overall Study|Non-Compliance with Study Drug|8
5815362|NCT02669758|20077336|P1|Overall Study|Adverse Event|16
5815363|NCT02669758|20077336|P1|Overall Study|Lost to Follow-up|19
5815364|NCT02669758|20077336|P1|Overall Study|Withdrawal by Subject|43
5815365|NCT02669667|20077347|P7|Overall Study|Lost to Follow-up|0
5815366|NCT02669667|20077348|P6|Overall Study|Lost to Follow-up|1
5815367|NCT02669667|20077349|P5|Overall Study|Lost to Follow-up|0
5815368|NCT02669667|20077350|P4|Overall Study|Lost to Follow-up|0
5815369|NCT02669667|20077351|P3|Overall Study|Lost to Follow-up|0
5815370|NCT02669667|20077352|P2|Overall Study|Lost to Follow-up|0
5815371|NCT02669667|20077353|P1|Overall Study|Lost to Follow-up|0
5815372|NCT02669433|20077456|P3|Overall Study|Death|1
5815373|NCT02669433|20077457|P2|Overall Study|Death|1
5815374|NCT02669433|20077458|P1|Overall Study|Death|0
5815375|NCT02669433|20077456|P3|Overall Study|Withdrawal by Caregiver|2
5815376|NCT02669433|20077457|P2|Overall Study|Withdrawal by Caregiver|0
5815377|NCT02669433|20077458|P1|Overall Study|Withdrawal by Caregiver|1
5815378|NCT02669433|20077456|P3|Overall Study|Withdrawal by Subject|0
5815379|NCT02669433|20077457|P2|Overall Study|Withdrawal by Subject|1
5815380|NCT02669433|20077458|P1|Overall Study|Withdrawal by Subject|5
5815381|NCT02669433|20077456|P3|Overall Study|Sponsor Termination|1
5815382|NCT02669433|20077457|P2|Overall Study|Sponsor Termination|0
5815383|NCT02669433|20077458|P1|Overall Study|Sponsor Termination|1
5815384|NCT02669433|20077456|P3|Overall Study|Adverse Event|10
5815385|NCT02669433|20077457|P2|Overall Study|Adverse Event|7
5815386|NCT02669433|20077458|P1|Overall Study|Adverse Event|6
5815387|NCT02669433|20077456|P3|Overall Study|Physician Decision|0
5815388|NCT02669433|20077457|P2|Overall Study|Physician Decision|1
5815389|NCT02669433|20077458|P1|Overall Study|Physician Decision|1
5815390|NCT02669433|20077456|P3|Overall Study|Disease Progression|0
5815391|NCT02669433|20077457|P2|Overall Study|Disease Progression|0
5815392|NCT02669433|20077458|P1|Overall Study|Disease Progression|1
5815393|NCT02669433|20077456|P3|Overall Study|Protocol Violation|1
5815394|NCT02669433|20077457|P2|Overall Study|Protocol Violation|4
5815395|NCT02669433|20077458|P1|Overall Study|Protocol Violation|0
5815396|NCT02669407|20077472|P1|Overall Study|Physician Decision|3
5815425|NCT02669095|20077653|P2|Overall Study|Visit 5 assessments not completed|1
5815426|NCT02669095|20077654|P1|Overall Study|Visit 5 assessments not completed|0
5815427|NCT02669095|20077653|P2|Overall Study|Torn Lens|1
5815428|NCT02669095|20077654|P1|Overall Study|Torn Lens|0
5815429|NCT02669095|20077653|P2|Overall Study|Unsatisfactory Lens Fitting|1
5815430|NCT02669095|20077654|P1|Overall Study|Unsatisfactory Lens Fitting|0
5815431|NCT02669095|20077653|P2|Overall Study|Adverse Event|0
5815432|NCT02669095|20077654|P1|Overall Study|Adverse Event|1
5815433|NCT02669082|20077662|P1|Overall Study|Adverse Event|1
5815434|NCT02669043|20077674|P1|Overall Study|Didn't meet I/E criteria|4
5815471|NCT02668822|20077840|P2|Overall Study|Study Terminated by Sponsor|9
5815472|NCT02668822|20077841|P1|Overall Study|Study Terminated by Sponsor|7
5815473|NCT02668822|20077840|P2|Overall Study|Protocol Violation|0
5815474|NCT02668822|20077841|P1|Overall Study|Protocol Violation|2
5815475|NCT02668783|20077863|P2|Overall Study|Withdrawal by Subject|0
5815476|NCT02668783|20077864|P1|Overall Study|Withdrawal by Subject|1
5815477|NCT02668783|20077863|P2|Overall Study|Subject moved|0
5815478|NCT02668783|20077864|P1|Overall Study|Subject moved|1
5815479|NCT02668783|20077863|P2|Overall Study|Study terminated by sponsor|10
5815480|NCT02668783|20077864|P1|Overall Study|Study terminated by sponsor|9
5815481|NCT02668783|20077863|P2|Overall Study|Protocol Violation|1
5815482|NCT02668783|20077864|P1|Overall Study|Protocol Violation|2
5815483|NCT02668783|20077863|P2|Overall Study|Pregnancy|1
5815484|NCT02668783|20077864|P1|Overall Study|Pregnancy|0
5815485|NCT02668640|20077884|P1|Overall Study|Other, not specified|1
5815486|NCT02668640|20077884|P1|Overall Study|Lost to Follow-up|13
5815487|NCT02668302|20077936|P2|Overall Study|Withdrawal by Subject|0
5815488|NCT02668302|20077937|P1|Overall Study|Withdrawal by Subject|1
5815489|NCT02667912|20077976|P2|Overall Study|Withdrawal by Subject|0
5815490|NCT02667912|20077977|P1|Overall Study|Withdrawal by Subject|1
5815491|NCT02667912|20077976|P2|Overall Study|Withdrawal by Subject|2
5815492|NCT02667912|20077977|P1|Overall Study|Withdrawal by Subject|1
5815493|NCT02667912|20077976|P2|Overall Study|Death|1
5815494|NCT02667912|20077977|P1|Overall Study|Death|3
5815495|NCT02667626|20078077|P2|Overall Study|Withdrawal by Subject|1
5815496|NCT02667626|20078078|P1|Overall Study|Withdrawal by Subject|0
5815497|NCT02667457|20078094|P2|Overall Study|Other Reason|2
5815498|NCT02667457|20078095|P1|Overall Study|Other Reason|0
5815499|NCT02667457|20078094|P2|Overall Study|Withdrawal by Subject|0
5815500|NCT02667457|20078095|P1|Overall Study|Withdrawal by Subject|1
5815501|NCT02667288|20078119|P1|Overall Study|Withdrawal by Subject|5
5815502|NCT02667288|20078119|P1|Overall Study|Lost to Follow-up|3
5815503|NCT02667288|20078119|P1|Overall Study|Protocol Violation|5
5815504|NCT02667275|20078126|P2|Overall Study|Discontinued early without completing|1
5815505|NCT02667275|20078127|P1|Overall Study|Discontinued early without completing|0
5815506|NCT02667275|20078126|P2|Overall Study|Withdrawal by Subject|5
5815507|NCT02667275|20078127|P1|Overall Study|Withdrawal by Subject|0
5815508|NCT02667275|20078126|P2|Overall Study|Lost to Follow-up|2
5815509|NCT02667275|20078127|P1|Overall Study|Lost to Follow-up|0
5815510|NCT02667275|20078126|P2|Overall Study|Protocol Violation|7
5815511|NCT02667275|20078127|P1|Overall Study|Protocol Violation|11
5815512|NCT02667236|20078137|P2|Overall Study|Withdrawal by Subject|0
5815513|NCT02667236|20078138|P1|Overall Study|Withdrawal by Subject|2
5815514|NCT02667236|20078137|P2|Overall Study|Adverse Event|1
5815515|NCT02667236|20078138|P1|Overall Study|Adverse Event|1
5815516|NCT02666664|20078260|P2|Overall Study|Lost to Follow-up|2
5815517|NCT02666664|20078261|P1|Overall Study|Lost to Follow-up|1
5815518|NCT02666664|20078260|P2|Overall Study|Sponsor decision|1
5815519|NCT02666664|20078261|P1|Overall Study|Sponsor decision|0
5815520|NCT02666664|20078260|P2|Overall Study|Withdrawal by participant|40
5815521|NCT02666664|20078261|P1|Overall Study|Withdrawal by participant|23
5815522|NCT02666664|20078260|P2|Overall Study|Adverse Event|37
5815523|NCT02666664|20078261|P1|Overall Study|Adverse Event|12
5815524|NCT02666664|20078260|P2|Overall Study|Other|1
5815525|NCT02666664|20078261|P1|Overall Study|Other|0
5815526|NCT02666664|20078260|P2|Overall Study|Protocol Violation|2
5815527|NCT02666664|20078261|P1|Overall Study|Protocol Violation|0
5815528|NCT02666664|20078260|P2|Overall Study|Physician Decision|1
5815529|NCT02666664|20078261|P1|Overall Study|Physician Decision|0
5815530|NCT02666430|20078359|P2|Period 3|Lost to Follow-up|0
5815531|NCT02666430|20078360|P1|Period 3|Lost to Follow-up|1
5815532|NCT02666430|20078359|P2|Period 2|Withdrawal by Subject|4
5815533|NCT02666430|20078360|P1|Period 2|Withdrawal by Subject|1
5815534|NCT02666430|20078359|P2|Period 1|Adverse Event|1
5815535|NCT02666430|20078360|P1|Period 1|Adverse Event|0
5815536|NCT02666430|20078359|P2|Period 1|Lost to Follow-up|0
5815537|NCT02666430|20078360|P1|Period 1|Lost to Follow-up|1
5815538|NCT02666222|20078495|P1|Overall Study|Death|2
5815539|NCT02665689|20078531|P2|Overall Study|Lost to Follow-up|1
5815540|NCT02665689|20078532|P1|Overall Study|Lost to Follow-up|0
5815541|NCT02665689|20078531|P2|Overall Study|Trial termination|1
5815542|NCT02665689|20078532|P1|Overall Study|Trial termination|1
5815543|NCT02665689|20078531|P2|Overall Study|Adverse Event|0
5815544|NCT02665689|20078532|P1|Overall Study|Adverse Event|1
5815545|NCT02665455|20078567|P1|Overall Study|Protocol Violation|1
5815546|NCT02665455|20078567|P1|Overall Study|Adverse Event|1
5815547|NCT02665455|20078567|P1|Overall Study|Lost to Follow-up|1
5815548|NCT02665455|20078567|P1|Overall Study|Withdrawal by Subject|6
5815549|NCT02665286|20078611|P3|Overall Study|Lost to Follow-up|1
5815550|NCT02665286|20078612|P2|Overall Study|Lost to Follow-up|2
5815551|NCT02665286|20078613|P1|Overall Study|Lost to Follow-up|3
5815552|NCT02664415|20078764|P2|Overall Study|Adverse Event|0
5815553|NCT02664415|20078765|P1|Overall Study|Adverse Event|1
5815554|NCT02664272|20078811|P1|Overall Study|Fluoroscopic images not made available|2
5815555|NCT02663882|20078847|P2|Overall Study|Lost to Follow-up|2
5815556|NCT02663882|20078848|P1|Overall Study|Lost to Follow-up|4
5815557|NCT02663817|20078860|P1|Overall Study|Screen failure|2
5815558|NCT02663687|20078880|P5|Overall Study|Other|0
5815559|NCT02663687|20078881|P4|Overall Study|Other|0
5815560|NCT02663687|20078882|P3|Overall Study|Other|1
5815561|NCT02663687|20078883|P2|Overall Study|Other|0
5815562|NCT02663687|20078884|P1|Overall Study|Other|1
5815563|NCT02663687|20078880|P5|Overall Study|Adverse Event|0
5815564|NCT02663687|20078881|P4|Overall Study|Adverse Event|0
5815565|NCT02663687|20078882|P3|Overall Study|Adverse Event|0
5815566|NCT02663687|20078883|P2|Overall Study|Adverse Event|0
5815567|NCT02663687|20078884|P1|Overall Study|Adverse Event|1
5815568|NCT02663674|20078938|P2|Overall Study|Other Event (Health Related)|1
5815569|NCT02663674|20078939|P1|Overall Study|Other Event (Health Related)|0
5815570|NCT02663674|20078938|P2|Overall Study|Physician Decision|1
5815571|NCT02663674|20078939|P1|Overall Study|Physician Decision|1
5815572|NCT02663674|20078938|P2|Overall Study|Withdrawal by Subject|4
5815573|NCT02663674|20078939|P1|Overall Study|Withdrawal by Subject|1
5815574|NCT02663674|20078938|P2|Overall Study|Lost to Follow-up|4
5815575|NCT02663674|20078939|P1|Overall Study|Lost to Follow-up|5
5815576|NCT02663453|20079203|P2|Overall Study|Withdrawal by Subject|0
5815577|NCT02663453|20079204|P1|Overall Study|Withdrawal by Subject|1
5815578|NCT02663453|20079203|P2|Overall Study|Death|4
5815579|NCT02663453|20079204|P1|Overall Study|Death|4
5815580|NCT02663128|20079249|P6|Period 2|Physician Decision|0
5815581|NCT02663128|20079250|P5|Period 2|Physician Decision|1
5815582|NCT02663128|20079251|P4|Period 2|Physician Decision|0
5815583|NCT02663128|20079252|P3|Period 2|Physician Decision|0
5815584|NCT02663128|20079253|P2|Period 2|Physician Decision|0
5815585|NCT02663128|20079254|P1|Period 2|Physician Decision|0
5815586|NCT02662764|20079268|P1|Overall Study|Patient discharged prior to 24 hrs|5
5815587|NCT02662764|20079268|P1|Overall Study|Patient changed treatment|1
5815588|NCT02662764|20079268|P1|Overall Study|Device failure|4
5815589|NCT02662764|20079268|P1|Overall Study|Withdrawal by Subject|5
5815590|NCT02662764|20079268|P1|Overall Study|Protocol Violation|1
5815591|NCT02662764|20079268|P1|Overall Study|Lack of Efficacy|8
5815592|NCT02662764|20079268|P1|Overall Study|Adverse Event|6
5815593|NCT02662569|20079336|P4|Overall Study|Lost to Follow-up|0
5815594|NCT02662569|20079337|P3|Overall Study|Lost to Follow-up|0
5815595|NCT02662569|20079338|P2|Overall Study|Lost to Follow-up|0
5815596|NCT02662569|20079339|P1|Overall Study|Lost to Follow-up|1
5815597|NCT02662569|20079336|P4|Overall Study|Withdrawal by Subject|4
5815598|NCT02662569|20079337|P3|Overall Study|Withdrawal by Subject|6
5815599|NCT02662569|20079338|P2|Overall Study|Withdrawal by Subject|1
5815600|NCT02662569|20079339|P1|Overall Study|Withdrawal by Subject|6
5815601|NCT02662556|20079437|P1|Overall Study|Lack of Efficacy|4
5815602|NCT02662556|20079437|P1|Overall Study|Adverse Event|4
5815603|NCT02661815|20079506|P4|Overall Study|Withdrawal by Subject|0
5815604|NCT02661815|20079507|P3|Overall Study|Withdrawal by Subject|0
5815605|NCT02661815|20079508|P2|Overall Study|Withdrawal by Subject|0
5815606|NCT02661815|20079509|P1|Overall Study|Withdrawal by Subject|1
5815607|NCT02661594|20079531|P4|Overall Study|Protocol Violation|0
5815608|NCT02661594|20079532|P3|Overall Study|Protocol Violation|1
5815609|NCT02661594|20079533|P2|Overall Study|Protocol Violation|0
5815610|NCT02661594|20079534|P1|Overall Study|Protocol Violation|1
5815611|NCT02661490|20079549|P5|Overall Study|Reason not Specified|1
5815612|NCT02661490|20079550|P4|Overall Study|Reason not Specified|0
5815613|NCT02661490|20079551|P3|Overall Study|Reason not Specified|0
5815614|NCT02661490|20079552|P2|Overall Study|Reason not Specified|0
5815615|NCT02661490|20079553|P1|Overall Study|Reason not Specified|0
5815616|NCT02661490|20079549|P5|Overall Study|Death|0
5815617|NCT02661490|20079550|P4|Overall Study|Death|1
5815618|NCT02661490|20079551|P3|Overall Study|Death|0
5815619|NCT02661490|20079552|P2|Overall Study|Death|1
5815620|NCT02661490|20079553|P1|Overall Study|Death|1
5815621|NCT02661490|20079549|P5|Overall Study|Withdrawal by Subject|0
5815622|NCT02661490|20079550|P4|Overall Study|Withdrawal by Subject|0
5815623|NCT02661490|20079551|P3|Overall Study|Withdrawal by Subject|2
5815624|NCT02661490|20079552|P2|Overall Study|Withdrawal by Subject|0
5815625|NCT02661490|20079553|P1|Overall Study|Withdrawal by Subject|2
5815626|NCT02661490|20079549|P5|Overall Study|Lost to Follow-up|2
5815627|NCT02661490|20079550|P4|Overall Study|Lost to Follow-up|0
5815628|NCT02661490|20079551|P3|Overall Study|Lost to Follow-up|0
5815629|NCT02661490|20079552|P2|Overall Study|Lost to Follow-up|1
5815630|NCT02661490|20079553|P1|Overall Study|Lost to Follow-up|0
5815631|NCT02661178|20079721|P15|Part 1|Protocol Violation|0
5815632|NCT02661178|20079722|P14|Part 1|Protocol Violation|0
5815633|NCT02661178|20079723|P13|Part 1|Protocol Violation|0
5815634|NCT02661178|20079724|P12|Part 1|Protocol Violation|0
5815635|NCT02661178|20079725|P11|Part 1|Protocol Violation|0
5815636|NCT02661178|20079726|P10|Part 1|Protocol Violation|0
5815637|NCT02661178|20079727|P9|Part 1|Protocol Violation|0
5815638|NCT02661178|20079728|P8|Part 1|Protocol Violation|0
5815639|NCT02661178|20079729|P7|Part 1|Protocol Violation|0
5815640|NCT02661178|20079730|P6|Part 1|Protocol Violation|0
5815641|NCT02661178|20079731|P5|Part 1|Protocol Violation|0
5815642|NCT02661178|20079732|P4|Part 1|Protocol Violation|0
5815643|NCT02661178|20079733|P3|Part 1|Protocol Violation|0
5815644|NCT02661178|20079734|P2|Part 1|Protocol Violation|0
5815645|NCT02661178|20079735|P1|Part 1|Protocol Violation|1
5815646|NCT02661061|20080093|P2|Overall Study|Withdrawal by Subject|1
5815647|NCT02661061|20080094|P1|Overall Study|Withdrawal by Subject|1
5815648|NCT02661061|20080093|P2|Overall Study|Lack of Efficacy|1
5815649|NCT02661061|20080094|P1|Overall Study|Lack of Efficacy|1
5815650|NCT02660983|20080104|P2|Open Label Extension Phase (24 Weeks)|Other|1
5815651|NCT02660983|20080105|P1|Open Label Extension Phase (24 Weeks)|Other|0
5815652|NCT02660983|20080104|P2|Open Label Extension Phase (24 Weeks)|Adverse Event|3
5815653|NCT02660983|20080105|P1|Open Label Extension Phase (24 Weeks)|Adverse Event|1
5815654|NCT02660983|20080104|P2|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|4
5815655|NCT02660983|20080105|P1|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|1
5815656|NCT02660983|20080104|P2|Open Label Extension Phase (24 Weeks)|Protocol Violation|1
5815657|NCT02660983|20080105|P1|Open Label Extension Phase (24 Weeks)|Protocol Violation|1
5815658|NCT02660983|20080104|P2|Double-blind (DB) Phase (24 Weeks)|Adverse Event|9
5815659|NCT02660983|20080105|P1|Double-blind (DB) Phase (24 Weeks)|Adverse Event|8
5815660|NCT02660983|20080104|P2|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|12
5815661|NCT02660983|20080105|P1|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|15
5815662|NCT02660983|20080104|P2|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|5
5815663|NCT02660983|20080105|P1|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|1
5815664|NCT02660580|20080171|P5|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1
5815665|NCT02660580|20080172|P4|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1
5815666|NCT02660580|20080173|P3|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0
5815667|NCT02660580|20080174|P2|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0
5815668|NCT02660580|20080175|P1|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0
5815669|NCT02660580|20080171|P5|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2
5815670|NCT02660580|20080172|P4|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2
5815671|NCT02660580|20080173|P3|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|3
5815672|NCT02660580|20080174|P2|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0
5815673|NCT02660580|20080175|P1|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0
5815674|NCT02660580|20080171|P5|Extended Treatment Period(Week 16 to 52)|Adverse Event|4
5815675|NCT02660580|20080172|P4|Extended Treatment Period(Week 16 to 52)|Adverse Event|6
5815676|NCT02660580|20080173|P3|Extended Treatment Period(Week 16 to 52)|Adverse Event|8
5815677|NCT02660580|20080174|P2|Extended Treatment Period(Week 16 to 52)|Adverse Event|0
5815678|NCT02660580|20080175|P1|Extended Treatment Period(Week 16 to 52)|Adverse Event|0
5815679|NCT02660580|20080171|P5|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2
5815680|NCT02660580|20080172|P4|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2
5815681|NCT02660580|20080173|P3|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|4
5815682|NCT02660580|20080174|P2|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0
5815683|NCT02660580|20080175|P1|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0
5815684|NCT02660580|20080171|P5|Extended Treatment Period(Week 16 to 52)|Other un-specified|1
5815685|NCT02660580|20080172|P4|Extended Treatment Period(Week 16 to 52)|Other un-specified|0
5815686|NCT02660580|20080173|P3|Extended Treatment Period(Week 16 to 52)|Other un-specified|1
5815687|NCT02660580|20080174|P2|Extended Treatment Period(Week 16 to 52)|Other un-specified|0
5815688|NCT02660580|20080175|P1|Extended Treatment Period(Week 16 to 52)|Other un-specified|0
5815689|NCT02660580|20080171|P5|Extended Treatment Period(Week 16 to 52)|Protocol Violation|1
5815690|NCT02660580|20080172|P4|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0
5815691|NCT02660580|20080173|P3|Extended Treatment Period(Week 16 to 52)|Protocol Violation|2
5815692|NCT02660580|20080174|P2|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0
5815693|NCT02660580|20080175|P1|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0
5815694|NCT02660580|20080171|P5|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0
5815695|NCT02660580|20080172|P4|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0
5815696|NCT02660580|20080173|P3|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0
5815697|NCT02660580|20080174|P2|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|2
5815698|NCT02660580|20080175|P1|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|1
5815699|NCT02660580|20080171|P5|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0
5815700|NCT02660580|20080172|P4|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0
5815701|NCT02660580|20080173|P3|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0
5815702|NCT02660580|20080174|P2|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|4
5815703|NCT02660580|20080175|P1|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|1
5815704|NCT02660580|20080171|P5|Core Treatment Period (Week 1 to 16)|Adverse Event|0
5815705|NCT02660580|20080172|P4|Core Treatment Period (Week 1 to 16)|Adverse Event|0
5815706|NCT02660580|20080173|P3|Core Treatment Period (Week 1 to 16)|Adverse Event|0
5815707|NCT02660580|20080174|P2|Core Treatment Period (Week 1 to 16)|Adverse Event|9
5815708|NCT02660580|20080175|P1|Core Treatment Period (Week 1 to 16)|Adverse Event|2
5815709|NCT02660580|20080171|P5|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0
5815710|NCT02660580|20080172|P4|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0
5815711|NCT02660580|20080173|P3|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0
5815712|NCT02660580|20080174|P2|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|2
5815713|NCT02660580|20080175|P1|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0
5815714|NCT02660580|20080171|P5|Core Treatment Period (Week 1 to 16)|Other un-specified|0
5815715|NCT02660580|20080172|P4|Core Treatment Period (Week 1 to 16)|Other un-specified|0
5815716|NCT02660580|20080173|P3|Core Treatment Period (Week 1 to 16)|Other un-specified|0
5815717|NCT02660580|20080174|P2|Core Treatment Period (Week 1 to 16)|Other un-specified|0
5815718|NCT02660580|20080175|P1|Core Treatment Period (Week 1 to 16)|Other un-specified|1
5815719|NCT02660580|20080171|P5|Core Treatment Period (Week 1 to 16)|Protocol Violation|0
5815720|NCT02660580|20080172|P4|Core Treatment Period (Week 1 to 16)|Protocol Violation|0
5815721|NCT02660580|20080173|P3|Core Treatment Period (Week 1 to 16)|Protocol Violation|0
5815722|NCT02660580|20080174|P2|Core Treatment Period (Week 1 to 16)|Protocol Violation|1
5815723|NCT02660580|20080175|P1|Core Treatment Period (Week 1 to 16)|Protocol Violation|3
5815724|NCT02660580|20080171|P5|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0
5815725|NCT02660580|20080172|P4|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0
5815726|NCT02660580|20080173|P3|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0
5815727|NCT02660580|20080174|P2|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1
5815728|NCT02660580|20080175|P1|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1
5815729|NCT02660242|20080290|P1|Glucagon Injection|Lost to Follow-up|1
5815730|NCT02660242|20080290|P1|Glucose Tabs|Lost to Follow-up|1
5815731|NCT02660229|20080346|P2|Overall Study|Withdrawal by Subject|1
5815732|NCT02660229|20080347|P1|Overall Study|Withdrawal by Subject|0
5815733|NCT02660229|20080346|P2|Overall Study|Adverse Event|0
5815734|NCT02660229|20080347|P1|Overall Study|Adverse Event|2
5815735|NCT02659631|20080388|P10|Overall Study|Death (treatment phase)|0
5815736|NCT02659631|20080389|P9|Overall Study|Death (treatment phase)|0
5815737|NCT02659631|20080390|P8|Overall Study|Death (treatment phase)|0
5815738|NCT02659631|20080391|P7|Overall Study|Death (treatment phase)|1
5815739|NCT02659631|20080392|P6|Overall Study|Death (treatment phase)|0
5815740|NCT02659631|20080393|P5|Overall Study|Death (treatment phase)|1
5815741|NCT02659631|20080394|P4|Overall Study|Death (treatment phase)|0
5815742|NCT02659631|20080395|P3|Overall Study|Death (treatment phase)|0
5815743|NCT02659631|20080396|P2|Overall Study|Death (treatment phase)|0
5815744|NCT02659631|20080397|P1|Overall Study|Death (treatment phase)|0
5815745|NCT02659631|20080388|P10|Overall Study|Death (follow-up phase)|0
5815746|NCT02659631|20080389|P9|Overall Study|Death (follow-up phase)|1
5815747|NCT02659631|20080390|P8|Overall Study|Death (follow-up phase)|3
5815748|NCT02659631|20080391|P7|Overall Study|Death (follow-up phase)|0
5815749|NCT02659631|20080392|P6|Overall Study|Death (follow-up phase)|2
5815750|NCT02659631|20080393|P5|Overall Study|Death (follow-up phase)|3
5815751|NCT02659631|20080394|P4|Overall Study|Death (follow-up phase)|1
5815752|NCT02659631|20080395|P3|Overall Study|Death (follow-up phase)|1
5815753|NCT02659631|20080396|P2|Overall Study|Death (follow-up phase)|2
5815754|NCT02659631|20080397|P1|Overall Study|Death (follow-up phase)|1
5815755|NCT02659631|20080388|P10|Overall Study|Participant refused further follow-up|0
5815756|NCT02659631|20080389|P9|Overall Study|Participant refused further follow-up|1
5815757|NCT02659631|20080390|P8|Overall Study|Participant refused further follow-up|0
5815758|NCT02659631|20080391|P7|Overall Study|Participant refused further follow-up|0
5815759|NCT02659631|20080392|P6|Overall Study|Participant refused further follow-up|0
5815760|NCT02659631|20080393|P5|Overall Study|Participant refused further follow-up|0
5815761|NCT02659631|20080394|P4|Overall Study|Participant refused further follow-up|1
5815762|NCT02659631|20080395|P3|Overall Study|Participant refused further follow-up|0
5815763|NCT02659631|20080396|P2|Overall Study|Participant refused further follow-up|0
5815764|NCT02659631|20080397|P1|Overall Study|Participant refused further follow-up|0
5815765|NCT02659631|20080388|P10|Overall Study|Withdrawal prior to treatment|0
5815766|NCT02659631|20080389|P9|Overall Study|Withdrawal prior to treatment|0
5815767|NCT02659631|20080390|P8|Overall Study|Withdrawal prior to treatment|0
5815768|NCT02659631|20080391|P7|Overall Study|Withdrawal prior to treatment|0
5815769|NCT02659631|20080392|P6|Overall Study|Withdrawal prior to treatment|0
5815770|NCT02659631|20080393|P5|Overall Study|Withdrawal prior to treatment|1
5815771|NCT02659631|20080394|P4|Overall Study|Withdrawal prior to treatment|0
5815772|NCT02659631|20080395|P3|Overall Study|Withdrawal prior to treatment|0
5815773|NCT02659631|20080396|P2|Overall Study|Withdrawal prior to treatment|0
5815774|NCT02659631|20080397|P1|Overall Study|Withdrawal prior to treatment|0
5815775|NCT02659631|20080388|P10|Overall Study|Lost to Follow-up|0
5815776|NCT02659631|20080389|P9|Overall Study|Lost to Follow-up|0
5815777|NCT02659631|20080390|P8|Overall Study|Lost to Follow-up|0
5815778|NCT02659631|20080391|P7|Overall Study|Lost to Follow-up|0
5815779|NCT02659631|20080392|P6|Overall Study|Lost to Follow-up|1
5815780|NCT02659631|20080393|P5|Overall Study|Lost to Follow-up|0
5815781|NCT02659631|20080394|P4|Overall Study|Lost to Follow-up|0
5815782|NCT02659631|20080395|P3|Overall Study|Lost to Follow-up|2
5815783|NCT02659631|20080396|P2|Overall Study|Lost to Follow-up|0
5815784|NCT02659631|20080397|P1|Overall Study|Lost to Follow-up|0
5815785|NCT02659540|20080531|P2|Overall Study|Progressive disease|6
5815786|NCT02659540|20080532|P1|Overall Study|Progressive disease|2
5815787|NCT02659540|20080531|P2|Overall Study|Death|0
5815788|NCT02659540|20080532|P1|Overall Study|Death|1
5815789|NCT02659540|20080531|P2|Overall Study|Adverse Event|2
5815790|NCT02659540|20080532|P1|Overall Study|Adverse Event|3
5815791|NCT02659098|20080563|P1|Overall Study|Withdrawal by Subject|7
5815792|NCT02658487|20080625|P1|Overall Study|Refractory AML|1
5815793|NCT02658487|20080625|P1|Overall Study|Treatment Failure, circulating blasts|1
5815794|NCT02658487|20080625|P1|Overall Study|Adverse Event|1
5815795|NCT02658487|20080625|P1|Overall Study|Alternative therapy|1
5815796|NCT02658487|20080625|P1|Overall Study|Disease progression|10
5815797|NCT02658487|20080625|P1|Overall Study|Death|2
5815798|NCT02658149|20080696|P2|Overall Study|Physician Decision|0
5815799|NCT02658149|20080697|P1|Overall Study|Physician Decision|1
5815800|NCT02658084|20080713|P2|Overall Study|Study Termination|0
5815801|NCT02658084|20080714|P1|Overall Study|Study Termination|1
5815802|NCT02658084|20080713|P2|Overall Study|Withdrawal by Subject|0
5815803|NCT02658084|20080714|P1|Overall Study|Withdrawal by Subject|1
5815804|NCT02658019|20080723|P1|Overall Study|Adverse Event|1
5815805|NCT02657889|20080776|P4|Overall Study|Ongoing in Study|19
5815806|NCT02657889|20080777|P3|Overall Study|Ongoing in Study|24
5815807|NCT02657889|20080778|P2|Overall Study|Ongoing in Study|5
5815808|NCT02657889|20080779|P1|Overall Study|Ongoing in Study|0
5815809|NCT02657889|20080776|P4|Overall Study|Withdrawal by Subject|0
5815810|NCT02657889|20080777|P3|Overall Study|Withdrawal by Subject|8
5815811|NCT02657889|20080778|P2|Overall Study|Withdrawal by Subject|0
5815812|NCT02657889|20080779|P1|Overall Study|Withdrawal by Subject|0
5815813|NCT02657889|20080776|P4|Overall Study|Lost to Follow-up|2
5815814|NCT02657889|20080777|P3|Overall Study|Lost to Follow-up|1
5815815|NCT02657889|20080778|P2|Overall Study|Lost to Follow-up|0
5815816|NCT02657889|20080779|P1|Overall Study|Lost to Follow-up|2
5815817|NCT02657889|20080776|P4|Overall Study|Death|34
5815818|NCT02657889|20080777|P3|Overall Study|Death|20
5815819|NCT02657889|20080778|P2|Overall Study|Death|2
5815820|NCT02657889|20080779|P1|Overall Study|Death|5
5815821|NCT02657434|20080820|P2|Overall Study|Protocol Violation|0
5815822|NCT02657434|20080821|P1|Overall Study|Protocol Violation|1
5815823|NCT02657434|20080820|P2|Overall Study|Withdrawal by Subject|16
5815824|NCT02657434|20080821|P1|Overall Study|Withdrawal by Subject|27
5815825|NCT02657434|20080820|P2|Overall Study|Randomization by Error|0
5815826|NCT02657434|20080821|P1|Overall Study|Randomization by Error|2
5815827|NCT02657434|20080820|P2|Overall Study|Lost to Follow-up|2
5815828|NCT02657434|20080821|P1|Overall Study|Lost to Follow-up|2
5815829|NCT02657434|20080820|P2|Overall Study|Death|183
5815830|NCT02657434|20080821|P1|Overall Study|Death|177
5815831|NCT02657434|20080820|P2|Overall Study|On-Going in Study|91
5815832|NCT02657434|20080821|P1|Overall Study|On-Going in Study|77
5815833|NCT02657408|20080851|P2|Overall Study|Adverse Event|7
5815834|NCT02657408|20080852|P1|Overall Study|Adverse Event|3
5815835|NCT02657369|20080876|P1|Overall Study|Study terminated by sponsor|7
5815836|NCT02657369|20080876|P1|Overall Study|Death|27
5815837|NCT02657031|20080907|P2|Overall Study|Adverse Event|2
5815838|NCT02657031|20080908|P1|Overall Study|Adverse Event|1
5815839|NCT02656693|20080940|P3|Overall Study|Bariatric surgery|2
5815840|NCT02656693|20080941|P2|Overall Study|Bariatric surgery|1
5815841|NCT02656693|20080942|P1|Overall Study|Bariatric surgery|0
5815842|NCT02656693|20080940|P3|Overall Study|Pregnancy|1
5815843|NCT02656693|20080941|P2|Overall Study|Pregnancy|1
5815844|NCT02656693|20080942|P1|Overall Study|Pregnancy|1
5815845|NCT02656329|20081067|P2|Overall Study|Other than specified above|6
5815846|NCT02656329|20081068|P1|Overall Study|Other than specified above|5
5815847|NCT02656329|20081067|P2|Overall Study|Study termination by Sponsor|142
5815848|NCT02656329|20081068|P1|Overall Study|Study termination by Sponsor|150
5815849|NCT02656329|20081067|P2|Overall Study|Withdrawal by Subject|6
5815850|NCT02656329|20081068|P1|Overall Study|Withdrawal by Subject|7
5815851|NCT02656329|20081067|P2|Overall Study|Lost to Follow-up|3
5815852|NCT02656329|20081068|P1|Overall Study|Lost to Follow-up|2
5815853|NCT02656290|20081091|P1|Overall Study|Subjects Remain On Study|26
5815854|NCT02656173|20081101|P2|Overall Study|Miscellaneous|0
5815855|NCT02656173|20081102|P1|Overall Study|Miscellaneous|2
5815856|NCT02656173|20081101|P2|Overall Study|Protocol Violation|1
5815857|NCT02656173|20081102|P1|Overall Study|Protocol Violation|0
5815858|NCT02656173|20081101|P2|Overall Study|Withdrawal by Subject|3
5815859|NCT02656173|20081102|P1|Overall Study|Withdrawal by Subject|1
5815860|NCT02656173|20081101|P2|Overall Study|Adverse Event|5
5815861|NCT02656173|20081102|P1|Overall Study|Adverse Event|7
5815862|NCT02656173|20081101|P2|Overall Study|Deviation from the Eligible Criteria|2
5815863|NCT02656173|20081102|P1|Overall Study|Deviation from the Eligible Criteria|3
5815868|NCT02655679|20081193|P5|Overall Study|Other Miscellaneous Reasons|0
5815869|NCT02655679|20081194|P4|Overall Study|Other Miscellaneous Reasons|0
5815870|NCT02655679|20081195|P3|Overall Study|Other Miscellaneous Reasons|0
5815871|NCT02655679|20081196|P2|Overall Study|Other Miscellaneous Reasons|0
5815872|NCT02655679|20081197|P1|Overall Study|Other Miscellaneous Reasons|1
5815873|NCT02655679|20081193|P5|Overall Study|Lost to Follow-up|0
5815874|NCT02655679|20081194|P4|Overall Study|Lost to Follow-up|1
5815875|NCT02655679|20081195|P3|Overall Study|Lost to Follow-up|1
5815876|NCT02655679|20081196|P2|Overall Study|Lost to Follow-up|1
5815877|NCT02655679|20081197|P1|Overall Study|Lost to Follow-up|0
5815878|NCT02655679|20081193|P5|Overall Study|Inability to Comply with the Protocol|0
5815879|NCT02655679|20081194|P4|Overall Study|Inability to Comply with the Protocol|0
5815880|NCT02655679|20081195|P3|Overall Study|Inability to Comply with the Protocol|0
5815881|NCT02655679|20081196|P2|Overall Study|Inability to Comply with the Protocol|0
5815882|NCT02655679|20081197|P1|Overall Study|Inability to Comply with the Protocol|1
5815883|NCT02655679|20081193|P5|Overall Study|Withdrawal by Subject|1
5815884|NCT02655679|20081194|P4|Overall Study|Withdrawal by Subject|3
5815885|NCT02655679|20081195|P3|Overall Study|Withdrawal by Subject|0
5815886|NCT02655679|20081196|P2|Overall Study|Withdrawal by Subject|1
5815887|NCT02655679|20081197|P1|Overall Study|Withdrawal by Subject|1
5815888|NCT02655679|20081193|P5|Overall Study|Adverse Event|0
5815889|NCT02655679|20081194|P4|Overall Study|Adverse Event|0
5815890|NCT02655679|20081195|P3|Overall Study|Adverse Event|0
5815891|NCT02655679|20081196|P2|Overall Study|Adverse Event|1
5815892|NCT02655679|20081197|P1|Overall Study|Adverse Event|0
5815893|NCT02655666|20081269|P1|Overall Study|Sponsor stopped this clinical research.|12
5815894|NCT02655419|20081323|P2|Overall Study|Other|1
5815895|NCT02655419|20081324|P1|Overall Study|Other|0
5815896|NCT02655419|20081323|P2|Overall Study|Withdrawal by Subject|1
5815897|NCT02655419|20081324|P1|Overall Study|Withdrawal by Subject|4
5815898|NCT02655419|20081323|P2|Overall Study|Enrolled but not treated|5
5815899|NCT02655419|20081324|P1|Overall Study|Enrolled but not treated|1
5815900|NCT02655237|20081444|P2|Overall Study|Randomized but Not Treated|0
5815901|NCT02655237|20081445|P1|Overall Study|Randomized but Not Treated|1
5815902|NCT02655237|20081444|P2|Overall Study|Reduction of Hemoglobin Concentration|0
5815903|NCT02655237|20081445|P1|Overall Study|Reduction of Hemoglobin Concentration|1
5815904|NCT02655237|20081444|P2|Overall Study|Recovery Leading to Surgery|1
5815905|NCT02655237|20081445|P1|Overall Study|Recovery Leading to Surgery|2
5815906|NCT02655237|20081444|P2|Overall Study|Lack of Efficacy|1
5815907|NCT02655237|20081445|P1|Overall Study|Lack of Efficacy|0
5815908|NCT02655237|20081444|P2|Overall Study|Withdrawal by Participant|2
5815909|NCT02655237|20081445|P1|Overall Study|Withdrawal by Participant|1
5815910|NCT02655237|20081444|P2|Overall Study|Protocol Deviation|0
5815911|NCT02655237|20081445|P1|Overall Study|Protocol Deviation|2
5815912|NCT02655237|20081444|P2|Overall Study|Adverse Event|7
5815913|NCT02655237|20081445|P1|Overall Study|Adverse Event|10
5815914|NCT02655224|20081485|P2|Overall Study|Adverse Event|1
5815915|NCT02655224|20081486|P1|Overall Study|Adverse Event|1
5815916|NCT02655016|20081518|P2|Overall Study|Withdrawal by Subject|36
5815917|NCT02655016|20081519|P1|Overall Study|Withdrawal by Subject|18
5815918|NCT02655016|20081518|P2|Overall Study|Lost to Follow-up|1
5815919|NCT02655016|20081519|P1|Overall Study|Lost to Follow-up|1
5815920|NCT02655016|20081518|P2|Overall Study|Death|48
5815921|NCT02655016|20081519|P1|Overall Study|Death|30
5815922|NCT02655016|20081518|P2|Overall Study|Site closed|1
5815923|NCT02655016|20081519|P1|Overall Study|Site closed|0
5815924|NCT02655016|20081518|P2|Overall Study|Disease progression|4
5815925|NCT02655016|20081519|P1|Overall Study|Disease progression|6
5815926|NCT02654977|20081551|P1|Overall Study|Lack of Efficacy|3
5815927|NCT02654977|20081551|P1|Overall Study|Withdrawal by Subject|1
5815928|NCT02654977|20081551|P1|Overall Study|Adverse Event|1
5815929|NCT02654977|20081551|P1|Overall Study|Lost to Follow-up|1
5815930|NCT02654977|20081551|P1|Overall Study|Death|1
5815931|NCT02654717|20081585|P2|Overall Study|Non-permitted medication|0
5815932|NCT02654717|20081586|P1|Overall Study|Non-permitted medication|3
5815933|NCT02654717|20081585|P2|Overall Study|Withdrawal by Subject|1
5815934|NCT02654717|20081586|P1|Overall Study|Withdrawal by Subject|0
5815935|NCT02654717|20081585|P2|Overall Study|Protocol Violation|2
5815936|NCT02654717|20081586|P1|Overall Study|Protocol Violation|1
5815937|NCT02654717|20081585|P2|Overall Study|Adverse Event|2
5815938|NCT02654717|20081586|P1|Overall Study|Adverse Event|2
5815939|NCT02654145|20081637|P1|Overall Study|Withdrawal by Subject|5
5815940|NCT02654145|20081637|P1|Overall Study|Protocol Violation|1
5815941|NCT02654145|20081637|P1|Overall Study|Lack of Efficacy|1
5815942|NCT02654132|20081646|P2|Overall Study|Never treated|2
5815943|NCT02654132|20081647|P1|Overall Study|Never treated|0
5815944|NCT02654132|20081646|P2|Overall Study|Clinical Progression (not protocol)|1
5815945|NCT02654132|20081647|P1|Overall Study|Clinical Progression (not protocol)|0
5815946|NCT02654132|20081646|P2|Overall Study|Inadequate response to therapy|0
5815947|NCT02654132|20081647|P1|Overall Study|Inadequate response to therapy|1
5815948|NCT02654132|20081646|P2|Overall Study|Subject Withdrew Consent|1
5815949|NCT02654132|20081647|P1|Overall Study|Subject Withdrew Consent|2
5815950|NCT02654132|20081646|P2|Overall Study|Not Reported|1
5815951|NCT02654132|20081647|P1|Overall Study|Not Reported|0
5815952|NCT02654132|20081646|P2|Overall Study|Subj Request to Discontinue Treatment|0
5815953|NCT02654132|20081647|P1|Overall Study|Subj Request to Discontinue Treatment|1
5815954|NCT02654132|20081646|P2|Overall Study|Maximum Clinical Benefit|2
5815955|NCT02654132|20081647|P1|Overall Study|Maximum Clinical Benefit|0
5815956|NCT02654132|20081646|P2|Overall Study|Study Drug Toxicity|2
5815957|NCT02654132|20081647|P1|Overall Study|Study Drug Toxicity|1
5815958|NCT02654132|20081646|P2|Overall Study|Switched to another tx|1
5815959|NCT02654132|20081647|P1|Overall Study|Switched to another tx|0
5815960|NCT02654132|20081646|P2|Overall Study|Adverse Event Unrelated to Study Drug|5
5815961|NCT02654132|20081647|P1|Overall Study|Adverse Event Unrelated to Study Drug|5
5815962|NCT02654132|20081646|P2|Overall Study|Disease Progression|31
5815963|NCT02654132|20081647|P1|Overall Study|Disease Progression|26
5815964|NCT02654054|20081658|P3|Post-Treatment Follow-Up Period|Non-Compliance|4
5815965|NCT02654054|20081659|P2|Post-Treatment Follow-Up Period|Non-Compliance|0
5815966|NCT02654054|20081660|P1|Post-Treatment Follow-Up Period|Non-Compliance|0
5815967|NCT02654054|20081658|P3|Post-Treatment Follow-Up Period|Other|4
5815968|NCT02654054|20081659|P2|Post-Treatment Follow-Up Period|Other|0
5815969|NCT02654054|20081660|P1|Post-Treatment Follow-Up Period|Other|1
5815970|NCT02654054|20081658|P3|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2
5815971|NCT02654054|20081659|P2|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2
5815972|NCT02654054|20081660|P1|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2
5815973|NCT02654054|20081658|P3|Post-Treatment Follow-Up Period|Lost to Follow-up|13
5815974|NCT02654054|20081659|P2|Post-Treatment Follow-Up Period|Lost to Follow-up|0
5815975|NCT02654054|20081660|P1|Post-Treatment Follow-Up Period|Lost to Follow-up|3
5815976|NCT02654054|20081658|P3|Post-Treatment Follow-Up Period|Withdrawal by Subject|7
5815977|NCT02654054|20081659|P2|Post-Treatment Follow-Up Period|Withdrawal by Subject|6
5815978|NCT02654054|20081660|P1|Post-Treatment Follow-Up Period|Withdrawal by Subject|2
5815979|NCT02654002|20081695|P9|Overall Study|Withdrew Consent|0
5815980|NCT02654002|20081696|P8|Overall Study|Withdrew Consent|1
5815981|NCT02654002|20081697|P7|Overall Study|Withdrew Consent|0
5815982|NCT02654002|20081698|P6|Overall Study|Withdrew Consent|1
5815983|NCT02654002|20081699|P5|Overall Study|Withdrew Consent|0
5815984|NCT02654002|20081700|P4|Overall Study|Withdrew Consent|0
5815985|NCT02654002|20081701|P3|Overall Study|Withdrew Consent|0
5815986|NCT02654002|20081702|P2|Overall Study|Withdrew Consent|0
5815987|NCT02654002|20081703|P1|Overall Study|Withdrew Consent|0
5815988|NCT02654002|20081695|P9|Overall Study|Adverse Event|0
5815989|NCT02654002|20081696|P8|Overall Study|Adverse Event|0
5815990|NCT02654002|20081697|P7|Overall Study|Adverse Event|1
5815991|NCT02654002|20081698|P6|Overall Study|Adverse Event|0
5815992|NCT02654002|20081699|P5|Overall Study|Adverse Event|0
5815993|NCT02654002|20081700|P4|Overall Study|Adverse Event|0
5815994|NCT02654002|20081701|P3|Overall Study|Adverse Event|0
5815995|NCT02654002|20081702|P2|Overall Study|Adverse Event|0
5815996|NCT02654002|20081703|P1|Overall Study|Adverse Event|0
5815997|NCT02653625|20081877|P1|Overall Study|Suspected Drug Induced Liver Injury|1
5815998|NCT02653625|20081877|P1|Overall Study|Protocol Violation|1
5815999|NCT02653625|20081877|P1|Overall Study|Non-compliance with Study Drug|1
5816000|NCT02653625|20081877|P1|Overall Study|Adverse Event|1
5816001|NCT02653495|20081901|P2|Overall Study|Screening Failure|0
5816002|NCT02653495|20081902|P1|Overall Study|Screening Failure|10
5816003|NCT02653495|20081901|P2|Overall Study|Lost to Follow-up|0
5816004|NCT02653495|20081902|P1|Overall Study|Lost to Follow-up|2
5816005|NCT02653326|20081954|P2|Overall Study|Lost to Follow-up|7
5816006|NCT02653326|20081955|P1|Overall Study|Lost to Follow-up|10
5816007|NCT02653170|20081993|P3|Overall Study|Lost to Follow-up|10
5816008|NCT02653170|20081994|P2|Overall Study|Lost to Follow-up|4
5816009|NCT02653170|20081995|P1|Overall Study|Lost to Follow-up|12
5816010|NCT02653170|20081993|P3|Overall Study|withdrawn by study team|5
5816011|NCT02653170|20081994|P2|Overall Study|withdrawn by study team|4
5816012|NCT02653170|20081995|P1|Overall Study|withdrawn by study team|2
5816013|NCT02653170|20081993|P3|Overall Study|Withdrawal by Subject|3
5816014|NCT02653170|20081994|P2|Overall Study|Withdrawal by Subject|8
5816015|NCT02653170|20081995|P1|Overall Study|Withdrawal by Subject|3
5816022|NCT02652767|20082072|P1|Overall Study|Withdrawal by Subject|1
5816023|NCT02652767|20082072|P1|Overall Study|Lost to Follow-up|1
5816024|NCT02652767|20082072|P1|Overall Study|Death|2
5816025|NCT02652624|20082100|P2|Extension Phase|Withdrew Consent|1
5816026|NCT02652624|20082101|P1|Extension Phase|Withdrew Consent|0
5816027|NCT02652624|20082100|P2|Extension Phase|Adverse Event|1
5816028|NCT02652624|20082101|P1|Extension Phase|Adverse Event|0
5816029|NCT02652624|20082100|P2|Extension Phase|Pregnancy|1
5816030|NCT02652624|20082101|P1|Extension Phase|Pregnancy|1
5816031|NCT02652624|20082100|P2|Extension Phase|Lost to Follow-up|1
5816032|NCT02652624|20082101|P1|Extension Phase|Lost to Follow-up|3
5816033|NCT02652624|20082100|P2|Randomized Phase|Lost to Follow-up|1
5816034|NCT02652624|20082101|P1|Randomized Phase|Lost to Follow-up|0
5816035|NCT02652624|20082100|P2|Randomized Phase|Death|1
5816036|NCT02652624|20082101|P1|Randomized Phase|Death|0
5816037|NCT02652624|20082100|P2|Randomized Phase|Investigator's Discretion|2
5816038|NCT02652624|20082101|P1|Randomized Phase|Investigator's Discretion|0
5816039|NCT02652624|20082100|P2|Randomized Phase|Pregnancy|1
5816040|NCT02652624|20082101|P1|Randomized Phase|Pregnancy|3
5816041|NCT02652260|20082189|P2|Overall Study|Withdrawal by Subject|1
5816042|NCT02652260|20082190|P1|Overall Study|Withdrawal by Subject|0
5816043|NCT02652260|20082189|P2|Overall Study|Pregnancy|1
5816044|NCT02652260|20082190|P1|Overall Study|Pregnancy|0
5816045|NCT02652156|20082249|P3|Overall Study|Physician Decision|0
5816046|NCT02652156|20082250|P2|Overall Study|Physician Decision|0
5816047|NCT02652156|20082251|P1|Overall Study|Physician Decision|1
5816048|NCT02651987|20082279|P2|Overall Study|Investigator Decision|1
5816049|NCT02651987|20082280|P1|Overall Study|Investigator Decision|1
5816050|NCT02651987|20082279|P2|Overall Study|Local PD|2
5816051|NCT02651987|20082280|P1|Overall Study|Local PD|0
5816052|NCT02651987|20082279|P2|Overall Study|Consent Withdrawn|0
5816053|NCT02651987|20082280|P1|Overall Study|Consent Withdrawn|2
5816054|NCT02651987|20082279|P2|Overall Study|Adverse Event|2
5816055|NCT02651987|20082280|P1|Overall Study|Adverse Event|2
5816056|NCT02651922|20082321|P1|Overall Study|due to exclusion criteria|2
5816057|NCT02651688|20082341|P3|Overall Study|Withdrawal by Subject|2
5816058|NCT02651688|20082342|P2|Overall Study|Withdrawal by Subject|0
5816059|NCT02651688|20082343|P1|Overall Study|Withdrawal by Subject|1
5816060|NCT02651688|20082341|P3|Overall Study|Lost to Follow-up|0
5816061|NCT02651688|20082342|P2|Overall Study|Lost to Follow-up|3
5816062|NCT02651688|20082343|P1|Overall Study|Lost to Follow-up|1
5816063|NCT02651688|20082341|P3|Overall Study|Principal Investigator (PI) decision|0
5816064|NCT02651688|20082342|P2|Overall Study|Principal Investigator (PI) decision|2
5816065|NCT02651688|20082343|P1|Overall Study|Principal Investigator (PI) decision|0
5816066|NCT02651688|20082341|P3|Overall Study|Non-compliance|1
5816067|NCT02651688|20082342|P2|Overall Study|Non-compliance|0
5816068|NCT02651688|20082343|P1|Overall Study|Non-compliance|0
5816069|NCT02651467|20082426|P3|Overall Study|Other (Not specified)|2
5816070|NCT02651467|20082427|P2|Overall Study|Other (Not specified)|0
5816071|NCT02651467|20082428|P1|Overall Study|Other (Not specified)|1
5816072|NCT02651467|20082426|P3|Overall Study|Withdrawal by Subject|2
5816073|NCT02651467|20082427|P2|Overall Study|Withdrawal by Subject|0
5816074|NCT02651467|20082428|P1|Overall Study|Withdrawal by Subject|0
5816075|NCT02651220|20082522|P3|Overall Study|Withdrawal by Parent/Guardian|1
5816076|NCT02651220|20082523|P2|Overall Study|Withdrawal by Parent/Guardian|1
5816077|NCT02651220|20082524|P1|Overall Study|Withdrawal by Parent/Guardian|0
5816078|NCT02651220|20082522|P3|Overall Study|Miscellaneous|2
5816079|NCT02651220|20082523|P2|Overall Study|Miscellaneous|1
5816080|NCT02651220|20082524|P1|Overall Study|Miscellaneous|4
5816081|NCT02651220|20082522|P3|Overall Study|Withdrawal by Subject|8
5816082|NCT02651220|20082523|P2|Overall Study|Withdrawal by Subject|6
5816083|NCT02651220|20082524|P1|Overall Study|Withdrawal by Subject|5
5816084|NCT02651220|20082522|P3|Overall Study|Protocol Violation|1
5816085|NCT02651220|20082523|P2|Overall Study|Protocol Violation|0
5816086|NCT02651220|20082524|P1|Overall Study|Protocol Violation|0
5816087|NCT02651220|20082522|P3|Overall Study|Pregnancy|1
5816088|NCT02651220|20082523|P2|Overall Study|Pregnancy|0
5816089|NCT02651220|20082524|P1|Overall Study|Pregnancy|1
5816090|NCT02651220|20082522|P3|Overall Study|Non-Compliance with Study Drug|1
5816091|NCT02651220|20082523|P2|Overall Study|Non-Compliance with Study Drug|0
5816092|NCT02651220|20082524|P1|Overall Study|Non-Compliance with Study Drug|4
5816093|NCT02651220|20082522|P3|Overall Study|Lost to Follow-up|14
5816094|NCT02651220|20082523|P2|Overall Study|Lost to Follow-up|14
5816095|NCT02651220|20082524|P1|Overall Study|Lost to Follow-up|8
5816096|NCT02651220|20082522|P3|Overall Study|Adverse Event|1
5816097|NCT02651220|20082523|P2|Overall Study|Adverse Event|5
5816098|NCT02651220|20082524|P1|Overall Study|Adverse Event|1
5816099|NCT02651194|20082538|P1|Overall Study|Other|2
5816100|NCT02651194|20082538|P1|Overall Study|Lost to Follow-up|3
5816101|NCT02651155|20082546|P2|Overall Study|Voluntary Withdrawal|0
5816102|NCT02651155|20082547|P1|Overall Study|Voluntary Withdrawal|5
5816103|NCT02651155|20082546|P2|Overall Study|Pretreatment Event/Adverse Event|2
5816104|NCT02651155|20082547|P1|Overall Study|Pretreatment Event/Adverse Event|1
5816105|NCT02650921|20082572|P1|Overall Study|Due to Medical Condition|1
5816106|NCT02650921|20082572|P1|Overall Study|Adverse Event|1
5816107|NCT02650921|20082572|P1|Overall Study|Lost to Follow-up|2
5816108|NCT02650921|20082572|P1|Overall Study|Withdrawal by Subject|4
5816109|NCT02650895|20082626|P6|Overall Study|Withdrawal by Subject|0
5816110|NCT02650895|20082627|P5|Overall Study|Withdrawal by Subject|0
5816111|NCT02650895|20082628|P4|Overall Study|Withdrawal by Subject|0
5816112|NCT02650895|20082629|P3|Overall Study|Withdrawal by Subject|0
5816113|NCT02650895|20082630|P2|Overall Study|Withdrawal by Subject|1
5816114|NCT02650895|20082631|P1|Overall Study|Withdrawal by Subject|0
5816115|NCT02650466|20082678|P1|Overall Study|Lost to Follow-up|1
5816116|NCT02650466|20082678|P1|Overall Study|Withdrawal by Subject|5
5816117|NCT02650466|20082678|P1|Overall Study|Physician Decision|1
5816118|NCT02650128|20082808|P1|Overall Study|Death|2
5816119|NCT02649946|20082817|P2|Overall Study|Missed 6-month follow-up visit|4
5816120|NCT02649946|20082818|P1|Overall Study|Missed 6-month follow-up visit|0
5816121|NCT02649946|20082817|P2|Overall Study|Erroneously enrolled|0
5816122|NCT02649946|20082818|P1|Overall Study|Erroneously enrolled|1
5816123|NCT02649946|20082817|P2|Overall Study|Lost to Follow-up|1
5816124|NCT02649946|20082818|P1|Overall Study|Lost to Follow-up|2
5816125|NCT02649946|20082817|P2|Overall Study|Physician Decision|0
5816126|NCT02649946|20082818|P1|Overall Study|Physician Decision|1
5816127|NCT02649946|20082817|P2|Overall Study|Death|9
5816128|NCT02649946|20082818|P1|Overall Study|Death|7
5816129|NCT02649946|20082817|P2|Overall Study|Withdrawal by Subject|1
5816130|NCT02649946|20082818|P1|Overall Study|Withdrawal by Subject|1
5816131|NCT02649894|20082847|P2|Overall Study|Other, not specified|0
5816132|NCT02649894|20082848|P1|Overall Study|Other, not specified|6
5816133|NCT02649894|20082847|P2|Overall Study|Death|7
5816134|NCT02649894|20082848|P1|Overall Study|Death|30
5816135|NCT02649894|20082847|P2|Overall Study|Lost to Follow-up|1
5816136|NCT02649894|20082848|P1|Overall Study|Lost to Follow-up|2
5816137|NCT02649894|20082847|P2|Overall Study|Withdrawal by Subject|2
5816138|NCT02649894|20082848|P1|Overall Study|Withdrawal by Subject|5
5816139|NCT02649894|20082847|P2|Overall Study|Physician Decision|1
5816140|NCT02649894|20082848|P1|Overall Study|Physician Decision|0
5816141|NCT02649894|20082847|P2|Overall Study|Adverse Event|0
5816142|NCT02649894|20082848|P1|Overall Study|Adverse Event|1
5816143|NCT02649634|20082876|P2|Overall Study|Lost to Follow-up|1
5816144|NCT02649634|20082877|P1|Overall Study|Lost to Follow-up|0
5816145|NCT02649634|20082876|P2|Overall Study|Withdrawal by Subject|5
5816146|NCT02649634|20082877|P1|Overall Study|Withdrawal by Subject|3
5816153|NCT02648698|20083137|P2|Overall Study|Protocol Violation|5
5816154|NCT02648698|20083138|P1|Overall Study|Protocol Violation|1
5816155|NCT02648438|20083195|P3|Overall Study|Withdrawal by Subject|0
5816156|NCT02648438|20083196|P2|Overall Study|Withdrawal by Subject|1
5816157|NCT02648438|20083197|P1|Overall Study|Withdrawal by Subject|1
5816158|NCT02648438|20083195|P3|Overall Study|Protocol Violation|0
5816159|NCT02648438|20083196|P2|Overall Study|Protocol Violation|0
5816160|NCT02648438|20083197|P1|Overall Study|Protocol Violation|2
5816161|NCT02648438|20083195|P3|Overall Study|Eligibility criteria not fulfilled|0
5816162|NCT02648438|20083196|P2|Overall Study|Eligibility criteria not fulfilled|2
5816163|NCT02648438|20083197|P1|Overall Study|Eligibility criteria not fulfilled|0
5816164|NCT02648217|20083243|P2|Overall Study|Unclassified|0
5816165|NCT02648217|20083244|P1|Overall Study|Unclassified|5
5816166|NCT02648217|20083243|P2|Overall Study|Withdrawal by Subject|3
5816167|NCT02648217|20083244|P1|Overall Study|Withdrawal by Subject|4
5816168|NCT02648217|20083243|P2|Overall Study|Lost to Follow-up|1
5816169|NCT02648217|20083244|P1|Overall Study|Lost to Follow-up|1
5816170|NCT02648217|20083243|P2|Overall Study|Adverse Event|1
5816171|NCT02648217|20083244|P1|Overall Study|Adverse Event|0
5816172|NCT02648204|20083266|P4|Overall Study|Adverse Event|0
5816173|NCT02648204|20083267|P3|Overall Study|Adverse Event|1
5816174|NCT02648204|20083268|P2|Overall Study|Adverse Event|0
5816175|NCT02648204|20083269|P1|Overall Study|Adverse Event|0
5816176|NCT02648204|20083266|P4|Overall Study|Death|2
5816177|NCT02648204|20083267|P3|Overall Study|Death|2
5816178|NCT02648204|20083268|P2|Overall Study|Death|1
5816179|NCT02648204|20083269|P1|Overall Study|Death|1
5816180|NCT02648204|20083266|P4|Overall Study|Missing follow-up information|2
5816181|NCT02648204|20083267|P3|Overall Study|Missing follow-up information|4
5816182|NCT02648204|20083268|P2|Overall Study|Missing follow-up information|4
5816183|NCT02648204|20083269|P1|Overall Study|Missing follow-up information|4
5816184|NCT02648204|20083266|P4|Overall Study|Lost to Follow-up|6
5816185|NCT02648204|20083267|P3|Overall Study|Lost to Follow-up|4
5816186|NCT02648204|20083268|P2|Overall Study|Lost to Follow-up|8
5816187|NCT02648204|20083269|P1|Overall Study|Lost to Follow-up|5
5816188|NCT02648204|20083266|P4|Overall Study|Withdrawal by Subject|6
5816189|NCT02648204|20083267|P3|Overall Study|Withdrawal by Subject|2
5816190|NCT02648204|20083268|P2|Overall Study|Withdrawal by Subject|8
5816191|NCT02648204|20083269|P1|Overall Study|Withdrawal by Subject|12
5816192|NCT02647944|20083407|P2|Overall Study|Adverse Event|0
5816193|NCT02647944|20083408|P1|Overall Study|Adverse Event|2
5816194|NCT02647944|20083407|P2|Overall Study|Withdrawal by Subject|3
5816195|NCT02647944|20083408|P1|Overall Study|Withdrawal by Subject|0
5816196|NCT02647905|20083432|P1|Overall Study|Withdrawal by Subject|2
5816197|NCT02647905|20083432|P1|Overall Study|Lost to Follow-up|1
5816198|NCT02647866|20083442|P5|Overall Study|Subject moved to different country|0
5816199|NCT02647866|20083443|P4|Overall Study|Subject moved to different country|0
5816200|NCT02647866|20083444|P3|Overall Study|Subject moved to different country|0
5816201|NCT02647866|20083445|P2|Overall Study|Subject moved to different country|0
5816202|NCT02647866|20083446|P1|Overall Study|Subject moved to different country|1
5816203|NCT02647866|20083442|P5|Overall Study|Death|0
5816204|NCT02647866|20083443|P4|Overall Study|Death|0
5816205|NCT02647866|20083444|P3|Overall Study|Death|0
5816206|NCT02647866|20083445|P2|Overall Study|Death|1
5816207|NCT02647866|20083446|P1|Overall Study|Death|0
5816208|NCT02647866|20083442|P5|Overall Study|Physician Decision|2
5816209|NCT02647866|20083443|P4|Overall Study|Physician Decision|0
5816210|NCT02647866|20083444|P3|Overall Study|Physician Decision|1
5816211|NCT02647866|20083445|P2|Overall Study|Physician Decision|1
5816212|NCT02647866|20083446|P1|Overall Study|Physician Decision|0
5816213|NCT02647866|20083442|P5|Overall Study|Withdrawal by Subject|4
5816214|NCT02647866|20083443|P4|Overall Study|Withdrawal by Subject|4
5816215|NCT02647866|20083444|P3|Overall Study|Withdrawal by Subject|2
5816216|NCT02647866|20083445|P2|Overall Study|Withdrawal by Subject|1
5816217|NCT02647866|20083446|P1|Overall Study|Withdrawal by Subject|1
5816218|NCT02647866|20083442|P5|Overall Study|Disease Worsening|1
5816219|NCT02647866|20083443|P4|Overall Study|Disease Worsening|0
5816220|NCT02647866|20083444|P3|Overall Study|Disease Worsening|0
5816221|NCT02647866|20083445|P2|Overall Study|Disease Worsening|1
5816222|NCT02647866|20083446|P1|Overall Study|Disease Worsening|3
5816223|NCT02647866|20083442|P5|Overall Study|Adverse Event|1
5816224|NCT02647866|20083443|P4|Overall Study|Adverse Event|2
5816225|NCT02647866|20083444|P3|Overall Study|Adverse Event|2
5816226|NCT02647866|20083445|P2|Overall Study|Adverse Event|0
5816227|NCT02647866|20083446|P1|Overall Study|Adverse Event|0
5816228|NCT02647788|20083523|P2|Overall Study|Felt nauseous with assigned medication|1
5816229|NCT02647788|20083524|P1|Overall Study|Felt nauseous with assigned medication|1
5816230|NCT02647788|20083523|P2|Overall Study|Felt itchy with assigned medication|0
5816231|NCT02647788|20083524|P1|Overall Study|Felt itchy with assigned medication|1
5816232|NCT02647788|20083523|P2|Overall Study|Withdrawal by Subject|0
5816233|NCT02647788|20083524|P1|Overall Study|Withdrawal by Subject|1
5816234|NCT02647788|20083523|P2|Overall Study|Did not want opiate|1
5816235|NCT02647788|20083524|P1|Overall Study|Did not want opiate|0
5816236|NCT02647788|20083523|P2|Overall Study|Lost to Follow-up|11
5816237|NCT02647788|20083524|P1|Overall Study|Lost to Follow-up|13
5816238|NCT02647658|20083536|P2|Overall Study|Consent refusal|24
5816239|NCT02647658|20083537|P1|Overall Study|Consent refusal|15
5816240|NCT02647645|20083565|P2|Overall Study|Lost to Follow-up|1
5816241|NCT02647645|20083566|P1|Overall Study|Lost to Follow-up|2
5816242|NCT02647320|20083588|P5|Overall Study|Disposition Missing Due to Fire at Site|4
5816243|NCT02647320|20083589|P4|Overall Study|Disposition Missing Due to Fire at Site|3
5816244|NCT02647320|20083590|P3|Overall Study|Disposition Missing Due to Fire at Site|4
5816245|NCT02647320|20083591|P2|Overall Study|Disposition Missing Due to Fire at Site|3
5816246|NCT02647320|20083592|P1|Overall Study|Disposition Missing Due to Fire at Site|2
5816247|NCT02647320|20083588|P5|Overall Study|Lack of Efficacy|0
5816248|NCT02647320|20083589|P4|Overall Study|Lack of Efficacy|1
5816249|NCT02647320|20083590|P3|Overall Study|Lack of Efficacy|0
5816250|NCT02647320|20083591|P2|Overall Study|Lack of Efficacy|0
5816251|NCT02647320|20083592|P1|Overall Study|Lack of Efficacy|0
5816252|NCT02647320|20083588|P5|Overall Study|Develop anemia|0
5816253|NCT02647320|20083589|P4|Overall Study|Develop anemia|0
5816254|NCT02647320|20083590|P3|Overall Study|Develop anemia|0
5816255|NCT02647320|20083591|P2|Overall Study|Develop anemia|0
5816256|NCT02647320|20083592|P1|Overall Study|Develop anemia|1
5816257|NCT02647320|20083588|P5|Overall Study|Lost to Follow-up|0
5816258|NCT02647320|20083589|P4|Overall Study|Lost to Follow-up|0
5816259|NCT02647320|20083590|P3|Overall Study|Lost to Follow-up|0
5816260|NCT02647320|20083591|P2|Overall Study|Lost to Follow-up|1
5816261|NCT02647320|20083592|P1|Overall Study|Lost to Follow-up|1
5816262|NCT02647320|20083588|P5|Overall Study|Reason not provided|2
5816263|NCT02647320|20083589|P4|Overall Study|Reason not provided|0
5816264|NCT02647320|20083590|P3|Overall Study|Reason not provided|1
5816265|NCT02647320|20083591|P2|Overall Study|Reason not provided|0
5816266|NCT02647320|20083592|P1|Overall Study|Reason not provided|0
5816267|NCT02647320|20083588|P5|Overall Study|Study terminated by sponsor|2
5816268|NCT02647320|20083589|P4|Overall Study|Study terminated by sponsor|1
5816269|NCT02647320|20083590|P3|Overall Study|Study terminated by sponsor|1
5816270|NCT02647320|20083591|P2|Overall Study|Study terminated by sponsor|1
5816271|NCT02647320|20083592|P1|Overall Study|Study terminated by sponsor|1
5816272|NCT02647320|20083588|P5|Overall Study|Persistent hyperglycemia|1
5816273|NCT02647320|20083589|P4|Overall Study|Persistent hyperglycemia|1
5816274|NCT02647320|20083590|P3|Overall Study|Persistent hyperglycemia|1
5816275|NCT02647320|20083591|P2|Overall Study|Persistent hyperglycemia|1
5816276|NCT02647320|20083592|P1|Overall Study|Persistent hyperglycemia|0
5816277|NCT02647320|20083588|P5|Overall Study|Withdrawal by Subject|7
5816278|NCT02647320|20083589|P4|Overall Study|Withdrawal by Subject|2
5816279|NCT02647320|20083590|P3|Overall Study|Withdrawal by Subject|2
5816280|NCT02647320|20083591|P2|Overall Study|Withdrawal by Subject|4
5816281|NCT02647320|20083592|P1|Overall Study|Withdrawal by Subject|7
5816282|NCT02647320|20083588|P5|Overall Study|Protocol Violation|0
5816283|NCT02647320|20083589|P4|Overall Study|Protocol Violation|0
5816284|NCT02647320|20083590|P3|Overall Study|Protocol Violation|3
5816285|NCT02647320|20083591|P2|Overall Study|Protocol Violation|0
5816286|NCT02647320|20083592|P1|Overall Study|Protocol Violation|0
5816287|NCT02647320|20083588|P5|Overall Study|Adverse Event|1
5816288|NCT02647320|20083589|P4|Overall Study|Adverse Event|2
5816289|NCT02647320|20083590|P3|Overall Study|Adverse Event|3
5816290|NCT02647320|20083591|P2|Overall Study|Adverse Event|1
5816291|NCT02647320|20083592|P1|Overall Study|Adverse Event|0
5816292|NCT02647281|20083683|P9|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|1
5816293|NCT02647281|20083684|P8|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
5816294|NCT02647281|20083685|P7|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
5816295|NCT02647281|20083686|P6|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
5816296|NCT02647281|20083687|P5|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
5816297|NCT02647281|20083688|P4|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
5816298|NCT02647281|20083689|P3|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
5816299|NCT02647281|20083690|P2|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
5816300|NCT02647281|20083691|P1|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
5816301|NCT02646891|20083890|P10|Overall Study|Death|0
5816302|NCT02646891|20083891|P9|Overall Study|Death|1
5816303|NCT02646891|20083892|P8|Overall Study|Death|1
5816304|NCT02646891|20083893|P7|Overall Study|Death|1
5816305|NCT02646891|20083894|P6|Overall Study|Death|0
5816306|NCT02646891|20083895|P5|Overall Study|Death|0
5816307|NCT02646891|20083896|P4|Overall Study|Death|0
5816308|NCT02646891|20083897|P3|Overall Study|Death|0
5816309|NCT02646891|20083898|P2|Overall Study|Death|0
5816310|NCT02646891|20083899|P1|Overall Study|Death|0
5816311|NCT02646891|20083890|P10|Overall Study|Withdrawal by Subject|3
5816312|NCT02646891|20083891|P9|Overall Study|Withdrawal by Subject|7
5816313|NCT02646891|20083892|P8|Overall Study|Withdrawal by Subject|9
5816314|NCT02646891|20083893|P7|Overall Study|Withdrawal by Subject|5
5816315|NCT02646891|20083894|P6|Overall Study|Withdrawal by Subject|0
5816316|NCT02646891|20083895|P5|Overall Study|Withdrawal by Subject|0
5816317|NCT02646891|20083896|P4|Overall Study|Withdrawal by Subject|0
5816318|NCT02646891|20083897|P3|Overall Study|Withdrawal by Subject|1
5816319|NCT02646891|20083898|P2|Overall Study|Withdrawal by Subject|0
5816320|NCT02646891|20083899|P1|Overall Study|Withdrawal by Subject|2
5816321|NCT02646891|20083890|P10|Overall Study|Protocol Violation|0
5816322|NCT02646891|20083891|P9|Overall Study|Protocol Violation|0
5816323|NCT02646891|20083892|P8|Overall Study|Protocol Violation|1
5816324|NCT02646891|20083893|P7|Overall Study|Protocol Violation|1
5816325|NCT02646891|20083894|P6|Overall Study|Protocol Violation|0
5816326|NCT02646891|20083895|P5|Overall Study|Protocol Violation|0
5816327|NCT02646891|20083896|P4|Overall Study|Protocol Violation|0
5816328|NCT02646891|20083897|P3|Overall Study|Protocol Violation|0
5816329|NCT02646891|20083898|P2|Overall Study|Protocol Violation|0
5816330|NCT02646891|20083899|P1|Overall Study|Protocol Violation|0
5816331|NCT02646891|20083890|P10|Overall Study|Lost to Follow-up|2
5816332|NCT02646891|20083891|P9|Overall Study|Lost to Follow-up|2
5816333|NCT02646891|20083892|P8|Overall Study|Lost to Follow-up|2
5816334|NCT02646891|20083893|P7|Overall Study|Lost to Follow-up|2
5816335|NCT02646891|20083894|P6|Overall Study|Lost to Follow-up|0
5816336|NCT02646891|20083895|P5|Overall Study|Lost to Follow-up|0
5816337|NCT02646891|20083896|P4|Overall Study|Lost to Follow-up|0
5816338|NCT02646891|20083897|P3|Overall Study|Lost to Follow-up|0
5816339|NCT02646891|20083898|P2|Overall Study|Lost to Follow-up|0
5816340|NCT02646891|20083899|P1|Overall Study|Lost to Follow-up|0
5816341|NCT02646891|20083890|P10|Overall Study|Adverse Event|0
5816342|NCT02646891|20083891|P9|Overall Study|Adverse Event|0
5816343|NCT02646891|20083892|P8|Overall Study|Adverse Event|0
5816344|NCT02646891|20083893|P7|Overall Study|Adverse Event|0
5816345|NCT02646891|20083894|P6|Overall Study|Adverse Event|0
5816346|NCT02646891|20083895|P5|Overall Study|Adverse Event|0
5816347|NCT02646891|20083896|P4|Overall Study|Adverse Event|0
5816348|NCT02646891|20083897|P3|Overall Study|Adverse Event|0
5816349|NCT02646891|20083898|P2|Overall Study|Adverse Event|1
5816350|NCT02646891|20083899|P1|Overall Study|Adverse Event|0
5816351|NCT02646566|20084073|P3|Overall Study|Treatment failure|0
5816352|NCT02646566|20084074|P2|Overall Study|Treatment failure|0
5816353|NCT02646566|20084075|P1|Overall Study|Treatment failure|1
5816354|NCT02646566|20084073|P3|Overall Study|Lost to Follow-up|5
5816355|NCT02646566|20084074|P2|Overall Study|Lost to Follow-up|4
5816356|NCT02646566|20084075|P1|Overall Study|Lost to Follow-up|5
5816357|NCT02646332|20084135|P2|Overall Study|Lost to Follow-up|3
5816358|NCT02646332|20084136|P1|Overall Study|Lost to Follow-up|0
5816359|NCT02646124|20084144|P2|Overall Study|Lost to Follow-up|2
5816360|NCT02646124|20084145|P1|Overall Study|Lost to Follow-up|0
5816361|NCT02645409|20084181|P2|Overall Study|Physician Decision|0
5816362|NCT02645409|20084182|P1|Overall Study|Physician Decision|1
5816363|NCT02645409|20084181|P2|Overall Study|Withdrawal by Subject|0
5816364|NCT02645409|20084182|P1|Overall Study|Withdrawal by Subject|3
5816365|NCT02644668|20084369|P3|Overall Study|Withdrawal by Subject|1
5816366|NCT02644668|20084370|P2|Overall Study|Withdrawal by Subject|0
5816367|NCT02644668|20084371|P1|Overall Study|Withdrawal by Subject|0
5816368|NCT02644668|20084369|P3|Overall Study|Protocol Violation|1
5816369|NCT02644668|20084370|P2|Overall Study|Protocol Violation|0
5816370|NCT02644668|20084371|P1|Overall Study|Protocol Violation|0
5816371|NCT02644668|20084369|P3|Overall Study|Adverse Event|1
5816372|NCT02644668|20084370|P2|Overall Study|Adverse Event|0
5816373|NCT02644668|20084371|P1|Overall Study|Adverse Event|2
5816374|NCT02644356|20084410|P1|Overall Study|Withdrawal by Subject|2
5816375|NCT02644343|20084420|P1|Overall Study|Withdrawal by Subject|1
5816376|NCT02644122|20084497|P1|Overall Study|Withdrawal by Subject|1
5816377|NCT02644109|20084507|P2|Overall Study|Adverse Event|4
5816378|NCT02644109|20084508|P1|Overall Study|Adverse Event|0
5816379|NCT02644096|20084516|P2|Overall Study|Withdrawal by Subject|25
5816380|NCT02644096|20084517|P1|Overall Study|Withdrawal by Subject|28
5816381|NCT02643693|20084569|P6|Overall Study|Protocol Adherence Issues|1
5816382|NCT02643693|20084570|P5|Overall Study|Protocol Adherence Issues|0
5816383|NCT02643693|20084571|P4|Overall Study|Protocol Adherence Issues|0
5816384|NCT02643693|20084572|P3|Overall Study|Protocol Adherence Issues|1
5816385|NCT02643693|20084573|P2|Overall Study|Protocol Adherence Issues|0
5816386|NCT02643693|20084574|P1|Overall Study|Protocol Adherence Issues|2
5816387|NCT02643693|20084569|P6|Overall Study|Withdrawal by Subject|0
5816388|NCT02643693|20084570|P5|Overall Study|Withdrawal by Subject|0
5816389|NCT02643693|20084571|P4|Overall Study|Withdrawal by Subject|0
5816390|NCT02643693|20084572|P3|Overall Study|Withdrawal by Subject|0
5816391|NCT02643693|20084573|P2|Overall Study|Withdrawal by Subject|1
5816392|NCT02643693|20084574|P1|Overall Study|Withdrawal by Subject|0
5816393|NCT02643693|20084569|P6|Overall Study|Physician Decision|0
5816394|NCT02643693|20084570|P5|Overall Study|Physician Decision|0
5816395|NCT02643693|20084571|P4|Overall Study|Physician Decision|0
5816396|NCT02643693|20084572|P3|Overall Study|Physician Decision|0
5816397|NCT02643693|20084573|P2|Overall Study|Physician Decision|1
5816398|NCT02643693|20084574|P1|Overall Study|Physician Decision|0
5816399|NCT02643628|20084587|P2|Overall Study|Relocated out of state|1
5816400|NCT02643628|20084588|P1|Overall Study|Relocated out of state|0
5816401|NCT02643628|20084587|P2|Overall Study|Withdrawal by Subject|1
5816402|NCT02643628|20084588|P1|Overall Study|Withdrawal by Subject|0
5816403|NCT02643628|20084587|P2|Overall Study|Lost to Follow-up|4
5816404|NCT02643628|20084588|P1|Overall Study|Lost to Follow-up|1
5816405|NCT02643472|20084619|P2|Overall Study|Lost to Follow-up|26
5816406|NCT02643472|20084620|P1|Overall Study|Lost to Follow-up|22
5816407|NCT02643472|20084619|P2|Overall Study|Protocol Violation|1
5816408|NCT02643472|20084620|P1|Overall Study|Protocol Violation|0
5816409|NCT02643472|20084619|P2|Overall Study|Withdrawal by Subject|2
5816410|NCT02643472|20084620|P1|Overall Study|Withdrawal by Subject|3
5816411|NCT02643472|20084619|P2|Overall Study|Death|5
5816412|NCT02643472|20084620|P1|Overall Study|Death|2
5816413|NCT02643394|20084646|P2|Overall Study|Protocol Violation|5
5816414|NCT02643394|20084647|P1|Overall Study|Protocol Violation|4
5816415|NCT02643355|20084657|P2|Overall Study|Protocol Violation|2
5816416|NCT02643355|20084658|P1|Overall Study|Protocol Violation|0
5816417|NCT02643355|20084657|P2|Overall Study|Withdrawal by Subject|3
5816418|NCT02643355|20084658|P1|Overall Study|Withdrawal by Subject|1
5816419|NCT02643251|20084672|P2|Overall Study|PI Decision to terminate patient|0
5816420|NCT02643251|20084673|P1|Overall Study|PI Decision to terminate patient|1
5816421|NCT02643251|20084672|P2|Overall Study|Protocol Violation|0
5816422|NCT02643251|20084673|P1|Overall Study|Protocol Violation|1
5816423|NCT02643251|20084672|P2|Overall Study|Lost to Follow-up|1
5816424|NCT02643251|20084673|P1|Overall Study|Lost to Follow-up|4
5816425|NCT02643251|20084672|P2|Overall Study|Withdrawal by Subject|0
5816426|NCT02643251|20084673|P1|Overall Study|Withdrawal by Subject|2
5816427|NCT02643251|20084672|P2|Overall Study|Adverse Event|1
5816428|NCT02643251|20084673|P1|Overall Study|Adverse Event|3
5816429|NCT02643082|20084705|P2|Period 1|Adverse Event|0
5816430|NCT02643082|20084706|P1|Period 1|Adverse Event|1
5816431|NCT02642965|20084846|P1|Overall Study|Physician Decision|9
5816432|NCT02642965|20084846|P1|Overall Study|Lack of Efficacy|4
5816433|NCT02642679|20084890|P1|Overall Study|Physician Decision|1
5816434|NCT02642679|20084890|P1|Overall Study|Physician Decision|1
5816435|NCT02642679|20084890|P1|Overall Study|Withdrawal by Subject|1
5816436|NCT02642653|20084898|P2|Overall Study|Adverse Event|0
5816437|NCT02642653|20084899|P1|Overall Study|Adverse Event|2
5816438|NCT02642614|20084940|P4|Overall Study|Withdrawal by Subject|0
5816439|NCT02642614|20084941|P3|Overall Study|Withdrawal by Subject|0
5816440|NCT02642614|20084942|P2|Overall Study|Withdrawal by Subject|1
5816441|NCT02642614|20084943|P1|Overall Study|Withdrawal by Subject|1
5816442|NCT02642614|20084940|P4|Overall Study|Lost to Follow-up|0
5816443|NCT02642614|20084941|P3|Overall Study|Lost to Follow-up|0
5816444|NCT02642614|20084942|P2|Overall Study|Lost to Follow-up|0
5816445|NCT02642614|20084943|P1|Overall Study|Lost to Follow-up|1
5816446|NCT02642614|20084940|P4|Overall Study|Adverse Event|2
5816447|NCT02642614|20084941|P3|Overall Study|Adverse Event|2
5816448|NCT02642614|20084942|P2|Overall Study|Adverse Event|1
5816449|NCT02642614|20084943|P1|Overall Study|Adverse Event|1
5816450|NCT02642432|20085010|P1|Overall Study|Other|3
5816451|NCT02642432|20085010|P1|Overall Study|Lost to Follow-up|2
5816452|NCT02642432|20085010|P1|Overall Study|Withdrew Consent|1
5816453|NCT02642432|20085010|P1|Overall Study|Adverse Event|2
5816454|NCT02642159|20085056|P2|Overall Study|Other than specified above|3
5816455|NCT02642159|20085057|P1|Overall Study|Other than specified above|10
5816456|NCT02642159|20085056|P2|Overall Study|Poor compliance to study protocol|0
5816457|NCT02642159|20085057|P1|Overall Study|Poor compliance to study protocol|1
5816458|NCT02642159|20085056|P2|Overall Study|Withdrawal by Subject|1
5816459|NCT02642159|20085057|P1|Overall Study|Withdrawal by Subject|9
5816460|NCT02642159|20085056|P2|Overall Study|Adverse Event|4
5816461|NCT02642159|20085057|P1|Overall Study|Adverse Event|10
5816462|NCT02642159|20085056|P2|Overall Study|Randomized but not treated|0
5816463|NCT02642159|20085057|P1|Overall Study|Randomized but not treated|1
5816464|NCT02641730|20085181|P5|Observational Period (Week 60 - Week 84)|Other|1
5816465|NCT02641730|20085182|P4|Observational Period (Week 60 - Week 84)|Other|0
5816466|NCT02641730|20085183|P3|Observational Period (Week 60 - Week 84)|Other|0
5816467|NCT02641730|20085184|P2|Observational Period (Week 60 - Week 84)|Other|0
5816468|NCT02641730|20085185|P1|Observational Period (Week 60 - Week 84)|Other|0
5816469|NCT02641730|20085181|P5|After Controlled Period (Week 16 - 52)|Other|1
5816470|NCT02641730|20085182|P4|After Controlled Period (Week 16 - 52)|Other|0
5816471|NCT02641730|20085183|P3|After Controlled Period (Week 16 - 52)|Other|1
5816472|NCT02641730|20085184|P2|After Controlled Period (Week 16 - 52)|Other|1
5816473|NCT02641730|20085185|P1|After Controlled Period (Week 16 - 52)|Other|0
5816474|NCT02641730|20085181|P5|After Controlled Period (Week 16 - 52)|Pregnancy|1
5816475|NCT02641730|20085182|P4|After Controlled Period (Week 16 - 52)|Pregnancy|1
5816476|NCT02641730|20085183|P3|After Controlled Period (Week 16 - 52)|Pregnancy|0
5816477|NCT02641730|20085184|P2|After Controlled Period (Week 16 - 52)|Pregnancy|0
5816478|NCT02641730|20085185|P1|After Controlled Period (Week 16 - 52)|Pregnancy|0
5816479|NCT02641730|20085181|P5|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0
5816480|NCT02641730|20085182|P4|After Controlled Period (Week 16 - 52)|Lack of Efficacy|2
5816481|NCT02641730|20085183|P3|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0
5816482|NCT02641730|20085184|P2|After Controlled Period (Week 16 - 52)|Lack of Efficacy|2
5816483|NCT02641730|20085185|P1|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0
5816484|NCT02641730|20085181|P5|After Controlled Period (Week 16 - 52)|Adverse Event|4
5816485|NCT02641730|20085182|P4|After Controlled Period (Week 16 - 52)|Adverse Event|5
5816486|NCT02641730|20085183|P3|After Controlled Period (Week 16 - 52)|Adverse Event|1
5816487|NCT02641730|20085184|P2|After Controlled Period (Week 16 - 52)|Adverse Event|1
5816488|NCT02641730|20085185|P1|After Controlled Period (Week 16 - 52)|Adverse Event|0
5816489|NCT02641730|20085181|P5|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2
5816490|NCT02641730|20085182|P4|Placebo Controlled Period (Week 0 - 16)|Adverse Event|1
5816491|NCT02641730|20085183|P3|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0
5816492|NCT02641730|20085184|P2|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0
5816493|NCT02641730|20085185|P1|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2
5816494|NCT02641587|20085289|P2|Ambulatory Period|Withdrawal by Subject|0
5816495|NCT02641587|20085290|P1|Ambulatory Period|Withdrawal by Subject|1
5816496|NCT02641587|20085289|P2|Confinement Period|Withdrawal by Subject|1
5816497|NCT02641587|20085290|P1|Confinement Period|Withdrawal by Subject|2
5816498|NCT02641587|20085289|P2|Confinement Period|Adverse Event|0
5816499|NCT02641587|20085290|P1|Confinement Period|Adverse Event|1
5816500|NCT02641392|20085411|P3|Overall Study|Death|1
5816501|NCT02641392|20085412|P2|Overall Study|Death|0
5816502|NCT02641392|20085413|P1|Overall Study|Death|0
5816503|NCT02641392|20085411|P3|Overall Study|Miscellaneous|3
5816504|NCT02641392|20085412|P2|Overall Study|Miscellaneous|0
5816505|NCT02641392|20085413|P1|Overall Study|Miscellaneous|0
5816506|NCT02641392|20085411|P3|Overall Study|Lack of Efficacy|101
5816507|NCT02641392|20085412|P2|Overall Study|Lack of Efficacy|0
5816508|NCT02641392|20085413|P1|Overall Study|Lack of Efficacy|0
5816509|NCT02641392|20085411|P3|Overall Study|Study Terminated by Sponsor|144
5816510|NCT02641392|20085412|P2|Overall Study|Study Terminated by Sponsor|12
5816511|NCT02641392|20085413|P1|Overall Study|Study Terminated by Sponsor|4
5816512|NCT02641392|20085411|P3|Overall Study|Adverse Event|25
5816513|NCT02641392|20085412|P2|Overall Study|Adverse Event|1
5816514|NCT02641392|20085413|P1|Overall Study|Adverse Event|0
5816515|NCT02641392|20085411|P3|Overall Study|Withdrawal by Subject|17
5816516|NCT02641392|20085412|P2|Overall Study|Withdrawal by Subject|0
5816517|NCT02641392|20085413|P1|Overall Study|Withdrawal by Subject|0
5816518|NCT02641392|20085411|P3|Overall Study|Lost to Follow-up|2
5816519|NCT02641392|20085412|P2|Overall Study|Lost to Follow-up|0
5816520|NCT02641392|20085413|P1|Overall Study|Lost to Follow-up|0
5816521|NCT02641379|20085432|P11|Overall Study|PCR positive|0
5816522|NCT02641379|20085433|P10|Overall Study|PCR positive|0
5816523|NCT02641379|20085434|P9|Overall Study|PCR positive|0
5816524|NCT02641379|20085435|P8|Overall Study|PCR positive|0
5816525|NCT02641379|20085436|P7|Overall Study|PCR positive|1
5816526|NCT02641379|20085437|P6|Overall Study|PCR positive|0
5816527|NCT02641379|20085438|P5|Overall Study|PCR positive|0
5816528|NCT02641379|20085439|P4|Overall Study|PCR positive|0
5816529|NCT02641379|20085440|P3|Overall Study|PCR positive|0
5816530|NCT02641379|20085441|P2|Overall Study|PCR positive|0
5816531|NCT02641379|20085442|P1|Overall Study|PCR positive|0
5816532|NCT02641379|20085432|P11|Overall Study|Missing PCR result at Week 8|0
5816533|NCT02641379|20085433|P10|Overall Study|Missing PCR result at Week 8|1
5816534|NCT02641379|20085434|P9|Overall Study|Missing PCR result at Week 8|0
5816535|NCT02641379|20085435|P8|Overall Study|Missing PCR result at Week 8|0
5816536|NCT02641379|20085436|P7|Overall Study|Missing PCR result at Week 8|0
5816537|NCT02641379|20085437|P6|Overall Study|Missing PCR result at Week 8|0
5816538|NCT02641379|20085438|P5|Overall Study|Missing PCR result at Week 8|0
5816539|NCT02641379|20085439|P4|Overall Study|Missing PCR result at Week 8|0
5816540|NCT02641379|20085440|P3|Overall Study|Missing PCR result at Week 8|0
5816541|NCT02641379|20085441|P2|Overall Study|Missing PCR result at Week 8|0
5816542|NCT02641379|20085442|P1|Overall Study|Missing PCR result at Week 8|0
5816543|NCT02641379|20085432|P11|Overall Study|Participant treated after Week 24|0
5816544|NCT02641379|20085433|P10|Overall Study|Participant treated after Week 24|0
5816545|NCT02641379|20085434|P9|Overall Study|Participant treated after Week 24|1
5816546|NCT02641379|20085435|P8|Overall Study|Participant treated after Week 24|0
5816547|NCT02641379|20085436|P7|Overall Study|Participant treated after Week 24|0
5816548|NCT02641379|20085437|P6|Overall Study|Participant treated after Week 24|0
5816549|NCT02641379|20085438|P5|Overall Study|Participant treated after Week 24|0
5816550|NCT02641379|20085439|P4|Overall Study|Participant treated after Week 24|0
5816551|NCT02641379|20085440|P3|Overall Study|Participant treated after Week 24|0
5816552|NCT02641379|20085441|P2|Overall Study|Participant treated after Week 24|0
5816553|NCT02641379|20085442|P1|Overall Study|Participant treated after Week 24|0
5816554|NCT02641379|20085432|P11|Overall Study|Participant's PCR high|0
5816555|NCT02641379|20085433|P10|Overall Study|Participant's PCR high|0
5816556|NCT02641379|20085434|P9|Overall Study|Participant's PCR high|0
5816557|NCT02641379|20085435|P8|Overall Study|Participant's PCR high|1
5816558|NCT02641379|20085436|P7|Overall Study|Participant's PCR high|0
5816559|NCT02641379|20085437|P6|Overall Study|Participant's PCR high|0
5816560|NCT02641379|20085438|P5|Overall Study|Participant's PCR high|0
5816561|NCT02641379|20085439|P4|Overall Study|Participant's PCR high|0
5816562|NCT02641379|20085440|P3|Overall Study|Participant's PCR high|0
5816563|NCT02641379|20085441|P2|Overall Study|Participant's PCR high|0
5816564|NCT02641379|20085442|P1|Overall Study|Participant's PCR high|0
5816565|NCT02641379|20085432|P11|Overall Study|Negative PCR result|0
5816566|NCT02641379|20085433|P10|Overall Study|Negative PCR result|1
5816567|NCT02641379|20085434|P9|Overall Study|Negative PCR result|0
5816568|NCT02641379|20085435|P8|Overall Study|Negative PCR result|0
5816569|NCT02641379|20085436|P7|Overall Study|Negative PCR result|0
5816570|NCT02641379|20085437|P6|Overall Study|Negative PCR result|0
5816571|NCT02641379|20085438|P5|Overall Study|Negative PCR result|0
5816572|NCT02641379|20085439|P4|Overall Study|Negative PCR result|0
5816573|NCT02641379|20085440|P3|Overall Study|Negative PCR result|0
5816574|NCT02641379|20085441|P2|Overall Study|Negative PCR result|0
5816575|NCT02641379|20085442|P1|Overall Study|Negative PCR result|0
5816576|NCT02641379|20085432|P11|Overall Study|No 2 Log drop at Week 12|1
5816577|NCT02641379|20085433|P10|Overall Study|No 2 Log drop at Week 12|0
5816578|NCT02641379|20085434|P9|Overall Study|No 2 Log drop at Week 12|0
5816579|NCT02641379|20085435|P8|Overall Study|No 2 Log drop at Week 12|0
5816580|NCT02641379|20085436|P7|Overall Study|No 2 Log drop at Week 12|0
5816581|NCT02641379|20085437|P6|Overall Study|No 2 Log drop at Week 12|0
5816582|NCT02641379|20085438|P5|Overall Study|No 2 Log drop at Week 12|0
5816583|NCT02641379|20085439|P4|Overall Study|No 2 Log drop at Week 12|0
5816584|NCT02641379|20085440|P3|Overall Study|No 2 Log drop at Week 12|0
5816585|NCT02641379|20085441|P2|Overall Study|No 2 Log drop at Week 12|0
5816586|NCT02641379|20085442|P1|Overall Study|No 2 Log drop at Week 12|0
5816587|NCT02641379|20085432|P11|Overall Study|Non-response Week 12|0
5816588|NCT02641379|20085433|P10|Overall Study|Non-response Week 12|0
5816589|NCT02641379|20085434|P9|Overall Study|Non-response Week 12|0
5816590|NCT02641379|20085435|P8|Overall Study|Non-response Week 12|1
5816591|NCT02641379|20085436|P7|Overall Study|Non-response Week 12|0
5816592|NCT02641379|20085437|P6|Overall Study|Non-response Week 12|0
5816593|NCT02641379|20085438|P5|Overall Study|Non-response Week 12|0
5816594|NCT02641379|20085439|P4|Overall Study|Non-response Week 12|0
5816595|NCT02641379|20085440|P3|Overall Study|Non-response Week 12|0
5816596|NCT02641379|20085441|P2|Overall Study|Non-response Week 12|0
5816597|NCT02641379|20085442|P1|Overall Study|Non-response Week 12|0
5816598|NCT02641379|20085432|P11|Overall Study|Participant showed weight reduction|0
5816599|NCT02641379|20085433|P10|Overall Study|Participant showed weight reduction|0
5816600|NCT02641379|20085434|P9|Overall Study|Participant showed weight reduction|0
5816601|NCT02641379|20085435|P8|Overall Study|Participant showed weight reduction|1
5816602|NCT02641379|20085436|P7|Overall Study|Participant showed weight reduction|0
5816603|NCT02641379|20085437|P6|Overall Study|Participant showed weight reduction|0
5816604|NCT02641379|20085438|P5|Overall Study|Participant showed weight reduction|0
5816605|NCT02641379|20085439|P4|Overall Study|Participant showed weight reduction|0
5816606|NCT02641379|20085440|P3|Overall Study|Participant showed weight reduction|0
5816607|NCT02641379|20085441|P2|Overall Study|Participant showed weight reduction|0
5816608|NCT02641379|20085442|P1|Overall Study|Participant showed weight reduction|0
5816609|NCT02641379|20085432|P11|Overall Study|Source data not found|0
5816610|NCT02641379|20085433|P10|Overall Study|Source data not found|0
5816611|NCT02641379|20085434|P9|Overall Study|Source data not found|0
5816612|NCT02641379|20085435|P8|Overall Study|Source data not found|0
5816613|NCT02641379|20085436|P7|Overall Study|Source data not found|0
5816614|NCT02641379|20085437|P6|Overall Study|Source data not found|1
5816615|NCT02641379|20085438|P5|Overall Study|Source data not found|0
5816616|NCT02641379|20085439|P4|Overall Study|Source data not found|0
5816617|NCT02641379|20085440|P3|Overall Study|Source data not found|0
5816618|NCT02641379|20085441|P2|Overall Study|Source data not found|0
5816619|NCT02641379|20085442|P1|Overall Study|Source data not found|0
5816620|NCT02641379|20085432|P11|Overall Study|Lost to Follow-up|0
5816621|NCT02641379|20085433|P10|Overall Study|Lost to Follow-up|0
5816622|NCT02641379|20085434|P9|Overall Study|Lost to Follow-up|1
5816623|NCT02641379|20085435|P8|Overall Study|Lost to Follow-up|0
5816624|NCT02641379|20085436|P7|Overall Study|Lost to Follow-up|0
5816625|NCT02641379|20085437|P6|Overall Study|Lost to Follow-up|0
5816626|NCT02641379|20085438|P5|Overall Study|Lost to Follow-up|0
5816627|NCT02641379|20085439|P4|Overall Study|Lost to Follow-up|0
5816628|NCT02641379|20085440|P3|Overall Study|Lost to Follow-up|0
5816629|NCT02641379|20085441|P2|Overall Study|Lost to Follow-up|0
5816630|NCT02641379|20085442|P1|Overall Study|Lost to Follow-up|0
5816631|NCT02641379|20085432|P11|Overall Study|Participation in sili rescue study|0
5816632|NCT02641379|20085433|P10|Overall Study|Participation in sili rescue study|0
5816633|NCT02641379|20085434|P9|Overall Study|Participation in sili rescue study|0
5816634|NCT02641379|20085435|P8|Overall Study|Participation in sili rescue study|0
5816635|NCT02641379|20085436|P7|Overall Study|Participation in sili rescue study|0
5816636|NCT02641379|20085437|P6|Overall Study|Participation in sili rescue study|1
5816637|NCT02641379|20085438|P5|Overall Study|Participation in sili rescue study|0
5816638|NCT02641379|20085439|P4|Overall Study|Participation in sili rescue study|0
5816639|NCT02641379|20085440|P3|Overall Study|Participation in sili rescue study|0
5816640|NCT02641379|20085441|P2|Overall Study|Participation in sili rescue study|0
5816641|NCT02641379|20085442|P1|Overall Study|Participation in sili rescue study|0
5816642|NCT02641379|20085432|P11|Overall Study|Protocol Violation|0
5816643|NCT02641379|20085433|P10|Overall Study|Protocol Violation|0
5816644|NCT02641379|20085434|P9|Overall Study|Protocol Violation|1
5816645|NCT02641379|20085435|P8|Overall Study|Protocol Violation|0
5816646|NCT02641379|20085436|P7|Overall Study|Protocol Violation|0
5816647|NCT02641379|20085437|P6|Overall Study|Protocol Violation|0
5816648|NCT02641379|20085438|P5|Overall Study|Protocol Violation|2
5816649|NCT02641379|20085439|P4|Overall Study|Protocol Violation|0
5816650|NCT02641379|20085440|P3|Overall Study|Protocol Violation|0
5816651|NCT02641379|20085441|P2|Overall Study|Protocol Violation|0
5816652|NCT02641379|20085442|P1|Overall Study|Protocol Violation|0
5816653|NCT02641379|20085432|P11|Overall Study|Blood could not be drawn|0
5816654|NCT02641379|20085433|P10|Overall Study|Blood could not be drawn|0
5816655|NCT02641379|20085434|P9|Overall Study|Blood could not be drawn|0
5816656|NCT02641379|20085435|P8|Overall Study|Blood could not be drawn|0
5816657|NCT02641379|20085436|P7|Overall Study|Blood could not be drawn|0
5816658|NCT02641379|20085437|P6|Overall Study|Blood could not be drawn|0
5816659|NCT02641379|20085438|P5|Overall Study|Blood could not be drawn|1
5816660|NCT02641379|20085439|P4|Overall Study|Blood could not be drawn|0
5816661|NCT02641379|20085440|P3|Overall Study|Blood could not be drawn|0
5816662|NCT02641379|20085441|P2|Overall Study|Blood could not be drawn|0
5816663|NCT02641379|20085442|P1|Overall Study|Blood could not be drawn|0
5816664|NCT02641379|20085432|P11|Overall Study|Baseline viral load unavailable|0
5816665|NCT02641379|20085433|P10|Overall Study|Baseline viral load unavailable|0
5816666|NCT02641379|20085434|P9|Overall Study|Baseline viral load unavailable|0
5816667|NCT02641379|20085435|P8|Overall Study|Baseline viral load unavailable|0
5816668|NCT02641379|20085436|P7|Overall Study|Baseline viral load unavailable|0
5816669|NCT02641379|20085437|P6|Overall Study|Baseline viral load unavailable|0
5816670|NCT02641379|20085438|P5|Overall Study|Baseline viral load unavailable|0
5816671|NCT02641379|20085439|P4|Overall Study|Baseline viral load unavailable|1
5816672|NCT02641379|20085440|P3|Overall Study|Baseline viral load unavailable|0
5816673|NCT02641379|20085441|P2|Overall Study|Baseline viral load unavailable|0
5816674|NCT02641379|20085442|P1|Overall Study|Baseline viral load unavailable|0
5816675|NCT02641379|20085432|P11|Overall Study|Inclusion criteria not fulfilled|0
5816676|NCT02641379|20085433|P10|Overall Study|Inclusion criteria not fulfilled|0
5816677|NCT02641379|20085434|P9|Overall Study|Inclusion criteria not fulfilled|0
5816678|NCT02641379|20085435|P8|Overall Study|Inclusion criteria not fulfilled|0
5816679|NCT02641379|20085436|P7|Overall Study|Inclusion criteria not fulfilled|0
5816680|NCT02641379|20085437|P6|Overall Study|Inclusion criteria not fulfilled|0
5816681|NCT02641379|20085438|P5|Overall Study|Inclusion criteria not fulfilled|0
5816682|NCT02641379|20085439|P4|Overall Study|Inclusion criteria not fulfilled|1
5816683|NCT02641379|20085440|P3|Overall Study|Inclusion criteria not fulfilled|0
5816684|NCT02641379|20085441|P2|Overall Study|Inclusion criteria not fulfilled|0
5816685|NCT02641379|20085442|P1|Overall Study|Inclusion criteria not fulfilled|0
5816686|NCT02641379|20085432|P11|Overall Study|PCR sample for Week 4 not drawn|0
5816687|NCT02641379|20085433|P10|Overall Study|PCR sample for Week 4 not drawn|0
5816688|NCT02641379|20085434|P9|Overall Study|PCR sample for Week 4 not drawn|0
5816689|NCT02641379|20085435|P8|Overall Study|PCR sample for Week 4 not drawn|0
5816690|NCT02641379|20085436|P7|Overall Study|PCR sample for Week 4 not drawn|0
5816691|NCT02641379|20085437|P6|Overall Study|PCR sample for Week 4 not drawn|0
5816692|NCT02641379|20085438|P5|Overall Study|PCR sample for Week 4 not drawn|0
5816693|NCT02641379|20085439|P4|Overall Study|PCR sample for Week 4 not drawn|1
5816694|NCT02641379|20085440|P3|Overall Study|PCR sample for Week 4 not drawn|0
5816695|NCT02641379|20085441|P2|Overall Study|PCR sample for Week 4 not drawn|0
5816696|NCT02641379|20085442|P1|Overall Study|PCR sample for Week 4 not drawn|0
5816697|NCT02641379|20085432|P11|Overall Study|PCR positive at Week 28|0
5816698|NCT02641379|20085433|P10|Overall Study|PCR positive at Week 28|0
5816699|NCT02641379|20085434|P9|Overall Study|PCR positive at Week 28|0
5816700|NCT02641379|20085435|P8|Overall Study|PCR positive at Week 28|0
5816701|NCT02641379|20085436|P7|Overall Study|PCR positive at Week 28|0
5816702|NCT02641379|20085437|P6|Overall Study|PCR positive at Week 28|0
5816703|NCT02641379|20085438|P5|Overall Study|PCR positive at Week 28|0
5816704|NCT02641379|20085439|P4|Overall Study|PCR positive at Week 28|0
5816705|NCT02641379|20085440|P3|Overall Study|PCR positive at Week 28|1
5816706|NCT02641379|20085441|P2|Overall Study|PCR positive at Week 28|0
5816707|NCT02641379|20085442|P1|Overall Study|PCR positive at Week 28|0
5816708|NCT02641379|20085432|P11|Overall Study|No PCR at baseline|0
5816709|NCT02641379|20085433|P10|Overall Study|No PCR at baseline|0
5816710|NCT02641379|20085434|P9|Overall Study|No PCR at baseline|0
5816711|NCT02641379|20085435|P8|Overall Study|No PCR at baseline|0
5816712|NCT02641379|20085436|P7|Overall Study|No PCR at baseline|0
5816713|NCT02641379|20085437|P6|Overall Study|No PCR at baseline|0
5816714|NCT02641379|20085438|P5|Overall Study|No PCR at baseline|0
5816715|NCT02641379|20085439|P4|Overall Study|No PCR at baseline|0
5816716|NCT02641379|20085440|P3|Overall Study|No PCR at baseline|1
5816717|NCT02641379|20085441|P2|Overall Study|No PCR at baseline|0
5816718|NCT02641379|20085442|P1|Overall Study|No PCR at baseline|0
5816719|NCT02641379|20085432|P11|Overall Study|PCR not performed at Week 12|0
5816720|NCT02641379|20085433|P10|Overall Study|PCR not performed at Week 12|0
5816721|NCT02641379|20085434|P9|Overall Study|PCR not performed at Week 12|0
5816722|NCT02641379|20085435|P8|Overall Study|PCR not performed at Week 12|0
5816723|NCT02641379|20085436|P7|Overall Study|PCR not performed at Week 12|0
5816724|NCT02641379|20085437|P6|Overall Study|PCR not performed at Week 12|0
5816725|NCT02641379|20085438|P5|Overall Study|PCR not performed at Week 12|0
5816726|NCT02641379|20085439|P4|Overall Study|PCR not performed at Week 12|0
5816727|NCT02641379|20085440|P3|Overall Study|PCR not performed at Week 12|1
5816728|NCT02641379|20085441|P2|Overall Study|PCR not performed at Week 12|0
5816729|NCT02641379|20085442|P1|Overall Study|PCR not performed at Week 12|0
5816730|NCT02641379|20085432|P11|Overall Study|PCR positive at Week 48|0
5816731|NCT02641379|20085433|P10|Overall Study|PCR positive at Week 48|0
5816732|NCT02641379|20085434|P9|Overall Study|PCR positive at Week 48|0
5816733|NCT02641379|20085435|P8|Overall Study|PCR positive at Week 48|0
5816734|NCT02641379|20085436|P7|Overall Study|PCR positive at Week 48|0
5816735|NCT02641379|20085437|P6|Overall Study|PCR positive at Week 48|0
5816736|NCT02641379|20085438|P5|Overall Study|PCR positive at Week 48|0
5816737|NCT02641379|20085439|P4|Overall Study|PCR positive at Week 48|0
5816738|NCT02641379|20085440|P3|Overall Study|PCR positive at Week 48|0
5816739|NCT02641379|20085441|P2|Overall Study|PCR positive at Week 48|1
5816740|NCT02641379|20085442|P1|Overall Study|PCR positive at Week 48|0
5816741|NCT02641379|20085432|P11|Overall Study|PCR positive at Week 68|0
5816742|NCT02641379|20085433|P10|Overall Study|PCR positive at Week 68|0
5816743|NCT02641379|20085434|P9|Overall Study|PCR positive at Week 68|0
5816744|NCT02641379|20085435|P8|Overall Study|PCR positive at Week 68|0
5816745|NCT02641379|20085436|P7|Overall Study|PCR positive at Week 68|0
5816746|NCT02641379|20085437|P6|Overall Study|PCR positive at Week 68|0
5816747|NCT02641379|20085438|P5|Overall Study|PCR positive at Week 68|0
5816748|NCT02641379|20085439|P4|Overall Study|PCR positive at Week 68|0
5816749|NCT02641379|20085440|P3|Overall Study|PCR positive at Week 68|0
5816750|NCT02641379|20085441|P2|Overall Study|PCR positive at Week 68|1
5816751|NCT02641379|20085442|P1|Overall Study|PCR positive at Week 68|0
5816752|NCT02641379|20085432|P11|Overall Study|Financial problems|0
5816753|NCT02641379|20085433|P10|Overall Study|Financial problems|0
5816754|NCT02641379|20085434|P9|Overall Study|Financial problems|0
5816755|NCT02641379|20085435|P8|Overall Study|Financial problems|0
5816756|NCT02641379|20085436|P7|Overall Study|Financial problems|0
5816757|NCT02641379|20085437|P6|Overall Study|Financial problems|0
5816758|NCT02641379|20085438|P5|Overall Study|Financial problems|0
5816759|NCT02641379|20085439|P4|Overall Study|Financial problems|0
5816760|NCT02641379|20085440|P3|Overall Study|Financial problems|0
5816761|NCT02641379|20085441|P2|Overall Study|Financial problems|1
5816762|NCT02641379|20085442|P1|Overall Study|Financial problems|0
5816763|NCT02641379|20085432|P11|Overall Study|Therapy stopped due to misunderstanding|0
5816764|NCT02641379|20085433|P10|Overall Study|Therapy stopped due to misunderstanding|0
5816765|NCT02641379|20085434|P9|Overall Study|Therapy stopped due to misunderstanding|0
5816766|NCT02641379|20085435|P8|Overall Study|Therapy stopped due to misunderstanding|0
5816767|NCT02641379|20085436|P7|Overall Study|Therapy stopped due to misunderstanding|0
5816768|NCT02641379|20085437|P6|Overall Study|Therapy stopped due to misunderstanding|0
5816769|NCT02641379|20085438|P5|Overall Study|Therapy stopped due to misunderstanding|0
5816770|NCT02641379|20085439|P4|Overall Study|Therapy stopped due to misunderstanding|0
5816771|NCT02641379|20085440|P3|Overall Study|Therapy stopped due to misunderstanding|0
5816772|NCT02641379|20085441|P2|Overall Study|Therapy stopped due to misunderstanding|0
5816773|NCT02641379|20085442|P1|Overall Study|Therapy stopped due to misunderstanding|1
5816774|NCT02641379|20085432|P11|Overall Study|Participant stopped study/treatment|0
5816775|NCT02641379|20085433|P10|Overall Study|Participant stopped study/treatment|0
5816776|NCT02641379|20085434|P9|Overall Study|Participant stopped study/treatment|1
5816777|NCT02641379|20085435|P8|Overall Study|Participant stopped study/treatment|0
5816778|NCT02641379|20085436|P7|Overall Study|Participant stopped study/treatment|2
5816779|NCT02641379|20085437|P6|Overall Study|Participant stopped study/treatment|1
5816780|NCT02641379|20085438|P5|Overall Study|Participant stopped study/treatment|0
5816781|NCT02641379|20085439|P4|Overall Study|Participant stopped study/treatment|0
5816782|NCT02641379|20085440|P3|Overall Study|Participant stopped study/treatment|1
5816783|NCT02641379|20085441|P2|Overall Study|Participant stopped study/treatment|3
5816784|NCT02641379|20085442|P1|Overall Study|Participant stopped study/treatment|1
5816785|NCT02641379|20085432|P11|Overall Study|Participant showed relapse|0
5816786|NCT02641379|20085433|P10|Overall Study|Participant showed relapse|0
5816787|NCT02641379|20085434|P9|Overall Study|Participant showed relapse|0
5816788|NCT02641379|20085435|P8|Overall Study|Participant showed relapse|0
5816789|NCT02641379|20085436|P7|Overall Study|Participant showed relapse|1
5816790|NCT02641379|20085437|P6|Overall Study|Participant showed relapse|0
5816791|NCT02641379|20085438|P5|Overall Study|Participant showed relapse|0
5816792|NCT02641379|20085439|P4|Overall Study|Participant showed relapse|0
5816793|NCT02641379|20085440|P3|Overall Study|Participant showed relapse|0
5816794|NCT02641379|20085441|P2|Overall Study|Participant showed relapse|0
5816795|NCT02641379|20085442|P1|Overall Study|Participant showed relapse|1
5816796|NCT02641379|20085432|P11|Overall Study|PCR positive at follow up 2|0
5816797|NCT02641379|20085433|P10|Overall Study|PCR positive at follow up 2|0
5816798|NCT02641379|20085434|P9|Overall Study|PCR positive at follow up 2|0
5816799|NCT02641379|20085435|P8|Overall Study|PCR positive at follow up 2|0
5816800|NCT02641379|20085436|P7|Overall Study|PCR positive at follow up 2|0
5816801|NCT02641379|20085437|P6|Overall Study|PCR positive at follow up 2|0
5816802|NCT02641379|20085438|P5|Overall Study|PCR positive at follow up 2|0
5816803|NCT02641379|20085439|P4|Overall Study|PCR positive at follow up 2|0
5816804|NCT02641379|20085440|P3|Overall Study|PCR positive at follow up 2|0
5816805|NCT02641379|20085441|P2|Overall Study|PCR positive at follow up 2|0
5816806|NCT02641379|20085442|P1|Overall Study|PCR positive at follow up 2|1
5816807|NCT02641379|20085432|P11|Overall Study|PCR positive at Week 24|0
5816808|NCT02641379|20085433|P10|Overall Study|PCR positive at Week 24|1
5816809|NCT02641379|20085434|P9|Overall Study|PCR positive at Week 24|0
5816810|NCT02641379|20085435|P8|Overall Study|PCR positive at Week 24|8
5816811|NCT02641379|20085436|P7|Overall Study|PCR positive at Week 24|3
5816812|NCT02641379|20085437|P6|Overall Study|PCR positive at Week 24|6
5816813|NCT02641379|20085438|P5|Overall Study|PCR positive at Week 24|0
5816814|NCT02641379|20085439|P4|Overall Study|PCR positive at Week 24|0
5816815|NCT02641379|20085440|P3|Overall Study|PCR positive at Week 24|62
5816816|NCT02641379|20085441|P2|Overall Study|PCR positive at Week 24|21
5816817|NCT02641379|20085442|P1|Overall Study|PCR positive at Week 24|15
5816818|NCT02641379|20085432|P11|Overall Study|Participant cannot be reached|1
5816819|NCT02641379|20085433|P10|Overall Study|Participant cannot be reached|2
5816820|NCT02641379|20085434|P9|Overall Study|Participant cannot be reached|0
5816821|NCT02641379|20085435|P8|Overall Study|Participant cannot be reached|1
5816822|NCT02641379|20085436|P7|Overall Study|Participant cannot be reached|0
5816823|NCT02641379|20085437|P6|Overall Study|Participant cannot be reached|1
5816824|NCT02641379|20085438|P5|Overall Study|Participant cannot be reached|2
5816825|NCT02641379|20085439|P4|Overall Study|Participant cannot be reached|8
5816826|NCT02641379|20085440|P3|Overall Study|Participant cannot be reached|0
5816827|NCT02641379|20085441|P2|Overall Study|Participant cannot be reached|4
5816828|NCT02641379|20085442|P1|Overall Study|Participant cannot be reached|4
5816829|NCT02641379|20085432|P11|Overall Study|Participant's compliance|1
5816830|NCT02641379|20085433|P10|Overall Study|Participant's compliance|1
5816831|NCT02641379|20085434|P9|Overall Study|Participant's compliance|1
5816832|NCT02641379|20085435|P8|Overall Study|Participant's compliance|0
5816833|NCT02641379|20085436|P7|Overall Study|Participant's compliance|0
5816834|NCT02641379|20085437|P6|Overall Study|Participant's compliance|2
5816835|NCT02641379|20085438|P5|Overall Study|Participant's compliance|0
5816836|NCT02641379|20085439|P4|Overall Study|Participant's compliance|1
5816837|NCT02641379|20085440|P3|Overall Study|Participant's compliance|0
5816838|NCT02641379|20085441|P2|Overall Study|Participant's compliance|1
5816839|NCT02641379|20085442|P1|Overall Study|Participant's compliance|0
5816840|NCT02641379|20085432|P11|Overall Study|Participant unable to attend study visit|0
5816841|NCT02641379|20085433|P10|Overall Study|Participant unable to attend study visit|2
5816842|NCT02641379|20085434|P9|Overall Study|Participant unable to attend study visit|0
5816843|NCT02641379|20085435|P8|Overall Study|Participant unable to attend study visit|1
5816844|NCT02641379|20085436|P7|Overall Study|Participant unable to attend study visit|1
5816845|NCT02641379|20085437|P6|Overall Study|Participant unable to attend study visit|1
5816846|NCT02641379|20085438|P5|Overall Study|Participant unable to attend study visit|5
5816847|NCT02641379|20085439|P4|Overall Study|Participant unable to attend study visit|2
5816848|NCT02641379|20085440|P3|Overall Study|Participant unable to attend study visit|1
5816849|NCT02641379|20085441|P2|Overall Study|Participant unable to attend study visit|10
5816850|NCT02641379|20085442|P1|Overall Study|Participant unable to attend study visit|4
5816851|NCT02641379|20085432|P11|Overall Study|Lack of Efficacy|0
5816852|NCT02641379|20085433|P10|Overall Study|Lack of Efficacy|0
5816853|NCT02641379|20085434|P9|Overall Study|Lack of Efficacy|0
5816854|NCT02641379|20085435|P8|Overall Study|Lack of Efficacy|5
5816855|NCT02641379|20085436|P7|Overall Study|Lack of Efficacy|0
5816856|NCT02641379|20085437|P6|Overall Study|Lack of Efficacy|2
5816857|NCT02641379|20085438|P5|Overall Study|Lack of Efficacy|0
5816858|NCT02641379|20085439|P4|Overall Study|Lack of Efficacy|0
5816859|NCT02641379|20085440|P3|Overall Study|Lack of Efficacy|2
5816860|NCT02641379|20085441|P2|Overall Study|Lack of Efficacy|0
5816861|NCT02641379|20085442|P1|Overall Study|Lack of Efficacy|0
5816862|NCT02641379|20085432|P11|Overall Study|Adverse Event|5
5816863|NCT02641379|20085433|P10|Overall Study|Adverse Event|1
5816864|NCT02641379|20085434|P9|Overall Study|Adverse Event|1
5816865|NCT02641379|20085435|P8|Overall Study|Adverse Event|0
5816866|NCT02641379|20085436|P7|Overall Study|Adverse Event|5
5816867|NCT02641379|20085437|P6|Overall Study|Adverse Event|1
5816868|NCT02641379|20085438|P5|Overall Study|Adverse Event|5
5816869|NCT02641379|20085439|P4|Overall Study|Adverse Event|2
5816870|NCT02641379|20085440|P3|Overall Study|Adverse Event|2
5816871|NCT02641379|20085441|P2|Overall Study|Adverse Event|8
5816872|NCT02641379|20085442|P1|Overall Study|Adverse Event|7
5816873|NCT02641379|20085432|P11|Overall Study|Withdrawal of informed consent|0
5816874|NCT02641379|20085433|P10|Overall Study|Withdrawal of informed consent|0
5816875|NCT02641379|20085434|P9|Overall Study|Withdrawal of informed consent|0
5816876|NCT02641379|20085435|P8|Overall Study|Withdrawal of informed consent|1
5816877|NCT02641379|20085436|P7|Overall Study|Withdrawal of informed consent|0
5816878|NCT02641379|20085437|P6|Overall Study|Withdrawal of informed consent|0
5816879|NCT02641379|20085438|P5|Overall Study|Withdrawal of informed consent|0
5816880|NCT02641379|20085439|P4|Overall Study|Withdrawal of informed consent|0
5816881|NCT02641379|20085440|P3|Overall Study|Withdrawal of informed consent|0
5816882|NCT02641379|20085441|P2|Overall Study|Withdrawal of informed consent|1
5816883|NCT02641379|20085442|P1|Overall Study|Withdrawal of informed consent|0
5816884|NCT02641379|20085432|P11|Overall Study|Exclusion criterion during screening|0
5816885|NCT02641379|20085433|P10|Overall Study|Exclusion criterion during screening|0
5816886|NCT02641379|20085434|P9|Overall Study|Exclusion criterion during screening|0
5816887|NCT02641379|20085435|P8|Overall Study|Exclusion criterion during screening|0
5816888|NCT02641379|20085436|P7|Overall Study|Exclusion criterion during screening|0
5816889|NCT02641379|20085437|P6|Overall Study|Exclusion criterion during screening|0
5816890|NCT02641379|20085438|P5|Overall Study|Exclusion criterion during screening|2
5816891|NCT02641379|20085439|P4|Overall Study|Exclusion criterion during screening|1
5816892|NCT02641379|20085440|P3|Overall Study|Exclusion criterion during screening|0
5816893|NCT02641379|20085441|P2|Overall Study|Exclusion criterion during screening|0
5816894|NCT02641379|20085442|P1|Overall Study|Exclusion criterion during screening|1
5816895|NCT02641080|20085518|P2|Overall Study|Lost to Follow-up|3
5816896|NCT02641080|20085519|P1|Overall Study|Lost to Follow-up|0
5816897|NCT02641080|20085518|P2|Overall Study|Rehab Center denied use of pumps|3
5816898|NCT02641080|20085519|P1|Overall Study|Rehab Center denied use of pumps|0
5816899|NCT02641080|20085518|P2|Overall Study|Withdrawal by Subject|1
5816900|NCT02641080|20085519|P1|Overall Study|Withdrawal by Subject|0
5816901|NCT02641080|20085518|P2|Overall Study|Physician Decision|0
5816902|NCT02641080|20085519|P1|Overall Study|Physician Decision|2
5816903|NCT02640755|20085575|P2|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|0
5816904|NCT02640755|20085576|P1|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|1
5816905|NCT02640755|20085575|P2|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|0
5816906|NCT02640755|20085576|P1|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|1
5816907|NCT02640755|20085575|P2|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|1
5816908|NCT02640755|20085576|P1|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|0
5816909|NCT02640677|20085630|P1|Overall Study|Withdrawal by Subject|1
5816910|NCT02640677|20085630|P1|Overall Study|Lost to Follow-up|1
5816911|NCT02640625|20085637|P1|Overall Study|Adverse Event|1
5816912|NCT02640612|20085646|P3|Overall Study|Lack of Efficacy|0
5816913|NCT02640612|20085647|P2|Overall Study|Lack of Efficacy|1
5816914|NCT02640612|20085648|P1|Overall Study|Lack of Efficacy|1
5816915|NCT02640612|20085646|P3|Overall Study|Protocol Violation|0
5816916|NCT02640612|20085647|P2|Overall Study|Protocol Violation|2
5816917|NCT02640612|20085648|P1|Overall Study|Protocol Violation|0
5816918|NCT02640612|20085646|P3|Overall Study|Lost to Follow-up|1
5816919|NCT02640612|20085647|P2|Overall Study|Lost to Follow-up|1
5816920|NCT02640612|20085648|P1|Overall Study|Lost to Follow-up|4
5816921|NCT02640612|20085646|P3|Overall Study|Withdrawal by Subject|3
5816922|NCT02640612|20085647|P2|Overall Study|Withdrawal by Subject|3
5816923|NCT02640612|20085648|P1|Overall Study|Withdrawal by Subject|10
5816924|NCT02640612|20085646|P3|Overall Study|Death|0
5816925|NCT02640612|20085647|P2|Overall Study|Death|0
5816926|NCT02640612|20085648|P1|Overall Study|Death|1
5816927|NCT02640612|20085646|P3|Overall Study|Adverse Event|2
5816928|NCT02640612|20085647|P2|Overall Study|Adverse Event|7
5816929|NCT02640612|20085648|P1|Overall Study|Adverse Event|6
5816930|NCT02640547|20085672|P1|Overall Study|Miscellaneous|3
5816931|NCT02640547|20085672|P1|Overall Study|Death|6
5816932|NCT02640547|20085672|P1|Overall Study|Withdrawal by Subject|1
5816933|NCT02640547|20085672|P1|Overall Study|Failure to Return|1
5816934|NCT02640482|20085749|P2|Overall Study|Lost to Follow-up|0
5816935|NCT02640482|20085750|P1|Overall Study|Lost to Follow-up|3
5816936|NCT02640404|20085762|P2|Overall Study|Withdrawal by Subject|0
5816937|NCT02640404|20085763|P1|Overall Study|Withdrawal by Subject|1
5816938|NCT02640404|20085762|P2|Overall Study|Protocol Violation|0
5816939|NCT02640404|20085763|P1|Overall Study|Protocol Violation|1
5816940|NCT02640235|20085773|P2|Overall Study|Other|2
5816941|NCT02640235|20085774|P1|Overall Study|Other|1
5816942|NCT02640235|20085773|P2|Overall Study|Death|3
5816943|NCT02640235|20085774|P1|Overall Study|Death|2
5816944|NCT02640235|20085773|P2|Overall Study|Lost to Follow-up|3
5816945|NCT02640235|20085774|P1|Overall Study|Lost to Follow-up|4
5816946|NCT02640235|20085773|P2|Overall Study|Withdrawal by Subject|6
5816947|NCT02640235|20085774|P1|Overall Study|Withdrawal by Subject|7
5816948|NCT02640157|20085797|P3|Overall Study|Randomized in error; did not receive Tx|0
5816949|NCT02640157|20085798|P2|Overall Study|Randomized in error; did not receive Tx|1
5816950|NCT02640157|20085799|P1|Overall Study|Randomized in error; did not receive Tx|0
5816951|NCT02640157|20085797|P3|Overall Study|Lost to Follow-up|7
5816952|NCT02640157|20085798|P2|Overall Study|Lost to Follow-up|2
5816953|NCT02640157|20085799|P1|Overall Study|Lost to Follow-up|9
5816954|NCT02640157|20085797|P3|Overall Study|Withdrew consent|2
5816955|NCT02640157|20085798|P2|Overall Study|Withdrew consent|0
5816956|NCT02640157|20085799|P1|Overall Study|Withdrew consent|2
5816957|NCT02640157|20085797|P3|Overall Study|Adverse Event|1
5816958|NCT02640157|20085798|P2|Overall Study|Adverse Event|2
5816959|NCT02640157|20085799|P1|Overall Study|Adverse Event|2
5816960|NCT02640053|20085818|P2|Overall Study|Chemo regimen changed after 1st Rx|1
5816961|NCT02640053|20085819|P1|Overall Study|Chemo regimen changed after 1st Rx|0
5816962|NCT02640053|20085818|P2|Overall Study|Alternative Therapy|1
5816963|NCT02640053|20085819|P1|Overall Study|Alternative Therapy|1
5816964|NCT02640053|20085818|P2|Overall Study|Adverse Event|1
5816965|NCT02640053|20085819|P1|Overall Study|Adverse Event|1
5816966|NCT02640053|20085818|P2|Overall Study|Withdrawal by Subject|1
5816967|NCT02640053|20085819|P1|Overall Study|Withdrawal by Subject|2
5816968|NCT02639559|20085926|P2|Overall Study|Issues with vascular acess|0
5816969|NCT02639559|20085927|P1|Overall Study|Issues with vascular acess|1
5816970|NCT02639559|20085926|P2|Overall Study|Mobilization failure|3
5816971|NCT02639559|20085927|P1|Overall Study|Mobilization failure|0
5816972|NCT02639390|20086007|P2|Overall Study|Subject unable to comply with treatment schedule.|2
5816973|NCT02639390|20086008|P1|Overall Study|Subject unable to comply with treatment schedule.|0
5816974|NCT02639338|20086382|P2|Overall Study|Randomized but Not Treated|1
5816975|NCT02639338|20086383|P1|Overall Study|Randomized but Not Treated|0
5816976|NCT02639338|20086382|P2|Overall Study|Death|0
5816977|NCT02639338|20086383|P1|Overall Study|Death|1
5816978|NCT02639338|20086382|P2|Overall Study|Withdrew Consent|2
5816979|NCT02639338|20086383|P1|Overall Study|Withdrew Consent|1
5816980|NCT02639338|20086382|P2|Overall Study|Lost to Follow-up|2
5816981|NCT02639338|20086383|P1|Overall Study|Lost to Follow-up|2
5816982|NCT02639247|20086428|P2|Overall Study|Protocol Violation|0
5816983|NCT02639247|20086429|P1|Overall Study|Protocol Violation|1
5816984|NCT02639247|20086428|P2|Overall Study|Withdrew Consent|1
5816985|NCT02639247|20086429|P1|Overall Study|Withdrew Consent|0
5816986|NCT02639247|20086428|P2|Overall Study|Death|0
5816987|NCT02639247|20086429|P1|Overall Study|Death|2
5816988|NCT02639247|20086428|P2|Overall Study|Lost to Follow-up|1
5816989|NCT02639247|20086429|P1|Overall Study|Lost to Follow-up|2
5816990|NCT02639182|20086447|P2|Overall Study|Participants Still on Study|24
5816991|NCT02639182|20086448|P1|Overall Study|Participants Still on Study|25
5816992|NCT02639182|20086447|P2|Overall Study|Withdrew consent|0
5816993|NCT02639182|20086448|P1|Overall Study|Withdrew consent|6
5816994|NCT02639182|20086447|P2|Overall Study|Lost to Follow-up|1
5816995|NCT02639182|20086448|P1|Overall Study|Lost to Follow-up|1
5816996|NCT02639182|20086447|P2|Overall Study|Death|41
5816997|NCT02639182|20086448|P1|Overall Study|Death|35
5816998|NCT02639052|20086481|P1|Overall Study|Lost to Follow-up|1
5816999|NCT02638948|20086518|P4|Overall Study|Other than specified above|1
5817000|NCT02638948|20086519|P3|Overall Study|Other than specified above|1
5817001|NCT02638948|20086520|P2|Overall Study|Other than specified above|1
5817002|NCT02638948|20086521|P1|Overall Study|Other than specified above|4
5817003|NCT02638948|20086518|P4|Overall Study|Participant no longer met study criteria|0
5817004|NCT02638948|20086519|P3|Overall Study|Participant no longer met study criteria|0
5817005|NCT02638948|20086520|P2|Overall Study|Participant no longer met study criteria|1
5817006|NCT02638948|20086521|P1|Overall Study|Participant no longer met study criteria|0
5817007|NCT02638948|20086518|P4|Overall Study|Poor/Non-Compliance|0
5817008|NCT02638948|20086519|P3|Overall Study|Poor/Non-Compliance|1
5817009|NCT02638948|20086520|P2|Overall Study|Poor/Non-Compliance|2
5817010|NCT02638948|20086521|P1|Overall Study|Poor/Non-Compliance|0
5817011|NCT02638948|20086518|P4|Overall Study|Lost to Follow-up|1
5817012|NCT02638948|20086519|P3|Overall Study|Lost to Follow-up|1
5817013|NCT02638948|20086520|P2|Overall Study|Lost to Follow-up|0
5817014|NCT02638948|20086521|P1|Overall Study|Lost to Follow-up|0
5817015|NCT02638948|20086518|P4|Overall Study|Lack of Efficacy|0
5817016|NCT02638948|20086519|P3|Overall Study|Lack of Efficacy|0
5817017|NCT02638948|20086520|P2|Overall Study|Lack of Efficacy|1
5817018|NCT02638948|20086521|P1|Overall Study|Lack of Efficacy|1
5817019|NCT02638948|20086518|P4|Overall Study|Adverse Event|1
5817020|NCT02638948|20086519|P3|Overall Study|Adverse Event|1
5817021|NCT02638948|20086520|P2|Overall Study|Adverse Event|0
5817022|NCT02638948|20086521|P1|Overall Study|Adverse Event|0
5817023|NCT02638948|20086518|P4|Overall Study|Administrative Reason by Sponsor|4
5817024|NCT02638948|20086519|P3|Overall Study|Administrative Reason by Sponsor|0
5817025|NCT02638948|20086520|P2|Overall Study|Administrative Reason by Sponsor|1
5817026|NCT02638948|20086521|P1|Overall Study|Administrative Reason by Sponsor|0
5817027|NCT02638948|20086518|P4|Overall Study|Withdrawal by Subject|1
5817028|NCT02638948|20086519|P3|Overall Study|Withdrawal by Subject|3
5817029|NCT02638948|20086520|P2|Overall Study|Withdrawal by Subject|5
5817030|NCT02638948|20086521|P1|Overall Study|Withdrawal by Subject|4
5817031|NCT02638623|20086608|P2|Overall Study|Not given intervention|0
5817032|NCT02638623|20086609|P1|Overall Study|Not given intervention|2
5817033|NCT02638623|20086608|P2|Overall Study|Surgery timing|6
5817034|NCT02638623|20086609|P1|Overall Study|Surgery timing|5
5817035|NCT02638493|20086639|P3|Overall Study|Inability to provide semen samples|0
5817036|NCT02638493|20086640|P2|Overall Study|Inability to provide semen samples|0
5817037|NCT02638493|20086641|P1|Overall Study|Inability to provide semen samples|2
5817038|NCT02638337|20086672|P2|Overall Study|Other - Miscellaneous|3
5817039|NCT02638337|20086673|P1|Overall Study|Other - Miscellaneous|4
5817040|NCT02638337|20086672|P2|Overall Study|Lost to Follow-up|7
5817041|NCT02638337|20086673|P1|Overall Study|Lost to Follow-up|7
5817042|NCT02638337|20086672|P2|Overall Study|Withdrawal by Subject|16
5817043|NCT02638337|20086673|P1|Overall Study|Withdrawal by Subject|13
5817044|NCT02638337|20086672|P2|Overall Study|Protocol Violation|0
5817045|NCT02638337|20086673|P1|Overall Study|Protocol Violation|3
5817046|NCT02638337|20086672|P2|Overall Study|Adverse Event|10
5817047|NCT02638337|20086673|P1|Overall Study|Adverse Event|6
5817048|NCT02638259|20086757|P2|Treatment Period 2|Withdrawal by Subject|7
5817049|NCT02638259|20086758|P1|Treatment Period 2|Withdrawal by Subject|1
5817050|NCT02638259|20086757|P2|Treatment Period 2|Adverse Event|4
5817051|NCT02638259|20086758|P1|Treatment Period 2|Adverse Event|5
5817052|NCT02638259|20086757|P2|Treatment Period 1|Withdrawn per sponsor decision|2
5817053|NCT02638259|20086758|P1|Treatment Period 1|Withdrawn per sponsor decision|0
5817054|NCT02638259|20086757|P2|Treatment Period 1|Withdrawal by Subject|6
5817055|NCT02638259|20086758|P1|Treatment Period 1|Withdrawal by Subject|4
5817056|NCT02638259|20086757|P2|Treatment Period 1|Protocol Violation|3
5817057|NCT02638259|20086758|P1|Treatment Period 1|Protocol Violation|0
5817058|NCT02638259|20086757|P2|Treatment Period 1|Lack of Efficacy|1
5817059|NCT02638259|20086758|P1|Treatment Period 1|Lack of Efficacy|0
5817060|NCT02638259|20086757|P2|Treatment Period 1|Death|1
5817061|NCT02638259|20086758|P1|Treatment Period 1|Death|0
5817062|NCT02638259|20086757|P2|Treatment Period 1|Adverse Event|5
5817063|NCT02638259|20086758|P1|Treatment Period 1|Adverse Event|1
5817064|NCT02638129|20086850|P2|Overall Study|Study terminated|30
5817065|NCT02638129|20086851|P1|Overall Study|Study terminated|28
5817066|NCT02638103|20086867|P4|Overall Study|Other than specified|4
5817067|NCT02638103|20086868|P3|Overall Study|Other than specified|2
5817068|NCT02638103|20086869|P2|Overall Study|Other than specified|4
5817069|NCT02638103|20086870|P1|Overall Study|Other than specified|5
5817070|NCT02638103|20086867|P4|Overall Study|Lack of Efficacy|22
5817071|NCT02638103|20086868|P3|Overall Study|Lack of Efficacy|12
5817072|NCT02638103|20086869|P2|Overall Study|Lack of Efficacy|10
5817073|NCT02638103|20086870|P1|Overall Study|Lack of Efficacy|14
5817074|NCT02638103|20086867|P4|Overall Study|Lost to Follow-up|37
5817075|NCT02638103|20086868|P3|Overall Study|Lost to Follow-up|20
5817076|NCT02638103|20086869|P2|Overall Study|Lost to Follow-up|33
5817077|NCT02638103|20086870|P1|Overall Study|Lost to Follow-up|26
5817078|NCT02638103|20086867|P4|Overall Study|Non-compliance to Study Procedures|1
5817079|NCT02638103|20086868|P3|Overall Study|Non-compliance to Study Procedures|1
5817080|NCT02638103|20086869|P2|Overall Study|Non-compliance to Study Procedures|1
5817081|NCT02638103|20086870|P1|Overall Study|Non-compliance to Study Procedures|2
5817082|NCT02638103|20086867|P4|Overall Study|Pregnancy|1
5817083|NCT02638103|20086868|P3|Overall Study|Pregnancy|0
5817084|NCT02638103|20086869|P2|Overall Study|Pregnancy|3
5817085|NCT02638103|20086870|P1|Overall Study|Pregnancy|2
5817086|NCT02638103|20086867|P4|Overall Study|Protocol Violation|4
5817087|NCT02638103|20086868|P3|Overall Study|Protocol Violation|1
5817088|NCT02638103|20086869|P2|Overall Study|Protocol Violation|2
5817089|NCT02638103|20086870|P1|Overall Study|Protocol Violation|1
5817090|NCT02638103|20086867|P4|Overall Study|Withdrawal by Subject|61
5817091|NCT02638103|20086868|P3|Overall Study|Withdrawal by Subject|30
5817092|NCT02638103|20086869|P2|Overall Study|Withdrawal by Subject|53
5817093|NCT02638103|20086870|P1|Overall Study|Withdrawal by Subject|43
5817094|NCT02638103|20086867|P4|Overall Study|Adverse Event|12
5817095|NCT02638103|20086868|P3|Overall Study|Adverse Event|19
5817096|NCT02638103|20086869|P2|Overall Study|Adverse Event|12
5817097|NCT02638103|20086870|P1|Overall Study|Adverse Event|13
5817098|NCT02638012|20086957|P1|Overall Study|Lost to Follow-up|1
5817099|NCT02637856|20087002|P2|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|3
5817100|NCT02637856|20087003|P1|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|0
5817101|NCT02637856|20087002|P2|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|1
5817102|NCT02637856|20087003|P1|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|0
5817103|NCT02637856|20087002|P2|Main Study (Baseline to Week 100)|Site Closing|0
5817104|NCT02637856|20087003|P1|Main Study (Baseline to Week 100)|Site Closing|6
5817105|NCT02637856|20087002|P2|Main Study (Baseline to Week 100)|Pregnancy Attempts|0
5817106|NCT02637856|20087003|P1|Main Study (Baseline to Week 100)|Pregnancy Attempts|2
5817107|NCT02637856|20087002|P2|Main Study (Baseline to Week 100)|Incarceration|0
5817108|NCT02637856|20087003|P1|Main Study (Baseline to Week 100)|Incarceration|1
5817109|NCT02637856|20087002|P2|Main Study (Baseline to Week 100)|Failed Drug Test|0
5817110|NCT02637856|20087003|P1|Main Study (Baseline to Week 100)|Failed Drug Test|1
5817111|NCT02637856|20087002|P2|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|0
5817112|NCT02637856|20087003|P1|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|164
5817113|NCT02637856|20087002|P2|Main Study (Baseline to Week 100)|Protocol Deviation|0
5817114|NCT02637856|20087003|P1|Main Study (Baseline to Week 100)|Protocol Deviation|2
5817115|NCT02637856|20087002|P2|Main Study (Baseline to Week 100)|Withdrawal by Subject|0
5817116|NCT02637856|20087003|P1|Main Study (Baseline to Week 100)|Withdrawal by Subject|20
5817117|NCT02637856|20087002|P2|Main Study (Baseline to Week 100)|Pregnancy|0
5817118|NCT02637856|20087003|P1|Main Study (Baseline to Week 100)|Pregnancy|7
5817119|NCT02637856|20087002|P2|Main Study (Baseline to Week 100)|Physician Decision|0
5817120|NCT02637856|20087003|P1|Main Study (Baseline to Week 100)|Physician Decision|2
5817121|NCT02637856|20087002|P2|Main Study (Baseline to Week 100)|Lost to Follow-up|0
5817122|NCT02637856|20087003|P1|Main Study (Baseline to Week 100)|Lost to Follow-up|5
5817123|NCT02637856|20087002|P2|Main Study (Baseline to Week 100)|Adverse Event|0
5817124|NCT02637856|20087003|P1|Main Study (Baseline to Week 100)|Adverse Event|9
5817125|NCT02637557|20087133|P4|Overall Study|Withdrawal by Subject|2
5817126|NCT02637557|20087134|P3|Overall Study|Withdrawal by Subject|4
5817127|NCT02637557|20087135|P2|Overall Study|Withdrawal by Subject|3
5817128|NCT02637557|20087136|P1|Overall Study|Withdrawal by Subject|1
5817129|NCT02637557|20087133|P4|Overall Study|Protocol Violation|1
5817130|NCT02637557|20087134|P3|Overall Study|Protocol Violation|2
5817131|NCT02637557|20087135|P2|Overall Study|Protocol Violation|0
5817132|NCT02637557|20087136|P1|Overall Study|Protocol Violation|2
5817133|NCT02637557|20087133|P4|Overall Study|Physician Decision|0
5817134|NCT02637557|20087134|P3|Overall Study|Physician Decision|0
5817135|NCT02637557|20087135|P2|Overall Study|Physician Decision|0
5817136|NCT02637557|20087136|P1|Overall Study|Physician Decision|1
5817137|NCT02637557|20087133|P4|Overall Study|Lost to Follow-up|1
5817138|NCT02637557|20087134|P3|Overall Study|Lost to Follow-up|0
5817139|NCT02637557|20087135|P2|Overall Study|Lost to Follow-up|1
5817140|NCT02637557|20087136|P1|Overall Study|Lost to Follow-up|1
5817141|NCT02637557|20087133|P4|Overall Study|Adverse Event|3
5817142|NCT02637557|20087134|P3|Overall Study|Adverse Event|3
5817143|NCT02637557|20087135|P2|Overall Study|Adverse Event|1
5817144|NCT02637557|20087136|P1|Overall Study|Adverse Event|3
5817145|NCT02637323|20087228|P2|Overall Study|Protocol Violation|1
5817146|NCT02637323|20087229|P1|Overall Study|Protocol Violation|0
5817147|NCT02637323|20087228|P2|Overall Study|Lost to Follow-up|0
5817148|NCT02637323|20087229|P1|Overall Study|Lost to Follow-up|2
5817149|NCT02637141|20087240|P3|Overall Study|Withdrawal by Subject|1
5817150|NCT02637141|20087241|P2|Overall Study|Withdrawal by Subject|1
5817151|NCT02637141|20087242|P1|Overall Study|Withdrawal by Subject|1
5817152|NCT02637141|20087240|P3|Overall Study|Adverse Event|0
5817153|NCT02637141|20087241|P2|Overall Study|Adverse Event|1
5817154|NCT02637141|20087242|P1|Overall Study|Adverse Event|1
5817155|NCT02637063|20087277|P3|Overall Study|Withdrawal by Subject|3
5817156|NCT02637063|20087278|P2|Overall Study|Withdrawal by Subject|2
5817157|NCT02637063|20087279|P1|Overall Study|Withdrawal by Subject|2
5817158|NCT02637063|20087277|P3|Overall Study|Lost to Follow-up|3
5817159|NCT02637063|20087278|P2|Overall Study|Lost to Follow-up|2
5817160|NCT02637063|20087279|P1|Overall Study|Lost to Follow-up|3
5817161|NCT02637037|20087307|P2|Overall Study|Adverse Event|0
5817162|NCT02637037|20087308|P1|Overall Study|Adverse Event|1
5817163|NCT02637037|20087307|P2|Overall Study|Withdrawal by Subject|1
5817164|NCT02637037|20087308|P1|Overall Study|Withdrawal by Subject|2
5817165|NCT02637037|20087307|P2|Overall Study|Positive drug screen at admission|0
5817166|NCT02637037|20087308|P1|Overall Study|Positive drug screen at admission|1
5817167|NCT02636907|20087374|P1|Extension Phase|Lack of Efficacy|1
5817168|NCT02636907|20087374|P1|Extension Phase|Lost to Follow-up|2
5817169|NCT02636907|20087374|P1|Extension Phase|Physician Decision|1
5817170|NCT02636907|20087374|P1|Extension Phase|Withdrawal by Subject|4
5817171|NCT02636907|20087374|P1|Extension Phase|Adverse Event|2
5817172|NCT02636907|20087374|P1|Autoinjector Assessment Period|Withdrawal by Subject|2
5817173|NCT02636907|20087374|P1|Autoinjector Assessment Period|Adverse Event|2
5817174|NCT02636608|20087391|P1|Overall Study|Did Not Receive Treatment|1
5817175|NCT02636608|20087391|P1|Overall Study|Other|2
5817176|NCT02636608|20087391|P1|Overall Study|Death|3
5817177|NCT02636608|20087391|P1|Overall Study|Insufficient Virological Response|1
5817178|NCT02636608|20087391|P1|Overall Study|Failure to Return|4
5817179|NCT02636595|20087419|P1|Overall Study|Other|1
5817180|NCT02636595|20087419|P1|Overall Study|Lost to Follow-up|1
5817181|NCT02636361|20087425|P5|Period 4|Physician Decision|0
5817182|NCT02636361|20087426|P4|Period 4|Physician Decision|1
5817183|NCT02636361|20087427|P3|Period 4|Physician Decision|0
5817184|NCT02636361|20087428|P2|Period 4|Physician Decision|0
5817185|NCT02636361|20087429|P1|Period 4|Physician Decision|0
5817186|NCT02636283|20087448|P2|Overall Study|Trial Terminated Prematurely|3
5817187|NCT02636283|20087449|P1|Overall Study|Trial Terminated Prematurely|0
5817188|NCT02636283|20087448|P2|Overall Study|Adverse Event|0
5817189|NCT02636283|20087449|P1|Overall Study|Adverse Event|2
5817190|NCT02635984|20087477|P2|Overall Study|Study Arm Closed|0
5817191|NCT02635984|20087478|P1|Overall Study|Study Arm Closed|1
5817192|NCT02635984|20087477|P2|Overall Study|Lost to Follow-up|4
5817193|NCT02635984|20087478|P1|Overall Study|Lost to Follow-up|2
5817194|NCT02635737|20087508|P1|Overall Study|Protocol Violation|1
5817195|NCT02635646|20087521|P2|Overall Study|Pregnancy|1
5817196|NCT02635646|20087522|P1|Overall Study|Pregnancy|1
5817197|NCT02635646|20087521|P2|Overall Study|Lost to Follow-up|25
5817198|NCT02635646|20087522|P1|Overall Study|Lost to Follow-up|24
5817199|NCT02635347|20087558|P2|Overall Study|Failed screening|7
5817200|NCT02635347|20087559|P1|Overall Study|Failed screening|20
5817201|NCT02635204|20087590|P2|Overall Study|Lost to Follow-up|1
5817202|NCT02635204|20087591|P1|Overall Study|Lost to Follow-up|1
5817203|NCT02635204|20087590|P2|Overall Study|Adverse Event|0
5817204|NCT02635204|20087591|P1|Overall Study|Adverse Event|1
5817205|NCT02634983|20087601|P2|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|0
5817206|NCT02634983|20087602|P1|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|2
5817207|NCT02634801|20087661|P3|Follow-up Period|Adverse Event|0
5817208|NCT02634801|20087662|P2|Follow-up Period|Adverse Event|5
5817209|NCT02634801|20087663|P1|Follow-up Period|Adverse Event|1
5817210|NCT02634801|20087661|P3|Follow-up Period|Withdrawal by Subject|5
5817211|NCT02634801|20087662|P2|Follow-up Period|Withdrawal by Subject|2
5817212|NCT02634801|20087663|P1|Follow-up Period|Withdrawal by Subject|1
5817213|NCT02634801|20087661|P3|Follow-up Period|Physician Decision|1
5817214|NCT02634801|20087662|P2|Follow-up Period|Physician Decision|0
5817215|NCT02634801|20087663|P1|Follow-up Period|Physician Decision|0
5817216|NCT02634801|20087661|P3|Follow-up Period|Lost to Follow-up|2
5817217|NCT02634801|20087662|P2|Follow-up Period|Lost to Follow-up|1
5817218|NCT02634801|20087663|P1|Follow-up Period|Lost to Follow-up|3
5817219|NCT02634801|20087661|P3|Extension Period (Weeks 24 to 36)|Missing|0
5817220|NCT02634801|20087662|P2|Extension Period (Weeks 24 to 36)|Missing|0
5817221|NCT02634801|20087663|P1|Extension Period (Weeks 24 to 36)|Missing|1
5817222|NCT02634801|20087661|P3|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1
5817223|NCT02634801|20087662|P2|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1
5817224|NCT02634801|20087663|P1|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1
5817225|NCT02634801|20087661|P3|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0
5817226|NCT02634801|20087662|P2|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0
5817227|NCT02634801|20087663|P1|Extension Period (Weeks 24 to 36)|Lost to Follow-up|1
5817228|NCT02634801|20087661|P3|Extension Period (Weeks 24 to 36)|Adverse Event|1
5817229|NCT02634801|20087662|P2|Extension Period (Weeks 24 to 36)|Adverse Event|0
5817230|NCT02634801|20087663|P1|Extension Period (Weeks 24 to 36)|Adverse Event|0
5817231|NCT02634801|20087661|P3|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|3
5817232|NCT02634801|20087662|P2|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|8
5817233|NCT02634801|20087663|P1|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|0
5817234|NCT02634801|20087661|P3|Treatment Period (Weeks 0 to 24)|Protocol Violation|1
5817235|NCT02634801|20087662|P2|Treatment Period (Weeks 0 to 24)|Protocol Violation|0
5817236|NCT02634801|20087663|P1|Treatment Period (Weeks 0 to 24)|Protocol Violation|0
5817237|NCT02634801|20087661|P3|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1
5817238|NCT02634801|20087662|P2|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1
5817239|NCT02634801|20087663|P1|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|2
5817240|NCT02634801|20087661|P3|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0
5817241|NCT02634801|20087662|P2|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|2
5817242|NCT02634801|20087663|P1|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0
5817243|NCT02634801|20087661|P3|Treatment Period (Weeks 0 to 24)|Adverse Event|0
5817244|NCT02634801|20087662|P2|Treatment Period (Weeks 0 to 24)|Adverse Event|20
5817245|NCT02634801|20087663|P1|Treatment Period (Weeks 0 to 24)|Adverse Event|2
5817246|NCT02634788|20087763|P4|Overall Study|Withdrawal by Subject|0
5817247|NCT02634788|20087764|P3|Overall Study|Withdrawal by Subject|1
5817248|NCT02634788|20087765|P2|Overall Study|Withdrawal by Subject|1
5817249|NCT02634788|20087766|P1|Overall Study|Withdrawal by Subject|0
5817250|NCT02634788|20087763|P4|Overall Study|Lost to Follow-up|0
5817251|NCT02634788|20087764|P3|Overall Study|Lost to Follow-up|0
5817252|NCT02634788|20087765|P2|Overall Study|Lost to Follow-up|1
5817253|NCT02634788|20087766|P1|Overall Study|Lost to Follow-up|0
5817254|NCT02634788|20087763|P4|Overall Study|Lack of Efficacy|4
5817255|NCT02634788|20087764|P3|Overall Study|Lack of Efficacy|1
5817256|NCT02634788|20087765|P2|Overall Study|Lack of Efficacy|0
5817257|NCT02634788|20087766|P1|Overall Study|Lack of Efficacy|4
5817258|NCT02634788|20087763|P4|Overall Study|Adverse Event|1
5817259|NCT02634788|20087764|P3|Overall Study|Adverse Event|3
5817260|NCT02634788|20087765|P2|Overall Study|Adverse Event|8
5817261|NCT02634788|20087766|P1|Overall Study|Adverse Event|0
5817262|NCT02634606|20087832|P1|Overall Study|unable to obtain the drug at start|13
5817263|NCT02634580|20087844|P4|Open-label Extension Period|Withdrawal by Subject|1
5817264|NCT02634580|20087845|P3|Open-label Extension Period|Withdrawal by Subject|0
5817265|NCT02634580|20087846|P2|Open-label Extension Period|Withdrawal by Subject|1
5817266|NCT02634580|20087847|P1|Open-label Extension Period|Withdrawal by Subject|0
5817267|NCT02634580|20087844|P4|Double-blind Treatment Period|Subject Request|1
5817268|NCT02634580|20087845|P3|Double-blind Treatment Period|Subject Request|1
5817269|NCT02634580|20087846|P2|Double-blind Treatment Period|Subject Request|0
5817270|NCT02634580|20087847|P1|Double-blind Treatment Period|Subject Request|1
5817271|NCT02634346|20087905|P3|Overall Study|Protocol Violation|0
5817272|NCT02634346|20087906|P2|Overall Study|Protocol Violation|1
5817273|NCT02634346|20087907|P1|Overall Study|Protocol Violation|0
5817274|NCT02634346|20087905|P3|Overall Study|Lost to Follow-up|0
5817275|NCT02634346|20087906|P2|Overall Study|Lost to Follow-up|0
5817276|NCT02634346|20087907|P1|Overall Study|Lost to Follow-up|1
5817277|NCT02634346|20087905|P3|Overall Study|Lack of Efficacy|8
5817278|NCT02634346|20087906|P2|Overall Study|Lack of Efficacy|2
5817279|NCT02634346|20087907|P1|Overall Study|Lack of Efficacy|1
5817280|NCT02634346|20087905|P3|Overall Study|Adverse Event|7
5817281|NCT02634346|20087906|P2|Overall Study|Adverse Event|2
5817282|NCT02634346|20087907|P1|Overall Study|Adverse Event|2
5817283|NCT02634346|20087905|P3|Overall Study|Withdrawal by Subject|8
5817284|NCT02634346|20087906|P2|Overall Study|Withdrawal by Subject|9
5817285|NCT02634346|20087907|P1|Overall Study|Withdrawal by Subject|8
5817286|NCT02634320|20087921|P1|Overall Study|Lack of Efficacy|2
5817287|NCT02634320|20087921|P1|Overall Study|Withdrawal by Subject|5
5817288|NCT02634320|20087921|P1|Overall Study|Protocol Violation|1
5817289|NCT02634320|20087921|P1|Overall Study|Out of window for study visits|1
5817290|NCT02634320|20087921|P1|Overall Study|Moved out of area|2
5817291|NCT02634320|20087921|P1|Overall Study|Lost to Follow-up|3
5817292|NCT02634320|20087921|P1|Overall Study|Adverse Event|2
5817293|NCT02634151|20087957|P2|Overall Study|Other|1
5817294|NCT02634151|20087958|P1|Overall Study|Other|0
5817295|NCT02634151|20087957|P2|Overall Study|Non-Compliance|1
5817296|NCT02634151|20087958|P1|Overall Study|Non-Compliance|0
5817297|NCT02634151|20087957|P2|Overall Study|Withdrawal by Subject|0
5817298|NCT02634151|20087958|P1|Overall Study|Withdrawal by Subject|1
5817299|NCT02633800|20088160|P2|Overall Study|Patient Request|1
5817300|NCT02633800|20088161|P1|Overall Study|Patient Request|1
5817301|NCT02633800|20088160|P2|Overall Study|Withdrawal by Subject|3
5817302|NCT02633800|20088161|P1|Overall Study|Withdrawal by Subject|0
5817303|NCT02633800|20088160|P2|Overall Study|Adverse event, non-fatal|2
5817304|NCT02633800|20088161|P1|Overall Study|Adverse event, non-fatal|7
5817305|NCT02633800|20088160|P2|Overall Study|Study terminated by sponsor|5
5817306|NCT02633800|20088161|P1|Overall Study|Study terminated by sponsor|6
5817307|NCT02633800|20088160|P2|Overall Study|Clinical progression|6
5817308|NCT02633800|20088161|P1|Overall Study|Clinical progression|3
5817309|NCT02633800|20088160|P2|Overall Study|Radiologic(al) progression|23
5817310|NCT02633800|20088161|P1|Overall Study|Radiologic(al) progression|23
5817311|NCT02633800|20088160|P2|Overall Study|Reason not provided|0
5817312|NCT02633800|20088161|P1|Overall Study|Reason not provided|1
5817313|NCT02633800|20088160|P2|Overall Study|Death|3
5817314|NCT02633800|20088161|P1|Overall Study|Death|3
5817315|NCT02633787|20088171|P1|Overall Study|Withdrawal by Subject|1
5817316|NCT02633501|20088192|P6|Overall Study|Lost to Follow-up|0
5817317|NCT02633501|20088193|P5|Overall Study|Lost to Follow-up|2
5817318|NCT02633501|20088194|P4|Overall Study|Lost to Follow-up|1
5817319|NCT02633501|20088195|P3|Overall Study|Lost to Follow-up|0
5817320|NCT02633501|20088196|P2|Overall Study|Lost to Follow-up|0
5817321|NCT02633501|20088197|P1|Overall Study|Lost to Follow-up|0
5817322|NCT02633501|20088192|P6|Overall Study|Various other reasons|11
5817323|NCT02633501|20088193|P5|Overall Study|Various other reasons|7
5817324|NCT02633501|20088194|P4|Overall Study|Various other reasons|1
5817325|NCT02633501|20088195|P3|Overall Study|Various other reasons|4
5817326|NCT02633501|20088196|P2|Overall Study|Various other reasons|2
5817327|NCT02633501|20088197|P1|Overall Study|Various other reasons|0
5817328|NCT02633501|20088192|P6|Overall Study|Withdrawal by Subject|3
5817329|NCT02633501|20088193|P5|Overall Study|Withdrawal by Subject|1
5817330|NCT02633501|20088194|P4|Overall Study|Withdrawal by Subject|2
5817331|NCT02633501|20088195|P3|Overall Study|Withdrawal by Subject|2
5817332|NCT02633501|20088196|P2|Overall Study|Withdrawal by Subject|1
5817333|NCT02633501|20088197|P1|Overall Study|Withdrawal by Subject|2
5817334|NCT02633501|20088192|P6|Overall Study|Adverse Event|1
5817335|NCT02633501|20088193|P5|Overall Study|Adverse Event|1
5817336|NCT02633501|20088194|P4|Overall Study|Adverse Event|0
5817337|NCT02633501|20088195|P3|Overall Study|Adverse Event|1
5817338|NCT02633501|20088196|P2|Overall Study|Adverse Event|0
5817339|NCT02633501|20088197|P1|Overall Study|Adverse Event|0
5817340|NCT02633215|20088259|P2|Overall Study|Lost to Follow-up|3
5817341|NCT02633215|20088260|P1|Overall Study|Lost to Follow-up|2
5817342|NCT02633020|20088272|P2|Overall Study|Adverse Event|0
5817343|NCT02633020|20088273|P1|Overall Study|Adverse Event|1
5817344|NCT02632838|20088297|P2|Overall Study|Lost to Follow-up|2
5817345|NCT02632838|20088298|P1|Overall Study|Lost to Follow-up|0
5817346|NCT02632838|20088297|P2|Overall Study|Withdrawal by Subject|0
5817347|NCT02632838|20088298|P1|Overall Study|Withdrawal by Subject|3
5817348|NCT02632786|20088335|P2|Overall Study|Withdrawal by Subject|0
5817349|NCT02632786|20088336|P1|Overall Study|Withdrawal by Subject|1
5817350|NCT02632786|20088335|P2|Overall Study|Physician Decision|4
5817351|NCT02632786|20088336|P1|Overall Study|Physician Decision|5
5817352|NCT02632786|20088335|P2|Overall Study|Death|2
5817353|NCT02632786|20088336|P1|Overall Study|Death|3
5817354|NCT02632786|20088335|P2|Overall Study|Adverse Event|1
5817355|NCT02632786|20088336|P1|Overall Study|Adverse Event|2
5817356|NCT02632747|20088356|P2|Wash-out Period|Adverse Event|0
5817357|NCT02632747|20088357|P1|Wash-out Period|Adverse Event|1
5817358|NCT02632110|20088557|P10|Overall Study|Withdrawal by Subject|1
5817359|NCT02632110|20088558|P9|Overall Study|Withdrawal by Subject|1
5817360|NCT02632110|20088559|P8|Overall Study|Withdrawal by Subject|3
5817361|NCT02632110|20088560|P7|Overall Study|Withdrawal by Subject|3
5817362|NCT02632110|20088561|P6|Overall Study|Withdrawal by Subject|1
5817363|NCT02632110|20088562|P5|Overall Study|Withdrawal by Subject|1
5817364|NCT02632110|20088563|P4|Overall Study|Withdrawal by Subject|0
5817365|NCT02632110|20088564|P3|Overall Study|Withdrawal by Subject|0
5817366|NCT02632110|20088565|P2|Overall Study|Withdrawal by Subject|1
5817367|NCT02632110|20088566|P1|Overall Study|Withdrawal by Subject|1
5817368|NCT02631876|20089056|P2|Overall Study|Other than specified|4
5817369|NCT02631876|20089057|P1|Overall Study|Other than specified|4
5817370|NCT02631876|20089056|P2|Overall Study|Withdrawal by Subject|9
5817371|NCT02631876|20089057|P1|Overall Study|Withdrawal by Subject|16
5817372|NCT02631876|20089056|P2|Overall Study|Lost to Follow-up|0
5817373|NCT02631876|20089057|P1|Overall Study|Lost to Follow-up|2
5817374|NCT02631876|20089056|P2|Overall Study|Investigator's discretion|0
5817375|NCT02631876|20089057|P1|Overall Study|Investigator's discretion|1
5817376|NCT02631876|20089056|P2|Overall Study|Death|50
5817377|NCT02631876|20089057|P1|Overall Study|Death|96
5817378|NCT02631746|20089133|P1|Overall Study|Lack of Efficacy|3
5817379|NCT02631551|20089154|P4|Overall Study|Other, specific reasons not collected|2
5817380|NCT02631551|20089155|P3|Overall Study|Other, specific reasons not collected|2
5817381|NCT02631551|20089156|P2|Overall Study|Other, specific reasons not collected|7
5817382|NCT02631551|20089157|P1|Overall Study|Other, specific reasons not collected|5
5817383|NCT02631551|20089154|P4|Overall Study|Non-compliance with study drug|0
5817384|NCT02631551|20089155|P3|Overall Study|Non-compliance with study drug|0
5817385|NCT02631551|20089156|P2|Overall Study|Non-compliance with study drug|0
5817386|NCT02631551|20089157|P1|Overall Study|Non-compliance with study drug|1
5817387|NCT02631551|20089154|P4|Overall Study|Non-compliance with study procedures|1
5817388|NCT02631551|20089155|P3|Overall Study|Non-compliance with study procedures|1
5817389|NCT02631551|20089156|P2|Overall Study|Non-compliance with study procedures|0
5817390|NCT02631551|20089157|P1|Overall Study|Non-compliance with study procedures|0
5817391|NCT02631551|20089154|P4|Overall Study|Protocol deviation|0
5817392|NCT02631551|20089155|P3|Overall Study|Protocol deviation|3
5817393|NCT02631551|20089156|P2|Overall Study|Protocol deviation|6
5817394|NCT02631551|20089157|P1|Overall Study|Protocol deviation|3
5817395|NCT02631551|20089154|P4|Overall Study|Withdrawal by Subject|5
5817396|NCT02631551|20089155|P3|Overall Study|Withdrawal by Subject|0
5817397|NCT02631551|20089156|P2|Overall Study|Withdrawal by Subject|2
5817398|NCT02631551|20089157|P1|Overall Study|Withdrawal by Subject|2
5817399|NCT02631551|20089154|P4|Overall Study|Lost to Follow-up|3
5817400|NCT02631551|20089155|P3|Overall Study|Lost to Follow-up|0
5817401|NCT02631551|20089156|P2|Overall Study|Lost to Follow-up|2
5817402|NCT02631551|20089157|P1|Overall Study|Lost to Follow-up|1
5817403|NCT02631551|20089154|P4|Overall Study|Lack of Efficacy|0
5817404|NCT02631551|20089155|P3|Overall Study|Lack of Efficacy|1
5817405|NCT02631551|20089156|P2|Overall Study|Lack of Efficacy|0
5817406|NCT02631551|20089157|P1|Overall Study|Lack of Efficacy|0
5817407|NCT02631551|20089154|P4|Overall Study|Adverse Event|0
5817408|NCT02631551|20089155|P3|Overall Study|Adverse Event|4
5817409|NCT02631551|20089156|P2|Overall Study|Adverse Event|2
5817410|NCT02631551|20089157|P1|Overall Study|Adverse Event|1
5817411|NCT02631070|20089178|P2|Overall Study|Miscellaneous|10
5817412|NCT02631070|20089179|P1|Overall Study|Miscellaneous|4
5817413|NCT02631070|20089178|P2|Overall Study|Progressive Disease|2
5817414|NCT02631070|20089179|P1|Overall Study|Progressive Disease|6
5817415|NCT02631070|20089178|P2|Overall Study|Protocol Violation|0
5817416|NCT02631070|20089179|P1|Overall Study|Protocol Violation|2
5817417|NCT02631070|20089178|P2|Overall Study|Withdrawal by Subject|10
5817418|NCT02631070|20089179|P1|Overall Study|Withdrawal by Subject|17
5817419|NCT02631070|20089178|P2|Overall Study|Lack of Efficacy|50
5817420|NCT02631070|20089179|P1|Overall Study|Lack of Efficacy|68
5817421|NCT02631070|20089178|P2|Overall Study|Adverse Event|4
5817422|NCT02631070|20089179|P1|Overall Study|Adverse Event|15
5817423|NCT02630966|20089273|P2|Overall Study|Lack of Efficacy|2
5817424|NCT02630966|20089274|P1|Overall Study|Lack of Efficacy|0
5817425|NCT02630966|20089273|P2|Overall Study|Voluntary Withdrawal|1
5817426|NCT02630966|20089274|P1|Overall Study|Voluntary Withdrawal|1
5817427|NCT02630966|20089273|P2|Overall Study|Significant Protocol Deviation|2
5817428|NCT02630966|20089274|P1|Overall Study|Significant Protocol Deviation|0
5817429|NCT02630966|20089273|P2|Overall Study|Adverse Event|3
5817430|NCT02630966|20089274|P1|Overall Study|Adverse Event|1
5817431|NCT02630706|20089302|P3|Overall Study|Withdrawal by Subject|7
5817432|NCT02630706|20089303|P2|Overall Study|Withdrawal by Subject|5
5817433|NCT02630706|20089304|P1|Overall Study|Withdrawal by Subject|4
5817434|NCT02630706|20089302|P3|Overall Study|Pregnancy|0
5817435|NCT02630706|20089303|P2|Overall Study|Pregnancy|1
5817436|NCT02630706|20089304|P1|Overall Study|Pregnancy|0
5817437|NCT02630706|20089302|P3|Overall Study|Physician Decision|0
5817438|NCT02630706|20089303|P2|Overall Study|Physician Decision|1
5817439|NCT02630706|20089304|P1|Overall Study|Physician Decision|1
5817440|NCT02630706|20089302|P3|Overall Study|Lost to Follow-up|2
5817441|NCT02630706|20089303|P2|Overall Study|Lost to Follow-up|1
5817442|NCT02630706|20089304|P1|Overall Study|Lost to Follow-up|0
5817443|NCT02630706|20089302|P3|Overall Study|Adverse Event|1
5817444|NCT02630706|20089303|P2|Overall Study|Adverse Event|1
5817445|NCT02630706|20089304|P1|Overall Study|Adverse Event|2
5817446|NCT02630693|20089413|P2|Overall Study|No receive treatment|1
5817447|NCT02630693|20089414|P1|Overall Study|No receive treatment|0
5817448|NCT02630563|20089426|P1|Overall Study|Administrative|1
5817449|NCT02630472|20089437|P2|Overall Study|Physician Decision|0
5817450|NCT02630472|20089438|P1|Overall Study|Physician Decision|10
5817451|NCT02630459|20089456|P8|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0
5817452|NCT02630459|20089457|P7|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0
5817453|NCT02630459|20089458|P6|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0
5817454|NCT02630459|20089459|P5|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|1
5817455|NCT02630459|20089460|P4|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0
5817456|NCT02630459|20089461|P3|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0
5817457|NCT02630459|20089462|P2|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0
5817458|NCT02630459|20089463|P1|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0
5817459|NCT02630459|20089456|P8|Open-Label Treatment Phase (OLTP)|Subject Request|0
5817460|NCT02630459|20089457|P7|Open-Label Treatment Phase (OLTP)|Subject Request|0
5817461|NCT02630459|20089458|P6|Open-Label Treatment Phase (OLTP)|Subject Request|3
5817462|NCT02630459|20089459|P5|Open-Label Treatment Phase (OLTP)|Subject Request|24
5817463|NCT02630459|20089460|P4|Open-Label Treatment Phase (OLTP)|Subject Request|0
5817464|NCT02630459|20089461|P3|Open-Label Treatment Phase (OLTP)|Subject Request|0
5817465|NCT02630459|20089462|P2|Open-Label Treatment Phase (OLTP)|Subject Request|0
5817466|NCT02630459|20089463|P1|Open-Label Treatment Phase (OLTP)|Subject Request|0
5817467|NCT02630459|20089456|P8|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0
5817468|NCT02630459|20089457|P7|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0
5817469|NCT02630459|20089458|P6|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|1
5817470|NCT02630459|20089459|P5|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|4
5817471|NCT02630459|20089460|P4|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0
5817472|NCT02630459|20089461|P3|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0
5817473|NCT02630459|20089462|P2|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0
5817474|NCT02630459|20089463|P1|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0
5817475|NCT02630459|20089456|P8|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0
5817476|NCT02630459|20089457|P7|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0
5817477|NCT02630459|20089458|P6|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0
5817478|NCT02630459|20089459|P5|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0
5817479|NCT02630459|20089460|P4|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0
5817480|NCT02630459|20089461|P3|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0
5817481|NCT02630459|20089462|P2|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0
5817482|NCT02630459|20089463|P1|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|1
5817483|NCT02630459|20089456|P8|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0
5817484|NCT02630459|20089457|P7|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0
5817485|NCT02630459|20089458|P6|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0
5817486|NCT02630459|20089459|P5|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0
5817487|NCT02630459|20089460|P4|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|1
5817488|NCT02630459|20089461|P3|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|4
5817489|NCT02630459|20089462|P2|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|1
5817490|NCT02630459|20089463|P1|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|2
5817491|NCT02630459|20089456|P8|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0
5817492|NCT02630459|20089457|P7|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0
5817493|NCT02630459|20089458|P6|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0
5817494|NCT02630459|20089459|P5|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0
5817495|NCT02630459|20089460|P4|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0
5817496|NCT02630459|20089461|P3|Double-Blind Treatment Phase (DBTP)|Sponsor decision|1
5817497|NCT02630459|20089462|P2|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0
5817498|NCT02630459|20089463|P1|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0
5817499|NCT02630459|20089456|P8|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0
5817500|NCT02630459|20089457|P7|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0
5817501|NCT02630459|20089458|P6|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0
5817502|NCT02630459|20089459|P5|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0
5817503|NCT02630459|20089460|P4|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|2
5817504|NCT02630459|20089461|P3|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0
5817505|NCT02630459|20089462|P2|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|1
5817506|NCT02630459|20089463|P1|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0
5817507|NCT02630251|20089522|P4|Overall Study|Physician Decision|0
5817508|NCT02630251|20089523|P3|Overall Study|Physician Decision|1
5817509|NCT02630251|20089524|P2|Overall Study|Physician Decision|0
5817510|NCT02630251|20089525|P1|Overall Study|Physician Decision|0
5817511|NCT02630186|20089639|P1|Overall Study|Withdrawal by Subject|1
5817512|NCT02629965|20089655|P2|Period 2|Adverse Event|0
5817513|NCT02629965|20089656|P1|Period 2|Adverse Event|1
5817514|NCT02629965|20089655|P2|Period 1|Other than listed above|2
5817515|NCT02629965|20089656|P1|Period 1|Other than listed above|1
5817516|NCT02629965|20089655|P2|Period 1|Unexpected worsening of disease|0
5817517|NCT02629965|20089656|P1|Period 1|Unexpected worsening of disease|2
5817518|NCT02629965|20089655|P2|Period 1|Adverse Event|0
5817519|NCT02629965|20089656|P1|Period 1|Adverse Event|1
5817520|NCT02629861|20089695|P3|Overall Study|Pregnancy|0
5817521|NCT02629861|20089696|P2|Overall Study|Pregnancy|1
5817522|NCT02629861|20089697|P1|Overall Study|Pregnancy|2
5817523|NCT02629861|20089695|P3|Overall Study|Other|0
5817524|NCT02629861|20089696|P2|Overall Study|Other|1
5817525|NCT02629861|20089697|P1|Overall Study|Other|1
5817526|NCT02629861|20089695|P3|Overall Study|Lost to Follow-up|4
5817527|NCT02629861|20089696|P2|Overall Study|Lost to Follow-up|9
5817528|NCT02629861|20089697|P1|Overall Study|Lost to Follow-up|12
5817529|NCT02629861|20089695|P3|Overall Study|Protocol Violation|7
5817530|NCT02629861|20089696|P2|Overall Study|Protocol Violation|3
5817531|NCT02629861|20089697|P1|Overall Study|Protocol Violation|2
5817532|NCT02629861|20089695|P3|Overall Study|Withdrawal by Subject|13
5817533|NCT02629861|20089696|P2|Overall Study|Withdrawal by Subject|8
5817534|NCT02629861|20089697|P1|Overall Study|Withdrawal by Subject|5
5817535|NCT02629861|20089695|P3|Overall Study|Adverse Event|4
5817536|NCT02629861|20089696|P2|Overall Study|Adverse Event|5
5817537|NCT02629861|20089697|P1|Overall Study|Adverse Event|7
5817538|NCT02629822|20089744|P1|Extension Study|Extension Period is Ongoing|6
5817539|NCT02629822|20089744|P1|Base Study|Non-Compliance With Study Drug|1
5817540|NCT02629822|20089744|P1|Base Study|Lost to Follow-up|2
5817541|NCT02629159|20089786|P3|Overall Study|Other|8
5817542|NCT02629159|20089787|P2|Overall Study|Other|4
5817543|NCT02629159|20089788|P1|Overall Study|Other|6
5817544|NCT02629159|20089786|P3|Overall Study|Lack of Efficacy|1
5817545|NCT02629159|20089787|P2|Overall Study|Lack of Efficacy|0
5817546|NCT02629159|20089788|P1|Overall Study|Lack of Efficacy|4
5817547|NCT02629159|20089786|P3|Overall Study|Lost to Follow-up|5
5817548|NCT02629159|20089787|P2|Overall Study|Lost to Follow-up|4
5817549|NCT02629159|20089788|P1|Overall Study|Lost to Follow-up|7
5817550|NCT02629159|20089786|P3|Overall Study|Withdrawal by Subject|15
5817551|NCT02629159|20089787|P2|Overall Study|Withdrawal by Subject|11
5817552|NCT02629159|20089788|P1|Overall Study|Withdrawal by Subject|22
5817553|NCT02629159|20089786|P3|Overall Study|Adverse Event|22
5817554|NCT02629159|20089787|P2|Overall Study|Adverse Event|20
5817555|NCT02629159|20089788|P1|Overall Study|Adverse Event|17
5817556|NCT02629133|20089840|P2|Overall Study|Withdrawal by Subject|1
5817557|NCT02629133|20089841|P1|Overall Study|Withdrawal by Subject|1
5817558|NCT02629133|20089840|P2|Overall Study|Lost to Follow-up|1
5817559|NCT02629133|20089841|P1|Overall Study|Lost to Follow-up|3
5817560|NCT02628938|20089884|P3|Overall Study|Failure to comply with the instructions|3
5817561|NCT02628938|20089885|P2|Overall Study|Failure to comply with the instructions|0
5817562|NCT02628938|20089886|P1|Overall Study|Failure to comply with the instructions|3
5817563|NCT02628938|20089884|P3|Overall Study|Did not attend the follow up recall|1
5817564|NCT02628938|20089885|P2|Overall Study|Did not attend the follow up recall|2
5817565|NCT02628938|20089886|P1|Overall Study|Did not attend the follow up recall|2
5817566|NCT02628873|20089902|P2|Second Test (1 Hour)|Physician Decision|0
5817567|NCT02628873|20089903|P1|Second Test (1 Hour)|Physician Decision|1
5817568|NCT02628873|20089902|P2|Break (1 Hour)|Withdrawal by Subject|1
5817569|NCT02628873|20089903|P1|Break (1 Hour)|Withdrawal by Subject|0
5817570|NCT02628769|20089913|P2|Second Intervention|Physician Decision|1
5817571|NCT02628769|20089914|P1|Second Intervention|Physician Decision|0
5817572|NCT02628769|20089913|P2|Second Intervention|Adverse Event|0
5817573|NCT02628769|20089914|P1|Second Intervention|Adverse Event|2
5817574|NCT02628769|20089913|P2|First Intervention|Withdrawal by Subject|1
5817575|NCT02628769|20089914|P1|First Intervention|Withdrawal by Subject|0
5817576|NCT02628769|20089913|P2|First Intervention|Adverse Event|0
5817577|NCT02628769|20089914|P1|First Intervention|Adverse Event|1
5817578|NCT02628743|20089952|P1|Overall Study|Physician Decision|2
5817579|NCT02628743|20089952|P1|Overall Study|Study Terminated by Sponsor|76
5817580|NCT02628743|20089952|P1|Overall Study|Withdrawal by Subject|50
5817581|NCT02628743|20089952|P1|Overall Study|Other|3
5817582|NCT02628600|20089978|P2|Overall Study|Other not specified|0
5817583|NCT02628600|20089979|P1|Overall Study|Other not specified|1
5817584|NCT02628600|20089978|P2|Overall Study|Physician Decision|2
5817585|NCT02628600|20089979|P1|Overall Study|Physician Decision|2
5817586|NCT02628600|20089978|P2|Overall Study|Lost to Follow-up|0
5817587|NCT02628600|20089979|P1|Overall Study|Lost to Follow-up|1
5817588|NCT02628600|20089978|P2|Overall Study|Withdrawal by Subject|8
5817589|NCT02628600|20089979|P1|Overall Study|Withdrawal by Subject|13
5817590|NCT02628600|20089978|P2|Overall Study|Lack of Efficacy|0
5817591|NCT02628600|20089979|P1|Overall Study|Lack of Efficacy|2
5817592|NCT02628600|20089978|P2|Overall Study|Protocol Violation|1
5817593|NCT02628600|20089979|P1|Overall Study|Protocol Violation|0
5817594|NCT02628600|20089978|P2|Overall Study|Adverse Event|20
5817595|NCT02628600|20089979|P1|Overall Study|Adverse Event|3
5817596|NCT02628600|20089978|P2|Overall Study|Death|1
5817597|NCT02628600|20089979|P1|Overall Study|Death|2
5817598|NCT02628418|20089993|P2|Overall Study|Lost to Follow-up|2
5817599|NCT02628418|20089994|P1|Overall Study|Lost to Follow-up|1
5817600|NCT02628028|20090104|P8|Long-term Extension (LTE) Period|Other|3
5817601|NCT02628028|20090105|P7|Long-term Extension (LTE) Period|Other|4
5817602|NCT02628028|20090106|P6|Long-term Extension (LTE) Period|Other|3
5817603|NCT02628028|20090107|P5|Long-term Extension (LTE) Period|Other|0
5817604|NCT02628028|20090108|P4|Long-term Extension (LTE) Period|Other|0
5817605|NCT02628028|20090109|P3|Long-term Extension (LTE) Period|Other|0
5817606|NCT02628028|20090110|P2|Long-term Extension (LTE) Period|Other|0
5817607|NCT02628028|20090111|P1|Long-term Extension (LTE) Period|Other|0
5817608|NCT02628028|20090104|P8|Long-term Extension (LTE) Period|Withdrawal by Subject|3
5817609|NCT02628028|20090105|P7|Long-term Extension (LTE) Period|Withdrawal by Subject|3
5817610|NCT02628028|20090106|P6|Long-term Extension (LTE) Period|Withdrawal by Subject|2
5817611|NCT02628028|20090107|P5|Long-term Extension (LTE) Period|Withdrawal by Subject|0
5817612|NCT02628028|20090108|P4|Long-term Extension (LTE) Period|Withdrawal by Subject|0
5817613|NCT02628028|20090109|P3|Long-term Extension (LTE) Period|Withdrawal by Subject|0
5817614|NCT02628028|20090110|P2|Long-term Extension (LTE) Period|Withdrawal by Subject|0
5817615|NCT02628028|20090111|P1|Long-term Extension (LTE) Period|Withdrawal by Subject|0
5817616|NCT02628028|20090104|P8|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51
5817617|NCT02628028|20090105|P7|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51
5817618|NCT02628028|20090106|P6|Long-term Extension (LTE) Period|Study Terminated by Sponsor|52
5817619|NCT02628028|20090107|P5|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0
5817620|NCT02628028|20090108|P4|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0
5817621|NCT02628028|20090109|P3|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0
5817622|NCT02628028|20090110|P2|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0
5817623|NCT02628028|20090111|P1|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0
5817624|NCT02628028|20090104|P8|Long-term Extension (LTE) Period|Lack of Efficacy|1
5817625|NCT02628028|20090105|P7|Long-term Extension (LTE) Period|Lack of Efficacy|0
5817626|NCT02628028|20090106|P6|Long-term Extension (LTE) Period|Lack of Efficacy|2
5817627|NCT02628028|20090107|P5|Long-term Extension (LTE) Period|Lack of Efficacy|0
5817628|NCT02628028|20090108|P4|Long-term Extension (LTE) Period|Lack of Efficacy|0
5817629|NCT02628028|20090109|P3|Long-term Extension (LTE) Period|Lack of Efficacy|0
5817630|NCT02628028|20090110|P2|Long-term Extension (LTE) Period|Lack of Efficacy|0
5817631|NCT02628028|20090111|P1|Long-term Extension (LTE) Period|Lack of Efficacy|0
5817632|NCT02628028|20090104|P8|Long-term Extension (LTE) Period|Adverse Event|3
5817633|NCT02628028|20090105|P7|Long-term Extension (LTE) Period|Adverse Event|0
5817634|NCT02628028|20090106|P6|Long-term Extension (LTE) Period|Adverse Event|1
5817635|NCT02628028|20090107|P5|Long-term Extension (LTE) Period|Adverse Event|0
5817636|NCT02628028|20090108|P4|Long-term Extension (LTE) Period|Adverse Event|0
5817637|NCT02628028|20090109|P3|Long-term Extension (LTE) Period|Adverse Event|0
5817638|NCT02628028|20090110|P2|Long-term Extension (LTE) Period|Adverse Event|0
5817639|NCT02628028|20090111|P1|Long-term Extension (LTE) Period|Adverse Event|0
5817640|NCT02628028|20090104|P8|Dosing Period|Other|4
5817641|NCT02628028|20090105|P7|Dosing Period|Other|2
5817642|NCT02628028|20090106|P6|Dosing Period|Other|1
5817643|NCT02628028|20090107|P5|Dosing Period|Other|2
5817644|NCT02628028|20090108|P4|Dosing Period|Other|0
5817645|NCT02628028|20090109|P3|Dosing Period|Other|0
5817646|NCT02628028|20090110|P2|Dosing Period|Other|0
5817647|NCT02628028|20090111|P1|Dosing Period|Other|0
5817648|NCT02628028|20090104|P8|Dosing Period|Lost to Follow-up|0
5817649|NCT02628028|20090105|P7|Dosing Period|Lost to Follow-up|1
5817650|NCT02628028|20090106|P6|Dosing Period|Lost to Follow-up|0
5817651|NCT02628028|20090107|P5|Dosing Period|Lost to Follow-up|0
5817652|NCT02628028|20090108|P4|Dosing Period|Lost to Follow-up|0
5817653|NCT02628028|20090109|P3|Dosing Period|Lost to Follow-up|0
5817654|NCT02628028|20090110|P2|Dosing Period|Lost to Follow-up|0
5817655|NCT02628028|20090111|P1|Dosing Period|Lost to Follow-up|0
5817656|NCT02628028|20090104|P8|Dosing Period|Site Terminated by Sponsor|0
5817657|NCT02628028|20090105|P7|Dosing Period|Site Terminated by Sponsor|1
5817658|NCT02628028|20090106|P6|Dosing Period|Site Terminated by Sponsor|1
5817659|NCT02628028|20090107|P5|Dosing Period|Site Terminated by Sponsor|0
5817660|NCT02628028|20090108|P4|Dosing Period|Site Terminated by Sponsor|0
5817661|NCT02628028|20090109|P3|Dosing Period|Site Terminated by Sponsor|0
5817662|NCT02628028|20090110|P2|Dosing Period|Site Terminated by Sponsor|0
5817663|NCT02628028|20090111|P1|Dosing Period|Site Terminated by Sponsor|0
5817664|NCT02628028|20090104|P8|Dosing Period|Physician Decision|0
5817665|NCT02628028|20090105|P7|Dosing Period|Physician Decision|0
5817666|NCT02628028|20090106|P6|Dosing Period|Physician Decision|1
5817667|NCT02628028|20090107|P5|Dosing Period|Physician Decision|0
5817668|NCT02628028|20090108|P4|Dosing Period|Physician Decision|0
5817669|NCT02628028|20090109|P3|Dosing Period|Physician Decision|0
5817670|NCT02628028|20090110|P2|Dosing Period|Physician Decision|0
5817671|NCT02628028|20090111|P1|Dosing Period|Physician Decision|0
5817672|NCT02628028|20090104|P8|Dosing Period|Study Terminated by Sponsor|7
5817673|NCT02628028|20090105|P7|Dosing Period|Study Terminated by Sponsor|7
5817674|NCT02628028|20090106|P6|Dosing Period|Study Terminated by Sponsor|6
5817675|NCT02628028|20090107|P5|Dosing Period|Study Terminated by Sponsor|7
5817676|NCT02628028|20090108|P4|Dosing Period|Study Terminated by Sponsor|0
5817677|NCT02628028|20090109|P3|Dosing Period|Study Terminated by Sponsor|0
5817678|NCT02628028|20090110|P2|Dosing Period|Study Terminated by Sponsor|0
5817679|NCT02628028|20090111|P1|Dosing Period|Study Terminated by Sponsor|0
5817680|NCT02628028|20090104|P8|Dosing Period|Lack of Efficacy|0
5817681|NCT02628028|20090105|P7|Dosing Period|Lack of Efficacy|1
5817682|NCT02628028|20090106|P6|Dosing Period|Lack of Efficacy|0
5817683|NCT02628028|20090107|P5|Dosing Period|Lack of Efficacy|3
5817684|NCT02628028|20090108|P4|Dosing Period|Lack of Efficacy|0
5817685|NCT02628028|20090109|P3|Dosing Period|Lack of Efficacy|0
5817686|NCT02628028|20090110|P2|Dosing Period|Lack of Efficacy|0
5817687|NCT02628028|20090111|P1|Dosing Period|Lack of Efficacy|0
5817688|NCT02628028|20090104|P8|Dosing Period|Death|1
5817689|NCT02628028|20090105|P7|Dosing Period|Death|0
5817690|NCT02628028|20090106|P6|Dosing Period|Death|0
5817691|NCT02628028|20090107|P5|Dosing Period|Death|0
5817692|NCT02628028|20090108|P4|Dosing Period|Death|0
5817693|NCT02628028|20090109|P3|Dosing Period|Death|0
5817694|NCT02628028|20090110|P2|Dosing Period|Death|0
5817695|NCT02628028|20090111|P1|Dosing Period|Death|0
5817696|NCT02628028|20090104|P8|Dosing Period|Adverse Event|2
5817697|NCT02628028|20090105|P7|Dosing Period|Adverse Event|3
5817698|NCT02628028|20090106|P6|Dosing Period|Adverse Event|1
5817699|NCT02628028|20090107|P5|Dosing Period|Adverse Event|2
5817700|NCT02628028|20090108|P4|Dosing Period|Adverse Event|0
5817701|NCT02628028|20090109|P3|Dosing Period|Adverse Event|0
5817702|NCT02628028|20090110|P2|Dosing Period|Adverse Event|0
5817703|NCT02628028|20090111|P1|Dosing Period|Adverse Event|0
5817704|NCT02628028|20090104|P8|Dosing Period|Withdrawal by Subject|1
5817705|NCT02628028|20090105|P7|Dosing Period|Withdrawal by Subject|1
5817706|NCT02628028|20090106|P6|Dosing Period|Withdrawal by Subject|4
5817707|NCT02628028|20090107|P5|Dosing Period|Withdrawal by Subject|2
5817708|NCT02628028|20090108|P4|Dosing Period|Withdrawal by Subject|0
5817709|NCT02628028|20090109|P3|Dosing Period|Withdrawal by Subject|1
5817710|NCT02628028|20090110|P2|Dosing Period|Withdrawal by Subject|0
5817711|NCT02628028|20090111|P1|Dosing Period|Withdrawal by Subject|0
5817712|NCT02627144|20090196|P1|Overall Study|Other|17
5817713|NCT02627144|20090196|P1|Overall Study|Enrolled, not treated|6
5817714|NCT02627144|20090196|P1|Overall Study|Lost to Follow-up|8
5817715|NCT02627144|20090196|P1|Overall Study|Administrative reasons|65
5817716|NCT02627144|20090196|P1|Overall Study|Refusal of treatment / poor cooperation|38
5817717|NCT02627144|20090196|P1|Overall Study|Death from other cause|8
5817718|NCT02627144|20090196|P1|Overall Study|Death from cancer|20
5817719|NCT02627144|20090196|P1|Overall Study|Cancer progression|171
5817720|NCT02627144|20090196|P1|Overall Study|Serious adverse event|32
5817721|NCT02626819|20090237|P2|Overall Study|Diagnosed w/ catastrophic illness|1
5817722|NCT02626819|20090238|P1|Overall Study|Diagnosed w/ catastrophic illness|0
5817723|NCT02626819|20090237|P2|Overall Study|Withdrawal by Subject|0
5817724|NCT02626819|20090238|P1|Overall Study|Withdrawal by Subject|1
5817725|NCT02626819|20090237|P2|Overall Study|Lost to Follow-up|2
5817726|NCT02626819|20090238|P1|Overall Study|Lost to Follow-up|3
5817727|NCT02626780|20090258|P1|Overall Study|Withdrawal by Subject|3
5817728|NCT02626520|20090291|P2|Overall Study|Study terminated|1
5817729|NCT02626520|20090292|P1|Overall Study|Study terminated|0
5817730|NCT02626520|20090291|P2|Overall Study|Did not start protocol therapy|2
5817731|NCT02626520|20090292|P1|Overall Study|Did not start protocol therapy|0
5817732|NCT02626520|20090291|P2|Overall Study|Lack of Efficacy|2
5817733|NCT02626520|20090292|P1|Overall Study|Lack of Efficacy|0
5817734|NCT02626520|20090291|P2|Overall Study|Adverse Event|4
5817735|NCT02626520|20090292|P1|Overall Study|Adverse Event|0
5817736|NCT02626520|20090291|P2|Overall Study|Physician Decision|1
5817737|NCT02626520|20090292|P1|Overall Study|Physician Decision|1
5817738|NCT02626182|20090304|P2|Overall Study|Adverse Event|0
5817739|NCT02626182|20090305|P1|Overall Study|Adverse Event|2
5817740|NCT02626026|20090321|P6|Overall Study|Randomized but Never Treated|0
5817741|NCT02626026|20090322|P5|Overall Study|Randomized but Never Treated|1
5817742|NCT02626026|20090323|P4|Overall Study|Randomized but Never Treated|0
5817743|NCT02626026|20090324|P3|Overall Study|Randomized but Never Treated|0
5817744|NCT02626026|20090325|P2|Overall Study|Randomized but Never Treated|0
5817745|NCT02626026|20090326|P1|Overall Study|Randomized but Never Treated|0
5817746|NCT02626000|20090404|P1|Overall Study|Death|23
5817747|NCT02626000|20090404|P1|Overall Study|Continuing Study|13
5817758|NCT02625922|20090529|P2|Overall Study|Systolic blood pressure < 125 mmHg|1
5817759|NCT02625922|20090530|P1|Overall Study|Systolic blood pressure < 125 mmHg|1
5817760|NCT02625922|20090529|P2|Overall Study|Non-availability of IMP|1
5817761|NCT02625922|20090530|P1|Overall Study|Non-availability of IMP|1
5817762|NCT02625623|20090549|P2|Overall Study|Participants randomized but not treated|1
5817763|NCT02625623|20090550|P1|Overall Study|Participants randomized but not treated|9
5817770|NCT02625259|20090638|P5|First Intervention (Day 1)|Withdrawal by Subject|0
5817771|NCT02625259|20090639|P4|First Intervention (Day 1)|Withdrawal by Subject|1
5817772|NCT02625259|20090640|P3|First Intervention (Day 1)|Withdrawal by Subject|0
5817773|NCT02625259|20090641|P2|First Intervention (Day 1)|Withdrawal by Subject|0
5817774|NCT02625259|20090642|P1|First Intervention (Day 1)|Withdrawal by Subject|0
5817775|NCT02625259|20090638|P5|First Intervention (Day 1)|Adverse Event|0
5817776|NCT02625259|20090639|P4|First Intervention (Day 1)|Adverse Event|0
5817777|NCT02625259|20090640|P3|First Intervention (Day 1)|Adverse Event|0
5817778|NCT02625259|20090641|P2|First Intervention (Day 1)|Adverse Event|1
5817779|NCT02625259|20090642|P1|First Intervention (Day 1)|Adverse Event|2
5817780|NCT02625259|20090638|P5|First Intervention (Day 1)|Other|0
5817781|NCT02625259|20090639|P4|First Intervention (Day 1)|Other|0
5817782|NCT02625259|20090640|P3|First Intervention (Day 1)|Other|1
5817783|NCT02625259|20090641|P2|First Intervention (Day 1)|Other|0
5817784|NCT02625259|20090642|P1|First Intervention (Day 1)|Other|0
5817785|NCT02625233|20090679|P2|Overall Study|Adverse Event|0
5817786|NCT02625233|20090680|P1|Overall Study|Adverse Event|2
5817787|NCT02625220|20090688|P1|Overall Study|Study discontinued at site|2
5817788|NCT02625220|20090688|P1|Overall Study|Protocol Violation|1
5817789|NCT02625220|20090688|P1|Overall Study|Lost to Follow-up|2
5817790|NCT02625220|20090688|P1|Overall Study|Adverse Event|2
5817791|NCT02624986|20090816|P8|Overall Study|Withdrawal by Subject|1
5817792|NCT02624986|20090817|P7|Overall Study|Withdrawal by Subject|0
5817793|NCT02624986|20090818|P6|Overall Study|Withdrawal by Subject|0
5817794|NCT02624986|20090819|P5|Overall Study|Withdrawal by Subject|0
5817795|NCT02624986|20090820|P4|Overall Study|Withdrawal by Subject|0
5817796|NCT02624986|20090821|P3|Overall Study|Withdrawal by Subject|0
5817797|NCT02624986|20090822|P2|Overall Study|Withdrawal by Subject|0
5817798|NCT02624986|20090823|P1|Overall Study|Withdrawal by Subject|0
5817799|NCT02624986|20090816|P8|Overall Study|Protocol Violation|0
5817800|NCT02624986|20090817|P7|Overall Study|Protocol Violation|0
5817801|NCT02624986|20090818|P6|Overall Study|Protocol Violation|0
5817802|NCT02624986|20090819|P5|Overall Study|Protocol Violation|0
5817803|NCT02624986|20090820|P4|Overall Study|Protocol Violation|0
5817804|NCT02624986|20090821|P3|Overall Study|Protocol Violation|0
5817805|NCT02624986|20090822|P2|Overall Study|Protocol Violation|0
5817806|NCT02624986|20090823|P1|Overall Study|Protocol Violation|1
5817807|NCT02624986|20090816|P8|Overall Study|Progressive Disease|0
5817808|NCT02624986|20090817|P7|Overall Study|Progressive Disease|0
5817809|NCT02624986|20090818|P6|Overall Study|Progressive Disease|0
5817810|NCT02624986|20090819|P5|Overall Study|Progressive Disease|0
5817811|NCT02624986|20090820|P4|Overall Study|Progressive Disease|0
5817812|NCT02624986|20090821|P3|Overall Study|Progressive Disease|0
5817813|NCT02624986|20090822|P2|Overall Study|Progressive Disease|1
5817814|NCT02624986|20090823|P1|Overall Study|Progressive Disease|0
5817815|NCT02624986|20090816|P8|Overall Study|Study Terminated by Sponsor|3
5817816|NCT02624986|20090817|P7|Overall Study|Study Terminated by Sponsor|4
5817817|NCT02624986|20090818|P6|Overall Study|Study Terminated by Sponsor|2
5817818|NCT02624986|20090819|P5|Overall Study|Study Terminated by Sponsor|2
5817819|NCT02624986|20090820|P4|Overall Study|Study Terminated by Sponsor|1
5817820|NCT02624986|20090821|P3|Overall Study|Study Terminated by Sponsor|0
5817821|NCT02624986|20090822|P2|Overall Study|Study Terminated by Sponsor|1
5817822|NCT02624986|20090823|P1|Overall Study|Study Terminated by Sponsor|1
5817823|NCT02624986|20090816|P8|Overall Study|Death|1
5817824|NCT02624986|20090817|P7|Overall Study|Death|0
5817825|NCT02624986|20090818|P6|Overall Study|Death|0
5817826|NCT02624986|20090819|P5|Overall Study|Death|2
5817827|NCT02624986|20090820|P4|Overall Study|Death|2
5817828|NCT02624986|20090821|P3|Overall Study|Death|2
5817829|NCT02624986|20090822|P2|Overall Study|Death|1
5817830|NCT02624986|20090823|P1|Overall Study|Death|0
5817831|NCT02624791|20091013|P6|Overall Study|Withdrawal by Subject|0
5817832|NCT02624791|20091014|P5|Overall Study|Withdrawal by Subject|0
5817833|NCT02624791|20091015|P4|Overall Study|Withdrawal by Subject|0
5817834|NCT02624791|20091016|P3|Overall Study|Withdrawal by Subject|0
5817835|NCT02624791|20091017|P2|Overall Study|Withdrawal by Subject|0
5817836|NCT02624791|20091018|P1|Overall Study|Withdrawal by Subject|2
5817837|NCT02624713|20091025|P2|Overall Study|Lost to Follow-up|0
5817838|NCT02624713|20091026|P1|Overall Study|Lost to Follow-up|14
5817839|NCT02624687|20091050|P2|Overall Study|medical leave from work|1
5817840|NCT02624687|20091051|P1|Overall Study|medical leave from work|0
5817841|NCT02624687|20091050|P2|Overall Study|Withdrawal by Subject|1
5817842|NCT02624687|20091051|P1|Overall Study|Withdrawal by Subject|1
5817843|NCT02624492|20091082|P3|Overall Study|Progressive disease|3
5817844|NCT02624492|20091083|P2|Overall Study|Progressive disease|2
5817845|NCT02624492|20091084|P1|Overall Study|Progressive disease|0
5817846|NCT02624492|20091082|P3|Overall Study|Adverse Event|2
5817847|NCT02624492|20091083|P2|Overall Study|Adverse Event|2
5817848|NCT02624492|20091084|P1|Overall Study|Adverse Event|2
5817849|NCT02624284|20091119|P3|Overall Study|Adverse Event|1
5817850|NCT02624284|20091120|P2|Overall Study|Adverse Event|0
5817851|NCT02624284|20091121|P1|Overall Study|Adverse Event|0
5817852|NCT02624284|20091119|P3|Overall Study|Revealed exclusionary condition|0
5817853|NCT02624284|20091120|P2|Overall Study|Revealed exclusionary condition|2
5817854|NCT02624284|20091121|P1|Overall Study|Revealed exclusionary condition|2
5817855|NCT02624284|20091119|P3|Overall Study|Protocol Violation|7
5817856|NCT02624284|20091120|P2|Overall Study|Protocol Violation|10
5817857|NCT02624284|20091121|P1|Overall Study|Protocol Violation|9
5817858|NCT02624284|20091119|P3|Overall Study|Withdrawal by Subject|3
5817859|NCT02624284|20091120|P2|Overall Study|Withdrawal by Subject|6
5817860|NCT02624284|20091121|P1|Overall Study|Withdrawal by Subject|3
5817861|NCT02624050|20091140|P2|Overall Study|Protocol Violation|0
5817862|NCT02624050|20091141|P1|Overall Study|Protocol Violation|2
5817863|NCT02624050|20091140|P2|Overall Study|Physician Decision|0
5817864|NCT02624050|20091141|P1|Overall Study|Physician Decision|4
5817865|NCT02623959|20091169|P2|Overall Study|Progression|1
5817866|NCT02623959|20091170|P1|Overall Study|Progression|0
5817867|NCT02623829|20091203|P2|Overall Study|Lost to Follow-up|1
5817868|NCT02623829|20091204|P1|Overall Study|Lost to Follow-up|1
5817869|NCT02623725|20091263|P2|Overall Study|Withdrawal by Subject|1
5817870|NCT02623725|20091264|P1|Overall Study|Withdrawal by Subject|7
5817871|NCT02623725|20091263|P2|Overall Study|Serious adverse event|2
5817872|NCT02623725|20091264|P1|Overall Study|Serious adverse event|0
5817873|NCT02623725|20091263|P2|Overall Study|Non compliance with protocol|3
5817874|NCT02623725|20091264|P1|Overall Study|Non compliance with protocol|9
5817875|NCT02623361|20091298|P2|Overall Study|Withdrawal by Subject|1
5817876|NCT02623361|20091299|P1|Overall Study|Withdrawal by Subject|0
5817877|NCT02623361|20091298|P2|Overall Study|Protocol Violation|1
5817878|NCT02623361|20091299|P1|Overall Study|Protocol Violation|0
5817879|NCT02623335|20091338|P2|Overall Study|Protocol Violation|1
5817880|NCT02623335|20091339|P1|Overall Study|Protocol Violation|2
5817881|NCT02623335|20091338|P2|Overall Study|Withdrawal by Subject|5
5817882|NCT02623335|20091339|P1|Overall Study|Withdrawal by Subject|2
5817883|NCT02623335|20091338|P2|Overall Study|Lost to Follow-up|23
5817884|NCT02623335|20091339|P1|Overall Study|Lost to Follow-up|15
5817885|NCT02623335|20091338|P2|Overall Study|Death|7
5817886|NCT02623335|20091339|P1|Overall Study|Death|8
5817887|NCT02623322|20091366|P3|Overall Study|Lost to Follow-up|0
5817888|NCT02623322|20091367|P2|Overall Study|Lost to Follow-up|1
5817889|NCT02623322|20091368|P1|Overall Study|Lost to Follow-up|2
5817890|NCT02623218|20091406|P5|Overall Study|Lost to Follow-up|0
5817891|NCT02623218|20091407|P4|Overall Study|Lost to Follow-up|0
5817892|NCT02623218|20091408|P3|Overall Study|Lost to Follow-up|0
5817893|NCT02623218|20091409|P2|Overall Study|Lost to Follow-up|1
5817894|NCT02623218|20091410|P1|Overall Study|Lost to Follow-up|0
5817895|NCT02622828|20091432|P1|Overall Study|participant withdrew|3
5817896|NCT02622724|20091439|P2|Overall Study|Early termination of study|43
5817897|NCT02622724|20091440|P1|Overall Study|Early termination of study|38
5817898|NCT02622724|20091439|P2|Overall Study|Lost to Follow-UP, withdrawal of consent|7
5817899|NCT02622724|20091440|P1|Overall Study|Lost to Follow-UP, withdrawal of consent|4
5817900|NCT02622724|20091439|P2|Overall Study|Death|53
5817901|NCT02622724|20091440|P1|Overall Study|Death|51
5817902|NCT02622568|20091518|P2|Overall Study|Lost to Follow-up|5
5817903|NCT02622568|20091519|P1|Overall Study|Lost to Follow-up|5
5817904|NCT02622321|20091529|P4|Overall Study|Withdrawal by Subject|0
5817905|NCT02622321|20091530|P3|Overall Study|Withdrawal by Subject|0
5817906|NCT02622321|20091531|P2|Overall Study|Withdrawal by Subject|0
5817907|NCT02622321|20091532|P1|Overall Study|Withdrawal by Subject|1
5817908|NCT02622321|20091529|P4|Overall Study|Ongoing treatment with emicizumab|7
5817909|NCT02622321|20091530|P3|Overall Study|Ongoing treatment with emicizumab|49
5817910|NCT02622321|20091531|P2|Overall Study|Ongoing treatment with emicizumab|13
5817911|NCT02622321|20091532|P1|Overall Study|Ongoing treatment with emicizumab|31
5817912|NCT02622321|20091529|P4|Overall Study|Ongoing in safety follow-up|0
5817913|NCT02622321|20091530|P3|Overall Study|Ongoing in safety follow-up|0
5817914|NCT02622321|20091531|P2|Overall Study|Ongoing in safety follow-up|0
5817915|NCT02622321|20091532|P1|Overall Study|Ongoing in safety follow-up|3
5817916|NCT02622321|20091529|P4|Overall Study|Ongoing treatment with no emicizumab|0
5817917|NCT02622321|20091530|P3|Overall Study|Ongoing treatment with no emicizumab|0
5817918|NCT02622321|20091531|P2|Overall Study|Ongoing treatment with no emicizumab|5
5817919|NCT02622321|20091532|P1|Overall Study|Ongoing treatment with no emicizumab|0
5817920|NCT02622113|20091603|P2|Overall Study|Stopping Criteria|3
5817921|NCT02622113|20091604|P1|Overall Study|Stopping Criteria|1
5817922|NCT02622113|20091603|P2|Overall Study|Withdrawal by Subject|2
5817923|NCT02622113|20091604|P1|Overall Study|Withdrawal by Subject|0
5817924|NCT02622113|20091603|P2|Overall Study|Physician Decision|1
5817925|NCT02622113|20091604|P1|Overall Study|Physician Decision|0
5817926|NCT02622113|20091603|P2|Overall Study|Adverse Event|4
5817927|NCT02622113|20091604|P1|Overall Study|Adverse Event|4
5817928|NCT02622074|20091622|P6|Overall Study|Withdrawal by Subject|0
5817929|NCT02622074|20091623|P5|Overall Study|Withdrawal by Subject|0
5817930|NCT02622074|20091624|P4|Overall Study|Withdrawal by Subject|0
5817931|NCT02622074|20091625|P3|Overall Study|Withdrawal by Subject|0
5817932|NCT02622074|20091626|P2|Overall Study|Withdrawal by Subject|1
5817933|NCT02622074|20091627|P1|Overall Study|Withdrawal by Subject|0
5817934|NCT02622074|20091622|P6|Overall Study|Death|0
5817935|NCT02622074|20091623|P5|Overall Study|Death|1
5817936|NCT02622074|20091624|P4|Overall Study|Death|1
5817937|NCT02622074|20091625|P3|Overall Study|Death|0
5817938|NCT02622074|20091626|P2|Overall Study|Death|0
5817939|NCT02622074|20091627|P1|Overall Study|Death|4
5817940|NCT02621931|20091731|P3|Overall Study|Other|3
5817941|NCT02621931|20091732|P2|Overall Study|Other|1
5817942|NCT02621931|20091733|P1|Overall Study|Other|1
5817943|NCT02621931|20091731|P3|Overall Study|Lack of Efficacy|1
5817944|NCT02621931|20091732|P2|Overall Study|Lack of Efficacy|0
5817945|NCT02621931|20091733|P1|Overall Study|Lack of Efficacy|0
5817946|NCT02621931|20091731|P3|Overall Study|Lost to Follow-up|10
5817947|NCT02621931|20091732|P2|Overall Study|Lost to Follow-up|7
5817948|NCT02621931|20091733|P1|Overall Study|Lost to Follow-up|8
5817949|NCT02621931|20091731|P3|Overall Study|Noncompliance to study procedures|2
5817950|NCT02621931|20091732|P2|Overall Study|Noncompliance to study procedures|1
5817951|NCT02621931|20091733|P1|Overall Study|Noncompliance to study procedures|0
5817952|NCT02621931|20091731|P3|Overall Study|Pregnancy|0
5817953|NCT02621931|20091732|P2|Overall Study|Pregnancy|0
5817954|NCT02621931|20091733|P1|Overall Study|Pregnancy|2
5817955|NCT02621931|20091731|P3|Overall Study|Protocol Violation|2
5817956|NCT02621931|20091732|P2|Overall Study|Protocol Violation|2
5817957|NCT02621931|20091733|P1|Overall Study|Protocol Violation|2
5817958|NCT02621931|20091731|P3|Overall Study|Withdrawal by Subject|11
5817959|NCT02621931|20091732|P2|Overall Study|Withdrawal by Subject|10
5817960|NCT02621931|20091733|P1|Overall Study|Withdrawal by Subject|12
5817961|NCT02621931|20091731|P3|Overall Study|Adverse Event|7
5817962|NCT02621931|20091732|P2|Overall Study|Adverse Event|5
5817963|NCT02621931|20091733|P1|Overall Study|Adverse Event|8
5817964|NCT02621931|20091731|P3|Overall Study|Death|0
5817965|NCT02621931|20091732|P2|Overall Study|Death|1
5817966|NCT02621931|20091733|P1|Overall Study|Death|0
5817967|NCT02621606|20091815|P3|Overall Study|Withdrawal by Subject|0
5817968|NCT02621606|20091816|P2|Overall Study|Withdrawal by Subject|1
5817969|NCT02621606|20091817|P1|Overall Study|Withdrawal by Subject|0
5817970|NCT02621424|20091845|P2|Overall Study|Withdrawal by Subject|2
5817971|NCT02621424|20091846|P1|Overall Study|Withdrawal by Subject|1
5817972|NCT02621073|20091854|P2|Overall Study|Physician Decision|2
5817973|NCT02621073|20091855|P1|Overall Study|Physician Decision|3
5817974|NCT02621073|20091854|P2|Overall Study|Lost to Follow-up|1
5817975|NCT02621073|20091855|P1|Overall Study|Lost to Follow-up|0
5817976|NCT02621047|20091917|P3|Overall Study|Adverse Event|1
5817977|NCT02621047|20091918|P2|Overall Study|Adverse Event|0
5817978|NCT02621047|20091919|P1|Overall Study|Adverse Event|0
5817979|NCT02621034|20092035|P3|Overall Study|Lost to Follow-up|5
5817980|NCT02621034|20092036|P2|Overall Study|Lost to Follow-up|2
5817981|NCT02621034|20092037|P1|Overall Study|Lost to Follow-up|3
5817982|NCT02620787|20092071|P2|Overall Study|Eligibility Criteria Not Met|0
5817983|NCT02620787|20092072|P1|Overall Study|Eligibility Criteria Not Met|1
5817984|NCT02620787|20092071|P2|Overall Study|Adverse Event|0
5817985|NCT02620787|20092072|P1|Overall Study|Adverse Event|1
5817986|NCT02620384|20092114|P2|Overall Study|Drug shortage prevented 2nd dose|1
5817987|NCT02620384|20092115|P1|Overall Study|Drug shortage prevented 2nd dose|0
5817988|NCT02620384|20092114|P2|Overall Study|Discharged prior to 2nd dose|5
5817989|NCT02620384|20092115|P1|Overall Study|Discharged prior to 2nd dose|2
5817990|NCT02620384|20092114|P2|Overall Study|Adverse Event|1
5817991|NCT02620384|20092115|P1|Overall Study|Adverse Event|2
5817992|NCT02620020|20092147|P4|Overall Study|Death|0
5817993|NCT02620020|20092148|P3|Overall Study|Death|0
5817994|NCT02620020|20092149|P2|Overall Study|Death|1
5817995|NCT02620020|20092150|P1|Overall Study|Death|0
5817996|NCT02620020|20092147|P4|Overall Study|Withdrawal by Subject|12
5817997|NCT02620020|20092148|P3|Overall Study|Withdrawal by Subject|17
5817998|NCT02620020|20092149|P2|Overall Study|Withdrawal by Subject|16
5817999|NCT02620020|20092150|P1|Overall Study|Withdrawal by Subject|20
5818000|NCT02620020|20092147|P4|Overall Study|Protocol Violation|1
5818001|NCT02620020|20092148|P3|Overall Study|Protocol Violation|1
5818002|NCT02620020|20092149|P2|Overall Study|Protocol Violation|2
5818003|NCT02620020|20092150|P1|Overall Study|Protocol Violation|5
5818004|NCT02620020|20092147|P4|Overall Study|Physician Decision|4
5818005|NCT02620020|20092148|P3|Overall Study|Physician Decision|3
5818006|NCT02620020|20092149|P2|Overall Study|Physician Decision|4
5818007|NCT02620020|20092150|P1|Overall Study|Physician Decision|7
5818008|NCT02620020|20092147|P4|Overall Study|Lost to Follow-up|4
5818009|NCT02620020|20092148|P3|Overall Study|Lost to Follow-up|1
5818010|NCT02620020|20092149|P2|Overall Study|Lost to Follow-up|8
5818011|NCT02620020|20092150|P1|Overall Study|Lost to Follow-up|4
5818012|NCT02620020|20092147|P4|Overall Study|Adverse Event|5
5818013|NCT02620020|20092148|P3|Overall Study|Adverse Event|3
5818014|NCT02620020|20092149|P2|Overall Study|Adverse Event|4
5818015|NCT02620020|20092150|P1|Overall Study|Adverse Event|8
5818016|NCT02619812|20092176|P4|Overall Study|Withdrawal by Subject|2
5818017|NCT02619812|20092177|P3|Overall Study|Withdrawal by Subject|1
5818018|NCT02619812|20092178|P2|Overall Study|Withdrawal by Subject|0
5818019|NCT02619812|20092179|P1|Overall Study|Withdrawal by Subject|0
5818020|NCT02619617|20092212|P2|Period 2 SOM230 - 2nd Attack|Physician Decision|3
5818021|NCT02619617|20092213|P1|Period 2 SOM230 - 2nd Attack|Physician Decision|0
5818022|NCT02619617|20092212|P2|Period 2 SOM230 - 2nd Attack|Protocol Violation|1
5818023|NCT02619617|20092213|P1|Period 2 SOM230 - 2nd Attack|Protocol Violation|0
5818024|NCT02619175|20092309|P2|Overall Study|foot pain|0
5818025|NCT02619175|20092310|P1|Overall Study|foot pain|1
5818026|NCT02619175|20092309|P2|Overall Study|Withdrawal by Subject|0
5818027|NCT02619175|20092310|P1|Overall Study|Withdrawal by Subject|1
5818028|NCT02618928|20092324|P1|Overall Study|Treatment Never Started|7
5818029|NCT02618928|20092324|P1|Overall Study|Missing|6
5818030|NCT02618928|20092324|P1|Overall Study|Other|11
5818031|NCT02618928|20092324|P1|Overall Study|Death|3
5818032|NCT02618928|20092324|P1|Overall Study|Withdrawal by Subject|2
5818033|NCT02618928|20092324|P1|Overall Study|Insufficient Virological Response|1
5818034|NCT02618928|20092324|P1|Overall Study|Failure to Return|28
5818035|NCT02618759|20092419|P2|Overall Study|Other Reasons|4
5818036|NCT02618759|20092420|P1|Overall Study|Other Reasons|1
5818037|NCT02618759|20092419|P2|Overall Study|Withdrawal by Subject|0
5818038|NCT02618759|20092420|P1|Overall Study|Withdrawal by Subject|1
5818039|NCT02618759|20092419|P2|Overall Study|Lost to Follow-up|1
5818040|NCT02618759|20092420|P1|Overall Study|Lost to Follow-up|0
5818041|NCT02616900|20092606|P1|Overall Study|Incomplete data|6
5818042|NCT02616900|20092606|P1|Overall Study|Withdrawal by Subject|3
5818043|NCT02616900|20092606|P1|Overall Study|Protocol Violation|5
5818044|NCT02616900|20092606|P1|Overall Study|Lost to Follow-up|2
5818045|NCT02616900|20092606|P1|Overall Study|Lack of Efficacy|7
5818046|NCT02616783|20092614|P2|Overall Study|Withdrew Consent|1
5818047|NCT02616783|20092615|P1|Overall Study|Withdrew Consent|1
5818048|NCT02616783|20092614|P2|Overall Study|Protocol Violation|1
5818049|NCT02616783|20092615|P1|Overall Study|Protocol Violation|1
5818050|NCT02616783|20092614|P2|Overall Study|Non-Compliance with Study Drug|0
5818051|NCT02616783|20092615|P1|Overall Study|Non-Compliance with Study Drug|1
5818052|NCT02616783|20092614|P2|Overall Study|Death|0
5818053|NCT02616783|20092615|P1|Overall Study|Death|1
5818054|NCT02616783|20092614|P2|Overall Study|Adverse Event|0
5818055|NCT02616783|20092615|P1|Overall Study|Adverse Event|1
5818056|NCT02616783|20092614|P2|Overall Study|Randomized but Not Treated|0
5818057|NCT02616783|20092615|P1|Overall Study|Randomized but Not Treated|1
5818058|NCT02616614|20092638|P3|Overall Study|Other|1
5818059|NCT02616614|20092639|P2|Overall Study|Other|2
5818060|NCT02616614|20092640|P1|Overall Study|Other|1
5818061|NCT02616614|20092638|P3|Overall Study|Pregnancy|1
5818062|NCT02616614|20092639|P2|Overall Study|Pregnancy|0
5818063|NCT02616614|20092640|P1|Overall Study|Pregnancy|2
5818064|NCT02616614|20092638|P3|Overall Study|Lost to Follow-up|13
5818065|NCT02616614|20092639|P2|Overall Study|Lost to Follow-up|28
5818066|NCT02616614|20092640|P1|Overall Study|Lost to Follow-up|31
5818067|NCT02616614|20092638|P3|Overall Study|More than 3 applications missed|1
5818068|NCT02616614|20092639|P2|Overall Study|More than 3 applications missed|8
5818069|NCT02616614|20092640|P1|Overall Study|More than 3 applications missed|6
5818070|NCT02616614|20092638|P3|Overall Study|Prohibited Medication|5
5818071|NCT02616614|20092639|P2|Overall Study|Prohibited Medication|9
5818072|NCT02616614|20092640|P1|Overall Study|Prohibited Medication|12
5818073|NCT02616614|20092638|P3|Overall Study|Protocol Violation|1
5818074|NCT02616614|20092639|P2|Overall Study|Protocol Violation|3
5818075|NCT02616614|20092640|P1|Overall Study|Protocol Violation|0
5818076|NCT02616614|20092638|P3|Overall Study|Adverse Event|1
5818077|NCT02616614|20092639|P2|Overall Study|Adverse Event|4
5818078|NCT02616614|20092640|P1|Overall Study|Adverse Event|1
5818079|NCT02616614|20092638|P3|Overall Study|Physician Decision|0
5818080|NCT02616614|20092639|P2|Overall Study|Physician Decision|1
5818081|NCT02616614|20092640|P1|Overall Study|Physician Decision|2
5818082|NCT02616614|20092638|P3|Overall Study|Withdrawal by Subject|6
5818083|NCT02616614|20092639|P2|Overall Study|Withdrawal by Subject|5
5818084|NCT02616614|20092640|P1|Overall Study|Withdrawal by Subject|10
5818085|NCT02616601|20092657|P3|Overall Study|Non-Compliance with Test Article|1
5818086|NCT02616601|20092658|P2|Overall Study|Non-Compliance with Test Article|0
5818087|NCT02616601|20092659|P1|Overall Study|Non-Compliance with Test Article|1
5818088|NCT02616601|20092657|P3|Overall Study|Lost to Follow-up|1
5818089|NCT02616601|20092658|P2|Overall Study|Lost to Follow-up|0
5818090|NCT02616601|20092659|P1|Overall Study|Lost to Follow-up|1
5818091|NCT02616601|20092657|P3|Overall Study|Death|0
5818092|NCT02616601|20092658|P2|Overall Study|Death|0
5818093|NCT02616601|20092659|P1|Overall Study|Death|1
5818094|NCT02616601|20092657|P3|Overall Study|Adverse Event|2
5818095|NCT02616601|20092658|P2|Overall Study|Adverse Event|0
5818096|NCT02616601|20092659|P1|Overall Study|Adverse Event|2
5818097|NCT02616601|20092657|P3|Overall Study|Withdrawal by Subject|3
5818098|NCT02616601|20092658|P2|Overall Study|Withdrawal by Subject|4
5818099|NCT02616601|20092659|P1|Overall Study|Withdrawal by Subject|4
5818100|NCT02616380|20092686|P1|Overall Study|Other|2
5818101|NCT02616380|20092686|P1|Overall Study|Lost to Follow-up|1
5818124|NCT02616029|20092727|P2|Overall Study|Enrolled and Never Treated|1
5818125|NCT02616029|20092728|P1|Overall Study|Enrolled and Never Treated|1
5818126|NCT02616029|20092727|P2|Overall Study|Withdrew Consent|0
5818127|NCT02616029|20092728|P1|Overall Study|Withdrew Consent|1
5818128|NCT02616029|20092727|P2|Overall Study|Protocol Violation|0
5818129|NCT02616029|20092728|P1|Overall Study|Protocol Violation|1
5818130|NCT02616029|20092727|P2|Overall Study|Death|1
5818131|NCT02616029|20092728|P1|Overall Study|Death|0
5818132|NCT02616029|20092727|P2|Overall Study|Adverse Event|0
5818133|NCT02616029|20092728|P1|Overall Study|Adverse Event|1
5818134|NCT02615990|20092799|P2|Overall Study|study terminated|1
5818135|NCT02615990|20092800|P1|Overall Study|study terminated|1
5818136|NCT02615509|20092897|P1|Overall Study|Withdrawal by Subject|8
5818137|NCT02615509|20092897|P1|Overall Study|Death|4
5818138|NCT02615509|20092897|P1|Overall Study|Lost to Follow-up|134
5818139|NCT02615470|20092907|P2|Overall Study|Lost to Follow-up|32
5818140|NCT02615470|20092908|P1|Overall Study|Lost to Follow-up|21
5818141|NCT02615249|20092918|P1|Overall Study|Withdrawal by Subject|1
5818142|NCT02615145|20092959|P4|Overall Study|Other, Not Specified|0
5818143|NCT02615145|20092960|P3|Overall Study|Other, Not Specified|0
5818144|NCT02615145|20092961|P2|Overall Study|Other, Not Specified|2
5818145|NCT02615145|20092962|P1|Overall Study|Other, Not Specified|5
5818146|NCT02615145|20092959|P4|Overall Study|Death|0
5818147|NCT02615145|20092960|P3|Overall Study|Death|0
5818148|NCT02615145|20092961|P2|Overall Study|Death|3
5818149|NCT02615145|20092962|P1|Overall Study|Death|2
5818150|NCT02615145|20092959|P4|Overall Study|Failure to Return|0
5818151|NCT02615145|20092960|P3|Overall Study|Failure to Return|7
5818152|NCT02615145|20092961|P2|Overall Study|Failure to Return|10
5818153|NCT02615145|20092962|P1|Overall Study|Failure to Return|20
5818154|NCT02615145|20092959|P4|Overall Study|Did Not Start Treatment|1
5818155|NCT02615145|20092960|P3|Overall Study|Did Not Start Treatment|1
5818156|NCT02615145|20092961|P2|Overall Study|Did Not Start Treatment|0
5818157|NCT02615145|20092962|P1|Overall Study|Did Not Start Treatment|0
5818158|NCT02614898|20093049|P2|Overall Study|Missing|1
5818159|NCT02614898|20093050|P1|Overall Study|Missing|0
5818160|NCT02614898|20093049|P2|Overall Study|Other-Additional Information Unavailable|11
5818161|NCT02614898|20093050|P1|Overall Study|Other-Additional Information Unavailable|0
5818162|NCT02614898|20093049|P2|Overall Study|Withdrawal by Parent/Guardian|1
5818163|NCT02614898|20093050|P1|Overall Study|Withdrawal by Parent/Guardian|1
5818164|NCT02614898|20093049|P2|Overall Study|Withdrawal by Subject|2
5818165|NCT02614898|20093050|P1|Overall Study|Withdrawal by Subject|0
5818166|NCT02614898|20093049|P2|Overall Study|Study Terminated by Sponsor|0
5818167|NCT02614898|20093050|P1|Overall Study|Study Terminated by Sponsor|3
5818168|NCT02614898|20093049|P2|Overall Study|Physician Decision|8
5818169|NCT02614898|20093050|P1|Overall Study|Physician Decision|1
5818170|NCT02614898|20093049|P2|Overall Study|Lost to Follow-up|2
5818171|NCT02614898|20093050|P1|Overall Study|Lost to Follow-up|0
5818172|NCT02614898|20093049|P2|Overall Study|Participated until study termination|26
5818173|NCT02614898|20093050|P1|Overall Study|Participated until study termination|10
5818174|NCT02614794|20093062|P2|Overall Study|Physician Decision|1
5818175|NCT02614794|20093063|P1|Overall Study|Physician Decision|0
5818176|NCT02614794|20093062|P2|Overall Study|Lost to Follow-up|0
5818177|NCT02614794|20093063|P1|Overall Study|Lost to Follow-up|2
5818178|NCT02614794|20093062|P2|Overall Study|Withdrawal by Subject|5
5818179|NCT02614794|20093063|P1|Overall Study|Withdrawal by Subject|16
5818180|NCT02614794|20093062|P2|Overall Study|Death|84
5818181|NCT02614794|20093063|P1|Overall Study|Death|126
5818182|NCT02614794|20093062|P2|Overall Study|In long term follow up|85
5818183|NCT02614794|20093063|P1|Overall Study|In long term follow up|148
5818184|NCT02614794|20093062|P2|Overall Study|On treatment|27
5818185|NCT02614794|20093063|P1|Overall Study|On treatment|118
5818186|NCT02614729|20093097|P2|Overall Study|Withdrawal by Subject|0
5818187|NCT02614729|20093098|P1|Overall Study|Withdrawal by Subject|1
5818188|NCT02614703|20093118|P2|Overall Study|Withdrawal by Subject|1
5818189|NCT02614703|20093119|P1|Overall Study|Withdrawal by Subject|7
5818190|NCT02614560|20093163|P2|Overall Study|Death|2
5818191|NCT02614560|20093164|P1|Overall Study|Death|6
5818192|NCT02614287|20093212|P2|Post Treatment Follow-up Phase|Withdrawal by Subject|3
5818193|NCT02614287|20093213|P1|Post Treatment Follow-up Phase|Withdrawal by Subject|6
5818194|NCT02614287|20093212|P2|Post Treatment Follow-up Phase|Lost to Follow-up|2
5818195|NCT02614287|20093213|P1|Post Treatment Follow-up Phase|Lost to Follow-up|2
5818196|NCT02614287|20093212|P2|Post Treatment Follow-up Phase|Adverse Event|0
5818197|NCT02614287|20093213|P1|Post Treatment Follow-up Phase|Adverse Event|1
5818198|NCT02614287|20093212|P2|Open Label (OL) Treatment Phase|Withdrawal by Subject|7
5818199|NCT02614287|20093213|P1|Open Label (OL) Treatment Phase|Withdrawal by Subject|10
5818200|NCT02614287|20093212|P2|Open Label (OL) Treatment Phase|Physician Decision|0
5818201|NCT02614287|20093213|P1|Open Label (OL) Treatment Phase|Physician Decision|1
5818202|NCT02614287|20093212|P2|Open Label (OL) Treatment Phase|Lost to Follow-up|4
5818203|NCT02614287|20093213|P1|Open Label (OL) Treatment Phase|Lost to Follow-up|7
5818204|NCT02614287|20093212|P2|Open Label (OL) Treatment Phase|Lack of Efficacy|5
5818205|NCT02614287|20093213|P1|Open Label (OL) Treatment Phase|Lack of Efficacy|13
5818206|NCT02614287|20093212|P2|Open Label (OL) Treatment Phase|Adverse Event|6
5818207|NCT02614287|20093213|P1|Open Label (OL) Treatment Phase|Adverse Event|7
5818208|NCT02614261|20093259|P3|Overall Study|Withdrawal by Subject|7
5818209|NCT02614261|20093260|P2|Overall Study|Withdrawal by Subject|4
5818210|NCT02614261|20093261|P1|Overall Study|Withdrawal by Subject|19
5818211|NCT02614261|20093259|P3|Overall Study|Protocol Violation|0
5818212|NCT02614261|20093260|P2|Overall Study|Protocol Violation|1
5818213|NCT02614261|20093261|P1|Overall Study|Protocol Violation|6
5818214|NCT02614261|20093259|P3|Overall Study|Pregnancy|0
5818215|NCT02614261|20093260|P2|Overall Study|Pregnancy|2
5818216|NCT02614261|20093261|P1|Overall Study|Pregnancy|2
5818217|NCT02614261|20093259|P3|Overall Study|Physician Decision|1
5818218|NCT02614261|20093260|P2|Overall Study|Physician Decision|1
5818219|NCT02614261|20093261|P1|Overall Study|Physician Decision|2
5818220|NCT02614261|20093259|P3|Overall Study|Lost to Follow-up|1
5818221|NCT02614261|20093260|P2|Overall Study|Lost to Follow-up|4
5818222|NCT02614261|20093261|P1|Overall Study|Lost to Follow-up|10
5818223|NCT02614261|20093259|P3|Overall Study|Lack of Efficacy|0
5818224|NCT02614261|20093260|P2|Overall Study|Lack of Efficacy|0
5818225|NCT02614261|20093261|P1|Overall Study|Lack of Efficacy|4
5818226|NCT02614261|20093259|P3|Overall Study|Adverse Event|2
5818227|NCT02614261|20093260|P2|Overall Study|Adverse Event|3
5818228|NCT02614261|20093261|P1|Overall Study|Adverse Event|6
5818229|NCT02614196|20093327|P6|Post Treatment Follow-up Phase|Withdrawal by Subject|0
5818230|NCT02614196|20093328|P5|Post Treatment Follow-up Phase|Withdrawal by Subject|0
5818231|NCT02614196|20093329|P4|Post Treatment Follow-up Phase|Withdrawal by Subject|1
5818232|NCT02614196|20093330|P3|Post Treatment Follow-up Phase|Withdrawal by Subject|5
5818233|NCT02614196|20093331|P2|Post Treatment Follow-up Phase|Withdrawal by Subject|1
5818234|NCT02614196|20093332|P1|Post Treatment Follow-up Phase|Withdrawal by Subject|10
5818235|NCT02614196|20093327|P6|Post Treatment Follow-up Phase|Protocol Violation|0
5818236|NCT02614196|20093328|P5|Post Treatment Follow-up Phase|Protocol Violation|1
5818237|NCT02614196|20093329|P4|Post Treatment Follow-up Phase|Protocol Violation|0
5818238|NCT02614196|20093330|P3|Post Treatment Follow-up Phase|Protocol Violation|0
5818239|NCT02614196|20093331|P2|Post Treatment Follow-up Phase|Protocol Violation|1
5818240|NCT02614196|20093332|P1|Post Treatment Follow-up Phase|Protocol Violation|0
5818241|NCT02614196|20093327|P6|Post Treatment Follow-up Phase|Pregnancy|0
5818242|NCT02614196|20093328|P5|Post Treatment Follow-up Phase|Pregnancy|0
5818243|NCT02614196|20093329|P4|Post Treatment Follow-up Phase|Pregnancy|0
5818244|NCT02614196|20093330|P3|Post Treatment Follow-up Phase|Pregnancy|0
5818245|NCT02614196|20093331|P2|Post Treatment Follow-up Phase|Pregnancy|0
5818246|NCT02614196|20093332|P1|Post Treatment Follow-up Phase|Pregnancy|2
5818247|NCT02614196|20093327|P6|Post Treatment Follow-up Phase|Lost to Follow-up|0
5818248|NCT02614196|20093328|P5|Post Treatment Follow-up Phase|Lost to Follow-up|1
5818249|NCT02614196|20093329|P4|Post Treatment Follow-up Phase|Lost to Follow-up|0
5818250|NCT02614196|20093330|P3|Post Treatment Follow-up Phase|Lost to Follow-up|3
5818251|NCT02614196|20093331|P2|Post Treatment Follow-up Phase|Lost to Follow-up|3
5818252|NCT02614196|20093332|P1|Post Treatment Follow-up Phase|Lost to Follow-up|8
5818253|NCT02614196|20093327|P6|Double Blind Treatment Phase|Did not receive study drug|0
5818254|NCT02614196|20093328|P5|Double Blind Treatment Phase|Did not receive study drug|0
5818255|NCT02614196|20093329|P4|Double Blind Treatment Phase|Did not receive study drug|0
5818256|NCT02614196|20093330|P3|Double Blind Treatment Phase|Did not receive study drug|3
5818257|NCT02614196|20093331|P2|Double Blind Treatment Phase|Did not receive study drug|2
5818258|NCT02614196|20093332|P1|Double Blind Treatment Phase|Did not receive study drug|2
5818259|NCT02614196|20093327|P6|Double Blind Treatment Phase|Withdrawal by Subject|0
5818260|NCT02614196|20093328|P5|Double Blind Treatment Phase|Withdrawal by Subject|0
5818261|NCT02614196|20093329|P4|Double Blind Treatment Phase|Withdrawal by Subject|4
5818262|NCT02614196|20093330|P3|Double Blind Treatment Phase|Withdrawal by Subject|14
5818263|NCT02614196|20093331|P2|Double Blind Treatment Phase|Withdrawal by Subject|11
5818264|NCT02614196|20093332|P1|Double Blind Treatment Phase|Withdrawal by Subject|39
5818265|NCT02614196|20093327|P6|Double Blind Treatment Phase|Terminated by sponsor|0
5818266|NCT02614196|20093328|P5|Double Blind Treatment Phase|Terminated by sponsor|0
5818267|NCT02614196|20093329|P4|Double Blind Treatment Phase|Terminated by sponsor|0
5818268|NCT02614196|20093330|P3|Double Blind Treatment Phase|Terminated by sponsor|0
5818269|NCT02614196|20093331|P2|Double Blind Treatment Phase|Terminated by sponsor|0
5818270|NCT02614196|20093332|P1|Double Blind Treatment Phase|Terminated by sponsor|1
5818271|NCT02614196|20093327|P6|Double Blind Treatment Phase|Protocol Violation|0
5818272|NCT02614196|20093328|P5|Double Blind Treatment Phase|Protocol Violation|1
5818273|NCT02614196|20093329|P4|Double Blind Treatment Phase|Protocol Violation|0
5818274|NCT02614196|20093330|P3|Double Blind Treatment Phase|Protocol Violation|1
5818275|NCT02614196|20093331|P2|Double Blind Treatment Phase|Protocol Violation|2
5818276|NCT02614196|20093332|P1|Double Blind Treatment Phase|Protocol Violation|5
5818277|NCT02614196|20093327|P6|Double Blind Treatment Phase|Pregnancy|0
5818278|NCT02614196|20093328|P5|Double Blind Treatment Phase|Pregnancy|0
5818279|NCT02614196|20093329|P4|Double Blind Treatment Phase|Pregnancy|0
5818280|NCT02614196|20093330|P3|Double Blind Treatment Phase|Pregnancy|0
5818281|NCT02614196|20093331|P2|Double Blind Treatment Phase|Pregnancy|2
5818282|NCT02614196|20093332|P1|Double Blind Treatment Phase|Pregnancy|1
5818283|NCT02614196|20093327|P6|Double Blind Treatment Phase|Physician Decision|0
5818284|NCT02614196|20093328|P5|Double Blind Treatment Phase|Physician Decision|0
5818285|NCT02614196|20093329|P4|Double Blind Treatment Phase|Physician Decision|0
5818286|NCT02614196|20093330|P3|Double Blind Treatment Phase|Physician Decision|2
5818287|NCT02614196|20093331|P2|Double Blind Treatment Phase|Physician Decision|0
5818288|NCT02614196|20093332|P1|Double Blind Treatment Phase|Physician Decision|4
5818289|NCT02614196|20093327|P6|Double Blind Treatment Phase|Lost to Follow-up|0
5818290|NCT02614196|20093328|P5|Double Blind Treatment Phase|Lost to Follow-up|0
5818291|NCT02614196|20093329|P4|Double Blind Treatment Phase|Lost to Follow-up|0
5818292|NCT02614196|20093330|P3|Double Blind Treatment Phase|Lost to Follow-up|1
5818293|NCT02614196|20093331|P2|Double Blind Treatment Phase|Lost to Follow-up|7
5818294|NCT02614196|20093332|P1|Double Blind Treatment Phase|Lost to Follow-up|10
5818295|NCT02614196|20093327|P6|Double Blind Treatment Phase|Lack of Efficacy|0
5818296|NCT02614196|20093328|P5|Double Blind Treatment Phase|Lack of Efficacy|0
5818297|NCT02614196|20093329|P4|Double Blind Treatment Phase|Lack of Efficacy|0
5818298|NCT02614196|20093330|P3|Double Blind Treatment Phase|Lack of Efficacy|1
5818299|NCT02614196|20093331|P2|Double Blind Treatment Phase|Lack of Efficacy|1
5818300|NCT02614196|20093332|P1|Double Blind Treatment Phase|Lack of Efficacy|6
5818301|NCT02614196|20093327|P6|Double Blind Treatment Phase|Adverse Event|0
5818302|NCT02614196|20093328|P5|Double Blind Treatment Phase|Adverse Event|0
5818303|NCT02614196|20093329|P4|Double Blind Treatment Phase|Adverse Event|0
5818304|NCT02614196|20093330|P3|Double Blind Treatment Phase|Adverse Event|9
5818305|NCT02614196|20093331|P2|Double Blind Treatment Phase|Adverse Event|5
5818306|NCT02614196|20093332|P1|Double Blind Treatment Phase|Adverse Event|8
5818307|NCT02614183|20093378|P3|Post Treatment Follow-up Phase|Withdrawal by Subject|5
5818308|NCT02614183|20093379|P2|Post Treatment Follow-up Phase|Withdrawal by Subject|2
5818309|NCT02614183|20093380|P1|Post Treatment Follow-up Phase|Withdrawal by Subject|7
5818310|NCT02614183|20093378|P3|Post Treatment Follow-up Phase|Protocol Violation|0
5818311|NCT02614183|20093379|P2|Post Treatment Follow-up Phase|Protocol Violation|0
5818312|NCT02614183|20093380|P1|Post Treatment Follow-up Phase|Protocol Violation|1
5818313|NCT02614183|20093378|P3|Post Treatment Follow-up Phase|Physician Decision|2
5818314|NCT02614183|20093379|P2|Post Treatment Follow-up Phase|Physician Decision|1
5818315|NCT02614183|20093380|P1|Post Treatment Follow-up Phase|Physician Decision|5
5818316|NCT02614183|20093378|P3|Post Treatment Follow-up Phase|Lost to Follow-up|5
5818317|NCT02614183|20093379|P2|Post Treatment Follow-up Phase|Lost to Follow-up|3
5818318|NCT02614183|20093380|P1|Post Treatment Follow-up Phase|Lost to Follow-up|5
5818319|NCT02614183|20093378|P3|Double Blind Treatment Phase|Did not receive study drug|2
5818320|NCT02614183|20093379|P2|Double Blind Treatment Phase|Did not receive study drug|1
5818321|NCT02614183|20093380|P1|Double Blind Treatment Phase|Did not receive study drug|1
5818322|NCT02614183|20093378|P3|Double Blind Treatment Phase|Withdrawal by Subject|16
5818323|NCT02614183|20093379|P2|Double Blind Treatment Phase|Withdrawal by Subject|11
5818324|NCT02614183|20093380|P1|Double Blind Treatment Phase|Withdrawal by Subject|33
5818325|NCT02614183|20093378|P3|Double Blind Treatment Phase|Protocol Violation|2
5818326|NCT02614183|20093379|P2|Double Blind Treatment Phase|Protocol Violation|2
5818327|NCT02614183|20093380|P1|Double Blind Treatment Phase|Protocol Violation|2
5818328|NCT02614183|20093378|P3|Double Blind Treatment Phase|Pregnancy|3
5818329|NCT02614183|20093379|P2|Double Blind Treatment Phase|Pregnancy|1
5818330|NCT02614183|20093380|P1|Double Blind Treatment Phase|Pregnancy|2
5818331|NCT02614183|20093378|P3|Double Blind Treatment Phase|Physician Decision|2
5818332|NCT02614183|20093379|P2|Double Blind Treatment Phase|Physician Decision|3
5818333|NCT02614183|20093380|P1|Double Blind Treatment Phase|Physician Decision|7
5818334|NCT02614183|20093378|P3|Double Blind Treatment Phase|Lost to Follow-up|5
5818335|NCT02614183|20093379|P2|Double Blind Treatment Phase|Lost to Follow-up|9
5818336|NCT02614183|20093380|P1|Double Blind Treatment Phase|Lost to Follow-up|18
5818337|NCT02614183|20093378|P3|Double Blind Treatment Phase|Lack of Efficacy|2
5818338|NCT02614183|20093379|P2|Double Blind Treatment Phase|Lack of Efficacy|1
5818339|NCT02614183|20093380|P1|Double Blind Treatment Phase|Lack of Efficacy|10
5818340|NCT02614183|20093378|P3|Double Blind Treatment Phase|Adverse Event|7
5818341|NCT02614183|20093379|P2|Double Blind Treatment Phase|Adverse Event|9
5818342|NCT02614183|20093380|P1|Double Blind Treatment Phase|Adverse Event|10
5818343|NCT02614131|20093424|P7|Overall Study|Adverse Event|1
5818344|NCT02614131|20093425|P6|Overall Study|Adverse Event|0
5818345|NCT02614131|20093426|P5|Overall Study|Adverse Event|0
5818346|NCT02614131|20093427|P4|Overall Study|Adverse Event|0
5818347|NCT02614131|20093428|P3|Overall Study|Adverse Event|0
5818348|NCT02614131|20093429|P2|Overall Study|Adverse Event|0
5818349|NCT02614131|20093430|P1|Overall Study|Adverse Event|0
5818350|NCT02614131|20093424|P7|Overall Study|Withdrawal by Subject|0
5818351|NCT02614131|20093425|P6|Overall Study|Withdrawal by Subject|0
5818352|NCT02614131|20093426|P5|Overall Study|Withdrawal by Subject|0
5818353|NCT02614131|20093427|P4|Overall Study|Withdrawal by Subject|0
5818354|NCT02614131|20093428|P3|Overall Study|Withdrawal by Subject|0
5818355|NCT02614131|20093429|P2|Overall Study|Withdrawal by Subject|0
5818356|NCT02614131|20093430|P1|Overall Study|Withdrawal by Subject|1
5818357|NCT02614079|20093461|P1|Overall Study|Withdrawal by Subject|1
5818358|NCT02613910|20093465|P1|Overall Study|Termination of study|1
5818359|NCT02613871|20093551|P1|Overall Study|Withdrew Consent|1
5818360|NCT02613871|20093551|P1|Overall Study|Death|2
5818361|NCT02613572|20093573|P3|Phase II: Double-Blind Rand Plac Control|Death|0
5818362|NCT02613572|20093574|P2|Phase II: Double-Blind Rand Plac Control|Death|1
5818363|NCT02613572|20093575|P1|Phase II: Double-Blind Rand Plac Control|Death|0
5818364|NCT02613572|20093573|P3|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|0
5818365|NCT02613572|20093574|P2|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|0
5818366|NCT02613572|20093575|P1|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|1
5818367|NCT02613507|20093597|P2|Overall Study|Randomized but not Treated|10
5818368|NCT02613507|20093598|P1|Overall Study|Randomized but not Treated|1
5818369|NCT02613507|20093597|P2|Overall Study|Subject no Longer Meets Study Criteria|0
5818370|NCT02613507|20093598|P1|Overall Study|Subject no Longer Meets Study Criteria|1
5818371|NCT02613507|20093597|P2|Overall Study|Brain Radiotherapy Activity Limited|0
5818372|NCT02613507|20093598|P1|Overall Study|Brain Radiotherapy Activity Limited|1
5818373|NCT02613507|20093597|P2|Overall Study|Maximum Clinical Benefit|10
5818374|NCT02613507|20093598|P1|Overall Study|Maximum Clinical Benefit|4
5818375|NCT02613507|20093597|P2|Overall Study|Lost to Follow-up|0
5818376|NCT02613507|20093598|P1|Overall Study|Lost to Follow-up|1
5818377|NCT02613507|20093597|P2|Overall Study|Participant Withdrew Consent|2
5818378|NCT02613507|20093598|P1|Overall Study|Participant Withdrew Consent|0
5818379|NCT02613507|20093597|P2|Overall Study|Request to Discontinue Study Treatment|17
5818380|NCT02613507|20093598|P1|Overall Study|Request to Discontinue Study Treatment|8
5818381|NCT02613507|20093597|P2|Overall Study|Adverse Event Unrelated to Study Drug|2
5818382|NCT02613507|20093598|P1|Overall Study|Adverse Event Unrelated to Study Drug|17
5818383|NCT02613507|20093597|P2|Overall Study|Death|0
5818384|NCT02613507|20093598|P1|Overall Study|Death|3
5818385|NCT02613507|20093597|P2|Overall Study|Study Drug Toxicity|14
5818386|NCT02613507|20093598|P1|Overall Study|Study Drug Toxicity|15
5818387|NCT02613507|20093597|P2|Overall Study|Disease Progression|109
5818388|NCT02613507|20093598|P1|Overall Study|Disease Progression|237
5818389|NCT02613481|20093614|P1|Overall Study|Withdrawal by Subject|2
5818390|NCT02613481|20093614|P1|Overall Study|Lost to Follow-up|7
5818391|NCT02613403|20093625|P5|Overall Study|Withdrawal by Subject|0
5818392|NCT02613403|20093626|P4|Overall Study|Withdrawal by Subject|0
5818393|NCT02613403|20093627|P3|Overall Study|Withdrawal by Subject|0
5818394|NCT02613403|20093628|P2|Overall Study|Withdrawal by Subject|0
5818395|NCT02613403|20093629|P1|Overall Study|Withdrawal by Subject|2
5818396|NCT02613403|20093625|P5|Overall Study|Lost to Follow-up|0
5818397|NCT02613403|20093626|P4|Overall Study|Lost to Follow-up|0
5818398|NCT02613403|20093627|P3|Overall Study|Lost to Follow-up|0
5818399|NCT02613403|20093628|P2|Overall Study|Lost to Follow-up|1
5818400|NCT02613403|20093629|P1|Overall Study|Lost to Follow-up|0
5818401|NCT02613221|20093681|P1|Overall Study|Enrolled but Not Treated|1
5818402|NCT02613221|20093681|P1|Overall Study|Delayed Treatment|1
5818403|NCT02613221|20093681|P1|Overall Study|Voluntary Discontinuation|1
5818404|NCT02613221|20093681|P1|Overall Study|Adverse Event|2
5818405|NCT02613221|20093681|P1|Overall Study|Lack of efficacy (exacerbation)|50
5818406|NCT02613208|20093693|P1|Overall Study|Death|37
5818407|NCT02613208|20093693|P1|Overall Study|Lost to Follow-up|5
5818408|NCT02613208|20093693|P1|Overall Study|Physician Decision|2
5818409|NCT02613208|20093693|P1|Overall Study|Change of address|2
5818410|NCT02613208|20093693|P1|Overall Study|Withdrawal by Subject|1
5818411|NCT02613182|20093707|P1|Overall Study|Withdrawal by Subject|6
5818412|NCT02613182|20093707|P1|Overall Study|Study Terminated by Sponsor|21
5818413|NCT02613182|20093707|P1|Overall Study|Physician Decision|1
5818414|NCT02613182|20093707|P1|Overall Study|Death|6
5818415|NCT02612909|20093729|P5|Phase 3|Withdrawal by Subject|0
5818416|NCT02612909|20093730|P4|Phase 3|Withdrawal by Subject|1
5818417|NCT02612909|20093731|P3|Phase 3|Withdrawal by Subject|0
5818418|NCT02612909|20093732|P2|Phase 3|Withdrawal by Subject|0
5818419|NCT02612909|20093733|P1|Phase 3|Withdrawal by Subject|0
5818420|NCT02612909|20093729|P5|Phase 2|Pregnancy|0
5818421|NCT02612909|20093730|P4|Phase 2|Pregnancy|0
5818422|NCT02612909|20093731|P3|Phase 2|Pregnancy|1
5818423|NCT02612909|20093732|P2|Phase 2|Pregnancy|0
5818424|NCT02612909|20093733|P1|Phase 2|Pregnancy|0
5818425|NCT02612909|20093729|P5|Phase 2|Withdrawal by Subject|0
5818426|NCT02612909|20093730|P4|Phase 2|Withdrawal by Subject|0
5818427|NCT02612909|20093731|P3|Phase 2|Withdrawal by Subject|0
5818428|NCT02612909|20093732|P2|Phase 2|Withdrawal by Subject|5
5818429|NCT02612909|20093733|P1|Phase 2|Withdrawal by Subject|2
5818430|NCT02612779|20093816|P2|Overall Study|Subsequent therapy|0
5818431|NCT02612779|20093817|P1|Overall Study|Subsequent therapy|3
5818432|NCT02612779|20093816|P2|Overall Study|Principal Investigator decision|0
5818433|NCT02612779|20093817|P1|Overall Study|Principal Investigator decision|2
5818434|NCT02612779|20093816|P2|Overall Study|Maximum clinical benefit|1
5818435|NCT02612779|20093817|P1|Overall Study|Maximum clinical benefit|10
5818436|NCT02612779|20093816|P2|Overall Study|Lost to Follow-up|0
5818437|NCT02612779|20093817|P1|Overall Study|Lost to Follow-up|1
5818438|NCT02612779|20093816|P2|Overall Study|Participant withdrew consent|0
5818439|NCT02612779|20093817|P1|Overall Study|Participant withdrew consent|4
5818440|NCT02612779|20093816|P2|Overall Study|Adverse event unrelated to study drug|0
5818441|NCT02612779|20093817|P1|Overall Study|Adverse event unrelated to study drug|5
5818442|NCT02612779|20093816|P2|Overall Study|Death|0
5818443|NCT02612779|20093817|P1|Overall Study|Death|1
5818444|NCT02612779|20093816|P2|Overall Study|Study drug toxicity|0
5818445|NCT02612779|20093817|P1|Overall Study|Study drug toxicity|9
5818446|NCT02612779|20093816|P2|Overall Study|Disease progression|2
5818447|NCT02612779|20093817|P1|Overall Study|Disease progression|29
5818448|NCT02612779|20093816|P2|Overall Study|No longer meet study criteria|1
5818449|NCT02612779|20093817|P1|Overall Study|No longer meet study criteria|0
5818450|NCT02612779|20093816|P2|Overall Study|Administrative reason by sponsor|1
5818451|NCT02612779|20093817|P1|Overall Study|Administrative reason by sponsor|0
5818452|NCT02612727|20093829|P2|Overall Study|Direct hyperbilirubinemia|2
5818453|NCT02612727|20093830|P1|Overall Study|Direct hyperbilirubinemia|0
5818454|NCT02612727|20093829|P2|Overall Study|Needed treatment incompatible with PT|1
5818455|NCT02612727|20093830|P1|Overall Study|Needed treatment incompatible with PT|1
5818456|NCT02612727|20093829|P2|Overall Study|Parent request|1
5818457|NCT02612727|20093830|P1|Overall Study|Parent request|4
5818458|NCT02612623|20093889|P4|Overall Study|Adverse Event|0
5818459|NCT02612623|20093890|P3|Overall Study|Adverse Event|1
5818460|NCT02612623|20093891|P2|Overall Study|Adverse Event|0
5818461|NCT02612623|20093892|P1|Overall Study|Adverse Event|1
5818462|NCT02612623|20093889|P4|Overall Study|Withdrawal by Subject|0
5818463|NCT02612623|20093890|P3|Overall Study|Withdrawal by Subject|0
5818464|NCT02612623|20093891|P2|Overall Study|Withdrawal by Subject|1
5818465|NCT02612623|20093892|P1|Overall Study|Withdrawal by Subject|0
5818466|NCT02612610|20093906|P4|Overall Study|Cough Improvement|0
5818467|NCT02612610|20093907|P3|Overall Study|Cough Improvement|1
5818468|NCT02612610|20093908|P2|Overall Study|Cough Improvement|0
5818469|NCT02612610|20093909|P1|Overall Study|Cough Improvement|0
5818470|NCT02612610|20093906|P4|Overall Study|Noncompliance|0
5818471|NCT02612610|20093907|P3|Overall Study|Noncompliance|0
5818472|NCT02612610|20093908|P2|Overall Study|Noncompliance|0
5818473|NCT02612610|20093909|P1|Overall Study|Noncompliance|1
5818474|NCT02612610|20093906|P4|Overall Study|Physician Decision|0
5818475|NCT02612610|20093907|P3|Overall Study|Physician Decision|0
5818476|NCT02612610|20093908|P2|Overall Study|Physician Decision|1
5818477|NCT02612610|20093909|P1|Overall Study|Physician Decision|0
5818478|NCT02612610|20093906|P4|Overall Study|Lack of Efficacy|1
5818479|NCT02612610|20093907|P3|Overall Study|Lack of Efficacy|0
5818480|NCT02612610|20093908|P2|Overall Study|Lack of Efficacy|2
5818481|NCT02612610|20093909|P1|Overall Study|Lack of Efficacy|1
5818482|NCT02612610|20093906|P4|Overall Study|Protocol Violation|0
5818483|NCT02612610|20093907|P3|Overall Study|Protocol Violation|1
5818484|NCT02612610|20093908|P2|Overall Study|Protocol Violation|1
5818485|NCT02612610|20093909|P1|Overall Study|Protocol Violation|0
5818486|NCT02612610|20093906|P4|Overall Study|Lost to Follow-up|0
5818487|NCT02612610|20093907|P3|Overall Study|Lost to Follow-up|0
5818488|NCT02612610|20093908|P2|Overall Study|Lost to Follow-up|1
5818489|NCT02612610|20093909|P1|Overall Study|Lost to Follow-up|0
5818490|NCT02612610|20093906|P4|Overall Study|Adverse Event|10
5818491|NCT02612610|20093907|P3|Overall Study|Adverse Event|3
5818492|NCT02612610|20093908|P2|Overall Study|Adverse Event|2
5818493|NCT02612610|20093909|P1|Overall Study|Adverse Event|2
5818494|NCT02612610|20093906|P4|Overall Study|Withdrawal by Subject|2
5818495|NCT02612610|20093907|P3|Overall Study|Withdrawal by Subject|0
5818496|NCT02612610|20093908|P2|Overall Study|Withdrawal by Subject|1
5818497|NCT02612610|20093909|P1|Overall Study|Withdrawal by Subject|1
5818498|NCT02612428|20094153|P2|VTL-308E|Lost to Follow-up|0
5818499|NCT02612428|20094154|P1|VTL-308E|Lost to Follow-up|2
5818500|NCT02612428|20094153|P2|VTL-308E|Death|7
5818501|NCT02612428|20094154|P1|VTL-308E|Death|9
5818502|NCT02612428|20094153|P2|VTL-308|Withdrawal by Subject|1
5818503|NCT02612428|20094154|P1|VTL-308|Withdrawal by Subject|0
5818504|NCT02612428|20094153|P2|VTL-308|Death|16
5818505|NCT02612428|20094154|P1|VTL-308|Death|14
5818506|NCT02612285|20094164|P1|Overall Study|Withdrawal by Subject|1
5818507|NCT02612155|20094170|P2|Overall Study|Lost to Follow-up|2
5818508|NCT02612155|20094171|P1|Overall Study|Lost to Follow-up|2
5818509|NCT02612155|20094170|P2|Overall Study|Death|1
5818510|NCT02612155|20094171|P1|Overall Study|Death|1
5818511|NCT02612077|20094191|P1|Overall Study|Unknown reason|2
5818512|NCT02612077|20094191|P1|Overall Study|Disease Progression|3
5818513|NCT02612077|20094191|P1|Overall Study|Enrollment in a Clinical Trial|1
5818514|NCT02612077|20094191|P1|Overall Study|Moved or Changed Medical Team|23
5818515|NCT02612077|20094191|P1|Overall Study|Death|377
5818516|NCT02612077|20094191|P1|Overall Study|Lost to Follow-up|20
5818517|NCT02612077|20094191|P1|Overall Study|Protocol Violation|28
5818518|NCT02612077|20094191|P1|Overall Study|Withdrawal by Subject|9
5818519|NCT02612077|20094191|P1|Overall Study|Adverse Event|3
5818520|NCT02612064|20094203|P2|Overall Study|Other|2
5818521|NCT02612064|20094204|P1|Overall Study|Other|0
5818522|NCT02612064|20094203|P2|Overall Study|Withdrawal by Subject|1
5818523|NCT02612064|20094204|P1|Overall Study|Withdrawal by Subject|1
5818524|NCT02611882|20094217|P3|Overall Study|Did not complete prostatectomy per protocol stipulation|0
5818525|NCT02611882|20094218|P2|Overall Study|Did not complete prostatectomy per protocol stipulation|0
5818526|NCT02611882|20094219|P1|Overall Study|Did not complete prostatectomy per protocol stipulation|33
5818527|NCT02611830|20094237|P4|Maintenance Phase|Reason not specified|0
5818528|NCT02611830|20094238|P3|Maintenance Phase|Reason not specified|4
5818529|NCT02611830|20094239|P2|Maintenance Phase|Reason not specified|1
5818530|NCT02611830|20094240|P1|Maintenance Phase|Reason not specified|0
5818531|NCT02611830|20094237|P4|Maintenance Phase|Pregnancy|0
5818532|NCT02611830|20094238|P3|Maintenance Phase|Pregnancy|1
5818533|NCT02611830|20094239|P2|Maintenance Phase|Pregnancy|0
5818534|NCT02611830|20094240|P1|Maintenance Phase|Pregnancy|0
5818535|NCT02611830|20094237|P4|Maintenance Phase|Voluntary Withdrawal|5
5818536|NCT02611830|20094238|P3|Maintenance Phase|Voluntary Withdrawal|2
5818537|NCT02611830|20094239|P2|Maintenance Phase|Voluntary Withdrawal|1
5818538|NCT02611830|20094240|P1|Maintenance Phase|Voluntary Withdrawal|0
5818539|NCT02611830|20094237|P4|Maintenance Phase|Lost to Follow-up|1
5818540|NCT02611830|20094238|P3|Maintenance Phase|Lost to Follow-up|0
5818541|NCT02611830|20094239|P2|Maintenance Phase|Lost to Follow-up|0
5818542|NCT02611830|20094240|P1|Maintenance Phase|Lost to Follow-up|0
5818543|NCT02611830|20094237|P4|Maintenance Phase|Significant Protocol Deviation|1
5818544|NCT02611830|20094238|P3|Maintenance Phase|Significant Protocol Deviation|1
5818545|NCT02611830|20094239|P2|Maintenance Phase|Significant Protocol Deviation|0
5818546|NCT02611830|20094240|P1|Maintenance Phase|Significant Protocol Deviation|0
5818547|NCT02611830|20094237|P4|Maintenance Phase|Pretreatment Event/Adverse Event|2
5818548|NCT02611830|20094238|P3|Maintenance Phase|Pretreatment Event/Adverse Event|5
5818549|NCT02611830|20094239|P2|Maintenance Phase|Pretreatment Event/Adverse Event|5
5818550|NCT02611830|20094240|P1|Maintenance Phase|Pretreatment Event/Adverse Event|0
5818551|NCT02611830|20094237|P4|Maintenance Phase|Lack of Efficacy|6
5818552|NCT02611830|20094238|P3|Maintenance Phase|Lack of Efficacy|18
5818553|NCT02611830|20094239|P2|Maintenance Phase|Lack of Efficacy|29
5818554|NCT02611830|20094240|P1|Maintenance Phase|Lack of Efficacy|0
5818555|NCT02611830|20094237|P4|OL Induction Phase|Reason not specified|0
5818556|NCT02611830|20094238|P3|OL Induction Phase|Reason not specified|0
5818557|NCT02611830|20094239|P2|OL Induction Phase|Reason not specified|0
5818558|NCT02611830|20094240|P1|OL Induction Phase|Reason not specified|3
5818559|NCT02611830|20094237|P4|OL Induction Phase|Lack of Efficacy|0
5818560|NCT02611830|20094238|P3|OL Induction Phase|Lack of Efficacy|0
5818561|NCT02611830|20094239|P2|OL Induction Phase|Lack of Efficacy|0
5818562|NCT02611830|20094240|P1|OL Induction Phase|Lack of Efficacy|9
5818563|NCT02611830|20094237|P4|OL Induction Phase|Voluntary Withdrawal|0
5818564|NCT02611830|20094238|P3|OL Induction Phase|Voluntary Withdrawal|0
5818565|NCT02611830|20094239|P2|OL Induction Phase|Voluntary Withdrawal|0
5818566|NCT02611830|20094240|P1|OL Induction Phase|Voluntary Withdrawal|5
5818567|NCT02611830|20094237|P4|OL Induction Phase|Significant Protocol Deviation|0
5818568|NCT02611830|20094238|P3|OL Induction Phase|Significant Protocol Deviation|0
5818569|NCT02611830|20094239|P2|OL Induction Phase|Significant Protocol Deviation|0
5818570|NCT02611830|20094240|P1|OL Induction Phase|Significant Protocol Deviation|4
5818571|NCT02611830|20094237|P4|OL Induction Phase|Pretreatment Event/Adverse Event|0
5818572|NCT02611830|20094238|P3|OL Induction Phase|Pretreatment Event/Adverse Event|0
5818573|NCT02611830|20094239|P2|OL Induction Phase|Pretreatment Event/Adverse Event|0
5818574|NCT02611830|20094240|P1|OL Induction Phase|Pretreatment Event/Adverse Event|9
5818575|NCT02611817|20094264|P3|Double-blind Maintenance Phase|Lost to Follow-up|1
5818576|NCT02611817|20094265|P2|Double-blind Maintenance Phase|Lost to Follow-up|0
5818662|NCT02610777|20094509|P2|Overall Study|Ongoing in Follow-up|12
5818577|NCT02611817|20094266|P1|Double-blind Maintenance Phase|Lost to Follow-up|0
5818578|NCT02611817|20094264|P3|Double-blind Maintenance Phase|Withdrawal by Subject|14
5818579|NCT02611817|20094265|P2|Double-blind Maintenance Phase|Withdrawal by Subject|5
5818580|NCT02611817|20094266|P1|Double-blind Maintenance Phase|Withdrawal by Subject|0
5818581|NCT02611817|20094264|P3|Double-blind Maintenance Phase|Pregnancy|1
5818582|NCT02611817|20094265|P2|Double-blind Maintenance Phase|Pregnancy|0
5818583|NCT02611817|20094266|P1|Double-blind Maintenance Phase|Pregnancy|0
5818584|NCT02611817|20094264|P3|Double-blind Maintenance Phase|Lack of Efficacy|78
5818585|NCT02611817|20094265|P2|Double-blind Maintenance Phase|Lack of Efficacy|43
5818586|NCT02611817|20094266|P1|Double-blind Maintenance Phase|Lack of Efficacy|0
5818587|NCT02611817|20094264|P3|Double-blind Maintenance Phase|Reason not Specified|2
5818588|NCT02611817|20094265|P2|Double-blind Maintenance Phase|Reason not Specified|1
5818589|NCT02611817|20094266|P1|Double-blind Maintenance Phase|Reason not Specified|0
5818590|NCT02611817|20094264|P3|Double-blind Maintenance Phase|Randomized but not Treated|0
5818591|NCT02611817|20094265|P2|Double-blind Maintenance Phase|Randomized but not Treated|1
5818592|NCT02611817|20094266|P1|Double-blind Maintenance Phase|Randomized but not Treated|0
5818593|NCT02611817|20094264|P3|Double-blind Maintenance Phase|Adverse Event|11
5818594|NCT02611817|20094265|P2|Double-blind Maintenance Phase|Adverse Event|12
5818595|NCT02611817|20094266|P1|Double-blind Maintenance Phase|Adverse Event|0
5818596|NCT02611817|20094264|P3|Open-label Induction Phase|Adverse Event|0
5818597|NCT02611817|20094265|P2|Open-label Induction Phase|Adverse Event|0
5818598|NCT02611817|20094266|P1|Open-label Induction Phase|Adverse Event|16
5818599|NCT02611817|20094264|P3|Open-label Induction Phase|Protocol Violation|0
5818600|NCT02611817|20094265|P2|Open-label Induction Phase|Protocol Violation|0
5818601|NCT02611817|20094266|P1|Open-label Induction Phase|Protocol Violation|5
5818602|NCT02611817|20094264|P3|Open-label Induction Phase|Lost to Follow-up|0
5818603|NCT02611817|20094265|P2|Open-label Induction Phase|Lost to Follow-up|0
5818604|NCT02611817|20094266|P1|Open-label Induction Phase|Lost to Follow-up|2
5818605|NCT02611817|20094264|P3|Open-label Induction Phase|Withdrawal by Subject|0
5818606|NCT02611817|20094265|P2|Open-label Induction Phase|Withdrawal by Subject|0
5818607|NCT02611817|20094266|P1|Open-label Induction Phase|Withdrawal by Subject|9
5818608|NCT02611817|20094264|P3|Open-label Induction Phase|Pregnancy|0
5818609|NCT02611817|20094265|P2|Open-label Induction Phase|Pregnancy|0
5818610|NCT02611817|20094266|P1|Open-label Induction Phase|Pregnancy|1
5818611|NCT02611817|20094264|P3|Open-label Induction Phase|Lack of Efficacy|0
5818612|NCT02611817|20094265|P2|Open-label Induction Phase|Lack of Efficacy|0
5818613|NCT02611817|20094266|P1|Open-label Induction Phase|Lack of Efficacy|8
5818614|NCT02611817|20094264|P3|Open-label Induction Phase|Reason not Specified|0
5818615|NCT02611817|20094265|P2|Open-label Induction Phase|Reason not Specified|0
5818616|NCT02611817|20094266|P1|Open-label Induction Phase|Reason not Specified|9
5818617|NCT02611752|20094290|P2|Overall Study|Adverse Event|1
5818618|NCT02611752|20094291|P1|Overall Study|Adverse Event|0
5818619|NCT02611479|20094323|P1|Data Cleaning|No baseline function or pain metrics|2
5818620|NCT02611479|20094323|P1|Post-Surgery Follow-up at 1-Year|Lost to Follow-up|18
5818621|NCT02611479|20094323|P1|Post-Surgery Follow-up at 30-90 Days|No surgery reported|2
5818622|NCT02611479|20094323|P1|Baseline Enrollment|Exited study|13
5818623|NCT02611362|20094329|P2|Overall Study|Lost to Follow-up|4
5818624|NCT02611362|20094330|P1|Overall Study|Lost to Follow-up|2
5818625|NCT02611362|20094329|P2|Overall Study|Withdrawal by Subject|2
5818626|NCT02611362|20094330|P1|Overall Study|Withdrawal by Subject|7
5818627|NCT02610842|20094474|P1|Overall Study|Lost to Follow-up|5
5818628|NCT02610816|20094483|P4|Phase 2|Pregnancy|1
5818629|NCT02610816|20094484|P3|Phase 2|Pregnancy|0
5818630|NCT02610816|20094485|P2|Phase 2|Pregnancy|0
5818631|NCT02610816|20094486|P1|Phase 2|Pregnancy|0
5818632|NCT02610816|20094483|P4|Phase 2|Physician Decision|2
5818633|NCT02610816|20094484|P3|Phase 2|Physician Decision|0
5818634|NCT02610816|20094485|P2|Phase 2|Physician Decision|0
5818635|NCT02610816|20094486|P1|Phase 2|Physician Decision|0
5818636|NCT02610816|20094483|P4|Phase 2|Lost to Follow-up|0
5818637|NCT02610816|20094484|P3|Phase 2|Lost to Follow-up|2
5818638|NCT02610816|20094485|P2|Phase 2|Lost to Follow-up|0
5818639|NCT02610816|20094486|P1|Phase 2|Lost to Follow-up|0
5818640|NCT02610816|20094483|P4|Phase 2|Withdrawal by Subject|3
5818641|NCT02610816|20094484|P3|Phase 2|Withdrawal by Subject|9
5818642|NCT02610816|20094485|P2|Phase 2|Withdrawal by Subject|0
5818643|NCT02610816|20094486|P1|Phase 2|Withdrawal by Subject|0
5818644|NCT02610816|20094483|P4|Phase 1|Physician Decision|0
5818645|NCT02610816|20094484|P3|Phase 1|Physician Decision|0
5818646|NCT02610816|20094485|P2|Phase 1|Physician Decision|1
5818647|NCT02610816|20094486|P1|Phase 1|Physician Decision|0
5818648|NCT02610816|20094483|P4|Phase 1|Lost to Follow-up|0
5818649|NCT02610816|20094484|P3|Phase 1|Lost to Follow-up|0
5818650|NCT02610816|20094485|P2|Phase 1|Lost to Follow-up|1
5818651|NCT02610816|20094486|P1|Phase 1|Lost to Follow-up|2
5818652|NCT02610816|20094483|P4|Phase 1|Withdrawal by Subject|0
5818653|NCT02610816|20094484|P3|Phase 1|Withdrawal by Subject|0
5818654|NCT02610816|20094485|P2|Phase 1|Withdrawal by Subject|6
5818655|NCT02610816|20094486|P1|Phase 1|Withdrawal by Subject|2
5818656|NCT02610777|20094509|P2|Overall Study|Ongoing on Treatment|7
5818657|NCT02610777|20094510|P1|Overall Study|Ongoing on Treatment|6
5818658|NCT02610777|20094509|P2|Overall Study|Other|1
5818659|NCT02610777|20094510|P1|Overall Study|Other|0
5818660|NCT02610777|20094509|P2|Overall Study|Withdrawal by Subject|2
5818661|NCT02610777|20094510|P1|Overall Study|Withdrawal by Subject|1
5818663|NCT02610777|20094510|P1|Overall Study|Ongoing in Follow-up|14
5818664|NCT02610725|20094516|P1|Overall Study|self-reported contraindication|9
5818665|NCT02610725|20094516|P1|Overall Study|Lost to Follow-up|197
5818666|NCT02610231|20094531|P1|Overall Study|Other|3
5818667|NCT02610231|20094531|P1|Overall Study|Non Compliance|2
5818668|NCT02610231|20094531|P1|Overall Study|Physician Decision|1
5818669|NCT02610231|20094531|P1|Overall Study|Surgery|2
5818670|NCT02610231|20094531|P1|Overall Study|Death|5
5818671|NCT02610231|20094531|P1|Overall Study|Adverse Event|20
5818672|NCT02610231|20094531|P1|Overall Study|Withdrawal by Subject|27
5818673|NCT02610192|20094538|P1|Overall Study|Physician Decision|1
5818674|NCT02610192|20094538|P1|Overall Study|Received other treatment|8
5818675|NCT02610140|20094553|P2|Long-term Follow-up|Ongoing but not completed|17
5818676|NCT02610140|20094554|P1|Long-term Follow-up|Ongoing but not completed|30
5818677|NCT02610140|20094553|P2|Long-term Follow-up|Lost to Follow-up|2
5818678|NCT02610140|20094554|P1|Long-term Follow-up|Lost to Follow-up|1
5818679|NCT02610140|20094553|P2|Long-term Follow-up|Withdrawal by Subject|3
5818680|NCT02610140|20094554|P1|Long-term Follow-up|Withdrawal by Subject|6
5818681|NCT02610140|20094553|P2|Long-term Follow-up|Death|44
5818682|NCT02610140|20094554|P1|Long-term Follow-up|Death|86
5818683|NCT02610140|20094553|P2|Active Follow-up|Ongoing but not completed|1
5818684|NCT02610140|20094554|P1|Active Follow-up|Ongoing but not completed|4
5818685|NCT02610140|20094553|P2|Active Follow-up|Deterioration of general conditions|0
5818686|NCT02610140|20094554|P1|Active Follow-up|Deterioration of general conditions|1
5818687|NCT02610140|20094553|P2|Active Follow-up|Progressive disease - clinical|2
5818688|NCT02610140|20094554|P1|Active Follow-up|Progressive disease - clinical|1
5818689|NCT02610140|20094553|P2|Active Follow-up|Withdrawal by Subject|0
5818690|NCT02610140|20094554|P1|Active Follow-up|Withdrawal by Subject|4
5818691|NCT02610140|20094553|P2|Active Follow-up|Death|1
5818692|NCT02610140|20094554|P1|Active Follow-up|Death|8
5818693|NCT02610140|20094553|P2|Active Follow-up|Progressive disease - radiological|22
5818694|NCT02610140|20094554|P1|Active Follow-up|Progressive disease - radiological|30
5818695|NCT02610140|20094553|P2|Safety Follow-up|Withdrawal by Subject|12
5818696|NCT02610140|20094554|P1|Safety Follow-up|Withdrawal by Subject|12
5818697|NCT02610140|20094553|P2|Safety Follow-up|Deterioration of general conditions|5
5818698|NCT02610140|20094554|P1|Safety Follow-up|Deterioration of general conditions|15
5818699|NCT02610140|20094553|P2|Safety Follow-up|Death|2
5818700|NCT02610140|20094554|P1|Safety Follow-up|Death|12
5818701|NCT02610140|20094553|P2|Safety Follow-up|No follow-up|3
5818702|NCT02610140|20094554|P1|Safety Follow-up|No follow-up|5
5818703|NCT02610140|20094553|P2|Safety Follow-up|Lost to Follow-up|0
5818704|NCT02610140|20094554|P1|Safety Follow-up|Lost to Follow-up|1
5818705|NCT02610140|20094553|P2|Safety Follow-up|Other|2
5818706|NCT02610140|20094554|P1|Safety Follow-up|Other|0
5818707|NCT02610140|20094553|P2|Randomization and Treatment Period|Not treated|10
5818708|NCT02610140|20094554|P1|Randomization and Treatment Period|Not treated|3
5818709|NCT02610140|20094553|P2|Randomization and Treatment Period|Ongoing but not completed|2
5818710|NCT02610140|20094554|P1|Randomization and Treatment Period|Ongoing but not completed|9
5818711|NCT02610140|20094553|P2|Randomization and Treatment Period|Progressive disease - clinical|5
5818712|NCT02610140|20094554|P1|Randomization and Treatment Period|Progressive disease - clinical|12
5818713|NCT02610140|20094553|P2|Randomization and Treatment Period|Adverse Event|13
5818714|NCT02610140|20094554|P1|Randomization and Treatment Period|Adverse Event|44
5818715|NCT02610140|20094553|P2|Randomization and Treatment Period|Withdrawal by Subject|12
5818716|NCT02610140|20094554|P1|Randomization and Treatment Period|Withdrawal by Subject|12
5818717|NCT02610140|20094553|P2|Randomization and Treatment Period|Death|1
5818718|NCT02610140|20094554|P1|Randomization and Treatment Period|Death|7
5818719|NCT02610140|20094553|P2|Randomization and Treatment Period|Lack of Efficacy|0
5818720|NCT02610140|20094554|P1|Randomization and Treatment Period|Lack of Efficacy|1
5818721|NCT02610140|20094553|P2|Randomization and Treatment Period|Physician Decision|1
5818722|NCT02610140|20094554|P1|Randomization and Treatment Period|Physician Decision|0
5818723|NCT02610140|20094553|P2|Randomization and Treatment Period|Protocol Violation|0
5818724|NCT02610140|20094554|P1|Randomization and Treatment Period|Protocol Violation|1
5818725|NCT02610140|20094553|P2|Randomization and Treatment Period|Progressive disease - radiological|23
5818726|NCT02610140|20094554|P1|Randomization and Treatment Period|Progressive disease - radiological|54
5818727|NCT02610140|20094553|P2|Randomization and Treatment Period|Radiological progression|15
5818728|NCT02610140|20094554|P1|Randomization and Treatment Period|Radiological progression|23
5818729|NCT02609984|20094586|P2|Overall Study|Disease Progression|0
5818730|NCT02609984|20094587|P1|Overall Study|Disease Progression|2
5818731|NCT02609984|20094586|P2|Overall Study|Withdrawal by Subject|1
5818732|NCT02609984|20094587|P1|Overall Study|Withdrawal by Subject|0
5818733|NCT02609984|20094586|P2|Overall Study|Lost to Follow-up|2
5818734|NCT02609984|20094587|P1|Overall Study|Lost to Follow-up|1
5818735|NCT02609984|20094586|P2|Overall Study|Participation Discontinued by Sponsor|10
5818736|NCT02609984|20094587|P1|Overall Study|Participation Discontinued by Sponsor|12
5818737|NCT02609984|20094586|P2|Overall Study|Death|26
5818738|NCT02609984|20094587|P1|Overall Study|Death|29
5818739|NCT02609672|20094629|P2|Overall Study|Lost to Follow-up|1
5818740|NCT02609672|20094630|P1|Overall Study|Lost to Follow-up|3
5818741|NCT02609659|20094664|P1|Overall Study|Other|1
5818742|NCT02609659|20094664|P1|Overall Study|Lost to Follow-up|6
5818743|NCT02609659|20094664|P1|Overall Study|Adverse Event|1
5818744|NCT02609633|20094674|P2|Overall Study|Reason not Specified|1
5818745|NCT02609633|20094675|P1|Overall Study|Reason not Specified|2
5818746|NCT02609633|20094674|P2|Overall Study|Non-Compliant with Study Procedures|0
5818747|NCT02609633|20094675|P1|Overall Study|Non-Compliant with Study Procedures|2
5818748|NCT02609633|20094674|P2|Overall Study|Protocol Deviation|0
5818749|NCT02609633|20094675|P1|Overall Study|Protocol Deviation|1
5818750|NCT02609633|20094674|P2|Overall Study|Consent Withdrawn|1
5818751|NCT02609633|20094675|P1|Overall Study|Consent Withdrawn|0
5818752|NCT02609607|20094702|P2|Overall Study|Lost to Follow-up|1
5818753|NCT02609607|20094703|P1|Overall Study|Lost to Follow-up|0
5818754|NCT02609399|20094727|P2|Influenza Season 2016-2017|Found ineligible after randomization|0
5818755|NCT02609399|20094728|P1|Influenza Season 2016-2017|Found ineligible after randomization|1
5818756|NCT02609399|20094727|P2|Influenza Season 2016-2017|Lost to Follow-up|5
5818757|NCT02609399|20094728|P1|Influenza Season 2016-2017|Lost to Follow-up|8
5818758|NCT02609399|20094727|P2|Influenza Season 2015-2016|Lost to Follow-up|2
5818759|NCT02609399|20094728|P1|Influenza Season 2015-2016|Lost to Follow-up|3
5818760|NCT02609178|20094758|P6|First Crown|Withdrawal by Subject|0
5818761|NCT02609178|20094759|P5|First Crown|Withdrawal by Subject|0
5818762|NCT02609178|20094760|P4|First Crown|Withdrawal by Subject|1
5818763|NCT02609178|20094761|P3|First Crown|Withdrawal by Subject|1
5818764|NCT02609178|20094762|P2|First Crown|Withdrawal by Subject|0
5818765|NCT02609178|20094763|P1|First Crown|Withdrawal by Subject|0
5818766|NCT02608892|20094825|P2|Overall Study|Lost to Follow-up|0
5818767|NCT02608892|20094826|P1|Overall Study|Lost to Follow-up|1
5818768|NCT02608879|20094838|P3|Overall Study|Did not meet continuation criteria|3
5818769|NCT02608879|20094839|P2|Overall Study|Did not meet continuation criteria|0
5818770|NCT02608879|20094840|P1|Overall Study|Did not meet continuation criteria|0
5818771|NCT02608879|20094838|P3|Overall Study|Lost to Follow-up|0
5818772|NCT02608879|20094839|P2|Overall Study|Lost to Follow-up|0
5818773|NCT02608879|20094840|P1|Overall Study|Lost to Follow-up|1
5818774|NCT02608684|20094859|P1|Overall Study|Withdrawal by Subject|1
5818775|NCT02608684|20094859|P1|Overall Study|Physician Decision|2
5818776|NCT02608476|20094894|P2|Overall Study|Progressive disease|0
5818777|NCT02608476|20094895|P1|Overall Study|Progressive disease|1
5818778|NCT02608476|20094894|P2|Overall Study|Pregnancy|1
5818779|NCT02608476|20094895|P1|Overall Study|Pregnancy|0
5818780|NCT02608476|20094894|P2|Overall Study|Physician Decision|0
5818781|NCT02608476|20094895|P1|Overall Study|Physician Decision|1
5818782|NCT02608476|20094894|P2|Overall Study|Other|1
5818783|NCT02608476|20094895|P1|Overall Study|Other|0
5818784|NCT02608476|20094894|P2|Overall Study|Lack of Efficacy|1
5818785|NCT02608476|20094895|P1|Overall Study|Lack of Efficacy|3
5818786|NCT02608476|20094894|P2|Overall Study|Noncompliance with treatment|5
5818787|NCT02608476|20094895|P1|Overall Study|Noncompliance with treatment|1
5818788|NCT02608476|20094894|P2|Overall Study|Withdrawal by Parent/Guardian|4
5818789|NCT02608476|20094895|P1|Overall Study|Withdrawal by Parent/Guardian|5
5818790|NCT02608476|20094894|P2|Overall Study|Adverse Event|8
5818791|NCT02608476|20094895|P1|Overall Study|Adverse Event|2
5818792|NCT02608476|20094894|P2|Overall Study|Lost to Follow-up|24
5818793|NCT02608476|20094895|P1|Overall Study|Lost to Follow-up|24
5818794|NCT02608476|20094894|P2|Overall Study|Withdrawal by Subject|37
5818795|NCT02608476|20094895|P1|Overall Study|Withdrawal by Subject|30
5818796|NCT02608450|20094925|P2|Overall Study|Multiple reasons|2
5818797|NCT02608450|20094926|P1|Overall Study|Multiple reasons|0
5818798|NCT02608450|20094925|P2|Overall Study|Progressive disease|0
5818799|NCT02608450|20094926|P1|Overall Study|Progressive disease|1
5818800|NCT02608450|20094925|P2|Overall Study|Pregnancy|1
5818801|NCT02608450|20094926|P1|Overall Study|Pregnancy|0
5818802|NCT02608450|20094925|P2|Overall Study|Physician Decision|1
5818803|NCT02608450|20094926|P1|Overall Study|Physician Decision|0
5818804|NCT02608450|20094925|P2|Overall Study|Noncompliance with study drug|2
5818805|NCT02608450|20094926|P1|Overall Study|Noncompliance with study drug|0
5818806|NCT02608450|20094925|P2|Overall Study|Lack of Efficacy|3
5818807|NCT02608450|20094926|P1|Overall Study|Lack of Efficacy|0
5818808|NCT02608450|20094925|P2|Overall Study|Withdrawal by parent|3
5818809|NCT02608450|20094926|P1|Overall Study|Withdrawal by parent|2
5818810|NCT02608450|20094925|P2|Overall Study|Adverse Event|6
5818811|NCT02608450|20094926|P1|Overall Study|Adverse Event|3
5818812|NCT02608450|20094925|P2|Overall Study|Withdrawal by Subject|15
5818813|NCT02608450|20094926|P1|Overall Study|Withdrawal by Subject|21
5818814|NCT02608450|20094925|P2|Overall Study|Lost to Follow-up|32
5818815|NCT02608450|20094926|P1|Overall Study|Lost to Follow-up|39
5818816|NCT02608099|20094988|P2|Overall Study|Ablation procedure not initiated|2
5818817|NCT02608099|20094989|P1|Overall Study|Ablation procedure not initiated|3
5818818|NCT02607956|20095027|P2|Overall Study|Lost to Follow-up|15
5818819|NCT02607956|20095028|P1|Overall Study|Lost to Follow-up|18
5818820|NCT02607956|20095027|P2|Overall Study|Withdrew Consent|16
5818821|NCT02607956|20095028|P1|Overall Study|Withdrew Consent|16
5818822|NCT02607956|20095027|P2|Overall Study|Protocol Violation|1
5818823|NCT02607956|20095028|P1|Overall Study|Protocol Violation|3
5818824|NCT02607956|20095027|P2|Overall Study|Non-Compliance with Study Drug|3
5818825|NCT02607956|20095028|P1|Overall Study|Non-Compliance with Study Drug|0
5818826|NCT02607956|20095027|P2|Overall Study|Investigator's Discretion|2
5818827|NCT02607956|20095028|P1|Overall Study|Investigator's Discretion|7
5818828|NCT02607956|20095027|P2|Overall Study|Death|4
5818829|NCT02607956|20095028|P1|Overall Study|Death|4
5818830|NCT02607956|20095027|P2|Overall Study|Adverse Event|3
5818831|NCT02607956|20095028|P1|Overall Study|Adverse Event|4
5818832|NCT02607956|20095027|P2|Overall Study|Still on Study|281
5818833|NCT02607956|20095028|P1|Overall Study|Still on Study|268
5818834|NCT02607956|20095027|P2|Overall Study|Randomized and Never Treated|5
5818835|NCT02607956|20095028|P1|Overall Study|Randomized and Never Treated|7
5818836|NCT02607930|20095058|P2|Overall Study|Lost to Follow-up|16
5818837|NCT02607930|20095059|P1|Overall Study|Lost to Follow-up|24
5818838|NCT02607930|20095058|P2|Overall Study|Withdrew Consent|15
5818839|NCT02607930|20095059|P1|Overall Study|Withdrew Consent|14
5818840|NCT02607930|20095058|P2|Overall Study|Protocol Violation|3
5818841|NCT02607930|20095059|P1|Overall Study|Protocol Violation|2
5818842|NCT02607930|20095058|P2|Overall Study|Non-Compliance with Study Drug|5
5818843|NCT02607930|20095059|P1|Overall Study|Non-Compliance with Study Drug|3
5818844|NCT02607930|20095058|P2|Overall Study|Investigator's Discretion|2
5818845|NCT02607930|20095059|P1|Overall Study|Investigator's Discretion|6
5818846|NCT02607930|20095058|P2|Overall Study|Death|1
5818847|NCT02607930|20095059|P1|Overall Study|Death|2
5818848|NCT02607930|20095058|P2|Overall Study|Adverse Event|4
5818849|NCT02607930|20095059|P1|Overall Study|Adverse Event|0
5818850|NCT02607930|20095058|P2|Overall Study|Still in Study|269
5818851|NCT02607930|20095059|P1|Overall Study|Still in Study|263
5818852|NCT02607930|20095058|P2|Overall Study|Randomized and Never Treated|0
5818853|NCT02607930|20095059|P1|Overall Study|Randomized and Never Treated|2
5818854|NCT02607865|20095103|P4|Overall Study|Unclassified|0
5818855|NCT02607865|20095104|P3|Overall Study|Unclassified|2
5818856|NCT02607865|20095105|P2|Overall Study|Unclassified|1
5818857|NCT02607865|20095106|P1|Overall Study|Unclassified|1
5818858|NCT02607865|20095103|P4|Overall Study|Death|3
5818859|NCT02607865|20095104|P3|Overall Study|Death|1
5818860|NCT02607865|20095105|P2|Overall Study|Death|4
5818861|NCT02607865|20095106|P1|Overall Study|Death|5
5818862|NCT02607865|20095103|P4|Overall Study|Withdrawal by Subject|8
5818863|NCT02607865|20095104|P3|Overall Study|Withdrawal by Subject|17
5818864|NCT02607865|20095105|P2|Overall Study|Withdrawal by Subject|18
5818865|NCT02607865|20095106|P1|Overall Study|Withdrawal by Subject|18
5818866|NCT02607865|20095103|P4|Overall Study|Lost to Follow-up|5
5818867|NCT02607865|20095104|P3|Overall Study|Lost to Follow-up|7
5818868|NCT02607865|20095105|P2|Overall Study|Lost to Follow-up|7
5818869|NCT02607865|20095106|P1|Overall Study|Lost to Follow-up|9
5818870|NCT02607800|20095280|P2|Overall Study|Randomized/Enrolled but Not Treated|1
5818871|NCT02607800|20095281|P1|Overall Study|Randomized/Enrolled but Not Treated|1
5818872|NCT02607800|20095280|P2|Overall Study|Withdrew Consent|0
5818873|NCT02607800|20095281|P1|Overall Study|Withdrew Consent|2
5818874|NCT02607800|20095280|P2|Overall Study|Lost to Follow-up|10
5818875|NCT02607800|20095281|P1|Overall Study|Lost to Follow-up|7
5818876|NCT02607735|20095299|P3|Deferred Treatment Substudy|Withdrew Consent|1
5818877|NCT02607735|20095300|P2|Deferred Treatment Substudy|Withdrew Consent|0
5818878|NCT02607735|20095301|P1|Deferred Treatment Substudy|Withdrew Consent|0
5818879|NCT02607735|20095299|P3|Deferred Treatment Substudy|Lost to Follow-up|4
5818880|NCT02607735|20095300|P2|Deferred Treatment Substudy|Lost to Follow-up|0
5818881|NCT02607735|20095301|P1|Deferred Treatment Substudy|Lost to Follow-up|0
5818882|NCT02607735|20095299|P3|Primary Study|Withdrew Consent|0
5818883|NCT02607735|20095300|P2|Primary Study|Withdrew Consent|0
5818884|NCT02607735|20095301|P1|Primary Study|Withdrew Consent|2
5818885|NCT02607735|20095299|P3|Primary Study|Lost to Follow-up|0
5818886|NCT02607735|20095300|P2|Primary Study|Lost to Follow-up|0
5818887|NCT02607735|20095301|P1|Primary Study|Lost to Follow-up|4
5818888|NCT02607735|20095299|P3|Primary Study|Randomized but Never Treated|0
5818889|NCT02607735|20095300|P2|Primary Study|Randomized but Never Treated|0
5818890|NCT02607735|20095301|P1|Primary Study|Randomized but Never Treated|1
5818891|NCT02607306|20095335|P3|Overall Study|Protocol Violation|1
5818892|NCT02607306|20095336|P2|Overall Study|Protocol Violation|2
5818893|NCT02607306|20095337|P1|Overall Study|Protocol Violation|4
5818894|NCT02607306|20095335|P3|Overall Study|Lack of Efficacy|1
5818895|NCT02607306|20095336|P2|Overall Study|Lack of Efficacy|1
5818896|NCT02607306|20095337|P1|Overall Study|Lack of Efficacy|0
5818897|NCT02607306|20095335|P3|Overall Study|Withdrawal by Subject|2
5818898|NCT02607306|20095336|P2|Overall Study|Withdrawal by Subject|10
5818899|NCT02607306|20095337|P1|Overall Study|Withdrawal by Subject|8
5818900|NCT02607306|20095335|P3|Overall Study|Unclassified|0
5818901|NCT02607306|20095336|P2|Overall Study|Unclassified|4
5818902|NCT02607306|20095337|P1|Overall Study|Unclassified|1
5818903|NCT02607306|20095335|P3|Overall Study|Adverse Event|6
5818904|NCT02607306|20095336|P2|Overall Study|Adverse Event|6
5818905|NCT02607306|20095337|P1|Overall Study|Adverse Event|8
5818906|NCT02607280|20095459|P2|Overall Study|Decrease in CrCl <15|1
5818907|NCT02607280|20095460|P1|Overall Study|Decrease in CrCl <15|0
5818908|NCT02607280|20095459|P2|Overall Study|Adverse Event|0
5818909|NCT02607280|20095460|P1|Overall Study|Adverse Event|4
5818910|NCT02607228|20095495|P7|Overall Study|Study Terminated by Sponsor|0
5818911|NCT02607228|20095496|P6|Overall Study|Study Terminated by Sponsor|0
5818912|NCT02607228|20095497|P5|Overall Study|Study Terminated by Sponsor|0
5818913|NCT02607228|20095498|P4|Overall Study|Study Terminated by Sponsor|1
5818914|NCT02607228|20095499|P3|Overall Study|Study Terminated by Sponsor|0
5818915|NCT02607228|20095500|P2|Overall Study|Study Terminated by Sponsor|0
5818916|NCT02607228|20095501|P1|Overall Study|Study Terminated by Sponsor|0
5818917|NCT02607228|20095495|P7|Overall Study|Withdrew Consent|0
5818918|NCT02607228|20095496|P6|Overall Study|Withdrew Consent|1
5818919|NCT02607228|20095497|P5|Overall Study|Withdrew Consent|0
5818920|NCT02607228|20095498|P4|Overall Study|Withdrew Consent|0
5818921|NCT02607228|20095499|P3|Overall Study|Withdrew Consent|0
5818922|NCT02607228|20095500|P2|Overall Study|Withdrew Consent|1
5818923|NCT02607228|20095501|P1|Overall Study|Withdrew Consent|0
5818924|NCT02607228|20095495|P7|Overall Study|Investigator's Discretion|0
5818925|NCT02607228|20095496|P6|Overall Study|Investigator's Discretion|1
5818926|NCT02607228|20095497|P5|Overall Study|Investigator's Discretion|0
5818927|NCT02607228|20095498|P4|Overall Study|Investigator's Discretion|0
5818928|NCT02607228|20095499|P3|Overall Study|Investigator's Discretion|1
5818929|NCT02607228|20095500|P2|Overall Study|Investigator's Discretion|0
5818930|NCT02607228|20095501|P1|Overall Study|Investigator's Discretion|0
5818931|NCT02607228|20095495|P7|Overall Study|Adverse Event|1
5818932|NCT02607228|20095496|P6|Overall Study|Adverse Event|1
5818933|NCT02607228|20095497|P5|Overall Study|Adverse Event|1
5818934|NCT02607228|20095498|P4|Overall Study|Adverse Event|0
5818935|NCT02607228|20095499|P3|Overall Study|Adverse Event|1
5818936|NCT02607228|20095500|P2|Overall Study|Adverse Event|0
5818937|NCT02607228|20095501|P1|Overall Study|Adverse Event|1
5818938|NCT02607228|20095495|P7|Overall Study|Progressive Disease|1
5818939|NCT02607228|20095496|P6|Overall Study|Progressive Disease|3
5818940|NCT02607228|20095497|P5|Overall Study|Progressive Disease|4
5818941|NCT02607228|20095498|P4|Overall Study|Progressive Disease|5
5818942|NCT02607228|20095499|P3|Overall Study|Progressive Disease|1
5818943|NCT02607228|20095500|P2|Overall Study|Progressive Disease|3
5818944|NCT02607228|20095501|P1|Overall Study|Progressive Disease|4
5818945|NCT02606877|20095604|P2|Overall Study|Other than listed above|0
5818946|NCT02606877|20095605|P1|Overall Study|Other than listed above|1
5818947|NCT02606877|20095604|P2|Overall Study|Non-compliance with protocol|1
5818948|NCT02606877|20095605|P1|Overall Study|Non-compliance with protocol|0
5818949|NCT02606877|20095604|P2|Overall Study|Adverse Event|0
5818950|NCT02606877|20095605|P1|Overall Study|Adverse Event|3
5818951|NCT02606643|20095644|P2|Overall Study|did not meet inclusion criteria|3
5818952|NCT02606643|20095645|P1|Overall Study|did not meet inclusion criteria|1
5818953|NCT02606279|20095703|P2|Overall Study|Lost to Follow-up|1
5818954|NCT02606279|20095704|P1|Overall Study|Lost to Follow-up|0
5818955|NCT02606253|20095719|P3|Overall Study|Physician Decision|0
5818956|NCT02606253|20095720|P2|Overall Study|Physician Decision|1
5818957|NCT02606253|20095721|P1|Overall Study|Physician Decision|1
5818958|NCT02606253|20095719|P3|Overall Study|Protocol Violation|0
5818959|NCT02606253|20095720|P2|Overall Study|Protocol Violation|1
5818960|NCT02606253|20095721|P1|Overall Study|Protocol Violation|2
5818961|NCT02606253|20095719|P3|Overall Study|Adverse Event|0
5818962|NCT02606253|20095720|P2|Overall Study|Adverse Event|0
5818963|NCT02606253|20095721|P1|Overall Study|Adverse Event|2
5818964|NCT02605954|20095823|P2|Overall Study|Randomized but not treated|1
5818965|NCT02605954|20095824|P1|Overall Study|Randomized but not treated|0
5818966|NCT02605954|20095823|P2|Overall Study|Lost to Follow-up|0
5818967|NCT02605954|20095824|P1|Overall Study|Lost to Follow-up|3
5818968|NCT02605954|20095823|P2|Overall Study|Withdrew Consent|2
5818969|NCT02605954|20095824|P1|Overall Study|Withdrew Consent|2
5818970|NCT02605954|20095823|P2|Overall Study|Non-Compliance with Study Drug|0
5818971|NCT02605954|20095824|P1|Overall Study|Non-Compliance with Study Drug|1
5818972|NCT02605954|20095823|P2|Overall Study|Investigator's Discretion|0
5818973|NCT02605954|20095824|P1|Overall Study|Investigator's Discretion|1
5818974|NCT02605954|20095823|P2|Overall Study|Adverse Event|1
5818975|NCT02605954|20095824|P1|Overall Study|Adverse Event|5
5818976|NCT02605928|20095841|P1|Overall Study|Lack of Efficacy|5
5818977|NCT02605928|20095841|P1|Overall Study|Model tuning phase|28
5818978|NCT02605837|20095884|P2|Overall Study|Physician Decision|1
5818979|NCT02605837|20095885|P1|Overall Study|Physician Decision|0
5818980|NCT02605837|20095884|P2|Overall Study|Withdrawal by Subject|8
5818981|NCT02605837|20095885|P1|Overall Study|Withdrawal by Subject|8
5818982|NCT02605837|20095884|P2|Overall Study|Non-Compliance with Study Drug|1
5818983|NCT02605837|20095885|P1|Overall Study|Non-Compliance with Study Drug|0
5818984|NCT02605837|20095884|P2|Overall Study|Adverse Event|1
5818985|NCT02605837|20095885|P1|Overall Study|Adverse Event|3
5818986|NCT02605824|20095924|P2|Overall Study|Physician Decision|0
5818987|NCT02605824|20095925|P1|Overall Study|Physician Decision|1
5818988|NCT02605642|20095935|P2|Overall Study|Lack of response|11
5818989|NCT02605642|20095936|P1|Overall Study|Lack of response|24
5818990|NCT02605642|20095935|P2|Overall Study|Withdrawal by Subject|2
5818991|NCT02605642|20095936|P1|Overall Study|Withdrawal by Subject|23
5818992|NCT02605642|20095935|P2|Overall Study|Adverse Event|2
5818993|NCT02605642|20095936|P1|Overall Study|Adverse Event|14
5818994|NCT02605642|20095935|P2|Overall Study|Lost to Follow-up|1
5818995|NCT02605642|20095936|P1|Overall Study|Lost to Follow-up|12
5818996|NCT02605642|20095935|P2|Overall Study|Physician Decision|0
5818997|NCT02605642|20095936|P1|Overall Study|Physician Decision|10
5818998|NCT02605642|20095935|P2|Overall Study|Participant non-compliance|4
5818999|NCT02605642|20095936|P1|Overall Study|Participant non-compliance|2
5819000|NCT02605642|20095935|P2|Overall Study|Other|1
5819001|NCT02605642|20095936|P1|Overall Study|Other|11
5819002|NCT02605447|20095978|P1|Overall Study|Not disclosed|1
5819003|NCT02605447|20095978|P1|Overall Study|Withdrawal by Subject|10
5819004|NCT02605447|20095978|P1|Overall Study|Lost to Follow-up|24
5819005|NCT02605447|20095978|P1|Overall Study|Physician Decision|1
5819006|NCT02605447|20095978|P1|Overall Study|Death|66
5819007|NCT02605174|20096089|P7|Overall Study|Randomization Failure|30
5819008|NCT02605174|20096090|P6|Overall Study|Randomization Failure|11
5819009|NCT02605174|20096091|P5|Overall Study|Randomization Failure|16
5819010|NCT02605174|20096092|P4|Overall Study|Randomization Failure|7
5819011|NCT02605174|20096093|P3|Overall Study|Randomization Failure|20
5819012|NCT02605174|20096094|P2|Overall Study|Randomization Failure|6
5819013|NCT02605174|20096095|P1|Overall Study|Randomization Failure|22
5819014|NCT02605174|20096089|P7|Overall Study|Physician Decision|3
5819015|NCT02605174|20096090|P6|Overall Study|Physician Decision|0
5819016|NCT02605174|20096091|P5|Overall Study|Physician Decision|0
5819017|NCT02605174|20096092|P4|Overall Study|Physician Decision|0
5819018|NCT02605174|20096093|P3|Overall Study|Physician Decision|0
5819019|NCT02605174|20096094|P2|Overall Study|Physician Decision|0
5819020|NCT02605174|20096095|P1|Overall Study|Physician Decision|2
5819021|NCT02605174|20096089|P7|Overall Study|Withdrawal by Subject|15
5819022|NCT02605174|20096090|P6|Overall Study|Withdrawal by Subject|4
5819023|NCT02605174|20096091|P5|Overall Study|Withdrawal by Subject|6
5819024|NCT02605174|20096092|P4|Overall Study|Withdrawal by Subject|11
5819025|NCT02605174|20096093|P3|Overall Study|Withdrawal by Subject|14
5819026|NCT02605174|20096094|P2|Overall Study|Withdrawal by Subject|6
5819027|NCT02605174|20096095|P1|Overall Study|Withdrawal by Subject|9
5819028|NCT02605174|20096089|P7|Overall Study|Pregnancy|0
5819029|NCT02605174|20096090|P6|Overall Study|Pregnancy|0
5819030|NCT02605174|20096091|P5|Overall Study|Pregnancy|0
5819031|NCT02605174|20096092|P4|Overall Study|Pregnancy|2
5819032|NCT02605174|20096093|P3|Overall Study|Pregnancy|0
5819033|NCT02605174|20096094|P2|Overall Study|Pregnancy|0
5819034|NCT02605174|20096095|P1|Overall Study|Pregnancy|1
5819035|NCT02605174|20096089|P7|Overall Study|Protocol Violation|12
5819036|NCT02605174|20096090|P6|Overall Study|Protocol Violation|7
5819037|NCT02605174|20096091|P5|Overall Study|Protocol Violation|7
5819038|NCT02605174|20096092|P4|Overall Study|Protocol Violation|6
5819039|NCT02605174|20096093|P3|Overall Study|Protocol Violation|14
5819040|NCT02605174|20096094|P2|Overall Study|Protocol Violation|4
5819041|NCT02605174|20096095|P1|Overall Study|Protocol Violation|10
5819042|NCT02605174|20096089|P7|Overall Study|Lost to Follow-up|29
5819043|NCT02605174|20096090|P6|Overall Study|Lost to Follow-up|10
5819044|NCT02605174|20096091|P5|Overall Study|Lost to Follow-up|20
5819045|NCT02605174|20096092|P4|Overall Study|Lost to Follow-up|10
5819046|NCT02605174|20096093|P3|Overall Study|Lost to Follow-up|27
5819047|NCT02605174|20096094|P2|Overall Study|Lost to Follow-up|7
5819048|NCT02605174|20096095|P1|Overall Study|Lost to Follow-up|20
5819049|NCT02605174|20096089|P7|Overall Study|Adverse Event|0
5819050|NCT02605174|20096090|P6|Overall Study|Adverse Event|0
5819051|NCT02605174|20096091|P5|Overall Study|Adverse Event|4
5819052|NCT02605174|20096092|P4|Overall Study|Adverse Event|0
5819053|NCT02605174|20096093|P3|Overall Study|Adverse Event|1
5819054|NCT02605174|20096094|P2|Overall Study|Adverse Event|0
5819055|NCT02605174|20096095|P1|Overall Study|Adverse Event|0
5819056|NCT02605122|20096157|P2|Overall Study|Lost to Follow-up|1
5819057|NCT02605122|20096158|P1|Overall Study|Lost to Follow-up|1
5819058|NCT02605122|20096157|P2|Overall Study|Withdrawal by Subject|1
5819059|NCT02605122|20096158|P1|Overall Study|Withdrawal by Subject|4
5819060|NCT02604589|20096181|P3|Overall Study|catheter dislodgement|1
5819061|NCT02604589|20096182|P2|Overall Study|catheter dislodgement|0
5819062|NCT02604589|20096183|P1|Overall Study|catheter dislodgement|0
5819063|NCT02604550|20096211|P2|Overall Study|Incomplete data using paper journal|19
5819064|NCT02604550|20096212|P1|Overall Study|Incomplete data using paper journal|18
5819065|NCT02604550|20096211|P2|Overall Study|Withdrawal by Subject|1
5819066|NCT02604550|20096212|P1|Overall Study|Withdrawal by Subject|0
5819067|NCT02604550|20096211|P2|Overall Study|Lost to Follow-up|6
5819068|NCT02604550|20096212|P1|Overall Study|Lost to Follow-up|7
5819069|NCT02604433|20096238|P2|Post Treatment Follow-up Period|Follow-up is ongoing|24
5819070|NCT02604433|20096239|P1|Post Treatment Follow-up Period|Follow-up is ongoing|42
5819071|NCT02604433|20096238|P2|Double-blind Treatment Period|Study is ongoing|74
5819072|NCT02604433|20096239|P1|Double-blind Treatment Period|Study is ongoing|156
5819073|NCT02604433|20096238|P2|Double-blind Treatment Period|D/C TRT: protocol violation|0
5819074|NCT02604433|20096239|P1|Double-blind Treatment Period|D/C TRT: protocol violation|1
5819075|NCT02604433|20096238|P2|Double-blind Treatment Period|D/C TRT: other, e.g. moved, personal|3
5819076|NCT02604433|20096239|P1|Double-blind Treatment Period|D/C TRT: other, e.g. moved, personal|3
5819077|NCT02604433|20096238|P2|Double-blind Treatment Period|D/C TRT: lack of efficacy|8
5819078|NCT02604433|20096239|P1|Double-blind Treatment Period|D/C TRT: lack of efficacy|2
5819079|NCT02604433|20096238|P2|Double-blind Treatment Period|D/C TRT: adverse event|1
5819080|NCT02604433|20096239|P1|Double-blind Treatment Period|D/C TRT: adverse event|10
5819081|NCT02604433|20096238|P2|Double-blind Treatment Period|D/C TRT: withdrawal by subject|12
5819082|NCT02604433|20096239|P1|Double-blind Treatment Period|D/C TRT: withdrawal by subject|26
5819083|NCT02604433|20096238|P2|Double-blind Treatment Period|Death|1
5819084|NCT02604433|20096239|P1|Double-blind Treatment Period|Death|1
5819085|NCT02604433|20096238|P2|Double-blind Treatment Period|Personal reasons or moved|1
5819086|NCT02604433|20096239|P1|Double-blind Treatment Period|Personal reasons or moved|2
5819087|NCT02604433|20096238|P2|Double-blind Treatment Period|Adverse Event|0
5819088|NCT02604433|20096239|P1|Double-blind Treatment Period|Adverse Event|4
5819089|NCT02604433|20096238|P2|Double-blind Treatment Period|Withdrawal by Subject|6
5819090|NCT02604433|20096239|P1|Double-blind Treatment Period|Withdrawal by Subject|13
5819091|NCT02604407|20096308|P3|Overall Study|Other|4
5819092|NCT02604407|20096309|P2|Overall Study|Other|1
5819093|NCT02604407|20096310|P1|Overall Study|Other|3
5819094|NCT02604407|20096308|P3|Overall Study|Lack of Efficacy|0
5819095|NCT02604407|20096309|P2|Overall Study|Lack of Efficacy|0
5819096|NCT02604407|20096310|P1|Overall Study|Lack of Efficacy|1
5819097|NCT02604407|20096308|P3|Overall Study|Lost to Follow-up|2
5819098|NCT02604407|20096309|P2|Overall Study|Lost to Follow-up|1
5819099|NCT02604407|20096310|P1|Overall Study|Lost to Follow-up|2
5819100|NCT02604407|20096308|P3|Overall Study|Withdrawal by Subject|5
5819101|NCT02604407|20096309|P2|Overall Study|Withdrawal by Subject|3
5819102|NCT02604407|20096310|P1|Overall Study|Withdrawal by Subject|3
5819103|NCT02604407|20096308|P3|Overall Study|Protocol Violation|0
5819104|NCT02604407|20096309|P2|Overall Study|Protocol Violation|0
5819105|NCT02604407|20096310|P1|Overall Study|Protocol Violation|2
5819106|NCT02604407|20096308|P3|Overall Study|Adverse Event|5
5819107|NCT02604407|20096309|P2|Overall Study|Adverse Event|7
5819108|NCT02604407|20096310|P1|Overall Study|Adverse Event|0
5819109|NCT02604342|20096323|P2|Overall Study|Physician Decision|0
5819110|NCT02604342|20096324|P1|Overall Study|Physician Decision|2
5819111|NCT02604342|20096323|P2|Overall Study|Lost to Follow-up|1
5819112|NCT02604342|20096324|P1|Overall Study|Lost to Follow-up|1
5819113|NCT02604342|20096323|P2|Overall Study|Study Termination by Sponsor|0
5819114|NCT02604342|20096324|P1|Overall Study|Study Termination by Sponsor|1
5819115|NCT02604342|20096323|P2|Overall Study|Other|0
5819116|NCT02604342|20096324|P1|Overall Study|Other|1
5819117|NCT02604342|20096323|P2|Overall Study|Withdrawal by Subject|6
5819118|NCT02604342|20096324|P1|Overall Study|Withdrawal by Subject|5
5819119|NCT02604342|20096323|P2|Overall Study|Progression of disease|0
5819120|NCT02604342|20096324|P1|Overall Study|Progression of disease|1
5819121|NCT02604342|20096323|P2|Overall Study|Death|16
5819122|NCT02604342|20096324|P1|Overall Study|Death|32
5819123|NCT02604264|20096376|P2|Intervention|Didn't use CVC for at least 21 days|242
5819124|NCT02604264|20096377|P1|Intervention|Didn't use CVC for at least 21 days|200
5819125|NCT02604212|20096387|P4|Overall Study|Withdrawal by Subject|0
5819126|NCT02604212|20096388|P3|Overall Study|Withdrawal by Subject|1
5819127|NCT02604212|20096389|P2|Overall Study|Withdrawal by Subject|0
5819128|NCT02604212|20096390|P1|Overall Study|Withdrawal by Subject|0
5819129|NCT02604212|20096387|P4|Overall Study|Study Terminated by Sponsor|3
5819130|NCT02604212|20096388|P3|Overall Study|Study Terminated by Sponsor|3
5819131|NCT02604212|20096389|P2|Overall Study|Study Terminated by Sponsor|1
5819132|NCT02604212|20096390|P1|Overall Study|Study Terminated by Sponsor|2
5819133|NCT02604199|20096458|P4|Overall Study|Withdrawal by Subject|0
5819134|NCT02604199|20096459|P3|Overall Study|Withdrawal by Subject|0
5819135|NCT02604199|20096460|P2|Overall Study|Withdrawal by Subject|1
5819136|NCT02604199|20096461|P1|Overall Study|Withdrawal by Subject|0
5819137|NCT02604199|20096458|P4|Overall Study|Study terminated by sponsor|2
5819138|NCT02604199|20096459|P3|Overall Study|Study terminated by sponsor|0
5819139|NCT02604199|20096460|P2|Overall Study|Study terminated by sponsor|2
5819140|NCT02604199|20096461|P1|Overall Study|Study terminated by sponsor|0
5819141|NCT02604199|20096458|P4|Overall Study|Pregnancy|1
5819142|NCT02604199|20096459|P3|Overall Study|Pregnancy|0
5819143|NCT02604199|20096460|P2|Overall Study|Pregnancy|0
5819144|NCT02604199|20096461|P1|Overall Study|Pregnancy|0
5819145|NCT02604160|20096530|P2|Overall Study|Physician Decision|1
5819146|NCT02604160|20096531|P1|Overall Study|Physician Decision|0
5819147|NCT02604160|20096530|P2|Overall Study|Protocol Violation|1
5819148|NCT02604160|20096531|P1|Overall Study|Protocol Violation|0
5819149|NCT02604017|20096545|P2|Overall Study|Other|0
5819150|NCT02604017|20096546|P1|Overall Study|Other|1
5819151|NCT02604017|20096545|P2|Overall Study|Lost to Follow-up|6
5819152|NCT02604017|20096546|P1|Overall Study|Lost to Follow-up|5
5819153|NCT02604017|20096545|P2|Overall Study|Withdrew Consent|2
5819154|NCT02604017|20096546|P1|Overall Study|Withdrew Consent|0
5819155|NCT02603952|20096575|P4|Overall Study|Received oseltamivir by error|1
5819156|NCT02603952|20096576|P3|Overall Study|Received oseltamivir by error|0
5819157|NCT02603952|20096577|P2|Overall Study|Received oseltamivir by error|0
5819158|NCT02603952|20096578|P1|Overall Study|Received oseltamivir by error|0
5819159|NCT02603952|20096575|P4|Overall Study|Withdrawal by Subject|0
5819160|NCT02603952|20096576|P3|Overall Study|Withdrawal by Subject|0
5819161|NCT02603952|20096577|P2|Overall Study|Withdrawal by Subject|0
5819162|NCT02603952|20096578|P1|Overall Study|Withdrawal by Subject|1
5819163|NCT02603887|20096626|P1|Overall Study|Disease progression|1
5819164|NCT02603887|20096626|P1|Overall Study|Adverse Event|4
5819165|NCT02603887|20096626|P1|Overall Study|FDA Guidance|1
5819166|NCT02603809|20096639|P6|Overall Study|Lack of Efficacy|1
5819167|NCT02603809|20096640|P5|Overall Study|Lack of Efficacy|0
5819168|NCT02603809|20096641|P4|Overall Study|Lack of Efficacy|0
5819169|NCT02603809|20096642|P3|Overall Study|Lack of Efficacy|0
5819170|NCT02603809|20096643|P2|Overall Study|Lack of Efficacy|1
5819171|NCT02603809|20096644|P1|Overall Study|Lack of Efficacy|0
5819172|NCT02603809|20096639|P6|Overall Study|Adverse Event|1
5819173|NCT02603809|20096640|P5|Overall Study|Adverse Event|1
5819174|NCT02603809|20096641|P4|Overall Study|Adverse Event|2
5819175|NCT02603809|20096642|P3|Overall Study|Adverse Event|2
5819176|NCT02603809|20096643|P2|Overall Study|Adverse Event|0
5819177|NCT02603809|20096644|P1|Overall Study|Adverse Event|3
5819178|NCT02603809|20096639|P6|Overall Study|Physician Decision|1
5819179|NCT02603809|20096640|P5|Overall Study|Physician Decision|2
5819180|NCT02603809|20096641|P4|Overall Study|Physician Decision|1
5819181|NCT02603809|20096642|P3|Overall Study|Physician Decision|0
5819182|NCT02603809|20096643|P2|Overall Study|Physician Decision|0
5819183|NCT02603809|20096644|P1|Overall Study|Physician Decision|0
5819184|NCT02603809|20096639|P6|Overall Study|Pre-specified discontinuation criteria|1
5819185|NCT02603809|20096640|P5|Overall Study|Pre-specified discontinuation criteria|3
5819186|NCT02603809|20096641|P4|Overall Study|Pre-specified discontinuation criteria|2
5819187|NCT02603809|20096642|P3|Overall Study|Pre-specified discontinuation criteria|2
5819188|NCT02603809|20096643|P2|Overall Study|Pre-specified discontinuation criteria|3
5819189|NCT02603809|20096644|P1|Overall Study|Pre-specified discontinuation criteria|3
5819190|NCT02603809|20096639|P6|Overall Study|Lost to Follow-up|2
5819191|NCT02603809|20096640|P5|Overall Study|Lost to Follow-up|2
5819192|NCT02603809|20096641|P4|Overall Study|Lost to Follow-up|4
5819193|NCT02603809|20096642|P3|Overall Study|Lost to Follow-up|1
5819194|NCT02603809|20096643|P2|Overall Study|Lost to Follow-up|3
5819195|NCT02603809|20096644|P1|Overall Study|Lost to Follow-up|2
5819196|NCT02603809|20096639|P6|Overall Study|Withdrawal by Subject|4
5819197|NCT02603809|20096640|P5|Overall Study|Withdrawal by Subject|3
5819198|NCT02603809|20096641|P4|Overall Study|Withdrawal by Subject|3
5819199|NCT02603809|20096642|P3|Overall Study|Withdrawal by Subject|2
5819200|NCT02603809|20096643|P2|Overall Study|Withdrawal by Subject|1
5819201|NCT02603809|20096644|P1|Overall Study|Withdrawal by Subject|4
5819218|NCT02603419|20096761|P6|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|1
5819219|NCT02603419|20096762|P5|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0
5819220|NCT02603419|20096763|P4|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0
5819221|NCT02603419|20096764|P3|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0
5819222|NCT02603419|20096765|P2|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0
5819223|NCT02603419|20096766|P1|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0
5819224|NCT02603419|20096761|P6|Expansion Phase:Maximum Exposure:48Weeks|Death|1
5819225|NCT02603419|20096762|P5|Expansion Phase:Maximum Exposure:48Weeks|Death|0
5819226|NCT02603419|20096763|P4|Expansion Phase:Maximum Exposure:48Weeks|Death|0
5819227|NCT02603419|20096764|P3|Expansion Phase:Maximum Exposure:48Weeks|Death|0
5819228|NCT02603419|20096765|P2|Expansion Phase:Maximum Exposure:48Weeks|Death|0
5819229|NCT02603419|20096766|P1|Expansion Phase:Maximum Exposure:48Weeks|Death|0
5819230|NCT02603419|20096761|P6|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|1
5819231|NCT02603419|20096762|P5|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0
5819232|NCT02603419|20096763|P4|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0
5819233|NCT02603419|20096764|P3|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0
5819234|NCT02603419|20096765|P2|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0
5819235|NCT02603419|20096766|P1|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0
5819236|NCT02603419|20096761|P6|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0
5819237|NCT02603419|20096762|P5|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0
5819238|NCT02603419|20096763|P4|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|2
5819239|NCT02603419|20096764|P3|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0
5819240|NCT02603419|20096765|P2|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0
5819241|NCT02603419|20096766|P1|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0
5819242|NCT02603419|20096761|P6|Lead-in Phase:Maximum Exposure:123Weeks|Other|0
5819243|NCT02603419|20096762|P5|Lead-in Phase:Maximum Exposure:123Weeks|Other|1
5819244|NCT02603419|20096763|P4|Lead-in Phase:Maximum Exposure:123Weeks|Other|0
5819245|NCT02603419|20096764|P3|Lead-in Phase:Maximum Exposure:123Weeks|Other|1
5819246|NCT02603419|20096765|P2|Lead-in Phase:Maximum Exposure:123Weeks|Other|1
5819247|NCT02603419|20096766|P1|Lead-in Phase:Maximum Exposure:123Weeks|Other|2
5819248|NCT02603419|20096761|P6|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0
5819249|NCT02603419|20096762|P5|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0
5819250|NCT02603419|20096763|P4|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0
5819251|NCT02603419|20096764|P3|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0
5819252|NCT02603419|20096765|P2|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|1
5819253|NCT02603419|20096766|P1|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0
5819254|NCT02603419|20096761|P6|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0
5819255|NCT02603419|20096762|P5|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|1
5819256|NCT02603419|20096763|P4|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0
5819257|NCT02603419|20096764|P3|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0
5819258|NCT02603419|20096765|P2|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0
5819259|NCT02603419|20096766|P1|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0
5819260|NCT02603419|20096761|P6|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0
5819261|NCT02603419|20096762|P5|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|1
5819262|NCT02603419|20096763|P4|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0
5819263|NCT02603419|20096764|P3|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|3
5819264|NCT02603419|20096765|P2|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0
5819265|NCT02603419|20096766|P1|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|2
5819266|NCT02603419|20096761|P6|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|0
5819267|NCT02603419|20096762|P5|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|3
5819268|NCT02603419|20096763|P4|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4
5819269|NCT02603419|20096764|P3|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2
5819270|NCT02603419|20096765|P2|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4
5819271|NCT02603419|20096766|P1|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2
5819272|NCT02603419|20096761|P6|Lead-in Phase:Maximum Exposure:123Weeks|Death|0
5819273|NCT02603419|20096762|P5|Lead-in Phase:Maximum Exposure:123Weeks|Death|0
5819274|NCT02603419|20096763|P4|Lead-in Phase:Maximum Exposure:123Weeks|Death|0
5819275|NCT02603419|20096764|P3|Lead-in Phase:Maximum Exposure:123Weeks|Death|0
5819276|NCT02603419|20096765|P2|Lead-in Phase:Maximum Exposure:123Weeks|Death|1
5819277|NCT02603419|20096766|P1|Lead-in Phase:Maximum Exposure:123Weeks|Death|0
5819278|NCT02603393|20096953|P2|Overall Study|Sponsor decision|0
5819279|NCT02603393|20096954|P1|Overall Study|Sponsor decision|1
5819280|NCT02603393|20096953|P2|Overall Study|Non-compliance with study treatment|0
5819281|NCT02603393|20096954|P1|Overall Study|Non-compliance with study treatment|1
5819282|NCT02603393|20096953|P2|Overall Study|Lost to Follow-up|2
5819283|NCT02603393|20096954|P1|Overall Study|Lost to Follow-up|1
5819284|NCT02603393|20096953|P2|Overall Study|Protocol deviation|3
5819285|NCT02603393|20096954|P1|Overall Study|Protocol deviation|2
5819286|NCT02603393|20096953|P2|Overall Study|Physician Decision|3
5819287|NCT02603393|20096954|P1|Overall Study|Physician Decision|3
5819288|NCT02603393|20096953|P2|Overall Study|Death|4
5819289|NCT02603393|20096954|P1|Overall Study|Death|3
5819290|NCT02603393|20096953|P2|Overall Study|Lack of Efficacy|2
5819291|NCT02603393|20096954|P1|Overall Study|Lack of Efficacy|7
5819292|NCT02603393|20096953|P2|Overall Study|Technical problems|7
5819293|NCT02603393|20096954|P1|Overall Study|Technical problems|4
5819294|NCT02603393|20096953|P2|Overall Study|Adverse Event|15
5819295|NCT02603393|20096954|P1|Overall Study|Adverse Event|17
5819296|NCT02603393|20096953|P2|Overall Study|Patient/guardian decision|18
5819297|NCT02603393|20096954|P1|Overall Study|Patient/guardian decision|32
5819298|NCT02603172|20096993|P8|Part A (Approximately 16 Weeks)|Adverse Event|0
5819299|NCT02603172|20096994|P7|Part A (Approximately 16 Weeks)|Adverse Event|0
5819300|NCT02603172|20096995|P6|Part A (Approximately 16 Weeks)|Adverse Event|0
5819301|NCT02603172|20096996|P5|Part A (Approximately 16 Weeks)|Adverse Event|0
5819302|NCT02603172|20096997|P4|Part A (Approximately 16 Weeks)|Adverse Event|0
5819303|NCT02603172|20096998|P3|Part A (Approximately 16 Weeks)|Adverse Event|1
5819304|NCT02603172|20096999|P2|Part A (Approximately 16 Weeks)|Adverse Event|0
5819305|NCT02603172|20097000|P1|Part A (Approximately 16 Weeks)|Adverse Event|0
5819306|NCT02603120|20097128|P2|OL Extension B/F/TAF Treatment Phase|Lack of Efficacy|1
5819307|NCT02603120|20097129|P1|OL Extension B/F/TAF Treatment Phase|Lack of Efficacy|0
5819308|NCT02603120|20097128|P2|OL Extension B/F/TAF Treatment Phase|Death|1
5819309|NCT02603120|20097129|P1|OL Extension B/F/TAF Treatment Phase|Death|0
5819310|NCT02603120|20097128|P2|OL Extension B/F/TAF Treatment Phase|Adverse Event|1
5819311|NCT02603120|20097129|P1|OL Extension B/F/TAF Treatment Phase|Adverse Event|0
5819312|NCT02603120|20097128|P2|OL Extension B/F/TAF Treatment Phase|Withdrew consent|2
5819313|NCT02603120|20097129|P1|OL Extension B/F/TAF Treatment Phase|Withdrew consent|1
5819314|NCT02603120|20097128|P2|OL Extension B/F/TAF Treatment Phase|Investigator's discretion|2
5819315|NCT02603120|20097129|P1|OL Extension B/F/TAF Treatment Phase|Investigator's discretion|1
5819316|NCT02603120|20097128|P2|OL Extension B/F/TAF Treatment Phase|Lost to Follow-up|4
5819317|NCT02603120|20097129|P1|OL Extension B/F/TAF Treatment Phase|Lost to Follow-up|3
5819318|NCT02603120|20097128|P2|Double-Blind Treatment Phase|Did not receive study drug|2
5819319|NCT02603120|20097129|P1|Double-Blind Treatment Phase|Did not receive study drug|2
5819320|NCT02603120|20097128|P2|Double-Blind Treatment Phase|Non-compliance with study drug|0
5819321|NCT02603120|20097129|P1|Double-Blind Treatment Phase|Non-compliance with study drug|1
5819322|NCT02603120|20097128|P2|Double-Blind Treatment Phase|Pregnancy|1
5819323|NCT02603120|20097129|P1|Double-Blind Treatment Phase|Pregnancy|1
5819324|NCT02603120|20097128|P2|Double-Blind Treatment Phase|Investigator's discretion|0
5819325|NCT02603120|20097129|P1|Double-Blind Treatment Phase|Investigator's discretion|2
5819326|NCT02603120|20097128|P2|Double-Blind Treatment Phase|Death|0
5819327|NCT02603120|20097129|P1|Double-Blind Treatment Phase|Death|2
5819328|NCT02603120|20097128|P2|Double-Blind Treatment Phase|Lost to Follow-up|2
5819329|NCT02603120|20097129|P1|Double-Blind Treatment Phase|Lost to Follow-up|4
5819330|NCT02603120|20097128|P2|Double-Blind Treatment Phase|Adverse Event|3
5819331|NCT02603120|20097129|P1|Double-Blind Treatment Phase|Adverse Event|3
5819332|NCT02603120|20097128|P2|Double-Blind Treatment Phase|Withdrew consent|8
5819333|NCT02603120|20097129|P1|Double-Blind Treatment Phase|Withdrew consent|4
5819334|NCT02603107|20097151|P2|Optional Extension Phase|Protocol Violation|0
5819335|NCT02603107|20097152|P1|Optional Extension Phase|Protocol Violation|1
5819336|NCT02603107|20097151|P2|Optional Extension Phase|Not treated in extension phase|1
5819337|NCT02603107|20097152|P1|Optional Extension Phase|Not treated in extension phase|0
5819338|NCT02603107|20097151|P2|Optional Extension Phase|Adverse Event|2
5819339|NCT02603107|20097152|P1|Optional Extension Phase|Adverse Event|0
5819340|NCT02603107|20097151|P2|Optional Extension Phase|Pregnancy|3
5819341|NCT02603107|20097152|P1|Optional Extension Phase|Pregnancy|0
5819342|NCT02603107|20097151|P2|Optional Extension Phase|Investigator's discretion|2
5819343|NCT02603107|20097152|P1|Optional Extension Phase|Investigator's discretion|2
5819344|NCT02603107|20097151|P2|Optional Extension Phase|Withdrew consent|2
5819345|NCT02603107|20097152|P1|Optional Extension Phase|Withdrew consent|3
5819346|NCT02603107|20097151|P2|Optional Extension Phase|Lost to Follow-up|3
5819347|NCT02603107|20097152|P1|Optional Extension Phase|Lost to Follow-up|3
5819348|NCT02603107|20097151|P2|Randomized Phase|Protocol Violation|0
5819349|NCT02603107|20097152|P1|Randomized Phase|Protocol Violation|1
5819350|NCT02603107|20097151|P2|Randomized Phase|Lack of Efficacy|0
5819351|NCT02603107|20097152|P1|Randomized Phase|Lack of Efficacy|1
5819352|NCT02603107|20097151|P2|Randomized Phase|Investigator's discretion|1
5819353|NCT02603107|20097152|P1|Randomized Phase|Investigator's discretion|0
5819354|NCT02603107|20097151|P2|Randomized Phase|Non-compliance with study drug|1
5819355|NCT02603107|20097152|P1|Randomized Phase|Non-compliance with study drug|1
5819356|NCT02603107|20097151|P2|Randomized Phase|Death|1
5819357|NCT02603107|20097152|P1|Randomized Phase|Death|1
5819358|NCT02603107|20097151|P2|Randomized Phase|Adverse Event|0
5819359|NCT02603107|20097152|P1|Randomized Phase|Adverse Event|2
5819360|NCT02603107|20097151|P2|Randomized Phase|Lost to Follow-up|3
5819361|NCT02603107|20097152|P1|Randomized Phase|Lost to Follow-up|1
5819362|NCT02603107|20097151|P2|Randomized Phase|Withdrew consent|15
5819363|NCT02603107|20097152|P1|Randomized Phase|Withdrew consent|8
5819364|NCT02602080|20097217|P3|Overall Study|Protocol Violation|3
5819365|NCT02602080|20097218|P2|Overall Study|Protocol Violation|1
5819366|NCT02602080|20097219|P1|Overall Study|Protocol Violation|6
5819367|NCT02601820|20097262|P1|1-Yr Post-Treatment (T5)|Missing T5 Record|88
5819368|NCT02601820|20097262|P1|12 Weeks Post-Treatment (T4)|Missing T4 record|3
5819369|NCT02601820|20097262|P1|Late On-Treatment (T3)|missing T3 Record|49
5819370|NCT02601820|20097262|P1|Early On-Treatment (T2)|Missing T2 Record|51
5819371|NCT02601625|20097291|P4|Overall Study|Lost to Follow-up|1
5819372|NCT02601625|20097292|P3|Overall Study|Lost to Follow-up|1
5819373|NCT02601625|20097293|P2|Overall Study|Lost to Follow-up|0
5819374|NCT02601625|20097294|P1|Overall Study|Lost to Follow-up|0
5819375|NCT02601573|20097347|P5|Overall Study|Withdrawal by Subject|0
5819376|NCT02601573|20097348|P4|Overall Study|Withdrawal by Subject|1
5819377|NCT02601573|20097349|P3|Overall Study|Withdrawal by Subject|0
5819378|NCT02601573|20097350|P2|Overall Study|Withdrawal by Subject|1
5819379|NCT02601573|20097351|P1|Overall Study|Withdrawal by Subject|0
5819380|NCT02601573|20097347|P5|Overall Study|Lost to Follow-up|2
5819381|NCT02601573|20097348|P4|Overall Study|Lost to Follow-up|0
5819382|NCT02601573|20097349|P3|Overall Study|Lost to Follow-up|1
5819383|NCT02601573|20097350|P2|Overall Study|Lost to Follow-up|3
5819384|NCT02601573|20097351|P1|Overall Study|Lost to Follow-up|0
5819385|NCT02601560|20097386|P8|Overall Study|Other|0
5819386|NCT02601560|20097387|P7|Overall Study|Other|1
5819387|NCT02601560|20097388|P6|Overall Study|Other|0
5819388|NCT02601560|20097389|P5|Overall Study|Other|0
5819389|NCT02601560|20097390|P4|Overall Study|Other|0
5819390|NCT02601560|20097391|P3|Overall Study|Other|0
5819391|NCT02601560|20097392|P2|Overall Study|Other|0
5819392|NCT02601560|20097393|P1|Overall Study|Other|0
5819393|NCT02601469|20097577|P2|Overall Study|Enrolled in Error|0
5819394|NCT02601469|20097578|P1|Overall Study|Enrolled in Error|1
5819410|NCT02601300|20097608|P1|Extension Phase|Lack of Efficacy|10
5819411|NCT02601300|20097608|P1|Extension Phase|Adverse Event|4
5819412|NCT02601300|20097608|P1|Extension Phase|Withdrawal by Subject|3
5819413|NCT02601300|20097608|P1|Induction Phase|Protocol Violation|1
5819414|NCT02601300|20097608|P1|Induction Phase|Lack of Efficacy|2
5819415|NCT02601209|20097628|P9|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0
5819416|NCT02601209|20097629|P8|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0
5819417|NCT02601209|20097630|P7|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1
5819418|NCT02601209|20097631|P6|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|2
5819419|NCT02601209|20097632|P5|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1
5819420|NCT02601209|20097633|P4|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0
5819421|NCT02601209|20097634|P3|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0
5819422|NCT02601209|20097635|P2|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0
5819423|NCT02601209|20097636|P1|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0
5819424|NCT02601209|20097628|P9|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0
5819425|NCT02601209|20097629|P8|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0
5819426|NCT02601209|20097630|P7|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0
5819427|NCT02601209|20097631|P6|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0
5819428|NCT02601209|20097632|P5|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0
5819429|NCT02601209|20097633|P4|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0
5819430|NCT02601209|20097634|P3|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1
5819431|NCT02601209|20097635|P2|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1
5819432|NCT02601209|20097636|P1|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1
5819433|NCT02600923|20097683|P1|Overall Study|Not treated|1
5819434|NCT02600923|20097683|P1|Overall Study|Study terminated by Sponsor|53
5819435|NCT02600923|20097683|P1|Overall Study|Objective progression or relapse|50
5819436|NCT02600923|20097683|P1|Overall Study|Withdrawal by Subject|5
5819437|NCT02600923|20097683|P1|Overall Study|Lost to Follow-up|1
5819438|NCT02600923|20097683|P1|Overall Study|Insufficient clinical response|6
5819439|NCT02600923|20097683|P1|Overall Study|Global deterioration of health status|2
5819440|NCT02600923|20097683|P1|Overall Study|Adverse Event|3
5819441|NCT02600923|20097683|P1|Overall Study|Death|10
5819442|NCT02600871|20097693|P2|Overall Study|Lost to Follow-up|10
5819443|NCT02600871|20097694|P1|Overall Study|Lost to Follow-up|13
5819444|NCT02600845|20097704|P1|Overall Study|Consent Withdrawal|5
5819445|NCT02600845|20097704|P1|Overall Study|Non-compliance with Study Procedures|10
5819446|NCT02600845|20097704|P1|Overall Study|Reason Not Specified|3
5819447|NCT02600819|20097719|P2|GEN Phase|Lost to Follow-up|0
5819448|NCT02600819|20097720|P1|GEN Phase|Lost to Follow-up|2
5819449|NCT02600819|20097719|P2|GEN Phase|Withdrew Consent|0
5819450|NCT02600819|20097720|P1|GEN Phase|Withdrew Consent|5
5819451|NCT02600819|20097719|P2|GEN Phase|Non-Compliance with Study Drug|0
5819452|NCT02600819|20097720|P1|GEN Phase|Non-Compliance with Study Drug|1
5819453|NCT02600819|20097719|P2|GEN Phase|Investigator's Discretion|0
5819454|NCT02600819|20097720|P1|GEN Phase|Investigator's Discretion|4
5819455|NCT02600819|20097719|P2|GEN Phase|Death|0
5819456|NCT02600819|20097720|P1|GEN Phase|Death|2
5819457|NCT02600819|20097719|P2|GEN Phase|Adverse Event|0
5819458|NCT02600819|20097720|P1|GEN Phase|Adverse Event|2
5819459|NCT02600559|20097800|P1|Overall Study|Lost to Follow-up|20
5819460|NCT02600559|20097800|P1|Overall Study|Withdrawal by Subject|3
5819461|NCT02600351|20097841|P4|Overall Study|Randomized but Not Treated|3
5819462|NCT02600351|20097842|P3|Overall Study|Randomized but Not Treated|1
5819463|NCT02600351|20097843|P2|Overall Study|Randomized but Not Treated|0
5819464|NCT02600351|20097844|P1|Overall Study|Randomized but Not Treated|1
5819465|NCT02600351|20097841|P4|Overall Study|Lost to Follow-up|0
5819466|NCT02600351|20097842|P3|Overall Study|Lost to Follow-up|0
5819467|NCT02600351|20097843|P2|Overall Study|Lost to Follow-up|0
5819468|NCT02600351|20097844|P1|Overall Study|Lost to Follow-up|1
5819469|NCT02600351|20097841|P4|Overall Study|Lack of Efficacy|2
5819470|NCT02600351|20097842|P3|Overall Study|Lack of Efficacy|5
5819471|NCT02600351|20097843|P2|Overall Study|Lack of Efficacy|0
5819472|NCT02600351|20097844|P1|Overall Study|Lack of Efficacy|3
5819473|NCT02599961|20097879|P1|Overall Study|Other, Not Specified|3
5819474|NCT02599961|20097879|P1|Overall Study|Discontinuation of Study by Sponsor|9
5819475|NCT02599961|20097879|P1|Overall Study|Subject Non-Compliance|2
5819476|NCT02599961|20097879|P1|Overall Study|Withdrawal by Subject|1
5819477|NCT02599688|20097921|P1|Overall Study|Termination by Sponsor|2
5819478|NCT02599688|20097921|P1|Overall Study|Withdrawal by Subject|1
5819479|NCT02599688|20097921|P1|Overall Study|Lack of Efficacy|1
5819480|NCT02599129|20097957|P2|Overall Study|Withdrawal by Subject|1
5819481|NCT02599129|20097958|P1|Overall Study|Withdrawal by Subject|2
5819482|NCT02599129|20097957|P2|Overall Study|Lost to Follow-up|0
5819483|NCT02599129|20097958|P1|Overall Study|Lost to Follow-up|1
5819484|NCT02599129|20097957|P2|Overall Study|Lack of Efficacy|2
5819485|NCT02599129|20097958|P1|Overall Study|Lack of Efficacy|2
5819486|NCT02598934|20097974|P2|Overall Study|Protocol Violation|2
5819487|NCT02598934|20097975|P1|Overall Study|Protocol Violation|1
5819488|NCT02598934|20097974|P2|Overall Study|Administrative|1
5819489|NCT02598934|20097975|P1|Overall Study|Administrative|2
5819490|NCT02598934|20097974|P2|Overall Study|Withdrawal by Subject|3
5819491|NCT02598934|20097975|P1|Overall Study|Withdrawal by Subject|2
5819492|NCT02598934|20097974|P2|Overall Study|Failure to Return|3
5819493|NCT02598934|20097975|P1|Overall Study|Failure to Return|3
5819494|NCT02598934|20097974|P2|Overall Study|Adverse Event|13
5819495|NCT02598934|20097975|P1|Overall Study|Adverse Event|11
5819496|NCT02598622|20097987|P2|Overall Study|Physician Decision|0
5819497|NCT02598622|20097988|P1|Overall Study|Physician Decision|3
5819498|NCT02598622|20097987|P2|Overall Study|Withdrawal by Subject|0
5819499|NCT02598622|20097988|P1|Overall Study|Withdrawal by Subject|3
5819500|NCT02598297|20098017|P2|Overall Study|Followed for survival|0
5819501|NCT02598297|20098018|P1|Overall Study|Followed for survival|1
5819502|NCT02598297|20098017|P2|Overall Study|Subject/guardian decision|0
5819503|NCT02598297|20098018|P1|Overall Study|Subject/guardian decision|1
5819504|NCT02598297|20098017|P2|Overall Study|Physician Decision|0
5819505|NCT02598297|20098018|P1|Overall Study|Physician Decision|1
5819506|NCT02598297|20098017|P2|Overall Study|Adverse Event|1
5819507|NCT02598297|20098018|P1|Overall Study|Adverse Event|1
5819508|NCT02598297|20098017|P2|Overall Study|Study terminated by Sponsor|23
5819509|NCT02598297|20098018|P1|Overall Study|Study terminated by Sponsor|21
5819510|NCT02598193|20098044|P1|Overall Study|Does not want to take Nintedanib|1
5819511|NCT02598193|20098044|P1|Overall Study|Listed in active lung transplant list|1
5819512|NCT02598193|20098044|P1|Overall Study|Withdrawal by Subject|1
5819513|NCT02598193|20098044|P1|Overall Study|Adverse Event|13
5819514|NCT02598128|20098052|P4|Period A: Days -7 to -1|Adverse Event|0
5819515|NCT02598128|20098053|P3|Period A: Days -7 to -1|Adverse Event|0
5819516|NCT02598128|20098054|P2|Period A: Days -7 to -1|Adverse Event|0
5819517|NCT02598128|20098055|P1|Period A: Days -7 to -1|Adverse Event|1
5819518|NCT02598076|20098098|P2|Overall Study|Lost to Follow-up|3
5819519|NCT02598076|20098099|P1|Overall Study|Lost to Follow-up|2
5819520|NCT02597946|20098113|P1|Overall Study|Other than above|1
5819521|NCT02597946|20098113|P1|Overall Study|Progressive disease|16
5819522|NCT02597946|20098113|P1|Overall Study|Withdrawal by Subject|1
5819523|NCT02597933|20098124|P2|Overall Study|Other than stated above|14
5819524|NCT02597933|20098125|P1|Overall Study|Other than stated above|7
5819525|NCT02597933|20098124|P2|Overall Study|Not treated|2
5819526|NCT02597933|20098125|P1|Overall Study|Not treated|2
5819527|NCT02597933|20098124|P2|Overall Study|Adverse Event|28
5819528|NCT02597933|20098125|P1|Overall Study|Adverse Event|20
5819529|NCT02597933|20098124|P2|Overall Study|Protocol Violation|2
5819530|NCT02597933|20098125|P1|Overall Study|Protocol Violation|2
5819531|NCT02597933|20098124|P2|Overall Study|Withdrawal by Subject|5
5819532|NCT02597933|20098125|P1|Overall Study|Withdrawal by Subject|7
5819533|NCT02597920|20098156|P3|Overall Study|Other|0
5819534|NCT02597920|20098157|P2|Overall Study|Other|0
5819535|NCT02597920|20098158|P1|Overall Study|Other|1
5819536|NCT02597920|20098156|P3|Overall Study|Other than specified|5
5819537|NCT02597920|20098157|P2|Overall Study|Other than specified|31
5819538|NCT02597920|20098158|P1|Overall Study|Other than specified|10
5819539|NCT02597920|20098156|P3|Overall Study|Refuse to continue in the study|1
5819540|NCT02597920|20098157|P2|Overall Study|Refuse to continue in the study|13
5819541|NCT02597920|20098158|P1|Overall Study|Refuse to continue in the study|3
5819542|NCT02597920|20098156|P3|Overall Study|Lost to Follow-up|0
5819543|NCT02597920|20098157|P2|Overall Study|Lost to Follow-up|9
5819544|NCT02597920|20098158|P1|Overall Study|Lost to Follow-up|7
5819545|NCT02597920|20098156|P3|Overall Study|Other adverse event|0
5819546|NCT02597920|20098157|P2|Overall Study|Other adverse event|30
5819547|NCT02597920|20098158|P1|Overall Study|Other adverse event|20
5819548|NCT02597920|20098156|P3|Overall Study|Worsening of other pre-existing disease|0
5819549|NCT02597920|20098157|P2|Overall Study|Worsening of other pre-existing disease|1
5819550|NCT02597920|20098158|P1|Overall Study|Worsening of other pre-existing disease|0
5819551|NCT02597855|20098192|P2|Overall Study|Lost to Follow-up|1
5819552|NCT02597855|20098193|P1|Overall Study|Lost to Follow-up|2
5819559|NCT02597452|20098313|P1|Overall Study|testing incomplete|30
5819560|NCT02597062|20098425|P1|Overall Study|Ineligible|1
5819561|NCT02597049|20098434|P3|Overall Study|Noncompliant with Study Visits|0
5819562|NCT02597049|20098435|P2|Overall Study|Noncompliant with Study Visits|0
5819563|NCT02597049|20098436|P1|Overall Study|Noncompliant with Study Visits|1
5819564|NCT02597049|20098434|P3|Overall Study|Death|0
5819565|NCT02597049|20098435|P2|Overall Study|Death|0
5819566|NCT02597049|20098436|P1|Overall Study|Death|2
5819567|NCT02597049|20098434|P3|Overall Study|Adverse Event|0
5819568|NCT02597049|20098435|P2|Overall Study|Adverse Event|0
5819569|NCT02597049|20098436|P1|Overall Study|Adverse Event|2
5819570|NCT02597049|20098434|P3|Overall Study|Withdrawal by Subject|1
5819571|NCT02597049|20098435|P2|Overall Study|Withdrawal by Subject|2
5819572|NCT02597049|20098436|P1|Overall Study|Withdrawal by Subject|2
5819573|NCT02597049|20098434|P3|Overall Study|Lost to Follow-up|2
5819574|NCT02597049|20098435|P2|Overall Study|Lost to Follow-up|3
5819575|NCT02597049|20098436|P1|Overall Study|Lost to Follow-up|0
5819576|NCT02596971|20098477|P3|Overall Study|Death|0
5819577|NCT02596971|20098478|P2|Overall Study|Death|0
5819578|NCT02596971|20098479|P1|Overall Study|Death|2
5819579|NCT02596971|20098477|P3|Overall Study|In Follow-up|15
5819580|NCT02596971|20098478|P2|Overall Study|In Follow-up|0
5819581|NCT02596971|20098479|P1|Overall Study|In Follow-up|4
5819582|NCT02596971|20098477|P3|Overall Study|Ongoing|24
5819583|NCT02596971|20098478|P2|Overall Study|Ongoing|6
5819584|NCT02596971|20098479|P1|Overall Study|Ongoing|36
5819585|NCT02596971|20098477|P3|Overall Study|Withdrawal by Subject|2
5819586|NCT02596971|20098478|P2|Overall Study|Withdrawal by Subject|0
5819587|NCT02596971|20098479|P1|Overall Study|Withdrawal by Subject|0
5819588|NCT02596971|20098477|P3|Overall Study|Physician Decision|1
5819589|NCT02596971|20098478|P2|Overall Study|Physician Decision|0
5819590|NCT02596971|20098479|P1|Overall Study|Physician Decision|0
5819591|NCT02596971|20098477|P3|Overall Study|Disease Progression|0
5819592|NCT02596971|20098478|P2|Overall Study|Disease Progression|1
5819593|NCT02596971|20098479|P1|Overall Study|Disease Progression|0
5819594|NCT02596958|20098508|P1|Overall Study|Excluded Due to Second Line Treatment|9
5819595|NCT02596958|20098508|P1|Overall Study|Missing|32
5819596|NCT02596958|20098508|P1|Overall Study|Lost to Follow-up|33
5819597|NCT02596958|20098508|P1|Overall Study|Administrative Reasons/Other|231
5819598|NCT02596958|20098508|P1|Overall Study|Refusal of Treatment/Poor Cooperation|61
5819599|NCT02596958|20098508|P1|Overall Study|Death From Other Cause|33
5819600|NCT02596958|20098508|P1|Overall Study|Death From Cancer|112
5819601|NCT02596958|20098508|P1|Overall Study|Cancer Progression|441
5819602|NCT02596958|20098508|P1|Overall Study|Serious Adverse Drug Reactions|44
5819603|NCT02596945|20098520|P1|Overall Study|Missing|1
5819604|NCT02596945|20098520|P1|Overall Study|Withdrawal by Subject|1
5819605|NCT02596945|20098520|P1|Overall Study|Other Erythropoietin stimulating agent|4
5819606|NCT02596945|20098520|P1|Overall Study|Change to hemodialysis|15
5819607|NCT02596945|20098520|P1|Overall Study|Other|32
5819608|NCT02596945|20098520|P1|Overall Study|No documentation of study drug dosing|3
5819609|NCT02596893|20098541|P4|Overall Double-Blind Period Weeks 0-52|Early Escape|70
5819610|NCT02596893|20098542|P3|Overall Double-Blind Period Weeks 0-52|Early Escape|69
5819611|NCT02596893|20098543|P2|Overall Double-Blind Period Weeks 0-52|Early Escape|76
5819612|NCT02596893|20098544|P1|Overall Double-Blind Period Weeks 0-52|Early Escape|66
5819613|NCT02596893|20098541|P4|Overall Double-Blind Period Weeks 0-52|Protocol Violation|2
5819614|NCT02596893|20098542|P3|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0
5819615|NCT02596893|20098543|P2|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0
5819616|NCT02596893|20098544|P1|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0
5819617|NCT02596893|20098541|P4|Overall Double-Blind Period Weeks 0-52|Death|0
5819618|NCT02596893|20098542|P3|Overall Double-Blind Period Weeks 0-52|Death|1
5819619|NCT02596893|20098543|P2|Overall Double-Blind Period Weeks 0-52|Death|0
5819620|NCT02596893|20098544|P1|Overall Double-Blind Period Weeks 0-52|Death|0
5819621|NCT02596893|20098541|P4|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|2
5819622|NCT02596893|20098542|P3|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|1
5819623|NCT02596893|20098543|P2|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0
5819624|NCT02596893|20098544|P1|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0
5819625|NCT02596893|20098541|P4|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1
5819626|NCT02596893|20098542|P3|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1
5819627|NCT02596893|20098543|P2|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1
5819628|NCT02596893|20098544|P1|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|0
5819629|NCT02596893|20098541|P4|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2
5819630|NCT02596893|20098542|P3|Overall Double-Blind Period Weeks 0-52|Miscellaneous|0
5819631|NCT02596893|20098543|P2|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2
5819632|NCT02596893|20098544|P1|Overall Double-Blind Period Weeks 0-52|Miscellaneous|1
5819633|NCT02596893|20098541|P4|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|5
5819634|NCT02596893|20098542|P3|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|13
5819635|NCT02596893|20098543|P2|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|4
5819636|NCT02596893|20098544|P1|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|10
5819637|NCT02596893|20098541|P4|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|13
5819638|NCT02596893|20098542|P3|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14
5819639|NCT02596893|20098543|P2|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14
5819640|NCT02596893|20098544|P1|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|15
5819641|NCT02596893|20098541|P4|Overall Double-Blind Period Weeks 0-52|Pregnancy|1
5819642|NCT02596893|20098542|P3|Overall Double-Blind Period Weeks 0-52|Pregnancy|0
5819643|NCT02596893|20098543|P2|Overall Double-Blind Period Weeks 0-52|Pregnancy|0
5819644|NCT02596893|20098544|P1|Overall Double-Blind Period Weeks 0-52|Pregnancy|0
5819645|NCT02596893|20098541|P4|Overall Double-Blind Period Weeks 0-52|Adverse Event|12
5819646|NCT02596893|20098542|P3|Overall Double-Blind Period Weeks 0-52|Adverse Event|15
5819647|NCT02596893|20098543|P2|Overall Double-Blind Period Weeks 0-52|Adverse Event|15
5819648|NCT02596893|20098544|P1|Overall Double-Blind Period Weeks 0-52|Adverse Event|11
5819649|NCT02596893|20098541|P4|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|58
5819650|NCT02596893|20098542|P3|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|48
5819651|NCT02596893|20098543|P2|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|56
5819652|NCT02596893|20098544|P1|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|61
5819653|NCT02596854|20098603|P1|Overall Study|Withdrawn|8
5819654|NCT02596711|20098625|P3|Overall Study|Lost to Follow-up|3
5819655|NCT02596711|20098626|P2|Overall Study|Lost to Follow-up|2
5819656|NCT02596711|20098627|P1|Overall Study|Lost to Follow-up|1
5819657|NCT02596620|20098643|P2|Overall Study|Lost to Follow-up|1
5819658|NCT02596620|20098644|P1|Overall Study|Lost to Follow-up|1
5819659|NCT02596230|20098682|P5|Objective 2, One Year|Other|0
5819660|NCT02596230|20098683|P4|Objective 2, One Year|Other|0
5819661|NCT02596230|20098684|P3|Objective 2, One Year|Other|2
5819662|NCT02596230|20098685|P2|Objective 2, One Year|Other|3
5819663|NCT02596230|20098686|P1|Objective 2, One Year|Other|0
5819664|NCT02596230|20098682|P5|Objective 2, One Year|Death|30
5819665|NCT02596230|20098683|P4|Objective 2, One Year|Death|21
5819666|NCT02596230|20098684|P3|Objective 2, One Year|Death|41
5819667|NCT02596230|20098685|P2|Objective 2, One Year|Death|12
5819668|NCT02596230|20098686|P1|Objective 2, One Year|Death|0
5819669|NCT02596230|20098682|P5|Objective 2, One Year|Adverse drug reaction|0
5819670|NCT02596230|20098683|P4|Objective 2, One Year|Adverse drug reaction|0
5819671|NCT02596230|20098684|P3|Objective 2, One Year|Adverse drug reaction|0
5819672|NCT02596230|20098685|P2|Objective 2, One Year|Adverse drug reaction|1
5819673|NCT02596230|20098686|P1|Objective 2, One Year|Adverse drug reaction|0
5819674|NCT02596230|20098682|P5|Objective 2, One Year|Withdrawal by Subject|2
5819675|NCT02596230|20098683|P4|Objective 2, One Year|Withdrawal by Subject|5
5819676|NCT02596230|20098684|P3|Objective 2, One Year|Withdrawal by Subject|14
5819677|NCT02596230|20098685|P2|Objective 2, One Year|Withdrawal by Subject|11
5819678|NCT02596230|20098686|P1|Objective 2, One Year|Withdrawal by Subject|0
5819679|NCT02596230|20098682|P5|Objective 2, One Year|Lost to Follow-up|46
5819680|NCT02596230|20098683|P4|Objective 2, One Year|Lost to Follow-up|32
5819681|NCT02596230|20098684|P3|Objective 2, One Year|Lost to Follow-up|41
5819682|NCT02596230|20098685|P2|Objective 2, One Year|Lost to Follow-up|41
5819683|NCT02596230|20098686|P1|Objective 2, One Year|Lost to Follow-up|0
5819684|NCT02596230|20098682|P5|Screening Period for Objective 2|Participants not participating in obj 2|0
5819685|NCT02596230|20098683|P4|Screening Period for Objective 2|Participants not participating in obj 2|846
5819686|NCT02596230|20098684|P3|Screening Period for Objective 2|Participants not participating in obj 2|0
5819687|NCT02596230|20098685|P2|Screening Period for Objective 2|Participants not participating in obj 2|228
5819688|NCT02596230|20098686|P1|Screening Period for Objective 2|Participants not participating in obj 2|3714
5819689|NCT02596035|20098710|P3|Overall Study|Other Reasons|0
5819690|NCT02596035|20098711|P2|Overall Study|Other Reasons|4
5819691|NCT02596035|20098712|P1|Overall Study|Other Reasons|3
5819692|NCT02596035|20098710|P3|Overall Study|Poor/Non-Compliance|0
5819693|NCT02596035|20098711|P2|Overall Study|Poor/Non-Compliance|1
5819694|NCT02596035|20098712|P1|Overall Study|Poor/Non-Compliance|0
5819695|NCT02596035|20098710|P3|Overall Study|Withdrawal by Subject|0
5819696|NCT02596035|20098711|P2|Overall Study|Withdrawal by Subject|2
5819697|NCT02596035|20098712|P1|Overall Study|Withdrawal by Subject|4
5819698|NCT02596035|20098710|P3|Overall Study|Adverse Event|0
5819699|NCT02596035|20098711|P2|Overall Study|Adverse Event|2
5819700|NCT02596035|20098712|P1|Overall Study|Adverse Event|6
5819701|NCT02596035|20098710|P3|Overall Study|Study Drug Toxicity|0
5819702|NCT02596035|20098711|P2|Overall Study|Study Drug Toxicity|3
5819703|NCT02596035|20098712|P1|Overall Study|Study Drug Toxicity|11
5819704|NCT02596035|20098710|P3|Overall Study|Disease Progression|1
5819705|NCT02596035|20098711|P2|Overall Study|Disease Progression|32
5819706|NCT02596035|20098712|P1|Overall Study|Disease Progression|62
5819707|NCT02596009|20098748|P6|Overall Study|Administrative problems|0
5819708|NCT02596009|20098749|P5|Overall Study|Administrative problems|0
5819709|NCT02596009|20098750|P4|Overall Study|Administrative problems|0
5819710|NCT02596009|20098751|P3|Overall Study|Administrative problems|0
5819711|NCT02596009|20098752|P2|Overall Study|Administrative problems|1
5819712|NCT02596009|20098753|P1|Overall Study|Administrative problems|0
5819713|NCT02595970|20098770|P1|Overall Study|Lack of Efficacy|7
5819714|NCT02595970|20098770|P1|Overall Study|Adverse Event|5
5819715|NCT02595970|20098770|P1|Overall Study|Protocol Violation|4
5819716|NCT02595970|20098770|P1|Overall Study|Physician Decision|2
5819717|NCT02595970|20098770|P1|Overall Study|Withdrawal by Subject|2
5819718|NCT02595723|20098787|P3|First Washout (21 Days)|Lost to Follow-up|0
5819719|NCT02595723|20098788|P2|First Washout (21 Days)|Lost to Follow-up|0
5819720|NCT02595723|20098789|P1|First Washout (21 Days)|Lost to Follow-up|1
5819721|NCT02595723|20098787|P3|First Washout (21 Days)|Withdrawal by Subject|0
5819722|NCT02595723|20098788|P2|First Washout (21 Days)|Withdrawal by Subject|0
5819723|NCT02595723|20098789|P1|First Washout (21 Days)|Withdrawal by Subject|1
5819724|NCT02595528|20098846|P4|Overall Study|Lost to Follow-up|1
5819725|NCT02595528|20098847|P3|Overall Study|Lost to Follow-up|0
5819726|NCT02595528|20098848|P2|Overall Study|Lost to Follow-up|1
5819727|NCT02595528|20098849|P1|Overall Study|Lost to Follow-up|1
5819728|NCT02595528|20098846|P4|Overall Study|Withdrawal by Subject|3
5819729|NCT02595528|20098847|P3|Overall Study|Withdrawal by Subject|1
5819730|NCT02595528|20098848|P2|Overall Study|Withdrawal by Subject|2
5819731|NCT02595528|20098849|P1|Overall Study|Withdrawal by Subject|1
5819732|NCT02595502|20098859|P2|Period 3|Received Incorrect Treatment at period 3|1
5819733|NCT02595502|20098860|P1|Period 3|Received Incorrect Treatment at period 3|0
5819734|NCT02595502|20098859|P2|Period 3|Lost to Follow-up|0
5819735|NCT02595502|20098860|P1|Period 3|Lost to Follow-up|1
5819736|NCT02595502|20098859|P2|Period 3|Protocol Violation|1
5819737|NCT02595502|20098860|P1|Period 3|Protocol Violation|0
5819738|NCT02595502|20098859|P2|Period 2|Received incorrect lens at Period 1|1
5819739|NCT02595502|20098860|P1|Period 2|Received incorrect lens at Period 1|0
5819740|NCT02595502|20098859|P2|Period 2|Adverse Event|1
5819741|NCT02595502|20098860|P1|Period 2|Adverse Event|1
5819742|NCT02595502|20098859|P2|Period 1|Lost to Follow-up|1
5819743|NCT02595502|20098860|P1|Period 1|Lost to Follow-up|0
5819744|NCT02595502|20098859|P2|Period 1|Withdrawal by Subject|0
5819745|NCT02595502|20098860|P1|Period 1|Withdrawal by Subject|1
5819746|NCT02595502|20098859|P2|Period 1|Adverse Event|1
5819747|NCT02595502|20098860|P1|Period 1|Adverse Event|0
5819748|NCT02595450|20098866|P1|Overall Study|Enrolled, but not treated|8
5819749|NCT02595450|20098866|P1|Overall Study|Unspecified (only completed 1 cycle)|73
5819750|NCT02595437|20098872|P1|Triferic Via IV|Withdrawal by Subject|1
5819751|NCT02595372|20098890|P1|Overall Study|Disease Progression|1
5819752|NCT02595372|20098890|P1|Overall Study|Physician Decision|2
5819753|NCT02595372|20098890|P1|Overall Study|Adverse Event|6
5819754|NCT02595073|20098901|P2|Overall Study|Protocol Violation|0
5819755|NCT02595073|20098902|P1|Overall Study|Protocol Violation|2
5819756|NCT02595073|20098901|P2|Overall Study|Progressive Disease|1
5819757|NCT02595073|20098902|P1|Overall Study|Progressive Disease|0
5819758|NCT02595008|20098912|P2|Overall Study|Enrolled In Error|0
5819759|NCT02595008|20098913|P1|Overall Study|Enrolled In Error|1
5819760|NCT02594163|20098951|P2|Follow-up Period|Physician Decision|1
5819761|NCT02594163|20098952|P1|Follow-up Period|Physician Decision|0
5819762|NCT02594163|20098951|P2|Follow-up Period|Progressive Disease|0
5819763|NCT02594163|20098952|P1|Follow-up Period|Progressive Disease|2
5819764|NCT02594163|20098951|P2|Follow-up Period|Adverse Event|1
5819765|NCT02594163|20098952|P1|Follow-up Period|Adverse Event|0
5819766|NCT02594163|20098951|P2|Follow-up Period|Death|5
5819767|NCT02594163|20098952|P1|Follow-up Period|Death|2
5819768|NCT02594163|20098951|P2|Follow-up Period|Lost to Follow-up|0
5819769|NCT02594163|20098952|P1|Follow-up Period|Lost to Follow-up|1
5819770|NCT02594163|20098951|P2|Follow-up Period|Study Termination by Sponsor|4
5819771|NCT02594163|20098952|P1|Follow-up Period|Study Termination by Sponsor|6
5819772|NCT02594163|20098951|P2|Follow-up Period|Withdrawal by Subject|1
5819773|NCT02594163|20098952|P1|Follow-up Period|Withdrawal by Subject|0
5819774|NCT02594163|20098951|P2|Treatment Period|Other, Non-AE|0
5819775|NCT02594163|20098952|P1|Treatment Period|Other, Non-AE|1
5819776|NCT02594163|20098951|P2|Treatment Period|Study termination by sponsor|1
5819777|NCT02594163|20098952|P1|Treatment Period|Study termination by sponsor|2
5819778|NCT02594163|20098951|P2|Treatment Period|Physician Decision|3
5819779|NCT02594163|20098952|P1|Treatment Period|Physician Decision|1
5819780|NCT02594163|20098951|P2|Treatment Period|Adverse Event|5
5819781|NCT02594163|20098952|P1|Treatment Period|Adverse Event|1
5819782|NCT02594163|20098951|P2|Treatment Period|Progressive disease|3
5819783|NCT02594163|20098952|P1|Treatment Period|Progressive disease|2
5819784|NCT02594098|20098983|P2|Overall Study|Other|1
5819785|NCT02594098|20098984|P1|Overall Study|Other|0
5819786|NCT02594098|20098983|P2|Overall Study|Seek alternative treatment|1
5819787|NCT02594098|20098984|P1|Overall Study|Seek alternative treatment|2
5819788|NCT02594098|20098983|P2|Overall Study|Terminated participation|2
5819789|NCT02594098|20098984|P1|Overall Study|Terminated participation|6
5819790|NCT02594098|20098983|P2|Overall Study|Withdrawal by Subject|3
5819791|NCT02594098|20098984|P1|Overall Study|Withdrawal by Subject|1
5819792|NCT02594098|20098983|P2|Overall Study|Lack of Efficacy|6
5819793|NCT02594098|20098984|P1|Overall Study|Lack of Efficacy|17
5819794|NCT02593864|20099053|P1|Overall Study|Lost to Follow-up|3
5819795|NCT02593864|20099053|P1|Overall Study|Withdrawal by Subject|3
5819796|NCT02593825|20099060|P2|Intervention|Lost to Follow-up|12
5819797|NCT02593825|20099061|P1|Intervention|Lost to Follow-up|10
5819798|NCT02593773|20099073|P1|Overall Study|Death|1
5819799|NCT02593773|20099073|P1|Overall Study|Study Terminated by Sponsor|31
5819800|NCT02593773|20099073|P1|Overall Study|Voluntary Withdrawal|3
5819801|NCT02593305|20099105|P3|Post 1|Comparison only group. No intervention.|10
5819802|NCT02593305|20099106|P2|Post 1|Comparison only group. No intervention.|0
5819803|NCT02593305|20099107|P1|Post 1|Comparison only group. No intervention.|0
5819804|NCT02593149|20099122|P2|Intervention|Didn't use CVC for at least 21 day|115
5819805|NCT02593149|20099123|P1|Intervention|Didn't use CVC for at least 21 day|116
5819806|NCT02593149|20099122|P2|Run-In|Didn't use CVC for at least 21 days|38
5819807|NCT02593149|20099123|P1|Run-In|Didn't use CVC for at least 21 days|36
5819808|NCT02593097|20099131|P2|Second Intervention (12 Weeks)|Withdrawal by Subject|0
5819809|NCT02593097|20099132|P1|Second Intervention (12 Weeks)|Withdrawal by Subject|1
5819810|NCT02593097|20099131|P2|Second Intervention (12 Weeks)|Lack of Efficacy|0
5819811|NCT02593097|20099132|P1|Second Intervention (12 Weeks)|Lack of Efficacy|1
5819812|NCT02593097|20099131|P2|Second Intervention (12 Weeks)|Lost to Follow-up|1
5819813|NCT02593097|20099132|P1|Second Intervention (12 Weeks)|Lost to Follow-up|1
5819814|NCT02593097|20099131|P2|First Intervention (12 Weeks)|Withdrawal by Subject|2
5819815|NCT02593097|20099132|P1|First Intervention (12 Weeks)|Withdrawal by Subject|1
5819816|NCT02593097|20099131|P2|First Intervention (12 Weeks)|Lost to Follow-up|2
5819817|NCT02593097|20099132|P1|First Intervention (12 Weeks)|Lost to Follow-up|1
5819818|NCT02592876|20099153|P2|Overall Study|Death|9
5819819|NCT02592876|20099154|P1|Overall Study|Death|6
5819820|NCT02592876|20099153|P2|Overall Study|Lost to Follow-up|1
5819821|NCT02592876|20099154|P1|Overall Study|Lost to Follow-up|0
5819822|NCT02592876|20099153|P2|Overall Study|Study Termination by Sponsor|27
5819823|NCT02592876|20099154|P1|Overall Study|Study Termination by Sponsor|32
5819824|NCT02592876|20099153|P2|Overall Study|Withdrawal by Subject|3
5819825|NCT02592876|20099154|P1|Overall Study|Withdrawal by Subject|3
5819826|NCT02592447|20099225|P2|Overall Study|Withdrawal by Subject|1
5819827|NCT02592447|20099226|P1|Overall Study|Withdrawal by Subject|0
5819828|NCT02592447|20099225|P2|Overall Study|Ineligible after randomization|0
5819829|NCT02592447|20099226|P1|Overall Study|Ineligible after randomization|1
5819830|NCT02592447|20099225|P2|Overall Study|Lost to Follow-up|0
5819831|NCT02592447|20099226|P1|Overall Study|Lost to Follow-up|1
5819832|NCT02592434|20099234|P3|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0
5819833|NCT02592434|20099235|P2|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|1
5819834|NCT02592434|20099236|P1|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0
5819835|NCT02592434|20099234|P3|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0
5820060|NCT02590432|20099558|P2|Open-label Treatment Period|Adverse Event|79
5819836|NCT02592434|20099235|P2|Double Blind Phase (26 Weeks)|Medication error without associated AEs|1
5819837|NCT02592434|20099236|P1|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0
5819838|NCT02592434|20099234|P3|Double Blind Phase (26 Weeks)|Protocol Deviation|1
5819839|NCT02592434|20099235|P2|Double Blind Phase (26 Weeks)|Protocol Deviation|0
5819840|NCT02592434|20099236|P1|Double Blind Phase (26 Weeks)|Protocol Deviation|0
5819841|NCT02592434|20099234|P3|Double Blind Phase (26 Weeks)|Other|0
5819842|NCT02592434|20099235|P2|Double Blind Phase (26 Weeks)|Other|1
5819843|NCT02592434|20099236|P1|Double Blind Phase (26 Weeks)|Other|0
5819844|NCT02592434|20099234|P3|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|44
5819845|NCT02592434|20099235|P2|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|22
5819846|NCT02592434|20099236|P1|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|0
5819847|NCT02592434|20099234|P3|Double Blind Phase (26 Weeks)|Adverse Event|2
5819848|NCT02592434|20099235|P2|Double Blind Phase (26 Weeks)|Adverse Event|2
5819849|NCT02592434|20099236|P1|Double Blind Phase (26 Weeks)|Adverse Event|0
5819850|NCT02592434|20099234|P3|Open-Label Phase (18 Weeks)|Protocol Deviation|0
5819851|NCT02592434|20099235|P2|Open-Label Phase (18 Weeks)|Protocol Deviation|0
5819852|NCT02592434|20099236|P1|Open-Label Phase (18 Weeks)|Protocol Deviation|4
5819853|NCT02592434|20099234|P3|Open-Label Phase (18 Weeks)|Other|0
5819854|NCT02592434|20099235|P2|Open-Label Phase (18 Weeks)|Other|0
5819855|NCT02592434|20099236|P1|Open-Label Phase (18 Weeks)|Other|3
5819856|NCT02592434|20099234|P3|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0
5819857|NCT02592434|20099235|P2|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0
5819858|NCT02592434|20099236|P1|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|21
5819859|NCT02592434|20099234|P3|Open-Label Phase (18 Weeks)|Adverse Event|0
5819860|NCT02592434|20099235|P2|Open-Label Phase (18 Weeks)|Adverse Event|0
5819861|NCT02592434|20099236|P1|Open-Label Phase (18 Weeks)|Adverse Event|12
5819862|NCT02592018|20099367|P1|Overall Study|Lost to Follow-up|1
5819863|NCT02592018|20099367|P1|Overall Study|Adverse Event|1
5819864|NCT02591290|20099414|P1|Overall Study|Withdrawal by Subject|2
5819865|NCT02591238|20099424|P4|Overall Study|personal circumstances|0
5819866|NCT02591238|20099425|P3|Overall Study|personal circumstances|0
5819867|NCT02591238|20099426|P2|Overall Study|personal circumstances|1
5819868|NCT02591238|20099427|P1|Overall Study|personal circumstances|0
5819869|NCT02591238|20099424|P4|Overall Study|personal circumstances|1
5819870|NCT02591238|20099425|P3|Overall Study|personal circumstances|0
5819871|NCT02591238|20099426|P2|Overall Study|personal circumstances|0
5819872|NCT02591238|20099427|P1|Overall Study|personal circumstances|0
5819873|NCT02591238|20099424|P4|Overall Study|influenza|1
5819874|NCT02591238|20099425|P3|Overall Study|influenza|0
5819875|NCT02591238|20099426|P2|Overall Study|influenza|0
5819876|NCT02591238|20099427|P1|Overall Study|influenza|0
5819877|NCT02591238|20099424|P4|Overall Study|Withdrawal by Subject|1
5819878|NCT02591238|20099425|P3|Overall Study|Withdrawal by Subject|0
5819879|NCT02591238|20099426|P2|Overall Study|Withdrawal by Subject|0
5819880|NCT02591238|20099427|P1|Overall Study|Withdrawal by Subject|0
5819881|NCT02591238|20099424|P4|Overall Study|Pregnancy|0
5819882|NCT02591238|20099425|P3|Overall Study|Pregnancy|0
5819883|NCT02591238|20099426|P2|Overall Study|Pregnancy|0
5819884|NCT02591238|20099427|P1|Overall Study|Pregnancy|1
5819885|NCT02590939|20099463|P2|Overall Study|Failed the nociceptive test|1
5819886|NCT02590939|20099464|P1|Overall Study|Failed the nociceptive test|2
5819887|NCT02590939|20099463|P2|Overall Study|Withdrawal by Subject|1
5819888|NCT02590939|20099464|P1|Overall Study|Withdrawal by Subject|3
5819889|NCT02590588|20099484|P1|Overall Study|Adverse Event|1
5819890|NCT02590562|20099492|P1|Overall Study|Did Not Meet the Inclusion Criteria|6
5819891|NCT02590432|20099551|P9|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0
5819892|NCT02590432|20099552|P8|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|1
5819893|NCT02590432|20099553|P7|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0
5819894|NCT02590432|20099554|P6|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0
5819895|NCT02590432|20099555|P5|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0
5819896|NCT02590432|20099556|P4|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0
5819897|NCT02590432|20099557|P3|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0
5819898|NCT02590432|20099558|P2|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0
5819899|NCT02590432|20099559|P1|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0
5819900|NCT02590432|20099551|P9|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0
5819901|NCT02590432|20099552|P8|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|1
5819902|NCT02590432|20099553|P7|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0
5819903|NCT02590432|20099554|P6|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0
5819904|NCT02590432|20099555|P5|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0
5819905|NCT02590432|20099556|P4|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0
5819906|NCT02590432|20099557|P3|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0
5819907|NCT02590432|20099558|P2|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0
5819908|NCT02590432|20099559|P1|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0
5819909|NCT02590432|20099551|P9|Dose-reduced Open Label Treatment Period|Protocol Violation|1
5819910|NCT02590432|20099552|P8|Dose-reduced Open Label Treatment Period|Protocol Violation|0
5819911|NCT02590432|20099553|P7|Dose-reduced Open Label Treatment Period|Protocol Violation|0
5819912|NCT02590432|20099554|P6|Dose-reduced Open Label Treatment Period|Protocol Violation|0
5819913|NCT02590432|20099555|P5|Dose-reduced Open Label Treatment Period|Protocol Violation|0
5819914|NCT02590432|20099556|P4|Dose-reduced Open Label Treatment Period|Protocol Violation|0
5819915|NCT02590432|20099557|P3|Dose-reduced Open Label Treatment Period|Protocol Violation|0
5819916|NCT02590432|20099558|P2|Dose-reduced Open Label Treatment Period|Protocol Violation|0
5819917|NCT02590432|20099559|P1|Dose-reduced Open Label Treatment Period|Protocol Violation|0
5819918|NCT02590432|20099551|P9|Dose-reduced Open Label Treatment Period|Lost to Follow-up|1
5819919|NCT02590432|20099552|P8|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0
5819920|NCT02590432|20099553|P7|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0
5819921|NCT02590432|20099554|P6|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0
5819922|NCT02590432|20099555|P5|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0
5819923|NCT02590432|20099556|P4|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0
5819924|NCT02590432|20099557|P3|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0
5819925|NCT02590432|20099558|P2|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0
5819926|NCT02590432|20099559|P1|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0
5819927|NCT02590432|20099551|P9|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|1
5819928|NCT02590432|20099552|P8|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|3
5819929|NCT02590432|20099553|P7|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0
5819930|NCT02590432|20099554|P6|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0
5819931|NCT02590432|20099555|P5|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0
5819932|NCT02590432|20099556|P4|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0
5819933|NCT02590432|20099557|P3|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0
5819934|NCT02590432|20099558|P2|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0
5819935|NCT02590432|20099559|P1|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0
5819936|NCT02590432|20099551|P9|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0
5819937|NCT02590432|20099552|P8|Dose-reduced Open Label Treatment Period|Lack of Efficacy|1
5819938|NCT02590432|20099553|P7|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0
5819939|NCT02590432|20099554|P6|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0
5819940|NCT02590432|20099555|P5|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0
5819941|NCT02590432|20099556|P4|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0
5819942|NCT02590432|20099557|P3|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0
5819943|NCT02590432|20099558|P2|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0
5819944|NCT02590432|20099559|P1|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0
5819945|NCT02590432|20099551|P9|Dose-reduced Open Label Treatment Period|Adverse Event|15
5819946|NCT02590432|20099552|P8|Dose-reduced Open Label Treatment Period|Adverse Event|12
5819947|NCT02590432|20099553|P7|Dose-reduced Open Label Treatment Period|Adverse Event|0
5819948|NCT02590432|20099554|P6|Dose-reduced Open Label Treatment Period|Adverse Event|0
5819949|NCT02590432|20099555|P5|Dose-reduced Open Label Treatment Period|Adverse Event|0
5819950|NCT02590432|20099556|P4|Dose-reduced Open Label Treatment Period|Adverse Event|0
5819951|NCT02590432|20099557|P3|Dose-reduced Open Label Treatment Period|Adverse Event|0
5819952|NCT02590432|20099558|P2|Dose-reduced Open Label Treatment Period|Adverse Event|0
5819953|NCT02590432|20099559|P1|Dose-reduced Open Label Treatment Period|Adverse Event|0
5819954|NCT02590432|20099551|P9|Double-blind Treatment Period|Non-compliance with Study Drug|0
5819955|NCT02590432|20099552|P8|Double-blind Treatment Period|Non-compliance with Study Drug|0
5819956|NCT02590432|20099553|P7|Double-blind Treatment Period|Non-compliance with Study Drug|0
5819957|NCT02590432|20099554|P6|Double-blind Treatment Period|Non-compliance with Study Drug|1
5819958|NCT02590432|20099555|P5|Double-blind Treatment Period|Non-compliance with Study Drug|0
5819959|NCT02590432|20099556|P4|Double-blind Treatment Period|Non-compliance with Study Drug|0
5819960|NCT02590432|20099557|P3|Double-blind Treatment Period|Non-compliance with Study Drug|0
5819961|NCT02590432|20099558|P2|Double-blind Treatment Period|Non-compliance with Study Drug|0
5819962|NCT02590432|20099559|P1|Double-blind Treatment Period|Non-compliance with Study Drug|0
5819963|NCT02590432|20099551|P9|Double-blind Treatment Period|Lost to Follow-up|0
5819964|NCT02590432|20099552|P8|Double-blind Treatment Period|Lost to Follow-up|0
5819965|NCT02590432|20099553|P7|Double-blind Treatment Period|Lost to Follow-up|0
5819966|NCT02590432|20099554|P6|Double-blind Treatment Period|Lost to Follow-up|2
5819967|NCT02590432|20099555|P5|Double-blind Treatment Period|Lost to Follow-up|0
5819968|NCT02590432|20099556|P4|Double-blind Treatment Period|Lost to Follow-up|0
5819969|NCT02590432|20099557|P3|Double-blind Treatment Period|Lost to Follow-up|1
5819970|NCT02590432|20099558|P2|Double-blind Treatment Period|Lost to Follow-up|0
5819971|NCT02590432|20099559|P1|Double-blind Treatment Period|Lost to Follow-up|0
5819972|NCT02590432|20099551|P9|Double-blind Treatment Period|Withdrawal of Consent|0
5819973|NCT02590432|20099552|P8|Double-blind Treatment Period|Withdrawal of Consent|0
5819974|NCT02590432|20099553|P7|Double-blind Treatment Period|Withdrawal of Consent|1
5819975|NCT02590432|20099554|P6|Double-blind Treatment Period|Withdrawal of Consent|1
5819976|NCT02590432|20099555|P5|Double-blind Treatment Period|Withdrawal of Consent|3
5819977|NCT02590432|20099556|P4|Double-blind Treatment Period|Withdrawal of Consent|3
5819978|NCT02590432|20099557|P3|Double-blind Treatment Period|Withdrawal of Consent|1
5819979|NCT02590432|20099558|P2|Double-blind Treatment Period|Withdrawal of Consent|0
5819980|NCT02590432|20099559|P1|Double-blind Treatment Period|Withdrawal of Consent|0
5819981|NCT02590432|20099551|P9|Double-blind Treatment Period|Lack of Efficacy|0
5819982|NCT02590432|20099552|P8|Double-blind Treatment Period|Lack of Efficacy|0
5819983|NCT02590432|20099553|P7|Double-blind Treatment Period|Lack of Efficacy|0
5819984|NCT02590432|20099554|P6|Double-blind Treatment Period|Lack of Efficacy|0
5819985|NCT02590432|20099555|P5|Double-blind Treatment Period|Lack of Efficacy|0
5819986|NCT02590432|20099556|P4|Double-blind Treatment Period|Lack of Efficacy|0
5819987|NCT02590432|20099557|P3|Double-blind Treatment Period|Lack of Efficacy|1
5819988|NCT02590432|20099558|P2|Double-blind Treatment Period|Lack of Efficacy|0
5819989|NCT02590432|20099559|P1|Double-blind Treatment Period|Lack of Efficacy|0
5819990|NCT02590432|20099551|P9|Double-blind Treatment Period|Adverse Event|0
5819991|NCT02590432|20099552|P8|Double-blind Treatment Period|Adverse Event|0
5819992|NCT02590432|20099553|P7|Double-blind Treatment Period|Adverse Event|20
5819993|NCT02590432|20099554|P6|Double-blind Treatment Period|Adverse Event|22
5819994|NCT02590432|20099555|P5|Double-blind Treatment Period|Adverse Event|6
5819995|NCT02590432|20099556|P4|Double-blind Treatment Period|Adverse Event|12
5819996|NCT02590432|20099557|P3|Double-blind Treatment Period|Adverse Event|14
5819997|NCT02590432|20099558|P2|Double-blind Treatment Period|Adverse Event|0
5819998|NCT02590432|20099559|P1|Double-blind Treatment Period|Adverse Event|0
5819999|NCT02590432|20099551|P9|Open-label Treatment Period|Other Miscellaneous Reasons|0
5820000|NCT02590432|20099552|P8|Open-label Treatment Period|Other Miscellaneous Reasons|0
5820001|NCT02590432|20099553|P7|Open-label Treatment Period|Other Miscellaneous Reasons|0
5820002|NCT02590432|20099554|P6|Open-label Treatment Period|Other Miscellaneous Reasons|0
5820003|NCT02590432|20099555|P5|Open-label Treatment Period|Other Miscellaneous Reasons|0
5820004|NCT02590432|20099556|P4|Open-label Treatment Period|Other Miscellaneous Reasons|0
5820005|NCT02590432|20099557|P3|Open-label Treatment Period|Other Miscellaneous Reasons|0
5820006|NCT02590432|20099558|P2|Open-label Treatment Period|Other Miscellaneous Reasons|6
5820007|NCT02590432|20099559|P1|Open-label Treatment Period|Other Miscellaneous Reasons|10
5820008|NCT02590432|20099551|P9|Open-label Treatment Period|Non-compliance with Study Drug|0
5820009|NCT02590432|20099552|P8|Open-label Treatment Period|Non-compliance with Study Drug|0
5820010|NCT02590432|20099553|P7|Open-label Treatment Period|Non-compliance with Study Drug|0
5820011|NCT02590432|20099554|P6|Open-label Treatment Period|Non-compliance with Study Drug|0
5820012|NCT02590432|20099555|P5|Open-label Treatment Period|Non-compliance with Study Drug|0
5820013|NCT02590432|20099556|P4|Open-label Treatment Period|Non-compliance with Study Drug|0
5820014|NCT02590432|20099557|P3|Open-label Treatment Period|Non-compliance with Study Drug|0
5820015|NCT02590432|20099558|P2|Open-label Treatment Period|Non-compliance with Study Drug|1
5820016|NCT02590432|20099559|P1|Open-label Treatment Period|Non-compliance with Study Drug|7
5820017|NCT02590432|20099551|P9|Open-label Treatment Period|Protocol Violation|0
5820018|NCT02590432|20099552|P8|Open-label Treatment Period|Protocol Violation|0
5820019|NCT02590432|20099553|P7|Open-label Treatment Period|Protocol Violation|0
5820020|NCT02590432|20099554|P6|Open-label Treatment Period|Protocol Violation|0
5820021|NCT02590432|20099555|P5|Open-label Treatment Period|Protocol Violation|0
5820022|NCT02590432|20099556|P4|Open-label Treatment Period|Protocol Violation|0
5820023|NCT02590432|20099557|P3|Open-label Treatment Period|Protocol Violation|0
5820024|NCT02590432|20099558|P2|Open-label Treatment Period|Protocol Violation|4
5820025|NCT02590432|20099559|P1|Open-label Treatment Period|Protocol Violation|10
5820026|NCT02590432|20099551|P9|Open-label Treatment Period|Lost to Follow-up|0
5820027|NCT02590432|20099552|P8|Open-label Treatment Period|Lost to Follow-up|0
5820028|NCT02590432|20099553|P7|Open-label Treatment Period|Lost to Follow-up|0
5820029|NCT02590432|20099554|P6|Open-label Treatment Period|Lost to Follow-up|0
5820030|NCT02590432|20099555|P5|Open-label Treatment Period|Lost to Follow-up|0
5820031|NCT02590432|20099556|P4|Open-label Treatment Period|Lost to Follow-up|0
5820032|NCT02590432|20099557|P3|Open-label Treatment Period|Lost to Follow-up|0
5820033|NCT02590432|20099558|P2|Open-label Treatment Period|Lost to Follow-up|29
5820034|NCT02590432|20099559|P1|Open-label Treatment Period|Lost to Follow-up|51
5820035|NCT02590432|20099551|P9|Open-label Treatment Period|Withdrawal of Consent|0
5820036|NCT02590432|20099552|P8|Open-label Treatment Period|Withdrawal of Consent|0
5820037|NCT02590432|20099553|P7|Open-label Treatment Period|Withdrawal of Consent|0
5820038|NCT02590432|20099554|P6|Open-label Treatment Period|Withdrawal of Consent|0
5820039|NCT02590432|20099555|P5|Open-label Treatment Period|Withdrawal of Consent|0
5820040|NCT02590432|20099556|P4|Open-label Treatment Period|Withdrawal of Consent|0
5820041|NCT02590432|20099557|P3|Open-label Treatment Period|Withdrawal of Consent|0
5820042|NCT02590432|20099558|P2|Open-label Treatment Period|Withdrawal of Consent|28
5820043|NCT02590432|20099559|P1|Open-label Treatment Period|Withdrawal of Consent|43
5820044|NCT02590432|20099551|P9|Open-label Treatment Period|Lack of Efficacy|0
5820045|NCT02590432|20099552|P8|Open-label Treatment Period|Lack of Efficacy|0
5820046|NCT02590432|20099553|P7|Open-label Treatment Period|Lack of Efficacy|0
5820047|NCT02590432|20099554|P6|Open-label Treatment Period|Lack of Efficacy|0
5820048|NCT02590432|20099555|P5|Open-label Treatment Period|Lack of Efficacy|0
5820049|NCT02590432|20099556|P4|Open-label Treatment Period|Lack of Efficacy|0
5820050|NCT02590432|20099557|P3|Open-label Treatment Period|Lack of Efficacy|0
5820051|NCT02590432|20099558|P2|Open-label Treatment Period|Lack of Efficacy|5
5820052|NCT02590432|20099559|P1|Open-label Treatment Period|Lack of Efficacy|14
5820053|NCT02590432|20099551|P9|Open-label Treatment Period|Adverse Event|0
5820054|NCT02590432|20099552|P8|Open-label Treatment Period|Adverse Event|0
5820055|NCT02590432|20099553|P7|Open-label Treatment Period|Adverse Event|0
5820056|NCT02590432|20099554|P6|Open-label Treatment Period|Adverse Event|0
5820057|NCT02590432|20099555|P5|Open-label Treatment Period|Adverse Event|0
5820058|NCT02590432|20099556|P4|Open-label Treatment Period|Adverse Event|0
5820059|NCT02590432|20099557|P3|Open-label Treatment Period|Adverse Event|0
5820061|NCT02590432|20099559|P1|Open-label Treatment Period|Adverse Event|97
5820062|NCT02590406|20099595|P2|Overall Study|Saturometer malfunction|1
5820063|NCT02590406|20099596|P1|Overall Study|Saturometer malfunction|0
5820064|NCT02590406|20099595|P2|Overall Study|Adverse Event|0
5820065|NCT02590406|20099596|P1|Overall Study|Adverse Event|1
5820066|NCT02590354|20099610|P1|Phase 2 - Treatment Interruption|Lost to Follow-up|2
5820067|NCT02590354|20099610|P1|Phase 1|Lost to Follow-up|1
5820068|NCT02590354|20099610|P1|Phase 1|Subject does not want to participate|20
5820069|NCT02590354|20099610|P1|Phase 1|Detectable level of HIV DNA or caRNA|75
5820070|NCT02590354|20099610|P1|Phase 1|Confirmed neutrophil count <1200/µl|1
5820071|NCT02590354|20099610|P1|Phase 1|Active hepatitis B or C infection|1
5820072|NCT02590003|20099637|P2|Overall Study|Death|2
5820073|NCT02590003|20099638|P1|Overall Study|Death|1
5820074|NCT02589665|20099675|P10|Maintenance Extension Period|Non-responder|1
5820075|NCT02589665|20099676|P9|Maintenance Extension Period|Non-responder|0
5820076|NCT02589665|20099677|P8|Maintenance Extension Period|Non-responder|0
5820077|NCT02589665|20099678|P7|Maintenance Extension Period|Non-responder|0
5820078|NCT02589665|20099679|P6|Maintenance Extension Period|Non-responder|0
5820079|NCT02589665|20099680|P5|Maintenance Extension Period|Non-responder|0
5820080|NCT02589665|20099681|P4|Maintenance Extension Period|Non-responder|0
5820081|NCT02589665|20099682|P3|Maintenance Extension Period|Non-responder|0
5820082|NCT02589665|20099683|P2|Maintenance Extension Period|Non-responder|0
5820083|NCT02589665|20099684|P1|Maintenance Extension Period|Non-responder|0
5820084|NCT02589665|20099675|P10|Maintenance Extension Period|Adverse Event|2
5820085|NCT02589665|20099676|P9|Maintenance Extension Period|Adverse Event|0
5820086|NCT02589665|20099677|P8|Maintenance Extension Period|Adverse Event|0
5820087|NCT02589665|20099678|P7|Maintenance Extension Period|Adverse Event|0
5820088|NCT02589665|20099679|P6|Maintenance Extension Period|Adverse Event|0
5820089|NCT02589665|20099680|P5|Maintenance Extension Period|Adverse Event|0
5820090|NCT02589665|20099681|P4|Maintenance Extension Period|Adverse Event|0
5820091|NCT02589665|20099682|P3|Maintenance Extension Period|Adverse Event|0
5820092|NCT02589665|20099683|P2|Maintenance Extension Period|Adverse Event|0
5820093|NCT02589665|20099684|P1|Maintenance Extension Period|Adverse Event|0
5820094|NCT02589665|20099675|P10|Maintenance Extension Period|Lack of Efficacy|4
5820095|NCT02589665|20099676|P9|Maintenance Extension Period|Lack of Efficacy|0
5820096|NCT02589665|20099677|P8|Maintenance Extension Period|Lack of Efficacy|0
5820097|NCT02589665|20099678|P7|Maintenance Extension Period|Lack of Efficacy|0
5820098|NCT02589665|20099679|P6|Maintenance Extension Period|Lack of Efficacy|0
5820099|NCT02589665|20099680|P5|Maintenance Extension Period|Lack of Efficacy|0
5820100|NCT02589665|20099681|P4|Maintenance Extension Period|Lack of Efficacy|0
5820101|NCT02589665|20099682|P3|Maintenance Extension Period|Lack of Efficacy|0
5820102|NCT02589665|20099683|P2|Maintenance Extension Period|Lack of Efficacy|0
5820103|NCT02589665|20099684|P1|Maintenance Extension Period|Lack of Efficacy|0
5820104|NCT02589665|20099675|P10|Maintenance Extension Period|Withdrawal by Subject|4
5820105|NCT02589665|20099676|P9|Maintenance Extension Period|Withdrawal by Subject|0
5820106|NCT02589665|20099677|P8|Maintenance Extension Period|Withdrawal by Subject|0
5820107|NCT02589665|20099678|P7|Maintenance Extension Period|Withdrawal by Subject|0
5820108|NCT02589665|20099679|P6|Maintenance Extension Period|Withdrawal by Subject|0
5820109|NCT02589665|20099680|P5|Maintenance Extension Period|Withdrawal by Subject|0
5820110|NCT02589665|20099681|P4|Maintenance Extension Period|Withdrawal by Subject|0
5820111|NCT02589665|20099682|P3|Maintenance Extension Period|Withdrawal by Subject|0
5820112|NCT02589665|20099683|P2|Maintenance Extension Period|Withdrawal by Subject|0
5820113|NCT02589665|20099684|P1|Maintenance Extension Period|Withdrawal by Subject|0
5820114|NCT02589665|20099675|P10|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|57
5820115|NCT02589665|20099676|P9|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0
5820116|NCT02589665|20099677|P8|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0
5820117|NCT02589665|20099678|P7|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0
5820118|NCT02589665|20099679|P6|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0
5820119|NCT02589665|20099680|P5|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0
5820120|NCT02589665|20099681|P4|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0
5820121|NCT02589665|20099682|P3|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0
5820122|NCT02589665|20099683|P2|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0
5820123|NCT02589665|20099684|P1|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0
5820124|NCT02589665|20099675|P10|Induction Extension Period|Reason Not Collected|0
5820125|NCT02589665|20099676|P9|Induction Extension Period|Reason Not Collected|1
5820126|NCT02589665|20099677|P8|Induction Extension Period|Reason Not Collected|0
5820127|NCT02589665|20099678|P7|Induction Extension Period|Reason Not Collected|0
5820128|NCT02589665|20099679|P6|Induction Extension Period|Reason Not Collected|0
5820129|NCT02589665|20099680|P5|Induction Extension Period|Reason Not Collected|0
5820130|NCT02589665|20099681|P4|Induction Extension Period|Reason Not Collected|0
5820131|NCT02589665|20099682|P3|Induction Extension Period|Reason Not Collected|0
5820132|NCT02589665|20099683|P2|Induction Extension Period|Reason Not Collected|0
5820133|NCT02589665|20099684|P1|Induction Extension Period|Reason Not Collected|0
5820134|NCT02589665|20099675|P10|Induction Extension Period|Physician Decision|0
5820135|NCT02589665|20099676|P9|Induction Extension Period|Physician Decision|1
5820136|NCT02589665|20099677|P8|Induction Extension Period|Physician Decision|0
5820137|NCT02589665|20099678|P7|Induction Extension Period|Physician Decision|0
5820138|NCT02589665|20099679|P6|Induction Extension Period|Physician Decision|0
5820139|NCT02589665|20099680|P5|Induction Extension Period|Physician Decision|0
5820140|NCT02589665|20099681|P4|Induction Extension Period|Physician Decision|0
5820141|NCT02589665|20099682|P3|Induction Extension Period|Physician Decision|0
5820142|NCT02589665|20099683|P2|Induction Extension Period|Physician Decision|0
5820143|NCT02589665|20099684|P1|Induction Extension Period|Physician Decision|0
5820144|NCT02589665|20099675|P10|Induction Extension Period|Withdrawal by Subject|0
5820145|NCT02589665|20099676|P9|Induction Extension Period|Withdrawal by Subject|3
5820146|NCT02589665|20099677|P8|Induction Extension Period|Withdrawal by Subject|2
5820147|NCT02589665|20099678|P7|Induction Extension Period|Withdrawal by Subject|0
5820148|NCT02589665|20099679|P6|Induction Extension Period|Withdrawal by Subject|0
5820149|NCT02589665|20099680|P5|Induction Extension Period|Withdrawal by Subject|0
5820150|NCT02589665|20099681|P4|Induction Extension Period|Withdrawal by Subject|0
5820151|NCT02589665|20099682|P3|Induction Extension Period|Withdrawal by Subject|0
5820152|NCT02589665|20099683|P2|Induction Extension Period|Withdrawal by Subject|0
5820153|NCT02589665|20099684|P1|Induction Extension Period|Withdrawal by Subject|0
5820154|NCT02589665|20099675|P10|Induction Extension Period|Lack of Efficacy|0
5820155|NCT02589665|20099676|P9|Induction Extension Period|Lack of Efficacy|3
5820156|NCT02589665|20099677|P8|Induction Extension Period|Lack of Efficacy|0
5820157|NCT02589665|20099678|P7|Induction Extension Period|Lack of Efficacy|0
5820158|NCT02589665|20099679|P6|Induction Extension Period|Lack of Efficacy|0
5820159|NCT02589665|20099680|P5|Induction Extension Period|Lack of Efficacy|0
5820160|NCT02589665|20099681|P4|Induction Extension Period|Lack of Efficacy|0
5820161|NCT02589665|20099682|P3|Induction Extension Period|Lack of Efficacy|0
5820162|NCT02589665|20099683|P2|Induction Extension Period|Lack of Efficacy|0
5820163|NCT02589665|20099684|P1|Induction Extension Period|Lack of Efficacy|0
5820164|NCT02589665|20099675|P10|Induction Extension Period|Adverse Event|0
5820165|NCT02589665|20099676|P9|Induction Extension Period|Adverse Event|4
5820166|NCT02589665|20099677|P8|Induction Extension Period|Adverse Event|0
5820167|NCT02589665|20099678|P7|Induction Extension Period|Adverse Event|0
5820168|NCT02589665|20099679|P6|Induction Extension Period|Adverse Event|0
5820169|NCT02589665|20099680|P5|Induction Extension Period|Adverse Event|0
5820170|NCT02589665|20099681|P4|Induction Extension Period|Adverse Event|0
5820171|NCT02589665|20099682|P3|Induction Extension Period|Adverse Event|0
5820172|NCT02589665|20099683|P2|Induction Extension Period|Adverse Event|0
5820173|NCT02589665|20099684|P1|Induction Extension Period|Adverse Event|0
5820174|NCT02589665|20099675|P10|Maintenance Period|Reason Not Collected|0
5820175|NCT02589665|20099676|P9|Maintenance Period|Reason Not Collected|0
5820176|NCT02589665|20099677|P8|Maintenance Period|Reason Not Collected|0
5820177|NCT02589665|20099678|P7|Maintenance Period|Reason Not Collected|1
5820178|NCT02589665|20099679|P6|Maintenance Period|Reason Not Collected|1
5820179|NCT02589665|20099680|P5|Maintenance Period|Reason Not Collected|0
5820180|NCT02589665|20099681|P4|Maintenance Period|Reason Not Collected|0
5820181|NCT02589665|20099682|P3|Maintenance Period|Reason Not Collected|0
5820182|NCT02589665|20099683|P2|Maintenance Period|Reason Not Collected|0
5820183|NCT02589665|20099684|P1|Maintenance Period|Reason Not Collected|0
5820184|NCT02589665|20099675|P10|Maintenance Period|Physician Decision|0
5820185|NCT02589665|20099676|P9|Maintenance Period|Physician Decision|0
5820186|NCT02589665|20099677|P8|Maintenance Period|Physician Decision|0
5820187|NCT02589665|20099678|P7|Maintenance Period|Physician Decision|0
5820188|NCT02589665|20099679|P6|Maintenance Period|Physician Decision|1
5820189|NCT02589665|20099680|P5|Maintenance Period|Physician Decision|0
5820190|NCT02589665|20099681|P4|Maintenance Period|Physician Decision|0
5820191|NCT02589665|20099682|P3|Maintenance Period|Physician Decision|0
5820192|NCT02589665|20099683|P2|Maintenance Period|Physician Decision|0
5820193|NCT02589665|20099684|P1|Maintenance Period|Physician Decision|0
5820194|NCT02589665|20099675|P10|Maintenance Period|Lost to Follow-up|0
5820195|NCT02589665|20099676|P9|Maintenance Period|Lost to Follow-up|0
5820196|NCT02589665|20099677|P8|Maintenance Period|Lost to Follow-up|0
5820197|NCT02589665|20099678|P7|Maintenance Period|Lost to Follow-up|0
5820198|NCT02589665|20099679|P6|Maintenance Period|Lost to Follow-up|1
5820199|NCT02589665|20099680|P5|Maintenance Period|Lost to Follow-up|0
5820200|NCT02589665|20099681|P4|Maintenance Period|Lost to Follow-up|0
5820201|NCT02589665|20099682|P3|Maintenance Period|Lost to Follow-up|0
5820202|NCT02589665|20099683|P2|Maintenance Period|Lost to Follow-up|0
5820203|NCT02589665|20099684|P1|Maintenance Period|Lost to Follow-up|0
5820204|NCT02589665|20099675|P10|Maintenance Period|Adverse Event|0
5820205|NCT02589665|20099676|P9|Maintenance Period|Adverse Event|0
5820206|NCT02589665|20099677|P8|Maintenance Period|Adverse Event|0
5820207|NCT02589665|20099678|P7|Maintenance Period|Adverse Event|2
5820208|NCT02589665|20099679|P6|Maintenance Period|Adverse Event|0
5820209|NCT02589665|20099680|P5|Maintenance Period|Adverse Event|0
5820210|NCT02589665|20099681|P4|Maintenance Period|Adverse Event|0
5820211|NCT02589665|20099682|P3|Maintenance Period|Adverse Event|0
5820212|NCT02589665|20099683|P2|Maintenance Period|Adverse Event|0
5820213|NCT02589665|20099684|P1|Maintenance Period|Adverse Event|0
5820214|NCT02589665|20099675|P10|Maintenance Period|Lack of Efficacy|0
5820215|NCT02589665|20099676|P9|Maintenance Period|Lack of Efficacy|0
5820216|NCT02589665|20099677|P8|Maintenance Period|Lack of Efficacy|0
5820217|NCT02589665|20099678|P7|Maintenance Period|Lack of Efficacy|0
5820218|NCT02589665|20099679|P6|Maintenance Period|Lack of Efficacy|1
5820219|NCT02589665|20099680|P5|Maintenance Period|Lack of Efficacy|2
5820220|NCT02589665|20099681|P4|Maintenance Period|Lack of Efficacy|0
5820221|NCT02589665|20099682|P3|Maintenance Period|Lack of Efficacy|0
5820222|NCT02589665|20099683|P2|Maintenance Period|Lack of Efficacy|0
5820223|NCT02589665|20099684|P1|Maintenance Period|Lack of Efficacy|0
5820224|NCT02589665|20099675|P10|Maintenance Period|Withdrawal by Subject|0
5820225|NCT02589665|20099676|P9|Maintenance Period|Withdrawal by Subject|0
5820226|NCT02589665|20099677|P8|Maintenance Period|Withdrawal by Subject|0
5820227|NCT02589665|20099678|P7|Maintenance Period|Withdrawal by Subject|4
5820228|NCT02589665|20099679|P6|Maintenance Period|Withdrawal by Subject|2
5820229|NCT02589665|20099680|P5|Maintenance Period|Withdrawal by Subject|4
5820230|NCT02589665|20099681|P4|Maintenance Period|Withdrawal by Subject|0
5820231|NCT02589665|20099682|P3|Maintenance Period|Withdrawal by Subject|0
5820232|NCT02589665|20099683|P2|Maintenance Period|Withdrawal by Subject|0
5820233|NCT02589665|20099684|P1|Maintenance Period|Withdrawal by Subject|0
5820234|NCT02589665|20099675|P10|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0
5820235|NCT02589665|20099676|P9|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0
5820236|NCT02589665|20099677|P8|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0
5820237|NCT02589665|20099678|P7|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|39
5820238|NCT02589665|20099679|P6|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|41
5820239|NCT02589665|20099680|P5|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|7
5820240|NCT02589665|20099681|P4|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0
5820241|NCT02589665|20099682|P3|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0
5820242|NCT02589665|20099683|P2|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0
5820243|NCT02589665|20099684|P1|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0
5820244|NCT02589665|20099675|P10|Induction Period|Protocol Violation|0
5820245|NCT02589665|20099676|P9|Induction Period|Protocol Violation|0
5820246|NCT02589665|20099677|P8|Induction Period|Protocol Violation|0
5820247|NCT02589665|20099678|P7|Induction Period|Protocol Violation|0
5820248|NCT02589665|20099679|P6|Induction Period|Protocol Violation|0
5820249|NCT02589665|20099680|P5|Induction Period|Protocol Violation|0
5820250|NCT02589665|20099681|P4|Induction Period|Protocol Violation|0
5820251|NCT02589665|20099682|P3|Induction Period|Protocol Violation|0
5820252|NCT02589665|20099683|P2|Induction Period|Protocol Violation|1
5820253|NCT02589665|20099684|P1|Induction Period|Protocol Violation|0
5820254|NCT02589665|20099675|P10|Induction Period|Withdrawal by Subject|0
5820255|NCT02589665|20099676|P9|Induction Period|Withdrawal by Subject|0
5820256|NCT02589665|20099677|P8|Induction Period|Withdrawal by Subject|0
5820257|NCT02589665|20099678|P7|Induction Period|Withdrawal by Subject|0
5820258|NCT02589665|20099679|P6|Induction Period|Withdrawal by Subject|0
5820259|NCT02589665|20099680|P5|Induction Period|Withdrawal by Subject|0
5820260|NCT02589665|20099681|P4|Induction Period|Withdrawal by Subject|1
5820261|NCT02589665|20099682|P3|Induction Period|Withdrawal by Subject|0
5820262|NCT02589665|20099683|P2|Induction Period|Withdrawal by Subject|1
5820263|NCT02589665|20099684|P1|Induction Period|Withdrawal by Subject|0
5820264|NCT02589665|20099675|P10|Induction Period|Adverse Event|0
5820265|NCT02589665|20099676|P9|Induction Period|Adverse Event|0
5820266|NCT02589665|20099677|P8|Induction Period|Adverse Event|0
5820267|NCT02589665|20099678|P7|Induction Period|Adverse Event|0
5820268|NCT02589665|20099679|P6|Induction Period|Adverse Event|0
5820269|NCT02589665|20099680|P5|Induction Period|Adverse Event|0
5820270|NCT02589665|20099681|P4|Induction Period|Adverse Event|2
5820271|NCT02589665|20099682|P3|Induction Period|Adverse Event|2
5820272|NCT02589665|20099683|P2|Induction Period|Adverse Event|0
5820273|NCT02589665|20099684|P1|Induction Period|Adverse Event|3
5820274|NCT02589665|20099675|P10|Induction Period|Did not receive drug|0
5820275|NCT02589665|20099676|P9|Induction Period|Did not receive drug|0
5820276|NCT02589665|20099677|P8|Induction Period|Did not receive drug|0
5820277|NCT02589665|20099678|P7|Induction Period|Did not receive drug|0
5820278|NCT02589665|20099679|P6|Induction Period|Did not receive drug|0
5820279|NCT02589665|20099680|P5|Induction Period|Did not receive drug|0
5820280|NCT02589665|20099681|P4|Induction Period|Did not receive drug|1
5820281|NCT02589665|20099682|P3|Induction Period|Did not receive drug|0
5820282|NCT02589665|20099683|P2|Induction Period|Did not receive drug|0
5820283|NCT02589665|20099684|P1|Induction Period|Did not receive drug|0
5820284|NCT02589639|20099749|P3|Overall Study|Not Treated|0
5820285|NCT02589639|20099750|P2|Overall Study|Not Treated|3
5820286|NCT02589639|20099751|P1|Overall Study|Not Treated|0
5820287|NCT02589639|20099749|P3|Overall Study|Other reason than specified above|1
5820288|NCT02589639|20099750|P2|Overall Study|Other reason than specified above|2
5820289|NCT02589639|20099751|P1|Overall Study|Other reason than specified above|1
5820290|NCT02589639|20099749|P3|Overall Study|Adverse Event|3
5820291|NCT02589639|20099750|P2|Overall Study|Adverse Event|5
5820292|NCT02589639|20099751|P1|Overall Study|Adverse Event|4
5820293|NCT02589639|20099749|P3|Overall Study|Patient withdrawal, not due to AE|0
5820294|NCT02589639|20099750|P2|Overall Study|Patient withdrawal, not due to AE|0
5820295|NCT02589639|20099751|P1|Overall Study|Patient withdrawal, not due to AE|3
5820296|NCT02589639|20099749|P3|Overall Study|Protocol Violation|0
5820297|NCT02589639|20099750|P2|Overall Study|Protocol Violation|0
5820298|NCT02589639|20099751|P1|Overall Study|Protocol Violation|1
5820299|NCT02589639|20099749|P3|Overall Study|Lost to Follow-up|0
5820300|NCT02589639|20099750|P2|Overall Study|Lost to Follow-up|0
5820301|NCT02589639|20099751|P1|Overall Study|Lost to Follow-up|1
5820302|NCT02589626|20099764|P2|Overall Study|Adverse Event|1
5820303|NCT02589626|20099765|P1|Overall Study|Adverse Event|1
5820304|NCT02589626|20099764|P2|Overall Study|Withdrawal by Subject|1
5820305|NCT02589626|20099765|P1|Overall Study|Withdrawal by Subject|1
5820306|NCT02589626|20099764|P2|Overall Study|Other than the reason specified|0
5820307|NCT02589626|20099765|P1|Overall Study|Other than the reason specified|1
5820310|NCT02588833|20099890|P2|Part 3 (Safety Follow-up)|Other|2
5820311|NCT02588833|20099891|P1|Part 3 (Safety Follow-up)|Other|0
5820312|NCT02588833|20099890|P2|Part 2C|Withdrawal by Subject|1
5820313|NCT02588833|20099891|P1|Part 2C|Withdrawal by Subject|0
5820314|NCT02588833|20099890|P2|Part 2C|Adverse Event|1
5820315|NCT02588833|20099891|P1|Part 2C|Adverse Event|0
5820316|NCT02588833|20099890|P2|Part 2B|Adverse Event|1
5820317|NCT02588833|20099891|P1|Part 2B|Adverse Event|0
5820318|NCT02588833|20099890|P2|Part 2A|Withdrawal by Subject|1
5820319|NCT02588833|20099891|P1|Part 2A|Withdrawal by Subject|0
5820320|NCT02588833|20099890|P2|Part 2A|Physician Decision|1
5820321|NCT02588833|20099891|P1|Part 2A|Physician Decision|0
5820322|NCT02588833|20099890|P2|Part 1|Withdrawal by Subject|0
5820323|NCT02588833|20099891|P1|Part 1|Withdrawal by Subject|1
5820324|NCT02588339|20099948|P1|Overall Study|GVHD Progression prior to treatment|2
5820325|NCT02588339|20099948|P1|Overall Study|Withdrawal by Subject|1
5820326|NCT02588261|20099960|P2|Overall Study|Lost to Follow-up|0
5820327|NCT02588261|20099961|P1|Overall Study|Lost to Follow-up|1
5820328|NCT02588261|20099960|P2|Overall Study|Adverse Event|24
5820329|NCT02588261|20099961|P1|Overall Study|Adverse Event|29
5820330|NCT02588261|20099960|P2|Overall Study|Progressive Disease|82
5820331|NCT02588261|20099961|P1|Overall Study|Progressive Disease|61
5820332|NCT02588261|20099960|P2|Overall Study|Miscellaneous|4
5820333|NCT02588261|20099961|P1|Overall Study|Miscellaneous|5
5820334|NCT02588261|20099960|P2|Overall Study|Noncompliance with Study Drug|1
5820335|NCT02588261|20099961|P1|Overall Study|Noncompliance with Study Drug|0
5820336|NCT02588261|20099960|P2|Overall Study|Withdrawal by Subject|8
5820337|NCT02588261|20099961|P1|Overall Study|Withdrawal by Subject|12
5820338|NCT02588261|20099960|P2|Overall Study|Death|2
5820339|NCT02588261|20099961|P1|Overall Study|Death|1
5820340|NCT02588261|20099960|P2|Overall Study|Protocol Deviation|0
5820341|NCT02588261|20099961|P1|Overall Study|Protocol Deviation|1
5820342|NCT02588261|20099960|P2|Overall Study|Study Terminated by Sponsor|142
5820343|NCT02588261|20099961|P1|Overall Study|Study Terminated by Sponsor|157
5820344|NCT02588092|20099997|P10|Overall Study|Sponsor Decision|1
5820345|NCT02588092|20099998|P9|Overall Study|Sponsor Decision|1
5820346|NCT02588092|20099999|P8|Overall Study|Sponsor Decision|0
5820347|NCT02588092|20100000|P7|Overall Study|Sponsor Decision|0
5820348|NCT02588092|20100001|P6|Overall Study|Sponsor Decision|0
5820349|NCT02588092|20100002|P5|Overall Study|Sponsor Decision|0
5820350|NCT02588092|20100003|P4|Overall Study|Sponsor Decision|0
5820351|NCT02588092|20100004|P3|Overall Study|Sponsor Decision|0
5820352|NCT02588092|20100005|P2|Overall Study|Sponsor Decision|0
5820353|NCT02588092|20100006|P1|Overall Study|Sponsor Decision|0
5820354|NCT02588092|20099997|P10|Overall Study|Started Another Treatment|0
5820355|NCT02588092|20099998|P9|Overall Study|Started Another Treatment|0
5820356|NCT02588092|20099999|P8|Overall Study|Started Another Treatment|1
5820357|NCT02588092|20100000|P7|Overall Study|Started Another Treatment|0
5820358|NCT02588092|20100001|P6|Overall Study|Started Another Treatment|0
5820359|NCT02588092|20100002|P5|Overall Study|Started Another Treatment|1
5820360|NCT02588092|20100003|P4|Overall Study|Started Another Treatment|0
5820361|NCT02588092|20100004|P3|Overall Study|Started Another Treatment|0
5820362|NCT02588092|20100005|P2|Overall Study|Started Another Treatment|0
5820363|NCT02588092|20100006|P1|Overall Study|Started Another Treatment|0
5820364|NCT02588092|20099997|P10|Overall Study|Withdrawal by Subject|0
5820365|NCT02588092|20099998|P9|Overall Study|Withdrawal by Subject|0
5820366|NCT02588092|20099999|P8|Overall Study|Withdrawal by Subject|2
5820367|NCT02588092|20100000|P7|Overall Study|Withdrawal by Subject|1
5820368|NCT02588092|20100001|P6|Overall Study|Withdrawal by Subject|1
5820369|NCT02588092|20100002|P5|Overall Study|Withdrawal by Subject|0
5820370|NCT02588092|20100003|P4|Overall Study|Withdrawal by Subject|0
5820371|NCT02588092|20100004|P3|Overall Study|Withdrawal by Subject|0
5820372|NCT02588092|20100005|P2|Overall Study|Withdrawal by Subject|0
5820373|NCT02588092|20100006|P1|Overall Study|Withdrawal by Subject|0
5820374|NCT02588092|20099997|P10|Overall Study|Death|2
5820375|NCT02588092|20099998|P9|Overall Study|Death|5
5820376|NCT02588092|20099999|P8|Overall Study|Death|1
5820377|NCT02588092|20100000|P7|Overall Study|Death|2
5820378|NCT02588092|20100001|P6|Overall Study|Death|2
5820379|NCT02588092|20100002|P5|Overall Study|Death|2
5820380|NCT02588092|20100003|P4|Overall Study|Death|3
5820381|NCT02588092|20100004|P3|Overall Study|Death|3
5820382|NCT02588092|20100005|P2|Overall Study|Death|3
5820383|NCT02588092|20100006|P1|Overall Study|Death|4
5820384|NCT02587962|20100205|P5|Overall Study|Clinical progression|1
5820385|NCT02587962|20100206|P4|Overall Study|Clinical progression|0
5820386|NCT02587962|20100207|P3|Overall Study|Clinical progression|2
5820387|NCT02587962|20100208|P2|Overall Study|Clinical progression|1
5820388|NCT02587962|20100209|P1|Overall Study|Clinical progression|0
5820389|NCT02587962|20100205|P5|Overall Study|Radiological progression|10
5820390|NCT02587962|20100206|P4|Overall Study|Radiological progression|5
5820391|NCT02587962|20100207|P3|Overall Study|Radiological progression|2
5820392|NCT02587962|20100208|P2|Overall Study|Radiological progression|2
5820393|NCT02587962|20100209|P1|Overall Study|Radiological progression|2
5820394|NCT02587962|20100205|P5|Overall Study|Withdrawal by Subject|4
5820395|NCT02587962|20100206|P4|Overall Study|Withdrawal by Subject|1
5820396|NCT02587962|20100207|P3|Overall Study|Withdrawal by Subject|1
5820397|NCT02587962|20100208|P2|Overall Study|Withdrawal by Subject|0
5820398|NCT02587962|20100209|P1|Overall Study|Withdrawal by Subject|0
5820399|NCT02587962|20100205|P5|Overall Study|Adverse Event|0
5820400|NCT02587962|20100206|P4|Overall Study|Adverse Event|0
5820401|NCT02587962|20100207|P3|Overall Study|Adverse Event|1
5820402|NCT02587962|20100208|P2|Overall Study|Adverse Event|0
5820403|NCT02587962|20100209|P1|Overall Study|Adverse Event|0
5820404|NCT02587819|20100281|P1|Overall Study|Lost to Follow-up|1
5820405|NCT02587819|20100281|P1|Overall Study|Adverse Event|1
5820406|NCT02587520|20100317|P18|Overall Study|Lost to Follow-up|0
5820407|NCT02587520|20100318|P17|Overall Study|Lost to Follow-up|0
5820408|NCT02587520|20100319|P16|Overall Study|Lost to Follow-up|0
5820409|NCT02587520|20100320|P15|Overall Study|Lost to Follow-up|0
5820410|NCT02587520|20100321|P14|Overall Study|Lost to Follow-up|0
5820411|NCT02587520|20100322|P13|Overall Study|Lost to Follow-up|0
5820412|NCT02587520|20100323|P12|Overall Study|Lost to Follow-up|1
5820413|NCT02587520|20100324|P11|Overall Study|Lost to Follow-up|2
5820414|NCT02587520|20100325|P10|Overall Study|Lost to Follow-up|2
5820415|NCT02587520|20100326|P9|Overall Study|Lost to Follow-up|0
5820416|NCT02587520|20100327|P8|Overall Study|Lost to Follow-up|1
5820417|NCT02587520|20100328|P7|Overall Study|Lost to Follow-up|1
5820418|NCT02587520|20100329|P6|Overall Study|Lost to Follow-up|1
5820419|NCT02587520|20100330|P5|Overall Study|Lost to Follow-up|0
5820420|NCT02587520|20100331|P4|Overall Study|Lost to Follow-up|2
5820421|NCT02587520|20100332|P3|Overall Study|Lost to Follow-up|0
5820422|NCT02587520|20100333|P2|Overall Study|Lost to Follow-up|2
5820423|NCT02587520|20100334|P1|Overall Study|Lost to Follow-up|0
5820424|NCT02587520|20100317|P18|Overall Study|Withdrawal by Subject|0
5820425|NCT02587520|20100318|P17|Overall Study|Withdrawal by Subject|0
5820426|NCT02587520|20100319|P16|Overall Study|Withdrawal by Subject|0
5820427|NCT02587520|20100320|P15|Overall Study|Withdrawal by Subject|0
5820428|NCT02587520|20100321|P14|Overall Study|Withdrawal by Subject|1
5820429|NCT02587520|20100322|P13|Overall Study|Withdrawal by Subject|0
5820430|NCT02587520|20100323|P12|Overall Study|Withdrawal by Subject|0
5820431|NCT02587520|20100324|P11|Overall Study|Withdrawal by Subject|0
5820432|NCT02587520|20100325|P10|Overall Study|Withdrawal by Subject|0
5820433|NCT02587520|20100326|P9|Overall Study|Withdrawal by Subject|0
5820434|NCT02587520|20100327|P8|Overall Study|Withdrawal by Subject|0
5820435|NCT02587520|20100328|P7|Overall Study|Withdrawal by Subject|1
5820436|NCT02587520|20100329|P6|Overall Study|Withdrawal by Subject|1
5820437|NCT02587520|20100330|P5|Overall Study|Withdrawal by Subject|0
5820438|NCT02587520|20100331|P4|Overall Study|Withdrawal by Subject|1
5820439|NCT02587520|20100332|P3|Overall Study|Withdrawal by Subject|1
5820440|NCT02587520|20100333|P2|Overall Study|Withdrawal by Subject|0
5820441|NCT02587520|20100334|P1|Overall Study|Withdrawal by Subject|0
5820442|NCT02587520|20100317|P18|Overall Study|Adverse Event|0
5820443|NCT02587520|20100318|P17|Overall Study|Adverse Event|0
5820444|NCT02587520|20100319|P16|Overall Study|Adverse Event|0
5820445|NCT02587520|20100320|P15|Overall Study|Adverse Event|0
5820446|NCT02587520|20100321|P14|Overall Study|Adverse Event|0
5820447|NCT02587520|20100322|P13|Overall Study|Adverse Event|0
5820448|NCT02587520|20100323|P12|Overall Study|Adverse Event|1
5820449|NCT02587520|20100324|P11|Overall Study|Adverse Event|0
5820450|NCT02587520|20100325|P10|Overall Study|Adverse Event|0
5820451|NCT02587520|20100326|P9|Overall Study|Adverse Event|0
5820452|NCT02587520|20100327|P8|Overall Study|Adverse Event|0
5820453|NCT02587520|20100328|P7|Overall Study|Adverse Event|0
5820454|NCT02587520|20100329|P6|Overall Study|Adverse Event|0
5820455|NCT02587520|20100330|P5|Overall Study|Adverse Event|0
5820456|NCT02587520|20100331|P4|Overall Study|Adverse Event|0
5820457|NCT02587520|20100332|P3|Overall Study|Adverse Event|0
5820458|NCT02587520|20100333|P2|Overall Study|Adverse Event|0
5820459|NCT02587520|20100334|P1|Overall Study|Adverse Event|0
5820460|NCT02587520|20100317|P18|Overall Study|Protocol Violation|0
5820461|NCT02587520|20100318|P17|Overall Study|Protocol Violation|0
5820462|NCT02587520|20100319|P16|Overall Study|Protocol Violation|0
5820463|NCT02587520|20100320|P15|Overall Study|Protocol Violation|0
5820464|NCT02587520|20100321|P14|Overall Study|Protocol Violation|0
5820465|NCT02587520|20100322|P13|Overall Study|Protocol Violation|0
5820466|NCT02587520|20100323|P12|Overall Study|Protocol Violation|2
5820467|NCT02587520|20100324|P11|Overall Study|Protocol Violation|1
5820468|NCT02587520|20100325|P10|Overall Study|Protocol Violation|3
5820469|NCT02587520|20100326|P9|Overall Study|Protocol Violation|3
5820470|NCT02587520|20100327|P8|Overall Study|Protocol Violation|1
5820471|NCT02587520|20100328|P7|Overall Study|Protocol Violation|1
5820472|NCT02587520|20100329|P6|Overall Study|Protocol Violation|1
5820473|NCT02587520|20100330|P5|Overall Study|Protocol Violation|0
5820474|NCT02587520|20100331|P4|Overall Study|Protocol Violation|2
5820475|NCT02587520|20100332|P3|Overall Study|Protocol Violation|0
5820476|NCT02587520|20100333|P2|Overall Study|Protocol Violation|0
5820477|NCT02587520|20100334|P1|Overall Study|Protocol Violation|2
5820478|NCT02587234|20100429|P2|Overall Study|Lost to Follow-up|2
5820479|NCT02587234|20100430|P1|Overall Study|Lost to Follow-up|0
5820480|NCT02587234|20100429|P2|Overall Study|Withdrawal by Subject|1
5820481|NCT02587234|20100430|P1|Overall Study|Withdrawal by Subject|1
5820482|NCT02587221|20100442|P2|Overall Study|Other Reason or Unspecified|1
5820483|NCT02587221|20100443|P1|Overall Study|Other Reason or Unspecified|2
5820484|NCT02587221|20100442|P2|Overall Study|Protocol Violation|5
5820485|NCT02587221|20100443|P1|Overall Study|Protocol Violation|6
5820486|NCT02587221|20100442|P2|Overall Study|Lost to Follow-up|19
5820487|NCT02587221|20100443|P1|Overall Study|Lost to Follow-up|21
5820488|NCT02587221|20100442|P2|Overall Study|Withdrawal by Subject|61
5820489|NCT02587221|20100443|P1|Overall Study|Withdrawal by Subject|66
5820490|NCT02587221|20100442|P2|Overall Study|Death|34
5820491|NCT02587221|20100443|P1|Overall Study|Death|33
5820492|NCT02587221|20100442|P2|Overall Study|Adverse Event|3
5820493|NCT02587221|20100443|P1|Overall Study|Adverse Event|3
5820494|NCT02587143|20100489|P2|Overall Study|Adverse Event|0
5820495|NCT02587143|20100490|P1|Overall Study|Adverse Event|1
5820496|NCT02587065|20100507|P1|Overall Study|Reason not Specified|3
5820497|NCT02587065|20100507|P1|Overall Study|Discontinuation of Study Medication|2
5820498|NCT02587065|20100507|P1|Overall Study|Non-adherence to the Protocol|3
5820499|NCT02587065|20100507|P1|Overall Study|Withdrawal of Informed Consent (IC)|5
5820500|NCT02587065|20100507|P1|Overall Study|Adverse Event|14
5820501|NCT02586805|20100572|P4|Overall Study|Physician Decision|0
5820502|NCT02586805|20100573|P3|Overall Study|Physician Decision|0
5820503|NCT02586805|20100574|P2|Overall Study|Physician Decision|0
5820504|NCT02586805|20100575|P1|Overall Study|Physician Decision|1
5820505|NCT02586805|20100572|P4|Overall Study|Lost to Follow-up|0
5820506|NCT02586805|20100573|P3|Overall Study|Lost to Follow-up|1
5820507|NCT02586805|20100574|P2|Overall Study|Lost to Follow-up|0
5820508|NCT02586805|20100575|P1|Overall Study|Lost to Follow-up|0
5820509|NCT02586805|20100572|P4|Overall Study|Adverse Event|0
5820510|NCT02586805|20100573|P3|Overall Study|Adverse Event|1
5820511|NCT02586805|20100574|P2|Overall Study|Adverse Event|0
5820512|NCT02586805|20100575|P1|Overall Study|Adverse Event|2
5820513|NCT02586805|20100572|P4|Overall Study|Withdrawal by Subject|2
5820514|NCT02586805|20100573|P3|Overall Study|Withdrawal by Subject|1
5820515|NCT02586805|20100574|P2|Overall Study|Withdrawal by Subject|1
5820516|NCT02586805|20100575|P1|Overall Study|Withdrawal by Subject|3
5820517|NCT02586506|20100603|P1|Overall Study|Other Reason|2
5820518|NCT02586506|20100603|P1|Overall Study|Lost to Follow-up|1
5820519|NCT02586506|20100603|P1|Overall Study|Protocol Violation|6
5820520|NCT02586493|20100609|P1|Overall Study|Withdrawal by Subject|1
5820521|NCT02586493|20100609|P1|Overall Study|Lost to Follow-up|1
5820522|NCT02586493|20100609|P1|Overall Study|Protocol Violation|6
5820523|NCT02586493|20100609|P1|Overall Study|Adverse Event|4
5820524|NCT02586415|20100617|P2|Overall Study|Lost to Follow-up|2
5820525|NCT02586415|20100618|P1|Overall Study|Lost to Follow-up|1
5820526|NCT02586415|20100617|P2|Overall Study|Death|23
5820527|NCT02586415|20100618|P1|Overall Study|Death|13
5820528|NCT02586233|20100635|P7|Overall Study|Death|0
5820529|NCT02586233|20100636|P6|Overall Study|Death|0
5820530|NCT02586233|20100637|P5|Overall Study|Death|2
5820531|NCT02586233|20100638|P4|Overall Study|Death|0
5820532|NCT02586233|20100639|P3|Overall Study|Death|0
5820533|NCT02586233|20100640|P2|Overall Study|Death|1
5820534|NCT02586233|20100641|P1|Overall Study|Death|0
5820535|NCT02586233|20100635|P7|Overall Study|Randomized but did not receive treatment|2
5820536|NCT02586233|20100636|P6|Overall Study|Randomized but did not receive treatment|2
5820537|NCT02586233|20100637|P5|Overall Study|Randomized but did not receive treatment|0
5820538|NCT02586233|20100638|P4|Overall Study|Randomized but did not receive treatment|0
5820539|NCT02586233|20100639|P3|Overall Study|Randomized but did not receive treatment|0
5820540|NCT02586233|20100640|P2|Overall Study|Randomized but did not receive treatment|1
5820541|NCT02586233|20100641|P1|Overall Study|Randomized but did not receive treatment|0
5820544|NCT02586077|20100705|P1|Overall Study|Lost to Follow-up|3
5820545|NCT02586077|20100705|P1|Overall Study|Physician Decision|4
5820546|NCT02586077|20100705|P1|Overall Study|Withdrawal by Subject|1
5820569|NCT02586012|20100752|P6|Overall Study|study terminated|0
5820570|NCT02586012|20100753|P5|Overall Study|study terminated|1
5820571|NCT02586012|20100754|P4|Overall Study|study terminated|1
5820572|NCT02586012|20100755|P3|Overall Study|study terminated|1
5820573|NCT02586012|20100756|P2|Overall Study|study terminated|2
5820574|NCT02586012|20100757|P1|Overall Study|study terminated|0
5820575|NCT02586012|20100752|P6|Overall Study|Protocol Violation|1
5820576|NCT02586012|20100753|P5|Overall Study|Protocol Violation|0
5820577|NCT02586012|20100754|P4|Overall Study|Protocol Violation|0
5820578|NCT02586012|20100755|P3|Overall Study|Protocol Violation|0
5820579|NCT02586012|20100756|P2|Overall Study|Protocol Violation|0
5820580|NCT02586012|20100757|P1|Overall Study|Protocol Violation|0
5820581|NCT02586012|20100752|P6|Overall Study|Withdrawal by Subject|2
5820582|NCT02586012|20100753|P5|Overall Study|Withdrawal by Subject|0
5820583|NCT02586012|20100754|P4|Overall Study|Withdrawal by Subject|1
5820584|NCT02586012|20100755|P3|Overall Study|Withdrawal by Subject|0
5820585|NCT02586012|20100756|P2|Overall Study|Withdrawal by Subject|1
5820586|NCT02586012|20100757|P1|Overall Study|Withdrawal by Subject|1
5820587|NCT02585999|20100768|P1|Overall Study|Protocol Violation|1
5820588|NCT02585999|20100768|P1|Overall Study|Lost to Follow-up|1
5820589|NCT02585960|20100776|P3|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0
5820590|NCT02585960|20100777|P2|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|1
5820591|NCT02585960|20100778|P1|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0
5820592|NCT02585960|20100776|P3|Prophylactic Treatment Period|Major protocol deviation|0
5820593|NCT02585960|20100777|P2|Prophylactic Treatment Period|Major protocol deviation|4
5820594|NCT02585960|20100778|P1|Prophylactic Treatment Period|Major protocol deviation|0
5820595|NCT02585960|20100776|P3|PK/Safety Assessment Period|Screen Failure|1
5820596|NCT02585960|20100777|P2|PK/Safety Assessment Period|Screen Failure|0
5820597|NCT02585960|20100778|P1|PK/Safety Assessment Period|Screen Failure|0
5820598|NCT02585960|20100776|P3|PK/Safety Assessment Period|Withdrawn by sponsor|0
5820599|NCT02585960|20100777|P2|PK/Safety Assessment Period|Withdrawn by sponsor|1
5820600|NCT02585960|20100778|P1|PK/Safety Assessment Period|Withdrawn by sponsor|0
5820601|NCT02585960|20100776|P3|PK/Safety Assessment Period|Other|0
5820602|NCT02585960|20100777|P2|PK/Safety Assessment Period|Other|4
5820603|NCT02585960|20100778|P1|PK/Safety Assessment Period|Other|4
5820604|NCT02585960|20100776|P3|PK/Safety Assessment Period|Non-compliance to study procedures|0
5820605|NCT02585960|20100777|P2|PK/Safety Assessment Period|Non-compliance to study procedures|2
5820606|NCT02585960|20100778|P1|PK/Safety Assessment Period|Non-compliance to study procedures|0
5820607|NCT02585960|20100776|P3|PK/Safety Assessment Period|Withdrawal by Subject|5
5820608|NCT02585960|20100777|P2|PK/Safety Assessment Period|Withdrawal by Subject|2
5820609|NCT02585960|20100778|P1|PK/Safety Assessment Period|Withdrawal by Subject|1
5820610|NCT02585960|20100776|P3|PK/Safety Assessment Period|Physician Decision|0
5820611|NCT02585960|20100777|P2|PK/Safety Assessment Period|Physician Decision|1
5820612|NCT02585960|20100778|P1|PK/Safety Assessment Period|Physician Decision|0
5820613|NCT02585934|20100848|P2|Overall Study|Another Reason|5
5820614|NCT02585934|20100849|P1|Overall Study|Another Reason|10
5820615|NCT02585934|20100848|P2|Overall Study|Sponsor Termination|2
5820616|NCT02585934|20100849|P1|Overall Study|Sponsor Termination|1
5820617|NCT02585934|20100848|P2|Overall Study|Caregiver Withdrew Consent|7
5820618|NCT02585934|20100849|P1|Overall Study|Caregiver Withdrew Consent|7
5820619|NCT02585934|20100848|P2|Overall Study|Death|0
5820620|NCT02585934|20100849|P1|Overall Study|Death|2
5820621|NCT02585934|20100848|P2|Overall Study|Lack of Efficacy|1
5820622|NCT02585934|20100849|P1|Overall Study|Lack of Efficacy|2
5820623|NCT02585934|20100848|P2|Overall Study|Withdrawal by Subject|21
5820624|NCT02585934|20100849|P1|Overall Study|Withdrawal by Subject|7
5820625|NCT02585934|20100848|P2|Overall Study|Physician Decision|2
5820626|NCT02585934|20100849|P1|Overall Study|Physician Decision|3
5820627|NCT02585934|20100848|P2|Overall Study|Adverse Event|22
5820628|NCT02585934|20100849|P1|Overall Study|Adverse Event|21
5820629|NCT02585934|20100848|P2|Overall Study|Protocol Violation|11
5820630|NCT02585934|20100849|P1|Overall Study|Protocol Violation|14
5820631|NCT02585934|20100848|P2|Overall Study|Lost to Follow-up|2
5820632|NCT02585934|20100849|P1|Overall Study|Lost to Follow-up|2
5820633|NCT02585830|20100905|P1|Overall Study|Withdrawal by Subject|3
5820634|NCT02585778|20100914|P2|Overall Study|Other than specified above|2
5820635|NCT02585778|20100915|P1|Overall Study|Other than specified above|6
5820636|NCT02585778|20100914|P2|Overall Study|Randomized but not treated|2
5820637|NCT02585778|20100915|P1|Overall Study|Randomized but not treated|1
5820638|NCT02585778|20100914|P2|Overall Study|Death|1
5820639|NCT02585778|20100915|P1|Overall Study|Death|0
5820640|NCT02585778|20100914|P2|Overall Study|Poor compliance to study protocol|2
5820641|NCT02585778|20100915|P1|Overall Study|Poor compliance to study protocol|0
5820642|NCT02585778|20100914|P2|Overall Study|Participant did not wish to continue|4
5820643|NCT02585778|20100915|P1|Overall Study|Participant did not wish to continue|9
5820644|NCT02585778|20100914|P2|Overall Study|Adverse Event|4
5820645|NCT02585778|20100915|P1|Overall Study|Adverse Event|17
5820646|NCT02585713|20101031|P2|Overall Study|Other|1
5820647|NCT02585713|20101032|P1|Overall Study|Other|3
5820648|NCT02585713|20101031|P2|Overall Study|Withdrew prior to treatment|7
5820649|NCT02585713|20101032|P1|Overall Study|Withdrew prior to treatment|2
5820650|NCT02584959|20101095|P3|Period 2|Withdrawn from study|2
5820651|NCT02584959|20101096|P2|Period 2|Withdrawn from study|1
5820652|NCT02584959|20101097|P1|Period 2|Withdrawn from study|6
5820653|NCT02584959|20101095|P3|Period 1|Withdrawn from study|0
5820654|NCT02584959|20101096|P2|Period 1|Withdrawn from study|4
5820655|NCT02584959|20101097|P1|Period 1|Withdrawn from study|3
5820656|NCT02584855|20101225|P6|Post Treatment Follow-up Period|Protocol Violation|0
5820657|NCT02584855|20101226|P5|Post Treatment Follow-up Period|Protocol Violation|1
5820658|NCT02584855|20101227|P4|Post Treatment Follow-up Period|Protocol Violation|0
5820659|NCT02584855|20101228|P3|Post Treatment Follow-up Period|Protocol Violation|0
5820660|NCT02584855|20101229|P2|Post Treatment Follow-up Period|Protocol Violation|0
5820661|NCT02584855|20101230|P1|Post Treatment Follow-up Period|Protocol Violation|0
5820662|NCT02584855|20101225|P6|Post Treatment Follow-up Period|Withdrawal by Subject|0
5820663|NCT02584855|20101226|P5|Post Treatment Follow-up Period|Withdrawal by Subject|7
5820664|NCT02584855|20101227|P4|Post Treatment Follow-up Period|Withdrawal by Subject|0
5820665|NCT02584855|20101228|P3|Post Treatment Follow-up Period|Withdrawal by Subject|0
5820666|NCT02584855|20101229|P2|Post Treatment Follow-up Period|Withdrawal by Subject|0
5820667|NCT02584855|20101230|P1|Post Treatment Follow-up Period|Withdrawal by Subject|0
5820668|NCT02584855|20101225|P6|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0
5820669|NCT02584855|20101226|P5|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0
5820670|NCT02584855|20101227|P4|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0
5820671|NCT02584855|20101228|P3|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0
5820672|NCT02584855|20101229|P2|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|1
5820673|NCT02584855|20101230|P1|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0
5820674|NCT02584855|20101225|P6|Double-Blind Withdrawal Period|Lack of Efficacy|0
5820675|NCT02584855|20101226|P5|Double-Blind Withdrawal Period|Lack of Efficacy|0
5820676|NCT02584855|20101227|P4|Double-Blind Withdrawal Period|Lack of Efficacy|0
5820677|NCT02584855|20101228|P3|Double-Blind Withdrawal Period|Lack of Efficacy|0
5820678|NCT02584855|20101229|P2|Double-Blind Withdrawal Period|Lack of Efficacy|10
5820679|NCT02584855|20101230|P1|Double-Blind Withdrawal Period|Lack of Efficacy|0
5820680|NCT02584855|20101225|P6|Double-Blind Withdrawal Period|Adverse Event|0
5820681|NCT02584855|20101226|P5|Double-Blind Withdrawal Period|Adverse Event|0
5820682|NCT02584855|20101227|P4|Double-Blind Withdrawal Period|Adverse Event|1
5820683|NCT02584855|20101228|P3|Double-Blind Withdrawal Period|Adverse Event|0
5820684|NCT02584855|20101229|P2|Double-Blind Withdrawal Period|Adverse Event|4
5820685|NCT02584855|20101230|P1|Double-Blind Withdrawal Period|Adverse Event|0
5820686|NCT02584855|20101225|P6|Double-Blind Withdrawal Period|Withdrawal by Subject|0
5820687|NCT02584855|20101226|P5|Double-Blind Withdrawal Period|Withdrawal by Subject|0
5820688|NCT02584855|20101227|P4|Double-Blind Withdrawal Period|Withdrawal by Subject|0
5820689|NCT02584855|20101228|P3|Double-Blind Withdrawal Period|Withdrawal by Subject|2
5820690|NCT02584855|20101229|P2|Double-Blind Withdrawal Period|Withdrawal by Subject|0
5820691|NCT02584855|20101230|P1|Double-Blind Withdrawal Period|Withdrawal by Subject|0
5820692|NCT02584855|20101225|P6|Open-Label Treatment Period|Sponsor Decision|0
5820693|NCT02584855|20101226|P5|Open-Label Treatment Period|Sponsor Decision|0
5820694|NCT02584855|20101227|P4|Open-Label Treatment Period|Sponsor Decision|0
5820695|NCT02584855|20101228|P3|Open-Label Treatment Period|Sponsor Decision|0
5820696|NCT02584855|20101229|P2|Open-Label Treatment Period|Sponsor Decision|0
5820697|NCT02584855|20101230|P1|Open-Label Treatment Period|Sponsor Decision|1
5820698|NCT02584855|20101225|P6|Open-Label Treatment Period|No PI Available|0
5820699|NCT02584855|20101226|P5|Open-Label Treatment Period|No PI Available|0
5820700|NCT02584855|20101227|P4|Open-Label Treatment Period|No PI Available|0
5820701|NCT02584855|20101228|P3|Open-Label Treatment Period|No PI Available|0
5820702|NCT02584855|20101229|P2|Open-Label Treatment Period|No PI Available|0
5820703|NCT02584855|20101230|P1|Open-Label Treatment Period|No PI Available|2
5820704|NCT02584855|20101225|P6|Open-Label Treatment Period|Protocol Violation|0
5820705|NCT02584855|20101226|P5|Open-Label Treatment Period|Protocol Violation|0
5820706|NCT02584855|20101227|P4|Open-Label Treatment Period|Protocol Violation|0
5820707|NCT02584855|20101228|P3|Open-Label Treatment Period|Protocol Violation|0
5820708|NCT02584855|20101229|P2|Open-Label Treatment Period|Protocol Violation|0
5820709|NCT02584855|20101230|P1|Open-Label Treatment Period|Protocol Violation|1
5820710|NCT02584855|20101225|P6|Open-Label Treatment Period|Lost to Follow-up|0
5820711|NCT02584855|20101226|P5|Open-Label Treatment Period|Lost to Follow-up|0
5820712|NCT02584855|20101227|P4|Open-Label Treatment Period|Lost to Follow-up|0
5820713|NCT02584855|20101228|P3|Open-Label Treatment Period|Lost to Follow-up|0
5820714|NCT02584855|20101229|P2|Open-Label Treatment Period|Lost to Follow-up|0
5820715|NCT02584855|20101230|P1|Open-Label Treatment Period|Lost to Follow-up|1
5820716|NCT02584855|20101225|P6|Open-Label Treatment Period|Death|0
5820717|NCT02584855|20101226|P5|Open-Label Treatment Period|Death|0
5820718|NCT02584855|20101227|P4|Open-Label Treatment Period|Death|0
5820719|NCT02584855|20101228|P3|Open-Label Treatment Period|Death|0
5820720|NCT02584855|20101229|P2|Open-Label Treatment Period|Death|0
5820721|NCT02584855|20101230|P1|Open-Label Treatment Period|Death|2
5820722|NCT02584855|20101225|P6|Open-Label Treatment Period|Adverse Event|0
5820723|NCT02584855|20101226|P5|Open-Label Treatment Period|Adverse Event|0
5820724|NCT02584855|20101227|P4|Open-Label Treatment Period|Adverse Event|0
5820725|NCT02584855|20101228|P3|Open-Label Treatment Period|Adverse Event|0
5820726|NCT02584855|20101229|P2|Open-Label Treatment Period|Adverse Event|0
5820727|NCT02584855|20101230|P1|Open-Label Treatment Period|Adverse Event|14
5820728|NCT02584855|20101225|P6|Open-Label Treatment Period|Withdrawal by Subject|0
5820729|NCT02584855|20101226|P5|Open-Label Treatment Period|Withdrawal by Subject|0
5820730|NCT02584855|20101227|P4|Open-Label Treatment Period|Withdrawal by Subject|0
5820731|NCT02584855|20101228|P3|Open-Label Treatment Period|Withdrawal by Subject|0
5820732|NCT02584855|20101229|P2|Open-Label Treatment Period|Withdrawal by Subject|0
5820733|NCT02584855|20101230|P1|Open-Label Treatment Period|Withdrawal by Subject|21
5820734|NCT02584855|20101225|P6|Open-Label Treatment Period|Lack of Efficacy|0
5820735|NCT02584855|20101226|P5|Open-Label Treatment Period|Lack of Efficacy|0
5820736|NCT02584855|20101227|P4|Open-Label Treatment Period|Lack of Efficacy|0
5820737|NCT02584855|20101228|P3|Open-Label Treatment Period|Lack of Efficacy|0
5820738|NCT02584855|20101229|P2|Open-Label Treatment Period|Lack of Efficacy|0
5820739|NCT02584855|20101230|P1|Open-Label Treatment Period|Lack of Efficacy|61
5820740|NCT02584660|20101362|P2|Overall Study|Other|1
5820741|NCT02584660|20101363|P1|Overall Study|Other|0
5820742|NCT02584660|20101362|P2|Overall Study|Withdrawal by Subject|2
5820743|NCT02584660|20101363|P1|Overall Study|Withdrawal by Subject|0
5820744|NCT02584660|20101362|P2|Overall Study|Protocol Violation|1
5820745|NCT02584660|20101363|P1|Overall Study|Protocol Violation|0
5820746|NCT02584660|20101362|P2|Overall Study|Lost to Follow-up|4
5820747|NCT02584660|20101363|P1|Overall Study|Lost to Follow-up|3
5820748|NCT02584660|20101362|P2|Overall Study|Adverse Event|0
5820749|NCT02584660|20101363|P1|Overall Study|Adverse Event|4
5820750|NCT02584504|20101387|P3|Open-label Treatment|Entered but not treated|1
5820751|NCT02584504|20101388|P2|Open-label Treatment|Entered but not treated|1
5820752|NCT02584504|20101389|P1|Open-label Treatment|Entered but not treated|0
5820753|NCT02584504|20101387|P3|Open-label Treatment|Physician Decision|0
5820754|NCT02584504|20101388|P2|Open-label Treatment|Physician Decision|1
5820755|NCT02584504|20101389|P1|Open-label Treatment|Physician Decision|0
5820756|NCT02584504|20101387|P3|Open-label Treatment|Adverse Event|3
5820757|NCT02584504|20101388|P2|Open-label Treatment|Adverse Event|2
5820758|NCT02584504|20101389|P1|Open-label Treatment|Adverse Event|2
5820759|NCT02584504|20101387|P3|Open-label Treatment|Participant withdrew consent|4
5820760|NCT02584504|20101388|P2|Open-label Treatment|Participant withdrew consent|0
5820761|NCT02584504|20101389|P1|Open-label Treatment|Participant withdrew consent|0
5820762|NCT02584504|20101387|P3|Double-blind Treatment|Family Matter|0
5820763|NCT02584504|20101388|P2|Double-blind Treatment|Family Matter|1
5820764|NCT02584504|20101389|P1|Double-blind Treatment|Family Matter|0
5820765|NCT02584504|20101387|P3|Double-blind Treatment|Adverse Event|0
5820766|NCT02584504|20101388|P2|Double-blind Treatment|Adverse Event|1
5820767|NCT02584504|20101389|P1|Double-blind Treatment|Adverse Event|0
5820768|NCT02584504|20101387|P3|Double-blind Treatment|Participant withdrew consent|1
5820769|NCT02584504|20101388|P2|Double-blind Treatment|Participant withdrew consent|0
5820770|NCT02584504|20101389|P1|Double-blind Treatment|Participant withdrew consent|0
5820771|NCT02584452|20101445|P2|Overall Study|Lost to Follow-up|1
5820772|NCT02584452|20101446|P1|Overall Study|Lost to Follow-up|1
5820773|NCT02584452|20101445|P2|Overall Study|Physician Decision|1
5820774|NCT02584452|20101446|P1|Overall Study|Physician Decision|1
5820775|NCT02584257|20101474|P9|Period 2|Adverse Event|0
5820776|NCT02584257|20101475|P8|Period 2|Adverse Event|0
5820777|NCT02584257|20101476|P7|Period 2|Adverse Event|0
5820778|NCT02584257|20101477|P6|Period 2|Adverse Event|0
5820779|NCT02584257|20101478|P5|Period 2|Adverse Event|0
5820780|NCT02584257|20101479|P4|Period 2|Adverse Event|0
5820781|NCT02584257|20101480|P3|Period 2|Adverse Event|0
5820782|NCT02584257|20101481|P2|Period 2|Adverse Event|1
5820783|NCT02584257|20101482|P1|Period 2|Adverse Event|0
5820784|NCT02584257|20101474|P9|Period 2|Physician Decision|0
5820785|NCT02584257|20101475|P8|Period 2|Physician Decision|0
5820786|NCT02584257|20101476|P7|Period 2|Physician Decision|0
5820787|NCT02584257|20101477|P6|Period 2|Physician Decision|0
5820788|NCT02584257|20101478|P5|Period 2|Physician Decision|0
5820789|NCT02584257|20101479|P4|Period 2|Physician Decision|0
5820790|NCT02584257|20101480|P3|Period 2|Physician Decision|0
5820791|NCT02584257|20101481|P2|Period 2|Physician Decision|0
5820792|NCT02584257|20101482|P1|Period 2|Physician Decision|1
5820793|NCT02584257|20101474|P9|Period 1|Withdrawal by Subject|0
5820794|NCT02584257|20101475|P8|Period 1|Withdrawal by Subject|0
5820795|NCT02584257|20101476|P7|Period 1|Withdrawal by Subject|1
5820796|NCT02584257|20101477|P6|Period 1|Withdrawal by Subject|0
5820797|NCT02584257|20101478|P5|Period 1|Withdrawal by Subject|0
5820798|NCT02584257|20101479|P4|Period 1|Withdrawal by Subject|0
5820799|NCT02584257|20101480|P3|Period 1|Withdrawal by Subject|0
5820800|NCT02584257|20101481|P2|Period 1|Withdrawal by Subject|0
5820801|NCT02584257|20101482|P1|Period 1|Withdrawal by Subject|0
5820802|NCT02583477|20101503|P2|Overall Study|Study terminated|2
5820803|NCT02583477|20101504|P1|Overall Study|Study terminated|2
5820804|NCT02583477|20101503|P2|Overall Study|Death|16
5820805|NCT02583477|20101504|P1|Overall Study|Death|1
5820806|NCT02583477|20101503|P2|Overall Study|Adverse Event|2
5820807|NCT02583477|20101504|P1|Overall Study|Adverse Event|0
5820808|NCT02583425|20101524|P1|Treatment Period|Adverse Event|1
5820809|NCT02583425|20101524|P1|Baseline|Did not meet continued criteria|5
5820810|NCT02583425|20101524|P1|Screening|Did not meet entry criteria|12
5820811|NCT02583399|20101529|P1|Overall Study|Wanted to use a restricted medication|3
5820812|NCT02583399|20101529|P1|Overall Study|Able to be discharged|3
5820813|NCT02583269|20101554|P5|Overall Study|Patient hospitalized prior to start|0
5820814|NCT02583269|20101555|P4|Overall Study|Patient hospitalized prior to start|0
5820815|NCT02583269|20101556|P3|Overall Study|Patient hospitalized prior to start|0
5820816|NCT02583269|20101557|P2|Overall Study|Patient hospitalized prior to start|0
5820817|NCT02583269|20101558|P1|Overall Study|Patient hospitalized prior to start|1
5820818|NCT02583256|20101587|P4|Overall Study|Administrative/Other|2
5820819|NCT02583256|20101588|P3|Overall Study|Administrative/Other|1
5820820|NCT02583256|20101589|P2|Overall Study|Administrative/Other|0
5820821|NCT02583256|20101590|P1|Overall Study|Administrative/Other|2
5820822|NCT02583256|20101587|P4|Overall Study|Lost to Follow-up|1
5820823|NCT02583256|20101588|P3|Overall Study|Lost to Follow-up|0
5820824|NCT02583256|20101589|P2|Overall Study|Lost to Follow-up|1
5820825|NCT02583256|20101590|P1|Overall Study|Lost to Follow-up|1
5820826|NCT02583256|20101587|P4|Overall Study|Withdrawal by Subject|0
5820827|NCT02583256|20101588|P3|Overall Study|Withdrawal by Subject|1
5820828|NCT02583256|20101589|P2|Overall Study|Withdrawal by Subject|1
5820829|NCT02583256|20101590|P1|Overall Study|Withdrawal by Subject|0
5820836|NCT02582983|20101748|P1|Overall Study|Adverse Event|1
5820837|NCT02582983|20101748|P1|Overall Study|Withdrawal by Subject|2
5820838|NCT02582983|20101748|P1|Overall Study|Death|3
5820839|NCT02582866|20101763|P1|Overall Study|Withdrawal due to personal reasons|1
5820840|NCT02582866|20101763|P1|Overall Study|Sponsor decision|1
5820841|NCT02582866|20101763|P1|Overall Study|Pregnancy|2
5820842|NCT02582866|20101763|P1|Overall Study|Participant wants to get pregnant|1
5820843|NCT02582866|20101763|P1|Overall Study|Investigator decision|5
5820844|NCT02582866|20101763|P1|Overall Study|Withdrawal by Subject|7
5820845|NCT02582866|20101763|P1|Overall Study|Lost to Follow-up|2
5820846|NCT02582866|20101763|P1|Overall Study|Lack of Efficacy|2
5820847|NCT02582866|20101763|P1|Overall Study|Death|1
5820848|NCT02582814|20101817|P2|Overall Study|Adverse Event|4
5820849|NCT02582814|20101818|P1|Overall Study|Adverse Event|4
5820850|NCT02582814|20101817|P2|Overall Study|Withdrawal by Subject|3
5820851|NCT02582814|20101818|P1|Overall Study|Withdrawal by Subject|4
5820852|NCT02582814|20101817|P2|Overall Study|Study-specific withdrawal criteria|0
5820853|NCT02582814|20101818|P1|Overall Study|Study-specific withdrawal criteria|1
5820854|NCT02582749|20101858|P2|Overall Study|Withdrawal by Subject|1
5820855|NCT02582749|20101859|P1|Overall Study|Withdrawal by Subject|0
5820856|NCT02582749|20101858|P2|Overall Study|Study terminated by funder|10
5820857|NCT02582749|20101859|P1|Overall Study|Study terminated by funder|5
5820858|NCT02582684|20101889|P1|Overall Study|Found to be ineligible after enrollment|2
5820859|NCT02582684|20101889|P1|Overall Study|Subject withdrew consent|1
5820860|NCT02582684|20101889|P1|Overall Study|Subject not able to get to clinic|10
5820861|NCT02582684|20101889|P1|Overall Study|Unable to contact subject/parent|4
5820862|NCT02582671|20101908|P1|Overall Study|Other, not specified|1
5820863|NCT02582671|20101908|P1|Overall Study|Failure to return|1
5820864|NCT02582658|20101920|P1|Overall Study|Not further specified|11
5820865|NCT02582658|20101920|P1|Overall Study|Death|1
5820866|NCT02582658|20101920|P1|Overall Study|Withdrawn Consent|1
5820867|NCT02582658|20101920|P1|Overall Study|Insufficient Virological Response|2
5820868|NCT02582658|20101920|P1|Overall Study|Failure to Return|10
5820869|NCT02582632|20101938|P1|Overall Study|Other|1
5820870|NCT02582515|20101953|P2|Overall Study|Withdrawal by Subject|1
5820871|NCT02582515|20101954|P1|Overall Study|Withdrawal by Subject|0
5820872|NCT02582255|20101962|P2|Overall Study|Protocol Violation|3
5820873|NCT02582255|20101963|P1|Overall Study|Protocol Violation|0
5820874|NCT02582242|20101976|P2|Overall Study|Unclassified|1
5820875|NCT02582242|20101977|P1|Overall Study|Unclassified|2
5820876|NCT02582242|20101976|P2|Overall Study|Withdrawal by Subject|11
5820877|NCT02582242|20101977|P1|Overall Study|Withdrawal by Subject|11
5820878|NCT02582242|20101976|P2|Overall Study|Lost to Follow-up|1
5820879|NCT02582242|20101977|P1|Overall Study|Lost to Follow-up|0
5820880|NCT02582242|20101976|P2|Overall Study|Protocol Violation|1
5820881|NCT02582242|20101977|P1|Overall Study|Protocol Violation|3
5820882|NCT02582242|20101976|P2|Overall Study|Adverse Event|3
5820883|NCT02582242|20101977|P1|Overall Study|Adverse Event|4
5820884|NCT02581995|20102041|P1|Overall Study|Death|4
5820885|NCT02581995|20102041|P1|Overall Study|Physician Decision|1
5820886|NCT02581995|20102041|P1|Overall Study|Withdrawal by participant|12
5820887|NCT02581995|20102041|P1|Overall Study|Lost to Follow-up|5
5820888|NCT02581995|20102041|P1|Overall Study|Adverse Event|6
5820889|NCT02581995|20102041|P1|Overall Study|Unspecified other|3
5820890|NCT02581930|20102055|P1|Overall Study|patient declined further treatment|1
5820891|NCT02581930|20102055|P1|Overall Study|Withdrawal by Subject|1
5820892|NCT02581891|20102063|P2|Overall Study|Discontinued during followup|0
5820893|NCT02581891|20102064|P1|Overall Study|Discontinued during followup|1
5820894|NCT02581891|20102063|P2|Overall Study|Other Reasons|1
5820895|NCT02581891|20102064|P1|Overall Study|Other Reasons|3
5820896|NCT02581891|20102063|P2|Overall Study|Withdrawal by Subject|5
5820897|NCT02581891|20102064|P1|Overall Study|Withdrawal by Subject|4
5820898|NCT02581891|20102063|P2|Overall Study|Physician Decision|1
5820899|NCT02581891|20102064|P1|Overall Study|Physician Decision|0
5820900|NCT02581891|20102063|P2|Overall Study|Lost to Follow-up|2
5820901|NCT02581891|20102064|P1|Overall Study|Lost to Follow-up|1
5820902|NCT02581891|20102063|P2|Overall Study|Death|4
5820903|NCT02581891|20102064|P1|Overall Study|Death|3
5820904|NCT02581891|20102063|P2|Overall Study|Adverse Event|6
5820905|NCT02581891|20102064|P1|Overall Study|Adverse Event|4
5820906|NCT02581488|20102127|P2|Overall Study|Protocol Violation|4
5820907|NCT02581488|20102128|P1|Overall Study|Protocol Violation|0
5820908|NCT02581488|20102127|P2|Overall Study|Non-Compliance|0
5820909|NCT02581488|20102128|P1|Overall Study|Non-Compliance|1
5820910|NCT02581488|20102127|P2|Overall Study|Withdrawal by Subject|0
5820911|NCT02581488|20102128|P1|Overall Study|Withdrawal by Subject|1
5820912|NCT02581488|20102127|P2|Overall Study|Lost to Follow-up|0
5820913|NCT02581488|20102128|P1|Overall Study|Lost to Follow-up|1
5820914|NCT02581488|20102127|P2|Overall Study|Adverse Event|7
5820915|NCT02581488|20102128|P1|Overall Study|Adverse Event|6
5820916|NCT02581410|20102159|P2|End of Study Phase|Other-transfer of subject not completed|1
5820917|NCT02581410|20102160|P1|End of Study Phase|Other-transfer of subject not completed|0
5820918|NCT02581410|20102159|P2|End of Study Phase|Lost to Follow-up|2
5820919|NCT02581410|20102160|P1|End of Study Phase|Lost to Follow-up|0
5820920|NCT02581410|20102159|P2|End of Study Phase|Migrated/moved from study area|3
5820921|NCT02581410|20102160|P1|End of Study Phase|Migrated/moved from study area|0
5820922|NCT02581410|20102159|P2|End of Study Phase|Withdrawal by Subject|2
5820923|NCT02581410|20102160|P1|End of Study Phase|Withdrawal by Subject|1
5820924|NCT02581410|20102159|P2|End of Study Phase|Adverse Event|3
5820925|NCT02581410|20102160|P1|End of Study Phase|Adverse Event|4
5820926|NCT02581410|20102159|P2|Vaccination Phase|Migrated/moved from study area|1
5820927|NCT02581410|20102160|P1|Vaccination Phase|Migrated/moved from study area|0
5820928|NCT02581410|20102159|P2|Vaccination Phase|Withdrawal by Subject|1
5820929|NCT02581410|20102160|P1|Vaccination Phase|Withdrawal by Subject|0
5820930|NCT02581410|20102159|P2|Vaccination Phase|Adverse Event|1
5820931|NCT02581410|20102160|P1|Vaccination Phase|Adverse Event|2
5820932|NCT02581345|20102190|P4|Part 2: Week 17 to Week 47|Unspecified Reason|1
5820933|NCT02581345|20102191|P3|Part 2: Week 17 to Week 47|Unspecified Reason|1
5820934|NCT02581345|20102192|P2|Part 2: Week 17 to Week 47|Unspecified Reason|0
5820935|NCT02581345|20102193|P1|Part 2: Week 17 to Week 47|Unspecified Reason|2
5820936|NCT02581345|20102190|P4|Part 2: Week 17 to Week 47|Lost to Follow-up|1
5820937|NCT02581345|20102191|P3|Part 2: Week 17 to Week 47|Lost to Follow-up|0
5820938|NCT02581345|20102192|P2|Part 2: Week 17 to Week 47|Lost to Follow-up|0
5820939|NCT02581345|20102193|P1|Part 2: Week 17 to Week 47|Lost to Follow-up|2
5820940|NCT02581345|20102190|P4|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|2
5820941|NCT02581345|20102191|P3|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|3
5820942|NCT02581345|20102192|P2|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|0
5820943|NCT02581345|20102193|P1|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|8
5820944|NCT02581345|20102190|P4|Part 2: Week 17 to Week 47|Withdrawal by Subject|5
5820945|NCT02581345|20102191|P3|Part 2: Week 17 to Week 47|Withdrawal by Subject|7
5820946|NCT02581345|20102192|P2|Part 2: Week 17 to Week 47|Withdrawal by Subject|0
5820947|NCT02581345|20102193|P1|Part 2: Week 17 to Week 47|Withdrawal by Subject|9
5820948|NCT02581345|20102190|P4|Part 2: Week 17 to Week 47|Physician Decision|1
5820949|NCT02581345|20102191|P3|Part 2: Week 17 to Week 47|Physician Decision|2
5820950|NCT02581345|20102192|P2|Part 2: Week 17 to Week 47|Physician Decision|0
5820951|NCT02581345|20102193|P1|Part 2: Week 17 to Week 47|Physician Decision|3
5820952|NCT02581345|20102190|P4|Part 2: Week 17 to Week 47|Adverse Event|2
5820953|NCT02581345|20102191|P3|Part 2: Week 17 to Week 47|Adverse Event|2
5820954|NCT02581345|20102192|P2|Part 2: Week 17 to Week 47|Adverse Event|0
5820955|NCT02581345|20102193|P1|Part 2: Week 17 to Week 47|Adverse Event|5
5820956|NCT02581345|20102190|P4|Part 1: up to Week 16|Did Not Receive Treatment|0
5820957|NCT02581345|20102191|P3|Part 1: up to Week 16|Did Not Receive Treatment|0
5820958|NCT02581345|20102192|P2|Part 1: up to Week 16|Did Not Receive Treatment|1
5820959|NCT02581345|20102193|P1|Part 1: up to Week 16|Did Not Receive Treatment|1
5820960|NCT02581345|20102190|P4|Part 1: up to Week 16|Unspecified Reason|0
5820961|NCT02581345|20102191|P3|Part 1: up to Week 16|Unspecified Reason|0
5820962|NCT02581345|20102192|P2|Part 1: up to Week 16|Unspecified Reason|3
5820963|NCT02581345|20102193|P1|Part 1: up to Week 16|Unspecified Reason|3
5820964|NCT02581345|20102190|P4|Part 1: up to Week 16|Lost to Follow-up|0
5820965|NCT02581345|20102191|P3|Part 1: up to Week 16|Lost to Follow-up|0
5820966|NCT02581345|20102192|P2|Part 1: up to Week 16|Lost to Follow-up|0
5820967|NCT02581345|20102193|P1|Part 1: up to Week 16|Lost to Follow-up|2
5820968|NCT02581345|20102190|P4|Part 1: up to Week 16|Withdrawal by Subject|0
5820969|NCT02581345|20102191|P3|Part 1: up to Week 16|Withdrawal by Subject|0
5820970|NCT02581345|20102192|P2|Part 1: up to Week 16|Withdrawal by Subject|7
5820971|NCT02581345|20102193|P1|Part 1: up to Week 16|Withdrawal by Subject|4
5820972|NCT02581345|20102190|P4|Part 1: up to Week 16|Physician Decision|0
5820973|NCT02581345|20102191|P3|Part 1: up to Week 16|Physician Decision|0
5820974|NCT02581345|20102192|P2|Part 1: up to Week 16|Physician Decision|4
5820975|NCT02581345|20102193|P1|Part 1: up to Week 16|Physician Decision|2
5820976|NCT02581345|20102190|P4|Part 1: up to Week 16|Adverse Event|0
5820977|NCT02581345|20102191|P3|Part 1: up to Week 16|Adverse Event|0
5820978|NCT02581345|20102192|P2|Part 1: up to Week 16|Adverse Event|8
5820979|NCT02581345|20102193|P1|Part 1: up to Week 16|Adverse Event|3
5820980|NCT02581202|20102295|P1|Overall Study|Pregnancy|3
5820981|NCT02581202|20102295|P1|Overall Study|Lost to Follow-up|5
5820982|NCT02581202|20102295|P1|Overall Study|Withdrawal by Subject|4
5820983|NCT02581202|20102295|P1|Overall Study|Lack of Efficacy|2
5820984|NCT02581189|20102334|P1|Overall Study|Other, not specified|7
5820985|NCT02581189|20102334|P1|Overall Study|Insufficient virological response|2
5820986|NCT02581189|20102334|P1|Overall Study|Death|3
5820987|NCT02581189|20102334|P1|Overall Study|Withdrew consent|5
5820988|NCT02581189|20102334|P1|Overall Study|Failure to return|36
5820989|NCT02581163|20102348|P1|Overall Study|Other, not specified|9
5820990|NCT02581163|20102348|P1|Overall Study|Death|1
5820991|NCT02581163|20102348|P1|Overall Study|Withdrew consent|1
5820992|NCT02581163|20102348|P1|Overall Study|Insufficient virological response|3
5820993|NCT02581163|20102348|P1|Overall Study|Failure to return|15
5820994|NCT02580877|20102382|P2|Overall Study|Adverse Event|1
5820995|NCT02580877|20102383|P1|Overall Study|Adverse Event|0
5820996|NCT02580877|20102382|P2|Overall Study|Withdrawal by Subject|3
5820997|NCT02580877|20102383|P1|Overall Study|Withdrawal by Subject|1
5820998|NCT02580591|20102417|P4|Overall Study|Other than specified|2
5820999|NCT02580591|20102418|P3|Overall Study|Other than specified|5
5821000|NCT02580591|20102419|P2|Overall Study|Other than specified|2
5821001|NCT02580591|20102420|P1|Overall Study|Other than specified|3
5821002|NCT02580591|20102417|P4|Overall Study|Not treated|0
5821003|NCT02580591|20102418|P3|Overall Study|Not treated|0
5821004|NCT02580591|20102419|P2|Overall Study|Not treated|1
5821005|NCT02580591|20102420|P1|Overall Study|Not treated|1
5821006|NCT02580591|20102417|P4|Overall Study|Withdrawal by Subject|3
5821007|NCT02580591|20102418|P3|Overall Study|Withdrawal by Subject|2
5821008|NCT02580591|20102419|P2|Overall Study|Withdrawal by Subject|1
5821009|NCT02580591|20102420|P1|Overall Study|Withdrawal by Subject|6
5821010|NCT02580591|20102417|P4|Overall Study|Lost to Follow-up|1
5821011|NCT02580591|20102418|P3|Overall Study|Lost to Follow-up|3
5821012|NCT02580591|20102419|P2|Overall Study|Lost to Follow-up|3
5821013|NCT02580591|20102420|P1|Overall Study|Lost to Follow-up|5
5821014|NCT02580591|20102417|P4|Overall Study|Protocol Violation|1
5821015|NCT02580591|20102418|P3|Overall Study|Protocol Violation|1
5821016|NCT02580591|20102419|P2|Overall Study|Protocol Violation|2
5821017|NCT02580591|20102420|P1|Overall Study|Protocol Violation|3
5821018|NCT02580591|20102417|P4|Overall Study|Adverse Event|5
5821019|NCT02580591|20102418|P3|Overall Study|Adverse Event|2
5821020|NCT02580591|20102419|P2|Overall Study|Adverse Event|1
5821021|NCT02580591|20102420|P1|Overall Study|Adverse Event|0
5821022|NCT02580357|20102453|P3|Overall Study|Protocol Violation|0
5821023|NCT02580357|20102454|P2|Overall Study|Protocol Violation|0
5821024|NCT02580357|20102455|P1|Overall Study|Protocol Violation|1
5821025|NCT02580357|20102453|P3|Overall Study|Lost to Follow-up|0
5821026|NCT02580357|20102454|P2|Overall Study|Lost to Follow-up|0
5821027|NCT02580357|20102455|P1|Overall Study|Lost to Follow-up|2
5821028|NCT02580240|20102472|P2|Overall Study|Physician Decision|0
5821029|NCT02580240|20102473|P1|Overall Study|Physician Decision|2
5821030|NCT02580058|20102511|P3|Overall Study|Withdrawal by Subject|36
5821031|NCT02580058|20102512|P2|Overall Study|Withdrawal by Subject|26
5821032|NCT02580058|20102513|P1|Overall Study|Withdrawal by Subject|24
5821033|NCT02580058|20102511|P3|Overall Study|Ongoing|46
5821034|NCT02580058|20102512|P2|Overall Study|Ongoing|55
5821035|NCT02580058|20102513|P1|Overall Study|Ongoing|51
5821036|NCT02580058|20102511|P3|Overall Study|Lost to Follow-up|4
5821037|NCT02580058|20102512|P2|Overall Study|Lost to Follow-up|5
5821038|NCT02580058|20102513|P1|Overall Study|Lost to Follow-up|4
5821039|NCT02579928|20102580|P2|Overall Study|Withdrawal by Subject|0
5821040|NCT02579928|20102581|P1|Overall Study|Withdrawal by Subject|1
5821041|NCT02579863|20102621|P2|Overall Study|Withdrawal by Subject|19
5821042|NCT02579863|20102622|P1|Overall Study|Withdrawal by Subject|17
5821043|NCT02579863|20102621|P2|Overall Study|Study Terminated at Selected Sites|3
5821044|NCT02579863|20102622|P1|Overall Study|Study Terminated at Selected Sites|3
5821045|NCT02579863|20102621|P2|Overall Study|Screen Failure|2
5821046|NCT02579863|20102622|P1|Overall Study|Screen Failure|1
5821047|NCT02579863|20102621|P2|Overall Study|Physician Decision|2
5821048|NCT02579863|20102622|P1|Overall Study|Physician Decision|0
5821049|NCT02579863|20102621|P2|Overall Study|Lost to Follow-up|1
5821050|NCT02579863|20102622|P1|Overall Study|Lost to Follow-up|2
5821051|NCT02579863|20102621|P2|Overall Study|Death|3
5821052|NCT02579863|20102622|P1|Overall Study|Death|11
5821053|NCT02579863|20102621|P2|Overall Study|Adverse Event|12
5821054|NCT02579863|20102622|P1|Overall Study|Adverse Event|17
5821055|NCT02579863|20102621|P2|Overall Study|Ongoing in Trial|112
5821056|NCT02579863|20102622|P1|Overall Study|Ongoing in Trial|105
5821057|NCT02579772|20102649|P2|Overall Study|flu-like illness, orthopedic trauma|1
5821058|NCT02579772|20102650|P1|Overall Study|flu-like illness, orthopedic trauma|1
5821059|NCT02579772|20102649|P2|Overall Study|Usage of additional antioxidants|0
5821060|NCT02579772|20102650|P1|Overall Study|Usage of additional antioxidants|1
5821061|NCT02579772|20102649|P2|Overall Study|Withdrawal by Subject|1
5821062|NCT02579772|20102650|P1|Overall Study|Withdrawal by Subject|0
5821063|NCT02579759|20102671|P3|Overall Study|Lost to Follow-up|2
5821064|NCT02579759|20102672|P2|Overall Study|Lost to Follow-up|2
5821065|NCT02579759|20102673|P1|Overall Study|Lost to Follow-up|2
5821066|NCT02579759|20102671|P3|Overall Study|Withdrawal by Subject|5
5821067|NCT02579759|20102672|P2|Overall Study|Withdrawal by Subject|3
5821068|NCT02579759|20102673|P1|Overall Study|Withdrawal by Subject|3
5821069|NCT02579759|20102671|P3|Overall Study|Adverse Event|1
5821070|NCT02579759|20102672|P2|Overall Study|Adverse Event|3
5821071|NCT02579759|20102673|P1|Overall Study|Adverse Event|4
5821072|NCT02579759|20102671|P3|Overall Study|Inclusion/exclusion criteria|1
5821073|NCT02579759|20102672|P2|Overall Study|Inclusion/exclusion criteria|0
5821074|NCT02579759|20102673|P1|Overall Study|Inclusion/exclusion criteria|0
5821075|NCT02579759|20102671|P3|Overall Study|Pregnancy|0
5821076|NCT02579759|20102672|P2|Overall Study|Pregnancy|1
5821077|NCT02579759|20102673|P1|Overall Study|Pregnancy|0
5821078|NCT02579759|20102671|P3|Overall Study|Non compliance|0
5821079|NCT02579759|20102672|P2|Overall Study|Non compliance|1
5821080|NCT02579759|20102673|P1|Overall Study|Non compliance|0
5821081|NCT02579759|20102671|P3|Overall Study|Sponsor stopped Dose 2|0
5821082|NCT02579759|20102672|P2|Overall Study|Sponsor stopped Dose 2|41
5821083|NCT02579759|20102673|P1|Overall Study|Sponsor stopped Dose 2|0
5821084|NCT02579759|20102671|P3|Overall Study|BfArM hold|12
5821085|NCT02579759|20102672|P2|Overall Study|BfArM hold|12
5821086|NCT02579759|20102673|P1|Overall Study|BfArM hold|13
5821087|NCT02579759|20102671|P3|Overall Study|Other (Sponsor stopped Dose 2)|0
5821088|NCT02579759|20102672|P2|Overall Study|Other (Sponsor stopped Dose 2)|1
5821089|NCT02579759|20102673|P1|Overall Study|Other (Sponsor stopped Dose 2)|0
5821090|NCT02579759|20102671|P3|Overall Study|Protocol Violation|0
5821091|NCT02579759|20102672|P2|Overall Study|Protocol Violation|0
5821092|NCT02579759|20102673|P1|Overall Study|Protocol Violation|2
5821093|NCT02579629|20102720|P3|Overall Study|Screen Failure|2
5821094|NCT02579629|20102721|P2|Overall Study|Screen Failure|0
5821095|NCT02579629|20102722|P1|Overall Study|Screen Failure|2
5821096|NCT02579629|20102720|P3|Overall Study|Withdrawal by Subject|0
5821097|NCT02579629|20102721|P2|Overall Study|Withdrawal by Subject|1
5821098|NCT02579629|20102722|P1|Overall Study|Withdrawal by Subject|0
5821099|NCT02579616|20102769|P1|Overall Study|Participants did not receive treatment|3
5821100|NCT02579603|20102782|P2|Overall Study|Other than stated|0
5821101|NCT02579603|20102783|P1|Overall Study|Other than stated|1
5821102|NCT02579603|20102782|P2|Overall Study|Adverse Event|2
5821103|NCT02579603|20102783|P1|Overall Study|Adverse Event|2
5821104|NCT02579603|20102782|P2|Overall Study|Not treated|0
5821105|NCT02579603|20102783|P1|Overall Study|Not treated|1
5821106|NCT02579382|20102813|P4|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0
5821107|NCT02579382|20102814|P3|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0
5821108|NCT02579382|20102815|P2|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|1
5821109|NCT02579382|20102816|P1|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0
5821110|NCT02579382|20102813|P4|Optional Treatment Extension Phase(OTEP)|Pregnancy|0
5821111|NCT02579382|20102814|P3|Optional Treatment Extension Phase(OTEP)|Pregnancy|0
5821112|NCT02579382|20102815|P2|Optional Treatment Extension Phase(OTEP)|Pregnancy|1
5821113|NCT02579382|20102816|P1|Optional Treatment Extension Phase(OTEP)|Pregnancy|0
5821114|NCT02579382|20102813|P4|Optional Treatment Extension Phase(OTEP)|Adverse Event|0
5821115|NCT02579382|20102814|P3|Optional Treatment Extension Phase(OTEP)|Adverse Event|0
5821116|NCT02579382|20102815|P2|Optional Treatment Extension Phase(OTEP)|Adverse Event|1
5821117|NCT02579382|20102816|P1|Optional Treatment Extension Phase(OTEP)|Adverse Event|0
5821118|NCT02579382|20102813|P4|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1
5821119|NCT02579382|20102814|P3|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1
5821120|NCT02579382|20102815|P2|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1
5821121|NCT02579382|20102816|P1|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|0
5821122|NCT02579382|20102813|P4|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|0
5821123|NCT02579382|20102814|P3|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|2
5821124|NCT02579382|20102815|P2|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|0
5821125|NCT02579382|20102816|P1|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|1
5821126|NCT02579382|20102813|P4|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|4
5821127|NCT02579382|20102814|P3|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|1
5821128|NCT02579382|20102815|P2|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|3
5821129|NCT02579382|20102816|P1|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|0
5821130|NCT02579382|20102813|P4|Main Study Phase|Lack of Efficacy|1
5821131|NCT02579382|20102814|P3|Main Study Phase|Lack of Efficacy|0
5821132|NCT02579382|20102815|P2|Main Study Phase|Lack of Efficacy|0
5821133|NCT02579382|20102816|P1|Main Study Phase|Lack of Efficacy|0
5821134|NCT02579382|20102813|P4|Main Study Phase|Withdrew Consent|2
5821135|NCT02579382|20102814|P3|Main Study Phase|Withdrew Consent|0
5821136|NCT02579382|20102815|P2|Main Study Phase|Withdrew Consent|0
5821137|NCT02579382|20102816|P1|Main Study Phase|Withdrew Consent|0
5821138|NCT02579382|20102813|P4|Main Study Phase|Lost to Follow-up|0
5821139|NCT02579382|20102814|P3|Main Study Phase|Lost to Follow-up|2
5821140|NCT02579382|20102815|P2|Main Study Phase|Lost to Follow-up|0
5821141|NCT02579382|20102816|P1|Main Study Phase|Lost to Follow-up|0
5821142|NCT02578992|20102938|P2|Overall Study|equipment not available or malfunction|3
5821143|NCT02578992|20102939|P1|Overall Study|equipment not available or malfunction|3
5821144|NCT02578940|20102951|P1|Overall Study|Lost to Follow-up|1
5821145|NCT02578940|20102951|P1|Overall Study|Screening failure|5
5821146|NCT02578862|20102960|P2|Overall Study|Unplanned unilateral procedure|1
5821147|NCT02578862|20102961|P1|Overall Study|Unplanned unilateral procedure|0
5821148|NCT02578862|20102960|P2|Overall Study|Withdrawal by Subject|1
5821149|NCT02578862|20102961|P1|Overall Study|Withdrawal by Subject|0
5821150|NCT02578706|20102999|P3|Overall Study|Physician Decision|0
5821151|NCT02578706|20103000|P2|Overall Study|Physician Decision|1
5821152|NCT02578706|20103001|P1|Overall Study|Physician Decision|0
5821153|NCT02578706|20102999|P3|Overall Study|Lost to Follow-up|0
5821154|NCT02578706|20103000|P2|Overall Study|Lost to Follow-up|4
5821155|NCT02578706|20103001|P1|Overall Study|Lost to Follow-up|0
5821156|NCT02578706|20102999|P3|Overall Study|Withdrawal by Subject|0
5821157|NCT02578706|20103000|P2|Overall Study|Withdrawal by Subject|0
5821158|NCT02578706|20103001|P1|Overall Study|Withdrawal by Subject|1
5821159|NCT02578680|20103080|P2|Overall Study|Ongoing in Study|96
5821160|NCT02578680|20103081|P1|Overall Study|Ongoing in Study|276
5821161|NCT02578680|20103080|P2|Overall Study|Withdrawal by Subject|5
5821162|NCT02578680|20103081|P1|Overall Study|Withdrawal by Subject|8
5821163|NCT02578680|20103080|P2|Overall Study|Withdrawal by Parent/Guardian|0
5821164|NCT02578680|20103081|P1|Overall Study|Withdrawal by Parent/Guardian|1
5821165|NCT02578680|20103080|P2|Overall Study|Protocol Violation|1
5821166|NCT02578680|20103081|P1|Overall Study|Protocol Violation|1
5821167|NCT02578680|20103080|P2|Overall Study|Death|104
5821168|NCT02578680|20103081|P1|Overall Study|Death|124
5821169|NCT02578316|20103097|P1|Extension Phase|Progression of disease|6
5821170|NCT02578186|20103130|P2|Period 1 (First of Crossover)|Withdrawal by Subject|1
5821171|NCT02578186|20103131|P1|Period 1 (First of Crossover)|Withdrawal by Subject|1
5821172|NCT02578186|20103130|P2|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4
5821173|NCT02578186|20103131|P1|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4
5821174|NCT02577887|20103220|P1|Overall Study|Withdrawal by Subject|80
5821175|NCT02577887|20103220|P1|Overall Study|Protocol Violation|125
5821176|NCT02577887|20103220|P1|Overall Study|Death|93
5821177|NCT02577718|20103246|P1|Overall Study|Withdrawal by Subject|2
5821178|NCT02577718|20103246|P1|Overall Study|Death|6
5821179|NCT02577354|20103288|P2|Overall Study|Adverse Event|5
5821180|NCT02577354|20103289|P1|Overall Study|Adverse Event|4
5821181|NCT02577354|20103288|P2|Overall Study|Missed Visit|3
5821182|NCT02577354|20103289|P1|Overall Study|Missed Visit|4
5821183|NCT02577354|20103288|P2|Overall Study|Lost to Follow-up|1
5821184|NCT02577354|20103289|P1|Overall Study|Lost to Follow-up|3
5821185|NCT02577354|20103288|P2|Overall Study|Lack of Efficacy|4
5821186|NCT02577354|20103289|P1|Overall Study|Lack of Efficacy|4
5821187|NCT02577315|20103349|P2|Treatment Period 1 (4 Days)|Withdrawal by Subject|1
5821188|NCT02577315|20103350|P1|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
5821189|NCT02577146|20103366|P1|Overall Study|Screen Failure|17
5821190|NCT02577146|20103366|P1|Overall Study|Physician Decision|3
5821191|NCT02577146|20103366|P1|Overall Study|Lost to Follow-up|8
5821192|NCT02577107|20103373|P2|Overall Study|Protocol deviation|1
5821193|NCT02577107|20103374|P1|Overall Study|Protocol deviation|0
5821194|NCT02577029|20103441|P8|Overall Study|Sponsor Termination of the Study|12
5821195|NCT02577029|20103442|P7|Overall Study|Sponsor Termination of the Study|12
5821196|NCT02577029|20103443|P6|Overall Study|Sponsor Termination of the Study|12
5821197|NCT02577029|20103444|P5|Overall Study|Sponsor Termination of the Study|10
5821198|NCT02577029|20103445|P4|Overall Study|Sponsor Termination of the Study|12
5821199|NCT02577029|20103446|P3|Overall Study|Sponsor Termination of the Study|5
5821200|NCT02577029|20103447|P2|Overall Study|Sponsor Termination of the Study|2
5821201|NCT02577029|20103448|P1|Overall Study|Sponsor Termination of the Study|9
5821202|NCT02577029|20103441|P8|Overall Study|Withdrawal by Subject|0
5821203|NCT02577029|20103442|P7|Overall Study|Withdrawal by Subject|0
5821204|NCT02577029|20103443|P6|Overall Study|Withdrawal by Subject|1
5821205|NCT02577029|20103444|P5|Overall Study|Withdrawal by Subject|0
5821206|NCT02577029|20103445|P4|Overall Study|Withdrawal by Subject|0
5821207|NCT02577029|20103446|P3|Overall Study|Withdrawal by Subject|0
5821208|NCT02577029|20103447|P2|Overall Study|Withdrawal by Subject|0
5821209|NCT02577029|20103448|P1|Overall Study|Withdrawal by Subject|0
5821210|NCT02577029|20103441|P8|Overall Study|Adverse Event|0
5821211|NCT02577029|20103442|P7|Overall Study|Adverse Event|0
5821212|NCT02577029|20103443|P6|Overall Study|Adverse Event|0
5821213|NCT02577029|20103444|P5|Overall Study|Adverse Event|1
5821214|NCT02577029|20103445|P4|Overall Study|Adverse Event|0
5821215|NCT02577029|20103446|P3|Overall Study|Adverse Event|2
5821216|NCT02577029|20103447|P2|Overall Study|Adverse Event|0
5821217|NCT02577029|20103448|P1|Overall Study|Adverse Event|1
5821218|NCT02577016|20103556|P2|Overall Study|Physician Decision|1
5821219|NCT02577016|20103557|P1|Overall Study|Physician Decision|0
5821220|NCT02577016|20103556|P2|Overall Study|Adverse Event|1
5821221|NCT02577016|20103557|P1|Overall Study|Adverse Event|2
5821222|NCT02577003|20103575|P2|Overall Study|Withdrawal by Subject|1
5821223|NCT02577003|20103576|P1|Overall Study|Withdrawal by Subject|0
5821224|NCT02577003|20103575|P2|Overall Study|Adverse Event|4
5821225|NCT02577003|20103576|P1|Overall Study|Adverse Event|2
5821226|NCT02576990|20103596|P2|Overall Study|Clinical Progression|4
5821227|NCT02576990|20103597|P1|Overall Study|Clinical Progression|13
5821228|NCT02576990|20103596|P2|Overall Study|Did not receive study treatment|1
5821229|NCT02576990|20103597|P1|Overall Study|Did not receive study treatment|3
5821230|NCT02576990|20103596|P2|Overall Study|Withdrawal by Subject|2
5821231|NCT02576990|20103597|P1|Overall Study|Withdrawal by Subject|0
5821232|NCT02576990|20103596|P2|Overall Study|Complete Response|0
5821233|NCT02576990|20103597|P1|Overall Study|Complete Response|1
5821234|NCT02576990|20103596|P2|Overall Study|Adverse Event|4
5821235|NCT02576990|20103597|P1|Overall Study|Adverse Event|6
5821236|NCT02576990|20103596|P2|Overall Study|Progressive Disease|12
5821237|NCT02576990|20103597|P1|Overall Study|Progressive Disease|17
5821238|NCT02576990|20103596|P2|Overall Study|Physician Decision|1
5821239|NCT02576990|20103597|P1|Overall Study|Physician Decision|3
5821240|NCT02576977|20103625|P2|Overall Study|Ongoing in trial|77
5821241|NCT02576977|20103626|P1|Overall Study|Ongoing in trial|53
5821242|NCT02576977|20103625|P2|Overall Study|Withdrawal by Subject|9
5821243|NCT02576977|20103626|P1|Overall Study|Withdrawal by Subject|9
5821244|NCT02576977|20103625|P2|Overall Study|Study Terminated at Selected Sites|2
5821245|NCT02576977|20103626|P1|Overall Study|Study Terminated at Selected Sites|3
5821246|NCT02576977|20103625|P2|Overall Study|Screen failure|0
5821247|NCT02576977|20103626|P1|Overall Study|Screen failure|1
5821248|NCT02576977|20103625|P2|Overall Study|Death|35
5821249|NCT02576977|20103626|P1|Overall Study|Death|47
5821250|NCT02576977|20103625|P2|Overall Study|Adverse Event|2
5821251|NCT02576977|20103626|P1|Overall Study|Adverse Event|13
5821252|NCT02576951|20103648|P4|Overall Study|Protocol Violation|1
5821253|NCT02576951|20103649|P3|Overall Study|Protocol Violation|0
5821254|NCT02576951|20103650|P2|Overall Study|Protocol Violation|0
5821255|NCT02576951|20103651|P1|Overall Study|Protocol Violation|0
5821256|NCT02576951|20103648|P4|Overall Study|Withdrawal by Subject|2
5821257|NCT02576951|20103649|P3|Overall Study|Withdrawal by Subject|0
5821258|NCT02576951|20103650|P2|Overall Study|Withdrawal by Subject|0
5821259|NCT02576951|20103651|P1|Overall Study|Withdrawal by Subject|1
5821260|NCT02576951|20103648|P4|Overall Study|Lost to Follow-up|2
5821261|NCT02576951|20103649|P3|Overall Study|Lost to Follow-up|2
5821262|NCT02576951|20103650|P2|Overall Study|Lost to Follow-up|0
5821263|NCT02576951|20103651|P1|Overall Study|Lost to Follow-up|0
5821264|NCT02576938|20103675|P3|Overall Study|Met Exclusion Criteria|0
5821265|NCT02576938|20103676|P2|Overall Study|Met Exclusion Criteria|1
5821266|NCT02576938|20103677|P1|Overall Study|Met Exclusion Criteria|0
5821267|NCT02576938|20103675|P3|Overall Study|Physician Decision|0
5821268|NCT02576938|20103676|P2|Overall Study|Physician Decision|1
5821269|NCT02576938|20103677|P1|Overall Study|Physician Decision|0
5821270|NCT02576938|20103675|P3|Overall Study|Lost to Follow-up|1
5821271|NCT02576938|20103676|P2|Overall Study|Lost to Follow-up|0
5821272|NCT02576938|20103677|P1|Overall Study|Lost to Follow-up|2
5821273|NCT02576938|20103675|P3|Overall Study|Lack of Efficacy|0
5821274|NCT02576938|20103676|P2|Overall Study|Lack of Efficacy|4
5821275|NCT02576938|20103677|P1|Overall Study|Lack of Efficacy|9
5821276|NCT02576938|20103675|P3|Overall Study|Withdrawal by Subject|4
5821277|NCT02576938|20103676|P2|Overall Study|Withdrawal by Subject|2
5821278|NCT02576938|20103677|P1|Overall Study|Withdrawal by Subject|3
5821279|NCT02576938|20103675|P3|Overall Study|Protocol Violation|1
5821280|NCT02576938|20103676|P2|Overall Study|Protocol Violation|1
5821281|NCT02576938|20103677|P1|Overall Study|Protocol Violation|1
5821282|NCT02576938|20103675|P3|Overall Study|Adverse Event|6
5821283|NCT02576938|20103676|P2|Overall Study|Adverse Event|3
5821284|NCT02576938|20103677|P1|Overall Study|Adverse Event|5
5821285|NCT02576678|20103723|P3|Overall Study|Miscellaneous|0
5821286|NCT02576678|20103724|P2|Overall Study|Miscellaneous|0
5821287|NCT02576678|20103725|P1|Overall Study|Miscellaneous|2
5821288|NCT02576678|20103723|P3|Overall Study|Lost to Follow-up|1
5821289|NCT02576678|20103724|P2|Overall Study|Lost to Follow-up|0
5821290|NCT02576678|20103725|P1|Overall Study|Lost to Follow-up|0
5821291|NCT02576678|20103723|P3|Overall Study|Withdrawal by Subject|2
5821292|NCT02576678|20103724|P2|Overall Study|Withdrawal by Subject|1
5821293|NCT02576678|20103725|P1|Overall Study|Withdrawal by Subject|3
5821294|NCT02576678|20103723|P3|Overall Study|Adverse Event|2
5821295|NCT02576678|20103724|P2|Overall Study|Adverse Event|0
5821296|NCT02576678|20103725|P1|Overall Study|Adverse Event|0
5821297|NCT02576652|20103757|P1|Overall Study|Withdrawal by Subject|2
5821298|NCT02576639|20103769|P5|Overall Study|Physician Decision|1
5821299|NCT02576639|20103770|P4|Overall Study|Physician Decision|0
5821300|NCT02576639|20103771|P3|Overall Study|Physician Decision|0
5821301|NCT02576639|20103772|P2|Overall Study|Physician Decision|0
5821302|NCT02576639|20103773|P1|Overall Study|Physician Decision|0
5821303|NCT02576639|20103769|P5|Overall Study|Adverse Event|2
5821304|NCT02576639|20103770|P4|Overall Study|Adverse Event|1
5821305|NCT02576639|20103771|P3|Overall Study|Adverse Event|1
5821306|NCT02576639|20103772|P2|Overall Study|Adverse Event|0
5821307|NCT02576639|20103773|P1|Overall Study|Adverse Event|1
5821308|NCT02576639|20103769|P5|Overall Study|Withdrawal by Subject|1
5821309|NCT02576639|20103770|P4|Overall Study|Withdrawal by Subject|0
5821310|NCT02576639|20103771|P3|Overall Study|Withdrawal by Subject|1
5821311|NCT02576639|20103772|P2|Overall Study|Withdrawal by Subject|2
5821312|NCT02576639|20103773|P1|Overall Study|Withdrawal by Subject|1
5821313|NCT02576587|20103832|P2|Follow up Period (Case Only)|Controls not eligible for followup|155
5821314|NCT02576587|20103833|P1|Follow up Period (Case Only)|Controls not eligible for followup|0
5821315|NCT02576587|20103832|P2|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|0
5821316|NCT02576587|20103833|P1|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|92
5821317|NCT02576587|20103832|P2|Follow up Period (Case Only)|Withdrawal by Subject|0
5821318|NCT02576587|20103833|P1|Follow up Period (Case Only)|Withdrawal by Subject|25
5821319|NCT02576587|20103832|P2|Baseline|Equipment failure|1
5821320|NCT02576587|20103833|P1|Baseline|Equipment failure|0
5821321|NCT02576535|20103851|P1|Overall Study|Withdrawal by Subject|2
5821358|NCT02576145|20103892|P2|Overall Study|Tetanus Titers Decreased|1
5821359|NCT02576145|20103893|P1|Overall Study|Tetanus Titers Decreased|0
5821360|NCT02576145|20103892|P2|Overall Study|Acute rejection|0
5821361|NCT02576145|20103893|P1|Overall Study|Acute rejection|1
5821362|NCT02576145|20103892|P2|Overall Study|Withdrawal by Subject|0
5821363|NCT02576145|20103893|P1|Overall Study|Withdrawal by Subject|1
5821364|NCT02576145|20103892|P2|Overall Study|Adverse Event|0
5821365|NCT02576145|20103893|P1|Overall Study|Adverse Event|1
5821366|NCT02576067|20103931|P2|Overall Study|Physician Decision|0
5821367|NCT02576067|20103932|P1|Overall Study|Physician Decision|4
5821368|NCT02576067|20103931|P2|Overall Study|screen failure/ re-enrolled|25
5821369|NCT02576067|20103932|P1|Overall Study|screen failure/ re-enrolled|0
5821370|NCT02576067|20103931|P2|Overall Study|not randomized, failed run-in|0
5821371|NCT02576067|20103932|P1|Overall Study|not randomized, failed run-in|7
5821372|NCT02576067|20103931|P2|Overall Study|study closure of main CIRT trial)|8
5821373|NCT02576067|20103932|P1|Overall Study|study closure of main CIRT trial)|0
5821374|NCT02576067|20103931|P2|Overall Study|Withdrawal by Subject|2
5821375|NCT02576067|20103932|P1|Overall Study|Withdrawal by Subject|11
5821376|NCT02576067|20103931|P2|Overall Study|Lost to Follow-up|0
5821377|NCT02576067|20103932|P1|Overall Study|Lost to Follow-up|11
5821378|NCT02576067|20103931|P2|Overall Study|Lack of Efficacy|0
5821379|NCT02576067|20103932|P1|Overall Study|Lack of Efficacy|1
5821380|NCT02576067|20103931|P2|Overall Study|Death|1
5821381|NCT02576067|20103932|P1|Overall Study|Death|0
5821382|NCT02576054|20103942|P1|Overall Study|Withdrawal by Subject|1
5821383|NCT02575950|20103963|P4|Overall Study|Lost to Follow-up|3
5821384|NCT02575950|20103964|P3|Overall Study|Lost to Follow-up|0
5821385|NCT02575950|20103965|P2|Overall Study|Lost to Follow-up|1
5821386|NCT02575950|20103966|P1|Overall Study|Lost to Follow-up|0
5821387|NCT02575950|20103963|P4|Overall Study|Withdrawal by Subject|2
5821388|NCT02575950|20103964|P3|Overall Study|Withdrawal by Subject|0
5821389|NCT02575950|20103965|P2|Overall Study|Withdrawal by Subject|0
5821390|NCT02575950|20103966|P1|Overall Study|Withdrawal by Subject|0
5821391|NCT02575911|20103995|P1|Overall Study|Lost to Follow-up|1
5821392|NCT02575833|20104015|P2|Overall Study|Lost to Follow-up|0
5821393|NCT02575833|20104016|P1|Overall Study|Lost to Follow-up|1
5821394|NCT02575833|20104015|P2|Overall Study|Withdrawal by Subject|1
5821395|NCT02575833|20104016|P1|Overall Study|Withdrawal by Subject|0
5821396|NCT02575807|20104031|P5|Overall Study|Withdrawal by Subject|2
5821397|NCT02575807|20104032|P4|Overall Study|Withdrawal by Subject|1
5821398|NCT02575807|20104033|P3|Overall Study|Withdrawal by Subject|1
5821399|NCT02575807|20104034|P2|Overall Study|Withdrawal by Subject|0
5821400|NCT02575807|20104035|P1|Overall Study|Withdrawal by Subject|0
5821401|NCT02575807|20104031|P5|Overall Study|Subject ineligible - medical implant|0
5821402|NCT02575807|20104032|P4|Overall Study|Subject ineligible - medical implant|1
5821403|NCT02575807|20104033|P3|Overall Study|Subject ineligible - medical implant|0
5821404|NCT02575807|20104034|P2|Overall Study|Subject ineligible - medical implant|0
5821405|NCT02575807|20104035|P1|Overall Study|Subject ineligible - medical implant|0
5821406|NCT02575807|20104031|P5|Overall Study|Terminated due to physician decision|0
5821407|NCT02575807|20104032|P4|Overall Study|Terminated due to physician decision|0
5821408|NCT02575807|20104033|P3|Overall Study|Terminated due to physician decision|1
5821409|NCT02575807|20104034|P2|Overall Study|Terminated due to physician decision|0
5821410|NCT02575807|20104035|P1|Overall Study|Terminated due to physician decision|0
5821411|NCT02575807|20104031|P5|Overall Study|Terminated due to FDA clinical hold|0
5821412|NCT02575807|20104032|P4|Overall Study|Terminated due to FDA clinical hold|0
5821413|NCT02575807|20104033|P3|Overall Study|Terminated due to FDA clinical hold|0
5821414|NCT02575807|20104034|P2|Overall Study|Terminated due to FDA clinical hold|0
5821415|NCT02575807|20104035|P1|Overall Study|Terminated due to FDA clinical hold|1
5821416|NCT02575807|20104031|P5|Overall Study|Study terminated by Sponsor|1
5821417|NCT02575807|20104032|P4|Overall Study|Study terminated by Sponsor|0
5821418|NCT02575807|20104033|P3|Overall Study|Study terminated by Sponsor|7
5821419|NCT02575807|20104034|P2|Overall Study|Study terminated by Sponsor|1
5821420|NCT02575807|20104035|P1|Overall Study|Study terminated by Sponsor|0
5821421|NCT02575807|20104031|P5|Overall Study|Death|1
5821422|NCT02575807|20104032|P4|Overall Study|Death|0
5821423|NCT02575807|20104033|P3|Overall Study|Death|7
5821424|NCT02575807|20104034|P2|Overall Study|Death|3
5821425|NCT02575807|20104035|P1|Overall Study|Death|8
5821426|NCT02575365|20104075|P1|Overall Study|Lost to Follow-up|4
5821427|NCT02575079|20104095|P2|Overall Study|Withdrawal by Subject|0
5821428|NCT02575079|20104096|P1|Overall Study|Withdrawal by Subject|3
5821429|NCT02575079|20104095|P2|Overall Study|Death|0
5821430|NCT02575079|20104096|P1|Overall Study|Death|3
5821431|NCT02574845|20104121|P6|Overall Study|Adverse Event|1
5821432|NCT02574845|20104122|P5|Overall Study|Adverse Event|0
5821433|NCT02574845|20104123|P4|Overall Study|Adverse Event|0
5821434|NCT02574845|20104124|P3|Overall Study|Adverse Event|0
5821435|NCT02574845|20104125|P2|Overall Study|Adverse Event|1
5821436|NCT02574845|20104126|P1|Overall Study|Adverse Event|0
5821437|NCT02574845|20104121|P6|Overall Study|Consent withdrawn further participation|0
5821438|NCT02574845|20104122|P5|Overall Study|Consent withdrawn further participation|1
5821439|NCT02574845|20104123|P4|Overall Study|Consent withdrawn further participation|0
5821440|NCT02574845|20104124|P3|Overall Study|Consent withdrawn further participation|0
5821441|NCT02574845|20104125|P2|Overall Study|Consent withdrawn further participation|0
5821442|NCT02574845|20104126|P1|Overall Study|Consent withdrawn further participation|0
5821443|NCT02574637|20104161|P10|Open-label (OL) Period|Study Terminated By Sponsor|0
5821444|NCT02574637|20104162|P9|Open-label (OL) Period|Study Terminated By Sponsor|1
5821445|NCT02574637|20104163|P8|Open-label (OL) Period|Study Terminated By Sponsor|1
5821446|NCT02574637|20104164|P7|Open-label (OL) Period|Study Terminated By Sponsor|2
5821447|NCT02574637|20104165|P6|Open-label (OL) Period|Study Terminated By Sponsor|1
5821448|NCT02574637|20104166|P5|Open-label (OL) Period|Study Terminated By Sponsor|0
5821449|NCT02574637|20104167|P4|Open-label (OL) Period|Study Terminated By Sponsor|0
5821450|NCT02574637|20104168|P3|Open-label (OL) Period|Study Terminated By Sponsor|0
5821451|NCT02574637|20104169|P2|Open-label (OL) Period|Study Terminated By Sponsor|0
5821452|NCT02574637|20104170|P1|Open-label (OL) Period|Study Terminated By Sponsor|0
5821453|NCT02574637|20104161|P10|Open-label (OL) Period|Withdrawal by Subject|1
5821454|NCT02574637|20104162|P9|Open-label (OL) Period|Withdrawal by Subject|0
5821455|NCT02574637|20104163|P8|Open-label (OL) Period|Withdrawal by Subject|0
5821456|NCT02574637|20104164|P7|Open-label (OL) Period|Withdrawal by Subject|0
5821457|NCT02574637|20104165|P6|Open-label (OL) Period|Withdrawal by Subject|1
5821458|NCT02574637|20104166|P5|Open-label (OL) Period|Withdrawal by Subject|0
5821459|NCT02574637|20104167|P4|Open-label (OL) Period|Withdrawal by Subject|0
5821460|NCT02574637|20104168|P3|Open-label (OL) Period|Withdrawal by Subject|0
5821461|NCT02574637|20104169|P2|Open-label (OL) Period|Withdrawal by Subject|0
5821462|NCT02574637|20104170|P1|Open-label (OL) Period|Withdrawal by Subject|0
5821463|NCT02574637|20104161|P10|Open-label (OL) Period|Adverse Event|0
5821464|NCT02574637|20104162|P9|Open-label (OL) Period|Adverse Event|1
5821465|NCT02574637|20104163|P8|Open-label (OL) Period|Adverse Event|0
5821466|NCT02574637|20104164|P7|Open-label (OL) Period|Adverse Event|0
5821467|NCT02574637|20104165|P6|Open-label (OL) Period|Adverse Event|0
5821468|NCT02574637|20104166|P5|Open-label (OL) Period|Adverse Event|0
5821469|NCT02574637|20104167|P4|Open-label (OL) Period|Adverse Event|0
5821470|NCT02574637|20104168|P3|Open-label (OL) Period|Adverse Event|0
5821471|NCT02574637|20104169|P2|Open-label (OL) Period|Adverse Event|0
5821472|NCT02574637|20104170|P1|Open-label (OL) Period|Adverse Event|0
5821473|NCT02574637|20104161|P10|Double-blind Period|Reason Not Specified|0
5821474|NCT02574637|20104162|P9|Double-blind Period|Reason Not Specified|0
5821475|NCT02574637|20104163|P8|Double-blind Period|Reason Not Specified|0
5821476|NCT02574637|20104164|P7|Double-blind Period|Reason Not Specified|0
5821477|NCT02574637|20104165|P6|Double-blind Period|Reason Not Specified|0
5821478|NCT02574637|20104166|P5|Double-blind Period|Reason Not Specified|0
5821479|NCT02574637|20104167|P4|Double-blind Period|Reason Not Specified|1
5821480|NCT02574637|20104168|P3|Double-blind Period|Reason Not Specified|0
5821481|NCT02574637|20104169|P2|Double-blind Period|Reason Not Specified|0
5821482|NCT02574637|20104170|P1|Double-blind Period|Reason Not Specified|0
5821483|NCT02574637|20104161|P10|Double-blind Period|Study Terminated By Sponsor|0
5821484|NCT02574637|20104162|P9|Double-blind Period|Study Terminated By Sponsor|0
5821485|NCT02574637|20104163|P8|Double-blind Period|Study Terminated By Sponsor|0
5821486|NCT02574637|20104164|P7|Double-blind Period|Study Terminated By Sponsor|0
5821487|NCT02574637|20104165|P6|Double-blind Period|Study Terminated By Sponsor|0
5821488|NCT02574637|20104166|P5|Double-blind Period|Study Terminated By Sponsor|2
5821489|NCT02574637|20104167|P4|Double-blind Period|Study Terminated By Sponsor|2
5821490|NCT02574637|20104168|P3|Double-blind Period|Study Terminated By Sponsor|5
5821491|NCT02574637|20104169|P2|Double-blind Period|Study Terminated By Sponsor|1
5821492|NCT02574637|20104170|P1|Double-blind Period|Study Terminated By Sponsor|1
5821493|NCT02574637|20104161|P10|Double-blind Period|Non-Compliance With Study Drug|0
5821494|NCT02574637|20104162|P9|Double-blind Period|Non-Compliance With Study Drug|0
5821495|NCT02574637|20104163|P8|Double-blind Period|Non-Compliance With Study Drug|0
5821496|NCT02574637|20104164|P7|Double-blind Period|Non-Compliance With Study Drug|0
5821497|NCT02574637|20104165|P6|Double-blind Period|Non-Compliance With Study Drug|0
5821498|NCT02574637|20104166|P5|Double-blind Period|Non-Compliance With Study Drug|0
5821499|NCT02574637|20104167|P4|Double-blind Period|Non-Compliance With Study Drug|1
5821500|NCT02574637|20104168|P3|Double-blind Period|Non-Compliance With Study Drug|0
5821501|NCT02574637|20104169|P2|Double-blind Period|Non-Compliance With Study Drug|0
5821502|NCT02574637|20104170|P1|Double-blind Period|Non-Compliance With Study Drug|0
5821503|NCT02574637|20104161|P10|Double-blind Period|Protocol Deviation|0
5821504|NCT02574637|20104162|P9|Double-blind Period|Protocol Deviation|0
5821505|NCT02574637|20104163|P8|Double-blind Period|Protocol Deviation|0
5821506|NCT02574637|20104164|P7|Double-blind Period|Protocol Deviation|0
5821507|NCT02574637|20104165|P6|Double-blind Period|Protocol Deviation|0
5821508|NCT02574637|20104166|P5|Double-blind Period|Protocol Deviation|0
5821509|NCT02574637|20104167|P4|Double-blind Period|Protocol Deviation|0
5821510|NCT02574637|20104168|P3|Double-blind Period|Protocol Deviation|0
5821511|NCT02574637|20104169|P2|Double-blind Period|Protocol Deviation|0
5821512|NCT02574637|20104170|P1|Double-blind Period|Protocol Deviation|1
5821513|NCT02574637|20104161|P10|Double-blind Period|Lack of Efficacy|0
5821514|NCT02574637|20104162|P9|Double-blind Period|Lack of Efficacy|0
5821515|NCT02574637|20104163|P8|Double-blind Period|Lack of Efficacy|0
5821516|NCT02574637|20104164|P7|Double-blind Period|Lack of Efficacy|0
5821517|NCT02574637|20104165|P6|Double-blind Period|Lack of Efficacy|0
5821518|NCT02574637|20104166|P5|Double-blind Period|Lack of Efficacy|0
5821519|NCT02574637|20104167|P4|Double-blind Period|Lack of Efficacy|0
5821520|NCT02574637|20104168|P3|Double-blind Period|Lack of Efficacy|2
5821521|NCT02574637|20104169|P2|Double-blind Period|Lack of Efficacy|0
5821522|NCT02574637|20104170|P1|Double-blind Period|Lack of Efficacy|0
5821523|NCT02574637|20104161|P10|Double-blind Period|Adverse Event|0
5821524|NCT02574637|20104162|P9|Double-blind Period|Adverse Event|0
5821525|NCT02574637|20104163|P8|Double-blind Period|Adverse Event|0
5821526|NCT02574637|20104164|P7|Double-blind Period|Adverse Event|0
5821527|NCT02574637|20104165|P6|Double-blind Period|Adverse Event|0
5821528|NCT02574637|20104166|P5|Double-blind Period|Adverse Event|0
5821529|NCT02574637|20104167|P4|Double-blind Period|Adverse Event|0
5821530|NCT02574637|20104168|P3|Double-blind Period|Adverse Event|0
5821531|NCT02574637|20104169|P2|Double-blind Period|Adverse Event|0
5821532|NCT02574637|20104170|P1|Double-blind Period|Adverse Event|1
5821553|NCT02574312|20104322|P2|3 Months Follow-up|Withdrawal by Subject|0
5821554|NCT02574312|20104323|P1|3 Months Follow-up|Withdrawal by Subject|1
5821555|NCT02574260|20104339|P1|Overall Study|Disease Progression|1
5821556|NCT02574247|20104348|P3|Overall Study|Did not meet inclusion criteria|5
5821557|NCT02574247|20104349|P2|Overall Study|Did not meet inclusion criteria|3
5821558|NCT02574247|20104350|P1|Overall Study|Did not meet inclusion criteria|4
5821559|NCT02574247|20104348|P3|Overall Study|Withdrawal by Subject|0
5821560|NCT02574247|20104349|P2|Overall Study|Withdrawal by Subject|0
5821561|NCT02574247|20104350|P1|Overall Study|Withdrawal by Subject|1
5821562|NCT02573948|20104362|P1|Longitudinal Cohort|Incarcerated|25
5821563|NCT02573948|20104362|P1|Longitudinal Cohort|Lost to Follow-up|22
5821564|NCT02573948|20104362|P1|Longitudinal Cohort|Death|9
5821565|NCT02573870|20104372|P2|Overall Study|Other: Fail to Meet Visit|2
5821566|NCT02573870|20104373|P1|Overall Study|Other: Fail to Meet Visit|0
5821567|NCT02573870|20104372|P2|Overall Study|Lost to Follow-up|1
5821568|NCT02573870|20104373|P1|Overall Study|Lost to Follow-up|0
5821569|NCT02573870|20104372|P2|Overall Study|Other: Reached defined stopping criteria|1
5821570|NCT02573870|20104373|P1|Overall Study|Other: Reached defined stopping criteria|0
5821571|NCT02573870|20104372|P2|Overall Study|Lack of Efficacy|1
5821572|NCT02573870|20104373|P1|Overall Study|Lack of Efficacy|0
5821573|NCT02573870|20104372|P2|Overall Study|Adverse Event|2
5821574|NCT02573870|20104373|P1|Overall Study|Adverse Event|0
5821575|NCT02573467|20104421|P4|Post-treatment Follow up Epoch|Technical problems|0
5821576|NCT02573467|20104422|P3|Post-treatment Follow up Epoch|Technical problems|1
5821577|NCT02573467|20104423|P2|Post-treatment Follow up Epoch|Technical problems|0
5821578|NCT02573467|20104424|P1|Post-treatment Follow up Epoch|Technical problems|0
5821579|NCT02573467|20104421|P4|Post-treatment Follow up Epoch|Withdrawal by Subject|2
5821580|NCT02573467|20104422|P3|Post-treatment Follow up Epoch|Withdrawal by Subject|9
5821581|NCT02573467|20104423|P2|Post-treatment Follow up Epoch|Withdrawal by Subject|4
5821582|NCT02573467|20104424|P1|Post-treatment Follow up Epoch|Withdrawal by Subject|5
5821583|NCT02573467|20104421|P4|Post-treatment Follow up Epoch|Death|1
5821584|NCT02573467|20104422|P3|Post-treatment Follow up Epoch|Death|0
5821585|NCT02573467|20104423|P2|Post-treatment Follow up Epoch|Death|1
5821586|NCT02573467|20104424|P1|Post-treatment Follow up Epoch|Death|1
5821587|NCT02573467|20104421|P4|Double-blind Treatment Epoch|Study Terminated by sponsor|55
5821588|NCT02573467|20104422|P3|Double-blind Treatment Epoch|Study Terminated by sponsor|48
5821589|NCT02573467|20104423|P2|Double-blind Treatment Epoch|Study Terminated by sponsor|51
5821590|NCT02573467|20104424|P1|Double-blind Treatment Epoch|Study Terminated by sponsor|50
5821591|NCT02573467|20104421|P4|Double-blind Treatment Epoch|Withdrawal by Subject|0
5821592|NCT02573467|20104422|P3|Double-blind Treatment Epoch|Withdrawal by Subject|1
5821593|NCT02573467|20104423|P2|Double-blind Treatment Epoch|Withdrawal by Subject|1
5821594|NCT02573467|20104424|P1|Double-blind Treatment Epoch|Withdrawal by Subject|2
5821595|NCT02573467|20104421|P4|Double-blind Treatment Epoch|Adverse Event|0
5821596|NCT02573467|20104422|P3|Double-blind Treatment Epoch|Adverse Event|1
5821597|NCT02573467|20104423|P2|Double-blind Treatment Epoch|Adverse Event|0
5821598|NCT02573467|20104424|P1|Double-blind Treatment Epoch|Adverse Event|1
5821599|NCT02573467|20104421|P4|Double-blind Treatment Epoch|Lack of Efficacy|0
5821600|NCT02573467|20104422|P3|Double-blind Treatment Epoch|Lack of Efficacy|1
5821601|NCT02573467|20104423|P2|Double-blind Treatment Epoch|Lack of Efficacy|0
5821602|NCT02573467|20104424|P1|Double-blind Treatment Epoch|Lack of Efficacy|0
5821603|NCT02573311|20104488|P2|Disposition for Part 2|Other than specified above|3
5821604|NCT02573311|20104489|P1|Disposition for Part 2|Other than specified above|13
5821605|NCT02573311|20104488|P2|Disposition for Part 2|Investigator decision|1
5821606|NCT02573311|20104489|P1|Disposition for Part 2|Investigator decision|0
5821607|NCT02573311|20104488|P2|Disposition for Part 2|Withdrawal by Subject|3
5821608|NCT02573311|20104489|P1|Disposition for Part 2|Withdrawal by Subject|60
5821609|NCT02573311|20104488|P2|Disposition for Part 2|Lost to Follow-up|7
5821610|NCT02573311|20104489|P1|Disposition for Part 2|Lost to Follow-up|76
5821611|NCT02573311|20104488|P2|Disposition for Part 2|Adverse Event|5
5821612|NCT02573311|20104489|P1|Disposition for Part 2|Adverse Event|36
5821613|NCT02573311|20104488|P2|Disposition for Part 2|Physician Decision|7
5821614|NCT02573311|20104489|P1|Disposition for Part 2|Physician Decision|25
5821615|NCT02573311|20104488|P2|Disposition for Part 1|Withdrawal by Subject|3
5821616|NCT02573311|20104489|P1|Disposition for Part 1|Withdrawal by Subject|7
5821617|NCT02573155|20104558|P2|Washout Between Treatment Period 4 and 5|Adverse Event|1
5821618|NCT02573155|20104559|P1|Washout Between Treatment Period 4 and 5|Adverse Event|0
5821619|NCT02573155|20104558|P2|Washout Between Treatment Period 3 and 4|Adverse Event|1
5821620|NCT02573155|20104559|P1|Washout Between Treatment Period 3 and 4|Adverse Event|0
5821621|NCT02573155|20104558|P2|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|1
5821622|NCT02573155|20104559|P1|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|0
5821623|NCT02573155|20104558|P2|Washout Between Treatment Period 2 and 3|Adverse Event|2
5821624|NCT02573155|20104559|P1|Washout Between Treatment Period 2 and 3|Adverse Event|0
5821625|NCT02573155|20104558|P2|Washout Between Treatment Period 2 and 3|Sponsor's decision|0
5821626|NCT02573155|20104559|P1|Washout Between Treatment Period 2 and 3|Sponsor's decision|1
5821627|NCT02573155|20104558|P2|Washout Between Treatment Period 1 and 2|Adverse Event|3
5821628|NCT02573155|20104559|P1|Washout Between Treatment Period 1 and 2|Adverse Event|0
5821629|NCT02573155|20104558|P2|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|1
5821630|NCT02573155|20104559|P1|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|0
5821631|NCT02573155|20104558|P2|Washout Between Treatment Period 1 and 2|Physician Decision|1
5821632|NCT02573155|20104559|P1|Washout Between Treatment Period 1 and 2|Physician Decision|0
5821633|NCT02573012|20104707|P2|Overall Study|Physician Decision|2
5821634|NCT02573012|20104708|P1|Overall Study|Physician Decision|1
5821635|NCT02573012|20104707|P2|Overall Study|Study Ended per Protocol|0
5821636|NCT02573012|20104708|P1|Overall Study|Study Ended per Protocol|1
5821637|NCT02573012|20104707|P2|Overall Study|Withdrawal by Subject|2
5821638|NCT02573012|20104708|P1|Overall Study|Withdrawal by Subject|2
5821639|NCT02573012|20104707|P2|Overall Study|Non-compliance|2
5821640|NCT02573012|20104708|P1|Overall Study|Non-compliance|1
5821641|NCT02573012|20104707|P2|Overall Study|Lack of Efficacy|4
5821642|NCT02573012|20104708|P1|Overall Study|Lack of Efficacy|5
5821643|NCT02573012|20104707|P2|Overall Study|Adverse Event|5
5821644|NCT02573012|20104708|P1|Overall Study|Adverse Event|5
5821645|NCT02572817|20104760|P2|Overall Study|Lost to Follow-up|3
5821646|NCT02572817|20104761|P1|Overall Study|Lost to Follow-up|3
5821647|NCT02572817|20104760|P2|Overall Study|Death|3
5821648|NCT02572817|20104761|P1|Overall Study|Death|6
5821649|NCT02572570|20104854|P1|Overall Study|Study Terminated|27
5821650|NCT02572401|20104884|P4|Overall Study|Death|1
5821651|NCT02572401|20104885|P3|Overall Study|Death|0
5821652|NCT02572401|20104886|P2|Overall Study|Death|0
5821653|NCT02572401|20104887|P1|Overall Study|Death|0
5821654|NCT02572401|20104884|P4|Overall Study|Lost to Follow-up|9
5821655|NCT02572401|20104885|P3|Overall Study|Lost to Follow-up|9
5821656|NCT02572401|20104886|P2|Overall Study|Lost to Follow-up|8
5821657|NCT02572401|20104887|P1|Overall Study|Lost to Follow-up|5
5821658|NCT02572388|20104917|P4|Overall Study|Withdrawal by Subject|2
5821659|NCT02572388|20104918|P3|Overall Study|Withdrawal by Subject|2
5821660|NCT02572388|20104919|P2|Overall Study|Withdrawal by Subject|1
5821661|NCT02572388|20104920|P1|Overall Study|Withdrawal by Subject|1
5821662|NCT02572167|20104945|P3|Overall Study|Did not meet inclusion criteria|1
5821663|NCT02572167|20104946|P2|Overall Study|Did not meet inclusion criteria|0
5821664|NCT02572167|20104947|P1|Overall Study|Did not meet inclusion criteria|0
5821665|NCT02572167|20104945|P3|Overall Study|Death|1
5821666|NCT02572167|20104946|P2|Overall Study|Death|3
5821667|NCT02572167|20104947|P1|Overall Study|Death|0
5821668|NCT02572167|20104945|P3|Overall Study|Lost to Follow-up|1
5821669|NCT02572167|20104946|P2|Overall Study|Lost to Follow-up|2
5821670|NCT02572167|20104947|P1|Overall Study|Lost to Follow-up|0
5821671|NCT02572167|20104945|P3|Overall Study|Withdrawal by Subject|1
5821672|NCT02572167|20104946|P2|Overall Study|Withdrawal by Subject|3
5821673|NCT02572167|20104947|P1|Overall Study|Withdrawal by Subject|0
5821674|NCT02572167|20104945|P3|Overall Study|In follow up|27
5821675|NCT02572167|20104946|P2|Overall Study|In follow up|48
5821676|NCT02572167|20104947|P1|Overall Study|In follow up|6
5821677|NCT02572076|20104961|P1|Overall Study|Protocol Violation|1
5821678|NCT02571972|20104965|P1|Overall Study|Withdrawal by Subject|2
5821679|NCT02571972|20104965|P1|Overall Study|Protocol Violation|2
5821680|NCT02571777|20104977|P5|Overall Study|Pregnancy|0
5821681|NCT02571777|20104978|P4|Overall Study|Pregnancy|2
5821682|NCT02571777|20104979|P3|Overall Study|Pregnancy|0
5821683|NCT02571777|20104980|P2|Overall Study|Pregnancy|0
5821684|NCT02571777|20104981|P1|Overall Study|Pregnancy|0
5821685|NCT02571777|20104977|P5|Overall Study|Physician Decision|4
5821686|NCT02571777|20104978|P4|Overall Study|Physician Decision|2
5821687|NCT02571777|20104979|P3|Overall Study|Physician Decision|5
5821688|NCT02571777|20104980|P2|Overall Study|Physician Decision|7
5821689|NCT02571777|20104981|P1|Overall Study|Physician Decision|1
5821690|NCT02571777|20104977|P5|Overall Study|Lost to Follow-up|1
5821691|NCT02571777|20104978|P4|Overall Study|Lost to Follow-up|0
5821692|NCT02571777|20104979|P3|Overall Study|Lost to Follow-up|2
5821693|NCT02571777|20104980|P2|Overall Study|Lost to Follow-up|1
5821694|NCT02571777|20104981|P1|Overall Study|Lost to Follow-up|1
5821695|NCT02571777|20104977|P5|Overall Study|Death|0
5821696|NCT02571777|20104978|P4|Overall Study|Death|0
5821697|NCT02571777|20104979|P3|Overall Study|Death|4
5821698|NCT02571777|20104980|P2|Overall Study|Death|1
5821699|NCT02571777|20104981|P1|Overall Study|Death|1
5821700|NCT02571777|20104977|P5|Overall Study|Protocol Deviation|4
5821701|NCT02571777|20104978|P4|Overall Study|Protocol Deviation|8
5821702|NCT02571777|20104979|P3|Overall Study|Protocol Deviation|4
5821703|NCT02571777|20104980|P2|Overall Study|Protocol Deviation|3
5821704|NCT02571777|20104981|P1|Overall Study|Protocol Deviation|2
5821705|NCT02571777|20104977|P5|Overall Study|Subject/guardian decision|27
5821706|NCT02571777|20104978|P4|Overall Study|Subject/guardian decision|25
5821707|NCT02571777|20104979|P3|Overall Study|Subject/guardian decision|26
5821708|NCT02571777|20104980|P2|Overall Study|Subject/guardian decision|26
5821709|NCT02571777|20104981|P1|Overall Study|Subject/guardian decision|34
5821710|NCT02571452|20105118|P2|Overall Study 6-Month Follow-up|Protocol Violation|0
5821711|NCT02571452|20105119|P1|Overall Study 6-Month Follow-up|Protocol Violation|1
5821712|NCT02571452|20105118|P2|Overall Study 6-Month Follow-up|Lost to Follow-up|0
5821713|NCT02571452|20105119|P1|Overall Study 6-Month Follow-up|Lost to Follow-up|4
5821714|NCT02571452|20105118|P2|Overall Study Treatment|Protocol Violation|1
5821715|NCT02571452|20105119|P1|Overall Study Treatment|Protocol Violation|0
5821716|NCT02571244|20105160|P2|Overall Study|Unable to reach out post discharge|0
5821717|NCT02571244|20105161|P1|Overall Study|Unable to reach out post discharge|3
5821718|NCT02571244|20105160|P2|Overall Study|Lost to Follow-up|1
5821719|NCT02571244|20105161|P1|Overall Study|Lost to Follow-up|0
5821720|NCT02571075|20105219|P2|Overall Study|Lost to Follow-up|24
5821721|NCT02571075|20105220|P1|Overall Study|Lost to Follow-up|20
5821722|NCT02571049|20105234|P2|Randomization|Adverse Event|1
5821723|NCT02571049|20105235|P1|Randomization|Adverse Event|0
5821724|NCT02571049|20105234|P2|Randomization|No migraine attack|1
5821725|NCT02571049|20105235|P1|Randomization|No migraine attack|0
5821726|NCT02571049|20105234|P2|Screening|Did not meet entry criteria|2
5821727|NCT02571049|20105235|P1|Screening|Did not meet entry criteria|2
5821728|NCT02570750|20105243|P2|Overall Study|Adverse Event|1
5821729|NCT02570750|20105244|P1|Overall Study|Adverse Event|2
5821730|NCT02570750|20105243|P2|Overall Study|Lost to Follow-up|2
5821731|NCT02570750|20105244|P1|Overall Study|Lost to Follow-up|2
5821732|NCT02570750|20105243|P2|Overall Study|Withdrawal by Subject|0
5821733|NCT02570750|20105244|P1|Overall Study|Withdrawal by Subject|5
5821734|NCT02570750|20105243|P2|Overall Study|Protocol deviation|2
5821735|NCT02570750|20105244|P1|Overall Study|Protocol deviation|4
5821736|NCT02570750|20105243|P2|Overall Study|Inclusion/exclusion criteria deviation|0
5821737|NCT02570750|20105244|P1|Overall Study|Inclusion/exclusion criteria deviation|1
5821738|NCT02570711|20105262|P2|Overall Study|Early Termination of Study by Sponsor|2
5821739|NCT02570711|20105263|P1|Overall Study|Early Termination of Study by Sponsor|0
5821740|NCT02570711|20105262|P2|Overall Study|Death|0
5821741|NCT02570711|20105263|P1|Overall Study|Death|1
5821742|NCT02570165|20105351|P7|Overall Study|Withdrawal Request by GSK|0
5821743|NCT02570165|20105352|P6|Overall Study|Withdrawal Request by GSK|0
5821744|NCT02570165|20105353|P5|Overall Study|Withdrawal Request by GSK|0
5821745|NCT02570165|20105354|P4|Overall Study|Withdrawal Request by GSK|0
5821746|NCT02570165|20105355|P3|Overall Study|Withdrawal Request by GSK|2
5821747|NCT02570165|20105356|P2|Overall Study|Withdrawal Request by GSK|0
5821748|NCT02570165|20105357|P1|Overall Study|Withdrawal Request by GSK|0
5821749|NCT02570165|20105351|P7|Overall Study|Par. did not Meet Continuation Criteria|0
5821750|NCT02570165|20105352|P6|Overall Study|Par. did not Meet Continuation Criteria|1
5821751|NCT02570165|20105353|P5|Overall Study|Par. did not Meet Continuation Criteria|0
5821752|NCT02570165|20105354|P4|Overall Study|Par. did not Meet Continuation Criteria|0
5821753|NCT02570165|20105355|P3|Overall Study|Par. did not Meet Continuation Criteria|0
5821754|NCT02570165|20105356|P2|Overall Study|Par. did not Meet Continuation Criteria|0
5821755|NCT02570165|20105357|P1|Overall Study|Par. did not Meet Continuation Criteria|0
5821756|NCT02570165|20105351|P7|Overall Study|Withdrawal by Subject|0
5821757|NCT02570165|20105352|P6|Overall Study|Withdrawal by Subject|0
5821758|NCT02570165|20105353|P5|Overall Study|Withdrawal by Subject|1
5821759|NCT02570165|20105354|P4|Overall Study|Withdrawal by Subject|2
5821760|NCT02570165|20105355|P3|Overall Study|Withdrawal by Subject|0
5821761|NCT02570165|20105356|P2|Overall Study|Withdrawal by Subject|0
5821762|NCT02570165|20105357|P1|Overall Study|Withdrawal by Subject|0
5821763|NCT02570165|20105351|P7|Overall Study|Physician Decision|0
5821764|NCT02570165|20105352|P6|Overall Study|Physician Decision|0
5821765|NCT02570165|20105353|P5|Overall Study|Physician Decision|0
5821766|NCT02570165|20105354|P4|Overall Study|Physician Decision|0
5821767|NCT02570165|20105355|P3|Overall Study|Physician Decision|0
5821768|NCT02570165|20105356|P2|Overall Study|Physician Decision|1
5821769|NCT02570165|20105357|P1|Overall Study|Physician Decision|0
5821770|NCT02570165|20105351|P7|Overall Study|Lost to Follow-up|0
5821771|NCT02570165|20105352|P6|Overall Study|Lost to Follow-up|0
5821772|NCT02570165|20105353|P5|Overall Study|Lost to Follow-up|0
5821773|NCT02570165|20105354|P4|Overall Study|Lost to Follow-up|1
5821774|NCT02570165|20105355|P3|Overall Study|Lost to Follow-up|1
5821775|NCT02570165|20105356|P2|Overall Study|Lost to Follow-up|0
5821776|NCT02570165|20105357|P1|Overall Study|Lost to Follow-up|0
5821777|NCT02570165|20105351|P7|Overall Study|Par. Reached Stopping Criteria|0
5821778|NCT02570165|20105352|P6|Overall Study|Par. Reached Stopping Criteria|1
5821779|NCT02570165|20105353|P5|Overall Study|Par. Reached Stopping Criteria|1
5821780|NCT02570165|20105354|P4|Overall Study|Par. Reached Stopping Criteria|2
5821781|NCT02570165|20105355|P3|Overall Study|Par. Reached Stopping Criteria|0
5821782|NCT02570165|20105356|P2|Overall Study|Par. Reached Stopping Criteria|1
5821783|NCT02570165|20105357|P1|Overall Study|Par. Reached Stopping Criteria|1
5821784|NCT02570165|20105351|P7|Overall Study|Lack of Efficacy|0
5821785|NCT02570165|20105352|P6|Overall Study|Lack of Efficacy|0
5821786|NCT02570165|20105353|P5|Overall Study|Lack of Efficacy|4
5821787|NCT02570165|20105354|P4|Overall Study|Lack of Efficacy|0
5821788|NCT02570165|20105355|P3|Overall Study|Lack of Efficacy|0
5821789|NCT02570165|20105356|P2|Overall Study|Lack of Efficacy|1
5821790|NCT02570165|20105357|P1|Overall Study|Lack of Efficacy|0
5821791|NCT02570165|20105351|P7|Overall Study|Adverse Event|0
5821792|NCT02570165|20105352|P6|Overall Study|Adverse Event|0
5821793|NCT02570165|20105353|P5|Overall Study|Adverse Event|0
5821794|NCT02570165|20105354|P4|Overall Study|Adverse Event|0
5821795|NCT02570165|20105355|P3|Overall Study|Adverse Event|2
5821796|NCT02570165|20105356|P2|Overall Study|Adverse Event|0
5821797|NCT02570165|20105357|P1|Overall Study|Adverse Event|1
5821798|NCT02570152|20105380|P1|Overall Study|Migrated/moved from study area|13
5821799|NCT02570152|20105380|P1|Overall Study|Protocol Violation|2
5821800|NCT02570126|20105411|P2|Overall Study|Withdrawal by Subject|7
5821801|NCT02570126|20105412|P1|Overall Study|Withdrawal by Subject|3
5821802|NCT02570126|20105411|P2|Overall Study|Protocol Violation|1
5821803|NCT02570126|20105412|P1|Overall Study|Protocol Violation|0
5821804|NCT02570126|20105411|P2|Overall Study|Violation Of Procedures GSK|1
5821805|NCT02570126|20105412|P1|Overall Study|Violation Of Procedures GSK|0
5821806|NCT02570126|20105411|P2|Overall Study|Unable To Arrange Visit 3|0
5821807|NCT02570126|20105412|P1|Overall Study|Unable To Arrange Visit 3|1
5821808|NCT02570126|20105411|P2|Overall Study|Lost to Follow-up|0
5821809|NCT02570126|20105412|P1|Overall Study|Lost to Follow-up|2
5821810|NCT02570074|20105438|P2|Period 2 (Second Dosing Regimen)|Lost to Follow-up|0
5821811|NCT02570074|20105439|P1|Period 2 (Second Dosing Regimen)|Lost to Follow-up|1
5821812|NCT02569996|20105508|P1|Overall Study|Unknown reason|1
5821813|NCT02569996|20105508|P1|Overall Study|Complete remission|7
5821814|NCT02569996|20105508|P1|Overall Study|Lost to Follow-up|5
5821815|NCT02569996|20105508|P1|Overall Study|Withdrawal by Subject|5
5821816|NCT02569996|20105508|P1|Overall Study|Non-compliance|9
5821817|NCT02569996|20105508|P1|Overall Study|New anti-lymphoma treatment|1
5821818|NCT02569996|20105508|P1|Overall Study|Progression of the disease|18
5821819|NCT02569996|20105508|P1|Overall Study|Physician Decision|3
5821820|NCT02569996|20105508|P1|Overall Study|Adverse Event|6
5821821|NCT02569957|20105520|P2|Overall Study|Withdrawal by Subject|1
5821822|NCT02569957|20105521|P1|Overall Study|Withdrawal by Subject|0
5821823|NCT02569853|20105553|P2|Overall Study|Physician Decision|1
5821824|NCT02569853|20105554|P1|Overall Study|Physician Decision|1
5821825|NCT02569853|20105553|P2|Overall Study|Did not experience migraine attack|7
5821826|NCT02569853|20105554|P1|Overall Study|Did not experience migraine attack|10
5821827|NCT02569853|20105553|P2|Overall Study|Protocol Violation|1
5821828|NCT02569853|20105554|P1|Overall Study|Protocol Violation|1
5821829|NCT02569853|20105553|P2|Overall Study|Lost to Follow-up|3
5821830|NCT02569853|20105554|P1|Overall Study|Lost to Follow-up|3
5821831|NCT02569853|20105553|P2|Overall Study|Withdrawal by Subject|2
5821832|NCT02569853|20105554|P1|Overall Study|Withdrawal by Subject|3
5821833|NCT02569853|20105553|P2|Overall Study|Adverse Event|0
5821834|NCT02569853|20105554|P1|Overall Study|Adverse Event|2
5821835|NCT02569710|20105572|P10|Overall Study|Withdrawal by Subject|0
5821836|NCT02569710|20105573|P9|Overall Study|Withdrawal by Subject|0
5821837|NCT02569710|20105574|P8|Overall Study|Withdrawal by Subject|0
5821838|NCT02569710|20105575|P7|Overall Study|Withdrawal by Subject|0
5821839|NCT02569710|20105576|P6|Overall Study|Withdrawal by Subject|1
5821840|NCT02569710|20105577|P5|Overall Study|Withdrawal by Subject|0
5821841|NCT02569710|20105578|P4|Overall Study|Withdrawal by Subject|0
5821842|NCT02569710|20105579|P3|Overall Study|Withdrawal by Subject|0
5821843|NCT02569710|20105580|P2|Overall Study|Withdrawal by Subject|0
5821844|NCT02569710|20105581|P1|Overall Study|Withdrawal by Subject|0
5821845|NCT02569710|20105572|P10|Overall Study|Virologic failure|0
5821846|NCT02569710|20105573|P9|Overall Study|Virologic failure|0
5821847|NCT02569710|20105574|P8|Overall Study|Virologic failure|0
5821848|NCT02569710|20105575|P7|Overall Study|Virologic failure|1
5821849|NCT02569710|20105576|P6|Overall Study|Virologic failure|0
5821850|NCT02569710|20105577|P5|Overall Study|Virologic failure|1
5821851|NCT02569710|20105578|P4|Overall Study|Virologic failure|0
5821852|NCT02569710|20105579|P3|Overall Study|Virologic failure|0
5821853|NCT02569710|20105580|P2|Overall Study|Virologic failure|0
5821854|NCT02569710|20105581|P1|Overall Study|Virologic failure|0
5821855|NCT02569710|20105572|P10|Overall Study|Lost to Follow-up|0
5821856|NCT02569710|20105573|P9|Overall Study|Lost to Follow-up|1
5821857|NCT02569710|20105574|P8|Overall Study|Lost to Follow-up|0
5821858|NCT02569710|20105575|P7|Overall Study|Lost to Follow-up|1
5821859|NCT02569710|20105576|P6|Overall Study|Lost to Follow-up|0
5821860|NCT02569710|20105577|P5|Overall Study|Lost to Follow-up|0
5821861|NCT02569710|20105578|P4|Overall Study|Lost to Follow-up|0
5821862|NCT02569710|20105579|P3|Overall Study|Lost to Follow-up|0
5821863|NCT02569710|20105580|P2|Overall Study|Lost to Follow-up|0
5821864|NCT02569710|20105581|P1|Overall Study|Lost to Follow-up|0
5821865|NCT02569710|20105572|P10|Overall Study|Adverse Event|0
5821866|NCT02569710|20105573|P9|Overall Study|Adverse Event|0
5821867|NCT02569710|20105574|P8|Overall Study|Adverse Event|0
5821868|NCT02569710|20105575|P7|Overall Study|Adverse Event|0
5821869|NCT02569710|20105576|P6|Overall Study|Adverse Event|0
5821870|NCT02569710|20105577|P5|Overall Study|Adverse Event|0
5821871|NCT02569710|20105578|P4|Overall Study|Adverse Event|0
5821872|NCT02569710|20105579|P3|Overall Study|Adverse Event|0
5821873|NCT02569710|20105580|P2|Overall Study|Adverse Event|0
5821874|NCT02569710|20105581|P1|Overall Study|Adverse Event|1
5821875|NCT02569437|20105921|P2|Overall Study|Lost to Follow-up|14
5821876|NCT02569437|20105922|P1|Overall Study|Lost to Follow-up|12
5821877|NCT02569398|20105952|P3|Overall Study|Other|13
5821878|NCT02569398|20105953|P2|Overall Study|Other|14
5821879|NCT02569398|20105954|P1|Overall Study|Other|12
5821880|NCT02569398|20105952|P3|Overall Study|Study terminated by sponsor|134
5821881|NCT02569398|20105953|P2|Overall Study|Study terminated by sponsor|131
5821882|NCT02569398|20105954|P1|Overall Study|Study terminated by sponsor|130
5821883|NCT02569398|20105952|P3|Overall Study|Withdrawal by Subject|30
5821884|NCT02569398|20105953|P2|Overall Study|Withdrawal by Subject|43
5821885|NCT02569398|20105954|P1|Overall Study|Withdrawal by Subject|43
5821886|NCT02569398|20105952|P3|Overall Study|Adverse Event|6
5821887|NCT02569398|20105953|P2|Overall Study|Adverse Event|1
5821888|NCT02569398|20105954|P1|Overall Study|Adverse Event|0
5821889|NCT02568683|20106029|P2|Overall Study|Study Terminated By Sponsor|2
5821890|NCT02568683|20106030|P1|Overall Study|Study Terminated By Sponsor|5
5821891|NCT02568683|20106029|P2|Overall Study|Withdrew Consent|0
5821892|NCT02568683|20106030|P1|Overall Study|Withdrew Consent|1
5821893|NCT02568683|20106029|P2|Overall Study|Death|2
5821894|NCT02568683|20106030|P1|Overall Study|Death|0
5821895|NCT02568475|20106059|P2|Overall Study|Transferred to another facility|0
5821896|NCT02568475|20106060|P1|Overall Study|Transferred to another facility|1
5821897|NCT02568475|20106059|P2|Overall Study|Short-term: Discharge location unknown|0
5821898|NCT02568475|20106060|P1|Overall Study|Short-term: Discharge location unknown|4
5821899|NCT02568475|20106059|P2|Overall Study|Discharged home|4
5821900|NCT02568475|20106060|P1|Overall Study|Discharged home|4
5821901|NCT02568475|20106059|P2|Overall Study|Withdrawal by Subject|0
5821902|NCT02568475|20106060|P1|Overall Study|Withdrawal by Subject|2
5821903|NCT02568475|20106059|P2|Overall Study|Lost to Follow-up|39
5821904|NCT02568475|20106060|P1|Overall Study|Lost to Follow-up|40
5821905|NCT02568397|20106074|P2|Period 2|Physician Decision|1
5821906|NCT02568397|20106075|P1|Period 2|Physician Decision|0
5821907|NCT02568397|20106074|P2|Period 2|Withdrawal by Subject|1
5821908|NCT02568397|20106075|P1|Period 2|Withdrawal by Subject|0
5821909|NCT02568384|20106099|P1|Overall Study|Mobile devices incompatible with App|2
5821910|NCT02568254|20106113|P6|Period 3|Unstatisfactory Lens fitting|0
5821911|NCT02568254|20106114|P5|Period 3|Unstatisfactory Lens fitting|1
5821912|NCT02568254|20106115|P4|Period 3|Unstatisfactory Lens fitting|0
5821913|NCT02568254|20106116|P3|Period 3|Unstatisfactory Lens fitting|0
5821914|NCT02568254|20106117|P2|Period 3|Unstatisfactory Lens fitting|0
5821915|NCT02568254|20106118|P1|Period 3|Unstatisfactory Lens fitting|0
5821916|NCT02568254|20106113|P6|Period 2|Adverse Event|0
5821917|NCT02568254|20106114|P5|Period 2|Adverse Event|0
5821918|NCT02568254|20106115|P4|Period 2|Adverse Event|0
5821919|NCT02568254|20106116|P3|Period 2|Adverse Event|1
5821920|NCT02568254|20106117|P2|Period 2|Adverse Event|0
5821921|NCT02568254|20106118|P1|Period 2|Adverse Event|0
5821922|NCT02568046|20106128|P2|Overall Study|Other Events|1
5821923|NCT02568046|20106129|P1|Overall Study|Other Events|0
5821924|NCT02568046|20106128|P2|Overall Study|Withdrawal by Subject|1
5821925|NCT02568046|20106129|P1|Overall Study|Withdrawal by Subject|2
5821926|NCT02568046|20106128|P2|Overall Study|Progressive Disease|0
5821927|NCT02568046|20106129|P1|Overall Study|Progressive Disease|1
5821928|NCT02568046|20106128|P2|Overall Study|Death|0
5821929|NCT02568046|20106129|P1|Overall Study|Death|2
5821930|NCT02568046|20106128|P2|Overall Study|Adverse Event|1
5821931|NCT02568046|20106129|P1|Overall Study|Adverse Event|0
5821932|NCT02567708|20106192|P2|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|3
5821933|NCT02567708|20106193|P1|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|0
5821934|NCT02567708|20106192|P2|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|0
5821935|NCT02567708|20106193|P1|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|2
5821936|NCT02567708|20106192|P2|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|1
5821937|NCT02567708|20106193|P1|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|0
5821938|NCT02567708|20106192|P2|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|2
5821939|NCT02567708|20106193|P1|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0
5821940|NCT02567656|20106238|P6|Overall Study|Premature discontinuation due to PD|0
5821941|NCT02567656|20106239|P5|Overall Study|Premature discontinuation due to PD|0
5821942|NCT02567656|20106240|P4|Overall Study|Premature discontinuation due to PD|0
5821943|NCT02567656|20106241|P3|Overall Study|Premature discontinuation due to PD|2
5821944|NCT02567656|20106242|P2|Overall Study|Premature discontinuation due to PD|1
5821945|NCT02567656|20106243|P1|Overall Study|Premature discontinuation due to PD|1
5821946|NCT02567552|20106275|P2|Overall Study|Adverse Event|1
5821947|NCT02567552|20106276|P1|Overall Study|Adverse Event|0
5821948|NCT02567188|20106306|P1|Overall Study|Protocol Violation|5
5821949|NCT02567188|20106306|P1|Overall Study|Started Hemodialysis|2
5821950|NCT02567188|20106306|P1|Overall Study|Moved and Changed Clinic|1
5821951|NCT02567188|20106306|P1|Overall Study|Refused Treatment/ Did not Cooperate|1
5821952|NCT02567188|20106306|P1|Overall Study|Withdrawal by Subject|1
5821953|NCT02567188|20106306|P1|Overall Study|Adverse Event|1
5821954|NCT02567188|20106306|P1|Overall Study|Lost to Follow-up|5
5821955|NCT02567188|20106306|P1|Overall Study|Terminated Mircera Treatment|9
5821956|NCT02567188|20106306|P1|Overall Study|Death|10
5821957|NCT02566889|20106337|P2|Overall Study|Other|2
5821958|NCT02566889|20106338|P1|Overall Study|Other|6
5821959|NCT02566889|20106337|P2|Overall Study|Adverse Event|2
5821960|NCT02566889|20106338|P1|Overall Study|Adverse Event|4
5821961|NCT02566889|20106337|P2|Overall Study|Withdrawal by Subject|1
5821962|NCT02566889|20106338|P1|Overall Study|Withdrawal by Subject|3
5821963|NCT02566785|20106356|P2|Overall Study|Worsening condition|1
5821964|NCT02566785|20106357|P1|Overall Study|Worsening condition|1
5821965|NCT02566785|20106356|P2|Overall Study|Lost to Follow-up|2
5821966|NCT02566785|20106357|P1|Overall Study|Lost to Follow-up|0
5821967|NCT02566759|20106384|P17|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|1
5821968|NCT02566759|20106385|P16|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
5821969|NCT02566759|20106386|P15|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
5821970|NCT02566759|20106387|P14|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
5821971|NCT02566759|20106388|P13|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
5821972|NCT02566759|20106389|P12|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
5821973|NCT02566759|20106390|P11|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
5821974|NCT02566759|20106391|P10|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
5821975|NCT02566759|20106392|P9|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
5821976|NCT02566759|20106393|P8|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
5821977|NCT02566759|20106394|P7|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
5821978|NCT02566759|20106395|P6|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
5821979|NCT02566759|20106396|P5|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
5821980|NCT02566759|20106397|P4|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
5821981|NCT02566759|20106398|P3|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
5821982|NCT02566759|20106399|P2|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
5821983|NCT02566759|20106400|P1|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
5821984|NCT02566759|20106384|P17|All Parts|Other|0
5821985|NCT02566759|20106385|P16|All Parts|Other|0
5821986|NCT02566759|20106386|P15|All Parts|Other|0
5821987|NCT02566759|20106387|P14|All Parts|Other|2
5821988|NCT02566759|20106388|P13|All Parts|Other|0
5821989|NCT02566759|20106389|P12|All Parts|Other|0
5821990|NCT02566759|20106390|P11|All Parts|Other|0
5821991|NCT02566759|20106391|P10|All Parts|Other|0
5821992|NCT02566759|20106392|P9|All Parts|Other|0
5821993|NCT02566759|20106393|P8|All Parts|Other|0
5821994|NCT02566759|20106394|P7|All Parts|Other|0
5821995|NCT02566759|20106395|P6|All Parts|Other|0
5821996|NCT02566759|20106396|P5|All Parts|Other|0
5821997|NCT02566759|20106397|P4|All Parts|Other|0
5821998|NCT02566759|20106398|P3|All Parts|Other|0
5821999|NCT02566759|20106399|P2|All Parts|Other|0
5822000|NCT02566759|20106400|P1|All Parts|Other|0
5822001|NCT02566759|20106384|P17|All Parts|Adverse Event|0
5822002|NCT02566759|20106385|P16|All Parts|Adverse Event|0
5822003|NCT02566759|20106386|P15|All Parts|Adverse Event|0
5822004|NCT02566759|20106387|P14|All Parts|Adverse Event|3
5822005|NCT02566759|20106388|P13|All Parts|Adverse Event|1
5822006|NCT02566759|20106389|P12|All Parts|Adverse Event|0
5822007|NCT02566759|20106390|P11|All Parts|Adverse Event|0
5822008|NCT02566759|20106391|P10|All Parts|Adverse Event|0
5822009|NCT02566759|20106392|P9|All Parts|Adverse Event|0
5822010|NCT02566759|20106393|P8|All Parts|Adverse Event|0
5822011|NCT02566759|20106394|P7|All Parts|Adverse Event|0
5822012|NCT02566759|20106395|P6|All Parts|Adverse Event|0
5822013|NCT02566759|20106396|P5|All Parts|Adverse Event|0
5822014|NCT02566759|20106397|P4|All Parts|Adverse Event|0
5822015|NCT02566759|20106398|P3|All Parts|Adverse Event|0
5822016|NCT02566759|20106399|P2|All Parts|Adverse Event|0
5822017|NCT02566759|20106400|P1|All Parts|Adverse Event|0
5822018|NCT02566759|20106384|P17|All Parts|Withdrawal by Subject|0
5822019|NCT02566759|20106385|P16|All Parts|Withdrawal by Subject|0
5822020|NCT02566759|20106386|P15|All Parts|Withdrawal by Subject|0
5822021|NCT02566759|20106387|P14|All Parts|Withdrawal by Subject|0
5822022|NCT02566759|20106388|P13|All Parts|Withdrawal by Subject|0
5822023|NCT02566759|20106389|P12|All Parts|Withdrawal by Subject|0
5822024|NCT02566759|20106390|P11|All Parts|Withdrawal by Subject|0
5822025|NCT02566759|20106391|P10|All Parts|Withdrawal by Subject|0
5822026|NCT02566759|20106392|P9|All Parts|Withdrawal by Subject|0
5822027|NCT02566759|20106393|P8|All Parts|Withdrawal by Subject|0
5822028|NCT02566759|20106394|P7|All Parts|Withdrawal by Subject|0
5822029|NCT02566759|20106395|P6|All Parts|Withdrawal by Subject|0
5822030|NCT02566759|20106396|P5|All Parts|Withdrawal by Subject|0
5822031|NCT02566759|20106397|P4|All Parts|Withdrawal by Subject|0
5822032|NCT02566759|20106398|P3|All Parts|Withdrawal by Subject|0
5822033|NCT02566759|20106399|P2|All Parts|Withdrawal by Subject|1
5822034|NCT02566759|20106400|P1|All Parts|Withdrawal by Subject|0
5822035|NCT02566577|20106562|P2|Overall Study|Physical limitation|0
5822036|NCT02566577|20106563|P1|Overall Study|Physical limitation|1
5822037|NCT02566577|20106562|P2|Overall Study|Equipment failure|1
5822038|NCT02566577|20106563|P1|Overall Study|Equipment failure|1
5822039|NCT02566577|20106562|P2|Overall Study|Withdrawal by Subject|1
5822040|NCT02566577|20106563|P1|Overall Study|Withdrawal by Subject|1
5822041|NCT02566109|20106643|P1|Overall Study|Withdrawal by Subject|1
5822042|NCT02566031|20106707|P2|Overall Study|Lost to Follow-up|1
5822043|NCT02566031|20106708|P1|Overall Study|Lost to Follow-up|1
5822044|NCT02566031|20106707|P2|Overall Study|Adverse Event|1
5822045|NCT02566031|20106708|P1|Overall Study|Adverse Event|3
5822046|NCT02566031|20106707|P2|Overall Study|Protocol deviation|3
5822047|NCT02566031|20106708|P1|Overall Study|Protocol deviation|2
5822048|NCT02566031|20106707|P2|Overall Study|Patient/guardian decision|7
5822049|NCT02566031|20106708|P1|Overall Study|Patient/guardian decision|14
5822050|NCT02566005|20106725|P2|Overall Study|labor after randomization|4
5822051|NCT02566005|20106726|P1|Overall Study|labor after randomization|0
5822052|NCT02566005|20106725|P2|Overall Study|did not receive foley|1
5822053|NCT02566005|20106726|P1|Overall Study|did not receive foley|0
5822054|NCT02566005|20106725|P2|Overall Study|received foley|0
5822055|NCT02566005|20106726|P1|Overall Study|received foley|8
5822056|NCT02566005|20106725|P2|Overall Study|vaginal bleeding|1
5822057|NCT02566005|20106726|P1|Overall Study|vaginal bleeding|0
5822058|NCT02565914|20106754|P1|Overall Study|Enrolled, but did not receive study drug|2
5822059|NCT02565914|20106754|P1|Overall Study|Other|18
5822060|NCT02565914|20106754|P1|Overall Study|Commercial drug available|5
5822061|NCT02565914|20106754|P1|Overall Study|Parent study termination by sponsor|1
5822062|NCT02565914|20106754|P1|Overall Study|Physician Decision|6
5822063|NCT02565914|20106754|P1|Overall Study|Other noncompliance|6
5822064|NCT02565914|20106754|P1|Overall Study|Death (not treatment emergent)|1
5822065|NCT02565914|20106754|P1|Overall Study|Lost to Follow-up|12
5822066|NCT02565914|20106754|P1|Overall Study|Withdrawal of consent (not due to AE)|25
5822067|NCT02565914|20106754|P1|Overall Study|Adverse Event|17
5822068|NCT02565810|20106788|P1|Overall Study|Withdrawal by Subject|1
5822069|NCT02565784|20106797|P1|Second Treatment|Withdrawal by Subject|2
5822070|NCT02565784|20106797|P1|First Treatment|Withdrawal by Subject|1
5822071|NCT02565784|20106797|P1|First Treatment|Adverse Event|1
5822072|NCT02565706|20106809|P4|Overall Study|Lost to Follow-up|74
5822073|NCT02565706|20106810|P3|Overall Study|Lost to Follow-up|82
5822074|NCT02565706|20106811|P2|Overall Study|Lost to Follow-up|75
5822075|NCT02565706|20106812|P1|Overall Study|Lost to Follow-up|72
5822076|NCT02565706|20106809|P4|Overall Study|Withdrawal by Subject|11
5822077|NCT02565706|20106810|P3|Overall Study|Withdrawal by Subject|7
5822078|NCT02565706|20106811|P2|Overall Study|Withdrawal by Subject|7
5822079|NCT02565706|20106812|P1|Overall Study|Withdrawal by Subject|5
5822115|NCT02565576|20107036|P2|Overall Study|Adverse Event|0
5822116|NCT02565576|20107037|P1|Overall Study|Adverse Event|1
5822117|NCT02565576|20107036|P2|Overall Study|Death|2
5822118|NCT02565576|20107037|P1|Overall Study|Death|0
5822119|NCT02565576|20107036|P2|Overall Study|Lost to Follow-up|0
5822120|NCT02565576|20107037|P1|Overall Study|Lost to Follow-up|1
5822121|NCT02565576|20107036|P2|Overall Study|subject / guardian decision|3
5822122|NCT02565576|20107037|P1|Overall Study|subject / guardian decision|1
5822123|NCT02565576|20107036|P2|Overall Study|abnormal lab value|0
5822124|NCT02565576|20107037|P1|Overall Study|abnormal lab value|2
5822125|NCT02565381|20107080|P3|Overall Study|Lost to Follow-up|1
5822126|NCT02565381|20107081|P2|Overall Study|Lost to Follow-up|0
5822127|NCT02565381|20107082|P1|Overall Study|Lost to Follow-up|1
5822128|NCT02565186|20107122|P2|Overall Study|Did Not Receive Study Drug|86
5822129|NCT02565186|20107123|P1|Overall Study|Did Not Receive Study Drug|55
5822130|NCT02565186|20107122|P2|Overall Study|Missing|0
5822131|NCT02565186|20107123|P1|Overall Study|Missing|1
5822132|NCT02565186|20107122|P2|Overall Study|Sponsor Request|9
5822133|NCT02565186|20107123|P1|Overall Study|Sponsor Request|5
5822134|NCT02565186|20107122|P2|Overall Study|Physician Decision|16
5822135|NCT02565186|20107123|P1|Overall Study|Physician Decision|18
5822136|NCT02565186|20107122|P2|Overall Study|Withdrawal by Subject|214
5822137|NCT02565186|20107123|P1|Overall Study|Withdrawal by Subject|229
5822138|NCT02565186|20107122|P2|Overall Study|Non-Compliance|55
5822139|NCT02565186|20107123|P1|Overall Study|Non-Compliance|57
5822140|NCT02565186|20107122|P2|Overall Study|Lost to Follow-up|93
5822141|NCT02565186|20107123|P1|Overall Study|Lost to Follow-up|102
5822142|NCT02565186|20107122|P2|Overall Study|Adverse Event|148
5822143|NCT02565186|20107123|P1|Overall Study|Adverse Event|113
5822144|NCT02565147|20107137|P2|Overall Study|Death|1
5822145|NCT02565147|20107138|P1|Overall Study|Death|1
5822146|NCT02565147|20107137|P2|Overall Study|Lost to Follow-up|1
5822147|NCT02565147|20107138|P1|Overall Study|Lost to Follow-up|0
5822148|NCT02565147|20107137|P2|Overall Study|Withdrawal by Subject|1
5822149|NCT02565147|20107138|P1|Overall Study|Withdrawal by Subject|5
5822150|NCT02565108|20107162|P2|Overall Study|Withdrew Consent|0
5822151|NCT02565108|20107163|P1|Overall Study|Withdrew Consent|1
5822152|NCT02565108|20107162|P2|Overall Study|Adverse Event|0
5822153|NCT02565108|20107163|P1|Overall Study|Adverse Event|1
5822154|NCT02564952|20107179|P1|Overall Study|Participant Met Withdrawal Criteria|1
5822155|NCT02564952|20107179|P1|Overall Study|Low Efficacy|1
5822156|NCT02564952|20107179|P1|Overall Study|Withdrawal by Subject|1
5822157|NCT02564952|20107179|P1|Overall Study|Participant Withdrawn by Investigator|1
5822158|NCT02564952|20107179|P1|Overall Study|Lost to Follow-up|1
5822159|NCT02564952|20107179|P1|Overall Study|Adverse Event|6
5822160|NCT02564887|20107224|P2|Overall Study|Lost to Follow-up|0
5822161|NCT02564887|20107225|P1|Overall Study|Lost to Follow-up|6
5822162|NCT02564718|20107243|P2|Overall Study|Withdrew from treatment|1
5822163|NCT02564718|20107244|P1|Overall Study|Withdrew from treatment|0
5822164|NCT02564263|20107332|P2|Overall Study|Ongoing in Study|25
5822165|NCT02564263|20107333|P1|Overall Study|Ongoing in Study|42
5822166|NCT02564263|20107332|P2|Overall Study|Withdrawal by Subject|18
5822167|NCT02564263|20107333|P1|Overall Study|Withdrawal by Subject|5
5822168|NCT02564263|20107332|P2|Overall Study|Death|242
5822169|NCT02564263|20107333|P1|Overall Study|Death|236
5822170|NCT02564263|20107332|P2|Overall Study|Adverse Event|29
5822171|NCT02564263|20107333|P1|Overall Study|Adverse Event|31
5822172|NCT02564211|20107355|P1|Overall Study|Adverse Event|4
5822173|NCT02564120|20107366|P1|Overall Study|Other medical condition|24
5822174|NCT02564120|20107366|P1|Overall Study|Withdrawal by Subject|204
5822175|NCT02564120|20107366|P1|Overall Study|Death|58
5822176|NCT02564120|20107366|P1|Overall Study|Did not return release forms|160
5822177|NCT02564055|20107414|P6|Overall Study|Withdrawal by Subject|10
5822178|NCT02564055|20107415|P5|Overall Study|Withdrawal by Subject|10
5822179|NCT02564055|20107416|P4|Overall Study|Withdrawal by Subject|3
5822180|NCT02564055|20107417|P3|Overall Study|Withdrawal by Subject|3
5822181|NCT02564055|20107418|P2|Overall Study|Withdrawal by Subject|4
5822182|NCT02564055|20107419|P1|Overall Study|Withdrawal by Subject|4
5822183|NCT02564055|20107414|P6|Overall Study|Physician Decision|0
5822184|NCT02564055|20107415|P5|Overall Study|Physician Decision|0
5822185|NCT02564055|20107416|P4|Overall Study|Physician Decision|0
5822186|NCT02564055|20107417|P3|Overall Study|Physician Decision|1
5822187|NCT02564055|20107418|P2|Overall Study|Physician Decision|0
5822188|NCT02564055|20107419|P1|Overall Study|Physician Decision|0
5822189|NCT02564055|20107414|P6|Overall Study|Lost to Follow-up|0
5822190|NCT02564055|20107415|P5|Overall Study|Lost to Follow-up|1
5822191|NCT02564055|20107416|P4|Overall Study|Lost to Follow-up|2
5822192|NCT02564055|20107417|P3|Overall Study|Lost to Follow-up|4
5822193|NCT02564055|20107418|P2|Overall Study|Lost to Follow-up|1
5822194|NCT02564055|20107419|P1|Overall Study|Lost to Follow-up|0
5822195|NCT02564055|20107414|P6|Overall Study|Reached stopping criteria|1
5822196|NCT02564055|20107415|P5|Overall Study|Reached stopping criteria|0
5822197|NCT02564055|20107416|P4|Overall Study|Reached stopping criteria|0
5822198|NCT02564055|20107417|P3|Overall Study|Reached stopping criteria|0
5822199|NCT02564055|20107418|P2|Overall Study|Reached stopping criteria|0
5822200|NCT02564055|20107419|P1|Overall Study|Reached stopping criteria|0
5822201|NCT02564055|20107414|P6|Overall Study|Protocol Violation|0
5822202|NCT02564055|20107415|P5|Overall Study|Protocol Violation|0
5822203|NCT02564055|20107416|P4|Overall Study|Protocol Violation|0
5822204|NCT02564055|20107417|P3|Overall Study|Protocol Violation|0
5822205|NCT02564055|20107418|P2|Overall Study|Protocol Violation|0
5822206|NCT02564055|20107419|P1|Overall Study|Protocol Violation|1
5822207|NCT02564055|20107414|P6|Overall Study|Adverse Event|1
5822208|NCT02564055|20107415|P5|Overall Study|Adverse Event|4
5822209|NCT02564055|20107416|P4|Overall Study|Adverse Event|1
5822210|NCT02564055|20107417|P3|Overall Study|Adverse Event|4
5822211|NCT02564055|20107418|P2|Overall Study|Adverse Event|0
5822212|NCT02564055|20107419|P1|Overall Study|Adverse Event|1
5822213|NCT02564042|20107673|P6|Overall Study|Withdrawal by Subject|12
5822214|NCT02564042|20107674|P5|Overall Study|Withdrawal by Subject|10
5822215|NCT02564042|20107675|P4|Overall Study|Withdrawal by Subject|2
5822216|NCT02564042|20107676|P3|Overall Study|Withdrawal by Subject|2
5822217|NCT02564042|20107677|P2|Overall Study|Withdrawal by Subject|3
5822218|NCT02564042|20107678|P1|Overall Study|Withdrawal by Subject|5
5822219|NCT02564042|20107673|P6|Overall Study|Physician Decision|0
5822220|NCT02564042|20107674|P5|Overall Study|Physician Decision|0
5822221|NCT02564042|20107675|P4|Overall Study|Physician Decision|1
5822222|NCT02564042|20107676|P3|Overall Study|Physician Decision|0
5822223|NCT02564042|20107677|P2|Overall Study|Physician Decision|0
5822224|NCT02564042|20107678|P1|Overall Study|Physician Decision|1
5822225|NCT02564042|20107673|P6|Overall Study|Lost to Follow-up|1
5822226|NCT02564042|20107674|P5|Overall Study|Lost to Follow-up|1
5822227|NCT02564042|20107675|P4|Overall Study|Lost to Follow-up|0
5822228|NCT02564042|20107676|P3|Overall Study|Lost to Follow-up|1
5822229|NCT02564042|20107677|P2|Overall Study|Lost to Follow-up|1
5822230|NCT02564042|20107678|P1|Overall Study|Lost to Follow-up|1
5822231|NCT02564042|20107673|P6|Overall Study|Adverse Event|1
5822232|NCT02564042|20107674|P5|Overall Study|Adverse Event|0
5822233|NCT02564042|20107675|P4|Overall Study|Adverse Event|0
5822234|NCT02564042|20107676|P3|Overall Study|Adverse Event|3
5822235|NCT02564042|20107677|P2|Overall Study|Adverse Event|4
5822236|NCT02564042|20107678|P1|Overall Study|Adverse Event|4
5822237|NCT02563899|20107973|P4|Overall Study|Withdrawal by Subject|0
5822238|NCT02563899|20107974|P3|Overall Study|Withdrawal by Subject|1
5822239|NCT02563899|20107975|P2|Overall Study|Withdrawal by Subject|0
5822240|NCT02563899|20107976|P1|Overall Study|Withdrawal by Subject|0
5822241|NCT02563899|20107973|P4|Overall Study|Protocol Violation|0
5822242|NCT02563899|20107974|P3|Overall Study|Protocol Violation|0
5822243|NCT02563899|20107975|P2|Overall Study|Protocol Violation|0
5822244|NCT02563899|20107976|P1|Overall Study|Protocol Violation|1
5822245|NCT02563548|20108052|P6|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0
5822246|NCT02563548|20108053|P5|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|1
5822247|NCT02563548|20108054|P4|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0
5822248|NCT02563548|20108055|P3|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0
5822249|NCT02563548|20108056|P2|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0
5822250|NCT02563548|20108057|P1|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0
5822251|NCT02563548|20108052|P6|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|1
5822252|NCT02563548|20108053|P5|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0
5822253|NCT02563548|20108054|P4|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0
5822254|NCT02563548|20108055|P3|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0
5822255|NCT02563548|20108056|P2|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0
5822256|NCT02563548|20108057|P1|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0
5822257|NCT02563548|20108052|P6|Dose Expansion (Up to 60 Weeks)|Protocol Violation|2
5822258|NCT02563548|20108053|P5|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0
5822259|NCT02563548|20108054|P4|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0
5822260|NCT02563548|20108055|P3|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0
5822261|NCT02563548|20108056|P2|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0
5822262|NCT02563548|20108057|P1|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0
5822263|NCT02563548|20108052|P6|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|2
5822264|NCT02563548|20108053|P5|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0
5822265|NCT02563548|20108054|P4|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0
5822266|NCT02563548|20108055|P3|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0
5822267|NCT02563548|20108056|P2|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0
5822268|NCT02563548|20108057|P1|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0
5822269|NCT02563548|20108052|P6|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|1
5822270|NCT02563548|20108053|P5|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|2
5822271|NCT02563548|20108054|P4|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0
5822272|NCT02563548|20108055|P3|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0
5822273|NCT02563548|20108056|P2|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0
5822274|NCT02563548|20108057|P1|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0
5822275|NCT02563548|20108052|P6|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0
5822276|NCT02563548|20108053|P5|Dose Expansion (Up to 60 Weeks)|Clinical Progression|6
5822277|NCT02563548|20108054|P4|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0
5822278|NCT02563548|20108055|P3|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0
5822279|NCT02563548|20108056|P2|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0
5822280|NCT02563548|20108057|P1|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0
5822281|NCT02563548|20108052|P6|Dose Expansion (Up to 60 Weeks)|Radiological Progression|3
5822282|NCT02563548|20108053|P5|Dose Expansion (Up to 60 Weeks)|Radiological Progression|15
5822283|NCT02563548|20108054|P4|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0
5822284|NCT02563548|20108055|P3|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0
5822285|NCT02563548|20108056|P2|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0
5822286|NCT02563548|20108057|P1|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0
5822287|NCT02563548|20108052|P6|Dose Expansion (Up to 60 Weeks)|Adverse Event|8
5822288|NCT02563548|20108053|P5|Dose Expansion (Up to 60 Weeks)|Adverse Event|1
5822289|NCT02563548|20108054|P4|Dose Expansion (Up to 60 Weeks)|Adverse Event|0
5822290|NCT02563548|20108055|P3|Dose Expansion (Up to 60 Weeks)|Adverse Event|0
5822291|NCT02563548|20108056|P2|Dose Expansion (Up to 60 Weeks)|Adverse Event|0
5822292|NCT02563548|20108057|P1|Dose Expansion (Up to 60 Weeks)|Adverse Event|0
5822293|NCT02563548|20108052|P6|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0
5822294|NCT02563548|20108053|P5|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0
5822295|NCT02563548|20108054|P4|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|1
5822296|NCT02563548|20108055|P3|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|2
5822297|NCT02563548|20108056|P2|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0
5822298|NCT02563548|20108057|P1|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0
5822299|NCT02563548|20108052|P6|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0
5822300|NCT02563548|20108053|P5|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0
5822301|NCT02563548|20108054|P4|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0
5822302|NCT02563548|20108055|P3|Dose Escalation (Up to 46 Weeks)|Clinical Progression|3
5822303|NCT02563548|20108056|P2|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0
5822304|NCT02563548|20108057|P1|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0
5822305|NCT02563548|20108052|P6|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0
5822306|NCT02563548|20108053|P5|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0
5822307|NCT02563548|20108054|P4|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0
5822308|NCT02563548|20108055|P3|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2
5822309|NCT02563548|20108056|P2|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2
5822310|NCT02563548|20108057|P1|Dose Escalation (Up to 46 Weeks)|Radiological Progression|1
5822311|NCT02563548|20108052|P6|Dose Escalation (Up to 46 Weeks)|Adverse Event|0
5822312|NCT02563548|20108053|P5|Dose Escalation (Up to 46 Weeks)|Adverse Event|0
5822313|NCT02563548|20108054|P4|Dose Escalation (Up to 46 Weeks)|Adverse Event|1
5822314|NCT02563548|20108055|P3|Dose Escalation (Up to 46 Weeks)|Adverse Event|0
5822315|NCT02563548|20108056|P2|Dose Escalation (Up to 46 Weeks)|Adverse Event|0
5822316|NCT02563548|20108057|P1|Dose Escalation (Up to 46 Weeks)|Adverse Event|2
5822317|NCT02563106|20108166|P2|Overall Study|Other reason - not specified|1
5822318|NCT02563106|20108167|P1|Overall Study|Other reason - not specified|2
5822319|NCT02563106|20108166|P2|Overall Study|Physician Decision|1
5822320|NCT02563106|20108167|P1|Overall Study|Physician Decision|3
5822321|NCT02563106|20108166|P2|Overall Study|Lost to Follow-up|2
5822322|NCT02563106|20108167|P1|Overall Study|Lost to Follow-up|3
5822323|NCT02563106|20108166|P2|Overall Study|Use of non-permitted concurrent therapy|2
5822324|NCT02563106|20108167|P1|Overall Study|Use of non-permitted concurrent therapy|1
5822325|NCT02563106|20108166|P2|Overall Study|Protocol Violation|0
5822326|NCT02563106|20108167|P1|Overall Study|Protocol Violation|1
5822327|NCT02563106|20108166|P2|Overall Study|Adverse Event|15
5822328|NCT02563106|20108167|P1|Overall Study|Adverse Event|17
5822329|NCT02563106|20108166|P2|Overall Study|Withdrawal by Subject|8
5822330|NCT02563106|20108167|P1|Overall Study|Withdrawal by Subject|7
5822331|NCT02563028|20108206|P1|Overall Study|Unable to elicit VEP post induction|1
5822332|NCT02563028|20108206|P1|Overall Study|Lack of equipment|1
5822333|NCT02562482|20108304|P2|Overall Study|Illness/Injury unrelated to product|1
5822334|NCT02562482|20108305|P1|Overall Study|Illness/Injury unrelated to product|0
5822335|NCT02562482|20108304|P2|Overall Study|Physician Decision|3
5822336|NCT02562482|20108305|P1|Overall Study|Physician Decision|1
5822337|NCT02562482|20108304|P2|Overall Study|Withdrawal by Subject|3
5822338|NCT02562482|20108305|P1|Overall Study|Withdrawal by Subject|5
5822339|NCT02562482|20108304|P2|Overall Study|Moved from area|3
5822340|NCT02562482|20108305|P1|Overall Study|Moved from area|2
5822341|NCT02562482|20108304|P2|Overall Study|Lost to Follow-up|6
5822342|NCT02562482|20108305|P1|Overall Study|Lost to Follow-up|9
5822343|NCT02562482|20108304|P2|Overall Study|Enrolled, but did not receive product|0
5822344|NCT02562482|20108305|P1|Overall Study|Enrolled, but did not receive product|4
5822345|NCT02561832|20108340|P2|Overall Study|Disease progression|3
5822346|NCT02561832|20108341|P1|Overall Study|Disease progression|3
5822347|NCT02561832|20108340|P2|Overall Study|Adverse Event|0
5822348|NCT02561832|20108341|P1|Overall Study|Adverse Event|3
5822349|NCT02561832|20108340|P2|Overall Study|Withdrawal by Subject|1
5822350|NCT02561832|20108341|P1|Overall Study|Withdrawal by Subject|1
5822351|NCT02561806|20108349|P2|Post-Treatment Follow-up|Withdrawal by Subject|0
5822352|NCT02561806|20108350|P1|Post-Treatment Follow-up|Withdrawal by Subject|1
5822353|NCT02561806|20108349|P2|Post-Treatment Follow-up|Lost to Follow-up|1
5822354|NCT02561806|20108350|P1|Post-Treatment Follow-up|Lost to Follow-up|1
5822355|NCT02561806|20108349|P2|Maintenance Period|Site staff became unblinded|1
5822356|NCT02561806|20108350|P1|Maintenance Period|Site staff became unblinded|0
5822357|NCT02561806|20108349|P2|Maintenance Period|Withdrawal by Subject|3
5822358|NCT02561806|20108350|P1|Maintenance Period|Withdrawal by Subject|5
5822359|NCT02561806|20108349|P2|Maintenance Period|Protocol Violation|0
5822360|NCT02561806|20108350|P1|Maintenance Period|Protocol Violation|1
5822361|NCT02561806|20108349|P2|Maintenance Period|Lost to Follow-up|2
5822362|NCT02561806|20108350|P1|Maintenance Period|Lost to Follow-up|2
5822363|NCT02561806|20108349|P2|Maintenance Period|Lack of Efficacy|1
5822364|NCT02561806|20108350|P1|Maintenance Period|Lack of Efficacy|3
5822365|NCT02561806|20108349|P2|Maintenance Period|Adverse Event|1
5822366|NCT02561806|20108350|P1|Maintenance Period|Adverse Event|2
5822367|NCT02561806|20108349|P2|Induction Period|Randomized but not treated|1
5822368|NCT02561806|20108350|P1|Induction Period|Randomized but not treated|0
5822369|NCT02561806|20108349|P2|Induction Period|Site staff became unblinded|0
5822370|NCT02561806|20108350|P1|Induction Period|Site staff became unblinded|1
5822371|NCT02561806|20108349|P2|Induction Period|Withdrawal by Subject|2
5822372|NCT02561806|20108350|P1|Induction Period|Withdrawal by Subject|0
5822373|NCT02561806|20108349|P2|Induction Period|Lack of Efficacy|0
5822374|NCT02561806|20108350|P1|Induction Period|Lack of Efficacy|1
5822375|NCT02561806|20108349|P2|Induction Period|Adverse Event|2
5822376|NCT02561806|20108350|P1|Induction Period|Adverse Event|0
5822377|NCT02561572|20108454|P2|Overall Study|Protocol Violation|1
5822378|NCT02561572|20108455|P1|Overall Study|Protocol Violation|0
5822379|NCT02561572|20108454|P2|Overall Study|Inadequate time before surgery|1
5822380|NCT02561572|20108455|P1|Overall Study|Inadequate time before surgery|2
5822381|NCT02561195|20108609|P6|Overall Study|Randomized but not treated|0
5822382|NCT02561195|20108610|P5|Overall Study|Randomized but not treated|0
5822383|NCT02561195|20108611|P4|Overall Study|Randomized but not treated|0
5822384|NCT02561195|20108612|P3|Overall Study|Randomized but not treated|0
5822385|NCT02561195|20108613|P2|Overall Study|Randomized but not treated|0
5822386|NCT02561195|20108614|P1|Overall Study|Randomized but not treated|1
5822387|NCT02561195|20108609|P6|Overall Study|Withdrawal by Subject|0
5822388|NCT02561195|20108610|P5|Overall Study|Withdrawal by Subject|6
5822389|NCT02561195|20108611|P4|Overall Study|Withdrawal by Subject|2
5822390|NCT02561195|20108612|P3|Overall Study|Withdrawal by Subject|4
5822391|NCT02561195|20108613|P2|Overall Study|Withdrawal by Subject|4
5822392|NCT02561195|20108614|P1|Overall Study|Withdrawal by Subject|3
5822393|NCT02561195|20108609|P6|Overall Study|Death|0
5822394|NCT02561195|20108610|P5|Overall Study|Death|0
5822395|NCT02561195|20108611|P4|Overall Study|Death|2
5822396|NCT02561195|20108612|P3|Overall Study|Death|0
5822397|NCT02561195|20108613|P2|Overall Study|Death|1
5822398|NCT02561195|20108614|P1|Overall Study|Death|2
5822399|NCT02561195|20108609|P6|Overall Study|Protocol Violation|2
5822400|NCT02561195|20108610|P5|Overall Study|Protocol Violation|5
5822401|NCT02561195|20108611|P4|Overall Study|Protocol Violation|2
5822402|NCT02561195|20108612|P3|Overall Study|Protocol Violation|1
5822403|NCT02561195|20108613|P2|Overall Study|Protocol Violation|0
5822404|NCT02561195|20108614|P1|Overall Study|Protocol Violation|1
5822405|NCT02561195|20108609|P6|Overall Study|Other|1
5822406|NCT02561195|20108610|P5|Overall Study|Other|5
5822407|NCT02561195|20108611|P4|Overall Study|Other|7
5822408|NCT02561195|20108612|P3|Overall Study|Other|1
5822409|NCT02561195|20108613|P2|Overall Study|Other|3
5822410|NCT02561195|20108614|P1|Overall Study|Other|7
5822411|NCT02561195|20108609|P6|Overall Study|No longer willing to participate|3
5822412|NCT02561195|20108610|P5|Overall Study|No longer willing to participate|1
5822413|NCT02561195|20108611|P4|Overall Study|No longer willing to participate|4
5822414|NCT02561195|20108612|P3|Overall Study|No longer willing to participate|0
5822415|NCT02561195|20108613|P2|Overall Study|No longer willing to participate|4
5822416|NCT02561195|20108614|P1|Overall Study|No longer willing to participate|2
5822417|NCT02561195|20108609|P6|Overall Study|No longer meets eligibility criteria|1
5822418|NCT02561195|20108610|P5|Overall Study|No longer meets eligibility criteria|4
5822419|NCT02561195|20108611|P4|Overall Study|No longer meets eligibility criteria|4
5822420|NCT02561195|20108612|P3|Overall Study|No longer meets eligibility criteria|0
5822421|NCT02561195|20108613|P2|Overall Study|No longer meets eligibility criteria|1
5822422|NCT02561195|20108614|P1|Overall Study|No longer meets eligibility criteria|0
5822423|NCT02561195|20108609|P6|Overall Study|Lost to Follow-up|3
5822424|NCT02561195|20108610|P5|Overall Study|Lost to Follow-up|3
5822425|NCT02561195|20108611|P4|Overall Study|Lost to Follow-up|2
5822426|NCT02561195|20108612|P3|Overall Study|Lost to Follow-up|0
5822427|NCT02561195|20108613|P2|Overall Study|Lost to Follow-up|4
5822428|NCT02561195|20108614|P1|Overall Study|Lost to Follow-up|3
5822429|NCT02561195|20108609|P6|Overall Study|Adverse Event|0
5822430|NCT02561195|20108610|P5|Overall Study|Adverse Event|4
5822431|NCT02561195|20108611|P4|Overall Study|Adverse Event|3
5822432|NCT02561195|20108612|P3|Overall Study|Adverse Event|0
5822433|NCT02561195|20108613|P2|Overall Study|Adverse Event|5
5822434|NCT02561195|20108614|P1|Overall Study|Adverse Event|4
5822435|NCT02561156|20108775|P13|Part 2|Adverse Event|0
5822436|NCT02561156|20108776|P12|Part 2|Adverse Event|1
5822437|NCT02561156|20108777|P11|Part 2|Adverse Event|0
5822438|NCT02561156|20108778|P10|Part 2|Adverse Event|0
5822439|NCT02561156|20108779|P9|Part 2|Adverse Event|0
5822440|NCT02561156|20108780|P8|Part 2|Adverse Event|0
5822441|NCT02561156|20108781|P7|Part 2|Adverse Event|0
5822442|NCT02561156|20108782|P6|Part 2|Adverse Event|0
5822443|NCT02561156|20108783|P5|Part 2|Adverse Event|0
5822444|NCT02561156|20108784|P4|Part 2|Adverse Event|0
5822445|NCT02561156|20108785|P3|Part 2|Adverse Event|0
5822446|NCT02561156|20108786|P2|Part 2|Adverse Event|0
5822447|NCT02561156|20108787|P1|Part 2|Adverse Event|0
5822448|NCT02561078|20108984|P2|Overall Study|Withdrawal by Subject|10
5822449|NCT02561078|20108985|P1|Overall Study|Withdrawal by Subject|13
5822450|NCT02561078|20108984|P2|Overall Study|Physician Decision|3
5822451|NCT02561078|20108985|P1|Overall Study|Physician Decision|2
5822452|NCT02561078|20108984|P2|Overall Study|Non-Compliance with Study Drug|3
5822453|NCT02561078|20108985|P1|Overall Study|Non-Compliance with Study Drug|6
5822454|NCT02561078|20108984|P2|Overall Study|Lost to Follow-up|6
5822455|NCT02561078|20108985|P1|Overall Study|Lost to Follow-up|2
5822456|NCT02561078|20108984|P2|Overall Study|Death|1
5822457|NCT02561078|20108985|P1|Overall Study|Death|2
5822458|NCT02561078|20108984|P2|Overall Study|Adverse Event|2
5822459|NCT02561078|20108985|P1|Overall Study|Adverse Event|5
5822460|NCT02560558|20109110|P2|Overall Study|Withdrawal by Subject|0
5822461|NCT02560558|20109111|P1|Overall Study|Withdrawal by Subject|3
5822462|NCT02560558|20109110|P2|Overall Study|Protocol Violation|0
5822463|NCT02560558|20109111|P1|Overall Study|Protocol Violation|3
5822464|NCT02560558|20109110|P2|Overall Study|Lost to Follow-up|4
5822465|NCT02560558|20109111|P1|Overall Study|Lost to Follow-up|0
5822466|NCT02560558|20109110|P2|Overall Study|Death|2
5822467|NCT02560558|20109111|P1|Overall Study|Death|0
5822468|NCT02560558|20109110|P2|Overall Study|Adverse Event|0
5822469|NCT02560558|20109111|P1|Overall Study|Adverse Event|1
5822470|NCT02560389|20109163|P3|Overall Study|Tested positive for illicit substance|0
5822471|NCT02560389|20109164|P2|Overall Study|Tested positive for illicit substance|1
5822472|NCT02560389|20109165|P1|Overall Study|Tested positive for illicit substance|0
5822473|NCT02560389|20109163|P3|Overall Study|Lost to Follow-up|2
5822474|NCT02560389|20109164|P2|Overall Study|Lost to Follow-up|2
5822475|NCT02560389|20109165|P1|Overall Study|Lost to Follow-up|1
5822476|NCT02560025|20109263|P1|Overall Study|Ineligible after consent/ registration|3
5822477|NCT02560012|20109272|P1|Overall Study|Study Terminated|2
5822478|NCT02559895|20109280|P4|Overall Study|Other|3
5822479|NCT02559895|20109281|P3|Overall Study|Other|3
5822480|NCT02559895|20109282|P2|Overall Study|Other|5
5822481|NCT02559895|20109283|P1|Overall Study|Other|1
5822482|NCT02559895|20109280|P4|Overall Study|Study Burden|22
5822483|NCT02559895|20109281|P3|Overall Study|Study Burden|12
5822484|NCT02559895|20109282|P2|Overall Study|Study Burden|16
5822485|NCT02559895|20109283|P1|Overall Study|Study Burden|10
5822486|NCT02559895|20109280|P4|Overall Study|Withdrawal by Subject|9
5822487|NCT02559895|20109281|P3|Overall Study|Withdrawal by Subject|20
5822488|NCT02559895|20109282|P2|Overall Study|Withdrawal by Subject|9
5822489|NCT02559895|20109283|P1|Overall Study|Withdrawal by Subject|16
5822490|NCT02559895|20109280|P4|Overall Study|Physician Decision|0
5822491|NCT02559895|20109281|P3|Overall Study|Physician Decision|3
5822492|NCT02559895|20109282|P2|Overall Study|Physician Decision|1
5822493|NCT02559895|20109283|P1|Overall Study|Physician Decision|1
5822494|NCT02559895|20109280|P4|Overall Study|Lost to Follow-up|17
5822495|NCT02559895|20109281|P3|Overall Study|Lost to Follow-up|12
5822496|NCT02559895|20109282|P2|Overall Study|Lost to Follow-up|16
5822497|NCT02559895|20109283|P1|Overall Study|Lost to Follow-up|22
5822498|NCT02559895|20109280|P4|Overall Study|Lack of Efficacy|8
5822499|NCT02559895|20109281|P3|Overall Study|Lack of Efficacy|2
5822500|NCT02559895|20109282|P2|Overall Study|Lack of Efficacy|3
5822501|NCT02559895|20109283|P1|Overall Study|Lack of Efficacy|2
5822502|NCT02559895|20109280|P4|Overall Study|Adverse Event|1
5822503|NCT02559895|20109281|P3|Overall Study|Adverse Event|2
5822504|NCT02559895|20109282|P2|Overall Study|Adverse Event|3
5822505|NCT02559895|20109283|P1|Overall Study|Adverse Event|3
5822506|NCT02559817|20109378|P5|Treatment Period|Protocol Violation|0
5822507|NCT02559817|20109379|P4|Treatment Period|Protocol Violation|1
5822508|NCT02559817|20109380|P3|Treatment Period|Protocol Violation|0
5822509|NCT02559817|20109381|P2|Treatment Period|Protocol Violation|0
5822510|NCT02559817|20109382|P1|Treatment Period|Protocol Violation|0
5822511|NCT02559817|20109378|P5|Treatment Period|Non-Compliance With Study Drug|0
5822512|NCT02559817|20109379|P4|Treatment Period|Non-Compliance With Study Drug|0
5822513|NCT02559817|20109380|P3|Treatment Period|Non-Compliance With Study Drug|1
5822514|NCT02559817|20109381|P2|Treatment Period|Non-Compliance With Study Drug|0
5822515|NCT02559817|20109382|P1|Treatment Period|Non-Compliance With Study Drug|0
5822516|NCT02559817|20109378|P5|Treatment Period|Lost to Follow-up|0
5822517|NCT02559817|20109379|P4|Treatment Period|Lost to Follow-up|1
5822518|NCT02559817|20109380|P3|Treatment Period|Lost to Follow-up|0
5822519|NCT02559817|20109381|P2|Treatment Period|Lost to Follow-up|1
5822520|NCT02559817|20109382|P1|Treatment Period|Lost to Follow-up|0
5822521|NCT02559817|20109378|P5|Treatment Period|Lack of Efficacy|0
5822522|NCT02559817|20109379|P4|Treatment Period|Lack of Efficacy|0
5822523|NCT02559817|20109380|P3|Treatment Period|Lack of Efficacy|0
5822524|NCT02559817|20109381|P2|Treatment Period|Lack of Efficacy|1
5822525|NCT02559817|20109382|P1|Treatment Period|Lack of Efficacy|0
5822526|NCT02559817|20109378|P5|Treatment Period|Adverse Event|0
5822527|NCT02559817|20109379|P4|Treatment Period|Adverse Event|0
5822528|NCT02559817|20109380|P3|Treatment Period|Adverse Event|1
5822529|NCT02559817|20109381|P2|Treatment Period|Adverse Event|0
5822530|NCT02559817|20109382|P1|Treatment Period|Adverse Event|1
5822531|NCT02559713|20109419|P1|Overall Study|Pretreatment Event/ Adverse Event|1
5822535|NCT02559622|20109442|P4|Overall Study|Patient/guardian decision|1
5822536|NCT02559622|20109443|P3|Overall Study|Patient/guardian decision|0
5822537|NCT02559622|20109444|P2|Overall Study|Patient/guardian decision|2
5822538|NCT02559622|20109445|P1|Overall Study|Patient/guardian decision|1
5822539|NCT02559622|20109442|P4|Overall Study|Adverse Event|2
5822540|NCT02559622|20109443|P3|Overall Study|Adverse Event|2
5822541|NCT02559622|20109444|P2|Overall Study|Adverse Event|2
5822542|NCT02559622|20109445|P1|Overall Study|Adverse Event|0
5822543|NCT02559622|20109442|P4|Overall Study|Progressive disease|0
5822544|NCT02559622|20109443|P3|Overall Study|Progressive disease|0
5822545|NCT02559622|20109444|P2|Overall Study|Progressive disease|1
5822546|NCT02559622|20109445|P1|Overall Study|Progressive disease|0
5822547|NCT02559570|20109529|P5|Overall Study|Other Miscellaneous Reasons|0
5822548|NCT02559570|20109530|P4|Overall Study|Other Miscellaneous Reasons|0
5822549|NCT02559570|20109531|P3|Overall Study|Other Miscellaneous Reasons|1
5822550|NCT02559570|20109532|P2|Overall Study|Other Miscellaneous Reasons|0
5822551|NCT02559570|20109533|P1|Overall Study|Other Miscellaneous Reasons|0
5822552|NCT02559570|20109529|P5|Overall Study|Protocol Violation|1
5822553|NCT02559570|20109530|P4|Overall Study|Protocol Violation|0
5822554|NCT02559570|20109531|P3|Overall Study|Protocol Violation|0
5822555|NCT02559570|20109532|P2|Overall Study|Protocol Violation|0
5822556|NCT02559570|20109533|P1|Overall Study|Protocol Violation|1
5822557|NCT02559570|20109529|P5|Overall Study|Lost to Follow-up|0
5822558|NCT02559570|20109530|P4|Overall Study|Lost to Follow-up|0
5822559|NCT02559570|20109531|P3|Overall Study|Lost to Follow-up|0
5822560|NCT02559570|20109532|P2|Overall Study|Lost to Follow-up|0
5822561|NCT02559570|20109533|P1|Overall Study|Lost to Follow-up|1
5822562|NCT02559570|20109529|P5|Overall Study|Withdrawal of Consent|1
5822563|NCT02559570|20109530|P4|Overall Study|Withdrawal of Consent|2
5822564|NCT02559570|20109531|P3|Overall Study|Withdrawal of Consent|1
5822565|NCT02559570|20109532|P2|Overall Study|Withdrawal of Consent|0
5822566|NCT02559570|20109533|P1|Overall Study|Withdrawal of Consent|0
5822567|NCT02559570|20109529|P5|Overall Study|Adverse Event|0
5822568|NCT02559570|20109530|P4|Overall Study|Adverse Event|1
5822569|NCT02559570|20109531|P3|Overall Study|Adverse Event|0
5822570|NCT02559570|20109532|P2|Overall Study|Adverse Event|2
5822571|NCT02559570|20109533|P1|Overall Study|Adverse Event|0
5822572|NCT02559414|20109571|P3|Overall Study|Other|1
5822573|NCT02559414|20109572|P2|Overall Study|Other|1
5822574|NCT02559414|20109573|P1|Overall Study|Other|0
5822575|NCT02559414|20109571|P3|Overall Study|Withdrawal by Subject|1
5822576|NCT02559414|20109572|P2|Overall Study|Withdrawal by Subject|0
5822577|NCT02559414|20109573|P1|Overall Study|Withdrawal by Subject|1
5822578|NCT02559414|20109571|P3|Overall Study|Lost to Follow-up|0
5822579|NCT02559414|20109572|P2|Overall Study|Lost to Follow-up|1
5822580|NCT02559414|20109573|P1|Overall Study|Lost to Follow-up|0
5822581|NCT02559310|20109613|P2|Overall Study|Randomized but not treated|2
5822582|NCT02559310|20109614|P1|Overall Study|Randomized but not treated|3
5822583|NCT02559310|20109613|P2|Overall Study|Sponsor Decision|1
5822584|NCT02559310|20109614|P1|Overall Study|Sponsor Decision|0
5822585|NCT02559310|20109613|P2|Overall Study|Withdrawal by Subject|9
5822586|NCT02559310|20109614|P1|Overall Study|Withdrawal by Subject|13
5822587|NCT02559310|20109613|P2|Overall Study|Physician Decision|1
5822588|NCT02559310|20109614|P1|Overall Study|Physician Decision|2
5822589|NCT02559310|20109613|P2|Overall Study|Lost to Follow-up|3
5822590|NCT02559310|20109614|P1|Overall Study|Lost to Follow-up|5
5822591|NCT02559310|20109613|P2|Overall Study|Death|3
5822592|NCT02559310|20109614|P1|Overall Study|Death|4
5822593|NCT02559206|20109632|P8|Overall Study|Other Not Specified|0
5822594|NCT02559206|20109633|P7|Overall Study|Other Not Specified|0
5822595|NCT02559206|20109634|P6|Overall Study|Other Not Specified|0
5822596|NCT02559206|20109635|P5|Overall Study|Other Not Specified|0
5822597|NCT02559206|20109636|P4|Overall Study|Other Not Specified|1
5822598|NCT02559206|20109637|P3|Overall Study|Other Not Specified|0
5822599|NCT02559206|20109638|P2|Overall Study|Other Not Specified|0
5822600|NCT02559206|20109639|P1|Overall Study|Other Not Specified|0
5822601|NCT02559206|20109632|P8|Overall Study|Lack of Efficacy|3
5822602|NCT02559206|20109633|P7|Overall Study|Lack of Efficacy|3
5822603|NCT02559206|20109634|P6|Overall Study|Lack of Efficacy|3
5822604|NCT02559206|20109635|P5|Overall Study|Lack of Efficacy|2
5822605|NCT02559206|20109636|P4|Overall Study|Lack of Efficacy|2
5822606|NCT02559206|20109637|P3|Overall Study|Lack of Efficacy|3
5822607|NCT02559206|20109638|P2|Overall Study|Lack of Efficacy|0
5822608|NCT02559206|20109639|P1|Overall Study|Lack of Efficacy|1
5822609|NCT02559206|20109632|P8|Overall Study|Lost to Follow-up|4
5822610|NCT02559206|20109633|P7|Overall Study|Lost to Follow-up|1
5822611|NCT02559206|20109634|P6|Overall Study|Lost to Follow-up|5
5822612|NCT02559206|20109635|P5|Overall Study|Lost to Follow-up|2
5822613|NCT02559206|20109636|P4|Overall Study|Lost to Follow-up|3
5822614|NCT02559206|20109637|P3|Overall Study|Lost to Follow-up|3
5822615|NCT02559206|20109638|P2|Overall Study|Lost to Follow-up|5
5822616|NCT02559206|20109639|P1|Overall Study|Lost to Follow-up|3
5822617|NCT02559206|20109632|P8|Overall Study|Withdrawal by Subject|2
5822618|NCT02559206|20109633|P7|Overall Study|Withdrawal by Subject|1
5822619|NCT02559206|20109634|P6|Overall Study|Withdrawal by Subject|4
5822620|NCT02559206|20109635|P5|Overall Study|Withdrawal by Subject|5
5822621|NCT02559206|20109636|P4|Overall Study|Withdrawal by Subject|3
5822622|NCT02559206|20109637|P3|Overall Study|Withdrawal by Subject|1
5822623|NCT02559206|20109638|P2|Overall Study|Withdrawal by Subject|3
5822624|NCT02559206|20109639|P1|Overall Study|Withdrawal by Subject|3
5822625|NCT02559206|20109632|P8|Overall Study|Protocol Violation|0
5822626|NCT02559206|20109633|P7|Overall Study|Protocol Violation|0
5822627|NCT02559206|20109634|P6|Overall Study|Protocol Violation|2
5822628|NCT02559206|20109635|P5|Overall Study|Protocol Violation|0
5822629|NCT02559206|20109636|P4|Overall Study|Protocol Violation|0
5822630|NCT02559206|20109637|P3|Overall Study|Protocol Violation|1
5822631|NCT02559206|20109638|P2|Overall Study|Protocol Violation|0
5822632|NCT02559206|20109639|P1|Overall Study|Protocol Violation|1
5822633|NCT02559206|20109632|P8|Overall Study|Adverse Event|0
5822634|NCT02559206|20109633|P7|Overall Study|Adverse Event|1
5822635|NCT02559206|20109634|P6|Overall Study|Adverse Event|0
5822636|NCT02559206|20109635|P5|Overall Study|Adverse Event|3
5822637|NCT02559206|20109636|P4|Overall Study|Adverse Event|5
5822638|NCT02559206|20109637|P3|Overall Study|Adverse Event|1
5822639|NCT02559206|20109638|P2|Overall Study|Adverse Event|4
5822640|NCT02559206|20109639|P1|Overall Study|Adverse Event|0
5822641|NCT02558894|20109681|P2|Overall Study|Closure of Part A|1
5822642|NCT02558894|20109682|P1|Overall Study|Closure of Part A|2
5822643|NCT02558894|20109681|P2|Overall Study|Withdrawal by Subject|1
5822644|NCT02558894|20109682|P1|Overall Study|Withdrawal by Subject|2
5822645|NCT02558894|20109681|P2|Overall Study|Death; any cause, entire study duration|31
5822646|NCT02558894|20109682|P1|Overall Study|Death; any cause, entire study duration|28
5822647|NCT02558790|20109743|P1|Overall Study|Screen Fail|3
5822648|NCT02558790|20109743|P1|Overall Study|Withdrawal by Subject|1
5822649|NCT02558790|20109743|P1|Overall Study|Physician Decision|1
5822650|NCT02558790|20109743|P1|Overall Study|Lost to Follow-up|2
5822651|NCT02558400|20109750|P3|Overall Study|Ineligible for the study|0
5822652|NCT02558400|20109751|P2|Overall Study|Ineligible for the study|2
5822653|NCT02558400|20109752|P1|Overall Study|Ineligible for the study|0
5822654|NCT02558400|20109750|P3|Overall Study|Death|0
5822655|NCT02558400|20109751|P2|Overall Study|Death|1
5822656|NCT02558400|20109752|P1|Overall Study|Death|0
5822657|NCT02558400|20109750|P3|Overall Study|Protocol Violation|8
5822658|NCT02558400|20109751|P2|Overall Study|Protocol Violation|3
5822659|NCT02558400|20109752|P1|Overall Study|Protocol Violation|6
5822660|NCT02558400|20109750|P3|Overall Study|Physician Decision|0
5822661|NCT02558400|20109751|P2|Overall Study|Physician Decision|2
5822662|NCT02558400|20109752|P1|Overall Study|Physician Decision|2
5822663|NCT02558400|20109750|P3|Overall Study|Disallowed Concurrent Medication|5
5822664|NCT02558400|20109751|P2|Overall Study|Disallowed Concurrent Medication|7
5822665|NCT02558400|20109752|P1|Overall Study|Disallowed Concurrent Medication|6
5822666|NCT02558400|20109750|P3|Overall Study|Lack of Efficacy|1
5822667|NCT02558400|20109751|P2|Overall Study|Lack of Efficacy|13
5822668|NCT02558400|20109752|P1|Overall Study|Lack of Efficacy|0
5822669|NCT02558400|20109750|P3|Overall Study|Lost to Follow-up|4
5822670|NCT02558400|20109751|P2|Overall Study|Lost to Follow-up|5
5822671|NCT02558400|20109752|P1|Overall Study|Lost to Follow-up|5
5822672|NCT02558400|20109750|P3|Overall Study|Non-Compliant|3
5822673|NCT02558400|20109751|P2|Overall Study|Non-Compliant|1
5822674|NCT02558400|20109752|P1|Overall Study|Non-Compliant|0
5822675|NCT02558400|20109750|P3|Overall Study|Withdrawal by Subject|8
5822676|NCT02558400|20109751|P2|Overall Study|Withdrawal by Subject|9
5822677|NCT02558400|20109752|P1|Overall Study|Withdrawal by Subject|13
5822678|NCT02558400|20109750|P3|Overall Study|Adverse Event|4
5822679|NCT02558400|20109751|P2|Overall Study|Adverse Event|53
5822680|NCT02558400|20109752|P1|Overall Study|Adverse Event|47
5822681|NCT02558231|20109776|P2|Overall Study|Ongoing|104
5822682|NCT02558231|20109777|P1|Overall Study|Ongoing|109
5822683|NCT02558231|20109776|P2|Overall Study|Sponsor Decision|1
5822684|NCT02558231|20109777|P1|Overall Study|Sponsor Decision|0
5822685|NCT02558231|20109776|P2|Overall Study|Physician Decision|5
5822686|NCT02558231|20109777|P1|Overall Study|Physician Decision|6
5822687|NCT02558231|20109776|P2|Overall Study|Withdrawal by Subject|3
5822688|NCT02558231|20109777|P1|Overall Study|Withdrawal by Subject|4
5822689|NCT02558231|20109776|P2|Overall Study|Lost to Follow-up|2
5822690|NCT02558231|20109777|P1|Overall Study|Lost to Follow-up|2
5822691|NCT02558231|20109776|P2|Overall Study|Death|9
5822692|NCT02558231|20109777|P1|Overall Study|Death|2
5822693|NCT02557646|20109868|P1|Overall Study|Other|14
5822694|NCT02557646|20109868|P1|Overall Study|Lost to Follow-up|17
5822695|NCT02557646|20109868|P1|Overall Study|Withdrawal by Subject|18
5822696|NCT02557646|20109868|P1|Overall Study|Lack of Efficacy|186
5822697|NCT02557646|20109868|P1|Overall Study|Death|1
5822698|NCT02557646|20109868|P1|Overall Study|Adverse Event|40
5822699|NCT02557516|20109895|P4|Overall Study|Sponsor decision|8
5822700|NCT02557516|20109896|P3|Overall Study|Sponsor decision|2
5822701|NCT02557516|20109897|P2|Overall Study|Sponsor decision|1
5822702|NCT02557516|20109898|P1|Overall Study|Sponsor decision|0
5822703|NCT02557516|20109895|P4|Overall Study|Physician Decision|0
5822704|NCT02557516|20109896|P3|Overall Study|Physician Decision|0
5822705|NCT02557516|20109897|P2|Overall Study|Physician Decision|2
5822706|NCT02557516|20109898|P1|Overall Study|Physician Decision|0
5822707|NCT02557516|20109895|P4|Overall Study|Disease progression|0
5822708|NCT02557516|20109896|P3|Overall Study|Disease progression|0
5822709|NCT02557516|20109897|P2|Overall Study|Disease progression|2
5822710|NCT02557516|20109898|P1|Overall Study|Disease progression|0
5822711|NCT02557516|20109895|P4|Overall Study|Adverse Event|1
5822712|NCT02557516|20109896|P3|Overall Study|Adverse Event|2
5822713|NCT02557516|20109897|P2|Overall Study|Adverse Event|0
5822714|NCT02557516|20109898|P1|Overall Study|Adverse Event|1
5822715|NCT02557399|20109919|P2|Overall Study|Withdrawal by Subject|1
5822716|NCT02557399|20109920|P1|Overall Study|Withdrawal by Subject|1
5822717|NCT02557399|20109919|P2|Overall Study|Protocol-defined stopping criteria|1
5822718|NCT02557399|20109920|P1|Overall Study|Protocol-defined stopping criteria|0
5822719|NCT02557399|20109919|P2|Overall Study|Protocol Violation|1
5822720|NCT02557399|20109920|P1|Overall Study|Protocol Violation|0
5822721|NCT02557399|20109919|P2|Overall Study|Adverse Event|5
5822722|NCT02557399|20109920|P1|Overall Study|Adverse Event|6
5822723|NCT02557100|20109955|P3|Cumulative Abatacept Period|Request to Discontinue|1
5822724|NCT02557100|20109956|P2|Cumulative Abatacept Period|Request to Discontinue|0
5822725|NCT02557100|20109957|P1|Cumulative Abatacept Period|Request to Discontinue|0
5822726|NCT02557100|20109955|P3|Cumulative Abatacept Period|Lost to Follow-up|2
5822727|NCT02557100|20109956|P2|Cumulative Abatacept Period|Lost to Follow-up|0
5822728|NCT02557100|20109957|P1|Cumulative Abatacept Period|Lost to Follow-up|0
5822729|NCT02557100|20109955|P3|Cumulative Abatacept Period|Other Reasons|1
5822730|NCT02557100|20109956|P2|Cumulative Abatacept Period|Other Reasons|0
5822731|NCT02557100|20109957|P1|Cumulative Abatacept Period|Other Reasons|0
5822732|NCT02557100|20109955|P3|Transition to Open Label|Entered Cumulative Abatacept Period|0
5822733|NCT02557100|20109956|P2|Transition to Open Label|Entered Cumulative Abatacept Period|36
5822734|NCT02557100|20109957|P1|Transition to Open Label|Entered Cumulative Abatacept Period|40
5822735|NCT02557100|20109955|P3|Single Blind Treatment Period|Adverse Event|0
5822736|NCT02557100|20109956|P2|Single Blind Treatment Period|Adverse Event|1
5822737|NCT02557100|20109957|P1|Single Blind Treatment Period|Adverse Event|0
5822738|NCT02557100|20109955|P3|Single Blind Treatment Period|Request to Discontinue|0
5822739|NCT02557100|20109956|P2|Single Blind Treatment Period|Request to Discontinue|1
5822740|NCT02557100|20109957|P1|Single Blind Treatment Period|Request to Discontinue|0
5822741|NCT02557100|20109955|P3|Single Blind Treatment Period|Death|0
5822742|NCT02557100|20109956|P2|Single Blind Treatment Period|Death|1
5822743|NCT02557100|20109957|P1|Single Blind Treatment Period|Death|0
5822744|NCT02557100|20109955|P3|Single Blind Treatment Period|Lost to Follow-up|0
5822745|NCT02557100|20109956|P2|Single Blind Treatment Period|Lost to Follow-up|1
5822746|NCT02557100|20109957|P1|Single Blind Treatment Period|Lost to Follow-up|0
5822747|NCT02556918|20110010|P2|Overall Study|Withdrawal by Subject|4
5822748|NCT02556918|20110011|P1|Overall Study|Withdrawal by Subject|4
5822749|NCT02556918|20110010|P2|Overall Study|Protocol Violation|6
5822750|NCT02556918|20110011|P1|Overall Study|Protocol Violation|5
5822751|NCT02556801|20110071|P4|Overall Study|Personal reasons patient|1
5822752|NCT02556801|20110072|P3|Overall Study|Personal reasons patient|0
5822753|NCT02556801|20110073|P2|Overall Study|Personal reasons patient|0
5822754|NCT02556801|20110074|P1|Overall Study|Personal reasons patient|0
5822755|NCT02556801|20110071|P4|Overall Study|Pregnancy|0
5822756|NCT02556801|20110072|P3|Overall Study|Pregnancy|0
5822757|NCT02556801|20110073|P2|Overall Study|Pregnancy|1
5822758|NCT02556801|20110074|P1|Overall Study|Pregnancy|0
5822759|NCT02556801|20110071|P4|Overall Study|Adverse Event|3
5822760|NCT02556801|20110072|P3|Overall Study|Adverse Event|0
5822761|NCT02556801|20110073|P2|Overall Study|Adverse Event|2
5822762|NCT02556801|20110074|P1|Overall Study|Adverse Event|0
5822763|NCT02556801|20110071|P4|Overall Study|Protocol Violation|1
5822764|NCT02556801|20110072|P3|Overall Study|Protocol Violation|1
5822765|NCT02556801|20110073|P2|Overall Study|Protocol Violation|3
5822766|NCT02556801|20110074|P1|Overall Study|Protocol Violation|0
5822767|NCT02556801|20110071|P4|Overall Study|Withdrawal by Subject|0
5822768|NCT02556801|20110072|P3|Overall Study|Withdrawal by Subject|1
5822769|NCT02556801|20110073|P2|Overall Study|Withdrawal by Subject|1
5822770|NCT02556801|20110074|P1|Overall Study|Withdrawal by Subject|1
5822771|NCT02556801|20110071|P4|Overall Study|Lost to Follow-up|0
5822772|NCT02556801|20110072|P3|Overall Study|Lost to Follow-up|2
5822773|NCT02556801|20110073|P2|Overall Study|Lost to Follow-up|0
5822774|NCT02556801|20110074|P1|Overall Study|Lost to Follow-up|1
5822775|NCT02556632|20110136|P3|Overall Study|Treatment or Change Delay|1
5822776|NCT02556632|20110137|P2|Overall Study|Treatment or Change Delay|0
5822777|NCT02556632|20110138|P1|Overall Study|Treatment or Change Delay|0
5822778|NCT02556632|20110136|P3|Overall Study|Disliked Study Procedures|1
5822779|NCT02556632|20110137|P2|Overall Study|Disliked Study Procedures|0
5822780|NCT02556632|20110138|P1|Overall Study|Disliked Study Procedures|0
5822781|NCT02556632|20110136|P3|Overall Study|Ineligible|0
5822782|NCT02556632|20110137|P2|Overall Study|Ineligible|1
5822783|NCT02556632|20110138|P1|Overall Study|Ineligible|0
5822784|NCT02556632|20110136|P3|Overall Study|Did Not Start RT|0
5822785|NCT02556632|20110137|P2|Overall Study|Did Not Start RT|1
5822786|NCT02556632|20110138|P1|Overall Study|Did Not Start RT|0
5822787|NCT02556632|20110136|P3|Overall Study|Possibly Related Adverse Event|1
5822788|NCT02556632|20110137|P2|Overall Study|Possibly Related Adverse Event|0
5822789|NCT02556632|20110138|P1|Overall Study|Possibly Related Adverse Event|0
5822790|NCT02556632|20110136|P3|Overall Study|Related Adverse Event|0
5822791|NCT02556632|20110137|P2|Overall Study|Related Adverse Event|1
5822792|NCT02556632|20110138|P1|Overall Study|Related Adverse Event|0
5822793|NCT02556632|20110136|P3|Overall Study|Unrelated Adverse Event|3
5822794|NCT02556632|20110137|P2|Overall Study|Unrelated Adverse Event|0
5822795|NCT02556632|20110138|P1|Overall Study|Unrelated Adverse Event|1
5822796|NCT02556632|20110136|P3|Overall Study|Withdrew (Unrelated Medical)|0
5822797|NCT02556632|20110137|P2|Overall Study|Withdrew (Unrelated Medical)|0
5822798|NCT02556632|20110138|P1|Overall Study|Withdrew (Unrelated Medical)|1
5822799|NCT02556632|20110136|P3|Overall Study|Changed Mind|0
5822800|NCT02556632|20110137|P2|Overall Study|Changed Mind|1
5822801|NCT02556632|20110138|P1|Overall Study|Changed Mind|0
5822802|NCT02556632|20110136|P3|Overall Study|Personal Issues|1
5822803|NCT02556632|20110137|P2|Overall Study|Personal Issues|1
5822804|NCT02556632|20110138|P1|Overall Study|Personal Issues|0
5822805|NCT02556632|20110136|P3|Overall Study|No Reason|1
5822806|NCT02556632|20110137|P2|Overall Study|No Reason|0
5822807|NCT02556632|20110138|P1|Overall Study|No Reason|1
5822808|NCT02556632|20110136|P3|Overall Study|Disliked Intervention|1
5822809|NCT02556632|20110137|P2|Overall Study|Disliked Intervention|1
5822810|NCT02556632|20110138|P1|Overall Study|Disliked Intervention|1
5822811|NCT02556632|20110136|P3|Overall Study|Lost to Follow-up|0
5822812|NCT02556632|20110137|P2|Overall Study|Lost to Follow-up|0
5822813|NCT02556632|20110138|P1|Overall Study|Lost to Follow-up|1
5822814|NCT02556307|20110178|P1|Overall Study|Enrolled but not treated|2
5822815|NCT02556307|20110178|P1|Overall Study|Change to triple therapy|4
5822816|NCT02556307|20110178|P1|Overall Study|Lost to Follow-up|36
5822817|NCT02556307|20110178|P1|Overall Study|Premature treatment interruption|11
5822818|NCT02556255|20110188|P1|Overall Study|Lost to Follow-up|4
5822819|NCT02556203|20110203|P2|Overall Study|Adverse Event|0
5822820|NCT02556203|20110204|P1|Overall Study|Adverse Event|1
5822821|NCT02556203|20110203|P2|Overall Study|Lost to Follow-up|5
5822822|NCT02556203|20110204|P1|Overall Study|Lost to Follow-up|5
5822823|NCT02556203|20110203|P2|Overall Study|Withdrawal by Subject|21
5822824|NCT02556203|20110204|P1|Overall Study|Withdrawal by Subject|21
5822825|NCT02556177|20110226|P2|Overall Study|Subjects did not complete all 4 visits|61
5822826|NCT02556177|20110227|P1|Overall Study|Subjects did not complete all 4 visits|283
5822827|NCT02556138|20110235|P1|Overall Study|Withdrawal by Subject|1
5822828|NCT02555878|20110271|P2|Overall Study|Other|17
5822829|NCT02555878|20110272|P1|Overall Study|Other|17
5822830|NCT02555878|20110271|P2|Overall Study|Physician Decision|13
5822831|NCT02555878|20110272|P1|Overall Study|Physician Decision|12
5822832|NCT02555878|20110271|P2|Overall Study|Protocol Violation|2
5822833|NCT02555878|20110272|P1|Overall Study|Protocol Violation|1
5822834|NCT02555878|20110271|P2|Overall Study|Death|59
5822835|NCT02555878|20110272|P1|Overall Study|Death|74
5822836|NCT02555878|20110271|P2|Overall Study|Adverse Event|8
5822837|NCT02555878|20110272|P1|Overall Study|Adverse Event|12
5822838|NCT02555878|20110271|P2|Overall Study|Withdrawal by Subject|48
5822839|NCT02555878|20110272|P1|Overall Study|Withdrawal by Subject|48
5822840|NCT02555878|20110271|P2|Overall Study|Lost to Follow-up|3
5822841|NCT02555878|20110272|P1|Overall Study|Lost to Follow-up|2
5822842|NCT02555722|20110304|P2|Month 2|Lost to Follow-up|0
5822843|NCT02555722|20110305|P1|Month 2|Lost to Follow-up|1
5822844|NCT02555722|20110304|P2|Month 2|Withdrawal by Subject|0
5822845|NCT02555722|20110305|P1|Month 2|Withdrawal by Subject|3
5822846|NCT02555722|20110304|P2|Month 1|Lens Discomfort|0
5822847|NCT02555722|20110305|P1|Month 1|Lens Discomfort|1
5822848|NCT02555722|20110304|P2|Week 2|Withdrawal by Subject|0
5822849|NCT02555722|20110305|P1|Week 2|Withdrawal by Subject|1
5822850|NCT02555722|20110304|P2|Week 2|Adverse Event|1
5822851|NCT02555722|20110305|P1|Week 2|Adverse Event|0
5822852|NCT02555683|20110490|P3|Overall Study|Death post Treatment/safety period|0
5822853|NCT02555683|20110491|P2|Overall Study|Death post Treatment/safety period|1
5822854|NCT02555683|20110492|P1|Overall Study|Death post Treatment/safety period|0
5822855|NCT02555683|20110490|P3|Overall Study|Subject/guardian decision|22
5822856|NCT02555683|20110491|P2|Overall Study|Subject/guardian decision|12
5822857|NCT02555683|20110492|P1|Overall Study|Subject/guardian decision|12
5822858|NCT02555683|20110490|P3|Overall Study|Adverse Event|1
5822859|NCT02555683|20110491|P2|Overall Study|Adverse Event|0
5822860|NCT02555683|20110492|P1|Overall Study|Adverse Event|1
5822861|NCT02555683|20110490|P3|Overall Study|Death|2
5822862|NCT02555683|20110491|P2|Overall Study|Death|1
5822863|NCT02555683|20110492|P1|Overall Study|Death|0
5822864|NCT02555683|20110490|P3|Overall Study|Lack of Efficacy|0
5822865|NCT02555683|20110491|P2|Overall Study|Lack of Efficacy|0
5822866|NCT02555683|20110492|P1|Overall Study|Lack of Efficacy|2
5822867|NCT02555683|20110490|P3|Overall Study|Protocol deviation|0
5822868|NCT02555683|20110491|P2|Overall Study|Protocol deviation|1
5822869|NCT02555683|20110492|P1|Overall Study|Protocol deviation|0
5822870|NCT02555683|20110490|P3|Overall Study|Technical Problems|0
5822871|NCT02555683|20110491|P2|Overall Study|Technical Problems|1
5822872|NCT02555683|20110492|P1|Overall Study|Technical Problems|1
5822873|NCT02555683|20110490|P3|Overall Study|Lost to Follow-up|2
5822874|NCT02555683|20110491|P2|Overall Study|Lost to Follow-up|1
5822875|NCT02555683|20110492|P1|Overall Study|Lost to Follow-up|2
5822876|NCT02555683|20110490|P3|Overall Study|Physician Decision|2
5822877|NCT02555683|20110491|P2|Overall Study|Physician Decision|0
5822878|NCT02555683|20110492|P1|Overall Study|Physician Decision|1
5822879|NCT02555657|20110523|P2|Overall Study|Status Not Recorded|31
5822880|NCT02555657|20110524|P1|Overall Study|Status Not Recorded|44
5822881|NCT02555657|20110523|P2|Overall Study|Withdrawal by Subject|32
5822882|NCT02555657|20110524|P1|Overall Study|Withdrawal by Subject|11
5822883|NCT02555657|20110523|P2|Overall Study|Death|247
5822884|NCT02555657|20110524|P1|Overall Study|Death|257
5822885|NCT02555618|20110571|P2|Overall Study|Sponsor's Circumstances|0
5822886|NCT02555618|20110572|P1|Overall Study|Sponsor's Circumstances|1
5822887|NCT02555371|20110614|P5|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0
5822888|NCT02555371|20110615|P4|PartD(OL: 52W Post-randomization PartC)|Adverse Event|1
5822889|NCT02555371|20110616|P3|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0
5822890|NCT02555371|20110617|P2|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0
5822891|NCT02555371|20110618|P1|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0
5822892|NCT02555371|20110614|P5|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|1
5822893|NCT02555371|20110615|P4|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0
5822894|NCT02555371|20110616|P3|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0
5822895|NCT02555371|20110617|P2|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0
5822896|NCT02555371|20110618|P1|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0
5822897|NCT02555371|20110614|P5|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|2
5822898|NCT02555371|20110615|P4|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0
5822899|NCT02555371|20110616|P3|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0
5822900|NCT02555371|20110617|P2|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0
5822901|NCT02555371|20110618|P1|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0
5822902|NCT02555371|20110614|P5|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0
5822903|NCT02555371|20110615|P4|PartD(OL: 52W Post-randomization PartC)|Physician Decision|2
5822904|NCT02555371|20110616|P3|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0
5822905|NCT02555371|20110617|P2|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0
5822906|NCT02555371|20110618|P1|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0
5822907|NCT02555371|20110614|P5|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0
5822908|NCT02555371|20110615|P4|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|1
5822909|NCT02555371|20110616|P3|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0
5822910|NCT02555371|20110617|P2|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0
5822911|NCT02555371|20110618|P1|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0
5822912|NCT02555371|20110614|P5|Part C (DB Period: Up to 52W)|Adverse Event|0
5822913|NCT02555371|20110615|P4|Part C (DB Period: Up to 52W)|Adverse Event|0
5822914|NCT02555371|20110616|P3|Part C (DB Period: Up to 52W)|Adverse Event|1
5822915|NCT02555371|20110617|P2|Part C (DB Period: Up to 52W)|Adverse Event|2
5822916|NCT02555371|20110618|P1|Part C (DB Period: Up to 52W)|Adverse Event|0
5822917|NCT02555371|20110614|P5|Part C (DB Period: Up to 52W)|Lack of Efficacy|0
5822918|NCT02555371|20110615|P4|Part C (DB Period: Up to 52W)|Lack of Efficacy|0
5822919|NCT02555371|20110616|P3|Part C (DB Period: Up to 52W)|Lack of Efficacy|0
5822920|NCT02555371|20110617|P2|Part C (DB Period: Up to 52W)|Lack of Efficacy|1
5822921|NCT02555371|20110618|P1|Part C (DB Period: Up to 52W)|Lack of Efficacy|0
5822922|NCT02555371|20110614|P5|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0
5822923|NCT02555371|20110615|P4|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0
5822924|NCT02555371|20110616|P3|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2
5822925|NCT02555371|20110617|P2|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2
5822926|NCT02555371|20110618|P1|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0
5822927|NCT02555371|20110614|P5|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0
5822928|NCT02555371|20110615|P4|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0
5822929|NCT02555371|20110616|P3|Part C (DB Period: Up to 52W)|Switched to Part D treatment|45
5822930|NCT02555371|20110617|P2|Part C (DB Period: Up to 52W)|Switched to Part D treatment|84
5822931|NCT02555371|20110618|P1|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0
5822932|NCT02555371|20110614|P5|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0
5822933|NCT02555371|20110615|P4|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0
5822934|NCT02555371|20110616|P3|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0
5822935|NCT02555371|20110617|P2|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0
5822936|NCT02555371|20110618|P1|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|2
5822937|NCT02555371|20110614|P5|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0
5822938|NCT02555371|20110615|P4|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0
5822939|NCT02555371|20110616|P3|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0
5822940|NCT02555371|20110617|P2|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0
5822941|NCT02555371|20110618|P1|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|1
5822942|NCT02555371|20110614|P5|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0
5822943|NCT02555371|20110615|P4|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0
5822944|NCT02555371|20110616|P3|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0
5822945|NCT02555371|20110617|P2|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0
5822946|NCT02555371|20110618|P1|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|5
5822947|NCT02555371|20110614|P5|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0
5822948|NCT02555371|20110615|P4|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0
5822949|NCT02555371|20110616|P3|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0
5822950|NCT02555371|20110617|P2|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0
5822951|NCT02555371|20110618|P1|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|2
5822952|NCT02555371|20110614|P5|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0
5822953|NCT02555371|20110615|P4|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0
5822954|NCT02555371|20110616|P3|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0
5822955|NCT02555371|20110617|P2|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0
5822956|NCT02555371|20110618|P1|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|1
5822957|NCT02555215|20110669|P1|Overall Study|Investigator Decision|2
5822958|NCT02555215|20110669|P1|Overall Study|Other|1
5822959|NCT02554981|20110701|P1|Overall Study|Other Miscellaneous Reasons|3
5822960|NCT02554981|20110701|P1|Overall Study|Administrative Reasons|1
5822961|NCT02554981|20110701|P1|Overall Study|Adverse Event|1
5822962|NCT02554929|20110727|P2|Overall Study|Withdrawal by Subject|8
5822963|NCT02554929|20110728|P1|Overall Study|Withdrawal by Subject|2
5822964|NCT02554929|20110727|P2|Overall Study|Lost to Follow-up|4
5822965|NCT02554929|20110728|P1|Overall Study|Lost to Follow-up|4
5822966|NCT02554890|20110746|P2|Open-label|Withdrawal by Subject|1
5822967|NCT02554890|20110747|P1|Open-label|Withdrawal by Subject|0
5822968|NCT02554890|20110746|P2|Open-label|Technical problems|1
5822969|NCT02554890|20110747|P1|Open-label|Technical problems|0
5822970|NCT02554890|20110746|P2|Open-label|Lost to Follow-up|7
5822971|NCT02554890|20110747|P1|Open-label|Lost to Follow-up|0
5822972|NCT02554890|20110746|P2|Open-label|Subject/Guardian decision|11
5822973|NCT02554890|20110747|P1|Open-label|Subject/Guardian decision|0
5822974|NCT02554890|20110746|P2|Open-label|Physician Decision|1
5822975|NCT02554890|20110747|P1|Open-label|Physician Decision|0
5822976|NCT02554890|20110746|P2|Open-label|Death|1
5822977|NCT02554890|20110747|P1|Open-label|Death|0
5822978|NCT02554890|20110746|P2|Open-label|Adverse Event|30
5822979|NCT02554890|20110747|P1|Open-label|Adverse Event|0
5822980|NCT02554890|20110746|P2|Double-blind|Noncompliance with study treatment|5
5822981|NCT02554890|20110747|P1|Double-blind|Noncompliance with study treatment|6
5822982|NCT02554890|20110746|P2|Double-blind|Withdrawal by Subject|6
5822983|NCT02554890|20110747|P1|Double-blind|Withdrawal by Subject|5
5822984|NCT02554890|20110746|P2|Double-blind|Technical problems|0
5822985|NCT02554890|20110747|P1|Double-blind|Technical problems|1
5822986|NCT02554890|20110746|P2|Double-blind|Lost to Follow-up|5
5822987|NCT02554890|20110747|P1|Double-blind|Lost to Follow-up|7
5822988|NCT02554890|20110746|P2|Double-blind|Subject/Guardian decision|16
5822989|NCT02554890|20110747|P1|Double-blind|Subject/Guardian decision|21
5822990|NCT02554890|20110746|P2|Double-blind|Physician Decision|3
5822991|NCT02554890|20110747|P1|Double-blind|Physician Decision|4
5822992|NCT02554890|20110746|P2|Double-blind|Protocol Violation|1
5822993|NCT02554890|20110747|P1|Double-blind|Protocol Violation|1
5822994|NCT02554890|20110746|P2|Double-blind|Death|4
5822995|NCT02554890|20110747|P1|Double-blind|Death|6
5822996|NCT02554890|20110746|P2|Double-blind|Adverse Event|51
5822997|NCT02554890|20110747|P1|Double-blind|Adverse Event|45
5822998|NCT02554877|20110775|P4|Overall Study|No longer willing to participate|0
5822999|NCT02554877|20110776|P3|Overall Study|No longer willing to participate|2
5823000|NCT02554877|20110777|P2|Overall Study|No longer willing to participate|2
5823001|NCT02554877|20110778|P1|Overall Study|No longer willing to participate|0
5823002|NCT02554877|20110775|P4|Overall Study|Insufficient clinical response|0
5823003|NCT02554877|20110776|P3|Overall Study|Insufficient clinical response|0
5823004|NCT02554877|20110777|P2|Overall Study|Insufficient clinical response|0
5823005|NCT02554877|20110778|P1|Overall Study|Insufficient clinical response|4
5823006|NCT02554877|20110775|P4|Overall Study|Other|3
5823007|NCT02554877|20110776|P3|Overall Study|Other|0
5823008|NCT02554877|20110777|P2|Overall Study|Other|3
5823009|NCT02554877|20110778|P1|Overall Study|Other|1
5823010|NCT02554877|20110775|P4|Overall Study|Protocol Violation|0
5823011|NCT02554877|20110776|P3|Overall Study|Protocol Violation|1
5823012|NCT02554877|20110777|P2|Overall Study|Protocol Violation|1
5823013|NCT02554877|20110778|P1|Overall Study|Protocol Violation|3
5823014|NCT02554877|20110775|P4|Overall Study|No longer met eligibility criteria|1
5823015|NCT02554877|20110776|P3|Overall Study|No longer met eligibility criteria|1
5823016|NCT02554877|20110777|P2|Overall Study|No longer met eligibility criteria|0
5823017|NCT02554877|20110778|P1|Overall Study|No longer met eligibility criteria|1
5823018|NCT02554877|20110775|P4|Overall Study|Did not meet entrance criteria|0
5823019|NCT02554877|20110776|P3|Overall Study|Did not meet entrance criteria|1
5823020|NCT02554877|20110777|P2|Overall Study|Did not meet entrance criteria|0
5823021|NCT02554877|20110778|P1|Overall Study|Did not meet entrance criteria|0
5823022|NCT02554877|20110775|P4|Overall Study|Lost to Follow-up|2
5823023|NCT02554877|20110776|P3|Overall Study|Lost to Follow-up|1
5823024|NCT02554877|20110777|P2|Overall Study|Lost to Follow-up|1
5823025|NCT02554877|20110778|P1|Overall Study|Lost to Follow-up|1
5823026|NCT02554877|20110775|P4|Overall Study|Adverse Event|1
5823027|NCT02554877|20110776|P3|Overall Study|Adverse Event|0
5823028|NCT02554877|20110777|P2|Overall Study|Adverse Event|0
5823029|NCT02554877|20110778|P1|Overall Study|Adverse Event|2
5823030|NCT02554786|20110866|P5|Overall Study|Pregnancy|1
5823031|NCT02554786|20110867|P4|Overall Study|Pregnancy|1
5823032|NCT02554786|20110868|P3|Overall Study|Pregnancy|0
5823033|NCT02554786|20110869|P2|Overall Study|Pregnancy|0
5823034|NCT02554786|20110870|P1|Overall Study|Pregnancy|0
5823035|NCT02554786|20110866|P5|Overall Study|Physician Decision|1
5823036|NCT02554786|20110867|P4|Overall Study|Physician Decision|1
5823037|NCT02554786|20110868|P3|Overall Study|Physician Decision|4
5823038|NCT02554786|20110869|P2|Overall Study|Physician Decision|1
5823039|NCT02554786|20110870|P1|Overall Study|Physician Decision|0
5823040|NCT02554786|20110866|P5|Overall Study|Non-compliance with study treatment|1
5823041|NCT02554786|20110867|P4|Overall Study|Non-compliance with study treatment|0
5823042|NCT02554786|20110868|P3|Overall Study|Non-compliance with study treatment|1
5823043|NCT02554786|20110869|P2|Overall Study|Non-compliance with study treatment|1
5823044|NCT02554786|20110870|P1|Overall Study|Non-compliance with study treatment|0
5823045|NCT02554786|20110866|P5|Overall Study|Death|0
5823046|NCT02554786|20110867|P4|Overall Study|Death|1
5823047|NCT02554786|20110868|P3|Overall Study|Death|0
5823048|NCT02554786|20110869|P2|Overall Study|Death|0
5823049|NCT02554786|20110870|P1|Overall Study|Death|0
5823050|NCT02554786|20110866|P5|Overall Study|Adverse Event|2
5823051|NCT02554786|20110867|P4|Overall Study|Adverse Event|0
5823052|NCT02554786|20110868|P3|Overall Study|Adverse Event|0
5823053|NCT02554786|20110869|P2|Overall Study|Adverse Event|0
5823054|NCT02554786|20110870|P1|Overall Study|Adverse Event|0
5823055|NCT02554786|20110866|P5|Overall Study|Technical problems|1
5823056|NCT02554786|20110867|P4|Overall Study|Technical problems|2
5823057|NCT02554786|20110868|P3|Overall Study|Technical problems|0
5823058|NCT02554786|20110869|P2|Overall Study|Technical problems|1
5823059|NCT02554786|20110870|P1|Overall Study|Technical problems|1
5823060|NCT02554786|20110866|P5|Overall Study|Protocol deviation|2
5823061|NCT02554786|20110867|P4|Overall Study|Protocol deviation|4
5823062|NCT02554786|20110868|P3|Overall Study|Protocol deviation|3
5823063|NCT02554786|20110869|P2|Overall Study|Protocol deviation|3
5823064|NCT02554786|20110870|P1|Overall Study|Protocol deviation|1
5823065|NCT02554786|20110866|P5|Overall Study|Lost to Follow-up|2
5823066|NCT02554786|20110867|P4|Overall Study|Lost to Follow-up|2
5823067|NCT02554786|20110868|P3|Overall Study|Lost to Follow-up|4
5823068|NCT02554786|20110869|P2|Overall Study|Lost to Follow-up|3
5823069|NCT02554786|20110870|P1|Overall Study|Lost to Follow-up|4
5823070|NCT02554786|20110866|P5|Overall Study|Subject/guardian decision|20
5823071|NCT02554786|20110867|P4|Overall Study|Subject/guardian decision|30
5823072|NCT02554786|20110868|P3|Overall Study|Subject/guardian decision|18
5823073|NCT02554786|20110869|P2|Overall Study|Subject/guardian decision|17
5823074|NCT02554786|20110870|P1|Overall Study|Subject/guardian decision|29
5823075|NCT02554682|20111032|P10|Overall Study|Physician Decision|0
5823076|NCT02554682|20111033|P9|Overall Study|Physician Decision|0
5823077|NCT02554682|20111034|P8|Overall Study|Physician Decision|0
5823078|NCT02554682|20111035|P7|Overall Study|Physician Decision|0
5823079|NCT02554682|20111036|P6|Overall Study|Physician Decision|0
5823080|NCT02554682|20111037|P5|Overall Study|Physician Decision|0
5823081|NCT02554682|20111038|P4|Overall Study|Physician Decision|0
5823082|NCT02554682|20111039|P3|Overall Study|Physician Decision|0
5823083|NCT02554682|20111040|P2|Overall Study|Physician Decision|2
5823084|NCT02554682|20111041|P1|Overall Study|Physician Decision|2
5823085|NCT02554682|20111032|P10|Overall Study|Withdrawal by Subject|0
5823086|NCT02554682|20111033|P9|Overall Study|Withdrawal by Subject|0
5823087|NCT02554682|20111034|P8|Overall Study|Withdrawal by Subject|0
5823088|NCT02554682|20111035|P7|Overall Study|Withdrawal by Subject|0
5823089|NCT02554682|20111036|P6|Overall Study|Withdrawal by Subject|0
5823090|NCT02554682|20111037|P5|Overall Study|Withdrawal by Subject|0
5823091|NCT02554682|20111038|P4|Overall Study|Withdrawal by Subject|0
5823092|NCT02554682|20111039|P3|Overall Study|Withdrawal by Subject|0
5823093|NCT02554682|20111040|P2|Overall Study|Withdrawal by Subject|1
5823094|NCT02554682|20111041|P1|Overall Study|Withdrawal by Subject|2
5823095|NCT02554682|20111032|P10|Overall Study|Lost to Follow-up|2
5823096|NCT02554682|20111033|P9|Overall Study|Lost to Follow-up|2
5823097|NCT02554682|20111034|P8|Overall Study|Lost to Follow-up|6
5823098|NCT02554682|20111035|P7|Overall Study|Lost to Follow-up|6
5823099|NCT02554682|20111036|P6|Overall Study|Lost to Follow-up|1
5823100|NCT02554682|20111037|P5|Overall Study|Lost to Follow-up|2
5823101|NCT02554682|20111038|P4|Overall Study|Lost to Follow-up|3
5823102|NCT02554682|20111039|P3|Overall Study|Lost to Follow-up|4
5823103|NCT02554682|20111040|P2|Overall Study|Lost to Follow-up|9
5823104|NCT02554682|20111041|P1|Overall Study|Lost to Follow-up|11
5823105|NCT02554656|20111090|P1|Overall Study|Protocol Violation|3
5823106|NCT02554279|20111135|P2|Overall Study|Other reason|6
5823107|NCT02554279|20111136|P1|Overall Study|Other reason|19
5823108|NCT02554279|20111135|P2|Overall Study|Protocol Violation|1
5823109|NCT02554279|20111136|P1|Overall Study|Protocol Violation|2
5823110|NCT02554279|20111135|P2|Overall Study|Withdrawal by Subject|4
5823111|NCT02554279|20111136|P1|Overall Study|Withdrawal by Subject|6
5823112|NCT02554279|20111135|P2|Overall Study|Lost to Follow-up|2
5823113|NCT02554279|20111136|P1|Overall Study|Lost to Follow-up|3
5823114|NCT02554279|20111135|P2|Overall Study|Adverse Event|5
5823115|NCT02554279|20111136|P1|Overall Study|Adverse Event|2
5823116|NCT02554019|20111171|P3|Overall Study|Adverse Event|0
5823117|NCT02554019|20111172|P2|Overall Study|Adverse Event|0
5823118|NCT02554019|20111173|P1|Overall Study|Adverse Event|1
5823119|NCT02554019|20111171|P3|Overall Study|Withdrawal by Subject|2
5823120|NCT02554019|20111172|P2|Overall Study|Withdrawal by Subject|0
5823121|NCT02554019|20111173|P1|Overall Study|Withdrawal by Subject|1
5823122|NCT02553928|20111195|P2|Overall Study|Administrative reason(s)|1
5823123|NCT02553928|20111196|P1|Overall Study|Administrative reason(s)|0
5823124|NCT02553928|20111195|P2|Overall Study|Lost to Follow-up|1
5823125|NCT02553928|20111196|P1|Overall Study|Lost to Follow-up|0
5823126|NCT02553928|20111195|P2|Overall Study|Adverse Event|1
5823127|NCT02553928|20111196|P1|Overall Study|Adverse Event|2
5823128|NCT02553772|20111250|P2|Overall Study|Other Miscellaneous Reasons|1
5823129|NCT02553772|20111251|P1|Overall Study|Other Miscellaneous Reasons|0
5823130|NCT02553772|20111250|P2|Overall Study|Lack of Efficacy|0
5823131|NCT02553772|20111251|P1|Overall Study|Lack of Efficacy|1
5823132|NCT02553772|20111250|P2|Overall Study|Withdrawal of Consent|1
5823133|NCT02553772|20111251|P1|Overall Study|Withdrawal of Consent|1
5823134|NCT02553772|20111250|P2|Overall Study|Lost to Follow-up|1
5823135|NCT02553772|20111251|P1|Overall Study|Lost to Follow-up|2
5823136|NCT02553772|20111250|P2|Overall Study|Adverse Event|3
5823137|NCT02553772|20111251|P1|Overall Study|Adverse Event|2
5823138|NCT02553629|20111296|P2|Overall Study|Logistic reasons|6
5823139|NCT02553629|20111297|P1|Overall Study|Logistic reasons|3
5823140|NCT02553538|20111313|P2|Overall Study|Died or Left Network|56
5823141|NCT02553538|20111314|P1|Overall Study|Died or Left Network|54
5823142|NCT02553538|20111313|P2|Overall Study|Could Not Reach by Telephone|0
5823143|NCT02553538|20111314|P1|Overall Study|Could Not Reach by Telephone|133
5823144|NCT02553499|20111348|P14|Overall Study|Withdrawal by Subject|0
5823145|NCT02553499|20111349|P13|Overall Study|Withdrawal by Subject|0
5823146|NCT02553499|20111350|P12|Overall Study|Withdrawal by Subject|0
5823147|NCT02553499|20111351|P11|Overall Study|Withdrawal by Subject|1
5823148|NCT02553499|20111352|P10|Overall Study|Withdrawal by Subject|0
5823149|NCT02553499|20111353|P9|Overall Study|Withdrawal by Subject|1
5823150|NCT02553499|20111354|P8|Overall Study|Withdrawal by Subject|1
5823151|NCT02553499|20111355|P7|Overall Study|Withdrawal by Subject|0
5823152|NCT02553499|20111356|P6|Overall Study|Withdrawal by Subject|0
5823153|NCT02553499|20111357|P5|Overall Study|Withdrawal by Subject|0
5823154|NCT02553499|20111358|P4|Overall Study|Withdrawal by Subject|0
5823155|NCT02553499|20111359|P3|Overall Study|Withdrawal by Subject|0
5823156|NCT02553499|20111360|P2|Overall Study|Withdrawal by Subject|0
5823157|NCT02553499|20111361|P1|Overall Study|Withdrawal by Subject|2
5823158|NCT02553499|20111348|P14|Overall Study|Study Terminated by Sponsor|0
5823159|NCT02553499|20111349|P13|Overall Study|Study Terminated by Sponsor|0
5823160|NCT02553499|20111350|P12|Overall Study|Study Terminated by Sponsor|0
5823161|NCT02553499|20111351|P11|Overall Study|Study Terminated by Sponsor|0
5823162|NCT02553499|20111352|P10|Overall Study|Study Terminated by Sponsor|0
5823163|NCT02553499|20111353|P9|Overall Study|Study Terminated by Sponsor|1
5823164|NCT02553499|20111354|P8|Overall Study|Study Terminated by Sponsor|0
5823165|NCT02553499|20111355|P7|Overall Study|Study Terminated by Sponsor|0
5823166|NCT02553499|20111356|P6|Overall Study|Study Terminated by Sponsor|0
5823167|NCT02553499|20111357|P5|Overall Study|Study Terminated by Sponsor|0
5823168|NCT02553499|20111358|P4|Overall Study|Study Terminated by Sponsor|0
5823169|NCT02553499|20111359|P3|Overall Study|Study Terminated by Sponsor|0
5823170|NCT02553499|20111360|P2|Overall Study|Study Terminated by Sponsor|0
5823171|NCT02553499|20111361|P1|Overall Study|Study Terminated by Sponsor|0
5823172|NCT02553499|20111348|P14|Overall Study|Progressive Disease|1
5823173|NCT02553499|20111349|P13|Overall Study|Progressive Disease|2
5823174|NCT02553499|20111350|P12|Overall Study|Progressive Disease|0
5823175|NCT02553499|20111351|P11|Overall Study|Progressive Disease|0
5823176|NCT02553499|20111352|P10|Overall Study|Progressive Disease|1
5823177|NCT02553499|20111353|P9|Overall Study|Progressive Disease|0
5823178|NCT02553499|20111354|P8|Overall Study|Progressive Disease|0
5823179|NCT02553499|20111355|P7|Overall Study|Progressive Disease|1
5823180|NCT02553499|20111356|P6|Overall Study|Progressive Disease|1
5823181|NCT02553499|20111357|P5|Overall Study|Progressive Disease|1
5823182|NCT02553499|20111358|P4|Overall Study|Progressive Disease|2
5823183|NCT02553499|20111359|P3|Overall Study|Progressive Disease|0
5823184|NCT02553499|20111360|P2|Overall Study|Progressive Disease|0
5823185|NCT02553499|20111361|P1|Overall Study|Progressive Disease|0
5823186|NCT02553499|20111348|P14|Overall Study|Physician Decision|0
5823187|NCT02553499|20111349|P13|Overall Study|Physician Decision|1
5823188|NCT02553499|20111350|P12|Overall Study|Physician Decision|3
5823189|NCT02553499|20111351|P11|Overall Study|Physician Decision|1
5823190|NCT02553499|20111352|P10|Overall Study|Physician Decision|2
5823191|NCT02553499|20111353|P9|Overall Study|Physician Decision|1
5823192|NCT02553499|20111354|P8|Overall Study|Physician Decision|1
5823193|NCT02553499|20111355|P7|Overall Study|Physician Decision|0
5823194|NCT02553499|20111356|P6|Overall Study|Physician Decision|0
5823195|NCT02553499|20111357|P5|Overall Study|Physician Decision|1
5823196|NCT02553499|20111358|P4|Overall Study|Physician Decision|0
5823197|NCT02553499|20111359|P3|Overall Study|Physician Decision|1
5823198|NCT02553499|20111360|P2|Overall Study|Physician Decision|1
5823199|NCT02553499|20111361|P1|Overall Study|Physician Decision|0
5823200|NCT02553499|20111348|P14|Overall Study|Lost to Follow-up|0
5823201|NCT02553499|20111349|P13|Overall Study|Lost to Follow-up|0
5823202|NCT02553499|20111350|P12|Overall Study|Lost to Follow-up|0
5823203|NCT02553499|20111351|P11|Overall Study|Lost to Follow-up|0
5823204|NCT02553499|20111352|P10|Overall Study|Lost to Follow-up|0
5823205|NCT02553499|20111353|P9|Overall Study|Lost to Follow-up|0
5823206|NCT02553499|20111354|P8|Overall Study|Lost to Follow-up|0
5823207|NCT02553499|20111355|P7|Overall Study|Lost to Follow-up|1
5823208|NCT02553499|20111356|P6|Overall Study|Lost to Follow-up|0
5823209|NCT02553499|20111357|P5|Overall Study|Lost to Follow-up|0
5823210|NCT02553499|20111358|P4|Overall Study|Lost to Follow-up|0
5823211|NCT02553499|20111359|P3|Overall Study|Lost to Follow-up|0
5823212|NCT02553499|20111360|P2|Overall Study|Lost to Follow-up|0
5823213|NCT02553499|20111361|P1|Overall Study|Lost to Follow-up|0
5823214|NCT02553499|20111348|P14|Overall Study|Death|0
5823215|NCT02553499|20111349|P13|Overall Study|Death|0
5823216|NCT02553499|20111350|P12|Overall Study|Death|0
5823217|NCT02553499|20111351|P11|Overall Study|Death|1
5823218|NCT02553499|20111352|P10|Overall Study|Death|0
5823219|NCT02553499|20111353|P9|Overall Study|Death|0
5823220|NCT02553499|20111354|P8|Overall Study|Death|0
5823221|NCT02553499|20111355|P7|Overall Study|Death|0
5823222|NCT02553499|20111356|P6|Overall Study|Death|2
5823223|NCT02553499|20111357|P5|Overall Study|Death|1
5823224|NCT02553499|20111358|P4|Overall Study|Death|0
5823225|NCT02553499|20111359|P3|Overall Study|Death|1
5823226|NCT02553499|20111360|P2|Overall Study|Death|1
5823227|NCT02553499|20111361|P1|Overall Study|Death|0
5823228|NCT02553499|20111348|P14|Overall Study|Adverse Event|1
5823229|NCT02553499|20111349|P13|Overall Study|Adverse Event|0
5823230|NCT02553499|20111350|P12|Overall Study|Adverse Event|0
5823231|NCT02553499|20111351|P11|Overall Study|Adverse Event|0
5823232|NCT02553499|20111352|P10|Overall Study|Adverse Event|0
5823233|NCT02553499|20111353|P9|Overall Study|Adverse Event|0
5823234|NCT02553499|20111354|P8|Overall Study|Adverse Event|1
5823235|NCT02553499|20111355|P7|Overall Study|Adverse Event|1
5823236|NCT02553499|20111356|P6|Overall Study|Adverse Event|0
5823237|NCT02553499|20111357|P5|Overall Study|Adverse Event|0
5823238|NCT02553499|20111358|P4|Overall Study|Adverse Event|0
5823239|NCT02553499|20111359|P3|Overall Study|Adverse Event|0
5823240|NCT02553499|20111360|P2|Overall Study|Adverse Event|0
5823241|NCT02553499|20111361|P1|Overall Study|Adverse Event|0
5823242|NCT02553421|20111463|P2|Overall Study|Improper Device Placement|0
5823243|NCT02553421|20111464|P1|Overall Study|Improper Device Placement|3
5823244|NCT02553421|20111463|P2|Overall Study|Incomplete or Insufficient Data Collecte|0
5823245|NCT02553421|20111464|P1|Overall Study|Incomplete or Insufficient Data Collecte|5
5823246|NCT02553421|20111463|P2|Overall Study|Lost to Follow-up|1
5823247|NCT02553421|20111464|P1|Overall Study|Lost to Follow-up|21
5823248|NCT02553330|20111519|P3|Overall Study|Lost to Follow-up|4
5823249|NCT02553330|20111520|P2|Overall Study|Lost to Follow-up|4
5823250|NCT02553330|20111521|P1|Overall Study|Lost to Follow-up|0
5823251|NCT02553330|20111519|P3|Overall Study|Adverse Event|0
5823252|NCT02553330|20111520|P2|Overall Study|Adverse Event|1
5823253|NCT02553330|20111521|P1|Overall Study|Adverse Event|0
5823254|NCT02553330|20111519|P3|Overall Study|Non compliance to study treatment|0
5823255|NCT02553330|20111520|P2|Overall Study|Non compliance to study treatment|1
5823256|NCT02553330|20111521|P1|Overall Study|Non compliance to study treatment|0
5823257|NCT02553330|20111519|P3|Overall Study|Other|0
5823258|NCT02553330|20111520|P2|Overall Study|Other|1
5823259|NCT02553330|20111521|P1|Overall Study|Other|0
5823260|NCT02553330|20111519|P3|Overall Study|Withdrawal by Subject|21
5823261|NCT02553330|20111520|P2|Overall Study|Withdrawal by Subject|19
5823262|NCT02553330|20111521|P1|Overall Study|Withdrawal by Subject|3
5823263|NCT02553330|20111519|P3|Overall Study|Study Terminated by Sponsor|12
5823264|NCT02553330|20111520|P2|Overall Study|Study Terminated by Sponsor|13
5823265|NCT02553330|20111521|P1|Overall Study|Study Terminated by Sponsor|2
5823266|NCT02553317|20111545|P2|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|1
5823267|NCT02553317|20111546|P1|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|0
5823268|NCT02553317|20111545|P2|Overall Treatment Period + Follow-up|Protocol Violation|1
5823269|NCT02553317|20111546|P1|Overall Treatment Period + Follow-up|Protocol Violation|0
5823270|NCT02553317|20111545|P2|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1
5823271|NCT02553317|20111546|P1|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1
5823272|NCT02553317|20111545|P2|Overall Treatment Period + Follow-up|Lost to Follow-up|1
5823273|NCT02553317|20111546|P1|Overall Treatment Period + Follow-up|Lost to Follow-up|0
5823274|NCT02553317|20111545|P2|Overall Treatment Period + Follow-up|Withdrawal by Subject|5
5823275|NCT02553317|20111546|P1|Overall Treatment Period + Follow-up|Withdrawal by Subject|4
5823276|NCT02553317|20111545|P2|Overall Treatment Period + Follow-up|Adverse Event|5
5823277|NCT02553317|20111546|P1|Overall Treatment Period + Follow-up|Adverse Event|6
5823278|NCT02553317|20111545|P2|Overall Treatment Period + Follow-up|Death|3
5823279|NCT02553317|20111546|P1|Overall Treatment Period + Follow-up|Death|1
5823280|NCT02553317|20111545|P2|Overall Treatment Period + Follow-up|Non-compliance with study drug|1
5823281|NCT02553317|20111546|P1|Overall Treatment Period + Follow-up|Non-compliance with study drug|0
5823282|NCT02553317|20111545|P2|Overall Treatment Period + Follow-up|Physician Decision|4
5823283|NCT02553317|20111546|P1|Overall Treatment Period + Follow-up|Physician Decision|2
5823284|NCT02553317|20111545|P2|Overall Treatment Period + Follow-up|Withdrawn by legal representative|1
5823285|NCT02553317|20111546|P1|Overall Treatment Period + Follow-up|Withdrawn by legal representative|0
5823286|NCT02552966|20111576|P1|Overall Study|Withdrawal by Subject|3
5823287|NCT02552966|20111576|P1|Overall Study|Lost to Follow-up|2
5823288|NCT02552732|20111602|P1|Overall Study|Withdrawal by Subject|6
5823289|NCT02552732|20111602|P1|Overall Study|Day 1 SpO2 > 96%|1
5823290|NCT02552732|20111602|P1|Overall Study|Physician Decision|1
5823291|NCT02552732|20111602|P1|Overall Study|Lost to Follow-up|2
5823292|NCT02552355|20111638|P4|Overall Study|Withdrawal by Subject|1
5823293|NCT02552355|20111639|P3|Overall Study|Withdrawal by Subject|0
5823294|NCT02552355|20111640|P2|Overall Study|Withdrawal by Subject|0
5823295|NCT02552355|20111641|P1|Overall Study|Withdrawal by Subject|0
5823296|NCT02552355|20111638|P4|Overall Study|Adverse Event|0
5823297|NCT02552355|20111639|P3|Overall Study|Adverse Event|2
5823298|NCT02552355|20111640|P2|Overall Study|Adverse Event|2
5823299|NCT02552355|20111641|P1|Overall Study|Adverse Event|0
5823300|NCT02552316|20111683|P1|Overall Study|Withdrawal due to non-compliance|1
5823301|NCT02552316|20111683|P1|Overall Study|Withdrawal by Subject|1
5823302|NCT02552303|20111735|P4|Follow-Up|ineligible|0
5823303|NCT02552303|20111736|P3|Follow-Up|ineligible|0
5823304|NCT02552303|20111737|P2|Follow-Up|ineligible|2
5823305|NCT02552303|20111738|P1|Follow-Up|ineligible|0
5823306|NCT02552303|20111735|P4|Follow-Up|Lost to Follow-up|0
5823307|NCT02552303|20111736|P3|Follow-Up|Lost to Follow-up|1
5823308|NCT02552303|20111737|P2|Follow-Up|Lost to Follow-up|0
5823309|NCT02552303|20111738|P1|Follow-Up|Lost to Follow-up|0
5823310|NCT02552303|20111735|P4|Allocation|ineligible|0
5823311|NCT02552303|20111736|P3|Allocation|ineligible|0
5823312|NCT02552303|20111737|P2|Allocation|ineligible|1
5823313|NCT02552303|20111738|P1|Allocation|ineligible|1
5823314|NCT02552303|20111735|P4|Allocation|Withdrawal by Subject|1
5823315|NCT02552303|20111736|P3|Allocation|Withdrawal by Subject|1
5823316|NCT02552303|20111737|P2|Allocation|Withdrawal by Subject|1
5823317|NCT02552303|20111738|P1|Allocation|Withdrawal by Subject|2
5823318|NCT02552238|20111752|P1|Overall Study|Adverse Event|2
5823319|NCT02552212|20111765|P2|Overall Study|Missing/Unspecified|0
5823320|NCT02552212|20111766|P1|Overall Study|Missing/Unspecified|1
5823321|NCT02552212|20111765|P2|Overall Study|Not eligible|1
5823322|NCT02552212|20111766|P1|Overall Study|Not eligible|0
5823323|NCT02552212|20111765|P2|Overall Study|As per suggestion|1
5823324|NCT02552212|20111766|P1|Overall Study|As per suggestion|0
5823325|NCT02552212|20111765|P2|Overall Study|Patient's decision|1
5823326|NCT02552212|20111766|P1|Overall Study|Patient's decision|0
5823327|NCT02552212|20111765|P2|Overall Study|Study non-compliance|1
5823328|NCT02552212|20111766|P1|Overall Study|Study non-compliance|1
5823329|NCT02552212|20111765|P2|Overall Study|Withdrawal by Subject|7
5823330|NCT02552212|20111766|P1|Overall Study|Withdrawal by Subject|3
5823331|NCT02552212|20111765|P2|Overall Study|Lost to Follow-up|0
5823332|NCT02552212|20111766|P1|Overall Study|Lost to Follow-up|1
5823333|NCT02552212|20111765|P2|Overall Study|Protocol Violation|1
5823334|NCT02552212|20111766|P1|Overall Study|Protocol Violation|1
5823335|NCT02552212|20111765|P2|Overall Study|Lack of Efficacy|2
5823336|NCT02552212|20111766|P1|Overall Study|Lack of Efficacy|2
5823337|NCT02552212|20111765|P2|Overall Study|Adverse Event|3
5823338|NCT02552212|20111766|P1|Overall Study|Adverse Event|6
5823339|NCT02552147|20111840|P2|Second Intervention (7 Days)|Protocol Violation|0
5823340|NCT02552147|20111841|P1|Second Intervention (7 Days)|Protocol Violation|2
5823341|NCT02552147|20111840|P2|First Intervention (7 Days)|Protocol Violation|0
5823342|NCT02552147|20111841|P1|First Intervention (7 Days)|Protocol Violation|1
5823343|NCT02552121|20111875|P8|Part 2: Cohort Expansion|Death|0
5823344|NCT02552121|20111876|P7|Part 2: Cohort Expansion|Death|0
5823345|NCT02552121|20111877|P6|Part 2: Cohort Expansion|Death|0
5823346|NCT02552121|20111878|P5|Part 2: Cohort Expansion|Death|0
5823347|NCT02552121|20111879|P4|Part 2: Cohort Expansion|Death|0
5823348|NCT02552121|20111880|P3|Part 2: Cohort Expansion|Death|1
5823349|NCT02552121|20111881|P2|Part 2: Cohort Expansion|Death|0
5823350|NCT02552121|20111882|P1|Part 2: Cohort Expansion|Death|0
5823351|NCT02552121|20111875|P8|Part 2: Cohort Expansion|Adverse Event|0
5823352|NCT02552121|20111876|P7|Part 2: Cohort Expansion|Adverse Event|0
5823353|NCT02552121|20111877|P6|Part 2: Cohort Expansion|Adverse Event|0
5823354|NCT02552121|20111878|P5|Part 2: Cohort Expansion|Adverse Event|0
5823355|NCT02552121|20111879|P4|Part 2: Cohort Expansion|Adverse Event|1
5823356|NCT02552121|20111880|P3|Part 2: Cohort Expansion|Adverse Event|6
5823357|NCT02552121|20111881|P2|Part 2: Cohort Expansion|Adverse Event|0
5823358|NCT02552121|20111882|P1|Part 2: Cohort Expansion|Adverse Event|0
5823359|NCT02552121|20111875|P8|Part 2: Cohort Expansion|Disease Progression|3
5823360|NCT02552121|20111876|P7|Part 2: Cohort Expansion|Disease Progression|0
5823361|NCT02552121|20111877|P6|Part 2: Cohort Expansion|Disease Progression|4
5823362|NCT02552121|20111878|P5|Part 2: Cohort Expansion|Disease Progression|1
5823363|NCT02552121|20111879|P4|Part 2: Cohort Expansion|Disease Progression|2
5823364|NCT02552121|20111880|P3|Part 2: Cohort Expansion|Disease Progression|3
5823365|NCT02552121|20111881|P2|Part 2: Cohort Expansion|Disease Progression|0
5823366|NCT02552121|20111882|P1|Part 2: Cohort Expansion|Disease Progression|0
5823367|NCT02552121|20111875|P8|Part 2: Cohort Expansion|Patient Choice|0
5823368|NCT02552121|20111876|P7|Part 2: Cohort Expansion|Patient Choice|1
5823369|NCT02552121|20111877|P6|Part 2: Cohort Expansion|Patient Choice|0
5823370|NCT02552121|20111878|P5|Part 2: Cohort Expansion|Patient Choice|0
5823371|NCT02552121|20111879|P4|Part 2: Cohort Expansion|Patient Choice|0
5823372|NCT02552121|20111880|P3|Part 2: Cohort Expansion|Patient Choice|1
5823373|NCT02552121|20111881|P2|Part 2: Cohort Expansion|Patient Choice|0
5823374|NCT02552121|20111882|P1|Part 2: Cohort Expansion|Patient Choice|0
5823375|NCT02552121|20111875|P8|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0
5823376|NCT02552121|20111876|P7|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0
5823377|NCT02552121|20111877|P6|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0
5823378|NCT02552121|20111878|P5|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0
5823379|NCT02552121|20111879|P4|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0
5823380|NCT02552121|20111880|P3|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0
5823381|NCT02552121|20111881|P2|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|1
5823382|NCT02552121|20111882|P1|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0
5823383|NCT02552121|20111875|P8|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0
5823384|NCT02552121|20111876|P7|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0
5823385|NCT02552121|20111877|P6|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0
5823386|NCT02552121|20111878|P5|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0
5823387|NCT02552121|20111879|P4|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0
5823388|NCT02552121|20111880|P3|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0
5823389|NCT02552121|20111881|P2|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|2
5823390|NCT02552121|20111882|P1|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0
5823391|NCT02552121|20111875|P8|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0
5823392|NCT02552121|20111876|P7|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0
5823393|NCT02552121|20111877|P6|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0
5823394|NCT02552121|20111878|P5|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0
5823395|NCT02552121|20111879|P4|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0
5823396|NCT02552121|20111880|P3|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0
5823397|NCT02552121|20111881|P2|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|2
5823398|NCT02552121|20111882|P1|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0
5823399|NCT02552121|20111875|P8|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0
5823400|NCT02552121|20111876|P7|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0
5823401|NCT02552121|20111877|P6|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0
5823402|NCT02552121|20111878|P5|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0
5823403|NCT02552121|20111879|P4|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0
5823404|NCT02552121|20111880|P3|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0
5823405|NCT02552121|20111881|P2|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|1
5823406|NCT02552121|20111882|P1|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0
5823407|NCT02552121|20111875|P8|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0
5823408|NCT02552121|20111876|P7|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0
5823409|NCT02552121|20111877|P6|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0
5823410|NCT02552121|20111878|P5|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0
5823411|NCT02552121|20111879|P4|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0
5823412|NCT02552121|20111880|P3|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0
5823413|NCT02552121|20111881|P2|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0
5823414|NCT02552121|20111882|P1|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|1
5823415|NCT02552121|20111875|P8|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0
5823416|NCT02552121|20111876|P7|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0
5823417|NCT02552121|20111877|P6|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0
5823418|NCT02552121|20111878|P5|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0
5823419|NCT02552121|20111879|P4|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0
5823420|NCT02552121|20111880|P3|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0
5823421|NCT02552121|20111881|P2|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0
5823422|NCT02552121|20111882|P1|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|2
5823423|NCT02551874|20112143|P2|Overall Study|Did not enter long-term study|25
5823424|NCT02551874|20112144|P1|Overall Study|Did not enter long-term study|18
5823425|NCT02551874|20112143|P2|Overall Study|Did not receive randomized treatment|7
5823426|NCT02551874|20112144|P1|Overall Study|Did not receive randomized treatment|0
5823427|NCT02551874|20112143|P2|Overall Study|Reason not reported|4
5823428|NCT02551874|20112144|P1|Overall Study|Reason not reported|10
5823429|NCT02551874|20112143|P2|Overall Study|Pregnancy|1
5823430|NCT02551874|20112144|P1|Overall Study|Pregnancy|0
5823431|NCT02551874|20112143|P2|Overall Study|Lost to Follow-up|2
5823432|NCT02551874|20112144|P1|Overall Study|Lost to Follow-up|0
5823433|NCT02551731|20112226|P1|Overall Study|Withdrawal by Subject|2
5823434|NCT02551692|20112246|P3|Overall Study|Withdrawal by Subject|1
5823435|NCT02551692|20112247|P2|Overall Study|Withdrawal by Subject|0
5823436|NCT02551692|20112248|P1|Overall Study|Withdrawal by Subject|1
5823437|NCT02551692|20112246|P3|Overall Study|Lost to Follow-up|4
5823438|NCT02551692|20112247|P2|Overall Study|Lost to Follow-up|1
5823439|NCT02551692|20112248|P1|Overall Study|Lost to Follow-up|0
5823440|NCT02551666|20112264|P2|Overall Study|Withdrawal by Subject|3
5823441|NCT02551666|20112265|P1|Overall Study|Withdrawal by Subject|1
5823442|NCT02551055|20112355|P8|Overall Study|Reason not specified|0
5823443|NCT02551055|20112356|P7|Overall Study|Reason not specified|1
5823444|NCT02551055|20112357|P6|Overall Study|Reason not specified|0
5823445|NCT02551055|20112358|P5|Overall Study|Reason not specified|1
5823446|NCT02551055|20112359|P4|Overall Study|Reason not specified|0
5823447|NCT02551055|20112360|P3|Overall Study|Reason not specified|0
5823448|NCT02551055|20112361|P2|Overall Study|Reason not specified|0
5823449|NCT02551055|20112362|P1|Overall Study|Reason not specified|0
5823450|NCT02551055|20112355|P8|Overall Study|Withdrawal by Subject|0
5823451|NCT02551055|20112356|P7|Overall Study|Withdrawal by Subject|0
5823452|NCT02551055|20112357|P6|Overall Study|Withdrawal by Subject|0
5823453|NCT02551055|20112358|P5|Overall Study|Withdrawal by Subject|2
5823454|NCT02551055|20112359|P4|Overall Study|Withdrawal by Subject|1
5823455|NCT02551055|20112360|P3|Overall Study|Withdrawal by Subject|0
5823456|NCT02551055|20112361|P2|Overall Study|Withdrawal by Subject|1
5823457|NCT02551055|20112362|P1|Overall Study|Withdrawal by Subject|1
5823458|NCT02551055|20112355|P8|Overall Study|Study Terminated by Sponsor|0
5823459|NCT02551055|20112356|P7|Overall Study|Study Terminated by Sponsor|0
5823460|NCT02551055|20112357|P6|Overall Study|Study Terminated by Sponsor|0
5823461|NCT02551055|20112358|P5|Overall Study|Study Terminated by Sponsor|2
5823462|NCT02551055|20112359|P4|Overall Study|Study Terminated by Sponsor|2
5823463|NCT02551055|20112360|P3|Overall Study|Study Terminated by Sponsor|0
5823464|NCT02551055|20112361|P2|Overall Study|Study Terminated by Sponsor|1
5823465|NCT02551055|20112362|P1|Overall Study|Study Terminated by Sponsor|1
5823466|NCT02551055|20112355|P8|Overall Study|Death|0
5823467|NCT02551055|20112356|P7|Overall Study|Death|2
5823468|NCT02551055|20112357|P6|Overall Study|Death|1
5823469|NCT02551055|20112358|P5|Overall Study|Death|2
5823470|NCT02551055|20112359|P4|Overall Study|Death|2
5823471|NCT02551055|20112360|P3|Overall Study|Death|2
5823472|NCT02551055|20112361|P2|Overall Study|Death|4
5823473|NCT02551055|20112362|P1|Overall Study|Death|2
5823474|NCT02550873|20112437|P3|Open Label Extension|Study ongoing|111
5823475|NCT02550873|20112438|P2|Open Label Extension|Study ongoing|0
5823476|NCT02550873|20112439|P1|Open Label Extension|Study ongoing|0
5823477|NCT02550873|20112437|P3|Randomized Double Blind|Disease progression|0
5823478|NCT02550873|20112438|P2|Randomized Double Blind|Disease progression|1
5823479|NCT02550873|20112439|P1|Randomized Double Blind|Disease progression|1
5823480|NCT02550873|20112437|P3|Randomized Double Blind|Adverse Event|0
5823481|NCT02550873|20112438|P2|Randomized Double Blind|Adverse Event|1
5823482|NCT02550873|20112439|P1|Randomized Double Blind|Adverse Event|3
5823483|NCT02550795|20112520|P3|Overall Study|Physician Decision|0
5823484|NCT02550795|20112521|P2|Overall Study|Physician Decision|1
5823485|NCT02550795|20112522|P1|Overall Study|Physician Decision|0
5823486|NCT02550652|20112538|P2|Overall Study|Ongoing in study|56
5823487|NCT02550652|20112539|P1|Overall Study|Ongoing in study|59
5823488|NCT02550652|20112538|P2|Overall Study|Withdrawal by Subject|4
5823489|NCT02550652|20112539|P1|Overall Study|Withdrawal by Subject|3
5823490|NCT02550652|20112538|P2|Overall Study|Lack of Efficacy|0
5823491|NCT02550652|20112539|P1|Overall Study|Lack of Efficacy|1
5823492|NCT02550652|20112538|P2|Overall Study|Death|2
5823493|NCT02550652|20112539|P1|Overall Study|Death|0
5823494|NCT02550288|20112586|P5|Overall Study|Withdrawal by Subject|0
5823495|NCT02550288|20112587|P4|Overall Study|Withdrawal by Subject|1
5823496|NCT02550288|20112588|P3|Overall Study|Withdrawal by Subject|0
5823497|NCT02550288|20112589|P2|Overall Study|Withdrawal by Subject|0
5823498|NCT02550288|20112590|P1|Overall Study|Withdrawal by Subject|0
5823499|NCT02550288|20112586|P5|Overall Study|Participant moved|0
5823500|NCT02550288|20112587|P4|Overall Study|Participant moved|1
5823501|NCT02550288|20112588|P3|Overall Study|Participant moved|0
5823502|NCT02550288|20112589|P2|Overall Study|Participant moved|0
5823503|NCT02550288|20112590|P1|Overall Study|Participant moved|0
5823504|NCT02550288|20112586|P5|Overall Study|Protocol Violation|3
5823505|NCT02550288|20112587|P4|Overall Study|Protocol Violation|0
5823506|NCT02550288|20112588|P3|Overall Study|Protocol Violation|1
5823507|NCT02550288|20112589|P2|Overall Study|Protocol Violation|2
5823508|NCT02550288|20112590|P1|Overall Study|Protocol Violation|2
5823509|NCT02550288|20112586|P5|Overall Study|Physician Decision|0
5823510|NCT02550288|20112587|P4|Overall Study|Physician Decision|1
5823511|NCT02550288|20112588|P3|Overall Study|Physician Decision|0
5823512|NCT02550288|20112589|P2|Overall Study|Physician Decision|0
5823513|NCT02550288|20112590|P1|Overall Study|Physician Decision|0
5823514|NCT02550288|20112586|P5|Overall Study|Adverse Event|0
5823515|NCT02550288|20112587|P4|Overall Study|Adverse Event|0
5823516|NCT02550288|20112588|P3|Overall Study|Adverse Event|0
5823517|NCT02550288|20112589|P2|Overall Study|Adverse Event|1
5823518|NCT02550288|20112590|P1|Overall Study|Adverse Event|0
5823519|NCT02550106|20112746|P1|Overall Study|Withdrawal by Subject|2
5823520|NCT02550106|20112746|P1|Overall Study|Protocol Violation|6
5823521|NCT02550106|20112746|P1|Overall Study|Lack of Efficacy|3
5823522|NCT02550106|20112746|P1|Overall Study|Adverse Event|1
5823523|NCT02549859|20112770|P1|Long-term 60 Hz DBS|Study Closed|1
5823524|NCT02549573|20112856|P2|Overall Study|Protocol Violation|1
5823525|NCT02549573|20112857|P1|Overall Study|Protocol Violation|0
5823526|NCT02549573|20112856|P2|Overall Study|Withdrawal by Subject|2
5823527|NCT02549573|20112857|P1|Overall Study|Withdrawal by Subject|0
5823528|NCT02549352|20112924|P2|12-month Follow-up|Other|3
5823529|NCT02549352|20112925|P1|12-month Follow-up|Other|1
5823530|NCT02549352|20112924|P2|12-month Follow-up|Protocol Violation|1
5823531|NCT02549352|20112925|P1|12-month Follow-up|Protocol Violation|0
5823532|NCT02549352|20112924|P2|12-month Follow-up|Death|1
5823533|NCT02549352|20112925|P1|12-month Follow-up|Death|0
5823534|NCT02549352|20112924|P2|12-month Follow-up|Lost to Follow-up|2
5823535|NCT02549352|20112925|P1|12-month Follow-up|Lost to Follow-up|3
5823536|NCT02549352|20112924|P2|12-month Follow-up|Withdrawal by Subject|5
5823537|NCT02549352|20112925|P1|12-month Follow-up|Withdrawal by Subject|4
5823538|NCT02549352|20112924|P2|3-day Treatment and 8-week Follow-up|Other|2
5823539|NCT02549352|20112925|P1|3-day Treatment and 8-week Follow-up|Other|0
5823540|NCT02549352|20112924|P2|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3
5823541|NCT02549352|20112925|P1|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2
5823542|NCT02549352|20112924|P2|3-day Treatment and 8-week Follow-up|Adverse Event|1
5823543|NCT02549352|20112925|P1|3-day Treatment and 8-week Follow-up|Adverse Event|0
5823544|NCT02549339|20112941|P2|12-month Follow-up|Other|3
5823545|NCT02549339|20112942|P1|12-month Follow-up|Other|0
5823546|NCT02549339|20112941|P2|12-month Follow-up|Lost to Follow-up|3
5823547|NCT02549339|20112942|P1|12-month Follow-up|Lost to Follow-up|1
5823548|NCT02549339|20112941|P2|12-month Follow-up|Withdrawal by Subject|3
5823549|NCT02549339|20112942|P1|12-month Follow-up|Withdrawal by Subject|8
5823550|NCT02549339|20112941|P2|12-month Follow-up|Lack of Efficacy|2
5823551|NCT02549339|20112942|P1|12-month Follow-up|Lack of Efficacy|0
5823552|NCT02549339|20112941|P2|3-day Treatment and 8-week Follow-up|Lost to Follow-up|2
5823553|NCT02549339|20112942|P1|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0
5823554|NCT02549339|20112941|P2|3-day Treatment and 8-week Follow-up|Other|0
5823555|NCT02549339|20112942|P1|3-day Treatment and 8-week Follow-up|Other|1
5823556|NCT02549339|20112941|P2|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3
5823557|NCT02549339|20112942|P1|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|1
5823558|NCT02549339|20112941|P2|3-day Treatment and 8-week Follow-up|Protocol Violation|0
5823559|NCT02549339|20112942|P1|3-day Treatment and 8-week Follow-up|Protocol Violation|2
5823560|NCT02549287|20112958|P2|Overall Study|Withdrawal by Subject|6
5823561|NCT02549287|20112959|P1|Overall Study|Withdrawal by Subject|15
5823562|NCT02549287|20112958|P2|Overall Study|Lost to Follow-up|26
5823563|NCT02549287|20112959|P1|Overall Study|Lost to Follow-up|65
5823564|NCT02549196|20112993|P4|Overall Study|Withdrawal by Subject|0
5823565|NCT02549196|20112994|P3|Overall Study|Withdrawal by Subject|1
5823566|NCT02549196|20112995|P2|Overall Study|Withdrawal by Subject|0
5823567|NCT02549196|20112996|P1|Overall Study|Withdrawal by Subject|1
5823568|NCT02549196|20112993|P4|Overall Study|Protocol Violation|1
5823569|NCT02549196|20112994|P3|Overall Study|Protocol Violation|0
5823570|NCT02549196|20112995|P2|Overall Study|Protocol Violation|0
5823571|NCT02549196|20112996|P1|Overall Study|Protocol Violation|0
5823572|NCT02549027|20113052|P6|Period 5 - MK-6096 or Placebo|Protocol Violation|0
5823573|NCT02549027|20113053|P5|Period 5 - MK-6096 or Placebo|Protocol Violation|2
5823574|NCT02549027|20113054|P4|Period 5 - MK-6096 or Placebo|Protocol Violation|0
5823575|NCT02549027|20113055|P3|Period 5 - MK-6096 or Placebo|Protocol Violation|0
5823576|NCT02549027|20113056|P2|Period 5 - MK-6096 or Placebo|Protocol Violation|0
5823577|NCT02549027|20113057|P1|Period 5 - MK-6096 or Placebo|Protocol Violation|0
5823578|NCT02549027|20113052|P6|Washout After Period 4|Withdrawal by Subject|0
5823579|NCT02549027|20113053|P5|Washout After Period 4|Withdrawal by Subject|0
5823580|NCT02549027|20113054|P4|Washout After Period 4|Withdrawal by Subject|1
5823581|NCT02549027|20113055|P3|Washout After Period 4|Withdrawal by Subject|1
5823582|NCT02549027|20113056|P2|Washout After Period 4|Withdrawal by Subject|1
5823583|NCT02549027|20113057|P1|Washout After Period 4|Withdrawal by Subject|0
5823584|NCT02548962|20113187|P2|Overall Study|Withdrawal by Subject|0
5823585|NCT02548962|20113188|P1|Overall Study|Withdrawal by Subject|1
5823586|NCT02548650|20113240|P2|Double Therapy|Withdrawal by Subject|1
5823587|NCT02548650|20113241|P1|Double Therapy|Withdrawal by Subject|0
5823588|NCT02548650|20113240|P2|Double Therapy|Adverse Event|1
5823589|NCT02548650|20113241|P1|Double Therapy|Adverse Event|1
5823590|NCT02548650|20113240|P2|Triple Therapy|Withdrawal by Subject|4
5823591|NCT02548650|20113241|P1|Triple Therapy|Withdrawal by Subject|0
5823592|NCT02548650|20113240|P2|Triple Therapy|Adverse Event|0
5823593|NCT02548650|20113241|P1|Triple Therapy|Adverse Event|1
5823594|NCT02548585|20113256|P7|Overall Study|Randomized but not treated|0
5823595|NCT02548585|20113257|P6|Overall Study|Randomized but not treated|1
5823596|NCT02548585|20113258|P5|Overall Study|Randomized but not treated|0
5823597|NCT02548585|20113259|P4|Overall Study|Randomized but not treated|0
5823598|NCT02548585|20113260|P3|Overall Study|Randomized but not treated|0
5823599|NCT02548585|20113261|P2|Overall Study|Randomized but not treated|0
5823600|NCT02548585|20113262|P1|Overall Study|Randomized but not treated|0
5823601|NCT02548585|20113256|P7|Overall Study|Other|1
5823602|NCT02548585|20113257|P6|Overall Study|Other|0
5823603|NCT02548585|20113258|P5|Overall Study|Other|3
5823604|NCT02548585|20113259|P4|Overall Study|Other|2
5823605|NCT02548585|20113260|P3|Overall Study|Other|0
5823606|NCT02548585|20113261|P2|Overall Study|Other|0
5823607|NCT02548585|20113262|P1|Overall Study|Other|1
5823608|NCT02548585|20113256|P7|Overall Study|Lost to Follow-up|0
5823609|NCT02548585|20113257|P6|Overall Study|Lost to Follow-up|0
5823610|NCT02548585|20113258|P5|Overall Study|Lost to Follow-up|0
5823611|NCT02548585|20113259|P4|Overall Study|Lost to Follow-up|0
5823612|NCT02548585|20113260|P3|Overall Study|Lost to Follow-up|0
5823613|NCT02548585|20113261|P2|Overall Study|Lost to Follow-up|0
5823614|NCT02548585|20113262|P1|Overall Study|Lost to Follow-up|1
5823615|NCT02548585|20113256|P7|Overall Study|Withdrawal by Subject|0
5823616|NCT02548585|20113257|P6|Overall Study|Withdrawal by Subject|1
5823617|NCT02548585|20113258|P5|Overall Study|Withdrawal by Subject|0
5823618|NCT02548585|20113259|P4|Overall Study|Withdrawal by Subject|0
5823619|NCT02548585|20113260|P3|Overall Study|Withdrawal by Subject|0
5823620|NCT02548585|20113261|P2|Overall Study|Withdrawal by Subject|0
5823621|NCT02548585|20113262|P1|Overall Study|Withdrawal by Subject|0
5823622|NCT02548455|20113480|P1|Overall Study|Visit not completed|173
5823623|NCT02548455|20113480|P1|Overall Study|Lost to Follow-up|14
5823624|NCT02548455|20113480|P1|Overall Study|Death|26
5823625|NCT02548455|20113480|P1|Overall Study|Withdrawal by Subject|27
5823626|NCT02548156|20113541|P6|Washout Period 1|Lost to Follow-up|0
5823627|NCT02548156|20113542|P5|Washout Period 1|Lost to Follow-up|1
5823628|NCT02548156|20113543|P4|Washout Period 1|Lost to Follow-up|0
5823629|NCT02548156|20113544|P3|Washout Period 1|Lost to Follow-up|0
5823630|NCT02548156|20113545|P2|Washout Period 1|Lost to Follow-up|0
5823631|NCT02548156|20113546|P1|Washout Period 1|Lost to Follow-up|0
5823632|NCT02548143|20113565|P2|Overall Study|Withdrawal by Subject|1
5823633|NCT02548143|20113566|P1|Overall Study|Withdrawal by Subject|0
5823634|NCT02548143|20113565|P2|Overall Study|Adverse Event|0
5823635|NCT02548143|20113566|P1|Overall Study|Adverse Event|1
5823636|NCT02548078|20113578|P2|Overall Study|Lost to Follow-up|3
5823637|NCT02548078|20113579|P1|Overall Study|Lost to Follow-up|1
5823638|NCT02548078|20113578|P2|Overall Study|Moved from study area|3
5823639|NCT02548078|20113579|P1|Overall Study|Moved from study area|3
5823640|NCT02548078|20113578|P2|Overall Study|Serious adverse event/Adverse event|0
5823641|NCT02548078|20113579|P1|Overall Study|Serious adverse event/Adverse event|1
5823644|NCT02547974|20113775|P4|Overall Study|Withdrawal by Subject|0
5823645|NCT02547974|20113776|P3|Overall Study|Withdrawal by Subject|0
5823646|NCT02547974|20113777|P2|Overall Study|Withdrawal by Subject|0
5823647|NCT02547974|20113778|P1|Overall Study|Withdrawal by Subject|1
5823648|NCT02547935|20113865|P3|Overall Study|Death|0
5823649|NCT02547935|20113866|P2|Overall Study|Death|1
5823650|NCT02547935|20113867|P1|Overall Study|Death|1
5823651|NCT02547935|20113865|P3|Overall Study|Lost to Follow-up|1
5823652|NCT02547935|20113866|P2|Overall Study|Lost to Follow-up|2
5823653|NCT02547935|20113867|P1|Overall Study|Lost to Follow-up|0
5823654|NCT02547935|20113865|P3|Overall Study|Physician Decision|0
5823655|NCT02547935|20113866|P2|Overall Study|Physician Decision|1
5823656|NCT02547935|20113867|P1|Overall Study|Physician Decision|0
5823657|NCT02547935|20113865|P3|Overall Study|Screen Failure|0
5823658|NCT02547935|20113866|P2|Overall Study|Screen Failure|0
5823659|NCT02547935|20113867|P1|Overall Study|Screen Failure|2
5823660|NCT02547935|20113865|P3|Overall Study|Withdrawal by Subject|4
5823661|NCT02547935|20113866|P2|Overall Study|Withdrawal by Subject|3
5823662|NCT02547935|20113867|P1|Overall Study|Withdrawal by Subject|2
5823663|NCT02547935|20113865|P3|Overall Study|Other|0
5823664|NCT02547935|20113866|P2|Overall Study|Other|1
5823665|NCT02547935|20113867|P1|Overall Study|Other|0
5823666|NCT02547766|20113905|P1|Overall Study|Withdrawal by Subject|1
5823667|NCT02547649|20113925|P3|Overall Study|Withdrawal by Subject|2
5823668|NCT02547649|20113926|P2|Overall Study|Withdrawal by Subject|4
5823669|NCT02547649|20113927|P1|Overall Study|Withdrawal by Subject|0
5823670|NCT02547649|20113925|P3|Overall Study|Not vaccinated|1
5823671|NCT02547649|20113926|P2|Overall Study|Not vaccinated|0
5823672|NCT02547649|20113927|P1|Overall Study|Not vaccinated|0
5823673|NCT02547649|20113925|P3|Overall Study|Lost to Follow-up|1
5823674|NCT02547649|20113926|P2|Overall Study|Lost to Follow-up|1
5823675|NCT02547649|20113927|P1|Overall Study|Lost to Follow-up|3
5823676|NCT02547454|20113992|P1|Overall Study|No data|11
5823677|NCT02547454|20113992|P1|Overall Study|Other|39
5823678|NCT02547454|20113992|P1|Overall Study|Lost to Follow-up|26
5823679|NCT02547454|20113992|P1|Overall Study|Death|38
5823680|NCT02547454|20113992|P1|Overall Study|Due to no further need to treat|4
5823681|NCT02547454|20113992|P1|Overall Study|Due to transplantation|1
5823682|NCT02547454|20113992|P1|Overall Study|Due to hemodialysis|53
5823683|NCT02547363|20114022|P2|12-month Follow-up|Other|0
5823684|NCT02547363|20114023|P1|12-month Follow-up|Other|1
5823685|NCT02547363|20114022|P2|12-month Follow-up|Lack of Efficacy|1
5823686|NCT02547363|20114023|P1|12-month Follow-up|Lack of Efficacy|1
5823687|NCT02547363|20114022|P2|12-month Follow-up|Lost to Follow-up|1
5823688|NCT02547363|20114023|P1|12-month Follow-up|Lost to Follow-up|4
5823689|NCT02547363|20114022|P2|12-month Follow-up|Withdrawal by Subject|3
5823690|NCT02547363|20114023|P1|12-month Follow-up|Withdrawal by Subject|4
5823691|NCT02547363|20114022|P2|3-day Treatment and 8-week Follow-up|Other|1
5823692|NCT02547363|20114023|P1|3-day Treatment and 8-week Follow-up|Other|1
5823693|NCT02547363|20114022|P2|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1
5823694|NCT02547363|20114023|P1|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1
5823695|NCT02547363|20114022|P2|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|8
5823696|NCT02547363|20114023|P1|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2
5823697|NCT02547363|20114022|P2|3-day Treatment and 8-week Follow-up|Adverse Event|1
5823698|NCT02547363|20114023|P1|3-day Treatment and 8-week Follow-up|Adverse Event|0
5823699|NCT02547233|20114039|P2|12-month Follow-up|Other|1
5823700|NCT02547233|20114040|P1|12-month Follow-up|Other|0
5823701|NCT02547233|20114039|P2|12-month Follow-up|Protocol Violation|1
5823702|NCT02547233|20114040|P1|12-month Follow-up|Protocol Violation|0
5823703|NCT02547233|20114039|P2|12-month Follow-up|Lack of Efficacy|2
5823704|NCT02547233|20114040|P1|12-month Follow-up|Lack of Efficacy|1
5823705|NCT02547233|20114039|P2|12-month Follow-up|Lost to Follow-up|3
5823706|NCT02547233|20114040|P1|12-month Follow-up|Lost to Follow-up|3
5823707|NCT02547233|20114039|P2|12-month Follow-up|Withdrawal by Subject|10
5823708|NCT02547233|20114040|P1|12-month Follow-up|Withdrawal by Subject|10
5823709|NCT02547233|20114039|P2|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1
5823710|NCT02547233|20114040|P1|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0
5823711|NCT02547233|20114039|P2|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|9
5823712|NCT02547233|20114040|P1|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|0
5823713|NCT02547233|20114039|P2|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|0
5823714|NCT02547233|20114040|P1|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|1
5823715|NCT02547233|20114039|P2|3-day Treatment and 8-week Follow-up|Adverse Event|0
5823716|NCT02547233|20114040|P1|3-day Treatment and 8-week Follow-up|Adverse Event|1
5823717|NCT02547220|20114056|P2|Overall Study|Study terminated by sponsor|20
5823718|NCT02547220|20114057|P1|Overall Study|Study terminated by sponsor|18
5823719|NCT02547220|20114056|P2|Overall Study|Withdrawal by Subject|0
5823720|NCT02547220|20114057|P1|Overall Study|Withdrawal by Subject|1
5823721|NCT02547129|20114093|P2|Overall Study|Difficulty with ongoing infection|0
5823722|NCT02547129|20114094|P1|Overall Study|Difficulty with ongoing infection|1
5823723|NCT02547038|20114137|P2|Overall Study|Lost to Follow-up|2
5823724|NCT02547038|20114138|P1|Overall Study|Lost to Follow-up|3
5823725|NCT02546986|20114155|P2|Survival Follow-Up Phase|Lost to Follow-up|2
5823726|NCT02546986|20114156|P1|Survival Follow-Up Phase|Lost to Follow-up|2
5823727|NCT02546986|20114155|P2|Survival Follow-Up Phase|Alive|16
5823728|NCT02546986|20114156|P1|Survival Follow-Up Phase|Alive|13
5823729|NCT02546986|20114155|P2|Survival Follow-Up Phase|Death|12
5823730|NCT02546986|20114156|P1|Survival Follow-Up Phase|Death|18
5823731|NCT02546986|20114155|P2|Survival Follow-Up Phase|Missing Status|5
5823732|NCT02546986|20114156|P1|Survival Follow-Up Phase|Missing Status|3
5823733|NCT02546986|20114155|P2|Treatment Period|Miscellaneous|9
5823734|NCT02546986|20114156|P1|Treatment Period|Miscellaneous|7
5823735|NCT02546986|20114155|P2|Treatment Period|Study Terminated by Sponsor|1
5823736|NCT02546986|20114156|P1|Treatment Period|Study Terminated by Sponsor|0
5823737|NCT02546986|20114155|P2|Treatment Period|Non-compliance with Study Drug|1
5823738|NCT02546986|20114156|P1|Treatment Period|Non-compliance with Study Drug|0
5823739|NCT02546986|20114155|P2|Treatment Period|Withdrawal by Subject|1
5823740|NCT02546986|20114156|P1|Treatment Period|Withdrawal by Subject|1
5823741|NCT02546986|20114155|P2|Treatment Period|Protocol Violation|0
5823742|NCT02546986|20114156|P1|Treatment Period|Protocol Violation|1
5823743|NCT02546986|20114155|P2|Treatment Period|Physician Decision|2
5823744|NCT02546986|20114156|P1|Treatment Period|Physician Decision|1
5823745|NCT02546986|20114155|P2|Treatment Period|Death|4
5823746|NCT02546986|20114156|P1|Treatment Period|Death|3
5823747|NCT02546986|20114155|P2|Treatment Period|Symptomatic Deterioration|3
5823748|NCT02546986|20114156|P1|Treatment Period|Symptomatic Deterioration|4
5823749|NCT02546986|20114155|P2|Treatment Period|Adverse Event|6
5823750|NCT02546986|20114156|P1|Treatment Period|Adverse Event|14
5823751|NCT02546986|20114155|P2|Treatment Period|Progressive Disease|22
5823752|NCT02546986|20114156|P1|Treatment Period|Progressive Disease|20
5823753|NCT02546856|20114181|P2|6 Months Evaluation|reasons not due to titration|1
5823754|NCT02546856|20114182|P1|6 Months Evaluation|reasons not due to titration|0
5823755|NCT02546856|20114181|P2|6 Months Evaluation|Working or living abroad|4
5823756|NCT02546856|20114182|P1|6 Months Evaluation|Working or living abroad|6
5823757|NCT02546856|20114181|P2|6 Months Evaluation|Lost to Follow-up|1
5823758|NCT02546856|20114182|P1|6 Months Evaluation|Lost to Follow-up|1
5823759|NCT02546856|20114181|P2|6 Months Evaluation|Death|1
5823760|NCT02546856|20114182|P1|6 Months Evaluation|Death|1
5823761|NCT02546856|20114181|P2|4 Months Evaluation|HF Unit not active in summer|0
5823762|NCT02546856|20114182|P1|4 Months Evaluation|HF Unit not active in summer|1
5823763|NCT02546856|20114181|P2|4 Months Evaluation|reasons not due to titration|1
5823764|NCT02546856|20114182|P1|4 Months Evaluation|reasons not due to titration|4
5823765|NCT02546856|20114181|P2|4 Months Evaluation|Working or living abroad|1
5823766|NCT02546856|20114182|P1|4 Months Evaluation|Working or living abroad|5
5823767|NCT02546856|20114181|P2|4 Months Evaluation|Physician Decision|0
5823768|NCT02546856|20114182|P1|4 Months Evaluation|Physician Decision|3
5823769|NCT02546856|20114181|P2|4 Months Evaluation|Lost to Follow-up|3
5823770|NCT02546856|20114182|P1|4 Months Evaluation|Lost to Follow-up|3
5823771|NCT02546856|20114181|P2|4 Months Evaluation|Withdrawal by Subject|3
5823772|NCT02546856|20114182|P1|4 Months Evaluation|Withdrawal by Subject|2
5823773|NCT02546856|20114181|P2|4 Months Evaluation|Death|3
5823774|NCT02546856|20114182|P1|4 Months Evaluation|Death|2
5823775|NCT02546765|20114232|P4|Overall Study|Withdrawal by Subject|0
5823776|NCT02546765|20114233|P3|Overall Study|Withdrawal by Subject|0
5823777|NCT02546765|20114234|P2|Overall Study|Withdrawal by Subject|1
5823778|NCT02546765|20114235|P1|Overall Study|Withdrawal by Subject|0
5823779|NCT02546609|20114276|P3|Overall Study|travel or work schedule restriction|2
5823780|NCT02546609|20114277|P2|Overall Study|travel or work schedule restriction|0
5823781|NCT02546609|20114278|P1|Overall Study|travel or work schedule restriction|0
5823782|NCT02546609|20114276|P3|Overall Study|Lost to Follow-up|1
5823783|NCT02546609|20114277|P2|Overall Study|Lost to Follow-up|3
5823784|NCT02546609|20114278|P1|Overall Study|Lost to Follow-up|2
5823785|NCT02546609|20114276|P3|Overall Study|Protocol Violation|1
5823786|NCT02546609|20114277|P2|Overall Study|Protocol Violation|1
5823787|NCT02546609|20114278|P1|Overall Study|Protocol Violation|0
5823788|NCT02546609|20114276|P3|Overall Study|Adverse Event|1
5823789|NCT02546609|20114277|P2|Overall Study|Adverse Event|6
5823790|NCT02546609|20114278|P1|Overall Study|Adverse Event|0
5823791|NCT02546609|20114276|P3|Overall Study|Withdrawal by Subject|2
5823792|NCT02546609|20114277|P2|Overall Study|Withdrawal by Subject|1
5823793|NCT02546609|20114278|P1|Overall Study|Withdrawal by Subject|0
5823794|NCT02546544|20114358|P1|Overall Study|Withdrawal by Subject|1
5823795|NCT02546544|20114358|P1|Overall Study|Adverse Event|1
5823796|NCT02546544|20114358|P1|Overall Study|Disease Progression|14
5823797|NCT02546362|20114399|P1|12-week Treatment Period|Change in medication|1
5823798|NCT02546362|20114399|P1|12-week Treatment Period|Lost to Follow-up|2
5823799|NCT02546362|20114399|P1|12-week Treatment Period|Withdrawal by Subject|6
5823800|NCT02546362|20114399|P1|4-week Treatment Period|Change in medication|2
5823801|NCT02546362|20114399|P1|4-week Treatment Period|Lost to Follow-up|1
5823802|NCT02546323|20114420|P2|Overall Study|Met Withdrawal Criteria|14
5823803|NCT02546323|20114421|P1|Overall Study|Met Withdrawal Criteria|2
5823804|NCT02546323|20114420|P2|Overall Study|Non-compliance with Study Drug|2
5823805|NCT02546323|20114421|P1|Overall Study|Non-compliance with Study Drug|2
5823806|NCT02546323|20114420|P2|Overall Study|Lost to Follow-up|3
5823807|NCT02546323|20114421|P1|Overall Study|Lost to Follow-up|2
5823808|NCT02546323|20114420|P2|Overall Study|Patient Specific Reasons|2
5823809|NCT02546323|20114421|P1|Overall Study|Patient Specific Reasons|1
5823810|NCT02546323|20114420|P2|Overall Study|Adverse Event|11
5823811|NCT02546323|20114421|P1|Overall Study|Adverse Event|17
5823812|NCT02546323|20114420|P2|Overall Study|Eligibility Criteria not Fulfilled|1
5823813|NCT02546323|20114421|P1|Overall Study|Eligibility Criteria not Fulfilled|0
5823814|NCT02546323|20114420|P2|Overall Study|Withdrawal by Subject|33
5823815|NCT02546323|20114421|P1|Overall Study|Withdrawal by Subject|36
5823816|NCT02546193|20114441|P4|Overall Study|Not eligible at time of induction|0
5823817|NCT02546193|20114442|P3|Overall Study|Not eligible at time of induction|1
5823818|NCT02546193|20114443|P2|Overall Study|Not eligible at time of induction|6
5823819|NCT02546193|20114444|P1|Overall Study|Not eligible at time of induction|4
5823820|NCT02546193|20114441|P4|Overall Study|Withdrawal by Subject|0
5823821|NCT02546193|20114442|P3|Overall Study|Withdrawal by Subject|1
5823822|NCT02546193|20114443|P2|Overall Study|Withdrawal by Subject|0
5823823|NCT02546193|20114444|P1|Overall Study|Withdrawal by Subject|2
5823824|NCT02545933|20114481|P3|Overall Study|Protocol Violation|1
5823825|NCT02545933|20114482|P2|Overall Study|Protocol Violation|0
5823826|NCT02545933|20114483|P1|Overall Study|Protocol Violation|1
5823827|NCT02545933|20114481|P3|Overall Study|Withdrawal by Subject|3
5823828|NCT02545933|20114482|P2|Overall Study|Withdrawal by Subject|3
5823829|NCT02545933|20114483|P1|Overall Study|Withdrawal by Subject|2
5823830|NCT02545933|20114481|P3|Overall Study|Adverse Event|0
5823831|NCT02545933|20114482|P2|Overall Study|Adverse Event|0
5823832|NCT02545933|20114483|P1|Overall Study|Adverse Event|3
5823833|NCT02545868|20114494|P3|Optional Ocrelizumab Ext (OOE) Period|OOE period ongoing|34
5823834|NCT02545868|20114495|P2|Optional Ocrelizumab Ext (OOE) Period|OOE period ongoing|35
5823835|NCT02545868|20114496|P1|Optional Ocrelizumab Ext (OOE) Period|OOE period ongoing|33
5823836|NCT02545543|20114579|P2|Overall Study|Enrolment of subject at >1 study site|1
5823837|NCT02545543|20114580|P1|Overall Study|Enrolment of subject at >1 study site|1
5823838|NCT02545543|20114579|P2|Overall Study|Noncomplaince|0
5823839|NCT02545543|20114580|P1|Overall Study|Noncomplaince|1
5823840|NCT02545543|20114579|P2|Overall Study|Withdrawal by Subject|8
5823841|NCT02545543|20114580|P1|Overall Study|Withdrawal by Subject|9
5823842|NCT02545543|20114579|P2|Overall Study|Physician Decision|0
5823843|NCT02545543|20114580|P1|Overall Study|Physician Decision|3
5823844|NCT02545543|20114579|P2|Overall Study|Lost to Follow-up|25
5823845|NCT02545543|20114580|P1|Overall Study|Lost to Follow-up|67
5823846|NCT02545504|20114606|P2|Overall Study|Lost to Follow-up|2
5823847|NCT02545504|20114607|P1|Overall Study|Lost to Follow-up|2
5823848|NCT02545504|20114606|P2|Overall Study|Investigator's discretion|1
5823849|NCT02545504|20114607|P1|Overall Study|Investigator's discretion|3
5823850|NCT02545504|20114606|P2|Overall Study|Withdrew consent|11
5823851|NCT02545504|20114607|P1|Overall Study|Withdrew consent|9
5823852|NCT02545504|20114606|P2|Overall Study|Unknown reason|32
5823853|NCT02545504|20114607|P1|Overall Study|Unknown reason|30
5823854|NCT02545504|20114606|P2|Overall Study|Death|168
5823855|NCT02545504|20114607|P1|Overall Study|Death|174
5823856|NCT02545322|20114621|P1|Overall Study|Withdrawal by Subject|3
5823857|NCT02545270|20114629|P3|Overall Study|Videos being too similar to other|2
5823858|NCT02545270|20114630|P2|Overall Study|Videos being too similar to other|0
5823859|NCT02545270|20114631|P1|Overall Study|Videos being too similar to other|0
5823860|NCT02545270|20114629|P3|Overall Study|technical difficulties|0
5823861|NCT02545270|20114630|P2|Overall Study|technical difficulties|1
5823862|NCT02545270|20114631|P1|Overall Study|technical difficulties|0
5823863|NCT02545075|20114660|P2|Treatment|Completed treatment|12
5823864|NCT02545075|20114661|P1|Treatment|Completed treatment|40
5823865|NCT02545075|20114660|P2|Treatment|Participant drug toxicity|0
5823866|NCT02545075|20114661|P1|Treatment|Participant drug toxicity|1
5823867|NCT02545075|20114660|P2|Treatment|Death|0
5823868|NCT02545075|20114661|P1|Treatment|Death|1
5823869|NCT02545075|20114660|P2|Treatment|Adverse event not related to study drug|0
5823870|NCT02545075|20114661|P1|Treatment|Adverse event not related to study drug|1
5823871|NCT02545075|20114660|P2|Treatment|Withdrawal by Subject|0
5823872|NCT02545075|20114661|P1|Treatment|Withdrawal by Subject|1
5823873|NCT02545075|20114660|P2|Treatment|Participant dicontinued study treatment|9
5823874|NCT02545075|20114661|P1|Treatment|Participant dicontinued study treatment|7
5823875|NCT02545075|20114660|P2|Treatment|Disease progression|32
5823876|NCT02545075|20114661|P1|Treatment|Disease progression|71
5823877|NCT02545075|20114660|P2|Randomization|Withdrawal by Subject|6
5823878|NCT02545075|20114661|P1|Randomization|Withdrawal by Subject|0
5823879|NCT02545075|20114660|P2|Randomization|Lost to Follow-up|1
5823880|NCT02545075|20114661|P1|Randomization|Lost to Follow-up|0
5823881|NCT02544763|20114697|P3|Overall Study|Difficulties taking IMP|0
5823882|NCT02544763|20114698|P2|Overall Study|Difficulties taking IMP|0
5823883|NCT02544763|20114699|P1|Overall Study|Difficulties taking IMP|1
5823884|NCT02544763|20114697|P3|Overall Study|Physician Decision|0
5823885|NCT02544763|20114698|P2|Overall Study|Physician Decision|1
5823886|NCT02544763|20114699|P1|Overall Study|Physician Decision|0
5823887|NCT02544763|20114697|P3|Overall Study|Met withdrawal criteria|0
5823888|NCT02544763|20114698|P2|Overall Study|Met withdrawal criteria|2
5823889|NCT02544763|20114699|P1|Overall Study|Met withdrawal criteria|0
5823890|NCT02544763|20114697|P3|Overall Study|Withdrawn by parent/guardian|1
5823891|NCT02544763|20114698|P2|Overall Study|Withdrawn by parent/guardian|1
5823892|NCT02544763|20114699|P1|Overall Study|Withdrawn by parent/guardian|1
5823893|NCT02544763|20114697|P3|Overall Study|Adverse Event|0
5823894|NCT02544763|20114698|P2|Overall Study|Adverse Event|8
5823895|NCT02544763|20114699|P1|Overall Study|Adverse Event|8
5823896|NCT02544633|20114723|P4|Survival Follow-up Period|Study Terminated by Sponsor|3
5823897|NCT02544633|20114724|P3|Survival Follow-up Period|Study Terminated by Sponsor|2
5823898|NCT02544633|20114725|P2|Survival Follow-up Period|Study Terminated by Sponsor|4
5823899|NCT02544633|20114726|P1|Survival Follow-up Period|Study Terminated by Sponsor|12
5823900|NCT02544633|20114723|P4|Survival Follow-up Period|Withdrawal by Subject|0
5823901|NCT02544633|20114724|P3|Survival Follow-up Period|Withdrawal by Subject|1
5823902|NCT02544633|20114725|P2|Survival Follow-up Period|Withdrawal by Subject|0
5823903|NCT02544633|20114726|P1|Survival Follow-up Period|Withdrawal by Subject|4
5823904|NCT02544633|20114723|P4|Survival Follow-up Period|Lost to Follow-up|0
5823905|NCT02544633|20114724|P3|Survival Follow-up Period|Lost to Follow-up|1
5823906|NCT02544633|20114725|P2|Survival Follow-up Period|Lost to Follow-up|1
5823907|NCT02544633|20114726|P1|Survival Follow-up Period|Lost to Follow-up|0
5823908|NCT02544633|20114723|P4|Survival Follow-up Period|Death|9
5823909|NCT02544633|20114724|P3|Survival Follow-up Period|Death|3
5823910|NCT02544633|20114725|P2|Survival Follow-up Period|Death|14
5823911|NCT02544633|20114726|P1|Survival Follow-up Period|Death|12
5823912|NCT02544633|20114723|P4|Treatment Period|Clinical Disease Progression|1
5823913|NCT02544633|20114724|P3|Treatment Period|Clinical Disease Progression|0
5823914|NCT02544633|20114725|P2|Treatment Period|Clinical Disease Progression|0
5823915|NCT02544633|20114726|P1|Treatment Period|Clinical Disease Progression|0
5823916|NCT02544633|20114723|P4|Treatment Period|Non-compliance|0
5823917|NCT02544633|20114724|P3|Treatment Period|Non-compliance|1
5823918|NCT02544633|20114725|P2|Treatment Period|Non-compliance|0
5823919|NCT02544633|20114726|P1|Treatment Period|Non-compliance|0
5823920|NCT02544633|20114723|P4|Treatment Period|Death|0
5823921|NCT02544633|20114724|P3|Treatment Period|Death|1
5823922|NCT02544633|20114725|P2|Treatment Period|Death|0
5823923|NCT02544633|20114726|P1|Treatment Period|Death|0
5823924|NCT02544633|20114723|P4|Treatment Period|Lost to Follow-up|0
5823925|NCT02544633|20114724|P3|Treatment Period|Lost to Follow-up|0
5823926|NCT02544633|20114725|P2|Treatment Period|Lost to Follow-up|1
5823927|NCT02544633|20114726|P1|Treatment Period|Lost to Follow-up|0
5823928|NCT02544633|20114723|P4|Treatment Period|Withdrawal by Subject|0
5823929|NCT02544633|20114724|P3|Treatment Period|Withdrawal by Subject|0
5823930|NCT02544633|20114725|P2|Treatment Period|Withdrawal by Subject|0
5823931|NCT02544633|20114726|P1|Treatment Period|Withdrawal by Subject|1
5823932|NCT02544633|20114723|P4|Treatment Period|Global Deterioration of Health|1
5823933|NCT02544633|20114724|P3|Treatment Period|Global Deterioration of Health|0
5823934|NCT02544633|20114725|P2|Treatment Period|Global Deterioration of Health|3
5823935|NCT02544633|20114726|P1|Treatment Period|Global Deterioration of Health|3
5823936|NCT02544633|20114723|P4|Treatment Period|Lack of Efficacy|5
5823937|NCT02544633|20114724|P3|Treatment Period|Lack of Efficacy|5
5823938|NCT02544633|20114725|P2|Treatment Period|Lack of Efficacy|11
5823939|NCT02544633|20114726|P1|Treatment Period|Lack of Efficacy|17
5823940|NCT02544633|20114723|P4|Treatment Period|Adverse Event|5
5823941|NCT02544633|20114724|P3|Treatment Period|Adverse Event|0
5823942|NCT02544633|20114725|P2|Treatment Period|Adverse Event|4
5823943|NCT02544633|20114726|P1|Treatment Period|Adverse Event|7
5823944|NCT02544633|20114723|P4|Treatment Period|Patient Still on Treatment/Study|0
5823945|NCT02544633|20114724|P3|Treatment Period|Patient Still on Treatment/Study|1
5823946|NCT02544633|20114725|P2|Treatment Period|Patient Still on Treatment/Study|1
5823947|NCT02544633|20114726|P1|Treatment Period|Patient Still on Treatment/Study|0
5823948|NCT02544451|20114810|P3|Overall Study|Other|0
5823949|NCT02544451|20114811|P2|Overall Study|Other|4
5823950|NCT02544451|20114812|P1|Overall Study|Other|4
5823951|NCT02544451|20114810|P3|Overall Study|Physician Decision|0
5823952|NCT02544451|20114811|P2|Overall Study|Physician Decision|0
5823953|NCT02544451|20114812|P1|Overall Study|Physician Decision|4
5823954|NCT02544451|20114810|P3|Overall Study|Lost to Follow-up|0
5823955|NCT02544451|20114811|P2|Overall Study|Lost to Follow-up|0
5823956|NCT02544451|20114812|P1|Overall Study|Lost to Follow-up|2
5823957|NCT02544451|20114810|P3|Overall Study|Withdrawal of consent (not due to AE)|1
5823958|NCT02544451|20114811|P2|Overall Study|Withdrawal of consent (not due to AE)|2
5823959|NCT02544451|20114812|P1|Overall Study|Withdrawal of consent (not due to AE)|3
5823960|NCT02544451|20114810|P3|Overall Study|Adverse Event|0
5823961|NCT02544451|20114811|P2|Overall Study|Adverse Event|6
5823962|NCT02544451|20114812|P1|Overall Study|Adverse Event|1
5823963|NCT02544217|20114861|P6|Overall Study|Withdrawal by Subject|0
5823964|NCT02544217|20114862|P5|Overall Study|Withdrawal by Subject|0
5823965|NCT02544217|20114863|P4|Overall Study|Withdrawal by Subject|0
5823966|NCT02544217|20114864|P3|Overall Study|Withdrawal by Subject|0
5823967|NCT02544217|20114865|P2|Overall Study|Withdrawal by Subject|1
5823968|NCT02544217|20114866|P1|Overall Study|Withdrawal by Subject|1
5823969|NCT02544152|20115661|P2|Overall Study|Other|0
5823970|NCT02544152|20115662|P1|Overall Study|Other|1
5823971|NCT02544152|20115661|P2|Overall Study|Withdrawal by Subject|3
5823972|NCT02544152|20115662|P1|Overall Study|Withdrawal by Subject|0
5823973|NCT02544152|20115661|P2|Overall Study|Adverse Event|4
5823974|NCT02544152|20115662|P1|Overall Study|Adverse Event|0
5823975|NCT02544074|20115705|P21|Overall Study|Tablet error|0
5823976|NCT02544074|20115706|P20|Overall Study|Tablet error|0
5823977|NCT02544074|20115707|P19|Overall Study|Tablet error|0
5823978|NCT02544074|20115708|P18|Overall Study|Tablet error|0
5823979|NCT02544074|20115709|P17|Overall Study|Tablet error|0
5823980|NCT02544074|20115710|P16|Overall Study|Tablet error|0
5823981|NCT02544074|20115711|P15|Overall Study|Tablet error|0
5823982|NCT02544074|20115712|P14|Overall Study|Tablet error|0
5823983|NCT02544074|20115713|P13|Overall Study|Tablet error|0
5823984|NCT02544074|20115714|P12|Overall Study|Tablet error|0
5823985|NCT02544074|20115715|P11|Overall Study|Tablet error|0
5823986|NCT02544074|20115716|P10|Overall Study|Tablet error|1
5823987|NCT02544074|20115717|P9|Overall Study|Tablet error|0
5823988|NCT02544074|20115718|P8|Overall Study|Tablet error|0
5823989|NCT02544074|20115719|P7|Overall Study|Tablet error|0
5823990|NCT02544074|20115720|P6|Overall Study|Tablet error|1
5823991|NCT02544074|20115721|P5|Overall Study|Tablet error|0
5823992|NCT02544074|20115722|P4|Overall Study|Tablet error|0
5823993|NCT02544074|20115723|P3|Overall Study|Tablet error|0
5823994|NCT02544074|20115724|P2|Overall Study|Tablet error|0
5823995|NCT02544074|20115725|P1|Overall Study|Tablet error|0
5823996|NCT02544074|20115705|P21|Overall Study|Withdrawal by Subject|0
5823997|NCT02544074|20115706|P20|Overall Study|Withdrawal by Subject|0
5823998|NCT02544074|20115707|P19|Overall Study|Withdrawal by Subject|0
5823999|NCT02544074|20115708|P18|Overall Study|Withdrawal by Subject|0
5824000|NCT02544074|20115709|P17|Overall Study|Withdrawal by Subject|0
5824001|NCT02544074|20115710|P16|Overall Study|Withdrawal by Subject|0
5824002|NCT02544074|20115711|P15|Overall Study|Withdrawal by Subject|0
5824003|NCT02544074|20115712|P14|Overall Study|Withdrawal by Subject|0
5824004|NCT02544074|20115713|P13|Overall Study|Withdrawal by Subject|0
5824005|NCT02544074|20115714|P12|Overall Study|Withdrawal by Subject|0
5824006|NCT02544074|20115715|P11|Overall Study|Withdrawal by Subject|0
5824007|NCT02544074|20115716|P10|Overall Study|Withdrawal by Subject|0
5824008|NCT02544074|20115717|P9|Overall Study|Withdrawal by Subject|0
5824009|NCT02544074|20115718|P8|Overall Study|Withdrawal by Subject|0
5824010|NCT02544074|20115719|P7|Overall Study|Withdrawal by Subject|0
5824011|NCT02544074|20115720|P6|Overall Study|Withdrawal by Subject|0
5824012|NCT02544074|20115721|P5|Overall Study|Withdrawal by Subject|0
5824013|NCT02544074|20115722|P4|Overall Study|Withdrawal by Subject|0
5824014|NCT02544074|20115723|P3|Overall Study|Withdrawal by Subject|0
5824015|NCT02544074|20115724|P2|Overall Study|Withdrawal by Subject|1
5824016|NCT02544074|20115725|P1|Overall Study|Withdrawal by Subject|0
5824017|NCT02543918|20115761|P2|Overall Study|Adverse Event|1
5824018|NCT02543918|20115762|P1|Overall Study|Adverse Event|1
5824019|NCT02543918|20115761|P2|Overall Study|Withdrawal by Subject|1
5824020|NCT02543918|20115762|P1|Overall Study|Withdrawal by Subject|1
5824021|NCT02543918|20115761|P2|Overall Study|Lost to Follow-up|1
5824022|NCT02543918|20115762|P1|Overall Study|Lost to Follow-up|1
5824023|NCT02543918|20115761|P2|Overall Study|Never treated|1
5824024|NCT02543918|20115762|P1|Overall Study|Never treated|0
5824025|NCT02543892|20115776|P8|Had Immunology Data|Withdrawal by Subject|0
5824026|NCT02543892|20115777|P7|Had Immunology Data|Withdrawal by Subject|1
5824027|NCT02543892|20115778|P6|Had Immunology Data|Withdrawal by Subject|0
5824028|NCT02543892|20115779|P5|Had Immunology Data|Withdrawal by Subject|0
5824029|NCT02543892|20115780|P4|Had Immunology Data|Withdrawal by Subject|0
5824030|NCT02543892|20115781|P3|Had Immunology Data|Withdrawal by Subject|0
5824031|NCT02543892|20115782|P2|Had Immunology Data|Withdrawal by Subject|0
5824032|NCT02543892|20115783|P1|Had Immunology Data|Withdrawal by Subject|0
5824033|NCT02543892|20115776|P8|Received Vaccination 2|Adverse Event|0
5824034|NCT02543892|20115777|P7|Received Vaccination 2|Adverse Event|0
5824035|NCT02543892|20115778|P6|Received Vaccination 2|Adverse Event|0
5824036|NCT02543892|20115779|P5|Received Vaccination 2|Adverse Event|0
5824037|NCT02543892|20115780|P4|Received Vaccination 2|Adverse Event|0
5824038|NCT02543892|20115781|P3|Received Vaccination 2|Adverse Event|0
5824039|NCT02543892|20115782|P2|Received Vaccination 2|Adverse Event|1
5824040|NCT02543892|20115783|P1|Received Vaccination 2|Adverse Event|0
5824041|NCT02543892|20115776|P8|Received Vaccination 2|Physician Decision|0
5824042|NCT02543892|20115777|P7|Received Vaccination 2|Physician Decision|0
5824043|NCT02543892|20115778|P6|Received Vaccination 2|Physician Decision|1
5824044|NCT02543892|20115779|P5|Received Vaccination 2|Physician Decision|0
5824045|NCT02543892|20115780|P4|Received Vaccination 2|Physician Decision|0
5824046|NCT02543892|20115781|P3|Received Vaccination 2|Physician Decision|0
5824047|NCT02543892|20115782|P2|Received Vaccination 2|Physician Decision|0
5824048|NCT02543892|20115783|P1|Received Vaccination 2|Physician Decision|0
5824049|NCT02543892|20115776|P8|Received Vaccination 2|Withdrawal by Subject|1
5824050|NCT02543892|20115777|P7|Received Vaccination 2|Withdrawal by Subject|0
5824051|NCT02543892|20115778|P6|Received Vaccination 2|Withdrawal by Subject|0
5824052|NCT02543892|20115779|P5|Received Vaccination 2|Withdrawal by Subject|0
5824053|NCT02543892|20115780|P4|Received Vaccination 2|Withdrawal by Subject|0
5824054|NCT02543892|20115781|P3|Received Vaccination 2|Withdrawal by Subject|0
5824055|NCT02543892|20115782|P2|Received Vaccination 2|Withdrawal by Subject|0
5824056|NCT02543892|20115783|P1|Received Vaccination 2|Withdrawal by Subject|1
5824057|NCT02543801|20115850|P4|Overall Study|Protocol Violation|0
5824058|NCT02543801|20115851|P3|Overall Study|Protocol Violation|0
5824059|NCT02543801|20115852|P2|Overall Study|Protocol Violation|2
5824060|NCT02543801|20115853|P1|Overall Study|Protocol Violation|1
5824061|NCT02543658|20115873|P2|Overall Study|Lack of Efficacy|4
5824062|NCT02543658|20115874|P1|Overall Study|Lack of Efficacy|0
5824063|NCT02543528|20115911|P5|Extended Wear Period|Withdrawal by Subject|0
5824064|NCT02543528|20115912|P4|Extended Wear Period|Withdrawal by Subject|5
5824065|NCT02543528|20115913|P3|Extended Wear Period|Withdrawal by Subject|4
5824066|NCT02543528|20115914|P2|Extended Wear Period|Withdrawal by Subject|9
5824067|NCT02543528|20115915|P1|Extended Wear Period|Withdrawal by Subject|10
5824068|NCT02543528|20115911|P5|Extended Wear Period|Lost to Follow-up|0
5824069|NCT02543528|20115912|P4|Extended Wear Period|Lost to Follow-up|1
5824070|NCT02543528|20115913|P3|Extended Wear Period|Lost to Follow-up|2
5824071|NCT02543528|20115914|P2|Extended Wear Period|Lost to Follow-up|1
5824072|NCT02543528|20115915|P1|Extended Wear Period|Lost to Follow-up|0
5824073|NCT02543528|20115911|P5|Extended Wear Period|Unsatisfactory Lens Fitting|0
5824074|NCT02543528|20115912|P4|Extended Wear Period|Unsatisfactory Lens Fitting|0
5824075|NCT02543528|20115913|P3|Extended Wear Period|Unsatisfactory Lens Fitting|0
5824076|NCT02543528|20115914|P2|Extended Wear Period|Unsatisfactory Lens Fitting|0
5824077|NCT02543528|20115915|P1|Extended Wear Period|Unsatisfactory Lens Fitting|1
5824078|NCT02543528|20115911|P5|Extended Wear Period|Missed too many scheduled visits|0
5824079|NCT02543528|20115912|P4|Extended Wear Period|Missed too many scheduled visits|3
5824080|NCT02543528|20115913|P3|Extended Wear Period|Missed too many scheduled visits|1
5824081|NCT02543528|20115914|P2|Extended Wear Period|Missed too many scheduled visits|0
5824082|NCT02543528|20115915|P1|Extended Wear Period|Missed too many scheduled visits|0
5824083|NCT02543528|20115911|P5|Extended Wear Period|Adverse Event|0
5824084|NCT02543528|20115912|P4|Extended Wear Period|Adverse Event|3
5824085|NCT02543528|20115913|P3|Extended Wear Period|Adverse Event|16
5824086|NCT02543528|20115914|P2|Extended Wear Period|Adverse Event|11
5824087|NCT02543528|20115915|P1|Extended Wear Period|Adverse Event|17
5824088|NCT02543528|20115911|P5|Adaptation Period|Adverse Event|2
5824089|NCT02543528|20115912|P4|Adaptation Period|Adverse Event|0
5824090|NCT02543528|20115913|P3|Adaptation Period|Adverse Event|0
5824091|NCT02543528|20115914|P2|Adaptation Period|Adverse Event|0
5824092|NCT02543528|20115915|P1|Adaptation Period|Adverse Event|0
5824093|NCT02543528|20115911|P5|Adaptation Period|Lost to Follow-up|14
5824094|NCT02543528|20115912|P4|Adaptation Period|Lost to Follow-up|0
5824095|NCT02543528|20115913|P3|Adaptation Period|Lost to Follow-up|0
5824096|NCT02543528|20115914|P2|Adaptation Period|Lost to Follow-up|0
5824097|NCT02543528|20115915|P1|Adaptation Period|Lost to Follow-up|0
5824098|NCT02543528|20115911|P5|Adaptation Period|Lens Handling Difficultes|8
5824099|NCT02543528|20115912|P4|Adaptation Period|Lens Handling Difficultes|0
5824100|NCT02543528|20115913|P3|Adaptation Period|Lens Handling Difficultes|0
5824101|NCT02543528|20115914|P2|Adaptation Period|Lens Handling Difficultes|0
5824102|NCT02543528|20115915|P1|Adaptation Period|Lens Handling Difficultes|0
5824103|NCT02543528|20115911|P5|Adaptation Period|Unsatisfactory Lens Fitting|2
5824104|NCT02543528|20115912|P4|Adaptation Period|Unsatisfactory Lens Fitting|0
5824105|NCT02543528|20115913|P3|Adaptation Period|Unsatisfactory Lens Fitting|0
5824106|NCT02543528|20115914|P2|Adaptation Period|Unsatisfactory Lens Fitting|0
5824107|NCT02543528|20115915|P1|Adaptation Period|Unsatisfactory Lens Fitting|0
5824108|NCT02543346|20115948|P4|Second Priming Visit|Adverse Event|0
5824109|NCT02543346|20115949|P3|Second Priming Visit|Adverse Event|0
5824110|NCT02543346|20115950|P2|Second Priming Visit|Adverse Event|0
5824111|NCT02543346|20115951|P1|Second Priming Visit|Adverse Event|1
5824112|NCT02543346|20115948|P4|Second Priming Visit|Withdrawal by Subject|2
5824113|NCT02543346|20115949|P3|Second Priming Visit|Withdrawal by Subject|2
5824114|NCT02543346|20115950|P2|Second Priming Visit|Withdrawal by Subject|2
5824115|NCT02543346|20115951|P1|Second Priming Visit|Withdrawal by Subject|0
5824116|NCT02543294|20115977|P1|Overall Study|Withdrawal by Subject|7
5824117|NCT02543294|20115977|P1|Overall Study|Physician Decision|2
5824118|NCT02543294|20115977|P1|Overall Study|Lost to Follow-up|3
5824119|NCT02542943|20115985|P3|Overall Study|Withdrawal by Subject|0
5824120|NCT02542943|20115986|P2|Overall Study|Withdrawal by Subject|1
5824121|NCT02542943|20115987|P1|Overall Study|Withdrawal by Subject|0
5824122|NCT02542943|20115985|P3|Overall Study|Lost to Follow-up|0
5824123|NCT02542943|20115986|P2|Overall Study|Lost to Follow-up|0
5824124|NCT02542943|20115987|P1|Overall Study|Lost to Follow-up|1
5824125|NCT02542865|20116014|P2|Overall Study|Withdrawal by Subject|0
5824126|NCT02542865|20116015|P1|Overall Study|Withdrawal by Subject|16
5824127|NCT02542865|20116014|P2|Overall Study|Identified as screen failure|0
5824128|NCT02542865|20116015|P1|Overall Study|Identified as screen failure|1
5824129|NCT02542631|20116078|P2|Overall Study|Used Prohibited Medication|1
5824130|NCT02542631|20116079|P1|Overall Study|Used Prohibited Medication|2
5824131|NCT02542631|20116078|P2|Overall Study|Other|1
5824132|NCT02542631|20116079|P1|Overall Study|Other|2
5824133|NCT02542631|20116078|P2|Overall Study|Death|2
5824134|NCT02542631|20116079|P1|Overall Study|Death|1
5824135|NCT02542631|20116078|P2|Overall Study|Lost to Follow-up|5
5824136|NCT02542631|20116079|P1|Overall Study|Lost to Follow-up|6
5824137|NCT02542631|20116078|P2|Overall Study|Physician Decision|4
5824138|NCT02542631|20116079|P1|Overall Study|Physician Decision|6
5824139|NCT02542631|20116078|P2|Overall Study|Protocol Violation|1
5824140|NCT02542631|20116079|P1|Overall Study|Protocol Violation|1
5824141|NCT02542631|20116078|P2|Overall Study|Withdrawal by Subject|16
5824142|NCT02542631|20116079|P1|Overall Study|Withdrawal by Subject|11
5824143|NCT02542631|20116078|P2|Overall Study|Sponsor Termination|0
5824144|NCT02542631|20116079|P1|Overall Study|Sponsor Termination|1
5824145|NCT02542631|20116078|P2|Overall Study|Adverse Event|1
5824146|NCT02542631|20116079|P1|Overall Study|Adverse Event|1
5824147|NCT02542605|20116101|P3|Part B: Randomization Phase|Withdrawal by Subject|1
5824148|NCT02542605|20116102|P2|Part B: Randomization Phase|Withdrawal by Subject|0
5824149|NCT02542605|20116103|P1|Part B: Randomization Phase|Withdrawal by Subject|0
5824150|NCT02542605|20116101|P3|Part B: Challenge Phase|Sponsor decision|0
5824151|NCT02542605|20116102|P2|Part B: Challenge Phase|Sponsor decision|0
5824152|NCT02542605|20116103|P1|Part B: Challenge Phase|Sponsor decision|1
5824153|NCT02542267|20116191|P1|Overall Study|Other|5
5824154|NCT02542267|20116191|P1|Overall Study|Surgical Bypass of All Study Devices|12
5824155|NCT02542267|20116191|P1|Overall Study|Death|12
5824156|NCT02542267|20116191|P1|Overall Study|Lost to Follow-up|4
5824157|NCT02542267|20116191|P1|Overall Study|Physician Decision|5
5824158|NCT02542267|20116191|P1|Overall Study|Withdrawal by Subject|8
5824159|NCT02542267|20116191|P1|Overall Study|Ongoing|31
5824160|NCT02542072|20116199|P2|Second Intervention (1 Month)|Lens discomfort|0
5824161|NCT02542072|20116200|P1|Second Intervention (1 Month)|Lens discomfort|1
5824162|NCT02542072|20116199|P2|Second Intervention (1 Month)|Lost to Follow-up|0
5824163|NCT02542072|20116200|P1|Second Intervention (1 Month)|Lost to Follow-up|1
5824164|NCT02542072|20116199|P2|First Intervention (1 Month)|Protocol Violation|0
5824165|NCT02542072|20116200|P1|First Intervention (1 Month)|Protocol Violation|1
5824166|NCT02542072|20116199|P2|First Intervention (1 Month)|Lens discomfort|2
5824167|NCT02542072|20116200|P1|First Intervention (1 Month)|Lens discomfort|1
5824168|NCT02542072|20116199|P2|First Intervention (1 Month)|Lost to Follow-up|0
5824169|NCT02542072|20116200|P1|First Intervention (1 Month)|Lost to Follow-up|2
5824170|NCT02542072|20116199|P2|First Intervention (1 Month)|Adverse Event|1
5824171|NCT02542072|20116200|P1|First Intervention (1 Month)|Adverse Event|1
5824172|NCT02541903|20116324|P1|Overall Study|Death|1
5824173|NCT02541669|20116355|P5|Double-Blinded Treatment Period|Withdrawal by Subject|1
5824174|NCT02541669|20116356|P4|Double-Blinded Treatment Period|Withdrawal by Subject|0
5824175|NCT02541669|20116357|P3|Double-Blinded Treatment Period|Withdrawal by Subject|1
5824176|NCT02541669|20116358|P2|Double-Blinded Treatment Period|Withdrawal by Subject|0
5824177|NCT02541669|20116359|P1|Double-Blinded Treatment Period|Withdrawal by Subject|0
5824178|NCT02541604|20116406|P12|Overall Study|Medical condition may jeopardize safety|0
5824179|NCT02541604|20116407|P11|Overall Study|Medical condition may jeopardize safety|0
5824180|NCT02541604|20116408|P10|Overall Study|Medical condition may jeopardize safety|0
5824181|NCT02541604|20116409|P9|Overall Study|Medical condition may jeopardize safety|0
5824182|NCT02541604|20116410|P8|Overall Study|Medical condition may jeopardize safety|1
5824183|NCT02541604|20116411|P7|Overall Study|Medical condition may jeopardize safety|0
5824184|NCT02541604|20116412|P6|Overall Study|Medical condition may jeopardize safety|0
5824185|NCT02541604|20116413|P5|Overall Study|Medical condition may jeopardize safety|0
5824186|NCT02541604|20116414|P4|Overall Study|Medical condition may jeopardize safety|0
5824187|NCT02541604|20116415|P3|Overall Study|Medical condition may jeopardize safety|0
5824188|NCT02541604|20116416|P2|Overall Study|Medical condition may jeopardize safety|0
5824189|NCT02541604|20116417|P1|Overall Study|Medical condition may jeopardize safety|0
5824190|NCT02541604|20116406|P12|Overall Study|Study Terminated by Sponsor|0
5824191|NCT02541604|20116407|P11|Overall Study|Study Terminated by Sponsor|0
5824192|NCT02541604|20116408|P10|Overall Study|Study Terminated by Sponsor|0
5824193|NCT02541604|20116409|P9|Overall Study|Study Terminated by Sponsor|0
5824194|NCT02541604|20116410|P8|Overall Study|Study Terminated by Sponsor|0
5824195|NCT02541604|20116411|P7|Overall Study|Study Terminated by Sponsor|0
5824196|NCT02541604|20116412|P6|Overall Study|Study Terminated by Sponsor|0
5824197|NCT02541604|20116413|P5|Overall Study|Study Terminated by Sponsor|0
5824198|NCT02541604|20116414|P4|Overall Study|Study Terminated by Sponsor|1
5824199|NCT02541604|20116415|P3|Overall Study|Study Terminated by Sponsor|2
5824200|NCT02541604|20116416|P2|Overall Study|Study Terminated by Sponsor|4
5824201|NCT02541604|20116417|P1|Overall Study|Study Terminated by Sponsor|1
5824202|NCT02541604|20116406|P12|Overall Study|Withdrawal by Subject|0
5824203|NCT02541604|20116407|P11|Overall Study|Withdrawal by Subject|0
5824204|NCT02541604|20116408|P10|Overall Study|Withdrawal by Subject|0
5824205|NCT02541604|20116409|P9|Overall Study|Withdrawal by Subject|1
5824206|NCT02541604|20116410|P8|Overall Study|Withdrawal by Subject|0
5824207|NCT02541604|20116411|P7|Overall Study|Withdrawal by Subject|0
5824208|NCT02541604|20116412|P6|Overall Study|Withdrawal by Subject|1
5824209|NCT02541604|20116413|P5|Overall Study|Withdrawal by Subject|1
5824210|NCT02541604|20116414|P4|Overall Study|Withdrawal by Subject|0
5824211|NCT02541604|20116415|P3|Overall Study|Withdrawal by Subject|1
5824212|NCT02541604|20116416|P2|Overall Study|Withdrawal by Subject|0
5824213|NCT02541604|20116417|P1|Overall Study|Withdrawal by Subject|2
5824214|NCT02541604|20116406|P12|Overall Study|Lost to Follow-up|0
5824215|NCT02541604|20116407|P11|Overall Study|Lost to Follow-up|0
5824216|NCT02541604|20116408|P10|Overall Study|Lost to Follow-up|0
5824217|NCT02541604|20116409|P9|Overall Study|Lost to Follow-up|0
5824218|NCT02541604|20116410|P8|Overall Study|Lost to Follow-up|0
5824219|NCT02541604|20116411|P7|Overall Study|Lost to Follow-up|1
5824220|NCT02541604|20116412|P6|Overall Study|Lost to Follow-up|1
5824221|NCT02541604|20116413|P5|Overall Study|Lost to Follow-up|0
5824222|NCT02541604|20116414|P4|Overall Study|Lost to Follow-up|0
5824223|NCT02541604|20116415|P3|Overall Study|Lost to Follow-up|1
5824224|NCT02541604|20116416|P2|Overall Study|Lost to Follow-up|0
5824225|NCT02541604|20116417|P1|Overall Study|Lost to Follow-up|2
5824226|NCT02541604|20116406|P12|Overall Study|Death|3
5824227|NCT02541604|20116407|P11|Overall Study|Death|2
5824228|NCT02541604|20116408|P10|Overall Study|Death|4
5824229|NCT02541604|20116409|P9|Overall Study|Death|3
5824230|NCT02541604|20116410|P8|Overall Study|Death|9
5824231|NCT02541604|20116411|P7|Overall Study|Death|9
5824232|NCT02541604|20116412|P6|Overall Study|Death|8
5824233|NCT02541604|20116413|P5|Overall Study|Death|9
5824234|NCT02541604|20116414|P4|Overall Study|Death|2
5824235|NCT02541604|20116415|P3|Overall Study|Death|7
5824236|NCT02541604|20116416|P2|Overall Study|Death|5
5824237|NCT02541604|20116417|P1|Overall Study|Death|6
5824238|NCT02540850|20116536|P3|Overall Study|Lost to Follow-up|34
5824239|NCT02540850|20116537|P2|Overall Study|Lost to Follow-up|66
5824240|NCT02540850|20116538|P1|Overall Study|Lost to Follow-up|69
5824241|NCT02540668|20116579|P2|Period 2 - LY3314814 and Warfarin|Physician Decision|1
5824242|NCT02540668|20116580|P1|Period 2 - LY3314814 and Warfarin|Physician Decision|0
5824243|NCT02540538|20116611|P3|Overall Study|Pregnancy|0
5824244|NCT02540538|20116612|P2|Overall Study|Pregnancy|1
5824245|NCT02540538|20116613|P1|Overall Study|Pregnancy|0
5824246|NCT02540356|20116681|P2|Overall Study|Terminated due to disease progression|0
5824247|NCT02540356|20116682|P1|Overall Study|Terminated due to disease progression|1
5824248|NCT02540291|20116717|P4|Overall Study|Other|0
5824249|NCT02540291|20116718|P3|Overall Study|Other|1
5824250|NCT02540291|20116719|P2|Overall Study|Other|0
5824251|NCT02540291|20116720|P1|Overall Study|Other|0
5824252|NCT02540291|20116717|P4|Overall Study|Study Terminated By Sponsor|0
5824253|NCT02540291|20116718|P3|Overall Study|Study Terminated By Sponsor|0
5824254|NCT02540291|20116719|P2|Overall Study|Study Terminated By Sponsor|0
5824255|NCT02540291|20116720|P1|Overall Study|Study Terminated By Sponsor|1
5824256|NCT02540291|20116717|P4|Overall Study|Withdrawal Of Consent|0
5824257|NCT02540291|20116718|P3|Overall Study|Withdrawal Of Consent|0
5824258|NCT02540291|20116719|P2|Overall Study|Withdrawal Of Consent|1
5824259|NCT02540291|20116720|P1|Overall Study|Withdrawal Of Consent|0
5824260|NCT02540291|20116717|P4|Overall Study|Lost to Follow-up|0
5824261|NCT02540291|20116718|P3|Overall Study|Lost to Follow-up|1
5824262|NCT02540291|20116719|P2|Overall Study|Lost to Follow-up|0
5824263|NCT02540291|20116720|P1|Overall Study|Lost to Follow-up|0
5824264|NCT02540291|20116717|P4|Overall Study|Death|7
5824265|NCT02540291|20116718|P3|Overall Study|Death|5
5824266|NCT02540291|20116719|P2|Overall Study|Death|7
5824267|NCT02540291|20116720|P1|Overall Study|Death|7
5824268|NCT02540265|20116755|P3|Overall Study|Lost to Follow-up|1
5824269|NCT02540265|20116756|P2|Overall Study|Lost to Follow-up|0
5824270|NCT02540265|20116757|P1|Overall Study|Lost to Follow-up|0
5824271|NCT02540213|20116812|P1|Overall Study|Enrolled but not treated|2
5824272|NCT02540213|20116812|P1|Overall Study|Consent withdrawn|7
5824273|NCT02540213|20116812|P1|Overall Study|Lack of Efficacy|6
5824274|NCT02540213|20116812|P1|Overall Study|Kidney transplant|3
5824275|NCT02540213|20116812|P1|Overall Study|Administrative reasons|3
5824276|NCT02540213|20116812|P1|Overall Study|Death/adverse event|18
5824277|NCT02540083|20116866|P1|Overall Study|Withdrawal by Subject|16
5824278|NCT02539797|20116907|P3|Overall Study|Lost to Follow-up|0
5824279|NCT02539797|20116908|P2|Overall Study|Lost to Follow-up|1
5824280|NCT02539797|20116909|P1|Overall Study|Lost to Follow-up|0
5824281|NCT02539368|20116961|P5|Overall Study|Missing|0
5824282|NCT02539368|20116962|P4|Overall Study|Missing|0
5824283|NCT02539368|20116963|P3|Overall Study|Missing|0
5824284|NCT02539368|20116964|P2|Overall Study|Missing|3
5824285|NCT02539368|20116965|P1|Overall Study|Missing|10
5824286|NCT02539368|20116961|P5|Overall Study|Other|3
5824287|NCT02539368|20116962|P4|Overall Study|Other|1
5824288|NCT02539368|20116963|P3|Overall Study|Other|24
5824289|NCT02539368|20116964|P2|Overall Study|Other|18
5824290|NCT02539368|20116965|P1|Overall Study|Other|145
5824291|NCT02539368|20116961|P5|Overall Study|Participant Non-compliant|0
5824292|NCT02539368|20116962|P4|Overall Study|Participant Non-compliant|1
5824293|NCT02539368|20116963|P3|Overall Study|Participant Non-compliant|1
5824294|NCT02539368|20116964|P2|Overall Study|Participant Non-compliant|2
5824295|NCT02539368|20116965|P1|Overall Study|Participant Non-compliant|13
5824296|NCT02539368|20116961|P5|Overall Study|Adverse Event|3
5824297|NCT02539368|20116962|P4|Overall Study|Adverse Event|0
5824298|NCT02539368|20116963|P3|Overall Study|Adverse Event|9
5824299|NCT02539368|20116964|P2|Overall Study|Adverse Event|5
5824300|NCT02539368|20116965|P1|Overall Study|Adverse Event|44
5824301|NCT02539368|20116961|P5|Overall Study|Lost to Follow-up|3
5824302|NCT02539368|20116962|P4|Overall Study|Lost to Follow-up|4
5824303|NCT02539368|20116963|P3|Overall Study|Lost to Follow-up|16
5824304|NCT02539368|20116964|P2|Overall Study|Lost to Follow-up|21
5824305|NCT02539368|20116965|P1|Overall Study|Lost to Follow-up|96
5824306|NCT02539368|20116961|P5|Overall Study|Physician Decision|2
5824307|NCT02539368|20116962|P4|Overall Study|Physician Decision|0
5824308|NCT02539368|20116963|P3|Overall Study|Physician Decision|7
5824309|NCT02539368|20116964|P2|Overall Study|Physician Decision|15
5824310|NCT02539368|20116965|P1|Overall Study|Physician Decision|49
5824311|NCT02539368|20116961|P5|Overall Study|Withdrawal by Subject|3
5824312|NCT02539368|20116962|P4|Overall Study|Withdrawal by Subject|1
5824313|NCT02539368|20116963|P3|Overall Study|Withdrawal by Subject|9
5824314|NCT02539368|20116964|P2|Overall Study|Withdrawal by Subject|35
5824315|NCT02539368|20116965|P1|Overall Study|Withdrawal by Subject|44
5824316|NCT02539368|20116961|P5|Overall Study|Death|0
5824317|NCT02539368|20116962|P4|Overall Study|Death|0
5824318|NCT02539368|20116963|P3|Overall Study|Death|1
5824319|NCT02539368|20116964|P2|Overall Study|Death|2
5824320|NCT02539368|20116965|P1|Overall Study|Death|4
5824321|NCT02539225|20117098|P2|Part B|Physician Decision|9
5824322|NCT02539225|20117099|P1|Part B|Physician Decision|0
5824323|NCT02539225|20117098|P2|Part B|Withdrawal by Subject|3
5824324|NCT02539225|20117099|P1|Part B|Withdrawal by Subject|0
5824325|NCT02539225|20117098|P2|Part B|Adverse Event|4
5824326|NCT02539225|20117099|P1|Part B|Adverse Event|4
5824327|NCT02539225|20117098|P2|Pre Treatment for Part B|Physician Decision|0
5824328|NCT02539225|20117099|P1|Pre Treatment for Part B|Physician Decision|2
5824329|NCT02539225|20117098|P2|Pre Treatment for Part B|Withdrawal by Subject|0
5824330|NCT02539225|20117099|P1|Pre Treatment for Part B|Withdrawal by Subject|1
5824331|NCT02539225|20117098|P2|Pre Treatment for Part B|Adverse Event|1
5824332|NCT02539225|20117099|P1|Pre Treatment for Part B|Adverse Event|1
5824333|NCT02539225|20117098|P2|Pre Treatment for Part B|Progressive disease|1
5824334|NCT02539225|20117099|P1|Pre Treatment for Part B|Progressive disease|1
5824335|NCT02539225|20117098|P2|Part A|Did Not Receive study Drug|1
5824336|NCT02539225|20117099|P1|Part A|Did Not Receive study Drug|1
5824337|NCT02539225|20117098|P2|Part A|Physician Decision|7
5824338|NCT02539225|20117099|P1|Part A|Physician Decision|4
5824339|NCT02539225|20117098|P2|Part A|Withdrawal by Subject|4
5824340|NCT02539225|20117099|P1|Part A|Withdrawal by Subject|2
5824341|NCT02539225|20117098|P2|Part A|Adverse Event|4
5824342|NCT02539225|20117099|P1|Part A|Adverse Event|13
5824343|NCT02539134|20117126|P6|Overall Study|Lost to Follow-up|0
5824344|NCT02539134|20117127|P5|Overall Study|Lost to Follow-up|0
5824345|NCT02539134|20117128|P4|Overall Study|Lost to Follow-up|0
5824346|NCT02539134|20117129|P3|Overall Study|Lost to Follow-up|0
5824347|NCT02539134|20117130|P2|Overall Study|Lost to Follow-up|0
5824348|NCT02539134|20117131|P1|Overall Study|Lost to Follow-up|1
5824349|NCT02538965|20117200|P1|Follow-Up Period|Withdrawal by Parent|4
5824350|NCT02538965|20117200|P1|Follow-Up Period|Other = Death due to disease progression|13
5824351|NCT02538965|20117200|P1|Treatment Period|Physician Decision|2
5824352|NCT02538965|20117200|P1|Treatment Period|Disease Progression|1
5824353|NCT02538965|20117200|P1|Treatment Period|Treatment Failure|9
5824354|NCT02538965|20117200|P1|Treatment Period|Withdrawal by Parent/Guardian|2
5824355|NCT02538965|20117200|P1|Treatment Period|Adverse Event|2
5824356|NCT02538965|20117200|P1|Treatment Period|Other = Death due to disease progression|1
5824357|NCT02538666|20117246|P3|Overall Study|Withdrew Consent|1
5824358|NCT02538666|20117247|P2|Overall Study|Withdrew Consent|1
5824359|NCT02538666|20117248|P1|Overall Study|Withdrew Consent|0
5824360|NCT02538666|20117246|P3|Overall Study|no longer meets study criteria|0
5824361|NCT02538666|20117247|P2|Overall Study|no longer meets study criteria|0
5824362|NCT02538666|20117248|P1|Overall Study|no longer meets study criteria|1
5824363|NCT02538666|20117246|P3|Overall Study|Disease progression|0
5824364|NCT02538666|20117247|P2|Overall Study|Disease progression|0
5824365|NCT02538666|20117248|P1|Overall Study|Disease progression|1
5824366|NCT02538614|20117267|P1|Overall Study|Progressive Disease|2
5824367|NCT02538471|20117307|P1|Overall Study|Progression of disease|2
5824368|NCT02538107|20117343|P1|Overall Study|Not recorded|7
5824369|NCT02538107|20117343|P1|Overall Study|Other|7
5824370|NCT02538107|20117343|P1|Overall Study|Surgery|1
5824371|NCT02538107|20117343|P1|Overall Study|Adverse Event|4
5824372|NCT02538107|20117343|P1|Overall Study|Administrative reason|5
5824373|NCT02538107|20117343|P1|Overall Study|Death|4
5824374|NCT02538107|20117343|P1|Overall Study|Withdrawal by Subject|17
5824375|NCT02538107|20117343|P1|Overall Study|No further treatment necessary|18
5824376|NCT02538107|20117343|P1|Overall Study|Administration of other ESA|11
5824377|NCT02538107|20117343|P1|Overall Study|Necessity of dialysis|20
5824378|NCT02538107|20117343|P1|Overall Study|Missing|5
5824379|NCT02538107|20117343|P1|Overall Study|Did not receive any Mircera dose|11
5824380|NCT02538094|20117363|P2|Washout (4 Weeks)|Withdrawal by Subject|1
5824381|NCT02538094|20117364|P1|Washout (4 Weeks)|Withdrawal by Subject|0
5824382|NCT02538094|20117363|P2|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|1
5824383|NCT02538094|20117364|P1|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|0
5824384|NCT02538029|20117394|P3|Overall Study|unable to complete cognitive assessments|1
5824385|NCT02538029|20117395|P2|Overall Study|unable to complete cognitive assessments|0
5824386|NCT02538029|20117396|P1|Overall Study|unable to complete cognitive assessments|1
5824387|NCT02537574|20117487|P3|Overall Study|Noncompliance with Protocol|1
5824388|NCT02537574|20117488|P2|Overall Study|Noncompliance with Protocol|0
5824389|NCT02537574|20117489|P1|Overall Study|Noncompliance with Protocol|0
5824390|NCT02537574|20117487|P3|Overall Study|Subject did not want last Vivitrol Injec|1
5824391|NCT02537574|20117488|P2|Overall Study|Subject did not want last Vivitrol Injec|0
5824392|NCT02537574|20117489|P1|Overall Study|Subject did not want last Vivitrol Injec|0
5824393|NCT02537574|20117487|P3|Overall Study|Transportation Issues|1
5824394|NCT02537574|20117488|P2|Overall Study|Transportation Issues|0
5824395|NCT02537574|20117489|P1|Overall Study|Transportation Issues|0
5824396|NCT02537574|20117487|P3|Overall Study|Failed Naloxone Challenge|0
5824397|NCT02537574|20117488|P2|Overall Study|Failed Naloxone Challenge|1
5824398|NCT02537574|20117489|P1|Overall Study|Failed Naloxone Challenge|0
5824399|NCT02537574|20117487|P3|Overall Study|Incarceration|0
5824400|NCT02537574|20117488|P2|Overall Study|Incarceration|1
5824401|NCT02537574|20117489|P1|Overall Study|Incarceration|0
5824402|NCT02537574|20117487|P3|Overall Study|Patient not Stable|0
5824403|NCT02537574|20117488|P2|Overall Study|Patient not Stable|1
5824404|NCT02537574|20117489|P1|Overall Study|Patient not Stable|0
5824405|NCT02537574|20117487|P3|Overall Study|Duplicate Patient|0
5824406|NCT02537574|20117488|P2|Overall Study|Duplicate Patient|0
5824407|NCT02537574|20117489|P1|Overall Study|Duplicate Patient|1
5824408|NCT02537574|20117487|P3|Overall Study|Lack of Efficacy|15
5824409|NCT02537574|20117488|P2|Overall Study|Lack of Efficacy|16
5824410|NCT02537574|20117489|P1|Overall Study|Lack of Efficacy|14
5824411|NCT02537574|20117487|P3|Overall Study|Withdrawal by Subject|29
5824412|NCT02537574|20117488|P2|Overall Study|Withdrawal by Subject|27
5824413|NCT02537574|20117489|P1|Overall Study|Withdrawal by Subject|37
5824414|NCT02537574|20117487|P3|Overall Study|Protocol Violation|3
5824415|NCT02537574|20117488|P2|Overall Study|Protocol Violation|2
5824416|NCT02537574|20117489|P1|Overall Study|Protocol Violation|4
5824417|NCT02537574|20117487|P3|Overall Study|Physician Decision|0
5824418|NCT02537574|20117488|P2|Overall Study|Physician Decision|0
5824419|NCT02537574|20117489|P1|Overall Study|Physician Decision|2
5824420|NCT02537574|20117487|P3|Overall Study|Noncompliance with study drug|1
5824421|NCT02537574|20117488|P2|Overall Study|Noncompliance with study drug|1
5824422|NCT02537574|20117489|P1|Overall Study|Noncompliance with study drug|0
5824423|NCT02537574|20117487|P3|Overall Study|Lost to Follow-up|55
5824424|NCT02537574|20117488|P2|Overall Study|Lost to Follow-up|51
5824425|NCT02537574|20117489|P1|Overall Study|Lost to Follow-up|40
5824426|NCT02537574|20117487|P3|Overall Study|Adverse Event|2
5824427|NCT02537574|20117488|P2|Overall Study|Adverse Event|3
5824428|NCT02537574|20117489|P1|Overall Study|Adverse Event|1
5824429|NCT02537522|20117515|P4|Phase II - Period 1 Bilateral|Adverse Event|1
5824430|NCT02537522|20117516|P3|Phase II - Period 1 Bilateral|Adverse Event|0
5824431|NCT02537522|20117517|P2|Phase II - Period 1 Bilateral|Adverse Event|0
5824432|NCT02537522|20117518|P1|Phase II - Period 1 Bilateral|Adverse Event|0
5824433|NCT02537522|20117515|P4|Phase I - Contralateral|unsatisfactory lens fitting|0
5824434|NCT02537522|20117516|P3|Phase I - Contralateral|unsatisfactory lens fitting|0
5824435|NCT02537522|20117517|P2|Phase I - Contralateral|unsatisfactory lens fitting|1
5824436|NCT02537522|20117518|P1|Phase I - Contralateral|unsatisfactory lens fitting|0
5824437|NCT02537522|20117515|P4|Phase I - Contralateral|incorrect randomization|0
5824438|NCT02537522|20117516|P3|Phase I - Contralateral|incorrect randomization|0
5824439|NCT02537522|20117517|P2|Phase I - Contralateral|incorrect randomization|1
5824440|NCT02537522|20117518|P1|Phase I - Contralateral|incorrect randomization|0
5824441|NCT02537522|20117515|P4|Phase I - Contralateral|Withdrawal by Subject|0
5824442|NCT02537522|20117516|P3|Phase I - Contralateral|Withdrawal by Subject|0
5824443|NCT02537522|20117517|P2|Phase I - Contralateral|Withdrawal by Subject|1
5824444|NCT02537522|20117518|P1|Phase I - Contralateral|Withdrawal by Subject|0
5824445|NCT02537522|20117515|P4|Phase I - Contralateral|Subject no longer eligible|0
5824446|NCT02537522|20117516|P3|Phase I - Contralateral|Subject no longer eligible|0
5824447|NCT02537522|20117517|P2|Phase I - Contralateral|Subject no longer eligible|7
5824448|NCT02537522|20117518|P1|Phase I - Contralateral|Subject no longer eligible|15
5824449|NCT02537431|20117535|P1|Open-Label Period (Week 0 to Week 48)|Withdrawal by Subject|1
5824450|NCT02537015|20117564|P1|Overall Study|Other Miscellaneous Reasons|1
5824451|NCT02537015|20117564|P1|Overall Study|Withdrawal by Subject|2
5824452|NCT02537015|20117564|P1|Overall Study|Adverse Event|3
5824453|NCT02536976|20117570|P2|Overall Study|Physician Decision|1
5824454|NCT02536976|20117571|P1|Overall Study|Physician Decision|0
5824455|NCT02536963|20117581|P1|Overall Study|Withdrawal by Subject|18
5824456|NCT02536833|20117589|P4|Overall Study|Withdrawal by Subject|11
5824457|NCT02536833|20117590|P3|Overall Study|Withdrawal by Subject|5
5824458|NCT02536833|20117591|P2|Overall Study|Withdrawal by Subject|3
5824459|NCT02536833|20117592|P1|Overall Study|Withdrawal by Subject|4
5824460|NCT02536833|20117589|P4|Overall Study|Subject Non-Compliance|0
5824461|NCT02536833|20117590|P3|Overall Study|Subject Non-Compliance|1
5824462|NCT02536833|20117591|P2|Overall Study|Subject Non-Compliance|1
5824463|NCT02536833|20117592|P1|Overall Study|Subject Non-Compliance|0
5824464|NCT02536833|20117589|P4|Overall Study|Site Terminated by Sponsor|2
5824465|NCT02536833|20117590|P3|Overall Study|Site Terminated by Sponsor|2
5824466|NCT02536833|20117591|P2|Overall Study|Site Terminated by Sponsor|2
5824467|NCT02536833|20117592|P1|Overall Study|Site Terminated by Sponsor|2
5824468|NCT02536833|20117589|P4|Overall Study|Physician Decision|1
5824469|NCT02536833|20117590|P3|Overall Study|Physician Decision|0
5824470|NCT02536833|20117591|P2|Overall Study|Physician Decision|0
5824471|NCT02536833|20117592|P1|Overall Study|Physician Decision|0
5824472|NCT02536833|20117589|P4|Overall Study|Lost to Follow-up|2
5824473|NCT02536833|20117590|P3|Overall Study|Lost to Follow-up|2
5824474|NCT02536833|20117591|P2|Overall Study|Lost to Follow-up|1
5824475|NCT02536833|20117592|P1|Overall Study|Lost to Follow-up|2
5824476|NCT02536833|20117589|P4|Overall Study|Adverse Event|1
5824477|NCT02536833|20117590|P3|Overall Study|Adverse Event|4
5824478|NCT02536833|20117591|P2|Overall Study|Adverse Event|3
5824479|NCT02536833|20117592|P1|Overall Study|Adverse Event|1
5824480|NCT02536833|20117589|P4|Overall Study|Discontinued Before Treatment|2
5824481|NCT02536833|20117590|P3|Overall Study|Discontinued Before Treatment|1
5824482|NCT02536833|20117591|P2|Overall Study|Discontinued Before Treatment|0
5824483|NCT02536833|20117592|P1|Overall Study|Discontinued Before Treatment|0
5824484|NCT02536781|20117653|P2|Overall Study|Lost to Follow-up|0
5824485|NCT02536781|20117654|P1|Overall Study|Lost to Follow-up|2
5824486|NCT02536664|20117664|P2|Overall Study|Missing|20
5824487|NCT02536664|20117665|P1|Overall Study|Missing|53
5824488|NCT02536664|20117664|P2|Overall Study|Other|24
5824489|NCT02536664|20117665|P1|Overall Study|Other|18
5824490|NCT02536664|20117664|P2|Overall Study|Withdrawal by Subject|5
5824491|NCT02536664|20117665|P1|Overall Study|Withdrawal by Subject|8
5824492|NCT02536664|20117664|P2|Overall Study|Intolerability|6
5824493|NCT02536664|20117665|P1|Overall Study|Intolerability|8
5824494|NCT02536664|20117664|P2|Overall Study|Death due to other reason|2
5824495|NCT02536664|20117665|P1|Overall Study|Death due to other reason|3
5824496|NCT02536664|20117664|P2|Overall Study|Death due to lymphoma|1
5824497|NCT02536664|20117665|P1|Overall Study|Death due to lymphoma|2
5824498|NCT02536664|20117664|P2|Overall Study|Progression|18
5824499|NCT02536664|20117665|P1|Overall Study|Progression|13
5824500|NCT02536664|20117664|P2|Overall Study|Inadequate completion of documentation|4
5824501|NCT02536664|20117665|P1|Overall Study|Inadequate completion of documentation|2
5824502|NCT02536378|20117685|P2|Overall Study|Patient refused further follow up|2
5824503|NCT02536378|20117686|P1|Overall Study|Patient refused further follow up|6
5824504|NCT02536378|20117685|P2|Overall Study|Death|2
5824505|NCT02536378|20117686|P1|Overall Study|Death|1
5824506|NCT02536378|20117685|P2|Overall Study|Withdrawal by Subject|1
5824507|NCT02536378|20117686|P1|Overall Study|Withdrawal by Subject|0
5824508|NCT02536378|20117685|P2|Overall Study|Physician Decision|2
5824509|NCT02536378|20117686|P1|Overall Study|Physician Decision|0
5824515|NCT02536313|20117726|P2|Overall Study|Lack of Efficacy|1
5824516|NCT02536313|20117727|P1|Overall Study|Lack of Efficacy|0
5824517|NCT02535741|20117796|P1|Overall Study|Missing data|6
5824518|NCT02535741|20117796|P1|Overall Study|Exclusion criteria: Bilateral implant|4
5824519|NCT02535741|20117796|P1|Overall Study|Lost to Follow-up|10
5824520|NCT02535741|20117796|P1|Overall Study|Withdrawal by Subject|9
5824521|NCT02535741|20117796|P1|Overall Study|Adverse Event|3
5824522|NCT02535715|20117804|P3|Overall Study|Withdrawal by Subject|1
5824523|NCT02535715|20117805|P2|Overall Study|Withdrawal by Subject|0
5824524|NCT02535715|20117806|P1|Overall Study|Withdrawal by Subject|0
5824525|NCT02535416|20117869|P9|Overall Study|Family bereavement overseas|0
5824526|NCT02535416|20117870|P8|Overall Study|Family bereavement overseas|0
5824527|NCT02535416|20117871|P7|Overall Study|Family bereavement overseas|0
5824528|NCT02535416|20117872|P6|Overall Study|Family bereavement overseas|0
5824529|NCT02535416|20117873|P5|Overall Study|Family bereavement overseas|0
5824530|NCT02535416|20117874|P4|Overall Study|Family bereavement overseas|0
5824531|NCT02535416|20117875|P3|Overall Study|Family bereavement overseas|0
5824532|NCT02535416|20117876|P2|Overall Study|Family bereavement overseas|0
5824533|NCT02535416|20117877|P1|Overall Study|Family bereavement overseas|1
5824534|NCT02535364|20117929|P1|12-Month Follow-up Period|Subject transferred to hospice|1
5824535|NCT02535364|20117929|P1|12-Month Follow-up Period|Subject received alternative therapy|2
5824536|NCT02535364|20117929|P1|12-Month Follow-up Period|Underwent stem cell transplant|5
5824537|NCT02535364|20117929|P1|12-Month Follow-up Period|Death|5
5824538|NCT02535364|20117929|P1|12-Month Follow-up Period|Disease progression|22
5824539|NCT02535364|20117929|P1|Study Treatment|Study placed on clinical hold by FDA|1
5824540|NCT02535364|20117929|P1|Study Treatment|Death|1
5824541|NCT02535364|20117929|P1|Part B Screening|Change in diagnosis, no longer eligible|2
5824542|NCT02535364|20117929|P1|Part B Screening|Adverse Event|1
5824543|NCT02535364|20117929|P1|Part B Screening|Withdrawal by Subject|1
5824544|NCT02535364|20117929|P1|Part B Screening|Physician Decision|1
5824545|NCT02535364|20117929|P1|Part B Screening|Death|2
5824546|NCT02535364|20117929|P1|Part B Screening|Unable to manufacture JCAR015|3
5824547|NCT02535364|20117929|P1|Part B Screening|Study placed on clinical hold by FDA|7
5824548|NCT02535364|20117929|P1|Part A Screening Through Leukapheresis|Disease progression|1
5824549|NCT02535364|20117929|P1|Part A Screening Through Leukapheresis|Study placed on clinical hold by FDA|2
5824550|NCT02535364|20117929|P1|Part A Screening Through Leukapheresis|Failure to meet criteria for Part A|22
5824551|NCT02535000|20118013|P2|Overall Study|Cancellation of surgery.|2
5824552|NCT02535000|20118014|P1|Overall Study|Cancellation of surgery.|1
5824553|NCT02534935|20118025|P3|Overall Study|Lost to Follow-up|1
5824554|NCT02534935|20118026|P2|Overall Study|Lost to Follow-up|1
5824555|NCT02534935|20118027|P1|Overall Study|Lost to Follow-up|0
5824556|NCT02534935|20118025|P3|Overall Study|Adverse Event|0
5824557|NCT02534935|20118026|P2|Overall Study|Adverse Event|2
5824558|NCT02534935|20118027|P1|Overall Study|Adverse Event|0
5824559|NCT02534935|20118025|P3|Overall Study|No longer meets the eligibility criteria|0
5824560|NCT02534935|20118026|P2|Overall Study|No longer meets the eligibility criteria|3
5824561|NCT02534935|20118027|P1|Overall Study|No longer meets the eligibility criteria|0
5824562|NCT02534935|20118025|P3|Overall Study|Withdrawal by Subject|3
5824563|NCT02534935|20118026|P2|Overall Study|Withdrawal by Subject|3
5824564|NCT02534935|20118027|P1|Overall Study|Withdrawal by Subject|0
5824565|NCT02534935|20118025|P3|Overall Study|No longer willing to participate|1
5824566|NCT02534935|20118026|P2|Overall Study|No longer willing to participate|1
5824567|NCT02534935|20118027|P1|Overall Study|No longer willing to participate|0
5824568|NCT02534896|20118188|P3|Overall Study|Insufficient therapeutic response|0
5824569|NCT02534896|20118189|P2|Overall Study|Insufficient therapeutic response|0
5824570|NCT02534896|20118190|P1|Overall Study|Insufficient therapeutic response|2
5824571|NCT02534896|20118188|P3|Overall Study|Adverse Event|1
5824572|NCT02534896|20118189|P2|Overall Study|Adverse Event|1
5824573|NCT02534896|20118190|P1|Overall Study|Adverse Event|2
5824574|NCT02534883|20118209|P2|Overall Study|Early Termination|3
5824575|NCT02534883|20118210|P1|Overall Study|Early Termination|8
5824576|NCT02534493|20118226|P1|Overall Study|Withdrawal by Subject|1
5824577|NCT02534493|20118226|P1|Overall Study|Lost to Follow-up|1
5824578|NCT02534350|20118237|P2|Overall Study|Withdrew Consent|0
5824579|NCT02534350|20118238|P1|Overall Study|Withdrew Consent|2
5824580|NCT02534350|20118237|P2|Overall Study|Protocol Violation|0
5824581|NCT02534350|20118238|P1|Overall Study|Protocol Violation|1
5824582|NCT02534350|20118237|P2|Overall Study|Randomized But Not Treated|0
5824583|NCT02534350|20118238|P1|Overall Study|Randomized But Not Treated|1
5824584|NCT02534324|20118252|P2|Overall Study|Adverse Event|0
5824585|NCT02534324|20118253|P1|Overall Study|Adverse Event|1
5824586|NCT02534324|20118252|P2|Overall Study|Lost to Follow-up|7
5824587|NCT02534324|20118253|P1|Overall Study|Lost to Follow-up|20
5824588|NCT02534324|20118252|P2|Overall Study|Protocol Violation|1
5824589|NCT02534324|20118253|P1|Overall Study|Protocol Violation|4
5824590|NCT02533999|20118318|P2|Overall Study|Randomized but intervention not received|1
5824591|NCT02533999|20118319|P1|Overall Study|Randomized but intervention not received|0
5824592|NCT02533999|20118318|P2|Overall Study|Adverse Event|1
5824593|NCT02533999|20118319|P1|Overall Study|Adverse Event|0
5824594|NCT02533999|20118318|P2|Overall Study|Protocol Violation|0
5824595|NCT02533999|20118319|P1|Overall Study|Protocol Violation|3
5824596|NCT02533999|20118318|P2|Overall Study|Lost to Follow-up|5
5824597|NCT02533999|20118319|P1|Overall Study|Lost to Follow-up|3
5824598|NCT02533570|20118370|P3|Overall Study|Adverse Event|1
5824599|NCT02533570|20118371|P2|Overall Study|Adverse Event|1
5824600|NCT02533570|20118372|P1|Overall Study|Adverse Event|0
5824601|NCT02533531|20118383|P1|Overall Study|Device did not turn on|1
5824602|NCT02533453|20118446|P1|Overall Study|Withdrawal by Subject|2
5824603|NCT02533453|20118446|P1|Overall Study|Protocol Violation|1
5824604|NCT02533453|20118446|P1|Overall Study|Adverse Event|6
5824605|NCT02533401|20118505|P1|Overall Study|Violation of Selection Criteria|1
5824606|NCT02533401|20118505|P1|Overall Study|Lost to Follow-up|1
5824607|NCT02533401|20118505|P1|Overall Study|Insufficient Response/Progressed Disease|1
5824608|NCT02533401|20118505|P1|Overall Study|Death|5
5824609|NCT02533401|20118505|P1|Overall Study|Adverse Event/Intercurrent Disease|3
5824610|NCT02533375|20118513|P1|Overall Study|Adverse Event|2
5824611|NCT02533375|20118513|P1|Overall Study|Lack of Efficacy|3
5824612|NCT02533258|20118545|P1|Overall Study|Lack of Efficacy|2
5824613|NCT02533258|20118545|P1|Overall Study|Progression of pleural effusion|1
5824614|NCT02533258|20118545|P1|Overall Study|Economic factor|1
5824615|NCT02533258|20118545|P1|Overall Study|Other|1
5824616|NCT02533258|20118545|P1|Overall Study|Death|2
5824617|NCT02533258|20118545|P1|Overall Study|Adverse Event|1
5824618|NCT02532972|20118686|P1|Overall Study|Withdrawal by Subject|1
5824619|NCT02532855|20118703|P2|Overall Study|Withdrawal by Subject|8
5824620|NCT02532855|20118704|P1|Overall Study|Withdrawal by Subject|4
5824621|NCT02532855|20118703|P2|Overall Study|Lost to Follow-up|3
5824622|NCT02532855|20118704|P1|Overall Study|Lost to Follow-up|4
5824623|NCT02532764|20118738|P10|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1
5824624|NCT02532764|20118739|P9|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1
5824625|NCT02532764|20118740|P8|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1
5824626|NCT02532764|20118741|P7|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0
5824627|NCT02532764|20118742|P6|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0
5824628|NCT02532764|20118743|P5|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0
5824629|NCT02532764|20118744|P4|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0
5824630|NCT02532764|20118745|P3|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0
5824631|NCT02532764|20118746|P2|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0
5824632|NCT02532764|20118747|P1|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0
5824633|NCT02532647|20118898|P3|Overall Study|Did not receive trial medication|1
5824634|NCT02532647|20118899|P2|Overall Study|Did not receive trial medication|0
5824635|NCT02532647|20118900|P1|Overall Study|Did not receive trial medication|1
5824636|NCT02532543|20118942|P4|Overall Study|Lost to Follow-up|0
5824637|NCT02532543|20118943|P3|Overall Study|Lost to Follow-up|1
5824638|NCT02532543|20118944|P2|Overall Study|Lost to Follow-up|0
5824639|NCT02532543|20118945|P1|Overall Study|Lost to Follow-up|0
5824640|NCT02532517|20118979|P1|Overall Study|Death|4
5824641|NCT02532517|20118979|P1|Overall Study|Withdrawal by Subject|4
5824642|NCT02532517|20118979|P1|Overall Study|Lost to Follow-up|4
5824643|NCT02532517|20118979|P1|Overall Study|Failed Angiographic eligibility|1
5824644|NCT02532517|20118979|P1|Overall Study|Did not complete 24-Month visit|4
5824645|NCT02532465|20118999|P2|Overall Study|Lack of Efficacy|1
5824646|NCT02532465|20119000|P1|Overall Study|Lack of Efficacy|0
5824647|NCT02532465|20118999|P2|Overall Study|Protocol Violation|0
5824648|NCT02532465|20119000|P1|Overall Study|Protocol Violation|1
5824649|NCT02532374|20119010|P1|Overall Study|Physician Decision|1
5824650|NCT02532374|20119010|P1|Overall Study|Withdrawal by Subject|1
5824651|NCT02532283|20119036|P2|Overall Study|Withdrawal by Subject|3
5824652|NCT02532283|20119037|P1|Overall Study|Withdrawal by Subject|8
5824653|NCT02532283|20119036|P2|Overall Study|Lost to Follow-up|1
5824654|NCT02532283|20119037|P1|Overall Study|Lost to Follow-up|0
5824655|NCT02532283|20119036|P2|Overall Study|Death|0
5824656|NCT02532283|20119037|P1|Overall Study|Death|1
5824657|NCT02532283|20119036|P2|Overall Study|Adverse Event|1
5824658|NCT02532283|20119037|P1|Overall Study|Adverse Event|0
5824659|NCT02532179|20119079|P1|Overall Study|Subject received depot steroid injection|1
5824660|NCT02532179|20119079|P1|Overall Study|Pregnancy|1
5824661|NCT02532179|20119079|P1|Overall Study|Lost to Follow-up|1
5824662|NCT02531802|20119149|P21|Received Vaccination 2|Withdrawal by Subject|0
5824663|NCT02531802|20119150|P20|Received Vaccination 2|Withdrawal by Subject|1
5824664|NCT02531802|20119151|P19|Received Vaccination 2|Withdrawal by Subject|1
5824665|NCT02531802|20119152|P18|Received Vaccination 2|Withdrawal by Subject|1
5824666|NCT02531802|20119153|P17|Received Vaccination 2|Withdrawal by Subject|0
5824667|NCT02531802|20119154|P16|Received Vaccination 2|Withdrawal by Subject|0
5824668|NCT02531802|20119155|P15|Received Vaccination 2|Withdrawal by Subject|1
5824669|NCT02531802|20119156|P14|Received Vaccination 2|Withdrawal by Subject|1
5824670|NCT02531802|20119157|P13|Received Vaccination 2|Withdrawal by Subject|1
5824671|NCT02531802|20119158|P12|Received Vaccination 2|Withdrawal by Subject|0
5824672|NCT02531802|20119159|P11|Received Vaccination 2|Withdrawal by Subject|1
5824673|NCT02531802|20119160|P10|Received Vaccination 2|Withdrawal by Subject|0
5824674|NCT02531802|20119161|P9|Received Vaccination 2|Withdrawal by Subject|0
5824675|NCT02531802|20119162|P8|Received Vaccination 2|Withdrawal by Subject|0
5824676|NCT02531802|20119163|P7|Received Vaccination 2|Withdrawal by Subject|0
5824677|NCT02531802|20119164|P6|Received Vaccination 2|Withdrawal by Subject|0
5824678|NCT02531802|20119165|P5|Received Vaccination 2|Withdrawal by Subject|0
5824679|NCT02531802|20119166|P4|Received Vaccination 2|Withdrawal by Subject|0
5824680|NCT02531802|20119167|P3|Received Vaccination 2|Withdrawal by Subject|0
5824681|NCT02531802|20119168|P2|Received Vaccination 2|Withdrawal by Subject|0
5824682|NCT02531802|20119169|P1|Received Vaccination 2|Withdrawal by Subject|0
5824683|NCT02531802|20119149|P21|Received Vaccination 2|Adverse Event|1
5824684|NCT02531802|20119150|P20|Received Vaccination 2|Adverse Event|0
5824685|NCT02531802|20119151|P19|Received Vaccination 2|Adverse Event|1
5824686|NCT02531802|20119152|P18|Received Vaccination 2|Adverse Event|2
5824687|NCT02531802|20119153|P17|Received Vaccination 2|Adverse Event|0
5824688|NCT02531802|20119154|P16|Received Vaccination 2|Adverse Event|0
5824689|NCT02531802|20119155|P15|Received Vaccination 2|Adverse Event|0
5824690|NCT02531802|20119156|P14|Received Vaccination 2|Adverse Event|0
5824691|NCT02531802|20119157|P13|Received Vaccination 2|Adverse Event|0
5824692|NCT02531802|20119158|P12|Received Vaccination 2|Adverse Event|0
5824693|NCT02531802|20119159|P11|Received Vaccination 2|Adverse Event|0
5824694|NCT02531802|20119160|P10|Received Vaccination 2|Adverse Event|0
5824695|NCT02531802|20119161|P9|Received Vaccination 2|Adverse Event|0
5824696|NCT02531802|20119162|P8|Received Vaccination 2|Adverse Event|0
5824697|NCT02531802|20119163|P7|Received Vaccination 2|Adverse Event|0
5824698|NCT02531802|20119164|P6|Received Vaccination 2|Adverse Event|2
5824699|NCT02531802|20119165|P5|Received Vaccination 2|Adverse Event|0
5824700|NCT02531802|20119166|P4|Received Vaccination 2|Adverse Event|0
5824701|NCT02531802|20119167|P3|Received Vaccination 2|Adverse Event|0
5824702|NCT02531802|20119168|P2|Received Vaccination 2|Adverse Event|0
5824703|NCT02531802|20119169|P1|Received Vaccination 2|Adverse Event|0
5824704|NCT02531802|20119149|P21|Received Vaccination 2|Physician Decision|0
5824705|NCT02531802|20119150|P20|Received Vaccination 2|Physician Decision|0
5824706|NCT02531802|20119151|P19|Received Vaccination 2|Physician Decision|0
5824707|NCT02531802|20119152|P18|Received Vaccination 2|Physician Decision|1
5824708|NCT02531802|20119153|P17|Received Vaccination 2|Physician Decision|0
5824709|NCT02531802|20119154|P16|Received Vaccination 2|Physician Decision|0
5824710|NCT02531802|20119155|P15|Received Vaccination 2|Physician Decision|0
5824711|NCT02531802|20119156|P14|Received Vaccination 2|Physician Decision|1
5824712|NCT02531802|20119157|P13|Received Vaccination 2|Physician Decision|0
5824713|NCT02531802|20119158|P12|Received Vaccination 2|Physician Decision|0
5824714|NCT02531802|20119159|P11|Received Vaccination 2|Physician Decision|0
5824715|NCT02531802|20119160|P10|Received Vaccination 2|Physician Decision|2
5824716|NCT02531802|20119161|P9|Received Vaccination 2|Physician Decision|0
5824717|NCT02531802|20119162|P8|Received Vaccination 2|Physician Decision|0
5824718|NCT02531802|20119163|P7|Received Vaccination 2|Physician Decision|0
5824719|NCT02531802|20119164|P6|Received Vaccination 2|Physician Decision|1
5824720|NCT02531802|20119165|P5|Received Vaccination 2|Physician Decision|0
5824721|NCT02531802|20119166|P4|Received Vaccination 2|Physician Decision|0
5824722|NCT02531802|20119167|P3|Received Vaccination 2|Physician Decision|0
5824723|NCT02531802|20119168|P2|Received Vaccination 2|Physician Decision|0
5824724|NCT02531802|20119169|P1|Received Vaccination 2|Physician Decision|0
5824725|NCT02531802|20119149|P21|Received Vaccination 2|Medication interfering with study taken|0
5824726|NCT02531802|20119150|P20|Received Vaccination 2|Medication interfering with study taken|0
5824727|NCT02531802|20119151|P19|Received Vaccination 2|Medication interfering with study taken|1
5824728|NCT02531802|20119152|P18|Received Vaccination 2|Medication interfering with study taken|0
5824729|NCT02531802|20119153|P17|Received Vaccination 2|Medication interfering with study taken|0
5824730|NCT02531802|20119154|P16|Received Vaccination 2|Medication interfering with study taken|0
5824731|NCT02531802|20119155|P15|Received Vaccination 2|Medication interfering with study taken|0
5824732|NCT02531802|20119156|P14|Received Vaccination 2|Medication interfering with study taken|0
5824733|NCT02531802|20119157|P13|Received Vaccination 2|Medication interfering with study taken|1
5824734|NCT02531802|20119158|P12|Received Vaccination 2|Medication interfering with study taken|0
5824735|NCT02531802|20119159|P11|Received Vaccination 2|Medication interfering with study taken|1
5824736|NCT02531802|20119160|P10|Received Vaccination 2|Medication interfering with study taken|1
5824737|NCT02531802|20119161|P9|Received Vaccination 2|Medication interfering with study taken|0
5824738|NCT02531802|20119162|P8|Received Vaccination 2|Medication interfering with study taken|0
5824739|NCT02531802|20119163|P7|Received Vaccination 2|Medication interfering with study taken|0
5824740|NCT02531802|20119164|P6|Received Vaccination 2|Medication interfering with study taken|0
5824741|NCT02531802|20119165|P5|Received Vaccination 2|Medication interfering with study taken|0
5824742|NCT02531802|20119166|P4|Received Vaccination 2|Medication interfering with study taken|0
5824743|NCT02531802|20119167|P3|Received Vaccination 2|Medication interfering with study taken|1
5824744|NCT02531802|20119168|P2|Received Vaccination 2|Medication interfering with study taken|0
5824745|NCT02531802|20119169|P1|Received Vaccination 2|Medication interfering with study taken|0
5824746|NCT02531698|20119601|P2|Overall Study|Lost to Follow-up|0
5824747|NCT02531698|20119602|P1|Overall Study|Lost to Follow-up|1
5824748|NCT02531698|20119601|P2|Overall Study|Protocol Violation|0
5824749|NCT02531698|20119602|P1|Overall Study|Protocol Violation|2
5824750|NCT02531698|20119601|P2|Overall Study|Withdrawal by Subject|1
5824751|NCT02531698|20119602|P1|Overall Study|Withdrawal by Subject|6
5824752|NCT02531698|20119601|P2|Overall Study|Adverse Event|1
5824753|NCT02531698|20119602|P1|Overall Study|Adverse Event|2
5824754|NCT02531646|20119849|P3|Overall Study|equip. image processing issue|0
5824755|NCT02531646|20119850|P2|Overall Study|equip. image processing issue|1
5824756|NCT02531646|20119851|P1|Overall Study|equip. image processing issue|5
5824757|NCT02531633|20119870|P10|Part B (104 Weeks)|Lost to Follow-up|0
5824758|NCT02531633|20119871|P9|Part B (104 Weeks)|Lost to Follow-up|0
5824759|NCT02531633|20119872|P8|Part B (104 Weeks)|Lost to Follow-up|1
5824760|NCT02531633|20119873|P7|Part B (104 Weeks)|Lost to Follow-up|0
5824761|NCT02531633|20119874|P6|Part B (104 Weeks)|Lost to Follow-up|0
5824762|NCT02531633|20119875|P5|Part B (104 Weeks)|Lost to Follow-up|0
5824763|NCT02531633|20119876|P4|Part B (104 Weeks)|Lost to Follow-up|0
5824764|NCT02531633|20119877|P3|Part B (104 Weeks)|Lost to Follow-up|0
5824765|NCT02531633|20119878|P2|Part B (104 Weeks)|Lost to Follow-up|0
5824766|NCT02531633|20119879|P1|Part B (104 Weeks)|Lost to Follow-up|0
5824767|NCT02531633|20119870|P10|Part B (104 Weeks)|Sponsor request|4
5824768|NCT02531633|20119871|P9|Part B (104 Weeks)|Sponsor request|5
5824769|NCT02531633|20119872|P8|Part B (104 Weeks)|Sponsor request|3
5824770|NCT02531633|20119873|P7|Part B (104 Weeks)|Sponsor request|5
5824771|NCT02531633|20119874|P6|Part B (104 Weeks)|Sponsor request|8
5824772|NCT02531633|20119875|P5|Part B (104 Weeks)|Sponsor request|0
5824773|NCT02531633|20119876|P4|Part B (104 Weeks)|Sponsor request|0
5824774|NCT02531633|20119877|P3|Part B (104 Weeks)|Sponsor request|0
5824775|NCT02531633|20119878|P2|Part B (104 Weeks)|Sponsor request|0
5824776|NCT02531633|20119879|P1|Part B (104 Weeks)|Sponsor request|0
5824777|NCT02531633|20119870|P10|Part A (52 Weeks)|Other|0
5824778|NCT02531633|20119871|P9|Part A (52 Weeks)|Other|0
5824779|NCT02531633|20119872|P8|Part A (52 Weeks)|Other|0
5824780|NCT02531633|20119873|P7|Part A (52 Weeks)|Other|0
5824781|NCT02531633|20119874|P6|Part A (52 Weeks)|Other|0
5824782|NCT02531633|20119875|P5|Part A (52 Weeks)|Other|0
5824783|NCT02531633|20119876|P4|Part A (52 Weeks)|Other|0
5824784|NCT02531633|20119877|P3|Part A (52 Weeks)|Other|0
5824785|NCT02531633|20119878|P2|Part A (52 Weeks)|Other|0
5824786|NCT02531633|20119879|P1|Part A (52 Weeks)|Other|2
5824787|NCT02531633|20119870|P10|Part A (52 Weeks)|Withdrawal by Subject|0
5824788|NCT02531633|20119871|P9|Part A (52 Weeks)|Withdrawal by Subject|0
5824789|NCT02531633|20119872|P8|Part A (52 Weeks)|Withdrawal by Subject|0
5824790|NCT02531633|20119873|P7|Part A (52 Weeks)|Withdrawal by Subject|0
5824791|NCT02531633|20119874|P6|Part A (52 Weeks)|Withdrawal by Subject|0
5824792|NCT02531633|20119875|P5|Part A (52 Weeks)|Withdrawal by Subject|3
5824793|NCT02531633|20119876|P4|Part A (52 Weeks)|Withdrawal by Subject|3
5824794|NCT02531633|20119877|P3|Part A (52 Weeks)|Withdrawal by Subject|1
5824795|NCT02531633|20119878|P2|Part A (52 Weeks)|Withdrawal by Subject|6
5824796|NCT02531633|20119879|P1|Part A (52 Weeks)|Withdrawal by Subject|6
5824797|NCT02531633|20119870|P10|Part A (52 Weeks)|Physician Decision|0
5824798|NCT02531633|20119871|P9|Part A (52 Weeks)|Physician Decision|0
5824799|NCT02531633|20119872|P8|Part A (52 Weeks)|Physician Decision|0
5824800|NCT02531633|20119873|P7|Part A (52 Weeks)|Physician Decision|0
5824801|NCT02531633|20119874|P6|Part A (52 Weeks)|Physician Decision|0
5824802|NCT02531633|20119875|P5|Part A (52 Weeks)|Physician Decision|0
5824803|NCT02531633|20119876|P4|Part A (52 Weeks)|Physician Decision|1
5824804|NCT02531633|20119877|P3|Part A (52 Weeks)|Physician Decision|3
5824805|NCT02531633|20119878|P2|Part A (52 Weeks)|Physician Decision|4
5824806|NCT02531633|20119879|P1|Part A (52 Weeks)|Physician Decision|1
5824807|NCT02531633|20119870|P10|Part A (52 Weeks)|Lost to Follow-up|0
5824808|NCT02531633|20119871|P9|Part A (52 Weeks)|Lost to Follow-up|0
5824809|NCT02531633|20119872|P8|Part A (52 Weeks)|Lost to Follow-up|0
5824810|NCT02531633|20119873|P7|Part A (52 Weeks)|Lost to Follow-up|0
5824811|NCT02531633|20119874|P6|Part A (52 Weeks)|Lost to Follow-up|0
5824812|NCT02531633|20119875|P5|Part A (52 Weeks)|Lost to Follow-up|1
5824813|NCT02531633|20119876|P4|Part A (52 Weeks)|Lost to Follow-up|0
5824814|NCT02531633|20119877|P3|Part A (52 Weeks)|Lost to Follow-up|0
5824815|NCT02531633|20119878|P2|Part A (52 Weeks)|Lost to Follow-up|0
5824816|NCT02531633|20119879|P1|Part A (52 Weeks)|Lost to Follow-up|0
5824817|NCT02531633|20119870|P10|Part A (52 Weeks)|Protocol Violation|0
5824818|NCT02531633|20119871|P9|Part A (52 Weeks)|Protocol Violation|0
5824819|NCT02531633|20119872|P8|Part A (52 Weeks)|Protocol Violation|0
5824820|NCT02531633|20119873|P7|Part A (52 Weeks)|Protocol Violation|0
5824821|NCT02531633|20119874|P6|Part A (52 Weeks)|Protocol Violation|0
5824822|NCT02531633|20119875|P5|Part A (52 Weeks)|Protocol Violation|0
5824823|NCT02531633|20119876|P4|Part A (52 Weeks)|Protocol Violation|0
5824824|NCT02531633|20119877|P3|Part A (52 Weeks)|Protocol Violation|0
5824825|NCT02531633|20119878|P2|Part A (52 Weeks)|Protocol Violation|0
5824826|NCT02531633|20119879|P1|Part A (52 Weeks)|Protocol Violation|1
5824827|NCT02531633|20119870|P10|Part A (52 Weeks)|Sponsor request|0
5824828|NCT02531633|20119871|P9|Part A (52 Weeks)|Sponsor request|0
5824829|NCT02531633|20119872|P8|Part A (52 Weeks)|Sponsor request|0
5824830|NCT02531633|20119873|P7|Part A (52 Weeks)|Sponsor request|0
5824831|NCT02531633|20119874|P6|Part A (52 Weeks)|Sponsor request|0
5824832|NCT02531633|20119875|P5|Part A (52 Weeks)|Sponsor request|19
5824833|NCT02531633|20119876|P4|Part A (52 Weeks)|Sponsor request|18
5824834|NCT02531633|20119877|P3|Part A (52 Weeks)|Sponsor request|18
5824835|NCT02531633|20119878|P2|Part A (52 Weeks)|Sponsor request|24
5824836|NCT02531633|20119879|P1|Part A (52 Weeks)|Sponsor request|24
5824837|NCT02531438|20120358|P2|Overall Study|Randomized with Exclusion Criteria|0
5824838|NCT02531438|20120359|P1|Overall Study|Randomized with Exclusion Criteria|1
5824839|NCT02531438|20120358|P2|Overall Study|Missed EOT/PTE Visit|2
5824840|NCT02531438|20120359|P1|Overall Study|Missed EOT/PTE Visit|5
5824841|NCT02531438|20120358|P2|Overall Study|Randomized, but Not Treated|0
5824842|NCT02531438|20120359|P1|Overall Study|Randomized, but Not Treated|4
5824843|NCT02531438|20120358|P2|Overall Study|Death|3
5824844|NCT02531438|20120359|P1|Overall Study|Death|6
5824845|NCT02531438|20120358|P2|Overall Study|Physician Decision|1
5824846|NCT02531438|20120359|P1|Overall Study|Physician Decision|0
5824847|NCT02531438|20120358|P2|Overall Study|Withdrawal by Subject|8
5824848|NCT02531438|20120359|P1|Overall Study|Withdrawal by Subject|7
5824849|NCT02531438|20120358|P2|Overall Study|Lost to Follow-up|3
5824850|NCT02531438|20120359|P1|Overall Study|Lost to Follow-up|0
5824851|NCT02531438|20120358|P2|Overall Study|Adverse Event|9
5824852|NCT02531438|20120359|P1|Overall Study|Adverse Event|7
5824853|NCT02531373|20120378|P9|Overall Study|Withdrawal by Subject|0
5824854|NCT02531373|20120379|P8|Overall Study|Withdrawal by Subject|0
5824855|NCT02531373|20120380|P7|Overall Study|Withdrawal by Subject|0
5824856|NCT02531373|20120381|P6|Overall Study|Withdrawal by Subject|0
5824857|NCT02531373|20120382|P5|Overall Study|Withdrawal by Subject|3
5824858|NCT02531373|20120383|P4|Overall Study|Withdrawal by Subject|0
5824859|NCT02531373|20120384|P3|Overall Study|Withdrawal by Subject|0
5824860|NCT02531373|20120385|P2|Overall Study|Withdrawal by Subject|0
5824861|NCT02531373|20120386|P1|Overall Study|Withdrawal by Subject|0
5824862|NCT02531373|20120378|P9|Overall Study|Withdrawal by Parent/Guardian|3
5824863|NCT02531373|20120379|P8|Overall Study|Withdrawal by Parent/Guardian|1
5824864|NCT02531373|20120380|P7|Overall Study|Withdrawal by Parent/Guardian|4
5824865|NCT02531373|20120381|P6|Overall Study|Withdrawal by Parent/Guardian|3
5824866|NCT02531373|20120382|P5|Overall Study|Withdrawal by Parent/Guardian|0
5824867|NCT02531373|20120383|P4|Overall Study|Withdrawal by Parent/Guardian|0
5824868|NCT02531373|20120384|P3|Overall Study|Withdrawal by Parent/Guardian|0
5824869|NCT02531373|20120385|P2|Overall Study|Withdrawal by Parent/Guardian|0
5824870|NCT02531373|20120386|P1|Overall Study|Withdrawal by Parent/Guardian|0
5824871|NCT02531373|20120378|P9|Overall Study|Protocol Violation|1
5824872|NCT02531373|20120379|P8|Overall Study|Protocol Violation|0
5824873|NCT02531373|20120380|P7|Overall Study|Protocol Violation|1
5824874|NCT02531373|20120381|P6|Overall Study|Protocol Violation|1
5824875|NCT02531373|20120382|P5|Overall Study|Protocol Violation|0
5824876|NCT02531373|20120383|P4|Overall Study|Protocol Violation|0
5824877|NCT02531373|20120384|P3|Overall Study|Protocol Violation|0
5824878|NCT02531373|20120385|P2|Overall Study|Protocol Violation|0
5824879|NCT02531373|20120386|P1|Overall Study|Protocol Violation|0
5824880|NCT02531373|20120378|P9|Overall Study|Physician Decision|0
5824881|NCT02531373|20120379|P8|Overall Study|Physician Decision|0
5824882|NCT02531373|20120380|P7|Overall Study|Physician Decision|0
5824883|NCT02531373|20120381|P6|Overall Study|Physician Decision|1
5824884|NCT02531373|20120382|P5|Overall Study|Physician Decision|2
5824885|NCT02531373|20120383|P4|Overall Study|Physician Decision|0
5824886|NCT02531373|20120384|P3|Overall Study|Physician Decision|0
5824887|NCT02531373|20120385|P2|Overall Study|Physician Decision|0
5824888|NCT02531373|20120386|P1|Overall Study|Physician Decision|0
5824889|NCT02531373|20120378|P9|Overall Study|Lost to Follow-up|0
5824890|NCT02531373|20120379|P8|Overall Study|Lost to Follow-up|0
5824891|NCT02531373|20120380|P7|Overall Study|Lost to Follow-up|2
5824892|NCT02531373|20120381|P6|Overall Study|Lost to Follow-up|2
5824893|NCT02531373|20120382|P5|Overall Study|Lost to Follow-up|0
5824894|NCT02531373|20120383|P4|Overall Study|Lost to Follow-up|0
5824895|NCT02531373|20120384|P3|Overall Study|Lost to Follow-up|0
5824896|NCT02531373|20120385|P2|Overall Study|Lost to Follow-up|0
5824897|NCT02531373|20120386|P1|Overall Study|Lost to Follow-up|0
5824898|NCT02531373|20120378|P9|Overall Study|Lack of Efficacy|5
5824899|NCT02531373|20120379|P8|Overall Study|Lack of Efficacy|8
5824900|NCT02531373|20120380|P7|Overall Study|Lack of Efficacy|4
5824901|NCT02531373|20120381|P6|Overall Study|Lack of Efficacy|2
5824902|NCT02531373|20120382|P5|Overall Study|Lack of Efficacy|3
5824903|NCT02531373|20120383|P4|Overall Study|Lack of Efficacy|0
5824904|NCT02531373|20120384|P3|Overall Study|Lack of Efficacy|0
5824905|NCT02531373|20120385|P2|Overall Study|Lack of Efficacy|0
5824906|NCT02531373|20120386|P1|Overall Study|Lack of Efficacy|0
5824907|NCT02531113|20120458|P1|Extension Period: Week 12 up to Week 160|Pregnancy|1
5824908|NCT02531113|20120458|P1|Extension Period: Week 12 up to Week 160|Withdrawal by Subject|11
5824909|NCT02531113|20120458|P1|Extension Period: Week 12 up to Week 160|Lack of Efficacy|19
5824910|NCT02531113|20120458|P1|Extension Period: Week 12 up to Week 160|Adverse Event|5
5824911|NCT02531113|20120458|P1|Extension Period: Week 12 up to Week 160|Physician Decision|2
5824912|NCT02531113|20120458|P1|Induction Period: Week 0 to 12|Withdrawal by Subject|3
5824913|NCT02531113|20120458|P1|Induction Period: Week 0 to 12|Lack of Efficacy|4
5824914|NCT02531113|20120458|P1|Induction Period: Week 0 to 12|Adverse Event|4
5824915|NCT02531035|20120494|P2|Overall Study|Randomized, not treated|1
5824916|NCT02531035|20120495|P1|Overall Study|Randomized, not treated|2
5824917|NCT02531035|20120494|P2|Overall Study|Lost to Follow-up|10
5824918|NCT02531035|20120495|P1|Overall Study|Lost to Follow-up|8
5824919|NCT02531035|20120494|P2|Overall Study|Withdrawal by Subject|32
5824920|NCT02531035|20120495|P1|Overall Study|Withdrawal by Subject|42
5824921|NCT02531035|20120494|P2|Overall Study|Other|2
5824922|NCT02531035|20120495|P1|Overall Study|Other|3
5824923|NCT02531035|20120494|P2|Overall Study|Adverse Event|45
5824924|NCT02531035|20120495|P1|Overall Study|Adverse Event|16
5824925|NCT02531035|20120494|P2|Overall Study|Physician Decision|0
5824926|NCT02531035|20120495|P1|Overall Study|Physician Decision|1
5824927|NCT02531035|20120494|P2|Overall Study|Noncompliance with study drug|3
5824928|NCT02531035|20120495|P1|Overall Study|Noncompliance with study drug|8
5824929|NCT02531035|20120494|P2|Overall Study|Protocol Violation|1
5824930|NCT02531035|20120495|P1|Overall Study|Protocol Violation|1
5824931|NCT02531035|20120494|P2|Overall Study|Death|1
5824932|NCT02531035|20120495|P1|Overall Study|Death|0
5824933|NCT02530970|20120520|P1|Overall Study|Relocation|3
5824934|NCT02530970|20120520|P1|Overall Study|Change in Provider|5
5824935|NCT02530970|20120520|P1|Overall Study|Explant|2
5824936|NCT02530970|20120520|P1|Overall Study|Insurance|2
5824937|NCT02530970|20120520|P1|Overall Study|Hospitalization|1
5824938|NCT02530970|20120520|P1|Overall Study|Death|6
5824939|NCT02530970|20120520|P1|Overall Study|Withdrawal by Subject|14
5824940|NCT02530970|20120520|P1|Overall Study|Physician Decision|5
5824941|NCT02530970|20120520|P1|Overall Study|Lost to Follow-up|88
5824942|NCT02530970|20120520|P1|Overall Study|Adverse Event|8
5824943|NCT02530671|20120527|P2|Overall Study|Withdrawal by Subject|0
5824944|NCT02530671|20120528|P1|Overall Study|Withdrawal by Subject|1
5824945|NCT02530671|20120527|P2|Overall Study|Lost to Follow-up|0
5824946|NCT02530671|20120528|P1|Overall Study|Lost to Follow-up|2
5824947|NCT02530619|20120544|P1|Follow-up Period (6 Months)|Withdrawal by Subject|5
5824948|NCT02530619|20120544|P1|Follow-up Period (6 Months)|Lost to Follow-up|2
5824949|NCT02530619|20120544|P1|Follow-up Period (6 Months)|Death|4
5824950|NCT02530619|20120544|P1|Continued Treatment Cycles 2 Through 6|Lack of Efficacy|2
5824951|NCT02530619|20120544|P1|Continued Treatment Cycles 2 Through 6|Progressive Disease|4
5824952|NCT02530619|20120544|P1|Continued Treatment Cycles 2 Through 6|Withdrawal by Subject|2
5824953|NCT02530619|20120544|P1|Continued Treatment Cycles 2 Through 6|Adverse Event|2
5824954|NCT02530619|20120544|P1|Registered for Study|Withdrawal by Subject|2
5824955|NCT02530385|20120620|P2|Overall Study|Withdrawal by Subject|1
5824956|NCT02530385|20120621|P1|Overall Study|Withdrawal by Subject|0
5824957|NCT02530242|20120673|P2|Overall Study|excluded due to asthma and oxcarbazepine|1
5824958|NCT02530242|20120674|P1|Overall Study|excluded due to asthma and oxcarbazepine|0
5824959|NCT02530125|20120693|P1|Followed for Survival for 2 Years|Early termination of study|3
5824960|NCT02530125|20120693|P1|Completed Treatment|Early termination of study|1
5824961|NCT02529995|20120707|P2|Part B|Discontinued Study|5
5824962|NCT02529995|20120708|P1|Part B|Discontinued Study|6
5824963|NCT02529995|20120707|P2|Part B|Ongoing Study at Data Cut-off|7
5824964|NCT02529995|20120708|P1|Part B|Ongoing Study at Data Cut-off|0
5824965|NCT02529995|20120707|P2|Part A|Discontinued Study|0
5824966|NCT02529995|20120708|P1|Part A|Discontinued Study|1
5824967|NCT02529995|20120707|P2|Part A|Ongoing Study at Data Cut-off|16
5824968|NCT02529995|20120708|P1|Part A|Ongoing Study at Data Cut-off|14
5824969|NCT02529553|20120751|P9|Overall Study|Withdrawal by Subject|0
5824970|NCT02529553|20120752|P8|Overall Study|Withdrawal by Subject|1
5824971|NCT02529553|20120753|P7|Overall Study|Withdrawal by Subject|0
5824972|NCT02529553|20120754|P6|Overall Study|Withdrawal by Subject|1
5824973|NCT02529553|20120755|P5|Overall Study|Withdrawal by Subject|0
5824974|NCT02529553|20120756|P4|Overall Study|Withdrawal by Subject|0
5824975|NCT02529553|20120757|P3|Overall Study|Withdrawal by Subject|0
5824976|NCT02529553|20120758|P2|Overall Study|Withdrawal by Subject|0
5824977|NCT02529553|20120759|P1|Overall Study|Withdrawal by Subject|0
5824978|NCT02529553|20120751|P9|Overall Study|Physician Decision|0
5824979|NCT02529553|20120752|P8|Overall Study|Physician Decision|0
5824980|NCT02529553|20120753|P7|Overall Study|Physician Decision|0
5824981|NCT02529553|20120754|P6|Overall Study|Physician Decision|0
5824982|NCT02529553|20120755|P5|Overall Study|Physician Decision|1
5824983|NCT02529553|20120756|P4|Overall Study|Physician Decision|0
5824984|NCT02529553|20120757|P3|Overall Study|Physician Decision|0
5824985|NCT02529553|20120758|P2|Overall Study|Physician Decision|1
5824986|NCT02529553|20120759|P1|Overall Study|Physician Decision|0
5824987|NCT02529553|20120751|P9|Overall Study|Progressive Disease|3
5824988|NCT02529553|20120752|P8|Overall Study|Progressive Disease|5
5824989|NCT02529553|20120753|P7|Overall Study|Progressive Disease|3
5824990|NCT02529553|20120754|P6|Overall Study|Progressive Disease|3
5824991|NCT02529553|20120755|P5|Overall Study|Progressive Disease|2
5824992|NCT02529553|20120756|P4|Overall Study|Progressive Disease|3
5824993|NCT02529553|20120757|P3|Overall Study|Progressive Disease|1
5824994|NCT02529553|20120758|P2|Overall Study|Progressive Disease|0
5824995|NCT02529553|20120759|P1|Overall Study|Progressive Disease|1
5824996|NCT02529488|20120798|P1|Overall Study|Death|3
5824997|NCT02529488|20120798|P1|Overall Study|Adverse Event|1
5824998|NCT02529137|20120806|P1|Overall Study|Discontinuation for different reasons|8
5824999|NCT02528643|20120843|P2|Overall Study|No End of Study Information Available|0
5825000|NCT02528643|20120844|P1|Overall Study|No End of Study Information Available|1
5825001|NCT02528643|20120843|P2|Overall Study|Miscellaneous|1
5825002|NCT02528643|20120844|P1|Overall Study|Miscellaneous|0
5825003|NCT02528643|20120843|P2|Overall Study|Withdrawal by Subject|7
5825004|NCT02528643|20120844|P1|Overall Study|Withdrawal by Subject|0
5825005|NCT02528643|20120843|P2|Overall Study|Lost to Follow-up|1
5825006|NCT02528643|20120844|P1|Overall Study|Lost to Follow-up|0
5825007|NCT02528643|20120843|P2|Overall Study|Death|76
5825008|NCT02528643|20120844|P1|Overall Study|Death|38
5825009|NCT02528331|20120886|P1|Overall Study|Withdrawal by Subject|2
5825010|NCT02528305|20120954|P1|Overall Study|Physician Decision|1
5825011|NCT02528305|20120954|P1|Overall Study|Adverse Event|1
5825012|NCT02528305|20120954|P1|Overall Study|Withdrawal by Subject|1
5825013|NCT02528253|20121001|P5|Overall Study|Withdrawn Due to Pregnancy|1
5825014|NCT02528253|20121002|P4|Overall Study|Withdrawn Due to Pregnancy|0
5825015|NCT02528253|20121003|P3|Overall Study|Withdrawn Due to Pregnancy|0
5825016|NCT02528253|20121004|P2|Overall Study|Withdrawn Due to Pregnancy|1
5825017|NCT02528253|20121005|P1|Overall Study|Withdrawn Due to Pregnancy|0
5825018|NCT02528253|20121001|P5|Overall Study|Protocol Violation|4
5825019|NCT02528253|20121002|P4|Overall Study|Protocol Violation|0
5825020|NCT02528253|20121003|P3|Overall Study|Protocol Violation|4
5825021|NCT02528253|20121004|P2|Overall Study|Protocol Violation|2
5825022|NCT02528253|20121005|P1|Overall Study|Protocol Violation|1
5825023|NCT02528253|20121001|P5|Overall Study|Withdrawal by Subject|73
5825024|NCT02528253|20121002|P4|Overall Study|Withdrawal by Subject|48
5825025|NCT02528253|20121003|P3|Overall Study|Withdrawal by Subject|29
5825026|NCT02528253|20121004|P2|Overall Study|Withdrawal by Subject|20
5825027|NCT02528253|20121005|P1|Overall Study|Withdrawal by Subject|25
5825028|NCT02528253|20121001|P5|Overall Study|Other|76
5825029|NCT02528253|20121002|P4|Overall Study|Other|52
5825030|NCT02528253|20121003|P3|Overall Study|Other|58
5825031|NCT02528253|20121004|P2|Overall Study|Other|22
5825032|NCT02528253|20121005|P1|Overall Study|Other|21
5825033|NCT02528253|20121001|P5|Overall Study|Lost to Follow-up|34
5825034|NCT02528253|20121002|P4|Overall Study|Lost to Follow-up|16
5825035|NCT02528253|20121003|P3|Overall Study|Lost to Follow-up|31
5825036|NCT02528253|20121004|P2|Overall Study|Lost to Follow-up|9
5825037|NCT02528253|20121005|P1|Overall Study|Lost to Follow-up|16
5825038|NCT02528253|20121001|P5|Overall Study|Insufficient clinical response|16
5825039|NCT02528253|20121002|P4|Overall Study|Insufficient clinical response|12
5825040|NCT02528253|20121003|P3|Overall Study|Insufficient clinical response|13
5825041|NCT02528253|20121004|P2|Overall Study|Insufficient clinical response|10
5825042|NCT02528253|20121005|P1|Overall Study|Insufficient clinical response|7
5825043|NCT02528253|20121001|P5|Overall Study|Death|1
5825044|NCT02528253|20121002|P4|Overall Study|Death|0
5825045|NCT02528253|20121003|P3|Overall Study|Death|1
5825046|NCT02528253|20121004|P2|Overall Study|Death|2
5825047|NCT02528253|20121005|P1|Overall Study|Death|2
5825048|NCT02528253|20121001|P5|Overall Study|Adverse Event|18
5825049|NCT02528253|20121002|P4|Overall Study|Adverse Event|8
5825050|NCT02528253|20121003|P3|Overall Study|Adverse Event|4
5825051|NCT02528253|20121004|P2|Overall Study|Adverse Event|4
5825052|NCT02528253|20121005|P1|Overall Study|Adverse Event|3
5825053|NCT02528214|20121298|P2|Overall Study|Other than specified above|1
5825054|NCT02528214|20121299|P1|Overall Study|Other than specified above|0
5825055|NCT02528214|20121298|P2|Overall Study|Adverse Event|1
5825056|NCT02528214|20121299|P1|Overall Study|Adverse Event|0
5825057|NCT02528214|20121298|P2|Overall Study|Protocol Violation|1
5825058|NCT02528214|20121299|P1|Overall Study|Protocol Violation|0
5825059|NCT02528188|20121334|P3|Overall Study|Randomized but not treated|12
5825060|NCT02528188|20121335|P2|Overall Study|Randomized but not treated|7
5825061|NCT02528188|20121336|P1|Overall Study|Randomized but not treated|6
5825062|NCT02528188|20121334|P3|Overall Study|Other|74
5825063|NCT02528188|20121335|P2|Overall Study|Other|91
5825064|NCT02528188|20121336|P1|Overall Study|Other|89
5825065|NCT02528188|20121334|P3|Overall Study|Death|0
5825066|NCT02528188|20121335|P2|Overall Study|Death|4
5825067|NCT02528188|20121336|P1|Overall Study|Death|4
5825068|NCT02528188|20121334|P3|Overall Study|Lost to Follow-up|31
5825069|NCT02528188|20121335|P2|Overall Study|Lost to Follow-up|21
5825070|NCT02528188|20121336|P1|Overall Study|Lost to Follow-up|25
5825071|NCT02528188|20121334|P3|Overall Study|Withdrawal by Subject|100
5825072|NCT02528188|20121335|P2|Overall Study|Withdrawal by Subject|104
5825073|NCT02528188|20121336|P1|Overall Study|Withdrawal by Subject|97
5825074|NCT02528188|20121334|P3|Overall Study|Lack of Efficacy|22
5825075|NCT02528188|20121335|P2|Overall Study|Lack of Efficacy|21
5825076|NCT02528188|20121336|P1|Overall Study|Lack of Efficacy|19
5825077|NCT02528188|20121334|P3|Overall Study|Protocol Violation|4
5825078|NCT02528188|20121335|P2|Overall Study|Protocol Violation|6
5825079|NCT02528188|20121336|P1|Overall Study|Protocol Violation|4
5825080|NCT02528188|20121334|P3|Overall Study|Adverse Event|8
5825081|NCT02528188|20121335|P2|Overall Study|Adverse Event|22
5825082|NCT02528188|20121336|P1|Overall Study|Adverse Event|23
5825083|NCT02527434|20121618|P3|Overall Study|Site closure|0
5825084|NCT02527434|20121619|P2|Overall Study|Site closure|0
5825085|NCT02527434|20121620|P1|Overall Study|Site closure|1
5825086|NCT02527434|20121618|P3|Overall Study|Reason Not Specified|0
5825087|NCT02527434|20121619|P2|Overall Study|Reason Not Specified|0
5825088|NCT02527434|20121620|P1|Overall Study|Reason Not Specified|1
5825089|NCT02527434|20121618|P3|Overall Study|Withdrawal by Subject|3
5825090|NCT02527434|20121619|P2|Overall Study|Withdrawal by Subject|3
5825091|NCT02527434|20121620|P1|Overall Study|Withdrawal by Subject|5
5825092|NCT02527434|20121618|P3|Overall Study|Death|17
5825093|NCT02527434|20121619|P2|Overall Study|Death|6
5825094|NCT02527434|20121620|P1|Overall Study|Death|19
5825095|NCT02527434|20121618|P3|Overall Study|Lost to Follow-up|0
5825096|NCT02527434|20121619|P2|Overall Study|Lost to Follow-up|2
5825097|NCT02527434|20121620|P1|Overall Study|Lost to Follow-up|2
5825098|NCT02527161|20121678|P1|Overall Study|Lost to Follow-up|6
5825099|NCT02527161|20121678|P1|Overall Study|Adverse Event|1
5825100|NCT02527161|20121678|P1|Overall Study|Physician Decision|1
5825101|NCT02527161|20121678|P1|Overall Study|Only Recruited to Part A|27
5825102|NCT02527161|20121678|P1|Overall Study|Consent violation|4
5825103|NCT02527161|20121678|P1|Overall Study|MRI contraindication|6
5825104|NCT02527161|20121678|P1|Overall Study|Delay in or unfit for surgery|16
5825105|NCT02527161|20121678|P1|Overall Study|Withdrawal by Subject|19
5825106|NCT02527161|20121678|P1|Overall Study|Failed MRI|52
5825107|NCT02527148|20121697|P2|Overall Study|Did not receive study intervention|0
5825108|NCT02527148|20121698|P1|Overall Study|Did not receive study intervention|1
5825109|NCT02526693|20121728|P2|Overall Study|Physician Decision|1
5825110|NCT02526693|20121729|P1|Overall Study|Physician Decision|3
5825111|NCT02526550|20121774|P1|Overall Study|Lost to Follow-up|1
5825112|NCT02526524|20121786|P6|Overall Study|Sponsor Decision|0
5825113|NCT02526524|20121787|P5|Overall Study|Sponsor Decision|0
5825114|NCT02526524|20121788|P4|Overall Study|Sponsor Decision|0
5825115|NCT02526524|20121789|P3|Overall Study|Sponsor Decision|0
5825116|NCT02526524|20121790|P2|Overall Study|Sponsor Decision|0
5825117|NCT02526524|20121791|P1|Overall Study|Sponsor Decision|1
5825118|NCT02526524|20121786|P6|Overall Study|Physician Decision|0
5825119|NCT02526524|20121787|P5|Overall Study|Physician Decision|1
5825120|NCT02526524|20121788|P4|Overall Study|Physician Decision|0
5825121|NCT02526524|20121789|P3|Overall Study|Physician Decision|0
5825122|NCT02526524|20121790|P2|Overall Study|Physician Decision|0
5825123|NCT02526524|20121791|P1|Overall Study|Physician Decision|0
5825124|NCT02526524|20121786|P6|Overall Study|Loss of Glucose Control|0
5825125|NCT02526524|20121787|P5|Overall Study|Loss of Glucose Control|2
5825126|NCT02526524|20121788|P4|Overall Study|Loss of Glucose Control|0
5825127|NCT02526524|20121789|P3|Overall Study|Loss of Glucose Control|3
5825128|NCT02526524|20121790|P2|Overall Study|Loss of Glucose Control|0
5825129|NCT02526524|20121791|P1|Overall Study|Loss of Glucose Control|0
5825130|NCT02526524|20121786|P6|Overall Study|Protocol Violation|3
5825131|NCT02526524|20121787|P5|Overall Study|Protocol Violation|4
5825132|NCT02526524|20121788|P4|Overall Study|Protocol Violation|3
5825133|NCT02526524|20121789|P3|Overall Study|Protocol Violation|5
5825134|NCT02526524|20121790|P2|Overall Study|Protocol Violation|1
5825135|NCT02526524|20121791|P1|Overall Study|Protocol Violation|3
5825136|NCT02526524|20121786|P6|Overall Study|Lost to Follow-up|5
5825137|NCT02526524|20121787|P5|Overall Study|Lost to Follow-up|2
5825138|NCT02526524|20121788|P4|Overall Study|Lost to Follow-up|1
5825139|NCT02526524|20121789|P3|Overall Study|Lost to Follow-up|8
5825140|NCT02526524|20121790|P2|Overall Study|Lost to Follow-up|3
5825141|NCT02526524|20121791|P1|Overall Study|Lost to Follow-up|2
5825142|NCT02526524|20121786|P6|Overall Study|Adverse Event|8
5825143|NCT02526524|20121787|P5|Overall Study|Adverse Event|6
5825144|NCT02526524|20121788|P4|Overall Study|Adverse Event|2
5825145|NCT02526524|20121789|P3|Overall Study|Adverse Event|4
5825146|NCT02526524|20121790|P2|Overall Study|Adverse Event|2
5825147|NCT02526524|20121791|P1|Overall Study|Adverse Event|3
5825148|NCT02526524|20121786|P6|Overall Study|Withdrawal by Subject|5
5825149|NCT02526524|20121787|P5|Overall Study|Withdrawal by Subject|9
5825150|NCT02526524|20121788|P4|Overall Study|Withdrawal by Subject|1
5825151|NCT02526524|20121789|P3|Overall Study|Withdrawal by Subject|6
5825152|NCT02526524|20121790|P2|Overall Study|Withdrawal by Subject|3
5825153|NCT02526524|20121791|P1|Overall Study|Withdrawal by Subject|3
5825154|NCT02526290|20121805|P1|Overall Study|Physician Decision|1
5825155|NCT02526290|20121805|P1|Overall Study|Withdrawal by Subject|4
5825156|NCT02526290|20121805|P1|Overall Study|Adverse Event|3
5825157|NCT02526212|20121814|P2|Overall Study|Death|1
5825158|NCT02526212|20121815|P1|Overall Study|Death|0
5825159|NCT02526212|20121814|P2|Overall Study|Lost to Follow-up|0
5825160|NCT02526212|20121815|P1|Overall Study|Lost to Follow-up|1
5825161|NCT02526212|20121814|P2|Overall Study|Incarceration|0
5825162|NCT02526212|20121815|P1|Overall Study|Incarceration|1
5825163|NCT02525874|20121829|P1|Overall Study|New lesions in Brain|1
5825164|NCT02525874|20121829|P1|Overall Study|Alternative Treatment for MS|2
5825165|NCT02525874|20121829|P1|Overall Study|Disease relapse|4
5825166|NCT02525874|20121829|P1|Overall Study|Disease progression, defined by protocol|2
5825167|NCT02525874|20121829|P1|Overall Study|Lost to Follow-up|7
5825168|NCT02525874|20121829|P1|Overall Study|Adverse Event|17
5825169|NCT02525874|20121829|P1|Overall Study|Non-compliance with study drug|3
5825170|NCT02525874|20121829|P1|Overall Study|Consent withdrawn|22
5825171|NCT02525874|20121829|P1|Overall Study|Investigator Decision|1
5825172|NCT02525874|20121829|P1|Overall Study|Other|1
5825173|NCT02525744|20121842|P4|Period 5|Physician Decision|0
5825174|NCT02525744|20121843|P3|Period 5|Physician Decision|0
5825175|NCT02525744|20121844|P2|Period 5|Physician Decision|0
5825176|NCT02525744|20121845|P1|Period 5|Physician Decision|1
5825177|NCT02525744|20121842|P4|Period 4|Withdrawal by Subject|0
5825178|NCT02525744|20121843|P3|Period 4|Withdrawal by Subject|0
5825179|NCT02525744|20121844|P2|Period 4|Withdrawal by Subject|0
5825180|NCT02525744|20121845|P1|Period 4|Withdrawal by Subject|1
5825181|NCT02525744|20121842|P4|Period 3|Adverse Event|0
5825182|NCT02525744|20121843|P3|Period 3|Adverse Event|0
5825183|NCT02525744|20121844|P2|Period 3|Adverse Event|1
5825184|NCT02525744|20121845|P1|Period 3|Adverse Event|0
5825185|NCT02525744|20121842|P4|Period 1|Physician Decision|0
5825186|NCT02525744|20121843|P3|Period 1|Physician Decision|1
5825187|NCT02525744|20121844|P2|Period 1|Physician Decision|0
5825188|NCT02525744|20121845|P1|Period 1|Physician Decision|0
5825189|NCT02525627|20121881|P2|Overall Study|Site terminated|10
5825190|NCT02525627|20121882|P1|Overall Study|Site terminated|11
5825191|NCT02525627|20121881|P2|Overall Study|Death|0
5825192|NCT02525627|20121882|P1|Overall Study|Death|1
5825193|NCT02525627|20121881|P2|Overall Study|Withdrawal by Subject|2
5825194|NCT02525627|20121882|P1|Overall Study|Withdrawal by Subject|1
5825195|NCT02525627|20121881|P2|Overall Study|Revision|1
5825196|NCT02525627|20121882|P1|Overall Study|Revision|1
5825197|NCT02525588|20121894|P2|Overall Study|Adverse Event|1
5825198|NCT02525588|20121895|P1|Overall Study|Adverse Event|0
5825199|NCT02525588|20121894|P2|Overall Study|Withdrawal by Subject|1
5825200|NCT02525588|20121895|P1|Overall Study|Withdrawal by Subject|1
5825201|NCT02525588|20121894|P2|Overall Study|Lost to Follow-up|0
5825202|NCT02525588|20121895|P1|Overall Study|Lost to Follow-up|2
5825203|NCT02525588|20121894|P2|Overall Study|Death|1
5825204|NCT02525588|20121895|P1|Overall Study|Death|3
5825205|NCT02525133|20122023|P2|Overall Study|Withdrawal by Subject|0
5825206|NCT02525133|20122024|P1|Overall Study|Withdrawal by Subject|1
5825207|NCT02525133|20122023|P2|Overall Study|randomized not enrolled|0
5825208|NCT02525133|20122024|P1|Overall Study|randomized not enrolled|3
5825209|NCT02525133|20122023|P2|Overall Study|Lost to Follow-up|1
5825210|NCT02525133|20122024|P1|Overall Study|Lost to Follow-up|5
5825211|NCT02525133|20122023|P2|Overall Study|did not meet randomization criteria|0
5825212|NCT02525133|20122024|P1|Overall Study|did not meet randomization criteria|1
5825213|NCT02525133|20122023|P2|Overall Study|Death|1
5825214|NCT02525133|20122024|P1|Overall Study|Death|0
5825215|NCT02525133|20122023|P2|Overall Study|Adverse Event|1
5825216|NCT02525133|20122024|P1|Overall Study|Adverse Event|0
5825217|NCT02525094|20122042|P2|Overall Study|Not Treated|1
5825218|NCT02525094|20122043|P1|Overall Study|Not Treated|1
5825219|NCT02525094|20122042|P2|Overall Study|Withdrawal by Subject|6
5825220|NCT02525094|20122043|P1|Overall Study|Withdrawal by Subject|5
5825221|NCT02525094|20122042|P2|Overall Study|Lost to Follow-up|1
5825222|NCT02525094|20122043|P1|Overall Study|Lost to Follow-up|2
5825223|NCT02524847|20122106|P1|Overall Study|Reason not Specified|1
5825224|NCT02524847|20122106|P1|Overall Study|Death|1
5825225|NCT02524847|20122106|P1|Overall Study|Condition no Longer Requires Treatment|4
5825226|NCT02524847|20122106|P1|Overall Study|Unsatisfactory Therapeutic Effect|4
5825227|NCT02524847|20122106|P1|Overall Study|Adverse Event|4
5825228|NCT02524665|20122118|P1|Overall Study|Lost to Follow-up|1
5825242|NCT02524158|20122179|P2|6-month Assessment|Lost to Follow-up|20
5825243|NCT02524158|20122180|P1|6-month Assessment|Lost to Follow-up|21
5825244|NCT02524158|20122179|P2|6-month Assessment|Withdrawal by Subject|1
5825245|NCT02524158|20122180|P1|6-month Assessment|Withdrawal by Subject|1
5825246|NCT02524158|20122179|P2|12-weeks Assessment|Lost to Follow-up|12
5825247|NCT02524158|20122180|P1|12-weeks Assessment|Lost to Follow-up|18
5825248|NCT02524158|20122179|P2|12-weeks Assessment|Withdrawal by Subject|1
5825249|NCT02524158|20122180|P1|12-weeks Assessment|Withdrawal by Subject|1
5825250|NCT02524145|20122222|P3|Overall Study|Withdrawal by Subject|3
5825251|NCT02524145|20122223|P2|Overall Study|Withdrawal by Subject|2
5825252|NCT02524145|20122224|P1|Overall Study|Withdrawal by Subject|2
5825253|NCT02523599|20122289|P2|Overall Study|Did not return for Day 30 visit|0
5825254|NCT02523599|20122290|P1|Overall Study|Did not return for Day 30 visit|2
5825255|NCT02523599|20122289|P2|Overall Study|Lost to Follow-up|1
5825256|NCT02523599|20122290|P1|Overall Study|Lost to Follow-up|4
5825257|NCT02523599|20122289|P2|Overall Study|Physician Decision|0
5825258|NCT02523599|20122290|P1|Overall Study|Physician Decision|1
5825259|NCT02523599|20122289|P2|Overall Study|Adverse Event|0
5825260|NCT02523599|20122290|P1|Overall Study|Adverse Event|1
5825261|NCT02522884|20122340|P1|Overall Study|Missed 12-month Follow-up|9
5825262|NCT02522884|20122340|P1|Overall Study|Death|3
5825263|NCT02522884|20122340|P1|Overall Study|Withdrawal by Subject|6
5825264|NCT02522728|20122372|P2|Overall Study|Did not receive randomized study device|1
5825265|NCT02522728|20122373|P1|Overall Study|Did not receive randomized study device|0
5825266|NCT02522728|20122372|P2|Overall Study|Adverse Event|1
5825267|NCT02522728|20122373|P1|Overall Study|Adverse Event|2
5825268|NCT02522728|20122372|P2|Overall Study|Death|3
5825269|NCT02522728|20122373|P1|Overall Study|Death|4
5825270|NCT02522728|20122372|P2|Overall Study|Withdrawal by Subject|6
5825271|NCT02522728|20122373|P1|Overall Study|Withdrawal by Subject|6
5825272|NCT02522624|20122400|P2|Overall Study|Technical failure|0
5825273|NCT02522624|20122401|P1|Overall Study|Technical failure|1
5825274|NCT02522481|20122417|P1|Overall Study|Not dosed|1
5825275|NCT02522481|20122417|P1|Overall Study|discontinued|1
5825276|NCT02522403|20122447|P2|Overall Study|Withdrawal by Subject|4
5825277|NCT02522403|20122448|P1|Overall Study|Withdrawal by Subject|2
5825278|NCT02522403|20122447|P2|Overall Study|Lost to Follow-up|2
5825279|NCT02522403|20122448|P1|Overall Study|Lost to Follow-up|2
5825280|NCT02522377|20122460|P2|Overall Study|Remission Achieved|0
5825281|NCT02522377|20122461|P1|Overall Study|Remission Achieved|3
5825282|NCT02522377|20122460|P2|Overall Study|Withdrawal by Subject|0
5825283|NCT02522377|20122461|P1|Overall Study|Withdrawal by Subject|1
5825284|NCT02522325|20122477|P2|Overall Study|Adverse Event|1
5825285|NCT02522325|20122478|P1|Overall Study|Adverse Event|0
5825286|NCT02522299|20122486|P2|Overall Study|Withdrawal by Subject|0
5825287|NCT02522299|20122487|P1|Overall Study|Withdrawal by Subject|2
5825288|NCT02522299|20122486|P2|Overall Study|Physician Decision|1
5825289|NCT02522299|20122487|P1|Overall Study|Physician Decision|0
5825290|NCT02522299|20122486|P2|Overall Study|Adverse Event|0
5825291|NCT02522299|20122487|P1|Overall Study|Adverse Event|2
5825292|NCT02522286|20122570|P4|Overall Study|Withdrawal by Subject|3
5825293|NCT02522286|20122571|P3|Overall Study|Withdrawal by Subject|0
5825294|NCT02522286|20122572|P2|Overall Study|Withdrawal by Subject|0
5825295|NCT02522286|20122573|P1|Overall Study|Withdrawal by Subject|3
5825296|NCT02521948|20122609|P1|Overall Study|Did not attend one or both follow-ups|6
5825297|NCT02521948|20122609|P1|Overall Study|Lost to Follow-up|1
5825298|NCT02521948|20122609|P1|Overall Study|Death|4
5825299|NCT02521948|20122609|P1|Overall Study|Adverse Event|2
5825300|NCT02521792|20122618|P1|Overall Study|Study Terminated|6
5825301|NCT02521376|20122668|P4|Overall Study|Enrolled, But Not Treated|0
5825302|NCT02521376|20122669|P3|Overall Study|Enrolled, But Not Treated|0
5825303|NCT02521376|20122670|P2|Overall Study|Enrolled, But Not Treated|0
5825304|NCT02521376|20122671|P1|Overall Study|Enrolled, But Not Treated|1
5825305|NCT02520726|20122725|P2|Overall Study|Lost to Follow-up|2
5825306|NCT02520726|20122726|P1|Overall Study|Lost to Follow-up|3
5825307|NCT02520531|20122736|P2|Overall Study|Not study device|0
5825308|NCT02520531|20122737|P1|Overall Study|Not study device|1
5825309|NCT02520531|20122736|P2|Overall Study|Withdrawal by Subject|0
5825310|NCT02520531|20122737|P1|Overall Study|Withdrawal by Subject|1
5825311|NCT02520531|20122736|P2|Overall Study|Meet exclusion criterion|1
5825312|NCT02520531|20122737|P1|Overall Study|Meet exclusion criterion|0
5825313|NCT02520531|20122736|P2|Overall Study|Lost to Follow-up|1
5825314|NCT02520531|20122737|P1|Overall Study|Lost to Follow-up|1
5825315|NCT02520531|20122736|P2|Overall Study|Death|2
5825316|NCT02520531|20122737|P1|Overall Study|Death|1
5825317|NCT02520531|20122736|P2|Overall Study|Revision of study device components|2
5825318|NCT02520531|20122737|P1|Overall Study|Revision of study device components|2
5825319|NCT02520388|20122822|P2|Overall Study|Other (reason not defined)|4
5825320|NCT02520388|20122823|P1|Overall Study|Other (reason not defined)|4
5825321|NCT02520388|20122822|P2|Overall Study|Lost to Follow-up|2
5825322|NCT02520388|20122823|P1|Overall Study|Lost to Follow-up|3
5825323|NCT02520388|20122822|P2|Overall Study|Adverse Event|4
5825324|NCT02520388|20122823|P1|Overall Study|Adverse Event|1
5825325|NCT02520388|20122822|P2|Overall Study|Subject or parent/guardian request|6
5825326|NCT02520388|20122823|P1|Overall Study|Subject or parent/guardian request|0
5825327|NCT02520388|20122822|P2|Overall Study|Physician Decision|0
5825328|NCT02520388|20122823|P1|Overall Study|Physician Decision|1
5825333|NCT02520284|20123012|P3|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1
5825334|NCT02520284|20123013|P2|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1
5825335|NCT02520284|20123014|P1|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|2
5825336|NCT02520284|20123012|P3|Open-Label MaintenancePhase: Upto Week51|Adverse Event|3
5825337|NCT02520284|20123013|P2|Open-Label MaintenancePhase: Upto Week51|Adverse Event|1
5825338|NCT02520284|20123014|P1|Open-Label MaintenancePhase: Upto Week51|Adverse Event|2
5825339|NCT02520284|20123012|P3|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|2
5825340|NCT02520284|20123013|P2|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|4
5825341|NCT02520284|20123014|P1|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|3
5825342|NCT02520284|20123012|P3|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|28
5825343|NCT02520284|20123013|P2|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|29
5825344|NCT02520284|20123014|P1|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|25
5825345|NCT02520284|20123012|P3|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0
5825346|NCT02520284|20123013|P2|Blinded Maintenance Phase: Up to Week 51|Disposition Error|2
5825347|NCT02520284|20123014|P1|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0
5825348|NCT02520284|20123012|P3|Blinded Maintenance Phase: Up to Week 51|Adverse Event|0
5825349|NCT02520284|20123013|P2|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1
5825350|NCT02520284|20123014|P1|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1
5825351|NCT02520284|20123012|P3|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|3
5825352|NCT02520284|20123013|P2|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2
5825353|NCT02520284|20123014|P1|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2
5825354|NCT02520284|20123012|P3|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|15
5825355|NCT02520284|20123013|P2|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|11
5825356|NCT02520284|20123014|P1|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|17
5825357|NCT02520284|20123012|P3|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|1
5825358|NCT02520284|20123013|P2|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0
5825359|NCT02520284|20123014|P1|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0
5825360|NCT02520284|20123012|P3|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1
5825361|NCT02520284|20123013|P2|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1
5825362|NCT02520284|20123014|P1|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1
5825363|NCT02520284|20123012|P3|Blinded Induction Phase: Up to Week 8|Adverse Event|0
5825364|NCT02520284|20123013|P2|Blinded Induction Phase: Up to Week 8|Adverse Event|3
5825365|NCT02520284|20123014|P1|Blinded Induction Phase: Up to Week 8|Adverse Event|1
5825366|NCT02520089|20123048|P2|Overall Study|Lost to Follow-up|4
5825367|NCT02520089|20123049|P1|Overall Study|Lost to Follow-up|3
5825368|NCT02519855|20123059|P2|Overall Study|Lost to Follow-up|3
5825369|NCT02519855|20123060|P1|Overall Study|Lost to Follow-up|3
5825370|NCT02519855|20123059|P2|Overall Study|Adverse Event|1
5825371|NCT02519855|20123060|P1|Overall Study|Adverse Event|0
5825372|NCT02519842|20123078|P3|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|2
5825373|NCT02519842|20123079|P2|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0
5825374|NCT02519842|20123080|P1|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0
5825375|NCT02519842|20123078|P3|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|1
5825376|NCT02519842|20123079|P2|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0
5825377|NCT02519842|20123080|P1|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0
5825378|NCT02519842|20123078|P3|Optional Extension: Cycles 2-6|Completed Chemotherapy|13
5825379|NCT02519842|20123079|P2|Optional Extension: Cycles 2-6|Completed Chemotherapy|0
5825380|NCT02519842|20123080|P1|Optional Extension: Cycles 2-6|Completed Chemotherapy|0
5825381|NCT02519842|20123078|P3|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|2
5825382|NCT02519842|20123079|P2|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0
5825383|NCT02519842|20123080|P1|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0
5825384|NCT02519842|20123078|P3|Optional Extension: Cycles 2-6|Death|1
5825385|NCT02519842|20123079|P2|Optional Extension: Cycles 2-6|Death|0
5825386|NCT02519842|20123080|P1|Optional Extension: Cycles 2-6|Death|0
5825387|NCT02519842|20123078|P3|Optional Extension: Cycles 2-6|Withdrawal by Subject|1
5825388|NCT02519842|20123079|P2|Optional Extension: Cycles 2-6|Withdrawal by Subject|0
5825389|NCT02519842|20123080|P1|Optional Extension: Cycles 2-6|Withdrawal by Subject|0
5825390|NCT02519842|20123078|P3|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|3
5825391|NCT02519842|20123079|P2|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0
5825392|NCT02519842|20123080|P1|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0
5825393|NCT02519842|20123078|P3|Optional Extension: Cycles 2-6|Adverse Event|1
5825394|NCT02519842|20123079|P2|Optional Extension: Cycles 2-6|Adverse Event|0
5825395|NCT02519842|20123080|P1|Optional Extension: Cycles 2-6|Adverse Event|0
5825396|NCT02519842|20123078|P3|Optional Extension: Cycles 2-6|Physician Decision|5
5825397|NCT02519842|20123079|P2|Optional Extension: Cycles 2-6|Physician Decision|0
5825398|NCT02519842|20123080|P1|Optional Extension: Cycles 2-6|Physician Decision|0
5825399|NCT02519842|20123078|P3|Base Study: Cycle 1|Non-compliance with Study Drug|0
5825400|NCT02519842|20123079|P2|Base Study: Cycle 1|Non-compliance with Study Drug|1
5825401|NCT02519842|20123080|P1|Base Study: Cycle 1|Non-compliance with Study Drug|0
5825402|NCT02519842|20123078|P3|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0
5825403|NCT02519842|20123079|P2|Base Study: Cycle 1|Withdrawn by Parent/Guardian|1
5825404|NCT02519842|20123080|P1|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0
5825405|NCT02519842|20123078|P3|Base Study: Cycle 1|Adverse Event|0
5825406|NCT02519842|20123079|P2|Base Study: Cycle 1|Adverse Event|0
5825407|NCT02519842|20123080|P1|Base Study: Cycle 1|Adverse Event|1
5825408|NCT02519842|20123078|P3|Base Study: Cycle 1|Screening Failure|0
5825409|NCT02519842|20123079|P2|Base Study: Cycle 1|Screening Failure|1
5825410|NCT02519842|20123080|P1|Base Study: Cycle 1|Screening Failure|1
5825411|NCT02519712|20123099|P1|Overall Study|Accruals are donors|2
5825412|NCT02519712|20123099|P1|Overall Study|Disease Progression|1
5825413|NCT02519712|20123099|P1|Overall Study|Disease Relapse|1
5825414|NCT02519595|20123128|P3|Overall Study|Protocol Violation|16
5825415|NCT02519595|20123129|P2|Overall Study|Protocol Violation|22
5825416|NCT02519595|20123130|P1|Overall Study|Protocol Violation|8
5825417|NCT02519504|20123155|P2|Overall Study|Did not participate in direct testing|86
5825418|NCT02519504|20123156|P1|Overall Study|Did not participate in direct testing|95
5825419|NCT02519504|20123155|P2|Overall Study|Ineligible for direct testing|12
5825420|NCT02519504|20123156|P1|Overall Study|Ineligible for direct testing|12
5825421|NCT02519504|20123155|P2|Overall Study|Protocol Violation|5
5825422|NCT02519504|20123156|P1|Overall Study|Protocol Violation|6
5825423|NCT02519231|20123255|P2|Overall Study|Withdrawal by Subject|1
5825424|NCT02519231|20123256|P1|Overall Study|Withdrawal by Subject|0
5825425|NCT02519231|20123255|P2|Overall Study|Lost to Follow-up|5
5825426|NCT02519231|20123256|P1|Overall Study|Lost to Follow-up|2
5825427|NCT02518971|20123372|P2|Overall Study|eligibility criteria no longer met|3
5825428|NCT02518971|20123373|P1|Overall Study|eligibility criteria no longer met|6
5825429|NCT02518971|20123372|P2|Overall Study|medication lost in mail|1
5825430|NCT02518971|20123373|P1|Overall Study|medication lost in mail|0
5825431|NCT02518971|20123372|P2|Overall Study|Side effects|0
5825432|NCT02518971|20123373|P1|Overall Study|Side effects|1
5825433|NCT02518971|20123372|P2|Overall Study|Withdrawal by Subject|5
5825434|NCT02518971|20123373|P1|Overall Study|Withdrawal by Subject|4
5825435|NCT02518971|20123372|P2|Overall Study|Protocol Violation|4
5825436|NCT02518971|20123373|P1|Overall Study|Protocol Violation|6
5825437|NCT02518971|20123372|P2|Overall Study|Physician Decision|6
5825438|NCT02518971|20123373|P1|Overall Study|Physician Decision|6
5825439|NCT02518971|20123372|P2|Overall Study|Lost to Follow-up|1
5825440|NCT02518971|20123373|P1|Overall Study|Lost to Follow-up|0
5825441|NCT02518919|20123393|P3|Overall Study|Protocol Violation|2
5825442|NCT02518919|20123394|P2|Overall Study|Protocol Violation|1
5825443|NCT02518919|20123395|P1|Overall Study|Protocol Violation|1
5825444|NCT02518685|20123425|P2|Overall Study|Lost to Follow-up|4
5825445|NCT02518685|20123426|P1|Overall Study|Lost to Follow-up|1
5825446|NCT02518685|20123425|P2|Overall Study|Physician Decision|0
5825447|NCT02518685|20123426|P1|Overall Study|Physician Decision|1
5825448|NCT02518685|20123425|P2|Overall Study|Pregnancy|0
5825449|NCT02518685|20123426|P1|Overall Study|Pregnancy|1
5825450|NCT02518685|20123425|P2|Overall Study|relocation, study fatigue|2
5825451|NCT02518685|20123426|P1|Overall Study|relocation, study fatigue|7
5825452|NCT02518685|20123425|P2|Overall Study|Withdrawal by Subject|3
5825453|NCT02518685|20123426|P1|Overall Study|Withdrawal by Subject|10
5825454|NCT02518685|20123425|P2|Overall Study|Adverse Event|1
5825455|NCT02518685|20123426|P1|Overall Study|Adverse Event|29
5825456|NCT02518620|20123435|P2|Overall Study|Relocation|1
5825457|NCT02518620|20123436|P1|Overall Study|Relocation|2
5825458|NCT02518620|20123435|P2|Overall Study|Pregnancy|0
5825459|NCT02518620|20123436|P1|Overall Study|Pregnancy|1
5825460|NCT02518620|20123435|P2|Overall Study|Pregnancy Wish|0
5825461|NCT02518620|20123436|P1|Overall Study|Pregnancy Wish|3
5825462|NCT02518620|20123435|P2|Overall Study|Death|0
5825463|NCT02518620|20123436|P1|Overall Study|Death|1
5825464|NCT02518620|20123435|P2|Overall Study|Withdrawal by Subject|9
5825465|NCT02518620|20123436|P1|Overall Study|Withdrawal by Subject|17
5825466|NCT02518620|20123435|P2|Overall Study|Lost to Follow-up|1
5825467|NCT02518620|20123436|P1|Overall Study|Lost to Follow-up|1
5825468|NCT02518620|20123435|P2|Overall Study|Sponsor's Decision|3
5825469|NCT02518620|20123436|P1|Overall Study|Sponsor's Decision|0
5825470|NCT02518620|20123435|P2|Overall Study|Physician Decision|1
5825471|NCT02518620|20123436|P1|Overall Study|Physician Decision|1
5825472|NCT02518620|20123435|P2|Overall Study|Non-Compliance with Study Drug|0
5825473|NCT02518620|20123436|P1|Overall Study|Non-Compliance with Study Drug|1
5825474|NCT02518620|20123435|P2|Overall Study|Lack of Efficacy|0
5825475|NCT02518620|20123436|P1|Overall Study|Lack of Efficacy|2
5825476|NCT02518620|20123435|P2|Overall Study|Adverse Event|11
5825477|NCT02518620|20123436|P1|Overall Study|Adverse Event|23
5825478|NCT02518490|20123459|P2|Overall Study|Withdrawal by Subject|1
5825479|NCT02518490|20123460|P1|Overall Study|Withdrawal by Subject|1
5825480|NCT02518464|20123478|P1|Overall Study|Adverse Event|2
5825481|NCT02518113|20123499|P4|Overall Study|Progressive Disease|0
5825482|NCT02518113|20123500|P3|Overall Study|Progressive Disease|3
5825483|NCT02518113|20123501|P2|Overall Study|Progressive Disease|2
5825484|NCT02518113|20123502|P1|Overall Study|Progressive Disease|1
5825485|NCT02518113|20123499|P4|Overall Study|Physician Decision|0
5825486|NCT02518113|20123500|P3|Overall Study|Physician Decision|0
5825487|NCT02518113|20123501|P2|Overall Study|Physician Decision|1
5825488|NCT02518113|20123502|P1|Overall Study|Physician Decision|0
5825489|NCT02518113|20123499|P4|Overall Study|Death|0
5825490|NCT02518113|20123500|P3|Overall Study|Death|0
5825491|NCT02518113|20123501|P2|Overall Study|Death|2
5825492|NCT02518113|20123502|P1|Overall Study|Death|1
5825493|NCT02518113|20123499|P4|Overall Study|Adverse Event|0
5825494|NCT02518113|20123500|P3|Overall Study|Adverse Event|1
5825495|NCT02518113|20123501|P2|Overall Study|Adverse Event|0
5825496|NCT02518113|20123502|P1|Overall Study|Adverse Event|1
5825497|NCT02518048|20123543|P1|Overall Study|Withdrawal by Subject|1
5825498|NCT02517905|20123571|P2|Overall Study|Screen failure|2
5825499|NCT02517905|20123572|P1|Overall Study|Screen failure|2
5825500|NCT02517905|20123571|P2|Overall Study|Withdrawal by Subject|0
5825501|NCT02517905|20123572|P1|Overall Study|Withdrawal by Subject|4
5825502|NCT02517905|20123571|P2|Overall Study|Lost to Follow-up|0
5825503|NCT02517905|20123572|P1|Overall Study|Lost to Follow-up|4
5825504|NCT02517866|20123588|P3|Overall Study|Reason not specified|0
5825505|NCT02517866|20123589|P2|Overall Study|Reason not specified|0
5825506|NCT02517866|20123590|P1|Overall Study|Reason not specified|2
5825507|NCT02517866|20123588|P3|Overall Study|Investigator Decision|0
5825508|NCT02517866|20123589|P2|Overall Study|Investigator Decision|1
5825509|NCT02517866|20123590|P1|Overall Study|Investigator Decision|2
5825510|NCT02517866|20123588|P3|Overall Study|Voluntary Withdrawal|0
5825511|NCT02517866|20123589|P2|Overall Study|Voluntary Withdrawal|2
5825512|NCT02517866|20123590|P1|Overall Study|Voluntary Withdrawal|2
5825513|NCT02517866|20123588|P3|Overall Study|Lost to Follow-up|0
5825514|NCT02517866|20123589|P2|Overall Study|Lost to Follow-up|0
5825515|NCT02517866|20123590|P1|Overall Study|Lost to Follow-up|1
5825516|NCT02517866|20123588|P3|Overall Study|Significant Protocol Deviation|0
5825517|NCT02517866|20123589|P2|Overall Study|Significant Protocol Deviation|1
5825518|NCT02517866|20123590|P1|Overall Study|Significant Protocol Deviation|4
5825519|NCT02517866|20123588|P3|Overall Study|Pretreatment Event/Adverse Event|0
5825520|NCT02517866|20123589|P2|Overall Study|Pretreatment Event/Adverse Event|2
5825521|NCT02517866|20123590|P1|Overall Study|Pretreatment Event/Adverse Event|9
5825522|NCT02517541|20123661|P1|Test Period (SenSura Mio Convex Soft)|One subjects was not suited for the tes|2
5825523|NCT02517541|20123661|P1|Test Period (SenSura Mio Convex Soft)|Withdrawal by Subject|4
5825524|NCT02517541|20123661|P1|Test Period (SenSura Mio Convex Soft)|Protocol Violation|1
5825525|NCT02517541|20123661|P1|Test Period (SenSura Mio Convex Soft)|Lack of Efficacy|2
5825526|NCT02517541|20123661|P1|Test Period (SenSura Mio Convex Soft)|Adverse Event|3
5825527|NCT02517541|20123661|P1|Baseline Period (Own Product)|Protocol Violation|1
5825528|NCT02517528|20123667|P1|Overall Study|Withdrawal by Subject|1
5825529|NCT02517515|20123677|P2|Overall Study|Other|0
5825530|NCT02517515|20123678|P1|Overall Study|Other|1
5825531|NCT02517515|20123677|P2|Overall Study|Lost to Follow-up|0
5825532|NCT02517515|20123678|P1|Overall Study|Lost to Follow-up|1
5825533|NCT02517515|20123677|P2|Overall Study|Withdrew Consent|1
5825534|NCT02517515|20123678|P1|Overall Study|Withdrew Consent|0
5825535|NCT02517515|20123677|P2|Overall Study|Adverse Event|1
5825536|NCT02517515|20123678|P1|Overall Study|Adverse Event|0
5825537|NCT02517463|20123695|P2|Overall Study|Lost to Follow-up|2
5825538|NCT02517463|20123696|P1|Overall Study|Lost to Follow-up|5
5825539|NCT02517268|20123708|P2|Overall Study|Withdrawal by Subject|0
5825540|NCT02517268|20123709|P1|Overall Study|Withdrawal by Subject|1
5825541|NCT02516982|20123761|P4|Overall Study|Did not install the app|47
5825542|NCT02516982|20123762|P3|Overall Study|Did not install the app|46
5825543|NCT02516982|20123763|P2|Overall Study|Did not install the app|0
5825544|NCT02516982|20123764|P1|Overall Study|Did not install the app|0
5825545|NCT02516982|20123761|P4|Overall Study|Protocol Violation|1
5825546|NCT02516982|20123762|P3|Overall Study|Protocol Violation|1
5825547|NCT02516982|20123763|P2|Overall Study|Protocol Violation|0
5825548|NCT02516982|20123764|P1|Overall Study|Protocol Violation|0
5825549|NCT02516982|20123761|P4|Overall Study|Withdrawal by Subject|2
5825550|NCT02516982|20123762|P3|Overall Study|Withdrawal by Subject|1
5825551|NCT02516982|20123763|P2|Overall Study|Withdrawal by Subject|0
5825552|NCT02516982|20123764|P1|Overall Study|Withdrawal by Subject|0
5825553|NCT02516982|20123761|P4|Overall Study|Called in to antenatal appointment|0
5825554|NCT02516982|20123762|P3|Overall Study|Called in to antenatal appointment|0
5825555|NCT02516982|20123763|P2|Overall Study|Called in to antenatal appointment|35
5825556|NCT02516982|20123764|P1|Overall Study|Called in to antenatal appointment|32
5825557|NCT02516605|20123791|P5|Overall Study|Withdrawal by Subject|0
5825558|NCT02516605|20123792|P4|Overall Study|Withdrawal by Subject|1
5825559|NCT02516605|20123793|P3|Overall Study|Withdrawal by Subject|0
5825560|NCT02516605|20123794|P2|Overall Study|Withdrawal by Subject|0
5825561|NCT02516605|20123795|P1|Overall Study|Withdrawal by Subject|0
5825562|NCT02516605|20123791|P5|Overall Study|Protocol Violation|1
5825563|NCT02516605|20123792|P4|Overall Study|Protocol Violation|0
5825564|NCT02516605|20123793|P3|Overall Study|Protocol Violation|0
5825565|NCT02516605|20123794|P2|Overall Study|Protocol Violation|0
5825566|NCT02516605|20123795|P1|Overall Study|Protocol Violation|0
5825567|NCT02516592|20123866|P2|Overall Study|Death|1
5825568|NCT02516592|20123867|P1|Overall Study|Death|1
5825569|NCT02516592|20123866|P2|Overall Study|Abnormal test procedure result|0
5825570|NCT02516592|20123867|P1|Overall Study|Abnormal test procedure result|1
5825571|NCT02516592|20123866|P2|Overall Study|Adverse Event|2
5825572|NCT02516592|20123867|P1|Overall Study|Adverse Event|1
5825573|NCT02516592|20123866|P2|Overall Study|Patient/guardian decision|1
5825574|NCT02516592|20123867|P1|Overall Study|Patient/guardian decision|2
5825575|NCT02516592|20123866|P2|Overall Study|Lost to Follow-up|3
5825576|NCT02516592|20123867|P1|Overall Study|Lost to Follow-up|2
5825577|NCT02516592|20123866|P2|Overall Study|Protocol deviation|4
5825578|NCT02516592|20123867|P1|Overall Study|Protocol deviation|4
5825579|NCT02516592|20123866|P2|Overall Study|Patient withdrew consent|2
5825580|NCT02516592|20123867|P1|Overall Study|Patient withdrew consent|5
5825581|NCT02516410|20123889|P2|Overall Study|Withdrawal by Subject|1
5825582|NCT02516410|20123890|P1|Overall Study|Withdrawal by Subject|0
5825583|NCT02516410|20123889|P2|Overall Study|Adverse Event|1
5825584|NCT02516410|20123890|P1|Overall Study|Adverse Event|0
5825585|NCT02516306|20123919|P2|Period 2: Day 8 - 91|Protocol Violation|2
5825586|NCT02516306|20123920|P1|Period 2: Day 8 - 91|Protocol Violation|1
5825587|NCT02516228|20123926|P1|Overall Study|Physician Decision|1
5825588|NCT02516228|20123926|P1|Overall Study|Withdrawal by Subject|1
5825589|NCT02516228|20123926|P1|Overall Study|Lost to Follow-up|1
5825590|NCT02516202|20123937|P3|Overall Study|Stopped Follow-up|1
5825591|NCT02516202|20123938|P2|Overall Study|Stopped Follow-up|0
5825592|NCT02516202|20123939|P1|Overall Study|Stopped Follow-up|0
5825593|NCT02516202|20123937|P3|Overall Study|Lost to Follow-up|1
5825594|NCT02516202|20123938|P2|Overall Study|Lost to Follow-up|1
5825595|NCT02516202|20123939|P1|Overall Study|Lost to Follow-up|1
5825596|NCT02516202|20123937|P3|Overall Study|Withdrawal by Subject|1
5825597|NCT02516202|20123938|P2|Overall Study|Withdrawal by Subject|0
5825598|NCT02516202|20123939|P1|Overall Study|Withdrawal by Subject|1
5825599|NCT02516163|20123965|P1|Overall Study|MRI contraindication exclusion|6
5825600|NCT02516163|20123965|P1|Overall Study|Data not recorded|2
5825601|NCT02516163|20123965|P1|Overall Study|Use of incorrect measurement technique|5
5825602|NCT02516163|20123965|P1|Overall Study|Unfit/delay in surgery|3
5825603|NCT02516163|20123965|P1|Overall Study|Failed MRI/incorrect MRI protocol|11
5825604|NCT02516163|20123965|P1|Overall Study|Withdrawal by Subject|1
5825605|NCT02516098|20123979|P2|Period 2|Withdrawal by Subject|1
5825606|NCT02516098|20123980|P1|Period 2|Withdrawal by Subject|0
5825607|NCT02516098|20123979|P2|Washout After Period 1|Adverse Event|1
5825608|NCT02516098|20123980|P1|Washout After Period 1|Adverse Event|0
5825609|NCT02516098|20123979|P2|Period 1|Protocol Violation|0
5825610|NCT02516098|20123980|P1|Period 1|Protocol Violation|1
5825611|NCT02515994|20124008|P2|Overall Study|Withdrawal by Subject|0
5825612|NCT02515994|20124009|P1|Overall Study|Withdrawal by Subject|2
5825613|NCT02515994|20124008|P2|Overall Study|Adverse Event|1
5825614|NCT02515994|20124009|P1|Overall Study|Adverse Event|3
5825615|NCT02515994|20124008|P2|Overall Study|No Longer Meets Eligibility Criteria|1
5825616|NCT02515994|20124009|P1|Overall Study|No Longer Meets Eligibility Criteria|2
5825617|NCT02515994|20124008|P2|Overall Study|Protocol Violation|5
5825618|NCT02515994|20124009|P1|Overall Study|Protocol Violation|3
5825619|NCT02515942|20124024|P3|Overall Study|Withdrawal by Subject|2
5825620|NCT02515942|20124025|P2|Overall Study|Withdrawal by Subject|3
5825621|NCT02515942|20124026|P1|Overall Study|Withdrawal by Subject|0
5825622|NCT02515942|20124024|P3|Overall Study|Lost to Follow-up|0
5825623|NCT02515942|20124025|P2|Overall Study|Lost to Follow-up|0
5825624|NCT02515942|20124026|P1|Overall Study|Lost to Follow-up|2
5825625|NCT02515942|20124024|P3|Overall Study|Lack of Efficacy|1
5825626|NCT02515942|20124025|P2|Overall Study|Lack of Efficacy|0
5825627|NCT02515942|20124026|P1|Overall Study|Lack of Efficacy|0
5825628|NCT02515942|20124024|P3|Overall Study|Death|1
5825629|NCT02515942|20124025|P2|Overall Study|Death|0
5825630|NCT02515942|20124026|P1|Overall Study|Death|0
5825631|NCT02515942|20124024|P3|Overall Study|Adverse Event|0
5825632|NCT02515942|20124025|P2|Overall Study|Adverse Event|0
5825633|NCT02515942|20124026|P1|Overall Study|Adverse Event|5
5825634|NCT02515669|20124112|P4|228 Week Open-Label Phase|Missing|2
5825635|NCT02515669|20124113|P3|228 Week Open-Label Phase|Missing|2
5825636|NCT02515669|20124114|P2|228 Week Open-Label Phase|Missing|2
5825637|NCT02515669|20124115|P1|228 Week Open-Label Phase|Missing|0
5825638|NCT02515669|20124112|P4|228 Week Open-Label Phase|Administrative Reason by Sponsor|17
5825639|NCT02515669|20124113|P3|228 Week Open-Label Phase|Administrative Reason by Sponsor|2
5825640|NCT02515669|20124114|P2|228 Week Open-Label Phase|Administrative Reason by Sponsor|7
5825641|NCT02515669|20124115|P1|228 Week Open-Label Phase|Administrative Reason by Sponsor|0
5825642|NCT02515669|20124112|P4|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|3
5825643|NCT02515669|20124113|P3|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|2
5825644|NCT02515669|20124114|P2|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|0
5825645|NCT02515669|20124115|P1|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|0
5825646|NCT02515669|20124112|P4|228 Week Open-Label Phase|Lack of Efficacy|0
5825647|NCT02515669|20124113|P3|228 Week Open-Label Phase|Lack of Efficacy|1
5825648|NCT02515669|20124114|P2|228 Week Open-Label Phase|Lack of Efficacy|0
5825649|NCT02515669|20124115|P1|228 Week Open-Label Phase|Lack of Efficacy|0
5825650|NCT02515669|20124112|P4|228 Week Open-Label Phase|Other|4
5825651|NCT02515669|20124113|P3|228 Week Open-Label Phase|Other|1
5825652|NCT02515669|20124114|P2|228 Week Open-Label Phase|Other|0
5825653|NCT02515669|20124115|P1|228 Week Open-Label Phase|Other|0
5825654|NCT02515630|20124212|P1|Overall Study|Disease Progression|1
5825655|NCT02515630|20124212|P1|Overall Study|Death|2
5825656|NCT02515630|20124212|P1|Overall Study|Physician Decision|4
5825657|NCT02515630|20124212|P1|Overall Study|Adverse Event|4
5825658|NCT02515630|20124212|P1|Overall Study|Withdrawal by Subject|5
5825659|NCT02515331|20124285|P3|Overall Study|Adverse Event|0
5825660|NCT02515331|20124286|P2|Overall Study|Adverse Event|0
5825661|NCT02515331|20124287|P1|Overall Study|Adverse Event|2
5825662|NCT02515331|20124285|P3|Overall Study|Protocol deviation|3
5825663|NCT02515331|20124286|P2|Overall Study|Protocol deviation|0
5825664|NCT02515331|20124287|P1|Overall Study|Protocol deviation|0
5825665|NCT02515331|20124285|P3|Overall Study|Withdrawal by Subject|1
5825666|NCT02515331|20124286|P2|Overall Study|Withdrawal by Subject|0
5825667|NCT02515331|20124287|P1|Overall Study|Withdrawal by Subject|0
5825668|NCT02515279|20124324|P1|Overall Study|Other|22
5825669|NCT02515279|20124324|P1|Overall Study|End-of-treatment visit not attended|17
5825670|NCT02515279|20124324|P1|Overall Study|Withdrawal by Subject|18
5825671|NCT02515279|20124324|P1|Overall Study|Lost to Follow-up|9
5825672|NCT02515279|20124324|P1|Overall Study|Lack of Efficacy|31
5825673|NCT02515279|20124324|P1|Overall Study|Adverse Event|7
5825674|NCT02515097|20124343|P2|Overall Study|Adverse Event|1
5825675|NCT02515097|20124344|P1|Overall Study|Adverse Event|2
5825676|NCT02515097|20124343|P2|Overall Study|Withdrawal by Subject|3
5825677|NCT02515097|20124344|P1|Overall Study|Withdrawal by Subject|1
5825678|NCT02515097|20124343|P2|Overall Study|Lost to Follow-up|2
5825679|NCT02515097|20124344|P1|Overall Study|Lost to Follow-up|4
5825680|NCT02515045|20124365|P3|Overall Study|Lost to Follow-up|1
5825681|NCT02515045|20124366|P2|Overall Study|Lost to Follow-up|1
5825682|NCT02515045|20124367|P1|Overall Study|Lost to Follow-up|0
5825683|NCT02515045|20124365|P3|Overall Study|Adverse Event|3
5825684|NCT02515045|20124366|P2|Overall Study|Adverse Event|3
5825685|NCT02515045|20124367|P1|Overall Study|Adverse Event|0
5825686|NCT02514824|20124404|P4|Overall Study|Dose-Limiting Toxicity|0
5825687|NCT02514824|20124405|P3|Overall Study|Dose-Limiting Toxicity|0
5825688|NCT02514824|20124406|P2|Overall Study|Dose-Limiting Toxicity|1
5825689|NCT02514824|20124407|P1|Overall Study|Dose-Limiting Toxicity|0
5825690|NCT02514824|20124404|P4|Overall Study|Withdrawal by Subject|0
5825691|NCT02514824|20124405|P3|Overall Study|Withdrawal by Subject|0
5825692|NCT02514824|20124406|P2|Overall Study|Withdrawal by Subject|0
5825693|NCT02514824|20124407|P1|Overall Study|Withdrawal by Subject|1
5825694|NCT02514772|20124418|P2|Overall Study|Withdrawal by Subject|1
5825695|NCT02514772|20124419|P1|Overall Study|Withdrawal by Subject|2
5825696|NCT02514772|20124418|P2|Overall Study|Death|1
5825697|NCT02514772|20124419|P1|Overall Study|Death|0
5825698|NCT02514772|20124418|P2|Overall Study|Adverse Event|0
5825699|NCT02514772|20124419|P1|Overall Study|Adverse Event|1
5825700|NCT02514746|20124433|P2|Overall Study|Other|1
5825701|NCT02514746|20124434|P1|Overall Study|Other|5
5825702|NCT02514746|20124433|P2|Overall Study|Withdrawal by Subject|10
5825703|NCT02514746|20124434|P1|Overall Study|Withdrawal by Subject|12
5825704|NCT02514746|20124433|P2|Overall Study|Physician Decision|2
5825705|NCT02514746|20124434|P1|Overall Study|Physician Decision|4
5825706|NCT02514746|20124433|P2|Overall Study|Chronically Ill|2
5825707|NCT02514746|20124434|P1|Overall Study|Chronically Ill|1
5825708|NCT02514577|20124471|P2|Overall Study|Adverse Event|1
5825709|NCT02514577|20124472|P1|Overall Study|Adverse Event|1
5825710|NCT02514577|20124471|P2|Overall Study|Withdrawal by Subject|6
5825711|NCT02514577|20124472|P1|Overall Study|Withdrawal by Subject|6
5825712|NCT02514577|20124471|P2|Overall Study|Protocol Violation|0
5825713|NCT02514577|20124472|P1|Overall Study|Protocol Violation|1
5825714|NCT02514577|20124471|P2|Overall Study|Lost to Follow-up|6
5825715|NCT02514577|20124472|P1|Overall Study|Lost to Follow-up|6
5825716|NCT02514551|20124482|P2|Overall Study|Participant Never Treated|2
5825717|NCT02514551|20124483|P1|Overall Study|Participant Never Treated|0
5825718|NCT02514551|20124482|P2|Overall Study|Lost to Follow-up|1
5825719|NCT02514551|20124483|P1|Overall Study|Lost to Follow-up|0
5825720|NCT02514473|20124500|P2|Overall Study|Other|1
5825721|NCT02514473|20124501|P1|Overall Study|Other|1
5825722|NCT02514473|20124500|P2|Overall Study|Lost to Follow-up|1
5825723|NCT02514473|20124501|P1|Overall Study|Lost to Follow-up|0
5825724|NCT02514473|20124500|P2|Overall Study|Withdrawal by Subject|1
5825725|NCT02514473|20124501|P1|Overall Study|Withdrawal by Subject|2
5825726|NCT02514473|20124500|P2|Overall Study|Adverse Event|2
5825727|NCT02514473|20124501|P1|Overall Study|Adverse Event|0
5825728|NCT02514174|20124542|P1|Overall Study|Treated off study with Afatinib.|1
5825729|NCT02514174|20124542|P1|Overall Study|Treatment change|1
5825730|NCT02514174|20124542|P1|Overall Study|Progressive disease|11
5825731|NCT02514174|20124542|P1|Overall Study|Study closed by sponsor|9
5825732|NCT02514174|20124542|P1|Overall Study|Adverse Event|2
5825733|NCT02514174|20124542|P1|Overall Study|Patient refused to continue medication|1
5825734|NCT02514122|20124553|P2|Overall Study|Withdrawal by Subject|0
5825735|NCT02514122|20124554|P1|Overall Study|Withdrawal by Subject|2
5825736|NCT02514083|20124562|P1|Overall Study|Adverse Event|1
5825737|NCT02513823|20124620|P1|Overall Study|Physician Decision|1
5825738|NCT02513823|20124620|P1|Overall Study|Lost to Follow-up|4
5825739|NCT02513771|20124627|P2|Overall Study|Not being able to get to clinic|0
5825740|NCT02513771|20124628|P1|Overall Study|Not being able to get to clinic|1
5825741|NCT02513771|20124627|P2|Overall Study|Lost to Follow-up|1
5825742|NCT02513771|20124628|P1|Overall Study|Lost to Follow-up|1
5825743|NCT02513745|20124666|P2|Overall Study|Criteria at time of surgery not met.|3
5825744|NCT02513745|20124667|P1|Overall Study|Criteria at time of surgery not met.|3
5825745|NCT02513550|20124921|P6|Post-Treatment Follow-up Period|Labor Reasons|0
5825746|NCT02513550|20124922|P5|Post-Treatment Follow-up Period|Labor Reasons|0
5825747|NCT02513550|20124923|P4|Post-Treatment Follow-up Period|Labor Reasons|0
5825748|NCT02513550|20124924|P3|Post-Treatment Follow-up Period|Labor Reasons|1
5825749|NCT02513550|20124925|P2|Post-Treatment Follow-up Period|Labor Reasons|0
5825750|NCT02513550|20124926|P1|Post-Treatment Follow-up Period|Labor Reasons|0
5825751|NCT02513550|20124921|P6|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0
5825752|NCT02513550|20124922|P5|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0
5825753|NCT02513550|20124923|P4|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0
5825754|NCT02513550|20124924|P3|Post-Treatment Follow-up Period|Subject did not come for Visit-802|3
5825755|NCT02513550|20124925|P2|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0
5825756|NCT02513550|20124926|P1|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0
5825757|NCT02513550|20124921|P6|Post-Treatment Follow-up Period|Subject move out of town|0
5825758|NCT02513550|20124922|P5|Post-Treatment Follow-up Period|Subject move out of town|0
5825759|NCT02513550|20124923|P4|Post-Treatment Follow-up Period|Subject move out of town|0
5825760|NCT02513550|20124924|P3|Post-Treatment Follow-up Period|Subject move out of town|1
5825761|NCT02513550|20124925|P2|Post-Treatment Follow-up Period|Subject move out of town|0
5825762|NCT02513550|20124926|P1|Post-Treatment Follow-up Period|Subject move out of town|0
5825763|NCT02513550|20124921|P6|Post-Treatment Follow-up Period|Death|0
5825764|NCT02513550|20124922|P5|Post-Treatment Follow-up Period|Death|0
5825765|NCT02513550|20124923|P4|Post-Treatment Follow-up Period|Death|0
5825766|NCT02513550|20124924|P3|Post-Treatment Follow-up Period|Death|1
5825767|NCT02513550|20124925|P2|Post-Treatment Follow-up Period|Death|0
5825768|NCT02513550|20124926|P1|Post-Treatment Follow-up Period|Death|0
5825769|NCT02513550|20124921|P6|Post-Treatment Follow-up Period|Physician Decision|0
5825770|NCT02513550|20124922|P5|Post-Treatment Follow-up Period|Physician Decision|0
5825771|NCT02513550|20124923|P4|Post-Treatment Follow-up Period|Physician Decision|0
5825772|NCT02513550|20124924|P3|Post-Treatment Follow-up Period|Physician Decision|0
5825773|NCT02513550|20124925|P2|Post-Treatment Follow-up Period|Physician Decision|0
5825774|NCT02513550|20124926|P1|Post-Treatment Follow-up Period|Physician Decision|2
5825775|NCT02513550|20124921|P6|Post-Treatment Follow-up Period|Adverse Event|0
5825776|NCT02513550|20124922|P5|Post-Treatment Follow-up Period|Adverse Event|0
5825777|NCT02513550|20124923|P4|Post-Treatment Follow-up Period|Adverse Event|0
5825778|NCT02513550|20124924|P3|Post-Treatment Follow-up Period|Adverse Event|4
5825779|NCT02513550|20124925|P2|Post-Treatment Follow-up Period|Adverse Event|1
5825780|NCT02513550|20124926|P1|Post-Treatment Follow-up Period|Adverse Event|1
5825781|NCT02513550|20124921|P6|Post-Treatment Follow-up Period|Lost to Follow-up|0
5825782|NCT02513550|20124922|P5|Post-Treatment Follow-up Period|Lost to Follow-up|0
5825783|NCT02513550|20124923|P4|Post-Treatment Follow-up Period|Lost to Follow-up|0
5825784|NCT02513550|20124924|P3|Post-Treatment Follow-up Period|Lost to Follow-up|7
5825785|NCT02513550|20124925|P2|Post-Treatment Follow-up Period|Lost to Follow-up|2
5825786|NCT02513550|20124926|P1|Post-Treatment Follow-up Period|Lost to Follow-up|4
5825787|NCT02513550|20124921|P6|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0
5825788|NCT02513550|20124922|P5|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0
5825789|NCT02513550|20124923|P4|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0
5825790|NCT02513550|20124924|P3|Post-Treatment Follow-up Period|Early terminated but completed follow-up|20
5825791|NCT02513550|20124925|P2|Post-Treatment Follow-up Period|Early terminated but completed follow-up|16
5825792|NCT02513550|20124926|P1|Post-Treatment Follow-up Period|Early terminated but completed follow-up|12
5825793|NCT02513550|20124921|P6|Post-Treatment Follow-up Period|Withdrawal by Subject|0
5825794|NCT02513550|20124922|P5|Post-Treatment Follow-up Period|Withdrawal by Subject|0
5825795|NCT02513550|20124923|P4|Post-Treatment Follow-up Period|Withdrawal by Subject|0
5825796|NCT02513550|20124924|P3|Post-Treatment Follow-up Period|Withdrawal by Subject|26
5825797|NCT02513550|20124925|P2|Post-Treatment Follow-up Period|Withdrawal by Subject|20
5825798|NCT02513550|20124926|P1|Post-Treatment Follow-up Period|Withdrawal by Subject|12
5825799|NCT02513550|20124921|P6|Double Blind Treatment Period|Death|0
5825800|NCT02513550|20124922|P5|Double Blind Treatment Period|Death|0
5825801|NCT02513550|20124923|P4|Double Blind Treatment Period|Death|0
5825802|NCT02513550|20124924|P3|Double Blind Treatment Period|Death|2
5825803|NCT02513550|20124925|P2|Double Blind Treatment Period|Death|0
5825804|NCT02513550|20124926|P1|Double Blind Treatment Period|Death|1
5825805|NCT02513550|20124921|P6|Double Blind Treatment Period|Due to personal business|0
5825806|NCT02513550|20124922|P5|Double Blind Treatment Period|Due to personal business|0
5825807|NCT02513550|20124923|P4|Double Blind Treatment Period|Due to personal business|0
5825808|NCT02513550|20124924|P3|Double Blind Treatment Period|Due to personal business|1
5825809|NCT02513550|20124925|P2|Double Blind Treatment Period|Due to personal business|0
5825810|NCT02513550|20124926|P1|Double Blind Treatment Period|Due to personal business|2
5825811|NCT02513550|20124921|P6|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0
5825812|NCT02513550|20124922|P5|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0
5825813|NCT02513550|20124923|P4|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0
5825814|NCT02513550|20124924|P3|Double Blind Treatment Period|Met exclusion criteria and was not dosed|1
5825815|NCT02513550|20124925|P2|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0
5825816|NCT02513550|20124926|P1|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0
5825817|NCT02513550|20124921|P6|Double Blind Treatment Period|Site terminated by sponsor|0
5825818|NCT02513550|20124922|P5|Double Blind Treatment Period|Site terminated by sponsor|0
5825819|NCT02513550|20124923|P4|Double Blind Treatment Period|Site terminated by sponsor|0
5825820|NCT02513550|20124924|P3|Double Blind Treatment Period|Site terminated by sponsor|3
5825821|NCT02513550|20124925|P2|Double Blind Treatment Period|Site terminated by sponsor|1
5825822|NCT02513550|20124926|P1|Double Blind Treatment Period|Site terminated by sponsor|1
5825823|NCT02513550|20124921|P6|Double Blind Treatment Period|Physician Decision|0
5825824|NCT02513550|20124922|P5|Double Blind Treatment Period|Physician Decision|0
5825825|NCT02513550|20124923|P4|Double Blind Treatment Period|Physician Decision|0
5825826|NCT02513550|20124924|P3|Double Blind Treatment Period|Physician Decision|4
5825827|NCT02513550|20124925|P2|Double Blind Treatment Period|Physician Decision|0
5825828|NCT02513550|20124926|P1|Double Blind Treatment Period|Physician Decision|2
5825829|NCT02513550|20124921|P6|Double Blind Treatment Period|Protocol Violation|0
5825830|NCT02513550|20124922|P5|Double Blind Treatment Period|Protocol Violation|0
5825831|NCT02513550|20124923|P4|Double Blind Treatment Period|Protocol Violation|0
5825832|NCT02513550|20124924|P3|Double Blind Treatment Period|Protocol Violation|4
5825833|NCT02513550|20124925|P2|Double Blind Treatment Period|Protocol Violation|1
5825834|NCT02513550|20124926|P1|Double Blind Treatment Period|Protocol Violation|1
5825835|NCT02513550|20124921|P6|Double Blind Treatment Period|Lack of Efficacy|0
5825836|NCT02513550|20124922|P5|Double Blind Treatment Period|Lack of Efficacy|0
5825837|NCT02513550|20124923|P4|Double Blind Treatment Period|Lack of Efficacy|0
5825838|NCT02513550|20124924|P3|Double Blind Treatment Period|Lack of Efficacy|6
5825839|NCT02513550|20124925|P2|Double Blind Treatment Period|Lack of Efficacy|5
5825840|NCT02513550|20124926|P1|Double Blind Treatment Period|Lack of Efficacy|4
5825841|NCT02513550|20124921|P6|Double Blind Treatment Period|Lost to Follow-up|1
5825842|NCT02513550|20124922|P5|Double Blind Treatment Period|Lost to Follow-up|0
5825843|NCT02513550|20124923|P4|Double Blind Treatment Period|Lost to Follow-up|0
5825844|NCT02513550|20124924|P3|Double Blind Treatment Period|Lost to Follow-up|11
5825845|NCT02513550|20124925|P2|Double Blind Treatment Period|Lost to Follow-up|7
5825846|NCT02513550|20124926|P1|Double Blind Treatment Period|Lost to Follow-up|9
5825847|NCT02513550|20124921|P6|Double Blind Treatment Period|Adverse Event|0
5825848|NCT02513550|20124922|P5|Double Blind Treatment Period|Adverse Event|1
5825849|NCT02513550|20124923|P4|Double Blind Treatment Period|Adverse Event|0
5825850|NCT02513550|20124924|P3|Double Blind Treatment Period|Adverse Event|17
5825851|NCT02513550|20124925|P2|Double Blind Treatment Period|Adverse Event|13
5825852|NCT02513550|20124926|P1|Double Blind Treatment Period|Adverse Event|5
5825853|NCT02513550|20124921|P6|Double Blind Treatment Period|Withdrawal by Subject|0
5825854|NCT02513550|20124922|P5|Double Blind Treatment Period|Withdrawal by Subject|0
5825855|NCT02513550|20124923|P4|Double Blind Treatment Period|Withdrawal by Subject|0
5825856|NCT02513550|20124924|P3|Double Blind Treatment Period|Withdrawal by Subject|25
5825857|NCT02513550|20124925|P2|Double Blind Treatment Period|Withdrawal by Subject|11
5825858|NCT02513550|20124926|P1|Double Blind Treatment Period|Withdrawal by Subject|11
5825859|NCT02513472|20125020|P2|Overall Study|Other|3
5825860|NCT02513472|20125021|P1|Overall Study|Other|3
5825861|NCT02513472|20125020|P2|Overall Study|Treatment Completed as per Protocol|1
5825862|NCT02513472|20125021|P1|Overall Study|Treatment Completed as per Protocol|3
5825863|NCT02513472|20125020|P2|Overall Study|Subject Choice|6
5825864|NCT02513472|20125021|P1|Overall Study|Subject Choice|2
5825865|NCT02513472|20125020|P2|Overall Study|Withdrawal by Subject|4
5825866|NCT02513472|20125021|P1|Overall Study|Withdrawal by Subject|0
5825867|NCT02513472|20125020|P2|Overall Study|Adverse Event|11
5825868|NCT02513472|20125021|P1|Overall Study|Adverse Event|7
5825869|NCT02513472|20125020|P2|Overall Study|Clinical Disease Progression|12
5825870|NCT02513472|20125021|P1|Overall Study|Clinical Disease Progression|5
5825871|NCT02513472|20125020|P2|Overall Study|Radiological Disease Progression|56
5825872|NCT02513472|20125021|P1|Overall Study|Radiological Disease Progression|45
5825873|NCT02513459|20125056|P1|Overall Study|Surgery planned-- not done|1
5825874|NCT02513459|20125056|P1|Overall Study|Reproductive plans|1
5825875|NCT02513459|20125056|P1|Overall Study|Lack of response|1
5825876|NCT02513459|20125056|P1|Overall Study|Subject decision|2
5825877|NCT02513459|20125056|P1|Overall Study|Pregnancy|2
5825878|NCT02513459|20125056|P1|Overall Study|Loss of efficacy|2
5825879|NCT02513459|20125056|P1|Overall Study|Withdrew consent|5
5825880|NCT02513459|20125056|P1|Overall Study|Adverse Event|7
5825881|NCT02513160|20125124|P4|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0
5825882|NCT02513160|20125125|P3|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0
5825883|NCT02513160|20125126|P2|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|1
5825884|NCT02513160|20125127|P1|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0
5825885|NCT02513160|20125124|P4|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0
5825886|NCT02513160|20125125|P3|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0
5825887|NCT02513160|20125126|P2|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0
5825888|NCT02513160|20125127|P1|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|1
5825889|NCT02513160|20125124|P4|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1
5825890|NCT02513160|20125125|P3|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1
5825891|NCT02513160|20125126|P2|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1
5825892|NCT02513160|20125127|P1|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|2
5825893|NCT02513160|20125124|P4|Treatment Period (Day 0 to Week 6)|Noncompliance|0
5825894|NCT02513160|20125125|P3|Treatment Period (Day 0 to Week 6)|Noncompliance|0
5825895|NCT02513160|20125126|P2|Treatment Period (Day 0 to Week 6)|Noncompliance|0
5825896|NCT02513160|20125127|P1|Treatment Period (Day 0 to Week 6)|Noncompliance|1
5825897|NCT02513160|20125124|P4|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|1
5825898|NCT02513160|20125125|P3|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|0
5825899|NCT02513160|20125126|P2|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2
5825900|NCT02513160|20125127|P1|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2
5825901|NCT02513160|20125124|P4|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0
5825902|NCT02513160|20125125|P3|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0
5825903|NCT02513160|20125126|P2|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0
5825904|NCT02513160|20125127|P1|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|10
5825905|NCT02513160|20125124|P4|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0
5825906|NCT02513160|20125125|P3|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0
5825907|NCT02513160|20125126|P2|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0
5825908|NCT02513160|20125127|P1|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|1
5825909|NCT02513160|20125124|P4|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0
5825910|NCT02513160|20125125|P3|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0
5825911|NCT02513160|20125126|P2|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0
5825912|NCT02513160|20125127|P1|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|20
5825913|NCT02513160|20125124|P4|Run-In Period (Days -14 to Day -1)|Adverse Event|0
5825914|NCT02513160|20125125|P3|Run-In Period (Days -14 to Day -1)|Adverse Event|0
5825915|NCT02513160|20125126|P2|Run-In Period (Days -14 to Day -1)|Adverse Event|0
5825916|NCT02513160|20125127|P1|Run-In Period (Days -14 to Day -1)|Adverse Event|4
5825917|NCT02513160|20125124|P4|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0
5825918|NCT02513160|20125125|P3|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0
5825919|NCT02513160|20125126|P2|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0
5825920|NCT02513160|20125127|P1|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|6
5825921|NCT02513160|20125124|P4|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0
5825922|NCT02513160|20125125|P3|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0
5825923|NCT02513160|20125126|P2|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0
5825924|NCT02513160|20125127|P1|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|214
5825925|NCT02513160|20125124|P4|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0
5825926|NCT02513160|20125125|P3|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0
5825927|NCT02513160|20125126|P2|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0
5825928|NCT02513160|20125127|P1|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|33
5825929|NCT02513095|20125185|P2|Overall Study|Stampede resulted in transfers out of ER|16
5825930|NCT02513095|20125186|P1|Overall Study|Stampede resulted in transfers out of ER|14
5825931|NCT02512861|20125237|P2|Overall Study|Withdrawal by Subject|1
5825932|NCT02512861|20125238|P1|Overall Study|Withdrawal by Subject|0
5825933|NCT02512861|20125237|P2|Overall Study|Physician Decision|1
5825934|NCT02512861|20125238|P1|Overall Study|Physician Decision|3
5825935|NCT02512861|20125237|P2|Overall Study|Protocol Violation|7
5825936|NCT02512861|20125238|P1|Overall Study|Protocol Violation|3
5825937|NCT02512302|20125516|P10|Period 4|Adverse Event|0
5825938|NCT02512302|20125517|P9|Period 4|Adverse Event|0
5825939|NCT02512302|20125518|P8|Period 4|Adverse Event|0
5825940|NCT02512302|20125519|P7|Period 4|Adverse Event|1
5825941|NCT02512302|20125520|P6|Period 4|Adverse Event|0
5825942|NCT02512302|20125521|P5|Period 4|Adverse Event|0
5825943|NCT02512302|20125522|P4|Period 4|Adverse Event|0
5825944|NCT02512302|20125523|P3|Period 4|Adverse Event|0
5825945|NCT02512302|20125524|P2|Period 4|Adverse Event|0
5825946|NCT02512302|20125525|P1|Period 4|Adverse Event|0
5825947|NCT02512302|20125516|P10|Period 3|Lost to Follow-up|0
5825948|NCT02512302|20125517|P9|Period 3|Lost to Follow-up|0
5825949|NCT02512302|20125518|P8|Period 3|Lost to Follow-up|0
5825950|NCT02512302|20125519|P7|Period 3|Lost to Follow-up|0
5825951|NCT02512302|20125520|P6|Period 3|Lost to Follow-up|0
5825952|NCT02512302|20125521|P5|Period 3|Lost to Follow-up|0
5825953|NCT02512302|20125522|P4|Period 3|Lost to Follow-up|0
5825954|NCT02512302|20125523|P3|Period 3|Lost to Follow-up|1
5825955|NCT02512302|20125524|P2|Period 3|Lost to Follow-up|0
5825956|NCT02512302|20125525|P1|Period 3|Lost to Follow-up|0
5825957|NCT02512302|20125516|P10|Period 2|Adverse Event|1
5825958|NCT02512302|20125517|P9|Period 2|Adverse Event|0
5825959|NCT02512302|20125518|P8|Period 2|Adverse Event|0
5825960|NCT02512302|20125519|P7|Period 2|Adverse Event|0
5825961|NCT02512302|20125520|P6|Period 2|Adverse Event|0
5825962|NCT02512302|20125521|P5|Period 2|Adverse Event|0
5825963|NCT02512302|20125522|P4|Period 2|Adverse Event|0
5825964|NCT02512302|20125523|P3|Period 2|Adverse Event|0
5825965|NCT02512302|20125524|P2|Period 2|Adverse Event|0
5825966|NCT02512302|20125525|P1|Period 2|Adverse Event|0
5825967|NCT02512302|20125516|P10|Period 1|Adverse Event|0
5825968|NCT02512302|20125517|P9|Period 1|Adverse Event|0
5825969|NCT02512302|20125518|P8|Period 1|Adverse Event|0
5825970|NCT02512302|20125519|P7|Period 1|Adverse Event|0
5825971|NCT02512302|20125520|P6|Period 1|Adverse Event|0
5825972|NCT02512302|20125521|P5|Period 1|Adverse Event|0
5825973|NCT02512302|20125522|P4|Period 1|Adverse Event|0
5825974|NCT02512302|20125523|P3|Period 1|Adverse Event|0
5825975|NCT02512302|20125524|P2|Period 1|Adverse Event|1
5825976|NCT02512302|20125525|P1|Period 1|Adverse Event|0
5825977|NCT02512068|20125641|P2|Overall Study|Reason Not Specified|5
5825978|NCT02512068|20125642|P1|Overall Study|Reason Not Specified|3
5825979|NCT02512068|20125641|P2|Overall Study|Lack of Efficacy|1
5825980|NCT02512068|20125642|P1|Overall Study|Lack of Efficacy|0
5825981|NCT02512068|20125641|P2|Overall Study|Voluntary Withdrawal|1
5825982|NCT02512068|20125642|P1|Overall Study|Voluntary Withdrawal|0
5825983|NCT02512068|20125641|P2|Overall Study|Major Protocol Deviation|0
5825984|NCT02512068|20125642|P1|Overall Study|Major Protocol Deviation|1
5825985|NCT02512068|20125641|P2|Overall Study|Pretreatment Event/Adverse Event|6
5825986|NCT02512068|20125642|P1|Overall Study|Pretreatment Event/Adverse Event|8
5825987|NCT02512042|20125668|P2|Overall Study|Other|11
5825988|NCT02512042|20125669|P1|Overall Study|Other|11
5825989|NCT02512042|20125668|P2|Overall Study|Lost to Follow-up|2
5825990|NCT02512042|20125669|P1|Overall Study|Lost to Follow-up|5
5825991|NCT02512042|20125668|P2|Overall Study|Non-compliance with study drug|2
5825992|NCT02512042|20125669|P1|Overall Study|Non-compliance with study drug|1
5825993|NCT02512042|20125668|P2|Overall Study|Withdrawal by Subject|6
5825994|NCT02512042|20125669|P1|Overall Study|Withdrawal by Subject|6
5825995|NCT02512042|20125668|P2|Overall Study|Adverse Event|4
5825996|NCT02512042|20125669|P1|Overall Study|Adverse Event|0
5825997|NCT02511782|20125678|P3|Overall Study|Withdrawal by Subject|0
5825998|NCT02511782|20125679|P2|Overall Study|Withdrawal by Subject|0
5825999|NCT02511782|20125680|P1|Overall Study|Withdrawal by Subject|1
5826000|NCT02511678|20125706|P1|Overall Study|Received Radiation Treatment|1
5826001|NCT02511678|20125706|P1|Overall Study|Protocol Violation|1
5826002|NCT02511678|20125706|P1|Overall Study|Biopsy was Negative|1
5826003|NCT02511678|20125706|P1|Overall Study|Required Radiofrequency Ablation|1
5826004|NCT02511678|20125706|P1|Overall Study|Oncologist Cancelled Study Cryoablation|1
5826005|NCT02511678|20125706|P1|Overall Study|Targeted Therapy to Index Tumor Required|5
5826006|NCT02511678|20125706|P1|Overall Study|Adverse Event|1
5826007|NCT02511678|20125706|P1|Overall Study|Death|19
5826008|NCT02511678|20125706|P1|Overall Study|Lost to Follow-up|4
5826009|NCT02511678|20125706|P1|Overall Study|Withdrawal by Subject|2
5826010|NCT02511431|20125788|P6|Treatment|Lost to Follow-up|1
5826011|NCT02511431|20125789|P5|Treatment|Lost to Follow-up|0
5826012|NCT02511431|20125790|P4|Treatment|Lost to Follow-up|0
5826013|NCT02511431|20125791|P3|Treatment|Lost to Follow-up|1
5826014|NCT02511431|20125792|P2|Treatment|Lost to Follow-up|0
5826015|NCT02511431|20125793|P1|Treatment|Lost to Follow-up|0
5826016|NCT02511184|20125820|P2|Overall Study|Withdrawal by Subject|1
5826017|NCT02511184|20125821|P1|Overall Study|Withdrawal by Subject|0
5826018|NCT02511184|20125820|P2|Overall Study|Study terminated by sponsor|5
5826019|NCT02511184|20125821|P1|Overall Study|Study terminated by sponsor|1
5826020|NCT02511184|20125820|P2|Overall Study|Lost to Follow-up|1
5826021|NCT02511184|20125821|P1|Overall Study|Lost to Follow-up|0
5826022|NCT02511184|20125820|P2|Overall Study|Death|0
5826023|NCT02511184|20125821|P1|Overall Study|Death|1
5826024|NCT02510820|20125871|P2|Second Intervention (4 Weeks)|Withdrawal by Subject|0
5826025|NCT02510820|20125872|P1|Second Intervention (4 Weeks)|Withdrawal by Subject|1
5826026|NCT02510820|20125871|P2|First Intervention (4 Weeks)|Withdrawal by Subject|1
5826027|NCT02510820|20125872|P1|First Intervention (4 Weeks)|Withdrawal by Subject|0
5826028|NCT02510664|20125913|P3|Overall Study|Time Constraints|0
5826029|NCT02510664|20125914|P2|Overall Study|Time Constraints|1
5826030|NCT02510664|20125915|P1|Overall Study|Time Constraints|1
5826031|NCT02510664|20125913|P3|Overall Study|Provider Retired/No Time to Reschedule|0
5826032|NCT02510664|20125914|P2|Overall Study|Provider Retired/No Time to Reschedule|10
5826033|NCT02510664|20125915|P1|Overall Study|Provider Retired/No Time to Reschedule|10
5826034|NCT02510664|20125913|P3|Overall Study|Transferred Care|0
5826035|NCT02510664|20125914|P2|Overall Study|Transferred Care|9
5826036|NCT02510664|20125915|P1|Overall Study|Transferred Care|9
5826037|NCT02510014|20125957|P2|Treatment Period|Incarceration, pregnancy, misc|5
5826038|NCT02510014|20125958|P1|Treatment Period|Incarceration, pregnancy, misc|29
5826039|NCT02510014|20125957|P2|Treatment Period|Protocol Violation|4
5826040|NCT02510014|20125958|P1|Treatment Period|Protocol Violation|4
5826041|NCT02510014|20125957|P2|Treatment Period|Withdrawn by the investigator|1
5826042|NCT02510014|20125958|P1|Treatment Period|Withdrawn by the investigator|7
5826043|NCT02510014|20125957|P2|Treatment Period|Withdrawal by Subject|24
5826044|NCT02510014|20125958|P1|Treatment Period|Withdrawal by Subject|67
5826045|NCT02510014|20125957|P2|Treatment Period|Physician Decision|0
5826046|NCT02510014|20125958|P1|Treatment Period|Physician Decision|5
5826047|NCT02510014|20125957|P2|Treatment Period|Lost to Follow-up|19
5826048|NCT02510014|20125958|P1|Treatment Period|Lost to Follow-up|80
5826049|NCT02510014|20125957|P2|Treatment Period|Withdrawal symptoms|0
5826050|NCT02510014|20125958|P1|Treatment Period|Withdrawal symptoms|3
5826051|NCT02510014|20125957|P2|Treatment Period|Adverse Event|4
5826052|NCT02510014|20125958|P1|Treatment Period|Adverse Event|11
5826053|NCT02510014|20125957|P2|Run-In Period (Days -14 to Day -1)|Other|1
5826054|NCT02510014|20125958|P1|Run-In Period (Days -14 to Day -1)|Other|19
5826055|NCT02510014|20125957|P2|Run-In Period (Days -14 to Day -1)|Protocol Violation|0
5826056|NCT02510014|20125958|P1|Run-In Period (Days -14 to Day -1)|Protocol Violation|2
5826057|NCT02510014|20125957|P2|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|1
5826058|NCT02510014|20125958|P1|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|7
5826059|NCT02510014|20125957|P2|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|3
5826060|NCT02510014|20125958|P1|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|22
5826061|NCT02510014|20125957|P2|Run-In Period (Days -14 to Day -1)|Physician Decision|1
5826062|NCT02510014|20125958|P1|Run-In Period (Days -14 to Day -1)|Physician Decision|0
5826063|NCT02510014|20125957|P2|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|3
5826064|NCT02510014|20125958|P1|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|44
5826065|NCT02510014|20125957|P2|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|0
5826066|NCT02510014|20125958|P1|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|1
5826067|NCT02510014|20125957|P2|Run-In Period (Days -14 to Day -1)|Adverse Event|1
5826068|NCT02510014|20125958|P1|Run-In Period (Days -14 to Day -1)|Adverse Event|1
5826069|NCT02509156|20126092|P2|Randomized Phase|Withdrawal by Subject|1
5826070|NCT02509156|20126093|P1|Randomized Phase|Withdrawal by Subject|1
5826071|NCT02509156|20126092|P2|Randomized Phase|Death|0
5826072|NCT02509156|20126093|P1|Randomized Phase|Death|1
5826073|NCT02509117|20126163|P10|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|1
5826074|NCT02509117|20126164|P9|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
5826075|NCT02509117|20126165|P8|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
5826076|NCT02509117|20126166|P7|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
5826077|NCT02509117|20126167|P6|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
5826078|NCT02509117|20126168|P5|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
5826079|NCT02509117|20126169|P4|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
5826080|NCT02509117|20126170|P3|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
5826081|NCT02509117|20126171|P2|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
5826082|NCT02509117|20126172|P1|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
5826083|NCT02509117|20126163|P10|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|1
5826084|NCT02509117|20126164|P9|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
5826085|NCT02509117|20126165|P8|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
5826086|NCT02509117|20126166|P7|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
5826087|NCT02509117|20126167|P6|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
5826088|NCT02509117|20126168|P5|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
5826089|NCT02509117|20126169|P4|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
5826090|NCT02509117|20126170|P3|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
5826091|NCT02509117|20126171|P2|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
5826092|NCT02509117|20126172|P1|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
5826093|NCT02509117|20126163|P10|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
5826094|NCT02509117|20126164|P9|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
5826095|NCT02509117|20126165|P8|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
5826096|NCT02509117|20126166|P7|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
5826097|NCT02509117|20126167|P6|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
5826098|NCT02509117|20126168|P5|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
5826099|NCT02509117|20126169|P4|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
5826100|NCT02509117|20126170|P3|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
5826101|NCT02509117|20126171|P2|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|1
5826102|NCT02509117|20126172|P1|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
5826103|NCT02509078|20126383|P2|Overall Study|Protocol Violation|1
5826104|NCT02509078|20126384|P1|Overall Study|Protocol Violation|1
5826105|NCT02509026|20126527|P1|Retreatment Period (12 Weeks)|Enrolled but not treated|1
5826106|NCT02509026|20126527|P1|Retreatment Period (12 Weeks)|Withdrawal by Subject|2
5826107|NCT02509026|20126527|P1|Retreatment Period (12 Weeks)|Lost to Follow-up|1
5826108|NCT02509026|20126527|P1|Withdrawal Period (40 Weeks)|Withdrawal by Subject|5
5826109|NCT02509026|20126527|P1|Withdrawal Period (40 Weeks)|Protocol Violation|2
5826110|NCT02509026|20126527|P1|Induction Period (24 Weeks)|Enrolled but not treated|1
5826111|NCT02509026|20126527|P1|Induction Period (24 Weeks)|Withdrawal by Subject|1
5826112|NCT02509026|20126527|P1|Induction Period (24 Weeks)|Protocol Violation|1
5826113|NCT02509026|20126527|P1|Induction Period (24 Weeks)|Other|2
5826114|NCT02509026|20126527|P1|Induction Period (24 Weeks)|Lost to Follow-up|1
5826115|NCT02509026|20126527|P1|Induction Period (24 Weeks)|Lack of Efficacy|6
5826116|NCT02509026|20126527|P1|Induction Period (24 Weeks)|Eligibility Criteria|5
5826117|NCT02509026|20126527|P1|Induction Period (24 Weeks)|Adverse Event|5
5826118|NCT02508935|20126724|P1|Overall Study|Trial terminated by sponsor|5
5826119|NCT02508935|20126724|P1|Overall Study|Physician Decision|1
5826120|NCT02508935|20126724|P1|Overall Study|Protocol Violation|1
5826121|NCT02508935|20126724|P1|Overall Study|Adverse Event|3
5826122|NCT02508935|20126724|P1|Overall Study|Emesis|3
5826123|NCT02508935|20126724|P1|Overall Study|Pain Score <4|1
5826124|NCT02508935|20126724|P1|Overall Study|Withdrawal by Caregiver|8
5826125|NCT02508935|20126724|P1|Overall Study|Withdrawal by Subject|1
5826126|NCT02508701|20126740|P4|Overall Study|Lost to Follow-up|3
5826127|NCT02508701|20126741|P3|Overall Study|Lost to Follow-up|5
5826128|NCT02508701|20126742|P2|Overall Study|Lost to Follow-up|5
5826129|NCT02508701|20126743|P1|Overall Study|Lost to Follow-up|9
5826130|NCT02508428|20126792|P2|Overall Study|Incomplete follow-up|15
5826131|NCT02508428|20126793|P1|Overall Study|Incomplete follow-up|17
5826132|NCT02508428|20126792|P2|Overall Study|Liner revised|19
5826133|NCT02508428|20126793|P1|Overall Study|Liner revised|3
5826134|NCT02508428|20126792|P2|Overall Study|Death|33
5826135|NCT02508428|20126793|P1|Overall Study|Death|32
5826136|NCT02508194|20126845|P2|Overall Study|Principal Investigator Decision|2
5826137|NCT02508194|20126846|P1|Overall Study|Principal Investigator Decision|1
5826138|NCT02508194|20126845|P2|Overall Study|Error in Randomization|3
5826139|NCT02508194|20126846|P1|Overall Study|Error in Randomization|1
5826140|NCT02508194|20126845|P2|Overall Study|Withdrawal by Subject|18
5826141|NCT02508194|20126846|P1|Overall Study|Withdrawal by Subject|20
5826142|NCT02508194|20126845|P2|Overall Study|Lost to Follow-up|18
5826143|NCT02508194|20126846|P1|Overall Study|Lost to Follow-up|25
5826144|NCT02508194|20126845|P2|Overall Study|Death|3
5826145|NCT02508194|20126846|P1|Overall Study|Death|5
5826146|NCT02508116|20126886|P2|Overall Study|Physician Decision|0
5826147|NCT02508116|20126887|P1|Overall Study|Physician Decision|2
5826148|NCT02508116|20126886|P2|Overall Study|Protocol Violation|2
5826149|NCT02508116|20126887|P1|Overall Study|Protocol Violation|1
5826150|NCT02508116|20126886|P2|Overall Study|Withdrawal by Subject|2
5826151|NCT02508116|20126887|P1|Overall Study|Withdrawal by Subject|3
5826152|NCT02508116|20126886|P2|Overall Study|Lost to Follow-up|3
5826153|NCT02508116|20126887|P1|Overall Study|Lost to Follow-up|2
5826154|NCT02507973|20126914|P1|Overall Study|Adverse Event|1
5826155|NCT02507752|20126920|P1|Overall Study|Participant didn't perform visit Week 24|1
5826156|NCT02507752|20126920|P1|Overall Study|Participant didn't perform visit Week 12|1
5826157|NCT02507752|20126920|P1|Overall Study|Infusion reaction at first infusion|1
5826158|NCT02507752|20126920|P1|Overall Study|Lost to Follow-up|7
5826159|NCT02507752|20126920|P1|Overall Study|Protocol Violation|6
5826160|NCT02507752|20126920|P1|Overall Study|Adverse Event|1
5826161|NCT02507375|20126964|P2|Overall Study|Adverse Event|1
5826162|NCT02507375|20126965|P1|Overall Study|Adverse Event|0
5826163|NCT02507375|20126964|P2|Overall Study|Refused treatment|1
5826164|NCT02507375|20126965|P1|Overall Study|Refused treatment|0
5826165|NCT02507375|20126964|P2|Overall Study|Death|1
5826166|NCT02507375|20126965|P1|Overall Study|Death|0
5826167|NCT02507375|20126964|P2|Overall Study|Progressive Disease|5
5826168|NCT02507375|20126965|P1|Overall Study|Progressive Disease|4
5826169|NCT02507349|20126984|P2|Overall Study|Lost to Follow-up|144
5826170|NCT02507349|20126985|P1|Overall Study|Lost to Follow-up|174
5826171|NCT02507349|20126984|P2|Overall Study|Withdrawal by Subject|1
5826172|NCT02507349|20126985|P1|Overall Study|Withdrawal by Subject|1
5826173|NCT02507349|20126984|P2|Overall Study|Death|16
5826174|NCT02507349|20126985|P1|Overall Study|Death|12
5826175|NCT02507219|20127009|P6|Overall Study|Withdrawal by Subject|0
5826176|NCT02507219|20127010|P5|Overall Study|Withdrawal by Subject|1
5826177|NCT02507219|20127011|P4|Overall Study|Withdrawal by Subject|0
5826178|NCT02507219|20127012|P3|Overall Study|Withdrawal by Subject|0
5826179|NCT02507219|20127013|P2|Overall Study|Withdrawal by Subject|0
5826180|NCT02507219|20127014|P1|Overall Study|Withdrawal by Subject|0
5826181|NCT02507219|20127009|P6|Overall Study|Physician Decision|0
5826182|NCT02507219|20127010|P5|Overall Study|Physician Decision|0
5826183|NCT02507219|20127011|P4|Overall Study|Physician Decision|0
5826184|NCT02507219|20127012|P3|Overall Study|Physician Decision|0
5826185|NCT02507219|20127013|P2|Overall Study|Physician Decision|0
5826186|NCT02507219|20127014|P1|Overall Study|Physician Decision|1
5826187|NCT02506881|20127050|P4|First Intervention (Day 1)|Violation of blood storage conditions|12
5826188|NCT02506881|20127051|P3|First Intervention (Day 1)|Violation of blood storage conditions|12
5826189|NCT02506881|20127052|P2|First Intervention (Day 1)|Violation of blood storage conditions|0
5826190|NCT02506881|20127053|P1|First Intervention (Day 1)|Violation of blood storage conditions|0
5826191|NCT02506881|20127050|P4|First Intervention (Day 1)|Withdrawal by Subject|0
5826192|NCT02506881|20127051|P3|First Intervention (Day 1)|Withdrawal by Subject|0
5826193|NCT02506881|20127052|P2|First Intervention (Day 1)|Withdrawal by Subject|0
5826194|NCT02506881|20127053|P1|First Intervention (Day 1)|Withdrawal by Subject|1
5826195|NCT02506881|20127050|P4|First Intervention (Day 1)|Protocol Violation|0
5826196|NCT02506881|20127051|P3|First Intervention (Day 1)|Protocol Violation|1
5826197|NCT02506881|20127052|P2|First Intervention (Day 1)|Protocol Violation|0
5826198|NCT02506881|20127053|P1|First Intervention (Day 1)|Protocol Violation|0
5826199|NCT02506816|20127126|P1|Overall Study|Adverse Event|3
5826200|NCT02506257|20127252|P4|Overall Study|Protocol Violation|0
5826201|NCT02506257|20127253|P3|Overall Study|Protocol Violation|1
5826202|NCT02506257|20127254|P2|Overall Study|Protocol Violation|0
5826203|NCT02506257|20127255|P1|Overall Study|Protocol Violation|0
5826204|NCT02506257|20127252|P4|Overall Study|Adverse Event|0
5826205|NCT02506257|20127253|P3|Overall Study|Adverse Event|3
5826206|NCT02506257|20127254|P2|Overall Study|Adverse Event|2
5826207|NCT02506257|20127255|P1|Overall Study|Adverse Event|0
5826208|NCT02506101|20127287|P2|Overall Study|No enrollment and staff unavailability|0
5826209|NCT02506101|20127288|P1|Overall Study|No enrollment and staff unavailability|1
5826210|NCT02506101|20127287|P2|Overall Study|Transportation issues|0
5826211|NCT02506101|20127288|P1|Overall Study|Transportation issues|1
5826212|NCT02506036|20127304|P2|First Intervention (4-6 Weeks)|Withdrawal by Subject|1
5826213|NCT02506036|20127305|P1|First Intervention (4-6 Weeks)|Withdrawal by Subject|0
5826214|NCT02506036|20127304|P2|First Intervention (4-6 Weeks)|Lost to Follow-up|1
5826215|NCT02506036|20127305|P1|First Intervention (4-6 Weeks)|Lost to Follow-up|0
5826216|NCT02506036|20127304|P2|First Intervention (4-6 Weeks)|Death|0
5826217|NCT02506036|20127305|P1|First Intervention (4-6 Weeks)|Death|1
5826218|NCT02505945|20127313|P2|Overall Study|Lost to Follow-up|1
5826219|NCT02505945|20127314|P1|Overall Study|Lost to Follow-up|6
5826220|NCT02505945|20127313|P2|Overall Study|Physician Decision|1
5826221|NCT02505945|20127314|P1|Overall Study|Physician Decision|2
5826222|NCT02505945|20127313|P2|Overall Study|Adverse Event|0
5826223|NCT02505945|20127314|P1|Overall Study|Adverse Event|1
5826224|NCT02505945|20127313|P2|Overall Study|Withdrawal by Subject|2
5826225|NCT02505945|20127314|P1|Overall Study|Withdrawal by Subject|13
5826226|NCT02505867|20127335|P2|Overall Study|Lack of Efficacy|6
5826227|NCT02505867|20127336|P1|Overall Study|Lack of Efficacy|6
5826228|NCT02505542|20127342|P4|Part B: Double-Blind Period|Subject did not complete all visits|0
5826229|NCT02505542|20127343|P3|Part B: Double-Blind Period|Subject did not complete all visits|0
5826230|NCT02505542|20127344|P2|Part B: Double-Blind Period|Subject did not complete all visits|1
5826231|NCT02505542|20127345|P1|Part B: Double-Blind Period|Subject did not complete all visits|0
5826232|NCT02505542|20127342|P4|Part B: Double-Blind Period|Miscalculation|0
5826233|NCT02505542|20127343|P3|Part B: Double-Blind Period|Miscalculation|0
5826234|NCT02505542|20127344|P2|Part B: Double-Blind Period|Miscalculation|1
5826235|NCT02505542|20127345|P1|Part B: Double-Blind Period|Miscalculation|0
5826236|NCT02505542|20127342|P4|Part B: Double-Blind Period|Lack of Efficacy|0
5826237|NCT02505542|20127343|P3|Part B: Double-Blind Period|Lack of Efficacy|0
5826238|NCT02505542|20127344|P2|Part B: Double-Blind Period|Lack of Efficacy|1
5826239|NCT02505542|20127345|P1|Part B: Double-Blind Period|Lack of Efficacy|0
5826240|NCT02505542|20127342|P4|Part B: Double-Blind Period|Patient was moved from the country|1
5826241|NCT02505542|20127343|P3|Part B: Double-Blind Period|Patient was moved from the country|0
5826242|NCT02505542|20127344|P2|Part B: Double-Blind Period|Patient was moved from the country|0
5826243|NCT02505542|20127345|P1|Part B: Double-Blind Period|Patient was moved from the country|0
5826244|NCT02505542|20127342|P4|Part B: Double-Blind Period|Week 94 missed|0
5826245|NCT02505542|20127343|P3|Part B: Double-Blind Period|Week 94 missed|1
5826246|NCT02505542|20127344|P2|Part B: Double-Blind Period|Week 94 missed|0
5826247|NCT02505542|20127345|P1|Part B: Double-Blind Period|Week 94 missed|0
5826248|NCT02505542|20127342|P4|Part B: Double-Blind Period|Planning pregnancy|0
5826249|NCT02505542|20127343|P3|Part B: Double-Blind Period|Planning pregnancy|0
5826250|NCT02505542|20127344|P2|Part B: Double-Blind Period|Planning pregnancy|1
5826251|NCT02505542|20127345|P1|Part B: Double-Blind Period|Planning pregnancy|0
5826252|NCT02505542|20127342|P4|Part B: Double-Blind Period|Withdrawal by Subject|2
5826253|NCT02505542|20127343|P3|Part B: Double-Blind Period|Withdrawal by Subject|7
5826254|NCT02505542|20127344|P2|Part B: Double-Blind Period|Withdrawal by Subject|8
5826255|NCT02505542|20127345|P1|Part B: Double-Blind Period|Withdrawal by Subject|0
5826256|NCT02505542|20127342|P4|Part B: Double-Blind Period|Lost to Follow-up|1
5826257|NCT02505542|20127343|P3|Part B: Double-Blind Period|Lost to Follow-up|0
5826258|NCT02505542|20127344|P2|Part B: Double-Blind Period|Lost to Follow-up|0
5826259|NCT02505542|20127345|P1|Part B: Double-Blind Period|Lost to Follow-up|0
5826260|NCT02505542|20127342|P4|Part B: Double-Blind Period|Adverse Event|3
5826261|NCT02505542|20127343|P3|Part B: Double-Blind Period|Adverse Event|1
5826262|NCT02505542|20127344|P2|Part B: Double-Blind Period|Adverse Event|0
5826263|NCT02505542|20127345|P1|Part B: Double-Blind Period|Adverse Event|0
5826264|NCT02505542|20127342|P4|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0
5826265|NCT02505542|20127343|P3|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0
5826266|NCT02505542|20127344|P2|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0
5826267|NCT02505542|20127345|P1|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|341
5826268|NCT02505542|20127342|P4|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0
5826269|NCT02505542|20127343|P3|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0
5826270|NCT02505542|20127344|P2|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0
5826271|NCT02505542|20127345|P1|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|3
5826272|NCT02505542|20127342|P4|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0
5826273|NCT02505542|20127343|P3|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0
5826274|NCT02505542|20127344|P2|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0
5826275|NCT02505542|20127345|P1|Completed Part A, Did Not Enter Part B|Lack of Efficacy|2
5826276|NCT02505542|20127342|P4|Part A: Open-Label Period|Non-compliance|0
5826277|NCT02505542|20127343|P3|Part A: Open-Label Period|Non-compliance|0
5826278|NCT02505542|20127344|P2|Part A: Open-Label Period|Non-compliance|0
5826279|NCT02505542|20127345|P1|Part A: Open-Label Period|Non-compliance|1
5826280|NCT02505542|20127342|P4|Part A: Open-Label Period|Screening failure (detected too late)|0
5826281|NCT02505542|20127343|P3|Part A: Open-Label Period|Screening failure (detected too late)|0
5826282|NCT02505542|20127344|P2|Part A: Open-Label Period|Screening failure (detected too late)|0
5826283|NCT02505542|20127345|P1|Part A: Open-Label Period|Screening failure (detected too late)|1
5826284|NCT02505542|20127342|P4|Part A: Open-Label Period|Medical monitor decision|0
5826285|NCT02505542|20127343|P3|Part A: Open-Label Period|Medical monitor decision|0
5826286|NCT02505542|20127344|P2|Part A: Open-Label Period|Medical monitor decision|0
5826287|NCT02505542|20127345|P1|Part A: Open-Label Period|Medical monitor decision|1
5826288|NCT02505542|20127342|P4|Part A: Open-Label Period|Sponsor directive|0
5826289|NCT02505542|20127343|P3|Part A: Open-Label Period|Sponsor directive|0
5826290|NCT02505542|20127344|P2|Part A: Open-Label Period|Sponsor directive|0
5826291|NCT02505542|20127345|P1|Part A: Open-Label Period|Sponsor directive|1
5826292|NCT02505542|20127342|P4|Part A: Open-Label Period|Pregnancy|0
5826293|NCT02505542|20127343|P3|Part A: Open-Label Period|Pregnancy|0
5826294|NCT02505542|20127344|P2|Part A: Open-Label Period|Pregnancy|0
5826295|NCT02505542|20127345|P1|Part A: Open-Label Period|Pregnancy|2
5826296|NCT02505542|20127342|P4|Part A: Open-Label Period|Participant did not attend week 48 visit|0
5826297|NCT02505542|20127343|P3|Part A: Open-Label Period|Participant did not attend week 48 visit|0
5826298|NCT02505542|20127344|P2|Part A: Open-Label Period|Participant did not attend week 48 visit|0
5826299|NCT02505542|20127345|P1|Part A: Open-Label Period|Participant did not attend week 48 visit|1
5826300|NCT02505542|20127342|P4|Part A: Open-Label Period|New medical history available|0
5826301|NCT02505542|20127343|P3|Part A: Open-Label Period|New medical history available|0
5826302|NCT02505542|20127344|P2|Part A: Open-Label Period|New medical history available|0
5826303|NCT02505542|20127345|P1|Part A: Open-Label Period|New medical history available|1
5826304|NCT02505542|20127342|P4|Part A: Open-Label Period|Withdrawal by Subject|0
5826305|NCT02505542|20127343|P3|Part A: Open-Label Period|Withdrawal by Subject|0
5826306|NCT02505542|20127344|P2|Part A: Open-Label Period|Withdrawal by Subject|0
5826307|NCT02505542|20127345|P1|Part A: Open-Label Period|Withdrawal by Subject|27
5826308|NCT02505542|20127342|P4|Part A: Open-Label Period|Lost to Follow-up|0
5826309|NCT02505542|20127343|P3|Part A: Open-Label Period|Lost to Follow-up|0
5826310|NCT02505542|20127344|P2|Part A: Open-Label Period|Lost to Follow-up|0
5826311|NCT02505542|20127345|P1|Part A: Open-Label Period|Lost to Follow-up|5
5826312|NCT02505542|20127342|P4|Part A: Open-Label Period|Protocol Violation|0
5826313|NCT02505542|20127343|P3|Part A: Open-Label Period|Protocol Violation|0
5826314|NCT02505542|20127344|P2|Part A: Open-Label Period|Protocol Violation|0
5826315|NCT02505542|20127345|P1|Part A: Open-Label Period|Protocol Violation|1
5826316|NCT02505542|20127342|P4|Part A: Open-Label Period|Lack of Efficacy|0
5826317|NCT02505542|20127343|P3|Part A: Open-Label Period|Lack of Efficacy|0
5826318|NCT02505542|20127344|P2|Part A: Open-Label Period|Lack of Efficacy|0
5826319|NCT02505542|20127345|P1|Part A: Open-Label Period|Lack of Efficacy|5
5826320|NCT02505542|20127342|P4|Part A: Open-Label Period|Adverse Event|0
5826321|NCT02505542|20127343|P3|Part A: Open-Label Period|Adverse Event|0
5826322|NCT02505542|20127344|P2|Part A: Open-Label Period|Adverse Event|0
5826323|NCT02505542|20127345|P1|Part A: Open-Label Period|Adverse Event|31
5826324|NCT02505334|20127453|P2|Extension Treatment Period|Unclassified|0
5826325|NCT02505334|20127454|P1|Extension Treatment Period|Unclassified|3
5826326|NCT02505334|20127453|P2|Extension Treatment Period|Withdrawal by Subject|0
5826327|NCT02505334|20127454|P1|Extension Treatment Period|Withdrawal by Subject|6
5826328|NCT02505334|20127453|P2|Extension Treatment Period|Lack of Efficacy|0
5826329|NCT02505334|20127454|P1|Extension Treatment Period|Lack of Efficacy|4
5826330|NCT02505334|20127453|P2|Extension Treatment Period|Adverse Event|0
5826331|NCT02505334|20127454|P1|Extension Treatment Period|Adverse Event|5
5826332|NCT02505334|20127453|P2|Main Treatment Period|Unclassified|10
5826333|NCT02505334|20127454|P1|Main Treatment Period|Unclassified|4
5826334|NCT02505334|20127453|P2|Main Treatment Period|Withdrawal by Subject|8
5826335|NCT02505334|20127454|P1|Main Treatment Period|Withdrawal by Subject|1
5826336|NCT02505334|20127453|P2|Main Treatment Period|Protocol Violation|1
5826337|NCT02505334|20127454|P1|Main Treatment Period|Protocol Violation|0
5826338|NCT02505334|20127453|P2|Main Treatment Period|Lack of Efficacy|17
5826339|NCT02505334|20127454|P1|Main Treatment Period|Lack of Efficacy|7
5826340|NCT02505334|20127453|P2|Main Treatment Period|Adverse Event|3
5826341|NCT02505334|20127454|P1|Main Treatment Period|Adverse Event|3
5826342|NCT02505217|20127587|P2|Overall Study|Withdrawal by Subject|2
5826343|NCT02505217|20127588|P1|Overall Study|Withdrawal by Subject|1
5826344|NCT02504892|20127607|P1|Overall Study|Adverse event-pneumonitis|2
5826345|NCT02504827|20127614|P1|Overall Study|Could not produce sputum|1
5826346|NCT02504671|20127653|P6|Overall Study|Protocol defined stopping criteria|3
5826347|NCT02504671|20127654|P5|Overall Study|Protocol defined stopping criteria|3
5826348|NCT02504671|20127655|P4|Overall Study|Protocol defined stopping criteria|5
5826349|NCT02504671|20127656|P3|Overall Study|Protocol defined stopping criteria|3
5826350|NCT02504671|20127657|P2|Overall Study|Protocol defined stopping criteria|4
5826351|NCT02504671|20127658|P1|Overall Study|Protocol defined stopping criteria|7
5826352|NCT02504671|20127653|P6|Overall Study|Lost to Follow-up|1
5826353|NCT02504671|20127654|P5|Overall Study|Lost to Follow-up|0
5826354|NCT02504671|20127655|P4|Overall Study|Lost to Follow-up|0
5826355|NCT02504671|20127656|P3|Overall Study|Lost to Follow-up|2
5826356|NCT02504671|20127657|P2|Overall Study|Lost to Follow-up|0
5826357|NCT02504671|20127658|P1|Overall Study|Lost to Follow-up|0
5826358|NCT02504671|20127653|P6|Overall Study|Protocol Violation|1
5826359|NCT02504671|20127654|P5|Overall Study|Protocol Violation|0
5826360|NCT02504671|20127655|P4|Overall Study|Protocol Violation|0
5826361|NCT02504671|20127656|P3|Overall Study|Protocol Violation|0
5826362|NCT02504671|20127657|P2|Overall Study|Protocol Violation|1
5826363|NCT02504671|20127658|P1|Overall Study|Protocol Violation|2
5826364|NCT02504671|20127653|P6|Overall Study|Adverse Event|2
5826365|NCT02504671|20127654|P5|Overall Study|Adverse Event|0
5826366|NCT02504671|20127655|P4|Overall Study|Adverse Event|1
5826367|NCT02504671|20127656|P3|Overall Study|Adverse Event|0
5826368|NCT02504671|20127657|P2|Overall Study|Adverse Event|1
5826369|NCT02504671|20127658|P1|Overall Study|Adverse Event|1
5826370|NCT02504671|20127653|P6|Overall Study|Lack of Efficacy|4
5826371|NCT02504671|20127654|P5|Overall Study|Lack of Efficacy|4
5826372|NCT02504671|20127655|P4|Overall Study|Lack of Efficacy|0
5826373|NCT02504671|20127656|P3|Overall Study|Lack of Efficacy|1
5826374|NCT02504671|20127657|P2|Overall Study|Lack of Efficacy|3
5826375|NCT02504671|20127658|P1|Overall Study|Lack of Efficacy|1
5826376|NCT02504671|20127653|P6|Overall Study|Withdrawal by Subject|3
5826377|NCT02504671|20127654|P5|Overall Study|Withdrawal by Subject|5
5826378|NCT02504671|20127655|P4|Overall Study|Withdrawal by Subject|4
5826379|NCT02504671|20127656|P3|Overall Study|Withdrawal by Subject|4
5826380|NCT02504671|20127657|P2|Overall Study|Withdrawal by Subject|5
5826381|NCT02504671|20127658|P1|Overall Study|Withdrawal by Subject|1
5826382|NCT02504541|20127830|P1|Overall Study|Multiple|5
5826383|NCT02504541|20127830|P1|Overall Study|Other|2
5826384|NCT02504541|20127830|P1|Overall Study|Termination by Sponsor|1
5826385|NCT02504541|20127830|P1|Overall Study|Protocol Violation|2
5826386|NCT02504541|20127830|P1|Overall Study|Met Stopping Criteria|1
5826387|NCT02504541|20127830|P1|Overall Study|Lost to Follow-up|1
5826388|NCT02504541|20127830|P1|Overall Study|Withdrawal by Subject|4
5826389|NCT02504541|20127830|P1|Overall Study|Adverse Event|4
5826390|NCT02504502|20127836|P2|Crossover to Enhanced Report|Lost to Follow-up|0
5826391|NCT02504502|20127837|P1|Crossover to Enhanced Report|Lost to Follow-up|5
5826392|NCT02504502|20127836|P2|Routine Care vs. Enhanced Report|Lost to Follow-up|7
5826393|NCT02504502|20127837|P1|Routine Care vs. Enhanced Report|Lost to Follow-up|4
5826394|NCT02504424|20127843|P1|Overall Study|Withdrawal by Subject|2
5826395|NCT02504320|20127852|P4|Treatment Period 3|Adverse Event|0
5826396|NCT02504320|20127853|P3|Treatment Period 3|Adverse Event|1
5826397|NCT02504320|20127854|P2|Treatment Period 3|Adverse Event|0
5826398|NCT02504320|20127855|P1|Treatment Period 3|Adverse Event|0
5826399|NCT02504320|20127852|P4|Treatment Period 3|Positive Drug Screen|1
5826400|NCT02504320|20127853|P3|Treatment Period 3|Positive Drug Screen|0
5826401|NCT02504320|20127854|P2|Treatment Period 3|Positive Drug Screen|0
5826402|NCT02504320|20127855|P1|Treatment Period 3|Positive Drug Screen|0
5826403|NCT02504320|20127852|P4|Treatment Period 2|Positive Drug Screen|0
5826404|NCT02504320|20127853|P3|Treatment Period 2|Positive Drug Screen|0
5826405|NCT02504320|20127854|P2|Treatment Period 2|Positive Drug Screen|1
5826406|NCT02504320|20127855|P1|Treatment Period 2|Positive Drug Screen|0
5826407|NCT02504320|20127852|P4|Treatment Period 1|Positive Drug Screen|0
5826408|NCT02504320|20127853|P3|Treatment Period 1|Positive Drug Screen|1
5826409|NCT02504320|20127854|P2|Treatment Period 1|Positive Drug Screen|0
5826410|NCT02504320|20127855|P1|Treatment Period 1|Positive Drug Screen|0
5826411|NCT02504294|20127875|P2|Overall Study|Lost to Follow-up|7
5826412|NCT02504294|20127876|P1|Overall Study|Lost to Follow-up|6
5826413|NCT02504294|20127875|P2|Overall Study|Physician Decision|2
5826414|NCT02504294|20127876|P1|Overall Study|Physician Decision|1
5826415|NCT02504294|20127875|P2|Overall Study|Protocol Violation|26
5826416|NCT02504294|20127876|P1|Overall Study|Protocol Violation|27
5826417|NCT02504294|20127875|P2|Overall Study|Withdrawal by Subject|1
5826418|NCT02504294|20127876|P1|Overall Study|Withdrawal by Subject|7
5826419|NCT02504294|20127875|P2|Overall Study|Adverse Event|12
5826420|NCT02504294|20127876|P1|Overall Study|Adverse Event|15
5826421|NCT02504268|20127886|P2|Overall Study|Not Disclosed|0
5826422|NCT02504268|20127887|P1|Overall Study|Not Disclosed|1
5826423|NCT02504268|20127886|P2|Overall Study|Poor/Non-Compliance|2
5826424|NCT02504268|20127887|P1|Overall Study|Poor/Non-Compliance|3
5826425|NCT02504268|20127886|P2|Overall Study|Lack of Efficacy|35
5826426|NCT02504268|20127887|P1|Overall Study|Lack of Efficacy|11
5826427|NCT02504268|20127886|P2|Overall Study|No Longer Meets Study Criteria|3
5826428|NCT02504268|20127887|P1|Overall Study|No Longer Meets Study Criteria|2
5826429|NCT02504268|20127886|P2|Overall Study|Subject Request to Discontinue|3
5826430|NCT02504268|20127887|P1|Overall Study|Subject Request to Discontinue|11
5826431|NCT02504268|20127886|P2|Overall Study|Death|1
5826432|NCT02504268|20127887|P1|Overall Study|Death|1
5826433|NCT02504268|20127886|P2|Overall Study|Lost to Follow-up|6
5826434|NCT02504268|20127887|P1|Overall Study|Lost to Follow-up|3
5826435|NCT02504268|20127886|P2|Overall Study|Pregnancy|0
5826436|NCT02504268|20127887|P1|Overall Study|Pregnancy|2
5826437|NCT02504268|20127886|P2|Overall Study|Withdrawal of Consent|10
5826438|NCT02504268|20127887|P1|Overall Study|Withdrawal of Consent|11
5826439|NCT02504268|20127886|P2|Overall Study|Adverse Event|8
5826440|NCT02504268|20127887|P1|Overall Study|Adverse Event|18
5826441|NCT02504216|20127903|P2|Overall Study|Withdrawal by Subject|12
5826442|NCT02504216|20127904|P1|Overall Study|Withdrawal by Subject|8
5826443|NCT02504216|20127903|P2|Overall Study|Lost to Follow-up|3
5826444|NCT02504216|20127904|P1|Overall Study|Lost to Follow-up|3
5826445|NCT02503865|20127951|P3|Overall Study|Refused treatment|2
5826446|NCT02503865|20127952|P2|Overall Study|Refused treatment|39
5826447|NCT02503865|20127953|P1|Overall Study|Refused treatment|4
5826448|NCT02503865|20127951|P3|Overall Study|Moved out of area|0
5826449|NCT02503865|20127952|P2|Overall Study|Moved out of area|8
5826450|NCT02503865|20127953|P1|Overall Study|Moved out of area|1
5826451|NCT02503787|20127998|P1|Implant to 3 Month Endpoint|Withdrawal by Subject|1
5826452|NCT02503787|20127998|P1|Implant to 3 Month Endpoint|Adverse Event|2
5826453|NCT02503787|20127998|P1|Successful Trial (≥50% Pain Relief)|Physician Decision|2
5826454|NCT02503787|20127998|P1|Successful Trial (≥50% Pain Relief)|Withdrawal by Subject|3
5826455|NCT02503787|20127998|P1|Device Trial (HD Programming Trial)|Withdrawal by Subject|1
5826456|NCT02503787|20127998|P1|Device Trial (HD Programming Trial)|Lack of Efficacy|6
5826457|NCT02503787|20127998|P1|Enrollment|Unable to be programmed|1
5826458|NCT02503787|20127998|P1|Enrollment|Inability to implant system|1
5826459|NCT02503787|20127998|P1|Enrollment|Protocol Violation|1
5826460|NCT02503787|20127998|P1|Enrollment|Adverse Event|1
5826461|NCT02503787|20127998|P1|Enrollment|Study closure|1
5826462|NCT02503787|20127998|P1|Enrollment|Lost to Follow-up|1
5826463|NCT02503787|20127998|P1|Enrollment|Insurance issue|2
5826464|NCT02503787|20127998|P1|Enrollment|Physician Decision|2
5826465|NCT02503787|20127998|P1|Enrollment|Inclusion/exclusion criteria not met|4
5826466|NCT02503787|20127998|P1|Enrollment|Withdrawal by Subject|6
5826467|NCT02503540|20128015|P1|Overall Study|Withdrawal by Subject|1
5826468|NCT02503540|20128015|P1|Overall Study|Death|2
5826469|NCT02503501|20128036|P2|Overall Study|Withdrawal by Subject|2
5826470|NCT02503501|20128037|P1|Overall Study|Withdrawal by Subject|0
5826471|NCT02503501|20128036|P2|Overall Study|Protocol Violation|1
5826472|NCT02503501|20128037|P1|Overall Study|Protocol Violation|0
5826473|NCT02503501|20128036|P2|Overall Study|Physician Decision|0
5826474|NCT02503501|20128037|P1|Overall Study|Physician Decision|1
5826475|NCT02503332|20128073|P4|Overall Study|Other|1
5826476|NCT02503332|20128074|P3|Overall Study|Other|1
5826477|NCT02503332|20128075|P2|Overall Study|Other|6
5826478|NCT02503332|20128076|P1|Overall Study|Other|5
5826479|NCT02503332|20128073|P4|Overall Study|Death|0
5826480|NCT02503332|20128074|P3|Overall Study|Death|2
5826481|NCT02503332|20128075|P2|Overall Study|Death|2
5826482|NCT02503332|20128076|P1|Overall Study|Death|0
5826483|NCT02503332|20128073|P4|Overall Study|Subject Request|1
5826484|NCT02503332|20128074|P3|Overall Study|Subject Request|2
5826485|NCT02503332|20128075|P2|Overall Study|Subject Request|5
5826486|NCT02503332|20128076|P1|Overall Study|Subject Request|6
5826487|NCT02503332|20128073|P4|Overall Study|Sponsor's Decision|1
5826488|NCT02503332|20128074|P3|Overall Study|Sponsor's Decision|0
5826489|NCT02503332|20128075|P2|Overall Study|Sponsor's Decision|0
5826490|NCT02503332|20128076|P1|Overall Study|Sponsor's Decision|1
5826491|NCT02503332|20128073|P4|Overall Study|Investigator's Decision|0
5826492|NCT02503332|20128074|P3|Overall Study|Investigator's Decision|0
5826493|NCT02503332|20128075|P2|Overall Study|Investigator's Decision|1
5826494|NCT02503332|20128076|P1|Overall Study|Investigator's Decision|5
5826495|NCT02503332|20128073|P4|Overall Study|Adverse Event|1
5826496|NCT02503332|20128074|P3|Overall Study|Adverse Event|3
5826497|NCT02503332|20128075|P2|Overall Study|Adverse Event|5
5826498|NCT02503332|20128076|P1|Overall Study|Adverse Event|17
5826499|NCT02503215|20128127|P1|Overall Study|Unable to use positive airway pressure|2
5826500|NCT02503215|20128127|P1|Overall Study|Unable to wear compression stockings|1
5826501|NCT02503202|20128138|P5|Extension: Month 6 to 24|Withdrawal by Subject|0
5826502|NCT02503202|20128139|P4|Extension: Month 6 to 24|Withdrawal by Subject|4
5826503|NCT02503202|20128140|P3|Extension: Month 6 to 24|Withdrawal by Subject|2
5826504|NCT02503202|20128141|P2|Extension: Month 6 to 24|Withdrawal by Subject|8
5826505|NCT02503202|20128142|P1|Extension: Month 6 to 24|Withdrawal by Subject|5
5826506|NCT02503202|20128138|P5|Extension: Month 6 to 24|Physician Decision|0
5826507|NCT02503202|20128139|P4|Extension: Month 6 to 24|Physician Decision|3
5826508|NCT02503202|20128140|P3|Extension: Month 6 to 24|Physician Decision|1
5826509|NCT02503202|20128141|P2|Extension: Month 6 to 24|Physician Decision|0
5826510|NCT02503202|20128142|P1|Extension: Month 6 to 24|Physician Decision|1
5826511|NCT02503202|20128138|P5|Extension: Month 6 to 24|Lost to Follow-up|1
5826512|NCT02503202|20128139|P4|Extension: Month 6 to 24|Lost to Follow-up|10
5826513|NCT02503202|20128140|P3|Extension: Month 6 to 24|Lost to Follow-up|6
5826514|NCT02503202|20128141|P2|Extension: Month 6 to 24|Lost to Follow-up|8
5826515|NCT02503202|20128142|P1|Extension: Month 6 to 24|Lost to Follow-up|4
5826516|NCT02503202|20128138|P5|Extension: Month 6 to 24|Death|0
5826517|NCT02503202|20128139|P4|Extension: Month 6 to 24|Death|0
5826518|NCT02503202|20128140|P3|Extension: Month 6 to 24|Death|0
5826519|NCT02503202|20128141|P2|Extension: Month 6 to 24|Death|0
5826520|NCT02503202|20128142|P1|Extension: Month 6 to 24|Death|1
5826521|NCT02503202|20128138|P5|Extension: Month 6 to 24|Protocol Violation|0
5826522|NCT02503202|20128139|P4|Extension: Month 6 to 24|Protocol Violation|1
5826523|NCT02503202|20128140|P3|Extension: Month 6 to 24|Protocol Violation|0
5826524|NCT02503202|20128141|P2|Extension: Month 6 to 24|Protocol Violation|0
5826525|NCT02503202|20128142|P1|Extension: Month 6 to 24|Protocol Violation|0
5826526|NCT02503202|20128138|P5|Base Study: Up to Month 6|Randomized not vaccinated|0
5826527|NCT02503202|20128139|P4|Base Study: Up to Month 6|Randomized not vaccinated|2
5826528|NCT02503202|20128140|P3|Base Study: Up to Month 6|Randomized not vaccinated|1
5826529|NCT02503202|20128141|P2|Base Study: Up to Month 6|Randomized not vaccinated|0
5826530|NCT02503202|20128142|P1|Base Study: Up to Month 6|Randomized not vaccinated|0
5826531|NCT02503202|20128138|P5|Base Study: Up to Month 6|Withdrawal by Subject|1
5826532|NCT02503202|20128139|P4|Base Study: Up to Month 6|Withdrawal by Subject|4
5826533|NCT02503202|20128140|P3|Base Study: Up to Month 6|Withdrawal by Subject|4
5826534|NCT02503202|20128141|P2|Base Study: Up to Month 6|Withdrawal by Subject|3
5826535|NCT02503202|20128142|P1|Base Study: Up to Month 6|Withdrawal by Subject|6
5826536|NCT02503202|20128138|P5|Base Study: Up to Month 6|Physician Decision|1
5826537|NCT02503202|20128139|P4|Base Study: Up to Month 6|Physician Decision|0
5826538|NCT02503202|20128140|P3|Base Study: Up to Month 6|Physician Decision|0
5826539|NCT02503202|20128141|P2|Base Study: Up to Month 6|Physician Decision|0
5826540|NCT02503202|20128142|P1|Base Study: Up to Month 6|Physician Decision|0
5826541|NCT02503202|20128138|P5|Base Study: Up to Month 6|Lost to Follow-up|1
5826542|NCT02503202|20128139|P4|Base Study: Up to Month 6|Lost to Follow-up|5
5826543|NCT02503202|20128140|P3|Base Study: Up to Month 6|Lost to Follow-up|10
5826544|NCT02503202|20128141|P2|Base Study: Up to Month 6|Lost to Follow-up|8
5826545|NCT02503202|20128142|P1|Base Study: Up to Month 6|Lost to Follow-up|11
5826546|NCT02503202|20128138|P5|Base Study: Up to Month 6|Death|0
5826547|NCT02503202|20128139|P4|Base Study: Up to Month 6|Death|0
5826548|NCT02503202|20128140|P3|Base Study: Up to Month 6|Death|0
5826549|NCT02503202|20128141|P2|Base Study: Up to Month 6|Death|1
5826550|NCT02503202|20128142|P1|Base Study: Up to Month 6|Death|1
5826551|NCT02503085|20128184|P4|Period 2: Washout (3 to 7 Days)|Adverse Event|0
5826552|NCT02503085|20128185|P3|Period 2: Washout (3 to 7 Days)|Adverse Event|1
5826553|NCT02503085|20128186|P2|Period 2: Washout (3 to 7 Days)|Adverse Event|0
5826554|NCT02503085|20128187|P1|Period 2: Washout (3 to 7 Days)|Adverse Event|1
5826555|NCT02502864|20128226|P1|Overall Study|Withdrawal by Subject|1
5826556|NCT02502734|20128235|P2|Washout Period|Adverse Event|0
5826557|NCT02502734|20128236|P1|Washout Period|Adverse Event|1
5826558|NCT02502734|20128235|P2|Double-blind Treatment Period 1|Adverse Event|0
5826559|NCT02502734|20128236|P1|Double-blind Treatment Period 1|Adverse Event|1
5826560|NCT02502526|20128247|P3|Overall Study|Enrollment suspension|1
5826561|NCT02502526|20128248|P2|Overall Study|Enrollment suspension|1
5826562|NCT02502526|20128249|P1|Overall Study|Enrollment suspension|4
5826563|NCT02502526|20128247|P3|Overall Study|Disqualified due to cataract grading|1
5826564|NCT02502526|20128248|P2|Overall Study|Disqualified due to cataract grading|0
5826565|NCT02502526|20128249|P1|Overall Study|Disqualified due to cataract grading|0
5826566|NCT02502526|20128247|P3|Overall Study|Withdrawal by Subject|1
5826567|NCT02502526|20128248|P2|Overall Study|Withdrawal by Subject|1
5826568|NCT02502526|20128249|P1|Overall Study|Withdrawal by Subject|0
5826569|NCT02502526|20128247|P3|Overall Study|Lost to Follow-up|3
5826570|NCT02502526|20128248|P2|Overall Study|Lost to Follow-up|2
5826571|NCT02502526|20128249|P1|Overall Study|Lost to Follow-up|2
5826572|NCT02502149|20128346|P5|Intermediate|Discontinued prematurely|0
5826573|NCT02502149|20128347|P4|Intermediate|Discontinued prematurely|0
5826574|NCT02502149|20128348|P3|Intermediate|Discontinued prematurely|0
5826575|NCT02502149|20128349|P2|Intermediate|Discontinued prematurely|0
5826576|NCT02502149|20128350|P1|Intermediate|Discontinued prematurely|1
5826577|NCT02501928|20128485|P6|Overall Study|Withdrawal By Parent/Guardian|0
5826578|NCT02501928|20128486|P5|Overall Study|Withdrawal By Parent/Guardian|1
5826579|NCT02501928|20128487|P4|Overall Study|Withdrawal By Parent/Guardian|0
5826580|NCT02501928|20128488|P3|Overall Study|Withdrawal By Parent/Guardian|0
5826581|NCT02501928|20128489|P2|Overall Study|Withdrawal By Parent/Guardian|0
5826582|NCT02501928|20128490|P1|Overall Study|Withdrawal By Parent/Guardian|0
5826583|NCT02501629|20128716|P2|Overall Study|Subject did not return to site|1
5826584|NCT02501629|20128717|P1|Overall Study|Subject did not return to site|0
5826585|NCT02501629|20128716|P2|Overall Study|Withdrawal by Subject|5
5826586|NCT02501629|20128717|P1|Overall Study|Withdrawal by Subject|3
5826587|NCT02501629|20128716|P2|Overall Study|Early termination by sponsor|0
5826588|NCT02501629|20128717|P1|Overall Study|Early termination by sponsor|1
5826589|NCT02501629|20128716|P2|Overall Study|Withdrawn from study by sponsor|0
5826590|NCT02501629|20128717|P1|Overall Study|Withdrawn from study by sponsor|1
5826591|NCT02501629|20128716|P2|Overall Study|Death|1
5826592|NCT02501629|20128717|P1|Overall Study|Death|0
5826593|NCT02501473|20128763|P8|Overall Study|Reason not specified|0
5826594|NCT02501473|20128764|P7|Overall Study|Reason not specified|0
5826595|NCT02501473|20128765|P6|Overall Study|Reason not specified|0
5826596|NCT02501473|20128766|P5|Overall Study|Reason not specified|0
5826597|NCT02501473|20128767|P4|Overall Study|Reason not specified|1
5826598|NCT02501473|20128768|P3|Overall Study|Reason not specified|1
5826599|NCT02501473|20128769|P2|Overall Study|Reason not specified|0
5826600|NCT02501473|20128770|P1|Overall Study|Reason not specified|0
5826601|NCT02501473|20128763|P8|Overall Study|Lost to Follow-up|0
5826602|NCT02501473|20128764|P7|Overall Study|Lost to Follow-up|0
5826603|NCT02501473|20128765|P6|Overall Study|Lost to Follow-up|1
5826604|NCT02501473|20128766|P5|Overall Study|Lost to Follow-up|0
5826605|NCT02501473|20128767|P4|Overall Study|Lost to Follow-up|0
5826606|NCT02501473|20128768|P3|Overall Study|Lost to Follow-up|1
5826607|NCT02501473|20128769|P2|Overall Study|Lost to Follow-up|0
5826608|NCT02501473|20128770|P1|Overall Study|Lost to Follow-up|1
5826609|NCT02501473|20128763|P8|Overall Study|Death|0
5826610|NCT02501473|20128764|P7|Overall Study|Death|0
5826611|NCT02501473|20128765|P6|Overall Study|Death|1
5826612|NCT02501473|20128766|P5|Overall Study|Death|0
5826613|NCT02501473|20128767|P4|Overall Study|Death|1
5826614|NCT02501473|20128768|P3|Overall Study|Death|1
5826615|NCT02501473|20128769|P2|Overall Study|Death|0
5826616|NCT02501473|20128770|P1|Overall Study|Death|0
5826617|NCT02501473|20128763|P8|Overall Study|Withdrawal by Subject|0
5826618|NCT02501473|20128764|P7|Overall Study|Withdrawal by Subject|0
5826619|NCT02501473|20128765|P6|Overall Study|Withdrawal by Subject|2
5826620|NCT02501473|20128766|P5|Overall Study|Withdrawal by Subject|2
5826621|NCT02501473|20128767|P4|Overall Study|Withdrawal by Subject|3
5826622|NCT02501473|20128768|P3|Overall Study|Withdrawal by Subject|3
5826623|NCT02501473|20128769|P2|Overall Study|Withdrawal by Subject|0
5826624|NCT02501473|20128770|P1|Overall Study|Withdrawal by Subject|0
5826625|NCT02501473|20128763|P8|Overall Study|Study Terminated|0
5826626|NCT02501473|20128764|P7|Overall Study|Study Terminated|1
5826627|NCT02501473|20128765|P6|Overall Study|Study Terminated|10
5826628|NCT02501473|20128766|P5|Overall Study|Study Terminated|2
5826629|NCT02501473|20128767|P4|Overall Study|Study Terminated|9
5826630|NCT02501473|20128768|P3|Overall Study|Study Terminated|7
5826631|NCT02501473|20128769|P2|Overall Study|Study Terminated|3
5826632|NCT02501473|20128770|P1|Overall Study|Study Terminated|2
5826633|NCT02501161|20128865|P2|Overall Study|Other|0
5826634|NCT02501161|20128866|P1|Overall Study|Other|3
5826635|NCT02501161|20128865|P2|Overall Study|Withdrawal by Subject|15
5826636|NCT02501161|20128866|P1|Overall Study|Withdrawal by Subject|10
5826637|NCT02501161|20128865|P2|Overall Study|Lost to Follow-up|4
5826638|NCT02501161|20128866|P1|Overall Study|Lost to Follow-up|7
5826639|NCT02501161|20128865|P2|Overall Study|Adverse Event|6
5826640|NCT02501161|20128866|P1|Overall Study|Adverse Event|2
5826641|NCT02500979|20128990|P2|Period 2|Change in risk|0
5826642|NCT02500979|20128991|P1|Period 2|Change in risk|1
5826643|NCT02500979|20128990|P2|Period 1|Subject decision|0
5826644|NCT02500979|20128991|P1|Period 1|Subject decision|2
5826645|NCT02500979|20128990|P2|Period 1|Adverse Event|0
5826646|NCT02500979|20128991|P1|Period 1|Adverse Event|1
5826647|NCT02500979|20128990|P2|Period 1|Severe non-compliance to protocol|1
5826648|NCT02500979|20128991|P1|Period 1|Severe non-compliance to protocol|0
5826649|NCT02500979|20128990|P2|Period 1|Hyperglycemia|0
5826650|NCT02500979|20128991|P1|Period 1|Hyperglycemia|1
5826651|NCT02500901|20129025|P1|Overall Study|Disease ProgressionDD|2
5826668|NCT02500758|20129120|P2|Second Intervention (2 Minutes)|Protocol Violation|1
5826669|NCT02500758|20129121|P1|Second Intervention (2 Minutes)|Protocol Violation|1
5826670|NCT02500758|20129120|P2|Second Intervention (2 Minutes)|Lost to Follow-up|1
5826671|NCT02500758|20129121|P1|Second Intervention (2 Minutes)|Lost to Follow-up|0
5826672|NCT02500758|20129120|P2|Second Intervention (2 Minutes)|Withdrawal by Subject|0
5826673|NCT02500758|20129121|P1|Second Intervention (2 Minutes)|Withdrawal by Subject|2
5826674|NCT02500758|20129120|P2|Washout (1 Week)|Lost to Follow-up|2
5826675|NCT02500758|20129121|P1|Washout (1 Week)|Lost to Follow-up|2
5826676|NCT02500758|20129120|P2|First Intervention (2 Minutes)|Withdrawal by Subject|1
5826677|NCT02500758|20129121|P1|First Intervention (2 Minutes)|Withdrawal by Subject|0
5826678|NCT02500732|20129131|P2|Overall Study|Physician Decision|1
5826679|NCT02500732|20129132|P1|Overall Study|Physician Decision|0
5826680|NCT02500706|20129149|P3|Overall Study|Unclassified|1
5826681|NCT02500706|20129150|P2|Overall Study|Unclassified|0
5826682|NCT02500706|20129151|P1|Overall Study|Unclassified|0
5826683|NCT02500706|20129149|P3|Overall Study|Withdrawal by Subject|4
5826684|NCT02500706|20129150|P2|Overall Study|Withdrawal by Subject|6
5826685|NCT02500706|20129151|P1|Overall Study|Withdrawal by Subject|4
5826686|NCT02500706|20129149|P3|Overall Study|Lost to Follow-up|1
5826687|NCT02500706|20129150|P2|Overall Study|Lost to Follow-up|1
5826688|NCT02500706|20129151|P1|Overall Study|Lost to Follow-up|0
5826689|NCT02500706|20129149|P3|Overall Study|Adverse Event|1
5826690|NCT02500706|20129150|P2|Overall Study|Adverse Event|0
5826691|NCT02500706|20129151|P1|Overall Study|Adverse Event|0
5826692|NCT02500641|20129305|P2|Overall Study|Non compliance to study drug|1
5826693|NCT02500641|20129306|P1|Overall Study|Non compliance to study drug|0
5826694|NCT02500641|20129305|P2|Overall Study|Sponsor decision|0
5826695|NCT02500641|20129306|P1|Overall Study|Sponsor decision|1
5826696|NCT02500641|20129305|P2|Overall Study|Lost to Follow-up|0
5826697|NCT02500641|20129306|P1|Overall Study|Lost to Follow-up|1
5826698|NCT02500641|20129305|P2|Overall Study|Protocol Violation|2
5826699|NCT02500641|20129306|P1|Overall Study|Protocol Violation|1
5826700|NCT02500641|20129305|P2|Overall Study|Unable to follow study procedures|2
5826701|NCT02500641|20129306|P1|Overall Study|Unable to follow study procedures|3
5826702|NCT02500641|20129305|P2|Overall Study|Withdrawal by Subject|5
5826703|NCT02500641|20129306|P1|Overall Study|Withdrawal by Subject|4
5826704|NCT02500641|20129305|P2|Overall Study|Adverse Event|2
5826705|NCT02500641|20129306|P1|Overall Study|Adverse Event|0
5826706|NCT02500550|20129325|P1|Overall Study|Death|7
5826707|NCT02500537|20129331|P2|Overall Study|Withdrawal by Subject|0
5826708|NCT02500537|20129332|P1|Overall Study|Withdrawal by Subject|1
5826709|NCT02500537|20129331|P2|Overall Study|Lost to Follow-up|1
5826710|NCT02500537|20129332|P1|Overall Study|Lost to Follow-up|0
5826711|NCT02500537|20129331|P2|Overall Study|Death|0
5826712|NCT02500537|20129332|P1|Overall Study|Death|2
5826713|NCT02500056|20129401|P2|Overall Study|Death|1
5826714|NCT02500056|20129402|P1|Overall Study|Death|3
5826715|NCT02500056|20129401|P2|Overall Study|Recurrence|0
5826716|NCT02500056|20129402|P1|Overall Study|Recurrence|1
5826717|NCT02500056|20129401|P2|Overall Study|Lost to Follow-up|7
5826718|NCT02500056|20129402|P1|Overall Study|Lost to Follow-up|3
5826719|NCT02499952|20129412|P1|Overall Study|Death|9
5826720|NCT02499952|20129412|P1|Overall Study|Lost to Follow-up|1
5826721|NCT02499900|20129421|P2|Extension Study Period|Other|2
5826722|NCT02499900|20129422|P1|Extension Study Period|Other|0
5826723|NCT02499900|20129421|P2|Extension Study Period|Lost to Follow-up|5
5826724|NCT02499900|20129422|P1|Extension Study Period|Lost to Follow-up|2
5826725|NCT02499900|20129421|P2|Extension Study Period|Pregnancy|2
5826726|NCT02499900|20129422|P1|Extension Study Period|Pregnancy|1
5826727|NCT02499900|20129421|P2|Extension Study Period|Physician Decision|5
5826728|NCT02499900|20129422|P1|Extension Study Period|Physician Decision|2
5826729|NCT02499900|20129421|P2|Extension Study Period|Withdrawal by Subject|2
5826730|NCT02499900|20129422|P1|Extension Study Period|Withdrawal by Subject|5
5826731|NCT02499900|20129421|P2|Extension Study Period|Adverse Event|4
5826732|NCT02499900|20129422|P1|Extension Study Period|Adverse Event|2
5826733|NCT02499900|20129421|P2|Completed Core, Continued Into Extension|Personal motivation|0
5826734|NCT02499900|20129422|P1|Completed Core, Continued Into Extension|Personal motivation|1
5826735|NCT02499900|20129421|P2|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|0
5826736|NCT02499900|20129422|P1|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|1
5826737|NCT02499900|20129421|P2|Completed Core, Continued Into Extension|Withdrawal by Subject|2
5826738|NCT02499900|20129422|P1|Completed Core, Continued Into Extension|Withdrawal by Subject|0
5826739|NCT02499900|20129421|P2|Completed Core, Continued Into Extension|Physician Decision|0
5826740|NCT02499900|20129422|P1|Completed Core, Continued Into Extension|Physician Decision|1
5826741|NCT02499900|20129421|P2|Core Study Period|Death|1
5826742|NCT02499900|20129422|P1|Core Study Period|Death|0
5826743|NCT02499900|20129421|P2|Core Study Period|Adverse Event|14
5826744|NCT02499900|20129422|P1|Core Study Period|Adverse Event|18
5826745|NCT02499900|20129421|P2|Core Study Period|Withdrawal by Subject|10
5826746|NCT02499900|20129422|P1|Core Study Period|Withdrawal by Subject|11
5826747|NCT02499900|20129421|P2|Core Study Period|Protocol Violation|0
5826748|NCT02499900|20129422|P1|Core Study Period|Protocol Violation|3
5826749|NCT02499900|20129421|P2|Core Study Period|Pregnancy|0
5826750|NCT02499900|20129422|P1|Core Study Period|Pregnancy|1
5826751|NCT02499900|20129421|P2|Core Study Period|Per sponsor request|1
5826752|NCT02499900|20129422|P1|Core Study Period|Per sponsor request|0
5826753|NCT02499900|20129421|P2|Core Study Period|Lost to Follow-up|2
5826754|NCT02499900|20129422|P1|Core Study Period|Lost to Follow-up|1
5826755|NCT02499900|20129421|P2|Core Study Period|Other|4
5826756|NCT02499900|20129422|P1|Core Study Period|Other|1
5826757|NCT02499783|20129453|P3|Open Label Period: Weeks 8 to 26|Subject Noncompliance|2
5826758|NCT02499783|20129454|P2|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0
5826759|NCT02499783|20129455|P1|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0
5826760|NCT02499783|20129453|P3|Open Label Period: Weeks 8 to 26|Lack of Efficacy|9
5826761|NCT02499783|20129454|P2|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0
5826762|NCT02499783|20129455|P1|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0
5826763|NCT02499783|20129453|P3|Open Label Period: Weeks 8 to 26|Withdrew Consent|2
5826764|NCT02499783|20129454|P2|Open Label Period: Weeks 8 to 26|Withdrew Consent|0
5826765|NCT02499783|20129455|P1|Open Label Period: Weeks 8 to 26|Withdrew Consent|0
5826766|NCT02499783|20129453|P3|Open Label Period: Weeks 8 to 26|Adverse Event|16
5826767|NCT02499783|20129454|P2|Open Label Period: Weeks 8 to 26|Adverse Event|0
5826768|NCT02499783|20129455|P1|Open Label Period: Weeks 8 to 26|Adverse Event|0
5826769|NCT02499783|20129453|P3|DB Period: Weeks 0-8|Other|0
5826770|NCT02499783|20129454|P2|DB Period: Weeks 0-8|Other|1
5826771|NCT02499783|20129455|P1|DB Period: Weeks 0-8|Other|1
5826772|NCT02499783|20129453|P3|DB Period: Weeks 0-8|Withdrew Consent|0
5826773|NCT02499783|20129454|P2|DB Period: Weeks 0-8|Withdrew Consent|0
5826774|NCT02499783|20129455|P1|DB Period: Weeks 0-8|Withdrew Consent|1
5826775|NCT02499783|20129453|P3|DB Period: Weeks 0-8|Adverse Event|0
5826776|NCT02499783|20129454|P2|DB Period: Weeks 0-8|Adverse Event|6
5826777|NCT02499783|20129455|P1|DB Period: Weeks 0-8|Adverse Event|8
5826778|NCT02499783|20129453|P3|DB Period/Placebo-Controlled: Weeks 0-4|Other|0
5826779|NCT02499783|20129454|P2|DB Period/Placebo-Controlled: Weeks 0-4|Other|1
5826780|NCT02499783|20129455|P1|DB Period/Placebo-Controlled: Weeks 0-4|Other|1
5826781|NCT02499783|20129453|P3|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0
5826782|NCT02499783|20129454|P2|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0
5826783|NCT02499783|20129455|P1|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|1
5826784|NCT02499783|20129453|P3|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|0
5826785|NCT02499783|20129454|P2|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|4
5826786|NCT02499783|20129455|P1|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|2
5826787|NCT02499770|20129504|P2|Overall Study|Randomized but not enrolled|1
5826788|NCT02499770|20129505|P1|Overall Study|Randomized but not enrolled|0
5826789|NCT02499770|20129504|P2|Overall Study|Withdrawn by PI for compassionate reason|1
5826790|NCT02499770|20129505|P1|Overall Study|Withdrawn by PI for compassionate reason|0
5826791|NCT02499770|20129504|P2|Overall Study|Subject declined further treatment|0
5826792|NCT02499770|20129505|P1|Overall Study|Subject declined further treatment|1
5826793|NCT02499770|20129504|P2|Overall Study|Lost to Follow-up|2
5826794|NCT02499770|20129505|P1|Overall Study|Lost to Follow-up|0
5826795|NCT02499770|20129504|P2|Overall Study|Withdrawal by Subject|7
5826796|NCT02499770|20129505|P1|Overall Study|Withdrawal by Subject|0
5826797|NCT02499770|20129504|P2|Overall Study|Study completion|10
5826798|NCT02499770|20129505|P1|Overall Study|Study completion|1
5826799|NCT02499770|20129504|P2|Overall Study|Death|56
5826800|NCT02499770|20129505|P1|Overall Study|Death|17
5826801|NCT02499575|20129625|P2|Overall Study|Protocol Violation|1
5826802|NCT02499575|20129626|P1|Overall Study|Protocol Violation|0
5826803|NCT02499406|20129636|P1|Overall Study|missed 3 treatment sessions|4
5826804|NCT02499263|20129657|P1|Overall Study|Pregnancy|1
5826805|NCT02499263|20129657|P1|Overall Study|Participant's decision|3
5826806|NCT02499263|20129657|P1|Overall Study|Adverse Events/Serious Adverse Events|11
5826807|NCT02499263|20129657|P1|Overall Study|investigator's judgment|12
5826808|NCT02499263|20129657|P1|Overall Study|Lack of Efficacy|22
5826809|NCT02499263|20129657|P1|Overall Study|Participant's withdrawal of consent|4
5826810|NCT02499263|20129657|P1|Overall Study|Lost to Follow-up|9
5826811|NCT02499172|20129694|P4|Overall Study|Lost to Follow-up|0
5826812|NCT02499172|20129695|P3|Overall Study|Lost to Follow-up|0
5826813|NCT02499172|20129696|P2|Overall Study|Lost to Follow-up|64
5826814|NCT02499172|20129697|P1|Overall Study|Lost to Follow-up|65
5826815|NCT02499172|20129694|P4|Overall Study|Financial reason|436
5826816|NCT02499172|20129695|P3|Overall Study|Financial reason|523
5826817|NCT02499172|20129696|P2|Overall Study|Financial reason|0
5826818|NCT02499172|20129697|P1|Overall Study|Financial reason|0
5826829|NCT02499146|20129734|P1|Overall Study|Began other treatment/therapy|13
5826830|NCT02499146|20129734|P1|Overall Study|Ongoing at date of cut-off|9
5826831|NCT02499146|20129734|P1|Overall Study|Other|2
5826832|NCT02499146|20129734|P1|Overall Study|Withdrawal by Subject|1
5826833|NCT02499146|20129734|P1|Overall Study|Lost to Follow-up|1
5826834|NCT02499120|20129774|P2|Overall Study|Ongoing on study|11
5826835|NCT02499120|20129775|P1|Overall Study|Ongoing on study|15
5826836|NCT02499120|20129774|P2|Overall Study|Other|0
5826837|NCT02499120|20129775|P1|Overall Study|Other|1
5826838|NCT02499120|20129774|P2|Overall Study|Withdrawal by Subject|5
5826839|NCT02499120|20129775|P1|Overall Study|Withdrawal by Subject|2
5826840|NCT02499120|20129774|P2|Overall Study|Participant refused further follow-up|0
5826841|NCT02499120|20129775|P1|Overall Study|Participant refused further follow-up|1
5826842|NCT02499120|20129774|P2|Overall Study|Lost to Follow-up|2
5826843|NCT02499120|20129775|P1|Overall Study|Lost to Follow-up|1
5826844|NCT02499120|20129774|P2|Overall Study|Death|42
5826845|NCT02499120|20129775|P1|Overall Study|Death|45
5826846|NCT02499029|20129806|P2|Overall Study|Death|0
5826847|NCT02499029|20129807|P1|Overall Study|Death|1
5826848|NCT02499029|20129806|P2|Overall Study|Physician Decision|1
5826849|NCT02499029|20129807|P1|Overall Study|Physician Decision|2
5826850|NCT02499029|20129806|P2|Overall Study|Lost to Follow-up|2
5826851|NCT02499029|20129807|P1|Overall Study|Lost to Follow-up|2
5826852|NCT02498821|20129834|P2|Overall Study|Screen failure|5
5826853|NCT02498821|20129835|P1|Overall Study|Screen failure|3
5826854|NCT02498678|20129879|P2|Overall Study|interference from the surgical team|2
5826855|NCT02498678|20129880|P1|Overall Study|interference from the surgical team|0
5826856|NCT02498652|20129896|P2|Overall Study|Protocol Violation|1
5826857|NCT02498652|20129897|P1|Overall Study|Protocol Violation|0
5826858|NCT02498418|20130040|P3|Overall Study|Participant taken prohibited medication|1
5826859|NCT02498418|20130041|P2|Overall Study|Participant taken prohibited medication|1
5826860|NCT02498418|20130042|P1|Overall Study|Participant taken prohibited medication|0
5826861|NCT02498418|20130040|P3|Overall Study|Lost to Follow-up|1
5826862|NCT02498418|20130041|P2|Overall Study|Lost to Follow-up|1
5826863|NCT02498418|20130042|P1|Overall Study|Lost to Follow-up|0
5826864|NCT02498418|20130040|P3|Overall Study|Withdrawal by Subject|3
5826865|NCT02498418|20130041|P2|Overall Study|Withdrawal by Subject|0
5826866|NCT02498418|20130042|P1|Overall Study|Withdrawal by Subject|2
5826867|NCT02498418|20130040|P3|Overall Study|Lack of Efficacy|1
5826868|NCT02498418|20130041|P2|Overall Study|Lack of Efficacy|0
5826869|NCT02498418|20130042|P1|Overall Study|Lack of Efficacy|0
5826870|NCT02498236|20130066|P8|Overall Study|Withdrawal by Subject|0
5826871|NCT02498236|20130067|P7|Overall Study|Withdrawal by Subject|0
5826872|NCT02498236|20130068|P6|Overall Study|Withdrawal by Subject|0
5826873|NCT02498236|20130069|P5|Overall Study|Withdrawal by Subject|1
5826874|NCT02498236|20130070|P4|Overall Study|Withdrawal by Subject|0
5826875|NCT02498236|20130071|P3|Overall Study|Withdrawal by Subject|0
5826876|NCT02498236|20130072|P2|Overall Study|Withdrawal by Subject|0
5826877|NCT02498236|20130073|P1|Overall Study|Withdrawal by Subject|0
5826878|NCT02498236|20130066|P8|Overall Study|Equipment failure|0
5826879|NCT02498236|20130067|P7|Overall Study|Equipment failure|1
5826880|NCT02498236|20130068|P6|Overall Study|Equipment failure|0
5826881|NCT02498236|20130069|P5|Overall Study|Equipment failure|0
5826882|NCT02498236|20130070|P4|Overall Study|Equipment failure|0
5826883|NCT02498236|20130071|P3|Overall Study|Equipment failure|0
5826884|NCT02498236|20130072|P2|Overall Study|Equipment failure|0
5826885|NCT02498236|20130073|P1|Overall Study|Equipment failure|0
5826886|NCT02498236|20130066|P8|Overall Study|Did not show for testing|1
5826887|NCT02498236|20130067|P7|Overall Study|Did not show for testing|0
5826888|NCT02498236|20130068|P6|Overall Study|Did not show for testing|0
5826889|NCT02498236|20130069|P5|Overall Study|Did not show for testing|0
5826890|NCT02498236|20130070|P4|Overall Study|Did not show for testing|0
5826891|NCT02498236|20130071|P3|Overall Study|Did not show for testing|0
5826892|NCT02498236|20130072|P2|Overall Study|Did not show for testing|0
5826893|NCT02498236|20130073|P1|Overall Study|Did not show for testing|1
5826894|NCT02498067|20130102|P1|Overall Study|Did not meet inclusion criteria|11
5826895|NCT02498067|20130102|P1|Overall Study|Lost to Follow-up|22
5826896|NCT02497976|20130123|P2|Overall Study|Moved out of area|1
5826897|NCT02497976|20130124|P1|Overall Study|Moved out of area|0
5826898|NCT02497976|20130123|P2|Overall Study|Withdrawal by Subject|0
5826899|NCT02497976|20130124|P1|Overall Study|Withdrawal by Subject|2
5826900|NCT02497781|20130219|P2|Overall Study|Lost to Follow-up|1
5826901|NCT02497781|20130220|P1|Overall Study|Lost to Follow-up|1
5826902|NCT02497781|20130219|P2|Overall Study|Randomised but not treated|1
5826903|NCT02497781|20130220|P1|Overall Study|Randomised but not treated|1
5826904|NCT02497781|20130219|P2|Overall Study|Lack of Efficacy|1
5826905|NCT02497781|20130220|P1|Overall Study|Lack of Efficacy|0
5826906|NCT02497781|20130219|P2|Overall Study|Withdrawal by Subject|0
5826907|NCT02497781|20130220|P1|Overall Study|Withdrawal by Subject|2
5826908|NCT02497755|20130283|P2|Overall Study|Protocol Violation|0
5826909|NCT02497755|20130284|P1|Overall Study|Protocol Violation|1
5826910|NCT02497612|20130301|P4|Overall Study|Not eligible|1
5826911|NCT02497612|20130302|P3|Overall Study|Not eligible|0
5826912|NCT02497612|20130303|P2|Overall Study|Not eligible|0
5826913|NCT02497612|20130304|P1|Overall Study|Not eligible|1
5826914|NCT02497612|20130301|P4|Overall Study|Other unspecified|0
5826915|NCT02497612|20130302|P3|Overall Study|Other unspecified|2
5826916|NCT02497612|20130303|P2|Overall Study|Other unspecified|1
5826917|NCT02497612|20130304|P1|Overall Study|Other unspecified|1
5826918|NCT02497612|20130301|P4|Overall Study|Lost to Follow-up|1
5826919|NCT02497612|20130302|P3|Overall Study|Lost to Follow-up|0
5826920|NCT02497612|20130303|P2|Overall Study|Lost to Follow-up|1
5826921|NCT02497612|20130304|P1|Overall Study|Lost to Follow-up|1
5826922|NCT02497612|20130301|P4|Overall Study|Adverse Event|1
5826923|NCT02497612|20130302|P3|Overall Study|Adverse Event|4
5826924|NCT02497612|20130303|P2|Overall Study|Adverse Event|1
5826925|NCT02497612|20130304|P1|Overall Study|Adverse Event|3
5826926|NCT02497612|20130301|P4|Overall Study|Investigator's judgement|2
5826927|NCT02497612|20130302|P3|Overall Study|Investigator's judgement|0
5826928|NCT02497612|20130303|P2|Overall Study|Investigator's judgement|0
5826929|NCT02497612|20130304|P1|Overall Study|Investigator's judgement|1
5826930|NCT02497612|20130301|P4|Overall Study|Participant's request|1
5826931|NCT02497612|20130302|P3|Overall Study|Participant's request|4
5826932|NCT02497612|20130303|P2|Overall Study|Participant's request|3
5826933|NCT02497612|20130304|P1|Overall Study|Participant's request|2
5826934|NCT02497612|20130301|P4|Overall Study|Met >=1 anti-malarial treatment criteria|41
5826935|NCT02497612|20130302|P3|Overall Study|Met >=1 anti-malarial treatment criteria|39
5826936|NCT02497612|20130303|P2|Overall Study|Met >=1 anti-malarial treatment criteria|51
5826937|NCT02497612|20130304|P1|Overall Study|Met >=1 anti-malarial treatment criteria|57
5826938|NCT02497469|20130432|P2|Overall Study|Reason not Specified|6
5826939|NCT02497469|20130433|P1|Overall Study|Reason not Specified|6
5826940|NCT02497469|20130432|P2|Overall Study|Lack of Efficacy|40
5826941|NCT02497469|20130433|P1|Overall Study|Lack of Efficacy|86
5826942|NCT02497469|20130432|P2|Overall Study|Pregnancy|1
5826943|NCT02497469|20130433|P1|Overall Study|Pregnancy|1
5826944|NCT02497469|20130432|P2|Overall Study|Voluntary Withdrawal|41
5826945|NCT02497469|20130433|P1|Overall Study|Voluntary Withdrawal|39
5826946|NCT02497469|20130432|P2|Overall Study|Lost to Follow-up|4
5826947|NCT02497469|20130433|P1|Overall Study|Lost to Follow-up|14
5826948|NCT02497469|20130432|P2|Overall Study|Significant Protocol Deviation|5
5826949|NCT02497469|20130433|P1|Overall Study|Significant Protocol Deviation|4
5826950|NCT02497469|20130432|P2|Overall Study|Leukopenia or Lymphopenia|0
5826951|NCT02497469|20130433|P1|Overall Study|Leukopenia or Lymphopenia|1
5826952|NCT02497469|20130432|P2|Overall Study|Pretreatment Event/Adverse Event|16
5826953|NCT02497469|20130433|P1|Overall Study|Pretreatment Event/Adverse Event|18
5826954|NCT02497469|20130432|P2|Overall Study|Randomized but not Treated|2
5826955|NCT02497469|20130433|P1|Overall Study|Randomized but not Treated|0
5826956|NCT02497391|20130443|P6|Period 3 (14 Days)|Withdrawal by Subject|0
5826957|NCT02497391|20130444|P5|Period 3 (14 Days)|Withdrawal by Subject|0
5826958|NCT02497391|20130445|P4|Period 3 (14 Days)|Withdrawal by Subject|0
5826959|NCT02497391|20130446|P3|Period 3 (14 Days)|Withdrawal by Subject|1
5826960|NCT02497391|20130447|P2|Period 3 (14 Days)|Withdrawal by Subject|0
5826961|NCT02497391|20130448|P1|Period 3 (14 Days)|Withdrawal by Subject|0
5826962|NCT02497391|20130443|P6|Period 3 (14 Days)|Sponsor Decision|0
5826963|NCT02497391|20130444|P5|Period 3 (14 Days)|Sponsor Decision|1
5826964|NCT02497391|20130445|P4|Period 3 (14 Days)|Sponsor Decision|0
5826965|NCT02497391|20130446|P3|Period 3 (14 Days)|Sponsor Decision|0
5826966|NCT02497391|20130447|P2|Period 3 (14 Days)|Sponsor Decision|0
5826967|NCT02497391|20130448|P1|Period 3 (14 Days)|Sponsor Decision|0
5826968|NCT02497391|20130443|P6|Period 3 (14 Days)|Adverse Event|0
5826969|NCT02497391|20130444|P5|Period 3 (14 Days)|Adverse Event|0
5826970|NCT02497391|20130445|P4|Period 3 (14 Days)|Adverse Event|0
5826971|NCT02497391|20130446|P3|Period 3 (14 Days)|Adverse Event|0
5826972|NCT02497391|20130447|P2|Period 3 (14 Days)|Adverse Event|1
5826973|NCT02497391|20130448|P1|Period 3 (14 Days)|Adverse Event|0
5826974|NCT02497391|20130443|P6|Period 2 (14 Days)|Sponsor Decision|3
5826975|NCT02497391|20130444|P5|Period 2 (14 Days)|Sponsor Decision|2
5826976|NCT02497391|20130445|P4|Period 2 (14 Days)|Sponsor Decision|3
5826977|NCT02497391|20130446|P3|Period 2 (14 Days)|Sponsor Decision|2
5826978|NCT02497391|20130447|P2|Period 2 (14 Days)|Sponsor Decision|1
5826979|NCT02497391|20130448|P1|Period 2 (14 Days)|Sponsor Decision|3
5826980|NCT02497391|20130443|P6|Period 2 (14 Days)|Withdrawal by Subject|0
5826981|NCT02497391|20130444|P5|Period 2 (14 Days)|Withdrawal by Subject|0
5826982|NCT02497391|20130445|P4|Period 2 (14 Days)|Withdrawal by Subject|0
5826983|NCT02497391|20130446|P3|Period 2 (14 Days)|Withdrawal by Subject|1
5826984|NCT02497391|20130447|P2|Period 2 (14 Days)|Withdrawal by Subject|0
5826985|NCT02497391|20130448|P1|Period 2 (14 Days)|Withdrawal by Subject|1
5826986|NCT02497287|20130459|P1|Follow-up Phase (4 Week)|Other|1
5826987|NCT02497287|20130459|P1|Follow-up Phase (4 Week)|Adverse Event|3
5826988|NCT02497287|20130459|P1|Follow-up Phase (4 Week)|Lost to Follow-up|5
5826989|NCT02497287|20130459|P1|Follow-up Phase (4 Week)|Withdrawal by Subject|10
5826990|NCT02497287|20130459|P1|Follow-up Phase (4 Week)|PI Decision|12
5826991|NCT02497287|20130459|P1|Optimization/Maintenance (48 Weeks)|Non-Compliance with Study Drug|1
5826992|NCT02497287|20130459|P1|Optimization/Maintenance (48 Weeks)|Death|2
5826993|NCT02497287|20130459|P1|Optimization/Maintenance (48 Weeks)|Pregnancy|2
5826994|NCT02497287|20130459|P1|Optimization/Maintenance (48 Weeks)|Missed Assessment or Treatment Sessions|3
5826995|NCT02497287|20130459|P1|Optimization/Maintenance (48 Weeks)|Protocol Violation|3
5826996|NCT02497287|20130459|P1|Optimization/Maintenance (48 Weeks)|Lost to Follow-up|10
5826997|NCT02497287|20130459|P1|Optimization/Maintenance (48 Weeks)|Other|21
5826998|NCT02497287|20130459|P1|Optimization/Maintenance (48 Weeks)|Lack of Efficacy|25
5826999|NCT02497287|20130459|P1|Optimization/Maintenance (48 Weeks)|Adverse Event|25
5827000|NCT02497287|20130459|P1|Optimization/Maintenance (48 Weeks)|Withdrawal by Subject|30
5827001|NCT02497287|20130459|P1|Optimization/Maintenance (48 Weeks)|Study Terminated by Sponsor|331
5827002|NCT02497287|20130459|P1|Induction Phase (4 Weeks)|Non-Compliance with Study Drug|1
5827003|NCT02497287|20130459|P1|Induction Phase (4 Weeks)|Protocol Violation|1
5827004|NCT02497287|20130459|P1|Induction Phase (4 Weeks)|Lost to Follow-up|5
5827005|NCT02497287|20130459|P1|Induction Phase (4 Weeks)|Other|13
5827006|NCT02497287|20130459|P1|Induction Phase (4 Weeks)|Lack of Efficacy|21
5827007|NCT02497287|20130459|P1|Induction Phase (4 Weeks)|Withdrawal by Subject|22
5827008|NCT02497287|20130459|P1|Induction Phase (4 Weeks)|Adverse Event|52
5827009|NCT02497287|20130459|P1|Induction Phase (4 Weeks)|Did Not Met Criteria for OP/MA Phase|84
5827010|NCT02497001|20130554|P4|Overall Study|Protocol Violation|1
5827011|NCT02497001|20130555|P3|Overall Study|Protocol Violation|3
5827012|NCT02497001|20130556|P2|Overall Study|Protocol Violation|1
5827013|NCT02497001|20130557|P1|Overall Study|Protocol Violation|3
5827014|NCT02497001|20130554|P4|Overall Study|Lack of Efficacy|6
5827015|NCT02497001|20130555|P3|Overall Study|Lack of Efficacy|6
5827016|NCT02497001|20130556|P2|Overall Study|Lack of Efficacy|16
5827017|NCT02497001|20130557|P1|Overall Study|Lack of Efficacy|10
5827018|NCT02497001|20130554|P4|Overall Study|Major Protocol Deviation|4
5827019|NCT02497001|20130555|P3|Overall Study|Major Protocol Deviation|4
5827020|NCT02497001|20130556|P2|Overall Study|Major Protocol Deviation|4
5827021|NCT02497001|20130557|P1|Overall Study|Major Protocol Deviation|3
5827022|NCT02497001|20130554|P4|Overall Study|subjects that were not treated|1
5827023|NCT02497001|20130555|P3|Overall Study|subjects that were not treated|2
5827024|NCT02497001|20130556|P2|Overall Study|subjects that were not treated|2
5827025|NCT02497001|20130557|P1|Overall Study|subjects that were not treated|1
5827026|NCT02497001|20130554|P4|Overall Study|Physician Decision|1
5827027|NCT02497001|20130555|P3|Overall Study|Physician Decision|5
5827028|NCT02497001|20130556|P2|Overall Study|Physician Decision|11
5827029|NCT02497001|20130557|P1|Overall Study|Physician Decision|5
5827030|NCT02497001|20130554|P4|Overall Study|Withdrawal by Subject|15
5827031|NCT02497001|20130555|P3|Overall Study|Withdrawal by Subject|19
5827032|NCT02497001|20130556|P2|Overall Study|Withdrawal by Subject|37
5827033|NCT02497001|20130557|P1|Overall Study|Withdrawal by Subject|14
5827034|NCT02497001|20130554|P4|Overall Study|Adverse Event|11
5827035|NCT02497001|20130555|P3|Overall Study|Adverse Event|11
5827036|NCT02497001|20130556|P2|Overall Study|Adverse Event|30
5827037|NCT02497001|20130557|P1|Overall Study|Adverse Event|28
5827038|NCT02497001|20130554|P4|Overall Study|Lost to Follow-up|2
5827039|NCT02497001|20130555|P3|Overall Study|Lost to Follow-up|0
5827040|NCT02497001|20130556|P2|Overall Study|Lost to Follow-up|2
5827041|NCT02497001|20130557|P1|Overall Study|Lost to Follow-up|10
5827042|NCT02496884|20130618|P4|Overall Study|Withdrawal by Subject|0
5827043|NCT02496884|20130619|P3|Overall Study|Withdrawal by Subject|0
5827044|NCT02496884|20130620|P2|Overall Study|Withdrawal by Subject|3
5827045|NCT02496884|20130621|P1|Overall Study|Withdrawal by Subject|0
5827046|NCT02496884|20130618|P4|Overall Study|Counted twice as enrolled|0
5827047|NCT02496884|20130619|P3|Overall Study|Counted twice as enrolled|0
5827048|NCT02496884|20130620|P2|Overall Study|Counted twice as enrolled|0
5827049|NCT02496884|20130621|P1|Overall Study|Counted twice as enrolled|2
5827050|NCT02496767|20130647|P8|Double-blind, Withdrawal Phase|Withdrawal by Subject|1
5827051|NCT02496767|20130648|P7|Double-blind, Withdrawal Phase|Withdrawal by Subject|1
5827052|NCT02496767|20130649|P6|Double-blind, Withdrawal Phase|Withdrawal by Subject|1
5827053|NCT02496767|20130650|P5|Double-blind, Withdrawal Phase|Withdrawal by Subject|0
5827054|NCT02496767|20130651|P4|Double-blind, Withdrawal Phase|Withdrawal by Subject|0
5827055|NCT02496767|20130652|P3|Double-blind, Withdrawal Phase|Withdrawal by Subject|0
5827056|NCT02496767|20130653|P2|Double-blind, Withdrawal Phase|Withdrawal by Subject|0
5827057|NCT02496767|20130654|P1|Double-blind, Withdrawal Phase|Withdrawal by Subject|0
5827058|NCT02496767|20130647|P8|Double-blind, Withdrawal Phase|Death|2
5827059|NCT02496767|20130648|P7|Double-blind, Withdrawal Phase|Death|1
5827060|NCT02496767|20130649|P6|Double-blind, Withdrawal Phase|Death|0
5827061|NCT02496767|20130650|P5|Double-blind, Withdrawal Phase|Death|0
5827062|NCT02496767|20130651|P4|Double-blind, Withdrawal Phase|Death|0
5827063|NCT02496767|20130652|P3|Double-blind, Withdrawal Phase|Death|0
5827064|NCT02496767|20130653|P2|Double-blind, Withdrawal Phase|Death|0
5827065|NCT02496767|20130654|P1|Double-blind, Withdrawal Phase|Death|0
5827066|NCT02496767|20130647|P8|Double-blind, Withdrawal Phase|Adverse Event|1
5827067|NCT02496767|20130648|P7|Double-blind, Withdrawal Phase|Adverse Event|2
5827068|NCT02496767|20130649|P6|Double-blind, Withdrawal Phase|Adverse Event|1
5827069|NCT02496767|20130650|P5|Double-blind, Withdrawal Phase|Adverse Event|0
5827070|NCT02496767|20130651|P4|Double-blind, Withdrawal Phase|Adverse Event|0
5827071|NCT02496767|20130652|P3|Double-blind, Withdrawal Phase|Adverse Event|0
5827072|NCT02496767|20130653|P2|Double-blind, Withdrawal Phase|Adverse Event|0
5827073|NCT02496767|20130654|P1|Double-blind, Withdrawal Phase|Adverse Event|0
5827074|NCT02496767|20130647|P8|Double-blind, Withdrawal Phase|Progressive disease|1
5827075|NCT02496767|20130648|P7|Double-blind, Withdrawal Phase|Progressive disease|0
5827076|NCT02496767|20130649|P6|Double-blind, Withdrawal Phase|Progressive disease|4
5827077|NCT02496767|20130650|P5|Double-blind, Withdrawal Phase|Progressive disease|0
5827078|NCT02496767|20130651|P4|Double-blind, Withdrawal Phase|Progressive disease|0
5827079|NCT02496767|20130652|P3|Double-blind, Withdrawal Phase|Progressive disease|0
5827080|NCT02496767|20130653|P2|Double-blind, Withdrawal Phase|Progressive disease|0
5827081|NCT02496767|20130654|P1|Double-blind, Withdrawal Phase|Progressive disease|0
5827082|NCT02496767|20130647|P8|Double-blind, Placebo-controlled Phase|Protocol Violation|0
5827083|NCT02496767|20130648|P7|Double-blind, Placebo-controlled Phase|Protocol Violation|0
5827084|NCT02496767|20130649|P6|Double-blind, Placebo-controlled Phase|Protocol Violation|0
5827085|NCT02496767|20130650|P5|Double-blind, Placebo-controlled Phase|Protocol Violation|0
5827086|NCT02496767|20130651|P4|Double-blind, Placebo-controlled Phase|Protocol Violation|0
5827087|NCT02496767|20130652|P3|Double-blind, Placebo-controlled Phase|Protocol Violation|0
5827088|NCT02496767|20130653|P2|Double-blind, Placebo-controlled Phase|Protocol Violation|1
5827089|NCT02496767|20130654|P1|Double-blind, Placebo-controlled Phase|Protocol Violation|0
5827090|NCT02496767|20130647|P8|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
5827091|NCT02496767|20130648|P7|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
5827092|NCT02496767|20130649|P6|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
5827093|NCT02496767|20130650|P5|Double-blind, Placebo-controlled Phase|Lost to Follow-up|1
5827094|NCT02496767|20130651|P4|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2
5827095|NCT02496767|20130652|P3|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
5827096|NCT02496767|20130653|P2|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2
5827097|NCT02496767|20130654|P1|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
5827098|NCT02496767|20130647|P8|Double-blind, Placebo-controlled Phase|Physician Decision|0
5827099|NCT02496767|20130648|P7|Double-blind, Placebo-controlled Phase|Physician Decision|0
5827100|NCT02496767|20130649|P6|Double-blind, Placebo-controlled Phase|Physician Decision|0
5827101|NCT02496767|20130650|P5|Double-blind, Placebo-controlled Phase|Physician Decision|0
5827102|NCT02496767|20130651|P4|Double-blind, Placebo-controlled Phase|Physician Decision|0
5827103|NCT02496767|20130652|P3|Double-blind, Placebo-controlled Phase|Physician Decision|1
5827104|NCT02496767|20130653|P2|Double-blind, Placebo-controlled Phase|Physician Decision|4
5827105|NCT02496767|20130654|P1|Double-blind, Placebo-controlled Phase|Physician Decision|0
5827106|NCT02496767|20130647|P8|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0
5827107|NCT02496767|20130648|P7|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0
5827108|NCT02496767|20130649|P6|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0
5827109|NCT02496767|20130650|P5|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|2
5827110|NCT02496767|20130651|P4|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|1
5827111|NCT02496767|20130652|P3|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|3
5827112|NCT02496767|20130653|P2|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|4
5827113|NCT02496767|20130654|P1|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0
5827114|NCT02496767|20130647|P8|Double-blind, Placebo-controlled Phase|Various|0
5827115|NCT02496767|20130648|P7|Double-blind, Placebo-controlled Phase|Various|0
5827116|NCT02496767|20130649|P6|Double-blind, Placebo-controlled Phase|Various|0
5827117|NCT02496767|20130650|P5|Double-blind, Placebo-controlled Phase|Various|2
5827118|NCT02496767|20130651|P4|Double-blind, Placebo-controlled Phase|Various|5
5827119|NCT02496767|20130652|P3|Double-blind, Placebo-controlled Phase|Various|4
5827120|NCT02496767|20130653|P2|Double-blind, Placebo-controlled Phase|Various|9
5827121|NCT02496767|20130654|P1|Double-blind, Placebo-controlled Phase|Various|0
5827122|NCT02496767|20130647|P8|Double-blind, Placebo-controlled Phase|Death|0
5827123|NCT02496767|20130648|P7|Double-blind, Placebo-controlled Phase|Death|0
5827124|NCT02496767|20130649|P6|Double-blind, Placebo-controlled Phase|Death|0
5827125|NCT02496767|20130650|P5|Double-blind, Placebo-controlled Phase|Death|4
5827126|NCT02496767|20130651|P4|Double-blind, Placebo-controlled Phase|Death|2
5827127|NCT02496767|20130652|P3|Double-blind, Placebo-controlled Phase|Death|6
5827128|NCT02496767|20130653|P2|Double-blind, Placebo-controlled Phase|Death|10
5827129|NCT02496767|20130654|P1|Double-blind, Placebo-controlled Phase|Death|0
5827130|NCT02496767|20130647|P8|Double-blind, Placebo-controlled Phase|Progressive disease|0
5827131|NCT02496767|20130648|P7|Double-blind, Placebo-controlled Phase|Progressive disease|0
5827132|NCT02496767|20130649|P6|Double-blind, Placebo-controlled Phase|Progressive disease|0
5827133|NCT02496767|20130650|P5|Double-blind, Placebo-controlled Phase|Progressive disease|14
5827134|NCT02496767|20130651|P4|Double-blind, Placebo-controlled Phase|Progressive disease|8
5827135|NCT02496767|20130652|P3|Double-blind, Placebo-controlled Phase|Progressive disease|9
5827136|NCT02496767|20130653|P2|Double-blind, Placebo-controlled Phase|Progressive disease|13
5827137|NCT02496767|20130654|P1|Double-blind, Placebo-controlled Phase|Progressive disease|0
5827138|NCT02496767|20130647|P8|Double-blind, Placebo-controlled Phase|Adverse Event|0
5827139|NCT02496767|20130648|P7|Double-blind, Placebo-controlled Phase|Adverse Event|0
5827140|NCT02496767|20130649|P6|Double-blind, Placebo-controlled Phase|Adverse Event|0
5827141|NCT02496767|20130650|P5|Double-blind, Placebo-controlled Phase|Adverse Event|43
5827142|NCT02496767|20130651|P4|Double-blind, Placebo-controlled Phase|Adverse Event|43
5827143|NCT02496767|20130652|P3|Double-blind, Placebo-controlled Phase|Adverse Event|23
5827144|NCT02496767|20130653|P2|Double-blind, Placebo-controlled Phase|Adverse Event|13
5827145|NCT02496767|20130654|P1|Double-blind, Placebo-controlled Phase|Adverse Event|0
5827146|NCT02496767|20130647|P8|Open-label Lead-in Phase|Lost to Follow-up|0
5827147|NCT02496767|20130648|P7|Open-label Lead-in Phase|Lost to Follow-up|0
5827148|NCT02496767|20130649|P6|Open-label Lead-in Phase|Lost to Follow-up|0
5827149|NCT02496767|20130650|P5|Open-label Lead-in Phase|Lost to Follow-up|0
5827150|NCT02496767|20130651|P4|Open-label Lead-in Phase|Lost to Follow-up|0
5827151|NCT02496767|20130652|P3|Open-label Lead-in Phase|Lost to Follow-up|0
5827152|NCT02496767|20130653|P2|Open-label Lead-in Phase|Lost to Follow-up|0
5827153|NCT02496767|20130654|P1|Open-label Lead-in Phase|Lost to Follow-up|1
5827154|NCT02496767|20130647|P8|Open-label Lead-in Phase|Protocol Violation|0
5827155|NCT02496767|20130648|P7|Open-label Lead-in Phase|Protocol Violation|0
5827156|NCT02496767|20130649|P6|Open-label Lead-in Phase|Protocol Violation|0
5827157|NCT02496767|20130650|P5|Open-label Lead-in Phase|Protocol Violation|0
5827158|NCT02496767|20130651|P4|Open-label Lead-in Phase|Protocol Violation|0
5827159|NCT02496767|20130652|P3|Open-label Lead-in Phase|Protocol Violation|0
5827160|NCT02496767|20130653|P2|Open-label Lead-in Phase|Protocol Violation|0
5827161|NCT02496767|20130654|P1|Open-label Lead-in Phase|Protocol Violation|2
5827162|NCT02496767|20130647|P8|Open-label Lead-in Phase|Adverse Event|0
5827163|NCT02496767|20130648|P7|Open-label Lead-in Phase|Adverse Event|0
5827164|NCT02496767|20130649|P6|Open-label Lead-in Phase|Adverse Event|0
5827165|NCT02496767|20130650|P5|Open-label Lead-in Phase|Adverse Event|0
5827166|NCT02496767|20130651|P4|Open-label Lead-in Phase|Adverse Event|0
5827167|NCT02496767|20130652|P3|Open-label Lead-in Phase|Adverse Event|0
5827168|NCT02496767|20130653|P2|Open-label Lead-in Phase|Adverse Event|0
5827169|NCT02496767|20130654|P1|Open-label Lead-in Phase|Adverse Event|176
5827170|NCT02496702|20130694|P2|Overall Study|Only partially tested|2
5827171|NCT02496702|20130695|P1|Overall Study|Only partially tested|0
5827172|NCT02496702|20130694|P2|Overall Study|Lost to Follow-up|6
5827173|NCT02496702|20130695|P1|Overall Study|Lost to Follow-up|8
5827174|NCT02496533|20130717|P2|Overall Study|Late for radiologic testing|2
5827175|NCT02496533|20130718|P1|Overall Study|Late for radiologic testing|0
5827176|NCT02496533|20130717|P2|Overall Study|Patient did not complete all measures|4
5827177|NCT02496533|20130718|P1|Overall Study|Patient did not complete all measures|0
5827178|NCT02496533|20130717|P2|Overall Study|Lack of data on outcome|0
5827179|NCT02496533|20130718|P1|Overall Study|Lack of data on outcome|3
5827180|NCT02496221|20130730|P2|Treatment Period 2 - 4 Days|Physician Decision|0
5827181|NCT02496221|20130731|P1|Treatment Period 2 - 4 Days|Physician Decision|1
5827182|NCT02496221|20130730|P2|Treatment Period 2 - 4 Days|Protocol Violation|0
5827183|NCT02496221|20130731|P1|Treatment Period 2 - 4 Days|Protocol Violation|1
5827184|NCT02496221|20130730|P2|Treatment Period 2 - 4 Days|Adverse Event|1
5827185|NCT02496221|20130731|P1|Treatment Period 2 - 4 Days|Adverse Event|0
5827186|NCT02496091|20130765|P1|Overall Study|Eligibility criteria not fulfilled|2
5827187|NCT02496039|20130774|P1|Overall Study|Protocol Violation|1
5827188|NCT02496039|20130774|P1|Overall Study|Adverse Event|3
5827189|NCT02496000|20130789|P3|Overall Study|undetermined|0
5827190|NCT02496000|20130790|P2|Overall Study|undetermined|1
5827191|NCT02496000|20130791|P1|Overall Study|undetermined|0
5827192|NCT02496000|20130789|P3|Overall Study|Non-compliance or lack of cooperation|0
5827193|NCT02496000|20130790|P2|Overall Study|Non-compliance or lack of cooperation|2
5827194|NCT02496000|20130791|P1|Overall Study|Non-compliance or lack of cooperation|0
5827195|NCT02496000|20130789|P3|Overall Study|Protocol Violation|1
5827196|NCT02496000|20130790|P2|Overall Study|Protocol Violation|0
5827197|NCT02496000|20130791|P1|Overall Study|Protocol Violation|0
5827198|NCT02496000|20130789|P3|Overall Study|Lost to Follow-up|1
5827199|NCT02496000|20130790|P2|Overall Study|Lost to Follow-up|0
5827200|NCT02496000|20130791|P1|Overall Study|Lost to Follow-up|1
5827201|NCT02496000|20130789|P3|Overall Study|Withdrawal by Subject|0
5827202|NCT02496000|20130790|P2|Overall Study|Withdrawal by Subject|2
5827203|NCT02496000|20130791|P1|Overall Study|Withdrawal by Subject|1
5827204|NCT02495948|20130812|P2|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1
5827205|NCT02495948|20130813|P1|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1
5827206|NCT02495948|20130812|P2|Period 1, First 30 Days of Wear|Adverse Event|1
5827207|NCT02495948|20130813|P1|Period 1, First 30 Days of Wear|Adverse Event|0
5827208|NCT02495883|20130822|P2|Overall Study|Excessive head motion|0
5827209|NCT02495883|20130823|P1|Overall Study|Excessive head motion|1
5827210|NCT02495857|20130831|P3|Overall Study|Other|2
5827211|NCT02495857|20130832|P2|Overall Study|Other|3
5827212|NCT02495857|20130833|P1|Overall Study|Other|3
5827213|NCT02495857|20130831|P3|Overall Study|Lost to Follow-up|3
5827214|NCT02495857|20130832|P2|Overall Study|Lost to Follow-up|5
5827215|NCT02495857|20130833|P1|Overall Study|Lost to Follow-up|4
5827216|NCT02495857|20130831|P3|Overall Study|Protocol Violation|2
5827217|NCT02495857|20130832|P2|Overall Study|Protocol Violation|1
5827218|NCT02495857|20130833|P1|Overall Study|Protocol Violation|1
5827219|NCT02495857|20130831|P3|Overall Study|Physician Decision|0
5827220|NCT02495857|20130832|P2|Overall Study|Physician Decision|1
5827221|NCT02495857|20130833|P1|Overall Study|Physician Decision|0
5827222|NCT02495857|20130831|P3|Overall Study|Withdrawal by Subject|10
5827223|NCT02495857|20130832|P2|Overall Study|Withdrawal by Subject|6
5827224|NCT02495857|20130833|P1|Overall Study|Withdrawal by Subject|9
5827225|NCT02495857|20130831|P3|Overall Study|Adverse Event|1
5827226|NCT02495857|20130832|P2|Overall Study|Adverse Event|0
5827227|NCT02495857|20130833|P1|Overall Study|Adverse Event|5
5827228|NCT02495844|20130849|P2|Overall Study|Hepatitis Positivity|1
5827229|NCT02495844|20130850|P1|Overall Study|Hepatitis Positivity|0
5827230|NCT02495844|20130849|P2|Overall Study|AE, non-fatal|1
5827231|NCT02495844|20130850|P1|Overall Study|AE, non-fatal|0
5827232|NCT02495844|20130849|P2|Overall Study|Lack of Efficacy|2
5827233|NCT02495844|20130850|P1|Overall Study|Lack of Efficacy|1
5827234|NCT02495389|20130952|P1|Overall Study|Withdrawal by Subject|40
5827235|NCT02495233|20130990|P2|Overall Study|Miscellaneous|1
5827236|NCT02495233|20130991|P1|Overall Study|Miscellaneous|0
5827237|NCT02495168|20131020|P3|Overall Study|Lack of Efficacy|3
5827238|NCT02495168|20131021|P2|Overall Study|Lack of Efficacy|0
5827239|NCT02495168|20131022|P1|Overall Study|Lack of Efficacy|0
5827240|NCT02495168|20131020|P3|Overall Study|Adverse Event|3
5827241|NCT02495168|20131021|P2|Overall Study|Adverse Event|8
5827242|NCT02495168|20131022|P1|Overall Study|Adverse Event|4
5827243|NCT02495168|20131020|P3|Overall Study|Protocol Violation|1
5827244|NCT02495168|20131021|P2|Overall Study|Protocol Violation|10
5827245|NCT02495168|20131022|P1|Overall Study|Protocol Violation|0
5827246|NCT02495168|20131020|P3|Overall Study|Withdrawal by Subject|2
5827247|NCT02495168|20131021|P2|Overall Study|Withdrawal by Subject|4
5827248|NCT02495168|20131022|P1|Overall Study|Withdrawal by Subject|1
5827249|NCT02495168|20131020|P3|Overall Study|Lost to Follow-up|1
5827250|NCT02495168|20131021|P2|Overall Study|Lost to Follow-up|6
5827251|NCT02495168|20131022|P1|Overall Study|Lost to Follow-up|10
5827252|NCT02495168|20131020|P3|Overall Study|Physician Decision|0
5827253|NCT02495168|20131021|P2|Overall Study|Physician Decision|1
5827254|NCT02495168|20131022|P1|Overall Study|Physician Decision|1
5827255|NCT02495168|20131020|P3|Overall Study|Did not Complete Final Visit On Time|2
5827256|NCT02495168|20131021|P2|Overall Study|Did not Complete Final Visit On Time|3
5827257|NCT02495168|20131022|P1|Overall Study|Did not Complete Final Visit On Time|4
5827258|NCT02495168|20131020|P3|Overall Study|Other than Specified|5
5827259|NCT02495168|20131021|P2|Overall Study|Other than Specified|22
5827260|NCT02495168|20131022|P1|Overall Study|Other than Specified|18
5827261|NCT02495025|20131096|P2|Overall Study|Withdrawal by Subject|0
5827262|NCT02495025|20131097|P1|Overall Study|Withdrawal by Subject|5
5827263|NCT02495025|20131096|P2|Overall Study|Lost to Follow-up|14
5827264|NCT02495025|20131097|P1|Overall Study|Lost to Follow-up|21
5827265|NCT02494596|20131149|P3|Overall Study|Refused Treatment|0
5827266|NCT02494596|20131150|P2|Overall Study|Refused Treatment|1
5827267|NCT02494596|20131151|P1|Overall Study|Refused Treatment|0
5827268|NCT02494596|20131149|P3|Overall Study|Adverse Event|0
5827269|NCT02494596|20131150|P2|Overall Study|Adverse Event|1
5827270|NCT02494596|20131151|P1|Overall Study|Adverse Event|0
5827271|NCT02494596|20131149|P3|Overall Study|Insufficient Therapeutic Response|1
5827272|NCT02494596|20131150|P2|Overall Study|Insufficient Therapeutic Response|3
5827273|NCT02494596|20131151|P1|Overall Study|Insufficient Therapeutic Response|3
5827274|NCT02494583|20131179|P3|Overall Study|Ongoing in Study|34
5827275|NCT02494583|20131180|P2|Overall Study|Ongoing in Study|51
5827276|NCT02494583|20131181|P1|Overall Study|Ongoing in Study|56
5827277|NCT02494583|20131179|P3|Overall Study|Withdrawal by Subject|15
5827278|NCT02494583|20131180|P2|Overall Study|Withdrawal by Subject|15
5827279|NCT02494583|20131181|P1|Overall Study|Withdrawal by Subject|3
5827280|NCT02494583|20131179|P3|Overall Study|Protocol Violation|0
5827281|NCT02494583|20131180|P2|Overall Study|Protocol Violation|2
5827282|NCT02494583|20131181|P1|Overall Study|Protocol Violation|1
5827283|NCT02494583|20131179|P3|Overall Study|Lost to Follow-up|0
5827284|NCT02494583|20131180|P2|Overall Study|Lost to Follow-up|0
5827285|NCT02494583|20131181|P1|Overall Study|Lost to Follow-up|1
5827286|NCT02494583|20131179|P3|Overall Study|Death|201
5827287|NCT02494583|20131180|P2|Overall Study|Death|189
5827288|NCT02494583|20131181|P1|Overall Study|Death|195
5827289|NCT02494401|20131279|P2|Overall Study|Withdrawal by Subject|2
5827290|NCT02494401|20131280|P1|Overall Study|Withdrawal by Subject|3
5827291|NCT02494401|20131279|P2|Overall Study|Lost to Follow-up|25
5827292|NCT02494401|20131280|P1|Overall Study|Lost to Follow-up|22
5827293|NCT02494206|20131344|P1|Overall Study|Disease Progression|1
5827294|NCT02494206|20131344|P1|Overall Study|Adverse Event|1
5827295|NCT02493946|20131398|P3|Open Label Period|Site error|1
5827296|NCT02493946|20131399|P2|Open Label Period|Site error|0
5827297|NCT02493946|20131400|P1|Open Label Period|Site error|0
5827298|NCT02493946|20131398|P3|Open Label Period|Pregnancy|3
5827299|NCT02493946|20131399|P2|Open Label Period|Pregnancy|0
5827300|NCT02493946|20131400|P1|Open Label Period|Pregnancy|0
5827301|NCT02493946|20131398|P3|Open Label Period|Investigator decision, non-availability|1
5827302|NCT02493946|20131399|P2|Open Label Period|Investigator decision, non-availability|0
5827303|NCT02493946|20131400|P1|Open Label Period|Investigator decision, non-availability|0
5827304|NCT02493946|20131398|P3|Open Label Period|Investigator decision, non-compliance|2
5827305|NCT02493946|20131399|P2|Open Label Period|Investigator decision, non-compliance|0
5827306|NCT02493946|20131400|P1|Open Label Period|Investigator decision, non-compliance|0
5827307|NCT02493946|20131398|P3|Open Label Period|Lost to Follow-up|1
5827308|NCT02493946|20131399|P2|Open Label Period|Lost to Follow-up|0
5827309|NCT02493946|20131400|P1|Open Label Period|Lost to Follow-up|0
5827310|NCT02493946|20131398|P3|Open Label Period|Adverse Event|4
5827311|NCT02493946|20131399|P2|Open Label Period|Adverse Event|0
5827312|NCT02493946|20131400|P1|Open Label Period|Adverse Event|0
5827313|NCT02493946|20131398|P3|Open Label Period|Withdrawal by Subject|74
5827314|NCT02493946|20131399|P2|Open Label Period|Withdrawal by Subject|0
5827315|NCT02493946|20131400|P1|Open Label Period|Withdrawal by Subject|0
5827316|NCT02493946|20131398|P3|DB Period|Withdrawal by Subject|0
5827317|NCT02493946|20131399|P2|DB Period|Withdrawal by Subject|5
5827318|NCT02493946|20131400|P1|DB Period|Withdrawal by Subject|8
5827319|NCT02493868|20131433|P2|Follow-up Phase|Other|1
5827320|NCT02493868|20131434|P1|Follow-up Phase|Other|2
5827321|NCT02493868|20131433|P2|Follow-up Phase|Investigator Decision|1
5827322|NCT02493868|20131434|P1|Follow-up Phase|Investigator Decision|5
5827323|NCT02493868|20131433|P2|Follow-up Phase|Withdrawal by Subject|0
5827324|NCT02493868|20131434|P1|Follow-up Phase|Withdrawal by Subject|3
5827325|NCT02493868|20131433|P2|Follow-up Phase|Lost to Follow-up|0
5827326|NCT02493868|20131434|P1|Follow-up Phase|Lost to Follow-up|1
5827327|NCT02493868|20131433|P2|Maintenance Phase: DE+TE Participants|Other|9
5827328|NCT02493868|20131434|P1|Maintenance Phase: DE+TE Participants|Other|4
5827329|NCT02493868|20131433|P2|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|1
5827330|NCT02493868|20131434|P1|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|0
5827331|NCT02493868|20131433|P2|Maintenance Phase: DE+TE Participants|Pregnancy|0
5827332|NCT02493868|20131434|P1|Maintenance Phase: DE+TE Participants|Pregnancy|1
5827333|NCT02493868|20131433|P2|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|7
5827334|NCT02493868|20131434|P1|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|5
5827335|NCT02493868|20131433|P2|Maintenance Phase: DE+TE Participants|Protocol Violation|1
5827336|NCT02493868|20131434|P1|Maintenance Phase: DE+TE Participants|Protocol Violation|1
5827337|NCT02493868|20131433|P2|Maintenance Phase: DE+TE Participants|Lost to Follow-up|0
5827338|NCT02493868|20131434|P1|Maintenance Phase: DE+TE Participants|Lost to Follow-up|1
5827339|NCT02493868|20131433|P2|Maintenance Phase: DE+TE Participants|Adverse Event|4
5827340|NCT02493868|20131434|P1|Maintenance Phase: DE+TE Participants|Adverse Event|1
5827341|NCT02493868|20131433|P2|Optimization Phase: DE+TE Participants|Other|2
5827342|NCT02493868|20131434|P1|Optimization Phase: DE+TE Participants|Other|10
5827343|NCT02493868|20131433|P2|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|20
5827344|NCT02493868|20131434|P1|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|107
5827345|NCT02493868|20131433|P2|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|5
5827346|NCT02493868|20131434|P1|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|14
5827347|NCT02493868|20131433|P2|Optimization Phase: DE+TE Participants|Withdrawal by Subject|3
5827348|NCT02493868|20131434|P1|Optimization Phase: DE+TE Participants|Withdrawal by Subject|8
5827349|NCT02493868|20131433|P2|Optimization Phase: DE+TE Participants|Protocol Violation|1
5827350|NCT02493868|20131434|P1|Optimization Phase: DE+TE Participants|Protocol Violation|4
5827351|NCT02493868|20131433|P2|Optimization Phase: DE+TE Participants|Lack of Efficacy|0
5827352|NCT02493868|20131434|P1|Optimization Phase: DE+TE Participants|Lack of Efficacy|8
5827353|NCT02493868|20131433|P2|Optimization Phase: DE+TE Participants|Lost to Follow-up|1
5827354|NCT02493868|20131434|P1|Optimization Phase: DE+TE Participants|Lost to Follow-up|2
5827355|NCT02493868|20131433|P2|Optimization Phase: DE+TE Participants|Adverse Event|0
5827356|NCT02493868|20131434|P1|Optimization Phase: DE+TE Participants|Adverse Event|5
5827357|NCT02493868|20131433|P2|Induction Phase: DE Participants|Other|0
5827358|NCT02493868|20131434|P1|Induction Phase: DE Participants|Other|8
5827359|NCT02493868|20131433|P2|Induction Phase: DE Participants|Not meet criteria to continue next phase|0
5827360|NCT02493868|20131434|P1|Induction Phase: DE Participants|Not meet criteria to continue next phase|114
5827361|NCT02493868|20131433|P2|Induction Phase: DE Participants|Withdrawal by Subject|0
5827362|NCT02493868|20131434|P1|Induction Phase: DE Participants|Withdrawal by Subject|15
5827363|NCT02493868|20131433|P2|Induction Phase: DE Participants|Protocol Violation|0
5827364|NCT02493868|20131434|P1|Induction Phase: DE Participants|Protocol Violation|2
5827365|NCT02493868|20131433|P2|Induction Phase: DE Participants|Lack of Efficacy|0
5827366|NCT02493868|20131434|P1|Induction Phase: DE Participants|Lack of Efficacy|2
5827367|NCT02493868|20131433|P2|Induction Phase: DE Participants|Lost to Follow-up|0
5827368|NCT02493868|20131434|P1|Induction Phase: DE Participants|Lost to Follow-up|1
5827369|NCT02493868|20131433|P2|Induction Phase: DE Participants|Adverse Event|0
5827370|NCT02493868|20131434|P1|Induction Phase: DE Participants|Adverse Event|22
5827371|NCT02493855|20131483|P3|Overall Study|Withdrawal by Subject|0
5827372|NCT02493855|20131484|P2|Overall Study|Withdrawal by Subject|0
5827373|NCT02493855|20131485|P1|Overall Study|Withdrawal by Subject|1
5827374|NCT02493855|20131483|P3|Overall Study|Adverse Event|0
5827375|NCT02493855|20131484|P2|Overall Study|Adverse Event|1
5827376|NCT02493855|20131485|P1|Overall Study|Adverse Event|0
5827377|NCT02493855|20131483|P3|Overall Study|Non-compliance|0
5827378|NCT02493855|20131484|P2|Overall Study|Non-compliance|0
5827379|NCT02493855|20131485|P1|Overall Study|Non-compliance|1
5827380|NCT02493777|20131495|P2|Overall Study|Lost to Follow-up|1
5827381|NCT02493777|20131496|P1|Overall Study|Lost to Follow-up|0
5827382|NCT02493764|20131506|P2|Overall Study|Withdrawal by Subject|7
5827383|NCT02493764|20131507|P1|Overall Study|Withdrawal by Subject|11
5827384|NCT02493764|20131506|P2|Overall Study|Withdrawal parent/guardian|1
5827385|NCT02493764|20131507|P1|Overall Study|Withdrawal parent/guardian|0
5827386|NCT02493764|20131506|P2|Overall Study|Participant moved|5
5827387|NCT02493764|20131507|P1|Overall Study|Participant moved|17
5827388|NCT02493764|20131506|P2|Overall Study|Physician Decision|1
5827389|NCT02493764|20131507|P1|Overall Study|Physician Decision|1
5827390|NCT02493764|20131506|P2|Overall Study|Protocol Violation|7
5827391|NCT02493764|20131507|P1|Overall Study|Protocol Violation|6
5827392|NCT02493764|20131506|P2|Overall Study|Lost to Follow-up|1
5827393|NCT02493764|20131507|P1|Overall Study|Lost to Follow-up|2
5827394|NCT02493764|20131506|P2|Overall Study|Death|58
5827395|NCT02493764|20131507|P1|Overall Study|Death|44
5827396|NCT02493764|20131506|P2|Overall Study|Adverse Event|2
5827397|NCT02493764|20131507|P1|Overall Study|Adverse Event|2
5827398|NCT02493751|20131557|P2|Overall Study|Ongoing|23
5827399|NCT02493751|20131558|P1|Overall Study|Ongoing|11
5827400|NCT02493751|20131557|P2|Overall Study|Withdrawal by Subject|5
5827401|NCT02493751|20131558|P1|Overall Study|Withdrawal by Subject|2
5827402|NCT02493751|20131557|P2|Overall Study|Lost to Follow-up|1
5827403|NCT02493751|20131558|P1|Overall Study|Lost to Follow-up|0
5827404|NCT02493712|20131566|P3|Overall Study|Lack of Efficacy|3
5827405|NCT02493712|20131567|P2|Overall Study|Lack of Efficacy|5
5827406|NCT02493712|20131568|P1|Overall Study|Lack of Efficacy|0
5827407|NCT02493712|20131566|P3|Overall Study|Physician Decision|0
5827408|NCT02493712|20131567|P2|Overall Study|Physician Decision|1
5827409|NCT02493712|20131568|P1|Overall Study|Physician Decision|0
5827410|NCT02493712|20131566|P3|Overall Study|Lost to Follow-up|0
5827411|NCT02493712|20131567|P2|Overall Study|Lost to Follow-up|0
5827412|NCT02493712|20131568|P1|Overall Study|Lost to Follow-up|1
5827413|NCT02493712|20131566|P3|Overall Study|Protocol Violation|1
5827414|NCT02493712|20131567|P2|Overall Study|Protocol Violation|0
5827415|NCT02493712|20131568|P1|Overall Study|Protocol Violation|0
5827416|NCT02493712|20131566|P3|Overall Study|Withdrawal by Subject|2
5827417|NCT02493712|20131567|P2|Overall Study|Withdrawal by Subject|0
5827418|NCT02493712|20131568|P1|Overall Study|Withdrawal by Subject|1
5827419|NCT02493517|20131605|P2|Overall Study|Missed study visit|1
5827420|NCT02493517|20131606|P1|Overall Study|Missed study visit|0
5827421|NCT02493517|20131605|P2|Overall Study|Adverse Event|2
5827422|NCT02493517|20131606|P1|Overall Study|Adverse Event|0
5827423|NCT02493517|20131605|P2|Overall Study|Withdrawal by Subject|2
5827424|NCT02493517|20131606|P1|Overall Study|Withdrawal by Subject|1
5827425|NCT02493517|20131605|P2|Overall Study|Protocol Violation|2
5827426|NCT02493517|20131606|P1|Overall Study|Protocol Violation|1
5827427|NCT02493361|20131665|P1|Overall Study|Withdrawal by Subject|3
5827428|NCT02493127|20131692|P2|Overall Study|Lost to Follow-up|1
5827429|NCT02493127|20131693|P1|Overall Study|Lost to Follow-up|1
5827430|NCT02493062|20131711|P1|Overall Study|Physician Decision|12
5827431|NCT02492997|20131734|P2|Overall Study|Lost to Follow-up|1
5827432|NCT02492997|20131735|P1|Overall Study|Lost to Follow-up|0
5827433|NCT02492997|20131734|P2|Overall Study|Gained Weight|0
5827434|NCT02492997|20131735|P1|Overall Study|Gained Weight|1
5827435|NCT02492997|20131734|P2|Overall Study|Withdrawal by Subject|0
5827436|NCT02492997|20131735|P1|Overall Study|Withdrawal by Subject|1
5827437|NCT02492984|20131745|P2|Overall Study|Withdrawal by Subject|0
5827438|NCT02492984|20131746|P1|Overall Study|Withdrawal by Subject|1
5827439|NCT02492984|20131745|P2|Overall Study|Protocol Violation|0
5827440|NCT02492984|20131746|P1|Overall Study|Protocol Violation|1
5827441|NCT02492984|20131745|P2|Overall Study|Adverse Event|0
5827442|NCT02492984|20131746|P1|Overall Study|Adverse Event|1
5827443|NCT02492958|20131770|P4|Overall Study|Adverse Event|0
5827444|NCT02492958|20131771|P3|Overall Study|Adverse Event|1
5827445|NCT02492958|20131772|P2|Overall Study|Adverse Event|0
5827446|NCT02492958|20131773|P1|Overall Study|Adverse Event|1
5827447|NCT02492958|20131770|P4|Overall Study|Withdrawal by Subject|0
5827448|NCT02492958|20131771|P3|Overall Study|Withdrawal by Subject|1
5827449|NCT02492958|20131772|P2|Overall Study|Withdrawal by Subject|0
5827450|NCT02492958|20131773|P1|Overall Study|Withdrawal by Subject|0
5827451|NCT02492880|20131859|P1|Overall Study|Protocol Violation|1
5827452|NCT02492880|20131859|P1|Overall Study|Lost to Follow-up|1
5827453|NCT02492841|20131866|P3|Overall Study|Lost to Follow-up|35
5827454|NCT02492841|20131867|P2|Overall Study|Lost to Follow-up|31
5827455|NCT02492841|20131868|P1|Overall Study|Lost to Follow-up|34
5827456|NCT02492763|20131887|P4|Overall Study|Study Terminated by Sponsor|10
5827457|NCT02492763|20131888|P3|Overall Study|Study Terminated by Sponsor|6
5827458|NCT02492763|20131889|P2|Overall Study|Study Terminated by Sponsor|10
5827459|NCT02492763|20131890|P1|Overall Study|Study Terminated by Sponsor|13
5827460|NCT02492763|20131887|P4|Overall Study|Screen Failure|1
5827461|NCT02492763|20131888|P3|Overall Study|Screen Failure|0
5827462|NCT02492763|20131889|P2|Overall Study|Screen Failure|0
5827463|NCT02492763|20131890|P1|Overall Study|Screen Failure|0
5827464|NCT02492763|20131887|P4|Overall Study|Non-Compliance With Study Drug|0
5827465|NCT02492763|20131888|P3|Overall Study|Non-Compliance With Study Drug|0
5827466|NCT02492763|20131889|P2|Overall Study|Non-Compliance With Study Drug|1
5827467|NCT02492763|20131890|P1|Overall Study|Non-Compliance With Study Drug|0
5827468|NCT02492763|20131887|P4|Overall Study|Lost to Follow-up|0
5827469|NCT02492763|20131888|P3|Overall Study|Lost to Follow-up|1
5827470|NCT02492763|20131889|P2|Overall Study|Lost to Follow-up|0
5827471|NCT02492763|20131890|P1|Overall Study|Lost to Follow-up|0
5827472|NCT02492763|20131887|P4|Overall Study|Hyperglycemia Discontinuation Criteria|0
5827473|NCT02492763|20131888|P3|Overall Study|Hyperglycemia Discontinuation Criteria|0
5827474|NCT02492763|20131889|P2|Overall Study|Hyperglycemia Discontinuation Criteria|1
5827475|NCT02492763|20131890|P1|Overall Study|Hyperglycemia Discontinuation Criteria|0
5827476|NCT02492763|20131887|P4|Overall Study|Death|0
5827477|NCT02492763|20131888|P3|Overall Study|Death|1
5827478|NCT02492763|20131889|P2|Overall Study|Death|0
5827479|NCT02492763|20131890|P1|Overall Study|Death|0
5827480|NCT02492763|20131887|P4|Overall Study|Adverse Event|2
5827481|NCT02492763|20131888|P3|Overall Study|Adverse Event|1
5827482|NCT02492763|20131889|P2|Overall Study|Adverse Event|1
5827483|NCT02492763|20131890|P1|Overall Study|Adverse Event|3
5827484|NCT02492763|20131887|P4|Overall Study|Withdrawal by Subject|0
5827485|NCT02492763|20131888|P3|Overall Study|Withdrawal by Subject|1
5827486|NCT02492763|20131889|P2|Overall Study|Withdrawal by Subject|2
5827487|NCT02492763|20131890|P1|Overall Study|Withdrawal by Subject|0
5827488|NCT02492165|20131995|P4|Overall Study|Withdrawal by Subject|0
5827489|NCT02492165|20131996|P3|Overall Study|Withdrawal by Subject|0
5827490|NCT02492165|20131997|P2|Overall Study|Withdrawal by Subject|1
5827491|NCT02492165|20131998|P1|Overall Study|Withdrawal by Subject|0
5827492|NCT02492100|20132020|P1|Overall Study|Death|1
5827493|NCT02491892|20132049|P2|Overall Study|Lost to Follow-up|0
5827494|NCT02491892|20132050|P1|Overall Study|Lost to Follow-up|1
5827495|NCT02491892|20132049|P2|Overall Study|Refused Treatment|0
5827496|NCT02491892|20132050|P1|Overall Study|Refused Treatment|1
5827497|NCT02491892|20132049|P2|Overall Study|Lack of Efficacy|36
5827498|NCT02491892|20132050|P1|Overall Study|Lack of Efficacy|37
5827499|NCT02491892|20132049|P2|Overall Study|Death|1
5827500|NCT02491892|20132050|P1|Overall Study|Death|1
5827501|NCT02491892|20132049|P2|Overall Study|Adverse Event|1
5827502|NCT02491892|20132050|P1|Overall Study|Adverse Event|1
5827503|NCT02491684|20132105|P2|Treatment Phase|Investigator and Sponsor decision|1
5827504|NCT02491684|20132106|P1|Treatment Phase|Investigator and Sponsor decision|0
5827505|NCT02491684|20132105|P2|Treatment Phase|Incorrect randomisation|0
5827506|NCT02491684|20132106|P1|Treatment Phase|Incorrect randomisation|1
5827507|NCT02491684|20132105|P2|Treatment Phase|Adverse Event|2
5827508|NCT02491684|20132106|P1|Treatment Phase|Adverse Event|2
5827509|NCT02491463|20132144|P4|Overall Study|Lost to Follow-up|0
5827510|NCT02491463|20132145|P3|Overall Study|Lost to Follow-up|3
5827511|NCT02491463|20132146|P2|Overall Study|Lost to Follow-up|3
5827512|NCT02491463|20132147|P1|Overall Study|Lost to Follow-up|0
5827513|NCT02491463|20132144|P4|Overall Study|Migrated/moved from study area|1
5827514|NCT02491463|20132145|P3|Overall Study|Migrated/moved from study area|1
5827515|NCT02491463|20132146|P2|Overall Study|Migrated/moved from study area|5
5827516|NCT02491463|20132147|P1|Overall Study|Migrated/moved from study area|1
5827517|NCT02491463|20132144|P4|Overall Study|Withdrawal by Subject|0
5827518|NCT02491463|20132145|P3|Overall Study|Withdrawal by Subject|0
5827519|NCT02491463|20132146|P2|Overall Study|Withdrawal by Subject|2
5827520|NCT02491463|20132147|P1|Overall Study|Withdrawal by Subject|1
5827521|NCT02491411|20132250|P1|Overall Study|Physician Decision|4
5827522|NCT02491073|20132281|P2|Overall Study|screen failure|0
5827523|NCT02491073|20132282|P1|Overall Study|screen failure|1
5827524|NCT02490475|20132334|P4|Period 2: Extension Phase|Adverse Event|0
5827525|NCT02490475|20132335|P3|Period 2: Extension Phase|Adverse Event|1
5827526|NCT02490475|20132336|P2|Period 2: Extension Phase|Adverse Event|0
5827527|NCT02490475|20132337|P1|Period 2: Extension Phase|Adverse Event|0
5827528|NCT02490475|20132334|P4|Period 2: Extension Phase|Refused Treatment|1
5827529|NCT02490475|20132335|P3|Period 2: Extension Phase|Refused Treatment|0
5827530|NCT02490475|20132336|P2|Period 2: Extension Phase|Refused Treatment|0
5827531|NCT02490475|20132337|P1|Period 2: Extension Phase|Refused Treatment|0
5827532|NCT02490475|20132334|P4|Period 2: Extension Phase|Insufficient Therapeutic Response|0
5827533|NCT02490475|20132335|P3|Period 2: Extension Phase|Insufficient Therapeutic Response|2
5827534|NCT02490475|20132336|P2|Period 2: Extension Phase|Insufficient Therapeutic Response|0
5827535|NCT02490475|20132337|P1|Period 2: Extension Phase|Insufficient Therapeutic Response|1
5827536|NCT02490475|20132334|P4|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|2
5827537|NCT02490475|20132335|P3|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|4
5827538|NCT02490475|20132336|P2|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1
5827539|NCT02490475|20132337|P1|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1
5827540|NCT02490475|20132334|P4|Period 1: First 6 Cycles|Refused Treatment|0
5827541|NCT02490475|20132335|P3|Period 1: First 6 Cycles|Refused Treatment|0
5827542|NCT02490475|20132336|P2|Period 1: First 6 Cycles|Refused Treatment|0
5827543|NCT02490475|20132337|P1|Period 1: First 6 Cycles|Refused Treatment|1
5827544|NCT02490475|20132334|P4|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2
5827545|NCT02490475|20132335|P3|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2
5827546|NCT02490475|20132336|P2|Period 1: First 6 Cycles|Insufficient Therapeutic Response|0
5827547|NCT02490475|20132337|P1|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2
5827548|NCT02490475|20132334|P4|Period 1: First 6 Cycles|Adverse Event|1
5827549|NCT02490475|20132335|P3|Period 1: First 6 Cycles|Adverse Event|0
5827550|NCT02490475|20132336|P2|Period 1: First 6 Cycles|Adverse Event|1
5827551|NCT02490475|20132337|P1|Period 1: First 6 Cycles|Adverse Event|2
5827552|NCT02490371|20132415|P2|Overall Study|Lost to Follow-up|1
5827553|NCT02490371|20132416|P1|Overall Study|Lost to Follow-up|1
5827554|NCT02489981|20132443|P1|Overall Study|Other than listed|28
5827555|NCT02489981|20132443|P1|Overall Study|Lost to Follow-up|31
5827556|NCT02489981|20132443|P1|Overall Study|Improved|31
5827557|NCT02489981|20132443|P1|Overall Study|Insufficient effectiveness|16
5827558|NCT02489981|20132443|P1|Overall Study|Adverse Event|21
5827559|NCT02489968|20132450|P6|Double-blind Treatment Period|Other than specified above|0
5827560|NCT02489968|20132451|P5|Double-blind Treatment Period|Other than specified above|1
5827561|NCT02489968|20132452|P4|Double-blind Treatment Period|Other than specified above|0
5827562|NCT02489968|20132453|P3|Double-blind Treatment Period|Other than specified above|0
5827563|NCT02489968|20132454|P2|Double-blind Treatment Period|Other than specified above|0
5827564|NCT02489968|20132455|P1|Double-blind Treatment Period|Other than specified above|0
5827565|NCT02489968|20132450|P6|Double-blind Treatment Period|Withdrawal by Subject|2
5827566|NCT02489968|20132451|P5|Double-blind Treatment Period|Withdrawal by Subject|0
5827567|NCT02489968|20132452|P4|Double-blind Treatment Period|Withdrawal by Subject|2
5827568|NCT02489968|20132453|P3|Double-blind Treatment Period|Withdrawal by Subject|0
5827569|NCT02489968|20132454|P2|Double-blind Treatment Period|Withdrawal by Subject|0
5827570|NCT02489968|20132455|P1|Double-blind Treatment Period|Withdrawal by Subject|0
5827571|NCT02489968|20132450|P6|Double-blind Treatment Period|Protocol Violation|1
5827572|NCT02489968|20132451|P5|Double-blind Treatment Period|Protocol Violation|1
5827573|NCT02489968|20132452|P4|Double-blind Treatment Period|Protocol Violation|0
5827574|NCT02489968|20132453|P3|Double-blind Treatment Period|Protocol Violation|0
5827575|NCT02489968|20132454|P2|Double-blind Treatment Period|Protocol Violation|0
5827576|NCT02489968|20132455|P1|Double-blind Treatment Period|Protocol Violation|0
5827577|NCT02489968|20132450|P6|Double-blind Treatment Period|Adverse Event|5
5827578|NCT02489968|20132451|P5|Double-blind Treatment Period|Adverse Event|4
5827579|NCT02489968|20132452|P4|Double-blind Treatment Period|Adverse Event|6
5827580|NCT02489968|20132453|P3|Double-blind Treatment Period|Adverse Event|2
5827581|NCT02489968|20132454|P2|Double-blind Treatment Period|Adverse Event|0
5827582|NCT02489968|20132455|P1|Double-blind Treatment Period|Adverse Event|0
5827583|NCT02489968|20132450|P6|Open-label Treatment Period|Other than specified above|0
5827584|NCT02489968|20132451|P5|Open-label Treatment Period|Other than specified above|0
5827585|NCT02489968|20132452|P4|Open-label Treatment Period|Other than specified above|0
5827586|NCT02489968|20132453|P3|Open-label Treatment Period|Other than specified above|0
5827587|NCT02489968|20132454|P2|Open-label Treatment Period|Other than specified above|189
5827588|NCT02489968|20132455|P1|Open-label Treatment Period|Other than specified above|204
5827589|NCT02489968|20132450|P6|Open-label Treatment Period|Withdrawal by Subject|0
5827590|NCT02489968|20132451|P5|Open-label Treatment Period|Withdrawal by Subject|0
5827591|NCT02489968|20132452|P4|Open-label Treatment Period|Withdrawal by Subject|0
5827592|NCT02489968|20132453|P3|Open-label Treatment Period|Withdrawal by Subject|0
5827593|NCT02489968|20132454|P2|Open-label Treatment Period|Withdrawal by Subject|7
5827594|NCT02489968|20132455|P1|Open-label Treatment Period|Withdrawal by Subject|4
5827595|NCT02489968|20132450|P6|Open-label Treatment Period|Lost to Follow-up|0
5827596|NCT02489968|20132451|P5|Open-label Treatment Period|Lost to Follow-up|0
5827597|NCT02489968|20132452|P4|Open-label Treatment Period|Lost to Follow-up|0
5827598|NCT02489968|20132453|P3|Open-label Treatment Period|Lost to Follow-up|0
5827599|NCT02489968|20132454|P2|Open-label Treatment Period|Lost to Follow-up|3
5827600|NCT02489968|20132455|P1|Open-label Treatment Period|Lost to Follow-up|0
5827601|NCT02489968|20132450|P6|Open-label Treatment Period|Protocol Violation|0
5827602|NCT02489968|20132451|P5|Open-label Treatment Period|Protocol Violation|0
5827603|NCT02489968|20132452|P4|Open-label Treatment Period|Protocol Violation|0
5827604|NCT02489968|20132453|P3|Open-label Treatment Period|Protocol Violation|0
5827605|NCT02489968|20132454|P2|Open-label Treatment Period|Protocol Violation|2
5827606|NCT02489968|20132455|P1|Open-label Treatment Period|Protocol Violation|2
5827607|NCT02489968|20132450|P6|Open-label Treatment Period|Adverse Event|0
5827608|NCT02489968|20132451|P5|Open-label Treatment Period|Adverse Event|0
5827609|NCT02489968|20132452|P4|Open-label Treatment Period|Adverse Event|0
5827610|NCT02489968|20132453|P3|Open-label Treatment Period|Adverse Event|0
5827611|NCT02489968|20132454|P2|Open-label Treatment Period|Adverse Event|7
5827612|NCT02489968|20132455|P1|Open-label Treatment Period|Adverse Event|14
5827613|NCT02489799|20132469|P2|Overall Study|Death|1
5827614|NCT02489799|20132470|P1|Overall Study|Death|0
5827615|NCT02489799|20132469|P2|Overall Study|Withdrawal by Subject|1
5827616|NCT02489799|20132470|P1|Overall Study|Withdrawal by Subject|1
5827617|NCT02489799|20132469|P2|Overall Study|Failure to Maintain Eligibility|6
5827618|NCT02489799|20132470|P1|Overall Study|Failure to Maintain Eligibility|4
5827619|NCT02489799|20132469|P2|Overall Study|Lost to Follow-up|1
5827620|NCT02489799|20132470|P1|Overall Study|Lost to Follow-up|4
5827621|NCT02489773|20132496|P2|Overall Study|Leave the country or the state|1
5827622|NCT02489773|20132497|P1|Overall Study|Leave the country or the state|1
5827623|NCT02489773|20132496|P2|Overall Study|Withdrawal by Subject|0
5827624|NCT02489773|20132497|P1|Overall Study|Withdrawal by Subject|1
5827625|NCT02489773|20132496|P2|Overall Study|Physician Decision|0
5827626|NCT02489773|20132497|P1|Overall Study|Physician Decision|1
5827627|NCT02489773|20132496|P2|Overall Study|Lost to Follow-up|1
5827628|NCT02489773|20132497|P1|Overall Study|Lost to Follow-up|4
5827629|NCT02489500|20132507|P2|Overall Study|Death|1
5827630|NCT02489500|20132508|P1|Overall Study|Death|1
5827631|NCT02489344|20132526|P1|LTS14116 (Extension Study): 31 Months|Treatment completed/Study not completed|2
5827632|NCT02489344|20132526|P1|LTS14116 (Extension Study): 31 Months|Adverse Event|1
5827633|NCT02489344|20132526|P1|ACT13739 (Initial Study): 26 Weeks|Lost to Follow-up|1
5827634|NCT02489344|20132526|P1|ACT13739 (Initial Study): 26 Weeks|Adverse Event|1
5827635|NCT02489279|20132568|P2|Overall Study|Lost to Follow-up|10
5827636|NCT02489279|20132569|P1|Overall Study|Lost to Follow-up|12
5827637|NCT02488980|20132610|P3|Overall Study|Protocol Violation|2
5827638|NCT02488980|20132611|P2|Overall Study|Protocol Violation|2
5827639|NCT02488980|20132612|P1|Overall Study|Protocol Violation|2
5827640|NCT02488915|20132629|P1|Overall Study|Withdrawal by Subject|1
5827641|NCT02488915|20132629|P1|Overall Study|Lost to Follow-up|4
5827642|NCT02488915|20132629|P1|Overall Study|Death|21
5827643|NCT02488824|20132647|P2|Overall Study|Adverse Event|1
5827644|NCT02488824|20132648|P1|Overall Study|Adverse Event|1
5827645|NCT02488681|20132662|P1|Overall Study|Implant unsuccessful|7
5827646|NCT02488330|20132666|P1|Overall Study|Study Termination by Sponsor|4
5827647|NCT02488330|20132666|P1|Overall Study|Disease Progression|3
5827648|NCT02488330|20132666|P1|Overall Study|Death|2
5827649|NCT02488330|20132666|P1|Overall Study|Physician Decision|2
5827650|NCT02488330|20132666|P1|Overall Study|Adverse Event|1
5827651|NCT02488239|20132687|P1|Overall Study|Did not undergo implant procedure|1
5827652|NCT02488239|20132687|P1|Overall Study|Consent ineligible|1
5827653|NCT02488239|20132687|P1|Overall Study|Physician Decision|2
5827654|NCT02488239|20132687|P1|Overall Study|Withdrawal by Subject|3
5827655|NCT02488239|20132687|P1|Overall Study|Death|3
5827656|NCT02488005|20132704|P1|Overall Study|Lost to Follow-up|2
5827657|NCT02487979|20132714|P1|Overall Study|Progressive Disease|17
5827658|NCT02487979|20132714|P1|Overall Study|Withdrawal by Subject|2
5827659|NCT02487979|20132714|P1|Overall Study|Physician Decision|2
5827660|NCT02487810|20132726|P2|Overall Study|Withdrawal by Subject|0
5827661|NCT02487810|20132727|P1|Overall Study|Withdrawal by Subject|1
5827662|NCT02487771|20132759|P2|Overall Study|Withdrawal by Subject|5
5827663|NCT02487771|20132760|P1|Overall Study|Withdrawal by Subject|3
5827664|NCT02487771|20132759|P2|Overall Study|Moved out of area|6
5827665|NCT02487771|20132760|P1|Overall Study|Moved out of area|5
5827666|NCT02487771|20132759|P2|Overall Study|Lost to Follow-up|3
5827667|NCT02487771|20132760|P1|Overall Study|Lost to Follow-up|2
5827668|NCT02487498|20132926|P2|Period: Period 2|Physician Decision|0
5827669|NCT02487498|20132927|P1|Period: Period 2|Physician Decision|1
5827670|NCT02487498|20132926|P2|Period: Period 2|Death|1
5827671|NCT02487498|20132927|P1|Period: Period 2|Death|0
5827672|NCT02487498|20132926|P2|Period: Period 2|Lost to Follow-up|1
5827673|NCT02487498|20132927|P1|Period: Period 2|Lost to Follow-up|1
5827674|NCT02487498|20132926|P2|Period: Period 2|Subject/guardian decision|1
5827675|NCT02487498|20132927|P1|Period: Period 2|Subject/guardian decision|2
5827676|NCT02487498|20132926|P2|Period: Period 2|Adverse Event|2
5827677|NCT02487498|20132927|P1|Period: Period 2|Adverse Event|2
5827678|NCT02487498|20132926|P2|Period: Washout|Non-compliance with study treatment|1
5827679|NCT02487498|20132927|P1|Period: Washout|Non-compliance with study treatment|0
5827680|NCT02487498|20132926|P2|Period: Washout|Physician Decision|0
5827681|NCT02487498|20132927|P1|Period: Washout|Physician Decision|1
5827682|NCT02487498|20132926|P2|Period: Washout|Lack of Efficacy|1
5827683|NCT02487498|20132927|P1|Period: Washout|Lack of Efficacy|1
5827684|NCT02487498|20132926|P2|Period: Washout|Subject/guardian decision|5
5827685|NCT02487498|20132927|P1|Period: Washout|Subject/guardian decision|0
5827686|NCT02487498|20132926|P2|Period: Period 1|Protocol deviation|0
5827687|NCT02487498|20132927|P1|Period: Period 1|Protocol deviation|1
5827688|NCT02487498|20132926|P2|Period: Period 1|Physician Decision|1
5827689|NCT02487498|20132927|P1|Period: Period 1|Physician Decision|0
5827690|NCT02487498|20132926|P2|Period: Period 1|Lack of Efficacy|0
5827691|NCT02487498|20132927|P1|Period: Period 1|Lack of Efficacy|1
5827692|NCT02487498|20132926|P2|Period: Period 1|Lost to Follow-up|2
5827693|NCT02487498|20132927|P1|Period: Period 1|Lost to Follow-up|0
5827694|NCT02487498|20132926|P2|Period: Period 1|Subject/guardian decision|4
5827695|NCT02487498|20132927|P1|Period: Period 1|Subject/guardian decision|2
5827696|NCT02487498|20132926|P2|Period: Period 1|Adverse Event|4
5827697|NCT02487498|20132927|P1|Period: Period 1|Adverse Event|2
5827698|NCT02487472|20132971|P1|Overall Study|Other|2
5827699|NCT02487472|20132971|P1|Overall Study|Did not complete telephonic interviews|9
5827700|NCT02487446|20132987|P2|Period 2|Adverse Event|2
5827701|NCT02487446|20132988|P1|Period 2|Adverse Event|6
5827702|NCT02487446|20132987|P2|Period 2|Withdrawal by Subject|1
5827703|NCT02487446|20132988|P1|Period 2|Withdrawal by Subject|1
5827704|NCT02487446|20132987|P2|Period 2|Lost to Follow-up|1
5827705|NCT02487446|20132988|P1|Period 2|Lost to Follow-up|1
5827706|NCT02487446|20132987|P2|Period 2|Protocol deviation|1
5827707|NCT02487446|20132988|P1|Period 2|Protocol deviation|0
5827708|NCT02487446|20132987|P2|Washout|Adverse Event|2
5827709|NCT02487446|20132988|P1|Washout|Adverse Event|2
5827710|NCT02487446|20132987|P2|Washout|Withdrawal by Subject|4
5827711|NCT02487446|20132988|P1|Washout|Withdrawal by Subject|1
5827712|NCT02487446|20132987|P2|Washout|Lost to Follow-up|2
5827713|NCT02487446|20132988|P1|Washout|Lost to Follow-up|0
5827714|NCT02487446|20132987|P2|Period 1|Adverse Event|5
5827715|NCT02487446|20132988|P1|Period 1|Adverse Event|5
5827716|NCT02487446|20132987|P2|Period 1|Withdrawal by Subject|0
5827717|NCT02487446|20132988|P1|Period 1|Withdrawal by Subject|2
5827718|NCT02487446|20132987|P2|Period 1|Lost to Follow-up|0
5827719|NCT02487446|20132988|P1|Period 1|Lost to Follow-up|2
5827720|NCT02487446|20132987|P2|Period 1|Protocol deviation|2
5827721|NCT02487446|20132988|P1|Period 1|Protocol deviation|3
5827722|NCT02487446|20132987|P2|Period 1|Lack of Efficacy|0
5827723|NCT02487446|20132988|P1|Period 1|Lack of Efficacy|1
5827724|NCT02487446|20132987|P2|Period 1|Physician Decision|1
5827725|NCT02487446|20132988|P1|Period 1|Physician Decision|0
5827726|NCT02487199|20133068|P2|Overall Study|Withdrew Consent|1
5827727|NCT02487199|20133069|P1|Overall Study|Withdrew Consent|0
5827728|NCT02487030|20133094|P7|Overall Study|Death|0
5827729|NCT02487030|20133095|P6|Overall Study|Death|0
5827730|NCT02487030|20133096|P5|Overall Study|Death|1
5827731|NCT02487030|20133097|P4|Overall Study|Death|0
5827732|NCT02487030|20133098|P3|Overall Study|Death|0
5827733|NCT02487030|20133099|P2|Overall Study|Death|0
5827734|NCT02487030|20133100|P1|Overall Study|Death|0
5827735|NCT02487030|20133094|P7|Overall Study|Adverse Event|0
5827736|NCT02487030|20133095|P6|Overall Study|Adverse Event|0
5827737|NCT02487030|20133096|P5|Overall Study|Adverse Event|0
5827738|NCT02487030|20133097|P4|Overall Study|Adverse Event|1
5827739|NCT02487030|20133098|P3|Overall Study|Adverse Event|0
5827740|NCT02487030|20133099|P2|Overall Study|Adverse Event|0
5827741|NCT02487030|20133100|P1|Overall Study|Adverse Event|0
5827742|NCT02487030|20133094|P7|Overall Study|Lost to Follow-up|0
5827743|NCT02487030|20133095|P6|Overall Study|Lost to Follow-up|1
5827744|NCT02487030|20133096|P5|Overall Study|Lost to Follow-up|0
5827745|NCT02487030|20133097|P4|Overall Study|Lost to Follow-up|1
5827746|NCT02487030|20133098|P3|Overall Study|Lost to Follow-up|1
5827747|NCT02487030|20133099|P2|Overall Study|Lost to Follow-up|0
5827748|NCT02487030|20133100|P1|Overall Study|Lost to Follow-up|0
5827749|NCT02487030|20133094|P7|Overall Study|Lack of Efficacy|0
5827750|NCT02487030|20133095|P6|Overall Study|Lack of Efficacy|0
5827751|NCT02487030|20133096|P5|Overall Study|Lack of Efficacy|1
5827752|NCT02487030|20133097|P4|Overall Study|Lack of Efficacy|0
5827753|NCT02487030|20133098|P3|Overall Study|Lack of Efficacy|1
5827754|NCT02487030|20133099|P2|Overall Study|Lack of Efficacy|4
5827755|NCT02487030|20133100|P1|Overall Study|Lack of Efficacy|2
5827756|NCT02486952|20133131|P1|Overall Study|Other|2
5827757|NCT02486952|20133131|P1|Overall Study|Lost to Follow-up|26
5827758|NCT02486952|20133131|P1|Overall Study|Lack of Efficacy|3
5827759|NCT02486952|20133131|P1|Overall Study|Death|15
5827760|NCT02486952|20133131|P1|Overall Study|Adverse Event|1
5827761|NCT02486952|20133131|P1|Overall Study|Not Started Induction Therapy|3
5827762|NCT02486796|20133149|P2|Overall Study|Physician Decision|0
5827763|NCT02486796|20133150|P1|Overall Study|Physician Decision|1
5827764|NCT02486796|20133149|P2|Overall Study|Withdrawal by Subject|1
5827765|NCT02486796|20133150|P1|Overall Study|Withdrawal by Subject|1
5827766|NCT02486757|20133162|P1|Overall Study|Lost to Follow-up|1
5827767|NCT02486692|20133168|P2|Overall Study|did not login for randomization|7
5827768|NCT02486692|20133169|P1|Overall Study|did not login for randomization|4
5827769|NCT02486653|20133181|P2|Overall Study|surgery cancelled|1
5827770|NCT02486653|20133182|P1|Overall Study|surgery cancelled|4
5827771|NCT02486653|20133181|P2|Overall Study|Protocol Violation|0
5827772|NCT02486653|20133182|P1|Overall Study|Protocol Violation|1
5827773|NCT02486653|20133181|P2|Overall Study|Withdrawal by Subject|3
5827774|NCT02486653|20133182|P1|Overall Study|Withdrawal by Subject|1
5827775|NCT02486627|20133206|P2|Overall Study|Lost to Follow-up|3
5827776|NCT02486627|20133207|P1|Overall Study|Lost to Follow-up|1
5827777|NCT02486627|20133206|P2|Overall Study|Significant Participant Noncompliance|1
5827778|NCT02486627|20133207|P1|Overall Study|Significant Participant Noncompliance|1
5827779|NCT02486627|20133206|P2|Overall Study|Consent Withdrawn by Participant|3
5827780|NCT02486627|20133207|P1|Overall Study|Consent Withdrawn by Participant|4
5827781|NCT02486627|20133206|P2|Overall Study|Other Unspecified|2
5827782|NCT02486627|20133207|P1|Overall Study|Other Unspecified|0
5827783|NCT02486627|20133206|P2|Overall Study|Death|0
5827784|NCT02486627|20133207|P1|Overall Study|Death|1
5827785|NCT02486588|20133230|P6|Overall Study|Randomized in error- ineligible|746
5827786|NCT02486588|20133231|P5|Overall Study|Randomized in error- ineligible|746
5827787|NCT02486588|20133232|P4|Overall Study|Randomized in error- ineligible|738
5827788|NCT02486588|20133233|P3|Overall Study|Randomized in error- ineligible|755
5827789|NCT02486588|20133234|P2|Overall Study|Randomized in error- ineligible|750
5827790|NCT02486588|20133235|P1|Overall Study|Randomized in error- ineligible|738
5827791|NCT02486302|20133310|P1|Overall Study|Not treated|3
5827792|NCT02486302|20133310|P1|Overall Study|Excluded due to legal reasons|8
5827793|NCT02486302|20133310|P1|Overall Study|Documentation not completed|255
5827794|NCT02486302|20133310|P1|Overall Study|Discontinued prematurely|410
5827795|NCT02485925|20133407|P1|Overall Study|Lost to Follow-up|11
5827796|NCT02485925|20133407|P1|Overall Study|Death|1
5827797|NCT02485925|20133407|P1|Overall Study|Withdrawal by Subject|3
5827798|NCT02485717|20133439|P3|Overall Study|Did Not Meet Exclusion Criteria #12|0
5827799|NCT02485717|20133440|P2|Overall Study|Did Not Meet Exclusion Criteria #12|1
5827800|NCT02485717|20133441|P1|Overall Study|Did Not Meet Exclusion Criteria #12|0
5827801|NCT02485717|20133439|P3|Overall Study|Did Not Meet Exclusion Criteria #2|0
5827802|NCT02485717|20133440|P2|Overall Study|Did Not Meet Exclusion Criteria #2|1
5827803|NCT02485717|20133441|P1|Overall Study|Did Not Meet Exclusion Criteria #2|0
5827804|NCT02485717|20133439|P3|Overall Study|Withdrawal by Subject|1
5827805|NCT02485717|20133440|P2|Overall Study|Withdrawal by Subject|0
5827806|NCT02485717|20133441|P1|Overall Study|Withdrawal by Subject|0
5827807|NCT02485717|20133439|P3|Overall Study|Lost to Follow-up|0
5827808|NCT02485717|20133440|P2|Overall Study|Lost to Follow-up|0
5827809|NCT02485717|20133441|P1|Overall Study|Lost to Follow-up|6
5827810|NCT02485704|20133456|P2|Overall Study|Did Not Meet Inclusion Criteria #2|0
5827811|NCT02485704|20133457|P1|Overall Study|Did Not Meet Inclusion Criteria #2|1
5827812|NCT02485704|20133456|P2|Overall Study|Withdrawal by Subject|3
5827813|NCT02485704|20133457|P1|Overall Study|Withdrawal by Subject|0
5827814|NCT02485704|20133456|P2|Overall Study|Lost to Follow-up|5
5827815|NCT02485704|20133457|P1|Overall Study|Lost to Follow-up|4
5827816|NCT02485483|20133505|P2|Overall Study|Discontinued after baseline|0
5827817|NCT02485483|20133506|P1|Overall Study|Discontinued after baseline|39
5827818|NCT02485483|20133505|P2|Overall Study|Depression at baseline|0
5827819|NCT02485483|20133506|P1|Overall Study|Depression at baseline|15
5827820|NCT02485353|20133521|P1|Overall Study|Disease Progression|1
5827821|NCT02485353|20133521|P1|Overall Study|Death|1
5827822|NCT02485301|20133528|P2|Overall Study|Other|4
5827823|NCT02485301|20133529|P1|Overall Study|Other|3
5827824|NCT02485301|20133528|P2|Overall Study|Lost to Follow-up|17
5827825|NCT02485301|20133529|P1|Overall Study|Lost to Follow-up|17
5827826|NCT02485301|20133528|P2|Overall Study|Migrated/moved from study area|19
5827827|NCT02485301|20133529|P1|Overall Study|Migrated/moved from study area|10
5827828|NCT02485301|20133528|P2|Overall Study|Withdrawal by Subject|7
5827829|NCT02485301|20133529|P1|Overall Study|Withdrawal by Subject|6
5827830|NCT02485301|20133528|P2|Overall Study|Protocol Violation|1
5827831|NCT02485301|20133529|P1|Overall Study|Protocol Violation|0
5827832|NCT02485301|20133528|P2|Overall Study|Serious Adverse Events|1
5827833|NCT02485301|20133529|P1|Overall Study|Serious Adverse Events|2
5827834|NCT02485158|20133579|P1|Overall Study|expected drug side effect|1
5827835|NCT02485158|20133579|P1|Overall Study|Withdrawal by Subject|3
5827836|NCT02484911|20133668|P2|Overall Study|Protocol Violation|1
5827837|NCT02484911|20133669|P1|Overall Study|Protocol Violation|2
5827838|NCT02484911|20133668|P2|Overall Study|Withdrawal by Subject|1
5827839|NCT02484911|20133669|P1|Overall Study|Withdrawal by Subject|2
5827840|NCT02484729|20133759|P10|Overall Study|Failure of IntelliCap Error|1
5827841|NCT02484729|20133760|P9|Overall Study|Failure of IntelliCap Error|0
5827842|NCT02484729|20133761|P8|Overall Study|Failure of IntelliCap Error|0
5827843|NCT02484729|20133762|P7|Overall Study|Failure of IntelliCap Error|0
5827844|NCT02484729|20133763|P6|Overall Study|Failure of IntelliCap Error|0
5827845|NCT02484729|20133764|P5|Overall Study|Failure of IntelliCap Error|0
5827846|NCT02484729|20133765|P4|Overall Study|Failure of IntelliCap Error|0
5827847|NCT02484729|20133766|P3|Overall Study|Failure of IntelliCap Error|0
5827848|NCT02484729|20133767|P2|Overall Study|Failure of IntelliCap Error|0
5827849|NCT02484729|20133768|P1|Overall Study|Failure of IntelliCap Error|0
5827850|NCT02484690|20133969|P5|Overall Study|Lost to Follow-up|0
5827851|NCT02484690|20133970|P4|Overall Study|Lost to Follow-up|0
5827852|NCT02484690|20133971|P3|Overall Study|Lost to Follow-up|1
5827853|NCT02484690|20133972|P2|Overall Study|Lost to Follow-up|0
5827854|NCT02484690|20133973|P1|Overall Study|Lost to Follow-up|0
5827855|NCT02484690|20133969|P5|Overall Study|Physician Decision|0
5827856|NCT02484690|20133970|P4|Overall Study|Physician Decision|0
5827857|NCT02484690|20133971|P3|Overall Study|Physician Decision|1
5827858|NCT02484690|20133972|P2|Overall Study|Physician Decision|0
5827859|NCT02484690|20133973|P1|Overall Study|Physician Decision|2
5827860|NCT02484690|20133969|P5|Overall Study|Withdrawal by Subject|0
5827861|NCT02484690|20133970|P4|Overall Study|Withdrawal by Subject|2
5827862|NCT02484690|20133971|P3|Overall Study|Withdrawal by Subject|1
5827863|NCT02484690|20133972|P2|Overall Study|Withdrawal by Subject|3
5827864|NCT02484690|20133973|P1|Overall Study|Withdrawal by Subject|1
5827865|NCT02484690|20133969|P5|Overall Study|Death|1
5827866|NCT02484690|20133970|P4|Overall Study|Death|0
5827867|NCT02484690|20133971|P3|Overall Study|Death|0
5827868|NCT02484690|20133972|P2|Overall Study|Death|0
5827869|NCT02484690|20133973|P1|Overall Study|Death|0
5827870|NCT02484690|20133969|P5|Overall Study|Adverse Event|5
5827871|NCT02484690|20133970|P4|Overall Study|Adverse Event|0
5827872|NCT02484690|20133971|P3|Overall Study|Adverse Event|0
5827873|NCT02484690|20133972|P2|Overall Study|Adverse Event|3
5827874|NCT02484690|20133973|P1|Overall Study|Adverse Event|1
5827875|NCT02484651|20134117|P2|Overall Study|Time of the procedure less than 90 min.|2
5827876|NCT02484651|20134118|P1|Overall Study|Time of the procedure less than 90 min.|1
5827877|NCT02484651|20134117|P2|Overall Study|BIS monitoring failed.|1
5827878|NCT02484651|20134118|P1|Overall Study|BIS monitoring failed.|1
5827879|NCT02484651|20134117|P2|Overall Study|Patients' data files were corrupted.|1
5827880|NCT02484651|20134118|P1|Overall Study|Patients' data files were corrupted.|1
5827881|NCT02483975|20134152|P2|Overall Study|Physician Decision|0
5827882|NCT02483975|20134153|P1|Overall Study|Physician Decision|2
5827883|NCT02483975|20134152|P2|Overall Study|Lost to Follow-up|1
5827884|NCT02483975|20134153|P1|Overall Study|Lost to Follow-up|0
5827885|NCT02483975|20134152|P2|Overall Study|Adverse Event|1
5827886|NCT02483975|20134153|P1|Overall Study|Adverse Event|0
5827887|NCT02483611|20134191|P3|Overall Study|Protocol Violation|1
5827888|NCT02483611|20134192|P2|Overall Study|Protocol Violation|0
5827889|NCT02483611|20134193|P1|Overall Study|Protocol Violation|0
5827890|NCT02483585|20134290|P2|Open-label Treatment Phase|Lost to Follow-up|5
5827891|NCT02483585|20134291|P1|Open-label Treatment Phase|Lost to Follow-up|3
5827892|NCT02483585|20134290|P2|Open-label Treatment Phase|Withdrawal by Subject|14
5827893|NCT02483585|20134291|P1|Open-label Treatment Phase|Withdrawal by Subject|18
5827894|NCT02483585|20134290|P2|Open-label Treatment Phase|Decision by Sponsor|1
5827895|NCT02483585|20134291|P1|Open-label Treatment Phase|Decision by Sponsor|0
5827896|NCT02483585|20134290|P2|Open-label Treatment Phase|Protocol-specified Criteria|5
5827897|NCT02483585|20134291|P1|Open-label Treatment Phase|Protocol-specified Criteria|6
5827898|NCT02483585|20134290|P2|Double-blind Treatment Phase|Lost to Follow-up|2
5827899|NCT02483585|20134291|P1|Double-blind Treatment Phase|Lost to Follow-up|3
5827900|NCT02483585|20134290|P2|Double-blind Treatment Phase|Withdrawal by Subject|12
5827901|NCT02483585|20134291|P1|Double-blind Treatment Phase|Withdrawal by Subject|12
5827902|NCT02483585|20134290|P2|Double-blind Treatment Phase|Decision by Sponsor|1
5827903|NCT02483585|20134291|P1|Double-blind Treatment Phase|Decision by Sponsor|1
5827904|NCT02483572|20134313|P2|Overall Study|Physician Decision|1
5827905|NCT02483572|20134314|P1|Overall Study|Physician Decision|0
5827906|NCT02483572|20134313|P2|Overall Study|Lost to Follow-up|0
5827907|NCT02483572|20134314|P1|Overall Study|Lost to Follow-up|1
5827908|NCT02483572|20134313|P2|Overall Study|Withdrawal by Subject|0
5827909|NCT02483572|20134314|P1|Overall Study|Withdrawal by Subject|1
5827910|NCT02483533|20134328|P2|Overall Study|Lack of Efficacy|50
5827911|NCT02483533|20134329|P1|Overall Study|Lack of Efficacy|50
5827912|NCT02483520|20134339|P2|Overall Study|Moved to LTC|3
5827913|NCT02483520|20134340|P1|Overall Study|Moved to LTC|2
5827914|NCT02483520|20134339|P2|Overall Study|Hospitalized|3
5827915|NCT02483520|20134340|P1|Overall Study|Hospitalized|2
5827916|NCT02483520|20134339|P2|Overall Study|Withdrawal by Subject|14
5827917|NCT02483520|20134340|P1|Overall Study|Withdrawal by Subject|4
5827918|NCT02483520|20134339|P2|Overall Study|Lost to Follow-up|4
5827919|NCT02483520|20134340|P1|Overall Study|Lost to Follow-up|3
5827920|NCT02483416|20134380|P2|Overall Study|Treatment stop|0
5827921|NCT02483416|20134381|P1|Overall Study|Treatment stop|3
5827922|NCT02483416|20134380|P2|Overall Study|Other reason|1
5827923|NCT02483416|20134381|P1|Overall Study|Other reason|0
5827924|NCT02482935|20134445|P2|Period 1|Withdrawal by Subject|0
5827925|NCT02482935|20134446|P1|Period 1|Withdrawal by Subject|1
5827926|NCT02482805|20134474|P3|Overall Study|Lost to Follow-up|0
5827927|NCT02482805|20134475|P2|Overall Study|Lost to Follow-up|4
5827928|NCT02482805|20134476|P1|Overall Study|Lost to Follow-up|4
5827929|NCT02482571|20134595|P1|Overall Study|Withdrawal by Subject|4
5827930|NCT02482571|20134595|P1|Overall Study|Scanner or Respiract failure|3
5827931|NCT02482571|20134595|P1|Overall Study|Adverse Event|1
5827932|NCT02482428|20134607|P5|Overall Study|subject/guardian decision|2
5827933|NCT02482428|20134608|P4|Overall Study|subject/guardian decision|0
5827934|NCT02482428|20134609|P3|Overall Study|subject/guardian decision|0
5827935|NCT02482428|20134610|P2|Overall Study|subject/guardian decision|2
5827936|NCT02482428|20134611|P1|Overall Study|subject/guardian decision|4
5827937|NCT02482428|20134607|P5|Overall Study|protocol deviation|0
5827938|NCT02482428|20134608|P4|Overall Study|protocol deviation|0
5827939|NCT02482428|20134609|P3|Overall Study|protocol deviation|0
5827940|NCT02482428|20134610|P2|Overall Study|protocol deviation|1
5827941|NCT02482428|20134611|P1|Overall Study|protocol deviation|1
5827942|NCT02482428|20134607|P5|Overall Study|Physician Decision|1
5827943|NCT02482428|20134608|P4|Overall Study|Physician Decision|0
5827944|NCT02482428|20134609|P3|Overall Study|Physician Decision|0
5827945|NCT02482428|20134610|P2|Overall Study|Physician Decision|0
5827946|NCT02482428|20134611|P1|Overall Study|Physician Decision|0
5827947|NCT02482428|20134607|P5|Overall Study|Lost to Follow-up|4
5827948|NCT02482428|20134608|P4|Overall Study|Lost to Follow-up|2
5827949|NCT02482428|20134609|P3|Overall Study|Lost to Follow-up|1
5827950|NCT02482428|20134610|P2|Overall Study|Lost to Follow-up|9
5827951|NCT02482428|20134611|P1|Overall Study|Lost to Follow-up|4
5827952|NCT02482298|20134634|P3|Overall Study|Lost to Follow-up|0
5827953|NCT02482298|20134635|P2|Overall Study|Lost to Follow-up|1
5827954|NCT02482298|20134636|P1|Overall Study|Lost to Follow-up|0
5827955|NCT02482298|20134634|P3|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|1
5827956|NCT02482298|20134635|P2|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0
5827957|NCT02482298|20134636|P1|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0
5827958|NCT02482298|20134634|P3|Overall Study|Did Not Fulfill Randomization Criteria|0
5827959|NCT02482298|20134635|P2|Overall Study|Did Not Fulfill Randomization Criteria|1
5827960|NCT02482298|20134636|P1|Overall Study|Did Not Fulfill Randomization Criteria|0
5827961|NCT02482298|20134634|P3|Overall Study|Withdrawal by Subject|2
5827962|NCT02482298|20134635|P2|Overall Study|Withdrawal by Subject|1
5827963|NCT02482298|20134636|P1|Overall Study|Withdrawal by Subject|2
5827964|NCT02482233|20134658|P2|Overall Study|Lost to Follow-up|1
5827965|NCT02482233|20134659|P1|Overall Study|Lost to Follow-up|1
5827966|NCT02482129|20134695|P2|Overall Study|Criteria not met|0
5827967|NCT02482129|20134696|P1|Overall Study|Criteria not met|1
5827968|NCT02482129|20134695|P2|Overall Study|Withdrawal by Subject|0
5827969|NCT02482129|20134696|P1|Overall Study|Withdrawal by Subject|2
5827970|NCT02482129|20134695|P2|Overall Study|Adverse Event|0
5827971|NCT02482129|20134696|P1|Overall Study|Adverse Event|1
5827972|NCT02482129|20134695|P2|Overall Study|Criteria not met-prior to treatment|0
5827973|NCT02482129|20134696|P1|Overall Study|Criteria not met-prior to treatment|1
5827974|NCT02482129|20134695|P2|Overall Study|Unable to draw blood-prior to treatment|0
5827975|NCT02482129|20134696|P1|Overall Study|Unable to draw blood-prior to treatment|1
5827976|NCT02482129|20134695|P2|Overall Study|Withdrawal by subject-prior to treatment|1
5827977|NCT02482129|20134696|P1|Overall Study|Withdrawal by subject-prior to treatment|0
5827978|NCT02482129|20134695|P2|Overall Study|Adverse Event-prior to treatment|1
5827979|NCT02482129|20134696|P1|Overall Study|Adverse Event-prior to treatment|0
5827980|NCT02481947|20134736|P2|Overall Study|Protocol Violation|5
5827981|NCT02481947|20134737|P1|Overall Study|Protocol Violation|1
5827982|NCT02481947|20134736|P2|Overall Study|Physician Decision|5
5827983|NCT02481947|20134737|P1|Overall Study|Physician Decision|4
5827984|NCT02481947|20134736|P2|Overall Study|Adverse Event|11
5827985|NCT02481947|20134737|P1|Overall Study|Adverse Event|6
5827986|NCT02481947|20134736|P2|Overall Study|Lost to Follow-up|5
5827987|NCT02481947|20134737|P1|Overall Study|Lost to Follow-up|11
5827988|NCT02481947|20134736|P2|Overall Study|Withdrawal by Subject|10
5827989|NCT02481947|20134737|P1|Overall Study|Withdrawal by Subject|24
5827990|NCT02481934|20134743|P1|Overall Study|Death|2
5827991|NCT02481830|20134750|P2|Overall Study|Participant not eligible for trial|1
5827992|NCT02481830|20134751|P1|Overall Study|Participant not eligible for trial|0
5827993|NCT02481830|20134750|P2|Overall Study|Disease Progression|1
5827994|NCT02481830|20134751|P1|Overall Study|Disease Progression|1
5827995|NCT02481830|20134750|P2|Overall Study|Withdrawal by Subject|14
5827996|NCT02481830|20134751|P1|Overall Study|Withdrawal by Subject|0
5827997|NCT02481830|20134750|P2|Overall Study|No longer meets Study Criteria|4
5827998|NCT02481830|20134751|P1|Overall Study|No longer meets Study Criteria|1
5827999|NCT02481050|20134958|P1|Overall Study|Other|3
5828000|NCT02481050|20134958|P1|Overall Study|Withdrawal by Subject|7
5828001|NCT02481050|20134958|P1|Overall Study|Disease Progression|47
5828002|NCT02481050|20134958|P1|Overall Study|Adverse Event|1
5828003|NCT02480764|20134989|P3|Overall Study|Reason not Specified|0
5828004|NCT02480764|20134990|P2|Overall Study|Reason not Specified|1
5828005|NCT02480764|20134991|P1|Overall Study|Reason not Specified|0
5828006|NCT02480764|20134989|P3|Overall Study|Lack of Efficacy|3
5828007|NCT02480764|20134990|P2|Overall Study|Lack of Efficacy|3
5828008|NCT02480764|20134991|P1|Overall Study|Lack of Efficacy|0
5828009|NCT02480764|20134989|P3|Overall Study|Voluntary Withdrawal|10
5828010|NCT02480764|20134990|P2|Overall Study|Voluntary Withdrawal|5
5828011|NCT02480764|20134991|P1|Overall Study|Voluntary Withdrawal|6
5828012|NCT02480764|20134989|P3|Overall Study|Lost to Follow-up|2
5828013|NCT02480764|20134990|P2|Overall Study|Lost to Follow-up|1
5828014|NCT02480764|20134991|P1|Overall Study|Lost to Follow-up|0
5828015|NCT02480764|20134989|P3|Overall Study|Major Protocol Deviation|3
5828016|NCT02480764|20134990|P2|Overall Study|Major Protocol Deviation|4
5828017|NCT02480764|20134991|P1|Overall Study|Major Protocol Deviation|1
5828018|NCT02480764|20134989|P3|Overall Study|Pretreatment Event/Adverse Event|3
5828019|NCT02480764|20134990|P2|Overall Study|Pretreatment Event/Adverse Event|6
5828020|NCT02480764|20134991|P1|Overall Study|Pretreatment Event/Adverse Event|3
5828021|NCT02480712|20135017|P1|Overall Study|Lack of Efficacy|1
5828022|NCT02480712|20135017|P1|Overall Study|Death|1
5828023|NCT02480712|20135017|P1|Overall Study|Withdrew Consent|3
5828024|NCT02480712|20135017|P1|Overall Study|Lost to Follow-up|5
5828025|NCT02480712|20135017|P1|Overall Study|Enrolled but Never Treated|1
5828026|NCT02480621|20135036|P2|Follow Up|Lost to Follow-up|2
5828027|NCT02480621|20135037|P1|Follow Up|Lost to Follow-up|4
5828028|NCT02480621|20135036|P2|Randomization|Surgeon did not give intervention|1
5828029|NCT02480621|20135037|P1|Randomization|Surgeon did not give intervention|0
5828030|NCT02480621|20135036|P2|Randomization|Withdrawal by Subject|0
5828031|NCT02480621|20135037|P1|Randomization|Withdrawal by Subject|1
5828032|NCT02480153|20135114|P3|Period 3: Week 52 Dosing to Week 78|Death|0
5828033|NCT02480153|20135115|P2|Period 3: Week 52 Dosing to Week 78|Death|1
5828034|NCT02480153|20135116|P1|Period 3: Week 52 Dosing to Week 78|Death|0
5828035|NCT02480153|20135114|P3|Period 3: Week 52 Dosing to Week 78|Adverse Event|1
5828036|NCT02480153|20135115|P2|Period 3: Week 52 Dosing to Week 78|Adverse Event|0
5828037|NCT02480153|20135116|P1|Period 3: Week 52 Dosing to Week 78|Adverse Event|0
5828038|NCT02480153|20135114|P3|Period 3: Week 52 Dosing to Week 78|Other|1
5828039|NCT02480153|20135115|P2|Period 3: Week 52 Dosing to Week 78|Other|0
5828040|NCT02480153|20135116|P1|Period 3: Week 52 Dosing to Week 78|Other|0
5828041|NCT02480153|20135114|P3|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|1
5828042|NCT02480153|20135115|P2|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|0
5828043|NCT02480153|20135116|P1|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|4
5828044|NCT02480153|20135114|P3|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|1
5828045|NCT02480153|20135115|P2|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|2
5828046|NCT02480153|20135116|P1|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|3
5828047|NCT02480153|20135114|P3|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0
5828048|NCT02480153|20135115|P2|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|1
5828049|NCT02480153|20135116|P1|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0
5828050|NCT02480153|20135114|P3|Period 2: Week 26 to Week 52 Pre-dose|Other|0
5828051|NCT02480153|20135115|P2|Period 2: Week 26 to Week 52 Pre-dose|Other|0
5828052|NCT02480153|20135116|P1|Period 2: Week 26 to Week 52 Pre-dose|Other|2
5828053|NCT02480153|20135114|P3|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|3
5828054|NCT02480153|20135115|P2|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|7
5828055|NCT02480153|20135116|P1|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|6
5828056|NCT02480153|20135114|P3|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|1
5828057|NCT02480153|20135115|P2|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|3
5828058|NCT02480153|20135116|P1|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|8
5828059|NCT02480153|20135114|P3|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0
5828060|NCT02480153|20135115|P2|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|1
5828061|NCT02480153|20135116|P1|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0
5828062|NCT02480153|20135114|P3|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|3
5828063|NCT02480153|20135115|P2|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|1
5828064|NCT02480153|20135116|P1|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|4
5828065|NCT02480153|20135114|P3|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0
5828066|NCT02480153|20135115|P2|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|2
5828067|NCT02480153|20135116|P1|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0
5828068|NCT02480153|20135114|P3|Period 1: First Dose to Week 26 Pre-dose|Death|0
5828069|NCT02480153|20135115|P2|Period 1: First Dose to Week 26 Pre-dose|Death|1
5828070|NCT02480153|20135116|P1|Period 1: First Dose to Week 26 Pre-dose|Death|0
5828071|NCT02480153|20135114|P3|Period 1: First Dose to Week 26 Pre-dose|Other|0
5828072|NCT02480153|20135115|P2|Period 1: First Dose to Week 26 Pre-dose|Other|1
5828073|NCT02480153|20135116|P1|Period 1: First Dose to Week 26 Pre-dose|Other|0
5828074|NCT02480153|20135114|P3|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|0
5828075|NCT02480153|20135115|P2|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|8
5828076|NCT02480153|20135116|P1|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|3
5828077|NCT02480153|20135114|P3|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|0
5828078|NCT02480153|20135115|P2|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|2
5828079|NCT02480153|20135116|P1|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|1
5828080|NCT02480153|20135114|P3|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0
5828081|NCT02480153|20135115|P2|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|1
5828082|NCT02480153|20135116|P1|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0
5828083|NCT02480153|20135114|P3|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0
5828084|NCT02480153|20135115|P2|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|1
5828085|NCT02480153|20135116|P1|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0
5828096|NCT02480010|20135306|P2|Overall Study|Refused Treatment|3
5828097|NCT02480010|20135307|P1|Overall Study|Refused Treatment|0
5828098|NCT02480010|20135306|P2|Overall Study|Insufficient therapeutic response|29
5828099|NCT02480010|20135307|P1|Overall Study|Insufficient therapeutic response|31
5828100|NCT02480010|20135306|P2|Overall Study|Death|0
5828101|NCT02480010|20135307|P1|Overall Study|Death|1
5828102|NCT02480010|20135306|P2|Overall Study|Adverse Event|1
5828103|NCT02480010|20135307|P1|Overall Study|Adverse Event|3
5828104|NCT02479880|20135353|P2|Overall Study|Pregnancy|1
5828105|NCT02479880|20135354|P1|Overall Study|Pregnancy|0
5828106|NCT02479880|20135353|P2|Overall Study|Study Terminated by Sponsor|12
5828107|NCT02479880|20135354|P1|Overall Study|Study Terminated by Sponsor|13
5828108|NCT02479802|20135360|P1|Overall Study|Adverse Event|1
5828109|NCT02479802|20135360|P1|Overall Study|Lost to Follow-up|1
5828110|NCT02479412|20135387|P9|Overall Study|Randomization to wrong PK sampling group|0
5828111|NCT02479412|20135388|P8|Overall Study|Randomization to wrong PK sampling group|0
5828112|NCT02479412|20135389|P7|Overall Study|Randomization to wrong PK sampling group|0
5828113|NCT02479412|20135390|P6|Overall Study|Randomization to wrong PK sampling group|0
5828114|NCT02479412|20135391|P5|Overall Study|Randomization to wrong PK sampling group|1
5828115|NCT02479412|20135392|P4|Overall Study|Randomization to wrong PK sampling group|0
5828116|NCT02479412|20135393|P3|Overall Study|Randomization to wrong PK sampling group|0
5828117|NCT02479412|20135394|P2|Overall Study|Randomization to wrong PK sampling group|0
5828118|NCT02479412|20135395|P1|Overall Study|Randomization to wrong PK sampling group|0
5828119|NCT02479412|20135387|P9|Overall Study|Study-specific withdrawal criteria|1
5828120|NCT02479412|20135388|P8|Overall Study|Study-specific withdrawal criteria|1
5828121|NCT02479412|20135389|P7|Overall Study|Study-specific withdrawal criteria|0
5828122|NCT02479412|20135390|P6|Overall Study|Study-specific withdrawal criteria|0
5828123|NCT02479412|20135391|P5|Overall Study|Study-specific withdrawal criteria|0
5828124|NCT02479412|20135392|P4|Overall Study|Study-specific withdrawal criteria|1
5828125|NCT02479412|20135393|P3|Overall Study|Study-specific withdrawal criteria|1
5828126|NCT02479412|20135394|P2|Overall Study|Study-specific withdrawal criteria|0
5828127|NCT02479412|20135395|P1|Overall Study|Study-specific withdrawal criteria|0
5828128|NCT02479412|20135387|P9|Overall Study|Adverse Event|0
5828129|NCT02479412|20135388|P8|Overall Study|Adverse Event|0
5828130|NCT02479412|20135389|P7|Overall Study|Adverse Event|0
5828131|NCT02479412|20135390|P6|Overall Study|Adverse Event|0
5828132|NCT02479412|20135391|P5|Overall Study|Adverse Event|0
5828133|NCT02479412|20135392|P4|Overall Study|Adverse Event|0
5828134|NCT02479412|20135393|P3|Overall Study|Adverse Event|1
5828135|NCT02479412|20135394|P2|Overall Study|Adverse Event|0
5828136|NCT02479412|20135395|P1|Overall Study|Adverse Event|0
5828137|NCT02479139|20135472|P6|Overall Study|Other Miscellaneous Reasons|0
5828138|NCT02479139|20135473|P5|Overall Study|Other Miscellaneous Reasons|1
5828139|NCT02479139|20135474|P4|Overall Study|Other Miscellaneous Reasons|1
5828140|NCT02479139|20135475|P3|Overall Study|Other Miscellaneous Reasons|1
5828141|NCT02479139|20135476|P2|Overall Study|Other Miscellaneous Reasons|0
5828142|NCT02479139|20135477|P1|Overall Study|Other Miscellaneous Reasons|1
5828143|NCT02479139|20135472|P6|Overall Study|Treatment Failure/Lack of Efficacy|0
5828144|NCT02479139|20135473|P5|Overall Study|Treatment Failure/Lack of Efficacy|0
5828145|NCT02479139|20135474|P4|Overall Study|Treatment Failure/Lack of Efficacy|0
5828146|NCT02479139|20135475|P3|Overall Study|Treatment Failure/Lack of Efficacy|1
5828147|NCT02479139|20135476|P2|Overall Study|Treatment Failure/Lack of Efficacy|0
5828148|NCT02479139|20135477|P1|Overall Study|Treatment Failure/Lack of Efficacy|0
5828149|NCT02479139|20135472|P6|Overall Study|Withdrew Consent|1
5828150|NCT02479139|20135473|P5|Overall Study|Withdrew Consent|1
5828151|NCT02479139|20135474|P4|Overall Study|Withdrew Consent|4
5828152|NCT02479139|20135475|P3|Overall Study|Withdrew Consent|1
5828153|NCT02479139|20135476|P2|Overall Study|Withdrew Consent|6
5828154|NCT02479139|20135477|P1|Overall Study|Withdrew Consent|5
5828155|NCT02479139|20135472|P6|Overall Study|Lost to Follow-up|5
5828156|NCT02479139|20135473|P5|Overall Study|Lost to Follow-up|3
5828157|NCT02479139|20135474|P4|Overall Study|Lost to Follow-up|2
5828158|NCT02479139|20135475|P3|Overall Study|Lost to Follow-up|4
5828159|NCT02479139|20135476|P2|Overall Study|Lost to Follow-up|4
5828160|NCT02479139|20135477|P1|Overall Study|Lost to Follow-up|2
5828161|NCT02478632|20135510|P2|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|1
5828162|NCT02478632|20135511|P1|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|5
5828163|NCT02478632|20135510|P2|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|3
5828164|NCT02478632|20135511|P1|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|2
5828165|NCT02478632|20135510|P2|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|5
5828166|NCT02478632|20135511|P1|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|4
5828167|NCT02478463|20135546|P1|Treatment Period 2 (Up to 52 Weeks)|Withdrawal by Subject|1
5828168|NCT02478463|20135546|P1|Washout Period (Up to 42 Days)|Lost to Follow-up|1
5828169|NCT02478463|20135546|P1|Treatment Period 1 (Up to Day 29)|Physician Decision|1
5828170|NCT02478398|20135663|P2|Overall Study|Withdrawal By Participant|4
5828171|NCT02478398|20135664|P1|Overall Study|Withdrawal By Participant|10
5828172|NCT02478398|20135663|P2|Overall Study|Withdrawal By Parent/Guardian|6
5828173|NCT02478398|20135664|P1|Overall Study|Withdrawal By Parent/Guardian|9
5828174|NCT02478398|20135663|P2|Overall Study|Protocol Violation|1
5828175|NCT02478398|20135664|P1|Overall Study|Protocol Violation|3
5828176|NCT02478398|20135663|P2|Overall Study|Non-Compliance With Study Drug|1
5828177|NCT02478398|20135664|P1|Overall Study|Non-Compliance With Study Drug|5
5828178|NCT02478398|20135663|P2|Overall Study|Lost to Follow-up|4
5828179|NCT02478398|20135664|P1|Overall Study|Lost to Follow-up|5
5828180|NCT02478398|20135663|P2|Overall Study|Adverse Event|5
5828181|NCT02478398|20135664|P1|Overall Study|Adverse Event|20
5828182|NCT02478372|20135684|P2|Overall Study|Death|2
5828183|NCT02478372|20135685|P1|Overall Study|Death|0
5828184|NCT02478372|20135684|P2|Overall Study|Lost to Follow-up|4
5828185|NCT02478372|20135685|P1|Overall Study|Lost to Follow-up|1
5828186|NCT02478372|20135684|P2|Overall Study|Protocol Violation|8
5828187|NCT02478372|20135685|P1|Overall Study|Protocol Violation|12
5828188|NCT02478359|20135709|P2|Overall Study|Disenrolled from health plan|65
5828189|NCT02478359|20135710|P1|Overall Study|Disenrolled from health plan|106
5828190|NCT02478164|20135782|P1|Overall Study|Withdrawal by Subject|1
5828191|NCT02478164|20135782|P1|Overall Study|Adverse Event|1
5828192|NCT02478164|20135782|P1|Overall Study|Lack of Efficacy|13
5828193|NCT02477670|20135795|P7|Stage 2|Withdrawal by Subject|0
5828194|NCT02477670|20135796|P6|Stage 2|Withdrawal by Subject|0
5828195|NCT02477670|20135797|P5|Stage 2|Withdrawal by Subject|0
5828196|NCT02477670|20135798|P4|Stage 2|Withdrawal by Subject|1
5828197|NCT02477670|20135799|P3|Stage 2|Withdrawal by Subject|0
5828198|NCT02477670|20135800|P2|Stage 2|Withdrawal by Subject|0
5828199|NCT02477670|20135801|P1|Stage 2|Withdrawal by Subject|0
5828200|NCT02477670|20135795|P7|Stage 2|Antipsychotic Medication Changed|0
5828201|NCT02477670|20135796|P6|Stage 2|Antipsychotic Medication Changed|0
5828202|NCT02477670|20135797|P5|Stage 2|Antipsychotic Medication Changed|0
5828203|NCT02477670|20135798|P4|Stage 2|Antipsychotic Medication Changed|0
5828204|NCT02477670|20135799|P3|Stage 2|Antipsychotic Medication Changed|1
5828205|NCT02477670|20135800|P2|Stage 2|Antipsychotic Medication Changed|0
5828206|NCT02477670|20135801|P1|Stage 2|Antipsychotic Medication Changed|0
5828207|NCT02477670|20135795|P7|Stage 2|Adverse Event|0
5828208|NCT02477670|20135796|P6|Stage 2|Adverse Event|0
5828209|NCT02477670|20135797|P5|Stage 2|Adverse Event|0
5828210|NCT02477670|20135798|P4|Stage 2|Adverse Event|0
5828211|NCT02477670|20135799|P3|Stage 2|Adverse Event|1
5828212|NCT02477670|20135800|P2|Stage 2|Adverse Event|0
5828213|NCT02477670|20135801|P1|Stage 2|Adverse Event|0
5828214|NCT02477670|20135795|P7|Stage 1|Non-compliance with Study Drug|0
5828215|NCT02477670|20135796|P6|Stage 1|Non-compliance with Study Drug|0
5828216|NCT02477670|20135797|P5|Stage 1|Non-compliance with Study Drug|0
5828217|NCT02477670|20135798|P4|Stage 1|Non-compliance with Study Drug|0
5828218|NCT02477670|20135799|P3|Stage 1|Non-compliance with Study Drug|0
5828219|NCT02477670|20135800|P2|Stage 1|Non-compliance with Study Drug|2
5828220|NCT02477670|20135801|P1|Stage 1|Non-compliance with Study Drug|1
5828221|NCT02477670|20135795|P7|Stage 1|Withdrawal by Subject|0
5828222|NCT02477670|20135796|P6|Stage 1|Withdrawal by Subject|0
5828223|NCT02477670|20135797|P5|Stage 1|Withdrawal by Subject|0
5828224|NCT02477670|20135798|P4|Stage 1|Withdrawal by Subject|0
5828225|NCT02477670|20135799|P3|Stage 1|Withdrawal by Subject|0
5828226|NCT02477670|20135800|P2|Stage 1|Withdrawal by Subject|2
5828227|NCT02477670|20135801|P1|Stage 1|Withdrawal by Subject|1
5828228|NCT02477670|20135795|P7|Stage 1|Lost to Follow-up|0
5828229|NCT02477670|20135796|P6|Stage 1|Lost to Follow-up|0
5828230|NCT02477670|20135797|P5|Stage 1|Lost to Follow-up|0
5828231|NCT02477670|20135798|P4|Stage 1|Lost to Follow-up|0
5828232|NCT02477670|20135799|P3|Stage 1|Lost to Follow-up|0
5828233|NCT02477670|20135800|P2|Stage 1|Lost to Follow-up|2
5828234|NCT02477670|20135801|P1|Stage 1|Lost to Follow-up|0
5828235|NCT02477670|20135795|P7|Stage 1|Adverse Event|0
5828236|NCT02477670|20135796|P6|Stage 1|Adverse Event|0
5828237|NCT02477670|20135797|P5|Stage 1|Adverse Event|0
5828238|NCT02477670|20135798|P4|Stage 1|Adverse Event|0
5828239|NCT02477670|20135799|P3|Stage 1|Adverse Event|0
5828240|NCT02477670|20135800|P2|Stage 1|Adverse Event|7
5828241|NCT02477670|20135801|P1|Stage 1|Adverse Event|2
5828242|NCT02477618|20136017|P2|Overall Study|Left Study Site for Rehabilitation|1
5828243|NCT02477618|20136018|P1|Overall Study|Left Study Site for Rehabilitation|0
5828244|NCT02477618|20136017|P2|Overall Study|Transferred Away from Study Site|0
5828245|NCT02477618|20136018|P1|Overall Study|Transferred Away from Study Site|1
5828246|NCT02477618|20136017|P2|Overall Study|Adverse Event|1
5828247|NCT02477618|20136018|P1|Overall Study|Adverse Event|1
5828248|NCT02477618|20136017|P2|Overall Study|Died in Double-Blind Treatment Period|11
5828249|NCT02477618|20136018|P1|Overall Study|Died in Double-Blind Treatment Period|11
5828250|NCT02477618|20136017|P2|Overall Study|Completed Visits but Discontinued Drug|1
5828251|NCT02477618|20136018|P1|Overall Study|Completed Visits but Discontinued Drug|2
5828252|NCT02477605|20136042|P2|Overall Study|Administered gas during surgery|1
5828253|NCT02477605|20136043|P1|Overall Study|Administered gas during surgery|0
5828254|NCT02477605|20136042|P2|Overall Study|Withdrawal by Subject|1
5828255|NCT02477605|20136043|P1|Overall Study|Withdrawal by Subject|0
5828256|NCT02477605|20136042|P2|Overall Study|Lost to Follow-up|2
5828257|NCT02477605|20136043|P1|Overall Study|Lost to Follow-up|0
5828258|NCT02477605|20136042|P2|Overall Study|Discontinued prior to treatment|0
5828259|NCT02477605|20136043|P1|Overall Study|Discontinued prior to treatment|1
5828260|NCT02477553|20136059|P2|Overall Study|patient deceased|0
5828261|NCT02477553|20136060|P1|Overall Study|patient deceased|1
5828262|NCT02477553|20136059|P2|Overall Study|MD advised against screening|3
5828263|NCT02477553|20136060|P1|Overall Study|MD advised against screening|1
5828264|NCT02477553|20136059|P2|Overall Study|Elevated risk for CRC|2
5828265|NCT02477553|20136060|P1|Overall Study|Elevated risk for CRC|2
5828266|NCT02477553|20136059|P2|Overall Study|Technical issues with intervention|0
5828267|NCT02477553|20136060|P1|Overall Study|Technical issues with intervention|2
5828268|NCT02477553|20136059|P2|Overall Study|Workup consistent w/CRC|1
5828269|NCT02477553|20136060|P1|Overall Study|Workup consistent w/CRC|1
5828270|NCT02477553|20136059|P2|Overall Study|No MD visit|1
5828271|NCT02477553|20136060|P1|Overall Study|No MD visit|1
5828272|NCT02477553|20136059|P2|Overall Study|Screening up-to-date|13
5828273|NCT02477553|20136060|P1|Overall Study|Screening up-to-date|12
5828274|NCT02477527|20136080|P1|Overall Study|Screen Failure|3
5828275|NCT02477527|20136080|P1|Overall Study|Withdrawal by Subject|1
5828276|NCT02477527|20136080|P1|Overall Study|Lost to Follow-up|2
5828277|NCT02477332|20136115|P6|Overall Study|Withdrawal by Subject|0
5828278|NCT02477332|20136116|P5|Overall Study|Withdrawal by Subject|1
5828279|NCT02477332|20136117|P4|Overall Study|Withdrawal by Subject|2
5828280|NCT02477332|20136118|P3|Overall Study|Withdrawal by Subject|1
5828281|NCT02477332|20136119|P2|Overall Study|Withdrawal by Subject|3
5828282|NCT02477332|20136120|P1|Overall Study|Withdrawal by Subject|0
5828283|NCT02477332|20136115|P6|Overall Study|Physician Decision|1
5828284|NCT02477332|20136116|P5|Overall Study|Physician Decision|0
5828285|NCT02477332|20136117|P4|Overall Study|Physician Decision|3
5828286|NCT02477332|20136118|P3|Overall Study|Physician Decision|1
5828287|NCT02477332|20136119|P2|Overall Study|Physician Decision|0
5828288|NCT02477332|20136120|P1|Overall Study|Physician Decision|0
5828289|NCT02477332|20136115|P6|Overall Study|Lost to Follow-up|0
5828290|NCT02477332|20136116|P5|Overall Study|Lost to Follow-up|0
5828291|NCT02477332|20136117|P4|Overall Study|Lost to Follow-up|0
5828292|NCT02477332|20136118|P3|Overall Study|Lost to Follow-up|2
5828293|NCT02477332|20136119|P2|Overall Study|Lost to Follow-up|0
5828294|NCT02477332|20136120|P1|Overall Study|Lost to Follow-up|0
5828295|NCT02477332|20136115|P6|Overall Study|Technical problems|0
5828296|NCT02477332|20136116|P5|Overall Study|Technical problems|0
5828297|NCT02477332|20136117|P4|Overall Study|Technical problems|0
5828298|NCT02477332|20136118|P3|Overall Study|Technical problems|1
5828299|NCT02477332|20136119|P2|Overall Study|Technical problems|0
5828300|NCT02477332|20136120|P1|Overall Study|Technical problems|0
5828301|NCT02477332|20136115|P6|Overall Study|Protocol Violation|1
5828302|NCT02477332|20136116|P5|Overall Study|Protocol Violation|1
5828303|NCT02477332|20136117|P4|Overall Study|Protocol Violation|3
5828304|NCT02477332|20136118|P3|Overall Study|Protocol Violation|3
5828305|NCT02477332|20136119|P2|Overall Study|Protocol Violation|0
5828306|NCT02477332|20136120|P1|Overall Study|Protocol Violation|2
5828307|NCT02477332|20136115|P6|Overall Study|Pregnancy|0
5828308|NCT02477332|20136116|P5|Overall Study|Pregnancy|0
5828309|NCT02477332|20136117|P4|Overall Study|Pregnancy|1
5828310|NCT02477332|20136118|P3|Overall Study|Pregnancy|0
5828311|NCT02477332|20136119|P2|Overall Study|Pregnancy|0
5828312|NCT02477332|20136120|P1|Overall Study|Pregnancy|0
5828313|NCT02477332|20136115|P6|Overall Study|Non-compliance with study treatment|0
5828314|NCT02477332|20136116|P5|Overall Study|Non-compliance with study treatment|0
5828315|NCT02477332|20136117|P4|Overall Study|Non-compliance with study treatment|0
5828316|NCT02477332|20136118|P3|Overall Study|Non-compliance with study treatment|2
5828317|NCT02477332|20136119|P2|Overall Study|Non-compliance with study treatment|1
5828318|NCT02477332|20136120|P1|Overall Study|Non-compliance with study treatment|0
5828319|NCT02477332|20136115|P6|Overall Study|Lack of Efficacy|1
5828320|NCT02477332|20136116|P5|Overall Study|Lack of Efficacy|1
5828321|NCT02477332|20136117|P4|Overall Study|Lack of Efficacy|2
5828322|NCT02477332|20136118|P3|Overall Study|Lack of Efficacy|1
5828323|NCT02477332|20136119|P2|Overall Study|Lack of Efficacy|2
5828324|NCT02477332|20136120|P1|Overall Study|Lack of Efficacy|1
5828325|NCT02477332|20136115|P6|Overall Study|Adverse Event|2
5828326|NCT02477332|20136116|P5|Overall Study|Adverse Event|1
5828327|NCT02477332|20136117|P4|Overall Study|Adverse Event|2
5828328|NCT02477332|20136118|P3|Overall Study|Adverse Event|1
5828329|NCT02477332|20136119|P2|Overall Study|Adverse Event|1
5828330|NCT02477332|20136120|P1|Overall Study|Adverse Event|0
5828331|NCT02477215|20136212|P3|Fixed Dose Phase|Physician Decision|0
5828332|NCT02477215|20136213|P2|Fixed Dose Phase|Physician Decision|7
5828333|NCT02477215|20136214|P1|Fixed Dose Phase|Physician Decision|0
5828334|NCT02477215|20136212|P3|Dose Escalation Phase|Physician Decision|0
5828335|NCT02477215|20136213|P2|Dose Escalation Phase|Physician Decision|2
5828336|NCT02477215|20136214|P1|Dose Escalation Phase|Physician Decision|1
5828337|NCT02477020|20136230|P2|Overall Study|Lack of Efficacy|5
5828338|NCT02477020|20136231|P1|Overall Study|Lack of Efficacy|14
5828339|NCT02477020|20136230|P2|Overall Study|Reason not Specified|1
5828340|NCT02477020|20136231|P1|Overall Study|Reason not Specified|3
5828341|NCT02477020|20136230|P2|Overall Study|Voluntary Withdrawal|16
5828342|NCT02477020|20136231|P1|Overall Study|Voluntary Withdrawal|7
5828343|NCT02477020|20136230|P2|Overall Study|Pretreatment Event/Adverse Event|6
5828344|NCT02477020|20136231|P1|Overall Study|Pretreatment Event/Adverse Event|6
5828345|NCT02476994|20136261|P2|Overall Study|Based on feedback from FDA|0
5828346|NCT02476994|20136262|P1|Overall Study|Based on feedback from FDA|1
5828347|NCT02476617|20136331|P1|Overall Study|Lost to Follow-up|1
5828348|NCT02476617|20136331|P1|Overall Study|Adverse Event|1
5828349|NCT02476578|20136337|P2|Overall Study|Lost to Follow-up|13
5828350|NCT02476578|20136338|P1|Overall Study|Lost to Follow-up|6
5828351|NCT02476578|20136337|P2|Overall Study|Died before Email was sent (<9.11.2015)|43
5828352|NCT02476578|20136338|P1|Overall Study|Died before Email was sent (<9.11.2015)|35
5828353|NCT02476422|20136400|P2|Overall Study|Subject/guardian decision|1
5828354|NCT02476422|20136401|P1|Overall Study|Subject/guardian decision|0
5828355|NCT02476201|20136442|P1|Overall Study|Unsuccessful implant|1
5828356|NCT02476201|20136442|P1|Overall Study|Withdrawal by Subject|1
5828357|NCT02476201|20136442|P1|Overall Study|MPP programmed to OFF|2
5828358|NCT02476201|20136442|P1|Overall Study|Lost to Follow-up|2
5828359|NCT02476201|20136442|P1|Overall Study|Death|2
5828360|NCT02476201|20136442|P1|Overall Study|Adverse Event|4
5828361|NCT02476201|20136442|P1|Overall Study|Study echo not performed|5
5828362|NCT02476201|20136442|P1|Overall Study|Unable to program MPP|9
5828363|NCT02476175|20136450|P1|Overall Study|Adverse Event|2
5828364|NCT02476006|20136474|P1|Overall Study|Enrolled but not treated|4
5828365|NCT02476006|20136474|P1|Overall Study|Protocol Violation|1
5828366|NCT02476006|20136474|P1|Overall Study|Excluded from study|1
5828367|NCT02476006|20136474|P1|Overall Study|Switched to commercial drug|4
5828368|NCT02476006|20136474|P1|Overall Study|Study ended treatment not available|4
5828369|NCT02476006|20136474|P1|Overall Study|Physician Decision|5
5828370|NCT02476006|20136474|P1|Overall Study|Lost to Follow-up|5
5828371|NCT02476006|20136474|P1|Overall Study|Sponsor decision|6
5828372|NCT02476006|20136474|P1|Overall Study|Poor compliance to study protocol|3
5828373|NCT02476006|20136474|P1|Overall Study|Adverse Event|41
5828374|NCT02476006|20136474|P1|Overall Study|Participant did not wish to continue|39
5828375|NCT02476006|20136474|P1|Overall Study|Pregnancy|1
5828376|NCT02476006|20136474|P1|Overall Study|Lack of treatment efficacy|2
5828377|NCT02476006|20136474|P1|Overall Study|Death|4
5828378|NCT02475980|20136488|P1|Overall Study|Withdrawal by Subject|1
5828379|NCT02475980|20136488|P1|Overall Study|Lost to Follow-up|4
5828380|NCT02475733|20136514|P2|Overall Study|Physician Decision|0
5828381|NCT02475733|20136515|P1|Overall Study|Physician Decision|1
5828382|NCT02475733|20136514|P2|Overall Study|Withdrawal by Subject|0
5828383|NCT02475733|20136515|P1|Overall Study|Withdrawal by Subject|1
5828384|NCT02475655|20136572|P2|Overall Study|Lost to Follow-up|1
5828385|NCT02475655|20136573|P1|Overall Study|Lost to Follow-up|0
5828386|NCT02475629|20136725|P1|Overall Study|Subject non-compliance|1
5828387|NCT02475629|20136725|P1|Overall Study|Lost to Follow-up|1
5828388|NCT02475629|20136725|P1|Overall Study|Withdrawal by Subject|1
5828389|NCT02475629|20136725|P1|Overall Study|Physician Decision|1
5828390|NCT02475629|20136725|P1|Overall Study|Death|4
5828391|NCT02475629|20136725|P1|Overall Study|Adverse Event|1
5828392|NCT02475564|20136748|P2|Overall Study|Intense Menstrual bleeding|0
5828393|NCT02475564|20136749|P1|Overall Study|Intense Menstrual bleeding|1
5828394|NCT02475564|20136748|P2|Overall Study|Lost to Follow-up|1
5828395|NCT02475564|20136749|P1|Overall Study|Lost to Follow-up|2
5828396|NCT02475564|20136748|P2|Overall Study|Withdrawal by Subject|0
5828397|NCT02475564|20136749|P1|Overall Study|Withdrawal by Subject|1
5828398|NCT02475395|20136761|P2|Overall Study|Protocol Violation|3
5828399|NCT02475395|20136762|P1|Overall Study|Protocol Violation|30
5828400|NCT02475278|20136772|P1|Overall Study|Reason Not Specified|1
5828401|NCT02475278|20136772|P1|Overall Study|Lost to Follow-up|1
5828402|NCT02475265|20136783|P1|Overall Study|Withdrawal by Subject|2
5828403|NCT02475265|20136783|P1|Overall Study|Physician Decision|1
5828404|NCT02474589|20136834|P2|Overall Study|Inability to complete study procedures|1
5828405|NCT02474589|20136835|P1|Overall Study|Inability to complete study procedures|5
5828406|NCT02474589|20136834|P2|Overall Study|Withdrawal by Subject|0
5828407|NCT02474589|20136835|P1|Overall Study|Withdrawal by Subject|4
5828408|NCT02474589|20136834|P2|Overall Study|Protocol Violation|1
5828409|NCT02474589|20136835|P1|Overall Study|Protocol Violation|4
5828410|NCT02474589|20136834|P2|Overall Study|Lost to Follow-up|1
5828411|NCT02474589|20136835|P1|Overall Study|Lost to Follow-up|6
5828412|NCT02474589|20136834|P2|Overall Study|Adverse Event|2
5828413|NCT02474589|20136835|P1|Overall Study|Adverse Event|6
5828414|NCT02474082|20136894|P2|Overall Study|Protocol deviation|1
5828415|NCT02474082|20136895|P1|Overall Study|Protocol deviation|0
5828416|NCT02474082|20136894|P2|Overall Study|Non-compliance with study treatment|2
5828417|NCT02474082|20136895|P1|Overall Study|Non-compliance with study treatment|0
5828418|NCT02474082|20136894|P2|Overall Study|Participant/guardian decision|2
5828419|NCT02474082|20136895|P1|Overall Study|Participant/guardian decision|1
5828420|NCT02474082|20136894|P2|Overall Study|Dose tapering not achieved|4
5828421|NCT02474082|20136895|P1|Overall Study|Dose tapering not achieved|0
5828422|NCT02474082|20136894|P2|Overall Study|Lost to Follow-up|2
5828423|NCT02474082|20136895|P1|Overall Study|Lost to Follow-up|2
5828424|NCT02474082|20136894|P2|Overall Study|Withdrawal of informed consent|11
5828425|NCT02474082|20136895|P1|Overall Study|Withdrawal of informed consent|1
5828426|NCT02474082|20136894|P2|Overall Study|Adverse Event|32
5828427|NCT02474082|20136895|P1|Overall Study|Adverse Event|2
5828428|NCT02474069|20136929|P3|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2
5828429|NCT02474069|20136930|P2|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2
5828430|NCT02474069|20136931|P1|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|0
5828516|NCT02472964|20137194|P2|Part 2 (Week 24-week 48)|Protocol Violation|1
5828431|NCT02474069|20136929|P3|Comparative Dosing Phase (CDP)|Withdrawal by Subject|1
5828432|NCT02474069|20136930|P2|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0
5828433|NCT02474069|20136931|P1|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0
5828434|NCT02474069|20136929|P3|Comparative Dosing Phase (CDP)|Lost to Follow-up|1
5828435|NCT02474069|20136930|P2|Comparative Dosing Phase (CDP)|Lost to Follow-up|4
5828436|NCT02474069|20136931|P1|Comparative Dosing Phase (CDP)|Lost to Follow-up|0
5828437|NCT02474069|20136929|P3|Comparative Dosing Phase (CDP)|Adverse Event|2
5828438|NCT02474069|20136930|P2|Comparative Dosing Phase (CDP)|Adverse Event|3
5828439|NCT02474069|20136931|P1|Comparative Dosing Phase (CDP)|Adverse Event|0
5828440|NCT02474069|20136929|P3|Selection Phase (SP)|Withdrawal of Informed Consent|0
5828441|NCT02474069|20136930|P2|Selection Phase (SP)|Withdrawal of Informed Consent|0
5828442|NCT02474069|20136931|P1|Selection Phase (SP)|Withdrawal of Informed Consent|3
5828443|NCT02474069|20136929|P3|Selection Phase (SP)|Withdrawal by Subject|0
5828444|NCT02474069|20136930|P2|Selection Phase (SP)|Withdrawal by Subject|0
5828445|NCT02474069|20136931|P1|Selection Phase (SP)|Withdrawal by Subject|3
5828446|NCT02474069|20136929|P3|Selection Phase (SP)|Technical Problem|0
5828447|NCT02474069|20136930|P2|Selection Phase (SP)|Technical Problem|0
5828448|NCT02474069|20136931|P1|Selection Phase (SP)|Technical Problem|1
5828449|NCT02474069|20136929|P3|Selection Phase (SP)|No longer requires treatment|0
5828450|NCT02474069|20136930|P2|Selection Phase (SP)|No longer requires treatment|0
5828451|NCT02474069|20136931|P1|Selection Phase (SP)|No longer requires treatment|1
5828452|NCT02474069|20136929|P3|Selection Phase (SP)|Protocol Violation|0
5828453|NCT02474069|20136930|P2|Selection Phase (SP)|Protocol Violation|0
5828454|NCT02474069|20136931|P1|Selection Phase (SP)|Protocol Violation|1
5828455|NCT02474069|20136929|P3|Selection Phase (SP)|Physician Decision|0
5828456|NCT02474069|20136930|P2|Selection Phase (SP)|Physician Decision|0
5828457|NCT02474069|20136931|P1|Selection Phase (SP)|Physician Decision|1
5828458|NCT02474069|20136929|P3|Selection Phase (SP)|Lost to Follow-up|0
5828459|NCT02474069|20136930|P2|Selection Phase (SP)|Lost to Follow-up|0
5828460|NCT02474069|20136931|P1|Selection Phase (SP)|Lost to Follow-up|4
5828461|NCT02474069|20136929|P3|Selection Phase (SP)|Lack of Efficacy|0
5828462|NCT02474069|20136930|P2|Selection Phase (SP)|Lack of Efficacy|0
5828463|NCT02474069|20136931|P1|Selection Phase (SP)|Lack of Efficacy|1
5828464|NCT02474069|20136929|P3|Selection Phase (SP)|Adverse Event|0
5828465|NCT02474069|20136930|P2|Selection Phase (SP)|Adverse Event|0
5828466|NCT02474069|20136931|P1|Selection Phase (SP)|Adverse Event|8
5828467|NCT02473965|20136964|P2|Overall Study|Physician Decision|2
5828468|NCT02473965|20136965|P1|Overall Study|Physician Decision|0
5828469|NCT02473965|20136964|P2|Overall Study|Withdrawal by Subject|3
5828470|NCT02473965|20136965|P1|Overall Study|Withdrawal by Subject|2
5828471|NCT02473965|20136964|P2|Overall Study|MG worsening|1
5828472|NCT02473965|20136965|P1|Overall Study|MG worsening|4
5828473|NCT02473965|20136964|P2|Overall Study|Adverse Event|4
5828474|NCT02473965|20136965|P1|Overall Study|Adverse Event|6
5828475|NCT02473952|20136977|P2|Overall Study|Withdrawal by Subject|6
5828476|NCT02473952|20136978|P1|Overall Study|Withdrawal by Subject|0
5828477|NCT02473952|20136977|P2|Overall Study|Adverse Event|2
5828478|NCT02473952|20136978|P1|Overall Study|Adverse Event|2
5828479|NCT02473913|20136986|P2|Overall Study|Lost to Follow-up|3
5828480|NCT02473913|20136987|P1|Overall Study|Lost to Follow-up|3
5828481|NCT02473640|20137039|P1|Treatment Period 1|Adverse Event|1
5828482|NCT02473523|20137048|P1|Overall Study|Lost to Follow-up|1
5828483|NCT02473523|20137048|P1|Overall Study|Death|1
5828484|NCT02473510|20137069|P2|Overall Study|Lost to Follow-up|2
5828485|NCT02473510|20137070|P1|Overall Study|Lost to Follow-up|1
5828486|NCT02473471|20137084|P1|Overall Study|Lost to Follow-up|1
5828487|NCT02473471|20137084|P1|Overall Study|poor oral hygiene|2
5828488|NCT02473445|20137115|P1|Overall Study|Sponsor Decision|20
5828489|NCT02473445|20137115|P1|Overall Study|Withdrawal by Subject|2
5828490|NCT02473367|20137121|P1|Period 4|Lost to Follow-up|1
5828491|NCT02473367|20137121|P1|Wait 1|Withdrawal by Subject|1
5828492|NCT02473289|20137141|P2|Overall Study|Other|0
5828493|NCT02473289|20137142|P1|Overall Study|Other|2
5828494|NCT02473289|20137141|P2|Overall Study|Treatment Unblinded + Adverse event|1
5828495|NCT02473289|20137142|P1|Overall Study|Treatment Unblinded + Adverse event|0
5828496|NCT02473289|20137141|P2|Overall Study|Withdrawal of consent|7
5828497|NCT02473289|20137142|P1|Overall Study|Withdrawal of consent|6
5828498|NCT02473289|20137141|P2|Overall Study|Protocol Violation|1
5828499|NCT02473289|20137142|P1|Overall Study|Protocol Violation|0
5828500|NCT02473289|20137141|P2|Overall Study|Lost to Follow-up|1
5828501|NCT02473289|20137142|P1|Overall Study|Lost to Follow-up|1
5828502|NCT02473289|20137141|P2|Overall Study|Adverse Event|3
5828503|NCT02473289|20137142|P1|Overall Study|Adverse Event|2
5828504|NCT02472977|20137167|P3|Overall Study|Subject request to discontinue treatment|0
5828505|NCT02472977|20137168|P2|Overall Study|Subject request to discontinue treatment|1
5828506|NCT02472977|20137169|P1|Overall Study|Subject request to discontinue treatment|0
5828507|NCT02472977|20137167|P3|Overall Study|Study drug toxicity|2
5828508|NCT02472977|20137168|P2|Overall Study|Study drug toxicity|0
5828509|NCT02472977|20137169|P1|Overall Study|Study drug toxicity|2
5828510|NCT02472977|20137167|P3|Overall Study|Withdrawal by Subject|0
5828511|NCT02472977|20137168|P2|Overall Study|Withdrawal by Subject|1
5828512|NCT02472977|20137169|P1|Overall Study|Withdrawal by Subject|0
5828513|NCT02472977|20137167|P3|Overall Study|Disease progression|6
5828514|NCT02472977|20137168|P2|Overall Study|Disease progression|25
5828515|NCT02472977|20137169|P1|Overall Study|Disease progression|4
5828517|NCT02472964|20137195|P1|Part 2 (Week 24-week 48)|Protocol Violation|3
5828518|NCT02472964|20137194|P2|Part 2 (Week 24-week 48)|Withdrawal by Subject|1
5828519|NCT02472964|20137195|P1|Part 2 (Week 24-week 48)|Withdrawal by Subject|3
5828520|NCT02472964|20137194|P2|Part 2 (Week 24-week 48)|Lost to Follow-up|1
5828521|NCT02472964|20137195|P1|Part 2 (Week 24-week 48)|Lost to Follow-up|2
5828522|NCT02472964|20137194|P2|Part 2 (Week 24-week 48)|Physician Decision|1
5828523|NCT02472964|20137195|P1|Part 2 (Week 24-week 48)|Physician Decision|1
5828524|NCT02472964|20137194|P2|Part 2 (Week 24-week 48)|Death|1
5828525|NCT02472964|20137195|P1|Part 2 (Week 24-week 48)|Death|0
5828526|NCT02472964|20137194|P2|Part 2 (Week 24-week 48)|Disease Progression|56
5828527|NCT02472964|20137195|P1|Part 2 (Week 24-week 48)|Disease Progression|52
5828528|NCT02472964|20137194|P2|Part 2 (Week 24-week 48)|Adverse Event|2
5828529|NCT02472964|20137195|P1|Part 2 (Week 24-week 48)|Adverse Event|4
5828530|NCT02472964|20137194|P2|Part 1 (up to Week 24)|Other|1
5828531|NCT02472964|20137195|P1|Part 1 (up to Week 24)|Other|2
5828532|NCT02472964|20137194|P2|Part 1 (up to Week 24)|Withdrawal by Subject|2
5828533|NCT02472964|20137195|P1|Part 1 (up to Week 24)|Withdrawal by Subject|7
5828534|NCT02472964|20137194|P2|Part 1 (up to Week 24)|Lost to Follow-up|1
5828535|NCT02472964|20137195|P1|Part 1 (up to Week 24)|Lost to Follow-up|0
5828536|NCT02472964|20137194|P2|Part 1 (up to Week 24)|Physician Decision|1
5828537|NCT02472964|20137195|P1|Part 1 (up to Week 24)|Physician Decision|3
5828538|NCT02472964|20137194|P2|Part 1 (up to Week 24)|Death|6
5828539|NCT02472964|20137195|P1|Part 1 (up to Week 24)|Death|3
5828540|NCT02472964|20137194|P2|Part 1 (up to Week 24)|disease progression|47
5828541|NCT02472964|20137195|P1|Part 1 (up to Week 24)|disease progression|58
5828542|NCT02472964|20137194|P2|Part 1 (up to Week 24)|Adverse Event|4
5828543|NCT02472964|20137195|P1|Part 1 (up to Week 24)|Adverse Event|2
5828544|NCT02472886|20137204|P3|Overall Study|Lack of Efficacy|1
5828545|NCT02472886|20137205|P2|Overall Study|Lack of Efficacy|2
5828546|NCT02472886|20137206|P1|Overall Study|Lack of Efficacy|0
5828547|NCT02472847|20137234|P2|Overall Study|Withdrawal by Subject|5
5828548|NCT02472847|20137235|P1|Overall Study|Withdrawal by Subject|1
5828549|NCT02472795|20137246|P5|Overall Study|Withdrawal by Subject|1
5828550|NCT02472795|20137247|P4|Overall Study|Withdrawal by Subject|0
5828551|NCT02472795|20137248|P3|Overall Study|Withdrawal by Subject|0
5828552|NCT02472795|20137249|P2|Overall Study|Withdrawal by Subject|0
5828553|NCT02472795|20137250|P1|Overall Study|Withdrawal by Subject|0
5828554|NCT02472795|20137246|P5|Overall Study|Adverse Event|2
5828555|NCT02472795|20137247|P4|Overall Study|Adverse Event|0
5828556|NCT02472795|20137248|P3|Overall Study|Adverse Event|0
5828557|NCT02472795|20137249|P2|Overall Study|Adverse Event|1
5828558|NCT02472795|20137250|P1|Overall Study|Adverse Event|0
5828559|NCT02472756|20137282|P1|Maintenance (Approximately 2 Years)|Adverse Event|1
5828560|NCT02472756|20137282|P1|Maintenance (Approximately 2 Years)|Progression Disease|2
5828561|NCT02472756|20137282|P1|Maintenance (Approximately 2 Years)|Lack of Drug|7
5828562|NCT02472756|20137282|P1|Induction (Approximately 6 Months)|Enrolled But Not Treated|1
5828563|NCT02472756|20137282|P1|Induction (Approximately 6 Months)|Adverse Event|1
5828564|NCT02472652|20137303|P1|Overall Study|Lost to Follow-up|1
5828565|NCT02472639|20137310|P2|Overall Study|Physician Decision|3
5828566|NCT02472639|20137311|P1|Overall Study|Physician Decision|4
5828567|NCT02472405|20137367|P1|Overall Study|Adverse Event|1
5828568|NCT02472405|20137367|P1|Overall Study|Lost to Follow-up|9
5828569|NCT02472366|20137375|P2|Overall Study|Lost to Follow-up|0
5828570|NCT02472366|20137376|P1|Overall Study|Lost to Follow-up|1
5828571|NCT02472353|20137392|P2|Overall Study|Study Termination|4
5828572|NCT02472353|20137393|P1|Overall Study|Study Termination|1
5828573|NCT02472353|20137392|P2|Overall Study|Withdrawal by Subject|1
5828574|NCT02472353|20137393|P1|Overall Study|Withdrawal by Subject|2
5828575|NCT02472353|20137392|P2|Overall Study|Lost to Follow-up|1
5828576|NCT02472353|20137393|P1|Overall Study|Lost to Follow-up|1
5828577|NCT02472145|20137441|P3|Overall Study|Other|43
5828578|NCT02472145|20137442|P2|Overall Study|Other|45
5828579|NCT02472145|20137443|P1|Overall Study|Other|0
5828580|NCT02472145|20137441|P3|Overall Study|Sponsor decision|2
5828581|NCT02472145|20137442|P2|Overall Study|Sponsor decision|3
5828582|NCT02472145|20137443|P1|Overall Study|Sponsor decision|0
5828583|NCT02472145|20137441|P3|Overall Study|Withdrawal by Subject|13
5828584|NCT02472145|20137442|P2|Overall Study|Withdrawal by Subject|9
5828585|NCT02472145|20137443|P1|Overall Study|Withdrawal by Subject|0
5828586|NCT02472145|20137441|P3|Overall Study|Lost to Follow-up|0
5828587|NCT02472145|20137442|P2|Overall Study|Lost to Follow-up|1
5828588|NCT02472145|20137443|P1|Overall Study|Lost to Follow-up|0
5828589|NCT02472145|20137441|P3|Overall Study|Death|99
5828590|NCT02472145|20137442|P2|Overall Study|Death|101
5828591|NCT02472145|20137443|P1|Overall Study|Death|10
5828592|NCT02471755|20137464|P2|Overall Study|Lost to Follow-up|1
5828593|NCT02471755|20137465|P1|Overall Study|Lost to Follow-up|0
5828594|NCT02471755|20137464|P2|Overall Study|Withdrawal by Subject|0
5828595|NCT02471755|20137465|P1|Overall Study|Withdrawal by Subject|1
5828596|NCT02471612|20137494|P1|Overall Study|Lost to Follow-up|2
5828597|NCT02471404|20137525|P3|Overall Study|Other reasons not specified|12
5828598|NCT02471404|20137526|P2|Overall Study|Other reasons not specified|7
5828599|NCT02471404|20137527|P1|Overall Study|Other reasons not specified|10
5828600|NCT02471404|20137525|P3|Overall Study|Withdrawal by Subject|5
5828601|NCT02471404|20137526|P2|Overall Study|Withdrawal by Subject|4
5828602|NCT02471404|20137527|P1|Overall Study|Withdrawal by Subject|8
5828603|NCT02471404|20137525|P3|Overall Study|Protocol Violation|0
5828604|NCT02471404|20137526|P2|Overall Study|Protocol Violation|0
5828605|NCT02471404|20137527|P1|Overall Study|Protocol Violation|1
5828606|NCT02471404|20137525|P3|Overall Study|Lost to Follow-up|3
5828607|NCT02471404|20137526|P2|Overall Study|Lost to Follow-up|1
5828608|NCT02471404|20137527|P1|Overall Study|Lost to Follow-up|1
5828609|NCT02471404|20137525|P3|Overall Study|Failure to Meet Randomization Criteria|1
5828610|NCT02471404|20137526|P2|Overall Study|Failure to Meet Randomization Criteria|0
5828611|NCT02471404|20137527|P1|Overall Study|Failure to Meet Randomization Criteria|2
5828612|NCT02471404|20137525|P3|Overall Study|Developed Study Withdrawal Criteria|2
5828613|NCT02471404|20137526|P2|Overall Study|Developed Study Withdrawal Criteria|1
5828614|NCT02471404|20137527|P1|Overall Study|Developed Study Withdrawal Criteria|4
5828615|NCT02471404|20137525|P3|Overall Study|Adverse Event|2
5828616|NCT02471404|20137526|P2|Overall Study|Adverse Event|1
5828617|NCT02471404|20137527|P1|Overall Study|Adverse Event|7
5828618|NCT02471183|20137559|P1|Extended Treatment Period|Lack of Efficacy|1
5828619|NCT02471183|20137559|P1|Main Treatment Period|Withdrawal by Subject|1
5828620|NCT02471183|20137559|P1|Main Treatment Period|Adverse Event|1
5828621|NCT02471014|20137576|P2|Overall Study|Lost to Follow-up|2
5828622|NCT02471014|20137577|P1|Overall Study|Lost to Follow-up|2
5828623|NCT02470806|20137603|P2|Overall Study|Lack of Efficacy|15
5828624|NCT02470806|20137604|P1|Overall Study|Lack of Efficacy|5
5828625|NCT02470806|20137603|P2|Overall Study|Withdrawal by Subject|10
5828626|NCT02470806|20137604|P1|Overall Study|Withdrawal by Subject|3
5828627|NCT02470806|20137603|P2|Overall Study|Physician Decision|3
5828628|NCT02470806|20137604|P1|Overall Study|Physician Decision|0
5828629|NCT02470806|20137603|P2|Overall Study|Protocol Violation|11
5828630|NCT02470806|20137604|P1|Overall Study|Protocol Violation|4
5828631|NCT02470806|20137603|P2|Overall Study|Adverse Event|2
5828632|NCT02470806|20137604|P1|Overall Study|Adverse Event|5
5828633|NCT02470806|20137603|P2|Overall Study|Lost to Follow-up|1
5828634|NCT02470806|20137604|P1|Overall Study|Lost to Follow-up|1
5828635|NCT02470585|20137657|P3|Overall Study|Other|6
5828636|NCT02470585|20137658|P2|Overall Study|Other|4
5828637|NCT02470585|20137659|P1|Overall Study|Other|4
5828638|NCT02470585|20137657|P3|Overall Study|Lost to Follow-up|4
5828639|NCT02470585|20137658|P2|Overall Study|Lost to Follow-up|5
5828640|NCT02470585|20137659|P1|Overall Study|Lost to Follow-up|2
5828641|NCT02470585|20137657|P3|Overall Study|Withdrawal by Subject|29
5828642|NCT02470585|20137658|P2|Overall Study|Withdrawal by Subject|21
5828643|NCT02470585|20137659|P1|Overall Study|Withdrawal by Subject|19
5828644|NCT02470585|20137657|P3|Overall Study|Death|86
5828645|NCT02470585|20137658|P2|Overall Study|Death|87
5828646|NCT02470585|20137659|P1|Overall Study|Death|82
5828647|NCT02470429|20137692|P2|Overall Study|Withdrawal by Subject|0
5828648|NCT02470429|20137693|P1|Overall Study|Withdrawal by Subject|1
5828649|NCT02470429|20137692|P2|Overall Study|Adverse Event|0
5828650|NCT02470429|20137693|P1|Overall Study|Adverse Event|1
5828651|NCT02470403|20137711|P5|Overall Study|Subject/guardian decision|0
5828652|NCT02470403|20137712|P4|Overall Study|Subject/guardian decision|4
5828653|NCT02470403|20137713|P3|Overall Study|Subject/guardian decision|0
5828654|NCT02470403|20137714|P2|Overall Study|Subject/guardian decision|0
5828655|NCT02470403|20137715|P1|Overall Study|Subject/guardian decision|1
5828656|NCT02470403|20137711|P5|Overall Study|Lost to Follow-up|0
5828657|NCT02470403|20137712|P4|Overall Study|Lost to Follow-up|0
5828658|NCT02470403|20137713|P3|Overall Study|Lost to Follow-up|0
5828659|NCT02470403|20137714|P2|Overall Study|Lost to Follow-up|1
5828660|NCT02470403|20137715|P1|Overall Study|Lost to Follow-up|0
5828661|NCT02470403|20137711|P5|Overall Study|Adverse Event|0
5828662|NCT02470403|20137712|P4|Overall Study|Adverse Event|0
5828663|NCT02470403|20137713|P3|Overall Study|Adverse Event|0
5828664|NCT02470403|20137714|P2|Overall Study|Adverse Event|0
5828665|NCT02470403|20137715|P1|Overall Study|Adverse Event|1
5828666|NCT02469961|20137795|P2|Overall Study|Physician Decision|1
5828667|NCT02469961|20137796|P1|Overall Study|Physician Decision|4
5828668|NCT02469896|20137810|P2|Overall Study|Withdrawal by Subject|0
5828669|NCT02469896|20137811|P1|Overall Study|Withdrawal by Subject|2
5828670|NCT02469623|20137881|P1|Overall Study|Death|3
5828671|NCT02469623|20137881|P1|Overall Study|Withdrawal by Subject|2
5828672|NCT02469623|20137881|P1|Overall Study|Lost to Follow-up|4
5828673|NCT02469623|20137881|P1|Overall Study|Not consented for long-term follow-up|4
5828674|NCT02469610|20137888|P2|Overall Study|exclusion criteria|1
5828675|NCT02469610|20137889|P1|Overall Study|exclusion criteria|2
5828676|NCT02469610|20137888|P2|Overall Study|Lost to Follow-up|0
5828677|NCT02469610|20137889|P1|Overall Study|Lost to Follow-up|1
5828678|NCT02469610|20137888|P2|Overall Study|Death|0
5828679|NCT02469610|20137889|P1|Overall Study|Death|1
5828680|NCT02469415|20137916|P1|Overall Study|Investigational agent placed on hold|2
5828681|NCT02469415|20137916|P1|Overall Study|Withdrawal by Subject|1
5828682|NCT02469298|20137924|P4|Overall Study|Withdrawal by Subject|1
5828683|NCT02469298|20137925|P3|Overall Study|Withdrawal by Subject|0
5828684|NCT02469298|20137926|P2|Overall Study|Withdrawal by Subject|0
5828685|NCT02469298|20137927|P1|Overall Study|Withdrawal by Subject|0
5828686|NCT02469298|20137924|P4|Overall Study|Physician Decision|1
5828687|NCT02469298|20137925|P3|Overall Study|Physician Decision|0
5828688|NCT02469298|20137926|P2|Overall Study|Physician Decision|0
5828689|NCT02469298|20137927|P1|Overall Study|Physician Decision|0
5828690|NCT02469298|20137924|P4|Overall Study|Lost to Follow-up|0
5828691|NCT02469298|20137925|P3|Overall Study|Lost to Follow-up|1
5828692|NCT02469298|20137926|P2|Overall Study|Lost to Follow-up|0
5828693|NCT02469298|20137927|P1|Overall Study|Lost to Follow-up|1
5828694|NCT02469298|20137924|P4|Overall Study|Protocol Violation|0
5828695|NCT02469298|20137925|P3|Overall Study|Protocol Violation|1
5828696|NCT02469298|20137926|P2|Overall Study|Protocol Violation|1
5828697|NCT02469298|20137927|P1|Overall Study|Protocol Violation|0
5828698|NCT02469246|20138067|P2|Double-Blind Phase|Lost to Follow-up|5
5828699|NCT02469246|20138068|P1|Double-Blind Phase|Lost to Follow-up|9
5828700|NCT02469246|20138067|P2|Double-Blind Phase|Withdrew Consent|25
5828701|NCT02469246|20138068|P1|Double-Blind Phase|Withdrew Consent|25
5828702|NCT02469246|20138067|P2|Double-Blind Phase|Protocol Violation|1
5828703|NCT02469246|20138068|P1|Double-Blind Phase|Protocol Violation|1
5828704|NCT02469246|20138067|P2|Double-Blind Phase|Non-Compliance with Study Drug|1
5828705|NCT02469246|20138068|P1|Double-Blind Phase|Non-Compliance with Study Drug|3
5828706|NCT02469246|20138067|P2|Double-Blind Phase|Investigator's Discretion|8
5828707|NCT02469246|20138068|P1|Double-Blind Phase|Investigator's Discretion|8
5828708|NCT02469246|20138067|P2|Double-Blind Phase|Lack of Efficacy|1
5828709|NCT02469246|20138068|P1|Double-Blind Phase|Lack of Efficacy|2
5828710|NCT02469246|20138067|P2|Double-Blind Phase|Death|0
5828711|NCT02469246|20138068|P1|Double-Blind Phase|Death|2
5828712|NCT02469246|20138067|P2|Double-Blind Phase|Adverse Event|9
5828713|NCT02469246|20138068|P1|Double-Blind Phase|Adverse Event|12
5828714|NCT02469246|20138067|P2|Double-Blind Phase|Randomized and Never Treated|6
5828715|NCT02469246|20138068|P1|Double-Blind Phase|Randomized and Never Treated|5
5828716|NCT02469168|20138100|P2|Overall Study|Trial closed|0
5828717|NCT02469168|20138101|P1|Overall Study|Trial closed|1
5828718|NCT02469090|20138121|P3|Period 2: Maintenance Treatment Phase|Death|1
5828719|NCT02469090|20138122|P2|Period 2: Maintenance Treatment Phase|Death|0
5828720|NCT02469090|20138123|P1|Period 2: Maintenance Treatment Phase|Death|0
5828721|NCT02469090|20138121|P3|Period 2: Maintenance Treatment Phase|Lack of Efficacy|0
5828722|NCT02469090|20138122|P2|Period 2: Maintenance Treatment Phase|Lack of Efficacy|1
5828723|NCT02469090|20138123|P1|Period 2: Maintenance Treatment Phase|Lack of Efficacy|0
5828724|NCT02469090|20138121|P3|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|4
5828725|NCT02469090|20138122|P2|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|3
5828726|NCT02469090|20138123|P1|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|0
5828727|NCT02469090|20138121|P3|Period 2: Maintenance Treatment Phase|Adverse Event|15
5828728|NCT02469090|20138122|P2|Period 2: Maintenance Treatment Phase|Adverse Event|5
5828729|NCT02469090|20138123|P1|Period 2: Maintenance Treatment Phase|Adverse Event|0
5828730|NCT02469090|20138121|P3|Period 1: Dose Titration Phase|Lack of Efficacy|0
5828731|NCT02469090|20138122|P2|Period 1: Dose Titration Phase|Lack of Efficacy|0
5828732|NCT02469090|20138123|P1|Period 1: Dose Titration Phase|Lack of Efficacy|11
5828733|NCT02469090|20138121|P3|Period 1: Dose Titration Phase|Lost to Follow-up|0
5828734|NCT02469090|20138122|P2|Period 1: Dose Titration Phase|Lost to Follow-up|0
5828735|NCT02469090|20138123|P1|Period 1: Dose Titration Phase|Lost to Follow-up|1
5828736|NCT02469090|20138121|P3|Period 1: Dose Titration Phase|Withdrawal by Subject|0
5828737|NCT02469090|20138122|P2|Period 1: Dose Titration Phase|Withdrawal by Subject|0
5828738|NCT02469090|20138123|P1|Period 1: Dose Titration Phase|Withdrawal by Subject|8
5828739|NCT02469090|20138121|P3|Period 1: Dose Titration Phase|Adverse Event|0
5828740|NCT02469090|20138122|P2|Period 1: Dose Titration Phase|Adverse Event|0
5828741|NCT02469090|20138123|P1|Period 1: Dose Titration Phase|Adverse Event|12
5828742|NCT02469077|20138150|P2|Post Intervention /Followup|Withdrawal by Subject|1
5828743|NCT02469077|20138151|P1|Post Intervention /Followup|Withdrawal by Subject|2
5828744|NCT02469077|20138150|P2|Post Randomization/Intervention Period|Conflicting health issues|1
5828745|NCT02469077|20138151|P1|Post Randomization/Intervention Period|Conflicting health issues|0
5828746|NCT02469077|20138150|P2|Post Randomization/Intervention Period|Relocated|1
5828747|NCT02469077|20138151|P1|Post Randomization/Intervention Period|Relocated|1
5828748|NCT02469077|20138150|P2|Post Randomization/Intervention Period|Scheduling issues|2
5828749|NCT02469077|20138151|P1|Post Randomization/Intervention Period|Scheduling issues|3
5828750|NCT02469064|20138183|P2|Overall Study|Request not to receive intervention.|3
5828751|NCT02469064|20138184|P1|Overall Study|Request not to receive intervention.|1
5828752|NCT02469038|20138194|P2|Overall Study|Physician Decision|5
5828753|NCT02469038|20138195|P1|Overall Study|Physician Decision|4
5828754|NCT02468934|20138213|P1|Overall Study|Screen Failure|3
5828755|NCT02468934|20138213|P1|Overall Study|Withdrawal by Subject|4
5828756|NCT02468674|20138264|P9|Overall Study|Protocol Deviation|1
5828757|NCT02468674|20138265|P8|Overall Study|Protocol Deviation|1
5828758|NCT02468674|20138266|P7|Overall Study|Protocol Deviation|0
5828759|NCT02468674|20138267|P6|Overall Study|Protocol Deviation|0
5828760|NCT02468674|20138268|P5|Overall Study|Protocol Deviation|0
5828761|NCT02468674|20138269|P4|Overall Study|Protocol Deviation|0
5828762|NCT02468674|20138270|P3|Overall Study|Protocol Deviation|0
5828763|NCT02468674|20138271|P2|Overall Study|Protocol Deviation|0
5828764|NCT02468674|20138272|P1|Overall Study|Protocol Deviation|0
5828765|NCT02468674|20138264|P9|Overall Study|Patient/Guardian Decision|1
5828766|NCT02468674|20138265|P8|Overall Study|Patient/Guardian Decision|2
5828767|NCT02468674|20138266|P7|Overall Study|Patient/Guardian Decision|0
5828768|NCT02468674|20138267|P6|Overall Study|Patient/Guardian Decision|0
5828769|NCT02468674|20138268|P5|Overall Study|Patient/Guardian Decision|1
5828770|NCT02468674|20138269|P4|Overall Study|Patient/Guardian Decision|0
5828771|NCT02468674|20138270|P3|Overall Study|Patient/Guardian Decision|0
5828772|NCT02468674|20138271|P2|Overall Study|Patient/Guardian Decision|0
5828773|NCT02468674|20138272|P1|Overall Study|Patient/Guardian Decision|0
5828774|NCT02468674|20138264|P9|Overall Study|Physician Decision|0
5828775|NCT02468674|20138265|P8|Overall Study|Physician Decision|0
5828776|NCT02468674|20138266|P7|Overall Study|Physician Decision|1
5828777|NCT02468674|20138267|P6|Overall Study|Physician Decision|0
5828778|NCT02468674|20138268|P5|Overall Study|Physician Decision|0
5828779|NCT02468674|20138269|P4|Overall Study|Physician Decision|0
5828780|NCT02468674|20138270|P3|Overall Study|Physician Decision|0
5828781|NCT02468674|20138271|P2|Overall Study|Physician Decision|0
5828782|NCT02468674|20138272|P1|Overall Study|Physician Decision|0
5828783|NCT02468674|20138264|P9|Overall Study|Lost to Follow-up|1
5828784|NCT02468674|20138265|P8|Overall Study|Lost to Follow-up|1
5828785|NCT02468674|20138266|P7|Overall Study|Lost to Follow-up|0
5828786|NCT02468674|20138267|P6|Overall Study|Lost to Follow-up|0
5828787|NCT02468674|20138268|P5|Overall Study|Lost to Follow-up|0
5828788|NCT02468674|20138269|P4|Overall Study|Lost to Follow-up|0
5828789|NCT02468674|20138270|P3|Overall Study|Lost to Follow-up|0
5828790|NCT02468674|20138271|P2|Overall Study|Lost to Follow-up|0
5828791|NCT02468674|20138272|P1|Overall Study|Lost to Follow-up|1
5828792|NCT02468674|20138264|P9|Overall Study|Adverse Event|0
5828793|NCT02468674|20138265|P8|Overall Study|Adverse Event|0
5828794|NCT02468674|20138266|P7|Overall Study|Adverse Event|0
5828795|NCT02468674|20138267|P6|Overall Study|Adverse Event|1
5828796|NCT02468674|20138268|P5|Overall Study|Adverse Event|0
5828797|NCT02468674|20138269|P4|Overall Study|Adverse Event|1
5828798|NCT02468674|20138270|P3|Overall Study|Adverse Event|0
5828799|NCT02468674|20138271|P2|Overall Study|Adverse Event|0
5828800|NCT02468674|20138272|P1|Overall Study|Adverse Event|0
5828801|NCT02468648|20138328|P1|Overall Study|Death|1
5828802|NCT02468414|20138395|P2|Overall Study|Screen Failure|0
5828803|NCT02468414|20138396|P1|Overall Study|Screen Failure|1
5828804|NCT02468414|20138395|P2|Overall Study|Poor in-vitro secreting TARGTs|0
5828805|NCT02468414|20138396|P1|Overall Study|Poor in-vitro secreting TARGTs|1
5828806|NCT02468414|20138395|P2|Overall Study|Early Study Termination by Sponsor|0
5828807|NCT02468414|20138396|P1|Overall Study|Early Study Termination by Sponsor|1
5828808|NCT02468193|20138402|P1|Overall Study|Subject/ Guardian decision|2
5828809|NCT02468193|20138402|P1|Overall Study|Adverse Event|4
5828810|NCT02466659|20138724|P2|Overall Study|Lost to Follow-up|2
5828811|NCT02466659|20138725|P1|Overall Study|Lost to Follow-up|5
5828812|NCT02466555|20138779|P1|Overall Study|Lost to Follow-up|2
5828813|NCT02466516|20138791|P5|Overall Study|Lost to Follow-up|0
5828814|NCT02466516|20138792|P4|Overall Study|Lost to Follow-up|0
5828815|NCT02466516|20138793|P3|Overall Study|Lost to Follow-up|1
5828816|NCT02466516|20138794|P2|Overall Study|Lost to Follow-up|0
5828817|NCT02466516|20138795|P1|Overall Study|Lost to Follow-up|2
5828818|NCT02466516|20138791|P5|Overall Study|Withdrew Consent|0
5828819|NCT02466516|20138792|P4|Overall Study|Withdrew Consent|0
5828820|NCT02466516|20138793|P3|Overall Study|Withdrew Consent|0
5828821|NCT02466516|20138794|P2|Overall Study|Withdrew Consent|0
5828822|NCT02466516|20138795|P1|Overall Study|Withdrew Consent|1
5828823|NCT02466516|20138791|P5|Overall Study|Adverse Event|0
5828824|NCT02466516|20138792|P4|Overall Study|Adverse Event|0
5828825|NCT02466516|20138793|P3|Overall Study|Adverse Event|0
5828826|NCT02466516|20138794|P2|Overall Study|Adverse Event|1
5828827|NCT02466516|20138795|P1|Overall Study|Adverse Event|1
5828828|NCT02466425|20138814|P2|Overall Study|Withdrawal by Parent/Guardian|0
5828829|NCT02466425|20138815|P1|Overall Study|Withdrawal by Parent/Guardian|2
5828830|NCT02466425|20138814|P2|Overall Study|Other|3
5828831|NCT02466425|20138815|P1|Overall Study|Other|1
5828832|NCT02466425|20138814|P2|Overall Study|Withdrawal by Subject|1
5828833|NCT02466425|20138815|P1|Overall Study|Withdrawal by Subject|0
5828834|NCT02466425|20138814|P2|Overall Study|Protocol Violation|0
5828835|NCT02466425|20138815|P1|Overall Study|Protocol Violation|1
5828836|NCT02466425|20138814|P2|Overall Study|Lost to Follow-up|0
5828837|NCT02466425|20138815|P1|Overall Study|Lost to Follow-up|3
5828838|NCT02466425|20138814|P2|Overall Study|Lack of Efficacy|1
5828839|NCT02466425|20138815|P1|Overall Study|Lack of Efficacy|4
5828840|NCT02466425|20138814|P2|Overall Study|Adverse Event|11
5828841|NCT02466425|20138815|P1|Overall Study|Adverse Event|3
5828842|NCT02466399|20138837|P2|Overall Study|Early exit due to family emergency|0
5828843|NCT02466399|20138838|P1|Overall Study|Early exit due to family emergency|1
5828844|NCT02466399|20138837|P2|Overall Study|Adverse Event|0
5828845|NCT02466399|20138838|P1|Overall Study|Adverse Event|1
5828846|NCT02465931|20138862|P2|Overall Study|Withdrawal by Subject|0
5828847|NCT02465931|20138863|P1|Overall Study|Withdrawal by Subject|1
5828848|NCT02465931|20138862|P2|Overall Study|Protocol Violation|0
5828849|NCT02465931|20138863|P1|Overall Study|Protocol Violation|1
5828850|NCT02465931|20138862|P2|Overall Study|Lost to Follow-up|11
5828851|NCT02465931|20138863|P1|Overall Study|Lost to Follow-up|9
5828852|NCT02465866|20138869|P4|Period 3|Withdrawal by Subject|0
5828853|NCT02465866|20138870|P3|Period 3|Withdrawal by Subject|0
5828854|NCT02465866|20138871|P2|Period 3|Withdrawal by Subject|1
5828855|NCT02465866|20138872|P1|Period 3|Withdrawal by Subject|0
5828856|NCT02465528|20138962|P4|Overall Study|Physician Decision|0
5828857|NCT02465528|20138963|P3|Overall Study|Physician Decision|1
5828858|NCT02465528|20138964|P2|Overall Study|Physician Decision|0
5828859|NCT02465528|20138965|P1|Overall Study|Physician Decision|0
5828860|NCT02465528|20138962|P4|Overall Study|Adverse Event|1
5828861|NCT02465528|20138963|P3|Overall Study|Adverse Event|0
5828862|NCT02465528|20138964|P2|Overall Study|Adverse Event|0
5828863|NCT02465528|20138965|P1|Overall Study|Adverse Event|0
5828864|NCT02465528|20138962|P4|Overall Study|Withdrawal by Subject|0
5828865|NCT02465528|20138963|P3|Overall Study|Withdrawal by Subject|2
5828866|NCT02465528|20138964|P2|Overall Study|Withdrawal by Subject|0
5828867|NCT02465528|20138965|P1|Overall Study|Withdrawal by Subject|0
5828868|NCT02465528|20138962|P4|Overall Study|Study terminated by sponsor|0
5828869|NCT02465528|20138963|P3|Overall Study|Study terminated by sponsor|0
5828870|NCT02465528|20138964|P2|Overall Study|Study terminated by sponsor|2
5828871|NCT02465528|20138965|P1|Overall Study|Study terminated by sponsor|1
5828872|NCT02465528|20138962|P4|Overall Study|Progressive disease|4
5828873|NCT02465528|20138963|P3|Overall Study|Progressive disease|9
5828874|NCT02465528|20138964|P2|Overall Study|Progressive disease|2
5828875|NCT02465528|20138965|P1|Overall Study|Progressive disease|0
5828876|NCT02465515|20138998|P2|Overall Study|Lost to Follow-up|51
5828877|NCT02465515|20138999|P1|Overall Study|Lost to Follow-up|68
5828878|NCT02465515|20138998|P2|Overall Study|Physician Decision|12
5828879|NCT02465515|20138999|P1|Overall Study|Physician Decision|8
5828880|NCT02465515|20138998|P2|Overall Study|Withdrawal by Subject|43
5828881|NCT02465515|20138999|P1|Overall Study|Withdrawal by Subject|74
5828882|NCT02465515|20138998|P2|Overall Study|Investigator site closed|5
5828883|NCT02465515|20138999|P1|Overall Study|Investigator site closed|4
5828884|NCT02465489|20139045|P1|Overall Study|Adverse Event|5
5828885|NCT02465463|20139074|P2|Overall Study|Protocol Violation|0
5828886|NCT02465463|20139075|P1|Overall Study|Protocol Violation|1
5828887|NCT02465463|20139074|P2|Overall Study|Death|0
5828888|NCT02465463|20139075|P1|Overall Study|Death|1
5828889|NCT02465463|20139074|P2|Overall Study|Lost to Follow-up|1
5828890|NCT02465463|20139075|P1|Overall Study|Lost to Follow-up|2
5828891|NCT02465437|20139123|P4|Overall Study|Adverse Event|0
5828892|NCT02465437|20139124|P3|Overall Study|Adverse Event|0
5828893|NCT02465437|20139125|P2|Overall Study|Adverse Event|1
5828894|NCT02465437|20139126|P1|Overall Study|Adverse Event|0
5828895|NCT02465437|20139123|P4|Overall Study|Withdrawal by Subject|1
5828896|NCT02465437|20139124|P3|Overall Study|Withdrawal by Subject|0
5828897|NCT02465437|20139125|P2|Overall Study|Withdrawal by Subject|0
5828898|NCT02465437|20139126|P1|Overall Study|Withdrawal by Subject|1
5828899|NCT02465437|20139123|P4|Overall Study|Physician Decision|0
5828900|NCT02465437|20139124|P3|Overall Study|Physician Decision|1
5828901|NCT02465437|20139125|P2|Overall Study|Physician Decision|0
5828902|NCT02465437|20139126|P1|Overall Study|Physician Decision|0
5828903|NCT02465203|20139186|P3|Overall Study|Patient/guardian decision|1
5828904|NCT02465203|20139187|P2|Overall Study|Patient/guardian decision|1
5828905|NCT02465203|20139188|P1|Overall Study|Patient/guardian decision|1
5828906|NCT02465203|20139186|P3|Overall Study|New therapy for study indication|0
5828907|NCT02465203|20139187|P2|Overall Study|New therapy for study indication|0
5828908|NCT02465203|20139188|P1|Overall Study|New therapy for study indication|4
5828909|NCT02465203|20139186|P3|Overall Study|Study terminated by sponsor|11
5828910|NCT02465203|20139187|P2|Overall Study|Study terminated by sponsor|34
5828911|NCT02465203|20139188|P1|Overall Study|Study terminated by sponsor|50
5828912|NCT02465203|20139186|P3|Overall Study|Protocol Violation|1
5828913|NCT02465203|20139187|P2|Overall Study|Protocol Violation|1
5828914|NCT02465203|20139188|P1|Overall Study|Protocol Violation|1
5828915|NCT02464059|20139308|P1|Overall Study|Lost to Follow-up|6
5828916|NCT02463409|20139367|P1|Overall Study|Screen failure|1
5828917|NCT02463409|20139367|P1|Overall Study|Withdrawal by Subject|1
5828918|NCT02463331|20139375|P2|Overall Study|Physician Decision|0
5828919|NCT02463331|20139376|P1|Overall Study|Physician Decision|3
5828920|NCT02463331|20139375|P2|Overall Study|Lack of Efficacy|0
5828921|NCT02463331|20139376|P1|Overall Study|Lack of Efficacy|6
5828922|NCT02463331|20139375|P2|Overall Study|Pregnancy|3
5828923|NCT02463331|20139376|P1|Overall Study|Pregnancy|2
5828924|NCT02463331|20139375|P2|Overall Study|Lost to Follow-up|1
5828925|NCT02463331|20139376|P1|Overall Study|Lost to Follow-up|1
5828926|NCT02463331|20139375|P2|Overall Study|Adverse Event|2
5828927|NCT02463331|20139376|P1|Overall Study|Adverse Event|4
5828928|NCT02463097|20139392|P1|Overall Study|Withdrawal by Subject|1
5828929|NCT02463071|20139401|P3|Overall Study|Lost to Follow-up|1
5828930|NCT02463071|20139402|P2|Overall Study|Lost to Follow-up|0
5828931|NCT02463071|20139403|P1|Overall Study|Lost to Follow-up|0
5828932|NCT02463071|20139401|P3|Overall Study|Protocol Violation|0
5828933|NCT02463071|20139402|P2|Overall Study|Protocol Violation|2
5828934|NCT02463071|20139403|P1|Overall Study|Protocol Violation|0
5828935|NCT02463071|20139401|P3|Overall Study|Reason not specified|4
5828936|NCT02463071|20139402|P2|Overall Study|Reason not specified|9
5828937|NCT02463071|20139403|P1|Overall Study|Reason not specified|7
5828938|NCT02463071|20139401|P3|Overall Study|Eligibility criteria not fulfilled|0
5828939|NCT02463071|20139402|P2|Overall Study|Eligibility criteria not fulfilled|0
5828940|NCT02463071|20139403|P1|Overall Study|Eligibility criteria not fulfilled|1
5828941|NCT02463071|20139401|P3|Overall Study|Death|0
5828942|NCT02463071|20139402|P2|Overall Study|Death|0
5828943|NCT02463071|20139403|P1|Overall Study|Death|1
5828944|NCT02463071|20139401|P3|Overall Study|Adverse Event|1
5828945|NCT02463071|20139402|P2|Overall Study|Adverse Event|5
5828946|NCT02463071|20139403|P1|Overall Study|Adverse Event|3
5828947|NCT02463032|20139431|P2|Overall Study|Adverse Event|6
5828948|NCT02463032|20139432|P1|Overall Study|Adverse Event|2
5828949|NCT02463032|20139431|P2|Overall Study|Death|8
5828950|NCT02463032|20139432|P1|Overall Study|Death|8
5828951|NCT02463032|20139431|P2|Overall Study|Lack of Efficacy|50
5828952|NCT02463032|20139432|P1|Overall Study|Lack of Efficacy|61
5828953|NCT02462928|20139484|P3|Overall Study|Reason not Specified|5
5828954|NCT02462928|20139485|P2|Overall Study|Reason not Specified|6
5828955|NCT02462928|20139486|P1|Overall Study|Reason not Specified|4
5828956|NCT02462928|20139484|P3|Overall Study|Protocol Violation|0
5828957|NCT02462928|20139485|P2|Overall Study|Protocol Violation|1
5828958|NCT02462928|20139486|P1|Overall Study|Protocol Violation|0
5828959|NCT02462928|20139484|P3|Overall Study|Withdrawal by Patient|21
5828960|NCT02462928|20139485|P2|Overall Study|Withdrawal by Patient|21
5828961|NCT02462928|20139486|P1|Overall Study|Withdrawal by Patient|31
5828962|NCT02462928|20139484|P3|Overall Study|Lost to Follow-up|1
5828963|NCT02462928|20139485|P2|Overall Study|Lost to Follow-up|4
5828964|NCT02462928|20139486|P1|Overall Study|Lost to Follow-up|4
5828965|NCT02462928|20139484|P3|Overall Study|Lack of Efficacy|3
5828966|NCT02462928|20139485|P2|Overall Study|Lack of Efficacy|8
5828967|NCT02462928|20139486|P1|Overall Study|Lack of Efficacy|3
5828968|NCT02462928|20139484|P3|Overall Study|Adverse Event|25
5828969|NCT02462928|20139485|P2|Overall Study|Adverse Event|51
5828970|NCT02462928|20139486|P1|Overall Study|Adverse Event|47
5828971|NCT02462928|20139484|P3|Overall Study|Screen Failure:Missed Exclusion Criteria|2
5828972|NCT02462928|20139485|P2|Overall Study|Screen Failure:Missed Exclusion Criteria|1
5828973|NCT02462928|20139486|P1|Overall Study|Screen Failure:Missed Exclusion Criteria|1
5828974|NCT02462876|20139506|P1|Overall Study|Ongoing|10
5828975|NCT02462876|20139506|P1|Overall Study|Other|6
5828976|NCT02462876|20139506|P1|Overall Study|Amputation Above the Metatarsals|1
5828977|NCT02462876|20139506|P1|Overall Study|Surgical Bypass|9
5828978|NCT02462876|20139506|P1|Overall Study|Lost to Follow-up|4
5828979|NCT02462876|20139506|P1|Overall Study|Death|3
5828983|NCT02462720|20139566|P2|Part 2|Protocol Violation|1
5828984|NCT02462720|20139567|P1|Part 2|Protocol Violation|0
5828985|NCT02462720|20139566|P2|Part 2|Withdrawal by Subject|0
5828986|NCT02462720|20139567|P1|Part 2|Withdrawal by Subject|1
5828987|NCT02462486|20139580|P3|Overall Study|Reason not Specified|3
5828988|NCT02462486|20139581|P2|Overall Study|Reason not Specified|4
5828989|NCT02462486|20139582|P1|Overall Study|Reason not Specified|3
5828990|NCT02462486|20139580|P3|Overall Study|Protocol Violation|1
5828991|NCT02462486|20139581|P2|Overall Study|Protocol Violation|1
5828992|NCT02462486|20139582|P1|Overall Study|Protocol Violation|3
5828993|NCT02462486|20139580|P3|Overall Study|Withdrawal by Subject|19
5828994|NCT02462486|20139581|P2|Overall Study|Withdrawal by Subject|22
5828995|NCT02462486|20139582|P1|Overall Study|Withdrawal by Subject|25
5828996|NCT02462486|20139580|P3|Overall Study|Lost to Follow-up|2
5828997|NCT02462486|20139581|P2|Overall Study|Lost to Follow-up|4
5828998|NCT02462486|20139582|P1|Overall Study|Lost to Follow-up|3
5828999|NCT02462486|20139580|P3|Overall Study|Lack of Efficacy|3
5829000|NCT02462486|20139581|P2|Overall Study|Lack of Efficacy|12
5829001|NCT02462486|20139582|P1|Overall Study|Lack of Efficacy|6
5829002|NCT02462486|20139580|P3|Overall Study|Adverse Event|21
5829003|NCT02462486|20139581|P2|Overall Study|Adverse Event|48
5829004|NCT02462486|20139582|P1|Overall Study|Adverse Event|53
5829005|NCT02462486|20139580|P3|Overall Study|Screen Failure:Missed Exclusion Criteria|3
5829006|NCT02462486|20139581|P2|Overall Study|Screen Failure:Missed Exclusion Criteria|1
5829007|NCT02462486|20139582|P1|Overall Study|Screen Failure:Missed Exclusion Criteria|1
5829008|NCT02462473|20139602|P1|Overall Study|Other|3
5829009|NCT02462473|20139602|P1|Overall Study|Death|1
5829010|NCT02462083|20139708|P1|Overall Study|Other than specified|45
5829011|NCT02462083|20139708|P1|Overall Study|Worsening condition|16
5829012|NCT02462083|20139708|P1|Overall Study|Adverse Event|33
5829013|NCT02462083|20139708|P1|Overall Study|Protocol Violation|6
5829014|NCT02462083|20139708|P1|Overall Study|Pregnancy|1
5829015|NCT02462083|20139708|P1|Overall Study|Lack of Efficacy|151
5829016|NCT02462083|20139708|P1|Overall Study|Lost to Follow-up|41
5829017|NCT02462083|20139708|P1|Overall Study|Withdrawal by Subject|87
5829018|NCT02462083|20139708|P1|Overall Study|Sponsor request|39
5829019|NCT02462057|20139728|P5|Overall Study|Joined HealthyFood Before Intervention|17
5829020|NCT02462057|20139729|P4|Overall Study|Joined HealthyFood Before Intervention|16
5829021|NCT02462057|20139730|P3|Overall Study|Joined HealthyFood Before Intervention|23
5829022|NCT02462057|20139731|P2|Overall Study|Joined HealthyFood Before Intervention|13
5829023|NCT02462057|20139732|P1|Overall Study|Joined HealthyFood Before Intervention|22
5829024|NCT02462057|20139728|P5|Overall Study|Left Vitality|33
5829025|NCT02462057|20139729|P4|Overall Study|Left Vitality|35
5829026|NCT02462057|20139730|P3|Overall Study|Left Vitality|23
5829027|NCT02462057|20139731|P2|Overall Study|Left Vitality|27
5829028|NCT02462057|20139732|P1|Overall Study|Left Vitality|32
5829029|NCT02461758|20139818|P4|Overall Study|Lost to Follow-up|0
5829030|NCT02461758|20139819|P3|Overall Study|Lost to Follow-up|1
5829031|NCT02461758|20139820|P2|Overall Study|Lost to Follow-up|1
5829032|NCT02461758|20139821|P1|Overall Study|Lost to Follow-up|0
5829033|NCT02461745|20139847|P2|Overall Study|Withdrawal by Subject|1
5829034|NCT02461745|20139848|P1|Overall Study|Withdrawal by Subject|3
5829035|NCT02461745|20139847|P2|Overall Study|Lost to Follow-up|2
5829036|NCT02461745|20139848|P1|Overall Study|Lost to Follow-up|2
5829037|NCT02461745|20139847|P2|Overall Study|Lack of Efficacy|1
5829038|NCT02461745|20139848|P1|Overall Study|Lack of Efficacy|9
5829039|NCT02461628|20139873|P2|Overall Study|Refused to complete survey|7
5829040|NCT02461628|20139874|P1|Overall Study|Refused to complete survey|4
5829041|NCT02461589|20139898|P10|Overall Study|Withdrawal from trial before exposure|1
5829042|NCT02461589|20139899|P9|Overall Study|Withdrawal from trial before exposure|0
5829043|NCT02461589|20139900|P8|Overall Study|Withdrawal from trial before exposure|0
5829044|NCT02461589|20139901|P7|Overall Study|Withdrawal from trial before exposure|0
5829045|NCT02461589|20139902|P6|Overall Study|Withdrawal from trial before exposure|0
5829046|NCT02461589|20139903|P5|Overall Study|Withdrawal from trial before exposure|0
5829047|NCT02461589|20139904|P4|Overall Study|Withdrawal from trial before exposure|0
5829048|NCT02461589|20139905|P3|Overall Study|Withdrawal from trial before exposure|0
5829049|NCT02461589|20139906|P2|Overall Study|Withdrawal from trial before exposure|0
5829050|NCT02461589|20139907|P1|Overall Study|Withdrawal from trial before exposure|0
5829051|NCT02461589|20139898|P10|Overall Study|Missing follow-up information|0
5829052|NCT02461589|20139899|P9|Overall Study|Missing follow-up information|0
5829053|NCT02461589|20139900|P8|Overall Study|Missing follow-up information|0
5829054|NCT02461589|20139901|P7|Overall Study|Missing follow-up information|1
5829055|NCT02461589|20139902|P6|Overall Study|Missing follow-up information|0
5829056|NCT02461589|20139903|P5|Overall Study|Missing follow-up information|0
5829057|NCT02461589|20139904|P4|Overall Study|Missing follow-up information|0
5829058|NCT02461589|20139905|P3|Overall Study|Missing follow-up information|0
5829059|NCT02461589|20139906|P2|Overall Study|Missing follow-up information|1
5829060|NCT02461589|20139907|P1|Overall Study|Missing follow-up information|1
5829061|NCT02461589|20139898|P10|Overall Study|Unclassified|2
5829062|NCT02461589|20139899|P9|Overall Study|Unclassified|0
5829063|NCT02461589|20139900|P8|Overall Study|Unclassified|0
5829064|NCT02461589|20139901|P7|Overall Study|Unclassified|1
5829065|NCT02461589|20139902|P6|Overall Study|Unclassified|0
5829066|NCT02461589|20139903|P5|Overall Study|Unclassified|0
5829067|NCT02461589|20139904|P4|Overall Study|Unclassified|0
5829068|NCT02461589|20139905|P3|Overall Study|Unclassified|0
5829069|NCT02461589|20139906|P2|Overall Study|Unclassified|0
5829070|NCT02461589|20139907|P1|Overall Study|Unclassified|0
5829071|NCT02461589|20139898|P10|Overall Study|Death|0
5829072|NCT02461589|20139899|P9|Overall Study|Death|0
5829073|NCT02461589|20139900|P8|Overall Study|Death|1
5829074|NCT02461589|20139901|P7|Overall Study|Death|0
5829075|NCT02461589|20139902|P6|Overall Study|Death|0
5829076|NCT02461589|20139903|P5|Overall Study|Death|0
5829077|NCT02461589|20139904|P4|Overall Study|Death|0
5829078|NCT02461589|20139905|P3|Overall Study|Death|0
5829079|NCT02461589|20139906|P2|Overall Study|Death|0
5829080|NCT02461589|20139907|P1|Overall Study|Death|0
5829081|NCT02461589|20139898|P10|Overall Study|Lost to Follow-up|1
5829082|NCT02461589|20139899|P9|Overall Study|Lost to Follow-up|3
5829083|NCT02461589|20139900|P8|Overall Study|Lost to Follow-up|1
5829084|NCT02461589|20139901|P7|Overall Study|Lost to Follow-up|3
5829085|NCT02461589|20139902|P6|Overall Study|Lost to Follow-up|1
5829086|NCT02461589|20139903|P5|Overall Study|Lost to Follow-up|1
5829087|NCT02461589|20139904|P4|Overall Study|Lost to Follow-up|3
5829088|NCT02461589|20139905|P3|Overall Study|Lost to Follow-up|2
5829089|NCT02461589|20139906|P2|Overall Study|Lost to Follow-up|0
5829090|NCT02461589|20139907|P1|Overall Study|Lost to Follow-up|0
5829091|NCT02461589|20139898|P10|Overall Study|Withdrawal by Subject|1
5829092|NCT02461589|20139899|P9|Overall Study|Withdrawal by Subject|3
5829093|NCT02461589|20139900|P8|Overall Study|Withdrawal by Subject|3
5829094|NCT02461589|20139901|P7|Overall Study|Withdrawal by Subject|1
5829095|NCT02461589|20139902|P6|Overall Study|Withdrawal by Subject|2
5829096|NCT02461589|20139903|P5|Overall Study|Withdrawal by Subject|1
5829097|NCT02461589|20139904|P4|Overall Study|Withdrawal by Subject|2
5829098|NCT02461589|20139905|P3|Overall Study|Withdrawal by Subject|3
5829099|NCT02461589|20139906|P2|Overall Study|Withdrawal by Subject|1
5829100|NCT02461589|20139907|P1|Overall Study|Withdrawal by Subject|5
5829101|NCT02461290|20140040|P1|Overall Study|Lost to Follow-up|3
5829102|NCT02461290|20140040|P1|Overall Study|Withdrawn for Inadequate Clinical Stage|7
5829103|NCT02461160|20140060|P13|Overall Study|Lost to Follow-up|0
5829104|NCT02461160|20140061|P12|Overall Study|Lost to Follow-up|0
5829105|NCT02461160|20140062|P11|Overall Study|Lost to Follow-up|0
5829106|NCT02461160|20140063|P10|Overall Study|Lost to Follow-up|0
5829107|NCT02461160|20140064|P9|Overall Study|Lost to Follow-up|0
5829108|NCT02461160|20140065|P8|Overall Study|Lost to Follow-up|1
5829109|NCT02461160|20140066|P7|Overall Study|Lost to Follow-up|0
5829110|NCT02461160|20140067|P6|Overall Study|Lost to Follow-up|0
5829111|NCT02461160|20140068|P5|Overall Study|Lost to Follow-up|0
5829112|NCT02461160|20140069|P4|Overall Study|Lost to Follow-up|0
5829113|NCT02461160|20140070|P3|Overall Study|Lost to Follow-up|0
5829114|NCT02461160|20140071|P2|Overall Study|Lost to Follow-up|0
5829115|NCT02461160|20140072|P1|Overall Study|Lost to Follow-up|0
5829116|NCT02461134|20140283|P1|Overall Study|Adverse Event|1
5829119|NCT02460978|20140309|P3|Overall Study|Pregnancy|2
5829120|NCT02460978|20140310|P2|Overall Study|Pregnancy|0
5829121|NCT02460978|20140311|P1|Overall Study|Pregnancy|0
5829122|NCT02460978|20140309|P3|Overall Study|Discontinued due to DKA/hypoglycemia|4
5829123|NCT02460978|20140310|P2|Overall Study|Discontinued due to DKA/hypoglycemia|5
5829124|NCT02460978|20140311|P1|Overall Study|Discontinued due to DKA/hypoglycemia|2
5829125|NCT02460978|20140309|P3|Overall Study|Protocol Violation|1
5829126|NCT02460978|20140310|P2|Overall Study|Protocol Violation|1
5829127|NCT02460978|20140311|P1|Overall Study|Protocol Violation|1
5829128|NCT02460978|20140309|P3|Overall Study|Lost to Follow-up|1
5829129|NCT02460978|20140310|P2|Overall Study|Lost to Follow-up|3
5829130|NCT02460978|20140311|P1|Overall Study|Lost to Follow-up|2
5829131|NCT02460978|20140309|P3|Overall Study|Withdrawal by Subject|14
5829132|NCT02460978|20140310|P2|Overall Study|Withdrawal by Subject|5
5829133|NCT02460978|20140311|P1|Overall Study|Withdrawal by Subject|5
5829134|NCT02460978|20140309|P3|Overall Study|Adverse Event|11
5829135|NCT02460978|20140310|P2|Overall Study|Adverse Event|11
5829136|NCT02460978|20140311|P1|Overall Study|Adverse Event|17
5829137|NCT02460822|20140337|P1|Overall Study|Withdrawal by Subject|1
5829138|NCT02460679|20140346|P1|Overall Study|Withdrawal by Subject|4
5829139|NCT02460679|20140346|P1|Overall Study|Investigator Decision|1
5829140|NCT02460575|20140371|P2|Overall Study|Lost to Follow-up|0
5829141|NCT02460575|20140372|P1|Overall Study|Lost to Follow-up|1
5829142|NCT02460562|20140382|P2|Overall Study|Lost to Follow-up|16
5829143|NCT02460562|20140383|P1|Overall Study|Lost to Follow-up|15
5829144|NCT02460458|20140391|P1|Confirmation of Clinical Phase Data|Lost to Follow-up|9
5829145|NCT02460458|20140391|P1|First Prospective Phase|Lost to Follow-up|16
5829146|NCT02460458|20140391|P1|Confirmatory Phase|Patients excluded due to lack of central characterized VWD mutations|14
5829147|NCT02460458|20140391|P1|Confirmatory Phase|Patients excluded due to lack of samples for central analyses|27
5829148|NCT02460458|20140391|P1|Confirmatory Phase|Patients excluded basing on phenotype central analyses|47
5829149|NCT02460380|20140407|P2|Overall Study|Withdrawal by Subject|5
5829150|NCT02460380|20140408|P1|Overall Study|Withdrawal by Subject|10
5829151|NCT02460263|20140428|P1|Transition Period|Death|1
5829152|NCT02460263|20140428|P1|Transition Period|Withdrawal by Subject|1
5829163|NCT02460159|20140476|P2|Overall Study|Withdrawal by Subject|0
5829164|NCT02460159|20140477|P1|Overall Study|Withdrawal by Subject|2
5829165|NCT02460159|20140476|P2|Overall Study|Adverse Event|1
5829166|NCT02460159|20140477|P1|Overall Study|Adverse Event|4
5829167|NCT02459951|20140505|P1|Overall Study|Unable to meet holding requirement|1
5829168|NCT02459899|20140516|P4|Overall Study|Withdrawal by Subject|0
5829169|NCT02459899|20140517|P3|Overall Study|Withdrawal by Subject|0
5829170|NCT02459899|20140518|P2|Overall Study|Withdrawal by Subject|3
5829171|NCT02459899|20140519|P1|Overall Study|Withdrawal by Subject|1
5829172|NCT02459899|20140516|P4|Overall Study|Non-compliance with the treatment|1
5829173|NCT02459899|20140517|P3|Overall Study|Non-compliance with the treatment|0
5829174|NCT02459899|20140518|P2|Overall Study|Non-compliance with the treatment|0
5829175|NCT02459899|20140519|P1|Overall Study|Non-compliance with the treatment|0
5829176|NCT02459899|20140516|P4|Overall Study|Lost to Follow-up|1
5829177|NCT02459899|20140517|P3|Overall Study|Lost to Follow-up|0
5829178|NCT02459899|20140518|P2|Overall Study|Lost to Follow-up|2
5829179|NCT02459899|20140519|P1|Overall Study|Lost to Follow-up|1
5829180|NCT02459899|20140516|P4|Overall Study|Adverse Event|0
5829181|NCT02459899|20140517|P3|Overall Study|Adverse Event|0
5829182|NCT02459899|20140518|P2|Overall Study|Adverse Event|1
5829183|NCT02459899|20140519|P1|Overall Study|Adverse Event|1
5829184|NCT02459665|20140566|P4|Overall Study|Withdrawal by Subject|2
5829185|NCT02459665|20140567|P3|Overall Study|Withdrawal by Subject|1
5829186|NCT02459665|20140568|P2|Overall Study|Withdrawal by Subject|1
5829187|NCT02459665|20140569|P1|Overall Study|Withdrawal by Subject|0
5829188|NCT02459418|20140600|P2|Overall Study|Abnormal Transvaginal Ultrasound|0
5829189|NCT02459418|20140601|P1|Overall Study|Abnormal Transvaginal Ultrasound|1
5829190|NCT02459418|20140600|P2|Overall Study|Elevated Creatine Kinase|0
5829191|NCT02459418|20140601|P1|Overall Study|Elevated Creatine Kinase|1
5829192|NCT02459418|20140600|P2|Overall Study|Withdrawal by Subject|1
5829193|NCT02459418|20140601|P1|Overall Study|Withdrawal by Subject|1
5829194|NCT02459418|20140600|P2|Overall Study|Adverse Event|1
5829195|NCT02459418|20140601|P1|Overall Study|Adverse Event|0
5829196|NCT02459418|20140600|P2|Overall Study|Endometrial thickness of >5 mm|0
5829197|NCT02459418|20140601|P1|Overall Study|Endometrial thickness of >5 mm|1
5829198|NCT02459418|20140600|P2|Overall Study|Physician Decision|2
5829199|NCT02459418|20140601|P1|Overall Study|Physician Decision|0
5829200|NCT02459418|20140600|P2|Overall Study|Protocol Violation|2
5829201|NCT02459418|20140601|P1|Overall Study|Protocol Violation|0
5829202|NCT02459418|20140600|P2|Overall Study|Exclusion Criteria|0
5829203|NCT02459418|20140601|P1|Overall Study|Exclusion Criteria|4
5829204|NCT02459262|20140651|P11|Overall Study|Withdrawal by Subject|0
5829205|NCT02459262|20140652|P10|Overall Study|Withdrawal by Subject|1
5829206|NCT02459262|20140653|P9|Overall Study|Withdrawal by Subject|0
5829207|NCT02459262|20140654|P8|Overall Study|Withdrawal by Subject|0
5829208|NCT02459262|20140655|P7|Overall Study|Withdrawal by Subject|0
5829209|NCT02459262|20140656|P6|Overall Study|Withdrawal by Subject|0
5829210|NCT02459262|20140657|P5|Overall Study|Withdrawal by Subject|0
5829211|NCT02459262|20140658|P4|Overall Study|Withdrawal by Subject|0
5829212|NCT02459262|20140659|P3|Overall Study|Withdrawal by Subject|0
5829213|NCT02459262|20140660|P2|Overall Study|Withdrawal by Subject|0
5829214|NCT02459262|20140661|P1|Overall Study|Withdrawal by Subject|0
5829215|NCT02459093|20140731|P2|Overall Study|Lost to Follow-up|7
5829216|NCT02459093|20140732|P1|Overall Study|Lost to Follow-up|6
5829217|NCT02459093|20140731|P2|Overall Study|Protocol Violation|11
5829218|NCT02459093|20140732|P1|Overall Study|Protocol Violation|6
5829219|NCT02458469|20140786|P6|Second Intervention (2 Weeks)|Withdrawal by Subject|1
5829220|NCT02458469|20140787|P5|Second Intervention (2 Weeks)|Withdrawal by Subject|0
5829221|NCT02458469|20140788|P4|Second Intervention (2 Weeks)|Withdrawal by Subject|0
5829222|NCT02458469|20140789|P3|Second Intervention (2 Weeks)|Withdrawal by Subject|0
5829223|NCT02458469|20140790|P2|Second Intervention (2 Weeks)|Withdrawal by Subject|0
5829224|NCT02458469|20140791|P1|Second Intervention (2 Weeks)|Withdrawal by Subject|0
5829225|NCT02458469|20140786|P6|First Intervention (2 Weeks)|Physician Decision|0
5829226|NCT02458469|20140787|P5|First Intervention (2 Weeks)|Physician Decision|0
5829227|NCT02458469|20140788|P4|First Intervention (2 Weeks)|Physician Decision|0
5829228|NCT02458469|20140789|P3|First Intervention (2 Weeks)|Physician Decision|0
5829229|NCT02458469|20140790|P2|First Intervention (2 Weeks)|Physician Decision|0
5829230|NCT02458469|20140791|P1|First Intervention (2 Weeks)|Physician Decision|1
5829231|NCT02458469|20140786|P6|First Intervention (2 Weeks)|Lost to Follow-up|0
5829232|NCT02458469|20140787|P5|First Intervention (2 Weeks)|Lost to Follow-up|0
5829233|NCT02458469|20140788|P4|First Intervention (2 Weeks)|Lost to Follow-up|0
5829234|NCT02458469|20140789|P3|First Intervention (2 Weeks)|Lost to Follow-up|1
5829235|NCT02458469|20140790|P2|First Intervention (2 Weeks)|Lost to Follow-up|0
5829236|NCT02458469|20140791|P1|First Intervention (2 Weeks)|Lost to Follow-up|0
5829237|NCT02458287|20140837|P4|Overall Study|Relocated Out of State|1
5829238|NCT02458287|20140838|P3|Overall Study|Relocated Out of State|0
5829239|NCT02458287|20140839|P2|Overall Study|Relocated Out of State|0
5829240|NCT02458287|20140840|P1|Overall Study|Relocated Out of State|0
5829241|NCT02458287|20140837|P4|Overall Study|Withdrawal by Subject|1
5829242|NCT02458287|20140838|P3|Overall Study|Withdrawal by Subject|2
5829243|NCT02458287|20140839|P2|Overall Study|Withdrawal by Subject|2
5829244|NCT02458287|20140840|P1|Overall Study|Withdrawal by Subject|0
5829245|NCT02458287|20140837|P4|Overall Study|Protocol Violation|0
5829246|NCT02458287|20140838|P3|Overall Study|Protocol Violation|0
5829247|NCT02458287|20140839|P2|Overall Study|Protocol Violation|1
5829248|NCT02458287|20140840|P1|Overall Study|Protocol Violation|0
5829249|NCT02458287|20140837|P4|Overall Study|Lost to Follow-up|0
5829250|NCT02458287|20140838|P3|Overall Study|Lost to Follow-up|1
5829251|NCT02458287|20140839|P2|Overall Study|Lost to Follow-up|1
5829252|NCT02458287|20140840|P1|Overall Study|Lost to Follow-up|0
5829253|NCT02458287|20140837|P4|Overall Study|Adverse Event|1
5829254|NCT02458287|20140838|P3|Overall Study|Adverse Event|0
5829255|NCT02458287|20140839|P2|Overall Study|Adverse Event|0
5829256|NCT02458287|20140840|P1|Overall Study|Adverse Event|0
5829289|NCT02457819|20140946|P1|Overall Study|Adverse Event|33
5829290|NCT02457819|20140946|P1|Overall Study|Lack of Efficacy|19
5829291|NCT02457819|20140946|P1|Overall Study|Lost to Follow-up|10
5829292|NCT02457819|20140946|P1|Overall Study|non compliance with study drug|4
5829293|NCT02457819|20140946|P1|Overall Study|Protocol Violation|1
5829294|NCT02457819|20140946|P1|Overall Study|Withdrawal by Subject|24
5829295|NCT02457819|20140946|P1|Overall Study|reason not given|8
5829296|NCT02457793|20140958|P6|Overall Study|Physician Decision|3
5829297|NCT02457793|20140959|P5|Overall Study|Physician Decision|1
5829298|NCT02457793|20140960|P4|Overall Study|Physician Decision|1
5829299|NCT02457793|20140961|P3|Overall Study|Physician Decision|1
5829300|NCT02457793|20140962|P2|Overall Study|Physician Decision|0
5829301|NCT02457793|20140963|P1|Overall Study|Physician Decision|1
5829302|NCT02457793|20140958|P6|Overall Study|Adverse Event|0
5829303|NCT02457793|20140959|P5|Overall Study|Adverse Event|0
5829304|NCT02457793|20140960|P4|Overall Study|Adverse Event|1
5829305|NCT02457793|20140961|P3|Overall Study|Adverse Event|0
5829306|NCT02457793|20140962|P2|Overall Study|Adverse Event|0
5829307|NCT02457793|20140963|P1|Overall Study|Adverse Event|0
5829308|NCT02457793|20140958|P6|Overall Study|Withdrawal by Subject|2
5829309|NCT02457793|20140959|P5|Overall Study|Withdrawal by Subject|2
5829310|NCT02457793|20140960|P4|Overall Study|Withdrawal by Subject|2
5829311|NCT02457793|20140961|P3|Overall Study|Withdrawal by Subject|2
5829312|NCT02457793|20140962|P2|Overall Study|Withdrawal by Subject|4
5829313|NCT02457793|20140963|P1|Overall Study|Withdrawal by Subject|0
5829314|NCT02457793|20140958|P6|Overall Study|Reason not specified|1
5829315|NCT02457793|20140959|P5|Overall Study|Reason not specified|1
5829316|NCT02457793|20140960|P4|Overall Study|Reason not specified|1
5829317|NCT02457793|20140961|P3|Overall Study|Reason not specified|0
5829318|NCT02457793|20140962|P2|Overall Study|Reason not specified|0
5829319|NCT02457793|20140963|P1|Overall Study|Reason not specified|0
5829320|NCT02457637|20141107|P1|Clinic or Telephone Follow-up|Lost to Follow-up|71
5829321|NCT02457611|20141115|P1|Overall Study|Lost to Follow-up|3
5829322|NCT02457546|20141129|P2|Overall Study|Adverse Event|1
5829323|NCT02457546|20141130|P1|Overall Study|Adverse Event|0
5829324|NCT02457546|20141129|P2|Overall Study|Lost to Follow-up|1
5829325|NCT02457546|20141130|P1|Overall Study|Lost to Follow-up|4
5829326|NCT02457546|20141129|P2|Overall Study|Refused to complete study/procedures|1
5829327|NCT02457546|20141130|P1|Overall Study|Refused to complete study/procedures|1
5829328|NCT02457546|20141129|P2|Overall Study|Other reasons|1
5829329|NCT02457546|20141130|P1|Overall Study|Other reasons|4
5829330|NCT02457325|20141151|P2|First Intervention (1 Day)|Lost to Follow-up|2
5829331|NCT02457325|20141152|P1|First Intervention (1 Day)|Lost to Follow-up|2
5829332|NCT02457247|20141225|P4|Period 2|Voluntary Withdrawal|0
5829333|NCT02457247|20141226|P3|Period 2|Voluntary Withdrawal|0
5829334|NCT02457247|20141227|P2|Period 2|Voluntary Withdrawal|1
5829335|NCT02457247|20141228|P1|Period 2|Voluntary Withdrawal|1
5829336|NCT02457247|20141225|P4|Period 2|Lost to Follow-up|0
5829337|NCT02457247|20141226|P3|Period 2|Lost to Follow-up|0
5829338|NCT02457247|20141227|P2|Period 2|Lost to Follow-up|1
5829339|NCT02457247|20141228|P1|Period 2|Lost to Follow-up|0
5829340|NCT02457247|20141225|P4|Period 2|Significant Protocol Deviation|0
5829341|NCT02457247|20141226|P3|Period 2|Significant Protocol Deviation|0
5829342|NCT02457247|20141227|P2|Period 2|Significant Protocol Deviation|0
5829343|NCT02457247|20141228|P1|Period 2|Significant Protocol Deviation|1
5829344|NCT02457247|20141225|P4|Period 2|Pretreatment Event/Adverse Event|0
5829345|NCT02457247|20141226|P3|Period 2|Pretreatment Event/Adverse Event|0
5829346|NCT02457247|20141227|P2|Period 2|Pretreatment Event/Adverse Event|1
5829347|NCT02457247|20141228|P1|Period 2|Pretreatment Event/Adverse Event|0
5829348|NCT02457247|20141225|P4|Period 1|Voluntary Withdrawal|0
5829349|NCT02457247|20141226|P3|Period 1|Voluntary Withdrawal|0
5829350|NCT02457247|20141227|P2|Period 1|Voluntary Withdrawal|0
5829351|NCT02457247|20141228|P1|Period 1|Voluntary Withdrawal|1
5829352|NCT02457247|20141225|P4|Period 1|Significant Protocol Deviation|0
5829353|NCT02457247|20141226|P3|Period 1|Significant Protocol Deviation|0
5829354|NCT02457247|20141227|P2|Period 1|Significant Protocol Deviation|1
5829355|NCT02457247|20141228|P1|Period 1|Significant Protocol Deviation|1
5829356|NCT02457247|20141225|P4|Period 1|Pretreatment Event/Adverse Event|0
5829357|NCT02457247|20141226|P3|Period 1|Pretreatment Event/Adverse Event|0
5829358|NCT02457247|20141227|P2|Period 1|Pretreatment Event/Adverse Event|1
5829359|NCT02457247|20141228|P1|Period 1|Pretreatment Event/Adverse Event|0
5829360|NCT02457195|20141248|P1|Overall Study|Withdrawal by Subject|4
5829361|NCT02457195|20141248|P1|Overall Study|Protocol Violation|2
5829362|NCT02457195|20141248|P1|Overall Study|Adverse Event|3
5829363|NCT02457182|20141254|P2|Overall Study|Lost to Follow-up|0
5829364|NCT02457182|20141255|P1|Overall Study|Lost to Follow-up|1
5829365|NCT02457065|20141273|P2|Overall Study|Lost to Follow-up|11
5829366|NCT02457065|20141274|P1|Overall Study|Lost to Follow-up|9
5829367|NCT02456740|20141296|P9|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4
5829368|NCT02456740|20141297|P8|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3
5829369|NCT02456740|20141298|P7|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1
5829370|NCT02456740|20141299|P6|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4
5829371|NCT02456740|20141300|P5|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|2
5829372|NCT02456740|20141301|P4|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3
5829373|NCT02456740|20141302|P3|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
5829374|NCT02456740|20141303|P2|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
5829375|NCT02456740|20141304|P1|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
5829376|NCT02456740|20141296|P9|Active Treatment Phase (Weeks 24 - 52)|Death|0
5829377|NCT02456740|20141297|P8|Active Treatment Phase (Weeks 24 - 52)|Death|1
5829378|NCT02456740|20141298|P7|Active Treatment Phase (Weeks 24 - 52)|Death|0
5829379|NCT02456740|20141299|P6|Active Treatment Phase (Weeks 24 - 52)|Death|0
5829380|NCT02456740|20141300|P5|Active Treatment Phase (Weeks 24 - 52)|Death|0
5829381|NCT02456740|20141301|P4|Active Treatment Phase (Weeks 24 - 52)|Death|0
5829382|NCT02456740|20141302|P3|Active Treatment Phase (Weeks 24 - 52)|Death|0
5829383|NCT02456740|20141303|P2|Active Treatment Phase (Weeks 24 - 52)|Death|0
5829384|NCT02456740|20141304|P1|Active Treatment Phase (Weeks 24 - 52)|Death|0
5829385|NCT02456740|20141296|P9|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9
5829386|NCT02456740|20141297|P8|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8
5829387|NCT02456740|20141298|P7|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8
5829388|NCT02456740|20141299|P6|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9
5829389|NCT02456740|20141300|P5|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|11
5829390|NCT02456740|20141301|P4|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|10
5829391|NCT02456740|20141302|P3|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
5829392|NCT02456740|20141303|P2|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
5829393|NCT02456740|20141304|P1|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
5829394|NCT02456740|20141296|P9|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|5
5829395|NCT02456740|20141297|P8|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0
5829396|NCT02456740|20141298|P7|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0
5829397|NCT02456740|20141299|P6|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0
5829398|NCT02456740|20141300|P5|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|4
5829399|NCT02456740|20141301|P4|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|1
5829400|NCT02456740|20141302|P3|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0
5829401|NCT02456740|20141303|P2|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0
5829402|NCT02456740|20141304|P1|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0
5829403|NCT02456740|20141296|P9|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0
5829404|NCT02456740|20141297|P8|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0
5829405|NCT02456740|20141298|P7|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0
5829406|NCT02456740|20141299|P6|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0
5829407|NCT02456740|20141300|P5|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0
5829408|NCT02456740|20141301|P4|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0
5829409|NCT02456740|20141302|P3|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|5
5829410|NCT02456740|20141303|P2|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|4
5829411|NCT02456740|20141304|P1|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|9
5829412|NCT02456740|20141296|P9|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0
5829413|NCT02456740|20141297|P8|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0
5829414|NCT02456740|20141298|P7|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0
5829415|NCT02456740|20141299|P6|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0
5829416|NCT02456740|20141300|P5|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0
5829417|NCT02456740|20141301|P4|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0
5829418|NCT02456740|20141302|P3|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|21
5829419|NCT02456740|20141303|P2|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|28
5829420|NCT02456740|20141304|P1|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|27
5829421|NCT02456740|20141296|P9|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0
5829422|NCT02456740|20141297|P8|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0
5829423|NCT02456740|20141298|P7|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0
5829424|NCT02456740|20141299|P6|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0
5829425|NCT02456740|20141300|P5|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0
5829426|NCT02456740|20141301|P4|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0
5829427|NCT02456740|20141302|P3|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1
5829428|NCT02456740|20141303|P2|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1
5829429|NCT02456740|20141304|P1|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1
5829430|NCT02456727|20141328|P2|Overall Study|Never Initiated Treatment|30
5829431|NCT02456727|20141329|P1|Overall Study|Never Initiated Treatment|43
5829432|NCT02456727|20141328|P2|Overall Study|Withdrawal by Subject|10
5829433|NCT02456727|20141329|P1|Overall Study|Withdrawal by Subject|1
5829434|NCT02456727|20141328|P2|Overall Study|Death|1
5829435|NCT02456727|20141329|P1|Overall Study|Death|2
5829436|NCT02456727|20141328|P2|Overall Study|Lost to Follow-up|65
5829437|NCT02456727|20141329|P1|Overall Study|Lost to Follow-up|63
5829438|NCT02456662|20141411|P2|Overall Study|Lost to Follow-up|1
5829439|NCT02456662|20141412|P1|Overall Study|Lost to Follow-up|2
5829440|NCT02456636|20141421|P3|Overall Study|Lost to Follow-up|50
5829441|NCT02456636|20141422|P2|Overall Study|Lost to Follow-up|44
5829442|NCT02456636|20141423|P1|Overall Study|Lost to Follow-up|50
5829443|NCT02456636|20141421|P3|Overall Study|Withdrawal by Subject|16
5829444|NCT02456636|20141422|P2|Overall Study|Withdrawal by Subject|14
5829445|NCT02456636|20141423|P1|Overall Study|Withdrawal by Subject|13
5829446|NCT02456636|20141421|P3|Overall Study|Physician Decision|4
5829447|NCT02456636|20141422|P2|Overall Study|Physician Decision|5
5829448|NCT02456636|20141423|P1|Overall Study|Physician Decision|4
5829449|NCT02456636|20141421|P3|Overall Study|Pregnancy|5
5829450|NCT02456636|20141422|P2|Overall Study|Pregnancy|3
5829451|NCT02456636|20141423|P1|Overall Study|Pregnancy|1
5829452|NCT02456636|20141421|P3|Overall Study|Death|0
5829453|NCT02456636|20141422|P2|Overall Study|Death|3
5829454|NCT02456636|20141423|P1|Overall Study|Death|0
5829455|NCT02456103|20141473|P1|Overall Study|Withdrawal by Subject|24
5829456|NCT02456103|20141473|P1|Overall Study|Lost to Follow-up|1
5829457|NCT02456103|20141473|P1|Overall Study|Abnormal Laboratory Value|2
5829458|NCT02456103|20141473|P1|Overall Study|Adverse Event|5
5829459|NCT02456103|20141473|P1|Overall Study|Protocol Violation|1
5829460|NCT02456103|20141473|P1|Overall Study|Required prohibited medications|5
5829461|NCT02456103|20141473|P1|Overall Study|Physician Decision|1
5829462|NCT02456103|20141473|P1|Overall Study|Study Closure|207
5829463|NCT02455518|20141486|P4|Overall Study|Protocol Violation|3
5829464|NCT02455518|20141487|P3|Overall Study|Protocol Violation|1
5829465|NCT02455518|20141488|P2|Overall Study|Protocol Violation|1
5829466|NCT02455518|20141489|P1|Overall Study|Protocol Violation|0
5829467|NCT02455388|20141511|P3|Overall Study|Withdrawal by Subject|7
5829468|NCT02455388|20141512|P2|Overall Study|Withdrawal by Subject|0
5829469|NCT02455388|20141513|P1|Overall Study|Withdrawal by Subject|0
5829470|NCT02455388|20141511|P3|Overall Study|Protocol Violation|4
5829471|NCT02455388|20141512|P2|Overall Study|Protocol Violation|0
5829472|NCT02455388|20141513|P1|Overall Study|Protocol Violation|1
5829473|NCT02455336|20141524|P2|Overall Study|Non-responder to treatment|0
5829474|NCT02455336|20141525|P1|Overall Study|Non-responder to treatment|2
5829475|NCT02455336|20141524|P2|Overall Study|Adverse Event|0
5829476|NCT02455336|20141525|P1|Overall Study|Adverse Event|3
5829477|NCT02455336|20141524|P2|Overall Study|Withdrawal by Subject|2
5829478|NCT02455336|20141525|P1|Overall Study|Withdrawal by Subject|0
5829479|NCT02455076|20141540|P5|Outpatient|Lost to Follow-up|12
5829480|NCT02455076|20141541|P4|Outpatient|Lost to Follow-up|1
5829481|NCT02455076|20141542|P3|Outpatient|Lost to Follow-up|0
5829482|NCT02455076|20141543|P2|Outpatient|Lost to Follow-up|0
5829483|NCT02455076|20141544|P1|Outpatient|Lost to Follow-up|0
5829484|NCT02455076|20141540|P5|Outpatient|Adverse Event|0
5829485|NCT02455076|20141541|P4|Outpatient|Adverse Event|5
5829486|NCT02455076|20141542|P3|Outpatient|Adverse Event|0
5829487|NCT02455076|20141543|P2|Outpatient|Adverse Event|0
5829488|NCT02455076|20141544|P1|Outpatient|Adverse Event|0
5829489|NCT02455076|20141540|P5|Inpatient|Adverse Event|0
5829490|NCT02455076|20141541|P4|Inpatient|Adverse Event|0
5829491|NCT02455076|20141542|P3|Inpatient|Adverse Event|0
5829492|NCT02455076|20141543|P2|Inpatient|Adverse Event|0
5829493|NCT02455076|20141544|P1|Inpatient|Adverse Event|3
5829494|NCT02455076|20141540|P5|Inpatient|Discharged <24 h after admission|0
5829495|NCT02455076|20141541|P4|Inpatient|Discharged <24 h after admission|0
5829496|NCT02455076|20141542|P3|Inpatient|Discharged <24 h after admission|0
5829497|NCT02455076|20141543|P2|Inpatient|Discharged <24 h after admission|1
5829498|NCT02455076|20141544|P1|Inpatient|Discharged <24 h after admission|0
5829499|NCT02455076|20141540|P5|Inpatient|Withdrawal by Subject|0
5829500|NCT02455076|20141541|P4|Inpatient|Withdrawal by Subject|0
5829501|NCT02455076|20141542|P3|Inpatient|Withdrawal by Subject|0
5829502|NCT02455076|20141543|P2|Inpatient|Withdrawal by Subject|0
5829503|NCT02455076|20141544|P1|Inpatient|Withdrawal by Subject|1
5829504|NCT02455050|20141630|P4|Treatment Period 2|Lost to Follow-up|1
5829505|NCT02455050|20141631|P3|Treatment Period 2|Lost to Follow-up|2
5829506|NCT02455050|20141632|P2|Treatment Period 2|Lost to Follow-up|0
5829507|NCT02455050|20141633|P1|Treatment Period 2|Lost to Follow-up|1
5829508|NCT02455050|20141630|P4|Treatment Period 1|Lost to Follow-up|2
5829509|NCT02455050|20141631|P3|Treatment Period 1|Lost to Follow-up|1
5829510|NCT02455050|20141632|P2|Treatment Period 1|Lost to Follow-up|1
5829511|NCT02455050|20141633|P1|Treatment Period 1|Lost to Follow-up|1
5829512|NCT02454959|20141697|P1|Overall Study|Adverse Event|2
5829513|NCT02454959|20141697|P1|Overall Study|Withdrawal by Subject|3
5829514|NCT02454959|20141697|P1|Overall Study|Physician Decision|1
5829515|NCT02454959|20141697|P1|Overall Study|Protocol-Specified Criteria|3
5829522|NCT02454608|20141726|P3|Open Label Period|Withdrawal by Subject|8
5829523|NCT02454608|20141727|P2|Open Label Period|Withdrawal by Subject|0
5829524|NCT02454608|20141728|P1|Open Label Period|Withdrawal by Subject|0
5829525|NCT02454608|20141726|P3|Open Label Period|Lost to Follow-up|11
5829526|NCT02454608|20141727|P2|Open Label Period|Lost to Follow-up|0
5829527|NCT02454608|20141728|P1|Open Label Period|Lost to Follow-up|0
5829528|NCT02454608|20141726|P3|Double-Blind Period|Lack of Efficacy|0
5829529|NCT02454608|20141727|P2|Double-Blind Period|Lack of Efficacy|2
5829530|NCT02454608|20141728|P1|Double-Blind Period|Lack of Efficacy|0
5829531|NCT02454530|20141751|P2|Overall Study|Lost to Follow-up|4
5829532|NCT02454530|20141752|P1|Overall Study|Lost to Follow-up|4
5829533|NCT02454530|20141751|P2|Overall Study|Death|41
5829534|NCT02454530|20141752|P1|Overall Study|Death|2
5829535|NCT02454530|20141751|P2|Overall Study|Missing information|69
5829536|NCT02454530|20141752|P1|Overall Study|Missing information|56
5829537|NCT02454530|20141751|P2|Overall Study|Other|13
5829538|NCT02454530|20141752|P1|Overall Study|Other|8
5829539|NCT02454478|20141789|P1|Overall Study|Incomplete DLT Evaluation|1
5829540|NCT02454101|20141883|P2|Overall Study|Lost to Follow-up|4
5829541|NCT02454101|20141884|P1|Overall Study|Lost to Follow-up|3
5829542|NCT02454101|20141883|P2|Overall Study|Adverse Event|3
5829543|NCT02454101|20141884|P1|Overall Study|Adverse Event|2
5829544|NCT02453841|20141906|P1|Overall Study|Unable to obtain blood samples|2
5829545|NCT02453841|20141906|P1|Overall Study|Protocol Violation|1
5829546|NCT02453711|20141929|P9|Overall Study|Unclassified|0
5829547|NCT02453711|20141930|P8|Overall Study|Unclassified|0
5829548|NCT02453711|20141931|P7|Overall Study|Unclassified|0
5829549|NCT02453711|20141932|P6|Overall Study|Unclassified|0
5829550|NCT02453711|20141933|P5|Overall Study|Unclassified|0
5829551|NCT02453711|20141934|P4|Overall Study|Unclassified|0
5829552|NCT02453711|20141935|P3|Overall Study|Unclassified|1
5829553|NCT02453711|20141936|P2|Overall Study|Unclassified|0
5829554|NCT02453711|20141937|P1|Overall Study|Unclassified|1
5829555|NCT02453711|20141929|P9|Overall Study|Death|0
5829556|NCT02453711|20141930|P8|Overall Study|Death|0
5829557|NCT02453711|20141931|P7|Overall Study|Death|1
5829558|NCT02453711|20141932|P6|Overall Study|Death|0
5829559|NCT02453711|20141933|P5|Overall Study|Death|0
5829560|NCT02453711|20141934|P4|Overall Study|Death|0
5829561|NCT02453711|20141935|P3|Overall Study|Death|0
5829562|NCT02453711|20141936|P2|Overall Study|Death|0
5829563|NCT02453711|20141937|P1|Overall Study|Death|0
5829564|NCT02453711|20141929|P9|Overall Study|Lost to Follow-up|6
5829565|NCT02453711|20141930|P8|Overall Study|Lost to Follow-up|6
5829566|NCT02453711|20141931|P7|Overall Study|Lost to Follow-up|2
5829567|NCT02453711|20141932|P6|Overall Study|Lost to Follow-up|5
5829568|NCT02453711|20141933|P5|Overall Study|Lost to Follow-up|1
5829569|NCT02453711|20141934|P4|Overall Study|Lost to Follow-up|3
5829570|NCT02453711|20141935|P3|Overall Study|Lost to Follow-up|2
5829571|NCT02453711|20141936|P2|Overall Study|Lost to Follow-up|3
5829572|NCT02453711|20141937|P1|Overall Study|Lost to Follow-up|5
5829573|NCT02453711|20141929|P9|Overall Study|Withdrawal by Subject|7
5829574|NCT02453711|20141930|P8|Overall Study|Withdrawal by Subject|1
5829575|NCT02453711|20141931|P7|Overall Study|Withdrawal by Subject|0
5829576|NCT02453711|20141932|P6|Overall Study|Withdrawal by Subject|1
5829577|NCT02453711|20141933|P5|Overall Study|Withdrawal by Subject|1
5829578|NCT02453711|20141934|P4|Overall Study|Withdrawal by Subject|4
5829579|NCT02453711|20141935|P3|Overall Study|Withdrawal by Subject|6
5829580|NCT02453711|20141936|P2|Overall Study|Withdrawal by Subject|4
5829581|NCT02453711|20141937|P1|Overall Study|Withdrawal by Subject|5
5829582|NCT02453685|20142281|P2|Overall Study|Unclassified|2
5829583|NCT02453685|20142282|P1|Overall Study|Unclassified|4
5829584|NCT02453685|20142281|P2|Overall Study|Withdrawal by Subject|4
5829585|NCT02453685|20142282|P1|Overall Study|Withdrawal by Subject|8
5829586|NCT02453685|20142281|P2|Overall Study|Lost to Follow-up|1
5829587|NCT02453685|20142282|P1|Overall Study|Lost to Follow-up|0
5829588|NCT02453685|20142281|P2|Overall Study|Protocol Violation|4
5829589|NCT02453685|20142282|P1|Overall Study|Protocol Violation|7
5829590|NCT02453685|20142281|P2|Overall Study|Adverse Event|1
5829591|NCT02453685|20142282|P1|Overall Study|Adverse Event|0
5829592|NCT02453555|20142340|P6|Extension Period|Withdrawal by Subject|0
5829593|NCT02453555|20142341|P5|Extension Period|Withdrawal by Subject|0
5829594|NCT02453555|20142342|P4|Extension Period|Withdrawal by Subject|0
5829595|NCT02453555|20142343|P3|Extension Period|Withdrawal by Subject|1
5829596|NCT02453555|20142344|P2|Extension Period|Withdrawal by Subject|0
5829597|NCT02453555|20142345|P1|Extension Period|Withdrawal by Subject|0
5829598|NCT02453555|20142340|P6|Extension Period|Protocol Violation|0
5829599|NCT02453555|20142341|P5|Extension Period|Protocol Violation|0
5829600|NCT02453555|20142342|P4|Extension Period|Protocol Violation|0
5829601|NCT02453555|20142343|P3|Extension Period|Protocol Violation|1
5829602|NCT02453555|20142344|P2|Extension Period|Protocol Violation|0
5829603|NCT02453555|20142345|P1|Extension Period|Protocol Violation|0
5829604|NCT02453555|20142340|P6|Extension Period|Adverse Event|1
5829605|NCT02453555|20142341|P5|Extension Period|Adverse Event|1
5829606|NCT02453555|20142342|P4|Extension Period|Adverse Event|2
5829607|NCT02453555|20142343|P3|Extension Period|Adverse Event|1
5829608|NCT02453555|20142344|P2|Extension Period|Adverse Event|0
5829609|NCT02453555|20142345|P1|Extension Period|Adverse Event|0
5829610|NCT02453555|20142340|P6|24-week Double-blind Treatment Period|Other than specified above|0
5829611|NCT02453555|20142341|P5|24-week Double-blind Treatment Period|Other than specified above|0
5829612|NCT02453555|20142342|P4|24-week Double-blind Treatment Period|Other than specified above|0
5829613|NCT02453555|20142343|P3|24-week Double-blind Treatment Period|Other than specified above|0
5829614|NCT02453555|20142344|P2|24-week Double-blind Treatment Period|Other than specified above|3
5829615|NCT02453555|20142345|P1|24-week Double-blind Treatment Period|Other than specified above|0
5829616|NCT02453555|20142340|P6|24-week Double-blind Treatment Period|Withdrawal by Subject|0
5829617|NCT02453555|20142341|P5|24-week Double-blind Treatment Period|Withdrawal by Subject|0
5829618|NCT02453555|20142342|P4|24-week Double-blind Treatment Period|Withdrawal by Subject|0
5829619|NCT02453555|20142343|P3|24-week Double-blind Treatment Period|Withdrawal by Subject|0
5829620|NCT02453555|20142344|P2|24-week Double-blind Treatment Period|Withdrawal by Subject|4
5829621|NCT02453555|20142345|P1|24-week Double-blind Treatment Period|Withdrawal by Subject|2
5829622|NCT02453555|20142340|P6|24-week Double-blind Treatment Period|Lost to Follow-up|0
5829623|NCT02453555|20142341|P5|24-week Double-blind Treatment Period|Lost to Follow-up|0
5829624|NCT02453555|20142342|P4|24-week Double-blind Treatment Period|Lost to Follow-up|0
5829625|NCT02453555|20142343|P3|24-week Double-blind Treatment Period|Lost to Follow-up|0
5829626|NCT02453555|20142344|P2|24-week Double-blind Treatment Period|Lost to Follow-up|0
5829627|NCT02453555|20142345|P1|24-week Double-blind Treatment Period|Lost to Follow-up|1
5829628|NCT02453555|20142340|P6|24-week Double-blind Treatment Period|Adverse Event|0
5829629|NCT02453555|20142341|P5|24-week Double-blind Treatment Period|Adverse Event|0
5829630|NCT02453555|20142342|P4|24-week Double-blind Treatment Period|Adverse Event|0
5829631|NCT02453555|20142343|P3|24-week Double-blind Treatment Period|Adverse Event|0
5829632|NCT02453555|20142344|P2|24-week Double-blind Treatment Period|Adverse Event|0
5829633|NCT02453555|20142345|P1|24-week Double-blind Treatment Period|Adverse Event|2
5829634|NCT02453386|20142361|P3|Overall Study|Other|1
5829635|NCT02453386|20142362|P2|Overall Study|Other|0
5829636|NCT02453386|20142363|P1|Overall Study|Other|1
5829637|NCT02453386|20142361|P3|Overall Study|Lost to Follow-up|1
5829638|NCT02453386|20142362|P2|Overall Study|Lost to Follow-up|0
5829639|NCT02453386|20142363|P1|Overall Study|Lost to Follow-up|0
5829640|NCT02453386|20142361|P3|Overall Study|Sponsor Terminated by Investigator|2
5829641|NCT02453386|20142362|P2|Overall Study|Sponsor Terminated by Investigator|1
5829642|NCT02453386|20142363|P1|Overall Study|Sponsor Terminated by Investigator|0
5829643|NCT02453386|20142361|P3|Overall Study|Subject Terminated by Sponsor|1
5829644|NCT02453386|20142362|P2|Overall Study|Subject Terminated by Sponsor|1
5829645|NCT02453386|20142363|P1|Overall Study|Subject Terminated by Sponsor|1
5829646|NCT02453386|20142361|P3|Overall Study|Sponsor Terminated Study|11
5829647|NCT02453386|20142362|P2|Overall Study|Sponsor Terminated Study|8
5829648|NCT02453386|20142363|P1|Overall Study|Sponsor Terminated Study|14
5829649|NCT02453386|20142361|P3|Overall Study|Withdrawal by Subject|9
5829650|NCT02453386|20142362|P2|Overall Study|Withdrawal by Subject|9
5829651|NCT02453386|20142363|P1|Overall Study|Withdrawal by Subject|10
5829652|NCT02453386|20142361|P3|Overall Study|Protocol Violation|1
5829653|NCT02453386|20142362|P2|Overall Study|Protocol Violation|0
5829654|NCT02453386|20142363|P1|Overall Study|Protocol Violation|1
5829655|NCT02453386|20142361|P3|Overall Study|Adverse Event|15
5829656|NCT02453386|20142362|P2|Overall Study|Adverse Event|30
5829657|NCT02453386|20142363|P1|Overall Study|Adverse Event|22
5829658|NCT02453321|20142427|P3|Overall Study|Deep Venous Thrombosis|0
5829659|NCT02453321|20142428|P2|Overall Study|Deep Venous Thrombosis|1
5829660|NCT02453321|20142429|P1|Overall Study|Deep Venous Thrombosis|0
5829661|NCT02453321|20142427|P3|Overall Study|Weakness|2
5829662|NCT02453321|20142428|P2|Overall Study|Weakness|1
5829663|NCT02453321|20142429|P1|Overall Study|Weakness|1
5829664|NCT02453282|20142449|P3|Overall Study|Other|1
5829665|NCT02453282|20142450|P2|Overall Study|Other|1
5829666|NCT02453282|20142451|P1|Overall Study|Other|1
5829667|NCT02453282|20142449|P3|Overall Study|Participants ongoing at data cut-off|62
5829668|NCT02453282|20142450|P2|Overall Study|Participants ongoing at data cut-off|84
5829669|NCT02453282|20142451|P1|Overall Study|Participants ongoing at data cut-off|85
5829670|NCT02453282|20142449|P3|Overall Study|Withdrawal by Subject|11
5829671|NCT02453282|20142450|P2|Overall Study|Withdrawal by Subject|10
5829672|NCT02453282|20142451|P1|Overall Study|Withdrawal by Subject|12
5829673|NCT02453282|20142449|P3|Overall Study|Lost to Follow-up|2
5829674|NCT02453282|20142450|P2|Overall Study|Lost to Follow-up|0
5829675|NCT02453282|20142451|P1|Overall Study|Lost to Follow-up|1
5829676|NCT02453282|20142449|P3|Overall Study|Death|296
5829677|NCT02453282|20142450|P2|Overall Study|Death|277
5829678|NCT02453282|20142451|P1|Overall Study|Death|275
5829679|NCT02453256|20142532|P2|Open Label Period|Withdrawal by Subject|1
5829680|NCT02453256|20142533|P1|Open Label Period|Withdrawal by Subject|5
5829681|NCT02453256|20142532|P2|Open Label Period|Other|2
5829682|NCT02453256|20142533|P1|Open Label Period|Other|0
5829683|NCT02453256|20142532|P2|Open Label Period|Lost to Follow-up|0
5829684|NCT02453256|20142533|P1|Open Label Period|Lost to Follow-up|1
5829685|NCT02453256|20142532|P2|Open Label Period|Death|1
5829686|NCT02453256|20142533|P1|Open Label Period|Death|0
5829687|NCT02453256|20142532|P2|Open Label Period|Adverse Event|3
5829688|NCT02453256|20142533|P1|Open Label Period|Adverse Event|1
5829689|NCT02453256|20142532|P2|Double Blind Period|Other|1
5829690|NCT02453256|20142533|P1|Double Blind Period|Other|0
5829691|NCT02453256|20142532|P2|Double Blind Period|Withdrawal by Subject|5
5829692|NCT02453256|20142533|P1|Double Blind Period|Withdrawal by Subject|9
5829693|NCT02453256|20142532|P2|Double Blind Period|Adverse Event|2
5829694|NCT02453256|20142533|P1|Double Blind Period|Adverse Event|3
5829695|NCT02453256|20142532|P2|Double Blind Period|Death|1
5829696|NCT02453256|20142533|P1|Double Blind Period|Death|1
5829697|NCT02453191|20142653|P1|Overall Study|Withdrawal by Subject|1
5829698|NCT02453048|20142670|P5|Overall Study|Lost to Follow-up|0
5829699|NCT02453048|20142671|P4|Overall Study|Lost to Follow-up|0
5829700|NCT02453048|20142672|P3|Overall Study|Lost to Follow-up|2
5829701|NCT02453048|20142673|P2|Overall Study|Lost to Follow-up|1
5829702|NCT02453048|20142674|P1|Overall Study|Lost to Follow-up|0
5829703|NCT02453048|20142670|P5|Overall Study|Only part of initial 6 mo. study|6
5829704|NCT02453048|20142671|P4|Overall Study|Only part of initial 6 mo. study|0
5829705|NCT02453048|20142672|P3|Overall Study|Only part of initial 6 mo. study|0
5829706|NCT02453048|20142673|P2|Overall Study|Only part of initial 6 mo. study|0
5829707|NCT02453048|20142674|P1|Overall Study|Only part of initial 6 mo. study|0
5829708|NCT02452892|20142734|P4|Follow-up|Subject left town on Day 42|0
5829709|NCT02452892|20142735|P3|Follow-up|Subject left town on Day 42|0
5829710|NCT02452892|20142736|P2|Follow-up|Subject left town on Day 42|0
5829711|NCT02452892|20142737|P1|Follow-up|Subject left town on Day 42|1
5829712|NCT02452892|20142734|P4|Follow-up|Withdrawal by Subject|1
5829713|NCT02452892|20142735|P3|Follow-up|Withdrawal by Subject|0
5829714|NCT02452892|20142736|P2|Follow-up|Withdrawal by Subject|0
5829715|NCT02452892|20142737|P1|Follow-up|Withdrawal by Subject|0
5829716|NCT02452892|20142734|P4|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0
5829717|NCT02452892|20142735|P3|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0
5829718|NCT02452892|20142736|P2|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0
5829719|NCT02452892|20142737|P1|Week 2 Stratification & Re-Randomization|Lost to Follow-up|2
5829720|NCT02452892|20142734|P4|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|2
5829721|NCT02452892|20142735|P3|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0
5829722|NCT02452892|20142736|P2|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0
5829723|NCT02452892|20142737|P1|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0
5829724|NCT02452892|20142734|P4|Week 1 Initial Randommization|Lost to Follow-up|0
5829725|NCT02452892|20142735|P3|Week 1 Initial Randommization|Lost to Follow-up|1
5829726|NCT02452892|20142736|P2|Week 1 Initial Randommization|Lost to Follow-up|0
5829727|NCT02452892|20142737|P1|Week 1 Initial Randommization|Lost to Follow-up|0
5829728|NCT02452892|20142734|P4|Week 1 Initial Randommization|Adverse Event|0
5829729|NCT02452892|20142735|P3|Week 1 Initial Randommization|Adverse Event|0
5829730|NCT02452892|20142736|P2|Week 1 Initial Randommization|Adverse Event|0
5829731|NCT02452892|20142737|P1|Week 1 Initial Randommization|Adverse Event|1
5829732|NCT02452554|20142772|P6|Overall Study|Never Received Treatment|0
5829733|NCT02452554|20142773|P5|Overall Study|Never Received Treatment|0
5829734|NCT02452554|20142774|P4|Overall Study|Never Received Treatment|0
5829735|NCT02452554|20142775|P3|Overall Study|Never Received Treatment|0
5829736|NCT02452554|20142776|P2|Overall Study|Never Received Treatment|0
5829737|NCT02452554|20142777|P1|Overall Study|Never Received Treatment|1
5829738|NCT02452554|20142772|P6|Overall Study|Ineligible|0
5829739|NCT02452554|20142773|P5|Overall Study|Ineligible|0
5829740|NCT02452554|20142774|P4|Overall Study|Ineligible|0
5829741|NCT02452554|20142775|P3|Overall Study|Ineligible|0
5829742|NCT02452554|20142776|P2|Overall Study|Ineligible|1
5829743|NCT02452554|20142777|P1|Overall Study|Ineligible|0
5829744|NCT02452554|20142772|P6|Overall Study|Withdrawal by Subject|1
5829745|NCT02452554|20142773|P5|Overall Study|Withdrawal by Subject|0
5829746|NCT02452554|20142774|P4|Overall Study|Withdrawal by Subject|0
5829747|NCT02452554|20142775|P3|Overall Study|Withdrawal by Subject|2
5829748|NCT02452554|20142776|P2|Overall Study|Withdrawal by Subject|0
5829749|NCT02452554|20142777|P1|Overall Study|Withdrawal by Subject|1
5829750|NCT02452554|20142772|P6|Overall Study|Physician Decision|0
5829751|NCT02452554|20142773|P5|Overall Study|Physician Decision|0
5829752|NCT02452554|20142774|P4|Overall Study|Physician Decision|0
5829753|NCT02452554|20142775|P3|Overall Study|Physician Decision|0
5829754|NCT02452554|20142776|P2|Overall Study|Physician Decision|1
5829755|NCT02452554|20142777|P1|Overall Study|Physician Decision|0
5829756|NCT02452554|20142772|P6|Overall Study|Lack of Efficacy|8
5829757|NCT02452554|20142773|P5|Overall Study|Lack of Efficacy|5
5829758|NCT02452554|20142774|P4|Overall Study|Lack of Efficacy|1
5829759|NCT02452554|20142775|P3|Overall Study|Lack of Efficacy|9
5829760|NCT02452554|20142776|P2|Overall Study|Lack of Efficacy|14
5829761|NCT02452554|20142777|P1|Overall Study|Lack of Efficacy|13
5829762|NCT02452554|20142772|P6|Overall Study|Death|0
5829763|NCT02452554|20142773|P5|Overall Study|Death|0
5829764|NCT02452554|20142774|P4|Overall Study|Death|0
5829765|NCT02452554|20142775|P3|Overall Study|Death|0
5829766|NCT02452554|20142776|P2|Overall Study|Death|1
5829767|NCT02452554|20142777|P1|Overall Study|Death|2
5829768|NCT02452463|20142830|P3|Overall Study|Withdrawal by Subject|0
5829769|NCT02452463|20142831|P2|Overall Study|Withdrawal by Subject|1
5829770|NCT02452463|20142832|P1|Overall Study|Withdrawal by Subject|0
5829771|NCT02452463|20142830|P3|Overall Study|Recommended by DSMB|0
5829772|NCT02452463|20142831|P2|Overall Study|Recommended by DSMB|1
5829773|NCT02452463|20142832|P1|Overall Study|Recommended by DSMB|0
5829774|NCT02452463|20142830|P3|Overall Study|Study Suspended|0
5829775|NCT02452463|20142831|P2|Overall Study|Study Suspended|0
5829776|NCT02452463|20142832|P1|Overall Study|Study Suspended|1
5829777|NCT02452463|20142830|P3|Overall Study|Death|0
5829778|NCT02452463|20142831|P2|Overall Study|Death|0
5829779|NCT02452463|20142832|P1|Overall Study|Death|1
5829780|NCT02452424|20142875|P11|Overall Study|Adverse Event|1
5829781|NCT02452424|20142876|P10|Overall Study|Adverse Event|0
5829782|NCT02452424|20142877|P9|Overall Study|Adverse Event|0
5829783|NCT02452424|20142878|P8|Overall Study|Adverse Event|0
5829784|NCT02452424|20142879|P7|Overall Study|Adverse Event|0
5829785|NCT02452424|20142880|P6|Overall Study|Adverse Event|0
5829786|NCT02452424|20142881|P5|Overall Study|Adverse Event|0
5829787|NCT02452424|20142882|P4|Overall Study|Adverse Event|0
5829788|NCT02452424|20142883|P3|Overall Study|Adverse Event|0
5829789|NCT02452424|20142884|P2|Overall Study|Adverse Event|0
5829790|NCT02452424|20142885|P1|Overall Study|Adverse Event|0
5829791|NCT02452424|20142875|P11|Overall Study|Progressive disease (per RECIST)|0
5829792|NCT02452424|20142876|P10|Overall Study|Progressive disease (per RECIST)|0
5829793|NCT02452424|20142877|P9|Overall Study|Progressive disease (per RECIST)|2
5829794|NCT02452424|20142878|P8|Overall Study|Progressive disease (per RECIST)|0
5829795|NCT02452424|20142879|P7|Overall Study|Progressive disease (per RECIST)|0
5829796|NCT02452424|20142880|P6|Overall Study|Progressive disease (per RECIST)|0
5829797|NCT02452424|20142881|P5|Overall Study|Progressive disease (per RECIST)|0
5829798|NCT02452424|20142882|P4|Overall Study|Progressive disease (per RECIST)|0
5829799|NCT02452424|20142883|P3|Overall Study|Progressive disease (per RECIST)|0
5829800|NCT02452424|20142884|P2|Overall Study|Progressive disease (per RECIST)|0
5829801|NCT02452424|20142885|P1|Overall Study|Progressive disease (per RECIST)|0
5829802|NCT02452424|20142875|P11|Overall Study|Other|1
5829803|NCT02452424|20142876|P10|Overall Study|Other|0
5829804|NCT02452424|20142877|P9|Overall Study|Other|0
5829805|NCT02452424|20142878|P8|Overall Study|Other|3
5829806|NCT02452424|20142879|P7|Overall Study|Other|4
5829807|NCT02452424|20142880|P6|Overall Study|Other|1
5829808|NCT02452424|20142881|P5|Overall Study|Other|0
5829809|NCT02452424|20142882|P4|Overall Study|Other|0
5829810|NCT02452424|20142883|P3|Overall Study|Other|1
5829811|NCT02452424|20142884|P2|Overall Study|Other|0
5829812|NCT02452424|20142885|P1|Overall Study|Other|0
5829813|NCT02452424|20142875|P11|Overall Study|Withdrawal by Subject|0
5829814|NCT02452424|20142876|P10|Overall Study|Withdrawal by Subject|1
5829815|NCT02452424|20142877|P9|Overall Study|Withdrawal by Subject|1
5829816|NCT02452424|20142878|P8|Overall Study|Withdrawal by Subject|0
5829817|NCT02452424|20142879|P7|Overall Study|Withdrawal by Subject|1
5829818|NCT02452424|20142880|P6|Overall Study|Withdrawal by Subject|0
5829819|NCT02452424|20142881|P5|Overall Study|Withdrawal by Subject|0
5829820|NCT02452424|20142882|P4|Overall Study|Withdrawal by Subject|2
5829821|NCT02452424|20142883|P3|Overall Study|Withdrawal by Subject|3
5829822|NCT02452424|20142884|P2|Overall Study|Withdrawal by Subject|0
5829823|NCT02452424|20142885|P1|Overall Study|Withdrawal by Subject|0
5829824|NCT02452424|20142875|P11|Overall Study|Lost to Follow-up|0
5829825|NCT02452424|20142876|P10|Overall Study|Lost to Follow-up|0
5829826|NCT02452424|20142877|P9|Overall Study|Lost to Follow-up|0
5829827|NCT02452424|20142878|P8|Overall Study|Lost to Follow-up|0
5829828|NCT02452424|20142879|P7|Overall Study|Lost to Follow-up|0
5829829|NCT02452424|20142880|P6|Overall Study|Lost to Follow-up|0
5829830|NCT02452424|20142881|P5|Overall Study|Lost to Follow-up|0
5829831|NCT02452424|20142882|P4|Overall Study|Lost to Follow-up|0
5829832|NCT02452424|20142883|P3|Overall Study|Lost to Follow-up|1
5829833|NCT02452424|20142884|P2|Overall Study|Lost to Follow-up|1
5829834|NCT02452424|20142885|P1|Overall Study|Lost to Follow-up|0
5829835|NCT02452424|20142875|P11|Overall Study|Death|0
5829836|NCT02452424|20142876|P10|Overall Study|Death|1
5829837|NCT02452424|20142877|P9|Overall Study|Death|3
5829838|NCT02452424|20142878|P8|Overall Study|Death|1
5829839|NCT02452424|20142879|P7|Overall Study|Death|5
5829840|NCT02452424|20142880|P6|Overall Study|Death|0
5829841|NCT02452424|20142881|P5|Overall Study|Death|2
5829842|NCT02452424|20142882|P4|Overall Study|Death|6
5829843|NCT02452424|20142883|P3|Overall Study|Death|2
5829844|NCT02452424|20142884|P2|Overall Study|Death|2
5829845|NCT02452424|20142885|P1|Overall Study|Death|2
5829846|NCT02452398|20142920|P1|Overall Study|Moved away|4
5829847|NCT02452398|20142920|P1|Overall Study|Withdrawal by Subject|6
5829848|NCT02452398|20142920|P1|Overall Study|Physician Decision|2
5829849|NCT02452398|20142920|P1|Overall Study|Lost to Follow-up|28
5829850|NCT02452398|20142920|P1|Overall Study|Adverse Event|1
5829851|NCT02452359|20142924|P1|Overall Study|Withdrawal by Subject|4
5829852|NCT02452359|20142924|P1|Overall Study|Pregnancy|1
5829853|NCT02452359|20142924|P1|Overall Study|Lost to Follow-up|15
5829854|NCT02452359|20142924|P1|Overall Study|Adverse Event|1
5829855|NCT02452320|20142936|P2|Overall Study|Adverse Event|1
5829856|NCT02452320|20142937|P1|Overall Study|Adverse Event|0
5829857|NCT02452190|20142949|P2|Overall Study|Death|1
5829858|NCT02452190|20142950|P1|Overall Study|Death|0
5829859|NCT02452190|20142949|P2|Overall Study|Participant traveled abroad|0
5829860|NCT02452190|20142950|P1|Overall Study|Participant traveled abroad|1
5829861|NCT02452190|20142949|P2|Overall Study|Noncompliance with study drug|0
5829862|NCT02452190|20142950|P1|Overall Study|Noncompliance with study drug|1
5829863|NCT02452190|20142949|P2|Overall Study|Withdrawal by Subject|11
5829864|NCT02452190|20142950|P1|Overall Study|Withdrawal by Subject|20
5829865|NCT02452190|20142949|P2|Overall Study|Adverse Event|5
5829866|NCT02452190|20142950|P1|Overall Study|Adverse Event|2
5829867|NCT02452190|20142949|P2|Overall Study|Lost to Follow-up|3
5829868|NCT02452190|20142950|P1|Overall Study|Lost to Follow-up|4
5829869|NCT02452190|20142949|P2|Overall Study|Lack of Efficacy|1
5829870|NCT02452190|20142950|P1|Overall Study|Lack of Efficacy|3
5829871|NCT02452190|20142949|P2|Overall Study|Investigator's Decision|0
5829872|NCT02452190|20142950|P1|Overall Study|Investigator's Decision|2
5829873|NCT02452190|20142949|P2|Overall Study|Pregnancy|0
5829874|NCT02452190|20142950|P1|Overall Study|Pregnancy|1
5829875|NCT02452190|20142949|P2|Overall Study|Withdrawal by Sponsor|3
5829876|NCT02452190|20142950|P1|Overall Study|Withdrawal by Sponsor|1
5829877|NCT02452047|20142988|P3|Overall Study|Withdrawal by Subject|0
5829878|NCT02452047|20142989|P2|Overall Study|Withdrawal by Subject|0
5829879|NCT02452047|20142990|P1|Overall Study|Withdrawal by Subject|1
5829880|NCT02452047|20142988|P3|Overall Study|Lost to Follow-up|0
5829881|NCT02452047|20142989|P2|Overall Study|Lost to Follow-up|1
5829882|NCT02452047|20142990|P1|Overall Study|Lost to Follow-up|1
5829883|NCT02452047|20142988|P3|Overall Study|Physician Decision|0
5829884|NCT02452047|20142989|P2|Overall Study|Physician Decision|0
5829885|NCT02452047|20142990|P1|Overall Study|Physician Decision|1
5829886|NCT02452047|20142988|P3|Overall Study|Death|1
5829887|NCT02452047|20142989|P2|Overall Study|Death|3
5829888|NCT02452047|20142990|P1|Overall Study|Death|1
5829889|NCT02452047|20142988|P3|Overall Study|Adverse Event|1
5829890|NCT02452047|20142989|P2|Overall Study|Adverse Event|1
5829891|NCT02452047|20142990|P1|Overall Study|Adverse Event|0
5829892|NCT02452034|20143055|P6|Overall Study|Withdrawn by Parent/Guardian|0
5829893|NCT02452034|20143056|P5|Overall Study|Withdrawn by Parent/Guardian|0
5829894|NCT02452034|20143057|P4|Overall Study|Withdrawn by Parent/Guardian|0
5829895|NCT02452034|20143058|P3|Overall Study|Withdrawn by Parent/Guardian|0
5829896|NCT02452034|20143059|P2|Overall Study|Withdrawn by Parent/Guardian|0
5829897|NCT02452034|20143060|P1|Overall Study|Withdrawn by Parent/Guardian|1
5829898|NCT02452034|20143055|P6|Overall Study|Screen Failure|0
5829899|NCT02452034|20143056|P5|Overall Study|Screen Failure|0
5829900|NCT02452034|20143057|P4|Overall Study|Screen Failure|1
5829901|NCT02452034|20143058|P3|Overall Study|Screen Failure|0
5829902|NCT02452034|20143059|P2|Overall Study|Screen Failure|0
5829903|NCT02452034|20143060|P1|Overall Study|Screen Failure|1
5829904|NCT02452034|20143055|P6|Overall Study|Protocol Violation|1
5829905|NCT02452034|20143056|P5|Overall Study|Protocol Violation|0
5829906|NCT02452034|20143057|P4|Overall Study|Protocol Violation|0
5829907|NCT02452034|20143058|P3|Overall Study|Protocol Violation|0
5829908|NCT02452034|20143059|P2|Overall Study|Protocol Violation|0
5829909|NCT02452034|20143060|P1|Overall Study|Protocol Violation|0
5829910|NCT02452034|20143055|P6|Overall Study|Physician Decision|0
5829911|NCT02452034|20143056|P5|Overall Study|Physician Decision|0
5829912|NCT02452034|20143057|P4|Overall Study|Physician Decision|0
5829913|NCT02452034|20143058|P3|Overall Study|Physician Decision|1
5829914|NCT02452034|20143059|P2|Overall Study|Physician Decision|1
5829915|NCT02452034|20143060|P1|Overall Study|Physician Decision|0
5829916|NCT02452034|20143055|P6|Overall Study|Death|1
5829917|NCT02452034|20143056|P5|Overall Study|Death|1
5829918|NCT02452034|20143057|P4|Overall Study|Death|0
5829919|NCT02452034|20143058|P3|Overall Study|Death|0
5829920|NCT02452034|20143059|P2|Overall Study|Death|0
5829921|NCT02452034|20143060|P1|Overall Study|Death|0
5829922|NCT02452034|20143055|P6|Overall Study|Adverse Event|1
5829923|NCT02452034|20143056|P5|Overall Study|Adverse Event|0
5829924|NCT02452034|20143057|P4|Overall Study|Adverse Event|0
5829925|NCT02452034|20143058|P3|Overall Study|Adverse Event|0
5829926|NCT02452034|20143059|P2|Overall Study|Adverse Event|0
5829927|NCT02452034|20143060|P1|Overall Study|Adverse Event|0
5829928|NCT02451943|20143133|P2|Overall Study|Lost to Follow-up|4
5829929|NCT02451943|20143134|P1|Overall Study|Lost to Follow-up|3
5829930|NCT02451943|20143133|P2|Overall Study|Withdrawal by Subject|16
5829931|NCT02451943|20143134|P1|Overall Study|Withdrawal by Subject|13
5829932|NCT02451943|20143133|P2|Overall Study|On Treatment|4
5829933|NCT02451943|20143134|P1|Overall Study|On Treatment|4
5829934|NCT02451930|20143163|P2|Overall Study|Other|1
5829935|NCT02451930|20143164|P1|Overall Study|Other|0
5829936|NCT02451930|20143163|P2|Overall Study|Withdrawal by Subject|1
5829937|NCT02451930|20143164|P1|Overall Study|Withdrawal by Subject|0
5829938|NCT02451930|20143163|P2|Overall Study|Sponsor Decision|10
5829939|NCT02451930|20143164|P1|Overall Study|Sponsor Decision|2
5829940|NCT02451930|20143163|P2|Overall Study|Lost to Follow-up|3
5829941|NCT02451930|20143164|P1|Overall Study|Lost to Follow-up|0
5829942|NCT02451930|20143163|P2|Overall Study|Death|15
5829943|NCT02451930|20143164|P1|Overall Study|Death|0
5829944|NCT02451917|20143187|P2|First Intervention (24 Weeks)|Adverse Event|2
5829945|NCT02451917|20143188|P1|First Intervention (24 Weeks)|Adverse Event|0
5829946|NCT02451917|20143187|P2|First Intervention (24 Weeks)|Death|1
5829947|NCT02451917|20143188|P1|First Intervention (24 Weeks)|Death|0
5829948|NCT02451917|20143187|P2|First Intervention (24 Weeks)|Lost to Follow-up|0
5829949|NCT02451917|20143188|P1|First Intervention (24 Weeks)|Lost to Follow-up|2
5829950|NCT02451670|20143230|P2|Overall Study|Did not have qualifying follow-up visit.|696
5829951|NCT02451670|20143231|P1|Overall Study|Did not have qualifying follow-up visit.|714
5829952|NCT02451358|20143341|P4|Overall Study|Protocol Violation|0
5829953|NCT02451358|20143342|P3|Overall Study|Protocol Violation|1
5829954|NCT02451358|20143343|P2|Overall Study|Protocol Violation|1
5829955|NCT02451358|20143344|P1|Overall Study|Protocol Violation|0
5829956|NCT02451358|20143341|P4|Overall Study|Withdrawal by Subject|0
5829957|NCT02451358|20143342|P3|Overall Study|Withdrawal by Subject|0
5829958|NCT02451358|20143343|P2|Overall Study|Withdrawal by Subject|1
5829959|NCT02451358|20143344|P1|Overall Study|Withdrawal by Subject|1
5829960|NCT02451137|20143432|P2|Overall Study|Other than specified above|3
5829961|NCT02451137|20143433|P1|Overall Study|Other than specified above|2
5829962|NCT02451137|20143432|P2|Overall Study|Withdrawal by Subject|63
5829963|NCT02451137|20143433|P1|Overall Study|Withdrawal by Subject|40
5829964|NCT02451137|20143432|P2|Overall Study|Sponsor decision|25
5829965|NCT02451137|20143433|P1|Overall Study|Sponsor decision|13
5829966|NCT02451137|20143432|P2|Overall Study|Physician Decision|5
5829967|NCT02451137|20143433|P1|Overall Study|Physician Decision|6
5829968|NCT02451137|20143432|P2|Overall Study|Lost to Follow-up|61
5829969|NCT02451137|20143433|P1|Overall Study|Lost to Follow-up|53
5829970|NCT02451137|20143432|P2|Overall Study|Investigator's decision|19
5829971|NCT02451137|20143433|P1|Overall Study|Investigator's decision|23
5829972|NCT02451137|20143432|P2|Overall Study|Hypoglycemia|1
5829973|NCT02451137|20143433|P1|Overall Study|Hypoglycemia|2
5829974|NCT02451137|20143432|P2|Overall Study|Participant decision:discontinue insulin|43
5829975|NCT02451137|20143433|P1|Overall Study|Participant decision:discontinue insulin|41
5829976|NCT02451137|20143432|P2|Overall Study|Lack of Efficacy|9
5829977|NCT02451137|20143433|P1|Overall Study|Lack of Efficacy|4
5829978|NCT02451137|20143432|P2|Overall Study|Adverse Event|42
5829979|NCT02451137|20143433|P1|Overall Study|Adverse Event|43
5829980|NCT02451137|20143432|P2|Overall Study|Randomized but not treated|27
5829981|NCT02451137|20143433|P1|Overall Study|Randomized but not treated|19
5829982|NCT02451124|20143463|P1|Overall Study|Withdrawal by Subject|1
5829983|NCT02451007|20143474|P1|Overall Study|Disease Progression|2
5829984|NCT02451007|20143474|P1|Overall Study|Adverse Event|1
5829985|NCT02451007|20143474|P1|Overall Study|Withdrawal by Subject|4
5829990|NCT02450578|20143525|P4|Overall Study|ECG abnormality so not treated|0
5829991|NCT02450578|20143526|P3|Overall Study|ECG abnormality so not treated|0
5829992|NCT02450578|20143527|P2|Overall Study|ECG abnormality so not treated|0
5829993|NCT02450578|20143528|P1|Overall Study|ECG abnormality so not treated|1
5829994|NCT02450552|20143574|P3|Overall Study|Physician Decision|1
5829995|NCT02450552|20143575|P2|Overall Study|Physician Decision|0
5829996|NCT02450552|20143576|P1|Overall Study|Physician Decision|1
5829997|NCT02450552|20143574|P3|Overall Study|Withdrawal by Subject|4
5829998|NCT02450552|20143575|P2|Overall Study|Withdrawal by Subject|0
5829999|NCT02450552|20143576|P1|Overall Study|Withdrawal by Subject|4
5830000|NCT02450539|20143619|P2|Overall Study|On study treatment/follow up|25
5830001|NCT02450539|20143620|P1|Overall Study|On study treatment/follow up|27
5830002|NCT02450539|20143619|P2|Overall Study|Lost to Follow-up|1
5830003|NCT02450539|20143620|P1|Overall Study|Lost to Follow-up|4
5830004|NCT02450539|20143619|P2|Overall Study|Withdrawal by Subject|7
5830005|NCT02450539|20143620|P1|Overall Study|Withdrawal by Subject|19
5830006|NCT02450526|20143644|P5|OL Period (Cycles 2-5)|Protocol Violation|7
5830007|NCT02450526|20143645|P4|OL Period (Cycles 2-5)|Protocol Violation|0
5830008|NCT02450526|20143646|P3|OL Period (Cycles 2-5)|Protocol Violation|0
5830009|NCT02450526|20143647|P2|OL Period (Cycles 2-5)|Protocol Violation|0
5830010|NCT02450526|20143648|P1|OL Period (Cycles 2-5)|Protocol Violation|0
5830011|NCT02450526|20143644|P5|OL Period (Cycles 2-5)|Lack of Efficacy|1
5830012|NCT02450526|20143645|P4|OL Period (Cycles 2-5)|Lack of Efficacy|0
5830013|NCT02450526|20143646|P3|OL Period (Cycles 2-5)|Lack of Efficacy|0
5830014|NCT02450526|20143647|P2|OL Period (Cycles 2-5)|Lack of Efficacy|0
5830015|NCT02450526|20143648|P1|OL Period (Cycles 2-5)|Lack of Efficacy|0
5830016|NCT02450526|20143644|P5|OL Period (Cycles 2-5)|Withdrawal by Subject|31
5830017|NCT02450526|20143645|P4|OL Period (Cycles 2-5)|Withdrawal by Subject|0
5830018|NCT02450526|20143646|P3|OL Period (Cycles 2-5)|Withdrawal by Subject|0
5830019|NCT02450526|20143647|P2|OL Period (Cycles 2-5)|Withdrawal by Subject|0
5830020|NCT02450526|20143648|P1|OL Period (Cycles 2-5)|Withdrawal by Subject|0
5830021|NCT02450526|20143644|P5|OL Period (Cycles 2-5)|Adverse Event|2
5830022|NCT02450526|20143645|P4|OL Period (Cycles 2-5)|Adverse Event|0
5830023|NCT02450526|20143646|P3|OL Period (Cycles 2-5)|Adverse Event|0
5830024|NCT02450526|20143647|P2|OL Period (Cycles 2-5)|Adverse Event|0
5830025|NCT02450526|20143648|P1|OL Period (Cycles 2-5)|Adverse Event|0
5830026|NCT02450526|20143644|P5|DB Period (Cycle 1)|Protocol Violation|0
5830027|NCT02450526|20143645|P4|DB Period (Cycle 1)|Protocol Violation|1
5830028|NCT02450526|20143646|P3|DB Period (Cycle 1)|Protocol Violation|0
5830029|NCT02450526|20143647|P2|DB Period (Cycle 1)|Protocol Violation|0
5830030|NCT02450526|20143648|P1|DB Period (Cycle 1)|Protocol Violation|2
5830031|NCT02450526|20143644|P5|DB Period (Cycle 1)|Lost to Follow-up|0
5830032|NCT02450526|20143645|P4|DB Period (Cycle 1)|Lost to Follow-up|0
5830033|NCT02450526|20143646|P3|DB Period (Cycle 1)|Lost to Follow-up|0
5830034|NCT02450526|20143647|P2|DB Period (Cycle 1)|Lost to Follow-up|0
5830035|NCT02450526|20143648|P1|DB Period (Cycle 1)|Lost to Follow-up|1
5830036|NCT02450526|20143644|P5|DB Period (Cycle 1)|Withdrawal by Subject|0
5830037|NCT02450526|20143645|P4|DB Period (Cycle 1)|Withdrawal by Subject|1
5830038|NCT02450526|20143646|P3|DB Period (Cycle 1)|Withdrawal by Subject|8
5830039|NCT02450526|20143647|P2|DB Period (Cycle 1)|Withdrawal by Subject|3
5830040|NCT02450526|20143648|P1|DB Period (Cycle 1)|Withdrawal by Subject|28
5830041|NCT02450526|20143644|P5|DB Period (Cycle 1)|Adverse Event|0
5830042|NCT02450526|20143645|P4|DB Period (Cycle 1)|Adverse Event|0
5830043|NCT02450526|20143646|P3|DB Period (Cycle 1)|Adverse Event|2
5830044|NCT02450526|20143647|P2|DB Period (Cycle 1)|Adverse Event|0
5830045|NCT02450526|20143648|P1|DB Period (Cycle 1)|Adverse Event|0
5830046|NCT02450487|20143733|P1|Overall Study|Lost to Follow-up|3
5830047|NCT02450331|20143755|P2|Overall Study|On-Study Status: In Survival follow-up|38
5830048|NCT02450331|20143756|P1|Overall Study|On-Study Status: In Survival follow-up|45
5830049|NCT02450331|20143755|P2|Overall Study|On-Study Status: In Disease recurrence follow-up|208
5830050|NCT02450331|20143756|P1|Overall Study|On-Study Status: In Disease recurrence follow-up|179
5830051|NCT02450331|20143755|P2|Overall Study|Withdrawal by Subject|39
5830052|NCT02450331|20143756|P1|Overall Study|Withdrawal by Subject|50
5830053|NCT02450331|20143755|P2|Overall Study|Lost to Follow-up|7
5830054|NCT02450331|20143756|P1|Overall Study|Lost to Follow-up|9
5830055|NCT02450331|20143755|P2|Overall Study|Death|114
5830056|NCT02450331|20143756|P1|Overall Study|Death|120
5830057|NCT02449915|20143779|P2|Overall Study|Abnormal preop lab|1
5830058|NCT02449915|20143780|P1|Overall Study|Abnormal preop lab|0
5830059|NCT02449915|20143779|P2|Overall Study|Intraoperative surgical findings|1
5830060|NCT02449915|20143780|P1|Overall Study|Intraoperative surgical findings|1
5830061|NCT02449915|20143779|P2|Overall Study|Withdrawal by Subject|2
5830062|NCT02449915|20143780|P1|Overall Study|Withdrawal by Subject|0
5830063|NCT02449915|20143779|P2|Overall Study|Exclusion criteria - drug use|0
5830064|NCT02449915|20143780|P1|Overall Study|Exclusion criteria - drug use|1
5830065|NCT02449902|20143788|P2|Overall Study|Withdrawal by Subject|1
5830066|NCT02449902|20143789|P1|Overall Study|Withdrawal by Subject|0
5830067|NCT02449902|20143788|P2|Overall Study|Adverse Event|1
5830068|NCT02449902|20143789|P1|Overall Study|Adverse Event|0
5830069|NCT02449889|20143816|P3|Overall Study|Protocol Violation|1
5830070|NCT02449889|20143817|P2|Overall Study|Protocol Violation|4
5830071|NCT02449889|20143818|P1|Overall Study|Protocol Violation|0
5830072|NCT02449889|20143816|P3|Overall Study|Adverse Event|0
5830073|NCT02449889|20143817|P2|Overall Study|Adverse Event|2
5830074|NCT02449889|20143818|P1|Overall Study|Adverse Event|1
5830075|NCT02449044|20143952|P1|Overall Study|Sponsor Discontinued Trial|3
5830076|NCT02449044|20143952|P1|Overall Study|Physician Decision|9
5830077|NCT02449044|20143952|P1|Overall Study|Met Withdrawal Criteria|7
5830078|NCT02449044|20143952|P1|Overall Study|Adverse Event|30
5830079|NCT02449044|20143952|P1|Overall Study|Withdrawal by Subject|13
5830080|NCT02449044|20143952|P1|Overall Study|Lost to Follow-up|2
5830081|NCT02449018|20143973|P2|Overall Study|Patient decision|0
5830082|NCT02449018|20143974|P1|Overall Study|Patient decision|2
5830083|NCT02449018|20143973|P2|Overall Study|Protocol deviation|0
5830084|NCT02449018|20143974|P1|Overall Study|Protocol deviation|4
5830085|NCT02449018|20143973|P2|Overall Study|Adverse Event|1
5830086|NCT02449018|20143974|P1|Overall Study|Adverse Event|5
5830087|NCT02449018|20143973|P2|Overall Study|Administrative problems|0
5830088|NCT02449018|20143974|P1|Overall Study|Administrative problems|1
5830089|NCT02449018|20143973|P2|Overall Study|Abnormal laboratory value|1
5830090|NCT02449018|20143974|P1|Overall Study|Abnormal laboratory value|0
5830091|NCT02448875|20144021|P3|Overall Study|Withdrawal by Subject|0
5830092|NCT02448875|20144022|P2|Overall Study|Withdrawal by Subject|0
5830093|NCT02448875|20144023|P1|Overall Study|Withdrawal by Subject|1
5830094|NCT02448875|20144021|P3|Overall Study|Investigator Decision|1
5830095|NCT02448875|20144022|P2|Overall Study|Investigator Decision|0
5830096|NCT02448875|20144023|P1|Overall Study|Investigator Decision|3
5830097|NCT02448875|20144021|P3|Overall Study|Lost to Follow-up|0
5830098|NCT02448875|20144022|P2|Overall Study|Lost to Follow-up|0
5830099|NCT02448875|20144023|P1|Overall Study|Lost to Follow-up|1
5830100|NCT02448875|20144021|P3|Overall Study|Adverse Event|0
5830101|NCT02448875|20144022|P2|Overall Study|Adverse Event|1
5830102|NCT02448875|20144023|P1|Overall Study|Adverse Event|2
5830103|NCT02448810|20144071|P8|Overall Study|Other (unspecified)|0
5830104|NCT02448810|20144072|P7|Overall Study|Other (unspecified)|2
5830105|NCT02448810|20144073|P6|Overall Study|Other (unspecified)|0
5830106|NCT02448810|20144074|P5|Overall Study|Other (unspecified)|0
5830107|NCT02448810|20144075|P4|Overall Study|Other (unspecified)|0
5830108|NCT02448810|20144076|P3|Overall Study|Other (unspecified)|0
5830109|NCT02448810|20144077|P2|Overall Study|Other (unspecified)|0
5830110|NCT02448810|20144078|P1|Overall Study|Other (unspecified)|0
5830111|NCT02448810|20144071|P8|Overall Study|Lost to Follow-up|0
5830112|NCT02448810|20144072|P7|Overall Study|Lost to Follow-up|0
5830113|NCT02448810|20144073|P6|Overall Study|Lost to Follow-up|0
5830114|NCT02448810|20144074|P5|Overall Study|Lost to Follow-up|0
5830115|NCT02448810|20144075|P4|Overall Study|Lost to Follow-up|0
5830116|NCT02448810|20144076|P3|Overall Study|Lost to Follow-up|0
5830117|NCT02448810|20144077|P2|Overall Study|Lost to Follow-up|1
5830118|NCT02448810|20144078|P1|Overall Study|Lost to Follow-up|0
5830119|NCT02448810|20144071|P8|Overall Study|Other (Progressive disease)|5
5830120|NCT02448810|20144072|P7|Overall Study|Other (Progressive disease)|14
5830121|NCT02448810|20144073|P6|Overall Study|Other (Progressive disease)|9
5830122|NCT02448810|20144074|P5|Overall Study|Other (Progressive disease)|23
5830123|NCT02448810|20144075|P4|Overall Study|Other (Progressive disease)|3
5830124|NCT02448810|20144076|P3|Overall Study|Other (Progressive disease)|0
5830125|NCT02448810|20144077|P2|Overall Study|Other (Progressive disease)|2
5830126|NCT02448810|20144078|P1|Overall Study|Other (Progressive disease)|2
5830127|NCT02448810|20144071|P8|Overall Study|Death|0
5830128|NCT02448810|20144072|P7|Overall Study|Death|0
5830129|NCT02448810|20144073|P6|Overall Study|Death|0
5830130|NCT02448810|20144074|P5|Overall Study|Death|1
5830131|NCT02448810|20144075|P4|Overall Study|Death|0
5830132|NCT02448810|20144076|P3|Overall Study|Death|1
5830133|NCT02448810|20144077|P2|Overall Study|Death|0
5830134|NCT02448810|20144078|P1|Overall Study|Death|1
5830135|NCT02448810|20144071|P8|Overall Study|Other (study terminated by sponsor)|1
5830136|NCT02448810|20144072|P7|Overall Study|Other (study terminated by sponsor)|2
5830137|NCT02448810|20144073|P6|Overall Study|Other (study terminated by sponsor)|2
5830138|NCT02448810|20144074|P5|Overall Study|Other (study terminated by sponsor)|4
5830139|NCT02448810|20144075|P4|Overall Study|Other (study terminated by sponsor)|0
5830140|NCT02448810|20144076|P3|Overall Study|Other (study terminated by sponsor)|0
5830141|NCT02448810|20144077|P2|Overall Study|Other (study terminated by sponsor)|0
5830142|NCT02448810|20144078|P1|Overall Study|Other (study terminated by sponsor)|0
5830143|NCT02448810|20144071|P8|Overall Study|Withdrawal by Subject|2
5830144|NCT02448810|20144072|P7|Overall Study|Withdrawal by Subject|0
5830145|NCT02448810|20144073|P6|Overall Study|Withdrawal by Subject|5
5830146|NCT02448810|20144074|P5|Overall Study|Withdrawal by Subject|3
5830147|NCT02448810|20144075|P4|Overall Study|Withdrawal by Subject|0
5830148|NCT02448810|20144076|P3|Overall Study|Withdrawal by Subject|1
5830149|NCT02448810|20144077|P2|Overall Study|Withdrawal by Subject|0
5830150|NCT02448810|20144078|P1|Overall Study|Withdrawal by Subject|0
5830151|NCT02448810|20144071|P8|Overall Study|Adverse Event|0
5830152|NCT02448810|20144072|P7|Overall Study|Adverse Event|0
5830153|NCT02448810|20144073|P6|Overall Study|Adverse Event|0
5830154|NCT02448810|20144074|P5|Overall Study|Adverse Event|0
5830155|NCT02448810|20144075|P4|Overall Study|Adverse Event|0
5830156|NCT02448810|20144076|P3|Overall Study|Adverse Event|1
5830157|NCT02448810|20144077|P2|Overall Study|Adverse Event|0
5830158|NCT02448810|20144078|P1|Overall Study|Adverse Event|0
5830159|NCT02448719|20144155|P11|Overall Study|Withdrawal by Subject|0
5830160|NCT02448719|20144156|P10|Overall Study|Withdrawal by Subject|0
5830161|NCT02448719|20144157|P9|Overall Study|Withdrawal by Subject|0
5830162|NCT02448719|20144158|P8|Overall Study|Withdrawal by Subject|0
5830163|NCT02448719|20144159|P7|Overall Study|Withdrawal by Subject|0
5830164|NCT02448719|20144160|P6|Overall Study|Withdrawal by Subject|0
5830165|NCT02448719|20144161|P5|Overall Study|Withdrawal by Subject|1
5830166|NCT02448719|20144162|P4|Overall Study|Withdrawal by Subject|0
5830167|NCT02448719|20144163|P3|Overall Study|Withdrawal by Subject|0
5830168|NCT02448719|20144164|P2|Overall Study|Withdrawal by Subject|0
5830169|NCT02448719|20144165|P1|Overall Study|Withdrawal by Subject|0
5830170|NCT02448706|20144389|P2|Overall Study|Protocol Violation|1
5830171|NCT02448706|20144390|P1|Overall Study|Protocol Violation|1
5830172|NCT02448706|20144389|P2|Overall Study|Withdrawal by Subject|3
5830173|NCT02448706|20144390|P1|Overall Study|Withdrawal by Subject|4
5830174|NCT02448680|20144404|P2|Overall Study|Withdrawal by Subject|2
5830175|NCT02448680|20144405|P1|Overall Study|Withdrawal by Subject|0
5830176|NCT02448680|20144404|P2|Overall Study|Physician Decision|1
5830177|NCT02448680|20144405|P1|Overall Study|Physician Decision|1
5830178|NCT02448563|20144474|P2|Overall Study|Withdrawal by Subject|1
5830179|NCT02448563|20144475|P1|Overall Study|Withdrawal by Subject|0
5830180|NCT02448563|20144474|P2|Overall Study|Lost to Follow-up|10
5830181|NCT02448563|20144475|P1|Overall Study|Lost to Follow-up|16
5830182|NCT02448537|20144497|P3|Overall Study|Withdrawal by Subject|1
5830183|NCT02448537|20144498|P2|Overall Study|Withdrawal by Subject|1
5830184|NCT02448537|20144499|P1|Overall Study|Withdrawal by Subject|1
5830185|NCT02448043|20144613|P2|Overall Study|Protocol Violation|2
5830186|NCT02448043|20144614|P1|Overall Study|Protocol Violation|1
5830187|NCT02448043|20144613|P2|Overall Study|Withdrawal by Subject|2
5830188|NCT02448043|20144614|P1|Overall Study|Withdrawal by Subject|2
5830189|NCT02447952|20144632|P1|Overall Study|Withdrawal by Subject|4
5830190|NCT02447952|20144632|P1|Overall Study|Physician Decision|1
5830191|NCT02447952|20144632|P1|Overall Study|Adverse Event|2
5830192|NCT02447887|20144689|P1|Overall Study|Study was terminated|3
5830193|NCT02447848|20144702|P1|Overall Study|Withdrawal by Subject|4
5830194|NCT02447848|20144702|P1|Overall Study|Lack of Efficacy|4
5830195|NCT02447848|20144702|P1|Overall Study|Patient discharged|3
5830196|NCT02447497|20144716|P4|Overall Study|Did not meet treatment day baseline|2
5830197|NCT02447497|20144717|P3|Overall Study|Did not meet treatment day baseline|2
5830198|NCT02447497|20144718|P2|Overall Study|Did not meet treatment day baseline|6
5830199|NCT02447497|20144719|P1|Overall Study|Did not meet treatment day baseline|6
5830200|NCT02447458|20144743|P6|Overall Study|Other|0
5830201|NCT02447458|20144744|P5|Overall Study|Other|0
5830202|NCT02447458|20144745|P4|Overall Study|Other|0
5830203|NCT02447458|20144746|P3|Overall Study|Other|1
5830204|NCT02447458|20144747|P2|Overall Study|Other|0
5830205|NCT02447458|20144748|P1|Overall Study|Other|0
5830206|NCT02447432|20144846|P2|Epoch 001|Lost to Follow-up|3
5830207|NCT02447432|20144847|P1|Epoch 001|Lost to Follow-up|1
5830208|NCT02447432|20144846|P2|Epoch 001|Migrated/moved from study area|5
5830209|NCT02447432|20144847|P1|Epoch 001|Migrated/moved from study area|3
5830210|NCT02447432|20144846|P2|Epoch 001|Withdrawal by Subject|4
5830211|NCT02447432|20144847|P1|Epoch 001|Withdrawal by Subject|0
5830212|NCT02447432|20144846|P2|Epoch 001|Adverse Event|1
5830213|NCT02447432|20144847|P1|Epoch 001|Adverse Event|1
5830214|NCT02447328|20144879|P1|Overall Study|Withdrawal by Subject|1
5830215|NCT02447250|20144883|P1|Third Dose (360 mcg Albuterol)|Elevated HR with 2nd dose|4
5830216|NCT02447250|20144883|P1|Third Dose (360 mcg Albuterol)|Clinically unstable, unable to do PFT|1
5830217|NCT02447250|20144883|P1|Second Dose (270 mcg Albuterol)|elevated HR with first dose|1
5830218|NCT02447081|20144900|P1|Overall Study|unsuccessful implant procedure|10
5830219|NCT02447081|20144900|P1|Overall Study|Visit not completed|17
5830220|NCT02447081|20144900|P1|Overall Study|Lost to Follow-up|36
5830221|NCT02447081|20144900|P1|Overall Study|Death|161
5830222|NCT02447029|20144916|P2|Overall Study|Withdrawal by Subject|2
5830223|NCT02447029|20144917|P1|Overall Study|Withdrawal by Subject|3
5830224|NCT02447003|20144937|P2|Overall Study|Death|63
5830225|NCT02447003|20144938|P1|Overall Study|Death|154
5830226|NCT02447003|20144937|P2|Overall Study|Lost to Follow-up|0
5830227|NCT02447003|20144938|P1|Overall Study|Lost to Follow-up|5
5830228|NCT02447003|20144937|P2|Overall Study|Progressive Disease|0
5830229|NCT02447003|20144938|P1|Overall Study|Progressive Disease|1
5830230|NCT02447003|20144937|P2|Overall Study|Sponsor Decision|11
5830231|NCT02447003|20144938|P1|Overall Study|Sponsor Decision|6
5830232|NCT02447003|20144937|P2|Overall Study|Withdrawal by Subject|3
5830233|NCT02447003|20144938|P1|Overall Study|Withdrawal by Subject|4
5830234|NCT02447003|20144937|P2|Overall Study|Physician Decision|1
5830235|NCT02447003|20144938|P1|Overall Study|Physician Decision|0
5830236|NCT02447003|20144937|P2|Overall Study|Site discontinued|2
5830237|NCT02447003|20144938|P1|Overall Study|Site discontinued|0
5830238|NCT02447003|20144937|P2|Overall Study|Other|4
5830239|NCT02447003|20144938|P1|Overall Study|Other|0
5830240|NCT02446990|20144974|P2|Overall Study|Withdrawal by Subject|199
5830241|NCT02446990|20144975|P1|Overall Study|Withdrawal by Subject|231
5830242|NCT02446990|20144974|P2|Overall Study|Physician Decision|0
5830243|NCT02446990|20144975|P1|Overall Study|Physician Decision|1
5830244|NCT02446990|20144974|P2|Overall Study|Lost to Follow-up|1
5830245|NCT02446990|20144975|P1|Overall Study|Lost to Follow-up|3
5830246|NCT02446990|20144974|P2|Overall Study|Death|458
5830247|NCT02446990|20144975|P1|Overall Study|Death|485
5830248|NCT02446912|20145010|P3|Overall Study|Miscellaneous|4
5830249|NCT02446912|20145011|P2|Overall Study|Miscellaneous|2
5830250|NCT02446912|20145012|P1|Overall Study|Miscellaneous|2
5830251|NCT02446912|20145010|P3|Overall Study|Withdrawal by Subject|15
5830252|NCT02446912|20145011|P2|Overall Study|Withdrawal by Subject|15
5830253|NCT02446912|20145012|P1|Overall Study|Withdrawal by Subject|10
5830254|NCT02446912|20145010|P3|Overall Study|Severe non-compliance to protocol|1
5830255|NCT02446912|20145011|P2|Overall Study|Severe non-compliance to protocol|0
5830256|NCT02446912|20145012|P1|Overall Study|Severe non-compliance to protocol|1
5830257|NCT02446912|20145010|P3|Overall Study|Lost to Follow-up|2
5830258|NCT02446912|20145011|P2|Overall Study|Lost to Follow-up|0
5830259|NCT02446912|20145012|P1|Overall Study|Lost to Follow-up|0
5830260|NCT02446912|20145010|P3|Overall Study|Lack of Efficacy|7
5830261|NCT02446912|20145011|P2|Overall Study|Lack of Efficacy|4
5830262|NCT02446912|20145012|P1|Overall Study|Lack of Efficacy|1
5830263|NCT02446912|20145010|P3|Overall Study|Study-specific withdrawal criteria|0
5830264|NCT02446912|20145011|P2|Overall Study|Study-specific withdrawal criteria|0
5830265|NCT02446912|20145012|P1|Overall Study|Study-specific withdrawal criteria|1
5830266|NCT02446912|20145010|P3|Overall Study|Condition under investigation worsened|1
5830267|NCT02446912|20145011|P2|Overall Study|Condition under investigation worsened|1
5830268|NCT02446912|20145012|P1|Overall Study|Condition under investigation worsened|0
5830269|NCT02446912|20145010|P3|Overall Study|Adverse Event|5
5830270|NCT02446912|20145011|P2|Overall Study|Adverse Event|13
5830271|NCT02446912|20145012|P1|Overall Study|Adverse Event|3
5830272|NCT02446899|20145085|P2|Overall Study|Failure to Meet Randomization Criteria|2
5830273|NCT02446899|20145086|P1|Overall Study|Failure to Meet Randomization Criteria|0
5830274|NCT02446899|20145085|P2|Overall Study|Miscellaneous|4
5830275|NCT02446899|20145086|P1|Overall Study|Miscellaneous|5
5830276|NCT02446899|20145085|P2|Overall Study|Withdrawal by Subject|19
5830277|NCT02446899|20145086|P1|Overall Study|Withdrawal by Subject|11
5830278|NCT02446899|20145085|P2|Overall Study|Severe Non-Compliance to Protocol|1
5830279|NCT02446899|20145086|P1|Overall Study|Severe Non-Compliance to Protocol|0
5830280|NCT02446899|20145085|P2|Overall Study|Lost to Follow-up|3
5830281|NCT02446899|20145086|P1|Overall Study|Lost to Follow-up|1
5830282|NCT02446899|20145085|P2|Overall Study|Lack of Efficacy|8
5830283|NCT02446899|20145086|P1|Overall Study|Lack of Efficacy|2
5830284|NCT02446899|20145085|P2|Overall Study|Study Specific Withdrawal Criteria|0
5830285|NCT02446899|20145086|P1|Overall Study|Study Specific Withdrawal Criteria|1
5830286|NCT02446899|20145085|P2|Overall Study|Condition Under Investigation Worsened|4
5830287|NCT02446899|20145086|P1|Overall Study|Condition Under Investigation Worsened|1
5830288|NCT02446899|20145085|P2|Overall Study|Adverse Event|7
5830289|NCT02446899|20145086|P1|Overall Study|Adverse Event|4
5830290|NCT02446886|20145112|P2|Overall Study|Withdrawal by Subject|1
5830291|NCT02446886|20145113|P1|Overall Study|Withdrawal by Subject|1
5830292|NCT02446886|20145112|P2|Overall Study|Adverse Event|3
5830293|NCT02446886|20145113|P1|Overall Study|Adverse Event|1
5830294|NCT02446769|20145142|P3|Study Period|Randomized in Error|0
5830295|NCT02446769|20145143|P2|Study Period|Randomized in Error|2
5830296|NCT02446769|20145144|P1|Study Period|Randomized in Error|0
5830297|NCT02446769|20145142|P3|Screening Period|Screen Failure|0
5830298|NCT02446769|20145143|P2|Screening Period|Screen Failure|0
5830299|NCT02446769|20145144|P1|Screening Period|Screen Failure|11
5830300|NCT02446743|20145167|P2|Overall Study|Other|3
5830301|NCT02446743|20145168|P1|Overall Study|Other|2
5830302|NCT02446743|20145167|P2|Overall Study|Adverse Event|1
5830303|NCT02446743|20145168|P1|Overall Study|Adverse Event|1
5830304|NCT02446743|20145167|P2|Overall Study|Lost to Follow-up|0
5830305|NCT02446743|20145168|P1|Overall Study|Lost to Follow-up|1
5830306|NCT02446743|20145167|P2|Overall Study|Withdrawal by Subject|1
5830307|NCT02446743|20145168|P1|Overall Study|Withdrawal by Subject|1
5830308|NCT02446717|20145323|P5|Overall Study|Withdrew consent|0
5830309|NCT02446717|20145324|P4|Overall Study|Withdrew consent|1
5830310|NCT02446717|20145325|P3|Overall Study|Withdrew consent|0
5830311|NCT02446717|20145326|P2|Overall Study|Withdrew consent|0
5830312|NCT02446717|20145327|P1|Overall Study|Withdrew consent|0
5830313|NCT02446717|20145323|P5|Overall Study|Lost to Follow-up|1
5830314|NCT02446717|20145324|P4|Overall Study|Lost to Follow-up|0
5830315|NCT02446717|20145325|P3|Overall Study|Lost to Follow-up|1
5830316|NCT02446717|20145326|P2|Overall Study|Lost to Follow-up|1
5830317|NCT02446717|20145327|P1|Overall Study|Lost to Follow-up|0
5830318|NCT02446717|20145323|P5|Overall Study|Adverse Event|0
5830319|NCT02446717|20145324|P4|Overall Study|Adverse Event|0
5830320|NCT02446717|20145325|P3|Overall Study|Adverse Event|1
5830321|NCT02446717|20145326|P2|Overall Study|Adverse Event|0
5830322|NCT02446717|20145327|P1|Overall Study|Adverse Event|0
5830323|NCT02446691|20145354|P1|Overall Study|Protocol Violation|1
5830324|NCT02446691|20145354|P1|Overall Study|Lost to Follow-up|8
5830325|NCT02446691|20145354|P1|Overall Study|Withdrawal by Subject|2
5830326|NCT02446418|20145424|P2|Overall Study|Protocol defined stopping criteria reach|0
5830327|NCT02446418|20145425|P1|Overall Study|Protocol defined stopping criteria reach|1
5830328|NCT02446418|20145424|P2|Overall Study|Lack of Efficacy|0
5830329|NCT02446418|20145425|P1|Overall Study|Lack of Efficacy|2
5830330|NCT02446418|20145424|P2|Overall Study|Protocol Violation|2
5830331|NCT02446418|20145425|P1|Overall Study|Protocol Violation|1
5830332|NCT02446418|20145424|P2|Overall Study|Lost to Follow-up|2
5830333|NCT02446418|20145425|P1|Overall Study|Lost to Follow-up|2
5830334|NCT02446418|20145424|P2|Overall Study|Withdrawal by Subject|3
5830335|NCT02446418|20145425|P1|Overall Study|Withdrawal by Subject|3
5830336|NCT02446418|20145424|P2|Overall Study|Physician Decision|1
5830337|NCT02446418|20145425|P1|Overall Study|Physician Decision|5
5830338|NCT02446418|20145424|P2|Overall Study|Adverse Event|8
5830339|NCT02446418|20145425|P1|Overall Study|Adverse Event|4
5830340|NCT02446171|20145496|P4|Overall Study|Withdrawal by Subject|0
5830341|NCT02446171|20145497|P3|Overall Study|Withdrawal by Subject|2
5830342|NCT02446171|20145498|P2|Overall Study|Withdrawal by Subject|0
5830343|NCT02446171|20145499|P1|Overall Study|Withdrawal by Subject|0
5830344|NCT02446015|20145570|P2|Overall Study|Withdrawal by Subject|0
5830345|NCT02446015|20145571|P1|Overall Study|Withdrawal by Subject|1
5830346|NCT02446015|20145570|P2|Overall Study|Adverse Event|1
5830347|NCT02446015|20145571|P1|Overall Study|Adverse Event|0
5830360|NCT02445794|20145714|P4|Overall Study|Adverse Event|0
5830361|NCT02445794|20145715|P3|Overall Study|Adverse Event|2
5830362|NCT02445794|20145716|P2|Overall Study|Adverse Event|0
5830363|NCT02445794|20145717|P1|Overall Study|Adverse Event|0
5830364|NCT02445755|20145747|P1|Overall Study|Screen Failure|5
5830365|NCT02445755|20145747|P1|Overall Study|Protocol Violation|6
5830366|NCT02445755|20145747|P1|Overall Study|Withdrawal by Subject|2
5830367|NCT02445586|20145761|P1|Overall Study|Medical Condition|1
5830368|NCT02445586|20145761|P1|Overall Study|Protocol Violation|1
5830369|NCT02445586|20145761|P1|Overall Study|Disease Progression|10
5830370|NCT02445586|20145761|P1|Overall Study|Withdrawal by Subject|13
5830371|NCT02445586|20145761|P1|Overall Study|Death|14
5830372|NCT02445573|20145801|P2|Overall Study|Lost to Follow-up|1
5830373|NCT02445573|20145802|P1|Overall Study|Lost to Follow-up|0
5830374|NCT02445573|20145801|P2|Overall Study|Withdrawal by Subject|1
5830375|NCT02445573|20145802|P1|Overall Study|Withdrawal by Subject|1
5830376|NCT02444793|20145899|P4|Overall Study|Objective progression or relapse|3
5830377|NCT02444793|20145900|P3|Overall Study|Objective progression or relapse|2
5830378|NCT02444793|20145901|P2|Overall Study|Objective progression or relapse|1
5830379|NCT02444793|20145902|P1|Overall Study|Objective progression or relapse|9
5830380|NCT02444793|20145899|P4|Overall Study|Other|0
5830381|NCT02444793|20145900|P3|Overall Study|Other|2
5830382|NCT02444793|20145901|P2|Overall Study|Other|0
5830383|NCT02444793|20145902|P1|Overall Study|Other|0
5830384|NCT02444793|20145899|P4|Overall Study|Death|0
5830385|NCT02444793|20145900|P3|Overall Study|Death|0
5830386|NCT02444793|20145901|P2|Overall Study|Death|3
5830387|NCT02444793|20145902|P1|Overall Study|Death|0
5830388|NCT02444793|20145899|P4|Overall Study|Lost to Follow-up|0
5830389|NCT02444793|20145900|P3|Overall Study|Lost to Follow-up|0
5830390|NCT02444793|20145901|P2|Overall Study|Lost to Follow-up|2
5830391|NCT02444793|20145902|P1|Overall Study|Lost to Follow-up|2
5830392|NCT02444533|20146061|P2|Overall Study|Only gave post-procedure complications|2
5830393|NCT02444533|20146062|P1|Overall Study|Only gave post-procedure complications|2
5830394|NCT02444533|20146061|P2|Overall Study|Not able to complete forms|2
5830395|NCT02444533|20146062|P1|Overall Study|Not able to complete forms|0
5830396|NCT02444182|20146095|P2|Overall Study|Lost to Follow-up|4
5830397|NCT02444182|20146096|P1|Overall Study|Lost to Follow-up|0
5830398|NCT02444182|20146095|P2|Overall Study|non-compliance|1
5830399|NCT02444182|20146096|P1|Overall Study|non-compliance|2
5830400|NCT02443883|20146119|P4|Overall Study|Randomized, but never treated|0
5830401|NCT02443883|20146120|P3|Overall Study|Randomized, but never treated|0
5830402|NCT02443883|20146121|P2|Overall Study|Randomized, but never treated|0
5830403|NCT02443883|20146122|P1|Overall Study|Randomized, but never treated|1
5830404|NCT02443883|20146119|P4|Overall Study|Withdrawal by Subject|2
5830405|NCT02443883|20146120|P3|Overall Study|Withdrawal by Subject|0
5830406|NCT02443883|20146121|P2|Overall Study|Withdrawal by Subject|0
5830407|NCT02443883|20146122|P1|Overall Study|Withdrawal by Subject|1
5830408|NCT02443883|20146119|P4|Overall Study|Physician Decision|3
5830409|NCT02443883|20146120|P3|Overall Study|Physician Decision|0
5830410|NCT02443883|20146121|P2|Overall Study|Physician Decision|1
5830411|NCT02443883|20146122|P1|Overall Study|Physician Decision|1
5830412|NCT02443883|20146119|P4|Overall Study|Lost to Follow-up|0
5830413|NCT02443883|20146120|P3|Overall Study|Lost to Follow-up|1
5830414|NCT02443883|20146121|P2|Overall Study|Lost to Follow-up|2
5830415|NCT02443883|20146122|P1|Overall Study|Lost to Follow-up|3
5830416|NCT02443883|20146119|P4|Overall Study|Adverse Event|0
5830417|NCT02443883|20146120|P3|Overall Study|Adverse Event|0
5830418|NCT02443883|20146121|P2|Overall Study|Adverse Event|1
5830419|NCT02443883|20146122|P1|Overall Study|Adverse Event|0
5830420|NCT02443805|20146142|P2|Overall Study|Any other reason not above-mentioned|2
5830421|NCT02443805|20146143|P1|Overall Study|Any other reason not above-mentioned|3
5830422|NCT02443805|20146142|P2|Overall Study|Withdrawal by parent/guardian|5
5830423|NCT02443805|20146143|P1|Overall Study|Withdrawal by parent/guardian|3
5830424|NCT02443805|20146142|P2|Overall Study|Non-compliance with study drug|4
5830425|NCT02443805|20146143|P1|Overall Study|Non-compliance with study drug|6
5830426|NCT02443805|20146142|P2|Overall Study|Lack of Efficacy|1
5830427|NCT02443805|20146143|P1|Overall Study|Lack of Efficacy|1
5830428|NCT02443805|20146142|P2|Overall Study|Protocol Violation|4
5830429|NCT02443805|20146143|P1|Overall Study|Protocol Violation|2
5830430|NCT02443805|20146142|P2|Overall Study|Pregnancy|5
5830431|NCT02443805|20146143|P1|Overall Study|Pregnancy|6
5830432|NCT02443805|20146142|P2|Overall Study|Lost to Follow-up|14
5830433|NCT02443805|20146143|P1|Overall Study|Lost to Follow-up|19
5830434|NCT02443805|20146142|P2|Overall Study|Withdrawal by Subject|74
5830435|NCT02443805|20146143|P1|Overall Study|Withdrawal by Subject|73
5830436|NCT02443805|20146142|P2|Overall Study|Adverse Event|18
5830437|NCT02443805|20146143|P1|Overall Study|Adverse Event|100
5830471|NCT02443688|20146366|P3|Overall Study|Sponsor Request|0
5830472|NCT02443688|20146367|P2|Overall Study|Sponsor Request|1
5830473|NCT02443688|20146368|P1|Overall Study|Sponsor Request|2
5830474|NCT02443688|20146366|P3|Overall Study|Non-compliance with study drug|4
5830475|NCT02443688|20146367|P2|Overall Study|Non-compliance with study drug|2
5830476|NCT02443688|20146368|P1|Overall Study|Non-compliance with study drug|1
5830477|NCT02443688|20146366|P3|Overall Study|Withdrawal by Subject|4
5830478|NCT02443688|20146367|P2|Overall Study|Withdrawal by Subject|3
5830479|NCT02443688|20146368|P1|Overall Study|Withdrawal by Subject|3
5830480|NCT02443688|20146366|P3|Overall Study|Pregnancy|1
5830481|NCT02443688|20146367|P2|Overall Study|Pregnancy|0
5830482|NCT02443688|20146368|P1|Overall Study|Pregnancy|0
5830483|NCT02443688|20146366|P3|Overall Study|Physician Decision|1
5830484|NCT02443688|20146367|P2|Overall Study|Physician Decision|0
5830485|NCT02443688|20146368|P1|Overall Study|Physician Decision|3
5830486|NCT02443688|20146366|P3|Overall Study|Lost to Follow-up|0
5830487|NCT02443688|20146367|P2|Overall Study|Lost to Follow-up|0
5830488|NCT02443688|20146368|P1|Overall Study|Lost to Follow-up|1
5830489|NCT02443688|20146366|P3|Overall Study|Adverse Event|2
5830490|NCT02443688|20146367|P2|Overall Study|Adverse Event|3
5830491|NCT02443688|20146368|P1|Overall Study|Adverse Event|2
5830492|NCT02443402|20146478|P2|Overall Study|Screen Failure|2
5830493|NCT02443402|20146479|P1|Overall Study|Screen Failure|1
5830494|NCT02443402|20146478|P2|Overall Study|Withdrawal by Subject|1
5830495|NCT02443402|20146479|P1|Overall Study|Withdrawal by Subject|3
5830496|NCT02443337|20146541|P2|Overall Study|Withdrawal by Subject|1
5830497|NCT02443337|20146542|P1|Overall Study|Withdrawal by Subject|2
5830498|NCT02443337|20146541|P2|Overall Study|Clinical Progressive Disease|0
5830499|NCT02443337|20146542|P1|Overall Study|Clinical Progressive Disease|3
5830500|NCT02443337|20146541|P2|Overall Study|Adverse Event|1
5830501|NCT02443337|20146542|P1|Overall Study|Adverse Event|0
5830502|NCT02443298|20146560|P2|Overall Study|Withdrawal by Subject|2
5830503|NCT02443298|20146561|P1|Overall Study|Withdrawal by Subject|1
5830504|NCT02443298|20146560|P2|Overall Study|Adverse Event|3
5830505|NCT02443298|20146561|P1|Overall Study|Adverse Event|3
5830534|NCT02443103|20147032|P1|Overall Study|Noncompliance|1
5830535|NCT02443103|20147032|P1|Overall Study|Adverse Event|2
5830536|NCT02442830|20147045|P2|Overall Study|Technical Failure|1
5830537|NCT02442830|20147046|P1|Overall Study|Technical Failure|0
5830538|NCT02442804|20147056|P2|Overall Study|Adverse Event|0
5830539|NCT02442804|20147057|P1|Overall Study|Adverse Event|1
5830540|NCT02442804|20147056|P2|Overall Study|Withdrawal by Subject|1
5830541|NCT02442804|20147057|P1|Overall Study|Withdrawal by Subject|0
5830542|NCT02442622|20147164|P2|Overall Study|Withdrawal by Subject|1
5830543|NCT02442622|20147165|P1|Overall Study|Withdrawal by Subject|3
5830544|NCT02442349|20147175|P1|Overall Study|On-going Study at Data Cut-off|149
5830545|NCT02442349|20147175|P1|Overall Study|Withdrawal by Subject|8
5830546|NCT02442349|20147175|P1|Overall Study|Death|14
5830547|NCT02442336|20147180|P1|Overall Study|Lost to Follow-up|11
5830548|NCT02442336|20147180|P1|Overall Study|Of the 74 who consented, 19 did not complete baseline assessment and were withdrawn from the study.|19
5830549|NCT02442336|20147180|P1|Overall Study|6 patients assisted with the intervention development only.|6
5830550|NCT02442310|20147184|P1|Overall Study|Withdrawal by Subject|1
5830551|NCT02442310|20147184|P1|Overall Study|Adverse Event|2
5830552|NCT02442284|20147206|P1|Overall Study|Other|1
5830553|NCT02442284|20147206|P1|Overall Study|Lost to Follow-up|3
5830554|NCT02442284|20147206|P1|Overall Study|Withdrew Consent|2
5830555|NCT02442284|20147206|P1|Overall Study|Adverse Event|1
5830556|NCT02442271|20147213|P1|Overall Study|Other|1
5830557|NCT02442271|20147213|P1|Overall Study|Lost to Follow-up|1
5830558|NCT02442271|20147213|P1|Overall Study|Withdrew Consent|1
5830559|NCT02442271|20147213|P1|Overall Study|Adverse Event|1
5830560|NCT02442206|20147239|P2|Period 2|Adverse Event|0
5830561|NCT02442206|20147240|P1|Period 2|Adverse Event|1
5830562|NCT02442206|20147239|P2|Period 1|COPD exacerbation|1
5830563|NCT02442206|20147240|P1|Period 1|COPD exacerbation|0
5830564|NCT02442206|20147239|P2|Period 1|withdrew consent|1
5830565|NCT02442206|20147240|P1|Period 1|withdrew consent|0
5830566|NCT02442206|20147239|P2|Period 1|Adverse Event|1
5830567|NCT02442206|20147240|P1|Period 1|Adverse Event|1
5830568|NCT02441946|20147272|P3|Extension Period (8 Weeks)|Withdrawal by Subject|0
5830569|NCT02441946|20147273|P2|Extension Period (8 Weeks)|Withdrawal by Subject|0
5830570|NCT02441946|20147274|P1|Extension Period (8 Weeks)|Withdrawal by Subject|1
5830571|NCT02441946|20147272|P3|Extension Period (8 Weeks)|Adverse Event|0
5830572|NCT02441946|20147273|P2|Extension Period (8 Weeks)|Adverse Event|0
5830573|NCT02441946|20147274|P1|Extension Period (8 Weeks)|Adverse Event|1
5830574|NCT02441946|20147272|P3|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0
5830575|NCT02441946|20147273|P2|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0
5830576|NCT02441946|20147274|P1|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|9
5830577|NCT02441946|20147272|P3|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0
5830578|NCT02441946|20147273|P2|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0
5830579|NCT02441946|20147274|P1|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|1
5830580|NCT02441946|20147272|P3|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0
5830581|NCT02441946|20147273|P2|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0
5830582|NCT02441946|20147274|P1|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|1
5830583|NCT02441946|20147272|P3|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0
5830584|NCT02441946|20147273|P2|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0
5830585|NCT02441946|20147274|P1|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|1
5830586|NCT02441946|20147272|P3|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0
5830587|NCT02441946|20147273|P2|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0
5830588|NCT02441946|20147274|P1|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|15
5830589|NCT02441946|20147272|P3|Cycle 1 Period 1 (2 Weeks)|Never Treated|0
5830590|NCT02441946|20147273|P2|Cycle 1 Period 1 (2 Weeks)|Never Treated|1
5830591|NCT02441946|20147274|P1|Cycle 1 Period 1 (2 Weeks)|Never Treated|0
5830592|NCT02441946|20147272|P3|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0
5830593|NCT02441946|20147273|P2|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|3
5830594|NCT02441946|20147274|P1|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0
5830595|NCT02441946|20147272|P3|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0
5830596|NCT02441946|20147273|P2|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0
5830597|NCT02441946|20147274|P1|Cycle 1 Period 1 (2 Weeks)|Physician Decision|1
5830598|NCT02441946|20147272|P3|Cycle 1 Period 1 (2 Weeks)|Adverse Event|0
5830599|NCT02441946|20147273|P2|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1
5830600|NCT02441946|20147274|P1|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1
5830601|NCT02441517|20147295|P1|Overall Study|Study Terminated by Sponsor|1
5830602|NCT02441517|20147295|P1|Overall Study|Withdrawal by Subject|2
5830603|NCT02441517|20147295|P1|Overall Study|Lost to Follow-up|1
5830604|NCT02441309|20147308|P3|Overall Study|Withdrawal by Subject|1
5830605|NCT02441309|20147309|P2|Overall Study|Withdrawal by Subject|0
5830606|NCT02441309|20147310|P1|Overall Study|Withdrawal by Subject|1
5830607|NCT02441309|20147308|P3|Overall Study|Adverse Event|0
5830608|NCT02441309|20147309|P2|Overall Study|Adverse Event|1
5830609|NCT02441309|20147310|P1|Overall Study|Adverse Event|0
5830610|NCT02441309|20147308|P3|Overall Study|Disease progression|2
5830611|NCT02441309|20147309|P2|Overall Study|Disease progression|1
5830612|NCT02441309|20147310|P1|Overall Study|Disease progression|2
5830613|NCT02441283|20147339|P1|Overall Study|Other, not specified|32
5830614|NCT02441283|20147339|P1|Overall Study|Death|1
5830615|NCT02441283|20147339|P1|Overall Study|Lost to Follow-up|42
5830616|NCT02441283|20147339|P1|Overall Study|Withdrew consent|15
5830617|NCT02441218|20147352|P2|Overall Study|Lost to Follow-up|1
5830618|NCT02441218|20147353|P1|Overall Study|Lost to Follow-up|2
5830619|NCT02441218|20147352|P2|Overall Study|Withdrawal by Subject|58
5830620|NCT02441218|20147353|P1|Overall Study|Withdrawal by Subject|73
5830621|NCT02441218|20147352|P2|Overall Study|Death|553
5830622|NCT02441218|20147353|P1|Overall Study|Death|503
5830623|NCT02441179|20147379|P2|Overall Study|Withdrawal by Subject|1
5830624|NCT02441179|20147380|P1|Overall Study|Withdrawal by Subject|1
5830625|NCT02441114|20147398|P1|Washout2|Withdrawal by Subject|4
5830626|NCT02441036|20147413|P5|Overall Study|No tissue resected|0
5830627|NCT02441036|20147414|P4|Overall Study|No tissue resected|1
5830628|NCT02441036|20147415|P3|Overall Study|No tissue resected|0
5830629|NCT02441036|20147416|P2|Overall Study|No tissue resected|1
5830630|NCT02441036|20147417|P1|Overall Study|No tissue resected|0
5830631|NCT02440789|20147444|P1|Overall Study|Not willing to adhere to reqs|1
5830632|NCT02440789|20147444|P1|Overall Study|Withdrawal by Subject|3
5830633|NCT02440594|20147519|P8|Overall Study|Administratively w/drawn|1
5830634|NCT02440594|20147520|P7|Overall Study|Administratively w/drawn|2
5830635|NCT02440594|20147521|P6|Overall Study|Administratively w/drawn|0
5830636|NCT02440594|20147522|P5|Overall Study|Administratively w/drawn|0
5830637|NCT02440594|20147523|P4|Overall Study|Administratively w/drawn|0
5830638|NCT02440594|20147524|P3|Overall Study|Administratively w/drawn|0
5830639|NCT02440594|20147525|P2|Overall Study|Administratively w/drawn|2
5830640|NCT02440594|20147526|P1|Overall Study|Administratively w/drawn|3
5830641|NCT02440594|20147519|P8|Overall Study|Withdrawal by Subject|7
5830642|NCT02440594|20147520|P7|Overall Study|Withdrawal by Subject|7
5830643|NCT02440594|20147521|P6|Overall Study|Withdrawal by Subject|2
5830644|NCT02440594|20147522|P5|Overall Study|Withdrawal by Subject|2
5830645|NCT02440594|20147523|P4|Overall Study|Withdrawal by Subject|38
5830646|NCT02440594|20147524|P3|Overall Study|Withdrawal by Subject|59
5830647|NCT02440594|20147525|P2|Overall Study|Withdrawal by Subject|67
5830648|NCT02440594|20147526|P1|Overall Study|Withdrawal by Subject|81
5830649|NCT02440594|20147519|P8|Overall Study|Cognitive Impairment/Communication Issue|0
5830650|NCT02440594|20147520|P7|Overall Study|Cognitive Impairment/Communication Issue|0
5830651|NCT02440594|20147521|P6|Overall Study|Cognitive Impairment/Communication Issue|1
5830652|NCT02440594|20147522|P5|Overall Study|Cognitive Impairment/Communication Issue|2
5830653|NCT02440594|20147523|P4|Overall Study|Cognitive Impairment/Communication Issue|4
5830654|NCT02440594|20147524|P3|Overall Study|Cognitive Impairment/Communication Issue|4
5830655|NCT02440594|20147525|P2|Overall Study|Cognitive Impairment/Communication Issue|6
5830656|NCT02440594|20147526|P1|Overall Study|Cognitive Impairment/Communication Issue|14
5830657|NCT02440594|20147519|P8|Overall Study|Lost to Follow-up|48
5830658|NCT02440594|20147520|P7|Overall Study|Lost to Follow-up|28
5830659|NCT02440594|20147521|P6|Overall Study|Lost to Follow-up|4
5830660|NCT02440594|20147522|P5|Overall Study|Lost to Follow-up|5
5830661|NCT02440594|20147523|P4|Overall Study|Lost to Follow-up|47
5830662|NCT02440594|20147524|P3|Overall Study|Lost to Follow-up|54
5830663|NCT02440594|20147525|P2|Overall Study|Lost to Follow-up|33
5830664|NCT02440594|20147526|P1|Overall Study|Lost to Follow-up|34
5830665|NCT02439320|20147643|P3|Overall Study|Randomization Failure|34
5830666|NCT02439320|20147644|P2|Overall Study|Randomization Failure|46
5830667|NCT02439320|20147645|P1|Overall Study|Randomization Failure|35
5830668|NCT02439320|20147643|P3|Overall Study|Sponsor Request|1
5830669|NCT02439320|20147644|P2|Overall Study|Sponsor Request|2
5830670|NCT02439320|20147645|P1|Overall Study|Sponsor Request|0
5830671|NCT02439320|20147643|P3|Overall Study|Physician Decision|0
5830672|NCT02439320|20147644|P2|Overall Study|Physician Decision|1
5830673|NCT02439320|20147645|P1|Overall Study|Physician Decision|2
5830674|NCT02439320|20147643|P3|Overall Study|Withdrawal by Subject|14
5830675|NCT02439320|20147644|P2|Overall Study|Withdrawal by Subject|16
5830676|NCT02439320|20147645|P1|Overall Study|Withdrawal by Subject|12
5830677|NCT02439320|20147643|P3|Overall Study|Pregnancy|1
5830678|NCT02439320|20147644|P2|Overall Study|Pregnancy|1
5830679|NCT02439320|20147645|P1|Overall Study|Pregnancy|0
5830680|NCT02439320|20147643|P3|Overall Study|Noncompliance with Protocol|7
5830681|NCT02439320|20147644|P2|Overall Study|Noncompliance with Protocol|11
5830682|NCT02439320|20147645|P1|Overall Study|Noncompliance with Protocol|10
5830683|NCT02439320|20147643|P3|Overall Study|Death|0
5830684|NCT02439320|20147644|P2|Overall Study|Death|1
5830685|NCT02439320|20147645|P1|Overall Study|Death|0
5830686|NCT02439320|20147643|P3|Overall Study|Lost to Follow-up|42
5830687|NCT02439320|20147644|P2|Overall Study|Lost to Follow-up|34
5830688|NCT02439320|20147645|P1|Overall Study|Lost to Follow-up|37
5830689|NCT02439320|20147643|P3|Overall Study|Adverse Event|0
5830690|NCT02439320|20147644|P2|Overall Study|Adverse Event|2
5830691|NCT02439320|20147645|P1|Overall Study|Adverse Event|0
5830692|NCT02439138|20147725|P1|Overall Study|PI decision to terminate the study|2
5830693|NCT02439138|20147725|P1|Overall Study|Adverse Event|1
5830694|NCT02438826|20147738|P4|Post-Treatment Phase|Withdrawal by Subject|0
5830695|NCT02438826|20147739|P3|Post-Treatment Phase|Withdrawal by Subject|0
5830696|NCT02438826|20147740|P2|Post-Treatment Phase|Withdrawal by Subject|1
5830697|NCT02438826|20147741|P1|Post-Treatment Phase|Withdrawal by Subject|1
5830698|NCT02438826|20147738|P4|Post-Treatment Phase|Physician Decision|0
5830699|NCT02438826|20147739|P3|Post-Treatment Phase|Physician Decision|0
5830700|NCT02438826|20147740|P2|Post-Treatment Phase|Physician Decision|0
5830701|NCT02438826|20147741|P1|Post-Treatment Phase|Physician Decision|1
5830702|NCT02438826|20147738|P4|Post-Treatment Phase|Lack of Efficacy|0
5830703|NCT02438826|20147739|P3|Post-Treatment Phase|Lack of Efficacy|0
5830704|NCT02438826|20147740|P2|Post-Treatment Phase|Lack of Efficacy|0
5830705|NCT02438826|20147741|P1|Post-Treatment Phase|Lack of Efficacy|4
5830706|NCT02438826|20147738|P4|Post-Treatment Phase|Adverse Event|0
5830707|NCT02438826|20147739|P3|Post-Treatment Phase|Adverse Event|0
5830708|NCT02438826|20147740|P2|Post-Treatment Phase|Adverse Event|0
5830709|NCT02438826|20147741|P1|Post-Treatment Phase|Adverse Event|3
5830710|NCT02438826|20147738|P4|Open-Label Treatment Phase|Withdrawal by Subject|0
5830711|NCT02438826|20147739|P3|Open-Label Treatment Phase|Withdrawal by Subject|0
5830712|NCT02438826|20147740|P2|Open-Label Treatment Phase|Withdrawal by Subject|7
5830713|NCT02438826|20147741|P1|Open-Label Treatment Phase|Withdrawal by Subject|6
5830714|NCT02438826|20147738|P4|Open-Label Treatment Phase|Lost to Follow-up|0
5830715|NCT02438826|20147739|P3|Open-Label Treatment Phase|Lost to Follow-up|0
5830716|NCT02438826|20147740|P2|Open-Label Treatment Phase|Lost to Follow-up|2
5830717|NCT02438826|20147741|P1|Open-Label Treatment Phase|Lost to Follow-up|0
5830718|NCT02438826|20147738|P4|Open-Label Treatment Phase|Lack of Efficacy|0
5830719|NCT02438826|20147739|P3|Open-Label Treatment Phase|Lack of Efficacy|0
5830720|NCT02438826|20147740|P2|Open-Label Treatment Phase|Lack of Efficacy|18
5830721|NCT02438826|20147741|P1|Open-Label Treatment Phase|Lack of Efficacy|27
5830722|NCT02438826|20147738|P4|Open-Label Treatment Phase|Adverse Event|0
5830723|NCT02438826|20147739|P3|Open-Label Treatment Phase|Adverse Event|0
5830724|NCT02438826|20147740|P2|Open-Label Treatment Phase|Adverse Event|6
5830725|NCT02438826|20147741|P1|Open-Label Treatment Phase|Adverse Event|11
5830726|NCT02438826|20147738|P4|Double-Blind Treatment Phase|Screen Failure|0
5830727|NCT02438826|20147739|P3|Double-Blind Treatment Phase|Screen Failure|0
5830728|NCT02438826|20147740|P2|Double-Blind Treatment Phase|Screen Failure|0
5830729|NCT02438826|20147741|P1|Double-Blind Treatment Phase|Screen Failure|2
5830730|NCT02438826|20147738|P4|Double-Blind Treatment Phase|Protocol Violation|0
5830731|NCT02438826|20147739|P3|Double-Blind Treatment Phase|Protocol Violation|0
5830732|NCT02438826|20147740|P2|Double-Blind Treatment Phase|Protocol Violation|2
5830733|NCT02438826|20147741|P1|Double-Blind Treatment Phase|Protocol Violation|1
5830734|NCT02438826|20147738|P4|Double-Blind Treatment Phase|Withdrawal by Subject|0
5830735|NCT02438826|20147739|P3|Double-Blind Treatment Phase|Withdrawal by Subject|0
5830736|NCT02438826|20147740|P2|Double-Blind Treatment Phase|Withdrawal by Subject|1
5830737|NCT02438826|20147741|P1|Double-Blind Treatment Phase|Withdrawal by Subject|1
5830738|NCT02438826|20147738|P4|Double-Blind Treatment Phase|Lack of Efficacy|0
5830739|NCT02438826|20147739|P3|Double-Blind Treatment Phase|Lack of Efficacy|0
5830740|NCT02438826|20147740|P2|Double-Blind Treatment Phase|Lack of Efficacy|0
5830741|NCT02438826|20147741|P1|Double-Blind Treatment Phase|Lack of Efficacy|1
5830742|NCT02438826|20147738|P4|Double-Blind Treatment Phase|Adverse Event|0
5830743|NCT02438826|20147739|P3|Double-Blind Treatment Phase|Adverse Event|0
5830744|NCT02438826|20147740|P2|Double-Blind Treatment Phase|Adverse Event|1
5830745|NCT02438826|20147741|P1|Double-Blind Treatment Phase|Adverse Event|1
5830746|NCT02438813|20147775|P1|Overall Study|Patients Not Treated/No EOT Visit|249
5830747|NCT02438813|20147775|P1|Overall Study|Study Ended by Sponsor|80
5830748|NCT02438813|20147775|P1|Overall Study|Patient Lost to Follow-Up|137
5830749|NCT02438813|20147775|P1|Overall Study|Patient Decision|59
5830750|NCT02438787|20147827|P3|Overall Study|Site terminated by sponsor|1
5830751|NCT02438787|20147828|P2|Overall Study|Site terminated by sponsor|0
5830752|NCT02438787|20147829|P1|Overall Study|Site terminated by sponsor|0
5830753|NCT02438787|20147827|P3|Overall Study|Other|0
5830754|NCT02438787|20147828|P2|Overall Study|Other|1
5830755|NCT02438787|20147829|P1|Overall Study|Other|0
5830756|NCT02438787|20147827|P3|Overall Study|Study discontinued by sponsor|69
5830757|NCT02438787|20147828|P2|Overall Study|Study discontinued by sponsor|72
5830758|NCT02438787|20147829|P1|Overall Study|Study discontinued by sponsor|64
5830759|NCT02438787|20147827|P3|Overall Study|Withdrawal by Subject|10
5830760|NCT02438787|20147828|P2|Overall Study|Withdrawal by Subject|7
5830761|NCT02438787|20147829|P1|Overall Study|Withdrawal by Subject|15
5830762|NCT02438787|20147827|P3|Overall Study|Protocol Violation|1
5830763|NCT02438787|20147828|P2|Overall Study|Protocol Violation|0
5830764|NCT02438787|20147829|P1|Overall Study|Protocol Violation|0
5830765|NCT02438787|20147827|P3|Overall Study|Lost to Follow-up|0
5830766|NCT02438787|20147828|P2|Overall Study|Lost to Follow-up|1
5830767|NCT02438787|20147829|P1|Overall Study|Lost to Follow-up|0
5830768|NCT02438787|20147827|P3|Overall Study|Lack of Efficacy|0
5830769|NCT02438787|20147828|P2|Overall Study|Lack of Efficacy|2
5830770|NCT02438787|20147829|P1|Overall Study|Lack of Efficacy|1
5830771|NCT02438787|20147827|P3|Overall Study|Adverse Event|2
5830772|NCT02438787|20147828|P2|Overall Study|Adverse Event|0
5830773|NCT02438787|20147829|P1|Overall Study|Adverse Event|1
5830774|NCT02438384|20147962|P3|Overall Study|Lost to Follow-up|4
5830775|NCT02438384|20147963|P2|Overall Study|Lost to Follow-up|6
5830776|NCT02438384|20147964|P1|Overall Study|Lost to Follow-up|8
5830777|NCT02438280|20147983|P2|Overall Study|Physician Decision|0
5830778|NCT02438280|20147984|P1|Overall Study|Physician Decision|1
5830779|NCT02438137|20147994|P2|Overall Study|Physician Decision|1
5830780|NCT02438137|20147995|P1|Overall Study|Physician Decision|0
5830781|NCT02438137|20147994|P2|Overall Study|Withdrawal by Subject|3
5830782|NCT02438137|20147995|P1|Overall Study|Withdrawal by Subject|4
5830783|NCT02438137|20147994|P2|Overall Study|Adverse Event|0
5830784|NCT02438137|20147995|P1|Overall Study|Adverse Event|1
5830785|NCT02438137|20147994|P2|Overall Study|Lost to Follow-up|2
5830786|NCT02438137|20147995|P1|Overall Study|Lost to Follow-up|3
5830787|NCT02437903|20148003|P1|Overall Study|Lost to Follow-up|3
5830788|NCT02437903|20148003|P1|Overall Study|Withdrawal by Subject|1
5830789|NCT02437903|20148003|P1|Overall Study|Adverse Event|1
5830790|NCT02437890|20148016|P5|Overall Study|Death|0
5830791|NCT02437890|20148017|P4|Overall Study|Death|2
5830792|NCT02437890|20148018|P3|Overall Study|Death|0
5830793|NCT02437890|20148019|P2|Overall Study|Death|0
5830794|NCT02437890|20148020|P1|Overall Study|Death|0
5830795|NCT02437890|20148016|P5|Overall Study|Withdrawal by Subject|5
5830796|NCT02437890|20148017|P4|Overall Study|Withdrawal by Subject|5
5830797|NCT02437890|20148018|P3|Overall Study|Withdrawal by Subject|6
5830798|NCT02437890|20148019|P2|Overall Study|Withdrawal by Subject|2
5830799|NCT02437890|20148020|P1|Overall Study|Withdrawal by Subject|1
5830800|NCT02437890|20148016|P5|Overall Study|Adverse Event|7
5830801|NCT02437890|20148017|P4|Overall Study|Adverse Event|11
5830802|NCT02437890|20148018|P3|Overall Study|Adverse Event|5
5830803|NCT02437890|20148019|P2|Overall Study|Adverse Event|9
5830804|NCT02437890|20148020|P1|Overall Study|Adverse Event|4
5830805|NCT02437890|20148016|P5|Overall Study|Lack of Efficacy|1
5830806|NCT02437890|20148017|P4|Overall Study|Lack of Efficacy|3
5830807|NCT02437890|20148018|P3|Overall Study|Lack of Efficacy|0
5830808|NCT02437890|20148019|P2|Overall Study|Lack of Efficacy|3
5830809|NCT02437890|20148020|P1|Overall Study|Lack of Efficacy|1
5830810|NCT02437890|20148016|P5|Overall Study|Unable to attend visit(s)|0
5830811|NCT02437890|20148017|P4|Overall Study|Unable to attend visit(s)|0
5830812|NCT02437890|20148018|P3|Overall Study|Unable to attend visit(s)|0
5830813|NCT02437890|20148019|P2|Overall Study|Unable to attend visit(s)|0
5830814|NCT02437890|20148020|P1|Overall Study|Unable to attend visit(s)|1
5830815|NCT02437890|20148016|P5|Overall Study|Physician Decision|0
5830816|NCT02437890|20148017|P4|Overall Study|Physician Decision|1
5830817|NCT02437890|20148018|P3|Overall Study|Physician Decision|0
5830818|NCT02437890|20148019|P2|Overall Study|Physician Decision|0
5830819|NCT02437890|20148020|P1|Overall Study|Physician Decision|0
5830820|NCT02437890|20148016|P5|Overall Study|Sponsor's decision|2
5830821|NCT02437890|20148017|P4|Overall Study|Sponsor's decision|0
5830822|NCT02437890|20148018|P3|Overall Study|Sponsor's decision|4
5830823|NCT02437890|20148019|P2|Overall Study|Sponsor's decision|1
5830824|NCT02437890|20148020|P1|Overall Study|Sponsor's decision|1
5830825|NCT02437890|20148016|P5|Overall Study|Non-compliance to study drug|1
5830826|NCT02437890|20148017|P4|Overall Study|Non-compliance to study drug|0
5830827|NCT02437890|20148018|P3|Overall Study|Non-compliance to study drug|0
5830828|NCT02437890|20148019|P2|Overall Study|Non-compliance to study drug|1
5830829|NCT02437890|20148020|P1|Overall Study|Non-compliance to study drug|0
5830830|NCT02437864|20148233|P2|Overall Study|Protocol Violation|0
5830831|NCT02437864|20148234|P1|Overall Study|Protocol Violation|4
5830832|NCT02437513|20148255|P1|Overall Study|Withdrawal by Subject|2
5830833|NCT02437409|20148280|P1|Overall Study|Screening failure|12
5830834|NCT02437409|20148280|P1|Overall Study|Withdrawal by Subject|3
5830835|NCT02437318|20148373|P2|Overall Study|Untreated|1
5830836|NCT02437318|20148374|P1|Overall Study|Untreated|0
5830837|NCT02437318|20148373|P2|Overall Study|Protocol Violation|6
5830838|NCT02437318|20148374|P1|Overall Study|Protocol Violation|5
5830839|NCT02437318|20148373|P2|Overall Study|Death|4
5830840|NCT02437318|20148374|P1|Overall Study|Death|4
5830841|NCT02437318|20148373|P2|Overall Study|Adverse Event|3
5830842|NCT02437318|20148374|P1|Overall Study|Adverse Event|14
5830843|NCT02437318|20148373|P2|Overall Study|Physician Decision|10
5830844|NCT02437318|20148374|P1|Overall Study|Physician Decision|11
5830845|NCT02437318|20148373|P2|Overall Study|Subject/guardian decision|10
5830846|NCT02437318|20148374|P1|Overall Study|Subject/guardian decision|22
5830847|NCT02437318|20148373|P2|Overall Study|Progressive disease|208
5830848|NCT02437318|20148374|P1|Overall Study|Progressive disease|173
5830849|NCT02437305|20148382|P2|Overall Study|Lost to Follow-up|12
5830850|NCT02437305|20148383|P1|Overall Study|Lost to Follow-up|18
5830851|NCT02437188|20148410|P2|Overall Study|Adverse Event|1
5830852|NCT02437188|20148411|P1|Overall Study|Adverse Event|0
5830853|NCT02437188|20148410|P2|Overall Study|Randomized but did not receive surgery|8
5830854|NCT02437188|20148411|P1|Overall Study|Randomized but did not receive surgery|4
5830855|NCT02437162|20148428|P3|Overall Study|Other|1
5830856|NCT02437162|20148429|P2|Overall Study|Other|0
5830857|NCT02437162|20148430|P1|Overall Study|Other|0
5830858|NCT02437162|20148428|P3|Overall Study|Death|0
5830859|NCT02437162|20148429|P2|Overall Study|Death|1
5830860|NCT02437162|20148430|P1|Overall Study|Death|0
5830861|NCT02437162|20148428|P3|Overall Study|Lost to Follow-up|1
5830862|NCT02437162|20148429|P2|Overall Study|Lost to Follow-up|0
5830863|NCT02437162|20148430|P1|Overall Study|Lost to Follow-up|1
5830864|NCT02437162|20148428|P3|Overall Study|Adverse Event|0
5830865|NCT02437162|20148429|P2|Overall Study|Adverse Event|1
5830866|NCT02437162|20148430|P1|Overall Study|Adverse Event|0
5830867|NCT02437162|20148428|P3|Overall Study|Withdrawal by Subject|9
5830868|NCT02437162|20148429|P2|Overall Study|Withdrawal by Subject|7
5830869|NCT02437162|20148430|P1|Overall Study|Withdrawal by Subject|13
5830870|NCT02437162|20148428|P3|Overall Study|Study discontinued by Sponsor|97
5830871|NCT02437162|20148429|P2|Overall Study|Study discontinued by Sponsor|98
5830872|NCT02437162|20148430|P1|Overall Study|Study discontinued by Sponsor|93
5830873|NCT02437162|20148428|P3|Overall Study|Randomized but not treated|1
5830874|NCT02437162|20148429|P2|Overall Study|Randomized but not treated|0
5830875|NCT02437162|20148430|P1|Overall Study|Randomized but not treated|0
5830876|NCT02437162|20148428|P3|Overall Study|Protocol Violation|0
5830877|NCT02437162|20148429|P2|Overall Study|Protocol Violation|1
5830878|NCT02437162|20148430|P1|Overall Study|Protocol Violation|0
5830879|NCT02436915|20148550|P2|Overall Study|Withdrawal by Subject|1
5830880|NCT02436915|20148551|P1|Overall Study|Withdrawal by Subject|0
5830881|NCT02436889|20148573|P2|Overall Study|Does not like/could not tolerate medicat|1
5830882|NCT02436889|20148574|P1|Overall Study|Does not like/could not tolerate medicat|0
5830883|NCT02436889|20148573|P2|Overall Study|No improvement in symptoms|0
5830884|NCT02436889|20148574|P1|Overall Study|No improvement in symptoms|1
5830885|NCT02436811|20148593|P3|Overall Study|Lost to Follow-up|7
5830886|NCT02436811|20148594|P2|Overall Study|Lost to Follow-up|9
5830887|NCT02436811|20148595|P1|Overall Study|Lost to Follow-up|2
5830888|NCT02436759|20148605|P2|Overall Study|Withdrawal by Subject|1
5830889|NCT02436759|20148606|P1|Overall Study|Withdrawal by Subject|0
5830890|NCT02436759|20148605|P2|Overall Study|Protocol Violation|0
5830891|NCT02436759|20148606|P1|Overall Study|Protocol Violation|1
5830892|NCT02436759|20148605|P2|Overall Study|Adverse Event|0
5830893|NCT02436759|20148606|P1|Overall Study|Adverse Event|3
5830894|NCT02436681|20148614|P1|Overall Study|Death|2
5830895|NCT02436681|20148614|P1|Overall Study|Withdrawal by Subject|2
5830896|NCT02436681|20148614|P1|Overall Study|Lost to Follow-up|10
5830897|NCT02436577|20148654|P6|Overall Study|Protocol Deviation|0
5830898|NCT02436577|20148655|P5|Overall Study|Protocol Deviation|0
5830899|NCT02436577|20148656|P4|Overall Study|Protocol Deviation|0
5830900|NCT02436577|20148657|P3|Overall Study|Protocol Deviation|0
5830901|NCT02436577|20148658|P2|Overall Study|Protocol Deviation|1
5830902|NCT02436577|20148659|P1|Overall Study|Protocol Deviation|0
5830903|NCT02436356|20148715|P3|Overall Study|Withdrawal by Subject|0
5830904|NCT02436356|20148716|P2|Overall Study|Withdrawal by Subject|0
5830905|NCT02436356|20148717|P1|Overall Study|Withdrawal by Subject|1
5830906|NCT02436356|20148715|P3|Overall Study|Excluded due to other medical conditions|0
5830907|NCT02436356|20148716|P2|Overall Study|Excluded due to other medical conditions|0
5830908|NCT02436356|20148717|P1|Overall Study|Excluded due to other medical conditions|3
5830909|NCT02436356|20148715|P3|Overall Study|Surgical Approach (Dorsal not volar)|0
5830910|NCT02436356|20148716|P2|Overall Study|Surgical Approach (Dorsal not volar)|0
5830911|NCT02436356|20148717|P1|Overall Study|Surgical Approach (Dorsal not volar)|1
5830912|NCT02436356|20148715|P3|Overall Study|Lost to Follow-up|0
5830913|NCT02436356|20148716|P2|Overall Study|Lost to Follow-up|1
5830914|NCT02436356|20148717|P1|Overall Study|Lost to Follow-up|0
5830915|NCT02436356|20148715|P3|Overall Study|Excluded by MRI Screening|2
5830916|NCT02436356|20148716|P2|Overall Study|Excluded by MRI Screening|0
5830917|NCT02436356|20148717|P1|Overall Study|Excluded by MRI Screening|0
5830918|NCT02436330|20148748|P2|Cohort 6|Withdrawal by Subject|1
5830919|NCT02436330|20148749|P1|Cohort 6|Withdrawal by Subject|1
5830920|NCT02436330|20148748|P2|Cohort 6|Lost to Follow-up|0
5830921|NCT02436330|20148749|P1|Cohort 6|Lost to Follow-up|2
5830922|NCT02436330|20148748|P2|Cohort 5|Withdrawal by Subject|2
5830923|NCT02436330|20148749|P1|Cohort 5|Withdrawal by Subject|3
5830924|NCT02436330|20148748|P2|Cohort 5|Lost to Follow-up|2
5830925|NCT02436330|20148749|P1|Cohort 5|Lost to Follow-up|3
5830926|NCT02436330|20148748|P2|Cohort 4|Withdrawal by Subject|0
5830927|NCT02436330|20148749|P1|Cohort 4|Withdrawal by Subject|1
5830928|NCT02436330|20148748|P2|Cohort 4|Lost to Follow-up|0
5830929|NCT02436330|20148749|P1|Cohort 4|Lost to Follow-up|1
5830930|NCT02436330|20148748|P2|Cohort 3|Withdrawal by Subject|0
5830931|NCT02436330|20148749|P1|Cohort 3|Withdrawal by Subject|4
5830932|NCT02436330|20148748|P2|Cohort 3|Lost to Follow-up|0
5830933|NCT02436330|20148749|P1|Cohort 3|Lost to Follow-up|1
5830934|NCT02436330|20148748|P2|Cohort 2|Withdrawal by Subject|3
5830935|NCT02436330|20148749|P1|Cohort 2|Withdrawal by Subject|2
5830936|NCT02436330|20148748|P2|Cohort 2|Lost to Follow-up|0
5830937|NCT02436330|20148749|P1|Cohort 2|Lost to Follow-up|2
5830938|NCT02436330|20148748|P2|Cohort 1|Withdrawal by Subject|1
5830939|NCT02436330|20148749|P1|Cohort 1|Withdrawal by Subject|0
5830940|NCT02436330|20148748|P2|Cohort 1|Lost to Follow-up|2
5830941|NCT02436330|20148749|P1|Cohort 1|Lost to Follow-up|5
5830942|NCT02436304|20148794|P3|Overall Study|Randomized in error didn't meet I/E crit|1
5830943|NCT02436304|20148795|P2|Overall Study|Randomized in error didn't meet I/E crit|0
5830944|NCT02436304|20148796|P1|Overall Study|Randomized in error didn't meet I/E crit|0
5830945|NCT02436304|20148794|P3|Overall Study|Withdrawal by Subject|0
5830946|NCT02436304|20148795|P2|Overall Study|Withdrawal by Subject|1
5830947|NCT02436304|20148796|P1|Overall Study|Withdrawal by Subject|0
5830948|NCT02436304|20148794|P3|Overall Study|Lost to Follow-up|0
5830949|NCT02436304|20148795|P2|Overall Study|Lost to Follow-up|1
5830950|NCT02436304|20148796|P1|Overall Study|Lost to Follow-up|0
5830951|NCT02436239|20148815|P4|Down-Taper Period|Withdrawal by Subject|2
5830952|NCT02436239|20148816|P3|Down-Taper Period|Withdrawal by Subject|1
5830953|NCT02436239|20148817|P2|Down-Taper Period|Withdrawal by Subject|4
5830954|NCT02436239|20148818|P1|Down-Taper Period|Withdrawal by Subject|4
5830955|NCT02436239|20148815|P4|Open-Lable Treatment Period|Other Reason|0
5830956|NCT02436239|20148816|P3|Open-Lable Treatment Period|Other Reason|0
5830957|NCT02436239|20148817|P2|Open-Lable Treatment Period|Other Reason|1
5830958|NCT02436239|20148818|P1|Open-Lable Treatment Period|Other Reason|1
5830959|NCT02436239|20148815|P4|Open-Lable Treatment Period|Noncompliance with Study Drug|1
5830960|NCT02436239|20148816|P3|Open-Lable Treatment Period|Noncompliance with Study Drug|3
5830961|NCT02436239|20148817|P2|Open-Lable Treatment Period|Noncompliance with Study Drug|6
5830962|NCT02436239|20148818|P1|Open-Lable Treatment Period|Noncompliance with Study Drug|5
5830963|NCT02436239|20148815|P4|Open-Lable Treatment Period|Protocol Violation|0
5830964|NCT02436239|20148816|P3|Open-Lable Treatment Period|Protocol Violation|1
5830965|NCT02436239|20148817|P2|Open-Lable Treatment Period|Protocol Violation|1
5830966|NCT02436239|20148818|P1|Open-Lable Treatment Period|Protocol Violation|0
5830967|NCT02436239|20148815|P4|Open-Lable Treatment Period|Lost to Follow-up|1
5830968|NCT02436239|20148816|P3|Open-Lable Treatment Period|Lost to Follow-up|4
5830969|NCT02436239|20148817|P2|Open-Lable Treatment Period|Lost to Follow-up|2
5830970|NCT02436239|20148818|P1|Open-Lable Treatment Period|Lost to Follow-up|4
5830971|NCT02436239|20148815|P4|Open-Lable Treatment Period|Withdrawal by Subject|0
5830972|NCT02436239|20148816|P3|Open-Lable Treatment Period|Withdrawal by Subject|9
5830973|NCT02436239|20148817|P2|Open-Lable Treatment Period|Withdrawal by Subject|15
5830974|NCT02436239|20148818|P1|Open-Lable Treatment Period|Withdrawal by Subject|10
5830975|NCT02436239|20148815|P4|Open-Lable Treatment Period|Lack of Efficacy|1
5830976|NCT02436239|20148816|P3|Open-Lable Treatment Period|Lack of Efficacy|6
5830977|NCT02436239|20148817|P2|Open-Lable Treatment Period|Lack of Efficacy|6
5830978|NCT02436239|20148818|P1|Open-Lable Treatment Period|Lack of Efficacy|1
5830979|NCT02436239|20148815|P4|Open-Lable Treatment Period|Adverse Event|2
5830980|NCT02436239|20148816|P3|Open-Lable Treatment Period|Adverse Event|4
5830981|NCT02436239|20148817|P2|Open-Lable Treatment Period|Adverse Event|3
5830982|NCT02436239|20148818|P1|Open-Lable Treatment Period|Adverse Event|12
5830983|NCT02436200|20148840|P1|Overall Study|Significant outlier|1
5830984|NCT02436135|20148847|P2|Overall Study|Study Terminated By Sponsor|1
5830985|NCT02436135|20148848|P1|Overall Study|Study Terminated By Sponsor|0
5830986|NCT02436135|20148847|P2|Overall Study|Withdrawal by Participant|0
5830987|NCT02436135|20148848|P1|Overall Study|Withdrawal by Participant|1
5830988|NCT02436135|20148847|P2|Overall Study|Adverse Event|0
5830989|NCT02436135|20148848|P1|Overall Study|Adverse Event|1
5830990|NCT02436135|20148847|P2|Overall Study|Investigator Discretion|2
5830991|NCT02436135|20148848|P1|Overall Study|Investigator Discretion|1
5830992|NCT02436135|20148847|P2|Overall Study|Progressive Disease|1
5830993|NCT02436135|20148848|P1|Overall Study|Progressive Disease|3
5830994|NCT02436005|20148883|P2|Second Intervention|Adverse Event|1
5830995|NCT02436005|20148884|P1|Second Intervention|Adverse Event|0
5830996|NCT02435966|20148949|P3|Overall Study|Withdrawal by Subject|0
5830997|NCT02435966|20148950|P2|Overall Study|Withdrawal by Subject|1
5830998|NCT02435966|20148951|P1|Overall Study|Withdrawal by Subject|0
5830999|NCT02435914|20148963|P4|Overall Study|Other Miscellaneous Reason|0
5831000|NCT02435914|20148964|P3|Overall Study|Other Miscellaneous Reason|1
5831001|NCT02435914|20148965|P2|Overall Study|Other Miscellaneous Reason|0
5831002|NCT02435914|20148966|P1|Overall Study|Other Miscellaneous Reason|0
5831003|NCT02435914|20148963|P4|Overall Study|Withdrawal by Subject|0
5831004|NCT02435914|20148964|P3|Overall Study|Withdrawal by Subject|0
5831005|NCT02435914|20148965|P2|Overall Study|Withdrawal by Subject|1
5831006|NCT02435914|20148966|P1|Overall Study|Withdrawal by Subject|0
5831007|NCT02435914|20148963|P4|Overall Study|Ocular Adverse Event|0
5831008|NCT02435914|20148964|P3|Overall Study|Ocular Adverse Event|0
5831009|NCT02435914|20148965|P2|Overall Study|Ocular Adverse Event|0
5831010|NCT02435914|20148966|P1|Overall Study|Ocular Adverse Event|1
5831011|NCT02435836|20148994|P1|Overall Study|AE of Worsening Schizophrenia|96
5831012|NCT02435836|20148994|P1|Overall Study|Met Withdrawal Criteria|7
5831013|NCT02435836|20148994|P1|Overall Study|Protocol Violation|6
5831014|NCT02435836|20148994|P1|Overall Study|Noncompliance|27
5831015|NCT02435836|20148994|P1|Overall Study|Sponsor discontinued trial|167
5831016|NCT02435836|20148994|P1|Overall Study|Adverse Event|44
5831017|NCT02435836|20148994|P1|Overall Study|Insufficient Clinical Response|26
5831018|NCT02435836|20148994|P1|Overall Study|Withdrawal by Subject|236
5831019|NCT02435836|20148994|P1|Overall Study|Lack of Efficacy|1
5831020|NCT02435836|20148994|P1|Overall Study|Lost to Follow-up|21
5831021|NCT02435433|20149053|P5|Overall Study|Lost to Follow-up|0
5831022|NCT02435433|20149054|P4|Overall Study|Lost to Follow-up|0
5831023|NCT02435433|20149055|P3|Overall Study|Lost to Follow-up|0
5831024|NCT02435433|20149056|P2|Overall Study|Lost to Follow-up|2
5831025|NCT02435433|20149057|P1|Overall Study|Lost to Follow-up|2
5831026|NCT02435433|20149053|P5|Overall Study|Withdrawal by Subject|0
5831027|NCT02435433|20149054|P4|Overall Study|Withdrawal by Subject|0
5831028|NCT02435433|20149055|P3|Overall Study|Withdrawal by Subject|0
5831029|NCT02435433|20149056|P2|Overall Study|Withdrawal by Subject|3
5831030|NCT02435433|20149057|P1|Overall Study|Withdrawal by Subject|2
5831031|NCT02435433|20149053|P5|Overall Study|On Treatment|0
5831032|NCT02435433|20149054|P4|Overall Study|On Treatment|0
5831033|NCT02435433|20149055|P3|Overall Study|On Treatment|0
5831034|NCT02435433|20149056|P2|Overall Study|On Treatment|0
5831035|NCT02435433|20149057|P1|Overall Study|On Treatment|11
5831036|NCT02435277|20149083|P4|Overall Study|Withdrawal by Subject|0
5831037|NCT02435277|20149084|P3|Overall Study|Withdrawal by Subject|0
5831038|NCT02435277|20149085|P2|Overall Study|Withdrawal by Subject|0
5831039|NCT02435277|20149086|P1|Overall Study|Withdrawal by Subject|1
5831040|NCT02435277|20149083|P4|Overall Study|Adverse Event|0
5831041|NCT02435277|20149084|P3|Overall Study|Adverse Event|0
5831042|NCT02435277|20149085|P2|Overall Study|Adverse Event|1
5831043|NCT02435277|20149086|P1|Overall Study|Adverse Event|1
5831044|NCT02435147|20149100|P1|Overall Study|non-evaluable DXA scan|11
5831045|NCT02435069|20149105|P5|Effectiveness - Second Intervention|Lack of Efficacy|1
5831046|NCT02435069|20149106|P4|Effectiveness - Second Intervention|Lack of Efficacy|0
5831047|NCT02435069|20149107|P3|Effectiveness - Second Intervention|Lack of Efficacy|0
5831048|NCT02435069|20149108|P2|Effectiveness - Second Intervention|Lack of Efficacy|0
5831049|NCT02435069|20149109|P1|Effectiveness - Second Intervention|Lack of Efficacy|0
5831050|NCT02435069|20149105|P5|Dose Response - First Intervention|Adverse Event|0
5831051|NCT02435069|20149106|P4|Dose Response - First Intervention|Adverse Event|0
5831052|NCT02435069|20149107|P3|Dose Response - First Intervention|Adverse Event|1
5831053|NCT02435069|20149108|P2|Dose Response - First Intervention|Adverse Event|1
5831054|NCT02435069|20149109|P1|Dose Response - First Intervention|Adverse Event|0
5831055|NCT02434939|20149131|P2|Overall Study|Adverse Event|1
5831056|NCT02434939|20149132|P1|Overall Study|Adverse Event|0
5831057|NCT02434939|20149131|P2|Overall Study|Withdrawal by Subject|0
5831058|NCT02434939|20149132|P1|Overall Study|Withdrawal by Subject|3
5831059|NCT02434939|20149131|P2|Overall Study|Lack of Efficacy|48
5831060|NCT02434939|20149132|P1|Overall Study|Lack of Efficacy|34
5831061|NCT02434770|20149147|P3|Week 18 to Week|Received Non-study Polio Vaccine|3
5831062|NCT02434770|20149148|P2|Week 18 to Week|Received Non-study Polio Vaccine|6
5831063|NCT02434770|20149149|P1|Week 18 to Week|Received Non-study Polio Vaccine|6
5831064|NCT02434770|20149147|P3|Week 18 to Week|Withdrawal by Subject|2
5831065|NCT02434770|20149148|P2|Week 18 to Week|Withdrawal by Subject|0
5831066|NCT02434770|20149149|P1|Week 18 to Week|Withdrawal by Subject|0
5831067|NCT02434770|20149147|P3|Week 18 to Week|Lost to Follow-up|1
5831068|NCT02434770|20149148|P2|Week 18 to Week|Lost to Follow-up|2
5831069|NCT02434770|20149149|P1|Week 18 to Week|Lost to Follow-up|2
5831070|NCT02434770|20149147|P3|Week 1 to Week 18|Death|0
5831071|NCT02434770|20149148|P2|Week 1 to Week 18|Death|0
5831072|NCT02434770|20149149|P1|Week 1 to Week 18|Death|1
5831073|NCT02434770|20149147|P3|Week 1 to Week 18|Relocated Out of Study Area|1
5831074|NCT02434770|20149148|P2|Week 1 to Week 18|Relocated Out of Study Area|0
5831075|NCT02434770|20149149|P1|Week 1 to Week 18|Relocated Out of Study Area|0
5831076|NCT02434770|20149147|P3|Week 1 to Week 18|Received Non-study Polio Vaccine|9
5831077|NCT02434770|20149148|P2|Week 1 to Week 18|Received Non-study Polio Vaccine|10
5831078|NCT02434770|20149149|P1|Week 1 to Week 18|Received Non-study Polio Vaccine|8
5831079|NCT02434770|20149147|P3|Week 1 to Week 18|Withdrawal by Subject|5
5831080|NCT02434770|20149148|P2|Week 1 to Week 18|Withdrawal by Subject|12
5831081|NCT02434770|20149149|P1|Week 1 to Week 18|Withdrawal by Subject|6
5831082|NCT02434770|20149147|P3|Week 1 to Week 18|Lost to Follow-up|2
5831083|NCT02434770|20149148|P2|Week 1 to Week 18|Lost to Follow-up|0
5831084|NCT02434770|20149149|P1|Week 1 to Week 18|Lost to Follow-up|0
5831085|NCT02434471|20149299|P1|Overall Study|Physician Decision|9
5831086|NCT02434354|20149306|P1|Overall Study|screen fail|3
5831087|NCT02434328|20149312|P2|Overall Study|Other|1
5831088|NCT02434328|20149313|P1|Overall Study|Other|4
5831089|NCT02434328|20149312|P2|Overall Study|Lost to Follow-up|6
5831090|NCT02434328|20149313|P1|Overall Study|Lost to Follow-up|1
5831091|NCT02434328|20149312|P2|Overall Study|Death|7
5831092|NCT02434328|20149313|P1|Overall Study|Death|4
5831093|NCT02434328|20149312|P2|Overall Study|Withdrawal by Subject|21
5831094|NCT02434328|20149313|P1|Overall Study|Withdrawal by Subject|12
5831095|NCT02434328|20149312|P2|Overall Study|Physician Decision|1
5831096|NCT02434328|20149313|P1|Overall Study|Physician Decision|0
5831097|NCT02434328|20149312|P2|Overall Study|Lack of Efficacy|2
5831098|NCT02434328|20149313|P1|Overall Study|Lack of Efficacy|0
5831099|NCT02434328|20149312|P2|Overall Study|Adverse Event|4
5831100|NCT02434328|20149313|P1|Overall Study|Adverse Event|9
5831101|NCT02433834|20149388|P1|Overall Study|Physician Decision|1
5831102|NCT02433834|20149388|P1|Overall Study|Adverse Event|6
5831103|NCT02433834|20149388|P1|Overall Study|Withdrawal by Subject|14
5831104|NCT02433834|20149388|P1|Overall Study|Lost to Follow-up|6
5831105|NCT02433834|20149388|P1|Overall Study|Protocol Violation|3
5831106|NCT02433834|20149388|P1|Overall Study|Protocol-specified criteria|7
5831107|NCT02433678|20149448|P2|Overall Study|Lost to Follow-up|2
5831108|NCT02433678|20149449|P1|Overall Study|Lost to Follow-up|1
5831109|NCT02433483|20149542|P1|Overall Study|Other antineoplastic therapy/HSCT|1
5831110|NCT02433483|20149542|P1|Overall Study|Unacceptable toxicity|1
5831111|NCT02433379|20149554|P1|Overall Study|Total Withdrawals|209
5831112|NCT02433379|20149554|P1|Overall Study|Death|57
5831113|NCT02433379|20149554|P1|Overall Study|Screen Failures|55
5831114|NCT02433340|20149577|P4|Overall Study|Other|0
5831115|NCT02433340|20149578|P3|Overall Study|Other|0
5831116|NCT02433340|20149579|P2|Overall Study|Other|1
5831117|NCT02433340|20149580|P1|Overall Study|Other|0
5831118|NCT02433340|20149577|P4|Overall Study|Required Alternative/Prohibited Therapy|0
5831119|NCT02433340|20149578|P3|Overall Study|Required Alternative/Prohibited Therapy|0
5831120|NCT02433340|20149579|P2|Overall Study|Required Alternative/Prohibited Therapy|0
5831121|NCT02433340|20149580|P1|Overall Study|Required Alternative/Prohibited Therapy|1
5831122|NCT02433340|20149577|P4|Overall Study|Lost to Follow-up|0
5831123|NCT02433340|20149578|P3|Overall Study|Lost to Follow-up|0
5831124|NCT02433340|20149579|P2|Overall Study|Lost to Follow-up|1
5831125|NCT02433340|20149580|P1|Overall Study|Lost to Follow-up|0
5831126|NCT02433340|20149577|P4|Overall Study|Withdrawal by Subject|2
5831127|NCT02433340|20149578|P3|Overall Study|Withdrawal by Subject|1
5831128|NCT02433340|20149579|P2|Overall Study|Withdrawal by Subject|0
5831129|NCT02433340|20149580|P1|Overall Study|Withdrawal by Subject|1
5831130|NCT02433340|20149577|P4|Overall Study|Adverse Event|0
5831131|NCT02433340|20149578|P3|Overall Study|Adverse Event|1
5831132|NCT02433340|20149579|P2|Overall Study|Adverse Event|0
5831133|NCT02433340|20149580|P1|Overall Study|Adverse Event|0
5831134|NCT02433288|20150474|P2|Overall Study|Death|3
5831135|NCT02433288|20150475|P1|Overall Study|Death|0
5831136|NCT02433288|20150474|P2|Overall Study|Lost to Follow-up|14
5831137|NCT02433288|20150475|P1|Overall Study|Lost to Follow-up|2
5831138|NCT02433288|20150474|P2|Overall Study|Withdrawal by Subject|99
5831139|NCT02433288|20150475|P1|Overall Study|Withdrawal by Subject|101
5831140|NCT02433288|20150474|P2|Overall Study|Eligibility criteria not fullfilled|3
5831141|NCT02433288|20150475|P1|Overall Study|Eligibility criteria not fullfilled|7
5831142|NCT02433288|20150474|P2|Overall Study|Severe non-compliance to protocol|7
5831143|NCT02433288|20150475|P1|Overall Study|Severe non-compliance to protocol|13
5831144|NCT02433080|20150491|P2|Overall Study|Withdrawal by Subject|2
5831145|NCT02433080|20150492|P1|Overall Study|Withdrawal by Subject|0
5831146|NCT02433080|20150491|P2|Overall Study|Lost to Follow-up|2
5831147|NCT02433080|20150492|P1|Overall Study|Lost to Follow-up|1
5831204|NCT02432196|20150737|P1|Overall Study|On Study|20
5831205|NCT02432196|20150737|P1|Overall Study|Reoperation|3
5831206|NCT02432196|20150737|P1|Overall Study|Death|2
5831207|NCT02432196|20150737|P1|Overall Study|Not Implanted with Device|1
5831208|NCT02432144|20150745|P1|Overall Study|Participant Non-Compliance|1
5831209|NCT02432105|20150753|P3|Overall Study|Randomized in error|2
5831210|NCT02432105|20150754|P2|Overall Study|Randomized in error|0
5831211|NCT02432105|20150755|P1|Overall Study|Randomized in error|0
5831212|NCT02432105|20150753|P3|Overall Study|Culture positive for yeast|0
5831213|NCT02432105|20150754|P2|Overall Study|Culture positive for yeast|1
5831214|NCT02432105|20150755|P1|Overall Study|Culture positive for yeast|0
5831215|NCT02432105|20150753|P3|Overall Study|Withdrawal by Subject|1
5831216|NCT02432105|20150754|P2|Overall Study|Withdrawal by Subject|0
5831217|NCT02432105|20150755|P1|Overall Study|Withdrawal by Subject|1
5831218|NCT02432105|20150753|P3|Overall Study|Lost to Follow-up|0
5831219|NCT02432105|20150754|P2|Overall Study|Lost to Follow-up|1
5831220|NCT02432105|20150755|P1|Overall Study|Lost to Follow-up|1
5831221|NCT02432040|20150772|P2|Overall Study|Physician Decision|1
5831222|NCT02432040|20150773|P1|Overall Study|Physician Decision|1
5831223|NCT02432040|20150772|P2|Overall Study|Lost to Follow-up|5
5831224|NCT02432040|20150773|P1|Overall Study|Lost to Follow-up|4
5831225|NCT02432040|20150772|P2|Overall Study|Lack of Efficacy|0
5831226|NCT02432040|20150773|P1|Overall Study|Lack of Efficacy|3
5831227|NCT02431806|20150797|P4|Double-blind Treatment Period|Reason Not Specified|2
5831228|NCT02431806|20150798|P3|Double-blind Treatment Period|Reason Not Specified|5
5831229|NCT02431806|20150799|P2|Double-blind Treatment Period|Reason Not Specified|1
5831230|NCT02431806|20150800|P1|Double-blind Treatment Period|Reason Not Specified|0
5831231|NCT02431806|20150797|P4|Double-blind Treatment Period|Investigational Product Non-compliance|1
5831232|NCT02431806|20150798|P3|Double-blind Treatment Period|Investigational Product Non-compliance|3
5831233|NCT02431806|20150799|P2|Double-blind Treatment Period|Investigational Product Non-compliance|0
5831234|NCT02431806|20150800|P1|Double-blind Treatment Period|Investigational Product Non-compliance|1
5831235|NCT02431806|20150797|P4|Double-blind Treatment Period|Lost to Follow-up|8
5831236|NCT02431806|20150798|P3|Double-blind Treatment Period|Lost to Follow-up|5
5831237|NCT02431806|20150799|P2|Double-blind Treatment Period|Lost to Follow-up|4
5831238|NCT02431806|20150800|P1|Double-blind Treatment Period|Lost to Follow-up|7
5831239|NCT02431806|20150797|P4|Double-blind Treatment Period|Withdrawal of Consent|5
5831240|NCT02431806|20150798|P3|Double-blind Treatment Period|Withdrawal of Consent|5
5831241|NCT02431806|20150799|P2|Double-blind Treatment Period|Withdrawal of Consent|7
5831242|NCT02431806|20150800|P1|Double-blind Treatment Period|Withdrawal of Consent|10
5831243|NCT02431806|20150797|P4|Double-blind Treatment Period|Lack of Efficacy|2
5831244|NCT02431806|20150798|P3|Double-blind Treatment Period|Lack of Efficacy|2
5831245|NCT02431806|20150799|P2|Double-blind Treatment Period|Lack of Efficacy|0
5831246|NCT02431806|20150800|P1|Double-blind Treatment Period|Lack of Efficacy|2
5831247|NCT02431806|20150797|P4|Double-blind Treatment Period|Adverse Event|7
5831248|NCT02431806|20150798|P3|Double-blind Treatment Period|Adverse Event|11
5831249|NCT02431806|20150799|P2|Double-blind Treatment Period|Adverse Event|7
5831250|NCT02431806|20150800|P1|Double-blind Treatment Period|Adverse Event|4
5831251|NCT02431806|20150797|P4|Double-blind Treatment Period|Did not Receive Treatment|1
5831252|NCT02431806|20150798|P3|Double-blind Treatment Period|Did not Receive Treatment|1
5831253|NCT02431806|20150799|P2|Double-blind Treatment Period|Did not Receive Treatment|2
5831254|NCT02431806|20150800|P1|Double-blind Treatment Period|Did not Receive Treatment|1
5831255|NCT02431793|20150817|P3|Overall Study|Lost to Follow-up|104
5831256|NCT02431793|20150818|P2|Overall Study|Lost to Follow-up|122
5831257|NCT02431793|20150819|P1|Overall Study|Lost to Follow-up|101
5831258|NCT02431793|20150817|P3|Overall Study|Withdrawal by Subject|5
5831259|NCT02431793|20150818|P2|Overall Study|Withdrawal by Subject|5
5831260|NCT02431793|20150819|P1|Overall Study|Withdrawal by Subject|7
5831261|NCT02431793|20150817|P3|Overall Study|Ineligible doe to not filling Rx|8
5831262|NCT02431793|20150818|P2|Overall Study|Ineligible doe to not filling Rx|7
5831263|NCT02431793|20150819|P1|Overall Study|Ineligible doe to not filling Rx|11
5831264|NCT02431702|20150864|P7|Part 3: 9 Month of Additional Treatment|Other|0
5831265|NCT02431702|20150865|P6|Part 3: 9 Month of Additional Treatment|Other|6
5831266|NCT02431702|20150866|P5|Part 3: 9 Month of Additional Treatment|Other|1
5831267|NCT02431702|20150867|P4|Part 3: 9 Month of Additional Treatment|Other|1
5831268|NCT02431702|20150868|P3|Part 3: 9 Month of Additional Treatment|Other|0
5831269|NCT02431702|20150869|P2|Part 3: 9 Month of Additional Treatment|Other|0
5831270|NCT02431702|20150870|P1|Part 3: 9 Month of Additional Treatment|Other|0
5831271|NCT02431702|20150864|P7|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0
5831272|NCT02431702|20150865|P6|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|6
5831273|NCT02431702|20150866|P5|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|6
5831274|NCT02431702|20150867|P4|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|5
5831275|NCT02431702|20150868|P3|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0
5831276|NCT02431702|20150869|P2|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0
5831277|NCT02431702|20150870|P1|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0
5831278|NCT02431702|20150864|P7|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0
5831279|NCT02431702|20150865|P6|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|5
5831280|NCT02431702|20150866|P5|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0
5831281|NCT02431702|20150867|P4|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|1
5831282|NCT02431702|20150868|P3|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0
5831283|NCT02431702|20150869|P2|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0
5831284|NCT02431702|20150870|P1|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0
5831285|NCT02431702|20150864|P7|Part 3: 9 Month of Additional Treatment|Adverse Event|0
5831286|NCT02431702|20150865|P6|Part 3: 9 Month of Additional Treatment|Adverse Event|0
5831287|NCT02431702|20150866|P5|Part 3: 9 Month of Additional Treatment|Adverse Event|3
5831288|NCT02431702|20150867|P4|Part 3: 9 Month of Additional Treatment|Adverse Event|2
5831289|NCT02431702|20150868|P3|Part 3: 9 Month of Additional Treatment|Adverse Event|0
5831290|NCT02431702|20150869|P2|Part 3: 9 Month of Additional Treatment|Adverse Event|0
5831291|NCT02431702|20150870|P1|Part 3: 9 Month of Additional Treatment|Adverse Event|0
5831292|NCT02431702|20150864|P7|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0
5831293|NCT02431702|20150865|P6|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0
5831294|NCT02431702|20150866|P5|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0
5831295|NCT02431702|20150867|P4|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0
5831296|NCT02431702|20150868|P3|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|5
5831297|NCT02431702|20150869|P2|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0
5831298|NCT02431702|20150870|P1|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0
5831299|NCT02431702|20150864|P7|Part 2: 9Month Disease Progression Phase|Other|0
5831300|NCT02431702|20150865|P6|Part 2: 9Month Disease Progression Phase|Other|0
5831301|NCT02431702|20150866|P5|Part 2: 9Month Disease Progression Phase|Other|0
5831302|NCT02431702|20150867|P4|Part 2: 9Month Disease Progression Phase|Other|0
5831303|NCT02431702|20150868|P3|Part 2: 9Month Disease Progression Phase|Other|2
5831304|NCT02431702|20150869|P2|Part 2: 9Month Disease Progression Phase|Other|2
5831305|NCT02431702|20150870|P1|Part 2: 9Month Disease Progression Phase|Other|0
5831306|NCT02431702|20150864|P7|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0
5831307|NCT02431702|20150865|P6|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0
5831308|NCT02431702|20150866|P5|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0
5831309|NCT02431702|20150867|P4|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0
5831310|NCT02431702|20150868|P3|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0
5831311|NCT02431702|20150869|P2|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|2
5831312|NCT02431702|20150870|P1|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0
5831313|NCT02431702|20150864|P7|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0
5831314|NCT02431702|20150865|P6|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0
5831315|NCT02431702|20150866|P5|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0
5831316|NCT02431702|20150867|P4|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0
5831317|NCT02431702|20150868|P3|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|8
5831318|NCT02431702|20150869|P2|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|11
5831319|NCT02431702|20150870|P1|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0
5831320|NCT02431702|20150864|P7|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0
5831321|NCT02431702|20150865|P6|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0
5831322|NCT02431702|20150866|P5|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0
5831323|NCT02431702|20150867|P4|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0
5831324|NCT02431702|20150868|P3|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|13
5831325|NCT02431702|20150869|P2|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|6
5831326|NCT02431702|20150870|P1|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0
5831327|NCT02431702|20150864|P7|Part 2: 9Month Disease Progression Phase|Adverse Event|0
5831328|NCT02431702|20150865|P6|Part 2: 9Month Disease Progression Phase|Adverse Event|0
5831329|NCT02431702|20150866|P5|Part 2: 9Month Disease Progression Phase|Adverse Event|0
5831330|NCT02431702|20150867|P4|Part 2: 9Month Disease Progression Phase|Adverse Event|0
5831331|NCT02431702|20150868|P3|Part 2: 9Month Disease Progression Phase|Adverse Event|1
5831332|NCT02431702|20150869|P2|Part 2: 9Month Disease Progression Phase|Adverse Event|5
5831333|NCT02431702|20150870|P1|Part 2: 9Month Disease Progression Phase|Adverse Event|0
5831334|NCT02431702|20150864|P7|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0
5831335|NCT02431702|20150865|P6|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0
5831336|NCT02431702|20150866|P5|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0
5831337|NCT02431702|20150867|P4|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0
5831338|NCT02431702|20150868|P3|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0
5831339|NCT02431702|20150869|P2|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0
5831340|NCT02431702|20150870|P1|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|2
5831341|NCT02431702|20150864|P7|Part 1: 2-Month Oral Run-in Phase|Other|3
5831342|NCT02431702|20150865|P6|Part 1: 2-Month Oral Run-in Phase|Other|0
5831343|NCT02431702|20150866|P5|Part 1: 2-Month Oral Run-in Phase|Other|0
5831344|NCT02431702|20150867|P4|Part 1: 2-Month Oral Run-in Phase|Other|0
5831345|NCT02431702|20150868|P3|Part 1: 2-Month Oral Run-in Phase|Other|0
5831346|NCT02431702|20150869|P2|Part 1: 2-Month Oral Run-in Phase|Other|0
5831347|NCT02431702|20150870|P1|Part 1: 2-Month Oral Run-in Phase|Other|5
5831521|NCT02430480|20151520|P1|Overall Study|Progressed on treatment|1
5831348|NCT02431702|20150864|P7|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|6
5831349|NCT02431702|20150865|P6|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0
5831350|NCT02431702|20150866|P5|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0
5831351|NCT02431702|20150867|P4|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0
5831352|NCT02431702|20150868|P3|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0
5831353|NCT02431702|20150869|P2|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0
5831354|NCT02431702|20150870|P1|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|9
5831355|NCT02431702|20150864|P7|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|23
5831356|NCT02431702|20150865|P6|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0
5831357|NCT02431702|20150866|P5|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0
5831358|NCT02431702|20150867|P4|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0
5831359|NCT02431702|20150868|P3|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0
5831360|NCT02431702|20150869|P2|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0
5831361|NCT02431702|20150870|P1|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|11
5831362|NCT02431702|20150864|P7|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0
5831363|NCT02431702|20150865|P6|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0
5831364|NCT02431702|20150866|P5|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0
5831365|NCT02431702|20150867|P4|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0
5831366|NCT02431702|20150868|P3|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0
5831367|NCT02431702|20150869|P2|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0
5831368|NCT02431702|20150870|P1|Part 1: 2-Month Oral Run-in Phase|Adverse Event|7
5831369|NCT02431676|20150946|P3|Overall Study|no lab obtained|2
5831370|NCT02431676|20150947|P2|Overall Study|no lab obtained|1
5831371|NCT02431676|20150948|P1|Overall Study|no lab obtained|0
5831372|NCT02431559|20151024|P4|Overall Study|Physician Decision|1
5831373|NCT02431559|20151025|P3|Overall Study|Physician Decision|0
5831374|NCT02431559|20151026|P2|Overall Study|Physician Decision|0
5831375|NCT02431559|20151027|P1|Overall Study|Physician Decision|0
5831376|NCT02431559|20151024|P4|Overall Study|Withdrawal by Subject|4
5831377|NCT02431559|20151025|P3|Overall Study|Withdrawal by Subject|0
5831378|NCT02431559|20151026|P2|Overall Study|Withdrawal by Subject|1
5831379|NCT02431559|20151027|P1|Overall Study|Withdrawal by Subject|0
5831380|NCT02431559|20151024|P4|Overall Study|Progressive disease|22
5831381|NCT02431559|20151025|P3|Overall Study|Progressive disease|4
5831382|NCT02431559|20151026|P2|Overall Study|Progressive disease|1
5831383|NCT02431559|20151027|P1|Overall Study|Progressive disease|2
5831384|NCT02431559|20151024|P4|Overall Study|Adverse Event|4
5831385|NCT02431559|20151025|P3|Overall Study|Adverse Event|0
5831386|NCT02431559|20151026|P2|Overall Study|Adverse Event|1
5831387|NCT02431559|20151027|P1|Overall Study|Adverse Event|0
5831388|NCT02431533|20151051|P2|Overall Study|Developed Exclusionary criteria|0
5831389|NCT02431533|20151052|P1|Overall Study|Developed Exclusionary criteria|1
5831390|NCT02431533|20151051|P2|Overall Study|Withdrawal by Subject|3
5831391|NCT02431533|20151052|P1|Overall Study|Withdrawal by Subject|1
5831392|NCT02431468|20151118|P3|Overall Study|noncompliance, investigator termination,|2
5831393|NCT02431468|20151119|P2|Overall Study|noncompliance, investigator termination,|2
5831394|NCT02431468|20151120|P1|Overall Study|noncompliance, investigator termination,|2
5831395|NCT02431468|20151118|P3|Overall Study|Withdrawal by Subject|2
5831396|NCT02431468|20151119|P2|Overall Study|Withdrawal by Subject|12
5831397|NCT02431468|20151120|P1|Overall Study|Withdrawal by Subject|4
5831398|NCT02431468|20151118|P3|Overall Study|Adverse Event|5
5831399|NCT02431468|20151119|P2|Overall Study|Adverse Event|4
5831400|NCT02431468|20151120|P1|Overall Study|Adverse Event|2
5831401|NCT02431260|20151211|P14|Overall Study|Other Unspecified|0
5831402|NCT02431260|20151212|P13|Overall Study|Other Unspecified|1
5831403|NCT02431260|20151213|P12|Overall Study|Other Unspecified|1
5831404|NCT02431260|20151214|P11|Overall Study|Other Unspecified|0
5831405|NCT02431260|20151215|P10|Overall Study|Other Unspecified|0
5831406|NCT02431260|20151216|P9|Overall Study|Other Unspecified|0
5831407|NCT02431260|20151217|P8|Overall Study|Other Unspecified|0
5831408|NCT02431260|20151218|P7|Overall Study|Other Unspecified|0
5831409|NCT02431260|20151219|P6|Overall Study|Other Unspecified|0
5831410|NCT02431260|20151220|P5|Overall Study|Other Unspecified|0
5831411|NCT02431260|20151221|P4|Overall Study|Other Unspecified|0
5831412|NCT02431260|20151222|P3|Overall Study|Other Unspecified|0
5831413|NCT02431260|20151223|P2|Overall Study|Other Unspecified|0
5831414|NCT02431260|20151224|P1|Overall Study|Other Unspecified|0
5831415|NCT02431260|20151211|P14|Overall Study|Physician Decision|0
5831416|NCT02431260|20151212|P13|Overall Study|Physician Decision|0
5831417|NCT02431260|20151213|P12|Overall Study|Physician Decision|0
5831418|NCT02431260|20151214|P11|Overall Study|Physician Decision|0
5831419|NCT02431260|20151215|P10|Overall Study|Physician Decision|0
5831420|NCT02431260|20151216|P9|Overall Study|Physician Decision|0
5831421|NCT02431260|20151217|P8|Overall Study|Physician Decision|0
5831422|NCT02431260|20151218|P7|Overall Study|Physician Decision|0
5831423|NCT02431260|20151219|P6|Overall Study|Physician Decision|1
5831424|NCT02431260|20151220|P5|Overall Study|Physician Decision|0
5831425|NCT02431260|20151221|P4|Overall Study|Physician Decision|0
5831426|NCT02431260|20151222|P3|Overall Study|Physician Decision|0
5831427|NCT02431260|20151223|P2|Overall Study|Physician Decision|0
5831428|NCT02431260|20151224|P1|Overall Study|Physician Decision|0
5831429|NCT02431260|20151211|P14|Overall Study|Study Terminated by the Sponsor|0
5831430|NCT02431260|20151212|P13|Overall Study|Study Terminated by the Sponsor|4
5831431|NCT02431260|20151213|P12|Overall Study|Study Terminated by the Sponsor|0
5831432|NCT02431260|20151214|P11|Overall Study|Study Terminated by the Sponsor|1
5831433|NCT02431260|20151215|P10|Overall Study|Study Terminated by the Sponsor|1
5831434|NCT02431260|20151216|P9|Overall Study|Study Terminated by the Sponsor|1
5831435|NCT02431260|20151217|P8|Overall Study|Study Terminated by the Sponsor|2
5831436|NCT02431260|20151218|P7|Overall Study|Study Terminated by the Sponsor|1
5831437|NCT02431260|20151219|P6|Overall Study|Study Terminated by the Sponsor|0
5831438|NCT02431260|20151220|P5|Overall Study|Study Terminated by the Sponsor|1
5831439|NCT02431260|20151221|P4|Overall Study|Study Terminated by the Sponsor|1
5831440|NCT02431260|20151222|P3|Overall Study|Study Terminated by the Sponsor|2
5831441|NCT02431260|20151223|P2|Overall Study|Study Terminated by the Sponsor|0
5831442|NCT02431260|20151224|P1|Overall Study|Study Terminated by the Sponsor|0
5831443|NCT02431260|20151211|P14|Overall Study|Lost to Follow-up|0
5831444|NCT02431260|20151212|P13|Overall Study|Lost to Follow-up|0
5831445|NCT02431260|20151213|P12|Overall Study|Lost to Follow-up|0
5831446|NCT02431260|20151214|P11|Overall Study|Lost to Follow-up|0
5831447|NCT02431260|20151215|P10|Overall Study|Lost to Follow-up|0
5831448|NCT02431260|20151216|P9|Overall Study|Lost to Follow-up|0
5831449|NCT02431260|20151217|P8|Overall Study|Lost to Follow-up|0
5831450|NCT02431260|20151218|P7|Overall Study|Lost to Follow-up|0
5831451|NCT02431260|20151219|P6|Overall Study|Lost to Follow-up|1
5831452|NCT02431260|20151220|P5|Overall Study|Lost to Follow-up|0
5831453|NCT02431260|20151221|P4|Overall Study|Lost to Follow-up|0
5831454|NCT02431260|20151222|P3|Overall Study|Lost to Follow-up|0
5831455|NCT02431260|20151223|P2|Overall Study|Lost to Follow-up|0
5831456|NCT02431260|20151224|P1|Overall Study|Lost to Follow-up|0
5831457|NCT02431260|20151211|P14|Overall Study|Death|1
5831458|NCT02431260|20151212|P13|Overall Study|Death|5
5831459|NCT02431260|20151213|P12|Overall Study|Death|2
5831460|NCT02431260|20151214|P11|Overall Study|Death|3
5831461|NCT02431260|20151215|P10|Overall Study|Death|6
5831462|NCT02431260|20151216|P9|Overall Study|Death|6
5831463|NCT02431260|20151217|P8|Overall Study|Death|1
5831464|NCT02431260|20151218|P7|Overall Study|Death|3
5831465|NCT02431260|20151219|P6|Overall Study|Death|2
5831466|NCT02431260|20151220|P5|Overall Study|Death|2
5831467|NCT02431260|20151221|P4|Overall Study|Death|4
5831468|NCT02431260|20151222|P3|Overall Study|Death|3
5831469|NCT02431260|20151223|P2|Overall Study|Death|4
5831470|NCT02431260|20151224|P1|Overall Study|Death|4
5831471|NCT02431260|20151211|P14|Overall Study|Subject Decision|0
5831472|NCT02431260|20151212|P13|Overall Study|Subject Decision|0
5831473|NCT02431260|20151213|P12|Overall Study|Subject Decision|1
5831474|NCT02431260|20151214|P11|Overall Study|Subject Decision|0
5831475|NCT02431260|20151215|P10|Overall Study|Subject Decision|1
5831476|NCT02431260|20151216|P9|Overall Study|Subject Decision|1
5831477|NCT02431260|20151217|P8|Overall Study|Subject Decision|0
5831478|NCT02431260|20151218|P7|Overall Study|Subject Decision|0
5831479|NCT02431260|20151219|P6|Overall Study|Subject Decision|0
5831480|NCT02431260|20151220|P5|Overall Study|Subject Decision|0
5831481|NCT02431260|20151221|P4|Overall Study|Subject Decision|0
5831482|NCT02431260|20151222|P3|Overall Study|Subject Decision|1
5831483|NCT02431260|20151223|P2|Overall Study|Subject Decision|1
5831484|NCT02431260|20151224|P1|Overall Study|Subject Decision|0
5831485|NCT02431247|20151317|P2|Overall Study|Non-compliance with study drug|0
5831486|NCT02431247|20151318|P1|Overall Study|Non-compliance with study drug|1
5831487|NCT02431247|20151317|P2|Overall Study|Ongoing|336
5831488|NCT02431247|20151318|P1|Overall Study|Ongoing|339
5831489|NCT02431247|20151317|P2|Overall Study|Other|1
5831490|NCT02431247|20151318|P1|Overall Study|Other|2
5831491|NCT02431247|20151317|P2|Overall Study|Withdrawal by Subject|6
5831492|NCT02431247|20151318|P1|Overall Study|Withdrawal by Subject|4
5831493|NCT02431247|20151317|P2|Overall Study|Physician Decision|0
5831494|NCT02431247|20151318|P1|Overall Study|Physician Decision|3
5831495|NCT02431247|20151317|P2|Overall Study|Adverse Event|15
5831496|NCT02431247|20151318|P1|Overall Study|Adverse Event|8
5831497|NCT02431247|20151317|P2|Overall Study|Lost to Follow-up|5
5831498|NCT02431247|20151318|P1|Overall Study|Lost to Follow-up|5
5831499|NCT02430870|20151411|P8|Part 2|Other Reason Not Specified|1
5831500|NCT02430870|20151412|P7|Part 2|Other Reason Not Specified|0
5831501|NCT02430870|20151413|P6|Part 2|Other Reason Not Specified|0
5831502|NCT02430870|20151414|P5|Part 2|Other Reason Not Specified|0
5831503|NCT02430870|20151415|P4|Part 2|Other Reason Not Specified|0
5831504|NCT02430870|20151416|P3|Part 2|Other Reason Not Specified|0
5831505|NCT02430870|20151417|P2|Part 2|Other Reason Not Specified|0
5831506|NCT02430870|20151418|P1|Part 2|Other Reason Not Specified|0
5831507|NCT02430870|20151411|P8|Part 2|Voluntary Withdrawal|0
5831508|NCT02430870|20151412|P7|Part 2|Voluntary Withdrawal|1
5831509|NCT02430870|20151413|P6|Part 2|Voluntary Withdrawal|0
5831510|NCT02430870|20151414|P5|Part 2|Voluntary Withdrawal|0
5831511|NCT02430870|20151415|P4|Part 2|Voluntary Withdrawal|0
5831512|NCT02430870|20151416|P3|Part 2|Voluntary Withdrawal|0
5831513|NCT02430870|20151417|P2|Part 2|Voluntary Withdrawal|0
5831514|NCT02430870|20151418|P1|Part 2|Voluntary Withdrawal|0
5831515|NCT02430532|20151505|P2|Overall Study|Adverse Event|1
5831516|NCT02430532|20151506|P1|Overall Study|Adverse Event|0
5831517|NCT02430532|20151505|P2|Overall Study|Consent Withdrawn|2
5831518|NCT02430532|20151506|P1|Overall Study|Consent Withdrawn|0
5831519|NCT02430532|20151505|P2|Overall Study|Sponsor Decision to Stop Study Early|25
5831520|NCT02430532|20151506|P1|Overall Study|Sponsor Decision to Stop Study Early|30
5831522|NCT02430480|20151520|P1|Overall Study|Anesthesia concerns|1
5831523|NCT02430480|20151520|P1|Overall Study|Death|1
5831524|NCT02430311|20151563|P2|Part B|Death|0
5831525|NCT02430311|20151564|P1|Part B|Death|1
5831526|NCT02430311|20151563|P2|Part B|Adverse Event|0
5831527|NCT02430311|20151564|P1|Part B|Adverse Event|1
5831528|NCT02430311|20151563|P2|Part B|Withdrawal by Subject|2
5831529|NCT02430311|20151564|P1|Part B|Withdrawal by Subject|2
5831530|NCT02430311|20151563|P2|Part B|Meet study-specific withdrawal criteria|6
5831531|NCT02430311|20151564|P1|Part B|Meet study-specific withdrawal criteria|6
5831532|NCT02430311|20151563|P2|Part A|Withdrawal by Subject|0
5831533|NCT02430311|20151564|P1|Part A|Withdrawal by Subject|1
5831534|NCT02430311|20151563|P2|Part A|Adverse Event|1
5831535|NCT02430311|20151564|P1|Part A|Adverse Event|0
5831536|NCT02429856|20151618|P2|Overall Study|Withdrawal by Subject|1
5831537|NCT02429856|20151619|P1|Overall Study|Withdrawal by Subject|1
5831538|NCT02429856|20151618|P2|Overall Study|Lost to Follow-up|5
5831539|NCT02429856|20151619|P1|Overall Study|Lost to Follow-up|6
5831540|NCT02429856|20151618|P2|Overall Study|Death|13
5831541|NCT02429856|20151619|P1|Overall Study|Death|12
5831542|NCT02429791|20151637|P2|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|5
5831543|NCT02429791|20151638|P1|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|7
5831544|NCT02429791|20151637|P2|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3
5831545|NCT02429791|20151638|P1|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3
5831546|NCT02429791|20151637|P2|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|1
5831547|NCT02429791|20151638|P1|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|0
5831548|NCT02429791|20151637|P2|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3
5831549|NCT02429791|20151638|P1|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|4
5831550|NCT02429791|20151637|P2|Late Switch Phase (Week 52 to Week 148)|Physician Decision|4
5831551|NCT02429791|20151638|P1|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0
5831552|NCT02429791|20151637|P2|Late Switch Phase (Week 52 to Week 148)|Adverse Event|12
5831553|NCT02429791|20151638|P1|Late Switch Phase (Week 52 to Week 148)|Adverse Event|11
5831554|NCT02429791|20151637|P2|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7
5831555|NCT02429791|20151638|P1|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|3
5831556|NCT02429791|20151637|P2|Early Switch Phase (Up to Week 52)|Protocol Violation|4
5831557|NCT02429791|20151638|P1|Early Switch Phase (Up to Week 52)|Protocol Violation|1
5831558|NCT02429791|20151637|P2|Early Switch Phase (Up to Week 52)|Lost to Follow-up|2
5831559|NCT02429791|20151638|P1|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1
5831560|NCT02429791|20151637|P2|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1
5831561|NCT02429791|20151638|P1|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2
5831562|NCT02429791|20151637|P2|Early Switch Phase (Up to Week 52)|Physician Decision|2
5831563|NCT02429791|20151638|P1|Early Switch Phase (Up to Week 52)|Physician Decision|0
5831564|NCT02429791|20151637|P2|Early Switch Phase (Up to Week 52)|Adverse Event|2
5831565|NCT02429791|20151638|P1|Early Switch Phase (Up to Week 52)|Adverse Event|6
5831566|NCT02429778|20151726|P2|Overall Study|Withdrawal by Subject|0
5831567|NCT02429778|20151727|P1|Overall Study|Withdrawal by Subject|5
5831568|NCT02429778|20151726|P2|Overall Study|Lost to Follow-up|0
5831569|NCT02429778|20151727|P1|Overall Study|Lost to Follow-up|2
5831570|NCT02429427|20151758|P2|Overall Study|Other|41
5831571|NCT02429427|20151759|P1|Overall Study|Other|62
5831572|NCT02429427|20151758|P2|Overall Study|Withdrawal by Subject|34
5831573|NCT02429427|20151759|P1|Overall Study|Withdrawal by Subject|64
5831574|NCT02429427|20151758|P2|Overall Study|Lost to Follow-up|6
5831575|NCT02429427|20151759|P1|Overall Study|Lost to Follow-up|15
5831576|NCT02429427|20151758|P2|Overall Study|Protocol Violation|6
5831577|NCT02429427|20151759|P1|Overall Study|Protocol Violation|10
5831578|NCT02429427|20151758|P2|Overall Study|Adverse Event|92
5831579|NCT02429427|20151759|P1|Overall Study|Adverse Event|220
5831580|NCT02429310|20151773|P2|Overall Study|Protocol Violation|1
5831581|NCT02429310|20151774|P1|Overall Study|Protocol Violation|1
5831582|NCT02429310|20151773|P2|Overall Study|Lost to Follow-up|2
5831583|NCT02429310|20151774|P1|Overall Study|Lost to Follow-up|1
5831584|NCT02429258|20151784|P2|Overall Study|Protocol Violation|1
5831585|NCT02429258|20151785|P1|Overall Study|Protocol Violation|0
5831586|NCT02429258|20151784|P2|Overall Study|Withdrawal by Subject|0
5831587|NCT02429258|20151785|P1|Overall Study|Withdrawal by Subject|2
5831588|NCT02428855|20151839|P1|Overall Study|Withdrawal by Subject|2
5831589|NCT02428699|20151846|P2|Washout Period 1|Screen Failure|2
5831590|NCT02428699|20151847|P1|Washout Period 1|Screen Failure|1
5831591|NCT02428608|20151875|P1|Overall Study|various|16
5831592|NCT02428608|20151875|P1|Overall Study|Death|1
5831593|NCT02428608|20151875|P1|Overall Study|moved away|10
5831594|NCT02428608|20151875|P1|Overall Study|scheduling conflicts|15
5831595|NCT02428608|20151875|P1|Overall Study|Withdrawal by Subject|2
5831596|NCT02428608|20151875|P1|Overall Study|Lost to Follow-up|37
5831597|NCT02428608|20151875|P1|Overall Study|Pregnancy|2
5831598|NCT02428413|20151907|P2|Overall Study|Nurse Refusal|0
5831599|NCT02428413|20151908|P1|Overall Study|Nurse Refusal|1
5831600|NCT02428413|20151907|P2|Overall Study|Missed Cases|2
5831601|NCT02428413|20151908|P1|Overall Study|Missed Cases|1
5831602|NCT02428413|20151907|P2|Overall Study|Case Cancelled|0
5831603|NCT02428413|20151908|P1|Overall Study|Case Cancelled|2
5831604|NCT02428413|20151907|P2|Overall Study|Protocol Violation|2
5831605|NCT02428413|20151908|P1|Overall Study|Protocol Violation|1
5831606|NCT02428413|20151907|P2|Overall Study|Device to measure WAG malfunctioned|5
5831607|NCT02428413|20151908|P1|Overall Study|Device to measure WAG malfunctioned|3
5831608|NCT02428296|20151943|P1|Overall Study|Withdrawal by Subject|2
5831609|NCT02428296|20151943|P1|Overall Study|Adverse Event|7
5831610|NCT02428231|20151955|P2|Overall Study|Adverse Event|0
5831611|NCT02428231|20151956|P1|Overall Study|Adverse Event|3
5831612|NCT02428231|20151955|P2|Overall Study|Required Symptomatic Therapy|1
5831613|NCT02428231|20151956|P1|Overall Study|Required Symptomatic Therapy|0
5831614|NCT02428231|20151955|P2|Overall Study|Other|16
5831615|NCT02428231|20151956|P1|Overall Study|Other|10
5831616|NCT02427984|20151988|P3|Overall Study|Lost to Follow-up|18
5831617|NCT02427984|20151989|P2|Overall Study|Lost to Follow-up|5
5831618|NCT02427984|20151990|P1|Overall Study|Lost to Follow-up|13
5831619|NCT02427958|20152004|P1|Overall Study|Lack of Efficacy|1
5831620|NCT02427958|20152004|P1|Overall Study|Withdrawal by Subject|14
5831621|NCT02427958|20152004|P1|Overall Study|Lost to Follow-up|6
5831622|NCT02427958|20152004|P1|Overall Study|Pretreatment Event (PTE) or AE|3
5831623|NCT02427841|20152009|P1|Overall Study|Physician Decision|8
5831624|NCT02427646|20152101|P2|Overall Study|Bothersome hand weakness|4
5831625|NCT02427646|20152102|P1|Overall Study|Bothersome hand weakness|2
5831626|NCT02427646|20152101|P2|Overall Study|Protocol Violation|3
5831627|NCT02427646|20152102|P1|Overall Study|Protocol Violation|3
5831628|NCT02427646|20152101|P2|Overall Study|Physician Decision|4
5831629|NCT02427646|20152102|P1|Overall Study|Physician Decision|1
5831630|NCT02427646|20152101|P2|Overall Study|Lack of Efficacy|3
5831631|NCT02427646|20152102|P1|Overall Study|Lack of Efficacy|2
5831632|NCT02427607|20152110|P1|Overall Study|Withdrawal by Subject|1
5831633|NCT02427477|20152116|P2|Period 1|Adverse Event|0
5831634|NCT02427477|20152117|P1|Period 1|Adverse Event|1
5831635|NCT02427399|20152130|P5|Overall Study|Protocol Violation|15
5831636|NCT02427399|20152131|P4|Overall Study|Protocol Violation|18
5831637|NCT02427399|20152132|P3|Overall Study|Protocol Violation|12
5831638|NCT02427399|20152133|P2|Overall Study|Protocol Violation|16
5831639|NCT02427399|20152134|P1|Overall Study|Protocol Violation|14
5831640|NCT02427100|20152158|P2|Overall Study|Lost to Follow-up|2
5831641|NCT02427100|20152159|P1|Overall Study|Lost to Follow-up|0
5831642|NCT02426918|20152170|P3|Overall Study|Other|9
5831643|NCT02426918|20152171|P2|Overall Study|Other|11
5831644|NCT02426918|20152172|P1|Overall Study|Other|9
5831645|NCT02426918|20152170|P3|Overall Study|Withdrawal by Subject|4
5831646|NCT02426918|20152171|P2|Overall Study|Withdrawal by Subject|5
5831647|NCT02426918|20152172|P1|Overall Study|Withdrawal by Subject|5
5831648|NCT02426918|20152170|P3|Overall Study|Physician Decision|1
5831649|NCT02426918|20152171|P2|Overall Study|Physician Decision|1
5831650|NCT02426918|20152172|P1|Overall Study|Physician Decision|1
5831651|NCT02426918|20152170|P3|Overall Study|Adverse Event|0
5831652|NCT02426918|20152171|P2|Overall Study|Adverse Event|2
5831653|NCT02426918|20152172|P1|Overall Study|Adverse Event|2
5831654|NCT02426658|20152207|P1|Overall Study|Patient expired before treatment|2
5831655|NCT02426658|20152207|P1|Overall Study|Withdrawal by Subject|1
5831656|NCT02426580|20152214|P2|Overall Study|Allergic to egg white|0
5831657|NCT02426580|20152215|P1|Overall Study|Allergic to egg white|1
5831658|NCT02426580|20152214|P2|Overall Study|Kidney transplant|0
5831659|NCT02426580|20152215|P1|Overall Study|Kidney transplant|3
5831660|NCT02426580|20152214|P2|Overall Study|transfer to hemodialysis|5
5831661|NCT02426580|20152215|P1|Overall Study|transfer to hemodialysis|5
5831662|NCT02426580|20152214|P2|Overall Study|Lost to Follow-up|9
5831663|NCT02426580|20152215|P1|Overall Study|Lost to Follow-up|0
5831664|NCT02426580|20152214|P2|Overall Study|Death|2
5831665|NCT02426580|20152215|P1|Overall Study|Death|2
5831666|NCT02426541|20152223|P2|Overall Study|Protocol Violation|0
5831667|NCT02426541|20152224|P1|Overall Study|Protocol Violation|1
5831668|NCT02426138|20152236|P2|First Intervention (12 Weeks)|Withdrawal by Subject|1
5831669|NCT02426138|20152237|P1|First Intervention (12 Weeks)|Withdrawal by Subject|1
5831670|NCT02426125|20152277|P2|Overall Study|Withdrawal by Subject|16
5831671|NCT02426125|20152278|P1|Overall Study|Withdrawal by Subject|16
5831672|NCT02426125|20152277|P2|Overall Study|Protocol Violation|0
5831673|NCT02426125|20152278|P1|Overall Study|Protocol Violation|1
5831674|NCT02426125|20152277|P2|Overall Study|Lost to Follow-up|10
5831675|NCT02426125|20152278|P1|Overall Study|Lost to Follow-up|12
5831676|NCT02425826|20152309|P3|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|1
5831677|NCT02425826|20152310|P2|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0
5831678|NCT02425826|20152311|P1|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0
5831679|NCT02425826|20152309|P3|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|1
5831680|NCT02425826|20152310|P2|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|0
5831681|NCT02425826|20152311|P1|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|8
5831682|NCT02425826|20152309|P3|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|4
5831683|NCT02425826|20152310|P2|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|0
5831684|NCT02425826|20152311|P1|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|12
5831685|NCT02425826|20152309|P3|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|6
5831686|NCT02425826|20152310|P2|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|0
5831687|NCT02425826|20152311|P1|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|8
5831688|NCT02425826|20152309|P3|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|2
5831689|NCT02425826|20152310|P2|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|0
5831690|NCT02425826|20152311|P1|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|7
5831691|NCT02425826|20152309|P3|Placebo-controlled Phase (Week 0 - 16)|Other|0
5831692|NCT02425826|20152310|P2|Placebo-controlled Phase (Week 0 - 16)|Other|1
5831693|NCT02425826|20152311|P1|Placebo-controlled Phase (Week 0 - 16)|Other|3
5831694|NCT02425826|20152309|P3|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|0
5831695|NCT02425826|20152310|P2|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|4
5831696|NCT02425826|20152311|P1|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|10
5831697|NCT02425826|20152309|P3|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|0
5831698|NCT02425826|20152310|P2|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|1
5831699|NCT02425826|20152311|P1|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|9
5831700|NCT02425826|20152309|P3|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0
5831701|NCT02425826|20152310|P2|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|1
5831702|NCT02425826|20152311|P1|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0
5831703|NCT02425826|20152309|P3|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|0
5831704|NCT02425826|20152310|P2|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|2
5831705|NCT02425826|20152311|P1|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|5
5831706|NCT02425111|20152365|P1|Part B: Treatment Extension Period|Lack of Efficacy|7
5831707|NCT02425111|20152365|P1|Part B: Treatment Extension Period|Pretreatment Event/Adverse Event(s)|3
5831708|NCT02425111|20152365|P1|Part A: Treatment Period|Lost to Follow-up|2
5831709|NCT02425111|20152365|P1|Part A: Treatment Period|Voluntary Withdrawal|4
5831710|NCT02425111|20152365|P1|Part A: Treatment Period|Lack of Efficacy|15
5831711|NCT02425111|20152365|P1|Part A: Treatment Period|Pretreatment Event/Adverse Event|2
5831712|NCT02425098|20152386|P2|Overall Study|Reason not Specified|1
5831713|NCT02425098|20152387|P1|Overall Study|Reason not Specified|0
5831714|NCT02425098|20152386|P2|Overall Study|Pregnancy|0
5831715|NCT02425098|20152387|P1|Overall Study|Pregnancy|2
5831716|NCT02425098|20152386|P2|Overall Study|Withdrawal by Subject|8
5831717|NCT02425098|20152387|P1|Overall Study|Withdrawal by Subject|4
5831718|NCT02425098|20152386|P2|Overall Study|Lost to Follow-up|7
5831719|NCT02425098|20152387|P1|Overall Study|Lost to Follow-up|7
5831720|NCT02424734|20152539|P3|Overall Study|Treatment stopped to be discharged home|0
5831721|NCT02424734|20152540|P2|Overall Study|Treatment stopped to be discharged home|2
5831722|NCT02424734|20152541|P1|Overall Study|Treatment stopped to be discharged home|2
5831723|NCT02424630|20152560|P2|Overall Study|Open procedure|1
5831724|NCT02424630|20152561|P1|Overall Study|Open procedure|0
5831725|NCT02424630|20152560|P2|Overall Study|No rotator cuff tear|2
5831726|NCT02424630|20152561|P1|Overall Study|No rotator cuff tear|1
5831727|NCT02424591|20152571|P2|Overall Study|Protocol Violation|3
5831728|NCT02424591|20152572|P1|Overall Study|Protocol Violation|2
5831729|NCT02424578|20152584|P2|Overall Study|Withdrawal by Subject|1
5831730|NCT02424578|20152585|P1|Overall Study|Withdrawal by Subject|0
5831731|NCT02424565|20152591|P2|Period 1 (D0)|Protocol Violation|1
5831732|NCT02424565|20152592|P1|Period 1 (D0)|Protocol Violation|0
5831733|NCT02424539|20152601|P3|Overall Study|Other: Reached stopping criteria|6
5831734|NCT02424539|20152602|P2|Overall Study|Other: Reached stopping criteria|7
5831735|NCT02424539|20152603|P1|Overall Study|Other: Reached stopping criteria|11
5831736|NCT02424539|20152601|P3|Overall Study|Withdrawal by Subject|0
5831737|NCT02424539|20152602|P2|Overall Study|Withdrawal by Subject|1
5831738|NCT02424539|20152603|P1|Overall Study|Withdrawal by Subject|3
5831739|NCT02424539|20152601|P3|Overall Study|Physician Decision|1
5831740|NCT02424539|20152602|P2|Overall Study|Physician Decision|0
5831741|NCT02424539|20152603|P1|Overall Study|Physician Decision|0
5831742|NCT02424539|20152601|P3|Overall Study|Adverse Event|1
5831743|NCT02424539|20152602|P2|Overall Study|Adverse Event|0
5831744|NCT02424539|20152603|P1|Overall Study|Adverse Event|0
5831745|NCT02424383|20152686|P1|Overall Study|Ineligible for Major Protocol Deviation|39
5831746|NCT02424383|20152686|P1|Overall Study|Other|7
5831747|NCT02424383|20152686|P1|Overall Study|Lost to Follow-up|81
5831748|NCT02424383|20152686|P1|Overall Study|Investigator's decision|44
5831749|NCT02424383|20152686|P1|Overall Study|Sponsor's decision|3
5831750|NCT02424383|20152686|P1|Overall Study|Death|170
5831751|NCT02424383|20152686|P1|Overall Study|Withdrawal by Subject|32
5831752|NCT02424344|20152710|P2|Overall Study|Adverse Event|8
5831753|NCT02424344|20152711|P1|Overall Study|Adverse Event|4
5831754|NCT02424344|20152710|P2|Overall Study|Lost to Follow-up|0
5831755|NCT02424344|20152711|P1|Overall Study|Lost to Follow-up|1
5831756|NCT02424344|20152710|P2|Overall Study|Withdrawal by Subject|1
5831757|NCT02424344|20152711|P1|Overall Study|Withdrawal by Subject|2
5831758|NCT02424344|20152710|P2|Overall Study|Lack of Efficacy|1
5831759|NCT02424344|20152711|P1|Overall Study|Lack of Efficacy|0
5831760|NCT02424149|20152729|P2|Overall Study|Withdrawal by Subject|1
5831761|NCT02424149|20152730|P1|Overall Study|Withdrawal by Subject|0
5831762|NCT02424149|20152729|P2|Overall Study|surgery cancelled|0
5831763|NCT02424149|20152730|P1|Overall Study|surgery cancelled|2
5831764|NCT02424097|20152746|P2|Overall Study|Lost to Follow-up|2
5831765|NCT02424097|20152747|P1|Overall Study|Lost to Follow-up|1
5831766|NCT02423798|20152802|P1|Overall Study|Withdrawal by Subject|3
5831767|NCT02423291|20152868|P1|Overall Study|Adverse Event|1
5831768|NCT02423291|20152868|P1|Overall Study|Lack of Efficacy|14
5831769|NCT02423109|20152898|P2|Lens 1|Adverse Event|0
5831770|NCT02423109|20152899|P1|Lens 1|Adverse Event|1
5831771|NCT02422797|20152932|P2|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|0
5831772|NCT02422797|20152933|P1|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3
5831773|NCT02422797|20152932|P2|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|0
5831774|NCT02422797|20152933|P1|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|1
5831775|NCT02422797|20152932|P2|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|6
5831776|NCT02422797|20152933|P1|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|2
5831777|NCT02422797|20152932|P2|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2
5831778|NCT02422797|20152933|P1|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2
5831779|NCT02422797|20152932|P2|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3
5831780|NCT02422797|20152933|P1|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|5
5831781|NCT02422797|20152932|P2|Late Switch Phase (Week 52 to Week 148)|Adverse Event|6
5831782|NCT02422797|20152933|P1|Late Switch Phase (Week 52 to Week 148)|Adverse Event|10
5831783|NCT02422797|20152932|P2|Late Switch Phase (Week 52 to Week 148)|Physician Decision|1
5831784|NCT02422797|20152933|P1|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0
5831785|NCT02422797|20152932|P2|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7
5831786|NCT02422797|20152933|P1|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|2
5831787|NCT02422797|20152932|P2|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1
5831788|NCT02422797|20152933|P1|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1
5831789|NCT02422797|20152932|P2|Early Switch Phase (Up to Week 52)|Protocol Violation|3
5831790|NCT02422797|20152933|P1|Early Switch Phase (Up to Week 52)|Protocol Violation|0
5831791|NCT02422797|20152932|P2|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1
5831792|NCT02422797|20152933|P1|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1
5831793|NCT02422797|20152932|P2|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2
5831794|NCT02422797|20152933|P1|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1
5831795|NCT02422797|20152932|P2|Early Switch Phase (Up to Week 52)|Physician Decision|1
5831796|NCT02422797|20152933|P1|Early Switch Phase (Up to Week 52)|Physician Decision|0
5831797|NCT02422797|20152932|P2|Early Switch Phase (Up to Week 52)|Adverse Event|1
5831798|NCT02422797|20152933|P1|Early Switch Phase (Up to Week 52)|Adverse Event|11
5831799|NCT02422615|20153021|P2|Overall Study|Technical problems|1
5831800|NCT02422615|20153022|P1|Overall Study|Technical problems|0
5831801|NCT02422615|20153021|P2|Overall Study|Protocol Violation|1
5831802|NCT02422615|20153022|P1|Overall Study|Protocol Violation|1
5831803|NCT02422615|20153021|P2|Overall Study|Death|0
5831804|NCT02422615|20153022|P1|Overall Study|Death|2
5831805|NCT02422615|20153021|P2|Overall Study|Subject/guardian decision|5
5831806|NCT02422615|20153022|P1|Overall Study|Subject/guardian decision|21
5831807|NCT02422615|20153021|P2|Overall Study|Physician Decision|7
5831808|NCT02422615|20153022|P1|Overall Study|Physician Decision|22
5831809|NCT02422615|20153021|P2|Overall Study|Adverse Event|10
5831810|NCT02422615|20153022|P1|Overall Study|Adverse Event|41
5831811|NCT02422615|20153021|P2|Overall Study|Progressive disease|142
5831812|NCT02422615|20153022|P1|Overall Study|Progressive disease|193
5831813|NCT02422303|20153039|P2|Overall Study|Lost to Follow-up|1
5831814|NCT02422303|20153040|P1|Overall Study|Lost to Follow-up|1
5831815|NCT02422264|20153055|P2|Overall Study|Subject vaccinated outside of the study|1
5831816|NCT02422264|20153056|P1|Overall Study|Subject vaccinated outside of the study|0
5831817|NCT02422264|20153055|P2|Overall Study|Migrated/moved from study area|1
5831818|NCT02422264|20153056|P1|Overall Study|Migrated/moved from study area|3
5831819|NCT02422264|20153055|P2|Overall Study|Withdrawal by Subject|2
5831820|NCT02422264|20153056|P1|Overall Study|Withdrawal by Subject|1
5831821|NCT02422264|20153055|P2|Overall Study|Serious Adverse Event|0
5831822|NCT02422264|20153056|P1|Overall Study|Serious Adverse Event|1
5831823|NCT02422186|20153102|P2|Follow-up Phase (2 Weeks)|Other|0
5831824|NCT02422186|20153103|P1|Follow-up Phase (2 Weeks)|Other|3
5831825|NCT02422186|20153102|P2|Follow-up Phase (2 Weeks)|Withdrawal by Subject|0
5831826|NCT02422186|20153103|P1|Follow-up Phase (2 Weeks)|Withdrawal by Subject|1
5831827|NCT02422186|20153102|P2|Double-blind Induction Phase (4 Weeks)|Other|0
5831828|NCT02422186|20153103|P1|Double-blind Induction Phase (4 Weeks)|Other|1
5831829|NCT02422186|20153102|P2|Double-blind Induction Phase (4 Weeks)|Adverse Event|2
5831830|NCT02422186|20153103|P1|Double-blind Induction Phase (4 Weeks)|Adverse Event|4
5831831|NCT02422186|20153102|P2|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1
5831832|NCT02422186|20153103|P1|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|3
5831833|NCT02422186|20153102|P2|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|2
5831834|NCT02422186|20153103|P1|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1
5831835|NCT02422186|20153102|P2|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1
5831836|NCT02422186|20153103|P1|Double-blind Induction Phase (4 Weeks)|Protocol Violation|0
5831837|NCT02422186|20153102|P2|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0
5831838|NCT02422186|20153103|P1|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1
5831839|NCT02421952|20153125|P1|Overall Study|Surgery cancelled|1
5831840|NCT02421952|20153125|P1|Overall Study|Subject uncooperative for baseline test|2
5831841|NCT02421952|20153125|P1|Overall Study|Failed seriation task|13
5831842|NCT02421952|20153125|P1|Overall Study|Diary Not Returned|93
5831843|NCT02421939|20153134|P2|Overall Study|Protocol deviation|1
5831844|NCT02421939|20153135|P1|Overall Study|Protocol deviation|1
5831845|NCT02421939|20153134|P2|Overall Study|Miscellaneous|5
5831846|NCT02421939|20153135|P1|Overall Study|Miscellaneous|4
5831847|NCT02421939|20153134|P2|Overall Study|Completed 1 or 2 chemo cycles with CRs|19
5831848|NCT02421939|20153135|P1|Overall Study|Completed 1 or 2 chemo cycles with CRs|0
5831849|NCT02421939|20153134|P2|Overall Study|Physician Decision|11
5831850|NCT02421939|20153135|P1|Overall Study|Physician Decision|11
5831851|NCT02421939|20153134|P2|Overall Study|Withdrawal by Subject|24
5831852|NCT02421939|20153135|P1|Overall Study|Withdrawal by Subject|5
5831853|NCT02421939|20153134|P2|Overall Study|Adverse Event|5
5831854|NCT02421939|20153135|P1|Overall Study|Adverse Event|28
5831855|NCT02421939|20153134|P2|Overall Study|Disease relapse|2
5831856|NCT02421939|20153135|P1|Overall Study|Disease relapse|33
5831857|NCT02421939|20153134|P2|Overall Study|Death|10
5831858|NCT02421939|20153135|P1|Overall Study|Death|36
5831859|NCT02421939|20153134|P2|Overall Study|Lack of Efficacy|31
5831860|NCT02421939|20153135|P1|Overall Study|Lack of Efficacy|21
5831861|NCT02421939|20153134|P2|Overall Study|Progressive disease|16
5831862|NCT02421939|20153135|P1|Overall Study|Progressive disease|70
5831863|NCT02421887|20153163|P2|Overall Study|Adverse Event|0
5831864|NCT02421887|20153164|P1|Overall Study|Adverse Event|2
5831865|NCT02421887|20153163|P2|Overall Study|Physician Decision|4
5831866|NCT02421887|20153164|P1|Overall Study|Physician Decision|2
5831867|NCT02421887|20153163|P2|Overall Study|Withdrawal by Subject|5
5831868|NCT02421887|20153164|P1|Overall Study|Withdrawal by Subject|8
5831869|NCT02421887|20153163|P2|Overall Study|Lost to Follow-up|0
5831870|NCT02421887|20153164|P1|Overall Study|Lost to Follow-up|5
5831871|NCT02421666|20153190|P2|12-month Follow-up|Withdrawal by Subject|11
5831872|NCT02421666|20153191|P1|12-month Follow-up|Withdrawal by Subject|6
5831873|NCT02421666|20153190|P2|12-month Follow-up|Lost to Follow-up|5
5831874|NCT02421666|20153191|P1|12-month Follow-up|Lost to Follow-up|5
5831875|NCT02421666|20153190|P2|6-month Follow-up|Withdrawal by Subject|6
5831876|NCT02421666|20153191|P1|6-month Follow-up|Withdrawal by Subject|5
5831877|NCT02421666|20153190|P2|6-month Follow-up|Lost to Follow-up|7
5831878|NCT02421666|20153191|P1|6-month Follow-up|Lost to Follow-up|8
5831879|NCT02421588|20153199|P2|Overall Study|Not treated|8
5831880|NCT02421588|20153200|P1|Overall Study|Not treated|2
5831881|NCT02421588|20153199|P2|Overall Study|Withdrawal by Subject|16
5831882|NCT02421588|20153200|P1|Overall Study|Withdrawal by Subject|14
5831883|NCT02421588|20153199|P2|Overall Study|Treatment-related AE|14
5831884|NCT02421588|20153200|P1|Overall Study|Treatment-related AE|10
5831885|NCT02421588|20153199|P2|Overall Study|Symptomatic deterioration|19
5831886|NCT02421588|20153200|P1|Overall Study|Symptomatic deterioration|13
5831887|NCT02421588|20153199|P2|Overall Study|Other reason not specified|1
5831888|NCT02421588|20153200|P1|Overall Study|Other reason not specified|3
5831889|NCT02421588|20153199|P2|Overall Study|Physician Decision|17
5831890|NCT02421588|20153200|P1|Overall Study|Physician Decision|8
5831891|NCT02421588|20153199|P2|Overall Study|Death|3
5831892|NCT02421588|20153200|P1|Overall Study|Death|11
5831893|NCT02421588|20153199|P2|Overall Study|Progressive disease|135
5831894|NCT02421588|20153200|P1|Overall Study|Progressive disease|152
5831895|NCT02421588|20153199|P2|Overall Study|Non-treatment-related AE|8
5831896|NCT02421588|20153200|P1|Overall Study|Non-treatment-related AE|8
5831897|NCT02421510|20153223|P3|Overall Study|Lost to Follow-up|0
5831898|NCT02421510|20153224|P2|Overall Study|Lost to Follow-up|1
5831899|NCT02421510|20153225|P1|Overall Study|Lost to Follow-up|1
5831900|NCT02421510|20153223|P3|Overall Study|Withdrawal by Subject|12
5831901|NCT02421510|20153224|P2|Overall Study|Withdrawal by Subject|18
5831902|NCT02421510|20153225|P1|Overall Study|Withdrawal by Subject|14
5831903|NCT02421510|20153223|P3|Overall Study|Pregnancy|0
5831904|NCT02421510|20153224|P2|Overall Study|Pregnancy|1
5831905|NCT02421510|20153225|P1|Overall Study|Pregnancy|1
5831906|NCT02421510|20153223|P3|Overall Study|Adverse Event|18
5831907|NCT02421510|20153224|P2|Overall Study|Adverse Event|10
5831908|NCT02421510|20153225|P1|Overall Study|Adverse Event|9
5831909|NCT02421510|20153223|P3|Overall Study|Physician Decision|3
5831910|NCT02421510|20153224|P2|Overall Study|Physician Decision|1
5831911|NCT02421510|20153225|P1|Overall Study|Physician Decision|1
5831912|NCT02421510|20153223|P3|Overall Study|Noncompliance with study drug|0
5831913|NCT02421510|20153224|P2|Overall Study|Noncompliance with study drug|0
5831914|NCT02421510|20153225|P1|Overall Study|Noncompliance with study drug|1
5831915|NCT02421510|20153223|P3|Overall Study|Death|0
5831916|NCT02421510|20153224|P2|Overall Study|Death|0
5831917|NCT02421510|20153225|P1|Overall Study|Death|1
5831918|NCT02421510|20153223|P3|Overall Study|Protocol Violation|0
5831919|NCT02421510|20153224|P2|Overall Study|Protocol Violation|2
5831920|NCT02421510|20153225|P1|Overall Study|Protocol Violation|1
5831921|NCT02421510|20153223|P3|Overall Study|Other|3
5831922|NCT02421510|20153224|P2|Overall Study|Other|2
5831923|NCT02421510|20153225|P1|Overall Study|Other|4
5831924|NCT02421419|20153257|P3|Overall Study|Physician Decision|1
5831925|NCT02421419|20153258|P2|Overall Study|Physician Decision|0
5831926|NCT02421419|20153259|P1|Overall Study|Physician Decision|0
5831927|NCT02421172|20153393|P5|Period 2|Patient/guardian decision|1
5831928|NCT02421172|20153394|P4|Period 2|Patient/guardian decision|2
5831929|NCT02421172|20153395|P3|Period 2|Patient/guardian decision|3
5831930|NCT02421172|20153396|P2|Period 2|Patient/guardian decision|0
5831931|NCT02421172|20153397|P1|Period 2|Patient/guardian decision|0
5831932|NCT02421172|20153393|P5|Period 2|Lost to Follow-up|0
5831933|NCT02421172|20153394|P4|Period 2|Lost to Follow-up|1
5831934|NCT02421172|20153395|P3|Period 2|Lost to Follow-up|0
5831935|NCT02421172|20153396|P2|Period 2|Lost to Follow-up|0
5831936|NCT02421172|20153397|P1|Period 2|Lost to Follow-up|0
5831937|NCT02421172|20153393|P5|Period 2|Adverse Event|0
5831938|NCT02421172|20153394|P4|Period 2|Adverse Event|0
5831939|NCT02421172|20153395|P3|Period 2|Adverse Event|4
5831940|NCT02421172|20153396|P2|Period 2|Adverse Event|0
5831941|NCT02421172|20153397|P1|Period 2|Adverse Event|0
5831942|NCT02421172|20153393|P5|Period 1|Patient/guardian decision|0
5831943|NCT02421172|20153394|P4|Period 1|Patient/guardian decision|0
5831944|NCT02421172|20153395|P3|Period 1|Patient/guardian decision|0
5831945|NCT02421172|20153396|P2|Period 1|Patient/guardian decision|1
5831946|NCT02421172|20153397|P1|Period 1|Patient/guardian decision|0
5831947|NCT02421172|20153393|P5|Period 1|Lost to Follow-up|0
5831948|NCT02421172|20153394|P4|Period 1|Lost to Follow-up|0
5831949|NCT02421172|20153395|P3|Period 1|Lost to Follow-up|0
5831950|NCT02421172|20153396|P2|Period 1|Lost to Follow-up|1
5831951|NCT02421172|20153397|P1|Period 1|Lost to Follow-up|3
5831952|NCT02421172|20153393|P5|Period 1|Adverse Event|0
5831953|NCT02421172|20153394|P4|Period 1|Adverse Event|0
5831954|NCT02421172|20153395|P3|Period 1|Adverse Event|0
5831955|NCT02421172|20153396|P2|Period 1|Adverse Event|0
5831956|NCT02421172|20153397|P1|Period 1|Adverse Event|1
5831957|NCT02421120|20153441|P1|Overall Study|Adverse Event|1
5831968|NCT02420691|20153594|P1|Overall Study|Withdrawal by Subject|3
5831969|NCT02420691|20153594|P1|Overall Study|Adverse Event|3
5831970|NCT02420379|20153604|P2|Overall Study|Transitioned to commercial drug|0
5831971|NCT02420379|20153605|P1|Overall Study|Transitioned to commercial drug|1
5831972|NCT02420379|20153604|P2|Overall Study|Unable to complete due to schooling|1
5831973|NCT02420379|20153605|P1|Overall Study|Unable to complete due to schooling|0
5831974|NCT02420379|20153604|P2|Overall Study|Withdrawal by Subject|3
5831975|NCT02420379|20153605|P1|Overall Study|Withdrawal by Subject|0
5831976|NCT02420353|20153625|P2|Overall Study|Withdrawal by Subject|1
5831977|NCT02420353|20153626|P1|Overall Study|Withdrawal by Subject|0
5831978|NCT02420327|20153718|P1|Overall Study|Protocol Violation|1
5831979|NCT02420327|20153718|P1|Overall Study|Lost to Follow-up|1
5831980|NCT02420327|20153718|P1|Overall Study|Withdrawal by Subject|6
5831981|NCT02420327|20153718|P1|Overall Study|Pregnancy|1
5831982|NCT02420327|20153718|P1|Overall Study|Adverse Event|7
5831983|NCT02420262|20153754|P2|Overall Study|Unclassified|1
5831984|NCT02420262|20153755|P1|Overall Study|Unclassified|0
5831985|NCT02420262|20153754|P2|Overall Study|Withdrawal by Subject|4
5831986|NCT02420262|20153755|P1|Overall Study|Withdrawal by Subject|1
5831987|NCT02420262|20153754|P2|Overall Study|Adverse Event|0
5831988|NCT02420262|20153755|P1|Overall Study|Adverse Event|1
5831989|NCT02420093|20153781|P2|Overall Study|Withdrawal by Subject|1
5831990|NCT02420093|20153782|P1|Overall Study|Withdrawal by Subject|1
5831991|NCT02419937|20153844|P2|Overall Study|Lost to Follow-up|0
5831992|NCT02419937|20153845|P1|Overall Study|Lost to Follow-up|1
5831993|NCT02419807|20153858|P1|Overall Study|Protocol Violation|5
5831994|NCT02419807|20153858|P1|Overall Study|Physician Decision|1
5831995|NCT02419807|20153858|P1|Overall Study|Withdrawal by Subject|4
5831996|NCT02419755|20153864|P2|Overall Study|Withdrawal by Subject|0
5831997|NCT02419755|20153865|P1|Overall Study|Withdrawal by Subject|1
5831998|NCT02419755|20153864|P2|Overall Study|Ineligible|0
5831999|NCT02419755|20153865|P1|Overall Study|Ineligible|1
5832000|NCT02419755|20153864|P2|Overall Study|Relapse|1
5832001|NCT02419755|20153865|P1|Overall Study|Relapse|0
5832002|NCT02419755|20153864|P2|Overall Study|Death|3
5832003|NCT02419755|20153865|P1|Overall Study|Death|1
5832004|NCT02419612|20153906|P2|Long-term Treatment Period|Withdrawal by Subject|2
5832005|NCT02419612|20153907|P1|Long-term Treatment Period|Withdrawal by Subject|8
5832006|NCT02419612|20153906|P2|Long-term Treatment Period|Subject Decision|4
5832007|NCT02419612|20153907|P1|Long-term Treatment Period|Subject Decision|2
5832008|NCT02419612|20153906|P2|Long-term Treatment Period|Other|4
5832009|NCT02419612|20153907|P1|Long-term Treatment Period|Other|4
5832010|NCT02419612|20153906|P2|Long-term Treatment Period|Adverse Event|5
5832011|NCT02419612|20153907|P1|Long-term Treatment Period|Adverse Event|0
5832012|NCT02419612|20153906|P2|Long-term Treatment Period|Death|1
5832013|NCT02419612|20153907|P1|Long-term Treatment Period|Death|0
5832014|NCT02419612|20153906|P2|Long-term Treatment Period|Lack of Efficacy|1
5832015|NCT02419612|20153907|P1|Long-term Treatment Period|Lack of Efficacy|1
5832016|NCT02419612|20153906|P2|Long-term Treatment Period|Lost to Follow-up|4
5832017|NCT02419612|20153907|P1|Long-term Treatment Period|Lost to Follow-up|6
5832018|NCT02419612|20153906|P2|Long-term Treatment Period|Non-compliance with Study Drug|1
5832019|NCT02419612|20153907|P1|Long-term Treatment Period|Non-compliance with Study Drug|1
5832020|NCT02419612|20153906|P2|Short-term Treatment Period|Subject moved out of state|1
5832021|NCT02419612|20153907|P1|Short-term Treatment Period|Subject moved out of state|0
5832022|NCT02419612|20153906|P2|Short-term Treatment Period|Worsening of liver function|1
5832023|NCT02419612|20153907|P1|Short-term Treatment Period|Worsening of liver function|0
5832024|NCT02419612|20153906|P2|Short-term Treatment Period|Non-compliance with Study Drug|2
5832025|NCT02419612|20153907|P1|Short-term Treatment Period|Non-compliance with Study Drug|0
5832026|NCT02419612|20153906|P2|Short-term Treatment Period|Subject Request To Discontinue Treatment|1
5832027|NCT02419612|20153907|P1|Short-term Treatment Period|Subject Request To Discontinue Treatment|1
5832028|NCT02419612|20153906|P2|Short-term Treatment Period|Withdrawal by Subject|9
5832029|NCT02419612|20153907|P1|Short-term Treatment Period|Withdrawal by Subject|9
5832030|NCT02419612|20153906|P2|Short-term Treatment Period|Lost to Follow-up|6
5832031|NCT02419612|20153907|P1|Short-term Treatment Period|Lost to Follow-up|6
5832032|NCT02419612|20153906|P2|Short-term Treatment Period|Death|2
5832033|NCT02419612|20153907|P1|Short-term Treatment Period|Death|0
5832034|NCT02419612|20153906|P2|Short-term Treatment Period|Adverse Event|1
5832035|NCT02419612|20153907|P1|Short-term Treatment Period|Adverse Event|1
5832036|NCT02419573|20153929|P2|Overall Study|Withdrawal by Subject|0
5832037|NCT02419573|20153930|P1|Overall Study|Withdrawal by Subject|1
5832038|NCT02419573|20153929|P2|Overall Study|Lost to Follow-up|0
5832039|NCT02419573|20153930|P1|Overall Study|Lost to Follow-up|3
5832040|NCT02419508|20153960|P2|Overall Study|Other - Reason not specified|1
5832041|NCT02419508|20153961|P1|Overall Study|Other - Reason not specified|0
5832042|NCT02419508|20153960|P2|Overall Study|Withdrawal by Subject|0
5832043|NCT02419508|20153961|P1|Overall Study|Withdrawal by Subject|1
5832044|NCT02419508|20153960|P2|Overall Study|Adverse Event|3
5832045|NCT02419508|20153961|P1|Overall Study|Adverse Event|9
5832046|NCT02419469|20153979|P1|Overall Study|Withdrawal by Subject|1
5832047|NCT02419313|20153983|P2|Second Intervention|Lost to Follow-up|0
5832048|NCT02419313|20153984|P1|Second Intervention|Lost to Follow-up|1
5832049|NCT02419313|20153983|P2|First Intervention|Lost to Follow-up|0
5832050|NCT02419313|20153984|P1|First Intervention|Lost to Follow-up|2
5832051|NCT02419001|20153996|P2|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|0
5832052|NCT02419001|20153997|P1|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|1
5832053|NCT02418910|20154007|P1|Overall Study|Withdrawal by Subject|4
5832054|NCT02418910|20154007|P1|Overall Study|Lost to Follow-up|3
5832055|NCT02418819|20154015|P4|Overall Study|No longer willing to participate|1
5832056|NCT02418819|20154016|P3|Overall Study|No longer willing to participate|2
5832057|NCT02418819|20154017|P2|Overall Study|No longer willing to participate|0
5832058|NCT02418819|20154018|P1|Overall Study|No longer willing to participate|0
5832059|NCT02418819|20154015|P4|Overall Study|No longer meets eligibility criteria|0
5832060|NCT02418819|20154016|P3|Overall Study|No longer meets eligibility criteria|1
5832061|NCT02418819|20154017|P2|Overall Study|No longer meets eligibility criteria|0
5832062|NCT02418819|20154018|P1|Overall Study|No longer meets eligibility criteria|0
5832063|NCT02418819|20154015|P4|Overall Study|Lost to Follow-up|0
5832064|NCT02418819|20154016|P3|Overall Study|Lost to Follow-up|0
5832065|NCT02418819|20154017|P2|Overall Study|Lost to Follow-up|0
5832066|NCT02418819|20154018|P1|Overall Study|Lost to Follow-up|1
5832067|NCT02418819|20154015|P4|Overall Study|Adverse Event|0
5832068|NCT02418819|20154016|P3|Overall Study|Adverse Event|1
5832069|NCT02418819|20154017|P2|Overall Study|Adverse Event|0
5832070|NCT02418819|20154018|P1|Overall Study|Adverse Event|0
5832071|NCT02418754|20154061|P5|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0
5832072|NCT02418754|20154062|P4|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|1
5832073|NCT02418754|20154063|P3|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0
5832074|NCT02418754|20154064|P2|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|1
5832075|NCT02418754|20154065|P1|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0
5832076|NCT02418754|20154061|P5|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|1
5832077|NCT02418754|20154062|P4|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|2
5832078|NCT02418754|20154063|P3|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|1
5832079|NCT02418754|20154064|P2|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|2
5832080|NCT02418754|20154065|P1|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|0
5832081|NCT02418754|20154061|P5|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|0
5832082|NCT02418754|20154062|P4|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|1
5832083|NCT02418754|20154063|P3|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|4
5832084|NCT02418754|20154064|P2|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|4
5832085|NCT02418754|20154065|P1|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|3
5832086|NCT02418754|20154061|P5|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|24
5832087|NCT02418754|20154062|P4|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|21
5832088|NCT02418754|20154063|P3|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|26
5832089|NCT02418754|20154064|P2|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|28
5832090|NCT02418754|20154065|P1|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|26
5832091|NCT02418754|20154061|P5|Period 2 (Day 1 to Week 52/End of Study)|Death|0
5832092|NCT02418754|20154062|P4|Period 2 (Day 1 to Week 52/End of Study)|Death|0
5832093|NCT02418754|20154063|P3|Period 2 (Day 1 to Week 52/End of Study)|Death|0
5832094|NCT02418754|20154064|P2|Period 2 (Day 1 to Week 52/End of Study)|Death|0
5832095|NCT02418754|20154065|P1|Period 2 (Day 1 to Week 52/End of Study)|Death|1
5832096|NCT02418754|20154061|P5|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|2
5832097|NCT02418754|20154062|P4|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|2
5832098|NCT02418754|20154063|P3|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|6
5832099|NCT02418754|20154064|P2|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|7
5832100|NCT02418754|20154065|P1|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|3
5832101|NCT02418754|20154061|P5|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0
5832102|NCT02418754|20154062|P4|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0
5832103|NCT02418754|20154063|P3|Period 1 (Day 1 to Week 12)|Lost to Follow-up|1
5832104|NCT02418754|20154064|P2|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0
5832105|NCT02418754|20154065|P1|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0
5832106|NCT02418754|20154061|P5|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0
5832107|NCT02418754|20154062|P4|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0
5832108|NCT02418754|20154063|P3|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|1
5832109|NCT02418754|20154064|P2|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|2
5832110|NCT02418754|20154065|P1|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0
5832111|NCT02418754|20154061|P5|Period 1 (Day 1 to Week 12)|Physician Decision|0
5832112|NCT02418754|20154062|P4|Period 1 (Day 1 to Week 12)|Physician Decision|0
5832113|NCT02418754|20154063|P3|Period 1 (Day 1 to Week 12)|Physician Decision|0
5832114|NCT02418754|20154064|P2|Period 1 (Day 1 to Week 12)|Physician Decision|0
5832115|NCT02418754|20154065|P1|Period 1 (Day 1 to Week 12)|Physician Decision|1
5832116|NCT02418754|20154061|P5|Period 1 (Day 1 to Week 12)|Death|0
5832117|NCT02418754|20154062|P4|Period 1 (Day 1 to Week 12)|Death|0
5832118|NCT02418754|20154063|P3|Period 1 (Day 1 to Week 12)|Death|0
5832119|NCT02418754|20154064|P2|Period 1 (Day 1 to Week 12)|Death|0
5832120|NCT02418754|20154065|P1|Period 1 (Day 1 to Week 12)|Death|1
5832121|NCT02418754|20154061|P5|Period 1 (Day 1 to Week 12)|Adverse Event|0
5832122|NCT02418754|20154062|P4|Period 1 (Day 1 to Week 12)|Adverse Event|0
5832123|NCT02418754|20154063|P3|Period 1 (Day 1 to Week 12)|Adverse Event|0
5832124|NCT02418754|20154064|P2|Period 1 (Day 1 to Week 12)|Adverse Event|2
5832125|NCT02418754|20154065|P1|Period 1 (Day 1 to Week 12)|Adverse Event|0
5832126|NCT02418585|20154114|P2|Follow-up Phase (24 Weeks)|Other|2
5832127|NCT02418585|20154115|P1|Follow-up Phase (24 Weeks)|Other|3
5832128|NCT02418585|20154114|P2|Follow-up Phase (24 Weeks)|Investigator Decision|17
5832129|NCT02418585|20154115|P1|Follow-up Phase (24 Weeks)|Investigator Decision|6
5832130|NCT02418585|20154114|P2|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3
5832131|NCT02418585|20154115|P1|Follow-up Phase (24 Weeks)|Withdrawal by Subject|6
5832132|NCT02418585|20154114|P2|Follow-up Phase (24 Weeks)|Lost to Follow-up|3
5832133|NCT02418585|20154115|P1|Follow-up Phase (24 Weeks)|Lost to Follow-up|3
5832134|NCT02418585|20154114|P2|Double Blind (DB) Phase (4 Weeks)|Other|1
5832135|NCT02418585|20154115|P1|Double Blind (DB) Phase (4 Weeks)|Other|0
5832136|NCT02418585|20154114|P2|Double Blind (DB) Phase (4 Weeks)|Adverse Event|1
5832137|NCT02418585|20154115|P1|Double Blind (DB) Phase (4 Weeks)|Adverse Event|9
5832138|NCT02418585|20154114|P2|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|0
5832139|NCT02418585|20154115|P1|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|2
5832140|NCT02418585|20154114|P2|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|7
5832141|NCT02418585|20154115|P1|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|4
5832142|NCT02418585|20154114|P2|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2
5832143|NCT02418585|20154115|P1|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2
5832144|NCT02418585|20154114|P2|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1
5832145|NCT02418585|20154115|P1|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1
5832146|NCT02418468|20154171|P2|Overall Study|Withdrawal of informed consent|1
5832147|NCT02418468|20154172|P1|Overall Study|Withdrawal of informed consent|1
5832148|NCT02418468|20154171|P2|Overall Study|Adverse Event|0
5832149|NCT02418468|20154172|P1|Overall Study|Adverse Event|1
5832150|NCT02418455|20154178|P1|Continuation Period|Sponsor Decision|7
5832151|NCT02418455|20154178|P1|48-Week Treatment Period|Other- Not Specified|1
5832152|NCT02418182|20154221|P2|Overall Study|Lost to Follow-up|2
5832153|NCT02418182|20154222|P1|Overall Study|Lost to Follow-up|0
5832154|NCT02418182|20154221|P2|Overall Study|Unable to re-consent|15
5832155|NCT02418182|20154222|P1|Overall Study|Unable to re-consent|18
5832156|NCT02418156|20154234|P1|Overall Study|Subject refused to return|1
5832157|NCT02418156|20154234|P1|Overall Study|Withdrawal by Subject|1
5832158|NCT02418156|20154234|P1|Overall Study|Physician Decision|1
5832159|NCT02418156|20154234|P1|Overall Study|Death|2
5832160|NCT02418156|20154234|P1|Overall Study|Lost to Follow-up|12
5832161|NCT02418000|20154276|P5|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|3
5832162|NCT02418000|20154277|P4|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0
5832163|NCT02418000|20154278|P3|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0
5832164|NCT02418000|20154279|P2|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0
5832165|NCT02418000|20154280|P1|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0
5832166|NCT02418000|20154276|P5|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|1
5832167|NCT02418000|20154277|P4|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0
5832168|NCT02418000|20154278|P3|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0
5832169|NCT02418000|20154279|P2|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0
5832170|NCT02418000|20154280|P1|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0
5832171|NCT02418000|20154276|P5|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0
5832172|NCT02418000|20154277|P4|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|3
5832173|NCT02418000|20154278|P3|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0
5832174|NCT02418000|20154279|P2|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0
5832175|NCT02418000|20154280|P1|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0
5832176|NCT02418000|20154276|P5|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0
5832177|NCT02418000|20154277|P4|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0
5832178|NCT02418000|20154278|P3|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|3
5832179|NCT02418000|20154279|P2|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0
5832180|NCT02418000|20154280|P1|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0
5832181|NCT02418000|20154276|P5|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0
5832182|NCT02418000|20154277|P4|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0
5832183|NCT02418000|20154278|P3|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0
5832184|NCT02418000|20154279|P2|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|9
5832185|NCT02418000|20154280|P1|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0
5832266|NCT02417064|20154622|P2|Double-blind Induction Phase (4 Weeks)|Other|4
5832186|NCT02418000|20154276|P5|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0
5832187|NCT02418000|20154277|P4|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0
5832188|NCT02418000|20154278|P3|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0
5832189|NCT02418000|20154279|P2|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|1
5832190|NCT02418000|20154280|P1|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0
5832191|NCT02418000|20154276|P5|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0
5832192|NCT02418000|20154277|P4|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0
5832193|NCT02418000|20154278|P3|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0
5832194|NCT02418000|20154279|P2|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0
5832195|NCT02418000|20154280|P1|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|1
5832196|NCT02418000|20154276|P5|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0
5832197|NCT02418000|20154277|P4|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0
5832198|NCT02418000|20154278|P3|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0
5832199|NCT02418000|20154279|P2|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0
5832200|NCT02418000|20154280|P1|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|4
5832201|NCT02418000|20154276|P5|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0
5832202|NCT02418000|20154277|P4|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0
5832203|NCT02418000|20154278|P3|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0
5832204|NCT02418000|20154279|P2|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0
5832205|NCT02418000|20154280|P1|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|2
5832206|NCT02417961|20154398|P1|Overall Study|Withdrawal by Subject|2
5832207|NCT02417961|20154398|P1|Overall Study|Lost to Follow-up|1
5832208|NCT02417961|20154398|P1|Overall Study|Adverse Event|1
5832209|NCT02417935|20154410|P2|Treatment Period|Physician Decision|1
5832210|NCT02417935|20154411|P1|Treatment Period|Physician Decision|3
5832211|NCT02417935|20154410|P2|Treatment Period|Withdrawal by Subject|3
5832212|NCT02417935|20154411|P1|Treatment Period|Withdrawal by Subject|3
5832213|NCT02417935|20154410|P2|Treatment Period|Protocol Violation|1
5832214|NCT02417935|20154411|P1|Treatment Period|Protocol Violation|2
5832215|NCT02417935|20154410|P2|Treatment Period|Entry Criteria not met|1
5832216|NCT02417935|20154411|P1|Treatment Period|Entry Criteria not met|0
5832217|NCT02417935|20154410|P2|Treatment Period|Lost to Follow-up|0
5832218|NCT02417935|20154411|P1|Treatment Period|Lost to Follow-up|1
5832219|NCT02417935|20154410|P2|Treatment Period|Adverse Event|10
5832220|NCT02417935|20154411|P1|Treatment Period|Adverse Event|12
5832221|NCT02417753|20154469|P1|Overall Study|Death|1
5832222|NCT02417441|20154489|P2|Overall Study|Inconclusive due to missing data|19
5832223|NCT02417441|20154490|P1|Overall Study|Inconclusive due to missing data|52
5832224|NCT02417246|20154558|P2|Phase 2 1st Generic Administered|Physician Decision|0
5832225|NCT02417246|20154559|P1|Phase 2 1st Generic Administered|Physician Decision|1
5832226|NCT02417246|20154558|P2|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|3
5832227|NCT02417246|20154559|P1|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|2
5832228|NCT02417246|20154558|P2|Phase 1 Brand Name Metoprolol ER|Physician Decision|0
5832229|NCT02417246|20154559|P1|Phase 1 Brand Name Metoprolol ER|Physician Decision|1
5832230|NCT02417246|20154558|P2|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1
5832231|NCT02417246|20154559|P1|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1
5832232|NCT02417233|20154582|P3|Overall Study|Mentally unstable|0
5832233|NCT02417233|20154583|P2|Overall Study|Mentally unstable|1
5832234|NCT02417233|20154584|P1|Overall Study|Mentally unstable|0
5832235|NCT02417233|20154582|P3|Overall Study|Relocation out of study area|1
5832236|NCT02417233|20154583|P2|Overall Study|Relocation out of study area|0
5832237|NCT02417233|20154584|P1|Overall Study|Relocation out of study area|1
5832238|NCT02417233|20154582|P3|Overall Study|Withdrawal by Subject|8
5832239|NCT02417233|20154583|P2|Overall Study|Withdrawal by Subject|1
5832240|NCT02417233|20154584|P1|Overall Study|Withdrawal by Subject|2
5832241|NCT02417233|20154582|P3|Overall Study|Protocol Violation|2
5832242|NCT02417233|20154583|P2|Overall Study|Protocol Violation|0
5832243|NCT02417233|20154584|P1|Overall Study|Protocol Violation|2
5832244|NCT02417233|20154582|P3|Overall Study|Lost to Follow-up|34
5832245|NCT02417233|20154583|P2|Overall Study|Lost to Follow-up|39
5832246|NCT02417233|20154584|P1|Overall Study|Lost to Follow-up|27
5832247|NCT02417233|20154582|P3|Overall Study|Death|14
5832248|NCT02417233|20154583|P2|Overall Study|Death|10
5832249|NCT02417233|20154584|P1|Overall Study|Death|4
5832250|NCT02417064|20154621|P3|Follow-up Phase (24 Weeks)|Other|3
5832251|NCT02417064|20154622|P2|Follow-up Phase (24 Weeks)|Other|2
5832252|NCT02417064|20154623|P1|Follow-up Phase (24 Weeks)|Other|2
5832253|NCT02417064|20154621|P3|Follow-up Phase (24 Weeks)|PI Decision|44
5832254|NCT02417064|20154622|P2|Follow-up Phase (24 Weeks)|PI Decision|29
5832255|NCT02417064|20154623|P1|Follow-up Phase (24 Weeks)|PI Decision|34
5832256|NCT02417064|20154621|P3|Follow-up Phase (24 Weeks)|Withdrawal by Subject|2
5832257|NCT02417064|20154622|P2|Follow-up Phase (24 Weeks)|Withdrawal by Subject|9
5832258|NCT02417064|20154623|P1|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3
5832259|NCT02417064|20154621|P3|Follow-up Phase (24 Weeks)|Protocol Violation|1
5832260|NCT02417064|20154622|P2|Follow-up Phase (24 Weeks)|Protocol Violation|0
5832261|NCT02417064|20154623|P1|Follow-up Phase (24 Weeks)|Protocol Violation|0
5832262|NCT02417064|20154621|P3|Follow-up Phase (24 Weeks)|Lost to Follow-up|1
5832263|NCT02417064|20154622|P2|Follow-up Phase (24 Weeks)|Lost to Follow-up|2
5832264|NCT02417064|20154623|P1|Follow-up Phase (24 Weeks)|Lost to Follow-up|0
5832265|NCT02417064|20154621|P3|Double-blind Induction Phase (4 Weeks)|Other|2
5832267|NCT02417064|20154623|P1|Double-blind Induction Phase (4 Weeks)|Other|1
5832268|NCT02417064|20154621|P3|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1
5832269|NCT02417064|20154622|P2|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|5
5832270|NCT02417064|20154623|P1|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1
5832271|NCT02417064|20154621|P3|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1
5832272|NCT02417064|20154622|P2|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1
5832273|NCT02417064|20154623|P1|Double-blind Induction Phase (4 Weeks)|Protocol Violation|2
5832274|NCT02417064|20154621|P3|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0
5832275|NCT02417064|20154622|P2|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1
5832276|NCT02417064|20154623|P1|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0
5832277|NCT02417064|20154621|P3|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|0
5832278|NCT02417064|20154622|P2|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1
5832279|NCT02417064|20154623|P1|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1
5832280|NCT02417064|20154621|P3|Double-blind Induction Phase (4 Weeks)|Adverse Event|2
5832281|NCT02417064|20154622|P2|Double-blind Induction Phase (4 Weeks)|Adverse Event|7
5832282|NCT02417064|20154623|P1|Double-blind Induction Phase (4 Weeks)|Adverse Event|1
5832283|NCT02416934|20154694|P2|Overall Study|re-operation|0
5832284|NCT02416934|20154695|P1|Overall Study|re-operation|1
5832285|NCT02416934|20154694|P2|Overall Study|surgery started late|1
5832286|NCT02416934|20154695|P1|Overall Study|surgery started late|0
5832287|NCT02416934|20154694|P2|Overall Study|Protocol Violation|1
5832288|NCT02416934|20154695|P1|Overall Study|Protocol Violation|0
5832289|NCT02416934|20154694|P2|Overall Study|recruited during continuing renewal proc|1
5832290|NCT02416934|20154695|P1|Overall Study|recruited during continuing renewal proc|0
5832291|NCT02416934|20154694|P2|Overall Study|Withdrawal by Subject|0
5832292|NCT02416934|20154695|P1|Overall Study|Withdrawal by Subject|1
5832293|NCT02416934|20154694|P2|Overall Study|Lost to Follow-up|2
5832294|NCT02416934|20154695|P1|Overall Study|Lost to Follow-up|0
5832295|NCT02416934|20154694|P2|Overall Study|given steroids|2
5832296|NCT02416934|20154695|P1|Overall Study|given steroids|1
5832297|NCT02416908|20154710|P4|Dose Escalation Phase|Withdrawal by Subject|0
5832298|NCT02416908|20154711|P3|Dose Escalation Phase|Withdrawal by Subject|1
5832299|NCT02416908|20154712|P2|Dose Escalation Phase|Withdrawal by Subject|0
5832300|NCT02416908|20154713|P1|Dose Escalation Phase|Withdrawal by Subject|0
5832301|NCT02416908|20154710|P4|Dose Escalation Phase|Adverse Event|0
5832302|NCT02416908|20154711|P3|Dose Escalation Phase|Adverse Event|3
5832303|NCT02416908|20154712|P2|Dose Escalation Phase|Adverse Event|0
5832304|NCT02416908|20154713|P1|Dose Escalation Phase|Adverse Event|0
5832305|NCT02416791|20154731|P3|6 Months|Lost to Follow-up|1
5832306|NCT02416791|20154732|P2|6 Months|Lost to Follow-up|0
5832307|NCT02416791|20154733|P1|6 Months|Lost to Follow-up|0
5832308|NCT02416180|20154831|P1|Overall Study|Withdrawal by Subject|1
5832309|NCT02415959|20154892|P5|Overall Study|Protocol Violation|0
5832310|NCT02415959|20154893|P4|Overall Study|Protocol Violation|1
5832311|NCT02415959|20154894|P3|Overall Study|Protocol Violation|0
5832312|NCT02415959|20154895|P2|Overall Study|Protocol Violation|0
5832313|NCT02415959|20154896|P1|Overall Study|Protocol Violation|0
5832314|NCT02415959|20154892|P5|Overall Study|Adverse Event|0
5832315|NCT02415959|20154893|P4|Overall Study|Adverse Event|0
5832316|NCT02415959|20154894|P3|Overall Study|Adverse Event|0
5832317|NCT02415959|20154895|P2|Overall Study|Adverse Event|1
5832318|NCT02415959|20154896|P1|Overall Study|Adverse Event|0
5832319|NCT02415595|20155342|P4|Overall Study|Other|0
5832320|NCT02415595|20155343|P3|Overall Study|Other|1
5832321|NCT02415595|20155344|P2|Overall Study|Other|1
5832322|NCT02415595|20155345|P1|Overall Study|Other|0
5832323|NCT02415595|20155342|P4|Overall Study|Withdrawal by Subject|3
5832324|NCT02415595|20155343|P3|Overall Study|Withdrawal by Subject|1
5832325|NCT02415595|20155344|P2|Overall Study|Withdrawal by Subject|0
5832326|NCT02415595|20155345|P1|Overall Study|Withdrawal by Subject|4
5832327|NCT02415595|20155342|P4|Overall Study|Reached stopping criteria|0
5832328|NCT02415595|20155343|P3|Overall Study|Reached stopping criteria|1
5832329|NCT02415595|20155344|P2|Overall Study|Reached stopping criteria|1
5832330|NCT02415595|20155345|P1|Overall Study|Reached stopping criteria|0
5832331|NCT02415595|20155342|P4|Overall Study|Poor/Non-compliance|0
5832332|NCT02415595|20155343|P3|Overall Study|Poor/Non-compliance|1
5832333|NCT02415595|20155344|P2|Overall Study|Poor/Non-compliance|0
5832334|NCT02415595|20155345|P1|Overall Study|Poor/Non-compliance|1
5832335|NCT02415595|20155342|P4|Overall Study|Lost to Follow-up|1
5832336|NCT02415595|20155343|P3|Overall Study|Lost to Follow-up|1
5832337|NCT02415595|20155344|P2|Overall Study|Lost to Follow-up|3
5832338|NCT02415595|20155345|P1|Overall Study|Lost to Follow-up|1
5832339|NCT02415595|20155342|P4|Overall Study|Lack of Efficacy|0
5832340|NCT02415595|20155343|P3|Overall Study|Lack of Efficacy|0
5832341|NCT02415595|20155344|P2|Overall Study|Lack of Efficacy|4
5832342|NCT02415595|20155345|P1|Overall Study|Lack of Efficacy|4
5832343|NCT02415595|20155342|P4|Overall Study|Adverse Event|10
5832344|NCT02415595|20155343|P3|Overall Study|Adverse Event|5
5832345|NCT02415595|20155344|P2|Overall Study|Adverse Event|3
5832346|NCT02415595|20155345|P1|Overall Study|Adverse Event|1
5832347|NCT02415595|20155342|P4|Overall Study|Administrative reason by sponsor|39
5832348|NCT02415595|20155343|P3|Overall Study|Administrative reason by sponsor|41
5832349|NCT02415595|20155344|P2|Overall Study|Administrative reason by sponsor|40
5832350|NCT02415595|20155345|P1|Overall Study|Administrative reason by sponsor|39
5832434|NCT02414958|20155576|P3|Overall Study|Protocol Violation|1
5832351|NCT02415400|20155487|P4|Overall Study|Site closure; participant won't transfer|1
5832352|NCT02415400|20155488|P3|Overall Study|Site closure; participant won't transfer|0
5832353|NCT02415400|20155489|P2|Overall Study|Site closure; participant won't transfer|0
5832354|NCT02415400|20155490|P1|Overall Study|Site closure; participant won't transfer|0
5832355|NCT02415400|20155487|P4|Overall Study|Investigator decision|1
5832356|NCT02415400|20155488|P3|Overall Study|Investigator decision|1
5832357|NCT02415400|20155489|P2|Overall Study|Investigator decision|0
5832358|NCT02415400|20155490|P1|Overall Study|Investigator decision|0
5832359|NCT02415400|20155487|P4|Overall Study|Participant in jail|0
5832360|NCT02415400|20155488|P3|Overall Study|Participant in jail|1
5832361|NCT02415400|20155489|P2|Overall Study|Participant in jail|0
5832362|NCT02415400|20155490|P1|Overall Study|Participant in jail|0
5832363|NCT02415400|20155487|P4|Overall Study|Poor treatment monitoring|0
5832364|NCT02415400|20155488|P3|Overall Study|Poor treatment monitoring|1
5832365|NCT02415400|20155489|P2|Overall Study|Poor treatment monitoring|0
5832366|NCT02415400|20155490|P1|Overall Study|Poor treatment monitoring|0
5832367|NCT02415400|20155487|P4|Overall Study|State regulations prevent participation|0
5832368|NCT02415400|20155488|P3|Overall Study|State regulations prevent participation|1
5832369|NCT02415400|20155489|P2|Overall Study|State regulations prevent participation|0
5832370|NCT02415400|20155490|P1|Overall Study|State regulations prevent participation|0
5832371|NCT02415400|20155487|P4|Overall Study|Coagulation values cannot be set|0
5832372|NCT02415400|20155488|P3|Overall Study|Coagulation values cannot be set|1
5832373|NCT02415400|20155489|P2|Overall Study|Coagulation values cannot be set|0
5832374|NCT02415400|20155490|P1|Overall Study|Coagulation values cannot be set|0
5832375|NCT02415400|20155487|P4|Overall Study|Stroke and stroke rehabilitation|0
5832376|NCT02415400|20155488|P3|Overall Study|Stroke and stroke rehabilitation|1
5832377|NCT02415400|20155489|P2|Overall Study|Stroke and stroke rehabilitation|0
5832378|NCT02415400|20155490|P1|Overall Study|Stroke and stroke rehabilitation|0
5832379|NCT02415400|20155487|P4|Overall Study|No study drug on site|0
5832380|NCT02415400|20155488|P3|Overall Study|No study drug on site|0
5832381|NCT02415400|20155489|P2|Overall Study|No study drug on site|1
5832382|NCT02415400|20155490|P1|Overall Study|No study drug on site|0
5832383|NCT02415400|20155487|P4|Overall Study|Randomized in error|0
5832384|NCT02415400|20155488|P3|Overall Study|Randomized in error|0
5832385|NCT02415400|20155489|P2|Overall Study|Randomized in error|0
5832386|NCT02415400|20155490|P1|Overall Study|Randomized in error|2
5832387|NCT02415400|20155487|P4|Overall Study|Participant wanted home visits|0
5832388|NCT02415400|20155488|P3|Overall Study|Participant wanted home visits|0
5832389|NCT02415400|20155489|P2|Overall Study|Participant wanted home visits|0
5832390|NCT02415400|20155490|P1|Overall Study|Participant wanted home visits|1
5832391|NCT02415400|20155487|P4|Overall Study|Participant doesn't answer phone|0
5832392|NCT02415400|20155488|P3|Overall Study|Participant doesn't answer phone|0
5832393|NCT02415400|20155489|P2|Overall Study|Participant doesn't answer phone|0
5832394|NCT02415400|20155490|P1|Overall Study|Participant doesn't answer phone|1
5832395|NCT02415400|20155487|P4|Overall Study|Participant no longer meets criteria|1
5832396|NCT02415400|20155488|P3|Overall Study|Participant no longer meets criteria|0
5832397|NCT02415400|20155489|P2|Overall Study|Participant no longer meets criteria|0
5832398|NCT02415400|20155490|P1|Overall Study|Participant no longer meets criteria|2
5832399|NCT02415400|20155487|P4|Overall Study|Poor/Non-Compliance|4
5832400|NCT02415400|20155488|P3|Overall Study|Poor/Non-Compliance|3
5832401|NCT02415400|20155489|P2|Overall Study|Poor/Non-Compliance|1
5832402|NCT02415400|20155490|P1|Overall Study|Poor/Non-Compliance|0
5832403|NCT02415400|20155487|P4|Overall Study|Lost to Follow-up|5
5832404|NCT02415400|20155488|P3|Overall Study|Lost to Follow-up|2
5832405|NCT02415400|20155489|P2|Overall Study|Lost to Follow-up|3
5832406|NCT02415400|20155490|P1|Overall Study|Lost to Follow-up|3
5832407|NCT02415400|20155487|P4|Overall Study|Death|42
5832408|NCT02415400|20155488|P3|Overall Study|Death|35
5832409|NCT02415400|20155489|P2|Overall Study|Death|41
5832410|NCT02415400|20155490|P1|Overall Study|Death|39
5832411|NCT02415400|20155487|P4|Overall Study|Participant withdrew consent|21
5832412|NCT02415400|20155488|P3|Overall Study|Participant withdrew consent|30
5832413|NCT02415400|20155489|P2|Overall Study|Participant withdrew consent|12
5832414|NCT02415400|20155490|P1|Overall Study|Participant withdrew consent|14
5832415|NCT02415400|20155487|P4|Overall Study|Participant request to stop therapy|6
5832416|NCT02415400|20155488|P3|Overall Study|Participant request to stop therapy|8
5832417|NCT02415400|20155489|P2|Overall Study|Participant request to stop therapy|3
5832418|NCT02415400|20155490|P1|Overall Study|Participant request to stop therapy|4
5832419|NCT02415400|20155487|P4|Overall Study|Adverse Event|2
5832420|NCT02415400|20155488|P3|Overall Study|Adverse Event|1
5832421|NCT02415400|20155489|P2|Overall Study|Adverse Event|1
5832422|NCT02415400|20155490|P1|Overall Study|Adverse Event|0
5832423|NCT02415127|20155558|P2|Overall Study|Adverse Event|0
5832424|NCT02415127|20155559|P1|Overall Study|Adverse Event|1
5832425|NCT02414958|20155576|P3|Overall Study|Other than specified|5
5832426|NCT02414958|20155577|P2|Overall Study|Other than specified|4
5832427|NCT02414958|20155578|P1|Overall Study|Other than specified|4
5832428|NCT02414958|20155576|P3|Overall Study|Withdrawal by Subject|5
5832429|NCT02414958|20155577|P2|Overall Study|Withdrawal by Subject|3
5832430|NCT02414958|20155578|P1|Overall Study|Withdrawal by Subject|5
5832431|NCT02414958|20155576|P3|Overall Study|Lost to Follow-up|0
5832432|NCT02414958|20155577|P2|Overall Study|Lost to Follow-up|4
5832433|NCT02414958|20155578|P1|Overall Study|Lost to Follow-up|7
5832435|NCT02414958|20155577|P2|Overall Study|Protocol Violation|3
5832436|NCT02414958|20155578|P1|Overall Study|Protocol Violation|10
5832437|NCT02414958|20155576|P3|Overall Study|Adverse Event|3
5832438|NCT02414958|20155577|P2|Overall Study|Adverse Event|6
5832439|NCT02414958|20155578|P1|Overall Study|Adverse Event|6
5832440|NCT02414854|20155611|P4|Overall Study|Other than specified above|37
5832441|NCT02414854|20155612|P3|Overall Study|Other than specified above|17
5832442|NCT02414854|20155613|P2|Overall Study|Other than specified above|37
5832443|NCT02414854|20155614|P1|Overall Study|Other than specified above|12
5832444|NCT02414854|20155611|P4|Overall Study|Poor compliance to protocol|2
5832445|NCT02414854|20155612|P3|Overall Study|Poor compliance to protocol|2
5832446|NCT02414854|20155613|P2|Overall Study|Poor compliance to protocol|1
5832447|NCT02414854|20155614|P1|Overall Study|Poor compliance to protocol|1
5832448|NCT02414854|20155611|P4|Overall Study|Adverse Event|12
5832449|NCT02414854|20155612|P3|Overall Study|Adverse Event|1
5832450|NCT02414854|20155613|P2|Overall Study|Adverse Event|7
5832451|NCT02414854|20155614|P1|Overall Study|Adverse Event|9
5832452|NCT02414841|20155778|P2|Overall Study|Randomized But Not Treated|4
5832453|NCT02414841|20155779|P1|Overall Study|Randomized But Not Treated|6
5832454|NCT02414841|20155778|P2|Overall Study|Received a Kidney Transplant|4
5832455|NCT02414841|20155779|P1|Overall Study|Received a Kidney Transplant|13
5832456|NCT02414841|20155778|P2|Overall Study|Death|14
5832457|NCT02414841|20155779|P1|Overall Study|Death|17
5832458|NCT02414841|20155778|P2|Overall Study|Lost to Follow-up|6
5832459|NCT02414841|20155779|P1|Overall Study|Lost to Follow-up|13
5832460|NCT02414841|20155778|P2|Overall Study|Withdrawal by Subject|5
5832461|NCT02414841|20155779|P1|Overall Study|Withdrawal by Subject|7
5832462|NCT02414828|20155791|P4|Overall Study|Lost to Follow-up|2
5832463|NCT02414828|20155792|P3|Overall Study|Lost to Follow-up|1
5832464|NCT02414828|20155793|P2|Overall Study|Lost to Follow-up|1
5832465|NCT02414828|20155794|P1|Overall Study|Lost to Follow-up|0
5832466|NCT02414152|20155887|P1|Overall Study|Lack of Efficacy|1
5832467|NCT02414152|20155887|P1|Overall Study|Withdrawal by Subject|1
5832468|NCT02413996|20155893|P2|Overall Study|not comfortable with the intervention|2
5832469|NCT02413996|20155894|P1|Overall Study|not comfortable with the intervention|9
5832470|NCT02413593|20155939|P1|Overall Study|Adverse Event|1
5832471|NCT02413593|20155939|P1|Overall Study|Lost to Follow-up|3
5832472|NCT02413489|20155958|P3|Overall Study|Study Terminated By Sponsor|1
5832473|NCT02413489|20155959|P2|Overall Study|Study Terminated By Sponsor|13
5832474|NCT02413489|20155960|P1|Overall Study|Study Terminated By Sponsor|2
5832475|NCT02413489|20155958|P3|Overall Study|Withdrawal by Subject|0
5832476|NCT02413489|20155959|P2|Overall Study|Withdrawal by Subject|0
5832477|NCT02413489|20155960|P1|Overall Study|Withdrawal by Subject|2
5832478|NCT02413489|20155958|P3|Overall Study|Death|4
5832479|NCT02413489|20155959|P2|Overall Study|Death|3
5832480|NCT02413489|20155960|P1|Overall Study|Death|11
5832481|NCT02413398|20156001|P2|Overall Study|Other Eligibility criteria|2
5832482|NCT02413398|20156002|P1|Overall Study|Other Eligibility criteria|1
5832483|NCT02413398|20156001|P2|Overall Study|Withdrawal by Subject|1
5832484|NCT02413398|20156002|P1|Overall Study|Withdrawal by Subject|1
5832485|NCT02413398|20156001|P2|Overall Study|Lost to Follow-up|4
5832486|NCT02413398|20156002|P1|Overall Study|Lost to Follow-up|2
5832502|NCT02413346|20156068|P2|Overall Study|Other Miscellaneous Reasons|3
5832503|NCT02413346|20156069|P1|Overall Study|Other Miscellaneous Reasons|4
5832504|NCT02413346|20156068|P2|Overall Study|Protocol Violation|0
5832505|NCT02413346|20156069|P1|Overall Study|Protocol Violation|2
5832506|NCT02413346|20156068|P2|Overall Study|Lost to Follow-up|21
5832507|NCT02413346|20156069|P1|Overall Study|Lost to Follow-up|17
5832508|NCT02413346|20156068|P2|Overall Study|Withdrawal by Subject|40
5832509|NCT02413346|20156069|P1|Overall Study|Withdrawal by Subject|30
5832510|NCT02413346|20156068|P2|Overall Study|Adverse Event|6
5832511|NCT02413346|20156069|P1|Overall Study|Adverse Event|6
5832512|NCT02413333|20156079|P2|Period 2|Protocol Deviation|0
5832513|NCT02413333|20156080|P1|Period 2|Protocol Deviation|1
5832514|NCT02413333|20156079|P2|Period 1|Reason Not Specified|1
5832515|NCT02413333|20156080|P1|Period 1|Reason Not Specified|0
5832516|NCT02413333|20156079|P2|Period 1|Adverse Event|0
5832517|NCT02413333|20156080|P1|Period 1|Adverse Event|1
5832518|NCT02413294|20156088|P1|Overall Study|Withdrawal by Subject|1
5832519|NCT02413255|20156123|P17|Overall Study|Voluntary Withdrawal|0
5832520|NCT02413255|20156124|P16|Overall Study|Voluntary Withdrawal|0
5832521|NCT02413255|20156125|P15|Overall Study|Voluntary Withdrawal|1
5832522|NCT02413255|20156126|P14|Overall Study|Voluntary Withdrawal|0
5832523|NCT02413255|20156127|P13|Overall Study|Voluntary Withdrawal|0
5832524|NCT02413255|20156128|P12|Overall Study|Voluntary Withdrawal|0
5832525|NCT02413255|20156129|P11|Overall Study|Voluntary Withdrawal|0
5832526|NCT02413255|20156130|P10|Overall Study|Voluntary Withdrawal|0
5832527|NCT02413255|20156131|P9|Overall Study|Voluntary Withdrawal|0
5832528|NCT02413255|20156132|P8|Overall Study|Voluntary Withdrawal|0
5832529|NCT02413255|20156133|P7|Overall Study|Voluntary Withdrawal|0
5832530|NCT02413255|20156134|P6|Overall Study|Voluntary Withdrawal|0
5832531|NCT02413255|20156135|P5|Overall Study|Voluntary Withdrawal|0
5832532|NCT02413255|20156136|P4|Overall Study|Voluntary Withdrawal|0
5832533|NCT02413255|20156137|P3|Overall Study|Voluntary Withdrawal|0
5832534|NCT02413255|20156138|P2|Overall Study|Voluntary Withdrawal|0
5832535|NCT02413255|20156139|P1|Overall Study|Voluntary Withdrawal|0
5832536|NCT02413229|20156495|P8|Overall Study|Progressive Disease|1
5832537|NCT02413229|20156496|P7|Overall Study|Progressive Disease|0
5832538|NCT02413229|20156497|P6|Overall Study|Progressive Disease|0
5832539|NCT02413229|20156498|P5|Overall Study|Progressive Disease|0
5832540|NCT02413229|20156499|P4|Overall Study|Progressive Disease|0
5832541|NCT02413229|20156500|P3|Overall Study|Progressive Disease|0
5832542|NCT02413229|20156501|P2|Overall Study|Progressive Disease|0
5832543|NCT02413229|20156502|P1|Overall Study|Progressive Disease|0
5832544|NCT02413229|20156495|P8|Overall Study|Withdrawal by Subject|2
5832545|NCT02413229|20156496|P7|Overall Study|Withdrawal by Subject|0
5832546|NCT02413229|20156497|P6|Overall Study|Withdrawal by Subject|0
5832547|NCT02413229|20156498|P5|Overall Study|Withdrawal by Subject|1
5832548|NCT02413229|20156499|P4|Overall Study|Withdrawal by Subject|0
5832549|NCT02413229|20156500|P3|Overall Study|Withdrawal by Subject|0
5832550|NCT02413229|20156501|P2|Overall Study|Withdrawal by Subject|1
5832551|NCT02413229|20156502|P1|Overall Study|Withdrawal by Subject|1
5832552|NCT02413229|20156495|P8|Overall Study|Lost to Follow-up|0
5832553|NCT02413229|20156496|P7|Overall Study|Lost to Follow-up|0
5832554|NCT02413229|20156497|P6|Overall Study|Lost to Follow-up|0
5832555|NCT02413229|20156498|P5|Overall Study|Lost to Follow-up|2
5832556|NCT02413229|20156499|P4|Overall Study|Lost to Follow-up|0
5832557|NCT02413229|20156500|P3|Overall Study|Lost to Follow-up|1
5832558|NCT02413229|20156501|P2|Overall Study|Lost to Follow-up|0
5832559|NCT02413229|20156502|P1|Overall Study|Lost to Follow-up|0
5832560|NCT02413229|20156495|P8|Overall Study|Adverse Event|1
5832561|NCT02413229|20156496|P7|Overall Study|Adverse Event|0
5832562|NCT02413229|20156497|P6|Overall Study|Adverse Event|0
5832563|NCT02413229|20156498|P5|Overall Study|Adverse Event|0
5832564|NCT02413229|20156499|P4|Overall Study|Adverse Event|1
5832565|NCT02413229|20156500|P3|Overall Study|Adverse Event|0
5832566|NCT02413229|20156501|P2|Overall Study|Adverse Event|0
5832567|NCT02413229|20156502|P1|Overall Study|Adverse Event|0
5832568|NCT02412878|20156641|P2|Overall Study|Lost to Follow-up|3
5832569|NCT02412878|20156642|P1|Overall Study|Lost to Follow-up|2
5832570|NCT02412878|20156641|P2|Overall Study|Withdrawal by Subject|10
5832571|NCT02412878|20156642|P1|Overall Study|Withdrawal by Subject|19
5832572|NCT02412852|20156660|P4|Overall Study|Physician Decision|1
5832573|NCT02412852|20156661|P3|Overall Study|Physician Decision|0
5832574|NCT02412852|20156662|P2|Overall Study|Physician Decision|0
5832575|NCT02412852|20156663|P1|Overall Study|Physician Decision|0
5832576|NCT02412852|20156660|P4|Overall Study|Withdrawal by Subject|0
5832577|NCT02412852|20156661|P3|Overall Study|Withdrawal by Subject|0
5832578|NCT02412852|20156662|P2|Overall Study|Withdrawal by Subject|1
5832579|NCT02412852|20156663|P1|Overall Study|Withdrawal by Subject|0
5832580|NCT02412761|20156689|P6|First Intervention (2 Weeks)|Withdrawal by Subject|1
5832581|NCT02412761|20156690|P5|First Intervention (2 Weeks)|Withdrawal by Subject|0
5832582|NCT02412761|20156691|P4|First Intervention (2 Weeks)|Withdrawal by Subject|0
5832583|NCT02412761|20156692|P3|First Intervention (2 Weeks)|Withdrawal by Subject|1
5832584|NCT02412761|20156693|P2|First Intervention (2 Weeks)|Withdrawal by Subject|1
5832585|NCT02412761|20156694|P1|First Intervention (2 Weeks)|Withdrawal by Subject|0
5832586|NCT02412722|20156708|P6|Overall Study|Reason not Specified|6
5832587|NCT02412722|20156709|P5|Overall Study|Reason not Specified|2
5832588|NCT02412722|20156710|P4|Overall Study|Reason not Specified|1
5832589|NCT02412722|20156711|P3|Overall Study|Reason not Specified|2
5832590|NCT02412722|20156712|P2|Overall Study|Reason not Specified|0
5832591|NCT02412722|20156713|P1|Overall Study|Reason not Specified|3
5832592|NCT02412722|20156708|P6|Overall Study|Received drug in run-in and discontinued|0
5832593|NCT02412722|20156709|P5|Overall Study|Received drug in run-in and discontinued|0
5832594|NCT02412722|20156710|P4|Overall Study|Received drug in run-in and discontinued|0
5832595|NCT02412722|20156711|P3|Overall Study|Received drug in run-in and discontinued|0
5832596|NCT02412722|20156712|P2|Overall Study|Received drug in run-in and discontinued|2
5832597|NCT02412722|20156713|P1|Overall Study|Received drug in run-in and discontinued|0
5832598|NCT02412722|20156708|P6|Overall Study|Lost to Follow-up|0
5832599|NCT02412722|20156709|P5|Overall Study|Lost to Follow-up|1
5832600|NCT02412722|20156710|P4|Overall Study|Lost to Follow-up|0
5832601|NCT02412722|20156711|P3|Overall Study|Lost to Follow-up|0
5832602|NCT02412722|20156712|P2|Overall Study|Lost to Follow-up|0
5832603|NCT02412722|20156713|P1|Overall Study|Lost to Follow-up|0
5832604|NCT02412722|20156708|P6|Overall Study|Withdrawal by Subject|1
5832605|NCT02412722|20156709|P5|Overall Study|Withdrawal by Subject|1
5832606|NCT02412722|20156710|P4|Overall Study|Withdrawal by Subject|2
5832607|NCT02412722|20156711|P3|Overall Study|Withdrawal by Subject|1
5832608|NCT02412722|20156712|P2|Overall Study|Withdrawal by Subject|0
5832609|NCT02412722|20156713|P1|Overall Study|Withdrawal by Subject|2
5832610|NCT02412722|20156708|P6|Overall Study|Progressive Disease|3
5832611|NCT02412722|20156709|P5|Overall Study|Progressive Disease|3
5832612|NCT02412722|20156710|P4|Overall Study|Progressive Disease|9
5832613|NCT02412722|20156711|P3|Overall Study|Progressive Disease|4
5832614|NCT02412722|20156712|P2|Overall Study|Progressive Disease|4
5832615|NCT02412722|20156713|P1|Overall Study|Progressive Disease|6
5832616|NCT02412722|20156708|P6|Overall Study|Adverse Event|3
5832617|NCT02412722|20156709|P5|Overall Study|Adverse Event|0
5832618|NCT02412722|20156710|P4|Overall Study|Adverse Event|3
5832619|NCT02412722|20156711|P3|Overall Study|Adverse Event|0
5832620|NCT02412722|20156712|P2|Overall Study|Adverse Event|2
5832621|NCT02412722|20156713|P1|Overall Study|Adverse Event|0
5832622|NCT02412670|20156783|P2|Overall Study|Ineligible|0
5832623|NCT02412670|20156784|P1|Overall Study|Ineligible|1
5832624|NCT02412670|20156783|P2|Overall Study|Withdrawal by Subject|0
5832625|NCT02412670|20156784|P1|Overall Study|Withdrawal by Subject|1
5832626|NCT02412670|20156783|P2|Overall Study|Physician Decision|0
5832627|NCT02412670|20156784|P1|Overall Study|Physician Decision|1
5832628|NCT02412670|20156783|P2|Overall Study|Adverse Event|1
5832629|NCT02412670|20156784|P1|Overall Study|Adverse Event|4
5832630|NCT02412657|20156805|P3|Overall Study|Protocol Violation|3
5832631|NCT02412657|20156806|P2|Overall Study|Protocol Violation|2
5832632|NCT02412657|20156807|P1|Overall Study|Protocol Violation|0
5832633|NCT02412657|20156805|P3|Overall Study|Lost to Follow-up|0
5832634|NCT02412657|20156806|P2|Overall Study|Lost to Follow-up|0
5832635|NCT02412657|20156807|P1|Overall Study|Lost to Follow-up|1
5832636|NCT02412488|20156851|P1|Overall Study|Reveal LINQ explant|1
5832637|NCT02412488|20156851|P1|Overall Study|No Reveal LINQ Insertion Attempt|1
5832638|NCT02412488|20156851|P1|Overall Study|Physician Decision|1
5832639|NCT02412488|20156851|P1|Overall Study|Withdrawal by Subject|5
5832640|NCT02412488|20156851|P1|Overall Study|Lost to Follow-up|10
5832641|NCT02412436|20156855|P1|Overall Study|Not Willing to Adhere to Requirements|1
5832642|NCT02412436|20156855|P1|Overall Study|Death|1
5832643|NCT02412436|20156855|P1|Overall Study|Unable to get to clinic|3
5832644|NCT02412436|20156855|P1|Overall Study|Lost to Follow-up|6
5832645|NCT02412436|20156855|P1|Overall Study|Protocol-mandated Discontinuation|7
5832646|NCT02412371|20156875|P6|Overall Study|Other|3
5832647|NCT02412371|20156876|P5|Overall Study|Other|1
5832648|NCT02412371|20156877|P4|Overall Study|Other|0
5832649|NCT02412371|20156878|P3|Overall Study|Other|0
5832650|NCT02412371|20156879|P2|Overall Study|Other|1
5832651|NCT02412371|20156880|P1|Overall Study|Other|2
5832652|NCT02412371|20156875|P6|Overall Study|Death|2
5832653|NCT02412371|20156876|P5|Overall Study|Death|5
5832654|NCT02412371|20156877|P4|Overall Study|Death|3
5832655|NCT02412371|20156878|P3|Overall Study|Death|1
5832656|NCT02412371|20156879|P2|Overall Study|Death|2
5832657|NCT02412371|20156880|P1|Overall Study|Death|4
5832658|NCT02412371|20156875|P6|Overall Study|Sponsor Discontinued Study|0
5832659|NCT02412371|20156876|P5|Overall Study|Sponsor Discontinued Study|5
5832660|NCT02412371|20156877|P4|Overall Study|Sponsor Discontinued Study|4
5832661|NCT02412371|20156878|P3|Overall Study|Sponsor Discontinued Study|6
5832662|NCT02412371|20156879|P2|Overall Study|Sponsor Discontinued Study|4
5832663|NCT02412371|20156880|P1|Overall Study|Sponsor Discontinued Study|1
5832664|NCT02412371|20156875|P6|Overall Study|Withdrawal by Subject|0
5832665|NCT02412371|20156876|P5|Overall Study|Withdrawal by Subject|1
5832666|NCT02412371|20156877|P4|Overall Study|Withdrawal by Subject|1
5832667|NCT02412371|20156878|P3|Overall Study|Withdrawal by Subject|0
5832668|NCT02412371|20156879|P2|Overall Study|Withdrawal by Subject|2
5832669|NCT02412371|20156880|P1|Overall Study|Withdrawal by Subject|0
5832670|NCT02412306|20156908|P5|Overall Study|Death|2
5832671|NCT02412306|20156909|P4|Overall Study|Death|0
5832672|NCT02412306|20156910|P3|Overall Study|Death|15
5832673|NCT02412306|20156911|P2|Overall Study|Death|7
5832674|NCT02412306|20156912|P1|Overall Study|Death|5
5832675|NCT02412306|20156908|P5|Overall Study|Withdrawal by Subject|0
5832676|NCT02412306|20156909|P4|Overall Study|Withdrawal by Subject|0
5832677|NCT02412306|20156910|P3|Overall Study|Withdrawal by Subject|1
5832678|NCT02412306|20156911|P2|Overall Study|Withdrawal by Subject|0
5832679|NCT02412306|20156912|P1|Overall Study|Withdrawal by Subject|0
5832680|NCT02412306|20156908|P5|Overall Study|Lost to Follow-up|0
5832681|NCT02412306|20156909|P4|Overall Study|Lost to Follow-up|0
5832682|NCT02412306|20156910|P3|Overall Study|Lost to Follow-up|0
5832683|NCT02412306|20156911|P2|Overall Study|Lost to Follow-up|1
5832684|NCT02412306|20156912|P1|Overall Study|Lost to Follow-up|0
5832685|NCT02412111|20156974|P3|Active Comparator Period (8 Weeks)|Other|2
5832686|NCT02412111|20156975|P2|Active Comparator Period (8 Weeks)|Other|0
5832687|NCT02412111|20156976|P1|Active Comparator Period (8 Weeks)|Other|0
5832688|NCT02412111|20156974|P3|Active Comparator Period (8 Weeks)|Other non-compliance|0
5832689|NCT02412111|20156975|P2|Active Comparator Period (8 Weeks)|Other non-compliance|1
5832690|NCT02412111|20156976|P1|Active Comparator Period (8 Weeks)|Other non-compliance|0
5832691|NCT02412111|20156974|P3|Active Comparator Period (8 Weeks)|Lost to Follow-up|1
5832692|NCT02412111|20156975|P2|Active Comparator Period (8 Weeks)|Lost to Follow-up|0
5832693|NCT02412111|20156976|P1|Active Comparator Period (8 Weeks)|Lost to Follow-up|0
5832694|NCT02412111|20156974|P3|Active Comparator Period (8 Weeks)|Participants refused further dosing|1
5832695|NCT02412111|20156975|P2|Active Comparator Period (8 Weeks)|Participants refused further dosing|0
5832696|NCT02412111|20156976|P1|Active Comparator Period (8 Weeks)|Participants refused further dosing|0
5832697|NCT02412111|20156974|P3|Active Comparator Period (8 Weeks)|Adverse Event|2
5832698|NCT02412111|20156975|P2|Active Comparator Period (8 Weeks)|Adverse Event|0
5832699|NCT02412111|20156976|P1|Active Comparator Period (8 Weeks)|Adverse Event|0
5832700|NCT02412111|20156974|P3|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0
5832701|NCT02412111|20156975|P2|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0
5832702|NCT02412111|20156976|P1|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|2
5832703|NCT02412111|20156974|P3|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0
5832704|NCT02412111|20156975|P2|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0
5832705|NCT02412111|20156976|P1|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|1
5832706|NCT02411747|20157059|P2|Overall Study|Protocol Violation|4
5832707|NCT02411747|20157060|P1|Overall Study|Protocol Violation|2
5832708|NCT02411747|20157059|P2|Overall Study|Withdrawal by Subject|0
5832709|NCT02411747|20157060|P1|Overall Study|Withdrawal by Subject|1
5832710|NCT02411591|20157076|P3|Overall Study|Physician Decision|1
5832711|NCT02411591|20157077|P2|Overall Study|Physician Decision|3
5832712|NCT02411591|20157078|P1|Overall Study|Physician Decision|0
5832713|NCT02411591|20157076|P3|Overall Study|Withdrawal by Subject|0
5832714|NCT02411591|20157077|P2|Overall Study|Withdrawal by Subject|3
5832715|NCT02411591|20157078|P1|Overall Study|Withdrawal by Subject|0
5832716|NCT02411591|20157076|P3|Overall Study|Adverse Event|2
5832717|NCT02411591|20157077|P2|Overall Study|Adverse Event|4
5832718|NCT02411591|20157078|P1|Overall Study|Adverse Event|0
5832719|NCT02411578|20157110|P2|Crossover Trial Phase|Pregnancy|1
5832720|NCT02411578|20157111|P1|Crossover Trial Phase|Pregnancy|0
5832721|NCT02411539|20157168|P2|Overall Study|Confounding medical condition|1
5832722|NCT02411539|20157169|P1|Overall Study|Confounding medical condition|0
5832723|NCT02411539|20157168|P2|Overall Study|Lost to Follow-up|0
5832724|NCT02411539|20157169|P1|Overall Study|Lost to Follow-up|2
5832725|NCT02411448|20157260|P3|Overall Study|Alive on study treatment|43
5832726|NCT02411448|20157261|P2|Overall Study|Alive on study treatment|64
5832727|NCT02411448|20157262|P1|Overall Study|Alive on study treatment|3
5832728|NCT02411448|20157260|P3|Overall Study|Did not receive study treatment|0
5832729|NCT02411448|20157261|P2|Overall Study|Did not receive study treatment|3
5832730|NCT02411448|20157262|P1|Overall Study|Did not receive study treatment|0
5832731|NCT02411448|20157260|P3|Overall Study|Other|0
5832732|NCT02411448|20157261|P2|Overall Study|Other|2
5832733|NCT02411448|20157262|P1|Overall Study|Other|0
5832734|NCT02411448|20157260|P3|Overall Study|Withdrawal by Subject|9
5832735|NCT02411448|20157261|P2|Overall Study|Withdrawal by Subject|14
5832736|NCT02411448|20157262|P1|Overall Study|Withdrawal by Subject|1
5832737|NCT02411396|20157291|P1|Overall Study|Death|10
5832738|NCT02411396|20157291|P1|Overall Study|Lost to Follow-up|31
5832739|NCT02411292|20157304|P1|Overall Study|Lost to Follow-up|3
5832740|NCT02411292|20157304|P1|Overall Study|Death|2
5832741|NCT02411292|20157304|P1|Overall Study|Discharged before 3rd enoxaparin dose|16
5832742|NCT02411201|20157310|P1|Overall Study|Age group completed|2
5832743|NCT02411201|20157310|P1|Overall Study|Withdrawal by Subject|2
5832744|NCT02411201|20157310|P1|Overall Study|Adverse Event|2
5832745|NCT02411110|20157323|P2|Treatment Period 2|Personal Reasons|2
5832746|NCT02411110|20157324|P1|Treatment Period 2|Personal Reasons|0
5832747|NCT02411110|20157323|P2|Treatment Period 2|Lost to Follow-up|2
5832748|NCT02411110|20157324|P1|Treatment Period 2|Lost to Follow-up|0
5832749|NCT02411110|20157323|P2|Treatment Period 2|Adverse Event|0
5832750|NCT02411110|20157324|P1|Treatment Period 2|Adverse Event|1
5832751|NCT02411110|20157323|P2|Treatment Period 1|Other Miscellaneous Reasons|0
5832752|NCT02411110|20157324|P1|Treatment Period 1|Other Miscellaneous Reasons|2
5832753|NCT02411110|20157323|P2|Treatment Period 1|Personal Reasons|5
5832754|NCT02411110|20157324|P1|Treatment Period 1|Personal Reasons|2
5832755|NCT02411110|20157323|P2|Treatment Period 1|Lost to Follow-up|0
5832756|NCT02411110|20157324|P1|Treatment Period 1|Lost to Follow-up|1
5832757|NCT02411110|20157323|P2|Treatment Period 1|Adverse Event|2
5832758|NCT02411110|20157324|P1|Treatment Period 1|Adverse Event|4
5832759|NCT02411084|20157334|P2|Overall Study|Other reasons|5
5832760|NCT02411084|20157335|P1|Overall Study|Other reasons|0
5832761|NCT02411084|20157334|P2|Overall Study|Adverse Event|1
5832762|NCT02411084|20157335|P1|Overall Study|Adverse Event|2
5832763|NCT02411084|20157334|P2|Overall Study|Death|4
5832764|NCT02411084|20157335|P1|Overall Study|Death|5
5832765|NCT02411084|20157334|P2|Overall Study|Lack of Efficacy|3
5832766|NCT02411084|20157335|P1|Overall Study|Lack of Efficacy|6
5832767|NCT02410824|20157367|P2|First Intervention (One Week)|Headache|1
5832768|NCT02410824|20157368|P1|First Intervention (One Week)|Headache|0
5832769|NCT02410811|20157404|P4|Overall Study|Withdrawal by Subject|0
5832770|NCT02410811|20157405|P3|Overall Study|Withdrawal by Subject|1
5832771|NCT02410811|20157406|P2|Overall Study|Withdrawal by Subject|0
5832772|NCT02410811|20157407|P1|Overall Study|Withdrawal by Subject|0
5832773|NCT02410629|20157434|P2|Overall Study|Subject underwent heart surgery|1
5832774|NCT02410629|20157435|P1|Overall Study|Subject underwent heart surgery|0
5832775|NCT02410629|20157434|P2|Overall Study|Subject moved back to home country|1
5832776|NCT02410629|20157435|P1|Overall Study|Subject moved back to home country|0
5832777|NCT02410629|20157434|P2|Overall Study|Subject returned to work|0
5832778|NCT02410629|20157435|P1|Overall Study|Subject returned to work|1
5832779|NCT02410629|20157434|P2|Overall Study|Family cannot commit to the study|1
5832780|NCT02410629|20157435|P1|Overall Study|Family cannot commit to the study|2
5832781|NCT02410551|20157451|P1|Overall Study|FDA Clinical hold-patients taken off|2
5832782|NCT02410551|20157451|P1|Overall Study|Withdrawal by Subject|1
5832783|NCT02410551|20157451|P1|Overall Study|Adverse Event|1
5832784|NCT02410343|20157469|P2|Extension Period (12 Months)|Early termination of study by sponsor|1
5832785|NCT02410343|20157470|P1|Extension Period (12 Months)|Early termination of study by sponsor|0
5832786|NCT02410343|20157469|P2|Extension Period (12 Months)|Adverse Event|0
5832787|NCT02410343|20157470|P1|Extension Period (12 Months)|Adverse Event|1
5832788|NCT02410343|20157469|P2|Core Period (24 Weeks)|Early termination of study by sponsor|7
5832789|NCT02410343|20157470|P1|Core Period (24 Weeks)|Early termination of study by sponsor|4
5832790|NCT02410343|20157469|P2|Core Period (24 Weeks)|Adverse Event|0
5832791|NCT02410343|20157470|P1|Core Period (24 Weeks)|Adverse Event|1
5832792|NCT02410278|20157516|P3|Study Treatment Period|GSRS Threshold Not Met|0
5832793|NCT02410278|20157517|P2|Study Treatment Period|GSRS Threshold Not Met|1
5832794|NCT02410278|20157518|P1|Study Treatment Period|GSRS Threshold Not Met|0
5832795|NCT02410278|20157516|P3|Study Treatment Period|Other|0
5832796|NCT02410278|20157517|P2|Study Treatment Period|Other|3
5832797|NCT02410278|20157518|P1|Study Treatment Period|Other|0
5832798|NCT02410278|20157516|P3|Study Treatment Period|Withdrawal by Subject|0
5832799|NCT02410278|20157517|P2|Study Treatment Period|Withdrawal by Subject|1
5832800|NCT02410278|20157518|P1|Study Treatment Period|Withdrawal by Subject|0
5832801|NCT02410278|20157516|P3|Study Treatment Period|Physician Decision|1
5832802|NCT02410278|20157517|P2|Study Treatment Period|Physician Decision|0
5832803|NCT02410278|20157518|P1|Study Treatment Period|Physician Decision|0
5832804|NCT02410278|20157516|P3|Study Treatment Period|Adverse Event|3
5832805|NCT02410278|20157517|P2|Study Treatment Period|Adverse Event|6
5832806|NCT02410278|20157518|P1|Study Treatment Period|Adverse Event|0
5832807|NCT02410278|20157516|P3|Run-in Period|Pregnancy|0
5832808|NCT02410278|20157517|P2|Run-in Period|Pregnancy|0
5832809|NCT02410278|20157518|P1|Run-in Period|Pregnancy|1
5832810|NCT02410278|20157516|P3|Run-in Period|Withdrawal by Subject|0
5832811|NCT02410278|20157517|P2|Run-in Period|Withdrawal by Subject|0
5832812|NCT02410278|20157518|P1|Run-in Period|Withdrawal by Subject|1
5832813|NCT02410278|20157516|P3|Run-in Period|Lost to Follow-up|0
5832814|NCT02410278|20157517|P2|Run-in Period|Lost to Follow-up|0
5832815|NCT02410278|20157518|P1|Run-in Period|Lost to Follow-up|1
5832816|NCT02410278|20157516|P3|Run-in Period|GSRS Threshold Not Met|0
5832817|NCT02410278|20157517|P2|Run-in Period|GSRS Threshold Not Met|0
5832818|NCT02410278|20157518|P1|Run-in Period|GSRS Threshold Not Met|30
5832819|NCT02410278|20157516|P3|Run-in Period|Adverse Event|0
5832820|NCT02410278|20157517|P2|Run-in Period|Adverse Event|0
5832821|NCT02410278|20157518|P1|Run-in Period|Adverse Event|5
5832822|NCT02410252|20157543|P1|Overall Study|Physician Decision|2
5832823|NCT02410252|20157543|P1|Overall Study|Withdrawal by Subject|4
5832824|NCT02410200|20157556|P1|Overall Study|Adverse Event|2
5832825|NCT02409732|20157626|P1|Overall Study|Lost to Follow-up|2
5832826|NCT02409732|20157626|P1|Overall Study|Withdrawal by Subject|4
5832827|NCT02409719|20157636|P2|Overall Study|Lost to Follow-up|3
5832828|NCT02409719|20157637|P1|Overall Study|Lost to Follow-up|3
5832829|NCT02409667|20157647|P5|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0
5832830|NCT02409667|20157648|P4|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0
5832831|NCT02409667|20157649|P3|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|3
5832832|NCT02409667|20157650|P2|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0
5832833|NCT02409667|20157651|P1|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0
5832834|NCT02409667|20157647|P5|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1
5832835|NCT02409667|20157648|P4|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0
5832836|NCT02409667|20157649|P3|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1
5832837|NCT02409667|20157650|P2|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0
5832838|NCT02409667|20157651|P1|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0
5832839|NCT02409667|20157647|P5|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0
5832840|NCT02409667|20157648|P4|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|2
5832841|NCT02409667|20157649|P3|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|5
5832842|NCT02409667|20157650|P2|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|4
5832843|NCT02409667|20157651|P1|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0
5832844|NCT02409667|20157647|P5|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0
5832845|NCT02409667|20157648|P4|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0
5832846|NCT02409667|20157649|P3|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|4
5832847|NCT02409667|20157650|P2|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|5
5832848|NCT02409667|20157651|P1|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0
5832849|NCT02409667|20157647|P5|Treatment Period 2, Week 24 to Week 52)|Adverse Event|2
5832850|NCT02409667|20157648|P4|Treatment Period 2, Week 24 to Week 52)|Adverse Event|1
5832851|NCT02409667|20157649|P3|Treatment Period 2, Week 24 to Week 52)|Adverse Event|4
5832852|NCT02409667|20157650|P2|Treatment Period 2, Week 24 to Week 52)|Adverse Event|7
5832853|NCT02409667|20157651|P1|Treatment Period 2, Week 24 to Week 52)|Adverse Event|0
5832854|NCT02409667|20157647|P5|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0
5832855|NCT02409667|20157648|P4|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|2
5832856|NCT02409667|20157649|P3|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0
5832857|NCT02409667|20157650|P2|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0
5832858|NCT02409667|20157651|P1|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0
5832859|NCT02409667|20157647|P5|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0
5832860|NCT02409667|20157648|P4|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|3
5832861|NCT02409667|20157649|P3|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|4
5832862|NCT02409667|20157650|P2|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|7
5832863|NCT02409667|20157651|P1|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0
5832864|NCT02409667|20157647|P5|Treatment Period 1, Baseline to Week 24|Adverse Event|0
5832865|NCT02409667|20157648|P4|Treatment Period 1, Baseline to Week 24|Adverse Event|0
5832866|NCT02409667|20157649|P3|Treatment Period 1, Baseline to Week 24|Adverse Event|0
5832867|NCT02409667|20157650|P2|Treatment Period 1, Baseline to Week 24|Adverse Event|0
5832868|NCT02409667|20157651|P1|Treatment Period 1, Baseline to Week 24|Adverse Event|25
5832869|NCT02409667|20157647|P5|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0
5832870|NCT02409667|20157648|P4|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0
5832871|NCT02409667|20157649|P3|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0
5832872|NCT02409667|20157650|P2|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0
5832873|NCT02409667|20157651|P1|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|48
5832874|NCT02409667|20157647|P5|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0
5832875|NCT02409667|20157648|P4|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0
5832876|NCT02409667|20157649|P3|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0
5832877|NCT02409667|20157650|P2|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0
5832878|NCT02409667|20157651|P1|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|6
5832879|NCT02409667|20157647|P5|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0
5832880|NCT02409667|20157648|P4|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0
5832881|NCT02409667|20157649|P3|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0
5832882|NCT02409667|20157650|P2|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0
5832883|NCT02409667|20157651|P1|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|5
5832884|NCT02409667|20157647|P5|Treatment Period 1, Baseline to Week 24|Physician Decision|0
5832885|NCT02409667|20157648|P4|Treatment Period 1, Baseline to Week 24|Physician Decision|0
5832886|NCT02409667|20157649|P3|Treatment Period 1, Baseline to Week 24|Physician Decision|0
5832887|NCT02409667|20157650|P2|Treatment Period 1, Baseline to Week 24|Physician Decision|0
5832888|NCT02409667|20157651|P1|Treatment Period 1, Baseline to Week 24|Physician Decision|4
5832889|NCT02409667|20157647|P5|Treatment Period 1, Baseline to Week 24|Pregnancy|0
5832890|NCT02409667|20157648|P4|Treatment Period 1, Baseline to Week 24|Pregnancy|0
5832891|NCT02409667|20157649|P3|Treatment Period 1, Baseline to Week 24|Pregnancy|0
5832892|NCT02409667|20157650|P2|Treatment Period 1, Baseline to Week 24|Pregnancy|0
5832893|NCT02409667|20157651|P1|Treatment Period 1, Baseline to Week 24|Pregnancy|1
5832894|NCT02409667|20157647|P5|Treatment Period 1, Baseline to Week 24|Protocol deviation|0
5832895|NCT02409667|20157648|P4|Treatment Period 1, Baseline to Week 24|Protocol deviation|0
5832896|NCT02409667|20157649|P3|Treatment Period 1, Baseline to Week 24|Protocol deviation|0
5832897|NCT02409667|20157650|P2|Treatment Period 1, Baseline to Week 24|Protocol deviation|0
5832898|NCT02409667|20157651|P1|Treatment Period 1, Baseline to Week 24|Protocol deviation|20
5832899|NCT02409667|20157647|P5|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0
5832900|NCT02409667|20157648|P4|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0
5832901|NCT02409667|20157649|P3|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0
5832902|NCT02409667|20157650|P2|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0
5832903|NCT02409667|20157651|P1|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|6
5832904|NCT02409667|20157647|P5|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0
5832905|NCT02409667|20157648|P4|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0
5832906|NCT02409667|20157649|P3|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0
5832907|NCT02409667|20157650|P2|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0
5832908|NCT02409667|20157651|P1|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|6
5832909|NCT02409355|20157713|P2|Overall Study|Study terminated by Sponsor|3
5832910|NCT02409355|20157714|P1|Overall Study|Study terminated by Sponsor|2
5832911|NCT02409355|20157713|P2|Overall Study|Death|1
5832912|NCT02409355|20157714|P1|Overall Study|Death|1
5832913|NCT02409355|20157713|P2|Overall Study|Withdrawal by Subject|0
5832914|NCT02409355|20157714|P1|Overall Study|Withdrawal by Subject|1
5832915|NCT02408523|20157837|P2|Overall Study|Did not satisfy extension conditions|1
5832916|NCT02408523|20157838|P1|Overall Study|Did not satisfy extension conditions|0
5832917|NCT02408523|20157837|P2|Overall Study|Sponsor request|0
5832918|NCT02408523|20157838|P1|Overall Study|Sponsor request|1
5832919|NCT02408523|20157837|P2|Overall Study|Withdrawal by Subject|1
5832920|NCT02408523|20157838|P1|Overall Study|Withdrawal by Subject|3
5832921|NCT02408523|20157837|P2|Overall Study|Lost to Follow-up|3
5832922|NCT02408523|20157838|P1|Overall Study|Lost to Follow-up|2
5832923|NCT02408523|20157837|P2|Overall Study|Protocol Violation|2
5832924|NCT02408523|20157838|P1|Overall Study|Protocol Violation|1
5832925|NCT02408523|20157837|P2|Overall Study|Lack of Efficacy|1
5832926|NCT02408523|20157838|P1|Overall Study|Lack of Efficacy|0
5832927|NCT02408523|20157837|P2|Overall Study|Adverse Event|10
5832928|NCT02408523|20157838|P1|Overall Study|Adverse Event|4
5832929|NCT02408484|20157858|P1|Overall Study|Not treated during study period|1
5832930|NCT02408484|20157858|P1|Overall Study|Withdrawal by Subject|3
5832931|NCT02408120|20157963|P2|Overall Study|Did not receive insulin|2
5832932|NCT02408120|20157964|P1|Overall Study|Did not receive insulin|1
5832933|NCT02408120|20157963|P2|Overall Study|Discharged same day|1
5832934|NCT02408120|20157964|P1|Overall Study|Discharged same day|1
5832935|NCT02408120|20157963|P2|Overall Study|Received Steroids|1
5832936|NCT02408120|20157964|P1|Overall Study|Received Steroids|1
5832937|NCT02408120|20157963|P2|Overall Study|Treatment Refusal|0
5832938|NCT02408120|20157964|P1|Overall Study|Treatment Refusal|1
5832939|NCT02408120|20157963|P2|Overall Study|Withdrawal by Subject|1
5832940|NCT02408120|20157964|P1|Overall Study|Withdrawal by Subject|0
5832941|NCT02408068|20157990|P6|Treatment 3 (1.5 Days)|Adverse Event|0
5832942|NCT02408068|20157991|P5|Treatment 3 (1.5 Days)|Adverse Event|0
5832943|NCT02408068|20157992|P4|Treatment 3 (1.5 Days)|Adverse Event|0
5832944|NCT02408068|20157993|P3|Treatment 3 (1.5 Days)|Adverse Event|1
5832945|NCT02408068|20157994|P2|Treatment 3 (1.5 Days)|Adverse Event|0
5832946|NCT02408068|20157995|P1|Treatment 3 (1.5 Days)|Adverse Event|0
5832947|NCT02407704|20158067|P4|Overall Study|Withdrawal by Subject|0
5832948|NCT02407704|20158068|P3|Overall Study|Withdrawal by Subject|1
5832949|NCT02407704|20158069|P2|Overall Study|Withdrawal by Subject|0
5832950|NCT02407704|20158070|P1|Overall Study|Withdrawal by Subject|0
5832951|NCT02407704|20158067|P4|Overall Study|Protocol Violation|1
5832952|NCT02407704|20158068|P3|Overall Study|Protocol Violation|0
5832953|NCT02407704|20158069|P2|Overall Study|Protocol Violation|0
5832954|NCT02407704|20158070|P1|Overall Study|Protocol Violation|0
5832955|NCT02407704|20158067|P4|Overall Study|Lost to Follow-up|2
5832956|NCT02407704|20158068|P3|Overall Study|Lost to Follow-up|0
5832957|NCT02407704|20158069|P2|Overall Study|Lost to Follow-up|0
5832958|NCT02407704|20158070|P1|Overall Study|Lost to Follow-up|0
5832959|NCT02407249|20158113|P1|Overall Study|Not treated|13
5832960|NCT02407249|20158113|P1|Overall Study|Did not complete 12-month follow-up|13
5832961|NCT02407236|20158129|P8|Maintenance Study (44 Weeks)|Other|1
5832962|NCT02407236|20158130|P7|Maintenance Study (44 Weeks)|Other|2
5832963|NCT02407236|20158131|P6|Maintenance Study (44 Weeks)|Other|1
5832964|NCT02407236|20158132|P5|Maintenance Study (44 Weeks)|Other|1
5832965|NCT02407236|20158133|P4|Maintenance Study (44 Weeks)|Other|0
5832966|NCT02407236|20158134|P3|Maintenance Study (44 Weeks)|Other|0
5832967|NCT02407236|20158135|P2|Maintenance Study (44 Weeks)|Other|0
5832968|NCT02407236|20158136|P1|Maintenance Study (44 Weeks)|Other|0
5832969|NCT02407236|20158129|P8|Maintenance Study (44 Weeks)|Sponsor decision|0
5832970|NCT02407236|20158130|P7|Maintenance Study (44 Weeks)|Sponsor decision|0
5832971|NCT02407236|20158131|P6|Maintenance Study (44 Weeks)|Sponsor decision|1
5832972|NCT02407236|20158132|P5|Maintenance Study (44 Weeks)|Sponsor decision|0
5832973|NCT02407236|20158133|P4|Maintenance Study (44 Weeks)|Sponsor decision|1
5832974|NCT02407236|20158134|P3|Maintenance Study (44 Weeks)|Sponsor decision|0
5832975|NCT02407236|20158135|P2|Maintenance Study (44 Weeks)|Sponsor decision|0
5832976|NCT02407236|20158136|P1|Maintenance Study (44 Weeks)|Sponsor decision|0
5832977|NCT02407236|20158129|P8|Maintenance Study (44 Weeks)|Withdraw of consent|5
5832978|NCT02407236|20158130|P7|Maintenance Study (44 Weeks)|Withdraw of consent|7
5832979|NCT02407236|20158131|P6|Maintenance Study (44 Weeks)|Withdraw of consent|5
5832980|NCT02407236|20158132|P5|Maintenance Study (44 Weeks)|Withdraw of consent|10
5832981|NCT02407236|20158133|P4|Maintenance Study (44 Weeks)|Withdraw of consent|8
5832982|NCT02407236|20158134|P3|Maintenance Study (44 Weeks)|Withdraw of consent|0
5832983|NCT02407236|20158135|P2|Maintenance Study (44 Weeks)|Withdraw of consent|0
5832984|NCT02407236|20158136|P1|Maintenance Study (44 Weeks)|Withdraw of consent|0
5832985|NCT02407236|20158129|P8|Maintenance Study (44 Weeks)|Death|1
5832986|NCT02407236|20158130|P7|Maintenance Study (44 Weeks)|Death|0
5832987|NCT02407236|20158131|P6|Maintenance Study (44 Weeks)|Death|0
5832988|NCT02407236|20158132|P5|Maintenance Study (44 Weeks)|Death|0
5832989|NCT02407236|20158133|P4|Maintenance Study (44 Weeks)|Death|0
5832990|NCT02407236|20158134|P3|Maintenance Study (44 Weeks)|Death|0
5832991|NCT02407236|20158135|P2|Maintenance Study (44 Weeks)|Death|0
5832992|NCT02407236|20158136|P1|Maintenance Study (44 Weeks)|Death|0
5832993|NCT02407236|20158129|P8|Maintenance Study (44 Weeks)|Lost to Follow-up|1
5832994|NCT02407236|20158130|P7|Maintenance Study (44 Weeks)|Lost to Follow-up|0
5832995|NCT02407236|20158131|P6|Maintenance Study (44 Weeks)|Lost to Follow-up|1
5832996|NCT02407236|20158132|P5|Maintenance Study (44 Weeks)|Lost to Follow-up|0
5832997|NCT02407236|20158133|P4|Maintenance Study (44 Weeks)|Lost to Follow-up|1
5832998|NCT02407236|20158134|P3|Maintenance Study (44 Weeks)|Lost to Follow-up|0
5832999|NCT02407236|20158135|P2|Maintenance Study (44 Weeks)|Lost to Follow-up|0
5833000|NCT02407236|20158136|P1|Maintenance Study (44 Weeks)|Lost to Follow-up|0
5833001|NCT02407236|20158129|P8|Induction Study (8 Weeks)|Other|0
5833002|NCT02407236|20158130|P7|Induction Study (8 Weeks)|Other|0
5833003|NCT02407236|20158131|P6|Induction Study (8 Weeks)|Other|0
5833004|NCT02407236|20158132|P5|Induction Study (8 Weeks)|Other|0
5833005|NCT02407236|20158133|P4|Induction Study (8 Weeks)|Other|0
5833006|NCT02407236|20158134|P3|Induction Study (8 Weeks)|Other|5
5833007|NCT02407236|20158135|P2|Induction Study (8 Weeks)|Other|1
5833008|NCT02407236|20158136|P1|Induction Study (8 Weeks)|Other|2
5833009|NCT02407236|20158129|P8|Induction Study (8 Weeks)|Physician Decision|0
5833010|NCT02407236|20158130|P7|Induction Study (8 Weeks)|Physician Decision|0
5833011|NCT02407236|20158131|P6|Induction Study (8 Weeks)|Physician Decision|0
5833012|NCT02407236|20158132|P5|Induction Study (8 Weeks)|Physician Decision|0
5833013|NCT02407236|20158133|P4|Induction Study (8 Weeks)|Physician Decision|0
5833014|NCT02407236|20158134|P3|Induction Study (8 Weeks)|Physician Decision|0
5833015|NCT02407236|20158135|P2|Induction Study (8 Weeks)|Physician Decision|1
5833016|NCT02407236|20158136|P1|Induction Study (8 Weeks)|Physician Decision|1
5833017|NCT02407236|20158129|P8|Induction Study (8 Weeks)|Lost to Follow-up|0
5833018|NCT02407236|20158130|P7|Induction Study (8 Weeks)|Lost to Follow-up|0
5833019|NCT02407236|20158131|P6|Induction Study (8 Weeks)|Lost to Follow-up|0
5833020|NCT02407236|20158132|P5|Induction Study (8 Weeks)|Lost to Follow-up|0
5833021|NCT02407236|20158133|P4|Induction Study (8 Weeks)|Lost to Follow-up|0
5833022|NCT02407236|20158134|P3|Induction Study (8 Weeks)|Lost to Follow-up|1
5833023|NCT02407236|20158135|P2|Induction Study (8 Weeks)|Lost to Follow-up|0
5833024|NCT02407236|20158136|P1|Induction Study (8 Weeks)|Lost to Follow-up|0
5833025|NCT02407236|20158129|P8|Induction Study (8 Weeks)|Withdrawal by Subject|0
5833026|NCT02407236|20158130|P7|Induction Study (8 Weeks)|Withdrawal by Subject|0
5833027|NCT02407236|20158131|P6|Induction Study (8 Weeks)|Withdrawal by Subject|0
5833028|NCT02407236|20158132|P5|Induction Study (8 Weeks)|Withdrawal by Subject|0
5833029|NCT02407236|20158133|P4|Induction Study (8 Weeks)|Withdrawal by Subject|0
5833030|NCT02407236|20158134|P3|Induction Study (8 Weeks)|Withdrawal by Subject|7
5833031|NCT02407236|20158135|P2|Induction Study (8 Weeks)|Withdrawal by Subject|9
5833032|NCT02407236|20158136|P1|Induction Study (8 Weeks)|Withdrawal by Subject|17
5833033|NCT02407236|20158129|P8|Induction Study (8 Weeks)|Death|0
5833034|NCT02407236|20158130|P7|Induction Study (8 Weeks)|Death|0
5833035|NCT02407236|20158131|P6|Induction Study (8 Weeks)|Death|0
5833036|NCT02407236|20158132|P5|Induction Study (8 Weeks)|Death|0
5833037|NCT02407236|20158133|P4|Induction Study (8 Weeks)|Death|0
5833038|NCT02407236|20158134|P3|Induction Study (8 Weeks)|Death|1
5833039|NCT02407236|20158135|P2|Induction Study (8 Weeks)|Death|0
5833040|NCT02407236|20158136|P1|Induction Study (8 Weeks)|Death|0
5833041|NCT02407236|20158129|P8|Induction Study (8 Weeks)|Adverse Event|0
5833042|NCT02407236|20158130|P7|Induction Study (8 Weeks)|Adverse Event|0
5833043|NCT02407236|20158131|P6|Induction Study (8 Weeks)|Adverse Event|0
5833044|NCT02407236|20158132|P5|Induction Study (8 Weeks)|Adverse Event|0
5833045|NCT02407236|20158133|P4|Induction Study (8 Weeks)|Adverse Event|0
5833046|NCT02407236|20158134|P3|Induction Study (8 Weeks)|Adverse Event|1
5833047|NCT02407236|20158135|P2|Induction Study (8 Weeks)|Adverse Event|0
5833048|NCT02407236|20158136|P1|Induction Study (8 Weeks)|Adverse Event|3
5833049|NCT02407223|20158376|P3|Overall Study|Other|25
5833050|NCT02407223|20158377|P2|Overall Study|Other|27
5833051|NCT02407223|20158378|P1|Overall Study|Other|29
5833052|NCT02407223|20158376|P3|Overall Study|Subject Refused Further Study Treatment|0
5833053|NCT02407223|20158377|P2|Overall Study|Subject Refused Further Study Treatment|1
5833054|NCT02407223|20158378|P1|Overall Study|Subject Refused Further Study Treatment|0
5833055|NCT02407223|20158376|P3|Overall Study|Study Terminated by Sponsor|86
5833056|NCT02407223|20158377|P2|Overall Study|Study Terminated by Sponsor|80
5833057|NCT02407223|20158378|P1|Overall Study|Study Terminated by Sponsor|77
5833058|NCT02407223|20158376|P3|Overall Study|Withdrawal by Subject|4
5833059|NCT02407223|20158377|P2|Overall Study|Withdrawal by Subject|4
5833060|NCT02407223|20158378|P1|Overall Study|Withdrawal by Subject|2
5833061|NCT02407223|20158376|P3|Overall Study|Lost to Follow-up|2
5833062|NCT02407223|20158377|P2|Overall Study|Lost to Follow-up|0
5833063|NCT02407223|20158378|P1|Overall Study|Lost to Follow-up|1
5833064|NCT02407223|20158376|P3|Overall Study|Lack of Efficacy|4
5833065|NCT02407223|20158377|P2|Overall Study|Lack of Efficacy|6
5833066|NCT02407223|20158378|P1|Overall Study|Lack of Efficacy|6
5833067|NCT02407223|20158376|P3|Overall Study|Adverse Event|1
5833068|NCT02407223|20158377|P2|Overall Study|Adverse Event|0
5833069|NCT02407223|20158378|P1|Overall Study|Adverse Event|1
5833070|NCT02406677|20158530|P2|Overall Study|Withdrawal by Subject|0
5833071|NCT02406677|20158531|P1|Overall Study|Withdrawal by Subject|1
5833072|NCT02406677|20158530|P2|Overall Study|Discharged on prasugrel|587
5833073|NCT02406677|20158531|P1|Overall Study|Discharged on prasugrel|283
5833074|NCT02406677|20158530|P2|Overall Study|Discharged without P2Y12|3
5833075|NCT02406677|20158531|P1|Overall Study|Discharged without P2Y12|1
5833076|NCT02406677|20158530|P2|Overall Study|Death|8
5833077|NCT02406677|20158531|P1|Overall Study|Death|16
5833078|NCT02406612|20158545|P2|Overall Study|Guidewire Failure|1
5833079|NCT02406612|20158546|P1|Overall Study|Guidewire Failure|0
5833080|NCT02406612|20158545|P2|Overall Study|Intra-procedural Exclusion|3
5833081|NCT02406612|20158546|P1|Overall Study|Intra-procedural Exclusion|1
5833082|NCT02406612|20158545|P2|Overall Study|Screening Failure|0
5833083|NCT02406612|20158546|P1|Overall Study|Screening Failure|3
5833084|NCT02406586|20158561|P3|Overall Study|Withdrawal by Subject|0
5833085|NCT02406586|20158562|P2|Overall Study|Withdrawal by Subject|0
5833086|NCT02406586|20158563|P1|Overall Study|Withdrawal by Subject|1
5833087|NCT02406586|20158561|P3|Overall Study|Lost to Follow-up|2
5833088|NCT02406586|20158562|P2|Overall Study|Lost to Follow-up|4
5833089|NCT02406586|20158563|P1|Overall Study|Lost to Follow-up|0
5833090|NCT02406261|20158705|P2|Period 2|Withdrawal by Subject|1
5833091|NCT02406261|20158706|P1|Period 2|Withdrawal by Subject|0
5833092|NCT02406261|20158705|P2|Period 2|Protocol Violation|1
5833093|NCT02406261|20158706|P1|Period 2|Protocol Violation|0
5833094|NCT02406261|20158705|P2|Period 2|Physician Decision|1
5833095|NCT02406261|20158706|P1|Period 2|Physician Decision|0
5833096|NCT02406261|20158705|P2|Period 1|Adverse Event|0
5833097|NCT02406261|20158706|P1|Period 1|Adverse Event|1
5833098|NCT02406261|20158705|P2|Period 1|Lost to Follow-up|0
5833099|NCT02406261|20158706|P1|Period 1|Lost to Follow-up|2
5833100|NCT02406248|20158718|P1|Overall Study|Withdrawal by Subject|2
5833101|NCT02406248|20158718|P1|Overall Study|Death|7
5833102|NCT02406027|20158729|P7|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0
5833103|NCT02406027|20158730|P6|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0
5833104|NCT02406027|20158731|P5|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|1
5833105|NCT02406027|20158732|P4|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0
5833106|NCT02406027|20158733|P3|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0
5833107|NCT02406027|20158734|P2|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0
5833108|NCT02406027|20158735|P1|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0
5833109|NCT02406027|20158729|P7|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0
5833110|NCT02406027|20158730|P6|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|1
5833111|NCT02406027|20158731|P5|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0
5833112|NCT02406027|20158732|P4|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0
5833113|NCT02406027|20158733|P3|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0
5833114|NCT02406027|20158734|P2|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0
5833115|NCT02406027|20158735|P1|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0
5833116|NCT02406027|20158729|P7|Open-label Phase (Period 2)|Study Terminated by Sponsor|19
5833117|NCT02406027|20158730|P6|Open-label Phase (Period 2)|Study Terminated by Sponsor|24
5833118|NCT02406027|20158731|P5|Open-label Phase (Period 2)|Study Terminated by Sponsor|7
5833119|NCT02406027|20158732|P4|Open-label Phase (Period 2)|Study Terminated by Sponsor|11
5833120|NCT02406027|20158733|P3|Open-label Phase (Period 2)|Study Terminated by Sponsor|0
5833121|NCT02406027|20158734|P2|Open-label Phase (Period 2)|Study Terminated by Sponsor|0
5833122|NCT02406027|20158735|P1|Open-label Phase (Period 2)|Study Terminated by Sponsor|0
5833123|NCT02406027|20158729|P7|Open-label Phase (Period 2)|Withdrawal by Subject|2
5833124|NCT02406027|20158730|P6|Open-label Phase (Period 2)|Withdrawal by Subject|0
5833125|NCT02406027|20158731|P5|Open-label Phase (Period 2)|Withdrawal by Subject|4
5833126|NCT02406027|20158732|P4|Open-label Phase (Period 2)|Withdrawal by Subject|2
5833127|NCT02406027|20158733|P3|Open-label Phase (Period 2)|Withdrawal by Subject|0
5833128|NCT02406027|20158734|P2|Open-label Phase (Period 2)|Withdrawal by Subject|0
5833129|NCT02406027|20158735|P1|Open-label Phase (Period 2)|Withdrawal by Subject|0
5833130|NCT02406027|20158729|P7|Open-label Phase (Period 2)|Physician Decision|1
5833131|NCT02406027|20158730|P6|Open-label Phase (Period 2)|Physician Decision|1
5833132|NCT02406027|20158731|P5|Open-label Phase (Period 2)|Physician Decision|0
5833133|NCT02406027|20158732|P4|Open-label Phase (Period 2)|Physician Decision|0
5833134|NCT02406027|20158733|P3|Open-label Phase (Period 2)|Physician Decision|0
5833135|NCT02406027|20158734|P2|Open-label Phase (Period 2)|Physician Decision|0
5833136|NCT02406027|20158735|P1|Open-label Phase (Period 2)|Physician Decision|0
5833137|NCT02406027|20158729|P7|Open-label Phase (Period 2)|Adverse Event|0
5833138|NCT02406027|20158730|P6|Open-label Phase (Period 2)|Adverse Event|0
5833139|NCT02406027|20158731|P5|Open-label Phase (Period 2)|Adverse Event|2
5833140|NCT02406027|20158732|P4|Open-label Phase (Period 2)|Adverse Event|2
5833141|NCT02406027|20158733|P3|Open-label Phase (Period 2)|Adverse Event|0
5833142|NCT02406027|20158734|P2|Open-label Phase (Period 2)|Adverse Event|0
5833143|NCT02406027|20158735|P1|Open-label Phase (Period 2)|Adverse Event|0
5833144|NCT02406027|20158729|P7|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0
5833145|NCT02406027|20158730|P6|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0
5833146|NCT02406027|20158731|P5|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0
5833147|NCT02406027|20158732|P4|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0
5833148|NCT02406027|20158733|P3|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1
5833149|NCT02406027|20158734|P2|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0
5833150|NCT02406027|20158735|P1|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1
5833151|NCT02406027|20158729|P7|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0
5833152|NCT02406027|20158730|P6|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0
5833153|NCT02406027|20158731|P5|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0
5833154|NCT02406027|20158732|P4|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0
5833155|NCT02406027|20158733|P3|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1
5833156|NCT02406027|20158734|P2|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1
5833157|NCT02406027|20158735|P1|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|2
5833158|NCT02406027|20158729|P7|Double-blind Treatment Phase (Period 1)|Physician Decision|0
5833159|NCT02406027|20158730|P6|Double-blind Treatment Phase (Period 1)|Physician Decision|0
5833160|NCT02406027|20158731|P5|Double-blind Treatment Phase (Period 1)|Physician Decision|0
5833161|NCT02406027|20158732|P4|Double-blind Treatment Phase (Period 1)|Physician Decision|0
5833162|NCT02406027|20158733|P3|Double-blind Treatment Phase (Period 1)|Physician Decision|1
5833163|NCT02406027|20158734|P2|Double-blind Treatment Phase (Period 1)|Physician Decision|0
5833164|NCT02406027|20158735|P1|Double-blind Treatment Phase (Period 1)|Physician Decision|3
5833165|NCT02406027|20158729|P7|Double-blind Treatment Phase (Period 1)|Adverse Event|0
5833166|NCT02406027|20158730|P6|Double-blind Treatment Phase (Period 1)|Adverse Event|0
5833167|NCT02406027|20158731|P5|Double-blind Treatment Phase (Period 1)|Adverse Event|0
5833168|NCT02406027|20158732|P4|Double-blind Treatment Phase (Period 1)|Adverse Event|0
5833169|NCT02406027|20158733|P3|Double-blind Treatment Phase (Period 1)|Adverse Event|1
5833170|NCT02406027|20158734|P2|Double-blind Treatment Phase (Period 1)|Adverse Event|2
5833171|NCT02406027|20158735|P1|Double-blind Treatment Phase (Period 1)|Adverse Event|0
5833172|NCT02405962|20158765|P2|Overall Study|A participant has moved to another place|1
5833173|NCT02405962|20158766|P1|Overall Study|A participant has moved to another place|0
5833174|NCT02405962|20158765|P2|Overall Study|Lost to Follow-up|4
5833175|NCT02405962|20158766|P1|Overall Study|Lost to Follow-up|1
5833176|NCT02405780|20158804|P4|Period II|Non-compliance with study procedures|4
5833177|NCT02405780|20158805|P3|Period II|Non-compliance with study procedures|7
5833178|NCT02405780|20158806|P2|Period II|Non-compliance with study procedures|2
5833179|NCT02405780|20158807|P1|Period II|Non-compliance with study procedures|5
5833180|NCT02405780|20158804|P4|Period II|Withdrawal by Subject|3
5833181|NCT02405780|20158805|P3|Period II|Withdrawal by Subject|0
5833182|NCT02405780|20158806|P2|Period II|Withdrawal by Subject|4
5833183|NCT02405780|20158807|P1|Period II|Withdrawal by Subject|7
5833184|NCT02405780|20158804|P4|Period II|Pregnancy|0
5833185|NCT02405780|20158805|P3|Period II|Pregnancy|1
5833186|NCT02405780|20158806|P2|Period II|Pregnancy|0
5833187|NCT02405780|20158807|P1|Period II|Pregnancy|0
5833188|NCT02405780|20158804|P4|Period II|Medical reason|0
5833189|NCT02405780|20158805|P3|Period II|Medical reason|0
5833190|NCT02405780|20158806|P2|Period II|Medical reason|1
5833191|NCT02405780|20158807|P1|Period II|Medical reason|0
5833192|NCT02405780|20158804|P4|Period II|Adverse Event|11
5833193|NCT02405780|20158805|P3|Period II|Adverse Event|4
5833194|NCT02405780|20158806|P2|Period II|Adverse Event|5
5833195|NCT02405780|20158807|P1|Period II|Adverse Event|3
5833196|NCT02405780|20158804|P4|Period I|Non-compliance with study procedures|11
5833197|NCT02405780|20158805|P3|Period I|Non-compliance with study procedures|8
5833198|NCT02405780|20158806|P2|Period I|Non-compliance with study procedures|6
5833199|NCT02405780|20158807|P1|Period I|Non-compliance with study procedures|8
5833200|NCT02405780|20158804|P4|Period I|Withdrawal by Subject|4
5833201|NCT02405780|20158805|P3|Period I|Withdrawal by Subject|3
5833202|NCT02405780|20158806|P2|Period I|Withdrawal by Subject|1
5833203|NCT02405780|20158807|P1|Period I|Withdrawal by Subject|9
5833204|NCT02405780|20158804|P4|Period I|Screening Failure|0
5833205|NCT02405780|20158805|P3|Period I|Screening Failure|1
5833206|NCT02405780|20158806|P2|Period I|Screening Failure|0
5833207|NCT02405780|20158807|P1|Period I|Screening Failure|1
5833208|NCT02405780|20158804|P4|Period I|Medical reasons|1
5833209|NCT02405780|20158805|P3|Period I|Medical reasons|0
5833210|NCT02405780|20158806|P2|Period I|Medical reasons|1
5833211|NCT02405780|20158807|P1|Period I|Medical reasons|1
5833212|NCT02405780|20158804|P4|Period I|Adverse Event|7
5833213|NCT02405780|20158805|P3|Period I|Adverse Event|3
5833214|NCT02405780|20158806|P2|Period I|Adverse Event|0
5833215|NCT02405780|20158807|P1|Period I|Adverse Event|8
5833216|NCT02405442|20158870|P4|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0
5833217|NCT02405442|20158871|P3|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0
5833218|NCT02405442|20158872|P2|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0
5833219|NCT02405442|20158873|P1|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|1
5833220|NCT02405442|20158870|P4|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0
5833221|NCT02405442|20158871|P3|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0
5833222|NCT02405442|20158872|P2|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|1
5833223|NCT02405442|20158873|P1|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0
5833224|NCT02405442|20158870|P4|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2
5833225|NCT02405442|20158871|P3|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2
5833226|NCT02405442|20158872|P2|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|1
5833227|NCT02405442|20158873|P1|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2
5833228|NCT02405442|20158870|P4|Open-Label Phase (up to Week 52)|Lost to Follow-up|0
5833229|NCT02405442|20158871|P3|Open-Label Phase (up to Week 52)|Lost to Follow-up|0
5833230|NCT02405442|20158872|P2|Open-Label Phase (up to Week 52)|Lost to Follow-up|1
5833231|NCT02405442|20158873|P1|Open-Label Phase (up to Week 52)|Lost to Follow-up|0
5833232|NCT02405442|20158870|P4|Open-Label Phase (up to Week 52)|Lack of Efficacy|0
5833233|NCT02405442|20158871|P3|Open-Label Phase (up to Week 52)|Lack of Efficacy|0
5833234|NCT02405442|20158872|P2|Open-Label Phase (up to Week 52)|Lack of Efficacy|1
5833235|NCT02405442|20158873|P1|Open-Label Phase (up to Week 52)|Lack of Efficacy|0
5833236|NCT02405442|20158870|P4|Open-Label Phase (up to Week 52)|Withdrew Consent|1
5833237|NCT02405442|20158871|P3|Open-Label Phase (up to Week 52)|Withdrew Consent|1
5833238|NCT02405442|20158872|P2|Open-Label Phase (up to Week 52)|Withdrew Consent|2
5833239|NCT02405442|20158873|P1|Open-Label Phase (up to Week 52)|Withdrew Consent|1
5833240|NCT02405442|20158870|P4|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|2
5833241|NCT02405442|20158871|P3|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|3
5833242|NCT02405442|20158872|P2|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|1
5833243|NCT02405442|20158873|P1|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|0
5833244|NCT02405442|20158870|P4|Open-Label Phase (up to Week 52)|Adverse Event|6
5833245|NCT02405442|20158871|P3|Open-Label Phase (up to Week 52)|Adverse Event|2
5833246|NCT02405442|20158872|P2|Open-Label Phase (up to Week 52)|Adverse Event|1
5833247|NCT02405442|20158873|P1|Open-Label Phase (up to Week 52)|Adverse Event|6
5833248|NCT02405442|20158870|P4|Open-Label Phase (up to Week 52)|Investigator's Discretion|2
5833249|NCT02405442|20158871|P3|Open-Label Phase (up to Week 52)|Investigator's Discretion|11
5833250|NCT02405442|20158872|P2|Open-Label Phase (up to Week 52)|Investigator's Discretion|11
5833251|NCT02405442|20158873|P1|Open-Label Phase (up to Week 52)|Investigator's Discretion|14
5833252|NCT02405442|20158870|P4|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|13
5833253|NCT02405442|20158871|P3|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28
5833254|NCT02405442|20158872|P2|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28
5833255|NCT02405442|20158873|P1|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|27
5833256|NCT02405442|20158870|P4|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0
5833257|NCT02405442|20158871|P3|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0
5833258|NCT02405442|20158872|P2|Double-Blind Phase (up to Week 8)|Investigator's Discretion|1
5833259|NCT02405442|20158873|P1|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0
5833260|NCT02405442|20158870|P4|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0
5833261|NCT02405442|20158871|P3|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0
5833262|NCT02405442|20158872|P2|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1
5833263|NCT02405442|20158873|P1|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1
5833264|NCT02405442|20158870|P4|Double-Blind Phase (up to Week 8)|Withdrew Consent|0
5833265|NCT02405442|20158871|P3|Double-Blind Phase (up to Week 8)|Withdrew Consent|2
5833266|NCT02405442|20158872|P2|Double-Blind Phase (up to Week 8)|Withdrew Consent|1
5833267|NCT02405442|20158873|P1|Double-Blind Phase (up to Week 8)|Withdrew Consent|0
5833268|NCT02405442|20158870|P4|Double-Blind Phase (up to Week 8)|Adverse Event|1
5833269|NCT02405442|20158871|P3|Double-Blind Phase (up to Week 8)|Adverse Event|4
5833270|NCT02405442|20158872|P2|Double-Blind Phase (up to Week 8)|Adverse Event|2
5833271|NCT02405442|20158873|P1|Double-Blind Phase (up to Week 8)|Adverse Event|0
5833272|NCT02405091|20158927|P3|Overall Study|Physician Decision|0
5833273|NCT02405091|20158928|P2|Overall Study|Physician Decision|2
5833274|NCT02405091|20158929|P1|Overall Study|Physician Decision|2
5833275|NCT02405091|20158927|P3|Overall Study|Lost to Follow-up|0
5833276|NCT02405091|20158928|P2|Overall Study|Lost to Follow-up|6
5833277|NCT02405091|20158929|P1|Overall Study|Lost to Follow-up|5
5833278|NCT02405091|20158927|P3|Overall Study|Death|0
5833279|NCT02405091|20158928|P2|Overall Study|Death|1
5833280|NCT02405091|20158929|P1|Overall Study|Death|0
5833281|NCT02405091|20158927|P3|Overall Study|Withdrawal by Subject|0
5833282|NCT02405091|20158928|P2|Overall Study|Withdrawal by Subject|8
5833283|NCT02405091|20158929|P1|Overall Study|Withdrawal by Subject|4
5833284|NCT02405091|20158927|P3|Overall Study|Noncompliance|2
5833285|NCT02405091|20158928|P2|Overall Study|Noncompliance|6
5833286|NCT02405091|20158929|P1|Overall Study|Noncompliance|1
5833287|NCT02405091|20158927|P3|Overall Study|Protocol Violation|0
5833288|NCT02405091|20158928|P2|Overall Study|Protocol Violation|0
5833289|NCT02405091|20158929|P1|Overall Study|Protocol Violation|1
5833290|NCT02405091|20158927|P3|Overall Study|Adverse Event|0
5833291|NCT02405091|20158928|P2|Overall Study|Adverse Event|10
5833292|NCT02405091|20158929|P1|Overall Study|Adverse Event|16
5833293|NCT02404649|20158965|P2|Overall Study|Adverse Event|2
5833294|NCT02404649|20158966|P1|Overall Study|Adverse Event|1
5833295|NCT02404545|20158985|P2|Overall Study|Sponsor Termination|6
5833296|NCT02404545|20158986|P1|Overall Study|Sponsor Termination|6
5833297|NCT02404493|20159005|P2|Overall Study|Adverse Event|1
5833298|NCT02404493|20159006|P1|Overall Study|Adverse Event|1
5833299|NCT02404389|20159251|P5|Overall Study|Subject/guardian decision|1
5833300|NCT02404389|20159252|P4|Overall Study|Subject/guardian decision|1
5833301|NCT02404389|20159253|P3|Overall Study|Subject/guardian decision|0
5833302|NCT02404389|20159254|P2|Overall Study|Subject/guardian decision|0
5833303|NCT02404389|20159255|P1|Overall Study|Subject/guardian decision|1
5833304|NCT02404389|20159251|P5|Overall Study|Adverse Event|2
5833305|NCT02404389|20159252|P4|Overall Study|Adverse Event|0
5833306|NCT02404389|20159253|P3|Overall Study|Adverse Event|1
5833307|NCT02404389|20159254|P2|Overall Study|Adverse Event|0
5833308|NCT02404389|20159255|P1|Overall Study|Adverse Event|1
5833309|NCT02404350|20159295|P4|Overall Study|Due to Technical problems|1
5833310|NCT02404350|20159296|P3|Overall Study|Due to Technical problems|0
5833311|NCT02404350|20159297|P2|Overall Study|Due to Technical problems|0
5833312|NCT02404350|20159298|P1|Overall Study|Due to Technical problems|0
5833313|NCT02404350|20159295|P4|Overall Study|Due to Non-compliance with treatment|1
5833314|NCT02404350|20159296|P3|Overall Study|Due to Non-compliance with treatment|0
5833315|NCT02404350|20159297|P2|Overall Study|Due to Non-compliance with treatment|0
5833316|NCT02404350|20159298|P1|Overall Study|Due to Non-compliance with treatment|0
5833317|NCT02404350|20159295|P4|Overall Study|Withdrawal by Subject|19
5833318|NCT02404350|20159296|P3|Overall Study|Withdrawal by Subject|3
5833319|NCT02404350|20159297|P2|Overall Study|Withdrawal by Subject|3
5833320|NCT02404350|20159298|P1|Overall Study|Withdrawal by Subject|7
5833321|NCT02404350|20159295|P4|Overall Study|Pregnancy|1
5833322|NCT02404350|20159296|P3|Overall Study|Pregnancy|0
5833323|NCT02404350|20159297|P2|Overall Study|Pregnancy|0
5833324|NCT02404350|20159298|P1|Overall Study|Pregnancy|0
5833325|NCT02404350|20159295|P4|Overall Study|Physician Decision|2
5833326|NCT02404350|20159296|P3|Overall Study|Physician Decision|0
5833327|NCT02404350|20159297|P2|Overall Study|Physician Decision|0
5833328|NCT02404350|20159298|P1|Overall Study|Physician Decision|1
5833329|NCT02404350|20159295|P4|Overall Study|Lost to Follow-up|1
5833330|NCT02404350|20159296|P3|Overall Study|Lost to Follow-up|0
5833331|NCT02404350|20159297|P2|Overall Study|Lost to Follow-up|0
5833332|NCT02404350|20159298|P1|Overall Study|Lost to Follow-up|2
5833333|NCT02404350|20159295|P4|Overall Study|Lack of Efficacy|3
5833334|NCT02404350|20159296|P3|Overall Study|Lack of Efficacy|0
5833335|NCT02404350|20159297|P2|Overall Study|Lack of Efficacy|1
5833336|NCT02404350|20159298|P1|Overall Study|Lack of Efficacy|3
5833337|NCT02404350|20159295|P4|Overall Study|Adverse Event|9
5833338|NCT02404350|20159296|P3|Overall Study|Adverse Event|3
5833339|NCT02404350|20159297|P2|Overall Study|Adverse Event|2
5833340|NCT02404350|20159298|P1|Overall Study|Adverse Event|2
5833341|NCT02404311|20159346|P5|Part A: Month 0-18|Participant unable to adhere|0
5833342|NCT02404311|20159347|P4|Part A: Month 0-18|Participant unable to adhere|0
5833343|NCT02404311|20159348|P3|Part A: Month 0-18|Participant unable to adhere|0
5833344|NCT02404311|20159349|P2|Part A: Month 0-18|Participant unable to adhere|0
5833345|NCT02404311|20159350|P1|Part A: Month 0-18|Participant unable to adhere|7
5833346|NCT02404311|20159346|P5|Part A: Month 0-18|HIV Infection|0
5833347|NCT02404311|20159347|P4|Part A: Month 0-18|HIV Infection|0
5833348|NCT02404311|20159348|P3|Part A: Month 0-18|HIV Infection|0
5833349|NCT02404311|20159349|P2|Part A: Month 0-18|HIV Infection|2
5833350|NCT02404311|20159350|P1|Part A: Month 0-18|HIV Infection|6
5833351|NCT02404311|20159346|P5|Part A: Month 0-18|Withdrawal by Subject|0
5833352|NCT02404311|20159347|P4|Part A: Month 0-18|Withdrawal by Subject|0
5833353|NCT02404311|20159348|P3|Part A: Month 0-18|Withdrawal by Subject|0
5833354|NCT02404311|20159349|P2|Part A: Month 0-18|Withdrawal by Subject|2
5833355|NCT02404311|20159350|P1|Part A: Month 0-18|Withdrawal by Subject|6
5833356|NCT02404311|20159346|P5|Part A: Month 0-18|Lost to Follow-up|0
5833357|NCT02404311|20159347|P4|Part A: Month 0-18|Lost to Follow-up|0
5833358|NCT02404311|20159348|P3|Part A: Month 0-18|Lost to Follow-up|0
5833359|NCT02404311|20159349|P2|Part A: Month 0-18|Lost to Follow-up|2
5833360|NCT02404311|20159350|P1|Part A: Month 0-18|Lost to Follow-up|4
5833361|NCT02404311|20159346|P5|Part A: Month 0-18|Physician Decision|0
5833362|NCT02404311|20159347|P4|Part A: Month 0-18|Physician Decision|0
5833363|NCT02404311|20159348|P3|Part A: Month 0-18|Physician Decision|0
5833364|NCT02404311|20159349|P2|Part A: Month 0-18|Physician Decision|0
5833365|NCT02404311|20159350|P1|Part A: Month 0-18|Physician Decision|1
5833366|NCT02404311|20159346|P5|Part A: Month 0-18|Death|0
5833367|NCT02404311|20159347|P4|Part A: Month 0-18|Death|0
5833368|NCT02404311|20159348|P3|Part A: Month 0-18|Death|0
5833369|NCT02404311|20159349|P2|Part A: Month 0-18|Death|0
5833370|NCT02404311|20159350|P1|Part A: Month 0-18|Death|2
5833371|NCT02404220|20159491|P4|Overall Study|Enrolled but Never Treated|0
5833372|NCT02404220|20159492|P3|Overall Study|Enrolled but Never Treated|0
5833373|NCT02404220|20159493|P2|Overall Study|Enrolled but Never Treated|2
5833374|NCT02404220|20159494|P1|Overall Study|Enrolled but Never Treated|0
5833375|NCT02404220|20159491|P4|Overall Study|Withdrawal by Subject|0
5833376|NCT02404220|20159492|P3|Overall Study|Withdrawal by Subject|0
5833377|NCT02404220|20159493|P2|Overall Study|Withdrawal by Subject|1
5833378|NCT02404220|20159494|P1|Overall Study|Withdrawal by Subject|0
5833379|NCT02404220|20159491|P4|Overall Study|Study Terminated by Sponsor|1
5833380|NCT02404220|20159492|P3|Overall Study|Study Terminated by Sponsor|2
5833381|NCT02404220|20159493|P2|Overall Study|Study Terminated by Sponsor|0
5833382|NCT02404220|20159494|P1|Overall Study|Study Terminated by Sponsor|0
5833383|NCT02404220|20159491|P4|Overall Study|Progressive Disease|1
5833384|NCT02404220|20159492|P3|Overall Study|Progressive Disease|1
5833385|NCT02404220|20159493|P2|Overall Study|Progressive Disease|0
5833386|NCT02404220|20159494|P1|Overall Study|Progressive Disease|0
5833387|NCT02404220|20159491|P4|Overall Study|Death|8
5833388|NCT02404220|20159492|P3|Overall Study|Death|3
5833389|NCT02404220|20159493|P2|Overall Study|Death|5
5833390|NCT02404220|20159494|P1|Overall Study|Death|5
5833391|NCT02404220|20159491|P4|Overall Study|Adverse Event|0
5833392|NCT02404220|20159492|P3|Overall Study|Adverse Event|1
5833393|NCT02404220|20159493|P2|Overall Study|Adverse Event|0
5833394|NCT02404220|20159494|P1|Overall Study|Adverse Event|0
5833395|NCT02404103|20159530|P2|Overall Study|Lost to Follow-up|3
5833396|NCT02404103|20159531|P1|Overall Study|Lost to Follow-up|3
5833397|NCT02404103|20159530|P2|Overall Study|Adverse Event|0
5833398|NCT02404103|20159531|P1|Overall Study|Adverse Event|1
5833399|NCT02404025|20159551|P1|Overall Study|Lack of Efficacy|3
5833400|NCT02404025|20159551|P1|Overall Study|Adverse Event|1
5833401|NCT02403817|20159633|P2|Overall Study|Withdrawal by Subject|0
5833402|NCT02403817|20159634|P1|Overall Study|Withdrawal by Subject|5
5833403|NCT02403674|20159665|P2|Overall Study|Protocol Violation|2
5833404|NCT02403674|20159666|P1|Overall Study|Protocol Violation|4
5833405|NCT02403674|20159665|P2|Overall Study|Pregnancy|1
5833406|NCT02403674|20159666|P1|Overall Study|Pregnancy|1
5833407|NCT02403674|20159665|P2|Overall Study|Not treated with study drug|2
5833408|NCT02403674|20159666|P1|Overall Study|Not treated with study drug|4
5833409|NCT02403674|20159665|P2|Overall Study|Physician Decision|2
5833410|NCT02403674|20159666|P1|Overall Study|Physician Decision|2
5833411|NCT02403674|20159665|P2|Overall Study|Withdrawal by Subject|11
5833412|NCT02403674|20159666|P1|Overall Study|Withdrawal by Subject|8
5833413|NCT02403674|20159665|P2|Overall Study|Noncompliance with study drug|2
5833414|NCT02403674|20159666|P1|Overall Study|Noncompliance with study drug|1
5833415|NCT02403674|20159665|P2|Overall Study|Lost to Follow-up|7
5833416|NCT02403674|20159666|P1|Overall Study|Lost to Follow-up|6
5833417|NCT02403674|20159665|P2|Overall Study|Lack of Efficacy|10
5833418|NCT02403674|20159666|P1|Overall Study|Lack of Efficacy|18
5833419|NCT02403674|20159665|P2|Overall Study|Death|3
5833420|NCT02403674|20159666|P1|Overall Study|Death|1
5833421|NCT02403674|20159665|P2|Overall Study|Adverse Event|23
5833422|NCT02403674|20159666|P1|Overall Study|Adverse Event|10
5833423|NCT02403635|20159705|P1|Overall Study|Not eligible|9
5833424|NCT02403271|20159782|P2|Period 2|Other varied reasons|10
5833425|NCT02403271|20159783|P1|Period 2|Other varied reasons|0
5833426|NCT02403271|20159782|P2|Period 2|Study Terminated by Sponsor|14
5833427|NCT02403271|20159783|P1|Period 2|Study Terminated by Sponsor|0
5833428|NCT02403271|20159782|P2|Period 2|Lost to Follow-up|2
5833429|NCT02403271|20159783|P1|Period 2|Lost to Follow-up|0
5833430|NCT02403271|20159782|P2|Period 2|Death|84
5833431|NCT02403271|20159783|P1|Period 2|Death|0
5833432|NCT02403271|20159782|P2|Period 2|Withdrawal by Subject|14
5833433|NCT02403271|20159783|P1|Period 2|Withdrawal by Subject|0
5833434|NCT02403271|20159782|P2|Period 1|Other varied reasons|0
5833435|NCT02403271|20159783|P1|Period 1|Other varied reasons|1
5833436|NCT02403206|20159797|P2|Overall Study|Reason not given|4
5833437|NCT02403206|20159798|P1|Overall Study|Reason not given|2
5833438|NCT02403206|20159797|P2|Overall Study|Withdrawal by Subject|3
5833439|NCT02403206|20159798|P1|Overall Study|Withdrawal by Subject|3
5833440|NCT02403206|20159797|P2|Overall Study|Physician Decision|0
5833441|NCT02403206|20159798|P1|Overall Study|Physician Decision|2
5833442|NCT02403206|20159797|P2|Overall Study|Lost to Follow-up|3
5833443|NCT02403206|20159798|P1|Overall Study|Lost to Follow-up|4
5833444|NCT02403180|20159809|P2|Period 2 (5 Days)|Withdrawal by Subject|1
5833445|NCT02403180|20159810|P1|Period 2 (5 Days)|Withdrawal by Subject|0
5833446|NCT02403180|20159809|P2|Pre-Treatment Period|Withdrawal by subject prior to treatment|1
5833447|NCT02403180|20159810|P1|Pre-Treatment Period|Withdrawal by subject prior to treatment|0
5833448|NCT02402933|20159839|P1|Overall Study|Discontinued; Site Termination|10
5833449|NCT02402933|20159839|P1|Overall Study|Withdrawal by Subject|4
5833450|NCT02402907|20159848|P2|Overall Study|Lost to follow up after C-Section|23
5833451|NCT02402907|20159849|P1|Overall Study|Lost to follow up after C-Section|10
5833452|NCT02402907|20159848|P2|Overall Study|Delivered outside of Sinai|1
5833453|NCT02402907|20159849|P1|Overall Study|Delivered outside of Sinai|1
5833454|NCT02402907|20159848|P2|Overall Study|Delivered vaginally|3
5833455|NCT02402907|20159849|P1|Overall Study|Delivered vaginally|9
5833456|NCT02402322|20159904|P3|Follow-up|Withdrawal by Subject|24
5833457|NCT02402322|20159905|P2|Follow-up|Withdrawal by Subject|3
5833458|NCT02402322|20159906|P1|Follow-up|Withdrawal by Subject|6
5833459|NCT02402322|20159904|P3|Pretreatment|Withdrawal by Subject|1
5833460|NCT02402322|20159905|P2|Pretreatment|Withdrawal by Subject|1
5833461|NCT02402322|20159906|P1|Pretreatment|Withdrawal by Subject|3
5833462|NCT02402218|20159956|P3|Overall Study|Withdrawal by Subject|1
5833463|NCT02402218|20159957|P2|Overall Study|Withdrawal by Subject|1
5833464|NCT02402218|20159958|P1|Overall Study|Withdrawal by Subject|1
5833465|NCT02402218|20159956|P3|Overall Study|Adverse Event|1
5833466|NCT02402218|20159957|P2|Overall Study|Adverse Event|2
5833467|NCT02402218|20159958|P1|Overall Study|Adverse Event|0
5833468|NCT02402218|20159956|P3|Overall Study|Reinfection|1
5833469|NCT02402218|20159957|P2|Overall Study|Reinfection|0
5833470|NCT02402218|20159958|P1|Overall Study|Reinfection|0
5833471|NCT02402218|20159956|P3|Overall Study|Death|0
5833472|NCT02402218|20159957|P2|Overall Study|Death|0
5833473|NCT02402218|20159958|P1|Overall Study|Death|1
5833474|NCT02402218|20159956|P3|Overall Study|Lack of Efficacy|1
5833475|NCT02402218|20159957|P2|Overall Study|Lack of Efficacy|1
5833476|NCT02402218|20159958|P1|Overall Study|Lack of Efficacy|0
5833477|NCT02402218|20159956|P3|Overall Study|Did not pickup study medication|13
5833478|NCT02402218|20159957|P2|Overall Study|Did not pickup study medication|9
5833479|NCT02402218|20159958|P1|Overall Study|Did not pickup study medication|12
5833480|NCT02402166|20159981|P1|Overall Study|Lost to Follow-up|1
5833481|NCT02402166|20159981|P1|Overall Study|Withdrawal by Subject|2
5833482|NCT02402166|20159981|P1|Overall Study|Adverse Event|2
5833483|NCT02401867|20160048|P1|Analysis|Cervical assay could not be conducted|9
5833484|NCT02401867|20160048|P1|Specimen Collection|Didn't receive 1 or more tests|10
5833485|NCT02401672|20160055|P2|Overall Study|Withdrawal by Subject|3
5833486|NCT02401672|20160056|P1|Overall Study|Withdrawal by Subject|1
5833487|NCT02401529|20160098|P2|Overall Study|Protocol Violation|0
5833488|NCT02401529|20160099|P1|Overall Study|Protocol Violation|5
5833489|NCT02401529|20160098|P2|Overall Study|Physician Decision|6
5833490|NCT02401529|20160099|P1|Overall Study|Physician Decision|2
5833491|NCT02401529|20160098|P2|Overall Study|Lost to Follow-up|1
5833492|NCT02401529|20160099|P1|Overall Study|Lost to Follow-up|2
5833493|NCT02401412|20160166|P2|Overall Study|Improper Enrollment per In/Ex Criteria|6
5833494|NCT02401412|20160167|P1|Overall Study|Improper Enrollment per In/Ex Criteria|10
5833495|NCT02401412|20160166|P2|Overall Study|Subject withdrawal prior to intervention|1
5833496|NCT02401412|20160167|P1|Overall Study|Subject withdrawal prior to intervention|0
5833497|NCT02401412|20160166|P2|Overall Study|Withdrawal by Subject|4
5833498|NCT02401412|20160167|P1|Overall Study|Withdrawal by Subject|4
5833499|NCT02401412|20160166|P2|Overall Study|Discontinued Intervention|21
5833500|NCT02401412|20160167|P1|Overall Study|Discontinued Intervention|15
5833501|NCT02401412|20160166|P2|Overall Study|Lost to Follow-up|0
5833502|NCT02401412|20160167|P1|Overall Study|Lost to Follow-up|1
5833503|NCT02401256|20160175|P1|Overall Study|Withdrawal by Subject|12
5833504|NCT02401256|20160175|P1|Overall Study|Adverse Event|5
5833505|NCT02401230|20160184|P3|Overall Study|Lost to Follow-up|3
5833506|NCT02401230|20160185|P2|Overall Study|Lost to Follow-up|3
5833507|NCT02401230|20160186|P1|Overall Study|Lost to Follow-up|1
5833508|NCT02401230|20160184|P3|Overall Study|Withdrawal by Subject|1
5833509|NCT02401230|20160185|P2|Overall Study|Withdrawal by Subject|1
5833510|NCT02401230|20160186|P1|Overall Study|Withdrawal by Subject|2
5833511|NCT02401230|20160184|P3|Overall Study|Adverse Event|0
5833512|NCT02401230|20160185|P2|Overall Study|Adverse Event|2
5833513|NCT02401230|20160186|P1|Overall Study|Adverse Event|3
5833514|NCT02400905|20160265|P1|Overall Study|Subject refused visit|1
5833515|NCT02400905|20160265|P1|Overall Study|Death|3
5833516|NCT02400905|20160265|P1|Overall Study|Withdrawal by Subject|5
5833517|NCT02400905|20160265|P1|Overall Study|Lost to Follow-up|6
5833518|NCT02400905|20160265|P1|Overall Study|Ongoing Follow-up|256
5833519|NCT02400749|20160275|P2|Week 17 - 32|Adverse Event|1
5833520|NCT02400749|20160276|P1|Week 17 - 32|Adverse Event|2
5833521|NCT02400749|20160275|P2|Week 17 - 32|Withdrawal by Subject|2
5833522|NCT02400749|20160276|P1|Week 17 - 32|Withdrawal by Subject|3
5833523|NCT02400749|20160275|P2|Week 0 -16|Protocol Violation|0
5833524|NCT02400749|20160276|P1|Week 0 -16|Protocol Violation|1
5833525|NCT02400749|20160275|P2|Week 0 -16|Lost to Follow-up|0
5833526|NCT02400749|20160276|P1|Week 0 -16|Lost to Follow-up|2
5833527|NCT02400749|20160275|P2|Week 0 -16|Adverse Event|1
5833528|NCT02400749|20160276|P1|Week 0 -16|Adverse Event|3
5833529|NCT02400749|20160275|P2|Week 0 -16|Withdrawal by Subject|5
5833530|NCT02400749|20160276|P1|Week 0 -16|Withdrawal by Subject|5
5833531|NCT02400580|20160303|P2|Overall Study|Adverse Event|0
5833532|NCT02400580|20160304|P1|Overall Study|Adverse Event|1
5833533|NCT02400580|20160303|P2|Overall Study|Withdrawal by Subject|1
5833534|NCT02400580|20160304|P1|Overall Study|Withdrawal by Subject|1
5833535|NCT02400346|20160339|P1|Overall Study|Lost to Follow-up|1
5833536|NCT02400346|20160339|P1|Overall Study|Administrative or other reason(s)|2
5833537|NCT02400346|20160339|P1|Overall Study|Withdrawal by Subject|7
5833538|NCT02400346|20160339|P1|Overall Study|Non-compliance with IMP|1
5833539|NCT02400346|20160339|P1|Overall Study|Lack of Efficacy|9
5833540|NCT02400346|20160339|P1|Overall Study|Adverse Event|24
5833541|NCT02400333|20160347|P4|Overall Study|Protocol Violation|1
5833542|NCT02400333|20160348|P3|Overall Study|Protocol Violation|2
5833543|NCT02400333|20160349|P2|Overall Study|Protocol Violation|0
5833544|NCT02400333|20160350|P1|Overall Study|Protocol Violation|1
5833545|NCT02400333|20160347|P4|Overall Study|Withdrawal by Subject|1
5833546|NCT02400333|20160348|P3|Overall Study|Withdrawal by Subject|0
5833547|NCT02400333|20160349|P2|Overall Study|Withdrawal by Subject|1
5833548|NCT02400333|20160350|P1|Overall Study|Withdrawal by Subject|0
5833549|NCT02400307|20160410|P2|Overall Study|Enrolled and Never Dosed|0
5833550|NCT02400307|20160411|P1|Overall Study|Enrolled and Never Dosed|1
5833551|NCT02399254|20160465|P1|Overall Study|Physician Decision|2
5833552|NCT02399163|20160472|P1|Overall Study|Withdrawal by Participant|5
5833553|NCT02399163|20160472|P1|Overall Study|Protocol Deviation|2
5833554|NCT02399163|20160472|P1|Overall Study|Adverse Event|2
5833555|NCT02398227|20160542|P2|Overall Study|Removed from treatment and dropped out|0
5833556|NCT02398227|20160543|P1|Overall Study|Removed from treatment and dropped out|1
5833557|NCT02398227|20160542|P2|Overall Study|Withdrawal by Subject|6
5833558|NCT02398227|20160543|P1|Overall Study|Withdrawal by Subject|5
5833559|NCT02398227|20160542|P2|Overall Study|Lost to Follow-up|12
5833560|NCT02398227|20160543|P1|Overall Study|Lost to Follow-up|21
5833561|NCT02398188|20160553|P2|Overall Study|Withdrawal by Subject|16
5833562|NCT02398188|20160554|P1|Overall Study|Withdrawal by Subject|7
5833563|NCT02398188|20160553|P2|Overall Study|Pregnancy|0
5833564|NCT02398188|20160554|P1|Overall Study|Pregnancy|1
5833565|NCT02398188|20160553|P2|Overall Study|Sponsor Decision|1
5833566|NCT02398188|20160554|P1|Overall Study|Sponsor Decision|2
5833567|NCT02398188|20160553|P2|Overall Study|Protocol Violation|10
5833568|NCT02398188|20160554|P1|Overall Study|Protocol Violation|6
5833569|NCT02398188|20160553|P2|Overall Study|Non-compliance|4
5833570|NCT02398188|20160554|P1|Overall Study|Non-compliance|4
5833571|NCT02398188|20160553|P2|Overall Study|Lost to Follow-up|0
5833572|NCT02398188|20160554|P1|Overall Study|Lost to Follow-up|5
5833573|NCT02398188|20160553|P2|Overall Study|Adverse Event|3
5833574|NCT02398188|20160554|P1|Overall Study|Adverse Event|2
5833575|NCT02397915|20160572|P4|Period 1|Physician Decision|0
5833576|NCT02397915|20160573|P3|Period 1|Physician Decision|0
5833577|NCT02397915|20160574|P2|Period 1|Physician Decision|0
5833578|NCT02397915|20160575|P1|Period 1|Physician Decision|1
5833579|NCT02397915|20160572|P4|Period 1|Protocol Violation|0
5833580|NCT02397915|20160573|P3|Period 1|Protocol Violation|0
5833581|NCT02397915|20160574|P2|Period 1|Protocol Violation|1
5833582|NCT02397915|20160575|P1|Period 1|Protocol Violation|0
5833583|NCT02397837|20160627|P2|Overall Study|Physician Decision|1
5833584|NCT02397837|20160628|P1|Overall Study|Physician Decision|1
5833585|NCT02397837|20160627|P2|Overall Study|Withdrawal by Subject|5
5833586|NCT02397837|20160628|P1|Overall Study|Withdrawal by Subject|6
5833587|NCT02397694|20160723|P2|Open Label Extension Phase|Lost to Follow-up|0
5833588|NCT02397694|20160724|P1|Open Label Extension Phase|Lost to Follow-up|4
5833589|NCT02397694|20160723|P2|Open Label Extension Phase|Withdrew Consent|1
5833590|NCT02397694|20160724|P1|Open Label Extension Phase|Withdrew Consent|3
5833591|NCT02397694|20160723|P2|Open Label Extension Phase|Protocol Violation|0
5833592|NCT02397694|20160724|P1|Open Label Extension Phase|Protocol Violation|1
5833593|NCT02397694|20160723|P2|Double-Blinded Phase|Lost to Follow-up|1
5833594|NCT02397694|20160724|P1|Double-Blinded Phase|Lost to Follow-up|1
5833595|NCT02397694|20160723|P2|Double-Blinded Phase|Withdrawal by Subject|0
5833596|NCT02397694|20160724|P1|Double-Blinded Phase|Withdrawal by Subject|1
5833597|NCT02397694|20160723|P2|Double-Blinded Phase|Non-compliance with study drug|2
5833598|NCT02397694|20160724|P1|Double-Blinded Phase|Non-compliance with study drug|0
5833599|NCT02397694|20160723|P2|Double-Blinded Phase|Adverse Event|0
5833600|NCT02397694|20160724|P1|Double-Blinded Phase|Adverse Event|1
5833601|NCT02397655|20160762|P1|Overall Study|data not completed|1301
5833602|NCT02397473|20160773|P2|Post Treatment Follow-up Phase|Withdrawal by Subject|1
5833603|NCT02397473|20160774|P1|Post Treatment Follow-up Phase|Withdrawal by Subject|0
5833604|NCT02397473|20160773|P2|Post Treatment Follow-up Phase|Protocol Violation|0
5833605|NCT02397473|20160774|P1|Post Treatment Follow-up Phase|Protocol Violation|1
5833606|NCT02397473|20160773|P2|Post Treatment Follow-up Phase|Lost to Follow-up|0
5833607|NCT02397473|20160774|P1|Post Treatment Follow-up Phase|Lost to Follow-up|1
5833608|NCT02397473|20160773|P2|Post Treatment Follow-up Phase|Lack of Efficacy|1
5833609|NCT02397473|20160774|P1|Post Treatment Follow-up Phase|Lack of Efficacy|1
5833610|NCT02397473|20160773|P2|Treatment Phase|Protocol Violation(did not receive drug)|3
5833611|NCT02397473|20160774|P1|Treatment Phase|Protocol Violation(did not receive drug)|0
5833612|NCT02397473|20160773|P2|Treatment Phase|Withdrawal by Subject|1
5833613|NCT02397473|20160774|P1|Treatment Phase|Withdrawal by Subject|2
5833614|NCT02397473|20160773|P2|Treatment Phase|Lost to Follow-up|0
5833615|NCT02397473|20160774|P1|Treatment Phase|Lost to Follow-up|1
5833616|NCT02397473|20160773|P2|Treatment Phase|Lack of Efficacy|1
5833617|NCT02397473|20160774|P1|Treatment Phase|Lack of Efficacy|8
5833618|NCT02397473|20160773|P2|Treatment Phase|Adverse Event|2
5833619|NCT02397473|20160774|P1|Treatment Phase|Adverse Event|1
5833620|NCT02397447|20160804|P2|Overall Study|Lost to Follow-up|2
5833621|NCT02397447|20160805|P1|Overall Study|Lost to Follow-up|2
5833622|NCT02397408|20160851|P1|Overall Study|Surgery not completed within protocol timeframe|2
5833623|NCT02397408|20160851|P1|Overall Study|Physician Decision|4
5833624|NCT02397096|20160900|P2|Study Extensions|Ongoing|202
5833625|NCT02397096|20160901|P1|Study Extensions|Ongoing|399
5833626|NCT02397096|20160900|P2|Week 24 to Week 48|Lost to Follow-up|0
5833627|NCT02397096|20160901|P1|Week 24 to Week 48|Lost to Follow-up|2
5833628|NCT02397096|20160900|P2|Week 24 to Week 48|Withdrawal by Subject|2
5833629|NCT02397096|20160901|P1|Week 24 to Week 48|Withdrawal by Subject|5
5833630|NCT02397096|20160900|P2|Week 24 to Week 48|Physician Decision|1
5833631|NCT02397096|20160901|P1|Week 24 to Week 48|Physician Decision|2
5833632|NCT02397096|20160900|P2|Week 24 to Week 48|Non-Compliance With Study Drug|1
5833633|NCT02397096|20160901|P1|Week 24 to Week 48|Non-Compliance With Study Drug|0
5833634|NCT02397096|20160900|P2|Week 24 to Week 48|Lack of Efficacy|1
5833635|NCT02397096|20160901|P1|Week 24 to Week 48|Lack of Efficacy|5
5833636|NCT02397096|20160900|P2|Week 24 to Week 48|Adverse Event|2
5833637|NCT02397096|20160901|P1|Week 24 to Week 48|Adverse Event|6
5833638|NCT02397096|20160900|P2|Day 1 to Week 24|Withdrawal by Subject|1
5833639|NCT02397096|20160901|P1|Day 1 to Week 24|Withdrawal by Subject|6
5833640|NCT02397096|20160900|P2|Day 1 to Week 24|Protocol Violation|4
5833641|NCT02397096|20160901|P1|Day 1 to Week 24|Protocol Violation|1
5833642|NCT02397096|20160900|P2|Day 1 to Week 24|Physician Decision|3
5833643|NCT02397096|20160901|P1|Day 1 to Week 24|Physician Decision|2
5833644|NCT02397096|20160900|P2|Day 1 to Week 24|Lost to Follow-up|4
5833645|NCT02397096|20160901|P1|Day 1 to Week 24|Lost to Follow-up|3
5833646|NCT02397096|20160900|P2|Day 1 to Week 24|Lack of Efficacy|1
5833647|NCT02397096|20160901|P1|Day 1 to Week 24|Lack of Efficacy|0
5833648|NCT02397096|20160900|P2|Day 1 to Week 24|Death|0
5833649|NCT02397096|20160901|P1|Day 1 to Week 24|Death|1
5833650|NCT02397096|20160900|P2|Day 1 to Week 24|Adverse Event|1
5833651|NCT02397096|20160901|P1|Day 1 to Week 24|Adverse Event|7
5833652|NCT02396953|20160934|P3|Overall Study|Personal Reasons|0
5833653|NCT02396953|20160935|P2|Overall Study|Personal Reasons|1
5833654|NCT02396953|20160936|P1|Overall Study|Personal Reasons|1
5833655|NCT02396953|20160934|P3|Overall Study|Insulin like Growth Factor-1 increased|2
5833656|NCT02396953|20160935|P2|Overall Study|Insulin like Growth Factor-1 increased|2
5833657|NCT02396953|20160936|P1|Overall Study|Insulin like Growth Factor-1 increased|3
5833658|NCT02396953|20160934|P3|Overall Study|Withdrawal by Subject|1
5833659|NCT02396953|20160935|P2|Overall Study|Withdrawal by Subject|0
5833660|NCT02396953|20160936|P1|Overall Study|Withdrawal by Subject|0
5833661|NCT02396537|20161011|P2|Overall Study|Protocol Violation|1
5833662|NCT02396537|20161012|P1|Overall Study|Protocol Violation|0
5833663|NCT02396420|20161024|P1|Overall Study|Death|1
5833664|NCT02396381|20161048|P2|Overall Study|Randomization/Screening Error|1
5833665|NCT02396381|20161049|P1|Overall Study|Randomization/Screening Error|3
5833666|NCT02396381|20161048|P2|Overall Study|Possible conflict of interest|0
5833667|NCT02396381|20161049|P1|Overall Study|Possible conflict of interest|1
5833668|NCT02396381|20161048|P2|Overall Study|Could not complete visit|0
5833669|NCT02396381|20161049|P1|Overall Study|Could not complete visit|1
5833670|NCT02396381|20161048|P2|Overall Study|Moved out of town/state|3
5833671|NCT02396381|20161049|P1|Overall Study|Moved out of town/state|1
5833672|NCT02396381|20161048|P2|Overall Study|Non-compliance with study procedures|0
5833673|NCT02396381|20161049|P1|Overall Study|Non-compliance with study procedures|1
5833674|NCT02396381|20161048|P2|Overall Study|Pregnancy|0
5833675|NCT02396381|20161049|P1|Overall Study|Pregnancy|2
5833676|NCT02396381|20161048|P2|Overall Study|Physician Decision|5
5833677|NCT02396381|20161049|P1|Overall Study|Physician Decision|5
5833678|NCT02396381|20161048|P2|Overall Study|Site terminated by sponsor|8
5833679|NCT02396381|20161049|P1|Overall Study|Site terminated by sponsor|7
5833680|NCT02396381|20161048|P2|Overall Study|Protocol Violation|0
5833681|NCT02396381|20161049|P1|Overall Study|Protocol Violation|1
5833682|NCT02396381|20161048|P2|Overall Study|Lost to Follow-up|31
5833683|NCT02396381|20161049|P1|Overall Study|Lost to Follow-up|49
5833684|NCT02396381|20161048|P2|Overall Study|Withdrawal by Subject|24
5833685|NCT02396381|20161049|P1|Overall Study|Withdrawal by Subject|33
5833686|NCT02396381|20161048|P2|Overall Study|Adverse Event|2
5833687|NCT02396381|20161049|P1|Overall Study|Adverse Event|3
5833688|NCT02396316|20161088|P2|Overall Study|Treatment unblinded|1
5833689|NCT02396316|20161089|P1|Overall Study|Treatment unblinded|0
5833690|NCT02396316|20161088|P2|Overall Study|Protocol Violation|1
5833691|NCT02396316|20161089|P1|Overall Study|Protocol Violation|0
5833692|NCT02396316|20161088|P2|Overall Study|Progressive disease|3
5833693|NCT02396316|20161089|P1|Overall Study|Progressive disease|6
5833694|NCT02396316|20161088|P2|Overall Study|Physician Decision|0
5833695|NCT02396316|20161089|P1|Overall Study|Physician Decision|1
5833696|NCT02396212|20161108|P1|Overall Study|Lack of Efficacy|2
5833697|NCT02396212|20161108|P1|Overall Study|Adverse Event|1
5833698|NCT02395822|20161261|P1|Overall Study|Death|1
5833699|NCT02395822|20161261|P1|Overall Study|Withdrawal by Subject|1
5833700|NCT02395666|20161282|P2|Overall Study|Withdrawal by Subject|1
5833701|NCT02395666|20161283|P1|Overall Study|Withdrawal by Subject|2
5833702|NCT02395666|20161282|P2|Overall Study|Lost to Follow-up|0
5833703|NCT02395666|20161283|P1|Overall Study|Lost to Follow-up|1
5833704|NCT02395666|20161282|P2|Overall Study|Physician Decision|0
5833705|NCT02395666|20161283|P1|Overall Study|Physician Decision|3
5833706|NCT02395653|20161297|P1|Overall Study|Lost to Follow-up|1
5833707|NCT02395653|20161297|P1|Overall Study|Withdrawal by Subject|1
5833708|NCT02395653|20161297|P1|Overall Study|Inclusion Criteria Not Met at Screening|3
5833709|NCT02395653|20161297|P1|Overall Study|Investigator Decision at Screening|1
5833710|NCT02395653|20161297|P1|Overall Study|SSEC Application But With 0 Dose|1
5833711|NCT02395653|20161297|P1|Overall Study|Consent Withdrawn at Screening|1
5833712|NCT02395653|20161297|P1|Overall Study|Exclusion Criteria Met at Screening|4
5833713|NCT02395627|20161307|P3|Overall Study|Did not receive pembrolizumab|0
5833714|NCT02395627|20161308|P2|Overall Study|Did not receive pembrolizumab|1
5833715|NCT02395627|20161309|P1|Overall Study|Did not receive pembrolizumab|3
5833716|NCT02395627|20161307|P3|Overall Study|Withdrawal by Subject|0
5833717|NCT02395627|20161308|P2|Overall Study|Withdrawal by Subject|2
5833718|NCT02395627|20161309|P1|Overall Study|Withdrawal by Subject|0
5833719|NCT02395536|20161337|P2|Overall Study|Insurance issue|1
5833720|NCT02395536|20161338|P1|Overall Study|Insurance issue|0
5833721|NCT02395536|20161337|P2|Overall Study|Inclusion/Excusion Criteria Violation|2
5833722|NCT02395536|20161338|P1|Overall Study|Inclusion/Excusion Criteria Violation|1
5833723|NCT02395536|20161337|P2|Overall Study|Withdrawal by Subject|17
5833724|NCT02395536|20161338|P1|Overall Study|Withdrawal by Subject|9
5833725|NCT02395536|20161337|P2|Overall Study|Physician Decision|6
5833726|NCT02395536|20161338|P1|Overall Study|Physician Decision|4
5833727|NCT02395536|20161337|P2|Overall Study|Death|0
5833728|NCT02395536|20161338|P1|Overall Study|Death|2
5833729|NCT02395536|20161337|P2|Overall Study|Lost to Follow-up|4
5833730|NCT02395536|20161338|P1|Overall Study|Lost to Follow-up|4
5833731|NCT02395471|20161346|P2|Overall Study|Subject not eligible|0
5833732|NCT02395471|20161347|P1|Overall Study|Subject not eligible|1
5833733|NCT02395471|20161346|P2|Overall Study|Patient did not return for procedure|1
5833734|NCT02395471|20161347|P1|Overall Study|Patient did not return for procedure|0
5833735|NCT02395471|20161346|P2|Overall Study|Failure to swollow sponge twice|0
5833736|NCT02395471|20161347|P1|Overall Study|Failure to swollow sponge twice|1
5833737|NCT02395471|20161346|P2|Overall Study|Protocol Violation|1
5833738|NCT02395471|20161347|P1|Overall Study|Protocol Violation|0
5833739|NCT02395471|20161346|P2|Overall Study|Physician Decision|0
5833740|NCT02395471|20161347|P1|Overall Study|Physician Decision|1
5833741|NCT02395471|20161346|P2|Overall Study|Withdrawal by Subject|1
5833742|NCT02395471|20161347|P1|Overall Study|Withdrawal by Subject|2
5833743|NCT02395471|20161346|P2|Overall Study|Lost to Follow-up|0
5833744|NCT02395471|20161347|P1|Overall Study|Lost to Follow-up|2
5833745|NCT02395302|20161362|P1|Overall Study|Physician Decision|2
5833746|NCT02395302|20161362|P1|Overall Study|Withdrawal by Subject|2
5833747|NCT02395302|20161362|P1|Overall Study|Run In Failure|7
5833748|NCT02395302|20161362|P1|Overall Study|Screen Failure|3
5833749|NCT02395172|20161382|P2|Overall Study|Participants randomized but not treated|31
5833750|NCT02395172|20161383|P1|Overall Study|Participants randomized but not treated|3
5833751|NCT02395133|20161422|P4|Overall Study|Other than specified above|4
5833752|NCT02395133|20161423|P3|Overall Study|Other than specified above|2
5833753|NCT02395133|20161424|P2|Overall Study|Other than specified above|2
5833754|NCT02395133|20161425|P1|Overall Study|Other than specified above|5
5833755|NCT02395133|20161422|P4|Overall Study|Sponsor decision|1
5833756|NCT02395133|20161423|P3|Overall Study|Sponsor decision|0
5833757|NCT02395133|20161424|P2|Overall Study|Sponsor decision|0
5833758|NCT02395133|20161425|P1|Overall Study|Sponsor decision|2
5833759|NCT02395133|20161422|P4|Overall Study|Consent withdrawn with personal reason|3
5833760|NCT02395133|20161423|P3|Overall Study|Consent withdrawn with personal reason|0
5833761|NCT02395133|20161424|P2|Overall Study|Consent withdrawn with personal reason|1
5833762|NCT02395133|20161425|P1|Overall Study|Consent withdrawn with personal reason|0
5833763|NCT02395133|20161422|P4|Overall Study|Consent withdrawn with no reason given|2
5833764|NCT02395133|20161423|P3|Overall Study|Consent withdrawn with no reason given|0
5833765|NCT02395133|20161424|P2|Overall Study|Consent withdrawn with no reason given|3
5833766|NCT02395133|20161425|P1|Overall Study|Consent withdrawn with no reason given|1
5833767|NCT02395133|20161422|P4|Overall Study|Pregnancy|0
5833768|NCT02395133|20161423|P3|Overall Study|Pregnancy|3
5833769|NCT02395133|20161424|P2|Overall Study|Pregnancy|0
5833770|NCT02395133|20161425|P1|Overall Study|Pregnancy|0
5833771|NCT02395133|20161422|P4|Overall Study|Lost to Follow-up|0
5833772|NCT02395133|20161423|P3|Overall Study|Lost to Follow-up|1
5833773|NCT02395133|20161424|P2|Overall Study|Lost to Follow-up|1
5833774|NCT02395133|20161425|P1|Overall Study|Lost to Follow-up|0
5833775|NCT02395133|20161422|P4|Overall Study|Protocol Violation|3
5833776|NCT02395133|20161423|P3|Overall Study|Protocol Violation|0
5833777|NCT02395133|20161424|P2|Overall Study|Protocol Violation|1
5833778|NCT02395133|20161425|P1|Overall Study|Protocol Violation|1
5833779|NCT02395133|20161422|P4|Overall Study|Lack of Efficacy|1
5833780|NCT02395133|20161423|P3|Overall Study|Lack of Efficacy|1
5833781|NCT02395133|20161424|P2|Overall Study|Lack of Efficacy|0
5833782|NCT02395133|20161425|P1|Overall Study|Lack of Efficacy|1
5833783|NCT02395133|20161422|P4|Overall Study|Adverse Event|0
5833784|NCT02395133|20161423|P3|Overall Study|Adverse Event|3
5833785|NCT02395133|20161424|P2|Overall Study|Adverse Event|1
5833786|NCT02395133|20161425|P1|Overall Study|Adverse Event|4
5833787|NCT02395055|20161513|P2|Overall Study|Withdrawal by Subject|3
5833788|NCT02395055|20161514|P1|Overall Study|Withdrawal by Subject|7
5833789|NCT02395042|20161527|P3|Treatment 2 Period|Lack of Efficacy|0
5833790|NCT02395042|20161528|P2|Treatment 2 Period|Lack of Efficacy|1
5833791|NCT02395042|20161529|P1|Treatment 2 Period|Lack of Efficacy|1
5833792|NCT02395042|20161527|P3|Treatment 1 Period|Other Miscellaneous Reasons|1
5833793|NCT02395042|20161528|P2|Treatment 1 Period|Other Miscellaneous Reasons|2
5833794|NCT02395042|20161529|P1|Treatment 1 Period|Other Miscellaneous Reasons|0
5833795|NCT02395042|20161527|P3|Treatment 1 Period|Lost to Follow-up|0
5833796|NCT02395042|20161528|P2|Treatment 1 Period|Lost to Follow-up|0
5833797|NCT02395042|20161529|P1|Treatment 1 Period|Lost to Follow-up|1
5833798|NCT02395042|20161527|P3|Treatment 1 Period|Lack of Efficacy|0
5833799|NCT02395042|20161528|P2|Treatment 1 Period|Lack of Efficacy|1
5833800|NCT02395042|20161529|P1|Treatment 1 Period|Lack of Efficacy|1
5833801|NCT02395042|20161527|P3|Treatment 1 Period|Adverse Event|1
5833802|NCT02395042|20161528|P2|Treatment 1 Period|Adverse Event|3
5833803|NCT02395042|20161529|P1|Treatment 1 Period|Adverse Event|1
5833804|NCT02394925|20161567|P1|Overall Study|Unsatisfactory Visual Response|5
5833805|NCT02394925|20161567|P1|Overall Study|No longer meet eligibility criteria|1
5833806|NCT02394925|20161567|P1|Overall Study|Protocol Violation|5
5833807|NCT02394925|20161567|P1|Overall Study|Lost to Follow-up|9
5833808|NCT02394925|20161567|P1|Overall Study|Lens handling difficulities|5
5833809|NCT02394925|20161567|P1|Overall Study|Lens Discomfort|3
5833810|NCT02394925|20161567|P1|Overall Study|Adverse Event|1
5833811|NCT02394808|20161577|P2|Period 2|Lost to Follow-up|0
5833812|NCT02394808|20161578|P1|Period 2|Lost to Follow-up|1
5833813|NCT02394808|20161577|P2|Period 1|Unsatisfactory lens fitting|1
5833814|NCT02394808|20161578|P1|Period 1|Unsatisfactory lens fitting|0
5833815|NCT02394756|20161586|P6|Period 2|Unsatisfactory Visual Response|0
5833816|NCT02394756|20161587|P5|Period 2|Unsatisfactory Visual Response|1
5833817|NCT02394756|20161588|P4|Period 2|Unsatisfactory Visual Response|0
5833818|NCT02394756|20161589|P3|Period 2|Unsatisfactory Visual Response|0
5833819|NCT02394756|20161590|P2|Period 2|Unsatisfactory Visual Response|0
5833820|NCT02394756|20161591|P1|Period 2|Unsatisfactory Visual Response|0
5833821|NCT02394756|20161586|P6|Period 1|Withdrawal by Subject|0
5833822|NCT02394756|20161587|P5|Period 1|Withdrawal by Subject|0
5833823|NCT02394756|20161588|P4|Period 1|Withdrawal by Subject|1
5833824|NCT02394756|20161589|P3|Period 1|Withdrawal by Subject|1
5833825|NCT02394756|20161590|P2|Period 1|Withdrawal by Subject|1
5833826|NCT02394756|20161591|P1|Period 1|Withdrawal by Subject|0
5833827|NCT02394756|20161586|P6|Period 1|Lens Discomfort|1
5833828|NCT02394756|20161587|P5|Period 1|Lens Discomfort|0
5833829|NCT02394756|20161588|P4|Period 1|Lens Discomfort|0
5833830|NCT02394756|20161589|P3|Period 1|Lens Discomfort|0
5833831|NCT02394756|20161590|P2|Period 1|Lens Discomfort|0
5833832|NCT02394756|20161591|P1|Period 1|Lens Discomfort|0
5833833|NCT02394730|20161604|P2|Overall Study|Withdrawal by Subject|1
5833834|NCT02394730|20161605|P1|Overall Study|Withdrawal by Subject|0
5833835|NCT02394730|20161604|P2|Overall Study|Lost to Follow-up|0
5833836|NCT02394730|20161605|P1|Overall Study|Lost to Follow-up|1
5833837|NCT02394665|20161642|P3|Overall Study|Physician Decision|0
5833838|NCT02394665|20161643|P2|Overall Study|Physician Decision|0
5833839|NCT02394665|20161644|P1|Overall Study|Physician Decision|1
5833840|NCT02394600|20161666|P2|Overall Study|Protocol Violation|0
5833841|NCT02394600|20161667|P1|Overall Study|Protocol Violation|1
5833842|NCT02394600|20161666|P2|Overall Study|Withdrawal by Subject|1
5833843|NCT02394600|20161667|P1|Overall Study|Withdrawal by Subject|0
5833844|NCT02394600|20161666|P2|Overall Study|Lost to Follow-up|1
5833845|NCT02394600|20161667|P1|Overall Study|Lost to Follow-up|0
5833846|NCT02394600|20161666|P2|Overall Study|Adverse Event|0
5833847|NCT02394600|20161667|P1|Overall Study|Adverse Event|3
5833848|NCT02394561|20161677|P2|Extension Phase|Lack of Efficacy|3
5833849|NCT02394561|20161678|P1|Extension Phase|Lack of Efficacy|3
5833850|NCT02394561|20161677|P2|Extension Phase|Withdrawal by Subject|5
5833851|NCT02394561|20161678|P1|Extension Phase|Withdrawal by Subject|0
5833852|NCT02394561|20161677|P2|Extension Phase|Physician Decision|2
5833853|NCT02394561|20161678|P1|Extension Phase|Physician Decision|0
5833854|NCT02394561|20161677|P2|Extension Phase|Lost to Follow-up|0
5833855|NCT02394561|20161678|P1|Extension Phase|Lost to Follow-up|1
5833856|NCT02394561|20161677|P2|Extension Phase|Protocol Violation|0
5833857|NCT02394561|20161678|P1|Extension Phase|Protocol Violation|1
5833858|NCT02394561|20161677|P2|Extension Phase|Death|1
5833859|NCT02394561|20161678|P1|Extension Phase|Death|0
5833860|NCT02394561|20161677|P2|Extension Phase|Adverse Event|1
5833861|NCT02394561|20161678|P1|Extension Phase|Adverse Event|6
5833862|NCT02394561|20161677|P2|CORE Phase|Lack of Efficacy|6
5833863|NCT02394561|20161678|P1|CORE Phase|Lack of Efficacy|1
5833864|NCT02394561|20161677|P2|CORE Phase|Withdrawal by Subject|2
5833865|NCT02394561|20161678|P1|CORE Phase|Withdrawal by Subject|2
5833866|NCT02394561|20161677|P2|CORE Phase|Physician Decision|1
5833867|NCT02394561|20161678|P1|CORE Phase|Physician Decision|1
5833868|NCT02394561|20161677|P2|CORE Phase|Lost to Follow-up|0
5833869|NCT02394561|20161678|P1|CORE Phase|Lost to Follow-up|1
5833870|NCT02394561|20161677|P2|CORE Phase|Pregnancy|0
5833871|NCT02394561|20161678|P1|CORE Phase|Pregnancy|1
5833872|NCT02394561|20161677|P2|CORE Phase|Death|1
5833873|NCT02394561|20161678|P1|CORE Phase|Death|0
5833874|NCT02394561|20161677|P2|CORE Phase|Adverse Event|9
5833875|NCT02394561|20161678|P1|CORE Phase|Adverse Event|7
5833876|NCT02394340|20161725|P1|Overall Study|Adverse Event|1
5833877|NCT02394340|20161725|P1|Overall Study|Failed drug screen test|1
5833878|NCT02393950|20161732|P2|Overall Study|Withdrawal by Subject|1
5833879|NCT02393950|20161733|P1|Overall Study|Withdrawal by Subject|0
5833880|NCT02393950|20161732|P2|Overall Study|Adverse Event|0
5833881|NCT02393950|20161733|P1|Overall Study|Adverse Event|1
5833882|NCT02393859|20161800|P2|Overall Study|Continuing Study|43
5833883|NCT02393859|20161801|P1|Overall Study|Continuing Study|32
5833884|NCT02393859|20161800|P2|Overall Study|Death|8
5833885|NCT02393859|20161801|P1|Overall Study|Death|16
5833886|NCT02393859|20161800|P2|Overall Study|Withdrawal by Subject|2
5833887|NCT02393859|20161801|P1|Overall Study|Withdrawal by Subject|5
5833888|NCT02393859|20161800|P2|Overall Study|Decision by Sponsor|1
5833889|NCT02393859|20161801|P1|Overall Study|Decision by Sponsor|1
5833890|NCT02393755|20161826|P2|Overall Study|Physician Decision|2
5833891|NCT02393755|20161827|P1|Overall Study|Physician Decision|0
5833892|NCT02393755|20161826|P2|Overall Study|Adverse Event|2
5833893|NCT02393755|20161827|P1|Overall Study|Adverse Event|0
5833894|NCT02393755|20161826|P2|Overall Study|Withdrawal by Subject|3
5833895|NCT02393755|20161827|P1|Overall Study|Withdrawal by Subject|0
5833896|NCT02393547|20161846|P1|Overall Study|Lost to Follow-up|1
5833897|NCT02393547|20161846|P1|Overall Study|Withdrawal by Subject|3
5833898|NCT02393547|20161846|P1|Overall Study|Adverse Event|2
5833899|NCT02393209|20161937|P4|Overall Study|Lost to Follow-up|0
5833900|NCT02393209|20161938|P3|Overall Study|Lost to Follow-up|0
5833901|NCT02393209|20161939|P2|Overall Study|Lost to Follow-up|1
5833902|NCT02393209|20161940|P1|Overall Study|Lost to Follow-up|0
5833903|NCT02393209|20161937|P4|Overall Study|Patient Seen by Another Oncologist|0
5833904|NCT02393209|20161938|P3|Overall Study|Patient Seen by Another Oncologist|0
5833905|NCT02393209|20161939|P2|Overall Study|Patient Seen by Another Oncologist|1
5833906|NCT02393209|20161940|P1|Overall Study|Patient Seen by Another Oncologist|0
5833907|NCT02393209|20161937|P4|Overall Study|Death from Legionella Infection|0
5833908|NCT02393209|20161938|P3|Overall Study|Death from Legionella Infection|0
5833909|NCT02393209|20161939|P2|Overall Study|Death from Legionella Infection|1
5833910|NCT02393209|20161940|P1|Overall Study|Death from Legionella Infection|0
5833911|NCT02393209|20161937|P4|Overall Study|Death due to Disease Progression|0
5833912|NCT02393209|20161938|P3|Overall Study|Death due to Disease Progression|0
5833913|NCT02393209|20161939|P2|Overall Study|Death due to Disease Progression|2
5833914|NCT02393209|20161940|P1|Overall Study|Death due to Disease Progression|2
5833915|NCT02393209|20161937|P4|Overall Study|Death|0
5833916|NCT02393209|20161938|P3|Overall Study|Death|0
5833917|NCT02393209|20161939|P2|Overall Study|Death|2
5833918|NCT02393209|20161940|P1|Overall Study|Death|2
5833919|NCT02393209|20161937|P4|Overall Study|Withdrawal by Patient|0
5833920|NCT02393209|20161938|P3|Overall Study|Withdrawal by Patient|0
5833921|NCT02393209|20161939|P2|Overall Study|Withdrawal by Patient|0
5833922|NCT02393209|20161940|P1|Overall Study|Withdrawal by Patient|1
5833923|NCT02393209|20161937|P4|Overall Study|Study Terminated by Sponsor|0
5833924|NCT02393209|20161938|P3|Overall Study|Study Terminated by Sponsor|0
5833925|NCT02393209|20161939|P2|Overall Study|Study Terminated by Sponsor|1
5833926|NCT02393209|20161940|P1|Overall Study|Study Terminated by Sponsor|1
5833927|NCT02392624|20162029|P3|Overall Study|Other|1
5833928|NCT02392624|20162030|P2|Overall Study|Other|1
5833929|NCT02392624|20162031|P1|Overall Study|Other|49
5833930|NCT02392624|20162029|P3|Overall Study|Sponsor/Investigator Decision|0
5833931|NCT02392624|20162030|P2|Overall Study|Sponsor/Investigator Decision|1
5833932|NCT02392624|20162031|P1|Overall Study|Sponsor/Investigator Decision|2
5833933|NCT02392624|20162029|P3|Overall Study|Protocol Violation|1
5833934|NCT02392624|20162030|P2|Overall Study|Protocol Violation|0
5833935|NCT02392624|20162031|P1|Overall Study|Protocol Violation|0
5833936|NCT02392624|20162029|P3|Overall Study|Pregnancy|0
5833937|NCT02392624|20162030|P2|Overall Study|Pregnancy|0
5833938|NCT02392624|20162031|P1|Overall Study|Pregnancy|1
5833939|NCT02392624|20162029|P3|Overall Study|Adverse Event|2
5833940|NCT02392624|20162030|P2|Overall Study|Adverse Event|1
5833941|NCT02392624|20162031|P1|Overall Study|Adverse Event|4
5833942|NCT02392624|20162029|P3|Overall Study|Withdrawal by Subject|9
5833943|NCT02392624|20162030|P2|Overall Study|Withdrawal by Subject|12
5833944|NCT02392624|20162031|P1|Overall Study|Withdrawal by Subject|15
5833945|NCT02392611|20162053|P9|Overall Study|Enrolled, not treated|0
5833946|NCT02392611|20162054|P8|Overall Study|Enrolled, not treated|0
5833947|NCT02392611|20162055|P7|Overall Study|Enrolled, not treated|0
5833948|NCT02392611|20162056|P6|Overall Study|Enrolled, not treated|0
5833949|NCT02392611|20162057|P5|Overall Study|Enrolled, not treated|0
5833950|NCT02392611|20162058|P4|Overall Study|Enrolled, not treated|2
5833951|NCT02392611|20162059|P3|Overall Study|Enrolled, not treated|0
5833952|NCT02392611|20162060|P2|Overall Study|Enrolled, not treated|0
5833953|NCT02392611|20162061|P1|Overall Study|Enrolled, not treated|0
5833954|NCT02392611|20162053|P9|Overall Study|Lost to Follow-up|0
5833955|NCT02392611|20162054|P8|Overall Study|Lost to Follow-up|0
5833956|NCT02392611|20162055|P7|Overall Study|Lost to Follow-up|1
5833957|NCT02392611|20162056|P6|Overall Study|Lost to Follow-up|0
5833958|NCT02392611|20162057|P5|Overall Study|Lost to Follow-up|0
5833959|NCT02392611|20162058|P4|Overall Study|Lost to Follow-up|0
5833960|NCT02392611|20162059|P3|Overall Study|Lost to Follow-up|0
5833961|NCT02392611|20162060|P2|Overall Study|Lost to Follow-up|0
5833962|NCT02392611|20162061|P1|Overall Study|Lost to Follow-up|0
5833963|NCT02392611|20162053|P9|Overall Study|Withdrawal by Subject|0
5833964|NCT02392611|20162054|P8|Overall Study|Withdrawal by Subject|0
5833965|NCT02392611|20162055|P7|Overall Study|Withdrawal by Subject|0
5833966|NCT02392611|20162056|P6|Overall Study|Withdrawal by Subject|0
5833967|NCT02392611|20162057|P5|Overall Study|Withdrawal by Subject|0
5833968|NCT02392611|20162058|P4|Overall Study|Withdrawal by Subject|1
5833969|NCT02392611|20162059|P3|Overall Study|Withdrawal by Subject|0
5833970|NCT02392611|20162060|P2|Overall Study|Withdrawal by Subject|0
5833971|NCT02392611|20162061|P1|Overall Study|Withdrawal by Subject|0
5833972|NCT02392611|20162053|P9|Overall Study|Death|0
5833973|NCT02392611|20162054|P8|Overall Study|Death|0
5833974|NCT02392611|20162055|P7|Overall Study|Death|0
5833975|NCT02392611|20162056|P6|Overall Study|Death|1
5833976|NCT02392611|20162057|P5|Overall Study|Death|0
5833977|NCT02392611|20162058|P4|Overall Study|Death|0
5833978|NCT02392611|20162059|P3|Overall Study|Death|0
5833979|NCT02392611|20162060|P2|Overall Study|Death|0
5833980|NCT02392611|20162061|P1|Overall Study|Death|1
5833981|NCT02392611|20162053|P9|Overall Study|Progressive disease|0
5833982|NCT02392611|20162054|P8|Overall Study|Progressive disease|0
5833983|NCT02392611|20162055|P7|Overall Study|Progressive disease|0
5833984|NCT02392611|20162056|P6|Overall Study|Progressive disease|0
5833985|NCT02392611|20162057|P5|Overall Study|Progressive disease|1
5833986|NCT02392611|20162058|P4|Overall Study|Progressive disease|2
5833987|NCT02392611|20162059|P3|Overall Study|Progressive disease|0
5833988|NCT02392611|20162060|P2|Overall Study|Progressive disease|0
5833989|NCT02392611|20162061|P1|Overall Study|Progressive disease|0
5833990|NCT02392611|20162053|P9|Overall Study|Adverse Event|0
5833991|NCT02392611|20162054|P8|Overall Study|Adverse Event|0
5833992|NCT02392611|20162055|P7|Overall Study|Adverse Event|0
5833993|NCT02392611|20162056|P6|Overall Study|Adverse Event|0
5833994|NCT02392611|20162057|P5|Overall Study|Adverse Event|0
5833995|NCT02392611|20162058|P4|Overall Study|Adverse Event|1
5833996|NCT02392611|20162059|P3|Overall Study|Adverse Event|0
5833997|NCT02392611|20162060|P2|Overall Study|Adverse Event|0
5833998|NCT02392611|20162061|P1|Overall Study|Adverse Event|0
5833999|NCT02392559|20162137|P2|Overall Study|Withdrawal by Subject|1
5834000|NCT02392559|20162138|P1|Overall Study|Withdrawal by Subject|0
5834001|NCT02392507|20162169|P1|Maintenance Regimen|On Study Treatment at Study Conclusion|1
5834002|NCT02392507|20162169|P1|Maintenance Regimen|Death|1
5834003|NCT02392507|20162169|P1|Induction Regimen|Withdrawal by Subject|2
5834004|NCT02392507|20162169|P1|Induction Regimen|Physician Decision|1
5834005|NCT02392507|20162169|P1|Induction Regimen|On Study Treatment at Study Conclusion|1
5834006|NCT02392507|20162169|P1|Induction Regimen|Death|3
5834007|NCT02392481|20162208|P4|Overall Study|Withdrawal by Subject|0
5834008|NCT02392481|20162209|P3|Overall Study|Withdrawal by Subject|1
5834009|NCT02392481|20162210|P2|Overall Study|Withdrawal by Subject|0
5834010|NCT02392481|20162211|P1|Overall Study|Withdrawal by Subject|0
5834011|NCT02392481|20162208|P4|Overall Study|Adverse Event|2
5834012|NCT02392481|20162209|P3|Overall Study|Adverse Event|1
5834013|NCT02392481|20162210|P2|Overall Study|Adverse Event|0
5834014|NCT02392481|20162211|P1|Overall Study|Adverse Event|0
5834015|NCT02392403|20162233|P1|Overall Study|Withdrawal by Subject|1
5834016|NCT02392403|20162233|P1|Overall Study|Death|1
5834017|NCT02392403|20162233|P1|Overall Study|Adverse Event|1
5834018|NCT02392377|20162247|P2|Overall Study|Withdrawal by Subject|1
5834019|NCT02392377|20162248|P1|Overall Study|Withdrawal by Subject|0
5834020|NCT02392247|20162340|P1|Overall Study|Surgery cancelled; no data|1
5834021|NCT02392247|20162340|P1|Overall Study|Withdrawal by Subject|1
5834022|NCT02392234|20162351|P6|Treatment Period 2 (8 Weeks)|Adverse Event|0
5834023|NCT02392234|20162352|P5|Treatment Period 2 (8 Weeks)|Adverse Event|0
5834024|NCT02392234|20162353|P4|Treatment Period 2 (8 Weeks)|Adverse Event|0
5834025|NCT02392234|20162354|P3|Treatment Period 2 (8 Weeks)|Adverse Event|0
5834026|NCT02392234|20162355|P2|Treatment Period 2 (8 Weeks)|Adverse Event|0
5834027|NCT02392234|20162356|P1|Treatment Period 2 (8 Weeks)|Adverse Event|1
5834028|NCT02392234|20162351|P6|Treatment Period 1 (8 Weeks)|Randomized but not treated|0
5834029|NCT02392234|20162352|P5|Treatment Period 1 (8 Weeks)|Randomized but not treated|1
5834030|NCT02392234|20162353|P4|Treatment Period 1 (8 Weeks)|Randomized but not treated|0
5834031|NCT02392234|20162354|P3|Treatment Period 1 (8 Weeks)|Randomized but not treated|1
5834032|NCT02392234|20162355|P2|Treatment Period 1 (8 Weeks)|Randomized but not treated|0
5834033|NCT02392234|20162356|P1|Treatment Period 1 (8 Weeks)|Randomized but not treated|0
5834034|NCT02392234|20162351|P6|Treatment Period 1 (8 Weeks)|Other|0
5834035|NCT02392234|20162352|P5|Treatment Period 1 (8 Weeks)|Other|0
5834036|NCT02392234|20162353|P4|Treatment Period 1 (8 Weeks)|Other|0
5834037|NCT02392234|20162354|P3|Treatment Period 1 (8 Weeks)|Other|0
5834038|NCT02392234|20162355|P2|Treatment Period 1 (8 Weeks)|Other|0
5834039|NCT02392234|20162356|P1|Treatment Period 1 (8 Weeks)|Other|1
5834040|NCT02392234|20162351|P6|Treatment Period 1 (8 Weeks)|Noncompliance|1
5834041|NCT02392234|20162352|P5|Treatment Period 1 (8 Weeks)|Noncompliance|0
5834042|NCT02392234|20162353|P4|Treatment Period 1 (8 Weeks)|Noncompliance|0
5834043|NCT02392234|20162354|P3|Treatment Period 1 (8 Weeks)|Noncompliance|0
5834044|NCT02392234|20162355|P2|Treatment Period 1 (8 Weeks)|Noncompliance|0
5834045|NCT02392234|20162356|P1|Treatment Period 1 (8 Weeks)|Noncompliance|0
5834046|NCT02392234|20162351|P6|Treatment Period 1 (8 Weeks)|Pregnancy|0
5834047|NCT02392234|20162352|P5|Treatment Period 1 (8 Weeks)|Pregnancy|0
5834048|NCT02392234|20162353|P4|Treatment Period 1 (8 Weeks)|Pregnancy|1
5834049|NCT02392234|20162354|P3|Treatment Period 1 (8 Weeks)|Pregnancy|0
5834050|NCT02392234|20162355|P2|Treatment Period 1 (8 Weeks)|Pregnancy|0
5834051|NCT02392234|20162356|P1|Treatment Period 1 (8 Weeks)|Pregnancy|1
5834052|NCT02392234|20162351|P6|Treatment Period 1 (8 Weeks)|Lost to Follow-up|1
5834053|NCT02392234|20162352|P5|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
5834054|NCT02392234|20162353|P4|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
5834055|NCT02392234|20162354|P3|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
5834056|NCT02392234|20162355|P2|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
5834057|NCT02392234|20162356|P1|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
5834058|NCT02392234|20162351|P6|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0
5834059|NCT02392234|20162352|P5|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|2
5834060|NCT02392234|20162353|P4|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0
5834061|NCT02392234|20162354|P3|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0
5834062|NCT02392234|20162355|P2|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0
5834063|NCT02392234|20162356|P1|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0
5834064|NCT02392234|20162351|P6|Treatment Period 1 (8 Weeks)|Adverse Event|1
5834065|NCT02392234|20162352|P5|Treatment Period 1 (8 Weeks)|Adverse Event|1
5834066|NCT02392234|20162353|P4|Treatment Period 1 (8 Weeks)|Adverse Event|0
5834067|NCT02392234|20162354|P3|Treatment Period 1 (8 Weeks)|Adverse Event|1
5834068|NCT02392234|20162355|P2|Treatment Period 1 (8 Weeks)|Adverse Event|0
5834069|NCT02392234|20162356|P1|Treatment Period 1 (8 Weeks)|Adverse Event|1
5834070|NCT02392195|20162388|P1|Overall Study|Withdrawal by Subject|4
5834071|NCT02392195|20162388|P1|Overall Study|Lost to Follow-up|4
5834072|NCT02392104|20162394|P1|Overall Study|INRs drawn by visiting nurse services|1
5834073|NCT02392104|20162394|P1|Overall Study|admitted to skilled nursing facility|3
5834074|NCT02392104|20162394|P1|Overall Study|INR goal range changed|1
5834075|NCT02392104|20162394|P1|Overall Study|transferred care to another doctor|2
5834076|NCT02392104|20162394|P1|Overall Study|bleeding event|1
5834077|NCT02392104|20162394|P1|Overall Study|discontinuation of warfarin|3
5834078|NCT02392000|20162405|P1|Overall Study|Lost to Follow-up|8
5834079|NCT02392000|20162405|P1|Overall Study|Withdrawal by Subject|1
5834080|NCT02392000|20162405|P1|Overall Study|Greater than mild sleep apnea exclusion|18
5834081|NCT02391961|20162428|P2|Second Intervention (4 Weeks)|Withdrawal by Subject|1
5834082|NCT02391961|20162429|P1|Second Intervention (4 Weeks)|Withdrawal by Subject|1
5834083|NCT02391961|20162428|P2|Washout (2 Weeks)|Withdrawal by Subject|1
5834084|NCT02391961|20162429|P1|Washout (2 Weeks)|Withdrawal by Subject|1
5834085|NCT02391961|20162428|P2|First Intervention (4 Weeks)|Adverse Event|0
5834086|NCT02391961|20162429|P1|First Intervention (4 Weeks)|Adverse Event|2
5834087|NCT02391948|20162452|P5|24-month Assessment|Not able to schedule visit in timeframe|8
5834088|NCT02391948|20162453|P4|24-month Assessment|Not able to schedule visit in timeframe|9
5834089|NCT02391948|20162454|P3|24-month Assessment|Not able to schedule visit in timeframe|2
5834090|NCT02391948|20162455|P2|24-month Assessment|Not able to schedule visit in timeframe|5
5834091|NCT02391948|20162456|P1|24-month Assessment|Not able to schedule visit in timeframe|8
5834092|NCT02391948|20162452|P5|24-month Assessment|Medical issue/illness|0
5834093|NCT02391948|20162453|P4|24-month Assessment|Medical issue/illness|0
5834094|NCT02391948|20162454|P3|24-month Assessment|Medical issue/illness|1
5834095|NCT02391948|20162455|P2|24-month Assessment|Medical issue/illness|0
5834096|NCT02391948|20162456|P1|24-month Assessment|Medical issue/illness|0
5834097|NCT02391948|20162452|P5|24-month Assessment|Lost to Follow-up|0
5834098|NCT02391948|20162453|P4|24-month Assessment|Lost to Follow-up|0
5834099|NCT02391948|20162454|P3|24-month Assessment|Lost to Follow-up|0
5834100|NCT02391948|20162455|P2|24-month Assessment|Lost to Follow-up|4
5834101|NCT02391948|20162456|P1|24-month Assessment|Lost to Follow-up|5
5834102|NCT02391948|20162452|P5|24-month Assessment|Withdrawal by Subject|1
5834103|NCT02391948|20162453|P4|24-month Assessment|Withdrawal by Subject|0
5834104|NCT02391948|20162454|P3|24-month Assessment|Withdrawal by Subject|0
5834105|NCT02391948|20162455|P2|24-month Assessment|Withdrawal by Subject|1
5834106|NCT02391948|20162456|P1|24-month Assessment|Withdrawal by Subject|1
5834107|NCT02391948|20162452|P5|24-month Assessment|Death|1
5834108|NCT02391948|20162453|P4|24-month Assessment|Death|0
5834109|NCT02391948|20162454|P3|24-month Assessment|Death|0
5834110|NCT02391948|20162455|P2|24-month Assessment|Death|0
5834111|NCT02391948|20162456|P1|24-month Assessment|Death|0
5834112|NCT02391948|20162452|P5|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22
5834113|NCT02391948|20162453|P4|18-month Assessment|In 2-visit study (18- and 24-month N/A)|31
5834114|NCT02391948|20162454|P3|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22
5834115|NCT02391948|20162455|P2|18-month Assessment|In 2-visit study (18- and 24-month N/A)|41
5834116|NCT02391948|20162456|P1|18-month Assessment|In 2-visit study (18- and 24-month N/A)|66
5834117|NCT02391948|20162452|P5|18-month Assessment|Not able to schedule visit in timeframe|4
5834118|NCT02391948|20162453|P4|18-month Assessment|Not able to schedule visit in timeframe|1
5834119|NCT02391948|20162454|P3|18-month Assessment|Not able to schedule visit in timeframe|2
5834120|NCT02391948|20162455|P2|18-month Assessment|Not able to schedule visit in timeframe|3
5834121|NCT02391948|20162456|P1|18-month Assessment|Not able to schedule visit in timeframe|3
5834122|NCT02391948|20162452|P5|18-month Assessment|Lost to Follow-up|3
5834123|NCT02391948|20162453|P4|18-month Assessment|Lost to Follow-up|2
5834124|NCT02391948|20162454|P3|18-month Assessment|Lost to Follow-up|2
5834125|NCT02391948|20162455|P2|18-month Assessment|Lost to Follow-up|6
5834126|NCT02391948|20162456|P1|18-month Assessment|Lost to Follow-up|2
5834127|NCT02391948|20162452|P5|18-month Assessment|Withdrawal by Subject|0
5834128|NCT02391948|20162453|P4|18-month Assessment|Withdrawal by Subject|1
5834129|NCT02391948|20162454|P3|18-month Assessment|Withdrawal by Subject|0
5834130|NCT02391948|20162455|P2|18-month Assessment|Withdrawal by Subject|0
5834131|NCT02391948|20162456|P1|18-month Assessment|Withdrawal by Subject|1
5834132|NCT02391948|20162452|P5|18-month Assessment|Death|1
5834133|NCT02391948|20162453|P4|18-month Assessment|Death|1
5834134|NCT02391948|20162454|P3|18-month Assessment|Death|0
5834135|NCT02391948|20162455|P2|18-month Assessment|Death|0
5834136|NCT02391948|20162456|P1|18-month Assessment|Death|0
5834137|NCT02391948|20162452|P5|12-month Assessment|Not able to schedule visit in timeframe|1
5834138|NCT02391948|20162453|P4|12-month Assessment|Not able to schedule visit in timeframe|2
5834139|NCT02391948|20162454|P3|12-month Assessment|Not able to schedule visit in timeframe|0
5834140|NCT02391948|20162455|P2|12-month Assessment|Not able to schedule visit in timeframe|4
5834141|NCT02391948|20162456|P1|12-month Assessment|Not able to schedule visit in timeframe|2
5834142|NCT02391948|20162452|P5|12-month Assessment|Medical issue/illness|0
5834143|NCT02391948|20162453|P4|12-month Assessment|Medical issue/illness|1
5834144|NCT02391948|20162454|P3|12-month Assessment|Medical issue/illness|0
5834145|NCT02391948|20162455|P2|12-month Assessment|Medical issue/illness|1
5834146|NCT02391948|20162456|P1|12-month Assessment|Medical issue/illness|0
5834147|NCT02391948|20162452|P5|12-month Assessment|Lost to Follow-up|5
5834148|NCT02391948|20162453|P4|12-month Assessment|Lost to Follow-up|4
5834149|NCT02391948|20162454|P3|12-month Assessment|Lost to Follow-up|4
5834150|NCT02391948|20162455|P2|12-month Assessment|Lost to Follow-up|4
5834151|NCT02391948|20162456|P1|12-month Assessment|Lost to Follow-up|5
5834152|NCT02391948|20162452|P5|12-month Assessment|Withdrawal by Subject|0
5834153|NCT02391948|20162453|P4|12-month Assessment|Withdrawal by Subject|1
5834154|NCT02391948|20162454|P3|12-month Assessment|Withdrawal by Subject|0
5834155|NCT02391948|20162455|P2|12-month Assessment|Withdrawal by Subject|0
5834156|NCT02391948|20162456|P1|12-month Assessment|Withdrawal by Subject|1
5834157|NCT02391948|20162452|P5|12-month Assessment|Death|0
5834158|NCT02391948|20162453|P4|12-month Assessment|Death|1
5834159|NCT02391948|20162454|P3|12-month Assessment|Death|0
5834160|NCT02391948|20162455|P2|12-month Assessment|Death|0
5834161|NCT02391948|20162456|P1|12-month Assessment|Death|0
5834162|NCT02391948|20162452|P5|6-month Assessment|In 2-visit study (6-month N/A)|24
5834163|NCT02391948|20162453|P4|6-month Assessment|In 2-visit study (6-month N/A)|35
5834164|NCT02391948|20162454|P3|6-month Assessment|In 2-visit study (6-month N/A)|24
5834165|NCT02391948|20162455|P2|6-month Assessment|In 2-visit study (6-month N/A)|42
5834166|NCT02391948|20162456|P1|6-month Assessment|In 2-visit study (6-month N/A)|68
5834167|NCT02391948|20162452|P5|6-month Assessment|Not able to schedule visit in timeframe|0
5834168|NCT02391948|20162453|P4|6-month Assessment|Not able to schedule visit in timeframe|5
5834169|NCT02391948|20162454|P3|6-month Assessment|Not able to schedule visit in timeframe|4
5834170|NCT02391948|20162455|P2|6-month Assessment|Not able to schedule visit in timeframe|8
5834171|NCT02391948|20162456|P1|6-month Assessment|Not able to schedule visit in timeframe|6
5834172|NCT02391948|20162452|P5|6-month Assessment|Medical issue/illness|0
5834173|NCT02391948|20162453|P4|6-month Assessment|Medical issue/illness|0
5834174|NCT02391948|20162454|P3|6-month Assessment|Medical issue/illness|0
5834175|NCT02391948|20162455|P2|6-month Assessment|Medical issue/illness|1
5834176|NCT02391948|20162456|P1|6-month Assessment|Medical issue/illness|1
5834177|NCT02391948|20162452|P5|6-month Assessment|Lost to Follow-up|1
5834178|NCT02391948|20162453|P4|6-month Assessment|Lost to Follow-up|3
5834179|NCT02391948|20162454|P3|6-month Assessment|Lost to Follow-up|2
5834180|NCT02391948|20162455|P2|6-month Assessment|Lost to Follow-up|5
5834181|NCT02391948|20162456|P1|6-month Assessment|Lost to Follow-up|4
5834182|NCT02391948|20162452|P5|6-month Assessment|Withdrawal by Subject|0
5834183|NCT02391948|20162453|P4|6-month Assessment|Withdrawal by Subject|2
5834184|NCT02391948|20162454|P3|6-month Assessment|Withdrawal by Subject|1
5834185|NCT02391948|20162455|P2|6-month Assessment|Withdrawal by Subject|0
5834186|NCT02391948|20162456|P1|6-month Assessment|Withdrawal by Subject|0
5834187|NCT02391948|20162452|P5|6-month Assessment|Death|1
5834188|NCT02391948|20162453|P4|6-month Assessment|Death|0
5834189|NCT02391948|20162454|P3|6-month Assessment|Death|0
5834190|NCT02391948|20162455|P2|6-month Assessment|Death|0
5834191|NCT02391948|20162456|P1|6-month Assessment|Death|0
5834192|NCT02391584|20162580|P2|12 Month (End of Study)|Lost to Follow-up|0
5834193|NCT02391584|20162581|P1|12 Month (End of Study)|Lost to Follow-up|2
5834194|NCT02391584|20162580|P2|6 Month|Withdrawal by Subject|0
5834195|NCT02391584|20162581|P1|6 Month|Withdrawal by Subject|1
5834196|NCT02391584|20162580|P2|3 Month|Lost to Follow-up|0
5834197|NCT02391584|20162581|P1|3 Month|Lost to Follow-up|1
5834198|NCT02391584|20162580|P2|Primary Endpoint (6-weeks)|Missed primary endpoint visit|0
5834199|NCT02391584|20162581|P1|Primary Endpoint (6-weeks)|Missed primary endpoint visit|1
5834200|NCT02391584|20162580|P2|Primary Endpoint (6-weeks)|Lost to Follow-up|2
5834201|NCT02391584|20162581|P1|Primary Endpoint (6-weeks)|Lost to Follow-up|1
5834202|NCT02391545|20162598|P2|Overall Study|Other Reasons|4
5834203|NCT02391545|20162599|P1|Overall Study|Other Reasons|6
5834204|NCT02391545|20162598|P2|Overall Study|Withdrawal by Subject|1
5834205|NCT02391545|20162599|P1|Overall Study|Withdrawal by Subject|0
5834206|NCT02391545|20162598|P2|Overall Study|Termination of study by sponsor|20
5834207|NCT02391545|20162599|P1|Overall Study|Termination of study by sponsor|20
5834208|NCT02391545|20162598|P2|Overall Study|Lost to Follow-up|1
5834209|NCT02391545|20162599|P1|Overall Study|Lost to Follow-up|0
5834210|NCT02391545|20162598|P2|Overall Study|Death|2
5834211|NCT02391545|20162599|P1|Overall Study|Death|0
5834212|NCT02391363|20162619|P2|Overall Study|Withdrawal by Subject|3
5834213|NCT02391363|20162620|P1|Overall Study|Withdrawal by Subject|6
5834214|NCT02391363|20162619|P2|Overall Study|Lost to Follow-up|5
5834215|NCT02391363|20162620|P1|Overall Study|Lost to Follow-up|5
5834216|NCT02391311|20162705|P2|Overall Study|deemed ineligible after baseline|1
5834217|NCT02391311|20162706|P1|Overall Study|deemed ineligible after baseline|1
5834218|NCT02391311|20162705|P2|Overall Study|Lost to Follow-up|1
5834219|NCT02391311|20162706|P1|Overall Study|Lost to Follow-up|2
5834220|NCT02391116|20162714|P1|Survival Follow-up|Switching to Other Therapy|1
5834221|NCT02391116|20162714|P1|Survival Follow-up|Withdrawal by Subject|3
5834222|NCT02391116|20162714|P1|Active Follow-up|Switching to Other Therapy|2
5834223|NCT02391116|20162714|P1|Active Follow-up|Withdrawal by Subject|1
5834224|NCT02391116|20162714|P1|Safety Follow-up|Deterioration of General Conditions|3
5834225|NCT02391116|20162714|P1|Safety Follow-up|No Follow Up|1
5834226|NCT02391116|20162714|P1|Safety Follow-up|Switching to Other Therapy|4
5834227|NCT02391116|20162714|P1|Safety Follow-up|Withdrawal by Subject|4
5834228|NCT02391116|20162714|P1|Safety Follow-up|Adverse Event|1
5834229|NCT02391116|20162714|P1|Treatment|AE with Clinical PD|3
5834230|NCT02391116|20162714|P1|Treatment|Adverse Event (AE) Without Clinical PD|9
5834231|NCT02391116|20162714|P1|Treatment|Protocol Violation|1
5834232|NCT02391116|20162714|P1|Treatment|Withdrawal by Subject|1
5834233|NCT02391038|20162768|P3|Overall Study|Progressive disease|6
5834234|NCT02391038|20162769|P2|Overall Study|Progressive disease|3
5834235|NCT02391038|20162770|P1|Overall Study|Progressive disease|3
5834236|NCT02390557|20162914|P3|Wave 2|Survey non-respondent|23
5834237|NCT02390557|20162915|P2|Wave 2|Survey non-respondent|41
5834238|NCT02390557|20162916|P1|Wave 2|Survey non-respondent|72
5834239|NCT02390362|20162926|P2|Overall Study|Withdrawal by Subject|1
5834240|NCT02390362|20162927|P1|Overall Study|Withdrawal by Subject|0
5834241|NCT02390219|20162935|P1|Overall Study|Other|2
5834242|NCT02390219|20162935|P1|Overall Study|Lost to Follow-up|2
5834243|NCT02390219|20162935|P1|Overall Study|Withdrawal by Subject|1
5834244|NCT02390219|20162935|P1|Overall Study|Adverse Event|6
5834245|NCT02390219|20162935|P1|Overall Study|Physician Decision|1
5834246|NCT02390219|20162935|P1|Overall Study|Death|1
5834247|NCT02390167|20162945|P1|Overall Study|Lost to Follow-up|1
5834248|NCT02390076|20162967|P3|Overall Study|Lost to Follow-up|4
5834249|NCT02390076|20162968|P2|Overall Study|Lost to Follow-up|1
5834250|NCT02390076|20162969|P1|Overall Study|Lost to Follow-up|2
5834251|NCT02389894|20162998|P3|Overall Study|Lost to Follow-up|1
5834252|NCT02389894|20162999|P2|Overall Study|Lost to Follow-up|1
5834253|NCT02389894|20163000|P1|Overall Study|Lost to Follow-up|2
5834254|NCT02389894|20162998|P3|Overall Study|Withdrawal by Subject|5
5834255|NCT02389894|20162999|P2|Overall Study|Withdrawal by Subject|4
5834256|NCT02389894|20163000|P1|Overall Study|Withdrawal by Subject|2
5834257|NCT02389894|20162998|P3|Overall Study|Death|3
5834258|NCT02389894|20162999|P2|Overall Study|Death|5
5834259|NCT02389894|20163000|P1|Overall Study|Death|4
5834260|NCT02389829|20163132|P2|Overall Study|Lost to Follow-up|1
5834261|NCT02389829|20163133|P1|Overall Study|Lost to Follow-up|0
5834262|NCT02389816|20163148|P3|Overall Study|Reason not Specified|0
5834263|NCT02389816|20163149|P2|Overall Study|Reason not Specified|2
5834264|NCT02389816|20163150|P1|Overall Study|Reason not Specified|0
5834265|NCT02389816|20163148|P3|Overall Study|Non Compliance with Study Drug|1
5834266|NCT02389816|20163149|P2|Overall Study|Non Compliance with Study Drug|1
5834267|NCT02389816|20163150|P1|Overall Study|Non Compliance with Study Drug|1
5834268|NCT02389816|20163148|P3|Overall Study|Lack of Efficacy|0
5834269|NCT02389816|20163149|P2|Overall Study|Lack of Efficacy|0
5834270|NCT02389816|20163150|P1|Overall Study|Lack of Efficacy|1
5834271|NCT02389816|20163148|P3|Overall Study|Withdrawal of Consent|4
5834272|NCT02389816|20163149|P2|Overall Study|Withdrawal of Consent|4
5834273|NCT02389816|20163150|P1|Overall Study|Withdrawal of Consent|6
5834274|NCT02389816|20163148|P3|Overall Study|Lost to Follow-up|0
5834275|NCT02389816|20163149|P2|Overall Study|Lost to Follow-up|0
5834276|NCT02389816|20163150|P1|Overall Study|Lost to Follow-up|1
5834277|NCT02389816|20163148|P3|Overall Study|Major Protocol Deviation|0
5834278|NCT02389816|20163149|P2|Overall Study|Major Protocol Deviation|0
5834279|NCT02389816|20163150|P1|Overall Study|Major Protocol Deviation|1
5834280|NCT02389816|20163148|P3|Overall Study|Pretreatment Event or Adverse Event (AE)|7
5834281|NCT02389816|20163149|P2|Overall Study|Pretreatment Event or Adverse Event (AE)|6
5834282|NCT02389816|20163150|P1|Overall Study|Pretreatment Event or Adverse Event (AE)|4
5834283|NCT02389816|20163148|P3|Overall Study|Randomized but Not Treated|0
5834284|NCT02389816|20163149|P2|Overall Study|Randomized but Not Treated|0
5834285|NCT02389816|20163150|P1|Overall Study|Randomized but Not Treated|1
5834286|NCT02389764|20163182|P1|Overall Study|Lack of Efficacy|9
5834287|NCT02389621|20163217|P2|Posttreatment Period|Other - Miscellaneous|0
5834288|NCT02389621|20163218|P1|Posttreatment Period|Other - Miscellaneous|2
5834289|NCT02389621|20163217|P2|Posttreatment Period|Lost to Follow-up|1
5834290|NCT02389621|20163218|P1|Posttreatment Period|Lost to Follow-up|1
5834291|NCT02389621|20163217|P2|Posttreatment Period|Withdrawal by Subject|2
5834292|NCT02389621|20163218|P1|Posttreatment Period|Withdrawal by Subject|3
5834293|NCT02389621|20163217|P2|Posttreatment Period|Adverse Event|1
5834294|NCT02389621|20163218|P1|Posttreatment Period|Adverse Event|3
5834295|NCT02389621|20163217|P2|Treatment Period|Withdrawal by Subject|1
5834296|NCT02389621|20163218|P1|Treatment Period|Withdrawal by Subject|1
5834297|NCT02389452|20163248|P1|Overall Study|Enrolled but Not Eligible for Study|6
5834298|NCT02389452|20163248|P1|Overall Study|Withdrawal by Subject|5
5834299|NCT02389452|20163248|P1|Overall Study|Adverse Event|1
5834300|NCT02389452|20163248|P1|Overall Study|Lost to Follow-up|13
5834301|NCT02388997|20163360|P2|Overall Study|Tested positive for virus during run-in|1
5834302|NCT02388997|20163361|P1|Overall Study|Tested positive for virus during run-in|0
5834303|NCT02388997|20163360|P2|Overall Study|Lung function exclusion criteria|2
5834304|NCT02388997|20163361|P1|Overall Study|Lung function exclusion criteria|0
5834305|NCT02388997|20163360|P2|Overall Study|Withdrawal by Subject|1
5834306|NCT02388997|20163361|P1|Overall Study|Withdrawal by Subject|2
5834307|NCT02388997|20163360|P2|Overall Study|Adverse Event|2
5834308|NCT02388997|20163361|P1|Overall Study|Adverse Event|1
5834309|NCT02388932|20163379|P1|Overall Study|Death|1
5834310|NCT02388776|20163400|P1|Overall Study|Lost to Follow-up|1
5834311|NCT02388776|20163400|P1|Overall Study|Death|1
5834312|NCT02388763|20163405|P2|Period 1, 10 Days of Wear|Withdrawal by Subject|1
5834313|NCT02388763|20163406|P1|Period 1, 10 Days of Wear|Withdrawal by Subject|1
5834314|NCT02388763|20163405|P2|Habitual, 10 Days of Wear|Withdrawal by Subject|1
5834315|NCT02388763|20163406|P1|Habitual, 10 Days of Wear|Withdrawal by Subject|1
5834316|NCT02388737|20163420|P3|Overall Study|Reason Not Specified|4
5834317|NCT02388737|20163421|P2|Overall Study|Reason Not Specified|5
5834318|NCT02388737|20163422|P1|Overall Study|Reason Not Specified|5
5834319|NCT02388737|20163420|P3|Overall Study|Lack of Efficacy|3
5834320|NCT02388737|20163421|P2|Overall Study|Lack of Efficacy|0
5834321|NCT02388737|20163422|P1|Overall Study|Lack of Efficacy|3
5834322|NCT02388737|20163420|P3|Overall Study|Voluntary Withdrawal|17
5834323|NCT02388737|20163421|P2|Overall Study|Voluntary Withdrawal|18
5834324|NCT02388737|20163422|P1|Overall Study|Voluntary Withdrawal|10
5834325|NCT02388737|20163420|P3|Overall Study|Lost to Follow-up|4
5834326|NCT02388737|20163421|P2|Overall Study|Lost to Follow-up|1
5834327|NCT02388737|20163422|P1|Overall Study|Lost to Follow-up|5
5834328|NCT02388737|20163420|P3|Overall Study|Major Protocol Deviation|22
5834329|NCT02388737|20163421|P2|Overall Study|Major Protocol Deviation|25
5834330|NCT02388737|20163422|P1|Overall Study|Major Protocol Deviation|18
5834331|NCT02388737|20163420|P3|Overall Study|Pretreatment Event/Adverse Event|12
5834332|NCT02388737|20163421|P2|Overall Study|Pretreatment Event/Adverse Event|11
5834333|NCT02388737|20163422|P1|Overall Study|Pretreatment Event/Adverse Event|13
5834334|NCT02388724|20163456|P2|Overall Study|Randomized but not Treated|2
5834335|NCT02388724|20163457|P1|Overall Study|Randomized but not Treated|0
5834336|NCT02388724|20163456|P2|Overall Study|Voluntary Withdrawal|5
5834337|NCT02388724|20163457|P1|Overall Study|Voluntary Withdrawal|6
5834338|NCT02388724|20163456|P2|Overall Study|Pretreatment Event/Adverse Event|2
5834339|NCT02388724|20163457|P1|Overall Study|Pretreatment Event/Adverse Event|3
5834340|NCT02388724|20163456|P2|Overall Study|Major Protocol Deviation|3
5834341|NCT02388724|20163457|P1|Overall Study|Major Protocol Deviation|3
5834342|NCT02388724|20163456|P2|Overall Study|Reason not Specified|1
5834343|NCT02388724|20163457|P1|Overall Study|Reason not Specified|0
5834344|NCT02388347|20163511|P5|Overall Study|Withdrawal by Subject|0
5834345|NCT02388347|20163512|P4|Overall Study|Withdrawal by Subject|0
5834346|NCT02388347|20163513|P3|Overall Study|Withdrawal by Subject|1
5834347|NCT02388347|20163514|P2|Overall Study|Withdrawal by Subject|0
5834348|NCT02388347|20163515|P1|Overall Study|Withdrawal by Subject|0
5834349|NCT02388295|20163594|P3|Treatment Weeks 3 to 12|Adverse Event|0
5834350|NCT02388295|20163595|P2|Treatment Weeks 3 to 12|Adverse Event|1
5834351|NCT02388295|20163596|P1|Treatment Weeks 3 to 12|Adverse Event|1
5834352|NCT02388295|20163594|P3|Dose Escalation Week 2|Determined not eligible|1
5834353|NCT02388295|20163595|P2|Dose Escalation Week 2|Determined not eligible|1
5834354|NCT02388295|20163596|P1|Dose Escalation Week 2|Determined not eligible|1
5834355|NCT02388295|20163594|P3|Dose Escalation Week 2|Protocol Violation|0
5834356|NCT02388295|20163595|P2|Dose Escalation Week 2|Protocol Violation|1
5834357|NCT02388295|20163596|P1|Dose Escalation Week 2|Protocol Violation|0
5834358|NCT02388295|20163594|P3|Dose Escalation Week 1|Determined not eligible|1
5834359|NCT02388295|20163595|P2|Dose Escalation Week 1|Determined not eligible|1
5834360|NCT02388295|20163596|P1|Dose Escalation Week 1|Determined not eligible|1
5834361|NCT02388295|20163594|P3|Dose Escalation Week 1|Adverse Event|1
5834362|NCT02388295|20163595|P2|Dose Escalation Week 1|Adverse Event|2
5834363|NCT02388295|20163596|P1|Dose Escalation Week 1|Adverse Event|1
5834364|NCT02388269|20163614|P3|Overall Study|Screen Failure|10
5834365|NCT02388269|20163615|P2|Overall Study|Screen Failure|0
5834366|NCT02388269|20163616|P1|Overall Study|Screen Failure|0
5834367|NCT02388269|20163614|P3|Overall Study|Protocol Violation|0
5834368|NCT02388269|20163615|P2|Overall Study|Protocol Violation|0
5834369|NCT02388269|20163616|P1|Overall Study|Protocol Violation|2
5834370|NCT02388269|20163614|P3|Overall Study|no diary data|0
5834371|NCT02388269|20163615|P2|Overall Study|no diary data|0
5834372|NCT02388269|20163616|P1|Overall Study|no diary data|3
5834373|NCT02388269|20163614|P3|Overall Study|less than 50% stimulations|0
5834374|NCT02388269|20163615|P2|Overall Study|less than 50% stimulations|0
5834375|NCT02388269|20163616|P1|Overall Study|less than 50% stimulations|1
5834376|NCT02388269|20163614|P3|Overall Study|Withdrawal by Subject|0
5834377|NCT02388269|20163615|P2|Overall Study|Withdrawal by Subject|2
5834378|NCT02388269|20163616|P1|Overall Study|Withdrawal by Subject|1
5834379|NCT02388269|20163614|P3|Overall Study|Adverse Event|0
5834380|NCT02388269|20163615|P2|Overall Study|Adverse Event|0
5834381|NCT02388269|20163616|P1|Overall Study|Adverse Event|2
5834382|NCT02388191|20163648|P2|Overall Study|Patient did not receive IUD|0
5834383|NCT02388191|20163649|P1|Overall Study|Patient did not receive IUD|1
5834384|NCT02388165|20163665|P2|Overall Study|Did not meet entrance criteria|2
5834385|NCT02388165|20163666|P1|Overall Study|Did not meet entrance criteria|5
5834386|NCT02388165|20163665|P2|Overall Study|Adverse Event|5
5834387|NCT02388165|20163666|P1|Overall Study|Adverse Event|3
5834388|NCT02388165|20163665|P2|Overall Study|Death|10
5834389|NCT02388165|20163666|P1|Overall Study|Death|13
5834390|NCT02388165|20163665|P2|Overall Study|Lost to Follow-up|20
5834391|NCT02388165|20163666|P1|Overall Study|Lost to Follow-up|19
5834392|NCT02388165|20163665|P2|Overall Study|Withdrawal of consent|32
5834393|NCT02388165|20163666|P1|Overall Study|Withdrawal of consent|31
5834394|NCT02388165|20163665|P2|Overall Study|No longer meet eligibility criteria|43
5834395|NCT02388165|20163666|P1|Overall Study|No longer meet eligibility criteria|40
5834396|NCT02388165|20163665|P2|Overall Study|Other|13
5834397|NCT02388165|20163666|P1|Overall Study|Other|11
5834398|NCT02388165|20163665|P2|Overall Study|Study terminated by sponsor|5
5834399|NCT02388165|20163666|P1|Overall Study|Study terminated by sponsor|5
5834400|NCT02388074|20163696|P1|Overall Study|Sample Not Returned|1
5834401|NCT02388074|20163696|P1|Overall Study|Lost in Transit|2
5834402|NCT02387996|20163700|P1|Overall Study|Poor/Non-Compliance|1
5834403|NCT02387996|20163700|P1|Overall Study|Lost to Follow-up|1
5834404|NCT02387996|20163700|P1|Overall Study|Subject Withdrew Consent|1
5834405|NCT02387996|20163700|P1|Overall Study|Subject Request to Discontinue Treatment|9
5834406|NCT02387996|20163700|P1|Overall Study|Adverse Event Unrelated to Study Drug|34
5834407|NCT02387996|20163700|P1|Overall Study|Study Drug Toxicity|14
5834408|NCT02387996|20163700|P1|Overall Study|Disease Progression|144
5834409|NCT02387983|20163711|P1|Overall Study|Withdrawal by Subject|2
5834410|NCT02387983|20163711|P1|Overall Study|Protocol Violation|1
5834411|NCT02387983|20163711|P1|Overall Study|Adverse Event|4
5834412|NCT02387970|20163725|P2|Overall Study|Did not complete 1-year follow up|2
5834413|NCT02387970|20163726|P1|Overall Study|Did not complete 1-year follow up|1
5834414|NCT02387957|20163747|P3|Overall Study|The study was discontinued|20
5834415|NCT02387957|20163748|P2|Overall Study|The study was discontinued|21
5834416|NCT02387957|20163749|P1|Overall Study|The study was discontinued|21
5834417|NCT02387840|20163782|P6|Overall Study|Death|1
5834418|NCT02387840|20163783|P5|Overall Study|Death|0
5834419|NCT02387840|20163784|P4|Overall Study|Death|0
5834420|NCT02387840|20163785|P3|Overall Study|Death|0
5834421|NCT02387840|20163786|P2|Overall Study|Death|0
5834422|NCT02387840|20163787|P1|Overall Study|Death|0
5834423|NCT02387762|20163857|P2|Overall Study|Withdrawal by Subject|0
5834424|NCT02387762|20163858|P1|Overall Study|Withdrawal by Subject|1
5834425|NCT02387580|20163890|P6|Overall Study|Withdrawal by Subject|0
5834426|NCT02387580|20163891|P5|Overall Study|Withdrawal by Subject|0
5834427|NCT02387580|20163892|P4|Overall Study|Withdrawal by Subject|1
5834428|NCT02387580|20163893|P3|Overall Study|Withdrawal by Subject|0
5834429|NCT02387580|20163894|P2|Overall Study|Withdrawal by Subject|0
5834430|NCT02387580|20163895|P1|Overall Study|Withdrawal by Subject|0
5834431|NCT02387372|20163988|P2|Overall Study|Not Treated|0
5834432|NCT02387372|20163989|P1|Overall Study|Not Treated|1
5834433|NCT02387164|20164079|P2|Overall Study|Diagnosed|2
5834434|NCT02387164|20164080|P1|Overall Study|Diagnosed|1
5834435|NCT02387164|20164079|P2|Overall Study|Lost to Follow-up|0
5834436|NCT02387164|20164080|P1|Overall Study|Lost to Follow-up|2
5834437|NCT02386345|20164129|P1|Overall Study|Did not complete 12-month follow-up|72
5834438|NCT02386345|20164129|P1|Overall Study|Repeat Procedure|10
5834439|NCT02386345|20164129|P1|Overall Study|Adverse Event|5
5834440|NCT02386345|20164129|P1|Overall Study|Lost to Follow-up|1
5834441|NCT02386345|20164129|P1|Overall Study|Not treated|14
5834442|NCT02386189|20164139|P2|Overall Study|Death|0
5834443|NCT02386189|20164140|P1|Overall Study|Death|1
5834444|NCT02386189|20164139|P2|Overall Study|Withdrawal by Subject|0
5834445|NCT02386189|20164140|P1|Overall Study|Withdrawal by Subject|1
5834446|NCT02386189|20164139|P2|Overall Study|Lost to Follow-up|3
5834447|NCT02386189|20164140|P1|Overall Study|Lost to Follow-up|2
5834448|NCT02386098|20164163|P5|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0
5834449|NCT02386098|20164164|P4|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0
5834450|NCT02386098|20164165|P3|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0
5834451|NCT02386098|20164166|P2|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|8
5834452|NCT02386098|20164167|P1|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|5
5834453|NCT02386098|20164163|P5|Stage 1 (96 Weeks)|Other|0
5834454|NCT02386098|20164164|P4|Stage 1 (96 Weeks)|Other|0
5834455|NCT02386098|20164165|P3|Stage 1 (96 Weeks)|Other|0
5834456|NCT02386098|20164166|P2|Stage 1 (96 Weeks)|Other|0
5834457|NCT02386098|20164167|P1|Stage 1 (96 Weeks)|Other|1
5834458|NCT02386098|20164163|P5|Stage 1 (96 Weeks)|Withdrawal by Subject|0
5834459|NCT02386098|20164164|P4|Stage 1 (96 Weeks)|Withdrawal by Subject|0
5834460|NCT02386098|20164165|P3|Stage 1 (96 Weeks)|Withdrawal by Subject|0
5834461|NCT02386098|20164166|P2|Stage 1 (96 Weeks)|Withdrawal by Subject|1
5834462|NCT02386098|20164167|P1|Stage 1 (96 Weeks)|Withdrawal by Subject|3
5834463|NCT02386098|20164163|P5|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0
5834464|NCT02386098|20164164|P4|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0
5834465|NCT02386098|20164165|P3|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0
5834466|NCT02386098|20164166|P2|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|2
5834467|NCT02386098|20164167|P1|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0
5834468|NCT02386098|20164163|P5|Stage 1 (96 Weeks)|Lost to Follow-up|0
5834469|NCT02386098|20164164|P4|Stage 1 (96 Weeks)|Lost to Follow-up|0
5834470|NCT02386098|20164165|P3|Stage 1 (96 Weeks)|Lost to Follow-up|0
5834471|NCT02386098|20164166|P2|Stage 1 (96 Weeks)|Lost to Follow-up|2
5834472|NCT02386098|20164167|P1|Stage 1 (96 Weeks)|Lost to Follow-up|2
5834473|NCT02386098|20164163|P5|Stage 1 (96 Weeks)|Adverse Event|0
5834474|NCT02386098|20164164|P4|Stage 1 (96 Weeks)|Adverse Event|0
5834475|NCT02386098|20164165|P3|Stage 1 (96 Weeks)|Adverse Event|0
5834476|NCT02386098|20164166|P2|Stage 1 (96 Weeks)|Adverse Event|1
5834477|NCT02386098|20164167|P1|Stage 1 (96 Weeks)|Adverse Event|2
5834478|NCT02386098|20164163|P5|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0
5834479|NCT02386098|20164164|P4|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0
5834480|NCT02386098|20164165|P3|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0
5834481|NCT02386098|20164166|P2|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|29
5834482|NCT02386098|20164167|P1|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|30
5834483|NCT02385799|20164246|P2|Overall Study|Withdrawal by Subject|4
5834484|NCT02385799|20164247|P1|Overall Study|Withdrawal by Subject|0
5834485|NCT02385799|20164246|P2|Overall Study|Adverse Event|2
5834486|NCT02385799|20164247|P1|Overall Study|Adverse Event|4
5834487|NCT02385799|20164246|P2|Overall Study|Lost to Follow-up|2
5834488|NCT02385799|20164247|P1|Overall Study|Lost to Follow-up|1
5834489|NCT02385708|20164288|P2|Overall Study|Protocol Violation|1
5834490|NCT02385708|20164289|P1|Overall Study|Protocol Violation|1
5834491|NCT02385708|20164288|P2|Overall Study|Investigator decision|7
5834492|NCT02385708|20164289|P1|Overall Study|Investigator decision|5
5834493|NCT02385708|20164288|P2|Overall Study|Withdrawn - surgery canceled|5
5834494|NCT02385708|20164289|P1|Overall Study|Withdrawn - surgery canceled|2
5834495|NCT02385708|20164288|P2|Overall Study|Withdrawal by Subject|2
5834496|NCT02385708|20164289|P1|Overall Study|Withdrawal by Subject|0
5834497|NCT02385669|20164295|P1|Overall Study|Adverse Event|2
5834498|NCT02385526|20164303|P3|Overall Study|Protocol Violation|0
5834499|NCT02385526|20164304|P2|Overall Study|Protocol Violation|0
5834500|NCT02385526|20164305|P1|Overall Study|Protocol Violation|1
5834501|NCT02385526|20164303|P3|Overall Study|Physician Decision|0
5834502|NCT02385526|20164304|P2|Overall Study|Physician Decision|0
5834503|NCT02385526|20164305|P1|Overall Study|Physician Decision|1
5834504|NCT02385526|20164303|P3|Overall Study|Lost to Follow-up|0
5834505|NCT02385526|20164304|P2|Overall Study|Lost to Follow-up|1
5834506|NCT02385526|20164305|P1|Overall Study|Lost to Follow-up|0
5834507|NCT02385526|20164303|P3|Overall Study|Withdrawal by Subject|0
5834508|NCT02385526|20164304|P2|Overall Study|Withdrawal by Subject|2
5834509|NCT02385526|20164305|P1|Overall Study|Withdrawal by Subject|0
5834510|NCT02385084|20164345|P6|Period 2|Protocol Violation|0
5834511|NCT02385084|20164346|P5|Period 2|Protocol Violation|0
5834512|NCT02385084|20164347|P4|Period 2|Protocol Violation|0
5834513|NCT02385084|20164348|P3|Period 2|Protocol Violation|1
5834514|NCT02385084|20164349|P2|Period 2|Protocol Violation|0
5834515|NCT02385084|20164350|P1|Period 2|Protocol Violation|0
5834516|NCT02384993|20164363|P2|Overall Study|Adverse Event|1
5834517|NCT02384993|20164364|P1|Overall Study|Adverse Event|0
5834518|NCT02384941|20164390|P3|Overall Study|Other than specified above|1
5834519|NCT02384941|20164391|P2|Overall Study|Other than specified above|0
5834520|NCT02384941|20164392|P1|Overall Study|Other than specified above|4
5834521|NCT02384941|20164390|P3|Overall Study|Pregnancy|1
5834522|NCT02384941|20164391|P2|Overall Study|Pregnancy|0
5834523|NCT02384941|20164392|P1|Overall Study|Pregnancy|0
5834524|NCT02384941|20164390|P3|Overall Study|Withdrawal by Subject|20
5834525|NCT02384941|20164391|P2|Overall Study|Withdrawal by Subject|19
5834526|NCT02384941|20164392|P1|Overall Study|Withdrawal by Subject|26
5834527|NCT02384941|20164390|P3|Overall Study|Protocol Violation|0
5834528|NCT02384941|20164391|P2|Overall Study|Protocol Violation|0
5834529|NCT02384941|20164392|P1|Overall Study|Protocol Violation|3
5834530|NCT02384941|20164390|P3|Overall Study|Physician Decision|0
5834531|NCT02384941|20164391|P2|Overall Study|Physician Decision|1
5834532|NCT02384941|20164392|P1|Overall Study|Physician Decision|1
5834533|NCT02384941|20164390|P3|Overall Study|Non-Compliance With Study Drug|1
5834534|NCT02384941|20164391|P2|Overall Study|Non-Compliance With Study Drug|0
5834535|NCT02384941|20164392|P1|Overall Study|Non-Compliance With Study Drug|2
5834536|NCT02384941|20164390|P3|Overall Study|Lost to Follow-up|1
5834537|NCT02384941|20164391|P2|Overall Study|Lost to Follow-up|2
5834538|NCT02384941|20164392|P1|Overall Study|Lost to Follow-up|3
5834539|NCT02384941|20164390|P3|Overall Study|Adverse Event|17
5834540|NCT02384941|20164391|P2|Overall Study|Adverse Event|13
5834541|NCT02384941|20164392|P1|Overall Study|Adverse Event|11
5834542|NCT02384538|20164423|P2|Overall Study|Other|3
5834543|NCT02384538|20164424|P1|Overall Study|Other|1
5834544|NCT02384538|20164423|P2|Overall Study|Withdrew Consent|4
5834545|NCT02384538|20164424|P1|Overall Study|Withdrew Consent|0
5834546|NCT02384538|20164423|P2|Overall Study|Lack of Efficacy|4
5834547|NCT02384538|20164424|P1|Overall Study|Lack of Efficacy|4
5834548|NCT02384538|20164423|P2|Overall Study|Adverse Event|4
5834549|NCT02384538|20164424|P1|Overall Study|Adverse Event|1
5834550|NCT02384460|20164444|P2|Overall Study|Non-compliance|0
5834551|NCT02384460|20164445|P1|Overall Study|Non-compliance|1
5834552|NCT02384460|20164444|P2|Overall Study|Elective medical treatment|0
5834553|NCT02384460|20164445|P1|Overall Study|Elective medical treatment|1
5834554|NCT02384460|20164444|P2|Overall Study|Withdrawal by Subject|3
5834555|NCT02384460|20164445|P1|Overall Study|Withdrawal by Subject|0
5834556|NCT02384460|20164444|P2|Overall Study|Adverse Event|2
5834557|NCT02384460|20164445|P1|Overall Study|Adverse Event|5
5834558|NCT02384460|20164444|P2|Overall Study|Returned to previous therapeutic regimen|1
5834559|NCT02384460|20164445|P1|Overall Study|Returned to previous therapeutic regimen|0
5834560|NCT02384460|20164444|P2|Overall Study|Protocol Violation|1
5834561|NCT02384460|20164445|P1|Overall Study|Protocol Violation|0
5834562|NCT02384382|20164463|P1|Overall Study|Disease progression|16
5834563|NCT02384382|20164463|P1|Overall Study|Adverse Event|1
5834564|NCT02384382|20164463|P1|Overall Study|Death|1
5834565|NCT02384382|20164463|P1|Overall Study|Transitioned to study-NCT02960022|5
5834566|NCT02383966|20164535|P2|Overall Study|Randomized, but not treated|3
5834567|NCT02383966|20164536|P1|Overall Study|Randomized, but not treated|1
5834568|NCT02383966|20164535|P2|Overall Study|Ongoing at clinical cut-off date|4
5834569|NCT02383966|20164536|P1|Overall Study|Ongoing at clinical cut-off date|25
5834570|NCT02383940|20164556|P2|Overall Study|Other than specified above|0
5834571|NCT02383940|20164557|P1|Overall Study|Other than specified above|1
5834572|NCT02383940|20164556|P2|Overall Study|Randomized but not treated|0
5834573|NCT02383940|20164557|P1|Overall Study|Randomized but not treated|2
5834574|NCT02383940|20164556|P2|Overall Study|Withdrawal by Subject|1
5834575|NCT02383940|20164557|P1|Overall Study|Withdrawal by Subject|1
5834576|NCT02383940|20164556|P2|Overall Study|Physician Decision|0
5834577|NCT02383940|20164557|P1|Overall Study|Physician Decision|2
5834578|NCT02383940|20164556|P2|Overall Study|Lost to Follow-up|2
5834579|NCT02383940|20164557|P1|Overall Study|Lost to Follow-up|2
5834580|NCT02383940|20164556|P2|Overall Study|Adverse Event|0
5834581|NCT02383940|20164557|P1|Overall Study|Adverse Event|1
5834582|NCT02383862|20164573|P2|3 Month Follow up|Lost to Follow-up|21
5834583|NCT02383862|20164574|P1|3 Month Follow up|Lost to Follow-up|23
5834584|NCT02383758|20164607|P2|Overall Study|Withdrawal by Subject|2
5834585|NCT02383758|20164608|P1|Overall Study|Withdrawal by Subject|0
5834586|NCT02383589|20164636|P2|Safety Follow-up (SFU)|Treated by not accepted treatment|1
5834587|NCT02383589|20164637|P1|Safety Follow-up (SFU)|Treated by not accepted treatment|0
5834588|NCT02383589|20164636|P2|Safety Follow-up (SFU)|Withdrawal by Subject|0
5834589|NCT02383589|20164637|P1|Safety Follow-up (SFU)|Withdrawal by Subject|5
5834590|NCT02383589|20164636|P2|Safety Follow-up (SFU)|Lost to Follow-up|4
5834591|NCT02383589|20164637|P1|Safety Follow-up (SFU)|Lost to Follow-up|2
5834592|NCT02383589|20164636|P2|Treatment Period|Non-compliance with study drug|1
5834593|NCT02383589|20164637|P1|Treatment Period|Non-compliance with study drug|0
5834594|NCT02383589|20164636|P2|Treatment Period|Withdrawal by Subject|5
5834595|NCT02383589|20164637|P1|Treatment Period|Withdrawal by Subject|0
5834596|NCT02383589|20164636|P2|Treatment Period|Lost to Follow-up|1
5834597|NCT02383589|20164637|P1|Treatment Period|Lost to Follow-up|0
5834598|NCT02383589|20164636|P2|Treatment Period|Adverse Event|3
5834599|NCT02383589|20164637|P1|Treatment Period|Adverse Event|1
5834600|NCT02383576|20164662|P2|Overall Study|Administrative/Other|4
5834601|NCT02383576|20164663|P1|Overall Study|Administrative/Other|2
5834602|NCT02383576|20164662|P2|Overall Study|Investigator's Decision|1
5834603|NCT02383576|20164663|P1|Overall Study|Investigator's Decision|0
5834604|NCT02383576|20164662|P2|Overall Study|Withdrew Consent|6
5834605|NCT02383576|20164663|P1|Overall Study|Withdrew Consent|1
5834606|NCT02383576|20164662|P2|Overall Study|Lost to Follow-up|1
5834607|NCT02383576|20164663|P1|Overall Study|Lost to Follow-up|7
5834608|NCT02383576|20164662|P2|Overall Study|Death|33
5834609|NCT02383576|20164663|P1|Overall Study|Death|53
5834610|NCT02383472|20164679|P2|Overall Study|Withdrawal by Subject|1
5834611|NCT02383472|20164680|P1|Overall Study|Withdrawal by Subject|1
5834612|NCT02383433|20164694|P1|Overall Study|Disease progression|2
5834613|NCT02383355|20164713|P2|Overall Study|Adverse Event|0
5834614|NCT02383355|20164714|P1|Overall Study|Adverse Event|2
5834615|NCT02383173|20164730|P2|Overall Study|Palliative Care Team withdrew|2
5834616|NCT02383173|20164731|P1|Overall Study|Palliative Care Team withdrew|0
5834617|NCT02383056|20164755|P2|Overall Study|Lost to Follow-up|2
5834618|NCT02383056|20164756|P1|Overall Study|Lost to Follow-up|0
5834619|NCT02383056|20164755|P2|Overall Study|Adverse Event|0
5834620|NCT02383056|20164756|P1|Overall Study|Adverse Event|1
5834621|NCT02383017|20164782|P2|Overall Study|Found to be Hypogonadal|0
5834622|NCT02383017|20164783|P1|Overall Study|Found to be Hypogonadal|1
5834623|NCT02383017|20164782|P2|Overall Study|Compliance|2
5834624|NCT02383017|20164783|P1|Overall Study|Compliance|3
5834625|NCT02383017|20164782|P2|Overall Study|Injury Sustained Outside Study|0
5834626|NCT02383017|20164783|P1|Overall Study|Injury Sustained Outside Study|1
5834627|NCT02382991|20164807|P2|Overall Study|Withdrawal by Subject|1
5834628|NCT02382991|20164808|P1|Overall Study|Withdrawal by Subject|0
5834629|NCT02382991|20164807|P2|Overall Study|Lost to Follow-up|0
5834630|NCT02382991|20164808|P1|Overall Study|Lost to Follow-up|1
5834631|NCT02382991|20164807|P2|Overall Study|Adverse Event|2
5834632|NCT02382991|20164808|P1|Overall Study|Adverse Event|1
5834633|NCT02382939|20164820|P2|Overall Study|Withdrawal by Subject|2
5834634|NCT02382939|20164821|P1|Overall Study|Withdrawal by Subject|2
5834635|NCT02382939|20164820|P2|Overall Study|Adverse Event|1
5834636|NCT02382939|20164821|P1|Overall Study|Adverse Event|1
5834637|NCT02382796|20164904|P1|Overall Study|Commercial dacomitinib became available|3
5834638|NCT02382796|20164904|P1|Overall Study|Objective progression or relapse|3
5834639|NCT02382796|20164904|P1|Overall Study|Global deterioration of health status|1
5834640|NCT02382640|20164954|P4|Intervention Period 4 (3 Days)|Laboratory Abnormality|0
5834641|NCT02382640|20164955|P3|Intervention Period 4 (3 Days)|Laboratory Abnormality|0
5834642|NCT02382640|20164956|P2|Intervention Period 4 (3 Days)|Laboratory Abnormality|0
5834643|NCT02382640|20164957|P1|Intervention Period 4 (3 Days)|Laboratory Abnormality|1
5834644|NCT02382276|20164998|P3|Overall Study|Physician Decision|2
5834645|NCT02382276|20164999|P2|Overall Study|Physician Decision|0
5834646|NCT02382276|20165000|P1|Overall Study|Physician Decision|0
5834647|NCT02382276|20164998|P3|Overall Study|Adverse Event|32
5834648|NCT02382276|20164999|P2|Overall Study|Adverse Event|2
5834649|NCT02382276|20165000|P1|Overall Study|Adverse Event|7
5834650|NCT02382276|20164998|P3|Overall Study|Withdrawal by Subject|5
5834651|NCT02382276|20164999|P2|Overall Study|Withdrawal by Subject|8
5834652|NCT02382276|20165000|P1|Overall Study|Withdrawal by Subject|4
5834653|NCT02382133|20165012|P1|Overall Study|pressure injury both sites|1
5834654|NCT02382133|20165012|P1|Overall Study|arterial catheter loss|4
5834655|NCT02382133|20165012|P1|Overall Study|Physician Decision|2
5834656|NCT02382133|20165012|P1|Overall Study|transfer out of ICU|4
5834657|NCT02382133|20165012|P1|Overall Study|Death|22
5834658|NCT02382016|20165019|P2|OL Extension Period|Withdrawal by Subject|0
5834659|NCT02382016|20165020|P1|OL Extension Period|Withdrawal by Subject|1
5834660|NCT02382016|20165019|P2|OL Extension Period|Death|0
5834661|NCT02382016|20165020|P1|OL Extension Period|Death|2
5834662|NCT02382016|20165019|P2|OL Extension Period|Physician Decision|0
5834663|NCT02382016|20165020|P1|OL Extension Period|Physician Decision|3
5834664|NCT02382016|20165019|P2|Open-label (OL) Treatment Period|Death|0
5834665|NCT02382016|20165020|P1|Open-label (OL) Treatment Period|Death|4
5834666|NCT02382016|20165019|P2|Open-label (OL) Treatment Period|Withdrawal by Subject|0
5834667|NCT02382016|20165020|P1|Open-label (OL) Treatment Period|Withdrawal by Subject|2
5834668|NCT02382016|20165019|P2|Open-label (OL) Treatment Period|Physician Decision|0
5834669|NCT02382016|20165020|P1|Open-label (OL) Treatment Period|Physician Decision|3
5834670|NCT02382016|20165019|P2|Double-blind (DB) Treatment Period|Withdrawal by Subject|1
5834671|NCT02382016|20165020|P1|Double-blind (DB) Treatment Period|Withdrawal by Subject|0
5834672|NCT02382016|20165019|P2|Double-blind (DB) Treatment Period|Lack of Efficacy|0
5834673|NCT02382016|20165020|P1|Double-blind (DB) Treatment Period|Lack of Efficacy|1
5834674|NCT02382016|20165019|P2|Double-blind (DB) Treatment Period|Physician Decision|0
5834675|NCT02382016|20165020|P1|Double-blind (DB) Treatment Period|Physician Decision|3
5834676|NCT02381795|20165044|P1|Overall Study|Study Terminated|2
5834677|NCT02381795|20165044|P1|Overall Study|Withdrawal by Subject|1
5834678|NCT02381652|20165059|P3|Overall Study|Withdrawal by Subject|1
5834679|NCT02381652|20165060|P2|Overall Study|Withdrawal by Subject|0
5834680|NCT02381652|20165061|P1|Overall Study|Withdrawal by Subject|0
5834681|NCT02380859|20165164|P2|Overall Study|Withdrawal by Subject|0
5834682|NCT02380859|20165165|P1|Overall Study|Withdrawal by Subject|2
5834683|NCT02380742|20165201|P2|Overall Study|Withdrawal by Subject|0
5834684|NCT02380742|20165202|P1|Overall Study|Withdrawal by Subject|1
5834685|NCT02380703|20165216|P2|Overall Study|Entered Long-term Care|7
5834686|NCT02380703|20165217|P1|Overall Study|Entered Long-term Care|4
5834687|NCT02380703|20165216|P2|Overall Study|Person with dementia (PWD) death|8
5834688|NCT02380703|20165217|P1|Overall Study|Person with dementia (PWD) death|7
5834689|NCT02380703|20165216|P2|Overall Study|Caregiver death|0
5834690|NCT02380703|20165217|P1|Overall Study|Caregiver death|1
5834691|NCT02380703|20165216|P2|Overall Study|Lost to Follow-up|12
5834692|NCT02380703|20165217|P1|Overall Study|Lost to Follow-up|12
5834693|NCT02380703|20165216|P2|Overall Study|Withdrawal by Subject|9
5834694|NCT02380703|20165217|P1|Overall Study|Withdrawal by Subject|12
5834695|NCT02380690|20165239|P2|Overall Study|Withdrawal by Subject|8
5834696|NCT02380690|20165240|P1|Overall Study|Withdrawal by Subject|20
5834697|NCT02380690|20165239|P2|Overall Study|Lost to Follow-up|4
5834698|NCT02380690|20165240|P1|Overall Study|Lost to Follow-up|14
5834699|NCT02380677|20165288|P12|Overall Study|Other|0
5834700|NCT02380677|20165289|P11|Overall Study|Other|0
5834701|NCT02380677|20165290|P10|Overall Study|Other|0
5834702|NCT02380677|20165291|P9|Overall Study|Other|0
5834703|NCT02380677|20165292|P8|Overall Study|Other|0
5834704|NCT02380677|20165293|P7|Overall Study|Other|0
5834705|NCT02380677|20165294|P6|Overall Study|Other|1
5834706|NCT02380677|20165295|P5|Overall Study|Other|1
5834707|NCT02380677|20165296|P4|Overall Study|Other|1
5834708|NCT02380677|20165297|P3|Overall Study|Other|0
5834709|NCT02380677|20165298|P2|Overall Study|Other|0
5834710|NCT02380677|20165299|P1|Overall Study|Other|0
5834711|NCT02380677|20165288|P12|Overall Study|Withdrawal by Subject|3
5834712|NCT02380677|20165289|P11|Overall Study|Withdrawal by Subject|0
5834713|NCT02380677|20165290|P10|Overall Study|Withdrawal by Subject|1
5834714|NCT02380677|20165291|P9|Overall Study|Withdrawal by Subject|0
5834715|NCT02380677|20165292|P8|Overall Study|Withdrawal by Subject|0
5834716|NCT02380677|20165293|P7|Overall Study|Withdrawal by Subject|0
5834717|NCT02380677|20165294|P6|Overall Study|Withdrawal by Subject|0
5834718|NCT02380677|20165295|P5|Overall Study|Withdrawal by Subject|0
5834719|NCT02380677|20165296|P4|Overall Study|Withdrawal by Subject|0
5834720|NCT02380677|20165297|P3|Overall Study|Withdrawal by Subject|0
5834721|NCT02380677|20165298|P2|Overall Study|Withdrawal by Subject|0
5834722|NCT02380677|20165299|P1|Overall Study|Withdrawal by Subject|0
5834723|NCT02380677|20165288|P12|Overall Study|Lack of Efficacy|1
5834724|NCT02380677|20165289|P11|Overall Study|Lack of Efficacy|2
5834725|NCT02380677|20165290|P10|Overall Study|Lack of Efficacy|0
5834726|NCT02380677|20165291|P9|Overall Study|Lack of Efficacy|2
5834727|NCT02380677|20165292|P8|Overall Study|Lack of Efficacy|2
5834728|NCT02380677|20165293|P7|Overall Study|Lack of Efficacy|1
5834729|NCT02380677|20165294|P6|Overall Study|Lack of Efficacy|1
5834730|NCT02380677|20165295|P5|Overall Study|Lack of Efficacy|4
5834731|NCT02380677|20165296|P4|Overall Study|Lack of Efficacy|0
5834732|NCT02380677|20165297|P3|Overall Study|Lack of Efficacy|2
5834733|NCT02380677|20165298|P2|Overall Study|Lack of Efficacy|1
5834734|NCT02380677|20165299|P1|Overall Study|Lack of Efficacy|0
5834735|NCT02380677|20165288|P12|Overall Study|Physician Decision|0
5834736|NCT02380677|20165289|P11|Overall Study|Physician Decision|0
5834737|NCT02380677|20165290|P10|Overall Study|Physician Decision|0
5834738|NCT02380677|20165291|P9|Overall Study|Physician Decision|0
5834739|NCT02380677|20165292|P8|Overall Study|Physician Decision|0
5834740|NCT02380677|20165293|P7|Overall Study|Physician Decision|0
5834741|NCT02380677|20165294|P6|Overall Study|Physician Decision|0
5834742|NCT02380677|20165295|P5|Overall Study|Physician Decision|0
5834743|NCT02380677|20165296|P4|Overall Study|Physician Decision|1
5834744|NCT02380677|20165297|P3|Overall Study|Physician Decision|1
5834745|NCT02380677|20165298|P2|Overall Study|Physician Decision|0
5834746|NCT02380677|20165299|P1|Overall Study|Physician Decision|1
5834747|NCT02380677|20165288|P12|Overall Study|Adverse Event|1
5834748|NCT02380677|20165289|P11|Overall Study|Adverse Event|2
5834749|NCT02380677|20165290|P10|Overall Study|Adverse Event|1
5834750|NCT02380677|20165291|P9|Overall Study|Adverse Event|2
5834751|NCT02380677|20165292|P8|Overall Study|Adverse Event|2
5834752|NCT02380677|20165293|P7|Overall Study|Adverse Event|2
5834753|NCT02380677|20165294|P6|Overall Study|Adverse Event|4
5834754|NCT02380677|20165295|P5|Overall Study|Adverse Event|1
5834755|NCT02380677|20165296|P4|Overall Study|Adverse Event|1
5834756|NCT02380677|20165297|P3|Overall Study|Adverse Event|0
5834757|NCT02380677|20165298|P2|Overall Study|Adverse Event|0
5834758|NCT02380677|20165299|P1|Overall Study|Adverse Event|0
5834759|NCT02380287|20165355|P8|Overall Study|Adverse Event|0
5834760|NCT02380287|20165356|P7|Overall Study|Adverse Event|0
5834761|NCT02380287|20165357|P6|Overall Study|Adverse Event|0
5834762|NCT02380287|20165358|P5|Overall Study|Adverse Event|0
5834763|NCT02380287|20165359|P4|Overall Study|Adverse Event|0
5834764|NCT02380287|20165360|P3|Overall Study|Adverse Event|1
5834765|NCT02380287|20165361|P2|Overall Study|Adverse Event|0
5834766|NCT02380287|20165362|P1|Overall Study|Adverse Event|0
5834767|NCT02380248|20165378|P1|Overall Study|Withdrawal by Subject|3
5834768|NCT02380248|20165378|P1|Overall Study|Lost to Follow-up|11
5834769|NCT02379923|20165394|P1|Overall Study|Death|5
5834770|NCT02379728|20165423|P4|Overall Study|Protocol Violation|0
5834771|NCT02379728|20165424|P3|Overall Study|Protocol Violation|2
5834772|NCT02379728|20165425|P2|Overall Study|Protocol Violation|0
5834773|NCT02379728|20165426|P1|Overall Study|Protocol Violation|0
5834774|NCT02379728|20165423|P4|Overall Study|Withdrawal by Subject|3
5834775|NCT02379728|20165424|P3|Overall Study|Withdrawal by Subject|5
5834776|NCT02379728|20165425|P2|Overall Study|Withdrawal by Subject|0
5834777|NCT02379728|20165426|P1|Overall Study|Withdrawal by Subject|5
5834778|NCT02379728|20165423|P4|Overall Study|Lost to Follow-up|0
5834779|NCT02379728|20165424|P3|Overall Study|Lost to Follow-up|3
5834780|NCT02379728|20165425|P2|Overall Study|Lost to Follow-up|0
5834781|NCT02379728|20165426|P1|Overall Study|Lost to Follow-up|1
5834782|NCT02379637|20165482|P2|Overall Study|Withdrawal by Subject|0
5834783|NCT02379637|20165483|P1|Overall Study|Withdrawal by Subject|1
5834784|NCT02379637|20165482|P2|Overall Study|Adverse Event|0
5834785|NCT02379637|20165483|P1|Overall Study|Adverse Event|1
5834786|NCT02379637|20165482|P2|Overall Study|Protocol Violation|1
5834787|NCT02379637|20165483|P1|Overall Study|Protocol Violation|0
5834788|NCT02379390|20165522|P2|Overall Study|Study Termination|1
5834789|NCT02379390|20165523|P1|Overall Study|Study Termination|0
5834790|NCT02379390|20165522|P2|Overall Study|Investigator's decision|0
5834791|NCT02379390|20165523|P1|Overall Study|Investigator's decision|1
5834792|NCT02379390|20165522|P2|Overall Study|Adverse Event|1
5834793|NCT02379390|20165523|P1|Overall Study|Adverse Event|1
5834794|NCT02379221|20165551|P1|Overall Study|Lost to Follow-up|1
5834795|NCT02379091|20165587|P4|Overall Study|Lack of Efficacy|0
5834796|NCT02379091|20165588|P3|Overall Study|Lack of Efficacy|0
5834797|NCT02379091|20165589|P2|Overall Study|Lack of Efficacy|0
5834798|NCT02379091|20165590|P1|Overall Study|Lack of Efficacy|3
5834799|NCT02379091|20165587|P4|Overall Study|Study Termination|8
5834800|NCT02379091|20165588|P3|Overall Study|Study Termination|5
5834801|NCT02379091|20165589|P2|Overall Study|Study Termination|2
5834802|NCT02379091|20165590|P1|Overall Study|Study Termination|7
5834803|NCT02379091|20165587|P4|Overall Study|Voluntary Withdrawal|4
5834804|NCT02379091|20165588|P3|Overall Study|Voluntary Withdrawal|2
5834805|NCT02379091|20165589|P2|Overall Study|Voluntary Withdrawal|5
5834806|NCT02379091|20165590|P1|Overall Study|Voluntary Withdrawal|2
5834807|NCT02379091|20165587|P4|Overall Study|Lost to Follow-up|1
5834808|NCT02379091|20165588|P3|Overall Study|Lost to Follow-up|0
5834809|NCT02379091|20165589|P2|Overall Study|Lost to Follow-up|0
5834810|NCT02379091|20165590|P1|Overall Study|Lost to Follow-up|0
5834811|NCT02379091|20165587|P4|Overall Study|Principal Investigator Discretion|0
5834812|NCT02379091|20165588|P3|Overall Study|Principal Investigator Discretion|0
5834813|NCT02379091|20165589|P2|Overall Study|Principal Investigator Discretion|1
5834814|NCT02379091|20165590|P1|Overall Study|Principal Investigator Discretion|0
5834815|NCT02379091|20165587|P4|Overall Study|Pretreatment Event/Adverse Event|1
5834816|NCT02379091|20165588|P3|Overall Study|Pretreatment Event/Adverse Event|0
5834817|NCT02379091|20165589|P2|Overall Study|Pretreatment Event/Adverse Event|2
5834818|NCT02379091|20165590|P1|Overall Study|Pretreatment Event/Adverse Event|0
5834819|NCT02379078|20165628|P2|Overall Study|Withdrawal by Subject|5
5834820|NCT02379078|20165629|P1|Overall Study|Withdrawal by Subject|6
5834821|NCT02379078|20165628|P2|Overall Study|Lost to Follow-up|30
5834822|NCT02379078|20165629|P1|Overall Study|Lost to Follow-up|33
5834823|NCT02379052|20165645|P2|Overall Study|Subject was Incarcerated|1
5834824|NCT02379052|20165646|P1|Overall Study|Subject was Incarcerated|0
5834825|NCT02379052|20165645|P2|Overall Study|Did Not Meet Inc./ Exclusion Criteria|0
5834826|NCT02379052|20165646|P1|Overall Study|Did Not Meet Inc./ Exclusion Criteria|1
5834827|NCT02379052|20165645|P2|Overall Study|Lost to Follow-up|1
5834828|NCT02379052|20165646|P1|Overall Study|Lost to Follow-up|2
5834829|NCT02379052|20165645|P2|Overall Study|Withdrawal by Subject|0
5834830|NCT02379052|20165646|P1|Overall Study|Withdrawal by Subject|2
5834831|NCT02379052|20165645|P2|Overall Study|Physician Decision|1
5834832|NCT02379052|20165646|P1|Overall Study|Physician Decision|1
5834833|NCT02379052|20165645|P2|Overall Study|Adverse Event|1
5834834|NCT02379052|20165646|P1|Overall Study|Adverse Event|0
5834835|NCT02379052|20165645|P2|Overall Study|Protocol Violation|1
5834836|NCT02379052|20165646|P1|Overall Study|Protocol Violation|0
5834837|NCT02378961|20165688|P4|Overall Study|Death|0
5834838|NCT02378961|20165689|P3|Overall Study|Death|1
5834839|NCT02378961|20165690|P2|Overall Study|Death|0
5834840|NCT02378961|20165691|P1|Overall Study|Death|0
5834841|NCT02378961|20165688|P4|Overall Study|Lack of Efficacy|1
5834842|NCT02378961|20165689|P3|Overall Study|Lack of Efficacy|0
5834843|NCT02378961|20165690|P2|Overall Study|Lack of Efficacy|2
5834844|NCT02378961|20165691|P1|Overall Study|Lack of Efficacy|4
5834845|NCT02378935|20165728|P7|Overall Study|Death|0
5834846|NCT02378935|20165729|P6|Overall Study|Death|0
5834847|NCT02378935|20165730|P5|Overall Study|Death|0
5834848|NCT02378935|20165731|P4|Overall Study|Death|0
5834849|NCT02378935|20165732|P3|Overall Study|Death|1
5834850|NCT02378935|20165733|P2|Overall Study|Death|0
5834851|NCT02378935|20165734|P1|Overall Study|Death|0
5834852|NCT02378935|20165728|P7|Overall Study|Lack of Efficacy|0
5834853|NCT02378935|20165729|P6|Overall Study|Lack of Efficacy|0
5834854|NCT02378935|20165730|P5|Overall Study|Lack of Efficacy|0
5834855|NCT02378935|20165731|P4|Overall Study|Lack of Efficacy|6
5834856|NCT02378935|20165732|P3|Overall Study|Lack of Efficacy|2
5834857|NCT02378935|20165733|P2|Overall Study|Lack of Efficacy|0
5834858|NCT02378935|20165734|P1|Overall Study|Lack of Efficacy|10
5834859|NCT02378883|20165785|P1|12 Months Follow-Up|Death|2
5834860|NCT02378883|20165785|P1|12 Months Follow-Up|Lost to Follow-up|3
5834861|NCT02378883|20165785|P1|30 Day Follow-Up|Death|1
5834862|NCT02378883|20165785|P1|30 Day Follow-Up|Missed Visit|2
5834863|NCT02378883|20165785|P1|30 Day Follow-Up|Physician Decision|2
5834864|NCT02378883|20165785|P1|30 Day Follow-Up|Withdrawal by Subject|1
5834865|NCT02378883|20165785|P1|Enrollment|Attempt to use Apollo was not performed|3
5834866|NCT02378883|20165785|P1|Enrollment|Subject did not meet Inclusion criteria|6
5834867|NCT02378662|20165851|P2|Overall Study|Early Discontinuation|0
5834868|NCT02378662|20165852|P1|Overall Study|Early Discontinuation|2
5834869|NCT02378506|20165858|P1|Overall Study|Randomized But Not Treated|1
5834870|NCT02378506|20165858|P1|Overall Study|Adverse Event|14
5834871|NCT02378506|20165858|P1|Overall Study|Death|1
5834872|NCT02378506|20165858|P1|Overall Study|Protocol Violation|2
5834873|NCT02378506|20165858|P1|Overall Study|Withdrawal by Subject|4
5834874|NCT02378506|20165858|P1|Overall Study|Lack of Efficacy|3
5834875|NCT02378480|20165877|P2|Overall Study|Lost to Follow-up|18
5834876|NCT02378480|20165878|P1|Overall Study|Lost to Follow-up|10
5834877|NCT02378480|20165877|P2|Overall Study|Withdrawal by Subject|4
5834878|NCT02378480|20165878|P1|Overall Study|Withdrawal by Subject|9
5834879|NCT02378480|20165877|P2|Overall Study|Missed EOT/PTE Visit|2
5834880|NCT02378480|20165878|P1|Overall Study|Missed EOT/PTE Visit|1
5834881|NCT02378480|20165877|P2|Overall Study|Adverse Event|1
5834882|NCT02378480|20165878|P1|Overall Study|Adverse Event|0
5834883|NCT02378480|20165877|P2|Overall Study|Randomized, but Not Treated|4
5834884|NCT02378480|20165878|P1|Overall Study|Randomized, but Not Treated|6
5834885|NCT02378480|20165877|P2|Overall Study|Death|2
5834886|NCT02378480|20165878|P1|Overall Study|Death|1
5834887|NCT02378480|20165877|P2|Overall Study|Physician Decision|1
5834888|NCT02378480|20165878|P1|Overall Study|Physician Decision|1
5834889|NCT02378220|20165905|P2|Overall Study|Death|1
5834890|NCT02378220|20165906|P1|Overall Study|Death|6
5834891|NCT02377921|20166004|P2|Overall Study|Subject non-compliance|1
5834892|NCT02377921|20166005|P1|Overall Study|Subject non-compliance|1
5834893|NCT02377817|20166029|P2|Overall Study|Unrelated injury prevented lateral sleep|0
5834894|NCT02377817|20166030|P1|Overall Study|Unrelated injury prevented lateral sleep|1
5834895|NCT02377817|20166029|P2|Overall Study|Transportation/childcare barriers.|0
5834896|NCT02377817|20166030|P1|Overall Study|Transportation/childcare barriers.|2
5834897|NCT02377466|20166105|P2|Overall Study|Other: Randomized and not treated|2
5834898|NCT02377466|20166106|P1|Overall Study|Other: Randomized and not treated|0
5834899|NCT02377427|20166224|P5|Part B (From Week 20 and up to Week 80)|Protocol Violation|0
5834900|NCT02377427|20166225|P4|Part B (From Week 20 and up to Week 80)|Protocol Violation|0
5834901|NCT02377427|20166226|P3|Part B (From Week 20 and up to Week 80)|Protocol Violation|1
5834902|NCT02377427|20166227|P2|Part B (From Week 20 and up to Week 80)|Protocol Violation|0
5834903|NCT02377427|20166228|P1|Part B (From Week 20 and up to Week 80)|Protocol Violation|0
5834904|NCT02377427|20166224|P5|Part A (Up to Week 20)|Withdrawal by Subject|0
5834905|NCT02377427|20166225|P4|Part A (Up to Week 20)|Withdrawal by Subject|0
5834906|NCT02377427|20166226|P3|Part A (Up to Week 20)|Withdrawal by Subject|0
5834907|NCT02377427|20166227|P2|Part A (Up to Week 20)|Withdrawal by Subject|0
5834908|NCT02377427|20166228|P1|Part A (Up to Week 20)|Withdrawal by Subject|2
5834909|NCT02377427|20166224|P5|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0
5834910|NCT02377427|20166225|P4|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0
5834911|NCT02377427|20166226|P3|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0
5834912|NCT02377427|20166227|P2|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0
5834913|NCT02377427|20166228|P1|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|1
5834914|NCT02377427|20166224|P5|Part A (Up to Week 20)|Physician Decision|0
5834915|NCT02377427|20166225|P4|Part A (Up to Week 20)|Physician Decision|0
5834916|NCT02377427|20166226|P3|Part A (Up to Week 20)|Physician Decision|0
5834917|NCT02377427|20166227|P2|Part A (Up to Week 20)|Physician Decision|0
5834918|NCT02377427|20166228|P1|Part A (Up to Week 20)|Physician Decision|1
5834919|NCT02377362|20166301|P13|Part B Overall|Withdrawal by Subject|0
5834920|NCT02377362|20166302|P12|Part B Overall|Withdrawal by Subject|1
5834921|NCT02377362|20166303|P11|Part B Overall|Withdrawal by Subject|0
5834922|NCT02377362|20166304|P10|Part B Overall|Withdrawal by Subject|0
5834923|NCT02377362|20166305|P9|Part B Overall|Withdrawal by Subject|0
5834924|NCT02377362|20166306|P8|Part B Overall|Withdrawal by Subject|0
5834925|NCT02377362|20166307|P7|Part B Overall|Withdrawal by Subject|1
5834926|NCT02377362|20166308|P6|Part B Overall|Withdrawal by Subject|0
5834927|NCT02377362|20166309|P5|Part B Overall|Withdrawal by Subject|0
5834928|NCT02377362|20166310|P4|Part B Overall|Withdrawal by Subject|0
5834929|NCT02377362|20166311|P3|Part B Overall|Withdrawal by Subject|0
5834930|NCT02377362|20166312|P2|Part B Overall|Withdrawal by Subject|0
5834931|NCT02377362|20166313|P1|Part B Overall|Withdrawal by Subject|0
5834932|NCT02377362|20166301|P13|Part B Overall|Adverse Event|0
5834933|NCT02377362|20166302|P12|Part B Overall|Adverse Event|0
5834934|NCT02377362|20166303|P11|Part B Overall|Adverse Event|0
5834935|NCT02377362|20166304|P10|Part B Overall|Adverse Event|0
5834936|NCT02377362|20166305|P9|Part B Overall|Adverse Event|0
5834937|NCT02377362|20166306|P8|Part B Overall|Adverse Event|1
5834938|NCT02377362|20166307|P7|Part B Overall|Adverse Event|1
5834939|NCT02377362|20166308|P6|Part B Overall|Adverse Event|0
5834940|NCT02377362|20166309|P5|Part B Overall|Adverse Event|0
5834941|NCT02377362|20166310|P4|Part B Overall|Adverse Event|0
5834942|NCT02377362|20166311|P3|Part B Overall|Adverse Event|0
5834943|NCT02377362|20166312|P2|Part B Overall|Adverse Event|0
5834944|NCT02377362|20166313|P1|Part B Overall|Adverse Event|0
5834945|NCT02377362|20166301|P13|Part B Overall|Protocol Violation|0
5834946|NCT02377362|20166302|P12|Part B Overall|Protocol Violation|0
5834947|NCT02377362|20166303|P11|Part B Overall|Protocol Violation|0
5834948|NCT02377362|20166304|P10|Part B Overall|Protocol Violation|1
5834949|NCT02377362|20166305|P9|Part B Overall|Protocol Violation|0
5834950|NCT02377362|20166306|P8|Part B Overall|Protocol Violation|0
5834951|NCT02377362|20166307|P7|Part B Overall|Protocol Violation|0
5834952|NCT02377362|20166308|P6|Part B Overall|Protocol Violation|0
5834953|NCT02377362|20166309|P5|Part B Overall|Protocol Violation|0
5834954|NCT02377362|20166310|P4|Part B Overall|Protocol Violation|0
5834955|NCT02377362|20166311|P3|Part B Overall|Protocol Violation|0
5834956|NCT02377362|20166312|P2|Part B Overall|Protocol Violation|0
5834957|NCT02377362|20166313|P1|Part B Overall|Protocol Violation|0
5834958|NCT02377362|20166301|P13|Part A Third Treatment|Highest dose level 1200 not used|0
5834959|NCT02377362|20166302|P12|Part A Third Treatment|Highest dose level 1200 not used|0
5834960|NCT02377362|20166303|P11|Part A Third Treatment|Highest dose level 1200 not used|0
5834961|NCT02377362|20166304|P10|Part A Third Treatment|Highest dose level 1200 not used|0
5834962|NCT02377362|20166305|P9|Part A Third Treatment|Highest dose level 1200 not used|0
5834963|NCT02377362|20166306|P8|Part A Third Treatment|Highest dose level 1200 not used|0
5834964|NCT02377362|20166307|P7|Part A Third Treatment|Highest dose level 1200 not used|0
5834965|NCT02377362|20166308|P6|Part A Third Treatment|Highest dose level 1200 not used|4
5834966|NCT02377362|20166309|P5|Part A Third Treatment|Highest dose level 1200 not used|3
5834967|NCT02377362|20166310|P4|Part A Third Treatment|Highest dose level 1200 not used|4
5834968|NCT02377362|20166311|P3|Part A Third Treatment|Highest dose level 1200 not used|0
5834969|NCT02377362|20166312|P2|Part A Third Treatment|Highest dose level 1200 not used|0
5834970|NCT02377362|20166313|P1|Part A Third Treatment|Highest dose level 1200 not used|0
5834971|NCT02377362|20166301|P13|Part A Second Treatment|Protocol Violation|0
5834972|NCT02377362|20166302|P12|Part A Second Treatment|Protocol Violation|0
5834973|NCT02377362|20166303|P11|Part A Second Treatment|Protocol Violation|0
5834974|NCT02377362|20166304|P10|Part A Second Treatment|Protocol Violation|0
5834975|NCT02377362|20166305|P9|Part A Second Treatment|Protocol Violation|0
5834976|NCT02377362|20166306|P8|Part A Second Treatment|Protocol Violation|0
5834977|NCT02377362|20166307|P7|Part A Second Treatment|Protocol Violation|0
5834978|NCT02377362|20166308|P6|Part A Second Treatment|Protocol Violation|0
5834979|NCT02377362|20166309|P5|Part A Second Treatment|Protocol Violation|1
5834980|NCT02377362|20166310|P4|Part A Second Treatment|Protocol Violation|0
5834981|NCT02377362|20166311|P3|Part A Second Treatment|Protocol Violation|0
5834982|NCT02377362|20166312|P2|Part A Second Treatment|Protocol Violation|0
5834983|NCT02377362|20166313|P1|Part A Second Treatment|Protocol Violation|0
5834984|NCT02377349|20166522|P2|Overall Study|Other|1
5834985|NCT02377349|20166523|P1|Overall Study|Other|0
5834986|NCT02377349|20166522|P2|Overall Study|Lost to follow-up (complete vaccination)|5
5834987|NCT02377349|20166523|P1|Overall Study|Lost to follow-up (complete vaccination)|6
5834988|NCT02377349|20166522|P2|Overall Study|Lost to follow-up (partial vaccination)|0
5834989|NCT02377349|20166523|P1|Overall Study|Lost to follow-up (partial vaccination)|1
5834990|NCT02377349|20166522|P2|Overall Study|Withdrawal by Subject|3
5834991|NCT02377349|20166523|P1|Overall Study|Withdrawal by Subject|5
5834992|NCT02377349|20166522|P2|Overall Study|Protocol Violation|2
5834993|NCT02377349|20166523|P1|Overall Study|Protocol Violation|3
5834994|NCT02377349|20166522|P2|Overall Study|Serious Adverse Event|0
5834995|NCT02377349|20166523|P1|Overall Study|Serious Adverse Event|1
5834996|NCT02377063|20166561|P1|Overall Study|Non-compliance|5
5835006|NCT02376166|20166772|P1|Overall Study|Discontinued metformin early|2
5835007|NCT02376166|20166772|P1|Overall Study|Adverse Event|1
5835008|NCT02375971|20166800|P3|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|0
5835009|NCT02375971|20166801|P2|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1
5835010|NCT02375971|20166802|P1|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1
5835011|NCT02375971|20166800|P3|Follow-Up Phase (up to Day 169)|Death|4
5835012|NCT02375971|20166801|P2|Follow-Up Phase (up to Day 169)|Death|4
5835013|NCT02375971|20166802|P1|Follow-Up Phase (up to Day 169)|Death|4
5835014|NCT02375971|20166800|P3|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1
5835015|NCT02375971|20166801|P2|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|0
5835016|NCT02375971|20166802|P1|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1
5835017|NCT02375971|20166800|P3|Follow-Up Phase (up to Day 169)|Adverse Event|0
5835018|NCT02375971|20166801|P2|Follow-Up Phase (up to Day 169)|Adverse Event|0
5835019|NCT02375971|20166802|P1|Follow-Up Phase (up to Day 169)|Adverse Event|1
5835020|NCT02375971|20166800|P3|Treatment (Day 1 - Baseline)|Adverse Event|1
5835021|NCT02375971|20166801|P2|Treatment (Day 1 - Baseline)|Adverse Event|0
5835022|NCT02375971|20166802|P1|Treatment (Day 1 - Baseline)|Adverse Event|0
5835023|NCT02375971|20166800|P3|Treatment (Day 1 - Baseline)|Lost to Follow-up|1
5835024|NCT02375971|20166801|P2|Treatment (Day 1 - Baseline)|Lost to Follow-up|0
5835025|NCT02375971|20166802|P1|Treatment (Day 1 - Baseline)|Lost to Follow-up|0
5835026|NCT02375971|20166800|P3|Treatment (Day 1 - Baseline)|Physician Decision|1
5835027|NCT02375971|20166801|P2|Treatment (Day 1 - Baseline)|Physician Decision|1
5835028|NCT02375971|20166802|P1|Treatment (Day 1 - Baseline)|Physician Decision|1
5835029|NCT02375971|20166800|P3|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|2
5835030|NCT02375971|20166801|P2|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0
5835031|NCT02375971|20166802|P1|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0
5835032|NCT02375724|20166844|P2|Overall Study|Adverse Event|4
5835033|NCT02375724|20166845|P1|Overall Study|Adverse Event|2
5835034|NCT02375724|20166844|P2|Overall Study|Protocol Violation|0
5835035|NCT02375724|20166845|P1|Overall Study|Protocol Violation|1
5835036|NCT02375724|20166844|P2|Overall Study|Lost to Follow-up|0
5835037|NCT02375724|20166845|P1|Overall Study|Lost to Follow-up|1
5835038|NCT02375724|20166844|P2|Overall Study|Withdrawal by Subject|1
5835039|NCT02375724|20166845|P1|Overall Study|Withdrawal by Subject|1
5835040|NCT02375724|20166844|P2|Overall Study|Lack of Efficacy|1
5835041|NCT02375724|20166845|P1|Overall Study|Lack of Efficacy|1
5835042|NCT02375698|20166857|P2|Overall Study|Physician Decision|0
5835043|NCT02375698|20166858|P1|Overall Study|Physician Decision|2
5835044|NCT02375698|20166857|P2|Overall Study|Withdrawal by Subject|2
5835045|NCT02375698|20166858|P1|Overall Study|Withdrawal by Subject|0
5835046|NCT02375373|20166866|P1|Overall Study|Withdrawal by Subject|11
5835047|NCT02375347|20166870|P1|Overall Study|Protocol Violation|1
5835048|NCT02374957|20166876|P2|Overall Study|Patient did not complete forms correctly|0
5835049|NCT02374957|20166877|P1|Overall Study|Patient did not complete forms correctly|1
5835050|NCT02374671|20166906|P3|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0
5835051|NCT02374671|20166907|P2|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0
5835052|NCT02374671|20166908|P1|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1
5835053|NCT02374671|20166906|P3|Implantation- Nonrandomized & Randomized|Adverse Event|1
5835054|NCT02374671|20166907|P2|Implantation- Nonrandomized & Randomized|Adverse Event|0
5835055|NCT02374671|20166908|P1|Implantation- Nonrandomized & Randomized|Adverse Event|7
5835056|NCT02374671|20166906|P3|Implantation- Nonrandomized & Randomized|Lost to Follow-up|2
5835057|NCT02374671|20166907|P2|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1
5835058|NCT02374671|20166908|P1|Implantation- Nonrandomized & Randomized|Lost to Follow-up|17
5835059|NCT02374671|20166906|P3|Observation (Deferred Implantation)|Adverse Event|1
5835060|NCT02374671|20166907|P2|Observation (Deferred Implantation)|Adverse Event|0
5835061|NCT02374671|20166908|P1|Observation (Deferred Implantation)|Adverse Event|0
5835062|NCT02374671|20166906|P3|Observation (Deferred Implantation)|Withdrawal by Subject|4
5835063|NCT02374671|20166907|P2|Observation (Deferred Implantation)|Withdrawal by Subject|0
5835064|NCT02374671|20166908|P1|Observation (Deferred Implantation)|Withdrawal by Subject|0
5835065|NCT02374593|20166916|P2|Overall Study|non-compliant|0
5835066|NCT02374593|20166917|P1|Overall Study|non-compliant|2
5835067|NCT02374463|20166929|P2|Overall Study|Withdrawal by Subject|3
5835068|NCT02374463|20166930|P1|Overall Study|Withdrawal by Subject|3
5835069|NCT02374346|20166979|P1|Overall Study|operated or discharged during weekend|48
5835070|NCT02374307|20166987|P2|6-months Follow-up|Withdrawal by Subject|3
5835071|NCT02374307|20166988|P1|6-months Follow-up|Withdrawal by Subject|0
5835072|NCT02374307|20166987|P2|6-months Follow-up|Death|1
5835073|NCT02374307|20166988|P1|6-months Follow-up|Death|2
5835074|NCT02374307|20166987|P2|6-months Follow-up|Lost to Follow-up|2
5835075|NCT02374307|20166988|P1|6-months Follow-up|Lost to Follow-up|1
5835076|NCT02374307|20166987|P2|3-months Follow-up|Missed first follow-up|1
5835077|NCT02374307|20166988|P1|3-months Follow-up|Missed first follow-up|5
5835078|NCT02374307|20166987|P2|3-months Follow-up|Death|2
5835079|NCT02374307|20166988|P1|3-months Follow-up|Death|1
5835080|NCT02374307|20166987|P2|3-months Follow-up|Withdrawal by Subject|4
5835081|NCT02374307|20166988|P1|3-months Follow-up|Withdrawal by Subject|1
5835082|NCT02374307|20166987|P2|3-months Follow-up|Lost to Follow-up|2
5835083|NCT02374307|20166988|P1|3-months Follow-up|Lost to Follow-up|1
5835084|NCT02374255|20167019|P4|Overall Study|Withdrawal by Subject|0
5835085|NCT02374255|20167020|P3|Overall Study|Withdrawal by Subject|0
5835086|NCT02374255|20167021|P2|Overall Study|Withdrawal by Subject|0
5835087|NCT02374255|20167022|P1|Overall Study|Withdrawal by Subject|2
5835088|NCT02374099|20167123|P2|Overall Study|Study Terminated by Sponsor|4
5835089|NCT02374099|20167124|P1|Overall Study|Study Terminated by Sponsor|3
5835090|NCT02374099|20167123|P2|Overall Study|Randomized, but not treated|1
5835091|NCT02374099|20167124|P1|Overall Study|Randomized, but not treated|2
5835092|NCT02374099|20167123|P2|Overall Study|Miscellaneous|3
5835093|NCT02374099|20167124|P1|Overall Study|Miscellaneous|2
5835094|NCT02374099|20167123|P2|Overall Study|Withdrawal by Subject|1
5835095|NCT02374099|20167124|P1|Overall Study|Withdrawal by Subject|5
5835096|NCT02374099|20167123|P2|Overall Study|Progressive Disease|40
5835097|NCT02374099|20167124|P1|Overall Study|Progressive Disease|35
5835098|NCT02374099|20167123|P2|Overall Study|Adverse Event|0
5835099|NCT02374099|20167124|P1|Overall Study|Adverse Event|1
5835100|NCT02373813|20167216|P4|Double-Blind Treatment Period|Withdrawal by Subject|3
5835101|NCT02373813|20167217|P3|Double-Blind Treatment Period|Withdrawal by Subject|6
5835102|NCT02373813|20167218|P2|Double-Blind Treatment Period|Withdrawal by Subject|10
5835103|NCT02373813|20167219|P1|Double-Blind Treatment Period|Withdrawal by Subject|0
5835104|NCT02373813|20167216|P4|Double-Blind Treatment Period|Lost to Follow-up|1
5835105|NCT02373813|20167217|P3|Double-Blind Treatment Period|Lost to Follow-up|1
5835106|NCT02373813|20167218|P2|Double-Blind Treatment Period|Lost to Follow-up|0
5835107|NCT02373813|20167219|P1|Double-Blind Treatment Period|Lost to Follow-up|0
5835108|NCT02373813|20167216|P4|Double-Blind Treatment Period|Protocol Violation|0
5835109|NCT02373813|20167217|P3|Double-Blind Treatment Period|Protocol Violation|0
5835110|NCT02373813|20167218|P2|Double-Blind Treatment Period|Protocol Violation|2
5835111|NCT02373813|20167219|P1|Double-Blind Treatment Period|Protocol Violation|0
5835112|NCT02373813|20167216|P4|Double-Blind Treatment Period|Decision by Sponsor|0
5835113|NCT02373813|20167217|P3|Double-Blind Treatment Period|Decision by Sponsor|2
5835114|NCT02373813|20167218|P2|Double-Blind Treatment Period|Decision by Sponsor|1
5835115|NCT02373813|20167219|P1|Double-Blind Treatment Period|Decision by Sponsor|0
5835116|NCT02373813|20167216|P4|Run-In Period|Ineligibility Determined|0
5835117|NCT02373813|20167217|P3|Run-In Period|Ineligibility Determined|0
5835118|NCT02373813|20167218|P2|Run-In Period|Ineligibility Determined|0
5835119|NCT02373813|20167219|P1|Run-In Period|Ineligibility Determined|3
5835120|NCT02373813|20167216|P4|Run-In Period|Noncompliance|0
5835121|NCT02373813|20167217|P3|Run-In Period|Noncompliance|0
5835122|NCT02373813|20167218|P2|Run-In Period|Noncompliance|0
5835123|NCT02373813|20167219|P1|Run-In Period|Noncompliance|1
5835124|NCT02373813|20167216|P4|Run-In Period|Adverse Event|0
5835125|NCT02373813|20167217|P3|Run-In Period|Adverse Event|0
5835126|NCT02373813|20167218|P2|Run-In Period|Adverse Event|0
5835127|NCT02373813|20167219|P1|Run-In Period|Adverse Event|3
5835128|NCT02373813|20167216|P4|Run-In Period|Lost to Follow-up|0
5835129|NCT02373813|20167217|P3|Run-In Period|Lost to Follow-up|0
5835130|NCT02373813|20167218|P2|Run-In Period|Lost to Follow-up|0
5835131|NCT02373813|20167219|P1|Run-In Period|Lost to Follow-up|2
5835132|NCT02373813|20167216|P4|Run-In Period|Protocol Violation|0
5835133|NCT02373813|20167217|P3|Run-In Period|Protocol Violation|0
5835134|NCT02373813|20167218|P2|Run-In Period|Protocol Violation|0
5835135|NCT02373813|20167219|P1|Run-In Period|Protocol Violation|75
5835136|NCT02373813|20167216|P4|Run-In Period|Decision by Sponsor|0
5835137|NCT02373813|20167217|P3|Run-In Period|Decision by Sponsor|0
5835138|NCT02373813|20167218|P2|Run-In Period|Decision by Sponsor|0
5835139|NCT02373813|20167219|P1|Run-In Period|Decision by Sponsor|11
5835140|NCT02373813|20167216|P4|Run-In Period|Withdrawal by Subject|0
5835141|NCT02373813|20167217|P3|Run-In Period|Withdrawal by Subject|0
5835142|NCT02373813|20167218|P2|Run-In Period|Withdrawal by Subject|0
5835143|NCT02373813|20167219|P1|Run-In Period|Withdrawal by Subject|16
5835144|NCT02373813|20167216|P4|Run-In Period|Other, Not Specified|0
5835145|NCT02373813|20167217|P3|Run-In Period|Other, Not Specified|0
5835146|NCT02373813|20167218|P2|Run-In Period|Other, Not Specified|0
5835147|NCT02373813|20167219|P1|Run-In Period|Other, Not Specified|5
5835148|NCT02373202|20167291|P4|Overall Study|Other|0
5835149|NCT02373202|20167292|P3|Overall Study|Other|0
5835150|NCT02373202|20167293|P2|Overall Study|Other|1
5835151|NCT02373202|20167294|P1|Overall Study|Other|0
5835152|NCT02373202|20167291|P4|Overall Study|Lack of Efficacy|0
5835153|NCT02373202|20167292|P3|Overall Study|Lack of Efficacy|1
5835154|NCT02373202|20167293|P2|Overall Study|Lack of Efficacy|0
5835155|NCT02373202|20167294|P1|Overall Study|Lack of Efficacy|0
5835156|NCT02373202|20167291|P4|Overall Study|Adverse Event|1
5835157|NCT02373202|20167292|P3|Overall Study|Adverse Event|2
5835158|NCT02373202|20167293|P2|Overall Study|Adverse Event|5
5835159|NCT02373202|20167294|P1|Overall Study|Adverse Event|2
5835160|NCT02373098|20167385|P2|Overall Study|Adverse Event|0
5835161|NCT02373098|20167386|P1|Overall Study|Adverse Event|3
5835162|NCT02373098|20167385|P2|Overall Study|Withdrawal by Subject|0
5835163|NCT02373098|20167386|P1|Overall Study|Withdrawal by Subject|5
5835164|NCT02373098|20167385|P2|Overall Study|Protocol Violation|0
5835165|NCT02373098|20167386|P1|Overall Study|Protocol Violation|3
5835166|NCT02373098|20167385|P2|Overall Study|Lost to Follow-up|0
5835167|NCT02373098|20167386|P1|Overall Study|Lost to Follow-up|1
5835168|NCT02372799|20167414|P3|Down-taper Period|Lost to Follow-up|2
5835169|NCT02372799|20167415|P2|Down-taper Period|Lost to Follow-up|2
5835170|NCT02372799|20167416|P1|Down-taper Period|Lost to Follow-up|1
5835171|NCT02372799|20167414|P3|Treatment Period|Miscellaneous Reasons|0
5835172|NCT02372799|20167415|P2|Treatment Period|Miscellaneous Reasons|1
5835173|NCT02372799|20167416|P1|Treatment Period|Miscellaneous Reasons|1
5835174|NCT02372799|20167414|P3|Treatment Period|Non-compliance with study drug|4
5835175|NCT02372799|20167415|P2|Treatment Period|Non-compliance with study drug|4
5835176|NCT02372799|20167416|P1|Treatment Period|Non-compliance with study drug|4
5835177|NCT02372799|20167414|P3|Treatment Period|Protocol Violation|0
5835178|NCT02372799|20167415|P2|Treatment Period|Protocol Violation|0
5835179|NCT02372799|20167416|P1|Treatment Period|Protocol Violation|3
5835180|NCT02372799|20167414|P3|Treatment Period|Lost to Follow-up|3
5835181|NCT02372799|20167415|P2|Treatment Period|Lost to Follow-up|5
5835182|NCT02372799|20167416|P1|Treatment Period|Lost to Follow-up|11
5835183|NCT02372799|20167414|P3|Treatment Period|Withdrawal by Subject|2
5835184|NCT02372799|20167415|P2|Treatment Period|Withdrawal by Subject|10
5835185|NCT02372799|20167416|P1|Treatment Period|Withdrawal by Subject|10
5835186|NCT02372799|20167414|P3|Treatment Period|Insufficient therapeutic response|0
5835187|NCT02372799|20167415|P2|Treatment Period|Insufficient therapeutic response|2
5835188|NCT02372799|20167416|P1|Treatment Period|Insufficient therapeutic response|2
5835189|NCT02372799|20167414|P3|Treatment Period|Adverse Event|6
5835190|NCT02372799|20167415|P2|Treatment Period|Adverse Event|10
5835191|NCT02372799|20167416|P1|Treatment Period|Adverse Event|3
5835192|NCT02372396|20167445|P2|Overall Study|Lost to Follow-up|9
5835193|NCT02372396|20167446|P1|Overall Study|Lost to Follow-up|7
5835194|NCT02372253|20167470|P2|Overall Study|Non Compliance|0
5835195|NCT02372253|20167471|P1|Overall Study|Non Compliance|2
5835196|NCT02372071|20167516|P1|Overall Study|Protocol Violation|18
5835197|NCT02372058|20167521|P1|Overall Study|Withdrawal by Subject|3
5835198|NCT02371980|20167527|P5|Double-blind Period|Missing|0
5835199|NCT02371980|20167528|P4|Double-blind Period|Missing|0
5835200|NCT02371980|20167529|P3|Double-blind Period|Missing|0
5835201|NCT02371980|20167530|P2|Double-blind Period|Missing|1
5835202|NCT02371980|20167531|P1|Double-blind Period|Missing|0
5835203|NCT02371980|20167527|P5|Double-blind Period|Reason not Specified|1
5835204|NCT02371980|20167528|P4|Double-blind Period|Reason not Specified|2
5835205|NCT02371980|20167529|P3|Double-blind Period|Reason not Specified|3
5835206|NCT02371980|20167530|P2|Double-blind Period|Reason not Specified|3
5835207|NCT02371980|20167531|P1|Double-blind Period|Reason not Specified|0
5835208|NCT02371980|20167527|P5|Double-blind Period|Relapse|26
5835209|NCT02371980|20167528|P4|Double-blind Period|Relapse|25
5835210|NCT02371980|20167529|P3|Double-blind Period|Relapse|25
5835211|NCT02371980|20167530|P2|Double-blind Period|Relapse|50
5835212|NCT02371980|20167531|P1|Double-blind Period|Relapse|0
5835213|NCT02371980|20167527|P5|Double-blind Period|Voluntary Withdrawal|11
5835214|NCT02371980|20167528|P4|Double-blind Period|Voluntary Withdrawal|9
5835215|NCT02371980|20167529|P3|Double-blind Period|Voluntary Withdrawal|8
5835216|NCT02371980|20167530|P2|Double-blind Period|Voluntary Withdrawal|12
5835217|NCT02371980|20167531|P1|Double-blind Period|Voluntary Withdrawal|0
5835218|NCT02371980|20167527|P5|Double-blind Period|Lost to Follow-up|5
5835219|NCT02371980|20167528|P4|Double-blind Period|Lost to Follow-up|6
5835220|NCT02371980|20167529|P3|Double-blind Period|Lost to Follow-up|8
5835221|NCT02371980|20167530|P2|Double-blind Period|Lost to Follow-up|8
5835222|NCT02371980|20167531|P1|Double-blind Period|Lost to Follow-up|0
5835223|NCT02371980|20167527|P5|Double-blind Period|Noncompliance with Study Drug|3
5835224|NCT02371980|20167528|P4|Double-blind Period|Noncompliance with Study Drug|2
5835225|NCT02371980|20167529|P3|Double-blind Period|Noncompliance with Study Drug|2
5835226|NCT02371980|20167530|P2|Double-blind Period|Noncompliance with Study Drug|1
5835227|NCT02371980|20167531|P1|Double-blind Period|Noncompliance with Study Drug|0
5835228|NCT02371980|20167527|P5|Double-blind Period|Significant Protocol Deviation|3
5835229|NCT02371980|20167528|P4|Double-blind Period|Significant Protocol Deviation|3
5835230|NCT02371980|20167529|P3|Double-blind Period|Significant Protocol Deviation|7
5835231|NCT02371980|20167530|P2|Double-blind Period|Significant Protocol Deviation|2
5835232|NCT02371980|20167531|P1|Double-blind Period|Significant Protocol Deviation|0
5835233|NCT02371980|20167527|P5|Double-blind Period|Pretreatment Event/Adverse Event|9
5835234|NCT02371980|20167528|P4|Double-blind Period|Pretreatment Event/Adverse Event|2
5835235|NCT02371980|20167529|P3|Double-blind Period|Pretreatment Event/Adverse Event|3
5835236|NCT02371980|20167530|P2|Double-blind Period|Pretreatment Event/Adverse Event|4
5835237|NCT02371980|20167531|P1|Double-blind Period|Pretreatment Event/Adverse Event|0
5835238|NCT02371980|20167527|P5|Open-label Period|Reason not Specified|0
5835239|NCT02371980|20167528|P4|Open-label Period|Reason not Specified|0
5835240|NCT02371980|20167529|P3|Open-label Period|Reason not Specified|0
5835241|NCT02371980|20167530|P2|Open-label Period|Reason not Specified|0
5835242|NCT02371980|20167531|P1|Open-label Period|Reason not Specified|9
5835243|NCT02371980|20167527|P5|Open-label Period|Did not Meet Randomization Criteria|0
5835244|NCT02371980|20167528|P4|Open-label Period|Did not Meet Randomization Criteria|0
5835245|NCT02371980|20167529|P3|Open-label Period|Did not Meet Randomization Criteria|0
5835246|NCT02371980|20167530|P2|Open-label Period|Did not Meet Randomization Criteria|0
5835247|NCT02371980|20167531|P1|Open-label Period|Did not Meet Randomization Criteria|162
5835248|NCT02371980|20167527|P5|Open-label Period|Lack of Efficacy|0
5835249|NCT02371980|20167528|P4|Open-label Period|Lack of Efficacy|0
5835250|NCT02371980|20167529|P3|Open-label Period|Lack of Efficacy|0
5835251|NCT02371980|20167530|P2|Open-label Period|Lack of Efficacy|0
5835252|NCT02371980|20167531|P1|Open-label Period|Lack of Efficacy|116
5835253|NCT02371980|20167527|P5|Open-label Period|Pregnancy|0
5835254|NCT02371980|20167528|P4|Open-label Period|Pregnancy|0
5835255|NCT02371980|20167529|P3|Open-label Period|Pregnancy|0
5835256|NCT02371980|20167530|P2|Open-label Period|Pregnancy|0
5835257|NCT02371980|20167531|P1|Open-label Period|Pregnancy|1
5835258|NCT02371980|20167527|P5|Open-label Period|Voluntary Withdrawal|0
5835259|NCT02371980|20167528|P4|Open-label Period|Voluntary Withdrawal|0
5835260|NCT02371980|20167529|P3|Open-label Period|Voluntary Withdrawal|0
5835261|NCT02371980|20167530|P2|Open-label Period|Voluntary Withdrawal|0
5835262|NCT02371980|20167531|P1|Open-label Period|Voluntary Withdrawal|91
5835263|NCT02371980|20167527|P5|Open-label Period|Lost to Follow-up|0
5835264|NCT02371980|20167528|P4|Open-label Period|Lost to Follow-up|0
5835265|NCT02371980|20167529|P3|Open-label Period|Lost to Follow-up|0
5835266|NCT02371980|20167530|P2|Open-label Period|Lost to Follow-up|0
5835267|NCT02371980|20167531|P1|Open-label Period|Lost to Follow-up|55
5835268|NCT02371980|20167527|P5|Open-label Period|Noncompliance with Study Drug|0
5835269|NCT02371980|20167528|P4|Open-label Period|Noncompliance with Study Drug|0
5835270|NCT02371980|20167529|P3|Open-label Period|Noncompliance with Study Drug|0
5835271|NCT02371980|20167530|P2|Open-label Period|Noncompliance with Study Drug|0
5835272|NCT02371980|20167531|P1|Open-label Period|Noncompliance with Study Drug|10
5835273|NCT02371980|20167527|P5|Open-label Period|Significant Protocol Deviation|0
5835274|NCT02371980|20167528|P4|Open-label Period|Significant Protocol Deviation|0
5835275|NCT02371980|20167529|P3|Open-label Period|Significant Protocol Deviation|0
5835276|NCT02371980|20167530|P2|Open-label Period|Significant Protocol Deviation|0
5835277|NCT02371980|20167531|P1|Open-label Period|Significant Protocol Deviation|19
5835278|NCT02371980|20167527|P5|Open-label Period|Pretreatment Event/Adverse Event|0
5835279|NCT02371980|20167528|P4|Open-label Period|Pretreatment Event/Adverse Event|0
5835280|NCT02371980|20167529|P3|Open-label Period|Pretreatment Event/Adverse Event|0
5835281|NCT02371980|20167530|P2|Open-label Period|Pretreatment Event/Adverse Event|0
5835282|NCT02371980|20167531|P1|Open-label Period|Pretreatment Event/Adverse Event|63
5835283|NCT02371759|20167591|P8|Overall Study|Withdrawal by Subject|1
5835284|NCT02371759|20167592|P7|Overall Study|Withdrawal by Subject|0
5835285|NCT02371759|20167593|P6|Overall Study|Withdrawal by Subject|0
5835286|NCT02371759|20167594|P5|Overall Study|Withdrawal by Subject|0
5835287|NCT02371759|20167595|P4|Overall Study|Withdrawal by Subject|0
5835288|NCT02371759|20167596|P3|Overall Study|Withdrawal by Subject|0
5835289|NCT02371759|20167597|P2|Overall Study|Withdrawal by Subject|0
5835290|NCT02371759|20167598|P1|Overall Study|Withdrawal by Subject|0
5835291|NCT02371759|20167591|P8|Overall Study|Protocol Violation|3
5835292|NCT02371759|20167592|P7|Overall Study|Protocol Violation|0
5835293|NCT02371759|20167593|P6|Overall Study|Protocol Violation|1
5835294|NCT02371759|20167594|P5|Overall Study|Protocol Violation|3
5835295|NCT02371759|20167595|P4|Overall Study|Protocol Violation|0
5835296|NCT02371759|20167596|P3|Overall Study|Protocol Violation|1
5835297|NCT02371759|20167597|P2|Overall Study|Protocol Violation|1
5835298|NCT02371759|20167598|P1|Overall Study|Protocol Violation|3
5835299|NCT02371746|20167815|P7|Overall Study|Consent withdrawn|1
5835300|NCT02371746|20167816|P6|Overall Study|Consent withdrawn|0
5835301|NCT02371746|20167817|P5|Overall Study|Consent withdrawn|0
5835302|NCT02371746|20167818|P4|Overall Study|Consent withdrawn|0
5835303|NCT02371746|20167819|P3|Overall Study|Consent withdrawn|0
5835304|NCT02371746|20167820|P2|Overall Study|Consent withdrawn|0
5835305|NCT02371746|20167821|P1|Overall Study|Consent withdrawn|0
5835306|NCT02371629|20167864|P2|Overall Study|Protocol deviation|1
5835307|NCT02371629|20167865|P1|Overall Study|Protocol deviation|0
5835308|NCT02371629|20167864|P2|Overall Study|Lack of Efficacy|2
5835309|NCT02371629|20167865|P1|Overall Study|Lack of Efficacy|0
5835310|NCT02371629|20167864|P2|Overall Study|Noncompliance with study treatment|0
5835311|NCT02371629|20167865|P1|Overall Study|Noncompliance with study treatment|1
5835312|NCT02371629|20167864|P2|Overall Study|Death|1
5835313|NCT02371629|20167865|P1|Overall Study|Death|1
5835314|NCT02371629|20167864|P2|Overall Study|Physician Decision|3
5835315|NCT02371629|20167865|P1|Overall Study|Physician Decision|2
5835316|NCT02371629|20167864|P2|Overall Study|Adverse Event|8
5835317|NCT02371629|20167865|P1|Overall Study|Adverse Event|8
5835318|NCT02371629|20167864|P2|Overall Study|Patient decision|10
5835319|NCT02371629|20167865|P1|Overall Study|Patient decision|14
5835320|NCT02371616|20167901|P2|Overall Study|Other (Not specified)|5
5835321|NCT02371616|20167902|P1|Overall Study|Other (Not specified)|1
5835322|NCT02371616|20167901|P2|Overall Study|Withdrawal of Consent|0
5835323|NCT02371616|20167902|P1|Overall Study|Withdrawal of Consent|1
5835324|NCT02371616|20167901|P2|Overall Study|Adverse Event|1
5835325|NCT02371616|20167902|P1|Overall Study|Adverse Event|0
5835326|NCT02371616|20167901|P2|Overall Study|Protocol Violation|1
5835327|NCT02371616|20167902|P1|Overall Study|Protocol Violation|2
5835328|NCT02370914|20167961|P1|Overall Study|Protocol Violation|2
5835329|NCT02370888|20167969|P1|Overall Study|did not meet chimerism criteria|6
5835330|NCT02370888|20167969|P1|Overall Study|disease progression|2
5835331|NCT02370784|20167979|P2|Overall Study|Patient started prohibited medication|1
5835332|NCT02370784|20167980|P1|Overall Study|Patient started prohibited medication|0
5835333|NCT02370667|20167995|P3|Overall Study|Lost to Follow-up|0
5835334|NCT02370667|20167996|P2|Overall Study|Lost to Follow-up|1
5835335|NCT02370667|20167997|P1|Overall Study|Lost to Follow-up|0
5835336|NCT02370641|20168061|P2|Overall Study|dropped study|2
5835337|NCT02370641|20168062|P1|Overall Study|dropped study|4
5835338|NCT02370615|20168070|P2|Overall Study|Adverse Event|0
5835339|NCT02370615|20168071|P1|Overall Study|Adverse Event|1
5835340|NCT02370602|20168114|P6|Overall Study|Pretreatment Event/Adverse Event|0
5835341|NCT02370602|20168115|P5|Overall Study|Pretreatment Event/Adverse Event|0
5835342|NCT02370602|20168116|P4|Overall Study|Pretreatment Event/Adverse Event|0
5835343|NCT02370602|20168117|P3|Overall Study|Pretreatment Event/Adverse Event|0
5835344|NCT02370602|20168118|P2|Overall Study|Pretreatment Event/Adverse Event|0
5835345|NCT02370602|20168119|P1|Overall Study|Pretreatment Event/Adverse Event|1
5835346|NCT02370537|20168213|P3|Part B|Withdrawal by Subject|0
5835347|NCT02370537|20168214|P2|Part B|Withdrawal by Subject|1
5835348|NCT02370537|20168215|P1|Part B|Withdrawal by Subject|0
5835349|NCT02370537|20168213|P3|Part B|Not randomised to receive treatment|259
5835350|NCT02370537|20168214|P2|Part B|Not randomised to receive treatment|2
5835351|NCT02370537|20168215|P1|Part B|Not randomised to receive treatment|1
5835352|NCT02370537|20168213|P3|Part A (Open-label Recruitment)|Adverse Event|1
5835353|NCT02370537|20168214|P2|Part A (Open-label Recruitment)|Adverse Event|0
5835354|NCT02370537|20168215|P1|Part A (Open-label Recruitment)|Adverse Event|0
5835355|NCT02370537|20168213|P3|Part A (Open-label Recruitment)|Withdrawal by Subject|0
5835356|NCT02370537|20168214|P2|Part A (Open-label Recruitment)|Withdrawal by Subject|1
5835357|NCT02370537|20168215|P1|Part A (Open-label Recruitment)|Withdrawal by Subject|0
5835358|NCT02370498|20168264|P2|Overall Study|Ongoing In Trial|33
5835359|NCT02370498|20168265|P1|Overall Study|Ongoing In Trial|56
5835360|NCT02370498|20168264|P2|Overall Study|Withdrawal by Subject|11
5835361|NCT02370498|20168265|P1|Overall Study|Withdrawal by Subject|6
5835362|NCT02370498|20168264|P2|Overall Study|Protocol Violation|2
5835363|NCT02370498|20168265|P1|Overall Study|Protocol Violation|1
5835364|NCT02370498|20168264|P2|Overall Study|Lost to Follow-up|0
5835365|NCT02370498|20168265|P1|Overall Study|Lost to Follow-up|1
5835366|NCT02370498|20168264|P2|Overall Study|Death|242
5835367|NCT02370498|20168265|P1|Overall Study|Death|222
5835368|NCT02370498|20168264|P2|Overall Study|Adverse Event|8
5835369|NCT02370498|20168265|P1|Overall Study|Adverse Event|10
5835370|NCT02370420|20168319|P2|Overall Study|Lost to Follow-up|9
5835371|NCT02370420|20168320|P1|Overall Study|Lost to Follow-up|11
5835372|NCT02370420|20168319|P2|Overall Study|Physician Decision|3
5835373|NCT02370420|20168320|P1|Overall Study|Physician Decision|3
5835374|NCT02370394|20168357|P2|Overall Study|Withdrawal by Subject|1
5835375|NCT02370394|20168358|P1|Overall Study|Withdrawal by Subject|0
5835376|NCT02370394|20168357|P2|Overall Study|Lost to Follow-up|1
5835377|NCT02370394|20168358|P1|Overall Study|Lost to Follow-up|2
5835378|NCT02370368|20168374|P2|Overall Study|Withdrawal by Subject|4
5835379|NCT02370368|20168375|P1|Overall Study|Withdrawal by Subject|5
5835380|NCT02370368|20168374|P2|Overall Study|Adverse Event|2
5835381|NCT02370368|20168375|P1|Overall Study|Adverse Event|1
5835382|NCT02370251|20168385|P1|Overall Study|Death|4
5835383|NCT02370251|20168385|P1|Overall Study|Received less than 8 days of Omegaven|7
5835384|NCT02370160|20168391|P3|Overall Study|Death|1
5835385|NCT02370160|20168392|P2|Overall Study|Death|4
5835386|NCT02370160|20168393|P1|Overall Study|Death|3
5835387|NCT02370121|20168417|P2|Overall Study|Lost to Follow-up|1
5835388|NCT02370121|20168418|P1|Overall Study|Lost to Follow-up|1
5835389|NCT02370095|20168458|P2|Overall Study|Withdrawal by Subject|1
5835390|NCT02370095|20168459|P1|Overall Study|Withdrawal by Subject|0
5835391|NCT02370043|20168500|P6|Overall Study|Withdrawal by Subject|1
5835392|NCT02370043|20168501|P5|Overall Study|Withdrawal by Subject|1
5835393|NCT02370043|20168502|P4|Overall Study|Withdrawal by Subject|0
5835394|NCT02370043|20168503|P3|Overall Study|Withdrawal by Subject|0
5835395|NCT02370043|20168504|P2|Overall Study|Withdrawal by Subject|0
5835396|NCT02370043|20168505|P1|Overall Study|Withdrawal by Subject|0
5835409|NCT02369848|20168695|P1|Overall Study|Lost to Follow-up|1
5835410|NCT02369848|20168695|P1|Overall Study|Withdrawal by Subject|2
5835411|NCT02369848|20168695|P1|Overall Study|Death|1
5835412|NCT02369510|20168788|P3|Overall Study|Epidural Activation|5
5835413|NCT02369510|20168789|P2|Overall Study|Epidural Activation|1
5835414|NCT02369510|20168790|P1|Overall Study|Epidural Activation|1
5835415|NCT02369510|20168788|P3|Overall Study|Spilled Medication|1
5835416|NCT02369510|20168789|P2|Overall Study|Spilled Medication|2
5835417|NCT02369510|20168790|P1|Overall Study|Spilled Medication|1
5835418|NCT02369341|20168829|P2|Overall Study|Migrated/moved from study area|0
5835419|NCT02369341|20168830|P1|Overall Study|Migrated/moved from study area|1
5835420|NCT02368886|20169006|P4|Overall Study|Ineligible|1
5835421|NCT02368886|20169007|P3|Overall Study|Ineligible|0
5835422|NCT02368886|20169008|P2|Overall Study|Ineligible|0
5835423|NCT02368886|20169009|P1|Overall Study|Ineligible|0
5835424|NCT02368886|20169006|P4|Overall Study|Cancel|3
5835425|NCT02368886|20169007|P3|Overall Study|Cancel|1
5835426|NCT02368886|20169008|P2|Overall Study|Cancel|1
5835427|NCT02368886|20169009|P1|Overall Study|Cancel|1
5835428|NCT02368691|20169027|P1|Overall Study|Physician Decision|4
5835429|NCT02368691|20169027|P1|Overall Study|Lack of Efficacy|15
5835430|NCT02368691|20169027|P1|Overall Study|Death|13
5835431|NCT02368314|20169072|P2|Overall Study|Adverse Event|2
5835432|NCT02368314|20169073|P1|Overall Study|Adverse Event|1
5835433|NCT02368314|20169072|P2|Overall Study|Withdrawal by Subject|1
5835434|NCT02368314|20169073|P1|Overall Study|Withdrawal by Subject|2
5835435|NCT02368210|20169085|P2|Overall Study|Adverse Event|1
5835436|NCT02368210|20169086|P1|Overall Study|Adverse Event|0
5835437|NCT02368210|20169085|P2|Overall Study|Withdrawal by Subject|0
5835438|NCT02368210|20169086|P1|Overall Study|Withdrawal by Subject|1
5835439|NCT02367911|20169113|P2|Overall Study|Lost to Follow-up|2
5835440|NCT02367911|20169114|P1|Overall Study|Lost to Follow-up|2
5835441|NCT02367911|20169113|P2|Overall Study|Withdrawal by Subject|2
5835442|NCT02367911|20169114|P1|Overall Study|Withdrawal by Subject|3
5835443|NCT02367885|20169125|P3|Overall Study|Withdrawal by Subject|0
5835444|NCT02367885|20169126|P2|Overall Study|Withdrawal by Subject|0
5835445|NCT02367885|20169127|P1|Overall Study|Withdrawal by Subject|1
5835446|NCT02367885|20169125|P3|Overall Study|Lost to Follow-up|0
5835447|NCT02367885|20169126|P2|Overall Study|Lost to Follow-up|0
5835448|NCT02367885|20169127|P1|Overall Study|Lost to Follow-up|1
5835449|NCT02367833|20169370|P3|Overall Study|Withdrawal by Subject|0
5835450|NCT02367833|20169371|P2|Overall Study|Withdrawal by Subject|1
5835451|NCT02367833|20169372|P1|Overall Study|Withdrawal by Subject|1
5835452|NCT02367794|20169411|P3|Overall Study|Hypercalcemia prior to C1D1|1
5835453|NCT02367794|20169412|P2|Overall Study|Hypercalcemia prior to C1D1|0
5835454|NCT02367794|20169413|P1|Overall Study|Hypercalcemia prior to C1D1|0
5835455|NCT02367794|20169411|P3|Overall Study|Patient unable to receive carboplatin|1
5835456|NCT02367794|20169412|P2|Overall Study|Patient unable to receive carboplatin|0
5835457|NCT02367794|20169413|P1|Overall Study|Patient unable to receive carboplatin|0
5835458|NCT02367794|20169411|P3|Overall Study|Randomized in error|1
5835459|NCT02367794|20169412|P2|Overall Study|Randomized in error|0
5835460|NCT02367794|20169413|P1|Overall Study|Randomized in error|0
5835461|NCT02367794|20169411|P3|Overall Study|Brain metastasis|0
5835462|NCT02367794|20169412|P2|Overall Study|Brain metastasis|0
5835463|NCT02367794|20169413|P1|Overall Study|Brain metastasis|1
5835464|NCT02367794|20169411|P3|Overall Study|Withdrawal by Subject|14
5835465|NCT02367794|20169412|P2|Overall Study|Withdrawal by Subject|12
5835466|NCT02367794|20169413|P1|Overall Study|Withdrawal by Subject|25
5835467|NCT02367794|20169411|P3|Overall Study|Protocol Violation|1
5835468|NCT02367794|20169412|P2|Overall Study|Protocol Violation|0
5835469|NCT02367794|20169413|P1|Overall Study|Protocol Violation|1
5835470|NCT02367794|20169411|P3|Overall Study|Physician Decision|1
5835471|NCT02367794|20169412|P2|Overall Study|Physician Decision|3
5835472|NCT02367794|20169413|P1|Overall Study|Physician Decision|0
5835473|NCT02367794|20169411|P3|Overall Study|Lost to Follow-up|1
5835474|NCT02367794|20169412|P2|Overall Study|Lost to Follow-up|2
5835475|NCT02367794|20169413|P1|Overall Study|Lost to Follow-up|1
5835476|NCT02367794|20169411|P3|Overall Study|Death|229
5835477|NCT02367794|20169412|P2|Overall Study|Death|223
5835478|NCT02367794|20169413|P1|Overall Study|Death|230
5835479|NCT02367781|20169426|P2|Overall Study|Administrative-Change Facility|0
5835480|NCT02367781|20169427|P1|Overall Study|Administrative-Change Facility|1
5835481|NCT02367781|20169426|P2|Overall Study|Death Prior First Dose|0
5835482|NCT02367781|20169427|P1|Overall Study|Death Prior First Dose|1
5835483|NCT02367781|20169426|P2|Overall Study|Prolonged Hospitalization|0
5835484|NCT02367781|20169427|P1|Overall Study|Prolonged Hospitalization|1
5835485|NCT02367781|20169426|P2|Overall Study|On-going in study|88
5835486|NCT02367781|20169427|P1|Overall Study|On-going in study|214
5835487|NCT02367781|20169426|P2|Overall Study|Death|136
5835488|NCT02367781|20169427|P1|Overall Study|Death|240
5835489|NCT02367781|20169426|P2|Overall Study|Lost to Follow-up|1
5835490|NCT02367781|20169427|P1|Overall Study|Lost to Follow-up|0
5835491|NCT02367781|20169426|P2|Overall Study|Non-Compliance|0
5835492|NCT02367781|20169427|P1|Overall Study|Non-Compliance|1
5835493|NCT02367781|20169426|P2|Overall Study|Randomized in Error|4
5835494|NCT02367781|20169427|P1|Overall Study|Randomized in Error|5
5835495|NCT02367781|20169426|P2|Overall Study|Physician Decision|0
5835496|NCT02367781|20169427|P1|Overall Study|Physician Decision|1
5835497|NCT02367781|20169426|P2|Overall Study|Protocol Violation|1
5835498|NCT02367781|20169427|P1|Overall Study|Protocol Violation|0
5835499|NCT02367781|20169426|P2|Overall Study|Withdrawal by Subject|10
5835500|NCT02367781|20169427|P1|Overall Study|Withdrawal by Subject|19
5835501|NCT02367729|20169437|P2|Overall Study|Withdrawal by Subject|5
5835502|NCT02367729|20169438|P1|Overall Study|Withdrawal by Subject|0
5835503|NCT02367729|20169437|P2|Overall Study|Adverse Event|2
5835504|NCT02367729|20169438|P1|Overall Study|Adverse Event|1
5835505|NCT02367729|20169437|P2|Overall Study|Organic disorder diagnosed|1
5835506|NCT02367729|20169438|P1|Overall Study|Organic disorder diagnosed|2
5835507|NCT02367716|20169454|P1|Overall Study|Patient did not meet inclusion criteria|1
5835508|NCT02367521|20169478|P2|Overall Study|unable to find transportation|0
5835509|NCT02367521|20169479|P1|Overall Study|unable to find transportation|2
5835510|NCT02367521|20169478|P2|Overall Study|severe headache after intervention|0
5835511|NCT02367521|20169479|P1|Overall Study|severe headache after intervention|2
5835512|NCT02367352|20169557|P3|Overall Study|Adverse Event|0
5835513|NCT02367352|20169558|P2|Overall Study|Adverse Event|0
5835514|NCT02367352|20169559|P1|Overall Study|Adverse Event|1
5835515|NCT02367352|20169557|P3|Overall Study|Participant Received Alternative Therapy|0
5835516|NCT02367352|20169558|P2|Overall Study|Participant Received Alternative Therapy|0
5835517|NCT02367352|20169559|P1|Overall Study|Participant Received Alternative Therapy|1
5835518|NCT02367352|20169557|P3|Overall Study|Progressive disease|0
5835519|NCT02367352|20169558|P2|Overall Study|Progressive disease|0
5835520|NCT02367352|20169559|P1|Overall Study|Progressive disease|7
5835521|NCT02367131|20169609|P1|Overall Study|Other than stated above|20
5835522|NCT02367131|20169609|P1|Overall Study|No change/progressive disease|78
5835523|NCT02367131|20169609|P1|Overall Study|Improvement/remission|2
5835524|NCT02367131|20169609|P1|Overall Study|Request by patient|54
5835525|NCT02367131|20169609|P1|Overall Study|No visit since the first visit|4
5835526|NCT02367131|20169609|P1|Overall Study|Adverse Event|64
5835527|NCT02366936|20169870|P1|Overall Study|Physician Decision|2
5835528|NCT02366936|20169870|P1|Overall Study|Lost to Follow-up|4
5835529|NCT02366936|20169870|P1|Overall Study|Withdrawal by Subject|2
5835530|NCT02366923|20169875|P1|Overall Study|High Astigmatism|3
5835531|NCT02366923|20169875|P1|Overall Study|Positive Slit Lamp Findings|2
5835532|NCT02366923|20169875|P1|Overall Study|Withdrawal by Subject|1
5835533|NCT02366910|20169888|P1|Overall Study|Screen Failure|3
5835534|NCT02366910|20169888|P1|Overall Study|Withdrawal by Subject|2
5835535|NCT02366767|20169936|P2|Overall Study|left for home after 1 day at camp|0
5835536|NCT02366767|20169937|P1|Overall Study|left for home after 1 day at camp|1
5835537|NCT02366689|20169950|P3|Overall Study|Pregnancy|1
5835538|NCT02366689|20169951|P2|Overall Study|Pregnancy|1
5835539|NCT02366689|20169952|P1|Overall Study|Pregnancy|0
5835540|NCT02366689|20169950|P3|Overall Study|Lost to Follow-up|0
5835541|NCT02366689|20169951|P2|Overall Study|Lost to Follow-up|2
5835542|NCT02366689|20169952|P1|Overall Study|Lost to Follow-up|3
5835543|NCT02366689|20169950|P3|Overall Study|Withdrawal by Subject|1
5835544|NCT02366689|20169951|P2|Overall Study|Withdrawal by Subject|0
5835545|NCT02366689|20169952|P1|Overall Study|Withdrawal by Subject|1
5835546|NCT02366637|20170004|P2|Second Intervention Period|Study Terminated by Sponsor|1
5835547|NCT02366637|20170005|P1|Second Intervention Period|Study Terminated by Sponsor|1
5835548|NCT02366637|20170004|P2|First Intervention Period|Study Terminated by Sponsor|4
5835549|NCT02366637|20170005|P1|First Intervention Period|Study Terminated by Sponsor|6
5835550|NCT02366637|20170004|P2|First Intervention Period|Adverse Event|1
5835551|NCT02366637|20170005|P1|First Intervention Period|Adverse Event|0
5835552|NCT02366468|20170053|P2|Overall Study|Other|2
5835553|NCT02366468|20170054|P1|Overall Study|Other|0
5835554|NCT02366468|20170053|P2|Overall Study|Death|2
5835555|NCT02366468|20170054|P1|Overall Study|Death|1
5835556|NCT02366468|20170053|P2|Overall Study|Lost to Follow-up|0
5835557|NCT02366468|20170054|P1|Overall Study|Lost to Follow-up|2
5835558|NCT02366468|20170053|P2|Overall Study|Withdrawal by Subject|5
5835559|NCT02366468|20170054|P1|Overall Study|Withdrawal by Subject|1
5835560|NCT02366468|20170053|P2|Overall Study|Adverse Event|0
5835561|NCT02366468|20170054|P1|Overall Study|Adverse Event|2
5835562|NCT02366195|20170085|P1|Overall Study|Death|26
5835563|NCT02366195|20170085|P1|Overall Study|Lost to Follow-up|1
5835564|NCT02366195|20170085|P1|Overall Study|Withdrawal by Subject|6
5835565|NCT02366195|20170085|P1|Overall Study|Continuing Study|79
5835566|NCT02366143|20170106|P3|Overall Study|Ineligible|0
5835567|NCT02366143|20170107|P2|Overall Study|Ineligible|0
5835568|NCT02366143|20170108|P1|Overall Study|Ineligible|1
5835569|NCT02366143|20170106|P3|Overall Study|PI Move and Site Closure|1
5835570|NCT02366143|20170107|P2|Overall Study|PI Move and Site Closure|1
5835571|NCT02366143|20170108|P1|Overall Study|PI Move and Site Closure|0
5835572|NCT02366143|20170106|P3|Overall Study|Randomization Error|1
5835573|NCT02366143|20170107|P2|Overall Study|Randomization Error|0
5835574|NCT02366143|20170108|P1|Overall Study|Randomization Error|0
5835575|NCT02366143|20170106|P3|Overall Study|Increased Microscopic RBCS on Urinalysis|0
5835576|NCT02366143|20170107|P2|Overall Study|Increased Microscopic RBCS on Urinalysis|0
5835577|NCT02366143|20170108|P1|Overall Study|Increased Microscopic RBCS on Urinalysis|1
5835578|NCT02366143|20170106|P3|Overall Study|On-Going in Study|79
5835579|NCT02366143|20170107|P2|Overall Study|On-Going in Study|101
5835580|NCT02366143|20170108|P1|Overall Study|On-Going in Study|107
5835581|NCT02366143|20170106|P3|Overall Study|Withdrawal by Subject|16
5835582|NCT02366143|20170107|P2|Overall Study|Withdrawal by Subject|21
5835583|NCT02366143|20170108|P1|Overall Study|Withdrawal by Subject|15
5835584|NCT02366143|20170106|P3|Overall Study|Protocol Violation|0
5835585|NCT02366143|20170107|P2|Overall Study|Protocol Violation|2
5835586|NCT02366143|20170108|P1|Overall Study|Protocol Violation|0
5835587|NCT02366143|20170106|P3|Overall Study|Physician Decision|1
5835588|NCT02366143|20170107|P2|Overall Study|Physician Decision|1
5835589|NCT02366143|20170108|P1|Overall Study|Physician Decision|2
5835590|NCT02366143|20170106|P3|Overall Study|Lost to Follow-up|1
5835591|NCT02366143|20170107|P2|Overall Study|Lost to Follow-up|1
5835592|NCT02366143|20170108|P1|Overall Study|Lost to Follow-up|2
5835593|NCT02366143|20170106|P3|Overall Study|Death|301
5835594|NCT02366143|20170107|P2|Overall Study|Death|275
5835595|NCT02366143|20170108|P1|Overall Study|Death|272
5835596|NCT02365636|20170212|P3|Overall Study|Other|0
5835597|NCT02365636|20170213|P2|Overall Study|Other|0
5835598|NCT02365636|20170214|P1|Overall Study|Other|2
5835599|NCT02365636|20170212|P3|Overall Study|Lost to Follow-up|1
5835600|NCT02365636|20170213|P2|Overall Study|Lost to Follow-up|0
5835601|NCT02365636|20170214|P1|Overall Study|Lost to Follow-up|0
5835602|NCT02365636|20170212|P3|Overall Study|Protocol Violation|0
5835603|NCT02365636|20170213|P2|Overall Study|Protocol Violation|4
5835604|NCT02365636|20170214|P1|Overall Study|Protocol Violation|1
5835605|NCT02365636|20170212|P3|Overall Study|Adverse Event|2
5835606|NCT02365636|20170213|P2|Overall Study|Adverse Event|3
5835607|NCT02365636|20170214|P1|Overall Study|Adverse Event|3
5835608|NCT02365584|20170260|P2|Overall Study|Disease Progression|12
5835609|NCT02365584|20170261|P1|Overall Study|Disease Progression|9
5835610|NCT02365584|20170260|P2|Overall Study|Withdrawal by Subject|0
5835611|NCT02365584|20170261|P1|Overall Study|Withdrawal by Subject|1
5835612|NCT02365584|20170260|P2|Overall Study|Adverse Event|2
5835613|NCT02365584|20170261|P1|Overall Study|Adverse Event|2
5835614|NCT02365558|20170285|P2|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|1
5835615|NCT02365558|20170286|P1|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|0
5835616|NCT02365558|20170285|P2|Period 1 (Day 1 Through Day 7)|Adverse Event|0
5835617|NCT02365558|20170286|P1|Period 1 (Day 1 Through Day 7)|Adverse Event|1
5835618|NCT02365519|20170299|P3|Randomized and Treated|Withdrawal by Subject|1
5835619|NCT02365519|20170300|P2|Randomized and Treated|Withdrawal by Subject|1
5835620|NCT02365519|20170301|P1|Randomized and Treated|Withdrawal by Subject|0
5835621|NCT02365519|20170299|P3|Randomized and Treated|Adverse Event|0
5835622|NCT02365519|20170300|P2|Randomized and Treated|Adverse Event|1
5835623|NCT02365519|20170301|P1|Randomized and Treated|Adverse Event|0
5835624|NCT02365506|20170325|P3|Overall Study|Investigator's Discretion|1
5835625|NCT02365506|20170326|P2|Overall Study|Investigator's Discretion|0
5835626|NCT02365506|20170327|P1|Overall Study|Investigator's Discretion|0
5835627|NCT02365298|20170356|P2|Period 2|Protocol Violation|1
5835628|NCT02365298|20170357|P1|Period 2|Protocol Violation|0
5835629|NCT02365298|20170356|P2|Period 2|Test Article longer available|1
5835630|NCT02365298|20170357|P1|Period 2|Test Article longer available|0
5835631|NCT02365298|20170356|P2|Period 2|Discontinued at request of Sponsor|0
5835632|NCT02365298|20170357|P1|Period 2|Discontinued at request of Sponsor|1
5835633|NCT02365298|20170356|P2|Period 2|incorrect Rx dispensed|0
5835634|NCT02365298|20170357|P1|Period 2|incorrect Rx dispensed|1
5835635|NCT02365285|20170377|P4|Overall Study|Adverse Event|2
5835636|NCT02365285|20170378|P3|Overall Study|Adverse Event|0
5835637|NCT02365285|20170379|P2|Overall Study|Adverse Event|0
5835638|NCT02365285|20170380|P1|Overall Study|Adverse Event|0
5835639|NCT02365285|20170377|P4|Overall Study|Physician Decision|0
5835640|NCT02365285|20170378|P3|Overall Study|Physician Decision|1
5835641|NCT02365285|20170379|P2|Overall Study|Physician Decision|1
5835642|NCT02365285|20170380|P1|Overall Study|Physician Decision|0
5835643|NCT02365233|20170397|P3|Overall Study|IRB withheld the data|2
5835644|NCT02365233|20170398|P2|Overall Study|IRB withheld the data|2
5835645|NCT02365233|20170399|P1|Overall Study|IRB withheld the data|1
5835646|NCT02365207|20170407|P1|Overall Study|Physician Decision|1
5835647|NCT02365207|20170407|P1|Overall Study|Withdrawal by Subject|1
5835648|NCT02364999|20170413|P2|Overall Study|Randomized but did not receive treatment|3
5835649|NCT02364999|20170414|P1|Overall Study|Randomized but did not receive treatment|2
5835650|NCT02364999|20170413|P2|Overall Study|Other|1
5835651|NCT02364999|20170414|P1|Overall Study|Other|0
5835652|NCT02364999|20170413|P2|Overall Study|Withdrawal by Subject|14
5835653|NCT02364999|20170414|P1|Overall Study|Withdrawal by Subject|14
5835654|NCT02364999|20170413|P2|Overall Study|Protocol Violation|2
5835655|NCT02364999|20170414|P1|Overall Study|Protocol Violation|3
5835656|NCT02364999|20170413|P2|Overall Study|Lost to Follow-up|15
5835657|NCT02364999|20170414|P1|Overall Study|Lost to Follow-up|10
5835658|NCT02364999|20170413|P2|Overall Study|Death|138
5835659|NCT02364999|20170414|P1|Overall Study|Death|136
5835660|NCT02364947|20170440|P3|Overall Study|Death|0
5835661|NCT02364947|20170441|P2|Overall Study|Death|1
5835662|NCT02364947|20170442|P1|Overall Study|Death|0
5835663|NCT02364947|20170440|P3|Overall Study|Physician Decision|5
5835664|NCT02364947|20170441|P2|Overall Study|Physician Decision|2
5835665|NCT02364947|20170442|P1|Overall Study|Physician Decision|3
5835666|NCT02364947|20170440|P3|Overall Study|Protocol Violation|1
5835667|NCT02364947|20170441|P2|Overall Study|Protocol Violation|1
5835668|NCT02364947|20170442|P1|Overall Study|Protocol Violation|1
5835669|NCT02364947|20170440|P3|Overall Study|Adverse Event|11
5835670|NCT02364947|20170441|P2|Overall Study|Adverse Event|33
5835671|NCT02364947|20170442|P1|Overall Study|Adverse Event|45
5835672|NCT02364947|20170440|P3|Overall Study|Withdrawal by Subject|9
5835673|NCT02364947|20170441|P2|Overall Study|Withdrawal by Subject|8
5835674|NCT02364947|20170442|P1|Overall Study|Withdrawal by Subject|10
5835675|NCT02364388|20170611|P1|Overall Study|No Biopsy|2
5835676|NCT02364388|20170611|P1|Overall Study|No OA/US data|2
5835677|NCT02364388|20170611|P1|Overall Study|Technical Failure|3
5835678|NCT02364388|20170611|P1|Overall Study|Protocol Violation|1
5835679|NCT02364336|20170618|P2|Overall Study|Adverse Event|1
5835680|NCT02364336|20170619|P1|Overall Study|Adverse Event|0
5835681|NCT02364180|20170632|P1|Overall Study|Screen Fail|1
5835682|NCT02364037|20170645|P2|Overall Study|Lost to Follow-up|49
5835683|NCT02364037|20170646|P1|Overall Study|Lost to Follow-up|37
5835684|NCT02364037|20170645|P2|Overall Study|Withdrawal by Subject|4
5835685|NCT02364037|20170646|P1|Overall Study|Withdrawal by Subject|7
5835686|NCT02363959|20170679|P2|Overall Study|Medical instability|0
5835687|NCT02363959|20170680|P1|Overall Study|Medical instability|1
5835688|NCT02363946|20170709|P13|Overall Study|Lost to Follow-up|0
5835689|NCT02363946|20170710|P12|Overall Study|Lost to Follow-up|0
5835690|NCT02363946|20170711|P11|Overall Study|Lost to Follow-up|0
5835691|NCT02363946|20170712|P10|Overall Study|Lost to Follow-up|0
5835692|NCT02363946|20170713|P9|Overall Study|Lost to Follow-up|0
5835693|NCT02363946|20170714|P8|Overall Study|Lost to Follow-up|1
5835694|NCT02363946|20170715|P7|Overall Study|Lost to Follow-up|0
5835695|NCT02363946|20170716|P6|Overall Study|Lost to Follow-up|0
5835696|NCT02363946|20170717|P5|Overall Study|Lost to Follow-up|0
5835697|NCT02363946|20170718|P4|Overall Study|Lost to Follow-up|0
5835698|NCT02363946|20170719|P3|Overall Study|Lost to Follow-up|0
5835699|NCT02363946|20170720|P2|Overall Study|Lost to Follow-up|0
5835700|NCT02363946|20170721|P1|Overall Study|Lost to Follow-up|0
5835701|NCT02363478|20170950|P1|Overall Study|Adverse Event|4
5835702|NCT02363478|20170950|P1|Overall Study|Lost to Follow-up|4
5835703|NCT02363439|20170957|P1|Overall Study|Lack of Efficacy|4
5835704|NCT02363322|20170963|P2|Overall Study|Lost to Follow-up|0
5835705|NCT02363322|20170964|P1|Overall Study|Lost to Follow-up|1
5835706|NCT02363283|20170974|P1|Overall Study|Not eligible due to transaminitis|1
5835707|NCT02363283|20170974|P1|Overall Study|Withdrawal by Subject|1
5835708|NCT02362789|20170993|P3|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|2
5835709|NCT02362789|20170994|P2|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|1
5835710|NCT02362789|20170995|P1|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|0
5835711|NCT02362789|20170993|P3|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|4
5835712|NCT02362789|20170994|P2|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|1
5835713|NCT02362789|20170995|P1|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|0
5835714|NCT02362789|20170993|P3|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|6
5835715|NCT02362789|20170994|P2|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|2
5835716|NCT02362789|20170995|P1|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|0
5835717|NCT02362789|20170993|P3|Run-in Phase (Week 0 to 16)|Adverse Event|0
5835718|NCT02362789|20170994|P2|Run-in Phase (Week 0 to 16)|Adverse Event|0
5835719|NCT02362789|20170995|P1|Run-in Phase (Week 0 to 16)|Adverse Event|1
5835720|NCT02362789|20170993|P3|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0
5835721|NCT02362789|20170994|P2|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0
5835722|NCT02362789|20170995|P1|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|1
5835723|NCT02362724|20171004|P2|Overall Study|Adverse Event|0
5835724|NCT02362724|20171005|P1|Overall Study|Adverse Event|3
5835725|NCT02362724|20171004|P2|Overall Study|Withdrawal by Subject|1
5835726|NCT02362724|20171005|P1|Overall Study|Withdrawal by Subject|3
5835727|NCT02362646|20171064|P2|Overall Study|received transplant|14
5835728|NCT02362646|20171065|P1|Overall Study|received transplant|21
5835729|NCT02362646|20171064|P2|Overall Study|Withdrawal by Subject|2
5835730|NCT02362646|20171065|P1|Overall Study|Withdrawal by Subject|2
5835731|NCT02362646|20171064|P2|Overall Study|Death|8
5835732|NCT02362646|20171065|P1|Overall Study|Death|15
5835733|NCT02362503|20171097|P3|Open Label Period-Up to Atleast 96 Weeks|Ongoing at the time of analysis|67
5835734|NCT02362503|20171098|P2|Open Label Period-Up to Atleast 96 Weeks|Ongoing at the time of analysis|160
5835735|NCT02362503|20171099|P1|Open Label Period-Up to Atleast 96 Weeks|Ongoing at the time of analysis|55
5835736|NCT02362503|20171097|P3|Open Label Period-Up to Atleast 96 Weeks|Progression of disease|0
5835737|NCT02362503|20171098|P2|Open Label Period-Up to Atleast 96 Weeks|Progression of disease|1
5835738|NCT02362503|20171099|P1|Open Label Period-Up to Atleast 96 Weeks|Progression of disease|0
5835739|NCT02362503|20171097|P3|Open Label Period-Up to Atleast 96 Weeks|No longer meets study criteria|2
5835740|NCT02362503|20171098|P2|Open Label Period-Up to Atleast 96 Weeks|No longer meets study criteria|2
5835741|NCT02362503|20171099|P1|Open Label Period-Up to Atleast 96 Weeks|No longer meets study criteria|0
5835742|NCT02362503|20171097|P3|Open Label Period-Up to Atleast 96 Weeks|Pregnancy|0
5835743|NCT02362503|20171098|P2|Open Label Period-Up to Atleast 96 Weeks|Pregnancy|1
5835744|NCT02362503|20171099|P1|Open Label Period-Up to Atleast 96 Weeks|Pregnancy|0
5835745|NCT02362503|20171097|P3|Open Label Period-Up to Atleast 96 Weeks|Non-compliance with study drug|5
5835746|NCT02362503|20171098|P2|Open Label Period-Up to Atleast 96 Weeks|Non-compliance with study drug|8
5835747|NCT02362503|20171099|P1|Open Label Period-Up to Atleast 96 Weeks|Non-compliance with study drug|3
5835748|NCT02362503|20171097|P3|Open Label Period-Up to Atleast 96 Weeks|Lost to Follow-up|1
5835749|NCT02362503|20171098|P2|Open Label Period-Up to Atleast 96 Weeks|Lost to Follow-up|3
5835750|NCT02362503|20171099|P1|Open Label Period-Up to Atleast 96 Weeks|Lost to Follow-up|3
5835751|NCT02362503|20171097|P3|Open Label Period-Up to Atleast 96 Weeks|Withdrawal by Subject|1
5835752|NCT02362503|20171098|P2|Open Label Period-Up to Atleast 96 Weeks|Withdrawal by Subject|5
5835753|NCT02362503|20171099|P1|Open Label Period-Up to Atleast 96 Weeks|Withdrawal by Subject|0
5835754|NCT02362503|20171097|P3|Open Label Period-Up to Atleast 96 Weeks|Death|12
5835755|NCT02362503|20171098|P2|Open Label Period-Up to Atleast 96 Weeks|Death|5
5835756|NCT02362503|20171099|P1|Open Label Period-Up to Atleast 96 Weeks|Death|1
5835757|NCT02362503|20171097|P3|Open Label Period-Up to Atleast 96 Weeks|Adverse Event|5
5835758|NCT02362503|20171098|P2|Open Label Period-Up to Atleast 96 Weeks|Adverse Event|4
5835759|NCT02362503|20171099|P1|Open Label Period-Up to Atleast 96 Weeks|Adverse Event|3
5835760|NCT02362503|20171097|P3|Open Label Period-Up to Atleast 96 Weeks|Lack of Efficacy|6
5835761|NCT02362503|20171098|P2|Open Label Period-Up to Atleast 96 Weeks|Lack of Efficacy|9
5835762|NCT02362503|20171099|P1|Open Label Period-Up to Atleast 96 Weeks|Lack of Efficacy|3
5835763|NCT02362503|20171097|P3|Double-blind Period-Up to 8 Days|No longer meets study criteria|0
5835764|NCT02362503|20171098|P2|Double-blind Period-Up to 8 Days|No longer meets study criteria|1
5835765|NCT02362503|20171099|P1|Double-blind Period-Up to 8 Days|No longer meets study criteria|0
5835766|NCT02362503|20171097|P3|Double-blind Period-Up to 8 Days|Lost to Follow-up|0
5835767|NCT02362503|20171098|P2|Double-blind Period-Up to 8 Days|Lost to Follow-up|1
5835768|NCT02362503|20171099|P1|Double-blind Period-Up to 8 Days|Lost to Follow-up|0
5835769|NCT02362503|20171097|P3|Double-blind Period-Up to 8 Days|Death|0
5835770|NCT02362503|20171098|P2|Double-blind Period-Up to 8 Days|Death|1
5835771|NCT02362503|20171099|P1|Double-blind Period-Up to 8 Days|Death|1
5835772|NCT02362503|20171097|P3|Double-blind Period-Up to 8 Days|Adverse Event|0
5835773|NCT02362503|20171098|P2|Double-blind Period-Up to 8 Days|Adverse Event|2
5835774|NCT02362503|20171099|P1|Double-blind Period-Up to 8 Days|Adverse Event|0
5835775|NCT02362425|20171128|P4|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0
5835776|NCT02362425|20171129|P3|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|1
5835777|NCT02362425|20171130|P2|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0
5835778|NCT02362425|20171131|P1|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0
5835779|NCT02362425|20171128|P4|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|1
5835780|NCT02362425|20171129|P3|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0
5835781|NCT02362425|20171130|P2|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0
5835782|NCT02362425|20171131|P1|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0
5835783|NCT02362425|20171128|P4|Phase 2 (up to 6 Months, Randomized)|Adverse Event|2
5835784|NCT02362425|20171129|P3|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0
5835785|NCT02362425|20171130|P2|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0
5835786|NCT02362425|20171131|P1|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0
5835787|NCT02362425|20171128|P4|Phase 1 (up to 6 Months)|Study closure|0
5835788|NCT02362425|20171129|P3|Phase 1 (up to 6 Months)|Study closure|0
5835789|NCT02362425|20171130|P2|Phase 1 (up to 6 Months)|Study closure|0
5835790|NCT02362425|20171131|P1|Phase 1 (up to 6 Months)|Study closure|9
5835791|NCT02362425|20171128|P4|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0
5835792|NCT02362425|20171129|P3|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0
5835793|NCT02362425|20171130|P2|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0
5835794|NCT02362425|20171131|P1|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|3
5835795|NCT02362425|20171128|P4|Phase 1 (up to 6 Months)|Screening failure|0
5835796|NCT02362425|20171129|P3|Phase 1 (up to 6 Months)|Screening failure|0
5835797|NCT02362425|20171130|P2|Phase 1 (up to 6 Months)|Screening failure|0
5835798|NCT02362425|20171131|P1|Phase 1 (up to 6 Months)|Screening failure|1
5835799|NCT02362425|20171128|P4|Phase 1 (up to 6 Months)|Medicinal contraindication|0
5835800|NCT02362425|20171129|P3|Phase 1 (up to 6 Months)|Medicinal contraindication|0
5835801|NCT02362425|20171130|P2|Phase 1 (up to 6 Months)|Medicinal contraindication|0
5835802|NCT02362425|20171131|P1|Phase 1 (up to 6 Months)|Medicinal contraindication|1
5835803|NCT02362425|20171128|P4|Phase 1 (up to 6 Months)|Withdrawal by Subject|0
5835804|NCT02362425|20171129|P3|Phase 1 (up to 6 Months)|Withdrawal by Subject|0
5835805|NCT02362425|20171130|P2|Phase 1 (up to 6 Months)|Withdrawal by Subject|0
5835806|NCT02362425|20171131|P1|Phase 1 (up to 6 Months)|Withdrawal by Subject|2
5835807|NCT02362412|20171249|P2|Treatment Period III|Lost to Follow-up|1
5835808|NCT02362412|20171250|P1|Treatment Period III|Lost to Follow-up|0
5835809|NCT02362360|20171284|P2|Period 1|Withdrawal by Subject|1
5835810|NCT02362360|20171285|P1|Period 1|Withdrawal by Subject|2
5835811|NCT02362360|20171284|P2|Period 1|Lack of Efficacy|0
5835812|NCT02362360|20171285|P1|Period 1|Lack of Efficacy|1
5835813|NCT02362282|20171302|P2|Overall Study|Withdrawal by Subject|0
5835814|NCT02362282|20171303|P1|Overall Study|Withdrawal by Subject|1
5835815|NCT02362269|20171311|P2|Overall Study|Lost to Follow-up|6
5835816|NCT02362269|20171312|P1|Overall Study|Lost to Follow-up|0
5835817|NCT02362269|20171311|P2|Overall Study|Moved|0
5835818|NCT02362269|20171312|P1|Overall Study|Moved|1
5835819|NCT02361762|20171334|P2|Overall Study|Lost to Follow-up|1
5835820|NCT02361762|20171335|P1|Overall Study|Lost to Follow-up|0
5835821|NCT02361762|20171334|P2|Overall Study|Withdrawal by Subject|1
5835822|NCT02361762|20171335|P1|Overall Study|Withdrawal by Subject|0
5835823|NCT02361580|20171386|P2|Overall Study|Lost to Follow-up|3
5835824|NCT02361580|20171387|P1|Overall Study|Lost to Follow-up|6
5835825|NCT02361216|20171416|P2|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|2
5835826|NCT02361216|20171417|P1|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|0
5835827|NCT02361216|20171416|P2|3 Day Treatment and 8 Week Follow/up|Trial site closed|3
5835828|NCT02361216|20171417|P1|3 Day Treatment and 8 Week Follow/up|Trial site closed|3
5835829|NCT02361216|20171416|P2|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|11
5835830|NCT02361216|20171417|P1|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|6
5835831|NCT02361216|20171416|P2|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|0
5835832|NCT02361216|20171417|P1|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|1
5835833|NCT02361216|20171416|P2|3 Day Treatment and 8 Week Follow/up|Adverse Event|2
5835834|NCT02361216|20171417|P1|3 Day Treatment and 8 Week Follow/up|Adverse Event|1
5835835|NCT02361216|20171416|P2|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|1
5835836|NCT02361216|20171417|P1|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|0
5835837|NCT02360995|20171432|P3|Overall Study|Withdrawal by Subject|0
5835838|NCT02360995|20171433|P2|Overall Study|Withdrawal by Subject|1
5835839|NCT02360995|20171434|P1|Overall Study|Withdrawal by Subject|0
5835840|NCT02360995|20171432|P3|Overall Study|Lost to Follow-up|2
5835841|NCT02360995|20171433|P2|Overall Study|Lost to Follow-up|0
5835842|NCT02360995|20171434|P1|Overall Study|Lost to Follow-up|2
5835843|NCT02360475|20171498|P4|Overall Study|Migrated/moved from study area|1
5835844|NCT02360475|20171499|P3|Overall Study|Migrated/moved from study area|0
5835845|NCT02360475|20171500|P2|Overall Study|Migrated/moved from study area|0
5835846|NCT02360475|20171501|P1|Overall Study|Migrated/moved from study area|0
5835847|NCT02360475|20171498|P4|Overall Study|Withdrawal by Subject|0
5835848|NCT02360475|20171499|P3|Overall Study|Withdrawal by Subject|2
5835849|NCT02360475|20171500|P2|Overall Study|Withdrawal by Subject|1
5835850|NCT02360475|20171501|P1|Overall Study|Withdrawal by Subject|0
5835851|NCT02360475|20171498|P4|Overall Study|Lost to Follow-up|4
5835852|NCT02360475|20171499|P3|Overall Study|Lost to Follow-up|6
5835853|NCT02360475|20171500|P2|Overall Study|Lost to Follow-up|12
5835854|NCT02360475|20171501|P1|Overall Study|Lost to Follow-up|4
5835855|NCT02360397|20171559|P1|Overall Study|Adverse Event|1
5835856|NCT02360397|20171559|P1|Overall Study|Incomplete screening|3
5835857|NCT02360293|20171585|P2|Overall Study|Excluded|0
5835858|NCT02360293|20171586|P1|Overall Study|Excluded|1
5835859|NCT02360293|20171585|P2|Overall Study|Withdrawal by Subject|1
5835860|NCT02360293|20171586|P1|Overall Study|Withdrawal by Subject|2
5835861|NCT02360293|20171585|P2|Overall Study|Lost to Follow-up|95
5835862|NCT02360293|20171586|P1|Overall Study|Lost to Follow-up|73
5835863|NCT02360280|20171600|P2|Overall Study|Lost to Follow-up|0
5835864|NCT02360280|20171601|P1|Overall Study|Lost to Follow-up|1
5835865|NCT02360280|20171600|P2|Overall Study|Adverse Event|1
5835866|NCT02360280|20171601|P1|Overall Study|Adverse Event|0
5835867|NCT02360280|20171600|P2|Overall Study|Withdrawal by Subject|0
5835868|NCT02360280|20171601|P1|Overall Study|Withdrawal by Subject|2
5835869|NCT02360228|20171616|P3|Overall Study|Unstable symptoms during screening|1
5835870|NCT02360228|20171617|P2|Overall Study|Unstable symptoms during screening|0
5835871|NCT02360228|20171618|P1|Overall Study|Unstable symptoms during screening|0
5835872|NCT02360228|20171616|P3|Overall Study|Self-discontinued medication|0
5835873|NCT02360228|20171617|P2|Overall Study|Self-discontinued medication|1
5835874|NCT02360228|20171618|P1|Overall Study|Self-discontinued medication|0
5835875|NCT02360228|20171616|P3|Overall Study|Withdrawal by Subject|0
5835876|NCT02360228|20171617|P2|Overall Study|Withdrawal by Subject|0
5835877|NCT02360228|20171618|P1|Overall Study|Withdrawal by Subject|1
5835878|NCT02360111|20171713|P1|Overall Study|Death|2
5835879|NCT02360098|20171723|P1|Overall Study|Physician Decision|7
5835880|NCT02359903|20171802|P2|Overall Study|Adverse Event|2
5835881|NCT02359903|20171803|P1|Overall Study|Adverse Event|0
5835882|NCT02359890|20171811|P1|Overall Study|Never treated with study catheter|6
5835883|NCT02359890|20171811|P1|Overall Study|Not meeting eligibility|4
5835884|NCT02359877|20171822|P4|Overall Study|Adverse Event|1
5835885|NCT02359877|20171823|P3|Overall Study|Adverse Event|0
5835886|NCT02359877|20171824|P2|Overall Study|Adverse Event|0
5835887|NCT02359877|20171825|P1|Overall Study|Adverse Event|0
5835888|NCT02359877|20171822|P4|Overall Study|Withdrawal by Subject|2
5835889|NCT02359877|20171823|P3|Overall Study|Withdrawal by Subject|0
5835890|NCT02359877|20171824|P2|Overall Study|Withdrawal by Subject|0
5835891|NCT02359877|20171825|P1|Overall Study|Withdrawal by Subject|1
5835892|NCT02359851|20171875|P1|Overall Study|Disease progression|1
5835893|NCT02359851|20171875|P1|Overall Study|Death|1
5835894|NCT02359552|20171885|P2|Overall Study|Lost to Follow-up|4
5835895|NCT02359552|20171886|P1|Overall Study|Lost to Follow-up|3
5835896|NCT02359435|20171908|P2|Overall Study|Lost to Follow-up|4
5835897|NCT02359435|20171909|P1|Overall Study|Lost to Follow-up|4
5835898|NCT02359045|20171969|P2|Overall Study|Adverse Event|1
5835899|NCT02359045|20171970|P1|Overall Study|Adverse Event|0
5835900|NCT02359045|20171969|P2|Overall Study|Lost to Follow-up|1
5835901|NCT02359045|20171970|P1|Overall Study|Lost to Follow-up|1
5835902|NCT02359045|20171969|P2|Overall Study|Eligibility criteria not fulfilled|1
5835903|NCT02359045|20171970|P1|Overall Study|Eligibility criteria not fulfilled|3
5835904|NCT02358863|20172278|P1|Overall Study|Physician Decision|3
5835905|NCT02358668|20172285|P3|Overall Study|Withdrawal by Subject|0
5835906|NCT02358668|20172286|P2|Overall Study|Withdrawal by Subject|1
5835907|NCT02358668|20172287|P1|Overall Study|Withdrawal by Subject|0
5835908|NCT02358668|20172285|P3|Overall Study|Adverse Event|0
5835909|NCT02358668|20172286|P2|Overall Study|Adverse Event|0
5835910|NCT02358668|20172287|P1|Overall Study|Adverse Event|2
5835911|NCT02358473|20172436|P1|Overall Study|Physician Decision|2
5835912|NCT02358473|20172436|P1|Overall Study|Withdrawal by Subject|2
5835913|NCT02358473|20172436|P1|Overall Study|Adverse Event|3
5835914|NCT02358473|20172436|P1|Overall Study|Disease Progession|6
5835915|NCT02358369|20172448|P5|Treatment Period C|Adverse Event|7
5835916|NCT02358369|20172449|P4|Treatment Period C|Adverse Event|0
5835917|NCT02358369|20172450|P3|Treatment Period C|Adverse Event|0
5835918|NCT02358369|20172451|P2|Treatment Period C|Adverse Event|0
5835919|NCT02358369|20172452|P1|Treatment Period C|Adverse Event|0
5835920|NCT02358369|20172448|P5|Treatment Period A/B|Withdrawal by Subject|0
5835921|NCT02358369|20172449|P4|Treatment Period A/B|Withdrawal by Subject|2
5835922|NCT02358369|20172450|P3|Treatment Period A/B|Withdrawal by Subject|0
5835923|NCT02358369|20172451|P2|Treatment Period A/B|Withdrawal by Subject|2
5835924|NCT02358369|20172452|P1|Treatment Period A/B|Withdrawal by Subject|0
5835925|NCT02358369|20172448|P5|Treatment Period A/B|Death|0
5835926|NCT02358369|20172449|P4|Treatment Period A/B|Death|0
5835927|NCT02358369|20172450|P3|Treatment Period A/B|Death|1
5835928|NCT02358369|20172451|P2|Treatment Period A/B|Death|0
5835929|NCT02358369|20172452|P1|Treatment Period A/B|Death|0
5835930|NCT02358369|20172448|P5|Treatment Period A/B|Adverse Event|0
5835931|NCT02358369|20172449|P4|Treatment Period A/B|Adverse Event|2
5835932|NCT02358369|20172450|P3|Treatment Period A/B|Adverse Event|1
5835933|NCT02358369|20172451|P2|Treatment Period A/B|Adverse Event|0
5835934|NCT02358369|20172452|P1|Treatment Period A/B|Adverse Event|0
5835935|NCT02358369|20172448|P5|Pre-Randomization Washout Period|Not Qualified for Randomization|0
5835936|NCT02358369|20172449|P4|Pre-Randomization Washout Period|Not Qualified for Randomization|0
5835937|NCT02358369|20172450|P3|Pre-Randomization Washout Period|Not Qualified for Randomization|0
5835938|NCT02358369|20172451|P2|Pre-Randomization Washout Period|Not Qualified for Randomization|0
5835939|NCT02358369|20172452|P1|Pre-Randomization Washout Period|Not Qualified for Randomization|35
5835940|NCT02358343|20172498|P5|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0
5835941|NCT02358343|20172499|P4|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0
5835942|NCT02358343|20172500|P3|Comparative Efficacy Trial / Observation|Administrative Withdrawal|1
5835943|NCT02358343|20172501|P2|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0
5835944|NCT02358343|20172502|P1|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0
5835945|NCT02358343|20172498|P5|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2
5835946|NCT02358343|20172499|P4|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2
5835947|NCT02358343|20172500|P3|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2
5835948|NCT02358343|20172501|P2|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0
5835949|NCT02358343|20172502|P1|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0
5835950|NCT02358343|20172498|P5|Comparative Efficacy Trial / Observation|Death|0
5835951|NCT02358343|20172499|P4|Comparative Efficacy Trial / Observation|Death|0
5835952|NCT02358343|20172500|P3|Comparative Efficacy Trial / Observation|Death|2
5835953|NCT02358343|20172501|P2|Comparative Efficacy Trial / Observation|Death|0
5835954|NCT02358343|20172502|P1|Comparative Efficacy Trial / Observation|Death|0
5835955|NCT02358343|20172498|P5|Screening Intervention|Determined Ineligible|0
5835956|NCT02358343|20172499|P4|Screening Intervention|Determined Ineligible|0
5835957|NCT02358343|20172500|P3|Screening Intervention|Determined Ineligible|0
5835958|NCT02358343|20172501|P2|Screening Intervention|Determined Ineligible|6
5835959|NCT02358343|20172502|P1|Screening Intervention|Determined Ineligible|5
5835960|NCT02358343|20172498|P5|Screening Intervention|Withdrawal by Subject|0
5835961|NCT02358343|20172499|P4|Screening Intervention|Withdrawal by Subject|0
5835962|NCT02358343|20172500|P3|Screening Intervention|Withdrawal by Subject|0
5835963|NCT02358343|20172501|P2|Screening Intervention|Withdrawal by Subject|0
5835964|NCT02358343|20172502|P1|Screening Intervention|Withdrawal by Subject|1
5835965|NCT02358343|20172498|P5|Screening Intervention|Death|0
5835966|NCT02358343|20172499|P4|Screening Intervention|Death|0
5835967|NCT02358343|20172500|P3|Screening Intervention|Death|0
5835968|NCT02358343|20172501|P2|Screening Intervention|Death|2
5835969|NCT02358343|20172502|P1|Screening Intervention|Death|0
5835970|NCT02358044|20172558|P2|Overall Study|Withdrawal by Subject|4
5835971|NCT02358044|20172559|P1|Overall Study|Withdrawal by Subject|0
5835972|NCT02358044|20172558|P2|Overall Study|Physician Decision|1
5835973|NCT02358044|20172559|P1|Overall Study|Physician Decision|0
5835974|NCT02358044|20172558|P2|Overall Study|Lost to Follow-up|1
5835975|NCT02358044|20172559|P1|Overall Study|Lost to Follow-up|2
5835976|NCT02358044|20172558|P2|Overall Study|Adverse Event|1
5835977|NCT02358044|20172559|P1|Overall Study|Adverse Event|0
5835978|NCT02358031|20172578|P3|Overall Study|Ongoing in Study|33
5835979|NCT02358031|20172579|P2|Overall Study|Ongoing in Study|64
5835980|NCT02358031|20172580|P1|Overall Study|Ongoing in Study|61
5835981|NCT02358031|20172578|P3|Overall Study|Withdrawal by Subject|17
5835982|NCT02358031|20172579|P2|Overall Study|Withdrawal by Subject|12
5835983|NCT02358031|20172580|P1|Overall Study|Withdrawal by Subject|14
5835984|NCT02358031|20172578|P3|Overall Study|Lost to Follow-up|1
5835985|NCT02358031|20172579|P2|Overall Study|Lost to Follow-up|1
5835986|NCT02358031|20172580|P1|Overall Study|Lost to Follow-up|0
5835987|NCT02358031|20172578|P3|Overall Study|Death|249
5835988|NCT02358031|20172579|P2|Overall Study|Death|204
5835989|NCT02358031|20172580|P1|Overall Study|Death|226
5835990|NCT02357940|20172707|P2|Overall Study|Investigator's judgement|1
5835991|NCT02357940|20172708|P1|Overall Study|Investigator's judgement|0
5835992|NCT02357940|20172707|P2|Overall Study|Adverse Event|1
5835993|NCT02357940|20172708|P1|Overall Study|Adverse Event|0
5835994|NCT02357901|20172835|P4|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|7
5835995|NCT02357901|20172836|P3|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|6
5835996|NCT02357901|20172837|P2|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|17
5835997|NCT02357901|20172838|P1|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|0
5835998|NCT02357901|20172835|P4|Treatment Period (Day 1 to Week 24)|Physician Decision|1
5835999|NCT02357901|20172836|P3|Treatment Period (Day 1 to Week 24)|Physician Decision|1
5836000|NCT02357901|20172837|P2|Treatment Period (Day 1 to Week 24)|Physician Decision|0
5836001|NCT02357901|20172838|P1|Treatment Period (Day 1 to Week 24)|Physician Decision|0
5836002|NCT02357901|20172835|P4|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|3
5836003|NCT02357901|20172836|P3|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0
5836004|NCT02357901|20172837|P2|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|1
5836005|NCT02357901|20172838|P1|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0
5836006|NCT02357901|20172835|P4|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2
5836007|NCT02357901|20172836|P3|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0
5836008|NCT02357901|20172837|P2|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2
5836009|NCT02357901|20172838|P1|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0
5836010|NCT02357901|20172835|P4|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|3
5836011|NCT02357901|20172836|P3|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1
5836012|NCT02357901|20172837|P2|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1
5836013|NCT02357901|20172838|P1|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|0
5836014|NCT02357901|20172835|P4|Treatment Period (Day 1 to Week 24)|Protocol Violation|0
5836015|NCT02357901|20172836|P3|Treatment Period (Day 1 to Week 24)|Protocol Violation|5
5836016|NCT02357901|20172837|P2|Treatment Period (Day 1 to Week 24)|Protocol Violation|2
5836017|NCT02357901|20172838|P1|Treatment Period (Day 1 to Week 24)|Protocol Violation|0
5836018|NCT02357901|20172835|P4|Treatment Period (Day 1 to Week 24)|Adverse Event|2
5836019|NCT02357901|20172836|P3|Treatment Period (Day 1 to Week 24)|Adverse Event|10
5836020|NCT02357901|20172837|P2|Treatment Period (Day 1 to Week 24)|Adverse Event|6
5836021|NCT02357901|20172838|P1|Treatment Period (Day 1 to Week 24)|Adverse Event|0
5836022|NCT02357901|20172835|P4|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|18
5836023|NCT02357901|20172836|P3|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|5
5836024|NCT02357901|20172837|P2|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|3
5836025|NCT02357901|20172838|P1|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|0
5836026|NCT02357901|20172835|P4|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|18
5836027|NCT02357901|20172836|P3|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|21
5836028|NCT02357901|20172837|P2|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|20
5836029|NCT02357901|20172838|P1|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|0
5836030|NCT02357901|20172835|P4|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|12
5836031|NCT02357901|20172836|P3|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|23
5836032|NCT02357901|20172837|P2|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|26
5836033|NCT02357901|20172838|P1|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|0
5836034|NCT02357901|20172835|P4|Run-In Period (Days -14 to Day -1)|Run-In failures|0
5836035|NCT02357901|20172836|P3|Run-In Period (Days -14 to Day -1)|Run-In failures|0
5836036|NCT02357901|20172837|P2|Run-In Period (Days -14 to Day -1)|Run-In failures|0
5836037|NCT02357901|20172838|P1|Run-In Period (Days -14 to Day -1)|Run-In failures|161
5836038|NCT02357810|20172888|P1|Follow-up at Treatment Discontinuation|Still in Follow-up|11
5836039|NCT02357810|20172888|P1|Follow-up at Treatment Discontinuation|Lost to Follow-up|3
5836040|NCT02357810|20172888|P1|Follow-up at Treatment Discontinuation|Withdrawal by Subject|4
5836041|NCT02357810|20172888|P1|12 Week Response and Further Treatment|Wound Complications|1
5836042|NCT02357810|20172888|P1|12 Week Response and Further Treatment|Progressive Disease|15
5836043|NCT02357810|20172888|P1|12 Week Response and Further Treatment|Withdrawal by Subject|1
5836044|NCT02357810|20172888|P1|12 Week Response and Further Treatment|Adverse Event|5
5836045|NCT02357810|20172888|P1|Reached 12 Weeks Response|Other|1
5836046|NCT02357810|20172888|P1|Reached 12 Weeks Response|Physician Decision|1
5836047|NCT02357810|20172888|P1|Reached 12 Weeks Response|Death|1
5836048|NCT02357810|20172888|P1|Reached 12 Weeks Response|Protocol Violation|1
5836049|NCT02357810|20172888|P1|Reached 12 Weeks Response|Withdrawal by Subject|8
5836050|NCT02357810|20172888|P1|Reached 12 Weeks Response|Progressive Disease|39
5836051|NCT02357810|20172888|P1|Reached 12 Weeks Response|Adverse Event|5
5836052|NCT02357810|20172888|P1|Registered and Started Treatment|Found not to be eligible for the study|26
5836053|NCT02357810|20172888|P1|Registered and Started Treatment|Withdrawal by Subject|1
5836054|NCT02357576|20172938|P2|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|0
5836055|NCT02357576|20172939|P1|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|2
5836056|NCT02357576|20172938|P2|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|4
5836057|NCT02357576|20172939|P1|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|1
5836058|NCT02357576|20172938|P2|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|0
5836059|NCT02357576|20172939|P1|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|1
5836060|NCT02357576|20172938|P2|Neurodevelopmental Outcome Follow Up|Scheduling error|1
5836061|NCT02357576|20172939|P1|Neurodevelopmental Outcome Follow Up|Scheduling error|1
5836062|NCT02357576|20172938|P2|Treatment Period|Physician Decision|1
5836063|NCT02357576|20172939|P1|Treatment Period|Physician Decision|0
5836064|NCT02357576|20172938|P2|Treatment Period|Withdrawal by Subject|1
5836065|NCT02357576|20172939|P1|Treatment Period|Withdrawal by Subject|0
5836066|NCT02357459|20172994|P3|Overall Study|Job Commitments|1
5836067|NCT02357459|20172995|P2|Overall Study|Job Commitments|0
5836068|NCT02357459|20172996|P1|Overall Study|Job Commitments|0
5836069|NCT02357459|20172994|P3|Overall Study|Pre-planned Knee surgery|2
5836070|NCT02357459|20172995|P2|Overall Study|Pre-planned Knee surgery|0
5836071|NCT02357459|20172996|P1|Overall Study|Pre-planned Knee surgery|0
5836072|NCT02357459|20172994|P3|Overall Study|Incarceration|1
5836073|NCT02357459|20172995|P2|Overall Study|Incarceration|0
5836074|NCT02357459|20172996|P1|Overall Study|Incarceration|0
5836075|NCT02357459|20172994|P3|Overall Study|Instruction from PCP|0
5836076|NCT02357459|20172995|P2|Overall Study|Instruction from PCP|0
5836077|NCT02357459|20172996|P1|Overall Study|Instruction from PCP|1
5836078|NCT02357459|20172994|P3|Overall Study|Patient Relocated|0
5836079|NCT02357459|20172995|P2|Overall Study|Patient Relocated|0
5836080|NCT02357459|20172996|P1|Overall Study|Patient Relocated|2
5836081|NCT02357459|20172994|P3|Overall Study|Lack of Efficacy|4
5836082|NCT02357459|20172995|P2|Overall Study|Lack of Efficacy|4
5836083|NCT02357459|20172996|P1|Overall Study|Lack of Efficacy|7
5836084|NCT02357459|20172994|P3|Overall Study|Lost to Follow-up|0
5836085|NCT02357459|20172995|P2|Overall Study|Lost to Follow-up|3
5836086|NCT02357459|20172996|P1|Overall Study|Lost to Follow-up|1
5836087|NCT02357459|20172994|P3|Overall Study|Protocol Violation|0
5836088|NCT02357459|20172995|P2|Overall Study|Protocol Violation|1
5836089|NCT02357459|20172996|P1|Overall Study|Protocol Violation|1
5836090|NCT02357459|20172994|P3|Overall Study|Physician Decision|0
5836091|NCT02357459|20172995|P2|Overall Study|Physician Decision|2
5836092|NCT02357459|20172996|P1|Overall Study|Physician Decision|0
5836093|NCT02357459|20172994|P3|Overall Study|Withdrawal by Subject|3
5836094|NCT02357459|20172995|P2|Overall Study|Withdrawal by Subject|3
5836095|NCT02357459|20172996|P1|Overall Study|Withdrawal by Subject|5
5836096|NCT02357459|20172994|P3|Overall Study|Adverse Event|1
5836097|NCT02357459|20172995|P2|Overall Study|Adverse Event|1
5836098|NCT02357459|20172996|P1|Overall Study|Adverse Event|0
5836099|NCT02357420|20173042|P4|Overall Study|Lost to Follow-up|3
5836100|NCT02357420|20173043|P3|Overall Study|Lost to Follow-up|2
5836101|NCT02357420|20173044|P2|Overall Study|Lost to Follow-up|0
5836102|NCT02357420|20173045|P1|Overall Study|Lost to Follow-up|3
5836103|NCT02357420|20173042|P4|Overall Study|Withdrawn Consent|6
5836104|NCT02357420|20173043|P3|Overall Study|Withdrawn Consent|6
5836105|NCT02357420|20173044|P2|Overall Study|Withdrawn Consent|8
5836106|NCT02357420|20173045|P1|Overall Study|Withdrawn Consent|4
5836107|NCT02357420|20173042|P4|Overall Study|Protocol Non-compliance|1
5836108|NCT02357420|20173043|P3|Overall Study|Protocol Non-compliance|0
5836109|NCT02357420|20173044|P2|Overall Study|Protocol Non-compliance|0
5836110|NCT02357420|20173045|P1|Overall Study|Protocol Non-compliance|0
5836111|NCT02357420|20173042|P4|Overall Study|Prohibited Medication|0
5836112|NCT02357420|20173043|P3|Overall Study|Prohibited Medication|0
5836113|NCT02357420|20173044|P2|Overall Study|Prohibited Medication|1
5836114|NCT02357420|20173045|P1|Overall Study|Prohibited Medication|1
5836115|NCT02357420|20173042|P4|Overall Study|Investigator Decision|0
5836116|NCT02357420|20173043|P3|Overall Study|Investigator Decision|0
5836117|NCT02357420|20173044|P2|Overall Study|Investigator Decision|0
5836118|NCT02357420|20173045|P1|Overall Study|Investigator Decision|1
5836119|NCT02357420|20173042|P4|Overall Study|Adverse Event|9
5836120|NCT02357420|20173043|P3|Overall Study|Adverse Event|8
5836121|NCT02357420|20173044|P2|Overall Study|Adverse Event|3
5836122|NCT02357420|20173045|P1|Overall Study|Adverse Event|3
5836123|NCT02357368|20173108|P4|Overall Study|Withdrawal by Subject|2
5836124|NCT02357368|20173109|P3|Overall Study|Withdrawal by Subject|1
5836125|NCT02357368|20173110|P2|Overall Study|Withdrawal by Subject|1
5836126|NCT02357368|20173111|P1|Overall Study|Withdrawal by Subject|3
5836127|NCT02357368|20173108|P4|Overall Study|Pregnancy|0
5836128|NCT02357368|20173109|P3|Overall Study|Pregnancy|0
5836129|NCT02357368|20173110|P2|Overall Study|Pregnancy|2
5836130|NCT02357368|20173111|P1|Overall Study|Pregnancy|3
5836131|NCT02357368|20173108|P4|Overall Study|Lost to Follow-up|1
5836132|NCT02357368|20173109|P3|Overall Study|Lost to Follow-up|0
5836133|NCT02357368|20173110|P2|Overall Study|Lost to Follow-up|0
5836134|NCT02357368|20173111|P1|Overall Study|Lost to Follow-up|0
5836135|NCT02357342|20173135|P2|First 6 Months|Death|0
5836136|NCT02357342|20173136|P1|First 6 Months|Death|2
5836137|NCT02357147|20173184|P2|Maintenance Treatment Phase|Not Treated|0
5836138|NCT02357147|20173185|P1|Maintenance Treatment Phase|Not Treated|1
5836139|NCT02357147|20173184|P2|Maintenance Treatment Phase|Sponsor Decision|15
5836140|NCT02357147|20173185|P1|Maintenance Treatment Phase|Sponsor Decision|0
5836141|NCT02357147|20173184|P2|Maintenance Treatment Phase|Adverse Event|3
5836142|NCT02357147|20173185|P1|Maintenance Treatment Phase|Adverse Event|0
5836143|NCT02357147|20173184|P2|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|0
5836144|NCT02357147|20173185|P1|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|10
5836145|NCT02357147|20173184|P2|Maintenance Treatment Phase|Withdrawal by Subject|1
5836146|NCT02357147|20173185|P1|Maintenance Treatment Phase|Withdrawal by Subject|0
5836147|NCT02357147|20173184|P2|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|10
5836148|NCT02357147|20173185|P1|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|15
5836149|NCT02357147|20173184|P2|Combination Treatment Phase|Not treated|2
5836150|NCT02357147|20173185|P1|Combination Treatment Phase|Not treated|0
5836151|NCT02357147|20173184|P2|Combination Treatment Phase|Other|0
5836152|NCT02357147|20173185|P1|Combination Treatment Phase|Other|1
5836153|NCT02357147|20173184|P2|Combination Treatment Phase|Sponsor Decision|12
5836154|NCT02357147|20173185|P1|Combination Treatment Phase|Sponsor Decision|0
5836155|NCT02357147|20173184|P2|Combination Treatment Phase|Death|1
5836156|NCT02357147|20173185|P1|Combination Treatment Phase|Death|1
5836157|NCT02357147|20173184|P2|Combination Treatment Phase|Adverse Event|4
5836158|NCT02357147|20173185|P1|Combination Treatment Phase|Adverse Event|12
5836159|NCT02357147|20173184|P2|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|1
5836160|NCT02357147|20173185|P1|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|4
5836161|NCT02357147|20173184|P2|Combination Treatment Phase|Withdrawal by Subject|2
5836162|NCT02357147|20173185|P1|Combination Treatment Phase|Withdrawal by Subject|4
5836163|NCT02357147|20173184|P2|Combination Treatment Phase|Investigator Discretion|1
5836164|NCT02357147|20173185|P1|Combination Treatment Phase|Investigator Discretion|1
5836165|NCT02357147|20173184|P2|Combination Treatment Phase|Progressive Disease(Clinical assessment)|1
5836166|NCT02357147|20173185|P1|Combination Treatment Phase|Progressive Disease(Clinical assessment)|0
5836167|NCT02357147|20173184|P2|Combination Treatment Phase|Progressive Disease (Radiographic test)|3
5836168|NCT02357147|20173185|P1|Combination Treatment Phase|Progressive Disease (Radiographic test)|3
5836169|NCT02356887|20173216|P1|Overall Study|poor compliance|2
5836170|NCT02356783|20173233|P2|Overall Study|Lost to Follow-up|3
5836171|NCT02356783|20173234|P1|Overall Study|Lost to Follow-up|1
5836172|NCT02356588|20173255|P2|Overall Study|Protocol Violation|1
5836173|NCT02356588|20173256|P1|Overall Study|Protocol Violation|0
5836174|NCT02356588|20173255|P2|Overall Study|Withdrawal by Subject|0
5836175|NCT02356588|20173256|P1|Overall Study|Withdrawal by Subject|1
5836176|NCT02356588|20173255|P2|Overall Study|Adverse Event|2
5836177|NCT02356588|20173256|P1|Overall Study|Adverse Event|0
5836178|NCT02356588|20173255|P2|Overall Study|Lack of Efficacy|10
5836179|NCT02356588|20173256|P1|Overall Study|Lack of Efficacy|4
5836180|NCT02356562|20173373|P2|Overall Study|site closure|0
5836181|NCT02356562|20173374|P1|Overall Study|site closure|1
5836182|NCT02356562|20173373|P2|Overall Study|Re-entered treatment in a previous study|0
5836183|NCT02356562|20173374|P1|Overall Study|Re-entered treatment in a previous study|1
5836184|NCT02356562|20173373|P2|Overall Study|Withdrawal by Subject|1
5836185|NCT02356562|20173374|P1|Overall Study|Withdrawal by Subject|0
5836186|NCT02356211|20173403|P2|Overall Study|ineligible|8
5836187|NCT02356211|20173404|P1|Overall Study|ineligible|1
5836188|NCT02356211|20173403|P2|Overall Study|Withdrawal by Subject|2
5836189|NCT02356211|20173404|P1|Overall Study|Withdrawal by Subject|2
5836190|NCT02355743|20173469|P1|Overall Study|Lost to Follow-up|1
5836191|NCT02355743|20173469|P1|Overall Study|Withdrawal by Subject|1
5836192|NCT02355691|20173477|P2|Overall Study|Loss of Research Personnel|9
5836193|NCT02355691|20173478|P1|Overall Study|Loss of Research Personnel|7
5836194|NCT02355665|20173488|P2|Overall Study|Compliance, PI decision, move, eligible|3
5836195|NCT02355665|20173489|P1|Overall Study|Compliance, PI decision, move, eligible|6
5836196|NCT02355665|20173488|P2|Overall Study|Death|2
5836197|NCT02355665|20173489|P1|Overall Study|Death|4
5836198|NCT02355665|20173488|P2|Overall Study|Lost to Follow-up|103
5836199|NCT02355665|20173489|P1|Overall Study|Lost to Follow-up|131
5836200|NCT02355665|20173488|P2|Overall Study|Withdrawal by Subject|100
5836201|NCT02355665|20173489|P1|Overall Study|Withdrawal by Subject|90
5836202|NCT02355665|20173488|P2|Overall Study|Protocol Violation|0
5836203|NCT02355665|20173489|P1|Overall Study|Protocol Violation|2
5836204|NCT02355665|20173488|P2|Overall Study|Adverse Event|24
5836205|NCT02355665|20173489|P1|Overall Study|Adverse Event|16
5836206|NCT02355028|20173947|P2|Overall Study|Deemed ineligible after randomization|4
5836207|NCT02355028|20173948|P1|Overall Study|Deemed ineligible after randomization|8
5836208|NCT02355028|20173947|P2|Overall Study|Withdrawal by Subject|1
5836209|NCT02355028|20173948|P1|Overall Study|Withdrawal by Subject|1
5836210|NCT02355028|20173947|P2|Overall Study|Adverse Event|0
5836211|NCT02355028|20173948|P1|Overall Study|Adverse Event|2
5836212|NCT02354976|20173984|P3|Overall Study|Adverse Event|2
5836213|NCT02354976|20173985|P2|Overall Study|Adverse Event|0
5836214|NCT02354976|20173986|P1|Overall Study|Adverse Event|1
5836215|NCT02354976|20173984|P3|Overall Study|Study-specifc withdrawal criteria|0
5836216|NCT02354976|20173985|P2|Overall Study|Study-specifc withdrawal criteria|1
5836217|NCT02354976|20173986|P1|Overall Study|Study-specifc withdrawal criteria|0
5836218|NCT02354976|20173984|P3|Overall Study|Other - reason not specified|1
5836219|NCT02354976|20173985|P2|Overall Study|Other - reason not specified|0
5836220|NCT02354976|20173986|P1|Overall Study|Other - reason not specified|1
5836221|NCT02354690|20174049|P1|Overall Study|Physician Decision|1
5836222|NCT02354599|20174063|P6|Overall Study|Withdrawal by Subject|0
5836223|NCT02354599|20174064|P5|Overall Study|Withdrawal by Subject|0
5836224|NCT02354599|20174065|P4|Overall Study|Withdrawal by Subject|0
5836225|NCT02354599|20174066|P3|Overall Study|Withdrawal by Subject|0
5836226|NCT02354599|20174067|P2|Overall Study|Withdrawal by Subject|1
5836227|NCT02354599|20174068|P1|Overall Study|Withdrawal by Subject|1
5836228|NCT02354599|20174063|P6|Overall Study|Pretreatment Event/Adverse Event|1
5836229|NCT02354599|20174064|P5|Overall Study|Pretreatment Event/Adverse Event|0
5836230|NCT02354599|20174065|P4|Overall Study|Pretreatment Event/Adverse Event|0
5836231|NCT02354599|20174066|P3|Overall Study|Pretreatment Event/Adverse Event|0
5836232|NCT02354599|20174067|P2|Overall Study|Pretreatment Event/Adverse Event|0
5836233|NCT02354599|20174068|P1|Overall Study|Pretreatment Event/Adverse Event|0
5836234|NCT02354586|20174138|P1|Overall Study|Disease progression|116
5836235|NCT02354586|20174138|P1|Overall Study|Lost to Follow-up|6
5836236|NCT02354586|20174138|P1|Overall Study|Withdrawal by Subject|51
5836237|NCT02354586|20174138|P1|Overall Study|Death|168
5836238|NCT02354508|20174157|P3|Period 3: Post-treatment Follow up Phase|Physician Decision|1
5836239|NCT02354508|20174158|P2|Period 3: Post-treatment Follow up Phase|Physician Decision|0
5836240|NCT02354508|20174159|P1|Period 3: Post-treatment Follow up Phase|Physician Decision|3
5836241|NCT02354508|20174157|P3|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0
5836242|NCT02354508|20174158|P2|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|1
5836243|NCT02354508|20174159|P1|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0
5836244|NCT02354508|20174157|P3|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2
5836245|NCT02354508|20174158|P2|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2
5836246|NCT02354508|20174159|P1|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|1
5836247|NCT02354508|20174157|P3|Period 2: Extension Phase|Physician Decision|1
5836248|NCT02354508|20174158|P2|Period 2: Extension Phase|Physician Decision|0
5836249|NCT02354508|20174159|P1|Period 2: Extension Phase|Physician Decision|5
5836250|NCT02354508|20174157|P3|Period 2: Extension Phase|Withdrawal by Subject|0
5836251|NCT02354508|20174158|P2|Period 2: Extension Phase|Withdrawal by Subject|1
5836252|NCT02354508|20174159|P1|Period 2: Extension Phase|Withdrawal by Subject|0
5836253|NCT02354508|20174157|P3|Period 2: Extension Phase|Unsatisfactory therapeutic effect|2
5836254|NCT02354508|20174158|P2|Period 2: Extension Phase|Unsatisfactory therapeutic effect|3
5836255|NCT02354508|20174159|P1|Period 2: Extension Phase|Unsatisfactory therapeutic effect|1
5836256|NCT02354508|20174157|P3|Period 1: Core Phase|Withdrawal by Subject|2
5836257|NCT02354508|20174158|P2|Period 1: Core Phase|Withdrawal by Subject|1
5836258|NCT02354508|20174159|P1|Period 1: Core Phase|Withdrawal by Subject|0
5836259|NCT02354508|20174157|P3|Period 1: Core Phase|Unsatisfactory therapeutic effect|2
5836260|NCT02354508|20174158|P2|Period 1: Core Phase|Unsatisfactory therapeutic effect|0
5836261|NCT02354508|20174159|P1|Period 1: Core Phase|Unsatisfactory therapeutic effect|1
5836262|NCT02354508|20174157|P3|Period 1: Core Phase|Adverse Event|2
5836263|NCT02354508|20174158|P2|Period 1: Core Phase|Adverse Event|1
5836264|NCT02354508|20174159|P1|Period 1: Core Phase|Adverse Event|1
5836265|NCT02354417|20174261|P1|Overall Study|Physician Decision|1
5836266|NCT02354235|20174328|P2|Overall Study|Conflict with the stopping criteria|1
5836267|NCT02354235|20174329|P1|Overall Study|Conflict with the stopping criteria|0
5836268|NCT02354235|20174328|P2|Overall Study|Withdrawal by Subject|3
5836269|NCT02354235|20174329|P1|Overall Study|Withdrawal by Subject|1
5836270|NCT02354235|20174328|P2|Overall Study|Physician Decision|1
5836271|NCT02354235|20174329|P1|Overall Study|Physician Decision|0
5836272|NCT02354235|20174328|P2|Overall Study|Adverse Event|2
5836273|NCT02354235|20174329|P1|Overall Study|Adverse Event|2
5836274|NCT02354222|20174345|P2|Overall Study|Conflict with the stopping criteria|4
5836275|NCT02354222|20174346|P1|Overall Study|Conflict with the stopping criteria|0
5836276|NCT02354222|20174345|P2|Overall Study|Withdrawal by Subject|3
5836277|NCT02354222|20174346|P1|Overall Study|Withdrawal by Subject|2
5836278|NCT02354222|20174345|P2|Overall Study|Pregnancy|0
5836279|NCT02354222|20174346|P1|Overall Study|Pregnancy|1
5836280|NCT02354222|20174345|P2|Overall Study|Physician Decision|1
5836281|NCT02354222|20174346|P1|Overall Study|Physician Decision|1
5836282|NCT02354222|20174345|P2|Overall Study|Adverse Event|3
5836283|NCT02354222|20174346|P1|Overall Study|Adverse Event|0
5836284|NCT02353871|20174377|P2|Overall Study|Lost to Follow-up|0
5836285|NCT02353871|20174378|P1|Overall Study|Lost to Follow-up|2
5836286|NCT02353871|20174377|P2|Overall Study|Consent withdrawn|8
5836287|NCT02353871|20174378|P1|Overall Study|Consent withdrawn|1
5836288|NCT02353871|20174377|P2|Overall Study|Protocol deviation|1
5836289|NCT02353871|20174378|P1|Overall Study|Protocol deviation|0
5836290|NCT02353572|20174471|P1|Overall Study|Study terminated|2
5836291|NCT02353572|20174471|P1|Overall Study|Withdrawal by Subject|1
5836292|NCT02353468|20174475|P1|Overall Study|Study terminated|3
5836293|NCT02353442|20174481|P2|Overall Study|Withdrawal by Subject|4
5836294|NCT02353442|20174482|P1|Overall Study|Withdrawal by Subject|3
5836295|NCT02353169|20174537|P4|Overall Study|Pre-op medication|0
5836296|NCT02353169|20174538|P3|Overall Study|Pre-op medication|1
5836297|NCT02353169|20174539|P2|Overall Study|Pre-op medication|0
5836298|NCT02353169|20174540|P1|Overall Study|Pre-op medication|0
5836299|NCT02353169|20174537|P4|Overall Study|ECG data error|2
5836300|NCT02353169|20174538|P3|Overall Study|ECG data error|2
5836301|NCT02353169|20174539|P2|Overall Study|ECG data error|3
5836302|NCT02353169|20174540|P1|Overall Study|ECG data error|0
5836303|NCT02353169|20174537|P4|Overall Study|Inhalational induction|0
5836304|NCT02353169|20174538|P3|Overall Study|Inhalational induction|0
5836305|NCT02353169|20174539|P2|Overall Study|Inhalational induction|2
5836306|NCT02353169|20174540|P1|Overall Study|Inhalational induction|0
5836307|NCT02353169|20174537|P4|Overall Study|OR team declined|0
5836308|NCT02353169|20174538|P3|Overall Study|OR team declined|0
5836309|NCT02353169|20174539|P2|Overall Study|OR team declined|0
5836310|NCT02353169|20174540|P1|Overall Study|OR team declined|2
5836311|NCT02353169|20174537|P4|Overall Study|QTc > 450 msec|1
5836312|NCT02353169|20174538|P3|Overall Study|QTc > 450 msec|1
5836313|NCT02353169|20174539|P2|Overall Study|QTc > 450 msec|1
5836314|NCT02353169|20174540|P1|Overall Study|QTc > 450 msec|1
5836345|NCT02352779|20174762|P3|Overall Study|No Reason|1
5836346|NCT02352779|20174763|P2|Overall Study|No Reason|0
5836347|NCT02352779|20174764|P1|Overall Study|No Reason|0
5836348|NCT02352779|20174762|P3|Overall Study|Other Medical Reason|1
5836349|NCT02352779|20174763|P2|Overall Study|Other Medical Reason|0
5836350|NCT02352779|20174764|P1|Overall Study|Other Medical Reason|0
5836351|NCT02352779|20174762|P3|Overall Study|Absence of Symptoms|0
5836352|NCT02352779|20174763|P2|Overall Study|Absence of Symptoms|0
5836353|NCT02352779|20174764|P1|Overall Study|Absence of Symptoms|1
5836354|NCT02352779|20174762|P3|Overall Study|Study Related Symptoms|0
5836355|NCT02352779|20174763|P2|Overall Study|Study Related Symptoms|0
5836356|NCT02352779|20174764|P1|Overall Study|Study Related Symptoms|1
5836357|NCT02352779|20174762|P3|Overall Study|Changed Mind|0
5836358|NCT02352779|20174763|P2|Overall Study|Changed Mind|0
5836359|NCT02352779|20174764|P1|Overall Study|Changed Mind|1
5836360|NCT02352779|20174762|P3|Overall Study|Disliked Intervention|0
5836361|NCT02352779|20174763|P2|Overall Study|Disliked Intervention|0
5836362|NCT02352779|20174764|P1|Overall Study|Disliked Intervention|1
5836363|NCT02352779|20174762|P3|Overall Study|Feeling Overwhelmed|0
5836364|NCT02352779|20174763|P2|Overall Study|Feeling Overwhelmed|0
5836365|NCT02352779|20174764|P1|Overall Study|Feeling Overwhelmed|1
5836366|NCT02352779|20174762|P3|Overall Study|Too Many Forms|0
5836367|NCT02352779|20174763|P2|Overall Study|Too Many Forms|0
5836368|NCT02352779|20174764|P1|Overall Study|Too Many Forms|2
5836369|NCT02352779|20174762|P3|Overall Study|Personal Issues|0
5836370|NCT02352779|20174763|P2|Overall Study|Personal Issues|1
5836371|NCT02352779|20174764|P1|Overall Study|Personal Issues|1
5836372|NCT02352493|20174790|P18|Overall Study|Lost to Follow-up|0
5836373|NCT02352493|20174791|P17|Overall Study|Lost to Follow-up|0
5836374|NCT02352493|20174792|P16|Overall Study|Lost to Follow-up|0
5836375|NCT02352493|20174793|P15|Overall Study|Lost to Follow-up|0
5836376|NCT02352493|20174794|P14|Overall Study|Lost to Follow-up|2
5836377|NCT02352493|20174795|P13|Overall Study|Lost to Follow-up|1
5836378|NCT02352493|20174796|P12|Overall Study|Lost to Follow-up|0
5836379|NCT02352493|20174797|P11|Overall Study|Lost to Follow-up|0
5836380|NCT02352493|20174798|P10|Overall Study|Lost to Follow-up|1
5836381|NCT02352493|20174799|P9|Overall Study|Lost to Follow-up|0
5836382|NCT02352493|20174800|P8|Overall Study|Lost to Follow-up|0
5836383|NCT02352493|20174801|P7|Overall Study|Lost to Follow-up|0
5836384|NCT02352493|20174802|P6|Overall Study|Lost to Follow-up|0
5836385|NCT02352493|20174803|P5|Overall Study|Lost to Follow-up|0
5836386|NCT02352493|20174804|P4|Overall Study|Lost to Follow-up|0
5836387|NCT02352493|20174805|P3|Overall Study|Lost to Follow-up|0
5836388|NCT02352493|20174806|P2|Overall Study|Lost to Follow-up|0
5836389|NCT02352493|20174807|P1|Overall Study|Lost to Follow-up|0
5836390|NCT02352493|20174790|P18|Overall Study|Withdrawal by Subject|0
5836391|NCT02352493|20174791|P17|Overall Study|Withdrawal by Subject|0
5836392|NCT02352493|20174792|P16|Overall Study|Withdrawal by Subject|0
5836393|NCT02352493|20174793|P15|Overall Study|Withdrawal by Subject|1
5836394|NCT02352493|20174794|P14|Overall Study|Withdrawal by Subject|0
5836395|NCT02352493|20174795|P13|Overall Study|Withdrawal by Subject|0
5836396|NCT02352493|20174796|P12|Overall Study|Withdrawal by Subject|0
5836397|NCT02352493|20174797|P11|Overall Study|Withdrawal by Subject|0
5836398|NCT02352493|20174798|P10|Overall Study|Withdrawal by Subject|0
5836399|NCT02352493|20174799|P9|Overall Study|Withdrawal by Subject|1
5836400|NCT02352493|20174800|P8|Overall Study|Withdrawal by Subject|0
5836401|NCT02352493|20174801|P7|Overall Study|Withdrawal by Subject|0
5836402|NCT02352493|20174802|P6|Overall Study|Withdrawal by Subject|0
5836403|NCT02352493|20174803|P5|Overall Study|Withdrawal by Subject|0
5836404|NCT02352493|20174804|P4|Overall Study|Withdrawal by Subject|0
5836405|NCT02352493|20174805|P3|Overall Study|Withdrawal by Subject|0
5836406|NCT02352493|20174806|P2|Overall Study|Withdrawal by Subject|0
5836407|NCT02352493|20174807|P1|Overall Study|Withdrawal by Subject|0
5836408|NCT02352493|20174790|P18|Overall Study|Pregnancy|0
5836409|NCT02352493|20174791|P17|Overall Study|Pregnancy|0
5836410|NCT02352493|20174792|P16|Overall Study|Pregnancy|0
5836411|NCT02352493|20174793|P15|Overall Study|Pregnancy|0
5836412|NCT02352493|20174794|P14|Overall Study|Pregnancy|0
5836413|NCT02352493|20174795|P13|Overall Study|Pregnancy|0
5836414|NCT02352493|20174796|P12|Overall Study|Pregnancy|0
5836415|NCT02352493|20174797|P11|Overall Study|Pregnancy|0
5836416|NCT02352493|20174798|P10|Overall Study|Pregnancy|0
5836417|NCT02352493|20174799|P9|Overall Study|Pregnancy|1
5836418|NCT02352493|20174800|P8|Overall Study|Pregnancy|0
5836419|NCT02352493|20174801|P7|Overall Study|Pregnancy|1
5836420|NCT02352493|20174802|P6|Overall Study|Pregnancy|0
5836421|NCT02352493|20174803|P5|Overall Study|Pregnancy|0
5836422|NCT02352493|20174804|P4|Overall Study|Pregnancy|0
5836423|NCT02352493|20174805|P3|Overall Study|Pregnancy|0
5836424|NCT02352493|20174806|P2|Overall Study|Pregnancy|0
5836425|NCT02352493|20174807|P1|Overall Study|Pregnancy|0
5836426|NCT02351960|20175040|P2|Overall Study|Significant Protocol Deviation|5
5836427|NCT02351960|20175041|P1|Overall Study|Significant Protocol Deviation|0
5836428|NCT02351960|20175040|P2|Overall Study|Voluntary Withdrawal|4
5836429|NCT02351960|20175041|P1|Overall Study|Voluntary Withdrawal|5
5836430|NCT02351960|20175040|P2|Overall Study|Pretreatment Event/Adverse Event|3
5836431|NCT02351960|20175041|P1|Overall Study|Pretreatment Event/Adverse Event|6
5836432|NCT02351934|20175062|P2|Follow-Up|2 ERAS Components Noncompliant|4
5836433|NCT02351934|20175063|P1|Follow-Up|2 ERAS Components Noncompliant|0
5836434|NCT02351934|20175062|P2|Follow-Up|1 ERAS Component Noncompliant|6
5836435|NCT02351934|20175063|P1|Follow-Up|1 ERAS Component Noncompliant|0
5836436|NCT02351934|20175062|P2|Follow-Up|No documentation|0
5836437|NCT02351934|20175063|P1|Follow-Up|No documentation|2
5836438|NCT02351934|20175062|P2|Follow-Up|Hypotension|0
5836439|NCT02351934|20175063|P1|Follow-Up|Hypotension|3
5836440|NCT02351934|20175062|P2|Follow-Up|Early dismissal|0
5836441|NCT02351934|20175063|P1|Follow-Up|Early dismissal|3
5836442|NCT02351934|20175062|P2|Follow-Up|Acute Kidney Injury|0
5836443|NCT02351934|20175063|P1|Follow-Up|Acute Kidney Injury|1
5836444|NCT02351934|20175062|P2|Follow-Up|POD weight<pre-op weight|0
5836445|NCT02351934|20175063|P1|Follow-Up|POD weight<pre-op weight|3
5836446|NCT02351934|20175062|P2|Allocation|Acute Kidney Injury on Post Op Day 1|0
5836447|NCT02351934|20175063|P1|Allocation|Acute Kidney Injury on Post Op Day 1|1
5836448|NCT02351934|20175062|P2|Allocation|Hypotension preventing administration|0
5836449|NCT02351934|20175063|P1|Allocation|Hypotension preventing administration|2
5836450|NCT02351934|20175062|P2|Allocation|POD weight<pre-op weight|0
5836451|NCT02351934|20175063|P1|Allocation|POD weight<pre-op weight|3
5836452|NCT02351817|20175079|P2|Period 2|Protocol Violation|0
5836453|NCT02351817|20175080|P1|Period 2|Protocol Violation|1
5836454|NCT02351817|20175079|P2|Period 2|Adverse Event|2
5836455|NCT02351817|20175080|P1|Period 2|Adverse Event|0
5836456|NCT02351817|20175079|P2|Period 1|Lack of Efficacy|1
5836457|NCT02351817|20175080|P1|Period 1|Lack of Efficacy|0
5836458|NCT02351817|20175079|P2|Period 1|Adverse Event|2
5836459|NCT02351817|20175080|P1|Period 1|Adverse Event|1
5836460|NCT02351167|20175141|P3|Overall Study|Withdrawal by Subject|21
5836461|NCT02351167|20175142|P2|Overall Study|Withdrawal by Subject|18
5836462|NCT02351167|20175143|P1|Overall Study|Withdrawal by Subject|19
5836463|NCT02350478|20175331|P2|Overall Study|Lost to Follow-up|1
5836464|NCT02350478|20175332|P1|Overall Study|Lost to Follow-up|5
5836465|NCT02350309|20175354|P6|Treatment Period 4 (2 Days)|Death in the Family|1
5836466|NCT02350309|20175355|P5|Treatment Period 4 (2 Days)|Death in the Family|0
5836467|NCT02350309|20175356|P4|Treatment Period 4 (2 Days)|Death in the Family|0
5836468|NCT02350309|20175357|P3|Treatment Period 4 (2 Days)|Death in the Family|0
5836469|NCT02350309|20175358|P2|Treatment Period 4 (2 Days)|Death in the Family|0
5836470|NCT02350309|20175359|P1|Treatment Period 4 (2 Days)|Death in the Family|0
5836471|NCT02350309|20175354|P6|Treatment Period 1 (2 Days)|Physician Decision|0
5836472|NCT02350309|20175355|P5|Treatment Period 1 (2 Days)|Physician Decision|0
5836473|NCT02350309|20175356|P4|Treatment Period 1 (2 Days)|Physician Decision|0
5836474|NCT02350309|20175357|P3|Treatment Period 1 (2 Days)|Physician Decision|1
5836475|NCT02350309|20175358|P2|Treatment Period 1 (2 Days)|Physician Decision|0
5836476|NCT02350309|20175359|P1|Treatment Period 1 (2 Days)|Physician Decision|0
5836477|NCT02350127|20175400|P2|8-Month Assessment|Withdrawal by Subject|8
5836478|NCT02350127|20175401|P1|8-Month Assessment|Withdrawal by Subject|5
5836479|NCT02350127|20175400|P2|8-Month Assessment|Death|1
5836480|NCT02350127|20175401|P1|8-Month Assessment|Death|1
5836481|NCT02350127|20175400|P2|4-Month Assessment|Death|0
5836482|NCT02350127|20175401|P1|4-Month Assessment|Death|1
5836483|NCT02350127|20175400|P2|4-Month Assessment|Withdrawal by Subject|9
5836484|NCT02350127|20175401|P1|4-Month Assessment|Withdrawal by Subject|10
5836485|NCT02349789|20175440|P1|Overall Study|Withdrawal by Subject|2
5836486|NCT02349711|20175451|P2|Overall Study|Lost to Follow-up|1
5836487|NCT02349711|20175452|P1|Overall Study|Lost to Follow-up|1
5836488|NCT02349711|20175451|P2|Overall Study|Withdrawal by Subject|1
5836489|NCT02349711|20175452|P1|Overall Study|Withdrawal by Subject|2
5836490|NCT02349542|20175485|P1|Overall Study|Withdrawal by Subject|5
5836491|NCT02349451|20175509|P4|Overall Study|Withdrawal by Subject|1
5836492|NCT02349451|20175510|P3|Overall Study|Withdrawal by Subject|2
5836493|NCT02349451|20175511|P2|Overall Study|Withdrawal by Subject|1
5836494|NCT02349451|20175512|P1|Overall Study|Withdrawal by Subject|0
5836495|NCT02349425|20175563|P4|Period 2|Adverse Event|0
5836496|NCT02349425|20175564|P3|Period 2|Adverse Event|1
5836497|NCT02349425|20175565|P2|Period 2|Adverse Event|1
5836498|NCT02349425|20175566|P1|Period 2|Adverse Event|0
5836499|NCT02349425|20175563|P4|Period 1|Adverse Event|0
5836500|NCT02349425|20175564|P3|Period 1|Adverse Event|0
5836501|NCT02349425|20175565|P2|Period 1|Adverse Event|1
5836502|NCT02349425|20175566|P1|Period 1|Adverse Event|1
5836503|NCT02349412|20175740|P2|Overall Study|Withdrawal by Subject|7
5836504|NCT02349412|20175741|P1|Overall Study|Withdrawal by Subject|7
5836505|NCT02349360|20175757|P2|Overall Study|Withdrawal by Subject|1
5836506|NCT02349360|20175758|P1|Overall Study|Withdrawal by Subject|0
5836507|NCT02349295|20175769|P14|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
5836508|NCT02349295|20175770|P13|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
5836509|NCT02349295|20175771|P12|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|4
5836510|NCT02349295|20175772|P11|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
5836511|NCT02349295|20175773|P10|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
5836512|NCT02349295|20175774|P9|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
5836513|NCT02349295|20175775|P8|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
5836514|NCT02349295|20175776|P7|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
5836515|NCT02349295|20175777|P6|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
5836516|NCT02349295|20175778|P5|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
5836517|NCT02349295|20175779|P4|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
5836518|NCT02349295|20175780|P3|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
5836519|NCT02349295|20175781|P2|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
5836520|NCT02349295|20175782|P1|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
5836521|NCT02349295|20175769|P14|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
5836522|NCT02349295|20175770|P13|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
5836523|NCT02349295|20175771|P12|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|2
5836524|NCT02349295|20175772|P11|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
5836525|NCT02349295|20175773|P10|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
5836526|NCT02349295|20175774|P9|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
5836527|NCT02349295|20175775|P8|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
5836528|NCT02349295|20175776|P7|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
5836529|NCT02349295|20175777|P6|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
5836530|NCT02349295|20175778|P5|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
5836531|NCT02349295|20175779|P4|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
5836532|NCT02349295|20175780|P3|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
5836533|NCT02349295|20175781|P2|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
5836534|NCT02349295|20175782|P1|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
5836535|NCT02349295|20175769|P14|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0
5836536|NCT02349295|20175770|P13|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|1
5836537|NCT02349295|20175771|P12|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|1
5836538|NCT02349295|20175772|P11|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0
5836539|NCT02349295|20175773|P10|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0
5836540|NCT02349295|20175774|P9|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0
5836541|NCT02349295|20175775|P8|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0
5836542|NCT02349295|20175776|P7|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0
5836543|NCT02349295|20175777|P6|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0
5836544|NCT02349295|20175778|P5|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0
5836545|NCT02349295|20175779|P4|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0
5836546|NCT02349295|20175780|P3|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0
5836547|NCT02349295|20175781|P2|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0
5836548|NCT02349295|20175782|P1|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0
5836549|NCT02349295|20175769|P14|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0
5836550|NCT02349295|20175770|P13|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|2
5836551|NCT02349295|20175771|P12|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|1
5836552|NCT02349295|20175772|P11|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0
5836553|NCT02349295|20175773|P10|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0
5836554|NCT02349295|20175774|P9|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0
5836555|NCT02349295|20175775|P8|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0
5836556|NCT02349295|20175776|P7|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0
5836557|NCT02349295|20175777|P6|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0
5836558|NCT02349295|20175778|P5|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0
5836559|NCT02349295|20175779|P4|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0
5836560|NCT02349295|20175780|P3|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0
5836561|NCT02349295|20175781|P2|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0
5836562|NCT02349295|20175782|P1|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0
5836563|NCT02349295|20175769|P14|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|1
5836564|NCT02349295|20175770|P13|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|5
5836565|NCT02349295|20175771|P12|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|1
5836566|NCT02349295|20175772|P11|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0
5836567|NCT02349295|20175773|P10|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0
5836568|NCT02349295|20175774|P9|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0
5836569|NCT02349295|20175775|P8|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0
5836570|NCT02349295|20175776|P7|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0
5836571|NCT02349295|20175777|P6|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0
5836572|NCT02349295|20175778|P5|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0
5836573|NCT02349295|20175779|P4|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0
5836574|NCT02349295|20175780|P3|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0
5836575|NCT02349295|20175781|P2|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0
5836576|NCT02349295|20175782|P1|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0
5836577|NCT02349295|20175769|P14|Long-Term Extension Period (Week 24-156)|Physician Decision|0
5836578|NCT02349295|20175770|P13|Long-Term Extension Period (Week 24-156)|Physician Decision|0
5836579|NCT02349295|20175771|P12|Long-Term Extension Period (Week 24-156)|Physician Decision|0
5836580|NCT02349295|20175772|P11|Long-Term Extension Period (Week 24-156)|Physician Decision|0
5836581|NCT02349295|20175773|P10|Long-Term Extension Period (Week 24-156)|Physician Decision|0
5836582|NCT02349295|20175774|P9|Long-Term Extension Period (Week 24-156)|Physician Decision|2
5836583|NCT02349295|20175775|P8|Long-Term Extension Period (Week 24-156)|Physician Decision|2
5836584|NCT02349295|20175776|P7|Long-Term Extension Period (Week 24-156)|Physician Decision|0
5836585|NCT02349295|20175777|P6|Long-Term Extension Period (Week 24-156)|Physician Decision|0
5836586|NCT02349295|20175778|P5|Long-Term Extension Period (Week 24-156)|Physician Decision|0
5836587|NCT02349295|20175779|P4|Long-Term Extension Period (Week 24-156)|Physician Decision|0
5836588|NCT02349295|20175780|P3|Long-Term Extension Period (Week 24-156)|Physician Decision|0
5836589|NCT02349295|20175781|P2|Long-Term Extension Period (Week 24-156)|Physician Decision|0
5836590|NCT02349295|20175782|P1|Long-Term Extension Period (Week 24-156)|Physician Decision|0
5836591|NCT02349295|20175769|P14|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0
5836592|NCT02349295|20175770|P13|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0
5836593|NCT02349295|20175771|P12|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0
5836594|NCT02349295|20175772|P11|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0
5836595|NCT02349295|20175773|P10|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0
5836596|NCT02349295|20175774|P9|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|2
5836597|NCT02349295|20175775|P8|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|2
5836598|NCT02349295|20175776|P7|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0
5836599|NCT02349295|20175777|P6|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0
5836600|NCT02349295|20175778|P5|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0
5836601|NCT02349295|20175779|P4|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0
5836602|NCT02349295|20175780|P3|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0
5836603|NCT02349295|20175781|P2|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0
5836604|NCT02349295|20175782|P1|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0
5836605|NCT02349295|20175769|P14|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0
5836606|NCT02349295|20175770|P13|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0
5836607|NCT02349295|20175771|P12|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0
5836608|NCT02349295|20175772|P11|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|3
5836609|NCT02349295|20175773|P10|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|1
5836610|NCT02349295|20175774|P9|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|2
5836611|NCT02349295|20175775|P8|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|4
5836612|NCT02349295|20175776|P7|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0
5836613|NCT02349295|20175777|P6|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0
5836614|NCT02349295|20175778|P5|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0
5836615|NCT02349295|20175779|P4|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0
5836616|NCT02349295|20175780|P3|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0
5836617|NCT02349295|20175781|P2|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0
5836618|NCT02349295|20175782|P1|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0
5836619|NCT02349295|20175769|P14|Long-Term Extension Period (Week 24-156)|Death|0
5836620|NCT02349295|20175770|P13|Long-Term Extension Period (Week 24-156)|Death|0
5836621|NCT02349295|20175771|P12|Long-Term Extension Period (Week 24-156)|Death|0
5836622|NCT02349295|20175772|P11|Long-Term Extension Period (Week 24-156)|Death|0
5836623|NCT02349295|20175773|P10|Long-Term Extension Period (Week 24-156)|Death|1
5836624|NCT02349295|20175774|P9|Long-Term Extension Period (Week 24-156)|Death|1
5836625|NCT02349295|20175775|P8|Long-Term Extension Period (Week 24-156)|Death|1
5836626|NCT02349295|20175776|P7|Long-Term Extension Period (Week 24-156)|Death|0
5836627|NCT02349295|20175777|P6|Long-Term Extension Period (Week 24-156)|Death|0
5836628|NCT02349295|20175778|P5|Long-Term Extension Period (Week 24-156)|Death|0
5836629|NCT02349295|20175779|P4|Long-Term Extension Period (Week 24-156)|Death|0
5836630|NCT02349295|20175780|P3|Long-Term Extension Period (Week 24-156)|Death|0
5836631|NCT02349295|20175781|P2|Long-Term Extension Period (Week 24-156)|Death|0
5836632|NCT02349295|20175782|P1|Long-Term Extension Period (Week 24-156)|Death|0
5836633|NCT02349295|20175769|P14|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0
5836634|NCT02349295|20175770|P13|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0
5836635|NCT02349295|20175771|P12|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0
5836636|NCT02349295|20175772|P11|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0
5836637|NCT02349295|20175773|P10|Long-Term Extension Period (Week 24-156)|Unknown/Missing|3
5836638|NCT02349295|20175774|P9|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0
5836639|NCT02349295|20175775|P8|Long-Term Extension Period (Week 24-156)|Unknown/Missing|2
5836640|NCT02349295|20175776|P7|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0
5836641|NCT02349295|20175777|P6|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0
5836642|NCT02349295|20175778|P5|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0
5836643|NCT02349295|20175779|P4|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0
5836644|NCT02349295|20175780|P3|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0
5836645|NCT02349295|20175781|P2|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0
5836646|NCT02349295|20175782|P1|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0
5836647|NCT02349295|20175769|P14|Long-Term Extension Period (Week 24-156)|Adverse Event|0
5836648|NCT02349295|20175770|P13|Long-Term Extension Period (Week 24-156)|Adverse Event|0
5836649|NCT02349295|20175771|P12|Long-Term Extension Period (Week 24-156)|Adverse Event|0
5836650|NCT02349295|20175772|P11|Long-Term Extension Period (Week 24-156)|Adverse Event|2
5836651|NCT02349295|20175773|P10|Long-Term Extension Period (Week 24-156)|Adverse Event|2
5836652|NCT02349295|20175774|P9|Long-Term Extension Period (Week 24-156)|Adverse Event|9
5836653|NCT02349295|20175775|P8|Long-Term Extension Period (Week 24-156)|Adverse Event|9
5836654|NCT02349295|20175776|P7|Long-Term Extension Period (Week 24-156)|Adverse Event|0
5836655|NCT02349295|20175777|P6|Long-Term Extension Period (Week 24-156)|Adverse Event|0
5836656|NCT02349295|20175778|P5|Long-Term Extension Period (Week 24-156)|Adverse Event|0
5836657|NCT02349295|20175779|P4|Long-Term Extension Period (Week 24-156)|Adverse Event|0
5836658|NCT02349295|20175780|P3|Long-Term Extension Period (Week 24-156)|Adverse Event|0
5836659|NCT02349295|20175781|P2|Long-Term Extension Period (Week 24-156)|Adverse Event|0
5836660|NCT02349295|20175782|P1|Long-Term Extension Period (Week 24-156)|Adverse Event|0
5836661|NCT02349295|20175769|P14|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0
5836662|NCT02349295|20175770|P13|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0
5836663|NCT02349295|20175771|P12|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0
5836664|NCT02349295|20175772|P11|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|18
5836665|NCT02349295|20175773|P10|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|19
5836666|NCT02349295|20175774|P9|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|25
5836667|NCT02349295|20175775|P8|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|32
5836668|NCT02349295|20175776|P7|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0
5836669|NCT02349295|20175777|P6|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0
5836670|NCT02349295|20175778|P5|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0
5836671|NCT02349295|20175779|P4|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0
5836672|NCT02349295|20175780|P3|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0
5836673|NCT02349295|20175781|P2|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0
5836674|NCT02349295|20175782|P1|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0
5836675|NCT02349295|20175769|P14|IR (Week 16-24)|Lack of Efficacy|0
5836676|NCT02349295|20175770|P13|IR (Week 16-24)|Lack of Efficacy|0
5836677|NCT02349295|20175771|P12|IR (Week 16-24)|Lack of Efficacy|0
5836678|NCT02349295|20175772|P11|IR (Week 16-24)|Lack of Efficacy|0
5836679|NCT02349295|20175773|P10|IR (Week 16-24)|Lack of Efficacy|0
5836680|NCT02349295|20175774|P9|IR (Week 16-24)|Lack of Efficacy|0
5836681|NCT02349295|20175775|P8|IR (Week 16-24)|Lack of Efficacy|0
5836682|NCT02349295|20175776|P7|IR (Week 16-24)|Lack of Efficacy|0
5836683|NCT02349295|20175777|P6|IR (Week 16-24)|Lack of Efficacy|0
5836684|NCT02349295|20175778|P5|IR (Week 16-24)|Lack of Efficacy|0
5836685|NCT02349295|20175779|P4|IR (Week 16-24)|Lack of Efficacy|1
5836686|NCT02349295|20175780|P3|IR (Week 16-24)|Lack of Efficacy|0
5836687|NCT02349295|20175781|P2|IR (Week 16-24)|Lack of Efficacy|0
5836688|NCT02349295|20175782|P1|IR (Week 16-24)|Lack of Efficacy|0
5836689|NCT02349295|20175769|P14|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
5836690|NCT02349295|20175770|P13|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
5836691|NCT02349295|20175771|P12|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
5836692|NCT02349295|20175772|P11|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
5836693|NCT02349295|20175773|P10|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
5836694|NCT02349295|20175774|P9|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
5836695|NCT02349295|20175775|P8|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
5836696|NCT02349295|20175776|P7|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
5836697|NCT02349295|20175777|P6|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
5836698|NCT02349295|20175778|P5|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
5836699|NCT02349295|20175779|P4|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
5836700|NCT02349295|20175780|P3|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1
5836701|NCT02349295|20175781|P2|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1
5836702|NCT02349295|20175782|P1|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
5836703|NCT02349295|20175769|P14|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
5836704|NCT02349295|20175770|P13|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
5836705|NCT02349295|20175771|P12|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
5836706|NCT02349295|20175772|P11|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
5836707|NCT02349295|20175773|P10|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
5836708|NCT02349295|20175774|P9|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
5836709|NCT02349295|20175775|P8|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
5836710|NCT02349295|20175776|P7|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
5836711|NCT02349295|20175777|P6|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
5836712|NCT02349295|20175778|P5|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
5836713|NCT02349295|20175779|P4|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
5836714|NCT02349295|20175780|P3|Double Blind Treatment (Week 0-24)|Lost to Follow-up|2
5836715|NCT02349295|20175781|P2|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1
5836716|NCT02349295|20175782|P1|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1
5836717|NCT02349295|20175769|P14|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
5836718|NCT02349295|20175770|P13|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
5836719|NCT02349295|20175771|P12|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
5836720|NCT02349295|20175772|P11|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
5836721|NCT02349295|20175773|P10|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
5836722|NCT02349295|20175774|P9|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
5836723|NCT02349295|20175775|P8|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
5836724|NCT02349295|20175776|P7|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
5836725|NCT02349295|20175777|P6|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
5836726|NCT02349295|20175778|P5|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
5836727|NCT02349295|20175779|P4|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
5836728|NCT02349295|20175780|P3|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|7
5836729|NCT02349295|20175781|P2|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2
5836730|NCT02349295|20175782|P1|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2
5836731|NCT02349295|20175769|P14|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
5836732|NCT02349295|20175770|P13|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
5836733|NCT02349295|20175771|P12|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
5836734|NCT02349295|20175772|P11|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
5836735|NCT02349295|20175773|P10|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
5836736|NCT02349295|20175774|P9|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
5836737|NCT02349295|20175775|P8|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
5836738|NCT02349295|20175776|P7|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
5836739|NCT02349295|20175777|P6|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
5836740|NCT02349295|20175778|P5|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
5836741|NCT02349295|20175779|P4|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
5836742|NCT02349295|20175780|P3|Double Blind Treatment (Week 0-24)|Lack of Efficacy|9
5836743|NCT02349295|20175781|P2|Double Blind Treatment (Week 0-24)|Lack of Efficacy|2
5836744|NCT02349295|20175782|P1|Double Blind Treatment (Week 0-24)|Lack of Efficacy|4
5836745|NCT02349295|20175769|P14|Double Blind Treatment (Week 0-24)|Adverse Event|0
5836746|NCT02349295|20175770|P13|Double Blind Treatment (Week 0-24)|Adverse Event|0
5836747|NCT02349295|20175771|P12|Double Blind Treatment (Week 0-24)|Adverse Event|0
5836748|NCT02349295|20175772|P11|Double Blind Treatment (Week 0-24)|Adverse Event|0
5836749|NCT02349295|20175773|P10|Double Blind Treatment (Week 0-24)|Adverse Event|0
5836750|NCT02349295|20175774|P9|Double Blind Treatment (Week 0-24)|Adverse Event|0
5836751|NCT02349295|20175775|P8|Double Blind Treatment (Week 0-24)|Adverse Event|0
5836752|NCT02349295|20175776|P7|Double Blind Treatment (Week 0-24)|Adverse Event|0
5836753|NCT02349295|20175777|P6|Double Blind Treatment (Week 0-24)|Adverse Event|0
5836754|NCT02349295|20175778|P5|Double Blind Treatment (Week 0-24)|Adverse Event|0
5836755|NCT02349295|20175779|P4|Double Blind Treatment (Week 0-24)|Adverse Event|0
5836756|NCT02349295|20175780|P3|Double Blind Treatment (Week 0-24)|Adverse Event|5
5836757|NCT02349295|20175781|P2|Double Blind Treatment (Week 0-24)|Adverse Event|5
5836758|NCT02349295|20175782|P1|Double Blind Treatment (Week 0-24)|Adverse Event|7
5836759|NCT02349061|20175922|P3|Study Extension (Week 56 to Week 120)|Physician Decision|1
5836760|NCT02349061|20175923|P2|Study Extension (Week 56 to Week 120)|Physician Decision|0
5836761|NCT02349061|20175924|P1|Study Extension (Week 56 to Week 120)|Physician Decision|0
5836762|NCT02349061|20175922|P3|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|1
5836763|NCT02349061|20175923|P2|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|2
5836764|NCT02349061|20175924|P1|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|0
5836765|NCT02349061|20175922|P3|Study Extension (Week 56 to Week 120)|Lack of Efficacy|1
5836766|NCT02349061|20175923|P2|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0
5836767|NCT02349061|20175924|P1|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0
5836768|NCT02349061|20175922|P3|Study Extension (Week 56 to Week 120)|Adverse Event|0
5836769|NCT02349061|20175923|P2|Study Extension (Week 56 to Week 120)|Adverse Event|3
5836770|NCT02349061|20175924|P1|Study Extension (Week 56 to Week 120)|Adverse Event|0
5836771|NCT02349061|20175922|P3|Main Study: Week 24 to 56|Physician Decision|1
5836772|NCT02349061|20175923|P2|Main Study: Week 24 to 56|Physician Decision|0
5836773|NCT02349061|20175924|P1|Main Study: Week 24 to 56|Physician Decision|0
5836774|NCT02349061|20175922|P3|Main Study: Week 24 to 56|Withdrawal by Subject|1
5836775|NCT02349061|20175923|P2|Main Study: Week 24 to 56|Withdrawal by Subject|0
5836776|NCT02349061|20175924|P1|Main Study: Week 24 to 56|Withdrawal by Subject|0
5836777|NCT02349061|20175922|P3|Main Study: Week 24 to 56|Lack of Efficacy|0
5836778|NCT02349061|20175923|P2|Main Study: Week 24 to 56|Lack of Efficacy|1
5836779|NCT02349061|20175924|P1|Main Study: Week 24 to 56|Lack of Efficacy|0
5836780|NCT02349061|20175922|P3|Main Study: Week 24 to 56|Adverse Event|1
5836781|NCT02349061|20175923|P2|Main Study: Week 24 to 56|Adverse Event|2
5836782|NCT02349061|20175924|P1|Main Study: Week 24 to 56|Adverse Event|0
5836783|NCT02349061|20175922|P3|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0
5836784|NCT02349061|20175923|P2|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0
5836785|NCT02349061|20175924|P1|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|2
5836786|NCT02349061|20175922|P3|Main Study: PCP (Up to Week 24)|Other|0
5836787|NCT02349061|20175923|P2|Main Study: PCP (Up to Week 24)|Other|1
5836788|NCT02349061|20175924|P1|Main Study: PCP (Up to Week 24)|Other|1
5836789|NCT02349061|20175922|P3|Main Study: PCP (Up to Week 24)|Physician Decision|0
5836790|NCT02349061|20175923|P2|Main Study: PCP (Up to Week 24)|Physician Decision|0
5836791|NCT02349061|20175924|P1|Main Study: PCP (Up to Week 24)|Physician Decision|1
5836792|NCT02349061|20175922|P3|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0
5836793|NCT02349061|20175923|P2|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0
5836794|NCT02349061|20175924|P1|Main Study: PCP (Up to Week 24)|Lack of Efficacy|1
5836795|NCT02349061|20175922|P3|Main Study: PCP (Up to Week 24)|Adverse Event|0
5836796|NCT02349061|20175923|P2|Main Study: PCP (Up to Week 24)|Adverse Event|3
5836797|NCT02349061|20175924|P1|Main Study: PCP (Up to Week 24)|Adverse Event|4
5836798|NCT02349048|20175944|P2|Overall Study|Lost to Follow-up|0
5836799|NCT02349048|20175945|P1|Overall Study|Lost to Follow-up|1
5836800|NCT02349048|20175944|P2|Overall Study|Withdrawal by Subject|0
5836801|NCT02349048|20175945|P1|Overall Study|Withdrawal by Subject|4
5836802|NCT02348840|20176006|P4|Overall Study|Withdrawal by Subject|0
5836803|NCT02348840|20176007|P3|Overall Study|Withdrawal by Subject|0
5836804|NCT02348840|20176008|P2|Overall Study|Withdrawal by Subject|1
5836805|NCT02348840|20176009|P1|Overall Study|Withdrawal by Subject|2
5836806|NCT02348723|20176023|P2|Overall Study|Adverse Event|1
5836807|NCT02348723|20176024|P1|Overall Study|Adverse Event|3
5836808|NCT02348723|20176023|P2|Overall Study|Reason other than specified|1
5836809|NCT02348723|20176024|P1|Overall Study|Reason other than specified|1
5836810|NCT02348723|20176023|P2|Overall Study|Consent withdrawn|3
5836811|NCT02348723|20176024|P1|Overall Study|Consent withdrawn|1
5836812|NCT02348723|20176023|P2|Overall Study|Lost to Follow-up|1
5836813|NCT02348723|20176024|P1|Overall Study|Lost to Follow-up|1
5836814|NCT02348723|20176023|P2|Overall Study|Non-compliant with Protocol|0
5836815|NCT02348723|20176024|P1|Overall Study|Non-compliant with Protocol|1
5836816|NCT02348723|20176023|P2|Overall Study|No ablation|20
5836817|NCT02348723|20176024|P1|Overall Study|No ablation|21
5836818|NCT02348489|20176213|P2|Overall Study|Lost to Follow-up|5
5836819|NCT02348489|20176214|P1|Overall Study|Lost to Follow-up|3
5836820|NCT02348489|20176213|P2|Overall Study|Withdrawal by Subject|27
5836821|NCT02348489|20176214|P1|Overall Study|Withdrawal by Subject|14
5836822|NCT02348489|20176213|P2|Overall Study|Death|335
5836823|NCT02348489|20176214|P1|Overall Study|Death|336
5836824|NCT02348008|20176275|P3|Overall Study|Symptomatic Deterioration|0
5836825|NCT02348008|20176276|P2|Overall Study|Symptomatic Deterioration|1
5836826|NCT02348008|20176277|P1|Overall Study|Symptomatic Deterioration|0
5836827|NCT02348008|20176275|P3|Overall Study|Withdrawal by Subject|0
5836828|NCT02348008|20176276|P2|Overall Study|Withdrawal by Subject|1
5836829|NCT02348008|20176277|P1|Overall Study|Withdrawal by Subject|0
5836830|NCT02348008|20176275|P3|Overall Study|Disease Progression|16
5836831|NCT02348008|20176276|P2|Overall Study|Disease Progression|5
5836832|NCT02348008|20176277|P1|Overall Study|Disease Progression|1
5836833|NCT02348008|20176275|P3|Overall Study|Adverse Event|3
5836834|NCT02348008|20176276|P2|Overall Study|Adverse Event|3
5836835|NCT02348008|20176277|P1|Overall Study|Adverse Event|2
5836836|NCT02347943|20176293|P3|Overall Study|Study was cancelled|45
5836837|NCT02347943|20176294|P2|Overall Study|Study was cancelled|67
5836838|NCT02347943|20176295|P1|Overall Study|Study was cancelled|140
5836839|NCT02347813|20176305|P2|First Intervention, 24 Weeks|Adverse Event|1
5836840|NCT02347813|20176306|P1|First Intervention, 24 Weeks|Adverse Event|1
5836841|NCT02347813|20176305|P2|First Intervention, 24 Weeks|Withdrawal by Subject|1
5836842|NCT02347813|20176306|P1|First Intervention, 24 Weeks|Withdrawal by Subject|1
5836843|NCT02347787|20176316|P2|9 Month Follow-Up|Withdrawal by Subject|12
5836844|NCT02347787|20176317|P1|9 Month Follow-Up|Withdrawal by Subject|9
5836845|NCT02347787|20176316|P2|9 Month Follow-Up|Lost to Follow-up|59
5836846|NCT02347787|20176317|P1|9 Month Follow-Up|Lost to Follow-up|52
5836847|NCT02347787|20176316|P2|6 Month Follow-Up|Withdrawal by Subject|9
5836848|NCT02347787|20176317|P1|6 Month Follow-Up|Withdrawal by Subject|3
5836849|NCT02347787|20176316|P2|6 Month Follow-Up|Lost to Follow-up|47
5836850|NCT02347787|20176317|P1|6 Month Follow-Up|Lost to Follow-up|63
5836851|NCT02347774|20176379|P3|On Study Treatment|ranomized in error|1
5836852|NCT02347774|20176380|P2|On Study Treatment|ranomized in error|0
5836853|NCT02347774|20176381|P1|On Study Treatment|ranomized in error|0
5836854|NCT02347774|20176379|P3|On Study Treatment|Met Prolonged QT criteria|0
5836855|NCT02347774|20176380|P2|On Study Treatment|Met Prolonged QT criteria|0
5836856|NCT02347774|20176381|P1|On Study Treatment|Met Prolonged QT criteria|1
5836857|NCT02347774|20176379|P3|On Study Treatment|Lost to Follow-up|1
5836858|NCT02347774|20176380|P2|On Study Treatment|Lost to Follow-up|6
5836859|NCT02347774|20176381|P1|On Study Treatment|Lost to Follow-up|2
5836860|NCT02347774|20176379|P3|On Study Treatment|withdrew consent|12
5836861|NCT02347774|20176380|P2|On Study Treatment|withdrew consent|8
5836862|NCT02347774|20176381|P1|On Study Treatment|withdrew consent|9
5836863|NCT02347774|20176379|P3|On Study Treatment|Protocol Violation|1
5836864|NCT02347774|20176380|P2|On Study Treatment|Protocol Violation|0
5836865|NCT02347774|20176381|P1|On Study Treatment|Protocol Violation|0
5836866|NCT02347774|20176379|P3|On Study Treatment|non-complicance with study medication|0
5836867|NCT02347774|20176380|P2|On Study Treatment|non-complicance with study medication|2
5836868|NCT02347774|20176381|P1|On Study Treatment|non-complicance with study medication|0
5836869|NCT02347774|20176379|P3|On Study Treatment|Lack of Efficacy|2
5836870|NCT02347774|20176380|P2|On Study Treatment|Lack of Efficacy|0
5836871|NCT02347774|20176381|P1|On Study Treatment|Lack of Efficacy|3
5836872|NCT02347774|20176379|P3|On Study Treatment|Adverse Event|19
5836873|NCT02347774|20176380|P2|On Study Treatment|Adverse Event|15
5836874|NCT02347774|20176381|P1|On Study Treatment|Adverse Event|9
5836875|NCT02347774|20176379|P3|Study Participation|randomized in error|1
5836876|NCT02347774|20176380|P2|Study Participation|randomized in error|0
5836877|NCT02347774|20176381|P1|Study Participation|randomized in error|0
5836878|NCT02347774|20176379|P3|Study Participation|incarceration|0
5836879|NCT02347774|20176380|P2|Study Participation|incarceration|0
5836880|NCT02347774|20176381|P1|Study Participation|incarceration|1
5836881|NCT02347774|20176379|P3|Study Participation|non-compliance with study drug|0
5836882|NCT02347774|20176380|P2|Study Participation|non-compliance with study drug|1
5836883|NCT02347774|20176381|P1|Study Participation|non-compliance with study drug|0
5836884|NCT02347774|20176379|P3|Study Participation|Met Prolonged QT criteria|0
5836885|NCT02347774|20176380|P2|Study Participation|Met Prolonged QT criteria|0
5836886|NCT02347774|20176381|P1|Study Participation|Met Prolonged QT criteria|1
5836887|NCT02347774|20176379|P3|Study Participation|withdrew consent|1
5836888|NCT02347774|20176380|P2|Study Participation|withdrew consent|1
5836889|NCT02347774|20176381|P1|Study Participation|withdrew consent|1
5836890|NCT02347774|20176379|P3|Study Participation|Adverse Event|6
5836891|NCT02347774|20176380|P2|Study Participation|Adverse Event|4
5836892|NCT02347774|20176381|P1|Study Participation|Adverse Event|1
5836893|NCT02347774|20176379|P3|Study Participation|Withdrawal by Subject|15
5836894|NCT02347774|20176380|P2|Study Participation|Withdrawal by Subject|9
5836895|NCT02347774|20176381|P1|Study Participation|Withdrawal by Subject|8
5836896|NCT02347774|20176379|P3|Study Participation|Lost to Follow-up|2
5836897|NCT02347774|20176380|P2|Study Participation|Lost to Follow-up|6
5836898|NCT02347774|20176381|P1|Study Participation|Lost to Follow-up|3
5836899|NCT02347761|20176437|P3|On Study Treatment|Adverse Event|20
5836900|NCT02347761|20176438|P2|On Study Treatment|Adverse Event|8
5836901|NCT02347761|20176439|P1|On Study Treatment|Adverse Event|10
5836902|NCT02347761|20176437|P3|On Study Treatment|durg not working|1
5836903|NCT02347761|20176438|P2|On Study Treatment|durg not working|1
5836904|NCT02347761|20176439|P1|On Study Treatment|durg not working|0
5836905|NCT02347761|20176437|P3|On Study Treatment|investigator discretion|0
5836906|NCT02347761|20176438|P2|On Study Treatment|investigator discretion|0
5836907|NCT02347761|20176439|P1|On Study Treatment|investigator discretion|2
5836908|NCT02347761|20176437|P3|On Study Treatment|Lost to Follow-up|1
5836909|NCT02347761|20176438|P2|On Study Treatment|Lost to Follow-up|1
5836910|NCT02347761|20176439|P1|On Study Treatment|Lost to Follow-up|2
5836911|NCT02347761|20176437|P3|On Study Treatment|dissastisfaction with device|4
5836912|NCT02347761|20176438|P2|On Study Treatment|dissastisfaction with device|1
5836913|NCT02347761|20176439|P1|On Study Treatment|dissastisfaction with device|2
5836914|NCT02347761|20176437|P3|On Study Treatment|move/travel|5
5836915|NCT02347761|20176438|P2|On Study Treatment|move/travel|6
5836916|NCT02347761|20176439|P1|On Study Treatment|move/travel|2
5836917|NCT02347761|20176437|P3|On Study Treatment|Withdrawal by Subject|5
5836918|NCT02347761|20176438|P2|On Study Treatment|Withdrawal by Subject|3
5836919|NCT02347761|20176439|P1|On Study Treatment|Withdrawal by Subject|7
5836920|NCT02347761|20176437|P3|On Study Treatment|non-compliance with study medication|2
5836921|NCT02347761|20176438|P2|On Study Treatment|non-compliance with study medication|0
5836922|NCT02347761|20176439|P1|On Study Treatment|non-compliance with study medication|0
5836923|NCT02347761|20176437|P3|On Study Treatment|Lack of Efficacy|4
5836924|NCT02347761|20176438|P2|On Study Treatment|Lack of Efficacy|3
5836925|NCT02347761|20176439|P1|On Study Treatment|Lack of Efficacy|2
5836926|NCT02347761|20176437|P3|All Collected|moved/travel|0
5836927|NCT02347761|20176438|P2|All Collected|moved/travel|1
5836928|NCT02347761|20176439|P1|All Collected|moved/travel|0
5836929|NCT02347761|20176437|P3|All Collected|exacerbation of COPD|1
5836930|NCT02347761|20176438|P2|All Collected|exacerbation of COPD|0
5836931|NCT02347761|20176439|P1|All Collected|exacerbation of COPD|0
5836932|NCT02347761|20176437|P3|All Collected|instillation site pain|1
5836933|NCT02347761|20176438|P2|All Collected|instillation site pain|0
5836934|NCT02347761|20176439|P1|All Collected|instillation site pain|0
5836935|NCT02347761|20176437|P3|All Collected|invetigator disretion|0
5836936|NCT02347761|20176438|P2|All Collected|invetigator disretion|0
5836937|NCT02347761|20176439|P1|All Collected|invetigator disretion|2
5836938|NCT02347761|20176437|P3|All Collected|Withdrawal by Subject|22
5836939|NCT02347761|20176438|P2|All Collected|Withdrawal by Subject|11
5836940|NCT02347761|20176439|P1|All Collected|Withdrawal by Subject|11
5836941|NCT02347761|20176437|P3|All Collected|Lost to Follow-up|3
5836942|NCT02347761|20176438|P2|All Collected|Lost to Follow-up|2
5836943|NCT02347761|20176439|P1|All Collected|Lost to Follow-up|3
5836944|NCT02347761|20176437|P3|All Collected|Death|0
5836945|NCT02347761|20176438|P2|All Collected|Death|0
5836946|NCT02347761|20176439|P1|All Collected|Death|1
5836947|NCT02347657|20176500|P2|Overall Study|Other|3
5836948|NCT02347657|20176501|P1|Overall Study|Other|3
5836949|NCT02347657|20176500|P2|Overall Study|Randomized but not treated|0
5836950|NCT02347657|20176501|P1|Overall Study|Randomized but not treated|1
5836951|NCT02347657|20176500|P2|Overall Study|Withdrawal by Subject|7
5836952|NCT02347657|20176501|P1|Overall Study|Withdrawal by Subject|6
5836953|NCT02347657|20176500|P2|Overall Study|Adverse Event|4
5836954|NCT02347657|20176501|P1|Overall Study|Adverse Event|8
5836955|NCT02347657|20176500|P2|Overall Study|Physician Decision|1
5836956|NCT02347657|20176501|P1|Overall Study|Physician Decision|0
5836957|NCT02347631|20176528|P2|Second Intervention (2 Months)|Withdrawal by Subject|0
5836958|NCT02347631|20176529|P1|Second Intervention (2 Months)|Withdrawal by Subject|6
5836959|NCT02347631|20176528|P2|Second Intervention (2 Months)|Lost to Follow-up|4
5836960|NCT02347631|20176529|P1|Second Intervention (2 Months)|Lost to Follow-up|7
5836961|NCT02347631|20176528|P2|Washout 2 (1 Month)|Lost to Follow-up|1
5836962|NCT02347631|20176529|P1|Washout 2 (1 Month)|Lost to Follow-up|0
5836963|NCT02347631|20176528|P2|Washout 2 (1 Month)|Withdrawal by Subject|2
5836964|NCT02347631|20176529|P1|Washout 2 (1 Month)|Withdrawal by Subject|2
5836965|NCT02347631|20176528|P2|First Intervention (2 Months)|Lost to Follow-up|3
5836966|NCT02347631|20176529|P1|First Intervention (2 Months)|Lost to Follow-up|5
5836967|NCT02347631|20176528|P2|First Intervention (2 Months)|Moved out of area|2
5836968|NCT02347631|20176529|P1|First Intervention (2 Months)|Moved out of area|0
5836969|NCT02347631|20176528|P2|First Intervention (2 Months)|Pregnancy|0
5836970|NCT02347631|20176529|P1|First Intervention (2 Months)|Pregnancy|1
5836971|NCT02347631|20176528|P2|First Intervention (2 Months)|Adverse Event|1
5836972|NCT02347631|20176529|P1|First Intervention (2 Months)|Adverse Event|1
5836973|NCT02347332|20176590|P2|Overall Study|Switch Post-Trial program|1
5836974|NCT02347332|20176591|P1|Overall Study|Switch Post-Trial program|0
5836975|NCT02347332|20176590|P2|Overall Study|Protocol requirement|1
5836976|NCT02347332|20176591|P1|Overall Study|Protocol requirement|1
5836977|NCT02347332|20176590|P2|Overall Study|Withdrawal by Subject|14
5836978|NCT02347332|20176591|P1|Overall Study|Withdrawal by Subject|20
5836979|NCT02347332|20176590|P2|Overall Study|Physician Decision|3
5836980|NCT02347332|20176591|P1|Overall Study|Physician Decision|4
5836981|NCT02347332|20176590|P2|Overall Study|Lost to Follow-up|1
5836982|NCT02347332|20176591|P1|Overall Study|Lost to Follow-up|2
5836983|NCT02347332|20176590|P2|Overall Study|Protocol Violation|1
5836984|NCT02347332|20176591|P1|Overall Study|Protocol Violation|1
5836985|NCT02347332|20176590|P2|Overall Study|Death (Unknown, Various reasons)|6
5836986|NCT02347332|20176591|P1|Overall Study|Death (Unknown, Various reasons)|6
5836987|NCT02347332|20176590|P2|Overall Study|Adverse Event|41
5836988|NCT02347332|20176591|P1|Overall Study|Adverse Event|50
5836989|NCT02347332|20176590|P2|Overall Study|Progressive disease|159
5836990|NCT02347332|20176591|P1|Overall Study|Progressive disease|141
5836991|NCT02347332|20176590|P2|Overall Study|Not treated|2
5836992|NCT02347332|20176591|P1|Overall Study|Not treated|5
5836993|NCT02347189|20176605|P1|Overall Study|No primary outcome data available|2
5836994|NCT02347189|20176605|P1|Overall Study|No implant attempted of study device|9
5836995|NCT02347176|20176624|P4|Overall Study|Other|0
5836996|NCT02347176|20176625|P3|Overall Study|Other|2
5836997|NCT02347176|20176626|P2|Overall Study|Other|2
5836998|NCT02347176|20176627|P1|Overall Study|Other|1
5836999|NCT02347176|20176624|P4|Overall Study|Withdrawal by Subject|3
5837000|NCT02347176|20176625|P3|Overall Study|Withdrawal by Subject|5
5837001|NCT02347176|20176626|P2|Overall Study|Withdrawal by Subject|5
5837002|NCT02347176|20176627|P1|Overall Study|Withdrawal by Subject|9
5837003|NCT02347176|20176624|P4|Overall Study|Lost to Follow-up|1
5837004|NCT02347176|20176625|P3|Overall Study|Lost to Follow-up|1
5837005|NCT02347176|20176626|P2|Overall Study|Lost to Follow-up|3
5837006|NCT02347176|20176627|P1|Overall Study|Lost to Follow-up|2
5837007|NCT02347098|20176712|P2|Overall Study|no visit due to illness|1
5837008|NCT02347098|20176713|P1|Overall Study|no visit due to illness|2
5837009|NCT02347098|20176712|P2|Overall Study|Refuse Follow-up Visit|5
5837010|NCT02347098|20176713|P1|Overall Study|Refuse Follow-up Visit|1
5837011|NCT02347098|20176712|P2|Overall Study|Lost to Follow-up|2
5837012|NCT02347098|20176713|P1|Overall Study|Lost to Follow-up|2
5837013|NCT02347098|20176712|P2|Overall Study|Withdrawal by Subject|0
5837014|NCT02347098|20176713|P1|Overall Study|Withdrawal by Subject|1
5837015|NCT02347098|20176712|P2|Overall Study|Death|0
5837016|NCT02347098|20176713|P1|Overall Study|Death|1
5837017|NCT02347085|20176725|P1|Overall Study|Protocol Criteria|2
5837018|NCT02347085|20176725|P1|Overall Study|Lost to Follow-up|1
5837019|NCT02347085|20176725|P1|Overall Study|Withdrawal by Subject|4
5837020|NCT02347085|20176725|P1|Overall Study|Lack of Efficacy|1
5837021|NCT02347085|20176725|P1|Overall Study|Adverse Event|2
5837022|NCT02347072|20176747|P1|Overall Study|Disc due to Protocol-specified Criteria|6
5837023|NCT02347072|20176747|P1|Overall Study|Protocol Violation|1
5837024|NCT02347072|20176747|P1|Overall Study|Lost to Follow-up|2
5837025|NCT02347072|20176747|P1|Overall Study|Physician Decision|1
5837026|NCT02347072|20176747|P1|Overall Study|Withdrawal by Subject|6
5837027|NCT02347072|20176747|P1|Overall Study|Adverse Event|2
5837028|NCT02346877|20176781|P2|Overall Study|Missing|0
5837029|NCT02346877|20176782|P1|Overall Study|Missing|5
5837030|NCT02346877|20176781|P2|Overall Study|Sponsor Decision|0
5837031|NCT02346877|20176782|P1|Overall Study|Sponsor Decision|12
5837032|NCT02346877|20176781|P2|Overall Study|Administrative Decision|0
5837033|NCT02346877|20176782|P1|Overall Study|Administrative Decision|1
5837034|NCT02346877|20176781|P2|Overall Study|Adverse Event|0
5837035|NCT02346877|20176782|P1|Overall Study|Adverse Event|1
5837036|NCT02346721|20176792|P1|Overall Study|Lack of Efficacy|1
5837037|NCT02346721|20176792|P1|Overall Study|Withdrew Consent|3
5837042|NCT02346370|20176842|P3|Overall Study|Physician Decision|0
5837043|NCT02346370|20176843|P2|Overall Study|Physician Decision|1
5837044|NCT02346370|20176844|P1|Overall Study|Physician Decision|0
5837045|NCT02346370|20176842|P3|Overall Study|Radiologic progression|1
5837046|NCT02346370|20176843|P2|Overall Study|Radiologic progression|0
5837047|NCT02346370|20176844|P1|Overall Study|Radiologic progression|0
5837048|NCT02346370|20176842|P3|Overall Study|Sponsor discontinued study|2
5837049|NCT02346370|20176843|P2|Overall Study|Sponsor discontinued study|0
5837050|NCT02346370|20176844|P1|Overall Study|Sponsor discontinued study|5
5837051|NCT02346370|20176842|P3|Overall Study|Death|1
5837052|NCT02346370|20176843|P2|Overall Study|Death|3
5837053|NCT02346370|20176844|P1|Overall Study|Death|1
5837054|NCT02346370|20176842|P3|Overall Study|Withdrawal of consent|0
5837055|NCT02346370|20176843|P2|Overall Study|Withdrawal of consent|0
5837056|NCT02346370|20176844|P1|Overall Study|Withdrawal of consent|1
5837057|NCT02346370|20176842|P3|Overall Study|Not treated|0
5837058|NCT02346370|20176843|P2|Overall Study|Not treated|0
5837059|NCT02346370|20176844|P1|Overall Study|Not treated|1
5837060|NCT02346240|20176893|P24|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
5837061|NCT02346240|20176894|P23|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
5837062|NCT02346240|20176895|P22|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
5837063|NCT02346240|20176896|P21|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
5837064|NCT02346240|20176897|P20|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
5837065|NCT02346240|20176898|P19|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|1
5837066|NCT02346240|20176899|P18|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
5837067|NCT02346240|20176900|P17|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
5837068|NCT02346240|20176901|P16|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
5837069|NCT02346240|20176902|P15|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
5837070|NCT02346240|20176903|P14|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
5837071|NCT02346240|20176904|P13|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
5837072|NCT02346240|20176905|P12|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
5837073|NCT02346240|20176906|P11|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
5837074|NCT02346240|20176907|P10|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
5837075|NCT02346240|20176908|P9|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
5837076|NCT02346240|20176909|P8|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
5837077|NCT02346240|20176910|P7|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
5837078|NCT02346240|20176911|P6|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
5837079|NCT02346240|20176912|P5|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
5837080|NCT02346240|20176913|P4|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
5837081|NCT02346240|20176914|P3|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
5837082|NCT02346240|20176915|P2|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
5837083|NCT02346240|20176916|P1|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
5837084|NCT02346240|20176893|P24|Open-Label Period (Week 48 to Week 144)|No PASI50 response|3
5837085|NCT02346240|20176894|P23|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2
5837086|NCT02346240|20176895|P22|Open-Label Period (Week 48 to Week 144)|No PASI50 response|4
5837087|NCT02346240|20176896|P21|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
5837088|NCT02346240|20176897|P20|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
5837089|NCT02346240|20176898|P19|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2
5837090|NCT02346240|20176899|P18|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
5837091|NCT02346240|20176900|P17|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
5837092|NCT02346240|20176901|P16|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
5837093|NCT02346240|20176902|P15|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
5837094|NCT02346240|20176903|P14|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
5837095|NCT02346240|20176904|P13|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
5837096|NCT02346240|20176905|P12|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
5837097|NCT02346240|20176906|P11|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
5837098|NCT02346240|20176907|P10|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
5837099|NCT02346240|20176908|P9|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
5837100|NCT02346240|20176909|P8|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
5837101|NCT02346240|20176910|P7|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
5837102|NCT02346240|20176911|P6|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
5837716|NCT02345889|20176994|P2|Overall Study|Cecum not intubated|0
5837103|NCT02346240|20176912|P5|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
5837104|NCT02346240|20176913|P4|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
5837105|NCT02346240|20176914|P3|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
5837106|NCT02346240|20176915|P2|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
5837107|NCT02346240|20176916|P1|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
5837108|NCT02346240|20176893|P24|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1
5837109|NCT02346240|20176894|P23|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1
5837110|NCT02346240|20176895|P22|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|10
5837111|NCT02346240|20176896|P21|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
5837112|NCT02346240|20176897|P20|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1
5837113|NCT02346240|20176898|P19|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|4
5837114|NCT02346240|20176899|P18|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
5837115|NCT02346240|20176900|P17|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
5837116|NCT02346240|20176901|P16|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
5837117|NCT02346240|20176902|P15|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
5837118|NCT02346240|20176903|P14|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
5837119|NCT02346240|20176904|P13|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
5837120|NCT02346240|20176905|P12|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
5837121|NCT02346240|20176906|P11|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
5837122|NCT02346240|20176907|P10|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
5837123|NCT02346240|20176908|P9|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
5837124|NCT02346240|20176909|P8|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
5837125|NCT02346240|20176910|P7|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
5837126|NCT02346240|20176911|P6|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
5837127|NCT02346240|20176912|P5|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
5837128|NCT02346240|20176913|P4|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
5837129|NCT02346240|20176914|P3|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
5837130|NCT02346240|20176915|P2|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
5837131|NCT02346240|20176916|P1|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
5837132|NCT02346240|20176893|P24|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1
5837133|NCT02346240|20176894|P23|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1
5837134|NCT02346240|20176895|P22|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1
5837135|NCT02346240|20176896|P21|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
5837136|NCT02346240|20176897|P20|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|3
5837137|NCT02346240|20176898|P19|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2
5837138|NCT02346240|20176899|P18|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2
5837139|NCT02346240|20176900|P17|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
5837140|NCT02346240|20176901|P16|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
5837141|NCT02346240|20176902|P15|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
5837142|NCT02346240|20176903|P14|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
5837143|NCT02346240|20176904|P13|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
5837144|NCT02346240|20176905|P12|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
5837145|NCT02346240|20176906|P11|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
5837146|NCT02346240|20176907|P10|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
5837147|NCT02346240|20176908|P9|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
5837148|NCT02346240|20176909|P8|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
5837149|NCT02346240|20176910|P7|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
5837150|NCT02346240|20176911|P6|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
5837151|NCT02346240|20176912|P5|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
5837152|NCT02346240|20176913|P4|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
5837153|NCT02346240|20176914|P3|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
5837154|NCT02346240|20176915|P2|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
5837155|NCT02346240|20176916|P1|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
5837156|NCT02346240|20176893|P24|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
5837157|NCT02346240|20176894|P23|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
5837158|NCT02346240|20176895|P22|Open-Label Period (Week 48 to Week 144)|Protocol Violation|1
5837159|NCT02346240|20176896|P21|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
5837160|NCT02346240|20176897|P20|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
5837161|NCT02346240|20176898|P19|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
5837162|NCT02346240|20176899|P18|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
5837163|NCT02346240|20176900|P17|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
5837164|NCT02346240|20176901|P16|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
5837165|NCT02346240|20176902|P15|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
5837166|NCT02346240|20176903|P14|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
5837167|NCT02346240|20176904|P13|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
5837168|NCT02346240|20176905|P12|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
5837169|NCT02346240|20176906|P11|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
5837170|NCT02346240|20176907|P10|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
5837171|NCT02346240|20176908|P9|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
5837172|NCT02346240|20176909|P8|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
5837173|NCT02346240|20176910|P7|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
5837174|NCT02346240|20176911|P6|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
5837175|NCT02346240|20176912|P5|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
5837176|NCT02346240|20176913|P4|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
5837177|NCT02346240|20176914|P3|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
5837178|NCT02346240|20176915|P2|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
5837179|NCT02346240|20176916|P1|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
5837180|NCT02346240|20176893|P24|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
5837181|NCT02346240|20176894|P23|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
5837182|NCT02346240|20176895|P22|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1
5837183|NCT02346240|20176896|P21|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
5837184|NCT02346240|20176897|P20|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
5837185|NCT02346240|20176898|P19|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1
5837186|NCT02346240|20176899|P18|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
5837187|NCT02346240|20176900|P17|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
5837188|NCT02346240|20176901|P16|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
5837189|NCT02346240|20176902|P15|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
5837190|NCT02346240|20176903|P14|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
5837191|NCT02346240|20176904|P13|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
5837192|NCT02346240|20176905|P12|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
5837193|NCT02346240|20176906|P11|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
5837194|NCT02346240|20176907|P10|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
5837195|NCT02346240|20176908|P9|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
5837196|NCT02346240|20176909|P8|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
5837197|NCT02346240|20176910|P7|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
5837198|NCT02346240|20176911|P6|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
5837199|NCT02346240|20176912|P5|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
5837200|NCT02346240|20176913|P4|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
5837201|NCT02346240|20176914|P3|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
5837202|NCT02346240|20176915|P2|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
5837203|NCT02346240|20176916|P1|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
5837204|NCT02346240|20176893|P24|Open-Label Period (Week 48 to Week 144)|Death|0
5837205|NCT02346240|20176894|P23|Open-Label Period (Week 48 to Week 144)|Death|0
5837206|NCT02346240|20176895|P22|Open-Label Period (Week 48 to Week 144)|Death|1
5837207|NCT02346240|20176896|P21|Open-Label Period (Week 48 to Week 144)|Death|0
5837208|NCT02346240|20176897|P20|Open-Label Period (Week 48 to Week 144)|Death|1
5837209|NCT02346240|20176898|P19|Open-Label Period (Week 48 to Week 144)|Death|1
5837210|NCT02346240|20176899|P18|Open-Label Period (Week 48 to Week 144)|Death|0
5837211|NCT02346240|20176900|P17|Open-Label Period (Week 48 to Week 144)|Death|0
5837212|NCT02346240|20176901|P16|Open-Label Period (Week 48 to Week 144)|Death|0
5837213|NCT02346240|20176902|P15|Open-Label Period (Week 48 to Week 144)|Death|0
5837214|NCT02346240|20176903|P14|Open-Label Period (Week 48 to Week 144)|Death|0
5837215|NCT02346240|20176904|P13|Open-Label Period (Week 48 to Week 144)|Death|0
5837216|NCT02346240|20176905|P12|Open-Label Period (Week 48 to Week 144)|Death|0
5837217|NCT02346240|20176906|P11|Open-Label Period (Week 48 to Week 144)|Death|0
5837218|NCT02346240|20176907|P10|Open-Label Period (Week 48 to Week 144)|Death|0
5837219|NCT02346240|20176908|P9|Open-Label Period (Week 48 to Week 144)|Death|0
5837220|NCT02346240|20176909|P8|Open-Label Period (Week 48 to Week 144)|Death|0
5837221|NCT02346240|20176910|P7|Open-Label Period (Week 48 to Week 144)|Death|0
5837222|NCT02346240|20176911|P6|Open-Label Period (Week 48 to Week 144)|Death|0
5837223|NCT02346240|20176912|P5|Open-Label Period (Week 48 to Week 144)|Death|0
5837224|NCT02346240|20176913|P4|Open-Label Period (Week 48 to Week 144)|Death|0
5837225|NCT02346240|20176914|P3|Open-Label Period (Week 48 to Week 144)|Death|0
5837226|NCT02346240|20176915|P2|Open-Label Period (Week 48 to Week 144)|Death|0
5837227|NCT02346240|20176916|P1|Open-Label Period (Week 48 to Week 144)|Death|0
5837228|NCT02346240|20176893|P24|Open-Label Period (Week 48 to Week 144)|Adverse Event|3
5837229|NCT02346240|20176894|P23|Open-Label Period (Week 48 to Week 144)|Adverse Event|3
5837230|NCT02346240|20176895|P22|Open-Label Period (Week 48 to Week 144)|Adverse Event|13
5837231|NCT02346240|20176896|P21|Open-Label Period (Week 48 to Week 144)|Adverse Event|3
5837232|NCT02346240|20176897|P20|Open-Label Period (Week 48 to Week 144)|Adverse Event|2
5837233|NCT02346240|20176898|P19|Open-Label Period (Week 48 to Week 144)|Adverse Event|6
5837234|NCT02346240|20176899|P18|Open-Label Period (Week 48 to Week 144)|Adverse Event|1
5837235|NCT02346240|20176900|P17|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
5837236|NCT02346240|20176901|P16|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
5837237|NCT02346240|20176902|P15|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
5837238|NCT02346240|20176903|P14|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
5837239|NCT02346240|20176904|P13|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
5837240|NCT02346240|20176905|P12|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
5837241|NCT02346240|20176906|P11|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
5837242|NCT02346240|20176907|P10|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
5837243|NCT02346240|20176908|P9|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
5837244|NCT02346240|20176909|P8|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
5837245|NCT02346240|20176910|P7|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
5837246|NCT02346240|20176911|P6|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
5837247|NCT02346240|20176912|P5|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
5837248|NCT02346240|20176913|P4|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
5837249|NCT02346240|20176914|P3|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
5837250|NCT02346240|20176915|P2|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
5837251|NCT02346240|20176916|P1|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
5837252|NCT02346240|20176893|P24|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
5837253|NCT02346240|20176894|P23|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
5837254|NCT02346240|20176895|P22|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
5837255|NCT02346240|20176896|P21|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
5837256|NCT02346240|20176897|P20|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
5837257|NCT02346240|20176898|P19|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
5837258|NCT02346240|20176899|P18|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
5837259|NCT02346240|20176900|P17|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
5837260|NCT02346240|20176901|P16|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
5837261|NCT02346240|20176902|P15|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|1
5837262|NCT02346240|20176903|P14|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
5837263|NCT02346240|20176904|P13|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
5837264|NCT02346240|20176905|P12|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
5837265|NCT02346240|20176906|P11|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
5837266|NCT02346240|20176907|P10|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
5837267|NCT02346240|20176908|P9|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
5837268|NCT02346240|20176909|P8|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
5837269|NCT02346240|20176910|P7|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
5837270|NCT02346240|20176911|P6|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
5837271|NCT02346240|20176912|P5|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
5837272|NCT02346240|20176913|P4|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
5837273|NCT02346240|20176914|P3|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
5837274|NCT02346240|20176915|P2|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
5837275|NCT02346240|20176916|P1|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
5837276|NCT02346240|20176893|P24|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
5837277|NCT02346240|20176894|P23|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
5837278|NCT02346240|20176895|P22|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
5837279|NCT02346240|20176896|P21|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
5837280|NCT02346240|20176897|P20|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
5837281|NCT02346240|20176898|P19|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
5837282|NCT02346240|20176899|P18|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
5837283|NCT02346240|20176900|P17|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
5837284|NCT02346240|20176901|P16|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
5837285|NCT02346240|20176902|P15|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|1
5837286|NCT02346240|20176903|P14|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
5837287|NCT02346240|20176904|P13|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
5837288|NCT02346240|20176905|P12|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
5837289|NCT02346240|20176906|P11|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
5837290|NCT02346240|20176907|P10|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
5837291|NCT02346240|20176908|P9|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
5837292|NCT02346240|20176909|P8|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
5837293|NCT02346240|20176910|P7|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
5837294|NCT02346240|20176911|P6|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
5837295|NCT02346240|20176912|P5|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
5837296|NCT02346240|20176913|P4|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
5837297|NCT02346240|20176914|P3|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
5837298|NCT02346240|20176915|P2|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
5837299|NCT02346240|20176916|P1|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
5837300|NCT02346240|20176893|P24|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
5837301|NCT02346240|20176894|P23|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
5837302|NCT02346240|20176895|P22|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
5837303|NCT02346240|20176896|P21|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
5837304|NCT02346240|20176897|P20|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
5837305|NCT02346240|20176898|P19|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
5837306|NCT02346240|20176899|P18|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
5837307|NCT02346240|20176900|P17|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
5837308|NCT02346240|20176901|P16|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
5837309|NCT02346240|20176902|P15|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|1
5837310|NCT02346240|20176903|P14|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
5837311|NCT02346240|20176904|P13|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
5837312|NCT02346240|20176905|P12|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
5837313|NCT02346240|20176906|P11|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
5837314|NCT02346240|20176907|P10|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
5837315|NCT02346240|20176908|P9|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
5837316|NCT02346240|20176909|P8|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
5837317|NCT02346240|20176910|P7|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
5837318|NCT02346240|20176911|P6|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
5837319|NCT02346240|20176912|P5|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
5837320|NCT02346240|20176913|P4|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
5837321|NCT02346240|20176914|P3|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
5837322|NCT02346240|20176915|P2|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
5837323|NCT02346240|20176916|P1|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
5837324|NCT02346240|20176893|P24|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
5837325|NCT02346240|20176894|P23|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
5837326|NCT02346240|20176895|P22|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
5837327|NCT02346240|20176896|P21|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
5837328|NCT02346240|20176897|P20|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
5837329|NCT02346240|20176898|P19|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
5837330|NCT02346240|20176899|P18|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
5837331|NCT02346240|20176900|P17|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
5837332|NCT02346240|20176901|P16|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
5837333|NCT02346240|20176902|P15|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
5837334|NCT02346240|20176903|P14|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
5837335|NCT02346240|20176904|P13|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
5837336|NCT02346240|20176905|P12|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
5837337|NCT02346240|20176906|P11|Maintenance Period (Week 16 to Week 48)|Patient's decisions|1
5837338|NCT02346240|20176907|P10|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
5837339|NCT02346240|20176908|P9|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
5837340|NCT02346240|20176909|P8|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
5837341|NCT02346240|20176910|P7|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
5837342|NCT02346240|20176911|P6|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
5837343|NCT02346240|20176912|P5|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
5837344|NCT02346240|20176913|P4|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
5837345|NCT02346240|20176914|P3|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
5837346|NCT02346240|20176915|P2|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
5837347|NCT02346240|20176916|P1|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
5837348|NCT02346240|20176893|P24|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
5837349|NCT02346240|20176894|P23|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
5837350|NCT02346240|20176895|P22|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
5837351|NCT02346240|20176896|P21|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
5837352|NCT02346240|20176897|P20|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
5837353|NCT02346240|20176898|P19|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
5837354|NCT02346240|20176899|P18|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
5837355|NCT02346240|20176900|P17|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
5837356|NCT02346240|20176901|P16|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
5837357|NCT02346240|20176902|P15|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
5837358|NCT02346240|20176903|P14|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
5837359|NCT02346240|20176904|P13|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
5837360|NCT02346240|20176905|P12|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
5837361|NCT02346240|20176906|P11|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
5837362|NCT02346240|20176907|P10|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|1
5837363|NCT02346240|20176908|P9|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
5837364|NCT02346240|20176909|P8|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
5837365|NCT02346240|20176910|P7|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
5837366|NCT02346240|20176911|P6|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
5837367|NCT02346240|20176912|P5|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
5837368|NCT02346240|20176913|P4|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
5837369|NCT02346240|20176914|P3|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
5837717|NCT02345889|20176995|P1|Overall Study|Cecum not intubated|1
5837370|NCT02346240|20176915|P2|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
5837371|NCT02346240|20176916|P1|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
5837372|NCT02346240|20176893|P24|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
5837373|NCT02346240|20176894|P23|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
5837374|NCT02346240|20176895|P22|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
5837375|NCT02346240|20176896|P21|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
5837376|NCT02346240|20176897|P20|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
5837377|NCT02346240|20176898|P19|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
5837378|NCT02346240|20176899|P18|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
5837379|NCT02346240|20176900|P17|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
5837380|NCT02346240|20176901|P16|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
5837381|NCT02346240|20176902|P15|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1
5837382|NCT02346240|20176903|P14|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1
5837383|NCT02346240|20176904|P13|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
5837384|NCT02346240|20176905|P12|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1
5837385|NCT02346240|20176906|P11|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
5837386|NCT02346240|20176907|P10|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
5837387|NCT02346240|20176908|P9|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1
5837388|NCT02346240|20176909|P8|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
5837389|NCT02346240|20176910|P7|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
5837390|NCT02346240|20176911|P6|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
5837391|NCT02346240|20176912|P5|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
5837392|NCT02346240|20176913|P4|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
5837393|NCT02346240|20176914|P3|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
5837394|NCT02346240|20176915|P2|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
5837395|NCT02346240|20176916|P1|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
5837396|NCT02346240|20176893|P24|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
5837397|NCT02346240|20176894|P23|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
5837398|NCT02346240|20176895|P22|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
5837399|NCT02346240|20176896|P21|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
5837400|NCT02346240|20176897|P20|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
5837401|NCT02346240|20176898|P19|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
5837402|NCT02346240|20176899|P18|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
5837403|NCT02346240|20176900|P17|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
5837404|NCT02346240|20176901|P16|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
5837405|NCT02346240|20176902|P15|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
5837406|NCT02346240|20176903|P14|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
5837407|NCT02346240|20176904|P13|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
5837408|NCT02346240|20176905|P12|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
5837409|NCT02346240|20176906|P11|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
5837410|NCT02346240|20176907|P10|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
5837411|NCT02346240|20176908|P9|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
5837412|NCT02346240|20176909|P8|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
5837413|NCT02346240|20176910|P7|Maintenance Period (Week 16 to Week 48)|Moved out of state|1
5837414|NCT02346240|20176911|P6|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
5837415|NCT02346240|20176912|P5|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
5837416|NCT02346240|20176913|P4|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
5837417|NCT02346240|20176914|P3|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
5837418|NCT02346240|20176915|P2|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
5837419|NCT02346240|20176916|P1|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
5837420|NCT02346240|20176893|P24|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
5837421|NCT02346240|20176894|P23|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
5837422|NCT02346240|20176895|P22|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
5837423|NCT02346240|20176896|P21|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
5837424|NCT02346240|20176897|P20|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
5837425|NCT02346240|20176898|P19|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
5837426|NCT02346240|20176899|P18|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
5837427|NCT02346240|20176900|P17|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|4
5837428|NCT02346240|20176901|P16|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|8
5837429|NCT02346240|20176902|P15|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3
5837430|NCT02346240|20176903|P14|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3
5837431|NCT02346240|20176904|P13|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
5837432|NCT02346240|20176905|P12|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
5837433|NCT02346240|20176906|P11|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
5837434|NCT02346240|20176907|P10|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
5837435|NCT02346240|20176908|P9|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
5837436|NCT02346240|20176909|P8|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
5837437|NCT02346240|20176910|P7|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
5837438|NCT02346240|20176911|P6|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
5837439|NCT02346240|20176912|P5|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
5837440|NCT02346240|20176913|P4|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
5837441|NCT02346240|20176914|P3|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
5837442|NCT02346240|20176915|P2|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
5837443|NCT02346240|20176916|P1|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
5837444|NCT02346240|20176893|P24|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
5837445|NCT02346240|20176894|P23|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
5837446|NCT02346240|20176895|P22|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
5837447|NCT02346240|20176896|P21|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
5837448|NCT02346240|20176897|P20|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
5837449|NCT02346240|20176898|P19|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
5837450|NCT02346240|20176899|P18|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
5837451|NCT02346240|20176900|P17|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
5837452|NCT02346240|20176901|P16|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2
5837453|NCT02346240|20176902|P15|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|5
5837454|NCT02346240|20176903|P14|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2
5837455|NCT02346240|20176904|P13|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
5837456|NCT02346240|20176905|P12|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2
5837457|NCT02346240|20176906|P11|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
5837458|NCT02346240|20176907|P10|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
5837459|NCT02346240|20176908|P9|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
5837460|NCT02346240|20176909|P8|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
5837461|NCT02346240|20176910|P7|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
5837462|NCT02346240|20176911|P6|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
5837463|NCT02346240|20176912|P5|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
5837464|NCT02346240|20176913|P4|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
5837465|NCT02346240|20176914|P3|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
5837466|NCT02346240|20176915|P2|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
5837467|NCT02346240|20176916|P1|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
5837468|NCT02346240|20176893|P24|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5837469|NCT02346240|20176894|P23|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5837470|NCT02346240|20176895|P22|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5837471|NCT02346240|20176896|P21|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5837472|NCT02346240|20176897|P20|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5837473|NCT02346240|20176898|P19|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5837474|NCT02346240|20176899|P18|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5837475|NCT02346240|20176900|P17|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5837476|NCT02346240|20176901|P16|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5837477|NCT02346240|20176902|P15|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1
5837478|NCT02346240|20176903|P14|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5837479|NCT02346240|20176904|P13|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5837480|NCT02346240|20176905|P12|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5837481|NCT02346240|20176906|P11|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5837482|NCT02346240|20176907|P10|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5837483|NCT02346240|20176908|P9|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5837484|NCT02346240|20176909|P8|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5837485|NCT02346240|20176910|P7|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5837486|NCT02346240|20176911|P6|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5837487|NCT02346240|20176912|P5|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5837488|NCT02346240|20176913|P4|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5837489|NCT02346240|20176914|P3|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5837490|NCT02346240|20176915|P2|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5837491|NCT02346240|20176916|P1|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5837492|NCT02346240|20176893|P24|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
5837493|NCT02346240|20176894|P23|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
5837494|NCT02346240|20176895|P22|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
5837495|NCT02346240|20176896|P21|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
5837496|NCT02346240|20176897|P20|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
5837497|NCT02346240|20176898|P19|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
5837498|NCT02346240|20176899|P18|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
5837499|NCT02346240|20176900|P17|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
5837500|NCT02346240|20176901|P16|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|3
5837501|NCT02346240|20176902|P15|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
5837502|NCT02346240|20176903|P14|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1
5837503|NCT02346240|20176904|P13|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
5837504|NCT02346240|20176905|P12|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
5837505|NCT02346240|20176906|P11|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
5837506|NCT02346240|20176907|P10|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
5837507|NCT02346240|20176908|P9|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
5837508|NCT02346240|20176909|P8|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
5837509|NCT02346240|20176910|P7|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
5837510|NCT02346240|20176911|P6|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
5837511|NCT02346240|20176912|P5|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
5837512|NCT02346240|20176913|P4|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
5837513|NCT02346240|20176914|P3|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
5837514|NCT02346240|20176915|P2|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
5837515|NCT02346240|20176916|P1|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
5837516|NCT02346240|20176893|P24|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
5837517|NCT02346240|20176894|P23|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
5837518|NCT02346240|20176895|P22|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
5837519|NCT02346240|20176896|P21|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
5837520|NCT02346240|20176897|P20|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
5837521|NCT02346240|20176898|P19|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
5837522|NCT02346240|20176899|P18|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
5837523|NCT02346240|20176900|P17|Maintenance Period (Week 16 to Week 48)|Adverse Event|2
5837524|NCT02346240|20176901|P16|Maintenance Period (Week 16 to Week 48)|Adverse Event|1
5837525|NCT02346240|20176902|P15|Maintenance Period (Week 16 to Week 48)|Adverse Event|4
5837526|NCT02346240|20176903|P14|Maintenance Period (Week 16 to Week 48)|Adverse Event|1
5837527|NCT02346240|20176904|P13|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
5837528|NCT02346240|20176905|P12|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
5837529|NCT02346240|20176906|P11|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
5837530|NCT02346240|20176907|P10|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
5837531|NCT02346240|20176908|P9|Maintenance Period (Week 16 to Week 48)|Adverse Event|2
5837532|NCT02346240|20176909|P8|Maintenance Period (Week 16 to Week 48)|Adverse Event|1
5837533|NCT02346240|20176910|P7|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
5837534|NCT02346240|20176911|P6|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
5837535|NCT02346240|20176912|P5|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
5837536|NCT02346240|20176913|P4|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
5837537|NCT02346240|20176914|P3|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
5837538|NCT02346240|20176915|P2|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
5837539|NCT02346240|20176916|P1|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
5837540|NCT02346240|20176893|P24|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
5837541|NCT02346240|20176894|P23|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
5837542|NCT02346240|20176895|P22|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
5837543|NCT02346240|20176896|P21|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
5837544|NCT02346240|20176897|P20|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
5837545|NCT02346240|20176898|P19|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
5837546|NCT02346240|20176899|P18|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
5837547|NCT02346240|20176900|P17|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
5837548|NCT02346240|20176901|P16|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
5837549|NCT02346240|20176902|P15|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
5837550|NCT02346240|20176903|P14|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
5837551|NCT02346240|20176904|P13|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
5837552|NCT02346240|20176905|P12|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
5837553|NCT02346240|20176906|P11|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
5837554|NCT02346240|20176907|P10|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
5837555|NCT02346240|20176908|P9|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
5837556|NCT02346240|20176909|P8|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
5837557|NCT02346240|20176910|P7|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
5837558|NCT02346240|20176911|P6|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
5837559|NCT02346240|20176912|P5|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
5837560|NCT02346240|20176913|P4|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
5837561|NCT02346240|20176914|P3|Initial Period (Baseline to Week 16)|Subject missed 3 visits|1
5837562|NCT02346240|20176915|P2|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
5837563|NCT02346240|20176916|P1|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
5837564|NCT02346240|20176893|P24|Initial Period (Baseline to Week 16)|Non-compliance|0
5837565|NCT02346240|20176894|P23|Initial Period (Baseline to Week 16)|Non-compliance|0
5837566|NCT02346240|20176895|P22|Initial Period (Baseline to Week 16)|Non-compliance|0
5837567|NCT02346240|20176896|P21|Initial Period (Baseline to Week 16)|Non-compliance|0
5837568|NCT02346240|20176897|P20|Initial Period (Baseline to Week 16)|Non-compliance|0
5837569|NCT02346240|20176898|P19|Initial Period (Baseline to Week 16)|Non-compliance|0
5837570|NCT02346240|20176899|P18|Initial Period (Baseline to Week 16)|Non-compliance|0
5837718|NCT02345889|20176992|P4|Overall Study|Ulcerative Colitis identified|0
5837571|NCT02346240|20176900|P17|Initial Period (Baseline to Week 16)|Non-compliance|0
5837572|NCT02346240|20176901|P16|Initial Period (Baseline to Week 16)|Non-compliance|0
5837573|NCT02346240|20176902|P15|Initial Period (Baseline to Week 16)|Non-compliance|0
5837574|NCT02346240|20176903|P14|Initial Period (Baseline to Week 16)|Non-compliance|0
5837575|NCT02346240|20176904|P13|Initial Period (Baseline to Week 16)|Non-compliance|0
5837576|NCT02346240|20176905|P12|Initial Period (Baseline to Week 16)|Non-compliance|0
5837577|NCT02346240|20176906|P11|Initial Period (Baseline to Week 16)|Non-compliance|0
5837578|NCT02346240|20176907|P10|Initial Period (Baseline to Week 16)|Non-compliance|0
5837579|NCT02346240|20176908|P9|Initial Period (Baseline to Week 16)|Non-compliance|0
5837580|NCT02346240|20176909|P8|Initial Period (Baseline to Week 16)|Non-compliance|0
5837581|NCT02346240|20176910|P7|Initial Period (Baseline to Week 16)|Non-compliance|0
5837582|NCT02346240|20176911|P6|Initial Period (Baseline to Week 16)|Non-compliance|0
5837583|NCT02346240|20176912|P5|Initial Period (Baseline to Week 16)|Non-compliance|0
5837584|NCT02346240|20176913|P4|Initial Period (Baseline to Week 16)|Non-compliance|1
5837585|NCT02346240|20176914|P3|Initial Period (Baseline to Week 16)|Non-compliance|0
5837586|NCT02346240|20176915|P2|Initial Period (Baseline to Week 16)|Non-compliance|1
5837587|NCT02346240|20176916|P1|Initial Period (Baseline to Week 16)|Non-compliance|0
5837588|NCT02346240|20176893|P24|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
5837589|NCT02346240|20176894|P23|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
5837590|NCT02346240|20176895|P22|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
5837591|NCT02346240|20176896|P21|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
5837592|NCT02346240|20176897|P20|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
5837593|NCT02346240|20176898|P19|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
5837594|NCT02346240|20176899|P18|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
5837595|NCT02346240|20176900|P17|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
5837596|NCT02346240|20176901|P16|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
5837597|NCT02346240|20176902|P15|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
5837598|NCT02346240|20176903|P14|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
5837599|NCT02346240|20176904|P13|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
5837600|NCT02346240|20176905|P12|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
5837601|NCT02346240|20176906|P11|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
5837602|NCT02346240|20176907|P10|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
5837603|NCT02346240|20176908|P9|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
5837604|NCT02346240|20176909|P8|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
5837605|NCT02346240|20176910|P7|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
5837606|NCT02346240|20176911|P6|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
5837607|NCT02346240|20176912|P5|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
5837608|NCT02346240|20176913|P4|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2
5837609|NCT02346240|20176914|P3|Initial Period (Baseline to Week 16)|Withdrawal by Subject|3
5837610|NCT02346240|20176915|P2|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2
5837611|NCT02346240|20176916|P1|Initial Period (Baseline to Week 16)|Withdrawal by Subject|1
5837612|NCT02346240|20176893|P24|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
5837613|NCT02346240|20176894|P23|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
5837614|NCT02346240|20176895|P22|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
5837615|NCT02346240|20176896|P21|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
5837616|NCT02346240|20176897|P20|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
5837617|NCT02346240|20176898|P19|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
5837618|NCT02346240|20176899|P18|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
5837619|NCT02346240|20176900|P17|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
5837620|NCT02346240|20176901|P16|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
5837621|NCT02346240|20176902|P15|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
5837622|NCT02346240|20176903|P14|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
5837623|NCT02346240|20176904|P13|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
5837624|NCT02346240|20176905|P12|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
5837625|NCT02346240|20176906|P11|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
5837626|NCT02346240|20176907|P10|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
5837627|NCT02346240|20176908|P9|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
5837628|NCT02346240|20176909|P8|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
5837629|NCT02346240|20176910|P7|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
5837630|NCT02346240|20176911|P6|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
5837631|NCT02346240|20176912|P5|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
5837632|NCT02346240|20176913|P4|Initial Period (Baseline to Week 16)|Lost to Follow-up|3
5837633|NCT02346240|20176914|P3|Initial Period (Baseline to Week 16)|Lost to Follow-up|1
5837634|NCT02346240|20176915|P2|Initial Period (Baseline to Week 16)|Lost to Follow-up|2
5837635|NCT02346240|20176916|P1|Initial Period (Baseline to Week 16)|Lost to Follow-up|1
5837636|NCT02346240|20176893|P24|Initial Period (Baseline to Week 16)|Protocol Violation|0
5837637|NCT02346240|20176894|P23|Initial Period (Baseline to Week 16)|Protocol Violation|0
5837638|NCT02346240|20176895|P22|Initial Period (Baseline to Week 16)|Protocol Violation|0
5837639|NCT02346240|20176896|P21|Initial Period (Baseline to Week 16)|Protocol Violation|0
5837640|NCT02346240|20176897|P20|Initial Period (Baseline to Week 16)|Protocol Violation|0
5837641|NCT02346240|20176898|P19|Initial Period (Baseline to Week 16)|Protocol Violation|0
5837642|NCT02346240|20176899|P18|Initial Period (Baseline to Week 16)|Protocol Violation|0
5837643|NCT02346240|20176900|P17|Initial Period (Baseline to Week 16)|Protocol Violation|0
5837644|NCT02346240|20176901|P16|Initial Period (Baseline to Week 16)|Protocol Violation|0
5837645|NCT02346240|20176902|P15|Initial Period (Baseline to Week 16)|Protocol Violation|0
5837646|NCT02346240|20176903|P14|Initial Period (Baseline to Week 16)|Protocol Violation|0
5837647|NCT02346240|20176904|P13|Initial Period (Baseline to Week 16)|Protocol Violation|0
5837648|NCT02346240|20176905|P12|Initial Period (Baseline to Week 16)|Protocol Violation|0
5837649|NCT02346240|20176906|P11|Initial Period (Baseline to Week 16)|Protocol Violation|0
5837650|NCT02346240|20176907|P10|Initial Period (Baseline to Week 16)|Protocol Violation|0
5837651|NCT02346240|20176908|P9|Initial Period (Baseline to Week 16)|Protocol Violation|0
5837652|NCT02346240|20176909|P8|Initial Period (Baseline to Week 16)|Protocol Violation|0
5837653|NCT02346240|20176910|P7|Initial Period (Baseline to Week 16)|Protocol Violation|0
5837654|NCT02346240|20176911|P6|Initial Period (Baseline to Week 16)|Protocol Violation|0
5837655|NCT02346240|20176912|P5|Initial Period (Baseline to Week 16)|Protocol Violation|0
5837656|NCT02346240|20176913|P4|Initial Period (Baseline to Week 16)|Protocol Violation|0
5837657|NCT02346240|20176914|P3|Initial Period (Baseline to Week 16)|Protocol Violation|0
5837658|NCT02346240|20176915|P2|Initial Period (Baseline to Week 16)|Protocol Violation|1
5837659|NCT02346240|20176916|P1|Initial Period (Baseline to Week 16)|Protocol Violation|0
5837660|NCT02346240|20176893|P24|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
5837661|NCT02346240|20176894|P23|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
5837662|NCT02346240|20176895|P22|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
5837663|NCT02346240|20176896|P21|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
5837664|NCT02346240|20176897|P20|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
5837665|NCT02346240|20176898|P19|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
5837666|NCT02346240|20176899|P18|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
5837667|NCT02346240|20176900|P17|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
5837668|NCT02346240|20176901|P16|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
5837669|NCT02346240|20176902|P15|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
5837670|NCT02346240|20176903|P14|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
5837671|NCT02346240|20176904|P13|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
5837672|NCT02346240|20176905|P12|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
5837673|NCT02346240|20176906|P11|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
5837674|NCT02346240|20176907|P10|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
5837675|NCT02346240|20176908|P9|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
5837676|NCT02346240|20176909|P8|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
5837677|NCT02346240|20176910|P7|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
5837678|NCT02346240|20176911|P6|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
5837679|NCT02346240|20176912|P5|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
5837680|NCT02346240|20176913|P4|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
5837681|NCT02346240|20176914|P3|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
5837682|NCT02346240|20176915|P2|Initial Period (Baseline to Week 16)|Lack of Efficacy|1
5837683|NCT02346240|20176916|P1|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
5837684|NCT02346240|20176893|P24|Initial Period (Baseline to Week 16)|Adverse Event|0
5837685|NCT02346240|20176894|P23|Initial Period (Baseline to Week 16)|Adverse Event|0
5837686|NCT02346240|20176895|P22|Initial Period (Baseline to Week 16)|Adverse Event|0
5837687|NCT02346240|20176896|P21|Initial Period (Baseline to Week 16)|Adverse Event|0
5837688|NCT02346240|20176897|P20|Initial Period (Baseline to Week 16)|Adverse Event|0
5837689|NCT02346240|20176898|P19|Initial Period (Baseline to Week 16)|Adverse Event|0
5837690|NCT02346240|20176899|P18|Initial Period (Baseline to Week 16)|Adverse Event|0
5837691|NCT02346240|20176900|P17|Initial Period (Baseline to Week 16)|Adverse Event|0
5837692|NCT02346240|20176901|P16|Initial Period (Baseline to Week 16)|Adverse Event|0
5837693|NCT02346240|20176902|P15|Initial Period (Baseline to Week 16)|Adverse Event|0
5837694|NCT02346240|20176903|P14|Initial Period (Baseline to Week 16)|Adverse Event|0
5837695|NCT02346240|20176904|P13|Initial Period (Baseline to Week 16)|Adverse Event|0
5837696|NCT02346240|20176905|P12|Initial Period (Baseline to Week 16)|Adverse Event|0
5837697|NCT02346240|20176906|P11|Initial Period (Baseline to Week 16)|Adverse Event|0
5837698|NCT02346240|20176907|P10|Initial Period (Baseline to Week 16)|Adverse Event|0
5837699|NCT02346240|20176908|P9|Initial Period (Baseline to Week 16)|Adverse Event|0
5837700|NCT02346240|20176909|P8|Initial Period (Baseline to Week 16)|Adverse Event|0
5837701|NCT02346240|20176910|P7|Initial Period (Baseline to Week 16)|Adverse Event|0
5837702|NCT02346240|20176911|P6|Initial Period (Baseline to Week 16)|Adverse Event|0
5837703|NCT02346240|20176912|P5|Initial Period (Baseline to Week 16)|Adverse Event|0
5837704|NCT02346240|20176913|P4|Initial Period (Baseline to Week 16)|Adverse Event|1
5837705|NCT02346240|20176914|P3|Initial Period (Baseline to Week 16)|Adverse Event|1
5837706|NCT02346240|20176915|P2|Initial Period (Baseline to Week 16)|Adverse Event|4
5837707|NCT02346240|20176916|P1|Initial Period (Baseline to Week 16)|Adverse Event|0
5837708|NCT02346136|20176955|P2|Overall Study|Study termination|18
5837709|NCT02346136|20176956|P1|Overall Study|Study termination|14
5837710|NCT02346136|20176955|P2|Overall Study|Death|0
5837711|NCT02346136|20176956|P1|Overall Study|Death|1
5837712|NCT02346136|20176955|P2|Overall Study|Withdrawal by Subject|5
5837713|NCT02346136|20176956|P1|Overall Study|Withdrawal by Subject|7
5837714|NCT02345889|20176992|P4|Overall Study|Cecum not intubated|0
5837715|NCT02345889|20176993|P3|Overall Study|Cecum not intubated|0
5837719|NCT02345889|20176993|P3|Overall Study|Ulcerative Colitis identified|0
5837720|NCT02345889|20176994|P2|Overall Study|Ulcerative Colitis identified|0
5837721|NCT02345889|20176995|P1|Overall Study|Ulcerative Colitis identified|1
5837722|NCT02345889|20176992|P4|Overall Study|Recognized ineligible post-randomization|1
5837723|NCT02345889|20176993|P3|Overall Study|Recognized ineligible post-randomization|2
5837724|NCT02345889|20176994|P2|Overall Study|Recognized ineligible post-randomization|0
5837725|NCT02345889|20176995|P1|Overall Study|Recognized ineligible post-randomization|1
5837726|NCT02345889|20176992|P4|Overall Study|Polyposis identified during procedure|1
5837727|NCT02345889|20176993|P3|Overall Study|Polyposis identified during procedure|0
5837728|NCT02345889|20176994|P2|Overall Study|Polyposis identified during procedure|1
5837729|NCT02345889|20176995|P1|Overall Study|Polyposis identified during procedure|1
5837730|NCT02345889|20176992|P4|Overall Study|Inadequate Bowel Prep|14
5837731|NCT02345889|20176993|P3|Overall Study|Inadequate Bowel Prep|18
5837732|NCT02345889|20176994|P2|Overall Study|Inadequate Bowel Prep|16
5837733|NCT02345889|20176995|P1|Overall Study|Inadequate Bowel Prep|17
5837734|NCT02345811|20177061|P2|First Intervention|Withdrawal by Subject|1
5837735|NCT02345811|20177062|P1|First Intervention|Withdrawal by Subject|1
5837736|NCT02345512|20177113|P1|Overall Study|Withdrawal by Subject|1
5837737|NCT02345512|20177113|P1|Overall Study|Adverse Event|1
5837738|NCT02345330|20177207|P1|Overall Study|Progressive Disease|2
5837739|NCT02345330|20177207|P1|Overall Study|Death|1
5837740|NCT02345252|20177219|P2|Double-Blind Phase|Randomized but Never Treated|2
5837741|NCT02345252|20177220|P1|Double-Blind Phase|Randomized but Never Treated|0
5837742|NCT02345252|20177219|P2|Double-Blind Phase|Lost to Follow-up|10
5837743|NCT02345252|20177220|P1|Double-Blind Phase|Lost to Follow-up|8
5837744|NCT02345252|20177219|P2|Double-Blind Phase|Withdrew Consent|23
5837745|NCT02345252|20177220|P1|Double-Blind Phase|Withdrew Consent|21
5837746|NCT02345252|20177219|P2|Double-Blind Phase|Protocol Violation|1
5837747|NCT02345252|20177220|P1|Double-Blind Phase|Protocol Violation|2
5837748|NCT02345252|20177219|P2|Double-Blind Phase|Non-Compliance with Study Drug|2
5837749|NCT02345252|20177220|P1|Double-Blind Phase|Non-Compliance with Study Drug|1
5837750|NCT02345252|20177219|P2|Double-Blind Phase|Investigator's Discretion|6
5837751|NCT02345252|20177220|P1|Double-Blind Phase|Investigator's Discretion|4
5837752|NCT02345252|20177219|P2|Double-Blind Phase|Lack of Efficacy|0
5837753|NCT02345252|20177220|P1|Double-Blind Phase|Lack of Efficacy|1
5837754|NCT02345252|20177219|P2|Double-Blind Phase|Death|2
5837755|NCT02345252|20177220|P1|Double-Blind Phase|Death|1
5837756|NCT02345252|20177219|P2|Double-Blind Phase|Adverse Event|3
5837757|NCT02345252|20177220|P1|Double-Blind Phase|Adverse Event|2
5837758|NCT02345226|20177248|P2|Open-Label Extension Phase|Lost to Follow-up|1
5837759|NCT02345226|20177249|P1|Open-Label Extension Phase|Lost to Follow-up|0
5837760|NCT02345226|20177248|P2|Double-Blind Phase|Randomized but Never Treated|4
5837761|NCT02345226|20177249|P1|Double-Blind Phase|Randomized but Never Treated|2
5837762|NCT02345226|20177248|P2|Double-Blind Phase|Lost to Follow-up|16
5837763|NCT02345226|20177249|P1|Double-Blind Phase|Lost to Follow-up|12
5837764|NCT02345226|20177248|P2|Double-Blind Phase|Withdrew Consent|39
5837765|NCT02345226|20177249|P1|Double-Blind Phase|Withdrew Consent|41
5837766|NCT02345226|20177248|P2|Double-Blind Phase|Non-Compliance with Study Drug|2
5837767|NCT02345226|20177249|P1|Double-Blind Phase|Non-Compliance with Study Drug|1
5837768|NCT02345226|20177248|P2|Double-Blind Phase|Investigator's Discretion|3
5837769|NCT02345226|20177249|P1|Double-Blind Phase|Investigator's Discretion|4
5837770|NCT02345226|20177248|P2|Double-Blind Phase|Lack of Efficacy|0
5837771|NCT02345226|20177249|P1|Double-Blind Phase|Lack of Efficacy|1
5837772|NCT02345226|20177248|P2|Double-Blind Phase|Pregnancy|1
5837773|NCT02345226|20177249|P1|Double-Blind Phase|Pregnancy|0
5837774|NCT02345226|20177248|P2|Double-Blind Phase|Death|0
5837775|NCT02345226|20177249|P1|Double-Blind Phase|Death|3
5837776|NCT02345226|20177248|P2|Double-Blind Phase|Adverse Event|6
5837777|NCT02345226|20177249|P1|Double-Blind Phase|Adverse Event|5
5837778|NCT02345161|20177281|P2|Overall Study|Lost to Follow-up|1
5837779|NCT02345161|20177282|P1|Overall Study|Lost to Follow-up|0
5837780|NCT02345161|20177281|P2|Overall Study|Physician Decision|4
5837781|NCT02345161|20177282|P1|Overall Study|Physician Decision|4
5837782|NCT02345161|20177281|P2|Overall Study|Adverse Event|19
5837783|NCT02345161|20177282|P1|Overall Study|Adverse Event|16
5837784|NCT02345161|20177281|P2|Overall Study|Withdrawal by Subject|33
5837785|NCT02345161|20177282|P1|Overall Study|Withdrawal by Subject|25
5837786|NCT02345070|20177387|P3|Overall Study|Other than specified above|7
5837787|NCT02345070|20177388|P2|Overall Study|Other than specified above|3
5837788|NCT02345070|20177389|P1|Overall Study|Other than specified above|6
5837789|NCT02345070|20177387|P3|Overall Study|Poor compliance to protocol|0
5837790|NCT02345070|20177388|P2|Overall Study|Poor compliance to protocol|0
5837791|NCT02345070|20177389|P1|Overall Study|Poor compliance to protocol|2
5837792|NCT02345070|20177387|P3|Overall Study|Adverse Event|16
5837793|NCT02345070|20177388|P2|Overall Study|Adverse Event|8
5837794|NCT02345070|20177389|P1|Overall Study|Adverse Event|12
5837795|NCT02344745|20177422|P2|Overall Study|Data collection sheets were lost|0
5837796|NCT02344745|20177423|P1|Overall Study|Data collection sheets were lost|2
5837797|NCT02344576|20177452|P4|6-Month Follow-Up|Lost to Follow-up|6
5837798|NCT02344576|20177453|P3|6-Month Follow-Up|Lost to Follow-up|13
5837799|NCT02344576|20177454|P2|6-Month Follow-Up|Lost to Follow-up|5
5837800|NCT02344576|20177455|P1|6-Month Follow-Up|Lost to Follow-up|4
5837801|NCT02344576|20177452|P4|6-Month Follow-Up|Withdrawal by Subject|2
5837802|NCT02344576|20177453|P3|6-Month Follow-Up|Withdrawal by Subject|1
5837803|NCT02344576|20177454|P2|6-Month Follow-Up|Withdrawal by Subject|0
5837804|NCT02344576|20177455|P1|6-Month Follow-Up|Withdrawal by Subject|1
5837805|NCT02344576|20177452|P4|6-Month Follow-Up|Death|0
5837806|NCT02344576|20177453|P3|6-Month Follow-Up|Death|0
5837807|NCT02344576|20177454|P2|6-Month Follow-Up|Death|14
5837808|NCT02344576|20177455|P1|6-Month Follow-Up|Death|14
5837809|NCT02344576|20177452|P4|1-Month Follow-Up|Lost to Follow-up|3
5837810|NCT02344576|20177453|P3|1-Month Follow-Up|Lost to Follow-up|11
5837811|NCT02344576|20177454|P2|1-Month Follow-Up|Lost to Follow-up|5
5837812|NCT02344576|20177455|P1|1-Month Follow-Up|Lost to Follow-up|2
5837813|NCT02344576|20177452|P4|1-Month Follow-Up|Withdrawal by Subject|10
5837814|NCT02344576|20177453|P3|1-Month Follow-Up|Withdrawal by Subject|8
5837815|NCT02344576|20177454|P2|1-Month Follow-Up|Withdrawal by Subject|14
5837816|NCT02344576|20177455|P1|1-Month Follow-Up|Withdrawal by Subject|3
5837817|NCT02344576|20177452|P4|1-Month Follow-Up|Death|0
5837818|NCT02344576|20177453|P3|1-Month Follow-Up|Death|0
5837819|NCT02344576|20177454|P2|1-Month Follow-Up|Death|8
5837820|NCT02344576|20177455|P1|1-Month Follow-Up|Death|13
5837821|NCT02344576|20177452|P4|Enrollment|Agreed to Medical Record Review Only|0
5837822|NCT02344576|20177453|P3|Enrollment|Agreed to Medical Record Review Only|0
5837823|NCT02344576|20177454|P2|Enrollment|Agreed to Medical Record Review Only|8
5837824|NCT02344576|20177455|P1|Enrollment|Agreed to Medical Record Review Only|7
5837825|NCT02344342|20177518|P4|Overall Study|Industry partner dropped out|10
5837826|NCT02344342|20177519|P3|Overall Study|Industry partner dropped out|14
5837827|NCT02344342|20177520|P2|Overall Study|Industry partner dropped out|9
5837828|NCT02344342|20177521|P1|Overall Study|Industry partner dropped out|11
5837829|NCT02344173|20177587|P1|12-month Visit|Lost to Follow-up|58
5837830|NCT02344173|20177587|P1|12-month Visit|Withdrawal by Subject|30
5837831|NCT02344173|20177587|P1|12-month Visit|Death|8
5837832|NCT02344173|20177587|P1|Procedure|Ablation Procedure Not Performed|7
5837833|NCT02344004|20177595|P2|Overall Study|Protocol Violation|0
5837834|NCT02344004|20177596|P1|Overall Study|Protocol Violation|1
5837835|NCT02344004|20177595|P2|Overall Study|Other Not Specified|0
5837836|NCT02344004|20177596|P1|Overall Study|Other Not Specified|12
5837837|NCT02344004|20177595|P2|Overall Study|Rescue Medication|0
5837838|NCT02344004|20177596|P1|Overall Study|Rescue Medication|2
5837839|NCT02344004|20177595|P2|Overall Study|Withdrawal by Subject|5
5837840|NCT02344004|20177596|P1|Overall Study|Withdrawal by Subject|22
5837841|NCT02344004|20177595|P2|Overall Study|Physician Decision|1
5837842|NCT02344004|20177596|P1|Overall Study|Physician Decision|4
5837843|NCT02344004|20177595|P2|Overall Study|Death|7
5837844|NCT02344004|20177596|P1|Overall Study|Death|9
5837845|NCT02344004|20177595|P2|Overall Study|Adverse Event|1
5837846|NCT02344004|20177596|P1|Overall Study|Adverse Event|11
5837847|NCT02343939|20177623|P9|Overall Study|Never Treated With ENTO|0
5837848|NCT02343939|20177624|P8|Overall Study|Never Treated With ENTO|2
5837849|NCT02343939|20177625|P7|Overall Study|Never Treated With ENTO|1
5837850|NCT02343939|20177626|P6|Overall Study|Never Treated With ENTO|0
5837851|NCT02343939|20177627|P5|Overall Study|Never Treated With ENTO|0
5837852|NCT02343939|20177628|P4|Overall Study|Never Treated With ENTO|0
5837853|NCT02343939|20177629|P3|Overall Study|Never Treated With ENTO|0
5837854|NCT02343939|20177630|P2|Overall Study|Never Treated With ENTO|0
5837855|NCT02343939|20177631|P1|Overall Study|Never Treated With ENTO|0
5837856|NCT02343939|20177623|P9|Overall Study|Adverse Event|0
5837857|NCT02343939|20177624|P8|Overall Study|Adverse Event|0
5837858|NCT02343939|20177625|P7|Overall Study|Adverse Event|0
5837859|NCT02343939|20177626|P6|Overall Study|Adverse Event|1
5837860|NCT02343939|20177627|P5|Overall Study|Adverse Event|0
5837861|NCT02343939|20177628|P4|Overall Study|Adverse Event|0
5837862|NCT02343939|20177629|P3|Overall Study|Adverse Event|0
5837863|NCT02343939|20177630|P2|Overall Study|Adverse Event|0
5837864|NCT02343939|20177631|P1|Overall Study|Adverse Event|0
5837865|NCT02343939|20177623|P9|Overall Study|Investigator's discretion|0
5837866|NCT02343939|20177624|P8|Overall Study|Investigator's discretion|0
5837867|NCT02343939|20177625|P7|Overall Study|Investigator's discretion|1
5837868|NCT02343939|20177626|P6|Overall Study|Investigator's discretion|0
5837869|NCT02343939|20177627|P5|Overall Study|Investigator's discretion|0
5837870|NCT02343939|20177628|P4|Overall Study|Investigator's discretion|1
5837871|NCT02343939|20177629|P3|Overall Study|Investigator's discretion|0
5837872|NCT02343939|20177630|P2|Overall Study|Investigator's discretion|0
5837873|NCT02343939|20177631|P1|Overall Study|Investigator's discretion|0
5837874|NCT02343939|20177623|P9|Overall Study|Treatment failure|0
5837875|NCT02343939|20177624|P8|Overall Study|Treatment failure|1
5837876|NCT02343939|20177625|P7|Overall Study|Treatment failure|2
5837877|NCT02343939|20177626|P6|Overall Study|Treatment failure|0
5837878|NCT02343939|20177627|P5|Overall Study|Treatment failure|0
5837879|NCT02343939|20177628|P4|Overall Study|Treatment failure|0
5837880|NCT02343939|20177629|P3|Overall Study|Treatment failure|0
5837881|NCT02343939|20177630|P2|Overall Study|Treatment failure|0
5837882|NCT02343939|20177631|P1|Overall Study|Treatment failure|0
5837883|NCT02343939|20177623|P9|Overall Study|Withdrew consent|6
5837884|NCT02343939|20177624|P8|Overall Study|Withdrew consent|8
5837885|NCT02343939|20177625|P7|Overall Study|Withdrew consent|0
5837886|NCT02343939|20177626|P6|Overall Study|Withdrew consent|0
5837887|NCT02343939|20177627|P5|Overall Study|Withdrew consent|2
5837888|NCT02343939|20177628|P4|Overall Study|Withdrew consent|2
5837889|NCT02343939|20177629|P3|Overall Study|Withdrew consent|1
5837890|NCT02343939|20177630|P2|Overall Study|Withdrew consent|6
5837891|NCT02343939|20177631|P1|Overall Study|Withdrew consent|3
5837892|NCT02343939|20177623|P9|Overall Study|Study terminated by sponsor|0
5837893|NCT02343939|20177624|P8|Overall Study|Study terminated by sponsor|4
5837894|NCT02343939|20177625|P7|Overall Study|Study terminated by sponsor|3
5837895|NCT02343939|20177626|P6|Overall Study|Study terminated by sponsor|5
5837896|NCT02343939|20177627|P5|Overall Study|Study terminated by sponsor|1
5837897|NCT02343939|20177628|P4|Overall Study|Study terminated by sponsor|1
5837898|NCT02343939|20177629|P3|Overall Study|Study terminated by sponsor|0
5837899|NCT02343939|20177630|P2|Overall Study|Study terminated by sponsor|27
5837900|NCT02343939|20177631|P1|Overall Study|Study terminated by sponsor|0
5837901|NCT02343939|20177623|P9|Overall Study|Death|1
5837902|NCT02343939|20177624|P8|Overall Study|Death|22
5837903|NCT02343939|20177625|P7|Overall Study|Death|8
5837904|NCT02343939|20177626|P6|Overall Study|Death|11
5837905|NCT02343939|20177627|P5|Overall Study|Death|5
5837906|NCT02343939|20177628|P4|Overall Study|Death|2
5837907|NCT02343939|20177629|P3|Overall Study|Death|4
5837908|NCT02343939|20177630|P2|Overall Study|Death|15
5837909|NCT02343939|20177631|P1|Overall Study|Death|0
5837910|NCT02343458|20177773|P4|Overall Study|Protocol Specified Criteria|8
5837911|NCT02343458|20177774|P3|Overall Study|Protocol Specified Criteria|14
5837912|NCT02343458|20177775|P2|Overall Study|Protocol Specified Criteria|13
5837913|NCT02343458|20177776|P1|Overall Study|Protocol Specified Criteria|17
5837914|NCT02343458|20177773|P4|Overall Study|Protocol Violation|2
5837915|NCT02343458|20177774|P3|Overall Study|Protocol Violation|2
5837916|NCT02343458|20177775|P2|Overall Study|Protocol Violation|5
5837917|NCT02343458|20177776|P1|Overall Study|Protocol Violation|2
5837918|NCT02343458|20177773|P4|Overall Study|Lost to Follow-up|1
5837919|NCT02343458|20177774|P3|Overall Study|Lost to Follow-up|3
5837920|NCT02343458|20177775|P2|Overall Study|Lost to Follow-up|5
5837921|NCT02343458|20177776|P1|Overall Study|Lost to Follow-up|5
5837922|NCT02343458|20177773|P4|Overall Study|Physician Decision|2
5837923|NCT02343458|20177774|P3|Overall Study|Physician Decision|2
5837924|NCT02343458|20177775|P2|Overall Study|Physician Decision|4
5837925|NCT02343458|20177776|P1|Overall Study|Physician Decision|1
5837926|NCT02343458|20177773|P4|Overall Study|Withdrawal by Subject|14
5837927|NCT02343458|20177774|P3|Overall Study|Withdrawal by Subject|23
5837928|NCT02343458|20177775|P2|Overall Study|Withdrawal by Subject|17
5837929|NCT02343458|20177776|P1|Overall Study|Withdrawal by Subject|18
5837930|NCT02343458|20177773|P4|Overall Study|Lack of Efficacy|8
5837931|NCT02343458|20177774|P3|Overall Study|Lack of Efficacy|4
5837932|NCT02343458|20177775|P2|Overall Study|Lack of Efficacy|8
5837933|NCT02343458|20177776|P1|Overall Study|Lack of Efficacy|3
5837934|NCT02343458|20177773|P4|Overall Study|Adverse Event|3
5837935|NCT02343458|20177774|P3|Overall Study|Adverse Event|15
5837936|NCT02343458|20177775|P2|Overall Study|Adverse Event|14
5837937|NCT02343458|20177776|P1|Overall Study|Adverse Event|15
5837938|NCT02343406|20177855|P5|Overall Study|Other, not specified|0
5837939|NCT02343406|20177856|P4|Overall Study|Other, not specified|4
5837940|NCT02343406|20177857|P3|Overall Study|Other, not specified|1
5837941|NCT02343406|20177858|P2|Overall Study|Other, not specified|1
5837942|NCT02343406|20177859|P1|Overall Study|Other, not specified|2
5837943|NCT02343406|20177855|P5|Overall Study|Other primary malignancy|0
5837944|NCT02343406|20177856|P4|Overall Study|Other primary malignancy|0
5837945|NCT02343406|20177857|P3|Overall Study|Other primary malignancy|0
5837946|NCT02343406|20177858|P2|Overall Study|Other primary malignancy|1
5837947|NCT02343406|20177859|P1|Overall Study|Other primary malignancy|0
5837948|NCT02343406|20177855|P5|Overall Study|Start of a new anti-cancer treatment|0
5837949|NCT02343406|20177856|P4|Overall Study|Start of a new anti-cancer treatment|1
5837950|NCT02343406|20177857|P3|Overall Study|Start of a new anti-cancer treatment|0
5837951|NCT02343406|20177858|P2|Overall Study|Start of a new anti-cancer treatment|1
5837952|NCT02343406|20177859|P1|Overall Study|Start of a new anti-cancer treatment|0
5837953|NCT02343406|20177855|P5|Overall Study|Death|0
5837954|NCT02343406|20177856|P4|Overall Study|Death|0
5837955|NCT02343406|20177857|P3|Overall Study|Death|0
5837956|NCT02343406|20177858|P2|Overall Study|Death|1
5837957|NCT02343406|20177859|P1|Overall Study|Death|2
5837958|NCT02343406|20177855|P5|Overall Study|Withdrawal by Subject|0
5837959|NCT02343406|20177856|P4|Overall Study|Withdrawal by Subject|3
5837960|NCT02343406|20177857|P3|Overall Study|Withdrawal by Subject|8
5837961|NCT02343406|20177858|P2|Overall Study|Withdrawal by Subject|4
5837962|NCT02343406|20177859|P1|Overall Study|Withdrawal by Subject|6
5837963|NCT02343406|20177855|P5|Overall Study|Adverse Event|0
5837964|NCT02343406|20177856|P4|Overall Study|Adverse Event|3
5837965|NCT02343406|20177857|P3|Overall Study|Adverse Event|6
5837966|NCT02343406|20177858|P2|Overall Study|Adverse Event|8
5837967|NCT02343406|20177859|P1|Overall Study|Adverse Event|6
5837968|NCT02343406|20177855|P5|Overall Study|Progressive disease|5
5837969|NCT02343406|20177856|P4|Overall Study|Progressive disease|15
5837970|NCT02343406|20177857|P3|Overall Study|Progressive disease|43
5837971|NCT02343406|20177858|P2|Overall Study|Progressive disease|70
5837972|NCT02343406|20177859|P1|Overall Study|Progressive disease|72
5837973|NCT02343263|20177927|P3|Overall Study|Physician Decision|1
5837974|NCT02343263|20177928|P2|Overall Study|Physician Decision|3
5837975|NCT02343263|20177929|P1|Overall Study|Physician Decision|5
5837976|NCT02343159|20177958|P3|Overall Study|Enrollment Error|0
5837977|NCT02343159|20177959|P2|Overall Study|Enrollment Error|0
5837978|NCT02343159|20177960|P1|Overall Study|Enrollment Error|1
5837979|NCT02343159|20177958|P3|Overall Study|Sponsor Decision|0
5837980|NCT02343159|20177959|P2|Overall Study|Sponsor Decision|1
5837981|NCT02343159|20177960|P1|Overall Study|Sponsor Decision|0
5837982|NCT02343159|20177958|P3|Overall Study|Adverse Event|2
5837983|NCT02343159|20177959|P2|Overall Study|Adverse Event|4
5837984|NCT02343159|20177960|P1|Overall Study|Adverse Event|4
5837985|NCT02343159|20177958|P3|Overall Study|Lost to Follow-up|2
5837986|NCT02343159|20177959|P2|Overall Study|Lost to Follow-up|2
5837987|NCT02343159|20177960|P1|Overall Study|Lost to Follow-up|0
5837988|NCT02343159|20177958|P3|Overall Study|Withdrawal by Subject|2
5837989|NCT02343159|20177959|P2|Overall Study|Withdrawal by Subject|0
5837990|NCT02343159|20177960|P1|Overall Study|Withdrawal by Subject|3
5837991|NCT02343159|20177958|P3|Overall Study|Physician Decision|1
5837992|NCT02343159|20177959|P2|Overall Study|Physician Decision|0
5837993|NCT02343159|20177960|P1|Overall Study|Physician Decision|2
5837994|NCT02343159|20177958|P3|Overall Study|Early Study Termination|23
5837995|NCT02343159|20177959|P2|Overall Study|Early Study Termination|19
5837996|NCT02343159|20177960|P1|Overall Study|Early Study Termination|16
5837997|NCT02343003|20178004|P2|Overall Study|terminated by sponsor|0
5837998|NCT02343003|20178005|P1|Overall Study|terminated by sponsor|2
5837999|NCT02343003|20178004|P2|Overall Study|exclusion criteria met|1
5838000|NCT02343003|20178005|P1|Overall Study|exclusion criteria met|1
5838001|NCT02343003|20178004|P2|Overall Study|Death|1
5838002|NCT02343003|20178005|P1|Overall Study|Death|0
5838003|NCT02343003|20178004|P2|Overall Study|Protocol Violation|0
5838004|NCT02343003|20178005|P1|Overall Study|Protocol Violation|1
5838005|NCT02343003|20178004|P2|Overall Study|Lost to Follow-up|1
5838006|NCT02343003|20178005|P1|Overall Study|Lost to Follow-up|5
5838007|NCT02343003|20178004|P2|Overall Study|Withdrawal by Subject|4
5838008|NCT02343003|20178005|P1|Overall Study|Withdrawal by Subject|9
5838009|NCT02342886|20178026|P5|Overall Study|Protocol Violation|0
5838010|NCT02342886|20178027|P4|Overall Study|Protocol Violation|2
5838011|NCT02342886|20178028|P3|Overall Study|Protocol Violation|0
5838012|NCT02342886|20178029|P2|Overall Study|Protocol Violation|0
5838013|NCT02342886|20178030|P1|Overall Study|Protocol Violation|0
5838014|NCT02342886|20178026|P5|Overall Study|Late exclusion: pyrazinamide resistance|0
5838015|NCT02342886|20178027|P4|Overall Study|Late exclusion: pyrazinamide resistance|0
5838016|NCT02342886|20178028|P3|Overall Study|Late exclusion: pyrazinamide resistance|1
5838017|NCT02342886|20178029|P2|Overall Study|Late exclusion: pyrazinamide resistance|0
5838018|NCT02342886|20178030|P1|Overall Study|Late exclusion: pyrazinamide resistance|0
5838019|NCT02342886|20178026|P5|Overall Study|Pregnancy|0
5838020|NCT02342886|20178027|P4|Overall Study|Pregnancy|0
5838021|NCT02342886|20178028|P3|Overall Study|Pregnancy|2
5838022|NCT02342886|20178029|P2|Overall Study|Pregnancy|0
5838023|NCT02342886|20178030|P1|Overall Study|Pregnancy|0
5838024|NCT02342886|20178026|P5|Overall Study|Investigator/sponsor decision|1
5838025|NCT02342886|20178027|P4|Overall Study|Investigator/sponsor decision|3
5838026|NCT02342886|20178028|P3|Overall Study|Investigator/sponsor decision|0
5838027|NCT02342886|20178029|P2|Overall Study|Investigator/sponsor decision|2
5838028|NCT02342886|20178030|P1|Overall Study|Investigator/sponsor decision|0
5838029|NCT02342886|20178026|P5|Overall Study|Withdrawal by Subject|0
5838030|NCT02342886|20178027|P4|Overall Study|Withdrawal by Subject|1
5838031|NCT02342886|20178028|P3|Overall Study|Withdrawal by Subject|0
5838032|NCT02342886|20178029|P2|Overall Study|Withdrawal by Subject|1
5838033|NCT02342886|20178030|P1|Overall Study|Withdrawal by Subject|0
5838034|NCT02342886|20178026|P5|Overall Study|Death|1
5838035|NCT02342886|20178027|P4|Overall Study|Death|0
5838036|NCT02342886|20178028|P3|Overall Study|Death|1
5838037|NCT02342886|20178029|P2|Overall Study|Death|2
5838038|NCT02342886|20178030|P1|Overall Study|Death|1
5838039|NCT02342886|20178026|P5|Overall Study|Lost to Follow-up|0
5838040|NCT02342886|20178027|P4|Overall Study|Lost to Follow-up|0
5838041|NCT02342886|20178028|P3|Overall Study|Lost to Follow-up|0
5838042|NCT02342886|20178029|P2|Overall Study|Lost to Follow-up|0
5838043|NCT02342886|20178030|P1|Overall Study|Lost to Follow-up|1
5838044|NCT02342886|20178026|P5|Overall Study|Adverse event/specific toxicity|1
5838045|NCT02342886|20178027|P4|Overall Study|Adverse event/specific toxicity|2
5838046|NCT02342886|20178028|P3|Overall Study|Adverse event/specific toxicity|11
5838047|NCT02342886|20178029|P2|Overall Study|Adverse event/specific toxicity|3
5838048|NCT02342886|20178030|P1|Overall Study|Adverse event/specific toxicity|4
5838049|NCT02342886|20178026|P5|Overall Study|Late exclusion: rifampicin resistance|0
5838050|NCT02342886|20178027|P4|Overall Study|Late exclusion: rifampicin resistance|0
5838051|NCT02342886|20178028|P3|Overall Study|Late exclusion: rifampicin resistance|0
5838052|NCT02342886|20178029|P2|Overall Study|Late exclusion: rifampicin resistance|0
5838053|NCT02342886|20178030|P1|Overall Study|Late exclusion: rifampicin resistance|1
5838054|NCT02342886|20178026|P5|Overall Study|Treatment non-compliance|0
5838055|NCT02342886|20178027|P4|Overall Study|Treatment non-compliance|1
5838056|NCT02342886|20178028|P3|Overall Study|Treatment non-compliance|0
5838057|NCT02342886|20178029|P2|Overall Study|Treatment non-compliance|0
5838058|NCT02342886|20178030|P1|Overall Study|Treatment non-compliance|1
5838059|NCT02342743|20178047|P1|Treatment Period|Change in prophylactic medication|1
5838060|NCT02342743|20178047|P1|Treatment Period|Lost to Follow-up|8
5838061|NCT02342743|20178047|P1|Treatment Period|Withdrawal by Subject|2
5838062|NCT02342743|20178047|P1|Baseline Period|Screening failure regarding baseline|7
5838063|NCT02342743|20178047|P1|Baseline Period|Change in prophylactic medication|3
5838064|NCT02342743|20178047|P1|Baseline Period|Lost to Follow-up|2
5838065|NCT02342743|20178047|P1|Baseline Period|Withdrawal by Subject|3
5838066|NCT02342704|20178060|P2|Overall Study|Adverse Event|3
5838067|NCT02342704|20178061|P1|Overall Study|Adverse Event|1
5838068|NCT02342704|20178060|P2|Overall Study|Lost to Follow-up|1
5838069|NCT02342704|20178061|P1|Overall Study|Lost to Follow-up|2
5838070|NCT02342704|20178060|P2|Overall Study|Withdrawal by Subject|0
5838071|NCT02342704|20178061|P1|Overall Study|Withdrawal by Subject|1
5838072|NCT02342704|20178060|P2|Overall Study|Other|1
5838073|NCT02342704|20178061|P1|Overall Study|Other|0
5838074|NCT02342704|20178060|P2|Overall Study|Sponsor Termination|43
5838075|NCT02342704|20178061|P1|Overall Study|Sponsor Termination|49
5838076|NCT02342704|20178060|P2|Overall Study|Physician Decision|3
5838077|NCT02342704|20178061|P1|Overall Study|Physician Decision|0
5838078|NCT02342678|20178089|P2|Overall Study|Illness/medical reason|1
5838079|NCT02342678|20178090|P1|Overall Study|Illness/medical reason|1
5838080|NCT02342678|20178089|P2|Overall Study|Family illness/emergency|1
5838081|NCT02342678|20178090|P1|Overall Study|Family illness/emergency|0
5838082|NCT02342678|20178089|P2|Overall Study|Too busy to complete study|2
5838083|NCT02342678|20178090|P1|Overall Study|Too busy to complete study|0
5838084|NCT02342678|20178089|P2|Overall Study|Lost to Follow-up|1
5838085|NCT02342678|20178090|P1|Overall Study|Lost to Follow-up|0
5838086|NCT02342548|20178121|P3|Overall Study|Other|1
5838087|NCT02342548|20178122|P2|Overall Study|Other|1
5838088|NCT02342548|20178123|P1|Overall Study|Other|1
5838089|NCT02342548|20178121|P3|Overall Study|Withdrawal by Subject|4
5838090|NCT02342548|20178122|P2|Overall Study|Withdrawal by Subject|3
5838091|NCT02342548|20178123|P1|Overall Study|Withdrawal by Subject|1
5838092|NCT02342548|20178121|P3|Overall Study|Protocol Violation|0
5838093|NCT02342548|20178122|P2|Overall Study|Protocol Violation|1
5838094|NCT02342548|20178123|P1|Overall Study|Protocol Violation|0
5838095|NCT02342548|20178121|P3|Overall Study|Study terminated by sponsor|25
5838096|NCT02342548|20178122|P2|Overall Study|Study terminated by sponsor|39
5838097|NCT02342548|20178123|P1|Overall Study|Study terminated by sponsor|20
5838098|NCT02342548|20178121|P3|Overall Study|Lost to Follow-up|0
5838099|NCT02342548|20178122|P2|Overall Study|Lost to Follow-up|1
5838100|NCT02342548|20178123|P1|Overall Study|Lost to Follow-up|0
5838101|NCT02342548|20178121|P3|Overall Study|Adverse Event|13
5838102|NCT02342548|20178122|P2|Overall Study|Adverse Event|17
5838103|NCT02342548|20178123|P1|Overall Study|Adverse Event|12
5838104|NCT02342418|20178167|P2|Overall Study|Adverse Event|1
5838105|NCT02342418|20178168|P1|Overall Study|Adverse Event|0
5838106|NCT02342288|20178347|P2|Overall Study|coordinator not available|2
5838107|NCT02342288|20178348|P1|Overall Study|coordinator not available|0
5838108|NCT02342288|20178347|P2|Overall Study|subject cannot tolerate numbing drops|1
5838109|NCT02342288|20178348|P1|Overall Study|subject cannot tolerate numbing drops|0
5838110|NCT02342288|20178347|P2|Overall Study|coordinator contaminated with blood|1
5838111|NCT02342288|20178348|P1|Overall Study|coordinator contaminated with blood|0
5838112|NCT02342288|20178347|P2|Overall Study|Withdrawal by Subject|0
5838113|NCT02342288|20178348|P1|Overall Study|Withdrawal by Subject|1
5838114|NCT02342288|20178347|P2|Overall Study|anesthesia leak in system|0
5838115|NCT02342288|20178348|P1|Overall Study|anesthesia leak in system|1
5838116|NCT02342288|20178347|P2|Overall Study|no protocol anesthesiologist available|2
5838117|NCT02342288|20178348|P1|Overall Study|no protocol anesthesiologist available|3
5838118|NCT02342223|20178354|P1|Overall Study|Lost to Follow-up|1
5838119|NCT02342171|20178374|P2|Overall Study|Missing age data|1
5838120|NCT02342171|20178375|P1|Overall Study|Missing age data|0
5838121|NCT02342171|20178374|P2|Overall Study|Unknown outcome|1
5838122|NCT02342171|20178375|P1|Overall Study|Unknown outcome|0
5838123|NCT02342171|20178374|P2|Overall Study|Missing cycle treshold value|0
5838124|NCT02342171|20178375|P1|Overall Study|Missing cycle treshold value|1
5838125|NCT02342171|20178374|P2|Overall Study|Received favipiravir|0
5838126|NCT02342171|20178375|P1|Overall Study|Received favipiravir|10
5838127|NCT02342171|20178374|P2|Overall Study|Death|87
5838128|NCT02342171|20178375|P1|Overall Study|Death|4
5838129|NCT02341482|20178629|P1|Overall Study|Adverse Event|1
5838130|NCT02341456|20178658|P3|Overall Study|Physician Decision|0
5838131|NCT02341456|20178659|P2|Overall Study|Physician Decision|0
5838132|NCT02341456|20178660|P1|Overall Study|Physician Decision|1
5838133|NCT02341456|20178658|P3|Overall Study|Moved to local access programme.|1
5838134|NCT02341456|20178659|P2|Overall Study|Moved to local access programme.|1
5838135|NCT02341456|20178660|P1|Overall Study|Moved to local access programme.|0
5838136|NCT02341456|20178658|P3|Overall Study|Withdrawal by Subject|1
5838137|NCT02341456|20178659|P2|Overall Study|Withdrawal by Subject|1
5838138|NCT02341456|20178660|P1|Overall Study|Withdrawal by Subject|0
5838139|NCT02341456|20178658|P3|Overall Study|Death|1
5838140|NCT02341456|20178659|P2|Overall Study|Death|1
5838141|NCT02341456|20178660|P1|Overall Study|Death|1
5838142|NCT02341456|20178658|P3|Overall Study|Disease progression|1
5838143|NCT02341456|20178659|P2|Overall Study|Disease progression|3
5838144|NCT02341456|20178660|P1|Overall Study|Disease progression|2
5838145|NCT02341417|20178785|P3|Overall Study|Death|1
5838146|NCT02341417|20178786|P2|Overall Study|Death|0
5838147|NCT02341417|20178787|P1|Overall Study|Death|0
5838148|NCT02341417|20178785|P3|Overall Study|Decision by sponsor|0
5838149|NCT02341417|20178786|P2|Overall Study|Decision by sponsor|0
5838150|NCT02341417|20178787|P1|Overall Study|Decision by sponsor|2
5838151|NCT02341417|20178785|P3|Overall Study|Withdrawal by Subject|0
5838152|NCT02341417|20178786|P2|Overall Study|Withdrawal by Subject|2
5838153|NCT02341417|20178787|P1|Overall Study|Withdrawal by Subject|0
5838154|NCT02340975|20178852|P6|Overall Study|Other|6
5838155|NCT02340975|20178853|P5|Overall Study|Other|0
5838156|NCT02340975|20178854|P4|Overall Study|Other|2
5838157|NCT02340975|20178855|P3|Overall Study|Other|0
5838158|NCT02340975|20178856|P2|Overall Study|Other|4
5838159|NCT02340975|20178857|P1|Overall Study|Other|0
5838160|NCT02340975|20178852|P6|Overall Study|Withdrawal by Subject|0
5838161|NCT02340975|20178853|P5|Overall Study|Withdrawal by Subject|2
5838162|NCT02340975|20178854|P4|Overall Study|Withdrawal by Subject|3
5838163|NCT02340975|20178855|P3|Overall Study|Withdrawal by Subject|3
5838164|NCT02340975|20178856|P2|Overall Study|Withdrawal by Subject|0
5838165|NCT02340975|20178857|P1|Overall Study|Withdrawal by Subject|0
5838166|NCT02340975|20178852|P6|Overall Study|Lost to Follow-up|0
5838167|NCT02340975|20178853|P5|Overall Study|Lost to Follow-up|2
5838168|NCT02340975|20178854|P4|Overall Study|Lost to Follow-up|0
5838169|NCT02340975|20178855|P3|Overall Study|Lost to Follow-up|0
5838170|NCT02340975|20178856|P2|Overall Study|Lost to Follow-up|0
5838171|NCT02340975|20178857|P1|Overall Study|Lost to Follow-up|0
5838172|NCT02340975|20178852|P6|Overall Study|Death|13
5838173|NCT02340975|20178853|P5|Overall Study|Death|21
5838174|NCT02340975|20178854|P4|Overall Study|Death|7
5838175|NCT02340975|20178855|P3|Overall Study|Death|21
5838176|NCT02340975|20178856|P2|Overall Study|Death|23
5838177|NCT02340975|20178857|P1|Overall Study|Death|6
5838178|NCT02340962|20178971|P2|Overall Study|Lost to Follow-up|0
5838179|NCT02340962|20178972|P1|Overall Study|Lost to Follow-up|1
5838180|NCT02340819|20178992|P1|Overall Study|Discontinued with other reason|1
5838181|NCT02340819|20178992|P1|Overall Study|Withdrawal by Subject|2
5838182|NCT02340819|20178992|P1|Overall Study|Adverse Event|1
5838183|NCT02340806|20179021|P2|Overall Study|re-dose < 90 min of CSE|3
5838184|NCT02340806|20179022|P1|Overall Study|re-dose < 90 min of CSE|1
5838185|NCT02340806|20179021|P2|Overall Study|history of chronic pain medication|0
5838186|NCT02340806|20179022|P1|Overall Study|history of chronic pain medication|1
5838187|NCT02340806|20179021|P2|Overall Study|epidural catheter replaced|1
5838188|NCT02340806|20179022|P1|Overall Study|epidural catheter replaced|2
5838189|NCT02340806|20179021|P2|Overall Study|Protocol Violation|0
5838190|NCT02340806|20179022|P1|Overall Study|Protocol Violation|2
5838191|NCT02340780|20179048|P1|Overall Study|Ineligible|1
5838192|NCT02340663|20179105|P2|Overall Study|Withdrawal by Subject|1
5838193|NCT02340663|20179106|P1|Overall Study|Withdrawal by Subject|3
5838194|NCT02340663|20179105|P2|Overall Study|Protocol Violation|0
5838195|NCT02340663|20179106|P1|Overall Study|Protocol Violation|1
5838196|NCT02340663|20179105|P2|Overall Study|Lost to Follow-up|0
5838197|NCT02340663|20179106|P1|Overall Study|Lost to Follow-up|1
5838198|NCT02340520|20179162|P1|Overall Study|Withdrawal by Subject|1
5838199|NCT02340520|20179162|P1|Overall Study|Patient did not take drug as specified|1
5838200|NCT02340520|20179162|P1|Overall Study|Lost to Follow-up|1
5838211|NCT02340078|20179249|P1|Overall Study|Protocol Violation|1
5838212|NCT02340000|20179256|P2|Time Period 2|Lost to Follow-up|8
5838213|NCT02340000|20179257|P1|Time Period 2|Lost to Follow-up|10
5838214|NCT02340000|20179256|P2|Time Period 2|Withdrawal by Subject|7
5838215|NCT02340000|20179257|P1|Time Period 2|Withdrawal by Subject|9
5838216|NCT02340000|20179256|P2|Time Period 1|Lost to Follow-up|7
5838217|NCT02340000|20179257|P1|Time Period 1|Lost to Follow-up|6
5838218|NCT02340000|20179256|P2|Time Period 1|Withdrawal by Subject|8
5838219|NCT02340000|20179257|P1|Time Period 1|Withdrawal by Subject|6
5838220|NCT02339909|20179287|P3|Overall Study|Became ineligible after randomisation|71
5838221|NCT02339909|20179288|P2|Overall Study|Became ineligible after randomisation|63
5838222|NCT02339909|20179289|P1|Overall Study|Became ineligible after randomisation|89
5838223|NCT02339584|20179327|P2|Overall Study|Withdrawal by Subject|4
5838224|NCT02339584|20179328|P1|Overall Study|Withdrawal by Subject|2
5838225|NCT02339584|20179327|P2|Overall Study|Protocol Violation|1
5838226|NCT02339584|20179328|P1|Overall Study|Protocol Violation|1
5838227|NCT02339584|20179327|P2|Overall Study|Physician Decision|2
5838228|NCT02339584|20179328|P1|Overall Study|Physician Decision|1
5838229|NCT02339584|20179327|P2|Overall Study|Lack of Efficacy|1
5838230|NCT02339584|20179328|P1|Overall Study|Lack of Efficacy|0
5838231|NCT02339584|20179327|P2|Overall Study|Adverse Event|7
5838232|NCT02339584|20179328|P1|Overall Study|Adverse Event|11
5838233|NCT02339506|20179348|P2|Washout (Period 2)|Withdrawal by Subject|0
5838234|NCT02339506|20179349|P1|Washout (Period 2)|Withdrawal by Subject|2
5838235|NCT02339506|20179348|P2|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|1
5838236|NCT02339506|20179349|P1|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|0
5838237|NCT02339285|20179378|P3|Overall Study|Protocol Deviation|0
5838238|NCT02339285|20179379|P2|Overall Study|Protocol Deviation|1
5838239|NCT02339285|20179380|P1|Overall Study|Protocol Deviation|0
5838240|NCT02339285|20179378|P3|Overall Study|Lost to Follow-up|1
5838241|NCT02339285|20179379|P2|Overall Study|Lost to Follow-up|1
5838242|NCT02339285|20179380|P1|Overall Study|Lost to Follow-up|1
5838243|NCT02339285|20179378|P3|Overall Study|Withdrawal by Subject|1
5838244|NCT02339285|20179379|P2|Overall Study|Withdrawal by Subject|1
5838245|NCT02339285|20179380|P1|Overall Study|Withdrawal by Subject|0
5838246|NCT02339155|20179426|P2|Overall Study|Withdrawal by Subject|4
5838247|NCT02339155|20179427|P1|Overall Study|Withdrawal by Subject|4
5838248|NCT02339155|20179426|P2|Overall Study|Physician Decision|1
5838249|NCT02339155|20179427|P1|Overall Study|Physician Decision|2
5838250|NCT02339155|20179426|P2|Overall Study|Lost to Follow-up|9
5838251|NCT02339155|20179427|P1|Overall Study|Lost to Follow-up|8
5838252|NCT02339155|20179426|P2|Overall Study|Death|1
5838253|NCT02339155|20179427|P1|Overall Study|Death|1
5838254|NCT02339155|20179426|P2|Overall Study|Adverse Event|6
5838255|NCT02339155|20179427|P1|Overall Study|Adverse Event|0
5838256|NCT02338882|20179633|P2|Overall Study|Lost to Follow-up|3
5838257|NCT02338882|20179634|P1|Overall Study|Lost to Follow-up|6
5838258|NCT02338882|20179633|P2|Overall Study|Death|0
5838259|NCT02338882|20179634|P1|Overall Study|Death|1
5838260|NCT02338843|20179672|P2|Overall Study|Discontinued prior to randomizat|0
5838261|NCT02338843|20179673|P1|Overall Study|Discontinued prior to randomizat|1
5838262|NCT02338843|20179672|P2|Overall Study|Subject Recovered|2
5838263|NCT02338843|20179673|P1|Overall Study|Subject Recovered|0
5838264|NCT02338843|20179672|P2|Overall Study|Withdrawal by Subject|2
5838265|NCT02338843|20179673|P1|Overall Study|Withdrawal by Subject|0
5838266|NCT02338843|20179672|P2|Overall Study|Physician Decision|0
5838267|NCT02338843|20179673|P1|Overall Study|Physician Decision|1
5838268|NCT02338843|20179672|P2|Overall Study|Death|53
5838269|NCT02338843|20179673|P1|Overall Study|Death|40
5838270|NCT02338843|20179672|P2|Overall Study|Adverse Event|1
5838271|NCT02338843|20179673|P1|Overall Study|Adverse Event|2
5838272|NCT02338492|20179701|P1|Overall Study|Reason not captured above|6
5838273|NCT02338492|20179701|P1|Overall Study|Lost to Follow-up|4
5838274|NCT02338492|20179701|P1|Overall Study|Adverse Event|3
5838275|NCT02338492|20179701|P1|Overall Study|Death|32
5838276|NCT02338362|20179717|P2|Overall Study|Withdrawal by Subject|1
5838277|NCT02338362|20179718|P1|Overall Study|Withdrawal by Subject|1
5838278|NCT02338193|20179748|P3|Overall Study|intolerant of side effects|0
5838279|NCT02338193|20179749|P2|Overall Study|intolerant of side effects|0
5838280|NCT02338193|20179750|P1|Overall Study|intolerant of side effects|1
5838281|NCT02338193|20179748|P3|Overall Study|moved out of state|0
5838282|NCT02338193|20179749|P2|Overall Study|moved out of state|1
5838283|NCT02338193|20179750|P1|Overall Study|moved out of state|0
5838284|NCT02338193|20179748|P3|Overall Study|Noncompliant with visits|7
5838285|NCT02338193|20179749|P2|Overall Study|Noncompliant with visits|2
5838286|NCT02338193|20179750|P1|Overall Study|Noncompliant with visits|2
5838287|NCT02338193|20179748|P3|Overall Study|Pregnancy|1
5838288|NCT02338193|20179749|P2|Overall Study|Pregnancy|1
5838289|NCT02338193|20179750|P1|Overall Study|Pregnancy|0
5838290|NCT02338193|20179748|P3|Overall Study|Withdrawal by Subject|2
5838291|NCT02338193|20179749|P2|Overall Study|Withdrawal by Subject|0
5838292|NCT02338193|20179750|P1|Overall Study|Withdrawal by Subject|0
5838293|NCT02338154|20179803|P1|Overall Study|Missing Exit Reason on Exit Form|1
5838294|NCT02338154|20179803|P1|Overall Study|Patients Without Exit Form|47
5838295|NCT02338154|20179803|P1|Overall Study|Other Reason|3
5838296|NCT02338154|20179803|P1|Overall Study|Lost to Follow-up|8
5838297|NCT02338154|20179803|P1|Overall Study|Withdrawal by Subject or by Investigator|10
5838298|NCT02338154|20179803|P1|Overall Study|Valve Explant|11
5838299|NCT02338154|20179803|P1|Overall Study|Valve Implant Failure|17
5838300|NCT02338154|20179803|P1|Overall Study|Death|46
5838301|NCT02337946|20179927|P3|Protocol Treatment 2 Period|Reason not specified|4
5838302|NCT02337946|20179928|P2|Protocol Treatment 2 Period|Reason not specified|4
5838303|NCT02337946|20179929|P1|Protocol Treatment 2 Period|Reason not specified|0
5838304|NCT02337946|20179927|P3|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|7
5838305|NCT02337946|20179928|P2|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|5
5838306|NCT02337946|20179929|P1|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|0
5838307|NCT02337946|20179927|P3|Protocol Treatment 2 Period|Death During Protocol Treatment|0
5838308|NCT02337946|20179928|P2|Protocol Treatment 2 Period|Death During Protocol Treatment|1
5838309|NCT02337946|20179929|P1|Protocol Treatment 2 Period|Death During Protocol Treatment|0
5838310|NCT02337946|20179927|P3|Protocol Treatment 2 Period|Lack of Efficacy|29
5838311|NCT02337946|20179928|P2|Protocol Treatment 2 Period|Lack of Efficacy|29
5838312|NCT02337946|20179929|P1|Protocol Treatment 2 Period|Lack of Efficacy|0
5838313|NCT02337946|20179927|P3|Protocol Treatment 2 Period|Voluntary Withdrawal|1
5838314|NCT02337946|20179928|P2|Protocol Treatment 2 Period|Voluntary Withdrawal|3
5838315|NCT02337946|20179929|P1|Protocol Treatment 2 Period|Voluntary Withdrawal|0
5838316|NCT02337946|20179927|P3|Protocol Treatment 2 Period|Adverse Event|9
5838317|NCT02337946|20179928|P2|Protocol Treatment 2 Period|Adverse Event|9
5838318|NCT02337946|20179929|P1|Protocol Treatment 2 Period|Adverse Event|0
5838319|NCT02337946|20179927|P3|In-between Period|Without Informed Consent|0
5838320|NCT02337946|20179928|P2|In-between Period|Without Informed Consent|0
5838321|NCT02337946|20179929|P1|In-between Period|Without Informed Consent|1
5838322|NCT02337946|20179927|P3|Protocol Treatment 1 Period|Reason not specified|0
5838323|NCT02337946|20179928|P2|Protocol Treatment 1 Period|Reason not specified|0
5838324|NCT02337946|20179929|P1|Protocol Treatment 1 Period|Reason not specified|8
5838325|NCT02337946|20179927|P3|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0
5838326|NCT02337946|20179928|P2|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0
5838327|NCT02337946|20179929|P1|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|1
5838328|NCT02337946|20179927|P3|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0
5838329|NCT02337946|20179928|P2|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0
5838330|NCT02337946|20179929|P1|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|9
5838331|NCT02337946|20179927|P3|Protocol Treatment 1 Period|Death During Protocol Treatment|0
5838332|NCT02337946|20179928|P2|Protocol Treatment 1 Period|Death During Protocol Treatment|0
5838333|NCT02337946|20179929|P1|Protocol Treatment 1 Period|Death During Protocol Treatment|3
5838334|NCT02337946|20179927|P3|Protocol Treatment 1 Period|Lack of Efficacy|0
5838335|NCT02337946|20179928|P2|Protocol Treatment 1 Period|Lack of Efficacy|0
5838336|NCT02337946|20179929|P1|Protocol Treatment 1 Period|Lack of Efficacy|15
5838337|NCT02337946|20179927|P3|Protocol Treatment 1 Period|Voluntary Withdrawal|0
5838338|NCT02337946|20179928|P2|Protocol Treatment 1 Period|Voluntary Withdrawal|0
5838339|NCT02337946|20179929|P1|Protocol Treatment 1 Period|Voluntary Withdrawal|6
5838340|NCT02337946|20179927|P3|Protocol Treatment 1 Period|Major Protocol Deviation|0
5838341|NCT02337946|20179928|P2|Protocol Treatment 1 Period|Major Protocol Deviation|0
5838342|NCT02337946|20179929|P1|Protocol Treatment 1 Period|Major Protocol Deviation|1
5838343|NCT02337946|20179927|P3|Protocol Treatment 1 Period|Adverse Event|0
5838344|NCT02337946|20179928|P2|Protocol Treatment 1 Period|Adverse Event|0
5838345|NCT02337946|20179929|P1|Protocol Treatment 1 Period|Adverse Event|7
5838346|NCT02337907|20179990|P6|Overall Study|Adverse Event|0
5838347|NCT02337907|20179991|P5|Overall Study|Adverse Event|4
5838348|NCT02337907|20179992|P4|Overall Study|Adverse Event|1
5838349|NCT02337907|20179993|P3|Overall Study|Adverse Event|1
5838350|NCT02337907|20179994|P2|Overall Study|Adverse Event|1
5838351|NCT02337907|20179995|P1|Overall Study|Adverse Event|1
5838352|NCT02337907|20179990|P6|Overall Study|Lost to Follow-up|1
5838353|NCT02337907|20179991|P5|Overall Study|Lost to Follow-up|0
5838354|NCT02337907|20179992|P4|Overall Study|Lost to Follow-up|0
5838355|NCT02337907|20179993|P3|Overall Study|Lost to Follow-up|0
5838356|NCT02337907|20179994|P2|Overall Study|Lost to Follow-up|0
5838357|NCT02337907|20179995|P1|Overall Study|Lost to Follow-up|0
5838358|NCT02337907|20179990|P6|Overall Study|Withdrawal by Subject|0
5838359|NCT02337907|20179991|P5|Overall Study|Withdrawal by Subject|5
5838360|NCT02337907|20179992|P4|Overall Study|Withdrawal by Subject|2
5838361|NCT02337907|20179993|P3|Overall Study|Withdrawal by Subject|0
5838362|NCT02337907|20179994|P2|Overall Study|Withdrawal by Subject|3
5838363|NCT02337907|20179995|P1|Overall Study|Withdrawal by Subject|2
5838364|NCT02337907|20179990|P6|Overall Study|Other than listed|0
5838365|NCT02337907|20179991|P5|Overall Study|Other than listed|1
5838366|NCT02337907|20179992|P4|Overall Study|Other than listed|1
5838367|NCT02337907|20179993|P3|Overall Study|Other than listed|0
5838368|NCT02337907|20179994|P2|Overall Study|Other than listed|0
5838369|NCT02337907|20179995|P1|Overall Study|Other than listed|1
5838370|NCT02337764|20180030|P1|Overall Study|Lack of Efficacy|2
5838371|NCT02337764|20180030|P1|Overall Study|Voluntary Withdrawal|12
5838372|NCT02337764|20180030|P1|Overall Study|Pretreatment Event/Adverse Event|46
5838373|NCT02337751|20180043|P2|Overall Study|Investigator's Judgement|0
5838374|NCT02337751|20180044|P1|Overall Study|Investigator's Judgement|1
5838375|NCT02337751|20180043|P2|Overall Study|Lack of Efficacy|5
5838376|NCT02337751|20180044|P1|Overall Study|Lack of Efficacy|2
5838377|NCT02337751|20180043|P2|Overall Study|Voluntary Withdrawal|8
5838378|NCT02337751|20180044|P1|Overall Study|Voluntary Withdrawal|6
5838379|NCT02337751|20180043|P2|Overall Study|Pretreatment Event/Adverse Event|3
5838380|NCT02337751|20180044|P1|Overall Study|Pretreatment Event/Adverse Event|2
5838381|NCT02337738|20180063|P3|Overall Study|Investigator's Judgment|3
5838382|NCT02337738|20180064|P2|Overall Study|Investigator's Judgment|1
5838383|NCT02337738|20180065|P1|Overall Study|Investigator's Judgment|1
5838384|NCT02337738|20180063|P3|Overall Study|Lack of Efficacy|0
5838385|NCT02337738|20180064|P2|Overall Study|Lack of Efficacy|4
5838386|NCT02337738|20180065|P1|Overall Study|Lack of Efficacy|2
5838387|NCT02337738|20180063|P3|Overall Study|Voluntary Withdrawal|2
5838388|NCT02337738|20180064|P2|Overall Study|Voluntary Withdrawal|5
5838389|NCT02337738|20180065|P1|Overall Study|Voluntary Withdrawal|10
5838390|NCT02337738|20180063|P3|Overall Study|Major Protocol Deviation (in-Treatment)|0
5838391|NCT02337738|20180064|P2|Overall Study|Major Protocol Deviation (in-Treatment)|1
5838392|NCT02337738|20180065|P1|Overall Study|Major Protocol Deviation (in-Treatment)|0
5838393|NCT02337738|20180063|P3|Overall Study|Pretreatment Event/Adverse Event|21
5838394|NCT02337738|20180064|P2|Overall Study|Pretreatment Event/Adverse Event|18
5838395|NCT02337738|20180065|P1|Overall Study|Pretreatment Event/Adverse Event|9
5838396|NCT02337738|20180063|P3|Overall Study|Major Protocol Deviation (Pre-Treatment)|0
5838397|NCT02337738|20180064|P2|Overall Study|Major Protocol Deviation (Pre-Treatment)|1
5838398|NCT02337738|20180065|P1|Overall Study|Major Protocol Deviation (Pre-Treatment)|0
5838399|NCT02337725|20180105|P2|Overall Study|Lack of Efficacy|0
5838400|NCT02337725|20180106|P1|Overall Study|Lack of Efficacy|4
5838401|NCT02337725|20180105|P2|Overall Study|Voluntary Withdrawal|3
5838402|NCT02337725|20180106|P1|Overall Study|Voluntary Withdrawal|14
5838403|NCT02337725|20180105|P2|Overall Study|Major Protocol Deviation|1
5838404|NCT02337725|20180106|P1|Overall Study|Major Protocol Deviation|0
5838405|NCT02337725|20180105|P2|Overall Study|Pretreatment Event/AE in Treatment|3
5838406|NCT02337725|20180106|P1|Overall Study|Pretreatment Event/AE in Treatment|8
5838407|NCT02337725|20180105|P2|Overall Study|Pretreatment Event/AE before Treatment|1
5838408|NCT02337725|20180106|P1|Overall Study|Pretreatment Event/AE before Treatment|0
5838409|NCT02337491|20180130|P2|Overall Study|On Treatment|0
5838410|NCT02337491|20180131|P1|Overall Study|On Treatment|2
5838411|NCT02337491|20180130|P2|Overall Study|Progressive Disease|28
5838412|NCT02337491|20180131|P1|Overall Study|Progressive Disease|44
5838413|NCT02337491|20180130|P2|Overall Study|Withdrawal by Subject|0
5838414|NCT02337491|20180131|P1|Overall Study|Withdrawal by Subject|3
5838415|NCT02337491|20180130|P2|Overall Study|Adverse Event|1
5838416|NCT02337491|20180131|P1|Overall Study|Adverse Event|0
5838417|NCT02337491|20180130|P2|Overall Study|Death|1
5838418|NCT02337491|20180131|P1|Overall Study|Death|1
5838419|NCT02337478|20180145|P1|Overall Study|Lack of Efficacy|5
5838420|NCT02337387|20180155|P4|Overall Study|Sponsor Decision to Terminate Study|3
5838421|NCT02337387|20180156|P3|Overall Study|Sponsor Decision to Terminate Study|3
5838422|NCT02337387|20180157|P2|Overall Study|Sponsor Decision to Terminate Study|7
5838423|NCT02337387|20180158|P1|Overall Study|Sponsor Decision to Terminate Study|14
5838424|NCT02337387|20180155|P4|Overall Study|Adverse Event|0
5838425|NCT02337387|20180156|P3|Overall Study|Adverse Event|0
5838426|NCT02337387|20180157|P2|Overall Study|Adverse Event|1
5838427|NCT02337387|20180158|P1|Overall Study|Adverse Event|0
5838428|NCT02337361|20180176|P2|6-month Follow-up|Lost to Follow-up|4
5838429|NCT02337361|20180177|P1|6-month Follow-up|Lost to Follow-up|2
5838430|NCT02337361|20180176|P2|3-month Follow-up|Lost to Follow-up|14
5838431|NCT02337361|20180177|P1|3-month Follow-up|Lost to Follow-up|19
5838432|NCT02336815|20180240|P2|Overall Study|Other|5
5838433|NCT02336815|20180241|P1|Overall Study|Other|1
5838434|NCT02336815|20180240|P2|Overall Study|Lost to Follow-up|3
5838435|NCT02336815|20180241|P1|Overall Study|Lost to Follow-up|1
5838436|NCT02336815|20180240|P2|Overall Study|Withdrawal by Subject|2
5838437|NCT02336815|20180241|P1|Overall Study|Withdrawal by Subject|3
5838438|NCT02336815|20180240|P2|Overall Study|Physician Decision|4
5838439|NCT02336815|20180241|P1|Overall Study|Physician Decision|11
5838440|NCT02336815|20180240|P2|Overall Study|Adverse Event|39
5838441|NCT02336815|20180241|P1|Overall Study|Adverse Event|18
5838442|NCT02336815|20180240|P2|Overall Study|Disease Progression|70
5838443|NCT02336815|20180241|P1|Overall Study|Disease Progression|45
5838444|NCT02336737|20180278|P1|Overall Study|Physician Decision|8
5838445|NCT02336737|20180278|P1|Overall Study|Withdrawal by Subject|5
5838446|NCT02336607|20180289|P4|Overall Study|Withdrawal by Subject|20
5838447|NCT02336607|20180290|P3|Overall Study|Withdrawal by Subject|0
5838448|NCT02336607|20180291|P2|Overall Study|Withdrawal by Subject|2
5838449|NCT02336607|20180292|P1|Overall Study|Withdrawal by Subject|0
5838450|NCT02336607|20180289|P4|Overall Study|Adverse Event|26
5838451|NCT02336607|20180290|P3|Overall Study|Adverse Event|2
5838452|NCT02336607|20180291|P2|Overall Study|Adverse Event|2
5838453|NCT02336607|20180292|P1|Overall Study|Adverse Event|0
5838454|NCT02336607|20180289|P4|Overall Study|Protocol Violation|3
5838455|NCT02336607|20180290|P3|Overall Study|Protocol Violation|1
5838456|NCT02336607|20180291|P2|Overall Study|Protocol Violation|1
5838457|NCT02336607|20180292|P1|Overall Study|Protocol Violation|0
5838458|NCT02336607|20180289|P4|Overall Study|Lost to Follow-up|21
5838459|NCT02336607|20180290|P3|Overall Study|Lost to Follow-up|0
5838460|NCT02336607|20180291|P2|Overall Study|Lost to Follow-up|1
5838461|NCT02336607|20180292|P1|Overall Study|Lost to Follow-up|2
5838462|NCT02336607|20180289|P4|Overall Study|Lack of Efficacy|2
5838463|NCT02336607|20180290|P3|Overall Study|Lack of Efficacy|0
5838464|NCT02336607|20180291|P2|Overall Study|Lack of Efficacy|0
5838465|NCT02336607|20180292|P1|Overall Study|Lack of Efficacy|1
5838466|NCT02336607|20180289|P4|Overall Study|Physician Decision|15
5838467|NCT02336607|20180290|P3|Overall Study|Physician Decision|3
5838468|NCT02336607|20180291|P2|Overall Study|Physician Decision|4
5838469|NCT02336607|20180292|P1|Overall Study|Physician Decision|1
5838470|NCT02336555|20180395|P2|Treatment Period 2 (28 Days)|Adverse Event|1
5838471|NCT02336555|20180396|P1|Treatment Period 2 (28 Days)|Adverse Event|0
5838472|NCT02336555|20180395|P2|Treatment Period 1 (28 Days)|Physician Decision|0
5838473|NCT02336555|20180396|P1|Treatment Period 1 (28 Days)|Physician Decision|2
5838474|NCT02336555|20180395|P2|Treatment Period 1 (28 Days)|Withdrawal by Subject|1
5838475|NCT02336555|20180396|P1|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
5838476|NCT02336451|20180409|P5|Overall Study|Patient/guardian decision|1
5838477|NCT02336451|20180410|P4|Overall Study|Patient/guardian decision|2
5838478|NCT02336451|20180411|P3|Overall Study|Patient/guardian decision|0
5838479|NCT02336451|20180412|P2|Overall Study|Patient/guardian decision|4
5838480|NCT02336451|20180413|P1|Overall Study|Patient/guardian decision|2
5838481|NCT02336451|20180409|P5|Overall Study|Protocol Violation|0
5838482|NCT02336451|20180410|P4|Overall Study|Protocol Violation|0
5838483|NCT02336451|20180411|P3|Overall Study|Protocol Violation|0
5838484|NCT02336451|20180412|P2|Overall Study|Protocol Violation|0
5838485|NCT02336451|20180413|P1|Overall Study|Protocol Violation|1
5838486|NCT02336451|20180409|P5|Overall Study|Progressive disease|4
5838487|NCT02336451|20180410|P4|Overall Study|Progressive disease|14
5838488|NCT02336451|20180411|P3|Overall Study|Progressive disease|2
5838489|NCT02336451|20180412|P2|Overall Study|Progressive disease|26
5838490|NCT02336451|20180413|P1|Overall Study|Progressive disease|23
5838491|NCT02336451|20180409|P5|Overall Study|Physician Decision|3
5838492|NCT02336451|20180410|P4|Overall Study|Physician Decision|16
5838493|NCT02336451|20180411|P3|Overall Study|Physician Decision|7
5838494|NCT02336451|20180412|P2|Overall Study|Physician Decision|6
5838495|NCT02336451|20180413|P1|Overall Study|Physician Decision|9
5838496|NCT02336451|20180409|P5|Overall Study|Death|6
5838497|NCT02336451|20180410|P4|Overall Study|Death|6
5838498|NCT02336451|20180411|P3|Overall Study|Death|3
5838499|NCT02336451|20180412|P2|Overall Study|Death|2
5838500|NCT02336451|20180413|P1|Overall Study|Death|6
5838501|NCT02336451|20180409|P5|Overall Study|Adverse Event|4
5838502|NCT02336451|20180410|P4|Overall Study|Adverse Event|6
5838503|NCT02336451|20180411|P3|Overall Study|Adverse Event|0
5838504|NCT02336451|20180412|P2|Overall Study|Adverse Event|2
5838505|NCT02336451|20180413|P1|Overall Study|Adverse Event|1
5838506|NCT02336425|20180570|P4|Overall Study|Study terminated.|3
5838507|NCT02336425|20180571|P3|Overall Study|Study terminated.|3
5838508|NCT02336425|20180572|P2|Overall Study|Study terminated.|2
5838509|NCT02336425|20180573|P1|Overall Study|Study terminated.|2
5838510|NCT02336373|20180623|P1|Overall Study|Physician Decision|14
5838511|NCT02336373|20180623|P1|Overall Study|Protocol closed early|4
5838512|NCT02336282|20180642|P1|Overall Study|Not enough time to complete sessions|2
5838513|NCT02336282|20180642|P1|Overall Study|Lost to Follow-up|1
5838514|NCT02336282|20180642|P1|Overall Study|Uncomfortable with technology|1
5838515|NCT02336282|20180642|P1|Overall Study|Unrelated illness|1
5838516|NCT02336178|20180666|P1|Overall Study|Other|1
5838517|NCT02336178|20180666|P1|Overall Study|Withdrawal by Subject|1
5838518|NCT02336178|20180666|P1|Overall Study|Protocol Violation|1
5838519|NCT02336178|20180666|P1|Overall Study|Lost to Follow-up|1
5838555|NCT02336074|20180795|P2|Overall Study|Adverse Event|2
5838556|NCT02336074|20180796|P1|Overall Study|Adverse Event|0
5838557|NCT02335983|20180819|P6|Overall Study|Protocol Specified Criteria|21
5838558|NCT02335983|20180820|P5|Overall Study|Protocol Specified Criteria|5
5838559|NCT02335983|20180821|P4|Overall Study|Protocol Specified Criteria|7
5838560|NCT02335983|20180822|P3|Overall Study|Protocol Specified Criteria|27
5838561|NCT02335983|20180823|P2|Overall Study|Protocol Specified Criteria|7
5838562|NCT02335983|20180824|P1|Overall Study|Protocol Specified Criteria|5
5838563|NCT02335983|20180819|P6|Overall Study|Lost to Follow-up|1
5838564|NCT02335983|20180820|P5|Overall Study|Lost to Follow-up|0
5838565|NCT02335983|20180821|P4|Overall Study|Lost to Follow-up|0
5838566|NCT02335983|20180822|P3|Overall Study|Lost to Follow-up|0
5838567|NCT02335983|20180823|P2|Overall Study|Lost to Follow-up|0
5838568|NCT02335983|20180824|P1|Overall Study|Lost to Follow-up|0
5838569|NCT02335983|20180819|P6|Overall Study|Death|0
5838570|NCT02335983|20180820|P5|Overall Study|Death|0
5838571|NCT02335983|20180821|P4|Overall Study|Death|0
5838572|NCT02335983|20180822|P3|Overall Study|Death|2
5838573|NCT02335983|20180823|P2|Overall Study|Death|0
5838574|NCT02335983|20180824|P1|Overall Study|Death|0
5838575|NCT02335983|20180819|P6|Overall Study|Withdrawal by Subject|9
5838576|NCT02335983|20180820|P5|Overall Study|Withdrawal by Subject|3
5838577|NCT02335983|20180821|P4|Overall Study|Withdrawal by Subject|1
5838578|NCT02335983|20180822|P3|Overall Study|Withdrawal by Subject|2
5838579|NCT02335983|20180823|P2|Overall Study|Withdrawal by Subject|2
5838580|NCT02335983|20180824|P1|Overall Study|Withdrawal by Subject|3
5838581|NCT02335983|20180819|P6|Overall Study|Sponsor Decision|1
5838582|NCT02335983|20180820|P5|Overall Study|Sponsor Decision|0
5838583|NCT02335983|20180821|P4|Overall Study|Sponsor Decision|1
5838584|NCT02335983|20180822|P3|Overall Study|Sponsor Decision|1
5838585|NCT02335983|20180823|P2|Overall Study|Sponsor Decision|0
5838586|NCT02335983|20180824|P1|Overall Study|Sponsor Decision|0
5838587|NCT02335658|20180931|P2|Overall Study|other reason|3
5838588|NCT02335658|20180932|P1|Overall Study|other reason|2
5838589|NCT02335658|20180931|P2|Overall Study|non-compliance|3
5838590|NCT02335658|20180932|P1|Overall Study|non-compliance|2
5838591|NCT02335658|20180931|P2|Overall Study|Withdrawal by Subject|21
5838592|NCT02335658|20180932|P1|Overall Study|Withdrawal by Subject|13
5838593|NCT02335658|20180931|P2|Overall Study|Pregnancy|0
5838594|NCT02335658|20180932|P1|Overall Study|Pregnancy|1
5838595|NCT02335658|20180931|P2|Overall Study|Lack of Efficacy|5
5838596|NCT02335658|20180932|P1|Overall Study|Lack of Efficacy|4
5838597|NCT02335658|20180931|P2|Overall Study|Adverse Event|12
5838598|NCT02335658|20180932|P1|Overall Study|Adverse Event|18
5838599|NCT02335489|20180947|P1|Overall Study|Lack of Efficacy|1
5838600|NCT02335489|20180947|P1|Overall Study|Physician Decision|2
5838601|NCT02335489|20180947|P1|Overall Study|Withdrawal by Subject|2
5838602|NCT02335489|20180947|P1|Overall Study|Lost to Follow-up|1
5838603|NCT02335489|20180947|P1|Overall Study|Sponsor terminated study|4
5838604|NCT02335450|20180951|P1|Overall Study|Pregnancy|1
5838605|NCT02335424|20180955|P1|Overall Study|Not treated|4
5838606|NCT02335424|20180955|P1|Overall Study|Physician Decision|3
5838607|NCT02335424|20180955|P1|Overall Study|Lost to Follow-up|2
5838608|NCT02335424|20180955|P1|Overall Study|Death|239
5838609|NCT02335424|20180955|P1|Overall Study|Adverse Event|25
5838610|NCT02335424|20180955|P1|Overall Study|Ongoing In Study|89
5838611|NCT02335424|20180955|P1|Overall Study|Withdrawal by Subject|12
5838612|NCT02335346|20180988|P1|Overall Study|Withdrawal by Subject|1
5838613|NCT02335346|20180988|P1|Overall Study|Adverse Event|11
5838614|NCT02334748|20181310|P1|Overall Study|Lack of Efficacy|4
5838615|NCT02334748|20181310|P1|Overall Study|Patient no longer required study drug|2
5838616|NCT02334748|20181310|P1|Overall Study|Inclusion in the CACZ8852306 study|1
5838617|NCT02334748|20181310|P1|Overall Study|Adverse Event|1
5838618|NCT02334423|20181341|P2|Overall Study|Protocol Violation|3
5838619|NCT02334423|20181342|P1|Overall Study|Protocol Violation|10
5838620|NCT02334384|20181356|P2|Overall Study|Lost to Follow-up|1
5838621|NCT02334384|20181357|P1|Overall Study|Lost to Follow-up|1
5838622|NCT02334306|20181369|P2|Double-blind Period|Withdrawal by Subject|1
5838623|NCT02334306|20181370|P1|Double-blind Period|Withdrawal by Subject|1
5838624|NCT02334306|20181369|P2|Double-blind Period|Adverse Event|1
5838625|NCT02334306|20181370|P1|Double-blind Period|Adverse Event|0
5838626|NCT02334215|20181408|P3|Overall Study|Incarcerated|7
5838627|NCT02334215|20181409|P2|Overall Study|Incarcerated|0
5838628|NCT02334215|20181410|P1|Overall Study|Incarcerated|0
5838629|NCT02334215|20181408|P3|Overall Study|Not released from incarceration on time|3
5838630|NCT02334215|20181409|P2|Overall Study|Not released from incarceration on time|3
5838631|NCT02334215|20181410|P1|Overall Study|Not released from incarceration on time|3
5838632|NCT02334215|20181408|P3|Overall Study|Withdrawal by Subject|1
5838633|NCT02334215|20181409|P2|Overall Study|Withdrawal by Subject|2
5838634|NCT02334215|20181410|P1|Overall Study|Withdrawal by Subject|2
5838635|NCT02334215|20181408|P3|Overall Study|Lost to Follow-up|4
5838636|NCT02334215|20181409|P2|Overall Study|Lost to Follow-up|0
5838637|NCT02334215|20181410|P1|Overall Study|Lost to Follow-up|1
5838638|NCT02334215|20181408|P3|Overall Study|Death|0
5838639|NCT02334215|20181409|P2|Overall Study|Death|1
5838640|NCT02334215|20181410|P1|Overall Study|Death|1
5838641|NCT02333630|20181490|P2|Overall Study|Lost to Follow-up|2
5838642|NCT02333630|20181491|P1|Overall Study|Lost to Follow-up|5
5838643|NCT02333487|20181506|P3|Overall Study|Adverse Event|0
5838644|NCT02333487|20181507|P2|Overall Study|Adverse Event|2
5838645|NCT02333487|20181508|P1|Overall Study|Adverse Event|0
5838646|NCT02333383|20181519|P1|Overall Study|Transfer to another hospital|2
5838647|NCT02333383|20181519|P1|Overall Study|Withdrawal by Subject|3
5838648|NCT02333383|20181519|P1|Overall Study|Lost to Follow-up|15
5838649|NCT02333383|20181519|P1|Overall Study|Adalimumab discontinuation|21
5838650|NCT02333331|20181533|P4|Overall Study|Patient/Guardian Decision|1
5838651|NCT02333331|20181534|P3|Overall Study|Patient/Guardian Decision|9
5838652|NCT02333331|20181535|P2|Overall Study|Patient/Guardian Decision|2
5838653|NCT02333331|20181536|P1|Overall Study|Patient/Guardian Decision|1
5838654|NCT02333331|20181533|P4|Overall Study|Protocol Deviation|1
5838655|NCT02333331|20181534|P3|Overall Study|Protocol Deviation|2
5838656|NCT02333331|20181535|P2|Overall Study|Protocol Deviation|3
5838657|NCT02333331|20181536|P1|Overall Study|Protocol Deviation|0
5838658|NCT02333331|20181533|P4|Overall Study|Physician Decision|0
5838659|NCT02333331|20181534|P3|Overall Study|Physician Decision|0
5838660|NCT02333331|20181535|P2|Overall Study|Physician Decision|1
5838661|NCT02333331|20181536|P1|Overall Study|Physician Decision|0
5838662|NCT02333331|20181533|P4|Overall Study|Lost to Follow-up|0
5838663|NCT02333331|20181534|P3|Overall Study|Lost to Follow-up|1
5838664|NCT02333331|20181535|P2|Overall Study|Lost to Follow-up|0
5838665|NCT02333331|20181536|P1|Overall Study|Lost to Follow-up|0
5838666|NCT02333331|20181533|P4|Overall Study|Death|0
5838667|NCT02333331|20181534|P3|Overall Study|Death|2
5838668|NCT02333331|20181535|P2|Overall Study|Death|0
5838669|NCT02333331|20181536|P1|Overall Study|Death|0
5838670|NCT02333331|20181533|P4|Overall Study|Adverse Event|1
5838671|NCT02333331|20181534|P3|Overall Study|Adverse Event|4
5838672|NCT02333331|20181535|P2|Overall Study|Adverse Event|0
5838673|NCT02333331|20181536|P1|Overall Study|Adverse Event|1
5838674|NCT02332915|20181616|P2|Overall Study|did not meet inclusion criteria|4
5838675|NCT02332915|20181617|P1|Overall Study|did not meet inclusion criteria|2
5838676|NCT02332915|20181616|P2|Overall Study|Travel distance prohibitive|1
5838677|NCT02332915|20181617|P1|Overall Study|Travel distance prohibitive|0
5838678|NCT02332915|20181616|P2|Overall Study|Unrelated illness|1
5838679|NCT02332915|20181617|P1|Overall Study|Unrelated illness|1
5838680|NCT02332915|20181616|P2|Overall Study|Moved out of region|0
5838681|NCT02332915|20181617|P1|Overall Study|Moved out of region|3
5838682|NCT02332889|20181630|P1|Overall Study|Physician Decision|1
5838683|NCT02332876|20181636|P2|Overall Study|Lost to Follow-up|1
5838684|NCT02332876|20181637|P1|Overall Study|Lost to Follow-up|1
5838685|NCT02332824|20181672|P6|Overall Study|Transfer|0
5838686|NCT02332824|20181673|P5|Overall Study|Transfer|0
5838687|NCT02332824|20181674|P4|Overall Study|Transfer|1
5838688|NCT02332824|20181675|P3|Overall Study|Transfer|1
5838689|NCT02332824|20181676|P2|Overall Study|Transfer|0
5838690|NCT02332824|20181677|P1|Overall Study|Transfer|0
5838691|NCT02332824|20181672|P6|Overall Study|Inconvenient schedule|0
5838692|NCT02332824|20181673|P5|Overall Study|Inconvenient schedule|0
5838693|NCT02332824|20181674|P4|Overall Study|Inconvenient schedule|0
5838694|NCT02332824|20181675|P3|Overall Study|Inconvenient schedule|0
5838695|NCT02332824|20181676|P2|Overall Study|Inconvenient schedule|1
5838696|NCT02332824|20181677|P1|Overall Study|Inconvenient schedule|1
5838697|NCT02332824|20181672|P6|Overall Study|Voluntary Withdrawal|0
5838698|NCT02332824|20181673|P5|Overall Study|Voluntary Withdrawal|0
5838699|NCT02332824|20181674|P4|Overall Study|Voluntary Withdrawal|0
5838700|NCT02332824|20181675|P3|Overall Study|Voluntary Withdrawal|0
5838701|NCT02332824|20181676|P2|Overall Study|Voluntary Withdrawal|0
5838702|NCT02332824|20181677|P1|Overall Study|Voluntary Withdrawal|1
5838703|NCT02332824|20181672|P6|Overall Study|Pretreatment Event/Adverse Event|1
5838704|NCT02332824|20181673|P5|Overall Study|Pretreatment Event/Adverse Event|4
5838705|NCT02332824|20181674|P4|Overall Study|Pretreatment Event/Adverse Event|1
5838706|NCT02332824|20181675|P3|Overall Study|Pretreatment Event/Adverse Event|1
5838707|NCT02332824|20181676|P2|Overall Study|Pretreatment Event/Adverse Event|0
5838708|NCT02332824|20181677|P1|Overall Study|Pretreatment Event/Adverse Event|4
5838709|NCT02332798|20181718|P3|Overall Study|Abnormal Laboratory Findings|0
5838710|NCT02332798|20181719|P2|Overall Study|Abnormal Laboratory Findings|0
5838711|NCT02332798|20181720|P1|Overall Study|Abnormal Laboratory Findings|1
5838712|NCT02332798|20181718|P3|Overall Study|Positive Urine Drug Test|0
5838713|NCT02332798|20181719|P2|Overall Study|Positive Urine Drug Test|1
5838714|NCT02332798|20181720|P1|Overall Study|Positive Urine Drug Test|0
5838715|NCT02332798|20181718|P3|Overall Study|Unwilling to Participate in Study|1
5838716|NCT02332798|20181719|P2|Overall Study|Unwilling to Participate in Study|1
5838717|NCT02332798|20181720|P1|Overall Study|Unwilling to Participate in Study|0
5838718|NCT02332720|20181793|P23|Part A and Part B|Withdrawal by Subject|0
5838719|NCT02332720|20181794|P22|Part A and Part B|Withdrawal by Subject|0
5838720|NCT02332720|20181795|P21|Part A and Part B|Withdrawal by Subject|0
5838721|NCT02332720|20181796|P20|Part A and Part B|Withdrawal by Subject|1
5838722|NCT02332720|20181797|P19|Part A and Part B|Withdrawal by Subject|0
5838723|NCT02332720|20181798|P18|Part A and Part B|Withdrawal by Subject|0
5838724|NCT02332720|20181799|P17|Part A and Part B|Withdrawal by Subject|0
5838725|NCT02332720|20181800|P16|Part A and Part B|Withdrawal by Subject|0
5838726|NCT02332720|20181801|P15|Part A and Part B|Withdrawal by Subject|0
5838727|NCT02332720|20181802|P14|Part A and Part B|Withdrawal by Subject|0
5838728|NCT02332720|20181803|P13|Part A and Part B|Withdrawal by Subject|0
5838729|NCT02332720|20181804|P12|Part A and Part B|Withdrawal by Subject|0
5838730|NCT02332720|20181805|P11|Part A and Part B|Withdrawal by Subject|0
5838731|NCT02332720|20181806|P10|Part A and Part B|Withdrawal by Subject|0
5838732|NCT02332720|20181807|P9|Part A and Part B|Withdrawal by Subject|0
5838733|NCT02332720|20181808|P8|Part A and Part B|Withdrawal by Subject|0
5838734|NCT02332720|20181809|P7|Part A and Part B|Withdrawal by Subject|0
5838735|NCT02332720|20181810|P6|Part A and Part B|Withdrawal by Subject|1
5838736|NCT02332720|20181811|P5|Part A and Part B|Withdrawal by Subject|0
5838737|NCT02332720|20181812|P4|Part A and Part B|Withdrawal by Subject|0
5838738|NCT02332720|20181813|P3|Part A and Part B|Withdrawal by Subject|0
5838739|NCT02332720|20181814|P2|Part A and Part B|Withdrawal by Subject|0
5838740|NCT02332720|20181815|P1|Part A and Part B|Withdrawal by Subject|0
5838741|NCT02332720|20181793|P23|Part A and Part B|Physician Decision|0
5838742|NCT02332720|20181794|P22|Part A and Part B|Physician Decision|0
5838743|NCT02332720|20181795|P21|Part A and Part B|Physician Decision|0
5838744|NCT02332720|20181796|P20|Part A and Part B|Physician Decision|0
5838745|NCT02332720|20181797|P19|Part A and Part B|Physician Decision|1
5838746|NCT02332720|20181798|P18|Part A and Part B|Physician Decision|0
5838747|NCT02332720|20181799|P17|Part A and Part B|Physician Decision|0
5838748|NCT02332720|20181800|P16|Part A and Part B|Physician Decision|0
5838749|NCT02332720|20181801|P15|Part A and Part B|Physician Decision|0
5838750|NCT02332720|20181802|P14|Part A and Part B|Physician Decision|0
5838751|NCT02332720|20181803|P13|Part A and Part B|Physician Decision|0
5838752|NCT02332720|20181804|P12|Part A and Part B|Physician Decision|0
5838753|NCT02332720|20181805|P11|Part A and Part B|Physician Decision|0
5838754|NCT02332720|20181806|P10|Part A and Part B|Physician Decision|0
5838755|NCT02332720|20181807|P9|Part A and Part B|Physician Decision|0
5838756|NCT02332720|20181808|P8|Part A and Part B|Physician Decision|0
5838757|NCT02332720|20181809|P7|Part A and Part B|Physician Decision|0
5838758|NCT02332720|20181810|P6|Part A and Part B|Physician Decision|0
5838759|NCT02332720|20181811|P5|Part A and Part B|Physician Decision|0
5838760|NCT02332720|20181812|P4|Part A and Part B|Physician Decision|0
5838761|NCT02332720|20181813|P3|Part A and Part B|Physician Decision|0
5838762|NCT02332720|20181814|P2|Part A and Part B|Physician Decision|0
5838763|NCT02332720|20181815|P1|Part A and Part B|Physician Decision|0
5838764|NCT02332720|20181793|P23|Part A and Part B|Adverse Event|0
5838765|NCT02332720|20181794|P22|Part A and Part B|Adverse Event|0
5838766|NCT02332720|20181795|P21|Part A and Part B|Adverse Event|0
5838767|NCT02332720|20181796|P20|Part A and Part B|Adverse Event|0
5838768|NCT02332720|20181797|P19|Part A and Part B|Adverse Event|0
5838769|NCT02332720|20181798|P18|Part A and Part B|Adverse Event|1
5838770|NCT02332720|20181799|P17|Part A and Part B|Adverse Event|0
5838771|NCT02332720|20181800|P16|Part A and Part B|Adverse Event|0
5838772|NCT02332720|20181801|P15|Part A and Part B|Adverse Event|0
5838773|NCT02332720|20181802|P14|Part A and Part B|Adverse Event|0
5838774|NCT02332720|20181803|P13|Part A and Part B|Adverse Event|0
5838775|NCT02332720|20181804|P12|Part A and Part B|Adverse Event|0
5838776|NCT02332720|20181805|P11|Part A and Part B|Adverse Event|0
5838777|NCT02332720|20181806|P10|Part A and Part B|Adverse Event|0
5838778|NCT02332720|20181807|P9|Part A and Part B|Adverse Event|0
5838779|NCT02332720|20181808|P8|Part A and Part B|Adverse Event|0
5838780|NCT02332720|20181809|P7|Part A and Part B|Adverse Event|0
5838781|NCT02332720|20181810|P6|Part A and Part B|Adverse Event|0
5838782|NCT02332720|20181811|P5|Part A and Part B|Adverse Event|0
5838783|NCT02332720|20181812|P4|Part A and Part B|Adverse Event|0
5838784|NCT02332720|20181813|P3|Part A and Part B|Adverse Event|0
5838785|NCT02332720|20181814|P2|Part A and Part B|Adverse Event|0
5838786|NCT02332720|20181815|P1|Part A and Part B|Adverse Event|0
5838787|NCT02332720|20181793|P23|Part A and Part B|Lost to Follow-up|0
5838788|NCT02332720|20181794|P22|Part A and Part B|Lost to Follow-up|0
5838789|NCT02332720|20181795|P21|Part A and Part B|Lost to Follow-up|0
5838790|NCT02332720|20181796|P20|Part A and Part B|Lost to Follow-up|0
5838791|NCT02332720|20181797|P19|Part A and Part B|Lost to Follow-up|0
5838792|NCT02332720|20181798|P18|Part A and Part B|Lost to Follow-up|0
5838793|NCT02332720|20181799|P17|Part A and Part B|Lost to Follow-up|0
5838794|NCT02332720|20181800|P16|Part A and Part B|Lost to Follow-up|1
5838795|NCT02332720|20181801|P15|Part A and Part B|Lost to Follow-up|0
5838796|NCT02332720|20181802|P14|Part A and Part B|Lost to Follow-up|0
5838797|NCT02332720|20181803|P13|Part A and Part B|Lost to Follow-up|0
5838798|NCT02332720|20181804|P12|Part A and Part B|Lost to Follow-up|0
5838799|NCT02332720|20181805|P11|Part A and Part B|Lost to Follow-up|0
5838800|NCT02332720|20181806|P10|Part A and Part B|Lost to Follow-up|0
5838801|NCT02332720|20181807|P9|Part A and Part B|Lost to Follow-up|0
5838802|NCT02332720|20181808|P8|Part A and Part B|Lost to Follow-up|1
5838803|NCT02332720|20181809|P7|Part A and Part B|Lost to Follow-up|1
5838804|NCT02332720|20181810|P6|Part A and Part B|Lost to Follow-up|2
5838805|NCT02332720|20181811|P5|Part A and Part B|Lost to Follow-up|0
5838806|NCT02332720|20181812|P4|Part A and Part B|Lost to Follow-up|0
5838807|NCT02332720|20181813|P3|Part A and Part B|Lost to Follow-up|0
5838808|NCT02332720|20181814|P2|Part A and Part B|Lost to Follow-up|0
5838809|NCT02332720|20181815|P1|Part A and Part B|Lost to Follow-up|1
5838810|NCT02332707|20181951|P18|Overall Study|Withdrawal by Subject|0
5838811|NCT02332707|20181952|P17|Overall Study|Withdrawal by Subject|0
5838812|NCT02332707|20181953|P16|Overall Study|Withdrawal by Subject|0
5838813|NCT02332707|20181954|P15|Overall Study|Withdrawal by Subject|0
5838814|NCT02332707|20181955|P14|Overall Study|Withdrawal by Subject|0
5838815|NCT02332707|20181956|P13|Overall Study|Withdrawal by Subject|0
5838816|NCT02332707|20181957|P12|Overall Study|Withdrawal by Subject|0
5838817|NCT02332707|20181958|P11|Overall Study|Withdrawal by Subject|0
5838818|NCT02332707|20181959|P10|Overall Study|Withdrawal by Subject|3
5838819|NCT02332707|20181960|P9|Overall Study|Withdrawal by Subject|0
5838820|NCT02332707|20181961|P8|Overall Study|Withdrawal by Subject|0
5838821|NCT02332707|20181962|P7|Overall Study|Withdrawal by Subject|0
5838822|NCT02332707|20181963|P6|Overall Study|Withdrawal by Subject|0
5838823|NCT02332707|20181964|P5|Overall Study|Withdrawal by Subject|0
5838824|NCT02332707|20181965|P4|Overall Study|Withdrawal by Subject|0
5838825|NCT02332707|20181966|P3|Overall Study|Withdrawal by Subject|1
5838826|NCT02332707|20181967|P2|Overall Study|Withdrawal by Subject|0
5838827|NCT02332707|20181968|P1|Overall Study|Withdrawal by Subject|0
5838828|NCT02332707|20181951|P18|Overall Study|Physician Decision|0
5838829|NCT02332707|20181952|P17|Overall Study|Physician Decision|0
5838830|NCT02332707|20181953|P16|Overall Study|Physician Decision|0
5838831|NCT02332707|20181954|P15|Overall Study|Physician Decision|0
5838832|NCT02332707|20181955|P14|Overall Study|Physician Decision|0
5838833|NCT02332707|20181956|P13|Overall Study|Physician Decision|1
5838834|NCT02332707|20181957|P12|Overall Study|Physician Decision|0
5838835|NCT02332707|20181958|P11|Overall Study|Physician Decision|0
5838836|NCT02332707|20181959|P10|Overall Study|Physician Decision|0
5838837|NCT02332707|20181960|P9|Overall Study|Physician Decision|0
5838838|NCT02332707|20181961|P8|Overall Study|Physician Decision|0
5838839|NCT02332707|20181962|P7|Overall Study|Physician Decision|0
5838840|NCT02332707|20181963|P6|Overall Study|Physician Decision|0
5838841|NCT02332707|20181964|P5|Overall Study|Physician Decision|0
5838842|NCT02332707|20181965|P4|Overall Study|Physician Decision|1
5838843|NCT02332707|20181966|P3|Overall Study|Physician Decision|0
5838844|NCT02332707|20181967|P2|Overall Study|Physician Decision|0
5838845|NCT02332707|20181968|P1|Overall Study|Physician Decision|0
5838846|NCT02332707|20181951|P18|Overall Study|Lost to Follow-up|0
5838847|NCT02332707|20181952|P17|Overall Study|Lost to Follow-up|0
5838848|NCT02332707|20181953|P16|Overall Study|Lost to Follow-up|0
5838849|NCT02332707|20181954|P15|Overall Study|Lost to Follow-up|0
5838850|NCT02332707|20181955|P14|Overall Study|Lost to Follow-up|0
5838851|NCT02332707|20181956|P13|Overall Study|Lost to Follow-up|3
5838852|NCT02332707|20181957|P12|Overall Study|Lost to Follow-up|0
5838853|NCT02332707|20181958|P11|Overall Study|Lost to Follow-up|2
5838854|NCT02332707|20181959|P10|Overall Study|Lost to Follow-up|0
5838855|NCT02332707|20181960|P9|Overall Study|Lost to Follow-up|0
5838856|NCT02332707|20181961|P8|Overall Study|Lost to Follow-up|0
5838857|NCT02332707|20181962|P7|Overall Study|Lost to Follow-up|0
5838858|NCT02332707|20181963|P6|Overall Study|Lost to Follow-up|1
5838859|NCT02332707|20181964|P5|Overall Study|Lost to Follow-up|0
5838860|NCT02332707|20181965|P4|Overall Study|Lost to Follow-up|0
5838861|NCT02332707|20181966|P3|Overall Study|Lost to Follow-up|0
5838862|NCT02332707|20181967|P2|Overall Study|Lost to Follow-up|0
5838863|NCT02332707|20181968|P1|Overall Study|Lost to Follow-up|0
5838864|NCT02332707|20181951|P18|Overall Study|Adverse Event|0
5838865|NCT02332707|20181952|P17|Overall Study|Adverse Event|0
5838866|NCT02332707|20181953|P16|Overall Study|Adverse Event|0
5838867|NCT02332707|20181954|P15|Overall Study|Adverse Event|0
5838868|NCT02332707|20181955|P14|Overall Study|Adverse Event|0
5838869|NCT02332707|20181956|P13|Overall Study|Adverse Event|1
5838870|NCT02332707|20181957|P12|Overall Study|Adverse Event|0
5838871|NCT02332707|20181958|P11|Overall Study|Adverse Event|0
5838872|NCT02332707|20181959|P10|Overall Study|Adverse Event|0
5838873|NCT02332707|20181960|P9|Overall Study|Adverse Event|0
5838874|NCT02332707|20181961|P8|Overall Study|Adverse Event|0
5838875|NCT02332707|20181962|P7|Overall Study|Adverse Event|0
5838876|NCT02332707|20181963|P6|Overall Study|Adverse Event|0
5838877|NCT02332707|20181964|P5|Overall Study|Adverse Event|0
5838878|NCT02332707|20181965|P4|Overall Study|Adverse Event|0
5838879|NCT02332707|20181966|P3|Overall Study|Adverse Event|0
5838880|NCT02332707|20181967|P2|Overall Study|Adverse Event|0
5838881|NCT02332707|20181968|P1|Overall Study|Adverse Event|0
5838882|NCT02332239|20182062|P2|Overall Study|Lost to Follow-up|6
5838883|NCT02332239|20182063|P1|Overall Study|Lost to Follow-up|4
5838884|NCT02331680|20182099|P3|Overall Study|Protocol Violation|3
5838885|NCT02331680|20182100|P2|Overall Study|Protocol Violation|0
5838886|NCT02331680|20182101|P1|Overall Study|Protocol Violation|0
5838887|NCT02331680|20182099|P3|Overall Study|Non-compliance with study drug|1
5838888|NCT02331680|20182100|P2|Overall Study|Non-compliance with study drug|0
5838889|NCT02331680|20182101|P1|Overall Study|Non-compliance with study drug|0
5838890|NCT02331680|20182099|P3|Overall Study|Met withdrawal criteria|5
5838891|NCT02331680|20182100|P2|Overall Study|Met withdrawal criteria|2
5838892|NCT02331680|20182101|P1|Overall Study|Met withdrawal criteria|2
5838893|NCT02331680|20182099|P3|Overall Study|Withdrawal by Subject|2
5838894|NCT02331680|20182100|P2|Overall Study|Withdrawal by Subject|1
5838895|NCT02331680|20182101|P1|Overall Study|Withdrawal by Subject|0
5838896|NCT02331680|20182099|P3|Overall Study|Physician Decision|2
5838897|NCT02331680|20182100|P2|Overall Study|Physician Decision|1
5838898|NCT02331680|20182101|P1|Overall Study|Physician Decision|1
5838899|NCT02331680|20182099|P3|Overall Study|Adverse Event|2
5838900|NCT02331680|20182100|P2|Overall Study|Adverse Event|0
5838901|NCT02331680|20182101|P1|Overall Study|Adverse Event|3
5838902|NCT02331446|20182131|P4|Overall Study|Lost before baseline analysis|0
5838903|NCT02331446|20182132|P3|Overall Study|Lost before baseline analysis|1
5838904|NCT02331446|20182133|P2|Overall Study|Lost before baseline analysis|1
5838905|NCT02331446|20182134|P1|Overall Study|Lost before baseline analysis|0
5838906|NCT02331446|20182131|P4|Overall Study|Physician Decision|1
5838907|NCT02331446|20182132|P3|Overall Study|Physician Decision|0
5838908|NCT02331446|20182133|P2|Overall Study|Physician Decision|1
5838909|NCT02331446|20182134|P1|Overall Study|Physician Decision|0
5838910|NCT02331446|20182131|P4|Overall Study|Disease|1
5838911|NCT02331446|20182132|P3|Overall Study|Disease|2
5838912|NCT02331446|20182133|P2|Overall Study|Disease|2
5838913|NCT02331446|20182134|P1|Overall Study|Disease|0
5838914|NCT02331446|20182131|P4|Overall Study|Personal Problem|0
5838915|NCT02331446|20182132|P3|Overall Study|Personal Problem|0
5838916|NCT02331446|20182133|P2|Overall Study|Personal Problem|0
5838917|NCT02331446|20182134|P1|Overall Study|Personal Problem|2
5838918|NCT02331446|20182131|P4|Overall Study|Lost to Follow-up|1
5838919|NCT02331446|20182132|P3|Overall Study|Lost to Follow-up|0
5838920|NCT02331446|20182133|P2|Overall Study|Lost to Follow-up|1
5838921|NCT02331446|20182134|P1|Overall Study|Lost to Follow-up|2
5838922|NCT02331394|20182210|P1|Overall Study|Disease progression|1
5838923|NCT02331368|20182221|P1|Overall Study|Withdrawal by Subject|3
5838924|NCT02330549|20182346|P2|Overall Study|Failure to meet randomization criteria|0
5838925|NCT02330549|20182347|P1|Overall Study|Failure to meet randomization criteria|1
5838926|NCT02330549|20182346|P2|Overall Study|Subject withdrew consent|1
5838927|NCT02330549|20182347|P1|Overall Study|Subject withdrew consent|2
5838928|NCT02330549|20182346|P2|Overall Study|Adverse Event|0
5838929|NCT02330549|20182347|P1|Overall Study|Adverse Event|1
5838930|NCT02330081|20182563|P1|Overall Study|Protocol Violation|6
5838931|NCT02330081|20182563|P1|Overall Study|Donation did not meet criteria|1
5838932|NCT02330081|20182563|P1|Overall Study|Adverse Event|1
5838933|NCT02330055|20182584|P2|Overall Study|participant did not sleep|1
5838934|NCT02330055|20182585|P1|Overall Study|participant did not sleep|0
5838935|NCT02330055|20182584|P2|Overall Study|data for less than 60 minutes|3
5838936|NCT02330055|20182585|P1|Overall Study|data for less than 60 minutes|3
5838937|NCT02330055|20182584|P2|Overall Study|participant forgot to wear device|5
5838938|NCT02330055|20182585|P1|Overall Study|participant forgot to wear device|5
5838939|NCT02330055|20182584|P2|Overall Study|technical issues|0
5838940|NCT02330055|20182585|P1|Overall Study|technical issues|2
5838941|NCT02329743|20182631|P3|Overall Study|Other|3
5838942|NCT02329743|20182632|P2|Overall Study|Other|2
5838943|NCT02329743|20182633|P1|Overall Study|Other|0
5838944|NCT02329743|20182631|P3|Overall Study|Withdrawal by Subject|1
5838945|NCT02329743|20182632|P2|Overall Study|Withdrawal by Subject|4
5838946|NCT02329743|20182633|P1|Overall Study|Withdrawal by Subject|4
5838947|NCT02329743|20182631|P3|Overall Study|Lost to Follow-up|1
5838948|NCT02329743|20182632|P2|Overall Study|Lost to Follow-up|0
5838949|NCT02329743|20182633|P1|Overall Study|Lost to Follow-up|1
5838950|NCT02329743|20182631|P3|Overall Study|Adverse Event|3
5838951|NCT02329743|20182632|P2|Overall Study|Adverse Event|1
5838952|NCT02329743|20182633|P1|Overall Study|Adverse Event|1
5838953|NCT02329730|20182648|P12|Overall Study|Withdrawal by Subject|0
5838954|NCT02329730|20182649|P11|Overall Study|Withdrawal by Subject|0
5838955|NCT02329730|20182650|P10|Overall Study|Withdrawal by Subject|1
5838956|NCT02329730|20182651|P9|Overall Study|Withdrawal by Subject|1
5838957|NCT02329730|20182652|P8|Overall Study|Withdrawal by Subject|1
5838958|NCT02329730|20182653|P7|Overall Study|Withdrawal by Subject|1
5838959|NCT02329730|20182654|P6|Overall Study|Withdrawal by Subject|0
5838960|NCT02329730|20182655|P5|Overall Study|Withdrawal by Subject|1
5838961|NCT02329730|20182656|P4|Overall Study|Withdrawal by Subject|0
5838962|NCT02329730|20182657|P3|Overall Study|Withdrawal by Subject|0
5838963|NCT02329730|20182658|P2|Overall Study|Withdrawal by Subject|0
5838964|NCT02329730|20182659|P1|Overall Study|Withdrawal by Subject|0
5838965|NCT02329730|20182648|P12|Overall Study|Protocol Violation|0
5838966|NCT02329730|20182649|P11|Overall Study|Protocol Violation|0
5838967|NCT02329730|20182650|P10|Overall Study|Protocol Violation|0
5838968|NCT02329730|20182651|P9|Overall Study|Protocol Violation|0
5838969|NCT02329730|20182652|P8|Overall Study|Protocol Violation|0
5838970|NCT02329730|20182653|P7|Overall Study|Protocol Violation|0
5838971|NCT02329730|20182654|P6|Overall Study|Protocol Violation|2
5838972|NCT02329730|20182655|P5|Overall Study|Protocol Violation|2
5838973|NCT02329730|20182656|P4|Overall Study|Protocol Violation|0
5838974|NCT02329730|20182657|P3|Overall Study|Protocol Violation|0
5838975|NCT02329730|20182658|P2|Overall Study|Protocol Violation|0
5838976|NCT02329730|20182659|P1|Overall Study|Protocol Violation|0
5838977|NCT02329431|20182770|P2|Overall Study|Lost to Follow-up|13
5838978|NCT02329431|20182771|P1|Overall Study|Lost to Follow-up|20
5838979|NCT02329223|20182790|P3|Overall Study|Adverse Event|0
5838980|NCT02329223|20182791|P2|Overall Study|Adverse Event|1
5838981|NCT02329223|20182792|P1|Overall Study|Adverse Event|0
5838982|NCT02329223|20182790|P3|Overall Study|Physician Decision|1
5838983|NCT02329223|20182791|P2|Overall Study|Physician Decision|0
5838984|NCT02329223|20182792|P1|Overall Study|Physician Decision|0
5838985|NCT02329223|20182790|P3|Overall Study|Withdrawal by Subject|5
5838986|NCT02329223|20182791|P2|Overall Study|Withdrawal by Subject|2
5838987|NCT02329223|20182792|P1|Overall Study|Withdrawal by Subject|1
5838988|NCT02328937|20182842|P6|Period 2|Adverse Event|0
5838989|NCT02328937|20182843|P5|Period 2|Adverse Event|0
5838990|NCT02328937|20182844|P4|Period 2|Adverse Event|0
5838991|NCT02328937|20182845|P3|Period 2|Adverse Event|1
5838992|NCT02328937|20182846|P2|Period 2|Adverse Event|0
5838993|NCT02328937|20182847|P1|Period 2|Adverse Event|0
5838994|NCT02328937|20182842|P6|Period 1|Lost to Follow-up|0
5838995|NCT02328937|20182843|P5|Period 1|Lost to Follow-up|0
5838996|NCT02328937|20182844|P4|Period 1|Lost to Follow-up|1
5838997|NCT02328937|20182845|P3|Period 1|Lost to Follow-up|0
5838998|NCT02328937|20182846|P2|Period 1|Lost to Follow-up|0
5838999|NCT02328937|20182847|P1|Period 1|Lost to Follow-up|0
5839000|NCT02328547|20182867|P2|First Intervention (12 Weeks)|Withdrawal by Subject|0
5839001|NCT02328547|20182868|P1|First Intervention (12 Weeks)|Withdrawal by Subject|2
5839002|NCT02328547|20182867|P2|First Intervention (12 Weeks)|Lost to Follow-up|0
5839003|NCT02328547|20182868|P1|First Intervention (12 Weeks)|Lost to Follow-up|1
5839004|NCT02328326|20182945|P2|Overall Study|Lost to Follow-up|4
5839005|NCT02328326|20182946|P1|Overall Study|Lost to Follow-up|10
5839006|NCT02328326|20182945|P2|Overall Study|Death|1
5839007|NCT02328326|20182946|P1|Overall Study|Death|2
5839008|NCT02328326|20182945|P2|Overall Study|Withdrawal by Subject|3
5839009|NCT02328326|20182946|P1|Overall Study|Withdrawal by Subject|10
5839010|NCT02328105|20182954|P1|Overall Study|Still On Study in Follow-Up|4
5839011|NCT02328105|20182954|P1|Overall Study|Withdrawal by Subject|1
5839012|NCT02328105|20182954|P1|Overall Study|Death|6
5839013|NCT02328040|20182963|P2|First Intervention (2 Days)|Withdrawal by Subject|1
5839014|NCT02328040|20182964|P1|First Intervention (2 Days)|Withdrawal by Subject|1
5839015|NCT02328027|20182974|P2|Overall Study|Withdrawal by Subject|1
5839016|NCT02328027|20182975|P1|Overall Study|Withdrawal by Subject|0
5839017|NCT02327325|20183034|P3|Overall Study|Excluded by Study Team|1
5839018|NCT02327325|20183035|P2|Overall Study|Excluded by Study Team|0
5839019|NCT02327325|20183036|P1|Overall Study|Excluded by Study Team|0
5839020|NCT02327325|20183034|P3|Overall Study|Withdrawal by Subject|4
5839021|NCT02327325|20183035|P2|Overall Study|Withdrawal by Subject|4
5839022|NCT02327325|20183036|P1|Overall Study|Withdrawal by Subject|1
5839023|NCT02327260|20183059|P3|Overall Study|cognitive concerns|0
5839024|NCT02327260|20183060|P2|Overall Study|cognitive concerns|0
5839025|NCT02327260|20183061|P1|Overall Study|cognitive concerns|1
5839026|NCT02327260|20183059|P3|Overall Study|non-adherence to protocol|0
5839027|NCT02327260|20183060|P2|Overall Study|non-adherence to protocol|0
5839028|NCT02327260|20183061|P1|Overall Study|non-adherence to protocol|2
5839029|NCT02327260|20183059|P3|Overall Study|invalid phone number|0
5839030|NCT02327260|20183060|P2|Overall Study|invalid phone number|1
5839031|NCT02327260|20183061|P1|Overall Study|invalid phone number|1
5839032|NCT02327260|20183059|P3|Overall Study|Lost to Follow-up|2
5839033|NCT02327260|20183060|P2|Overall Study|Lost to Follow-up|3
5839034|NCT02327260|20183061|P1|Overall Study|Lost to Follow-up|2
5839035|NCT02327169|20183108|P15|Overall Study|Lost to Follow-up|0
5839036|NCT02327169|20183109|P14|Overall Study|Lost to Follow-up|0
5839037|NCT02327169|20183110|P13|Overall Study|Lost to Follow-up|0
5839038|NCT02327169|20183111|P12|Overall Study|Lost to Follow-up|0
5839039|NCT02327169|20183112|P11|Overall Study|Lost to Follow-up|0
5839040|NCT02327169|20183113|P10|Overall Study|Lost to Follow-up|0
5839041|NCT02327169|20183114|P9|Overall Study|Lost to Follow-up|0
5839042|NCT02327169|20183115|P8|Overall Study|Lost to Follow-up|0
5839043|NCT02327169|20183116|P7|Overall Study|Lost to Follow-up|0
5839044|NCT02327169|20183117|P6|Overall Study|Lost to Follow-up|0
5839045|NCT02327169|20183118|P5|Overall Study|Lost to Follow-up|1
5839046|NCT02327169|20183119|P4|Overall Study|Lost to Follow-up|0
5839047|NCT02327169|20183120|P3|Overall Study|Lost to Follow-up|0
5839048|NCT02327169|20183121|P2|Overall Study|Lost to Follow-up|0
5839049|NCT02327169|20183122|P1|Overall Study|Lost to Follow-up|0
5839050|NCT02327169|20183108|P15|Overall Study|Withdrawal by Subject|3
5839051|NCT02327169|20183109|P14|Overall Study|Withdrawal by Subject|0
5839052|NCT02327169|20183110|P13|Overall Study|Withdrawal by Subject|0
5839053|NCT02327169|20183111|P12|Overall Study|Withdrawal by Subject|0
5839054|NCT02327169|20183112|P11|Overall Study|Withdrawal by Subject|0
5839055|NCT02327169|20183113|P10|Overall Study|Withdrawal by Subject|0
5839056|NCT02327169|20183114|P9|Overall Study|Withdrawal by Subject|0
5839057|NCT02327169|20183115|P8|Overall Study|Withdrawal by Subject|1
5839058|NCT02327169|20183116|P7|Overall Study|Withdrawal by Subject|0
5839059|NCT02327169|20183117|P6|Overall Study|Withdrawal by Subject|0
5839060|NCT02327169|20183118|P5|Overall Study|Withdrawal by Subject|1
5839061|NCT02327169|20183119|P4|Overall Study|Withdrawal by Subject|0
5839062|NCT02327169|20183120|P3|Overall Study|Withdrawal by Subject|0
5839063|NCT02327169|20183121|P2|Overall Study|Withdrawal by Subject|0
5839064|NCT02327169|20183122|P1|Overall Study|Withdrawal by Subject|1
5839065|NCT02327169|20183108|P15|Overall Study|Reason Not Specified|2
5839066|NCT02327169|20183109|P14|Overall Study|Reason Not Specified|0
5839067|NCT02327169|20183110|P13|Overall Study|Reason Not Specified|0
5839068|NCT02327169|20183111|P12|Overall Study|Reason Not Specified|1
5839069|NCT02327169|20183112|P11|Overall Study|Reason Not Specified|2
5839070|NCT02327169|20183113|P10|Overall Study|Reason Not Specified|1
5839071|NCT02327169|20183114|P9|Overall Study|Reason Not Specified|0
5839072|NCT02327169|20183115|P8|Overall Study|Reason Not Specified|0
5839073|NCT02327169|20183116|P7|Overall Study|Reason Not Specified|0
5839074|NCT02327169|20183117|P6|Overall Study|Reason Not Specified|0
5839075|NCT02327169|20183118|P5|Overall Study|Reason Not Specified|0
5839076|NCT02327169|20183119|P4|Overall Study|Reason Not Specified|0
5839077|NCT02327169|20183120|P3|Overall Study|Reason Not Specified|1
5839078|NCT02327169|20183121|P2|Overall Study|Reason Not Specified|0
5839079|NCT02327169|20183122|P1|Overall Study|Reason Not Specified|0
5839080|NCT02327169|20183108|P15|Overall Study|Symptomatic Deterioration|1
5839081|NCT02327169|20183109|P14|Overall Study|Symptomatic Deterioration|2
5839082|NCT02327169|20183110|P13|Overall Study|Symptomatic Deterioration|0
5839083|NCT02327169|20183111|P12|Overall Study|Symptomatic Deterioration|0
5839084|NCT02327169|20183112|P11|Overall Study|Symptomatic Deterioration|0
5839085|NCT02327169|20183113|P10|Overall Study|Symptomatic Deterioration|1
5839086|NCT02327169|20183114|P9|Overall Study|Symptomatic Deterioration|2
5839087|NCT02327169|20183115|P8|Overall Study|Symptomatic Deterioration|0
5839088|NCT02327169|20183116|P7|Overall Study|Symptomatic Deterioration|0
5839089|NCT02327169|20183117|P6|Overall Study|Symptomatic Deterioration|1
5839090|NCT02327169|20183118|P5|Overall Study|Symptomatic Deterioration|1
5839091|NCT02327169|20183119|P4|Overall Study|Symptomatic Deterioration|0
5839092|NCT02327169|20183120|P3|Overall Study|Symptomatic Deterioration|1
5839093|NCT02327169|20183121|P2|Overall Study|Symptomatic Deterioration|0
5839094|NCT02327169|20183122|P1|Overall Study|Symptomatic Deterioration|0
5839095|NCT02327169|20183108|P15|Overall Study|Adverse Event|1
5839096|NCT02327169|20183109|P14|Overall Study|Adverse Event|2
5839097|NCT02327169|20183110|P13|Overall Study|Adverse Event|0
5839098|NCT02327169|20183111|P12|Overall Study|Adverse Event|3
5839099|NCT02327169|20183112|P11|Overall Study|Adverse Event|0
5839100|NCT02327169|20183113|P10|Overall Study|Adverse Event|2
5839101|NCT02327169|20183114|P9|Overall Study|Adverse Event|0
5839102|NCT02327169|20183115|P8|Overall Study|Adverse Event|0
5839103|NCT02327169|20183116|P7|Overall Study|Adverse Event|0
5839104|NCT02327169|20183117|P6|Overall Study|Adverse Event|0
5839105|NCT02327169|20183118|P5|Overall Study|Adverse Event|1
5839106|NCT02327169|20183119|P4|Overall Study|Adverse Event|0
5839107|NCT02327169|20183120|P3|Overall Study|Adverse Event|1
5839108|NCT02327169|20183121|P2|Overall Study|Adverse Event|0
5839109|NCT02327169|20183122|P1|Overall Study|Adverse Event|2
5839110|NCT02327169|20183108|P15|Overall Study|Progressive Disease|3
5839111|NCT02327169|20183109|P14|Overall Study|Progressive Disease|3
5839112|NCT02327169|20183110|P13|Overall Study|Progressive Disease|1
5839113|NCT02327169|20183111|P12|Overall Study|Progressive Disease|3
5839114|NCT02327169|20183112|P11|Overall Study|Progressive Disease|4
5839115|NCT02327169|20183113|P10|Overall Study|Progressive Disease|4
5839116|NCT02327169|20183114|P9|Overall Study|Progressive Disease|4
5839117|NCT02327169|20183115|P8|Overall Study|Progressive Disease|3
5839118|NCT02327169|20183116|P7|Overall Study|Progressive Disease|3
5839119|NCT02327169|20183117|P6|Overall Study|Progressive Disease|3
5839120|NCT02327169|20183118|P5|Overall Study|Progressive Disease|4
5839121|NCT02327169|20183119|P4|Overall Study|Progressive Disease|3
5839122|NCT02327169|20183120|P3|Overall Study|Progressive Disease|4
5839123|NCT02327169|20183121|P2|Overall Study|Progressive Disease|3
5839124|NCT02327169|20183122|P1|Overall Study|Progressive Disease|1
5839125|NCT02327130|20183352|P1|Overall Study|Met exclusion criteria|3
5839126|NCT02327130|20183352|P1|Overall Study|Incorrectly place ventilator adaptor|1
5839127|NCT02327130|20183352|P1|Overall Study|Unable to provide breath sample|1
5839128|NCT02327130|20183352|P1|Overall Study|Physician Decision|2
5839129|NCT02327130|20183352|P1|Overall Study|Discharged in less than 5 days|5
5839130|NCT02327013|20183371|P5|Overall Study|Withdrawal before treatment|0
5839131|NCT02327013|20183372|P4|Overall Study|Withdrawal before treatment|0
5839132|NCT02327013|20183373|P3|Overall Study|Withdrawal before treatment|5
5839133|NCT02327013|20183374|P2|Overall Study|Withdrawal before treatment|1
5839134|NCT02327013|20183375|P1|Overall Study|Withdrawal before treatment|2
5839135|NCT02327013|20183371|P5|Overall Study|Protocol Violation|1
5839136|NCT02327013|20183372|P4|Overall Study|Protocol Violation|0
5839137|NCT02327013|20183373|P3|Overall Study|Protocol Violation|3
5839138|NCT02327013|20183374|P2|Overall Study|Protocol Violation|0
5839139|NCT02327013|20183375|P1|Overall Study|Protocol Violation|0
5839140|NCT02327013|20183371|P5|Overall Study|Administrative or other reason(s)|1
5839141|NCT02327013|20183372|P4|Overall Study|Administrative or other reason(s)|1
5839142|NCT02327013|20183373|P3|Overall Study|Administrative or other reason(s)|11
5839143|NCT02327013|20183374|P2|Overall Study|Administrative or other reason(s)|5
5839144|NCT02327013|20183375|P1|Overall Study|Administrative or other reason(s)|1
5839145|NCT02327013|20183371|P5|Overall Study|Lost to Follow-up|0
5839146|NCT02327013|20183372|P4|Overall Study|Lost to Follow-up|0
5839147|NCT02327013|20183373|P3|Overall Study|Lost to Follow-up|5
5839148|NCT02327013|20183374|P2|Overall Study|Lost to Follow-up|4
5839149|NCT02327013|20183375|P1|Overall Study|Lost to Follow-up|2
5839150|NCT02327013|20183371|P5|Overall Study|Withdrawal of Consent|0
5839151|NCT02327013|20183372|P4|Overall Study|Withdrawal of Consent|0
5839152|NCT02327013|20183373|P3|Overall Study|Withdrawal of Consent|3
5839153|NCT02327013|20183374|P2|Overall Study|Withdrawal of Consent|0
5839154|NCT02327013|20183375|P1|Overall Study|Withdrawal of Consent|1
5839155|NCT02327013|20183371|P5|Overall Study|Non-compliance with IMP|0
5839156|NCT02327013|20183372|P4|Overall Study|Non-compliance with IMP|0
5839157|NCT02327013|20183373|P3|Overall Study|Non-compliance with IMP|7
5839158|NCT02327013|20183374|P2|Overall Study|Non-compliance with IMP|2
5839159|NCT02327013|20183375|P1|Overall Study|Non-compliance with IMP|1
5839160|NCT02327013|20183371|P5|Overall Study|Lack of Efficacy|1
5839161|NCT02327013|20183372|P4|Overall Study|Lack of Efficacy|0
5839162|NCT02327013|20183373|P3|Overall Study|Lack of Efficacy|5
5839163|NCT02327013|20183374|P2|Overall Study|Lack of Efficacy|0
5839164|NCT02327013|20183375|P1|Overall Study|Lack of Efficacy|2
5839165|NCT02327013|20183371|P5|Overall Study|Adverse Event|1
5839166|NCT02327013|20183372|P4|Overall Study|Adverse Event|0
5839167|NCT02327013|20183373|P3|Overall Study|Adverse Event|3
5839168|NCT02327013|20183374|P2|Overall Study|Adverse Event|4
5839169|NCT02327013|20183375|P1|Overall Study|Adverse Event|4
5839170|NCT02326597|20183563|P2|Overall Study|Lost to Follow-up|32
5839171|NCT02326597|20183564|P1|Overall Study|Lost to Follow-up|42
5839172|NCT02326298|20183610|P14|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3
5839173|NCT02326298|20183611|P13|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6
5839174|NCT02326298|20183612|P12|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6
5839175|NCT02326298|20183613|P11|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
5839176|NCT02326298|20183614|P10|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
5839177|NCT02326298|20183615|P9|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
5839178|NCT02326298|20183616|P8|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
5839179|NCT02326298|20183617|P7|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
5839180|NCT02326298|20183618|P6|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
5839181|NCT02326298|20183619|P5|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
5839182|NCT02326298|20183620|P4|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
5839183|NCT02326298|20183621|P3|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
5839184|NCT02326298|20183622|P2|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
5839185|NCT02326298|20183623|P1|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
5839186|NCT02326298|20183610|P14|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3
5839187|NCT02326298|20183611|P13|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|7
5839188|NCT02326298|20183612|P12|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|2
5839189|NCT02326298|20183613|P11|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
5839190|NCT02326298|20183614|P10|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
5839191|NCT02326298|20183615|P9|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
5839192|NCT02326298|20183616|P8|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
5839193|NCT02326298|20183617|P7|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
5839194|NCT02326298|20183618|P6|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
5839195|NCT02326298|20183619|P5|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
5839196|NCT02326298|20183620|P4|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
5839197|NCT02326298|20183621|P3|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
5839198|NCT02326298|20183622|P2|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
5839199|NCT02326298|20183623|P1|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
5839200|NCT02326298|20183610|P14|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|1
5839201|NCT02326298|20183611|P13|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2
5839202|NCT02326298|20183612|P12|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|7
5839203|NCT02326298|20183613|P11|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
5839204|NCT02326298|20183614|P10|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
5839205|NCT02326298|20183615|P9|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
5839206|NCT02326298|20183616|P8|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
5839207|NCT02326298|20183617|P7|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
5839208|NCT02326298|20183618|P6|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
5839209|NCT02326298|20183619|P5|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
5839210|NCT02326298|20183620|P4|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
5839211|NCT02326298|20183621|P3|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
5839212|NCT02326298|20183622|P2|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
5839213|NCT02326298|20183623|P1|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
5839214|NCT02326298|20183610|P14|Open-label Period (Week 48 to Week 144)|Protocol Violation|2
5839215|NCT02326298|20183611|P13|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
5839216|NCT02326298|20183612|P12|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
5839217|NCT02326298|20183613|P11|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
5839218|NCT02326298|20183614|P10|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
5839219|NCT02326298|20183615|P9|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
5839220|NCT02326298|20183616|P8|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
5839221|NCT02326298|20183617|P7|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
5839222|NCT02326298|20183618|P6|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
5839223|NCT02326298|20183619|P5|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
5839224|NCT02326298|20183620|P4|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
5839225|NCT02326298|20183621|P3|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
5839226|NCT02326298|20183622|P2|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
5839227|NCT02326298|20183623|P1|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
5839228|NCT02326298|20183610|P14|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
5839229|NCT02326298|20183611|P13|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1
5839230|NCT02326298|20183612|P12|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1
5839231|NCT02326298|20183613|P11|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
5839232|NCT02326298|20183614|P10|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
5839233|NCT02326298|20183615|P9|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
5839234|NCT02326298|20183616|P8|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
5839235|NCT02326298|20183617|P7|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
5839236|NCT02326298|20183618|P6|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
5839237|NCT02326298|20183619|P5|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
5839238|NCT02326298|20183620|P4|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
5839239|NCT02326298|20183621|P3|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
5839240|NCT02326298|20183622|P2|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
5839241|NCT02326298|20183623|P1|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
5839242|NCT02326298|20183610|P14|Open-label Period (Week 48 to Week 144)|Adverse Event|0
5839243|NCT02326298|20183611|P13|Open-label Period (Week 48 to Week 144)|Adverse Event|3
5839244|NCT02326298|20183612|P12|Open-label Period (Week 48 to Week 144)|Adverse Event|3
5839245|NCT02326298|20183613|P11|Open-label Period (Week 48 to Week 144)|Adverse Event|0
5839246|NCT02326298|20183614|P10|Open-label Period (Week 48 to Week 144)|Adverse Event|0
5839247|NCT02326298|20183615|P9|Open-label Period (Week 48 to Week 144)|Adverse Event|0
5839248|NCT02326298|20183616|P8|Open-label Period (Week 48 to Week 144)|Adverse Event|0
5839249|NCT02326298|20183617|P7|Open-label Period (Week 48 to Week 144)|Adverse Event|0
5839250|NCT02326298|20183618|P6|Open-label Period (Week 48 to Week 144)|Adverse Event|0
5839251|NCT02326298|20183619|P5|Open-label Period (Week 48 to Week 144)|Adverse Event|0
5839252|NCT02326298|20183620|P4|Open-label Period (Week 48 to Week 144)|Adverse Event|0
5839253|NCT02326298|20183621|P3|Open-label Period (Week 48 to Week 144)|Adverse Event|0
5839254|NCT02326298|20183622|P2|Open-label Period (Week 48 to Week 144)|Adverse Event|0
5839255|NCT02326298|20183623|P1|Open-label Period (Week 48 to Week 144)|Adverse Event|0
5839256|NCT02326298|20183610|P14|Open-label Period (Week 48 to Week 144)|Death|0
5839257|NCT02326298|20183611|P13|Open-label Period (Week 48 to Week 144)|Death|0
5839258|NCT02326298|20183612|P12|Open-label Period (Week 48 to Week 144)|Death|1
5839259|NCT02326298|20183613|P11|Open-label Period (Week 48 to Week 144)|Death|0
5839260|NCT02326298|20183614|P10|Open-label Period (Week 48 to Week 144)|Death|0
5839261|NCT02326298|20183615|P9|Open-label Period (Week 48 to Week 144)|Death|0
5839262|NCT02326298|20183616|P8|Open-label Period (Week 48 to Week 144)|Death|0
5839263|NCT02326298|20183617|P7|Open-label Period (Week 48 to Week 144)|Death|0
5839264|NCT02326298|20183618|P6|Open-label Period (Week 48 to Week 144)|Death|0
5839265|NCT02326298|20183619|P5|Open-label Period (Week 48 to Week 144)|Death|0
5839266|NCT02326298|20183620|P4|Open-label Period (Week 48 to Week 144)|Death|0
5839267|NCT02326298|20183621|P3|Open-label Period (Week 48 to Week 144)|Death|0
5839268|NCT02326298|20183622|P2|Open-label Period (Week 48 to Week 144)|Death|0
5839269|NCT02326298|20183623|P1|Open-label Period (Week 48 to Week 144)|Death|0
5839270|NCT02326298|20183610|P14|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
5839271|NCT02326298|20183611|P13|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
5839272|NCT02326298|20183612|P12|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
5839273|NCT02326298|20183613|P11|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
5839274|NCT02326298|20183614|P10|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
5839275|NCT02326298|20183615|P9|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
5839276|NCT02326298|20183616|P8|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
5839277|NCT02326298|20183617|P7|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
5839278|NCT02326298|20183618|P6|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|2
5839279|NCT02326298|20183619|P5|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
5839280|NCT02326298|20183620|P4|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
5839281|NCT02326298|20183621|P3|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
5839282|NCT02326298|20183622|P2|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
5839283|NCT02326298|20183623|P1|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
5839284|NCT02326298|20183610|P14|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
5839285|NCT02326298|20183611|P13|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
5839286|NCT02326298|20183612|P12|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
5839287|NCT02326298|20183613|P11|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
5839288|NCT02326298|20183614|P10|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
5839289|NCT02326298|20183615|P9|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
5839290|NCT02326298|20183616|P8|Maintenance Period (Week 16 to Week 48)|Adverse Event|1
5839291|NCT02326298|20183617|P7|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
5839292|NCT02326298|20183618|P6|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
5839293|NCT02326298|20183619|P5|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
5839294|NCT02326298|20183620|P4|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
5839295|NCT02326298|20183621|P3|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
5839296|NCT02326298|20183622|P2|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
5839297|NCT02326298|20183623|P1|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
5839298|NCT02326298|20183610|P14|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5839299|NCT02326298|20183611|P13|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5839300|NCT02326298|20183612|P12|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5839301|NCT02326298|20183613|P11|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5839302|NCT02326298|20183614|P10|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5839303|NCT02326298|20183615|P9|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5839304|NCT02326298|20183616|P8|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2
5839305|NCT02326298|20183617|P7|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1
5839306|NCT02326298|20183618|P6|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5839307|NCT02326298|20183619|P5|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5839308|NCT02326298|20183620|P4|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5839309|NCT02326298|20183621|P3|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5839310|NCT02326298|20183622|P2|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5839311|NCT02326298|20183623|P1|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5839312|NCT02326298|20183610|P14|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
5839313|NCT02326298|20183611|P13|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
5839314|NCT02326298|20183612|P12|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
5839315|NCT02326298|20183613|P11|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
5839316|NCT02326298|20183614|P10|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
5839317|NCT02326298|20183615|P9|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
5839318|NCT02326298|20183616|P8|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|1
5839319|NCT02326298|20183617|P7|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
5839320|NCT02326298|20183618|P6|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
5839321|NCT02326298|20183619|P5|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
5839322|NCT02326298|20183620|P4|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
5839323|NCT02326298|20183621|P3|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
5839324|NCT02326298|20183622|P2|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
5839325|NCT02326298|20183623|P1|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
5839326|NCT02326298|20183610|P14|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
5839327|NCT02326298|20183611|P13|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
5839328|NCT02326298|20183612|P12|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
5839883|NCT02325791|20183800|P4|Overall Study|Death|1
5839329|NCT02326298|20183613|P11|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
5839330|NCT02326298|20183614|P10|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
5839331|NCT02326298|20183615|P9|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
5839332|NCT02326298|20183616|P8|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
5839333|NCT02326298|20183617|P7|Maintenance Period (Week 16 to Week 48)|Pregnancy|1
5839334|NCT02326298|20183618|P6|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
5839335|NCT02326298|20183619|P5|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
5839336|NCT02326298|20183620|P4|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
5839337|NCT02326298|20183621|P3|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
5839338|NCT02326298|20183622|P2|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
5839339|NCT02326298|20183623|P1|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
5839340|NCT02326298|20183610|P14|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
5839341|NCT02326298|20183611|P13|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
5839342|NCT02326298|20183612|P12|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
5839343|NCT02326298|20183613|P11|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
5839344|NCT02326298|20183614|P10|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
5839345|NCT02326298|20183615|P9|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
5839346|NCT02326298|20183616|P8|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
5839347|NCT02326298|20183617|P7|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
5839348|NCT02326298|20183618|P6|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|1
5839349|NCT02326298|20183619|P5|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
5839350|NCT02326298|20183620|P4|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
5839351|NCT02326298|20183621|P3|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
5839352|NCT02326298|20183622|P2|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
5839353|NCT02326298|20183623|P1|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
5839354|NCT02326298|20183610|P14|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
5839355|NCT02326298|20183611|P13|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
5839356|NCT02326298|20183612|P12|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
5839357|NCT02326298|20183613|P11|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
5839358|NCT02326298|20183614|P10|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
5839359|NCT02326298|20183615|P9|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|4
5839360|NCT02326298|20183616|P8|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
5839361|NCT02326298|20183617|P7|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|2
5839362|NCT02326298|20183618|P6|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|1
5839363|NCT02326298|20183619|P5|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
5839364|NCT02326298|20183620|P4|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
5839365|NCT02326298|20183621|P3|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
5839366|NCT02326298|20183622|P2|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
5839367|NCT02326298|20183623|P1|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
5839368|NCT02326298|20183610|P14|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
5839369|NCT02326298|20183611|P13|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
5839370|NCT02326298|20183612|P12|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
5839371|NCT02326298|20183613|P11|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
5839372|NCT02326298|20183614|P10|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
5839373|NCT02326298|20183615|P9|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
5839374|NCT02326298|20183616|P8|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
5839375|NCT02326298|20183617|P7|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3
5839376|NCT02326298|20183618|P6|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
5839377|NCT02326298|20183619|P5|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
5839378|NCT02326298|20183620|P4|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
5839379|NCT02326298|20183621|P3|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
5839380|NCT02326298|20183622|P2|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
5839381|NCT02326298|20183623|P1|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
5839382|NCT02326298|20183610|P14|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
5839383|NCT02326298|20183611|P13|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
5839384|NCT02326298|20183612|P12|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
5839385|NCT02326298|20183613|P11|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
5839386|NCT02326298|20183614|P10|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
5839387|NCT02326298|20183615|P9|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
5839388|NCT02326298|20183616|P8|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
5839389|NCT02326298|20183617|P7|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
5839390|NCT02326298|20183618|P6|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
5839391|NCT02326298|20183619|P5|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
5839392|NCT02326298|20183620|P4|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
5839393|NCT02326298|20183621|P3|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|2
5839394|NCT02326298|20183622|P2|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
5839395|NCT02326298|20183623|P1|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
5839396|NCT02326298|20183610|P14|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
5839397|NCT02326298|20183611|P13|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
5839398|NCT02326298|20183612|P12|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
5839399|NCT02326298|20183613|P11|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
5839400|NCT02326298|20183614|P10|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
5839401|NCT02326298|20183615|P9|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
5839402|NCT02326298|20183616|P8|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
5839403|NCT02326298|20183617|P7|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
5839404|NCT02326298|20183618|P6|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
5839405|NCT02326298|20183619|P5|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
5839406|NCT02326298|20183620|P4|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
5839407|NCT02326298|20183621|P3|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
5839408|NCT02326298|20183622|P2|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2
5839409|NCT02326298|20183623|P1|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3
5839410|NCT02326298|20183610|P14|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
5839411|NCT02326298|20183611|P13|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
5839412|NCT02326298|20183612|P12|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
5839413|NCT02326298|20183613|P11|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
5839414|NCT02326298|20183614|P10|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
5839415|NCT02326298|20183615|P9|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
5839416|NCT02326298|20183616|P8|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
5839417|NCT02326298|20183617|P7|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
5839418|NCT02326298|20183618|P6|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
5839419|NCT02326298|20183619|P5|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
5839420|NCT02326298|20183620|P4|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
5839421|NCT02326298|20183621|P3|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
5839422|NCT02326298|20183622|P2|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1
5839423|NCT02326298|20183623|P1|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1
5839424|NCT02326298|20183610|P14|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
5839425|NCT02326298|20183611|P13|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
5839426|NCT02326298|20183612|P12|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
5839427|NCT02326298|20183613|P11|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
5839428|NCT02326298|20183614|P10|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
5839429|NCT02326298|20183615|P9|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
5839430|NCT02326298|20183616|P8|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
5839431|NCT02326298|20183617|P7|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
5839432|NCT02326298|20183618|P6|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
5839433|NCT02326298|20183619|P5|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
5839434|NCT02326298|20183620|P4|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
5839435|NCT02326298|20183621|P3|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
5839436|NCT02326298|20183622|P2|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
5839437|NCT02326298|20183623|P1|Initial Period (Week 0 to Week 16)|Lack of Efficacy|1
5839438|NCT02326298|20183610|P14|Initial Period (Week 0 to Week 16)|Adverse Event|0
5839439|NCT02326298|20183611|P13|Initial Period (Week 0 to Week 16)|Adverse Event|0
5839440|NCT02326298|20183612|P12|Initial Period (Week 0 to Week 16)|Adverse Event|0
5839441|NCT02326298|20183613|P11|Initial Period (Week 0 to Week 16)|Adverse Event|0
5839442|NCT02326298|20183614|P10|Initial Period (Week 0 to Week 16)|Adverse Event|0
5839443|NCT02326298|20183615|P9|Initial Period (Week 0 to Week 16)|Adverse Event|0
5839444|NCT02326298|20183616|P8|Initial Period (Week 0 to Week 16)|Adverse Event|0
5839445|NCT02326298|20183617|P7|Initial Period (Week 0 to Week 16)|Adverse Event|0
5839446|NCT02326298|20183618|P6|Initial Period (Week 0 to Week 16)|Adverse Event|0
5839447|NCT02326298|20183619|P5|Initial Period (Week 0 to Week 16)|Adverse Event|0
5839448|NCT02326298|20183620|P4|Initial Period (Week 0 to Week 16)|Adverse Event|0
5839449|NCT02326298|20183621|P3|Initial Period (Week 0 to Week 16)|Adverse Event|1
5839450|NCT02326298|20183622|P2|Initial Period (Week 0 to Week 16)|Adverse Event|0
5839451|NCT02326298|20183623|P1|Initial Period (Week 0 to Week 16)|Adverse Event|0
5839452|NCT02326272|20183646|P15|Open-label Period (Week 48 to Week 144)|Pregnancy|0
5839453|NCT02326272|20183647|P14|Open-label Period (Week 48 to Week 144)|Pregnancy|0
5839454|NCT02326272|20183648|P13|Open-label Period (Week 48 to Week 144)|Pregnancy|1
5839455|NCT02326272|20183649|P12|Open-label Period (Week 48 to Week 144)|Pregnancy|0
5839456|NCT02326272|20183650|P11|Open-label Period (Week 48 to Week 144)|Pregnancy|0
5839457|NCT02326272|20183651|P10|Open-label Period (Week 48 to Week 144)|Pregnancy|0
5839458|NCT02326272|20183652|P9|Open-label Period (Week 48 to Week 144)|Pregnancy|0
5839459|NCT02326272|20183653|P8|Open-label Period (Week 48 to Week 144)|Pregnancy|0
5839460|NCT02326272|20183654|P7|Open-label Period (Week 48 to Week 144)|Pregnancy|0
5839461|NCT02326272|20183655|P6|Open-label Period (Week 48 to Week 144)|Pregnancy|0
5839462|NCT02326272|20183656|P5|Open-label Period (Week 48 to Week 144)|Pregnancy|0
5839463|NCT02326272|20183657|P4|Open-label Period (Week 48 to Week 144)|Pregnancy|0
5839464|NCT02326272|20183658|P3|Open-label Period (Week 48 to Week 144)|Pregnancy|0
5839465|NCT02326272|20183659|P2|Open-label Period (Week 48 to Week 144)|Pregnancy|0
5839466|NCT02326272|20183660|P1|Open-label Period (Week 48 to Week 144)|Pregnancy|0
5839467|NCT02326272|20183646|P15|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
5839468|NCT02326272|20183647|P14|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
5839469|NCT02326272|20183648|P13|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
5839470|NCT02326272|20183649|P12|Open-label Period (Week 48 to Week 144)|Loss of efficacy|1
5839471|NCT02326272|20183650|P11|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
5839472|NCT02326272|20183651|P10|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
5839473|NCT02326272|20183652|P9|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
5839474|NCT02326272|20183653|P8|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
5839475|NCT02326272|20183654|P7|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
5839476|NCT02326272|20183655|P6|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
5839477|NCT02326272|20183656|P5|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
5839478|NCT02326272|20183657|P4|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
5839479|NCT02326272|20183658|P3|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
5839480|NCT02326272|20183659|P2|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
5839481|NCT02326272|20183660|P1|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
5839482|NCT02326272|20183646|P15|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3
5839483|NCT02326272|20183647|P14|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
5839484|NCT02326272|20183648|P13|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3
5839485|NCT02326272|20183649|P12|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|1
5839486|NCT02326272|20183650|P11|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
5839487|NCT02326272|20183651|P10|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
5839488|NCT02326272|20183652|P9|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
5839489|NCT02326272|20183653|P8|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
5839490|NCT02326272|20183654|P7|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
5839491|NCT02326272|20183655|P6|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
5839492|NCT02326272|20183656|P5|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
5839493|NCT02326272|20183657|P4|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
5839494|NCT02326272|20183658|P3|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
5839495|NCT02326272|20183659|P2|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
5839496|NCT02326272|20183660|P1|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
5839497|NCT02326272|20183646|P15|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2
5839498|NCT02326272|20183647|P14|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
5839499|NCT02326272|20183648|P13|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
5839500|NCT02326272|20183649|P12|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|4
5839501|NCT02326272|20183650|P11|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
5839502|NCT02326272|20183651|P10|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
5839503|NCT02326272|20183652|P9|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
5839504|NCT02326272|20183653|P8|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
5839505|NCT02326272|20183654|P7|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
5839506|NCT02326272|20183655|P6|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
5839507|NCT02326272|20183656|P5|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
5839508|NCT02326272|20183657|P4|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
5839509|NCT02326272|20183658|P3|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
5839510|NCT02326272|20183659|P2|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
5839511|NCT02326272|20183660|P1|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
5839512|NCT02326272|20183646|P15|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3
5839513|NCT02326272|20183647|P14|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
5839514|NCT02326272|20183648|P13|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|2
5839515|NCT02326272|20183649|P12|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
5839516|NCT02326272|20183650|P11|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|1
5839517|NCT02326272|20183651|P10|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
5839518|NCT02326272|20183652|P9|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
5839519|NCT02326272|20183653|P8|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
5839520|NCT02326272|20183654|P7|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
5839521|NCT02326272|20183655|P6|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
5839522|NCT02326272|20183656|P5|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
5839523|NCT02326272|20183657|P4|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
5839524|NCT02326272|20183658|P3|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
5839525|NCT02326272|20183659|P2|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
5839526|NCT02326272|20183660|P1|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
5839527|NCT02326272|20183646|P15|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
5839528|NCT02326272|20183647|P14|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
5839529|NCT02326272|20183648|P13|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
5839530|NCT02326272|20183649|P12|Open-label Period (Week 48 to Week 144)|Protocol Violation|1
5839531|NCT02326272|20183650|P11|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
5839532|NCT02326272|20183651|P10|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
5839533|NCT02326272|20183652|P9|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
5839534|NCT02326272|20183653|P8|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
5839535|NCT02326272|20183654|P7|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
5839536|NCT02326272|20183655|P6|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
5839537|NCT02326272|20183656|P5|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
5839538|NCT02326272|20183657|P4|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
5839539|NCT02326272|20183658|P3|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
5839540|NCT02326272|20183659|P2|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
5839541|NCT02326272|20183660|P1|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
5839542|NCT02326272|20183646|P15|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
5839543|NCT02326272|20183647|P14|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
5839544|NCT02326272|20183648|P13|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1
5839545|NCT02326272|20183649|P12|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
5839546|NCT02326272|20183650|P11|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1
5839547|NCT02326272|20183651|P10|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
5839548|NCT02326272|20183652|P9|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
5839549|NCT02326272|20183653|P8|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
5839550|NCT02326272|20183654|P7|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
5839551|NCT02326272|20183655|P6|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
5839552|NCT02326272|20183656|P5|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
5839553|NCT02326272|20183657|P4|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
5839554|NCT02326272|20183658|P3|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
5839555|NCT02326272|20183659|P2|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
5839556|NCT02326272|20183660|P1|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
5839557|NCT02326272|20183646|P15|Open-label Period (Week 48 to Week 144)|Adverse Event|1
5839558|NCT02326272|20183647|P14|Open-label Period (Week 48 to Week 144)|Adverse Event|0
5839559|NCT02326272|20183648|P13|Open-label Period (Week 48 to Week 144)|Adverse Event|3
5839560|NCT02326272|20183649|P12|Open-label Period (Week 48 to Week 144)|Adverse Event|8
5839561|NCT02326272|20183650|P11|Open-label Period (Week 48 to Week 144)|Adverse Event|1
5839562|NCT02326272|20183651|P10|Open-label Period (Week 48 to Week 144)|Adverse Event|0
5839563|NCT02326272|20183652|P9|Open-label Period (Week 48 to Week 144)|Adverse Event|0
5839564|NCT02326272|20183653|P8|Open-label Period (Week 48 to Week 144)|Adverse Event|0
5839565|NCT02326272|20183654|P7|Open-label Period (Week 48 to Week 144)|Adverse Event|0
5839566|NCT02326272|20183655|P6|Open-label Period (Week 48 to Week 144)|Adverse Event|0
5839567|NCT02326272|20183656|P5|Open-label Period (Week 48 to Week 144)|Adverse Event|0
5839568|NCT02326272|20183657|P4|Open-label Period (Week 48 to Week 144)|Adverse Event|0
5839569|NCT02326272|20183658|P3|Open-label Period (Week 48 to Week 144)|Adverse Event|0
5839570|NCT02326272|20183659|P2|Open-label Period (Week 48 to Week 144)|Adverse Event|0
5839571|NCT02326272|20183660|P1|Open-label Period (Week 48 to Week 144)|Adverse Event|0
5839572|NCT02326272|20183646|P15|Open-label Period (Week 48 to Week 144)|Death|0
5839573|NCT02326272|20183647|P14|Open-label Period (Week 48 to Week 144)|Death|0
5839574|NCT02326272|20183648|P13|Open-label Period (Week 48 to Week 144)|Death|1
5839575|NCT02326272|20183649|P12|Open-label Period (Week 48 to Week 144)|Death|0
5839576|NCT02326272|20183650|P11|Open-label Period (Week 48 to Week 144)|Death|0
5839577|NCT02326272|20183651|P10|Open-label Period (Week 48 to Week 144)|Death|0
5839578|NCT02326272|20183652|P9|Open-label Period (Week 48 to Week 144)|Death|0
5839579|NCT02326272|20183653|P8|Open-label Period (Week 48 to Week 144)|Death|0
5839580|NCT02326272|20183654|P7|Open-label Period (Week 48 to Week 144)|Death|0
5839581|NCT02326272|20183655|P6|Open-label Period (Week 48 to Week 144)|Death|0
5839582|NCT02326272|20183656|P5|Open-label Period (Week 48 to Week 144)|Death|0
5839583|NCT02326272|20183657|P4|Open-label Period (Week 48 to Week 144)|Death|0
5839584|NCT02326272|20183658|P3|Open-label Period (Week 48 to Week 144)|Death|0
5839585|NCT02326272|20183659|P2|Open-label Period (Week 48 to Week 144)|Death|0
5839586|NCT02326272|20183660|P1|Open-label Period (Week 48 to Week 144)|Death|0
5839587|NCT02326272|20183646|P15|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
5839588|NCT02326272|20183647|P14|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
5839589|NCT02326272|20183648|P13|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
5839590|NCT02326272|20183649|P12|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
5839591|NCT02326272|20183650|P11|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
5839592|NCT02326272|20183651|P10|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
5839593|NCT02326272|20183652|P9|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
5839594|NCT02326272|20183653|P8|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
5839595|NCT02326272|20183654|P7|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|1
5839596|NCT02326272|20183655|P6|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
5839597|NCT02326272|20183656|P5|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
5839598|NCT02326272|20183657|P4|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
5839599|NCT02326272|20183658|P3|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
5839600|NCT02326272|20183659|P2|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
5839601|NCT02326272|20183660|P1|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
5839602|NCT02326272|20183646|P15|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
5839603|NCT02326272|20183647|P14|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
5839604|NCT02326272|20183648|P13|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
5839605|NCT02326272|20183649|P12|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
5839606|NCT02326272|20183650|P11|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
5839607|NCT02326272|20183651|P10|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
5839608|NCT02326272|20183652|P9|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
5839609|NCT02326272|20183653|P8|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
5839610|NCT02326272|20183654|P7|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
5839611|NCT02326272|20183655|P6|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|1
5839612|NCT02326272|20183656|P5|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
5839613|NCT02326272|20183657|P4|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
5839614|NCT02326272|20183658|P3|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
5839615|NCT02326272|20183659|P2|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
5839616|NCT02326272|20183660|P1|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
5839617|NCT02326272|20183646|P15|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
5839618|NCT02326272|20183647|P14|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
5839619|NCT02326272|20183648|P13|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
5839620|NCT02326272|20183649|P12|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
5839621|NCT02326272|20183650|P11|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
5839622|NCT02326272|20183651|P10|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
5839623|NCT02326272|20183652|P9|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2
5839624|NCT02326272|20183653|P8|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1
5839625|NCT02326272|20183654|P7|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1
5839626|NCT02326272|20183655|P6|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2
5839627|NCT02326272|20183656|P5|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
5839628|NCT02326272|20183657|P4|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
5839629|NCT02326272|20183658|P3|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
5839630|NCT02326272|20183659|P2|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
5839631|NCT02326272|20183660|P1|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
5839632|NCT02326272|20183646|P15|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
5839633|NCT02326272|20183647|P14|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
5839634|NCT02326272|20183648|P13|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
5839635|NCT02326272|20183649|P12|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
5839636|NCT02326272|20183650|P11|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
5839637|NCT02326272|20183651|P10|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
5839638|NCT02326272|20183652|P9|Maintenance Period (Week 16 to Week 48)|Non-compliance|1
5839639|NCT02326272|20183653|P8|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
5839640|NCT02326272|20183654|P7|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
5839641|NCT02326272|20183655|P6|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
5839642|NCT02326272|20183656|P5|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
5839643|NCT02326272|20183657|P4|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
5839644|NCT02326272|20183658|P3|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
5839645|NCT02326272|20183659|P2|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
5839646|NCT02326272|20183660|P1|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
5839647|NCT02326272|20183646|P15|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
5839648|NCT02326272|20183647|P14|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
5839649|NCT02326272|20183648|P13|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
5839650|NCT02326272|20183649|P12|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
5839651|NCT02326272|20183650|P11|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
5839652|NCT02326272|20183651|P10|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
5839653|NCT02326272|20183652|P9|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
5839654|NCT02326272|20183653|P8|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
5839655|NCT02326272|20183654|P7|Maintenance Period (Week 16 to Week 48)|Pregnancy|1
5839656|NCT02326272|20183655|P6|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
5839657|NCT02326272|20183656|P5|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
5839658|NCT02326272|20183657|P4|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
5839659|NCT02326272|20183658|P3|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
5839660|NCT02326272|20183659|P2|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
5839661|NCT02326272|20183660|P1|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
5839662|NCT02326272|20183646|P15|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
5839663|NCT02326272|20183647|P14|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
5839664|NCT02326272|20183648|P13|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
5839665|NCT02326272|20183649|P12|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
5839666|NCT02326272|20183650|P11|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
5839667|NCT02326272|20183651|P10|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
5839668|NCT02326272|20183652|P9|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
5839669|NCT02326272|20183653|P8|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|1
5839884|NCT02325791|20183801|P3|Overall Study|Death|0
5839670|NCT02326272|20183654|P7|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
5839671|NCT02326272|20183655|P6|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
5839672|NCT02326272|20183656|P5|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
5839673|NCT02326272|20183657|P4|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
5839674|NCT02326272|20183658|P3|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
5839675|NCT02326272|20183659|P2|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
5839676|NCT02326272|20183660|P1|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
5839677|NCT02326272|20183646|P15|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
5839678|NCT02326272|20183647|P14|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
5839679|NCT02326272|20183648|P13|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
5839680|NCT02326272|20183649|P12|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
5839681|NCT02326272|20183650|P11|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
5839682|NCT02326272|20183651|P10|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
5839683|NCT02326272|20183652|P9|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
5839684|NCT02326272|20183653|P8|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
5839685|NCT02326272|20183654|P7|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
5839686|NCT02326272|20183655|P6|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3
5839687|NCT02326272|20183656|P5|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
5839688|NCT02326272|20183657|P4|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
5839689|NCT02326272|20183658|P3|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
5839690|NCT02326272|20183659|P2|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
5839691|NCT02326272|20183660|P1|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
5839692|NCT02326272|20183646|P15|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5839693|NCT02326272|20183647|P14|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5839694|NCT02326272|20183648|P13|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5839695|NCT02326272|20183649|P12|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5839696|NCT02326272|20183650|P11|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5839697|NCT02326272|20183651|P10|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5839698|NCT02326272|20183652|P9|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5839699|NCT02326272|20183653|P8|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2
5839700|NCT02326272|20183654|P7|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5839701|NCT02326272|20183655|P6|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2
5839702|NCT02326272|20183656|P5|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5839703|NCT02326272|20183657|P4|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5839704|NCT02326272|20183658|P3|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5839705|NCT02326272|20183659|P2|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5839706|NCT02326272|20183660|P1|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5839707|NCT02326272|20183646|P15|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
5839708|NCT02326272|20183647|P14|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
5839709|NCT02326272|20183648|P13|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
5839710|NCT02326272|20183649|P12|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
5839711|NCT02326272|20183650|P11|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
5839712|NCT02326272|20183651|P10|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1
5839713|NCT02326272|20183652|P9|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1
5839714|NCT02326272|20183653|P8|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
5839715|NCT02326272|20183654|P7|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1
5839716|NCT02326272|20183655|P6|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|2
5839717|NCT02326272|20183656|P5|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
5839718|NCT02326272|20183657|P4|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
5839719|NCT02326272|20183658|P3|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
5839720|NCT02326272|20183659|P2|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
5839721|NCT02326272|20183660|P1|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
5839722|NCT02326272|20183646|P15|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
5839723|NCT02326272|20183647|P14|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
5839724|NCT02326272|20183648|P13|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
5839725|NCT02326272|20183649|P12|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
5839726|NCT02326272|20183650|P11|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
5839727|NCT02326272|20183651|P10|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
5839728|NCT02326272|20183652|P9|Maintenance Period (Week 16 to Week 48)|Adverse Event|1
5839729|NCT02326272|20183653|P8|Maintenance Period (Week 16 to Week 48)|Adverse Event|2
5839730|NCT02326272|20183654|P7|Maintenance Period (Week 16 to Week 48)|Adverse Event|4
5839731|NCT02326272|20183655|P6|Maintenance Period (Week 16 to Week 48)|Adverse Event|3
5839732|NCT02326272|20183656|P5|Maintenance Period (Week 16 to Week 48)|Adverse Event|2
5839733|NCT02326272|20183657|P4|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
5839734|NCT02326272|20183658|P3|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
5839735|NCT02326272|20183659|P2|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
5839736|NCT02326272|20183660|P1|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
5839737|NCT02326272|20183646|P15|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
5839738|NCT02326272|20183647|P14|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
5839739|NCT02326272|20183648|P13|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
5839740|NCT02326272|20183649|P12|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
5839741|NCT02326272|20183650|P11|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
5839742|NCT02326272|20183651|P10|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
5839743|NCT02326272|20183652|P9|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
5839744|NCT02326272|20183653|P8|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
5839745|NCT02326272|20183654|P7|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
5839746|NCT02326272|20183655|P6|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
5839747|NCT02326272|20183656|P5|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
5839748|NCT02326272|20183657|P4|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
5839749|NCT02326272|20183658|P3|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|1
5839750|NCT02326272|20183659|P2|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
5839751|NCT02326272|20183660|P1|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
5839752|NCT02326272|20183646|P15|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
5839753|NCT02326272|20183647|P14|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
5839754|NCT02326272|20183648|P13|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
5839755|NCT02326272|20183649|P12|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
5839756|NCT02326272|20183650|P11|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
5839757|NCT02326272|20183651|P10|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
5839758|NCT02326272|20183652|P9|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
5839759|NCT02326272|20183653|P8|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
5839760|NCT02326272|20183654|P7|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
5839761|NCT02326272|20183655|P6|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
5839762|NCT02326272|20183656|P5|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
5839763|NCT02326272|20183657|P4|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
5839764|NCT02326272|20183658|P3|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|1
5839765|NCT02326272|20183659|P2|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
5839766|NCT02326272|20183660|P1|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
5839767|NCT02326272|20183646|P15|Initial Period (Week 0 to Week 16)|Missed two doses|0
5839768|NCT02326272|20183647|P14|Initial Period (Week 0 to Week 16)|Missed two doses|0
5839769|NCT02326272|20183648|P13|Initial Period (Week 0 to Week 16)|Missed two doses|0
5839770|NCT02326272|20183649|P12|Initial Period (Week 0 to Week 16)|Missed two doses|0
5839771|NCT02326272|20183650|P11|Initial Period (Week 0 to Week 16)|Missed two doses|0
5839772|NCT02326272|20183651|P10|Initial Period (Week 0 to Week 16)|Missed two doses|0
5839773|NCT02326272|20183652|P9|Initial Period (Week 0 to Week 16)|Missed two doses|0
5839774|NCT02326272|20183653|P8|Initial Period (Week 0 to Week 16)|Missed two doses|0
5839775|NCT02326272|20183654|P7|Initial Period (Week 0 to Week 16)|Missed two doses|0
5839776|NCT02326272|20183655|P6|Initial Period (Week 0 to Week 16)|Missed two doses|0
5839777|NCT02326272|20183656|P5|Initial Period (Week 0 to Week 16)|Missed two doses|0
5839778|NCT02326272|20183657|P4|Initial Period (Week 0 to Week 16)|Missed two doses|0
5839779|NCT02326272|20183658|P3|Initial Period (Week 0 to Week 16)|Missed two doses|1
5839780|NCT02326272|20183659|P2|Initial Period (Week 0 to Week 16)|Missed two doses|0
5839781|NCT02326272|20183660|P1|Initial Period (Week 0 to Week 16)|Missed two doses|0
5839782|NCT02326272|20183646|P15|Initial Period (Week 0 to Week 16)|Moved from the study area|0
5839783|NCT02326272|20183647|P14|Initial Period (Week 0 to Week 16)|Moved from the study area|0
5839784|NCT02326272|20183648|P13|Initial Period (Week 0 to Week 16)|Moved from the study area|0
5839785|NCT02326272|20183649|P12|Initial Period (Week 0 to Week 16)|Moved from the study area|0
5839786|NCT02326272|20183650|P11|Initial Period (Week 0 to Week 16)|Moved from the study area|0
5839787|NCT02326272|20183651|P10|Initial Period (Week 0 to Week 16)|Moved from the study area|0
5839788|NCT02326272|20183652|P9|Initial Period (Week 0 to Week 16)|Moved from the study area|0
5839789|NCT02326272|20183653|P8|Initial Period (Week 0 to Week 16)|Moved from the study area|0
5839790|NCT02326272|20183654|P7|Initial Period (Week 0 to Week 16)|Moved from the study area|0
5839791|NCT02326272|20183655|P6|Initial Period (Week 0 to Week 16)|Moved from the study area|0
5839792|NCT02326272|20183656|P5|Initial Period (Week 0 to Week 16)|Moved from the study area|0
5839793|NCT02326272|20183657|P4|Initial Period (Week 0 to Week 16)|Moved from the study area|0
5839794|NCT02326272|20183658|P3|Initial Period (Week 0 to Week 16)|Moved from the study area|1
5839795|NCT02326272|20183659|P2|Initial Period (Week 0 to Week 16)|Moved from the study area|0
5839796|NCT02326272|20183660|P1|Initial Period (Week 0 to Week 16)|Moved from the study area|0
5839797|NCT02326272|20183646|P15|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
5839798|NCT02326272|20183647|P14|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
5839799|NCT02326272|20183648|P13|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
5839800|NCT02326272|20183649|P12|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
5839801|NCT02326272|20183650|P11|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
5839802|NCT02326272|20183651|P10|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
5839803|NCT02326272|20183652|P9|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
5839804|NCT02326272|20183653|P8|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
5839805|NCT02326272|20183654|P7|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
5839806|NCT02326272|20183655|P6|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
5839807|NCT02326272|20183656|P5|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
5839808|NCT02326272|20183657|P4|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
5839809|NCT02326272|20183658|P3|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1
5839810|NCT02326272|20183659|P2|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2
5839811|NCT02326272|20183660|P1|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3
5839812|NCT02326272|20183646|P15|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
5839813|NCT02326272|20183647|P14|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
5839814|NCT02326272|20183648|P13|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
5839815|NCT02326272|20183649|P12|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
5839816|NCT02326272|20183650|P11|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
5839817|NCT02326272|20183651|P10|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
5839818|NCT02326272|20183652|P9|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
5839819|NCT02326272|20183653|P8|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
5839820|NCT02326272|20183654|P7|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
5839821|NCT02326272|20183655|P6|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
5839822|NCT02326272|20183656|P5|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
5839823|NCT02326272|20183657|P4|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
5839824|NCT02326272|20183658|P3|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
5839825|NCT02326272|20183659|P2|Initial Period (Week 0 to Week 16)|Lost to Follow-up|2
5839826|NCT02326272|20183660|P1|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1
5839827|NCT02326272|20183646|P15|Initial Period (Week 0 to Week 16)|Adverse Event|0
5839828|NCT02326272|20183647|P14|Initial Period (Week 0 to Week 16)|Adverse Event|0
5839829|NCT02326272|20183648|P13|Initial Period (Week 0 to Week 16)|Adverse Event|0
5839830|NCT02326272|20183649|P12|Initial Period (Week 0 to Week 16)|Adverse Event|0
5839831|NCT02326272|20183650|P11|Initial Period (Week 0 to Week 16)|Adverse Event|0
5839832|NCT02326272|20183651|P10|Initial Period (Week 0 to Week 16)|Adverse Event|0
5839833|NCT02326272|20183652|P9|Initial Period (Week 0 to Week 16)|Adverse Event|0
5839834|NCT02326272|20183653|P8|Initial Period (Week 0 to Week 16)|Adverse Event|0
5839835|NCT02326272|20183654|P7|Initial Period (Week 0 to Week 16)|Adverse Event|0
5839836|NCT02326272|20183655|P6|Initial Period (Week 0 to Week 16)|Adverse Event|0
5839837|NCT02326272|20183656|P5|Initial Period (Week 0 to Week 16)|Adverse Event|0
5839838|NCT02326272|20183657|P4|Initial Period (Week 0 to Week 16)|Adverse Event|0
5839839|NCT02326272|20183658|P3|Initial Period (Week 0 to Week 16)|Adverse Event|1
5839840|NCT02326272|20183659|P2|Initial Period (Week 0 to Week 16)|Adverse Event|3
5839841|NCT02326272|20183660|P1|Initial Period (Week 0 to Week 16)|Adverse Event|0
5839842|NCT02326220|20183697|P3|Open-label Treatment Period|Lost to Follow-up|1
5839843|NCT02326220|20183698|P2|Open-label Treatment Period|Lost to Follow-up|0
5839844|NCT02326220|20183699|P1|Open-label Treatment Period|Lost to Follow-up|0
5839845|NCT02326220|20183697|P3|Open-label Treatment Period|Withdrawal by Subject|1
5839846|NCT02326220|20183698|P2|Open-label Treatment Period|Withdrawal by Subject|0
5839847|NCT02326220|20183699|P1|Open-label Treatment Period|Withdrawal by Subject|0
5839848|NCT02326220|20183697|P3|Double-blind Treatment Period|Withdrawal by Subject|0
5839849|NCT02326220|20183698|P2|Double-blind Treatment Period|Withdrawal by Subject|1
5839850|NCT02326220|20183699|P1|Double-blind Treatment Period|Withdrawal by Subject|0
5839851|NCT02326220|20183697|P3|Double-blind Treatment Period|Protocol Violation|0
5839852|NCT02326220|20183698|P2|Double-blind Treatment Period|Protocol Violation|1
5839853|NCT02326220|20183699|P1|Double-blind Treatment Period|Protocol Violation|0
5839854|NCT02326220|20183697|P3|Double-blind Treatment Period|Adverse Event|0
5839855|NCT02326220|20183698|P2|Double-blind Treatment Period|Adverse Event|2
5839856|NCT02326220|20183699|P1|Double-blind Treatment Period|Adverse Event|1
5839857|NCT02326025|20183752|P2|Overall Study|Protocol Violation|1
5839858|NCT02326025|20183753|P1|Overall Study|Protocol Violation|0
5839859|NCT02326025|20183752|P2|Overall Study|Withdrawal by Subject|2
5839860|NCT02326025|20183753|P1|Overall Study|Withdrawal by Subject|0
5839861|NCT02326025|20183752|P2|Overall Study|Physician and Participant Decision|0
5839862|NCT02326025|20183753|P1|Overall Study|Physician and Participant Decision|1
5839863|NCT02326025|20183752|P2|Overall Study|Physician Decision|2
5839864|NCT02326025|20183753|P1|Overall Study|Physician Decision|1
5839865|NCT02326025|20183752|P2|Overall Study|Adverse Event|0
5839866|NCT02326025|20183753|P1|Overall Study|Adverse Event|3
5839867|NCT02325791|20183800|P4|Overall Study|Withdrawal by Subject|16
5839868|NCT02325791|20183801|P3|Overall Study|Withdrawal by Subject|8
5839869|NCT02325791|20183802|P2|Overall Study|Withdrawal by Subject|5
5839870|NCT02325791|20183803|P1|Overall Study|Withdrawal by Subject|0
5839871|NCT02325791|20183800|P4|Overall Study|Protocol Violation|0
5839872|NCT02325791|20183801|P3|Overall Study|Protocol Violation|1
5839873|NCT02325791|20183802|P2|Overall Study|Protocol Violation|0
5839874|NCT02325791|20183803|P1|Overall Study|Protocol Violation|0
5839875|NCT02325791|20183800|P4|Overall Study|Physician Decision|0
5839876|NCT02325791|20183801|P3|Overall Study|Physician Decision|1
5839877|NCT02325791|20183802|P2|Overall Study|Physician Decision|1
5839878|NCT02325791|20183803|P1|Overall Study|Physician Decision|0
5839879|NCT02325791|20183800|P4|Overall Study|Lost to Follow-up|9
5839880|NCT02325791|20183801|P3|Overall Study|Lost to Follow-up|14
5839881|NCT02325791|20183802|P2|Overall Study|Lost to Follow-up|15
5839882|NCT02325791|20183803|P1|Overall Study|Lost to Follow-up|0
5839885|NCT02325791|20183802|P2|Overall Study|Death|3
5839886|NCT02325791|20183803|P1|Overall Study|Death|0
5839887|NCT02325791|20183800|P4|Overall Study|Adverse Event|0
5839888|NCT02325791|20183801|P3|Overall Study|Adverse Event|1
5839889|NCT02325791|20183802|P2|Overall Study|Adverse Event|1
5839890|NCT02325791|20183803|P1|Overall Study|Adverse Event|0
5839891|NCT02325739|20183833|P11|Phase II Part|Subject/guardian decision|1
5839892|NCT02325739|20183834|P10|Phase II Part|Subject/guardian decision|1
5839893|NCT02325739|20183835|P9|Phase II Part|Subject/guardian decision|4
5839894|NCT02325739|20183836|P8|Phase II Part|Subject/guardian decision|0
5839895|NCT02325739|20183837|P7|Phase II Part|Subject/guardian decision|0
5839896|NCT02325739|20183838|P6|Phase II Part|Subject/guardian decision|0
5839897|NCT02325739|20183839|P5|Phase II Part|Subject/guardian decision|0
5839898|NCT02325739|20183840|P4|Phase II Part|Subject/guardian decision|0
5839899|NCT02325739|20183841|P3|Phase II Part|Subject/guardian decision|0
5839900|NCT02325739|20183842|P2|Phase II Part|Subject/guardian decision|0
5839901|NCT02325739|20183843|P1|Phase II Part|Subject/guardian decision|0
5839902|NCT02325739|20183833|P11|Phase II Part|Progressive disease|18
5839903|NCT02325739|20183834|P10|Phase II Part|Progressive disease|29
5839904|NCT02325739|20183835|P9|Phase II Part|Progressive disease|22
5839905|NCT02325739|20183836|P8|Phase II Part|Progressive disease|0
5839906|NCT02325739|20183837|P7|Phase II Part|Progressive disease|0
5839907|NCT02325739|20183838|P6|Phase II Part|Progressive disease|0
5839908|NCT02325739|20183839|P5|Phase II Part|Progressive disease|0
5839909|NCT02325739|20183840|P4|Phase II Part|Progressive disease|0
5839910|NCT02325739|20183841|P3|Phase II Part|Progressive disease|0
5839911|NCT02325739|20183842|P2|Phase II Part|Progressive disease|0
5839912|NCT02325739|20183843|P1|Phase II Part|Progressive disease|0
5839913|NCT02325739|20183833|P11|Phase II Part|Physician Decision|0
5839914|NCT02325739|20183834|P10|Phase II Part|Physician Decision|1
5839915|NCT02325739|20183835|P9|Phase II Part|Physician Decision|0
5839916|NCT02325739|20183836|P8|Phase II Part|Physician Decision|0
5839917|NCT02325739|20183837|P7|Phase II Part|Physician Decision|0
5839918|NCT02325739|20183838|P6|Phase II Part|Physician Decision|0
5839919|NCT02325739|20183839|P5|Phase II Part|Physician Decision|0
5839920|NCT02325739|20183840|P4|Phase II Part|Physician Decision|0
5839921|NCT02325739|20183841|P3|Phase II Part|Physician Decision|0
5839922|NCT02325739|20183842|P2|Phase II Part|Physician Decision|0
5839923|NCT02325739|20183843|P1|Phase II Part|Physician Decision|0
5839924|NCT02325739|20183833|P11|Phase II Part|Adverse Event|1
5839925|NCT02325739|20183834|P10|Phase II Part|Adverse Event|5
5839926|NCT02325739|20183835|P9|Phase II Part|Adverse Event|4
5839927|NCT02325739|20183836|P8|Phase II Part|Adverse Event|0
5839928|NCT02325739|20183837|P7|Phase II Part|Adverse Event|0
5839929|NCT02325739|20183838|P6|Phase II Part|Adverse Event|0
5839930|NCT02325739|20183839|P5|Phase II Part|Adverse Event|0
5839931|NCT02325739|20183840|P4|Phase II Part|Adverse Event|0
5839932|NCT02325739|20183841|P3|Phase II Part|Adverse Event|0
5839933|NCT02325739|20183842|P2|Phase II Part|Adverse Event|0
5839934|NCT02325739|20183843|P1|Phase II Part|Adverse Event|0
5839935|NCT02325739|20183833|P11|Phase I Part|Death|0
5839936|NCT02325739|20183834|P10|Phase I Part|Death|0
5839937|NCT02325739|20183835|P9|Phase I Part|Death|0
5839938|NCT02325739|20183836|P8|Phase I Part|Death|0
5839939|NCT02325739|20183837|P7|Phase I Part|Death|0
5839940|NCT02325739|20183838|P6|Phase I Part|Death|0
5839941|NCT02325739|20183839|P5|Phase I Part|Death|2
5839942|NCT02325739|20183840|P4|Phase I Part|Death|0
5839943|NCT02325739|20183841|P3|Phase I Part|Death|0
5839944|NCT02325739|20183842|P2|Phase I Part|Death|0
5839945|NCT02325739|20183843|P1|Phase I Part|Death|0
5839946|NCT02325739|20183833|P11|Phase I Part|Subject/guardian decision|0
5839947|NCT02325739|20183834|P10|Phase I Part|Subject/guardian decision|0
5839948|NCT02325739|20183835|P9|Phase I Part|Subject/guardian decision|0
5839949|NCT02325739|20183836|P8|Phase I Part|Subject/guardian decision|1
5839950|NCT02325739|20183837|P7|Phase I Part|Subject/guardian decision|0
5839951|NCT02325739|20183838|P6|Phase I Part|Subject/guardian decision|0
5839952|NCT02325739|20183839|P5|Phase I Part|Subject/guardian decision|0
5839953|NCT02325739|20183840|P4|Phase I Part|Subject/guardian decision|1
5839954|NCT02325739|20183841|P3|Phase I Part|Subject/guardian decision|1
5839955|NCT02325739|20183842|P2|Phase I Part|Subject/guardian decision|0
5839956|NCT02325739|20183843|P1|Phase I Part|Subject/guardian decision|1
5839957|NCT02325739|20183833|P11|Phase I Part|Progressive disease|0
5839958|NCT02325739|20183834|P10|Phase I Part|Progressive disease|0
5839959|NCT02325739|20183835|P9|Phase I Part|Progressive disease|0
5839960|NCT02325739|20183836|P8|Phase I Part|Progressive disease|3
5839961|NCT02325739|20183837|P7|Phase I Part|Progressive disease|6
5839962|NCT02325739|20183838|P6|Phase I Part|Progressive disease|6
5839963|NCT02325739|20183839|P5|Phase I Part|Progressive disease|14
5839964|NCT02325739|20183840|P4|Phase I Part|Progressive disease|23
5839965|NCT02325739|20183841|P3|Phase I Part|Progressive disease|3
5839966|NCT02325739|20183842|P2|Phase I Part|Progressive disease|6
5839967|NCT02325739|20183843|P1|Phase I Part|Progressive disease|9
5839968|NCT02325739|20183833|P11|Phase I Part|Adverse Event|0
5839969|NCT02325739|20183834|P10|Phase I Part|Adverse Event|0
5839970|NCT02325739|20183835|P9|Phase I Part|Adverse Event|0
5839971|NCT02325739|20183836|P8|Phase I Part|Adverse Event|2
5839972|NCT02325739|20183837|P7|Phase I Part|Adverse Event|0
5839973|NCT02325739|20183838|P6|Phase I Part|Adverse Event|1
5839974|NCT02325739|20183839|P5|Phase I Part|Adverse Event|3
5839975|NCT02325739|20183840|P4|Phase I Part|Adverse Event|2
5839976|NCT02325739|20183841|P3|Phase I Part|Adverse Event|1
5839977|NCT02325739|20183842|P2|Phase I Part|Adverse Event|0
5839978|NCT02325739|20183843|P1|Phase I Part|Adverse Event|1
5839979|NCT02325713|20183973|P16|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
5839980|NCT02325713|20183974|P15|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
5839981|NCT02325713|20183975|P14|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
5839982|NCT02325713|20183976|P13|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
5839983|NCT02325713|20183977|P12|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
5839984|NCT02325713|20183978|P11|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
5839985|NCT02325713|20183979|P10|Intervention Period 3 (2 Days)|Withdrawal by Subject|1
5839986|NCT02325713|20183980|P9|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
5839987|NCT02325713|20183981|P8|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
5839988|NCT02325713|20183982|P7|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
5839989|NCT02325713|20183983|P6|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
5839990|NCT02325713|20183984|P5|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
5839991|NCT02325713|20183985|P4|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
5839992|NCT02325713|20183986|P3|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
5839993|NCT02325713|20183987|P2|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
5839994|NCT02325713|20183988|P1|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
5839995|NCT02325713|20183973|P16|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
5839996|NCT02325713|20183974|P15|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
5839997|NCT02325713|20183975|P14|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
5839998|NCT02325713|20183976|P13|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
5839999|NCT02325713|20183977|P12|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
5840000|NCT02325713|20183978|P11|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
5840001|NCT02325713|20183979|P10|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
5840002|NCT02325713|20183980|P9|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
5840003|NCT02325713|20183981|P8|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
5840004|NCT02325713|20183982|P7|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
5840005|NCT02325713|20183983|P6|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
5840006|NCT02325713|20183984|P5|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
5840007|NCT02325713|20183985|P4|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
5840008|NCT02325713|20183986|P3|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
5840009|NCT02325713|20183987|P2|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
5840010|NCT02325713|20183988|P1|Intervention Period 2 (2 Days)|Protocol Non-Compliance|1
5840011|NCT02325713|20183973|P16|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
5840012|NCT02325713|20183974|P15|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
5840013|NCT02325713|20183975|P14|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
5840014|NCT02325713|20183976|P13|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
5840015|NCT02325713|20183977|P12|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
5840016|NCT02325713|20183978|P11|Intervention Period 1 (2 Days)|Protocol Non-Compliance|1
5840017|NCT02325713|20183979|P10|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
5840018|NCT02325713|20183980|P9|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
5840019|NCT02325713|20183981|P8|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
5840020|NCT02325713|20183982|P7|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
5840021|NCT02325713|20183983|P6|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
5840022|NCT02325713|20183984|P5|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
5840023|NCT02325713|20183985|P4|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
5840024|NCT02325713|20183986|P3|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
5840025|NCT02325713|20183987|P2|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
5840026|NCT02325713|20183988|P1|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
5840027|NCT02325518|20184102|P2|Overall Study|Withdrawal by Subject|1
5840028|NCT02325518|20184103|P1|Overall Study|Withdrawal by Subject|0
5840029|NCT02325518|20184102|P2|Overall Study|Physician Decision|1
5840030|NCT02325518|20184103|P1|Overall Study|Physician Decision|0
5840031|NCT02325518|20184102|P2|Overall Study|Adverse Event|1
5840032|NCT02325518|20184103|P1|Overall Study|Adverse Event|4
5840033|NCT02325401|20184112|P3|Overall Study|Withdrawal by Subject|1
5840034|NCT02325401|20184113|P2|Overall Study|Withdrawal by Subject|1
5840035|NCT02325401|20184114|P1|Overall Study|Withdrawal by Subject|0
5840036|NCT02325219|20184137|P5|After Controlled Period (Week 16 - 52)|Pregnancy|0
5840037|NCT02325219|20184138|P4|After Controlled Period (Week 16 - 52)|Pregnancy|0
5840038|NCT02325219|20184139|P3|After Controlled Period (Week 16 - 52)|Pregnancy|0
5840039|NCT02325219|20184140|P2|After Controlled Period (Week 16 - 52)|Pregnancy|1
5840040|NCT02325219|20184141|P1|After Controlled Period (Week 16 - 52)|Pregnancy|0
5840041|NCT02325219|20184137|P5|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0
5840042|NCT02325219|20184138|P4|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0
5840043|NCT02325219|20184139|P3|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0
5840044|NCT02325219|20184140|P2|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|2
5840045|NCT02325219|20184141|P1|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0
5840046|NCT02325219|20184137|P5|After Controlled Period (Week 16 - 52)|Adverse Event|1
5840047|NCT02325219|20184138|P4|After Controlled Period (Week 16 - 52)|Adverse Event|0
5840048|NCT02325219|20184139|P3|After Controlled Period (Week 16 - 52)|Adverse Event|0
5840049|NCT02325219|20184140|P2|After Controlled Period (Week 16 - 52)|Adverse Event|0
5840050|NCT02325219|20184141|P1|After Controlled Period (Week 16 - 52)|Adverse Event|0
5840051|NCT02325219|20184137|P5|Controlled Period (Week 0 - 16)|Other|0
5840052|NCT02325219|20184138|P4|Controlled Period (Week 0 - 16)|Other|0
5840053|NCT02325219|20184139|P3|Controlled Period (Week 0 - 16)|Other|1
5840054|NCT02325219|20184140|P2|Controlled Period (Week 0 - 16)|Other|0
5840055|NCT02325219|20184141|P1|Controlled Period (Week 0 - 16)|Other|0
5840056|NCT02325219|20184137|P5|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0
5840057|NCT02325219|20184138|P4|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0
5840058|NCT02325219|20184139|P3|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0
5840059|NCT02325219|20184140|P2|Controlled Period (Week 0 - 16)|Withdrawal by Subject|1
5840060|NCT02325219|20184141|P1|Controlled Period (Week 0 - 16)|Withdrawal by Subject|6
5840061|NCT02325219|20184137|P5|Controlled Period (Week 0 - 16)|Adverse Event|0
5840062|NCT02325219|20184138|P4|Controlled Period (Week 0 - 16)|Adverse Event|0
5840063|NCT02325219|20184139|P3|Controlled Period (Week 0 - 16)|Adverse Event|0
5840064|NCT02325219|20184140|P2|Controlled Period (Week 0 - 16)|Adverse Event|1
5840065|NCT02325219|20184141|P1|Controlled Period (Week 0 - 16)|Adverse Event|6
5840066|NCT02324842|20184333|P3|Overall Study|Lost to Follow-up|2
5840067|NCT02324842|20184334|P2|Overall Study|Lost to Follow-up|1
5840068|NCT02324842|20184335|P1|Overall Study|Lost to Follow-up|1
5840069|NCT02324699|20184369|P1|Overall Study|study terminated|1
5840070|NCT02324569|20184489|P2|Overall Study|Inconvenient Schedule|0
5840071|NCT02324569|20184490|P1|Overall Study|Inconvenient Schedule|2
5840072|NCT02324569|20184489|P2|Overall Study|Change Insulin Dosage Exceeding Criteria|2
5840073|NCT02324569|20184490|P1|Overall Study|Change Insulin Dosage Exceeding Criteria|0
5840074|NCT02324569|20184489|P2|Overall Study|Lack of Efficacy|3
5840075|NCT02324569|20184490|P1|Overall Study|Lack of Efficacy|2
5840076|NCT02324569|20184489|P2|Overall Study|Voluntary Withdrawal|6
5840077|NCT02324569|20184490|P1|Overall Study|Voluntary Withdrawal|3
5840078|NCT02324569|20184489|P2|Overall Study|Pretreatment Event/Adverse Event|10
5840079|NCT02324569|20184490|P1|Overall Study|Pretreatment Event/Adverse Event|9
5840080|NCT02324465|20184552|P2|Overall Study|device failure|1
5840081|NCT02324465|20184553|P1|Overall Study|device failure|0
5840082|NCT02324361|20184567|P2|Overall Study|Lost to Follow-up|2
5840083|NCT02324361|20184568|P1|Overall Study|Lost to Follow-up|5
5840084|NCT02324270|20184598|P3|Overall Study|Non Compliance with Study Drug|0
5840085|NCT02324270|20184599|P2|Overall Study|Non Compliance with Study Drug|2
5840086|NCT02324270|20184600|P1|Overall Study|Non Compliance with Study Drug|1
5840087|NCT02324270|20184598|P3|Overall Study|Protocol Violation|1
5840088|NCT02324270|20184599|P2|Overall Study|Protocol Violation|1
5840089|NCT02324270|20184600|P1|Overall Study|Protocol Violation|0
5840090|NCT02324270|20184598|P3|Overall Study|Lost to Follow-up|4
5840091|NCT02324270|20184599|P2|Overall Study|Lost to Follow-up|3
5840092|NCT02324270|20184600|P1|Overall Study|Lost to Follow-up|4
5840093|NCT02324270|20184598|P3|Overall Study|Withdrawal by Subject|0
5840094|NCT02324270|20184599|P2|Overall Study|Withdrawal by Subject|1
5840095|NCT02324270|20184600|P1|Overall Study|Withdrawal by Subject|0
5840096|NCT02324205|20184610|P1|Overall Study|Withdrawal by Subject|37
5840097|NCT02324153|20184622|P2|Overall Study|Developed delirium preoperatively|0
5840098|NCT02324153|20184623|P1|Overall Study|Developed delirium preoperatively|1
5840099|NCT02324153|20184622|P2|Overall Study|Surgery postponed after randomization|0
5840100|NCT02324153|20184623|P1|Overall Study|Surgery postponed after randomization|3
5840101|NCT02324153|20184622|P2|Overall Study|Withdrawal by Subject|1
5840102|NCT02324153|20184623|P1|Overall Study|Withdrawal by Subject|4
5840103|NCT02324049|20184668|P1|Part C|Study terminated|11
5840104|NCT02323646|20184681|P3|Treatment Course 2|Non-compliance|1
5840105|NCT02323646|20184682|P2|Treatment Course 2|Non-compliance|1
5840106|NCT02323646|20184683|P1|Treatment Course 2|Non-compliance|0
5840107|NCT02323646|20184681|P3|Treatment Course 2|Lost to Follow-up|1
5840108|NCT02323646|20184682|P2|Treatment Course 2|Lost to Follow-up|0
5840109|NCT02323646|20184683|P1|Treatment Course 2|Lost to Follow-up|0
5840110|NCT02323646|20184681|P3|Treatment Course 2|Adverse Event|1
5840111|NCT02323646|20184682|P2|Treatment Course 2|Adverse Event|0
5840112|NCT02323646|20184683|P1|Treatment Course 2|Adverse Event|1
5840113|NCT02323646|20184681|P3|Treatment Course 1|Withdrawal by Subject|0
5840114|NCT02323646|20184682|P2|Treatment Course 1|Withdrawal by Subject|2
5840115|NCT02323646|20184683|P1|Treatment Course 1|Withdrawal by Subject|0
5840116|NCT02323646|20184681|P3|Treatment Course 1|Lost to Follow-up|2
5840117|NCT02323646|20184682|P2|Treatment Course 1|Lost to Follow-up|0
5840118|NCT02323646|20184683|P1|Treatment Course 1|Lost to Follow-up|1
5840119|NCT02323646|20184681|P3|Treatment Course 1|Heavy Bleeding|0
5840120|NCT02323646|20184682|P2|Treatment Course 1|Heavy Bleeding|1
5840121|NCT02323646|20184683|P1|Treatment Course 1|Heavy Bleeding|1
5840122|NCT02323646|20184681|P3|Treatment Course 1|Adverse Event|1
5840123|NCT02323646|20184682|P2|Treatment Course 1|Adverse Event|0
5840124|NCT02323646|20184683|P1|Treatment Course 1|Adverse Event|1
5840125|NCT02323204|20184731|P4|6-month Follow-up Survey Completion|Withdrawal by Subject|1
5840126|NCT02323204|20184732|P3|6-month Follow-up Survey Completion|Withdrawal by Subject|3
5840127|NCT02323204|20184733|P2|6-month Follow-up Survey Completion|Withdrawal by Subject|0
5840128|NCT02323204|20184734|P1|6-month Follow-up Survey Completion|Withdrawal by Subject|0
5840129|NCT02323204|20184731|P4|6-month Follow-up Survey Completion|Lost to Follow-up|43
5840130|NCT02323204|20184732|P3|6-month Follow-up Survey Completion|Lost to Follow-up|38
5840131|NCT02323204|20184733|P2|6-month Follow-up Survey Completion|Lost to Follow-up|50
5840132|NCT02323204|20184734|P1|6-month Follow-up Survey Completion|Lost to Follow-up|49
5840133|NCT02323204|20184731|P4|3-month Follow-up Survey Completion|Withdrawal by Subject|2
5840134|NCT02323204|20184732|P3|3-month Follow-up Survey Completion|Withdrawal by Subject|0
5840135|NCT02323204|20184733|P2|3-month Follow-up Survey Completion|Withdrawal by Subject|2
5840136|NCT02323204|20184734|P1|3-month Follow-up Survey Completion|Withdrawal by Subject|0
5840137|NCT02323204|20184731|P4|3-month Follow-up Survey Completion|Lost to Follow-up|42
5840138|NCT02323204|20184732|P3|3-month Follow-up Survey Completion|Lost to Follow-up|41
5840139|NCT02323204|20184733|P2|3-month Follow-up Survey Completion|Lost to Follow-up|45
5840140|NCT02323204|20184734|P1|3-month Follow-up Survey Completion|Lost to Follow-up|54
5840141|NCT02323204|20184731|P4|6-week Follow-up Intervention Booster|Withdrawal by Subject|2
5840142|NCT02323204|20184732|P3|6-week Follow-up Intervention Booster|Withdrawal by Subject|0
5840143|NCT02323204|20184733|P2|6-week Follow-up Intervention Booster|Withdrawal by Subject|8
5840144|NCT02323204|20184734|P1|6-week Follow-up Intervention Booster|Withdrawal by Subject|0
5840145|NCT02323204|20184731|P4|6-week Follow-up Intervention Booster|Lost to Follow-up|34
5840146|NCT02323204|20184732|P3|6-week Follow-up Intervention Booster|Lost to Follow-up|0
5840147|NCT02323204|20184733|P2|6-week Follow-up Intervention Booster|Lost to Follow-up|35
5840148|NCT02323204|20184734|P1|6-week Follow-up Intervention Booster|Lost to Follow-up|0
5840149|NCT02323204|20184731|P4|6-week Follow-up Survey Completion|Withdrawal by Subject|2
5840150|NCT02323204|20184732|P3|6-week Follow-up Survey Completion|Withdrawal by Subject|3
5840151|NCT02323204|20184733|P2|6-week Follow-up Survey Completion|Withdrawal by Subject|8
5840152|NCT02323204|20184734|P1|6-week Follow-up Survey Completion|Withdrawal by Subject|12
5840153|NCT02323204|20184731|P4|6-week Follow-up Survey Completion|Lost to Follow-up|35
5840154|NCT02323204|20184732|P3|6-week Follow-up Survey Completion|Lost to Follow-up|39
5840155|NCT02323204|20184733|P2|6-week Follow-up Survey Completion|Lost to Follow-up|28
5840156|NCT02323204|20184734|P1|6-week Follow-up Survey Completion|Lost to Follow-up|29
5840157|NCT02323204|20184731|P4|Baseline Survey Completion|Withdrawal by Subject|3
5840158|NCT02323204|20184732|P3|Baseline Survey Completion|Withdrawal by Subject|5
5840159|NCT02323204|20184733|P2|Baseline Survey Completion|Withdrawal by Subject|9
5840160|NCT02323204|20184734|P1|Baseline Survey Completion|Withdrawal by Subject|10
5840161|NCT02322892|20184807|P2|Overall Study|Protocol Violation|0
5840162|NCT02322892|20184808|P1|Overall Study|Protocol Violation|1
5840163|NCT02322892|20184807|P2|Overall Study|Met exclusion criteria|1
5840164|NCT02322892|20184808|P1|Overall Study|Met exclusion criteria|0
5840165|NCT02322892|20184807|P2|Overall Study|Surgery cancelled|2
5840166|NCT02322892|20184808|P1|Overall Study|Surgery cancelled|1
5840167|NCT02322879|20184824|P2|First Intervention|Physician Decision|0
5840168|NCT02322879|20184825|P1|First Intervention|Physician Decision|1
5840169|NCT02322866|20184833|P2|Overall Study|Other Miscellaneous Reasons|6
5840170|NCT02322866|20184834|P1|Overall Study|Other Miscellaneous Reasons|6
5840171|NCT02322866|20184833|P2|Overall Study|Lack of Efficacy|1
5840172|NCT02322866|20184834|P1|Overall Study|Lack of Efficacy|3
5840173|NCT02322866|20184833|P2|Overall Study|Noncompliance with Treatment|4
5840174|NCT02322866|20184834|P1|Overall Study|Noncompliance with Treatment|3
5840175|NCT02322866|20184833|P2|Overall Study|Protocol Violation|0
5840176|NCT02322866|20184834|P1|Overall Study|Protocol Violation|1
5840177|NCT02322866|20184833|P2|Overall Study|Lost to Follow-up|39
5840178|NCT02322866|20184834|P1|Overall Study|Lost to Follow-up|36
5840179|NCT02322866|20184833|P2|Overall Study|Withdrawal of Consent|25
5840180|NCT02322866|20184834|P1|Overall Study|Withdrawal of Consent|16
5840181|NCT02322866|20184833|P2|Overall Study|Adverse Event|11
5840182|NCT02322866|20184834|P1|Overall Study|Adverse Event|6
5840218|NCT02322775|20184891|P2|Overall Study|Not willing to perform all FU visits|1
5840219|NCT02322775|20184892|P1|Overall Study|Not willing to perform all FU visits|0
5840220|NCT02322775|20184891|P2|Overall Study|Withdrawal by Subject|4
5840221|NCT02322775|20184892|P1|Overall Study|Withdrawal by Subject|3
5840222|NCT02322775|20184891|P2|Overall Study|Protocol Violation|0
5840223|NCT02322775|20184892|P1|Overall Study|Protocol Violation|1
5840224|NCT02322775|20184891|P2|Overall Study|Lost to Follow-up|1
5840225|NCT02322775|20184892|P1|Overall Study|Lost to Follow-up|0
5840226|NCT02322775|20184891|P2|Overall Study|Adverse Event|0
5840227|NCT02322775|20184892|P1|Overall Study|Adverse Event|1
5840228|NCT02322749|20184918|P6|Period 3|Withdrawal by Subject|0
5840229|NCT02322749|20184919|P5|Period 3|Withdrawal by Subject|0
5840230|NCT02322749|20184920|P4|Period 3|Withdrawal by Subject|0
5840231|NCT02322749|20184921|P3|Period 3|Withdrawal by Subject|1
5840232|NCT02322749|20184922|P2|Period 3|Withdrawal by Subject|0
5840233|NCT02322749|20184923|P1|Period 3|Withdrawal by Subject|0
5840234|NCT02322749|20184918|P6|Period 2|Withdrawal by Subject|0
5840235|NCT02322749|20184919|P5|Period 2|Withdrawal by Subject|0
5840236|NCT02322749|20184920|P4|Period 2|Withdrawal by Subject|1
5840237|NCT02322749|20184921|P3|Period 2|Withdrawal by Subject|0
5840238|NCT02322749|20184922|P2|Period 2|Withdrawal by Subject|0
5840239|NCT02322749|20184923|P1|Period 2|Withdrawal by Subject|0
5840240|NCT02322749|20184918|P6|Period 2|Adverse Event|0
5840241|NCT02322749|20184919|P5|Period 2|Adverse Event|0
5840242|NCT02322749|20184920|P4|Period 2|Adverse Event|1
5840243|NCT02322749|20184921|P3|Period 2|Adverse Event|0
5840244|NCT02322749|20184922|P2|Period 2|Adverse Event|0
5840245|NCT02322749|20184923|P1|Period 2|Adverse Event|0
5840246|NCT02322710|20184948|P2|Overall Study|Protocol Violation|25
5840247|NCT02322710|20184949|P1|Overall Study|Protocol Violation|20
5840248|NCT02322710|20184948|P2|Overall Study|No efficacy assessment post-baseline|1
5840249|NCT02322710|20184949|P1|Overall Study|No efficacy assessment post-baseline|0
5840250|NCT02322411|20184962|P2|Overall Study|Withdrawal by Subject|0
5840251|NCT02322411|20184963|P1|Overall Study|Withdrawal by Subject|1
5840252|NCT02322411|20184962|P2|Overall Study|Lost to Follow-up|7
5840253|NCT02322411|20184963|P1|Overall Study|Lost to Follow-up|4
5840254|NCT02322281|20185032|P3|Overall Study|Miscellaneous|4
5840255|NCT02322281|20185033|P2|Overall Study|Miscellaneous|0
5840256|NCT02322281|20185034|P1|Overall Study|Miscellaneous|0
5840257|NCT02322281|20185032|P3|Overall Study|Missing|1
5840258|NCT02322281|20185033|P2|Overall Study|Missing|0
5840259|NCT02322281|20185034|P1|Overall Study|Missing|0
5840260|NCT02322281|20185032|P3|Overall Study|Study Terminated by Sponsor|0
5840261|NCT02322281|20185033|P2|Overall Study|Study Terminated by Sponsor|0
5840262|NCT02322281|20185034|P1|Overall Study|Study Terminated by Sponsor|2
5840263|NCT02322281|20185032|P3|Overall Study|Physician Decision|5
5840264|NCT02322281|20185033|P2|Overall Study|Physician Decision|0
5840265|NCT02322281|20185034|P1|Overall Study|Physician Decision|2
5840266|NCT02322281|20185032|P3|Overall Study|Withdrawal by Subject|6
5840267|NCT02322281|20185033|P2|Overall Study|Withdrawal by Subject|1
5840268|NCT02322281|20185034|P1|Overall Study|Withdrawal by Subject|1
5840269|NCT02322281|20185032|P3|Overall Study|Death|3
5840270|NCT02322281|20185033|P2|Overall Study|Death|3
5840271|NCT02322281|20185034|P1|Overall Study|Death|3
5840272|NCT02322281|20185032|P3|Overall Study|Adverse Event|6
5840273|NCT02322281|20185033|P2|Overall Study|Adverse Event|4
5840274|NCT02322281|20185034|P1|Overall Study|Adverse Event|3
5840275|NCT02322281|20185032|P3|Overall Study|Progressive Disease|49
5840276|NCT02322281|20185033|P2|Overall Study|Progressive Disease|14
5840277|NCT02322281|20185034|P1|Overall Study|Progressive Disease|42
5840278|NCT02322229|20185082|P1|Overall Study|Physician Decision|2
5840279|NCT02322216|20185094|P2|Overall Study|Withdrawal by Subject|4
5840280|NCT02322216|20185095|P1|Overall Study|Withdrawal by Subject|1
5840281|NCT02322216|20185094|P2|Overall Study|Adverse Event|0
5840282|NCT02322216|20185095|P1|Overall Study|Adverse Event|1
5840283|NCT02322190|20185102|P2|Overall Study|Death on study|0
5840284|NCT02322190|20185103|P1|Overall Study|Death on study|1
5840285|NCT02322047|20185115|P4|Overall Study|Lost to Follow-up|1
5840286|NCT02322047|20185116|P3|Overall Study|Lost to Follow-up|1
5840287|NCT02322047|20185117|P2|Overall Study|Lost to Follow-up|0
5840288|NCT02322047|20185118|P1|Overall Study|Lost to Follow-up|0
5840289|NCT02322047|20185115|P4|Overall Study|Adverse Event|0
5840290|NCT02322047|20185116|P3|Overall Study|Adverse Event|0
5840291|NCT02322047|20185117|P2|Overall Study|Adverse Event|1
5840292|NCT02322047|20185118|P1|Overall Study|Adverse Event|0
5840293|NCT02322047|20185115|P4|Overall Study|Withdrawal by Subject|1
5840294|NCT02322047|20185116|P3|Overall Study|Withdrawal by Subject|0
5840295|NCT02322047|20185117|P2|Overall Study|Withdrawal by Subject|0
5840296|NCT02322047|20185118|P1|Overall Study|Withdrawal by Subject|1
5840297|NCT02322047|20185115|P4|Overall Study|Physician Decision|0
5840298|NCT02322047|20185116|P3|Overall Study|Physician Decision|0
5840299|NCT02322047|20185117|P2|Overall Study|Physician Decision|0
5840300|NCT02322047|20185118|P1|Overall Study|Physician Decision|1
5840301|NCT02321930|20185140|P1|Overall Study|Lost to Follow-up|1
5840302|NCT02321800|20185150|P2|Overall Study|Other, Miscellaneous|1
5840303|NCT02321800|20185151|P1|Overall Study|Other, Miscellaneous|3
5840304|NCT02321800|20185150|P2|Overall Study|Adverse Event|3
5840305|NCT02321800|20185151|P1|Overall Study|Adverse Event|2
5840306|NCT02321800|20185150|P2|Overall Study|Lost to Follow-up|4
5840307|NCT02321800|20185151|P1|Overall Study|Lost to Follow-up|10
5840308|NCT02321800|20185150|P2|Overall Study|Protocol Violation|0
5840309|NCT02321800|20185151|P1|Overall Study|Protocol Violation|1
5840310|NCT02321800|20185150|P2|Overall Study|Death|0
5840311|NCT02321800|20185151|P1|Overall Study|Death|1
5840312|NCT02321800|20185150|P2|Overall Study|Withdrawal by Subject|3
5840313|NCT02321800|20185151|P1|Overall Study|Withdrawal by Subject|3
5840314|NCT02321462|20185240|P2|Overall Study|Subject withdrawn before any treatment|1
5840315|NCT02321462|20185241|P1|Overall Study|Subject withdrawn before any treatment|1
5840316|NCT02321462|20185240|P2|Overall Study|Withdrawal by Subject|2
5840317|NCT02321462|20185241|P1|Overall Study|Withdrawal by Subject|5
5840318|NCT02321436|20185263|P2|Overall Study|Lost to Follow-up|1
5840319|NCT02321436|20185264|P1|Overall Study|Lost to Follow-up|0
5840320|NCT02321436|20185263|P2|Overall Study|Withdrawal by Subject|0
5840321|NCT02321436|20185264|P1|Overall Study|Withdrawal by Subject|1
5840322|NCT02321319|20185280|P1|Overall Study|Product discontinued|5
5840323|NCT02321098|20185312|P3|Additional 15 Months Treatment|Withdrawal by Subject|1
5840324|NCT02321098|20185313|P2|Additional 15 Months Treatment|Withdrawal by Subject|0
5840325|NCT02321098|20185314|P1|Additional 15 Months Treatment|Withdrawal by Subject|0
5840326|NCT02321098|20185312|P3|Additional 15 Months Treatment|Lost to Follow-up|1
5840327|NCT02321098|20185313|P2|Additional 15 Months Treatment|Lost to Follow-up|0
5840328|NCT02321098|20185314|P1|Additional 15 Months Treatment|Lost to Follow-up|0
5840329|NCT02321098|20185312|P3|Additional 15 Months Treatment|Lack of Efficacy|6
5840330|NCT02321098|20185313|P2|Additional 15 Months Treatment|Lack of Efficacy|0
5840331|NCT02321098|20185314|P1|Additional 15 Months Treatment|Lack of Efficacy|0
5840332|NCT02321098|20185312|P3|12 Weeks Treament|Lost to Follow-up|0
5840333|NCT02321098|20185313|P2|12 Weeks Treament|Lost to Follow-up|1
5840334|NCT02321098|20185314|P1|12 Weeks Treament|Lost to Follow-up|1
5840335|NCT02320903|20185326|P3|Overall Study|Lost to Follow-up|5
5840336|NCT02320903|20185327|P2|Overall Study|Lost to Follow-up|5
5840337|NCT02320903|20185328|P1|Overall Study|Lost to Follow-up|0
5840338|NCT02320903|20185326|P3|Overall Study|Exited therapy; no longer eligible|2
5840339|NCT02320903|20185327|P2|Overall Study|Exited therapy; no longer eligible|2
5840340|NCT02320903|20185328|P1|Overall Study|Exited therapy; no longer eligible|8
5840341|NCT02320903|20185326|P3|Overall Study|Withdrawal by Subject|9
5840342|NCT02320903|20185327|P2|Overall Study|Withdrawal by Subject|9
5840343|NCT02320903|20185328|P1|Overall Study|Withdrawal by Subject|0
5840344|NCT02320721|20185453|P2|Overall Study|Other than specified above|20
5840345|NCT02320721|20185454|P1|Overall Study|Other than specified above|15
5840346|NCT02320721|20185453|P2|Overall Study|Hypoglycemia|0
5840347|NCT02320721|20185454|P1|Overall Study|Hypoglycemia|1
5840348|NCT02320721|20185453|P2|Overall Study|Randomized but not treated|1
5840349|NCT02320721|20185454|P1|Overall Study|Randomized but not treated|0
5840350|NCT02320721|20185453|P2|Overall Study|Poor compliance to protocol|7
5840351|NCT02320721|20185454|P1|Overall Study|Poor compliance to protocol|3
5840352|NCT02320721|20185453|P2|Overall Study|Lack of Efficacy|0
5840353|NCT02320721|20185454|P1|Overall Study|Lack of Efficacy|2
5840354|NCT02320721|20185453|P2|Overall Study|Adverse Event|6
5840355|NCT02320721|20185454|P1|Overall Study|Adverse Event|6
5840356|NCT02320487|20185509|P1|Overall Study|Adverse Event|11
5840357|NCT02320487|20185509|P1|Overall Study|Death|3
5840358|NCT02320487|20185509|P1|Overall Study|Withdrawal by Subject|1
5840359|NCT02320487|20185509|P1|Overall Study|Physician Decision|5
5840360|NCT02320487|20185509|P1|Overall Study|Reason not Specified|1
5840361|NCT02320396|20185529|P2|Overall Study|Withdrawal by Subject|0
5840362|NCT02320396|20185530|P1|Overall Study|Withdrawal by Subject|2
5840363|NCT02320396|20185529|P2|Overall Study|Protocol Violation|1
5840364|NCT02320396|20185530|P1|Overall Study|Protocol Violation|0
5840365|NCT02320396|20185529|P2|Overall Study|Pregnancy|1
5840366|NCT02320396|20185530|P1|Overall Study|Pregnancy|0
5840367|NCT02320396|20185529|P2|Overall Study|Adverse Event|2
5840368|NCT02320396|20185530|P1|Overall Study|Adverse Event|2
5840369|NCT02320149|20185589|P2|Overall Study|Other Miscellaneous Reasons|3
5840370|NCT02320149|20185590|P1|Overall Study|Other Miscellaneous Reasons|2
5840371|NCT02320149|20185589|P2|Overall Study|Lack of Efficacy|1
5840372|NCT02320149|20185590|P1|Overall Study|Lack of Efficacy|0
5840373|NCT02320149|20185589|P2|Overall Study|Noncompliance with Study Treatment|2
5840374|NCT02320149|20185590|P1|Overall Study|Noncompliance with Study Treatment|7
5840375|NCT02320149|20185589|P2|Overall Study|Protocol Violation|1
5840376|NCT02320149|20185590|P1|Overall Study|Protocol Violation|2
5840377|NCT02320149|20185589|P2|Overall Study|Lost to Follow-up|34
5840378|NCT02320149|20185590|P1|Overall Study|Lost to Follow-up|21
5840379|NCT02320149|20185589|P2|Overall Study|Withdrawal of Consent|32
5840380|NCT02320149|20185590|P1|Overall Study|Withdrawal of Consent|28
5840381|NCT02320149|20185589|P2|Overall Study|Adverse Event|7
5840382|NCT02320149|20185590|P1|Overall Study|Adverse Event|3
5840383|NCT02320123|20185630|P2|Overall Study|Death|5
5840384|NCT02320123|20185631|P1|Overall Study|Death|6
5840385|NCT02320123|20185630|P2|Overall Study|Lost to Follow-up|6
5840386|NCT02320123|20185631|P1|Overall Study|Lost to Follow-up|4
5840387|NCT02319759|20185722|P5|Week 24 - 56|Lost to Follow-up|1
5840388|NCT02319759|20185723|P4|Week 24 - 56|Lost to Follow-up|0
5840389|NCT02319759|20185724|P3|Week 24 - 56|Lost to Follow-up|0
5840390|NCT02319759|20185725|P2|Week 24 - 56|Lost to Follow-up|0
5840391|NCT02319759|20185726|P1|Week 24 - 56|Lost to Follow-up|0
5840392|NCT02319759|20185722|P5|Week 24 - 56|Withdrawal by Subject|0
5840393|NCT02319759|20185723|P4|Week 24 - 56|Withdrawal by Subject|0
5840394|NCT02319759|20185724|P3|Week 24 - 56|Withdrawal by Subject|0
5840395|NCT02319759|20185725|P2|Week 24 - 56|Withdrawal by Subject|1
5840396|NCT02319759|20185726|P1|Week 24 - 56|Withdrawal by Subject|0
5840397|NCT02319759|20185722|P5|Week 24 - 56|Lack of Efficacy|1
5840398|NCT02319759|20185723|P4|Week 24 - 56|Lack of Efficacy|2
5840399|NCT02319759|20185724|P3|Week 24 - 56|Lack of Efficacy|0
5840400|NCT02319759|20185725|P2|Week 24 - 56|Lack of Efficacy|0
5840401|NCT02319759|20185726|P1|Week 24 - 56|Lack of Efficacy|0
5840402|NCT02319759|20185722|P5|Week 24 - 56|Adverse Event|0
5840403|NCT02319759|20185723|P4|Week 24 - 56|Adverse Event|0
5840404|NCT02319759|20185724|P3|Week 24 - 56|Adverse Event|2
5840405|NCT02319759|20185725|P2|Week 24 - 56|Adverse Event|0
5840406|NCT02319759|20185726|P1|Week 24 - 56|Adverse Event|0
5840407|NCT02319759|20185722|P5|Week 16 - 24|Withdrawal by Subject|0
5840408|NCT02319759|20185723|P4|Week 16 - 24|Withdrawal by Subject|0
5840409|NCT02319759|20185724|P3|Week 16 - 24|Withdrawal by Subject|2
5840410|NCT02319759|20185725|P2|Week 16 - 24|Withdrawal by Subject|0
5840411|NCT02319759|20185726|P1|Week 16 - 24|Withdrawal by Subject|0
5840412|NCT02319759|20185722|P5|Week 16 - 24|Lost to Follow-up|0
5840413|NCT02319759|20185723|P4|Week 16 - 24|Lost to Follow-up|0
5840414|NCT02319759|20185724|P3|Week 16 - 24|Lost to Follow-up|0
5840415|NCT02319759|20185725|P2|Week 16 - 24|Lost to Follow-up|0
5840416|NCT02319759|20185726|P1|Week 16 - 24|Lost to Follow-up|1
5840417|NCT02319759|20185722|P5|Week 16 - 24|Lack of Efficacy|0
5840418|NCT02319759|20185723|P4|Week 16 - 24|Lack of Efficacy|0
5840419|NCT02319759|20185724|P3|Week 16 - 24|Lack of Efficacy|1
5840420|NCT02319759|20185725|P2|Week 16 - 24|Lack of Efficacy|0
5840421|NCT02319759|20185726|P1|Week 16 - 24|Lack of Efficacy|1
5840422|NCT02319759|20185722|P5|Week 0 - 16|Not met all Inclusion Criteria|0
5840423|NCT02319759|20185723|P4|Week 0 - 16|Not met all Inclusion Criteria|0
5840424|NCT02319759|20185724|P3|Week 0 - 16|Not met all Inclusion Criteria|1
5840425|NCT02319759|20185725|P2|Week 0 - 16|Not met all Inclusion Criteria|0
5840426|NCT02319759|20185726|P1|Week 0 - 16|Not met all Inclusion Criteria|0
5840427|NCT02319759|20185722|P5|Week 0 - 16|Lack of Efficacy|0
5840428|NCT02319759|20185723|P4|Week 0 - 16|Lack of Efficacy|0
5840429|NCT02319759|20185724|P3|Week 0 - 16|Lack of Efficacy|0
5840430|NCT02319759|20185725|P2|Week 0 - 16|Lack of Efficacy|0
5840431|NCT02319759|20185726|P1|Week 0 - 16|Lack of Efficacy|1
5840432|NCT02319668|20185823|P2|Overall Study|Other (Not specified)|2
5840433|NCT02319668|20185824|P1|Overall Study|Other (Not specified)|0
5840434|NCT02319642|20185838|P2|Overall Study|Withdrawal by Subject|1
5840435|NCT02319642|20185839|P1|Overall Study|Withdrawal by Subject|1
5840436|NCT02319642|20185838|P2|Overall Study|Lack of Efficacy|1
5840437|NCT02319642|20185839|P1|Overall Study|Lack of Efficacy|1
5840438|NCT02319642|20185838|P2|Overall Study|Adverse Event|4
5840439|NCT02319642|20185839|P1|Overall Study|Adverse Event|2
5840440|NCT02319525|20185859|P2|Overall Study|Withdrawal by Subject|1
5840441|NCT02319525|20185860|P1|Overall Study|Withdrawal by Subject|2
5840442|NCT02319148|20185902|P4|Second Intervention Period|Other|1
5840443|NCT02319148|20185903|P3|Second Intervention Period|Other|0
5840444|NCT02319148|20185904|P2|Second Intervention Period|Other|0
5840445|NCT02319148|20185905|P1|Second Intervention Period|Other|0
5840446|NCT02319148|20185902|P4|Second Intervention Period|No longer willing to participate|0
5840447|NCT02319148|20185903|P3|Second Intervention Period|No longer willing to participate|0
5840448|NCT02319148|20185904|P2|Second Intervention Period|No longer willing to participate|1
5840449|NCT02319148|20185905|P1|Second Intervention Period|No longer willing to participate|0
5840450|NCT02319148|20185902|P4|Second Intervention Period|Adverse event (AE) related to study drug|1
5840451|NCT02319148|20185903|P3|Second Intervention Period|Adverse event (AE) related to study drug|1
5840452|NCT02319148|20185904|P2|Second Intervention Period|Adverse event (AE) related to study drug|0
5840453|NCT02319148|20185905|P1|Second Intervention Period|Adverse event (AE) related to study drug|0
5840454|NCT02319044|20185968|P3|Overall Study|Not treated|2
5840455|NCT02319044|20185969|P2|Overall Study|Not treated|2
5840456|NCT02319044|20185970|P1|Overall Study|Not treated|0
5840457|NCT02319044|20185968|P3|Overall Study|Study specific discontinuation criteria|1
5840458|NCT02319044|20185969|P2|Overall Study|Study specific discontinuation criteria|2
5840459|NCT02319044|20185970|P1|Overall Study|Study specific discontinuation criteria|2
5840460|NCT02319044|20185968|P3|Overall Study|Adverse Event|8
5840461|NCT02319044|20185969|P2|Overall Study|Adverse Event|2
5840462|NCT02319044|20185970|P1|Overall Study|Adverse Event|17
5840463|NCT02319044|20185968|P3|Overall Study|Condition under investigation worsened|46
5840464|NCT02319044|20185969|P2|Overall Study|Condition under investigation worsened|50
5840465|NCT02319044|20185970|P1|Overall Study|Condition under investigation worsened|100
5840466|NCT02319044|20185968|P3|Overall Study|Withdrawal by Subject|6
5840467|NCT02319044|20185969|P2|Overall Study|Withdrawal by Subject|3
5840468|NCT02319044|20185970|P1|Overall Study|Withdrawal by Subject|3
5840469|NCT02319044|20185968|P3|Overall Study|Death, PI/sponsor decision, med history|4
5840470|NCT02319044|20185969|P2|Overall Study|Death, PI/sponsor decision, med history|1
5840471|NCT02319044|20185970|P1|Overall Study|Death, PI/sponsor decision, med history|0
5840472|NCT02319031|20186026|P2|Treatment Period|Death|0
5840473|NCT02319031|20186027|P1|Treatment Period|Death|1
5840474|NCT02318940|20186091|P2|Overall Study|lost the record|0
5840475|NCT02318940|20186092|P1|Overall Study|lost the record|1
5840476|NCT02318797|20186134|P2|Overall Study|Lost to Follow-up|96
5840477|NCT02318797|20186135|P1|Overall Study|Lost to Follow-up|85
5840478|NCT02318797|20186134|P2|Overall Study|Death|6
5840479|NCT02318797|20186135|P1|Overall Study|Death|3
5840480|NCT02318719|20186177|P5|Open-label Extension Phase|Other|7
5840481|NCT02318719|20186178|P4|Open-label Extension Phase|Other|0
5840482|NCT02318719|20186179|P3|Open-label Extension Phase|Other|0
5840483|NCT02318719|20186180|P2|Open-label Extension Phase|Other|0
5840484|NCT02318719|20186181|P1|Open-label Extension Phase|Other|0
5840485|NCT02318719|20186177|P5|Open-label Extension Phase|Withdrawal by Subject|31
5840486|NCT02318719|20186178|P4|Open-label Extension Phase|Withdrawal by Subject|0
5840487|NCT02318719|20186179|P3|Open-label Extension Phase|Withdrawal by Subject|0
5840488|NCT02318719|20186180|P2|Open-label Extension Phase|Withdrawal by Subject|0
5840489|NCT02318719|20186181|P1|Open-label Extension Phase|Withdrawal by Subject|0
5840490|NCT02318719|20186177|P5|Open-label Extension Phase|Lack of Efficacy|1
5840491|NCT02318719|20186178|P4|Open-label Extension Phase|Lack of Efficacy|0
5840492|NCT02318719|20186179|P3|Open-label Extension Phase|Lack of Efficacy|0
5840493|NCT02318719|20186180|P2|Open-label Extension Phase|Lack of Efficacy|0
5840494|NCT02318719|20186181|P1|Open-label Extension Phase|Lack of Efficacy|0
5840495|NCT02318719|20186177|P5|Open-label Extension Phase|Death|1
5840496|NCT02318719|20186178|P4|Open-label Extension Phase|Death|0
5840497|NCT02318719|20186179|P3|Open-label Extension Phase|Death|0
5840498|NCT02318719|20186180|P2|Open-label Extension Phase|Death|0
5840499|NCT02318719|20186181|P1|Open-label Extension Phase|Death|0
5840500|NCT02318719|20186177|P5|Open-label Extension Phase|Adverse Event|15
5840501|NCT02318719|20186178|P4|Open-label Extension Phase|Adverse Event|0
5840502|NCT02318719|20186179|P3|Open-label Extension Phase|Adverse Event|0
5840503|NCT02318719|20186180|P2|Open-label Extension Phase|Adverse Event|0
5840504|NCT02318719|20186181|P1|Open-label Extension Phase|Adverse Event|0
5840505|NCT02318719|20186177|P5|Double-blind Phase|Other|0
5840506|NCT02318719|20186178|P4|Double-blind Phase|Other|0
5840507|NCT02318719|20186179|P3|Double-blind Phase|Other|0
5840508|NCT02318719|20186180|P2|Double-blind Phase|Other|2
5840509|NCT02318719|20186181|P1|Double-blind Phase|Other|1
5840510|NCT02318719|20186177|P5|Double-blind Phase|Withdrawal by Subject|0
5840511|NCT02318719|20186178|P4|Double-blind Phase|Withdrawal by Subject|10
5840512|NCT02318719|20186179|P3|Double-blind Phase|Withdrawal by Subject|9
5840513|NCT02318719|20186180|P2|Double-blind Phase|Withdrawal by Subject|7
5840514|NCT02318719|20186181|P1|Double-blind Phase|Withdrawal by Subject|25
5840515|NCT02318719|20186177|P5|Double-blind Phase|Protocol Violation|0
5840516|NCT02318719|20186178|P4|Double-blind Phase|Protocol Violation|0
5840517|NCT02318719|20186179|P3|Double-blind Phase|Protocol Violation|3
5840518|NCT02318719|20186180|P2|Double-blind Phase|Protocol Violation|1
5840519|NCT02318719|20186181|P1|Double-blind Phase|Protocol Violation|0
5840520|NCT02318719|20186177|P5|Double-blind Phase|Lack of Efficacy|0
5840521|NCT02318719|20186178|P4|Double-blind Phase|Lack of Efficacy|1
5840522|NCT02318719|20186179|P3|Double-blind Phase|Lack of Efficacy|1
5840523|NCT02318719|20186180|P2|Double-blind Phase|Lack of Efficacy|0
5840524|NCT02318719|20186181|P1|Double-blind Phase|Lack of Efficacy|5
5840525|NCT02318719|20186177|P5|Double-blind Phase|Adverse Event|0
5840526|NCT02318719|20186178|P4|Double-blind Phase|Adverse Event|4
5840527|NCT02318719|20186179|P3|Double-blind Phase|Adverse Event|12
5840528|NCT02318719|20186180|P2|Double-blind Phase|Adverse Event|6
5840529|NCT02318719|20186181|P1|Double-blind Phase|Adverse Event|7
5840530|NCT02318706|20186197|P5|Open-label Extension Phase|Withdrawal by Subject|19
5840531|NCT02318706|20186198|P4|Open-label Extension Phase|Withdrawal by Subject|0
5840532|NCT02318706|20186199|P3|Open-label Extension Phase|Withdrawal by Subject|0
5840533|NCT02318706|20186200|P2|Open-label Extension Phase|Withdrawal by Subject|0
5840534|NCT02318706|20186201|P1|Open-label Extension Phase|Withdrawal by Subject|0
5840535|NCT02318706|20186197|P5|Open-label Extension Phase|Death|1
5840536|NCT02318706|20186198|P4|Open-label Extension Phase|Death|0
5840537|NCT02318706|20186199|P3|Open-label Extension Phase|Death|0
5840538|NCT02318706|20186200|P2|Open-label Extension Phase|Death|0
5840539|NCT02318706|20186201|P1|Open-label Extension Phase|Death|0
5840540|NCT02318706|20186197|P5|Open-label Extension Phase|Lack of Efficacy|1
5840541|NCT02318706|20186198|P4|Open-label Extension Phase|Lack of Efficacy|0
5840542|NCT02318706|20186199|P3|Open-label Extension Phase|Lack of Efficacy|0
5840543|NCT02318706|20186200|P2|Open-label Extension Phase|Lack of Efficacy|0
5840544|NCT02318706|20186201|P1|Open-label Extension Phase|Lack of Efficacy|0
5840545|NCT02318706|20186197|P5|Open-label Extension Phase|Adverse Event|21
5840546|NCT02318706|20186198|P4|Open-label Extension Phase|Adverse Event|0
5840547|NCT02318706|20186199|P3|Open-label Extension Phase|Adverse Event|0
5840548|NCT02318706|20186200|P2|Open-label Extension Phase|Adverse Event|0
5840549|NCT02318706|20186201|P1|Open-label Extension Phase|Adverse Event|0
5840550|NCT02318706|20186197|P5|Double-blind Phase|Death|0
5840551|NCT02318706|20186198|P4|Double-blind Phase|Death|0
5840552|NCT02318706|20186199|P3|Double-blind Phase|Death|2
5840553|NCT02318706|20186200|P2|Double-blind Phase|Death|0
5840554|NCT02318706|20186201|P1|Double-blind Phase|Death|0
5840555|NCT02318706|20186197|P5|Double-blind Phase|Other|0
5840556|NCT02318706|20186198|P4|Double-blind Phase|Other|1
5840557|NCT02318706|20186199|P3|Double-blind Phase|Other|2
5840558|NCT02318706|20186200|P2|Double-blind Phase|Other|1
5840559|NCT02318706|20186201|P1|Double-blind Phase|Other|4
5840560|NCT02318706|20186197|P5|Double-blind Phase|Withdrawal by Subject|0
5840561|NCT02318706|20186198|P4|Double-blind Phase|Withdrawal by Subject|10
5840562|NCT02318706|20186199|P3|Double-blind Phase|Withdrawal by Subject|7
5840563|NCT02318706|20186200|P2|Double-blind Phase|Withdrawal by Subject|5
5840564|NCT02318706|20186201|P1|Double-blind Phase|Withdrawal by Subject|9
5840565|NCT02318706|20186197|P5|Double-blind Phase|Protocol Violation|0
5840566|NCT02318706|20186198|P4|Double-blind Phase|Protocol Violation|3
5840567|NCT02318706|20186199|P3|Double-blind Phase|Protocol Violation|4
5840568|NCT02318706|20186200|P2|Double-blind Phase|Protocol Violation|2
5840569|NCT02318706|20186201|P1|Double-blind Phase|Protocol Violation|4
5840570|NCT02318706|20186197|P5|Double-blind Phase|Lost to Follow-up|0
5840571|NCT02318706|20186198|P4|Double-blind Phase|Lost to Follow-up|0
5840572|NCT02318706|20186199|P3|Double-blind Phase|Lost to Follow-up|0
5840573|NCT02318706|20186200|P2|Double-blind Phase|Lost to Follow-up|0
5840574|NCT02318706|20186201|P1|Double-blind Phase|Lost to Follow-up|1
5840575|NCT02318706|20186197|P5|Double-blind Phase|Adverse Event|0
5840576|NCT02318706|20186198|P4|Double-blind Phase|Adverse Event|10
5840577|NCT02318706|20186199|P3|Double-blind Phase|Adverse Event|3
5840578|NCT02318706|20186200|P2|Double-blind Phase|Adverse Event|4
5840579|NCT02318706|20186201|P1|Double-blind Phase|Adverse Event|7
5840580|NCT02318693|20186215|P2|Overall Study|Protocol Violation|1
5840581|NCT02318693|20186216|P1|Overall Study|Protocol Violation|0
5840582|NCT02318667|20186230|P1|Overall Study|Protocol Violation|2
5840583|NCT02318667|20186230|P1|Overall Study|Lack of Efficacy|6
5840584|NCT02318667|20186230|P1|Overall Study|Adverse Event|1
5840585|NCT02318602|20186249|P3|Overall Study|Guardian decision to withdraw|1
5840586|NCT02318602|20186250|P2|Overall Study|Guardian decision to withdraw|0
5840587|NCT02318602|20186251|P1|Overall Study|Guardian decision to withdraw|0
5840588|NCT02318602|20186249|P3|Overall Study|Death|0
5840589|NCT02318602|20186250|P2|Overall Study|Death|0
5840590|NCT02318602|20186251|P1|Overall Study|Death|1
5840591|NCT02318602|20186249|P3|Overall Study|Withdrawal by Subject|0
5840592|NCT02318602|20186250|P2|Overall Study|Withdrawal by Subject|3
5840593|NCT02318602|20186251|P1|Overall Study|Withdrawal by Subject|0
5840594|NCT02318602|20186249|P3|Overall Study|Adverse Event|1
5840595|NCT02318602|20186250|P2|Overall Study|Adverse Event|1
5840596|NCT02318602|20186251|P1|Overall Study|Adverse Event|0
5840597|NCT02318368|20186284|P2|Overall Study|Death|1
5840598|NCT02318368|20186285|P1|Overall Study|Death|0
5840599|NCT02318368|20186284|P2|Overall Study|Study terminated by the sponsor|2
5840600|NCT02318368|20186285|P1|Overall Study|Study terminated by the sponsor|5
5840601|NCT02318368|20186284|P2|Overall Study|Withdrawal by Subject|0
5840602|NCT02318368|20186285|P1|Overall Study|Withdrawal by Subject|2
5840603|NCT02318329|20186303|P10|Overall Study|Other|1
5840604|NCT02318329|20186304|P9|Overall Study|Other|1
5840605|NCT02318329|20186305|P8|Overall Study|Other|0
5840606|NCT02318329|20186306|P7|Overall Study|Other|0
5840607|NCT02318329|20186307|P6|Overall Study|Other|0
5840608|NCT02318329|20186308|P5|Overall Study|Other|0
5840609|NCT02318329|20186309|P4|Overall Study|Other|0
5840610|NCT02318329|20186310|P3|Overall Study|Other|1
5840611|NCT02318329|20186311|P2|Overall Study|Other|1
5840612|NCT02318329|20186312|P1|Overall Study|Other|1
5840613|NCT02318329|20186303|P10|Overall Study|Withdrawal by Subject|6
5840614|NCT02318329|20186304|P9|Overall Study|Withdrawal by Subject|0
5840615|NCT02318329|20186305|P8|Overall Study|Withdrawal by Subject|0
5840616|NCT02318329|20186306|P7|Overall Study|Withdrawal by Subject|0
5840617|NCT02318329|20186307|P6|Overall Study|Withdrawal by Subject|0
5840618|NCT02318329|20186308|P5|Overall Study|Withdrawal by Subject|0
5840619|NCT02318329|20186309|P4|Overall Study|Withdrawal by Subject|0
5840620|NCT02318329|20186310|P3|Overall Study|Withdrawal by Subject|0
5840621|NCT02318329|20186311|P2|Overall Study|Withdrawal by Subject|0
5840622|NCT02318329|20186312|P1|Overall Study|Withdrawal by Subject|0
5840623|NCT02318329|20186303|P10|Overall Study|Lost to Follow-up|1
5840624|NCT02318329|20186304|P9|Overall Study|Lost to Follow-up|0
5840625|NCT02318329|20186305|P8|Overall Study|Lost to Follow-up|0
5840626|NCT02318329|20186306|P7|Overall Study|Lost to Follow-up|0
5840627|NCT02318329|20186307|P6|Overall Study|Lost to Follow-up|0
5840628|NCT02318329|20186308|P5|Overall Study|Lost to Follow-up|0
5840629|NCT02318329|20186309|P4|Overall Study|Lost to Follow-up|0
5840630|NCT02318329|20186310|P3|Overall Study|Lost to Follow-up|0
5840631|NCT02318329|20186311|P2|Overall Study|Lost to Follow-up|0
5840632|NCT02318329|20186312|P1|Overall Study|Lost to Follow-up|0
5840633|NCT02318329|20186303|P10|Overall Study|Death|5
5840634|NCT02318329|20186304|P9|Overall Study|Death|0
5840635|NCT02318329|20186305|P8|Overall Study|Death|0
5840636|NCT02318329|20186306|P7|Overall Study|Death|0
5840637|NCT02318329|20186307|P6|Overall Study|Death|0
5840638|NCT02318329|20186308|P5|Overall Study|Death|0
5840639|NCT02318329|20186309|P4|Overall Study|Death|0
5840640|NCT02318329|20186310|P3|Overall Study|Death|0
5840641|NCT02318329|20186311|P2|Overall Study|Death|0
5840642|NCT02318329|20186312|P1|Overall Study|Death|0
5840643|NCT02318329|20186303|P10|Overall Study|Progressive Disease|39
5840644|NCT02318329|20186304|P9|Overall Study|Progressive Disease|5
5840645|NCT02318329|20186305|P8|Overall Study|Progressive Disease|1
5840646|NCT02318329|20186306|P7|Overall Study|Progressive Disease|1
5840647|NCT02318329|20186307|P6|Overall Study|Progressive Disease|3
5840648|NCT02318329|20186308|P5|Overall Study|Progressive Disease|3
5840649|NCT02318329|20186309|P4|Overall Study|Progressive Disease|3
5840650|NCT02318329|20186310|P3|Overall Study|Progressive Disease|2
5840651|NCT02318329|20186311|P2|Overall Study|Progressive Disease|3
5840652|NCT02318329|20186312|P1|Overall Study|Progressive Disease|2
5840653|NCT02318277|20186405|P8|Overall Study|Participants Ongoing in study|0
5840654|NCT02318277|20186406|P7|Overall Study|Participants Ongoing in study|0
5840655|NCT02318277|20186407|P6|Overall Study|Participants Ongoing in study|1
5840656|NCT02318277|20186408|P5|Overall Study|Participants Ongoing in study|0
5840657|NCT02318277|20186409|P4|Overall Study|Participants Ongoing in study|0
5840658|NCT02318277|20186410|P3|Overall Study|Participants Ongoing in study|0
5840659|NCT02318277|20186411|P2|Overall Study|Participants Ongoing in study|0
5840660|NCT02318277|20186412|P1|Overall Study|Participants Ongoing in study|0
5840661|NCT02318277|20186405|P8|Overall Study|Death|58
5840662|NCT02318277|20186406|P7|Overall Study|Death|34
5840663|NCT02318277|20186407|P6|Overall Study|Death|5
5840664|NCT02318277|20186408|P5|Overall Study|Death|6
5840665|NCT02318277|20186409|P4|Overall Study|Death|4
5840666|NCT02318277|20186410|P3|Overall Study|Death|1
5840667|NCT02318277|20186411|P2|Overall Study|Death|3
5840668|NCT02318277|20186412|P1|Overall Study|Death|5
5840669|NCT02318277|20186405|P8|Overall Study|Lost to Follow-up|4
5840670|NCT02318277|20186406|P7|Overall Study|Lost to Follow-up|3
5840671|NCT02318277|20186407|P6|Overall Study|Lost to Follow-up|0
5840672|NCT02318277|20186408|P5|Overall Study|Lost to Follow-up|0
5840673|NCT02318277|20186409|P4|Overall Study|Lost to Follow-up|0
5840674|NCT02318277|20186410|P3|Overall Study|Lost to Follow-up|1
5840675|NCT02318277|20186411|P2|Overall Study|Lost to Follow-up|0
5840676|NCT02318277|20186412|P1|Overall Study|Lost to Follow-up|1
5840677|NCT02318277|20186405|P8|Overall Study|Participant trial terminated by sponsor|16
5840678|NCT02318277|20186406|P7|Overall Study|Participant trial terminated by sponsor|5
5840679|NCT02318277|20186407|P6|Overall Study|Participant trial terminated by sponsor|2
5840680|NCT02318277|20186408|P5|Overall Study|Participant trial terminated by sponsor|1
5840681|NCT02318277|20186409|P4|Overall Study|Participant trial terminated by sponsor|0
5840682|NCT02318277|20186410|P3|Overall Study|Participant trial terminated by sponsor|1
5840683|NCT02318277|20186411|P2|Overall Study|Participant trial terminated by sponsor|0
5840684|NCT02318277|20186412|P1|Overall Study|Participant trial terminated by sponsor|0
5840685|NCT02318277|20186405|P8|Overall Study|Withdrawal by Subject|14
5840686|NCT02318277|20186406|P7|Overall Study|Withdrawal by Subject|6
5840687|NCT02318277|20186407|P6|Overall Study|Withdrawal by Subject|1
5840688|NCT02318277|20186408|P5|Overall Study|Withdrawal by Subject|1
5840689|NCT02318277|20186409|P4|Overall Study|Withdrawal by Subject|0
5840690|NCT02318277|20186410|P3|Overall Study|Withdrawal by Subject|1
5840691|NCT02318277|20186411|P2|Overall Study|Withdrawal by Subject|0
5840692|NCT02318277|20186412|P1|Overall Study|Withdrawal by Subject|0
5840693|NCT02318277|20186405|P8|Overall Study|Other|0
5840694|NCT02318277|20186406|P7|Overall Study|Other|1
5840695|NCT02318277|20186407|P6|Overall Study|Other|0
5840696|NCT02318277|20186408|P5|Overall Study|Other|0
5840697|NCT02318277|20186409|P4|Overall Study|Other|0
5840698|NCT02318277|20186410|P3|Overall Study|Other|0
5840699|NCT02318277|20186411|P2|Overall Study|Other|0
5840700|NCT02318277|20186412|P1|Overall Study|Other|0
5840701|NCT02318277|20186405|P8|Overall Study|Physician Decision|1
5840702|NCT02318277|20186406|P7|Overall Study|Physician Decision|0
5840703|NCT02318277|20186407|P6|Overall Study|Physician Decision|0
5840704|NCT02318277|20186408|P5|Overall Study|Physician Decision|0
5840705|NCT02318277|20186409|P4|Overall Study|Physician Decision|0
5840706|NCT02318277|20186410|P3|Overall Study|Physician Decision|0
5840707|NCT02318277|20186411|P2|Overall Study|Physician Decision|0
5840708|NCT02318277|20186412|P1|Overall Study|Physician Decision|0
5840709|NCT02317809|20186475|P2|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|0
5840710|NCT02317809|20186476|P1|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|1
5840711|NCT02317809|20186475|P2|First Intervention Period (8 Days)|Protocol Non-Compliance|0
5840712|NCT02317809|20186476|P1|First Intervention Period (8 Days)|Protocol Non-Compliance|2
5840713|NCT02317614|20186564|P2|Overall Study|Death|1
5840714|NCT02317614|20186565|P1|Overall Study|Death|1
5840715|NCT02317614|20186564|P2|Overall Study|Withdrawal by Subject|0
5840716|NCT02317614|20186565|P1|Overall Study|Withdrawal by Subject|1
5840717|NCT02317614|20186564|P2|Overall Study|Lost to Follow-up|1
5840718|NCT02317614|20186565|P1|Overall Study|Lost to Follow-up|1
5840719|NCT02317575|20186581|P5|Period 1|Withdrawal by Subject|0
5840720|NCT02317575|20186582|P4|Period 1|Withdrawal by Subject|0
5840721|NCT02317575|20186583|P3|Period 1|Withdrawal by Subject|0
5840722|NCT02317575|20186584|P2|Period 1|Withdrawal by Subject|0
5840723|NCT02317575|20186585|P1|Period 1|Withdrawal by Subject|1
5840724|NCT02317575|20186581|P5|Period 1|Difficulty with venous cannulation|0
5840725|NCT02317575|20186582|P4|Period 1|Difficulty with venous cannulation|0
5840726|NCT02317575|20186583|P3|Period 1|Difficulty with venous cannulation|0
5840727|NCT02317575|20186584|P2|Period 1|Difficulty with venous cannulation|1
5840728|NCT02317575|20186585|P1|Period 1|Difficulty with venous cannulation|0
5840729|NCT02317510|20186620|P2|Overall Study|Adverse Event|1
5840730|NCT02317510|20186621|P1|Overall Study|Adverse Event|0
5840731|NCT02317016|20186653|P1|Part B: Day 35 to End Part B (AZD9291)|Death|5
5840732|NCT02317016|20186653|P1|Part B: Day 35 to End Part B (AZD9291)|Withdrawal by Subject|2
5840733|NCT02317016|20186653|P1|Part B: Day 35 to End Part B (AZD9291)|Adverse Event|1
5840734|NCT02317016|20186653|P1|Part B: Day 35 to End Part B (AZD9291)|Condition under investigation worsened|23
5840735|NCT02317016|20186653|P1|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Death|1
5840736|NCT02317016|20186653|P1|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Condition under investigation worsened|1
5840737|NCT02317016|20186653|P1|Part A: Day 4-31 (AZD9291 Alone)|Adverse Event|1
5840738|NCT02316847|20186681|P2|Overall Study|Withdrawn due to termination by Sponsor|67
5840739|NCT02316847|20186682|P1|Overall Study|Withdrawn due to termination by Sponsor|7
5840740|NCT02316847|20186681|P2|Overall Study|Noncompliance with study drug|3
5840741|NCT02316847|20186682|P1|Overall Study|Noncompliance with study drug|0
5840742|NCT02316847|20186681|P2|Overall Study|Withdrawal by Subject|9
5840743|NCT02316847|20186682|P1|Overall Study|Withdrawal by Subject|2
5840744|NCT02316847|20186681|P2|Overall Study|Pregnancy|1
5840745|NCT02316847|20186682|P1|Overall Study|Pregnancy|0
5840746|NCT02316847|20186681|P2|Overall Study|Physician Decision|1
5840747|NCT02316847|20186682|P1|Overall Study|Physician Decision|0
5840748|NCT02316847|20186681|P2|Overall Study|Lost to Follow-up|2
5840749|NCT02316847|20186682|P1|Overall Study|Lost to Follow-up|0
5840750|NCT02316847|20186681|P2|Overall Study|Adverse Event|3
5840751|NCT02316847|20186682|P1|Overall Study|Adverse Event|0
5840752|NCT02316769|20186693|P2|Overall Study|Withdrawal by Subject|0
5840753|NCT02316769|20186694|P1|Overall Study|Withdrawal by Subject|1
5840754|NCT02316769|20186693|P2|Overall Study|Physician Decision|0
5840755|NCT02316769|20186694|P1|Overall Study|Physician Decision|1
5840756|NCT02316717|20186705|P3|Overall Study|TBC|0
5840757|NCT02316717|20186706|P2|Overall Study|TBC|0
5840758|NCT02316717|20186707|P1|Overall Study|TBC|1
5840759|NCT02316717|20186705|P3|Overall Study|Physician Decision|0
5840760|NCT02316717|20186706|P2|Overall Study|Physician Decision|1
5840761|NCT02316717|20186707|P1|Overall Study|Physician Decision|0
5840762|NCT02316717|20186705|P3|Overall Study|Death|1
5840763|NCT02316717|20186706|P2|Overall Study|Death|0
5840764|NCT02316717|20186707|P1|Overall Study|Death|0
5840765|NCT02316717|20186705|P3|Overall Study|Withdrawal by Subject|1
5840766|NCT02316717|20186706|P2|Overall Study|Withdrawal by Subject|1
5840767|NCT02316717|20186707|P1|Overall Study|Withdrawal by Subject|2
5840768|NCT02316717|20186705|P3|Overall Study|Protocol Violation|0
5840769|NCT02316717|20186706|P2|Overall Study|Protocol Violation|0
5840770|NCT02316717|20186707|P1|Overall Study|Protocol Violation|2
5840771|NCT02316717|20186705|P3|Overall Study|Non compliance|0
5840772|NCT02316717|20186706|P2|Overall Study|Non compliance|1
5840773|NCT02316717|20186707|P1|Overall Study|Non compliance|3
5840774|NCT02316717|20186705|P3|Overall Study|Lost to Follow-up|1
5840775|NCT02316717|20186706|P2|Overall Study|Lost to Follow-up|2
5840776|NCT02316717|20186707|P1|Overall Study|Lost to Follow-up|1
5840777|NCT02316717|20186705|P3|Overall Study|Adverse Event|0
5840778|NCT02316717|20186706|P2|Overall Study|Adverse Event|2
5840779|NCT02316717|20186707|P1|Overall Study|Adverse Event|2
5840780|NCT02316613|20186844|P1|Overall Study|Did not met selection criteria|14
5840781|NCT02316613|20186844|P1|Overall Study|No data and duplicate cases|5
5840782|NCT02316613|20186844|P1|Overall Study|Participant moved/changed medical team|11
5840783|NCT02316613|20186844|P1|Overall Study|Lymphoma transformation|2
5840784|NCT02316613|20186844|P1|Overall Study|Lost to Follow-up|9
5840785|NCT02316613|20186844|P1|Overall Study|Death|63
5840786|NCT02316548|20186883|P2|Overall Study|Protocol Violation|1
5840787|NCT02316548|20186884|P1|Overall Study|Protocol Violation|0
5840788|NCT02316353|20187014|P2|Overall Study|Withdrawal by Subject|2
5840789|NCT02316353|20187015|P1|Overall Study|Withdrawal by Subject|6
5840790|NCT02316353|20187014|P2|Overall Study|Adverse Event|3
5840791|NCT02316353|20187015|P1|Overall Study|Adverse Event|1
5840792|NCT02316353|20187014|P2|Overall Study|Pregnancy|3
5840793|NCT02316353|20187015|P1|Overall Study|Pregnancy|1
5840794|NCT02316171|20187035|P4|Overall Study|difficulties with urinary catheter|0
5840795|NCT02316171|20187036|P3|Overall Study|difficulties with urinary catheter|0
5840796|NCT02316171|20187037|P2|Overall Study|difficulties with urinary catheter|0
5840797|NCT02316171|20187038|P1|Overall Study|difficulties with urinary catheter|1
5840798|NCT02315703|20187108|P8|Overall Study|Other|2
5840799|NCT02315703|20187109|P7|Overall Study|Other|8
5840800|NCT02315703|20187110|P6|Overall Study|Other|2
5840801|NCT02315703|20187111|P5|Overall Study|Other|1
5840802|NCT02315703|20187112|P4|Overall Study|Other|2
5840803|NCT02315703|20187113|P3|Overall Study|Other|2
5840804|NCT02315703|20187114|P2|Overall Study|Other|2
5840805|NCT02315703|20187115|P1|Overall Study|Other|4
5840806|NCT02315703|20187108|P8|Overall Study|Physician Decision|0
5840807|NCT02315703|20187109|P7|Overall Study|Physician Decision|1
5840808|NCT02315703|20187110|P6|Overall Study|Physician Decision|2
5840809|NCT02315703|20187111|P5|Overall Study|Physician Decision|0
5840810|NCT02315703|20187112|P4|Overall Study|Physician Decision|0
5840811|NCT02315703|20187113|P3|Overall Study|Physician Decision|0
5840812|NCT02315703|20187114|P2|Overall Study|Physician Decision|0
5840813|NCT02315703|20187115|P1|Overall Study|Physician Decision|0
5840814|NCT02315703|20187108|P8|Overall Study|Withdrawal by Subject|2
5840815|NCT02315703|20187109|P7|Overall Study|Withdrawal by Subject|1
5840816|NCT02315703|20187110|P6|Overall Study|Withdrawal by Subject|1
5840817|NCT02315703|20187111|P5|Overall Study|Withdrawal by Subject|4
5840818|NCT02315703|20187112|P4|Overall Study|Withdrawal by Subject|3
5840819|NCT02315703|20187113|P3|Overall Study|Withdrawal by Subject|0
5840820|NCT02315703|20187114|P2|Overall Study|Withdrawal by Subject|3
5840821|NCT02315703|20187115|P1|Overall Study|Withdrawal by Subject|1
5840822|NCT02315703|20187108|P8|Overall Study|Pregnancy|1
5840823|NCT02315703|20187109|P7|Overall Study|Pregnancy|0
5840824|NCT02315703|20187110|P6|Overall Study|Pregnancy|0
5840825|NCT02315703|20187111|P5|Overall Study|Pregnancy|0
5840826|NCT02315703|20187112|P4|Overall Study|Pregnancy|0
5840827|NCT02315703|20187113|P3|Overall Study|Pregnancy|0
5840828|NCT02315703|20187114|P2|Overall Study|Pregnancy|0
5840829|NCT02315703|20187115|P1|Overall Study|Pregnancy|0
5840830|NCT02315703|20187108|P8|Overall Study|Lost to Follow-up|2
5840831|NCT02315703|20187109|P7|Overall Study|Lost to Follow-up|2
5840832|NCT02315703|20187110|P6|Overall Study|Lost to Follow-up|1
5840833|NCT02315703|20187111|P5|Overall Study|Lost to Follow-up|2
5840834|NCT02315703|20187112|P4|Overall Study|Lost to Follow-up|3
5840835|NCT02315703|20187113|P3|Overall Study|Lost to Follow-up|3
5840836|NCT02315703|20187114|P2|Overall Study|Lost to Follow-up|5
5840837|NCT02315703|20187115|P1|Overall Study|Lost to Follow-up|1
5840838|NCT02315703|20187108|P8|Overall Study|Adverse Event|0
5840839|NCT02315703|20187109|P7|Overall Study|Adverse Event|1
5840840|NCT02315703|20187110|P6|Overall Study|Adverse Event|0
5840841|NCT02315703|20187111|P5|Overall Study|Adverse Event|1
5840842|NCT02315703|20187112|P4|Overall Study|Adverse Event|1
5840843|NCT02315703|20187113|P3|Overall Study|Adverse Event|0
5840844|NCT02315703|20187114|P2|Overall Study|Adverse Event|0
5840845|NCT02315703|20187115|P1|Overall Study|Adverse Event|0
5840846|NCT02315664|20187215|P2|Overall Study|Withdrawal by Subject|3
5840847|NCT02315664|20187216|P1|Overall Study|Withdrawal by Subject|0
5840848|NCT02315664|20187215|P2|Overall Study|Lost to Follow-up|1
5840849|NCT02315664|20187216|P1|Overall Study|Lost to Follow-up|1
5840850|NCT02315625|20187238|P2|Second Intervention|Disease Progression|0
5840851|NCT02315625|20187239|P1|Second Intervention|Disease Progression|1
5840852|NCT02315625|20187238|P2|Second Intervention|Study closure|0
5840853|NCT02315625|20187239|P1|Second Intervention|Study closure|1
5840854|NCT02315625|20187238|P2|Second Intervention|Physician Decision|1
5840855|NCT02315625|20187239|P1|Second Intervention|Physician Decision|2
5840856|NCT02315625|20187238|P2|First Intervention|Disease Progression|0
5840857|NCT02315625|20187239|P1|First Intervention|Disease Progression|1
5840858|NCT02315560|20187253|P1|Overall Study|noncompliance by subjects|3
5840859|NCT02314923|20187512|P10|Overall Study|Participant relocation|0
5840860|NCT02314923|20187513|P9|Overall Study|Participant relocation|0
5840861|NCT02314923|20187514|P8|Overall Study|Participant relocation|1
5840862|NCT02314923|20187515|P7|Overall Study|Participant relocation|0
5840863|NCT02314923|20187516|P6|Overall Study|Participant relocation|0
5840864|NCT02314923|20187517|P5|Overall Study|Participant relocation|0
5840865|NCT02314923|20187518|P4|Overall Study|Participant relocation|0
5840866|NCT02314923|20187519|P3|Overall Study|Participant relocation|0
5840867|NCT02314923|20187520|P2|Overall Study|Participant relocation|0
5840868|NCT02314923|20187521|P1|Overall Study|Participant relocation|1
5840869|NCT02314923|20187512|P10|Overall Study|Screen failure|0
5840870|NCT02314923|20187513|P9|Overall Study|Screen failure|0
5840871|NCT02314923|20187514|P8|Overall Study|Screen failure|0
5840872|NCT02314923|20187515|P7|Overall Study|Screen failure|1
5840873|NCT02314923|20187516|P6|Overall Study|Screen failure|0
5840874|NCT02314923|20187517|P5|Overall Study|Screen failure|0
5840875|NCT02314923|20187518|P4|Overall Study|Screen failure|0
5840876|NCT02314923|20187519|P3|Overall Study|Screen failure|0
5840877|NCT02314923|20187520|P2|Overall Study|Screen failure|0
5840878|NCT02314923|20187521|P1|Overall Study|Screen failure|0
5840879|NCT02314923|20187512|P10|Overall Study|Participant unavailable|0
5840880|NCT02314923|20187513|P9|Overall Study|Participant unavailable|0
5840881|NCT02314923|20187514|P8|Overall Study|Participant unavailable|0
5840882|NCT02314923|20187515|P7|Overall Study|Participant unavailable|0
5840883|NCT02314923|20187516|P6|Overall Study|Participant unavailable|1
5840884|NCT02314923|20187517|P5|Overall Study|Participant unavailable|0
5840885|NCT02314923|20187518|P4|Overall Study|Participant unavailable|0
5840886|NCT02314923|20187519|P3|Overall Study|Participant unavailable|0
5840887|NCT02314923|20187520|P2|Overall Study|Participant unavailable|0
5840888|NCT02314923|20187521|P1|Overall Study|Participant unavailable|0
5840889|NCT02314923|20187512|P10|Overall Study|Physician Decision|0
5840890|NCT02314923|20187513|P9|Overall Study|Physician Decision|0
5840891|NCT02314923|20187514|P8|Overall Study|Physician Decision|0
5840892|NCT02314923|20187515|P7|Overall Study|Physician Decision|0
5840893|NCT02314923|20187516|P6|Overall Study|Physician Decision|0
5840894|NCT02314923|20187517|P5|Overall Study|Physician Decision|0
5840895|NCT02314923|20187518|P4|Overall Study|Physician Decision|0
5840896|NCT02314923|20187519|P3|Overall Study|Physician Decision|0
5840897|NCT02314923|20187520|P2|Overall Study|Physician Decision|1
5840898|NCT02314923|20187521|P1|Overall Study|Physician Decision|0
5840899|NCT02314923|20187512|P10|Overall Study|Withdrawal by Subject|0
5840900|NCT02314923|20187513|P9|Overall Study|Withdrawal by Subject|0
5840901|NCT02314923|20187514|P8|Overall Study|Withdrawal by Subject|0
5840902|NCT02314923|20187515|P7|Overall Study|Withdrawal by Subject|1
5840903|NCT02314923|20187516|P6|Overall Study|Withdrawal by Subject|0
5840904|NCT02314923|20187517|P5|Overall Study|Withdrawal by Subject|1
5840905|NCT02314923|20187518|P4|Overall Study|Withdrawal by Subject|0
5840906|NCT02314923|20187519|P3|Overall Study|Withdrawal by Subject|1
5840907|NCT02314923|20187520|P2|Overall Study|Withdrawal by Subject|0
5840908|NCT02314923|20187521|P1|Overall Study|Withdrawal by Subject|0
5840909|NCT02314923|20187512|P10|Overall Study|Lost to Follow-up|0
5840910|NCT02314923|20187513|P9|Overall Study|Lost to Follow-up|2
5840911|NCT02314923|20187514|P8|Overall Study|Lost to Follow-up|4
5840912|NCT02314923|20187515|P7|Overall Study|Lost to Follow-up|3
5840913|NCT02314923|20187516|P6|Overall Study|Lost to Follow-up|0
5840914|NCT02314923|20187517|P5|Overall Study|Lost to Follow-up|0
5840915|NCT02314923|20187518|P4|Overall Study|Lost to Follow-up|0
5840916|NCT02314923|20187519|P3|Overall Study|Lost to Follow-up|1
5840917|NCT02314923|20187520|P2|Overall Study|Lost to Follow-up|3
5840918|NCT02314923|20187521|P1|Overall Study|Lost to Follow-up|2
5840919|NCT02314923|20187512|P10|Overall Study|Death|0
5840920|NCT02314923|20187513|P9|Overall Study|Death|0
5840921|NCT02314923|20187514|P8|Overall Study|Death|0
5840922|NCT02314923|20187515|P7|Overall Study|Death|0
5840923|NCT02314923|20187516|P6|Overall Study|Death|0
5840924|NCT02314923|20187517|P5|Overall Study|Death|0
5840925|NCT02314923|20187518|P4|Overall Study|Death|1
5840926|NCT02314923|20187519|P3|Overall Study|Death|0
5840927|NCT02314923|20187520|P2|Overall Study|Death|0
5840928|NCT02314923|20187521|P1|Overall Study|Death|0
5840929|NCT02314637|20187620|P2|Overall Study|Other Reason|0
5840930|NCT02314637|20187621|P1|Overall Study|Other Reason|1
5840931|NCT02314637|20187620|P2|Overall Study|Withdrawal by Subject|4
5840932|NCT02314637|20187621|P1|Overall Study|Withdrawal by Subject|5
5840933|NCT02314637|20187620|P2|Overall Study|Physician Decision|2
5840934|NCT02314637|20187621|P1|Overall Study|Physician Decision|5
5840935|NCT02314637|20187620|P2|Overall Study|Lack of Efficacy|0
5840936|NCT02314637|20187621|P1|Overall Study|Lack of Efficacy|1
5840937|NCT02314637|20187620|P2|Overall Study|Adverse Event|8
5840938|NCT02314637|20187621|P1|Overall Study|Adverse Event|4
5840939|NCT02314247|20187692|P3|Overall Study|Progression of Disease|0
5840940|NCT02314247|20187693|P2|Overall Study|Progression of Disease|2
5840941|NCT02314247|20187694|P1|Overall Study|Progression of Disease|6
5840942|NCT02314247|20187692|P3|Overall Study|Withdrawal by Subject|1
5840943|NCT02314247|20187693|P2|Overall Study|Withdrawal by Subject|3
5840944|NCT02314247|20187694|P1|Overall Study|Withdrawal by Subject|1
5840945|NCT02314247|20187692|P3|Overall Study|Adverse Event|0
5840946|NCT02314247|20187693|P2|Overall Study|Adverse Event|1
5840947|NCT02314247|20187694|P1|Overall Study|Adverse Event|2
5840948|NCT02314143|20187719|P3|Overall Study|Withdrawal by Subject|1
5840949|NCT02314143|20187720|P2|Overall Study|Withdrawal by Subject|0
5840950|NCT02314143|20187721|P1|Overall Study|Withdrawal by Subject|1
5840951|NCT02314143|20187719|P3|Overall Study|Physician Decision|0
5840952|NCT02314143|20187720|P2|Overall Study|Physician Decision|1
5840953|NCT02314143|20187721|P1|Overall Study|Physician Decision|2
5840954|NCT02314143|20187719|P3|Overall Study|Other (Study Closed/Terminated)|4
5840955|NCT02314143|20187720|P2|Overall Study|Other (Study Closed/Terminated)|3
5840956|NCT02314143|20187721|P1|Overall Study|Other (Study Closed/Terminated)|5
5840957|NCT02314143|20187719|P3|Overall Study|Adverse Event|4
5840958|NCT02314143|20187720|P2|Overall Study|Adverse Event|6
5840959|NCT02314143|20187721|P1|Overall Study|Adverse Event|0
5840960|NCT02314117|20187767|P2|Overall Study|No post-discontinuation follow-up|19
5840961|NCT02314117|20187768|P1|Overall Study|No post-discontinuation follow-up|21
5840962|NCT02314117|20187767|P2|Overall Study|Withdrawal by Subject|2
5840963|NCT02314117|20187768|P1|Overall Study|Withdrawal by Subject|2
5840964|NCT02314117|20187767|P2|Overall Study|On Treatment|6
5840965|NCT02314117|20187768|P1|Overall Study|On Treatment|10
5840966|NCT02314117|20187767|P2|Overall Study|Lost to Follow-up|11
5840967|NCT02314117|20187768|P1|Overall Study|Lost to Follow-up|8
5840968|NCT02314052|20187821|P6|Cycle One|Adverse Event|0
5840969|NCT02314052|20187822|P5|Cycle One|Adverse Event|0
5840970|NCT02314052|20187823|P4|Cycle One|Adverse Event|1
5840971|NCT02314052|20187824|P3|Cycle One|Adverse Event|0
5840972|NCT02314052|20187825|P2|Cycle One|Adverse Event|0
5840973|NCT02314052|20187826|P1|Cycle One|Adverse Event|0
5840974|NCT02314026|20187894|P1|Overall Study|Protocol Violation|28
5840975|NCT02313909|20187912|P2|Overall Study|Lost to Follow-up|17
5840976|NCT02313909|20187913|P1|Overall Study|Lost to Follow-up|24
5840977|NCT02313909|20187912|P2|Overall Study|Consent withdrawn by participant|33
5840978|NCT02313909|20187913|P1|Overall Study|Consent withdrawn by participant|33
5840979|NCT02313766|20187936|P3|Overall Study|Adverse Event|0
5840980|NCT02313766|20187937|P2|Overall Study|Adverse Event|1
5840981|NCT02313766|20187938|P1|Overall Study|Adverse Event|0
5840982|NCT02313766|20187936|P3|Overall Study|Lost to Follow-up|0
5840983|NCT02313766|20187937|P2|Overall Study|Lost to Follow-up|2
5840984|NCT02313766|20187938|P1|Overall Study|Lost to Follow-up|0
5840985|NCT02313766|20187936|P3|Overall Study|surgery cancelled|0
5840986|NCT02313766|20187937|P2|Overall Study|surgery cancelled|0
5840987|NCT02313766|20187938|P1|Overall Study|surgery cancelled|1
5840988|NCT02313558|20187992|P2|Overall Study|Lost to Follow-up|4
5840989|NCT02313558|20187993|P1|Overall Study|Lost to Follow-up|4
5840990|NCT02313558|20187992|P2|Overall Study|Withdrawal by Subject|0
5840991|NCT02313558|20187993|P1|Overall Study|Withdrawal by Subject|2
5840992|NCT02313233|20188039|P2|Overall Study|Administrative reason|1
5840993|NCT02313233|20188040|P1|Overall Study|Administrative reason|1
5840994|NCT02313233|20188039|P2|Overall Study|Withdrawal by Subject|2
5840995|NCT02313233|20188040|P1|Overall Study|Withdrawal by Subject|1
5840996|NCT02313155|20188062|P2|Overall Study|Lost to Follow-up|1
5840997|NCT02313155|20188063|P1|Overall Study|Lost to Follow-up|0
5840998|NCT02312934|20188113|P2|Overall Study|Physician Decision|0
5840999|NCT02312934|20188114|P1|Overall Study|Physician Decision|1
5841000|NCT02312934|20188113|P2|Overall Study|Lost to Follow-up|0
5841001|NCT02312934|20188114|P1|Overall Study|Lost to Follow-up|1
5841002|NCT02312856|20188126|P1|Overall Study|Lost to Follow-up|3
5841003|NCT02312856|20188126|P1|Overall Study|Death|1
5841004|NCT02312687|20188219|P1|Overall Study|Other, Not Specified|1
5841005|NCT02312258|20188311|P2|Overall Study|Participants Ongoing Treatment|83
5841006|NCT02312258|20188312|P1|Overall Study|Participants Ongoing Treatment|43
5841007|NCT02312258|20188311|P2|Overall Study|Reason not Specified|31
5841008|NCT02312258|20188312|P1|Overall Study|Reason not Specified|11
5841009|NCT02312258|20188311|P2|Overall Study|Withdrawal by Subject|9
5841010|NCT02312258|20188312|P1|Overall Study|Withdrawal by Subject|8
5841011|NCT02312258|20188311|P2|Overall Study|Progressive Disease|188
5841012|NCT02312258|20188312|P1|Overall Study|Progressive Disease|174
5841013|NCT02312258|20188311|P2|Overall Study|Lost to Follow-up|1
5841014|NCT02312258|20188312|P1|Overall Study|Lost to Follow-up|0
5841015|NCT02312258|20188311|P2|Overall Study|Adverse Event|47
5841016|NCT02312258|20188312|P1|Overall Study|Adverse Event|15
5841017|NCT02312219|20188320|P2|Overall Study|Not randomized. Ineligible|1
5841018|NCT02312219|20188321|P1|Overall Study|Not randomized. Ineligible|0
5841019|NCT02312219|20188320|P2|Overall Study|Other|1
5841020|NCT02312219|20188321|P1|Overall Study|Other|0
5841021|NCT02312219|20188320|P2|Overall Study|could not schedule imaging in time|2
5841022|NCT02312219|20188321|P1|Overall Study|could not schedule imaging in time|0
5841023|NCT02312219|20188320|P2|Overall Study|Withdrawal by Subject|2
5841024|NCT02312219|20188321|P1|Overall Study|Withdrawal by Subject|1
5841025|NCT02312206|20188331|P2|Overall Study|Subject missed 3 consecutive tx visits|1
5841026|NCT02312206|20188332|P1|Overall Study|Subject missed 3 consecutive tx visits|0
5841027|NCT02312206|20188331|P2|Overall Study|Patient transferred to hospice|1
5841028|NCT02312206|20188332|P1|Overall Study|Patient transferred to hospice|0
5841029|NCT02312206|20188331|P2|Overall Study|Patient progression and new therapy|0
5841030|NCT02312206|20188332|P1|Overall Study|Patient progression and new therapy|1
5841031|NCT02312206|20188331|P2|Overall Study|Disease Progression|0
5841032|NCT02312206|20188332|P1|Overall Study|Disease Progression|1
5841033|NCT02312206|20188331|P2|Overall Study|Study Terminated by Sponsor|74
5841034|NCT02312206|20188332|P1|Overall Study|Study Terminated by Sponsor|81
5841035|NCT02312206|20188331|P2|Overall Study|Death|36
5841036|NCT02312206|20188332|P1|Overall Study|Death|30
5841037|NCT02312206|20188331|P2|Overall Study|Physician Decision|6
5841038|NCT02312206|20188332|P1|Overall Study|Physician Decision|7
5841039|NCT02312206|20188331|P2|Overall Study|Withdrawal by Subject|6
5841040|NCT02312206|20188332|P1|Overall Study|Withdrawal by Subject|7
5841041|NCT02312206|20188331|P2|Overall Study|Adverse Event|6
5841042|NCT02312206|20188332|P1|Overall Study|Adverse Event|3
5841043|NCT02312063|20188355|P2|Overall Study|Withdrawal by Subject|1
5841044|NCT02312063|20188356|P1|Overall Study|Withdrawal by Subject|0
5841045|NCT02311894|20188409|P1|Overall Study|Withdrawal by Subject|1
5841046|NCT02311894|20188409|P1|Overall Study|Adverse Event|1
5841047|NCT02311894|20188409|P1|Overall Study|Lost to Follow-up|1
5841048|NCT02311894|20188409|P1|Overall Study|Discontinued in error|1
5841049|NCT02311881|20188421|P3|Overall Study|Serious Adverse Event|0
5841050|NCT02311881|20188422|P2|Overall Study|Serious Adverse Event|1
5841051|NCT02311881|20188423|P1|Overall Study|Serious Adverse Event|0
5841052|NCT02311881|20188421|P3|Overall Study|Participant taking another medication|1
5841053|NCT02311881|20188422|P2|Overall Study|Participant taking another medication|0
5841054|NCT02311881|20188423|P1|Overall Study|Participant taking another medication|0
5841055|NCT02311881|20188421|P3|Overall Study|Medical Monitor Discretion|1
5841056|NCT02311881|20188422|P2|Overall Study|Medical Monitor Discretion|0
5841057|NCT02311881|20188423|P1|Overall Study|Medical Monitor Discretion|0
5841058|NCT02311881|20188421|P3|Overall Study|Physician Decision|1
5841059|NCT02311881|20188422|P2|Overall Study|Physician Decision|0
5841060|NCT02311881|20188423|P1|Overall Study|Physician Decision|0
5841061|NCT02311881|20188421|P3|Overall Study|Non-Compliance|2
5841062|NCT02311881|20188422|P2|Overall Study|Non-Compliance|0
5841063|NCT02311881|20188423|P1|Overall Study|Non-Compliance|1
5841064|NCT02311881|20188421|P3|Overall Study|Protocol Deviation|0
5841065|NCT02311881|20188422|P2|Overall Study|Protocol Deviation|0
5841066|NCT02311881|20188423|P1|Overall Study|Protocol Deviation|1
5841067|NCT02311881|20188421|P3|Overall Study|Sponsor Decision|1
5841068|NCT02311881|20188422|P2|Overall Study|Sponsor Decision|1
5841069|NCT02311881|20188423|P1|Overall Study|Sponsor Decision|1
5841070|NCT02311881|20188421|P3|Overall Study|Withdrawal by Subject|4
5841071|NCT02311881|20188422|P2|Overall Study|Withdrawal by Subject|1
5841072|NCT02311881|20188423|P1|Overall Study|Withdrawal by Subject|3
5841073|NCT02311881|20188421|P3|Overall Study|Subject has border line pregnancy test|0
5841074|NCT02311881|20188422|P2|Overall Study|Subject has border line pregnancy test|0
5841075|NCT02311881|20188423|P1|Overall Study|Subject has border line pregnancy test|1
5841076|NCT02311881|20188421|P3|Overall Study|Lack of Efficacy|0
5841077|NCT02311881|20188422|P2|Overall Study|Lack of Efficacy|2
5841078|NCT02311881|20188423|P1|Overall Study|Lack of Efficacy|1
5841079|NCT02311881|20188421|P3|Overall Study|Other|1
5841080|NCT02311881|20188422|P2|Overall Study|Other|0
5841081|NCT02311881|20188423|P1|Overall Study|Other|0
5841082|NCT02311881|20188421|P3|Overall Study|Withdrawal of consent|17
5841083|NCT02311881|20188422|P2|Overall Study|Withdrawal of consent|16
5841084|NCT02311881|20188423|P1|Overall Study|Withdrawal of consent|14
5841085|NCT02311881|20188421|P3|Overall Study|Protocol Violation|3
5841086|NCT02311881|20188422|P2|Overall Study|Protocol Violation|2
5841087|NCT02311881|20188423|P1|Overall Study|Protocol Violation|1
5841088|NCT02311881|20188421|P3|Overall Study|Lost to Follow-up|2
5841089|NCT02311881|20188422|P2|Overall Study|Lost to Follow-up|3
5841090|NCT02311881|20188423|P1|Overall Study|Lost to Follow-up|3
5841091|NCT02311881|20188421|P3|Overall Study|Adverse Event|8
5841092|NCT02311881|20188422|P2|Overall Study|Adverse Event|15
5841093|NCT02311881|20188423|P1|Overall Study|Adverse Event|7
5841094|NCT02311881|20188421|P3|Overall Study|Did not meet the study criteria|0
5841095|NCT02311881|20188422|P2|Overall Study|Did not meet the study criteria|2
5841096|NCT02311881|20188423|P1|Overall Study|Did not meet the study criteria|2
5841097|NCT02311478|20188458|P1|Overall Study|Failed IUD Insertion|1
5841098|NCT02311478|20188458|P1|Overall Study|Lost to Follow-up|5
5841099|NCT02311478|20188458|P1|Overall Study|Withdrawal by Subject|1
5841100|NCT02311361|20188467|P4|Overall Study|Did not receive treatment|1
5841101|NCT02311361|20188468|P3|Overall Study|Did not receive treatment|0
5841102|NCT02311361|20188469|P2|Overall Study|Did not receive treatment|1
5841103|NCT02311361|20188470|P1|Overall Study|Did not receive treatment|0
5841104|NCT02311153|20188522|P2|Overall Study|Lost to Follow-up|7
5841105|NCT02311153|20188523|P1|Overall Study|Lost to Follow-up|5
5841106|NCT02310906|20188543|P4|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|1
5841107|NCT02310906|20188544|P3|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0
5841108|NCT02310906|20188545|P2|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0
5841109|NCT02310906|20188546|P1|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0
5841110|NCT02310906|20188543|P4|Part 2: Open Label Phase (168 Weeks)|Personal reasons|1
5841111|NCT02310906|20188544|P3|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0
5841112|NCT02310906|20188545|P2|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0
5841113|NCT02310906|20188546|P1|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0
5841114|NCT02310906|20188543|P4|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|4
5841115|NCT02310906|20188544|P3|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|2
5841116|NCT02310906|20188545|P2|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|0
5841117|NCT02310906|20188546|P1|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|0
5841118|NCT02310906|20188543|P4|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|2
5841119|NCT02310906|20188544|P3|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0
5841120|NCT02310906|20188545|P2|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0
5841121|NCT02310906|20188546|P1|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0
5841122|NCT02310789|20188625|P1|Overall Study|Adverse Event|1
5841123|NCT02310763|20188637|P3|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16
5841124|NCT02310763|20188638|P2|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16
5841125|NCT02310763|20188639|P1|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16
5841126|NCT02310763|20188637|P3|Period 1 (Weeks 1 to 48)|Adverse Event|0
5841127|NCT02310763|20188638|P2|Period 1 (Weeks 1 to 48)|Adverse Event|0
5841128|NCT02310763|20188639|P1|Period 1 (Weeks 1 to 48)|Adverse Event|1
5841129|NCT02310763|20188637|P3|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0
5841130|NCT02310763|20188638|P2|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0
5841131|NCT02310763|20188639|P1|Period 1 (Weeks 1 to 48)|Lost to Follow-up|1
5841132|NCT02310763|20188637|P3|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1
5841133|NCT02310763|20188638|P2|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1
5841134|NCT02310763|20188639|P1|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|0
5841135|NCT02310763|20188637|P3|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1
5841136|NCT02310763|20188638|P2|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1
5841137|NCT02310763|20188639|P1|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1
5841138|NCT02310750|20188842|P16|HP Washout 2|Lost to Follow-up|0
5841139|NCT02310750|20188843|P15|HP Washout 2|Lost to Follow-up|0
5841140|NCT02310750|20188844|P14|HP Washout 2|Lost to Follow-up|0
5841141|NCT02310750|20188845|P13|HP Washout 2|Lost to Follow-up|0
5841142|NCT02310750|20188846|P12|HP Washout 2|Lost to Follow-up|0
5841143|NCT02310750|20188847|P11|HP Washout 2|Lost to Follow-up|0
5841144|NCT02310750|20188848|P10|HP Washout 2|Lost to Follow-up|0
5841145|NCT02310750|20188849|P9|HP Washout 2|Lost to Follow-up|0
5841146|NCT02310750|20188850|P8|HP Washout 2|Lost to Follow-up|0
5841147|NCT02310750|20188851|P7|HP Washout 2|Lost to Follow-up|7
5841148|NCT02310750|20188852|P6|HP Washout 2|Lost to Follow-up|0
5841149|NCT02310750|20188853|P5|HP Washout 2|Lost to Follow-up|1
5841150|NCT02310750|20188854|P4|HP Washout 2|Lost to Follow-up|0
5841151|NCT02310750|20188855|P3|HP Washout 2|Lost to Follow-up|0
5841152|NCT02310750|20188856|P2|HP Washout 2|Lost to Follow-up|0
5841153|NCT02310750|20188857|P1|HP Washout 2|Lost to Follow-up|0
5841154|NCT02310750|20188842|P16|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
5841155|NCT02310750|20188843|P15|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
5841156|NCT02310750|20188844|P14|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
5841157|NCT02310750|20188845|P13|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
5841158|NCT02310750|20188846|P12|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
5841159|NCT02310750|20188847|P11|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
5841160|NCT02310750|20188848|P10|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
5841161|NCT02310750|20188849|P9|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1
5841162|NCT02310750|20188850|P8|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1
5841163|NCT02310750|20188851|P7|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
5841164|NCT02310750|20188852|P6|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
5841165|NCT02310750|20188853|P5|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
5841166|NCT02310750|20188854|P4|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
5841167|NCT02310750|20188855|P3|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
5841168|NCT02310750|20188856|P2|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
5841169|NCT02310750|20188857|P1|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
5841170|NCT02310750|20188842|P16|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
5841250|NCT02310750|20188842|P16|HP Period 1|Lost to Follow-up|0
5841171|NCT02310750|20188843|P15|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
5841172|NCT02310750|20188844|P14|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
5841173|NCT02310750|20188845|P13|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
5841174|NCT02310750|20188846|P12|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
5841175|NCT02310750|20188847|P11|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
5841176|NCT02310750|20188848|P10|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1
5841177|NCT02310750|20188849|P9|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1
5841178|NCT02310750|20188850|P8|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1
5841179|NCT02310750|20188851|P7|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
5841180|NCT02310750|20188852|P6|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
5841181|NCT02310750|20188853|P5|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
5841182|NCT02310750|20188854|P4|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
5841183|NCT02310750|20188855|P3|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
5841184|NCT02310750|20188856|P2|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
5841185|NCT02310750|20188857|P1|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
5841186|NCT02310750|20188842|P16|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
5841187|NCT02310750|20188843|P15|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
5841188|NCT02310750|20188844|P14|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
5841189|NCT02310750|20188845|P13|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
5841190|NCT02310750|20188846|P12|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
5841191|NCT02310750|20188847|P11|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
5841192|NCT02310750|20188848|P10|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|1
5841193|NCT02310750|20188849|P9|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
5841194|NCT02310750|20188850|P8|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
5841195|NCT02310750|20188851|P7|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
5841196|NCT02310750|20188852|P6|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
5841197|NCT02310750|20188853|P5|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
5841198|NCT02310750|20188854|P4|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
5841199|NCT02310750|20188855|P3|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
5841200|NCT02310750|20188856|P2|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
5841201|NCT02310750|20188857|P1|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
5841202|NCT02310750|20188842|P16|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
5841203|NCT02310750|20188843|P15|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
5841204|NCT02310750|20188844|P14|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
5841205|NCT02310750|20188845|P13|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
5841206|NCT02310750|20188846|P12|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
5841207|NCT02310750|20188847|P11|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
5841208|NCT02310750|20188848|P10|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1
5841209|NCT02310750|20188849|P9|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|6
5841210|NCT02310750|20188850|P8|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
5841211|NCT02310750|20188851|P7|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
5841212|NCT02310750|20188852|P6|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|2
5841213|NCT02310750|20188853|P5|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
5841214|NCT02310750|20188854|P4|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1
5841215|NCT02310750|20188855|P3|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
5841216|NCT02310750|20188856|P2|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
5841217|NCT02310750|20188857|P1|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
5841218|NCT02310750|20188842|P16|HP Washout 1|Lost to Follow-up|0
5841219|NCT02310750|20188843|P15|HP Washout 1|Lost to Follow-up|0
5841220|NCT02310750|20188844|P14|HP Washout 1|Lost to Follow-up|0
5841221|NCT02310750|20188845|P13|HP Washout 1|Lost to Follow-up|0
5841222|NCT02310750|20188846|P12|HP Washout 1|Lost to Follow-up|0
5841223|NCT02310750|20188847|P11|HP Washout 1|Lost to Follow-up|0
5841224|NCT02310750|20188848|P10|HP Washout 1|Lost to Follow-up|0
5841225|NCT02310750|20188849|P9|HP Washout 1|Lost to Follow-up|0
5841226|NCT02310750|20188850|P8|HP Washout 1|Lost to Follow-up|0
5841227|NCT02310750|20188851|P7|HP Washout 1|Lost to Follow-up|3
5841228|NCT02310750|20188852|P6|HP Washout 1|Lost to Follow-up|2
5841229|NCT02310750|20188853|P5|HP Washout 1|Lost to Follow-up|2
5841230|NCT02310750|20188854|P4|HP Washout 1|Lost to Follow-up|1
5841231|NCT02310750|20188855|P3|HP Washout 1|Lost to Follow-up|1
5841232|NCT02310750|20188856|P2|HP Washout 1|Lost to Follow-up|0
5841233|NCT02310750|20188857|P1|HP Washout 1|Lost to Follow-up|0
5841234|NCT02310750|20188842|P16|HP Period 1|Withdrawal by Subject|0
5841235|NCT02310750|20188843|P15|HP Period 1|Withdrawal by Subject|0
5841236|NCT02310750|20188844|P14|HP Period 1|Withdrawal by Subject|0
5841237|NCT02310750|20188845|P13|HP Period 1|Withdrawal by Subject|0
5841238|NCT02310750|20188846|P12|HP Period 1|Withdrawal by Subject|0
5841239|NCT02310750|20188847|P11|HP Period 1|Withdrawal by Subject|0
5841240|NCT02310750|20188848|P10|HP Period 1|Withdrawal by Subject|0
5841241|NCT02310750|20188849|P9|HP Period 1|Withdrawal by Subject|0
5841242|NCT02310750|20188850|P8|HP Period 1|Withdrawal by Subject|0
5841243|NCT02310750|20188851|P7|HP Period 1|Withdrawal by Subject|0
5841244|NCT02310750|20188852|P6|HP Period 1|Withdrawal by Subject|0
5841245|NCT02310750|20188853|P5|HP Period 1|Withdrawal by Subject|0
5841246|NCT02310750|20188854|P4|HP Period 1|Withdrawal by Subject|1
5841247|NCT02310750|20188855|P3|HP Period 1|Withdrawal by Subject|0
5841248|NCT02310750|20188856|P2|HP Period 1|Withdrawal by Subject|0
5841249|NCT02310750|20188857|P1|HP Period 1|Withdrawal by Subject|1
5841251|NCT02310750|20188843|P15|HP Period 1|Lost to Follow-up|0
5841252|NCT02310750|20188844|P14|HP Period 1|Lost to Follow-up|0
5841253|NCT02310750|20188845|P13|HP Period 1|Lost to Follow-up|0
5841254|NCT02310750|20188846|P12|HP Period 1|Lost to Follow-up|0
5841255|NCT02310750|20188847|P11|HP Period 1|Lost to Follow-up|0
5841256|NCT02310750|20188848|P10|HP Period 1|Lost to Follow-up|0
5841257|NCT02310750|20188849|P9|HP Period 1|Lost to Follow-up|0
5841258|NCT02310750|20188850|P8|HP Period 1|Lost to Follow-up|0
5841259|NCT02310750|20188851|P7|HP Period 1|Lost to Follow-up|1
5841260|NCT02310750|20188852|P6|HP Period 1|Lost to Follow-up|0
5841261|NCT02310750|20188853|P5|HP Period 1|Lost to Follow-up|0
5841262|NCT02310750|20188854|P4|HP Period 1|Lost to Follow-up|0
5841263|NCT02310750|20188855|P3|HP Period 1|Lost to Follow-up|0
5841264|NCT02310750|20188856|P2|HP Period 1|Lost to Follow-up|0
5841265|NCT02310750|20188857|P1|HP Period 1|Lost to Follow-up|0
5841266|NCT02310672|20189296|P1|Overall Study|Sponsor's decision|12
5841267|NCT02310672|20189296|P1|Overall Study|Withdrawal by Subject|1
5841268|NCT02310672|20189296|P1|Overall Study|Lost to Follow-up|1
5841269|NCT02310672|20189296|P1|Overall Study|Death|1
5841270|NCT02310646|20189309|P2|First Intervention (Day 1 - Day 7)|Lost to Follow-up|0
5841271|NCT02310646|20189310|P1|First Intervention (Day 1 - Day 7)|Lost to Follow-up|1
5841272|NCT02310646|20189309|P2|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|0
5841273|NCT02310646|20189310|P1|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|1
5841274|NCT02310581|20189338|P4|Overall Study|Withdrawal by Subject|1
5841275|NCT02310581|20189339|P3|Overall Study|Withdrawal by Subject|0
5841276|NCT02310581|20189340|P2|Overall Study|Withdrawal by Subject|1
5841277|NCT02310581|20189341|P1|Overall Study|Withdrawal by Subject|2
5841278|NCT02310581|20189338|P4|Overall Study|Adverse Event|0
5841279|NCT02310581|20189339|P3|Overall Study|Adverse Event|1
5841280|NCT02310581|20189340|P2|Overall Study|Adverse Event|1
5841281|NCT02310581|20189341|P1|Overall Study|Adverse Event|1
5841282|NCT02310568|20189380|P5|Stage 2 (4 Weeks)|Lost to Follow-up|0
5841283|NCT02310568|20189381|P4|Stage 2 (4 Weeks)|Lost to Follow-up|2
5841284|NCT02310568|20189382|P3|Stage 2 (4 Weeks)|Lost to Follow-up|0
5841285|NCT02310568|20189383|P2|Stage 2 (4 Weeks)|Lost to Follow-up|0
5841286|NCT02310568|20189384|P1|Stage 2 (4 Weeks)|Lost to Follow-up|0
5841287|NCT02310568|20189380|P5|Stage 2 (4 Weeks)|Protocol Violation|0
5841288|NCT02310568|20189381|P4|Stage 2 (4 Weeks)|Protocol Violation|1
5841289|NCT02310568|20189382|P3|Stage 2 (4 Weeks)|Protocol Violation|0
5841290|NCT02310568|20189383|P2|Stage 2 (4 Weeks)|Protocol Violation|0
5841291|NCT02310568|20189384|P1|Stage 2 (4 Weeks)|Protocol Violation|0
5841292|NCT02310568|20189380|P5|Stage 2 (4 Weeks)|Adverse Event|1
5841293|NCT02310568|20189381|P4|Stage 2 (4 Weeks)|Adverse Event|1
5841294|NCT02310568|20189382|P3|Stage 2 (4 Weeks)|Adverse Event|0
5841295|NCT02310568|20189383|P2|Stage 2 (4 Weeks)|Adverse Event|0
5841296|NCT02310568|20189384|P1|Stage 2 (4 Weeks)|Adverse Event|0
5841297|NCT02310568|20189380|P5|Stage 2 (4 Weeks)|Other|0
5841298|NCT02310568|20189381|P4|Stage 2 (4 Weeks)|Other|0
5841299|NCT02310568|20189382|P3|Stage 2 (4 Weeks)|Other|1
5841300|NCT02310568|20189383|P2|Stage 2 (4 Weeks)|Other|1
5841301|NCT02310568|20189384|P1|Stage 2 (4 Weeks)|Other|0
5841302|NCT02310568|20189380|P5|Stage 2 (4 Weeks)|Withdrawal by Participants|0
5841303|NCT02310568|20189381|P4|Stage 2 (4 Weeks)|Withdrawal by Participants|1
5841304|NCT02310568|20189382|P3|Stage 2 (4 Weeks)|Withdrawal by Participants|0
5841305|NCT02310568|20189383|P2|Stage 2 (4 Weeks)|Withdrawal by Participants|0
5841306|NCT02310568|20189384|P1|Stage 2 (4 Weeks)|Withdrawal by Participants|1
5841307|NCT02310568|20189380|P5|Stage 1 ( 4 Weeks)|Lost to Follow-up|0
5841308|NCT02310568|20189381|P4|Stage 1 ( 4 Weeks)|Lost to Follow-up|1
5841309|NCT02310568|20189382|P3|Stage 1 ( 4 Weeks)|Lost to Follow-up|0
5841310|NCT02310568|20189383|P2|Stage 1 ( 4 Weeks)|Lost to Follow-up|0
5841311|NCT02310568|20189384|P1|Stage 1 ( 4 Weeks)|Lost to Follow-up|0
5841312|NCT02310568|20189380|P5|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0
5841313|NCT02310568|20189381|P4|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|1
5841314|NCT02310568|20189382|P3|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0
5841315|NCT02310568|20189383|P2|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0
5841316|NCT02310568|20189384|P1|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0
5841317|NCT02310568|20189380|P5|Stage 1 ( 4 Weeks)|Adverse Event|0
5841318|NCT02310568|20189381|P4|Stage 1 ( 4 Weeks)|Adverse Event|0
5841319|NCT02310568|20189382|P3|Stage 1 ( 4 Weeks)|Adverse Event|1
5841320|NCT02310568|20189383|P2|Stage 1 ( 4 Weeks)|Adverse Event|1
5841321|NCT02310568|20189384|P1|Stage 1 ( 4 Weeks)|Adverse Event|1
5841322|NCT02310568|20189380|P5|Stage 1 ( 4 Weeks)|Other|0
5841323|NCT02310568|20189381|P4|Stage 1 ( 4 Weeks)|Other|0
5841324|NCT02310568|20189382|P3|Stage 1 ( 4 Weeks)|Other|0
5841325|NCT02310568|20189383|P2|Stage 1 ( 4 Weeks)|Other|1
5841326|NCT02310568|20189384|P1|Stage 1 ( 4 Weeks)|Other|1
5841327|NCT02310568|20189380|P5|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0
5841328|NCT02310568|20189381|P4|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0
5841329|NCT02310568|20189382|P3|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0
5841330|NCT02310568|20189383|P2|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0
5841331|NCT02310568|20189384|P1|Stage 1 ( 4 Weeks)|Withdrawal by Participants|1
5841332|NCT02310568|20189380|P5|Stage 1 ( 4 Weeks)|Lack of Efficacy|1
5841333|NCT02310568|20189381|P4|Stage 1 ( 4 Weeks)|Lack of Efficacy|0
5841334|NCT02310568|20189382|P3|Stage 1 ( 4 Weeks)|Lack of Efficacy|0
5841335|NCT02310568|20189383|P2|Stage 1 ( 4 Weeks)|Lack of Efficacy|0
5841336|NCT02310568|20189384|P1|Stage 1 ( 4 Weeks)|Lack of Efficacy|0
5841337|NCT02310126|20189464|P2|Period 1 (15 Minutes)|Protocol Violation|1
5841338|NCT02310126|20189465|P1|Period 1 (15 Minutes)|Protocol Violation|0
5841339|NCT02310126|20189464|P2|Period 1 (15 Minutes)|Lost to Follow-up|1
5841340|NCT02310126|20189465|P1|Period 1 (15 Minutes)|Lost to Follow-up|0
5841341|NCT02310100|20189471|P1|Overall Study|Lost to Follow-up|2
5841342|NCT02310100|20189471|P1|Overall Study|Visit compliance|1
5841343|NCT02310100|20189471|P1|Overall Study|Unapproved ablation operator|1
5841344|NCT02310100|20189471|P1|Overall Study|Enrollment closure|1
5841345|NCT02310100|20189471|P1|Overall Study|Withdrawal by Subject|10
5841346|NCT02310100|20189471|P1|Overall Study|Physician Decision|3
5841347|NCT02309723|20189490|P3|Overall Study|Withdrawal by Subject|24
5841348|NCT02309723|20189491|P2|Overall Study|Withdrawal by Subject|23
5841349|NCT02309723|20189492|P1|Overall Study|Withdrawal by Subject|24
5841350|NCT02309515|20189508|P2|Overall Study|Withdrawal by Subject|1
5841351|NCT02309515|20189509|P1|Overall Study|Withdrawal by Subject|0
5841352|NCT02309411|20189550|P3|Overall Study|Withdrawal by Subject|0
5841353|NCT02309411|20189551|P2|Overall Study|Withdrawal by Subject|1
5841354|NCT02309411|20189552|P1|Overall Study|Withdrawal by Subject|1
5841355|NCT02309411|20189550|P3|Overall Study|Physician Decision|0
5841356|NCT02309411|20189551|P2|Overall Study|Physician Decision|0
5841357|NCT02309411|20189552|P1|Overall Study|Physician Decision|1
5841358|NCT02309372|20189573|P2|Overall Study|Lost to Follow-up|2
5841359|NCT02309372|20189574|P1|Overall Study|Lost to Follow-up|3
5841360|NCT02309359|20189591|P5|Overall Study|Other|2
5841361|NCT02309359|20189592|P4|Overall Study|Other|3
5841362|NCT02309359|20189593|P3|Overall Study|Other|2
5841363|NCT02309359|20189594|P2|Overall Study|Other|0
5841364|NCT02309359|20189595|P1|Overall Study|Other|2
5841365|NCT02309359|20189591|P5|Overall Study|Lost to Follow-up|0
5841366|NCT02309359|20189592|P4|Overall Study|Lost to Follow-up|1
5841367|NCT02309359|20189593|P3|Overall Study|Lost to Follow-up|0
5841368|NCT02309359|20189594|P2|Overall Study|Lost to Follow-up|0
5841369|NCT02309359|20189595|P1|Overall Study|Lost to Follow-up|0
5841370|NCT02309359|20189591|P5|Overall Study|Lack of Efficacy|3
5841371|NCT02309359|20189592|P4|Overall Study|Lack of Efficacy|0
5841372|NCT02309359|20189593|P3|Overall Study|Lack of Efficacy|0
5841373|NCT02309359|20189594|P2|Overall Study|Lack of Efficacy|1
5841374|NCT02309359|20189595|P1|Overall Study|Lack of Efficacy|3
5841375|NCT02309359|20189591|P5|Overall Study|Withdrawal by Subject|0
5841376|NCT02309359|20189592|P4|Overall Study|Withdrawal by Subject|4
5841377|NCT02309359|20189593|P3|Overall Study|Withdrawal by Subject|4
5841378|NCT02309359|20189594|P2|Overall Study|Withdrawal by Subject|2
5841379|NCT02309359|20189595|P1|Overall Study|Withdrawal by Subject|2
5841380|NCT02309359|20189591|P5|Overall Study|Death|0
5841381|NCT02309359|20189592|P4|Overall Study|Death|0
5841382|NCT02309359|20189593|P3|Overall Study|Death|0
5841383|NCT02309359|20189594|P2|Overall Study|Death|0
5841384|NCT02309359|20189595|P1|Overall Study|Death|1
5841385|NCT02309359|20189591|P5|Overall Study|Adverse Event|4
5841386|NCT02309359|20189592|P4|Overall Study|Adverse Event|4
5841387|NCT02309359|20189593|P3|Overall Study|Adverse Event|5
5841388|NCT02309359|20189594|P2|Overall Study|Adverse Event|5
5841389|NCT02309359|20189595|P1|Overall Study|Adverse Event|4
5841390|NCT02309294|20189722|P1|Overall Study|Withdrawal by Subject|2
5841391|NCT02309138|20189728|P2|Overall Study|delivered before visit 2|1
5841392|NCT02309138|20189729|P1|Overall Study|delivered before visit 2|0
5841393|NCT02309138|20189728|P2|Overall Study|Protocol Violation|2
5841394|NCT02309138|20189729|P1|Overall Study|Protocol Violation|4
5841395|NCT02309138|20189728|P2|Overall Study|Withdrawal by Subject|15
5841396|NCT02309138|20189729|P1|Overall Study|Withdrawal by Subject|44
5841397|NCT02309112|20189752|P3|Overall Study|Lost to Follow-up|0
5841398|NCT02309112|20189753|P2|Overall Study|Lost to Follow-up|1
5841399|NCT02309112|20189754|P1|Overall Study|Lost to Follow-up|0
5841400|NCT02309112|20189752|P3|Overall Study|Withdrawal by Subject|1
5841401|NCT02309112|20189753|P2|Overall Study|Withdrawal by Subject|0
5841402|NCT02309112|20189754|P1|Overall Study|Withdrawal by Subject|1
5841403|NCT02309099|20189777|P2|Overall Study|Adverse Event|0
5841404|NCT02309099|20189778|P1|Overall Study|Adverse Event|2
5841405|NCT02308748|20189849|P10|Period 5|Adverse Event|0
5841406|NCT02308748|20189850|P9|Period 5|Adverse Event|1
5841407|NCT02308748|20189851|P8|Period 5|Adverse Event|0
5841408|NCT02308748|20189852|P7|Period 5|Adverse Event|0
5841409|NCT02308748|20189853|P6|Period 5|Adverse Event|0
5841410|NCT02308748|20189854|P5|Period 5|Adverse Event|0
5841411|NCT02308748|20189855|P4|Period 5|Adverse Event|0
5841412|NCT02308748|20189856|P3|Period 5|Adverse Event|0
5841413|NCT02308748|20189857|P2|Period 5|Adverse Event|0
5841414|NCT02308748|20189858|P1|Period 5|Adverse Event|1
5841415|NCT02308748|20189849|P10|Period 3|Protocol Violation|1
5841416|NCT02308748|20189850|P9|Period 3|Protocol Violation|0
5841417|NCT02308748|20189851|P8|Period 3|Protocol Violation|0
5841418|NCT02308748|20189852|P7|Period 3|Protocol Violation|0
5841419|NCT02308748|20189853|P6|Period 3|Protocol Violation|0
5841420|NCT02308748|20189854|P5|Period 3|Protocol Violation|0
5841421|NCT02308748|20189855|P4|Period 3|Protocol Violation|0
5841422|NCT02308748|20189856|P3|Period 3|Protocol Violation|0
5841423|NCT02308748|20189857|P2|Period 3|Protocol Violation|0
5841424|NCT02308748|20189858|P1|Period 3|Protocol Violation|0
5841425|NCT02308748|20189849|P10|Period 2|Adverse Event|0
5841426|NCT02308748|20189850|P9|Period 2|Adverse Event|0
5841427|NCT02308748|20189851|P8|Period 2|Adverse Event|1
5841428|NCT02308748|20189852|P7|Period 2|Adverse Event|0
5841429|NCT02308748|20189853|P6|Period 2|Adverse Event|0
5841430|NCT02308748|20189854|P5|Period 2|Adverse Event|0
5841431|NCT02308748|20189855|P4|Period 2|Adverse Event|0
5841432|NCT02308748|20189856|P3|Period 2|Adverse Event|0
5841433|NCT02308748|20189857|P2|Period 2|Adverse Event|0
5841434|NCT02308748|20189858|P1|Period 2|Adverse Event|0
5841435|NCT02308748|20189849|P10|Period 1|Withdrawal by Subject|0
5841436|NCT02308748|20189850|P9|Period 1|Withdrawal by Subject|0
5841437|NCT02308748|20189851|P8|Period 1|Withdrawal by Subject|0
5841438|NCT02308748|20189852|P7|Period 1|Withdrawal by Subject|0
5841439|NCT02308748|20189853|P6|Period 1|Withdrawal by Subject|0
5841440|NCT02308748|20189854|P5|Period 1|Withdrawal by Subject|0
5841441|NCT02308748|20189855|P4|Period 1|Withdrawal by Subject|0
5841442|NCT02308748|20189856|P3|Period 1|Withdrawal by Subject|1
5841443|NCT02308748|20189857|P2|Period 1|Withdrawal by Subject|0
5841444|NCT02308748|20189858|P1|Period 1|Withdrawal by Subject|0
5841445|NCT02308696|20189872|P2|Overall Study|Moved to a Higher Level of Care|6
5841446|NCT02308696|20189873|P1|Overall Study|Moved to a Higher Level of Care|17
5841447|NCT02308696|20189872|P2|Overall Study|Death|4
5841448|NCT02308696|20189873|P1|Overall Study|Death|8
5841449|NCT02308696|20189872|P2|Overall Study|Lost to Follow-up|21
5841450|NCT02308696|20189873|P1|Overall Study|Lost to Follow-up|28
5841451|NCT02308540|20189907|P6|Overall Study|Lost to Follow-up|1
5841452|NCT02308540|20189908|P5|Overall Study|Lost to Follow-up|0
5841453|NCT02308540|20189909|P4|Overall Study|Lost to Follow-up|0
5841454|NCT02308540|20189910|P3|Overall Study|Lost to Follow-up|0
5841455|NCT02308540|20189911|P2|Overall Study|Lost to Follow-up|0
5841456|NCT02308540|20189912|P1|Overall Study|Lost to Follow-up|0
5841457|NCT02308228|20190001|P2|Overall Study|Withdrawal by Subject|3
5841458|NCT02308228|20190002|P1|Overall Study|Withdrawal by Subject|5
5841459|NCT02308228|20190001|P2|Overall Study|Adverse Event|4
5841460|NCT02308228|20190002|P1|Overall Study|Adverse Event|3
5841461|NCT02308163|20190031|P5|Overall Study|Miscellaneous|5
5841462|NCT02308163|20190032|P4|Overall Study|Miscellaneous|0
5841463|NCT02308163|20190033|P3|Overall Study|Miscellaneous|1
5841464|NCT02308163|20190034|P2|Overall Study|Miscellaneous|2
5841465|NCT02308163|20190035|P1|Overall Study|Miscellaneous|2
5841466|NCT02308163|20190031|P5|Overall Study|Lab data met discontinuation criteria|0
5841467|NCT02308163|20190032|P4|Overall Study|Lab data met discontinuation criteria|2
5841468|NCT02308163|20190033|P3|Overall Study|Lab data met discontinuation criteria|0
5841469|NCT02308163|20190034|P2|Overall Study|Lab data met discontinuation criteria|0
5841470|NCT02308163|20190035|P1|Overall Study|Lab data met discontinuation criteria|3
5841471|NCT02308163|20190031|P5|Overall Study|Protocol Violation|5
5841472|NCT02308163|20190032|P4|Overall Study|Protocol Violation|2
5841473|NCT02308163|20190033|P3|Overall Study|Protocol Violation|3
5841474|NCT02308163|20190034|P2|Overall Study|Protocol Violation|3
5841475|NCT02308163|20190035|P1|Overall Study|Protocol Violation|3
5841476|NCT02308163|20190031|P5|Overall Study|Withdrawal of consent|6
5841477|NCT02308163|20190032|P4|Overall Study|Withdrawal of consent|2
5841478|NCT02308163|20190033|P3|Overall Study|Withdrawal of consent|0
5841479|NCT02308163|20190034|P2|Overall Study|Withdrawal of consent|3
5841480|NCT02308163|20190035|P1|Overall Study|Withdrawal of consent|2
5841481|NCT02308163|20190031|P5|Overall Study|Lack of Efficacy|6
5841482|NCT02308163|20190032|P4|Overall Study|Lack of Efficacy|4
5841483|NCT02308163|20190033|P3|Overall Study|Lack of Efficacy|8
5841484|NCT02308163|20190034|P2|Overall Study|Lack of Efficacy|3
5841485|NCT02308163|20190035|P1|Overall Study|Lack of Efficacy|11
5841486|NCT02308163|20190031|P5|Overall Study|Adverse Event|11
5841487|NCT02308163|20190032|P4|Overall Study|Adverse Event|2
5841488|NCT02308163|20190033|P3|Overall Study|Adverse Event|2
5841489|NCT02308163|20190034|P2|Overall Study|Adverse Event|5
5841490|NCT02308163|20190035|P1|Overall Study|Adverse Event|9
5841491|NCT02308163|20190031|P5|Overall Study|Not fulfill eligible criteria|1
5841492|NCT02308163|20190032|P4|Overall Study|Not fulfill eligible criteria|1
5841493|NCT02308163|20190033|P3|Overall Study|Not fulfill eligible criteria|0
5841494|NCT02308163|20190034|P2|Overall Study|Not fulfill eligible criteria|2
5841495|NCT02308163|20190035|P1|Overall Study|Not fulfill eligible criteria|1
5841496|NCT02308124|20190345|P3|Overall Study|Adverse Event|2
5841497|NCT02308124|20190346|P2|Overall Study|Adverse Event|2
5841498|NCT02308124|20190347|P1|Overall Study|Adverse Event|0
5841499|NCT02308124|20190345|P3|Overall Study|Lost to Follow-up|6
5841500|NCT02308124|20190346|P2|Overall Study|Lost to Follow-up|6
5841501|NCT02308124|20190347|P1|Overall Study|Lost to Follow-up|6
5841502|NCT02308046|20190369|P2|Overall Study|Lost to Follow-up|3
5841503|NCT02308046|20190370|P1|Overall Study|Lost to Follow-up|1
5841504|NCT02308046|20190369|P2|Overall Study|Positive for STD at Baseline|2
5841505|NCT02308046|20190370|P1|Overall Study|Positive for STD at Baseline|1
5841506|NCT02308046|20190369|P2|Overall Study|Negative yeast culture at Baseline|33
5841507|NCT02308046|20190370|P1|Overall Study|Negative yeast culture at Baseline|32
5841508|NCT02308033|20190386|P2|Overall Study|Lost to Follow-up|5
5841509|NCT02308033|20190387|P1|Overall Study|Lost to Follow-up|6
5841510|NCT02308033|20190386|P2|Overall Study|Positive for STD at Baseline|4
5841511|NCT02308033|20190387|P1|Overall Study|Positive for STD at Baseline|7
5841512|NCT02308033|20190386|P2|Overall Study|Normal Gram stain at Baseline|10
5841513|NCT02308033|20190387|P1|Overall Study|Normal Gram stain at Baseline|13
5841514|NCT02308020|20190407|P6|Overall Study|Withdrawal by Subject|2
5841515|NCT02308020|20190408|P5|Overall Study|Withdrawal by Subject|1
5841516|NCT02308020|20190409|P4|Overall Study|Withdrawal by Subject|2
5841517|NCT02308020|20190410|P3|Overall Study|Withdrawal by Subject|3
5841518|NCT02308020|20190411|P2|Overall Study|Withdrawal by Subject|5
5841519|NCT02308020|20190412|P1|Overall Study|Withdrawal by Subject|3
5841520|NCT02308020|20190407|P6|Overall Study|Sponsor Decision|1
5841521|NCT02308020|20190408|P5|Overall Study|Sponsor Decision|2
5841522|NCT02308020|20190409|P4|Overall Study|Sponsor Decision|2
5841523|NCT02308020|20190410|P3|Overall Study|Sponsor Decision|0
5841524|NCT02308020|20190411|P2|Overall Study|Sponsor Decision|8
5841525|NCT02308020|20190412|P1|Overall Study|Sponsor Decision|0
5841526|NCT02308020|20190407|P6|Overall Study|Lost to Follow-up|2
5841527|NCT02308020|20190408|P5|Overall Study|Lost to Follow-up|1
5841528|NCT02308020|20190409|P4|Overall Study|Lost to Follow-up|0
5841529|NCT02308020|20190410|P3|Overall Study|Lost to Follow-up|0
5841530|NCT02308020|20190411|P2|Overall Study|Lost to Follow-up|7
5841531|NCT02308020|20190412|P1|Overall Study|Lost to Follow-up|1
5841532|NCT02308007|20190469|P3|Overall Study|Lost to Follow-up|1
5841533|NCT02308007|20190470|P2|Overall Study|Lost to Follow-up|0
5841534|NCT02308007|20190471|P1|Overall Study|Lost to Follow-up|3
5841535|NCT02308007|20190469|P3|Overall Study|Positive for STD at Baseline|7
5841536|NCT02308007|20190470|P2|Overall Study|Positive for STD at Baseline|11
5841537|NCT02308007|20190471|P1|Overall Study|Positive for STD at Baseline|7
5841538|NCT02308007|20190469|P3|Overall Study|Normal Gram stain or neg yeast culture|67
5841539|NCT02308007|20190470|P2|Overall Study|Normal Gram stain or neg yeast culture|64
5841540|NCT02308007|20190471|P1|Overall Study|Normal Gram stain or neg yeast culture|66
5841541|NCT02307682|20190562|P3|Overall Study|Other|0
5841542|NCT02307682|20190563|P2|Overall Study|Other|1
5841543|NCT02307682|20190564|P1|Overall Study|Other|1
5841544|NCT02307682|20190562|P3|Overall Study|Protocol Deviation|2
5841545|NCT02307682|20190563|P2|Overall Study|Protocol Deviation|0
5841546|NCT02307682|20190564|P1|Overall Study|Protocol Deviation|0
5841547|NCT02307682|20190562|P3|Overall Study|Lost to Follow-up|6
5841548|NCT02307682|20190563|P2|Overall Study|Lost to Follow-up|5
5841549|NCT02307682|20190564|P1|Overall Study|Lost to Follow-up|1
5841550|NCT02307682|20190562|P3|Overall Study|Death|12
5841551|NCT02307682|20190563|P2|Overall Study|Death|7
5841552|NCT02307682|20190564|P1|Overall Study|Death|9
5841553|NCT02307682|20190562|P3|Overall Study|Withdrawal by Subject|23
5841554|NCT02307682|20190563|P2|Overall Study|Withdrawal by Subject|34
5841555|NCT02307682|20190564|P1|Overall Study|Withdrawal by Subject|26
5841556|NCT02307682|20190562|P3|Overall Study|Progressive Disease|0
5841557|NCT02307682|20190563|P2|Overall Study|Progressive Disease|0
5841558|NCT02307682|20190564|P1|Overall Study|Progressive Disease|1
5841559|NCT02307682|20190562|P3|Overall Study|Physician Decision|8
5841560|NCT02307682|20190563|P2|Overall Study|Physician Decision|2
5841561|NCT02307682|20190564|P1|Overall Study|Physician Decision|2
5841562|NCT02307682|20190562|P3|Overall Study|Lack of Efficacy|1
5841563|NCT02307682|20190563|P2|Overall Study|Lack of Efficacy|0
5841564|NCT02307682|20190564|P1|Overall Study|Lack of Efficacy|1
5841565|NCT02307682|20190562|P3|Overall Study|Adverse Event|12
5841566|NCT02307682|20190563|P2|Overall Study|Adverse Event|8
5841567|NCT02307682|20190564|P1|Overall Study|Adverse Event|9
5841568|NCT02307513|20190680|P2|Active Treatment Phase (Weeks 13-64)|Pregnancy|1
5841569|NCT02307513|20190681|P1|Active Treatment Phase (Weeks 13-64)|Pregnancy|0
5841570|NCT02307513|20190680|P2|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1
5841571|NCT02307513|20190681|P1|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1
5841572|NCT02307513|20190680|P2|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7
5841573|NCT02307513|20190681|P1|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7
5841574|NCT02307513|20190680|P2|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2
5841575|NCT02307513|20190681|P1|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2
5841576|NCT02307513|20190680|P2|Active Treatment Phase (Weeks 13-64)|Adverse Event|4
5841577|NCT02307513|20190681|P1|Active Treatment Phase (Weeks 13-64)|Adverse Event|9
5841578|NCT02307513|20190680|P2|Active Treatment Phase (Weeks 13-64)|Miscellaneous|0
5841579|NCT02307513|20190681|P1|Active Treatment Phase (Weeks 13-64)|Miscellaneous|1
5841580|NCT02307513|20190680|P2|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1
5841581|NCT02307513|20190681|P1|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1
5841582|NCT02307513|20190680|P2|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|1
5841583|NCT02307513|20190681|P1|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|0
5841584|NCT02307513|20190680|P2|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|5
5841585|NCT02307513|20190681|P1|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|4
5841586|NCT02307513|20190680|P2|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|1
5841587|NCT02307513|20190681|P1|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|0
5841588|NCT02307513|20190680|P2|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|8
5841589|NCT02307513|20190681|P1|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|0
5841590|NCT02307513|20190680|P2|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|4
5841591|NCT02307513|20190681|P1|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|3
5841601|NCT02306850|20190759|P1|Overall Study|Lack of Efficacy|2
5841602|NCT02306694|20190781|P1|Overall Study|Lost to Follow-up|1
5841603|NCT02306694|20190781|P1|Overall Study|Withdrawal by Subject|3
5841604|NCT02306265|20190791|P1|Overall Study|Withdrawal by Subject|1
5841605|NCT02305888|20190800|P3|Overall Study|Adverse Event|0
5841606|NCT02305888|20190801|P2|Overall Study|Adverse Event|1
5841607|NCT02305888|20190802|P1|Overall Study|Adverse Event|0
5841608|NCT02305888|20190800|P3|Overall Study|Lost to Follow-up|1
5841609|NCT02305888|20190801|P2|Overall Study|Lost to Follow-up|0
5841610|NCT02305888|20190802|P1|Overall Study|Lost to Follow-up|0
5841611|NCT02305849|20190822|P4|Overall Study|Not fulfill eligibility criteria|0
5841612|NCT02305849|20190823|P3|Overall Study|Not fulfill eligibility criteria|0
5841613|NCT02305849|20190824|P2|Overall Study|Not fulfill eligibility criteria|1
5841614|NCT02305849|20190825|P1|Overall Study|Not fulfill eligibility criteria|1
5841615|NCT02305849|20190822|P4|Overall Study|Miscellaneous|1
5841616|NCT02305849|20190823|P3|Overall Study|Miscellaneous|4
5841617|NCT02305849|20190824|P2|Overall Study|Miscellaneous|2
5841618|NCT02305849|20190825|P1|Overall Study|Miscellaneous|1
5841619|NCT02305849|20190822|P4|Overall Study|Lab data met discontinuation criteria|1
5841620|NCT02305849|20190823|P3|Overall Study|Lab data met discontinuation criteria|2
5841621|NCT02305849|20190824|P2|Overall Study|Lab data met discontinuation criteria|1
5841622|NCT02305849|20190825|P1|Overall Study|Lab data met discontinuation criteria|0
5841623|NCT02305849|20190822|P4|Overall Study|Protocol Violation|1
5841624|NCT02305849|20190823|P3|Overall Study|Protocol Violation|1
5841625|NCT02305849|20190824|P2|Overall Study|Protocol Violation|2
5841626|NCT02305849|20190825|P1|Overall Study|Protocol Violation|3
5841627|NCT02305849|20190822|P4|Overall Study|Lost to Follow-up|0
5841628|NCT02305849|20190823|P3|Overall Study|Lost to Follow-up|0
5841629|NCT02305849|20190824|P2|Overall Study|Lost to Follow-up|2
5841630|NCT02305849|20190825|P1|Overall Study|Lost to Follow-up|0
5841631|NCT02305849|20190822|P4|Overall Study|Withdrawal by Subject|4
5841632|NCT02305849|20190823|P3|Overall Study|Withdrawal by Subject|1
5841633|NCT02305849|20190824|P2|Overall Study|Withdrawal by Subject|2
5841634|NCT02305849|20190825|P1|Overall Study|Withdrawal by Subject|2
5841635|NCT02305849|20190822|P4|Overall Study|Lack of Efficacy|9
5841636|NCT02305849|20190823|P3|Overall Study|Lack of Efficacy|3
5841637|NCT02305849|20190824|P2|Overall Study|Lack of Efficacy|6
5841638|NCT02305849|20190825|P1|Overall Study|Lack of Efficacy|10
5841639|NCT02305849|20190822|P4|Overall Study|Adverse Event|3
5841640|NCT02305849|20190823|P3|Overall Study|Adverse Event|7
5841641|NCT02305849|20190824|P2|Overall Study|Adverse Event|12
5841642|NCT02305849|20190825|P1|Overall Study|Adverse Event|10
5841643|NCT02305797|20191059|P2|Overall Study|Reason not collected|1
5841644|NCT02305797|20191060|P1|Overall Study|Reason not collected|0
5841645|NCT02305797|20191059|P2|Overall Study|Noncompliance|12
5841646|NCT02305797|20191060|P1|Overall Study|Noncompliance|14
5841647|NCT02305797|20191059|P2|Overall Study|Pregnancy|2
5841648|NCT02305797|20191060|P1|Overall Study|Pregnancy|0
5841649|NCT02305797|20191059|P2|Overall Study|Lost to Follow-up|11
5841650|NCT02305797|20191060|P1|Overall Study|Lost to Follow-up|5
5841651|NCT02305797|20191059|P2|Overall Study|Lack of Efficacy|0
5841652|NCT02305797|20191060|P1|Overall Study|Lack of Efficacy|6
5841653|NCT02305797|20191059|P2|Overall Study|Withdrawal by Subject|10
5841654|NCT02305797|20191060|P1|Overall Study|Withdrawal by Subject|9
5841655|NCT02305797|20191059|P2|Overall Study|Adverse Event|2
5841656|NCT02305797|20191060|P1|Overall Study|Adverse Event|11
5841657|NCT02305758|20191070|P2|Overall Study|Other, not specified|1
5841658|NCT02305758|20191071|P1|Overall Study|Other, not specified|2
5841659|NCT02305758|20191070|P2|Overall Study|Study Terminated by Sponsor|34
5841660|NCT02305758|20191071|P1|Overall Study|Study Terminated by Sponsor|21
5841661|NCT02305758|20191070|P2|Overall Study|Lost to Follow-up|1
5841662|NCT02305758|20191071|P1|Overall Study|Lost to Follow-up|6
5841663|NCT02305758|20191070|P2|Overall Study|Withdrew consent|2
5841664|NCT02305758|20191071|P1|Overall Study|Withdrew consent|9
5841665|NCT02305758|20191070|P2|Overall Study|Death|27
5841666|NCT02305758|20191071|P1|Overall Study|Death|27
5841667|NCT02305446|20191089|P1|Overall Study|Adverse Event|1
5841668|NCT02305381|20191097|P3|Overall Study|Unclassified|7
5841669|NCT02305381|20191098|P2|Overall Study|Unclassified|5
5841670|NCT02305381|20191099|P1|Overall Study|Unclassified|5
5841671|NCT02305238|20191212|P3|Overall Study|Required procedure failed|0
5841672|NCT02305238|20191213|P2|Overall Study|Required procedure failed|1
5841673|NCT02305238|20191214|P1|Overall Study|Required procedure failed|0
5841674|NCT02305238|20191212|P3|Overall Study|Randomized failure|8
5841675|NCT02305238|20191213|P2|Overall Study|Randomized failure|0
5841676|NCT02305238|20191214|P1|Overall Study|Randomized failure|0
5841677|NCT02305238|20191212|P3|Overall Study|Withdrawal by Subject|0
5841678|NCT02305238|20191213|P2|Overall Study|Withdrawal by Subject|4
5841679|NCT02305238|20191214|P1|Overall Study|Withdrawal by Subject|3
5841680|NCT02305238|20191212|P3|Overall Study|Adverse Event|0
5841681|NCT02305238|20191213|P2|Overall Study|Adverse Event|2
5841682|NCT02305238|20191214|P1|Overall Study|Adverse Event|4
5841683|NCT02305238|20191212|P3|Overall Study|Physician Decision|0
5841684|NCT02305238|20191213|P2|Overall Study|Physician Decision|1
5841685|NCT02305238|20191214|P1|Overall Study|Physician Decision|2
5841686|NCT02305238|20191212|P3|Overall Study|Protocol Violation|0
5841687|NCT02305238|20191213|P2|Overall Study|Protocol Violation|3
5841688|NCT02305238|20191214|P1|Overall Study|Protocol Violation|0
5841689|NCT02305238|20191212|P3|Overall Study|Logistical difficulties|0
5841690|NCT02305238|20191213|P2|Overall Study|Logistical difficulties|3
5841691|NCT02305238|20191214|P1|Overall Study|Logistical difficulties|1
5841692|NCT02305238|20191212|P3|Overall Study|Progressive disease|0
5841693|NCT02305238|20191213|P2|Overall Study|Progressive disease|4
5841694|NCT02305238|20191214|P1|Overall Study|Progressive disease|4
5841695|NCT02305238|20191212|P3|Overall Study|Death|0
5841696|NCT02305238|20191213|P2|Overall Study|Death|1
5841697|NCT02305238|20191214|P1|Overall Study|Death|2
5841698|NCT02304926|20191246|P2|Overall Study|Lost to Follow-up|1
5841699|NCT02304926|20191247|P1|Overall Study|Lost to Follow-up|2
5841700|NCT02304705|20191293|P2|Overall Study|Lost to Follow-up|2
5841701|NCT02304705|20191294|P1|Overall Study|Lost to Follow-up|0
5841702|NCT02304705|20191293|P2|Overall Study|Death|1
5841703|NCT02304705|20191294|P1|Overall Study|Death|0
5841704|NCT02304705|20191293|P2|Overall Study|Physician Decision|4
5841705|NCT02304705|20191294|P1|Overall Study|Physician Decision|2
5841706|NCT02304705|20191293|P2|Overall Study|Withdrawal by Subject|0
5841707|NCT02304705|20191294|P1|Overall Study|Withdrawal by Subject|2
5841708|NCT02304484|20191300|P1|Overall Study|Lost to Follow-up|2
5841709|NCT02304484|20191300|P1|Overall Study|Withdrawal by Subject|14
5841710|NCT02304484|20191300|P1|Overall Study|Death|9
5841711|NCT02304380|20191363|P6|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0
5841712|NCT02304380|20191364|P5|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0
5841713|NCT02304380|20191365|P4|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|34
5841714|NCT02304380|20191366|P3|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0
5841715|NCT02304380|20191367|P2|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0
5841716|NCT02304380|20191368|P1|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0
5841723|NCT02303574|20191531|P10|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
5841724|NCT02303574|20191532|P9|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
5841725|NCT02303574|20191533|P8|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|1
5841726|NCT02303574|20191534|P7|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
5841727|NCT02303574|20191535|P6|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
5841728|NCT02303574|20191536|P5|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
5841729|NCT02303574|20191537|P4|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
5841730|NCT02303574|20191538|P3|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
5841731|NCT02303574|20191539|P2|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
5841732|NCT02303574|20191540|P1|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
5841733|NCT02303574|20191531|P10|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
5841734|NCT02303574|20191532|P9|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
5841735|NCT02303574|20191533|P8|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
5841736|NCT02303574|20191534|P7|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
5841737|NCT02303574|20191535|P6|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
5841738|NCT02303574|20191536|P5|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
5841739|NCT02303574|20191537|P4|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
5841740|NCT02303574|20191538|P3|Part 1a (Fasted State)- SAD|Withdrawal by Subject|1
5841741|NCT02303574|20191539|P2|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
5841742|NCT02303574|20191540|P1|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
5841743|NCT02303262|20191761|P1|Overall Study|Withdrawal by Subject|2
5841744|NCT02303041|20191769|P2|Overall Study|Adverse Event|2
5841745|NCT02303041|20191770|P1|Overall Study|Adverse Event|1
5841746|NCT02302859|20191786|P2|Overall Study|Withdrawal by Subject|1
5841747|NCT02302859|20191787|P1|Overall Study|Withdrawal by Subject|0
5841748|NCT02302859|20191786|P2|Overall Study|Lost Phone|1
5841749|NCT02302859|20191787|P1|Overall Study|Lost Phone|1
5841750|NCT02302846|20191793|P1|Overall Study|Withdrawal by Subject|1
5841751|NCT02302807|20191799|P2|Overall Study|Physician Decision|1
5841752|NCT02302807|20191800|P1|Overall Study|Physician Decision|0
5841753|NCT02302807|20191799|P2|Overall Study|Study Terminated By Sponsor|64
5841754|NCT02302807|20191800|P1|Overall Study|Study Terminated By Sponsor|35
5841755|NCT02302807|20191799|P2|Overall Study|Death|385
5841756|NCT02302807|20191800|P1|Overall Study|Death|397
5841757|NCT02302807|20191799|P2|Overall Study|Lost to Follow-up|6
5841758|NCT02302807|20191800|P1|Overall Study|Lost to Follow-up|4
5841759|NCT02302807|20191799|P2|Overall Study|Withdrawal by Subject|11
5841760|NCT02302807|20191800|P1|Overall Study|Withdrawal by Subject|28
5841761|NCT02302716|20191847|P2|Overall Study|Protocol Violation|1
5841762|NCT02302716|20191848|P1|Overall Study|Protocol Violation|0
5841763|NCT02302716|20191847|P2|Overall Study|Withdrawal by Subject|7
5841764|NCT02302716|20191848|P1|Overall Study|Withdrawal by Subject|13
5841765|NCT02302716|20191847|P2|Overall Study|Physician Decision|4
5841766|NCT02302716|20191848|P1|Overall Study|Physician Decision|3
5841767|NCT02302716|20191847|P2|Overall Study|Lost to Follow-up|4
5841768|NCT02302716|20191848|P1|Overall Study|Lost to Follow-up|2
5841769|NCT02302716|20191847|P2|Overall Study|Lack of Efficacy|1
5841770|NCT02302716|20191848|P1|Overall Study|Lack of Efficacy|0
5841771|NCT02302716|20191847|P2|Overall Study|Death|1
5841772|NCT02302716|20191848|P1|Overall Study|Death|0
5841773|NCT02302716|20191847|P2|Overall Study|Adverse Event|1
5841774|NCT02302716|20191848|P1|Overall Study|Adverse Event|1
5841775|NCT02302339|20191896|P4|Overall Study|Withdrawal by Subject|0
5841776|NCT02302339|20191897|P3|Overall Study|Withdrawal by Subject|1
5841777|NCT02302339|20191898|P2|Overall Study|Withdrawal by Subject|2
5841778|NCT02302339|20191899|P1|Overall Study|Withdrawal by Subject|0
5841779|NCT02302339|20191896|P4|Overall Study|Lost to Follow-up|0
5841780|NCT02302339|20191897|P3|Overall Study|Lost to Follow-up|0
5841781|NCT02302339|20191898|P2|Overall Study|Lost to Follow-up|0
5841782|NCT02302339|20191899|P1|Overall Study|Lost to Follow-up|1
5841783|NCT02302222|20191932|P2|Overall Study|Withdrawn prior to any treatment|1
5841784|NCT02302222|20191933|P1|Overall Study|Withdrawn prior to any treatment|0
5841785|NCT02302222|20191932|P2|Overall Study|Treatment discontinued before day 5|1
5841786|NCT02302222|20191933|P1|Overall Study|Treatment discontinued before day 5|0
5841787|NCT02302222|20191932|P2|Overall Study|Lost to Follow-up|0
5841788|NCT02302222|20191933|P1|Overall Study|Lost to Follow-up|1
5841789|NCT02302222|20191932|P2|Overall Study|Physician Decision|4
5841790|NCT02302222|20191933|P1|Overall Study|Physician Decision|0
5841791|NCT02302066|20191972|P4|Overall Study|Reason Not Specified|1
5841792|NCT02302066|20191973|P3|Overall Study|Reason Not Specified|9
5841793|NCT02302066|20191974|P2|Overall Study|Reason Not Specified|1
5841794|NCT02302066|20191975|P1|Overall Study|Reason Not Specified|1
5841795|NCT02302066|20191972|P4|Overall Study|Pregnancy|0
5841796|NCT02302066|20191973|P3|Overall Study|Pregnancy|12
5841797|NCT02302066|20191974|P2|Overall Study|Pregnancy|10
5841798|NCT02302066|20191975|P1|Overall Study|Pregnancy|2
5841799|NCT02302066|20191972|P4|Overall Study|Withdrawal by Subject|33
5841800|NCT02302066|20191973|P3|Overall Study|Withdrawal by Subject|124
5841801|NCT02302066|20191974|P2|Overall Study|Withdrawal by Subject|58
5841802|NCT02302066|20191975|P1|Overall Study|Withdrawal by Subject|25
5841803|NCT02302066|20191972|P4|Overall Study|Lost to Follow-up|7
5841804|NCT02302066|20191973|P3|Overall Study|Lost to Follow-up|24
5841805|NCT02302066|20191974|P2|Overall Study|Lost to Follow-up|5
5841806|NCT02302066|20191975|P1|Overall Study|Lost to Follow-up|4
5841807|NCT02302066|20191972|P4|Overall Study|Adverse Event|0
5841808|NCT02302066|20191973|P3|Overall Study|Adverse Event|3
5841809|NCT02302066|20191974|P2|Overall Study|Adverse Event|1
5841810|NCT02302066|20191975|P1|Overall Study|Adverse Event|1
5841811|NCT02301988|20192019|P2|Overall Study|Adverse Event|1
5841812|NCT02301988|20192020|P1|Overall Study|Adverse Event|1
5841813|NCT02301988|20192019|P2|Overall Study|Death|0
5841814|NCT02301988|20192020|P1|Overall Study|Death|1
5841815|NCT02301988|20192019|P2|Overall Study|Lack of Efficacy|2
5841816|NCT02301988|20192020|P1|Overall Study|Lack of Efficacy|3
5841817|NCT02301988|20192019|P2|Overall Study|Unknown Reason|3
5841818|NCT02301988|20192020|P1|Overall Study|Unknown Reason|1
5841819|NCT02301988|20192019|P2|Overall Study|Physician Decision|2
5841820|NCT02301988|20192020|P1|Overall Study|Physician Decision|2
5841821|NCT02301988|20192019|P2|Overall Study|Withdrawal by Subject|1
5841822|NCT02301988|20192020|P1|Overall Study|Withdrawal by Subject|2
5841823|NCT02301975|20192053|P3|Overall Study|Withdrawal by Subject|11
5841824|NCT02301975|20192054|P2|Overall Study|Withdrawal by Subject|12
5841825|NCT02301975|20192055|P1|Overall Study|Withdrawal by Subject|15
5841826|NCT02301975|20192053|P3|Overall Study|Physician Decision|3
5841827|NCT02301975|20192054|P2|Overall Study|Physician Decision|2
5841828|NCT02301975|20192055|P1|Overall Study|Physician Decision|4
5841829|NCT02301975|20192053|P3|Overall Study|Lost to Follow-up|2
5841830|NCT02301975|20192054|P2|Overall Study|Lost to Follow-up|2
5841831|NCT02301975|20192055|P1|Overall Study|Lost to Follow-up|0
5841832|NCT02301975|20192053|P3|Overall Study|Protocol Violation|3
5841833|NCT02301975|20192054|P2|Overall Study|Protocol Violation|5
5841834|NCT02301975|20192055|P1|Overall Study|Protocol Violation|3
5841835|NCT02301975|20192053|P3|Overall Study|Lack of Efficacy|1
5841836|NCT02301975|20192054|P2|Overall Study|Lack of Efficacy|1
5841837|NCT02301975|20192055|P1|Overall Study|Lack of Efficacy|1
5841838|NCT02301975|20192053|P3|Overall Study|Adverse Event|2
5841839|NCT02301975|20192054|P2|Overall Study|Adverse Event|3
5841840|NCT02301975|20192055|P1|Overall Study|Adverse Event|8
5841841|NCT02301936|20192083|P2|Overall Study|Lost to Follow-up|0
5841842|NCT02301936|20192084|P1|Overall Study|Lost to Follow-up|1
5841843|NCT02301897|20192109|P3|Treatment Course 2|Other Miscellaneous Reasons|0
5841844|NCT02301897|20192110|P2|Treatment Course 2|Other Miscellaneous Reasons|0
5841845|NCT02301897|20192111|P1|Treatment Course 2|Other Miscellaneous Reasons|1
5841846|NCT02301897|20192109|P3|Treatment Course 2|Withdrawal by Subject|0
5841847|NCT02301897|20192110|P2|Treatment Course 2|Withdrawal by Subject|2
5841848|NCT02301897|20192111|P1|Treatment Course 2|Withdrawal by Subject|0
5841849|NCT02301897|20192109|P3|Treatment Course 2|Pregnancy|1
5841850|NCT02301897|20192110|P2|Treatment Course 2|Pregnancy|1
5841851|NCT02301897|20192111|P1|Treatment Course 2|Pregnancy|0
5841852|NCT02301897|20192109|P3|Treatment Course 2|Lost to Follow-up|0
5841853|NCT02301897|20192110|P2|Treatment Course 2|Lost to Follow-up|2
5841854|NCT02301897|20192111|P1|Treatment Course 2|Lost to Follow-up|0
5841855|NCT02301897|20192109|P3|Treatment Course 1|Other Miscellaneous Reasons|0
5841856|NCT02301897|20192110|P2|Treatment Course 1|Other Miscellaneous Reasons|0
5841857|NCT02301897|20192111|P1|Treatment Course 1|Other Miscellaneous Reasons|1
5841858|NCT02301897|20192109|P3|Treatment Course 1|Withdrawal by Subject|2
5841859|NCT02301897|20192110|P2|Treatment Course 1|Withdrawal by Subject|0
5841860|NCT02301897|20192111|P1|Treatment Course 1|Withdrawal by Subject|0
5841861|NCT02301897|20192109|P3|Treatment Course 1|Withdrawal by Sponsor|2
5841862|NCT02301897|20192110|P2|Treatment Course 1|Withdrawal by Sponsor|0
5841863|NCT02301897|20192111|P1|Treatment Course 1|Withdrawal by Sponsor|0
5841864|NCT02301897|20192109|P3|Treatment Course 1|Lost to Follow-up|1
5841865|NCT02301897|20192110|P2|Treatment Course 1|Lost to Follow-up|2
5841866|NCT02301897|20192111|P1|Treatment Course 1|Lost to Follow-up|1
5841867|NCT02301897|20192109|P3|Treatment Course 1|Adverse Event|0
5841868|NCT02301897|20192110|P2|Treatment Course 1|Adverse Event|1
5841869|NCT02301897|20192111|P1|Treatment Course 1|Adverse Event|1
5841870|NCT02301897|20192109|P3|Treatment Course 1|Non-Compliance|1
5841871|NCT02301897|20192110|P2|Treatment Course 1|Non-Compliance|0
5841872|NCT02301897|20192111|P1|Treatment Course 1|Non-Compliance|0
5841873|NCT02301624|20192177|P2|Open-label Maintenance Phase|Participant felt no change in condition|0
5841874|NCT02301624|20192178|P1|Open-label Maintenance Phase|Participant felt no change in condition|1
5841875|NCT02301624|20192177|P2|Open-label Maintenance Phase|Death|1
5841876|NCT02301624|20192178|P1|Open-label Maintenance Phase|Death|2
5841877|NCT02301624|20192177|P2|Open-label Maintenance Phase|Physician Decision|3
5841878|NCT02301624|20192178|P1|Open-label Maintenance Phase|Physician Decision|3
5841879|NCT02301624|20192177|P2|Open-label Maintenance Phase|Adverse Event|5
5841880|NCT02301624|20192178|P1|Open-label Maintenance Phase|Adverse Event|2
5841881|NCT02301624|20192177|P2|Open-label Maintenance Phase|Withdrawal by Subject|8
5841882|NCT02301624|20192178|P1|Open-label Maintenance Phase|Withdrawal by Subject|4
5841883|NCT02301624|20192177|P2|Blind Induction Phase|Withdrawal by Subject|0
5841884|NCT02301624|20192178|P1|Blind Induction Phase|Withdrawal by Subject|1
5841885|NCT02301546|20192189|P2|Long Term Effectiveness (~1 Year)|moved away|2
5841886|NCT02301546|20192190|P1|Long Term Effectiveness (~1 Year)|moved away|1
5841887|NCT02301546|20192189|P2|Long Term Effectiveness (~1 Year)|Withdrawal by Subject|2
5841888|NCT02301546|20192190|P1|Long Term Effectiveness (~1 Year)|Withdrawal by Subject|6
5841889|NCT02301546|20192189|P2|Long Term Effectiveness (~1 Year)|Death|0
5841890|NCT02301546|20192190|P1|Long Term Effectiveness (~1 Year)|Death|2
5841891|NCT02301546|20192189|P2|Long Term Effectiveness (~1 Year)|Lost to Follow-up|3
5841892|NCT02301546|20192190|P1|Long Term Effectiveness (~1 Year)|Lost to Follow-up|3
5841893|NCT02301546|20192189|P2|Short-term Effectiveness (~13 Weeks)|screen fail|0
5841894|NCT02301546|20192190|P1|Short-term Effectiveness (~13 Weeks)|screen fail|1
5841895|NCT02301546|20192189|P2|Short-term Effectiveness (~13 Weeks)|non-compliant|7
5841896|NCT02301546|20192190|P1|Short-term Effectiveness (~13 Weeks)|non-compliant|10
5841897|NCT02301546|20192189|P2|Short-term Effectiveness (~13 Weeks)|Withdrawal by Subject|8
5841898|NCT02301546|20192190|P1|Short-term Effectiveness (~13 Weeks)|Withdrawal by Subject|7
5841899|NCT02301429|20192196|P1|Overall Study|not acceptable vascular anatomy|3
5841900|NCT02301403|20192242|P2|Overall Study|Withdrawal by Subject|41
5841901|NCT02301403|20192243|P1|Overall Study|Withdrawal by Subject|28
5841902|NCT02301390|20192251|P2|Overall Study|study terminated|0
5841903|NCT02301390|20192252|P1|Overall Study|study terminated|2
5841904|NCT02301390|20192251|P2|Overall Study|Missed multiple visits|1
5841905|NCT02301390|20192252|P1|Overall Study|Missed multiple visits|1
5841906|NCT02301390|20192251|P2|Overall Study|Procedure not completed|4
5841907|NCT02301390|20192252|P1|Overall Study|Procedure not completed|0
5841908|NCT02301390|20192251|P2|Overall Study|Death|2
5841909|NCT02301390|20192252|P1|Overall Study|Death|2
5841910|NCT02301390|20192251|P2|Overall Study|Lost to Follow-up|1
5841911|NCT02301390|20192252|P1|Overall Study|Lost to Follow-up|0
5841912|NCT02301390|20192251|P2|Overall Study|Physician Decision|0
5841913|NCT02301390|20192252|P1|Overall Study|Physician Decision|1
5841914|NCT02301390|20192251|P2|Overall Study|Protocol Violation|0
5841915|NCT02301390|20192252|P1|Overall Study|Protocol Violation|1
5841916|NCT02301390|20192251|P2|Overall Study|Withdrawal by Subject|5
5841917|NCT02301390|20192252|P1|Overall Study|Withdrawal by Subject|3
5841918|NCT02301169|20192293|P2|Overall Study|Adverse Event|0
5841919|NCT02301169|20192294|P1|Overall Study|Adverse Event|1
5841920|NCT02301143|20192308|P2|Investigator's Choice|Unresectable Surgery|1
5841921|NCT02301143|20192309|P1|Investigator's Choice|Unresectable Surgery|0
5841922|NCT02301143|20192308|P2|Investigator's Choice|Other|1
5841923|NCT02301143|20192309|P1|Investigator's Choice|Other|0
5841924|NCT02301143|20192308|P2|Investigator's Choice|Symptomatic Deterioration|1
5841925|NCT02301143|20192309|P1|Investigator's Choice|Symptomatic Deterioration|0
5841926|NCT02301143|20192308|P2|Investigator's Choice|Noncompliance With Study Drug|1
5841927|NCT02301143|20192309|P1|Investigator's Choice|Noncompliance With Study Drug|0
5841928|NCT02301143|20192308|P2|Investigator's Choice|Progressive Disease|3
5841929|NCT02301143|20192309|P1|Investigator's Choice|Progressive Disease|0
5841930|NCT02301143|20192308|P2|Investigator's Choice|Adverse Event|3
5841931|NCT02301143|20192309|P1|Investigator's Choice|Adverse Event|0
5841932|NCT02301143|20192308|P2|Induction Period|Other|0
5841933|NCT02301143|20192309|P1|Induction Period|Other|1
5841934|NCT02301143|20192308|P2|Induction Period|Protocol Violation|0
5841935|NCT02301143|20192309|P1|Induction Period|Protocol Violation|2
5841936|NCT02301143|20192308|P2|Induction Period|Symptomatic Deterioration|0
5841937|NCT02301143|20192309|P1|Induction Period|Symptomatic Deterioration|2
5841938|NCT02301143|20192308|P2|Induction Period|Physician Decision|0
5841939|NCT02301143|20192309|P1|Induction Period|Physician Decision|4
5841940|NCT02301143|20192308|P2|Induction Period|Noncompliance with Study Drug|0
5841941|NCT02301143|20192309|P1|Induction Period|Noncompliance with Study Drug|1
5841942|NCT02301143|20192308|P2|Induction Period|Withdrawal by Subject|0
5841943|NCT02301143|20192309|P1|Induction Period|Withdrawal by Subject|3
5841944|NCT02301143|20192308|P2|Induction Period|Progressive Disease|0
5841945|NCT02301143|20192309|P1|Induction Period|Progressive Disease|8
5841946|NCT02301143|20192308|P2|Induction Period|Adverse Event|0
5841947|NCT02301143|20192309|P1|Induction Period|Adverse Event|22
5841948|NCT02301143|20192308|P2|Induction Period|Death|0
5841949|NCT02301143|20192309|P1|Induction Period|Death|1
5841950|NCT02301143|20192308|P2|Induction Period|Enrolled But Not Treated|0
5841951|NCT02301143|20192309|P1|Induction Period|Enrolled But Not Treated|1
5841952|NCT02300987|20192352|P2|Secondary Phase : Cross-over to LEE011|Adverse Event|1
5841953|NCT02300987|20192353|P1|Secondary Phase : Cross-over to LEE011|Adverse Event|0
5841954|NCT02300987|20192352|P2|Secondary Phase : Cross-over to LEE011|Lack of Efficacy|0
5841955|NCT02300987|20192353|P1|Secondary Phase : Cross-over to LEE011|Lack of Efficacy|1
5841956|NCT02300987|20192352|P2|Primary Phase : Prior to Cross-over|progressive disease|2
5841957|NCT02300987|20192353|P1|Primary Phase : Prior to Cross-over|progressive disease|3
5841958|NCT02300987|20192352|P2|Primary Phase : Prior to Cross-over|Physician Decision|0
5841959|NCT02300987|20192353|P1|Primary Phase : Prior to Cross-over|Physician Decision|2
5841960|NCT02300987|20192352|P2|Primary Phase : Prior to Cross-over|Withdrawal by Subject|0
5841961|NCT02300987|20192353|P1|Primary Phase : Prior to Cross-over|Withdrawal by Subject|1
5841962|NCT02300610|20192400|P3|Overall Study|Withdrawal by Subject|1
5841963|NCT02300610|20192401|P2|Overall Study|Withdrawal by Subject|0
5841964|NCT02300610|20192402|P1|Overall Study|Withdrawal by Subject|1
5841965|NCT02300558|20192417|P1|Open-Label (OL) Extension Phase|Study Terminated by Sponsor|29
5841966|NCT02300558|20192417|P1|Open-Label (OL) Extension Phase|Withdrew Consent|1
5841967|NCT02300558|20192417|P1|Open-Label (OL) Extension Phase|Lack of Efficacy|2
5841968|NCT02300558|20192417|P1|Single Blind Phase (24 Weeks)|Study Terminated by Sponsor|6
5841969|NCT02300311|20192439|P2|Overall Study|Refused to continue taking medication|0
5841970|NCT02300311|20192440|P1|Overall Study|Refused to continue taking medication|18
5841971|NCT02300311|20192439|P2|Overall Study|Other than the reason specified|0
5841972|NCT02300311|20192440|P1|Overall Study|Other than the reason specified|1
5841973|NCT02300298|20192452|P2|Disposition for Docetaxel|other adverse event|4
5841974|NCT02300298|20192453|P1|Disposition for Docetaxel|other adverse event|0
5841975|NCT02300298|20192452|P2|Disposition for Docetaxel|Progressive disease|6
5841976|NCT02300298|20192453|P1|Disposition for Docetaxel|Progressive disease|0
5841977|NCT02300298|20192452|P2|Disposition for Nintedanib|Progressive disease|0
5841978|NCT02300298|20192453|P1|Disposition for Nintedanib|Progressive disease|10
5841979|NCT02300259|20192466|P3|Period 2|Withdrawal by Subject|1
5841980|NCT02300259|20192467|P2|Period 2|Withdrawal by Subject|0
5841981|NCT02300259|20192468|P1|Period 2|Withdrawal by Subject|0
5841982|NCT02300259|20192466|P3|Period 2|Adverse Event|0
5841983|NCT02300259|20192467|P2|Period 2|Adverse Event|0
5841984|NCT02300259|20192468|P1|Period 2|Adverse Event|1
5841985|NCT02300259|20192466|P3|Period 1|Withdrawal by Subject|1
5841986|NCT02300259|20192467|P2|Period 1|Withdrawal by Subject|0
5841987|NCT02300259|20192468|P1|Period 1|Withdrawal by Subject|0
5841988|NCT02300259|20192466|P3|Period 1|Adverse Event|1
5841989|NCT02300259|20192467|P2|Period 1|Adverse Event|0
5841990|NCT02300259|20192468|P1|Period 1|Adverse Event|0
5841991|NCT02300129|20192497|P4|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0
5841992|NCT02300129|20192498|P3|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0
5841993|NCT02300129|20192499|P2|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0
5841994|NCT02300129|20192500|P1|Period 2 Treatment 1 (2 Weeks)|Adverse Event|1
5841995|NCT02300129|20192497|P4|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|1
5841996|NCT02300129|20192498|P3|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0
5841997|NCT02300129|20192499|P2|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0
5841998|NCT02300129|20192500|P1|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0
5841999|NCT02300129|20192497|P4|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0
5842000|NCT02300129|20192498|P3|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0
5842001|NCT02300129|20192499|P2|Period 1 Session 2 (Day 3)|Withdrawal by Subject|1
5842002|NCT02300129|20192500|P1|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0
5842003|NCT02300103|20192510|P1|Overall Study|Withdrew Consent|2
5842004|NCT02300103|20192510|P1|Overall Study|Protocol Violation|1
5842005|NCT02300103|20192510|P1|Overall Study|Lack of Efficacy|3
5842006|NCT02299934|20192590|P1|Overall Study|Termination of study|13
5842007|NCT02299635|20192640|P1|Overall Study|Other|3
5842008|NCT02299635|20192640|P1|Overall Study|Withdrawal by Subject|2
5842009|NCT02299635|20192640|P1|Overall Study|Objective progression or relapse|10
5842010|NCT02299635|20192640|P1|Overall Study|Global deterioration of health status|1
5842011|NCT02299635|20192640|P1|Overall Study|Death|1
5842012|NCT02299635|20192640|P1|Overall Study|Adverse Event|2
5842013|NCT02299427|20192692|P2|Overall Study|not adherent to dog website use|0
5842014|NCT02299427|20192693|P1|Overall Study|not adherent to dog website use|21
5842015|NCT02299427|20192692|P2|Overall Study|Lost to Follow-up|3
5842016|NCT02299427|20192693|P1|Overall Study|Lost to Follow-up|1
5842017|NCT02299427|20192692|P2|Overall Study|Withdrawal by Subject|0
5842018|NCT02299427|20192693|P1|Overall Study|Withdrawal by Subject|1
5842019|NCT02299388|20192703|P2|Overall Study|Withdrawal by Subject|1
5842020|NCT02299388|20192704|P1|Overall Study|Withdrawal by Subject|0
5842021|NCT02299375|20192714|P2|Overall Study|Withdrawal by Subject|4
5842022|NCT02299375|20192715|P1|Overall Study|Withdrawal by Subject|1
5842023|NCT02299375|20192714|P2|Overall Study|Physician Decision|1
5842024|NCT02299375|20192715|P1|Overall Study|Physician Decision|1
5842025|NCT02299375|20192714|P2|Overall Study|Lost to Follow-up|2
5842026|NCT02299375|20192715|P1|Overall Study|Lost to Follow-up|0
5842027|NCT02299375|20192714|P2|Overall Study|Other: Study closed/terminated|55
5842028|NCT02299375|20192715|P1|Overall Study|Other: Study closed/terminated|66
5842029|NCT02299375|20192714|P2|Overall Study|Other: Met stopping criteria|0
5842030|NCT02299375|20192715|P1|Overall Study|Other: Met stopping criteria|1
5842031|NCT02299375|20192714|P2|Overall Study|Protocol Violation|3
5842032|NCT02299375|20192715|P1|Overall Study|Protocol Violation|1
5842033|NCT02299375|20192714|P2|Overall Study|Lack of Efficacy|3
5842034|NCT02299375|20192715|P1|Overall Study|Lack of Efficacy|1
5842035|NCT02299375|20192714|P2|Overall Study|Adverse Event, non-fatal|9
5842036|NCT02299375|20192715|P1|Overall Study|Adverse Event, non-fatal|8
5842037|NCT02299375|20192714|P2|Overall Study|Adverse Event, serious fatal|3
5842038|NCT02299375|20192715|P1|Overall Study|Adverse Event, serious fatal|1
5842039|NCT02299336|20192774|P1|Overall Study|Lost to Follow-up|1
5842040|NCT02299336|20192774|P1|Overall Study|Death|1
5842041|NCT02299336|20192774|P1|Overall Study|Adverse Event|1
5842042|NCT02299336|20192774|P1|Overall Study|Withdrawal by Subject|11
5842043|NCT02299206|20192809|P1|Overall Study|Withdrawal by Subject|1
5842044|NCT02299206|20192809|P1|Overall Study|Lost to Follow-up|1
5842045|NCT02299167|20192817|P1|Overall Study|patients were excluded from the study|11
5842046|NCT02299076|20192878|P2|Overall Study|Fraudulent Entries|14
5842047|NCT02299076|20192879|P1|Overall Study|Fraudulent Entries|20
5842048|NCT02298946|20192900|P2|Overall Study|Unevaluable|1
5842049|NCT02298946|20192901|P1|Overall Study|Unevaluable|2
5842050|NCT02298946|20192900|P2|Overall Study|Did not receive treatment|0
5842051|NCT02298946|20192901|P1|Overall Study|Did not receive treatment|2
5842052|NCT02298868|20192929|P1|Overall Study|Patient underwent transplant|1
5842053|NCT02298868|20192929|P1|Overall Study|Death|1
5842054|NCT02298868|20192929|P1|Overall Study|Adverse Event|1
5842055|NCT02298192|20193007|P2|Overall Study|Adverse Event|2
5842056|NCT02298192|20193008|P1|Overall Study|Adverse Event|6
5842057|NCT02298192|20193007|P2|Overall Study|Lost to Follow-up|1
5842058|NCT02298192|20193008|P1|Overall Study|Lost to Follow-up|2
5842059|NCT02298192|20193007|P2|Overall Study|Withdrawal by Subject|1
5842060|NCT02298192|20193008|P1|Overall Study|Withdrawal by Subject|6
5842061|NCT02298192|20193007|P2|Overall Study|Withdrawal criteria|0
5842062|NCT02298192|20193008|P1|Overall Study|Withdrawal criteria|2
5842063|NCT02298192|20193007|P2|Overall Study|Unclassified|2
5842064|NCT02298192|20193008|P1|Overall Study|Unclassified|3
5842065|NCT02298179|20193032|P12|Overall Study|Lost to Follow-up|0
5842066|NCT02298179|20193033|P11|Overall Study|Lost to Follow-up|0
5842067|NCT02298179|20193034|P10|Overall Study|Lost to Follow-up|0
5842068|NCT02298179|20193035|P9|Overall Study|Lost to Follow-up|0
5842069|NCT02298179|20193036|P8|Overall Study|Lost to Follow-up|1
5842070|NCT02298179|20193037|P7|Overall Study|Lost to Follow-up|0
5842071|NCT02298179|20193038|P6|Overall Study|Lost to Follow-up|0
5842072|NCT02298179|20193039|P5|Overall Study|Lost to Follow-up|0
5842073|NCT02298179|20193040|P4|Overall Study|Lost to Follow-up|0
5842074|NCT02298179|20193041|P3|Overall Study|Lost to Follow-up|1
5842075|NCT02298179|20193042|P2|Overall Study|Lost to Follow-up|0
5842076|NCT02298179|20193043|P1|Overall Study|Lost to Follow-up|0
5842077|NCT02297841|20193285|P1|Overall Study|Protocol Violation|7
5842078|NCT02297841|20193285|P1|Overall Study|Withdrawal by Subject|1
5842079|NCT02297815|20193291|P2|Overall Study|Lost to Follow-up|140
5842080|NCT02297815|20193292|P1|Overall Study|Lost to Follow-up|236
5842081|NCT02297516|20193310|P2|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|1
5842082|NCT02297516|20193311|P1|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|0
5842083|NCT02297516|20193310|P2|Single Treatment Phase (6 Months)|Protocol Violation|2
5842084|NCT02297516|20193311|P1|Single Treatment Phase (6 Months)|Protocol Violation|0
5842085|NCT02297516|20193310|P2|Single Treatment Phase (6 Months)|Medical reason|0
5842086|NCT02297516|20193311|P1|Single Treatment Phase (6 Months)|Medical reason|1
5842087|NCT02297503|20193332|P2|Overall Study|Medical reason|1
5842088|NCT02297503|20193333|P1|Overall Study|Medical reason|0
5842089|NCT02297503|20193332|P2|Overall Study|Lost to Follow-up|1
5842090|NCT02297503|20193333|P1|Overall Study|Lost to Follow-up|0
5842091|NCT02297503|20193332|P2|Overall Study|Pregnancy|1
5842092|NCT02297503|20193333|P1|Overall Study|Pregnancy|0
5842093|NCT02297503|20193332|P2|Overall Study|Protocol Violation|0
5842094|NCT02297503|20193333|P1|Overall Study|Protocol Violation|1
5842095|NCT02297503|20193332|P2|Overall Study|Withdrawal by Subject|1
5842096|NCT02297503|20193333|P1|Overall Study|Withdrawal by Subject|1
5842097|NCT02297412|20193360|P2|Overall Study|Canceled|1
5842098|NCT02297412|20193361|P1|Overall Study|Canceled|1
5842099|NCT02296931|20193422|P2|Overall Study|Protocol Violation|2
5842100|NCT02296931|20193423|P1|Overall Study|Protocol Violation|0
5842101|NCT02296892|20193432|P3|Overall Study|Lost to Follow-up|1
5842102|NCT02296892|20193433|P2|Overall Study|Lost to Follow-up|0
5842103|NCT02296892|20193434|P1|Overall Study|Lost to Follow-up|5
5842104|NCT02296892|20193432|P3|Overall Study|Exclusion Criteria at Day of Procedure|4
5842105|NCT02296892|20193433|P2|Overall Study|Exclusion Criteria at Day of Procedure|4
5842106|NCT02296892|20193434|P1|Overall Study|Exclusion Criteria at Day of Procedure|7
5842107|NCT02296840|20193470|P2|Overall Study|Lost to Follow-up|17
5842108|NCT02296840|20193471|P1|Overall Study|Lost to Follow-up|6
5842109|NCT02296840|20193470|P2|Overall Study|Protocol Violation|1
5842110|NCT02296840|20193471|P1|Overall Study|Protocol Violation|2
5842111|NCT02296840|20193470|P2|Overall Study|Adverse Event|1
5842112|NCT02296840|20193471|P1|Overall Study|Adverse Event|1
5842113|NCT02296476|20193579|P3|Overall Study|Disease Progression|2
5842114|NCT02296476|20193580|P2|Overall Study|Disease Progression|4
5842115|NCT02296476|20193581|P1|Overall Study|Disease Progression|6
5842116|NCT02296424|20193636|P4|Part 2|Lost to Follow-up|0
5842117|NCT02296424|20193637|P3|Part 2|Lost to Follow-up|1
5842118|NCT02296424|20193638|P2|Part 2|Lost to Follow-up|0
5842119|NCT02296424|20193639|P1|Part 2|Lost to Follow-up|0
5842120|NCT02296424|20193636|P4|Part 2|Adverse Event|0
5842121|NCT02296424|20193637|P3|Part 2|Adverse Event|1
5842122|NCT02296424|20193638|P2|Part 2|Adverse Event|0
5842123|NCT02296424|20193639|P1|Part 2|Adverse Event|0
5842124|NCT02296424|20193636|P4|Part 2|Lack of Efficacy|0
5842125|NCT02296424|20193637|P3|Part 2|Lack of Efficacy|1
5842126|NCT02296424|20193638|P2|Part 2|Lack of Efficacy|0
5842127|NCT02296424|20193639|P1|Part 2|Lack of Efficacy|0
5842128|NCT02296424|20193636|P4|Part 1|16 directly started part II|0
5842129|NCT02296424|20193637|P3|Part 1|16 directly started part II|0
5842130|NCT02296424|20193638|P2|Part 1|16 directly started part II|0
5842131|NCT02296424|20193639|P1|Part 1|16 directly started part II|16
5842132|NCT02296424|20193636|P4|Part 1|Lack of Efficacy|0
5842133|NCT02296424|20193637|P3|Part 1|Lack of Efficacy|0
5842134|NCT02296424|20193638|P2|Part 1|Lack of Efficacy|17
5842135|NCT02296424|20193639|P1|Part 1|Lack of Efficacy|5
5842136|NCT02296424|20193636|P4|Part 1|Adverse Event|0
5842137|NCT02296424|20193637|P3|Part 1|Adverse Event|0
5842138|NCT02296424|20193638|P2|Part 1|Adverse Event|11
5842139|NCT02296424|20193639|P1|Part 1|Adverse Event|2
5842140|NCT02296424|20193636|P4|Part 1|Study terminated by sponsor|0
5842141|NCT02296424|20193637|P3|Part 1|Study terminated by sponsor|0
5842142|NCT02296424|20193638|P2|Part 1|Study terminated by sponsor|1
5842143|NCT02296424|20193639|P1|Part 1|Study terminated by sponsor|0
5842144|NCT02296424|20193636|P4|Part 1|Withdrawal by Subject|0
5842145|NCT02296424|20193637|P3|Part 1|Withdrawal by Subject|0
5842146|NCT02296424|20193638|P2|Part 1|Withdrawal by Subject|2
5842147|NCT02296424|20193639|P1|Part 1|Withdrawal by Subject|0
5842148|NCT02296424|20193636|P4|Part 1|Protocol Violation|0
5842149|NCT02296424|20193637|P3|Part 1|Protocol Violation|0
5842150|NCT02296424|20193638|P2|Part 1|Protocol Violation|1
5842151|NCT02296424|20193639|P1|Part 1|Protocol Violation|0
5842152|NCT02296424|20193636|P4|Part 1|New therapy for study indication|0
5842153|NCT02296424|20193637|P3|Part 1|New therapy for study indication|0
5842154|NCT02296424|20193638|P2|Part 1|New therapy for study indication|1
5842155|NCT02296424|20193639|P1|Part 1|New therapy for study indication|0
5842156|NCT02296320|20193664|P3|Overall Study|Not - specified|1
5842157|NCT02296320|20193665|P2|Overall Study|Not - specified|0
5842158|NCT02296320|20193666|P1|Overall Study|Not - specified|0
5842159|NCT02296320|20193664|P3|Overall Study|Not treated|0
5842160|NCT02296320|20193665|P2|Overall Study|Not treated|0
5842161|NCT02296320|20193666|P1|Overall Study|Not treated|2
5842162|NCT02296320|20193664|P3|Overall Study|Lost to Follow-up|7
5842163|NCT02296320|20193665|P2|Overall Study|Lost to Follow-up|2
5842164|NCT02296320|20193666|P1|Overall Study|Lost to Follow-up|5
5842165|NCT02296320|20193664|P3|Overall Study|Death|27
5842166|NCT02296320|20193665|P2|Overall Study|Death|3
5842167|NCT02296320|20193666|P1|Overall Study|Death|24
5842168|NCT02296320|20193664|P3|Overall Study|Withdrawal by Subject|2
5842169|NCT02296320|20193665|P2|Overall Study|Withdrawal by Subject|0
5842170|NCT02296320|20193666|P1|Overall Study|Withdrawal by Subject|4
5842171|NCT02296242|20193705|P5|Overall Study|Lack of Efficacy|3
5842172|NCT02296242|20193706|P4|Overall Study|Lack of Efficacy|0
5842173|NCT02296242|20193707|P3|Overall Study|Lack of Efficacy|0
5842174|NCT02296242|20193708|P2|Overall Study|Lack of Efficacy|0
5842175|NCT02296242|20193709|P1|Overall Study|Lack of Efficacy|0
5842176|NCT02296242|20193705|P5|Overall Study|Adverse Event|0
5842177|NCT02296242|20193706|P4|Overall Study|Adverse Event|1
5842178|NCT02296242|20193707|P3|Overall Study|Adverse Event|0
5842179|NCT02296242|20193708|P2|Overall Study|Adverse Event|0
5842180|NCT02296242|20193709|P1|Overall Study|Adverse Event|0
5842181|NCT02296242|20193705|P5|Overall Study|Alternative Treatment|0
5842182|NCT02296242|20193706|P4|Overall Study|Alternative Treatment|1
5842183|NCT02296242|20193707|P3|Overall Study|Alternative Treatment|0
5842184|NCT02296242|20193708|P2|Overall Study|Alternative Treatment|0
5842185|NCT02296242|20193709|P1|Overall Study|Alternative Treatment|0
5842186|NCT02296242|20193705|P5|Overall Study|Physician Decision|0
5842187|NCT02296242|20193706|P4|Overall Study|Physician Decision|1
5842188|NCT02296242|20193707|P3|Overall Study|Physician Decision|0
5842189|NCT02296242|20193708|P2|Overall Study|Physician Decision|1
5842190|NCT02296242|20193709|P1|Overall Study|Physician Decision|0
5842191|NCT02296242|20193705|P5|Overall Study|Screened for Other Protocol|0
5842192|NCT02296242|20193706|P4|Overall Study|Screened for Other Protocol|0
5842193|NCT02296242|20193707|P3|Overall Study|Screened for Other Protocol|0
5842194|NCT02296242|20193708|P2|Overall Study|Screened for Other Protocol|1
5842195|NCT02296242|20193709|P1|Overall Study|Screened for Other Protocol|0
5842196|NCT02296242|20193705|P5|Overall Study|Need for Hydroxyurea|0
5842197|NCT02296242|20193706|P4|Overall Study|Need for Hydroxyurea|0
5842198|NCT02296242|20193707|P3|Overall Study|Need for Hydroxyurea|0
5842199|NCT02296242|20193708|P2|Overall Study|Need for Hydroxyurea|0
5842200|NCT02296242|20193709|P1|Overall Study|Need for Hydroxyurea|2
5842201|NCT02296242|20193705|P5|Overall Study|Lost to Follow-up|0
5842202|NCT02296242|20193706|P4|Overall Study|Lost to Follow-up|0
5842203|NCT02296242|20193707|P3|Overall Study|Lost to Follow-up|0
5842204|NCT02296242|20193708|P2|Overall Study|Lost to Follow-up|0
5842205|NCT02296242|20193709|P1|Overall Study|Lost to Follow-up|1
5842206|NCT02296242|20193705|P5|Overall Study|At Least 3 Drug Interruptions|1
5842207|NCT02296242|20193706|P4|Overall Study|At Least 3 Drug Interruptions|1
5842208|NCT02296242|20193707|P3|Overall Study|At Least 3 Drug Interruptions|1
5842209|NCT02296242|20193708|P2|Overall Study|At Least 3 Drug Interruptions|0
5842210|NCT02296242|20193709|P1|Overall Study|At Least 3 Drug Interruptions|0
5842211|NCT02296242|20193705|P5|Overall Study|Patient Condition Changed|1
5842212|NCT02296242|20193706|P4|Overall Study|Patient Condition Changed|0
5842213|NCT02296242|20193707|P3|Overall Study|Patient Condition Changed|2
5842214|NCT02296242|20193708|P2|Overall Study|Patient Condition Changed|0
5842215|NCT02296242|20193709|P1|Overall Study|Patient Condition Changed|0
5842216|NCT02296242|20193705|P5|Overall Study|Unacceptable Toxicity|1
5842217|NCT02296242|20193706|P4|Overall Study|Unacceptable Toxicity|0
5842218|NCT02296242|20193707|P3|Overall Study|Unacceptable Toxicity|0
5842219|NCT02296242|20193708|P2|Overall Study|Unacceptable Toxicity|0
5842220|NCT02296242|20193709|P1|Overall Study|Unacceptable Toxicity|0
5842221|NCT02296242|20193705|P5|Overall Study|Disease Progression|11
5842222|NCT02296242|20193706|P4|Overall Study|Disease Progression|8
5842223|NCT02296242|20193707|P3|Overall Study|Disease Progression|2
5842224|NCT02296242|20193708|P2|Overall Study|Disease Progression|3
5842225|NCT02296242|20193709|P1|Overall Study|Disease Progression|1
5842226|NCT02296242|20193705|P5|Overall Study|Withdrawal by Subject|3
5842227|NCT02296242|20193706|P4|Overall Study|Withdrawal by Subject|1
5842228|NCT02296242|20193707|P3|Overall Study|Withdrawal by Subject|1
5842229|NCT02296242|20193708|P2|Overall Study|Withdrawal by Subject|0
5842230|NCT02296242|20193709|P1|Overall Study|Withdrawal by Subject|0
5842231|NCT02296242|20193705|P5|Overall Study|Death|1
5842232|NCT02296242|20193706|P4|Overall Study|Death|1
5842233|NCT02296242|20193707|P3|Overall Study|Death|1
5842234|NCT02296242|20193708|P2|Overall Study|Death|1
5842235|NCT02296242|20193709|P1|Overall Study|Death|1
5842236|NCT02296190|20193737|P6|Overall Study|Lab result not available in time|0
5842237|NCT02296190|20193738|P5|Overall Study|Lab result not available in time|0
5842238|NCT02296190|20193739|P4|Overall Study|Lab result not available in time|0
5842239|NCT02296190|20193740|P3|Overall Study|Lab result not available in time|0
5842240|NCT02296190|20193741|P2|Overall Study|Lab result not available in time|0
5842241|NCT02296190|20193742|P1|Overall Study|Lab result not available in time|1
5842242|NCT02296190|20193737|P6|Overall Study|Failed PSVT with mechanism of AVNRT|0
5842243|NCT02296190|20193738|P5|Overall Study|Failed PSVT with mechanism of AVNRT|0
5842244|NCT02296190|20193739|P4|Overall Study|Failed PSVT with mechanism of AVNRT|0
5842245|NCT02296190|20193740|P3|Overall Study|Failed PSVT with mechanism of AVNRT|0
5842246|NCT02296190|20193741|P2|Overall Study|Failed PSVT with mechanism of AVNRT|1
5842247|NCT02296190|20193742|P1|Overall Study|Failed PSVT with mechanism of AVNRT|0
5842248|NCT02296190|20193737|P6|Overall Study|Patient on antiarrhythmic medication|0
5842249|NCT02296190|20193738|P5|Overall Study|Patient on antiarrhythmic medication|0
5842250|NCT02296190|20193739|P4|Overall Study|Patient on antiarrhythmic medication|0
5842251|NCT02296190|20193740|P3|Overall Study|Patient on antiarrhythmic medication|0
5842252|NCT02296190|20193741|P2|Overall Study|Patient on antiarrhythmic medication|0
5842253|NCT02296190|20193742|P1|Overall Study|Patient on antiarrhythmic medication|1
5842254|NCT02296190|20193737|P6|Overall Study|Atrial Tachycardia induced not PSVT|0
5842255|NCT02296190|20193738|P5|Overall Study|Atrial Tachycardia induced not PSVT|0
5842256|NCT02296190|20193739|P4|Overall Study|Atrial Tachycardia induced not PSVT|0
5842257|NCT02296190|20193740|P3|Overall Study|Atrial Tachycardia induced not PSVT|1
5842258|NCT02296190|20193741|P2|Overall Study|Atrial Tachycardia induced not PSVT|1
5842259|NCT02296190|20193742|P1|Overall Study|Atrial Tachycardia induced not PSVT|0
5842260|NCT02296190|20193737|P6|Overall Study|Blood pressure <100 after sedation|0
5842261|NCT02296190|20193738|P5|Overall Study|Blood pressure <100 after sedation|0
5842262|NCT02296190|20193739|P4|Overall Study|Blood pressure <100 after sedation|1
5842263|NCT02296190|20193740|P3|Overall Study|Blood pressure <100 after sedation|0
5842264|NCT02296190|20193741|P2|Overall Study|Blood pressure <100 after sedation|0
5842265|NCT02296190|20193742|P1|Overall Study|Blood pressure <100 after sedation|0
5842266|NCT02296190|20193737|P6|Overall Study|Patient with Atrial Tachycardia|0
5842267|NCT02296190|20193738|P5|Overall Study|Patient with Atrial Tachycardia|0
5842268|NCT02296190|20193739|P4|Overall Study|Patient with Atrial Tachycardia|1
5842269|NCT02296190|20193740|P3|Overall Study|Patient with Atrial Tachycardia|0
5842270|NCT02296190|20193741|P2|Overall Study|Patient with Atrial Tachycardia|0
5842271|NCT02296190|20193742|P1|Overall Study|Patient with Atrial Tachycardia|0
5842272|NCT02296190|20193737|P6|Overall Study|Patient was given Propofol|0
5842273|NCT02296190|20193738|P5|Overall Study|Patient was given Propofol|0
5842274|NCT02296190|20193739|P4|Overall Study|Patient was given Propofol|1
5842275|NCT02296190|20193740|P3|Overall Study|Patient was given Propofol|0
5842276|NCT02296190|20193741|P2|Overall Study|Patient was given Propofol|1
5842277|NCT02296190|20193742|P1|Overall Study|Patient was given Propofol|0
5842278|NCT02296190|20193737|P6|Overall Study|PSVT < 5 minutes|0
5842279|NCT02296190|20193738|P5|Overall Study|PSVT < 5 minutes|5
5842280|NCT02296190|20193739|P4|Overall Study|PSVT < 5 minutes|6
5842281|NCT02296190|20193740|P3|Overall Study|PSVT < 5 minutes|6
5842282|NCT02296190|20193741|P2|Overall Study|PSVT < 5 minutes|6
5842283|NCT02296190|20193742|P1|Overall Study|PSVT < 5 minutes|5
5842284|NCT02296190|20193737|P6|Overall Study|Withdrawal by Subject|0
5842285|NCT02296190|20193738|P5|Overall Study|Withdrawal by Subject|0
5842286|NCT02296190|20193739|P4|Overall Study|Withdrawal by Subject|0
5842287|NCT02296190|20193740|P3|Overall Study|Withdrawal by Subject|0
5842288|NCT02296190|20193741|P2|Overall Study|Withdrawal by Subject|1
5842289|NCT02296190|20193742|P1|Overall Study|Withdrawal by Subject|0
5842290|NCT02296190|20193737|P6|Overall Study|Physician Decision|0
5842291|NCT02296190|20193738|P5|Overall Study|Physician Decision|2
5842292|NCT02296190|20193739|P4|Overall Study|Physician Decision|1
5842293|NCT02296190|20193740|P3|Overall Study|Physician Decision|0
5842294|NCT02296190|20193741|P2|Overall Study|Physician Decision|1
5842295|NCT02296190|20193742|P1|Overall Study|Physician Decision|1
5842296|NCT02296190|20193737|P6|Overall Study|Failure to induce PSVT|0
5842297|NCT02296190|20193738|P5|Overall Study|Failure to induce PSVT|8
5842298|NCT02296190|20193739|P4|Overall Study|Failure to induce PSVT|13
5842299|NCT02296190|20193740|P3|Overall Study|Failure to induce PSVT|5
5842300|NCT02296190|20193741|P2|Overall Study|Failure to induce PSVT|10
5842301|NCT02296190|20193742|P1|Overall Study|Failure to induce PSVT|6
5842302|NCT02296190|20193737|P6|Overall Study|Lost to Follow-up|0
5842303|NCT02296190|20193738|P5|Overall Study|Lost to Follow-up|1
5842304|NCT02296190|20193739|P4|Overall Study|Lost to Follow-up|0
5842305|NCT02296190|20193740|P3|Overall Study|Lost to Follow-up|0
5842306|NCT02296190|20193741|P2|Overall Study|Lost to Follow-up|0
5842307|NCT02296190|20193742|P1|Overall Study|Lost to Follow-up|0
5842308|NCT02296138|20193761|P2|Overall Study|Other than specified|13
5842309|NCT02296138|20193762|P1|Overall Study|Other than specified|15
5842310|NCT02296138|20193761|P2|Overall Study|Patients with data irregularities|11
5842311|NCT02296138|20193762|P1|Overall Study|Patients with data irregularities|10
5842312|NCT02296138|20193761|P2|Overall Study|Not Treated|1
5842313|NCT02296138|20193762|P1|Overall Study|Not Treated|1
5842314|NCT02296138|20193761|P2|Overall Study|Withdrawal by Subject|131
5842315|NCT02296138|20193762|P1|Overall Study|Withdrawal by Subject|184
5842316|NCT02296138|20193761|P2|Overall Study|Lost to Follow-up|12
5842317|NCT02296138|20193762|P1|Overall Study|Lost to Follow-up|9
5842318|NCT02296138|20193761|P2|Overall Study|Protocol Violation|36
5842319|NCT02296138|20193762|P1|Overall Study|Protocol Violation|35
5842320|NCT02296138|20193761|P2|Overall Study|Lack of Efficacy|37
5842321|NCT02296138|20193762|P1|Overall Study|Lack of Efficacy|59
5842322|NCT02296138|20193761|P2|Overall Study|Adverse Event|259
5842323|NCT02296138|20193762|P1|Overall Study|Adverse Event|348
5842324|NCT02296125|20193778|P4|Overall Study|Any reason not specifically recorded|0
5842325|NCT02296125|20193779|P3|Overall Study|Any reason not specifically recorded|2
5842326|NCT02296125|20193780|P2|Overall Study|Any reason not specifically recorded|4
5842327|NCT02296125|20193781|P1|Overall Study|Any reason not specifically recorded|6
5842328|NCT02296125|20193778|P4|Overall Study|Condition under investigation worsened|56
5842329|NCT02296125|20193779|P3|Overall Study|Condition under investigation worsened|39
5842330|NCT02296125|20193780|P2|Overall Study|Condition under investigation worsened|199
5842331|NCT02296125|20193781|P1|Overall Study|Condition under investigation worsened|153
5842332|NCT02296125|20193778|P4|Overall Study|Severe non-compliance to protocol|0
5842333|NCT02296125|20193779|P3|Overall Study|Severe non-compliance to protocol|0
5842334|NCT02296125|20193780|P2|Overall Study|Severe non-compliance to protocol|1
5842335|NCT02296125|20193781|P1|Overall Study|Severe non-compliance to protocol|0
5842336|NCT02296125|20193778|P4|Overall Study|Adverse Event|4
5842337|NCT02296125|20193779|P3|Overall Study|Adverse Event|9
5842338|NCT02296125|20193780|P2|Overall Study|Adverse Event|52
5842339|NCT02296125|20193781|P1|Overall Study|Adverse Event|41
5842340|NCT02296125|20193778|P4|Overall Study|Withdrawal by Subject|2
5842341|NCT02296125|20193779|P3|Overall Study|Withdrawal by Subject|6
5842342|NCT02296125|20193780|P2|Overall Study|Withdrawal by Subject|8
5842343|NCT02296125|20193781|P1|Overall Study|Withdrawal by Subject|18
5842344|NCT02296112|20193833|P1|Overall Study|Began an alternate therapy|1
5842345|NCT02296112|20193833|P1|Overall Study|Toxicity|1
5842346|NCT02296112|20193833|P1|Overall Study|Disease progression|7
5842347|NCT02295995|20193875|P2|Overall Study|Lost to Follow-up|1
5842348|NCT02295995|20193876|P1|Overall Study|Lost to Follow-up|5
5842349|NCT02295774|20193887|P1|Overall Study|Withdrawal by Subject|2
5842350|NCT02295774|20193887|P1|Overall Study|Physician Decision|1
5842351|NCT02295644|20193927|P4|Overall Study|Did not meet inclusion criterion|2
5842352|NCT02295644|20193928|P3|Overall Study|Did not meet inclusion criterion|1
5842353|NCT02295644|20193929|P2|Overall Study|Did not meet inclusion criterion|0
5842354|NCT02295644|20193930|P1|Overall Study|Did not meet inclusion criterion|0
5842355|NCT02295280|20193979|P2|Overall Study|Adverse Event|1
5842356|NCT02295280|20193980|P1|Overall Study|Adverse Event|0
5842357|NCT02295020|20193988|P2|Overall Study|Withdrawal by Subject|2
5842358|NCT02295020|20193989|P1|Overall Study|Withdrawal by Subject|3
5842359|NCT02295020|20193988|P2|Overall Study|Adverse Event|1
5842360|NCT02295020|20193989|P1|Overall Study|Adverse Event|0
5842361|NCT02294981|20194019|P1|Overall Study|Lost to Follow-up|1
5842362|NCT02294786|20194025|P2|Overall Study|Death|3
5842363|NCT02294786|20194026|P1|Overall Study|Death|2
5842364|NCT02294786|20194025|P2|Overall Study|Adverse Event|1
5842365|NCT02294786|20194026|P1|Overall Study|Adverse Event|1
5842366|NCT02294786|20194025|P2|Overall Study|Protocol Violation|0
5842367|NCT02294786|20194026|P1|Overall Study|Protocol Violation|1
5842368|NCT02294786|20194025|P2|Overall Study|Lost to Follow-up|2
5842369|NCT02294786|20194026|P1|Overall Study|Lost to Follow-up|1
5842370|NCT02294786|20194025|P2|Overall Study|Physician Decision|7
5842371|NCT02294786|20194026|P1|Overall Study|Physician Decision|6
5842372|NCT02294786|20194025|P2|Overall Study|Withdrawal by Subject|1
5842373|NCT02294786|20194026|P1|Overall Study|Withdrawal by Subject|0
5842374|NCT02294773|20194073|P2|Overall Study|Withdrawal by Subject|2
5842375|NCT02294773|20194074|P1|Overall Study|Withdrawal by Subject|0
5842376|NCT02294734|20194090|P2|Overall Study|Withdrawal by Subject|2
5842377|NCT02294734|20194091|P1|Overall Study|Withdrawal by Subject|4
5842378|NCT02294734|20194090|P2|Overall Study|Physician Decision|1
5842379|NCT02294734|20194091|P1|Overall Study|Physician Decision|2
5842380|NCT02294734|20194090|P2|Overall Study|Lost to Follow-up|0
5842381|NCT02294734|20194091|P1|Overall Study|Lost to Follow-up|2
5842382|NCT02294734|20194090|P2|Overall Study|Met Protocol Defined Stopping Criteria|0
5842383|NCT02294734|20194091|P1|Overall Study|Met Protocol Defined Stopping Criteria|1
5842384|NCT02294734|20194090|P2|Overall Study|Adverse Event|5
5842385|NCT02294734|20194091|P1|Overall Study|Adverse Event|5
5842386|NCT02294682|20194143|P2|Overall Study|Could not swallow pills|0
5842387|NCT02294682|20194144|P1|Overall Study|Could not swallow pills|1
5842388|NCT02294604|20194187|P3|Overall Study|Culture contamination|0
5842389|NCT02294604|20194188|P2|Overall Study|Culture contamination|2
5842390|NCT02294604|20194189|P1|Overall Study|Culture contamination|1
5842391|NCT02294604|20194187|P3|Overall Study|Did not provide samples for culture|0
5842392|NCT02294604|20194188|P2|Overall Study|Did not provide samples for culture|1
5842393|NCT02294604|20194189|P1|Overall Study|Did not provide samples for culture|0
5842394|NCT02294474|20194208|P2|Overall Study|Other than specified above|12
5842395|NCT02294474|20194209|P1|Overall Study|Other than specified above|12
5842396|NCT02294474|20194208|P2|Overall Study|Protocol Violation|2
5842397|NCT02294474|20194209|P1|Overall Study|Protocol Violation|4
5842398|NCT02294474|20194208|P2|Overall Study|Lack of Efficacy|1
5842399|NCT02294474|20194209|P1|Overall Study|Lack of Efficacy|2
5842400|NCT02294474|20194208|P2|Overall Study|Adverse Event|7
5842401|NCT02294474|20194209|P1|Overall Study|Adverse Event|7
5842402|NCT02294461|20194233|P2|Overall Study|Miscellaneous|32
5842403|NCT02294461|20194234|P1|Overall Study|Miscellaneous|11
5842404|NCT02294461|20194233|P2|Overall Study|Adverse Event|10
5842405|NCT02294461|20194234|P1|Overall Study|Adverse Event|11
5842406|NCT02294461|20194233|P2|Overall Study|Disease Progression|39
5842407|NCT02294461|20194234|P1|Overall Study|Disease Progression|23
5842408|NCT02294461|20194233|P2|Overall Study|Withdrawal by Subject|45
5842409|NCT02294461|20194234|P1|Overall Study|Withdrawal by Subject|14
5842410|NCT02294461|20194233|P2|Overall Study|Protocol Violation|2
5842411|NCT02294461|20194234|P1|Overall Study|Protocol Violation|0
5842412|NCT02294461|20194233|P2|Overall Study|Death|3
5842413|NCT02294461|20194234|P1|Overall Study|Death|3
5842414|NCT02294396|20194290|P4|Overall Study|Miscellaneous|2
5842415|NCT02294396|20194291|P3|Overall Study|Miscellaneous|5
5842416|NCT02294396|20194292|P2|Overall Study|Miscellaneous|0
5842417|NCT02294396|20194293|P1|Overall Study|Miscellaneous|2
5842418|NCT02294396|20194290|P4|Overall Study|Protocol Deviation|1
5842419|NCT02294396|20194291|P3|Overall Study|Protocol Deviation|2
5842420|NCT02294396|20194292|P2|Overall Study|Protocol Deviation|2
5842421|NCT02294396|20194293|P1|Overall Study|Protocol Deviation|3
5842422|NCT02294396|20194290|P4|Overall Study|Lost to Follow-up|1
5842423|NCT02294396|20194291|P3|Overall Study|Lost to Follow-up|1
5842424|NCT02294396|20194292|P2|Overall Study|Lost to Follow-up|0
5842425|NCT02294396|20194293|P1|Overall Study|Lost to Follow-up|0
5842426|NCT02294396|20194290|P4|Overall Study|Withdrawal by Subject|8
5842427|NCT02294396|20194291|P3|Overall Study|Withdrawal by Subject|6
5842428|NCT02294396|20194292|P2|Overall Study|Withdrawal by Subject|6
5842429|NCT02294396|20194293|P1|Overall Study|Withdrawal by Subject|8
5842430|NCT02294396|20194290|P4|Overall Study|Electrocardiogram adviser's judgment|1
5842431|NCT02294396|20194291|P3|Overall Study|Electrocardiogram adviser's judgment|0
5842432|NCT02294396|20194292|P2|Overall Study|Electrocardiogram adviser's judgment|0
5842433|NCT02294396|20194293|P1|Overall Study|Electrocardiogram adviser's judgment|1
5842434|NCT02294396|20194290|P4|Overall Study|Adverse Event|24
5842435|NCT02294396|20194291|P3|Overall Study|Adverse Event|21
5842436|NCT02294396|20194292|P2|Overall Study|Adverse Event|25
5842437|NCT02294396|20194293|P1|Overall Study|Adverse Event|26
5842438|NCT02294318|20194365|P2|Overall Study|Not exposed to intervention|2
5842439|NCT02294318|20194366|P1|Overall Study|Not exposed to intervention|0
5842440|NCT02294318|20194365|P2|Overall Study|Worsening of drinking|0
5842441|NCT02294318|20194366|P1|Overall Study|Worsening of drinking|3
5842442|NCT02294227|20194385|P3|Overall Study|Adverse Event|2
5842443|NCT02294227|20194386|P2|Overall Study|Adverse Event|8
5842444|NCT02294227|20194387|P1|Overall Study|Adverse Event|6
5842445|NCT02294227|20194385|P3|Overall Study|Lack of Efficacy|8
5842446|NCT02294227|20194386|P2|Overall Study|Lack of Efficacy|12
5842447|NCT02294227|20194387|P1|Overall Study|Lack of Efficacy|11
5842448|NCT02294227|20194385|P3|Overall Study|Lost to Follow-up|0
5842449|NCT02294227|20194386|P2|Overall Study|Lost to Follow-up|0
5842450|NCT02294227|20194387|P1|Overall Study|Lost to Follow-up|1
5842451|NCT02294227|20194385|P3|Overall Study|Physician Decision|1
5842452|NCT02294227|20194386|P2|Overall Study|Physician Decision|2
5842453|NCT02294227|20194387|P1|Overall Study|Physician Decision|1
5842454|NCT02294227|20194385|P3|Overall Study|Subject/Guardian Decision|7
5842455|NCT02294227|20194386|P2|Overall Study|Subject/Guardian Decision|3
5842456|NCT02294227|20194387|P1|Overall Study|Subject/Guardian Decision|6
5842457|NCT02294227|20194385|P3|Overall Study|Death|1
5842458|NCT02294227|20194386|P2|Overall Study|Death|0
5842459|NCT02294227|20194387|P1|Overall Study|Death|0
5842460|NCT02294175|20194413|P2|Overall Study|wound healed|2
5842461|NCT02294175|20194414|P1|Overall Study|wound healed|0
5842462|NCT02294175|20194413|P2|Overall Study|Lost to Follow-up|1
5842463|NCT02294175|20194414|P1|Overall Study|Lost to Follow-up|0
5842464|NCT02294175|20194413|P2|Overall Study|Protocol Violation|0
5842465|NCT02294175|20194414|P1|Overall Study|Protocol Violation|1
5842466|NCT02294175|20194413|P2|Overall Study|pt taking excluded medication|1
5842467|NCT02294175|20194414|P1|Overall Study|pt taking excluded medication|3
5842468|NCT02294175|20194413|P2|Overall Study|Withdrawal by Subject|2
5842469|NCT02294175|20194414|P1|Overall Study|Withdrawal by Subject|1
5842470|NCT02294058|20194441|P3|Overall Study|Miscellaneous|1
5842471|NCT02294058|20194442|P2|Overall Study|Miscellaneous|1
5842472|NCT02294058|20194443|P1|Overall Study|Miscellaneous|4
5842473|NCT02294058|20194441|P3|Overall Study|Physician Decision|0
5842474|NCT02294058|20194442|P2|Overall Study|Physician Decision|1
5842475|NCT02294058|20194443|P1|Overall Study|Physician Decision|2
5842476|NCT02294058|20194441|P3|Overall Study|Withdrawal by Subject|13
5842477|NCT02294058|20194442|P2|Overall Study|Withdrawal by Subject|14
5842478|NCT02294058|20194443|P1|Overall Study|Withdrawal by Subject|10
5842479|NCT02294058|20194441|P3|Overall Study|Lost to Follow-up|2
5842480|NCT02294058|20194442|P2|Overall Study|Lost to Follow-up|0
5842481|NCT02294058|20194443|P1|Overall Study|Lost to Follow-up|1
5842482|NCT02294058|20194441|P3|Overall Study|Lack of Efficacy|0
5842483|NCT02294058|20194442|P2|Overall Study|Lack of Efficacy|3
5842484|NCT02294058|20194443|P1|Overall Study|Lack of Efficacy|3
5842485|NCT02294058|20194441|P3|Overall Study|Adverse Event|13
5842486|NCT02294058|20194442|P2|Overall Study|Adverse Event|7
5842487|NCT02294058|20194443|P1|Overall Study|Adverse Event|16
5842488|NCT02294019|20194481|P1|Overall Study|Withdrawal by Subject|1
5842489|NCT02294019|20194481|P1|Overall Study|Other|1
5842490|NCT02294019|20194481|P1|Overall Study|Lost to Follow-up|31
5842491|NCT02294019|20194481|P1|Overall Study|Protocol Violation|68
5842492|NCT02294019|20194481|P1|Overall Study|Adverse Event|2
5842493|NCT02293902|20194489|P5|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0
5842494|NCT02293902|20194490|P4|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0
5842495|NCT02293902|20194491|P3|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1
5842496|NCT02293902|20194492|P2|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1
5842497|NCT02293902|20194493|P1|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0
5842498|NCT02293902|20194489|P5|Single-Blind Period (Week 25 to Week 52)|Adverse Event|6
5842499|NCT02293902|20194490|P4|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1
5842500|NCT02293902|20194491|P3|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1
5842501|NCT02293902|20194492|P2|Single-Blind Period (Week 25 to Week 52)|Adverse Event|7
5842502|NCT02293902|20194493|P1|Single-Blind Period (Week 25 to Week 52)|Adverse Event|0
5842503|NCT02293902|20194489|P5|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0
5842504|NCT02293902|20194490|P4|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0
5842505|NCT02293902|20194491|P3|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0
5842506|NCT02293902|20194492|P2|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0
5842507|NCT02293902|20194493|P1|Double-Blind Period (Up to Week 24)|Randomized but not Treated|1
5842508|NCT02293902|20194489|P5|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0
5842509|NCT02293902|20194490|P4|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0
5842510|NCT02293902|20194491|P3|Double-Blind Period (Up to Week 24)|Lack of Efficacy|2
5842511|NCT02293902|20194492|P2|Double-Blind Period (Up to Week 24)|Lack of Efficacy|1
5842512|NCT02293902|20194493|P1|Double-Blind Period (Up to Week 24)|Lack of Efficacy|5
5842513|NCT02293902|20194489|P5|Double-Blind Period (Up to Week 24)|Adverse Event|0
5842514|NCT02293902|20194490|P4|Double-Blind Period (Up to Week 24)|Adverse Event|0
5842515|NCT02293902|20194491|P3|Double-Blind Period (Up to Week 24)|Adverse Event|8
5842516|NCT02293902|20194492|P2|Double-Blind Period (Up to Week 24)|Adverse Event|6
5842517|NCT02293902|20194493|P1|Double-Blind Period (Up to Week 24)|Adverse Event|5
5842518|NCT02293863|20194555|P3|Overall Study|Reason Not Specified|2
5842519|NCT02293863|20194556|P2|Overall Study|Reason Not Specified|2
5842520|NCT02293863|20194557|P1|Overall Study|Reason Not Specified|0
5842521|NCT02293863|20194555|P3|Overall Study|Withdrawal by Subject|1
5842522|NCT02293863|20194556|P2|Overall Study|Withdrawal by Subject|3
5842523|NCT02293863|20194557|P1|Overall Study|Withdrawal by Subject|3
5842524|NCT02293863|20194555|P3|Overall Study|Lost to Follow-up|2
5842525|NCT02293863|20194556|P2|Overall Study|Lost to Follow-up|2
5842526|NCT02293863|20194557|P1|Overall Study|Lost to Follow-up|2
5842527|NCT02293863|20194555|P3|Overall Study|Death|4
5842528|NCT02293863|20194556|P2|Overall Study|Death|6
5842529|NCT02293863|20194557|P1|Overall Study|Death|4
5842530|NCT02293538|20194626|P2|Overall Study|Withdrawal by Subject|1
5842531|NCT02293538|20194627|P1|Overall Study|Withdrawal by Subject|0
5842532|NCT02293538|20194626|P2|Overall Study|Lost to Follow-up|0
5842533|NCT02293538|20194627|P1|Overall Study|Lost to Follow-up|1
5842534|NCT02293538|20194626|P2|Overall Study|Adverse Event|1
5842535|NCT02293538|20194627|P1|Overall Study|Adverse Event|0
5842536|NCT02293460|20194657|P1|Overall Study|Withdrawal by Subject|1
5842537|NCT02293460|20194657|P1|Overall Study|Adverse Event|2
5842538|NCT02293460|20194657|P1|Overall Study|Lack of Efficacy|2
5842539|NCT02293460|20194657|P1|Overall Study|Protocol Violation|1
5842540|NCT02293395|20194663|P2|Overall Study|Withdrawal by Subject|7
5842541|NCT02293395|20194664|P1|Overall Study|Withdrawal by Subject|8
5842542|NCT02293395|20194663|P2|Overall Study|Lost to Follow-up|0
5842543|NCT02293395|20194664|P1|Overall Study|Lost to Follow-up|1
5842544|NCT02292927|20194677|P2|Overall Study|Protocol Violation|7
5842545|NCT02292927|20194678|P1|Overall Study|Protocol Violation|13
5842546|NCT02292849|20194695|P3|Overall Study|Physician Decision|0
5842547|NCT02292849|20194696|P2|Overall Study|Physician Decision|0
5842548|NCT02292849|20194697|P1|Overall Study|Physician Decision|4
5842549|NCT02292849|20194695|P3|Overall Study|Lost to Follow-up|2
5842550|NCT02292849|20194696|P2|Overall Study|Lost to Follow-up|2
5842551|NCT02292849|20194697|P1|Overall Study|Lost to Follow-up|0
5842552|NCT02292784|20194708|P3|Overall Study|Withdrawal by Subject|3
5842553|NCT02292784|20194709|P2|Overall Study|Withdrawal by Subject|3
5842554|NCT02292784|20194710|P1|Overall Study|Withdrawal by Subject|0
5842555|NCT02292784|20194708|P3|Overall Study|Lost to Follow-up|18
5842556|NCT02292784|20194709|P2|Overall Study|Lost to Follow-up|17
5842557|NCT02292784|20194710|P1|Overall Study|Lost to Follow-up|1
5842558|NCT02292771|20194777|P2|Overall Study|Lost to Follow-up|1
5842559|NCT02292771|20194778|P1|Overall Study|Lost to Follow-up|2
5842560|NCT02292771|20194777|P2|Overall Study|Withdrawal by Subject|1
5842561|NCT02292771|20194778|P1|Overall Study|Withdrawal by Subject|2
5842562|NCT02292719|20194901|P6|Overall Study|Subject enrolled in new study.|0
5842563|NCT02292719|20194902|P5|Overall Study|Subject enrolled in new study.|0
5842564|NCT02292719|20194903|P4|Overall Study|Subject enrolled in new study.|0
5842565|NCT02292719|20194904|P3|Overall Study|Subject enrolled in new study.|1
5842566|NCT02292719|20194905|P2|Overall Study|Subject enrolled in new study.|0
5842567|NCT02292719|20194906|P1|Overall Study|Subject enrolled in new study.|0
5842568|NCT02292719|20194901|P6|Overall Study|Withdrawal by Subject|0
5842569|NCT02292719|20194902|P5|Overall Study|Withdrawal by Subject|1
5842570|NCT02292719|20194903|P4|Overall Study|Withdrawal by Subject|1
5842571|NCT02292719|20194904|P3|Overall Study|Withdrawal by Subject|0
5842572|NCT02292719|20194905|P2|Overall Study|Withdrawal by Subject|0
5842573|NCT02292719|20194906|P1|Overall Study|Withdrawal by Subject|0
5842574|NCT02292446|20194969|P1|Overall Study|Withdrawal by Subject|3
5842575|NCT02292446|20194969|P1|Overall Study|Subject/guardian decision|2
5842576|NCT02292446|20194969|P1|Overall Study|Disease progression|2
5842577|NCT02292446|20194969|P1|Overall Study|Death|1
5842578|NCT02292446|20194969|P1|Overall Study|Adverse Event|12
5842579|NCT02292212|20195058|P1|ViE Phase|Protocol Violation|2
5842580|NCT02292212|20195058|P1|ViE Phase|Withdrawal by Subject|1
5842581|NCT02291913|20195127|P1|Overall Study|Protocol Violation|1
5842582|NCT02291913|20195127|P1|Overall Study|Withdrawal by Subject|1
5842583|NCT02291913|20195127|P1|Overall Study|Physician Decision|1
5842584|NCT02291913|20195127|P1|Overall Study|Death|2
5842585|NCT02291913|20195127|P1|Overall Study|Adverse Event|11
5842586|NCT02291913|20195127|P1|Overall Study|Progressive Disease|32
5842587|NCT02291861|20195140|P4|Overall Study|Other|1
5842588|NCT02291861|20195141|P3|Overall Study|Other|0
5842589|NCT02291861|20195142|P2|Overall Study|Other|0
5842590|NCT02291861|20195143|P1|Overall Study|Other|0
5842591|NCT02291861|20195140|P4|Overall Study|Lost to Follow-up|0
5842592|NCT02291861|20195141|P3|Overall Study|Lost to Follow-up|4
5842593|NCT02291861|20195142|P2|Overall Study|Lost to Follow-up|1
5842594|NCT02291861|20195143|P1|Overall Study|Lost to Follow-up|2
5842595|NCT02291861|20195140|P4|Overall Study|Noncompliance|1
5842596|NCT02291861|20195141|P3|Overall Study|Noncompliance|2
5842597|NCT02291861|20195142|P2|Overall Study|Noncompliance|1
5842598|NCT02291861|20195143|P1|Overall Study|Noncompliance|1
5842599|NCT02291861|20195140|P4|Overall Study|Withdrawal by Subject|4
5842600|NCT02291861|20195141|P3|Overall Study|Withdrawal by Subject|1
5842601|NCT02291861|20195142|P2|Overall Study|Withdrawal by Subject|2
5842602|NCT02291861|20195143|P1|Overall Study|Withdrawal by Subject|1
5842603|NCT02291861|20195140|P4|Overall Study|Protocol Violation|1
5842604|NCT02291861|20195141|P3|Overall Study|Protocol Violation|0
5842605|NCT02291861|20195142|P2|Overall Study|Protocol Violation|0
5842606|NCT02291861|20195143|P1|Overall Study|Protocol Violation|1
5842607|NCT02291861|20195140|P4|Overall Study|Death|1
5842608|NCT02291861|20195141|P3|Overall Study|Death|1
5842609|NCT02291861|20195142|P2|Overall Study|Death|0
5842610|NCT02291861|20195143|P1|Overall Study|Death|0
5842611|NCT02291861|20195140|P4|Overall Study|Adverse Event|2
5842612|NCT02291861|20195141|P3|Overall Study|Adverse Event|1
5842613|NCT02291861|20195142|P2|Overall Study|Adverse Event|4
5842614|NCT02291861|20195143|P1|Overall Study|Adverse Event|2
5842615|NCT02291679|20195206|P3|Overall Study|Other|2
5842616|NCT02291679|20195207|P2|Overall Study|Other|4
5842617|NCT02291679|20195208|P1|Overall Study|Other|2
5842618|NCT02291679|20195206|P3|Overall Study|Insufficient Therapeutic Response|7
5842619|NCT02291679|20195207|P2|Overall Study|Insufficient Therapeutic Response|5
5842620|NCT02291679|20195208|P1|Overall Study|Insufficient Therapeutic Response|5
5842621|NCT02291679|20195206|P3|Overall Study|Lost to Follow-up|9
5842622|NCT02291679|20195207|P2|Overall Study|Lost to Follow-up|10
5842623|NCT02291679|20195208|P1|Overall Study|Lost to Follow-up|12
5842624|NCT02291679|20195206|P3|Overall Study|Withdrew Consent|15
5842625|NCT02291679|20195207|P2|Overall Study|Withdrew Consent|10
5842626|NCT02291679|20195208|P1|Overall Study|Withdrew Consent|18
5842627|NCT02291679|20195206|P3|Overall Study|Protocol Violation|7
5842628|NCT02291679|20195207|P2|Overall Study|Protocol Violation|1
5842629|NCT02291679|20195208|P1|Overall Study|Protocol Violation|5
5842630|NCT02291679|20195206|P3|Overall Study|Adverse Event|19
5842631|NCT02291679|20195207|P2|Overall Study|Adverse Event|12
5842632|NCT02291679|20195208|P1|Overall Study|Adverse Event|2
5842633|NCT02291549|20195239|P2|Overall Study|Withdrawal by Subject|1
5842634|NCT02291549|20195240|P1|Overall Study|Withdrawal by Subject|0
5842635|NCT02291549|20195239|P2|Overall Study|Lost to Follow-up|0
5842636|NCT02291549|20195240|P1|Overall Study|Lost to Follow-up|1
5842637|NCT02291510|20195262|P4|Overall Study|Adverse Event|1
5842638|NCT02291510|20195263|P3|Overall Study|Adverse Event|0
5842639|NCT02291510|20195264|P2|Overall Study|Adverse Event|0
5842640|NCT02291510|20195265|P1|Overall Study|Adverse Event|0
5842641|NCT02291419|20195281|P2|Overall Study|Early study termination|5
5842642|NCT02291419|20195282|P1|Overall Study|Early study termination|1
5842763|NCT02291237|20195394|P2|Overall Study|Subject Required Prohibited Medication|0
5842764|NCT02291237|20195395|P1|Overall Study|Subject Required Prohibited Medication|2
5842765|NCT02291237|20195394|P2|Overall Study|Lost to Follow-up|2
5842766|NCT02291237|20195395|P1|Overall Study|Lost to Follow-up|0
5842767|NCT02291237|20195394|P2|Overall Study|Withdrew Consent|11
5842768|NCT02291237|20195395|P1|Overall Study|Withdrew Consent|11
5842769|NCT02291237|20195394|P2|Overall Study|Investigator's Discretion|3
5842770|NCT02291237|20195395|P1|Overall Study|Investigator's Discretion|0
5842771|NCT02291237|20195394|P2|Overall Study|Adverse Event|3
5842772|NCT02291237|20195395|P1|Overall Study|Adverse Event|1
5842773|NCT02291237|20195394|P2|Overall Study|Study Terminated by Sponsor|67
5842774|NCT02291237|20195395|P1|Overall Study|Study Terminated by Sponsor|72
5842775|NCT02291029|20195417|P6|Overall Study|Adverse Event|0
5842776|NCT02291029|20195418|P5|Overall Study|Adverse Event|0
5842777|NCT02291029|20195419|P4|Overall Study|Adverse Event|0
5842778|NCT02291029|20195420|P3|Overall Study|Adverse Event|0
5842779|NCT02291029|20195421|P2|Overall Study|Adverse Event|1
5842780|NCT02291029|20195422|P1|Overall Study|Adverse Event|0
5842781|NCT02291029|20195417|P6|Overall Study|Withdrawal by Subject|0
5842782|NCT02291029|20195418|P5|Overall Study|Withdrawal by Subject|0
5842783|NCT02291029|20195419|P4|Overall Study|Withdrawal by Subject|0
5842784|NCT02291029|20195420|P3|Overall Study|Withdrawal by Subject|1
5842785|NCT02291029|20195421|P2|Overall Study|Withdrawal by Subject|0
5842786|NCT02291029|20195422|P1|Overall Study|Withdrawal by Subject|0
5842787|NCT02290925|20195493|P2|Second Period of 3 Months|insulin started|1
5842788|NCT02290925|20195494|P1|Second Period of 3 Months|insulin started|0
5842789|NCT02290925|20195493|P2|Second Period of 3 Months|Lost to Follow-up|3
5842790|NCT02290925|20195494|P1|Second Period of 3 Months|Lost to Follow-up|1
5842791|NCT02290925|20195493|P2|First Period of Three Months|Insulin Started|1
5842792|NCT02290925|20195494|P1|First Period of Three Months|Insulin Started|1
5842793|NCT02290925|20195493|P2|First Period of Three Months|Death|0
5842794|NCT02290925|20195494|P1|First Period of Three Months|Death|1
5842795|NCT02290925|20195493|P2|First Period of Three Months|Lost to Follow-up|1
5842796|NCT02290925|20195494|P1|First Period of Three Months|Lost to Follow-up|2
5842797|NCT02290873|20195509|P3|Overall Study|Protocol Violation|1
5842798|NCT02290873|20195510|P2|Overall Study|Protocol Violation|0
5842799|NCT02290873|20195511|P1|Overall Study|Protocol Violation|0
5842800|NCT02290873|20195509|P3|Overall Study|Esophagogastroduodenoscopy was added|0
5842801|NCT02290873|20195510|P2|Overall Study|Esophagogastroduodenoscopy was added|0
5842802|NCT02290873|20195511|P1|Overall Study|Esophagogastroduodenoscopy was added|1
5842803|NCT02290873|20195509|P3|Overall Study|Nellcor device error|0
5842804|NCT02290873|20195510|P2|Overall Study|Nellcor device error|0
5842805|NCT02290873|20195511|P1|Overall Study|Nellcor device error|1
5842806|NCT02290873|20195509|P3|Overall Study|Withdrawal by Subject|1
5842807|NCT02290873|20195510|P2|Overall Study|Withdrawal by Subject|1
5842808|NCT02290873|20195511|P1|Overall Study|Withdrawal by Subject|0
5842809|NCT02290821|20195530|P2|Overall Study|Lost to Follow-up|2
5842810|NCT02290821|20195531|P1|Overall Study|Lost to Follow-up|3
5842811|NCT02290821|20195530|P2|Overall Study|Unable or unwilling to cooperate with|0
5842812|NCT02290821|20195531|P1|Overall Study|Unable or unwilling to cooperate with|2
5842813|NCT02290821|20195530|P2|Overall Study|Withdrawal by Subject|1
5842814|NCT02290821|20195531|P1|Overall Study|Withdrawal by Subject|1
5842815|NCT02290691|20195539|P2|Overall Study|Lost to Follow-up|7
5842816|NCT02290691|20195540|P1|Overall Study|Lost to Follow-up|7
5842817|NCT02290691|20195539|P2|Overall Study|Withdrawal by Subject|1
5842818|NCT02290691|20195540|P1|Overall Study|Withdrawal by Subject|1
5842819|NCT02290691|20195539|P2|Overall Study|Noncompliance|1
5842820|NCT02290691|20195540|P1|Overall Study|Noncompliance|0
5842821|NCT02290431|20195653|P1|Overall Study|Physician Decision|2
5842822|NCT02290431|20195653|P1|Overall Study|Study terminated by Sponsor|1
5842823|NCT02290431|20195653|P1|Overall Study|Progressive disease|4
5842824|NCT02290431|20195653|P1|Overall Study|Adverse Event|20
5842825|NCT02290340|20195676|P4|Overall Study|Other|1
5842826|NCT02290340|20195677|P3|Overall Study|Other|0
5842827|NCT02290340|20195678|P2|Overall Study|Other|0
5842828|NCT02290340|20195679|P1|Overall Study|Other|1
5842829|NCT02290340|20195676|P4|Overall Study|Withdrawal by Subject|0
5842830|NCT02290340|20195677|P3|Overall Study|Withdrawal by Subject|0
5842831|NCT02290340|20195678|P2|Overall Study|Withdrawal by Subject|0
5842832|NCT02290340|20195679|P1|Overall Study|Withdrawal by Subject|1
5842833|NCT02290340|20195676|P4|Overall Study|Lost to Follow-up|1
5842834|NCT02290340|20195677|P3|Overall Study|Lost to Follow-up|0
5842835|NCT02290340|20195678|P2|Overall Study|Lost to Follow-up|0
5842836|NCT02290340|20195679|P1|Overall Study|Lost to Follow-up|0
5842837|NCT02290223|20195724|P2|12 Months|Refusal|1
5842838|NCT02290223|20195725|P1|12 Months|Refusal|0
5842839|NCT02290223|20195724|P2|12 Months|Lost to Follow-up|10
5842840|NCT02290223|20195725|P1|12 Months|Lost to Follow-up|16
5842841|NCT02290223|20195724|P2|6 Months|deceased (not related to study)|0
5842842|NCT02290223|20195725|P1|6 Months|deceased (not related to study)|2
5842843|NCT02290223|20195724|P2|6 Months|Withdrawal by Subject|0
5842844|NCT02290223|20195725|P1|6 Months|Withdrawal by Subject|5
5842845|NCT02290223|20195724|P2|6 Months|Lost to Follow-up|6
5842846|NCT02290223|20195725|P1|6 Months|Lost to Follow-up|9
5842847|NCT02289963|20195840|P2|Overall Study|Other than specified above|2
5842848|NCT02289963|20195841|P1|Overall Study|Other than specified above|0
5842849|NCT02289963|20195840|P2|Overall Study|End treatment visit outside visit window|4
5842850|NCT02289963|20195841|P1|Overall Study|End treatment visit outside visit window|0
5842851|NCT02289963|20195840|P2|Overall Study|Last injection missed|2
5842852|NCT02289963|20195841|P1|Overall Study|Last injection missed|2
5842853|NCT02289963|20195840|P2|Overall Study|Withdrawal by Subject|0
5842854|NCT02289963|20195841|P1|Overall Study|Withdrawal by Subject|1
5842855|NCT02289963|20195840|P2|Overall Study|Poor compliance to protocol|0
5842856|NCT02289963|20195841|P1|Overall Study|Poor compliance to protocol|1
5842857|NCT02289963|20195840|P2|Overall Study|Adverse Event|2
5842858|NCT02289963|20195841|P1|Overall Study|Adverse Event|1
5842859|NCT02289898|20195892|P3|Overall Study|Other|10
5842860|NCT02289898|20195893|P2|Overall Study|Other|7
5842861|NCT02289898|20195894|P1|Overall Study|Other|8
5842862|NCT02289898|20195892|P3|Overall Study|Use of another anticancer therapy|1
5842863|NCT02289898|20195893|P2|Overall Study|Use of another anticancer therapy|0
5842864|NCT02289898|20195894|P1|Overall Study|Use of another anticancer therapy|0
5842865|NCT02289898|20195892|P3|Overall Study|Disease progression|34
5842866|NCT02289898|20195893|P2|Overall Study|Disease progression|28
5842867|NCT02289898|20195894|P1|Overall Study|Disease progression|34
5842868|NCT02289898|20195892|P3|Overall Study|Adverse Event|5
5842869|NCT02289898|20195893|P2|Overall Study|Adverse Event|5
5842870|NCT02289898|20195894|P1|Overall Study|Adverse Event|3
5842871|NCT02289898|20195892|P3|Overall Study|Withdrawal by Subject|1
5842872|NCT02289898|20195893|P2|Overall Study|Withdrawal by Subject|4
5842873|NCT02289898|20195894|P1|Overall Study|Withdrawal by Subject|0
5842874|NCT02289898|20195892|P3|Overall Study|Physician Decision|2
5842875|NCT02289898|20195893|P2|Overall Study|Physician Decision|5
5842876|NCT02289898|20195894|P1|Overall Study|Physician Decision|2
5842877|NCT02289898|20195892|P3|Overall Study|Death|3
5842878|NCT02289898|20195893|P2|Overall Study|Death|4
5842879|NCT02289898|20195894|P1|Overall Study|Death|5
5842880|NCT02289833|20195903|P2|Overall Study|Death|16
5842881|NCT02289833|20195904|P1|Overall Study|Death|23
5842882|NCT02289833|20195903|P2|Overall Study|Lost to Follow-up|0
5842883|NCT02289833|20195904|P1|Overall Study|Lost to Follow-up|4
5842884|NCT02289833|20195903|P2|Overall Study|Study discontinuation|1
5842885|NCT02289833|20195904|P1|Overall Study|Study discontinuation|0
5842886|NCT02289820|20195940|P7|Overall Study|withdrawal of consent|0
5842887|NCT02289820|20195941|P6|Overall Study|withdrawal of consent|0
5842888|NCT02289820|20195942|P5|Overall Study|withdrawal of consent|0
5842889|NCT02289820|20195943|P4|Overall Study|withdrawal of consent|0
5842890|NCT02289820|20195944|P3|Overall Study|withdrawal of consent|0
5842891|NCT02289820|20195945|P2|Overall Study|withdrawal of consent|1
5842892|NCT02289820|20195946|P1|Overall Study|withdrawal of consent|0
5842893|NCT02289820|20195940|P7|Overall Study|Lost to Follow-up|1
5842894|NCT02289820|20195941|P6|Overall Study|Lost to Follow-up|1
5842895|NCT02289820|20195942|P5|Overall Study|Lost to Follow-up|0
5842896|NCT02289820|20195943|P4|Overall Study|Lost to Follow-up|1
5842897|NCT02289820|20195944|P3|Overall Study|Lost to Follow-up|3
5842898|NCT02289820|20195945|P2|Overall Study|Lost to Follow-up|0
5842899|NCT02289820|20195946|P1|Overall Study|Lost to Follow-up|0
5842900|NCT02289820|20195940|P7|Overall Study|Death|0
5842901|NCT02289820|20195941|P6|Overall Study|Death|0
5842902|NCT02289820|20195942|P5|Overall Study|Death|0
5842903|NCT02289820|20195943|P4|Overall Study|Death|0
5842904|NCT02289820|20195944|P3|Overall Study|Death|1
5842905|NCT02289820|20195945|P2|Overall Study|Death|0
5842906|NCT02289820|20195946|P1|Overall Study|Death|0
5842907|NCT02289820|20195940|P7|Overall Study|Withdrawal by Subject|1
5842908|NCT02289820|20195941|P6|Overall Study|Withdrawal by Subject|0
5842909|NCT02289820|20195942|P5|Overall Study|Withdrawal by Subject|0
5842910|NCT02289820|20195943|P4|Overall Study|Withdrawal by Subject|1
5842911|NCT02289820|20195944|P3|Overall Study|Withdrawal by Subject|2
5842912|NCT02289820|20195945|P2|Overall Study|Withdrawal by Subject|1
5842913|NCT02289820|20195946|P1|Overall Study|Withdrawal by Subject|2
5842914|NCT02289742|20196064|P4|Third Wear Period|Reason not given|1
5842915|NCT02289742|20196065|P3|Third Wear Period|Reason not given|0
5842916|NCT02289742|20196066|P2|Third Wear Period|Reason not given|0
5842917|NCT02289742|20196067|P1|Third Wear Period|Reason not given|0
5842918|NCT02289742|20196064|P4|Third Wear Period|Adverse Event|0
5842919|NCT02289742|20196065|P3|Third Wear Period|Adverse Event|0
5842920|NCT02289742|20196066|P2|Third Wear Period|Adverse Event|1
5842921|NCT02289742|20196067|P1|Third Wear Period|Adverse Event|0
5842922|NCT02289742|20196064|P4|First Wear Period|Other prior to treatment|1
5842923|NCT02289742|20196065|P3|First Wear Period|Other prior to treatment|0
5842924|NCT02289742|20196066|P2|First Wear Period|Other prior to treatment|0
5842925|NCT02289742|20196067|P1|First Wear Period|Other prior to treatment|0
5842926|NCT02289742|20196064|P4|First Wear Period|Adverse Event|0
5842927|NCT02289742|20196065|P3|First Wear Period|Adverse Event|1
5842928|NCT02289742|20196066|P2|First Wear Period|Adverse Event|0
5842929|NCT02289742|20196067|P1|First Wear Period|Adverse Event|0
5842930|NCT02289742|20196064|P4|First Wear Period|Adverse event prior to treatment|0
5842931|NCT02289742|20196065|P3|First Wear Period|Adverse event prior to treatment|0
5842932|NCT02289742|20196066|P2|First Wear Period|Adverse event prior to treatment|1
5842933|NCT02289742|20196067|P1|First Wear Period|Adverse event prior to treatment|0
5842934|NCT02289729|20196084|P1|Overall Study|Death|1
5842935|NCT02289729|20196084|P1|Overall Study|Withdrawal by Subject|1
5842936|NCT02289729|20196084|P1|Overall Study|Very Narrow Therapeutic Margin|1
5842937|NCT02289729|20196084|P1|Overall Study|Lack of Efficacy|3
5842938|NCT02289690|20196148|P10|Overall Study|Other|1
5842939|NCT02289690|20196149|P9|Overall Study|Other|3
5842940|NCT02289690|20196150|P8|Overall Study|Other|2
5842941|NCT02289690|20196151|P7|Overall Study|Other|1
5842942|NCT02289690|20196152|P6|Overall Study|Other|0
5842943|NCT02289690|20196153|P5|Overall Study|Other|1
5842944|NCT02289690|20196154|P4|Overall Study|Other|1
5842945|NCT02289690|20196155|P3|Overall Study|Other|0
5842946|NCT02289690|20196156|P2|Overall Study|Other|0
5842947|NCT02289690|20196157|P1|Overall Study|Other|0
5842948|NCT02289690|20196148|P10|Overall Study|Sponsor Discontinued Study|15
5842949|NCT02289690|20196149|P9|Overall Study|Sponsor Discontinued Study|7
5842950|NCT02289690|20196150|P8|Overall Study|Sponsor Discontinued Study|9
5842951|NCT02289690|20196151|P7|Overall Study|Sponsor Discontinued Study|0
5842952|NCT02289690|20196152|P6|Overall Study|Sponsor Discontinued Study|0
5842953|NCT02289690|20196153|P5|Overall Study|Sponsor Discontinued Study|0
5842954|NCT02289690|20196154|P4|Overall Study|Sponsor Discontinued Study|0
5842955|NCT02289690|20196155|P3|Overall Study|Sponsor Discontinued Study|0
5842956|NCT02289690|20196156|P2|Overall Study|Sponsor Discontinued Study|0
5842957|NCT02289690|20196157|P1|Overall Study|Sponsor Discontinued Study|0
5842958|NCT02289690|20196148|P10|Overall Study|Death|41
5842959|NCT02289690|20196149|P9|Overall Study|Death|45
5842960|NCT02289690|20196150|P8|Overall Study|Death|49
5842961|NCT02289690|20196151|P7|Overall Study|Death|0
5842962|NCT02289690|20196152|P6|Overall Study|Death|0
5842963|NCT02289690|20196153|P5|Overall Study|Death|0
5842964|NCT02289690|20196154|P4|Overall Study|Death|0
5842965|NCT02289690|20196155|P3|Overall Study|Death|0
5842966|NCT02289690|20196156|P2|Overall Study|Death|0
5842967|NCT02289690|20196157|P1|Overall Study|Death|0
5842968|NCT02289690|20196148|P10|Overall Study|Lost to Follow-up|2
5842969|NCT02289690|20196149|P9|Overall Study|Lost to Follow-up|0
5842970|NCT02289690|20196150|P8|Overall Study|Lost to Follow-up|1
5842971|NCT02289690|20196151|P7|Overall Study|Lost to Follow-up|0
5842972|NCT02289690|20196152|P6|Overall Study|Lost to Follow-up|0
5842973|NCT02289690|20196153|P5|Overall Study|Lost to Follow-up|0
5842974|NCT02289690|20196154|P4|Overall Study|Lost to Follow-up|0
5842975|NCT02289690|20196155|P3|Overall Study|Lost to Follow-up|0
5842976|NCT02289690|20196156|P2|Overall Study|Lost to Follow-up|0
5842977|NCT02289690|20196157|P1|Overall Study|Lost to Follow-up|0
5842978|NCT02289690|20196148|P10|Overall Study|Progressive Disease, Per Protocol|0
5842979|NCT02289690|20196149|P9|Overall Study|Progressive Disease, Per Protocol|0
5842980|NCT02289690|20196150|P8|Overall Study|Progressive Disease, Per Protocol|0
5842981|NCT02289690|20196151|P7|Overall Study|Progressive Disease, Per Protocol|2
5842982|NCT02289690|20196152|P6|Overall Study|Progressive Disease, Per Protocol|13
5842983|NCT02289690|20196153|P5|Overall Study|Progressive Disease, Per Protocol|5
5842984|NCT02289690|20196154|P4|Overall Study|Progressive Disease, Per Protocol|2
5842985|NCT02289690|20196155|P3|Overall Study|Progressive Disease, Per Protocol|3
5842986|NCT02289690|20196156|P2|Overall Study|Progressive Disease, Per Protocol|2
5842987|NCT02289690|20196157|P1|Overall Study|Progressive Disease, Per Protocol|3
5842988|NCT02289690|20196148|P10|Overall Study|Withdrawal by Subject|2
5842989|NCT02289690|20196149|P9|Overall Study|Withdrawal by Subject|4
5842990|NCT02289690|20196150|P8|Overall Study|Withdrawal by Subject|0
5842991|NCT02289690|20196151|P7|Overall Study|Withdrawal by Subject|0
5842992|NCT02289690|20196152|P6|Overall Study|Withdrawal by Subject|1
5842993|NCT02289690|20196153|P5|Overall Study|Withdrawal by Subject|1
5842994|NCT02289690|20196154|P4|Overall Study|Withdrawal by Subject|0
5842995|NCT02289690|20196155|P3|Overall Study|Withdrawal by Subject|0
5842996|NCT02289690|20196156|P2|Overall Study|Withdrawal by Subject|0
5842997|NCT02289690|20196157|P1|Overall Study|Withdrawal by Subject|1
5842998|NCT02289690|20196148|P10|Overall Study|Adverse Event Related to Progression|0
5842999|NCT02289690|20196149|P9|Overall Study|Adverse Event Related to Progression|0
5843000|NCT02289690|20196150|P8|Overall Study|Adverse Event Related to Progression|0
5843001|NCT02289690|20196151|P7|Overall Study|Adverse Event Related to Progression|1
5843002|NCT02289690|20196152|P6|Overall Study|Adverse Event Related to Progression|0
5843003|NCT02289690|20196153|P5|Overall Study|Adverse Event Related to Progression|1
5843004|NCT02289690|20196154|P4|Overall Study|Adverse Event Related to Progression|0
5843005|NCT02289690|20196155|P3|Overall Study|Adverse Event Related to Progression|1
5843006|NCT02289690|20196156|P2|Overall Study|Adverse Event Related to Progression|1
5843007|NCT02289690|20196157|P1|Overall Study|Adverse Event Related to Progression|0
5843008|NCT02289469|20196245|P2|Overall Study|Unable to match a control|0
5843009|NCT02289469|20196246|P1|Overall Study|Unable to match a control|6
5843010|NCT02289456|20196254|P1|Monotherapy Period|Miscellaneous|1
5843011|NCT02289456|20196254|P1|Monotherapy Period|Study Terminated by Sponsor|2
5843012|NCT02289456|20196254|P1|Monotherapy Period|Withdrawal by Subject|2
5843013|NCT02289456|20196254|P1|Monotherapy Period|Symptomatic Deterioration|1
5843014|NCT02289456|20196254|P1|Monotherapy Period|Progressive Disease (PD)|8
5843015|NCT02289456|20196254|P1|Monotherapy Period|Adverse Event|1
5843016|NCT02289456|20196254|P1|Monotherapy Period|Death|1
5843017|NCT02289456|20196254|P1|Induction Period|Miscellaneous|1
5843018|NCT02289456|20196254|P1|Induction Period|Withdrawal by Subject|2
5843019|NCT02289456|20196254|P1|Induction Period|Symptomatic Deterioration|4
5843020|NCT02289456|20196254|P1|Induction Period|Progressive Disease (PD)|4
5843021|NCT02289456|20196254|P1|Induction Period|Adverse Event|11
5843022|NCT02289456|20196254|P1|Induction Period|Death|2
5843023|NCT02289417|20196277|P9|Extension Phase Weeks 52-104|Miscellaneous|0
5843024|NCT02289417|20196278|P8|Extension Phase Weeks 52-104|Miscellaneous|1
5843025|NCT02289417|20196279|P7|Extension Phase Weeks 52-104|Miscellaneous|0
5843026|NCT02289417|20196280|P6|Extension Phase Weeks 52-104|Miscellaneous|0
5843027|NCT02289417|20196281|P5|Extension Phase Weeks 52-104|Miscellaneous|0
5843028|NCT02289417|20196282|P4|Extension Phase Weeks 52-104|Miscellaneous|0
5843029|NCT02289417|20196283|P3|Extension Phase Weeks 52-104|Miscellaneous|0
5843030|NCT02289417|20196284|P2|Extension Phase Weeks 52-104|Miscellaneous|0
5843031|NCT02289417|20196285|P1|Extension Phase Weeks 52-104|Miscellaneous|0
5843032|NCT02289417|20196277|P9|Extension Phase Weeks 52-104|Withdrawal by Subject|1
5843033|NCT02289417|20196278|P8|Extension Phase Weeks 52-104|Withdrawal by Subject|2
5843034|NCT02289417|20196279|P7|Extension Phase Weeks 52-104|Withdrawal by Subject|0
5843035|NCT02289417|20196280|P6|Extension Phase Weeks 52-104|Withdrawal by Subject|0
5843036|NCT02289417|20196281|P5|Extension Phase Weeks 52-104|Withdrawal by Subject|0
5843037|NCT02289417|20196282|P4|Extension Phase Weeks 52-104|Withdrawal by Subject|0
5843038|NCT02289417|20196283|P3|Extension Phase Weeks 52-104|Withdrawal by Subject|0
5843039|NCT02289417|20196284|P2|Extension Phase Weeks 52-104|Withdrawal by Subject|0
5843040|NCT02289417|20196285|P1|Extension Phase Weeks 52-104|Withdrawal by Subject|0
5843041|NCT02289417|20196277|P9|Extension Phase Weeks 52-104|Lack of Efficacy|2
5843042|NCT02289417|20196278|P8|Extension Phase Weeks 52-104|Lack of Efficacy|2
5843043|NCT02289417|20196279|P7|Extension Phase Weeks 52-104|Lack of Efficacy|0
5843044|NCT02289417|20196280|P6|Extension Phase Weeks 52-104|Lack of Efficacy|0
5843045|NCT02289417|20196281|P5|Extension Phase Weeks 52-104|Lack of Efficacy|0
5843046|NCT02289417|20196282|P4|Extension Phase Weeks 52-104|Lack of Efficacy|0
5843047|NCT02289417|20196283|P3|Extension Phase Weeks 52-104|Lack of Efficacy|0
5843048|NCT02289417|20196284|P2|Extension Phase Weeks 52-104|Lack of Efficacy|0
5843049|NCT02289417|20196285|P1|Extension Phase Weeks 52-104|Lack of Efficacy|0
5843050|NCT02289417|20196277|P9|Extension Phase Weeks 52-104|Adverse Event|3
5843051|NCT02289417|20196278|P8|Extension Phase Weeks 52-104|Adverse Event|2
5843052|NCT02289417|20196279|P7|Extension Phase Weeks 52-104|Adverse Event|0
5843053|NCT02289417|20196280|P6|Extension Phase Weeks 52-104|Adverse Event|0
5843054|NCT02289417|20196281|P5|Extension Phase Weeks 52-104|Adverse Event|0
5843055|NCT02289417|20196282|P4|Extension Phase Weeks 52-104|Adverse Event|0
5843056|NCT02289417|20196283|P3|Extension Phase Weeks 52-104|Adverse Event|0
5843057|NCT02289417|20196284|P2|Extension Phase Weeks 52-104|Adverse Event|0
5843058|NCT02289417|20196285|P1|Extension Phase Weeks 52-104|Adverse Event|0
5843059|NCT02289417|20196277|P9|Active Treatment Phase Weeks 12-52|Miscellaneous|0
5843060|NCT02289417|20196278|P8|Active Treatment Phase Weeks 12-52|Miscellaneous|0
5843061|NCT02289417|20196279|P7|Active Treatment Phase Weeks 12-52|Miscellaneous|1
5843062|NCT02289417|20196280|P6|Active Treatment Phase Weeks 12-52|Miscellaneous|0
5843063|NCT02289417|20196281|P5|Active Treatment Phase Weeks 12-52|Miscellaneous|0
5843064|NCT02289417|20196282|P4|Active Treatment Phase Weeks 12-52|Miscellaneous|1
5843065|NCT02289417|20196283|P3|Active Treatment Phase Weeks 12-52|Miscellaneous|0
5843066|NCT02289417|20196284|P2|Active Treatment Phase Weeks 12-52|Miscellaneous|0
5843067|NCT02289417|20196285|P1|Active Treatment Phase Weeks 12-52|Miscellaneous|0
5843068|NCT02289417|20196277|P9|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0
5843069|NCT02289417|20196278|P8|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0
5843070|NCT02289417|20196279|P7|Active Treatment Phase Weeks 12-52|Lost to Follow-up|1
5843071|NCT02289417|20196280|P6|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0
5843072|NCT02289417|20196281|P5|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0
5843073|NCT02289417|20196282|P4|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0
5843074|NCT02289417|20196283|P3|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0
5843075|NCT02289417|20196284|P2|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0
5843076|NCT02289417|20196285|P1|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0
5843077|NCT02289417|20196277|P9|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0
5843078|NCT02289417|20196278|P8|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0
5843079|NCT02289417|20196279|P7|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0
5843080|NCT02289417|20196280|P6|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1
5843081|NCT02289417|20196281|P5|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1
5843082|NCT02289417|20196282|P4|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0
5843083|NCT02289417|20196283|P3|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1
5843084|NCT02289417|20196284|P2|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0
5843085|NCT02289417|20196285|P1|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0
5843086|NCT02289417|20196277|P9|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0
5843087|NCT02289417|20196278|P8|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0
5843088|NCT02289417|20196279|P7|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0
5843089|NCT02289417|20196280|P6|Active Treatment Phase Weeks 12-52|Lack of Efficacy|3
5843090|NCT02289417|20196281|P5|Active Treatment Phase Weeks 12-52|Lack of Efficacy|2
5843091|NCT02289417|20196282|P4|Active Treatment Phase Weeks 12-52|Lack of Efficacy|6
5843092|NCT02289417|20196283|P3|Active Treatment Phase Weeks 12-52|Lack of Efficacy|4
5843093|NCT02289417|20196284|P2|Active Treatment Phase Weeks 12-52|Lack of Efficacy|1
5843094|NCT02289417|20196285|P1|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0
5843095|NCT02289417|20196277|P9|Active Treatment Phase Weeks 12-52|Pregnancy|0
5843096|NCT02289417|20196278|P8|Active Treatment Phase Weeks 12-52|Pregnancy|0
5843097|NCT02289417|20196279|P7|Active Treatment Phase Weeks 12-52|Pregnancy|0
5843098|NCT02289417|20196280|P6|Active Treatment Phase Weeks 12-52|Pregnancy|0
5843099|NCT02289417|20196281|P5|Active Treatment Phase Weeks 12-52|Pregnancy|0
5843100|NCT02289417|20196282|P4|Active Treatment Phase Weeks 12-52|Pregnancy|0
5843101|NCT02289417|20196283|P3|Active Treatment Phase Weeks 12-52|Pregnancy|1
5843102|NCT02289417|20196284|P2|Active Treatment Phase Weeks 12-52|Pregnancy|0
5843103|NCT02289417|20196285|P1|Active Treatment Phase Weeks 12-52|Pregnancy|0
5843104|NCT02289417|20196277|P9|Active Treatment Phase Weeks 12-52|Adverse Event|0
5843105|NCT02289417|20196278|P8|Active Treatment Phase Weeks 12-52|Adverse Event|0
5843106|NCT02289417|20196279|P7|Active Treatment Phase Weeks 12-52|Adverse Event|0
5843107|NCT02289417|20196280|P6|Active Treatment Phase Weeks 12-52|Adverse Event|1
5843108|NCT02289417|20196281|P5|Active Treatment Phase Weeks 12-52|Adverse Event|2
5843109|NCT02289417|20196282|P4|Active Treatment Phase Weeks 12-52|Adverse Event|2
5843110|NCT02289417|20196283|P3|Active Treatment Phase Weeks 12-52|Adverse Event|4
5843111|NCT02289417|20196284|P2|Active Treatment Phase Weeks 12-52|Adverse Event|1
5843112|NCT02289417|20196285|P1|Active Treatment Phase Weeks 12-52|Adverse Event|0
5843113|NCT02289417|20196277|P9|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0
5843114|NCT02289417|20196278|P8|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0
5843115|NCT02289417|20196279|P7|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0
5843116|NCT02289417|20196280|P6|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0
5843117|NCT02289417|20196281|P5|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0
5843118|NCT02289417|20196282|P4|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0
5843119|NCT02289417|20196283|P3|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0
5843120|NCT02289417|20196284|P2|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0
5843121|NCT02289417|20196285|P1|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|3
5843122|NCT02289417|20196277|P9|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0
5843123|NCT02289417|20196278|P8|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0
5843124|NCT02289417|20196279|P7|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0
5843125|NCT02289417|20196280|P6|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0
5843126|NCT02289417|20196281|P5|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0
5843127|NCT02289417|20196282|P4|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0
5843128|NCT02289417|20196283|P3|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0
5843129|NCT02289417|20196284|P2|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|1
5843130|NCT02289417|20196285|P1|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0
5843131|NCT02289417|20196277|P9|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0
5843132|NCT02289417|20196278|P8|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0
5843133|NCT02289417|20196279|P7|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0
5843134|NCT02289417|20196280|P6|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0
5843135|NCT02289417|20196281|P5|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0
5843136|NCT02289417|20196282|P4|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0
5843137|NCT02289417|20196283|P3|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|2
5843138|NCT02289417|20196284|P2|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|3
5843139|NCT02289417|20196285|P1|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|1
5843140|NCT02289417|20196277|P9|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0
5843141|NCT02289417|20196278|P8|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0
5843142|NCT02289417|20196279|P7|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0
5843143|NCT02289417|20196280|P6|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0
5843144|NCT02289417|20196281|P5|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0
5843145|NCT02289417|20196282|P4|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0
5843146|NCT02289417|20196283|P3|Placebo-Controlled Phase Weeks 0-12|Adverse Event|1
5843147|NCT02289417|20196284|P2|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0
5843148|NCT02289417|20196285|P1|Placebo-Controlled Phase Weeks 0-12|Adverse Event|3
5843149|NCT02289352|20196334|P3|Overall Study|Withdrawal by Subject|0
5843150|NCT02289352|20196335|P2|Overall Study|Withdrawal by Subject|1
5843151|NCT02289352|20196336|P1|Overall Study|Withdrawal by Subject|1
5843152|NCT02289079|20196403|P2|Overall Study|Lost to Follow-up|1
5843153|NCT02289079|20196404|P1|Overall Study|Lost to Follow-up|0
5843154|NCT02289079|20196403|P2|Overall Study|Physician Decision|0
5843155|NCT02289079|20196404|P1|Overall Study|Physician Decision|2
5843156|NCT02288559|20196433|P4|Overall Study|Reason Not Specified|0
5843157|NCT02288559|20196434|P3|Overall Study|Reason Not Specified|3
5843158|NCT02288559|20196435|P2|Overall Study|Reason Not Specified|0
5843159|NCT02288559|20196436|P1|Overall Study|Reason Not Specified|0
5843160|NCT02288559|20196433|P4|Overall Study|Withdrawal by Subject|1
5843161|NCT02288559|20196434|P3|Overall Study|Withdrawal by Subject|2
5843162|NCT02288559|20196435|P2|Overall Study|Withdrawal by Subject|0
5843163|NCT02288559|20196436|P1|Overall Study|Withdrawal by Subject|0
5843164|NCT02288559|20196433|P4|Overall Study|Lost to Follow-up|1
5843165|NCT02288559|20196434|P3|Overall Study|Lost to Follow-up|0
5843166|NCT02288559|20196435|P2|Overall Study|Lost to Follow-up|0
5843167|NCT02288559|20196436|P1|Overall Study|Lost to Follow-up|0
5843168|NCT02288559|20196433|P4|Overall Study|Death|0
5843169|NCT02288559|20196434|P3|Overall Study|Death|1
5843170|NCT02288559|20196435|P2|Overall Study|Death|0
5843171|NCT02288559|20196436|P1|Overall Study|Death|0
5843172|NCT02288559|20196433|P4|Overall Study|Adverse Event|0
5843173|NCT02288559|20196434|P3|Overall Study|Adverse Event|5
5843174|NCT02288559|20196435|P2|Overall Study|Adverse Event|1
5843175|NCT02288559|20196436|P1|Overall Study|Adverse Event|1
5843176|NCT02288325|20196487|P3|Double-blind Treatment Period|Multiple Reasons|2
5843177|NCT02288325|20196488|P2|Double-blind Treatment Period|Multiple Reasons|8
5843178|NCT02288325|20196489|P1|Double-blind Treatment Period|Multiple Reasons|0
5843179|NCT02288325|20196487|P3|Double-blind Treatment Period|Non-Compliance With Study Drug|4
5843180|NCT02288325|20196488|P2|Double-blind Treatment Period|Non-Compliance With Study Drug|1
5843181|NCT02288325|20196489|P1|Double-blind Treatment Period|Non-Compliance With Study Drug|0
5843182|NCT02288325|20196487|P3|Double-blind Treatment Period|Protocol Violation|2
5843183|NCT02288325|20196488|P2|Double-blind Treatment Period|Protocol Violation|1
5843184|NCT02288325|20196489|P1|Double-blind Treatment Period|Protocol Violation|0
5843185|NCT02288325|20196487|P3|Double-blind Treatment Period|Lost to Follow-up|5
5843186|NCT02288325|20196488|P2|Double-blind Treatment Period|Lost to Follow-up|4
5843187|NCT02288325|20196489|P1|Double-blind Treatment Period|Lost to Follow-up|0
5843188|NCT02288325|20196487|P3|Double-blind Treatment Period|Withdrawal of Consent|8
5843189|NCT02288325|20196488|P2|Double-blind Treatment Period|Withdrawal of Consent|8
5843190|NCT02288325|20196489|P1|Double-blind Treatment Period|Withdrawal of Consent|0
5843191|NCT02288325|20196487|P3|Double-blind Treatment Period|Adverse Event|5
5843192|NCT02288325|20196488|P2|Double-blind Treatment Period|Adverse Event|2
5843193|NCT02288325|20196489|P1|Double-blind Treatment Period|Adverse Event|0
5843194|NCT02288325|20196487|P3|Stabilization Period|Reason not Specified|0
5843195|NCT02288325|20196488|P2|Stabilization Period|Reason not Specified|0
5843196|NCT02288325|20196489|P1|Stabilization Period|Reason not Specified|15
5843197|NCT02288325|20196487|P3|Stabilization Period|Non-Compliance With Study Drug|0
5843198|NCT02288325|20196488|P2|Stabilization Period|Non-Compliance With Study Drug|0
5843199|NCT02288325|20196489|P1|Stabilization Period|Non-Compliance With Study Drug|5
5843200|NCT02288325|20196487|P3|Stabilization Period|Protocol Violation|0
5843201|NCT02288325|20196488|P2|Stabilization Period|Protocol Violation|0
5843202|NCT02288325|20196489|P1|Stabilization Period|Protocol Violation|8
5843203|NCT02288325|20196487|P3|Stabilization Period|Lost to Follow-up|0
5843204|NCT02288325|20196488|P2|Stabilization Period|Lost to Follow-up|0
5843205|NCT02288325|20196489|P1|Stabilization Period|Lost to Follow-up|12
5843206|NCT02288325|20196487|P3|Stabilization Period|Withdrawal of Consent|0
5843207|NCT02288325|20196488|P2|Stabilization Period|Withdrawal of Consent|0
5843208|NCT02288325|20196489|P1|Stabilization Period|Withdrawal of Consent|23
5843209|NCT02288325|20196487|P3|Stabilization Period|Lack of Efficacy|0
5843210|NCT02288325|20196488|P2|Stabilization Period|Lack of Efficacy|0
5843211|NCT02288325|20196489|P1|Stabilization Period|Lack of Efficacy|22
5843212|NCT02288325|20196487|P3|Stabilization Period|Adverse Event|0
5843213|NCT02288325|20196488|P2|Stabilization Period|Adverse Event|0
5843214|NCT02288325|20196489|P1|Stabilization Period|Adverse Event|13
5843215|NCT02288325|20196487|P3|Run-in Period|Reason not Specified|0
5843216|NCT02288325|20196488|P2|Run-in Period|Reason not Specified|0
5843217|NCT02288325|20196489|P1|Run-in Period|Reason not Specified|8
5843218|NCT02288325|20196487|P3|Run-in Period|Non-Compliance With Study Drug|0
5843219|NCT02288325|20196488|P2|Run-in Period|Non-Compliance With Study Drug|0
5843220|NCT02288325|20196489|P1|Run-in Period|Non-Compliance With Study Drug|3
5843221|NCT02288325|20196487|P3|Run-in Period|Protocol Violation|0
5843222|NCT02288325|20196488|P2|Run-in Period|Protocol Violation|0
5843223|NCT02288325|20196489|P1|Run-in Period|Protocol Violation|17
5843224|NCT02288325|20196487|P3|Run-in Period|Lost to Follow-up|0
5843225|NCT02288325|20196488|P2|Run-in Period|Lost to Follow-up|0
5843226|NCT02288325|20196489|P1|Run-in Period|Lost to Follow-up|25
5843227|NCT02288325|20196487|P3|Run-in Period|Withdrawal of Consent|0
5843228|NCT02288325|20196488|P2|Run-in Period|Withdrawal of Consent|0
5843229|NCT02288325|20196489|P1|Run-in Period|Withdrawal of Consent|28
5843230|NCT02288325|20196487|P3|Run-in Period|Lack of Efficacy|0
5843231|NCT02288325|20196488|P2|Run-in Period|Lack of Efficacy|0
5843232|NCT02288325|20196489|P1|Run-in Period|Lack of Efficacy|16
5843233|NCT02288325|20196487|P3|Run-in Period|Adverse Event|0
5843234|NCT02288325|20196488|P2|Run-in Period|Adverse Event|0
5843235|NCT02288325|20196489|P1|Run-in Period|Adverse Event|48
5843236|NCT02288312|20196499|P3|Overall Study|Pregnancy|0
5843237|NCT02288312|20196500|P2|Overall Study|Pregnancy|0
5843238|NCT02288312|20196501|P1|Overall Study|Pregnancy|1
5843239|NCT02288182|20196541|P2|Overall Study|Lost to Follow-up|1
5843240|NCT02288182|20196542|P1|Overall Study|Lost to Follow-up|0
5843241|NCT02288182|20196541|P2|Overall Study|Adverse Event|1
5843242|NCT02288182|20196542|P1|Overall Study|Adverse Event|0
5843243|NCT02288091|20196571|P1|Overall Study|Screen fail|7
5843244|NCT02288091|20196571|P1|Overall Study|Lost to Follow-up|1
5843245|NCT02287922|20196583|P4|Overall Study|Other|0
5843246|NCT02287922|20196584|P3|Overall Study|Other|2
5843247|NCT02287922|20196585|P2|Overall Study|Other|0
5843248|NCT02287922|20196586|P1|Overall Study|Other|1
5843249|NCT02287922|20196583|P4|Overall Study|Sponsor's decision|1
5843250|NCT02287922|20196584|P3|Overall Study|Sponsor's decision|0
5843251|NCT02287922|20196585|P2|Overall Study|Sponsor's decision|0
5843252|NCT02287922|20196586|P1|Overall Study|Sponsor's decision|0
5843253|NCT02287922|20196583|P4|Overall Study|Lost to Follow-up|0
5843254|NCT02287922|20196584|P3|Overall Study|Lost to Follow-up|1
5843255|NCT02287922|20196585|P2|Overall Study|Lost to Follow-up|0
5843256|NCT02287922|20196586|P1|Overall Study|Lost to Follow-up|0
5843257|NCT02287922|20196583|P4|Overall Study|Withdrawal by Subject|2
5843258|NCT02287922|20196584|P3|Overall Study|Withdrawal by Subject|1
5843259|NCT02287922|20196585|P2|Overall Study|Withdrawal by Subject|1
5843260|NCT02287922|20196586|P1|Overall Study|Withdrawal by Subject|1
5843261|NCT02287922|20196583|P4|Overall Study|Adverse Event|4
5843262|NCT02287922|20196584|P3|Overall Study|Adverse Event|3
5843263|NCT02287922|20196585|P2|Overall Study|Adverse Event|1
5843264|NCT02287922|20196586|P1|Overall Study|Adverse Event|1
5843265|NCT02287896|20196694|P2|Second Injection Visit|Withdrawal by Subject|1
5843266|NCT02287896|20196695|P1|Second Injection Visit|Withdrawal by Subject|0
5843267|NCT02287883|20196713|P2|Overall Study|Non-response to survey|237
5843268|NCT02287883|20196714|P1|Overall Study|Non-response to survey|229
5843269|NCT02287883|20196713|P2|Overall Study|No longer eligible|182
5843270|NCT02287883|20196714|P1|Overall Study|No longer eligible|222
5843271|NCT02287883|20196713|P2|Overall Study|Death|7
5843272|NCT02287883|20196714|P1|Overall Study|Death|8
5843273|NCT02287623|20196925|P2|Overall Study|Protocol Violation|1
5843274|NCT02287623|20196926|P1|Overall Study|Protocol Violation|0
5843275|NCT02287610|20196942|P1|Overall Study|Excluded-investigator non-responsiveness|5
5843276|NCT02287610|20196942|P1|Overall Study|Withdrawal by Subject|8
5843277|NCT02287610|20196942|P1|Overall Study|Lost to Follow-up|3
5843278|NCT02287584|20196978|P6|the Open-label Phase|other reasons|6
5843279|NCT02287584|20196979|P5|the Open-label Phase|other reasons|6
5843280|NCT02287584|20196980|P4|the Open-label Phase|other reasons|3
5843281|NCT02287584|20196981|P3|the Open-label Phase|other reasons|0
5843282|NCT02287584|20196982|P2|the Open-label Phase|other reasons|0
5843283|NCT02287584|20196983|P1|the Open-label Phase|other reasons|0
5843284|NCT02287584|20196978|P6|the Open-label Phase|non-compliance|1
5843285|NCT02287584|20196979|P5|the Open-label Phase|non-compliance|5
5843286|NCT02287584|20196980|P4|the Open-label Phase|non-compliance|2
5843287|NCT02287584|20196981|P3|the Open-label Phase|non-compliance|0
5843288|NCT02287584|20196982|P2|the Open-label Phase|non-compliance|0
5843289|NCT02287584|20196983|P1|the Open-label Phase|non-compliance|0
5843290|NCT02287584|20196978|P6|the Open-label Phase|Withdrawal by Subject|21
5843291|NCT02287584|20196979|P5|the Open-label Phase|Withdrawal by Subject|29
5843292|NCT02287584|20196980|P4|the Open-label Phase|Withdrawal by Subject|18
5843293|NCT02287584|20196981|P3|the Open-label Phase|Withdrawal by Subject|0
5843294|NCT02287584|20196982|P2|the Open-label Phase|Withdrawal by Subject|0
5843295|NCT02287584|20196983|P1|the Open-label Phase|Withdrawal by Subject|0
5843296|NCT02287584|20196978|P6|the Open-label Phase|Lost to Follow-up|2
5843297|NCT02287584|20196979|P5|the Open-label Phase|Lost to Follow-up|1
5843298|NCT02287584|20196980|P4|the Open-label Phase|Lost to Follow-up|4
5843299|NCT02287584|20196981|P3|the Open-label Phase|Lost to Follow-up|0
5843300|NCT02287584|20196982|P2|the Open-label Phase|Lost to Follow-up|0
5843301|NCT02287584|20196983|P1|the Open-label Phase|Lost to Follow-up|0
5843302|NCT02287584|20196978|P6|the Open-label Phase|Lack of Efficacy|7
5843303|NCT02287584|20196979|P5|the Open-label Phase|Lack of Efficacy|3
5843304|NCT02287584|20196980|P4|the Open-label Phase|Lack of Efficacy|8
5843305|NCT02287584|20196981|P3|the Open-label Phase|Lack of Efficacy|0
5843306|NCT02287584|20196982|P2|the Open-label Phase|Lack of Efficacy|0
5843307|NCT02287584|20196983|P1|the Open-label Phase|Lack of Efficacy|0
5843308|NCT02287584|20196978|P6|the Open-label Phase|Adverse Event|16
5843309|NCT02287584|20196979|P5|the Open-label Phase|Adverse Event|12
5843310|NCT02287584|20196980|P4|the Open-label Phase|Adverse Event|15
5843311|NCT02287584|20196981|P3|the Open-label Phase|Adverse Event|0
5843312|NCT02287584|20196982|P2|the Open-label Phase|Adverse Event|0
5843313|NCT02287584|20196983|P1|the Open-label Phase|Adverse Event|0
5843314|NCT02287584|20196978|P6|the Open-label Phase|Did not receive drug|4
5843315|NCT02287584|20196979|P5|the Open-label Phase|Did not receive drug|6
5843316|NCT02287584|20196980|P4|the Open-label Phase|Did not receive drug|7
5843317|NCT02287584|20196981|P3|the Open-label Phase|Did not receive drug|0
5843318|NCT02287584|20196982|P2|the Open-label Phase|Did not receive drug|0
5843319|NCT02287584|20196983|P1|the Open-label Phase|Did not receive drug|0
5843320|NCT02287584|20196978|P6|the Double-blind Phase|other reasons|0
5843321|NCT02287584|20196979|P5|the Double-blind Phase|other reasons|0
5843322|NCT02287584|20196980|P4|the Double-blind Phase|other reasons|0
5843323|NCT02287584|20196981|P3|the Double-blind Phase|other reasons|1
5843324|NCT02287584|20196982|P2|the Double-blind Phase|other reasons|0
5843325|NCT02287584|20196983|P1|the Double-blind Phase|other reasons|0
5843326|NCT02287584|20196978|P6|the Double-blind Phase|Protocol Violation|0
5843327|NCT02287584|20196979|P5|the Double-blind Phase|Protocol Violation|0
5843328|NCT02287584|20196980|P4|the Double-blind Phase|Protocol Violation|0
5843329|NCT02287584|20196981|P3|the Double-blind Phase|Protocol Violation|0
5843330|NCT02287584|20196982|P2|the Double-blind Phase|Protocol Violation|3
5843331|NCT02287584|20196983|P1|the Double-blind Phase|Protocol Violation|0
5843332|NCT02287584|20196978|P6|the Double-blind Phase|Pregnancy|0
5843333|NCT02287584|20196979|P5|the Double-blind Phase|Pregnancy|0
5843334|NCT02287584|20196980|P4|the Double-blind Phase|Pregnancy|0
5843335|NCT02287584|20196981|P3|the Double-blind Phase|Pregnancy|0
5843336|NCT02287584|20196982|P2|the Double-blind Phase|Pregnancy|1
5843337|NCT02287584|20196983|P1|the Double-blind Phase|Pregnancy|0
5843338|NCT02287584|20196978|P6|the Double-blind Phase|Withdrawal by Subject|0
5843339|NCT02287584|20196979|P5|the Double-blind Phase|Withdrawal by Subject|0
5843340|NCT02287584|20196980|P4|the Double-blind Phase|Withdrawal by Subject|0
5843341|NCT02287584|20196981|P3|the Double-blind Phase|Withdrawal by Subject|11
5843342|NCT02287584|20196982|P2|the Double-blind Phase|Withdrawal by Subject|17
5843343|NCT02287584|20196983|P1|the Double-blind Phase|Withdrawal by Subject|17
5843344|NCT02287584|20196978|P6|the Double-blind Phase|Lost to Follow-up|0
5843345|NCT02287584|20196979|P5|the Double-blind Phase|Lost to Follow-up|0
5843346|NCT02287584|20196980|P4|the Double-blind Phase|Lost to Follow-up|0
5843347|NCT02287584|20196981|P3|the Double-blind Phase|Lost to Follow-up|1
5843348|NCT02287584|20196982|P2|the Double-blind Phase|Lost to Follow-up|1
5843349|NCT02287584|20196983|P1|the Double-blind Phase|Lost to Follow-up|0
5843350|NCT02287584|20196978|P6|the Double-blind Phase|Lack of Efficacy|0
5843351|NCT02287584|20196979|P5|the Double-blind Phase|Lack of Efficacy|0
5843352|NCT02287584|20196980|P4|the Double-blind Phase|Lack of Efficacy|0
5843353|NCT02287584|20196981|P3|the Double-blind Phase|Lack of Efficacy|8
5843354|NCT02287584|20196982|P2|the Double-blind Phase|Lack of Efficacy|8
5843355|NCT02287584|20196983|P1|the Double-blind Phase|Lack of Efficacy|18
5843356|NCT02287584|20196978|P6|the Double-blind Phase|Adverse Event|0
5843357|NCT02287584|20196979|P5|the Double-blind Phase|Adverse Event|0
5843358|NCT02287584|20196980|P4|the Double-blind Phase|Adverse Event|0
5843359|NCT02287584|20196981|P3|the Double-blind Phase|Adverse Event|12
5843360|NCT02287584|20196982|P2|the Double-blind Phase|Adverse Event|17
5843361|NCT02287584|20196983|P1|the Double-blind Phase|Adverse Event|17
5843362|NCT02287467|20197002|P2|Overall Study|Protocol Violation|9
5843363|NCT02287467|20197003|P1|Overall Study|Protocol Violation|12
5843364|NCT02287402|20197051|P1|Follow-up|Voluntary Withdrawal|2
5843365|NCT02287402|20197051|P1|Follow-up|Lost to Follow-up|1
5843366|NCT02287402|20197051|P1|Treatment Period|Voluntary Withdrawal|10
5843367|NCT02287402|20197051|P1|Treatment Period|Adverse Event|17
5843368|NCT02287038|20197156|P2|Overall Study|Abnormal ECG after starting medication|0
5843369|NCT02287038|20197157|P1|Overall Study|Abnormal ECG after starting medication|1
5843370|NCT02287038|20197156|P2|Overall Study|Nausea after starting medication|0
5843371|NCT02287038|20197157|P1|Overall Study|Nausea after starting medication|1
5843372|NCT02287038|20197156|P2|Overall Study|Anxiety after starting medication|1
5843373|NCT02287038|20197157|P1|Overall Study|Anxiety after starting medication|0
5843374|NCT02287038|20197156|P2|Overall Study|Stopped attending appointments|2
5843375|NCT02287038|20197157|P1|Overall Study|Stopped attending appointments|3
5843376|NCT02287025|20197167|P2|Overall Study|Screening failed|1
5843377|NCT02287025|20197168|P1|Overall Study|Screening failed|1
5843378|NCT02287025|20197167|P2|Overall Study|Withdrawal by Subject|2
5843379|NCT02287025|20197168|P1|Overall Study|Withdrawal by Subject|2
5843380|NCT02287025|20197167|P2|Overall Study|Adverse Event|4
5843381|NCT02287025|20197168|P1|Overall Study|Adverse Event|2
5843382|NCT02287025|20197167|P2|Overall Study|Progression of disease|2
5843383|NCT02287025|20197168|P1|Overall Study|Progression of disease|3
5843384|NCT02287025|20197167|P2|Overall Study|Not treated|0
5843385|NCT02287025|20197168|P1|Overall Study|Not treated|2
5843386|NCT02286960|20197179|P2|Overall Study|Lost to Follow-up|3
5843387|NCT02286960|20197180|P1|Overall Study|Lost to Follow-up|3
5843388|NCT02286947|20197192|P1|Overall Study|Withdrawal by Subject|2
5843389|NCT02286895|20197238|P2|Assessed for Measles Seroconversion|Baseline measure non-negative|32
5843390|NCT02286895|20197239|P1|Assessed for Measles Seroconversion|Baseline measure non-negative|41
5843391|NCT02286895|20197238|P2|Assessed for Measles Seroconversion|Missing measurement|3
5843392|NCT02286895|20197239|P1|Assessed for Measles Seroconversion|Missing measurement|6
5843393|NCT02286895|20197238|P2|Assessed for Measles Seroconversion|Protocol Violation|4
5843394|NCT02286895|20197239|P1|Assessed for Measles Seroconversion|Protocol Violation|1
5843411|NCT02286466|20197481|P2|Overall Study|Declined Clinician Assessment|1
5843412|NCT02286466|20197482|P1|Overall Study|Declined Clinician Assessment|0
5843413|NCT02286466|20197481|P2|Overall Study|Lost to Follow-up|4
5843414|NCT02286466|20197482|P1|Overall Study|Lost to Follow-up|1
5843415|NCT02286466|20197481|P2|Overall Study|Withdrawal by Subject|2
5843416|NCT02286466|20197482|P1|Overall Study|Withdrawal by Subject|5
5843417|NCT02286466|20197481|P2|Overall Study|Death|3
5843418|NCT02286466|20197482|P1|Overall Study|Death|1
5843419|NCT02286193|20197494|P1|Overall Study|Referred: Declined service|38
5843420|NCT02286193|20197494|P1|Overall Study|Referred: unable to reach/resource sent|104
5843421|NCT02286193|20197494|P1|Overall Study|Referred: CRS unable to make contact|62
5843422|NCT02286102|20197501|P2|Overall Study|Screen Failure|1
5843423|NCT02286102|20197502|P1|Overall Study|Screen Failure|1
5843424|NCT02285998|20197514|P2|Overall Study|Other Reasons|10
5843425|NCT02285998|20197515|P1|Overall Study|Other Reasons|7
5843426|NCT02285998|20197514|P2|Overall Study|Withdrawal by Subject|61
5843427|NCT02285998|20197515|P1|Overall Study|Withdrawal by Subject|53
5843428|NCT02285998|20197514|P2|Overall Study|Lost to Follow-up|172
5843429|NCT02285998|20197515|P1|Overall Study|Lost to Follow-up|176
5843430|NCT02285998|20197514|P2|Overall Study|Physician Decision|2
5843431|NCT02285998|20197515|P1|Overall Study|Physician Decision|1
5843432|NCT02285998|20197514|P2|Overall Study|Adverse Event|8
5843433|NCT02285998|20197515|P1|Overall Study|Adverse Event|9
5843434|NCT02285920|20197543|P4|Overall Study|Death|1
5843435|NCT02285920|20197544|P3|Overall Study|Death|2
5843436|NCT02285920|20197545|P2|Overall Study|Death|0
5843437|NCT02285920|20197546|P1|Overall Study|Death|2
5843438|NCT02285920|20197543|P4|Overall Study|Dialysis discontinuation|0
5843439|NCT02285920|20197544|P3|Overall Study|Dialysis discontinuation|0
5843440|NCT02285920|20197545|P2|Overall Study|Dialysis discontinuation|1
5843441|NCT02285920|20197546|P1|Overall Study|Dialysis discontinuation|0
5843442|NCT02285920|20197543|P4|Overall Study|Transfer to non-participating unit|0
5843443|NCT02285920|20197544|P3|Overall Study|Transfer to non-participating unit|0
5843444|NCT02285920|20197545|P2|Overall Study|Transfer to non-participating unit|1
5843445|NCT02285920|20197546|P1|Overall Study|Transfer to non-participating unit|0
5843446|NCT02285920|20197543|P4|Overall Study|Change to peritoneal dialysis|0
5843447|NCT02285920|20197544|P3|Overall Study|Change to peritoneal dialysis|1
5843448|NCT02285920|20197545|P2|Overall Study|Change to peritoneal dialysis|0
5843449|NCT02285920|20197546|P1|Overall Study|Change to peritoneal dialysis|0
5843450|NCT02285920|20197543|P4|Overall Study|Kidney transplantation|0
5843451|NCT02285920|20197544|P3|Overall Study|Kidney transplantation|2
5843452|NCT02285920|20197545|P2|Overall Study|Kidney transplantation|2
5843453|NCT02285920|20197546|P1|Overall Study|Kidney transplantation|2
5843454|NCT02285855|20197636|P2|Overall Study|Withdrawal by Subject|1
5843455|NCT02285855|20197637|P1|Overall Study|Withdrawal by Subject|2
5843456|NCT02285777|20197645|P2|Overall Study|Lost to Follow-up|2
5843457|NCT02285777|20197646|P1|Overall Study|Lost to Follow-up|4
5843458|NCT02285777|20197645|P2|Overall Study|Withdrawal by Subject|1
5843459|NCT02285777|20197646|P1|Overall Study|Withdrawal by Subject|1
5843460|NCT02285270|20197738|P1|Overall Study|Determined to be ineligible|1
5843461|NCT02285270|20197738|P1|Overall Study|Physician Decision|3
5843462|NCT02285270|20197738|P1|Overall Study|Lost to Follow-up|1
5843463|NCT02285153|20197746|P2|Overall Study|Adverse Event|0
5843464|NCT02285153|20197747|P1|Overall Study|Adverse Event|1
5843465|NCT02285114|20197762|P3|Overall Study|Still on study|2
5843466|NCT02285114|20197763|P2|Overall Study|Still on study|5
5843467|NCT02285114|20197764|P1|Overall Study|Still on study|21
5843468|NCT02285114|20197762|P3|Overall Study|Enrolled but not treated|0
5843469|NCT02285114|20197763|P2|Overall Study|Enrolled but not treated|0
5843470|NCT02285114|20197764|P1|Overall Study|Enrolled but not treated|1
5843471|NCT02285114|20197762|P3|Overall Study|Withdrew Consent|1
5843472|NCT02285114|20197763|P2|Overall Study|Withdrew Consent|0
5843473|NCT02285114|20197764|P1|Overall Study|Withdrew Consent|0
5843474|NCT02285114|20197762|P3|Overall Study|Investigator's Discretion|0
5843475|NCT02285114|20197763|P2|Overall Study|Investigator's Discretion|2
5843476|NCT02285114|20197764|P1|Overall Study|Investigator's Discretion|0
5843477|NCT02285062|20197829|P2|Overall Study|Lost to Follow-up|5
5843478|NCT02285062|20197830|P1|Overall Study|Lost to Follow-up|8
5843479|NCT02285062|20197829|P2|Overall Study|Death|62
5843480|NCT02285062|20197830|P1|Overall Study|Death|58
5843481|NCT02285062|20197829|P2|Overall Study|Withdrawal by Subject|17
5843482|NCT02285062|20197830|P1|Overall Study|Withdrawal by Subject|12
5843483|NCT02285010|20197878|P2|Overall Study|Not spinal anesthesia|1
5843484|NCT02285010|20197879|P1|Overall Study|Not spinal anesthesia|3
5843485|NCT02285010|20197878|P2|Overall Study|not abdominal hysterectomy|0
5843486|NCT02285010|20197879|P1|Overall Study|not abdominal hysterectomy|2
5843487|NCT02284906|20197896|P3|Overall Study|Reason not Specified|0
5843488|NCT02284906|20197897|P2|Overall Study|Reason not Specified|1
5843489|NCT02284906|20197898|P1|Overall Study|Reason not Specified|1
5843490|NCT02284906|20197896|P3|Overall Study|Study Termination|14
5843491|NCT02284906|20197897|P2|Overall Study|Study Termination|11
5843492|NCT02284906|20197898|P1|Overall Study|Study Termination|0
5843493|NCT02284906|20197896|P3|Overall Study|Voluntary Withdrawal|5
5843494|NCT02284906|20197897|P2|Overall Study|Voluntary Withdrawal|4
5843495|NCT02284906|20197898|P1|Overall Study|Voluntary Withdrawal|2
5843496|NCT02284906|20197896|P3|Overall Study|Major Protocol Deviation|0
5843497|NCT02284906|20197897|P2|Overall Study|Major Protocol Deviation|1
5843498|NCT02284906|20197898|P1|Overall Study|Major Protocol Deviation|0
5843499|NCT02284906|20197896|P3|Overall Study|Pretreatment Event/Adverse Event|0
5843500|NCT02284906|20197897|P2|Overall Study|Pretreatment Event/Adverse Event|1
5843501|NCT02284906|20197898|P1|Overall Study|Pretreatment Event/Adverse Event|0
5843502|NCT02284893|20197911|P2|52 Week (Long Term)|Non-Compliance|3
5843503|NCT02284893|20197912|P1|52 Week (Long Term)|Non-Compliance|2
5843504|NCT02284893|20197911|P2|52 Week (Long Term)|Lost to Follow-up|2
5843505|NCT02284893|20197912|P1|52 Week (Long Term)|Lost to Follow-up|2
5843506|NCT02284893|20197911|P2|52 Week (Long Term)|Withrawal of the consent by the subject|6
5843507|NCT02284893|20197912|P1|52 Week (Long Term)|Withrawal of the consent by the subject|4
5843508|NCT02284893|20197911|P2|52 Week (Long Term)|Subject no longer meets study criteria|1
5843509|NCT02284893|20197912|P1|52 Week (Long Term)|Subject no longer meets study criteria|0
5843510|NCT02284893|20197911|P2|52 Week (Long Term)|Adverse Event|1
5843511|NCT02284893|20197912|P1|52 Week (Long Term)|Adverse Event|3
5843512|NCT02284893|20197911|P2|26 Week (Short Term)|Other|1
5843513|NCT02284893|20197912|P1|26 Week (Short Term)|Other|1
5843514|NCT02284893|20197911|P2|26 Week (Short Term)|Subject no longer meets study criteria|8
5843515|NCT02284893|20197912|P1|26 Week (Short Term)|Subject no longer meets study criteria|5
5843516|NCT02284893|20197911|P2|26 Week (Short Term)|Lost to Follow-up|1
5843517|NCT02284893|20197912|P1|26 Week (Short Term)|Lost to Follow-up|3
5843518|NCT02284893|20197911|P2|26 Week (Short Term)|Withrawal of the consent by the subject|10
5843519|NCT02284893|20197912|P1|26 Week (Short Term)|Withrawal of the consent by the subject|7
5843520|NCT02284893|20197911|P2|26 Week (Short Term)|Discontinuation by the subject|2
5843521|NCT02284893|20197912|P1|26 Week (Short Term)|Discontinuation by the subject|2
5843522|NCT02284893|20197911|P2|26 Week (Short Term)|Adverse Event|9
5843523|NCT02284893|20197912|P1|26 Week (Short Term)|Adverse Event|1
5843524|NCT02284568|20197989|P3|Overall Study|Withdrew before taking study drug|0
5843525|NCT02284568|20197990|P2|Overall Study|Withdrew before taking study drug|1
5843526|NCT02284568|20197991|P1|Overall Study|Withdrew before taking study drug|0
5843527|NCT02284568|20197989|P3|Overall Study|Other|0
5843528|NCT02284568|20197990|P2|Overall Study|Other|2
5843529|NCT02284568|20197991|P1|Overall Study|Other|1
5843530|NCT02284568|20197989|P3|Overall Study|Lack of Efficacy|0
5843531|NCT02284568|20197990|P2|Overall Study|Lack of Efficacy|7
5843532|NCT02284568|20197991|P1|Overall Study|Lack of Efficacy|4
5843533|NCT02284568|20197989|P3|Overall Study|Lost to Follow-up|0
5843534|NCT02284568|20197990|P2|Overall Study|Lost to Follow-up|3
5843535|NCT02284568|20197991|P1|Overall Study|Lost to Follow-up|0
5843536|NCT02284568|20197989|P3|Overall Study|Sponsor requested patient stop treatment|90
5843537|NCT02284568|20197990|P2|Overall Study|Sponsor requested patient stop treatment|0
5843538|NCT02284568|20197991|P1|Overall Study|Sponsor requested patient stop treatment|0
5843539|NCT02284568|20197989|P3|Overall Study|Protocol Violation|0
5843540|NCT02284568|20197990|P2|Overall Study|Protocol Violation|1
5843541|NCT02284568|20197991|P1|Overall Study|Protocol Violation|0
5843542|NCT02284568|20197989|P3|Overall Study|Noncompliance|0
5843543|NCT02284568|20197990|P2|Overall Study|Noncompliance|0
5843544|NCT02284568|20197991|P1|Overall Study|Noncompliance|1
5843545|NCT02284568|20197989|P3|Overall Study|Noncompliance with study drug admin|0
5843546|NCT02284568|20197990|P2|Overall Study|Noncompliance with study drug admin|2
5843547|NCT02284568|20197991|P1|Overall Study|Noncompliance with study drug admin|1
5843548|NCT02284568|20197989|P3|Overall Study|Withdrawal by Subject|1
5843549|NCT02284568|20197990|P2|Overall Study|Withdrawal by Subject|21
5843550|NCT02284568|20197991|P1|Overall Study|Withdrawal by Subject|22
5843551|NCT02284568|20197989|P3|Overall Study|Adverse Event|4
5843552|NCT02284568|20197990|P2|Overall Study|Adverse Event|9
5843553|NCT02284568|20197991|P1|Overall Study|Adverse Event|2
5843554|NCT02284373|20198085|P3|Overall Study|Lost to Follow-up|0
5843555|NCT02284373|20198086|P2|Overall Study|Lost to Follow-up|1
5843556|NCT02284373|20198087|P1|Overall Study|Lost to Follow-up|0
5843557|NCT02284373|20198085|P3|Overall Study|Other|0
5843558|NCT02284373|20198086|P2|Overall Study|Other|1
5843559|NCT02284373|20198087|P1|Overall Study|Other|0
5843560|NCT02284373|20198085|P3|Overall Study|Withdrawal by Subject|0
5843561|NCT02284373|20198086|P2|Overall Study|Withdrawal by Subject|1
5843562|NCT02284373|20198087|P1|Overall Study|Withdrawal by Subject|0
5843563|NCT02284347|20198095|P1|Overall Study|Withdrawn prior to treatment|1
5843564|NCT02284347|20198095|P1|Overall Study|Lost to Follow-up|2
5843565|NCT02284243|20198103|P2|Overall Study|Adverse Event|0
5843566|NCT02284243|20198104|P1|Overall Study|Adverse Event|1
5843567|NCT02284243|20198103|P2|Overall Study|Lack of Efficacy|3
5843568|NCT02284243|20198104|P1|Overall Study|Lack of Efficacy|3
5843569|NCT02284178|20198124|P2|Overall Study|Met exclusion criteria|54
5843570|NCT02284178|20198125|P1|Overall Study|Met exclusion criteria|49
5843571|NCT02284009|20198179|P2|Overall Study|Withdrawal by Subject|5
5843572|NCT02284009|20198180|P1|Overall Study|Withdrawal by Subject|2
5843573|NCT02284009|20198179|P2|Overall Study|Physician Decision|2
5843574|NCT02284009|20198180|P1|Overall Study|Physician Decision|0
5843575|NCT02284009|20198179|P2|Overall Study|Lost to Follow-up|3
5843576|NCT02284009|20198180|P1|Overall Study|Lost to Follow-up|1
5843577|NCT02284009|20198179|P2|Overall Study|Adverse Event|0
5843578|NCT02284009|20198180|P1|Overall Study|Adverse Event|3
5843579|NCT02283788|20198279|P4|Overall Study|Withdrawal by Subject|1
5843580|NCT02283788|20198280|P3|Overall Study|Withdrawal by Subject|0
5843581|NCT02283788|20198281|P2|Overall Study|Withdrawal by Subject|1
5843582|NCT02283788|20198282|P1|Overall Study|Withdrawal by Subject|0
5843583|NCT02283788|20198279|P4|Overall Study|Adverse Event|1
5843584|NCT02283788|20198280|P3|Overall Study|Adverse Event|5
5843585|NCT02283788|20198281|P2|Overall Study|Adverse Event|3
5843586|NCT02283788|20198282|P1|Overall Study|Adverse Event|1
5843587|NCT02283762|20198294|P2|Long-term Extension Phase (LTE)|Physician Decision|2
5843588|NCT02283762|20198295|P1|Long-term Extension Phase (LTE)|Physician Decision|1
5843589|NCT02283762|20198294|P2|Long-term Extension Phase (LTE)|Lost to Follow-up|1
5843590|NCT02283762|20198295|P1|Long-term Extension Phase (LTE)|Lost to Follow-up|0
5843591|NCT02283762|20198294|P2|Long-term Extension Phase (LTE)|Protocol Violation|1
5843592|NCT02283762|20198295|P1|Long-term Extension Phase (LTE)|Protocol Violation|1
5843593|NCT02283762|20198294|P2|Long-term Extension Phase (LTE)|Withdrawal by Subject|3
5843594|NCT02283762|20198295|P1|Long-term Extension Phase (LTE)|Withdrawal by Subject|4
5843595|NCT02283762|20198294|P2|Long-term Extension Phase (LTE)|Study terminated at site|0
5843596|NCT02283762|20198295|P1|Long-term Extension Phase (LTE)|Study terminated at site|1
5843597|NCT02283762|20198294|P2|Long-term Extension Phase (LTE)|Lack of Efficacy|1
5843598|NCT02283762|20198295|P1|Long-term Extension Phase (LTE)|Lack of Efficacy|1
5843599|NCT02283762|20198294|P2|Long-term Extension Phase (LTE)|Adverse Event|6
5843600|NCT02283762|20198295|P1|Long-term Extension Phase (LTE)|Adverse Event|2
5843601|NCT02283762|20198294|P2|Main Treatment Phase (MT)|Withdrawal by Subject|4
5843602|NCT02283762|20198295|P1|Main Treatment Phase (MT)|Withdrawal by Subject|7
5843603|NCT02283762|20198294|P2|Main Treatment Phase (MT)|Pregnancy|1
5843604|NCT02283762|20198295|P1|Main Treatment Phase (MT)|Pregnancy|0
5843605|NCT02283762|20198294|P2|Main Treatment Phase (MT)|Physician Decision|1
5843606|NCT02283762|20198295|P1|Main Treatment Phase (MT)|Physician Decision|1
5843607|NCT02283762|20198294|P2|Main Treatment Phase (MT)|Lack of Efficacy|0
5843608|NCT02283762|20198295|P1|Main Treatment Phase (MT)|Lack of Efficacy|1
5843609|NCT02283762|20198294|P2|Main Treatment Phase (MT)|Adverse Event|9
5843610|NCT02283762|20198295|P1|Main Treatment Phase (MT)|Adverse Event|9
5843611|NCT02283658|20198319|P1|Overall Study|Withdrawal by Subject|1
5843612|NCT02283411|20198341|P1|Overall Study|Screen Failed|28
5843613|NCT02283411|20198341|P1|Overall Study|Withdrawal by Subject|3
5843614|NCT02283268|20198349|P1|Overall Study|Withdrawal by Subject|1
5843615|NCT02282982|20198410|P1|Overall Study|Other, not specified|18
5843616|NCT02282982|20198410|P1|Overall Study|Palivizumab is ended|11
5843617|NCT02282982|20198410|P1|Overall Study|Lack of product|156
5843618|NCT02282982|20198410|P1|Overall Study|Death|4
5843619|NCT02282982|20198410|P1|Overall Study|Withdrew consent|2
5843620|NCT02282982|20198410|P1|Overall Study|Lost to Follow-up|15
5843621|NCT02282813|20198438|P3|Overall Study|Administrative reasons|0
5843622|NCT02282813|20198439|P2|Overall Study|Administrative reasons|1
5843623|NCT02282813|20198440|P1|Overall Study|Administrative reasons|0
5843624|NCT02282813|20198438|P3|Overall Study|Lack of Efficacy|0
5843625|NCT02282813|20198439|P2|Overall Study|Lack of Efficacy|0
5843626|NCT02282813|20198440|P1|Overall Study|Lack of Efficacy|1
5843627|NCT02282813|20198438|P3|Overall Study|Serum Ca >/=11.0mg/dL|0
5843628|NCT02282813|20198439|P2|Overall Study|Serum Ca >/=11.0mg/dL|0
5843629|NCT02282813|20198440|P1|Overall Study|Serum Ca >/=11.0mg/dL|1
5843630|NCT02282813|20198438|P3|Overall Study|Lost to Follow-up|1
5843631|NCT02282813|20198439|P2|Overall Study|Lost to Follow-up|0
5843632|NCT02282813|20198440|P1|Overall Study|Lost to Follow-up|2
5843633|NCT02282813|20198438|P3|Overall Study|Physician Decision|1
5843634|NCT02282813|20198439|P2|Overall Study|Physician Decision|3
5843635|NCT02282813|20198440|P1|Overall Study|Physician Decision|0
5843636|NCT02282813|20198438|P3|Overall Study|Subject non-compliance|0
5843637|NCT02282813|20198439|P2|Overall Study|Subject non-compliance|4
5843638|NCT02282813|20198440|P1|Overall Study|Subject non-compliance|1
5843639|NCT02282813|20198438|P3|Overall Study|Adverse Event|1
5843640|NCT02282813|20198439|P2|Overall Study|Adverse Event|10
5843641|NCT02282813|20198440|P1|Overall Study|Adverse Event|3
5843642|NCT02282813|20198438|P3|Overall Study|Withdrawal by Subject|0
5843643|NCT02282813|20198439|P2|Overall Study|Withdrawal by Subject|5
5843644|NCT02282813|20198440|P1|Overall Study|Withdrawal by Subject|4
5843645|NCT02282631|20198486|P2|Overall Study|Lost to Follow-up|0
5843646|NCT02282631|20198487|P1|Overall Study|Lost to Follow-up|2
5843647|NCT02282605|20198528|P3|Overall Study|negative SA result on Day -1|0
5843648|NCT02282605|20198529|P2|Overall Study|negative SA result on Day -1|0
5843649|NCT02282605|20198530|P1|Overall Study|negative SA result on Day -1|3
5843650|NCT02282527|20198552|P2|Overall Study|Lack of home health aid|0
5843651|NCT02282527|20198553|P1|Overall Study|Lack of home health aid|1
5843652|NCT02282527|20198552|P2|Overall Study|Lost to Follow-up|1
5843653|NCT02282527|20198553|P1|Overall Study|Lost to Follow-up|0
5843654|NCT02282293|20198571|P2|Overall Study|Moved out of study area|1
5843655|NCT02282293|20198572|P1|Overall Study|Moved out of study area|0
5843656|NCT02282293|20198571|P2|Overall Study|Unable to comply with study procedures|0
5843657|NCT02282293|20198572|P1|Overall Study|Unable to comply with study procedures|1
5843658|NCT02282293|20198571|P2|Overall Study|Lost to Follow-up|2
5843659|NCT02282293|20198572|P1|Overall Study|Lost to Follow-up|2
5843660|NCT02282163|20198590|P1|Overall Study|Protocol Violation|1
5843661|NCT02282020|20198622|P2|Overall Study|Withdrew Consent Prior to Dosing|12
5843662|NCT02282020|20198623|P1|Overall Study|Withdrew Consent Prior to Dosing|0
5843663|NCT02282020|20198622|P2|Overall Study|Developed Discontinuation Criteria|3
5843664|NCT02282020|20198623|P1|Overall Study|Developed Discontinuation Criteria|1
5843665|NCT02282020|20198622|P2|Overall Study|Severe Non-compliance to Protocol|0
5843666|NCT02282020|20198623|P1|Overall Study|Severe Non-compliance to Protocol|1
5843667|NCT02282020|20198622|P2|Overall Study|Miscellaneous|17
5843668|NCT02282020|20198623|P1|Overall Study|Miscellaneous|4
5843669|NCT02282020|20198622|P2|Overall Study|Withdrawal by Subject|10
5843670|NCT02282020|20198623|P1|Overall Study|Withdrawal by Subject|5
5843671|NCT02282020|20198622|P2|Overall Study|Adverse Event|15
5843672|NCT02282020|20198623|P1|Overall Study|Adverse Event|13
5843673|NCT02282020|20198622|P2|Overall Study|Objective Disease Progression|30
5843674|NCT02282020|20198623|P1|Overall Study|Objective Disease Progression|111
5843675|NCT02281955|20198668|P1|Overall Study|Death|1
5843676|NCT02281773|20198691|P5|Overall Study|Other Reason|1
5843677|NCT02281773|20198692|P4|Overall Study|Other Reason|3
5843678|NCT02281773|20198693|P3|Overall Study|Other Reason|2
5843679|NCT02281773|20198694|P2|Overall Study|Other Reason|4
5843680|NCT02281773|20198695|P1|Overall Study|Other Reason|0
5843681|NCT02281773|20198691|P5|Overall Study|Withdrawal by Subject|8
5843682|NCT02281773|20198692|P4|Overall Study|Withdrawal by Subject|6
5843683|NCT02281773|20198693|P3|Overall Study|Withdrawal by Subject|6
5843684|NCT02281773|20198694|P2|Overall Study|Withdrawal by Subject|8
5843685|NCT02281773|20198695|P1|Overall Study|Withdrawal by Subject|2
5843686|NCT02281773|20198691|P5|Overall Study|Lost to Follow-up|10
5843687|NCT02281773|20198692|P4|Overall Study|Lost to Follow-up|2
5843688|NCT02281773|20198693|P3|Overall Study|Lost to Follow-up|6
5843689|NCT02281773|20198694|P2|Overall Study|Lost to Follow-up|2
5843690|NCT02281773|20198695|P1|Overall Study|Lost to Follow-up|2
5843691|NCT02281773|20198691|P5|Overall Study|Protocol Violation|2
5843692|NCT02281773|20198692|P4|Overall Study|Protocol Violation|2
5843693|NCT02281773|20198693|P3|Overall Study|Protocol Violation|0
5843694|NCT02281773|20198694|P2|Overall Study|Protocol Violation|0
5843695|NCT02281773|20198695|P1|Overall Study|Protocol Violation|1
5843696|NCT02281773|20198691|P5|Overall Study|Adverse Event|9
5843697|NCT02281773|20198692|P4|Overall Study|Adverse Event|8
5843698|NCT02281773|20198693|P3|Overall Study|Adverse Event|4
5843699|NCT02281773|20198694|P2|Overall Study|Adverse Event|1
5843700|NCT02281773|20198695|P1|Overall Study|Adverse Event|6
5843701|NCT02281552|20198783|P2|Overall Study|Adverse Event|9
5843702|NCT02281552|20198784|P1|Overall Study|Adverse Event|3
5843703|NCT02281552|20198783|P2|Overall Study|Insufficient clinical response|1
5843704|NCT02281552|20198784|P1|Overall Study|Insufficient clinical response|0
5843705|NCT02281552|20198783|P2|Overall Study|Medication error|0
5843706|NCT02281552|20198784|P1|Overall Study|Medication error|1
5843707|NCT02281357|20198906|P2|Overall Study|Withdrawal by Subject|3
5843708|NCT02281357|20198907|P1|Overall Study|Withdrawal by Subject|4
5843709|NCT02281357|20198906|P2|Overall Study|Lost to Follow-up|0
5843710|NCT02281357|20198907|P1|Overall Study|Lost to Follow-up|1
5843711|NCT02281357|20198906|P2|Overall Study|Adverse Event|1
5843712|NCT02281357|20198907|P1|Overall Study|Adverse Event|2
5843713|NCT02281318|20198926|P2|Overall Study|Withdrawal by Subject|2
5843714|NCT02281318|20198927|P1|Overall Study|Withdrawal by Subject|6
5843715|NCT02281318|20198926|P2|Overall Study|Physician Decision|0
5843716|NCT02281318|20198927|P1|Overall Study|Physician Decision|2
5843717|NCT02281318|20198926|P2|Overall Study|Lost to Follow-up|1
5843718|NCT02281318|20198927|P1|Overall Study|Lost to Follow-up|2
5843719|NCT02281318|20198926|P2|Overall Study|Lack of Efficacy|0
5843720|NCT02281318|20198927|P1|Overall Study|Lack of Efficacy|2
5843721|NCT02281318|20198926|P2|Overall Study|Adverse Event|2
5843722|NCT02281318|20198927|P1|Overall Study|Adverse Event|2
5843723|NCT02281084|20198975|P4|Overall Study|Physician Decision|0
5843724|NCT02281084|20198976|P3|Overall Study|Physician Decision|1
5843725|NCT02281084|20198977|P2|Overall Study|Physician Decision|0
5843726|NCT02281084|20198978|P1|Overall Study|Physician Decision|0
5843727|NCT02281084|20198975|P4|Overall Study|Death|5
5843728|NCT02281084|20198976|P3|Overall Study|Death|3
5843729|NCT02281084|20198977|P2|Overall Study|Death|16
5843730|NCT02281084|20198978|P1|Overall Study|Death|20
5843731|NCT02281084|20198975|P4|Overall Study|Withdrawal by Subject|0
5843732|NCT02281084|20198976|P3|Overall Study|Withdrawal by Subject|0
5843733|NCT02281084|20198977|P2|Overall Study|Withdrawal by Subject|2
5843734|NCT02281084|20198978|P1|Overall Study|Withdrawal by Subject|1
5843735|NCT02281084|20198975|P4|Overall Study|Adverse Event|0
5843736|NCT02281084|20198976|P3|Overall Study|Adverse Event|0
5843737|NCT02281084|20198977|P2|Overall Study|Adverse Event|0
5843738|NCT02281084|20198978|P1|Overall Study|Adverse Event|1
5843739|NCT02280863|20199034|P2|Integrated Platform|Met stopping criteria|1
5843740|NCT02280863|20199035|P1|Integrated Platform|Met stopping criteria|0
5843741|NCT02280499|20199119|P1|Overall Study|Adverse Event|5
5843742|NCT02280499|20199119|P1|Overall Study|Lost to Follow-up|42
5843743|NCT02280499|20199119|P1|Overall Study|Death|14
5843744|NCT02280473|20199127|P2|Overall Study|Lost to Follow-up|1
5843745|NCT02280473|20199128|P1|Overall Study|Lost to Follow-up|0
5843746|NCT02280473|20199127|P2|Overall Study|Lack of Efficacy|1
5843747|NCT02280473|20199128|P1|Overall Study|Lack of Efficacy|0
5843748|NCT02280473|20199127|P2|Overall Study|Adverse Event|1
5843749|NCT02280473|20199128|P1|Overall Study|Adverse Event|1
5843750|NCT02280421|20199144|P2|Washout (2 Weeks)|Withdrawal by Subject|0
5843751|NCT02280421|20199145|P1|Washout (2 Weeks)|Withdrawal by Subject|1
5843752|NCT02280421|20199144|P2|Washout (2 Weeks)|Adverse Event|1
5843753|NCT02280421|20199145|P1|Washout (2 Weeks)|Adverse Event|0
5843754|NCT02280408|20199211|P4|Overall Study|Lost to Follow-up|0
5843755|NCT02280408|20199212|P3|Overall Study|Lost to Follow-up|0
5843756|NCT02280408|20199213|P2|Overall Study|Lost to Follow-up|2
5843757|NCT02280408|20199214|P1|Overall Study|Lost to Follow-up|0
5843758|NCT02280304|20199286|P2|Overall Study|Lost to Follow-up|8
5843759|NCT02280304|20199287|P1|Overall Study|Lost to Follow-up|7
5843760|NCT02280291|20199308|P4|Overall Study|Other|0
5843761|NCT02280291|20199309|P3|Overall Study|Other|0
5843762|NCT02280291|20199310|P2|Overall Study|Other|1
5843763|NCT02280291|20199311|P1|Overall Study|Other|1
5843764|NCT02280291|20199308|P4|Overall Study|Protocol Violation|0
5843765|NCT02280291|20199309|P3|Overall Study|Protocol Violation|0
5843766|NCT02280291|20199310|P2|Overall Study|Protocol Violation|0
5843767|NCT02280291|20199311|P1|Overall Study|Protocol Violation|1
5843768|NCT02280291|20199308|P4|Overall Study|Lost to Follow-up|8
5843769|NCT02280291|20199309|P3|Overall Study|Lost to Follow-up|3
5843770|NCT02280291|20199310|P2|Overall Study|Lost to Follow-up|1
5843771|NCT02280291|20199311|P1|Overall Study|Lost to Follow-up|2
5843772|NCT02280187|20199352|P1|Overall Study|Lost to Follow-up|218
5843773|NCT02280096|20199380|P2|Overall Study|Lack of attachment|1
5843774|NCT02280096|20199381|P1|Overall Study|Lack of attachment|0
5843775|NCT02280096|20199380|P2|Overall Study|Functional neurological disorder|0
5843776|NCT02280096|20199381|P1|Overall Study|Functional neurological disorder|1
5843777|NCT02280096|20199380|P2|Overall Study|Pregnancy|0
5843778|NCT02280096|20199381|P1|Overall Study|Pregnancy|1
5843779|NCT02280044|20199411|P2|Overall Study|Planned alternate|2
5843780|NCT02280044|20199412|P1|Overall Study|Planned alternate|0
5843781|NCT02279862|20199422|P2|Overall Study|Withdrawal by Subject|0
5843782|NCT02279862|20199423|P1|Overall Study|Withdrawal by Subject|1
5843783|NCT02279862|20199422|P2|Overall Study|Other|2
5843784|NCT02279862|20199423|P1|Overall Study|Other|1
5843785|NCT02279862|20199422|P2|Overall Study|Study closed by sponsor|13
5843786|NCT02279862|20199423|P1|Overall Study|Study closed by sponsor|16
5843787|NCT02279862|20199422|P2|Overall Study|Disease progression|2
5843788|NCT02279862|20199423|P1|Overall Study|Disease progression|5
5843789|NCT02279862|20199422|P2|Overall Study|Administrative reason by sponsor|1
5843790|NCT02279862|20199423|P1|Overall Study|Administrative reason by sponsor|0
5843791|NCT02279862|20199422|P2|Overall Study|No longer meets criteria|1
5843792|NCT02279862|20199423|P1|Overall Study|No longer meets criteria|0
5843793|NCT02279862|20199422|P2|Overall Study|Study drug toxicity|6
5843794|NCT02279862|20199423|P1|Overall Study|Study drug toxicity|3
5843795|NCT02279732|20199441|P2|Overall Study|Other|3
5843796|NCT02279732|20199442|P1|Overall Study|Other|3
5843797|NCT02279732|20199441|P2|Overall Study|Other|67
5843798|NCT02279732|20199442|P1|Overall Study|Other|53
5843799|NCT02279732|20199441|P2|Overall Study|Subject Requested to Discontinue|1
5843800|NCT02279732|20199442|P1|Overall Study|Subject Requested to Discontinue|0
5843801|NCT02279732|20199441|P2|Overall Study|Maximum Clinical Benefit|0
5843802|NCT02279732|20199442|P1|Overall Study|Maximum Clinical Benefit|1
5843803|NCT02279732|20199441|P2|Overall Study|Lost to Follow-up|1
5843804|NCT02279732|20199442|P1|Overall Study|Lost to Follow-up|0
5843805|NCT02279732|20199441|P2|Overall Study|Study Drug Toxicity|0
5843806|NCT02279732|20199442|P1|Overall Study|Study Drug Toxicity|2
5843807|NCT02279732|20199441|P2|Overall Study|Administrative Reason By Sponsor|2
5843808|NCT02279732|20199442|P1|Overall Study|Administrative Reason By Sponsor|0
5843809|NCT02279732|20199441|P2|Overall Study|Adverse Event|2
5843810|NCT02279732|20199442|P1|Overall Study|Adverse Event|1
5843811|NCT02279732|20199441|P2|Overall Study|Withdrawal by Subject|7
5843812|NCT02279732|20199442|P1|Overall Study|Withdrawal by Subject|2
5843813|NCT02279732|20199441|P2|Overall Study|Disease Progression|3
5843814|NCT02279732|20199442|P1|Overall Study|Disease Progression|13
5843815|NCT02279732|20199441|P2|Overall Study|Death|20
5843816|NCT02279732|20199442|P1|Overall Study|Death|23
5843817|NCT02279498|20199534|P2|Overall Study|Undefined|1
5843818|NCT02279498|20199535|P1|Overall Study|Undefined|2
5843819|NCT02279498|20199534|P2|Overall Study|Withdrawal by Subject|2
5843820|NCT02279498|20199535|P1|Overall Study|Withdrawal by Subject|9
5843821|NCT02279498|20199534|P2|Overall Study|Lost to Follow-up|1
5843822|NCT02279498|20199535|P1|Overall Study|Lost to Follow-up|0
5843823|NCT02279498|20199534|P2|Overall Study|Lack of Efficacy|0
5843824|NCT02279498|20199535|P1|Overall Study|Lack of Efficacy|4
5843825|NCT02279498|20199534|P2|Overall Study|Adverse Event|0
5843826|NCT02279498|20199535|P1|Overall Study|Adverse Event|3
5843827|NCT02279420|20199544|P1|Overall Study|Lost to Follow-up|23
5843828|NCT02279407|20199552|P4|Overall Study|Adverse Event|0
5843829|NCT02279407|20199553|P3|Overall Study|Adverse Event|2
5843830|NCT02279407|20199554|P2|Overall Study|Adverse Event|1
5843831|NCT02279407|20199555|P1|Overall Study|Adverse Event|1
5843832|NCT02279407|20199552|P4|Overall Study|Withdrawal by Subject|1
5843833|NCT02279407|20199553|P3|Overall Study|Withdrawal by Subject|1
5843834|NCT02279407|20199554|P2|Overall Study|Withdrawal by Subject|0
5843835|NCT02279407|20199555|P1|Overall Study|Withdrawal by Subject|1
5843836|NCT02279407|20199552|P4|Overall Study|Couldn't swallow IP; noncompliance|0
5843837|NCT02279407|20199553|P3|Overall Study|Couldn't swallow IP; noncompliance|2
5843838|NCT02279407|20199554|P2|Overall Study|Couldn't swallow IP; noncompliance|0
5843839|NCT02279407|20199555|P1|Overall Study|Couldn't swallow IP; noncompliance|0
5843840|NCT02279173|20199566|P1|Overall Study|Lost to Follow-up|3
5843841|NCT02279173|20199566|P1|Overall Study|Decision by Sponsor|4
5843842|NCT02279173|20199566|P1|Overall Study|Withdrawal by Subject|20
5843843|NCT02279173|20199566|P1|Overall Study|Protocol-specified Criteria|67
5843844|NCT02279043|20199626|P3|Overall Study|Lost to Follow-up|0
5843845|NCT02279043|20199627|P2|Overall Study|Lost to Follow-up|88
5843846|NCT02279043|20199628|P1|Overall Study|Lost to Follow-up|46
5843847|NCT02279043|20199626|P3|Overall Study|Post-rand. exclusion - not eligible|0
5843848|NCT02279043|20199627|P2|Overall Study|Post-rand. exclusion - not eligible|1
5843849|NCT02279043|20199628|P1|Overall Study|Post-rand. exclusion - not eligible|1
5843850|NCT02278952|20199658|P1|Overall Study|Insufficient Sample|6
5843851|NCT02278939|20199670|P2|Overall Study|family emergency unable to commit|0
5843852|NCT02278939|20199671|P1|Overall Study|family emergency unable to commit|2
5843853|NCT02278939|20199670|P2|Overall Study|death in family|0
5843854|NCT02278939|20199671|P1|Overall Study|death in family|1
5843855|NCT02278939|20199670|P2|Overall Study|Lost to Follow-up|1
5843856|NCT02278939|20199671|P1|Overall Study|Lost to Follow-up|1
5843857|NCT02278939|20199670|P2|Overall Study|lack of time|0
5843858|NCT02278939|20199671|P1|Overall Study|lack of time|1
5843859|NCT02278614|20199699|P2|Overall Study|left eye was not eligible|0
5843860|NCT02278614|20199700|P1|Overall Study|left eye was not eligible|1
5843861|NCT02278614|20199699|P2|Overall Study|Adverse Event|0
5843862|NCT02278614|20199700|P1|Overall Study|Adverse Event|1
5843863|NCT02278614|20199699|P2|Overall Study|Withdrawal by Subject|5
5843864|NCT02278614|20199700|P1|Overall Study|Withdrawal by Subject|3
5843865|NCT02278471|20199734|P2|Overall Study|Withdrawal by Subject|3
5843866|NCT02278471|20199735|P1|Overall Study|Withdrawal by Subject|0
5843867|NCT02278471|20199734|P2|Overall Study|Death|2
5843868|NCT02278471|20199735|P1|Overall Study|Death|2
5843869|NCT02278471|20199734|P2|Overall Study|Lost to Follow-up|15
5843870|NCT02278471|20199735|P1|Overall Study|Lost to Follow-up|6
5843871|NCT02278367|20199753|P2|Overall Study|Withdrawal by Subject|0
5843872|NCT02278367|20199754|P1|Overall Study|Withdrawal by Subject|5
5843873|NCT02278367|20199753|P2|Overall Study|Physician Decision|0
5843874|NCT02278367|20199754|P1|Overall Study|Physician Decision|5
5843875|NCT02278354|20199764|P2|Overall Study|<10 professional fights|0
5843876|NCT02278354|20199765|P1|Overall Study|<10 professional fights|2
5843877|NCT02278354|20199764|P2|Overall Study|Withdrawal by Subject|1
5843878|NCT02278354|20199765|P1|Overall Study|Withdrawal by Subject|0
5843879|NCT02278354|20199764|P2|Overall Study|Lost to Follow-up|2
5843880|NCT02278354|20199765|P1|Overall Study|Lost to Follow-up|2
5843895|NCT02278328|20199874|P3|Neuropsych Screening|incomplete consent|2
5843896|NCT02278328|20199875|P2|Neuropsych Screening|incomplete consent|0
5843897|NCT02278328|20199876|P1|Neuropsych Screening|incomplete consent|0
5843898|NCT02278328|20199874|P3|Neuropsych Screening|Withdrawal by Subject|0
5843899|NCT02278328|20199875|P2|Neuropsych Screening|Withdrawal by Subject|1
5843900|NCT02278328|20199876|P1|Neuropsych Screening|Withdrawal by Subject|0
5843901|NCT02278328|20199874|P3|Neuropsych Screening|found ineligible on neuropsych|0
5843902|NCT02278328|20199875|P2|Neuropsych Screening|found ineligible on neuropsych|0
5843903|NCT02278328|20199876|P1|Neuropsych Screening|found ineligible on neuropsych|1
5843904|NCT02278263|20199889|P3|Overall Study|Protocol Violation|9
5843905|NCT02278263|20199890|P2|Overall Study|Protocol Violation|0
5843906|NCT02278263|20199891|P1|Overall Study|Protocol Violation|7
5843907|NCT02278120|20199936|P2|Overall Study|Protocol Violation|2
5843908|NCT02278120|20199937|P1|Overall Study|Protocol Violation|0
5843909|NCT02278120|20199936|P2|Overall Study|Lost to Follow-up|0
5843910|NCT02278120|20199937|P1|Overall Study|Lost to Follow-up|2
5843911|NCT02278120|20199936|P2|Overall Study|Death|3
5843912|NCT02278120|20199937|P1|Overall Study|Death|3
5843913|NCT02278120|20199936|P2|Overall Study|Physician Decision|19
5843914|NCT02278120|20199937|P1|Overall Study|Physician Decision|8
5843915|NCT02278120|20199936|P2|Overall Study|Adverse Event|10
5843916|NCT02278120|20199937|P1|Overall Study|Adverse Event|12
5843917|NCT02278120|20199936|P2|Overall Study|Patient/guardian decision|8
5843918|NCT02278120|20199937|P1|Overall Study|Patient/guardian decision|14
5843919|NCT02278120|20199936|P2|Overall Study|Progressive disease|174
5843920|NCT02278120|20199937|P1|Overall Study|Progressive disease|122
5843921|NCT02278003|20199953|P2|Overall Study|Recognition task improperly completed|0
5843922|NCT02278003|20199954|P1|Overall Study|Recognition task improperly completed|7
5843923|NCT02278003|20199953|P2|Overall Study|Not Treated|0
5843924|NCT02278003|20199954|P1|Overall Study|Not Treated|1
5843925|NCT02278003|20199953|P2|Overall Study|Withdrawal by Subject|0
5843926|NCT02278003|20199954|P1|Overall Study|Withdrawal by Subject|11
5843927|NCT02277990|20199964|P2|Overall Study|Had other reason|32
5843928|NCT02277990|20199965|P1|Overall Study|Had other reason|26
5843929|NCT02277990|20199964|P2|Overall Study|Lost to Follow-up|69
5843930|NCT02277990|20199965|P1|Overall Study|Lost to Follow-up|66
5843931|NCT02277990|20199964|P2|Overall Study|Physician Decision|34
5843932|NCT02277990|20199965|P1|Overall Study|Physician Decision|40
5843933|NCT02277990|20199964|P2|Overall Study|Withdrawal by Subject|53
5843934|NCT02277990|20199965|P1|Overall Study|Withdrawal by Subject|64
5843935|NCT02277990|20199964|P2|Overall Study|Death|188
5843936|NCT02277990|20199965|P1|Overall Study|Death|170
5843937|NCT02277769|20199993|P3|Overall Study|Other than specified above|5
5843938|NCT02277769|20199994|P2|Overall Study|Other than specified above|8
5843939|NCT02277769|20199995|P1|Overall Study|Other than specified above|12
5843940|NCT02277769|20199993|P3|Overall Study|Adverse Event|4
5843941|NCT02277769|20199994|P2|Overall Study|Adverse Event|2
5843942|NCT02277769|20199995|P1|Overall Study|Adverse Event|14
5843943|NCT02277769|20199993|P3|Overall Study|Lack of Efficacy|4
5843944|NCT02277769|20199994|P2|Overall Study|Lack of Efficacy|0
5843945|NCT02277769|20199995|P1|Overall Study|Lack of Efficacy|17
5843946|NCT02277769|20199993|P3|Overall Study|Protocol Violation|5
5843947|NCT02277769|20199994|P2|Overall Study|Protocol Violation|3
5843948|NCT02277769|20199995|P1|Overall Study|Protocol Violation|3
5843949|NCT02277743|20200066|P3|Overall Study|Other than specified above|16
5843950|NCT02277743|20200067|P2|Overall Study|Other than specified above|5
5843951|NCT02277743|20200068|P1|Overall Study|Other than specified above|18
5843952|NCT02277743|20200066|P3|Overall Study|Lack of Efficacy|3
5843953|NCT02277743|20200067|P2|Overall Study|Lack of Efficacy|4
5843954|NCT02277743|20200068|P1|Overall Study|Lack of Efficacy|11
5843955|NCT02277743|20200066|P3|Overall Study|Adverse Event|6
5843956|NCT02277743|20200067|P2|Overall Study|Adverse Event|6
5843957|NCT02277743|20200068|P1|Overall Study|Adverse Event|10
5843958|NCT02277743|20200066|P3|Overall Study|Protocol Violation|1
5843959|NCT02277743|20200067|P2|Overall Study|Protocol Violation|1
5843960|NCT02277743|20200068|P1|Overall Study|Protocol Violation|1
5843961|NCT02277691|20200136|P1|Overall Study|Used Other Antihypertensive Drug|1
5843962|NCT02277691|20200136|P1|Overall Study|Lack of Efficacy|5
5843963|NCT02277691|20200136|P1|Overall Study|Voluntary Withdrawal|7
5843964|NCT02277691|20200136|P1|Overall Study|Pretreatment Event/Adverse Event|33
5843965|NCT02277444|20200198|P1|Overall Study|Ongoing|113
5843966|NCT02277444|20200198|P1|Overall Study|Enrolled and not Treated|3
5843967|NCT02277444|20200198|P1|Overall Study|Other|1
5843968|NCT02277444|20200198|P1|Overall Study|Withdrawal by Subject|3
5843969|NCT02277444|20200198|P1|Overall Study|Adverse Event|10
5843970|NCT02277119|20200217|P3|Overall Study|Protocol Violation|7
5843971|NCT02277119|20200218|P2|Overall Study|Protocol Violation|3
5843972|NCT02277119|20200219|P1|Overall Study|Protocol Violation|2
5843973|NCT02277119|20200217|P3|Overall Study|Lack of Efficacy|1
5843974|NCT02277119|20200218|P2|Overall Study|Lack of Efficacy|1
5843975|NCT02277119|20200219|P1|Overall Study|Lack of Efficacy|1
5843976|NCT02276872|20200257|P3|Overall Study|Adverse Event|0
5843977|NCT02276872|20200258|P2|Overall Study|Adverse Event|0
5843978|NCT02276872|20200259|P1|Overall Study|Adverse Event|1
5843979|NCT02276807|20200335|P2|Overall Study|Lost to Follow-up|10
5843980|NCT02276807|20200336|P1|Overall Study|Lost to Follow-up|10
5843981|NCT02276807|20200335|P2|Overall Study|Withdrawal by Subject|7
5843982|NCT02276807|20200336|P1|Overall Study|Withdrawal by Subject|8
5843983|NCT02276612|20200371|P2|Overall Study|Lost to Follow-up|0
5843984|NCT02276612|20200372|P1|Overall Study|Lost to Follow-up|1
5843985|NCT02276612|20200371|P2|Overall Study|Withdrew Consent|0
5843986|NCT02276612|20200372|P1|Overall Study|Withdrew Consent|1
5843987|NCT02276612|20200371|P2|Overall Study|Pregnancy|0
5843988|NCT02276612|20200372|P1|Overall Study|Pregnancy|1
5843989|NCT02276612|20200371|P2|Overall Study|Death|0
5843990|NCT02276612|20200372|P1|Overall Study|Death|1
5843991|NCT02276560|20200395|P3|Overall Study|Adverse Event|0
5843992|NCT02276560|20200396|P2|Overall Study|Adverse Event|0
5843993|NCT02276560|20200397|P1|Overall Study|Adverse Event|1
5843994|NCT02276482|20200407|P2|Overall Study|Reason not specified|1
5843995|NCT02276482|20200408|P1|Overall Study|Reason not specified|0
5843996|NCT02276482|20200407|P2|Overall Study|Gram-negative infection|0
5843997|NCT02276482|20200408|P1|Overall Study|Gram-negative infection|1
5843998|NCT02276482|20200407|P2|Overall Study|Withdrawal by Subject|0
5843999|NCT02276482|20200408|P1|Overall Study|Withdrawal by Subject|1
5844000|NCT02276482|20200407|P2|Overall Study|Adverse Event|0
5844001|NCT02276482|20200408|P1|Overall Study|Adverse Event|1
5844002|NCT02276222|20200543|P2|Overall Study|subject withdrew after randomization|0
5844003|NCT02276222|20200544|P1|Overall Study|subject withdrew after randomization|1
5844004|NCT02276222|20200543|P2|Overall Study|sheduling conflict|0
5844005|NCT02276222|20200544|P1|Overall Study|sheduling conflict|1
5844006|NCT02276222|20200543|P2|Overall Study|Physician Decision|1
5844007|NCT02276222|20200544|P1|Overall Study|Physician Decision|2
5844008|NCT02276222|20200543|P2|Overall Study|Lost to Follow-up|5
5844009|NCT02276222|20200544|P1|Overall Study|Lost to Follow-up|15
5844010|NCT02276222|20200543|P2|Overall Study|sponsor decision|3
5844011|NCT02276222|20200544|P1|Overall Study|sponsor decision|0
5844012|NCT02276222|20200543|P2|Overall Study|non compliance with study medication|2
5844013|NCT02276222|20200544|P1|Overall Study|non compliance with study medication|6
5844014|NCT02276222|20200543|P2|Overall Study|Withdrawal by Subject|33
5844015|NCT02276222|20200544|P1|Overall Study|Withdrawal by Subject|79
5844016|NCT02276222|20200543|P2|Overall Study|Protocol Violation|2
5844017|NCT02276222|20200544|P1|Overall Study|Protocol Violation|3
5844018|NCT02276222|20200543|P2|Overall Study|Lack of Efficacy|3
5844019|NCT02276222|20200544|P1|Overall Study|Lack of Efficacy|13
5844020|NCT02276222|20200543|P2|Overall Study|Death|4
5844021|NCT02276222|20200544|P1|Overall Study|Death|3
5844022|NCT02276222|20200543|P2|Overall Study|Adverse Event|11
5844023|NCT02276222|20200544|P1|Overall Study|Adverse Event|62
5844024|NCT02276053|20200568|P1|Overall Study|Patient needs to increase baseline AED|1
5844025|NCT02276053|20200568|P1|Overall Study|Patient does not meet selection criteria|3
5844026|NCT02276053|20200568|P1|Overall Study|Withdrawal by Subject|1
5844027|NCT02276053|20200568|P1|Overall Study|Lack of Efficacy|2
5844028|NCT02276053|20200568|P1|Overall Study|Adverse Event|5
5844029|NCT02276053|20200568|P1|Overall Study|Death|2
5844030|NCT02276040|20200584|P1|Overall Study|Physician Decision|15
5844031|NCT02276027|20200592|P4|Overall Study|Adverse Event|2
5844032|NCT02276027|20200593|P3|Overall Study|Adverse Event|8
5844033|NCT02276027|20200594|P2|Overall Study|Adverse Event|2
5844034|NCT02276027|20200595|P1|Overall Study|Adverse Event|0
5844035|NCT02276027|20200592|P4|Overall Study|Subject/guardian decision|3
5844036|NCT02276027|20200593|P3|Overall Study|Subject/guardian decision|0
5844037|NCT02276027|20200594|P2|Overall Study|Subject/guardian decision|1
5844038|NCT02276027|20200595|P1|Overall Study|Subject/guardian decision|0
5844039|NCT02276027|20200592|P4|Overall Study|Progressive disease|14
5844040|NCT02276027|20200593|P3|Overall Study|Progressive disease|12
5844041|NCT02276027|20200594|P2|Overall Study|Progressive disease|13
5844042|NCT02276027|20200595|P1|Overall Study|Progressive disease|1
5844043|NCT02276027|20200592|P4|Overall Study|Physician Decision|1
5844044|NCT02276027|20200593|P3|Overall Study|Physician Decision|0
5844045|NCT02276027|20200594|P2|Overall Study|Physician Decision|0
5844046|NCT02276027|20200595|P1|Overall Study|Physician Decision|0
5844047|NCT02276027|20200592|P4|Overall Study|Death|2
5844048|NCT02276027|20200593|P3|Overall Study|Death|0
5844049|NCT02276027|20200594|P2|Overall Study|Death|0
5844050|NCT02276027|20200595|P1|Overall Study|Death|1
5844073|NCT02275611|20200701|P4|Inpatient Withdrawal|Withdrawal by Subject|0
5844074|NCT02275611|20200702|P3|Inpatient Withdrawal|Withdrawal by Subject|0
5844075|NCT02275611|20200703|P2|Inpatient Withdrawal|Withdrawal by Subject|0
5844076|NCT02275611|20200704|P1|Inpatient Withdrawal|Withdrawal by Subject|1
5844077|NCT02275546|20200716|P2|Treatment Period 2|Protocol Violation|1
5844078|NCT02275546|20200717|P1|Treatment Period 2|Protocol Violation|0
5844079|NCT02275546|20200716|P2|Treatment Period 2|Withdrawal by Subject|1
5844080|NCT02275546|20200717|P1|Treatment Period 2|Withdrawal by Subject|2
5844081|NCT02275481|20200727|P2|Overall Study|Physician Decision|1
5844082|NCT02275481|20200728|P1|Overall Study|Physician Decision|0
5844083|NCT02275481|20200727|P2|Overall Study|all other reasons combined|1
5844084|NCT02275481|20200728|P1|Overall Study|all other reasons combined|2
5844085|NCT02275481|20200727|P2|Overall Study|Withdrawal by Subject|0
5844086|NCT02275481|20200728|P1|Overall Study|Withdrawal by Subject|3
5844087|NCT02275481|20200727|P2|Overall Study|Lost to Follow-up|0
5844088|NCT02275481|20200728|P1|Overall Study|Lost to Follow-up|2
5844089|NCT02275481|20200727|P2|Overall Study|Death|1
5844090|NCT02275481|20200728|P1|Overall Study|Death|2
5844091|NCT02275364|20200734|P2|Period 1|Other reason|0
5844092|NCT02275364|20200735|P1|Period 1|Other reason|1
5844093|NCT02275364|20200734|P2|Period 1|Withdrawal by Subject|0
5844094|NCT02275364|20200735|P1|Period 1|Withdrawal by Subject|1
5844095|NCT02275338|20200764|P1|Overall Study|Does not meet entry criteria|1
5844096|NCT02275338|20200764|P1|Overall Study|Reason not specified|5
5844097|NCT02275338|20200764|P1|Overall Study|Ineligible to start Phase 2|4
5844098|NCT02275338|20200764|P1|Overall Study|Disease progression (death)|1
5844099|NCT02275338|20200764|P1|Overall Study|Withdrawal by Subject|4
5844100|NCT02275338|20200764|P1|Overall Study|Lack of Efficacy|3
5844101|NCT02275338|20200764|P1|Overall Study|Adverse Event|15
5844102|NCT02275117|20200813|P5|Overall Study|Other|2
5844103|NCT02275117|20200814|P4|Overall Study|Other|0
5844104|NCT02275117|20200815|P3|Overall Study|Other|0
5844105|NCT02275117|20200816|P2|Overall Study|Other|0
5844106|NCT02275117|20200817|P1|Overall Study|Other|1
5844107|NCT02275117|20200813|P5|Overall Study|Study Burden|7
5844108|NCT02275117|20200814|P4|Overall Study|Study Burden|5
5844109|NCT02275117|20200815|P3|Overall Study|Study Burden|7
5844110|NCT02275117|20200816|P2|Overall Study|Study Burden|4
5844111|NCT02275117|20200817|P1|Overall Study|Study Burden|5
5844112|NCT02275117|20200813|P5|Overall Study|Worsening of Study Indication|0
5844113|NCT02275117|20200814|P4|Overall Study|Worsening of Study Indication|0
5844114|NCT02275117|20200815|P3|Overall Study|Worsening of Study Indication|2
5844115|NCT02275117|20200816|P2|Overall Study|Worsening of Study Indication|1
5844116|NCT02275117|20200817|P1|Overall Study|Worsening of Study Indication|0
5844117|NCT02275117|20200813|P5|Overall Study|Terminated by Sponsor|4
5844118|NCT02275117|20200814|P4|Overall Study|Terminated by Sponsor|6
5844119|NCT02275117|20200815|P3|Overall Study|Terminated by Sponsor|4
5844120|NCT02275117|20200816|P2|Overall Study|Terminated by Sponsor|4
5844121|NCT02275117|20200817|P1|Overall Study|Terminated by Sponsor|4
5844122|NCT02275117|20200813|P5|Overall Study|Withdrawal by Subject|3
5844123|NCT02275117|20200814|P4|Overall Study|Withdrawal by Subject|3
5844124|NCT02275117|20200815|P3|Overall Study|Withdrawal by Subject|7
5844125|NCT02275117|20200816|P2|Overall Study|Withdrawal by Subject|4
5844126|NCT02275117|20200817|P1|Overall Study|Withdrawal by Subject|6
5844127|NCT02275117|20200813|P5|Overall Study|Protocol Violation|0
5844128|NCT02275117|20200814|P4|Overall Study|Protocol Violation|1
5844129|NCT02275117|20200815|P3|Overall Study|Protocol Violation|1
5844130|NCT02275117|20200816|P2|Overall Study|Protocol Violation|0
5844131|NCT02275117|20200817|P1|Overall Study|Protocol Violation|1
5844132|NCT02275117|20200813|P5|Overall Study|Physician Decision|1
5844133|NCT02275117|20200814|P4|Overall Study|Physician Decision|0
5844134|NCT02275117|20200815|P3|Overall Study|Physician Decision|1
5844135|NCT02275117|20200816|P2|Overall Study|Physician Decision|1
5844136|NCT02275117|20200817|P1|Overall Study|Physician Decision|0
5844137|NCT02275117|20200813|P5|Overall Study|Lost to Follow-up|8
5844138|NCT02275117|20200814|P4|Overall Study|Lost to Follow-up|16
5844139|NCT02275117|20200815|P3|Overall Study|Lost to Follow-up|15
5844140|NCT02275117|20200816|P2|Overall Study|Lost to Follow-up|16
5844141|NCT02275117|20200817|P1|Overall Study|Lost to Follow-up|11
5844142|NCT02275117|20200813|P5|Overall Study|Lack of Efficacy|10
5844143|NCT02275117|20200814|P4|Overall Study|Lack of Efficacy|2
5844144|NCT02275117|20200815|P3|Overall Study|Lack of Efficacy|5
5844145|NCT02275117|20200816|P2|Overall Study|Lack of Efficacy|7
5844146|NCT02275117|20200817|P1|Overall Study|Lack of Efficacy|6
5844147|NCT02275117|20200813|P5|Overall Study|Adverse Event|1
5844148|NCT02275117|20200814|P4|Overall Study|Adverse Event|0
5844149|NCT02275117|20200815|P3|Overall Study|Adverse Event|0
5844150|NCT02275117|20200816|P2|Overall Study|Adverse Event|0
5844151|NCT02275117|20200817|P1|Overall Study|Adverse Event|0
5844152|NCT02275065|20200929|P5|Overall Study|Randomized but not treated|0
5844153|NCT02275065|20200930|P4|Overall Study|Randomized but not treated|1
5844154|NCT02275065|20200931|P3|Overall Study|Randomized but not treated|1
5844155|NCT02275065|20200932|P2|Overall Study|Randomized but not treated|0
5844156|NCT02275065|20200933|P1|Overall Study|Randomized but not treated|1
5844157|NCT02275052|20201014|P4|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|2
5844158|NCT02275052|20201015|P3|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
5844159|NCT02275052|20201016|P2|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
5844160|NCT02275052|20201017|P1|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
5844161|NCT02275052|20201014|P4|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|6
5844162|NCT02275052|20201015|P3|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|1
5844163|NCT02275052|20201016|P2|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0
5844164|NCT02275052|20201017|P1|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0
5844165|NCT02275052|20201014|P4|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|4
5844166|NCT02275052|20201015|P3|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
5844167|NCT02275052|20201016|P2|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
5844168|NCT02275052|20201017|P1|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
5844169|NCT02275052|20201014|P4|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|2
5844170|NCT02275052|20201015|P3|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|3
5844171|NCT02275052|20201016|P2|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0
5844172|NCT02275052|20201017|P1|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0
5844173|NCT02275052|20201014|P4|Washout Period (12-17 Days)|Lack of Efficacy|0
5844174|NCT02275052|20201015|P3|Washout Period (12-17 Days)|Lack of Efficacy|0
5844175|NCT02275052|20201016|P2|Washout Period (12-17 Days)|Lack of Efficacy|0
5844176|NCT02275052|20201017|P1|Washout Period (12-17 Days)|Lack of Efficacy|1
5844177|NCT02275052|20201014|P4|Washout Period (12-17 Days)|Withdrawal by Subject|0
5844178|NCT02275052|20201015|P3|Washout Period (12-17 Days)|Withdrawal by Subject|0
5844179|NCT02275052|20201016|P2|Washout Period (12-17 Days)|Withdrawal by Subject|0
5844180|NCT02275052|20201017|P1|Washout Period (12-17 Days)|Withdrawal by Subject|3
5844181|NCT02275052|20201014|P4|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0
5844182|NCT02275052|20201015|P3|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0
5844183|NCT02275052|20201016|P2|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0
5844184|NCT02275052|20201017|P1|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|2
5844185|NCT02275052|20201014|P4|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0
5844186|NCT02275052|20201015|P3|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0
5844187|NCT02275052|20201016|P2|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0
5844188|NCT02275052|20201017|P1|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|1
5844189|NCT02275052|20201014|P4|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
5844190|NCT02275052|20201015|P3|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
5844191|NCT02275052|20201016|P2|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|4
5844192|NCT02275052|20201017|P1|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|6
5844193|NCT02275052|20201014|P4|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0
5844194|NCT02275052|20201015|P3|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0
5844195|NCT02275052|20201016|P2|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|1
5844196|NCT02275052|20201017|P1|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0
5844197|NCT02275052|20201014|P4|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
5844198|NCT02275052|20201015|P3|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
5844199|NCT02275052|20201016|P2|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
5844200|NCT02275052|20201017|P1|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
5844201|NCT02274948|20201031|P2|Overall Study|Left the area|3
5844202|NCT02274948|20201032|P1|Overall Study|Left the area|4
5844203|NCT02274948|20201031|P2|Overall Study|Stopped on family Practitioner advice|5
5844204|NCT02274948|20201032|P1|Overall Study|Stopped on family Practitioner advice|2
5844205|NCT02274948|20201031|P2|Overall Study|Withdrawal by Subject|58
5844206|NCT02274948|20201032|P1|Overall Study|Withdrawal by Subject|64
5844207|NCT02274948|20201031|P2|Overall Study|Lost to Follow-up|25
5844208|NCT02274948|20201032|P1|Overall Study|Lost to Follow-up|28
5844209|NCT02274857|20201075|P2|Overall Study|Other|0
5844210|NCT02274857|20201076|P1|Overall Study|Other|2
5844211|NCT02274857|20201075|P2|Overall Study|Withdrawal by Subject|2
5844212|NCT02274857|20201076|P1|Overall Study|Withdrawal by Subject|11
5844213|NCT02274857|20201075|P2|Overall Study|Trial screen failure|2
5844214|NCT02274857|20201076|P1|Overall Study|Trial screen failure|0
5844215|NCT02274857|20201075|P2|Overall Study|Physician Decision|0
5844216|NCT02274857|20201076|P1|Overall Study|Physician Decision|2
5844217|NCT02274857|20201075|P2|Overall Study|Lost to Follow-up|0
5844218|NCT02274857|20201076|P1|Overall Study|Lost to Follow-up|3
5844219|NCT02274857|20201075|P2|Overall Study|Death|2
5844220|NCT02274857|20201076|P1|Overall Study|Death|1
5844221|NCT02274857|20201075|P2|Overall Study|Adverse Event|0
5844222|NCT02274857|20201076|P1|Overall Study|Adverse Event|1
5844223|NCT02274792|20201128|P1|Overall Study|Sponsor Decision|2
5844224|NCT02274792|20201128|P1|Overall Study|Protocol Specified Criteria|2
5844225|NCT02274792|20201128|P1|Overall Study|Lost to Follow-up|8
5844226|NCT02274792|20201128|P1|Overall Study|Withdrawal by Subject|13
5844227|NCT02274766|20201138|P2|Overall Study|Adverse Event|1
5844228|NCT02274766|20201139|P1|Overall Study|Adverse Event|0
5844229|NCT02274766|20201138|P2|Overall Study|Subject Unwilling to Proceed|1
5844230|NCT02274766|20201139|P1|Overall Study|Subject Unwilling to Proceed|0
5844231|NCT02274766|20201138|P2|Overall Study|Did Not Receive Study Drug|1
5844232|NCT02274766|20201139|P1|Overall Study|Did Not Receive Study Drug|1
5844233|NCT02274766|20201138|P2|Overall Study|Withdrawal by Subject|6
5844234|NCT02274766|20201139|P1|Overall Study|Withdrawal by Subject|3
5844235|NCT02274558|20201206|P3|Overall Study|Physician Decision|1
5844236|NCT02274558|20201207|P2|Overall Study|Physician Decision|2
5844237|NCT02274558|20201208|P1|Overall Study|Physician Decision|0
5844238|NCT02274558|20201206|P3|Overall Study|Lost to Follow-up|1
5844239|NCT02274558|20201207|P2|Overall Study|Lost to Follow-up|1
5844240|NCT02274558|20201208|P1|Overall Study|Lost to Follow-up|2
5844241|NCT02274558|20201206|P3|Overall Study|Death|1
5844242|NCT02274558|20201207|P2|Overall Study|Death|0
5844243|NCT02274558|20201208|P1|Overall Study|Death|0
5844244|NCT02274558|20201206|P3|Overall Study|Withdrawal by Subject|4
5844245|NCT02274558|20201207|P2|Overall Study|Withdrawal by Subject|5
5844246|NCT02274558|20201208|P1|Overall Study|Withdrawal by Subject|1
5844247|NCT02274558|20201206|P3|Overall Study|Non-compliance|0
5844248|NCT02274558|20201207|P2|Overall Study|Non-compliance|1
5844249|NCT02274558|20201208|P1|Overall Study|Non-compliance|2
5844250|NCT02274558|20201206|P3|Overall Study|Adverse Event|2
5844251|NCT02274558|20201207|P2|Overall Study|Adverse Event|4
5844252|NCT02274558|20201208|P1|Overall Study|Adverse Event|2
5844253|NCT02274493|20201222|P1|Overall Study|Withdrawal by Subject|1
5844254|NCT02274311|20201229|P1|Three Months of Clomiphene Wash-out|Lost to Follow-up|1
5844255|NCT02273973|20201237|P2|Overall Study|Reason not specified|1
5844256|NCT02273973|20201238|P1|Overall Study|Reason not specified|0
5844257|NCT02273973|20201237|P2|Overall Study|Physician Decision|1
5844258|NCT02273973|20201238|P1|Overall Study|Physician Decision|0
5844259|NCT02273973|20201237|P2|Overall Study|Lost to Follow-up|1
5844260|NCT02273973|20201238|P1|Overall Study|Lost to Follow-up|0
5844261|NCT02273973|20201237|P2|Overall Study|Progression of disease|2
5844262|NCT02273973|20201238|P1|Overall Study|Progression of disease|0
5844263|NCT02273973|20201237|P2|Overall Study|Protocol Violation|0
5844264|NCT02273973|20201238|P1|Overall Study|Protocol Violation|1
5844265|NCT02273973|20201237|P2|Overall Study|Non-compliance|0
5844266|NCT02273973|20201238|P1|Overall Study|Non-compliance|1
5844267|NCT02273973|20201237|P2|Overall Study|Death|0
5844268|NCT02273973|20201238|P1|Overall Study|Death|1
5844269|NCT02273973|20201237|P2|Overall Study|Withdrawal by Subject|3
5844270|NCT02273973|20201238|P1|Overall Study|Withdrawal by Subject|2
5844271|NCT02273973|20201237|P2|Overall Study|Adverse Event|0
5844272|NCT02273973|20201238|P1|Overall Study|Adverse Event|4
5844273|NCT02273960|20201282|P4|Long Term Extension|Death|1
5844274|NCT02273960|20201283|P3|Long Term Extension|Death|0
5844275|NCT02273960|20201284|P2|Long Term Extension|Death|0
5844276|NCT02273960|20201285|P1|Long Term Extension|Death|0
5844277|NCT02273960|20201282|P4|Short Term Period|ST complete, not entering LTE|5
5844278|NCT02273960|20201283|P3|Short Term Period|ST complete, not entering LTE|4
5844279|NCT02273960|20201284|P2|Short Term Period|ST complete, not entering LTE|6
5844280|NCT02273960|20201285|P1|Short Term Period|ST complete, not entering LTE|4
5844281|NCT02273960|20201282|P4|Short Term Period|Lack of Efficacy|1
5844282|NCT02273960|20201283|P3|Short Term Period|Lack of Efficacy|0
5844283|NCT02273960|20201284|P2|Short Term Period|Lack of Efficacy|0
5844284|NCT02273960|20201285|P1|Short Term Period|Lack of Efficacy|0
5844285|NCT02273960|20201282|P4|Short Term Period|Lost to Follow-up|0
5844286|NCT02273960|20201283|P3|Short Term Period|Lost to Follow-up|0
5844287|NCT02273960|20201284|P2|Short Term Period|Lost to Follow-up|0
5844288|NCT02273960|20201285|P1|Short Term Period|Lost to Follow-up|1
5844297|NCT02273752|20201352|P1|Overall Study|Trial was terminated early|2
5844298|NCT02273180|20201443|P2|Overall Study|Other than specified above|10
5844299|NCT02273180|20201444|P1|Overall Study|Other than specified above|21
5844300|NCT02273180|20201443|P2|Overall Study|Hypoglycemia(not reported as serious AE)|0
5844301|NCT02273180|20201444|P1|Overall Study|Hypoglycemia(not reported as serious AE)|1
5844302|NCT02273180|20201443|P2|Overall Study|Randomized but not treated|0
5844303|NCT02273180|20201444|P1|Overall Study|Randomized but not treated|1
5844304|NCT02273180|20201443|P2|Overall Study|Protocol Violation|7
5844305|NCT02273180|20201444|P1|Overall Study|Protocol Violation|1
5844306|NCT02273180|20201443|P2|Overall Study|Lack of Efficacy|0
5844307|NCT02273180|20201444|P1|Overall Study|Lack of Efficacy|1
5844308|NCT02273180|20201443|P2|Overall Study|Adverse Event|2
5844309|NCT02273180|20201444|P1|Overall Study|Adverse Event|2
5844310|NCT02273167|20201469|P3|Overall Study|Various|8
5844311|NCT02273167|20201470|P2|Overall Study|Various|9
5844312|NCT02273167|20201471|P1|Overall Study|Various|10
5844313|NCT02273167|20201469|P3|Overall Study|Withdrawal by Subject|11
5844314|NCT02273167|20201470|P2|Overall Study|Withdrawal by Subject|12
5844315|NCT02273167|20201471|P1|Overall Study|Withdrawal by Subject|10
5844316|NCT02273167|20201469|P3|Overall Study|Lost to Follow-up|1
5844317|NCT02273167|20201470|P2|Overall Study|Lost to Follow-up|1
5844318|NCT02273167|20201471|P1|Overall Study|Lost to Follow-up|0
5844319|NCT02273167|20201469|P3|Overall Study|Protocol Violation|1
5844320|NCT02273167|20201470|P2|Overall Study|Protocol Violation|1
5844321|NCT02273167|20201471|P1|Overall Study|Protocol Violation|3
5844322|NCT02273167|20201469|P3|Overall Study|Adverse Event|0
5844323|NCT02273167|20201470|P2|Overall Study|Adverse Event|0
5844324|NCT02273167|20201471|P1|Overall Study|Adverse Event|1
5844325|NCT02273141|20201496|P2|Overall Study|Various|6
5844326|NCT02273141|20201497|P1|Overall Study|Various|6
5844327|NCT02273141|20201496|P2|Overall Study|Withdrawal by Subject|15
5844328|NCT02273141|20201497|P1|Overall Study|Withdrawal by Subject|10
5844329|NCT02273141|20201496|P2|Overall Study|Lost to Follow-up|3
5844330|NCT02273141|20201497|P1|Overall Study|Lost to Follow-up|1
5844331|NCT02273141|20201496|P2|Overall Study|Adverse Event|1
5844332|NCT02273141|20201497|P1|Overall Study|Adverse Event|0
5844333|NCT02273050|20201570|P3|Overall Study|Protocol Violation|4
5844334|NCT02273050|20201571|P2|Overall Study|Protocol Violation|1
5844335|NCT02273050|20201572|P1|Overall Study|Protocol Violation|3
5844336|NCT02273050|20201570|P3|Overall Study|Lost to Follow-up|3
5844337|NCT02273050|20201571|P2|Overall Study|Lost to Follow-up|2
5844338|NCT02273050|20201572|P1|Overall Study|Lost to Follow-up|0
5844339|NCT02273050|20201570|P3|Overall Study|Withdrawal by Subject|16
5844340|NCT02273050|20201571|P2|Overall Study|Withdrawal by Subject|14
5844341|NCT02273050|20201572|P1|Overall Study|Withdrawal by Subject|17
5844342|NCT02273050|20201570|P3|Overall Study|Lack of Efficacy|1
5844343|NCT02273050|20201571|P2|Overall Study|Lack of Efficacy|1
5844344|NCT02273050|20201572|P1|Overall Study|Lack of Efficacy|0
5844345|NCT02273050|20201570|P3|Overall Study|Dev. of study spec. withdrawal criteria|1
5844346|NCT02273050|20201571|P2|Overall Study|Dev. of study spec. withdrawal criteria|1
5844347|NCT02273050|20201572|P1|Overall Study|Dev. of study spec. withdrawal criteria|0
5844348|NCT02273050|20201570|P3|Overall Study|Death|1
5844349|NCT02273050|20201571|P2|Overall Study|Death|0
5844350|NCT02273050|20201572|P1|Overall Study|Death|0
5844351|NCT02273050|20201570|P3|Overall Study|Adverse Event|3
5844352|NCT02273050|20201571|P2|Overall Study|Adverse Event|3
5844353|NCT02273050|20201572|P1|Overall Study|Adverse Event|4
5844354|NCT02273037|20201600|P2|Overall Study|Other complication|0
5844355|NCT02273037|20201601|P1|Overall Study|Other complication|2
5844356|NCT02273037|20201600|P2|Overall Study|Multiple delivery|2
5844357|NCT02273037|20201601|P1|Overall Study|Multiple delivery|2
5844358|NCT02273037|20201600|P2|Overall Study|Breech delivery|3
5844359|NCT02273037|20201601|P1|Overall Study|Breech delivery|2
5844360|NCT02273037|20201600|P2|Overall Study|Delivered before monitoring initiated|3
5844361|NCT02273037|20201601|P1|Overall Study|Delivered before monitoring initiated|1
5844362|NCT02273037|20201600|P2|Overall Study|Lost to Follow-up|0
5844363|NCT02273037|20201601|P1|Overall Study|Lost to Follow-up|1
5844364|NCT02272985|20201611|P1|Overall Study|kidney transplantation|1
5844365|NCT02272985|20201611|P1|Overall Study|hip fracture|1
5844366|NCT02272985|20201611|P1|Overall Study|Withdrawal by Subject|1
5844367|NCT02272816|20201616|P1|Overall Study|Adverse Event|1
5844368|NCT02272803|20201624|P2|Overall Study|Withdrawal by Subject|0
5844369|NCT02272803|20201625|P1|Overall Study|Withdrawal by Subject|1
5844370|NCT02272803|20201624|P2|Overall Study|Poor/non-compliance|1
5844371|NCT02272803|20201625|P1|Overall Study|Poor/non-compliance|0
5844372|NCT02272803|20201624|P2|Overall Study|Subject moved to care facility|1
5844373|NCT02272803|20201625|P1|Overall Study|Subject moved to care facility|0
5844374|NCT02272803|20201624|P2|Overall Study|Maximum clinical benefit|1
5844375|NCT02272803|20201625|P1|Overall Study|Maximum clinical benefit|1
5844376|NCT02272803|20201624|P2|Overall Study|Subj request to discontinue study trt|4
5844377|NCT02272803|20201625|P1|Overall Study|Subj request to discontinue study trt|1
5844378|NCT02272803|20201624|P2|Overall Study|Study drug toxicity|4
5844379|NCT02272803|20201625|P1|Overall Study|Study drug toxicity|1
5844380|NCT02272803|20201624|P2|Overall Study|Adverse Event unrelated to study drug|4
5844381|NCT02272803|20201625|P1|Overall Study|Adverse Event unrelated to study drug|1
5844382|NCT02272803|20201624|P2|Overall Study|Disease progression|2
5844383|NCT02272803|20201625|P1|Overall Study|Disease progression|4
5844390|NCT02272777|20201783|P2|Overall Study|Other|0
5844391|NCT02272777|20201784|P1|Overall Study|Other|2
5844392|NCT02272777|20201783|P2|Overall Study|Lost to Follow-up|0
5844393|NCT02272777|20201784|P1|Overall Study|Lost to Follow-up|2
5844394|NCT02272777|20201783|P2|Overall Study|Withdrawal by Subject|3
5844395|NCT02272777|20201784|P1|Overall Study|Withdrawal by Subject|0
5844396|NCT02272777|20201783|P2|Overall Study|Adverse Event|1
5844397|NCT02272777|20201784|P1|Overall Study|Adverse Event|0
5844398|NCT02272725|20201792|P2|Overall Study|equipment malfunction|0
5844399|NCT02272725|20201793|P1|Overall Study|equipment malfunction|2
5844400|NCT02272413|20201810|P2|Post-switch Period|Other than listed|5
5844401|NCT02272413|20201811|P1|Post-switch Period|Other than listed|4
5844402|NCT02272413|20201810|P2|Post-switch Period|Study terminated by sponsor|11
5844403|NCT02272413|20201811|P1|Post-switch Period|Study terminated by sponsor|8
5844404|NCT02272413|20201810|P2|Post-switch Period|Progressive disease|21
5844405|NCT02272413|20201811|P1|Post-switch Period|Progressive disease|21
5844406|NCT02272413|20201810|P2|Post-switch Period|Physician Decision|1
5844407|NCT02272413|20201811|P1|Post-switch Period|Physician Decision|1
5844408|NCT02272413|20201810|P2|Post-switch Period|Withdrawal by Subject|2
5844409|NCT02272413|20201811|P1|Post-switch Period|Withdrawal by Subject|1
5844410|NCT02272413|20201810|P2|Post-switch Period|Death|2
5844411|NCT02272413|20201811|P1|Post-switch Period|Death|3
5844412|NCT02272413|20201810|P2|Post-switch Period|Adverse Event|4
5844413|NCT02272413|20201811|P1|Post-switch Period|Adverse Event|4
5844414|NCT02272413|20201810|P2|Pre-switch Period|Other than listed|11
5844415|NCT02272413|20201811|P1|Pre-switch Period|Other than listed|10
5844416|NCT02272413|20201810|P2|Pre-switch Period|Protocol Violation|0
5844417|NCT02272413|20201811|P1|Pre-switch Period|Protocol Violation|1
5844418|NCT02272413|20201810|P2|Pre-switch Period|Lost to Follow-up|2
5844419|NCT02272413|20201811|P1|Pre-switch Period|Lost to Follow-up|0
5844420|NCT02272413|20201810|P2|Pre-switch Period|Progressive disease|173
5844421|NCT02272413|20201811|P1|Pre-switch Period|Progressive disease|185
5844422|NCT02272413|20201810|P2|Pre-switch Period|Physician Decision|18
5844423|NCT02272413|20201811|P1|Pre-switch Period|Physician Decision|6
5844424|NCT02272413|20201810|P2|Pre-switch Period|Withdrawal by Subject|15
5844425|NCT02272413|20201811|P1|Pre-switch Period|Withdrawal by Subject|27
5844426|NCT02272413|20201810|P2|Pre-switch Period|Death|26
5844427|NCT02272413|20201811|P1|Pre-switch Period|Death|26
5844428|NCT02272413|20201810|P2|Pre-switch Period|Adverse Event|37
5844429|NCT02272413|20201811|P1|Pre-switch Period|Adverse Event|38
5844430|NCT02272413|20201810|P2|Randomized Through Treatment Start|Not treated|5
5844431|NCT02272413|20201811|P1|Randomized Through Treatment Start|Not treated|3
5844432|NCT02271984|20201842|P12|Washout Period 4 (7 Days)|Withdrawal by Subject|0
5844433|NCT02271984|20201843|P11|Washout Period 4 (7 Days)|Withdrawal by Subject|0
5844434|NCT02271984|20201844|P10|Washout Period 4 (7 Days)|Withdrawal by Subject|0
5844435|NCT02271984|20201845|P9|Washout Period 4 (7 Days)|Withdrawal by Subject|0
5844436|NCT02271984|20201846|P8|Washout Period 4 (7 Days)|Withdrawal by Subject|1
5844437|NCT02271984|20201847|P7|Washout Period 4 (7 Days)|Withdrawal by Subject|0
5844438|NCT02271984|20201848|P6|Washout Period 4 (7 Days)|Withdrawal by Subject|1
5844439|NCT02271984|20201849|P5|Washout Period 4 (7 Days)|Withdrawal by Subject|0
5844440|NCT02271984|20201850|P4|Washout Period 4 (7 Days)|Withdrawal by Subject|0
5844441|NCT02271984|20201851|P3|Washout Period 4 (7 Days)|Withdrawal by Subject|0
5844442|NCT02271984|20201852|P2|Washout Period 4 (7 Days)|Withdrawal by Subject|0
5844443|NCT02271984|20201853|P1|Washout Period 4 (7 Days)|Withdrawal by Subject|0
5844444|NCT02271945|20201942|P2|Overall Study|Other|1
5844445|NCT02271945|20201943|P1|Overall Study|Other|1
5844446|NCT02271945|20201942|P2|Overall Study|Withdrawal by Subject|1
5844447|NCT02271945|20201943|P1|Overall Study|Withdrawal by Subject|1
5844448|NCT02271945|20201942|P2|Overall Study|Death|3
5844449|NCT02271945|20201943|P1|Overall Study|Death|3
5844450|NCT02271880|20201986|P2|Overall Study|Premature discontinuation of study|4
5844451|NCT02271880|20201987|P1|Overall Study|Premature discontinuation of study|3
5844452|NCT02271854|20202017|P1|Overall Study|Lost to Follow-up|1
5844453|NCT02271854|20202017|P1|Overall Study|Unable or unwilling to cooperate with st|1
5844454|NCT02271854|20202017|P1|Overall Study|Withdrawal by Subject|2
5844455|NCT02271529|20202057|P1|Overall Study|Withdrawal by Subject|1
5844456|NCT02270983|20202178|P3|Overall Study|moved away from study site|0
5844457|NCT02270983|20202179|P2|Overall Study|moved away from study site|1
5844458|NCT02270983|20202180|P1|Overall Study|moved away from study site|0
5844459|NCT02270983|20202178|P3|Overall Study|study procedure non-compliance|0
5844460|NCT02270983|20202179|P2|Overall Study|study procedure non-compliance|0
5844461|NCT02270983|20202180|P1|Overall Study|study procedure non-compliance|1
5844462|NCT02270983|20202178|P3|Overall Study|family emergency|0
5844463|NCT02270983|20202179|P2|Overall Study|family emergency|1
5844464|NCT02270983|20202180|P1|Overall Study|family emergency|0
5844465|NCT02270983|20202178|P3|Overall Study|Protocol Violation|1
5844466|NCT02270983|20202179|P2|Overall Study|Protocol Violation|1
5844467|NCT02270983|20202180|P1|Overall Study|Protocol Violation|1
5844468|NCT02270983|20202178|P3|Overall Study|Lost to Follow-up|2
5844469|NCT02270983|20202179|P2|Overall Study|Lost to Follow-up|1
5844470|NCT02270983|20202180|P1|Overall Study|Lost to Follow-up|1
5844471|NCT02270983|20202178|P3|Overall Study|Withdrawal by Subject|2
5844472|NCT02270983|20202179|P2|Overall Study|Withdrawal by Subject|0
5844473|NCT02270983|20202180|P1|Overall Study|Withdrawal by Subject|1
5844474|NCT02270983|20202178|P3|Overall Study|Lack of Efficacy|1
5844475|NCT02270983|20202179|P2|Overall Study|Lack of Efficacy|1
5844476|NCT02270983|20202180|P1|Overall Study|Lack of Efficacy|2
5844477|NCT02270983|20202178|P3|Overall Study|Adverse Event|6
5844478|NCT02270983|20202179|P2|Overall Study|Adverse Event|2
5844479|NCT02270983|20202180|P1|Overall Study|Adverse Event|3
5844480|NCT02270957|20202205|P2|Overall Study|Adverse Event|0
5844481|NCT02270957|20202206|P1|Overall Study|Adverse Event|2
5844482|NCT02270957|20202205|P2|Overall Study|Lack of Efficacy|4
5844483|NCT02270957|20202206|P1|Overall Study|Lack of Efficacy|2
5844484|NCT02270944|20202218|P2|Overall Study|Withdrawal by Subject|1
5844485|NCT02270944|20202219|P1|Overall Study|Withdrawal by Subject|2
5844486|NCT02270944|20202218|P2|Overall Study|Lost to Follow-up|4
5844487|NCT02270944|20202219|P1|Overall Study|Lost to Follow-up|9
5844488|NCT02270736|20202238|P5|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0
5844489|NCT02270736|20202239|P4|OLEX Period (up to 48 Weeks)|Lost to Follow-up|2
5844490|NCT02270736|20202240|P3|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0
5844491|NCT02270736|20202241|P2|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0
5844492|NCT02270736|20202242|P1|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0
5844493|NCT02270736|20202238|P5|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0
5844494|NCT02270736|20202239|P4|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|16
5844495|NCT02270736|20202240|P3|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0
5844496|NCT02270736|20202241|P2|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0
5844497|NCT02270736|20202242|P1|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0
5844498|NCT02270736|20202238|P5|OLEX Period (up to 48 Weeks)|Adverse Event|0
5844499|NCT02270736|20202239|P4|OLEX Period (up to 48 Weeks)|Adverse Event|4
5844500|NCT02270736|20202240|P3|OLEX Period (up to 48 Weeks)|Adverse Event|0
5844501|NCT02270736|20202241|P2|OLEX Period (up to 48 Weeks)|Adverse Event|0
5844502|NCT02270736|20202242|P1|OLEX Period (up to 48 Weeks)|Adverse Event|0
5844503|NCT02270736|20202238|P5|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0
5844504|NCT02270736|20202239|P4|OLEX Period (up to 48 Weeks)|Lack of Efficacy|2
5844505|NCT02270736|20202240|P3|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0
5844506|NCT02270736|20202241|P2|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0
5844507|NCT02270736|20202242|P1|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0
5844508|NCT02270736|20202238|P5|OLEX Period (up to 48 Weeks)|Physician Decision|0
5844509|NCT02270736|20202239|P4|OLEX Period (up to 48 Weeks)|Physician Decision|1
5844510|NCT02270736|20202240|P3|OLEX Period (up to 48 Weeks)|Physician Decision|0
5844511|NCT02270736|20202241|P2|OLEX Period (up to 48 Weeks)|Physician Decision|0
5844512|NCT02270736|20202242|P1|OLEX Period (up to 48 Weeks)|Physician Decision|0
5844513|NCT02270736|20202238|P5|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0
5844514|NCT02270736|20202239|P4|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0
5844515|NCT02270736|20202240|P3|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|1
5844516|NCT02270736|20202241|P2|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0
5844517|NCT02270736|20202242|P1|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0
5844518|NCT02270736|20202238|P5|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0
5844519|NCT02270736|20202239|P4|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0
5844520|NCT02270736|20202240|P3|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0
5844521|NCT02270736|20202241|P2|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|1
5844522|NCT02270736|20202242|P1|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0
5844523|NCT02270736|20202238|P5|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0
5844524|NCT02270736|20202239|P4|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0
5844525|NCT02270736|20202240|P3|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|1
5844526|NCT02270736|20202241|P2|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0
5844527|NCT02270736|20202242|P1|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|2
5844528|NCT02270736|20202238|P5|Main Period (MP) (up to 16 Weeks)|Adverse Event|0
5844529|NCT02270736|20202239|P4|Main Period (MP) (up to 16 Weeks)|Adverse Event|0
5844530|NCT02270736|20202240|P3|Main Period (MP) (up to 16 Weeks)|Adverse Event|0
5844531|NCT02270736|20202241|P2|Main Period (MP) (up to 16 Weeks)|Adverse Event|1
5844532|NCT02270736|20202242|P1|Main Period (MP) (up to 16 Weeks)|Adverse Event|0
5844533|NCT02270684|20202284|P2|Overall Study|Study terminated|0
5844534|NCT02270684|20202285|P1|Overall Study|Study terminated|1
5844535|NCT02270684|20202284|P2|Overall Study|Lost to Follow-up|3
5844536|NCT02270684|20202285|P1|Overall Study|Lost to Follow-up|0
5844537|NCT02270671|20202293|P2|Overall Study|Lost to Follow-up|1
5844538|NCT02270671|20202294|P1|Overall Study|Lost to Follow-up|2
5844539|NCT02270671|20202293|P2|Overall Study|Missed Post-intervention Data Collection|2
5844540|NCT02270671|20202294|P1|Overall Study|Missed Post-intervention Data Collection|2
5844541|NCT02270671|20202293|P2|Overall Study|Protocol Violation|1
5844542|NCT02270671|20202294|P1|Overall Study|Protocol Violation|0
5844543|NCT02270671|20202293|P2|Overall Study|Withdrawal by Subject|1
5844544|NCT02270671|20202294|P1|Overall Study|Withdrawal by Subject|1
5844545|NCT02270515|20202319|P1|Intervention Period 3: 12-18 Months|Intervention ended before follow-up|16
5844546|NCT02270515|20202319|P1|Intervention Period 3: 12-18 Months|Death|3
5844547|NCT02270515|20202319|P1|Intervention Period 3: 12-18 Months|Received transplant|2
5844548|NCT02270515|20202319|P1|Intervention Period 3: 12-18 Months|No longer patient at study site|2
5844549|NCT02270515|20202319|P1|Intervention Period 3: 12-18 Months|Withdrawal by Subject|1
5844550|NCT02270515|20202319|P1|Intervention Period 2: 6-12 Months|Intervention ended before follow-up|17
5844551|NCT02270515|20202319|P1|Intervention Period 2: 6-12 Months|Death|5
5844552|NCT02270515|20202319|P1|Intervention Period 2: 6-12 Months|Received transplant|1
5844553|NCT02270515|20202319|P1|Intervention Period 2: 6-12 Months|No longer patient at study site|7
5844554|NCT02270515|20202319|P1|Intervention Period 2: 6-12 Months|Withdrawal by Subject|2
5844555|NCT02270515|20202319|P1|Intervention Period 1: 0-6 Months|Death|7
5844556|NCT02270515|20202319|P1|Intervention Period 1: 0-6 Months|Received transplant|3
5844557|NCT02270515|20202319|P1|Intervention Period 1: 0-6 Months|No longer patient at study site|5
5844558|NCT02270515|20202319|P1|Intervention Period 1: 0-6 Months|Withdrawal by Subject|1
5844559|NCT02270242|20202347|P2|Overall Study|Physician Decision|1
5844560|NCT02270242|20202348|P1|Overall Study|Physician Decision|0
5844561|NCT02270242|20202347|P2|Overall Study|Lost to Follow-up|27
5844562|NCT02270242|20202348|P1|Overall Study|Lost to Follow-up|41
5844563|NCT02270242|20202347|P2|Overall Study|Withdrawal by Subject|25
5844564|NCT02270242|20202348|P1|Overall Study|Withdrawal by Subject|18
5844565|NCT02269943|20202389|P2|Follow-Up Survival Period|Alive|8
5844566|NCT02269943|20202390|P1|Follow-Up Survival Period|Alive|2
5844567|NCT02269943|20202389|P2|Follow-Up Survival Period|Lost to Follow-up|2
5844568|NCT02269943|20202390|P1|Follow-Up Survival Period|Lost to Follow-up|0
5844569|NCT02269943|20202389|P2|Follow-Up Survival Period|Death|16
5844570|NCT02269943|20202390|P1|Follow-Up Survival Period|Death|3
5844571|NCT02269943|20202389|P2|Treatment Period|Symptomatic Deterioration|2
5844572|NCT02269943|20202390|P1|Treatment Period|Symptomatic Deterioration|0
5844573|NCT02269943|20202389|P2|Treatment Period|Progressive Disease|17
5844574|NCT02269943|20202390|P1|Treatment Period|Progressive Disease|5
5844575|NCT02269943|20202389|P2|Treatment Period|Adverse Event|10
5844576|NCT02269943|20202390|P1|Treatment Period|Adverse Event|1
5844577|NCT02269943|20202389|P2|Treatment Period|Death|1
5844578|NCT02269943|20202390|P1|Treatment Period|Death|0
5844579|NCT02269917|20202420|P2|Overall Study|Randomized but not treated|5
5844580|NCT02269917|20202421|P1|Overall Study|Randomized but not treated|3
5844581|NCT02269917|20202420|P2|Overall Study|Non-compliance with study drug|0
5844582|NCT02269917|20202421|P1|Overall Study|Non-compliance with study drug|2
5844583|NCT02269917|20202420|P2|Overall Study|Adverse Event|4
5844584|NCT02269917|20202421|P1|Overall Study|Adverse Event|11
5844585|NCT02269917|20202420|P2|Overall Study|Withdrawal by Subject|8
5844586|NCT02269917|20202421|P1|Overall Study|Withdrawal by Subject|9
5844587|NCT02269917|20202420|P2|Overall Study|Other|3
5844588|NCT02269917|20202421|P1|Overall Study|Other|6
5844589|NCT02269917|20202420|P2|Overall Study|Ongoing|360
5844590|NCT02269917|20202421|P1|Overall Study|Ongoing|731
5844591|NCT02269917|20202420|P2|Overall Study|Lost to Follow-up|3
5844592|NCT02269917|20202421|P1|Overall Study|Lost to Follow-up|4
5844593|NCT02269787|20202474|P2|Overall Study|Incapacitated|1
5844594|NCT02269787|20202475|P1|Overall Study|Incapacitated|0
5844595|NCT02269787|20202474|P2|Overall Study|Death|3
5844596|NCT02269787|20202475|P1|Overall Study|Death|2
5844597|NCT02269787|20202474|P2|Overall Study|Lost to Follow-up|6
5844598|NCT02269787|20202475|P1|Overall Study|Lost to Follow-up|20
5844599|NCT02269709|20202481|P1|Six Month Follow-up|Lost to Follow-up|12
5844600|NCT02269709|20202481|P1|Follow-up #1 (24-72 Hours Post-surgery)|Lost to Follow-up|1
5844601|NCT02269709|20202481|P1|Time of Enrollment|Withdrawal by Subject|3
5844602|NCT02269657|20202486|P1|Overall Study|Protocol Violation|3
5844603|NCT02269475|20202523|P2|Overall Study|Withdrawal by Subject|1
5844604|NCT02269475|20202524|P1|Overall Study|Withdrawal by Subject|0
5844605|NCT02269475|20202523|P2|Overall Study|Meet Exclusion Criteria No. 17|0
5844606|NCT02269475|20202524|P1|Overall Study|Meet Exclusion Criteria No. 17|3
5844607|NCT02269423|20202539|P4|Overall Study|Discontinued due to change in residence|1
5844608|NCT02269423|20202540|P3|Overall Study|Discontinued due to change in residence|0
5844609|NCT02269423|20202541|P2|Overall Study|Discontinued due to change in residence|1
5844610|NCT02269423|20202542|P1|Overall Study|Discontinued due to change in residence|0
5844611|NCT02269241|20202604|P1|Overall Study|Screening failures|546
5844612|NCT02269241|20202604|P1|Overall Study|Several reasons not classified|53
5844613|NCT02269241|20202604|P1|Overall Study|At the specific request of the sponsor|20
5844614|NCT02269241|20202604|P1|Overall Study|Adverse Event|113
5844615|NCT02269241|20202604|P1|Overall Study|Development of an exclusion criteria|16
5844616|NCT02269241|20202604|P1|Overall Study|Wish for pregnancy|5
5844617|NCT02269241|20202604|P1|Overall Study|Pregnancy|15
5844618|NCT02269241|20202604|P1|Overall Study|Physician Decision|7
5844619|NCT02269241|20202604|P1|Overall Study|Protocol Violation|1
5844620|NCT02269241|20202604|P1|Overall Study|Withdrawal by Subject|155
5844621|NCT02269241|20202604|P1|Overall Study|Lost to Follow-up|269
5844622|NCT02269098|20202618|P2|Overall Study|Lost to Follow-up|9
5844623|NCT02269098|20202619|P1|Overall Study|Lost to Follow-up|14
5844624|NCT02268864|20202680|P3|Overall Study|Death|0
5844625|NCT02268864|20202681|P2|Overall Study|Death|1
5844626|NCT02268864|20202682|P1|Overall Study|Death|0
5844627|NCT02268864|20202680|P3|Overall Study|Withdrawal by Subject|0
5844628|NCT02268864|20202681|P2|Overall Study|Withdrawal by Subject|0
5844629|NCT02268864|20202682|P1|Overall Study|Withdrawal by Subject|2
5844630|NCT02268851|20202710|P6|Overall Study|Co-Morbid Condition|1
5844631|NCT02268851|20202711|P5|Overall Study|Co-Morbid Condition|1
5844632|NCT02268851|20202712|P4|Overall Study|Co-Morbid Condition|0
5844633|NCT02268851|20202713|P3|Overall Study|Co-Morbid Condition|0
5844634|NCT02268851|20202714|P2|Overall Study|Co-Morbid Condition|0
5844635|NCT02268851|20202715|P1|Overall Study|Co-Morbid Condition|0
5844636|NCT02268851|20202710|P6|Overall Study|Patient Compliance|1
5844637|NCT02268851|20202711|P5|Overall Study|Patient Compliance|1
5844638|NCT02268851|20202712|P4|Overall Study|Patient Compliance|0
5844639|NCT02268851|20202713|P3|Overall Study|Patient Compliance|0
5844640|NCT02268851|20202714|P2|Overall Study|Patient Compliance|0
5844641|NCT02268851|20202715|P1|Overall Study|Patient Compliance|0
5844642|NCT02268851|20202710|P6|Overall Study|Physician Decision|1
5844643|NCT02268851|20202711|P5|Overall Study|Physician Decision|0
5844644|NCT02268851|20202712|P4|Overall Study|Physician Decision|0
5844645|NCT02268851|20202713|P3|Overall Study|Physician Decision|1
5844646|NCT02268851|20202714|P2|Overall Study|Physician Decision|0
5844647|NCT02268851|20202715|P1|Overall Study|Physician Decision|0
5844648|NCT02268851|20202710|P6|Overall Study|Progressive Disease|4
5844649|NCT02268851|20202711|P5|Overall Study|Progressive Disease|1
5844650|NCT02268851|20202712|P4|Overall Study|Progressive Disease|0
5844651|NCT02268851|20202713|P3|Overall Study|Progressive Disease|0
5844652|NCT02268851|20202714|P2|Overall Study|Progressive Disease|3
5844653|NCT02268851|20202715|P1|Overall Study|Progressive Disease|1
5844654|NCT02268851|20202710|P6|Overall Study|Withdrawal by Subject|1
5844655|NCT02268851|20202711|P5|Overall Study|Withdrawal by Subject|0
5844656|NCT02268851|20202712|P4|Overall Study|Withdrawal by Subject|2
5844657|NCT02268851|20202713|P3|Overall Study|Withdrawal by Subject|0
5844658|NCT02268851|20202714|P2|Overall Study|Withdrawal by Subject|0
5844659|NCT02268851|20202715|P1|Overall Study|Withdrawal by Subject|0
5844660|NCT02268851|20202710|P6|Overall Study|Adverse Event|2
5844661|NCT02268851|20202711|P5|Overall Study|Adverse Event|2
5844662|NCT02268851|20202712|P4|Overall Study|Adverse Event|0
5844663|NCT02268851|20202713|P3|Overall Study|Adverse Event|0
5844664|NCT02268851|20202714|P2|Overall Study|Adverse Event|0
5844665|NCT02268851|20202715|P1|Overall Study|Adverse Event|0
5844666|NCT02268851|20202710|P6|Overall Study|Death|1
5844667|NCT02268851|20202711|P5|Overall Study|Death|2
5844668|NCT02268851|20202712|P4|Overall Study|Death|1
5844669|NCT02268851|20202713|P3|Overall Study|Death|0
5844670|NCT02268851|20202714|P2|Overall Study|Death|0
5844671|NCT02268851|20202715|P1|Overall Study|Death|0
5844672|NCT02268812|20202733|P4|Overall Study|Other|3
5844673|NCT02268812|20202734|P3|Overall Study|Other|1
5844674|NCT02268812|20202735|P2|Overall Study|Other|4
5844675|NCT02268812|20202736|P1|Overall Study|Other|5
5844676|NCT02268812|20202733|P4|Overall Study|Physician Decision|1
5844677|NCT02268812|20202734|P3|Overall Study|Physician Decision|0
5844678|NCT02268812|20202735|P2|Overall Study|Physician Decision|1
5844679|NCT02268812|20202736|P1|Overall Study|Physician Decision|3
5844680|NCT02268812|20202733|P4|Overall Study|Withdrawal by Subject|0
5844681|NCT02268812|20202734|P3|Overall Study|Withdrawal by Subject|0
5844682|NCT02268812|20202735|P2|Overall Study|Withdrawal by Subject|1
5844683|NCT02268812|20202736|P1|Overall Study|Withdrawal by Subject|0
5844684|NCT02268812|20202733|P4|Overall Study|Protocol deviation|0
5844685|NCT02268812|20202734|P3|Overall Study|Protocol deviation|1
5844686|NCT02268812|20202735|P2|Overall Study|Protocol deviation|0
5844687|NCT02268812|20202736|P1|Overall Study|Protocol deviation|0
5844688|NCT02268812|20202733|P4|Overall Study|Adverse Event|10
5844689|NCT02268812|20202734|P3|Overall Study|Adverse Event|7
5844690|NCT02268812|20202735|P2|Overall Study|Adverse Event|26
5844691|NCT02268812|20202736|P1|Overall Study|Adverse Event|8
5844692|NCT02268786|20202768|P2|Overall Study|Protocol Violation|0
5844693|NCT02268786|20202769|P1|Overall Study|Protocol Violation|1
5844694|NCT02268786|20202768|P2|Overall Study|Thaw Failure|4
5844695|NCT02268786|20202769|P1|Overall Study|Thaw Failure|6
5844696|NCT02268786|20202768|P2|Overall Study|Withdrawal by Subject|14
5844697|NCT02268786|20202769|P1|Overall Study|Withdrawal by Subject|7
5844698|NCT02268786|20202768|P2|Overall Study|No Euploid Embryos available|0
5844699|NCT02268786|20202769|P1|Overall Study|No Euploid Embryos available|42
5844700|NCT02268526|20202778|P3|Overall Study|Subject/guardian decision|3
5844701|NCT02268526|20202779|P2|Overall Study|Subject/guardian decision|7
5844702|NCT02268526|20202780|P1|Overall Study|Subject/guardian decision|0
5844703|NCT02268526|20202778|P3|Overall Study|Physician Decision|1
5844704|NCT02268526|20202779|P2|Overall Study|Physician Decision|0
5844705|NCT02268526|20202780|P1|Overall Study|Physician Decision|0
5844706|NCT02268526|20202778|P3|Overall Study|protocol deviation|0
5844707|NCT02268526|20202779|P2|Overall Study|protocol deviation|1
5844708|NCT02268526|20202780|P1|Overall Study|protocol deviation|0
5844709|NCT02268526|20202778|P3|Overall Study|Death|0
5844710|NCT02268526|20202779|P2|Overall Study|Death|11
5844711|NCT02268526|20202780|P1|Overall Study|Death|1
5844712|NCT02268526|20202778|P3|Overall Study|Adverse Event|1
5844713|NCT02268526|20202779|P2|Overall Study|Adverse Event|2
5844714|NCT02268526|20202780|P1|Overall Study|Adverse Event|0
5844715|NCT02268396|20202801|P1|Overall Study|2 Subjects no Day 29 Assessment|2
5844716|NCT02268396|20202801|P1|Overall Study|Protocol-Specified Criteria|2
5844717|NCT02268396|20202801|P1|Overall Study|Lost to Follow-up|2
5844718|NCT02268396|20202801|P1|Overall Study|Withdrawal by Subject|1
5844719|NCT02268396|20202801|P1|Overall Study|Administrative|2
5844720|NCT02268396|20202801|P1|Overall Study|Adverse Event|3
5844721|NCT02268214|20202813|P3|Overall Study|Not entering long-term period|5
5844722|NCT02268214|20202814|P2|Overall Study|Not entering long-term period|3
5844723|NCT02268214|20202815|P1|Overall Study|Not entering long-term period|2
5844724|NCT02268214|20202813|P3|Overall Study|Other reasons|3
5844725|NCT02268214|20202814|P2|Overall Study|Other reasons|3
5844726|NCT02268214|20202815|P1|Overall Study|Other reasons|7
5844727|NCT02268214|20202813|P3|Overall Study|Poor/non-compliance|2
5844728|NCT02268214|20202814|P2|Overall Study|Poor/non-compliance|1
5844729|NCT02268214|20202815|P1|Overall Study|Poor/non-compliance|2
5844730|NCT02268214|20202813|P3|Overall Study|Subject request to discontinue treatment|6
5844731|NCT02268214|20202814|P2|Overall Study|Subject request to discontinue treatment|8
5844732|NCT02268214|20202815|P1|Overall Study|Subject request to discontinue treatment|10
5844733|NCT02268214|20202813|P3|Overall Study|Withdrawal by Subject|10
5844734|NCT02268214|20202814|P2|Overall Study|Withdrawal by Subject|5
5844735|NCT02268214|20202815|P1|Overall Study|Withdrawal by Subject|4
5844736|NCT02268214|20202813|P3|Overall Study|Adverse Event|9
5844737|NCT02268214|20202814|P2|Overall Study|Adverse Event|14
5844738|NCT02268214|20202815|P1|Overall Study|Adverse Event|11
5844739|NCT02268214|20202813|P3|Overall Study|Lack of Efficacy|2
5844740|NCT02268214|20202814|P2|Overall Study|Lack of Efficacy|0
5844741|NCT02268214|20202815|P1|Overall Study|Lack of Efficacy|1
5844742|NCT02268214|20202813|P3|Overall Study|Lost to Follow-up|4
5844743|NCT02268214|20202814|P2|Overall Study|Lost to Follow-up|3
5844744|NCT02268214|20202815|P1|Overall Study|Lost to Follow-up|3
5844745|NCT02268214|20202813|P3|Overall Study|Pregnancy|1
5844746|NCT02268214|20202814|P2|Overall Study|Pregnancy|2
5844747|NCT02268214|20202815|P1|Overall Study|Pregnancy|2
5844748|NCT02268214|20202813|P3|Overall Study|Subject no longer meets study criteria|0
5844749|NCT02268214|20202814|P2|Overall Study|Subject no longer meets study criteria|2
5844750|NCT02268214|20202815|P1|Overall Study|Subject no longer meets study criteria|0
5844751|NCT02268058|20202862|P4|Overall Study|Protocol Violation|0
5844752|NCT02268058|20202863|P3|Overall Study|Protocol Violation|0
5844753|NCT02268058|20202864|P2|Overall Study|Protocol Violation|0
5844754|NCT02268058|20202865|P1|Overall Study|Protocol Violation|1
5844755|NCT02268045|20202889|P2|Overall Study|Protocol Violation|1
5844756|NCT02268045|20202890|P1|Overall Study|Protocol Violation|1
5844757|NCT02268045|20202889|P2|Overall Study|Physician Decision|1
5844758|NCT02268045|20202890|P1|Overall Study|Physician Decision|0
5844759|NCT02268045|20202889|P2|Overall Study|Withdrawal by Subject|6
5844760|NCT02268045|20202890|P1|Overall Study|Withdrawal by Subject|2
5844761|NCT02268045|20202889|P2|Overall Study|Adverse Event|7
5844762|NCT02268045|20202890|P1|Overall Study|Adverse Event|7
5844763|NCT02268045|20202889|P2|Overall Study|Disease Progression|1
5844764|NCT02268045|20202890|P1|Overall Study|Disease Progression|2
5844765|NCT02268045|20202889|P2|Overall Study|Death|4
5844766|NCT02268045|20202890|P1|Overall Study|Death|4
5844767|NCT02267824|20202932|P2|Overall Study|Did Not Meet Initial Dental Criteria|0
5844768|NCT02267824|20202933|P1|Overall Study|Did Not Meet Initial Dental Criteria|2
5844769|NCT02267824|20202932|P2|Overall Study|Protocol Violation|0
5844770|NCT02267824|20202933|P1|Overall Study|Protocol Violation|3
5844771|NCT02267824|20202932|P2|Overall Study|Lost to Follow-up|0
5844772|NCT02267824|20202933|P1|Overall Study|Lost to Follow-up|4
5844773|NCT02267824|20202932|P2|Overall Study|Pregnancy|1
5844774|NCT02267824|20202933|P1|Overall Study|Pregnancy|1
5844775|NCT02267746|20202978|P3|Overall Study|Miscellaneous|1
5844776|NCT02267746|20202979|P2|Overall Study|Miscellaneous|0
5844777|NCT02267746|20202980|P1|Overall Study|Miscellaneous|1
5844778|NCT02267746|20202978|P3|Overall Study|Protocol Violation|1
5844779|NCT02267746|20202979|P2|Overall Study|Protocol Violation|2
5844780|NCT02267746|20202980|P1|Overall Study|Protocol Violation|1
5844781|NCT02267746|20202978|P3|Overall Study|Lack of Efficacy|15
5844782|NCT02267746|20202979|P2|Overall Study|Lack of Efficacy|11
5844783|NCT02267746|20202980|P1|Overall Study|Lack of Efficacy|11
5844784|NCT02267746|20202978|P3|Overall Study|Protocol Violation|3
5844785|NCT02267746|20202979|P2|Overall Study|Protocol Violation|7
5844786|NCT02267746|20202980|P1|Overall Study|Protocol Violation|8
5844787|NCT02267746|20202978|P3|Overall Study|Adverse Event|1
5844788|NCT02267746|20202979|P2|Overall Study|Adverse Event|2
5844789|NCT02267746|20202980|P1|Overall Study|Adverse Event|0
5844790|NCT02267317|20203090|P6|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0
5844791|NCT02267317|20203091|P5|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0
5844792|NCT02267317|20203092|P4|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0
5844793|NCT02267317|20203093|P3|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0
5844794|NCT02267317|20203094|P2|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0
5844795|NCT02267317|20203095|P1|Washout (3-4weeks Between Infusions)|Lost to Follow-up|1
5844796|NCT02267317|20203090|P6|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0
5844797|NCT02267317|20203091|P5|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0
5844798|NCT02267317|20203092|P4|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0
5844799|NCT02267317|20203093|P3|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0
5844800|NCT02267317|20203094|P2|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0
5844801|NCT02267317|20203095|P1|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|1
5844802|NCT02267278|20203145|P1|Overall Study|prescribed prohibited medication|1
5844803|NCT02267278|20203145|P1|Overall Study|Developed new cancer diagnoses|2
5844804|NCT02267278|20203145|P1|Overall Study|transformation to acute leukemia (AML)|1
5844805|NCT02267278|20203145|P1|Overall Study|Proceeded to transplantation (allo-HCT)|1
5844806|NCT02267187|20203169|P1|Overall Study|Screen fail|3
5844807|NCT02267187|20203169|P1|Overall Study|Physician Decision|2
5844808|NCT02267135|20203177|P2|Period 2 (Randomized Set)|Withdrawal by Subject|0
5844809|NCT02267135|20203178|P1|Period 2 (Randomized Set)|Withdrawal by Subject|1
5844810|NCT02267135|20203177|P2|Period 2 (Randomized Set)|Adverse Event|0
5844811|NCT02267135|20203178|P1|Period 2 (Randomized Set)|Adverse Event|2
5844812|NCT02267135|20203177|P2|Period 2 (Randomized Set)|Lost to Follow-up|1
5844813|NCT02267135|20203178|P1|Period 2 (Randomized Set)|Lost to Follow-up|1
5844814|NCT02267135|20203177|P2|Period 1 (Randomized Set)|Lost to Follow-up|1
5844815|NCT02267135|20203178|P1|Period 1 (Randomized Set)|Lost to Follow-up|0
5844816|NCT02267135|20203177|P2|Period 1 (Randomized Set)|Withdrawal by Subject|3
5844817|NCT02267135|20203178|P1|Period 1 (Randomized Set)|Withdrawal by Subject|1
5844818|NCT02266888|20203222|P4|Overall Study|Transfer of care|0
5844819|NCT02266888|20203223|P3|Overall Study|Transfer of care|1
5844820|NCT02266888|20203224|P2|Overall Study|Transfer of care|0
5844821|NCT02266888|20203225|P1|Overall Study|Transfer of care|0
5844822|NCT02266888|20203222|P4|Overall Study|Personnel unavailable at transplant|1
5844823|NCT02266888|20203223|P3|Overall Study|Personnel unavailable at transplant|0
5844824|NCT02266888|20203224|P2|Overall Study|Personnel unavailable at transplant|0
5844825|NCT02266888|20203225|P1|Overall Study|Personnel unavailable at transplant|0
5844826|NCT02266888|20203222|P4|Overall Study|Randomization Closed|0
5844827|NCT02266888|20203223|P3|Overall Study|Randomization Closed|4
5844828|NCT02266888|20203224|P2|Overall Study|Randomization Closed|0
5844829|NCT02266888|20203225|P1|Overall Study|Randomization Closed|0
5844830|NCT02266888|20203222|P4|Overall Study|No Longer Eligible|2
5844831|NCT02266888|20203223|P3|Overall Study|No Longer Eligible|0
5844832|NCT02266888|20203224|P2|Overall Study|No Longer Eligible|0
5844833|NCT02266888|20203225|P1|Overall Study|No Longer Eligible|0
5844834|NCT02266888|20203222|P4|Overall Study|Study Terminated|0
5844835|NCT02266888|20203223|P3|Overall Study|Study Terminated|0
5844836|NCT02266888|20203224|P2|Overall Study|Study Terminated|1
5844837|NCT02266888|20203225|P1|Overall Study|Study Terminated|5
5844838|NCT02266888|20203222|P4|Overall Study|Physician Decision|2
5844839|NCT02266888|20203223|P3|Overall Study|Physician Decision|2
5844840|NCT02266888|20203224|P2|Overall Study|Physician Decision|1
5844841|NCT02266888|20203225|P1|Overall Study|Physician Decision|0
5844842|NCT02266888|20203222|P4|Overall Study|Death|2
5844843|NCT02266888|20203223|P3|Overall Study|Death|4
5844844|NCT02266888|20203224|P2|Overall Study|Death|2
5844845|NCT02266888|20203225|P1|Overall Study|Death|2
5844846|NCT02266875|20203259|P2|Overall Study|Lost to Follow-up|0
5844847|NCT02266875|20203260|P1|Overall Study|Lost to Follow-up|2
5844848|NCT02266875|20203259|P2|Overall Study|Withdrawal by Subject|0
5844849|NCT02266875|20203260|P1|Overall Study|Withdrawal by Subject|9
5844850|NCT02266706|20203325|P9|Overall Study|Enrollment in another study|0
5844851|NCT02266706|20203326|P8|Overall Study|Enrollment in another study|0
5844852|NCT02266706|20203327|P7|Overall Study|Enrollment in another study|0
5844853|NCT02266706|20203328|P6|Overall Study|Enrollment in another study|0
5844854|NCT02266706|20203329|P5|Overall Study|Enrollment in another study|0
5844855|NCT02266706|20203330|P4|Overall Study|Enrollment in another study|1
5844856|NCT02266706|20203331|P3|Overall Study|Enrollment in another study|0
5844857|NCT02266706|20203332|P2|Overall Study|Enrollment in another study|0
5844858|NCT02266706|20203333|P1|Overall Study|Enrollment in another study|0
5844859|NCT02266706|20203325|P9|Overall Study|Screen failure|0
5844860|NCT02266706|20203326|P8|Overall Study|Screen failure|0
5844861|NCT02266706|20203327|P7|Overall Study|Screen failure|1
5844862|NCT02266706|20203328|P6|Overall Study|Screen failure|1
5844863|NCT02266706|20203329|P5|Overall Study|Screen failure|0
5844864|NCT02266706|20203330|P4|Overall Study|Screen failure|0
5844865|NCT02266706|20203331|P3|Overall Study|Screen failure|0
5844866|NCT02266706|20203332|P2|Overall Study|Screen failure|0
5844867|NCT02266706|20203333|P1|Overall Study|Screen failure|0
5844868|NCT02266706|20203325|P9|Overall Study|Withdrawal by Subject|0
5844869|NCT02266706|20203326|P8|Overall Study|Withdrawal by Subject|0
5844870|NCT02266706|20203327|P7|Overall Study|Withdrawal by Subject|0
5844871|NCT02266706|20203328|P6|Overall Study|Withdrawal by Subject|1
5844872|NCT02266706|20203329|P5|Overall Study|Withdrawal by Subject|0
5844873|NCT02266706|20203330|P4|Overall Study|Withdrawal by Subject|0
5844874|NCT02266706|20203331|P3|Overall Study|Withdrawal by Subject|1
5844875|NCT02266706|20203332|P2|Overall Study|Withdrawal by Subject|1
5844876|NCT02266706|20203333|P1|Overall Study|Withdrawal by Subject|0
5844877|NCT02266433|20203564|P2|Overall Study|Withdrawal by Subject|7
5844878|NCT02266433|20203565|P1|Overall Study|Withdrawal by Subject|5
5844879|NCT02266433|20203564|P2|Overall Study|Lost to Follow-up|46
5844880|NCT02266433|20203565|P1|Overall Study|Lost to Follow-up|54
5844881|NCT02266381|20203682|P3|Overall Study|Physician Decision|4
5844882|NCT02266381|20203683|P2|Overall Study|Physician Decision|5
5844883|NCT02266381|20203684|P1|Overall Study|Physician Decision|3
5844884|NCT02266225|20203734|P1|Overall Study|Withdrawal by Subject|13
5844885|NCT02266225|20203734|P1|Overall Study|Death|1
5844886|NCT02266225|20203734|P1|Overall Study|Lost to Follow-up|2
5844887|NCT02266147|20203759|P4|PART 2: Dose Expansion|Study Terminated by Sponsor|8
5844888|NCT02266147|20203760|P3|PART 2: Dose Expansion|Study Terminated by Sponsor|0
5844889|NCT02266147|20203761|P2|PART 2: Dose Expansion|Study Terminated by Sponsor|0
5844890|NCT02266147|20203762|P1|PART 2: Dose Expansion|Study Terminated by Sponsor|6
5844891|NCT02266147|20203759|P4|PART 2: Dose Expansion|Lack of Efficacy|1
5844892|NCT02266147|20203760|P3|PART 2: Dose Expansion|Lack of Efficacy|0
5844893|NCT02266147|20203761|P2|PART 2: Dose Expansion|Lack of Efficacy|0
5844894|NCT02266147|20203762|P1|PART 2: Dose Expansion|Lack of Efficacy|1
5844895|NCT02266147|20203759|P4|PART 1: Dose Escalation|Other|0
5844896|NCT02266147|20203760|P3|PART 1: Dose Escalation|Other|0
5844897|NCT02266147|20203761|P2|PART 1: Dose Escalation|Other|1
5844898|NCT02266147|20203762|P1|PART 1: Dose Escalation|Other|1
5844899|NCT02266147|20203759|P4|PART 1: Dose Escalation|Study Terminated by Sponsor|3
5844900|NCT02266147|20203760|P3|PART 1: Dose Escalation|Study Terminated by Sponsor|1
5844901|NCT02266147|20203761|P2|PART 1: Dose Escalation|Study Terminated by Sponsor|0
5844902|NCT02266147|20203762|P1|PART 1: Dose Escalation|Study Terminated by Sponsor|0
5844903|NCT02266147|20203759|P4|PART 1: Dose Escalation|Lack of Efficacy|1
5844904|NCT02266147|20203760|P3|PART 1: Dose Escalation|Lack of Efficacy|1
5844905|NCT02266147|20203761|P2|PART 1: Dose Escalation|Lack of Efficacy|2
5844906|NCT02266147|20203762|P1|PART 1: Dose Escalation|Lack of Efficacy|0
5844907|NCT02266147|20203759|P4|PART 1: Dose Escalation|Physician Decision|0
5844908|NCT02266147|20203760|P3|PART 1: Dose Escalation|Physician Decision|1
5844909|NCT02266147|20203761|P2|PART 1: Dose Escalation|Physician Decision|0
5844910|NCT02266147|20203762|P1|PART 1: Dose Escalation|Physician Decision|0
5844911|NCT02266004|20203805|P1|Overall Study|Physician Decision|1
5844912|NCT02266004|20203805|P1|Overall Study|unrelated adverse event|1
5844913|NCT02265952|20203843|P2|Open Label Extension (OLE) Period|Withdrawal by Subject|1
5844914|NCT02265952|20203844|P1|Open Label Extension (OLE) Period|Withdrawal by Subject|0
5844915|NCT02265952|20203843|P2|Open Label Extension (OLE) Period|Physician Decision|7
5844916|NCT02265952|20203844|P1|Open Label Extension (OLE) Period|Physician Decision|0
5844917|NCT02265796|20203900|P2|Overall Study|Withdrawal by Subject|1
5844918|NCT02265796|20203901|P1|Overall Study|Withdrawal by Subject|1
5844919|NCT02265796|20203900|P2|Overall Study|started on excluded medication|0
5844920|NCT02265796|20203901|P1|Overall Study|started on excluded medication|1
5844921|NCT02265796|20203900|P2|Overall Study|Death|0
5844922|NCT02265796|20203901|P1|Overall Study|Death|1
5844923|NCT02265744|20203920|P5|Overall Study|Pregnancy|0
5844924|NCT02265744|20203921|P4|Overall Study|Pregnancy|1
5844925|NCT02265744|20203922|P3|Overall Study|Pregnancy|1
5844926|NCT02265744|20203923|P2|Overall Study|Pregnancy|2
5844927|NCT02265744|20203924|P1|Overall Study|Pregnancy|1
5844928|NCT02265744|20203920|P5|Overall Study|Subject no longer meets study criteria|1
5844929|NCT02265744|20203921|P4|Overall Study|Subject no longer meets study criteria|0
5844930|NCT02265744|20203922|P3|Overall Study|Subject no longer meets study criteria|0
5844931|NCT02265744|20203923|P2|Overall Study|Subject no longer meets study criteria|0
5844932|NCT02265744|20203924|P1|Overall Study|Subject no longer meets study criteria|0
5844933|NCT02265744|20203920|P5|Overall Study|Administrative reason by sponsor|3
5844934|NCT02265744|20203921|P4|Overall Study|Administrative reason by sponsor|3
5844935|NCT02265744|20203922|P3|Overall Study|Administrative reason by sponsor|2
5844936|NCT02265744|20203923|P2|Overall Study|Administrative reason by sponsor|2
5844937|NCT02265744|20203924|P1|Overall Study|Administrative reason by sponsor|3
5844938|NCT02265744|20203920|P5|Overall Study|Reason not provided by Investigator|0
5844939|NCT02265744|20203921|P4|Overall Study|Reason not provided by Investigator|2
5844940|NCT02265744|20203922|P3|Overall Study|Reason not provided by Investigator|0
5844941|NCT02265744|20203923|P2|Overall Study|Reason not provided by Investigator|0
5844942|NCT02265744|20203924|P1|Overall Study|Reason not provided by Investigator|1
5844943|NCT02265744|20203920|P5|Overall Study|Lack of Efficacy|5
5844944|NCT02265744|20203921|P4|Overall Study|Lack of Efficacy|4
5844945|NCT02265744|20203922|P3|Overall Study|Lack of Efficacy|3
5844946|NCT02265744|20203923|P2|Overall Study|Lack of Efficacy|4
5844947|NCT02265744|20203924|P1|Overall Study|Lack of Efficacy|2
5844948|NCT02265744|20203920|P5|Overall Study|Adverse Event|2
5844949|NCT02265744|20203921|P4|Overall Study|Adverse Event|8
5844950|NCT02265744|20203922|P3|Overall Study|Adverse Event|9
5844951|NCT02265744|20203923|P2|Overall Study|Adverse Event|4
5844952|NCT02265744|20203924|P1|Overall Study|Adverse Event|8
5844953|NCT02265744|20203920|P5|Overall Study|Participant request to discontinue|0
5844954|NCT02265744|20203921|P4|Overall Study|Participant request to discontinue|0
5844955|NCT02265744|20203922|P3|Overall Study|Participant request to discontinue|2
5844956|NCT02265744|20203923|P2|Overall Study|Participant request to discontinue|2
5844957|NCT02265744|20203924|P1|Overall Study|Participant request to discontinue|2
5844958|NCT02265744|20203920|P5|Overall Study|Withdrawal by Subject|0
5844959|NCT02265744|20203921|P4|Overall Study|Withdrawal by Subject|2
5844960|NCT02265744|20203922|P3|Overall Study|Withdrawal by Subject|0
5844961|NCT02265744|20203923|P2|Overall Study|Withdrawal by Subject|0
5844962|NCT02265744|20203924|P1|Overall Study|Withdrawal by Subject|2
5844963|NCT02265744|20203920|P5|Overall Study|Death|0
5844964|NCT02265744|20203921|P4|Overall Study|Death|2
5844965|NCT02265744|20203922|P3|Overall Study|Death|0
5844966|NCT02265744|20203923|P2|Overall Study|Death|0
5844967|NCT02265744|20203924|P1|Overall Study|Death|0
5844968|NCT02265744|20203920|P5|Overall Study|Lost to Follow-up|0
5844969|NCT02265744|20203921|P4|Overall Study|Lost to Follow-up|1
5844970|NCT02265744|20203922|P3|Overall Study|Lost to Follow-up|0
5844971|NCT02265744|20203923|P2|Overall Study|Lost to Follow-up|0
5844972|NCT02265744|20203924|P1|Overall Study|Lost to Follow-up|0
5844973|NCT02265744|20203920|P5|Overall Study|Poor/Non-compliance|2
5844974|NCT02265744|20203921|P4|Overall Study|Poor/Non-compliance|0
5844975|NCT02265744|20203922|P3|Overall Study|Poor/Non-compliance|0
5844976|NCT02265744|20203923|P2|Overall Study|Poor/Non-compliance|1
5844977|NCT02265744|20203924|P1|Overall Study|Poor/Non-compliance|1
5844978|NCT02265705|20204103|P7|Follow-up Period|Withdrawal by Subject|1
5844979|NCT02265705|20204104|P6|Follow-up Period|Withdrawal by Subject|0
5844980|NCT02265705|20204105|P5|Follow-up Period|Withdrawal by Subject|0
5844981|NCT02265705|20204106|P4|Follow-up Period|Withdrawal by Subject|0
5844982|NCT02265705|20204107|P3|Follow-up Period|Withdrawal by Subject|0
5844983|NCT02265705|20204108|P2|Follow-up Period|Withdrawal by Subject|0
5844984|NCT02265705|20204109|P1|Follow-up Period|Withdrawal by Subject|0
5844985|NCT02265705|20204103|P7|Follow-up Period|Physician Decision|1
5844986|NCT02265705|20204104|P6|Follow-up Period|Physician Decision|0
5844987|NCT02265705|20204105|P5|Follow-up Period|Physician Decision|0
5844988|NCT02265705|20204106|P4|Follow-up Period|Physician Decision|0
5844989|NCT02265705|20204107|P3|Follow-up Period|Physician Decision|0
5844990|NCT02265705|20204108|P2|Follow-up Period|Physician Decision|0
5844991|NCT02265705|20204109|P1|Follow-up Period|Physician Decision|0
5844992|NCT02265705|20204103|P7|Follow-up Period|Adverse Event|3
5844993|NCT02265705|20204104|P6|Follow-up Period|Adverse Event|0
5844994|NCT02265705|20204105|P5|Follow-up Period|Adverse Event|0
5844995|NCT02265705|20204106|P4|Follow-up Period|Adverse Event|0
5844996|NCT02265705|20204107|P3|Follow-up Period|Adverse Event|0
5844997|NCT02265705|20204108|P2|Follow-up Period|Adverse Event|0
5844998|NCT02265705|20204109|P1|Follow-up Period|Adverse Event|0
5844999|NCT02265705|20204103|P7|Follow-up Period|Sponsor Decision|6
5845000|NCT02265705|20204104|P6|Follow-up Period|Sponsor Decision|1
5845001|NCT02265705|20204105|P5|Follow-up Period|Sponsor Decision|0
5845002|NCT02265705|20204106|P4|Follow-up Period|Sponsor Decision|0
5845003|NCT02265705|20204107|P3|Follow-up Period|Sponsor Decision|0
5845004|NCT02265705|20204108|P2|Follow-up Period|Sponsor Decision|0
5845005|NCT02265705|20204109|P1|Follow-up Period|Sponsor Decision|0
5845006|NCT02265705|20204103|P7|Open Label Period|Withdrawal by Subject|0
5845007|NCT02265705|20204104|P6|Open Label Period|Withdrawal by Subject|0
5845008|NCT02265705|20204105|P5|Open Label Period|Withdrawal by Subject|2
5845009|NCT02265705|20204106|P4|Open Label Period|Withdrawal by Subject|0
5845010|NCT02265705|20204107|P3|Open Label Period|Withdrawal by Subject|0
5845011|NCT02265705|20204108|P2|Open Label Period|Withdrawal by Subject|0
5845012|NCT02265705|20204109|P1|Open Label Period|Withdrawal by Subject|0
5845013|NCT02265705|20204103|P7|Open Label Period|Physician Decision|0
5845014|NCT02265705|20204104|P6|Open Label Period|Physician Decision|0
5845015|NCT02265705|20204105|P5|Open Label Period|Physician Decision|1
5845016|NCT02265705|20204106|P4|Open Label Period|Physician Decision|0
5845017|NCT02265705|20204107|P3|Open Label Period|Physician Decision|0
5845018|NCT02265705|20204108|P2|Open Label Period|Physician Decision|0
5845019|NCT02265705|20204109|P1|Open Label Period|Physician Decision|0
5845020|NCT02265705|20204103|P7|Open Label Period|Adverse Event|0
5845021|NCT02265705|20204104|P6|Open Label Period|Adverse Event|0
5845022|NCT02265705|20204105|P5|Open Label Period|Adverse Event|2
5845023|NCT02265705|20204106|P4|Open Label Period|Adverse Event|2
5845024|NCT02265705|20204107|P3|Open Label Period|Adverse Event|0
5845025|NCT02265705|20204108|P2|Open Label Period|Adverse Event|0
5845026|NCT02265705|20204109|P1|Open Label Period|Adverse Event|0
5845027|NCT02265705|20204103|P7|Rescue Period|Lack of Efficacy|0
5845028|NCT02265705|20204104|P6|Rescue Period|Lack of Efficacy|0
5845029|NCT02265705|20204105|P5|Rescue Period|Lack of Efficacy|0
5845030|NCT02265705|20204106|P4|Rescue Period|Lack of Efficacy|0
5845031|NCT02265705|20204107|P3|Rescue Period|Lack of Efficacy|1
5845032|NCT02265705|20204108|P2|Rescue Period|Lack of Efficacy|0
5845033|NCT02265705|20204109|P1|Rescue Period|Lack of Efficacy|0
5845034|NCT02265705|20204103|P7|Rescue Period|Death|0
5845035|NCT02265705|20204104|P6|Rescue Period|Death|0
5845036|NCT02265705|20204105|P5|Rescue Period|Death|0
5845037|NCT02265705|20204106|P4|Rescue Period|Death|0
5845038|NCT02265705|20204107|P3|Rescue Period|Death|1
5845039|NCT02265705|20204108|P2|Rescue Period|Death|0
5845040|NCT02265705|20204109|P1|Rescue Period|Death|0
5845041|NCT02265705|20204103|P7|Rescue Period|Withdrawal by Subject|0
5845042|NCT02265705|20204104|P6|Rescue Period|Withdrawal by Subject|0
5845043|NCT02265705|20204105|P5|Rescue Period|Withdrawal by Subject|0
5845044|NCT02265705|20204106|P4|Rescue Period|Withdrawal by Subject|0
5845045|NCT02265705|20204107|P3|Rescue Period|Withdrawal by Subject|1
5845046|NCT02265705|20204108|P2|Rescue Period|Withdrawal by Subject|0
5845047|NCT02265705|20204109|P1|Rescue Period|Withdrawal by Subject|0
5845048|NCT02265705|20204103|P7|Treatment Period Week 0-24|Lack of Efficacy|0
5845049|NCT02265705|20204104|P6|Treatment Period Week 0-24|Lack of Efficacy|0
5845050|NCT02265705|20204105|P5|Treatment Period Week 0-24|Lack of Efficacy|0
5845051|NCT02265705|20204106|P4|Treatment Period Week 0-24|Lack of Efficacy|0
5845052|NCT02265705|20204107|P3|Treatment Period Week 0-24|Lack of Efficacy|0
5845053|NCT02265705|20204108|P2|Treatment Period Week 0-24|Lack of Efficacy|1
5845054|NCT02265705|20204109|P1|Treatment Period Week 0-24|Lack of Efficacy|0
5845055|NCT02265705|20204103|P7|Treatment Period Week 0-24|Withdrawal by Subject|0
5845056|NCT02265705|20204104|P6|Treatment Period Week 0-24|Withdrawal by Subject|0
5845057|NCT02265705|20204105|P5|Treatment Period Week 0-24|Withdrawal by Subject|0
5845058|NCT02265705|20204106|P4|Treatment Period Week 0-24|Withdrawal by Subject|0
5845059|NCT02265705|20204107|P3|Treatment Period Week 0-24|Withdrawal by Subject|0
5845060|NCT02265705|20204108|P2|Treatment Period Week 0-24|Withdrawal by Subject|5
5845061|NCT02265705|20204109|P1|Treatment Period Week 0-24|Withdrawal by Subject|7
5845062|NCT02265705|20204103|P7|Treatment Period Week 0-24|Physician Decision|0
5845063|NCT02265705|20204104|P6|Treatment Period Week 0-24|Physician Decision|0
5845064|NCT02265705|20204105|P5|Treatment Period Week 0-24|Physician Decision|0
5845065|NCT02265705|20204106|P4|Treatment Period Week 0-24|Physician Decision|0
5845066|NCT02265705|20204107|P3|Treatment Period Week 0-24|Physician Decision|0
5845067|NCT02265705|20204108|P2|Treatment Period Week 0-24|Physician Decision|0
5845068|NCT02265705|20204109|P1|Treatment Period Week 0-24|Physician Decision|1
5845069|NCT02265705|20204103|P7|Treatment Period Week 0-24|Entry Criteria Not Met|0
5845070|NCT02265705|20204104|P6|Treatment Period Week 0-24|Entry Criteria Not Met|0
5845071|NCT02265705|20204105|P5|Treatment Period Week 0-24|Entry Criteria Not Met|0
5845072|NCT02265705|20204106|P4|Treatment Period Week 0-24|Entry Criteria Not Met|0
5845073|NCT02265705|20204107|P3|Treatment Period Week 0-24|Entry Criteria Not Met|0
5845074|NCT02265705|20204108|P2|Treatment Period Week 0-24|Entry Criteria Not Met|1
5845075|NCT02265705|20204109|P1|Treatment Period Week 0-24|Entry Criteria Not Met|1
5845076|NCT02265705|20204103|P7|Treatment Period Week 0-24|Adverse Event|0
5845077|NCT02265705|20204104|P6|Treatment Period Week 0-24|Adverse Event|0
5845078|NCT02265705|20204105|P5|Treatment Period Week 0-24|Adverse Event|0
5845079|NCT02265705|20204106|P4|Treatment Period Week 0-24|Adverse Event|0
5845080|NCT02265705|20204107|P3|Treatment Period Week 0-24|Adverse Event|0
5845081|NCT02265705|20204108|P2|Treatment Period Week 0-24|Adverse Event|2
5845082|NCT02265705|20204109|P1|Treatment Period Week 0-24|Adverse Event|3
5845083|NCT02265510|20204148|P14|Overall Study|Study Terminated by Sponsor|2
5845084|NCT02265510|20204149|P13|Overall Study|Study Terminated by Sponsor|1
5845085|NCT02265510|20204150|P12|Overall Study|Study Terminated by Sponsor|4
5845086|NCT02265510|20204151|P11|Overall Study|Study Terminated by Sponsor|1
5845087|NCT02265510|20204152|P10|Overall Study|Study Terminated by Sponsor|2
5845088|NCT02265510|20204153|P9|Overall Study|Study Terminated by Sponsor|1
5845089|NCT02265510|20204154|P8|Overall Study|Study Terminated by Sponsor|1
5845090|NCT02265510|20204155|P7|Overall Study|Study Terminated by Sponsor|1
5845091|NCT02265510|20204156|P6|Overall Study|Study Terminated by Sponsor|1
5845092|NCT02265510|20204157|P5|Overall Study|Study Terminated by Sponsor|0
5845093|NCT02265510|20204158|P4|Overall Study|Study Terminated by Sponsor|0
5845094|NCT02265510|20204159|P3|Overall Study|Study Terminated by Sponsor|0
5845095|NCT02265510|20204160|P2|Overall Study|Study Terminated by Sponsor|0
5845096|NCT02265510|20204161|P1|Overall Study|Study Terminated by Sponsor|0
5845097|NCT02265510|20204148|P14|Overall Study|Other|0
5845098|NCT02265510|20204149|P13|Overall Study|Other|0
5845099|NCT02265510|20204150|P12|Overall Study|Other|0
5845100|NCT02265510|20204151|P11|Overall Study|Other|0
5845101|NCT02265510|20204152|P10|Overall Study|Other|0
5845102|NCT02265510|20204153|P9|Overall Study|Other|0
5845103|NCT02265510|20204154|P8|Overall Study|Other|0
5845104|NCT02265510|20204155|P7|Overall Study|Other|0
5845105|NCT02265510|20204156|P6|Overall Study|Other|0
5845106|NCT02265510|20204157|P5|Overall Study|Other|0
5845107|NCT02265510|20204158|P4|Overall Study|Other|0
5845108|NCT02265510|20204159|P3|Overall Study|Other|0
5845109|NCT02265510|20204160|P2|Overall Study|Other|1
5845110|NCT02265510|20204161|P1|Overall Study|Other|0
5845111|NCT02265510|20204148|P14|Overall Study|Lost to Follow-up|2
5845112|NCT02265510|20204149|P13|Overall Study|Lost to Follow-up|0
5845113|NCT02265510|20204150|P12|Overall Study|Lost to Follow-up|0
5845114|NCT02265510|20204151|P11|Overall Study|Lost to Follow-up|0
5845115|NCT02265510|20204152|P10|Overall Study|Lost to Follow-up|2
5845116|NCT02265510|20204153|P9|Overall Study|Lost to Follow-up|0
5845117|NCT02265510|20204154|P8|Overall Study|Lost to Follow-up|0
5845118|NCT02265510|20204155|P7|Overall Study|Lost to Follow-up|0
5845119|NCT02265510|20204156|P6|Overall Study|Lost to Follow-up|0
5845120|NCT02265510|20204157|P5|Overall Study|Lost to Follow-up|1
5845121|NCT02265510|20204158|P4|Overall Study|Lost to Follow-up|0
5845122|NCT02265510|20204159|P3|Overall Study|Lost to Follow-up|0
5845123|NCT02265510|20204160|P2|Overall Study|Lost to Follow-up|0
5845124|NCT02265510|20204161|P1|Overall Study|Lost to Follow-up|0
5845125|NCT02265510|20204148|P14|Overall Study|Death|6
5845126|NCT02265510|20204149|P13|Overall Study|Death|7
5845127|NCT02265510|20204150|P12|Overall Study|Death|12
5845128|NCT02265510|20204151|P11|Overall Study|Death|4
5845129|NCT02265510|20204152|P10|Overall Study|Death|3
5845130|NCT02265510|20204153|P9|Overall Study|Death|3
5845131|NCT02265510|20204154|P8|Overall Study|Death|1
5845132|NCT02265510|20204155|P7|Overall Study|Death|2
5845133|NCT02265510|20204156|P6|Overall Study|Death|3
5845134|NCT02265510|20204157|P5|Overall Study|Death|1
5845135|NCT02265510|20204158|P4|Overall Study|Death|2
5845136|NCT02265510|20204159|P3|Overall Study|Death|2
5845137|NCT02265510|20204160|P2|Overall Study|Death|0
5845138|NCT02265510|20204161|P1|Overall Study|Death|2
5845139|NCT02265510|20204148|P14|Overall Study|Disease Progression|0
5845140|NCT02265510|20204149|P13|Overall Study|Disease Progression|0
5845141|NCT02265510|20204150|P12|Overall Study|Disease Progression|0
5845142|NCT02265510|20204151|P11|Overall Study|Disease Progression|0
5845143|NCT02265510|20204152|P10|Overall Study|Disease Progression|0
5845144|NCT02265510|20204153|P9|Overall Study|Disease Progression|0
5845145|NCT02265510|20204154|P8|Overall Study|Disease Progression|0
5845146|NCT02265510|20204155|P7|Overall Study|Disease Progression|0
5845147|NCT02265510|20204156|P6|Overall Study|Disease Progression|0
5845148|NCT02265510|20204157|P5|Overall Study|Disease Progression|1
5845149|NCT02265510|20204158|P4|Overall Study|Disease Progression|1
5845150|NCT02265510|20204159|P3|Overall Study|Disease Progression|2
5845151|NCT02265510|20204160|P2|Overall Study|Disease Progression|1
5845152|NCT02265510|20204161|P1|Overall Study|Disease Progression|0
5845153|NCT02265510|20204148|P14|Overall Study|Withdrawal by Subject|0
5845154|NCT02265510|20204149|P13|Overall Study|Withdrawal by Subject|1
5845155|NCT02265510|20204150|P12|Overall Study|Withdrawal by Subject|0
5845156|NCT02265510|20204151|P11|Overall Study|Withdrawal by Subject|0
5845157|NCT02265510|20204152|P10|Overall Study|Withdrawal by Subject|0
5845158|NCT02265510|20204153|P9|Overall Study|Withdrawal by Subject|0
5845159|NCT02265510|20204154|P8|Overall Study|Withdrawal by Subject|2
5845160|NCT02265510|20204155|P7|Overall Study|Withdrawal by Subject|0
5845161|NCT02265510|20204156|P6|Overall Study|Withdrawal by Subject|2
5845162|NCT02265510|20204157|P5|Overall Study|Withdrawal by Subject|0
5845163|NCT02265510|20204158|P4|Overall Study|Withdrawal by Subject|1
5845164|NCT02265510|20204159|P3|Overall Study|Withdrawal by Subject|2
5845165|NCT02265510|20204160|P2|Overall Study|Withdrawal by Subject|1
5845166|NCT02265510|20204161|P1|Overall Study|Withdrawal by Subject|1
5845167|NCT02265237|20204261|P4|As Treated (Overall Study)|Other|1
5845168|NCT02265237|20204262|P3|As Treated (Overall Study)|Other|3
5845169|NCT02265237|20204263|P2|As Treated (Overall Study)|Other|0
5845170|NCT02265237|20204264|P1|As Treated (Overall Study)|Other|2
5845171|NCT02265237|20204261|P4|As Treated (Overall Study)|Lost to Follow-up|0
5845172|NCT02265237|20204262|P3|As Treated (Overall Study)|Lost to Follow-up|6
5845173|NCT02265237|20204263|P2|As Treated (Overall Study)|Lost to Follow-up|2
5845174|NCT02265237|20204264|P1|As Treated (Overall Study)|Lost to Follow-up|1
5845175|NCT02265237|20204261|P4|As Treated (Overall Study)|Withdrawal by Subject|0
5845176|NCT02265237|20204262|P3|As Treated (Overall Study)|Withdrawal by Subject|1
5845177|NCT02265237|20204263|P2|As Treated (Overall Study)|Withdrawal by Subject|0
5845178|NCT02265237|20204264|P1|As Treated (Overall Study)|Withdrawal by Subject|1
5845179|NCT02265237|20204261|P4|As Treated (Overall Study)|Adverse Event|0
5845180|NCT02265237|20204262|P3|As Treated (Overall Study)|Adverse Event|0
5845181|NCT02265237|20204263|P2|As Treated (Overall Study)|Adverse Event|1
5845182|NCT02265237|20204264|P1|As Treated (Overall Study)|Adverse Event|1
5845183|NCT02264821|20204294|P3|Overall Study|Protocol Violation|6
5845184|NCT02264821|20204295|P2|Overall Study|Protocol Violation|3
5845185|NCT02264821|20204296|P1|Overall Study|Protocol Violation|1
5845186|NCT02264639|20204312|P5|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|1
5845187|NCT02264639|20204313|P4|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0
5845188|NCT02264639|20204314|P3|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0
5845189|NCT02264639|20204315|P2|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0
5845190|NCT02264639|20204316|P1|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0
5845191|NCT02264639|20204312|P5|Overall Study|Pregnancy (during multiple-dose phase)|0
5845192|NCT02264639|20204313|P4|Overall Study|Pregnancy (during multiple-dose phase)|0
5845193|NCT02264639|20204314|P3|Overall Study|Pregnancy (during multiple-dose phase)|1
5845194|NCT02264639|20204315|P2|Overall Study|Pregnancy (during multiple-dose phase)|0
5845195|NCT02264639|20204316|P1|Overall Study|Pregnancy (during multiple-dose phase)|0
5845196|NCT02264639|20204312|P5|Overall Study|Withdrawal by subject (during multiple-dose phase)|0
5845197|NCT02264639|20204313|P4|Overall Study|Withdrawal by subject (during multiple-dose phase)|0
5845198|NCT02264639|20204314|P3|Overall Study|Withdrawal by subject (during multiple-dose phase)|0
5845199|NCT02264639|20204315|P2|Overall Study|Withdrawal by subject (during multiple-dose phase)|0
5845200|NCT02264639|20204316|P1|Overall Study|Withdrawal by subject (during multiple-dose phase)|1
5845201|NCT02264639|20204312|P5|Overall Study|Death (after completing single-dose phase)|0
5845202|NCT02264639|20204313|P4|Overall Study|Death (after completing single-dose phase)|0
5845203|NCT02264639|20204314|P3|Overall Study|Death (after completing single-dose phase)|0
5845204|NCT02264639|20204315|P2|Overall Study|Death (after completing single-dose phase)|0
5845205|NCT02264639|20204316|P1|Overall Study|Death (after completing single-dose phase)|1
5845206|NCT02264574|20204334|P2|Overall Study|Other, Not Specified|3
5845207|NCT02264574|20204335|P1|Overall Study|Other, Not Specified|0
5845208|NCT02264574|20204334|P2|Overall Study|Withdrawal by Subject|6
5845209|NCT02264574|20204335|P1|Overall Study|Withdrawal by Subject|8
5845210|NCT02264574|20204334|P2|Overall Study|Death|21
5845211|NCT02264574|20204335|P1|Overall Study|Death|21
5845212|NCT02263547|20204431|P1|Overall Study|Lost to Follow-up|2
5845213|NCT02263547|20204431|P1|Overall Study|Adverse Event|1
5845214|NCT02263365|20204438|P2|Overall Study|Physician Decision|18
5845215|NCT02263365|20204439|P1|Overall Study|Physician Decision|22
5845216|NCT02263326|20204453|P2|Overall Study|Lost to Follow-up|1
5845217|NCT02263326|20204454|P1|Overall Study|Lost to Follow-up|1
5845218|NCT02263079|20204527|P3|Overall Study|Withdrawal by Subject|0
5845219|NCT02263079|20204528|P2|Overall Study|Withdrawal by Subject|8
5845220|NCT02263079|20204529|P1|Overall Study|Withdrawal by Subject|2
5845221|NCT02263079|20204527|P3|Overall Study|Physician Decision|0
5845222|NCT02263079|20204528|P2|Overall Study|Physician Decision|0
5845223|NCT02263079|20204529|P1|Overall Study|Physician Decision|1
5845224|NCT02262754|20204600|P3|Overall Study|Other|2
5845225|NCT02262754|20204601|P2|Overall Study|Other|0
5845226|NCT02262754|20204602|P1|Overall Study|Other|4
5845227|NCT02262754|20204600|P3|Overall Study|Withdrawal by Subject|1
5845228|NCT02262754|20204601|P2|Overall Study|Withdrawal by Subject|0
5845229|NCT02262754|20204602|P1|Overall Study|Withdrawal by Subject|1
5845230|NCT02262754|20204600|P3|Overall Study|Protocol Violation|0
5845231|NCT02262754|20204601|P2|Overall Study|Protocol Violation|0
5845232|NCT02262754|20204602|P1|Overall Study|Protocol Violation|1
5845233|NCT02262754|20204600|P3|Overall Study|Study terminated by sponsor|4
5845234|NCT02262754|20204601|P2|Overall Study|Study terminated by sponsor|4
5845235|NCT02262754|20204602|P1|Overall Study|Study terminated by sponsor|5
5845236|NCT02262754|20204600|P3|Overall Study|No longer meets eligibility criteria|0
5845237|NCT02262754|20204601|P2|Overall Study|No longer meets eligibility criteria|1
5845238|NCT02262754|20204602|P1|Overall Study|No longer meets eligibility criteria|0
5845239|NCT02262754|20204600|P3|Overall Study|Lost to Follow-up|1
5845240|NCT02262754|20204601|P2|Overall Study|Lost to Follow-up|0
5845241|NCT02262754|20204602|P1|Overall Study|Lost to Follow-up|0
5845242|NCT02262754|20204600|P3|Overall Study|Lack of Efficacy|1
5845243|NCT02262754|20204601|P2|Overall Study|Lack of Efficacy|0
5845244|NCT02262754|20204602|P1|Overall Study|Lack of Efficacy|2
5845245|NCT02262754|20204600|P3|Overall Study|Adverse Event|0
5845246|NCT02262754|20204601|P2|Overall Study|Adverse Event|4
5845247|NCT02262754|20204602|P1|Overall Study|Adverse Event|3
5845248|NCT02262728|20204677|P2|Follow-up Phase (3 Years)|Withdrawal by Subject|1
5845249|NCT02262728|20204678|P1|Follow-up Phase (3 Years)|Withdrawal by Subject|0
5845250|NCT02262728|20204677|P2|Follow-up Phase (3 Years)|Lost to Follow-up|1
5845251|NCT02262728|20204678|P1|Follow-up Phase (3 Years)|Lost to Follow-up|4
5845252|NCT02262728|20204677|P2|Follow-up Phase (3 Years)|Death|1
5845253|NCT02262728|20204678|P1|Follow-up Phase (3 Years)|Death|0
5845254|NCT02262377|20204715|P2|Overall Study|Withdrawal by Subject|0
5845255|NCT02262377|20204716|P1|Overall Study|Withdrawal by Subject|4
5845256|NCT02262377|20204715|P2|Overall Study|Found ineligible after enrollment|0
5845257|NCT02262377|20204716|P1|Overall Study|Found ineligible after enrollment|3
5845258|NCT02262377|20204715|P2|Overall Study|Lost to Follow-up|6
5845259|NCT02262377|20204716|P1|Overall Study|Lost to Follow-up|5
5845260|NCT02262364|20204731|P1|Blood Draw for Device Processing|Insufficient blood could be drawn|1
5845261|NCT02262260|20204740|P2|Overall Study|Protocol deviation|5
5845262|NCT02262260|20204741|P1|Overall Study|Protocol deviation|2
5845263|NCT02262260|20204740|P2|Overall Study|Lost to Follow-up|2
5845264|NCT02262260|20204741|P1|Overall Study|Lost to Follow-up|1
5845265|NCT02262260|20204740|P2|Overall Study|Withdrawal of consent|2
5845266|NCT02262260|20204741|P1|Overall Study|Withdrawal of consent|4
5845267|NCT02262260|20204740|P2|Overall Study|Adverse Event|1
5845268|NCT02262260|20204741|P1|Overall Study|Adverse Event|4
5845269|NCT02261974|20204810|P2|Overall Study|Adverse Event|0
5845270|NCT02261974|20204811|P1|Overall Study|Adverse Event|1
5845271|NCT02261974|20204810|P2|Overall Study|Lost to Follow-up|0
5845272|NCT02261974|20204811|P1|Overall Study|Lost to Follow-up|2
5845273|NCT02261974|20204810|P2|Overall Study|Received partial treatment; FU to 1 mo|1
5845274|NCT02261974|20204811|P1|Overall Study|Received partial treatment; FU to 1 mo|3
5845275|NCT02261974|20204810|P2|Overall Study|Missed treatment cut-off date|3
5845276|NCT02261974|20204811|P1|Overall Study|Missed treatment cut-off date|6
5845277|NCT02261974|20204810|P2|Overall Study|Pregnancy|1
5845278|NCT02261974|20204811|P1|Overall Study|Pregnancy|0
5845279|NCT02261974|20204810|P2|Overall Study|Withdrawal by Subject|2
5845280|NCT02261974|20204811|P1|Overall Study|Withdrawal by Subject|3
5845281|NCT02261493|20204875|P3|Overall Study|Adverse Event|0
5845282|NCT02261493|20204876|P2|Overall Study|Adverse Event|1
5845283|NCT02261493|20204877|P1|Overall Study|Adverse Event|0
5845284|NCT02261493|20204875|P3|Overall Study|Lack of Efficacy|0
5845285|NCT02261493|20204876|P2|Overall Study|Lack of Efficacy|1
5845286|NCT02261493|20204877|P1|Overall Study|Lack of Efficacy|0
5845287|NCT02261493|20204875|P3|Overall Study|Pregnancy|0
5845288|NCT02261493|20204876|P2|Overall Study|Pregnancy|2
5845289|NCT02261493|20204877|P1|Overall Study|Pregnancy|1
5845290|NCT02261493|20204875|P3|Overall Study|Lost to Follow-up|8
5845291|NCT02261493|20204876|P2|Overall Study|Lost to Follow-up|27
5845292|NCT02261493|20204877|P1|Overall Study|Lost to Follow-up|14
5845293|NCT02261493|20204875|P3|Overall Study|Personal Reasons|16
5845294|NCT02261493|20204876|P2|Overall Study|Personal Reasons|14
5845295|NCT02261493|20204877|P1|Overall Study|Personal Reasons|14
5845296|NCT02261493|20204875|P3|Overall Study|Protocol Violation|0
5845297|NCT02261493|20204876|P2|Overall Study|Protocol Violation|0
5845298|NCT02261493|20204877|P1|Overall Study|Protocol Violation|1
5845299|NCT02261493|20204875|P3|Overall Study|Undisclosed alcohol abuse|0
5845300|NCT02261493|20204876|P2|Overall Study|Undisclosed alcohol abuse|1
5845301|NCT02261493|20204877|P1|Overall Study|Undisclosed alcohol abuse|0
5845302|NCT02261493|20204875|P3|Overall Study|Physician Decision|0
5845303|NCT02261493|20204876|P2|Overall Study|Physician Decision|1
5845304|NCT02261493|20204877|P1|Overall Study|Physician Decision|0
5845305|NCT02261493|20204875|P3|Overall Study|Noncompliance|2
5845306|NCT02261493|20204876|P2|Overall Study|Noncompliance|0
5845307|NCT02261493|20204877|P1|Overall Study|Noncompliance|0
5845308|NCT02261467|20204905|P2|Overall Study|Adverse Event|1
5845309|NCT02261467|20204906|P1|Overall Study|Adverse Event|1
5845310|NCT02261467|20204905|P2|Overall Study|Lost to Follow-up|13
5845311|NCT02261467|20204906|P1|Overall Study|Lost to Follow-up|2
5845312|NCT02261467|20204905|P2|Overall Study|Personal Reasons|22
5845313|NCT02261467|20204906|P1|Overall Study|Personal Reasons|17
5845314|NCT02261467|20204905|P2|Overall Study|Protocol Violation|1
5845315|NCT02261467|20204906|P1|Overall Study|Protocol Violation|0
5845316|NCT02261467|20204905|P2|Overall Study|Enrolled in Error|0
5845317|NCT02261467|20204906|P1|Overall Study|Enrolled in Error|1
5845318|NCT02260986|20204948|P3|Overall Study|Pregnancy|0
5845319|NCT02260986|20204949|P2|Overall Study|Pregnancy|0
5845320|NCT02260986|20204950|P1|Overall Study|Pregnancy|2
5845321|NCT02260986|20204948|P3|Overall Study|Lost to Follow-up|3
5845322|NCT02260986|20204949|P2|Overall Study|Lost to Follow-up|0
5845323|NCT02260986|20204950|P1|Overall Study|Lost to Follow-up|4
5845324|NCT02260986|20204948|P3|Overall Study|Lack of investigation product supply|1
5845325|NCT02260986|20204949|P2|Overall Study|Lack of investigation product supply|0
5845326|NCT02260986|20204950|P1|Overall Study|Lack of investigation product supply|2
5845327|NCT02260986|20204948|P3|Overall Study|Incorrect randomization|0
5845328|NCT02260986|20204949|P2|Overall Study|Incorrect randomization|1
5845329|NCT02260986|20204950|P1|Overall Study|Incorrect randomization|0
5845330|NCT02260986|20204948|P3|Overall Study|Withdrawal by Subject|9
5845331|NCT02260986|20204949|P2|Overall Study|Withdrawal by Subject|4
5845332|NCT02260986|20204950|P1|Overall Study|Withdrawal by Subject|17
5845333|NCT02260986|20204948|P3|Overall Study|Car accident|1
5845334|NCT02260986|20204949|P2|Overall Study|Car accident|0
5845335|NCT02260986|20204950|P1|Overall Study|Car accident|0
5845336|NCT02260986|20204948|P3|Overall Study|Protocol Violation|16
5845337|NCT02260986|20204949|P2|Overall Study|Protocol Violation|5
5845338|NCT02260986|20204950|P1|Overall Study|Protocol Violation|14
5845339|NCT02260986|20204948|P3|Overall Study|Lack of Efficacy|0
5845340|NCT02260986|20204949|P2|Overall Study|Lack of Efficacy|3
5845341|NCT02260986|20204950|P1|Overall Study|Lack of Efficacy|27
5845342|NCT02260986|20204948|P3|Overall Study|Adverse Event|11
5845343|NCT02260986|20204949|P2|Overall Study|Adverse Event|0
5845344|NCT02260986|20204950|P1|Overall Study|Adverse Event|24
5845345|NCT02260934|20205068|P2|Overall Study|Site error|1
5845346|NCT02260934|20205069|P1|Overall Study|Site error|0
5845347|NCT02260934|20205068|P2|Overall Study|Participant Relocated|0
5845348|NCT02260934|20205069|P1|Overall Study|Participant Relocated|1
5845349|NCT02260934|20205068|P2|Overall Study|Withdrawal by Subject|2
5845350|NCT02260934|20205069|P1|Overall Study|Withdrawal by Subject|0
5845351|NCT02260934|20205068|P2|Overall Study|Lost to Follow-up|1
5845352|NCT02260934|20205069|P1|Overall Study|Lost to Follow-up|2
5845363|NCT02260882|20205132|P2|Overall Study|Protocol Violation|1
5845364|NCT02260882|20205133|P1|Overall Study|Protocol Violation|0
5845365|NCT02260817|20205157|P2|Overall Study|Protocol Violation|14
5845366|NCT02260817|20205158|P1|Overall Study|Protocol Violation|0
5845367|NCT02260817|20205157|P2|Overall Study|Biopsy infeasible, ADT & rad. therapy|1
5845368|NCT02260817|20205158|P1|Overall Study|Biopsy infeasible, ADT & rad. therapy|0
5845369|NCT02260817|20205157|P2|Overall Study|Observation, no biopsy|1
5845370|NCT02260817|20205158|P1|Overall Study|Observation, no biopsy|0
5845371|NCT02260817|20205157|P2|Overall Study|Androgen deprivation therapy, no biopsy|7
5845372|NCT02260817|20205158|P1|Overall Study|Androgen deprivation therapy, no biopsy|0
5845373|NCT02260817|20205157|P2|Overall Study|Lost to Follow-up|14
5845374|NCT02260817|20205158|P1|Overall Study|Lost to Follow-up|0
5845375|NCT02260791|20205206|P2|Overall Study|Protocol deviation|3
5845376|NCT02260791|20205207|P1|Overall Study|Protocol deviation|2
5845377|NCT02260791|20205206|P2|Overall Study|Screen failure|1
5845378|NCT02260791|20205207|P1|Overall Study|Screen failure|0
5845379|NCT02260791|20205206|P2|Overall Study|Withdrawal by Subject|16
5845380|NCT02260791|20205207|P1|Overall Study|Withdrawal by Subject|11
5845381|NCT02260791|20205206|P2|Overall Study|Death|0
5845382|NCT02260791|20205207|P1|Overall Study|Death|1
5845383|NCT02260791|20205206|P2|Overall Study|Adverse Event|9
5845384|NCT02260791|20205207|P1|Overall Study|Adverse Event|13
5845385|NCT02260791|20205206|P2|Overall Study|Lack of Efficacy|1
5845386|NCT02260791|20205207|P1|Overall Study|Lack of Efficacy|2
5845387|NCT02260791|20205206|P2|Overall Study|Lost to Follow-up|4
5845388|NCT02260791|20205207|P1|Overall Study|Lost to Follow-up|4
5845389|NCT02260648|20205246|P3|Overall Study|Discontinue Due to Study Termination|7
5845390|NCT02260648|20205247|P2|Overall Study|Discontinue Due to Study Termination|12
5845391|NCT02260648|20205248|P1|Overall Study|Discontinue Due to Study Termination|13
5845392|NCT02260648|20205246|P3|Overall Study|Protocol Violation|0
5845393|NCT02260648|20205247|P2|Overall Study|Protocol Violation|0
5845394|NCT02260648|20205248|P1|Overall Study|Protocol Violation|1
5845395|NCT02260648|20205246|P3|Overall Study|Withdrawal by Subject|0
5845396|NCT02260648|20205247|P2|Overall Study|Withdrawal by Subject|1
5845397|NCT02260648|20205248|P1|Overall Study|Withdrawal by Subject|1
5845398|NCT02260648|20205246|P3|Overall Study|Adverse Event|1
5845399|NCT02260648|20205247|P2|Overall Study|Adverse Event|0
5845400|NCT02260648|20205248|P1|Overall Study|Adverse Event|3
5845401|NCT02260635|20205276|P2|Open-Label Extension|Withdrawal by Subject|0
5845402|NCT02260635|20205277|P1|Open-Label Extension|Withdrawal by Subject|1
5845403|NCT02260635|20205276|P2|Open-Label Extension|Study Termination|25
5845404|NCT02260635|20205277|P1|Open-Label Extension|Study Termination|25
5845405|NCT02260635|20205276|P2|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|2
5845406|NCT02260635|20205277|P1|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|1
5845407|NCT02260492|20205329|P3|Overall Study|Withdrawal by Subject|2
5845408|NCT02260492|20205330|P2|Overall Study|Withdrawal by Subject|2
5845409|NCT02260492|20205331|P1|Overall Study|Withdrawal by Subject|3
5845410|NCT02260492|20205329|P3|Overall Study|Physician Decision|1
5845411|NCT02260492|20205330|P2|Overall Study|Physician Decision|0
5845412|NCT02260492|20205331|P1|Overall Study|Physician Decision|2
5845413|NCT02260492|20205329|P3|Overall Study|Lost to Follow-up|0
5845414|NCT02260492|20205330|P2|Overall Study|Lost to Follow-up|9
5845415|NCT02260492|20205331|P1|Overall Study|Lost to Follow-up|12
5845416|NCT02260492|20205329|P3|Overall Study|Death|0
5845417|NCT02260492|20205330|P2|Overall Study|Death|1
5845418|NCT02260492|20205331|P1|Overall Study|Death|0
5845419|NCT02260492|20205329|P3|Overall Study|Adverse Event|2
5845420|NCT02260492|20205330|P2|Overall Study|Adverse Event|1
5845421|NCT02260492|20205331|P1|Overall Study|Adverse Event|6
5845422|NCT02260388|20205364|P4|Overall Study|Lost to Follow-up|4
5845423|NCT02260388|20205365|P3|Overall Study|Lost to Follow-up|3
5845424|NCT02260388|20205366|P2|Overall Study|Lost to Follow-up|8
5845425|NCT02260388|20205367|P1|Overall Study|Lost to Follow-up|2
5845426|NCT02260180|20205396|P3|Overall Study|Adverse Event|1
5845427|NCT02260180|20205397|P2|Overall Study|Adverse Event|0
5845428|NCT02260180|20205398|P1|Overall Study|Adverse Event|2
5845429|NCT02260154|20205409|P1|Overall Study|Screening failure|2
5845430|NCT02259582|20205449|P3|Overall Study|Lack of Subject Adherence to Protocol|1
5845431|NCT02259582|20205450|P2|Overall Study|Lack of Subject Adherence to Protocol|1
5845432|NCT02259582|20205451|P1|Overall Study|Lack of Subject Adherence to Protocol|1
5845433|NCT02259582|20205449|P3|Overall Study|Disease progression|17
5845434|NCT02259582|20205450|P2|Overall Study|Disease progression|15
5845435|NCT02259582|20205451|P1|Overall Study|Disease progression|14
5845436|NCT02259582|20205449|P3|Overall Study|Withdrawal by Subject|1
5845437|NCT02259582|20205450|P2|Overall Study|Withdrawal by Subject|0
5845438|NCT02259582|20205451|P1|Overall Study|Withdrawal by Subject|0
5845439|NCT02259582|20205449|P3|Overall Study|Adverse Event|1
5845440|NCT02259582|20205450|P2|Overall Study|Adverse Event|0
5845441|NCT02259582|20205451|P1|Overall Study|Adverse Event|1
5845442|NCT02259582|20205449|P3|Overall Study|Death|1
5845443|NCT02259582|20205450|P2|Overall Study|Death|0
5845444|NCT02259582|20205451|P1|Overall Study|Death|0
5845445|NCT02259582|20205449|P3|Overall Study|Physician Decision|0
5845446|NCT02259582|20205450|P2|Overall Study|Physician Decision|1
5845447|NCT02259582|20205451|P1|Overall Study|Physician Decision|0
5845448|NCT02259400|20205461|P2|Overall Study|Death|2
5845449|NCT02259400|20205462|P1|Overall Study|Death|0
5845450|NCT02259348|20205494|P1|Overall Study|Death|4
5845451|NCT02259348|20205494|P1|Overall Study|Donors|6
5845452|NCT02259114|20205511|P5|Overall Study|Not Treated|0
5845453|NCT02259114|20205512|P4|Overall Study|Not Treated|0
5845454|NCT02259114|20205513|P3|Overall Study|Not Treated|0
5845455|NCT02259114|20205514|P2|Overall Study|Not Treated|0
5845456|NCT02259114|20205515|P1|Overall Study|Not Treated|1
5845457|NCT02259114|20205511|P5|Overall Study|Treatment Delay >2 wks: Toxicity|0
5845458|NCT02259114|20205512|P4|Overall Study|Treatment Delay >2 wks: Toxicity|0
5845459|NCT02259114|20205513|P3|Overall Study|Treatment Delay >2 wks: Toxicity|0
5845460|NCT02259114|20205514|P2|Overall Study|Treatment Delay >2 wks: Toxicity|1
5845461|NCT02259114|20205515|P1|Overall Study|Treatment Delay >2 wks: Toxicity|1
5845462|NCT02259114|20205511|P5|Overall Study|Withdrawal by Subject|0
5845463|NCT02259114|20205512|P4|Overall Study|Withdrawal by Subject|1
5845464|NCT02259114|20205513|P3|Overall Study|Withdrawal by Subject|1
5845465|NCT02259114|20205514|P2|Overall Study|Withdrawal by Subject|0
5845466|NCT02259114|20205515|P1|Overall Study|Withdrawal by Subject|0
5845467|NCT02259114|20205511|P5|Overall Study|Treatment Delay >2 wks: Adverse Event|0
5845468|NCT02259114|20205512|P4|Overall Study|Treatment Delay >2 wks: Adverse Event|0
5845469|NCT02259114|20205513|P3|Overall Study|Treatment Delay >2 wks: Adverse Event|1
5845470|NCT02259114|20205514|P2|Overall Study|Treatment Delay >2 wks: Adverse Event|0
5845471|NCT02259114|20205515|P1|Overall Study|Treatment Delay >2 wks: Adverse Event|0
5845472|NCT02259114|20205511|P5|Overall Study|Death|0
5845473|NCT02259114|20205512|P4|Overall Study|Death|0
5845474|NCT02259114|20205513|P3|Overall Study|Death|1
5845475|NCT02259114|20205514|P2|Overall Study|Death|0
5845476|NCT02259114|20205515|P1|Overall Study|Death|3
5845477|NCT02259114|20205511|P5|Overall Study|Adverse Event|1
5845478|NCT02259114|20205512|P4|Overall Study|Adverse Event|0
5845479|NCT02259114|20205513|P3|Overall Study|Adverse Event|0
5845480|NCT02259114|20205514|P2|Overall Study|Adverse Event|1
5845481|NCT02259114|20205515|P1|Overall Study|Adverse Event|2
5845482|NCT02259114|20205511|P5|Overall Study|Progressive Disease|5
5845483|NCT02259114|20205512|P4|Overall Study|Progressive Disease|2
5845484|NCT02259114|20205513|P3|Overall Study|Progressive Disease|10
5845485|NCT02259114|20205514|P2|Overall Study|Progressive Disease|2
5845486|NCT02259114|20205515|P1|Overall Study|Progressive Disease|14
5845487|NCT02259088|20205574|P2|Overall Study|Subject/guardian decision|8
5845488|NCT02259088|20205575|P1|Overall Study|Subject/guardian decision|8
5845489|NCT02259088|20205574|P2|Overall Study|Protocol deviation|0
5845490|NCT02259088|20205575|P1|Overall Study|Protocol deviation|5
5845491|NCT02259088|20205574|P2|Overall Study|Physician Decision|2
5845492|NCT02259088|20205575|P1|Overall Study|Physician Decision|5
5845493|NCT02259088|20205574|P2|Overall Study|Death|0
5845494|NCT02259088|20205575|P1|Overall Study|Death|2
5845495|NCT02259088|20205574|P2|Overall Study|Lost to Follow-up|0
5845496|NCT02259088|20205575|P1|Overall Study|Lost to Follow-up|2
5845497|NCT02259088|20205574|P2|Overall Study|Adverse Event|4
5845498|NCT02259088|20205575|P1|Overall Study|Adverse Event|6
5845499|NCT02259010|20205620|P1|Overall Study|Didn't Completed Dosing; PK Assessment|5
5845500|NCT02258659|20205645|P1|Overall Study|Withdrawal by Subject|1
5845501|NCT02258542|20205662|P4|Overall Study|Eligibility criteria not fulfilled|0
5845502|NCT02258542|20205663|P3|Overall Study|Eligibility criteria not fulfilled|0
5845503|NCT02258542|20205664|P2|Overall Study|Eligibility criteria not fulfilled|2
5845504|NCT02258542|20205665|P1|Overall Study|Eligibility criteria not fulfilled|0
5845505|NCT02258542|20205662|P4|Overall Study|Protocol Violation|0
5845506|NCT02258542|20205663|P3|Overall Study|Protocol Violation|0
5845507|NCT02258542|20205664|P2|Overall Study|Protocol Violation|2
5845508|NCT02258542|20205665|P1|Overall Study|Protocol Violation|1
5845509|NCT02258542|20205662|P4|Overall Study|Adverse Event|0
5845510|NCT02258542|20205663|P3|Overall Study|Adverse Event|0
5845511|NCT02258542|20205664|P2|Overall Study|Adverse Event|4
5845512|NCT02258542|20205665|P1|Overall Study|Adverse Event|3
5845513|NCT02258542|20205662|P4|Overall Study|Death|1
5845514|NCT02258542|20205663|P3|Overall Study|Death|0
5845515|NCT02258542|20205664|P2|Overall Study|Death|4
5845516|NCT02258542|20205665|P1|Overall Study|Death|5
5845517|NCT02258542|20205662|P4|Overall Study|Lost to Follow-up|2
5845518|NCT02258542|20205663|P3|Overall Study|Lost to Follow-up|1
5845519|NCT02258542|20205664|P2|Overall Study|Lost to Follow-up|12
5845520|NCT02258542|20205665|P1|Overall Study|Lost to Follow-up|5
5845521|NCT02258542|20205662|P4|Overall Study|Withdrawal by Subject|1
5845522|NCT02258542|20205663|P3|Overall Study|Withdrawal by Subject|7
5845523|NCT02258542|20205664|P2|Overall Study|Withdrawal by Subject|20
5845524|NCT02258542|20205665|P1|Overall Study|Withdrawal by Subject|20
5845525|NCT02258542|20205662|P4|Overall Study|study specific discount. criteria|0
5845526|NCT02258542|20205663|P3|Overall Study|study specific discount. criteria|0
5845527|NCT02258542|20205664|P2|Overall Study|study specific discount. criteria|1
5845528|NCT02258542|20205665|P1|Overall Study|study specific discount. criteria|1
5845529|NCT02258542|20205662|P4|Overall Study|eg. not made to the visit|1
5845530|NCT02258542|20205663|P3|Overall Study|eg. not made to the visit|0
5845531|NCT02258542|20205664|P2|Overall Study|eg. not made to the visit|4
5845532|NCT02258542|20205665|P1|Overall Study|eg. not made to the visit|7
5845533|NCT02258529|20205889|P1|Overall Study|Adverse Event|1
5845534|NCT02258529|20205889|P1|Overall Study|Study Terminated by Sponsor|9
5845535|NCT02258464|20205921|P2|Overall Study|AE related to clinical PD|0
5845536|NCT02258464|20205922|P1|Overall Study|AE related to clinical PD|1
5845537|NCT02258464|20205921|P2|Overall Study|Withdrawal by Subject|4
5845538|NCT02258464|20205922|P1|Overall Study|Withdrawal by Subject|5
5845539|NCT02258464|20205921|P2|Overall Study|AE not related to clinical PD|3
5845540|NCT02258464|20205922|P1|Overall Study|AE not related to clinical PD|1
5845541|NCT02258464|20205921|P2|Overall Study|Study drug never administered|1
5845542|NCT02258464|20205922|P1|Overall Study|Study drug never administered|1
5845543|NCT02258464|20205921|P2|Overall Study|Progressive disease (PD)|17
5845544|NCT02258464|20205922|P1|Overall Study|Progressive disease (PD)|9
5845545|NCT02258334|20206003|P4|Overall Study|Adverse Event|0
5845546|NCT02258334|20206004|P3|Overall Study|Adverse Event|0
5845547|NCT02258334|20206005|P2|Overall Study|Adverse Event|0
5845548|NCT02258334|20206006|P1|Overall Study|Adverse Event|1
5845549|NCT02257918|20206098|P3|Overall Study|Pregnancy|1
5845550|NCT02257918|20206099|P2|Overall Study|Pregnancy|0
5845551|NCT02257918|20206100|P1|Overall Study|Pregnancy|0
5845552|NCT02257918|20206098|P3|Overall Study|Withdrawal by Subject|1
5845553|NCT02257918|20206099|P2|Overall Study|Withdrawal by Subject|0
5845554|NCT02257918|20206100|P1|Overall Study|Withdrawal by Subject|0
5845555|NCT02257918|20206098|P3|Overall Study|Lost to Follow-up|0
5845556|NCT02257918|20206099|P2|Overall Study|Lost to Follow-up|1
5845557|NCT02257918|20206100|P1|Overall Study|Lost to Follow-up|4
5845558|NCT02257684|20206150|P1|Overall Study|Sponsor's Decision|1
5845559|NCT02257684|20206150|P1|Overall Study|Lack of Efficacy|1
5845560|NCT02257684|20206150|P1|Overall Study|Adverse Event|2
5845561|NCT02257632|20206160|P2|Overall Study|Adverse Event|2
5845562|NCT02257632|20206161|P1|Overall Study|Adverse Event|1
5845563|NCT02257632|20206160|P2|Overall Study|Withdrawal by Subject|1
5845564|NCT02257632|20206161|P1|Overall Study|Withdrawal by Subject|0
5845565|NCT02257528|20206201|P1|Overall Study|Never received study treatment|1
5845566|NCT02257489|20206217|P9|Overall Study|Withdrawal by Subject|0
5845567|NCT02257489|20206218|P8|Overall Study|Withdrawal by Subject|0
5845568|NCT02257489|20206219|P7|Overall Study|Withdrawal by Subject|0
5845569|NCT02257489|20206220|P6|Overall Study|Withdrawal by Subject|0
5845570|NCT02257489|20206221|P5|Overall Study|Withdrawal by Subject|0
5845571|NCT02257489|20206222|P4|Overall Study|Withdrawal by Subject|1
5845572|NCT02257489|20206223|P3|Overall Study|Withdrawal by Subject|0
5845573|NCT02257489|20206224|P2|Overall Study|Withdrawal by Subject|0
5845574|NCT02257489|20206225|P1|Overall Study|Withdrawal by Subject|0
5845575|NCT02257385|20206261|P2|Overall Study|Withdrawal by Subject|4
5845576|NCT02257385|20206262|P1|Overall Study|Withdrawal by Subject|4
5845577|NCT02257385|20206261|P2|Overall Study|Lost to Follow-up|1
5845578|NCT02257385|20206262|P1|Overall Study|Lost to Follow-up|0
5845579|NCT02257385|20206261|P2|Overall Study|Protocol Violation|7
5845580|NCT02257385|20206262|P1|Overall Study|Protocol Violation|5
5845581|NCT02257385|20206261|P2|Overall Study|Lack of Efficacy|2
5845582|NCT02257385|20206262|P1|Overall Study|Lack of Efficacy|1
5845583|NCT02257385|20206261|P2|Overall Study|Adverse Event|8
5845584|NCT02257385|20206262|P1|Overall Study|Adverse Event|12
5845585|NCT02257372|20206272|P2|Overall Study|Withdrew consent|0
5845586|NCT02257372|20206273|P1|Overall Study|Withdrew consent|1
5845587|NCT02257372|20206272|P2|Overall Study|Lost to Follow-up|1
5845588|NCT02257372|20206273|P1|Overall Study|Lost to Follow-up|0
5845589|NCT02257372|20206272|P2|Overall Study|Protocol Violation|1
5845590|NCT02257372|20206273|P1|Overall Study|Protocol Violation|1
5845591|NCT02257372|20206272|P2|Overall Study|Lack of Efficacy|1
5845592|NCT02257372|20206273|P1|Overall Study|Lack of Efficacy|2
5845593|NCT02257372|20206272|P2|Overall Study|Adverse Event|7
5845594|NCT02257372|20206273|P1|Overall Study|Adverse Event|3
5845595|NCT02256982|20206290|P2|Overall Study|Disease Progression|1
5845596|NCT02256982|20206291|P1|Overall Study|Disease Progression|0
5845597|NCT02256969|20206300|P3|Overall Study|Screenfailed or withdrew|1
5845598|NCT02256969|20206301|P2|Overall Study|Screenfailed or withdrew|1
5845599|NCT02256969|20206302|P1|Overall Study|Screenfailed or withdrew|2
5845600|NCT02256917|20206319|P1|Prophylactic Treatment Phase II|Discontinued medication|1
5845601|NCT02256917|20206319|P1|Prophylactic Treatment Phase II|Did not attend completion visit|1
5845602|NCT02256917|20206319|P1|Prophylactic Treatment Phase II|Withdrawn Consent|1
5845603|NCT02256917|20206319|P1|Prophylactic Treatment Phase II|Lost to Follow-up|1
5845604|NCT02256917|20206319|P1|Prophylactic Treatment Phase I|Lost to Follow-up|1
5845605|NCT02256891|20206340|P2|Overall Study|Equipment Malfunction|1
5845606|NCT02256891|20206341|P1|Overall Study|Equipment Malfunction|0
5845607|NCT02256891|20206340|P2|Overall Study|Screen Fail|4
5845608|NCT02256891|20206341|P1|Overall Study|Screen Fail|5
5845609|NCT02256891|20206340|P2|Overall Study|Physician Decision|3
5845610|NCT02256891|20206341|P1|Overall Study|Physician Decision|7
5845611|NCT02256891|20206340|P2|Overall Study|Lost to Follow-up|3
5845612|NCT02256891|20206341|P1|Overall Study|Lost to Follow-up|0
5845613|NCT02256891|20206340|P2|Overall Study|Death|2
5845614|NCT02256891|20206341|P1|Overall Study|Death|0
5845615|NCT02256839|20206367|P2|Overall Study|Did not meet Eligibility Criteria|3
5845616|NCT02256839|20206368|P1|Overall Study|Did not meet Eligibility Criteria|2
5845617|NCT02256553|20206374|P1|Period III|Adverse Event|3
5845618|NCT02256553|20206374|P1|Period II|Subject Moved|1
5845619|NCT02256553|20206374|P1|Period II|Adverse Event|1
5845620|NCT02256553|20206374|P1|Period I|Protocol Violation|1
5845621|NCT02256553|20206374|P1|Period I|Adverse Event|5
5845622|NCT02256540|20206383|P3|Overall Study|Back pain preventing exercise|1
5845623|NCT02256540|20206384|P2|Overall Study|Back pain preventing exercise|0
5845624|NCT02256540|20206385|P1|Overall Study|Back pain preventing exercise|0
5845625|NCT02256540|20206383|P3|Overall Study|Withdrawal by Subject|1
5845626|NCT02256540|20206384|P2|Overall Study|Withdrawal by Subject|1
5845627|NCT02256540|20206385|P1|Overall Study|Withdrawal by Subject|0
5845628|NCT02256488|20206403|P4|Overall Study|Withdrawal by Subject|2
5845629|NCT02256488|20206404|P3|Overall Study|Withdrawal by Subject|0
5845630|NCT02256488|20206405|P2|Overall Study|Withdrawal by Subject|0
5845631|NCT02256488|20206406|P1|Overall Study|Withdrawal by Subject|1
5845632|NCT02256488|20206403|P4|Overall Study|OTHER|1
5845633|NCT02256488|20206404|P3|Overall Study|OTHER|1
5845634|NCT02256488|20206405|P2|Overall Study|OTHER|0
5845635|NCT02256488|20206406|P1|Overall Study|OTHER|1
5845636|NCT02256488|20206403|P4|Overall Study|Lost to Follow-up|3
5845637|NCT02256488|20206404|P3|Overall Study|Lost to Follow-up|9
5845638|NCT02256488|20206405|P2|Overall Study|Lost to Follow-up|6
5845639|NCT02256488|20206406|P1|Overall Study|Lost to Follow-up|6
5845640|NCT02256436|20206422|P2|Overall Study|Ongoing in Study|67
5845641|NCT02256436|20206423|P1|Overall Study|Ongoing in Study|108
5845642|NCT02256436|20206422|P2|Overall Study|Withdrawal by Subject|30
5845643|NCT02256436|20206423|P1|Overall Study|Withdrawal by Subject|7
5845644|NCT02256436|20206422|P2|Overall Study|Protocol Violation|0
5845645|NCT02256436|20206423|P1|Overall Study|Protocol Violation|1
5845646|NCT02256436|20206422|P2|Overall Study|Physician Decision|3
5845647|NCT02256436|20206423|P1|Overall Study|Physician Decision|1
5845648|NCT02256436|20206422|P2|Overall Study|Lost to Follow-up|1
5845649|NCT02256436|20206423|P1|Overall Study|Lost to Follow-up|1
5845650|NCT02256436|20206422|P2|Overall Study|Death|158
5845651|NCT02256436|20206423|P1|Overall Study|Death|137
5845652|NCT02256436|20206422|P2|Overall Study|Adverse Event|13
5845653|NCT02256436|20206423|P1|Overall Study|Adverse Event|15
5845654|NCT02256384|20206459|P1|Overall Study|Equipment not capturing data|2
5845655|NCT02256384|20206459|P1|Overall Study|Withdrawal by Subject|12
5845656|NCT02256267|20206492|P1|Period 2 (Day 7 to Day 14)|Adverse Event|1
5845657|NCT02256267|20206492|P1|Period 1 (Day 1; Day 2 to Day 9 Washout)|Adverse Event|1
5845658|NCT02255981|20206565|P1|Overall Study|Withdrawal by Subject|1
5845659|NCT02255981|20206565|P1|Overall Study|Lost to Follow-up|3
5845660|NCT02255760|20206580|P5|Overall Study|Lost to Follow-up|0
5845661|NCT02255760|20206581|P4|Overall Study|Lost to Follow-up|0
5845662|NCT02255760|20206582|P3|Overall Study|Lost to Follow-up|0
5845663|NCT02255760|20206583|P2|Overall Study|Lost to Follow-up|1
5845664|NCT02255760|20206584|P1|Overall Study|Lost to Follow-up|0
5845665|NCT02255565|20206639|P3|Overall Study|Withdrawal by Subject|0
5845666|NCT02255565|20206640|P2|Overall Study|Withdrawal by Subject|1
5845667|NCT02255565|20206641|P1|Overall Study|Withdrawal by Subject|0
5845668|NCT02255552|20206702|P2|Overall Study|Withdrawal by Subject|4
5845669|NCT02255552|20206703|P1|Overall Study|Withdrawal by Subject|1
5845670|NCT02255552|20206702|P2|Overall Study|Participants enrolled into another study|11
5845671|NCT02255552|20206703|P1|Overall Study|Participants enrolled into another study|0
5845672|NCT02255500|20206721|P2|Overall Study|Withdrawal by Subject|0
5845673|NCT02255500|20206722|P1|Overall Study|Withdrawal by Subject|1
5845674|NCT02255461|20206743|P5|Overall Study|Not meet dose reduction BSA requirement|0
5845675|NCT02255461|20206744|P4|Overall Study|Not meet dose reduction BSA requirement|0
5845676|NCT02255461|20206745|P3|Overall Study|Not meet dose reduction BSA requirement|0
5845677|NCT02255461|20206746|P2|Overall Study|Not meet dose reduction BSA requirement|1
5845678|NCT02255461|20206747|P1|Overall Study|Not meet dose reduction BSA requirement|0
5845679|NCT02255461|20206743|P5|Overall Study|Withdrawal by Subject|1
5845680|NCT02255461|20206744|P4|Overall Study|Withdrawal by Subject|0
5845681|NCT02255461|20206745|P3|Overall Study|Withdrawal by Subject|1
5845682|NCT02255461|20206746|P2|Overall Study|Withdrawal by Subject|0
5845683|NCT02255461|20206747|P1|Overall Study|Withdrawal by Subject|0
5845684|NCT02255461|20206743|P5|Overall Study|Adverse Event|1
5845685|NCT02255461|20206744|P4|Overall Study|Adverse Event|0
5845686|NCT02255461|20206745|P3|Overall Study|Adverse Event|0
5845687|NCT02255461|20206746|P2|Overall Study|Adverse Event|1
5845688|NCT02255461|20206747|P1|Overall Study|Adverse Event|0
5845689|NCT02255422|20206826|P7|Overall Study|Lost to Follow-up|0
5845690|NCT02255422|20206827|P6|Overall Study|Lost to Follow-up|0
5845691|NCT02255422|20206828|P5|Overall Study|Lost to Follow-up|0
5845692|NCT02255422|20206829|P4|Overall Study|Lost to Follow-up|0
5845693|NCT02255422|20206830|P3|Overall Study|Lost to Follow-up|1
5845694|NCT02255422|20206831|P2|Overall Study|Lost to Follow-up|0
5845695|NCT02255422|20206832|P1|Overall Study|Lost to Follow-up|0
5845696|NCT02255422|20206826|P7|Overall Study|Withdrawal by Subject|2
5845697|NCT02255422|20206827|P6|Overall Study|Withdrawal by Subject|0
5845698|NCT02255422|20206828|P5|Overall Study|Withdrawal by Subject|0
5845699|NCT02255422|20206829|P4|Overall Study|Withdrawal by Subject|0
5845700|NCT02255422|20206830|P3|Overall Study|Withdrawal by Subject|0
5845701|NCT02255422|20206831|P2|Overall Study|Withdrawal by Subject|0
5845702|NCT02255422|20206832|P1|Overall Study|Withdrawal by Subject|0
5845703|NCT02255279|20206866|P2|Overall Study|Withdrawal by Subject|6
5845704|NCT02255279|20206867|P1|Overall Study|Withdrawal by Subject|3
5845705|NCT02255279|20206866|P2|Overall Study|Protocol Violation|1
5845706|NCT02255279|20206867|P1|Overall Study|Protocol Violation|0
5845707|NCT02255279|20206866|P2|Overall Study|Lost to Follow-up|2
5845708|NCT02255279|20206867|P1|Overall Study|Lost to Follow-up|2
5845709|NCT02255149|20206920|P1|Overall Study|Implant Failure|1
5845710|NCT02255149|20206920|P1|Overall Study|Withdrawal by PI|1
5845711|NCT02255149|20206920|P1|Overall Study|Withdrawal by Subject|1
5845712|NCT02255149|20206920|P1|Overall Study|Lost to Follow-up|2
5845724|NCT02254772|20206957|P1|Overall Study|Withdrawal by Subject|1
5845725|NCT02254772|20206957|P1|Overall Study|Ineligible|1
5845726|NCT02254681|20206963|P1|Overall Study|Lack of Efficacy|6
5845727|NCT02254551|20206973|P1|Dose Escalation|Dose-limiting toxicity|2
5845728|NCT02254551|20206973|P1|Dose Escalation|Physician Decision|1
5845729|NCT02254486|20206983|P2|Overall Study|Various|12
5845730|NCT02254486|20206984|P1|Overall Study|Various|12
5845731|NCT02254486|20206983|P2|Overall Study|GFR<60mL/min|21
5845732|NCT02254486|20206984|P1|Overall Study|GFR<60mL/min|16
5845733|NCT02254486|20206983|P2|Overall Study|Withdrawal by Subject|15
5845734|NCT02254486|20206984|P1|Overall Study|Withdrawal by Subject|17
5845735|NCT02254486|20206983|P2|Overall Study|Protocol Violation|2
5845736|NCT02254486|20206984|P1|Overall Study|Protocol Violation|1
5845737|NCT02254486|20206983|P2|Overall Study|Lost to Follow-up|4
5845738|NCT02254486|20206984|P1|Overall Study|Lost to Follow-up|2
5845739|NCT02254486|20206983|P2|Overall Study|Lack of Efficacy|0
5845740|NCT02254486|20206984|P1|Overall Study|Lack of Efficacy|1
5845741|NCT02254486|20206983|P2|Overall Study|Adverse Event|1
5845742|NCT02254486|20206984|P1|Overall Study|Adverse Event|1
5845743|NCT02254460|20207023|P2|Overall Study|Adverse Event|0
5845744|NCT02254460|20207024|P1|Overall Study|Adverse Event|1
5845745|NCT02254421|20207032|P2|Overall Study|Withdrew Consent|1
5845746|NCT02254421|20207033|P1|Overall Study|Withdrew Consent|1
5845747|NCT02254421|20207032|P2|Overall Study|Death|2
5845748|NCT02254421|20207033|P1|Overall Study|Death|0
5845749|NCT02254421|20207032|P2|Overall Study|Randomized but Not Treated|0
5845750|NCT02254421|20207033|P1|Overall Study|Randomized but Not Treated|1
5845751|NCT02254408|20207047|P2|Overall Study|Lost to Follow-up|0
5845752|NCT02254408|20207048|P1|Overall Study|Lost to Follow-up|1
5845753|NCT02254408|20207047|P2|Overall Study|Withdrawal by Subject|3
5845754|NCT02254408|20207048|P1|Overall Study|Withdrawal by Subject|3
5845755|NCT02254408|20207047|P2|Overall Study|Investigator's Discretion|1
5845756|NCT02254408|20207048|P1|Overall Study|Investigator's Discretion|0
5845757|NCT02254408|20207047|P2|Overall Study|Death|3
5845758|NCT02254408|20207048|P1|Overall Study|Death|2
5845759|NCT02254408|20207047|P2|Overall Study|Adverse Event|0
5845760|NCT02254408|20207048|P1|Overall Study|Adverse Event|1
5845761|NCT02254408|20207047|P2|Overall Study|Randomized But Not Treated|3
5845762|NCT02254408|20207048|P1|Overall Study|Randomized But Not Treated|1
5845763|NCT02254304|20207060|P2|Overall Study|Personal decision|0
5845764|NCT02254304|20207061|P1|Overall Study|Personal decision|1
5845765|NCT02254304|20207060|P2|Overall Study|Personal causes|1
5845766|NCT02254304|20207061|P1|Overall Study|Personal causes|4
5845767|NCT02254304|20207060|P2|Overall Study|Injection site pain and Injection fear|0
5845768|NCT02254304|20207061|P1|Overall Study|Injection site pain and Injection fear|1
5845769|NCT02254304|20207060|P2|Overall Study|Withdrawal by Subject|0
5845770|NCT02254304|20207061|P1|Overall Study|Withdrawal by Subject|3
5845771|NCT02254304|20207060|P2|Overall Study|Protocol Violation|0
5845772|NCT02254304|20207061|P1|Overall Study|Protocol Violation|1
5845773|NCT02254304|20207060|P2|Overall Study|Lost to Follow-up|2
5845774|NCT02254304|20207061|P1|Overall Study|Lost to Follow-up|2
5845775|NCT02254304|20207060|P2|Overall Study|Adverse Event|1
5845776|NCT02254304|20207061|P1|Overall Study|Adverse Event|2
5845777|NCT02254291|20207121|P3|Overall Study|Missing follow-up information|1
5845778|NCT02254291|20207122|P2|Overall Study|Missing follow-up information|0
5845779|NCT02254291|20207123|P1|Overall Study|Missing follow-up information|0
5845780|NCT02254291|20207121|P3|Overall Study|Withdrawal by Subject|1
5845781|NCT02254291|20207122|P2|Overall Study|Withdrawal by Subject|3
5845782|NCT02254291|20207123|P1|Overall Study|Withdrawal by Subject|0
5845783|NCT02254278|20207139|P2|Overall Study|Protocol Violation|1
5845784|NCT02254278|20207140|P1|Overall Study|Protocol Violation|1
5845785|NCT02253992|20207201|P3|Overall Study|Other|1
5845786|NCT02253992|20207202|P2|Overall Study|Other|0
5845787|NCT02253992|20207203|P1|Overall Study|Other|0
5845788|NCT02253992|20207201|P3|Overall Study|Completed treatment as per protocol|22
5845789|NCT02253992|20207202|P2|Overall Study|Completed treatment as per protocol|1
5845790|NCT02253992|20207203|P1|Overall Study|Completed treatment as per protocol|0
5845791|NCT02253992|20207201|P3|Overall Study|Subject discontinued study drug|1
5845792|NCT02253992|20207202|P2|Overall Study|Subject discontinued study drug|0
5845793|NCT02253992|20207203|P1|Overall Study|Subject discontinued study drug|1
5845794|NCT02253992|20207201|P3|Overall Study|Death|1
5845795|NCT02253992|20207202|P2|Overall Study|Death|0
5845796|NCT02253992|20207203|P1|Overall Study|Death|0
5845797|NCT02253992|20207201|P3|Overall Study|Adverse Event|8
5845798|NCT02253992|20207202|P2|Overall Study|Adverse Event|0
5845799|NCT02253992|20207203|P1|Overall Study|Adverse Event|0
5845800|NCT02253992|20207201|P3|Overall Study|Withdrawal by Subject|3
5845801|NCT02253992|20207202|P2|Overall Study|Withdrawal by Subject|0
5845802|NCT02253992|20207203|P1|Overall Study|Withdrawal by Subject|0
5845803|NCT02253992|20207201|P3|Overall Study|Disease progression|98
5845804|NCT02253992|20207202|P2|Overall Study|Disease progression|3
5845805|NCT02253992|20207203|P1|Overall Study|Disease progression|4
5845806|NCT02253992|20207201|P3|Overall Study|Study drug toxicity|10
5845807|NCT02253992|20207202|P2|Overall Study|Study drug toxicity|0
5845808|NCT02253992|20207203|P1|Overall Study|Study drug toxicity|1
5845809|NCT02253654|20207269|P2|Overall Study|Did Not Receive Study Treatment|1
5845810|NCT02253654|20207270|P1|Overall Study|Did Not Receive Study Treatment|4
5845811|NCT02253654|20207269|P2|Overall Study|Death|7
5845812|NCT02253654|20207270|P1|Overall Study|Death|4
5845813|NCT02253654|20207269|P2|Overall Study|Lost to Follow-up|5
5845814|NCT02253654|20207270|P1|Overall Study|Lost to Follow-up|2
5845815|NCT02253654|20207269|P2|Overall Study|Decision by Sponsor|1
5845816|NCT02253654|20207270|P1|Overall Study|Decision by Sponsor|1
5845817|NCT02253654|20207269|P2|Overall Study|Withdrawal by Subject|4
5845818|NCT02253654|20207270|P1|Overall Study|Withdrawal by Subject|12
5845819|NCT02253433|20207296|P2|Overall Study|Medical or Other Concerns|2
5845820|NCT02253433|20207297|P1|Overall Study|Medical or Other Concerns|1
5845821|NCT02253433|20207296|P2|Overall Study|Too Busy|4
5845822|NCT02253433|20207297|P1|Overall Study|Too Busy|0
5845823|NCT02253433|20207296|P2|Overall Study|Unstable Housing/Homeless|7
5845824|NCT02253433|20207297|P1|Overall Study|Unstable Housing/Homeless|0
5845825|NCT02253433|20207296|P2|Overall Study|Uncomfortable with home visitors|3
5845826|NCT02253433|20207297|P1|Overall Study|Uncomfortable with home visitors|0
5845827|NCT02253433|20207296|P2|Overall Study|Out of Study Area|7
5845828|NCT02253433|20207297|P1|Overall Study|Out of Study Area|2
5845829|NCT02253433|20207296|P2|Overall Study|No Longer Interested|15
5845830|NCT02253433|20207297|P1|Overall Study|No Longer Interested|3
5845831|NCT02253433|20207296|P2|Overall Study|Death|1
5845832|NCT02253433|20207297|P1|Overall Study|Death|1
5845833|NCT02253433|20207296|P2|Overall Study|Unable to Contact|16
5845834|NCT02253433|20207297|P1|Overall Study|Unable to Contact|9
5845835|NCT02253147|20207556|P1|Overall Study|Withdrawal by Subject|1
5845836|NCT02253147|20207556|P1|Overall Study|Lost to Follow-up|2
5845837|NCT02253147|20207556|P1|Overall Study|Conditional re-treatment at W52|5
5845838|NCT02253147|20207556|P1|Overall Study|Did not consent to study extension|9
5845839|NCT02253147|20207556|P1|Overall Study|Protocol Violation|30
5845840|NCT02252965|20207590|P2|Overall Study|Other|5
5845841|NCT02252965|20207591|P1|Overall Study|Other|4
5845842|NCT02252965|20207590|P2|Overall Study|Withdrawal by Subject|9
5845843|NCT02252965|20207591|P1|Overall Study|Withdrawal by Subject|7
5845844|NCT02252965|20207590|P2|Overall Study|Lack of Efficacy|2
5845845|NCT02252965|20207591|P1|Overall Study|Lack of Efficacy|0
5845846|NCT02252965|20207590|P2|Overall Study|Protocol Violation|5
5845847|NCT02252965|20207591|P1|Overall Study|Protocol Violation|4
5845848|NCT02252965|20207590|P2|Overall Study|Lost to Follow-up|8
5845849|NCT02252965|20207591|P1|Overall Study|Lost to Follow-up|16
5845850|NCT02252965|20207590|P2|Overall Study|Adverse Event|14
5845851|NCT02252965|20207591|P1|Overall Study|Adverse Event|9
5845852|NCT02252939|20207618|P1|Overall Study|Lost to Follow-up|3
5845853|NCT02252588|20207659|P2|Overall Study|Withdrawal by Subject|0
5845854|NCT02252588|20207660|P1|Overall Study|Withdrawal by Subject|4
5845855|NCT02252536|20207688|P2|Overall Study|Lost to Follow-up|3
5845856|NCT02252536|20207689|P1|Overall Study|Lost to Follow-up|5
5845857|NCT02252406|20207750|P2|Titrated to Ranolazine 1000mg BID|Adverse Event|0
5845858|NCT02252406|20207751|P1|Titrated to Ranolazine 1000mg BID|Adverse Event|2
5845859|NCT02252406|20207750|P2|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1
5845860|NCT02252406|20207751|P1|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1
5845861|NCT02252406|20207750|P2|Starting Dose Ranolazine 500 mg BID|Adverse Event|0
5845862|NCT02252406|20207751|P1|Starting Dose Ranolazine 500 mg BID|Adverse Event|1
5845863|NCT02252406|20207750|P2|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|0
5845864|NCT02252406|20207751|P1|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|1
5845865|NCT02252406|20207750|P2|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|3
5845866|NCT02252406|20207751|P1|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|2
5845867|NCT02252211|20207809|P3|Overall Study|Serious Adverse Event During Screening|1
5845868|NCT02252211|20207810|P2|Overall Study|Serious Adverse Event During Screening|0
5845869|NCT02252211|20207811|P1|Overall Study|Serious Adverse Event During Screening|1
5845870|NCT02252211|20207809|P3|Overall Study|Withdrawal by Subject|0
5845871|NCT02252211|20207810|P2|Overall Study|Withdrawal by Subject|0
5845872|NCT02252211|20207811|P1|Overall Study|Withdrawal by Subject|1
5845873|NCT02252211|20207809|P3|Overall Study|Progressive disease|0
5845874|NCT02252211|20207810|P2|Overall Study|Progressive disease|2
5845875|NCT02252211|20207811|P1|Overall Study|Progressive disease|3
5845876|NCT02252211|20207809|P3|Overall Study|Adverse Event|0
5845877|NCT02252211|20207810|P2|Overall Study|Adverse Event|1
5845878|NCT02252211|20207811|P1|Overall Study|Adverse Event|0
5845879|NCT02252172|20207848|P2|Overall Study|Ongoing|298
5845880|NCT02252172|20207849|P1|Overall Study|Ongoing|276
5845881|NCT02252172|20207848|P2|Overall Study|Lost to Follow-up|1
5845882|NCT02252172|20207849|P1|Overall Study|Lost to Follow-up|3
5845883|NCT02252146|20207861|P1|Overall Study|Inability to travel to study site|1
5845884|NCT02252146|20207861|P1|Overall Study|Entered hospice care|1
5845885|NCT02252146|20207861|P1|Overall Study|Lack of Efficacy|4
5845886|NCT02252042|20207902|P2|Overall Study|Ongoing in study|35
5845887|NCT02252042|20207903|P1|Overall Study|Ongoing in study|64
5845888|NCT02252042|20207902|P2|Overall Study|Withdrawal by Subject|20
5845889|NCT02252042|20207903|P1|Overall Study|Withdrawal by Subject|13
5845890|NCT02252042|20207902|P2|Overall Study|Physician Decision|1
5845891|NCT02252042|20207903|P1|Overall Study|Physician Decision|0
5845892|NCT02252042|20207902|P2|Overall Study|Death|192
5845893|NCT02252042|20207903|P1|Overall Study|Death|170
5845894|NCT02252016|20207943|P2|Overall Study|Withdrawal by Subject|2
5845895|NCT02252016|20207944|P1|Overall Study|Withdrawal by Subject|0
5845896|NCT02252016|20207943|P2|Overall Study|Physician Decision|0
5845897|NCT02252016|20207944|P1|Overall Study|Physician Decision|1
5845898|NCT02252016|20207943|P2|Overall Study|Lost to Follow-up|1
5845899|NCT02252016|20207944|P1|Overall Study|Lost to Follow-up|2
5845900|NCT02251990|20207958|P2|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|2
5845901|NCT02251990|20207959|P1|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|0
5845902|NCT02251990|20207958|P2|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|1
5845903|NCT02251990|20207959|P1|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|0
5845904|NCT02251990|20207958|P2|Period 1 (Double-blind [DB])|Not Treated|0
5845905|NCT02251990|20207959|P1|Period 1 (Double-blind [DB])|Not Treated|1
5845906|NCT02251990|20207958|P2|Period 1 (Double-blind [DB])|Withdrawal by Subject|0
5845907|NCT02251990|20207959|P1|Period 1 (Double-blind [DB])|Withdrawal by Subject|1
5845908|NCT02251990|20207958|P2|Period 1 (Double-blind [DB])|Lack of Efficacy|0
5845909|NCT02251990|20207959|P1|Period 1 (Double-blind [DB])|Lack of Efficacy|5
5845910|NCT02251990|20207958|P2|Period 1 (Double-blind [DB])|Adverse Event|1
5845911|NCT02251990|20207959|P1|Period 1 (Double-blind [DB])|Adverse Event|1
5845912|NCT02251912|20207987|P2|Overall Study|Adverse Event|2
5845913|NCT02251912|20207988|P1|Overall Study|Adverse Event|0
5845914|NCT02251912|20207987|P2|Overall Study|Withdrawal by Subject|3
5845915|NCT02251912|20207988|P1|Overall Study|Withdrawal by Subject|2
5845916|NCT02251743|20208017|P2|Overall Study|Withdrawal by Subject|1
5845917|NCT02251743|20208018|P1|Overall Study|Withdrawal by Subject|1
5845918|NCT02251717|20208026|P2|Overall Study|Withdrew Consent|0
5845919|NCT02251717|20208027|P1|Overall Study|Withdrew Consent|1
5845920|NCT02251717|20208026|P2|Overall Study|Adverse Event|1
5845921|NCT02251717|20208027|P1|Overall Study|Adverse Event|0
5845922|NCT02251652|20208039|P1|Overall Study|Withdrawal by Subject|1
5845923|NCT02251275|20208106|P5|Overall Study|Withdrawal by Subject|0
5845924|NCT02251275|20208107|P4|Overall Study|Withdrawal by Subject|1
5845925|NCT02251275|20208108|P3|Overall Study|Withdrawal by Subject|35
5845926|NCT02251275|20208109|P2|Overall Study|Withdrawal by Subject|51
5845927|NCT02251275|20208110|P1|Overall Study|Withdrawal by Subject|25
5845928|NCT02251275|20208106|P5|Overall Study|Protocol Deviation|0
5845929|NCT02251275|20208107|P4|Overall Study|Protocol Deviation|0
5845930|NCT02251275|20208108|P3|Overall Study|Protocol Deviation|1
5845931|NCT02251275|20208109|P2|Overall Study|Protocol Deviation|0
5845932|NCT02251275|20208110|P1|Overall Study|Protocol Deviation|0
5845933|NCT02251275|20208106|P5|Overall Study|Physician Decision|1
5845934|NCT02251275|20208107|P4|Overall Study|Physician Decision|0
5845935|NCT02251275|20208108|P3|Overall Study|Physician Decision|26
5845936|NCT02251275|20208109|P2|Overall Study|Physician Decision|30
5845937|NCT02251275|20208110|P1|Overall Study|Physician Decision|19
5845938|NCT02251275|20208106|P5|Overall Study|Lost to Follow-up|0
5845939|NCT02251275|20208107|P4|Overall Study|Lost to Follow-up|0
5845940|NCT02251275|20208108|P3|Overall Study|Lost to Follow-up|4
5845941|NCT02251275|20208109|P2|Overall Study|Lost to Follow-up|6
5845942|NCT02251275|20208110|P1|Overall Study|Lost to Follow-up|5
5845943|NCT02251275|20208106|P5|Overall Study|Adverse Event|0
5845944|NCT02251275|20208107|P4|Overall Study|Adverse Event|0
5845945|NCT02251275|20208108|P3|Overall Study|Adverse Event|28
5845946|NCT02251275|20208109|P2|Overall Study|Adverse Event|60
5845947|NCT02251275|20208110|P1|Overall Study|Adverse Event|23
5845948|NCT02250443|20208214|P1|Overall Study|Adverse Event|3
5845949|NCT02250443|20208214|P1|Overall Study|Administrative problems|7
5845950|NCT02250326|20208243|P3|Follow-Up Period|Lost to Follow-up|3
5845951|NCT02250326|20208244|P2|Follow-Up Period|Lost to Follow-up|1
5845952|NCT02250326|20208245|P1|Follow-Up Period|Lost to Follow-up|1
5845953|NCT02250326|20208243|P3|Follow-Up Period|Unknown or Missing|3
5845954|NCT02250326|20208244|P2|Follow-Up Period|Unknown or Missing|3
5845955|NCT02250326|20208245|P1|Follow-Up Period|Unknown or Missing|2
5845956|NCT02250326|20208243|P3|Follow-Up Period|Death|32
5845957|NCT02250326|20208244|P2|Follow-Up Period|Death|26
5845958|NCT02250326|20208245|P1|Follow-Up Period|Death|46
5845959|NCT02250326|20208243|P3|Treatment Period|Randomized or assigned; not treated|1
5845960|NCT02250326|20208244|P2|Treatment Period|Randomized or assigned; not treated|1
5845961|NCT02250326|20208245|P1|Treatment Period|Randomized or assigned; not treated|2
5845962|NCT02250326|20208243|P3|Treatment Period|Miscellaneous|7
5845963|NCT02250326|20208244|P2|Treatment Period|Miscellaneous|2
5845964|NCT02250326|20208245|P1|Treatment Period|Miscellaneous|8
5845965|NCT02250326|20208243|P3|Treatment Period|Withdrawal by Subject|4
5845966|NCT02250326|20208244|P2|Treatment Period|Withdrawal by Subject|5
5845967|NCT02250326|20208245|P1|Treatment Period|Withdrawal by Subject|11
5845968|NCT02250326|20208243|P3|Treatment Period|Symptomatic Deterioration|10
5845969|NCT02250326|20208244|P2|Treatment Period|Symptomatic Deterioration|4
5845970|NCT02250326|20208245|P1|Treatment Period|Symptomatic Deterioration|9
5845971|NCT02250326|20208243|P3|Treatment Period|Progressive Disease|45
5845972|NCT02250326|20208244|P2|Treatment Period|Progressive Disease|36
5845973|NCT02250326|20208245|P1|Treatment Period|Progressive Disease|42
5845974|NCT02250326|20208243|P3|Treatment Period|Adverse Event|8
5845975|NCT02250326|20208244|P2|Treatment Period|Adverse Event|4
5845976|NCT02250326|20208245|P1|Treatment Period|Adverse Event|8
5845977|NCT02250326|20208243|P3|Treatment Period|Death|2
5845978|NCT02250326|20208244|P2|Treatment Period|Death|12
5845979|NCT02250326|20208245|P1|Treatment Period|Death|1
5845980|NCT02250274|20208278|P2|Overall Study|Insufficient blood draw amount|6
5845981|NCT02250274|20208279|P1|Overall Study|Insufficient blood draw amount|7
5845982|NCT02250183|20208295|P1|Overall Study|Lost to Follow-up|1
5845983|NCT02250183|20208295|P1|Overall Study|Adverse Event|5
5845984|NCT02250183|20208295|P1|Overall Study|Withdrawal by Subject|2
5845985|NCT02249949|20208317|P1|Overall Study|Cancelled prior to treatment|2
5845986|NCT02249832|20208324|P1|Overall Study|Lost to Follow-up|10
5845987|NCT02249832|20208324|P1|Overall Study|Withdrawal by Subject|3
5845988|NCT02249767|20208368|P3|Overall Study|Did not use medication|8
5845989|NCT02249767|20208369|P2|Overall Study|Did not use medication|9
5845990|NCT02249767|20208370|P1|Overall Study|Did not use medication|8
5845991|NCT02249182|20208436|P5|Treatment Phase|Lost to Follow-up|0
5845992|NCT02249182|20208437|P4|Treatment Phase|Lost to Follow-up|0
5845993|NCT02249182|20208438|P3|Treatment Phase|Lost to Follow-up|0
5845994|NCT02249182|20208439|P2|Treatment Phase|Lost to Follow-up|0
5845995|NCT02249182|20208440|P1|Treatment Phase|Lost to Follow-up|4
5845996|NCT02248974|20208590|P2|1-Month Follow-Up|Lost to Follow-up|3
5845997|NCT02248974|20208591|P1|1-Month Follow-Up|Lost to Follow-up|2
5845998|NCT02248974|20208590|P2|1-Week Follow-Up|Lost to Follow-up|8
5845999|NCT02248974|20208591|P1|1-Week Follow-Up|Lost to Follow-up|0
5846000|NCT02248974|20208590|P2|1-Week Follow-Up|Withdrawal by Subject|2
5846001|NCT02248974|20208591|P1|1-Week Follow-Up|Withdrawal by Subject|0
5846002|NCT02248974|20208590|P2|1-Week Follow-Up|Timing: implanted before survey|2
5846003|NCT02248974|20208591|P1|1-Week Follow-Up|Timing: implanted before survey|0
5846004|NCT02248974|20208590|P2|1-Week Follow-Up|Noncompliant with terms of participation|1
5846005|NCT02248974|20208591|P1|1-Week Follow-Up|Noncompliant with terms of participation|0
5846006|NCT02248974|20208590|P2|1-Week Follow-Up|Excluded because of age|1
5846007|NCT02248974|20208591|P1|1-Week Follow-Up|Excluded because of age|0
5846008|NCT02248974|20208590|P2|1-Week Follow-Up|Death|1
5846009|NCT02248974|20208591|P1|1-Week Follow-Up|Death|1
5846010|NCT02248974|20208590|P2|1-Week Follow-Up|Cognitive Difficulty|0
5846011|NCT02248974|20208591|P1|1-Week Follow-Up|Cognitive Difficulty|1
5846012|NCT02248974|20208590|P2|1-Week Follow-Up|Transferred to another facility|0
5846013|NCT02248974|20208591|P1|1-Week Follow-Up|Transferred to another facility|1
5846014|NCT02248974|20208590|P2|1-Week Follow-Up|Enrolled in another study|1
5846015|NCT02248974|20208591|P1|1-Week Follow-Up|Enrolled in another study|1
5846016|NCT02248974|20208590|P2|1-Week Follow-Up|Became ineligible for LVAD|1
5846017|NCT02248974|20208591|P1|1-Week Follow-Up|Became ineligible for LVAD|4
5846018|NCT02248974|20208590|P2|1-Day Follow-Up|Enrolled in another study|0
5846019|NCT02248974|20208591|P1|1-Day Follow-Up|Enrolled in another study|1
5846020|NCT02248974|20208590|P2|1-Day Follow-Up|Withdrawal by Subject|0
5846021|NCT02248974|20208591|P1|1-Day Follow-Up|Withdrawal by Subject|5
5846022|NCT02248974|20208590|P2|1-Day Follow-Up|Lost to Follow-up|0
5846023|NCT02248974|20208591|P1|1-Day Follow-Up|Lost to Follow-up|4
5846024|NCT02248961|20208669|P2|Overall Study|Unmet inclusion/exclusion criteria|0
5846025|NCT02248961|20208670|P1|Overall Study|Unmet inclusion/exclusion criteria|1
5846026|NCT02248961|20208669|P2|Overall Study|Withdrawal by Subject|2
5846027|NCT02248961|20208670|P1|Overall Study|Withdrawal by Subject|1
5846028|NCT02248961|20208669|P2|Overall Study|Adverse Event|0
5846029|NCT02248961|20208670|P1|Overall Study|Adverse Event|1
5846030|NCT02248857|20208705|P3|6 Month|Death|0
5846031|NCT02248857|20208706|P2|6 Month|Death|0
5846032|NCT02248857|20208707|P1|6 Month|Death|1
5846033|NCT02248857|20208705|P3|6 Month|Withdrawal by Subject|2
5846034|NCT02248857|20208706|P2|6 Month|Withdrawal by Subject|2
5846035|NCT02248857|20208707|P1|6 Month|Withdrawal by Subject|0
5846036|NCT02248857|20208705|P3|6 Month|Partially completed, unable to finish|0
5846037|NCT02248857|20208706|P2|6 Month|Partially completed, unable to finish|1
5846038|NCT02248857|20208707|P1|6 Month|Partially completed, unable to finish|0
5846039|NCT02248857|20208705|P3|6 Month|Lost to Follow-up|15
5846040|NCT02248857|20208706|P2|6 Month|Lost to Follow-up|26
5846041|NCT02248857|20208707|P1|6 Month|Lost to Follow-up|27
5846042|NCT02248857|20208705|P3|3 Month|Partially completed, unable to finish|1
5846043|NCT02248857|20208706|P2|3 Month|Partially completed, unable to finish|2
5846044|NCT02248857|20208707|P1|3 Month|Partially completed, unable to finish|2
5846045|NCT02248857|20208705|P3|3 Month|Unable to reach for 3 month|26
5846046|NCT02248857|20208706|P2|3 Month|Unable to reach for 3 month|29
5846047|NCT02248857|20208707|P1|3 Month|Unable to reach for 3 month|35
5846048|NCT02248857|20208705|P3|3 Month|Withdrawal by Subject|4
5846049|NCT02248857|20208706|P2|3 Month|Withdrawal by Subject|3
5846050|NCT02248857|20208707|P1|3 Month|Withdrawal by Subject|9
5846051|NCT02248818|20208744|P9|Randomised Study|Administrative - randomization error|0
5846052|NCT02248818|20208745|P8|Randomised Study|Administrative - randomization error|0
5846053|NCT02248818|20208746|P7|Randomised Study|Administrative - randomization error|0
5846054|NCT02248818|20208747|P6|Randomised Study|Administrative - randomization error|8
5846055|NCT02248818|20208748|P5|Randomised Study|Administrative - randomization error|0
5846056|NCT02248818|20208749|P4|Randomised Study|Administrative - randomization error|0
5846057|NCT02248818|20208750|P3|Randomised Study|Administrative - randomization error|0
5846058|NCT02248818|20208751|P2|Randomised Study|Administrative - randomization error|0
5846059|NCT02248818|20208752|P1|Randomised Study|Administrative - randomization error|0
5846060|NCT02248818|20208744|P9|Screening|Lost to Follow-up|7
5846061|NCT02248818|20208745|P8|Screening|Lost to Follow-up|0
5846062|NCT02248818|20208746|P7|Screening|Lost to Follow-up|0
5846063|NCT02248818|20208747|P6|Screening|Lost to Follow-up|0
5846064|NCT02248818|20208748|P5|Screening|Lost to Follow-up|0
5846065|NCT02248818|20208749|P4|Screening|Lost to Follow-up|0
5846066|NCT02248818|20208750|P3|Screening|Lost to Follow-up|0
5846067|NCT02248818|20208751|P2|Screening|Lost to Follow-up|0
5846068|NCT02248818|20208752|P1|Screening|Lost to Follow-up|0
5846069|NCT02248818|20208744|P9|Screening|Withdrawal by Subject|6
5846070|NCT02248818|20208745|P8|Screening|Withdrawal by Subject|0
5846071|NCT02248818|20208746|P7|Screening|Withdrawal by Subject|0
5846072|NCT02248818|20208747|P6|Screening|Withdrawal by Subject|0
5846073|NCT02248818|20208748|P5|Screening|Withdrawal by Subject|0
5846074|NCT02248818|20208749|P4|Screening|Withdrawal by Subject|0
5846075|NCT02248818|20208750|P3|Screening|Withdrawal by Subject|0
5846076|NCT02248818|20208751|P2|Screening|Withdrawal by Subject|0
5846077|NCT02248818|20208752|P1|Screening|Withdrawal by Subject|0
5846078|NCT02248818|20208744|P9|Screening|Physician Decision|73
5846079|NCT02248818|20208745|P8|Screening|Physician Decision|0
5846080|NCT02248818|20208746|P7|Screening|Physician Decision|0
5846081|NCT02248818|20208747|P6|Screening|Physician Decision|0
5846082|NCT02248818|20208748|P5|Screening|Physician Decision|0
5846083|NCT02248818|20208749|P4|Screening|Physician Decision|0
5846084|NCT02248818|20208750|P3|Screening|Physician Decision|0
5846085|NCT02248818|20208751|P2|Screening|Physician Decision|0
5846086|NCT02248818|20208752|P1|Screening|Physician Decision|0
5846087|NCT02248818|20208744|P9|Screening|Study fully enrolled|14
5846088|NCT02248818|20208745|P8|Screening|Study fully enrolled|0
5846089|NCT02248818|20208746|P7|Screening|Study fully enrolled|0
5846090|NCT02248818|20208747|P6|Screening|Study fully enrolled|0
5846091|NCT02248818|20208748|P5|Screening|Study fully enrolled|0
5846092|NCT02248818|20208749|P4|Screening|Study fully enrolled|0
5846093|NCT02248818|20208750|P3|Screening|Study fully enrolled|0
5846094|NCT02248818|20208751|P2|Screening|Study fully enrolled|0
5846095|NCT02248818|20208752|P1|Screening|Study fully enrolled|0
5846096|NCT02248818|20208744|P9|Screening|Protocol Violation|7
5846097|NCT02248818|20208745|P8|Screening|Protocol Violation|0
5846098|NCT02248818|20208746|P7|Screening|Protocol Violation|0
5846099|NCT02248818|20208747|P6|Screening|Protocol Violation|0
5846100|NCT02248818|20208748|P5|Screening|Protocol Violation|0
5846101|NCT02248818|20208749|P4|Screening|Protocol Violation|0
5846102|NCT02248818|20208750|P3|Screening|Protocol Violation|0
5846103|NCT02248818|20208751|P2|Screening|Protocol Violation|0
5846104|NCT02248818|20208752|P1|Screening|Protocol Violation|0
5846105|NCT02248675|20208967|P2|Overall Study|Lost to Follow-up|1
5846106|NCT02248675|20208968|P1|Overall Study|Lost to Follow-up|3
5846107|NCT02248649|20208995|P2|Overall Study|Lost to Follow-up|10
5846108|NCT02248649|20208996|P1|Overall Study|Lost to Follow-up|14
5846109|NCT02248649|20208995|P2|Overall Study|Death|11
5846110|NCT02248649|20208996|P1|Overall Study|Death|7
5846111|NCT02248480|20209040|P2|Overall Study|Other:Physician Decision|1
5846112|NCT02248480|20209041|P1|Overall Study|Other:Physician Decision|0
5846113|NCT02248480|20209040|P2|Overall Study|Entry Criteria Not Met|1
5846114|NCT02248480|20209041|P1|Overall Study|Entry Criteria Not Met|0
5846115|NCT02248480|20209040|P2|Overall Study|Withdrawal by Subject|4
5846116|NCT02248480|20209041|P1|Overall Study|Withdrawal by Subject|2
5846117|NCT02248480|20209040|P2|Overall Study|Adverse Event|2
5846118|NCT02248480|20209041|P1|Overall Study|Adverse Event|11
5846119|NCT02248480|20209040|P2|Overall Study|Lack of Efficacy|6
5846120|NCT02248480|20209041|P1|Overall Study|Lack of Efficacy|4
5846121|NCT02247960|20209108|P2|Catheter Removed|Lost to Follow-up|10
5846122|NCT02247960|20209109|P1|Catheter Removed|Lost to Follow-up|7
5846123|NCT02247960|20209108|P2|Patient Consent and Randomization|Withdrawal by Subject|4
5846124|NCT02247960|20209109|P1|Patient Consent and Randomization|Withdrawal by Subject|0
5846125|NCT02247960|20209108|P2|Patient Consent and Randomization|Physician Decision|2
5846126|NCT02247960|20209109|P1|Patient Consent and Randomization|Physician Decision|2
5846127|NCT02247804|20209122|P3|Treatment Period 3|Reason not Specified|3
5846128|NCT02247804|20209123|P2|Treatment Period 3|Reason not Specified|1
5846129|NCT02247804|20209124|P1|Treatment Period 3|Reason not Specified|2
5846130|NCT02247804|20209122|P3|Treatment Period 3|Personal Reasons|2
5846131|NCT02247804|20209123|P2|Treatment Period 3|Personal Reasons|3
5846132|NCT02247804|20209124|P1|Treatment Period 3|Personal Reasons|4
5846133|NCT02247804|20209122|P3|Treatment Period 3|Lost to Follow-up|2
5846134|NCT02247804|20209123|P2|Treatment Period 3|Lost to Follow-up|2
5846135|NCT02247804|20209124|P1|Treatment Period 3|Lost to Follow-up|1
5846136|NCT02247804|20209122|P3|Treatment Period 3|Lack of Efficacy|0
5846137|NCT02247804|20209123|P2|Treatment Period 3|Lack of Efficacy|1
5846138|NCT02247804|20209124|P1|Treatment Period 3|Lack of Efficacy|0
5846139|NCT02247804|20209122|P3|Treatment Period 3|Adverse Event|3
5846140|NCT02247804|20209123|P2|Treatment Period 3|Adverse Event|3
5846141|NCT02247804|20209124|P1|Treatment Period 3|Adverse Event|4
5846142|NCT02247804|20209122|P3|Treatment Period 2|Reason not Specified|2
5846143|NCT02247804|20209123|P2|Treatment Period 2|Reason not Specified|0
5846144|NCT02247804|20209124|P1|Treatment Period 2|Reason not Specified|0
5846145|NCT02247804|20209122|P3|Treatment Period 2|Personal Reasons|1
5846146|NCT02247804|20209123|P2|Treatment Period 2|Personal Reasons|1
5846147|NCT02247804|20209124|P1|Treatment Period 2|Personal Reasons|2
5846148|NCT02247804|20209122|P3|Treatment Period 2|Lost to Follow-up|1
5846149|NCT02247804|20209123|P2|Treatment Period 2|Lost to Follow-up|1
5846150|NCT02247804|20209124|P1|Treatment Period 2|Lost to Follow-up|0
5846151|NCT02247804|20209122|P3|Treatment Period 2|Lack of Efficacy|1
5846152|NCT02247804|20209123|P2|Treatment Period 2|Lack of Efficacy|0
5846153|NCT02247804|20209124|P1|Treatment Period 2|Lack of Efficacy|0
5846154|NCT02247804|20209122|P3|Treatment Period 2|Adverse Event|3
5846155|NCT02247804|20209123|P2|Treatment Period 2|Adverse Event|3
5846156|NCT02247804|20209124|P1|Treatment Period 2|Adverse Event|6
5846157|NCT02247804|20209122|P3|Treatment Period 1|Randomized but not Treated|1
5846158|NCT02247804|20209123|P2|Treatment Period 1|Randomized but not Treated|1
5846159|NCT02247804|20209124|P1|Treatment Period 1|Randomized but not Treated|5
5846160|NCT02247804|20209122|P3|Treatment Period 1|Protocol Deviation|1
5846161|NCT02247804|20209123|P2|Treatment Period 1|Protocol Deviation|0
5846162|NCT02247804|20209124|P1|Treatment Period 1|Protocol Deviation|0
5846163|NCT02247804|20209122|P3|Treatment Period 1|Personal Reasons|2
5846164|NCT02247804|20209123|P2|Treatment Period 1|Personal Reasons|1
5846165|NCT02247804|20209124|P1|Treatment Period 1|Personal Reasons|7
5846166|NCT02247804|20209122|P3|Treatment Period 1|Lost to Follow-up|2
5846167|NCT02247804|20209123|P2|Treatment Period 1|Lost to Follow-up|0
5846168|NCT02247804|20209124|P1|Treatment Period 1|Lost to Follow-up|1
5846169|NCT02247804|20209122|P3|Treatment Period 1|Lack of Efficacy|2
5846170|NCT02247804|20209123|P2|Treatment Period 1|Lack of Efficacy|0
5846171|NCT02247804|20209124|P1|Treatment Period 1|Lack of Efficacy|0
5846172|NCT02247804|20209122|P3|Treatment Period 1|Adverse Event|0
5846173|NCT02247804|20209123|P2|Treatment Period 1|Adverse Event|2
5846174|NCT02247804|20209124|P1|Treatment Period 1|Adverse Event|9
5846175|NCT02247531|20209182|P3|Overall Study|Unspecified Reason|4
5846176|NCT02247531|20209183|P2|Overall Study|Unspecified Reason|3
5846177|NCT02247531|20209184|P1|Overall Study|Unspecified Reason|2
5846178|NCT02247531|20209182|P3|Overall Study|Physician Decision|2
5846179|NCT02247531|20209183|P2|Overall Study|Physician Decision|2
5846180|NCT02247531|20209184|P1|Overall Study|Physician Decision|0
5846181|NCT02247531|20209182|P3|Overall Study|Study Terminated by Sponsor|62
5846182|NCT02247531|20209183|P2|Overall Study|Study Terminated by Sponsor|66
5846183|NCT02247531|20209184|P1|Overall Study|Study Terminated by Sponsor|64
5846184|NCT02247531|20209182|P3|Overall Study|Withdrawal by Subject|25
5846185|NCT02247531|20209183|P2|Overall Study|Withdrawal by Subject|31
5846186|NCT02247531|20209184|P1|Overall Study|Withdrawal by Subject|26
5846187|NCT02247531|20209182|P3|Overall Study|Non-compliance|0
5846188|NCT02247531|20209183|P2|Overall Study|Non-compliance|2
5846189|NCT02247531|20209184|P1|Overall Study|Non-compliance|2
5846190|NCT02247531|20209182|P3|Overall Study|Lost to Follow-up|3
5846191|NCT02247531|20209183|P2|Overall Study|Lost to Follow-up|8
5846192|NCT02247531|20209184|P1|Overall Study|Lost to Follow-up|1
5846193|NCT02247531|20209182|P3|Overall Study|Death|5
5846194|NCT02247531|20209183|P2|Overall Study|Death|9
5846195|NCT02247531|20209184|P1|Overall Study|Death|8
5846196|NCT02247531|20209182|P3|Overall Study|Adverse Event|9
5846197|NCT02247531|20209183|P2|Overall Study|Adverse Event|4
5846198|NCT02247531|20209184|P1|Overall Study|Adverse Event|3
5846199|NCT02247479|20209234|P3|Overall Study|Unspecified Reason|2
5846200|NCT02247479|20209235|P2|Overall Study|Unspecified Reason|5
5846201|NCT02247479|20209236|P1|Overall Study|Unspecified Reason|2
5846202|NCT02247479|20209234|P3|Overall Study|Physician Decision|2
5846203|NCT02247479|20209235|P2|Overall Study|Physician Decision|0
5846204|NCT02247479|20209236|P1|Overall Study|Physician Decision|1
5846205|NCT02247479|20209234|P3|Overall Study|Study Terminated by Sponsor|94
5846206|NCT02247479|20209235|P2|Overall Study|Study Terminated by Sponsor|88
5846207|NCT02247479|20209236|P1|Overall Study|Study Terminated by Sponsor|98
5846208|NCT02247479|20209234|P3|Overall Study|Withdrawal by Subject|24
5846209|NCT02247479|20209235|P2|Overall Study|Withdrawal by Subject|29
5846210|NCT02247479|20209236|P1|Overall Study|Withdrawal by Subject|25
5846211|NCT02247479|20209234|P3|Overall Study|Non-compliance|1
5846212|NCT02247479|20209235|P2|Overall Study|Non-compliance|0
5846213|NCT02247479|20209236|P1|Overall Study|Non-compliance|0
5846214|NCT02247479|20209234|P3|Overall Study|Lost to Follow-up|1
5846215|NCT02247479|20209235|P2|Overall Study|Lost to Follow-up|3
5846216|NCT02247479|20209236|P1|Overall Study|Lost to Follow-up|3
5846217|NCT02247479|20209234|P3|Overall Study|Death|6
5846218|NCT02247479|20209235|P2|Overall Study|Death|4
5846219|NCT02247479|20209236|P1|Overall Study|Death|5
5846220|NCT02247479|20209234|P3|Overall Study|Adverse Event|8
5846221|NCT02247479|20209235|P2|Overall Study|Adverse Event|9
5846222|NCT02247479|20209236|P1|Overall Study|Adverse Event|8
5846223|NCT02247466|20209285|P2|Overall Study|Procedure changed to open surgery|3
5846224|NCT02247466|20209286|P1|Overall Study|Procedure changed to open surgery|0
5846225|NCT02247440|20209304|P1|Overall Study|Lack of Efficacy|3
5846226|NCT02247440|20209304|P1|Overall Study|Withdrawal by Subject|1
5846227|NCT02247401|20209317|P3|Overall Study|Lost to Follow-up|1
5846228|NCT02247401|20209318|P2|Overall Study|Lost to Follow-up|1
5846229|NCT02247401|20209319|P1|Overall Study|Lost to Follow-up|1
5846230|NCT02247401|20209317|P3|Overall Study|Withdrawal by Subject|1
5846231|NCT02247401|20209318|P2|Overall Study|Withdrawal by Subject|1
5846232|NCT02247401|20209319|P1|Overall Study|Withdrawal by Subject|4
5846233|NCT02247401|20209317|P3|Overall Study|Adverse Event|0
5846234|NCT02247401|20209318|P2|Overall Study|Adverse Event|0
5846235|NCT02247401|20209319|P1|Overall Study|Adverse Event|1
5846236|NCT02247011|20209366|P1|Overall Study|Poor quality of radiological results|125
5846237|NCT02246998|20209387|P4|Overall Study|Randomized but Never Dosed|1
5846238|NCT02246998|20209388|P3|Overall Study|Randomized but Never Dosed|2
5846239|NCT02246998|20209389|P2|Overall Study|Randomized but Never Dosed|2
5846240|NCT02246998|20209390|P1|Overall Study|Randomized but Never Dosed|1
5846241|NCT02246998|20209387|P4|Overall Study|Lost to Follow-up|1
5846242|NCT02246998|20209388|P3|Overall Study|Lost to Follow-up|0
5846243|NCT02246998|20209389|P2|Overall Study|Lost to Follow-up|0
5846244|NCT02246998|20209390|P1|Overall Study|Lost to Follow-up|1
5846245|NCT02246998|20209387|P4|Overall Study|Adverse Event|0
5846246|NCT02246998|20209388|P3|Overall Study|Adverse Event|1
5846247|NCT02246998|20209389|P2|Overall Study|Adverse Event|1
5846248|NCT02246998|20209390|P1|Overall Study|Adverse Event|0
5846249|NCT02246777|20209500|P1|Overall Study|Change of residence|1
5846250|NCT02246777|20209500|P1|Overall Study|Adverse Event|2
5846251|NCT02246764|20209516|P3|Overall Study|Protocol Violation|1
5846252|NCT02246764|20209517|P2|Overall Study|Protocol Violation|1
5846253|NCT02246764|20209518|P1|Overall Study|Protocol Violation|2
5846254|NCT02246764|20209516|P3|Overall Study|Physician Decision|1
5846255|NCT02246764|20209517|P2|Overall Study|Physician Decision|2
5846256|NCT02246764|20209518|P1|Overall Study|Physician Decision|0
5846257|NCT02246764|20209516|P3|Overall Study|Disallowed Concomitant Medication|0
5846258|NCT02246764|20209517|P2|Overall Study|Disallowed Concomitant Medication|0
5846259|NCT02246764|20209518|P1|Overall Study|Disallowed Concomitant Medication|1
5846260|NCT02246764|20209516|P3|Overall Study|Withdrawal by Subject|1
5846261|NCT02246764|20209517|P2|Overall Study|Withdrawal by Subject|0
5846262|NCT02246764|20209518|P1|Overall Study|Withdrawal by Subject|0
5846263|NCT02246764|20209516|P3|Overall Study|Adverse Event|1
5846264|NCT02246764|20209517|P2|Overall Study|Adverse Event|29
5846265|NCT02246764|20209518|P1|Overall Study|Adverse Event|15
5846266|NCT02246673|20209531|P5|Overall Study|Protocol Violation|0
5846267|NCT02246673|20209532|P4|Overall Study|Protocol Violation|1
5846268|NCT02246673|20209533|P3|Overall Study|Protocol Violation|0
5846269|NCT02246673|20209534|P2|Overall Study|Protocol Violation|0
5846270|NCT02246673|20209535|P1|Overall Study|Protocol Violation|0
5846271|NCT02246673|20209531|P5|Overall Study|Lost to Follow-up|0
5846272|NCT02246673|20209532|P4|Overall Study|Lost to Follow-up|1
5846273|NCT02246673|20209533|P3|Overall Study|Lost to Follow-up|0
5846274|NCT02246673|20209534|P2|Overall Study|Lost to Follow-up|0
5846275|NCT02246673|20209535|P1|Overall Study|Lost to Follow-up|0
5846276|NCT02246673|20209531|P5|Overall Study|Withdrawal by Subject|1
5846277|NCT02246673|20209532|P4|Overall Study|Withdrawal by Subject|0
5846278|NCT02246673|20209533|P3|Overall Study|Withdrawal by Subject|0
5846279|NCT02246673|20209534|P2|Overall Study|Withdrawal by Subject|0
5846280|NCT02246673|20209535|P1|Overall Study|Withdrawal by Subject|0
5846281|NCT02246673|20209531|P5|Overall Study|Sponsor Decision|0
5846282|NCT02246673|20209532|P4|Overall Study|Sponsor Decision|0
5846283|NCT02246673|20209533|P3|Overall Study|Sponsor Decision|0
5846284|NCT02246673|20209534|P2|Overall Study|Sponsor Decision|0
5846285|NCT02246673|20209535|P1|Overall Study|Sponsor Decision|1
5846286|NCT02246660|20209643|P3|Overall Study|Death|1
5846287|NCT02246660|20209644|P2|Overall Study|Death|0
5846288|NCT02246660|20209645|P1|Overall Study|Death|0
5846289|NCT02246660|20209643|P3|Overall Study|Withdrawal by Subject|0
5846290|NCT02246660|20209644|P2|Overall Study|Withdrawal by Subject|1
5846291|NCT02246660|20209645|P1|Overall Study|Withdrawal by Subject|0
5846292|NCT02246647|20209655|P2|Overall Study|Withdrawal by Subject|1
5846293|NCT02246647|20209656|P1|Overall Study|Withdrawal by Subject|1
5846294|NCT02246621|20209690|P2|Overall Study|On Study Treatment/ Follow Up|119
5846295|NCT02246621|20209691|P1|Overall Study|On Study Treatment/ Follow Up|236
5846296|NCT02246621|20209690|P2|Overall Study|Lost to Follow-up|0
5846297|NCT02246621|20209691|P1|Overall Study|Lost to Follow-up|1
5846298|NCT02246621|20209690|P2|Overall Study|Withdrawal by Subject|16
5846299|NCT02246621|20209691|P1|Overall Study|Withdrawal by Subject|28
5846300|NCT02246582|20209728|P2|Overall Study|Withdrawal by Subject|4
5846301|NCT02246582|20209729|P1|Overall Study|Withdrawal by Subject|3
5846302|NCT02246439|20209737|P2|Overall Study|Withdrawal by Subject|0
5846303|NCT02246439|20209738|P1|Overall Study|Withdrawal by Subject|1
5846304|NCT02246439|20209737|P2|Overall Study|Unkonwn|3
5846305|NCT02246439|20209738|P1|Overall Study|Unkonwn|1
5846306|NCT02246439|20209737|P2|Overall Study|Physician Decision|1
5846307|NCT02246439|20209738|P1|Overall Study|Physician Decision|0
5846308|NCT02246439|20209737|P2|Overall Study|Protocol Violation|2
5846309|NCT02246439|20209738|P1|Overall Study|Protocol Violation|0
5846310|NCT02246439|20209737|P2|Overall Study|Lost to Follow-up|5
5846311|NCT02246439|20209738|P1|Overall Study|Lost to Follow-up|7
5846312|NCT02246439|20209737|P2|Overall Study|Adverse Event|0
5846313|NCT02246439|20209738|P1|Overall Study|Adverse Event|3
5846314|NCT02246218|20209870|P2|Overall Study|Lost to Follow-up|0
5846315|NCT02246218|20209871|P1|Overall Study|Lost to Follow-up|1
5846316|NCT02246218|20209870|P2|Overall Study|Adverse Event|1
5846317|NCT02246218|20209871|P1|Overall Study|Adverse Event|1
5846318|NCT02246218|20209870|P2|Overall Study|Stopping Rule: Liver Transplant|4
5846319|NCT02246218|20209871|P1|Overall Study|Stopping Rule: Liver Transplant|2
5846320|NCT02246218|20209870|P2|Overall Study|Withdrawal by Parent/Guardian|1
5846321|NCT02246218|20209871|P1|Overall Study|Withdrawal by Parent/Guardian|0
5846322|NCT02246166|20209931|P2|Overall Study|Protocol Violation|0
5846323|NCT02246166|20209932|P1|Overall Study|Protocol Violation|1
5846324|NCT02246114|20209968|P2|Overall Study|miscarriage|0
5846325|NCT02246114|20209969|P1|Overall Study|miscarriage|1
5846326|NCT02245737|20210020|P3|Overall Study|Sponsor Decision|432
5846327|NCT02245737|20210021|P2|Overall Study|Sponsor Decision|430
5846328|NCT02245737|20210022|P1|Overall Study|Sponsor Decision|445
5846329|NCT02245737|20210020|P3|Overall Study|Withdrawal due to Caregiver Circumstance|22
5846330|NCT02245737|20210021|P2|Overall Study|Withdrawal due to Caregiver Circumstance|20
5846331|NCT02245737|20210022|P1|Overall Study|Withdrawal due to Caregiver Circumstance|10
5846332|NCT02245737|20210020|P3|Overall Study|Withdrawal by Subject|44
5846333|NCT02245737|20210021|P2|Overall Study|Withdrawal by Subject|41
5846334|NCT02245737|20210022|P1|Overall Study|Withdrawal by Subject|40
5846335|NCT02245737|20210020|P3|Overall Study|Protocol Violation|3
5846336|NCT02245737|20210021|P2|Overall Study|Protocol Violation|2
5846337|NCT02245737|20210022|P1|Overall Study|Protocol Violation|3
5846338|NCT02245737|20210020|P3|Overall Study|Physician Decision|6
5846339|NCT02245737|20210021|P2|Overall Study|Physician Decision|3
5846340|NCT02245737|20210022|P1|Overall Study|Physician Decision|6
5846341|NCT02245737|20210020|P3|Overall Study|Other-determined by Investigator|10
5846342|NCT02245737|20210021|P2|Overall Study|Other-determined by Investigator|10
5846343|NCT02245737|20210022|P1|Overall Study|Other-determined by Investigator|9
5846344|NCT02245737|20210020|P3|Overall Study|Lost to Follow-up|4
5846345|NCT02245737|20210021|P2|Overall Study|Lost to Follow-up|5
5846346|NCT02245737|20210022|P1|Overall Study|Lost to Follow-up|2
5846347|NCT02245737|20210020|P3|Overall Study|Initiation of Symptomatic AD medication|0
5846348|NCT02245737|20210021|P2|Overall Study|Initiation of Symptomatic AD medication|0
5846349|NCT02245737|20210022|P1|Overall Study|Initiation of Symptomatic AD medication|2
5846350|NCT02245737|20210020|P3|Overall Study|Eligibility Criteria No Longer Met|4
5846351|NCT02245737|20210021|P2|Overall Study|Eligibility Criteria No Longer Met|4
5846352|NCT02245737|20210022|P1|Overall Study|Eligibility Criteria No Longer Met|2
5846353|NCT02245737|20210020|P3|Overall Study|Death|4
5846354|NCT02245737|20210021|P2|Overall Study|Death|4
5846355|NCT02245737|20210022|P1|Overall Study|Death|2
5846356|NCT02245737|20210020|P3|Overall Study|Condition Worsened|9
5846357|NCT02245737|20210021|P2|Overall Study|Condition Worsened|10
5846358|NCT02245737|20210022|P1|Overall Study|Condition Worsened|9
5846359|NCT02245737|20210020|P3|Overall Study|Adverse Event|33
5846360|NCT02245737|20210021|P2|Overall Study|Adverse Event|26
5846361|NCT02245737|20210022|P1|Overall Study|Adverse Event|23
5846362|NCT02245672|20210080|P3|Overall Study|Randomized in error (not treated)|0
5846363|NCT02245672|20210081|P2|Overall Study|Randomized in error (not treated)|1
5846364|NCT02245672|20210082|P1|Overall Study|Randomized in error (not treated)|0
5846365|NCT02245672|20210080|P3|Overall Study|Withdrawal by Subject|0
5846366|NCT02245672|20210081|P2|Overall Study|Withdrawal by Subject|3
5846367|NCT02245672|20210082|P1|Overall Study|Withdrawal by Subject|6
5846368|NCT02245672|20210080|P3|Overall Study|Lost to Follow-up|1
5846369|NCT02245672|20210081|P2|Overall Study|Lost to Follow-up|5
5846370|NCT02245672|20210082|P1|Overall Study|Lost to Follow-up|3
5846371|NCT02245672|20210080|P3|Overall Study|Adverse Event|4
5846372|NCT02245672|20210081|P2|Overall Study|Adverse Event|4
5846373|NCT02245672|20210082|P1|Overall Study|Adverse Event|4
5846374|NCT02245620|20210101|P2|Overall Study|Physician Decision|1
5846375|NCT02245620|20210102|P1|Overall Study|Physician Decision|1
5846376|NCT02245568|20210114|P1|Overall Study|Lost to Follow-up|5
5846377|NCT02245568|20210114|P1|Overall Study|Intolerance/dosing issues/interruption|5
5846378|NCT02245568|20210114|P1|Overall Study|Worsening dementia/caregiver withdrawal|6
5846379|NCT02245568|20210114|P1|Overall Study|Blue staining|6
5846380|NCT02245568|20210114|P1|Overall Study|Death|9
5846381|NCT02245568|20210114|P1|Overall Study|Non-compliance with study drug|11
5846382|NCT02245568|20210114|P1|Overall Study|Physician Decision|14
5846383|NCT02245568|20210114|P1|Overall Study|Missing (Site closure)|16
5846384|NCT02245568|20210114|P1|Overall Study|Withdrawal by Legal Representative|31
5846385|NCT02245568|20210114|P1|Overall Study|Withdrawal by Subject|77
5846386|NCT02245568|20210114|P1|Overall Study|Withdrawal by Caregiver|85
5846387|NCT02245568|20210114|P1|Overall Study|Lack of Efficacy|98
5846388|NCT02245568|20210114|P1|Overall Study|Adverse Event|144
5846389|NCT02245568|20210114|P1|Overall Study|Study terminated by Sponsor|346
5846390|NCT02245412|20210136|P3|Follow-Up Period|Other - Terminated by Sponsor|1
5846391|NCT02245412|20210137|P2|Follow-Up Period|Other - Terminated by Sponsor|0
5846392|NCT02245412|20210138|P1|Follow-Up Period|Other - Terminated by Sponsor|0
5846393|NCT02245412|20210136|P3|Follow-Up Period|Physician Decision|0
5846394|NCT02245412|20210137|P2|Follow-Up Period|Physician Decision|0
5846395|NCT02245412|20210138|P1|Follow-Up Period|Physician Decision|1
5846396|NCT02245412|20210136|P3|Follow-Up Period|Death|1
5846397|NCT02245412|20210137|P2|Follow-Up Period|Death|2
5846398|NCT02245412|20210138|P1|Follow-Up Period|Death|4
5846399|NCT02245412|20210136|P3|Treatment Period|Biopsy did not confirm GI GVHD|0
5846400|NCT02245412|20210137|P2|Treatment Period|Biopsy did not confirm GI GVHD|0
5846401|NCT02245412|20210138|P1|Treatment Period|Biopsy did not confirm GI GVHD|1
5846402|NCT02245412|20210136|P3|Treatment Period|Withdrawal by Subject|0
5846403|NCT02245412|20210137|P2|Treatment Period|Withdrawal by Subject|1
5846404|NCT02245412|20210138|P1|Treatment Period|Withdrawal by Subject|2
5846405|NCT02245412|20210136|P3|Treatment Period|Physician Decision|0
5846406|NCT02245412|20210137|P2|Treatment Period|Physician Decision|1
5846407|NCT02245412|20210138|P1|Treatment Period|Physician Decision|1
5846408|NCT02245412|20210136|P3|Treatment Period|Death|0
5846409|NCT02245412|20210137|P2|Treatment Period|Death|1
5846410|NCT02245412|20210138|P1|Treatment Period|Death|1
5846411|NCT02244996|20210185|P2|Overall Study|Lack of Efficacy|6
5846412|NCT02244996|20210186|P1|Overall Study|Lack of Efficacy|2
5846413|NCT02244957|20210200|P2|Overall Study|Lack of Efficacy|0
5846414|NCT02244957|20210201|P1|Overall Study|Lack of Efficacy|1
5846415|NCT02244944|20210245|P1|Overall Study|Study Terminated|1
5846416|NCT02244944|20210245|P1|Overall Study|Withdrawal by Subject|1
5846417|NCT02244619|20210276|P2|Overall Study|Did not receive study intervention|21
5846418|NCT02244619|20210277|P1|Overall Study|Did not receive study intervention|8
5846419|NCT02244580|20210295|P1|Overall Study|No cancer tissues available|241
5846420|NCT02244424|20210305|P2|Overall Study|Lost to Follow-up|10
5846421|NCT02244424|20210306|P1|Overall Study|Lost to Follow-up|20
5846422|NCT02243696|20210325|P1|Overall Study|Study Terminated for EP PASSION|961
5846423|NCT02243696|20210325|P1|Overall Study|Subject Withdrawn by Investigator|273
5846424|NCT02243696|20210325|P1|Overall Study|Subject No Longer has Study System|42
5846425|NCT02243696|20210325|P1|Overall Study|Lost to Follow-up|57
5846426|NCT02243696|20210325|P1|Overall Study|Withdrawal by Subject|79
5846427|NCT02243696|20210325|P1|Overall Study|Death|282
5846428|NCT02243605|20210337|P2|Stage 2 - Final Analysis Population|Progression|1
5846429|NCT02243605|20210338|P1|Stage 2 - Final Analysis Population|Progression|0
5846430|NCT02243605|20210337|P2|Stage 2 - Final Analysis Population|Adverse Event|1
5846431|NCT02243605|20210338|P1|Stage 2 - Final Analysis Population|Adverse Event|1
5846432|NCT02243605|20210337|P2|Stage 2 - Final Analysis Population|Protocol Violation|1
5846433|NCT02243605|20210338|P1|Stage 2 - Final Analysis Population|Protocol Violation|5
5846434|NCT02243605|20210337|P2|Stage 1 - Interim Analysis Population|Adverse Event|0
5846435|NCT02243605|20210338|P1|Stage 1 - Interim Analysis Population|Adverse Event|1
5846436|NCT02243605|20210337|P2|Stage 1 - Interim Analysis Population|Protocol Violation|1
5846437|NCT02243605|20210338|P1|Stage 1 - Interim Analysis Population|Protocol Violation|1
5846438|NCT02243371|20210372|P2|Overall Study|Withdrawal by Subject|2
5846439|NCT02243371|20210373|P1|Overall Study|Withdrawal by Subject|0
5846440|NCT02243371|20210372|P2|Overall Study|Lack of Clinical Benefit|1
5846441|NCT02243371|20210373|P1|Overall Study|Lack of Clinical Benefit|0
5846442|NCT02243371|20210372|P2|Overall Study|Adverse Event (unrelated)|1
5846443|NCT02243371|20210373|P1|Overall Study|Adverse Event (unrelated)|0
5846444|NCT02243371|20210372|P2|Overall Study|Death (unrelated)|4
5846445|NCT02243371|20210373|P1|Overall Study|Death (unrelated)|2
5846446|NCT02243371|20210372|P2|Overall Study|Progressive Disease (clinic & radio)|24
5846447|NCT02243371|20210373|P1|Overall Study|Progressive Disease (clinic & radio)|35
5846448|NCT02243306|20210393|P2|Overall Study|Physician Decision|1
5846449|NCT02243306|20210394|P1|Overall Study|Physician Decision|0
5846450|NCT02243306|20210393|P2|Overall Study|Other: Reached stopping criteria|1
5846451|NCT02243306|20210394|P1|Overall Study|Other: Reached stopping criteria|0
5846452|NCT02243306|20210393|P2|Overall Study|Adverse Event|1
5846453|NCT02243306|20210394|P1|Overall Study|Adverse Event|0
5846454|NCT02243293|20210469|P22|Overall Study|Randomized but did'nt receive study drug|0
5846455|NCT02243293|20210470|P21|Overall Study|Randomized but did'nt receive study drug|0
5846456|NCT02243293|20210471|P20|Overall Study|Randomized but did'nt receive study drug|1
5846457|NCT02243293|20210472|P19|Overall Study|Randomized but did'nt receive study drug|0
5846458|NCT02243293|20210473|P18|Overall Study|Randomized but did'nt receive study drug|0
5846459|NCT02243293|20210474|P17|Overall Study|Randomized but did'nt receive study drug|0
5846460|NCT02243293|20210475|P16|Overall Study|Randomized but did'nt receive study drug|0
5846461|NCT02243293|20210476|P15|Overall Study|Randomized but did'nt receive study drug|0
5846462|NCT02243293|20210477|P14|Overall Study|Randomized but did'nt receive study drug|0
5846463|NCT02243293|20210478|P13|Overall Study|Randomized but did'nt receive study drug|0
5846464|NCT02243293|20210479|P12|Overall Study|Randomized but did'nt receive study drug|0
5846465|NCT02243293|20210480|P11|Overall Study|Randomized but did'nt receive study drug|0
5846466|NCT02243293|20210481|P10|Overall Study|Randomized but did'nt receive study drug|1
5846467|NCT02243293|20210482|P9|Overall Study|Randomized but did'nt receive study drug|0
5846468|NCT02243293|20210483|P8|Overall Study|Randomized but did'nt receive study drug|0
5846469|NCT02243293|20210484|P7|Overall Study|Randomized but did'nt receive study drug|0
5846470|NCT02243293|20210485|P6|Overall Study|Randomized but did'nt receive study drug|0
5846471|NCT02243293|20210486|P5|Overall Study|Randomized but did'nt receive study drug|1
5846472|NCT02243293|20210487|P4|Overall Study|Randomized but did'nt receive study drug|0
5846473|NCT02243293|20210488|P3|Overall Study|Randomized but did'nt receive study drug|0
5846474|NCT02243293|20210489|P2|Overall Study|Randomized but did'nt receive study drug|0
5846475|NCT02243293|20210490|P1|Overall Study|Randomized but did'nt receive study drug|0
5846476|NCT02243293|20210469|P22|Overall Study|Enrolled into a Re-treatment Study|0
5846477|NCT02243293|20210470|P21|Overall Study|Enrolled into a Re-treatment Study|0
5846478|NCT02243293|20210471|P20|Overall Study|Enrolled into a Re-treatment Study|0
5846479|NCT02243293|20210472|P19|Overall Study|Enrolled into a Re-treatment Study|0
5846480|NCT02243293|20210473|P18|Overall Study|Enrolled into a Re-treatment Study|0
5846481|NCT02243293|20210474|P17|Overall Study|Enrolled into a Re-treatment Study|0
5846482|NCT02243293|20210475|P16|Overall Study|Enrolled into a Re-treatment Study|0
5846483|NCT02243293|20210476|P15|Overall Study|Enrolled into a Re-treatment Study|1
5846484|NCT02243293|20210477|P14|Overall Study|Enrolled into a Re-treatment Study|0
5846485|NCT02243293|20210478|P13|Overall Study|Enrolled into a Re-treatment Study|0
5846486|NCT02243293|20210479|P12|Overall Study|Enrolled into a Re-treatment Study|0
5846487|NCT02243293|20210480|P11|Overall Study|Enrolled into a Re-treatment Study|0
5846488|NCT02243293|20210481|P10|Overall Study|Enrolled into a Re-treatment Study|0
5846489|NCT02243293|20210482|P9|Overall Study|Enrolled into a Re-treatment Study|0
5846490|NCT02243293|20210483|P8|Overall Study|Enrolled into a Re-treatment Study|0
5846491|NCT02243293|20210484|P7|Overall Study|Enrolled into a Re-treatment Study|0
5846492|NCT02243293|20210485|P6|Overall Study|Enrolled into a Re-treatment Study|0
5846493|NCT02243293|20210486|P5|Overall Study|Enrolled into a Re-treatment Study|0
5846494|NCT02243293|20210487|P4|Overall Study|Enrolled into a Re-treatment Study|0
5846495|NCT02243293|20210488|P3|Overall Study|Enrolled into a Re-treatment Study|0
5846496|NCT02243293|20210489|P2|Overall Study|Enrolled into a Re-treatment Study|0
5846497|NCT02243293|20210490|P1|Overall Study|Enrolled into a Re-treatment Study|0
5846498|NCT02243293|20210469|P22|Overall Study|Lost to Follow-up|2
5846499|NCT02243293|20210470|P21|Overall Study|Lost to Follow-up|1
5846500|NCT02243293|20210471|P20|Overall Study|Lost to Follow-up|0
5846501|NCT02243293|20210472|P19|Overall Study|Lost to Follow-up|0
5846502|NCT02243293|20210473|P18|Overall Study|Lost to Follow-up|1
5846503|NCT02243293|20210474|P17|Overall Study|Lost to Follow-up|3
5846504|NCT02243293|20210475|P16|Overall Study|Lost to Follow-up|0
5846505|NCT02243293|20210476|P15|Overall Study|Lost to Follow-up|0
5846506|NCT02243293|20210477|P14|Overall Study|Lost to Follow-up|0
5846507|NCT02243293|20210478|P13|Overall Study|Lost to Follow-up|0
5846508|NCT02243293|20210479|P12|Overall Study|Lost to Follow-up|2
5846509|NCT02243293|20210480|P11|Overall Study|Lost to Follow-up|0
5846510|NCT02243293|20210481|P10|Overall Study|Lost to Follow-up|0
5846511|NCT02243293|20210482|P9|Overall Study|Lost to Follow-up|0
5846512|NCT02243293|20210483|P8|Overall Study|Lost to Follow-up|0
5846513|NCT02243293|20210484|P7|Overall Study|Lost to Follow-up|3
5846514|NCT02243293|20210485|P6|Overall Study|Lost to Follow-up|0
5846515|NCT02243293|20210486|P5|Overall Study|Lost to Follow-up|0
5846516|NCT02243293|20210487|P4|Overall Study|Lost to Follow-up|1
5846517|NCT02243293|20210488|P3|Overall Study|Lost to Follow-up|1
5846518|NCT02243293|20210489|P2|Overall Study|Lost to Follow-up|1
5846519|NCT02243293|20210490|P1|Overall Study|Lost to Follow-up|0
5846520|NCT02243293|20210469|P22|Overall Study|Withdrawal by Subject|1
5846521|NCT02243293|20210470|P21|Overall Study|Withdrawal by Subject|0
5846522|NCT02243293|20210471|P20|Overall Study|Withdrawal by Subject|0
5846523|NCT02243293|20210472|P19|Overall Study|Withdrawal by Subject|0
5846524|NCT02243293|20210473|P18|Overall Study|Withdrawal by Subject|0
5846525|NCT02243293|20210474|P17|Overall Study|Withdrawal by Subject|0
5846526|NCT02243293|20210475|P16|Overall Study|Withdrawal by Subject|0
5846527|NCT02243293|20210476|P15|Overall Study|Withdrawal by Subject|0
5846528|NCT02243293|20210477|P14|Overall Study|Withdrawal by Subject|0
5846529|NCT02243293|20210478|P13|Overall Study|Withdrawal by Subject|0
5846530|NCT02243293|20210479|P12|Overall Study|Withdrawal by Subject|1
5846531|NCT02243293|20210480|P11|Overall Study|Withdrawal by Subject|0
5846532|NCT02243293|20210481|P10|Overall Study|Withdrawal by Subject|1
5846533|NCT02243293|20210482|P9|Overall Study|Withdrawal by Subject|0
5846534|NCT02243293|20210483|P8|Overall Study|Withdrawal by Subject|0
5846535|NCT02243293|20210484|P7|Overall Study|Withdrawal by Subject|0
5846536|NCT02243293|20210485|P6|Overall Study|Withdrawal by Subject|0
5846537|NCT02243293|20210486|P5|Overall Study|Withdrawal by Subject|0
5846538|NCT02243293|20210487|P4|Overall Study|Withdrawal by Subject|0
5846539|NCT02243293|20210488|P3|Overall Study|Withdrawal by Subject|0
5846540|NCT02243293|20210489|P2|Overall Study|Withdrawal by Subject|0
5846541|NCT02243293|20210490|P1|Overall Study|Withdrawal by Subject|1
5846542|NCT02243293|20210469|P22|Overall Study|Adverse Event|0
5846543|NCT02243293|20210470|P21|Overall Study|Adverse Event|1
5846544|NCT02243293|20210471|P20|Overall Study|Adverse Event|0
5846545|NCT02243293|20210472|P19|Overall Study|Adverse Event|0
5846546|NCT02243293|20210473|P18|Overall Study|Adverse Event|0
5846547|NCT02243293|20210474|P17|Overall Study|Adverse Event|0
5846548|NCT02243293|20210475|P16|Overall Study|Adverse Event|1
5846549|NCT02243293|20210476|P15|Overall Study|Adverse Event|0
5846550|NCT02243293|20210477|P14|Overall Study|Adverse Event|0
5846551|NCT02243293|20210478|P13|Overall Study|Adverse Event|0
5846552|NCT02243293|20210479|P12|Overall Study|Adverse Event|0
5846553|NCT02243293|20210480|P11|Overall Study|Adverse Event|0
5846554|NCT02243293|20210481|P10|Overall Study|Adverse Event|0
5846555|NCT02243293|20210482|P9|Overall Study|Adverse Event|0
5846556|NCT02243293|20210483|P8|Overall Study|Adverse Event|0
5846557|NCT02243293|20210484|P7|Overall Study|Adverse Event|0
5846558|NCT02243293|20210485|P6|Overall Study|Adverse Event|0
5846559|NCT02243293|20210486|P5|Overall Study|Adverse Event|0
5846560|NCT02243293|20210487|P4|Overall Study|Adverse Event|0
5846561|NCT02243293|20210488|P3|Overall Study|Adverse Event|0
5846562|NCT02243293|20210489|P2|Overall Study|Adverse Event|0
5846563|NCT02243293|20210490|P1|Overall Study|Adverse Event|1
5846564|NCT02243280|20210589|P11|Treated|Lost to Follow-up|2
5846565|NCT02243280|20210590|P10|Treated|Lost to Follow-up|0
5846566|NCT02243280|20210591|P9|Treated|Lost to Follow-up|1
5846567|NCT02243280|20210592|P8|Treated|Lost to Follow-up|0
5846568|NCT02243280|20210593|P7|Treated|Lost to Follow-up|0
5846569|NCT02243280|20210594|P6|Treated|Lost to Follow-up|0
5846570|NCT02243280|20210595|P5|Treated|Lost to Follow-up|0
5846571|NCT02243280|20210596|P4|Treated|Lost to Follow-up|0
5846572|NCT02243280|20210597|P3|Treated|Lost to Follow-up|0
5846573|NCT02243280|20210598|P2|Treated|Lost to Follow-up|0
5846574|NCT02243280|20210599|P1|Treated|Lost to Follow-up|0
5846575|NCT02243280|20210589|P11|Treated|Adverse Event|1
5846576|NCT02243280|20210590|P10|Treated|Adverse Event|0
5846577|NCT02243280|20210591|P9|Treated|Adverse Event|0
5846578|NCT02243280|20210592|P8|Treated|Adverse Event|0
5846579|NCT02243280|20210593|P7|Treated|Adverse Event|0
5846580|NCT02243280|20210594|P6|Treated|Adverse Event|0
5846581|NCT02243280|20210595|P5|Treated|Adverse Event|0
5846582|NCT02243280|20210596|P4|Treated|Adverse Event|0
5846583|NCT02243280|20210597|P3|Treated|Adverse Event|0
5846584|NCT02243280|20210598|P2|Treated|Adverse Event|0
5846585|NCT02243280|20210599|P1|Treated|Adverse Event|1
5846586|NCT02243202|20210654|P4|Overall Study|Randomized but not received treatment|1
5846587|NCT02243202|20210655|P3|Overall Study|Randomized but not received treatment|0
5846588|NCT02243202|20210656|P2|Overall Study|Randomized but not received treatment|0
5846589|NCT02243202|20210657|P1|Overall Study|Randomized but not received treatment|0
5846590|NCT02243202|20210654|P4|Overall Study|Other|2
5846591|NCT02243202|20210655|P3|Overall Study|Other|1
5846592|NCT02243202|20210656|P2|Overall Study|Other|3
5846593|NCT02243202|20210657|P1|Overall Study|Other|1
5846594|NCT02243202|20210654|P4|Overall Study|Withdrawal by Subject|4
5846595|NCT02243202|20210655|P3|Overall Study|Withdrawal by Subject|4
5846596|NCT02243202|20210656|P2|Overall Study|Withdrawal by Subject|6
5846597|NCT02243202|20210657|P1|Overall Study|Withdrawal by Subject|7
5846598|NCT02243202|20210654|P4|Overall Study|Protocol Violation|1
5846599|NCT02243202|20210655|P3|Overall Study|Protocol Violation|2
5846600|NCT02243202|20210656|P2|Overall Study|Protocol Violation|1
5846601|NCT02243202|20210657|P1|Overall Study|Protocol Violation|3
5846602|NCT02243202|20210654|P4|Overall Study|Lost to Follow-up|11
5846603|NCT02243202|20210655|P3|Overall Study|Lost to Follow-up|14
5846604|NCT02243202|20210656|P2|Overall Study|Lost to Follow-up|9
5846605|NCT02243202|20210657|P1|Overall Study|Lost to Follow-up|9
5846606|NCT02243202|20210654|P4|Overall Study|Adverse Event|4
5846607|NCT02243202|20210655|P3|Overall Study|Adverse Event|10
5846608|NCT02243202|20210656|P2|Overall Study|Adverse Event|6
5846609|NCT02243202|20210657|P1|Overall Study|Adverse Event|5
5846610|NCT02243176|20210693|P2|Overall Study|Adverse Event|2
5846611|NCT02243176|20210694|P1|Overall Study|Adverse Event|2
5846612|NCT02243176|20210693|P2|Overall Study|Withdrawal by Subject|7
5846613|NCT02243176|20210694|P1|Overall Study|Withdrawal by Subject|8
5846614|NCT02243176|20210693|P2|Overall Study|Protocol Violation|1
5846615|NCT02243176|20210694|P1|Overall Study|Protocol Violation|2
5846616|NCT02243176|20210693|P2|Overall Study|protocol specified withdrawal critera|3
5846617|NCT02243176|20210694|P1|Overall Study|protocol specified withdrawal critera|1
5846618|NCT02243176|20210693|P2|Overall Study|Other reason|2
5846619|NCT02243176|20210694|P1|Overall Study|Other reason|1
5846620|NCT02243046|20210719|P3|Overall Study|Lost to Follow-up|4
5846621|NCT02243046|20210720|P2|Overall Study|Lost to Follow-up|1
5846622|NCT02243046|20210721|P1|Overall Study|Lost to Follow-up|1
5846623|NCT02242981|20210785|P1|Overall Study|Withdrawal by Subject|1
5846636|NCT02242903|20210832|P7|Overall Study|Withdrawal by Subject|0
5846637|NCT02242903|20210833|P6|Overall Study|Withdrawal by Subject|0
5846638|NCT02242903|20210834|P5|Overall Study|Withdrawal by Subject|0
5846639|NCT02242903|20210835|P4|Overall Study|Withdrawal by Subject|0
5846640|NCT02242903|20210836|P3|Overall Study|Withdrawal by Subject|0
5846641|NCT02242903|20210837|P2|Overall Study|Withdrawal by Subject|0
5846642|NCT02242903|20210838|P1|Overall Study|Withdrawal by Subject|1
5846643|NCT02242643|20210868|P2|Overall Study|Withdrawal by subject at Visit 2|1
5846644|NCT02242643|20210869|P1|Overall Study|Withdrawal by subject at Visit 2|0
5846645|NCT02242643|20210868|P2|Overall Study|Language barrier|0
5846646|NCT02242643|20210869|P1|Overall Study|Language barrier|1
5846647|NCT02242643|20210868|P2|Overall Study|Protocol requirements not followed|0
5846648|NCT02242643|20210869|P1|Overall Study|Protocol requirements not followed|1
5846649|NCT02242643|20210868|P2|Overall Study|Consent withdrawal by parent|0
5846650|NCT02242643|20210869|P1|Overall Study|Consent withdrawal by parent|1
5846651|NCT02242643|20210868|P2|Overall Study|Non-compliance|0
5846652|NCT02242643|20210869|P1|Overall Study|Non-compliance|1
5846653|NCT02242643|20210868|P2|Overall Study|Child placed in foster care by family|1
5846654|NCT02242643|20210869|P1|Overall Study|Child placed in foster care by family|0
5846655|NCT02242643|20210868|P2|Overall Study|Lost to Follow-up|61
5846656|NCT02242643|20210869|P1|Overall Study|Lost to Follow-up|54
5846657|NCT02242643|20210868|P2|Overall Study|Migrated/moved from study area|3
5846658|NCT02242643|20210869|P1|Overall Study|Migrated/moved from study area|1
5846659|NCT02242643|20210868|P2|Overall Study|Withdrawal by Subject|10
5846660|NCT02242643|20210869|P1|Overall Study|Withdrawal by Subject|15
5846661|NCT02242643|20210868|P2|Overall Study|Protocol Violation|2
5846662|NCT02242643|20210869|P1|Overall Study|Protocol Violation|1
5846663|NCT02242487|20210924|P2|Overall Study|Withdrawal by Subject|19
5846664|NCT02242487|20210925|P1|Overall Study|Withdrawal by Subject|37
5846665|NCT02242487|20210924|P2|Overall Study|Other - Miscellaneous|6
5846666|NCT02242487|20210925|P1|Overall Study|Other - Miscellaneous|4
5846667|NCT02242487|20210924|P2|Overall Study|Lost to Follow-up|1
5846668|NCT02242487|20210925|P1|Overall Study|Lost to Follow-up|2
5846669|NCT02242487|20210924|P2|Overall Study|Protocol Violation|0
5846670|NCT02242487|20210925|P1|Overall Study|Protocol Violation|2
5846671|NCT02242487|20210924|P2|Overall Study|Lack of Efficacy|6
5846672|NCT02242487|20210925|P1|Overall Study|Lack of Efficacy|4
5846673|NCT02242487|20210924|P2|Overall Study|Adverse Event|15
5846674|NCT02242487|20210925|P1|Overall Study|Adverse Event|13
5846675|NCT02242305|20210941|P2|Overall Study|Lost to Follow-up|0
5846676|NCT02242305|20210942|P1|Overall Study|Lost to Follow-up|2
5846677|NCT02242305|20210941|P2|Overall Study|Subject withdraws inform consent|4
5846678|NCT02242305|20210942|P1|Overall Study|Subject withdraws inform consent|0
5846679|NCT02242305|20210941|P2|Overall Study|Non-compliance dosing regimen or visit|2
5846680|NCT02242305|20210942|P1|Overall Study|Non-compliance dosing regimen or visit|2
5846681|NCT02242305|20210941|P2|Overall Study|Adverse Event|0
5846682|NCT02242305|20210942|P1|Overall Study|Adverse Event|1
5846683|NCT02242305|20210941|P2|Overall Study|Without spasm-like pain during 3 weeks|4
5846684|NCT02242305|20210942|P1|Overall Study|Without spasm-like pain during 3 weeks|1
5846685|NCT02242201|20210963|P3|Overall Study|preoperative opioid consumption|0
5846686|NCT02242201|20210964|P2|Overall Study|preoperative opioid consumption|1
5846687|NCT02242201|20210965|P1|Overall Study|preoperative opioid consumption|0
5846688|NCT02242201|20210963|P3|Overall Study|postponed surgery|1
5846689|NCT02242201|20210964|P2|Overall Study|postponed surgery|0
5846690|NCT02242201|20210965|P1|Overall Study|postponed surgery|0
5846691|NCT02242201|20210963|P3|Overall Study|changed surgical procedure|0
5846692|NCT02242201|20210964|P2|Overall Study|changed surgical procedure|0
5846693|NCT02242201|20210965|P1|Overall Study|changed surgical procedure|1
5846694|NCT02242201|20210963|P3|Overall Study|planned post-op anticoagulation|0
5846695|NCT02242201|20210964|P2|Overall Study|planned post-op anticoagulation|0
5846696|NCT02242201|20210965|P1|Overall Study|planned post-op anticoagulation|1
5846697|NCT02242201|20210963|P3|Overall Study|preoperative identified neuropathy|0
5846698|NCT02242201|20210964|P2|Overall Study|preoperative identified neuropathy|0
5846699|NCT02242201|20210965|P1|Overall Study|preoperative identified neuropathy|2
5846700|NCT02241889|20211003|P6|Overall Study|Withdrawal by Subject|1
5846701|NCT02241889|20211004|P5|Overall Study|Withdrawal by Subject|0
5846702|NCT02241889|20211005|P4|Overall Study|Withdrawal by Subject|0
5846703|NCT02241889|20211006|P3|Overall Study|Withdrawal by Subject|0
5846704|NCT02241889|20211007|P2|Overall Study|Withdrawal by Subject|0
5846705|NCT02241889|20211008|P1|Overall Study|Withdrawal by Subject|0
5846706|NCT02241889|20211003|P6|Overall Study|device issues|0
5846707|NCT02241889|20211004|P5|Overall Study|device issues|0
5846708|NCT02241889|20211005|P4|Overall Study|device issues|0
5846709|NCT02241889|20211006|P3|Overall Study|device issues|1
5846710|NCT02241889|20211007|P2|Overall Study|device issues|0
5846711|NCT02241889|20211008|P1|Overall Study|device issues|0
5846712|NCT02241785|20211043|P1|Overall Study|Adverse Event|1
5846713|NCT02241785|20211043|P1|Overall Study|Lost to Follow-up|2
5846714|NCT02241785|20211043|P1|Overall Study|Withdrawal by Subject|1
5846715|NCT02241785|20211043|P1|Overall Study|Sponsor Termination|43
5846716|NCT02241733|20211053|P2|Overall Study|Death|2
5846717|NCT02241733|20211054|P1|Overall Study|Death|0
5846718|NCT02241733|20211053|P2|Overall Study|Withdrawal by Subject|2
5846719|NCT02241733|20211054|P1|Overall Study|Withdrawal by Subject|0
5846720|NCT02241733|20211053|P2|Overall Study|Physician Decision|2
5846721|NCT02241733|20211054|P1|Overall Study|Physician Decision|6
5846722|NCT02241733|20211053|P2|Overall Study|Lost to Follow-up|4
5846723|NCT02241733|20211054|P1|Overall Study|Lost to Follow-up|9
5846724|NCT02241551|20211093|P2|Overall Study|Adverse Event|0
5846725|NCT02241551|20211094|P1|Overall Study|Adverse Event|1
5846726|NCT02241512|20211116|P2|Overall Study|Pump malfunction, drug not delivered|0
5846727|NCT02241512|20211117|P1|Overall Study|Pump malfunction, drug not delivered|1
5846728|NCT02241343|20211133|P1|Overall Study|Adverse Event|1
5846729|NCT02241187|20211138|P1|Overall Study|Protocol closed due to lack of accrual.|2
5846730|NCT02240706|20211170|P7|Overall Study|Insurance billing concerns|0
5846731|NCT02240706|20211171|P6|Overall Study|Insurance billing concerns|0
5846732|NCT02240706|20211172|P5|Overall Study|Insurance billing concerns|0
5846733|NCT02240706|20211173|P4|Overall Study|Insurance billing concerns|1
5846734|NCT02240706|20211174|P3|Overall Study|Insurance billing concerns|0
5846735|NCT02240706|20211175|P2|Overall Study|Insurance billing concerns|0
5846736|NCT02240706|20211176|P1|Overall Study|Insurance billing concerns|0
5846737|NCT02240706|20211170|P7|Overall Study|Refused to continue taking medication|0
5846738|NCT02240706|20211171|P6|Overall Study|Refused to continue taking medication|0
5846739|NCT02240706|20211172|P5|Overall Study|Refused to continue taking medication|2
5846740|NCT02240706|20211173|P4|Overall Study|Refused to continue taking medication|1
5846741|NCT02240706|20211174|P3|Overall Study|Refused to continue taking medication|3
5846742|NCT02240706|20211175|P2|Overall Study|Refused to continue taking medication|1
5846743|NCT02240706|20211176|P1|Overall Study|Refused to continue taking medication|0
5846744|NCT02240706|20211170|P7|Overall Study|Dose limiting toxicity|0
5846745|NCT02240706|20211171|P6|Overall Study|Dose limiting toxicity|0
5846746|NCT02240706|20211172|P5|Overall Study|Dose limiting toxicity|1
5846747|NCT02240706|20211173|P4|Overall Study|Dose limiting toxicity|0
5846748|NCT02240706|20211174|P3|Overall Study|Dose limiting toxicity|0
5846749|NCT02240706|20211175|P2|Overall Study|Dose limiting toxicity|0
5846750|NCT02240706|20211176|P1|Overall Study|Dose limiting toxicity|0
5846751|NCT02240706|20211170|P7|Overall Study|Progressive disease|0
5846752|NCT02240706|20211171|P6|Overall Study|Progressive disease|0
5846753|NCT02240706|20211172|P5|Overall Study|Progressive disease|1
5846754|NCT02240706|20211173|P4|Overall Study|Progressive disease|0
5846755|NCT02240706|20211174|P3|Overall Study|Progressive disease|0
5846756|NCT02240706|20211175|P2|Overall Study|Progressive disease|0
5846757|NCT02240706|20211176|P1|Overall Study|Progressive disease|0
5846758|NCT02240706|20211170|P7|Overall Study|Adverse Event|0
5846759|NCT02240706|20211171|P6|Overall Study|Adverse Event|0
5846760|NCT02240706|20211172|P5|Overall Study|Adverse Event|2
5846761|NCT02240706|20211173|P4|Overall Study|Adverse Event|0
5846762|NCT02240706|20211174|P3|Overall Study|Adverse Event|1
5846763|NCT02240706|20211175|P2|Overall Study|Adverse Event|0
5846764|NCT02240706|20211176|P1|Overall Study|Adverse Event|1
5846765|NCT02240706|20211170|P7|Overall Study|Lack of Efficacy|0
5846766|NCT02240706|20211171|P6|Overall Study|Lack of Efficacy|0
5846767|NCT02240706|20211172|P5|Overall Study|Lack of Efficacy|5
5846768|NCT02240706|20211173|P4|Overall Study|Lack of Efficacy|2
5846769|NCT02240706|20211174|P3|Overall Study|Lack of Efficacy|2
5846770|NCT02240706|20211175|P2|Overall Study|Lack of Efficacy|2
5846771|NCT02240706|20211176|P1|Overall Study|Lack of Efficacy|2
5846772|NCT02240693|20211236|P5|Overall Study|Other than specified|0
5846773|NCT02240693|20211237|P4|Overall Study|Other than specified|0
5846774|NCT02240693|20211238|P3|Overall Study|Other than specified|2
5846775|NCT02240693|20211239|P2|Overall Study|Other than specified|0
5846776|NCT02240693|20211240|P1|Overall Study|Other than specified|0
5846777|NCT02240693|20211236|P5|Overall Study|Withdrawal by Subject|0
5846778|NCT02240693|20211237|P4|Overall Study|Withdrawal by Subject|1
5846779|NCT02240693|20211238|P3|Overall Study|Withdrawal by Subject|2
5846780|NCT02240693|20211239|P2|Overall Study|Withdrawal by Subject|0
5846781|NCT02240693|20211240|P1|Overall Study|Withdrawal by Subject|0
5846782|NCT02240693|20211236|P5|Overall Study|Adverse Event|1
5846783|NCT02240693|20211237|P4|Overall Study|Adverse Event|0
5846784|NCT02240693|20211238|P3|Overall Study|Adverse Event|0
5846785|NCT02240693|20211239|P2|Overall Study|Adverse Event|0
5846786|NCT02240693|20211240|P1|Overall Study|Adverse Event|0
5846787|NCT02240680|20211276|P4|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0
5846788|NCT02240680|20211277|P3|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|1
5846789|NCT02240680|20211278|P2|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0
5846790|NCT02240680|20211279|P1|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0
5846791|NCT02240680|20211276|P4|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0
5846792|NCT02240680|20211277|P3|Japanese Patients (Up to 52 Weeks)|Protocol Violation|1
5846793|NCT02240680|20211278|P2|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0
5846794|NCT02240680|20211279|P1|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0
5846795|NCT02240680|20211276|P4|Japanese Patients (Up to 52 Weeks)|Adverse Event|7
5846796|NCT02240680|20211277|P3|Japanese Patients (Up to 52 Weeks)|Adverse Event|6
5846797|NCT02240680|20211278|P2|Japanese Patients (Up to 52 Weeks)|Adverse Event|0
5846798|NCT02240680|20211279|P1|Japanese Patients (Up to 52 Weeks)|Adverse Event|0
5846799|NCT02240680|20211276|P4|Overall Study (Up to 24 Weeks)|Other than specified|0
5846800|NCT02240680|20211277|P3|Overall Study (Up to 24 Weeks)|Other than specified|0
5846801|NCT02240680|20211278|P2|Overall Study (Up to 24 Weeks)|Other than specified|0
5846802|NCT02240680|20211279|P1|Overall Study (Up to 24 Weeks)|Other than specified|1
5846803|NCT02240680|20211276|P4|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0
5846804|NCT02240680|20211277|P3|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0
5846805|NCT02240680|20211278|P2|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|1
5846806|NCT02240680|20211279|P1|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|3
5846807|NCT02240680|20211276|P4|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0
5846808|NCT02240680|20211277|P3|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0
5846809|NCT02240680|20211278|P2|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0
5846810|NCT02240680|20211279|P1|Overall Study (Up to 24 Weeks)|Lost to Follow-up|1
5846811|NCT02240680|20211276|P4|Overall Study (Up to 24 Weeks)|Protocol Violation|0
5846812|NCT02240680|20211277|P3|Overall Study (Up to 24 Weeks)|Protocol Violation|0
5846813|NCT02240680|20211278|P2|Overall Study (Up to 24 Weeks)|Protocol Violation|1
5846814|NCT02240680|20211279|P1|Overall Study (Up to 24 Weeks)|Protocol Violation|4
5846815|NCT02240680|20211276|P4|Overall Study (Up to 24 Weeks)|Adverse Event|0
5846816|NCT02240680|20211277|P3|Overall Study (Up to 24 Weeks)|Adverse Event|0
5846817|NCT02240680|20211278|P2|Overall Study (Up to 24 Weeks)|Adverse Event|6
5846818|NCT02240680|20211279|P1|Overall Study (Up to 24 Weeks)|Adverse Event|6
5846819|NCT02240628|20211333|P2|Overall Study|Physician Decision|5
5846820|NCT02240628|20211334|P1|Overall Study|Physician Decision|6
5846821|NCT02240368|20211368|P3|Overall Study|Entropy failed to detect more than 50%|1
5846822|NCT02240368|20211369|P2|Overall Study|Entropy failed to detect more than 50%|0
5846823|NCT02240368|20211370|P1|Overall Study|Entropy failed to detect more than 50%|0
5846824|NCT02240368|20211368|P3|Overall Study|Surgery lasted less then 20 minutes|0
5846825|NCT02240368|20211369|P2|Overall Study|Surgery lasted less then 20 minutes|0
5846826|NCT02240368|20211370|P1|Overall Study|Surgery lasted less then 20 minutes|1
5846827|NCT02240121|20211402|P2|Overall Study|Other than specified|3
5846828|NCT02240121|20211403|P1|Overall Study|Other than specified|1
5846829|NCT02240121|20211402|P2|Overall Study|Lost to Follow-up|4
5846830|NCT02240121|20211403|P1|Overall Study|Lost to Follow-up|3
5846831|NCT02240121|20211402|P2|Overall Study|Withdrawal by Subject|2
5846832|NCT02240121|20211403|P1|Overall Study|Withdrawal by Subject|6
5846833|NCT02240121|20211402|P2|Overall Study|Adverse Event|4
5846834|NCT02240121|20211403|P1|Overall Study|Adverse Event|2
5846835|NCT02240121|20211402|P2|Overall Study|Pregnancy|0
5846836|NCT02240121|20211403|P1|Overall Study|Pregnancy|1
5846837|NCT02240121|20211402|P2|Overall Study|Site closed|1
5846838|NCT02240121|20211403|P1|Overall Study|Site closed|1
5846839|NCT02240121|20211402|P2|Overall Study|Lack of Efficacy|3
5846840|NCT02240121|20211403|P1|Overall Study|Lack of Efficacy|2
5846841|NCT02240121|20211402|P2|Overall Study|Change in protocol interpretation|0
5846842|NCT02240121|20211403|P1|Overall Study|Change in protocol interpretation|1
5846843|NCT02240121|20211402|P2|Overall Study|Physician Decision|1
5846844|NCT02240121|20211403|P1|Overall Study|Physician Decision|0
5846845|NCT02240121|20211402|P2|Overall Study|Protocol Violation|2
5846846|NCT02240121|20211403|P1|Overall Study|Protocol Violation|1
5846847|NCT02240108|20211431|P2|Overall Study|StudyTerminated by Sponsor|1
5846848|NCT02240108|20211432|P1|Overall Study|StudyTerminated by Sponsor|0
5846849|NCT02240108|20211431|P2|Overall Study|Withdrawal by Subject|9
5846850|NCT02240108|20211432|P1|Overall Study|Withdrawal by Subject|4
5846851|NCT02240108|20211431|P2|Overall Study|Pregnancy|0
5846852|NCT02240108|20211432|P1|Overall Study|Pregnancy|1
5846853|NCT02240108|20211431|P2|Overall Study|Adverse Event|9
5846854|NCT02240108|20211432|P1|Overall Study|Adverse Event|1
5846855|NCT02240108|20211431|P2|Overall Study|Other than specified|6
5846856|NCT02240108|20211432|P1|Overall Study|Other than specified|8
5846857|NCT02239978|20211487|P2|Overall Study|Withdrawal by Subject|0
5846858|NCT02239978|20211488|P1|Overall Study|Withdrawal by Subject|2
5846859|NCT02239939|20211505|P2|Overall Study|Lost to Follow-up|1
5846860|NCT02239939|20211506|P1|Overall Study|Lost to Follow-up|0
5846861|NCT02239939|20211505|P2|Overall Study|Withdrawal by Subject|1
5846862|NCT02239939|20211506|P1|Overall Study|Withdrawal by Subject|1
5846863|NCT02239939|20211505|P2|Overall Study|Adverse Event|0
5846864|NCT02239939|20211506|P1|Overall Study|Adverse Event|1
5846865|NCT02239926|20211522|P2|Overall Study|Withdrawal by Subject|1
5846866|NCT02239926|20211523|P1|Overall Study|Withdrawal by Subject|0
5846867|NCT02239692|20211585|P2|Overall Study|Other reason|0
5846868|NCT02239692|20211586|P1|Overall Study|Other reason|1
5846869|NCT02239692|20211585|P2|Overall Study|Withdrawal by Subject|5
5846870|NCT02239692|20211586|P1|Overall Study|Withdrawal by Subject|3
5846871|NCT02239692|20211585|P2|Overall Study|Lost to Follow-up|4
5846872|NCT02239692|20211586|P1|Overall Study|Lost to Follow-up|1
5846873|NCT02239692|20211585|P2|Overall Study|Physician Decision|1
5846874|NCT02239692|20211586|P1|Overall Study|Physician Decision|0
5846875|NCT02239692|20211585|P2|Overall Study|Adverse Event|1
5846876|NCT02239692|20211586|P1|Overall Study|Adverse Event|0
5846877|NCT02239692|20211585|P2|Overall Study|Incomplete colonoscopy|2
5846878|NCT02239692|20211586|P1|Overall Study|Incomplete colonoscopy|1
5846879|NCT02239679|20211605|P3|Overall Study|Withdrawal by Subject|1
5846880|NCT02239679|20211606|P2|Overall Study|Withdrawal by Subject|3
5846881|NCT02239679|20211607|P1|Overall Study|Withdrawal by Subject|2
5846882|NCT02239679|20211605|P3|Overall Study|Lost to Follow-up|0
5846883|NCT02239679|20211606|P2|Overall Study|Lost to Follow-up|0
5846884|NCT02239679|20211607|P1|Overall Study|Lost to Follow-up|1
5846885|NCT02239640|20211819|P1|Overall Study|Death|142
5846886|NCT02239640|20211819|P1|Overall Study|Lost to Follow-up|72
5846887|NCT02239640|20211819|P1|Overall Study|Withdrawal by Subject|3
5846888|NCT02239601|20211846|P2|Overall Study|Protocol Violation|2
5846889|NCT02239601|20211847|P1|Overall Study|Protocol Violation|4
5846890|NCT02239601|20211846|P2|Overall Study|Withdrawal by Subject|4
5846891|NCT02239601|20211847|P1|Overall Study|Withdrawal by Subject|3
5846892|NCT02239536|20211900|P2|Overall Study|Non-neoplastic polyp|17
5846893|NCT02239536|20211901|P1|Overall Study|Non-neoplastic polyp|23
5846894|NCT02239510|20211911|P2|Overall Study|Lost to Follow-up|1
5846895|NCT02239510|20211912|P1|Overall Study|Lost to Follow-up|2
5846896|NCT02239328|20211934|P1|Overall Study|Equipment or website malfunction|2
5846897|NCT02239328|20211934|P1|Overall Study|Benign disease noted at time of surgery|6
5846898|NCT02239120|20211959|P2|Overall Study|Lost to Follow-up|14
5846899|NCT02239120|20211960|P1|Overall Study|Lost to Follow-up|19
5846900|NCT02239120|20211959|P2|Overall Study|Death|58
5846901|NCT02239120|20211960|P1|Overall Study|Death|56
5846902|NCT02239094|20211984|P1|Overall Study|Remitted before started|1
5846903|NCT02239094|20211984|P1|Overall Study|Withdrawal by Subject|1
5846904|NCT02238483|20212039|P2|Overall Study|Illness in family member|0
5846905|NCT02238483|20212040|P1|Overall Study|Illness in family member|1
5846906|NCT02238483|20212039|P2|Overall Study|Completion status not recorded|1
5846907|NCT02238483|20212040|P1|Overall Study|Completion status not recorded|1
5846908|NCT02238483|20212039|P2|Overall Study|Withdrawn due to physician decision|0
5846909|NCT02238483|20212040|P1|Overall Study|Withdrawn due to physician decision|1
5846910|NCT02238483|20212039|P2|Overall Study|Adverse Event|3
5846911|NCT02238483|20212040|P1|Overall Study|Adverse Event|7
5846912|NCT02238483|20212039|P2|Overall Study|Death|0
5846913|NCT02238483|20212040|P1|Overall Study|Death|1
5846914|NCT02238483|20212039|P2|Overall Study|Protocol Violation|2
5846915|NCT02238483|20212040|P1|Overall Study|Protocol Violation|1
5846916|NCT02238483|20212039|P2|Overall Study|Lost to Follow-up|1
5846917|NCT02238483|20212040|P1|Overall Study|Lost to Follow-up|1
5846918|NCT02238483|20212039|P2|Overall Study|Withdrawal by Subject|7
5846919|NCT02238483|20212040|P1|Overall Study|Withdrawal by Subject|2
5846920|NCT02238379|20212078|P2|Overall Study|Lost to Follow-up|0
5846921|NCT02238379|20212079|P1|Overall Study|Lost to Follow-up|1
5846922|NCT02238080|20212105|P1|Overall Study|Other|4
5846923|NCT02238080|20212105|P1|Overall Study|Withdrawal by Subject|2
5846924|NCT02238080|20212105|P1|Overall Study|Treatment interrupted|6
5846925|NCT02238080|20212105|P1|Overall Study|Death|13
5846926|NCT02238067|20212119|P1|Overall Study|Not completed survey at Month 6|45
5846927|NCT02237911|20212207|P3|Overall Study|Lost to Follow-up|1
5846928|NCT02237911|20212208|P2|Overall Study|Lost to Follow-up|1
5846929|NCT02237911|20212209|P1|Overall Study|Lost to Follow-up|3
5846930|NCT02237911|20212207|P3|Overall Study|Withdrawal by Subject|2
5846931|NCT02237911|20212208|P2|Overall Study|Withdrawal by Subject|7
5846932|NCT02237911|20212209|P1|Overall Study|Withdrawal by Subject|4
5846933|NCT02237196|20212249|P4|Overall Study|Site Error|2
5846934|NCT02237196|20212250|P3|Overall Study|Site Error|0
5846935|NCT02237196|20212251|P2|Overall Study|Site Error|2
5846936|NCT02237196|20212252|P1|Overall Study|Site Error|1
5846937|NCT02237196|20212249|P4|Overall Study|Withdrawal by Subject|1
5846938|NCT02237196|20212250|P3|Overall Study|Withdrawal by Subject|4
5846939|NCT02237196|20212251|P2|Overall Study|Withdrawal by Subject|1
5846940|NCT02237196|20212252|P1|Overall Study|Withdrawal by Subject|1
5846941|NCT02237196|20212249|P4|Overall Study|Pregnancy|1
5846942|NCT02237196|20212250|P3|Overall Study|Pregnancy|1
5846943|NCT02237196|20212251|P2|Overall Study|Pregnancy|0
5846944|NCT02237196|20212252|P1|Overall Study|Pregnancy|0
5846945|NCT02237196|20212249|P4|Overall Study|Physician Decision|1
5846946|NCT02237196|20212250|P3|Overall Study|Physician Decision|0
5846947|NCT02237196|20212251|P2|Overall Study|Physician Decision|0
5846948|NCT02237196|20212252|P1|Overall Study|Physician Decision|2
5846949|NCT02237196|20212249|P4|Overall Study|Lost to Follow-up|6
5846950|NCT02237196|20212250|P3|Overall Study|Lost to Follow-up|4
5846951|NCT02237196|20212251|P2|Overall Study|Lost to Follow-up|2
5846952|NCT02237196|20212252|P1|Overall Study|Lost to Follow-up|4
5846953|NCT02237196|20212249|P4|Overall Study|Adverse Event|0
5846954|NCT02237196|20212250|P3|Overall Study|Adverse Event|1
5846955|NCT02237196|20212251|P2|Overall Study|Adverse Event|1
5846956|NCT02237196|20212252|P1|Overall Study|Adverse Event|0
5846957|NCT02237118|20212296|P2|Overall Study|consent withdrawn|0
5846958|NCT02237118|20212297|P1|Overall Study|consent withdrawn|1
5846959|NCT02237118|20212296|P2|Overall Study|Protocol Violation|1
5846960|NCT02237118|20212297|P1|Overall Study|Protocol Violation|0
5846961|NCT02237001|20212328|P1|Overall Study|Incarceration|1
5846962|NCT02237001|20212328|P1|Overall Study|Re-operation|4
5846963|NCT02237001|20212328|P1|Overall Study|Eligibility criteria/Late Screen Failure|3
5846964|NCT02237001|20212328|P1|Overall Study|Withdrawal by Subject|1
5846965|NCT02237001|20212328|P1|Overall Study|Lost to Follow-up|2
5846966|NCT02236611|20212346|P2|Overall Study|Withdrew consent|4
5846967|NCT02236611|20212347|P1|Overall Study|Withdrew consent|9
5846968|NCT02236611|20212346|P2|Overall Study|Protocol deviation|5
5846969|NCT02236611|20212347|P1|Overall Study|Protocol deviation|3
5846970|NCT02236611|20212346|P2|Overall Study|Lost to Follow-up|2
5846971|NCT02236611|20212347|P1|Overall Study|Lost to Follow-up|0
5846972|NCT02236611|20212346|P2|Overall Study|Lack of Efficacy|7
5846973|NCT02236611|20212347|P1|Overall Study|Lack of Efficacy|4
5846974|NCT02236611|20212346|P2|Overall Study|Adverse Event|16
5846975|NCT02236611|20212347|P1|Overall Study|Adverse Event|10
5846976|NCT02236598|20212355|P2|Overall Study|Withdrawal by Subject|1
5846977|NCT02236598|20212356|P1|Overall Study|Withdrawal by Subject|0
5846978|NCT02236598|20212355|P2|Overall Study|Adverse Event|1
5846979|NCT02236598|20212356|P1|Overall Study|Adverse Event|0
5846980|NCT02236559|20212370|P2|Overall Study|Withdrawal by Subject|0
5846981|NCT02236559|20212371|P1|Overall Study|Withdrawal by Subject|1
5846982|NCT02236559|20212370|P2|Overall Study|Physician Decision|1
5846983|NCT02236559|20212371|P1|Overall Study|Physician Decision|1
5846984|NCT02236559|20212370|P2|Overall Study|Subject Did Not Consent|2
5846985|NCT02236559|20212371|P1|Overall Study|Subject Did Not Consent|4
5846986|NCT02236559|20212370|P2|Overall Study|Did not Meet Inclusion|3
5846987|NCT02236559|20212371|P1|Overall Study|Did not Meet Inclusion|3
5846988|NCT02236559|20212370|P2|Overall Study|Met Exclusion|6
5846989|NCT02236559|20212371|P1|Overall Study|Met Exclusion|3
5846990|NCT02236520|20212408|P4|Overall Study|Pregnancy|0
5846991|NCT02236520|20212409|P3|Overall Study|Pregnancy|0
5846992|NCT02236520|20212410|P2|Overall Study|Pregnancy|0
5846993|NCT02236520|20212411|P1|Overall Study|Pregnancy|1
5846994|NCT02236520|20212408|P4|Overall Study|Withdrawal by Subject|1
5846995|NCT02236520|20212409|P3|Overall Study|Withdrawal by Subject|0
5846996|NCT02236520|20212410|P2|Overall Study|Withdrawal by Subject|0
5846997|NCT02236520|20212411|P1|Overall Study|Withdrawal by Subject|1
5846998|NCT02236520|20212408|P4|Overall Study|Physician Decision|0
5846999|NCT02236520|20212409|P3|Overall Study|Physician Decision|0
5847000|NCT02236520|20212410|P2|Overall Study|Physician Decision|5
5847001|NCT02236520|20212411|P1|Overall Study|Physician Decision|0
5847002|NCT02236130|20212438|P2|Overall Study|Lost to Follow-up|12
5847003|NCT02236130|20212439|P1|Overall Study|Lost to Follow-up|7
5847004|NCT02235454|20212489|P1|Overall Study|Withdrawal by Subject|2
5847005|NCT02235311|20212495|P2|Overall Study|Protocol Violation|1
5847006|NCT02235311|20212496|P1|Overall Study|Protocol Violation|0
5847007|NCT02235311|20212495|P2|Overall Study|Lost to Follow-up|1
5847008|NCT02235311|20212496|P1|Overall Study|Lost to Follow-up|0
5847009|NCT02235077|20212514|P2|Overall Study|Physician Decision|1
5847010|NCT02235077|20212515|P1|Overall Study|Physician Decision|0
5847011|NCT02235077|20212514|P2|Overall Study|Withdrawal by Subject|5
5847012|NCT02235077|20212515|P1|Overall Study|Withdrawal by Subject|8
5847013|NCT02235077|20212514|P2|Overall Study|Lost to Follow-up|6
5847014|NCT02235077|20212515|P1|Overall Study|Lost to Follow-up|5
5847015|NCT02235077|20212514|P2|Overall Study|Death|7
5847016|NCT02235077|20212515|P1|Overall Study|Death|5
5847017|NCT02234843|20212580|P10|Overall Study|Lost to Follow-up|0
5847018|NCT02234843|20212581|P9|Overall Study|Lost to Follow-up|0
5847019|NCT02234843|20212582|P8|Overall Study|Lost to Follow-up|0
5847020|NCT02234843|20212583|P7|Overall Study|Lost to Follow-up|1
5847021|NCT02234843|20212584|P6|Overall Study|Lost to Follow-up|0
5847022|NCT02234843|20212585|P5|Overall Study|Lost to Follow-up|0
5847023|NCT02234843|20212586|P4|Overall Study|Lost to Follow-up|0
5847024|NCT02234843|20212587|P3|Overall Study|Lost to Follow-up|0
5847025|NCT02234843|20212588|P2|Overall Study|Lost to Follow-up|1
5847026|NCT02234843|20212589|P1|Overall Study|Lost to Follow-up|0
5847027|NCT02234843|20212580|P10|Overall Study|Non-compliance with study drug|0
5847028|NCT02234843|20212581|P9|Overall Study|Non-compliance with study drug|0
5847029|NCT02234843|20212582|P8|Overall Study|Non-compliance with study drug|0
5847030|NCT02234843|20212583|P7|Overall Study|Non-compliance with study drug|1
5847031|NCT02234843|20212584|P6|Overall Study|Non-compliance with study drug|1
5847032|NCT02234843|20212585|P5|Overall Study|Non-compliance with study drug|0
5847033|NCT02234843|20212586|P4|Overall Study|Non-compliance with study drug|0
5847034|NCT02234843|20212587|P3|Overall Study|Non-compliance with study drug|0
5847035|NCT02234843|20212588|P2|Overall Study|Non-compliance with study drug|0
5847036|NCT02234843|20212589|P1|Overall Study|Non-compliance with study drug|1
5847037|NCT02234843|20212580|P10|Overall Study|Adverse Event|0
5847038|NCT02234843|20212581|P9|Overall Study|Adverse Event|1
5847039|NCT02234843|20212582|P8|Overall Study|Adverse Event|0
5847040|NCT02234843|20212583|P7|Overall Study|Adverse Event|0
5847041|NCT02234843|20212584|P6|Overall Study|Adverse Event|1
5847042|NCT02234843|20212585|P5|Overall Study|Adverse Event|2
5847043|NCT02234843|20212586|P4|Overall Study|Adverse Event|3
5847044|NCT02234843|20212587|P3|Overall Study|Adverse Event|1
5847045|NCT02234843|20212588|P2|Overall Study|Adverse Event|1
5847046|NCT02234843|20212589|P1|Overall Study|Adverse Event|5
5847047|NCT02234843|20212580|P10|Overall Study|Physician Decision|0
5847048|NCT02234843|20212581|P9|Overall Study|Physician Decision|0
5847049|NCT02234843|20212582|P8|Overall Study|Physician Decision|1
5847050|NCT02234843|20212583|P7|Overall Study|Physician Decision|0
5847051|NCT02234843|20212584|P6|Overall Study|Physician Decision|0
5847052|NCT02234843|20212585|P5|Overall Study|Physician Decision|0
5847053|NCT02234843|20212586|P4|Overall Study|Physician Decision|1
5847054|NCT02234843|20212587|P3|Overall Study|Physician Decision|0
5847055|NCT02234843|20212588|P2|Overall Study|Physician Decision|1
5847056|NCT02234843|20212589|P1|Overall Study|Physician Decision|4
5847057|NCT02234843|20212580|P10|Overall Study|Other|0
5847058|NCT02234843|20212581|P9|Overall Study|Other|0
5847059|NCT02234843|20212582|P8|Overall Study|Other|1
5847060|NCT02234843|20212583|P7|Overall Study|Other|0
5847061|NCT02234843|20212584|P6|Overall Study|Other|1
5847062|NCT02234843|20212585|P5|Overall Study|Other|0
5847063|NCT02234843|20212586|P4|Overall Study|Other|1
5847064|NCT02234843|20212587|P3|Overall Study|Other|0
5847065|NCT02234843|20212588|P2|Overall Study|Other|2
5847066|NCT02234843|20212589|P1|Overall Study|Other|0
5847067|NCT02234843|20212580|P10|Overall Study|Recovery|0
5847068|NCT02234843|20212581|P9|Overall Study|Recovery|0
5847069|NCT02234843|20212582|P8|Overall Study|Recovery|0
5847070|NCT02234843|20212583|P7|Overall Study|Recovery|0
5847071|NCT02234843|20212584|P6|Overall Study|Recovery|0
5847072|NCT02234843|20212585|P5|Overall Study|Recovery|0
5847073|NCT02234843|20212586|P4|Overall Study|Recovery|0
5847074|NCT02234843|20212587|P3|Overall Study|Recovery|0
5847075|NCT02234843|20212588|P2|Overall Study|Recovery|0
5847076|NCT02234843|20212589|P1|Overall Study|Recovery|1
5847077|NCT02234843|20212580|P10|Overall Study|Withdrawal by Subject|0
5847078|NCT02234843|20212581|P9|Overall Study|Withdrawal by Subject|0
5847079|NCT02234843|20212582|P8|Overall Study|Withdrawal by Subject|0
5847080|NCT02234843|20212583|P7|Overall Study|Withdrawal by Subject|0
5847081|NCT02234843|20212584|P6|Overall Study|Withdrawal by Subject|7
5847082|NCT02234843|20212585|P5|Overall Study|Withdrawal by Subject|0
5847083|NCT02234843|20212586|P4|Overall Study|Withdrawal by Subject|0
5847084|NCT02234843|20212587|P3|Overall Study|Withdrawal by Subject|1
5847085|NCT02234843|20212588|P2|Overall Study|Withdrawal by Subject|1
5847086|NCT02234843|20212589|P1|Overall Study|Withdrawal by Subject|5
5847087|NCT02234843|20212580|P10|Overall Study|Patient convenience|0
5847088|NCT02234843|20212581|P9|Overall Study|Patient convenience|0
5847089|NCT02234843|20212582|P8|Overall Study|Patient convenience|0
5847090|NCT02234843|20212583|P7|Overall Study|Patient convenience|0
5847091|NCT02234843|20212584|P6|Overall Study|Patient convenience|1
5847092|NCT02234843|20212585|P5|Overall Study|Patient convenience|0
5847093|NCT02234843|20212586|P4|Overall Study|Patient convenience|0
5847094|NCT02234843|20212587|P3|Overall Study|Patient convenience|0
5847095|NCT02234843|20212588|P2|Overall Study|Patient convenience|0
5847096|NCT02234843|20212589|P1|Overall Study|Patient convenience|2
5847097|NCT02234843|20212580|P10|Overall Study|Efficacy outcome reached|0
5847098|NCT02234843|20212581|P9|Overall Study|Efficacy outcome reached|0
5847099|NCT02234843|20212582|P8|Overall Study|Efficacy outcome reached|0
5847100|NCT02234843|20212583|P7|Overall Study|Efficacy outcome reached|0
5847101|NCT02234843|20212584|P6|Overall Study|Efficacy outcome reached|2
5847102|NCT02234843|20212585|P5|Overall Study|Efficacy outcome reached|0
5847103|NCT02234843|20212586|P4|Overall Study|Efficacy outcome reached|0
5847104|NCT02234843|20212587|P3|Overall Study|Efficacy outcome reached|0
5847105|NCT02234843|20212588|P2|Overall Study|Efficacy outcome reached|0
5847106|NCT02234843|20212589|P1|Overall Study|Efficacy outcome reached|2
5847107|NCT02234843|20212580|P10|Overall Study|Protocol Violation|0
5847108|NCT02234843|20212581|P9|Overall Study|Protocol Violation|0
5847109|NCT02234843|20212582|P8|Overall Study|Protocol Violation|0
5847110|NCT02234843|20212583|P7|Overall Study|Protocol Violation|0
5847111|NCT02234843|20212584|P6|Overall Study|Protocol Violation|0
5847112|NCT02234843|20212585|P5|Overall Study|Protocol Violation|0
5847113|NCT02234843|20212586|P4|Overall Study|Protocol Violation|0
5847114|NCT02234843|20212587|P3|Overall Study|Protocol Violation|1
5847115|NCT02234843|20212588|P2|Overall Study|Protocol Violation|0
5847116|NCT02234843|20212589|P1|Overall Study|Protocol Violation|1
5847117|NCT02234843|20212580|P10|Overall Study|Death|0
5847118|NCT02234843|20212581|P9|Overall Study|Death|0
5847119|NCT02234843|20212582|P8|Overall Study|Death|0
5847120|NCT02234843|20212583|P7|Overall Study|Death|0
5847121|NCT02234843|20212584|P6|Overall Study|Death|0
5847122|NCT02234843|20212585|P5|Overall Study|Death|0
5847123|NCT02234843|20212586|P4|Overall Study|Death|0
5847124|NCT02234843|20212587|P3|Overall Study|Death|0
5847125|NCT02234843|20212588|P2|Overall Study|Death|0
5847126|NCT02234843|20212589|P1|Overall Study|Death|1
5847127|NCT02234622|20212747|P2|Overall Study|Lost to Follow-up|14
5847128|NCT02234622|20212748|P1|Overall Study|Lost to Follow-up|27
5847129|NCT02234622|20212747|P2|Overall Study|Withdrawal by Subject|22
5847130|NCT02234622|20212748|P1|Overall Study|Withdrawal by Subject|16
5847131|NCT02234596|20212766|P1|Overall Study|Participant not treated|2
5847132|NCT02234583|20212774|P2|Overall Study|Other|97
5847133|NCT02234583|20212775|P1|Overall Study|Other|39
5847134|NCT02234583|20212774|P2|Overall Study|Protocol Violation|42
5847135|NCT02234583|20212775|P1|Overall Study|Protocol Violation|35
5847136|NCT02234583|20212774|P2|Overall Study|Lack of Efficacy|103
5847137|NCT02234583|20212775|P1|Overall Study|Lack of Efficacy|58
5847138|NCT02234583|20212774|P2|Overall Study|Lost to Follow-up|1
5847139|NCT02234583|20212775|P1|Overall Study|Lost to Follow-up|0
5847140|NCT02234583|20212774|P2|Overall Study|Withdrawal by Subject|157
5847141|NCT02234583|20212775|P1|Overall Study|Withdrawal by Subject|109
5847142|NCT02234583|20212774|P2|Overall Study|Adverse Event|156
5847143|NCT02234583|20212775|P1|Overall Study|Adverse Event|172
5847144|NCT02234479|20212894|P2|Overall Study|Withdrawal by Subject|3
5847145|NCT02234479|20212895|P1|Overall Study|Withdrawal by Subject|1
5847146|NCT02234362|20212905|P1|Overall Study|Withdrawal by Subject|3
5847147|NCT02234362|20212905|P1|Overall Study|Lost to Follow-up|6
5847148|NCT02234362|20212905|P1|Overall Study|Not eligible after first screening visit|17
5847149|NCT02234323|20212922|P1|All Treated|Other|7
5847150|NCT02234323|20212922|P1|All Treated|Exceeded lab value limit|2
5847151|NCT02234323|20212922|P1|All Treated|Lack of Efficacy|3
5847152|NCT02234323|20212922|P1|All Treated|Physician Decision|5
5847153|NCT02234323|20212922|P1|All Treated|Death|1
5847154|NCT02234323|20212922|P1|All Enrolled|Not Treated: Exceeded lab value limit|1
5847155|NCT02234323|20212922|P1|All Enrolled|Not Treated:Consent withdrawn by subject|2
5847156|NCT02234323|20212922|P1|All Enrolled|Not Treated: Completed study in database|2
5847157|NCT02234310|20212935|P1|Overall Study|Withdrawal by Subject|2
5847158|NCT02234310|20212935|P1|Overall Study|Eligibility Criteria not fulfilled|2
5847159|NCT02234310|20212935|P1|Overall Study|Adverse Event|1
5847160|NCT02234310|20212935|P1|Overall Study|Physician Decision|1
5847161|NCT02234284|20212949|P2|Overall Study|Lost to Follow-up|7
5847162|NCT02234284|20212950|P1|Overall Study|Lost to Follow-up|20
5847163|NCT02234284|20212949|P2|Overall Study|Withdrawal by Subject|0
5847164|NCT02234284|20212950|P1|Overall Study|Withdrawal by Subject|1
5847165|NCT02234284|20212949|P2|Overall Study|Death|2
5847166|NCT02234284|20212950|P1|Overall Study|Death|4
5847167|NCT02234141|20213009|P7|Long-Term Treatment Period|Study Discontinued by Sponsor|8
5847168|NCT02234141|20213010|P6|Long-Term Treatment Period|Study Discontinued by Sponsor|10
5847169|NCT02234141|20213011|P5|Long-Term Treatment Period|Study Discontinued by Sponsor|9
5847170|NCT02234141|20213012|P4|Long-Term Treatment Period|Study Discontinued by Sponsor|0
5847171|NCT02234141|20213013|P3|Long-Term Treatment Period|Study Discontinued by Sponsor|25
5847172|NCT02234141|20213014|P2|Long-Term Treatment Period|Study Discontinued by Sponsor|27
5847173|NCT02234141|20213015|P1|Long-Term Treatment Period|Study Discontinued by Sponsor|28
5847174|NCT02234141|20213009|P7|Long-Term Treatment Period|Withdrew Consent|0
5847175|NCT02234141|20213010|P6|Long-Term Treatment Period|Withdrew Consent|0
5847176|NCT02234141|20213011|P5|Long-Term Treatment Period|Withdrew Consent|0
5847177|NCT02234141|20213012|P4|Long-Term Treatment Period|Withdrew Consent|0
5847178|NCT02234141|20213013|P3|Long-Term Treatment Period|Withdrew Consent|1
5847179|NCT02234141|20213014|P2|Long-Term Treatment Period|Withdrew Consent|1
5847180|NCT02234141|20213015|P1|Long-Term Treatment Period|Withdrew Consent|0
5847181|NCT02234141|20213009|P7|Long-Term Treatment Period|Adverse Event|1
5847182|NCT02234141|20213010|P6|Long-Term Treatment Period|Adverse Event|1
5847183|NCT02234141|20213011|P5|Long-Term Treatment Period|Adverse Event|1
5847184|NCT02234141|20213012|P4|Long-Term Treatment Period|Adverse Event|0
5847185|NCT02234141|20213013|P3|Long-Term Treatment Period|Adverse Event|5
5847186|NCT02234141|20213014|P2|Long-Term Treatment Period|Adverse Event|0
5847187|NCT02234141|20213015|P1|Long-Term Treatment Period|Adverse Event|4
5847188|NCT02234141|20213009|P7|Long-Term Treatment Period|Investigator's discretion|1
5847189|NCT02234141|20213010|P6|Long-Term Treatment Period|Investigator's discretion|0
5847190|NCT02234141|20213011|P5|Long-Term Treatment Period|Investigator's discretion|0
5847191|NCT02234141|20213012|P4|Long-Term Treatment Period|Investigator's discretion|0
5847192|NCT02234141|20213013|P3|Long-Term Treatment Period|Investigator's discretion|2
5847193|NCT02234141|20213014|P2|Long-Term Treatment Period|Investigator's discretion|3
5847194|NCT02234141|20213015|P1|Long-Term Treatment Period|Investigator's discretion|1
5847195|NCT02234141|20213009|P7|Long-Term Treatment Period|Death|0
5847196|NCT02234141|20213010|P6|Long-Term Treatment Period|Death|1
5847197|NCT02234141|20213011|P5|Long-Term Treatment Period|Death|0
5847198|NCT02234141|20213012|P4|Long-Term Treatment Period|Death|0
5847199|NCT02234141|20213013|P3|Long-Term Treatment Period|Death|0
5847200|NCT02234141|20213014|P2|Long-Term Treatment Period|Death|0
5847201|NCT02234141|20213015|P1|Long-Term Treatment Period|Death|0
5847202|NCT02234141|20213009|P7|Treatment Period (24 Weeks)|Randomized but not treated|0
5847203|NCT02234141|20213010|P6|Treatment Period (24 Weeks)|Randomized but not treated|0
5847204|NCT02234141|20213011|P5|Treatment Period (24 Weeks)|Randomized but not treated|0
5847205|NCT02234141|20213012|P4|Treatment Period (24 Weeks)|Randomized but not treated|0
5847206|NCT02234141|20213013|P3|Treatment Period (24 Weeks)|Randomized but not treated|0
5847207|NCT02234141|20213014|P2|Treatment Period (24 Weeks)|Randomized but not treated|1
5847208|NCT02234141|20213015|P1|Treatment Period (24 Weeks)|Randomized but not treated|0
5847209|NCT02234141|20213009|P7|Treatment Period (24 Weeks)|Adverse Event|0
5847210|NCT02234141|20213010|P6|Treatment Period (24 Weeks)|Adverse Event|0
5847211|NCT02234141|20213011|P5|Treatment Period (24 Weeks)|Adverse Event|0
5847212|NCT02234141|20213012|P4|Treatment Period (24 Weeks)|Adverse Event|3
5847213|NCT02234141|20213013|P3|Treatment Period (24 Weeks)|Adverse Event|2
5847214|NCT02234141|20213014|P2|Treatment Period (24 Weeks)|Adverse Event|1
5847215|NCT02234141|20213015|P1|Treatment Period (24 Weeks)|Adverse Event|3
5847216|NCT02234141|20213009|P7|Treatment Period (24 Weeks)|Death|0
5847217|NCT02234141|20213010|P6|Treatment Period (24 Weeks)|Death|0
5847218|NCT02234141|20213011|P5|Treatment Period (24 Weeks)|Death|0
5847219|NCT02234141|20213012|P4|Treatment Period (24 Weeks)|Death|1
5847220|NCT02234141|20213013|P3|Treatment Period (24 Weeks)|Death|0
5847221|NCT02234141|20213014|P2|Treatment Period (24 Weeks)|Death|2
5847222|NCT02234141|20213015|P1|Treatment Period (24 Weeks)|Death|1
5847223|NCT02234141|20213009|P7|Treatment Period (24 Weeks)|Investigator's discretion|0
5847224|NCT02234141|20213010|P6|Treatment Period (24 Weeks)|Investigator's discretion|0
5847225|NCT02234141|20213011|P5|Treatment Period (24 Weeks)|Investigator's discretion|0
5847226|NCT02234141|20213012|P4|Treatment Period (24 Weeks)|Investigator's discretion|0
5847227|NCT02234141|20213013|P3|Treatment Period (24 Weeks)|Investigator's discretion|0
5847228|NCT02234141|20213014|P2|Treatment Period (24 Weeks)|Investigator's discretion|2
5847229|NCT02234141|20213015|P1|Treatment Period (24 Weeks)|Investigator's discretion|0
5847230|NCT02234141|20213009|P7|Treatment Period (24 Weeks)|Protocol Violation|0
5847231|NCT02234141|20213010|P6|Treatment Period (24 Weeks)|Protocol Violation|0
5847232|NCT02234141|20213011|P5|Treatment Period (24 Weeks)|Protocol Violation|0
5847233|NCT02234141|20213012|P4|Treatment Period (24 Weeks)|Protocol Violation|1
5847234|NCT02234141|20213013|P3|Treatment Period (24 Weeks)|Protocol Violation|0
5847235|NCT02234141|20213014|P2|Treatment Period (24 Weeks)|Protocol Violation|0
5847236|NCT02234141|20213015|P1|Treatment Period (24 Weeks)|Protocol Violation|0
5847237|NCT02234063|20213120|P2|Overall Study|Withdrawal by Subject|1
5847238|NCT02234063|20213121|P1|Overall Study|Withdrawal by Subject|20
5847239|NCT02234063|20213120|P2|Overall Study|Lost to Follow-up|42
5847240|NCT02234063|20213121|P1|Overall Study|Lost to Follow-up|235
5847241|NCT02233803|20213200|P2|Treatment Period 2 (4-Wks)|Withdrawal by Subject|2
5847242|NCT02233803|20213201|P1|Treatment Period 2 (4-Wks)|Withdrawal by Subject|1
5847243|NCT02233803|20213200|P2|Treatment Period 2 (4-Wks)|Lost to Follow-up|0
5847244|NCT02233803|20213201|P1|Treatment Period 2 (4-Wks)|Lost to Follow-up|1
5847245|NCT02233803|20213200|P2|Washout Period (4-Wks)|Withdrawal by Subject|1
5847246|NCT02233803|20213201|P1|Washout Period (4-Wks)|Withdrawal by Subject|1
5847247|NCT02233803|20213200|P2|Washout Period (4-Wks)|Physician Decision|0
5847248|NCT02233803|20213201|P1|Washout Period (4-Wks)|Physician Decision|1
5847249|NCT02233803|20213200|P2|Washout Period (4-Wks)|Lost to Follow-up|1
5847250|NCT02233803|20213201|P1|Washout Period (4-Wks)|Lost to Follow-up|0
5847251|NCT02233803|20213200|P2|Treatment Period 1 (4-Wks)|Withdrawal by Subject|1
5847252|NCT02233803|20213201|P1|Treatment Period 1 (4-Wks)|Withdrawal by Subject|0
5847253|NCT02233803|20213200|P2|Treatment Period 1 (4-Wks)|Protocol Violation|2
5847254|NCT02233803|20213201|P1|Treatment Period 1 (4-Wks)|Protocol Violation|2
5847255|NCT02233803|20213200|P2|Treatment Period 1 (4-Wks)|Adverse Event|1
5847256|NCT02233803|20213201|P1|Treatment Period 1 (4-Wks)|Adverse Event|0
5847257|NCT02233803|20213200|P2|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|0
5847258|NCT02233803|20213201|P1|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|1
5847259|NCT02233738|20213234|P2|Overall Study|Did not return after Baseline|2
5847260|NCT02233738|20213235|P1|Overall Study|Did not return after Baseline|3
5847261|NCT02233738|20213234|P2|Overall Study|Withdrawal by Subject|1
5847262|NCT02233738|20213235|P1|Overall Study|Withdrawal by Subject|0
5847263|NCT02233738|20213234|P2|Overall Study|Death|1
5847264|NCT02233738|20213235|P1|Overall Study|Death|0
5847265|NCT02233738|20213234|P2|Overall Study|Lost to Follow-up|12
5847266|NCT02233738|20213235|P1|Overall Study|Lost to Follow-up|5
5847267|NCT02233647|20213405|P1|Overall Study|Adverse Event|1
5847268|NCT02233543|20213434|P2|Period 2|COPD exacerbation|0
5847269|NCT02233543|20213435|P1|Period 2|COPD exacerbation|1
5847270|NCT02233543|20213434|P2|Period 2|Participant required other treatment.|1
5847271|NCT02233543|20213435|P1|Period 2|Participant required other treatment.|0
5847272|NCT02233543|20213434|P2|Period 2|Adverse Event|0
5847273|NCT02233543|20213435|P1|Period 2|Adverse Event|1
5847274|NCT02233543|20213434|P2|Period 1|Participants required other treatment.|3
5847275|NCT02233543|20213435|P1|Period 1|Participants required other treatment.|2
5847276|NCT02233543|20213434|P2|Period 1|Withdrawal by Subject|0
5847277|NCT02233543|20213435|P1|Period 1|Withdrawal by Subject|1
5847278|NCT02233413|20213487|P2|Overall Study|Withdrawal by Subject|5
5847279|NCT02233413|20213488|P1|Overall Study|Withdrawal by Subject|4
5847280|NCT02233413|20213487|P2|Overall Study|Lost to Follow-up|9
5847281|NCT02233413|20213488|P1|Overall Study|Lost to Follow-up|7
5847282|NCT02233309|20213500|P1|Overall Study|Physician Decision|5
5847283|NCT02232984|20213534|P1|Overall Study|Protocol Violation|1
5847284|NCT02232984|20213534|P1|Overall Study|not disclosed by site|7
5847285|NCT02232984|20213534|P1|Overall Study|Device implant unsuccessful|53
5847286|NCT02232984|20213534|P1|Overall Study|Investigator withdrawal|10
5847287|NCT02232984|20213534|P1|Overall Study|Death|1
5847288|NCT02232984|20213534|P1|Overall Study|Withdrawal by Subject|5
5847289|NCT02232893|20213545|P2|Overall Study|Other|3
5847290|NCT02232893|20213546|P1|Overall Study|Other|0
5847291|NCT02232893|20213545|P2|Overall Study|Developed exclusion criteria|1
5847292|NCT02232893|20213546|P1|Overall Study|Developed exclusion criteria|0
5847293|NCT02232893|20213545|P2|Overall Study|Sponsor request early termination|1
5847294|NCT02232893|20213546|P1|Overall Study|Sponsor request early termination|0
5847295|NCT02232893|20213545|P2|Overall Study|Adverse Event|1
5847296|NCT02232893|20213546|P1|Overall Study|Adverse Event|0
5847297|NCT02232893|20213545|P2|Overall Study|Withdrawal by Subject|1
5847298|NCT02232893|20213546|P1|Overall Study|Withdrawal by Subject|4
5847299|NCT02232880|20213552|P1|Overall Study|study stopped prior to randomization|1
5847300|NCT02232802|20213561|P2|Period 1|Adverse Event|1
5847301|NCT02232802|20213562|P1|Period 1|Adverse Event|1
5847302|NCT02232802|20213561|P2|Period 1|Sponsor request|0
5847303|NCT02232802|20213562|P1|Period 1|Sponsor request|1
5847304|NCT02232698|20213628|P2|Overall Study|Withdrawal by Subject|11
5847305|NCT02232698|20213629|P1|Overall Study|Withdrawal by Subject|0
5847306|NCT02232698|20213628|P2|Overall Study|Allocated to control group|3
5847307|NCT02232698|20213629|P1|Overall Study|Allocated to control group|0
5847308|NCT02232698|20213628|P2|Overall Study|Non-compliance with study device|4
5847309|NCT02232698|20213629|P1|Overall Study|Non-compliance with study device|1
5847310|NCT02232698|20213628|P2|Overall Study|Had device-associated symptoms|0
5847311|NCT02232698|20213629|P1|Overall Study|Had device-associated symptoms|7
5847312|NCT02232698|20213628|P2|Overall Study|Met exclusion criteria|1
5847313|NCT02232698|20213629|P1|Overall Study|Met exclusion criteria|1
5847314|NCT02232698|20213628|P2|Overall Study|Pregnancy|1
5847315|NCT02232698|20213629|P1|Overall Study|Pregnancy|1
5847316|NCT02232425|20213652|P2|Overall Study|Lack of Efficacy|0
5847317|NCT02232425|20213653|P1|Overall Study|Lack of Efficacy|1
5847318|NCT02232425|20213652|P2|Overall Study|Withdrawal by Subject|6
5847319|NCT02232425|20213653|P1|Overall Study|Withdrawal by Subject|5
5847320|NCT02232425|20213652|P2|Overall Study|Adverse Event|0
5847321|NCT02232425|20213653|P1|Overall Study|Adverse Event|2
5847322|NCT02232425|20213652|P2|Overall Study|Lost to Follow-up|2
5847323|NCT02232425|20213653|P1|Overall Study|Lost to Follow-up|6
5847324|NCT02232243|20213686|P3|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0
5847325|NCT02232243|20213687|P2|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|1
5847326|NCT02232243|20213688|P1|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0
5847327|NCT02232178|20213700|P3|Overall Study|surgical complication|0
5847328|NCT02232178|20213701|P2|Overall Study|surgical complication|0
5847329|NCT02232178|20213702|P1|Overall Study|surgical complication|1
5847330|NCT02232178|20213700|P3|Overall Study|ineligibility|1
5847331|NCT02232178|20213701|P2|Overall Study|ineligibility|0
5847332|NCT02232178|20213702|P1|Overall Study|ineligibility|0
5847333|NCT02232178|20213700|P3|Overall Study|Lost to Follow-up|0
5847334|NCT02232178|20213701|P2|Overall Study|Lost to Follow-up|1
5847335|NCT02232178|20213702|P1|Overall Study|Lost to Follow-up|0
5847336|NCT02232087|20213730|P6|Overall Study|Adverse Event|0
5847337|NCT02232087|20213731|P5|Overall Study|Adverse Event|1
5847338|NCT02232087|20213732|P4|Overall Study|Adverse Event|0
5847339|NCT02232087|20213733|P3|Overall Study|Adverse Event|0
5847340|NCT02232087|20213734|P2|Overall Study|Adverse Event|0
5847341|NCT02232087|20213735|P1|Overall Study|Adverse Event|0
5847342|NCT02232087|20213730|P6|Overall Study|protocol stop criteria|0
5847343|NCT02232087|20213731|P5|Overall Study|protocol stop criteria|0
5847344|NCT02232087|20213732|P4|Overall Study|protocol stop criteria|1
5847345|NCT02232087|20213733|P3|Overall Study|protocol stop criteria|0
5847346|NCT02232087|20213734|P2|Overall Study|protocol stop criteria|1
5847347|NCT02232087|20213735|P1|Overall Study|protocol stop criteria|0
5847348|NCT02232087|20213730|P6|Overall Study|poor inhalation technique|2
5847349|NCT02232087|20213731|P5|Overall Study|poor inhalation technique|0
5847350|NCT02232087|20213732|P4|Overall Study|poor inhalation technique|0
5847351|NCT02232087|20213733|P3|Overall Study|poor inhalation technique|0
5847352|NCT02232087|20213734|P2|Overall Study|poor inhalation technique|1
5847353|NCT02232087|20213735|P1|Overall Study|poor inhalation technique|0
5847354|NCT02232087|20213730|P6|Overall Study|Withdrawal by Subject|1
5847355|NCT02232087|20213731|P5|Overall Study|Withdrawal by Subject|0
5847356|NCT02232087|20213732|P4|Overall Study|Withdrawal by Subject|0
5847357|NCT02232087|20213733|P3|Overall Study|Withdrawal by Subject|0
5847358|NCT02232087|20213734|P2|Overall Study|Withdrawal by Subject|0
5847359|NCT02232087|20213735|P1|Overall Study|Withdrawal by Subject|2
5847360|NCT02232074|20213771|P2|Overall Study|deemed ineligible|1
5847361|NCT02232074|20213772|P1|Overall Study|deemed ineligible|0
5847362|NCT02232074|20213771|P2|Overall Study|No legal concerns at baseline|41
5847363|NCT02232074|20213772|P1|Overall Study|No legal concerns at baseline|36
5847364|NCT02232074|20213771|P2|Overall Study|Withdrawal by Subject|3
5847365|NCT02232074|20213772|P1|Overall Study|Withdrawal by Subject|5
5847366|NCT02231918|20213839|P3|Overall Study|Adverse Event|1
5847367|NCT02231918|20213840|P2|Overall Study|Adverse Event|0
5847368|NCT02231918|20213841|P1|Overall Study|Adverse Event|0
5847369|NCT02231918|20213839|P3|Overall Study|Withdrawal by Subject|0
5847370|NCT02231918|20213840|P2|Overall Study|Withdrawal by Subject|1
5847371|NCT02231918|20213841|P1|Overall Study|Withdrawal by Subject|0
5847372|NCT02231892|20213906|P3|Overall Study|Could not find reliable motor hotspot|1
5847373|NCT02231892|20213907|P2|Overall Study|Could not find reliable motor hotspot|0
5847374|NCT02231892|20213908|P1|Overall Study|Could not find reliable motor hotspot|0
5847375|NCT02231892|20213906|P3|Overall Study|Could not find motor threshold|1
5847376|NCT02231892|20213907|P2|Overall Study|Could not find motor threshold|0
5847377|NCT02231892|20213908|P1|Overall Study|Could not find motor threshold|2
5847378|NCT02231892|20213906|P3|Overall Study|Participant motor threshold was >83%|9
5847379|NCT02231892|20213907|P2|Overall Study|Participant motor threshold was >83%|0
5847380|NCT02231892|20213908|P1|Overall Study|Participant motor threshold was >83%|0
5847381|NCT02231892|20213906|P3|Overall Study|Motor activity when stimulating ante ACC|12
5847382|NCT02231892|20213907|P2|Overall Study|Motor activity when stimulating ante ACC|7
5847383|NCT02231892|20213908|P1|Overall Study|Motor activity when stimulating ante ACC|4
5847384|NCT02231892|20213906|P3|Overall Study|Physician Decision|4
5847385|NCT02231892|20213907|P2|Overall Study|Physician Decision|2
5847386|NCT02231892|20213908|P1|Overall Study|Physician Decision|0
5847387|NCT02231892|20213906|P3|Overall Study|Withdrawal by Subject|15
5847388|NCT02231892|20213907|P2|Overall Study|Withdrawal by Subject|3
5847389|NCT02231892|20213908|P1|Overall Study|Withdrawal by Subject|4
5847390|NCT02231892|20213906|P3|Overall Study|Lost to Follow-up|3
5847391|NCT02231892|20213907|P2|Overall Study|Lost to Follow-up|0
5847392|NCT02231892|20213908|P1|Overall Study|Lost to Follow-up|1
5847393|NCT02231762|20213925|P4|Maintenance Phase|Adverse Event|2
5847394|NCT02231762|20213926|P3|Maintenance Phase|Adverse Event|1
5847395|NCT02231762|20213927|P2|Maintenance Phase|Adverse Event|0
5847396|NCT02231762|20213928|P1|Maintenance Phase|Adverse Event|0
5847397|NCT02231762|20213925|P4|Maintenance Phase|Disease progression|3
5847398|NCT02231762|20213926|P3|Maintenance Phase|Disease progression|4
5847399|NCT02231762|20213927|P2|Maintenance Phase|Disease progression|3
5847400|NCT02231762|20213928|P1|Maintenance Phase|Disease progression|0
5847401|NCT02231762|20213925|P4|Combination Phase|Protocol Violation|0
5847402|NCT02231762|20213926|P3|Combination Phase|Protocol Violation|0
5847403|NCT02231762|20213927|P2|Combination Phase|Protocol Violation|0
5847404|NCT02231762|20213928|P1|Combination Phase|Protocol Violation|1
5847405|NCT02231762|20213925|P4|Combination Phase|Did not meet inclusion criteria|0
5847406|NCT02231762|20213926|P3|Combination Phase|Did not meet inclusion criteria|0
5847407|NCT02231762|20213927|P2|Combination Phase|Did not meet inclusion criteria|0
5847408|NCT02231762|20213928|P1|Combination Phase|Did not meet inclusion criteria|1
5847409|NCT02231762|20213925|P4|Combination Phase|Disease Progression|0
5847410|NCT02231762|20213926|P3|Combination Phase|Disease Progression|0
5847411|NCT02231762|20213927|P2|Combination Phase|Disease Progression|0
5847412|NCT02231762|20213928|P1|Combination Phase|Disease Progression|6
5847413|NCT02231762|20213925|P4|Combination Phase|Withdrawal by Subject|0
5847414|NCT02231762|20213926|P3|Combination Phase|Withdrawal by Subject|0
5847415|NCT02231762|20213927|P2|Combination Phase|Withdrawal by Subject|0
5847416|NCT02231762|20213928|P1|Combination Phase|Withdrawal by Subject|2
5847417|NCT02231762|20213925|P4|Combination Phase|Adverse Event|0
5847418|NCT02231762|20213926|P3|Combination Phase|Adverse Event|0
5847419|NCT02231762|20213927|P2|Combination Phase|Adverse Event|0
5847420|NCT02231762|20213928|P1|Combination Phase|Adverse Event|10
5847421|NCT02231749|20213961|P2|Overall Study|No longer meets Study Criteria|0
5847422|NCT02231749|20213962|P1|Overall Study|No longer meets Study Criteria|1
5847423|NCT02231749|20213961|P2|Overall Study|other|8
5847424|NCT02231749|20213962|P1|Overall Study|other|0
5847425|NCT02231749|20213961|P2|Overall Study|Pregnancy|0
5847426|NCT02231749|20213962|P1|Overall Study|Pregnancy|1
5847427|NCT02231749|20213961|P2|Overall Study|Poor/Non-Compliance|3
5847428|NCT02231749|20213962|P1|Overall Study|Poor/Non-Compliance|0
5847429|NCT02231749|20213961|P2|Overall Study|Maximum Clinical Benefit|8
5847430|NCT02231749|20213962|P1|Overall Study|Maximum Clinical Benefit|5
5847431|NCT02231749|20213961|P2|Overall Study|Lost to Follow-up|2
5847432|NCT02231749|20213962|P1|Overall Study|Lost to Follow-up|1
5847433|NCT02231749|20213961|P2|Overall Study|Participant withdrew Consent|15
5847434|NCT02231749|20213962|P1|Overall Study|Participant withdrew Consent|8
5847435|NCT02231749|20213961|P2|Overall Study|Participant's request to discontinue|21
5847436|NCT02231749|20213962|P1|Overall Study|Participant's request to discontinue|10
5847437|NCT02231749|20213961|P2|Overall Study|AE unrelated to Study drug|31
5847438|NCT02231749|20213962|P1|Overall Study|AE unrelated to Study drug|32
5847439|NCT02231749|20213961|P2|Overall Study|Death|1
5847440|NCT02231749|20213962|P1|Overall Study|Death|1
5847441|NCT02231749|20213961|P2|Overall Study|Study Drug Toxicity|63
5847442|NCT02231749|20213962|P1|Overall Study|Study Drug Toxicity|134
5847443|NCT02231749|20213961|P2|Overall Study|Disease progression|297
5847444|NCT02231749|20213962|P1|Overall Study|Disease progression|229
5847445|NCT02231580|20213980|P2|Overall Study|Adverse Event|0
5847446|NCT02231580|20213981|P1|Overall Study|Adverse Event|5
5847447|NCT02231164|20214098|P2|Overall Study|Withdrawal by Subject|2
5847448|NCT02231164|20214099|P1|Overall Study|Withdrawal by Subject|1
5847449|NCT02231164|20214098|P2|Overall Study|Lack of Efficacy|3
5847450|NCT02231164|20214099|P1|Overall Study|Lack of Efficacy|4
5847451|NCT02231164|20214098|P2|Overall Study|Adverse Event|1
5847452|NCT02231164|20214099|P1|Overall Study|Adverse Event|1
5847453|NCT02230956|20214127|P3|Overall Study|Other Miscellaneous Reason|2
5847454|NCT02230956|20214128|P2|Overall Study|Other Miscellaneous Reason|1
5847455|NCT02230956|20214129|P1|Overall Study|Other Miscellaneous Reason|0
5847456|NCT02230956|20214127|P3|Overall Study|Protocol Violation|1
5847457|NCT02230956|20214128|P2|Overall Study|Protocol Violation|1
5847458|NCT02230956|20214129|P1|Overall Study|Protocol Violation|0
5847459|NCT02230956|20214127|P3|Overall Study|Personal Reasons|1
5847460|NCT02230956|20214128|P2|Overall Study|Personal Reasons|1
5847461|NCT02230956|20214129|P1|Overall Study|Personal Reasons|2
5847462|NCT02230956|20214127|P3|Overall Study|Lost to Follow-up|2
5847463|NCT02230956|20214128|P2|Overall Study|Lost to Follow-up|1
5847464|NCT02230956|20214129|P1|Overall Study|Lost to Follow-up|1
5847465|NCT02230956|20214127|P3|Overall Study|Lack of Efficacy|1
5847466|NCT02230956|20214128|P2|Overall Study|Lack of Efficacy|1
5847467|NCT02230956|20214129|P1|Overall Study|Lack of Efficacy|1
5847468|NCT02230956|20214127|P3|Overall Study|Adverse Event|0
5847469|NCT02230956|20214128|P2|Overall Study|Adverse Event|1
5847470|NCT02230956|20214129|P1|Overall Study|Adverse Event|1
5847471|NCT02230904|20214151|P2|Overall Study|Safety follow up could not take place|1
5847472|NCT02230904|20214152|P1|Overall Study|Safety follow up could not take place|0
5847473|NCT02230683|20214185|P1|Overall Study|Adverse Event|1
5847474|NCT02230670|20214202|P2|Overall Study|Progression to Child-Pugh C|2
5847475|NCT02230670|20214203|P1|Overall Study|Progression to Child-Pugh C|1
5847476|NCT02230670|20214202|P2|Overall Study|Protocol Violation|1
5847477|NCT02230670|20214203|P1|Overall Study|Protocol Violation|0
5847478|NCT02230670|20214202|P2|Overall Study|Physician Decision|1
5847479|NCT02230670|20214203|P1|Overall Study|Physician Decision|0
5847480|NCT02230670|20214202|P2|Overall Study|Withdrawal by Subject|2
5847481|NCT02230670|20214203|P1|Overall Study|Withdrawal by Subject|2
5847482|NCT02230670|20214202|P2|Overall Study|Adverse Event|2
5847483|NCT02230670|20214203|P1|Overall Study|Adverse Event|1
5847484|NCT02230384|20214289|P2|Phase 2 - Switch|Adverse Event|0
5847485|NCT02230384|20214290|P1|Phase 2 - Switch|Adverse Event|2
5847486|NCT02230384|20214289|P2|Phase 2 - Switch|Lost to Follow-up|0
5847487|NCT02230384|20214290|P1|Phase 2 - Switch|Lost to Follow-up|1
5847488|NCT02230384|20214289|P2|Phase 2 - Switch|Withdrawal by Subject|1
5847489|NCT02230384|20214290|P1|Phase 2 - Switch|Withdrawal by Subject|0
5847490|NCT02230384|20214289|P2|Phase 1|Physician Decision|1
5847491|NCT02230384|20214290|P1|Phase 1|Physician Decision|0
5847492|NCT02230384|20214289|P2|Phase 1|Lost to Follow-up|0
5847493|NCT02230384|20214290|P1|Phase 1|Lost to Follow-up|1
5847494|NCT02230332|20214310|P2|Overall Study|Protocol Violation|0
5847495|NCT02230332|20214311|P1|Overall Study|Protocol Violation|1
5847496|NCT02230332|20214310|P2|Overall Study|Lost to Follow-up|0
5847497|NCT02230332|20214311|P1|Overall Study|Lost to Follow-up|1
5847498|NCT02230332|20214310|P2|Overall Study|Adverse Event|1
5847499|NCT02230332|20214311|P1|Overall Study|Adverse Event|2
5847500|NCT02230306|20214327|P1|Overall Study|Did not receive study treatment|1
5847501|NCT02230085|20214338|P1|Overall Study|Withdrawal by Subject|3
5847502|NCT02230085|20214338|P1|Overall Study|Physician Decision|1
5847503|NCT02229864|20214342|P1|Overall Study|Lost to Follow-up|1
5847504|NCT02229864|20214342|P1|Overall Study|Death|2
5847505|NCT02229851|20214366|P7|Extension Phase (Open-label Phase)|Death|1
5847506|NCT02229851|20214367|P6|Extension Phase (Open-label Phase)|Death|1
5847507|NCT02229851|20214368|P5|Extension Phase (Open-label Phase)|Death|0
5847508|NCT02229851|20214369|P4|Extension Phase (Open-label Phase)|Death|1
5847509|NCT02229851|20214370|P3|Extension Phase (Open-label Phase)|Death|0
5847510|NCT02229851|20214371|P2|Extension Phase (Open-label Phase)|Death|0
5847511|NCT02229851|20214372|P1|Extension Phase (Open-label Phase)|Death|0
5847512|NCT02229851|20214366|P7|Extension Phase (Open-label Phase)|Withdrawal by Subject|1
5847513|NCT02229851|20214367|P6|Extension Phase (Open-label Phase)|Withdrawal by Subject|3
5847514|NCT02229851|20214368|P5|Extension Phase (Open-label Phase)|Withdrawal by Subject|4
5847515|NCT02229851|20214369|P4|Extension Phase (Open-label Phase)|Withdrawal by Subject|1
5847516|NCT02229851|20214370|P3|Extension Phase (Open-label Phase)|Withdrawal by Subject|0
5847517|NCT02229851|20214371|P2|Extension Phase (Open-label Phase)|Withdrawal by Subject|0
5847518|NCT02229851|20214372|P1|Extension Phase (Open-label Phase)|Withdrawal by Subject|0
5847519|NCT02229851|20214366|P7|Extension Phase (Open-label Phase)|Lost to Follow-up|1
5847520|NCT02229851|20214367|P6|Extension Phase (Open-label Phase)|Lost to Follow-up|1
5847521|NCT02229851|20214368|P5|Extension Phase (Open-label Phase)|Lost to Follow-up|1
5847522|NCT02229851|20214369|P4|Extension Phase (Open-label Phase)|Lost to Follow-up|0
5847523|NCT02229851|20214370|P3|Extension Phase (Open-label Phase)|Lost to Follow-up|0
5847524|NCT02229851|20214371|P2|Extension Phase (Open-label Phase)|Lost to Follow-up|0
5847525|NCT02229851|20214372|P1|Extension Phase (Open-label Phase)|Lost to Follow-up|0
5847526|NCT02229851|20214366|P7|Main Phase (Double-blind Phase)|Death|0
5847527|NCT02229851|20214367|P6|Main Phase (Double-blind Phase)|Death|0
5847528|NCT02229851|20214368|P5|Main Phase (Double-blind Phase)|Death|0
5847529|NCT02229851|20214369|P4|Main Phase (Double-blind Phase)|Death|0
5847530|NCT02229851|20214370|P3|Main Phase (Double-blind Phase)|Death|0
5847531|NCT02229851|20214371|P2|Main Phase (Double-blind Phase)|Death|1
5847532|NCT02229851|20214372|P1|Main Phase (Double-blind Phase)|Death|1
5847533|NCT02229851|20214366|P7|Main Phase (Double-blind Phase)|Protocol Violation|0
5847534|NCT02229851|20214367|P6|Main Phase (Double-blind Phase)|Protocol Violation|0
5847535|NCT02229851|20214368|P5|Main Phase (Double-blind Phase)|Protocol Violation|0
5847536|NCT02229851|20214369|P4|Main Phase (Double-blind Phase)|Protocol Violation|0
5847537|NCT02229851|20214370|P3|Main Phase (Double-blind Phase)|Protocol Violation|2
5847538|NCT02229851|20214371|P2|Main Phase (Double-blind Phase)|Protocol Violation|0
5847539|NCT02229851|20214372|P1|Main Phase (Double-blind Phase)|Protocol Violation|0
5847540|NCT02229851|20214366|P7|Main Phase (Double-blind Phase)|Withdrawal by Subject|0
5847541|NCT02229851|20214367|P6|Main Phase (Double-blind Phase)|Withdrawal by Subject|0
5847542|NCT02229851|20214368|P5|Main Phase (Double-blind Phase)|Withdrawal by Subject|0
5847543|NCT02229851|20214369|P4|Main Phase (Double-blind Phase)|Withdrawal by Subject|0
5847544|NCT02229851|20214370|P3|Main Phase (Double-blind Phase)|Withdrawal by Subject|4
5847545|NCT02229851|20214371|P2|Main Phase (Double-blind Phase)|Withdrawal by Subject|12
5847546|NCT02229851|20214372|P1|Main Phase (Double-blind Phase)|Withdrawal by Subject|4
5847547|NCT02229851|20214366|P7|Main Phase (Double-blind Phase)|Lost to Follow-up|0
5847548|NCT02229851|20214367|P6|Main Phase (Double-blind Phase)|Lost to Follow-up|0
5847549|NCT02229851|20214368|P5|Main Phase (Double-blind Phase)|Lost to Follow-up|0
5847550|NCT02229851|20214369|P4|Main Phase (Double-blind Phase)|Lost to Follow-up|0
5847551|NCT02229851|20214370|P3|Main Phase (Double-blind Phase)|Lost to Follow-up|0
5847552|NCT02229851|20214371|P2|Main Phase (Double-blind Phase)|Lost to Follow-up|1
5847553|NCT02229851|20214372|P1|Main Phase (Double-blind Phase)|Lost to Follow-up|0
5847554|NCT02229851|20214366|P7|Main Phase (Double-blind Phase)|Unclassified|0
5847555|NCT02229851|20214367|P6|Main Phase (Double-blind Phase)|Unclassified|0
5847556|NCT02229851|20214368|P5|Main Phase (Double-blind Phase)|Unclassified|0
5847557|NCT02229851|20214369|P4|Main Phase (Double-blind Phase)|Unclassified|0
5847558|NCT02229851|20214370|P3|Main Phase (Double-blind Phase)|Unclassified|0
5847559|NCT02229851|20214371|P2|Main Phase (Double-blind Phase)|Unclassified|2
5847560|NCT02229851|20214372|P1|Main Phase (Double-blind Phase)|Unclassified|1
5847561|NCT02229552|20214804|P1|2-Year Follow up|Lost to Follow-up|17
5847562|NCT02229552|20214804|P1|2-Year Follow up|Withdrawal by Subject|9
5847563|NCT02229552|20214804|P1|1-year Follow up|Lost to Follow-up|18
5847564|NCT02229552|20214804|P1|1-year Follow up|Withdrawal by Subject|7
5847565|NCT02229552|20214804|P1|Baseline|Withdrawal by Subject|6
5847566|NCT02229539|20214811|P3|Cycle 2 (Optional Continuation Phase)|Data being queried at the time of report|0
5847567|NCT02229539|20214812|P2|Cycle 2 (Optional Continuation Phase)|Data being queried at the time of report|1
5847568|NCT02229539|20214813|P1|Cycle 2 (Optional Continuation Phase)|Data being queried at the time of report|2
5847569|NCT02229539|20214811|P3|Cycle 2 (Optional Continuation Phase)|Other Unknown Reason|3
5847570|NCT02229539|20214812|P2|Cycle 2 (Optional Continuation Phase)|Other Unknown Reason|0
5847571|NCT02229539|20214813|P1|Cycle 2 (Optional Continuation Phase)|Other Unknown Reason|0
5847572|NCT02229539|20214811|P3|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|1
5847573|NCT02229539|20214812|P2|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|1
5847574|NCT02229539|20214813|P1|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|0
5847575|NCT02229539|20214811|P3|Cycle 2 (Optional Continuation Phase)|Adverse Event|0
5847576|NCT02229539|20214812|P2|Cycle 2 (Optional Continuation Phase)|Adverse Event|0
5847577|NCT02229539|20214813|P1|Cycle 2 (Optional Continuation Phase)|Adverse Event|2
5847578|NCT02229539|20214811|P3|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|6
5847579|NCT02229539|20214812|P2|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|5
5847580|NCT02229539|20214813|P1|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|5
5847581|NCT02229539|20214811|P3|Cycle 1 (Treatment Per Protocol)|Data being queried at the time of report|1
5847582|NCT02229539|20214812|P2|Cycle 1 (Treatment Per Protocol)|Data being queried at the time of report|4
5847583|NCT02229539|20214813|P1|Cycle 1 (Treatment Per Protocol)|Data being queried at the time of report|3
5847584|NCT02229539|20214811|P3|Cycle 1 (Treatment Per Protocol)|Medical Problems|1
5847585|NCT02229539|20214812|P2|Cycle 1 (Treatment Per Protocol)|Medical Problems|0
5847586|NCT02229539|20214813|P1|Cycle 1 (Treatment Per Protocol)|Medical Problems|0
5847587|NCT02229539|20214811|P3|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|1
5847588|NCT02229539|20214812|P2|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0
5847589|NCT02229539|20214813|P1|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0
5847590|NCT02229539|20214811|P3|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0
5847591|NCT02229539|20214812|P2|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|1
5847592|NCT02229539|20214813|P1|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0
5847593|NCT02229396|20214944|P3|Overall Study|Withdrew; No Record on Termination Page|1
5847594|NCT02229396|20214945|P2|Overall Study|Withdrew; No Record on Termination Page|0
5847595|NCT02229396|20214946|P1|Overall Study|Withdrew; No Record on Termination Page|2
5847596|NCT02229396|20214944|P3|Overall Study|Study-Specific Withdrawal Criteria|3
5847597|NCT02229396|20214945|P2|Overall Study|Study-Specific Withdrawal Criteria|1
5847598|NCT02229396|20214946|P1|Overall Study|Study-Specific Withdrawal Criteria|0
5847599|NCT02229396|20214944|P3|Overall Study|Withdrawal by Subject|41
5847600|NCT02229396|20214945|P2|Overall Study|Withdrawal by Subject|28
5847601|NCT02229396|20214946|P1|Overall Study|Withdrawal by Subject|42
5847602|NCT02229396|20214944|P3|Overall Study|Other|15
5847603|NCT02229396|20214945|P2|Overall Study|Other|18
5847604|NCT02229396|20214946|P1|Overall Study|Other|10
5847605|NCT02229396|20214944|P3|Overall Study|Patient Incorrectly Randomized|1
5847606|NCT02229396|20214945|P2|Overall Study|Patient Incorrectly Randomized|0
5847607|NCT02229396|20214946|P1|Overall Study|Patient Incorrectly Randomized|0
5847608|NCT02229396|20214944|P3|Overall Study|Protocol Violation|0
5847609|NCT02229396|20214945|P2|Overall Study|Protocol Violation|1
5847610|NCT02229396|20214946|P1|Overall Study|Protocol Violation|2
5847611|NCT02229396|20214944|P3|Overall Study|Lost to Follow-up|21
5847612|NCT02229396|20214945|P2|Overall Study|Lost to Follow-up|14
5847613|NCT02229396|20214946|P1|Overall Study|Lost to Follow-up|14
5847614|NCT02229396|20214944|P3|Overall Study|Death|1
5847615|NCT02229396|20214945|P2|Overall Study|Death|3
5847616|NCT02229396|20214946|P1|Overall Study|Death|2
5847617|NCT02229396|20214944|P3|Overall Study|Adverse Event|12
5847618|NCT02229396|20214945|P2|Overall Study|Adverse Event|12
5847619|NCT02229396|20214946|P1|Overall Study|Adverse Event|6
5847620|NCT02229383|20214977|P2|Overall Study|Other|8
5847621|NCT02229383|20214978|P1|Overall Study|Other|3
5847622|NCT02229383|20214977|P2|Overall Study|Did not receive treatment|0
5847623|NCT02229383|20214978|P1|Overall Study|Did not receive treatment|1
5847624|NCT02229383|20214977|P2|Overall Study|Withdrawal by Subject|6
5847625|NCT02229383|20214978|P1|Overall Study|Withdrawal by Subject|4
5847626|NCT02229383|20214977|P2|Overall Study|Lost to Follow-up|3
5847627|NCT02229383|20214978|P1|Overall Study|Lost to Follow-up|5
5847628|NCT02229383|20214977|P2|Overall Study|Death|1
5847629|NCT02229383|20214978|P1|Overall Study|Death|0
5847630|NCT02229383|20214977|P2|Overall Study|Adverse Event|4
5847631|NCT02229383|20214978|P1|Overall Study|Adverse Event|7
5847632|NCT02229227|20215003|P2|Overall Study|Physician Decision|12
5847633|NCT02229227|20215004|P1|Overall Study|Physician Decision|5
5847634|NCT02229227|20215003|P2|Overall Study|Other|1
5847635|NCT02229227|20215004|P1|Overall Study|Other|0
5847636|NCT02229227|20215003|P2|Overall Study|Withdrawal by Subject|12
5847637|NCT02229227|20215004|P1|Overall Study|Withdrawal by Subject|8
5847638|NCT02229227|20215003|P2|Overall Study|Study terminated by sponsor|11
5847639|NCT02229227|20215004|P1|Overall Study|Study terminated by sponsor|11
5847640|NCT02229227|20215003|P2|Overall Study|Lost to Follow-up|3
5847641|NCT02229227|20215004|P1|Overall Study|Lost to Follow-up|3
5847642|NCT02229227|20215003|P2|Overall Study|Protocol defined stopping criteria|3
5847643|NCT02229227|20215004|P1|Overall Study|Protocol defined stopping criteria|1
5847644|NCT02229227|20215003|P2|Overall Study|Protocol Violation|8
5847645|NCT02229227|20215004|P1|Overall Study|Protocol Violation|6
5847646|NCT02229227|20215003|P2|Overall Study|Lack of Efficacy|3
5847647|NCT02229227|20215004|P1|Overall Study|Lack of Efficacy|3
5847648|NCT02229227|20215003|P2|Overall Study|Adverse Event|9
5847649|NCT02229227|20215004|P1|Overall Study|Adverse Event|14
5847650|NCT02229214|20215089|P2|Overall Study|Withdrawal by Subject|0
5847651|NCT02229214|20215090|P1|Overall Study|Withdrawal by Subject|4
5847652|NCT02229214|20215089|P2|Overall Study|Adverse Event|0
5847653|NCT02229214|20215090|P1|Overall Study|Adverse Event|2
5847654|NCT02228980|20215114|P4|Overall Study|Withdrawal by Subject|3
5847655|NCT02228980|20215115|P3|Overall Study|Withdrawal by Subject|2
5847656|NCT02228980|20215116|P2|Overall Study|Withdrawal by Subject|3
5847657|NCT02228980|20215117|P1|Overall Study|Withdrawal by Subject|3
5847658|NCT02228980|20215114|P4|Overall Study|Protocol Violation|0
5847659|NCT02228980|20215115|P3|Overall Study|Protocol Violation|0
5847660|NCT02228980|20215116|P2|Overall Study|Protocol Violation|0
5847661|NCT02228980|20215117|P1|Overall Study|Protocol Violation|7
5847662|NCT02228980|20215114|P4|Overall Study|Adverse Event|0
5847663|NCT02228980|20215115|P3|Overall Study|Adverse Event|0
5847664|NCT02228980|20215116|P2|Overall Study|Adverse Event|0
5847665|NCT02228980|20215117|P1|Overall Study|Adverse Event|14
5847666|NCT02228967|20215141|P2|Overall Study|Withdrawal by Subject|18
5847667|NCT02228967|20215142|P1|Overall Study|Withdrawal by Subject|13
5847668|NCT02228967|20215141|P2|Overall Study|Lost to Follow-up|142
5847669|NCT02228967|20215142|P1|Overall Study|Lost to Follow-up|146
5847670|NCT02228720|20215203|P1|Open Label - Day 30|Lost to Follow-up|1
5847671|NCT02228590|20215226|P1|Overall Study|Withdrawal by Subject|1
5847672|NCT02228564|20215239|P1|Overall Study|Other|6
5847673|NCT02228564|20215239|P1|Overall Study|Lost to Follow-up|17
5847674|NCT02228564|20215239|P1|Overall Study|Physician Decision|5
5847675|NCT02228564|20215239|P1|Overall Study|Death|11
5847676|NCT02228564|20215239|P1|Overall Study|Withdrawal by Subject|10
5847677|NCT02228460|20215263|P1|Overall Study|Lost to Follow-up|1
5847678|NCT02228460|20215263|P1|Overall Study|Adverse Event|1
5847679|NCT02228395|20215286|P3|First Intervention Period|Unable to comply with study dates|1
5847680|NCT02228395|20215287|P2|First Intervention Period|Unable to comply with study dates|1
5847681|NCT02228395|20215288|P1|First Intervention Period|Unable to comply with study dates|0
5847682|NCT02228395|20215286|P3|First Intervention Period|No longer willing to participate|0
5847683|NCT02228395|20215287|P2|First Intervention Period|No longer willing to participate|0
5847684|NCT02228395|20215288|P1|First Intervention Period|No longer willing to participate|1
5847685|NCT02228096|20215374|P1|Overall Study|Enrolled, not infused|11
5847686|NCT02228096|20215374|P1|Overall Study|New therapy for study indication|1
5847687|NCT02228096|20215374|P1|Overall Study|Subject/guardian decision|2
5847688|NCT02228096|20215374|P1|Overall Study|Physician Decision|3
5847689|NCT02228096|20215374|P1|Overall Study|Death|12
5847690|NCT02228096|20215374|P1|Overall Study|Lack of Efficacy|18
5847691|NCT02228096|20215374|P1|Overall Study|Study terminated by Sponsor|24
5847692|NCT02227875|20215476|P2|Overall Study|Lost to Follow-up|10
5847693|NCT02227875|20215477|P1|Overall Study|Lost to Follow-up|10
5847694|NCT02227875|20215476|P2|Overall Study|Withdrawal by Subject|13
5847695|NCT02227875|20215477|P1|Overall Study|Withdrawal by Subject|12
5847696|NCT02227875|20215476|P2|Overall Study|Adverse Event|0
5847697|NCT02227875|20215477|P1|Overall Study|Adverse Event|3
5847698|NCT02227875|20215476|P2|Overall Study|Physician Decision|0
5847699|NCT02227875|20215477|P1|Overall Study|Physician Decision|1
5847700|NCT02227875|20215476|P2|Overall Study|Other|3
5847701|NCT02227875|20215477|P1|Overall Study|Other|1
5847702|NCT02227875|20215476|P2|Overall Study|Protocol Violation|7
5847703|NCT02227875|20215477|P1|Overall Study|Protocol Violation|10
5847704|NCT02227862|20215497|P2|Overall Study|Lost to Follow-up|2
5847705|NCT02227862|20215498|P1|Overall Study|Lost to Follow-up|1
5847706|NCT02227862|20215497|P2|Overall Study|Withdrawal by Subject|6
5847707|NCT02227862|20215498|P1|Overall Study|Withdrawal by Subject|7
5847708|NCT02227862|20215497|P2|Overall Study|Adverse Event|3
5847709|NCT02227862|20215498|P1|Overall Study|Adverse Event|4
5847710|NCT02227862|20215497|P2|Overall Study|Other|2
5847711|NCT02227862|20215498|P1|Overall Study|Other|0
5847712|NCT02227862|20215497|P2|Overall Study|Protocol Violation|9
5847713|NCT02227862|20215498|P1|Overall Study|Protocol Violation|7
5847714|NCT02227849|20215528|P1|Overall Study|Withdrawal by Subject|3
5847715|NCT02227849|20215528|P1|Overall Study|Physician Decision|1
5847716|NCT02227849|20215528|P1|Overall Study|Adverse Event|4
5847717|NCT02227784|20215559|P5|Open-Label Extension Phase (OLE)|Withdrawal by Subject|3
5847718|NCT02227784|20215560|P4|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0
5847719|NCT02227784|20215561|P3|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0
5847720|NCT02227784|20215562|P2|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0
5847721|NCT02227784|20215563|P1|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0
5847722|NCT02227784|20215559|P5|Open-Label Extension Phase (OLE)|Sponsor Decision|243
5847723|NCT02227784|20215560|P4|Open-Label Extension Phase (OLE)|Sponsor Decision|0
5847724|NCT02227784|20215561|P3|Open-Label Extension Phase (OLE)|Sponsor Decision|0
5847725|NCT02227784|20215562|P2|Open-Label Extension Phase (OLE)|Sponsor Decision|0
5847726|NCT02227784|20215563|P1|Open-Label Extension Phase (OLE)|Sponsor Decision|0
5847727|NCT02227784|20215559|P5|Open-Label Extension Phase (OLE)|Death|1
5847728|NCT02227784|20215560|P4|Open-Label Extension Phase (OLE)|Death|0
5847729|NCT02227784|20215561|P3|Open-Label Extension Phase (OLE)|Death|0
5847730|NCT02227784|20215562|P2|Open-Label Extension Phase (OLE)|Death|0
5847731|NCT02227784|20215563|P1|Open-Label Extension Phase (OLE)|Death|0
5847732|NCT02227784|20215559|P5|Open-Label Extension Phase (OLE)|Adverse Event|1
5847733|NCT02227784|20215560|P4|Open-Label Extension Phase (OLE)|Adverse Event|0
5847734|NCT02227784|20215561|P3|Open-Label Extension Phase (OLE)|Adverse Event|0
5847735|NCT02227784|20215562|P2|Open-Label Extension Phase (OLE)|Adverse Event|0
5847736|NCT02227784|20215563|P1|Open-Label Extension Phase (OLE)|Adverse Event|0
5847737|NCT02227784|20215559|P5|Double-Blind Phase|Withdrawal by Subject|0
5847738|NCT02227784|20215560|P4|Double-Blind Phase|Withdrawal by Subject|2
5847739|NCT02227784|20215561|P3|Double-Blind Phase|Withdrawal by Subject|5
5847740|NCT02227784|20215562|P2|Double-Blind Phase|Withdrawal by Subject|1
5847741|NCT02227784|20215563|P1|Double-Blind Phase|Withdrawal by Subject|2
5847742|NCT02227784|20215559|P5|Double-Blind Phase|Sponsor Decision|0
5847743|NCT02227784|20215560|P4|Double-Blind Phase|Sponsor Decision|32
5847744|NCT02227784|20215561|P3|Double-Blind Phase|Sponsor Decision|14
5847745|NCT02227784|20215562|P2|Double-Blind Phase|Sponsor Decision|15
5847746|NCT02227784|20215563|P1|Double-Blind Phase|Sponsor Decision|34
5847747|NCT02227784|20215559|P5|Double-Blind Phase|Protocol Violation|0
5847748|NCT02227784|20215560|P4|Double-Blind Phase|Protocol Violation|1
5847749|NCT02227784|20215561|P3|Double-Blind Phase|Protocol Violation|1
5847750|NCT02227784|20215562|P2|Double-Blind Phase|Protocol Violation|0
5847751|NCT02227784|20215563|P1|Double-Blind Phase|Protocol Violation|0
5847752|NCT02227784|20215559|P5|Double-Blind Phase|Physician Decision|0
5847753|NCT02227784|20215560|P4|Double-Blind Phase|Physician Decision|1
5847754|NCT02227784|20215561|P3|Double-Blind Phase|Physician Decision|0
5847755|NCT02227784|20215562|P2|Double-Blind Phase|Physician Decision|0
5847756|NCT02227784|20215563|P1|Double-Blind Phase|Physician Decision|1
5847757|NCT02227784|20215559|P5|Double-Blind Phase|Adverse Event|0
5847758|NCT02227784|20215560|P4|Double-Blind Phase|Adverse Event|3
5847759|NCT02227784|20215561|P3|Double-Blind Phase|Adverse Event|1
5847760|NCT02227784|20215562|P2|Double-Blind Phase|Adverse Event|2
5847761|NCT02227784|20215563|P1|Double-Blind Phase|Adverse Event|3
5847762|NCT02227368|20215737|P2|Overall Study|Adverse Event|0
5847763|NCT02227368|20215738|P1|Overall Study|Adverse Event|1
5847764|NCT02227368|20215737|P2|Overall Study|Lost to Follow-up|0
5847765|NCT02227368|20215738|P1|Overall Study|Lost to Follow-up|1
5847766|NCT02227368|20215737|P2|Overall Study|No EVR/not PAD/PI decision/RLE bypass|4
5847767|NCT02227368|20215738|P1|Overall Study|No EVR/not PAD/PI decision/RLE bypass|0
5847782|NCT02227147|20215861|P2|Follow-up Period|Other|5
5847783|NCT02227147|20215862|P1|Follow-up Period|Other|3
5847784|NCT02227147|20215861|P2|Controlled Treatment Period|Other|0
5847785|NCT02227147|20215862|P1|Controlled Treatment Period|Other|2
5847786|NCT02227147|20215861|P2|Controlled Treatment Period|Adverse Event|3
5847787|NCT02227147|20215862|P1|Controlled Treatment Period|Adverse Event|4
5847788|NCT02227108|20215889|P1|Overall Study|Adverse Event|6
5847789|NCT02227108|20215889|P1|Overall Study|Investigator discretion|1
5847790|NCT02227108|20215889|P1|Overall Study|Initiation of alternative therapy|2
5847791|NCT02227108|20215889|P1|Overall Study|Progressive disease|17
5847792|NCT02227108|20215889|P1|Overall Study|Other|3
5847793|NCT02227108|20215889|P1|Overall Study|Did not receive treatment|2
5847794|NCT02226653|20215928|P2|Treatment Period 5 Fed State|Adverse Event|1
5847795|NCT02226653|20215929|P1|Treatment Period 5 Fed State|Adverse Event|0
5847796|NCT02226653|20215928|P2|Treatment Period 2 Fasted State|Lost to Follow-up|0
5847797|NCT02226653|20215929|P1|Treatment Period 2 Fasted State|Lost to Follow-up|1
5847798|NCT02226562|20215953|P2|Overall Study|Lost to Follow-up|1
5847799|NCT02226562|20215954|P1|Overall Study|Lost to Follow-up|0
5847800|NCT02226549|20215972|P2|Overall Study|Lost to Follow-up|1
5847801|NCT02226549|20215973|P1|Overall Study|Lost to Follow-up|0
5847802|NCT02226549|20215972|P2|Overall Study|Randomized but Never Treated|0
5847803|NCT02226549|20215973|P1|Overall Study|Randomized but Never Treated|1
5847804|NCT02226198|20215983|P3|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0
5847805|NCT02226198|20215984|P2|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|1
5847806|NCT02226198|20215985|P1|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0
5847807|NCT02226198|20215983|P3|Lead-in Phase|Protocol Violation|0
5847808|NCT02226198|20215984|P2|Lead-in Phase|Protocol Violation|0
5847809|NCT02226198|20215985|P1|Lead-in Phase|Protocol Violation|1
5847810|NCT02226172|20216058|P1|Overall Study|Adverse Event|6
5847811|NCT02226172|20216058|P1|Overall Study|Study terminated by sponsor|1
5847812|NCT02226172|20216058|P1|Overall Study|Death|1
5847813|NCT02226172|20216058|P1|Overall Study|Other|5
5847814|NCT02226172|20216058|P1|Overall Study|Participant refused further follow-up|4
5847815|NCT02226120|20216122|P1|Overall Study|missing treatment disposition pages|2
5847816|NCT02226120|20216122|P1|Overall Study|Protocol deviation|1
5847817|NCT02226120|20216122|P1|Overall Study|Non-compliance with study drug|10
5847818|NCT02226120|20216122|P1|Overall Study|Withdrawal by parent/guardian|36
5847819|NCT02226120|20216122|P1|Overall Study|Physician Decision|21
5847820|NCT02226120|20216122|P1|Overall Study|Lost to Follow-up|13
5847821|NCT02226120|20216122|P1|Overall Study|Technical problems|4
5847822|NCT02226120|20216122|P1|Overall Study|Study terminated by sponsor|1
5847823|NCT02226120|20216122|P1|Overall Study|Death|172
5847824|NCT02226120|20216122|P1|Overall Study|Adverse Event|60
5847825|NCT02226003|20216129|P3|Overall Study|Withdrawal by Subject|3
5847826|NCT02226003|20216130|P2|Overall Study|Withdrawal by Subject|0
5847827|NCT02226003|20216131|P1|Overall Study|Withdrawal by Subject|0
5847828|NCT02226003|20216129|P3|Overall Study|Lost to Follow-up|3
5847829|NCT02226003|20216130|P2|Overall Study|Lost to Follow-up|1
5847830|NCT02226003|20216131|P1|Overall Study|Lost to Follow-up|2
5847831|NCT02225743|20216187|P1|Overall Study|Withdrawal by Subject|18
5847832|NCT02225587|20216193|P2|Overall Study|Withdrawal by Subject|28
5847833|NCT02225587|20216194|P1|Overall Study|Withdrawal by Subject|13
5847834|NCT02225587|20216193|P2|Overall Study|Participant Moved|0
5847835|NCT02225587|20216194|P1|Overall Study|Participant Moved|1
5847836|NCT02225587|20216193|P2|Overall Study|Protocol Violation|0
5847837|NCT02225587|20216194|P1|Overall Study|Protocol Violation|1
5847838|NCT02225587|20216193|P2|Overall Study|Physician Decision|0
5847839|NCT02225587|20216194|P1|Overall Study|Physician Decision|2
5847840|NCT02225587|20216193|P2|Overall Study|Non-Compliance With Study Drug|0
5847841|NCT02225587|20216194|P1|Overall Study|Non-Compliance With Study Drug|1
5847842|NCT02225587|20216193|P2|Overall Study|Lost to Follow-up|5
5847843|NCT02225587|20216194|P1|Overall Study|Lost to Follow-up|5
5847844|NCT02225587|20216193|P2|Overall Study|Adverse Event|5
5847845|NCT02225587|20216194|P1|Overall Study|Adverse Event|5
5847846|NCT02225353|20216223|P3|Overall Study|Protocol Violation|12
5847847|NCT02225353|20216224|P2|Overall Study|Protocol Violation|5
5847848|NCT02225353|20216225|P1|Overall Study|Protocol Violation|4
5847849|NCT02225353|20216223|P3|Overall Study|Lost to Follow-up|3
5847850|NCT02225353|20216224|P2|Overall Study|Lost to Follow-up|1
5847851|NCT02225353|20216225|P1|Overall Study|Lost to Follow-up|0
5847852|NCT02224846|20216266|P2|Period 2 (Month 12 to Month 24)|Sponsor Decision|1
5847853|NCT02224846|20216267|P1|Period 2 (Month 12 to Month 24)|Sponsor Decision|2
5847854|NCT02224846|20216266|P2|Period 2 (Month 12 to Month 24)|Physician Decision|2
5847855|NCT02224846|20216267|P1|Period 2 (Month 12 to Month 24)|Physician Decision|0
5847856|NCT02224846|20216266|P2|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|43
5847857|NCT02224846|20216267|P1|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|25
5847858|NCT02224846|20216266|P2|Period 2 (Month 12 to Month 24)|Protocol Violation|11
5847859|NCT02224846|20216267|P1|Period 2 (Month 12 to Month 24)|Protocol Violation|4
5847860|NCT02224846|20216266|P2|Period 2 (Month 12 to Month 24)|Lost to Follow-up|13
5847861|NCT02224846|20216267|P1|Period 2 (Month 12 to Month 24)|Lost to Follow-up|7
5847862|NCT02224846|20216266|P2|Period 2 (Month 12 to Month 24)|Death|0
5847863|NCT02224846|20216267|P1|Period 2 (Month 12 to Month 24)|Death|1
5847864|NCT02224846|20216266|P2|Period 2 (Month 12 to Month 24)|Adverse Event|4
5847865|NCT02224846|20216267|P1|Period 2 (Month 12 to Month 24)|Adverse Event|3
5847866|NCT02224846|20216266|P2|Period 2 (Month 3 to Month 12)|Physician Decision|2
5847867|NCT02224846|20216267|P1|Period 2 (Month 3 to Month 12)|Physician Decision|0
5847868|NCT02224846|20216266|P2|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|19
5847869|NCT02224846|20216267|P1|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|15
5847870|NCT02224846|20216266|P2|Period 2 (Month 3 to Month 12)|Protocol Violation|3
5847871|NCT02224846|20216267|P1|Period 2 (Month 3 to Month 12)|Protocol Violation|0
5847872|NCT02224846|20216266|P2|Period 2 (Month 3 to Month 12)|Lost to Follow-up|5
5847873|NCT02224846|20216267|P1|Period 2 (Month 3 to Month 12)|Lost to Follow-up|3
5847874|NCT02224846|20216266|P2|Period 2 (Month 3 to Month 12)|Adverse Event|2
5847875|NCT02224846|20216267|P1|Period 2 (Month 3 to Month 12)|Adverse Event|1
5847876|NCT02224846|20216266|P2|Period 1 (Month 3)|Sponsor Decision|1
5847877|NCT02224846|20216267|P1|Period 1 (Month 3)|Sponsor Decision|2
5847878|NCT02224846|20216266|P2|Period 1 (Month 3)|Withdrawal by Subject|18
5847879|NCT02224846|20216267|P1|Period 1 (Month 3)|Withdrawal by Subject|8
5847880|NCT02224846|20216266|P2|Period 1 (Month 3)|Protocol Violation|8
5847881|NCT02224846|20216267|P1|Period 1 (Month 3)|Protocol Violation|4
5847882|NCT02224846|20216266|P2|Period 1 (Month 3)|Lost to Follow-up|8
5847883|NCT02224846|20216267|P1|Period 1 (Month 3)|Lost to Follow-up|3
5847884|NCT02224846|20216266|P2|Period 1 (Month 3)|Adverse Event|1
5847885|NCT02224846|20216267|P1|Period 1 (Month 3)|Adverse Event|2
5847886|NCT02224755|20216297|P2|Two Year Follow up Post-implant|Withdrawn post-implant|6
5847887|NCT02224755|20216298|P1|Two Year Follow up Post-implant|Withdrawn post-implant|15
5847888|NCT02224755|20216297|P2|Two Year Follow up Post-implant|Device explant or permanent deactivation|3
5847889|NCT02224755|20216298|P1|Two Year Follow up Post-implant|Device explant or permanent deactivation|3
5847890|NCT02224755|20216297|P2|Two Year Follow up Post-implant|Heart transplant|119
5847891|NCT02224755|20216298|P1|Two Year Follow up Post-implant|Heart transplant|137
5847892|NCT02224755|20216297|P2|Two Year Follow up Post-implant|Death|98
5847893|NCT02224755|20216298|P1|Two Year Follow up Post-implant|Death|103
5847894|NCT02224755|20216297|P2|Randomization to Device Implant|Withdrawn prior to implant|1
5847895|NCT02224755|20216298|P1|Randomization to Device Implant|Withdrawn prior to implant|7
5847896|NCT02224703|20216333|P3|Overall Study|Lack of Efficacy|0
5847897|NCT02224703|20216334|P2|Overall Study|Lack of Efficacy|0
5847898|NCT02224703|20216335|P1|Overall Study|Lack of Efficacy|1
5847899|NCT02224703|20216333|P3|Overall Study|Withdrawn by parent/guardian|0
5847900|NCT02224703|20216334|P2|Overall Study|Withdrawn by parent/guardian|1
5847901|NCT02224703|20216335|P1|Overall Study|Withdrawn by parent/guardian|0
5847902|NCT02224703|20216333|P3|Overall Study|Advised by medical monitor|0
5847903|NCT02224703|20216334|P2|Overall Study|Advised by medical monitor|0
5847904|NCT02224703|20216335|P1|Overall Study|Advised by medical monitor|1
5847905|NCT02224703|20216333|P3|Overall Study|Withdrawn by investigator|0
5847906|NCT02224703|20216334|P2|Overall Study|Withdrawn by investigator|0
5847907|NCT02224703|20216335|P1|Overall Study|Withdrawn by investigator|1
5847908|NCT02224703|20216333|P3|Overall Study|Adverse Event|0
5847909|NCT02224703|20216334|P2|Overall Study|Adverse Event|5
5847910|NCT02224703|20216335|P1|Overall Study|Adverse Event|0
5847911|NCT02224690|20216354|P2|Overall Study|Did not meet eligibility criteria|0
5847912|NCT02224690|20216355|P1|Overall Study|Did not meet eligibility criteria|1
5847913|NCT02224690|20216354|P2|Overall Study|Use of G-tube|0
5847914|NCT02224690|20216355|P1|Overall Study|Use of G-tube|1
5847915|NCT02224690|20216354|P2|Overall Study|Met Withdrawal Criteria|0
5847916|NCT02224690|20216355|P1|Overall Study|Met Withdrawal Criteria|4
5847917|NCT02224690|20216354|P2|Overall Study|Adverse Event|1
5847918|NCT02224690|20216355|P1|Overall Study|Adverse Event|8
5847919|NCT02224664|20216367|P5|Dose Escalation Period (21 Days)|Withdrawal by Subject|4
5847920|NCT02224664|20216368|P4|Dose Escalation Period (21 Days)|Withdrawal by Subject|1
5847921|NCT02224664|20216369|P3|Dose Escalation Period (21 Days)|Withdrawal by Subject|0
5847922|NCT02224664|20216370|P2|Dose Escalation Period (21 Days)|Withdrawal by Subject|0
5847923|NCT02224664|20216371|P1|Dose Escalation Period (21 Days)|Withdrawal by Subject|0
5847924|NCT02224664|20216367|P5|Dose Escalation Period (21 Days)|Adverse Event|7
5847925|NCT02224664|20216368|P4|Dose Escalation Period (21 Days)|Adverse Event|2
5847926|NCT02224664|20216369|P3|Dose Escalation Period (21 Days)|Adverse Event|2
5847927|NCT02224664|20216370|P2|Dose Escalation Period (21 Days)|Adverse Event|0
5847928|NCT02224664|20216371|P1|Dose Escalation Period (21 Days)|Adverse Event|0
5847929|NCT02224664|20216367|P5|Lead-in Period (3 Days)|Does not meet entrance criteria|0
5847930|NCT02224664|20216368|P4|Lead-in Period (3 Days)|Does not meet entrance criteria|0
5847931|NCT02224664|20216369|P3|Lead-in Period (3 Days)|Does not meet entrance criteria|0
5847932|NCT02224664|20216370|P2|Lead-in Period (3 Days)|Does not meet entrance criteria|0
5847933|NCT02224664|20216371|P1|Lead-in Period (3 Days)|Does not meet entrance criteria|5
5847934|NCT02224638|20216453|P2|Overall Study|Adverse Event|1
5847935|NCT02224638|20216454|P1|Overall Study|Adverse Event|1
5847936|NCT02224625|20216462|P1|Sensitization|Adverse Event|55
5847937|NCT02224625|20216462|P1|Irritation|Adverse Event|6
5847938|NCT02224599|20216483|P1|Overall Study|Progression of Disease|1
5847939|NCT02224599|20216483|P1|Overall Study|Physician Decision|1
5847940|NCT02224560|20216492|P3|Overall Study|Withdrawn by Investigator|0
5847941|NCT02224560|20216493|P2|Overall Study|Withdrawn by Investigator|1
5847942|NCT02224560|20216494|P1|Overall Study|Withdrawn by Investigator|1
5847943|NCT02224560|20216492|P3|Overall Study|Adverse Event|1
5847944|NCT02224560|20216493|P2|Overall Study|Adverse Event|1
5847945|NCT02224560|20216494|P1|Overall Study|Adverse Event|4
5847946|NCT02224560|20216492|P3|Overall Study|Met Withdrawal Criteria|0
5847947|NCT02224560|20216493|P2|Overall Study|Met Withdrawal Criteria|0
5847948|NCT02224560|20216494|P1|Overall Study|Met Withdrawal Criteria|1
5847949|NCT02224560|20216492|P3|Overall Study|Withdrawal by Subject|1
5847950|NCT02224560|20216493|P2|Overall Study|Withdrawal by Subject|0
5847951|NCT02224560|20216494|P1|Overall Study|Withdrawal by Subject|2
5847952|NCT02224560|20216492|P3|Overall Study|Protocol Deviation|0
5847953|NCT02224560|20216493|P2|Overall Study|Protocol Deviation|0
5847954|NCT02224560|20216494|P1|Overall Study|Protocol Deviation|1
5847955|NCT02224274|20216542|P2|Overall Study|Death|0
5847956|NCT02224274|20216543|P1|Overall Study|Death|1
5847957|NCT02224157|20216555|P2|Overall Study|Adverse Event|3
5847958|NCT02224157|20216556|P1|Overall Study|Adverse Event|1
5847959|NCT02224157|20216555|P2|Overall Study|Death|1
5847960|NCT02224157|20216556|P1|Overall Study|Death|1
5847961|NCT02224157|20216555|P2|Overall Study|Lost to Follow-up|35
5847962|NCT02224157|20216556|P1|Overall Study|Lost to Follow-up|27
5847963|NCT02224157|20216555|P2|Overall Study|Eligibility criteria not fulfilled|8
5847964|NCT02224157|20216556|P1|Overall Study|Eligibility criteria not fulfilled|4
5847965|NCT02224157|20216555|P2|Overall Study|Prematurely closed site|2
5847966|NCT02224157|20216556|P1|Overall Study|Prematurely closed site|4
5847967|NCT02224157|20216555|P2|Overall Study|Subject decision|50
5847968|NCT02224157|20216556|P1|Overall Study|Subject decision|58
5847969|NCT02224157|20216555|P2|Overall Study|Other|10
5847970|NCT02224157|20216556|P1|Overall Study|Other|13
5847971|NCT02224157|20216555|P2|Overall Study|Severe non-compliance to protocol|2
5847972|NCT02224157|20216556|P1|Overall Study|Severe non-compliance to protocol|2
5847973|NCT02224053|20216580|P1|AZD9291 and Omeprazole Co-administration|Protocol non-compliance|2
5847974|NCT02224053|20216580|P1|AZD9291 and Omeprazole Co-administration|Withdrawal by Subject|1
5847975|NCT02224053|20216580|P1|AZD9291 and Omeprazole Co-administration|Adverse Event|3
5847976|NCT02224053|20216580|P1|AZD9291 and Omeprazole Co-administration|Protocol Violation|4
5847977|NCT02224053|20216580|P1|AZD9291 and Omeprazole Co-administration|Exceeding PK limits after Period 1|11
5847978|NCT02223858|20216626|P2|Overall Study|Refused|9
5847979|NCT02223858|20216627|P1|Overall Study|Refused|9
5847980|NCT02223858|20216626|P2|Overall Study|Withdrawal by Subject|5
5847981|NCT02223858|20216627|P1|Overall Study|Withdrawal by Subject|8
5847982|NCT02223858|20216626|P2|Overall Study|Lost to Follow-up|11
5847983|NCT02223858|20216627|P1|Overall Study|Lost to Follow-up|6
5847984|NCT02223858|20216626|P2|Overall Study|Death|1
5847985|NCT02223858|20216627|P1|Overall Study|Death|1
5847986|NCT02223793|20216640|P3|Overall Study|Moved/studycenter unable to participate|8
5847987|NCT02223793|20216641|P2|Overall Study|Moved/studycenter unable to participate|6
5847988|NCT02223793|20216642|P1|Overall Study|Moved/studycenter unable to participate|4
5847989|NCT02223793|20216640|P3|Overall Study|Withdrawal by Subject|3
5847990|NCT02223793|20216641|P2|Overall Study|Withdrawal by Subject|2
5847991|NCT02223793|20216642|P1|Overall Study|Withdrawal by Subject|3
5847992|NCT02223793|20216640|P3|Overall Study|Lost to Follow-up|2
5847993|NCT02223793|20216641|P2|Overall Study|Lost to Follow-up|1
5847994|NCT02223793|20216642|P1|Overall Study|Lost to Follow-up|10
5847995|NCT02223754|20216655|P2|Period 2|Test Article No Longer Available|1
5847996|NCT02223754|20216656|P1|Period 2|Test Article No Longer Available|0
5847997|NCT02223754|20216655|P2|Period 2|Lost to Follow-up|0
5847998|NCT02223754|20216656|P1|Period 2|Lost to Follow-up|1
5847999|NCT02223754|20216655|P2|Period 2|Lens Discomfort|1
5848000|NCT02223754|20216656|P1|Period 2|Lens Discomfort|1
5848001|NCT02223754|20216655|P2|Period 2|Protocol Violation|0
5848002|NCT02223754|20216656|P1|Period 2|Protocol Violation|1
5848003|NCT02223754|20216655|P2|Period 2|Adverse Event|1
5848004|NCT02223754|20216656|P1|Period 2|Adverse Event|0
5848005|NCT02223754|20216655|P2|Period 1|Unsatisfactory Visual Response|1
5848006|NCT02223754|20216656|P1|Period 1|Unsatisfactory Visual Response|0
5848007|NCT02223754|20216655|P2|Period 1|Test Article No Longer Available|5
5848008|NCT02223754|20216656|P1|Period 1|Test Article No Longer Available|1
5848009|NCT02223754|20216655|P2|Period 1|Withdrawal by Subject|4
5848010|NCT02223754|20216656|P1|Period 1|Withdrawal by Subject|0
5848011|NCT02223754|20216655|P2|Period 1|Protocol Violation|4
5848012|NCT02223754|20216656|P1|Period 1|Protocol Violation|2
5848013|NCT02223754|20216655|P2|Period 1|Lost to Follow-up|1
5848014|NCT02223754|20216656|P1|Period 1|Lost to Follow-up|0
5848015|NCT02223754|20216655|P2|Period 1|Adverse Event|0
5848016|NCT02223754|20216656|P1|Period 1|Adverse Event|1
5848017|NCT02223715|20216676|P1|Overall Study|Lost to Follow-up|73
5848018|NCT02223715|20216676|P1|Overall Study|Death|31
5848019|NCT02223390|20216819|P2|Overall Study|Lost to Follow-up|4
5848020|NCT02223390|20216820|P1|Overall Study|Lost to Follow-up|9
5848021|NCT02223364|20216831|P3|Overall Study|Physician Decision|0
5848022|NCT02223364|20216832|P2|Overall Study|Physician Decision|0
5848023|NCT02223364|20216833|P1|Overall Study|Physician Decision|1
5848024|NCT02223364|20216831|P3|Overall Study|subject expired before surgery|0
5848025|NCT02223364|20216832|P2|Overall Study|subject expired before surgery|0
5848026|NCT02223364|20216833|P1|Overall Study|subject expired before surgery|1
5848027|NCT02223364|20216831|P3|Overall Study|Protocol Violation|3
5848028|NCT02223364|20216832|P2|Overall Study|Protocol Violation|0
5848029|NCT02223364|20216833|P1|Overall Study|Protocol Violation|3
5848030|NCT02222922|20216999|P9|Overall Study|Participant refused further follow-up|3
5848031|NCT02222922|20217000|P8|Overall Study|Participant refused further follow-up|0
5848032|NCT02222922|20217001|P7|Overall Study|Participant refused further follow-up|0
5848033|NCT02222922|20217002|P6|Overall Study|Participant refused further follow-up|0
5848034|NCT02222922|20217003|P5|Overall Study|Participant refused further follow-up|6
5848035|NCT02222922|20217004|P4|Overall Study|Participant refused further follow-up|1
5848036|NCT02222922|20217005|P3|Overall Study|Participant refused further follow-up|0
5848037|NCT02222922|20217006|P2|Overall Study|Participant refused further follow-up|0
5848038|NCT02222922|20217007|P1|Overall Study|Participant refused further follow-up|1
5848039|NCT02222922|20216999|P9|Overall Study|Other|1
5848040|NCT02222922|20217000|P8|Overall Study|Other|4
5848041|NCT02222922|20217001|P7|Overall Study|Other|2
5848042|NCT02222922|20217002|P6|Overall Study|Other|2
5848043|NCT02222922|20217003|P5|Overall Study|Other|10
5848044|NCT02222922|20217004|P4|Overall Study|Other|2
5848045|NCT02222922|20217005|P3|Overall Study|Other|0
5848046|NCT02222922|20217006|P2|Overall Study|Other|0
5848047|NCT02222922|20217007|P1|Overall Study|Other|0
5848048|NCT02222922|20216999|P9|Overall Study|Lost to Follow-up|0
5848049|NCT02222922|20217000|P8|Overall Study|Lost to Follow-up|0
5848050|NCT02222922|20217001|P7|Overall Study|Lost to Follow-up|0
5848051|NCT02222922|20217002|P6|Overall Study|Lost to Follow-up|1
5848052|NCT02222922|20217003|P5|Overall Study|Lost to Follow-up|9
5848053|NCT02222922|20217004|P4|Overall Study|Lost to Follow-up|0
5848054|NCT02222922|20217005|P3|Overall Study|Lost to Follow-up|1
5848055|NCT02222922|20217006|P2|Overall Study|Lost to Follow-up|0
5848056|NCT02222922|20217007|P1|Overall Study|Lost to Follow-up|0
5848057|NCT02222922|20216999|P9|Overall Study|Death|2
5848058|NCT02222922|20217000|P8|Overall Study|Death|0
5848059|NCT02222922|20217001|P7|Overall Study|Death|0
5848060|NCT02222922|20217002|P6|Overall Study|Death|0
5848061|NCT02222922|20217003|P5|Overall Study|Death|13
5848062|NCT02222922|20217004|P4|Overall Study|Death|0
5848063|NCT02222922|20217005|P3|Overall Study|Death|0
5848064|NCT02222922|20217006|P2|Overall Study|Death|0
5848065|NCT02222922|20217007|P1|Overall Study|Death|0
5848066|NCT02222818|20217374|P2|Period 1|Eligibility criteria not met|3
5848067|NCT02222818|20217375|P1|Period 1|Eligibility criteria not met|0
5848068|NCT02222714|20217387|P5|Overall Study|Withdrawal by Subject|1
5848069|NCT02222714|20217388|P4|Overall Study|Withdrawal by Subject|0
5848070|NCT02222714|20217389|P3|Overall Study|Withdrawal by Subject|1
5848071|NCT02222714|20217390|P2|Overall Study|Withdrawal by Subject|0
5848072|NCT02222714|20217391|P1|Overall Study|Withdrawal by Subject|0
5848073|NCT02222714|20217387|P5|Overall Study|Death|6
5848074|NCT02222714|20217388|P4|Overall Study|Death|4
5848075|NCT02222714|20217389|P3|Overall Study|Death|3
5848076|NCT02222714|20217390|P2|Overall Study|Death|2
5848077|NCT02222714|20217391|P1|Overall Study|Death|0
5848078|NCT02222688|20217437|P7|Overall Study|Disease progression|0
5848079|NCT02222688|20217438|P6|Overall Study|Disease progression|0
5848080|NCT02222688|20217439|P5|Overall Study|Disease progression|0
5848081|NCT02222688|20217440|P4|Overall Study|Disease progression|0
5848082|NCT02222688|20217441|P3|Overall Study|Disease progression|0
5848083|NCT02222688|20217442|P2|Overall Study|Disease progression|0
5848084|NCT02222688|20217443|P1|Overall Study|Disease progression|1
5848085|NCT02222688|20217437|P7|Overall Study|Withdrawal by Subject|1
5848086|NCT02222688|20217438|P6|Overall Study|Withdrawal by Subject|0
5848087|NCT02222688|20217439|P5|Overall Study|Withdrawal by Subject|1
5848088|NCT02222688|20217440|P4|Overall Study|Withdrawal by Subject|2
5848089|NCT02222688|20217441|P3|Overall Study|Withdrawal by Subject|0
5848090|NCT02222688|20217442|P2|Overall Study|Withdrawal by Subject|0
5848091|NCT02222688|20217443|P1|Overall Study|Withdrawal by Subject|0
5848092|NCT02222558|20217481|P6|Period 3|Withdrawal by Subject|1
5848093|NCT02222558|20217482|P5|Period 3|Withdrawal by Subject|0
5848094|NCT02222558|20217483|P4|Period 3|Withdrawal by Subject|0
5848095|NCT02222558|20217484|P3|Period 3|Withdrawal by Subject|0
5848096|NCT02222558|20217485|P2|Period 3|Withdrawal by Subject|0
5848097|NCT02222558|20217486|P1|Period 3|Withdrawal by Subject|0
5848098|NCT02222558|20217481|P6|Period 1: Single Dose|Withdrawal by Subject|0
5848099|NCT02222558|20217482|P5|Period 1: Single Dose|Withdrawal by Subject|0
5848100|NCT02222558|20217483|P4|Period 1: Single Dose|Withdrawal by Subject|0
5848101|NCT02222558|20217484|P3|Period 1: Single Dose|Withdrawal by Subject|0
5848102|NCT02222558|20217485|P2|Period 1: Single Dose|Withdrawal by Subject|0
5848103|NCT02222558|20217486|P1|Period 1: Single Dose|Withdrawal by Subject|4
5848104|NCT02222493|20217502|P2|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|0
5848105|NCT02222493|20217503|P1|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|9
5848106|NCT02222493|20217502|P2|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|0
5848107|NCT02222493|20217503|P1|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|1
5848108|NCT02222493|20217502|P2|Period 3: Week 54 Dosing-Week 78 Visit|Other|0
5848109|NCT02222493|20217503|P1|Period 3: Week 54 Dosing-Week 78 Visit|Other|4
5848110|NCT02222493|20217502|P2|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|0
5848111|NCT02222493|20217503|P1|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|14
5848112|NCT02222493|20217502|P2|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|0
5848113|NCT02222493|20217503|P1|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|3
5848114|NCT02222493|20217502|P2|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|3
5848195|NCT02220907|20218037|P1|Overall Study|Withdrawal by Subject|2
5848115|NCT02222493|20217503|P1|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|9
5848116|NCT02222493|20217502|P2|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1
5848117|NCT02222493|20217503|P1|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1
5848118|NCT02222493|20217502|P2|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|4
5848119|NCT02222493|20217503|P1|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|6
5848120|NCT02222493|20217502|P2|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|0
5848121|NCT02222493|20217503|P1|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|1
5848122|NCT02222493|20217502|P2|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|0
5848123|NCT02222493|20217503|P1|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|3
5848124|NCT02222493|20217502|P2|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|9
5848125|NCT02222493|20217503|P1|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|22
5848126|NCT02222493|20217502|P2|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|0
5848127|NCT02222493|20217503|P1|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|1
5848128|NCT02222493|20217502|P2|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|0
5848129|NCT02222493|20217503|P1|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|1
5848130|NCT02222493|20217502|P2|Period 1: First Dose-Week 30 (Pre-dose)|Other|0
5848131|NCT02222493|20217503|P1|Period 1: First Dose-Week 30 (Pre-dose)|Other|4
5848132|NCT02222493|20217502|P2|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|20
5848133|NCT02222493|20217503|P1|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|18
5848134|NCT02222493|20217502|P2|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|0
5848135|NCT02222493|20217503|P1|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|2
5848136|NCT02222493|20217502|P2|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|0
5848137|NCT02222493|20217503|P1|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|1
5848138|NCT02222493|20217502|P2|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|7
5848139|NCT02222493|20217503|P1|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|0
5848140|NCT02222493|20217502|P2|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|1
5848141|NCT02222493|20217503|P1|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|5
5848142|NCT02222493|20217502|P2|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|9
5848143|NCT02222493|20217503|P1|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|11
5848144|NCT02222493|20217502|P2|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|1
5848145|NCT02222493|20217503|P1|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|0
5848146|NCT02222493|20217502|P2|Period 1: First Dose-Week 30 (Pre-dose)|Death|2
5848147|NCT02222493|20217503|P1|Period 1: First Dose-Week 30 (Pre-dose)|Death|2
5848148|NCT02222246|20217654|P2|Overall Study|Physician Decision|1
5848149|NCT02222246|20217655|P1|Overall Study|Physician Decision|0
5848150|NCT02222246|20217654|P2|Overall Study|No Emergency Department Visits|26
5848151|NCT02222246|20217655|P1|Overall Study|No Emergency Department Visits|27
5848152|NCT02222207|20217683|P1|Overall Study|Adverse Event|1
5848153|NCT02222207|20217683|P1|Overall Study|Other reasons|2
5848154|NCT02222207|20217683|P1|Overall Study|Death|1
5848155|NCT02221882|20217730|P6|Overall Study|Death|0
5848156|NCT02221882|20217731|P5|Overall Study|Death|0
5848157|NCT02221882|20217732|P4|Overall Study|Death|0
5848158|NCT02221882|20217733|P3|Overall Study|Death|0
5848159|NCT02221882|20217734|P2|Overall Study|Death|1
5848160|NCT02221882|20217735|P1|Overall Study|Death|0
5848161|NCT02221882|20217730|P6|Overall Study|Withdrawal by Subject|2
5848162|NCT02221882|20217731|P5|Overall Study|Withdrawal by Subject|2
5848163|NCT02221882|20217732|P4|Overall Study|Withdrawal by Subject|2
5848164|NCT02221882|20217733|P3|Overall Study|Withdrawal by Subject|4
5848165|NCT02221882|20217734|P2|Overall Study|Withdrawal by Subject|0
5848166|NCT02221882|20217735|P1|Overall Study|Withdrawal by Subject|0
5848167|NCT02221674|20217817|P3|Overall Study|Lost to Follow-up|0
5848168|NCT02221674|20217818|P2|Overall Study|Lost to Follow-up|0
5848169|NCT02221674|20217819|P1|Overall Study|Lost to Follow-up|1
5848170|NCT02221648|20217835|P2|Overall Study|Withdrawal by Subject|3
5848171|NCT02221648|20217836|P1|Overall Study|Withdrawal by Subject|3
5848172|NCT02221284|20217865|P1|Overall Study|Protocol Deviation|5
5848173|NCT02221284|20217865|P1|Overall Study|Case Report Forms Uncollected|56
5848174|NCT02221037|20217914|P4|Overall Study|Physician Decision|0
5848175|NCT02221037|20217915|P3|Overall Study|Physician Decision|1
5848176|NCT02221037|20217916|P2|Overall Study|Physician Decision|0
5848177|NCT02221037|20217917|P1|Overall Study|Physician Decision|0
5848178|NCT02220998|20218003|P2|Overall Study|Lost to Follow-up|4
5848179|NCT02220998|20218004|P1|Overall Study|Lost to Follow-up|4
5848180|NCT02220998|20218003|P2|Overall Study|Lack of Efficacy|5
5848181|NCT02220998|20218004|P1|Overall Study|Lack of Efficacy|0
5848182|NCT02220998|20218003|P2|Overall Study|Death|0
5848183|NCT02220998|20218004|P1|Overall Study|Death|2
5848184|NCT02220998|20218003|P2|Overall Study|Randomized but Never Treated|2
5848185|NCT02220998|20218004|P1|Overall Study|Randomized but Never Treated|1
5848186|NCT02220920|20218022|P2|Overall Study|Conflict with the stopping criteria|2
5848187|NCT02220920|20218023|P1|Overall Study|Conflict with the stopping criteria|1
5848188|NCT02220920|20218022|P2|Overall Study|Withdrawal by Subject|0
5848189|NCT02220920|20218023|P1|Overall Study|Withdrawal by Subject|1
5848190|NCT02220920|20218022|P2|Overall Study|Lack of Efficacy|1
5848191|NCT02220920|20218023|P1|Overall Study|Lack of Efficacy|0
5848192|NCT02220920|20218022|P2|Overall Study|Adverse Event|0
5848193|NCT02220920|20218023|P1|Overall Study|Adverse Event|1
5848194|NCT02220907|20218037|P1|Overall Study|Conflict with the stopping criteria|1
5848196|NCT02220907|20218037|P1|Overall Study|Physician Decision|1
5848197|NCT02220907|20218037|P1|Overall Study|Adverse Event|7
5848198|NCT02220894|20218046|P2|Overall Study|Ongoing in Study|183
5848199|NCT02220894|20218047|P1|Overall Study|Ongoing in Study|265
5848200|NCT02220894|20218046|P2|Overall Study|Withdrawal by Subject|13
5848201|NCT02220894|20218047|P1|Overall Study|Withdrawal by Subject|2
5848202|NCT02220894|20218046|P2|Overall Study|Withdrawal by Parent/Guardian|1
5848203|NCT02220894|20218047|P1|Overall Study|Withdrawal by Parent/Guardian|0
5848204|NCT02220894|20218046|P2|Overall Study|Lost to Follow-up|2
5848205|NCT02220894|20218047|P1|Overall Study|Lost to Follow-up|0
5848206|NCT02220894|20218046|P2|Overall Study|Death|368
5848207|NCT02220894|20218047|P1|Overall Study|Death|252
5848208|NCT02220894|20218046|P2|Overall Study|Adverse Event|70
5848209|NCT02220894|20218047|P1|Overall Study|Adverse Event|118
5848210|NCT02220855|20218073|P1|Overall Study|Withdrawal by Subject|1
5848211|NCT02220855|20218073|P1|Overall Study|Disease Progression|5
5848212|NCT02220855|20218073|P1|Overall Study|Adverse Event|8
5848213|NCT02220764|20218083|P2|Overall Study|Death|0
5848214|NCT02220764|20218084|P1|Overall Study|Death|1
5848215|NCT02220764|20218083|P2|Overall Study|Lost to Follow-up|1
5848216|NCT02220764|20218084|P1|Overall Study|Lost to Follow-up|3
5848217|NCT02220725|20218098|P4|Overall Study|Withdrawal by Subject|1
5848218|NCT02220725|20218099|P3|Overall Study|Withdrawal by Subject|0
5848219|NCT02220725|20218100|P2|Overall Study|Withdrawal by Subject|0
5848220|NCT02220725|20218101|P1|Overall Study|Withdrawal by Subject|0
5848221|NCT02220725|20218098|P4|Overall Study|Lost to Follow-up|1
5848222|NCT02220725|20218099|P3|Overall Study|Lost to Follow-up|0
5848223|NCT02220725|20218100|P2|Overall Study|Lost to Follow-up|0
5848224|NCT02220725|20218101|P1|Overall Study|Lost to Follow-up|0
5848225|NCT02220712|20218129|P1|Overall Study|Exacerbation of symptoms of an underlying disease|1
5848226|NCT02220712|20218129|P1|Overall Study|Withdrawal by Subject|2
5848227|NCT02220712|20218129|P1|Overall Study|Adverse Event|1
5848228|NCT02220205|20218139|P2|Overall Study|Withdrawal by Subject|0
5848229|NCT02220205|20218140|P1|Overall Study|Withdrawal by Subject|1
5848230|NCT02219932|20218165|P2|Overall Study|Adverse Event|21
5848231|NCT02219932|20218166|P1|Overall Study|Adverse Event|23
5848232|NCT02219932|20218165|P2|Overall Study|Lost to Follow-up|2
5848233|NCT02219932|20218166|P1|Overall Study|Lost to Follow-up|4
5848234|NCT02219932|20218165|P2|Overall Study|Pregnancy|0
5848235|NCT02219932|20218166|P1|Overall Study|Pregnancy|1
5848236|NCT02219932|20218165|P2|Overall Study|Protocol Violation|6
5848237|NCT02219932|20218166|P1|Overall Study|Protocol Violation|10
5848238|NCT02219932|20218165|P2|Overall Study|Lack of Efficacy (Subject Perception)|2
5848239|NCT02219932|20218166|P1|Overall Study|Lack of Efficacy (Subject Perception)|10
5848240|NCT02219932|20218165|P2|Overall Study|Consent Withdrawn|7
5848241|NCT02219932|20218166|P1|Overall Study|Consent Withdrawn|11
5848242|NCT02219932|20218165|P2|Overall Study|Investigator Decision|1
5848243|NCT02219932|20218166|P1|Overall Study|Investigator Decision|0
5848244|NCT02219932|20218165|P2|Overall Study|Death|1
5848245|NCT02219932|20218166|P1|Overall Study|Death|1
5848246|NCT02219932|20218165|P2|Overall Study|Other|11
5848247|NCT02219932|20218166|P1|Overall Study|Other|5
5848248|NCT02219685|20218182|P2|Blinded Treatment Phase|Withdrew Consent|0
5848249|NCT02219685|20218183|P1|Blinded Treatment Phase|Withdrew Consent|1
5848250|NCT02219685|20218182|P2|Blinded Treatment Phase|Lost to Follow-up|0
5848251|NCT02219685|20218183|P1|Blinded Treatment Phase|Lost to Follow-up|1
5848252|NCT02219477|20218289|P3|Overall Study|Withdrawal by Subject|0
5848253|NCT02219477|20218290|P2|Overall Study|Withdrawal by Subject|1
5848254|NCT02219477|20218291|P1|Overall Study|Withdrawal by Subject|0
5848255|NCT02219477|20218289|P3|Overall Study|Adverse Event|1
5848256|NCT02219477|20218290|P2|Overall Study|Adverse Event|1
5848257|NCT02219477|20218291|P1|Overall Study|Adverse Event|0
5848258|NCT02219464|20218319|P2|Overall Study|catheter malfunction|0
5848259|NCT02219464|20218320|P1|Overall Study|catheter malfunction|1
5848260|NCT02219464|20218319|P2|Overall Study|case cancelled|0
5848261|NCT02219464|20218320|P1|Overall Study|case cancelled|1
5848262|NCT02219464|20218319|P2|Overall Study|Withdrawal by Subject|0
5848263|NCT02219464|20218320|P1|Overall Study|Withdrawal by Subject|1
5848264|NCT02219334|20218330|P2|Overall Study|Protocol Violation|3
5848265|NCT02219334|20218331|P1|Overall Study|Protocol Violation|7
5848266|NCT02219334|20218330|P2|Overall Study|Withdrawal by Subject|0
5848267|NCT02219334|20218331|P1|Overall Study|Withdrawal by Subject|1
5848268|NCT02219308|20218354|P2|Overall Study|Withdrawal by Subject|2
5848269|NCT02219308|20218355|P1|Overall Study|Withdrawal by Subject|1
5848270|NCT02219087|20218515|P2|Overall Study|Randomization envelope pulled out of seq|1
5848271|NCT02219087|20218516|P1|Overall Study|Randomization envelope pulled out of seq|0
5848272|NCT02219048|20218536|P2|Overall Study|Other|1
5848273|NCT02219048|20218537|P1|Overall Study|Other|0
5848274|NCT02219048|20218536|P2|Overall Study|Withdrawal by Subject|0
5848275|NCT02219048|20218537|P1|Overall Study|Withdrawal by Subject|2
5848276|NCT02219048|20218536|P2|Overall Study|Study terminated by sponsor|15
5848277|NCT02219048|20218537|P1|Overall Study|Study terminated by sponsor|16
5848278|NCT02219048|20218536|P2|Overall Study|No longer meets eligibility criteria|0
5848279|NCT02219048|20218537|P1|Overall Study|No longer meets eligibility criteria|1
5848280|NCT02219048|20218536|P2|Overall Study|Adverse Event|5
5848281|NCT02219048|20218537|P1|Overall Study|Adverse Event|2
5848282|NCT02219009|20218563|P2|Overall Study|Physician Decision|1
5848283|NCT02219009|20218564|P1|Overall Study|Physician Decision|0
5848284|NCT02219009|20218563|P2|Overall Study|Protocol deviation|0
5848285|NCT02219009|20218564|P1|Overall Study|Protocol deviation|1
5848286|NCT02219009|20218563|P2|Overall Study|Lost to Follow-up|2
5848287|NCT02219009|20218564|P1|Overall Study|Lost to Follow-up|2
5848288|NCT02219009|20218563|P2|Overall Study|Adverse Event|4
5848289|NCT02219009|20218564|P1|Overall Study|Adverse Event|2
5848290|NCT02219009|20218563|P2|Overall Study|Withdrawal by Subject|1
5848291|NCT02219009|20218564|P1|Overall Study|Withdrawal by Subject|5
5848292|NCT02218736|20218576|P2|Overall Study|Protocol Violation|0
5848293|NCT02218736|20218577|P1|Overall Study|Protocol Violation|2
5848294|NCT02218736|20218576|P2|Overall Study|Withdrawal by Subject|9
5848295|NCT02218736|20218577|P1|Overall Study|Withdrawal by Subject|10
5848296|NCT02218697|20218589|P2|Overall Study|Withdrawal by Subject|3
5848297|NCT02218697|20218590|P1|Overall Study|Withdrawal by Subject|2
5848298|NCT02218697|20218589|P2|Overall Study|Unwilling to be vaccinated in left arm|1
5848299|NCT02218697|20218590|P1|Overall Study|Unwilling to be vaccinated in left arm|0
5848300|NCT02218697|20218589|P2|Overall Study|Adverse Event|2
5848301|NCT02218697|20218590|P1|Overall Study|Adverse Event|0
5848302|NCT02218541|20218630|P2|Overall Study|Implant Failure|1
5848303|NCT02218541|20218631|P1|Overall Study|Implant Failure|4
5848304|NCT02218541|20218630|P2|Overall Study|Lost to Follow-up|1
5848305|NCT02218541|20218631|P1|Overall Study|Lost to Follow-up|2
5848306|NCT02218489|20218643|P2|Overall Study|Lost to Follow-up|0
5848307|NCT02218489|20218644|P1|Overall Study|Lost to Follow-up|1
5848308|NCT02218489|20218643|P2|Overall Study|Withdrawal by Subject|3
5848309|NCT02218489|20218644|P1|Overall Study|Withdrawal by Subject|4
5848310|NCT02218372|20218696|P2|Overall Study|Withdrawal by Parent/Guardian|1
5848311|NCT02218372|20218697|P1|Overall Study|Withdrawal by Parent/Guardian|0
5848312|NCT02218372|20218696|P2|Overall Study|Randomized but did not receive treatment|3
5848313|NCT02218372|20218697|P1|Overall Study|Randomized but did not receive treatment|2
5848314|NCT02218372|20218696|P2|Overall Study|Miscellaneous|1
5848315|NCT02218372|20218697|P1|Overall Study|Miscellaneous|2
5848316|NCT02218372|20218696|P2|Overall Study|Adverse Event|1
5848317|NCT02218372|20218697|P1|Overall Study|Adverse Event|1
5848318|NCT02218268|20218777|P2|24 Hour Washout|Physician Decision|9
5848319|NCT02218268|20218778|P1|24 Hour Washout|Physician Decision|11
5848320|NCT02218216|20218790|P3|Overall Study|Study terminated before completed|0
5848321|NCT02218216|20218791|P2|Overall Study|Study terminated before completed|0
5848322|NCT02218216|20218792|P1|Overall Study|Study terminated before completed|6
5848323|NCT02218008|20218845|P6|Stage 2 (S2)|Lost to Follow-up|1
5848324|NCT02218008|20218846|P5|Stage 2 (S2)|Lost to Follow-up|0
5848325|NCT02218008|20218847|P4|Stage 2 (S2)|Lost to Follow-up|0
5848326|NCT02218008|20218848|P3|Stage 2 (S2)|Lost to Follow-up|0
5848327|NCT02218008|20218849|P2|Stage 2 (S2)|Lost to Follow-up|0
5848328|NCT02218008|20218850|P1|Stage 2 (S2)|Lost to Follow-up|0
5848329|NCT02218008|20218845|P6|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0
5848330|NCT02218008|20218846|P5|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0
5848331|NCT02218008|20218847|P4|Stage 2 (S2)|Failure to Meet Eligibility Criteria|1
5848332|NCT02218008|20218848|P3|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0
5848333|NCT02218008|20218849|P2|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0
5848334|NCT02218008|20218850|P1|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0
5848335|NCT02218008|20218845|P6|Stage 2 (S2)|Lack of Efficacy|2
5848336|NCT02218008|20218846|P5|Stage 2 (S2)|Lack of Efficacy|0
5848337|NCT02218008|20218847|P4|Stage 2 (S2)|Lack of Efficacy|0
5848338|NCT02218008|20218848|P3|Stage 2 (S2)|Lack of Efficacy|0
5848339|NCT02218008|20218849|P2|Stage 2 (S2)|Lack of Efficacy|0
5848340|NCT02218008|20218850|P1|Stage 2 (S2)|Lack of Efficacy|0
5848341|NCT02218008|20218845|P6|Stage 2 (S2)|Withdrawal by Subject|0
5848342|NCT02218008|20218846|P5|Stage 2 (S2)|Withdrawal by Subject|1
5848343|NCT02218008|20218847|P4|Stage 2 (S2)|Withdrawal by Subject|1
5848344|NCT02218008|20218848|P3|Stage 2 (S2)|Withdrawal by Subject|0
5848345|NCT02218008|20218849|P2|Stage 2 (S2)|Withdrawal by Subject|0
5848346|NCT02218008|20218850|P1|Stage 2 (S2)|Withdrawal by Subject|0
5848347|NCT02218008|20218845|P6|Stage 2 (S2)|Adverse Event|3
5848348|NCT02218008|20218846|P5|Stage 2 (S2)|Adverse Event|3
5848349|NCT02218008|20218847|P4|Stage 2 (S2)|Adverse Event|2
5848350|NCT02218008|20218848|P3|Stage 2 (S2)|Adverse Event|0
5848351|NCT02218008|20218849|P2|Stage 2 (S2)|Adverse Event|0
5848352|NCT02218008|20218850|P1|Stage 2 (S2)|Adverse Event|0
5848353|NCT02218008|20218845|P6|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0
5848354|NCT02218008|20218846|P5|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0
5848355|NCT02218008|20218847|P4|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0
5848356|NCT02218008|20218848|P3|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0
5848357|NCT02218008|20218849|P2|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0
5848358|NCT02218008|20218850|P1|Stage 1 (S1)|Failure to Meet Eligibility Criteria|1
5848359|NCT02218008|20218845|P6|Stage 1 (S1)|Protocol Violation|0
5848360|NCT02218008|20218846|P5|Stage 1 (S1)|Protocol Violation|0
5848361|NCT02218008|20218847|P4|Stage 1 (S1)|Protocol Violation|0
5848362|NCT02218008|20218848|P3|Stage 1 (S1)|Protocol Violation|1
5848363|NCT02218008|20218849|P2|Stage 1 (S1)|Protocol Violation|0
5848364|NCT02218008|20218850|P1|Stage 1 (S1)|Protocol Violation|0
5848365|NCT02218008|20218845|P6|Stage 1 (S1)|Pregnancy|0
5848366|NCT02218008|20218846|P5|Stage 1 (S1)|Pregnancy|0
5848367|NCT02218008|20218847|P4|Stage 1 (S1)|Pregnancy|0
5848368|NCT02218008|20218848|P3|Stage 1 (S1)|Pregnancy|1
5848369|NCT02218008|20218849|P2|Stage 1 (S1)|Pregnancy|0
5848370|NCT02218008|20218850|P1|Stage 1 (S1)|Pregnancy|0
5848371|NCT02218008|20218845|P6|Stage 1 (S1)|Non-compliance; drug use|0
5848372|NCT02218008|20218846|P5|Stage 1 (S1)|Non-compliance; drug use|0
5848373|NCT02218008|20218847|P4|Stage 1 (S1)|Non-compliance; drug use|0
5848374|NCT02218008|20218848|P3|Stage 1 (S1)|Non-compliance; drug use|0
5848375|NCT02218008|20218849|P2|Stage 1 (S1)|Non-compliance; drug use|0
5848376|NCT02218008|20218850|P1|Stage 1 (S1)|Non-compliance; drug use|1
5848377|NCT02218008|20218845|P6|Stage 1 (S1)|Non-compliance with Study Drug|0
5848378|NCT02218008|20218846|P5|Stage 1 (S1)|Non-compliance with Study Drug|0
5848379|NCT02218008|20218847|P4|Stage 1 (S1)|Non-compliance with Study Drug|0
5848380|NCT02218008|20218848|P3|Stage 1 (S1)|Non-compliance with Study Drug|0
5848381|NCT02218008|20218849|P2|Stage 1 (S1)|Non-compliance with Study Drug|1
5848382|NCT02218008|20218850|P1|Stage 1 (S1)|Non-compliance with Study Drug|2
5848383|NCT02218008|20218845|P6|Stage 1 (S1)|Lost to Follow-up|0
5848384|NCT02218008|20218846|P5|Stage 1 (S1)|Lost to Follow-up|0
5848385|NCT02218008|20218847|P4|Stage 1 (S1)|Lost to Follow-up|0
5848386|NCT02218008|20218848|P3|Stage 1 (S1)|Lost to Follow-up|1
5848387|NCT02218008|20218849|P2|Stage 1 (S1)|Lost to Follow-up|0
5848388|NCT02218008|20218850|P1|Stage 1 (S1)|Lost to Follow-up|3
5848389|NCT02218008|20218845|P6|Stage 1 (S1)|Lack of Efficacy|0
5848390|NCT02218008|20218846|P5|Stage 1 (S1)|Lack of Efficacy|0
5848391|NCT02218008|20218847|P4|Stage 1 (S1)|Lack of Efficacy|0
5848392|NCT02218008|20218848|P3|Stage 1 (S1)|Lack of Efficacy|0
5848393|NCT02218008|20218849|P2|Stage 1 (S1)|Lack of Efficacy|0
5848394|NCT02218008|20218850|P1|Stage 1 (S1)|Lack of Efficacy|3
5848395|NCT02218008|20218845|P6|Stage 1 (S1)|Withdrawal by Subject|0
5848396|NCT02218008|20218846|P5|Stage 1 (S1)|Withdrawal by Subject|0
5848397|NCT02218008|20218847|P4|Stage 1 (S1)|Withdrawal by Subject|0
5848398|NCT02218008|20218848|P3|Stage 1 (S1)|Withdrawal by Subject|1
5848399|NCT02218008|20218849|P2|Stage 1 (S1)|Withdrawal by Subject|1
5848400|NCT02218008|20218850|P1|Stage 1 (S1)|Withdrawal by Subject|6
5848401|NCT02218008|20218845|P6|Stage 1 (S1)|Adverse Event|0
5848402|NCT02218008|20218846|P5|Stage 1 (S1)|Adverse Event|0
5848403|NCT02218008|20218847|P4|Stage 1 (S1)|Adverse Event|0
5848404|NCT02218008|20218848|P3|Stage 1 (S1)|Adverse Event|11
5848405|NCT02218008|20218849|P2|Stage 1 (S1)|Adverse Event|5
5848406|NCT02218008|20218850|P1|Stage 1 (S1)|Adverse Event|6
5848407|NCT02217982|20218896|P2|Overall Study|Adverse Event|1
5848408|NCT02217982|20218897|P1|Overall Study|Adverse Event|0
5848409|NCT02217982|20218896|P2|Overall Study|Trial discontinued|0
5848410|NCT02217982|20218897|P1|Overall Study|Trial discontinued|1
5848411|NCT02217878|20218980|P2|Overall Study|initial diagnosis of STEMI not confirmed|0
5848412|NCT02217878|20218981|P1|Overall Study|initial diagnosis of STEMI not confirmed|1
5848413|NCT02217878|20218980|P2|Overall Study|required morphine due to chest pain|2
5848414|NCT02217878|20218981|P1|Overall Study|required morphine due to chest pain|1
5848415|NCT02217566|20219079|P1|Overall Study|Early study termination|6
5848416|NCT02217566|20219079|P1|Overall Study|Death|3
5848417|NCT02217566|20219079|P1|Overall Study|Lost to Follow-up|2
5848418|NCT02217527|20219090|P2|Drug Condition 2: Second Study Phase|Withdrawal by Subject|1
5848419|NCT02217527|20219091|P1|Drug Condition 2: Second Study Phase|Withdrawal by Subject|0
5848420|NCT02217527|20219090|P2|Drug Condition 1: First Study Phase|Withdrawal by Subject|3
5848421|NCT02217527|20219091|P1|Drug Condition 1: First Study Phase|Withdrawal by Subject|1
5848422|NCT02217475|20219104|P3|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|1
5848423|NCT02217475|20219105|P2|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0
5848424|NCT02217475|20219106|P1|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0
5848425|NCT02217475|20219104|P3|Treatment Period 2 (Year 2)|Physician Decision|2
5848426|NCT02217475|20219105|P2|Treatment Period 2 (Year 2)|Physician Decision|0
5848427|NCT02217475|20219106|P1|Treatment Period 2 (Year 2)|Physician Decision|0
5848428|NCT02217475|20219104|P3|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2
5848429|NCT02217475|20219105|P2|Treatment Period 2 (Year 2)|Subject Withdrew Consent|0
5848430|NCT02217475|20219106|P1|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2
5848431|NCT02217475|20219104|P3|Treatment Period 2 (Year 2)|Lost to Follow-up|2
5848432|NCT02217475|20219105|P2|Treatment Period 2 (Year 2)|Lost to Follow-up|1
5848433|NCT02217475|20219106|P1|Treatment Period 2 (Year 2)|Lost to Follow-up|0
5848434|NCT02217475|20219104|P3|Treatment Period 2 (Year 2)|Adverse Event|5
5848435|NCT02217475|20219105|P2|Treatment Period 2 (Year 2)|Adverse Event|1
5848436|NCT02217475|20219106|P1|Treatment Period 2 (Year 2)|Adverse Event|0
5848437|NCT02217475|20219104|P3|Discontinued After Period 1|Physician Decision|1
5848438|NCT02217475|20219105|P2|Discontinued After Period 1|Physician Decision|0
5848439|NCT02217475|20219106|P1|Discontinued After Period 1|Physician Decision|0
5848440|NCT02217475|20219104|P3|Discontinued After Period 1|Participant Withdrew Consent|2
5848441|NCT02217475|20219105|P2|Discontinued After Period 1|Participant Withdrew Consent|1
5848442|NCT02217475|20219106|P1|Discontinued After Period 1|Participant Withdrew Consent|1
5848443|NCT02217475|20219104|P3|Discontinued After Period 1|Adverse Event|0
5848444|NCT02217475|20219105|P2|Discontinued After Period 1|Adverse Event|2
5848445|NCT02217475|20219106|P1|Discontinued After Period 1|Adverse Event|1
5848446|NCT02217475|20219104|P3|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|1
5848447|NCT02217475|20219105|P2|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0
5848448|NCT02217475|20219106|P1|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0
5848449|NCT02217475|20219104|P3|Treatment Period 1 (Year 1)|Subject Withdrew Consent|11
5848450|NCT02217475|20219105|P2|Treatment Period 1 (Year 1)|Subject Withdrew Consent|2
5848451|NCT02217475|20219106|P1|Treatment Period 1 (Year 1)|Subject Withdrew Consent|5
5848452|NCT02217475|20219104|P3|Treatment Period 1 (Year 1)|Lost to Follow-up|0
5848453|NCT02217475|20219105|P2|Treatment Period 1 (Year 1)|Lost to Follow-up|0
5848454|NCT02217475|20219106|P1|Treatment Period 1 (Year 1)|Lost to Follow-up|1
5848455|NCT02217475|20219104|P3|Treatment Period 1 (Year 1)|Adverse Event|9
5848456|NCT02217475|20219105|P2|Treatment Period 1 (Year 1)|Adverse Event|5
5848457|NCT02217475|20219106|P1|Treatment Period 1 (Year 1)|Adverse Event|4
5848458|NCT02217475|20219104|P3|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0
5848459|NCT02217475|20219105|P2|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|1
5848460|NCT02217475|20219106|P1|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0
5848461|NCT02217436|20219223|P2|Overall Study|Incomplete data|1
5848462|NCT02217436|20219224|P1|Overall Study|Incomplete data|0
5848463|NCT02217436|20219223|P2|Overall Study|Protocol Violation|1
5848464|NCT02217436|20219224|P1|Overall Study|Protocol Violation|1
5848465|NCT02217410|20219235|P3|Overall Study|Physician Decision|0
5848466|NCT02217410|20219236|P2|Overall Study|Physician Decision|3
5848467|NCT02217410|20219237|P1|Overall Study|Physician Decision|1
5848468|NCT02217410|20219235|P3|Overall Study|Lack of Efficacy|0
5848469|NCT02217410|20219236|P2|Overall Study|Lack of Efficacy|1
5848470|NCT02217410|20219237|P1|Overall Study|Lack of Efficacy|0
5848471|NCT02217410|20219235|P3|Overall Study|Lost to Follow-up|1
5848472|NCT02217410|20219236|P2|Overall Study|Lost to Follow-up|0
5848473|NCT02217410|20219237|P1|Overall Study|Lost to Follow-up|0
5848474|NCT02217410|20219235|P3|Overall Study|Withdrawal by Subject|2
5848475|NCT02217410|20219236|P2|Overall Study|Withdrawal by Subject|0
5848476|NCT02217410|20219237|P1|Overall Study|Withdrawal by Subject|0
5848477|NCT02217410|20219235|P3|Overall Study|Graft Loss|2
5848478|NCT02217410|20219236|P2|Overall Study|Graft Loss|0
5848479|NCT02217410|20219237|P1|Overall Study|Graft Loss|0
5848480|NCT02217280|20219260|P1|Overall Study|Post-consent sceen fail|2
5848481|NCT02217280|20219260|P1|Overall Study|Withdrawal by Subject|2
5848482|NCT02216812|20219267|P2|Overall Study|Lost to Follow-up|5
5848483|NCT02216812|20219268|P1|Overall Study|Lost to Follow-up|10
5848484|NCT02216773|20219284|P2|Overall Study|Abandoned|3
5848485|NCT02216773|20219285|P1|Overall Study|Abandoned|4
5848486|NCT02216773|20219284|P2|Overall Study|Insufficient FLRV|0
5848487|NCT02216773|20219285|P1|Overall Study|Insufficient FLRV|4
5848488|NCT02216773|20219284|P2|Overall Study|Disease progression|2
5848489|NCT02216773|20219285|P1|Overall Study|Disease progression|4
5848490|NCT02216591|20219306|P2|Overall Study|Lost to Follow-up|1
5848491|NCT02216591|20219307|P1|Overall Study|Lost to Follow-up|0
5848492|NCT02216526|20219320|P3|Overall Study|Hospitalization|3
5848493|NCT02216526|20219321|P2|Overall Study|Hospitalization|1
5848494|NCT02216526|20219322|P1|Overall Study|Hospitalization|2
5848495|NCT02216526|20219320|P3|Overall Study|Protocol Violation|2
5848496|NCT02216526|20219321|P2|Overall Study|Protocol Violation|0
5848497|NCT02216526|20219322|P1|Overall Study|Protocol Violation|2
5848498|NCT02216526|20219320|P3|Overall Study|Death|3
5848499|NCT02216526|20219321|P2|Overall Study|Death|1
5848500|NCT02216526|20219322|P1|Overall Study|Death|0
5848501|NCT02216526|20219320|P3|Overall Study|Adverse Event|0
5848502|NCT02216526|20219321|P2|Overall Study|Adverse Event|1
5848503|NCT02216526|20219322|P1|Overall Study|Adverse Event|1
5848504|NCT02216357|20219440|P2|Overall Study|Inclusion or exclusion criteria not met|1
5848505|NCT02216357|20219441|P1|Overall Study|Inclusion or exclusion criteria not met|2
5848506|NCT02216214|20219467|P2|Overall Study|Miscellaneous|1
5848507|NCT02216214|20219468|P1|Overall Study|Miscellaneous|1
5848508|NCT02216214|20219467|P2|Overall Study|Study Terminated By Sponsor|1
5848509|NCT02216214|20219468|P1|Overall Study|Study Terminated By Sponsor|0
5848510|NCT02216214|20219467|P2|Overall Study|Withdrawal by Subject|20
5848511|NCT02216214|20219468|P1|Overall Study|Withdrawal by Subject|22
5848512|NCT02216214|20219467|P2|Overall Study|Protocol Violation|2
5848513|NCT02216214|20219468|P1|Overall Study|Protocol Violation|4
5848514|NCT02216214|20219467|P2|Overall Study|Lost to Follow-up|2
5848515|NCT02216214|20219468|P1|Overall Study|Lost to Follow-up|3
5848516|NCT02216214|20219467|P2|Overall Study|Lack of Efficacy|2
5848517|NCT02216214|20219468|P1|Overall Study|Lack of Efficacy|2
5848518|NCT02216214|20219467|P2|Overall Study|Adverse Event|8
5848519|NCT02216214|20219468|P1|Overall Study|Adverse Event|10
5848520|NCT02216214|20219467|P2|Overall Study|Randomized Never Received Study Drug|0
5848521|NCT02216214|20219468|P1|Overall Study|Randomized Never Received Study Drug|1
5848522|NCT02216123|20219539|P2|Overall Study|Withdrawal by Subject|0
5848523|NCT02216123|20219540|P1|Overall Study|Withdrawal by Subject|2
5848524|NCT02216123|20219539|P2|Overall Study|Lost to Follow-up|2
5848525|NCT02216123|20219540|P1|Overall Study|Lost to Follow-up|4
5848526|NCT02215967|20219633|P4|Overall Study|Patient did not get CAR T-Cells|0
5848527|NCT02215967|20219634|P3|Overall Study|Patient did not get CAR T-Cells|1
5848528|NCT02215967|20219635|P2|Overall Study|Patient did not get CAR T-Cells|0
5848529|NCT02215967|20219636|P1|Overall Study|Patient did not get CAR T-Cells|0
5848530|NCT02215967|20219633|P4|Overall Study|Patient became ineligible for treatment|3
5848531|NCT02215967|20219634|P3|Overall Study|Patient became ineligible for treatment|0
5848532|NCT02215967|20219635|P2|Overall Study|Patient became ineligible for treatment|0
5848533|NCT02215967|20219636|P1|Overall Study|Patient became ineligible for treatment|0
5848534|NCT02215954|20219657|P3|Overall Study|Not exposed|3
5848535|NCT02215954|20219658|P2|Overall Study|Not exposed|1
5848536|NCT02215954|20219659|P1|Overall Study|Not exposed|1
5848537|NCT02215954|20219657|P3|Overall Study|Withdrawal by Subject|2
5848538|NCT02215954|20219658|P2|Overall Study|Withdrawal by Subject|0
5848539|NCT02215954|20219659|P1|Overall Study|Withdrawal by Subject|0
5848540|NCT02215954|20219657|P3|Overall Study|Adverse Event|1
5848541|NCT02215954|20219658|P2|Overall Study|Adverse Event|0
5848542|NCT02215954|20219659|P1|Overall Study|Adverse Event|0
5848543|NCT02215616|20219683|P4|Overall Study|Other than specified|1
5848544|NCT02215616|20219684|P3|Overall Study|Other than specified|1
5848545|NCT02215616|20219685|P2|Overall Study|Other than specified|0
5848546|NCT02215616|20219686|P1|Overall Study|Other than specified|1
5848547|NCT02215616|20219683|P4|Overall Study|Lost to Follow-up|1
5848548|NCT02215616|20219684|P3|Overall Study|Lost to Follow-up|0
5848549|NCT02215616|20219685|P2|Overall Study|Lost to Follow-up|1
5848550|NCT02215616|20219686|P1|Overall Study|Lost to Follow-up|1
5848551|NCT02215616|20219683|P4|Overall Study|Protocol Violation|0
5848552|NCT02215616|20219684|P3|Overall Study|Protocol Violation|0
5848553|NCT02215616|20219685|P2|Overall Study|Protocol Violation|2
5848554|NCT02215616|20219686|P1|Overall Study|Protocol Violation|0
5848555|NCT02215616|20219683|P4|Overall Study|Non-compliance|0
5848556|NCT02215616|20219684|P3|Overall Study|Non-compliance|1
5848557|NCT02215616|20219685|P2|Overall Study|Non-compliance|2
5848558|NCT02215616|20219686|P1|Overall Study|Non-compliance|0
5848559|NCT02215616|20219683|P4|Overall Study|Withdrawal by Subject|5
5848560|NCT02215616|20219684|P3|Overall Study|Withdrawal by Subject|2
5848561|NCT02215616|20219685|P2|Overall Study|Withdrawal by Subject|8
5848562|NCT02215616|20219686|P1|Overall Study|Withdrawal by Subject|1
5848563|NCT02215616|20219683|P4|Overall Study|Adverse Event|2
5848564|NCT02215616|20219684|P3|Overall Study|Adverse Event|9
5848565|NCT02215616|20219685|P2|Overall Study|Adverse Event|4
5848566|NCT02215616|20219686|P1|Overall Study|Adverse Event|7
5848567|NCT02215616|20219683|P4|Overall Study|Death|0
5848568|NCT02215616|20219684|P3|Overall Study|Death|0
5848569|NCT02215616|20219685|P2|Overall Study|Death|0
5848570|NCT02215616|20219686|P1|Overall Study|Death|1
5848571|NCT02215616|20219683|P4|Overall Study|Sponsor requested to stop study drug|4
5848572|NCT02215616|20219684|P3|Overall Study|Sponsor requested to stop study drug|1
5848573|NCT02215616|20219685|P2|Overall Study|Sponsor requested to stop study drug|0
5848574|NCT02215616|20219686|P1|Overall Study|Sponsor requested to stop study drug|0
5848575|NCT02215252|20219708|P3|Overall Study|Other|1
5848576|NCT02215252|20219709|P2|Overall Study|Other|1
5848577|NCT02215252|20219710|P1|Overall Study|Other|0
5848578|NCT02215252|20219708|P3|Overall Study|Withdrawal by Subject|0
5848579|NCT02215252|20219709|P2|Overall Study|Withdrawal by Subject|0
5848580|NCT02215252|20219710|P1|Overall Study|Withdrawal by Subject|1
5848581|NCT02215252|20219708|P3|Overall Study|Protocol Violation|0
5848582|NCT02215252|20219709|P2|Overall Study|Protocol Violation|1
5848583|NCT02215252|20219710|P1|Overall Study|Protocol Violation|0
5848584|NCT02215252|20219708|P3|Overall Study|Does not Meet Entrance Criteria|0
5848585|NCT02215252|20219709|P2|Overall Study|Does not Meet Entrance Criteria|1
5848586|NCT02215252|20219710|P1|Overall Study|Does not Meet Entrance Criteria|0
5848587|NCT02215252|20219708|P3|Overall Study|Lost to Follow-up|1
5848588|NCT02215252|20219709|P2|Overall Study|Lost to Follow-up|0
5848589|NCT02215252|20219710|P1|Overall Study|Lost to Follow-up|0
5848590|NCT02215252|20219708|P3|Overall Study|Adverse Event|2
5848591|NCT02215252|20219709|P2|Overall Study|Adverse Event|5
5848592|NCT02215252|20219710|P1|Overall Study|Adverse Event|1
5848593|NCT02215096|20219798|P5|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|0
5848594|NCT02215096|20219799|P4|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|1
5848595|NCT02215096|20219800|P3|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|1
5848596|NCT02215096|20219801|P2|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|2
5848597|NCT02215096|20219802|P1|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|0
5848598|NCT02215096|20219798|P5|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0
5848599|NCT02215096|20219799|P4|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|1
5848600|NCT02215096|20219800|P3|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0
5848601|NCT02215096|20219801|P2|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0
5848602|NCT02215096|20219802|P1|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0
5848603|NCT02215096|20219798|P5|Combination TP (Up to Maximum 654 Days)|Physician Decision|1
5848604|NCT02215096|20219799|P4|Combination TP (Up to Maximum 654 Days)|Physician Decision|0
5848605|NCT02215096|20219800|P3|Combination TP (Up to Maximum 654 Days)|Physician Decision|0
5848606|NCT02215096|20219801|P2|Combination TP (Up to Maximum 654 Days)|Physician Decision|0
5848607|NCT02215096|20219802|P1|Combination TP (Up to Maximum 654 Days)|Physician Decision|0
5848608|NCT02215096|20219798|P5|Run-In Period (Up to Week 2)|Adverse Event|0
5848609|NCT02215096|20219799|P4|Run-In Period (Up to Week 2)|Adverse Event|0
5848610|NCT02215096|20219800|P3|Run-In Period (Up to Week 2)|Adverse Event|0
5848611|NCT02215096|20219801|P2|Run-In Period (Up to Week 2)|Adverse Event|0
5848612|NCT02215096|20219802|P1|Run-In Period (Up to Week 2)|Adverse Event|1
5848613|NCT02214225|20219964|P3|Overall Study|randomized in error, not vaccinated|1
5848614|NCT02214225|20219965|P2|Overall Study|randomized in error, not vaccinated|1
5848615|NCT02214225|20219966|P1|Overall Study|randomized in error, not vaccinated|2
5848616|NCT02214225|20219964|P3|Overall Study|Death|1
5848617|NCT02214225|20219965|P2|Overall Study|Death|0
5848618|NCT02214225|20219966|P1|Overall Study|Death|5
5848619|NCT02214225|20219964|P3|Overall Study|Withdrawal by Subject|2
5848620|NCT02214225|20219965|P2|Overall Study|Withdrawal by Subject|0
5848621|NCT02214225|20219966|P1|Overall Study|Withdrawal by Subject|2
5848622|NCT02214225|20219964|P3|Overall Study|Lost to Follow-up|18
5848623|NCT02214225|20219965|P2|Overall Study|Lost to Follow-up|18
5848624|NCT02214225|20219966|P1|Overall Study|Lost to Follow-up|46
5848625|NCT02214186|20220025|P2|Overall Study|Protocol Violation|1
5848626|NCT02214186|20220026|P1|Overall Study|Protocol Violation|1
5848627|NCT02214186|20220025|P2|Overall Study|Lost to Follow-up|1
5848628|NCT02214186|20220026|P1|Overall Study|Lost to Follow-up|1
5848629|NCT02214121|20220094|P3|Part B|Lost to Follow-up|1
5848630|NCT02214121|20220095|P2|Part B|Lost to Follow-up|0
5848631|NCT02214121|20220096|P1|Part B|Lost to Follow-up|0
5848632|NCT02214121|20220094|P3|Part B|Dev. of study-specific withdrawal crit.|0
5848633|NCT02214121|20220095|P2|Part B|Dev. of study-specific withdrawal crit.|2
5848634|NCT02214121|20220096|P1|Part B|Dev. of study-specific withdrawal crit.|0
5848635|NCT02214121|20220094|P3|Part B|Patient decision|0
5848636|NCT02214121|20220095|P2|Part B|Patient decision|1
5848637|NCT02214121|20220096|P1|Part B|Patient decision|0
5848638|NCT02214121|20220094|P3|Part A|Other|0
5848639|NCT02214121|20220095|P2|Part A|Other|0
5848640|NCT02214121|20220096|P1|Part A|Other|1
5848641|NCT02214121|20220094|P3|Part A|Dev. of study-specific withdrawal crit.|0
5848642|NCT02214121|20220095|P2|Part A|Dev. of study-specific withdrawal crit.|0
5848643|NCT02214121|20220096|P1|Part A|Dev. of study-specific withdrawal crit.|4
5848644|NCT02214121|20220094|P3|Part A|Patient decision|0
5848645|NCT02214121|20220095|P2|Part A|Patient decision|0
5848646|NCT02214121|20220096|P1|Part A|Patient decision|2
5848647|NCT02213666|20220205|P1|Overall Study|Withdrawal by Subject|1
5848648|NCT02213510|20220211|P2|Overall Study|Lost to Follow-up|0
5848649|NCT02213510|20220212|P1|Overall Study|Lost to Follow-up|1
5848650|NCT02213510|20220211|P2|Overall Study|Death|1
5848651|NCT02213510|20220212|P1|Overall Study|Death|0
5848652|NCT02213263|20220240|P2|Overall Study|Adverse Event|3
5848653|NCT02213263|20220241|P1|Overall Study|Adverse Event|1
5848654|NCT02213263|20220240|P2|Overall Study|Protocol Violation|1
5848655|NCT02213263|20220241|P1|Overall Study|Protocol Violation|0
5848656|NCT02213263|20220240|P2|Overall Study|Progressive disease|14
5848657|NCT02213263|20220241|P1|Overall Study|Progressive disease|20
5848658|NCT02213263|20220240|P2|Overall Study|No longer willing to participate|4
5848659|NCT02213263|20220241|P1|Overall Study|No longer willing to participate|3
5848660|NCT02213263|20220240|P2|Overall Study|Lost to Follow-up|1
5848661|NCT02213263|20220241|P1|Overall Study|Lost to Follow-up|0
5848662|NCT02213263|20220240|P2|Overall Study|Insufficient clinical response|3
5848663|NCT02213263|20220241|P1|Overall Study|Insufficient clinical response|4
5848664|NCT02213198|20220309|P2|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|7
5848665|NCT02213198|20220310|P1|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|23
5848666|NCT02213198|20220309|P2|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|10
5848667|NCT02213198|20220310|P1|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|17
5848668|NCT02213198|20220309|P2|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|25
5848669|NCT02213198|20220310|P1|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|68
5848670|NCT02213198|20220309|P2|Follow up 1 3 Mos Post BL End of TCC tx|Death|0
5848671|NCT02213198|20220310|P1|Follow up 1 3 Mos Post BL End of TCC tx|Death|1
5848672|NCT02213198|20220309|P2|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|2
5848673|NCT02213198|20220310|P1|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|3
5848674|NCT02213198|20220309|P2|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4
5848675|NCT02213198|20220310|P1|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4
5848676|NCT02213198|20220309|P2|Baseline|incarcerated,violent|1
5848677|NCT02213198|20220310|P1|Baseline|incarcerated,violent|0
5848678|NCT02213198|20220309|P2|Baseline|Lost to Follow-up|21
5848679|NCT02213198|20220310|P1|Baseline|Lost to Follow-up|40
5848680|NCT02213198|20220309|P2|Baseline|transferred out of clinic|9
5848681|NCT02213198|20220310|P1|Baseline|transferred out of clinic|7
5848682|NCT02213198|20220309|P2|Baseline|Withdrawal by Subject|11
5848683|NCT02213198|20220310|P1|Baseline|Withdrawal by Subject|34
5848684|NCT02213198|20220309|P2|Baseline|No show for intake|9
5848685|NCT02213198|20220310|P1|Baseline|No show for intake|7
5848686|NCT02213133|20220321|P3|Overall Study|Other|0
5848687|NCT02213133|20220322|P2|Overall Study|Other|0
5848688|NCT02213133|20220323|P1|Overall Study|Other|5
5848689|NCT02213133|20220321|P3|Overall Study|Death|1
5848690|NCT02213133|20220322|P2|Overall Study|Death|2
5848691|NCT02213133|20220323|P1|Overall Study|Death|16
5848692|NCT02213133|20220321|P3|Overall Study|Adverse Event (AE)|0
5848693|NCT02213133|20220322|P2|Overall Study|Adverse Event (AE)|0
5848694|NCT02213133|20220323|P1|Overall Study|Adverse Event (AE)|1
5848695|NCT02213133|20220321|P3|Overall Study|Disease progression|0
5848696|NCT02213133|20220322|P2|Overall Study|Disease progression|2
5848697|NCT02213133|20220323|P1|Overall Study|Disease progression|11
5848698|NCT02213133|20220321|P3|Overall Study|Participant withdrew informed consent|2
5848699|NCT02213133|20220322|P2|Overall Study|Participant withdrew informed consent|1
5848700|NCT02213133|20220323|P1|Overall Study|Participant withdrew informed consent|2
5848701|NCT02213133|20220321|P3|Overall Study|Participant discontinued study therapy|0
5848702|NCT02213133|20220322|P2|Overall Study|Participant discontinued study therapy|0
5848703|NCT02213133|20220323|P1|Overall Study|Participant discontinued study therapy|2
5848704|NCT02213094|20220339|P2|Overall Study|Adverse Event|0
5848705|NCT02213094|20220340|P1|Overall Study|Adverse Event|1
5848706|NCT02213055|20220348|P2|Overall Study|Did not Return to School|0
5848707|NCT02213055|20220349|P1|Overall Study|Did not Return to School|5
5848708|NCT02213055|20220348|P2|Overall Study|Did not meet Inclusion Criteria|0
5848709|NCT02213055|20220349|P1|Overall Study|Did not meet Inclusion Criteria|6
5848710|NCT02213055|20220348|P2|Overall Study|Had another Treatment during the Study|0
5848711|NCT02213055|20220349|P1|Overall Study|Had another Treatment during the Study|3
5848712|NCT02213055|20220348|P2|Overall Study|Did not have Live Lice|0
5848713|NCT02213055|20220349|P1|Overall Study|Did not have Live Lice|8
5848714|NCT02213055|20220348|P2|Overall Study|Documentation Issue during Study|0
5848715|NCT02213055|20220349|P1|Overall Study|Documentation Issue during Study|10
5848716|NCT02213055|20220348|P2|Overall Study|Documentation Issue at Enrollment|0
5848717|NCT02213055|20220349|P1|Overall Study|Documentation Issue at Enrollment|1
5848718|NCT02213055|20220348|P2|Overall Study|Protocol was not Followed during Study|0
5848719|NCT02213055|20220349|P1|Overall Study|Protocol was not Followed during Study|1
5848720|NCT02213055|20220348|P2|Overall Study|Protocol was not Followed at Enrollment|0
5848721|NCT02213055|20220349|P1|Overall Study|Protocol was not Followed at Enrollment|5
5848722|NCT02212730|20220383|P2|Overall Study|Disease progression prior to RCC surgery|1
5848723|NCT02212730|20220384|P1|Overall Study|Disease progression prior to RCC surgery|0
5848724|NCT02212730|20220383|P2|Overall Study|Withdrawal by Subject|0
5848725|NCT02212730|20220384|P1|Overall Study|Withdrawal by Subject|1
5848726|NCT02212730|20220383|P2|Overall Study|Tumor not of the required cell histology|0
5848727|NCT02212730|20220384|P1|Overall Study|Tumor not of the required cell histology|1
5848728|NCT02212678|20220406|P1|Overall Study|Adverse Event|1
5848729|NCT02212457|20220426|P6|Overall Study|Other|1
5848730|NCT02212457|20220427|P5|Overall Study|Other|0
5848731|NCT02212457|20220428|P4|Overall Study|Other|1
5848732|NCT02212457|20220429|P3|Overall Study|Other|2
5848733|NCT02212457|20220430|P2|Overall Study|Other|1
5848734|NCT02212457|20220431|P1|Overall Study|Other|2
5848735|NCT02212457|20220426|P6|Overall Study|Protocol Violation|3
5848736|NCT02212457|20220427|P5|Overall Study|Protocol Violation|2
5848737|NCT02212457|20220428|P4|Overall Study|Protocol Violation|1
5848738|NCT02212457|20220429|P3|Overall Study|Protocol Violation|0
5848739|NCT02212457|20220430|P2|Overall Study|Protocol Violation|1
5848740|NCT02212457|20220431|P1|Overall Study|Protocol Violation|2
5848741|NCT02212457|20220426|P6|Overall Study|Lost to Follow-up|4
5848742|NCT02212457|20220427|P5|Overall Study|Lost to Follow-up|8
5848743|NCT02212457|20220428|P4|Overall Study|Lost to Follow-up|1
5848744|NCT02212457|20220429|P3|Overall Study|Lost to Follow-up|4
5848745|NCT02212457|20220430|P2|Overall Study|Lost to Follow-up|7
5848746|NCT02212457|20220431|P1|Overall Study|Lost to Follow-up|6
5848747|NCT02212457|20220426|P6|Overall Study|Withdrawal by Subject|4
5848748|NCT02212457|20220427|P5|Overall Study|Withdrawal by Subject|5
5848749|NCT02212457|20220428|P4|Overall Study|Withdrawal by Subject|6
5848750|NCT02212457|20220429|P3|Overall Study|Withdrawal by Subject|8
5848751|NCT02212457|20220430|P2|Overall Study|Withdrawal by Subject|10
5848752|NCT02212457|20220431|P1|Overall Study|Withdrawal by Subject|8
5848753|NCT02212457|20220426|P6|Overall Study|Adverse Event|1
5848754|NCT02212457|20220427|P5|Overall Study|Adverse Event|0
5848755|NCT02212457|20220428|P4|Overall Study|Adverse Event|2
5848756|NCT02212457|20220429|P3|Overall Study|Adverse Event|2
5848757|NCT02212457|20220430|P2|Overall Study|Adverse Event|2
5848758|NCT02212457|20220431|P1|Overall Study|Adverse Event|1
5848759|NCT02212301|20220555|P2|Period 1|Lost to Follow-up|1
5848760|NCT02212301|20220556|P1|Period 1|Lost to Follow-up|0
5848761|NCT02212197|20220567|P3|Overall Study|Need for radiotherapy|0
5848762|NCT02212197|20220568|P2|Overall Study|Need for radiotherapy|0
5848763|NCT02212197|20220569|P1|Overall Study|Need for radiotherapy|1
5848764|NCT02211638|20220622|P1|Overall Study|Protocol Violation|692
5848765|NCT02211638|20220622|P1|Overall Study|Case Report Forms Uncollected|291
5848766|NCT02211313|20220669|P2|Overall Study|No Follow up Questionnaires|1
5848767|NCT02211313|20220670|P1|Overall Study|No Follow up Questionnaires|1
5848768|NCT02211313|20220669|P2|Overall Study|Treatment Failure|2
5848769|NCT02211313|20220670|P1|Overall Study|Treatment Failure|5
5848770|NCT02211261|20220687|P11|Overall Study|Lost to Follow-up|0
5848771|NCT02211261|20220688|P10|Overall Study|Lost to Follow-up|0
5848772|NCT02211261|20220689|P9|Overall Study|Lost to Follow-up|0
5848773|NCT02211261|20220690|P8|Overall Study|Lost to Follow-up|1
5848774|NCT02211261|20220691|P7|Overall Study|Lost to Follow-up|0
5848775|NCT02211261|20220692|P6|Overall Study|Lost to Follow-up|0
5848776|NCT02211261|20220693|P5|Overall Study|Lost to Follow-up|0
5848777|NCT02211261|20220694|P4|Overall Study|Lost to Follow-up|0
5848778|NCT02211261|20220695|P3|Overall Study|Lost to Follow-up|0
5848779|NCT02211261|20220696|P2|Overall Study|Lost to Follow-up|0
5848780|NCT02211261|20220697|P1|Overall Study|Lost to Follow-up|0
5848781|NCT02211261|20220687|P11|Overall Study|Other|0
5848782|NCT02211261|20220688|P10|Overall Study|Other|2
5848783|NCT02211261|20220689|P9|Overall Study|Other|0
5848784|NCT02211261|20220690|P8|Overall Study|Other|0
5848785|NCT02211261|20220691|P7|Overall Study|Other|0
5848786|NCT02211261|20220692|P6|Overall Study|Other|1
5848787|NCT02211261|20220693|P5|Overall Study|Other|0
5848788|NCT02211261|20220694|P4|Overall Study|Other|0
5848789|NCT02211261|20220695|P3|Overall Study|Other|0
5848790|NCT02211261|20220696|P2|Overall Study|Other|0
5848791|NCT02211261|20220697|P1|Overall Study|Other|0
5848792|NCT02211261|20220687|P11|Overall Study|Withdrawal by Subject|0
5848793|NCT02211261|20220688|P10|Overall Study|Withdrawal by Subject|0
5848794|NCT02211261|20220689|P9|Overall Study|Withdrawal by Subject|0
5848795|NCT02211261|20220690|P8|Overall Study|Withdrawal by Subject|0
5848796|NCT02211261|20220691|P7|Overall Study|Withdrawal by Subject|0
5848797|NCT02211261|20220692|P6|Overall Study|Withdrawal by Subject|0
5848798|NCT02211261|20220693|P5|Overall Study|Withdrawal by Subject|2
5848799|NCT02211261|20220694|P4|Overall Study|Withdrawal by Subject|0
5848800|NCT02211261|20220695|P3|Overall Study|Withdrawal by Subject|1
5848801|NCT02211261|20220696|P2|Overall Study|Withdrawal by Subject|0
5848802|NCT02211261|20220697|P1|Overall Study|Withdrawal by Subject|0
5848803|NCT02211131|20220820|P2|Overall Study|Continuing on Study|60
5848804|NCT02211131|20220821|P1|Overall Study|Continuing on Study|49
5848805|NCT02211131|20220820|P2|Overall Study|Withdrawal by Subject|4
5848806|NCT02211131|20220821|P1|Overall Study|Withdrawal by Subject|3
5848807|NCT02211131|20220820|P2|Overall Study|Decision by Sponsor|1
5848808|NCT02211131|20220821|P1|Overall Study|Decision by Sponsor|1
5848809|NCT02211131|20220820|P2|Overall Study|Lost to Follow-up|0
5848810|NCT02211131|20220821|P1|Overall Study|Lost to Follow-up|1
5848811|NCT02211131|20220820|P2|Overall Study|Death|11
5848812|NCT02211131|20220821|P1|Overall Study|Death|20
5848813|NCT02211014|20220855|P2|Overall Study|In agreement with patient, no benefit|1
5848814|NCT02211014|20220856|P1|Overall Study|In agreement with patient, no benefit|0
5848815|NCT02211014|20220855|P2|Overall Study|Withdrawal by Subject|1
5848816|NCT02211014|20220856|P1|Overall Study|Withdrawal by Subject|0
5848817|NCT02211014|20220855|P2|Overall Study|Started another cancer therapy|0
5848818|NCT02211014|20220856|P1|Overall Study|Started another cancer therapy|1
5848819|NCT02211014|20220855|P2|Overall Study|Physician Decision|2
5848820|NCT02211014|20220856|P1|Overall Study|Physician Decision|1
5848821|NCT02211014|20220855|P2|Overall Study|Adverse Event|2
5848822|NCT02211014|20220856|P1|Overall Study|Adverse Event|0
5848823|NCT02210780|20220882|P2|Overall Study|Other than specified above|1
5848824|NCT02210780|20220883|P1|Overall Study|Other than specified above|0
5848825|NCT02210780|20220882|P2|Overall Study|Protocol Violation|0
5848826|NCT02210780|20220883|P1|Overall Study|Protocol Violation|1
5848827|NCT02210780|20220882|P2|Overall Study|Physician Decision|0
5848828|NCT02210780|20220883|P1|Overall Study|Physician Decision|1
5848829|NCT02210780|20220882|P2|Overall Study|Withdrawal by Subject|1
5848830|NCT02210780|20220883|P1|Overall Study|Withdrawal by Subject|1
5848831|NCT02210780|20220882|P2|Overall Study|Lost to Follow-up|1
5848832|NCT02210780|20220883|P1|Overall Study|Lost to Follow-up|2
5848833|NCT02210780|20220882|P2|Overall Study|Adverse Event|5
5848834|NCT02210780|20220883|P1|Overall Study|Adverse Event|0
5848835|NCT02210689|20220912|P3|Overall Study|Other|8
5848836|NCT02210689|20220913|P2|Overall Study|Other|21
5848837|NCT02210689|20220914|P1|Overall Study|Other|25
5848838|NCT02210689|20220912|P3|Overall Study|Negative Nugent score at baseline|2
5848839|NCT02210689|20220913|P2|Overall Study|Negative Nugent score at baseline|2
5848840|NCT02210689|20220914|P1|Overall Study|Negative Nugent score at baseline|6
5848841|NCT02210689|20220912|P3|Overall Study|Prohibited medication|1
5848842|NCT02210689|20220913|P2|Overall Study|Prohibited medication|8
5848843|NCT02210689|20220914|P1|Overall Study|Prohibited medication|2
5848844|NCT02210689|20220912|P3|Overall Study|Lack of Efficacy|5
5848845|NCT02210689|20220913|P2|Overall Study|Lack of Efficacy|1
5848846|NCT02210689|20220914|P1|Overall Study|Lack of Efficacy|0
5848847|NCT02210689|20220912|P3|Overall Study|Pregnancy|0
5848848|NCT02210689|20220913|P2|Overall Study|Pregnancy|1
5848849|NCT02210689|20220914|P1|Overall Study|Pregnancy|0
5848850|NCT02210689|20220912|P3|Overall Study|Lost to Follow-up|5
5848851|NCT02210689|20220913|P2|Overall Study|Lost to Follow-up|9
5848852|NCT02210689|20220914|P1|Overall Study|Lost to Follow-up|11
5848853|NCT02210689|20220912|P3|Overall Study|Protocol Violation|0
5848854|NCT02210689|20220913|P2|Overall Study|Protocol Violation|0
5848855|NCT02210689|20220914|P1|Overall Study|Protocol Violation|1
5848856|NCT02210689|20220912|P3|Overall Study|Adverse Event|0
5848857|NCT02210689|20220913|P2|Overall Study|Adverse Event|1
5848858|NCT02210689|20220914|P1|Overall Study|Adverse Event|0
5848859|NCT02210689|20220912|P3|Overall Study|Withdrawal by Subject|2
5848860|NCT02210689|20220913|P2|Overall Study|Withdrawal by Subject|4
5848861|NCT02210689|20220914|P1|Overall Study|Withdrawal by Subject|7
5848862|NCT02210221|20220922|P1|Overall Study|Withdrawal by Subject|43
5848863|NCT02210221|20220922|P1|Overall Study|Lack of Efficacy|7
5848864|NCT02210208|20220937|P1|Period B (Donor Site)|7 subjects healed at or before Day 14|7
5848865|NCT02210208|20220937|P1|Period A (Graft Site)|Physician decided not to graft at OR|1
5848866|NCT02210208|20220937|P1|Period A (Graft Site)|Withdrawal by Subject|1
5848867|NCT02210091|20220957|P2|Overall Study|Withdrawal by Sponsor|1
5848868|NCT02210091|20220958|P1|Overall Study|Withdrawal by Sponsor|0
5848869|NCT02210091|20220957|P2|Overall Study|Physician Decision|1
5848870|NCT02210091|20220958|P1|Overall Study|Physician Decision|0
5848871|NCT02210000|20221045|P2|Overall Study|Physician Decision|1
5848872|NCT02210000|20221046|P1|Overall Study|Physician Decision|0
5848873|NCT02210000|20221045|P2|Overall Study|Lost to Follow-up|2
5848874|NCT02210000|20221046|P1|Overall Study|Lost to Follow-up|0
5848875|NCT02210000|20221045|P2|Overall Study|Adverse Event|5
5848876|NCT02210000|20221046|P1|Overall Study|Adverse Event|1
5848877|NCT02210000|20221045|P2|Overall Study|Withdrawal by Subject|1
5848878|NCT02210000|20221046|P1|Overall Study|Withdrawal by Subject|7
5848879|NCT02210000|20221045|P2|Overall Study|Study Terminated|12
5848880|NCT02210000|20221046|P1|Overall Study|Study Terminated|11
5848881|NCT02209766|20221093|P5|Overall Study|Withdrawal by Subject|0
5848882|NCT02209766|20221094|P4|Overall Study|Withdrawal by Subject|1
5848883|NCT02209766|20221095|P3|Overall Study|Withdrawal by Subject|0
5848884|NCT02209766|20221096|P2|Overall Study|Withdrawal by Subject|0
5848885|NCT02209766|20221097|P1|Overall Study|Withdrawal by Subject|0
5848886|NCT02209597|20221156|P1|Phase 2 (Randomized: 1 Brand, 3 Generic)|Adverse Event|1
5848887|NCT02209597|20221156|P1|Phase 2 (Randomized: 1 Brand, 3 Generic)|Withdrawal by Subject|3
5848888|NCT02209597|20221156|P1|Phase 1 Current Tx (Non-randomized)|Adverse Event|1
5848889|NCT02209597|20221156|P1|Phase 1 Current Tx (Non-randomized)|Withdrawal by Subject|2
5848890|NCT02209506|20221201|P5|Overall Study|Withdrawal by Subject|1
5848891|NCT02209506|20221202|P4|Overall Study|Withdrawal by Subject|0
5848892|NCT02209506|20221203|P3|Overall Study|Withdrawal by Subject|0
5848893|NCT02209506|20221204|P2|Overall Study|Withdrawal by Subject|0
5848894|NCT02209506|20221205|P1|Overall Study|Withdrawal by Subject|0
5848895|NCT02209454|20221280|P2|Second Period|Adverse Event|0
5848896|NCT02209454|20221281|P1|Second Period|Adverse Event|1
5848897|NCT02209181|20221331|P4|Overall Study|Withdrawal by Subject|0
5848898|NCT02209181|20221332|P3|Overall Study|Withdrawal by Subject|0
5848899|NCT02209181|20221333|P2|Overall Study|Withdrawal by Subject|1
5848900|NCT02209181|20221334|P1|Overall Study|Withdrawal by Subject|0
5848901|NCT02209181|20221331|P4|Overall Study|Adverse Event|0
5848902|NCT02209181|20221332|P3|Overall Study|Adverse Event|1
5848903|NCT02209181|20221333|P2|Overall Study|Adverse Event|0
5848904|NCT02209181|20221334|P1|Overall Study|Adverse Event|1
5848905|NCT02208999|20221505|P1|Overall Study|Lost to Follow-up|1
5848906|NCT02208843|20221527|P1|Overall Study|Switched to commercial afatinib|20
5848907|NCT02208843|20221527|P1|Overall Study|Withdrawal by Subject|1
5848908|NCT02208843|20221527|P1|Overall Study|Protocol Violation|1
5848909|NCT02208843|20221527|P1|Overall Study|Adverse Event|12
5848910|NCT02208843|20221527|P1|Overall Study|Progression disease according to RECIST|24
5848911|NCT02208843|20221527|P1|Overall Study|Clinical symptoms of progression|2
5848912|NCT02208089|20221598|P2|Overall Study|Lost to Follow-up|0
5848913|NCT02208089|20221599|P1|Overall Study|Lost to Follow-up|6
5848914|NCT02208089|20221598|P2|Overall Study|Withdrawal by Subject|0
5848915|NCT02208089|20221599|P1|Overall Study|Withdrawal by Subject|1
5848916|NCT02208063|20221615|P2|Overall Study|Lost to Follow-up|0
5848917|NCT02208063|20221616|P1|Overall Study|Lost to Follow-up|1
5848918|NCT02208063|20221615|P2|Overall Study|Withdrawal by Subject|2
5848919|NCT02208063|20221616|P1|Overall Study|Withdrawal by Subject|5
5848920|NCT02208063|20221615|P2|Overall Study|Not Specified in report|4
5848921|NCT02208063|20221616|P1|Overall Study|Not Specified in report|3
5848922|NCT02208063|20221615|P2|Overall Study|Death|5
5848923|NCT02208063|20221616|P1|Overall Study|Death|3
5848924|NCT02207907|20221695|P2|Overall Study|Pregnancy|1
5848925|NCT02207907|20221696|P1|Overall Study|Pregnancy|0
5848926|NCT02207907|20221695|P2|Overall Study|Did not meet study criteria|0
5848927|NCT02207907|20221696|P1|Overall Study|Did not meet study criteria|3
5848928|NCT02207907|20221695|P2|Overall Study|Withdrawal by Subject|6
5848929|NCT02207907|20221696|P1|Overall Study|Withdrawal by Subject|5
5848930|NCT02207907|20221695|P2|Overall Study|Lost to Follow-up|1
5848931|NCT02207907|20221696|P1|Overall Study|Lost to Follow-up|3
5848932|NCT02207829|20221714|P2|Overall Study|Withdrew consent|14
5848933|NCT02207829|20221715|P1|Overall Study|Withdrew consent|18
5848934|NCT02207829|20221714|P2|Overall Study|Protocol deviation|4
5848935|NCT02207829|20221715|P1|Overall Study|Protocol deviation|5
5848936|NCT02207829|20221714|P2|Overall Study|Lost to Follow-up|2
5848937|NCT02207829|20221715|P1|Overall Study|Lost to Follow-up|2
5848938|NCT02207829|20221714|P2|Overall Study|Lack of Efficacy|5
5848939|NCT02207829|20221715|P1|Overall Study|Lack of Efficacy|7
5848940|NCT02207829|20221714|P2|Overall Study|Adverse Event|9
5848941|NCT02207829|20221715|P1|Overall Study|Adverse Event|10
5848942|NCT02207816|20221724|P3|Overall Study|Other|4
5848943|NCT02207816|20221725|P2|Overall Study|Other|2
5848944|NCT02207816|20221726|P1|Overall Study|Other|1
5848945|NCT02207816|20221724|P3|Overall Study|Lost to Follow-up|1
5848946|NCT02207816|20221725|P2|Overall Study|Lost to Follow-up|9
5848947|NCT02207816|20221726|P1|Overall Study|Lost to Follow-up|3
5848948|NCT02207816|20221724|P3|Overall Study|Migrated/Moved From Study Area|51
5848949|NCT02207816|20221725|P2|Overall Study|Migrated/Moved From Study Area|60
5848950|NCT02207816|20221726|P1|Overall Study|Migrated/Moved From Study Area|41
5848951|NCT02207816|20221724|P3|Overall Study|Withdrawal by Subject|7
5848952|NCT02207816|20221725|P2|Overall Study|Withdrawal by Subject|9
5848953|NCT02207816|20221726|P1|Overall Study|Withdrawal by Subject|4
5848954|NCT02207816|20221724|P3|Overall Study|Eligibility Criteria Not Fulfilled|2
5848955|NCT02207816|20221725|P2|Overall Study|Eligibility Criteria Not Fulfilled|1
5848956|NCT02207816|20221726|P1|Overall Study|Eligibility Criteria Not Fulfilled|2
5848957|NCT02207816|20221724|P3|Overall Study|Serious Adverse Event|2
5848958|NCT02207816|20221725|P2|Overall Study|Serious Adverse Event|5
5848959|NCT02207816|20221726|P1|Overall Study|Serious Adverse Event|0
5848960|NCT02207725|20221884|P4|Overall Study|Did Not Receive Treatment|1
5848961|NCT02207725|20221885|P3|Overall Study|Did Not Receive Treatment|1
5848962|NCT02207725|20221886|P2|Overall Study|Did Not Receive Treatment|1
5848963|NCT02207725|20221887|P1|Overall Study|Did Not Receive Treatment|0
5848964|NCT02207634|20221917|P2|Overall Study|Lost to Follow-up|0
5848965|NCT02207634|20221918|P1|Overall Study|Lost to Follow-up|1
5848966|NCT02207634|20221917|P2|Overall Study|Withdrawal by Subject|31
5848967|NCT02207634|20221918|P1|Overall Study|Withdrawal by Subject|21
5848968|NCT02207621|20221933|P3|Overall Study|Other(Site,Sponsor and Subject request)|5
5849058|NCT02207374|20222145|P2|Overall Study|Missing follow-up information|1
5848969|NCT02207621|20221934|P2|Overall Study|Other(Site,Sponsor and Subject request)|1
5848970|NCT02207621|20221935|P1|Overall Study|Other(Site,Sponsor and Subject request)|2
5848971|NCT02207621|20221933|P3|Overall Study|Death|0
5848972|NCT02207621|20221934|P2|Overall Study|Death|0
5848973|NCT02207621|20221935|P1|Overall Study|Death|2
5848974|NCT02207621|20221933|P3|Overall Study|Protocol Violation|6
5848975|NCT02207621|20221934|P2|Overall Study|Protocol Violation|10
5848976|NCT02207621|20221935|P1|Overall Study|Protocol Violation|4
5848977|NCT02207621|20221933|P3|Overall Study|Physician Decision|2
5848978|NCT02207621|20221934|P2|Overall Study|Physician Decision|2
5848979|NCT02207621|20221935|P1|Overall Study|Physician Decision|1
5848980|NCT02207621|20221933|P3|Overall Study|Disallowed Concurrent Medication|2
5848981|NCT02207621|20221934|P2|Overall Study|Disallowed Concurrent Medication|5
5848982|NCT02207621|20221935|P1|Overall Study|Disallowed Concurrent Medication|2
5848983|NCT02207621|20221933|P3|Overall Study|Lack of Efficacy|4
5848984|NCT02207621|20221934|P2|Overall Study|Lack of Efficacy|2
5848985|NCT02207621|20221935|P1|Overall Study|Lack of Efficacy|10
5848986|NCT02207621|20221933|P3|Overall Study|Lost to Follow-up|3
5848987|NCT02207621|20221934|P2|Overall Study|Lost to Follow-up|0
5848988|NCT02207621|20221935|P1|Overall Study|Lost to Follow-up|1
5848989|NCT02207621|20221933|P3|Overall Study|Non-Compliant|1
5848990|NCT02207621|20221934|P2|Overall Study|Non-Compliant|3
5848991|NCT02207621|20221935|P1|Overall Study|Non-Compliant|3
5848992|NCT02207621|20221933|P3|Overall Study|Withdrawal by Subject|13
5848993|NCT02207621|20221934|P2|Overall Study|Withdrawal by Subject|9
5848994|NCT02207621|20221935|P1|Overall Study|Withdrawal by Subject|9
5848995|NCT02207621|20221933|P3|Overall Study|Adverse Event|132
5848996|NCT02207621|20221934|P2|Overall Study|Adverse Event|15
5848997|NCT02207621|20221935|P1|Overall Study|Adverse Event|71
5848998|NCT02207608|20221948|P2|Overall Study|Adverse Event|0
5848999|NCT02207608|20221949|P1|Overall Study|Adverse Event|1
5849000|NCT02207556|20221975|P2|Overall Study|Death|5
5849001|NCT02207556|20221976|P1|Overall Study|Death|0
5849002|NCT02207556|20221975|P2|Overall Study|Withdrawal by Subject|0
5849003|NCT02207556|20221976|P1|Overall Study|Withdrawal by Subject|1
5849004|NCT02207556|20221975|P2|Overall Study|Physician Decision|0
5849005|NCT02207556|20221976|P1|Overall Study|Physician Decision|1
5849006|NCT02207530|20221981|P1|Overall Study|Adverse Event|8
5849007|NCT02207530|20221981|P1|Overall Study|Patient decision to stop study treatment|5
5849008|NCT02207530|20221981|P1|Overall Study|Worsening condition under investigation|78
5849009|NCT02207491|20221995|P2|Overall Study|Protocol Violation|5
5849010|NCT02207491|20221996|P1|Overall Study|Protocol Violation|3
5849011|NCT02207491|20221995|P2|Overall Study|Physician Decision|0
5849012|NCT02207491|20221996|P1|Overall Study|Physician Decision|2
5849013|NCT02207491|20221995|P2|Overall Study|Lack of Efficacy|0
5849014|NCT02207491|20221996|P1|Overall Study|Lack of Efficacy|3
5849015|NCT02207491|20221995|P2|Overall Study|Lost to Follow-up|1
5849016|NCT02207491|20221996|P1|Overall Study|Lost to Follow-up|0
5849017|NCT02207491|20221995|P2|Overall Study|Non-compliant|1
5849018|NCT02207491|20221996|P1|Overall Study|Non-compliant|0
5849019|NCT02207491|20221995|P2|Overall Study|Withdrawal by Subject|2
5849020|NCT02207491|20221996|P1|Overall Study|Withdrawal by Subject|3
5849021|NCT02207491|20221995|P2|Overall Study|Adverse Event|4
5849022|NCT02207491|20221996|P1|Overall Study|Adverse Event|20
5849023|NCT02207413|20222021|P6|Overall Study|Migrated/moved from study area|0
5849024|NCT02207413|20222022|P5|Overall Study|Migrated/moved from study area|1
5849025|NCT02207413|20222023|P4|Overall Study|Migrated/moved from study area|0
5849026|NCT02207413|20222024|P3|Overall Study|Migrated/moved from study area|0
5849027|NCT02207413|20222025|P2|Overall Study|Migrated/moved from study area|0
5849028|NCT02207413|20222026|P1|Overall Study|Migrated/moved from study area|0
5849029|NCT02207413|20222021|P6|Overall Study|Adverse Event|1
5849030|NCT02207413|20222022|P5|Overall Study|Adverse Event|2
5849031|NCT02207413|20222023|P4|Overall Study|Adverse Event|0
5849032|NCT02207413|20222024|P3|Overall Study|Adverse Event|0
5849033|NCT02207413|20222025|P2|Overall Study|Adverse Event|0
5849034|NCT02207413|20222026|P1|Overall Study|Adverse Event|0
5849035|NCT02207413|20222021|P6|Overall Study|Lost to Follow-up|5
5849036|NCT02207413|20222022|P5|Overall Study|Lost to Follow-up|1
5849037|NCT02207413|20222023|P4|Overall Study|Lost to Follow-up|1
5849038|NCT02207413|20222024|P3|Overall Study|Lost to Follow-up|0
5849039|NCT02207413|20222025|P2|Overall Study|Lost to Follow-up|0
5849040|NCT02207413|20222026|P1|Overall Study|Lost to Follow-up|0
5849041|NCT02207413|20222021|P6|Overall Study|Withdrawal by Subject|7
5849042|NCT02207413|20222022|P5|Overall Study|Withdrawal by Subject|3
5849043|NCT02207413|20222023|P4|Overall Study|Withdrawal by Subject|0
5849044|NCT02207413|20222024|P3|Overall Study|Withdrawal by Subject|0
5849045|NCT02207413|20222025|P2|Overall Study|Withdrawal by Subject|0
5849046|NCT02207413|20222026|P1|Overall Study|Withdrawal by Subject|1
5849047|NCT02207400|20222122|P2|Overall Study|Positive Urine Pregnancy Test|1
5849048|NCT02207400|20222123|P1|Overall Study|Positive Urine Pregnancy Test|0
5849049|NCT02207400|20222122|P2|Overall Study|Withdrawal by Subject|4
5849050|NCT02207400|20222123|P1|Overall Study|Withdrawal by Subject|8
5849051|NCT02207400|20222122|P2|Overall Study|Protocol Violation|1
5849052|NCT02207400|20222123|P1|Overall Study|Protocol Violation|1
5849053|NCT02207400|20222122|P2|Overall Study|Lost to Follow-up|7
5849054|NCT02207400|20222123|P1|Overall Study|Lost to Follow-up|6
5849055|NCT02207400|20222122|P2|Overall Study|Adverse Event|1
5849056|NCT02207400|20222123|P1|Overall Study|Adverse Event|1
5849057|NCT02207374|20222144|P3|Overall Study|Missing follow-up information|1
5849059|NCT02207374|20222146|P1|Overall Study|Missing follow-up information|0
5849060|NCT02207374|20222144|P3|Overall Study|Death|1
5849061|NCT02207374|20222145|P2|Overall Study|Death|0
5849062|NCT02207374|20222146|P1|Overall Study|Death|1
5849063|NCT02207374|20222144|P3|Overall Study|Withdrawal by Subject|4
5849064|NCT02207374|20222145|P2|Overall Study|Withdrawal by Subject|9
5849065|NCT02207374|20222146|P1|Overall Study|Withdrawal by Subject|5
5849066|NCT02207244|20222210|P9|Withdrawal, Retreatment Period:Week28-48|Other|0
5849067|NCT02207244|20222211|P8|Withdrawal, Retreatment Period:Week28-48|Other|1
5849068|NCT02207244|20222212|P7|Withdrawal, Retreatment Period:Week28-48|Other|0
5849069|NCT02207244|20222213|P6|Withdrawal, Retreatment Period:Week28-48|Other|0
5849070|NCT02207244|20222214|P5|Withdrawal, Retreatment Period:Week28-48|Other|0
5849071|NCT02207244|20222215|P4|Withdrawal, Retreatment Period:Week28-48|Other|0
5849072|NCT02207244|20222216|P3|Withdrawal, Retreatment Period:Week28-48|Other|0
5849073|NCT02207244|20222217|P2|Withdrawal, Retreatment Period:Week28-48|Other|0
5849074|NCT02207244|20222218|P1|Withdrawal, Retreatment Period:Week28-48|Other|0
5849075|NCT02207244|20222210|P9|Withdrawal, Retreatment Period:Week28-48|Non-compliance|0
5849076|NCT02207244|20222211|P8|Withdrawal, Retreatment Period:Week28-48|Non-compliance|0
5849077|NCT02207244|20222212|P7|Withdrawal, Retreatment Period:Week28-48|Non-compliance|1
5849078|NCT02207244|20222213|P6|Withdrawal, Retreatment Period:Week28-48|Non-compliance|0
5849079|NCT02207244|20222214|P5|Withdrawal, Retreatment Period:Week28-48|Non-compliance|0
5849080|NCT02207244|20222215|P4|Withdrawal, Retreatment Period:Week28-48|Non-compliance|0
5849081|NCT02207244|20222216|P3|Withdrawal, Retreatment Period:Week28-48|Non-compliance|0
5849082|NCT02207244|20222217|P2|Withdrawal, Retreatment Period:Week28-48|Non-compliance|0
5849083|NCT02207244|20222218|P1|Withdrawal, Retreatment Period:Week28-48|Non-compliance|0
5849084|NCT02207244|20222210|P9|Withdrawal, Retreatment Period:Week28-48|Protocol Violation|0
5849085|NCT02207244|20222211|P8|Withdrawal, Retreatment Period:Week28-48|Protocol Violation|0
5849086|NCT02207244|20222212|P7|Withdrawal, Retreatment Period:Week28-48|Protocol Violation|1
5849087|NCT02207244|20222213|P6|Withdrawal, Retreatment Period:Week28-48|Protocol Violation|0
5849088|NCT02207244|20222214|P5|Withdrawal, Retreatment Period:Week28-48|Protocol Violation|0
5849089|NCT02207244|20222215|P4|Withdrawal, Retreatment Period:Week28-48|Protocol Violation|0
5849090|NCT02207244|20222216|P3|Withdrawal, Retreatment Period:Week28-48|Protocol Violation|0
5849091|NCT02207244|20222217|P2|Withdrawal, Retreatment Period:Week28-48|Protocol Violation|0
5849092|NCT02207244|20222218|P1|Withdrawal, Retreatment Period:Week28-48|Protocol Violation|0
5849093|NCT02207244|20222210|P9|Withdrawal, Retreatment Period:Week28-48|Withdrawal by Subject|1
5849094|NCT02207244|20222211|P8|Withdrawal, Retreatment Period:Week28-48|Withdrawal by Subject|2
5849095|NCT02207244|20222212|P7|Withdrawal, Retreatment Period:Week28-48|Withdrawal by Subject|1
5849096|NCT02207244|20222213|P6|Withdrawal, Retreatment Period:Week28-48|Withdrawal by Subject|0
5849097|NCT02207244|20222214|P5|Withdrawal, Retreatment Period:Week28-48|Withdrawal by Subject|0
5849098|NCT02207244|20222215|P4|Withdrawal, Retreatment Period:Week28-48|Withdrawal by Subject|0
5849099|NCT02207244|20222216|P3|Withdrawal, Retreatment Period:Week28-48|Withdrawal by Subject|0
5849100|NCT02207244|20222217|P2|Withdrawal, Retreatment Period:Week28-48|Withdrawal by Subject|0
5849101|NCT02207244|20222218|P1|Withdrawal, Retreatment Period:Week28-48|Withdrawal by Subject|0
5849102|NCT02207244|20222210|P9|Withdrawal, Retreatment Period:Week28-48|Lost to Follow-up|2
5849103|NCT02207244|20222211|P8|Withdrawal, Retreatment Period:Week28-48|Lost to Follow-up|5
5849104|NCT02207244|20222212|P7|Withdrawal, Retreatment Period:Week28-48|Lost to Follow-up|2
5849105|NCT02207244|20222213|P6|Withdrawal, Retreatment Period:Week28-48|Lost to Follow-up|0
5849106|NCT02207244|20222214|P5|Withdrawal, Retreatment Period:Week28-48|Lost to Follow-up|0
5849107|NCT02207244|20222215|P4|Withdrawal, Retreatment Period:Week28-48|Lost to Follow-up|0
5849108|NCT02207244|20222216|P3|Withdrawal, Retreatment Period:Week28-48|Lost to Follow-up|0
5849109|NCT02207244|20222217|P2|Withdrawal, Retreatment Period:Week28-48|Lost to Follow-up|0
5849110|NCT02207244|20222218|P1|Withdrawal, Retreatment Period:Week28-48|Lost to Follow-up|0
5849111|NCT02207244|20222210|P9|Withdrawal, Retreatment Period:Week28-48|Lack of Efficacy|2
5849112|NCT02207244|20222211|P8|Withdrawal, Retreatment Period:Week28-48|Lack of Efficacy|2
5849113|NCT02207244|20222212|P7|Withdrawal, Retreatment Period:Week28-48|Lack of Efficacy|0
5849114|NCT02207244|20222213|P6|Withdrawal, Retreatment Period:Week28-48|Lack of Efficacy|0
5849115|NCT02207244|20222214|P5|Withdrawal, Retreatment Period:Week28-48|Lack of Efficacy|0
5849116|NCT02207244|20222215|P4|Withdrawal, Retreatment Period:Week28-48|Lack of Efficacy|0
5849117|NCT02207244|20222216|P3|Withdrawal, Retreatment Period:Week28-48|Lack of Efficacy|0
5849118|NCT02207244|20222217|P2|Withdrawal, Retreatment Period:Week28-48|Lack of Efficacy|0
5849119|NCT02207244|20222218|P1|Withdrawal, Retreatment Period:Week28-48|Lack of Efficacy|0
5849120|NCT02207244|20222210|P9|Withdrawal, Retreatment Period:Week28-48|Pregnancy|0
5849121|NCT02207244|20222211|P8|Withdrawal, Retreatment Period:Week28-48|Pregnancy|2
5849122|NCT02207244|20222212|P7|Withdrawal, Retreatment Period:Week28-48|Pregnancy|0
5849123|NCT02207244|20222213|P6|Withdrawal, Retreatment Period:Week28-48|Pregnancy|0
5849124|NCT02207244|20222214|P5|Withdrawal, Retreatment Period:Week28-48|Pregnancy|0
5849125|NCT02207244|20222215|P4|Withdrawal, Retreatment Period:Week28-48|Pregnancy|0
5849126|NCT02207244|20222216|P3|Withdrawal, Retreatment Period:Week28-48|Pregnancy|0
5849127|NCT02207244|20222217|P2|Withdrawal, Retreatment Period:Week28-48|Pregnancy|0
5849128|NCT02207244|20222218|P1|Withdrawal, Retreatment Period:Week28-48|Pregnancy|0
5849129|NCT02207244|20222210|P9|Withdrawal, Retreatment Period:Week28-48|Adverse Event|3
5849130|NCT02207244|20222211|P8|Withdrawal, Retreatment Period:Week28-48|Adverse Event|1
5849131|NCT02207244|20222212|P7|Withdrawal, Retreatment Period:Week28-48|Adverse Event|3
5849132|NCT02207244|20222213|P6|Withdrawal, Retreatment Period:Week28-48|Adverse Event|0
5849133|NCT02207244|20222214|P5|Withdrawal, Retreatment Period:Week28-48|Adverse Event|0
5849134|NCT02207244|20222215|P4|Withdrawal, Retreatment Period:Week28-48|Adverse Event|0
5849135|NCT02207244|20222216|P3|Withdrawal, Retreatment Period:Week28-48|Adverse Event|0
5849136|NCT02207244|20222217|P2|Withdrawal, Retreatment Period:Week28-48|Adverse Event|0
5849137|NCT02207244|20222218|P1|Withdrawal, Retreatment Period:Week28-48|Adverse Event|0
5849138|NCT02207244|20222210|P9|Placebo Crossover and ACP: Week 16 - 28|Other|0
5849139|NCT02207244|20222211|P8|Placebo Crossover and ACP: Week 16 - 28|Other|0
5849140|NCT02207244|20222212|P7|Placebo Crossover and ACP: Week 16 - 28|Other|0
5849141|NCT02207244|20222213|P6|Placebo Crossover and ACP: Week 16 - 28|Other|0
5849142|NCT02207244|20222214|P5|Placebo Crossover and ACP: Week 16 - 28|Other|0
5849143|NCT02207244|20222215|P4|Placebo Crossover and ACP: Week 16 - 28|Other|1
5849144|NCT02207244|20222216|P3|Placebo Crossover and ACP: Week 16 - 28|Other|0
5849145|NCT02207244|20222217|P2|Placebo Crossover and ACP: Week 16 - 28|Other|0
5849146|NCT02207244|20222218|P1|Placebo Crossover and ACP: Week 16 - 28|Other|0
5849147|NCT02207244|20222210|P9|Placebo Crossover and ACP: Week 16 - 28|Protocol Violation|0
5849148|NCT02207244|20222211|P8|Placebo Crossover and ACP: Week 16 - 28|Protocol Violation|0
5849149|NCT02207244|20222212|P7|Placebo Crossover and ACP: Week 16 - 28|Protocol Violation|0
5849150|NCT02207244|20222213|P6|Placebo Crossover and ACP: Week 16 - 28|Protocol Violation|1
5849151|NCT02207244|20222214|P5|Placebo Crossover and ACP: Week 16 - 28|Protocol Violation|0
5849152|NCT02207244|20222215|P4|Placebo Crossover and ACP: Week 16 - 28|Protocol Violation|1
5849153|NCT02207244|20222216|P3|Placebo Crossover and ACP: Week 16 - 28|Protocol Violation|0
5849154|NCT02207244|20222217|P2|Placebo Crossover and ACP: Week 16 - 28|Protocol Violation|0
5849155|NCT02207244|20222218|P1|Placebo Crossover and ACP: Week 16 - 28|Protocol Violation|0
5849156|NCT02207244|20222210|P9|Placebo Crossover and ACP: Week 16 - 28|Withdrawal by Subject|0
5849157|NCT02207244|20222211|P8|Placebo Crossover and ACP: Week 16 - 28|Withdrawal by Subject|0
5849158|NCT02207244|20222212|P7|Placebo Crossover and ACP: Week 16 - 28|Withdrawal by Subject|0
5849159|NCT02207244|20222213|P6|Placebo Crossover and ACP: Week 16 - 28|Withdrawal by Subject|2
5849160|NCT02207244|20222214|P5|Placebo Crossover and ACP: Week 16 - 28|Withdrawal by Subject|3
5849161|NCT02207244|20222215|P4|Placebo Crossover and ACP: Week 16 - 28|Withdrawal by Subject|3
5849162|NCT02207244|20222216|P3|Placebo Crossover and ACP: Week 16 - 28|Withdrawal by Subject|0
5849163|NCT02207244|20222217|P2|Placebo Crossover and ACP: Week 16 - 28|Withdrawal by Subject|0
5849164|NCT02207244|20222218|P1|Placebo Crossover and ACP: Week 16 - 28|Withdrawal by Subject|0
5849165|NCT02207244|20222210|P9|Placebo Crossover and ACP: Week 16 - 28|Lost to Follow-up|0
5849166|NCT02207244|20222211|P8|Placebo Crossover and ACP: Week 16 - 28|Lost to Follow-up|0
5849167|NCT02207244|20222212|P7|Placebo Crossover and ACP: Week 16 - 28|Lost to Follow-up|0
5849168|NCT02207244|20222213|P6|Placebo Crossover and ACP: Week 16 - 28|Lost to Follow-up|2
5849169|NCT02207244|20222214|P5|Placebo Crossover and ACP: Week 16 - 28|Lost to Follow-up|2
5849170|NCT02207244|20222215|P4|Placebo Crossover and ACP: Week 16 - 28|Lost to Follow-up|1
5849171|NCT02207244|20222216|P3|Placebo Crossover and ACP: Week 16 - 28|Lost to Follow-up|0
5849172|NCT02207244|20222217|P2|Placebo Crossover and ACP: Week 16 - 28|Lost to Follow-up|0
5849173|NCT02207244|20222218|P1|Placebo Crossover and ACP: Week 16 - 28|Lost to Follow-up|0
5849174|NCT02207244|20222210|P9|Placebo Crossover and ACP: Week 16 - 28|Lack of Efficacy|0
5849175|NCT02207244|20222211|P8|Placebo Crossover and ACP: Week 16 - 28|Lack of Efficacy|0
5849176|NCT02207244|20222212|P7|Placebo Crossover and ACP: Week 16 - 28|Lack of Efficacy|0
5849177|NCT02207244|20222213|P6|Placebo Crossover and ACP: Week 16 - 28|Lack of Efficacy|2
5849178|NCT02207244|20222214|P5|Placebo Crossover and ACP: Week 16 - 28|Lack of Efficacy|0
5849179|NCT02207244|20222215|P4|Placebo Crossover and ACP: Week 16 - 28|Lack of Efficacy|0
5849180|NCT02207244|20222216|P3|Placebo Crossover and ACP: Week 16 - 28|Lack of Efficacy|0
5849181|NCT02207244|20222217|P2|Placebo Crossover and ACP: Week 16 - 28|Lack of Efficacy|0
5849182|NCT02207244|20222218|P1|Placebo Crossover and ACP: Week 16 - 28|Lack of Efficacy|0
5849183|NCT02207244|20222210|P9|Placebo Crossover and ACP: Week 16 - 28|Adverse Event|0
5849184|NCT02207244|20222211|P8|Placebo Crossover and ACP: Week 16 - 28|Adverse Event|0
5849185|NCT02207244|20222212|P7|Placebo Crossover and ACP: Week 16 - 28|Adverse Event|0
5849186|NCT02207244|20222213|P6|Placebo Crossover and ACP: Week 16 - 28|Adverse Event|2
5849187|NCT02207244|20222214|P5|Placebo Crossover and ACP: Week 16 - 28|Adverse Event|3
5849188|NCT02207244|20222215|P4|Placebo Crossover and ACP: Week 16 - 28|Adverse Event|0
5849189|NCT02207244|20222216|P3|Placebo Crossover and ACP: Week 16 - 28|Adverse Event|0
5849190|NCT02207244|20222217|P2|Placebo Crossover and ACP: Week 16 - 28|Adverse Event|0
5849191|NCT02207244|20222218|P1|Placebo Crossover and ACP: Week 16 - 28|Adverse Event|0
5849192|NCT02207244|20222210|P9|Placebo Controlled Period: Week 0 - 16|Other|0
5849193|NCT02207244|20222211|P8|Placebo Controlled Period: Week 0 - 16|Other|0
5849194|NCT02207244|20222212|P7|Placebo Controlled Period: Week 0 - 16|Other|0
5849195|NCT02207244|20222213|P6|Placebo Controlled Period: Week 0 - 16|Other|0
5849196|NCT02207244|20222214|P5|Placebo Controlled Period: Week 0 - 16|Other|0
5849197|NCT02207244|20222215|P4|Placebo Controlled Period: Week 0 - 16|Other|0
5849198|NCT02207244|20222216|P3|Placebo Controlled Period: Week 0 - 16|Other|0
5849199|NCT02207244|20222217|P2|Placebo Controlled Period: Week 0 - 16|Other|1
5849200|NCT02207244|20222218|P1|Placebo Controlled Period: Week 0 - 16|Other|0
5849201|NCT02207244|20222210|P9|Placebo Controlled Period: Week 0 - 16|Non-Compliance|0
5849202|NCT02207244|20222211|P8|Placebo Controlled Period: Week 0 - 16|Non-Compliance|0
5849203|NCT02207244|20222212|P7|Placebo Controlled Period: Week 0 - 16|Non-Compliance|0
5849204|NCT02207244|20222213|P6|Placebo Controlled Period: Week 0 - 16|Non-Compliance|0
5849205|NCT02207244|20222214|P5|Placebo Controlled Period: Week 0 - 16|Non-Compliance|0
5849206|NCT02207244|20222215|P4|Placebo Controlled Period: Week 0 - 16|Non-Compliance|0
5849207|NCT02207244|20222216|P3|Placebo Controlled Period: Week 0 - 16|Non-Compliance|2
5849208|NCT02207244|20222217|P2|Placebo Controlled Period: Week 0 - 16|Non-Compliance|1
5849209|NCT02207244|20222218|P1|Placebo Controlled Period: Week 0 - 16|Non-Compliance|0
5849210|NCT02207244|20222210|P9|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
5849211|NCT02207244|20222211|P8|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
5849212|NCT02207244|20222212|P7|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
5849213|NCT02207244|20222213|P6|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
5849214|NCT02207244|20222214|P5|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
5849215|NCT02207244|20222215|P4|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
5849216|NCT02207244|20222216|P3|Placebo Controlled Period: Week 0 - 16|Protocol Violation|1
5849217|NCT02207244|20222217|P2|Placebo Controlled Period: Week 0 - 16|Protocol Violation|3
5849218|NCT02207244|20222218|P1|Placebo Controlled Period: Week 0 - 16|Protocol Violation|1
5849219|NCT02207244|20222210|P9|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0
5849220|NCT02207244|20222211|P8|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0
5849221|NCT02207244|20222212|P7|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0
5849222|NCT02207244|20222213|P6|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0
5849223|NCT02207244|20222214|P5|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0
5849224|NCT02207244|20222215|P4|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0
5849225|NCT02207244|20222216|P3|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0
5849226|NCT02207244|20222217|P2|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|1
5849227|NCT02207244|20222218|P1|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|7
5849228|NCT02207244|20222210|P9|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0
5849229|NCT02207244|20222211|P8|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0
5849230|NCT02207244|20222212|P7|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0
5849231|NCT02207244|20222213|P6|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0
5849232|NCT02207244|20222214|P5|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0
5849233|NCT02207244|20222215|P4|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0
5849234|NCT02207244|20222216|P3|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|2
5849235|NCT02207244|20222217|P2|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|3
5849236|NCT02207244|20222218|P1|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1
5849237|NCT02207244|20222210|P9|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0
5849238|NCT02207244|20222211|P8|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0
5849239|NCT02207244|20222212|P7|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0
5849240|NCT02207244|20222213|P6|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0
5849241|NCT02207244|20222214|P5|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0
5849242|NCT02207244|20222215|P4|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0
5849243|NCT02207244|20222216|P3|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|2
5849244|NCT02207244|20222217|P2|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0
5849245|NCT02207244|20222218|P1|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|4
5849246|NCT02207244|20222210|P9|Placebo Controlled Period: Week 0 - 16|Adverse Event|0
5849247|NCT02207244|20222211|P8|Placebo Controlled Period: Week 0 - 16|Adverse Event|0
5849248|NCT02207244|20222212|P7|Placebo Controlled Period: Week 0 - 16|Adverse Event|0
5849249|NCT02207244|20222213|P6|Placebo Controlled Period: Week 0 - 16|Adverse Event|0
5849250|NCT02207244|20222214|P5|Placebo Controlled Period: Week 0 - 16|Adverse Event|0
5849251|NCT02207244|20222215|P4|Placebo Controlled Period: Week 0 - 16|Adverse Event|0
5849252|NCT02207244|20222216|P3|Placebo Controlled Period: Week 0 - 16|Adverse Event|4
5849253|NCT02207244|20222217|P2|Placebo Controlled Period: Week 0 - 16|Adverse Event|9
5849254|NCT02207244|20222218|P1|Placebo Controlled Period: Week 0 - 16|Adverse Event|2
5849255|NCT02207231|20222259|P3|Active Controlled Period: Week 16 - 48|Non-compliance|3
5849256|NCT02207231|20222260|P2|Active Controlled Period: Week 16 - 48|Non-compliance|3
5849257|NCT02207231|20222261|P1|Active Controlled Period: Week 16 - 48|Non-compliance|0
5849258|NCT02207231|20222259|P3|Active Controlled Period: Week 16 - 48|Other|3
5849259|NCT02207231|20222260|P2|Active Controlled Period: Week 16 - 48|Other|2
5849260|NCT02207231|20222261|P1|Active Controlled Period: Week 16 - 48|Other|0
5849261|NCT02207231|20222259|P3|Active Controlled Period: Week 16 - 48|Protocol Violation|0
5849262|NCT02207231|20222260|P2|Active Controlled Period: Week 16 - 48|Protocol Violation|1
5849263|NCT02207231|20222261|P1|Active Controlled Period: Week 16 - 48|Protocol Violation|0
5849264|NCT02207231|20222259|P3|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|10
5849265|NCT02207231|20222260|P2|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|4
5849266|NCT02207231|20222261|P1|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|1
5849267|NCT02207231|20222259|P3|Active Controlled Period: Week 16 - 48|Lost to Follow-up|5
5849268|NCT02207231|20222260|P2|Active Controlled Period: Week 16 - 48|Lost to Follow-up|2
5849269|NCT02207231|20222261|P1|Active Controlled Period: Week 16 - 48|Lost to Follow-up|1
5849270|NCT02207231|20222259|P3|Active Controlled Period: Week 16 - 48|Lack of Efficacy|11
5849271|NCT02207231|20222260|P2|Active Controlled Period: Week 16 - 48|Lack of Efficacy|3
5849272|NCT02207231|20222261|P1|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0
5849273|NCT02207231|20222259|P3|Active Controlled Period: Week 16 - 48|Pregnancy|1
5849274|NCT02207231|20222260|P2|Active Controlled Period: Week 16 - 48|Pregnancy|0
5849275|NCT02207231|20222261|P1|Active Controlled Period: Week 16 - 48|Pregnancy|0
5849276|NCT02207231|20222259|P3|Active Controlled Period: Week 16 - 48|Adverse Event|9
5849277|NCT02207231|20222260|P2|Active Controlled Period: Week 16 - 48|Adverse Event|6
5849278|NCT02207231|20222261|P1|Active Controlled Period: Week 16 - 48|Adverse Event|1
5849279|NCT02207231|20222259|P3|Placebo Controlled Period: Week 0 - 16|Noncompliance|1
5849280|NCT02207231|20222260|P2|Placebo Controlled Period: Week 0 - 16|Noncompliance|2
5849281|NCT02207231|20222261|P1|Placebo Controlled Period: Week 0 - 16|Noncompliance|0
5849282|NCT02207231|20222259|P3|Placebo Controlled Period: Week 0 - 16|Protocol Violation|1
5849283|NCT02207231|20222260|P2|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
5849284|NCT02207231|20222261|P1|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
5849285|NCT02207231|20222259|P3|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|4
5849286|NCT02207231|20222260|P2|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0
5849287|NCT02207231|20222261|P1|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|2
5849288|NCT02207231|20222259|P3|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1
5849289|NCT02207231|20222260|P2|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1
5849290|NCT02207231|20222261|P1|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1
5849291|NCT02207231|20222259|P3|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|1
5849292|NCT02207231|20222260|P2|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0
5849293|NCT02207231|20222261|P1|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|2
5849294|NCT02207231|20222259|P3|Placebo Controlled Period: Week 0 - 16|Adverse Event|2
5849295|NCT02207231|20222260|P2|Placebo Controlled Period: Week 0 - 16|Adverse Event|4
5849296|NCT02207231|20222261|P1|Placebo Controlled Period: Week 0 - 16|Adverse Event|2
5849297|NCT02207088|20222293|P1|Overall Study|Adverse Event|2
5849298|NCT02206828|20222299|P1|Overall Study|Lost to Follow-up|7
5849299|NCT02206620|20222335|P2|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|2
5849300|NCT02206620|20222336|P1|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|0
5849301|NCT02206620|20222335|P2|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1
5849302|NCT02206620|20222336|P1|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1
5849303|NCT02206607|20222352|P5|Second Intervention Period|Insufficient Clinical Response|0
5849304|NCT02206607|20222353|P4|Second Intervention Period|Insufficient Clinical Response|1
5849305|NCT02206607|20222354|P3|Second Intervention Period|Insufficient Clinical Response|0
5849306|NCT02206607|20222355|P2|Second Intervention Period|Insufficient Clinical Response|0
5849307|NCT02206607|20222356|P1|Second Intervention Period|Insufficient Clinical Response|0
5849308|NCT02206607|20222352|P5|Open-Label Run-In|Withdrawal by Subject|0
5849309|NCT02206607|20222353|P4|Open-Label Run-In|Withdrawal by Subject|0
5849310|NCT02206607|20222354|P3|Open-Label Run-In|Withdrawal by Subject|0
5849311|NCT02206607|20222355|P2|Open-Label Run-In|Withdrawal by Subject|0
5849312|NCT02206607|20222356|P1|Open-Label Run-In|Withdrawal by Subject|3
5849313|NCT02206152|20222419|P1|Pre-Randomization|Withdrawal by Subject|2
5849314|NCT02205814|20222446|P4|Overall Study|not compliant with study procedures|0
5849315|NCT02205814|20222447|P3|Overall Study|not compliant with study procedures|1
5849316|NCT02205814|20222448|P2|Overall Study|not compliant with study procedures|0
5849317|NCT02205814|20222449|P1|Overall Study|not compliant with study procedures|0
5849318|NCT02205814|20222446|P4|Overall Study|Withdrawal by Subject|1
5849319|NCT02205814|20222447|P3|Overall Study|Withdrawal by Subject|2
5849320|NCT02205814|20222448|P2|Overall Study|Withdrawal by Subject|1
5849321|NCT02205814|20222449|P1|Overall Study|Withdrawal by Subject|0
5849322|NCT02205814|20222446|P4|Overall Study|Protocol Violation|1
5849323|NCT02205814|20222447|P3|Overall Study|Protocol Violation|0
5849324|NCT02205814|20222448|P2|Overall Study|Protocol Violation|0
5849325|NCT02205814|20222449|P1|Overall Study|Protocol Violation|1
5849326|NCT02205814|20222446|P4|Overall Study|Physician Decision|0
5849327|NCT02205814|20222447|P3|Overall Study|Physician Decision|1
5849328|NCT02205814|20222448|P2|Overall Study|Physician Decision|0
5849329|NCT02205814|20222449|P1|Overall Study|Physician Decision|0
5849330|NCT02205814|20222446|P4|Overall Study|Lack of Efficacy|1
5849331|NCT02205814|20222447|P3|Overall Study|Lack of Efficacy|1
5849332|NCT02205814|20222448|P2|Overall Study|Lack of Efficacy|0
5849333|NCT02205814|20222449|P1|Overall Study|Lack of Efficacy|1
5849334|NCT02205814|20222446|P4|Overall Study|Lost to Follow-up|1
5849335|NCT02205814|20222447|P3|Overall Study|Lost to Follow-up|0
5849336|NCT02205814|20222448|P2|Overall Study|Lost to Follow-up|0
5849337|NCT02205814|20222449|P1|Overall Study|Lost to Follow-up|0
5849338|NCT02205476|20222502|P2|Overall Study|Study termination by Sponsor|3
5849339|NCT02205476|20222503|P1|Overall Study|Study termination by Sponsor|7
5849340|NCT02205333|20222542|P9|Overall Study|Withdrawal by Subject|0
5849341|NCT02205333|20222543|P8|Overall Study|Withdrawal by Subject|0
5849342|NCT02205333|20222544|P7|Overall Study|Withdrawal by Subject|2
5849343|NCT02205333|20222545|P6|Overall Study|Withdrawal by Subject|0
5849344|NCT02205333|20222546|P5|Overall Study|Withdrawal by Subject|0
5849345|NCT02205333|20222547|P4|Overall Study|Withdrawal by Subject|1
5849346|NCT02205333|20222548|P3|Overall Study|Withdrawal by Subject|0
5849347|NCT02205333|20222549|P2|Overall Study|Withdrawal by Subject|0
5849348|NCT02205333|20222550|P1|Overall Study|Withdrawal by Subject|1
5849349|NCT02205333|20222542|P9|Overall Study|Death|0
5849350|NCT02205333|20222543|P8|Overall Study|Death|2
5849351|NCT02205333|20222544|P7|Overall Study|Death|3
5849352|NCT02205333|20222545|P6|Overall Study|Death|3
5849353|NCT02205333|20222546|P5|Overall Study|Death|5
5849354|NCT02205333|20222547|P4|Overall Study|Death|6
5849355|NCT02205333|20222548|P3|Overall Study|Death|2
5849356|NCT02205333|20222549|P2|Overall Study|Death|6
5849357|NCT02205333|20222550|P1|Overall Study|Death|5
5849358|NCT02204982|20222749|P2|Overall Study|Termination of Study bySponsor|1
5849359|NCT02204982|20222750|P1|Overall Study|Termination of Study bySponsor|0
5849360|NCT02204982|20222749|P2|Overall Study|Protocol-Specified Disease Progression|4
5849361|NCT02204982|20222750|P1|Overall Study|Protocol-Specified Disease Progression|0
5849362|NCT02204982|20222749|P2|Overall Study|Physician Decision|2
5849363|NCT02204982|20222750|P1|Overall Study|Physician Decision|0
5849364|NCT02204982|20222749|P2|Overall Study|Adverse Event and Investigator decision|0
5849365|NCT02204982|20222750|P1|Overall Study|Adverse Event and Investigator decision|1
5849366|NCT02204982|20222749|P2|Overall Study|Adverse Event|0
5849367|NCT02204982|20222750|P1|Overall Study|Adverse Event|1
5849368|NCT02204982|20222749|P2|Overall Study|Withdrawal by Subject|0
5849369|NCT02204982|20222750|P1|Overall Study|Withdrawal by Subject|1
5849370|NCT02204982|20222749|P2|Overall Study|Patient ineligible-medical monitor|0
5849371|NCT02204982|20222750|P1|Overall Study|Patient ineligible-medical monitor|1
5849372|NCT02204917|20222758|P1|Overall Study|Protocol Violation|1
5849373|NCT02204579|20222795|P1|Overall Study|Screen failures|2
5849374|NCT02204449|20222853|P2|Overall Study|Withdrawal by Subject|1
5849375|NCT02204449|20222854|P1|Overall Study|Withdrawal by Subject|0
5849376|NCT02204449|20222853|P2|Overall Study|Death|1
5849377|NCT02204449|20222854|P1|Overall Study|Death|0
5849378|NCT02204449|20222853|P2|Overall Study|Lost to Follow-up|9
5849379|NCT02204449|20222854|P1|Overall Study|Lost to Follow-up|7
5849380|NCT02204410|20222864|P1|Overall Study|Withdrawal by Subject|3
5849381|NCT02204410|20222864|P1|Overall Study|Protocol Violation|1
5849382|NCT02204410|20222864|P1|Overall Study|Physician Decision|2
5849383|NCT02204410|20222864|P1|Overall Study|Lost to Follow-up|5
5849384|NCT02204371|20222869|P1|Overall Study|Adverse Event|1
5849385|NCT02204319|20222892|P1|Overall Study|Withdrawal by Subject|2
5849386|NCT02204319|20222892|P1|Overall Study|Pregnancy|1
5849387|NCT02204293|20222900|P6|LTE Phase|Study Suspended|7
5849388|NCT02204293|20222901|P5|LTE Phase|Study Suspended|0
5849389|NCT02204293|20222902|P4|LTE Phase|Study Suspended|0
5849390|NCT02204293|20222903|P3|LTE Phase|Study Suspended|0
5849391|NCT02204293|20222904|P2|LTE Phase|Study Suspended|0
5849392|NCT02204293|20222905|P1|LTE Phase|Study Suspended|0
5849393|NCT02204293|20222900|P6|Core Study Part I|Physician Decision|0
5849394|NCT02204293|20222901|P5|Core Study Part I|Physician Decision|0
5849395|NCT02204293|20222902|P4|Core Study Part I|Physician Decision|0
5849396|NCT02204293|20222903|P3|Core Study Part I|Physician Decision|0
5849397|NCT02204293|20222904|P2|Core Study Part I|Physician Decision|3
5849398|NCT02204293|20222905|P1|Core Study Part I|Physician Decision|0
5849399|NCT02204293|20222900|P6|Core Study Part I|Adverse Event|0
5849400|NCT02204293|20222901|P5|Core Study Part I|Adverse Event|0
5849401|NCT02204293|20222902|P4|Core Study Part I|Adverse Event|0
5849402|NCT02204293|20222903|P3|Core Study Part I|Adverse Event|0
5849403|NCT02204293|20222904|P2|Core Study Part I|Adverse Event|0
5849404|NCT02204293|20222905|P1|Core Study Part I|Adverse Event|1
5849405|NCT02204293|20222900|P6|Core Study Part I|Met one or more exclusion criteria|0
5849406|NCT02204293|20222901|P5|Core Study Part I|Met one or more exclusion criteria|0
5849407|NCT02204293|20222902|P4|Core Study Part I|Met one or more exclusion criteria|0
5849408|NCT02204293|20222903|P3|Core Study Part I|Met one or more exclusion criteria|0
5849409|NCT02204293|20222904|P2|Core Study Part I|Met one or more exclusion criteria|0
5849410|NCT02204293|20222905|P1|Core Study Part I|Met one or more exclusion criteria|1
5849411|NCT02204007|20223026|P2|Overall Study|Surgery Canceled|1
5849412|NCT02204007|20223027|P1|Overall Study|Surgery Canceled|1
5849413|NCT02203916|20223038|P3|Overall Study|Reason Not Specified|1
5849414|NCT02203916|20223039|P2|Overall Study|Reason Not Specified|2
5849415|NCT02203916|20223040|P1|Overall Study|Reason Not Specified|0
5849416|NCT02203916|20223038|P3|Overall Study|Lack of Efficacy|0
5849417|NCT02203916|20223039|P2|Overall Study|Lack of Efficacy|0
5849418|NCT02203916|20223040|P1|Overall Study|Lack of Efficacy|3
5849419|NCT02203916|20223038|P3|Overall Study|Voluntary Withdrawal|8
5849420|NCT02203916|20223039|P2|Overall Study|Voluntary Withdrawal|3
5849421|NCT02203916|20223040|P1|Overall Study|Voluntary Withdrawal|3
5849422|NCT02203916|20223038|P3|Overall Study|Lost to Follow-up|0
5849423|NCT02203916|20223039|P2|Overall Study|Lost to Follow-up|1
5849424|NCT02203916|20223040|P1|Overall Study|Lost to Follow-up|0
5849425|NCT02203916|20223038|P3|Overall Study|Major Protocol Deviation|0
5849426|NCT02203916|20223039|P2|Overall Study|Major Protocol Deviation|1
5849427|NCT02203916|20223040|P1|Overall Study|Major Protocol Deviation|1
5849428|NCT02203916|20223038|P3|Overall Study|Pretreatment Event/Adverse Event|2
5849429|NCT02203916|20223039|P2|Overall Study|Pretreatment Event/Adverse Event|3
5849430|NCT02203916|20223040|P1|Overall Study|Pretreatment Event/Adverse Event|1
5849431|NCT02203851|20223060|P1|Overall Study|Other|1
5849432|NCT02203851|20223060|P1|Overall Study|Withdrawal by Subject|6
5849433|NCT02203851|20223060|P1|Overall Study|Lost to Follow-up|4
5849434|NCT02203838|20223098|P4|Overall Study|Other|0
5849435|NCT02203838|20223099|P3|Overall Study|Other|0
5849436|NCT02203838|20223100|P2|Overall Study|Other|0
5849437|NCT02203838|20223101|P1|Overall Study|Other|1
5849438|NCT02203838|20223098|P4|Overall Study|Physician Decision|3
5849439|NCT02203838|20223099|P3|Overall Study|Physician Decision|2
5849440|NCT02203838|20223100|P2|Overall Study|Physician Decision|0
5849441|NCT02203838|20223101|P1|Overall Study|Physician Decision|27
5849442|NCT02203838|20223098|P4|Overall Study|Withdrawal by Subject|11
5849443|NCT02203838|20223099|P3|Overall Study|Withdrawal by Subject|8
5849444|NCT02203838|20223100|P2|Overall Study|Withdrawal by Subject|10
5849445|NCT02203838|20223101|P1|Overall Study|Withdrawal by Subject|83
5849446|NCT02203838|20223098|P4|Overall Study|Protocol Violation|0
5849447|NCT02203838|20223099|P3|Overall Study|Protocol Violation|0
5849448|NCT02203838|20223100|P2|Overall Study|Protocol Violation|3
5849449|NCT02203838|20223101|P1|Overall Study|Protocol Violation|7
5849450|NCT02203838|20223098|P4|Overall Study|Lost to Follow-up|1
5849451|NCT02203838|20223099|P3|Overall Study|Lost to Follow-up|2
5849452|NCT02203838|20223100|P2|Overall Study|Lost to Follow-up|3
5849453|NCT02203838|20223101|P1|Overall Study|Lost to Follow-up|39
5849454|NCT02203838|20223098|P4|Overall Study|Adverse Event|2
5849455|NCT02203838|20223099|P3|Overall Study|Adverse Event|3
5849456|NCT02203838|20223100|P2|Overall Study|Adverse Event|6
5849457|NCT02203838|20223101|P1|Overall Study|Adverse Event|46
5849458|NCT02203838|20223098|P4|Overall Study|Lack of Efficacy|1
5849459|NCT02203838|20223099|P3|Overall Study|Lack of Efficacy|1
5849460|NCT02203838|20223100|P2|Overall Study|Lack of Efficacy|0
5849461|NCT02203838|20223101|P1|Overall Study|Lack of Efficacy|7
5849462|NCT02203721|20223181|P2|Overall Study|Illness|1
5849463|NCT02203721|20223182|P1|Overall Study|Illness|0
5849464|NCT02203721|20223181|P2|Overall Study|Death|2
5849465|NCT02203721|20223182|P1|Overall Study|Death|0
5849466|NCT02203721|20223181|P2|Overall Study|Lost to Follow-up|0
5849467|NCT02203721|20223182|P1|Overall Study|Lost to Follow-up|1
5849468|NCT02203591|20223271|P8|Overall Study|Discontinued early due to compromised test sites|1
5849469|NCT02203591|20223272|P7|Overall Study|Discontinued early due to compromised test sites|0
5849470|NCT02203591|20223273|P6|Overall Study|Discontinued early due to compromised test sites|0
5849471|NCT02203591|20223274|P5|Overall Study|Discontinued early due to compromised test sites|1
5849472|NCT02203591|20223275|P4|Overall Study|Discontinued early due to compromised test sites|0
5849473|NCT02203591|20223276|P3|Overall Study|Discontinued early due to compromised test sites|1
5849474|NCT02203591|20223277|P2|Overall Study|Discontinued early due to compromised test sites|1
5849475|NCT02203591|20223278|P1|Overall Study|Discontinued early due to compromised test sites|0
5849476|NCT02203591|20223271|P8|Overall Study|Did not meet treatment day baseline|12
5849477|NCT02203591|20223272|P7|Overall Study|Did not meet treatment day baseline|29
5849478|NCT02203591|20223273|P6|Overall Study|Did not meet treatment day baseline|35
5849479|NCT02203591|20223274|P5|Overall Study|Did not meet treatment day baseline|33
5849480|NCT02203591|20223275|P4|Overall Study|Did not meet treatment day baseline|45
5849481|NCT02203591|20223276|P3|Overall Study|Did not meet treatment day baseline|150
5849482|NCT02203591|20223277|P2|Overall Study|Did not meet treatment day baseline|141
5849483|NCT02203591|20223278|P1|Overall Study|Did not meet treatment day baseline|147
5849484|NCT02203357|20223382|P3|Overall Study|Lost to Follow-up|70
5849485|NCT02203357|20223383|P2|Overall Study|Lost to Follow-up|66
5849486|NCT02203357|20223384|P1|Overall Study|Lost to Follow-up|58
5849487|NCT02203331|20223407|P6|Overall Study|Lost to Follow-up|0
5849488|NCT02203331|20223408|P5|Overall Study|Lost to Follow-up|1
5849489|NCT02203331|20223409|P4|Overall Study|Lost to Follow-up|0
5849490|NCT02203331|20223410|P3|Overall Study|Lost to Follow-up|0
5849491|NCT02203331|20223411|P2|Overall Study|Lost to Follow-up|0
5849492|NCT02203331|20223412|P1|Overall Study|Lost to Follow-up|0
5849493|NCT02203331|20223407|P6|Overall Study|Protocol Violation|0
5849494|NCT02203331|20223408|P5|Overall Study|Protocol Violation|1
5849495|NCT02203331|20223409|P4|Overall Study|Protocol Violation|1
5849496|NCT02203331|20223410|P3|Overall Study|Protocol Violation|0
5849497|NCT02203331|20223411|P2|Overall Study|Protocol Violation|2
5849498|NCT02203331|20223412|P1|Overall Study|Protocol Violation|0
5849499|NCT02203331|20223407|P6|Overall Study|Lack of Efficacy|1
5849500|NCT02203331|20223408|P5|Overall Study|Lack of Efficacy|0
5849501|NCT02203331|20223409|P4|Overall Study|Lack of Efficacy|0
5849502|NCT02203331|20223410|P3|Overall Study|Lack of Efficacy|1
5849503|NCT02203331|20223411|P2|Overall Study|Lack of Efficacy|2
5849504|NCT02203331|20223412|P1|Overall Study|Lack of Efficacy|0
5849505|NCT02203331|20223407|P6|Overall Study|Other Reasons|0
5849506|NCT02203331|20223408|P5|Overall Study|Other Reasons|0
5849507|NCT02203331|20223409|P4|Overall Study|Other Reasons|2
5849508|NCT02203331|20223410|P3|Overall Study|Other Reasons|0
5849509|NCT02203331|20223411|P2|Overall Study|Other Reasons|2
5849510|NCT02203331|20223412|P1|Overall Study|Other Reasons|1
5849511|NCT02203331|20223407|P6|Overall Study|Adverse Event|3
5849512|NCT02203331|20223408|P5|Overall Study|Adverse Event|3
5849513|NCT02203331|20223409|P4|Overall Study|Adverse Event|4
5849514|NCT02203331|20223410|P3|Overall Study|Adverse Event|3
5849515|NCT02203331|20223411|P2|Overall Study|Adverse Event|8
5849516|NCT02203331|20223412|P1|Overall Study|Adverse Event|4
5849517|NCT02203331|20223407|P6|Overall Study|Withdrawal by Subject|3
5849518|NCT02203331|20223408|P5|Overall Study|Withdrawal by Subject|0
5849519|NCT02203331|20223409|P4|Overall Study|Withdrawal by Subject|0
5849520|NCT02203331|20223410|P3|Overall Study|Withdrawal by Subject|1
5849521|NCT02203331|20223411|P2|Overall Study|Withdrawal by Subject|0
5849522|NCT02203331|20223412|P1|Overall Study|Withdrawal by Subject|1
5849523|NCT02203331|20223407|P6|Overall Study|Pregnancy|0
5849524|NCT02203331|20223408|P5|Overall Study|Pregnancy|2
5849525|NCT02203331|20223409|P4|Overall Study|Pregnancy|0
5849526|NCT02203331|20223410|P3|Overall Study|Pregnancy|0
5849527|NCT02203331|20223411|P2|Overall Study|Pregnancy|0
5849528|NCT02203331|20223412|P1|Overall Study|Pregnancy|1
5849529|NCT02203149|20223471|P5|Part 2|Adverse Event|1
5849530|NCT02203149|20223472|P4|Part 2|Adverse Event|1
5849531|NCT02203149|20223473|P3|Part 2|Adverse Event|0
5849532|NCT02203149|20223474|P2|Part 2|Adverse Event|0
5849533|NCT02203149|20223475|P1|Part 2|Adverse Event|0
5849534|NCT02203149|20223471|P5|Part 2|Withdrawal by Subject|0
5849535|NCT02203149|20223472|P4|Part 2|Withdrawal by Subject|1
5849536|NCT02203149|20223473|P3|Part 2|Withdrawal by Subject|0
5849537|NCT02203149|20223474|P2|Part 2|Withdrawal by Subject|0
5849538|NCT02203149|20223475|P1|Part 2|Withdrawal by Subject|0
5849539|NCT02203149|20223471|P5|Part 2|Death|0
5849540|NCT02203149|20223472|P4|Part 2|Death|1
5849541|NCT02203149|20223473|P3|Part 2|Death|1
5849542|NCT02203149|20223474|P2|Part 2|Death|0
5849543|NCT02203149|20223475|P1|Part 2|Death|0
5849544|NCT02203149|20223471|P5|Part 1|Adverse Event|0
5849545|NCT02203149|20223472|P4|Part 1|Adverse Event|0
5849546|NCT02203149|20223473|P3|Part 1|Adverse Event|0
5849547|NCT02203149|20223474|P2|Part 1|Adverse Event|1
5849548|NCT02203149|20223475|P1|Part 1|Adverse Event|0
5849549|NCT02203071|20223510|P2|Overall Study|Lost to Follow-up|1
5849550|NCT02203071|20223511|P1|Overall Study|Lost to Follow-up|3
5849551|NCT02203032|20223527|P4|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|2
5849552|NCT02203032|20223528|P3|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|3
5849553|NCT02203032|20223529|P2|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|1
5849554|NCT02203032|20223530|P1|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|0
5849555|NCT02203032|20223527|P4|Blinded Phase (Week 16 to Week 44)|Death|1
5849556|NCT02203032|20223528|P3|Blinded Phase (Week 16 to Week 44)|Death|0
5849557|NCT02203032|20223529|P2|Blinded Phase (Week 16 to Week 44)|Death|0
5849558|NCT02203032|20223530|P1|Blinded Phase (Week 16 to Week 44)|Death|0
5849559|NCT02203032|20223527|P4|Blinded Phase (Week 16 to Week 44)|Other|15
5849560|NCT02203032|20223528|P3|Blinded Phase (Week 16 to Week 44)|Other|1
5849561|NCT02203032|20223529|P2|Blinded Phase (Week 16 to Week 44)|Other|4
5849562|NCT02203032|20223530|P1|Blinded Phase (Week 16 to Week 44)|Other|0
5849563|NCT02203032|20223527|P4|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|20
5849564|NCT02203032|20223528|P3|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|19
5849565|NCT02203032|20223529|P2|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|8
5849566|NCT02203032|20223530|P1|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|0
5849567|NCT02203032|20223527|P4|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|8
5849568|NCT02203032|20223528|P3|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|3
5849569|NCT02203032|20223529|P2|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|2
5849570|NCT02203032|20223530|P1|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|0
5849571|NCT02203032|20223527|P4|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0
5849572|NCT02203032|20223528|P3|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0
5849573|NCT02203032|20223529|P2|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0
5849574|NCT02203032|20223530|P1|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|1
5849575|NCT02203032|20223527|P4|Open Label Run-in (Week 0 to Week 16)|Other|0
5849576|NCT02203032|20223528|P3|Open Label Run-in (Week 0 to Week 16)|Other|0
5849577|NCT02203032|20223529|P2|Open Label Run-in (Week 0 to Week 16)|Other|0
5849578|NCT02203032|20223530|P1|Open Label Run-in (Week 0 to Week 16)|Other|2
5849579|NCT02203032|20223527|P4|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0
5849580|NCT02203032|20223528|P3|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0
5849581|NCT02203032|20223529|P2|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0
5849582|NCT02203032|20223530|P1|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|4
5849583|NCT02203032|20223527|P4|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0
5849584|NCT02203032|20223528|P3|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0
5849585|NCT02203032|20223529|P2|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0
5849586|NCT02203032|20223530|P1|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|6
5849587|NCT02203032|20223527|P4|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0
5849588|NCT02203032|20223528|P3|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0
5849589|NCT02203032|20223529|P2|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0
5849590|NCT02203032|20223530|P1|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|3
5849591|NCT02203032|20223527|P4|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0
5849592|NCT02203032|20223528|P3|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0
5849593|NCT02203032|20223529|P2|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0
5849594|NCT02203032|20223530|P1|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|1
5849595|NCT02203032|20223527|P4|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0
5849596|NCT02203032|20223528|P3|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0
5849597|NCT02203032|20223529|P2|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0
5849598|NCT02203032|20223530|P1|Open Label Run-in (Week 0 to Week 16)|Adverse Event|2
5849599|NCT02202980|20223573|P14|Overall Study|Withdrew Consent|0
5849600|NCT02202980|20223574|P13|Overall Study|Withdrew Consent|0
5849601|NCT02202980|20223575|P12|Overall Study|Withdrew Consent|0
5849602|NCT02202980|20223576|P11|Overall Study|Withdrew Consent|0
5849603|NCT02202980|20223577|P10|Overall Study|Withdrew Consent|0
5849604|NCT02202980|20223578|P9|Overall Study|Withdrew Consent|1
5849605|NCT02202980|20223579|P8|Overall Study|Withdrew Consent|0
5849606|NCT02202980|20223580|P7|Overall Study|Withdrew Consent|0
5849607|NCT02202980|20223581|P6|Overall Study|Withdrew Consent|0
5849608|NCT02202980|20223582|P5|Overall Study|Withdrew Consent|0
5849609|NCT02202980|20223583|P4|Overall Study|Withdrew Consent|0
5849610|NCT02202980|20223584|P3|Overall Study|Withdrew Consent|2
5849611|NCT02202980|20223585|P2|Overall Study|Withdrew Consent|1
5849612|NCT02202980|20223586|P1|Overall Study|Withdrew Consent|0
5849613|NCT02202980|20223573|P14|Overall Study|Lost to Follow-up|0
5849614|NCT02202980|20223574|P13|Overall Study|Lost to Follow-up|1
5849615|NCT02202980|20223575|P12|Overall Study|Lost to Follow-up|0
5849616|NCT02202980|20223576|P11|Overall Study|Lost to Follow-up|0
5849617|NCT02202980|20223577|P10|Overall Study|Lost to Follow-up|0
5849618|NCT02202980|20223578|P9|Overall Study|Lost to Follow-up|1
5849619|NCT02202980|20223579|P8|Overall Study|Lost to Follow-up|1
5849620|NCT02202980|20223580|P7|Overall Study|Lost to Follow-up|0
5849621|NCT02202980|20223581|P6|Overall Study|Lost to Follow-up|0
5849622|NCT02202980|20223582|P5|Overall Study|Lost to Follow-up|0
5849623|NCT02202980|20223583|P4|Overall Study|Lost to Follow-up|1
5849624|NCT02202980|20223584|P3|Overall Study|Lost to Follow-up|1
5849625|NCT02202980|20223585|P2|Overall Study|Lost to Follow-up|1
5849626|NCT02202980|20223586|P1|Overall Study|Lost to Follow-up|0
5849627|NCT02202980|20223573|P14|Overall Study|Protocol Violation|0
5849628|NCT02202980|20223574|P13|Overall Study|Protocol Violation|0
5849629|NCT02202980|20223575|P12|Overall Study|Protocol Violation|0
5849630|NCT02202980|20223576|P11|Overall Study|Protocol Violation|0
5849631|NCT02202980|20223577|P10|Overall Study|Protocol Violation|0
5849632|NCT02202980|20223578|P9|Overall Study|Protocol Violation|0
5849633|NCT02202980|20223579|P8|Overall Study|Protocol Violation|0
5849634|NCT02202980|20223580|P7|Overall Study|Protocol Violation|0
5849635|NCT02202980|20223581|P6|Overall Study|Protocol Violation|0
5849636|NCT02202980|20223582|P5|Overall Study|Protocol Violation|3
5849637|NCT02202980|20223583|P4|Overall Study|Protocol Violation|3
5849638|NCT02202980|20223584|P3|Overall Study|Protocol Violation|0
5849639|NCT02202980|20223585|P2|Overall Study|Protocol Violation|0
5849640|NCT02202980|20223586|P1|Overall Study|Protocol Violation|0
5849641|NCT02202980|20223573|P14|Overall Study|Lack of Efficacy|0
5849642|NCT02202980|20223574|P13|Overall Study|Lack of Efficacy|10
5849643|NCT02202980|20223575|P12|Overall Study|Lack of Efficacy|3
5849644|NCT02202980|20223576|P11|Overall Study|Lack of Efficacy|0
5849645|NCT02202980|20223577|P10|Overall Study|Lack of Efficacy|0
5849646|NCT02202980|20223578|P9|Overall Study|Lack of Efficacy|2
5849647|NCT02202980|20223579|P8|Overall Study|Lack of Efficacy|2
5849648|NCT02202980|20223580|P7|Overall Study|Lack of Efficacy|11
5849649|NCT02202980|20223581|P6|Overall Study|Lack of Efficacy|1
5849650|NCT02202980|20223582|P5|Overall Study|Lack of Efficacy|3
5849651|NCT02202980|20223583|P4|Overall Study|Lack of Efficacy|0
5849652|NCT02202980|20223584|P3|Overall Study|Lack of Efficacy|7
5849653|NCT02202980|20223585|P2|Overall Study|Lack of Efficacy|0
5849654|NCT02202980|20223586|P1|Overall Study|Lack of Efficacy|1
5849655|NCT02202850|20223674|P2|Overall Study|Lost to Follow-up|1
5849656|NCT02202850|20223675|P1|Overall Study|Lost to Follow-up|7
5849657|NCT02202850|20223674|P2|Overall Study|Enbrel treatment discontinued|3
5849658|NCT02202850|20223675|P1|Overall Study|Enbrel treatment discontinued|15
5849659|NCT02202850|20223674|P2|Overall Study|Other|2
5849660|NCT02202850|20223675|P1|Overall Study|Other|2
5849661|NCT02202837|20223727|P2|Overall Study|Lost to Follow-up|1
5849662|NCT02202837|20223728|P1|Overall Study|Lost to Follow-up|7
5849663|NCT02202837|20223727|P2|Overall Study|Other|0
5849664|NCT02202837|20223728|P1|Overall Study|Other|10
5849665|NCT02202837|20223727|P2|Overall Study|Enbrel treatment discontinued|4
5849666|NCT02202837|20223728|P1|Overall Study|Enbrel treatment discontinued|36
5849667|NCT02202785|20223779|P3|Overall Study|Reason not Specified|13
5849668|NCT02202785|20223780|P2|Overall Study|Reason not Specified|7
5849669|NCT02202785|20223781|P1|Overall Study|Reason not Specified|10
5849670|NCT02202785|20223779|P3|Overall Study|Lost to Follow-up|0
5849671|NCT02202785|20223780|P2|Overall Study|Lost to Follow-up|1
5849672|NCT02202785|20223781|P1|Overall Study|Lost to Follow-up|0
5849673|NCT02202785|20223779|P3|Overall Study|Withdrawal by Subject|0
5849674|NCT02202785|20223780|P2|Overall Study|Withdrawal by Subject|1
5849675|NCT02202785|20223781|P1|Overall Study|Withdrawal by Subject|0
5849676|NCT02202785|20223779|P3|Overall Study|Study Terminated by Sponsor|4
5849677|NCT02202785|20223780|P2|Overall Study|Study Terminated by Sponsor|6
5849678|NCT02202785|20223781|P1|Overall Study|Study Terminated by Sponsor|1
5849679|NCT02202759|20223818|P3|Overall Study|Reason not Specified|10
5849680|NCT02202759|20223819|P2|Overall Study|Reason not Specified|11
5849681|NCT02202759|20223820|P1|Overall Study|Reason not Specified|4
5849682|NCT02202759|20223818|P3|Overall Study|Withdrawal by Subject|1
5849683|NCT02202759|20223819|P2|Overall Study|Withdrawal by Subject|1
5849684|NCT02202759|20223820|P1|Overall Study|Withdrawal by Subject|2
5849685|NCT02202759|20223818|P3|Overall Study|Study Terminated by Sponsor|3
5849686|NCT02202759|20223819|P2|Overall Study|Study Terminated by Sponsor|3
5849687|NCT02202759|20223820|P1|Overall Study|Study Terminated by Sponsor|3
5849688|NCT02202616|20223887|P1|Overall Study|Unsatisfactory therapeutic effect|1
5849689|NCT02202616|20223887|P1|Overall Study|Abnormal test procedure result|1
5849690|NCT02202616|20223887|P1|Overall Study|Administrative problems|6
5849691|NCT02202616|20223887|P1|Overall Study|Lost to Follow-up|6
5849692|NCT02202616|20223887|P1|Overall Study|Patient withdrew consent|12
5849693|NCT02202616|20223887|P1|Overall Study|Protocol deviation|18
5849694|NCT02202616|20223887|P1|Overall Study|Adverse Event|32
5849695|NCT02202616|20223887|P1|Overall Study|Screen failed|24
5849696|NCT02202551|20223902|P4|Overall Study|eGFR<50mL/min/m2|1
5849697|NCT02202551|20223903|P3|Overall Study|eGFR<50mL/min/m2|0
5849698|NCT02202551|20223904|P2|Overall Study|eGFR<50mL/min/m2|2
5849699|NCT02202551|20223905|P1|Overall Study|eGFR<50mL/min/m2|2
5849700|NCT02202551|20223902|P4|Overall Study|Subject consent withdrawn|2
5849701|NCT02202551|20223903|P3|Overall Study|Subject consent withdrawn|1
5849702|NCT02202551|20223904|P2|Overall Study|Subject consent withdrawn|3
5849703|NCT02202551|20223905|P1|Overall Study|Subject consent withdrawn|0
5849704|NCT02202551|20223902|P4|Overall Study|Subject unwilling to proceed|5
5849705|NCT02202551|20223903|P3|Overall Study|Subject unwilling to proceed|3
5849706|NCT02202551|20223904|P2|Overall Study|Subject unwilling to proceed|5
5849707|NCT02202551|20223905|P1|Overall Study|Subject unwilling to proceed|1
5849708|NCT02202551|20223902|P4|Overall Study|Sponsor's decision|0
5849709|NCT02202551|20223903|P3|Overall Study|Sponsor's decision|0
5849710|NCT02202551|20223904|P2|Overall Study|Sponsor's decision|0
5849711|NCT02202551|20223905|P1|Overall Study|Sponsor's decision|2
5849712|NCT02202551|20223902|P4|Overall Study|Protocol Violation|0
5849713|NCT02202551|20223903|P3|Overall Study|Protocol Violation|0
5849714|NCT02202551|20223904|P2|Overall Study|Protocol Violation|1
5849715|NCT02202551|20223905|P1|Overall Study|Protocol Violation|0
5849716|NCT02202551|20223902|P4|Overall Study|Worsening Dyskinesia|1
5849717|NCT02202551|20223903|P3|Overall Study|Worsening Dyskinesia|0
5849718|NCT02202551|20223904|P2|Overall Study|Worsening Dyskinesia|0
5849719|NCT02202551|20223905|P1|Overall Study|Worsening Dyskinesia|0
5849720|NCT02202551|20223902|P4|Overall Study|Unable to complete visits per protocol|0
5849721|NCT02202551|20223903|P3|Overall Study|Unable to complete visits per protocol|0
5849722|NCT02202551|20223904|P2|Overall Study|Unable to complete visits per protocol|0
5849723|NCT02202551|20223905|P1|Overall Study|Unable to complete visits per protocol|1
5849724|NCT02202551|20223902|P4|Overall Study|Site closure|1
5849725|NCT02202551|20223903|P3|Overall Study|Site closure|0
5849726|NCT02202551|20223904|P2|Overall Study|Site closure|0
5849727|NCT02202551|20223905|P1|Overall Study|Site closure|3
5849728|NCT02202551|20223902|P4|Overall Study|Physician Decision|0
5849729|NCT02202551|20223903|P3|Overall Study|Physician Decision|0
5849730|NCT02202551|20223904|P2|Overall Study|Physician Decision|0
5849731|NCT02202551|20223905|P1|Overall Study|Physician Decision|1
5849732|NCT02202551|20223902|P4|Overall Study|Lack of Efficacy|0
5849733|NCT02202551|20223903|P3|Overall Study|Lack of Efficacy|0
5849734|NCT02202551|20223904|P2|Overall Study|Lack of Efficacy|1
5849735|NCT02202551|20223905|P1|Overall Study|Lack of Efficacy|0
5849736|NCT02202551|20223902|P4|Overall Study|Dyskinesia upon taper|0
5849737|NCT02202551|20223903|P3|Overall Study|Dyskinesia upon taper|0
5849738|NCT02202551|20223904|P2|Overall Study|Dyskinesia upon taper|0
5849739|NCT02202551|20223905|P1|Overall Study|Dyskinesia upon taper|1
5849740|NCT02202551|20223902|P4|Overall Study|DBS surgery|0
5849741|NCT02202551|20223903|P3|Overall Study|DBS surgery|0
5849742|NCT02202551|20223904|P2|Overall Study|DBS surgery|0
5849743|NCT02202551|20223905|P1|Overall Study|DBS surgery|3
5849744|NCT02202551|20223902|P4|Overall Study|Subject moved away|0
5849745|NCT02202551|20223903|P3|Overall Study|Subject moved away|0
5849746|NCT02202551|20223904|P2|Overall Study|Subject moved away|1
5849747|NCT02202551|20223905|P1|Overall Study|Subject moved away|0
5849748|NCT02202551|20223902|P4|Overall Study|Needed to take excluded medication|1
5849749|NCT02202551|20223903|P3|Overall Study|Needed to take excluded medication|0
5849750|NCT02202551|20223904|P2|Overall Study|Needed to take excluded medication|2
5849751|NCT02202551|20223905|P1|Overall Study|Needed to take excluded medication|0
5849752|NCT02202551|20223902|P4|Overall Study|Lost to Follow-up|1
5849753|NCT02202551|20223903|P3|Overall Study|Lost to Follow-up|0
5849754|NCT02202551|20223904|P2|Overall Study|Lost to Follow-up|1
5849755|NCT02202551|20223905|P1|Overall Study|Lost to Follow-up|0
5849756|NCT02202551|20223902|P4|Overall Study|Death|1
5849757|NCT02202551|20223903|P3|Overall Study|Death|1
5849758|NCT02202551|20223904|P2|Overall Study|Death|2
5849759|NCT02202551|20223905|P1|Overall Study|Death|3
5849760|NCT02202551|20223902|P4|Overall Study|Adverse Event|9
5849761|NCT02202551|20223903|P3|Overall Study|Adverse Event|5
5849762|NCT02202551|20223904|P2|Overall Study|Adverse Event|19
5849763|NCT02202551|20223905|P1|Overall Study|Adverse Event|8
5849764|NCT02202538|20223923|P1|Overall Study|Investigator Decision|1
5849765|NCT02202538|20223923|P1|Overall Study|Did not meet all inclusion criteria|2
5849766|NCT02202538|20223923|P1|Overall Study|Withdrawal by Subject|5
5849767|NCT02202499|20223937|P3|Overall Study|Auto accident|0
5849768|NCT02202499|20223938|P2|Overall Study|Auto accident|0
5849769|NCT02202499|20223939|P1|Overall Study|Auto accident|1
5849770|NCT02202499|20223937|P3|Overall Study|Declined before randomization|0
5849771|NCT02202499|20223938|P2|Overall Study|Declined before randomization|0
5849772|NCT02202499|20223939|P1|Overall Study|Declined before randomization|1
5849773|NCT02202499|20223937|P3|Overall Study|Moved from area|1
5849774|NCT02202499|20223938|P2|Overall Study|Moved from area|0
5849775|NCT02202499|20223939|P1|Overall Study|Moved from area|0
5849776|NCT02202499|20223937|P3|Overall Study|Cancer diagnosis|1
5849777|NCT02202499|20223938|P2|Overall Study|Cancer diagnosis|0
5849778|NCT02202499|20223939|P1|Overall Study|Cancer diagnosis|0
5849807|NCT02202317|20224093|P1|Overall Study|Lost to Follow-up|1
5849808|NCT02202161|20224120|P8|Overall Study|Withdrawal by Subject|0
5849809|NCT02202161|20224121|P7|Overall Study|Withdrawal by Subject|0
5849810|NCT02202161|20224122|P6|Overall Study|Withdrawal by Subject|0
5849811|NCT02202161|20224123|P5|Overall Study|Withdrawal by Subject|1
5849812|NCT02202161|20224124|P4|Overall Study|Withdrawal by Subject|0
5849813|NCT02202161|20224125|P3|Overall Study|Withdrawal by Subject|0
5849814|NCT02202161|20224126|P2|Overall Study|Withdrawal by Subject|0
5849815|NCT02202161|20224127|P1|Overall Study|Withdrawal by Subject|0
5849816|NCT02202161|20224120|P8|Overall Study|Physician Decision|3
5849817|NCT02202161|20224121|P7|Overall Study|Physician Decision|0
5849818|NCT02202161|20224122|P6|Overall Study|Physician Decision|0
5849819|NCT02202161|20224123|P5|Overall Study|Physician Decision|0
5849820|NCT02202161|20224124|P4|Overall Study|Physician Decision|0
5849821|NCT02202161|20224125|P3|Overall Study|Physician Decision|0
5849822|NCT02202161|20224126|P2|Overall Study|Physician Decision|0
5849823|NCT02202161|20224127|P1|Overall Study|Physician Decision|0
5849824|NCT02202161|20224120|P8|Overall Study|Did not meet continuation criteria|3
5849825|NCT02202161|20224121|P7|Overall Study|Did not meet continuation criteria|0
5849826|NCT02202161|20224122|P6|Overall Study|Did not meet continuation criteria|0
5849827|NCT02202161|20224123|P5|Overall Study|Did not meet continuation criteria|0
5849828|NCT02202161|20224124|P4|Overall Study|Did not meet continuation criteria|0
5849829|NCT02202161|20224125|P3|Overall Study|Did not meet continuation criteria|0
5849830|NCT02202161|20224126|P2|Overall Study|Did not meet continuation criteria|0
5849831|NCT02202161|20224127|P1|Overall Study|Did not meet continuation criteria|0
5849832|NCT02202161|20224120|P8|Overall Study|Adverse Event|0
5849833|NCT02202161|20224121|P7|Overall Study|Adverse Event|0
5849834|NCT02202161|20224122|P6|Overall Study|Adverse Event|1
5849835|NCT02202161|20224123|P5|Overall Study|Adverse Event|0
5849836|NCT02202161|20224124|P4|Overall Study|Adverse Event|0
5849837|NCT02202161|20224125|P3|Overall Study|Adverse Event|0
5849838|NCT02202161|20224126|P2|Overall Study|Adverse Event|1
5849839|NCT02202161|20224127|P1|Overall Study|Adverse Event|1
5849840|NCT02202109|20224287|P2|Overall Study|Withdrawal by Subject|0
5849841|NCT02202109|20224288|P1|Overall Study|Withdrawal by Subject|2
5849842|NCT02202109|20224287|P2|Overall Study|Lost to Follow-up|87
5849843|NCT02202109|20224288|P1|Overall Study|Lost to Follow-up|88
5849844|NCT02202031|20224305|P2|Overall Study|Intolerance/Lack of Improvement|0
5849845|NCT02202031|20224306|P1|Overall Study|Intolerance/Lack of Improvement|3
5849846|NCT02202031|20224305|P2|Overall Study|Illness/Medical Reason|2
5849847|NCT02202031|20224306|P1|Overall Study|Illness/Medical Reason|0
5849848|NCT02202031|20224305|P2|Overall Study|Too Busy|3
5849849|NCT02202031|20224306|P1|Overall Study|Too Busy|1
5849850|NCT02202031|20224305|P2|Overall Study|Lost to Follow-up|0
5849851|NCT02202031|20224306|P1|Overall Study|Lost to Follow-up|1
5849852|NCT02201953|20224354|P2|Overall Study|Death|3
5849853|NCT02201953|20224355|P1|Overall Study|Death|0
5849854|NCT02201953|20224354|P2|Overall Study|Adverse Event|5
5849855|NCT02201953|20224355|P1|Overall Study|Adverse Event|0
5849856|NCT02201953|20224354|P2|Overall Study|Withdrew Consent|5
5849857|NCT02201953|20224355|P1|Overall Study|Withdrew Consent|2
5849858|NCT02201953|20224354|P2|Overall Study|Lost to Follow-up|8
5849859|NCT02201953|20224355|P1|Overall Study|Lost to Follow-up|8
5849860|NCT02201953|20224354|P2|Overall Study|Lack of Efficacy|30
5849861|NCT02201953|20224355|P1|Overall Study|Lack of Efficacy|9
5849862|NCT02201953|20224354|P2|Overall Study|Randomized but Never Treated|5
5849863|NCT02201953|20224355|P1|Overall Study|Randomized but Never Treated|1
5849864|NCT02201940|20224373|P2|Overall Study|Adverse Event|1
5849865|NCT02201940|20224374|P1|Overall Study|Adverse Event|0
5849866|NCT02201940|20224373|P2|Overall Study|Death|0
5849867|NCT02201940|20224374|P1|Overall Study|Death|1
5849868|NCT02201940|20224373|P2|Overall Study|Investigator's Discretion|1
5849869|NCT02201940|20224374|P1|Overall Study|Investigator's Discretion|1
5849870|NCT02201940|20224373|P2|Overall Study|Withdrew Consent|1
5849871|NCT02201940|20224374|P1|Overall Study|Withdrew Consent|2
5849872|NCT02201940|20224373|P2|Overall Study|Lost to Follow-up|0
5849873|NCT02201940|20224374|P1|Overall Study|Lost to Follow-up|5
5849874|NCT02201940|20224373|P2|Overall Study|Lack of Efficacy|113
5849875|NCT02201940|20224374|P1|Overall Study|Lack of Efficacy|2
5849876|NCT02201940|20224373|P2|Overall Study|Randomized/Enrolled but Never Treated|0
5849877|NCT02201940|20224374|P1|Overall Study|Randomized/Enrolled but Never Treated|1
5849878|NCT02201901|20224393|P3|Overall Study|Adverse Event|0
5849879|NCT02201901|20224394|P2|Overall Study|Adverse Event|1
5849880|NCT02201901|20224395|P1|Overall Study|Adverse Event|1
5849881|NCT02201901|20224393|P3|Overall Study|Withdrew Consent|2
5849882|NCT02201901|20224394|P2|Overall Study|Withdrew Consent|0
5849883|NCT02201901|20224395|P1|Overall Study|Withdrew Consent|2
5849884|NCT02201901|20224393|P3|Overall Study|Lost to Follow-up|2
5849885|NCT02201901|20224394|P2|Overall Study|Lost to Follow-up|3
5849886|NCT02201901|20224395|P1|Overall Study|Lost to Follow-up|2
5849887|NCT02201901|20224393|P3|Overall Study|Death|3
5849888|NCT02201901|20224394|P2|Overall Study|Death|3
5849889|NCT02201901|20224395|P1|Overall Study|Death|3
5849890|NCT02201901|20224393|P3|Overall Study|Lack of Efficacy|6
5849891|NCT02201901|20224394|P2|Overall Study|Lack of Efficacy|1
5849892|NCT02201901|20224395|P1|Overall Study|Lack of Efficacy|7
5849893|NCT02201901|20224393|P3|Overall Study|Randomized but never treated|0
5849894|NCT02201901|20224394|P2|Overall Study|Randomized but never treated|1
5849895|NCT02201901|20224395|P1|Overall Study|Randomized but never treated|0
5849896|NCT02201784|20224426|P2|Overall Study|Failure to achieve adequate block|0
5849897|NCT02201784|20224427|P1|Overall Study|Failure to achieve adequate block|2
5849898|NCT02201771|20224444|P3|Overall Study|Protocol Violation|10
5849899|NCT02201771|20224445|P2|Overall Study|Protocol Violation|8
5849900|NCT02201771|20224446|P1|Overall Study|Protocol Violation|10
5849901|NCT02201771|20224444|P3|Overall Study|Death|0
5849902|NCT02201771|20224445|P2|Overall Study|Death|2
5849903|NCT02201771|20224446|P1|Overall Study|Death|3
5849904|NCT02201524|20224473|P4|Overall Study|Other|0
5849905|NCT02201524|20224474|P3|Overall Study|Other|0
5849906|NCT02201524|20224475|P2|Overall Study|Other|1
5849907|NCT02201524|20224476|P1|Overall Study|Other|1
5849908|NCT02201524|20224473|P4|Overall Study|Withdrawal by Subject|1
5849909|NCT02201524|20224474|P3|Overall Study|Withdrawal by Subject|1
5849910|NCT02201524|20224475|P2|Overall Study|Withdrawal by Subject|0
5849911|NCT02201524|20224476|P1|Overall Study|Withdrawal by Subject|0
5849912|NCT02201524|20224473|P4|Overall Study|Protocol Violation|1
5849913|NCT02201524|20224474|P3|Overall Study|Protocol Violation|0
5849914|NCT02201524|20224475|P2|Overall Study|Protocol Violation|0
5849915|NCT02201524|20224476|P1|Overall Study|Protocol Violation|0
5849916|NCT02201524|20224473|P4|Overall Study|No longer meets eligibility criteria|2
5849917|NCT02201524|20224474|P3|Overall Study|No longer meets eligibility criteria|0
5849918|NCT02201524|20224475|P2|Overall Study|No longer meets eligibility criteria|0
5849919|NCT02201524|20224476|P1|Overall Study|No longer meets eligibility criteria|0
5849920|NCT02201524|20224473|P4|Overall Study|Lost to Follow-up|0
5849921|NCT02201524|20224474|P3|Overall Study|Lost to Follow-up|2
5849922|NCT02201524|20224475|P2|Overall Study|Lost to Follow-up|0
5849923|NCT02201524|20224476|P1|Overall Study|Lost to Follow-up|0
5849924|NCT02201524|20224473|P4|Overall Study|Insufficient clinical response|0
5849925|NCT02201524|20224474|P3|Overall Study|Insufficient clinical response|0
5849926|NCT02201524|20224475|P2|Overall Study|Insufficient clinical response|0
5849927|NCT02201524|20224476|P1|Overall Study|Insufficient clinical response|1
5849928|NCT02201524|20224473|P4|Overall Study|Adverse Event|0
5849929|NCT02201524|20224474|P3|Overall Study|Adverse Event|1
5849930|NCT02201524|20224475|P2|Overall Study|Adverse Event|2
5849931|NCT02201524|20224476|P1|Overall Study|Adverse Event|0
5849932|NCT02201472|20224558|P1|Overall Study|Lack of Efficacy|2
5849933|NCT02201329|20224605|P1|Overall Study|Withdrawal by Subject|2
5849934|NCT02201329|20224605|P1|Overall Study|Progressive Dis./Relapse/Clinical Prog.|3
5849935|NCT02201290|20224613|P1|Overall Study|Adverse Event|1
5849936|NCT02201290|20224613|P1|Overall Study|Lack of Efficacy|2
5849937|NCT02201290|20224613|P1|Overall Study|Withdrawal by Subject|2
5849938|NCT02201277|20224619|P2|Overall Study|Physician Decision|0
5849939|NCT02201277|20224620|P1|Overall Study|Physician Decision|1
5849940|NCT02201277|20224619|P2|Overall Study|Failed retrieval|0
5849941|NCT02201277|20224620|P1|Overall Study|Failed retrieval|1
5849942|NCT02201277|20224619|P2|Overall Study|Lost to Follow-up|1
5849943|NCT02201277|20224620|P1|Overall Study|Lost to Follow-up|2
5849944|NCT02201277|20224619|P2|Overall Study|Death|4
5849945|NCT02201277|20224620|P1|Overall Study|Death|3
5849946|NCT02201108|20224650|P2|Overall Study|Withdrawal by Subject|0
5849947|NCT02201108|20224651|P1|Overall Study|Withdrawal by Subject|2
5849948|NCT02201108|20224650|P2|Overall Study|Lack of Efficacy|1
5849949|NCT02201108|20224651|P1|Overall Study|Lack of Efficacy|2
5849950|NCT02201108|20224650|P2|Overall Study|Adverse Event|6
5849951|NCT02201108|20224651|P1|Overall Study|Adverse Event|0
5849952|NCT02200770|20224766|P2|Open-label Period (OLP)|Participants ongoing|162
5849953|NCT02200770|20224767|P1|Open-label Period (OLP)|Participants ongoing|51
5849954|NCT02200770|20224766|P2|Randomized-controlled Period (RCP)|Other|2
5849955|NCT02200770|20224767|P1|Randomized-controlled Period (RCP)|Other|1
5849956|NCT02200770|20224766|P2|Randomized-controlled Period (RCP)|Not treated|1
5849957|NCT02200770|20224767|P1|Randomized-controlled Period (RCP)|Not treated|0
5849958|NCT02200770|20224766|P2|Randomized-controlled Period (RCP)|Withdrawal by Subject|1
5849959|NCT02200770|20224767|P1|Randomized-controlled Period (RCP)|Withdrawal by Subject|1
5849960|NCT02200770|20224766|P2|Randomized-controlled Period (RCP)|Adverse Event|2
5849961|NCT02200770|20224767|P1|Randomized-controlled Period (RCP)|Adverse Event|0
5849992|NCT02200510|20224848|P2|Overall Study|potential COI - joined study team|0
5849993|NCT02200510|20224849|P1|Overall Study|potential COI - joined study team|1
5849994|NCT02200510|20224848|P2|Overall Study|Lost to Follow-up|1
5849995|NCT02200510|20224849|P1|Overall Study|Lost to Follow-up|7
5849996|NCT02200510|20224848|P2|Overall Study|Protocol Violation|1
5849997|NCT02200510|20224849|P1|Overall Study|Protocol Violation|0
5849998|NCT02200510|20224848|P2|Overall Study|Death|1
5849999|NCT02200510|20224849|P1|Overall Study|Death|1
5850000|NCT02200445|20224862|P3|Overall Study|Adverse Event|0
5850001|NCT02200445|20224863|P2|Overall Study|Adverse Event|2
5850002|NCT02200445|20224864|P1|Overall Study|Adverse Event|0
5850003|NCT02200445|20224862|P3|Overall Study|Lack of Efficacy|2
5850004|NCT02200445|20224863|P2|Overall Study|Lack of Efficacy|2
5850005|NCT02200445|20224864|P1|Overall Study|Lack of Efficacy|1
5850006|NCT02200211|20224893|P4|Overall Study|Withdrawal by Subject|0
5850007|NCT02200211|20224894|P3|Overall Study|Withdrawal by Subject|0
5850008|NCT02200211|20224895|P2|Overall Study|Withdrawal by Subject|0
5850009|NCT02200211|20224896|P1|Overall Study|Withdrawal by Subject|1
5850010|NCT02200211|20224893|P4|Overall Study|Lost to Follow-up|2
5850011|NCT02200211|20224894|P3|Overall Study|Lost to Follow-up|1
5850012|NCT02200211|20224895|P2|Overall Study|Lost to Follow-up|7
5850013|NCT02200211|20224896|P1|Overall Study|Lost to Follow-up|7
5850014|NCT02200042|20225009|P2|Overall Study|Withdrawal by Subject|1
5850015|NCT02200042|20225010|P1|Overall Study|Withdrawal by Subject|0
5850016|NCT02199795|20225039|P2|Overall Study|withdrew due to shoulder pain|0
5850017|NCT02199795|20225040|P1|Overall Study|withdrew due to shoulder pain|1
5850018|NCT02199795|20225039|P2|Overall Study|no longer met inclusion criteria|0
5850019|NCT02199795|20225040|P1|Overall Study|no longer met inclusion criteria|1
5850020|NCT02199691|20225063|P4|Overall Study|Lost to Follow-up|10
5850021|NCT02199691|20225064|P3|Overall Study|Lost to Follow-up|9
5850022|NCT02199691|20225065|P2|Overall Study|Lost to Follow-up|1
5850023|NCT02199691|20225066|P1|Overall Study|Lost to Follow-up|2
5850024|NCT02199691|20225063|P4|Overall Study|Withdrawal by Subject|13
5850025|NCT02199691|20225064|P3|Overall Study|Withdrawal by Subject|12
5850026|NCT02199691|20225065|P2|Overall Study|Withdrawal by Subject|3
5850027|NCT02199691|20225066|P1|Overall Study|Withdrawal by Subject|5
5850028|NCT02199691|20225063|P4|Overall Study|Protocol Violation|7
5850029|NCT02199691|20225064|P3|Overall Study|Protocol Violation|6
5850030|NCT02199691|20225065|P2|Overall Study|Protocol Violation|3
5850031|NCT02199691|20225066|P1|Overall Study|Protocol Violation|3
5850032|NCT02199509|20225108|P2|Overall Study|Misunderstood titration schedule|0
5850033|NCT02199509|20225109|P1|Overall Study|Misunderstood titration schedule|1
5850034|NCT02199509|20225108|P2|Overall Study|Suicidal Ideation|1
5850035|NCT02199509|20225109|P1|Overall Study|Suicidal Ideation|0
5850036|NCT02199314|20225132|P1|Overall Study|Physician Decision|10
5850037|NCT02199314|20225132|P1|Overall Study|Withdrawal by Subject|6
5850038|NCT02199080|20225159|P1|Overall Study|Protocol Violation|12
5850039|NCT02199028|20225184|P2|Week 3|Adverse Event|0
5850040|NCT02199028|20225185|P1|Week 3|Adverse Event|1
5850041|NCT02199028|20225184|P2|Week 1|Adverse Event|0
5850042|NCT02199028|20225185|P1|Week 1|Adverse Event|1
5850043|NCT02198963|20225194|P1|Overall Study|Withdrawal by Subject|6
5850044|NCT02198963|20225194|P1|Overall Study|Adverse Event|1
5850045|NCT02198651|20225218|P5|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0
5850046|NCT02198651|20225219|P4|Open-label Rescue Period|Incorrectly entered Open-label Rescue|1
5850047|NCT02198651|20225220|P3|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0
5850048|NCT02198651|20225221|P2|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0
5850049|NCT02198651|20225222|P1|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0
5850050|NCT02198651|20225218|P5|Open-label Rescue Period|Withdrew consent|0
5850051|NCT02198651|20225219|P4|Open-label Rescue Period|Withdrew consent|2
5850052|NCT02198651|20225220|P3|Open-label Rescue Period|Withdrew consent|0
5850053|NCT02198651|20225221|P2|Open-label Rescue Period|Withdrew consent|0
5850054|NCT02198651|20225222|P1|Open-label Rescue Period|Withdrew consent|0
5850055|NCT02198651|20225218|P5|Double-blind Period|Other, not specified|0
5850056|NCT02198651|20225219|P4|Double-blind Period|Other, not specified|0
5850057|NCT02198651|20225220|P3|Double-blind Period|Other, not specified|1
5850058|NCT02198651|20225221|P2|Double-blind Period|Other, not specified|4
5850059|NCT02198651|20225222|P1|Double-blind Period|Other, not specified|0
5850060|NCT02198651|20225218|P5|Double-blind Period|Adverse Event|0
5850061|NCT02198651|20225219|P4|Double-blind Period|Adverse Event|0
5850062|NCT02198651|20225220|P3|Double-blind Period|Adverse Event|0
5850063|NCT02198651|20225221|P2|Double-blind Period|Adverse Event|1
5850064|NCT02198651|20225222|P1|Double-blind Period|Adverse Event|0
5850065|NCT02198651|20225218|P5|Double-blind Period|Withdrew consent|0
5850066|NCT02198651|20225219|P4|Double-blind Period|Withdrew consent|0
5850067|NCT02198651|20225220|P3|Double-blind Period|Withdrew consent|0
5850068|NCT02198651|20225221|P2|Double-blind Period|Withdrew consent|4
5850069|NCT02198651|20225222|P1|Double-blind Period|Withdrew consent|0
5850070|NCT02198651|20225218|P5|Lead-in Period|Other, not specified|0
5850071|NCT02198651|20225219|P4|Lead-in Period|Other, not specified|0
5850072|NCT02198651|20225220|P3|Lead-in Period|Other, not specified|0
5850073|NCT02198651|20225221|P2|Lead-in Period|Other, not specified|0
5850074|NCT02198651|20225222|P1|Lead-in Period|Other, not specified|22
5850075|NCT02198651|20225218|P5|Lead-in Period|Adverse Event|0
5850076|NCT02198651|20225219|P4|Lead-in Period|Adverse Event|0
5850077|NCT02198651|20225220|P3|Lead-in Period|Adverse Event|0
5850078|NCT02198651|20225221|P2|Lead-in Period|Adverse Event|0
5850079|NCT02198651|20225222|P1|Lead-in Period|Adverse Event|2
5850080|NCT02198651|20225218|P5|Lead-in Period|Withdrew consent|0
5850081|NCT02198651|20225219|P4|Lead-in Period|Withdrew consent|0
5850082|NCT02198651|20225220|P3|Lead-in Period|Withdrew consent|0
5850083|NCT02198651|20225221|P2|Lead-in Period|Withdrew consent|0
5850084|NCT02198651|20225222|P1|Lead-in Period|Withdrew consent|13
5850085|NCT02198235|20225323|P3|Overall Study|Lost to Follow-up|2
5850086|NCT02198235|20225324|P2|Overall Study|Lost to Follow-up|2
5850087|NCT02198235|20225325|P1|Overall Study|Lost to Follow-up|3
5850088|NCT02198040|20225345|P3|Overall Study|Withdrawal by Subject|1
5850089|NCT02198040|20225346|P2|Overall Study|Withdrawal by Subject|0
5850090|NCT02198040|20225347|P1|Overall Study|Withdrawal by Subject|0
5850091|NCT02198040|20225345|P3|Overall Study|Work reasons|0
5850092|NCT02198040|20225346|P2|Overall Study|Work reasons|1
5850093|NCT02198040|20225347|P1|Overall Study|Work reasons|0
5850094|NCT02197897|20225373|P1|Overall Study|not eligible|1
5850095|NCT02197806|20225381|P4|Overall Study|Adverse Event|1
5850096|NCT02197806|20225382|P3|Overall Study|Adverse Event|0
5850097|NCT02197806|20225383|P2|Overall Study|Adverse Event|1
5850098|NCT02197806|20225384|P1|Overall Study|Adverse Event|0
5850099|NCT02197572|20225399|P1|Overall Study|Reason Not Specified|4
5850100|NCT02197572|20225399|P1|Overall Study|Adverse Event|3
5850101|NCT02197572|20225399|P1|Overall Study|Withdrawal by Subject|9
5850102|NCT02197572|20225399|P1|Overall Study|Progressive Disease|28
5850103|NCT02197520|20225416|P2|Period 2|Withdrawal by Subject|0
5850104|NCT02197520|20225417|P1|Period 2|Withdrawal by Subject|1
5850105|NCT02197520|20225416|P2|Period 2|Adverse Event|2
5850106|NCT02197520|20225417|P1|Period 2|Adverse Event|0
5850107|NCT02197520|20225416|P2|Period 1|Withdrawal by Subject|0
5850108|NCT02197520|20225417|P1|Period 1|Withdrawal by Subject|1
5850109|NCT02197416|20225464|P3|Overall Study|Adverse Event|1
5850110|NCT02197416|20225465|P2|Overall Study|Adverse Event|0
5850111|NCT02197416|20225466|P1|Overall Study|Adverse Event|0
5850112|NCT02197416|20225464|P3|Overall Study|Protocol Violation|1
5850113|NCT02197416|20225465|P2|Overall Study|Protocol Violation|0
5850114|NCT02197416|20225466|P1|Overall Study|Protocol Violation|1
5850115|NCT02197416|20225464|P3|Overall Study|Withdrawal by Subject|1
5850116|NCT02197416|20225465|P2|Overall Study|Withdrawal by Subject|2
5850117|NCT02197416|20225466|P1|Overall Study|Withdrawal by Subject|0
5850118|NCT02197416|20225464|P3|Overall Study|Other reasons|5
5850119|NCT02197416|20225465|P2|Overall Study|Other reasons|2
5850120|NCT02197416|20225466|P1|Overall Study|Other reasons|0
5850121|NCT02197377|20225504|P2|Overall Study|Insertion Failure|3
5850122|NCT02197377|20225505|P1|Overall Study|Insertion Failure|0
5850123|NCT02197247|20225526|P1|Part B: Day 78 to End Part B (AZD9291)|Condition under investigation worsened|9
5850124|NCT02197247|20225526|P1|Part B: Day 78 to End Part B (AZD9291)|Death|1
5850125|NCT02197247|20225526|P1|Part B: Day 78 to End Part B (AZD9291)|Newly discovered brain metastases|1
5850126|NCT02197247|20225526|P1|Part B: Day 78 to End Part B (AZD9291)|Withdrawal by Subject|2
5850127|NCT02197247|20225526|P1|Part B: Day 78 to End Part B (AZD9291)|Adverse Event|2
5850128|NCT02197247|20225526|P1|Part A: Day 50-77 (AZD9291 Alone)|Condition under investigation worsened|5
5850129|NCT02197247|20225526|P1|Part A: Day 29-49 (AZD9291+Rifampicin)|Condition under investigation worsened|2
5850130|NCT02197247|20225526|P1|Part A: Day 29-49 (AZD9291+Rifampicin)|Adverse Event|2
5850131|NCT02197234|20225571|P1|Part B: Day 33 to End Part B (AZD9291)|Condition under investigation worsened|22
5850132|NCT02197234|20225571|P1|Part B: Day 33 to End Part B (AZD9291)|Death|6
5850133|NCT02197234|20225571|P1|Part B: Day 33 to End Part B (AZD9291)|Withdrawal by Subject|1
5850134|NCT02197234|20225571|P1|Part B: Day 33 to End Part B (AZD9291)|Adverse Event|1
5850135|NCT02197234|20225571|P1|Part A: Day 3-30 (AZD9291 Alone)|Withdrawal by Subject|1
5850136|NCT02197234|20225571|P1|Part A: Day 3-30 (AZD9291 Alone)|Adverse Event|1
5850137|NCT02197234|20225571|P1|Part A: Day 3-30 (AZD9291 Alone)|Condition under investigation worsened|1
5850138|NCT02197130|20225593|P3|Overall Study|Other|3
5850139|NCT02197130|20225594|P2|Overall Study|Other|0
5850140|NCT02197130|20225595|P1|Overall Study|Other|1
5850141|NCT02197130|20225593|P3|Overall Study|Withdrawal by Subject|4
5850142|NCT02197130|20225594|P2|Overall Study|Withdrawal by Subject|3
5850143|NCT02197130|20225595|P1|Overall Study|Withdrawal by Subject|0
5850144|NCT02197130|20225593|P3|Overall Study|Does not meet entrance criteria|1
5850145|NCT02197130|20225594|P2|Overall Study|Does not meet entrance criteria|0
5850146|NCT02197130|20225595|P1|Overall Study|Does not meet entrance criteria|0
5850147|NCT02197130|20225593|P3|Overall Study|Lost to Follow-up|1
5850148|NCT02197130|20225594|P2|Overall Study|Lost to Follow-up|0
5850149|NCT02197130|20225595|P1|Overall Study|Lost to Follow-up|2
5850150|NCT02197130|20225593|P3|Overall Study|Death|0
5850151|NCT02197130|20225594|P2|Overall Study|Death|1
5850152|NCT02197130|20225595|P1|Overall Study|Death|0
5850153|NCT02197130|20225593|P3|Overall Study|Adverse Event|23
5850154|NCT02197130|20225594|P2|Overall Study|Adverse Event|4
5850155|NCT02197130|20225595|P1|Overall Study|Adverse Event|13
5850156|NCT02196714|20225841|P4|Overall Study|Protocol Violation|0
5850157|NCT02196714|20225842|P3|Overall Study|Protocol Violation|1
5850158|NCT02196714|20225843|P2|Overall Study|Protocol Violation|0
5850159|NCT02196714|20225844|P1|Overall Study|Protocol Violation|0
5850160|NCT02196701|20225966|P1|Overall Study|Non-adherence to Protocol|1
5850161|NCT02196701|20225966|P1|Overall Study|Lost to Follow-up|1
5850162|NCT02196701|20225966|P1|Overall Study|Adverse Event|1
5850163|NCT02196675|20226040|P3|Overall Study|Death|1
5850164|NCT02196675|20226041|P2|Overall Study|Death|0
5850165|NCT02196675|20226042|P1|Overall Study|Death|0
5850166|NCT02196675|20226040|P3|Overall Study|Protocol Violation|0
5850167|NCT02196675|20226041|P2|Overall Study|Protocol Violation|1
5850168|NCT02196675|20226042|P1|Overall Study|Protocol Violation|0
5850169|NCT02196675|20226040|P3|Overall Study|Intra-operative surgical exclusion|0
5850170|NCT02196675|20226041|P2|Overall Study|Intra-operative surgical exclusion|1
5850171|NCT02196675|20226042|P1|Overall Study|Intra-operative surgical exclusion|1
5850172|NCT02196675|20226040|P3|Overall Study|Withdrawal by Subject|0
5850173|NCT02196675|20226041|P2|Overall Study|Withdrawal by Subject|0
5850174|NCT02196675|20226042|P1|Overall Study|Withdrawal by Subject|1
5850175|NCT02196558|20226065|P3|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1
5850176|NCT02196558|20226066|P2|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1
5850177|NCT02196558|20226067|P1|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1
5850178|NCT02196558|20226065|P3|Extension Phase (40 Weeks)|Adverse Event|0
5850179|NCT02196558|20226066|P2|Extension Phase (40 Weeks)|Adverse Event|2
5850180|NCT02196558|20226067|P1|Extension Phase (40 Weeks)|Adverse Event|1
5850181|NCT02196558|20226065|P3|Treatment Phase (12 Weeks)|Progression of Disease|1
5850182|NCT02196558|20226066|P2|Treatment Phase (12 Weeks)|Progression of Disease|0
5850183|NCT02196558|20226067|P1|Treatment Phase (12 Weeks)|Progression of Disease|0
5850184|NCT02196558|20226065|P3|Treatment Phase (12 Weeks)|Participant Choice|1
5850185|NCT02196558|20226066|P2|Treatment Phase (12 Weeks)|Participant Choice|1
5850186|NCT02196558|20226067|P1|Treatment Phase (12 Weeks)|Participant Choice|0
5850187|NCT02196558|20226065|P3|Treatment Phase (12 Weeks)|Adverse Event|0
5850188|NCT02196558|20226066|P2|Treatment Phase (12 Weeks)|Adverse Event|2
5850189|NCT02196558|20226067|P1|Treatment Phase (12 Weeks)|Adverse Event|0
5850190|NCT02196506|20226083|P4|Phase A+|Participant withdrawn by investigator|1
5850191|NCT02196506|20226084|P3|Phase A+|Participant withdrawn by investigator|0
5850192|NCT02196506|20226085|P2|Phase A+|Participant withdrawn by investigator|0
5850193|NCT02196506|20226086|P1|Phase A+|Participant withdrawn by investigator|0
5850194|NCT02196506|20226083|P4|Phase A+|Lost to Follow-up|6
5850195|NCT02196506|20226084|P3|Phase A+|Lost to Follow-up|0
5850196|NCT02196506|20226085|P2|Phase A+|Lost to Follow-up|0
5850197|NCT02196506|20226086|P1|Phase A+|Lost to Follow-up|0
5850198|NCT02196506|20226083|P4|Phase A+|Adverse Event|1
5850199|NCT02196506|20226084|P3|Phase A+|Adverse Event|0
5850200|NCT02196506|20226085|P2|Phase A+|Adverse Event|0
5850201|NCT02196506|20226086|P1|Phase A+|Adverse Event|0
5850202|NCT02196506|20226083|P4|Phase A+|Withdrawal by Participant|5
5850203|NCT02196506|20226084|P3|Phase A+|Withdrawal by Participant|0
5850204|NCT02196506|20226085|P2|Phase A+|Withdrawal by Participant|0
5850205|NCT02196506|20226086|P1|Phase A+|Withdrawal by Participant|0
5850206|NCT02196506|20226083|P4|Phase A+|Participant Met Withdrawal Criteria|1
5850207|NCT02196506|20226084|P3|Phase A+|Participant Met Withdrawal Criteria|0
5850208|NCT02196506|20226085|P2|Phase A+|Participant Met Withdrawal Criteria|0
5850209|NCT02196506|20226086|P1|Phase A+|Participant Met Withdrawal Criteria|0
5850210|NCT02196506|20226083|P4|Phase B|Lost to Follow-up|0
5850211|NCT02196506|20226084|P3|Phase B|Lost to Follow-up|1
5850212|NCT02196506|20226085|P2|Phase B|Lost to Follow-up|2
5850213|NCT02196506|20226086|P1|Phase B|Lost to Follow-up|0
5850214|NCT02196506|20226083|P4|Phase B|Adverse Event|0
5850215|NCT02196506|20226084|P3|Phase B|Adverse Event|1
5850216|NCT02196506|20226085|P2|Phase B|Adverse Event|4
5850217|NCT02196506|20226086|P1|Phase B|Adverse Event|0
5850218|NCT02196506|20226083|P4|Phase B|Withdrawal by Participant|0
5850219|NCT02196506|20226084|P3|Phase B|Withdrawal by Participant|1
5850220|NCT02196506|20226085|P2|Phase B|Withdrawal by Participant|8
5850221|NCT02196506|20226086|P1|Phase B|Withdrawal by Participant|0
5850222|NCT02196506|20226083|P4|Phase B|Lack of Efficacy|0
5850223|NCT02196506|20226084|P3|Phase B|Lack of Efficacy|2
5850224|NCT02196506|20226085|P2|Phase B|Lack of Efficacy|1
5850225|NCT02196506|20226086|P1|Phase B|Lack of Efficacy|0
5850226|NCT02196506|20226083|P4|Phase B|Participant Met Withdrawal Criteria|0
5850227|NCT02196506|20226084|P3|Phase B|Participant Met Withdrawal Criteria|1
5850228|NCT02196506|20226085|P2|Phase B|Participant Met Withdrawal Criteria|0
5850229|NCT02196506|20226086|P1|Phase B|Participant Met Withdrawal Criteria|0
5850230|NCT02196506|20226083|P4|Phase A|Participant withdrawn by investigator|0
5850231|NCT02196506|20226084|P3|Phase A|Participant withdrawn by investigator|0
5850232|NCT02196506|20226085|P2|Phase A|Participant withdrawn by investigator|0
5850233|NCT02196506|20226086|P1|Phase A|Participant withdrawn by investigator|10
5850234|NCT02196506|20226083|P4|Phase A|Protocol deviation|0
5850235|NCT02196506|20226084|P3|Phase A|Protocol deviation|0
5850236|NCT02196506|20226085|P2|Phase A|Protocol deviation|0
5850237|NCT02196506|20226086|P1|Phase A|Protocol deviation|12
5850238|NCT02196506|20226083|P4|Phase A|Lost to Follow-up|0
5850239|NCT02196506|20226084|P3|Phase A|Lost to Follow-up|0
5850240|NCT02196506|20226085|P2|Phase A|Lost to Follow-up|0
5850241|NCT02196506|20226086|P1|Phase A|Lost to Follow-up|9
5850242|NCT02196506|20226083|P4|Phase A|Adverse Event|0
5850243|NCT02196506|20226084|P3|Phase A|Adverse Event|0
5850244|NCT02196506|20226085|P2|Phase A|Adverse Event|0
5850245|NCT02196506|20226086|P1|Phase A|Adverse Event|22
5850246|NCT02196506|20226083|P4|Phase A|Withdrawal by Subject|0
5850247|NCT02196506|20226084|P3|Phase A|Withdrawal by Subject|0
5850248|NCT02196506|20226085|P2|Phase A|Withdrawal by Subject|0
5850249|NCT02196506|20226086|P1|Phase A|Withdrawal by Subject|34
5850250|NCT02196506|20226083|P4|Phase A|Participant Met Withdrawal Criteria|0
5850251|NCT02196506|20226084|P3|Phase A|Participant Met Withdrawal Criteria|0
5850252|NCT02196506|20226085|P2|Phase A|Participant Met Withdrawal Criteria|0
5850253|NCT02196506|20226086|P1|Phase A|Participant Met Withdrawal Criteria|34
5850254|NCT02196259|20226101|P3|Overall Study|Partial data analysis|0
5850255|NCT02196259|20226102|P2|Overall Study|Partial data analysis|3
5850256|NCT02196259|20226103|P1|Overall Study|Partial data analysis|0
5850257|NCT02196259|20226101|P3|Overall Study|Researcher choice|1
5850258|NCT02196259|20226102|P2|Overall Study|Researcher choice|0
5850259|NCT02196259|20226103|P1|Overall Study|Researcher choice|0
5850260|NCT02196077|20226131|P1|Overall Study|Protocol Violation|24
5850261|NCT02196077|20226131|P1|Overall Study|Lost to Follow-up|3
5850262|NCT02196077|20226131|P1|Overall Study|Physician Decision|1
5850263|NCT02196077|20226131|P1|Overall Study|Withdrawal by Subject|14
5850264|NCT02196077|20226131|P1|Overall Study|Lack of Efficacy|1
5850265|NCT02196077|20226131|P1|Overall Study|Adverse Event|4
5850266|NCT02195986|20226181|P3|Overall Study|Non-compliance|0
5850267|NCT02195986|20226182|P2|Overall Study|Non-compliance|1
5850268|NCT02195986|20226183|P1|Overall Study|Non-compliance|0
5850269|NCT02195986|20226181|P3|Overall Study|Protocol Violation|1
5850270|NCT02195986|20226182|P2|Overall Study|Protocol Violation|1
5850271|NCT02195986|20226183|P1|Overall Study|Protocol Violation|0
5850272|NCT02195986|20226181|P3|Overall Study|Family Emergency|1
5850273|NCT02195986|20226182|P2|Overall Study|Family Emergency|0
5850274|NCT02195986|20226183|P1|Overall Study|Family Emergency|0
5850275|NCT02195986|20226181|P3|Overall Study|Withdrawal by Subject|0
5850276|NCT02195986|20226182|P2|Overall Study|Withdrawal by Subject|3
5850277|NCT02195986|20226183|P1|Overall Study|Withdrawal by Subject|0
5850278|NCT02195986|20226181|P3|Overall Study|Adverse Event|0
5850279|NCT02195986|20226182|P2|Overall Study|Adverse Event|0
5850280|NCT02195986|20226183|P1|Overall Study|Adverse Event|3
5850281|NCT02195869|20226206|P1|Overall Study|Noncompliance with study drug|2
5850282|NCT02195869|20226206|P1|Overall Study|Study Terminated by Sponsor|7
5850283|NCT02195869|20226206|P1|Overall Study|Physician Decision|4
5850284|NCT02195869|20226206|P1|Overall Study|Withdrawal by Subject|7
5850285|NCT02195869|20226206|P1|Overall Study|Adverse Event|15
5850286|NCT02195869|20226206|P1|Overall Study|Malignancy Progression/relapse|2
5850287|NCT02195869|20226206|P1|Overall Study|cGVHD Progression|5
5850288|NCT02195700|20226228|P2|Overall Study|Lost to Follow-up|1
5850289|NCT02195700|20226229|P1|Overall Study|Lost to Follow-up|1
5850290|NCT02195700|20226228|P2|Overall Study|Withdrawal by Subject|2
5850291|NCT02195700|20226229|P1|Overall Study|Withdrawal by Subject|3
5850292|NCT02195700|20226228|P2|Overall Study|Adverse Event|2
5850293|NCT02195700|20226229|P1|Overall Study|Adverse Event|1
5850294|NCT02195700|20226228|P2|Overall Study|Noncompliance|0
5850295|NCT02195700|20226229|P1|Overall Study|Noncompliance|1
5850296|NCT02195700|20226228|P2|Overall Study|Protocol Violation|2
5850297|NCT02195700|20226229|P1|Overall Study|Protocol Violation|0
5850298|NCT02195687|20226251|P2|Overall Study|Lost to Follow-up|1
5850299|NCT02195687|20226252|P1|Overall Study|Lost to Follow-up|4
5850300|NCT02195687|20226251|P2|Overall Study|Personal Reasons|1
5850301|NCT02195687|20226252|P1|Overall Study|Personal Reasons|1
5850302|NCT02195583|20226277|P1|Overall Study|Other Reason|2
5850303|NCT02195583|20226277|P1|Overall Study|Adverse Event|2
5850304|NCT02195583|20226277|P1|Overall Study|Withdrawal by Subject|4
5850305|NCT02195583|20226277|P1|Overall Study|Lost to Follow-up|1
5850306|NCT02195531|20226312|P3|Overall Study|Withdrawal by Subject|1
5850307|NCT02195531|20226313|P2|Overall Study|Withdrawal by Subject|1
5850308|NCT02195531|20226314|P1|Overall Study|Withdrawal by Subject|1
5850309|NCT02195518|20226339|P1|Overall Study|Lost to Follow-up|1
5850310|NCT02195518|20226339|P1|Overall Study|Withdrawal by Subject|1
5850311|NCT02195518|20226339|P1|Overall Study|Pregnancy|2
5850312|NCT02195518|20226339|P1|Overall Study|Protocol Violation|4
5850313|NCT02195518|20226339|P1|Overall Study|Adverse Event|1
5850314|NCT02195479|20226362|P2|Overall Study|Ongoing|297
5850315|NCT02195479|20226363|P1|Overall Study|Ongoing|291
5850316|NCT02195479|20226362|P2|Overall Study|Other|2
5850317|NCT02195479|20226363|P1|Overall Study|Other|2
5850318|NCT02195479|20226362|P2|Overall Study|Withdrawal by Subject|6
5850319|NCT02195479|20226363|P1|Overall Study|Withdrawal by Subject|11
5850320|NCT02195479|20226362|P2|Overall Study|Physician Decision|0
5850321|NCT02195479|20226363|P1|Overall Study|Physician Decision|1
5850322|NCT02195479|20226362|P2|Overall Study|Death|45
5850323|NCT02195479|20226363|P1|Overall Study|Death|48
5850324|NCT02195479|20226362|P2|Overall Study|Lost to Follow-up|0
5850325|NCT02195479|20226363|P1|Overall Study|Lost to Follow-up|3
5850326|NCT02195427|20226401|P2|Overall Study|Conditional re-treatment at W52|1
5850327|NCT02195427|20226402|P1|Overall Study|Conditional re-treatment at W52|2
5850328|NCT02195427|20226401|P2|Overall Study|Protocol Violation|14
5850329|NCT02195427|20226402|P1|Overall Study|Protocol Violation|7
5850330|NCT02195427|20226401|P2|Overall Study|Lost to Follow-up|1
5850331|NCT02195427|20226402|P1|Overall Study|Lost to Follow-up|0
5850332|NCT02195427|20226401|P2|Overall Study|Withdrawal by Subject|2
5850333|NCT02195427|20226402|P1|Overall Study|Withdrawal by Subject|4
5850334|NCT02195427|20226401|P2|Overall Study|Did not consent to study extension|9
5850335|NCT02195427|20226402|P1|Overall Study|Did not consent to study extension|13
5850336|NCT02195011|20226767|P2|Overall Study|Withdrawal by Subject|0
5850337|NCT02195011|20226768|P1|Overall Study|Withdrawal by Subject|3
5850338|NCT02195011|20226767|P2|Overall Study|Progressive Disease|1
5850339|NCT02195011|20226768|P1|Overall Study|Progressive Disease|18
5850340|NCT02195011|20226767|P2|Overall Study|Adverse Event|0
5850341|NCT02195011|20226768|P1|Overall Study|Adverse Event|4
5850342|NCT02194998|20226784|P4|Post-HCV Treatment Follow-Up|Lost to Follow-up|0
5850343|NCT02194998|20226785|P3|Post-HCV Treatment Follow-Up|Lost to Follow-up|1
5850344|NCT02194998|20226786|P2|Post-HCV Treatment Follow-Up|Lost to Follow-up|0
5850345|NCT02194998|20226787|P1|Post-HCV Treatment Follow-Up|Lost to Follow-up|1
5850346|NCT02194998|20226784|P4|On-HCV Treatment|Did not pick up study medication|0
5850347|NCT02194998|20226785|P3|On-HCV Treatment|Did not pick up study medication|0
5850348|NCT02194998|20226786|P2|On-HCV Treatment|Did not pick up study medication|1
5850349|NCT02194998|20226787|P1|On-HCV Treatment|Did not pick up study medication|0
5850350|NCT02194985|20226849|P1|Overall Study|Withdrawal by Subject|2
5850351|NCT02194985|20226849|P1|Overall Study|Lost to Follow-up|1
5850352|NCT02194985|20226849|P1|Overall Study|Physician Decision|4
5850353|NCT02194985|20226849|P1|Overall Study|Met Protocol Defined Stopping Criteria|3
5850354|NCT02194985|20226849|P1|Overall Study|Adverse Event|1
5850355|NCT02194933|20226863|P2|Overall Study|Lack of Efficacy|2
5850356|NCT02194933|20226864|P1|Overall Study|Lack of Efficacy|1
5850357|NCT02194933|20226863|P2|Overall Study|Withdrawal by Subject|2
5850358|NCT02194933|20226864|P1|Overall Study|Withdrawal by Subject|0
5850359|NCT02194933|20226863|P2|Overall Study|Participant met withdrawal criteria|3
5850360|NCT02194933|20226864|P1|Overall Study|Participant met withdrawal criteria|1
5850361|NCT02194933|20226863|P2|Overall Study|Lost to Follow-up|2
5850362|NCT02194933|20226864|P1|Overall Study|Lost to Follow-up|1
5850363|NCT02194699|20226918|P2|With Potential to Receive 52 Weeks of IP|Other|16
5850364|NCT02194699|20226919|P1|With Potential to Receive 52 Weeks of IP|Other|24
5850365|NCT02194699|20226918|P2|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|20
5850366|NCT02194699|20226919|P1|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|14
5850367|NCT02194699|20226918|P2|With Potential to Receive 52 Weeks of IP|Protocol Violation|2
5850368|NCT02194699|20226919|P1|With Potential to Receive 52 Weeks of IP|Protocol Violation|2
5850369|NCT02194699|20226918|P2|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|8
5850370|NCT02194699|20226919|P1|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|5
5850371|NCT02194699|20226918|P2|With Potential to Receive 52 Weeks of IP|Death|3
5850372|NCT02194699|20226919|P1|With Potential to Receive 52 Weeks of IP|Death|1
5850373|NCT02194699|20226918|P2|With Potential to Receive 52 Weeks of IP|Adverse Event|3
5850374|NCT02194699|20226919|P1|With Potential to Receive 52 Weeks of IP|Adverse Event|4
5850375|NCT02194699|20226918|P2|Randomised|Duplicate patient|1
5850376|NCT02194699|20226919|P1|Randomised|Duplicate patient|2
5850377|NCT02194699|20226918|P2|Randomised|Without potential for 52 weeks of IP|5
5850378|NCT02194699|20226919|P1|Randomised|Without potential for 52 weeks of IP|5
5850379|NCT02194699|20226918|P2|Randomised|Did not receive treatment|5
5850380|NCT02194699|20226919|P1|Randomised|Did not receive treatment|1
5850381|NCT02194621|20227027|P3|Overall Study|Withdrawal by Subject|7
5850382|NCT02194621|20227028|P2|Overall Study|Withdrawal by Subject|4
5850383|NCT02194621|20227029|P1|Overall Study|Withdrawal by Subject|4
5850384|NCT02194621|20227027|P3|Overall Study|6 withdrew prior to randomization|2
5850385|NCT02194621|20227028|P2|Overall Study|6 withdrew prior to randomization|2
5850386|NCT02194621|20227029|P1|Overall Study|6 withdrew prior to randomization|2
5850387|NCT02194465|20227053|P7|Overall Study|Discontinued follow-up period|0
5850388|NCT02194465|20227054|P6|Overall Study|Discontinued follow-up period|0
5850389|NCT02194465|20227055|P5|Overall Study|Discontinued follow-up period|2
5850390|NCT02194465|20227056|P4|Overall Study|Discontinued follow-up period|0
5850391|NCT02194465|20227057|P3|Overall Study|Discontinued follow-up period|1
5850392|NCT02194465|20227058|P2|Overall Study|Discontinued follow-up period|2
5850393|NCT02194465|20227059|P1|Overall Study|Discontinued follow-up period|0
5850394|NCT02194465|20227053|P7|Overall Study|Withdrawal by Subject|2
5850395|NCT02194465|20227054|P6|Overall Study|Withdrawal by Subject|1
5850396|NCT02194465|20227055|P5|Overall Study|Withdrawal by Subject|2
5850397|NCT02194465|20227056|P4|Overall Study|Withdrawal by Subject|2
5850398|NCT02194465|20227057|P3|Overall Study|Withdrawal by Subject|1
5850399|NCT02194465|20227058|P2|Overall Study|Withdrawal by Subject|3
5850400|NCT02194465|20227059|P1|Overall Study|Withdrawal by Subject|1
5850401|NCT02194465|20227053|P7|Overall Study|Protocol Violation|0
5850402|NCT02194465|20227054|P6|Overall Study|Protocol Violation|0
5850403|NCT02194465|20227055|P5|Overall Study|Protocol Violation|1
5850404|NCT02194465|20227056|P4|Overall Study|Protocol Violation|1
5850405|NCT02194465|20227057|P3|Overall Study|Protocol Violation|2
5850406|NCT02194465|20227058|P2|Overall Study|Protocol Violation|1
5850407|NCT02194465|20227059|P1|Overall Study|Protocol Violation|1
5850408|NCT02194465|20227053|P7|Overall Study|Physician Decision|0
5850409|NCT02194465|20227054|P6|Overall Study|Physician Decision|0
5850410|NCT02194465|20227055|P5|Overall Study|Physician Decision|0
5850411|NCT02194465|20227056|P4|Overall Study|Physician Decision|0
5850412|NCT02194465|20227057|P3|Overall Study|Physician Decision|0
5850413|NCT02194465|20227058|P2|Overall Study|Physician Decision|0
5850414|NCT02194465|20227059|P1|Overall Study|Physician Decision|1
5850415|NCT02194465|20227053|P7|Overall Study|Lost to Follow-up|0
5850416|NCT02194465|20227054|P6|Overall Study|Lost to Follow-up|1
5850417|NCT02194465|20227055|P5|Overall Study|Lost to Follow-up|0
5850418|NCT02194465|20227056|P4|Overall Study|Lost to Follow-up|1
5850419|NCT02194465|20227057|P3|Overall Study|Lost to Follow-up|0
5850420|NCT02194465|20227058|P2|Overall Study|Lost to Follow-up|0
5850421|NCT02194465|20227059|P1|Overall Study|Lost to Follow-up|0
5850422|NCT02194465|20227053|P7|Overall Study|Adverse Event|0
5850423|NCT02194465|20227054|P6|Overall Study|Adverse Event|2
5850424|NCT02194465|20227055|P5|Overall Study|Adverse Event|4
5850425|NCT02194465|20227056|P4|Overall Study|Adverse Event|4
5850426|NCT02194465|20227057|P3|Overall Study|Adverse Event|4
5850427|NCT02194465|20227058|P2|Overall Study|Adverse Event|1
5850428|NCT02194465|20227059|P1|Overall Study|Adverse Event|6
5850429|NCT02194062|20227116|P3|Overall Study|Lost to Follow-up|5
5850430|NCT02194062|20227117|P2|Overall Study|Lost to Follow-up|2
5850431|NCT02194062|20227118|P1|Overall Study|Lost to Follow-up|2
5850432|NCT02193880|20227129|P1|Overall Study|patients did not collect enough HPC|3
5850433|NCT02193867|20227134|P1|Overall Study|Sponsor Study Termination|2
5850434|NCT02193867|20227134|P1|Overall Study|Death|2
5850435|NCT02193828|20227152|P4|Overall Study|Withdrawal by Subject|1
5850436|NCT02193828|20227153|P3|Overall Study|Withdrawal by Subject|1
5850437|NCT02193828|20227154|P2|Overall Study|Withdrawal by Subject|0
5850438|NCT02193828|20227155|P1|Overall Study|Withdrawal by Subject|0
5850439|NCT02193776|20227232|P4|Overall Study|Adverse event/Specific toxicity|2
5850440|NCT02193776|20227233|P3|Overall Study|Adverse event/Specific toxicity|2
5850441|NCT02193776|20227234|P2|Overall Study|Adverse event/Specific toxicity|5
5850442|NCT02193776|20227235|P1|Overall Study|Adverse event/Specific toxicity|5
5850443|NCT02193776|20227232|P4|Overall Study|Death|0
5850444|NCT02193776|20227233|P3|Overall Study|Death|0
5850445|NCT02193776|20227234|P2|Overall Study|Death|0
5850446|NCT02193776|20227235|P1|Overall Study|Death|1
5850447|NCT02193776|20227232|P4|Overall Study|Investigator/Sponsor decision|0
5850448|NCT02193776|20227233|P3|Overall Study|Investigator/Sponsor decision|0
5850449|NCT02193776|20227234|P2|Overall Study|Investigator/Sponsor decision|1
5850450|NCT02193776|20227235|P1|Overall Study|Investigator/Sponsor decision|1
5850451|NCT02193776|20227232|P4|Overall Study|Failure to comply with protocol|0
5850452|NCT02193776|20227233|P3|Overall Study|Failure to comply with protocol|0
5850453|NCT02193776|20227234|P2|Overall Study|Failure to comply with protocol|1
5850454|NCT02193776|20227235|P1|Overall Study|Failure to comply with protocol|0
5850455|NCT02193776|20227232|P4|Overall Study|Consent withdrawn|0
5850456|NCT02193776|20227233|P3|Overall Study|Consent withdrawn|0
5850457|NCT02193776|20227234|P2|Overall Study|Consent withdrawn|0
5850458|NCT02193776|20227235|P1|Overall Study|Consent withdrawn|1
5850459|NCT02193178|20227262|P1|Overall Study|Dry eyes|1
5850460|NCT02193178|20227262|P1|Overall Study|Lost to Follow-up|1
5850461|NCT02193165|20227312|P3|6 Week Product Use|Lost to Follow-up|0
5850462|NCT02193165|20227313|P2|6 Week Product Use|Lost to Follow-up|1
5850463|NCT02193165|20227314|P1|6 Week Product Use|Lost to Follow-up|0
5850464|NCT02193165|20227312|P3|4 Week Product Use|Lost to Follow-up|1
5850465|NCT02193165|20227313|P2|4 Week Product Use|Lost to Follow-up|1
5850466|NCT02193165|20227314|P1|4 Week Product Use|Lost to Follow-up|1
5850467|NCT02193087|20227349|P4|Overall Study|Did Not Receive Any Vaccination|1
5850468|NCT02193087|20227350|P3|Overall Study|Did Not Receive Any Vaccination|0
5850469|NCT02193087|20227351|P2|Overall Study|Did Not Receive Any Vaccination|3
5850470|NCT02193087|20227352|P1|Overall Study|Did Not Receive Any Vaccination|2
5850471|NCT02193087|20227349|P4|Overall Study|Other Reason Not Specified|9
5850472|NCT02193087|20227350|P3|Overall Study|Other Reason Not Specified|1
5850473|NCT02193087|20227351|P2|Overall Study|Other Reason Not Specified|2
5850474|NCT02193087|20227352|P1|Overall Study|Other Reason Not Specified|7
5850475|NCT02193087|20227349|P4|Overall Study|Withdrawal by Subject|19
5850476|NCT02193087|20227350|P3|Overall Study|Withdrawal by Subject|1
5850477|NCT02193087|20227351|P2|Overall Study|Withdrawal by Subject|3
5850478|NCT02193087|20227352|P1|Overall Study|Withdrawal by Subject|10
5850479|NCT02193087|20227349|P4|Overall Study|Protocol Violation|2
5850480|NCT02193087|20227350|P3|Overall Study|Protocol Violation|1
5850481|NCT02193087|20227351|P2|Overall Study|Protocol Violation|0
5850482|NCT02193087|20227352|P1|Overall Study|Protocol Violation|2
5850483|NCT02193087|20227349|P4|Overall Study|Lost to Follow-up|37
5850484|NCT02193087|20227350|P3|Overall Study|Lost to Follow-up|4
5850485|NCT02193087|20227351|P2|Overall Study|Lost to Follow-up|6
5850486|NCT02193087|20227352|P1|Overall Study|Lost to Follow-up|14
5850487|NCT02193087|20227349|P4|Overall Study|Adverse Event|11
5850488|NCT02193087|20227350|P3|Overall Study|Adverse Event|0
5850489|NCT02193087|20227351|P2|Overall Study|Adverse Event|0
5850490|NCT02193087|20227352|P1|Overall Study|Adverse Event|2
5850495|NCT02192905|20227430|P1|Overall Study|Lost to Follow-up|1
5850496|NCT02192606|20227498|P2|Overall Study|3D equipment rep unable to join|1
5850497|NCT02192606|20227499|P1|Overall Study|3D equipment rep unable to join|0
5850498|NCT02192606|20227498|P2|Overall Study|Physician Decision|2
5850499|NCT02192606|20227499|P1|Overall Study|Physician Decision|1
5850500|NCT02192606|20227498|P2|Overall Study|surgery type was changed|1
5850501|NCT02192606|20227499|P1|Overall Study|surgery type was changed|1
5850502|NCT02192190|20227547|P6|Overall Study|Inadequate Pain Relief|0
5850503|NCT02192190|20227548|P5|Overall Study|Inadequate Pain Relief|0
5850504|NCT02192190|20227549|P4|Overall Study|Inadequate Pain Relief|0
5850505|NCT02192190|20227550|P3|Overall Study|Inadequate Pain Relief|1
5850506|NCT02192190|20227551|P2|Overall Study|Inadequate Pain Relief|1
5850507|NCT02192190|20227552|P1|Overall Study|Inadequate Pain Relief|0
5850508|NCT02192190|20227547|P6|Overall Study|Positive Drug Screen|0
5850509|NCT02192190|20227548|P5|Overall Study|Positive Drug Screen|0
5850510|NCT02192190|20227549|P4|Overall Study|Positive Drug Screen|1
5850511|NCT02192190|20227550|P3|Overall Study|Positive Drug Screen|0
5850512|NCT02192190|20227551|P2|Overall Study|Positive Drug Screen|0
5850513|NCT02192190|20227552|P1|Overall Study|Positive Drug Screen|0
5850514|NCT02192190|20227547|P6|Overall Study|Could not Keep Visit Schedule|0
5850515|NCT02192190|20227548|P5|Overall Study|Could not Keep Visit Schedule|0
5850516|NCT02192190|20227549|P4|Overall Study|Could not Keep Visit Schedule|0
5850517|NCT02192190|20227550|P3|Overall Study|Could not Keep Visit Schedule|0
5850518|NCT02192190|20227551|P2|Overall Study|Could not Keep Visit Schedule|0
5850519|NCT02192190|20227552|P1|Overall Study|Could not Keep Visit Schedule|1
5850520|NCT02192190|20227547|P6|Overall Study|Withdrawal by Subject|3
5850521|NCT02192190|20227548|P5|Overall Study|Withdrawal by Subject|5
5850522|NCT02192190|20227549|P4|Overall Study|Withdrawal by Subject|1
5850523|NCT02192190|20227550|P3|Overall Study|Withdrawal by Subject|2
5850524|NCT02192190|20227551|P2|Overall Study|Withdrawal by Subject|1
5850525|NCT02192190|20227552|P1|Overall Study|Withdrawal by Subject|4
5850526|NCT02192190|20227547|P6|Overall Study|Terminated by Sponsor|23
5850527|NCT02192190|20227548|P5|Overall Study|Terminated by Sponsor|21
5850528|NCT02192190|20227549|P4|Overall Study|Terminated by Sponsor|23
5850529|NCT02192190|20227550|P3|Overall Study|Terminated by Sponsor|20
5850530|NCT02192190|20227551|P2|Overall Study|Terminated by Sponsor|23
5850531|NCT02192190|20227552|P1|Overall Study|Terminated by Sponsor|43
5850532|NCT02192190|20227547|P6|Overall Study|Physician Decision|0
5850533|NCT02192190|20227548|P5|Overall Study|Physician Decision|0
5850534|NCT02192190|20227549|P4|Overall Study|Physician Decision|0
5850535|NCT02192190|20227550|P3|Overall Study|Physician Decision|0
5850536|NCT02192190|20227551|P2|Overall Study|Physician Decision|0
5850537|NCT02192190|20227552|P1|Overall Study|Physician Decision|2
5850538|NCT02192190|20227547|P6|Overall Study|Lost to Follow-up|3
5850539|NCT02192190|20227548|P5|Overall Study|Lost to Follow-up|4
5850540|NCT02192190|20227549|P4|Overall Study|Lost to Follow-up|1
5850541|NCT02192190|20227550|P3|Overall Study|Lost to Follow-up|2
5850542|NCT02192190|20227551|P2|Overall Study|Lost to Follow-up|3
5850543|NCT02192190|20227552|P1|Overall Study|Lost to Follow-up|3
5850544|NCT02192190|20227547|P6|Overall Study|Adverse Event|0
5850545|NCT02192190|20227548|P5|Overall Study|Adverse Event|0
5850546|NCT02192190|20227549|P4|Overall Study|Adverse Event|0
5850547|NCT02192190|20227550|P3|Overall Study|Adverse Event|0
5850548|NCT02192190|20227551|P2|Overall Study|Adverse Event|1
5850549|NCT02192190|20227552|P1|Overall Study|Adverse Event|1
5850550|NCT02192164|20227596|P1|Overall Study|Did not meet the exclusion criteria|1
5850551|NCT02192164|20227596|P1|Overall Study|Physician Decision|4
5850552|NCT02192164|20227596|P1|Overall Study|Withdrawal by Subject|1
5850553|NCT02192164|20227596|P1|Overall Study|Other|8
5850554|NCT02192099|20227612|P1|Overall Study|Miscellaneous Reasons|5
5850555|NCT02192099|20227612|P1|Overall Study|Withdrawal by Subject|11
5850556|NCT02192099|20227612|P1|Overall Study|Study Terminated by Sponsor|32
5850557|NCT02192099|20227612|P1|Overall Study|Protocol Violation|8
5850558|NCT02192099|20227612|P1|Overall Study|Pregnancy|1
5850559|NCT02192099|20227612|P1|Overall Study|Physician Decision|1
5850560|NCT02192099|20227612|P1|Overall Study|Lost to Follow-up|2
5850561|NCT02192099|20227612|P1|Overall Study|Adverse Event|1
5850562|NCT02191618|20227641|P1|Overall Study|Missed Visit|4
5850563|NCT02191618|20227641|P1|Overall Study|Withdrawal by Subject|3
5850564|NCT02191605|20227651|P5|Overall Study|Lost to Follow-up|4
5850565|NCT02191605|20227652|P4|Overall Study|Lost to Follow-up|3
5850566|NCT02191605|20227653|P3|Overall Study|Lost to Follow-up|7
5850567|NCT02191605|20227654|P2|Overall Study|Lost to Follow-up|4
5850568|NCT02191605|20227655|P1|Overall Study|Lost to Follow-up|9
5850569|NCT02191579|20227674|P2|Treatment 2|Multiple Reasons Specified|25
5850570|NCT02191579|20227675|P1|Treatment 2|Multiple Reasons Specified|0
5850571|NCT02191579|20227674|P2|Treatment 1|Multiple Reasons Specified|58
5850572|NCT02191579|20227675|P1|Treatment 1|Multiple Reasons Specified|27
5850573|NCT02191397|20227689|P2|Overall Study|Withdrawal by Subject|27
5850574|NCT02191397|20227690|P1|Overall Study|Withdrawal by Subject|22
5850575|NCT02191397|20227689|P2|Overall Study|Physician Decision|3
5850576|NCT02191397|20227690|P1|Overall Study|Physician Decision|8
5850577|NCT02191397|20227689|P2|Overall Study|Lost to Follow-up|11
5850578|NCT02191397|20227690|P1|Overall Study|Lost to Follow-up|10
5850579|NCT02191397|20227689|P2|Overall Study|Met protocol-defined stopping criteria|4
5850580|NCT02191397|20227690|P1|Overall Study|Met protocol-defined stopping criteria|5
5850581|NCT02191397|20227689|P2|Overall Study|Protocol Violation|3
5850582|NCT02191397|20227690|P1|Overall Study|Protocol Violation|0
5850583|NCT02191397|20227689|P2|Overall Study|Lack of Efficacy|5
5850584|NCT02191397|20227690|P1|Overall Study|Lack of Efficacy|10
5850585|NCT02191397|20227689|P2|Overall Study|Adverse Event|17
5850586|NCT02191397|20227690|P1|Overall Study|Adverse Event|28
5850587|NCT02191267|20227751|P3|Overall Study|Withdrawal by Subject|0
5850588|NCT02191267|20227752|P2|Overall Study|Withdrawal by Subject|0
5850589|NCT02191267|20227753|P1|Overall Study|Withdrawal by Subject|1
5850590|NCT02191137|20227764|P1|Follow-up|Adverse Event|1
5850591|NCT02191137|20227764|P1|Follow-up|Ongoing/unknown|2
5850592|NCT02191137|20227764|P1|Follow-up|Lost to Follow-up|2
5850593|NCT02191137|20227764|P1|Treatment|Other|1
5850594|NCT02191137|20227764|P1|Treatment|Adverse Event|2
5850595|NCT02191137|20227764|P1|Treatment|Withdrawal by Subject|3
5850596|NCT02191137|20227764|P1|Treatment|Death|4
5850597|NCT02191046|20227794|P2|Overall Study|low compliance|1
5850598|NCT02191046|20227795|P1|Overall Study|low compliance|5
5850599|NCT02190721|20227902|P3|Overall Study|Patient was out of the city|0
5850600|NCT02190721|20227903|P2|Overall Study|Patient was out of the city|1
5850601|NCT02190721|20227904|P1|Overall Study|Patient was out of the city|0
5850602|NCT02190604|20228027|P19|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
5850603|NCT02190604|20228028|P18|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
5850604|NCT02190604|20228029|P17|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
5850605|NCT02190604|20228030|P16|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
5850606|NCT02190604|20228031|P15|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
5850607|NCT02190604|20228032|P14|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|1
5850608|NCT02190604|20228033|P13|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
5850609|NCT02190604|20228034|P12|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
5850610|NCT02190604|20228035|P11|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
5850611|NCT02190604|20228036|P10|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
5850612|NCT02190604|20228037|P9|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
5850613|NCT02190604|20228038|P8|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
5850614|NCT02190604|20228039|P7|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
5850615|NCT02190604|20228040|P6|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
5850616|NCT02190604|20228041|P5|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
5850617|NCT02190604|20228042|P4|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
5850618|NCT02190604|20228043|P3|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
5850619|NCT02190604|20228044|P2|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
5850620|NCT02190604|20228045|P1|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
5850621|NCT02190604|20228027|P19|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
5850622|NCT02190604|20228028|P18|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
5850623|NCT02190604|20228029|P17|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
5850624|NCT02190604|20228030|P16|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
5850625|NCT02190604|20228031|P15|Part 1 and 2 (Healthy Volunteers)|Adverse Event|2
5850626|NCT02190604|20228032|P14|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
5850627|NCT02190604|20228033|P13|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
5850628|NCT02190604|20228034|P12|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
5850629|NCT02190604|20228035|P11|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
5850630|NCT02190604|20228036|P10|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
5850631|NCT02190604|20228037|P9|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
5850632|NCT02190604|20228038|P8|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
5850633|NCT02190604|20228039|P7|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
5850634|NCT02190604|20228040|P6|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
5850635|NCT02190604|20228041|P5|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
5850636|NCT02190604|20228042|P4|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
5850637|NCT02190604|20228043|P3|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
5850638|NCT02190604|20228044|P2|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
5850639|NCT02190604|20228045|P1|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
5850640|NCT02190591|20228236|P2|Overall Study|face presentation so she was ineligible|1
5850641|NCT02190591|20228237|P1|Overall Study|face presentation so she was ineligible|0
5850642|NCT02190591|20228236|P2|Overall Study|did not use peanut ball as instructed|2
5850643|NCT02190591|20228237|P1|Overall Study|did not use peanut ball as instructed|0
5850644|NCT02190591|20228236|P2|Overall Study|Protocol Violation|0
5850645|NCT02190591|20228237|P1|Overall Study|Protocol Violation|1
5850646|NCT02190591|20228236|P2|Overall Study|Withdrawal by Subject|8
5850647|NCT02190591|20228237|P1|Overall Study|Withdrawal by Subject|1
5850648|NCT02190435|20228260|P2|Overall Study|3 consented screen fails|0
5850649|NCT02190435|20228261|P1|Overall Study|3 consented screen fails|3
5850650|NCT02190435|20228260|P2|Overall Study|First 12 patients were lead-ins|0
5850651|NCT02190435|20228261|P1|Overall Study|First 12 patients were lead-ins|12
5850652|NCT02190279|20228272|P3|Overall Study|Screening failure|1
5850653|NCT02190279|20228273|P2|Overall Study|Screening failure|0
5850654|NCT02190279|20228274|P1|Overall Study|Screening failure|0
5850655|NCT02190279|20228272|P3|Overall Study|Refused further treatment|1
5850656|NCT02190279|20228273|P2|Overall Study|Refused further treatment|0
5850657|NCT02190279|20228274|P1|Overall Study|Refused further treatment|0
5850658|NCT02190279|20228272|P3|Overall Study|Lost to Follow-up|0
5850659|NCT02190279|20228273|P2|Overall Study|Lost to Follow-up|0
5850660|NCT02190279|20228274|P1|Overall Study|Lost to Follow-up|2
5850661|NCT02190279|20228272|P3|Overall Study|Withdrawal consent|1
5850662|NCT02190279|20228273|P2|Overall Study|Withdrawal consent|0
5850663|NCT02190279|20228274|P1|Overall Study|Withdrawal consent|1
5850664|NCT02189941|20228313|P3|Overall Study|Non-compliance|1
5850665|NCT02189941|20228314|P2|Overall Study|Non-compliance|0
5850666|NCT02189941|20228315|P1|Overall Study|Non-compliance|0
5850667|NCT02189863|20228360|P2|First 2 Weeks|Motion Sickness|2
5850668|NCT02189863|20228361|P1|First 2 Weeks|Motion Sickness|4
5850669|NCT02189837|20228376|P4|Overall Study|Sponsor Decision|1
5850670|NCT02189837|20228377|P3|Overall Study|Sponsor Decision|0
5850671|NCT02189837|20228378|P2|Overall Study|Sponsor Decision|0
5850672|NCT02189837|20228379|P1|Overall Study|Sponsor Decision|0
5850673|NCT02189837|20228376|P4|Overall Study|Withdrawal by Subject|1
5850674|NCT02189837|20228377|P3|Overall Study|Withdrawal by Subject|3
5850675|NCT02189837|20228378|P2|Overall Study|Withdrawal by Subject|1
5850676|NCT02189837|20228379|P1|Overall Study|Withdrawal by Subject|2
5850677|NCT02189759|20228409|P4|Overall Study|Lost to Follow-up|5
5850678|NCT02189759|20228410|P3|Overall Study|Lost to Follow-up|2
5850679|NCT02189759|20228411|P2|Overall Study|Lost to Follow-up|0
5850680|NCT02189759|20228412|P1|Overall Study|Lost to Follow-up|0
5850681|NCT02189473|20228448|P2|Overall Study|Lost to Follow-up|2
5850682|NCT02189473|20228449|P1|Overall Study|Lost to Follow-up|1
5850683|NCT02189473|20228448|P2|Overall Study|Death|23
5850684|NCT02189473|20228449|P1|Overall Study|Death|22
5850685|NCT02189252|20228497|P4|Period 1 (Visit 4b, Week 4)|Adverse Event|0
5850686|NCT02189252|20228498|P3|Period 1 (Visit 4b, Week 4)|Adverse Event|0
5850687|NCT02189252|20228499|P2|Period 1 (Visit 4b, Week 4)|Adverse Event|1
5850688|NCT02189252|20228500|P1|Period 1 (Visit 4b, Week 4)|Adverse Event|0
5850689|NCT02189252|20228497|P4|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0
5850690|NCT02189252|20228498|P3|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0
5850691|NCT02189252|20228499|P2|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|1
5850692|NCT02189252|20228500|P1|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0
5850693|NCT02188849|20228559|P2|Overall Study|Lost to Follow-up|8
5850694|NCT02188849|20228560|P1|Overall Study|Lost to Follow-up|3
5850695|NCT02188784|20228574|P2|Overall Study|Physician Decision|3
5850696|NCT02188784|20228575|P1|Overall Study|Physician Decision|2
5850697|NCT02188784|20228574|P2|Overall Study|Withdrawal by Subject|9
5850698|NCT02188784|20228575|P1|Overall Study|Withdrawal by Subject|3
5850699|NCT02188784|20228574|P2|Overall Study|Lost to Follow-up|0
5850700|NCT02188784|20228575|P1|Overall Study|Lost to Follow-up|1
5850701|NCT02188784|20228574|P2|Overall Study|Death|1
5850702|NCT02188784|20228575|P1|Overall Study|Death|3
5850703|NCT02188719|20228595|P4|Overall Study|Screen B Ineligible (Page 55, Protocol)|0
5850704|NCT02188719|20228596|P3|Overall Study|Screen B Ineligible (Page 55, Protocol)|0
5850705|NCT02188719|20228597|P2|Overall Study|Screen B Ineligible (Page 55, Protocol)|1
5850706|NCT02188719|20228598|P1|Overall Study|Screen B Ineligible (Page 55, Protocol)|0
5850707|NCT02188589|20228622|P1|Overall Study|Withdrawal by Subject|5
5850708|NCT02188160|20228641|P2|Overall Study|Use of an excluded medication|1
5850709|NCT02188160|20228642|P1|Overall Study|Use of an excluded medication|0
5850710|NCT02188160|20228641|P2|Overall Study|Adverse Event|0
5850711|NCT02188160|20228642|P1|Overall Study|Adverse Event|1
5850712|NCT02187861|20228671|P4|Overall Study|Other|1
5850713|NCT02187861|20228672|P3|Overall Study|Other|7
5850714|NCT02187861|20228673|P2|Overall Study|Other|1
5850715|NCT02187861|20228674|P1|Overall Study|Other|0
5850716|NCT02187861|20228671|P4|Overall Study|Withdrawal by Subject|3
5850717|NCT02187861|20228672|P3|Overall Study|Withdrawal by Subject|3
5850718|NCT02187861|20228673|P2|Overall Study|Withdrawal by Subject|0
5850719|NCT02187861|20228674|P1|Overall Study|Withdrawal by Subject|0
5850720|NCT02187861|20228671|P4|Overall Study|Progressive Disease|22
5850721|NCT02187861|20228672|P3|Overall Study|Progressive Disease|19
5850722|NCT02187861|20228673|P2|Overall Study|Progressive Disease|42
5850723|NCT02187861|20228674|P1|Overall Study|Progressive Disease|4
5850724|NCT02187861|20228671|P4|Overall Study|Physician Decision|3
5850725|NCT02187861|20228672|P3|Overall Study|Physician Decision|0
5850726|NCT02187861|20228673|P2|Overall Study|Physician Decision|1
5850727|NCT02187861|20228674|P1|Overall Study|Physician Decision|0
5850728|NCT02187861|20228671|P4|Overall Study|Death|2
5850729|NCT02187861|20228672|P3|Overall Study|Death|1
5850730|NCT02187861|20228673|P2|Overall Study|Death|3
5850731|NCT02187861|20228674|P1|Overall Study|Death|0
5850732|NCT02187861|20228671|P4|Overall Study|Adverse Event|1
5850733|NCT02187861|20228672|P3|Overall Study|Adverse Event|2
5850734|NCT02187861|20228673|P2|Overall Study|Adverse Event|1
5850735|NCT02187861|20228674|P1|Overall Study|Adverse Event|2
5850736|NCT02187809|20228770|P1|Overall Study|The study was terminated|3
5850737|NCT02187783|20228780|P1|Overall Study|Study terminated by sponsor|1
5850738|NCT02187783|20228780|P1|Overall Study|Withdrawal by Subject|9
5850739|NCT02187783|20228780|P1|Overall Study|Physician Decision|2
5850740|NCT02187783|20228780|P1|Overall Study|Protocol Violation|3
5850741|NCT02187783|20228780|P1|Overall Study|Progressive disease|80
5850742|NCT02187783|20228780|P1|Overall Study|Death|3
5850743|NCT02187783|20228780|P1|Overall Study|Adverse Event|8
5850744|NCT02187744|20228791|P2|Treatment|Participant refused continued treatment|1
5850745|NCT02187744|20228792|P1|Treatment|Participant refused continued treatment|1
5850746|NCT02187744|20228791|P2|Treatment|Other|0
5850747|NCT02187744|20228792|P1|Treatment|Other|2
5850748|NCT02187744|20228791|P2|Treatment|Lost to Follow-up|1
5850749|NCT02187744|20228792|P1|Treatment|Lost to Follow-up|0
5850750|NCT02187744|20228791|P2|Treatment|Related adverse event, not serious|2
5850751|NCT02187744|20228792|P1|Treatment|Related adverse event, not serious|0
5850752|NCT02187744|20228791|P2|Treatment|Related adverse event, serious non-fatal|1
5850753|NCT02187744|20228792|P1|Treatment|Related adverse event, serious non-fatal|0
5850754|NCT02187744|20228791|P2|Treatment|Death|0
5850755|NCT02187744|20228792|P1|Treatment|Death|1
5850756|NCT02187744|20228791|P2|Study|Related adverse event, serious non-fatal|1
5850757|NCT02187744|20228792|P1|Study|Related adverse event, serious non-fatal|0
5850758|NCT02187744|20228791|P2|Study|Death|0
5850759|NCT02187744|20228792|P1|Study|Death|1
5850760|NCT02187744|20228791|P2|Study|Related adverse event, not serious|2
5850761|NCT02187744|20228792|P1|Study|Related adverse event, not serious|0
5850762|NCT02187744|20228791|P2|Study|Lost to Follow-up|2
5850763|NCT02187744|20228792|P1|Study|Lost to Follow-up|0
5850764|NCT02187744|20228791|P2|Study|Other|1
5850765|NCT02187744|20228792|P1|Study|Other|2
5850766|NCT02187744|20228791|P2|Study|Participant refused further follow-up|0
5850767|NCT02187744|20228792|P1|Study|Participant refused further follow-up|1
5850768|NCT02187471|20228812|P4|Overall Study|Other|4
5850769|NCT02187471|20228813|P3|Overall Study|Other|3
5850770|NCT02187471|20228814|P2|Overall Study|Other|5
5850771|NCT02187471|20228815|P1|Overall Study|Other|7
5850772|NCT02187471|20228812|P4|Overall Study|Withdrawal by Subject|24
5850773|NCT02187471|20228813|P3|Overall Study|Withdrawal by Subject|22
5850774|NCT02187471|20228814|P2|Overall Study|Withdrawal by Subject|29
5850775|NCT02187471|20228815|P1|Overall Study|Withdrawal by Subject|23
5850776|NCT02187471|20228812|P4|Overall Study|Adverse Event|36
5850777|NCT02187471|20228813|P3|Overall Study|Adverse Event|44
5850778|NCT02187471|20228814|P2|Overall Study|Adverse Event|34
5850779|NCT02187471|20228815|P1|Overall Study|Adverse Event|24
5850780|NCT02187471|20228812|P4|Overall Study|Lack of Efficacy|11
5850781|NCT02187471|20228813|P3|Overall Study|Lack of Efficacy|13
5850782|NCT02187471|20228814|P2|Overall Study|Lack of Efficacy|9
5850783|NCT02187471|20228815|P1|Overall Study|Lack of Efficacy|18
5850784|NCT02187471|20228812|P4|Overall Study|Missing|1
5850785|NCT02187471|20228813|P3|Overall Study|Missing|0
5850786|NCT02187471|20228814|P2|Overall Study|Missing|0
5850787|NCT02187471|20228815|P1|Overall Study|Missing|0
5850788|NCT02187471|20228812|P4|Overall Study|Protocol Violation|4
5850789|NCT02187471|20228813|P3|Overall Study|Protocol Violation|4
5850790|NCT02187471|20228814|P2|Overall Study|Protocol Violation|5
5850791|NCT02187471|20228815|P1|Overall Study|Protocol Violation|4
5850792|NCT02187172|20228871|P2|Overall Study|Physician Decision|1
5850793|NCT02187172|20228872|P1|Overall Study|Physician Decision|1
5850794|NCT02187172|20228871|P2|Overall Study|Adverse Event|1
5850795|NCT02187172|20228872|P1|Overall Study|Adverse Event|0
5850796|NCT02187172|20228871|P2|Overall Study|Lack of Efficacy|2
5850797|NCT02187172|20228872|P1|Overall Study|Lack of Efficacy|1
5850798|NCT02187172|20228871|P2|Overall Study|Lost to Follow-up|2
5850799|NCT02187172|20228872|P1|Overall Study|Lost to Follow-up|1
5850800|NCT02187159|20229040|P4|Overall Study|Other|9
5850801|NCT02187159|20229041|P3|Overall Study|Other|3
5850802|NCT02187159|20229042|P2|Overall Study|Other|7
5850803|NCT02187159|20229043|P1|Overall Study|Other|3
5850804|NCT02187159|20229040|P4|Overall Study|Withdrawal by Subject|26
5850805|NCT02187159|20229041|P3|Overall Study|Withdrawal by Subject|25
5850806|NCT02187159|20229042|P2|Overall Study|Withdrawal by Subject|28
5850807|NCT02187159|20229043|P1|Overall Study|Withdrawal by Subject|24
5850808|NCT02187159|20229040|P4|Overall Study|Adverse Event|50
5850809|NCT02187159|20229041|P3|Overall Study|Adverse Event|42
5850810|NCT02187159|20229042|P2|Overall Study|Adverse Event|33
5850811|NCT02187159|20229043|P1|Overall Study|Adverse Event|28
5850812|NCT02187159|20229040|P4|Overall Study|Lack of Efficacy|7
5850813|NCT02187159|20229041|P3|Overall Study|Lack of Efficacy|4
5850814|NCT02187159|20229042|P2|Overall Study|Lack of Efficacy|5
5850815|NCT02187159|20229043|P1|Overall Study|Lack of Efficacy|10
5850816|NCT02187159|20229040|P4|Overall Study|Protocol Violation|4
5850817|NCT02187159|20229041|P3|Overall Study|Protocol Violation|3
5850818|NCT02187159|20229042|P2|Overall Study|Protocol Violation|6
5850819|NCT02187159|20229043|P1|Overall Study|Protocol Violation|4
5850820|NCT02187055|20229100|P3|Overall Study|Death|0
5850821|NCT02187055|20229101|P2|Overall Study|Death|0
5850822|NCT02187055|20229102|P1|Overall Study|Death|2
5850823|NCT02187055|20229100|P3|Overall Study|Adverse Event|36
5850824|NCT02187055|20229101|P2|Overall Study|Adverse Event|26
5850825|NCT02187055|20229102|P1|Overall Study|Adverse Event|21
5850826|NCT02187055|20229100|P3|Overall Study|Withdrawal by Subject|11
5850827|NCT02187055|20229101|P2|Overall Study|Withdrawal by Subject|11
5850828|NCT02187055|20229102|P1|Overall Study|Withdrawal by Subject|11
5850829|NCT02187055|20229100|P3|Overall Study|Pregnancy|0
5850830|NCT02187055|20229101|P2|Overall Study|Pregnancy|1
5850831|NCT02187055|20229102|P1|Overall Study|Pregnancy|3
5850832|NCT02187055|20229100|P3|Overall Study|Protocol Violation|4
5850833|NCT02187055|20229101|P2|Overall Study|Protocol Violation|9
5850834|NCT02187055|20229102|P1|Overall Study|Protocol Violation|9
5850835|NCT02187055|20229100|P3|Overall Study|Other|3
5850836|NCT02187055|20229101|P2|Overall Study|Other|6
5850837|NCT02187055|20229102|P1|Overall Study|Other|5
5850838|NCT02187055|20229100|P3|Overall Study|No longer willing to participate|10
5850839|NCT02187055|20229101|P2|Overall Study|No longer willing to participate|8
5850840|NCT02187055|20229102|P1|Overall Study|No longer willing to participate|6
5850841|NCT02187055|20229100|P3|Overall Study|No longer meets eligibility criteria|0
5850842|NCT02187055|20229101|P2|Overall Study|No longer meets eligibility criteria|2
5850843|NCT02187055|20229102|P1|Overall Study|No longer meets eligibility criteria|0
5850844|NCT02187055|20229100|P3|Overall Study|Lost to Follow-up|3
5850845|NCT02187055|20229101|P2|Overall Study|Lost to Follow-up|7
5850846|NCT02187055|20229102|P1|Overall Study|Lost to Follow-up|2
5850847|NCT02187055|20229100|P3|Overall Study|Lack of Efficacy|7
5850848|NCT02187055|20229101|P2|Overall Study|Lack of Efficacy|3
5850849|NCT02187055|20229102|P1|Overall Study|Lack of Efficacy|10
5850850|NCT02187042|20229202|P2|Overall Study|Progressive disease|8
5850851|NCT02187042|20229203|P1|Overall Study|Progressive disease|4
5850852|NCT02187042|20229202|P2|Overall Study|Doctor choice|0
5850853|NCT02187042|20229203|P1|Overall Study|Doctor choice|1
5850854|NCT02187042|20229202|P2|Overall Study|Participant choice|0
5850855|NCT02187042|20229203|P1|Overall Study|Participant choice|1
5850856|NCT02187042|20229202|P2|Overall Study|Toxicity|5
5850857|NCT02187042|20229203|P1|Overall Study|Toxicity|6
5850858|NCT02187042|20229202|P2|Overall Study|Death|1
5850859|NCT02187042|20229203|P1|Overall Study|Death|1
5850860|NCT02187029|20229249|P4|Overall Study|Withdrawal by Subject|0
5850861|NCT02187029|20229250|P3|Overall Study|Withdrawal by Subject|0
5850862|NCT02187029|20229251|P2|Overall Study|Withdrawal by Subject|0
5850863|NCT02187029|20229252|P1|Overall Study|Withdrawal by Subject|1
5850864|NCT02187029|20229249|P4|Overall Study|Study Terminated by Sponsor|3
5850865|NCT02187029|20229250|P3|Overall Study|Study Terminated by Sponsor|10
5850866|NCT02187029|20229251|P2|Overall Study|Study Terminated by Sponsor|0
5850867|NCT02187029|20229252|P1|Overall Study|Study Terminated by Sponsor|0
5850868|NCT02187029|20229249|P4|Overall Study|Adverse Event|0
5850869|NCT02187029|20229250|P3|Overall Study|Adverse Event|1
5850870|NCT02187029|20229251|P2|Overall Study|Adverse Event|1
5850871|NCT02187029|20229252|P1|Overall Study|Adverse Event|0
5850872|NCT02186873|20229374|P2|Overall Study|Withdrawal by Subject|2
5850873|NCT02186873|20229375|P1|Overall Study|Withdrawal by Subject|7
5850874|NCT02186873|20229374|P2|Overall Study|Lost to Follow-up|2
5850875|NCT02186873|20229375|P1|Overall Study|Lost to Follow-up|1
5850876|NCT02186873|20229374|P2|Overall Study|Lack of Efficacy|1
5850877|NCT02186873|20229375|P1|Overall Study|Lack of Efficacy|0
5850878|NCT02186873|20229374|P2|Overall Study|Adverse Event|3
5850879|NCT02186873|20229375|P1|Overall Study|Adverse Event|1
5850880|NCT02186847|20229400|P2|Overall Study|Protocol Violation|0
5850881|NCT02186847|20229401|P1|Overall Study|Protocol Violation|3
5850894|NCT02186652|20229456|P2|Overall Study|Lost to Follow-up|0
5850895|NCT02186652|20229457|P1|Overall Study|Lost to Follow-up|2
5850896|NCT02186561|20229490|P1|1- Year Post Index Procedure Visit|Missed|1
5850897|NCT02186561|20229490|P1|1- Year Post Index Procedure Visit|Death|1
5850898|NCT02186561|20229490|P1|30-Day Post Index Procedure Visit|Death|1
5850899|NCT02186561|20229490|P1|Enrollment|Investigator Withdrew Consent|1
5850900|NCT02186561|20229490|P1|Enrollment|Withdrawal by Subject|2
5850901|NCT02186561|20229490|P1|Enrollment|Insurance Denial|2
5850902|NCT02186561|20229490|P1|Enrollment|Enrollment Cap Reached|5
5850903|NCT02186561|20229490|P1|Enrollment|Did Not Meet Inclusion Criteria|46
5850904|NCT02186301|20229510|P3|Overall Study|Other|1
5850905|NCT02186301|20229511|P2|Overall Study|Other|0
5850906|NCT02186301|20229512|P1|Overall Study|Other|0
5850907|NCT02186301|20229510|P3|Overall Study|Missing|2
5850908|NCT02186301|20229511|P2|Overall Study|Missing|0
5850909|NCT02186301|20229512|P1|Overall Study|Missing|0
5850910|NCT02186301|20229510|P3|Overall Study|Protocol Deviation|0
5850911|NCT02186301|20229511|P2|Overall Study|Protocol Deviation|2
5850912|NCT02186301|20229512|P1|Overall Study|Protocol Deviation|0
5850913|NCT02186301|20229510|P3|Overall Study|Study Terminated by Sponsor|11
5850914|NCT02186301|20229511|P2|Overall Study|Study Terminated by Sponsor|0
5850915|NCT02186301|20229512|P1|Overall Study|Study Terminated by Sponsor|1
5850916|NCT02186301|20229510|P3|Overall Study|Physician Decision|1
5850917|NCT02186301|20229511|P2|Overall Study|Physician Decision|0
5850918|NCT02186301|20229512|P1|Overall Study|Physician Decision|1
5850919|NCT02186301|20229510|P3|Overall Study|Withdrawal by Subject|3
5850920|NCT02186301|20229511|P2|Overall Study|Withdrawal by Subject|1
5850921|NCT02186301|20229512|P1|Overall Study|Withdrawal by Subject|5
5850922|NCT02186301|20229510|P3|Overall Study|Death|0
5850923|NCT02186301|20229511|P2|Overall Study|Death|0
5850924|NCT02186301|20229512|P1|Overall Study|Death|1
5850925|NCT02186301|20229510|P3|Overall Study|Adverse Event|5
5850926|NCT02186301|20229511|P2|Overall Study|Adverse Event|5
5850927|NCT02186301|20229512|P1|Overall Study|Adverse Event|5
5850928|NCT02186301|20229510|P3|Overall Study|Progressive Disease|27
5850929|NCT02186301|20229511|P2|Overall Study|Progressive Disease|22
5850930|NCT02186301|20229512|P1|Overall Study|Progressive Disease|7
5850931|NCT02186223|20229528|P1|Overall Study|Device in place less than 48 hours|9
5850932|NCT02186223|20229528|P1|Overall Study|Death|3
5850933|NCT02186223|20229528|P1|Overall Study|Unable to obtain femoral access|3
5850934|NCT02186223|20229528|P1|Overall Study|Not eligible for device placement|6
5850935|NCT02186171|20229550|P2|Overall Study|Protocol-specified Criteria|2
5850936|NCT02186171|20229551|P1|Overall Study|Protocol-specified Criteria|0
5850937|NCT02186171|20229550|P2|Overall Study|Death|2
5850938|NCT02186171|20229551|P1|Overall Study|Death|1
5850939|NCT02186171|20229550|P2|Overall Study|Lost to Follow-up|2
5850940|NCT02186171|20229551|P1|Overall Study|Lost to Follow-up|2
5850941|NCT02186171|20229550|P2|Overall Study|Withdrawal by Subject|9
5850942|NCT02186171|20229551|P1|Overall Study|Withdrawal by Subject|1
5850943|NCT02185794|20229573|P6|Overall Study|Lost to Follow-up|1
5850944|NCT02185794|20229574|P5|Overall Study|Lost to Follow-up|0
5850945|NCT02185794|20229575|P4|Overall Study|Lost to Follow-up|3
5850946|NCT02185794|20229576|P3|Overall Study|Lost to Follow-up|2
5850947|NCT02185794|20229577|P2|Overall Study|Lost to Follow-up|2
5850948|NCT02185794|20229578|P1|Overall Study|Lost to Follow-up|1
5850949|NCT02185794|20229573|P6|Overall Study|Withdrew Consent|0
5850950|NCT02185794|20229574|P5|Overall Study|Withdrew Consent|0
5850951|NCT02185794|20229575|P4|Overall Study|Withdrew Consent|2
5850952|NCT02185794|20229576|P3|Overall Study|Withdrew Consent|10
5850953|NCT02185794|20229577|P2|Overall Study|Withdrew Consent|5
5850954|NCT02185794|20229578|P1|Overall Study|Withdrew Consent|2
5850955|NCT02185794|20229573|P6|Overall Study|Investigator's Discretion|15
5850956|NCT02185794|20229574|P5|Overall Study|Investigator's Discretion|2
5850957|NCT02185794|20229575|P4|Overall Study|Investigator's Discretion|2
5850958|NCT02185794|20229576|P3|Overall Study|Investigator's Discretion|1
5850959|NCT02185794|20229577|P2|Overall Study|Investigator's Discretion|0
5850960|NCT02185794|20229578|P1|Overall Study|Investigator's Discretion|1
5850961|NCT02185794|20229573|P6|Overall Study|Enrolled but Never Dosed|0
5850962|NCT02185794|20229574|P5|Overall Study|Enrolled but Never Dosed|1
5850963|NCT02185794|20229575|P4|Overall Study|Enrolled but Never Dosed|1
5850964|NCT02185794|20229576|P3|Overall Study|Enrolled but Never Dosed|3
5850965|NCT02185794|20229577|P2|Overall Study|Enrolled but Never Dosed|6
5850966|NCT02185794|20229578|P1|Overall Study|Enrolled but Never Dosed|1
5850967|NCT02185534|20229671|P6|First Washout Period|Protocol Violation|1
5850968|NCT02185534|20229672|P5|First Washout Period|Protocol Violation|0
5850969|NCT02185534|20229673|P4|First Washout Period|Protocol Violation|0
5850970|NCT02185534|20229674|P3|First Washout Period|Protocol Violation|0
5850971|NCT02185534|20229675|P2|First Washout Period|Protocol Violation|0
5850972|NCT02185534|20229676|P1|First Washout Period|Protocol Violation|0
5850973|NCT02185534|20229671|P6|First Washout Period|Withdrawal by Subject|0
5850974|NCT02185534|20229672|P5|First Washout Period|Withdrawal by Subject|1
5850975|NCT02185534|20229673|P4|First Washout Period|Withdrawal by Subject|0
5850976|NCT02185534|20229674|P3|First Washout Period|Withdrawal by Subject|0
5850977|NCT02185534|20229675|P2|First Washout Period|Withdrawal by Subject|0
5850978|NCT02185534|20229676|P1|First Washout Period|Withdrawal by Subject|1
5850979|NCT02185534|20229671|P6|First Period|Withdrawal by Subject|0
5850980|NCT02185534|20229672|P5|First Period|Withdrawal by Subject|0
5850981|NCT02185534|20229673|P4|First Period|Withdrawal by Subject|1
5850982|NCT02185534|20229674|P3|First Period|Withdrawal by Subject|0
5850983|NCT02185534|20229675|P2|First Period|Withdrawal by Subject|0
5850984|NCT02185534|20229676|P1|First Period|Withdrawal by Subject|0
5850985|NCT02185521|20229691|P1|Overall Study|Protocol Violation|1
5850986|NCT02185521|20229691|P1|Overall Study|Withdrawal by Subject|1
5850987|NCT02185053|20229779|P3|Donepezil Dose Maintenance Phase|Withdrawal by Subject|2
5850988|NCT02185053|20229780|P2|Donepezil Dose Maintenance Phase|Withdrawal by Subject|0
5850989|NCT02185053|20229781|P1|Donepezil Dose Maintenance Phase|Withdrawal by Subject|0
5850990|NCT02185053|20229779|P3|Donepezil Dose Maintenance Phase|Cardiac symptoms|1
5850991|NCT02185053|20229780|P2|Donepezil Dose Maintenance Phase|Cardiac symptoms|0
5850992|NCT02185053|20229781|P1|Donepezil Dose Maintenance Phase|Cardiac symptoms|0
5850993|NCT02185053|20229779|P3|Donepezil Dose Escalation Phase|Withdrawal by Subject|0
5850994|NCT02185053|20229780|P2|Donepezil Dose Escalation Phase|Withdrawal by Subject|1
5850995|NCT02185053|20229781|P1|Donepezil Dose Escalation Phase|Withdrawal by Subject|0
5850996|NCT02185053|20229779|P3|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|0
5850997|NCT02185053|20229780|P2|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|2
5850998|NCT02185053|20229781|P1|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|0
5850999|NCT02185053|20229779|P3|Donepezil Dose Escalation Phase|Adverse Event|0
5851000|NCT02185053|20229780|P2|Donepezil Dose Escalation Phase|Adverse Event|1
5851001|NCT02185053|20229781|P1|Donepezil Dose Escalation Phase|Adverse Event|0
5851002|NCT02185053|20229779|P3|Donepezil Dose Escalation Phase|Cardiac symptoms|0
5851003|NCT02185053|20229780|P2|Donepezil Dose Escalation Phase|Cardiac symptoms|1
5851004|NCT02185053|20229781|P1|Donepezil Dose Escalation Phase|Cardiac symptoms|0
5851005|NCT02185053|20229779|P3|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|0
5851006|NCT02185053|20229780|P2|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|0
5851007|NCT02185053|20229781|P1|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|2
5851008|NCT02185053|20229779|P3|Solifenacin Dose Escalation Phase|Cardiac symptoms|0
5851009|NCT02185053|20229780|P2|Solifenacin Dose Escalation Phase|Cardiac symptoms|0
5851010|NCT02185053|20229781|P1|Solifenacin Dose Escalation Phase|Cardiac symptoms|1
5851011|NCT02185040|20229795|P7|Active Treatment Extension Phase|Lost to Follow-up|2
5851012|NCT02185040|20229796|P6|Active Treatment Extension Phase|Lost to Follow-up|0
5851013|NCT02185040|20229797|P5|Active Treatment Extension Phase|Lost to Follow-up|0
5851014|NCT02185040|20229798|P4|Active Treatment Extension Phase|Lost to Follow-up|0
5851015|NCT02185040|20229799|P3|Active Treatment Extension Phase|Lost to Follow-up|0
5851016|NCT02185040|20229800|P2|Active Treatment Extension Phase|Lost to Follow-up|0
5851017|NCT02185040|20229801|P1|Active Treatment Extension Phase|Lost to Follow-up|0
5851018|NCT02185040|20229795|P7|Active Treatment Extension Phase|Withdrawal by Subject|1
5851019|NCT02185040|20229796|P6|Active Treatment Extension Phase|Withdrawal by Subject|1
5851020|NCT02185040|20229797|P5|Active Treatment Extension Phase|Withdrawal by Subject|0
5851021|NCT02185040|20229798|P4|Active Treatment Extension Phase|Withdrawal by Subject|0
5851022|NCT02185040|20229799|P3|Active Treatment Extension Phase|Withdrawal by Subject|0
5851023|NCT02185040|20229800|P2|Active Treatment Extension Phase|Withdrawal by Subject|0
5851024|NCT02185040|20229801|P1|Active Treatment Extension Phase|Withdrawal by Subject|0
5851025|NCT02185040|20229795|P7|Active Treatment Extension Phase|Adverse Event|4
5851026|NCT02185040|20229796|P6|Active Treatment Extension Phase|Adverse Event|1
5851027|NCT02185040|20229797|P5|Active Treatment Extension Phase|Adverse Event|0
5851028|NCT02185040|20229798|P4|Active Treatment Extension Phase|Adverse Event|0
5851029|NCT02185040|20229799|P3|Active Treatment Extension Phase|Adverse Event|0
5851030|NCT02185040|20229800|P2|Active Treatment Extension Phase|Adverse Event|0
5851031|NCT02185040|20229801|P1|Active Treatment Extension Phase|Adverse Event|0
5851032|NCT02185040|20229795|P7|Active Treatment Extension Phase|Miscellaneous|0
5851033|NCT02185040|20229796|P6|Active Treatment Extension Phase|Miscellaneous|1
5851034|NCT02185040|20229797|P5|Active Treatment Extension Phase|Miscellaneous|0
5851035|NCT02185040|20229798|P4|Active Treatment Extension Phase|Miscellaneous|0
5851036|NCT02185040|20229799|P3|Active Treatment Extension Phase|Miscellaneous|0
5851037|NCT02185040|20229800|P2|Active Treatment Extension Phase|Miscellaneous|0
5851038|NCT02185040|20229801|P1|Active Treatment Extension Phase|Miscellaneous|0
5851039|NCT02185040|20229795|P7|Part 1 Treatment Phase|Lost to Follow-up|0
5851040|NCT02185040|20229796|P6|Part 1 Treatment Phase|Lost to Follow-up|0
5851041|NCT02185040|20229797|P5|Part 1 Treatment Phase|Lost to Follow-up|0
5851042|NCT02185040|20229798|P4|Part 1 Treatment Phase|Lost to Follow-up|0
5851043|NCT02185040|20229799|P3|Part 1 Treatment Phase|Lost to Follow-up|0
5851044|NCT02185040|20229800|P2|Part 1 Treatment Phase|Lost to Follow-up|1
5851045|NCT02185040|20229801|P1|Part 1 Treatment Phase|Lost to Follow-up|0
5851046|NCT02185040|20229795|P7|Part 1 Treatment Phase|Withdrawal by Subject|0
5851047|NCT02185040|20229796|P6|Part 1 Treatment Phase|Withdrawal by Subject|0
5851048|NCT02185040|20229797|P5|Part 1 Treatment Phase|Withdrawal by Subject|0
5851049|NCT02185040|20229798|P4|Part 1 Treatment Phase|Withdrawal by Subject|0
5851050|NCT02185040|20229799|P3|Part 1 Treatment Phase|Withdrawal by Subject|0
5851051|NCT02185040|20229800|P2|Part 1 Treatment Phase|Withdrawal by Subject|1
5851052|NCT02185040|20229801|P1|Part 1 Treatment Phase|Withdrawal by Subject|0
5851053|NCT02185040|20229795|P7|Part 1 Treatment Phase|Adverse Event|0
5851054|NCT02185040|20229796|P6|Part 1 Treatment Phase|Adverse Event|0
5851055|NCT02185040|20229797|P5|Part 1 Treatment Phase|Adverse Event|3
5851056|NCT02185040|20229798|P4|Part 1 Treatment Phase|Adverse Event|2
5851057|NCT02185040|20229799|P3|Part 1 Treatment Phase|Adverse Event|0
5851058|NCT02185040|20229800|P2|Part 1 Treatment Phase|Adverse Event|0
5851059|NCT02185040|20229801|P1|Part 1 Treatment Phase|Adverse Event|1
5851060|NCT02185040|20229795|P7|Part 1 Treatment Phase|Miscellaneous|0
5851061|NCT02185040|20229796|P6|Part 1 Treatment Phase|Miscellaneous|0
5851062|NCT02185040|20229797|P5|Part 1 Treatment Phase|Miscellaneous|0
5851063|NCT02185040|20229798|P4|Part 1 Treatment Phase|Miscellaneous|0
5851064|NCT02185040|20229799|P3|Part 1 Treatment Phase|Miscellaneous|1
5851065|NCT02185040|20229800|P2|Part 1 Treatment Phase|Miscellaneous|0
5851066|NCT02185040|20229801|P1|Part 1 Treatment Phase|Miscellaneous|0
5851067|NCT02185014|20229855|P1|Overall Study|Other|4
5851068|NCT02185014|20229855|P1|Overall Study|Subject Noncompliance|1
5851069|NCT02185014|20229855|P1|Overall Study|Requires Alternative/Prohibited Therapy|5
5851070|NCT02185014|20229855|P1|Overall Study|Lack of Efficacy|14
5851071|NCT02185014|20229855|P1|Overall Study|Lost to Follow-up|4
5851072|NCT02185014|20229855|P1|Overall Study|Withdrew Consent|8
5851073|NCT02185014|20229855|P1|Overall Study|Adverse Event|18
5851074|NCT02184988|20229859|P1|Overall Study|Lost to Follow-up|32
5851075|NCT02184988|20229859|P1|Overall Study|various other reasons|9
5851076|NCT02184988|20229859|P1|Overall Study|work scheduling issues|4
5851163|NCT02182440|20230261|P1|Overall Study|Physician Decision|1
5851077|NCT02184988|20229859|P1|Overall Study|moving away/travelling/unable to complet|6
5851078|NCT02184988|20229859|P1|Overall Study|Adverse Event|2
5851079|NCT02184988|20229859|P1|Overall Study|Pregnancy|2
5851080|NCT02184611|20229917|P2|Overall Study|Protocol defined stopping criteria|1
5851081|NCT02184611|20229918|P1|Overall Study|Protocol defined stopping criteria|0
5851082|NCT02184611|20229917|P2|Overall Study|Protocol Violation|1
5851083|NCT02184611|20229918|P1|Overall Study|Protocol Violation|1
5851084|NCT02184611|20229917|P2|Overall Study|Adverse Event|5
5851085|NCT02184611|20229918|P1|Overall Study|Adverse Event|4
5851086|NCT02184611|20229917|P2|Overall Study|Withdrawal by Subject|6
5851087|NCT02184611|20229918|P1|Overall Study|Withdrawal by Subject|5
5851088|NCT02184611|20229917|P2|Overall Study|Lack of Efficacy|15
5851089|NCT02184611|20229918|P1|Overall Study|Lack of Efficacy|11
5851090|NCT02184572|20229954|P2|Overall Study|Withdrawal by Subject|9
5851091|NCT02184572|20229955|P1|Overall Study|Withdrawal by Subject|14
5851092|NCT02184572|20229954|P2|Overall Study|Traveling Outside The Country|0
5851093|NCT02184572|20229955|P1|Overall Study|Traveling Outside The Country|1
5851094|NCT02184572|20229954|P2|Overall Study|2nd blooddraw & diary card incomplete|0
5851095|NCT02184572|20229955|P1|Overall Study|2nd blooddraw & diary card incomplete|1
5851096|NCT02184572|20229954|P2|Overall Study|Loss Of Kaiser Insurance|0
5851097|NCT02184572|20229955|P1|Overall Study|Loss Of Kaiser Insurance|1
5851098|NCT02184572|20229954|P2|Overall Study|Family Out Of Country Until 9/29/2015|0
5851099|NCT02184572|20229955|P1|Overall Study|Family Out Of Country Until 9/29/2015|1
5851100|NCT02184572|20229954|P2|Overall Study|Lost to Follow-up|21
5851101|NCT02184572|20229955|P1|Overall Study|Lost to Follow-up|29
5851102|NCT02184455|20230016|P1|Overall Study|Lost to Follow-up|1
5851103|NCT02184442|20230027|P2|Overall Study|Withdrawal by Subject|11
5851104|NCT02184442|20230028|P1|Overall Study|Withdrawal by Subject|3
5851105|NCT02184442|20230027|P2|Overall Study|Death|65
5851106|NCT02184442|20230028|P1|Overall Study|Death|61
5851107|NCT02184195|20230048|P2|Overall Study|Other|2
5851108|NCT02184195|20230049|P1|Overall Study|Other|0
5851109|NCT02184195|20230048|P2|Overall Study|Lost to Follow-up|2
5851110|NCT02184195|20230049|P1|Overall Study|Lost to Follow-up|0
5851111|NCT02184195|20230048|P2|Overall Study|Death|29
5851112|NCT02184195|20230049|P1|Overall Study|Death|40
5851113|NCT02184195|20230048|P2|Overall Study|Eligibility criteria not fulfilled|1
5851114|NCT02184195|20230049|P1|Overall Study|Eligibility criteria not fulfilled|0
5851115|NCT02184195|20230048|P2|Overall Study|Patient decision|1
5851116|NCT02184195|20230049|P1|Overall Study|Patient decision|3
5851117|NCT02184143|20230086|P2|Overall Study|Death|0
5851118|NCT02184143|20230087|P1|Overall Study|Death|1
5851119|NCT02184143|20230086|P2|Overall Study|Lost to Follow-up|3
5851120|NCT02184143|20230087|P1|Overall Study|Lost to Follow-up|5
5851121|NCT02184143|20230086|P2|Overall Study|Withdrawal by Subject|4
5851122|NCT02184143|20230087|P1|Overall Study|Withdrawal by Subject|4
5851123|NCT02183675|20230116|P6|Treatment Period 2 (10 Days)|Adverse Event|2
5851124|NCT02183675|20230117|P5|Treatment Period 2 (10 Days)|Adverse Event|0
5851125|NCT02183675|20230118|P4|Treatment Period 2 (10 Days)|Adverse Event|0
5851126|NCT02183675|20230119|P3|Treatment Period 2 (10 Days)|Adverse Event|0
5851127|NCT02183675|20230120|P2|Treatment Period 2 (10 Days)|Adverse Event|0
5851128|NCT02183675|20230121|P1|Treatment Period 2 (10 Days)|Adverse Event|0
5851129|NCT02183519|20230145|P2|Overall Study|Did not respond to cough inducter|3
5851130|NCT02183519|20230146|P1|Overall Study|Did not respond to cough inducter|0
5851131|NCT02183519|20230145|P2|Overall Study|computer error|0
5851132|NCT02183519|20230146|P1|Overall Study|computer error|3
5851133|NCT02182999|20230154|P2|Overall Study|Physician Decision|0
5851134|NCT02182999|20230155|P1|Overall Study|Physician Decision|1
5851135|NCT02182999|20230154|P2|Overall Study|Adverse Event|3
5851136|NCT02182999|20230155|P1|Overall Study|Adverse Event|4
5851137|NCT02182973|20230171|P2|Overall Study|Withdrawal by Subject|0
5851138|NCT02182973|20230172|P1|Overall Study|Withdrawal by Subject|3
5851139|NCT02182895|20230184|P2|Overall Study|Discharged from hospital within 24 hours|4
5851140|NCT02182895|20230185|P1|Overall Study|Discharged from hospital within 24 hours|2
5851141|NCT02182843|20230205|P1|Overall Study|Adverse Event|1
5851142|NCT02182843|20230205|P1|Overall Study|Lost to Follow-up|2
5851143|NCT02182843|20230205|P1|Overall Study|Withdrawal by Subject|7
5851144|NCT02182830|20230212|P2|Overall Study|Lost to Follow-up|3
5851145|NCT02182830|20230213|P1|Overall Study|Lost to Follow-up|3
5851146|NCT02182830|20230212|P2|Overall Study|Consent withdrawn|8
5851147|NCT02182830|20230213|P1|Overall Study|Consent withdrawn|8
5851148|NCT02182830|20230212|P2|Overall Study|Trial stopped, reason missing|3
5851149|NCT02182830|20230213|P1|Overall Study|Trial stopped, reason missing|3
5851150|NCT02182830|20230212|P2|Overall Study|Not Treated|1
5851151|NCT02182830|20230213|P1|Overall Study|Not Treated|1
5851152|NCT02182440|20230258|P4|Overall Study|different, e.g adm other hospital|10
5851153|NCT02182440|20230259|P3|Overall Study|different, e.g adm other hospital|3
5851154|NCT02182440|20230260|P2|Overall Study|different, e.g adm other hospital|3
5851155|NCT02182440|20230261|P1|Overall Study|different, e.g adm other hospital|12
5851156|NCT02182440|20230258|P4|Overall Study|Withdrawal by Subject|4
5851157|NCT02182440|20230259|P3|Overall Study|Withdrawal by Subject|3
5851158|NCT02182440|20230260|P2|Overall Study|Withdrawal by Subject|1
5851159|NCT02182440|20230261|P1|Overall Study|Withdrawal by Subject|1
5851160|NCT02182440|20230258|P4|Overall Study|Physician Decision|0
5851161|NCT02182440|20230259|P3|Overall Study|Physician Decision|0
5851162|NCT02182440|20230260|P2|Overall Study|Physician Decision|0
5851164|NCT02182440|20230258|P4|Overall Study|Protocol Violation|0
5851165|NCT02182440|20230259|P3|Overall Study|Protocol Violation|0
5851166|NCT02182440|20230260|P2|Overall Study|Protocol Violation|1
5851167|NCT02182440|20230261|P1|Overall Study|Protocol Violation|0
5851168|NCT02182440|20230258|P4|Overall Study|Death|16
5851169|NCT02182440|20230259|P3|Overall Study|Death|5
5851170|NCT02182440|20230260|P2|Overall Study|Death|8
5851171|NCT02182440|20230261|P1|Overall Study|Death|31
5851172|NCT02182440|20230258|P4|Overall Study|Adverse Event|0
5851173|NCT02182440|20230259|P3|Overall Study|Adverse Event|0
5851174|NCT02182440|20230260|P2|Overall Study|Adverse Event|1
5851175|NCT02182440|20230261|P1|Overall Study|Adverse Event|0
5851176|NCT02181842|20230300|P1|Overall Study|Case Report Forms Uncollected|2
5851177|NCT02181816|20230317|P1|Overall Study|Protocol Deviation|21
5851178|NCT02181816|20230317|P1|Overall Study|Case Report Forms Uncollected|38
5851179|NCT02181803|20230332|P9|Overall Study|Adverse Event|0
5851180|NCT02181803|20230333|P8|Overall Study|Adverse Event|0
5851181|NCT02181803|20230334|P7|Overall Study|Adverse Event|1
5851182|NCT02181803|20230335|P6|Overall Study|Adverse Event|0
5851183|NCT02181803|20230336|P5|Overall Study|Adverse Event|0
5851184|NCT02181803|20230337|P4|Overall Study|Adverse Event|1
5851185|NCT02181803|20230338|P3|Overall Study|Adverse Event|0
5851186|NCT02181803|20230339|P2|Overall Study|Adverse Event|2
5851187|NCT02181803|20230340|P1|Overall Study|Adverse Event|0
5851188|NCT02181803|20230332|P9|Overall Study|Physician Decision|0
5851189|NCT02181803|20230333|P8|Overall Study|Physician Decision|1
5851190|NCT02181803|20230334|P7|Overall Study|Physician Decision|0
5851191|NCT02181803|20230335|P6|Overall Study|Physician Decision|0
5851192|NCT02181803|20230336|P5|Overall Study|Physician Decision|0
5851193|NCT02181803|20230337|P4|Overall Study|Physician Decision|1
5851194|NCT02181803|20230338|P3|Overall Study|Physician Decision|0
5851195|NCT02181803|20230339|P2|Overall Study|Physician Decision|0
5851196|NCT02181803|20230340|P1|Overall Study|Physician Decision|0
5851197|NCT02181803|20230332|P9|Overall Study|Withdrawal by Subject|0
5851198|NCT02181803|20230333|P8|Overall Study|Withdrawal by Subject|0
5851199|NCT02181803|20230334|P7|Overall Study|Withdrawal by Subject|0
5851200|NCT02181803|20230335|P6|Overall Study|Withdrawal by Subject|0
5851201|NCT02181803|20230336|P5|Overall Study|Withdrawal by Subject|0
5851202|NCT02181803|20230337|P4|Overall Study|Withdrawal by Subject|0
5851203|NCT02181803|20230338|P3|Overall Study|Withdrawal by Subject|0
5851204|NCT02181803|20230339|P2|Overall Study|Withdrawal by Subject|2
5851205|NCT02181803|20230340|P1|Overall Study|Withdrawal by Subject|0
5851206|NCT02181790|20230491|P2|Overall Study|study terminated|0
5851207|NCT02181790|20230492|P1|Overall Study|study terminated|2
5851208|NCT02181738|20230504|P4|Overall Study|Patient Return to Home Country|0
5851209|NCT02181738|20230505|P3|Overall Study|Patient Return to Home Country|0
5851210|NCT02181738|20230506|P2|Overall Study|Patient Return to Home Country|1
5851211|NCT02181738|20230507|P1|Overall Study|Patient Return to Home Country|0
5851212|NCT02181738|20230504|P4|Overall Study|Lost to Follow-up|0
5851213|NCT02181738|20230505|P3|Overall Study|Lost to Follow-up|2
5851214|NCT02181738|20230506|P2|Overall Study|Lost to Follow-up|4
5851215|NCT02181738|20230507|P1|Overall Study|Lost to Follow-up|0
5851216|NCT02181738|20230504|P4|Overall Study|Subject Withdrew Consent|1
5851217|NCT02181738|20230505|P3|Overall Study|Subject Withdrew Consent|2
5851218|NCT02181738|20230506|P2|Overall Study|Subject Withdrew Consent|3
5851219|NCT02181738|20230507|P1|Overall Study|Subject Withdrew Consent|1
5851220|NCT02181738|20230504|P4|Overall Study|Death|1
5851221|NCT02181738|20230505|P3|Overall Study|Death|6
5851222|NCT02181738|20230506|P2|Overall Study|Death|1
5851223|NCT02181738|20230507|P1|Overall Study|Death|1
5851224|NCT02181673|20230548|P3|Week 24-Week 60|Physician Decision|1
5851225|NCT02181673|20230549|P2|Week 24-Week 60|Physician Decision|0
5851226|NCT02181673|20230550|P1|Week 24-Week 60|Physician Decision|0
5851227|NCT02181673|20230548|P3|Week 24-Week 60|Lost to Follow-up|1
5851228|NCT02181673|20230549|P2|Week 24-Week 60|Lost to Follow-up|0
5851229|NCT02181673|20230550|P1|Week 24-Week 60|Lost to Follow-up|0
5851230|NCT02181673|20230548|P3|Week 24-Week 60|Lack of Efficacy|1
5851231|NCT02181673|20230549|P2|Week 24-Week 60|Lack of Efficacy|0
5851232|NCT02181673|20230550|P1|Week 24-Week 60|Lack of Efficacy|0
5851233|NCT02181673|20230548|P3|Week 24-Week 60|Pregnancy|1
5851234|NCT02181673|20230549|P2|Week 24-Week 60|Pregnancy|0
5851235|NCT02181673|20230550|P1|Week 24-Week 60|Pregnancy|0
5851236|NCT02181673|20230548|P3|Week 24-Week 60|Withdrawal by Subject|2
5851237|NCT02181673|20230549|P2|Week 24-Week 60|Withdrawal by Subject|2
5851238|NCT02181673|20230550|P1|Week 24-Week 60|Withdrawal by Subject|0
5851239|NCT02181673|20230548|P3|Week 24-Week 60|Other|1
5851240|NCT02181673|20230549|P2|Week 24-Week 60|Other|2
5851241|NCT02181673|20230550|P1|Week 24-Week 60|Other|0
5851242|NCT02181673|20230548|P3|Week 24-Week 60|Adverse Event|10
5851243|NCT02181673|20230549|P2|Week 24-Week 60|Adverse Event|4
5851244|NCT02181673|20230550|P1|Week 24-Week 60|Adverse Event|0
5851245|NCT02181673|20230548|P3|Up to Week 24|Randomized not Treated|1
5851246|NCT02181673|20230549|P2|Up to Week 24|Randomized not Treated|0
5851247|NCT02181673|20230550|P1|Up to Week 24|Randomized not Treated|0
5851248|NCT02181673|20230548|P3|Up to Week 24|Other|3
5851249|NCT02181673|20230549|P2|Up to Week 24|Other|0
5851250|NCT02181673|20230550|P1|Up to Week 24|Other|2
5851251|NCT02181673|20230548|P3|Up to Week 24|Withdrawal by Subject|1
5851252|NCT02181673|20230549|P2|Up to Week 24|Withdrawal by Subject|0
5851253|NCT02181673|20230550|P1|Up to Week 24|Withdrawal by Subject|10
5851254|NCT02181673|20230548|P3|Up to Week 24|Physician Decision|3
5851255|NCT02181673|20230549|P2|Up to Week 24|Physician Decision|0
5851256|NCT02181673|20230550|P1|Up to Week 24|Physician Decision|0
5851257|NCT02181673|20230548|P3|Up to Week 24|Lost to Follow-up|0
5851258|NCT02181673|20230549|P2|Up to Week 24|Lost to Follow-up|0
5851259|NCT02181673|20230550|P1|Up to Week 24|Lost to Follow-up|1
5851260|NCT02181673|20230548|P3|Up to Week 24|Lack of Efficacy|0
5851261|NCT02181673|20230549|P2|Up to Week 24|Lack of Efficacy|0
5851262|NCT02181673|20230550|P1|Up to Week 24|Lack of Efficacy|1
5851263|NCT02181673|20230548|P3|Up to Week 24|Death|0
5851264|NCT02181673|20230549|P2|Up to Week 24|Death|0
5851265|NCT02181673|20230550|P1|Up to Week 24|Death|1
5851266|NCT02181673|20230548|P3|Up to Week 24|Adverse Event|3
5851267|NCT02181673|20230549|P2|Up to Week 24|Adverse Event|0
5851268|NCT02181673|20230550|P1|Up to Week 24|Adverse Event|2
5851269|NCT02181634|20230577|P1|Overall Study|Patient opted to proceed to surgery|1
5851270|NCT02181634|20230577|P1|Overall Study|Symptomatic progression|1
5851271|NCT02181634|20230577|P1|Overall Study|Max number of dose reduction|1
5851272|NCT02181634|20230577|P1|Overall Study|Ineligible|1
5851273|NCT02181634|20230577|P1|Overall Study|Treatment delayed greater than 4 weeks|3
5851274|NCT02181634|20230577|P1|Overall Study|Death|2
5851275|NCT02181634|20230577|P1|Overall Study|Withdrawal by Subject|5
5851276|NCT02181634|20230577|P1|Overall Study|Physician Decision|8
5851277|NCT02181634|20230577|P1|Overall Study|Adverse Event|17
5851278|NCT02181634|20230577|P1|Overall Study|Lack of Efficacy|33
5851279|NCT02181504|20230626|P3|Overall Study|Adverse Event|1
5851280|NCT02181504|20230627|P2|Overall Study|Adverse Event|1
5851281|NCT02181504|20230628|P1|Overall Study|Adverse Event|1
5851282|NCT02181413|20230667|P2|Overall Study|Lost to Follow-up|1
5851283|NCT02181413|20230668|P1|Overall Study|Lost to Follow-up|0
5851284|NCT02181413|20230667|P2|Overall Study|Ongoing Study Treatment|1
5851285|NCT02181413|20230668|P1|Overall Study|Ongoing Study Treatment|0
5851286|NCT02181413|20230667|P2|Overall Study|Reason Not Specified|20
5851287|NCT02181413|20230668|P1|Overall Study|Reason Not Specified|19
5851288|NCT02181413|20230667|P2|Overall Study|Withdrawal by Subject|8
5851289|NCT02181413|20230668|P1|Overall Study|Withdrawal by Subject|5
5851290|NCT02181413|20230667|P2|Overall Study|Progressive Disease|143
5851291|NCT02181413|20230668|P1|Overall Study|Progressive Disease|121
5851292|NCT02181413|20230667|P2|Overall Study|Adverse Event|24
5851293|NCT02181413|20230668|P1|Overall Study|Adverse Event|7
5851294|NCT02181296|20230713|P2|Overall Study|Lost to Follow-up|6
5851295|NCT02181296|20230714|P1|Overall Study|Lost to Follow-up|7
5851296|NCT02180724|20230856|P2|Overall Study|Ongoing Study|11
5851297|NCT02180724|20230857|P1|Overall Study|Ongoing Study|78
5851298|NCT02180724|20230856|P2|Overall Study|Withdrawal by Subject|2
5851299|NCT02180724|20230857|P1|Overall Study|Withdrawal by Subject|1
5851300|NCT02180724|20230856|P2|Overall Study|Lost to Follow-up|0
5851301|NCT02180724|20230857|P1|Overall Study|Lost to Follow-up|1
5851302|NCT02180724|20230856|P2|Overall Study|Death|1
5851303|NCT02180724|20230857|P1|Overall Study|Death|12
5851304|NCT02180659|20230871|P2|Overall Study|AT REQUEST OF THE SPONSOR|1
5851305|NCT02180659|20230872|P1|Overall Study|AT REQUEST OF THE SPONSOR|0
5851306|NCT02180659|20230871|P2|Overall Study|Withdrawal by Subject|2
5851307|NCT02180659|20230872|P1|Overall Study|Withdrawal by Subject|0
5851308|NCT02180659|20230871|P2|Overall Study|Subject incarcerated during conduct|0
5851309|NCT02180659|20230872|P1|Overall Study|Subject incarcerated during conduct|1
5851310|NCT02180659|20230871|P2|Overall Study|Lost to Follow-up|2
5851311|NCT02180659|20230872|P1|Overall Study|Lost to Follow-up|4
5851312|NCT02180659|20230871|P2|Overall Study|Adverse Event|0
5851313|NCT02180659|20230872|P1|Overall Study|Adverse Event|1
5851314|NCT02180438|20230907|P1|Overall Study|Lost to Follow-up|1
5851315|NCT02180217|20230930|P3|Overall Study|Unsatisfactory therapeutic effect|0
5851316|NCT02180217|20230931|P2|Overall Study|Unsatisfactory therapeutic effect|0
5851317|NCT02180217|20230932|P1|Overall Study|Unsatisfactory therapeutic effect|1
5851318|NCT02180217|20230930|P3|Overall Study|Physician Decision|6
5851319|NCT02180217|20230931|P2|Overall Study|Physician Decision|1
5851320|NCT02180217|20230932|P1|Overall Study|Physician Decision|1
5851321|NCT02180217|20230930|P3|Overall Study|Subject/Guardian decision|6
5851322|NCT02180217|20230931|P2|Overall Study|Subject/Guardian decision|3
5851323|NCT02180217|20230932|P1|Overall Study|Subject/Guardian decision|5
5851324|NCT02180217|20230930|P3|Overall Study|Withdrawal by Subject|4
5851325|NCT02180217|20230931|P2|Overall Study|Withdrawal by Subject|1
5851326|NCT02180217|20230932|P1|Overall Study|Withdrawal by Subject|1
5851327|NCT02180217|20230930|P3|Overall Study|Death|0
5851328|NCT02180217|20230931|P2|Overall Study|Death|1
5851329|NCT02180217|20230932|P1|Overall Study|Death|1
5851330|NCT02180217|20230930|P3|Overall Study|Adverse Event|22
5851331|NCT02180217|20230931|P2|Overall Study|Adverse Event|2
5851332|NCT02180217|20230932|P1|Overall Study|Adverse Event|3
5851333|NCT02180061|20231015|P2|Overall Study|Physician Decision|0
5851334|NCT02180061|20231016|P1|Overall Study|Physician Decision|1
5851335|NCT02180061|20231015|P2|Overall Study|Progressive Disease|5
5851336|NCT02180061|20231016|P1|Overall Study|Progressive Disease|15
5851337|NCT02180061|20231015|P2|Overall Study|Clinical Progression|1
5851338|NCT02180061|20231016|P1|Overall Study|Clinical Progression|5
5851339|NCT02180061|20231015|P2|Overall Study|Adverse Event|2
5851340|NCT02180061|20231016|P1|Overall Study|Adverse Event|4
5851341|NCT02179918|20231035|P5|Overall Study|Subject refused further follow-up|1
5851342|NCT02179918|20231036|P4|Overall Study|Subject refused further follow-up|0
5851343|NCT02179918|20231037|P3|Overall Study|Subject refused further follow-up|0
5851344|NCT02179918|20231038|P2|Overall Study|Subject refused further follow-up|1
5851345|NCT02179918|20231039|P1|Overall Study|Subject refused further follow-up|0
5851346|NCT02179918|20231035|P5|Overall Study|Other|1
5851347|NCT02179918|20231036|P4|Overall Study|Other|0
5851348|NCT02179918|20231037|P3|Overall Study|Other|0
5851349|NCT02179918|20231038|P2|Overall Study|Other|1
5851350|NCT02179918|20231039|P1|Overall Study|Other|0
5851351|NCT02179918|20231035|P5|Overall Study|Progressive Disease|6
5851352|NCT02179918|20231036|P4|Overall Study|Progressive Disease|2
5851353|NCT02179918|20231037|P3|Overall Study|Progressive Disease|1
5851354|NCT02179918|20231038|P2|Overall Study|Progressive Disease|1
5851355|NCT02179918|20231039|P1|Overall Study|Progressive Disease|4
5851356|NCT02179918|20231035|P5|Overall Study|Lost to Follow-up|0
5851357|NCT02179918|20231036|P4|Overall Study|Lost to Follow-up|0
5851358|NCT02179918|20231037|P3|Overall Study|Lost to Follow-up|1
5851359|NCT02179918|20231038|P2|Overall Study|Lost to Follow-up|0
5851360|NCT02179918|20231039|P1|Overall Study|Lost to Follow-up|0
5851361|NCT02179918|20231035|P5|Overall Study|Death|0
5851362|NCT02179918|20231036|P4|Overall Study|Death|1
5851363|NCT02179918|20231037|P3|Overall Study|Death|0
5851364|NCT02179918|20231038|P2|Overall Study|Death|0
5851365|NCT02179918|20231039|P1|Overall Study|Death|0
5851366|NCT02179515|20231231|P3|Overall Study|Disease progression on study|8
5851367|NCT02179515|20231232|P2|Overall Study|Disease progression on study|11
5851368|NCT02179515|20231233|P1|Overall Study|Disease progression on study|2
5851369|NCT02179515|20231231|P3|Overall Study|refused further treatment|4
5851370|NCT02179515|20231232|P2|Overall Study|refused further treatment|3
5851371|NCT02179515|20231233|P1|Overall Study|refused further treatment|0
5851372|NCT02179515|20231231|P3|Overall Study|Death|1
5851373|NCT02179515|20231232|P2|Overall Study|Death|1
5851374|NCT02179515|20231233|P1|Overall Study|Death|0
5851375|NCT02179515|20231231|P3|Overall Study|switched to alternative treatment|1
5851376|NCT02179515|20231232|P2|Overall Study|switched to alternative treatment|1
5851377|NCT02179515|20231233|P1|Overall Study|switched to alternative treatment|0
5851378|NCT02179398|20231296|P2|Overall Study|Lost to Follow-up|1
5851379|NCT02179398|20231297|P1|Overall Study|Lost to Follow-up|0
5851380|NCT02179398|20231296|P2|Overall Study|Lack of obligatory data|3
5851381|NCT02179398|20231297|P1|Overall Study|Lack of obligatory data|3
5851382|NCT02179190|20231315|P1|Follow-Up Post Barrel VRD Implanted|Lost to Follow-up|1
5851383|NCT02179190|20231315|P1|Follow-Up Post Barrel VRD Implanted|Physician Decision|2
5851384|NCT02179190|20231315|P1|Follow-Up Post Barrel VRD Implanted|Withdrawal by Subject|3
5851385|NCT02179190|20231315|P1|Follow-Up Post Barrel VRD Implanted|Death|3
5851386|NCT02179190|20231315|P1|Index Procedure With Barrel VRD Attempt|Did not receive Barrel VRD|7
5851387|NCT02179190|20231315|P1|Enrollment|Exit Prior to Device Attempt|11
5851388|NCT02179177|20231328|P2|Overall Study|Withdrawal by Subject|1
5851389|NCT02179177|20231329|P1|Overall Study|Withdrawal by Subject|1
5851390|NCT02179177|20231328|P2|Overall Study|Lost to Follow-up|1
5851391|NCT02179177|20231329|P1|Overall Study|Lost to Follow-up|1
5851392|NCT02178995|20231369|P9|Open Label|Adverse Event|0
5851393|NCT02178995|20231370|P8|Open Label|Adverse Event|0
5851394|NCT02178995|20231371|P7|Open Label|Adverse Event|0
5851395|NCT02178995|20231372|P6|Open Label|Adverse Event|0
5851396|NCT02178995|20231373|P5|Open Label|Adverse Event|0
5851397|NCT02178995|20231374|P4|Open Label|Adverse Event|0
5851398|NCT02178995|20231375|P3|Open Label|Adverse Event|0
5851399|NCT02178995|20231376|P2|Open Label|Adverse Event|0
5851400|NCT02178995|20231377|P1|Open Label|Adverse Event|2
5851401|NCT02178995|20231369|P9|Double Blind|Lost to Follow-up|0
5851402|NCT02178995|20231370|P8|Double Blind|Lost to Follow-up|1
5851403|NCT02178995|20231371|P7|Double Blind|Lost to Follow-up|0
5851404|NCT02178995|20231372|P6|Double Blind|Lost to Follow-up|0
5851405|NCT02178995|20231373|P5|Double Blind|Lost to Follow-up|0
5851406|NCT02178995|20231374|P4|Double Blind|Lost to Follow-up|0
5851407|NCT02178995|20231375|P3|Double Blind|Lost to Follow-up|0
5851408|NCT02178995|20231376|P2|Double Blind|Lost to Follow-up|1
5851409|NCT02178995|20231377|P1|Double Blind|Lost to Follow-up|0
5851410|NCT02178995|20231369|P9|Double Blind|Adverse Event|1
5851411|NCT02178995|20231370|P8|Double Blind|Adverse Event|1
5851412|NCT02178995|20231371|P7|Double Blind|Adverse Event|0
5851413|NCT02178995|20231372|P6|Double Blind|Adverse Event|1
5851414|NCT02178995|20231373|P5|Double Blind|Adverse Event|0
5851415|NCT02178995|20231374|P4|Double Blind|Adverse Event|0
5851416|NCT02178995|20231375|P3|Double Blind|Adverse Event|0
5851417|NCT02178995|20231376|P2|Double Blind|Adverse Event|0
5851418|NCT02178995|20231377|P1|Double Blind|Adverse Event|0
5851419|NCT02178787|20231485|P2|Overall Study|Physician Decision|0
5851420|NCT02178787|20231486|P1|Overall Study|Physician Decision|1
5851421|NCT02178787|20231485|P2|Overall Study|No TCD window|7
5851422|NCT02178787|20231486|P1|Overall Study|No TCD window|3
5851423|NCT02178787|20231485|P2|Overall Study|Withdrawal by Subject|2
5851424|NCT02178787|20231486|P1|Overall Study|Withdrawal by Subject|0
5851425|NCT02178787|20231485|P2|Overall Study|Lost to Follow-up|0
5851426|NCT02178787|20231486|P1|Overall Study|Lost to Follow-up|1
5851462|NCT02178709|20231515|P1|Overall Study|Disease Progression|5
5851463|NCT02178709|20231515|P1|Overall Study|Physician Decision|2
5851464|NCT02178709|20231515|P1|Overall Study|Withdrawal by Subject|2
5851465|NCT02178709|20231515|P1|Overall Study|Death|2
5851466|NCT02178709|20231515|P1|Overall Study|Adverse Event|5
5851467|NCT02178592|20231542|P2|OLE Phase (Week 52 to Week 252)|Lost to Follow-up|1
5851468|NCT02178592|20231543|P1|OLE Phase (Week 52 to Week 252)|Lost to Follow-up|3
5851469|NCT02178592|20231542|P2|OLE Phase (Week 52 to Week 252)|Reached Protocol defined stopping criteria|0
5851470|NCT02178592|20231543|P1|OLE Phase (Week 52 to Week 252)|Reached Protocol defined stopping criteria|2
5851471|NCT02178592|20231542|P2|OLE Phase (Week 52 to Week 252)|Withdrawal by Subject|1
5851472|NCT02178592|20231543|P1|OLE Phase (Week 52 to Week 252)|Withdrawal by Subject|4
5851473|NCT02178592|20231542|P2|OLE Phase (Week 52 to Week 252)|Protocol Violation|0
5851474|NCT02178592|20231543|P1|OLE Phase (Week 52 to Week 252)|Protocol Violation|2
5851475|NCT02178592|20231542|P2|OLE Phase (Week 52 to Week 252)|Lack of Efficacy|1
5851476|NCT02178592|20231543|P1|OLE Phase (Week 52 to Week 252)|Lack of Efficacy|0
5851477|NCT02178592|20231542|P2|OLE Phase (Week 52 to Week 252)|Adverse Event|0
5851478|NCT02178592|20231543|P1|OLE Phase (Week 52 to Week 252)|Adverse Event|1
5851479|NCT02178592|20231542|P2|Randomized Phase (Up to Week 52)|Physician Decision|0
5851480|NCT02178592|20231543|P1|Randomized Phase (Up to Week 52)|Physician Decision|1
5851481|NCT02178592|20231542|P2|Randomized Phase (Up to Week 52)|Lost to Follow-up|3
5851482|NCT02178592|20231543|P1|Randomized Phase (Up to Week 52)|Lost to Follow-up|11
5851483|NCT02178592|20231542|P2|Randomized Phase (Up to Week 52)|Withdrawal by Subject|1
5851484|NCT02178592|20231543|P1|Randomized Phase (Up to Week 52)|Withdrawal by Subject|3
5851485|NCT02178592|20231542|P2|Randomized Phase (Up to Week 52)|Protocol Violation|2
5851486|NCT02178592|20231543|P1|Randomized Phase (Up to Week 52)|Protocol Violation|3
5851487|NCT02178592|20231542|P2|Randomized Phase (Up to Week 52)|Lack of Efficacy|1
5851488|NCT02178592|20231543|P1|Randomized Phase (Up to Week 52)|Lack of Efficacy|1
5851489|NCT02178592|20231542|P2|Randomized Phase (Up to Week 52)|Adverse Event|2
5851490|NCT02178592|20231543|P1|Randomized Phase (Up to Week 52)|Adverse Event|0
5851491|NCT02178553|20231585|P2|Overall Study|Technical problem with injection|3
5851492|NCT02178553|20231586|P1|Overall Study|Technical problem with injection|1
5851493|NCT02178553|20231585|P2|Overall Study|Physician Decision|4
5851494|NCT02178553|20231586|P1|Overall Study|Physician Decision|0
5851495|NCT02178553|20231585|P2|Overall Study|Did not proceed to open thoracotomy|3
5851496|NCT02178553|20231586|P1|Overall Study|Did not proceed to open thoracotomy|7
5851497|NCT02178475|20231605|P1|Overall Study|Protocol-specified Criteria|99
5851498|NCT02178475|20231605|P1|Overall Study|Death|13
5851499|NCT02178475|20231605|P1|Overall Study|Lost to Follow-up|10
5851500|NCT02178475|20231605|P1|Overall Study|Withdrawal by Subject|7
5851501|NCT02178059|20231632|P2|Washout|Physician Decision|0
5851502|NCT02178059|20231633|P1|Washout|Physician Decision|1
5851503|NCT02177942|20231651|P2|Overall Study|Withdrawal by Subject|81
5851504|NCT02177942|20231652|P1|Overall Study|Withdrawal by Subject|71
5851505|NCT02177942|20231651|P2|Overall Study|Protocol Violation|6
5851506|NCT02177942|20231652|P1|Overall Study|Protocol Violation|4
5851507|NCT02177942|20231651|P2|Overall Study|Lost to Follow-up|1
5851508|NCT02177942|20231652|P1|Overall Study|Lost to Follow-up|1
5851509|NCT02177942|20231651|P2|Overall Study|Adverse Event|0
5851510|NCT02177942|20231652|P1|Overall Study|Adverse Event|1
5851511|NCT02177838|20231674|P1|Overall Study|Death|1
5851512|NCT02177838|20231674|P1|Overall Study|Physician Decision|1
5851513|NCT02177838|20231674|P1|Overall Study|Withdrawal by Subject|1
5851514|NCT02177812|20231689|P9|Part 1 (Median of 4 Weeks)|Adverse Event|0
5851515|NCT02177812|20231690|P8|Part 1 (Median of 4 Weeks)|Adverse Event|1
5851516|NCT02177812|20231691|P7|Part 1 (Median of 4 Weeks)|Adverse Event|6
5851517|NCT02177812|20231692|P6|Part 1 (Median of 4 Weeks)|Adverse Event|1
5851518|NCT02177812|20231693|P5|Part 1 (Median of 4 Weeks)|Adverse Event|1
5851519|NCT02177812|20231694|P4|Part 1 (Median of 4 Weeks)|Adverse Event|1
5851520|NCT02177812|20231695|P3|Part 1 (Median of 4 Weeks)|Adverse Event|0
5851521|NCT02177812|20231696|P2|Part 1 (Median of 4 Weeks)|Adverse Event|0
5851522|NCT02177812|20231697|P1|Part 1 (Median of 4 Weeks)|Adverse Event|0
5851523|NCT02177812|20231689|P9|Part 1 (Median of 4 Weeks)|Physician Decision|0
5851524|NCT02177812|20231690|P8|Part 1 (Median of 4 Weeks)|Physician Decision|0
5851525|NCT02177812|20231691|P7|Part 1 (Median of 4 Weeks)|Physician Decision|1
5851526|NCT02177812|20231692|P6|Part 1 (Median of 4 Weeks)|Physician Decision|1
5851527|NCT02177812|20231693|P5|Part 1 (Median of 4 Weeks)|Physician Decision|0
5851528|NCT02177812|20231694|P4|Part 1 (Median of 4 Weeks)|Physician Decision|0
5851529|NCT02177812|20231695|P3|Part 1 (Median of 4 Weeks)|Physician Decision|0
5851530|NCT02177812|20231696|P2|Part 1 (Median of 4 Weeks)|Physician Decision|0
5851531|NCT02177812|20231697|P1|Part 1 (Median of 4 Weeks)|Physician Decision|0
5851532|NCT02177812|20231689|P9|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0
5851533|NCT02177812|20231690|P8|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1
5851534|NCT02177812|20231691|P7|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|2
5851535|NCT02177812|20231692|P6|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1
5851536|NCT02177812|20231693|P5|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0
5851537|NCT02177812|20231694|P4|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0
5851538|NCT02177812|20231695|P3|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0
5851539|NCT02177812|20231696|P2|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0
5851540|NCT02177812|20231697|P1|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0
5851541|NCT02177786|20231914|P4|Overall Study|Missing study completion status|0
5851542|NCT02177786|20231915|P3|Overall Study|Missing study completion status|0
5851543|NCT02177786|20231916|P2|Overall Study|Missing study completion status|1
5851544|NCT02177786|20231917|P1|Overall Study|Missing study completion status|0
5851545|NCT02177786|20231914|P4|Overall Study|Progressive Disease|0
5851546|NCT02177786|20231915|P3|Overall Study|Progressive Disease|0
5851547|NCT02177786|20231916|P2|Overall Study|Progressive Disease|1
5851548|NCT02177786|20231917|P1|Overall Study|Progressive Disease|0
5851549|NCT02177786|20231914|P4|Overall Study|Protocol Violation|0
5851550|NCT02177786|20231915|P3|Overall Study|Protocol Violation|2
5851551|NCT02177786|20231916|P2|Overall Study|Protocol Violation|0
5851552|NCT02177786|20231917|P1|Overall Study|Protocol Violation|0
5851553|NCT02177786|20231914|P4|Overall Study|Non-Compliance with Study Drug|1
5851554|NCT02177786|20231915|P3|Overall Study|Non-Compliance with Study Drug|0
5851555|NCT02177786|20231916|P2|Overall Study|Non-Compliance with Study Drug|1
5851556|NCT02177786|20231917|P1|Overall Study|Non-Compliance with Study Drug|0
5851557|NCT02177786|20231914|P4|Overall Study|Lost to Follow-up|2
5851558|NCT02177786|20231915|P3|Overall Study|Lost to Follow-up|2
5851559|NCT02177786|20231916|P2|Overall Study|Lost to Follow-up|0
5851560|NCT02177786|20231917|P1|Overall Study|Lost to Follow-up|0
5851561|NCT02177786|20231914|P4|Overall Study|Death|1
5851562|NCT02177786|20231915|P3|Overall Study|Death|1
5851563|NCT02177786|20231916|P2|Overall Study|Death|1
5851564|NCT02177786|20231917|P1|Overall Study|Death|1
5851565|NCT02177786|20231914|P4|Overall Study|Adverse Event|3
5851566|NCT02177786|20231915|P3|Overall Study|Adverse Event|2
5851567|NCT02177786|20231916|P2|Overall Study|Adverse Event|1
5851568|NCT02177786|20231917|P1|Overall Study|Adverse Event|1
5851569|NCT02177786|20231914|P4|Overall Study|Progression to End Stage Renal Disease|1
5851570|NCT02177786|20231915|P3|Overall Study|Progression to End Stage Renal Disease|2
5851571|NCT02177786|20231916|P2|Overall Study|Progression to End Stage Renal Disease|3
5851572|NCT02177786|20231917|P1|Overall Study|Progression to End Stage Renal Disease|2
5851573|NCT02177786|20231914|P4|Overall Study|Withdrew Consent|5
5851574|NCT02177786|20231915|P3|Overall Study|Withdrew Consent|9
5851575|NCT02177786|20231916|P2|Overall Study|Withdrew Consent|6
5851576|NCT02177786|20231917|P1|Overall Study|Withdrew Consent|2
5851577|NCT02177266|20231940|P2|Overall Study|Withdrawal by Subject|0
5851578|NCT02177266|20231941|P1|Overall Study|Withdrawal by Subject|1
5851579|NCT02177266|20231940|P2|Overall Study|Adverse Event|1
5851580|NCT02177266|20231941|P1|Overall Study|Adverse Event|0
5851581|NCT02177136|20231963|P3|Overall Study|Protocol Violation|1
5851582|NCT02177136|20231964|P2|Overall Study|Protocol Violation|0
5851583|NCT02177136|20231965|P1|Overall Study|Protocol Violation|0
5851584|NCT02177136|20231963|P3|Overall Study|Adverse Event|3
5851585|NCT02177136|20231964|P2|Overall Study|Adverse Event|2
5851586|NCT02177136|20231965|P1|Overall Study|Adverse Event|3
5851587|NCT02177136|20231963|P3|Overall Study|Discontinued due to pruritus|0
5851588|NCT02177136|20231964|P2|Overall Study|Discontinued due to pruritus|3
5851589|NCT02177136|20231965|P1|Overall Study|Discontinued due to pruritus|1
5851590|NCT02177136|20231963|P3|Overall Study|Withdrawal by Subject|0
5851591|NCT02177136|20231964|P2|Overall Study|Withdrawal by Subject|0
5851592|NCT02177136|20231965|P1|Overall Study|Withdrawal by Subject|2
5851593|NCT02177032|20231998|P4|Overall Study|Withdrawal by Subject|0
5851594|NCT02177032|20231999|P3|Overall Study|Withdrawal by Subject|1
5851595|NCT02177032|20232000|P2|Overall Study|Withdrawal by Subject|0
5851596|NCT02177032|20232001|P1|Overall Study|Withdrawal by Subject|1
5851597|NCT02177032|20231998|P4|Overall Study|OTHER|0
5851598|NCT02177032|20231999|P3|Overall Study|OTHER|1
5851599|NCT02177032|20232000|P2|Overall Study|OTHER|0
5851600|NCT02177032|20232001|P1|Overall Study|OTHER|2
5851601|NCT02177032|20231998|P4|Overall Study|Lost to Follow-up|0
5851602|NCT02177032|20231999|P3|Overall Study|Lost to Follow-up|0
5851603|NCT02177032|20232000|P2|Overall Study|Lost to Follow-up|2
5851604|NCT02177032|20232001|P1|Overall Study|Lost to Follow-up|0
5851605|NCT02177032|20231998|P4|Overall Study|ADMINISTRATIVE REASON|0
5851606|NCT02177032|20231999|P3|Overall Study|ADMINISTRATIVE REASON|1
5851607|NCT02177032|20232000|P2|Overall Study|ADMINISTRATIVE REASON|0
5851608|NCT02177032|20232001|P1|Overall Study|ADMINISTRATIVE REASON|2
5851609|NCT02176928|20232037|P2|Overall Study|Lost to Follow-up|4
5851610|NCT02176928|20232038|P1|Overall Study|Lost to Follow-up|2
5851611|NCT02176655|20232048|P1|Overall Study|Subjects did not treat|6
5851612|NCT02176642|20232071|P2|Overall Study|Withdrawal by Subject|1
5851613|NCT02176642|20232072|P1|Overall Study|Withdrawal by Subject|0
5851614|NCT02176525|20232102|P8|Overall Study|not treated|0
5851615|NCT02176525|20232103|P7|Overall Study|not treated|0
5851616|NCT02176525|20232104|P6|Overall Study|not treated|1
5851617|NCT02176525|20232105|P5|Overall Study|not treated|0
5851618|NCT02176525|20232106|P4|Overall Study|not treated|0
5851619|NCT02176525|20232107|P3|Overall Study|not treated|0
5851620|NCT02176525|20232108|P2|Overall Study|not treated|0
5851621|NCT02176525|20232109|P1|Overall Study|not treated|1
5851622|NCT02176525|20232102|P8|Overall Study|Adverse Event|0
5851623|NCT02176525|20232103|P7|Overall Study|Adverse Event|1
5851624|NCT02176525|20232104|P6|Overall Study|Adverse Event|0
5851625|NCT02176525|20232105|P5|Overall Study|Adverse Event|1
5851626|NCT02176525|20232106|P4|Overall Study|Adverse Event|1
5851627|NCT02176525|20232107|P3|Overall Study|Adverse Event|0
5851628|NCT02176525|20232108|P2|Overall Study|Adverse Event|0
5851629|NCT02176525|20232109|P1|Overall Study|Adverse Event|0
5851630|NCT02176421|20232325|P1|Overall Study|Adverse Event|1
5851631|NCT02176421|20232325|P1|Overall Study|Lost to Follow-up|4
5851632|NCT02176356|20232366|P1|Overall Study|Other Miscellaneous Reasons|2
5851633|NCT02176356|20232366|P1|Overall Study|Personal Reasons|3
5851634|NCT02176356|20232366|P1|Overall Study|Lost to Follow-up|4
5851635|NCT02176356|20232366|P1|Overall Study|Screen Failure|14
5851636|NCT02176291|20232396|P2|Overall Study|Withdrawal by Subject|0
5851637|NCT02176291|20232397|P1|Overall Study|Withdrawal by Subject|2
5851638|NCT02176291|20232396|P2|Overall Study|non compliance with protocol|0
5851639|NCT02176291|20232397|P1|Overall Study|non compliance with protocol|2
5851640|NCT02176291|20232396|P2|Overall Study|Death|0
5851641|NCT02176291|20232397|P1|Overall Study|Death|1
5851642|NCT02176226|20232405|P1|Overall Study|Withdrew prior to treatment|6
5851643|NCT02176226|20232405|P1|Overall Study|Lost to Follow-up|3
5851644|NCT02176018|20232431|P2|Overall Study|Withdrawal by Subject|2
5851645|NCT02176018|20232432|P1|Overall Study|Withdrawal by Subject|1
5851646|NCT02176018|20232431|P2|Overall Study|Protocol Violation|1
5851647|NCT02176018|20232432|P1|Overall Study|Protocol Violation|1
5851648|NCT02176018|20232431|P2|Overall Study|Lost to Follow-up|1
5851649|NCT02176018|20232432|P1|Overall Study|Lost to Follow-up|3
5851650|NCT02176018|20232431|P2|Overall Study|Adverse Event|2
5851651|NCT02176018|20232432|P1|Overall Study|Adverse Event|0
5851652|NCT02175966|20232516|P2|Follow-up Period|Lack of Efficacy|6
5851653|NCT02175966|20232517|P1|Follow-up Period|Lack of Efficacy|10
5851654|NCT02175771|20232545|P9|Treatment Period|Other|0
5851655|NCT02175771|20232546|P8|Treatment Period|Other|2
5851656|NCT02175771|20232547|P7|Treatment Period|Other|0
5851657|NCT02175771|20232548|P6|Treatment Period|Other|0
5851658|NCT02175771|20232549|P5|Treatment Period|Other|1
5851659|NCT02175771|20232550|P4|Treatment Period|Other|3
5851660|NCT02175771|20232551|P3|Treatment Period|Other|0
5851661|NCT02175771|20232552|P2|Treatment Period|Other|1
5851662|NCT02175771|20232553|P1|Treatment Period|Other|0
5851663|NCT02175771|20232545|P9|Treatment Period|Lack of Efficacy|0
5851664|NCT02175771|20232546|P8|Treatment Period|Lack of Efficacy|1
5851665|NCT02175771|20232547|P7|Treatment Period|Lack of Efficacy|0
5851666|NCT02175771|20232548|P6|Treatment Period|Lack of Efficacy|1
5851667|NCT02175771|20232549|P5|Treatment Period|Lack of Efficacy|0
5851668|NCT02175771|20232550|P4|Treatment Period|Lack of Efficacy|0
5851669|NCT02175771|20232551|P3|Treatment Period|Lack of Efficacy|0
5851670|NCT02175771|20232552|P2|Treatment Period|Lack of Efficacy|0
5851671|NCT02175771|20232553|P1|Treatment Period|Lack of Efficacy|0
5851672|NCT02175771|20232545|P9|Treatment Period|Lost to Follow-up|2
5851673|NCT02175771|20232546|P8|Treatment Period|Lost to Follow-up|2
5851674|NCT02175771|20232547|P7|Treatment Period|Lost to Follow-up|1
5851675|NCT02175771|20232548|P6|Treatment Period|Lost to Follow-up|2
5851676|NCT02175771|20232549|P5|Treatment Period|Lost to Follow-up|1
5851677|NCT02175771|20232550|P4|Treatment Period|Lost to Follow-up|3
5851678|NCT02175771|20232551|P3|Treatment Period|Lost to Follow-up|1
5851679|NCT02175771|20232552|P2|Treatment Period|Lost to Follow-up|3
5851680|NCT02175771|20232553|P1|Treatment Period|Lost to Follow-up|0
5851681|NCT02175771|20232545|P9|Treatment Period|Disease progression|0
5851682|NCT02175771|20232546|P8|Treatment Period|Disease progression|2
5851683|NCT02175771|20232547|P7|Treatment Period|Disease progression|0
5851684|NCT02175771|20232548|P6|Treatment Period|Disease progression|0
5851685|NCT02175771|20232549|P5|Treatment Period|Disease progression|0
5851686|NCT02175771|20232550|P4|Treatment Period|Disease progression|0
5851687|NCT02175771|20232551|P3|Treatment Period|Disease progression|0
5851688|NCT02175771|20232552|P2|Treatment Period|Disease progression|0
5851689|NCT02175771|20232553|P1|Treatment Period|Disease progression|0
5851690|NCT02175771|20232545|P9|Treatment Period|Protocol Violation|0
5851691|NCT02175771|20232546|P8|Treatment Period|Protocol Violation|1
5851692|NCT02175771|20232547|P7|Treatment Period|Protocol Violation|0
5851693|NCT02175771|20232548|P6|Treatment Period|Protocol Violation|0
5851694|NCT02175771|20232549|P5|Treatment Period|Protocol Violation|0
5851695|NCT02175771|20232550|P4|Treatment Period|Protocol Violation|0
5851696|NCT02175771|20232551|P3|Treatment Period|Protocol Violation|0
5851697|NCT02175771|20232552|P2|Treatment Period|Protocol Violation|0
5851698|NCT02175771|20232553|P1|Treatment Period|Protocol Violation|0
5851699|NCT02175771|20232545|P9|Treatment Period|Noncompliance|1
5851700|NCT02175771|20232546|P8|Treatment Period|Noncompliance|0
5851701|NCT02175771|20232547|P7|Treatment Period|Noncompliance|0
5851702|NCT02175771|20232548|P6|Treatment Period|Noncompliance|0
5851703|NCT02175771|20232549|P5|Treatment Period|Noncompliance|0
5851704|NCT02175771|20232550|P4|Treatment Period|Noncompliance|0
5851705|NCT02175771|20232551|P3|Treatment Period|Noncompliance|2
5851706|NCT02175771|20232552|P2|Treatment Period|Noncompliance|1
5851707|NCT02175771|20232553|P1|Treatment Period|Noncompliance|0
5851708|NCT02175771|20232545|P9|Treatment Period|Withdrawal by Subject|2
5851709|NCT02175771|20232546|P8|Treatment Period|Withdrawal by Subject|9
5851710|NCT02175771|20232547|P7|Treatment Period|Withdrawal by Subject|2
5851711|NCT02175771|20232548|P6|Treatment Period|Withdrawal by Subject|4
5851712|NCT02175771|20232549|P5|Treatment Period|Withdrawal by Subject|2
5851713|NCT02175771|20232550|P4|Treatment Period|Withdrawal by Subject|6
5851714|NCT02175771|20232551|P3|Treatment Period|Withdrawal by Subject|3
5851715|NCT02175771|20232552|P2|Treatment Period|Withdrawal by Subject|9
5851716|NCT02175771|20232553|P1|Treatment Period|Withdrawal by Subject|0
5851717|NCT02175771|20232545|P9|Treatment Period|Adverse Event|1
5851718|NCT02175771|20232546|P8|Treatment Period|Adverse Event|0
5851719|NCT02175771|20232547|P7|Treatment Period|Adverse Event|2
5851720|NCT02175771|20232548|P6|Treatment Period|Adverse Event|3
5851721|NCT02175771|20232549|P5|Treatment Period|Adverse Event|1
5851722|NCT02175771|20232550|P4|Treatment Period|Adverse Event|1
5851723|NCT02175771|20232551|P3|Treatment Period|Adverse Event|1
5851724|NCT02175771|20232552|P2|Treatment Period|Adverse Event|2
5851725|NCT02175771|20232553|P1|Treatment Period|Adverse Event|0
5851726|NCT02175771|20232545|P9|Run-In Period (Pre-assignment)|Other|0
5851727|NCT02175771|20232546|P8|Run-In Period (Pre-assignment)|Other|0
5851728|NCT02175771|20232547|P7|Run-In Period (Pre-assignment)|Other|0
5851729|NCT02175771|20232548|P6|Run-In Period (Pre-assignment)|Other|0
5851730|NCT02175771|20232549|P5|Run-In Period (Pre-assignment)|Other|0
5851731|NCT02175771|20232550|P4|Run-In Period (Pre-assignment)|Other|0
5851732|NCT02175771|20232551|P3|Run-In Period (Pre-assignment)|Other|0
5851733|NCT02175771|20232552|P2|Run-In Period (Pre-assignment)|Other|0
5851734|NCT02175771|20232553|P1|Run-In Period (Pre-assignment)|Other|8
5851735|NCT02175771|20232545|P9|Run-In Period (Pre-assignment)|Lost to Follow-up|0
5851736|NCT02175771|20232546|P8|Run-In Period (Pre-assignment)|Lost to Follow-up|0
5851737|NCT02175771|20232547|P7|Run-In Period (Pre-assignment)|Lost to Follow-up|0
5851738|NCT02175771|20232548|P6|Run-In Period (Pre-assignment)|Lost to Follow-up|0
5851739|NCT02175771|20232549|P5|Run-In Period (Pre-assignment)|Lost to Follow-up|0
5851740|NCT02175771|20232550|P4|Run-In Period (Pre-assignment)|Lost to Follow-up|0
5851741|NCT02175771|20232551|P3|Run-In Period (Pre-assignment)|Lost to Follow-up|0
5851742|NCT02175771|20232552|P2|Run-In Period (Pre-assignment)|Lost to Follow-up|0
5851743|NCT02175771|20232553|P1|Run-In Period (Pre-assignment)|Lost to Follow-up|6
5851744|NCT02175771|20232545|P9|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
5851745|NCT02175771|20232546|P8|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
5851746|NCT02175771|20232547|P7|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
5851747|NCT02175771|20232548|P6|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
5851748|NCT02175771|20232549|P5|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
5851749|NCT02175771|20232550|P4|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
5851750|NCT02175771|20232551|P3|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
5851751|NCT02175771|20232552|P2|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
5851752|NCT02175771|20232553|P1|Run-In Period (Pre-assignment)|Inclusion criteria not met|7
5851753|NCT02175771|20232545|P9|Run-In Period (Pre-assignment)|Adverse Event|0
5851754|NCT02175771|20232546|P8|Run-In Period (Pre-assignment)|Adverse Event|0
5851755|NCT02175771|20232547|P7|Run-In Period (Pre-assignment)|Adverse Event|0
5851756|NCT02175771|20232548|P6|Run-In Period (Pre-assignment)|Adverse Event|0
5851757|NCT02175771|20232549|P5|Run-In Period (Pre-assignment)|Adverse Event|0
5851758|NCT02175771|20232550|P4|Run-In Period (Pre-assignment)|Adverse Event|0
5851759|NCT02175771|20232551|P3|Run-In Period (Pre-assignment)|Adverse Event|0
5851760|NCT02175771|20232552|P2|Run-In Period (Pre-assignment)|Adverse Event|0
5851761|NCT02175771|20232553|P1|Run-In Period (Pre-assignment)|Adverse Event|9
5851762|NCT02175771|20232545|P9|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
5851763|NCT02175771|20232546|P8|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
5851764|NCT02175771|20232547|P7|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
5851765|NCT02175771|20232548|P6|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
5851766|NCT02175771|20232549|P5|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
5851767|NCT02175771|20232550|P4|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
5851768|NCT02175771|20232551|P3|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
5851769|NCT02175771|20232552|P2|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
5851770|NCT02175771|20232553|P1|Run-In Period (Pre-assignment)|Withdrawal by Subject|11
5851771|NCT02175771|20232545|P9|Run-In Period (Pre-assignment)|Exclusion criteria met|0
5851772|NCT02175771|20232546|P8|Run-In Period (Pre-assignment)|Exclusion criteria met|0
5851942|NCT02172040|20233805|P2|Overall Study|Family emergency abroad|0
5851773|NCT02175771|20232547|P7|Run-In Period (Pre-assignment)|Exclusion criteria met|0
5851774|NCT02175771|20232548|P6|Run-In Period (Pre-assignment)|Exclusion criteria met|0
5851775|NCT02175771|20232549|P5|Run-In Period (Pre-assignment)|Exclusion criteria met|0
5851776|NCT02175771|20232550|P4|Run-In Period (Pre-assignment)|Exclusion criteria met|0
5851777|NCT02175771|20232551|P3|Run-In Period (Pre-assignment)|Exclusion criteria met|0
5851778|NCT02175771|20232552|P2|Run-In Period (Pre-assignment)|Exclusion criteria met|0
5851779|NCT02175771|20232553|P1|Run-In Period (Pre-assignment)|Exclusion criteria met|20
5851780|NCT02175771|20232545|P9|Run-In Period (Pre-assignment)|Randomization criteria not met|0
5851781|NCT02175771|20232546|P8|Run-In Period (Pre-assignment)|Randomization criteria not met|0
5851782|NCT02175771|20232547|P7|Run-In Period (Pre-assignment)|Randomization criteria not met|0
5851783|NCT02175771|20232548|P6|Run-In Period (Pre-assignment)|Randomization criteria not met|0
5851784|NCT02175771|20232549|P5|Run-In Period (Pre-assignment)|Randomization criteria not met|0
5851785|NCT02175771|20232550|P4|Run-In Period (Pre-assignment)|Randomization criteria not met|0
5851786|NCT02175771|20232551|P3|Run-In Period (Pre-assignment)|Randomization criteria not met|0
5851787|NCT02175771|20232552|P2|Run-In Period (Pre-assignment)|Randomization criteria not met|0
5851788|NCT02175771|20232553|P1|Run-In Period (Pre-assignment)|Randomization criteria not met|23
5851789|NCT02175758|20232617|P6|Treatment Phase|Adverse Event|0
5851790|NCT02175758|20232618|P5|Treatment Phase|Adverse Event|1
5851791|NCT02175758|20232619|P4|Treatment Phase|Adverse Event|0
5851792|NCT02175758|20232620|P3|Treatment Phase|Adverse Event|0
5851793|NCT02175758|20232621|P2|Treatment Phase|Adverse Event|0
5851794|NCT02175758|20232622|P1|Treatment Phase|Adverse Event|0
5851795|NCT02175758|20232617|P6|Treatment Phase|Lost to Follow-up|0
5851796|NCT02175758|20232618|P5|Treatment Phase|Lost to Follow-up|0
5851797|NCT02175758|20232619|P4|Treatment Phase|Lost to Follow-up|0
5851798|NCT02175758|20232620|P3|Treatment Phase|Lost to Follow-up|0
5851799|NCT02175758|20232621|P2|Treatment Phase|Lost to Follow-up|1
5851800|NCT02175758|20232622|P1|Treatment Phase|Lost to Follow-up|0
5851801|NCT02175745|20232725|P1|Overall Study|Not Eligible|1
5851802|NCT02175368|20232764|P1|Overall Study|Lost to Follow-up|1
5851803|NCT02175277|20232769|P1|Overall Study|Protocol-specified Criteria|1
5851804|NCT02175225|20232775|P2|Overall Study|Study drug not administered|2
5851805|NCT02175225|20232776|P1|Overall Study|Study drug not administered|1
5851806|NCT02175225|20232775|P2|Overall Study|Lost to Follow-up|7
5851807|NCT02175225|20232776|P1|Overall Study|Lost to Follow-up|6
5851808|NCT02175225|20232775|P2|Overall Study|Withdrawal by Subject|2
5851809|NCT02175225|20232776|P1|Overall Study|Withdrawal by Subject|1
5851810|NCT02175199|20232827|P2|Overall Study|Sponsor Decision|0
5851811|NCT02175199|20232828|P1|Overall Study|Sponsor Decision|1
5851812|NCT02175199|20232827|P2|Overall Study|Randomized in Error|0
5851813|NCT02175199|20232828|P1|Overall Study|Randomized in Error|1
5851814|NCT02175199|20232827|P2|Overall Study|Withdrawal by Subject|5
5851815|NCT02175199|20232828|P1|Overall Study|Withdrawal by Subject|1
5851816|NCT02175121|20232842|P5|Overall Study|Time issues|0
5851817|NCT02175121|20232843|P4|Overall Study|Time issues|0
5851818|NCT02175121|20232844|P3|Overall Study|Time issues|1
5851819|NCT02175121|20232845|P2|Overall Study|Time issues|0
5851820|NCT02175121|20232846|P1|Overall Study|Time issues|0
5851821|NCT02175121|20232842|P5|Overall Study|Schedule conflict|0
5851822|NCT02175121|20232843|P4|Overall Study|Schedule conflict|0
5851823|NCT02175121|20232844|P3|Overall Study|Schedule conflict|1
5851824|NCT02175121|20232845|P2|Overall Study|Schedule conflict|0
5851825|NCT02175121|20232846|P1|Overall Study|Schedule conflict|0
5851826|NCT02175121|20232842|P5|Overall Study|Personal emergency|1
5851827|NCT02175121|20232843|P4|Overall Study|Personal emergency|0
5851828|NCT02175121|20232844|P3|Overall Study|Personal emergency|0
5851829|NCT02175121|20232845|P2|Overall Study|Personal emergency|0
5851830|NCT02175121|20232846|P1|Overall Study|Personal emergency|0
5851831|NCT02175121|20232842|P5|Overall Study|Lost to Follow-up|0
5851832|NCT02175121|20232843|P4|Overall Study|Lost to Follow-up|1
5851833|NCT02175121|20232844|P3|Overall Study|Lost to Follow-up|0
5851834|NCT02175121|20232845|P2|Overall Study|Lost to Follow-up|1
5851835|NCT02175121|20232846|P1|Overall Study|Lost to Follow-up|0
5851836|NCT02175121|20232842|P5|Overall Study|Lack of Efficacy|0
5851837|NCT02175121|20232843|P4|Overall Study|Lack of Efficacy|0
5851838|NCT02175121|20232844|P3|Overall Study|Lack of Efficacy|0
5851839|NCT02175121|20232845|P2|Overall Study|Lack of Efficacy|0
5851840|NCT02175121|20232846|P1|Overall Study|Lack of Efficacy|1
5851841|NCT02174861|20232984|P1|Overall Study|Lost to Follow-up|26
5851842|NCT02174861|20232984|P1|Overall Study|Withdrawal by Subject|124
5851843|NCT02174861|20232984|P1|Overall Study|Decision by sponsor|8
5851844|NCT02174848|20232998|P2|Overall Study|Unable to comply with study requirements|0
5851845|NCT02174848|20232999|P1|Overall Study|Unable to comply with study requirements|1
5851846|NCT02174848|20232998|P2|Overall Study|Worsening of disease|1
5851847|NCT02174848|20232999|P1|Overall Study|Worsening of disease|1
5851848|NCT02174848|20232998|P2|Overall Study|Lost to Follow-up|1
5851849|NCT02174848|20232999|P1|Overall Study|Lost to Follow-up|0
5851850|NCT02174848|20232998|P2|Overall Study|Withdrawal by Subject|3
5851851|NCT02174848|20232999|P1|Overall Study|Withdrawal by Subject|3
5851852|NCT02174848|20232998|P2|Overall Study|Adverse Event|1
5851853|NCT02174848|20232999|P1|Overall Study|Adverse Event|2
5851854|NCT02174731|20233016|P2|Overall Study|Missing|0
5851855|NCT02174731|20233017|P1|Overall Study|Missing|2
5851856|NCT02174731|20233016|P2|Overall Study|Incorrect enrolment before randomization|1
5851857|NCT02174731|20233017|P1|Overall Study|Incorrect enrolment before randomization|0
5851858|NCT02174731|20233016|P2|Overall Study|Participant decision|64
5851859|NCT02174731|20233017|P1|Overall Study|Participant decision|67
5851860|NCT02174627|20233039|P2|Overall Study|Participant decision|128
5851861|NCT02174627|20233040|P1|Overall Study|Participant decision|84
5851862|NCT02174627|20233039|P2|Overall Study|Incorrect enrolment before randomization|1
5851863|NCT02174627|20233040|P1|Overall Study|Incorrect enrolment before randomization|0
5851864|NCT02174627|20233039|P2|Overall Study|Missing|1
5851865|NCT02174627|20233040|P1|Overall Study|Missing|0
5851866|NCT02174562|20233068|P2|Overall Study|Lost to Follow-up|3
5851867|NCT02174562|20233069|P1|Overall Study|Lost to Follow-up|0
5851868|NCT02174562|20233068|P2|Overall Study|Death|0
5851869|NCT02174562|20233069|P1|Overall Study|Death|2
5851870|NCT02174562|20233068|P2|Overall Study|Withdrawal by Subject|2
5851871|NCT02174562|20233069|P1|Overall Study|Withdrawal by Subject|7
5851872|NCT02174523|20233079|P2|Overall Study|Withdrawal by Subject|0
5851873|NCT02174523|20233080|P1|Overall Study|Withdrawal by Subject|1
5851874|NCT02174276|20233165|P4|OTEP (Weeks 48 to 144)|Withdrew Consent|2
5851875|NCT02174276|20233166|P3|OTEP (Weeks 48 to 144)|Withdrew Consent|1
5851876|NCT02174276|20233167|P2|OTEP (Weeks 48 to 144)|Withdrew Consent|0
5851877|NCT02174276|20233168|P1|OTEP (Weeks 48 to 144)|Withdrew Consent|1
5851878|NCT02174276|20233165|P4|OTEP (Weeks 48 to 144)|Pregnancy|0
5851879|NCT02174276|20233166|P3|OTEP (Weeks 48 to 144)|Pregnancy|1
5851880|NCT02174276|20233167|P2|OTEP (Weeks 48 to 144)|Pregnancy|0
5851881|NCT02174276|20233168|P1|OTEP (Weeks 48 to 144)|Pregnancy|0
5851882|NCT02174276|20233165|P4|OTEP (Weeks 48 to 144)|Lost to Follow-up|0
5851883|NCT02174276|20233166|P3|OTEP (Weeks 48 to 144)|Lost to Follow-up|1
5851884|NCT02174276|20233167|P2|OTEP (Weeks 48 to 144)|Lost to Follow-up|0
5851885|NCT02174276|20233168|P1|OTEP (Weeks 48 to 144)|Lost to Follow-up|0
5851886|NCT02174276|20233165|P4|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0
5851887|NCT02174276|20233166|P3|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|2
5851888|NCT02174276|20233167|P2|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|1
5851889|NCT02174276|20233168|P1|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0
5851890|NCT02174276|20233165|P4|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0
5851891|NCT02174276|20233166|P3|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|1
5851892|NCT02174276|20233167|P2|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0
5851893|NCT02174276|20233168|P1|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0
5851894|NCT02174276|20233165|P4|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0
5851895|NCT02174276|20233166|P3|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0
5851896|NCT02174276|20233167|P2|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0
5851897|NCT02174276|20233168|P1|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|1
5851898|NCT02173769|20233275|P1|Overall Study|Protocol Violation|4
5851899|NCT02173704|20233288|P2|Overall Study|Withdrawal by Subject|4
5851900|NCT02173704|20233289|P1|Overall Study|Withdrawal by Subject|9
5851901|NCT02173704|20233288|P2|Overall Study|Protocol Violation|0
5851902|NCT02173704|20233289|P1|Overall Study|Protocol Violation|1
5851903|NCT02173704|20233288|P2|Overall Study|Other|0
5851904|NCT02173704|20233289|P1|Overall Study|Other|1
5851905|NCT02173704|20233288|P2|Overall Study|Lost to Follow-up|0
5851906|NCT02173704|20233289|P1|Overall Study|Lost to Follow-up|1
5851907|NCT02173704|20233288|P2|Overall Study|Adverse Event|0
5851908|NCT02173704|20233289|P1|Overall Study|Adverse Event|1
5851909|NCT02173548|20233317|P2|Overall Study|Withdrawal by Subject|0
5851910|NCT02173548|20233318|P1|Overall Study|Withdrawal by Subject|1
5851911|NCT02173548|20233317|P2|Overall Study|Lost to Follow-up|2
5851912|NCT02173548|20233318|P1|Overall Study|Lost to Follow-up|0
5851913|NCT02173379|20233450|P2|Overall Study|Death|22
5851914|NCT02173379|20233451|P1|Overall Study|Death|22
5851915|NCT02173379|20233450|P2|Overall Study|Physician Decision|4
5851916|NCT02173379|20233451|P1|Overall Study|Physician Decision|7
5851917|NCT02173379|20233450|P2|Overall Study|Withdrawal by Subject|17
5851918|NCT02173379|20233451|P1|Overall Study|Withdrawal by Subject|14
5851919|NCT02173379|20233450|P2|Overall Study|Lost to Follow-up|34
5851920|NCT02173379|20233451|P1|Overall Study|Lost to Follow-up|48
5851921|NCT02173158|20233695|P1|Efficacy Phase|Adverse Event|1
5851922|NCT02173054|20233712|P3|Overall Study|Withdrawal by Subject|1
5851923|NCT02173054|20233713|P2|Overall Study|Withdrawal by Subject|0
5851924|NCT02173054|20233714|P1|Overall Study|Withdrawal by Subject|0
5851925|NCT02173054|20233712|P3|Overall Study|lack of compliance|0
5851926|NCT02173054|20233713|P2|Overall Study|lack of compliance|0
5851927|NCT02173054|20233714|P1|Overall Study|lack of compliance|1
5851928|NCT02172664|20233770|P2|Overall Study|Moved out of area|1
5851929|NCT02172664|20233771|P1|Overall Study|Moved out of area|1
5851930|NCT02172664|20233770|P2|Overall Study|Death|1
5851931|NCT02172664|20233771|P1|Overall Study|Death|1
5851932|NCT02172664|20233770|P2|Overall Study|Lost to Follow-up|4
5851933|NCT02172664|20233771|P1|Overall Study|Lost to Follow-up|4
5851934|NCT02172625|20233780|P2|Overall Study|car accident|1
5851935|NCT02172625|20233781|P1|Overall Study|car accident|0
5851936|NCT02172625|20233780|P2|Overall Study|Pregnancy|1
5851937|NCT02172625|20233781|P1|Overall Study|Pregnancy|0
5851938|NCT02172625|20233780|P2|Overall Study|Adverse Event|1
5851939|NCT02172625|20233781|P1|Overall Study|Adverse Event|0
5851940|NCT02172040|20233803|P4|Overall Study|Family emergency abroad|1
5851941|NCT02172040|20233804|P3|Overall Study|Family emergency abroad|0
5851943|NCT02172040|20233806|P1|Overall Study|Family emergency abroad|0
5851944|NCT02172040|20233803|P4|Overall Study|Not available for Day 13 & 14 visits|0
5851945|NCT02172040|20233804|P3|Overall Study|Not available for Day 13 & 14 visits|1
5851946|NCT02172040|20233805|P2|Overall Study|Not available for Day 13 & 14 visits|0
5851947|NCT02172040|20233806|P1|Overall Study|Not available for Day 13 & 14 visits|0
5851948|NCT02172040|20233803|P4|Overall Study|Withdrawal by Subject|0
5851949|NCT02172040|20233804|P3|Overall Study|Withdrawal by Subject|1
5851950|NCT02172040|20233805|P2|Overall Study|Withdrawal by Subject|0
5851951|NCT02172040|20233806|P1|Overall Study|Withdrawal by Subject|0
5851952|NCT02172040|20233803|P4|Overall Study|Protocol Violation|0
5851953|NCT02172040|20233804|P3|Overall Study|Protocol Violation|0
5851954|NCT02172040|20233805|P2|Overall Study|Protocol Violation|1
5851955|NCT02172040|20233806|P1|Overall Study|Protocol Violation|0
5851956|NCT02172040|20233803|P4|Overall Study|Adverse Event|0
5851957|NCT02172040|20233804|P3|Overall Study|Adverse Event|0
5851958|NCT02172040|20233805|P2|Overall Study|Adverse Event|2
5851959|NCT02172040|20233806|P1|Overall Study|Adverse Event|0
5851960|NCT02171260|20233969|P4|Overall Study|Evidence of progressive disease|4
5851961|NCT02171260|20233970|P3|Overall Study|Evidence of progressive disease|4
5851962|NCT02171260|20233971|P2|Overall Study|Evidence of progressive disease|6
5851963|NCT02171260|20233972|P1|Overall Study|Evidence of progressive disease|4
5851964|NCT02171260|20233969|P4|Overall Study|Withdrawal by Subject|0
5851965|NCT02171260|20233970|P3|Overall Study|Withdrawal by Subject|0
5851966|NCT02171260|20233971|P2|Overall Study|Withdrawal by Subject|0
5851967|NCT02171260|20233972|P1|Overall Study|Withdrawal by Subject|1
5851968|NCT02171260|20233969|P4|Overall Study|Physician Decision|0
5851969|NCT02171260|20233970|P3|Overall Study|Physician Decision|1
5851970|NCT02171260|20233971|P2|Overall Study|Physician Decision|0
5851971|NCT02171260|20233972|P1|Overall Study|Physician Decision|1
5851972|NCT02171260|20233969|P4|Overall Study|Death|1
5851973|NCT02171260|20233970|P3|Overall Study|Death|0
5851974|NCT02171260|20233971|P2|Overall Study|Death|0
5851975|NCT02171260|20233972|P1|Overall Study|Death|0
5851976|NCT02171130|20234108|P1|Overall Study|Met Exclusion Criteria|1
5851977|NCT02171130|20234108|P1|Overall Study|Lost to Follow-up|1
5851978|NCT02171130|20234108|P1|Overall Study|Physician Decision|1
5851979|NCT02171130|20234108|P1|Overall Study|Withdrawal by Subject|3
5851980|NCT02171130|20234108|P1|Overall Study|Discontinued; Site Termination|5
5851981|NCT02171130|20234108|P1|Overall Study|Discontinued; Clinical Material Issue|16
5851982|NCT02171130|20234108|P1|Overall Study|Death|1
5851983|NCT02170779|20234149|P2|Overall Study|Lost to Follow-up|1
5851984|NCT02170779|20234150|P1|Overall Study|Lost to Follow-up|0
5851985|NCT02170779|20234149|P2|Overall Study|Withdrawal by Subject|0
5851986|NCT02170779|20234150|P1|Overall Study|Withdrawal by Subject|1
5851987|NCT02170727|20234174|P2|Overall Study|Withdrawal by Subject|0
5851988|NCT02170727|20234175|P1|Overall Study|Withdrawal by Subject|2
5851989|NCT02170727|20234174|P2|Overall Study|Lost to Follow-up|0
5851990|NCT02170727|20234175|P1|Overall Study|Lost to Follow-up|1
5851991|NCT02170688|20234206|P5|Overall Study|Physician Decision|0
5851992|NCT02170688|20234207|P4|Overall Study|Physician Decision|0
5851993|NCT02170688|20234208|P3|Overall Study|Physician Decision|1
5851994|NCT02170688|20234209|P2|Overall Study|Physician Decision|0
5851995|NCT02170688|20234210|P1|Overall Study|Physician Decision|0
5851996|NCT02170688|20234206|P5|Overall Study|Full dose not received|0
5851997|NCT02170688|20234207|P4|Overall Study|Full dose not received|0
5851998|NCT02170688|20234208|P3|Overall Study|Full dose not received|0
5851999|NCT02170688|20234209|P2|Overall Study|Full dose not received|1
5852000|NCT02170688|20234210|P1|Overall Study|Full dose not received|0
5852001|NCT02170688|20234206|P5|Overall Study|Exclusion Criteria: Fatty Liver|0
5852002|NCT02170688|20234207|P4|Overall Study|Exclusion Criteria: Fatty Liver|2
5852003|NCT02170688|20234208|P3|Overall Study|Exclusion Criteria: Fatty Liver|3
5852004|NCT02170688|20234209|P2|Overall Study|Exclusion Criteria: Fatty Liver|2
5852005|NCT02170688|20234210|P1|Overall Study|Exclusion Criteria: Fatty Liver|4
5852006|NCT02170389|20234296|P1|Overall Study|Study terminated prior to start of treat|1
5852007|NCT02170298|20234361|P2|Overall Study|unblinded, rerandomized to intervention|0
5852008|NCT02170298|20234362|P1|Overall Study|unblinded, rerandomized to intervention|1
5852009|NCT02170298|20234361|P2|Overall Study|Withdrawal by Subject|1
5852010|NCT02170298|20234362|P1|Overall Study|Withdrawal by Subject|0
5852011|NCT02170207|20234399|P1|Overall Study|Case report forms unavailable|5
5852012|NCT02170077|20234410|P3|Overall Study|Exacerbation of seizures|1
5852013|NCT02170077|20234411|P2|Overall Study|Exacerbation of seizures|2
5852014|NCT02170077|20234412|P1|Overall Study|Exacerbation of seizures|0
5852015|NCT02170077|20234410|P3|Overall Study|Exclusion criteria|5
5852016|NCT02170077|20234411|P2|Overall Study|Exclusion criteria|2
5852017|NCT02170077|20234412|P1|Overall Study|Exclusion criteria|2
5852018|NCT02170077|20234410|P3|Overall Study|Lost to Follow-up|0
5852019|NCT02170077|20234411|P2|Overall Study|Lost to Follow-up|1
5852020|NCT02170077|20234412|P1|Overall Study|Lost to Follow-up|0
5852021|NCT02170077|20234410|P3|Overall Study|Adverse Event|4
5852022|NCT02170077|20234411|P2|Overall Study|Adverse Event|4
5852023|NCT02170077|20234412|P1|Overall Study|Adverse Event|4
5852024|NCT02170077|20234410|P3|Overall Study|Withdrawal by Subject|2
5852025|NCT02170077|20234411|P2|Overall Study|Withdrawal by Subject|4
5852026|NCT02170077|20234412|P1|Overall Study|Withdrawal by Subject|3
5852027|NCT02170064|20234423|P3|Overall Study|Physician Decision|0
5852028|NCT02170064|20234424|P2|Overall Study|Physician Decision|1
5852029|NCT02170064|20234425|P1|Overall Study|Physician Decision|1
5852030|NCT02170064|20234423|P3|Overall Study|Withdrawal by Subject|1
5852031|NCT02170064|20234424|P2|Overall Study|Withdrawal by Subject|1
5852032|NCT02170064|20234425|P1|Overall Study|Withdrawal by Subject|5
5852033|NCT02170051|20234441|P2|Overall Study|Lost to Follow-up|3
5852034|NCT02170051|20234442|P1|Overall Study|Lost to Follow-up|1
5852035|NCT02170051|20234441|P2|Overall Study|Withdrawal by Subject|10
5852036|NCT02170051|20234442|P1|Overall Study|Withdrawal by Subject|10
5852037|NCT02170025|20234462|P2|Overall Study|Adverse Event|0
5852038|NCT02170025|20234463|P1|Overall Study|Adverse Event|2
5852039|NCT02169674|20234507|P2|Overall Study|Lost to Follow-up|1
5852040|NCT02169674|20234508|P1|Overall Study|Lost to Follow-up|0
5852041|NCT02169674|20234507|P2|Overall Study|Seroprotected|76
5852042|NCT02169674|20234508|P1|Overall Study|Seroprotected|30
5852043|NCT02169674|20234507|P2|Overall Study|Withdrawal by Subject|1
5852044|NCT02169674|20234508|P1|Overall Study|Withdrawal by Subject|2
5852045|NCT02169505|20234522|P1|Overall Study|Withdrawal by Subject|1
5852046|NCT02169414|20234650|P4|Overall Study|Adverse Event|0
5852047|NCT02169414|20234651|P3|Overall Study|Adverse Event|0
5852048|NCT02169414|20234652|P2|Overall Study|Adverse Event|1
5852049|NCT02169414|20234653|P1|Overall Study|Adverse Event|0
5852050|NCT02169414|20234650|P4|Overall Study|Withdrawal by Subject|0
5852051|NCT02169414|20234651|P3|Overall Study|Withdrawal by Subject|0
5852052|NCT02169414|20234652|P2|Overall Study|Withdrawal by Subject|0
5852053|NCT02169414|20234653|P1|Overall Study|Withdrawal by Subject|1
5852054|NCT02169336|20234694|P3|Overall Study|Subject declined to continue dosing|1
5852055|NCT02169336|20234695|P2|Overall Study|Subject declined to continue dosing|0
5852056|NCT02169336|20234696|P1|Overall Study|Subject declined to continue dosing|0
5852057|NCT02169336|20234694|P3|Overall Study|Physician Decision|1
5852058|NCT02169336|20234695|P2|Overall Study|Physician Decision|0
5852059|NCT02169336|20234696|P1|Overall Study|Physician Decision|0
5852060|NCT02169336|20234694|P3|Overall Study|Withdrawal by Subject|0
5852061|NCT02169336|20234695|P2|Overall Study|Withdrawal by Subject|0
5852062|NCT02169336|20234696|P1|Overall Study|Withdrawal by Subject|1
5852063|NCT02169336|20234694|P3|Overall Study|Adverse Event|1
5852064|NCT02169336|20234695|P2|Overall Study|Adverse Event|3
5852065|NCT02169336|20234696|P1|Overall Study|Adverse Event|2
5852066|NCT02169336|20234694|P3|Overall Study|Lack of Efficacy|0
5852067|NCT02169336|20234695|P2|Overall Study|Lack of Efficacy|1
5852068|NCT02169336|20234696|P1|Overall Study|Lack of Efficacy|1
5852069|NCT02169284|20234706|P2|Overall Study|Physician Decision|1
5852070|NCT02169284|20234707|P1|Overall Study|Physician Decision|0
5852071|NCT02169271|20234733|P2|Overall Study|Protocol Violation|2
5852072|NCT02169271|20234734|P1|Overall Study|Protocol Violation|1
5852073|NCT02169219|20234756|P1|Overall Study|Lack of Efficacy|6
5852074|NCT02168946|20234800|P2|Overall Study|Subject unable to come back for visits|0
5852075|NCT02168946|20234801|P1|Overall Study|Subject unable to come back for visits|1
5852076|NCT02168946|20234800|P2|Overall Study|Lost to Follow-up|0
5852077|NCT02168946|20234801|P1|Overall Study|Lost to Follow-up|3
5852078|NCT02168946|20234800|P2|Overall Study|Adverse Event|5
5852079|NCT02168946|20234801|P1|Overall Study|Adverse Event|8
5852080|NCT02168842|20234860|P2|Overall Study|Physician Decision|2
5852081|NCT02168842|20234861|P1|Overall Study|Physician Decision|1
5852082|NCT02168842|20234860|P2|Overall Study|Death|1
5852083|NCT02168842|20234861|P1|Overall Study|Death|2
5852084|NCT02168842|20234860|P2|Overall Study|Lost to Follow-up|2
5852085|NCT02168842|20234861|P1|Overall Study|Lost to Follow-up|0
5852086|NCT02168842|20234860|P2|Overall Study|Withdrawal by Subject|3
5852087|NCT02168842|20234861|P1|Overall Study|Withdrawal by Subject|5
5852088|NCT02168816|20234919|P2|Overall Study|Lost to Follow-up|2
5852089|NCT02168816|20234920|P1|Overall Study|Lost to Follow-up|2
5852090|NCT02168803|20234931|P3|Overall Study|Sponsor Decision|1
5852091|NCT02168803|20234932|P2|Overall Study|Sponsor Decision|0
5852092|NCT02168803|20234933|P1|Overall Study|Sponsor Decision|0
5852093|NCT02168803|20234931|P3|Overall Study|Death|1
5852094|NCT02168803|20234932|P2|Overall Study|Death|0
5852095|NCT02168803|20234933|P1|Overall Study|Death|0
5852096|NCT02168803|20234931|P3|Overall Study|Adverse Event|1
5852097|NCT02168803|20234932|P2|Overall Study|Adverse Event|1
5852098|NCT02168803|20234933|P1|Overall Study|Adverse Event|0
5852099|NCT02168803|20234931|P3|Overall Study|Physician Decision|0
5852100|NCT02168803|20234932|P2|Overall Study|Physician Decision|1
5852101|NCT02168803|20234933|P1|Overall Study|Physician Decision|0
5852102|NCT02168803|20234931|P3|Overall Study|Withdrawal by Subject|2
5852103|NCT02168803|20234932|P2|Overall Study|Withdrawal by Subject|1
5852104|NCT02168803|20234933|P1|Overall Study|Withdrawal by Subject|1
5852105|NCT02168803|20234931|P3|Overall Study|Lost to Follow-up|1
5852106|NCT02168803|20234932|P2|Overall Study|Lost to Follow-up|0
5852107|NCT02168803|20234933|P1|Overall Study|Lost to Follow-up|1
5852108|NCT02168777|20234963|P3|Overall Study|Other reason|0
5852109|NCT02168777|20234964|P2|Overall Study|Other reason|1
5852110|NCT02168777|20234965|P1|Overall Study|Other reason|0
5852111|NCT02168777|20234963|P3|Overall Study|Clinical disease progression|2
5852112|NCT02168777|20234964|P2|Overall Study|Clinical disease progression|1
5852113|NCT02168777|20234965|P1|Overall Study|Clinical disease progression|0
5852114|NCT02168777|20234963|P3|Overall Study|Radiological disease progression|5
5852115|NCT02168777|20234964|P2|Overall Study|Radiological disease progression|5
5852116|NCT02168777|20234965|P1|Overall Study|Radiological disease progression|0
5852117|NCT02168777|20234963|P3|Overall Study|Disease recurrence|1
5852118|NCT02168777|20234964|P2|Overall Study|Disease recurrence|0
5852119|NCT02168777|20234965|P1|Overall Study|Disease recurrence|0
5852120|NCT02168777|20234963|P3|Overall Study|Adverse Event|1
5852121|NCT02168777|20234964|P2|Overall Study|Adverse Event|0
5852122|NCT02168777|20234965|P1|Overall Study|Adverse Event|1
5852123|NCT02168777|20234963|P3|Overall Study|Withdrawal by Subject|2
5852124|NCT02168777|20234964|P2|Overall Study|Withdrawal by Subject|0
5852125|NCT02168777|20234965|P1|Overall Study|Withdrawal by Subject|1
5852126|NCT02168491|20235061|P1|Overall Study|Withdrawal by Subject|1
5852127|NCT02168478|20235067|P1|Overall Study|Did Not Meet Exclusionary Criteria|1
5852128|NCT02168478|20235067|P1|Overall Study|Did Not Consent to Participation|2
5852129|NCT02168478|20235067|P1|Overall Study|Withdrawal by Subject|1
5852130|NCT02168439|20235073|P2|Overall Study|Protocol Violation|2
5852131|NCT02168439|20235074|P1|Overall Study|Protocol Violation|0
5852132|NCT02168387|20235092|P2|Overall Study|Death|0
5852133|NCT02168387|20235093|P1|Overall Study|Death|1
5852134|NCT02168387|20235092|P2|Overall Study|Planned exubation|3
5852135|NCT02168387|20235093|P1|Overall Study|Planned exubation|6
5852136|NCT02168270|20235125|P1|Overall Study|Lack of Efficacy|4
5852137|NCT02168101|20235152|P3|Overall Study|Death|1
5852138|NCT02168101|20235153|P2|Overall Study|Death|2
5852139|NCT02168101|20235154|P1|Overall Study|Death|2
5852140|NCT02167893|20235224|P1|Overall Study|Case report forms not collected|68
5852141|NCT02167893|20235224|P1|Overall Study|Investigator health reasons|10
5852142|NCT02167893|20235224|P1|Overall Study|Investigator transferred|85
5852143|NCT02167594|20235259|P3|Overall Study|Death|0
5852144|NCT02167594|20235260|P2|Overall Study|Death|1
5852145|NCT02167594|20235261|P1|Overall Study|Death|0
5852146|NCT02167594|20235259|P3|Overall Study|Withdrawal by Subject|0
5852147|NCT02167594|20235260|P2|Overall Study|Withdrawal by Subject|0
5852148|NCT02167594|20235261|P1|Overall Study|Withdrawal by Subject|2
5852149|NCT02167451|20235270|P1|Overall Study|Withdrawal by Subject|1
5852150|NCT02167256|20235287|P2|Overall Study|Study partner unable to participate|0
5852151|NCT02167256|20235288|P1|Overall Study|Study partner unable to participate|1
5852152|NCT02167256|20235287|P2|Overall Study|non-compliance|0
5852153|NCT02167256|20235288|P1|Overall Study|non-compliance|3
5852154|NCT02167256|20235287|P2|Overall Study|Withdrawal by Subject|4
5852155|NCT02167256|20235288|P1|Overall Study|Withdrawal by Subject|4
5852156|NCT02167256|20235287|P2|Overall Study|Adverse Event|6
5852157|NCT02167256|20235288|P1|Overall Study|Adverse Event|13
5852158|NCT02167139|20235321|P4|Transition-extension|Lost to Follow-up|0
5852159|NCT02167139|20235322|P3|Transition-extension|Lost to Follow-up|0
5852160|NCT02167139|20235323|P2|Transition-extension|Lost to Follow-up|0
5852161|NCT02167139|20235324|P1|Transition-extension|Lost to Follow-up|1
5852162|NCT02167139|20235321|P4|Transition-extension|Other|0
5852163|NCT02167139|20235322|P3|Transition-extension|Other|1
5852164|NCT02167139|20235323|P2|Transition-extension|Other|0
5852165|NCT02167139|20235324|P1|Transition-extension|Other|1
5852166|NCT02167139|20235321|P4|Transition-extension|Lack of Efficacy|1
5852167|NCT02167139|20235322|P3|Transition-extension|Lack of Efficacy|1
5852168|NCT02167139|20235323|P2|Transition-extension|Lack of Efficacy|0
5852169|NCT02167139|20235324|P1|Transition-extension|Lack of Efficacy|0
5852170|NCT02167139|20235321|P4|Transition-extension|Withdrawal by Subject|1
5852171|NCT02167139|20235322|P3|Transition-extension|Withdrawal by Subject|4
5852172|NCT02167139|20235323|P2|Transition-extension|Withdrawal by Subject|0
5852173|NCT02167139|20235324|P1|Transition-extension|Withdrawal by Subject|2
5852174|NCT02167139|20235321|P4|Transition-extension|Adverse Event|3
5852175|NCT02167139|20235322|P3|Transition-extension|Adverse Event|2
5852176|NCT02167139|20235323|P2|Transition-extension|Adverse Event|0
5852177|NCT02167139|20235324|P1|Transition-extension|Adverse Event|2
5852178|NCT02167139|20235321|P4|Randomised, Double-blind|Other|0
5852179|NCT02167139|20235322|P3|Randomised, Double-blind|Other|0
5852180|NCT02167139|20235323|P2|Randomised, Double-blind|Other|0
5852181|NCT02167139|20235324|P1|Randomised, Double-blind|Other|3
5852182|NCT02167139|20235321|P4|Randomised, Double-blind|Lack of Efficacy|0
5852183|NCT02167139|20235322|P3|Randomised, Double-blind|Lack of Efficacy|0
5852184|NCT02167139|20235323|P2|Randomised, Double-blind|Lack of Efficacy|2
5852185|NCT02167139|20235324|P1|Randomised, Double-blind|Lack of Efficacy|1
5852186|NCT02167139|20235321|P4|Randomised, Double-blind|Adverse Event|0
5852187|NCT02167139|20235322|P3|Randomised, Double-blind|Adverse Event|0
5852188|NCT02167139|20235323|P2|Randomised, Double-blind|Adverse Event|9
5852189|NCT02167139|20235324|P1|Randomised, Double-blind|Adverse Event|2
5852190|NCT02167139|20235321|P4|Randomised, Double-blind|Withdrawal by Subject|0
5852191|NCT02167139|20235322|P3|Randomised, Double-blind|Withdrawal by Subject|0
5852192|NCT02167139|20235323|P2|Randomised, Double-blind|Withdrawal by Subject|8
5852193|NCT02167139|20235324|P1|Randomised, Double-blind|Withdrawal by Subject|11
5852194|NCT02167035|20235359|P2|Overall Study|Randomized to incorrect Study Medication|1
5852195|NCT02167035|20235360|P1|Overall Study|Randomized to incorrect Study Medication|0
5852196|NCT02167035|20235359|P2|Overall Study|Lost to Follow-up|3
5852197|NCT02167035|20235360|P1|Overall Study|Lost to Follow-up|3
5852198|NCT02167035|20235359|P2|Overall Study|Adverse Event|2
5852199|NCT02167035|20235360|P1|Overall Study|Adverse Event|2
5852200|NCT02166697|20235368|P1|Overall Study|Protocol Violation|347
5852201|NCT02166606|20235377|P1|Overall Study|Enrolled after End of Enrollment|4
5852202|NCT02166606|20235377|P1|Overall Study|Device upgrade|1
5852203|NCT02166606|20235377|P1|Overall Study|Physician Decision|1
5852204|NCT02166606|20235377|P1|Overall Study|Withdrawal by Subject|1
5852205|NCT02166606|20235377|P1|Overall Study|Lost to Follow-up|30
5852206|NCT02166606|20235377|P1|Overall Study|Protocol Violation|7
5852207|NCT02166606|20235377|P1|Overall Study|Death|31
5852208|NCT02166606|20235377|P1|Overall Study|Adverse Event|3
5852209|NCT02166476|20235384|P2|Overall Study|Unable to Come for Visit|3
5852210|NCT02166476|20235385|P1|Overall Study|Unable to Come for Visit|0
5852211|NCT02166476|20235384|P2|Overall Study|Physician Decision|0
5852212|NCT02166476|20235385|P1|Overall Study|Physician Decision|1
5852213|NCT02166476|20235384|P2|Overall Study|Lost to Follow-up|10
5852214|NCT02166476|20235385|P1|Overall Study|Lost to Follow-up|5
5852215|NCT02166476|20235384|P2|Overall Study|Adverse Event|3
5852216|NCT02166476|20235385|P1|Overall Study|Adverse Event|3
5852217|NCT02166476|20235384|P2|Overall Study|Withdrawal by Subject|7
5852218|NCT02166476|20235385|P1|Overall Study|Withdrawal by Subject|5
5852219|NCT02166047|20235439|P12|Overall Study|Adverse Event|0
5852220|NCT02166047|20235440|P11|Overall Study|Adverse Event|2
5852221|NCT02166047|20235441|P10|Overall Study|Adverse Event|0
5852222|NCT02166047|20235442|P9|Overall Study|Adverse Event|0
5852223|NCT02166047|20235443|P8|Overall Study|Adverse Event|0
5852224|NCT02166047|20235444|P7|Overall Study|Adverse Event|1
5852225|NCT02166047|20235445|P6|Overall Study|Adverse Event|0
5852226|NCT02166047|20235446|P5|Overall Study|Adverse Event|1
5852227|NCT02166047|20235447|P4|Overall Study|Adverse Event|0
5852228|NCT02166047|20235448|P3|Overall Study|Adverse Event|0
5852229|NCT02166047|20235449|P2|Overall Study|Adverse Event|0
5852230|NCT02166047|20235450|P1|Overall Study|Adverse Event|0
5852231|NCT02166047|20235439|P12|Overall Study|Withdrawal by Participant|0
5852232|NCT02166047|20235440|P11|Overall Study|Withdrawal by Participant|0
5852233|NCT02166047|20235441|P10|Overall Study|Withdrawal by Participant|0
5852234|NCT02166047|20235442|P9|Overall Study|Withdrawal by Participant|0
5852235|NCT02166047|20235443|P8|Overall Study|Withdrawal by Participant|0
5852236|NCT02166047|20235444|P7|Overall Study|Withdrawal by Participant|1
5852237|NCT02166047|20235445|P6|Overall Study|Withdrawal by Participant|0
5852238|NCT02166047|20235446|P5|Overall Study|Withdrawal by Participant|0
5852239|NCT02166047|20235447|P4|Overall Study|Withdrawal by Participant|0
5852240|NCT02166047|20235448|P3|Overall Study|Withdrawal by Participant|2
5852241|NCT02166047|20235449|P2|Overall Study|Withdrawal by Participant|1
5852242|NCT02166047|20235450|P1|Overall Study|Withdrawal by Participant|0
5852243|NCT02165826|20235617|P3|Down-Titration Period|Reason Not Specified|2
5852244|NCT02165826|20235618|P2|Down-Titration Period|Reason Not Specified|0
5852245|NCT02165826|20235619|P1|Down-Titration Period|Reason Not Specified|1
5852246|NCT02165826|20235617|P3|Down-Titration Period|Voluntary Withdrawal|2
5852247|NCT02165826|20235618|P2|Down-Titration Period|Voluntary Withdrawal|1
5852248|NCT02165826|20235619|P1|Down-Titration Period|Voluntary Withdrawal|2
5852249|NCT02165826|20235617|P3|Down-Titration Period|Pre-treatment Event/Adverse Event|3
5852250|NCT02165826|20235618|P2|Down-Titration Period|Pre-treatment Event/Adverse Event|10
5852251|NCT02165826|20235619|P1|Down-Titration Period|Pre-treatment Event/Adverse Event|4
5852252|NCT02165826|20235617|P3|Main Treatment Period|Did Not Receive Study Drug|0
5852253|NCT02165826|20235618|P2|Main Treatment Period|Did Not Receive Study Drug|2
5852254|NCT02165826|20235619|P1|Main Treatment Period|Did Not Receive Study Drug|0
5852255|NCT02165826|20235617|P3|Main Treatment Period|Reason Not Specified|16
5852256|NCT02165826|20235618|P2|Main Treatment Period|Reason Not Specified|5
5852257|NCT02165826|20235619|P1|Main Treatment Period|Reason Not Specified|8
5852258|NCT02165826|20235617|P3|Main Treatment Period|Lack of Efficacy|0
5852259|NCT02165826|20235618|P2|Main Treatment Period|Lack of Efficacy|0
5852260|NCT02165826|20235619|P1|Main Treatment Period|Lack of Efficacy|2
5852261|NCT02165826|20235617|P3|Main Treatment Period|Voluntary Withdrawal|21
5852262|NCT02165826|20235618|P2|Main Treatment Period|Voluntary Withdrawal|23
5852263|NCT02165826|20235619|P1|Main Treatment Period|Voluntary Withdrawal|23
5852264|NCT02165826|20235617|P3|Main Treatment Period|Lost to Follow-up|1
5852265|NCT02165826|20235618|P2|Main Treatment Period|Lost to Follow-up|2
5852266|NCT02165826|20235619|P1|Main Treatment Period|Lost to Follow-up|4
5852267|NCT02165826|20235617|P3|Main Treatment Period|Major/Significant Protocol Deviation|3
5852268|NCT02165826|20235618|P2|Main Treatment Period|Major/Significant Protocol Deviation|1
5852269|NCT02165826|20235619|P1|Main Treatment Period|Major/Significant Protocol Deviation|0
5852270|NCT02165826|20235617|P3|Main Treatment Period|Pre-treatment Event/Adverse Event|68
5852271|NCT02165826|20235618|P2|Main Treatment Period|Pre-treatment Event/Adverse Event|57
5852272|NCT02165826|20235619|P1|Main Treatment Period|Pre-treatment Event/Adverse Event|44
5852273|NCT02165735|20235687|P2|Overall Study|Protocol Violation|1
5852274|NCT02165735|20235688|P1|Overall Study|Protocol Violation|0
5852275|NCT02165735|20235687|P2|Overall Study|Participant indicated lack of time|3
5852276|NCT02165735|20235688|P1|Overall Study|Participant indicated lack of time|1
5852277|NCT02165735|20235687|P2|Overall Study|Withdrawal by Subject|0
5852278|NCT02165735|20235688|P1|Overall Study|Withdrawal by Subject|3
5852279|NCT02165735|20235687|P2|Overall Study|Lost to Follow-up|10
5852280|NCT02165735|20235688|P1|Overall Study|Lost to Follow-up|12
5852281|NCT02165397|20235762|P3|Overall Study|Other, Not Specified|1
5852282|NCT02165397|20235763|P2|Overall Study|Other, Not Specified|0
5852283|NCT02165397|20235764|P1|Overall Study|Other, Not Specified|0
5852284|NCT02165397|20235762|P3|Overall Study|Withdrawal by Subject|1
5852285|NCT02165397|20235763|P2|Overall Study|Withdrawal by Subject|6
5852286|NCT02165397|20235764|P1|Overall Study|Withdrawal by Subject|6
5852287|NCT02165397|20235762|P3|Overall Study|Lost to Follow-up|0
5852288|NCT02165397|20235763|P2|Overall Study|Lost to Follow-up|3
5852289|NCT02165397|20235764|P1|Overall Study|Lost to Follow-up|1
5852290|NCT02165397|20235762|P3|Overall Study|Death|8
5852291|NCT02165397|20235763|P2|Overall Study|Death|10
5852292|NCT02165397|20235764|P1|Overall Study|Death|7
5852293|NCT02165202|20235794|P2|Injection Phase|Participant unwilling to comply|0
5852294|NCT02165202|20235795|P1|Injection Phase|Participant unwilling to comply|1
5852295|NCT02165202|20235794|P2|Injection Phase|No longer interested|1
5852296|NCT02165202|20235795|P1|Injection Phase|No longer interested|0
5852297|NCT02165202|20235794|P2|Injection Phase|Study Product related Toxicity|0
5852298|NCT02165202|20235795|P1|Injection Phase|Study Product related Toxicity|1
5852299|NCT02165202|20235794|P2|Injection Phase|End of Study|1
5852300|NCT02165202|20235795|P1|Injection Phase|End of Study|2
5852301|NCT02165202|20235794|P2|Injection Phase|QTcF>500 ms or increase of>60 ms|1
5852302|NCT02165202|20235795|P1|Injection Phase|QTcF>500 ms or increase of>60 ms|0
5852303|NCT02165202|20235794|P2|Injection Phase|Unable to attend within Visit Window|0
5852304|NCT02165202|20235795|P1|Injection Phase|Unable to attend within Visit Window|1
5852305|NCT02165202|20235794|P2|Injection Phase|Reactive HIV or HIV Suspected|2
5852306|NCT02165202|20235795|P1|Injection Phase|Reactive HIV or HIV Suspected|0
5852307|NCT02165202|20235794|P2|Injection Phase|Abnormal Lab Value|1
5852308|NCT02165202|20235795|P1|Injection Phase|Abnormal Lab Value|5
5852309|NCT02165202|20235794|P2|Oral Phase|Abnormal EKG|1
5852310|NCT02165202|20235795|P1|Oral Phase|Abnormal EKG|0
5852311|NCT02165202|20235794|P2|Oral Phase|Relocated, no follow-up planned|0
5852312|NCT02165202|20235795|P1|Oral Phase|Relocated, no follow-up planned|1
5852313|NCT02165202|20235794|P2|Oral Phase|CMC advised termination|0
5852314|NCT02165202|20235795|P1|Oral Phase|CMC advised termination|1
5852315|NCT02165202|20235794|P2|Oral Phase|QTcF>500 ms or increase of>60 ms|0
5852316|NCT02165202|20235795|P1|Oral Phase|QTcF>500 ms or increase of>60 ms|1
5852317|NCT02165202|20235794|P2|Oral Phase|Clinical reasons|0
5852318|NCT02165202|20235795|P1|Oral Phase|Clinical reasons|1
5852319|NCT02165202|20235794|P2|Oral Phase|Unable to contact Participant|1
5852320|NCT02165202|20235795|P1|Oral Phase|Unable to contact Participant|1
5852321|NCT02165202|20235794|P2|Oral Phase|Study product Related Toxicity|0
5852322|NCT02165202|20235795|P1|Oral Phase|Study product Related Toxicity|1
5852323|NCT02165202|20235794|P2|Oral Phase|Refused further participation|1
5852324|NCT02165202|20235795|P1|Oral Phase|Refused further participation|5
5852325|NCT02164981|20235832|P3|Phase 2 (Day 14 - Day 28)|Protocol Violation|0
5852326|NCT02164981|20235833|P2|Phase 2 (Day 14 - Day 28)|Protocol Violation|1
5852327|NCT02164981|20235834|P1|Phase 2 (Day 14 - Day 28)|Protocol Violation|0
5852328|NCT02164981|20235832|P3|Phase 2 (Day 14 - Day 28)|Adverse Event|0
5852329|NCT02164981|20235833|P2|Phase 2 (Day 14 - Day 28)|Adverse Event|1
5852330|NCT02164981|20235834|P1|Phase 2 (Day 14 - Day 28)|Adverse Event|2
5852331|NCT02164981|20235832|P3|Phase 1 (Day 0 - Day 14)|Adverse Event|0
5852332|NCT02164981|20235833|P2|Phase 1 (Day 0 - Day 14)|Adverse Event|2
5852333|NCT02164981|20235834|P1|Phase 1 (Day 0 - Day 14)|Adverse Event|0
5852334|NCT02164981|20235832|P3|Started|Adverse Event|0
5852335|NCT02164981|20235833|P2|Started|Adverse Event|2
5852336|NCT02164981|20235834|P1|Started|Adverse Event|1
5852337|NCT02164981|20235832|P3|Started|Protocol Violation|0
5852338|NCT02164981|20235833|P2|Started|Protocol Violation|0
5852339|NCT02164981|20235834|P1|Started|Protocol Violation|2
5852340|NCT02164981|20235832|P3|Started|Withdrawal by Subject|0
5852341|NCT02164981|20235833|P2|Started|Withdrawal by Subject|1
5852342|NCT02164981|20235834|P1|Started|Withdrawal by Subject|2
5852343|NCT02164929|20235907|P4|Overall Study|Failed regional block|0
5852344|NCT02164929|20235908|P3|Overall Study|Failed regional block|1
5852345|NCT02164929|20235909|P2|Overall Study|Failed regional block|0
5852346|NCT02164929|20235910|P1|Overall Study|Failed regional block|0
5852347|NCT02164929|20235907|P4|Overall Study|Converted to open procedure|2
5852348|NCT02164929|20235908|P3|Overall Study|Converted to open procedure|0
5852349|NCT02164929|20235909|P2|Overall Study|Converted to open procedure|0
5852350|NCT02164929|20235910|P1|Overall Study|Converted to open procedure|1
5852351|NCT02164916|20235954|P2|Overall Study|Not eligible|5
5852352|NCT02164916|20235955|P1|Overall Study|Not eligible|2
5852353|NCT02164916|20235954|P2|Overall Study|Reason under review|6
5852354|NCT02164916|20235955|P1|Overall Study|Reason under review|1
5852355|NCT02164916|20235954|P2|Overall Study|Not protocol specified|1
5852356|NCT02164916|20235955|P1|Overall Study|Not protocol specified|5
5852357|NCT02164916|20235954|P2|Overall Study|Progression|26
5852358|NCT02164916|20235955|P1|Overall Study|Progression|37
5852359|NCT02164916|20235954|P2|Overall Study|Refusal unrelated to adverse event|7
5852360|NCT02164916|20235955|P1|Overall Study|Refusal unrelated to adverse event|3
5852361|NCT02164916|20235954|P2|Overall Study|Death|1
5852362|NCT02164916|20235955|P1|Overall Study|Death|1
5852363|NCT02164916|20235954|P2|Overall Study|Adverse Event|8
5852364|NCT02164916|20235955|P1|Overall Study|Adverse Event|3
5852365|NCT02164864|20235975|P3|Overall Study|Other than stated|14
5852366|NCT02164864|20235976|P2|Overall Study|Other than stated|4
5852367|NCT02164864|20235977|P1|Overall Study|Other than stated|3
5852368|NCT02164864|20235975|P3|Overall Study|Consent withdrawn, not due to AE|56
5852369|NCT02164864|20235976|P2|Overall Study|Consent withdrawn, not due to AE|8
5852370|NCT02164864|20235977|P1|Overall Study|Consent withdrawn, not due to AE|21
5852371|NCT02164864|20235975|P3|Overall Study|Lost to Follow-up|2
5852372|NCT02164864|20235976|P2|Overall Study|Lost to Follow-up|3
5852373|NCT02164864|20235977|P1|Overall Study|Lost to Follow-up|4
5852374|NCT02164864|20235975|P3|Overall Study|Protocol Violation|1
5852375|NCT02164864|20235976|P2|Overall Study|Protocol Violation|4
5852376|NCT02164864|20235977|P1|Overall Study|Protocol Violation|2
5852377|NCT02164864|20235975|P3|Overall Study|Other Adverse Event (AE)|49
5852378|NCT02164864|20235976|P2|Overall Study|Other Adverse Event (AE)|32
5852379|NCT02164864|20235977|P1|Overall Study|Other Adverse Event (AE)|52
5852380|NCT02164864|20235975|P3|Overall Study|Other pre-existing disease worsening|9
5852381|NCT02164864|20235976|P2|Overall Study|Other pre-existing disease worsening|4
5852382|NCT02164864|20235977|P1|Overall Study|Other pre-existing disease worsening|6
5852383|NCT02164864|20235975|P3|Overall Study|Trial disease worsening|1
5852384|NCT02164864|20235976|P2|Overall Study|Trial disease worsening|5
5852385|NCT02164864|20235977|P1|Overall Study|Trial disease worsening|7
5852386|NCT02164539|20236052|P7|Treatment Phase C (1 Week)|Physician Decision|1
5852387|NCT02164539|20236053|P6|Treatment Phase C (1 Week)|Physician Decision|0
5852388|NCT02164539|20236054|P5|Treatment Phase C (1 Week)|Physician Decision|0
5852389|NCT02164539|20236055|P4|Treatment Phase C (1 Week)|Physician Decision|0
5852390|NCT02164539|20236056|P3|Treatment Phase C (1 Week)|Physician Decision|0
5852391|NCT02164539|20236057|P2|Treatment Phase C (1 Week)|Physician Decision|0
5852392|NCT02164539|20236058|P1|Treatment Phase C (1 Week)|Physician Decision|0
5852393|NCT02164539|20236052|P7|Treatment Phase C (1 Week)|Adverse Event|1
5852394|NCT02164539|20236053|P6|Treatment Phase C (1 Week)|Adverse Event|0
5852395|NCT02164539|20236054|P5|Treatment Phase C (1 Week)|Adverse Event|0
5852396|NCT02164539|20236055|P4|Treatment Phase C (1 Week)|Adverse Event|0
5852397|NCT02164539|20236056|P3|Treatment Phase C (1 Week)|Adverse Event|0
5852398|NCT02164539|20236057|P2|Treatment Phase C (1 Week)|Adverse Event|0
5852399|NCT02164539|20236058|P1|Treatment Phase C (1 Week)|Adverse Event|0
5852400|NCT02164539|20236052|P7|Treatment Phase C (1 Week)|Withdrawal by Subject|0
5852401|NCT02164539|20236053|P6|Treatment Phase C (1 Week)|Withdrawal by Subject|0
5852402|NCT02164539|20236054|P5|Treatment Phase C (1 Week)|Withdrawal by Subject|0
5852403|NCT02164539|20236055|P4|Treatment Phase C (1 Week)|Withdrawal by Subject|0
5852404|NCT02164539|20236056|P3|Treatment Phase C (1 Week)|Withdrawal by Subject|0
5852405|NCT02164539|20236057|P2|Treatment Phase C (1 Week)|Withdrawal by Subject|0
5852406|NCT02164539|20236058|P1|Treatment Phase C (1 Week)|Withdrawal by Subject|1
5852407|NCT02164539|20236052|P7|Treatment Phase B (1 Week)|Physician Decision|1
5852408|NCT02164539|20236053|P6|Treatment Phase B (1 Week)|Physician Decision|0
5852409|NCT02164539|20236054|P5|Treatment Phase B (1 Week)|Physician Decision|1
5852410|NCT02164539|20236055|P4|Treatment Phase B (1 Week)|Physician Decision|0
5852411|NCT02164539|20236056|P3|Treatment Phase B (1 Week)|Physician Decision|0
5852412|NCT02164539|20236057|P2|Treatment Phase B (1 Week)|Physician Decision|0
5852413|NCT02164539|20236058|P1|Treatment Phase B (1 Week)|Physician Decision|0
5852414|NCT02164539|20236052|P7|Treatment Phase B (1 Week)|Adverse Event|0
5852415|NCT02164539|20236053|P6|Treatment Phase B (1 Week)|Adverse Event|0
5852416|NCT02164539|20236054|P5|Treatment Phase B (1 Week)|Adverse Event|2
5852417|NCT02164539|20236055|P4|Treatment Phase B (1 Week)|Adverse Event|0
5852418|NCT02164539|20236056|P3|Treatment Phase B (1 Week)|Adverse Event|0
5852419|NCT02164539|20236057|P2|Treatment Phase B (1 Week)|Adverse Event|0
5852420|NCT02164539|20236058|P1|Treatment Phase B (1 Week)|Adverse Event|0
5852421|NCT02164539|20236052|P7|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0
5852422|NCT02164539|20236053|P6|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1
5852423|NCT02164539|20236054|P5|Treatment Phase A (4 Weeks)|Withdrawal by Subject|3
5852424|NCT02164539|20236055|P4|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2
5852425|NCT02164539|20236056|P3|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1
5852426|NCT02164539|20236057|P2|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0
5852427|NCT02164539|20236058|P1|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2
5852428|NCT02164513|20236106|P3|Overall Study|Other: Reason not provided by site|0
5852429|NCT02164513|20236107|P2|Overall Study|Other: Reason not provided by site|0
5852430|NCT02164513|20236108|P1|Overall Study|Other: Reason not provided by site|1
5852431|NCT02164513|20236106|P3|Overall Study|Withdrawal by Subject|130
5852432|NCT02164513|20236107|P2|Overall Study|Withdrawal by Subject|261
5852433|NCT02164513|20236108|P1|Overall Study|Withdrawal by Subject|192
5852434|NCT02164513|20236106|P3|Overall Study|Physician Decision|28
5852435|NCT02164513|20236107|P2|Overall Study|Physician Decision|57
5852436|NCT02164513|20236108|P1|Overall Study|Physician Decision|47
5852437|NCT02164513|20236106|P3|Overall Study|Lost to Follow-up|22
5852438|NCT02164513|20236107|P2|Overall Study|Lost to Follow-up|36
5852439|NCT02164513|20236108|P1|Overall Study|Lost to Follow-up|30
5852440|NCT02164513|20236106|P3|Overall Study|Other: Study Closed or terminated|4
5852441|NCT02164513|20236107|P2|Overall Study|Other: Study Closed or terminated|2
5852442|NCT02164513|20236108|P1|Overall Study|Other: Study Closed or terminated|5
5852443|NCT02164513|20236106|P3|Overall Study|Adverse Event|111
5852444|NCT02164513|20236107|P2|Overall Study|Adverse Event|180
5852445|NCT02164513|20236108|P1|Overall Study|Adverse Event|162
5852446|NCT02164383|20236145|P2|Overall Study|Lost to Follow-up|0
5852447|NCT02164383|20236146|P1|Overall Study|Lost to Follow-up|1
5852448|NCT02164318|20236156|P4|Overall Study|Withdrawal by Subject|1
5852449|NCT02164318|20236157|P3|Overall Study|Withdrawal by Subject|0
5852450|NCT02164318|20236158|P2|Overall Study|Withdrawal by Subject|1
5852451|NCT02164318|20236159|P1|Overall Study|Withdrawal by Subject|0
5852452|NCT02163993|20236194|P5|Post-treatment Period|Withdrawal by Subject|2
5852453|NCT02163993|20236195|P4|Post-treatment Period|Withdrawal by Subject|1
5852454|NCT02163993|20236196|P3|Post-treatment Period|Withdrawal by Subject|0
5852455|NCT02163993|20236197|P2|Post-treatment Period|Withdrawal by Subject|4
5852456|NCT02163993|20236198|P1|Post-treatment Period|Withdrawal by Subject|2
5852457|NCT02163993|20236194|P5|Post-treatment Period|Protocol Violation|1
5852458|NCT02163993|20236195|P4|Post-treatment Period|Protocol Violation|0
5852459|NCT02163993|20236196|P3|Post-treatment Period|Protocol Violation|0
5852460|NCT02163993|20236197|P2|Post-treatment Period|Protocol Violation|0
5852461|NCT02163993|20236198|P1|Post-treatment Period|Protocol Violation|0
5852462|NCT02163993|20236194|P5|Post-treatment Period|Lost to Follow-up|0
5852463|NCT02163993|20236195|P4|Post-treatment Period|Lost to Follow-up|1
5852464|NCT02163993|20236196|P3|Post-treatment Period|Lost to Follow-up|3
5852465|NCT02163993|20236197|P2|Post-treatment Period|Lost to Follow-up|2
5852466|NCT02163993|20236198|P1|Post-treatment Period|Lost to Follow-up|2
5852467|NCT02163993|20236194|P5|Post-treatment Period|Adverse Event|0
5852468|NCT02163993|20236195|P4|Post-treatment Period|Adverse Event|0
5852469|NCT02163993|20236196|P3|Post-treatment Period|Adverse Event|1
5852470|NCT02163993|20236197|P2|Post-treatment Period|Adverse Event|0
5852471|NCT02163993|20236198|P1|Post-treatment Period|Adverse Event|0
5852472|NCT02163993|20236194|P5|Treatment Period|Not treated|2
5852473|NCT02163993|20236195|P4|Treatment Period|Not treated|1
5852474|NCT02163993|20236196|P3|Treatment Period|Not treated|0
5852475|NCT02163993|20236197|P2|Treatment Period|Not treated|0
5852476|NCT02163993|20236198|P1|Treatment Period|Not treated|1
5852477|NCT02163993|20236194|P5|Treatment Period|Withdrawal by Subject|1
5852478|NCT02163993|20236195|P4|Treatment Period|Withdrawal by Subject|4
5852479|NCT02163993|20236196|P3|Treatment Period|Withdrawal by Subject|1
5852480|NCT02163993|20236197|P2|Treatment Period|Withdrawal by Subject|4
5852481|NCT02163993|20236198|P1|Treatment Period|Withdrawal by Subject|6
5852482|NCT02163993|20236194|P5|Treatment Period|Protocol Violation|2
5852483|NCT02163993|20236195|P4|Treatment Period|Protocol Violation|1
5852484|NCT02163993|20236196|P3|Treatment Period|Protocol Violation|0
5852485|NCT02163993|20236197|P2|Treatment Period|Protocol Violation|1
5852486|NCT02163993|20236198|P1|Treatment Period|Protocol Violation|2
5852487|NCT02163993|20236194|P5|Treatment Period|Physician Decision|0
5852488|NCT02163993|20236195|P4|Treatment Period|Physician Decision|0
5852489|NCT02163993|20236196|P3|Treatment Period|Physician Decision|0
5852490|NCT02163993|20236197|P2|Treatment Period|Physician Decision|0
5852491|NCT02163993|20236198|P1|Treatment Period|Physician Decision|1
5852492|NCT02163993|20236194|P5|Treatment Period|Lost to Follow-up|1
5852493|NCT02163993|20236195|P4|Treatment Period|Lost to Follow-up|3
5852494|NCT02163993|20236196|P3|Treatment Period|Lost to Follow-up|1
5852495|NCT02163993|20236197|P2|Treatment Period|Lost to Follow-up|3
5852496|NCT02163993|20236198|P1|Treatment Period|Lost to Follow-up|2
5852497|NCT02163993|20236194|P5|Treatment Period|Adverse Event|1
5852498|NCT02163993|20236195|P4|Treatment Period|Adverse Event|0
5852499|NCT02163993|20236196|P3|Treatment Period|Adverse Event|0
5852500|NCT02163993|20236197|P2|Treatment Period|Adverse Event|1
5852501|NCT02163993|20236198|P1|Treatment Period|Adverse Event|0
5852502|NCT02163915|20236301|P5|Overall Study|Physician Decision|0
5852503|NCT02163915|20236302|P4|Overall Study|Physician Decision|1
5852504|NCT02163915|20236303|P3|Overall Study|Physician Decision|0
5852505|NCT02163915|20236304|P2|Overall Study|Physician Decision|0
5852506|NCT02163915|20236305|P1|Overall Study|Physician Decision|0
5852507|NCT02163915|20236301|P5|Overall Study|Study termination|2
5852508|NCT02163915|20236302|P4|Overall Study|Study termination|0
5852509|NCT02163915|20236303|P3|Overall Study|Study termination|0
5852510|NCT02163915|20236304|P2|Overall Study|Study termination|0
5852511|NCT02163915|20236305|P1|Overall Study|Study termination|1
5852512|NCT02163915|20236301|P5|Overall Study|Withdrawal by Subject|2
5852513|NCT02163915|20236302|P4|Overall Study|Withdrawal by Subject|2
5852514|NCT02163915|20236303|P3|Overall Study|Withdrawal by Subject|2
5852515|NCT02163915|20236304|P2|Overall Study|Withdrawal by Subject|0
5852516|NCT02163915|20236305|P1|Overall Study|Withdrawal by Subject|2
5852517|NCT02163902|20236360|P2|Overall Study|Administrative Decision|2
5852518|NCT02163902|20236361|P1|Overall Study|Administrative Decision|2
5852519|NCT02163902|20236360|P2|Overall Study|Lost to Follow-up|7
5852520|NCT02163902|20236361|P1|Overall Study|Lost to Follow-up|6
5852521|NCT02163902|20236360|P2|Overall Study|Subject's Request|4
5852522|NCT02163902|20236361|P1|Overall Study|Subject's Request|3
5852523|NCT02163733|20236410|P3|Part B: Day 15 to End Part B (AZD9291)|Disease progression|19
5852524|NCT02163733|20236411|P2|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0
5852525|NCT02163733|20236412|P1|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0
5852526|NCT02163733|20236410|P3|Part B: Day 15 to End Part B (AZD9291)|Death|5
5852527|NCT02163733|20236411|P2|Part B: Day 15 to End Part B (AZD9291)|Death|0
5852528|NCT02163733|20236412|P1|Part B: Day 15 to End Part B (AZD9291)|Death|0
5852529|NCT02163538|20236514|P2|Overall Study|Physician Decision|1
5852530|NCT02163538|20236515|P1|Overall Study|Physician Decision|0
5852531|NCT02163538|20236514|P2|Overall Study|Protocol Violation|0
5852532|NCT02163538|20236515|P1|Overall Study|Protocol Violation|1
5852533|NCT02163499|20236531|P1|Extended Dosing Phase: ZS|Various reasons|16
5852534|NCT02163499|20236531|P1|Extended Dosing Phase: ZS|Hyperkalemia|5
5852535|NCT02163499|20236531|P1|Extended Dosing Phase: ZS|Subject Compliance|17
5852536|NCT02163499|20236531|P1|Extended Dosing Phase: ZS|Death|8
5852537|NCT02163499|20236531|P1|Extended Dosing Phase: ZS|Protocol Violation|2
5852538|NCT02163499|20236531|P1|Extended Dosing Phase: ZS|Lost to Follow-up|31
5852539|NCT02163499|20236531|P1|Extended Dosing Phase: ZS|Physician Decision|8
5852540|NCT02163499|20236531|P1|Extended Dosing Phase: ZS|Withdrawal by Subject|81
5852541|NCT02163499|20236531|P1|Extended Dosing Phase: ZS|Met ECG Withdrawal Criteria|7
5852542|NCT02163499|20236531|P1|Extended Dosing Phase: ZS|Sponsor's Decision|5
5852543|NCT02163499|20236531|P1|Extended Dosing Phase: ZS|Hypokalemia|9
5852544|NCT02163499|20236531|P1|Extended Dosing Phase: ZS|Expected Progression of CKD|40
5852545|NCT02163499|20236531|P1|Extended Dosing Phase: ZS|Adverse Event|51
5852546|NCT02163499|20236531|P1|Acute Phase: ZS 10 g TID|Withdrawal by Subject|1
5852547|NCT02163499|20236531|P1|Acute Phase: ZS 10 g TID|Physician Decision|1
5852548|NCT02163499|20236531|P1|Acute Phase: ZS 10 g TID|Protocol Violation|1
5852549|NCT02163499|20236531|P1|Acute Phase: ZS 10 g TID|Hypo- or Hyperkalemia|1
5852550|NCT02163499|20236531|P1|Acute Phase: ZS 10 g TID|Participant's Compliance|1
5852551|NCT02163447|20236559|P3|Overall Study|Became HIV infected at time of delivery|0
5852552|NCT02163447|20236560|P2|Overall Study|Became HIV infected at time of delivery|0
5852553|NCT02163447|20236561|P1|Overall Study|Became HIV infected at time of delivery|1
5852554|NCT02163447|20236559|P3|Overall Study|Moved out of study area|2
5852555|NCT02163447|20236560|P2|Overall Study|Moved out of study area|3
5852556|NCT02163447|20236561|P1|Overall Study|Moved out of study area|2
5852557|NCT02163447|20236559|P3|Overall Study|Lost to Follow-up|0
5852558|NCT02163447|20236560|P2|Overall Study|Lost to Follow-up|3
5852559|NCT02163447|20236561|P1|Overall Study|Lost to Follow-up|1
5852560|NCT02163447|20236559|P3|Overall Study|Withdrawal by Subject|1
5852561|NCT02163447|20236560|P2|Overall Study|Withdrawal by Subject|0
5852562|NCT02163447|20236561|P1|Overall Study|Withdrawal by Subject|2
5852563|NCT02163395|20236636|P1|Overall Study|Adverse Event|1
5852564|NCT02163395|20236636|P1|Overall Study|Lost to Follow-up|3
5852565|NCT02163395|20236636|P1|Overall Study|Withdrawal by Subject|1
5852566|NCT02163187|20236645|P2|Overall Study|Progressive disease|0
5852567|NCT02163187|20236646|P1|Overall Study|Progressive disease|1
5852568|NCT02163187|20236645|P2|Overall Study|Device removed|0
5852569|NCT02163187|20236646|P1|Overall Study|Device removed|1
5852570|NCT02163057|20236656|P2|Overall Study|Progression of Disease|2
5852571|NCT02163057|20236657|P1|Overall Study|Progression of Disease|1
5852572|NCT02163057|20236656|P2|Overall Study|Participant Significant Noncompliance|1
5852573|NCT02163057|20236657|P1|Overall Study|Participant Significant Noncompliance|0
5852574|NCT02163057|20236656|P2|Overall Study|Participant Refusal to Continue|2
5852575|NCT02163057|20236657|P1|Overall Study|Participant Refusal to Continue|2
5852576|NCT02162862|20236704|P3|Overall Study|Subject did not feel the med was needed|4
5852577|NCT02162862|20236705|P2|Overall Study|Subject did not feel the med was needed|0
5852578|NCT02162862|20236706|P1|Overall Study|Subject did not feel the med was needed|0
5852579|NCT02162862|20236704|P3|Overall Study|Lost to Follow-up|0
5852580|NCT02162862|20236705|P2|Overall Study|Lost to Follow-up|11
5852581|NCT02162862|20236706|P1|Overall Study|Lost to Follow-up|0
5852582|NCT02162771|20236719|P2|Maintenance Study Period (Part 2)|Stable Disease|1
5852583|NCT02162771|20236720|P1|Maintenance Study Period (Part 2)|Stable Disease|0
5852584|NCT02162771|20236719|P2|Maintenance Study Period (Part 2)|Protocol Violation|1
5852585|NCT02162771|20236720|P1|Maintenance Study Period (Part 2)|Protocol Violation|0
5852586|NCT02162771|20236719|P2|Maintenance Study Period (Part 2)|Withdrawal by Subject|3
5852587|NCT02162771|20236720|P1|Maintenance Study Period (Part 2)|Withdrawal by Subject|0
5852588|NCT02162771|20236719|P2|Maintenance Study Period (Part 2)|Death|1
5852589|NCT02162771|20236720|P1|Maintenance Study Period (Part 2)|Death|2
5852590|NCT02162771|20236719|P2|Maintenance Study Period (Part 2)|Adverse Event|3
5852591|NCT02162771|20236720|P1|Maintenance Study Period (Part 2)|Adverse Event|3
5852592|NCT02162771|20236719|P2|Maintenance Study Period (Part 2)|Progressive Disease|13
5852593|NCT02162771|20236720|P1|Maintenance Study Period (Part 2)|Progressive Disease|11
5852594|NCT02162771|20236719|P2|Core Study Period (Part 2)|Death|0
5852595|NCT02162771|20236720|P1|Core Study Period (Part 2)|Death|1
5852596|NCT02162771|20236719|P2|Core Study Period (Part 2)|Physician Decision|2
5852597|NCT02162771|20236720|P1|Core Study Period (Part 2)|Physician Decision|0
5852598|NCT02162771|20236719|P2|Core Study Period (Part 2)|Withdrawal by Subject|2
5852599|NCT02162771|20236720|P1|Core Study Period (Part 2)|Withdrawal by Subject|1
5852600|NCT02162771|20236719|P2|Core Study Period (Part 2)|Adverse Event|1
5852601|NCT02162771|20236720|P1|Core Study Period (Part 2)|Adverse Event|4
5852602|NCT02162771|20236719|P2|Core Study Period (Part 2)|Progressive Disease|3
5852603|NCT02162771|20236720|P1|Core Study Period (Part 2)|Progressive Disease|2
5852604|NCT02162758|20236734|P2|Overall Study|Study termination|1
5852605|NCT02162758|20236735|P1|Overall Study|Study termination|0
5852616|NCT02161757|20236915|P3|Treatment Through Study Completion|Death|1
5852617|NCT02161757|20236916|P2|Treatment Through Study Completion|Death|1
5852618|NCT02161757|20236917|P1|Treatment Through Study Completion|Death|2
5852619|NCT02161757|20236915|P3|Treatment Through Study Completion|Other|12
5852620|NCT02161757|20236916|P2|Treatment Through Study Completion|Other|19
5852621|NCT02161757|20236917|P1|Treatment Through Study Completion|Other|20
5852622|NCT02161757|20236915|P3|Treatment Through Study Completion|Lost to Follow-up|4
5852623|NCT02161757|20236916|P2|Treatment Through Study Completion|Lost to Follow-up|2
5852624|NCT02161757|20236917|P1|Treatment Through Study Completion|Lost to Follow-up|7
5852625|NCT02161757|20236915|P3|Treatment Through Study Completion|Withdrawal by Subject|20
5852626|NCT02161757|20236916|P2|Treatment Through Study Completion|Withdrawal by Subject|19
5852627|NCT02161757|20236917|P1|Treatment Through Study Completion|Withdrawal by Subject|27
5852628|NCT02161757|20236915|P3|Treatment Through Study Completion|Protocol Violation|2
5852629|NCT02161757|20236916|P2|Treatment Through Study Completion|Protocol Violation|1
5852630|NCT02161757|20236917|P1|Treatment Through Study Completion|Protocol Violation|0
5852631|NCT02161757|20236915|P3|Treatment Through Study Completion|Adverse Event|0
5852632|NCT02161757|20236916|P2|Treatment Through Study Completion|Adverse Event|1
5852633|NCT02161757|20236917|P1|Treatment Through Study Completion|Adverse Event|1
5852634|NCT02161757|20236915|P3|Randomised Through Start Treatment|Did not receive treatment|0
5852635|NCT02161757|20236916|P2|Randomised Through Start Treatment|Did not receive treatment|2
5852636|NCT02161757|20236917|P1|Randomised Through Start Treatment|Did not receive treatment|3
5852637|NCT02161731|20236975|P2|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|1
5852638|NCT02161731|20236976|P1|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|0
5852639|NCT02161731|20236975|P2|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|1
5852640|NCT02161731|20236976|P1|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|0
5852641|NCT02161575|20237004|P1|Overall Study|Adverse Event|2
5852642|NCT02161575|20237004|P1|Overall Study|Lack of Efficacy|1
5852643|NCT02161575|20237004|P1|Overall Study|Protocol Violation|8
5852644|NCT02161562|20237024|P2|Overall Study|Participant moved out of province|0
5852645|NCT02161562|20237025|P1|Overall Study|Participant moved out of province|1
5852646|NCT02161562|20237024|P2|Overall Study|Withdrew due to being out of the country|0
5852647|NCT02161562|20237025|P1|Overall Study|Withdrew due to being out of the country|1
5852648|NCT02161562|20237024|P2|Overall Study|Participant moved back to home country|0
5852649|NCT02161562|20237025|P1|Overall Study|Participant moved back to home country|1
5852650|NCT02161562|20237024|P2|Overall Study|Adverse Event|1
5852651|NCT02161562|20237025|P1|Overall Study|Adverse Event|1
5852652|NCT02161562|20237024|P2|Overall Study|Lack of Efficacy|1
5852653|NCT02161562|20237025|P1|Overall Study|Lack of Efficacy|4
5852654|NCT02161562|20237024|P2|Overall Study|Lost to Follow-up|1
5852655|NCT02161562|20237025|P1|Overall Study|Lost to Follow-up|3
5852656|NCT02161562|20237024|P2|Overall Study|Pregnancy|2
5852657|NCT02161562|20237025|P1|Overall Study|Pregnancy|1
5852658|NCT02161562|20237024|P2|Overall Study|Protocol Violation|4
5852659|NCT02161562|20237025|P1|Overall Study|Protocol Violation|9
5852660|NCT02161562|20237024|P2|Overall Study|Withdrawal by Subject|8
5852661|NCT02161562|20237025|P1|Overall Study|Withdrawal by Subject|5
5852662|NCT02161549|20237053|P2|Overall Study|Physician Decision|2
5852663|NCT02161549|20237054|P1|Overall Study|Physician Decision|6
5852664|NCT02161458|20237102|P4|Overall Study|Lost to Follow-up|0
5852665|NCT02161458|20237103|P3|Overall Study|Lost to Follow-up|1
5852666|NCT02161458|20237104|P2|Overall Study|Lost to Follow-up|2
5852667|NCT02161458|20237105|P1|Overall Study|Lost to Follow-up|0
5852668|NCT02161458|20237102|P4|Overall Study|Withdrawal by Subject|0
5852669|NCT02161458|20237103|P3|Overall Study|Withdrawal by Subject|4
5852670|NCT02161458|20237104|P2|Overall Study|Withdrawal by Subject|4
5852671|NCT02161458|20237105|P1|Overall Study|Withdrawal by Subject|0
5852672|NCT02161406|20237117|P2|Overall Study|relocation|1
5852673|NCT02161406|20237118|P1|Overall Study|relocation|0
5852674|NCT02161406|20237117|P2|Overall Study|Lack of Efficacy|1
5852675|NCT02161406|20237118|P1|Overall Study|Lack of Efficacy|1
5852676|NCT02161406|20237117|P2|Overall Study|investigator withdrew subject|1
5852677|NCT02161406|20237118|P1|Overall Study|investigator withdrew subject|3
5852678|NCT02161406|20237117|P2|Overall Study|Withdrawal by Subject|4
5852679|NCT02161406|20237118|P1|Overall Study|Withdrawal by Subject|2
5852680|NCT02161406|20237117|P2|Overall Study|Lost to Follow-up|1
5852681|NCT02161406|20237118|P1|Overall Study|Lost to Follow-up|2
5852682|NCT02161406|20237117|P2|Overall Study|Death|1
5852683|NCT02161406|20237118|P1|Overall Study|Death|2
5852684|NCT02161185|20237192|P1|Treatment Phase|Administrative/Other|7
5852685|NCT02161146|20237202|P5|Overall Study|Other Miscellaneous Reasons|0
5852686|NCT02161146|20237203|P4|Overall Study|Other Miscellaneous Reasons|0
5852687|NCT02161146|20237204|P3|Overall Study|Other Miscellaneous Reasons|0
5852688|NCT02161146|20237205|P2|Overall Study|Other Miscellaneous Reasons|1
5852689|NCT02161146|20237206|P1|Overall Study|Other Miscellaneous Reasons|0
5852690|NCT02161146|20237202|P5|Overall Study|Personal Reasons|1
5852691|NCT02161146|20237203|P4|Overall Study|Personal Reasons|2
5852692|NCT02161146|20237204|P3|Overall Study|Personal Reasons|0
5852693|NCT02161146|20237205|P2|Overall Study|Personal Reasons|1
5852694|NCT02161146|20237206|P1|Overall Study|Personal Reasons|0
5852695|NCT02161146|20237202|P5|Overall Study|Lost to Follow-up|0
5852696|NCT02161146|20237203|P4|Overall Study|Lost to Follow-up|0
5852697|NCT02161146|20237204|P3|Overall Study|Lost to Follow-up|0
5852698|NCT02161146|20237205|P2|Overall Study|Lost to Follow-up|1
5852699|NCT02161146|20237206|P1|Overall Study|Lost to Follow-up|0
5852700|NCT02161146|20237202|P5|Overall Study|Adverse Event|0
5852701|NCT02161146|20237203|P4|Overall Study|Adverse Event|1
5852702|NCT02161146|20237204|P3|Overall Study|Adverse Event|0
5852703|NCT02161146|20237205|P2|Overall Study|Adverse Event|1
5852704|NCT02161146|20237206|P1|Overall Study|Adverse Event|1
5852705|NCT02161016|20237242|P1|Overall Study|withdrawn by IRB|1
5852706|NCT02160977|20237273|P2|Six Months After Surgery|Lost to Follow-up|1
5852707|NCT02160977|20237274|P1|Six Months After Surgery|Lost to Follow-up|2
5852708|NCT02160977|20237273|P2|Three Months After Surgery|Lost to Follow-up|2
5852709|NCT02160977|20237274|P1|Three Months After Surgery|Lost to Follow-up|0
5852710|NCT02160977|20237273|P2|Six Weeks After Surgery|Lost to Follow-up|0
5852711|NCT02160977|20237274|P1|Six Weeks After Surgery|Lost to Follow-up|1
5852712|NCT02160899|20237290|P6|Overall Study|Adverse Event or Serious Adverse Event|0
5852713|NCT02160899|20237291|P5|Overall Study|Adverse Event or Serious Adverse Event|2
5852714|NCT02160899|20237292|P4|Overall Study|Adverse Event or Serious Adverse Event|1
5852715|NCT02160899|20237293|P3|Overall Study|Adverse Event or Serious Adverse Event|0
5852716|NCT02160899|20237294|P2|Overall Study|Adverse Event or Serious Adverse Event|1
5852717|NCT02160899|20237295|P1|Overall Study|Adverse Event or Serious Adverse Event|0
5852718|NCT02160626|20237357|P3|Overall Study|Withdrawal by Subject|0
5852719|NCT02160626|20237358|P2|Overall Study|Withdrawal by Subject|1
5852720|NCT02160626|20237359|P1|Overall Study|Withdrawal by Subject|0
5852721|NCT02160626|20237357|P3|Overall Study|Schedule not conducive to study visits|1
5852722|NCT02160626|20237358|P2|Overall Study|Schedule not conducive to study visits|0
5852723|NCT02160626|20237359|P1|Overall Study|Schedule not conducive to study visits|0
5852724|NCT02160626|20237357|P3|Overall Study|Adverse Event|0
5852725|NCT02160626|20237358|P2|Overall Study|Adverse Event|0
5852726|NCT02160626|20237359|P1|Overall Study|Adverse Event|1
5852727|NCT02160314|20237382|P2|Overall Study|Lost to Follow-up|1
5852728|NCT02160314|20237383|P1|Overall Study|Lost to Follow-up|0
5852729|NCT02160314|20237382|P2|Overall Study|Withdrawal by Subject|2
5852730|NCT02160314|20237383|P1|Overall Study|Withdrawal by Subject|1
5852731|NCT02160314|20237382|P2|Overall Study|Protocol Violation|4
5852732|NCT02160314|20237383|P1|Overall Study|Protocol Violation|0
5852733|NCT02160314|20237382|P2|Overall Study|Adverse Event|6
5852734|NCT02160314|20237383|P1|Overall Study|Adverse Event|0
5852735|NCT02160145|20237418|P3|Randomized Double-blind Period|Physician Decision|5
5852736|NCT02160145|20237419|P2|Randomized Double-blind Period|Physician Decision|7
5852737|NCT02160145|20237420|P1|Randomized Double-blind Period|Physician Decision|0
5852738|NCT02160145|20237418|P3|Randomized Double-blind Period|Lost to Follow-up|3
5852739|NCT02160145|20237419|P2|Randomized Double-blind Period|Lost to Follow-up|1
5852740|NCT02160145|20237420|P1|Randomized Double-blind Period|Lost to Follow-up|0
5852741|NCT02160145|20237418|P3|Randomized Double-blind Period|Subject decision|20
5852742|NCT02160145|20237419|P2|Randomized Double-blind Period|Subject decision|21
5852743|NCT02160145|20237420|P1|Randomized Double-blind Period|Subject decision|0
5852744|NCT02160145|20237418|P3|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0
5852745|NCT02160145|20237419|P2|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0
5852746|NCT02160145|20237420|P1|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|126
5852747|NCT02160145|20237418|P3|Prerandomization Single-blind Period|Placebo run-in failure|0
5852748|NCT02160145|20237419|P2|Prerandomization Single-blind Period|Placebo run-in failure|0
5852749|NCT02160145|20237420|P1|Prerandomization Single-blind Period|Placebo run-in failure|23
5852750|NCT02160041|20237433|P1|Overall Study|study terminated by by sponsor|1
5852751|NCT02160041|20237433|P1|Overall Study|Withdrawal by Subject|8
5852752|NCT02160041|20237433|P1|Overall Study|Physician Decision|3
5852753|NCT02160041|20237433|P1|Overall Study|non-compliance with study|1
5852754|NCT02160041|20237433|P1|Overall Study|Protocol Violation|1
5852755|NCT02160041|20237433|P1|Overall Study|disease progression|57
5852756|NCT02160041|20237433|P1|Overall Study|Death|2
5852757|NCT02160041|20237433|P1|Overall Study|Adverse Event|11
5852758|NCT02160002|20237445|P2|Overall Study|Withdrawal by Subject|1
5852759|NCT02160002|20237446|P1|Overall Study|Withdrawal by Subject|2
5852760|NCT02159950|20237493|P2|Overall Study|Progression|1
5852761|NCT02159950|20237494|P1|Overall Study|Progression|0
5852762|NCT02159950|20237493|P2|Overall Study|Adverse Event|1
5852763|NCT02159950|20237494|P1|Overall Study|Adverse Event|0
5852764|NCT02159807|20237553|P3|Overall Study|elevated blood pressure|1
5852765|NCT02159807|20237554|P2|Overall Study|elevated blood pressure|0
5852766|NCT02159807|20237555|P1|Overall Study|elevated blood pressure|0
5852767|NCT02159807|20237553|P3|Overall Study|No CSF|1
5852768|NCT02159807|20237554|P2|Overall Study|No CSF|1
5852769|NCT02159807|20237555|P1|Overall Study|No CSF|1
5852770|NCT02159807|20237553|P3|Overall Study|Adverse Event|1
5852771|NCT02159807|20237554|P2|Overall Study|Adverse Event|0
5852772|NCT02159807|20237555|P1|Overall Study|Adverse Event|0
5852773|NCT02159729|20237576|P2|Overall Study|Other Unspecified|1
5852774|NCT02159729|20237577|P1|Overall Study|Other Unspecified|3
5852775|NCT02159729|20237576|P2|Overall Study|Non compliance|0
5852776|NCT02159729|20237577|P1|Overall Study|Non compliance|2
5852777|NCT02159729|20237576|P2|Overall Study|Lost to Follow-up|9
5852778|NCT02159729|20237577|P1|Overall Study|Lost to Follow-up|24
5852779|NCT02159729|20237576|P2|Overall Study|Subject's Request|10
5852780|NCT02159729|20237577|P1|Overall Study|Subject's Request|13
5852781|NCT02159729|20237576|P2|Overall Study|Adverse Event|1
5852782|NCT02159729|20237577|P1|Overall Study|Adverse Event|0
5852783|NCT02159521|20237604|P1|Overall Study|Other than specified|1
5852784|NCT02159521|20237604|P1|Overall Study|Death|1
5852785|NCT02159521|20237604|P1|Overall Study|Lost to Follow-up|6
5852786|NCT02159521|20237604|P1|Overall Study|Withdrawal by Subject|7
5852787|NCT02159521|20237604|P1|Overall Study|Enrolled but not treated|3
5852788|NCT02159482|20237625|P1|Overall Study|Physician Decision|3
5852789|NCT02159482|20237625|P1|Overall Study|Withdrawal by Subject|2
5852790|NCT02159469|20237630|P1|Overall Study|Multiple|29
5852791|NCT02159469|20237630|P1|Overall Study|Other|1
5852792|NCT02159469|20237630|P1|Overall Study|Met Stopping Criteria|3
5852793|NCT02159469|20237630|P1|Overall Study|Sponsor's request|2
5852794|NCT02159469|20237630|P1|Overall Study|Lost to Follow-up|1
5852795|NCT02159469|20237630|P1|Overall Study|Withdrawal by Subject|9
5852796|NCT02159469|20237630|P1|Overall Study|Non-compliance|2
5852797|NCT02159469|20237630|P1|Overall Study|Adverse Event|5
5852798|NCT02159469|20237630|P1|Overall Study|Missing Completion status|1
5852799|NCT02159365|20237635|P1|Overall Study|Lost to Follow-up|1
5852800|NCT02159365|20237635|P1|Overall Study|Death|1
5852801|NCT02159365|20237635|P1|Overall Study|Subject withdrew consent|3
5852802|NCT02159365|20237635|P1|Overall Study|Subject request to discontinue treatment|3
5852803|NCT02159365|20237635|P1|Overall Study|Maximum clinical benefit|3
5852804|NCT02159365|20237635|P1|Overall Study|Study drug toxicity|7
5852805|NCT02159365|20237635|P1|Overall Study|Adverse Event unrelated to study drug|9
5852806|NCT02159365|20237635|P1|Overall Study|Administrative reason by Sponsor|9
5852807|NCT02159365|20237635|P1|Overall Study|Other reasons|11
5852808|NCT02159365|20237635|P1|Overall Study|Disease Progression|23
5852809|NCT02159352|20237642|P2|Overall Study|Withdrawal by Subject|1
5852810|NCT02159352|20237643|P1|Overall Study|Withdrawal by Subject|0
5852811|NCT02159352|20237642|P2|Overall Study|Adverse Event|1
5852812|NCT02159352|20237643|P1|Overall Study|Adverse Event|3
5852813|NCT02159183|20237695|P2|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|1
5852814|NCT02159183|20237696|P1|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|2
5852815|NCT02159183|20237695|P2|Analysis of Primary Endpoint (12 Mts)|Adverse Event|0
5852816|NCT02159183|20237696|P1|Analysis of Primary Endpoint (12 Mts)|Adverse Event|1
5852817|NCT02159183|20237695|P2|Analysis After the 36 Months Follow-up|Death|1
5852818|NCT02159183|20237696|P1|Analysis After the 36 Months Follow-up|Death|0
5852819|NCT02159183|20237695|P2|Analysis After the 36 Months Follow-up|Adverse Event|0
5852820|NCT02159183|20237696|P1|Analysis After the 36 Months Follow-up|Adverse Event|1
5852821|NCT02159183|20237695|P2|Analysis After the 36 Months Follow-up|Protocol Violation|1
5852822|NCT02159183|20237696|P1|Analysis After the 36 Months Follow-up|Protocol Violation|2
5852823|NCT02159053|20237769|P3|Overall Study|Participants/guardian decision|6
5852824|NCT02159053|20237770|P2|Overall Study|Participants/guardian decision|10
5852825|NCT02159053|20237771|P1|Overall Study|Participants/guardian decision|8
5852826|NCT02159053|20237769|P3|Overall Study|Adverse Event|5
5852827|NCT02159053|20237770|P2|Overall Study|Adverse Event|6
5852828|NCT02159053|20237771|P1|Overall Study|Adverse Event|7
5852829|NCT02159053|20237769|P3|Overall Study|Lack of Efficacy|7
5852830|NCT02159053|20237770|P2|Overall Study|Lack of Efficacy|4
5852831|NCT02159053|20237771|P1|Overall Study|Lack of Efficacy|3
5852832|NCT02159053|20237769|P3|Overall Study|Physician Decision|1
5852833|NCT02159053|20237770|P2|Overall Study|Physician Decision|1
5852834|NCT02159053|20237771|P1|Overall Study|Physician Decision|0
5852835|NCT02159053|20237769|P3|Overall Study|Death|1
5852836|NCT02159053|20237770|P2|Overall Study|Death|0
5852837|NCT02159053|20237771|P1|Overall Study|Death|2
5852838|NCT02159040|20237808|P1|Overall Study|Death|1
5852839|NCT02158975|20237821|P1|Overall Study|Did not complete 1 cycle nor > 1dose|1
5852840|NCT02158949|20237831|P2|Overall Study|Lost to Follow-up|11
5852841|NCT02158949|20237832|P1|Overall Study|Lost to Follow-up|5
5852842|NCT02158949|20237831|P2|Overall Study|Withdrawal by Subject|0
5852843|NCT02158949|20237832|P1|Overall Study|Withdrawal by Subject|1
5852844|NCT02158936|20237848|P2|Overall Study|Lost to Follow-up|1
5852845|NCT02158936|20237849|P1|Overall Study|Lost to Follow-up|0
5852846|NCT02158936|20237848|P2|Overall Study|Physician Decision|13
5852847|NCT02158936|20237849|P1|Overall Study|Physician Decision|15
5852848|NCT02158936|20237848|P2|Overall Study|Withdrawal by Subject|16
5852849|NCT02158936|20237849|P1|Overall Study|Withdrawal by Subject|15
5852850|NCT02158936|20237848|P2|Overall Study|Adverse Event|24
5852851|NCT02158936|20237849|P1|Overall Study|Adverse Event|39
5852852|NCT02158936|20237848|P2|Overall Study|Azacitidine tx discontinued|46
5852853|NCT02158936|20237849|P1|Overall Study|Azacitidine tx discontinued|53
5852854|NCT02158936|20237848|P2|Overall Study|Study closed/ terminated|77
5852855|NCT02158936|20237849|P1|Overall Study|Study closed/ terminated|57
5852856|NCT02158884|20237891|P1|12 Month Assessment|Missed SMFA|17
5852857|NCT02158884|20237891|P1|6 Month Assessment|Missed SMFA|20
5852858|NCT02158884|20237891|P1|Post Intervention (~4 Weeks)|Did not complete performance assessment|10
5852859|NCT02158884|20237891|P1|Intervention: IDEO and PT Program|Did not complete PT intervention|6
5852860|NCT02158884|20237891|P1|Baseline Assessment|Missed SMFA|1
5852861|NCT02158884|20237891|P1|Baseline Assessment|Missed performance assessment|3
5852862|NCT02158806|20237926|P2|Overall Study|Transferred to palliative care|1
5852863|NCT02158806|20237927|P1|Overall Study|Transferred to palliative care|0
5852864|NCT02158806|20237926|P2|Overall Study|Moved out of area|1
5852865|NCT02158806|20237927|P1|Overall Study|Moved out of area|0
5852866|NCT02158806|20237926|P2|Overall Study|Lost to Follow-up|3
5852867|NCT02158806|20237927|P1|Overall Study|Lost to Follow-up|0
5852868|NCT02158806|20237926|P2|Overall Study|Withdrawal by Subject|0
5852869|NCT02158806|20237927|P1|Overall Study|Withdrawal by Subject|2
5852870|NCT02158806|20237926|P2|Overall Study|Death|0
5852871|NCT02158806|20237927|P1|Overall Study|Death|2
5852872|NCT02158728|20237947|P1|Overall Study|no qualified dataset|24
5852873|NCT02158728|20237947|P1|Overall Study|no procedure according to CIP done|3
5852874|NCT02158663|20237953|P2|Overall Study|Withdrawal by Subject|4
5852875|NCT02158663|20237954|P1|Overall Study|Withdrawal by Subject|5
5852876|NCT02158546|20237977|P4|Overall Study|Site Excluded|4
5852877|NCT02158546|20237978|P3|Overall Study|Site Excluded|3
5852878|NCT02158546|20237979|P2|Overall Study|Site Excluded|5
5852879|NCT02158546|20237980|P1|Overall Study|Site Excluded|5
5852880|NCT02158546|20237977|P4|Overall Study|Lost to Follow-up|1
5852881|NCT02158546|20237978|P3|Overall Study|Lost to Follow-up|0
5852882|NCT02158546|20237979|P2|Overall Study|Lost to Follow-up|4
5852883|NCT02158546|20237980|P1|Overall Study|Lost to Follow-up|5
5852884|NCT02158546|20237977|P4|Overall Study|Withdrawal by Subject|0
5852885|NCT02158546|20237978|P3|Overall Study|Withdrawal by Subject|1
5852886|NCT02158546|20237979|P2|Overall Study|Withdrawal by Subject|2
5852887|NCT02158546|20237980|P1|Overall Study|Withdrawal by Subject|6
5852888|NCT02158546|20237977|P4|Overall Study|Adverse Event|0
5852889|NCT02158546|20237978|P3|Overall Study|Adverse Event|0
5852890|NCT02158546|20237979|P2|Overall Study|Adverse Event|2
5852891|NCT02158546|20237980|P1|Overall Study|Adverse Event|2
5852892|NCT02158546|20237977|P4|Overall Study|Lack of Efficacy|0
5852893|NCT02158546|20237978|P3|Overall Study|Lack of Efficacy|0
5852894|NCT02158546|20237979|P2|Overall Study|Lack of Efficacy|1
5852895|NCT02158546|20237980|P1|Overall Study|Lack of Efficacy|1
5852896|NCT02158546|20237977|P4|Overall Study|Failure to meet eligibility criteria|0
5852897|NCT02158546|20237978|P3|Overall Study|Failure to meet eligibility criteria|0
5852898|NCT02158546|20237979|P2|Overall Study|Failure to meet eligibility criteria|1
5852899|NCT02158546|20237980|P1|Overall Study|Failure to meet eligibility criteria|0
5852900|NCT02158546|20237977|P4|Overall Study|Non-compliance|1
5852901|NCT02158546|20237978|P3|Overall Study|Non-compliance|0
5852902|NCT02158546|20237979|P2|Overall Study|Non-compliance|1
5852903|NCT02158546|20237980|P1|Overall Study|Non-compliance|0
5852904|NCT02158546|20237977|P4|Overall Study|Physician Decision|0
5852905|NCT02158546|20237978|P3|Overall Study|Physician Decision|0
5852906|NCT02158546|20237979|P2|Overall Study|Physician Decision|1
5852907|NCT02158546|20237980|P1|Overall Study|Physician Decision|0
5852908|NCT02158533|20237999|P6|Stage 2|Non-adherence with study visits|1
5852909|NCT02158533|20238000|P5|Stage 2|Non-adherence with study visits|0
5852910|NCT02158533|20238001|P4|Stage 2|Non-adherence with study visits|0
5852911|NCT02158533|20238002|P3|Stage 2|Non-adherence with study visits|0
5852912|NCT02158533|20238003|P2|Stage 2|Non-adherence with study visits|0
5852913|NCT02158533|20238004|P1|Stage 2|Non-adherence with study visits|0
5852914|NCT02158533|20237999|P6|Stage 2|Psychiatrist decision to try new tx|0
5852915|NCT02158533|20238000|P5|Stage 2|Psychiatrist decision to try new tx|0
5852916|NCT02158533|20238001|P4|Stage 2|Psychiatrist decision to try new tx|1
5852917|NCT02158533|20238002|P3|Stage 2|Psychiatrist decision to try new tx|0
5852918|NCT02158533|20238003|P2|Stage 2|Psychiatrist decision to try new tx|0
5852919|NCT02158533|20238004|P1|Stage 2|Psychiatrist decision to try new tx|0
5852920|NCT02158533|20237999|P6|Stage 2|Pregnancy|0
5852921|NCT02158533|20238000|P5|Stage 2|Pregnancy|0
5852922|NCT02158533|20238001|P4|Stage 2|Pregnancy|1
5852923|NCT02158533|20238002|P3|Stage 2|Pregnancy|0
5852924|NCT02158533|20238003|P2|Stage 2|Pregnancy|0
5852925|NCT02158533|20238004|P1|Stage 2|Pregnancy|0
5852926|NCT02158533|20237999|P6|Stage 2|Physician Decision|0
5852927|NCT02158533|20238000|P5|Stage 2|Physician Decision|1
5852928|NCT02158533|20238001|P4|Stage 2|Physician Decision|0
5852929|NCT02158533|20238002|P3|Stage 2|Physician Decision|0
5852930|NCT02158533|20238003|P2|Stage 2|Physician Decision|0
5852931|NCT02158533|20238004|P1|Stage 2|Physician Decision|0
5852932|NCT02158533|20237999|P6|Stage 2|Withdrawal by Subject|2
5852933|NCT02158533|20238000|P5|Stage 2|Withdrawal by Subject|1
5852934|NCT02158533|20238001|P4|Stage 2|Withdrawal by Subject|0
5852935|NCT02158533|20238002|P3|Stage 2|Withdrawal by Subject|0
5852936|NCT02158533|20238003|P2|Stage 2|Withdrawal by Subject|0
5852937|NCT02158533|20238004|P1|Stage 2|Withdrawal by Subject|0
5852938|NCT02158533|20237999|P6|Stage 2|Lost to Follow-up|2
5852939|NCT02158533|20238000|P5|Stage 2|Lost to Follow-up|1
5852940|NCT02158533|20238001|P4|Stage 2|Lost to Follow-up|1
5852941|NCT02158533|20238002|P3|Stage 2|Lost to Follow-up|0
5852942|NCT02158533|20238003|P2|Stage 2|Lost to Follow-up|0
5852943|NCT02158533|20238004|P1|Stage 2|Lost to Follow-up|0
5852944|NCT02158533|20237999|P6|Stage 2|Lack of Efficacy|0
5852945|NCT02158533|20238000|P5|Stage 2|Lack of Efficacy|1
5852946|NCT02158533|20238001|P4|Stage 2|Lack of Efficacy|0
5852947|NCT02158533|20238002|P3|Stage 2|Lack of Efficacy|0
5852948|NCT02158533|20238003|P2|Stage 2|Lack of Efficacy|0
5852949|NCT02158533|20238004|P1|Stage 2|Lack of Efficacy|0
5852950|NCT02158533|20237999|P6|Stage 2|Adverse Event|1
5852951|NCT02158533|20238000|P5|Stage 2|Adverse Event|0
5852952|NCT02158533|20238001|P4|Stage 2|Adverse Event|0
5852953|NCT02158533|20238002|P3|Stage 2|Adverse Event|0
5852954|NCT02158533|20238003|P2|Stage 2|Adverse Event|0
5852955|NCT02158533|20238004|P1|Stage 2|Adverse Event|0
5852956|NCT02158533|20237999|P6|Stage 1|Non-compliance with study visits|0
5852957|NCT02158533|20238000|P5|Stage 1|Non-compliance with study visits|0
5852958|NCT02158533|20238001|P4|Stage 1|Non-compliance with study visits|0
5852959|NCT02158533|20238002|P3|Stage 1|Non-compliance with study visits|0
5852960|NCT02158533|20238003|P2|Stage 1|Non-compliance with study visits|0
5852961|NCT02158533|20238004|P1|Stage 1|Non-compliance with study visits|1
5852962|NCT02158533|20237999|P6|Stage 1|Failure to Meet Eligibility Criteria|0
5852963|NCT02158533|20238000|P5|Stage 1|Failure to Meet Eligibility Criteria|0
5852964|NCT02158533|20238001|P4|Stage 1|Failure to Meet Eligibility Criteria|0
5852965|NCT02158533|20238002|P3|Stage 1|Failure to Meet Eligibility Criteria|0
5852966|NCT02158533|20238003|P2|Stage 1|Failure to Meet Eligibility Criteria|1
5852967|NCT02158533|20238004|P1|Stage 1|Failure to Meet Eligibility Criteria|0
5852968|NCT02158533|20237999|P6|Stage 1|Lost to Follow-up|0
5852969|NCT02158533|20238000|P5|Stage 1|Lost to Follow-up|0
5852970|NCT02158533|20238001|P4|Stage 1|Lost to Follow-up|0
5852971|NCT02158533|20238002|P3|Stage 1|Lost to Follow-up|0
5852972|NCT02158533|20238003|P2|Stage 1|Lost to Follow-up|1
5852973|NCT02158533|20238004|P1|Stage 1|Lost to Follow-up|3
5852974|NCT02158533|20237999|P6|Stage 1|Lack of Efficacy|0
5852975|NCT02158533|20238000|P5|Stage 1|Lack of Efficacy|0
5852976|NCT02158533|20238001|P4|Stage 1|Lack of Efficacy|0
5852977|NCT02158533|20238002|P3|Stage 1|Lack of Efficacy|0
5852978|NCT02158533|20238003|P2|Stage 1|Lack of Efficacy|0
5852979|NCT02158533|20238004|P1|Stage 1|Lack of Efficacy|1
5852980|NCT02158533|20237999|P6|Stage 1|Withdrawal by Subject|0
5852981|NCT02158533|20238000|P5|Stage 1|Withdrawal by Subject|0
5852982|NCT02158533|20238001|P4|Stage 1|Withdrawal by Subject|0
5852983|NCT02158533|20238002|P3|Stage 1|Withdrawal by Subject|1
5852984|NCT02158533|20238003|P2|Stage 1|Withdrawal by Subject|2
5852985|NCT02158533|20238004|P1|Stage 1|Withdrawal by Subject|3
5852986|NCT02158533|20237999|P6|Stage 1|Adverse Event|0
5852987|NCT02158533|20238000|P5|Stage 1|Adverse Event|0
5852988|NCT02158533|20238001|P4|Stage 1|Adverse Event|0
5852989|NCT02158533|20238002|P3|Stage 1|Adverse Event|7
5852990|NCT02158533|20238003|P2|Stage 1|Adverse Event|4
5852991|NCT02158533|20238004|P1|Stage 1|Adverse Event|6
5852992|NCT02158442|20238080|P2|Overall Study|Perfusion staff not available|0
5852993|NCT02158442|20238081|P1|Overall Study|Perfusion staff not available|1
5852994|NCT02158442|20238080|P2|Overall Study|Withdrawal by Subject|0
5852995|NCT02158442|20238081|P1|Overall Study|Withdrawal by Subject|1
5852996|NCT02158364|20238087|P1|Overall Study|Protocol Deviation|50
5852997|NCT02158364|20238087|P1|Overall Study|Case report forms uncollected|10
5852998|NCT02158247|20238105|P1|Overall Study|Invisible vocal cords|5
5852999|NCT02158091|20238124|P3|Overall Study|DLT|0
5853000|NCT02158091|20238125|P2|Overall Study|DLT|1
5853001|NCT02158091|20238126|P1|Overall Study|DLT|2
5853002|NCT02158039|20238134|P1|Overall Study|Screen Failure|9
5853003|NCT02158039|20238134|P1|Overall Study|Withdrawal by Subject|1
5853004|NCT02157948|20238141|P2|Overall Study|Decision by Sponsor|1
5853005|NCT02157948|20238142|P1|Overall Study|Decision by Sponsor|0
5853006|NCT02157948|20238141|P2|Overall Study|Protocol Specified Criteria|1
5853007|NCT02157948|20238142|P1|Overall Study|Protocol Specified Criteria|2
5853008|NCT02157948|20238141|P2|Overall Study|Lost to Follow-up|2
5853009|NCT02157948|20238142|P1|Overall Study|Lost to Follow-up|3
5853010|NCT02157948|20238141|P2|Overall Study|Withdrawal by Subject|5
5853011|NCT02157948|20238142|P1|Overall Study|Withdrawal by Subject|4
5853012|NCT02157935|20238154|P2|Overall Study|Adverse Event|5
5853013|NCT02157935|20238155|P1|Overall Study|Adverse Event|3
5853014|NCT02157935|20238154|P2|Overall Study|Death|4
5853015|NCT02157935|20238155|P1|Overall Study|Death|4
5853016|NCT02157935|20238154|P2|Overall Study|Lack of Efficacy|1
5853017|NCT02157935|20238155|P1|Overall Study|Lack of Efficacy|0
5853018|NCT02157935|20238154|P2|Overall Study|Other|12
5853019|NCT02157935|20238155|P1|Overall Study|Other|5
5853020|NCT02157935|20238154|P2|Overall Study|Progressive disease|2
5853021|NCT02157935|20238155|P1|Overall Study|Progressive disease|0
5853022|NCT02157935|20238154|P2|Overall Study|Protocol Violation|0
5853023|NCT02157935|20238155|P1|Overall Study|Protocol Violation|1
5853024|NCT02157935|20238154|P2|Overall Study|Screen failure|2
5853025|NCT02157935|20238155|P1|Overall Study|Screen failure|1
5853026|NCT02157935|20238154|P2|Overall Study|Withdrawal by Subject|39
5853027|NCT02157935|20238155|P1|Overall Study|Withdrawal by Subject|25
5853028|NCT02157883|20238181|P1|Part B: Day 19 to End Part B (AZD9291)|Death|3
5853029|NCT02157883|20238181|P1|Part B: Day 19 to End Part B (AZD9291)|Withdrawal by Subject|1
5853030|NCT02157883|20238181|P1|Part B: Day 19 to End Part B (AZD9291)|Disease progression|15
5853031|NCT02157883|20238181|P1|Part B: Day 19 to End Part B (AZD9291)|Adverse Event|3
5853032|NCT02157883|20238181|P1|Part A: Day 6-18 (AZD9291+Itraconozole)|Adverse Event|1
5853033|NCT02157779|20238212|P2|Overall Study|Legal issue|0
5853034|NCT02157779|20238213|P1|Overall Study|Legal issue|1
5853035|NCT02157779|20238212|P2|Overall Study|Medical|0
5853036|NCT02157779|20238213|P1|Overall Study|Medical|1
5853037|NCT02157779|20238212|P2|Overall Study|Moved|0
5853038|NCT02157779|20238213|P1|Overall Study|Moved|1
5853039|NCT02157779|20238212|P2|Overall Study|No response to outreach after Baseline|1
5853040|NCT02157779|20238213|P1|Overall Study|No response to outreach after Baseline|1
5853041|NCT02157779|20238212|P2|Overall Study|Stopped attending, reason unknown|7
5853042|NCT02157779|20238213|P1|Overall Study|Stopped attending, reason unknown|11
5853043|NCT02157779|20238212|P2|Overall Study|Logistical|3
5853044|NCT02157779|20238213|P1|Overall Study|Logistical|9
5853045|NCT02157519|20238247|P2|Overall Study|Lost to Follow-up|0
5853046|NCT02157519|20238248|P1|Overall Study|Lost to Follow-up|1
5853047|NCT02157519|20238247|P2|Overall Study|Withdrawal by Subject|0
5853048|NCT02157519|20238248|P1|Overall Study|Withdrawal by Subject|7
5853049|NCT02157519|20238247|P2|Overall Study|Death|1
5853050|NCT02157519|20238248|P1|Overall Study|Death|3
5853051|NCT02157506|20238271|P5|Overall Study|Lost to Follow-up|0
5853052|NCT02157506|20238272|P4|Overall Study|Lost to Follow-up|0
5853053|NCT02157506|20238273|P3|Overall Study|Lost to Follow-up|1
5853054|NCT02157506|20238274|P2|Overall Study|Lost to Follow-up|0
5853055|NCT02157506|20238275|P1|Overall Study|Lost to Follow-up|0
5853056|NCT02157506|20238271|P5|Overall Study|Adverse Event|0
5853057|NCT02157506|20238272|P4|Overall Study|Adverse Event|0
5853058|NCT02157506|20238273|P3|Overall Study|Adverse Event|0
5853059|NCT02157506|20238274|P2|Overall Study|Adverse Event|1
5853060|NCT02157506|20238275|P1|Overall Study|Adverse Event|0
5853061|NCT02157376|20238334|P2|Overall Study|Investigator's misjudgement|2
5853062|NCT02157376|20238335|P1|Overall Study|Investigator's misjudgement|1
5853063|NCT02157376|20238334|P2|Overall Study|Not treated|3
5853064|NCT02157376|20238335|P1|Overall Study|Not treated|8
5853065|NCT02157376|20238334|P2|Overall Study|Withdrawal by Subject|8
5853066|NCT02157376|20238335|P1|Overall Study|Withdrawal by Subject|3
5853067|NCT02157376|20238334|P2|Overall Study|Eligibility criteria not fulfilled|1
5853068|NCT02157376|20238335|P1|Overall Study|Eligibility criteria not fulfilled|0
5853069|NCT02157376|20238334|P2|Overall Study|Death|4
5853070|NCT02157376|20238335|P1|Overall Study|Death|10
5853071|NCT02157298|20238345|P2|Overall Study|Withdrawal by Subject|0
5853072|NCT02157298|20238346|P1|Overall Study|Withdrawal by Subject|1
5853073|NCT02157298|20238345|P2|Overall Study|Poor/Non-compliance|0
5853074|NCT02157298|20238346|P1|Overall Study|Poor/Non-compliance|1
5853075|NCT02157298|20238345|P2|Overall Study|Subject no longer meets study criteria|2
5853076|NCT02157298|20238346|P1|Overall Study|Subject no longer meets study criteria|1
5853077|NCT02157298|20238345|P2|Overall Study|Adverse Event|0
5853078|NCT02157298|20238346|P1|Overall Study|Adverse Event|1
5853079|NCT02157116|20238385|P1|Overall Study|Failed Screening|2
5853080|NCT02157116|20238385|P1|Overall Study|Physician Decision|3
5853081|NCT02157116|20238385|P1|Overall Study|Withdrawal by Subject|4
5853082|NCT02156804|20238411|P1|Overall Study|Withdrawal by Subject|1
5853083|NCT02156492|20238453|P3|Period 3|Adverse Event|0
5853084|NCT02156492|20238454|P2|Period 3|Adverse Event|1
5853085|NCT02156492|20238455|P1|Period 3|Adverse Event|0
5853086|NCT02156492|20238453|P3|Period 1|No Reason Given|0
5853087|NCT02156492|20238454|P2|Period 1|No Reason Given|1
5853088|NCT02156492|20238455|P1|Period 1|No Reason Given|0
5853089|NCT02156466|20238481|P5|Overall Study|Quantiferon Positivity|0
5853090|NCT02156466|20238482|P4|Overall Study|Quantiferon Positivity|1
5853091|NCT02156466|20238483|P3|Overall Study|Quantiferon Positivity|0
5853092|NCT02156466|20238484|P2|Overall Study|Quantiferon Positivity|0
5853093|NCT02156466|20238485|P1|Overall Study|Quantiferon Positivity|0
5853094|NCT02156466|20238481|P5|Overall Study|Adverse Event|0
5853095|NCT02156466|20238482|P4|Overall Study|Adverse Event|1
5853096|NCT02156466|20238483|P3|Overall Study|Adverse Event|1
5853097|NCT02156466|20238484|P2|Overall Study|Adverse Event|0
5853098|NCT02156466|20238485|P1|Overall Study|Adverse Event|0
5853099|NCT02156271|20238666|P2|Overall Study|Physician Decision|3
5853100|NCT02156271|20238667|P1|Overall Study|Physician Decision|4
5853101|NCT02156076|20238720|P4|Follow-up Period|Withdrawal by Subject|0
5853102|NCT02156076|20238721|P3|Follow-up Period|Withdrawal by Subject|0
5853103|NCT02156076|20238722|P2|Follow-up Period|Withdrawal by Subject|0
5853104|NCT02156076|20238723|P1|Follow-up Period|Withdrawal by Subject|1
5853105|NCT02156076|20238720|P4|Treatment Period|Adverse Event|1
5853106|NCT02156076|20238721|P3|Treatment Period|Adverse Event|0
5853107|NCT02156076|20238722|P2|Treatment Period|Adverse Event|0
5853108|NCT02156076|20238723|P1|Treatment Period|Adverse Event|0
5853109|NCT02156076|20238720|P4|Treatment Period|Subject request to discontinue treatment|0
5853110|NCT02156076|20238721|P3|Treatment Period|Subject request to discontinue treatment|0
5853111|NCT02156076|20238722|P2|Treatment Period|Subject request to discontinue treatment|1
5853112|NCT02156076|20238723|P1|Treatment Period|Subject request to discontinue treatment|0
5853113|NCT02156076|20238720|P4|Treatment Period|Withdrawal by Subject|0
5853114|NCT02156076|20238721|P3|Treatment Period|Withdrawal by Subject|1
5853115|NCT02156076|20238722|P2|Treatment Period|Withdrawal by Subject|0
5853116|NCT02156076|20238723|P1|Treatment Period|Withdrawal by Subject|0
5853117|NCT02156076|20238720|P4|Treatment Period|Lost to Follow-up|1
5853118|NCT02156076|20238721|P3|Treatment Period|Lost to Follow-up|0
5853119|NCT02156076|20238722|P2|Treatment Period|Lost to Follow-up|0
5853120|NCT02156076|20238723|P1|Treatment Period|Lost to Follow-up|0
5853121|NCT02156076|20238720|P4|Treatment Period|Poor/non-compliance|0
5853122|NCT02156076|20238721|P3|Treatment Period|Poor/non-compliance|0
5853123|NCT02156076|20238722|P2|Treatment Period|Poor/non-compliance|1
5853124|NCT02156076|20238723|P1|Treatment Period|Poor/non-compliance|0
5853125|NCT02156076|20238720|P4|Treatment Period|no longer meets study criteria|0
5853126|NCT02156076|20238721|P3|Treatment Period|no longer meets study criteria|1
5853127|NCT02156076|20238722|P2|Treatment Period|no longer meets study criteria|0
5853128|NCT02156076|20238723|P1|Treatment Period|no longer meets study criteria|0
5853129|NCT02155985|20238780|P3|Overall Study|Lost to Follow-up|0
5853130|NCT02155985|20238781|P2|Overall Study|Lost to Follow-up|0
5853131|NCT02155985|20238782|P1|Overall Study|Lost to Follow-up|1
5853132|NCT02155985|20238780|P3|Overall Study|Withdrawal by Subject|1
5853133|NCT02155985|20238781|P2|Overall Study|Withdrawal by Subject|0
5853134|NCT02155985|20238782|P1|Overall Study|Withdrawal by Subject|0
5853135|NCT02155881|20238849|P2|Overall Study|Inappropriately randomized|2
5853136|NCT02155881|20238850|P1|Overall Study|Inappropriately randomized|2
5853137|NCT02155881|20238849|P2|Overall Study|Withdrawal by Subject|2
5853138|NCT02155881|20238850|P1|Overall Study|Withdrawal by Subject|0
5853139|NCT02155829|20238872|P2|Overall Study|Protocol Violation|0
5853140|NCT02155829|20238873|P1|Overall Study|Protocol Violation|2
5853141|NCT02155829|20238872|P2|Overall Study|Withdrawal by Subject|3
5853142|NCT02155829|20238873|P1|Overall Study|Withdrawal by Subject|3
5853143|NCT02155829|20238872|P2|Overall Study|Adverse Event|0
5853144|NCT02155829|20238873|P1|Overall Study|Adverse Event|1
5853145|NCT02155738|20238895|P4|Overall Study|Missing critical information|1
5853146|NCT02155738|20238896|P3|Overall Study|Missing critical information|0
5853147|NCT02155738|20238897|P2|Overall Study|Missing critical information|0
5853148|NCT02155738|20238898|P1|Overall Study|Missing critical information|1
5853149|NCT02155712|20238935|P2|Primary Objective|Withdrawal by Subject|0
5853150|NCT02155712|20238936|P1|Primary Objective|Withdrawal by Subject|21
5853151|NCT02155712|20238935|P2|Primary Objective|Revision/Removal of Tibial Baseplate|0
5853152|NCT02155712|20238936|P1|Primary Objective|Revision/Removal of Tibial Baseplate|1
5853153|NCT02155712|20238935|P2|Primary Objective|No 2-Year Forms but not Terminated|0
5853154|NCT02155712|20238936|P1|Primary Objective|No 2-Year Forms but not Terminated|13
5853155|NCT02155712|20238935|P2|Primary Objective|Lost to Follow-up|0
5853156|NCT02155712|20238936|P1|Primary Objective|Lost to Follow-up|22
5853157|NCT02155712|20238935|P2|Primary Objective|Death|0
5853158|NCT02155712|20238936|P1|Primary Objective|Death|3
5853159|NCT02155660|20238946|P4|Overall Study|Withdrawal by Subject|21
5853160|NCT02155660|20238947|P3|Overall Study|Withdrawal by Subject|24
5853161|NCT02155660|20238948|P2|Overall Study|Withdrawal by Subject|31
5853162|NCT02155660|20238949|P1|Overall Study|Withdrawal by Subject|28
5853163|NCT02155660|20238946|P4|Overall Study|Death|19
5853164|NCT02155660|20238947|P3|Overall Study|Death|17
5853165|NCT02155660|20238948|P2|Overall Study|Death|19
5853166|NCT02155660|20238949|P1|Overall Study|Death|17
5853167|NCT02155660|20238946|P4|Overall Study|Lost to Follow-up|8
5853168|NCT02155660|20238947|P3|Overall Study|Lost to Follow-up|5
5853169|NCT02155660|20238948|P2|Overall Study|Lost to Follow-up|6
5853170|NCT02155660|20238949|P1|Overall Study|Lost to Follow-up|3
5853171|NCT02155660|20238946|P4|Overall Study|Adverse Event|1
5853172|NCT02155660|20238947|P3|Overall Study|Adverse Event|3
5853173|NCT02155660|20238948|P2|Overall Study|Adverse Event|6
5853174|NCT02155660|20238949|P1|Overall Study|Adverse Event|2
5853175|NCT02155660|20238946|P4|Overall Study|Severe non-compliance|1
5853176|NCT02155660|20238947|P3|Overall Study|Severe non-compliance|0
5853177|NCT02155660|20238948|P2|Overall Study|Severe non-compliance|4
5853178|NCT02155660|20238949|P1|Overall Study|Severe non-compliance|0
5853179|NCT02155660|20238946|P4|Overall Study|Study-specific withdrawal criteria|1
5853180|NCT02155660|20238947|P3|Overall Study|Study-specific withdrawal criteria|1
5853181|NCT02155660|20238948|P2|Overall Study|Study-specific withdrawal criteria|1
5853182|NCT02155660|20238949|P1|Overall Study|Study-specific withdrawal criteria|0
5853183|NCT02155660|20238946|P4|Overall Study|Other Reason|10
5853184|NCT02155660|20238947|P3|Overall Study|Other Reason|10
5853185|NCT02155660|20238948|P2|Overall Study|Other Reason|6
5853186|NCT02155660|20238949|P1|Overall Study|Other Reason|8
5853187|NCT02155647|20239032|P2|Overall Study|Off-Treatment, but follow up ongoing|26
5853188|NCT02155647|20239033|P1|Overall Study|Off-Treatment, but follow up ongoing|15
5853189|NCT02155647|20239032|P2|Overall Study|Still on Treatment|26
5853190|NCT02155647|20239033|P1|Overall Study|Still on Treatment|26
5853191|NCT02155608|20239061|P2|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1
5853192|NCT02155608|20239062|P1|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1
5853193|NCT02155608|20239061|P2|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|1
5853194|NCT02155608|20239062|P1|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|0
5853195|NCT02155322|20239159|P1|Overall Study|Withdrawal by Subject|4
5853196|NCT02155322|20239159|P1|Overall Study|Relapse/Recurrence|8
5853197|NCT02155322|20239159|P1|Overall Study|Physician Decision|1
5853198|NCT02155322|20239159|P1|Overall Study|Adverse Event|1
5853199|NCT02155309|20239166|P3|Overall Study|Protocol Violation|1
5853200|NCT02155309|20239167|P2|Overall Study|Protocol Violation|0
5853201|NCT02155309|20239168|P1|Overall Study|Protocol Violation|0
5853202|NCT02155283|20239175|P1|Overall Study|Protocol Violation|3
5853203|NCT02155283|20239175|P1|Overall Study|Withdrawal by Subject|1
5853204|NCT02155283|20239175|P1|Overall Study|Lost to Follow-up|3
5853205|NCT02154581|20239351|P2|Overall Study|Lost to Follow-up|8
5853206|NCT02154581|20239352|P1|Overall Study|Lost to Follow-up|7
5853207|NCT02154425|20239377|P1|Screening Period|Adverse Event|1
5853208|NCT02154347|20239422|P2|Open-label Period|Withdrawal by Subject|1
5853209|NCT02154347|20239423|P1|Open-label Period|Withdrawal by Subject|0
5853210|NCT02154347|20239422|P2|Open-label Period|Protocol Violation|1
5853211|NCT02154347|20239423|P1|Open-label Period|Protocol Violation|0
5853212|NCT02154347|20239422|P2|Open-label Period|Lack of Efficacy|19
5853213|NCT02154347|20239423|P1|Open-label Period|Lack of Efficacy|4
5853214|NCT02154347|20239422|P2|Open-label Period|Adverse Event|4
5853215|NCT02154347|20239423|P1|Open-label Period|Adverse Event|3
5853216|NCT02154347|20239422|P2|Double-blind Period|Withdrawal by Subject|1
5853217|NCT02154347|20239423|P1|Double-blind Period|Withdrawal by Subject|1
5853218|NCT02154347|20239422|P2|Double-blind Period|Physician Decision|1
5853219|NCT02154347|20239423|P1|Double-blind Period|Physician Decision|0
5853220|NCT02154347|20239422|P2|Double-blind Period|Lack of Efficacy|0
5853221|NCT02154347|20239423|P1|Double-blind Period|Lack of Efficacy|1
5853222|NCT02154347|20239422|P2|Double-blind Period|Adverse Event|2
5853223|NCT02154347|20239423|P1|Double-blind Period|Adverse Event|1
5853224|NCT02154139|20239446|P1|Overall Study|Investigator transferred|3
5853225|NCT02154139|20239446|P1|Overall Study|Other|2
5853226|NCT02154139|20239446|P1|Overall Study|Injection not administered|2
5853227|NCT02154087|20239454|P1|Overall Study|Study Termination|1
5853228|NCT02154061|20239460|P2|Overall Study|enrolled but not vaccinated|0
5853229|NCT02154061|20239461|P1|Overall Study|enrolled but not vaccinated|1
5853230|NCT02154061|20239460|P2|Overall Study|Pregnancy|0
5853231|NCT02154061|20239461|P1|Overall Study|Pregnancy|1
5853232|NCT02153918|20239508|P1|Overall Study|Refused further treatment|1
5853233|NCT02153905|20239519|P2|Overall Study|Death|0
5853234|NCT02153905|20239520|P1|Overall Study|Death|1
5853235|NCT02153827|20239538|P2|Overall Study|Lost to Follow-up|9
5853236|NCT02153827|20239539|P1|Overall Study|Lost to Follow-up|3
5853237|NCT02153788|20239555|P2|Overall Study|Physician Decision|1
5853238|NCT02153788|20239556|P1|Overall Study|Physician Decision|2
5853239|NCT02153736|20239576|P2|Overall Study|Withdrawal by Subject|1
5853240|NCT02153736|20239577|P1|Overall Study|Withdrawal by Subject|0
5853241|NCT02153736|20239576|P2|Overall Study|Death|1
5853242|NCT02153736|20239577|P1|Overall Study|Death|0
5853243|NCT02153736|20239576|P2|Overall Study|Medical status change made ineligible|0
5853244|NCT02153736|20239577|P1|Overall Study|Medical status change made ineligible|1
5853245|NCT02153736|20239576|P2|Overall Study|Lost to Follow-up|0
5853246|NCT02153736|20239577|P1|Overall Study|Lost to Follow-up|1
5853247|NCT02153398|20239804|P5|Overall Study|Adverse Event|0
5853248|NCT02153398|20239805|P4|Overall Study|Adverse Event|1
5853249|NCT02153398|20239806|P3|Overall Study|Adverse Event|1
5853250|NCT02153398|20239807|P2|Overall Study|Adverse Event|0
5853251|NCT02153398|20239808|P1|Overall Study|Adverse Event|0
5853252|NCT02153398|20239804|P5|Overall Study|Withdrawal by Subject|0
5853253|NCT02153398|20239805|P4|Overall Study|Withdrawal by Subject|0
5853254|NCT02153398|20239806|P3|Overall Study|Withdrawal by Subject|0
5853255|NCT02153398|20239807|P2|Overall Study|Withdrawal by Subject|0
5853256|NCT02153398|20239808|P1|Overall Study|Withdrawal by Subject|1
5853257|NCT02153359|20239930|P2|Intervention 2 (1 Month)|Lost to Follow-up|2
5853258|NCT02153359|20239931|P1|Intervention 2 (1 Month)|Lost to Follow-up|0
5853259|NCT02153346|20239965|P1|Overall Study|Lost to Follow-up|11
5853260|NCT02153112|20239982|P10|Overall Study|Reason not Specified|1
5853261|NCT02153112|20239983|P9|Overall Study|Reason not Specified|1
5853262|NCT02153112|20239984|P8|Overall Study|Reason not Specified|0
5853263|NCT02153112|20239985|P7|Overall Study|Reason not Specified|0
5853264|NCT02153112|20239986|P6|Overall Study|Reason not Specified|0
5853265|NCT02153112|20239987|P5|Overall Study|Reason not Specified|0
5853266|NCT02153112|20239988|P4|Overall Study|Reason not Specified|0
5853267|NCT02153112|20239989|P3|Overall Study|Reason not Specified|0
5853268|NCT02153112|20239990|P2|Overall Study|Reason not Specified|0
5853269|NCT02153112|20239991|P1|Overall Study|Reason not Specified|0
5853270|NCT02153112|20239982|P10|Overall Study|Withdrawal by Subject|12
5853271|NCT02153112|20239983|P9|Overall Study|Withdrawal by Subject|13
5853272|NCT02153112|20239984|P8|Overall Study|Withdrawal by Subject|2
5853273|NCT02153112|20239985|P7|Overall Study|Withdrawal by Subject|7
5853274|NCT02153112|20239986|P6|Overall Study|Withdrawal by Subject|1
5853275|NCT02153112|20239987|P5|Overall Study|Withdrawal by Subject|1
5853276|NCT02153112|20239988|P4|Overall Study|Withdrawal by Subject|2
5853277|NCT02153112|20239989|P3|Overall Study|Withdrawal by Subject|2
5853278|NCT02153112|20239990|P2|Overall Study|Withdrawal by Subject|1
5853279|NCT02153112|20239991|P1|Overall Study|Withdrawal by Subject|3
5853280|NCT02153112|20239982|P10|Overall Study|Lost to Follow-up|1
5853281|NCT02153112|20239983|P9|Overall Study|Lost to Follow-up|1
5853282|NCT02153112|20239984|P8|Overall Study|Lost to Follow-up|0
5853283|NCT02153112|20239985|P7|Overall Study|Lost to Follow-up|1
5853284|NCT02153112|20239986|P6|Overall Study|Lost to Follow-up|1
5853285|NCT02153112|20239987|P5|Overall Study|Lost to Follow-up|2
5853286|NCT02153112|20239988|P4|Overall Study|Lost to Follow-up|0
5853287|NCT02153112|20239989|P3|Overall Study|Lost to Follow-up|0
5853288|NCT02153112|20239990|P2|Overall Study|Lost to Follow-up|1
5853289|NCT02153112|20239991|P1|Overall Study|Lost to Follow-up|1
5853290|NCT02153112|20239982|P10|Overall Study|Adverse Event|0
5853291|NCT02153112|20239983|P9|Overall Study|Adverse Event|0
5853292|NCT02153112|20239984|P8|Overall Study|Adverse Event|0
5853293|NCT02153112|20239985|P7|Overall Study|Adverse Event|0
5853294|NCT02153112|20239986|P6|Overall Study|Adverse Event|0
5853295|NCT02153112|20239987|P5|Overall Study|Adverse Event|0
5853296|NCT02153112|20239988|P4|Overall Study|Adverse Event|0
5853297|NCT02153112|20239989|P3|Overall Study|Adverse Event|1
5853298|NCT02153112|20239990|P2|Overall Study|Adverse Event|0
5853299|NCT02153112|20239991|P1|Overall Study|Adverse Event|0
5853300|NCT02153086|20240330|P1|Overall Study|Other|2
5853301|NCT02153086|20240330|P1|Overall Study|Not enrolled >=28 days and <=56 days|2
5853302|NCT02153073|20240344|P1|Overall Study|Protocol Deviation|68
5853303|NCT02153073|20240344|P1|Overall Study|Case Report Forms Uncollected|230
5853304|NCT02152761|20240372|P4|Epoch: Post-treatment Follow-up Epoch|Death|1
5853305|NCT02152761|20240373|P3|Epoch: Post-treatment Follow-up Epoch|Death|0
5853306|NCT02152761|20240374|P2|Epoch: Post-treatment Follow-up Epoch|Death|0
5853307|NCT02152761|20240375|P1|Epoch: Post-treatment Follow-up Epoch|Death|1
5853308|NCT02152761|20240372|P4|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0
5853309|NCT02152761|20240373|P3|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0
5853310|NCT02152761|20240374|P2|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0
5853311|NCT02152761|20240375|P1|Epoch: Post-treatment Follow-up Epoch|Adverse Event|1
5853312|NCT02152761|20240372|P4|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|0
5853313|NCT02152761|20240373|P3|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|0
5853314|NCT02152761|20240374|P2|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|4
5853315|NCT02152761|20240375|P1|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|1
5853316|NCT02152761|20240372|P4|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|1
5853317|NCT02152761|20240373|P3|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|0
5853318|NCT02152761|20240374|P2|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|3
5853319|NCT02152761|20240375|P1|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|1
5853320|NCT02152761|20240372|P4|Epoch: Treatment Epoch|Non-compliance with treatment|0
5853321|NCT02152761|20240373|P3|Epoch: Treatment Epoch|Non-compliance with treatment|0
5853322|NCT02152761|20240374|P2|Epoch: Treatment Epoch|Non-compliance with treatment|1
5853323|NCT02152761|20240375|P1|Epoch: Treatment Epoch|Non-compliance with treatment|1
5853324|NCT02152761|20240372|P4|Epoch: Treatment Epoch|Death|0
5853325|NCT02152761|20240373|P3|Epoch: Treatment Epoch|Death|1
5853326|NCT02152761|20240374|P2|Epoch: Treatment Epoch|Death|3
5853327|NCT02152761|20240375|P1|Epoch: Treatment Epoch|Death|0
5853328|NCT02152761|20240372|P4|Epoch: Treatment Epoch|Adverse Event|2
5853329|NCT02152761|20240373|P3|Epoch: Treatment Epoch|Adverse Event|1
5853330|NCT02152761|20240374|P2|Epoch: Treatment Epoch|Adverse Event|6
5853331|NCT02152761|20240375|P1|Epoch: Treatment Epoch|Adverse Event|3
5853332|NCT02152761|20240372|P4|Epoch: Treatment Epoch|Withdrawal by Subject|5
5853333|NCT02152761|20240373|P3|Epoch: Treatment Epoch|Withdrawal by Subject|3
5853334|NCT02152761|20240374|P2|Epoch: Treatment Epoch|Withdrawal by Subject|8
5853335|NCT02152761|20240375|P1|Epoch: Treatment Epoch|Withdrawal by Subject|7
5853336|NCT02152761|20240372|P4|Epoch: Treatment Epoch|Lost to Follow-up|0
5853337|NCT02152761|20240373|P3|Epoch: Treatment Epoch|Lost to Follow-up|0
5853338|NCT02152761|20240374|P2|Epoch: Treatment Epoch|Lost to Follow-up|2
5853339|NCT02152761|20240375|P1|Epoch: Treatment Epoch|Lost to Follow-up|0
5853340|NCT02152761|20240372|P4|Epoch: Treatment Epoch|Technical problems|1
5853341|NCT02152761|20240373|P3|Epoch: Treatment Epoch|Technical problems|0
5853342|NCT02152761|20240374|P2|Epoch: Treatment Epoch|Technical problems|0
5853343|NCT02152761|20240375|P1|Epoch: Treatment Epoch|Technical problems|0
5853344|NCT02152631|20240415|P2|Overall Study|On Treatment|3
5853345|NCT02152631|20240416|P1|Overall Study|On Treatment|19
5853346|NCT02152631|20240415|P2|Overall Study|Lost to Follow-up|1
5853347|NCT02152631|20240416|P1|Overall Study|Lost to Follow-up|0
5853348|NCT02152631|20240415|P2|Overall Study|Physician Decision|2
5853349|NCT02152631|20240416|P1|Overall Study|Physician Decision|1
5853350|NCT02152631|20240415|P2|Overall Study|Noncompliance with study drug|0
5853351|NCT02152631|20240416|P1|Overall Study|Noncompliance with study drug|1
5853352|NCT02152631|20240415|P2|Overall Study|Withdrawal by Subject|16
5853353|NCT02152631|20240416|P1|Overall Study|Withdrawal by Subject|13
5853354|NCT02152631|20240415|P2|Overall Study|Adverse Event|4
5853355|NCT02152631|20240416|P1|Overall Study|Adverse Event|32
5853356|NCT02152605|20240435|P2|Overall Study|Withdrew consent|2
5853357|NCT02152605|20240436|P1|Overall Study|Withdrew consent|4
5853358|NCT02152605|20240435|P2|Overall Study|Lost to Follow-up|0
5853359|NCT02152605|20240436|P1|Overall Study|Lost to Follow-up|1
5853360|NCT02152605|20240435|P2|Overall Study|Protocol deviation|4
5853361|NCT02152605|20240436|P1|Overall Study|Protocol deviation|1
5853362|NCT02152605|20240435|P2|Overall Study|Lack of Efficacy|4
5853363|NCT02152605|20240436|P1|Overall Study|Lack of Efficacy|7
5853364|NCT02152605|20240435|P2|Overall Study|Adverse Event|8
5853365|NCT02152605|20240436|P1|Overall Study|Adverse Event|6
5853366|NCT02152566|20240446|P1|Overall Study|Withdrawal by Subject|2
5853367|NCT02152566|20240446|P1|Overall Study|Lost to Follow-up|1
5853368|NCT02152384|20240469|P2|Period 1|Adverse Event|1
5853369|NCT02152384|20240470|P1|Period 1|Adverse Event|1
5853370|NCT02152384|20240469|P2|Period 1|Withdrawal by Subject|1
5853371|NCT02152384|20240470|P1|Period 1|Withdrawal by Subject|0
5853372|NCT02152371|20240490|P2|Overall Study|Reason Not Given|1
5853373|NCT02152371|20240491|P1|Overall Study|Reason Not Given|0
5853374|NCT02152371|20240490|P2|Overall Study|Physician Decision|2
5853375|NCT02152371|20240491|P1|Overall Study|Physician Decision|0
5853376|NCT02152371|20240490|P2|Overall Study|Lack of Efficacy|1
5853377|NCT02152371|20240491|P1|Overall Study|Lack of Efficacy|0
5853378|NCT02152371|20240490|P2|Overall Study|Lost to Follow-up|0
5853379|NCT02152371|20240491|P1|Overall Study|Lost to Follow-up|1
5853380|NCT02152371|20240490|P2|Overall Study|Protocol Violation|3
5853381|NCT02152371|20240491|P1|Overall Study|Protocol Violation|2
5853382|NCT02152371|20240490|P2|Overall Study|Withdrawal by Subject|7
5853383|NCT02152371|20240491|P1|Overall Study|Withdrawal by Subject|3
5853384|NCT02152371|20240490|P2|Overall Study|Adverse Event|2
5853385|NCT02152371|20240491|P1|Overall Study|Adverse Event|6
5853390|NCT02152137|20240542|P1|Overall Study|Originally assigned to Arm B|3
5853391|NCT02152137|20240542|P1|Overall Study|Withdrawal by Subject|1
5853392|NCT02152007|20240550|P1|Overall Study|Withdrawal by Subject|1
5853403|NCT02151903|20240630|P2|Overall Study|Progressive disease|1
5853404|NCT02151903|20240631|P1|Overall Study|Progressive disease|2
5853405|NCT02151903|20240630|P2|Overall Study|Withdrawal by Subject|0
5853406|NCT02151903|20240631|P1|Overall Study|Withdrawal by Subject|1
5853407|NCT02151851|20240668|P2|Overall Study|Adverse Event|28
5853408|NCT02151851|20240669|P1|Overall Study|Adverse Event|6
5853409|NCT02151851|20240668|P2|Overall Study|Subject entered into study in error|1
5853410|NCT02151851|20240669|P1|Overall Study|Subject entered into study in error|0
5853411|NCT02151851|20240668|P2|Overall Study|Low compliance to study visits|1
5853412|NCT02151851|20240669|P1|Overall Study|Low compliance to study visits|0
5853413|NCT02151851|20240668|P2|Overall Study|Medical impairment|0
5853414|NCT02151851|20240669|P1|Overall Study|Medical impairment|1
5853415|NCT02151851|20240668|P2|Overall Study|Withdrawal by Subject|5
5853416|NCT02151851|20240669|P1|Overall Study|Withdrawal by Subject|2
5853417|NCT02151851|20240668|P2|Overall Study|Protocol Violation|1
5853418|NCT02151851|20240669|P1|Overall Study|Protocol Violation|0
5853419|NCT02151851|20240668|P2|Overall Study|Lack of Efficacy|94
5853420|NCT02151851|20240669|P1|Overall Study|Lack of Efficacy|67
5853421|NCT02151786|20240681|P1|Overall Study|Unavailability of Information|8
5853422|NCT02151786|20240681|P1|Overall Study|Randomized, not Treated|1
5853423|NCT02151786|20240681|P1|Overall Study|Outside the Contract Period|1
5853424|NCT02151786|20240681|P1|Overall Study|Unavailability of Case Report Form|26
5853425|NCT02151773|20240692|P1|Overall Study|Protocol Deviation|64
5853426|NCT02151682|20240699|P6|Part 2: Observ. Aft. Tapent. Extension|Various other|2
5853427|NCT02151682|20240700|P5|Part 2: Observ. Aft. Tapent. Extension|Various other|0
5853428|NCT02151682|20240701|P4|Part 2: Observ. Aft. Tapent. Extension|Various other|0
5853429|NCT02151682|20240702|P3|Part 2: Observ. Aft. Tapent. Extension|Various other|0
5853430|NCT02151682|20240703|P2|Part 2: Observ. Aft. Tapent. Extension|Various other|0
5853431|NCT02151682|20240704|P1|Part 2: Observ. Aft. Tapent. Extension|Various other|0
5853432|NCT02151682|20240699|P6|Part 2: Observ. Aft. Tapent. Extension|Missing|3
5853433|NCT02151682|20240700|P5|Part 2: Observ. Aft. Tapent. Extension|Missing|0
5853434|NCT02151682|20240701|P4|Part 2: Observ. Aft. Tapent. Extension|Missing|0
5853435|NCT02151682|20240702|P3|Part 2: Observ. Aft. Tapent. Extension|Missing|0
5853436|NCT02151682|20240703|P2|Part 2: Observ. Aft. Tapent. Extension|Missing|0
5853437|NCT02151682|20240704|P1|Part 2: Observ. Aft. Tapent. Extension|Missing|0
5853438|NCT02151682|20240699|P6|Part 2: Observ. Aft. Tapent. Extension|Death|1
5853439|NCT02151682|20240700|P5|Part 2: Observ. Aft. Tapent. Extension|Death|0
5853440|NCT02151682|20240701|P4|Part 2: Observ. Aft. Tapent. Extension|Death|0
5853441|NCT02151682|20240702|P3|Part 2: Observ. Aft. Tapent. Extension|Death|0
5853442|NCT02151682|20240703|P2|Part 2: Observ. Aft. Tapent. Extension|Death|0
5853443|NCT02151682|20240704|P1|Part 2: Observ. Aft. Tapent. Extension|Death|0
5853444|NCT02151682|20240699|P6|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|1
5853445|NCT02151682|20240700|P5|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0
5853446|NCT02151682|20240701|P4|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0
5853447|NCT02151682|20240702|P3|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0
5853448|NCT02151682|20240703|P2|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0
5853449|NCT02151682|20240704|P1|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0
5853450|NCT02151682|20240699|P6|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0
5853451|NCT02151682|20240700|P5|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0
5853452|NCT02151682|20240701|P4|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0
5853453|NCT02151682|20240702|P3|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|1
5853454|NCT02151682|20240703|P2|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0
5853455|NCT02151682|20240704|P1|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0
5853456|NCT02151682|20240699|P6|Part 2: Tapent. Extension or Observation|Various other|0
5853457|NCT02151682|20240700|P5|Part 2: Tapent. Extension or Observation|Various other|0
5853458|NCT02151682|20240701|P4|Part 2: Tapent. Extension or Observation|Various other|0
5853459|NCT02151682|20240702|P3|Part 2: Tapent. Extension or Observation|Various other|6
5853460|NCT02151682|20240703|P2|Part 2: Tapent. Extension or Observation|Various other|0
5853461|NCT02151682|20240704|P1|Part 2: Tapent. Extension or Observation|Various other|0
5853462|NCT02151682|20240699|P6|Part 2: Tapent. Extension or Observation|Missing|0
5853463|NCT02151682|20240700|P5|Part 2: Tapent. Extension or Observation|Missing|0
5853464|NCT02151682|20240701|P4|Part 2: Tapent. Extension or Observation|Missing|1
5853465|NCT02151682|20240702|P3|Part 2: Tapent. Extension or Observation|Missing|0
5853466|NCT02151682|20240703|P2|Part 2: Tapent. Extension or Observation|Missing|0
5853467|NCT02151682|20240704|P1|Part 2: Tapent. Extension or Observation|Missing|0
5853468|NCT02151682|20240699|P6|Part 2: Tapent. Extension or Observation|No need for opioid|0
5853469|NCT02151682|20240700|P5|Part 2: Tapent. Extension or Observation|No need for opioid|0
5853470|NCT02151682|20240701|P4|Part 2: Tapent. Extension or Observation|No need for opioid|0
5853471|NCT02151682|20240702|P3|Part 2: Tapent. Extension or Observation|No need for opioid|13
5853472|NCT02151682|20240703|P2|Part 2: Tapent. Extension or Observation|No need for opioid|0
5853473|NCT02151682|20240704|P1|Part 2: Tapent. Extension or Observation|No need for opioid|0
5853474|NCT02151682|20240699|P6|Part 2: Tapent. Extension or Observation|Protocol Violation|0
5853475|NCT02151682|20240700|P5|Part 2: Tapent. Extension or Observation|Protocol Violation|0
5853476|NCT02151682|20240701|P4|Part 2: Tapent. Extension or Observation|Protocol Violation|0
5853477|NCT02151682|20240702|P3|Part 2: Tapent. Extension or Observation|Protocol Violation|1
5853478|NCT02151682|20240703|P2|Part 2: Tapent. Extension or Observation|Protocol Violation|0
5853479|NCT02151682|20240704|P1|Part 2: Tapent. Extension or Observation|Protocol Violation|0
5853480|NCT02151682|20240699|P6|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0
5853481|NCT02151682|20240700|P5|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0
5853482|NCT02151682|20240701|P4|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0
5853483|NCT02151682|20240702|P3|Part 2: Tapent. Extension or Observation|Lack of Efficacy|3
5853484|NCT02151682|20240703|P2|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0
5853485|NCT02151682|20240704|P1|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0
5853486|NCT02151682|20240699|P6|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0
5853487|NCT02151682|20240700|P5|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0
5853488|NCT02151682|20240701|P4|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1
5853489|NCT02151682|20240702|P3|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1
5853490|NCT02151682|20240703|P2|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0
5853491|NCT02151682|20240704|P1|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0
5853492|NCT02151682|20240699|P6|Part 2: Tapent. Extension or Observation|Death|0
5853493|NCT02151682|20240700|P5|Part 2: Tapent. Extension or Observation|Death|0
5853494|NCT02151682|20240701|P4|Part 2: Tapent. Extension or Observation|Death|2
5853495|NCT02151682|20240702|P3|Part 2: Tapent. Extension or Observation|Death|0
5853496|NCT02151682|20240703|P2|Part 2: Tapent. Extension or Observation|Death|0
5853497|NCT02151682|20240704|P1|Part 2: Tapent. Extension or Observation|Death|0
5853498|NCT02151682|20240699|P6|Part 2: Tapent. Extension or Observation|Adverse Event|0
5853499|NCT02151682|20240700|P5|Part 2: Tapent. Extension or Observation|Adverse Event|0
5853500|NCT02151682|20240701|P4|Part 2: Tapent. Extension or Observation|Adverse Event|0
5853501|NCT02151682|20240702|P3|Part 2: Tapent. Extension or Observation|Adverse Event|3
5853502|NCT02151682|20240703|P2|Part 2: Tapent. Extension or Observation|Adverse Event|0
5853503|NCT02151682|20240704|P1|Part 2: Tapent. Extension or Observation|Adverse Event|0
5853504|NCT02151682|20240699|P6|Part 1: 14 Days Morphine or Tapentadol|Missing|0
5853505|NCT02151682|20240700|P5|Part 1: 14 Days Morphine or Tapentadol|Missing|0
5853506|NCT02151682|20240701|P4|Part 1: 14 Days Morphine or Tapentadol|Missing|0
5853507|NCT02151682|20240702|P3|Part 1: 14 Days Morphine or Tapentadol|Missing|0
5853508|NCT02151682|20240703|P2|Part 1: 14 Days Morphine or Tapentadol|Missing|0
5853509|NCT02151682|20240704|P1|Part 1: 14 Days Morphine or Tapentadol|Missing|1
5853510|NCT02151682|20240699|P6|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0
5853511|NCT02151682|20240700|P5|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0
5853512|NCT02151682|20240701|P4|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0
5853513|NCT02151682|20240702|P3|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0
5853514|NCT02151682|20240703|P2|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1
5853515|NCT02151682|20240704|P1|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1
5853516|NCT02151682|20240699|P6|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0
5853517|NCT02151682|20240700|P5|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0
5853518|NCT02151682|20240701|P4|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0
5853519|NCT02151682|20240702|P3|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0
5853520|NCT02151682|20240703|P2|Part 1: 14 Days Morphine or Tapentadol|Technical problems|1
5853521|NCT02151682|20240704|P1|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0
5853522|NCT02151682|20240699|P6|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0
5853523|NCT02151682|20240700|P5|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0
5853524|NCT02151682|20240701|P4|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0
5853525|NCT02151682|20240702|P3|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0
5853526|NCT02151682|20240703|P2|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|1
5853527|NCT02151682|20240704|P1|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0
5853528|NCT02151682|20240699|P6|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0
5853529|NCT02151682|20240700|P5|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0
5853530|NCT02151682|20240701|P4|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0
5853531|NCT02151682|20240702|P3|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0
5853532|NCT02151682|20240703|P2|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|2
5853533|NCT02151682|20240704|P1|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0
5853534|NCT02151643|20240754|P5|Overall Study|High Ferritin levels|1
5853535|NCT02151643|20240755|P4|Overall Study|High Ferritin levels|2
5853536|NCT02151643|20240756|P3|Overall Study|High Ferritin levels|2
5853537|NCT02151643|20240757|P2|Overall Study|High Ferritin levels|3
5853538|NCT02151643|20240758|P1|Overall Study|High Ferritin levels|3
5853539|NCT02151643|20240754|P5|Overall Study|Hyperphosphataemia|1
5853540|NCT02151643|20240755|P4|Overall Study|Hyperphosphataemia|0
5853541|NCT02151643|20240756|P3|Overall Study|Hyperphosphataemia|0
5853542|NCT02151643|20240757|P2|Overall Study|Hyperphosphataemia|0
5853543|NCT02151643|20240758|P1|Overall Study|Hyperphosphataemia|1
5853544|NCT02151643|20240754|P5|Overall Study|Withdrawal by Subject|1
5853545|NCT02151643|20240755|P4|Overall Study|Withdrawal by Subject|1
5853546|NCT02151643|20240756|P3|Overall Study|Withdrawal by Subject|1
5853547|NCT02151643|20240757|P2|Overall Study|Withdrawal by Subject|1
5853548|NCT02151643|20240758|P1|Overall Study|Withdrawal by Subject|0
5853549|NCT02151643|20240754|P5|Overall Study|Adverse Event|0
5853550|NCT02151643|20240755|P4|Overall Study|Adverse Event|4
5853551|NCT02151643|20240756|P3|Overall Study|Adverse Event|1
5853552|NCT02151643|20240757|P2|Overall Study|Adverse Event|0
5853553|NCT02151643|20240758|P1|Overall Study|Adverse Event|2
5853554|NCT02151591|20240797|P2|Overall Study|Lost to Follow-up|3
5853555|NCT02151591|20240798|P1|Overall Study|Lost to Follow-up|6
5853556|NCT02151461|20240869|P4|Overall Study|Treatment discontinuation|0
5853557|NCT02151461|20240870|P3|Overall Study|Treatment discontinuation|1
5853558|NCT02151461|20240871|P2|Overall Study|Treatment discontinuation|0
5853559|NCT02151461|20240872|P1|Overall Study|Treatment discontinuation|0
5853560|NCT02151461|20240869|P4|Overall Study|Withdrawal by Subject|1
5853561|NCT02151461|20240870|P3|Overall Study|Withdrawal by Subject|1
5853562|NCT02151461|20240871|P2|Overall Study|Withdrawal by Subject|0
5853563|NCT02151461|20240872|P1|Overall Study|Withdrawal by Subject|1
5853564|NCT02151461|20240869|P4|Overall Study|Lost to Follow-up|1
5853565|NCT02151461|20240870|P3|Overall Study|Lost to Follow-up|1
5853566|NCT02151461|20240871|P2|Overall Study|Lost to Follow-up|0
5853567|NCT02151461|20240872|P1|Overall Study|Lost to Follow-up|0
5853568|NCT02151461|20240869|P4|Overall Study|Adverse Event|2
5853569|NCT02151461|20240870|P3|Overall Study|Adverse Event|0
5853570|NCT02151461|20240871|P2|Overall Study|Adverse Event|1
5853571|NCT02151461|20240872|P1|Overall Study|Adverse Event|5
5853572|NCT02151266|20241004|P3|Overall Study|Not able to exercise|4
5853573|NCT02151266|20241005|P2|Overall Study|Not able to exercise|5
5853574|NCT02151266|20241006|P1|Overall Study|Not able to exercise|4
5853575|NCT02151266|20241004|P3|Overall Study|Did NOT receive intervention|2
5853576|NCT02151266|20241005|P2|Overall Study|Did NOT receive intervention|6
5853577|NCT02151266|20241006|P1|Overall Study|Did NOT receive intervention|3
5853578|NCT02151266|20241004|P3|Overall Study|Lost to Follow-up|1
5853579|NCT02151266|20241005|P2|Overall Study|Lost to Follow-up|4
5853580|NCT02151266|20241006|P1|Overall Study|Lost to Follow-up|1
5853581|NCT02151149|20241049|P2|Follow-Up Period|Death|34
5853582|NCT02151149|20241050|P1|Follow-Up Period|Death|37
5853583|NCT02151149|20241049|P2|Follow-Up Period|Lost to Follow-up|3
5853584|NCT02151149|20241050|P1|Follow-Up Period|Lost to Follow-up|2
5853585|NCT02151149|20241049|P2|Treatment Period|Participants randomized but not treated|2
5853586|NCT02151149|20241050|P1|Treatment Period|Participants randomized but not treated|3
5853587|NCT02151149|20241049|P2|Treatment Period|Miscellaneous|7
5853588|NCT02151149|20241050|P1|Treatment Period|Miscellaneous|8
5853589|NCT02151149|20241049|P2|Treatment Period|Withdrawal by Subject|11
5853590|NCT02151149|20241050|P1|Treatment Period|Withdrawal by Subject|13
5853591|NCT02151149|20241049|P2|Treatment Period|Symptomatic Deterioration|10
5853592|NCT02151149|20241050|P1|Treatment Period|Symptomatic Deterioration|2
5853593|NCT02151149|20241049|P2|Treatment Period|Progressive Disease|24
5853594|NCT02151149|20241050|P1|Treatment Period|Progressive Disease|25
5853595|NCT02151149|20241049|P2|Treatment Period|Adverse Event|14
5853596|NCT02151149|20241050|P1|Treatment Period|Adverse Event|17
5853597|NCT02151149|20241049|P2|Treatment Period|Death|3
5853598|NCT02151149|20241050|P1|Treatment Period|Death|2
5853599|NCT02151110|20241082|P8|Overall Study|Lost to Follow-up|2
5853600|NCT02151110|20241083|P7|Overall Study|Lost to Follow-up|0
5853601|NCT02151110|20241084|P6|Overall Study|Lost to Follow-up|0
5853602|NCT02151110|20241085|P5|Overall Study|Lost to Follow-up|0
5853603|NCT02151110|20241086|P4|Overall Study|Lost to Follow-up|0
5853604|NCT02151110|20241087|P3|Overall Study|Lost to Follow-up|0
5853605|NCT02151110|20241088|P2|Overall Study|Lost to Follow-up|0
5853606|NCT02151110|20241089|P1|Overall Study|Lost to Follow-up|0
5853607|NCT02151110|20241082|P8|Overall Study|Withdrawal by Subject|1
5853608|NCT02151110|20241083|P7|Overall Study|Withdrawal by Subject|0
5853609|NCT02151110|20241084|P6|Overall Study|Withdrawal by Subject|0
5853610|NCT02151110|20241085|P5|Overall Study|Withdrawal by Subject|0
5853611|NCT02151110|20241086|P4|Overall Study|Withdrawal by Subject|0
5853612|NCT02151110|20241087|P3|Overall Study|Withdrawal by Subject|0
5853613|NCT02151110|20241088|P2|Overall Study|Withdrawal by Subject|0
5853614|NCT02151110|20241089|P1|Overall Study|Withdrawal by Subject|0
5853615|NCT02151058|20241182|P3|Overall Study|Lost to Follow-up|2
5853616|NCT02151058|20241183|P2|Overall Study|Lost to Follow-up|0
5853617|NCT02151058|20241184|P1|Overall Study|Lost to Follow-up|1
5853618|NCT02151058|20241182|P3|Overall Study|Withdrawal by Subject|3
5853619|NCT02151058|20241183|P2|Overall Study|Withdrawal by Subject|1
5853620|NCT02151058|20241184|P1|Overall Study|Withdrawal by Subject|1
5853621|NCT02150954|20241218|P2|Overall Study|Protocol Violation|0
5853622|NCT02150954|20241219|P1|Overall Study|Protocol Violation|1
5853623|NCT02150863|20241244|P3|Overall Study|Lost to Follow-up|0
5853624|NCT02150863|20241245|P2|Overall Study|Lost to Follow-up|1
5853625|NCT02150863|20241246|P1|Overall Study|Lost to Follow-up|0
5853626|NCT02150343|20241492|P4|Overall Study|Other|2
5853627|NCT02150343|20241493|P3|Overall Study|Other|0
5853628|NCT02150343|20241494|P2|Overall Study|Other|6
5853629|NCT02150343|20241495|P1|Overall Study|Other|2
5853630|NCT02150343|20241492|P4|Overall Study|Lost to Follow-up|3
5853631|NCT02150343|20241493|P3|Overall Study|Lost to Follow-up|2
5853632|NCT02150343|20241494|P2|Overall Study|Lost to Follow-up|4
5853633|NCT02150343|20241495|P1|Overall Study|Lost to Follow-up|4
5853634|NCT02150343|20241492|P4|Overall Study|Withdrawal by Subject|4
5853635|NCT02150343|20241493|P3|Overall Study|Withdrawal by Subject|9
5853636|NCT02150343|20241494|P2|Overall Study|Withdrawal by Subject|10
5853637|NCT02150343|20241495|P1|Overall Study|Withdrawal by Subject|13
5853638|NCT02150343|20241492|P4|Overall Study|Adverse Event|1
5853639|NCT02150343|20241493|P3|Overall Study|Adverse Event|1
5853640|NCT02150343|20241494|P2|Overall Study|Adverse Event|0
5853641|NCT02150343|20241495|P1|Overall Study|Adverse Event|2
5853642|NCT02150213|20241533|P1|Overall Study|Withdrawal by Subject|1
5853643|NCT02150213|20241533|P1|Overall Study|Lost to Follow-up|1
5853644|NCT02150057|20241552|P2|Overall Study|Lost to Follow-up|4
5853645|NCT02150057|20241553|P1|Overall Study|Lost to Follow-up|6
5853646|NCT02149875|20241568|P3|Overall Study|Physician Decision|2
5853647|NCT02149875|20241569|P2|Overall Study|Physician Decision|2
5853648|NCT02149875|20241570|P1|Overall Study|Physician Decision|1
5853649|NCT02149875|20241568|P3|Overall Study|Withdrawal by Subject|2
5853650|NCT02149875|20241569|P2|Overall Study|Withdrawal by Subject|2
5853651|NCT02149875|20241570|P1|Overall Study|Withdrawal by Subject|3
5853652|NCT02149875|20241568|P3|Overall Study|Lost to Follow-up|5
5853653|NCT02149875|20241569|P2|Overall Study|Lost to Follow-up|4
5853654|NCT02149875|20241570|P1|Overall Study|Lost to Follow-up|3
5853655|NCT02149836|20241581|P1|Overall Study|Withdrawal by Subject|1
5853656|NCT02149420|20241608|P3|Open Label VAY736 10 mg/kg Extension|Administrative problems|0
5853657|NCT02149420|20241609|P2|Open Label VAY736 10 mg/kg Extension|Administrative problems|0
5853658|NCT02149420|20241610|P1|Open Label VAY736 10 mg/kg Extension|Administrative problems|1
5853659|NCT02149420|20241608|P3|Core Study|Administrative problems|2
5853660|NCT02149420|20241609|P2|Core Study|Administrative problems|1
5853661|NCT02149420|20241610|P1|Core Study|Administrative problems|0
5853662|NCT02149264|20241686|P1|Overall Study|Protocol Violation|1
5853663|NCT02149264|20241686|P1|Overall Study|Physician Decision|3
5853664|NCT02149264|20241686|P1|Overall Study|Adverse Event|7
5853665|NCT02149264|20241686|P1|Overall Study|Withdrawal by Subject|9
5853666|NCT02149199|20241702|P3|Overall Study|Adverse Event|9
5853667|NCT02149199|20241703|P2|Overall Study|Adverse Event|15
5853668|NCT02149199|20241704|P1|Overall Study|Adverse Event|6
5853669|NCT02149199|20241702|P3|Overall Study|Death|1
5853670|NCT02149199|20241703|P2|Overall Study|Death|0
5853671|NCT02149199|20241704|P1|Overall Study|Death|0
5853672|NCT02149199|20241702|P3|Overall Study|Lost to Follow-up|11
5853673|NCT02149199|20241703|P2|Overall Study|Lost to Follow-up|12
5853674|NCT02149199|20241704|P1|Overall Study|Lost to Follow-up|3
5853675|NCT02149199|20241702|P3|Overall Study|Protocol Violation|15
5853676|NCT02149199|20241703|P2|Overall Study|Protocol Violation|13
5853677|NCT02149199|20241704|P1|Overall Study|Protocol Violation|16
5853678|NCT02149199|20241702|P3|Overall Study|Withdrawal by Subject|77
5853679|NCT02149199|20241703|P2|Overall Study|Withdrawal by Subject|93
5853680|NCT02149199|20241704|P1|Overall Study|Withdrawal by Subject|75
5853681|NCT02149199|20241702|P3|Overall Study|Eligibility criteria not fulfilled|8
5853682|NCT02149199|20241703|P2|Overall Study|Eligibility criteria not fulfilled|14
5853683|NCT02149199|20241704|P1|Overall Study|Eligibility criteria not fulfilled|9
5853684|NCT02149199|20241702|P3|Overall Study|Other|20
5853685|NCT02149199|20241703|P2|Overall Study|Other|25
5853686|NCT02149199|20241704|P1|Overall Study|Other|20
5853687|NCT02149199|20241702|P3|Overall Study|Study specific withdrawal criteria|6
5853688|NCT02149199|20241703|P2|Overall Study|Study specific withdrawal criteria|21
5853689|NCT02149199|20241704|P1|Overall Study|Study specific withdrawal criteria|4
5853690|NCT02149108|20241783|P2|Overall Study|Lost to Follow-up|0
5853691|NCT02149108|20241784|P1|Overall Study|Lost to Follow-up|1
5853692|NCT02149108|20241783|P2|Overall Study|Refusal to continue trial medication|11
5853693|NCT02149108|20241784|P1|Overall Study|Refusal to continue trial medication|15
5853694|NCT02149108|20241783|P2|Overall Study|Other not defined above|2
5853695|NCT02149108|20241784|P1|Overall Study|Other not defined above|0
5853696|NCT02149108|20241783|P2|Overall Study|Other Adverse Event (AE)|18
5853697|NCT02149108|20241784|P1|Overall Study|Other Adverse Event (AE)|8
5853698|NCT02149108|20241783|P2|Overall Study|Worsening/adverse event cancer disease|32
5853699|NCT02149108|20241784|P1|Overall Study|Worsening/adverse event cancer disease|31
5853700|NCT02149108|20241783|P2|Overall Study|Progressive Disease (PD)|318
5853701|NCT02149108|20241784|P1|Overall Study|Progressive Disease (PD)|324
5853702|NCT02149108|20241783|P2|Overall Study|Not treated|2
5853703|NCT02149108|20241784|P1|Overall Study|Not treated|1
5853704|NCT02148952|20241798|P2|Follow-Up|Withdrawal by Subject|48
5853705|NCT02148952|20241799|P1|Follow-Up|Withdrawal by Subject|46
5853706|NCT02148952|20241798|P2|Follow-Up|Lost to Follow-up|231
5853707|NCT02148952|20241799|P1|Follow-Up|Lost to Follow-up|219
5853708|NCT02148952|20241798|P2|Assessing Eligibility and Consent|Did not consent or declined follow-up|1556
5853709|NCT02148952|20241799|P1|Assessing Eligibility and Consent|Did not consent or declined follow-up|1862
5853710|NCT02148952|20241798|P2|Assessing Eligibility and Consent|Were not eligible for inclusion|1591
5853711|NCT02148952|20241799|P1|Assessing Eligibility and Consent|Were not eligible for inclusion|1241
5853712|NCT02148718|20241882|P1|Overall Study|Discontinued Study Prematurely|5
5853713|NCT02148718|20241882|P1|Overall Study|Protocol Violation|26
5853714|NCT02148445|20241930|P2|Overall Study|Death|3
5853715|NCT02148445|20241931|P1|Overall Study|Death|1
5853716|NCT02148250|20241982|P2|Screening|Withdrawal by Subject|0
5853717|NCT02148250|20241983|P1|Screening|Withdrawal by Subject|5
5853718|NCT02148211|20241997|P1|Overall Study|Lost to Follow-up|352
5853719|NCT02148133|20242006|P1|Overall Study|Protocol-defined stopping criteria|2
5853720|NCT02148133|20242006|P1|Overall Study|Protocol deviation|1
5853721|NCT02148133|20242006|P1|Overall Study|Lack of Efficacy|1
5853722|NCT02148133|20242006|P1|Overall Study|Investigator discretion|1
5853723|NCT02147691|20242155|P2|Overall Study|Lost to Follow-up|1
5853724|NCT02147691|20242156|P1|Overall Study|Lost to Follow-up|0
5853725|NCT02147691|20242155|P2|Overall Study|Adverse Event|0
5853726|NCT02147691|20242156|P1|Overall Study|Adverse Event|2
5853727|NCT02147691|20242155|P2|Overall Study|Withdrawal by Subject|0
5853728|NCT02147691|20242156|P1|Overall Study|Withdrawal by Subject|2
5853729|NCT02147587|20242215|P2|Overall Study|Lack of Efficacy|1
5853730|NCT02147587|20242216|P1|Overall Study|Lack of Efficacy|2
5853731|NCT02147587|20242215|P2|Overall Study|Adverse Event|4
5853732|NCT02147587|20242216|P1|Overall Study|Adverse Event|9
5853733|NCT02147561|20242236|P1|Overall Study|Subjects who didn't receive BOTOX|1
5853734|NCT02147561|20242236|P1|Overall Study|Lost to Follow-up|3
5853735|NCT02147353|20242257|P2|Overall Study|medication noncompliance|0
5853736|NCT02147353|20242258|P1|Overall Study|medication noncompliance|3
5853737|NCT02147353|20242257|P2|Overall Study|unable to make visits|0
5853738|NCT02147353|20242258|P1|Overall Study|unable to make visits|4
5853739|NCT02147353|20242257|P2|Overall Study|Lost to Follow-up|0
5853740|NCT02147353|20242258|P1|Overall Study|Lost to Follow-up|2
5853741|NCT02147288|20242291|P10|Overall Study|complications from concurrent hernia rep|0
5853742|NCT02147288|20242292|P9|Overall Study|complications from concurrent hernia rep|0
5853743|NCT02147288|20242293|P8|Overall Study|complications from concurrent hernia rep|0
5853744|NCT02147288|20242294|P7|Overall Study|complications from concurrent hernia rep|0
5853745|NCT02147288|20242295|P6|Overall Study|complications from concurrent hernia rep|0
5853746|NCT02147288|20242296|P5|Overall Study|complications from concurrent hernia rep|0
5853747|NCT02147288|20242297|P4|Overall Study|complications from concurrent hernia rep|0
5853748|NCT02147288|20242298|P3|Overall Study|complications from concurrent hernia rep|0
5853749|NCT02147288|20242299|P2|Overall Study|complications from concurrent hernia rep|1
5853750|NCT02147288|20242300|P1|Overall Study|complications from concurrent hernia rep|0
5853751|NCT02147288|20242291|P10|Overall Study|post-operative hematoma|0
5853752|NCT02147288|20242292|P9|Overall Study|post-operative hematoma|0
5853753|NCT02147288|20242293|P8|Overall Study|post-operative hematoma|0
5853754|NCT02147288|20242294|P7|Overall Study|post-operative hematoma|0
5853755|NCT02147288|20242295|P6|Overall Study|post-operative hematoma|0
5853756|NCT02147288|20242296|P5|Overall Study|post-operative hematoma|0
5853757|NCT02147288|20242297|P4|Overall Study|post-operative hematoma|0
5853758|NCT02147288|20242298|P3|Overall Study|post-operative hematoma|0
5853759|NCT02147288|20242299|P2|Overall Study|post-operative hematoma|1
5853760|NCT02147288|20242300|P1|Overall Study|post-operative hematoma|1
5853761|NCT02147197|20242309|P3|Overall Study|Other Miscellaneous Reasons|3
5853762|NCT02147197|20242310|P2|Overall Study|Other Miscellaneous Reasons|0
5853763|NCT02147197|20242311|P1|Overall Study|Other Miscellaneous Reasons|1
5853764|NCT02147197|20242309|P3|Overall Study|Protocol Violation|3
5853765|NCT02147197|20242310|P2|Overall Study|Protocol Violation|0
5853766|NCT02147197|20242311|P1|Overall Study|Protocol Violation|1
5853767|NCT02147197|20242309|P3|Overall Study|Lost to Follow-up|1
5853768|NCT02147197|20242310|P2|Overall Study|Lost to Follow-up|3
5853769|NCT02147197|20242311|P1|Overall Study|Lost to Follow-up|2
5853770|NCT02147197|20242309|P3|Overall Study|Withdrawal of Consent|2
5853771|NCT02147197|20242310|P2|Overall Study|Withdrawal of Consent|3
5853772|NCT02147197|20242311|P1|Overall Study|Withdrawal of Consent|4
5853773|NCT02147197|20242309|P3|Overall Study|Adverse Event|0
5853774|NCT02147197|20242310|P2|Overall Study|Adverse Event|0
5853775|NCT02147197|20242311|P1|Overall Study|Adverse Event|1
5853776|NCT02147184|20242330|P2|Overall Study|Other|0
5853777|NCT02147184|20242331|P1|Overall Study|Other|1
5853778|NCT02147184|20242330|P2|Overall Study|Physician Decision|2
5853779|NCT02147184|20242331|P1|Overall Study|Physician Decision|0
5853780|NCT02147184|20242330|P2|Overall Study|Moved out of state|3
5853781|NCT02147184|20242331|P1|Overall Study|Moved out of state|3
5853782|NCT02147184|20242330|P2|Overall Study|Pregnancy|0
5853783|NCT02147184|20242331|P1|Overall Study|Pregnancy|6
5853784|NCT02147184|20242330|P2|Overall Study|Study Burden|7
5853785|NCT02147184|20242331|P1|Overall Study|Study Burden|11
5853786|NCT02147184|20242330|P2|Overall Study|Lost to Follow-up|15
5853787|NCT02147184|20242331|P1|Overall Study|Lost to Follow-up|28
5853788|NCT02147158|20242355|P6|Off-Treatment Interval 2|Other Miscellaneous Reasons|1
5853789|NCT02147158|20242356|P5|Off-Treatment Interval 2|Other Miscellaneous Reasons|0
5853790|NCT02147158|20242357|P4|Off-Treatment Interval 2|Other Miscellaneous Reasons|4
5853791|NCT02147158|20242358|P3|Off-Treatment Interval 2|Other Miscellaneous Reasons|1
5853792|NCT02147158|20242359|P2|Off-Treatment Interval 2|Other Miscellaneous Reasons|3
5853793|NCT02147158|20242360|P1|Off-Treatment Interval 2|Other Miscellaneous Reasons|0
5853794|NCT02147158|20242355|P6|Off-Treatment Interval 2|Protocol Violation|0
5853795|NCT02147158|20242356|P5|Off-Treatment Interval 2|Protocol Violation|0
5853796|NCT02147158|20242357|P4|Off-Treatment Interval 2|Protocol Violation|1
5853797|NCT02147158|20242358|P3|Off-Treatment Interval 2|Protocol Violation|0
5853798|NCT02147158|20242359|P2|Off-Treatment Interval 2|Protocol Violation|0
5853799|NCT02147158|20242360|P1|Off-Treatment Interval 2|Protocol Violation|0
5853800|NCT02147158|20242355|P6|Off-Treatment Interval 2|Lost to Follow-up|2
5853801|NCT02147158|20242356|P5|Off-Treatment Interval 2|Lost to Follow-up|2
5853802|NCT02147158|20242357|P4|Off-Treatment Interval 2|Lost to Follow-up|2
5853803|NCT02147158|20242358|P3|Off-Treatment Interval 2|Lost to Follow-up|3
5853804|NCT02147158|20242359|P2|Off-Treatment Interval 2|Lost to Follow-up|0
5853805|NCT02147158|20242360|P1|Off-Treatment Interval 2|Lost to Follow-up|0
5853806|NCT02147158|20242355|P6|Off-Treatment Interval 2|Withdrawal of Consent|1
5853807|NCT02147158|20242356|P5|Off-Treatment Interval 2|Withdrawal of Consent|0
5853808|NCT02147158|20242357|P4|Off-Treatment Interval 2|Withdrawal of Consent|4
5853809|NCT02147158|20242358|P3|Off-Treatment Interval 2|Withdrawal of Consent|5
5853810|NCT02147158|20242359|P2|Off-Treatment Interval 2|Withdrawal of Consent|0
5853811|NCT02147158|20242360|P1|Off-Treatment Interval 2|Withdrawal of Consent|4
5853812|NCT02147158|20242355|P6|Off-Treatment Interval 2|Lack of Efficacy|0
5853813|NCT02147158|20242356|P5|Off-Treatment Interval 2|Lack of Efficacy|0
5853814|NCT02147158|20242357|P4|Off-Treatment Interval 2|Lack of Efficacy|0
5853815|NCT02147158|20242358|P3|Off-Treatment Interval 2|Lack of Efficacy|1
5853816|NCT02147158|20242359|P2|Off-Treatment Interval 2|Lack of Efficacy|1
5853817|NCT02147158|20242360|P1|Off-Treatment Interval 2|Lack of Efficacy|0
5853818|NCT02147158|20242355|P6|Treatment Course 2|Lost to Follow-up|1
5853819|NCT02147158|20242356|P5|Treatment Course 2|Lost to Follow-up|0
5853820|NCT02147158|20242357|P4|Treatment Course 2|Lost to Follow-up|1
5853821|NCT02147158|20242358|P3|Treatment Course 2|Lost to Follow-up|1
5853822|NCT02147158|20242359|P2|Treatment Course 2|Lost to Follow-up|0
5853823|NCT02147158|20242360|P1|Treatment Course 2|Lost to Follow-up|1
5853824|NCT02147158|20242355|P6|Treatment Course 2|Withdrawal of Consent|0
5853825|NCT02147158|20242356|P5|Treatment Course 2|Withdrawal of Consent|0
5853826|NCT02147158|20242357|P4|Treatment Course 2|Withdrawal of Consent|3
5853827|NCT02147158|20242358|P3|Treatment Course 2|Withdrawal of Consent|2
5853828|NCT02147158|20242359|P2|Treatment Course 2|Withdrawal of Consent|1
5853829|NCT02147158|20242360|P1|Treatment Course 2|Withdrawal of Consent|0
5853830|NCT02147158|20242355|P6|Treatment Course 2|Adverse Event|1
5853831|NCT02147158|20242356|P5|Treatment Course 2|Adverse Event|0
5853832|NCT02147158|20242357|P4|Treatment Course 2|Adverse Event|1
5853833|NCT02147158|20242358|P3|Treatment Course 2|Adverse Event|2
5853834|NCT02147158|20242359|P2|Treatment Course 2|Adverse Event|4
5853835|NCT02147158|20242360|P1|Treatment Course 2|Adverse Event|0
5853836|NCT02147158|20242355|P6|Off-Treatment Interval 1|Other Miscellaneous Reasons|0
5853837|NCT02147158|20242356|P5|Off-Treatment Interval 1|Other Miscellaneous Reasons|0
5853838|NCT02147158|20242357|P4|Off-Treatment Interval 1|Other Miscellaneous Reasons|2
5853839|NCT02147158|20242358|P3|Off-Treatment Interval 1|Other Miscellaneous Reasons|3
5853840|NCT02147158|20242359|P2|Off-Treatment Interval 1|Other Miscellaneous Reasons|0
5853841|NCT02147158|20242360|P1|Off-Treatment Interval 1|Other Miscellaneous Reasons|2
5853842|NCT02147158|20242355|P6|Off-Treatment Interval 1|Lack of Efficacy|0
5853843|NCT02147158|20242356|P5|Off-Treatment Interval 1|Lack of Efficacy|1
5853844|NCT02147158|20242357|P4|Off-Treatment Interval 1|Lack of Efficacy|0
5853845|NCT02147158|20242358|P3|Off-Treatment Interval 1|Lack of Efficacy|2
5853846|NCT02147158|20242359|P2|Off-Treatment Interval 1|Lack of Efficacy|0
5853847|NCT02147158|20242360|P1|Off-Treatment Interval 1|Lack of Efficacy|0
5853848|NCT02147158|20242355|P6|Off-Treatment Interval 1|Withdrawal of Consent|3
5853849|NCT02147158|20242356|P5|Off-Treatment Interval 1|Withdrawal of Consent|2
5853850|NCT02147158|20242357|P4|Off-Treatment Interval 1|Withdrawal of Consent|10
5853851|NCT02147158|20242358|P3|Off-Treatment Interval 1|Withdrawal of Consent|5
5853852|NCT02147158|20242359|P2|Off-Treatment Interval 1|Withdrawal of Consent|3
5853853|NCT02147158|20242360|P1|Off-Treatment Interval 1|Withdrawal of Consent|4
5853854|NCT02147158|20242355|P6|Off-Treatment Interval 1|Protocol Violation|0
5853855|NCT02147158|20242356|P5|Off-Treatment Interval 1|Protocol Violation|1
5853856|NCT02147158|20242357|P4|Off-Treatment Interval 1|Protocol Violation|0
5853857|NCT02147158|20242358|P3|Off-Treatment Interval 1|Protocol Violation|2
5853858|NCT02147158|20242359|P2|Off-Treatment Interval 1|Protocol Violation|0
5853859|NCT02147158|20242360|P1|Off-Treatment Interval 1|Protocol Violation|1
5853860|NCT02147158|20242355|P6|Off-Treatment Interval 1|Lost to Follow-up|2
5853861|NCT02147158|20242356|P5|Off-Treatment Interval 1|Lost to Follow-up|4
5853862|NCT02147158|20242357|P4|Off-Treatment Interval 1|Lost to Follow-up|2
5853863|NCT02147158|20242358|P3|Off-Treatment Interval 1|Lost to Follow-up|3
5853864|NCT02147158|20242359|P2|Off-Treatment Interval 1|Lost to Follow-up|1
5853865|NCT02147158|20242360|P1|Off-Treatment Interval 1|Lost to Follow-up|2
5853866|NCT02147158|20242355|P6|Off-Treatment Interval 1|Adverse Event|0
5853867|NCT02147158|20242356|P5|Off-Treatment Interval 1|Adverse Event|0
5853868|NCT02147158|20242357|P4|Off-Treatment Interval 1|Adverse Event|1
5853869|NCT02147158|20242358|P3|Off-Treatment Interval 1|Adverse Event|0
5853870|NCT02147158|20242359|P2|Off-Treatment Interval 1|Adverse Event|0
5853871|NCT02147158|20242360|P1|Off-Treatment Interval 1|Adverse Event|1
5853872|NCT02147158|20242355|P6|Treatment Course 1|Withdrawal of Consent|2
5853873|NCT02147158|20242356|P5|Treatment Course 1|Withdrawal of Consent|3
5853874|NCT02147158|20242357|P4|Treatment Course 1|Withdrawal of Consent|5
5853875|NCT02147158|20242358|P3|Treatment Course 1|Withdrawal of Consent|1
5853876|NCT02147158|20242359|P2|Treatment Course 1|Withdrawal of Consent|1
5853877|NCT02147158|20242360|P1|Treatment Course 1|Withdrawal of Consent|1
5853878|NCT02147158|20242355|P6|Treatment Course 1|Protocol Violation|0
5853879|NCT02147158|20242356|P5|Treatment Course 1|Protocol Violation|0
5853880|NCT02147158|20242357|P4|Treatment Course 1|Protocol Violation|1
5853881|NCT02147158|20242358|P3|Treatment Course 1|Protocol Violation|1
5853882|NCT02147158|20242359|P2|Treatment Course 1|Protocol Violation|0
5853883|NCT02147158|20242360|P1|Treatment Course 1|Protocol Violation|0
5853884|NCT02147158|20242355|P6|Treatment Course 1|Lost to Follow-up|4
5853885|NCT02147158|20242356|P5|Treatment Course 1|Lost to Follow-up|2
5853886|NCT02147158|20242357|P4|Treatment Course 1|Lost to Follow-up|3
5853887|NCT02147158|20242358|P3|Treatment Course 1|Lost to Follow-up|3
5853888|NCT02147158|20242359|P2|Treatment Course 1|Lost to Follow-up|4
5853889|NCT02147158|20242360|P1|Treatment Course 1|Lost to Follow-up|2
5853890|NCT02147158|20242355|P6|Treatment Course 1|Adverse Event|2
5853891|NCT02147158|20242356|P5|Treatment Course 1|Adverse Event|1
5853892|NCT02147158|20242357|P4|Treatment Course 1|Adverse Event|4
5853893|NCT02147158|20242358|P3|Treatment Course 1|Adverse Event|3
5853894|NCT02147158|20242359|P2|Treatment Course 1|Adverse Event|4
5853895|NCT02147158|20242360|P1|Treatment Course 1|Adverse Event|1
5853896|NCT02147132|20242389|P4|Overall Study|Lost to Follow-up|0
5853897|NCT02147132|20242390|P3|Overall Study|Lost to Follow-up|0
5853898|NCT02147132|20242391|P2|Overall Study|Lost to Follow-up|0
5853899|NCT02147132|20242392|P1|Overall Study|Lost to Follow-up|1
5853900|NCT02147093|20242412|P2|Period 2|Protocol Violation|0
5853901|NCT02147093|20242413|P1|Period 2|Protocol Violation|2
5853902|NCT02147093|20242412|P2|Period 1|Lost to Follow-up|1
5853903|NCT02147093|20242413|P1|Period 1|Lost to Follow-up|0
5853904|NCT02147067|20242423|P2|Overall Study|Withdrawal by Subject|2
5853905|NCT02147067|20242424|P1|Overall Study|Withdrawal by Subject|2
5853906|NCT02146833|20242450|P1|Overall Study|No longer consented to study treatment|1
5853907|NCT02146833|20242450|P1|Overall Study|Death|10
5853908|NCT02146599|20242462|P1|Overall Study|Failed to meet inclusion criteria|5
5853909|NCT02146430|20242479|P4|Overall Study|Withdrawal by Subject|34
5853910|NCT02146430|20242480|P3|Overall Study|Withdrawal by Subject|30
5853911|NCT02146430|20242481|P2|Overall Study|Withdrawal by Subject|29
5853912|NCT02146430|20242482|P1|Overall Study|Withdrawal by Subject|27
5853913|NCT02146430|20242479|P4|Overall Study|Reason missing or not reported|5
5853914|NCT02146430|20242480|P3|Overall Study|Reason missing or not reported|4
5853915|NCT02146430|20242481|P2|Overall Study|Reason missing or not reported|3
5853916|NCT02146430|20242482|P1|Overall Study|Reason missing or not reported|2
5853917|NCT02146430|20242479|P4|Overall Study|Adverse Event|49
5853918|NCT02146430|20242480|P3|Overall Study|Adverse Event|32
5853919|NCT02146430|20242481|P2|Overall Study|Adverse Event|40
5853920|NCT02146430|20242482|P1|Overall Study|Adverse Event|20
5853921|NCT02146430|20242479|P4|Overall Study|Lack of Efficacy|5
5853922|NCT02146430|20242480|P3|Overall Study|Lack of Efficacy|8
5853923|NCT02146430|20242481|P2|Overall Study|Lack of Efficacy|11
5853924|NCT02146430|20242482|P1|Overall Study|Lack of Efficacy|13
5853925|NCT02146430|20242479|P4|Overall Study|Protocol Violation|6
5853926|NCT02146430|20242480|P3|Overall Study|Protocol Violation|8
5853927|NCT02146430|20242481|P2|Overall Study|Protocol Violation|4
5853928|NCT02146430|20242482|P1|Overall Study|Protocol Violation|5
5853929|NCT02146365|20242542|P8|Overall Study|Other|0
5853930|NCT02146365|20242543|P7|Overall Study|Other|0
5853931|NCT02146365|20242544|P6|Overall Study|Other|0
5853932|NCT02146365|20242545|P5|Overall Study|Other|0
5853933|NCT02146365|20242546|P4|Overall Study|Other|1
5853934|NCT02146365|20242547|P3|Overall Study|Other|2
5853935|NCT02146365|20242548|P2|Overall Study|Other|0
5853936|NCT02146365|20242549|P1|Overall Study|Other|1
5853937|NCT02146365|20242542|P8|Overall Study|Unable to Comply with Protocol|0
5853938|NCT02146365|20242543|P7|Overall Study|Unable to Comply with Protocol|0
5853939|NCT02146365|20242544|P6|Overall Study|Unable to Comply with Protocol|0
5853940|NCT02146365|20242545|P5|Overall Study|Unable to Comply with Protocol|0
5853941|NCT02146365|20242546|P4|Overall Study|Unable to Comply with Protocol|0
5853942|NCT02146365|20242547|P3|Overall Study|Unable to Comply with Protocol|1
5853943|NCT02146365|20242548|P2|Overall Study|Unable to Comply with Protocol|1
5853944|NCT02146365|20242549|P1|Overall Study|Unable to Comply with Protocol|0
5853945|NCT02146365|20242542|P8|Overall Study|Withdrawal by Subject|0
5853946|NCT02146365|20242543|P7|Overall Study|Withdrawal by Subject|0
5853947|NCT02146365|20242544|P6|Overall Study|Withdrawal by Subject|0
5853948|NCT02146365|20242545|P5|Overall Study|Withdrawal by Subject|1
5853949|NCT02146365|20242546|P4|Overall Study|Withdrawal by Subject|5
5853950|NCT02146365|20242547|P3|Overall Study|Withdrawal by Subject|1
5853951|NCT02146365|20242548|P2|Overall Study|Withdrawal by Subject|2
5853952|NCT02146365|20242549|P1|Overall Study|Withdrawal by Subject|1
5853953|NCT02146365|20242542|P8|Overall Study|Lost to Follow-up|1
5853954|NCT02146365|20242543|P7|Overall Study|Lost to Follow-up|0
5853955|NCT02146365|20242544|P6|Overall Study|Lost to Follow-up|1
5853956|NCT02146365|20242545|P5|Overall Study|Lost to Follow-up|1
5853957|NCT02146365|20242546|P4|Overall Study|Lost to Follow-up|3
5853958|NCT02146365|20242547|P3|Overall Study|Lost to Follow-up|3
5853959|NCT02146365|20242548|P2|Overall Study|Lost to Follow-up|1
5853960|NCT02146365|20242549|P1|Overall Study|Lost to Follow-up|2
5853961|NCT02146352|20242675|P1|Overall Study|Patient entered hospice care|1
5853962|NCT02146352|20242675|P1|Overall Study|Death|1
5853963|NCT02146326|20242693|P4|Overall Study|Unable to complete interview|6
5853964|NCT02146326|20242694|P3|Overall Study|Unable to complete interview|10
5853965|NCT02146326|20242695|P2|Overall Study|Unable to complete interview|0
5853966|NCT02146326|20242696|P1|Overall Study|Unable to complete interview|0
5853967|NCT02146326|20242693|P4|Overall Study|Death|4
5853968|NCT02146326|20242694|P3|Overall Study|Death|4
5853969|NCT02146326|20242695|P2|Overall Study|Death|0
5853970|NCT02146326|20242696|P1|Overall Study|Death|0
5853971|NCT02146326|20242693|P4|Overall Study|Incarcerated|8
5853972|NCT02146326|20242694|P3|Overall Study|Incarcerated|3
5853973|NCT02146326|20242695|P2|Overall Study|Incarcerated|0
5853974|NCT02146326|20242696|P1|Overall Study|Incarcerated|0
5853975|NCT02146326|20242693|P4|Overall Study|Separated from mental health center|0
5853976|NCT02146326|20242694|P3|Overall Study|Separated from mental health center|0
5853977|NCT02146326|20242695|P2|Overall Study|Separated from mental health center|33
5853978|NCT02146326|20242696|P1|Overall Study|Separated from mental health center|23
5853979|NCT02146326|20242693|P4|Overall Study|Withdrawal by Subject|11
5853980|NCT02146326|20242694|P3|Overall Study|Withdrawal by Subject|15
5853981|NCT02146326|20242695|P2|Overall Study|Withdrawal by Subject|1
5853982|NCT02146326|20242696|P1|Overall Study|Withdrawal by Subject|2
5853983|NCT02146326|20242693|P4|Overall Study|Lost to Follow-up|19
5853984|NCT02146326|20242694|P3|Overall Study|Lost to Follow-up|11
5853985|NCT02146326|20242695|P2|Overall Study|Lost to Follow-up|3
5853986|NCT02146326|20242696|P1|Overall Study|Lost to Follow-up|3
5853987|NCT02146274|20242858|P1|Overall Study|Protocol Violation|73
5853988|NCT02146248|20242865|P1|Overall Study|Withdrawal by Subject|2
5853989|NCT02146131|20242875|P2|Overall Study|Physician Decision|56
5853990|NCT02146131|20242876|P1|Overall Study|Physician Decision|61
5853991|NCT02146105|20242882|P1|Overall Study|Withdrawal by Subject|5
5853992|NCT02146105|20242882|P1|Overall Study|Adverse Event|1
5853993|NCT02145468|20242933|P2|Overall Study|Withdrawal by Subject|8
5853994|NCT02145468|20242934|P1|Overall Study|Withdrawal by Subject|5
5853995|NCT02145429|20242992|P2|Overall Study|Withdrawal by Subject|3
5853996|NCT02145429|20242993|P1|Overall Study|Withdrawal by Subject|8
5853997|NCT02145429|20242992|P2|Overall Study|Lost to Follow-up|3
5853998|NCT02145429|20242993|P1|Overall Study|Lost to Follow-up|4
5853999|NCT02145429|20242992|P2|Overall Study|Death|5
5854000|NCT02145429|20242993|P1|Overall Study|Death|4
5854001|NCT02145390|20243024|P1|Overall Study|Withdrawal by Subject|1
5854002|NCT02145182|20243073|P2|Overall Study|Withdrawal by Subject|4
5854003|NCT02145182|20243074|P1|Overall Study|Withdrawal by Subject|5
5854004|NCT02145182|20243073|P2|Overall Study|Pre-transplant Withdrawal|2
5854005|NCT02145182|20243074|P1|Overall Study|Pre-transplant Withdrawal|0
5854006|NCT02145182|20243073|P2|Overall Study|Lost to Follow-up|2
5854007|NCT02145182|20243074|P1|Overall Study|Lost to Follow-up|2
5854008|NCT02145182|20243073|P2|Overall Study|Death|7
5854009|NCT02145182|20243074|P1|Overall Study|Death|7
5854010|NCT02145182|20243073|P2|Overall Study|Adverse Event|1
5854011|NCT02145182|20243074|P1|Overall Study|Adverse Event|4
5854012|NCT02145156|20243107|P3|Overall Study|No match to vaccination records|41
5854013|NCT02145156|20243108|P2|Overall Study|No match to vaccination records|52
5854014|NCT02145156|20243109|P1|Overall Study|No match to vaccination records|60
5854015|NCT02145078|20243150|P1|Overall Study|Reason not given|3
5854016|NCT02145078|20243150|P1|Overall Study|Death|1
5854017|NCT02145026|20243167|P1|Overall Study|Physician Decision|4
5854018|NCT02145026|20243167|P1|Overall Study|Withdrawal by Subject|2
5854019|NCT02145026|20243167|P1|Overall Study|Death|4
5854020|NCT02145026|20243167|P1|Overall Study|Adverse Event|2
5854021|NCT02144701|20243198|P2|Overall Study|development of relapse, GVHD or death|3
5854022|NCT02144701|20243199|P1|Overall Study|development of relapse, GVHD or death|9
5854023|NCT02144610|20243226|P2|Overall Study|Other|1
5854024|NCT02144610|20243227|P1|Overall Study|Other|0
5854025|NCT02144610|20243226|P2|Overall Study|Study Discontinuation by Sponsor|14
5854026|NCT02144610|20243227|P1|Overall Study|Study Discontinuation by Sponsor|19
5854027|NCT02144610|20243226|P2|Overall Study|Death|2
5854028|NCT02144610|20243227|P1|Overall Study|Death|2
5854029|NCT02144610|20243226|P2|Overall Study|Withdrawal by Subject|5
5854030|NCT02144610|20243227|P1|Overall Study|Withdrawal by Subject|1
5854031|NCT02144610|20243226|P2|Overall Study|Physician Decision|0
5854032|NCT02144610|20243227|P1|Overall Study|Physician Decision|1
5854033|NCT02144337|20243268|P2|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|0
5854034|NCT02144337|20243269|P1|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|1
5854035|NCT02144337|20243268|P2|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|0
5854036|NCT02144337|20243269|P1|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|2
5854037|NCT02144337|20243268|P2|T2 Follow-up (Post-intervention)|Withdrawal by Subject|0
5854038|NCT02144337|20243269|P1|T2 Follow-up (Post-intervention)|Withdrawal by Subject|1
5854039|NCT02144337|20243268|P2|T2 Follow-up (Post-intervention)|Lost to Follow-up|0
5854040|NCT02144337|20243269|P1|T2 Follow-up (Post-intervention)|Lost to Follow-up|2
5854041|NCT02144337|20243268|P2|T2 Follow-up (Post-intervention)|Lack of Efficacy|1
5854042|NCT02144337|20243269|P1|T2 Follow-up (Post-intervention)|Lack of Efficacy|1
5854043|NCT02144285|20243289|P10|Overall Study|Withdrawal by Subject|0
5854044|NCT02144285|20243290|P9|Overall Study|Withdrawal by Subject|0
5854045|NCT02144285|20243291|P8|Overall Study|Withdrawal by Subject|0
5854046|NCT02144285|20243292|P7|Overall Study|Withdrawal by Subject|0
5854047|NCT02144285|20243293|P6|Overall Study|Withdrawal by Subject|0
5854048|NCT02144285|20243294|P5|Overall Study|Withdrawal by Subject|1
5854049|NCT02144285|20243295|P4|Overall Study|Withdrawal by Subject|0
5854050|NCT02144285|20243296|P3|Overall Study|Withdrawal by Subject|0
5854051|NCT02144285|20243297|P2|Overall Study|Withdrawal by Subject|0
5854052|NCT02144285|20243298|P1|Overall Study|Withdrawal by Subject|0
5854053|NCT02144220|20243424|P1|Overall Study|Protocol Violation|1
5854054|NCT02144220|20243424|P1|Overall Study|Withdrawal by Subject|2
5854055|NCT02144220|20243424|P1|Overall Study|Physician Decision|3
5854056|NCT02144220|20243424|P1|Overall Study|Lack of Efficacy|4
5854057|NCT02144220|20243424|P1|Overall Study|technology incompatibility|9
5854058|NCT02144077|20243443|P2|Overall Study|no visits 7 & 8/no visits after visit 4|0
5854059|NCT02144077|20243444|P1|Overall Study|no visits 7 & 8/no visits after visit 4|2
5854060|NCT02144077|20243443|P2|Overall Study|Death|1
5854061|NCT02144077|20243444|P1|Overall Study|Death|0
5854062|NCT02144077|20243443|P2|Overall Study|Protocol Violation|2
5854063|NCT02144077|20243444|P1|Overall Study|Protocol Violation|1
5854064|NCT02144077|20243443|P2|Overall Study|Lost to Follow-up|2
5854065|NCT02144077|20243444|P1|Overall Study|Lost to Follow-up|2
5854066|NCT02144077|20243443|P2|Overall Study|Adverse Event|3
5854067|NCT02144077|20243444|P1|Overall Study|Adverse Event|2
5854068|NCT02144077|20243443|P2|Overall Study|Withdrawal by Subject|3
5854069|NCT02144077|20243444|P1|Overall Study|Withdrawal by Subject|3
5854070|NCT02144012|20243462|P2|Overall Study|Other|0
5854071|NCT02144012|20243463|P1|Overall Study|Other|3
5854072|NCT02144012|20243462|P2|Overall Study|Study Terminated by Sponsor|12
5854073|NCT02144012|20243463|P1|Overall Study|Study Terminated by Sponsor|18
5854074|NCT02144012|20243462|P2|Overall Study|Withdrawal by Subject|3
5854075|NCT02144012|20243463|P1|Overall Study|Withdrawal by Subject|11
5854076|NCT02144012|20243462|P2|Overall Study|Death|0
5854077|NCT02144012|20243463|P1|Overall Study|Death|1
5854078|NCT02144012|20243462|P2|Overall Study|Adverse Event|0
5854079|NCT02144012|20243463|P1|Overall Study|Adverse Event|1
5854080|NCT02143947|20243504|P2|Overall Study|Lost to Follow-up|2
5854081|NCT02143947|20243505|P1|Overall Study|Lost to Follow-up|4
5854082|NCT02143843|20243517|P1|Overall Study|Withdrawal by Subject|2
5854083|NCT02143843|20243517|P1|Overall Study|Lack of Efficacy|2
5854084|NCT02143843|20243517|P1|Overall Study|Adverse Event|8
5854085|NCT02143778|20243522|P1|Overall Study|Device malfunction|1
5854086|NCT02143778|20243522|P1|Overall Study|Withdrawal by Subject|2
5854087|NCT02143713|20243531|P4|Post-treatment Follow-up (12 Months)|Other|7
5854088|NCT02143713|20243532|P3|Post-treatment Follow-up (12 Months)|Other|7
5854089|NCT02143713|20243533|P2|Post-treatment Follow-up (12 Months)|Other|4
5854090|NCT02143713|20243534|P1|Post-treatment Follow-up (12 Months)|Other|3
5854091|NCT02143713|20243531|P4|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1
5854092|NCT02143713|20243532|P3|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0
5854093|NCT02143713|20243533|P2|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1
5854094|NCT02143713|20243534|P1|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0
5854095|NCT02143713|20243531|P4|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|1
5854096|NCT02143713|20243532|P3|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4
5854097|NCT02143713|20243533|P2|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4
5854098|NCT02143713|20243534|P1|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|2
5854099|NCT02143713|20243531|P4|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8
5854100|NCT02143713|20243532|P3|Post-treatment Follow-up (12 Months)|Lost to Follow-up|11
5854101|NCT02143713|20243533|P2|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8
5854102|NCT02143713|20243534|P1|Post-treatment Follow-up (12 Months)|Lost to Follow-up|3
5854103|NCT02143713|20243531|P4|Post-treatment Follow-up (12 Months)|Adverse Event|0
5854104|NCT02143713|20243532|P3|Post-treatment Follow-up (12 Months)|Adverse Event|1
5854105|NCT02143713|20243533|P2|Post-treatment Follow-up (12 Months)|Adverse Event|0
5854106|NCT02143713|20243534|P1|Post-treatment Follow-up (12 Months)|Adverse Event|0
5854107|NCT02143713|20243531|P4|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|10
5854108|NCT02143713|20243532|P3|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6
5854109|NCT02143713|20243533|P2|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|7
5854110|NCT02143713|20243534|P1|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4
5854111|NCT02143713|20243531|P4|Treatment Period (6 Months)|Lack of Efficacy|1
5854112|NCT02143713|20243532|P3|Treatment Period (6 Months)|Lack of Efficacy|0
5854113|NCT02143713|20243533|P2|Treatment Period (6 Months)|Lack of Efficacy|0
5854114|NCT02143713|20243534|P1|Treatment Period (6 Months)|Lack of Efficacy|1
5854115|NCT02143713|20243531|P4|Treatment Period (6 Months)|Exclusionary Medication|0
5854116|NCT02143713|20243532|P3|Treatment Period (6 Months)|Exclusionary Medication|0
5854117|NCT02143713|20243533|P2|Treatment Period (6 Months)|Exclusionary Medication|0
5854118|NCT02143713|20243534|P1|Treatment Period (6 Months)|Exclusionary Medication|2
5854119|NCT02143713|20243531|P4|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|4
5854120|NCT02143713|20243532|P3|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0
5854121|NCT02143713|20243533|P2|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0
5854122|NCT02143713|20243534|P1|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0
5854123|NCT02143713|20243531|P4|Treatment Period (6 Months)|Other|2
5854124|NCT02143713|20243532|P3|Treatment Period (6 Months)|Other|3
5854125|NCT02143713|20243533|P2|Treatment Period (6 Months)|Other|0
5854126|NCT02143713|20243534|P1|Treatment Period (6 Months)|Other|3
5854127|NCT02143713|20243531|P4|Treatment Period (6 Months)|Non-compliance|3
5854128|NCT02143713|20243532|P3|Treatment Period (6 Months)|Non-compliance|0
5854129|NCT02143713|20243533|P2|Treatment Period (6 Months)|Non-compliance|0
5854130|NCT02143713|20243534|P1|Treatment Period (6 Months)|Non-compliance|1
5854131|NCT02143713|20243531|P4|Treatment Period (6 Months)|Pregnancy|0
5854132|NCT02143713|20243532|P3|Treatment Period (6 Months)|Pregnancy|2
5854133|NCT02143713|20243533|P2|Treatment Period (6 Months)|Pregnancy|2
5854134|NCT02143713|20243534|P1|Treatment Period (6 Months)|Pregnancy|0
5854135|NCT02143713|20243531|P4|Treatment Period (6 Months)|Surgery or Invasive Intervention|2
5854136|NCT02143713|20243532|P3|Treatment Period (6 Months)|Surgery or Invasive Intervention|0
5854137|NCT02143713|20243533|P2|Treatment Period (6 Months)|Surgery or Invasive Intervention|0
5854138|NCT02143713|20243534|P1|Treatment Period (6 Months)|Surgery or Invasive Intervention|2
5854139|NCT02143713|20243531|P4|Treatment Period (6 Months)|Lost to Follow-up|3
5854140|NCT02143713|20243532|P3|Treatment Period (6 Months)|Lost to Follow-up|4
5854141|NCT02143713|20243533|P2|Treatment Period (6 Months)|Lost to Follow-up|0
5854142|NCT02143713|20243534|P1|Treatment Period (6 Months)|Lost to Follow-up|3
5854143|NCT02143713|20243531|P4|Treatment Period (6 Months)|Adverse Event|9
5854144|NCT02143713|20243532|P3|Treatment Period (6 Months)|Adverse Event|8
5854145|NCT02143713|20243533|P2|Treatment Period (6 Months)|Adverse Event|8
5854146|NCT02143713|20243534|P1|Treatment Period (6 Months)|Adverse Event|7
5854147|NCT02143713|20243531|P4|Treatment Period (6 Months)|Withdrawal by Subject|4
5854148|NCT02143713|20243532|P3|Treatment Period (6 Months)|Withdrawal by Subject|5
5854149|NCT02143713|20243533|P2|Treatment Period (6 Months)|Withdrawal by Subject|2
5854150|NCT02143713|20243534|P1|Treatment Period (6 Months)|Withdrawal by Subject|1
5854151|NCT02143583|20243628|P3|Overall Study|husband illness|1
5854152|NCT02143583|20243629|P2|Overall Study|husband illness|0
5854153|NCT02143583|20243630|P1|Overall Study|husband illness|0
5854154|NCT02143583|20243628|P3|Overall Study|Withdrawal by Subject|1
5854155|NCT02143583|20243629|P2|Overall Study|Withdrawal by Subject|0
5854156|NCT02143583|20243630|P1|Overall Study|Withdrawal by Subject|1
5854157|NCT02143141|20243653|P2|Overall Study|pain scores at 24 hours not collected|0
5854158|NCT02143141|20243654|P1|Overall Study|pain scores at 24 hours not collected|1
5854159|NCT02143102|20243666|P2|Overall Study|Lost to Follow-up|0
5854160|NCT02143102|20243667|P1|Overall Study|Lost to Follow-up|11
5854161|NCT02143024|20243677|P2|Overall Study|Withdrawal by Subject|0
5854162|NCT02143024|20243678|P1|Overall Study|Withdrawal by Subject|1
5854163|NCT02143024|20243677|P2|Overall Study|Lost to Follow-up|1
5854164|NCT02143024|20243678|P1|Overall Study|Lost to Follow-up|1
5854165|NCT02142894|20243684|P1|Overall Study|Protocol Violation|8
5854166|NCT02142738|20243690|P2|Overall Study|Ongoing in Study|82
5854167|NCT02142738|20243691|P1|Overall Study|Ongoing in Study|107
5854168|NCT02142738|20243690|P2|Overall Study|Withdrawal by Subject|5
5854169|NCT02142738|20243691|P1|Overall Study|Withdrawal by Subject|5
5854170|NCT02142738|20243690|P2|Overall Study|Progressive Disease|1
5854171|NCT02142738|20243691|P1|Overall Study|Progressive Disease|0
5854172|NCT02142738|20243690|P2|Overall Study|Death|55
5854173|NCT02142738|20243691|P1|Overall Study|Death|33
5854174|NCT02142738|20243690|P2|Overall Study|Adverse Event|8
5854175|NCT02142738|20243691|P1|Overall Study|Adverse Event|9
5854176|NCT02142712|20243704|P4|Overall Study|Lost to Follow-up|0
5854177|NCT02142712|20243705|P3|Overall Study|Lost to Follow-up|1
5854178|NCT02142712|20243706|P2|Overall Study|Lost to Follow-up|1
5854179|NCT02142712|20243707|P1|Overall Study|Lost to Follow-up|1
5854180|NCT02142504|20243735|P3|Overall Study|Reason Not Specified|4
5854181|NCT02142504|20243736|P2|Overall Study|Reason Not Specified|5
5854182|NCT02142504|20243737|P1|Overall Study|Reason Not Specified|4
5854183|NCT02142504|20243735|P3|Overall Study|Physician Decision|3
5854184|NCT02142504|20243736|P2|Overall Study|Physician Decision|1
5854185|NCT02142504|20243737|P1|Overall Study|Physician Decision|0
5854186|NCT02142504|20243735|P3|Overall Study|Pregnancy|2
5854187|NCT02142504|20243736|P2|Overall Study|Pregnancy|4
5854188|NCT02142504|20243737|P1|Overall Study|Pregnancy|4
5854189|NCT02142504|20243735|P3|Overall Study|Withdrawal by Subject|11
5854190|NCT02142504|20243736|P2|Overall Study|Withdrawal by Subject|9
5854191|NCT02142504|20243737|P1|Overall Study|Withdrawal by Subject|7
5854192|NCT02142504|20243735|P3|Overall Study|Lost to Follow-up|17
5854193|NCT02142504|20243736|P2|Overall Study|Lost to Follow-up|19
5854194|NCT02142504|20243737|P1|Overall Study|Lost to Follow-up|12
5854195|NCT02142504|20243735|P3|Overall Study|Adverse Event|4
5854196|NCT02142504|20243736|P2|Overall Study|Adverse Event|3
5854197|NCT02142504|20243737|P1|Overall Study|Adverse Event|2
5854198|NCT02142504|20243735|P3|Overall Study|Protocol Violation|2
5854199|NCT02142504|20243736|P2|Overall Study|Protocol Violation|1
5854200|NCT02142504|20243737|P1|Overall Study|Protocol Violation|2
5854201|NCT02142387|20243825|P2|Overall Study|occurred not at home|2474
5854202|NCT02142387|20243826|P1|Overall Study|occurred not at home|298
5854203|NCT02142387|20243825|P2|Overall Study|incomplete data|9
5854204|NCT02142387|20243826|P1|Overall Study|incomplete data|1
5854205|NCT02142387|20243825|P2|Overall Study|witnessed by paramedic|917
5854206|NCT02142387|20243826|P1|Overall Study|witnessed by paramedic|139
5854207|NCT02142387|20243825|P2|Overall Study|CPR not performed|473
5854208|NCT02142387|20243826|P1|Overall Study|CPR not performed|74
5854209|NCT02142387|20243825|P2|Overall Study|non-cardiac etiology|3431
5854210|NCT02142387|20243826|P1|Overall Study|non-cardiac etiology|504
5854211|NCT02142387|20243825|P2|Overall Study|<19 years old|326
5854212|NCT02142387|20243826|P1|Overall Study|<19 years old|49
5854213|NCT02142283|20243939|P2|Overall Study|Withdrawal by Subject|3
5854214|NCT02142283|20243940|P1|Overall Study|Withdrawal by Subject|1
5854215|NCT02142283|20243939|P2|Overall Study|Death|18
5854216|NCT02142283|20243940|P1|Overall Study|Death|20
5854217|NCT02141997|20244049|P4|Overall Study|Other|0
5854218|NCT02141997|20244050|P3|Overall Study|Other|0
5854219|NCT02141997|20244051|P2|Overall Study|Other|4
5854220|NCT02141997|20244052|P1|Overall Study|Other|1
5854221|NCT02141997|20244049|P4|Overall Study|Withdrew consent|0
5854222|NCT02141997|20244050|P3|Overall Study|Withdrew consent|3
5854223|NCT02141997|20244051|P2|Overall Study|Withdrew consent|0
5854224|NCT02141997|20244052|P1|Overall Study|Withdrew consent|1
5854225|NCT02141997|20244049|P4|Overall Study|Participant noncompliance|0
5854226|NCT02141997|20244050|P3|Overall Study|Participant noncompliance|0
5854227|NCT02141997|20244051|P2|Overall Study|Participant noncompliance|0
5854228|NCT02141997|20244052|P1|Overall Study|Participant noncompliance|1
5854229|NCT02141997|20244049|P4|Overall Study|Adverse Event|1
5854230|NCT02141997|20244050|P3|Overall Study|Adverse Event|0
5854231|NCT02141997|20244051|P2|Overall Study|Adverse Event|2
5854232|NCT02141997|20244052|P1|Overall Study|Adverse Event|0
5854233|NCT02141984|20244090|P1|Overall Study|Lack of Efficacy|2
5854234|NCT02141854|20244109|P6|Treatment Period|Lost to Follow-up|1
5854235|NCT02141854|20244110|P5|Treatment Period|Lost to Follow-up|0
5854236|NCT02141854|20244111|P4|Treatment Period|Lost to Follow-up|1
5854237|NCT02141854|20244112|P3|Treatment Period|Lost to Follow-up|1
5854238|NCT02141854|20244113|P2|Treatment Period|Lost to Follow-up|1
5854239|NCT02141854|20244114|P1|Treatment Period|Lost to Follow-up|0
5854240|NCT02141854|20244109|P6|Treatment Period|Disease progression|18
5854241|NCT02141854|20244110|P5|Treatment Period|Disease progression|0
5854242|NCT02141854|20244111|P4|Treatment Period|Disease progression|3
5854243|NCT02141854|20244112|P3|Treatment Period|Disease progression|1
5854244|NCT02141854|20244113|P2|Treatment Period|Disease progression|2
5854245|NCT02141854|20244114|P1|Treatment Period|Disease progression|0
5854246|NCT02141854|20244109|P6|Treatment Period|Withdrawal by Subject|7
5854247|NCT02141854|20244110|P5|Treatment Period|Withdrawal by Subject|4
5854248|NCT02141854|20244111|P4|Treatment Period|Withdrawal by Subject|3
5854249|NCT02141854|20244112|P3|Treatment Period|Withdrawal by Subject|3
5854250|NCT02141854|20244113|P2|Treatment Period|Withdrawal by Subject|2
5854251|NCT02141854|20244114|P1|Treatment Period|Withdrawal by Subject|0
5854252|NCT02141854|20244109|P6|Treatment Period|Adverse Event|2
5854253|NCT02141854|20244110|P5|Treatment Period|Adverse Event|2
5854254|NCT02141854|20244111|P4|Treatment Period|Adverse Event|0
5854255|NCT02141854|20244112|P3|Treatment Period|Adverse Event|2
5854256|NCT02141854|20244113|P2|Treatment Period|Adverse Event|2
5854257|NCT02141854|20244114|P1|Treatment Period|Adverse Event|0
5854258|NCT02141854|20244109|P6|Treatment Period|Other|2
5854259|NCT02141854|20244110|P5|Treatment Period|Other|1
5854260|NCT02141854|20244111|P4|Treatment Period|Other|0
5854261|NCT02141854|20244112|P3|Treatment Period|Other|2
5854262|NCT02141854|20244113|P2|Treatment Period|Other|1
5854263|NCT02141854|20244114|P1|Treatment Period|Other|0
5854264|NCT02141854|20244109|P6|Treatment Period|Pregnancy|0
5854265|NCT02141854|20244110|P5|Treatment Period|Pregnancy|0
5854266|NCT02141854|20244111|P4|Treatment Period|Pregnancy|0
5854267|NCT02141854|20244112|P3|Treatment Period|Pregnancy|0
5854268|NCT02141854|20244113|P2|Treatment Period|Pregnancy|1
5854269|NCT02141854|20244114|P1|Treatment Period|Pregnancy|0
5854270|NCT02141854|20244109|P6|Treatment Period|Lack of Efficacy|7
5854271|NCT02141854|20244110|P5|Treatment Period|Lack of Efficacy|1
5854272|NCT02141854|20244111|P4|Treatment Period|Lack of Efficacy|1
5854273|NCT02141854|20244112|P3|Treatment Period|Lack of Efficacy|0
5854274|NCT02141854|20244113|P2|Treatment Period|Lack of Efficacy|0
5854275|NCT02141854|20244114|P1|Treatment Period|Lack of Efficacy|0
5854276|NCT02141854|20244109|P6|Treatment Period|Noncompliance|0
5854277|NCT02141854|20244110|P5|Treatment Period|Noncompliance|0
5854278|NCT02141854|20244111|P4|Treatment Period|Noncompliance|1
5854279|NCT02141854|20244112|P3|Treatment Period|Noncompliance|0
5854280|NCT02141854|20244113|P2|Treatment Period|Noncompliance|0
5854281|NCT02141854|20244114|P1|Treatment Period|Noncompliance|0
5854282|NCT02141854|20244109|P6|Treatment Period|Protocol Violation|1
5854283|NCT02141854|20244110|P5|Treatment Period|Protocol Violation|2
5854284|NCT02141854|20244111|P4|Treatment Period|Protocol Violation|2
5854285|NCT02141854|20244112|P3|Treatment Period|Protocol Violation|0
5854286|NCT02141854|20244113|P2|Treatment Period|Protocol Violation|1
5854287|NCT02141854|20244114|P1|Treatment Period|Protocol Violation|0
5854288|NCT02141854|20244109|P6|Run-In Period (Pre-assignment)|Lost to Follow-up|0
5854289|NCT02141854|20244110|P5|Run-In Period (Pre-assignment)|Lost to Follow-up|0
5854290|NCT02141854|20244111|P4|Run-In Period (Pre-assignment)|Lost to Follow-up|0
5854291|NCT02141854|20244112|P3|Run-In Period (Pre-assignment)|Lost to Follow-up|0
5854292|NCT02141854|20244113|P2|Run-In Period (Pre-assignment)|Lost to Follow-up|0
5854293|NCT02141854|20244114|P1|Run-In Period (Pre-assignment)|Lost to Follow-up|6
5854294|NCT02141854|20244109|P6|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
5854295|NCT02141854|20244110|P5|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
5854296|NCT02141854|20244111|P4|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
5854297|NCT02141854|20244112|P3|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
5854298|NCT02141854|20244113|P2|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
5854299|NCT02141854|20244114|P1|Run-In Period (Pre-assignment)|Withdrawal by Subject|9
5854300|NCT02141854|20244109|P6|Run-In Period (Pre-assignment)|Adverse Event|0
5854301|NCT02141854|20244110|P5|Run-In Period (Pre-assignment)|Adverse Event|0
5854302|NCT02141854|20244111|P4|Run-In Period (Pre-assignment)|Adverse Event|0
5854303|NCT02141854|20244112|P3|Run-In Period (Pre-assignment)|Adverse Event|0
5854304|NCT02141854|20244113|P2|Run-In Period (Pre-assignment)|Adverse Event|0
5854305|NCT02141854|20244114|P1|Run-In Period (Pre-assignment)|Adverse Event|10
5854306|NCT02141854|20244109|P6|Run-In Period (Pre-assignment)|Other|0
5854307|NCT02141854|20244110|P5|Run-In Period (Pre-assignment)|Other|0
5854308|NCT02141854|20244111|P4|Run-In Period (Pre-assignment)|Other|0
5854309|NCT02141854|20244112|P3|Run-In Period (Pre-assignment)|Other|0
5854310|NCT02141854|20244113|P2|Run-In Period (Pre-assignment)|Other|0
5854311|NCT02141854|20244114|P1|Run-In Period (Pre-assignment)|Other|14
5854312|NCT02141854|20244109|P6|Run-In Period (Pre-assignment)|Exclusion criteria met|0
5854313|NCT02141854|20244110|P5|Run-In Period (Pre-assignment)|Exclusion criteria met|0
5854314|NCT02141854|20244111|P4|Run-In Period (Pre-assignment)|Exclusion criteria met|0
5854315|NCT02141854|20244112|P3|Run-In Period (Pre-assignment)|Exclusion criteria met|0
5854316|NCT02141854|20244113|P2|Run-In Period (Pre-assignment)|Exclusion criteria met|0
5854317|NCT02141854|20244114|P1|Run-In Period (Pre-assignment)|Exclusion criteria met|14
5854402|NCT02141217|20244493|P1|Overall Study|Surgical Intervention|1
5854318|NCT02141854|20244109|P6|Run-In Period (Pre-assignment)|Randomization criteria not met|0
5854319|NCT02141854|20244110|P5|Run-In Period (Pre-assignment)|Randomization criteria not met|0
5854320|NCT02141854|20244111|P4|Run-In Period (Pre-assignment)|Randomization criteria not met|0
5854321|NCT02141854|20244112|P3|Run-In Period (Pre-assignment)|Randomization criteria not met|0
5854322|NCT02141854|20244113|P2|Run-In Period (Pre-assignment)|Randomization criteria not met|0
5854323|NCT02141854|20244114|P1|Run-In Period (Pre-assignment)|Randomization criteria not met|76
5854324|NCT02141854|20244109|P6|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
5854325|NCT02141854|20244110|P5|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
5854326|NCT02141854|20244111|P4|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
5854327|NCT02141854|20244112|P3|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
5854328|NCT02141854|20244113|P2|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
5854329|NCT02141854|20244114|P1|Run-In Period (Pre-assignment)|Inclusion criteria not met|25
5854330|NCT02141659|20244172|P6|Overall Study|Pretreatment Event/ Adverse Event|1
5854331|NCT02141659|20244173|P5|Overall Study|Pretreatment Event/ Adverse Event|2
5854332|NCT02141659|20244174|P4|Overall Study|Pretreatment Event/ Adverse Event|0
5854333|NCT02141659|20244175|P3|Overall Study|Pretreatment Event/ Adverse Event|0
5854334|NCT02141659|20244176|P2|Overall Study|Pretreatment Event/ Adverse Event|0
5854335|NCT02141659|20244177|P1|Overall Study|Pretreatment Event/ Adverse Event|0
5854336|NCT02141659|20244172|P6|Overall Study|Lack of Efficacy|1
5854337|NCT02141659|20244173|P5|Overall Study|Lack of Efficacy|0
5854338|NCT02141659|20244174|P4|Overall Study|Lack of Efficacy|0
5854339|NCT02141659|20244175|P3|Overall Study|Lack of Efficacy|0
5854340|NCT02141659|20244176|P2|Overall Study|Lack of Efficacy|0
5854341|NCT02141659|20244177|P1|Overall Study|Lack of Efficacy|0
5854342|NCT02141659|20244172|P6|Overall Study|Major Protocol Deviation|0
5854343|NCT02141659|20244173|P5|Overall Study|Major Protocol Deviation|0
5854344|NCT02141659|20244174|P4|Overall Study|Major Protocol Deviation|0
5854345|NCT02141659|20244175|P3|Overall Study|Major Protocol Deviation|0
5854346|NCT02141659|20244176|P2|Overall Study|Major Protocol Deviation|1
5854347|NCT02141659|20244177|P1|Overall Study|Major Protocol Deviation|0
5854348|NCT02141633|20244233|P2|Overall Study|Physician Decision|0
5854349|NCT02141633|20244234|P1|Overall Study|Physician Decision|1
5854350|NCT02141620|20244242|P2|Treatment Condition 1 (7 Days)|Adverse Event|0
5854351|NCT02141620|20244243|P1|Treatment Condition 1 (7 Days)|Adverse Event|1
5854352|NCT02141516|20244335|P3|Overall Study|Other|0
5854353|NCT02141516|20244336|P2|Overall Study|Other|3
5854354|NCT02141516|20244337|P1|Overall Study|Other|0
5854355|NCT02141516|20244335|P3|Overall Study|Lost to Follow-up|0
5854356|NCT02141516|20244336|P2|Overall Study|Lost to Follow-up|1
5854357|NCT02141516|20244337|P1|Overall Study|Lost to Follow-up|0
5854358|NCT02141516|20244335|P3|Overall Study|Adverse Event|0
5854359|NCT02141516|20244336|P2|Overall Study|Adverse Event|1
5854360|NCT02141516|20244337|P1|Overall Study|Adverse Event|0
5854361|NCT02141490|20244388|P3|Overall Study|Screening failures|0
5854362|NCT02141490|20244389|P2|Overall Study|Screening failures|0
5854363|NCT02141490|20244390|P1|Overall Study|Screening failures|4
5854364|NCT02141399|20244435|P1|Overall Study|Failure to meet eligibility criteria|14
5854365|NCT02141399|20244435|P1|Overall Study|Withdrawal by Subject|238
5854366|NCT02141399|20244435|P1|Overall Study|Protocol Violation|38
5854367|NCT02141399|20244435|P1|Overall Study|Pregnancy|3
5854368|NCT02141399|20244435|P1|Overall Study|Physician Decision|17
5854369|NCT02141399|20244435|P1|Overall Study|Other|45
5854370|NCT02141399|20244435|P1|Overall Study|Non-compliance with study drug|18
5854371|NCT02141399|20244435|P1|Overall Study|Lost to Follow-up|151
5854372|NCT02141399|20244435|P1|Overall Study|Lack of Efficacy|62
5854373|NCT02141399|20244435|P1|Overall Study|Adverse Event|158
5854374|NCT02141360|20244441|P3|Overall Study|Study Terminated before Visit|0
5854375|NCT02141360|20244442|P2|Overall Study|Study Terminated before Visit|0
5854376|NCT02141360|20244443|P1|Overall Study|Study Terminated before Visit|1
5854377|NCT02141360|20244441|P3|Overall Study|Withdrawal by Subject|0
5854378|NCT02141360|20244442|P2|Overall Study|Withdrawal by Subject|0
5854379|NCT02141360|20244443|P1|Overall Study|Withdrawal by Subject|6
5854380|NCT02141295|20244454|P3|Overall Study|Withdrawal by Subject|4
5854381|NCT02141295|20244455|P2|Overall Study|Withdrawal by Subject|9
5854382|NCT02141295|20244456|P1|Overall Study|Withdrawal by Subject|0
5854383|NCT02141295|20244454|P3|Overall Study|Reason not specified|10
5854384|NCT02141295|20244455|P2|Overall Study|Reason not specified|9
5854385|NCT02141295|20244456|P1|Overall Study|Reason not specified|0
5854386|NCT02141295|20244454|P3|Overall Study|Progressive disease|50
5854387|NCT02141295|20244455|P2|Overall Study|Progressive disease|32
5854388|NCT02141295|20244456|P1|Overall Study|Progressive disease|3
5854389|NCT02141295|20244454|P3|Overall Study|Non-compliance|0
5854390|NCT02141295|20244455|P2|Overall Study|Non-compliance|1
5854391|NCT02141295|20244456|P1|Overall Study|Non-compliance|0
5854392|NCT02141295|20244454|P3|Overall Study|Study terminated by sponsor|6
5854393|NCT02141295|20244455|P2|Overall Study|Study terminated by sponsor|6
5854394|NCT02141295|20244456|P1|Overall Study|Study terminated by sponsor|0
5854395|NCT02141295|20244454|P3|Overall Study|Physician Decision|14
5854396|NCT02141295|20244455|P2|Overall Study|Physician Decision|19
5854397|NCT02141295|20244456|P1|Overall Study|Physician Decision|2
5854398|NCT02141295|20244454|P3|Overall Study|Adverse Event|11
5854399|NCT02141295|20244455|P2|Overall Study|Adverse Event|18
5854400|NCT02141295|20244456|P1|Overall Study|Adverse Event|1
5854401|NCT02141217|20244492|P2|Overall Study|Surgical Intervention|1
5854403|NCT02141217|20244492|P2|Overall Study|Physician Decision|0
5854404|NCT02141217|20244493|P1|Overall Study|Physician Decision|1
5854405|NCT02141217|20244492|P2|Overall Study|Lost to Follow-up|1
5854406|NCT02141217|20244493|P1|Overall Study|Lost to Follow-up|1
5854407|NCT02141217|20244492|P2|Overall Study|Withdrawal by Subject|0
5854408|NCT02141217|20244493|P1|Overall Study|Withdrawal by Subject|6
5854409|NCT02141217|20244492|P2|Overall Study|Protocol Violation|4
5854410|NCT02141217|20244493|P1|Overall Study|Protocol Violation|1
5854411|NCT02141217|20244492|P2|Overall Study|Adverse Event|2
5854412|NCT02141217|20244493|P1|Overall Study|Adverse Event|1
5854413|NCT02141204|20244513|P2|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|7
5854414|NCT02141204|20244514|P1|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|9
5854415|NCT02141204|20244513|P2|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|5
5854416|NCT02141204|20244514|P1|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3
5854417|NCT02141204|20244513|P2|Overall Study|CONSENT WITHDRAWAL NOT DUE TO AE|2
5854418|NCT02141204|20244514|P1|Overall Study|CONSENT WITHDRAWAL NOT DUE TO AE|1
5854419|NCT02141204|20244513|P2|Overall Study|Lost to Follow-up|1
5854420|NCT02141204|20244514|P1|Overall Study|Lost to Follow-up|2
5854421|NCT02140775|20244572|P2|Overall Study|Withdrawal by Subject|7
5854422|NCT02140775|20244573|P1|Overall Study|Withdrawal by Subject|30
5854423|NCT02140762|20244585|P2|Overall Study|Other|1
5854424|NCT02140762|20244586|P1|Overall Study|Other|0
5854425|NCT02140762|20244585|P2|Overall Study|Withdrawal by Subject|4
5854426|NCT02140762|20244586|P1|Overall Study|Withdrawal by Subject|6
5854427|NCT02140762|20244585|P2|Overall Study|Protocol Violation|1
5854428|NCT02140762|20244586|P1|Overall Study|Protocol Violation|1
5854429|NCT02140762|20244585|P2|Overall Study|Lost to Follow-up|5
5854430|NCT02140762|20244586|P1|Overall Study|Lost to Follow-up|9
5854431|NCT02140762|20244585|P2|Overall Study|Adverse Event|1
5854432|NCT02140762|20244586|P1|Overall Study|Adverse Event|1
5854433|NCT02140645|20244652|P6|Overall Study|Not linked|70896
5854434|NCT02140645|20244653|P5|Overall Study|Not linked|3286
5854435|NCT02140645|20244654|P4|Overall Study|Not linked|13833
5854436|NCT02140645|20244655|P3|Overall Study|Not linked|4236
5854437|NCT02140645|20244656|P2|Overall Study|Not linked|61654
5854438|NCT02140645|20244657|P1|Overall Study|Not linked|5489
5854439|NCT02140567|20244755|P1|Overall Study|Problems with recording equipment|6
5854440|NCT02140411|20244760|P1|Overall Study|Adverse Event|1
5854441|NCT02140164|20244780|P1|Overall Study|Cystoid Macular Edema (CME) resolved|2
5854442|NCT02140060|20244801|P6|Overall Study|Lack of Efficacy|0
5854443|NCT02140060|20244802|P5|Overall Study|Lack of Efficacy|0
5854444|NCT02140060|20244803|P4|Overall Study|Lack of Efficacy|1
5854445|NCT02140060|20244804|P3|Overall Study|Lack of Efficacy|0
5854446|NCT02140060|20244805|P2|Overall Study|Lack of Efficacy|0
5854447|NCT02140060|20244806|P1|Overall Study|Lack of Efficacy|0
5854448|NCT02140060|20244801|P6|Overall Study|Adverse Event|1
5854449|NCT02140060|20244802|P5|Overall Study|Adverse Event|1
5854450|NCT02140060|20244803|P4|Overall Study|Adverse Event|1
5854451|NCT02140060|20244804|P3|Overall Study|Adverse Event|0
5854452|NCT02140060|20244805|P2|Overall Study|Adverse Event|0
5854453|NCT02140060|20244806|P1|Overall Study|Adverse Event|0
5854454|NCT02139982|20244831|P10|Overall Study|Lack of Efficacy|0
5854455|NCT02139982|20244832|P9|Overall Study|Lack of Efficacy|0
5854456|NCT02139982|20244833|P8|Overall Study|Lack of Efficacy|0
5854457|NCT02139982|20244834|P7|Overall Study|Lack of Efficacy|0
5854458|NCT02139982|20244835|P6|Overall Study|Lack of Efficacy|0
5854459|NCT02139982|20244836|P5|Overall Study|Lack of Efficacy|0
5854460|NCT02139982|20244837|P4|Overall Study|Lack of Efficacy|1
5854461|NCT02139982|20244838|P3|Overall Study|Lack of Efficacy|0
5854462|NCT02139982|20244839|P2|Overall Study|Lack of Efficacy|1
5854463|NCT02139982|20244840|P1|Overall Study|Lack of Efficacy|0
5854464|NCT02139943|20244904|P3|Overall Study|eGFR Withdrawal Criteria|1
5854465|NCT02139943|20244905|P2|Overall Study|eGFR Withdrawal Criteria|0
5854466|NCT02139943|20244906|P1|Overall Study|eGFR Withdrawal Criteria|0
5854467|NCT02139943|20244904|P3|Overall Study|Participant in Poor Compliance|1
5854468|NCT02139943|20244905|P2|Overall Study|Participant in Poor Compliance|0
5854469|NCT02139943|20244906|P1|Overall Study|Participant in Poor Compliance|1
5854470|NCT02139943|20244904|P3|Overall Study|Participant wishes to discontinue|0
5854471|NCT02139943|20244905|P2|Overall Study|Participant wishes to discontinue|0
5854472|NCT02139943|20244906|P1|Overall Study|Participant wishes to discontinue|2
5854473|NCT02139943|20244904|P3|Overall Study|Other|1
5854474|NCT02139943|20244905|P2|Overall Study|Other|0
5854475|NCT02139943|20244906|P1|Overall Study|Other|0
5854476|NCT02139943|20244904|P3|Overall Study|Withdrawal by Subject|0
5854477|NCT02139943|20244905|P2|Overall Study|Withdrawal by Subject|3
5854478|NCT02139943|20244906|P1|Overall Study|Withdrawal by Subject|4
5854479|NCT02139943|20244904|P3|Overall Study|Lost to Follow-up|2
5854480|NCT02139943|20244905|P2|Overall Study|Lost to Follow-up|2
5854481|NCT02139943|20244906|P1|Overall Study|Lost to Follow-up|3
5854482|NCT02139943|20244904|P3|Overall Study|Adverse Event|2
5854483|NCT02139943|20244905|P2|Overall Study|Adverse Event|1
5854484|NCT02139943|20244906|P1|Overall Study|Adverse Event|0
5854485|NCT02139826|20244926|P1|Overall Study|Adverse Event|1
5854486|NCT02139644|20244971|P6|Treatment Period|Other|1
5854487|NCT02139644|20244972|P5|Treatment Period|Other|0
5854488|NCT02139644|20244973|P4|Treatment Period|Other|1
5854489|NCT02139644|20244974|P3|Treatment Period|Other|1
5854490|NCT02139644|20244975|P2|Treatment Period|Other|3
5854491|NCT02139644|20244976|P1|Treatment Period|Other|0
5854492|NCT02139644|20244971|P6|Treatment Period|Lack of Efficacy|4
5854493|NCT02139644|20244972|P5|Treatment Period|Lack of Efficacy|1
5854494|NCT02139644|20244973|P4|Treatment Period|Lack of Efficacy|0
5854495|NCT02139644|20244974|P3|Treatment Period|Lack of Efficacy|1
5854496|NCT02139644|20244975|P2|Treatment Period|Lack of Efficacy|0
5854497|NCT02139644|20244976|P1|Treatment Period|Lack of Efficacy|0
5854498|NCT02139644|20244971|P6|Treatment Period|Lost to Follow-up|1
5854499|NCT02139644|20244972|P5|Treatment Period|Lost to Follow-up|1
5854500|NCT02139644|20244973|P4|Treatment Period|Lost to Follow-up|1
5854501|NCT02139644|20244974|P3|Treatment Period|Lost to Follow-up|1
5854502|NCT02139644|20244975|P2|Treatment Period|Lost to Follow-up|0
5854503|NCT02139644|20244976|P1|Treatment Period|Lost to Follow-up|0
5854504|NCT02139644|20244971|P6|Treatment Period|Disease progression|2
5854505|NCT02139644|20244972|P5|Treatment Period|Disease progression|1
5854506|NCT02139644|20244973|P4|Treatment Period|Disease progression|1
5854507|NCT02139644|20244974|P3|Treatment Period|Disease progression|0
5854508|NCT02139644|20244975|P2|Treatment Period|Disease progression|0
5854509|NCT02139644|20244976|P1|Treatment Period|Disease progression|0
5854510|NCT02139644|20244971|P6|Treatment Period|Protocol Violation|1
5854511|NCT02139644|20244972|P5|Treatment Period|Protocol Violation|1
5854512|NCT02139644|20244973|P4|Treatment Period|Protocol Violation|1
5854513|NCT02139644|20244974|P3|Treatment Period|Protocol Violation|0
5854514|NCT02139644|20244975|P2|Treatment Period|Protocol Violation|0
5854515|NCT02139644|20244976|P1|Treatment Period|Protocol Violation|0
5854516|NCT02139644|20244971|P6|Treatment Period|Non-compliance|0
5854517|NCT02139644|20244972|P5|Treatment Period|Non-compliance|0
5854518|NCT02139644|20244973|P4|Treatment Period|Non-compliance|1
5854519|NCT02139644|20244974|P3|Treatment Period|Non-compliance|0
5854520|NCT02139644|20244975|P2|Treatment Period|Non-compliance|0
5854521|NCT02139644|20244976|P1|Treatment Period|Non-compliance|0
5854522|NCT02139644|20244971|P6|Treatment Period|Withdrawal by Subject|2
5854523|NCT02139644|20244972|P5|Treatment Period|Withdrawal by Subject|3
5854524|NCT02139644|20244973|P4|Treatment Period|Withdrawal by Subject|2
5854525|NCT02139644|20244974|P3|Treatment Period|Withdrawal by Subject|2
5854526|NCT02139644|20244975|P2|Treatment Period|Withdrawal by Subject|0
5854527|NCT02139644|20244976|P1|Treatment Period|Withdrawal by Subject|0
5854528|NCT02139644|20244971|P6|Treatment Period|Adverse Event|6
5854529|NCT02139644|20244972|P5|Treatment Period|Adverse Event|1
5854530|NCT02139644|20244973|P4|Treatment Period|Adverse Event|2
5854531|NCT02139644|20244974|P3|Treatment Period|Adverse Event|3
5854532|NCT02139644|20244975|P2|Treatment Period|Adverse Event|0
5854533|NCT02139644|20244976|P1|Treatment Period|Adverse Event|0
5854534|NCT02139644|20244971|P6|Run-In Period (Pre-assignment)|Other|0
5854535|NCT02139644|20244972|P5|Run-In Period (Pre-assignment)|Other|0
5854536|NCT02139644|20244973|P4|Run-In Period (Pre-assignment)|Other|0
5854537|NCT02139644|20244974|P3|Run-In Period (Pre-assignment)|Other|0
5854538|NCT02139644|20244975|P2|Run-In Period (Pre-assignment)|Other|0
5854539|NCT02139644|20244976|P1|Run-In Period (Pre-assignment)|Other|6
5854540|NCT02139644|20244971|P6|Run-In Period (Pre-assignment)|Adverse Event|0
5854541|NCT02139644|20244972|P5|Run-In Period (Pre-assignment)|Adverse Event|0
5854542|NCT02139644|20244973|P4|Run-In Period (Pre-assignment)|Adverse Event|0
5854543|NCT02139644|20244974|P3|Run-In Period (Pre-assignment)|Adverse Event|0
5854544|NCT02139644|20244975|P2|Run-In Period (Pre-assignment)|Adverse Event|0
5854545|NCT02139644|20244976|P1|Run-In Period (Pre-assignment)|Adverse Event|3
5854546|NCT02139644|20244971|P6|Run-In Period (Pre-assignment)|Lost to Follow-up|0
5854547|NCT02139644|20244972|P5|Run-In Period (Pre-assignment)|Lost to Follow-up|0
5854548|NCT02139644|20244973|P4|Run-In Period (Pre-assignment)|Lost to Follow-up|0
5854549|NCT02139644|20244974|P3|Run-In Period (Pre-assignment)|Lost to Follow-up|0
5854550|NCT02139644|20244975|P2|Run-In Period (Pre-assignment)|Lost to Follow-up|0
5854551|NCT02139644|20244976|P1|Run-In Period (Pre-assignment)|Lost to Follow-up|8
5854552|NCT02139644|20244971|P6|Run-In Period (Pre-assignment)|Exclusion criteria met|0
5854553|NCT02139644|20244972|P5|Run-In Period (Pre-assignment)|Exclusion criteria met|0
5854554|NCT02139644|20244973|P4|Run-In Period (Pre-assignment)|Exclusion criteria met|0
5854555|NCT02139644|20244974|P3|Run-In Period (Pre-assignment)|Exclusion criteria met|0
5854556|NCT02139644|20244975|P2|Run-In Period (Pre-assignment)|Exclusion criteria met|0
5854557|NCT02139644|20244976|P1|Run-In Period (Pre-assignment)|Exclusion criteria met|11
5854558|NCT02139644|20244971|P6|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
5854559|NCT02139644|20244972|P5|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
5854560|NCT02139644|20244973|P4|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
5854561|NCT02139644|20244974|P3|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
5854562|NCT02139644|20244975|P2|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
5854563|NCT02139644|20244976|P1|Run-In Period (Pre-assignment)|Withdrawal by Subject|12
5854564|NCT02139644|20244971|P6|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
5854565|NCT02139644|20244972|P5|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
5854566|NCT02139644|20244973|P4|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
5854567|NCT02139644|20244974|P3|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
5854568|NCT02139644|20244975|P2|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
5854569|NCT02139644|20244976|P1|Run-In Period (Pre-assignment)|Inclusion criteria not met|30
5854570|NCT02139644|20244971|P6|Run-In Period (Pre-assignment)|Randomization criteria not met|0
5854571|NCT02139644|20244972|P5|Run-In Period (Pre-assignment)|Randomization criteria not met|0
5854572|NCT02139644|20244973|P4|Run-In Period (Pre-assignment)|Randomization criteria not met|0
5854573|NCT02139644|20244974|P3|Run-In Period (Pre-assignment)|Randomization criteria not met|0
5854574|NCT02139644|20244975|P2|Run-In Period (Pre-assignment)|Randomization criteria not met|0
5854575|NCT02139644|20244976|P1|Run-In Period (Pre-assignment)|Randomization criteria not met|70
5854576|NCT02139592|20245028|P1|Overall Study|Case Report Forms Uncollected|8
5854577|NCT02139306|20245054|P2|Overall Study|Protocol Violation|0
5854578|NCT02139306|20245055|P1|Overall Study|Protocol Violation|4
5854579|NCT02139306|20245054|P2|Overall Study|Other Unspecified|3
5854580|NCT02139306|20245055|P1|Overall Study|Other Unspecified|2
5854581|NCT02139306|20245054|P2|Overall Study|Physician Decision|1
5854582|NCT02139306|20245055|P1|Overall Study|Physician Decision|0
5854583|NCT02139306|20245054|P2|Overall Study|Adverse Event|4
5854584|NCT02139306|20245055|P1|Overall Study|Adverse Event|3
5854585|NCT02139306|20245054|P2|Overall Study|Withdrawal by Subject|6
5854586|NCT02139306|20245055|P1|Overall Study|Withdrawal by Subject|4
5854587|NCT02139124|20245125|P5|Overall Study|Lost to Follow-up|4
5854588|NCT02139124|20245126|P4|Overall Study|Lost to Follow-up|5
5854589|NCT02139124|20245127|P3|Overall Study|Lost to Follow-up|0
5854590|NCT02139124|20245128|P2|Overall Study|Lost to Follow-up|2
5854591|NCT02139124|20245129|P1|Overall Study|Lost to Follow-up|3
5854592|NCT02139124|20245125|P5|Overall Study|subject moved|0
5854593|NCT02139124|20245126|P4|Overall Study|subject moved|0
5854594|NCT02139124|20245127|P3|Overall Study|subject moved|0
5854595|NCT02139124|20245128|P2|Overall Study|subject moved|0
5854596|NCT02139124|20245129|P1|Overall Study|subject moved|1
5854597|NCT02139124|20245125|P5|Overall Study|incarceration|0
5854598|NCT02139124|20245126|P4|Overall Study|incarceration|0
5854599|NCT02139124|20245127|P3|Overall Study|incarceration|1
5854600|NCT02139124|20245128|P2|Overall Study|incarceration|0
5854601|NCT02139124|20245129|P1|Overall Study|incarceration|0
5854602|NCT02139124|20245125|P5|Overall Study|non-compliant|0
5854603|NCT02139124|20245126|P4|Overall Study|non-compliant|2
5854604|NCT02139124|20245127|P3|Overall Study|non-compliant|0
5854605|NCT02139124|20245128|P2|Overall Study|non-compliant|0
5854606|NCT02139124|20245129|P1|Overall Study|non-compliant|1
5854607|NCT02139124|20245125|P5|Overall Study|Protocol Violation|1
5854608|NCT02139124|20245126|P4|Overall Study|Protocol Violation|1
5854609|NCT02139124|20245127|P3|Overall Study|Protocol Violation|0
5854610|NCT02139124|20245128|P2|Overall Study|Protocol Violation|0
5854611|NCT02139124|20245129|P1|Overall Study|Protocol Violation|0
5854612|NCT02139124|20245125|P5|Overall Study|Withdrawal by Subject|3
5854613|NCT02139124|20245126|P4|Overall Study|Withdrawal by Subject|2
5854614|NCT02139124|20245127|P3|Overall Study|Withdrawal by Subject|2
5854615|NCT02139124|20245128|P2|Overall Study|Withdrawal by Subject|2
5854616|NCT02139124|20245129|P1|Overall Study|Withdrawal by Subject|2
5854617|NCT02139124|20245125|P5|Overall Study|Adverse Event|5
5854618|NCT02139124|20245126|P4|Overall Study|Adverse Event|2
5854619|NCT02139124|20245127|P3|Overall Study|Adverse Event|1
5854620|NCT02139124|20245128|P2|Overall Study|Adverse Event|0
5854621|NCT02139124|20245129|P1|Overall Study|Adverse Event|2
5854622|NCT02139046|20245146|P5|Overall Study|Other Miscellaneous Reasons|12
5854623|NCT02139046|20245147|P4|Overall Study|Other Miscellaneous Reasons|9
5854624|NCT02139046|20245148|P3|Overall Study|Other Miscellaneous Reasons|4
5854625|NCT02139046|20245149|P2|Overall Study|Other Miscellaneous Reasons|9
5854626|NCT02139046|20245150|P1|Overall Study|Other Miscellaneous Reasons|10
5854627|NCT02139046|20245146|P5|Overall Study|Withdrawal due to a Gout Flare|1
5854628|NCT02139046|20245147|P4|Overall Study|Withdrawal due to a Gout Flare|0
5854629|NCT02139046|20245148|P3|Overall Study|Withdrawal due to a Gout Flare|1
5854630|NCT02139046|20245149|P2|Overall Study|Withdrawal due to a Gout Flare|1
5854631|NCT02139046|20245150|P1|Overall Study|Withdrawal due to a Gout Flare|1
5854632|NCT02139046|20245146|P5|Overall Study|Lack of Efficacy|2
5854633|NCT02139046|20245147|P4|Overall Study|Lack of Efficacy|1
5854634|NCT02139046|20245148|P3|Overall Study|Lack of Efficacy|2
5854635|NCT02139046|20245149|P2|Overall Study|Lack of Efficacy|1
5854636|NCT02139046|20245150|P1|Overall Study|Lack of Efficacy|0
5854637|NCT02139046|20245146|P5|Overall Study|Voluntary Withdrawal|16
5854638|NCT02139046|20245147|P4|Overall Study|Voluntary Withdrawal|15
5854639|NCT02139046|20245148|P3|Overall Study|Voluntary Withdrawal|10
5854640|NCT02139046|20245149|P2|Overall Study|Voluntary Withdrawal|8
5854641|NCT02139046|20245150|P1|Overall Study|Voluntary Withdrawal|20
5854642|NCT02139046|20245146|P5|Overall Study|Lost to Follow-up|13
5854643|NCT02139046|20245147|P4|Overall Study|Lost to Follow-up|18
5854644|NCT02139046|20245148|P3|Overall Study|Lost to Follow-up|16
5854645|NCT02139046|20245149|P2|Overall Study|Lost to Follow-up|16
5854646|NCT02139046|20245150|P1|Overall Study|Lost to Follow-up|13
5854647|NCT02139046|20245146|P5|Overall Study|Major Protocol Deviation|6
5854648|NCT02139046|20245147|P4|Overall Study|Major Protocol Deviation|12
5854649|NCT02139046|20245148|P3|Overall Study|Major Protocol Deviation|16
5854650|NCT02139046|20245149|P2|Overall Study|Major Protocol Deviation|10
5854651|NCT02139046|20245150|P1|Overall Study|Major Protocol Deviation|9
5854652|NCT02139046|20245146|P5|Overall Study|Pretreatment Event/Adverse Event|7
5854653|NCT02139046|20245147|P4|Overall Study|Pretreatment Event/Adverse Event|13
5854654|NCT02139046|20245148|P3|Overall Study|Pretreatment Event/Adverse Event|10
5854655|NCT02139046|20245149|P2|Overall Study|Pretreatment Event/Adverse Event|9
5854656|NCT02139046|20245150|P1|Overall Study|Pretreatment Event/Adverse Event|9
5854657|NCT02138916|20245191|P3|Overall Study|Adverse Event|3
5854658|NCT02138916|20245192|P2|Overall Study|Adverse Event|4
5854659|NCT02138916|20245193|P1|Overall Study|Adverse Event|4
5854660|NCT02138916|20245191|P3|Overall Study|Lost to Follow-up|3
5854661|NCT02138916|20245192|P2|Overall Study|Lost to Follow-up|2
5854662|NCT02138916|20245193|P1|Overall Study|Lost to Follow-up|4
5854663|NCT02138916|20245191|P3|Overall Study|Severe non-compliance|1
5854664|NCT02138916|20245192|P2|Overall Study|Severe non-compliance|2
5854665|NCT02138916|20245193|P1|Overall Study|Severe non-compliance|1
5854666|NCT02138916|20245191|P3|Overall Study|incorrect enrolment|0
5854667|NCT02138916|20245192|P2|Overall Study|incorrect enrolment|1
5854668|NCT02138916|20245193|P1|Overall Study|incorrect enrolment|1
5854669|NCT02138916|20245191|P3|Overall Study|Study specific withdrawal criteria|1
5854670|NCT02138916|20245192|P2|Overall Study|Study specific withdrawal criteria|0
5854671|NCT02138916|20245193|P1|Overall Study|Study specific withdrawal criteria|0
5854672|NCT02138916|20245191|P3|Overall Study|Withdrawal by Subject|32
5854673|NCT02138916|20245192|P2|Overall Study|Withdrawal by Subject|31
5854674|NCT02138916|20245193|P1|Overall Study|Withdrawal by Subject|27
5854675|NCT02138916|20245191|P3|Overall Study|Death|12
5854676|NCT02138916|20245192|P2|Overall Study|Death|11
5854677|NCT02138916|20245193|P1|Overall Study|Death|14
5854678|NCT02138916|20245191|P3|Overall Study|eg., meds change, lack of efficacy, etc.|7
5854679|NCT02138916|20245192|P2|Overall Study|eg., meds change, lack of efficacy, etc.|9
5854680|NCT02138916|20245193|P1|Overall Study|eg., meds change, lack of efficacy, etc.|6
5854683|NCT02138838|20245299|P2|Overall Study|Withdrawal by Subject|5
5854684|NCT02138838|20245300|P1|Overall Study|Withdrawal by Subject|1
5854685|NCT02138838|20245299|P2|Overall Study|Study Closure|6
5854686|NCT02138838|20245300|P1|Overall Study|Study Closure|7
5854687|NCT02138825|20245318|P2|Safety Follow-up|withdrawn due to lung transplant|1
5854688|NCT02138825|20245319|P1|Safety Follow-up|withdrawn due to lung transplant|0
5854689|NCT02138825|20245318|P2|Safety Follow-up|treatment unblinded|1
5854690|NCT02138825|20245319|P1|Safety Follow-up|treatment unblinded|0
5854691|NCT02138825|20245318|P2|Safety Follow-up|too unwell to attend the visit|1
5854692|NCT02138825|20245319|P1|Safety Follow-up|too unwell to attend the visit|0
5854693|NCT02138825|20245318|P2|Safety Follow-up|progressive disease|2
5854694|NCT02138825|20245319|P1|Safety Follow-up|progressive disease|0
5854695|NCT02138825|20245318|P2|Safety Follow-up|logistical difficulties|1
5854696|NCT02138825|20245319|P1|Safety Follow-up|logistical difficulties|0
5854697|NCT02138825|20245318|P2|Safety Follow-up|withdrawal by PI|0
5854698|NCT02138825|20245319|P1|Safety Follow-up|withdrawal by PI|1
5854699|NCT02138825|20245318|P2|Safety Follow-up|clinic worsening|0
5854700|NCT02138825|20245319|P1|Safety Follow-up|clinic worsening|1
5854701|NCT02138825|20245318|P2|Safety Follow-up|Withdrawal by Subject|3
5854702|NCT02138825|20245319|P1|Safety Follow-up|Withdrawal by Subject|5
5854703|NCT02138825|20245318|P2|Safety Follow-up|Death|5
5854704|NCT02138825|20245319|P1|Safety Follow-up|Death|11
5854705|NCT02138825|20245318|P2|Safety Follow-up|Adverse Event|3
5854706|NCT02138825|20245319|P1|Safety Follow-up|Adverse Event|4
5854707|NCT02138825|20245318|P2|Long-term Extension|Study termination by sponsor|38
5854708|NCT02138825|20245319|P1|Long-term Extension|Study termination by sponsor|32
5854709|NCT02138825|20245318|P2|Main Study Treatment|Medical decision|0
5854710|NCT02138825|20245319|P1|Main Study Treatment|Medical decision|1
5854711|NCT02138825|20245318|P2|Main Study Treatment|Withdrawal by Subject|1
5854712|NCT02138825|20245319|P1|Main Study Treatment|Withdrawal by Subject|3
5854713|NCT02138825|20245318|P2|Main Study Treatment|Study terminated by sponsor|9
5854714|NCT02138825|20245319|P1|Main Study Treatment|Study terminated by sponsor|10
5854715|NCT02138825|20245318|P2|Main Study Treatment|Sponsor decision|18
5854716|NCT02138825|20245319|P1|Main Study Treatment|Sponsor decision|12
5854717|NCT02138825|20245318|P2|Main Study Treatment|Protocol Violation|2
5854718|NCT02138825|20245319|P1|Main Study Treatment|Protocol Violation|2
5854719|NCT02138825|20245318|P2|Main Study Treatment|Death|2
5854720|NCT02138825|20245319|P1|Main Study Treatment|Death|1
5854721|NCT02138825|20245318|P2|Main Study Treatment|Adverse Event|3
5854722|NCT02138825|20245319|P1|Main Study Treatment|Adverse Event|11
5854723|NCT02138786|20245336|P3|Overall Study|Non-Compliance|1
5854724|NCT02138786|20245337|P2|Overall Study|Non-Compliance|0
5854725|NCT02138786|20245338|P1|Overall Study|Non-Compliance|0
5854726|NCT02138786|20245336|P3|Overall Study|Sponsor Terminated Study|1
5854727|NCT02138786|20245337|P2|Overall Study|Sponsor Terminated Study|1
5854728|NCT02138786|20245338|P1|Overall Study|Sponsor Terminated Study|0
5854729|NCT02138786|20245336|P3|Overall Study|Patient's Wish|0
5854730|NCT02138786|20245337|P2|Overall Study|Patient's Wish|2
5854731|NCT02138786|20245338|P1|Overall Study|Patient's Wish|0
5854732|NCT02138786|20245336|P3|Overall Study|Withdrawal by Subject|0
5854733|NCT02138786|20245337|P2|Overall Study|Withdrawal by Subject|2
5854734|NCT02138786|20245338|P1|Overall Study|Withdrawal by Subject|1
5854735|NCT02138786|20245336|P3|Overall Study|Disease Progression|3
5854736|NCT02138786|20245337|P2|Overall Study|Disease Progression|1
5854737|NCT02138786|20245338|P1|Overall Study|Disease Progression|1
5854738|NCT02138786|20245336|P3|Overall Study|Death|2
5854739|NCT02138786|20245337|P2|Overall Study|Death|7
5854740|NCT02138786|20245338|P1|Overall Study|Death|1
5854741|NCT02138786|20245336|P3|Overall Study|Adverse Event|1
5854742|NCT02138786|20245337|P2|Overall Study|Adverse Event|2
5854743|NCT02138786|20245338|P1|Overall Study|Adverse Event|0
5854744|NCT02138747|20245355|P4|Treatment Period 2|Other - Miscellaneous|0
5854745|NCT02138747|20245356|P3|Treatment Period 2|Other - Miscellaneous|0
5854746|NCT02138747|20245357|P2|Treatment Period 2|Other - Miscellaneous|0
5854747|NCT02138747|20245358|P1|Treatment Period 2|Other - Miscellaneous|3
5854748|NCT02138747|20245355|P4|Treatment Period 2|Withdrawal by Subject|2
5854749|NCT02138747|20245356|P3|Treatment Period 2|Withdrawal by Subject|1
5854750|NCT02138747|20245357|P2|Treatment Period 2|Withdrawal by Subject|4
5854751|NCT02138747|20245358|P1|Treatment Period 2|Withdrawal by Subject|5
5854752|NCT02138747|20245355|P4|Treatment Period 2|Protocol Violation|0
5854753|NCT02138747|20245356|P3|Treatment Period 2|Protocol Violation|0
5854754|NCT02138747|20245357|P2|Treatment Period 2|Protocol Violation|0
5854755|NCT02138747|20245358|P1|Treatment Period 2|Protocol Violation|1
5854756|NCT02138747|20245355|P4|Treatment Period 2|Lost to Follow-up|0
5854757|NCT02138747|20245356|P3|Treatment Period 2|Lost to Follow-up|0
5854758|NCT02138747|20245357|P2|Treatment Period 2|Lost to Follow-up|0
5854759|NCT02138747|20245358|P1|Treatment Period 2|Lost to Follow-up|2
5854760|NCT02138747|20245355|P4|Treatment Period 2|Adverse Event|1
5854761|NCT02138747|20245356|P3|Treatment Period 2|Adverse Event|1
5854762|NCT02138747|20245357|P2|Treatment Period 2|Adverse Event|3
5854763|NCT02138747|20245358|P1|Treatment Period 2|Adverse Event|6
5854764|NCT02138747|20245355|P4|Treatment Period 1|Other - Miscellaneous|0
5854765|NCT02138747|20245356|P3|Treatment Period 1|Other - Miscellaneous|0
5854766|NCT02138747|20245357|P2|Treatment Period 1|Other - Miscellaneous|4
5854767|NCT02138747|20245358|P1|Treatment Period 1|Other - Miscellaneous|2
5854768|NCT02138747|20245355|P4|Treatment Period 1|Withdrawal by Subject|3
5854769|NCT02138747|20245356|P3|Treatment Period 1|Withdrawal by Subject|1
5854770|NCT02138747|20245357|P2|Treatment Period 1|Withdrawal by Subject|4
5854771|NCT02138747|20245358|P1|Treatment Period 1|Withdrawal by Subject|8
5854772|NCT02138747|20245355|P4|Treatment Period 1|Protocol Violation|0
5854773|NCT02138747|20245356|P3|Treatment Period 1|Protocol Violation|0
5854774|NCT02138747|20245357|P2|Treatment Period 1|Protocol Violation|2
5854775|NCT02138747|20245358|P1|Treatment Period 1|Protocol Violation|0
5854776|NCT02138747|20245355|P4|Treatment Period 1|Lost to Follow-up|0
5854777|NCT02138747|20245356|P3|Treatment Period 1|Lost to Follow-up|1
5854778|NCT02138747|20245357|P2|Treatment Period 1|Lost to Follow-up|1
5854779|NCT02138747|20245358|P1|Treatment Period 1|Lost to Follow-up|0
5854780|NCT02138747|20245355|P4|Treatment Period 1|Adverse Event|1
5854781|NCT02138747|20245356|P3|Treatment Period 1|Adverse Event|2
5854782|NCT02138747|20245357|P2|Treatment Period 1|Adverse Event|14
5854783|NCT02138747|20245358|P1|Treatment Period 1|Adverse Event|10
5854784|NCT02138253|20245432|P2|Overall Study|Withdrawal by Subject|0
5854785|NCT02138253|20245433|P1|Overall Study|Withdrawal by Subject|1
5854786|NCT02138253|20245432|P2|Overall Study|Non compliance|0
5854787|NCT02138253|20245433|P1|Overall Study|Non compliance|1
5854788|NCT02138253|20245432|P2|Overall Study|Physician Decision|0
5854789|NCT02138253|20245433|P1|Overall Study|Physician Decision|2
5854790|NCT02138253|20245432|P2|Overall Study|Lost to Follow-up|1
5854791|NCT02138253|20245433|P1|Overall Study|Lost to Follow-up|2
5854792|NCT02138253|20245432|P2|Overall Study|Adverse Event|3
5854793|NCT02138253|20245433|P1|Overall Study|Adverse Event|3
5854794|NCT02138214|20245508|P3|Overall Study|Screen Failure|0
5854795|NCT02138214|20245509|P2|Overall Study|Screen Failure|1
5854796|NCT02138214|20245510|P1|Overall Study|Screen Failure|0
5854797|NCT02138214|20245508|P3|Overall Study|Lost to Follow-up|4
5854798|NCT02138214|20245509|P2|Overall Study|Lost to Follow-up|2
5854799|NCT02138214|20245510|P1|Overall Study|Lost to Follow-up|0
5854800|NCT02138214|20245508|P3|Overall Study|Withdrawal by Subject|0
5854801|NCT02138214|20245509|P2|Overall Study|Withdrawal by Subject|1
5854802|NCT02138214|20245510|P1|Overall Study|Withdrawal by Subject|0
5854803|NCT02138136|20245531|P1|Overall Study|Withdrawn by Sponsor|5
5854804|NCT02138136|20245531|P1|Overall Study|Lost to Follow-up|32
5854805|NCT02138136|20245531|P1|Overall Study|Withdrawal by Subject|36
5854806|NCT02138136|20245531|P1|Overall Study|Adverse Event|18
5854807|NCT02138136|20245531|P1|Overall Study|Pregnancy|2
5854808|NCT02138136|20245531|P1|Overall Study|Lack of Efficacy|35
5854809|NCT02138136|20245531|P1|Overall Study|Physician Decision|7
5854810|NCT02138136|20245531|P1|Overall Study|Protocol Violation|4
5854811|NCT02138110|20245538|P1|Overall Scaffold Implantation|Death|3
5854812|NCT02138110|20245538|P1|Enrolled for Scaffold Implantation|Physician Decision|1
5854813|NCT02137785|20245770|P2|Overall Study|subject moved out of state|0
5854814|NCT02137785|20245771|P1|Overall Study|subject moved out of state|1
5854815|NCT02137785|20245770|P2|Overall Study|Withdrawal by Subject|4
5854816|NCT02137785|20245771|P1|Overall Study|Withdrawal by Subject|1
5854817|NCT02137785|20245770|P2|Overall Study|Lost to Follow-up|0
5854818|NCT02137785|20245771|P1|Overall Study|Lost to Follow-up|1
5854819|NCT02137772|20245879|P2|Overall Study|Not treated|2
5854820|NCT02137772|20245880|P1|Overall Study|Not treated|3
5854821|NCT02137772|20245879|P2|Overall Study|Non-compliance with study drug|0
5854822|NCT02137772|20245880|P1|Overall Study|Non-compliance with study drug|1
5854823|NCT02137772|20245879|P2|Overall Study|Withdrawal by Subject|17
5854824|NCT02137772|20245880|P1|Overall Study|Withdrawal by Subject|28
5854825|NCT02137772|20245879|P2|Overall Study|Physician Decision|5
5854826|NCT02137772|20245880|P1|Overall Study|Physician Decision|15
5854827|NCT02137772|20245879|P2|Overall Study|Lost to Follow-up|4
5854828|NCT02137772|20245880|P1|Overall Study|Lost to Follow-up|8
5854829|NCT02137772|20245879|P2|Overall Study|Death|44
5854830|NCT02137772|20245880|P1|Overall Study|Death|71
5854831|NCT02137772|20245879|P2|Overall Study|Adverse Event|3
5854832|NCT02137772|20245880|P1|Overall Study|Adverse Event|6
5854833|NCT02137369|20246138|P2|Overall Study|Moved away|0
5854834|NCT02137369|20246139|P1|Overall Study|Moved away|2
5854835|NCT02137369|20246138|P2|Overall Study|Lost to Follow-up|0
5854836|NCT02137369|20246139|P1|Overall Study|Lost to Follow-up|1
5854837|NCT02137369|20246138|P2|Overall Study|Adverse Event|0
5854838|NCT02137369|20246139|P1|Overall Study|Adverse Event|2
5854839|NCT02137369|20246138|P2|Overall Study|Withdrawal by Subject|2
5854840|NCT02137369|20246139|P1|Overall Study|Withdrawal by Subject|3
5854841|NCT02137226|20246149|P5|Period 2 (Re - Randomization)|Other Reason|1
5854842|NCT02137226|20246150|P4|Period 2 (Re - Randomization)|Other Reason|1
5854843|NCT02137226|20246151|P3|Period 2 (Re - Randomization)|Other Reason|1
5854844|NCT02137226|20246152|P2|Period 2 (Re - Randomization)|Other Reason|0
5854845|NCT02137226|20246153|P1|Period 2 (Re - Randomization)|Other Reason|0
5854846|NCT02137226|20246149|P5|Period 2 (Re - Randomization)|Lack of Efficacy|0
5854847|NCT02137226|20246150|P4|Period 2 (Re - Randomization)|Lack of Efficacy|0
5854848|NCT02137226|20246151|P3|Period 2 (Re - Randomization)|Lack of Efficacy|2
5854849|NCT02137226|20246152|P2|Period 2 (Re - Randomization)|Lack of Efficacy|0
5854850|NCT02137226|20246153|P1|Period 2 (Re - Randomization)|Lack of Efficacy|0
5854851|NCT02137226|20246149|P5|Period 2 (Re - Randomization)|Lost to Follow-up|0
5854852|NCT02137226|20246150|P4|Period 2 (Re - Randomization)|Lost to Follow-up|0
5854853|NCT02137226|20246151|P3|Period 2 (Re - Randomization)|Lost to Follow-up|3
5854854|NCT02137226|20246152|P2|Period 2 (Re - Randomization)|Lost to Follow-up|0
5854855|NCT02137226|20246153|P1|Period 2 (Re - Randomization)|Lost to Follow-up|0
5854856|NCT02137226|20246149|P5|Period 2 (Re - Randomization)|Physician Decision|0
5854857|NCT02137226|20246150|P4|Period 2 (Re - Randomization)|Physician Decision|1
5854858|NCT02137226|20246151|P3|Period 2 (Re - Randomization)|Physician Decision|0
5854859|NCT02137226|20246152|P2|Period 2 (Re - Randomization)|Physician Decision|0
5854860|NCT02137226|20246153|P1|Period 2 (Re - Randomization)|Physician Decision|0
5854861|NCT02137226|20246149|P5|Period 2 (Re - Randomization)|Withdrawal by Subject|4
5854862|NCT02137226|20246150|P4|Period 2 (Re - Randomization)|Withdrawal by Subject|5
5854863|NCT02137226|20246151|P3|Period 2 (Re - Randomization)|Withdrawal by Subject|8
5854864|NCT02137226|20246152|P2|Period 2 (Re - Randomization)|Withdrawal by Subject|0
5854865|NCT02137226|20246153|P1|Period 2 (Re - Randomization)|Withdrawal by Subject|0
5854866|NCT02137226|20246149|P5|Period 2 (Re - Randomization)|Adverse Event|4
5854867|NCT02137226|20246150|P4|Period 2 (Re - Randomization)|Adverse Event|1
5854868|NCT02137226|20246151|P3|Period 2 (Re - Randomization)|Adverse Event|3
5854869|NCT02137226|20246152|P2|Period 2 (Re - Randomization)|Adverse Event|0
5854870|NCT02137226|20246153|P1|Period 2 (Re - Randomization)|Adverse Event|0
5854871|NCT02137226|20246149|P5|Period 1 (Initial Randomization)|Other Reason|0
5854872|NCT02137226|20246150|P4|Period 1 (Initial Randomization)|Other Reason|0
5854873|NCT02137226|20246151|P3|Period 1 (Initial Randomization)|Other Reason|0
5854874|NCT02137226|20246152|P2|Period 1 (Initial Randomization)|Other Reason|3
5854875|NCT02137226|20246153|P1|Period 1 (Initial Randomization)|Other Reason|1
5854876|NCT02137226|20246149|P5|Period 1 (Initial Randomization)|Lack of Efficacy|0
5854877|NCT02137226|20246150|P4|Period 1 (Initial Randomization)|Lack of Efficacy|0
5854878|NCT02137226|20246151|P3|Period 1 (Initial Randomization)|Lack of Efficacy|0
5854879|NCT02137226|20246152|P2|Period 1 (Initial Randomization)|Lack of Efficacy|0
5854880|NCT02137226|20246153|P1|Period 1 (Initial Randomization)|Lack of Efficacy|1
5854881|NCT02137226|20246149|P5|Period 1 (Initial Randomization)|Lost to Follow-up|0
5854882|NCT02137226|20246150|P4|Period 1 (Initial Randomization)|Lost to Follow-up|0
5854883|NCT02137226|20246151|P3|Period 1 (Initial Randomization)|Lost to Follow-up|0
5854884|NCT02137226|20246152|P2|Period 1 (Initial Randomization)|Lost to Follow-up|2
5854885|NCT02137226|20246153|P1|Period 1 (Initial Randomization)|Lost to Follow-up|3
5854886|NCT02137226|20246149|P5|Period 1 (Initial Randomization)|Physician Decision|0
5854887|NCT02137226|20246150|P4|Period 1 (Initial Randomization)|Physician Decision|0
5854888|NCT02137226|20246151|P3|Period 1 (Initial Randomization)|Physician Decision|0
5854889|NCT02137226|20246152|P2|Period 1 (Initial Randomization)|Physician Decision|3
5854890|NCT02137226|20246153|P1|Period 1 (Initial Randomization)|Physician Decision|1
5854891|NCT02137226|20246149|P5|Period 1 (Initial Randomization)|Withdrawal by Subject|0
5854892|NCT02137226|20246150|P4|Period 1 (Initial Randomization)|Withdrawal by Subject|0
5854893|NCT02137226|20246151|P3|Period 1 (Initial Randomization)|Withdrawal by Subject|0
5854894|NCT02137226|20246152|P2|Period 1 (Initial Randomization)|Withdrawal by Subject|5
5854895|NCT02137226|20246153|P1|Period 1 (Initial Randomization)|Withdrawal by Subject|11
5854896|NCT02137226|20246149|P5|Period 1 (Initial Randomization)|Adverse Event|0
5854897|NCT02137226|20246150|P4|Period 1 (Initial Randomization)|Adverse Event|0
5854898|NCT02137226|20246151|P3|Period 1 (Initial Randomization)|Adverse Event|0
5854899|NCT02137226|20246152|P2|Period 1 (Initial Randomization)|Adverse Event|3
5854900|NCT02137226|20246153|P1|Period 1 (Initial Randomization)|Adverse Event|3
5854901|NCT02136914|20246171|P2|Overall Study|Death|1
5854902|NCT02136914|20246172|P1|Overall Study|Death|0
5854903|NCT02136914|20246171|P2|Overall Study|Lack of Efficacy|0
5854904|NCT02136914|20246172|P1|Overall Study|Lack of Efficacy|1
5854905|NCT02136914|20246171|P2|Overall Study|Did Not Receive Study Drug|0
5854906|NCT02136914|20246172|P1|Overall Study|Did Not Receive Study Drug|2
5854907|NCT02136914|20246171|P2|Overall Study|Lost to Follow-up|1
5854908|NCT02136914|20246172|P1|Overall Study|Lost to Follow-up|1
5854909|NCT02136914|20246171|P2|Overall Study|Subject Unwilling to Proceed|2
5854910|NCT02136914|20246172|P1|Overall Study|Subject Unwilling to Proceed|7
5854911|NCT02136914|20246171|P2|Overall Study|Withdrawal by Subject|10
5854912|NCT02136914|20246172|P1|Overall Study|Withdrawal by Subject|3
5854913|NCT02136914|20246171|P2|Overall Study|Sponsor's Decision to Stop the Study|7
5854914|NCT02136914|20246172|P1|Overall Study|Sponsor's Decision to Stop the Study|7
5854915|NCT02136680|20246192|P2|Overall Study|Study ended before interview due|3
5854916|NCT02136680|20246193|P1|Overall Study|Study ended before interview due|6
5854917|NCT02136680|20246192|P2|Overall Study|Unable to schedule|16
5854918|NCT02136680|20246193|P1|Overall Study|Unable to schedule|17
5854919|NCT02136680|20246192|P2|Overall Study|Moved away|4
5854920|NCT02136680|20246193|P1|Overall Study|Moved away|5
5854921|NCT02136680|20246192|P2|Overall Study|No longer receiving care at clinic|5
5854922|NCT02136680|20246193|P1|Overall Study|No longer receiving care at clinic|3
5854923|NCT02136680|20246192|P2|Overall Study|No Longer Interested|1
5854924|NCT02136680|20246193|P1|Overall Study|No Longer Interested|1
5854925|NCT02136576|20246210|P3|Overall Study|Lost to Follow-up|0
5854926|NCT02136576|20246211|P2|Overall Study|Lost to Follow-up|0
5854927|NCT02136576|20246212|P1|Overall Study|Lost to Follow-up|2
5854928|NCT02136134|20246281|P2|Overall Study|Subjects randomized but not treated|8
5854929|NCT02136134|20246282|P1|Overall Study|Subjects randomized but not treated|10
5854930|NCT02136134|20246281|P2|Overall Study|Ongoing|207
5854931|NCT02136134|20246282|P1|Overall Study|Ongoing|185
5854932|NCT02136134|20246281|P2|Overall Study|Other|3
5854933|NCT02136134|20246282|P1|Overall Study|Other|3
5854934|NCT02136134|20246281|P2|Overall Study|Withdrawal by Subject|4
5854935|NCT02136134|20246282|P1|Overall Study|Withdrawal by Subject|14
5854936|NCT02136134|20246281|P2|Overall Study|Death|29
5854937|NCT02136134|20246282|P1|Overall Study|Death|35
5854938|NCT02135848|20246344|P2|Overall Study|Withdrawal by Subject|1
5854939|NCT02135848|20246345|P1|Overall Study|Withdrawal by Subject|1
5854940|NCT02135848|20246344|P2|Overall Study|Adverse Event|0
5854941|NCT02135848|20246345|P1|Overall Study|Adverse Event|2
5854942|NCT02135692|20246403|P1|Overall Study|Withdrawal by Subject|15
5854943|NCT02135692|20246403|P1|Overall Study|Lost to Follow-up|4
5854944|NCT02135692|20246403|P1|Overall Study|Study closed/terminated|153
5854945|NCT02135692|20246403|P1|Overall Study|Product commercially available|159
5854946|NCT02135692|20246403|P1|Overall Study|Subject met Liver Stopping Criteria|1
5854947|NCT02135692|20246403|P1|Overall Study|Protocol Violation|2
5854948|NCT02135692|20246403|P1|Overall Study|Lack of Efficacy|2
5854949|NCT02135692|20246403|P1|Overall Study|Adverse Event|3
5854950|NCT02135614|20246422|P2|Overall Study|Lost to Follow-up|0
5854951|NCT02135614|20246423|P1|Overall Study|Lost to Follow-up|3
5854952|NCT02135614|20246422|P2|Overall Study|Withdrew Consent|2
5854953|NCT02135614|20246423|P1|Overall Study|Withdrew Consent|2
5854954|NCT02135614|20246422|P2|Overall Study|Investigator's Discretion|1
5854955|NCT02135614|20246423|P1|Overall Study|Investigator's Discretion|0
5854956|NCT02135614|20246422|P2|Overall Study|Death|0
5854957|NCT02135614|20246423|P1|Overall Study|Death|1
5854958|NCT02135614|20246422|P2|Overall Study|Adverse Event|1
5854959|NCT02135614|20246423|P1|Overall Study|Adverse Event|0
5854960|NCT02135614|20246422|P2|Overall Study|Randomized but Not Treated|1
5854961|NCT02135614|20246423|P1|Overall Study|Randomized but Not Treated|2
5854962|NCT02135445|20246437|P2|Overall Study|Withdrawal by Subject|0
5854963|NCT02135445|20246438|P1|Overall Study|Withdrawal by Subject|1
5854964|NCT02135445|20246437|P2|Overall Study|Lost to Follow-up|0
5854965|NCT02135445|20246438|P1|Overall Study|Lost to Follow-up|1
5854966|NCT02135107|20246523|P4|Maintenance Therapy Period|Other|8
5854967|NCT02135107|20246524|P3|Maintenance Therapy Period|Other|7
5854968|NCT02135107|20246525|P2|Maintenance Therapy Period|Other|0
5854969|NCT02135107|20246526|P1|Maintenance Therapy Period|Other|0
5854970|NCT02135107|20246523|P4|Maintenance Therapy Period|Pregnancy|1
5854971|NCT02135107|20246524|P3|Maintenance Therapy Period|Pregnancy|0
5854972|NCT02135107|20246525|P2|Maintenance Therapy Period|Pregnancy|0
5854973|NCT02135107|20246526|P1|Maintenance Therapy Period|Pregnancy|0
5854974|NCT02135107|20246523|P4|Maintenance Therapy Period|Withdrawal by Subject|4
5854975|NCT02135107|20246524|P3|Maintenance Therapy Period|Withdrawal by Subject|5
5854976|NCT02135107|20246525|P2|Maintenance Therapy Period|Withdrawal by Subject|0
5854977|NCT02135107|20246526|P1|Maintenance Therapy Period|Withdrawal by Subject|0
5854978|NCT02135107|20246523|P4|Maintenance Therapy Period|Adverse Event|7
5854979|NCT02135107|20246524|P3|Maintenance Therapy Period|Adverse Event|3
5854980|NCT02135107|20246525|P2|Maintenance Therapy Period|Adverse Event|0
5854981|NCT02135107|20246526|P1|Maintenance Therapy Period|Adverse Event|0
5854982|NCT02135107|20246523|P4|Treatment Period|Other|0
5854983|NCT02135107|20246524|P3|Treatment Period|Other|0
5854984|NCT02135107|20246525|P2|Treatment Period|Other|24
5854985|NCT02135107|20246526|P1|Treatment Period|Other|115
5854986|NCT02135107|20246523|P4|Treatment Period|Pregnancy|0
5854987|NCT02135107|20246524|P3|Treatment Period|Pregnancy|0
5854988|NCT02135107|20246525|P2|Treatment Period|Pregnancy|0
5854989|NCT02135107|20246526|P1|Treatment Period|Pregnancy|1
5854990|NCT02135107|20246523|P4|Treatment Period|Adverse Event|0
5854991|NCT02135107|20246524|P3|Treatment Period|Adverse Event|0
5854992|NCT02135107|20246525|P2|Treatment Period|Adverse Event|2
5854993|NCT02135107|20246526|P1|Treatment Period|Adverse Event|5
5854994|NCT02135107|20246523|P4|Treatment Period|Withdrawal by Subject|0
5854995|NCT02135107|20246524|P3|Treatment Period|Withdrawal by Subject|0
5854996|NCT02135107|20246525|P2|Treatment Period|Withdrawal by Subject|0
5854997|NCT02135107|20246526|P1|Treatment Period|Withdrawal by Subject|11
5854998|NCT02135029|20246572|P3|Overall Study|Death|0
5854999|NCT02135029|20246573|P2|Overall Study|Death|1
5855000|NCT02135029|20246574|P1|Overall Study|Death|0
5855001|NCT02135029|20246572|P3|Overall Study|Other|0
5855002|NCT02135029|20246573|P2|Overall Study|Other|1
5855003|NCT02135029|20246574|P1|Overall Study|Other|0
5855004|NCT02135029|20246572|P3|Overall Study|Withdrawal by Subject|1
5855005|NCT02135029|20246573|P2|Overall Study|Withdrawal by Subject|0
5855006|NCT02135029|20246574|P1|Overall Study|Withdrawal by Subject|2
5855007|NCT02135029|20246572|P3|Overall Study|Lost to Follow-up|0
5855008|NCT02135029|20246573|P2|Overall Study|Lost to Follow-up|1
5855009|NCT02135029|20246574|P1|Overall Study|Lost to Follow-up|0
5855010|NCT02135029|20246572|P3|Overall Study|Adverse Event|2
5855011|NCT02135029|20246573|P2|Overall Study|Adverse Event|2
5855012|NCT02135029|20246574|P1|Overall Study|Adverse Event|2
5855013|NCT02134977|20246679|P1|Overall Study|Protocol Deviation|102
5855014|NCT02134925|20246713|P2|Overall Study|Cancel|6
5855015|NCT02134925|20246714|P1|Overall Study|Cancel|1
5855016|NCT02134925|20246713|P2|Overall Study|Withdrawal by Subject|0
5855017|NCT02134925|20246714|P1|Overall Study|Withdrawal by Subject|1
5855018|NCT02134587|20246768|P1|Overall Study|Did not completed all meetings|30
5855019|NCT02134353|20246784|P2|Overall Study|Other - Patient's Choice|1
5855020|NCT02134353|20246785|P1|Overall Study|Other - Patient's Choice|0
5855021|NCT02134353|20246784|P2|Overall Study|Relocation|0
5855022|NCT02134353|20246785|P1|Overall Study|Relocation|1
5855023|NCT02134353|20246784|P2|Overall Study|Pregnancy|1
5855024|NCT02134353|20246785|P1|Overall Study|Pregnancy|0
5855025|NCT02134353|20246784|P2|Overall Study|Death|1
5855026|NCT02134353|20246785|P1|Overall Study|Death|0
5855027|NCT02134353|20246784|P2|Overall Study|Withdrawal by Subject|13
5855028|NCT02134353|20246785|P1|Overall Study|Withdrawal by Subject|12
5855029|NCT02134353|20246784|P2|Overall Study|Lack of Efficacy|1
5855030|NCT02134353|20246785|P1|Overall Study|Lack of Efficacy|2
5855031|NCT02134353|20246784|P2|Overall Study|Lost to Follow-up|1
5855032|NCT02134353|20246785|P1|Overall Study|Lost to Follow-up|1
5855033|NCT02134353|20246784|P2|Overall Study|Adverse Event|6
5855034|NCT02134353|20246785|P1|Overall Study|Adverse Event|10
5855035|NCT02134028|20246940|P8|Overall Study|Adverse Event|2
5855036|NCT02134028|20246941|P7|Overall Study|Adverse Event|1
5855037|NCT02134028|20246942|P6|Overall Study|Adverse Event|5
5855038|NCT02134028|20246943|P5|Overall Study|Adverse Event|4
5855039|NCT02134028|20246944|P4|Overall Study|Adverse Event|32
5855040|NCT02134028|20246945|P3|Overall Study|Adverse Event|13
5855041|NCT02134028|20246946|P2|Overall Study|Adverse Event|19
5855042|NCT02134028|20246947|P1|Overall Study|Adverse Event|3
5855043|NCT02134028|20246940|P8|Overall Study|Other unspecified|1
5855044|NCT02134028|20246941|P7|Overall Study|Other unspecified|2
5855045|NCT02134028|20246942|P6|Overall Study|Other unspecified|6
5855046|NCT02134028|20246943|P5|Overall Study|Other unspecified|8
5855047|NCT02134028|20246944|P4|Overall Study|Other unspecified|64
5855048|NCT02134028|20246945|P3|Overall Study|Other unspecified|33
5855049|NCT02134028|20246946|P2|Overall Study|Other unspecified|22
5855050|NCT02134028|20246947|P1|Overall Study|Other unspecified|4
5855051|NCT02134028|20246940|P8|Overall Study|Poor compliance to protocol|0
5855052|NCT02134028|20246941|P7|Overall Study|Poor compliance to protocol|0
5855053|NCT02134028|20246942|P6|Overall Study|Poor compliance to protocol|1
5855054|NCT02134028|20246943|P5|Overall Study|Poor compliance to protocol|1
5855055|NCT02134028|20246944|P4|Overall Study|Poor compliance to protocol|7
5855056|NCT02134028|20246945|P3|Overall Study|Poor compliance to protocol|3
5855057|NCT02134028|20246946|P2|Overall Study|Poor compliance to protocol|1
5855058|NCT02134028|20246947|P1|Overall Study|Poor compliance to protocol|1
5855059|NCT02134028|20246940|P8|Overall Study|Lack of Efficacy|0
5855060|NCT02134028|20246941|P7|Overall Study|Lack of Efficacy|1
5855061|NCT02134028|20246942|P6|Overall Study|Lack of Efficacy|2
5855062|NCT02134028|20246943|P5|Overall Study|Lack of Efficacy|1
5855063|NCT02134028|20246944|P4|Overall Study|Lack of Efficacy|2
5855064|NCT02134028|20246945|P3|Overall Study|Lack of Efficacy|3
5855065|NCT02134028|20246946|P2|Overall Study|Lack of Efficacy|0
5855066|NCT02134028|20246947|P1|Overall Study|Lack of Efficacy|1
5855067|NCT02134015|20247105|P2|Overall Study|Withdrawal by Subject|7
5855068|NCT02134015|20247106|P1|Overall Study|Withdrawal by Subject|3
5855069|NCT02134015|20247105|P2|Overall Study|Adverse Event|10
5855070|NCT02134015|20247106|P1|Overall Study|Adverse Event|9
5855071|NCT02134015|20247105|P2|Overall Study|Study terminated by sponsor|3
5855072|NCT02134015|20247106|P1|Overall Study|Study terminated by sponsor|2
5855073|NCT02134015|20247105|P2|Overall Study|Progressive disease (per RECIST 1.1)|43
5855074|NCT02134015|20247106|P1|Overall Study|Progressive disease (per RECIST 1.1)|40
5855075|NCT02134015|20247105|P2|Overall Study|Clinical progression|7
5855076|NCT02134015|20247106|P1|Overall Study|Clinical progression|14
5855077|NCT02134015|20247105|P2|Overall Study|Reason not provided|2
5855078|NCT02134015|20247106|P1|Overall Study|Reason not provided|1
5855079|NCT02134015|20247105|P2|Overall Study|Death|1
5855080|NCT02134015|20247106|P1|Overall Study|Death|2
5855081|NCT02134015|20247105|P2|Overall Study|Protocol Violation|1
5855082|NCT02134015|20247106|P1|Overall Study|Protocol Violation|0
5855083|NCT02133742|20247142|P1|Period 2:Dose Expansion Phase (1344days)|Adverse Event|1
5855084|NCT02133742|20247142|P1|Period 2:Dose Expansion Phase (1344days)|Participant refused further follow-up|5
5855085|NCT02133742|20247142|P1|Period 2:Dose Expansion Phase (1344days)|Death|13
5855086|NCT02133742|20247142|P1|Period 2:Dose Expansion Phase (1344days)|End of survival follow-up/treatment|31
5855087|NCT02133742|20247142|P1|Period 2:Dose Expansion Phase (1344days)|Lost to Follow-up|2
5855088|NCT02133664|20247171|P2|Overall Study|Adverse Event|6
5855089|NCT02133664|20247172|P1|Overall Study|Adverse Event|3
5855090|NCT02133664|20247171|P2|Overall Study|Lost to Follow-up|1
5855091|NCT02133664|20247172|P1|Overall Study|Lost to Follow-up|2
5855092|NCT02133508|20247188|P1|Overall Study|Lost to Follow-up|2
5855093|NCT02133508|20247188|P1|Overall Study|Death|12
5855094|NCT02133508|20247188|P1|Overall Study|Decision of Investigator or Sponsor|1
5855095|NCT02133352|20247196|P1|Longer Term Extension|4 of the initial 10 subjects agreed/cons|6
5855131|NCT02133001|20247287|P2|Follow-Up Phase (Day 26-81)|Other|1
5855132|NCT02133001|20247288|P1|Follow-Up Phase (Day 26-81)|Other|0
5855133|NCT02133001|20247287|P2|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1
5855134|NCT02133001|20247288|P1|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1
5855135|NCT02133001|20247287|P2|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1
5855136|NCT02133001|20247288|P1|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1
5855137|NCT02133001|20247287|P2|Double Blind (Day 1-25)|Withdrawal by Subject|1
5855138|NCT02133001|20247288|P1|Double Blind (Day 1-25)|Withdrawal by Subject|1
5855139|NCT02133001|20247287|P2|Double Blind (Day 1-25)|Other|2
5855140|NCT02133001|20247288|P1|Double Blind (Day 1-25)|Other|2
5855141|NCT02133001|20247287|P2|Double Blind (Day 1-25)|Lost to Follow-up|0
5855142|NCT02133001|20247288|P1|Double Blind (Day 1-25)|Lost to Follow-up|2
5855143|NCT02133001|20247287|P2|Double Blind (Day 1-25)|Lack of Efficacy|1
5855144|NCT02133001|20247288|P1|Double Blind (Day 1-25)|Lack of Efficacy|4
5855145|NCT02133001|20247287|P2|Double Blind (Day 1-25)|Adverse Event|5
5855146|NCT02133001|20247288|P1|Double Blind (Day 1-25)|Adverse Event|1
5855147|NCT02132949|20247336|P2|Adjuvant Treatment Period|Ongoing in Adjuvant Treatment|157
5855148|NCT02132949|20247337|P1|Adjuvant Treatment Period|Ongoing in Adjuvant Treatment|142
5855149|NCT02132949|20247336|P2|Adjuvant Treatment Period|Protocol Deviation|0
5855150|NCT02132949|20247337|P1|Adjuvant Treatment Period|Protocol Deviation|1
5855151|NCT02132949|20247336|P2|Adjuvant Treatment Period|Withdrawal by Subject|1
5855152|NCT02132949|20247337|P1|Adjuvant Treatment Period|Withdrawal by Subject|1
5855153|NCT02132949|20247336|P2|Adjuvant Treatment Period|Physician Decision|0
5855154|NCT02132949|20247337|P1|Adjuvant Treatment Period|Physician Decision|1
5855155|NCT02132949|20247336|P2|Adjuvant Treatment Period|Disease Relapse|1
5855156|NCT02132949|20247337|P1|Adjuvant Treatment Period|Disease Relapse|0
5855157|NCT02132949|20247336|P2|Adjuvant Treatment Period|Disease Progression|1
5855158|NCT02132949|20247337|P1|Adjuvant Treatment Period|Disease Progression|0
5855159|NCT02132949|20247336|P2|Adjuvant Treatment Period|Reason unspecified|1
5855160|NCT02132949|20247337|P1|Adjuvant Treatment Period|Reason unspecified|0
5855161|NCT02132949|20247336|P2|Adjuvant Treatment Period|Adverse Event|6
5855162|NCT02132949|20247337|P1|Adjuvant Treatment Period|Adverse Event|4
5855163|NCT02132949|20247336|P2|Neoadjuvant Treatment Period|Withdrew prior to treatment|3
5855164|NCT02132949|20247337|P1|Neoadjuvant Treatment Period|Withdrew prior to treatment|0
5855165|NCT02132949|20247336|P2|Neoadjuvant Treatment Period|Adverse Event|3
5855166|NCT02132949|20247337|P1|Neoadjuvant Treatment Period|Adverse Event|6
5855167|NCT02132949|20247336|P2|Neoadjuvant Treatment Period|Disease Progression|1
5855168|NCT02132949|20247337|P1|Neoadjuvant Treatment Period|Disease Progression|1
5855169|NCT02132949|20247336|P2|Neoadjuvant Treatment Period|Withdrawal by Subject|0
5855170|NCT02132949|20247337|P1|Neoadjuvant Treatment Period|Withdrawal by Subject|1
5855171|NCT02132949|20247336|P2|Neoadjuvant Treatment Period|Physician Decision|0
5855172|NCT02132949|20247337|P1|Neoadjuvant Treatment Period|Physician Decision|2
5855173|NCT02132949|20247336|P2|Neoadjuvant Treatment Period|Lack of Efficacy|1
5855174|NCT02132949|20247337|P1|Neoadjuvant Treatment Period|Lack of Efficacy|0
5855175|NCT02132949|20247336|P2|Neoadjuvant Treatment Period|Reason unspecified|1
5855176|NCT02132949|20247337|P1|Neoadjuvant Treatment Period|Reason unspecified|3
5855177|NCT02132949|20247336|P2|Neoadjuvant Treatment Period|Early surgery|3
5855178|NCT02132949|20247337|P1|Neoadjuvant Treatment Period|Early surgery|4
5855179|NCT02132767|20247449|P2|Overall Study|Lost to Follow-up|4
5855180|NCT02132767|20247450|P1|Overall Study|Lost to Follow-up|4
5855181|NCT02132767|20247449|P2|Overall Study|Withdrawal by Subject|9
5855182|NCT02132767|20247450|P1|Overall Study|Withdrawal by Subject|10
5855183|NCT02132767|20247449|P2|Overall Study|Death|2
5855184|NCT02132767|20247450|P1|Overall Study|Death|3
5855185|NCT02132637|20247516|P2|Study Period 2 (Crossover)|Physician Decision|0
5855186|NCT02132637|20247517|P1|Study Period 2 (Crossover)|Physician Decision|2
5855187|NCT02132637|20247516|P2|Study Period 2 (Crossover)|Adverse Event|1
5855188|NCT02132637|20247517|P1|Study Period 2 (Crossover)|Adverse Event|0
5855189|NCT02132637|20247516|P2|Study Period 1|Physician Decision|0
5855190|NCT02132637|20247517|P1|Study Period 1|Physician Decision|1
5855191|NCT02132637|20247516|P2|Study Period 1|Withdrawal by Subject|4
5855192|NCT02132637|20247517|P1|Study Period 1|Withdrawal by Subject|0
5855193|NCT02132611|20247541|P1|Overall Study|Death|2
5855194|NCT02132247|20247604|P2|Overall Study|Protocol Violation|0
5855195|NCT02132247|20247605|P1|Overall Study|Protocol Violation|1
5855196|NCT02132195|20247620|P3|Rescue Therapy|Adverse Event|2
5855197|NCT02132195|20247621|P2|Rescue Therapy|Adverse Event|0
5855198|NCT02132195|20247622|P1|Rescue Therapy|Adverse Event|0
5855199|NCT02132195|20247620|P3|Rescue Therapy|Withdrawal by Subject|1
5855200|NCT02132195|20247621|P2|Rescue Therapy|Withdrawal by Subject|0
5855201|NCT02132195|20247622|P1|Rescue Therapy|Withdrawal by Subject|0
5855202|NCT02132195|20247620|P3|Rescue Therapy|Physician Decision|1
5855203|NCT02132195|20247621|P2|Rescue Therapy|Physician Decision|0
5855204|NCT02132195|20247622|P1|Rescue Therapy|Physician Decision|0
5855205|NCT02132195|20247620|P3|Rescue Therapy|Relapsed|7
5855206|NCT02132195|20247621|P2|Rescue Therapy|Relapsed|0
5855207|NCT02132195|20247622|P1|Rescue Therapy|Relapsed|0
5855208|NCT02132195|20247620|P3|Initial Assignment|Relapsed|0
5855209|NCT02132195|20247621|P2|Initial Assignment|Relapsed|0
5855210|NCT02132195|20247622|P1|Initial Assignment|Relapsed|14
5855211|NCT02132117|20247653|P2|Overall Study|Other Miscellaneous Reasons|0
5855212|NCT02132117|20247654|P1|Overall Study|Other Miscellaneous Reasons|2
5855213|NCT02132117|20247653|P2|Overall Study|Personal Reasons|2
5855214|NCT02132117|20247654|P1|Overall Study|Personal Reasons|1
5855215|NCT02132117|20247653|P2|Overall Study|Lost to Follow-up|2
5855216|NCT02132117|20247654|P1|Overall Study|Lost to Follow-up|2
5855217|NCT02132117|20247653|P2|Overall Study|Adverse Event|1
5855218|NCT02132117|20247654|P1|Overall Study|Adverse Event|6
5855219|NCT02131766|20247670|P1|Overall Study|Withdrawal by Subject|4
5855220|NCT02131662|20247686|P5|Overall Study|Not treated|3
5855221|NCT02131662|20247687|P4|Overall Study|Not treated|2
5855222|NCT02131662|20247688|P3|Overall Study|Not treated|2
5855223|NCT02131662|20247689|P2|Overall Study|Not treated|0
5855224|NCT02131662|20247690|P1|Overall Study|Not treated|2
5855225|NCT02131662|20247686|P5|Overall Study|Lost to Follow-up|0
5855226|NCT02131662|20247687|P4|Overall Study|Lost to Follow-up|9
5855227|NCT02131662|20247688|P3|Overall Study|Lost to Follow-up|0
5855228|NCT02131662|20247689|P2|Overall Study|Lost to Follow-up|3
5855229|NCT02131662|20247690|P1|Overall Study|Lost to Follow-up|1
5855230|NCT02131662|20247686|P5|Overall Study|Withdrawal by Subject|6
5855231|NCT02131662|20247687|P4|Overall Study|Withdrawal by Subject|5
5855232|NCT02131662|20247688|P3|Overall Study|Withdrawal by Subject|1
5855233|NCT02131662|20247689|P2|Overall Study|Withdrawal by Subject|5
5855234|NCT02131662|20247690|P1|Overall Study|Withdrawal by Subject|1
5855235|NCT02131662|20247686|P5|Overall Study|Lack of Efficacy|1
5855236|NCT02131662|20247687|P4|Overall Study|Lack of Efficacy|0
5855237|NCT02131662|20247688|P3|Overall Study|Lack of Efficacy|0
5855238|NCT02131662|20247689|P2|Overall Study|Lack of Efficacy|0
5855239|NCT02131662|20247690|P1|Overall Study|Lack of Efficacy|1
5855240|NCT02131662|20247686|P5|Overall Study|Wish for pregnancy|1
5855241|NCT02131662|20247687|P4|Overall Study|Wish for pregnancy|0
5855242|NCT02131662|20247688|P3|Overall Study|Wish for pregnancy|0
5855243|NCT02131662|20247689|P2|Overall Study|Wish for pregnancy|0
5855244|NCT02131662|20247690|P1|Overall Study|Wish for pregnancy|0
5855245|NCT02131662|20247686|P5|Overall Study|Pregnancy|0
5855246|NCT02131662|20247687|P4|Overall Study|Pregnancy|1
5855247|NCT02131662|20247688|P3|Overall Study|Pregnancy|0
5855248|NCT02131662|20247689|P2|Overall Study|Pregnancy|1
5855249|NCT02131662|20247690|P1|Overall Study|Pregnancy|0
5855250|NCT02131662|20247686|P5|Overall Study|Adverse Event|3
5855251|NCT02131662|20247687|P4|Overall Study|Adverse Event|1
5855252|NCT02131662|20247688|P3|Overall Study|Adverse Event|1
5855253|NCT02131662|20247689|P2|Overall Study|Adverse Event|1
5855254|NCT02131662|20247690|P1|Overall Study|Adverse Event|0
5855255|NCT02131662|20247686|P5|Overall Study|Other|4
5855256|NCT02131662|20247687|P4|Overall Study|Other|3
5855257|NCT02131662|20247688|P3|Overall Study|Other|3
5855258|NCT02131662|20247689|P2|Overall Study|Other|4
5855259|NCT02131662|20247690|P1|Overall Study|Other|2
5855260|NCT02131662|20247686|P5|Overall Study|Protocol Violation|0
5855261|NCT02131662|20247687|P4|Overall Study|Protocol Violation|0
5855262|NCT02131662|20247688|P3|Overall Study|Protocol Violation|0
5855263|NCT02131662|20247689|P2|Overall Study|Protocol Violation|0
5855264|NCT02131662|20247690|P1|Overall Study|Protocol Violation|1
5855265|NCT02131636|20247736|P2|Overall Study|Adverse Event|1
5855266|NCT02131636|20247737|P1|Overall Study|Adverse Event|4
5855267|NCT02131636|20247736|P2|Overall Study|Lost to Follow-up|0
5855268|NCT02131636|20247737|P1|Overall Study|Lost to Follow-up|4
5855269|NCT02131636|20247736|P2|Overall Study|Personal Reasons|4
5855270|NCT02131636|20247737|P1|Overall Study|Personal Reasons|4
5855271|NCT02131532|20247753|P1|Overall Study|Other health conditions|2
5855272|NCT02131532|20247753|P1|Overall Study|Physician Decision|1
5855273|NCT02131532|20247753|P1|Overall Study|Withdrawal by Subject|1
5855274|NCT02131324|20247845|P2|Overall Study|Lost to Follow-up|1
5855275|NCT02131324|20247846|P1|Overall Study|Lost to Follow-up|1
5855276|NCT02131324|20247845|P2|Overall Study|Withdrawal by Subject|2
5855277|NCT02131324|20247846|P1|Overall Study|Withdrawal by Subject|1
5855278|NCT02131311|20247852|P1|Overall Study|Lost to Follow-up|1
5855279|NCT02131311|20247852|P1|Overall Study|Protocol Violation|1
5855280|NCT02131311|20247852|P1|Overall Study|Adverse Event|2
5855281|NCT02131272|20247864|P2|Overall Study|Withdrawal Criteria|0
5855282|NCT02131272|20247865|P1|Overall Study|Withdrawal Criteria|1
5855283|NCT02131272|20247864|P2|Overall Study|Withdrawal by Subject|1
5855284|NCT02131272|20247865|P1|Overall Study|Withdrawal by Subject|0
5855285|NCT02131272|20247864|P2|Overall Study|Withdrawal by parent|1
5855286|NCT02131272|20247865|P1|Overall Study|Withdrawal by parent|0
5855287|NCT02131259|20247883|P1|Overall Study|Missing|3
5855288|NCT02131259|20247883|P1|Overall Study|Progressive disease/AE/other|1
5855289|NCT02131259|20247883|P1|Overall Study|AE/other|1
5855290|NCT02131259|20247883|P1|Overall Study|AE/lost to follow-up|1
5855291|NCT02131259|20247883|P1|Overall Study|Progressive disease/other|2
5855292|NCT02131259|20247883|P1|Overall Study|Progressive disease/relocation|1
5855293|NCT02131259|20247883|P1|Overall Study|Progressive disease/Adverse Event (AE)|22
5855294|NCT02131259|20247883|P1|Overall Study|Other|63
5855295|NCT02131259|20247883|P1|Overall Study|Relocation|32
5855296|NCT02131259|20247883|P1|Overall Study|Lost to Follow-up|7
5855297|NCT02131259|20247883|P1|Overall Study|Adverse Event|341
5855298|NCT02131259|20247883|P1|Overall Study|Progressive disease|751
5855299|NCT02131233|20247890|P2|Overall Study|Withdrawal by Subject|11
5855300|NCT02131233|20247891|P1|Overall Study|Withdrawal by Subject|18
5855301|NCT02131233|20247890|P2|Overall Study|Pregnancy|0
5855302|NCT02131233|20247891|P1|Overall Study|Pregnancy|4
5855303|NCT02131233|20247890|P2|Overall Study|Physician Decision|0
5855304|NCT02131233|20247891|P1|Overall Study|Physician Decision|7
5855305|NCT02131233|20247890|P2|Overall Study|Non-Compliance With Study Drug|5
5855306|NCT02131233|20247891|P1|Overall Study|Non-Compliance With Study Drug|8
5855307|NCT02131233|20247890|P2|Overall Study|Lost to Follow-up|13
5855308|NCT02131233|20247891|P1|Overall Study|Lost to Follow-up|14
5855309|NCT02131233|20247890|P2|Overall Study|Lack of Efficacy|3
5855310|NCT02131233|20247891|P1|Overall Study|Lack of Efficacy|6
5855311|NCT02131233|20247890|P2|Overall Study|Death|1
5855312|NCT02131233|20247891|P1|Overall Study|Death|0
5855313|NCT02131233|20247890|P2|Overall Study|Adverse Event|6
5855314|NCT02131233|20247891|P1|Overall Study|Adverse Event|7
5855315|NCT02131233|20247890|P2|Overall Study|Not Treated|3
5855316|NCT02131233|20247891|P1|Overall Study|Not Treated|2
5855317|NCT02131155|20247925|P2|Overall Study|Study early termination|10
5855318|NCT02131155|20247926|P1|Overall Study|Study early termination|20
5855319|NCT02131155|20247925|P2|Overall Study|Refused to continue study medication|0
5855320|NCT02131155|20247926|P1|Overall Study|Refused to continue study medication|1
5855321|NCT02131155|20247925|P2|Overall Study|Primary tumour recurrence|1
5855322|NCT02131155|20247926|P1|Overall Study|Primary tumour recurrence|2
5855323|NCT02131155|20247925|P2|Overall Study|Treatment completed|0
5855324|NCT02131155|20247926|P1|Overall Study|Treatment completed|1
5855325|NCT02131155|20247925|P2|Overall Study|Adverse Event|0
5855326|NCT02131155|20247926|P1|Overall Study|Adverse Event|1
5855327|NCT02131129|20247940|P2|Overall Study|Withdrawal by Subject|0
5855328|NCT02131129|20247941|P1|Overall Study|Withdrawal by Subject|1
5855329|NCT02131064|20247959|P2|Overall Study|Other|2
5855330|NCT02131064|20247960|P1|Overall Study|Other|2
5855331|NCT02131064|20247959|P2|Overall Study|Withdrawal by Subject|18
5855332|NCT02131064|20247960|P1|Overall Study|Withdrawal by Subject|14
5855333|NCT02131064|20247959|P2|Overall Study|Lost to Follow-up|8
5855334|NCT02131064|20247960|P1|Overall Study|Lost to Follow-up|4
5855335|NCT02131064|20247959|P2|Overall Study|Death|6
5855336|NCT02131064|20247960|P1|Overall Study|Death|5
5855337|NCT02130986|20248029|P2|Overall Study|Lost to Follow-up|160
5855338|NCT02130986|20248030|P1|Overall Study|Lost to Follow-up|151
5855339|NCT02130986|20248029|P2|Overall Study|Withdrawal by Subject|4
5855340|NCT02130986|20248030|P1|Overall Study|Withdrawal by Subject|4
5855341|NCT02130765|20248044|P4|Overall Study|Did not receive treatment|0
5855342|NCT02130765|20248045|P3|Overall Study|Did not receive treatment|0
5855343|NCT02130765|20248046|P2|Overall Study|Did not receive treatment|0
5855344|NCT02130765|20248047|P1|Overall Study|Did not receive treatment|4
5855345|NCT02130570|20248293|P2|Overall Study|Part of practice that discontinued study|5
5855346|NCT02130570|20248294|P1|Overall Study|Part of practice that discontinued study|0
5855347|NCT02130570|20248293|P2|Overall Study|Withdrawal by Subject|3
5855348|NCT02130570|20248294|P1|Overall Study|Withdrawal by Subject|6
5855349|NCT02130570|20248293|P2|Overall Study|Death|5
5855350|NCT02130570|20248294|P1|Overall Study|Death|3
5855351|NCT02130557|20248312|P2|Overall Study|Ongoing|255
5855352|NCT02130557|20248313|P1|Overall Study|Ongoing|260
5855353|NCT02130557|20248312|P2|Overall Study|Deceased|6
5855354|NCT02130557|20248313|P1|Overall Study|Deceased|1
5855355|NCT02130557|20248312|P2|Overall Study|Lost to Follow-up|2
5855356|NCT02130557|20248313|P1|Overall Study|Lost to Follow-up|2
5855357|NCT02130557|20248312|P2|Overall Study|Withdrawal by Subject|2
5855358|NCT02130557|20248313|P1|Overall Study|Withdrawal by Subject|5
5855359|NCT02130557|20248312|P2|Overall Study|Randomized, not treated|3
5855360|NCT02130557|20248313|P1|Overall Study|Randomized, not treated|0
5855361|NCT02130284|20248345|P1|Overall Study|Screen Failure|1
5855362|NCT02130284|20248345|P1|Overall Study|Subject was screened as backup for study|3
5855363|NCT02130284|20248345|P1|Overall Study|Subject's sensor failed at Visit 2, Day|1
5855364|NCT02130284|20248345|P1|Overall Study|Subject Withdrew Consent|1
5855365|NCT02130284|20248345|P1|Overall Study|Withdrawal by Subject|3
5855366|NCT02130193|20248371|P3|Part B: 52-week Double-blind Period|Withdrawal by Subject|3
5855367|NCT02130193|20248372|P2|Part B: 52-week Double-blind Period|Withdrawal by Subject|3
5855368|NCT02130193|20248373|P1|Part B: 52-week Double-blind Period|Withdrawal by Subject|0
5855369|NCT02130193|20248371|P3|Part B: 52-week Double-blind Period|Physician Decision|1
5855370|NCT02130193|20248372|P2|Part B: 52-week Double-blind Period|Physician Decision|0
5855371|NCT02130193|20248373|P1|Part B: 52-week Double-blind Period|Physician Decision|0
5855372|NCT02130193|20248371|P3|Part B: 52-week Double-blind Period|Protocol Violation|1
5855373|NCT02130193|20248372|P2|Part B: 52-week Double-blind Period|Protocol Violation|2
5855374|NCT02130193|20248373|P1|Part B: 52-week Double-blind Period|Protocol Violation|0
5855375|NCT02130193|20248371|P3|Part B: 52-week Double-blind Period|Adverse Event|3
5855376|NCT02130193|20248372|P2|Part B: 52-week Double-blind Period|Adverse Event|5
5855377|NCT02130193|20248373|P1|Part B: 52-week Double-blind Period|Adverse Event|0
5855378|NCT02130024|20248454|P2|Overall Study|Subject Withdrew Consent|14
5855379|NCT02130024|20248455|P1|Overall Study|Subject Withdrew Consent|6
5855380|NCT02130024|20248454|P2|Overall Study|Site Administration Problems|0
5855381|NCT02130024|20248455|P1|Overall Study|Site Administration Problems|1
5855382|NCT02130024|20248454|P2|Overall Study|Protocol Deviation|0
5855383|NCT02130024|20248455|P1|Overall Study|Protocol Deviation|4
5855384|NCT02130024|20248454|P2|Overall Study|Physician Decision|3
5855385|NCT02130024|20248455|P1|Overall Study|Physician Decision|1
5855386|NCT02130024|20248454|P2|Overall Study|Lost to Follow-up|1
5855387|NCT02130024|20248455|P1|Overall Study|Lost to Follow-up|1
5855388|NCT02130024|20248454|P2|Overall Study|Death|2
5855389|NCT02130024|20248455|P1|Overall Study|Death|2
5855390|NCT02130024|20248454|P2|Overall Study|Adverse Event|11
5855391|NCT02130024|20248455|P1|Overall Study|Adverse Event|10
5855392|NCT02129803|20248489|P2|Overall Study|Withdrawal by Subject|1
5855393|NCT02129803|20248490|P1|Overall Study|Withdrawal by Subject|1
5855394|NCT02129803|20248489|P2|Overall Study|Morning headache|1
5855395|NCT02129803|20248490|P1|Overall Study|Morning headache|0
5855396|NCT02129803|20248489|P2|Overall Study|Difficulty sleeping|0
5855397|NCT02129803|20248490|P1|Overall Study|Difficulty sleeping|1
5855398|NCT02129803|20248489|P2|Overall Study|Physician Decision|1
5855399|NCT02129803|20248490|P1|Overall Study|Physician Decision|0
5855400|NCT02129803|20248489|P2|Overall Study|Protocol Violation|0
5855401|NCT02129803|20248490|P1|Overall Study|Protocol Violation|4
5855402|NCT02129777|20248503|P7|Open-Label Period|Study Termination|39
5855403|NCT02129777|20248504|P6|Open-Label Period|Study Termination|10
5855404|NCT02129777|20248505|P5|Open-Label Period|Study Termination|0
5855405|NCT02129777|20248506|P4|Open-Label Period|Study Termination|0
5855406|NCT02129777|20248507|P3|Open-Label Period|Study Termination|0
5855407|NCT02129777|20248508|P2|Open-Label Period|Study Termination|0
5855408|NCT02129777|20248509|P1|Open-Label Period|Study Termination|0
5855409|NCT02129777|20248503|P7|Open-Label Period|Withdrawal by Subject|3
5855410|NCT02129777|20248504|P6|Open-Label Period|Withdrawal by Subject|1
5855411|NCT02129777|20248505|P5|Open-Label Period|Withdrawal by Subject|0
5855412|NCT02129777|20248506|P4|Open-Label Period|Withdrawal by Subject|0
5855413|NCT02129777|20248507|P3|Open-Label Period|Withdrawal by Subject|0
5855414|NCT02129777|20248508|P2|Open-Label Period|Withdrawal by Subject|0
5855415|NCT02129777|20248509|P1|Open-Label Period|Withdrawal by Subject|0
5855416|NCT02129777|20248503|P7|Open-Label Period|Lost to Follow-up|1
5855417|NCT02129777|20248504|P6|Open-Label Period|Lost to Follow-up|1
5855418|NCT02129777|20248505|P5|Open-Label Period|Lost to Follow-up|0
5855419|NCT02129777|20248506|P4|Open-Label Period|Lost to Follow-up|0
5855420|NCT02129777|20248507|P3|Open-Label Period|Lost to Follow-up|0
5855421|NCT02129777|20248508|P2|Open-Label Period|Lost to Follow-up|0
5855422|NCT02129777|20248509|P1|Open-Label Period|Lost to Follow-up|0
5855423|NCT02129777|20248503|P7|Open-Label Period|Lack of Efficacy|5
5855424|NCT02129777|20248504|P6|Open-Label Period|Lack of Efficacy|0
5855425|NCT02129777|20248505|P5|Open-Label Period|Lack of Efficacy|0
5855426|NCT02129777|20248506|P4|Open-Label Period|Lack of Efficacy|0
5855427|NCT02129777|20248507|P3|Open-Label Period|Lack of Efficacy|0
5855428|NCT02129777|20248508|P2|Open-Label Period|Lack of Efficacy|0
5855429|NCT02129777|20248509|P1|Open-Label Period|Lack of Efficacy|0
5855430|NCT02129777|20248503|P7|Double-Blind Period|Other|0
5855431|NCT02129777|20248504|P6|Double-Blind Period|Other|0
5855432|NCT02129777|20248505|P5|Double-Blind Period|Other|0
5855433|NCT02129777|20248506|P4|Double-Blind Period|Other|0
5855434|NCT02129777|20248507|P3|Double-Blind Period|Other|0
5855435|NCT02129777|20248508|P2|Double-Blind Period|Other|2
5855436|NCT02129777|20248509|P1|Double-Blind Period|Other|1
5855437|NCT02129777|20248503|P7|Double-Blind Period|Lack of Efficacy|0
5855438|NCT02129777|20248504|P6|Double-Blind Period|Lack of Efficacy|0
5855439|NCT02129777|20248505|P5|Double-Blind Period|Lack of Efficacy|2
5855440|NCT02129777|20248506|P4|Double-Blind Period|Lack of Efficacy|3
5855441|NCT02129777|20248507|P3|Double-Blind Period|Lack of Efficacy|0
5855442|NCT02129777|20248508|P2|Double-Blind Period|Lack of Efficacy|1
5855443|NCT02129777|20248509|P1|Double-Blind Period|Lack of Efficacy|3
5855444|NCT02129777|20248503|P7|Double-Blind Period|Pregnancy|0
5855445|NCT02129777|20248504|P6|Double-Blind Period|Pregnancy|0
5855446|NCT02129777|20248505|P5|Double-Blind Period|Pregnancy|1
5855447|NCT02129777|20248506|P4|Double-Blind Period|Pregnancy|0
5855448|NCT02129777|20248507|P3|Double-Blind Period|Pregnancy|0
5855449|NCT02129777|20248508|P2|Double-Blind Period|Pregnancy|0
5855450|NCT02129777|20248509|P1|Double-Blind Period|Pregnancy|0
5855451|NCT02129777|20248503|P7|Double-Blind Period|Withdrawal by Subject|0
5855452|NCT02129777|20248504|P6|Double-Blind Period|Withdrawal by Subject|0
5855453|NCT02129777|20248505|P5|Double-Blind Period|Withdrawal by Subject|3
5855454|NCT02129777|20248506|P4|Double-Blind Period|Withdrawal by Subject|2
5855455|NCT02129777|20248507|P3|Double-Blind Period|Withdrawal by Subject|3
5855456|NCT02129777|20248508|P2|Double-Blind Period|Withdrawal by Subject|4
5855457|NCT02129777|20248509|P1|Double-Blind Period|Withdrawal by Subject|2
5855458|NCT02129777|20248503|P7|Double-Blind Period|Lost to Follow-up|0
5855459|NCT02129777|20248504|P6|Double-Blind Period|Lost to Follow-up|0
5855460|NCT02129777|20248505|P5|Double-Blind Period|Lost to Follow-up|0
5855461|NCT02129777|20248506|P4|Double-Blind Period|Lost to Follow-up|2
5855462|NCT02129777|20248507|P3|Double-Blind Period|Lost to Follow-up|1
5855463|NCT02129777|20248508|P2|Double-Blind Period|Lost to Follow-up|1
5855464|NCT02129777|20248509|P1|Double-Blind Period|Lost to Follow-up|1
5855465|NCT02129777|20248503|P7|Double-Blind Period|Adverse Event|0
5855466|NCT02129777|20248504|P6|Double-Blind Period|Adverse Event|0
5855467|NCT02129777|20248505|P5|Double-Blind Period|Adverse Event|1
5855468|NCT02129777|20248506|P4|Double-Blind Period|Adverse Event|0
5855469|NCT02129777|20248507|P3|Double-Blind Period|Adverse Event|0
5855470|NCT02129777|20248508|P2|Double-Blind Period|Adverse Event|0
5855471|NCT02129777|20248509|P1|Double-Blind Period|Adverse Event|0
5855472|NCT02129608|20248676|P3|Overall Study|Withdrawal by Subject|2
5855473|NCT02129608|20248677|P2|Overall Study|Withdrawal by Subject|0
5855474|NCT02129608|20248678|P1|Overall Study|Withdrawal by Subject|0
5855475|NCT02129608|20248676|P3|Overall Study|Lost to Follow-up|1
5855476|NCT02129608|20248677|P2|Overall Study|Lost to Follow-up|1
5855477|NCT02129608|20248678|P1|Overall Study|Lost to Follow-up|0
5855478|NCT02129205|20248735|P10|Overall Study|Other|0
5855479|NCT02129205|20248736|P9|Overall Study|Other|1
5855480|NCT02129205|20248737|P8|Overall Study|Other|2
5855481|NCT02129205|20248738|P7|Overall Study|Other|3
5855482|NCT02129205|20248739|P6|Overall Study|Other|3
5855483|NCT02129205|20248740|P5|Overall Study|Other|2
5855484|NCT02129205|20248741|P4|Overall Study|Other|0
5855485|NCT02129205|20248742|P3|Overall Study|Other|0
5855486|NCT02129205|20248743|P2|Overall Study|Other|0
5855487|NCT02129205|20248744|P1|Overall Study|Other|1
5855488|NCT02129205|20248735|P10|Overall Study|Withdrawal by Subject|0
5855489|NCT02129205|20248736|P9|Overall Study|Withdrawal by Subject|1
5855490|NCT02129205|20248737|P8|Overall Study|Withdrawal by Subject|0
5855491|NCT02129205|20248738|P7|Overall Study|Withdrawal by Subject|1
5855492|NCT02129205|20248739|P6|Overall Study|Withdrawal by Subject|1
5855493|NCT02129205|20248740|P5|Overall Study|Withdrawal by Subject|1
5855494|NCT02129205|20248741|P4|Overall Study|Withdrawal by Subject|0
5855495|NCT02129205|20248742|P3|Overall Study|Withdrawal by Subject|0
5855496|NCT02129205|20248743|P2|Overall Study|Withdrawal by Subject|0
5855497|NCT02129205|20248744|P1|Overall Study|Withdrawal by Subject|0
5855498|NCT02129192|20248897|P2|Period 1 Including Washout Period|Withdrawal by Subject|1
5855499|NCT02129192|20248898|P1|Period 1 Including Washout Period|Withdrawal by Subject|0
5855500|NCT02129062|20248915|P1|Overall Study|Disease Progression|2
5855501|NCT02129062|20248915|P1|Overall Study|Death|1
5855502|NCT02128997|20248922|P2|Overall Study|Lost to Follow-up|11
5855503|NCT02128997|20248923|P1|Overall Study|Lost to Follow-up|6
5855504|NCT02128932|20248938|P3|Overall Study|No reason for withdrawal|7
5855505|NCT02128932|20248939|P2|Overall Study|No reason for withdrawal|11
5855506|NCT02128932|20248940|P1|Overall Study|No reason for withdrawal|12
5855507|NCT02128932|20248938|P3|Overall Study|Lost to Follow-up|1
5855508|NCT02128932|20248939|P2|Overall Study|Lost to Follow-up|1
5855509|NCT02128932|20248940|P1|Overall Study|Lost to Follow-up|2
5855510|NCT02128932|20248938|P3|Overall Study|Death|2
5855511|NCT02128932|20248939|P2|Overall Study|Death|0
5855512|NCT02128932|20248940|P1|Overall Study|Death|2
5855513|NCT02128932|20248938|P3|Overall Study|Withdrawal by Subject|8
5855514|NCT02128932|20248939|P2|Overall Study|Withdrawal by Subject|7
5855515|NCT02128932|20248940|P1|Overall Study|Withdrawal by Subject|11
5855516|NCT02128763|20249001|P2|Overall Study|Lost to Follow-up|16
5855517|NCT02128763|20249002|P1|Overall Study|Lost to Follow-up|19
5855518|NCT02128763|20249001|P2|Overall Study|Death|0
5855519|NCT02128763|20249002|P1|Overall Study|Death|1
5855520|NCT02128724|20249048|P4|Overall Study|Withdrawal by Subject|1
5855521|NCT02128724|20249049|P3|Overall Study|Withdrawal by Subject|0
5855522|NCT02128724|20249050|P2|Overall Study|Withdrawal by Subject|0
5855523|NCT02128724|20249051|P1|Overall Study|Withdrawal by Subject|0
5855524|NCT02128724|20249048|P4|Overall Study|Physician Decision|2
5855525|NCT02128724|20249049|P3|Overall Study|Physician Decision|0
5855526|NCT02128724|20249050|P2|Overall Study|Physician Decision|0
5855527|NCT02128724|20249051|P1|Overall Study|Physician Decision|0
5855528|NCT02128724|20249048|P4|Overall Study|Adverse Event|0
5855529|NCT02128724|20249049|P3|Overall Study|Adverse Event|0
5855530|NCT02128724|20249050|P2|Overall Study|Adverse Event|1
5855531|NCT02128724|20249051|P1|Overall Study|Adverse Event|0
5855532|NCT02128724|20249048|P4|Overall Study|Death|0
5855533|NCT02128724|20249049|P3|Overall Study|Death|0
5855534|NCT02128724|20249050|P2|Overall Study|Death|0
5855535|NCT02128724|20249051|P1|Overall Study|Death|1
5855536|NCT02128542|20249106|P2|Overall Study|Withdrew Consent|0
5855537|NCT02128542|20249107|P1|Overall Study|Withdrew Consent|1
5855538|NCT02128542|20249106|P2|Overall Study|Lost to Follow-up|0
5855539|NCT02128542|20249107|P1|Overall Study|Lost to Follow-up|3
5855540|NCT02128490|20249125|P5|Overall Study|Other Miscellaneous Reasons|1
5855541|NCT02128490|20249126|P4|Overall Study|Other Miscellaneous Reasons|1
5855542|NCT02128490|20249127|P3|Overall Study|Other Miscellaneous Reasons|2
5855543|NCT02128490|20249128|P2|Overall Study|Other Miscellaneous Reasons|0
5855544|NCT02128490|20249129|P1|Overall Study|Other Miscellaneous Reasons|0
5855545|NCT02128490|20249125|P5|Overall Study|Withdraw from Study Drug, Gout Flare|1
5855546|NCT02128490|20249126|P4|Overall Study|Withdraw from Study Drug, Gout Flare|0
5855547|NCT02128490|20249127|P3|Overall Study|Withdraw from Study Drug, Gout Flare|0
5855548|NCT02128490|20249128|P2|Overall Study|Withdraw from Study Drug, Gout Flare|0
5855549|NCT02128490|20249129|P1|Overall Study|Withdraw from Study Drug, Gout Flare|0
5855550|NCT02128490|20249125|P5|Overall Study|Lack of Efficacy|0
5855551|NCT02128490|20249126|P4|Overall Study|Lack of Efficacy|0
5855552|NCT02128490|20249127|P3|Overall Study|Lack of Efficacy|0
5855553|NCT02128490|20249128|P2|Overall Study|Lack of Efficacy|1
5855554|NCT02128490|20249129|P1|Overall Study|Lack of Efficacy|0
5855555|NCT02128490|20249125|P5|Overall Study|Voluntary Withdrawal|2
5855556|NCT02128490|20249126|P4|Overall Study|Voluntary Withdrawal|1
5855557|NCT02128490|20249127|P3|Overall Study|Voluntary Withdrawal|1
5855558|NCT02128490|20249128|P2|Overall Study|Voluntary Withdrawal|3
5855559|NCT02128490|20249129|P1|Overall Study|Voluntary Withdrawal|3
5855560|NCT02128490|20249125|P5|Overall Study|Lost to Follow-up|1
5855561|NCT02128490|20249126|P4|Overall Study|Lost to Follow-up|1
5855562|NCT02128490|20249127|P3|Overall Study|Lost to Follow-up|1
5855563|NCT02128490|20249128|P2|Overall Study|Lost to Follow-up|0
5855564|NCT02128490|20249129|P1|Overall Study|Lost to Follow-up|0
5855565|NCT02128490|20249125|P5|Overall Study|Major Protocol Deviation|2
5855566|NCT02128490|20249126|P4|Overall Study|Major Protocol Deviation|2
5855567|NCT02128490|20249127|P3|Overall Study|Major Protocol Deviation|0
5855568|NCT02128490|20249128|P2|Overall Study|Major Protocol Deviation|2
5855569|NCT02128490|20249129|P1|Overall Study|Major Protocol Deviation|1
5855570|NCT02128490|20249125|P5|Overall Study|Pretreatment Event/Adverse Event|0
5855571|NCT02128490|20249126|P4|Overall Study|Pretreatment Event/Adverse Event|1
5855572|NCT02128490|20249127|P3|Overall Study|Pretreatment Event/Adverse Event|1
5855573|NCT02128490|20249128|P2|Overall Study|Pretreatment Event/Adverse Event|0
5855574|NCT02128490|20249129|P1|Overall Study|Pretreatment Event/Adverse Event|1
5855575|NCT02128269|20249151|P1|Treatment Period|Physician Decision|1
5855576|NCT02128269|20249151|P1|Treatment Period|Adverse Event|1
5855577|NCT02128217|20249157|P2|Overall Study|Lost to Follow-up|1
5855578|NCT02128217|20249158|P1|Overall Study|Lost to Follow-up|0
5855579|NCT02127970|20249206|P2|Overall Study|Subject Withdrew Consent|3
5855580|NCT02127970|20249207|P1|Overall Study|Subject Withdrew Consent|5
5855581|NCT02127970|20249206|P2|Overall Study|Pregnancy|1
5855582|NCT02127970|20249207|P1|Overall Study|Pregnancy|0
5855583|NCT02127970|20249206|P2|Overall Study|Reason not Specified|7
5855584|NCT02127970|20249207|P1|Overall Study|Reason not Specified|4
5855585|NCT02127970|20249206|P2|Overall Study|Lost to Follow-up|14
5855586|NCT02127970|20249207|P1|Overall Study|Lost to Follow-up|14
5855587|NCT02127970|20249206|P2|Overall Study|Death|1
5855588|NCT02127970|20249207|P1|Overall Study|Death|1
5855589|NCT02127970|20249206|P2|Overall Study|Adverse Event|1
5855590|NCT02127970|20249207|P1|Overall Study|Adverse Event|2
5855591|NCT02127931|20249229|P1|Overall Study|Glitch in Game|1
5855592|NCT02127372|20249355|P2|Overall Study|Withdrawal by Subject|0
5855593|NCT02127372|20249356|P1|Overall Study|Withdrawal by Subject|1
5855594|NCT02127307|20249366|P1|Overall Study|Other than specified above|169
5855595|NCT02127307|20249366|P1|Overall Study|Death|101
5855596|NCT02127307|20249366|P1|Overall Study|Lost to Follow-up|2
5855597|NCT02127307|20249366|P1|Overall Study|Protocol Violation|36
5855598|NCT02127281|20249372|P2|Overall Study|Lost to Follow-up|0
5855599|NCT02127281|20249373|P1|Overall Study|Lost to Follow-up|1
5855600|NCT02127125|20249408|P9|Overall Study|Physician Decision|0
5855601|NCT02127125|20249409|P8|Overall Study|Physician Decision|0
5855602|NCT02127125|20249410|P7|Overall Study|Physician Decision|0
5855603|NCT02127125|20249411|P6|Overall Study|Physician Decision|2
5855604|NCT02127125|20249412|P5|Overall Study|Physician Decision|1
5855605|NCT02127125|20249413|P4|Overall Study|Physician Decision|0
5855606|NCT02127125|20249414|P3|Overall Study|Physician Decision|1
5855607|NCT02127125|20249415|P2|Overall Study|Physician Decision|0
5855608|NCT02127125|20249416|P1|Overall Study|Physician Decision|0
5855609|NCT02127125|20249408|P9|Overall Study|Withdrawal by Subject|0
5855610|NCT02127125|20249409|P8|Overall Study|Withdrawal by Subject|0
5855611|NCT02127125|20249410|P7|Overall Study|Withdrawal by Subject|0
5855612|NCT02127125|20249411|P6|Overall Study|Withdrawal by Subject|0
5855613|NCT02127125|20249412|P5|Overall Study|Withdrawal by Subject|0
5855614|NCT02127125|20249413|P4|Overall Study|Withdrawal by Subject|1
5855615|NCT02127125|20249414|P3|Overall Study|Withdrawal by Subject|0
5855616|NCT02127125|20249415|P2|Overall Study|Withdrawal by Subject|0
5855617|NCT02127125|20249416|P1|Overall Study|Withdrawal by Subject|0
5855618|NCT02127125|20249408|P9|Overall Study|Lost to Follow-up|0
5855619|NCT02127125|20249409|P8|Overall Study|Lost to Follow-up|0
5855620|NCT02127125|20249410|P7|Overall Study|Lost to Follow-up|0
5855621|NCT02127125|20249411|P6|Overall Study|Lost to Follow-up|1
5855622|NCT02127125|20249412|P5|Overall Study|Lost to Follow-up|2
5855623|NCT02127125|20249413|P4|Overall Study|Lost to Follow-up|0
5855624|NCT02127125|20249414|P3|Overall Study|Lost to Follow-up|0
5855625|NCT02127125|20249415|P2|Overall Study|Lost to Follow-up|0
5855626|NCT02127125|20249416|P1|Overall Study|Lost to Follow-up|0
5855627|NCT02126969|20249456|P2|Overall Study|Withdrawal by Subject|2
5855628|NCT02126969|20249457|P1|Overall Study|Withdrawal by Subject|1
5855629|NCT02126839|20249488|P2|Overall Study|Other|5
5855630|NCT02126839|20249489|P1|Overall Study|Other|5
5855631|NCT02126839|20249488|P2|Overall Study|Lost to Follow-up|4
5855632|NCT02126839|20249489|P1|Overall Study|Lost to Follow-up|1
5855633|NCT02126839|20249488|P2|Overall Study|Sponsor request|1
5855634|NCT02126839|20249489|P1|Overall Study|Sponsor request|0
5855635|NCT02126839|20249488|P2|Overall Study|Protocol Violation|3
5855636|NCT02126839|20249489|P1|Overall Study|Protocol Violation|2
5855637|NCT02126839|20249488|P2|Overall Study|Withdrawal by parent/guardian|0
5855638|NCT02126839|20249489|P1|Overall Study|Withdrawal by parent/guardian|1
5855639|NCT02126839|20249488|P2|Overall Study|Withdrawal by Subject|0
5855640|NCT02126839|20249489|P1|Overall Study|Withdrawal by Subject|1
5855641|NCT02126839|20249488|P2|Overall Study|Adverse Event|1
5855642|NCT02126839|20249489|P1|Overall Study|Adverse Event|0
5855643|NCT02126826|20249506|P7|Overall Study|Withdrawal by Subject|0
5855644|NCT02126826|20249507|P6|Overall Study|Withdrawal by Subject|0
5855645|NCT02126826|20249508|P5|Overall Study|Withdrawal by Subject|0
5855646|NCT02126826|20249509|P4|Overall Study|Withdrawal by Subject|1
5855647|NCT02126826|20249510|P3|Overall Study|Withdrawal by Subject|0
5855648|NCT02126826|20249511|P2|Overall Study|Withdrawal by Subject|0
5855649|NCT02126826|20249512|P1|Overall Study|Withdrawal by Subject|0
5855650|NCT02126670|20249580|P4|Overall Study|Withdrawal by Subject|1
5855651|NCT02126670|20249581|P3|Overall Study|Withdrawal by Subject|0
5855652|NCT02126670|20249582|P2|Overall Study|Withdrawal by Subject|0
5855653|NCT02126670|20249583|P1|Overall Study|Withdrawal by Subject|1
5855654|NCT02125877|20249635|P2|Overall Study|Adverse Event|4
5855655|NCT02125877|20249636|P1|Overall Study|Adverse Event|6
5855656|NCT02125877|20249635|P2|Overall Study|Protocol deviation|1
5855657|NCT02125877|20249636|P1|Overall Study|Protocol deviation|4
5855658|NCT02125877|20249635|P2|Overall Study|Withdrawal by Subject|1
5855659|NCT02125877|20249636|P1|Overall Study|Withdrawal by Subject|2
5855660|NCT02125877|20249635|P2|Overall Study|Participant/guardian decision|2
5855661|NCT02125877|20249636|P1|Overall Study|Participant/guardian decision|0
5855662|NCT02125877|20249635|P2|Overall Study|Administrative problems|1
5855663|NCT02125877|20249636|P1|Overall Study|Administrative problems|0
5855664|NCT02125877|20249635|P2|Overall Study|Death|1
5855665|NCT02125877|20249636|P1|Overall Study|Death|0
5855666|NCT02125877|20249635|P2|Overall Study|Physician Decision|0
5855667|NCT02125877|20249636|P1|Overall Study|Physician Decision|1
5855668|NCT02125838|20249666|P2|Overall Study|Lost to Follow-up|4
5855669|NCT02125838|20249667|P1|Overall Study|Lost to Follow-up|4
5855670|NCT02125734|20249685|P2|Period 2|Adverse Event|1
5855671|NCT02125734|20249686|P1|Period 2|Adverse Event|0
5855672|NCT02125604|20249696|P1|Overall Study|Adverse Event|20
5855673|NCT02125604|20249696|P1|Overall Study|Consent Withdrawn|4
5855674|NCT02125604|20249696|P1|Overall Study|Lost to Follow-up|2
5855675|NCT02125604|20249696|P1|Overall Study|Investigator Decision|1
5855676|NCT02125604|20249696|P1|Overall Study|Other|4
5855677|NCT02125461|20249712|P2|Overall Study|Death|115
5855678|NCT02125461|20249713|P1|Overall Study|Death|180
5855679|NCT02125461|20249712|P2|Overall Study|Lost to Follow-up|0
5855680|NCT02125461|20249713|P1|Overall Study|Lost to Follow-up|1
5855681|NCT02125461|20249712|P2|Overall Study|Withdrawal by Subject|14
5855682|NCT02125461|20249713|P1|Overall Study|Withdrawal by Subject|22
5855683|NCT02125331|20249744|P2|Overall Study|screen failure|0
5855684|NCT02125331|20249745|P1|Overall Study|screen failure|2
5855685|NCT02125331|20249744|P2|Overall Study|technical problem|0
5855686|NCT02125331|20249745|P1|Overall Study|technical problem|2
5855687|NCT02125331|20249744|P2|Overall Study|Protocol Violation|0
5855688|NCT02125331|20249745|P1|Overall Study|Protocol Violation|1
5855693|NCT02124811|20249821|P2|Overall Study|Withdrawal by Subject|0
5855694|NCT02124811|20249822|P1|Overall Study|Withdrawal by Subject|1
5855695|NCT02124811|20249821|P2|Overall Study|Early termination|2
5855696|NCT02124811|20249822|P1|Overall Study|Early termination|2
5855697|NCT02124798|20249838|P1|Overall Study|Lost to Follow-up|1
5855698|NCT02124798|20249838|P1|Overall Study|Adverse Event|3
5855699|NCT02124707|20249844|P1|Overall Study|Death|1
5855700|NCT02124707|20249844|P1|Overall Study|Physician Decision|1
5855701|NCT02124707|20249844|P1|Overall Study|Adverse Event|5
5855702|NCT02124564|20249858|P1|Treatment Period|Withdrawal by Subject|2
5855703|NCT02124564|20249858|P1|Treatment Period|Lack of Efficacy|3
5855704|NCT02124564|20249858|P1|Treatment Period|Adverse Event|2
5855705|NCT02124265|20249923|P1|Overall Study|Adverse Event|1
5855706|NCT02124161|20249929|P2|Overall Study|Lost to Follow-up|4
5855707|NCT02124161|20249930|P1|Overall Study|Lost to Follow-up|3
5855708|NCT02124161|20249929|P2|Overall Study|No longer meets eligibility criteria|4
5855709|NCT02124161|20249930|P1|Overall Study|No longer meets eligibility criteria|5
5855710|NCT02124161|20249929|P2|Overall Study|Does not meet entrance criteria|3
5855711|NCT02124161|20249930|P1|Overall Study|Does not meet entrance criteria|2
5855712|NCT02124161|20249929|P2|Overall Study|Adverse Event|0
5855713|NCT02124161|20249930|P1|Overall Study|Adverse Event|2
5855714|NCT02124161|20249929|P2|Overall Study|Withdrawal by Subject|2
5855715|NCT02124161|20249930|P1|Overall Study|Withdrawal by Subject|1
5855716|NCT02124161|20249929|P2|Overall Study|Protocol Violation|1
5855717|NCT02124161|20249930|P1|Overall Study|Protocol Violation|2
5855718|NCT02124161|20249929|P2|Overall Study|Death|0
5855719|NCT02124161|20249930|P1|Overall Study|Death|1
5855720|NCT02124161|20249929|P2|Overall Study|Other unspecified|1
5855721|NCT02124161|20249930|P1|Overall Study|Other unspecified|0
5855722|NCT02123966|20250005|P1|Overall Study|Intercurrent Illness|1
5855723|NCT02123797|20250039|P5|6-month Follow up (Cumulative Counts)|Relocation|0
5855724|NCT02123797|20250040|P4|6-month Follow up (Cumulative Counts)|Relocation|0
5855725|NCT02123797|20250041|P3|6-month Follow up (Cumulative Counts)|Relocation|0
5855726|NCT02123797|20250042|P2|6-month Follow up (Cumulative Counts)|Relocation|2
5855727|NCT02123797|20250043|P1|6-month Follow up (Cumulative Counts)|Relocation|0
5855728|NCT02123797|20250039|P5|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0
5855729|NCT02123797|20250040|P4|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0
5855730|NCT02123797|20250041|P3|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0
5855731|NCT02123797|20250042|P2|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|9
5855732|NCT02123797|20250043|P1|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|1
5855733|NCT02123797|20250039|P5|6-month Follow up (Cumulative Counts)|Lost to Follow-up|3
5855734|NCT02123797|20250040|P4|6-month Follow up (Cumulative Counts)|Lost to Follow-up|113
5855735|NCT02123797|20250041|P3|6-month Follow up (Cumulative Counts)|Lost to Follow-up|66
5855736|NCT02123797|20250042|P2|6-month Follow up (Cumulative Counts)|Lost to Follow-up|20
5855737|NCT02123797|20250043|P1|6-month Follow up (Cumulative Counts)|Lost to Follow-up|3
5855738|NCT02123797|20250039|P5|6-month Follow up (Cumulative Counts)|Death|0
5855739|NCT02123797|20250040|P4|6-month Follow up (Cumulative Counts)|Death|0
5855740|NCT02123797|20250041|P3|6-month Follow up (Cumulative Counts)|Death|0
5855741|NCT02123797|20250042|P2|6-month Follow up (Cumulative Counts)|Death|97
5855742|NCT02123797|20250043|P1|6-month Follow up (Cumulative Counts)|Death|51
5855743|NCT02123797|20250039|P5|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0
5855744|NCT02123797|20250040|P4|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0
5855745|NCT02123797|20250041|P3|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0
5855746|NCT02123797|20250042|P2|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|36
5855747|NCT02123797|20250043|P1|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|16
5855748|NCT02123797|20250039|P5|3-month Follow up (Cumulative Counts)|Relocation|0
5855749|NCT02123797|20250040|P4|3-month Follow up (Cumulative Counts)|Relocation|0
5855750|NCT02123797|20250041|P3|3-month Follow up (Cumulative Counts)|Relocation|0
5855751|NCT02123797|20250042|P2|3-month Follow up (Cumulative Counts)|Relocation|1
5855752|NCT02123797|20250043|P1|3-month Follow up (Cumulative Counts)|Relocation|0
5855753|NCT02123797|20250039|P5|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0
5855754|NCT02123797|20250040|P4|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0
5855755|NCT02123797|20250041|P3|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0
5855756|NCT02123797|20250042|P2|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|16
5855757|NCT02123797|20250043|P1|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|6
5855758|NCT02123797|20250039|P5|3-month Follow up (Cumulative Counts)|Lost to Follow-up|3
5855759|NCT02123797|20250040|P4|3-month Follow up (Cumulative Counts)|Lost to Follow-up|82
5855760|NCT02123797|20250041|P3|3-month Follow up (Cumulative Counts)|Lost to Follow-up|50
5855761|NCT02123797|20250042|P2|3-month Follow up (Cumulative Counts)|Lost to Follow-up|7
5855762|NCT02123797|20250043|P1|3-month Follow up (Cumulative Counts)|Lost to Follow-up|2
5855763|NCT02123797|20250039|P5|3-month Follow up (Cumulative Counts)|Death|0
5855764|NCT02123797|20250040|P4|3-month Follow up (Cumulative Counts)|Death|0
5855765|NCT02123797|20250041|P3|3-month Follow up (Cumulative Counts)|Death|0
5855766|NCT02123797|20250042|P2|3-month Follow up (Cumulative Counts)|Death|57
5855767|NCT02123797|20250043|P1|3-month Follow up (Cumulative Counts)|Death|33
5855768|NCT02123797|20250039|P5|Baseline Intervention|Other Disease|0
5855769|NCT02123797|20250040|P4|Baseline Intervention|Other Disease|0
5855770|NCT02123797|20250041|P3|Baseline Intervention|Other Disease|0
5855771|NCT02123797|20250042|P2|Baseline Intervention|Other Disease|0
5855772|NCT02123797|20250043|P1|Baseline Intervention|Other Disease|3
5855773|NCT02123797|20250039|P5|Baseline Intervention|Lost to Follow-up|0
5855774|NCT02123797|20250040|P4|Baseline Intervention|Lost to Follow-up|0
5855775|NCT02123797|20250041|P3|Baseline Intervention|Lost to Follow-up|0
5855776|NCT02123797|20250042|P2|Baseline Intervention|Lost to Follow-up|5
5855777|NCT02123797|20250043|P1|Baseline Intervention|Lost to Follow-up|0
5855778|NCT02123797|20250039|P5|Baseline Intervention|Out of window for initial survey|0
5855779|NCT02123797|20250040|P4|Baseline Intervention|Out of window for initial survey|0
5855780|NCT02123797|20250041|P3|Baseline Intervention|Out of window for initial survey|0
5855781|NCT02123797|20250042|P2|Baseline Intervention|Out of window for initial survey|13
5855782|NCT02123797|20250043|P1|Baseline Intervention|Out of window for initial survey|6
5855783|NCT02123797|20250039|P5|Baseline Intervention|Relocation|0
5855784|NCT02123797|20250040|P4|Baseline Intervention|Relocation|0
5855785|NCT02123797|20250041|P3|Baseline Intervention|Relocation|0
5855786|NCT02123797|20250042|P2|Baseline Intervention|Relocation|0
5855787|NCT02123797|20250043|P1|Baseline Intervention|Relocation|2
5855788|NCT02123797|20250039|P5|Baseline Intervention|Withdrawal by Subject|0
5855789|NCT02123797|20250040|P4|Baseline Intervention|Withdrawal by Subject|0
5855790|NCT02123797|20250041|P3|Baseline Intervention|Withdrawal by Subject|0
5855791|NCT02123797|20250042|P2|Baseline Intervention|Withdrawal by Subject|8
5855792|NCT02123797|20250043|P1|Baseline Intervention|Withdrawal by Subject|2
5855793|NCT02123797|20250039|P5|Baseline Intervention|Death|0
5855794|NCT02123797|20250040|P4|Baseline Intervention|Death|0
5855795|NCT02123797|20250041|P3|Baseline Intervention|Death|0
5855796|NCT02123797|20250042|P2|Baseline Intervention|Death|16
5855797|NCT02123797|20250043|P1|Baseline Intervention|Death|9
5855798|NCT02123576|20250152|P2|Overall Study|Adverse Event|0
5855799|NCT02123576|20250153|P1|Overall Study|Adverse Event|1
5855800|NCT02123511|20250171|P2|Overall Study|Ineligible|1
5855801|NCT02123511|20250172|P1|Overall Study|Ineligible|0
5855802|NCT02123511|20250171|P2|Overall Study|Incomplete data|3
5855803|NCT02123511|20250172|P1|Overall Study|Incomplete data|1
5855804|NCT02123511|20250171|P2|Overall Study|Cancelled treatment|0
5855805|NCT02123511|20250172|P1|Overall Study|Cancelled treatment|1
5855806|NCT02123472|20250196|P2|Period 2 (7 Days)|Withdrawal by Subject|1
5855807|NCT02123472|20250197|P1|Period 2 (7 Days)|Withdrawal by Subject|0
5855808|NCT02123459|20250207|P2|Washout Period (1 Day)|Adverse Event|0
5855809|NCT02123459|20250208|P1|Washout Period (1 Day)|Adverse Event|1
5855810|NCT02123446|20250218|P2|Washout Period (1 Day)|Physician Decision|0
5855811|NCT02123446|20250219|P1|Washout Period (1 Day)|Physician Decision|1
5855812|NCT02123251|20250260|P2|Overall Study|Switched Managed Care Organization (MCO)|4
5855813|NCT02123251|20250261|P1|Overall Study|Switched Managed Care Organization (MCO)|4
5855814|NCT02123251|20250260|P2|Overall Study|Lost Medicaid eligibility|22
5855815|NCT02123251|20250261|P1|Overall Study|Lost Medicaid eligibility|29
5855816|NCT02123251|20250260|P2|Overall Study|Withdrawal by Subject|3
5855817|NCT02123251|20250261|P1|Overall Study|Withdrawal by Subject|0
5855818|NCT02123251|20250260|P2|Overall Study|Death|1
5855819|NCT02123251|20250261|P1|Overall Study|Death|1
5855820|NCT02123134|20250287|P2|Overall Study|Administrative decision|1
5855821|NCT02123134|20250288|P1|Overall Study|Administrative decision|0
5855822|NCT02123134|20250287|P2|Overall Study|Withdrawal of consent|2
5855823|NCT02123134|20250288|P1|Overall Study|Withdrawal of consent|3
5855824|NCT02122887|20250345|P2|Overall Study|Withdrawal by Subject|2
5855825|NCT02122887|20250346|P1|Overall Study|Withdrawal by Subject|20
5855826|NCT02122783|20250384|P2|Overall Study|Adverse Event|1
5855827|NCT02122783|20250385|P1|Overall Study|Adverse Event|0
5855828|NCT02122770|20250399|P6|Part B: Standard of Care|Progressive Disease|8
5855829|NCT02122770|20250400|P5|Part B: Standard of Care|Progressive Disease|10
5855830|NCT02122770|20250401|P4|Part B: Standard of Care|Progressive Disease|0
5855831|NCT02122770|20250402|P3|Part B: Standard of Care|Progressive Disease|0
5855832|NCT02122770|20250403|P2|Part B: Standard of Care|Progressive Disease|0
5855833|NCT02122770|20250404|P1|Part B: Standard of Care|Progressive Disease|0
5855834|NCT02122770|20250399|P6|Part B: Standard of Care|Symptomatic Deterioration|0
5855835|NCT02122770|20250400|P5|Part B: Standard of Care|Symptomatic Deterioration|5
5855836|NCT02122770|20250401|P4|Part B: Standard of Care|Symptomatic Deterioration|0
5855837|NCT02122770|20250402|P3|Part B: Standard of Care|Symptomatic Deterioration|0
5855838|NCT02122770|20250403|P2|Part B: Standard of Care|Symptomatic Deterioration|0
5855839|NCT02122770|20250404|P1|Part B: Standard of Care|Symptomatic Deterioration|0
5855840|NCT02122770|20250399|P6|Part B: Standard of Care|Withdrawal by Subject|2
5855841|NCT02122770|20250400|P5|Part B: Standard of Care|Withdrawal by Subject|4
5855842|NCT02122770|20250401|P4|Part B: Standard of Care|Withdrawal by Subject|0
5855843|NCT02122770|20250402|P3|Part B: Standard of Care|Withdrawal by Subject|0
5855844|NCT02122770|20250403|P2|Part B: Standard of Care|Withdrawal by Subject|0
5855845|NCT02122770|20250404|P1|Part B: Standard of Care|Withdrawal by Subject|0
5855846|NCT02122770|20250399|P6|Part B: Standard of Care|Other|2
5855847|NCT02122770|20250400|P5|Part B: Standard of Care|Other|0
5855848|NCT02122770|20250401|P4|Part B: Standard of Care|Other|0
5855849|NCT02122770|20250402|P3|Part B: Standard of Care|Other|0
5855850|NCT02122770|20250403|P2|Part B: Standard of Care|Other|0
5855851|NCT02122770|20250404|P1|Part B: Standard of Care|Other|0
5855852|NCT02122770|20250399|P6|Part B: Standard of Care|Adverse Event|1
5855853|NCT02122770|20250400|P5|Part B: Standard of Care|Adverse Event|4
5855854|NCT02122770|20250401|P4|Part B: Standard of Care|Adverse Event|0
5855855|NCT02122770|20250402|P3|Part B: Standard of Care|Adverse Event|0
5855856|NCT02122770|20250403|P2|Part B: Standard of Care|Adverse Event|0
5855857|NCT02122770|20250404|P1|Part B: Standard of Care|Adverse Event|0
5855858|NCT02122770|20250399|P6|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0
5855859|NCT02122770|20250400|P5|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0
5855860|NCT02122770|20250401|P4|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1
5855861|NCT02122770|20250402|P3|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0
5855862|NCT02122770|20250403|P2|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|5
5855863|NCT02122770|20250404|P1|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1
5855864|NCT02122770|20250399|P6|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0
5855865|NCT02122770|20250400|P5|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0
5855866|NCT02122770|20250401|P4|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0
5855867|NCT02122770|20250402|P3|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0
5855868|NCT02122770|20250403|P2|Part A: Drug-drug Interaction 2|Withdrawal by Subject|1
5855869|NCT02122770|20250404|P1|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0
5855870|NCT02122770|20250399|P6|Part A: Drug-drug Interaction 2|Other|0
5855871|NCT02122770|20250400|P5|Part A: Drug-drug Interaction 2|Other|0
5855872|NCT02122770|20250401|P4|Part A: Drug-drug Interaction 2|Other|0
5855873|NCT02122770|20250402|P3|Part A: Drug-drug Interaction 2|Other|1
5855874|NCT02122770|20250403|P2|Part A: Drug-drug Interaction 2|Other|0
5855875|NCT02122770|20250404|P1|Part A: Drug-drug Interaction 2|Other|0
5855876|NCT02122770|20250399|P6|Part A: Drug-drug Interaction 2|Adverse Event|0
5855877|NCT02122770|20250400|P5|Part A: Drug-drug Interaction 2|Adverse Event|0
5855878|NCT02122770|20250401|P4|Part A: Drug-drug Interaction 2|Adverse Event|2
5855879|NCT02122770|20250402|P3|Part A: Drug-drug Interaction 2|Adverse Event|1
5855880|NCT02122770|20250403|P2|Part A: Drug-drug Interaction 2|Adverse Event|0
5855881|NCT02122770|20250404|P1|Part A: Drug-drug Interaction 2|Adverse Event|3
5855882|NCT02122380|20250524|P2|Second Intervention (30 Days)|2 did not complete all of inpatient day|2
5855883|NCT02122380|20250525|P1|Second Intervention (30 Days)|2 did not complete all of inpatient day|0
5855884|NCT02122380|20250524|P2|Washout (8 Weeks)|No Longer Met Inclusion Criteria|2
5855885|NCT02122380|20250525|P1|Washout (8 Weeks)|No Longer Met Inclusion Criteria|0
5855886|NCT02122380|20250524|P2|Washout (8 Weeks)|Lost to Follow-up|0
5855887|NCT02122380|20250525|P1|Washout (8 Weeks)|Lost to Follow-up|1
5855888|NCT02122380|20250524|P2|First Intervention (30 Days)|Physician Decision|1
5855889|NCT02122380|20250525|P1|First Intervention (30 Days)|Physician Decision|0
5855890|NCT02122380|20250524|P2|First Intervention (30 Days)|Adverse Event|0
5855891|NCT02122380|20250525|P1|First Intervention (30 Days)|Adverse Event|1
5855892|NCT02122146|20250564|P8|Part 1: Dose Escalation|Other|2
5855893|NCT02122146|20250565|P7|Part 1: Dose Escalation|Other|1
5855894|NCT02122146|20250566|P6|Part 1: Dose Escalation|Other|1
5855895|NCT02122146|20250567|P5|Part 1: Dose Escalation|Other|0
5855896|NCT02122146|20250568|P4|Part 1: Dose Escalation|Other|0
5855897|NCT02122146|20250569|P3|Part 1: Dose Escalation|Other|0
5855898|NCT02122146|20250570|P2|Part 1: Dose Escalation|Other|0
5855899|NCT02122146|20250571|P1|Part 1: Dose Escalation|Other|1
5855900|NCT02122146|20250564|P8|Part 1: Dose Escalation|Withdrawal by Subject|0
5855901|NCT02122146|20250565|P7|Part 1: Dose Escalation|Withdrawal by Subject|0
5855902|NCT02122146|20250566|P6|Part 1: Dose Escalation|Withdrawal by Subject|0
5855903|NCT02122146|20250567|P5|Part 1: Dose Escalation|Withdrawal by Subject|0
5855904|NCT02122146|20250568|P4|Part 1: Dose Escalation|Withdrawal by Subject|1
5855905|NCT02122146|20250569|P3|Part 1: Dose Escalation|Withdrawal by Subject|0
5855906|NCT02122146|20250570|P2|Part 1: Dose Escalation|Withdrawal by Subject|0
5855907|NCT02122146|20250571|P1|Part 1: Dose Escalation|Withdrawal by Subject|0
5855908|NCT02122146|20250564|P8|Part 1: Dose Escalation|Lost to Follow-up|0
5855909|NCT02122146|20250565|P7|Part 1: Dose Escalation|Lost to Follow-up|0
5855910|NCT02122146|20250566|P6|Part 1: Dose Escalation|Lost to Follow-up|0
5855911|NCT02122146|20250567|P5|Part 1: Dose Escalation|Lost to Follow-up|1
5855912|NCT02122146|20250568|P4|Part 1: Dose Escalation|Lost to Follow-up|0
5855913|NCT02122146|20250569|P3|Part 1: Dose Escalation|Lost to Follow-up|1
5855914|NCT02122146|20250570|P2|Part 1: Dose Escalation|Lost to Follow-up|0
5855915|NCT02122146|20250571|P1|Part 1: Dose Escalation|Lost to Follow-up|0
5855916|NCT02122146|20250564|P8|Part 1: Dose Escalation|Death|0
5855917|NCT02122146|20250565|P7|Part 1: Dose Escalation|Death|0
5855918|NCT02122146|20250566|P6|Part 1: Dose Escalation|Death|0
5855919|NCT02122146|20250567|P5|Part 1: Dose Escalation|Death|0
5855920|NCT02122146|20250568|P4|Part 1: Dose Escalation|Death|0
5855921|NCT02122146|20250569|P3|Part 1: Dose Escalation|Death|1
5855922|NCT02122146|20250570|P2|Part 1: Dose Escalation|Death|1
5855923|NCT02122146|20250571|P1|Part 1: Dose Escalation|Death|0
5855924|NCT02121847|20250845|P1|Overall Study|Adverse Event|2
5855925|NCT02121847|20250845|P1|Overall Study|Administrative Reasons|1
5855926|NCT02121834|20250871|P7|Overall Study|Lost to Follow-up|0
5855927|NCT02121834|20250872|P6|Overall Study|Lost to Follow-up|0
5855928|NCT02121834|20250873|P5|Overall Study|Lost to Follow-up|0
5855929|NCT02121834|20250874|P4|Overall Study|Lost to Follow-up|0
5855930|NCT02121834|20250875|P3|Overall Study|Lost to Follow-up|1
5855931|NCT02121834|20250876|P2|Overall Study|Lost to Follow-up|0
5855932|NCT02121834|20250877|P1|Overall Study|Lost to Follow-up|0
5855933|NCT02121834|20250871|P7|Overall Study|Withdrawal by Subject|0
5855934|NCT02121834|20250872|P6|Overall Study|Withdrawal by Subject|0
5855935|NCT02121834|20250873|P5|Overall Study|Withdrawal by Subject|0
5855936|NCT02121834|20250874|P4|Overall Study|Withdrawal by Subject|0
5855937|NCT02121834|20250875|P3|Overall Study|Withdrawal by Subject|1
5855938|NCT02121834|20250876|P2|Overall Study|Withdrawal by Subject|1
5855939|NCT02121834|20250877|P1|Overall Study|Withdrawal by Subject|0
5855940|NCT02121834|20250871|P7|Overall Study|Protocol Violation|0
5855941|NCT02121834|20250872|P6|Overall Study|Protocol Violation|0
5855942|NCT02121834|20250873|P5|Overall Study|Protocol Violation|0
5855943|NCT02121834|20250874|P4|Overall Study|Protocol Violation|0
5855944|NCT02121834|20250875|P3|Overall Study|Protocol Violation|0
5855945|NCT02121834|20250876|P2|Overall Study|Protocol Violation|1
5855946|NCT02121834|20250877|P1|Overall Study|Protocol Violation|0
5855947|NCT02121808|20250903|P1|Overall Study|Technical problem|3
5855948|NCT02121795|20250914|P2|Open-Label Phase|Lost to Follow-up|0
5855949|NCT02121795|20250915|P1|Open-Label Phase|Lost to Follow-up|1
5855950|NCT02121795|20250914|P2|Open-Label Phase|Withdrawal by Subject|2
5855951|NCT02121795|20250915|P1|Open-Label Phase|Withdrawal by Subject|3
5855952|NCT02121795|20250914|P2|Open-Label Phase|Physician Decision|8
5855953|NCT02121795|20250915|P1|Open-Label Phase|Physician Decision|8
5855954|NCT02121795|20250914|P2|Double-Blind Phase|Death|1
5855955|NCT02121795|20250915|P1|Double-Blind Phase|Death|1
5855956|NCT02121795|20250914|P2|Double-Blind Phase|Protocol Violation|3
5855957|NCT02121795|20250915|P1|Double-Blind Phase|Protocol Violation|0
5855958|NCT02121795|20250914|P2|Double-Blind Phase|Non-Compliance with Study Drug|1
5855959|NCT02121795|20250915|P1|Double-Blind Phase|Non-Compliance with Study Drug|3
5855960|NCT02121795|20250914|P2|Double-Blind Phase|Adverse Event|0
5855961|NCT02121795|20250915|P1|Double-Blind Phase|Adverse Event|5
5855962|NCT02121795|20250914|P2|Double-Blind Phase|Physician Decision|5
5855963|NCT02121795|20250915|P1|Double-Blind Phase|Physician Decision|2
5855964|NCT02121795|20250914|P2|Double-Blind Phase|Lost to Follow-up|4
5855965|NCT02121795|20250915|P1|Double-Blind Phase|Lost to Follow-up|7
5855966|NCT02121795|20250914|P2|Double-Blind Phase|Withdrawal by Subject|16
5855967|NCT02121795|20250915|P1|Double-Blind Phase|Withdrawal by Subject|19
5855968|NCT02121795|20250914|P2|Double-Blind Phase|Randomized but Never Treated|4
5855969|NCT02121795|20250915|P1|Double-Blind Phase|Randomized but Never Treated|1
5855970|NCT02121756|20250943|P2|Overall Study|Physician Decision|1
5855971|NCT02121756|20250944|P1|Overall Study|Physician Decision|2
5855972|NCT02121756|20250943|P2|Overall Study|Protocol Violation|1
5855973|NCT02121756|20250944|P1|Overall Study|Protocol Violation|1
5855974|NCT02121756|20250943|P2|Overall Study|Adverse Event|0
5855975|NCT02121756|20250944|P1|Overall Study|Adverse Event|3
5855976|NCT02121535|20250981|P2|Period 3 (8 Trial Days)|Withdrawal by Subject|0
5855977|NCT02121535|20250982|P1|Period 3 (8 Trial Days)|Withdrawal by Subject|1
5855978|NCT02121535|20250981|P2|Period 1 (8 Trial Days)|Withdrawal by Subject|1
5855979|NCT02121535|20250982|P1|Period 1 (8 Trial Days)|Withdrawal by Subject|0
5855980|NCT02121522|20251005|P1|Overall Study|Adverse Event|1
5855981|NCT02121509|20251012|P4|Washout Period (35 Days)|elevated AST and ALT levels|0
5855982|NCT02121509|20251013|P3|Washout Period (35 Days)|elevated AST and ALT levels|0
5855983|NCT02121509|20251014|P2|Washout Period (35 Days)|elevated AST and ALT levels|0
5855984|NCT02121509|20251015|P1|Washout Period (35 Days)|elevated AST and ALT levels|1
5855985|NCT02121509|20251012|P4|Washout Period (35 Days)|Withdrawal by Subject|0
5855986|NCT02121509|20251013|P3|Washout Period (35 Days)|Withdrawal by Subject|0
5855987|NCT02121509|20251014|P2|Washout Period (35 Days)|Withdrawal by Subject|3
5855988|NCT02121509|20251015|P1|Washout Period (35 Days)|Withdrawal by Subject|0
5855989|NCT02121509|20251012|P4|Washout Period (35 Days)|Adverse Event|0
5855990|NCT02121509|20251013|P3|Washout Period (35 Days)|Adverse Event|0
5855991|NCT02121509|20251014|P2|Washout Period (35 Days)|Adverse Event|1
5855992|NCT02121509|20251015|P1|Washout Period (35 Days)|Adverse Event|1
5855993|NCT02121392|20251086|P2|After Placement of AC Block vs Sham|Lost to Follow-up|1
5855994|NCT02121392|20251087|P1|After Placement of AC Block vs Sham|Lost to Follow-up|0
5855995|NCT02121392|20251086|P2|After Placement of AC Block vs Sham|Protocol Violation|2
5855996|NCT02121392|20251087|P1|After Placement of AC Block vs Sham|Protocol Violation|3
5855997|NCT02121392|20251086|P2|Prior to Intervention|Withdrawal by Subject|6
5855998|NCT02121392|20251087|P1|Prior to Intervention|Withdrawal by Subject|8
5855999|NCT02121392|20251086|P2|Prior to Intervention|Protocol Violation|35
5856000|NCT02121392|20251087|P1|Prior to Intervention|Protocol Violation|40
5856001|NCT02121301|20251112|P3|Overall Study|Protocol Violation|1
5856002|NCT02121301|20251113|P2|Overall Study|Protocol Violation|4
5856003|NCT02121301|20251114|P1|Overall Study|Protocol Violation|1
5856004|NCT02121262|20251127|P2|Overall Study|Consent Withdrawn|0
5856005|NCT02121262|20251128|P1|Overall Study|Consent Withdrawn|1
5856006|NCT02121262|20251127|P2|Overall Study|Participant was Deemed Unsuitable|0
5856007|NCT02121262|20251128|P1|Overall Study|Participant was Deemed Unsuitable|1
5856008|NCT02121262|20251127|P2|Overall Study|Participant Dropped-out|1
5856009|NCT02121262|20251128|P1|Overall Study|Participant Dropped-out|0
5856010|NCT02121262|20251127|P2|Overall Study|Protocol Violation|1
5856011|NCT02121262|20251128|P1|Overall Study|Protocol Violation|1
5856012|NCT02121262|20251127|P2|Overall Study|Personal Reasons|5
5856013|NCT02121262|20251128|P1|Overall Study|Personal Reasons|19
5856014|NCT02121262|20251127|P2|Overall Study|Lack of Efficacy|0
5856015|NCT02121262|20251128|P1|Overall Study|Lack of Efficacy|3
5856016|NCT02121262|20251127|P2|Overall Study|Adverse Event|3
5856017|NCT02121262|20251128|P1|Overall Study|Adverse Event|6
5856018|NCT02121210|20251142|P2|Overall Study|Other than specified above|2
5856019|NCT02121210|20251143|P1|Overall Study|Other than specified above|0
5856020|NCT02121210|20251142|P2|Overall Study|Lack of Efficacy|0
5856021|NCT02121210|20251143|P1|Overall Study|Lack of Efficacy|2
5856022|NCT02121210|20251142|P2|Overall Study|Adverse Event|7
5856023|NCT02121210|20251143|P1|Overall Study|Adverse Event|5
5856024|NCT02120950|20251168|P3|Overall Study|Lost to Follow-up|1
5856025|NCT02120950|20251169|P2|Overall Study|Lost to Follow-up|2
5856026|NCT02120950|20251170|P1|Overall Study|Lost to Follow-up|0
5856027|NCT02120950|20251168|P3|Overall Study|Other reasons|1
5856028|NCT02120950|20251169|P2|Overall Study|Other reasons|4
5856029|NCT02120950|20251170|P1|Overall Study|Other reasons|5
5856030|NCT02120950|20251168|P3|Overall Study|Protocol Violation|7
5856031|NCT02120950|20251169|P2|Overall Study|Protocol Violation|1
5856032|NCT02120950|20251170|P1|Overall Study|Protocol Violation|1
5856033|NCT02120950|20251168|P3|Overall Study|Withdrawal by Subject|2
5856034|NCT02120950|20251169|P2|Overall Study|Withdrawal by Subject|3
5856035|NCT02120950|20251170|P1|Overall Study|Withdrawal by Subject|6
5856036|NCT02120950|20251168|P3|Overall Study|Death|1
5856037|NCT02120950|20251169|P2|Overall Study|Death|0
5856038|NCT02120950|20251170|P1|Overall Study|Death|3
5856039|NCT02120950|20251168|P3|Overall Study|Adverse Event|3
5856040|NCT02120950|20251169|P2|Overall Study|Adverse Event|4
5856041|NCT02120950|20251170|P1|Overall Study|Adverse Event|5
5856042|NCT02120924|20251206|P3|Overall Study|Compliance with IP|1
5856043|NCT02120924|20251207|P2|Overall Study|Compliance with IP|1
5856044|NCT02120924|20251208|P1|Overall Study|Compliance with IP|5
5856045|NCT02120924|20251206|P3|Overall Study|Death|0
5856046|NCT02120924|20251207|P2|Overall Study|Death|0
5856047|NCT02120924|20251208|P1|Overall Study|Death|1
5856048|NCT02120924|20251206|P3|Overall Study|Physician Decision|1
5856049|NCT02120924|20251207|P2|Overall Study|Physician Decision|1
5856050|NCT02120924|20251208|P1|Overall Study|Physician Decision|0
5856051|NCT02120924|20251206|P3|Overall Study|Protocol Violation|2
5856052|NCT02120924|20251207|P2|Overall Study|Protocol Violation|7
5856053|NCT02120924|20251208|P1|Overall Study|Protocol Violation|3
5856054|NCT02120924|20251206|P3|Overall Study|Pregnancy|0
5856055|NCT02120924|20251207|P2|Overall Study|Pregnancy|0
5856056|NCT02120924|20251208|P1|Overall Study|Pregnancy|2
5856057|NCT02120924|20251206|P3|Overall Study|Lost to Follow-up|11
5856058|NCT02120924|20251207|P2|Overall Study|Lost to Follow-up|14
5856059|NCT02120924|20251208|P1|Overall Study|Lost to Follow-up|14
5856060|NCT02120924|20251206|P3|Overall Study|Withdrawal by Subject|8
5856061|NCT02120924|20251207|P2|Overall Study|Withdrawal by Subject|20
5856062|NCT02120924|20251208|P1|Overall Study|Withdrawal by Subject|16
5856063|NCT02120924|20251206|P3|Overall Study|Adverse Event|3
5856064|NCT02120924|20251207|P2|Overall Study|Adverse Event|1
5856065|NCT02120924|20251208|P1|Overall Study|Adverse Event|0
5856066|NCT02120924|20251206|P3|Overall Study|Lack of Efficacy|3
5856067|NCT02120924|20251207|P2|Overall Study|Lack of Efficacy|2
5856068|NCT02120924|20251208|P1|Overall Study|Lack of Efficacy|1
5856069|NCT02120898|20251222|P3|Overall Study|Lost to Follow-up|1
5856070|NCT02120898|20251223|P2|Overall Study|Lost to Follow-up|0
5856071|NCT02120898|20251224|P1|Overall Study|Lost to Follow-up|0
5856072|NCT02120898|20251222|P3|Overall Study|Protocol Violation|0
5856073|NCT02120898|20251223|P2|Overall Study|Protocol Violation|2
5856074|NCT02120898|20251224|P1|Overall Study|Protocol Violation|1
5856075|NCT02120898|20251222|P3|Overall Study|Adverse Event|1
5856076|NCT02120898|20251223|P2|Overall Study|Adverse Event|2
5856077|NCT02120898|20251224|P1|Overall Study|Adverse Event|1
5856078|NCT02120898|20251222|P3|Overall Study|Non-compliance with study drug|0
5856079|NCT02120898|20251223|P2|Overall Study|Non-compliance with study drug|0
5856080|NCT02120898|20251224|P1|Overall Study|Non-compliance with study drug|3
5856081|NCT02120898|20251222|P3|Overall Study|Withdrawal by Subject|2
5856082|NCT02120898|20251223|P2|Overall Study|Withdrawal by Subject|2
5856083|NCT02120898|20251224|P1|Overall Study|Withdrawal by Subject|4
5856084|NCT02120833|20251246|P2|Overall Study|Lost to Follow-up|1
5856085|NCT02120833|20251247|P1|Overall Study|Lost to Follow-up|1
5856086|NCT02120833|20251246|P2|Overall Study|Withdrawal by Subject|0
5856087|NCT02120833|20251247|P1|Overall Study|Withdrawal by Subject|2
5856088|NCT02120833|20251246|P2|Overall Study|Adverse Event|0
5856089|NCT02120833|20251247|P1|Overall Study|Adverse Event|1
5856090|NCT02120794|20251401|P1|Overall Study|Due to insurance coverage|1
5856091|NCT02120794|20251401|P1|Overall Study|Physician Decision|4
5856092|NCT02120794|20251401|P1|Overall Study|Adverse Event|10
5856093|NCT02120794|20251401|P1|Overall Study|Withdrawal by Subject|43
5856094|NCT02120664|20251425|P5|Overall Study|Withdrawal by Subject|0
5856095|NCT02120664|20251426|P4|Overall Study|Withdrawal by Subject|1
5856096|NCT02120664|20251427|P3|Overall Study|Withdrawal by Subject|0
5856097|NCT02120664|20251428|P2|Overall Study|Withdrawal by Subject|0
5856098|NCT02120664|20251429|P1|Overall Study|Withdrawal by Subject|0
5856099|NCT02120625|20251447|P1|Overall Study|Physician Decision|2
5856100|NCT02120456|20251463|P9|Part 2 Double-blind Phase|Unable to attend visit due to work|1
5856101|NCT02120456|20251464|P8|Part 2 Double-blind Phase|Unable to attend visit due to work|0
5856102|NCT02120456|20251465|P7|Part 2 Double-blind Phase|Unable to attend visit due to work|0
5856103|NCT02120456|20251466|P6|Part 2 Double-blind Phase|Unable to attend visit due to work|0
5856104|NCT02120456|20251467|P5|Part 2 Double-blind Phase|Unable to attend visit due to work|0
5856105|NCT02120456|20251468|P4|Part 2 Double-blind Phase|Unable to attend visit due to work|0
5856106|NCT02120456|20251469|P3|Part 2 Double-blind Phase|Unable to attend visit due to work|0
5856107|NCT02120456|20251470|P2|Part 2 Double-blind Phase|Unable to attend visit due to work|0
5856108|NCT02120456|20251471|P1|Part 2 Double-blind Phase|Unable to attend visit due to work|0
5856109|NCT02120456|20251463|P9|Part 2 Double-blind Phase|Withdrawal of consent|0
5856110|NCT02120456|20251464|P8|Part 2 Double-blind Phase|Withdrawal of consent|0
5856111|NCT02120456|20251465|P7|Part 2 Double-blind Phase|Withdrawal of consent|1
5856112|NCT02120456|20251466|P6|Part 2 Double-blind Phase|Withdrawal of consent|0
5856113|NCT02120456|20251467|P5|Part 2 Double-blind Phase|Withdrawal of consent|0
5856114|NCT02120456|20251468|P4|Part 2 Double-blind Phase|Withdrawal of consent|0
5856115|NCT02120456|20251469|P3|Part 2 Double-blind Phase|Withdrawal of consent|0
5856116|NCT02120456|20251470|P2|Part 2 Double-blind Phase|Withdrawal of consent|0
5856117|NCT02120456|20251471|P1|Part 2 Double-blind Phase|Withdrawal of consent|0
5856118|NCT02120456|20251463|P9|Part 2 Double-blind Phase|Lost to Follow-up|0
5856119|NCT02120456|20251464|P8|Part 2 Double-blind Phase|Lost to Follow-up|0
5856120|NCT02120456|20251465|P7|Part 2 Double-blind Phase|Lost to Follow-up|1
5856121|NCT02120456|20251466|P6|Part 2 Double-blind Phase|Lost to Follow-up|0
5856122|NCT02120456|20251467|P5|Part 2 Double-blind Phase|Lost to Follow-up|0
5856123|NCT02120456|20251468|P4|Part 2 Double-blind Phase|Lost to Follow-up|0
5856124|NCT02120456|20251469|P3|Part 2 Double-blind Phase|Lost to Follow-up|0
5856125|NCT02120456|20251470|P2|Part 2 Double-blind Phase|Lost to Follow-up|0
5856126|NCT02120456|20251471|P1|Part 2 Double-blind Phase|Lost to Follow-up|0
5856127|NCT02120417|20251505|P2|Overall Study|Other unspecified|4
5856128|NCT02120417|20251506|P1|Overall Study|Other unspecified|5
5856129|NCT02120417|20251505|P2|Overall Study|Physician Decision|3
5856130|NCT02120417|20251506|P1|Overall Study|Physician Decision|2
5856131|NCT02120417|20251505|P2|Overall Study|Noncompliance with study treatment|2
5856132|NCT02120417|20251506|P1|Overall Study|Noncompliance with study treatment|0
5856133|NCT02120417|20251505|P2|Overall Study|Disease progression|45
5856134|NCT02120417|20251506|P1|Overall Study|Disease progression|41
5856135|NCT02120417|20251505|P2|Overall Study|Participant decision|4
5856136|NCT02120417|20251506|P1|Overall Study|Participant decision|4
5856137|NCT02120417|20251505|P2|Overall Study|Adverse Event|9
5856138|NCT02120417|20251506|P1|Overall Study|Adverse Event|3
5856139|NCT02120417|20251505|P2|Overall Study|Death|1
5856140|NCT02120417|20251506|P1|Overall Study|Death|5
5856141|NCT02120352|20251524|P4|Maintenance Period (32 Weeks)|Ongoing at the time of interim analysis|50
5856142|NCT02120352|20251525|P3|Maintenance Period (32 Weeks)|Ongoing at the time of interim analysis|105
5856143|NCT02120352|20251526|P2|Maintenance Period (32 Weeks)|Ongoing at the time of interim analysis|112
5856144|NCT02120352|20251527|P1|Maintenance Period (32 Weeks)|Ongoing at the time of interim analysis|0
5856145|NCT02120352|20251524|P4|Maintenance Period (32 Weeks)|Withdrawal by Subject|2
5856146|NCT02120352|20251525|P3|Maintenance Period (32 Weeks)|Withdrawal by Subject|1
5856147|NCT02120352|20251526|P2|Maintenance Period (32 Weeks)|Withdrawal by Subject|2
5856148|NCT02120352|20251527|P1|Maintenance Period (32 Weeks)|Withdrawal by Subject|0
5856149|NCT02120352|20251524|P4|Maintenance Period (32 Weeks)|Lost to Follow-up|1
5856150|NCT02120352|20251525|P3|Maintenance Period (32 Weeks)|Lost to Follow-up|0
5856151|NCT02120352|20251526|P2|Maintenance Period (32 Weeks)|Lost to Follow-up|0
5856152|NCT02120352|20251527|P1|Maintenance Period (32 Weeks)|Lost to Follow-up|0
5856153|NCT02120352|20251524|P4|Maintenance Period (32 Weeks)|Met protocol-defined stopping criteria|1
5856154|NCT02120352|20251525|P3|Maintenance Period (32 Weeks)|Met protocol-defined stopping criteria|1
5856155|NCT02120352|20251526|P2|Maintenance Period (32 Weeks)|Met protocol-defined stopping criteria|0
5856156|NCT02120352|20251527|P1|Maintenance Period (32 Weeks)|Met protocol-defined stopping criteria|0
5856157|NCT02120352|20251524|P4|Maintenance Period (32 Weeks)|Protocol Violation|0
5856158|NCT02120352|20251525|P3|Maintenance Period (32 Weeks)|Protocol Violation|2
5856159|NCT02120352|20251526|P2|Maintenance Period (32 Weeks)|Protocol Violation|0
5856160|NCT02120352|20251527|P1|Maintenance Period (32 Weeks)|Protocol Violation|0
5856161|NCT02120352|20251524|P4|Maintenance Period (32 Weeks)|Lack of Efficacy|1
5856162|NCT02120352|20251525|P3|Maintenance Period (32 Weeks)|Lack of Efficacy|0
5856163|NCT02120352|20251526|P2|Maintenance Period (32 Weeks)|Lack of Efficacy|1
5856164|NCT02120352|20251527|P1|Maintenance Period (32 Weeks)|Lack of Efficacy|0
5856165|NCT02120352|20251524|P4|Maintenance Period (32 Weeks)|Adverse Event|1
5856166|NCT02120352|20251525|P3|Maintenance Period (32 Weeks)|Adverse Event|6
5856167|NCT02120352|20251526|P2|Maintenance Period (32 Weeks)|Adverse Event|0
5856168|NCT02120352|20251527|P1|Maintenance Period (32 Weeks)|Adverse Event|0
5856169|NCT02120352|20251524|P4|Induction Period (20 Weeks)|Physician Decision|0
5856170|NCT02120352|20251525|P3|Induction Period (20 Weeks)|Physician Decision|0
5856171|NCT02120352|20251526|P2|Induction Period (20 Weeks)|Physician Decision|0
5856172|NCT02120352|20251527|P1|Induction Period (20 Weeks)|Physician Decision|1
5856173|NCT02120352|20251524|P4|Induction Period (20 Weeks)|Withdrawal by Subject|0
5856174|NCT02120352|20251525|P3|Induction Period (20 Weeks)|Withdrawal by Subject|0
5856175|NCT02120352|20251526|P2|Induction Period (20 Weeks)|Withdrawal by Subject|0
5856176|NCT02120352|20251527|P1|Induction Period (20 Weeks)|Withdrawal by Subject|5
5856177|NCT02120352|20251524|P4|Induction Period (20 Weeks)|Lost to Follow-up|0
5856178|NCT02120352|20251525|P3|Induction Period (20 Weeks)|Lost to Follow-up|0
5856179|NCT02120352|20251526|P2|Induction Period (20 Weeks)|Lost to Follow-up|0
5856180|NCT02120352|20251527|P1|Induction Period (20 Weeks)|Lost to Follow-up|2
5856181|NCT02120352|20251524|P4|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0
5856182|NCT02120352|20251525|P3|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0
5856183|NCT02120352|20251526|P2|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0
5856184|NCT02120352|20251527|P1|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|3
5856185|NCT02120352|20251524|P4|Induction Period (20 Weeks)|Protocol Violation|0
5856186|NCT02120352|20251525|P3|Induction Period (20 Weeks)|Protocol Violation|0
5856187|NCT02120352|20251526|P2|Induction Period (20 Weeks)|Protocol Violation|0
5856188|NCT02120352|20251527|P1|Induction Period (20 Weeks)|Protocol Violation|2
5856189|NCT02120352|20251524|P4|Induction Period (20 Weeks)|Lack of Efficacy|0
5856190|NCT02120352|20251525|P3|Induction Period (20 Weeks)|Lack of Efficacy|0
5856191|NCT02120352|20251526|P2|Induction Period (20 Weeks)|Lack of Efficacy|0
5856192|NCT02120352|20251527|P1|Induction Period (20 Weeks)|Lack of Efficacy|5
5856193|NCT02120352|20251524|P4|Induction Period (20 Weeks)|Adverse Event|0
5856194|NCT02120352|20251525|P3|Induction Period (20 Weeks)|Adverse Event|0
5856195|NCT02120352|20251526|P2|Induction Period (20 Weeks)|Adverse Event|0
5856196|NCT02120352|20251527|P1|Induction Period (20 Weeks)|Adverse Event|3
5856197|NCT02120300|20251678|P4|Overall Study|Lost to Follow-up|0
5856198|NCT02120300|20251679|P3|Overall Study|Lost to Follow-up|0
5856199|NCT02120300|20251680|P2|Overall Study|Lost to Follow-up|0
5856200|NCT02120300|20251681|P1|Overall Study|Lost to Follow-up|1
5856201|NCT02120300|20251678|P4|Overall Study|Lack of Efficacy|1
5856202|NCT02120300|20251679|P3|Overall Study|Lack of Efficacy|0
5856203|NCT02120300|20251680|P2|Overall Study|Lack of Efficacy|0
5856204|NCT02120300|20251681|P1|Overall Study|Lack of Efficacy|0
5856205|NCT02120300|20251678|P4|Overall Study|Enrolled but Never Treated|0
5856206|NCT02120300|20251679|P3|Overall Study|Enrolled but Never Treated|0
5856207|NCT02120300|20251680|P2|Overall Study|Enrolled but Never Treated|0
5856208|NCT02120300|20251681|P1|Overall Study|Enrolled but Never Treated|2
5856209|NCT02120157|20251752|P2|Overall Study|Graft Failure before Day 100|0
5856210|NCT02120157|20251753|P1|Overall Study|Graft Failure before Day 100|2
5856211|NCT02120157|20251752|P2|Overall Study|Death|2
5856212|NCT02120157|20251753|P1|Overall Study|Death|4
5856213|NCT02120027|20251763|P2|Overall Study|Withdrawal by Subject|25
5856214|NCT02120027|20251764|P1|Overall Study|Withdrawal by Subject|33
5856215|NCT02120027|20251763|P2|Overall Study|Study terminated by Sponsor|47
5856216|NCT02120027|20251764|P1|Overall Study|Study terminated by Sponsor|45
5856217|NCT02120027|20251763|P2|Overall Study|Protocol Violation|21
5856218|NCT02120027|20251764|P1|Overall Study|Protocol Violation|18
5856219|NCT02120027|20251763|P2|Overall Study|Physician Decision|3
5856220|NCT02120027|20251764|P1|Overall Study|Physician Decision|4
5856221|NCT02120027|20251763|P2|Overall Study|Other|0
5856222|NCT02120027|20251764|P1|Overall Study|Other|4
5856223|NCT02120027|20251763|P2|Overall Study|Lost to Follow-up|13
5856224|NCT02120027|20251764|P1|Overall Study|Lost to Follow-up|5
5856225|NCT02120027|20251763|P2|Overall Study|Lack of Efficacy|5
5856226|NCT02120027|20251764|P1|Overall Study|Lack of Efficacy|3
5856227|NCT02120027|20251763|P2|Overall Study|Adverse Event|5
5856228|NCT02120027|20251764|P1|Overall Study|Adverse Event|4
5856229|NCT02119936|20251789|P1|Overall Study|Lost to Follow-up|10
5856230|NCT02119676|20251823|P4|Overall Study|Did not receive study med|5
5856231|NCT02119676|20251824|P3|Overall Study|Did not receive study med|4
5856232|NCT02119676|20251825|P2|Overall Study|Did not receive study med|2
5856233|NCT02119676|20251826|P1|Overall Study|Did not receive study med|2
5856234|NCT02119676|20251823|P4|Overall Study|Other, unspecified|4
5856235|NCT02119676|20251824|P3|Overall Study|Other, unspecified|3
5856236|NCT02119676|20251825|P2|Overall Study|Other, unspecified|1
5856237|NCT02119676|20251826|P1|Overall Study|Other, unspecified|2
5856238|NCT02119676|20251823|P4|Overall Study|Protocol deviation|0
5856239|NCT02119676|20251824|P3|Overall Study|Protocol deviation|1
5856240|NCT02119676|20251825|P2|Overall Study|Protocol deviation|0
5856241|NCT02119676|20251826|P1|Overall Study|Protocol deviation|0
5856242|NCT02119676|20251823|P4|Overall Study|Lost to Follow-up|0
5856243|NCT02119676|20251824|P3|Overall Study|Lost to Follow-up|1
5856244|NCT02119676|20251825|P2|Overall Study|Lost to Follow-up|0
5856245|NCT02119676|20251826|P1|Overall Study|Lost to Follow-up|0
5856246|NCT02119676|20251823|P4|Overall Study|Noncompliance|0
5856247|NCT02119676|20251824|P3|Overall Study|Noncompliance|0
5856248|NCT02119676|20251825|P2|Overall Study|Noncompliance|1
5856249|NCT02119676|20251826|P1|Overall Study|Noncompliance|0
5856250|NCT02119676|20251823|P4|Overall Study|Death|1
5856251|NCT02119676|20251824|P3|Overall Study|Death|2
5856252|NCT02119676|20251825|P2|Overall Study|Death|3
5856253|NCT02119676|20251826|P1|Overall Study|Death|9
5856254|NCT02119676|20251823|P4|Overall Study|Physician Decision|2
5856255|NCT02119676|20251824|P3|Overall Study|Physician Decision|3
5856256|NCT02119676|20251825|P2|Overall Study|Physician Decision|2
5856257|NCT02119676|20251826|P1|Overall Study|Physician Decision|4
5856258|NCT02119676|20251823|P4|Overall Study|Patient decision, inc. consent withdrawn|6
5856259|NCT02119676|20251824|P3|Overall Study|Patient decision, inc. consent withdrawn|5
5856260|NCT02119676|20251825|P2|Overall Study|Patient decision, inc. consent withdrawn|5
5856261|NCT02119676|20251826|P1|Overall Study|Patient decision, inc. consent withdrawn|4
5856262|NCT02119676|20251823|P4|Overall Study|Disease progression|73
5856263|NCT02119676|20251824|P3|Overall Study|Disease progression|68
5856264|NCT02119676|20251825|P2|Overall Study|Disease progression|55
5856265|NCT02119676|20251826|P1|Overall Study|Disease progression|53
5856266|NCT02119676|20251823|P4|Overall Study|Adverse Event|10
5856267|NCT02119676|20251824|P3|Overall Study|Adverse Event|10
5856268|NCT02119676|20251825|P2|Overall Study|Adverse Event|17
5856269|NCT02119676|20251826|P1|Overall Study|Adverse Event|9
5856270|NCT02119663|20251858|P2|Overall Study|Study Terminated by the Sponsor|4
5856271|NCT02119663|20251859|P1|Overall Study|Study Terminated by the Sponsor|3
5856272|NCT02119663|20251858|P2|Overall Study|Subject decision|1
5856273|NCT02119663|20251859|P1|Overall Study|Subject decision|0
5856274|NCT02119663|20251858|P2|Overall Study|Other unspecified|0
5856275|NCT02119663|20251859|P1|Overall Study|Other unspecified|2
5856276|NCT02119663|20251858|P2|Overall Study|Physician Decision|2
5856277|NCT02119663|20251859|P1|Overall Study|Physician Decision|1
5856278|NCT02119663|20251858|P2|Overall Study|Death|2
5856279|NCT02119663|20251859|P1|Overall Study|Death|3
5856280|NCT02119663|20251858|P2|Overall Study|Adverse Event|5
5856281|NCT02119663|20251859|P1|Overall Study|Adverse Event|5
5856282|NCT02119663|20251858|P2|Overall Study|Disease progression|27
5856283|NCT02119663|20251859|P1|Overall Study|Disease progression|26
5856284|NCT02119650|20251877|P2|Overall Study|Multiple reasons for termination|1
5856285|NCT02119650|20251878|P1|Overall Study|Multiple reasons for termination|2
5856286|NCT02119650|20251877|P2|Overall Study|Physician Decision|2
5856287|NCT02119650|20251878|P1|Overall Study|Physician Decision|0
5856288|NCT02119650|20251877|P2|Overall Study|Study terminated by the sponsor|0
5856289|NCT02119650|20251878|P1|Overall Study|Study terminated by the sponsor|1
5856290|NCT02119650|20251877|P2|Overall Study|Noncompliance with study treatment|1
5856291|NCT02119650|20251878|P1|Overall Study|Noncompliance with study treatment|1
5856292|NCT02119650|20251877|P2|Overall Study|Death|1
5856293|NCT02119650|20251878|P1|Overall Study|Death|5
5856294|NCT02119650|20251877|P2|Overall Study|Disease progression|14
5856295|NCT02119650|20251878|P1|Overall Study|Disease progression|11
5856296|NCT02119650|20251877|P2|Overall Study|Subject decision|3
5856297|NCT02119650|20251878|P1|Overall Study|Subject decision|2
5856298|NCT02119650|20251877|P2|Overall Study|Adverse Event|4
5856299|NCT02119650|20251878|P1|Overall Study|Adverse Event|3
5856300|NCT02119325|20251913|P2|Washout Period 1|Adverse Event|1
5856301|NCT02119325|20251914|P1|Washout Period 1|Adverse Event|0
5856302|NCT02119299|20251958|P1|Overall Study|Pregnancy|1
5856303|NCT02119299|20251958|P1|Overall Study|Lack of Efficacy|1
5856304|NCT02119299|20251958|P1|Overall Study|Withdrawal by Subject|7
5856305|NCT02119286|20251972|P3|Overall Study|Withdrawal by Subject|0
5856306|NCT02119286|20251973|P2|Overall Study|Withdrawal by Subject|1
5856307|NCT02119286|20251974|P1|Overall Study|Withdrawal by Subject|4
5856308|NCT02119286|20251972|P3|Overall Study|Lost to Follow-up|1
5856309|NCT02119286|20251973|P2|Overall Study|Lost to Follow-up|0
5856310|NCT02119286|20251974|P1|Overall Study|Lost to Follow-up|2
5856311|NCT02119286|20251972|P3|Overall Study|Lack of Efficacy|4
5856312|NCT02119286|20251973|P2|Overall Study|Lack of Efficacy|3
5856313|NCT02119286|20251974|P1|Overall Study|Lack of Efficacy|11
5856314|NCT02119286|20251972|P3|Overall Study|Adverse Event|2
5856315|NCT02119286|20251973|P2|Overall Study|Adverse Event|7
5856316|NCT02119286|20251974|P1|Overall Study|Adverse Event|9
5856317|NCT02119260|20251992|P7|Overall Study|Withdrew consent|0
5856318|NCT02119260|20251993|P6|Overall Study|Withdrew consent|0
5856319|NCT02119260|20251994|P5|Overall Study|Withdrew consent|0
5856320|NCT02119260|20251995|P4|Overall Study|Withdrew consent|0
5856321|NCT02119260|20251996|P3|Overall Study|Withdrew consent|1
5856322|NCT02119260|20251997|P2|Overall Study|Withdrew consent|1
5856323|NCT02119260|20251998|P1|Overall Study|Withdrew consent|0
5856324|NCT02119260|20251992|P7|Overall Study|Adverse Event|0
5856325|NCT02119260|20251993|P6|Overall Study|Adverse Event|0
5856326|NCT02119260|20251994|P5|Overall Study|Adverse Event|0
5856327|NCT02119260|20251995|P4|Overall Study|Adverse Event|0
5856328|NCT02119260|20251996|P3|Overall Study|Adverse Event|0
5856329|NCT02119260|20251997|P2|Overall Study|Adverse Event|0
5856330|NCT02119260|20251998|P1|Overall Study|Adverse Event|1
5856331|NCT02119156|20252071|P3|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|7
5856332|NCT02119156|20252072|P2|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|10
5856333|NCT02119156|20252073|P1|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|0
5856334|NCT02119156|20252071|P3|Treatment Phase (Up to 52 Weeks)|Physician Decision|0
5856335|NCT02119156|20252072|P2|Treatment Phase (Up to 52 Weeks)|Physician Decision|0
5856336|NCT02119156|20252073|P1|Treatment Phase (Up to 52 Weeks)|Physician Decision|1
5856337|NCT02119156|20252071|P3|Treatment Phase (Up to 52 Weeks)|Protocol Violation|0
5856338|NCT02119156|20252072|P2|Treatment Phase (Up to 52 Weeks)|Protocol Violation|2
5856339|NCT02119156|20252073|P1|Treatment Phase (Up to 52 Weeks)|Protocol Violation|1
5856340|NCT02119156|20252071|P3|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0
5856341|NCT02119156|20252072|P2|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0
5856342|NCT02119156|20252073|P1|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|4
5856343|NCT02119156|20252071|P3|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|1
5856344|NCT02119156|20252072|P2|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0
5856345|NCT02119156|20252073|P1|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0
5856346|NCT02119104|20252131|P1|Overall Study|Protocol Violation|16
5856347|NCT02119026|20252137|P2|2nd-line Treatment|Adverse Event|1
5856348|NCT02119026|20252138|P1|2nd-line Treatment|Adverse Event|4
5856349|NCT02119026|20252137|P2|2nd-line Treatment|Withdrawal by Subject|1
5856350|NCT02119026|20252138|P1|2nd-line Treatment|Withdrawal by Subject|3
5856351|NCT02119026|20252137|P2|2nd-line Treatment|Lost to Follow-up|0
5856352|NCT02119026|20252138|P1|2nd-line Treatment|Lost to Follow-up|2
5856353|NCT02119026|20252137|P2|1st-line Treatment|Death|1
5856354|NCT02119026|20252138|P1|1st-line Treatment|Death|2
5856355|NCT02119026|20252137|P2|1st-line Treatment|Surgery of metastases|1
5856356|NCT02119026|20252138|P1|1st-line Treatment|Surgery of metastases|2
5856357|NCT02119026|20252137|P2|1st-line Treatment|Patient condition or compliance|4
5856358|NCT02119026|20252138|P1|1st-line Treatment|Patient condition or compliance|6
5856359|NCT02119026|20252137|P2|1st-line Treatment|Withdrawal by Subject|10
5856360|NCT02119026|20252138|P1|1st-line Treatment|Withdrawal by Subject|4
5856361|NCT02119026|20252137|P2|1st-line Treatment|Physician Decision|8
5856362|NCT02119026|20252138|P1|1st-line Treatment|Physician Decision|3
5856363|NCT02119026|20252137|P2|1st-line Treatment|Adverse Event|14
5856364|NCT02119026|20252138|P1|1st-line Treatment|Adverse Event|9
5856365|NCT02118961|20252162|P2|Overall Study|Withdrawal by Subject|0
5856366|NCT02118961|20252163|P1|Overall Study|Withdrawal by Subject|1
5856367|NCT02118896|20252191|P10|Overall Study|Miscellaneous|0
5856368|NCT02118896|20252192|P9|Overall Study|Miscellaneous|0
5856369|NCT02118896|20252193|P8|Overall Study|Miscellaneous|0
5856370|NCT02118896|20252194|P7|Overall Study|Miscellaneous|0
5856371|NCT02118896|20252195|P6|Overall Study|Miscellaneous|4
5856372|NCT02118896|20252196|P5|Overall Study|Miscellaneous|0
5856373|NCT02118896|20252197|P4|Overall Study|Miscellaneous|2
5856374|NCT02118896|20252198|P3|Overall Study|Miscellaneous|0
5856375|NCT02118896|20252199|P2|Overall Study|Miscellaneous|2
5856376|NCT02118896|20252200|P1|Overall Study|Miscellaneous|1
5856377|NCT02118896|20252191|P10|Overall Study|Prohibited medication|0
5856378|NCT02118896|20252192|P9|Overall Study|Prohibited medication|0
5856379|NCT02118896|20252193|P8|Overall Study|Prohibited medication|0
5856380|NCT02118896|20252194|P7|Overall Study|Prohibited medication|0
5856381|NCT02118896|20252195|P6|Overall Study|Prohibited medication|3
5856382|NCT02118896|20252196|P5|Overall Study|Prohibited medication|1
5856383|NCT02118896|20252197|P4|Overall Study|Prohibited medication|0
5856384|NCT02118896|20252198|P3|Overall Study|Prohibited medication|0
5856385|NCT02118896|20252199|P2|Overall Study|Prohibited medication|0
5856386|NCT02118896|20252200|P1|Overall Study|Prohibited medication|0
5856387|NCT02118896|20252191|P10|Overall Study|Immunosuppressive regimen (not MR4)|2
5856388|NCT02118896|20252192|P9|Overall Study|Immunosuppressive regimen (not MR4)|0
5856389|NCT02118896|20252193|P8|Overall Study|Immunosuppressive regimen (not MR4)|0
5856390|NCT02118896|20252194|P7|Overall Study|Immunosuppressive regimen (not MR4)|0
5856391|NCT02118896|20252195|P6|Overall Study|Immunosuppressive regimen (not MR4)|2
5856392|NCT02118896|20252196|P5|Overall Study|Immunosuppressive regimen (not MR4)|4
5856393|NCT02118896|20252197|P4|Overall Study|Immunosuppressive regimen (not MR4)|2
5856394|NCT02118896|20252198|P3|Overall Study|Immunosuppressive regimen (not MR4)|1
5856395|NCT02118896|20252199|P2|Overall Study|Immunosuppressive regimen (not MR4)|5
5856396|NCT02118896|20252200|P1|Overall Study|Immunosuppressive regimen (not MR4)|1
5856397|NCT02118896|20252191|P10|Overall Study|Lost to Follow-up|0
5856398|NCT02118896|20252192|P9|Overall Study|Lost to Follow-up|0
5856399|NCT02118896|20252193|P8|Overall Study|Lost to Follow-up|0
5856400|NCT02118896|20252194|P7|Overall Study|Lost to Follow-up|0
5856401|NCT02118896|20252195|P6|Overall Study|Lost to Follow-up|1
5856402|NCT02118896|20252196|P5|Overall Study|Lost to Follow-up|2
5856403|NCT02118896|20252197|P4|Overall Study|Lost to Follow-up|0
5856404|NCT02118896|20252198|P3|Overall Study|Lost to Follow-up|1
5856405|NCT02118896|20252199|P2|Overall Study|Lost to Follow-up|2
5856406|NCT02118896|20252200|P1|Overall Study|Lost to Follow-up|1
5856407|NCT02118896|20252191|P10|Overall Study|Pregnancy|0
5856408|NCT02118896|20252192|P9|Overall Study|Pregnancy|0
5856409|NCT02118896|20252193|P8|Overall Study|Pregnancy|0
5856410|NCT02118896|20252194|P7|Overall Study|Pregnancy|1
5856411|NCT02118896|20252195|P6|Overall Study|Pregnancy|3
5856412|NCT02118896|20252196|P5|Overall Study|Pregnancy|1
5856413|NCT02118896|20252197|P4|Overall Study|Pregnancy|0
5856414|NCT02118896|20252198|P3|Overall Study|Pregnancy|0
5856415|NCT02118896|20252199|P2|Overall Study|Pregnancy|1
5856416|NCT02118896|20252200|P1|Overall Study|Pregnancy|1
5856417|NCT02118896|20252191|P10|Overall Study|Non-compliance|0
5856418|NCT02118896|20252192|P9|Overall Study|Non-compliance|0
5856419|NCT02118896|20252193|P8|Overall Study|Non-compliance|1
5856420|NCT02118896|20252194|P7|Overall Study|Non-compliance|0
5856421|NCT02118896|20252195|P6|Overall Study|Non-compliance|1
5856422|NCT02118896|20252196|P5|Overall Study|Non-compliance|0
5856423|NCT02118896|20252197|P4|Overall Study|Non-compliance|5
5856424|NCT02118896|20252198|P3|Overall Study|Non-compliance|1
5856425|NCT02118896|20252199|P2|Overall Study|Non-compliance|1
5856426|NCT02118896|20252200|P1|Overall Study|Non-compliance|2
5856427|NCT02118896|20252191|P10|Overall Study|Consent withdrawn|0
5856428|NCT02118896|20252192|P9|Overall Study|Consent withdrawn|0
5856429|NCT02118896|20252193|P8|Overall Study|Consent withdrawn|0
5856430|NCT02118896|20252194|P7|Overall Study|Consent withdrawn|0
5856431|NCT02118896|20252195|P6|Overall Study|Consent withdrawn|4
5856432|NCT02118896|20252196|P5|Overall Study|Consent withdrawn|1
5856433|NCT02118896|20252197|P4|Overall Study|Consent withdrawn|4
5856434|NCT02118896|20252198|P3|Overall Study|Consent withdrawn|3
5856435|NCT02118896|20252199|P2|Overall Study|Consent withdrawn|0
5856436|NCT02118896|20252200|P1|Overall Study|Consent withdrawn|2
5856437|NCT02118896|20252191|P10|Overall Study|Adverse Event|0
5856438|NCT02118896|20252192|P9|Overall Study|Adverse Event|4
5856439|NCT02118896|20252193|P8|Overall Study|Adverse Event|1
5856440|NCT02118896|20252194|P7|Overall Study|Adverse Event|1
5856441|NCT02118896|20252195|P6|Overall Study|Adverse Event|9
5856442|NCT02118896|20252196|P5|Overall Study|Adverse Event|5
5856443|NCT02118896|20252197|P4|Overall Study|Adverse Event|5
5856444|NCT02118896|20252198|P3|Overall Study|Adverse Event|4
5856445|NCT02118896|20252199|P2|Overall Study|Adverse Event|4
5856446|NCT02118896|20252200|P1|Overall Study|Adverse Event|5
5856447|NCT02118896|20252191|P10|Overall Study|Death|0
5856448|NCT02118896|20252192|P9|Overall Study|Death|0
5856449|NCT02118896|20252193|P8|Overall Study|Death|0
5856450|NCT02118896|20252194|P7|Overall Study|Death|0
5856451|NCT02118896|20252195|P6|Overall Study|Death|1
5856452|NCT02118896|20252196|P5|Overall Study|Death|3
5856453|NCT02118896|20252197|P4|Overall Study|Death|6
5856454|NCT02118896|20252198|P3|Overall Study|Death|4
5856455|NCT02118896|20252199|P2|Overall Study|Death|0
5856456|NCT02118896|20252200|P1|Overall Study|Death|4
5856457|NCT02118792|20252290|P2|Overall Study|Randomised but not treated|0
5856458|NCT02118792|20252291|P1|Overall Study|Randomised but not treated|1
5856459|NCT02118792|20252290|P2|Overall Study|Other|6
5856460|NCT02118792|20252291|P1|Overall Study|Other|1
5856461|NCT02118792|20252290|P2|Overall Study|Withdrawal by parent/guardian|20
5856462|NCT02118792|20252291|P1|Overall Study|Withdrawal by parent/guardian|14
5856463|NCT02118792|20252290|P2|Overall Study|Adverse Event|4
5856464|NCT02118792|20252291|P1|Overall Study|Adverse Event|5
5856465|NCT02118792|20252290|P2|Overall Study|Lost to Follow-up|4
5856466|NCT02118792|20252291|P1|Overall Study|Lost to Follow-up|4
5856467|NCT02118792|20252290|P2|Overall Study|Withdrawal by Subject|3
5856468|NCT02118792|20252291|P1|Overall Study|Withdrawal by Subject|6
5856469|NCT02118766|20252333|P2|Overall Study|Other|1
5856470|NCT02118766|20252334|P1|Overall Study|Other|3
5856471|NCT02118766|20252333|P2|Overall Study|Withdrawal by parent/guardian|18
5856472|NCT02118766|20252334|P1|Overall Study|Withdrawal by parent/guardian|12
5856473|NCT02118766|20252333|P2|Overall Study|Lost to Follow-up|4
5856474|NCT02118766|20252334|P1|Overall Study|Lost to Follow-up|5
5856475|NCT02118766|20252333|P2|Overall Study|Withdrawal by Subject|6
5856476|NCT02118766|20252334|P1|Overall Study|Withdrawal by Subject|3
5856477|NCT02118766|20252333|P2|Overall Study|Adverse Event|2
5856478|NCT02118766|20252334|P1|Overall Study|Adverse Event|7
5856479|NCT02118714|20252356|P1|Overall Study|Protocol Violation|1
5856480|NCT02118714|20252356|P1|Overall Study|Lost to Follow-up|2
5856481|NCT02118597|20252381|P1|Overall Study|Investigator's decision|1
5856482|NCT02118597|20252381|P1|Overall Study|Serious Adverse Event|1
5856483|NCT02118597|20252381|P1|Overall Study|Sponsor terminated the study|14
5856484|NCT02118428|20252412|P3|Overall Study|Screen Failure or Became Inelegible|1
5856485|NCT02118428|20252413|P2|Overall Study|Screen Failure or Became Inelegible|0
5856486|NCT02118428|20252414|P1|Overall Study|Screen Failure or Became Inelegible|1
5856487|NCT02118428|20252412|P3|Overall Study|Lost to Follow-up|0
5856488|NCT02118428|20252413|P2|Overall Study|Lost to Follow-up|1
5856489|NCT02118428|20252414|P1|Overall Study|Lost to Follow-up|3
5856490|NCT02118428|20252412|P3|Overall Study|Death|0
5856491|NCT02118428|20252413|P2|Overall Study|Death|5
5856492|NCT02118428|20252414|P1|Overall Study|Death|7
5856493|NCT02118428|20252412|P3|Overall Study|Withdrawal by Subject|0
5856494|NCT02118428|20252413|P2|Overall Study|Withdrawal by Subject|2
5856495|NCT02118428|20252414|P1|Overall Study|Withdrawal by Subject|2
5856496|NCT02118428|20252412|P3|Overall Study|Physician Decision|0
5856497|NCT02118428|20252413|P2|Overall Study|Physician Decision|1
5856498|NCT02118428|20252414|P1|Overall Study|Physician Decision|0
5856499|NCT02118012|20252454|P2|Overall Study|Physician Decision|1
5856500|NCT02118012|20252455|P1|Overall Study|Physician Decision|0
5856501|NCT02118012|20252454|P2|Overall Study|Adverse Event|1
5856502|NCT02118012|20252455|P1|Overall Study|Adverse Event|0
5856503|NCT02117687|20252499|P2|Overall Study|Other Reasons|1
5856504|NCT02117687|20252500|P1|Overall Study|Other Reasons|1
5856505|NCT02117687|20252499|P2|Overall Study|Adverse Event|2
5856506|NCT02117687|20252500|P1|Overall Study|Adverse Event|0
5856507|NCT02117687|20252499|P2|Overall Study|Lost to Follow-up|1
5856508|NCT02117687|20252500|P1|Overall Study|Lost to Follow-up|0
5856509|NCT02117648|20252532|P1|Abemaciclib Safety-Extension Phase|Adverse Event|2
5856510|NCT02117648|20252532|P1|Abemaciclib Safety-Extension Phase|Withdrawal by Subject|2
5856511|NCT02117648|20252532|P1|Abemaciclib Safety-Extension Phase|Death|3
5856512|NCT02117648|20252532|P1|Abemaciclib Safety-Extension Phase|Physician Decision|1
5856513|NCT02117648|20252532|P1|Abemaciclib Safety-Extension Phase|Progressive Disease|12
5856514|NCT02117648|20252532|P1|Abemaciclib + Clarithromycin Period 2|Withdrawal by Subject|1
5856515|NCT02117648|20252532|P1|Abemaciclib + Clarithromycin Period 2|Adverse Event|1
5856516|NCT02117648|20252532|P1|Abemaciclib + Clarithromycin Period 2|Death|1
5856517|NCT02117648|20252532|P1|Abemaciclib + Clarithromycin Period 2|Progressive Disease|1
5856518|NCT02117648|20252532|P1|Abemaciclib Alone Period 1|Adverse Event|1
5856519|NCT02117648|20252532|P1|Abemaciclib Alone Period 1|Withdrawal by Subject|1
5856520|NCT02117570|20252545|P3|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0
5856521|NCT02117570|20252546|P2|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|1
5856522|NCT02117570|20252547|P1|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0
5856523|NCT02117570|20252545|P3|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2
5856524|NCT02117570|20252546|P2|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2
5856525|NCT02117570|20252547|P1|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|1
5856526|NCT02117570|20252545|P3|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|1
5856527|NCT02117570|20252546|P2|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0
5856528|NCT02117570|20252547|P1|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0
5856529|NCT02117570|20252545|P3|Stage 2 Participants Aged 65 to 85 Years|Death|1
5856530|NCT02117570|20252546|P2|Stage 2 Participants Aged 65 to 85 Years|Death|0
5856531|NCT02117570|20252547|P1|Stage 2 Participants Aged 65 to 85 Years|Death|0
5856532|NCT02117570|20252545|P3|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|2
5856533|NCT02117570|20252546|P2|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0
5856534|NCT02117570|20252547|P1|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0
5856535|NCT02117570|20252545|P3|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|0
5856536|NCT02117570|20252546|P2|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1
5856537|NCT02117570|20252547|P1|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1
5856538|NCT02117570|20252545|P3|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|1
5856539|NCT02117570|20252546|P2|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|2
5856540|NCT02117570|20252547|P1|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|0
5856541|NCT02117544|20252597|P2|Period 1|Lost to follow-up (prior to treatment)|0
5856542|NCT02117544|20252598|P1|Period 1|Lost to follow-up (prior to treatment)|2
5856543|NCT02117479|20252613|P2|Overall Study|Other unspecified|7
5856544|NCT02117479|20252614|P1|Overall Study|Other unspecified|11
5856545|NCT02117479|20252613|P2|Overall Study|Physician Decision|2
5856546|NCT02117479|20252614|P1|Overall Study|Physician Decision|7
5856547|NCT02117479|20252613|P2|Overall Study|Study terminated by the sponsor|6
5856548|NCT02117479|20252614|P1|Overall Study|Study terminated by the sponsor|4
5856549|NCT02117479|20252613|P2|Overall Study|Noncompliance with study treatment|0
5856550|NCT02117479|20252614|P1|Overall Study|Noncompliance with study treatment|1
5856551|NCT02117479|20252613|P2|Overall Study|Disease progression|108
5856552|NCT02117479|20252614|P1|Overall Study|Disease progression|104
5856553|NCT02117479|20252613|P2|Overall Study|Subject decision|9
5856554|NCT02117479|20252614|P1|Overall Study|Subject decision|8
5856555|NCT02117479|20252613|P2|Overall Study|Adverse Event|16
5856556|NCT02117479|20252614|P1|Overall Study|Adverse Event|8
5856557|NCT02117479|20252613|P2|Overall Study|Death|8
5856558|NCT02117479|20252614|P1|Overall Study|Death|13
5856559|NCT02117427|20252633|P3|Overall Study|Death|0
5856560|NCT02117427|20252634|P2|Overall Study|Death|1
5856561|NCT02117427|20252635|P1|Overall Study|Death|0
5856562|NCT02117427|20252633|P3|Overall Study|No longer meets inclusion criteria|0
5856563|NCT02117427|20252634|P2|Overall Study|No longer meets inclusion criteria|1
5856564|NCT02117427|20252635|P1|Overall Study|No longer meets inclusion criteria|0
5856565|NCT02117427|20252633|P3|Overall Study|Physician Decision|0
5856566|NCT02117427|20252634|P2|Overall Study|Physician Decision|2
5856567|NCT02117427|20252635|P1|Overall Study|Physician Decision|0
5856568|NCT02117427|20252633|P3|Overall Study|Permanent need for exogenous ESA Tx|0
5856569|NCT02117427|20252634|P2|Overall Study|Permanent need for exogenous ESA Tx|1
5856570|NCT02117427|20252635|P1|Overall Study|Permanent need for exogenous ESA Tx|3
5856571|NCT02117427|20252633|P3|Overall Study|Permanent need for exogenous EPO Tx|0
5856572|NCT02117427|20252634|P2|Overall Study|Permanent need for exogenous EPO Tx|0
5856573|NCT02117427|20252635|P1|Overall Study|Permanent need for exogenous EPO Tx|2
5856574|NCT02117414|20252645|P2|Overall Study|Withdrawal by Subject|4
5856575|NCT02117414|20252646|P1|Overall Study|Withdrawal by Subject|10
5856576|NCT02117414|20252645|P2|Overall Study|Death|2
5856577|NCT02117414|20252646|P1|Overall Study|Death|5
5856578|NCT02117349|20252666|P2|Overall Study|Death|0
5856579|NCT02117349|20252667|P1|Overall Study|Death|1
5856580|NCT02117349|20252666|P2|Overall Study|Lost to Follow-up|1
5856581|NCT02117349|20252667|P1|Overall Study|Lost to Follow-up|1
5856582|NCT02117349|20252666|P2|Overall Study|Withdrawal by Subject|0
5856583|NCT02117349|20252667|P1|Overall Study|Withdrawal by Subject|1
5856584|NCT02117050|20252703|P1|Overall Study|Subject Enrolled but not Dosed|1
5856585|NCT02117024|20252717|P2|Overall Study|Physician Decision|2
5856586|NCT02117024|20252718|P1|Overall Study|Physician Decision|0
5856587|NCT02117024|20252717|P2|Overall Study|Patient took treatment break|1
5856588|NCT02117024|20252718|P1|Overall Study|Patient took treatment break|0
5856589|NCT02117024|20252717|P2|Overall Study|Patient returned to primary oncologist|1
5856590|NCT02117024|20252718|P1|Overall Study|Patient returned to primary oncologist|0
5856591|NCT02117024|20252717|P2|Overall Study|Randomized in Error|0
5856592|NCT02117024|20252718|P1|Overall Study|Randomized in Error|1
5856593|NCT02117024|20252717|P2|Overall Study|Adverse Event|2
5856594|NCT02117024|20252718|P1|Overall Study|Adverse Event|1
5856595|NCT02117024|20252717|P2|Overall Study|Protocol Violation|0
5856596|NCT02117024|20252718|P1|Overall Study|Protocol Violation|1
5856597|NCT02117024|20252717|P2|Overall Study|Withdrawal by Subject|1
5856598|NCT02117024|20252718|P1|Overall Study|Withdrawal by Subject|3
5856599|NCT02117024|20252717|P2|Overall Study|Death|0
5856600|NCT02117024|20252718|P1|Overall Study|Death|5
5856601|NCT02117024|20252717|P2|Overall Study|Significant Clinical Progression|4
5856602|NCT02117024|20252718|P1|Overall Study|Significant Clinical Progression|7
5856603|NCT02117024|20252717|P2|Overall Study|Progressive Disease|9
5856604|NCT02117024|20252718|P1|Overall Study|Progressive Disease|26
5856605|NCT02116972|20252745|P3|Overall Study|scheduling conflicts and relocation|6
5856606|NCT02116972|20252746|P2|Overall Study|scheduling conflicts and relocation|3
5856607|NCT02116972|20252747|P1|Overall Study|scheduling conflicts and relocation|3
5856608|NCT02116972|20252745|P3|Overall Study|Lack of Efficacy|5
5856609|NCT02116972|20252746|P2|Overall Study|Lack of Efficacy|6
5856610|NCT02116972|20252747|P1|Overall Study|Lack of Efficacy|6
5856611|NCT02116972|20252745|P3|Overall Study|Lost to Follow-up|1
5856612|NCT02116972|20252746|P2|Overall Study|Lost to Follow-up|3
5856613|NCT02116972|20252747|P1|Overall Study|Lost to Follow-up|4
5856614|NCT02116972|20252745|P3|Overall Study|Protocol Violation|1
5856615|NCT02116972|20252746|P2|Overall Study|Protocol Violation|0
5856616|NCT02116972|20252747|P1|Overall Study|Protocol Violation|1
5856617|NCT02116972|20252745|P3|Overall Study|Withdrawal by Subject|5
5856618|NCT02116972|20252746|P2|Overall Study|Withdrawal by Subject|1
5856619|NCT02116972|20252747|P1|Overall Study|Withdrawal by Subject|1
5856620|NCT02116972|20252745|P3|Overall Study|Adverse Event|1
5856621|NCT02116972|20252746|P2|Overall Study|Adverse Event|4
5856622|NCT02116972|20252747|P1|Overall Study|Adverse Event|4
5856623|NCT02116803|20252779|P2|Overall Study|Death|0
5856624|NCT02116803|20252780|P1|Overall Study|Death|1
5856625|NCT02116803|20252779|P2|Overall Study|Study terminated by sponsor|1
5856626|NCT02116803|20252780|P1|Overall Study|Study terminated by sponsor|2
5856627|NCT02116803|20252779|P2|Overall Study|Progressive disease|0
5856628|NCT02116803|20252780|P1|Overall Study|Progressive disease|4
5856629|NCT02116803|20252779|P2|Overall Study|Physician Decision|0
5856630|NCT02116803|20252780|P1|Overall Study|Physician Decision|1
5856631|NCT02116803|20252779|P2|Overall Study|Adverse Event|1
5856632|NCT02116803|20252780|P1|Overall Study|Adverse Event|2
5856633|NCT02116660|20252788|P2|Overall Study|Organization reason|0
5856634|NCT02116660|20252789|P1|Overall Study|Organization reason|1
5856635|NCT02116660|20252788|P2|Overall Study|Withdrawal by Subject|2
5856636|NCT02116660|20252789|P1|Overall Study|Withdrawal by Subject|0
5856637|NCT02116660|20252788|P2|Overall Study|Adverse Event|1
5856638|NCT02116660|20252789|P1|Overall Study|Adverse Event|1
5856639|NCT02116660|20252788|P2|Overall Study|Deteriorating renal function|1
5856640|NCT02116660|20252789|P1|Overall Study|Deteriorating renal function|0
5856641|NCT02116621|20252833|P2|Twelve Month Follow-up|Enrolled within 12 months of study end|8
5856642|NCT02116621|20252834|P1|Twelve Month Follow-up|Enrolled within 12 months of study end|14
5856643|NCT02116621|20252833|P2|Twelve Month Follow-up|Did not complete follow-up survey|3
5856644|NCT02116621|20252834|P1|Twelve Month Follow-up|Did not complete follow-up survey|1
5856645|NCT02116621|20252833|P2|Twelve Month Follow-up|Lost to Follow-up|1
5856646|NCT02116621|20252834|P1|Twelve Month Follow-up|Lost to Follow-up|0
5856647|NCT02116621|20252833|P2|Twelve Month Follow-up|Withdrawal by Subject|0
5856648|NCT02116621|20252834|P1|Twelve Month Follow-up|Withdrawal by Subject|1
5856649|NCT02116621|20252833|P2|Six Month Follow-up|Did not complete follow-up survey|1
5856650|NCT02116621|20252834|P1|Six Month Follow-up|Did not complete follow-up survey|1
5856651|NCT02116621|20252833|P2|Six Month Follow-up|Lost to Follow-up|1
5856652|NCT02116621|20252834|P1|Six Month Follow-up|Lost to Follow-up|2
5856653|NCT02116621|20252833|P2|Six Month Follow-up|Withdrawal by Subject|1
5856654|NCT02116621|20252834|P1|Six Month Follow-up|Withdrawal by Subject|1
5856655|NCT02116621|20252833|P2|Three Month Follow-up|Did not complete follow-up survey|4
5856656|NCT02116621|20252834|P1|Three Month Follow-up|Did not complete follow-up survey|14
5856657|NCT02116621|20252833|P2|Three Month Follow-up|Lost to Follow-up|1
5856658|NCT02116621|20252834|P1|Three Month Follow-up|Lost to Follow-up|0
5856659|NCT02116621|20252833|P2|Three Month Follow-up|Withdrawal by Subject|1
5856660|NCT02116621|20252834|P1|Three Month Follow-up|Withdrawal by Subject|4
5856661|NCT02116621|20252833|P2|Three Month Follow-up|Death|1
5856662|NCT02116621|20252834|P1|Three Month Follow-up|Death|1
5856663|NCT02116621|20252833|P2|Baseline|Withdrawal by Subject|4
5856664|NCT02116621|20252834|P1|Baseline|Withdrawal by Subject|0
5856665|NCT02116582|20252922|P1|Overall Study|Other: Transitioned to 9785-CL-0123|12
5856666|NCT02116582|20252922|P1|Overall Study|Lost to Follow-up|1
5856667|NCT02116582|20252922|P1|Overall Study|Other: Miscellaneous|11
5856668|NCT02116582|20252922|P1|Overall Study|Withdrawal by Subject|8
5856669|NCT02116582|20252922|P1|Overall Study|Protocol Violation|3
5856670|NCT02116582|20252922|P1|Overall Study|Progressive Disease|148
5856671|NCT02116582|20252922|P1|Overall Study|Death|9
5856672|NCT02116582|20252922|P1|Overall Study|Adverse Event|22
5856673|NCT02116582|20252922|P1|Overall Study|Enrolled but Never Received Study Drug|1
5856674|NCT02116530|20252932|P2|Overall Study|Other Medical Problems|2
5856675|NCT02116530|20252933|P1|Overall Study|Other Medical Problems|2
5856676|NCT02116530|20252932|P2|Overall Study|Lost to Follow-up|0
5856677|NCT02116530|20252933|P1|Overall Study|Lost to Follow-up|1
5856678|NCT02116530|20252932|P2|Overall Study|Physician Decision|0
5856679|NCT02116530|20252933|P1|Overall Study|Physician Decision|1
5856680|NCT02116530|20252932|P2|Overall Study|Adverse Event|0
5856681|NCT02116530|20252933|P1|Overall Study|Adverse Event|4
5856682|NCT02116530|20252932|P2|Overall Study|Withdrawal by Subject|2
5856683|NCT02116530|20252933|P1|Overall Study|Withdrawal by Subject|1
5856684|NCT02116361|20252951|P4|Overall Study|Investigator Decision - Relapse|5
5856685|NCT02116361|20252952|P3|Overall Study|Investigator Decision - Relapse|8
5856686|NCT02116361|20252953|P2|Overall Study|Investigator Decision - Relapse|7
5856687|NCT02116361|20252954|P1|Overall Study|Investigator Decision - Relapse|9
5856688|NCT02116361|20252951|P4|Overall Study|Personal Reasons|9
5856689|NCT02116361|20252952|P3|Overall Study|Personal Reasons|4
5856690|NCT02116361|20252953|P2|Overall Study|Personal Reasons|6
5856691|NCT02116361|20252954|P1|Overall Study|Personal Reasons|6
5856692|NCT02116361|20252951|P4|Overall Study|Lost to Follow-up|5
5856693|NCT02116361|20252952|P3|Overall Study|Lost to Follow-up|7
5856694|NCT02116361|20252953|P2|Overall Study|Lost to Follow-up|5
5856695|NCT02116361|20252954|P1|Overall Study|Lost to Follow-up|4
5856696|NCT02116361|20252951|P4|Overall Study|Lack of Efficacy|3
5856697|NCT02116361|20252952|P3|Overall Study|Lack of Efficacy|4
5856698|NCT02116361|20252953|P2|Overall Study|Lack of Efficacy|7
5856699|NCT02116361|20252954|P1|Overall Study|Lack of Efficacy|5
5856700|NCT02116361|20252951|P4|Overall Study|Other Reasons|3
5856701|NCT02116361|20252952|P3|Overall Study|Other Reasons|3
5856702|NCT02116361|20252953|P2|Overall Study|Other Reasons|3
5856703|NCT02116361|20252954|P1|Overall Study|Other Reasons|3
5856704|NCT02116361|20252951|P4|Overall Study|Adverse Event|3
5856705|NCT02116361|20252952|P3|Overall Study|Adverse Event|0
5856706|NCT02116361|20252953|P2|Overall Study|Adverse Event|0
5856707|NCT02116361|20252954|P1|Overall Study|Adverse Event|1
5856708|NCT02116361|20252951|P4|Overall Study|Physician Decision|0
5856709|NCT02116361|20252952|P3|Overall Study|Physician Decision|0
5856710|NCT02116361|20252953|P2|Overall Study|Physician Decision|3
5856711|NCT02116361|20252954|P1|Overall Study|Physician Decision|2
5856712|NCT02116361|20252951|P4|Overall Study|Protocol Violation|2
5856713|NCT02116361|20252952|P3|Overall Study|Protocol Violation|0
5856714|NCT02116361|20252953|P2|Overall Study|Protocol Violation|0
5856715|NCT02116361|20252954|P1|Overall Study|Protocol Violation|1
5856716|NCT02116361|20252951|P4|Overall Study|Pregnancy|1
5856717|NCT02116361|20252952|P3|Overall Study|Pregnancy|0
5856718|NCT02116361|20252953|P2|Overall Study|Pregnancy|0
5856719|NCT02116361|20252954|P1|Overall Study|Pregnancy|0
5856720|NCT02116309|20252991|P2|Overall Study|Lost to Follow-up|1
5856721|NCT02116309|20252992|P1|Overall Study|Lost to Follow-up|0
5856738|NCT02115815|20253049|P7|Overall Study|Missed appointment, randomized in error|0
5856739|NCT02115815|20253050|P6|Overall Study|Missed appointment, randomized in error|1
5856740|NCT02115815|20253051|P5|Overall Study|Missed appointment, randomized in error|0
5856741|NCT02115815|20253052|P4|Overall Study|Missed appointment, randomized in error|0
5856742|NCT02115815|20253053|P3|Overall Study|Missed appointment, randomized in error|0
5856743|NCT02115815|20253054|P2|Overall Study|Missed appointment, randomized in error|0
5856744|NCT02115815|20253055|P1|Overall Study|Missed appointment, randomized in error|0
5856745|NCT02115815|20253049|P7|Overall Study|Not enough drug to dose participant|0
5856746|NCT02115815|20253050|P6|Overall Study|Not enough drug to dose participant|1
5856747|NCT02115815|20253051|P5|Overall Study|Not enough drug to dose participant|0
5856748|NCT02115815|20253052|P4|Overall Study|Not enough drug to dose participant|0
5856749|NCT02115815|20253053|P3|Overall Study|Not enough drug to dose participant|0
5856750|NCT02115815|20253054|P2|Overall Study|Not enough drug to dose participant|0
5856751|NCT02115815|20253055|P1|Overall Study|Not enough drug to dose participant|0
5856752|NCT02115815|20253049|P7|Overall Study|Withdrawal by Subject|0
5856753|NCT02115815|20253050|P6|Overall Study|Withdrawal by Subject|0
5856754|NCT02115815|20253051|P5|Overall Study|Withdrawal by Subject|0
5856755|NCT02115815|20253052|P4|Overall Study|Withdrawal by Subject|0
5856756|NCT02115815|20253053|P3|Overall Study|Withdrawal by Subject|0
5856757|NCT02115815|20253054|P2|Overall Study|Withdrawal by Subject|0
5856758|NCT02115815|20253055|P1|Overall Study|Withdrawal by Subject|2
5856759|NCT02115607|20253197|P1|Overall Study|Withdrawal by Subject|1
5856760|NCT02115386|20253223|P1|Overall Study|Administrative - trial was terminated|6
5856761|NCT02115386|20253223|P1|Overall Study|Protocol Violation|1
5856762|NCT02115321|20253326|P2|Overall Study|Death|0
5856763|NCT02115321|20253327|P1|Overall Study|Death|1
5856764|NCT02115308|20253349|P2|Overall Study|Safety Screening|2
5856765|NCT02115308|20253350|P1|Overall Study|Safety Screening|2
5856766|NCT02115269|20253366|P1|Overall Study|Didn't take study drug|2
5856767|NCT02115269|20253366|P1|Overall Study|Withdrawal by Subject|2
5856768|NCT02115269|20253366|P1|Overall Study|Moved to another city|7
5856769|NCT02115269|20253366|P1|Overall Study|Did not complete patient diary|3
5856770|NCT02115269|20253366|P1|Overall Study|Lost to Follow-up|43
5856771|NCT02115256|20253386|P2|Overall Study|Withdrawal by Subject|1
5856772|NCT02115256|20253387|P1|Overall Study|Withdrawal by Subject|0
5856773|NCT02115113|20253399|P3|Participants Randomized|Death|0
5856774|NCT02115113|20253400|P2|Participants Randomized|Death|0
5856775|NCT02115113|20253401|P1|Participants Randomized|Death|1
5856776|NCT02115113|20253399|P3|Participants Randomized|Lost to Follow-up|0
5856777|NCT02115113|20253400|P2|Participants Randomized|Lost to Follow-up|0
5856778|NCT02115113|20253401|P1|Participants Randomized|Lost to Follow-up|1
5856779|NCT02115113|20253399|P3|Participants in Run-in Period|Withdrawal by Subject|3
5856780|NCT02115113|20253400|P2|Participants in Run-in Period|Withdrawal by Subject|0
5856781|NCT02115113|20253401|P1|Participants in Run-in Period|Withdrawal by Subject|0
5856782|NCT02115113|20253399|P3|Participants in Run-in Period|Lost to Follow-up|5
5856783|NCT02115113|20253400|P2|Participants in Run-in Period|Lost to Follow-up|0
5856784|NCT02115113|20253401|P1|Participants in Run-in Period|Lost to Follow-up|0
5856785|NCT02115113|20253399|P3|Participants in Run-in Period|Administrative problems|1
5856786|NCT02115113|20253400|P2|Participants in Run-in Period|Administrative problems|0
5856787|NCT02115113|20253401|P1|Participants in Run-in Period|Administrative problems|0
5856788|NCT02115113|20253399|P3|Participants in Run-in Period|Death|1
5856789|NCT02115113|20253400|P2|Participants in Run-in Period|Death|0
5856790|NCT02115113|20253401|P1|Participants in Run-in Period|Death|0
5856791|NCT02114931|20253433|P2|Overall Study|Other|1
5856792|NCT02114931|20253434|P1|Overall Study|Other|2
5856793|NCT02114931|20253433|P2|Overall Study|Physician Decision|2
5856794|NCT02114931|20253434|P1|Overall Study|Physician Decision|1
5856795|NCT02114931|20253433|P2|Overall Study|Lost to Follow-up|3
5856796|NCT02114931|20253434|P1|Overall Study|Lost to Follow-up|3
5856797|NCT02114931|20253433|P2|Overall Study|Adverse Event|6
5856798|NCT02114931|20253434|P1|Overall Study|Adverse Event|4
5856799|NCT02114931|20253433|P2|Overall Study|Withdrawal by Subject|18
5856800|NCT02114931|20253434|P1|Overall Study|Withdrawal by Subject|15
5856801|NCT02114892|20253450|P2|Overall Study|Lost to Follow-up|2
5856802|NCT02114892|20253451|P1|Overall Study|Lost to Follow-up|1
5856803|NCT02114879|20253487|P2|Overall Study|Physician Decision|2
5856804|NCT02114879|20253488|P1|Overall Study|Physician Decision|0
5856805|NCT02114879|20253487|P2|Overall Study|Lost to Follow-up|6
5856806|NCT02114879|20253488|P1|Overall Study|Lost to Follow-up|4
5856807|NCT02114879|20253487|P2|Overall Study|Death|11
5856808|NCT02114879|20253488|P1|Overall Study|Death|6
5856809|NCT02114879|20253487|P2|Overall Study|Withdrawal by Subject|5
5856810|NCT02114879|20253488|P1|Overall Study|Withdrawal by Subject|9
5856811|NCT02114697|20253506|P2|Overall Study|Study terminated|4
5856812|NCT02114697|20253507|P1|Overall Study|Study terminated|5
5856813|NCT02114684|20253515|P2|Overall Study|Patient Incarcerated|0
5856814|NCT02114684|20253516|P1|Overall Study|Patient Incarcerated|1
5856815|NCT02114684|20253515|P2|Overall Study|Rifampicin resistant on culture|1
5856816|NCT02114684|20253516|P1|Overall Study|Rifampicin resistant on culture|0
5856817|NCT02114684|20253515|P2|Overall Study|Relocation|1
5856818|NCT02114684|20253516|P1|Overall Study|Relocation|3
5856819|NCT02114684|20253515|P2|Overall Study|Withdrawal by Subject|2
5856820|NCT02114684|20253516|P1|Overall Study|Withdrawal by Subject|1
5856821|NCT02114684|20253515|P2|Overall Study|Lost to Follow-up|2
5856822|NCT02114684|20253516|P1|Overall Study|Lost to Follow-up|1
5856823|NCT02114684|20253515|P2|Overall Study|Death|4
5856824|NCT02114684|20253516|P1|Overall Study|Death|6
5856825|NCT02114515|20253534|P2|Overall Study|Other|61
5856826|NCT02114515|20253535|P1|Overall Study|Other|65
5856827|NCT02114515|20253534|P2|Overall Study|Withdrawal by Subject|22
5856828|NCT02114515|20253535|P1|Overall Study|Withdrawal by Subject|4
5856829|NCT02114515|20253534|P2|Overall Study|Death|12
5856830|NCT02114515|20253535|P1|Overall Study|Death|12
5856831|NCT02114515|20253534|P2|Overall Study|Lost to Follow-up|55
5856832|NCT02114515|20253535|P1|Overall Study|Lost to Follow-up|52
5856833|NCT02114385|20253581|P2|Overall Study|Lost to Follow-up|6
5856834|NCT02114385|20253582|P1|Overall Study|Lost to Follow-up|0
5856835|NCT02114385|20253581|P2|Overall Study|Withdrawal by Subject|2
5856836|NCT02114385|20253582|P1|Overall Study|Withdrawal by Subject|3
5856837|NCT02114268|20253623|P6|Overall Study|Withdrawn by site due to noncompliance|0
5856838|NCT02114268|20253624|P5|Overall Study|Withdrawn by site due to noncompliance|0
5856839|NCT02114268|20253625|P4|Overall Study|Withdrawn by site due to noncompliance|0
5856840|NCT02114268|20253626|P3|Overall Study|Withdrawn by site due to noncompliance|0
5856841|NCT02114268|20253627|P2|Overall Study|Withdrawn by site due to noncompliance|0
5856842|NCT02114268|20253628|P1|Overall Study|Withdrawn by site due to noncompliance|1
5856843|NCT02114268|20253623|P6|Overall Study|Withdrawal by Subject|1
5856844|NCT02114268|20253624|P5|Overall Study|Withdrawal by Subject|0
5856845|NCT02114268|20253625|P4|Overall Study|Withdrawal by Subject|0
5856846|NCT02114268|20253626|P3|Overall Study|Withdrawal by Subject|0
5856847|NCT02114268|20253627|P2|Overall Study|Withdrawal by Subject|0
5856848|NCT02114268|20253628|P1|Overall Study|Withdrawal by Subject|1
5856849|NCT02114268|20253623|P6|Overall Study|Lost to Follow-up|2
5856850|NCT02114268|20253624|P5|Overall Study|Lost to Follow-up|0
5856851|NCT02114268|20253625|P4|Overall Study|Lost to Follow-up|0
5856852|NCT02114268|20253626|P3|Overall Study|Lost to Follow-up|1
5856853|NCT02114268|20253627|P2|Overall Study|Lost to Follow-up|1
5856854|NCT02114268|20253628|P1|Overall Study|Lost to Follow-up|4
5856855|NCT02114203|20253697|P3|Overall Study|Withdrawal by Subject|0
5856856|NCT02114203|20253698|P2|Overall Study|Withdrawal by Subject|1
5856857|NCT02114203|20253699|P1|Overall Study|Withdrawal by Subject|0
5856858|NCT02114203|20253697|P3|Overall Study|Adverse Event|0
5856859|NCT02114203|20253698|P2|Overall Study|Adverse Event|1
5856860|NCT02114203|20253699|P1|Overall Study|Adverse Event|0
5856861|NCT02114177|20253733|P2|Overall Study|Other|1
5856862|NCT02114177|20253734|P1|Overall Study|Other|2
5856863|NCT02114177|20253733|P2|Overall Study|Withdrawal by Subject|1
5856864|NCT02114177|20253734|P1|Overall Study|Withdrawal by Subject|6
5856865|NCT02114177|20253733|P2|Overall Study|Lost to Follow-up|2
5856866|NCT02114177|20253734|P1|Overall Study|Lost to Follow-up|1
5856867|NCT02114151|20253758|P1|Overall Study|Withdrawal by Subject|5
5856868|NCT02114151|20253758|P1|Overall Study|Lost to Follow-up|1
5856869|NCT02114151|20253758|P1|Overall Study|Death|1
5856870|NCT02113956|20253775|P2|3 Month Post-intervention|Lost to Follow-up|2
5856871|NCT02113956|20253776|P1|3 Month Post-intervention|Lost to Follow-up|4
5856872|NCT02113956|20253775|P2|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|3
5856873|NCT02113956|20253776|P1|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|4
5856874|NCT02113956|20253775|P2|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|1
5856875|NCT02113956|20253776|P1|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|5
5856876|NCT02113579|20253810|P2|Overall Study|Lost to Follow-up|2
5856877|NCT02113579|20253811|P1|Overall Study|Lost to Follow-up|6
5856878|NCT02113579|20253810|P2|Overall Study|Withdrawal by Subject|2
5856879|NCT02113579|20253811|P1|Overall Study|Withdrawal by Subject|3
5856880|NCT02113579|20253810|P2|Overall Study|Adverse Event|0
5856881|NCT02113579|20253811|P1|Overall Study|Adverse Event|1
5856882|NCT02113449|20253835|P1|Overall Study|Adverse Event|4
5856883|NCT02113436|20253851|P4|Period 2: 16 Weeks|Withdrawal by Subject|1
5856884|NCT02113436|20253852|P3|Period 2: 16 Weeks|Withdrawal by Subject|1
5856885|NCT02113436|20253853|P2|Period 2: 16 Weeks|Withdrawal by Subject|0
5856886|NCT02113436|20253854|P1|Period 2: 16 Weeks|Withdrawal by Subject|0
5856887|NCT02113436|20253851|P4|Period 2: 16 Weeks|Physician Decision|0
5856888|NCT02113436|20253852|P3|Period 2: 16 Weeks|Physician Decision|2
5856889|NCT02113436|20253853|P2|Period 2: 16 Weeks|Physician Decision|0
5856890|NCT02113436|20253854|P1|Period 2: 16 Weeks|Physician Decision|0
5856891|NCT02113436|20253851|P4|Period 2: 16 Weeks|Par. Reached Stopping Criteria|5
5856892|NCT02113436|20253852|P3|Period 2: 16 Weeks|Par. Reached Stopping Criteria|2
5856893|NCT02113436|20253853|P2|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0
5856894|NCT02113436|20253854|P1|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0
5856895|NCT02113436|20253851|P4|Period 2: 16 Weeks|Adverse Event|5
5856896|NCT02113436|20253852|P3|Period 2: 16 Weeks|Adverse Event|4
5856897|NCT02113436|20253853|P2|Period 2: 16 Weeks|Adverse Event|0
5856898|NCT02113436|20253854|P1|Period 2: 16 Weeks|Adverse Event|0
5856899|NCT02113436|20253851|P4|Period 1: 8 Weeks|Withdrawal by Subject|0
5856900|NCT02113436|20253852|P3|Period 1: 8 Weeks|Withdrawal by Subject|0
5856901|NCT02113436|20253853|P2|Period 1: 8 Weeks|Withdrawal by Subject|0
5856902|NCT02113436|20253854|P1|Period 1: 8 Weeks|Withdrawal by Subject|1
5856903|NCT02113436|20253851|P4|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0
5856904|NCT02113436|20253852|P3|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0
5856905|NCT02113436|20253853|P2|Period 1: 8 Weeks|Par. Reached Stopping Criteria|2
5856906|NCT02113436|20253854|P1|Period 1: 8 Weeks|Par. Reached Stopping Criteria|5
5856907|NCT02113436|20253851|P4|Period 1: 8 Weeks|Protocol Violation|0
5856908|NCT02113436|20253852|P3|Period 1: 8 Weeks|Protocol Violation|0
5856909|NCT02113436|20253853|P2|Period 1: 8 Weeks|Protocol Violation|0
5856910|NCT02113436|20253854|P1|Period 1: 8 Weeks|Protocol Violation|1
5856911|NCT02113436|20253851|P4|Period 1: 8 Weeks|Adverse Event|0
5856912|NCT02113436|20253852|P3|Period 1: 8 Weeks|Adverse Event|0
5856913|NCT02113436|20253853|P2|Period 1: 8 Weeks|Adverse Event|0
5856914|NCT02113436|20253854|P1|Period 1: 8 Weeks|Adverse Event|1
5856915|NCT02113189|20253960|P3|Overall Study|Lost to follow up|3
5856916|NCT02113189|20253961|P2|Overall Study|Lost to follow up|1
5856917|NCT02113189|20253962|P1|Overall Study|Lost to follow up|2
5856918|NCT02113124|20253978|P2|Overall Study|Unable to retrieve blood sample|1
5856919|NCT02113124|20253979|P1|Overall Study|Unable to retrieve blood sample|1
5856920|NCT02113007|20253985|P1|Overall Study|Progressive disease|2
5856921|NCT02112994|20253991|P3|Overall Study|Withdrawal by Subject|1
5856922|NCT02112994|20253992|P2|Overall Study|Withdrawal by Subject|0
5856923|NCT02112994|20253993|P1|Overall Study|Withdrawal by Subject|0
5856924|NCT02112994|20253991|P3|Overall Study|Liver Transplant|0
5856925|NCT02112994|20253992|P2|Overall Study|Liver Transplant|1
5856926|NCT02112994|20253993|P1|Overall Study|Liver Transplant|0
5856927|NCT02112994|20253991|P3|Overall Study|Pregnancy|1
5856928|NCT02112994|20253992|P2|Overall Study|Pregnancy|1
5856929|NCT02112994|20253993|P1|Overall Study|Pregnancy|0
5856930|NCT02112994|20253991|P3|Overall Study|Progressive Disease|1
5856931|NCT02112994|20253992|P2|Overall Study|Progressive Disease|0
5856932|NCT02112994|20253993|P1|Overall Study|Progressive Disease|0
5856937|NCT02112448|20254100|P2|Overall Study|required heparin so could not use ketoro|0
5856938|NCT02112448|20254101|P1|Overall Study|required heparin so could not use ketoro|1
5856939|NCT02112448|20254100|P2|Overall Study|Physician Decision|6
5856940|NCT02112448|20254101|P1|Overall Study|Physician Decision|4
5856941|NCT02112448|20254100|P2|Overall Study|Protocol Violation|2
5856942|NCT02112448|20254101|P1|Overall Study|Protocol Violation|1
5856943|NCT02112448|20254100|P2|Overall Study|lab values precluding use of ketorolac|2
5856944|NCT02112448|20254101|P1|Overall Study|lab values precluding use of ketorolac|2
5856945|NCT02112045|20254134|P2|Overall Study|Withdrawal by Subject|0
5856946|NCT02112045|20254135|P1|Overall Study|Withdrawal by Subject|1
5856947|NCT02111993|20254155|P2|Overall Study|Physician Decision|4
5856948|NCT02111993|20254156|P1|Overall Study|Physician Decision|5
5856949|NCT02111811|20254197|P2|Follow up Period (Aim 2)|Death|0
5856950|NCT02111811|20254198|P1|Follow up Period (Aim 2)|Death|2
5856951|NCT02111811|20254197|P2|Follow up Period (Aim 2)|Lost to Follow-up|17
5856952|NCT02111811|20254198|P1|Follow up Period (Aim 2)|Lost to Follow-up|26
5856953|NCT02111811|20254197|P2|Treatment Phase|Death|0
5856954|NCT02111811|20254198|P1|Treatment Phase|Death|2
5856955|NCT02111811|20254197|P2|Treatment Phase|Lost to Follow-up|18
5856956|NCT02111811|20254198|P1|Treatment Phase|Lost to Follow-up|22
5856957|NCT02111785|20254211|P4|Overall Study|Death|0
5856958|NCT02111785|20254212|P3|Overall Study|Death|0
5856959|NCT02111785|20254213|P2|Overall Study|Death|1
5856960|NCT02111785|20254214|P1|Overall Study|Death|0
5856961|NCT02111603|20254276|P1|Overall Study|Withdrawal by Subject|1
5856962|NCT02111564|20254287|P2|Overall Study|Withdrawal by Subject|20
5856963|NCT02111564|20254288|P1|Overall Study|Withdrawal by Subject|20
5856964|NCT02111564|20254287|P2|Overall Study|Lost to Follow-up|3
5856965|NCT02111564|20254288|P1|Overall Study|Lost to Follow-up|2
5856966|NCT02111564|20254287|P2|Overall Study|Death|120
5856967|NCT02111564|20254288|P1|Overall Study|Death|109
5856968|NCT02111369|20254327|P1|Overall Study|Withdrawal by Subject|1
5856969|NCT02111369|20254327|P1|Overall Study|Lost to Follow-up|2
5856970|NCT02111213|20254351|P2|Overall Study|Lost to Follow-up|4
5856971|NCT02111213|20254352|P1|Overall Study|Lost to Follow-up|3
5856972|NCT02111213|20254351|P2|Overall Study|Withdrawal by Subject|2
5856973|NCT02111213|20254352|P1|Overall Study|Withdrawal by Subject|3
5856974|NCT02111174|20254400|P2|Secondary Outcomes (2 and 3 Month f/u)|Death|1
5856975|NCT02111174|20254401|P1|Secondary Outcomes (2 and 3 Month f/u)|Death|0
5856976|NCT02111174|20254400|P2|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|6
5856977|NCT02111174|20254401|P1|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|8
5856978|NCT02111174|20254400|P2|Treatment and Primary Outcome|Withdrawal by Subject|2
5856979|NCT02111174|20254401|P1|Treatment and Primary Outcome|Withdrawal by Subject|2
5856980|NCT02111174|20254400|P2|Treatment and Primary Outcome|Ineligible (not used in analysis)|0
5856981|NCT02111174|20254401|P1|Treatment and Primary Outcome|Ineligible (not used in analysis)|1
5856982|NCT02111096|20254430|P3|Overall Study|Withdrawal by Subject|8
5856983|NCT02111096|20254431|P2|Overall Study|Withdrawal by Subject|2
5856984|NCT02111096|20254432|P1|Overall Study|Withdrawal by Subject|4
5856985|NCT02111096|20254430|P3|Overall Study|Terminated by Sponsor|54
5856986|NCT02111096|20254431|P2|Overall Study|Terminated by Sponsor|35
5856987|NCT02111096|20254432|P1|Overall Study|Terminated by Sponsor|53
5856988|NCT02111096|20254430|P3|Overall Study|Protocol Violation|1
5856989|NCT02111096|20254431|P2|Overall Study|Protocol Violation|0
5856990|NCT02111096|20254432|P1|Overall Study|Protocol Violation|1
5856991|NCT02111096|20254430|P3|Overall Study|Physician Decision|0
5856992|NCT02111096|20254431|P2|Overall Study|Physician Decision|1
5856993|NCT02111096|20254432|P1|Overall Study|Physician Decision|0
5856994|NCT02111096|20254430|P3|Overall Study|Lost to Follow Up|1
5856995|NCT02111096|20254431|P2|Overall Study|Lost to Follow Up|1
5856996|NCT02111096|20254432|P1|Overall Study|Lost to Follow Up|1
5856997|NCT02111096|20254430|P3|Overall Study|Non-Compliance with Study Drug|0
5856998|NCT02111096|20254431|P2|Overall Study|Non-Compliance with Study Drug|1
5856999|NCT02111096|20254432|P1|Overall Study|Non-Compliance with Study Drug|1
5857000|NCT02111096|20254430|P3|Overall Study|Adverse Event|2
5857001|NCT02111096|20254431|P2|Overall Study|Adverse Event|1
5857002|NCT02111096|20254432|P1|Overall Study|Adverse Event|4
5857003|NCT02111083|20254480|P2|Interval Between Dosing (7-8 Days)|Adverse Event|1
5857004|NCT02111083|20254481|P1|Interval Between Dosing (7-8 Days)|Adverse Event|1
5857005|NCT02110901|20254501|P2|Overall Study|received a kidney transplant|0
5857006|NCT02110901|20254502|P1|Overall Study|received a kidney transplant|5
5857007|NCT02110901|20254501|P2|Overall Study|Withdrawal by Subject|3
5857008|NCT02110901|20254502|P1|Overall Study|Withdrawal by Subject|7
5857009|NCT02110901|20254501|P2|Overall Study|Lost to Follow-up|8
5857010|NCT02110901|20254502|P1|Overall Study|Lost to Follow-up|12
5857011|NCT02110901|20254501|P2|Overall Study|Death|3
5857012|NCT02110901|20254502|P1|Overall Study|Death|6
5857013|NCT02110706|20254516|P2|Overall Study|Patients who didn't receive 2nd infusion|1
5857014|NCT02110706|20254517|P1|Overall Study|Patients who didn't receive 2nd infusion|3
5857015|NCT02110706|20254516|P2|Overall Study|Adverse Event|3
5857016|NCT02110706|20254517|P1|Overall Study|Adverse Event|2
5857017|NCT02110693|20254529|P2|Overall Study|Other|0
5857018|NCT02110693|20254530|P1|Overall Study|Other|1
5857019|NCT02110693|20254529|P2|Overall Study|technical difficulties|4
5857020|NCT02110693|20254530|P1|Overall Study|technical difficulties|6
5857021|NCT02110693|20254529|P2|Overall Study|skipped assessment|18
5857022|NCT02110693|20254530|P1|Overall Study|skipped assessment|15
5857023|NCT02110693|20254529|P2|Overall Study|Withdrawal by Subject|7
5857024|NCT02110693|20254530|P1|Overall Study|Withdrawal by Subject|6
5857025|NCT02110238|20254611|P2|14 Week Blinded Extension Phase|Withdrawal by Subject|3
5857026|NCT02110238|20254612|P1|14 Week Blinded Extension Phase|Withdrawal by Subject|4
5857027|NCT02110238|20254611|P2|14 Week Blinded Extension Phase|Protocol Violation|3
5857028|NCT02110238|20254612|P1|14 Week Blinded Extension Phase|Protocol Violation|2
5857029|NCT02110238|20254611|P2|14 Week Blinded Extension Phase|Lost to Follow-up|1
5857030|NCT02110238|20254612|P1|14 Week Blinded Extension Phase|Lost to Follow-up|3
5857031|NCT02110238|20254611|P2|14 Week Blinded Extension Phase|Lack of Efficacy|4
5857032|NCT02110238|20254612|P1|14 Week Blinded Extension Phase|Lack of Efficacy|2
5857033|NCT02110238|20254611|P2|14 Week Blinded Extension Phase|Adverse Event|1
5857034|NCT02110238|20254612|P1|14 Week Blinded Extension Phase|Adverse Event|1
5857035|NCT02110238|20254611|P2|12 Week Pivotal Phase|Withdrawal by Subject|3
5857036|NCT02110238|20254612|P1|12 Week Pivotal Phase|Withdrawal by Subject|3
5857037|NCT02110238|20254611|P2|12 Week Pivotal Phase|Protocol Violation|1
5857038|NCT02110238|20254612|P1|12 Week Pivotal Phase|Protocol Violation|0
5857039|NCT02110238|20254611|P2|12 Week Pivotal Phase|Physician Decision|2
5857040|NCT02110238|20254612|P1|12 Week Pivotal Phase|Physician Decision|0
5857041|NCT02110238|20254611|P2|12 Week Pivotal Phase|Lost to Follow-up|0
5857042|NCT02110238|20254612|P1|12 Week Pivotal Phase|Lost to Follow-up|2
5857043|NCT02110238|20254611|P2|12 Week Pivotal Phase|Lack of Efficacy|3
5857044|NCT02110238|20254612|P1|12 Week Pivotal Phase|Lack of Efficacy|2
5857045|NCT02110238|20254611|P2|12 Week Pivotal Phase|Adverse Event|0
5857046|NCT02110238|20254612|P1|12 Week Pivotal Phase|Adverse Event|3
5857047|NCT02110225|20254621|P3|Overall Study|Lost to Follow-up|0
5857048|NCT02110225|20254622|P2|Overall Study|Lost to Follow-up|1
5857049|NCT02110225|20254623|P1|Overall Study|Lost to Follow-up|0
5857050|NCT02109562|20254738|P3|Overall Study|Physician Decision|5
5857051|NCT02109562|20254739|P2|Overall Study|Physician Decision|4
5857052|NCT02109562|20254740|P1|Overall Study|Physician Decision|3
5857053|NCT02109562|20254738|P3|Overall Study|Withdrawal by Subject|21
5857054|NCT02109562|20254739|P2|Overall Study|Withdrawal by Subject|25
5857055|NCT02109562|20254740|P1|Overall Study|Withdrawal by Subject|20
5857056|NCT02109562|20254738|P3|Overall Study|Protocol Violation|1
5857057|NCT02109562|20254739|P2|Overall Study|Protocol Violation|3
5857058|NCT02109562|20254740|P1|Overall Study|Protocol Violation|0
5857059|NCT02109562|20254738|P3|Overall Study|Lost to Follow-up|1
5857060|NCT02109562|20254739|P2|Overall Study|Lost to Follow-up|0
5857061|NCT02109562|20254740|P1|Overall Study|Lost to Follow-up|1
5857062|NCT02109562|20254738|P3|Overall Study|Adverse Event|3
5857063|NCT02109562|20254739|P2|Overall Study|Adverse Event|2
5857064|NCT02109562|20254740|P1|Overall Study|Adverse Event|0
5857065|NCT02109562|20254738|P3|Overall Study|Insufficient clinical response|4
5857066|NCT02109562|20254739|P2|Overall Study|Insufficient clinical response|0
5857067|NCT02109562|20254740|P1|Overall Study|Insufficient clinical response|2
5857068|NCT02109484|20254767|P8|Overall Study|Moved away from study area|1
5857069|NCT02109484|20254768|P7|Overall Study|Moved away from study area|1
5857070|NCT02109484|20254769|P6|Overall Study|Moved away from study area|0
5857071|NCT02109484|20254770|P5|Overall Study|Moved away from study area|0
5857072|NCT02109484|20254771|P4|Overall Study|Moved away from study area|0
5857073|NCT02109484|20254772|P3|Overall Study|Moved away from study area|0
5857074|NCT02109484|20254773|P2|Overall Study|Moved away from study area|0
5857075|NCT02109484|20254774|P1|Overall Study|Moved away from study area|0
5857076|NCT02109484|20254767|P8|Overall Study|Death|2
5857077|NCT02109484|20254768|P7|Overall Study|Death|0
5857078|NCT02109484|20254769|P6|Overall Study|Death|0
5857079|NCT02109484|20254770|P5|Overall Study|Death|0
5857080|NCT02109484|20254771|P4|Overall Study|Death|0
5857081|NCT02109484|20254772|P3|Overall Study|Death|0
5857082|NCT02109484|20254773|P2|Overall Study|Death|0
5857083|NCT02109484|20254774|P1|Overall Study|Death|0
5857084|NCT02109484|20254767|P8|Overall Study|Physician Decision|0
5857085|NCT02109484|20254768|P7|Overall Study|Physician Decision|0
5857086|NCT02109484|20254769|P6|Overall Study|Physician Decision|0
5857087|NCT02109484|20254770|P5|Overall Study|Physician Decision|2
5857088|NCT02109484|20254771|P4|Overall Study|Physician Decision|0
5857089|NCT02109484|20254772|P3|Overall Study|Physician Decision|0
5857090|NCT02109484|20254773|P2|Overall Study|Physician Decision|0
5857091|NCT02109484|20254774|P1|Overall Study|Physician Decision|0
5857092|NCT02109484|20254767|P8|Overall Study|Withdrawal by Subject|0
5857093|NCT02109484|20254768|P7|Overall Study|Withdrawal by Subject|1
5857094|NCT02109484|20254769|P6|Overall Study|Withdrawal by Subject|1
5857095|NCT02109484|20254770|P5|Overall Study|Withdrawal by Subject|1
5857096|NCT02109484|20254771|P4|Overall Study|Withdrawal by Subject|0
5857097|NCT02109484|20254772|P3|Overall Study|Withdrawal by Subject|0
5857098|NCT02109484|20254773|P2|Overall Study|Withdrawal by Subject|0
5857099|NCT02109484|20254774|P1|Overall Study|Withdrawal by Subject|0
5857100|NCT02109484|20254767|P8|Overall Study|Lost to Follow-up|0
5857101|NCT02109484|20254768|P7|Overall Study|Lost to Follow-up|1
5857102|NCT02109484|20254769|P6|Overall Study|Lost to Follow-up|0
5857103|NCT02109484|20254770|P5|Overall Study|Lost to Follow-up|1
5857104|NCT02109484|20254771|P4|Overall Study|Lost to Follow-up|1
5857105|NCT02109484|20254772|P3|Overall Study|Lost to Follow-up|0
5857106|NCT02109484|20254773|P2|Overall Study|Lost to Follow-up|0
5857107|NCT02109484|20254774|P1|Overall Study|Lost to Follow-up|0
5857108|NCT02109445|20254830|P1|Overall Study|Adverse Event|1
5857109|NCT02109445|20254830|P1|Overall Study|Symptomatic deterioration|2
5857110|NCT02109432|20254863|P1|Overall Study|Withdrawal by Subject|1
5857111|NCT02109172|20254873|P6|Overall Study|Death|0
5857112|NCT02109172|20254874|P5|Overall Study|Death|1
5857113|NCT02109172|20254875|P4|Overall Study|Death|0
5857114|NCT02109172|20254876|P3|Overall Study|Death|0
5857115|NCT02109172|20254877|P2|Overall Study|Death|0
5857116|NCT02109172|20254878|P1|Overall Study|Death|0
5857117|NCT02109172|20254873|P6|Overall Study|Adverse Event|1
5857118|NCT02109172|20254874|P5|Overall Study|Adverse Event|0
5857119|NCT02109172|20254875|P4|Overall Study|Adverse Event|0
5857120|NCT02109172|20254876|P3|Overall Study|Adverse Event|1
5857121|NCT02109172|20254877|P2|Overall Study|Adverse Event|0
5857122|NCT02109172|20254878|P1|Overall Study|Adverse Event|0
5857123|NCT02109172|20254873|P6|Overall Study|Withdrawal by Subject|0
5857124|NCT02109172|20254874|P5|Overall Study|Withdrawal by Subject|0
5857125|NCT02109172|20254875|P4|Overall Study|Withdrawal by Subject|1
5857126|NCT02109172|20254876|P3|Overall Study|Withdrawal by Subject|0
5857127|NCT02109172|20254877|P2|Overall Study|Withdrawal by Subject|0
5857128|NCT02109172|20254878|P1|Overall Study|Withdrawal by Subject|1
5857129|NCT02109133|20254899|P2|Overall Study|Lost to Follow-up|0
5857130|NCT02109133|20254900|P1|Overall Study|Lost to Follow-up|1
5857131|NCT02109107|20254912|P1|Overall Study|Lost to Follow-up|2
5857132|NCT02109042|20254919|P1|Overall Study|Sponsor Decision|15
5857133|NCT02109029|20254928|P6|Part B|Adverse Event|1
5857134|NCT02109029|20254929|P5|Part B|Adverse Event|1
5857135|NCT02109029|20254930|P4|Part B|Adverse Event|0
5857136|NCT02109029|20254931|P3|Part B|Adverse Event|0
5857137|NCT02109029|20254932|P2|Part B|Adverse Event|0
5857138|NCT02109029|20254933|P1|Part B|Adverse Event|0
5857139|NCT02108964|20254970|P8|Overall Study|Subject/Guardian decision|1
5857140|NCT02108964|20254971|P7|Overall Study|Subject/Guardian decision|1
5857141|NCT02108964|20254972|P6|Overall Study|Subject/Guardian decision|0
5857142|NCT02108964|20254973|P5|Overall Study|Subject/Guardian decision|2
5857143|NCT02108964|20254974|P4|Overall Study|Subject/Guardian decision|0
5857144|NCT02108964|20254975|P3|Overall Study|Subject/Guardian decision|3
5857145|NCT02108964|20254976|P2|Overall Study|Subject/Guardian decision|1
5857146|NCT02108964|20254977|P1|Overall Study|Subject/Guardian decision|0
5857147|NCT02108964|20254970|P8|Overall Study|Death|1
5857148|NCT02108964|20254971|P7|Overall Study|Death|0
5857149|NCT02108964|20254972|P6|Overall Study|Death|0
5857150|NCT02108964|20254973|P5|Overall Study|Death|3
5857151|NCT02108964|20254974|P4|Overall Study|Death|0
5857152|NCT02108964|20254975|P3|Overall Study|Death|2
5857153|NCT02108964|20254976|P2|Overall Study|Death|1
5857154|NCT02108964|20254977|P1|Overall Study|Death|1
5857155|NCT02108964|20254970|P8|Overall Study|Adverse Event|1
5857156|NCT02108964|20254971|P7|Overall Study|Adverse Event|3
5857157|NCT02108964|20254972|P6|Overall Study|Adverse Event|0
5857158|NCT02108964|20254973|P5|Overall Study|Adverse Event|1
5857159|NCT02108964|20254974|P4|Overall Study|Adverse Event|0
5857160|NCT02108964|20254975|P3|Overall Study|Adverse Event|4
5857161|NCT02108964|20254976|P2|Overall Study|Adverse Event|0
5857162|NCT02108964|20254977|P1|Overall Study|Adverse Event|0
5857163|NCT02108964|20254970|P8|Overall Study|Physician Decision|0
5857164|NCT02108964|20254971|P7|Overall Study|Physician Decision|0
5857165|NCT02108964|20254972|P6|Overall Study|Physician Decision|0
5857166|NCT02108964|20254973|P5|Overall Study|Physician Decision|1
5857167|NCT02108964|20254974|P4|Overall Study|Physician Decision|0
5857168|NCT02108964|20254975|P3|Overall Study|Physician Decision|6
5857169|NCT02108964|20254976|P2|Overall Study|Physician Decision|5
5857170|NCT02108964|20254977|P1|Overall Study|Physician Decision|1
5857171|NCT02108964|20254970|P8|Overall Study|Progressive disease|9
5857172|NCT02108964|20254971|P7|Overall Study|Progressive disease|7
5857173|NCT02108964|20254972|P6|Overall Study|Progressive disease|5
5857174|NCT02108964|20254973|P5|Overall Study|Progressive disease|18
5857175|NCT02108964|20254974|P4|Overall Study|Progressive disease|6
5857176|NCT02108964|20254975|P3|Overall Study|Progressive disease|50
5857177|NCT02108964|20254976|P2|Overall Study|Progressive disease|25
5857178|NCT02108964|20254977|P1|Overall Study|Progressive disease|12
5857179|NCT02108951|20254996|P1|Overall Study|Study Terminated by Sponsor|14
5857180|NCT02108951|20254996|P1|Overall Study|Patient's/guardian's decision|1
5857181|NCT02108951|20254996|P1|Overall Study|Lost to Follow-up|1
5857182|NCT02108912|20255015|P2|Overall Study|high blood pressure|0
5857183|NCT02108912|20255016|P1|Overall Study|high blood pressure|1
5857184|NCT02108912|20255015|P2|Overall Study|lack of transportation|0
5857185|NCT02108912|20255016|P1|Overall Study|lack of transportation|1
5857186|NCT02108912|20255015|P2|Overall Study|Lost to Follow-up|1
5857187|NCT02108912|20255016|P1|Overall Study|Lost to Follow-up|1
5857188|NCT02108652|20255045|P1|Overall Study|Ongoing at data cutoff 04 July 2016|74
5857189|NCT02108652|20255045|P1|Overall Study|Withdrawal by Subject|8
5857190|NCT02108652|20255045|P1|Overall Study|Lost to Follow-up|2
5857191|NCT02108652|20255045|P1|Overall Study|Death|226
5857192|NCT02108600|20255068|P2|Overall Study|Lost to Follow-up|1
5857193|NCT02108600|20255069|P1|Overall Study|Lost to Follow-up|1
5857194|NCT02108600|20255068|P2|Overall Study|Withdrawal by Subject|0
5857195|NCT02108600|20255069|P1|Overall Study|Withdrawal by Subject|2
5857196|NCT02107898|20255238|P2|Overall Study|Randomized but not treated|1
5857197|NCT02107898|20255239|P1|Overall Study|Randomized but not treated|0
5857198|NCT02107898|20255238|P2|Overall Study|Consent withdrawn by participant|1
5857199|NCT02107898|20255239|P1|Overall Study|Consent withdrawn by participant|2
5857200|NCT02107898|20255238|P2|Overall Study|Participant moved|2
5857201|NCT02107898|20255239|P1|Overall Study|Participant moved|0
5857202|NCT02107898|20255238|P2|Overall Study|Poor compliance to protocol|1
5857203|NCT02107898|20255239|P1|Overall Study|Poor compliance to protocol|0
5857204|NCT02107898|20255238|P2|Overall Study|Adverse Event|7
5857205|NCT02107898|20255239|P1|Overall Study|Adverse Event|4
5857206|NCT02107859|20255291|P1|Overall Study|Other than specified|3
5857207|NCT02107859|20255291|P1|Overall Study|Study closure|41
5857208|NCT02107859|20255291|P1|Overall Study|Adverse Event|3
5857209|NCT02107859|20255291|P1|Overall Study|Withdrawal by Subject|14
5857210|NCT02107703|20255307|P2|Overall Study|On study treatment/follow up|152
5857211|NCT02107703|20255308|P1|Overall Study|On study treatment/follow up|319
5857212|NCT02107703|20255307|P2|Overall Study|Lost to Follow-up|4
5857213|NCT02107703|20255308|P1|Overall Study|Lost to Follow-up|6
5857214|NCT02107703|20255307|P2|Overall Study|Withdrawal by Subject|19
5857215|NCT02107703|20255308|P1|Overall Study|Withdrawal by Subject|36
5857216|NCT02107482|20255340|P1|Overall Study|Lack of Efficacy|1
5857217|NCT02107482|20255340|P1|Overall Study|Lost to Follow-up|1
5857218|NCT02107482|20255340|P1|Overall Study|inconveinence|2
5857219|NCT02107443|20255348|P2|Overall Study|Withdrawal: Personal Issues|3
5857220|NCT02107443|20255349|P1|Overall Study|Withdrawal: Personal Issues|0
5857221|NCT02107443|20255348|P2|Overall Study|Withdrawal: Disease Progression|2
5857222|NCT02107443|20255349|P1|Overall Study|Withdrawal: Disease Progression|4
5857223|NCT02107443|20255348|P2|Overall Study|Withdrawal: Other Medical|5
5857224|NCT02107443|20255349|P1|Overall Study|Withdrawal: Other Medical|9
5857225|NCT02107443|20255348|P2|Overall Study|Withdrawal: Feeling Overwhelmed|1
5857226|NCT02107443|20255349|P1|Overall Study|Withdrawal: Feeling Overwhelmed|2
5857227|NCT02107443|20255348|P2|Overall Study|Withdrawal: Too Time Consuming|6
5857228|NCT02107443|20255349|P1|Overall Study|Withdrawal: Too Time Consuming|3
5857229|NCT02107443|20255348|P2|Overall Study|Withdrawal: Too Many Forms|1
5857230|NCT02107443|20255349|P1|Overall Study|Withdrawal: Too Many Forms|3
5857231|NCT02107443|20255348|P2|Overall Study|Withdrawal: Changed MD/Facility|3
5857232|NCT02107443|20255349|P1|Overall Study|Withdrawal: Changed MD/Facility|1
5857233|NCT02107443|20255348|P2|Overall Study|Withdrawal: Changed Mind|0
5857234|NCT02107443|20255349|P1|Overall Study|Withdrawal: Changed Mind|2
5857235|NCT02107443|20255348|P2|Overall Study|Withdrawal: Disliked Study Procedures|2
5857236|NCT02107443|20255349|P1|Overall Study|Withdrawal: Disliked Study Procedures|1
5857237|NCT02107443|20255348|P2|Overall Study|Withdrawal: Hospitalization/Hospice|28
5857238|NCT02107443|20255349|P1|Overall Study|Withdrawal: Hospitalization/Hospice|28
5857239|NCT02107443|20255348|P2|Overall Study|Registered but Not Eligible|1
5857240|NCT02107443|20255349|P1|Overall Study|Registered but Not Eligible|0
5857241|NCT02107443|20255348|P2|Overall Study|Study Protocol Violation|1
5857242|NCT02107443|20255349|P1|Overall Study|Study Protocol Violation|3
5857243|NCT02107443|20255348|P2|Overall Study|Death|30
5857244|NCT02107443|20255349|P1|Overall Study|Death|42
5857245|NCT02107313|20255402|P2|Overall Study|One participant did not do the FED cohor|1
5857246|NCT02107313|20255403|P1|Overall Study|One participant did not do the FED cohor|0
5857247|NCT02107274|20255424|P2|Control Phase|Adverse Event|1
5857248|NCT02107274|20255425|P1|Control Phase|Adverse Event|0
5857249|NCT02107274|20255424|P2|Control Phase|Death|0
5857250|NCT02107274|20255425|P1|Control Phase|Death|2
5857251|NCT02107274|20255424|P2|Control Phase|Lost to Follow-up|1
5857252|NCT02107274|20255425|P1|Control Phase|Lost to Follow-up|1
5857253|NCT02107274|20255424|P2|Treatment vs. Placebo|Lost to Follow-up|2
5857254|NCT02107274|20255425|P1|Treatment vs. Placebo|Lost to Follow-up|0
5857255|NCT02107274|20255424|P2|Treatment vs. Placebo|Adverse Event|0
5857256|NCT02107274|20255425|P1|Treatment vs. Placebo|Adverse Event|3
5857257|NCT02107196|20255439|P2|4-week Randomized Withdrawal (RW) Period|Reason Missing|5
5857258|NCT02107196|20255440|P1|4-week Randomized Withdrawal (RW) Period|Reason Missing|18
5857259|NCT02107196|20255439|P2|4-week Randomized Withdrawal (RW) Period|Protocol Violation|0
5857260|NCT02107196|20255440|P1|4-week Randomized Withdrawal (RW) Period|Protocol Violation|2
5857261|NCT02107196|20255439|P2|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|0
5857262|NCT02107196|20255440|P1|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|1
5857263|NCT02107196|20255439|P2|4-week Randomized Withdrawal (RW) Period|Adverse Event|0
5857264|NCT02107196|20255440|P1|4-week Randomized Withdrawal (RW) Period|Adverse Event|2
5857265|NCT02107196|20255439|P2|12-week Treatment Period|Reason Missing|8
5857266|NCT02107196|20255440|P1|12-week Treatment Period|Reason Missing|11
5857267|NCT02107196|20255439|P2|12-week Treatment Period|Protocol Violation|8
5857268|NCT02107196|20255440|P1|12-week Treatment Period|Protocol Violation|7
5857269|NCT02107196|20255439|P2|12-week Treatment Period|Withdrawal by Subject|12
5857270|NCT02107196|20255440|P1|12-week Treatment Period|Withdrawal by Subject|15
5857271|NCT02107196|20255439|P2|12-week Treatment Period|Physician Decision|1
5857272|NCT02107196|20255440|P1|12-week Treatment Period|Physician Decision|0
5857273|NCT02107196|20255439|P2|12-week Treatment Period|Lost to Follow-up|6
5857274|NCT02107196|20255440|P1|12-week Treatment Period|Lost to Follow-up|3
5857275|NCT02107196|20255439|P2|12-week Treatment Period|Lack of Efficacy|1
5857276|NCT02107196|20255440|P1|12-week Treatment Period|Lack of Efficacy|2
5857277|NCT02107196|20255439|P2|12-week Treatment Period|Adverse Event|3
5857278|NCT02107196|20255440|P1|12-week Treatment Period|Adverse Event|6
5857279|NCT02107131|20255468|P2|Overall Study|Protocol Violation|4
5857280|NCT02107131|20255469|P1|Overall Study|Protocol Violation|0
5857281|NCT02107131|20255468|P2|Overall Study|Death|1
5857282|NCT02107131|20255469|P1|Overall Study|Death|0
5857283|NCT02107131|20255468|P2|Overall Study|mental instability|0
5857284|NCT02107131|20255469|P1|Overall Study|mental instability|1
5857285|NCT02107131|20255468|P2|Overall Study|Withdrawal by Subject|0
5857286|NCT02107131|20255469|P1|Overall Study|Withdrawal by Subject|2
5857287|NCT02107131|20255468|P2|Overall Study|Physician Decision|0
5857288|NCT02107131|20255469|P1|Overall Study|Physician Decision|1
5857289|NCT02107131|20255468|P2|Overall Study|Lost to Follow-up|4
5857290|NCT02107131|20255469|P1|Overall Study|Lost to Follow-up|4
5857291|NCT02107092|20255481|P1|Overall Study|Expected progression of CKD|12
5857292|NCT02107092|20255481|P1|Overall Study|Adverse Event|7
5857293|NCT02107092|20255481|P1|Overall Study|Withdrawal by Subject|9
5857294|NCT02107092|20255481|P1|Overall Study|Lost to Follow-up|2
5857295|NCT02107092|20255481|P1|Overall Study|Physician Decision|3
5857296|NCT02107092|20255481|P1|Overall Study|Met ECG withdrawal criteria|3
5857297|NCT02107092|20255481|P1|Overall Study|Hypo-or hyperkalemia|2
5857298|NCT02107092|20255481|P1|Overall Study|Subject compliance|3
5857299|NCT02107092|20255481|P1|Overall Study|Miscellaneous|3
5857300|NCT02107014|20255486|P1|Overall Study|Withdrew before drug: moving interstate|1
5857301|NCT02106975|20255556|P2|Overall Study|Death|39
5857302|NCT02106975|20255557|P1|Overall Study|Death|25
5857303|NCT02106923|20255617|P6|Overall Study|Protocol Violation|1
5857304|NCT02106923|20255618|P5|Overall Study|Protocol Violation|0
5857305|NCT02106923|20255619|P4|Overall Study|Protocol Violation|0
5857306|NCT02106923|20255620|P3|Overall Study|Protocol Violation|0
5857307|NCT02106923|20255621|P2|Overall Study|Protocol Violation|0
5857308|NCT02106923|20255622|P1|Overall Study|Protocol Violation|0
5857309|NCT02106910|20255668|P2|Overall Study|Lost to Follow-up|1
5857310|NCT02106910|20255669|P1|Overall Study|Lost to Follow-up|1
5857311|NCT02106884|20255685|P2|Overall Study|Change of diagnosis/exclusion|1
5857312|NCT02106884|20255686|P1|Overall Study|Change of diagnosis/exclusion|0
5857313|NCT02106832|20255710|P4|Overall Study|Technical problems|0
5857314|NCT02106832|20255711|P3|Overall Study|Technical problems|0
5857315|NCT02106832|20255712|P2|Overall Study|Technical problems|1
5857316|NCT02106832|20255713|P1|Overall Study|Technical problems|0
5857317|NCT02106832|20255710|P4|Overall Study|Withdrawal by Subject|7
5857318|NCT02106832|20255711|P3|Overall Study|Withdrawal by Subject|10
5857319|NCT02106832|20255712|P2|Overall Study|Withdrawal by Subject|17
5857320|NCT02106832|20255713|P1|Overall Study|Withdrawal by Subject|17
5857321|NCT02106832|20255710|P4|Overall Study|Protocol Violation|1
5857322|NCT02106832|20255711|P3|Overall Study|Protocol Violation|0
5857323|NCT02106832|20255712|P2|Overall Study|Protocol Violation|0
5857324|NCT02106832|20255713|P1|Overall Study|Protocol Violation|0
5857325|NCT02106832|20255710|P4|Overall Study|Physician Decision|0
5857326|NCT02106832|20255711|P3|Overall Study|Physician Decision|0
5857327|NCT02106832|20255712|P2|Overall Study|Physician Decision|0
5857328|NCT02106832|20255713|P1|Overall Study|Physician Decision|1
5857329|NCT02106832|20255710|P4|Overall Study|Lost to Follow-up|3
5857330|NCT02106832|20255711|P3|Overall Study|Lost to Follow-up|1
5857331|NCT02106832|20255712|P2|Overall Study|Lost to Follow-up|1
5857332|NCT02106832|20255713|P1|Overall Study|Lost to Follow-up|0
5857333|NCT02106832|20255710|P4|Overall Study|Deterioration of general conditions|0
5857334|NCT02106832|20255711|P3|Overall Study|Deterioration of general conditions|1
5857335|NCT02106832|20255712|P2|Overall Study|Deterioration of general conditions|0
5857336|NCT02106832|20255713|P1|Overall Study|Deterioration of general conditions|0
5857337|NCT02106832|20255710|P4|Overall Study|Death|4
5857338|NCT02106832|20255711|P3|Overall Study|Death|1
5857339|NCT02106832|20255712|P2|Overall Study|Death|4
5857340|NCT02106832|20255713|P1|Overall Study|Death|4
5857341|NCT02106832|20255710|P4|Overall Study|Adverse Event|0
5857342|NCT02106832|20255711|P3|Overall Study|Adverse Event|3
5857343|NCT02106832|20255712|P2|Overall Study|Adverse Event|2
5857344|NCT02106832|20255713|P1|Overall Study|Adverse Event|1
5857345|NCT02106455|20255780|P1|Overall Study|Protocol Deviation|2
5857346|NCT02106455|20255780|P1|Overall Study|Case Report Form Uncollected|6
5857347|NCT02106442|20255794|P1|Overall Study|Protocol Deviation|30
5857348|NCT02106442|20255794|P1|Overall Study|Case Report Forms Uncollected|7
5857349|NCT02106403|20255812|P6|Follow-Up Visit 3|Other Reason|1
5857350|NCT02106403|20255813|P5|Follow-Up Visit 3|Other Reason|0
5857351|NCT02106403|20255814|P4|Follow-Up Visit 3|Other Reason|0
5857352|NCT02106403|20255815|P3|Follow-Up Visit 3|Other Reason|0
5857353|NCT02106403|20255816|P2|Follow-Up Visit 3|Other Reason|0
5857354|NCT02106403|20255817|P1|Follow-Up Visit 3|Other Reason|0
5857355|NCT02106390|20255840|P3|Overall Study|Protocol Violation|0
5857356|NCT02106390|20255841|P2|Overall Study|Protocol Violation|1
5857357|NCT02106390|20255842|P1|Overall Study|Protocol Violation|0
5857358|NCT02106390|20255840|P3|Overall Study|Adverse Event|1
5857359|NCT02106390|20255841|P2|Overall Study|Adverse Event|2
5857360|NCT02106390|20255842|P1|Overall Study|Adverse Event|0
5857361|NCT02106390|20255840|P3|Overall Study|Other: Unspecified|2
5857362|NCT02106390|20255841|P2|Overall Study|Other: Unspecified|4
5857363|NCT02106390|20255842|P1|Overall Study|Other: Unspecified|1
5857364|NCT02106390|20255840|P3|Overall Study|Other: Administrative Reason|12
5857365|NCT02106390|20255841|P2|Overall Study|Other: Administrative Reason|5
5857366|NCT02106390|20255842|P1|Overall Study|Other: Administrative Reason|8
5857367|NCT02106390|20255840|P3|Overall Study|Lost to Follow-up|13
5857368|NCT02106390|20255841|P2|Overall Study|Lost to Follow-up|20
5857369|NCT02106390|20255842|P1|Overall Study|Lost to Follow-up|25
5857370|NCT02106390|20255840|P3|Overall Study|Withdrawal by Subject|15
5857371|NCT02106390|20255841|P2|Overall Study|Withdrawal by Subject|16
5857372|NCT02106390|20255842|P1|Overall Study|Withdrawal by Subject|15
5857373|NCT02106351|20255919|P3|Treatment Cycle 4|Other|0
5857374|NCT02106351|20255920|P2|Treatment Cycle 4|Other|1
5857375|NCT02106351|20255921|P1|Treatment Cycle 4|Other|0
5857376|NCT02106351|20255919|P3|Treatment Cycle 4|Consent withdrawn|2
5857377|NCT02106351|20255920|P2|Treatment Cycle 4|Consent withdrawn|0
5857378|NCT02106351|20255921|P1|Treatment Cycle 4|Consent withdrawn|0
5857379|NCT02106351|20255919|P3|Treatment Cycle 3|Other|3
5857380|NCT02106351|20255920|P2|Treatment Cycle 3|Other|2
5857381|NCT02106351|20255921|P1|Treatment Cycle 3|Other|0
5857382|NCT02106351|20255919|P3|Treatment Cycle 3|Lost to Follow-up|0
5857383|NCT02106351|20255920|P2|Treatment Cycle 3|Lost to Follow-up|1
5857384|NCT02106351|20255921|P1|Treatment Cycle 3|Lost to Follow-up|0
5857385|NCT02106351|20255919|P3|Treatment Cycle 3|Consent withdrawn|2
5857386|NCT02106351|20255920|P2|Treatment Cycle 3|Consent withdrawn|0
5857387|NCT02106351|20255921|P1|Treatment Cycle 3|Consent withdrawn|0
5857388|NCT02106351|20255919|P3|Treatment Cycle 3|Adverse Event|0
5857389|NCT02106351|20255920|P2|Treatment Cycle 3|Adverse Event|1
5857390|NCT02106351|20255921|P1|Treatment Cycle 3|Adverse Event|0
5857391|NCT02106351|20255919|P3|Treatment Cycle 2|Other|2
5857392|NCT02106351|20255920|P2|Treatment Cycle 2|Other|2
5857393|NCT02106351|20255921|P1|Treatment Cycle 2|Other|0
5857394|NCT02106351|20255919|P3|Treatment Cycle 2|Consent withdrawn|1
5857395|NCT02106351|20255920|P2|Treatment Cycle 2|Consent withdrawn|1
5857396|NCT02106351|20255921|P1|Treatment Cycle 2|Consent withdrawn|0
5857397|NCT02106351|20255919|P3|Treatment Cycle 2|Adverse Event|0
5857398|NCT02106351|20255920|P2|Treatment Cycle 2|Adverse Event|2
5857399|NCT02106351|20255921|P1|Treatment Cycle 2|Adverse Event|0
5857400|NCT02106351|20255919|P3|Treatment Cycle 1|Randomised but not treated|1
5857401|NCT02106351|20255920|P2|Treatment Cycle 1|Randomised but not treated|0
5857402|NCT02106351|20255921|P1|Treatment Cycle 1|Randomised but not treated|1
5857403|NCT02106351|20255919|P3|Treatment Cycle 1|Other|1
5857404|NCT02106351|20255920|P2|Treatment Cycle 1|Other|3
5857405|NCT02106351|20255921|P1|Treatment Cycle 1|Other|0
5857406|NCT02106351|20255919|P3|Treatment Cycle 1|Lost to Follow-up|0
5857407|NCT02106351|20255920|P2|Treatment Cycle 1|Lost to Follow-up|0
5857408|NCT02106351|20255921|P1|Treatment Cycle 1|Lost to Follow-up|1
5857409|NCT02106351|20255919|P3|Treatment Cycle 1|Consent withdrawn|2
5857410|NCT02106351|20255920|P2|Treatment Cycle 1|Consent withdrawn|0
5857411|NCT02106351|20255921|P1|Treatment Cycle 1|Consent withdrawn|1
5857412|NCT02106351|20255919|P3|Treatment Cycle 1|Adverse Event|0
5857413|NCT02106351|20255920|P2|Treatment Cycle 1|Adverse Event|0
5857414|NCT02106351|20255921|P1|Treatment Cycle 1|Adverse Event|2
5857415|NCT02106325|20255964|P2|Phase 3|Lost to Follow-up|1
5857416|NCT02106325|20255965|P1|Phase 3|Lost to Follow-up|2
5857417|NCT02106325|20255964|P2|Phase 2|Lost to Follow-up|3
5857418|NCT02106325|20255965|P1|Phase 2|Lost to Follow-up|2
5857419|NCT02106325|20255964|P2|Phase 1|Lost to Follow-up|2
5857420|NCT02106325|20255965|P1|Phase 1|Lost to Follow-up|2
5857421|NCT02106156|20255990|P3|Overall Study|Relocation/Change of Physician|0
5857422|NCT02106156|20255991|P2|Overall Study|Relocation/Change of Physician|1
5857423|NCT02106156|20255992|P1|Overall Study|Relocation/Change of Physician|40
5857424|NCT02106156|20255990|P3|Overall Study|Hospitalization/Surgical Intervention|0
5857425|NCT02106156|20255991|P2|Overall Study|Hospitalization/Surgical Intervention|0
5857426|NCT02106156|20255992|P1|Overall Study|Hospitalization/Surgical Intervention|6
5857427|NCT02106156|20255990|P3|Overall Study|Change of Laboratory Parameter|0
5857428|NCT02106156|20255991|P2|Overall Study|Change of Laboratory Parameter|0
5857429|NCT02106156|20255992|P1|Overall Study|Change of Laboratory Parameter|10
5857430|NCT02106156|20255990|P3|Overall Study|Unplanned Event|0
5857431|NCT02106156|20255991|P2|Overall Study|Unplanned Event|2
5857432|NCT02106156|20255992|P1|Overall Study|Unplanned Event|82
5857433|NCT02106156|20255990|P3|Overall Study|Lost to Follow-up|0
5857434|NCT02106156|20255991|P2|Overall Study|Lost to Follow-up|8
5857435|NCT02106156|20255992|P1|Overall Study|Lost to Follow-up|451
5857436|NCT02106156|20255990|P3|Overall Study|Patients Request|0
5857437|NCT02106156|20255991|P2|Overall Study|Patients Request|9
5857438|NCT02106156|20255992|P1|Overall Study|Patients Request|307
5857439|NCT02106156|20255990|P3|Overall Study|Lack of Compliance|0
5857440|NCT02106156|20255991|P2|Overall Study|Lack of Compliance|7
5857441|NCT02106156|20255992|P1|Overall Study|Lack of Compliance|211
5857442|NCT02106156|20255990|P3|Overall Study|Concomitant Disease|0
5857443|NCT02106156|20255991|P2|Overall Study|Concomitant Disease|2
5857444|NCT02106156|20255992|P1|Overall Study|Concomitant Disease|74
5857445|NCT02106156|20255990|P3|Overall Study|Lack of Virological Response|0
5857446|NCT02106156|20255991|P2|Overall Study|Lack of Virological Response|8
5857447|NCT02106156|20255992|P1|Overall Study|Lack of Virological Response|1044
5857448|NCT02106156|20255990|P3|Overall Study|Lack of Tolerability|0
5857449|NCT02106156|20255991|P2|Overall Study|Lack of Tolerability|3
5857450|NCT02106156|20255992|P1|Overall Study|Lack of Tolerability|305
5857451|NCT02106156|20255990|P3|Overall Study|Patient Died|0
5857452|NCT02106156|20255991|P2|Overall Study|Patient Died|0
5857453|NCT02106156|20255992|P1|Overall Study|Patient Died|19
5857454|NCT02105987|20256016|P6|Continuation Phase|Protocol Violation|0
5857455|NCT02105987|20256017|P5|Continuation Phase|Protocol Violation|1
5857456|NCT02105987|20256018|P4|Continuation Phase|Protocol Violation|0
5857457|NCT02105987|20256019|P3|Continuation Phase|Protocol Violation|0
5857458|NCT02105987|20256020|P2|Continuation Phase|Protocol Violation|0
5857459|NCT02105987|20256021|P1|Continuation Phase|Protocol Violation|0
5857460|NCT02105987|20256016|P6|Late Switch Phase (24 Weeks)|Per sponsor request|0
5857461|NCT02105987|20256017|P5|Late Switch Phase (24 Weeks)|Per sponsor request|0
5857462|NCT02105987|20256018|P4|Late Switch Phase (24 Weeks)|Per sponsor request|0
5857463|NCT02105987|20256019|P3|Late Switch Phase (24 Weeks)|Per sponsor request|1
5857464|NCT02105987|20256020|P2|Late Switch Phase (24 Weeks)|Per sponsor request|0
5857465|NCT02105987|20256021|P1|Late Switch Phase (24 Weeks)|Per sponsor request|0
5857466|NCT02105987|20256016|P6|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0
5857467|NCT02105987|20256017|P5|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0
5857468|NCT02105987|20256018|P4|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|1
5857469|NCT02105987|20256019|P3|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0
5857470|NCT02105987|20256020|P2|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0
5857471|NCT02105987|20256021|P1|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0
5857472|NCT02105987|20256016|P6|Late Switch Phase (24 Weeks)|Physician Decision|0
5857473|NCT02105987|20256017|P5|Late Switch Phase (24 Weeks)|Physician Decision|0
5857474|NCT02105987|20256018|P4|Late Switch Phase (24 Weeks)|Physician Decision|0
5857475|NCT02105987|20256019|P3|Late Switch Phase (24 Weeks)|Physician Decision|5
5857476|NCT02105987|20256020|P2|Late Switch Phase (24 Weeks)|Physician Decision|0
5857477|NCT02105987|20256021|P1|Late Switch Phase (24 Weeks)|Physician Decision|0
5857478|NCT02105987|20256016|P6|Late Switch Phase (24 Weeks)|Lost to Follow-up|0
5857479|NCT02105987|20256017|P5|Late Switch Phase (24 Weeks)|Lost to Follow-up|0
5857480|NCT02105987|20256018|P4|Late Switch Phase (24 Weeks)|Lost to Follow-up|3
5857481|NCT02105987|20256019|P3|Late Switch Phase (24 Weeks)|Lost to Follow-up|8
5857482|NCT02105987|20256020|P2|Late Switch Phase (24 Weeks)|Lost to Follow-up|0
5857483|NCT02105987|20256021|P1|Late Switch Phase (24 Weeks)|Lost to Follow-up|0
5857484|NCT02105987|20256016|P6|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0
5857485|NCT02105987|20256017|P5|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0
5857486|NCT02105987|20256018|P4|Late Switch Phase (24 Weeks)|Withdrawal by Subject|5
5857487|NCT02105987|20256019|P3|Late Switch Phase (24 Weeks)|Withdrawal by Subject|6
5857488|NCT02105987|20256020|P2|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0
5857489|NCT02105987|20256021|P1|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0
5857490|NCT02105987|20256016|P6|Late Switch Phase (24 Weeks)|Protocol Violation|0
5857491|NCT02105987|20256017|P5|Late Switch Phase (24 Weeks)|Protocol Violation|0
5857492|NCT02105987|20256018|P4|Late Switch Phase (24 Weeks)|Protocol Violation|1
5857493|NCT02105987|20256019|P3|Late Switch Phase (24 Weeks)|Protocol Violation|15
5857494|NCT02105987|20256020|P2|Late Switch Phase (24 Weeks)|Protocol Violation|0
5857495|NCT02105987|20256021|P1|Late Switch Phase (24 Weeks)|Protocol Violation|0
5857496|NCT02105987|20256016|P6|Late Switch Phase (24 Weeks)|Adverse Event|0
5857497|NCT02105987|20256017|P5|Late Switch Phase (24 Weeks)|Adverse Event|0
5857498|NCT02105987|20256018|P4|Late Switch Phase (24 Weeks)|Adverse Event|4
5857499|NCT02105987|20256019|P3|Late Switch Phase (24 Weeks)|Adverse Event|10
5857500|NCT02105987|20256020|P2|Late Switch Phase (24 Weeks)|Adverse Event|0
5857501|NCT02105987|20256021|P1|Late Switch Phase (24 Weeks)|Adverse Event|0
5857502|NCT02105987|20256016|P6|Early Switch Phase (24 Weeks)|Missing Disposition Data|0
5857503|NCT02105987|20256017|P5|Early Switch Phase (24 Weeks)|Missing Disposition Data|0
5857504|NCT02105987|20256018|P4|Early Switch Phase (24 Weeks)|Missing Disposition Data|0
5857505|NCT02105987|20256019|P3|Early Switch Phase (24 Weeks)|Missing Disposition Data|0
5857506|NCT02105987|20256020|P2|Early Switch Phase (24 Weeks)|Missing Disposition Data|1
5857507|NCT02105987|20256021|P1|Early Switch Phase (24 Weeks)|Missing Disposition Data|0
5857508|NCT02105987|20256016|P6|Early Switch Phase (24 Weeks)|Physician Decision|0
5857509|NCT02105987|20256017|P5|Early Switch Phase (24 Weeks)|Physician Decision|0
5857510|NCT02105987|20256018|P4|Early Switch Phase (24 Weeks)|Physician Decision|0
5857511|NCT02105987|20256019|P3|Early Switch Phase (24 Weeks)|Physician Decision|0
5857512|NCT02105987|20256020|P2|Early Switch Phase (24 Weeks)|Physician Decision|3
5857513|NCT02105987|20256021|P1|Early Switch Phase (24 Weeks)|Physician Decision|4
5857514|NCT02105987|20256016|P6|Early Switch Phase (24 Weeks)|Lost to Follow-up|0
5857515|NCT02105987|20256017|P5|Early Switch Phase (24 Weeks)|Lost to Follow-up|0
5857516|NCT02105987|20256018|P4|Early Switch Phase (24 Weeks)|Lost to Follow-up|0
5857517|NCT02105987|20256019|P3|Early Switch Phase (24 Weeks)|Lost to Follow-up|0
5857518|NCT02105987|20256020|P2|Early Switch Phase (24 Weeks)|Lost to Follow-up|3
5857519|NCT02105987|20256021|P1|Early Switch Phase (24 Weeks)|Lost to Follow-up|3
5857520|NCT02105987|20256016|P6|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0
5857521|NCT02105987|20256017|P5|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0
5857522|NCT02105987|20256018|P4|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0
5857523|NCT02105987|20256019|P3|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0
5857524|NCT02105987|20256020|P2|Early Switch Phase (24 Weeks)|Withdrawal by Subject|10
5857525|NCT02105987|20256021|P1|Early Switch Phase (24 Weeks)|Withdrawal by Subject|4
5857526|NCT02105987|20256016|P6|Early Switch Phase (24 Weeks)|Protocol Violation|0
5857527|NCT02105987|20256017|P5|Early Switch Phase (24 Weeks)|Protocol Violation|0
5857528|NCT02105987|20256018|P4|Early Switch Phase (24 Weeks)|Protocol Violation|0
5857529|NCT02105987|20256019|P3|Early Switch Phase (24 Weeks)|Protocol Violation|0
5857530|NCT02105987|20256020|P2|Early Switch Phase (24 Weeks)|Protocol Violation|17
5857531|NCT02105987|20256021|P1|Early Switch Phase (24 Weeks)|Protocol Violation|15
5857532|NCT02105987|20256016|P6|Early Switch Phase (24 Weeks)|Adverse Event|0
5857533|NCT02105987|20256017|P5|Early Switch Phase (24 Weeks)|Adverse Event|0
5857534|NCT02105987|20256018|P4|Early Switch Phase (24 Weeks)|Adverse Event|0
5857535|NCT02105987|20256019|P3|Early Switch Phase (24 Weeks)|Adverse Event|0
5857536|NCT02105987|20256020|P2|Early Switch Phase (24 Weeks)|Adverse Event|0
5857537|NCT02105987|20256021|P1|Early Switch Phase (24 Weeks)|Adverse Event|10
5857538|NCT02105974|20256075|P3|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|18
5857539|NCT02105974|20256076|P2|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|12
5857540|NCT02105974|20256077|P1|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|0
5857541|NCT02105974|20256075|P3|12 Week (Wk) Treatment Period (TP)|Physician Decision|4
5857542|NCT02105974|20256076|P2|12 Week (Wk) Treatment Period (TP)|Physician Decision|7
5857543|NCT02105974|20256077|P1|12 Week (Wk) Treatment Period (TP)|Physician Decision|0
5857544|NCT02105974|20256075|P3|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|1
5857545|NCT02105974|20256076|P2|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0
5857546|NCT02105974|20256077|P1|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0
5857547|NCT02105974|20256075|P3|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|2
5857548|NCT02105974|20256076|P2|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|1
5857549|NCT02105974|20256077|P1|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|0
5857550|NCT02105974|20256075|P3|12 Week (Wk) Treatment Period (TP)|Protocol deviation|6
5857551|NCT02105974|20256076|P2|12 Week (Wk) Treatment Period (TP)|Protocol deviation|2
5857552|NCT02105974|20256077|P1|12 Week (Wk) Treatment Period (TP)|Protocol deviation|0
5857553|NCT02105974|20256075|P3|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|9
5857554|NCT02105974|20256076|P2|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|6
5857555|NCT02105974|20256077|P1|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|0
5857556|NCT02105974|20256075|P3|12 Week (Wk) Treatment Period (TP)|Adverse Event|18
5857557|NCT02105974|20256076|P2|12 Week (Wk) Treatment Period (TP)|Adverse Event|14
5857558|NCT02105974|20256077|P1|12 Week (Wk) Treatment Period (TP)|Adverse Event|0
5857559|NCT02105974|20256075|P3|2 Week Run-in Period|Investigator discretion|0
5857560|NCT02105974|20256076|P2|2 Week Run-in Period|Investigator discretion|0
5857561|NCT02105974|20256077|P1|2 Week Run-in Period|Investigator discretion|8
5857562|NCT02105974|20256075|P3|2 Week Run-in Period|Withdrew consent|0
5857563|NCT02105974|20256076|P2|2 Week Run-in Period|Withdrew consent|0
5857564|NCT02105974|20256077|P1|2 Week Run-in Period|Withdrew consent|23
5857565|NCT02105974|20256075|P3|2 Week Run-in Period|Lost to Follow-up|0
5857566|NCT02105974|20256076|P2|2 Week Run-in Period|Lost to Follow-up|0
5857567|NCT02105974|20256077|P1|2 Week Run-in Period|Lost to Follow-up|2
5857568|NCT02105974|20256075|P3|2 Week Run-in Period|Study closed/terminated|0
5857569|NCT02105974|20256076|P2|2 Week Run-in Period|Study closed/terminated|0
5857570|NCT02105974|20256077|P1|2 Week Run-in Period|Study closed/terminated|1
5857571|NCT02105974|20256075|P3|2 Week Run-in Period|Adverse Event|0
5857572|NCT02105974|20256076|P2|2 Week Run-in Period|Adverse Event|0
5857573|NCT02105974|20256077|P1|2 Week Run-in Period|Adverse Event|6
5857574|NCT02105974|20256075|P3|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0
5857575|NCT02105974|20256076|P2|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0
5857576|NCT02105974|20256077|P1|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|603
5857577|NCT02105974|20256075|P3|2 Week Run-in Period|Withdrew during pre-screen period|0
5857578|NCT02105974|20256076|P2|2 Week Run-in Period|Withdrew during pre-screen period|0
5857579|NCT02105974|20256077|P1|2 Week Run-in Period|Withdrew during pre-screen period|158
5857580|NCT02105961|20256090|P3|Overall Study|Withdrawal by Subject|11
5857581|NCT02105961|20256091|P2|Overall Study|Withdrawal by Subject|7
5857582|NCT02105961|20256092|P1|Overall Study|Withdrawal by Subject|15
5857583|NCT02105961|20256090|P3|Overall Study|Physician Decision|2
5857584|NCT02105961|20256091|P2|Overall Study|Physician Decision|3
5857585|NCT02105961|20256092|P1|Overall Study|Physician Decision|3
5857586|NCT02105961|20256090|P3|Overall Study|Lost to Follow-up|1
5857587|NCT02105961|20256091|P2|Overall Study|Lost to Follow-up|0
5857588|NCT02105961|20256092|P1|Overall Study|Lost to Follow-up|2
5857589|NCT02105961|20256090|P3|Overall Study|Lack of Efficacy|3
5857590|NCT02105961|20256091|P2|Overall Study|Lack of Efficacy|0
5857591|NCT02105961|20256092|P1|Overall Study|Lack of Efficacy|3
5857592|NCT02105961|20256090|P3|Overall Study|Adverse Event|13
5857593|NCT02105961|20256091|P2|Overall Study|Adverse Event|7
5857594|NCT02105961|20256092|P1|Overall Study|Adverse Event|18
5857595|NCT02105948|20256116|P4|Overall Study|Withdrawal by Subject|11
5857596|NCT02105948|20256117|P3|Overall Study|Withdrawal by Subject|10
5857597|NCT02105948|20256118|P2|Overall Study|Withdrawal by Subject|10
5857598|NCT02105948|20256119|P1|Overall Study|Withdrawal by Subject|15
5857599|NCT02105948|20256116|P4|Overall Study|Physician Decision|2
5857600|NCT02105948|20256117|P3|Overall Study|Physician Decision|2
5857601|NCT02105948|20256118|P2|Overall Study|Physician Decision|2
5857602|NCT02105948|20256119|P1|Overall Study|Physician Decision|2
5857603|NCT02105948|20256116|P4|Overall Study|Lost to Follow-up|1
5857604|NCT02105948|20256117|P3|Overall Study|Lost to Follow-up|2
5857605|NCT02105948|20256118|P2|Overall Study|Lost to Follow-up|0
5857606|NCT02105948|20256119|P1|Overall Study|Lost to Follow-up|0
5857607|NCT02105948|20256116|P4|Overall Study|Lack of Efficacy|2
5857608|NCT02105948|20256117|P3|Overall Study|Lack of Efficacy|3
5857609|NCT02105948|20256118|P2|Overall Study|Lack of Efficacy|1
5857610|NCT02105948|20256119|P1|Overall Study|Lack of Efficacy|0
5857611|NCT02105948|20256116|P4|Overall Study|Adverse Event|11
5857612|NCT02105948|20256117|P3|Overall Study|Adverse Event|11
5857613|NCT02105948|20256118|P2|Overall Study|Adverse Event|7
5857614|NCT02105948|20256119|P1|Overall Study|Adverse Event|10
5857631|NCT02105688|20256187|P2|Part B: Observational Follow-up|Physician Decision|1
5857632|NCT02105688|20256188|P1|Part B: Observational Follow-up|Physician Decision|3
5857633|NCT02105688|20256187|P2|Part B: Observational Follow-up|Withdrawal by Subject|3
5857634|NCT02105688|20256188|P1|Part B: Observational Follow-up|Withdrawal by Subject|9
5857635|NCT02105688|20256187|P2|Part B: Observational Follow-up|Lost to Follow-up|15
5857636|NCT02105688|20256188|P1|Part B: Observational Follow-up|Lost to Follow-up|23
5857637|NCT02105688|20256187|P2|Part B: Observational Follow-up|Death|1
5857638|NCT02105688|20256188|P1|Part B: Observational Follow-up|Death|2
5857639|NCT02105688|20256187|P2|Part A: Double-Blind|Withdrawal by Subject|2
5857640|NCT02105688|20256188|P1|Part A: Double-Blind|Withdrawal by Subject|4
5857641|NCT02105688|20256187|P2|Part A: Double-Blind|Status Unknown|2
5857642|NCT02105688|20256188|P1|Part A: Double-Blind|Status Unknown|0
5857643|NCT02105688|20256187|P2|Part A: Double-Blind|Physician Decision|1
5857644|NCT02105688|20256188|P1|Part A: Double-Blind|Physician Decision|0
5857645|NCT02105688|20256187|P2|Part A: Double-Blind|Lost to Follow-up|11
5857646|NCT02105688|20256188|P1|Part A: Double-Blind|Lost to Follow-up|15
5857647|NCT02105688|20256187|P2|Part A: Double-Blind|Death|1
5857648|NCT02105688|20256188|P1|Part A: Double-Blind|Death|0
5857649|NCT02105688|20256187|P2|Part A: Double-Blind|Adverse Event|0
5857650|NCT02105688|20256188|P1|Part A: Double-Blind|Adverse Event|1
5857653|NCT02105636|20256210|P2|Overall Study|Not Reported|0
5857654|NCT02105636|20256211|P1|Overall Study|Not Reported|3
5857655|NCT02105636|20256210|P2|Overall Study|Reason Not Specified|2
5857656|NCT02105636|20256211|P1|Overall Study|Reason Not Specified|0
5857657|NCT02105636|20256210|P2|Overall Study|Poor/Non-compliance|1
5857658|NCT02105636|20256211|P1|Overall Study|Poor/Non-compliance|0
5857659|NCT02105636|20256210|P2|Overall Study|Maximum Clinical Benefit|1
5857660|NCT02105636|20256211|P1|Overall Study|Maximum Clinical Benefit|1
5857661|NCT02105636|20256210|P2|Overall Study|Subject Withdrew Consent|1
5857662|NCT02105636|20256211|P1|Overall Study|Subject Withdrew Consent|4
5857663|NCT02105636|20256210|P2|Overall Study|Subject Request to Discontinue Treatment|6
5857664|NCT02105636|20256211|P1|Overall Study|Subject Request to Discontinue Treatment|4
5857665|NCT02105636|20256210|P2|Overall Study|Adverse Event Unrelated to Study Drug|3
5857666|NCT02105636|20256211|P1|Overall Study|Adverse Event Unrelated to Study Drug|12
5857667|NCT02105636|20256210|P2|Overall Study|Study Drug Toxicity|11
5857668|NCT02105636|20256211|P1|Overall Study|Study Drug Toxicity|9
5857669|NCT02105636|20256210|P2|Overall Study|Disease Progression|83
5857670|NCT02105636|20256211|P1|Overall Study|Disease Progression|162
5857671|NCT02105467|20256254|P2|Period 3|Lost to Follow-up|1
5857672|NCT02105467|20256255|P1|Period 3|Lost to Follow-up|0
5857673|NCT02105467|20256254|P2|Period 2|Withdrawal by Subject|2
5857674|NCT02105467|20256255|P1|Period 2|Withdrawal by Subject|0
5857675|NCT02105467|20256254|P2|Period 2|Death|0
5857676|NCT02105467|20256255|P1|Period 2|Death|1
5857677|NCT02105467|20256254|P2|Period 2|Lost to Follow-up|0
5857678|NCT02105467|20256255|P1|Period 2|Lost to Follow-up|1
5857679|NCT02105467|20256254|P2|Period 1|Death|0
5857680|NCT02105467|20256255|P1|Period 1|Death|1
5857681|NCT02105467|20256254|P2|Period 1|Lost to Follow-up|0
5857682|NCT02105467|20256255|P1|Period 1|Lost to Follow-up|1
5857683|NCT02105454|20256267|P1|Overall Study|Withdrawal by Subject|1
5857684|NCT02105285|20256379|P3|Overall Study|Withdrawal by Subject|0
5857685|NCT02105285|20256380|P2|Overall Study|Withdrawal by Subject|0
5857686|NCT02105285|20256381|P1|Overall Study|Withdrawal by Subject|1
5857687|NCT02105285|20256379|P3|Overall Study|Protocol Violation|0
5857688|NCT02105285|20256380|P2|Overall Study|Protocol Violation|1
5857689|NCT02105285|20256381|P1|Overall Study|Protocol Violation|0
5857690|NCT02105285|20256379|P3|Overall Study|Adverse Event|0
5857691|NCT02105285|20256380|P2|Overall Study|Adverse Event|1
5857692|NCT02105285|20256381|P1|Overall Study|Adverse Event|1
5857693|NCT02105272|20256400|P2|Overall Study|Withdrawal by Subject|0
5857694|NCT02105272|20256401|P1|Overall Study|Withdrawal by Subject|2
5857695|NCT02105272|20256400|P2|Overall Study|Protocol Violation|0
5857696|NCT02105272|20256401|P1|Overall Study|Protocol Violation|2
5857697|NCT02105272|20256400|P2|Overall Study|Physician Decision|1
5857698|NCT02105272|20256401|P1|Overall Study|Physician Decision|0
5857699|NCT02105272|20256400|P2|Overall Study|Adverse Event|2
5857700|NCT02105272|20256401|P1|Overall Study|Adverse Event|1
5857701|NCT02105116|20256430|P1|Overall Study|Death|1
5857702|NCT02105116|20256430|P1|Overall Study|not eligible for step 2 of trial|5
5857703|NCT02105012|20256437|P1|Overall Study|Lack of Efficacy|1
5857704|NCT02105012|20256437|P1|Overall Study|Adverse Event|1
5857705|NCT02105012|20256437|P1|Overall Study|Physician Decision|3
5857706|NCT02105012|20256437|P1|Overall Study|Protocol Violation|4
5857707|NCT02105012|20256437|P1|Overall Study|Lost to Follow-up|4
5857708|NCT02105012|20256437|P1|Overall Study|Protocol Specified Criteria|9
5857709|NCT02105012|20256437|P1|Overall Study|Withdrawal by Subject|11
5857710|NCT02104947|20256471|P2|Overall Study|Other than stated above|3
5857711|NCT02104947|20256472|P1|Overall Study|Other than stated above|2
5857712|NCT02104947|20256471|P2|Overall Study|Adverse Event|38
5857713|NCT02104947|20256472|P1|Overall Study|Adverse Event|57
5857714|NCT02104947|20256471|P2|Overall Study|Protocol Violation|8
5857715|NCT02104947|20256472|P1|Overall Study|Protocol Violation|6
5857716|NCT02104947|20256471|P2|Overall Study|Lost to Follow-up|4
5857717|NCT02104947|20256472|P1|Overall Study|Lost to Follow-up|4
5857718|NCT02104947|20256471|P2|Overall Study|Withdrawal by Subject|3
5857719|NCT02104947|20256472|P1|Overall Study|Withdrawal by Subject|10
5857720|NCT02104895|20256490|P2|Overall Study|Withdrawal by Subject|14
5857721|NCT02104895|20256491|P1|Overall Study|Withdrawal by Subject|0
5857722|NCT02104804|20256531|P2|Overall Study|Withdrawal by Subject|12
5857723|NCT02104804|20256532|P1|Overall Study|Withdrawal by Subject|4
5857724|NCT02104804|20256531|P2|Overall Study|Adverse Event|3
5857725|NCT02104804|20256532|P1|Overall Study|Adverse Event|4
5857726|NCT02104804|20256531|P2|Overall Study|Protocol Violation|1
5857727|NCT02104804|20256532|P1|Overall Study|Protocol Violation|0
5857728|NCT02104804|20256531|P2|Overall Study|Other listed|1
5857729|NCT02104804|20256532|P1|Overall Study|Other listed|2
5857730|NCT02104804|20256531|P2|Overall Study|Study specific discontinuation criteria|1
5857731|NCT02104804|20256532|P1|Overall Study|Study specific discontinuation criteria|6
5857732|NCT02104804|20256531|P2|Overall Study|Did not take study medication|1
5857733|NCT02104804|20256532|P1|Overall Study|Did not take study medication|0
5857734|NCT02104765|20256555|P7|Overall Study|Withdrawal by Subject|1
5857735|NCT02104765|20256556|P6|Overall Study|Withdrawal by Subject|0
5857736|NCT02104765|20256557|P5|Overall Study|Withdrawal by Subject|1
5857737|NCT02104765|20256558|P4|Overall Study|Withdrawal by Subject|1
5857738|NCT02104765|20256559|P3|Overall Study|Withdrawal by Subject|0
5857739|NCT02104765|20256560|P2|Overall Study|Withdrawal by Subject|0
5857740|NCT02104765|20256561|P1|Overall Study|Withdrawal by Subject|0
5857741|NCT02104765|20256555|P7|Overall Study|Lost to Follow-up|0
5857742|NCT02104765|20256556|P6|Overall Study|Lost to Follow-up|0
5857743|NCT02104765|20256557|P5|Overall Study|Lost to Follow-up|0
5857744|NCT02104765|20256558|P4|Overall Study|Lost to Follow-up|0
5857745|NCT02104765|20256559|P3|Overall Study|Lost to Follow-up|1
5857746|NCT02104765|20256560|P2|Overall Study|Lost to Follow-up|0
5857747|NCT02104765|20256561|P1|Overall Study|Lost to Follow-up|0
5857748|NCT02104752|20256589|P2|Overall Study|Weight gain; unrelated anxiety|2
5857749|NCT02104752|20256590|P1|Overall Study|Weight gain; unrelated anxiety|0
5857750|NCT02104752|20256589|P2|Overall Study|Withdrawal by Subject|0
5857751|NCT02104752|20256590|P1|Overall Study|Withdrawal by Subject|1
5857752|NCT02104583|20256673|P5|Overall Study|Randomized but Never Treated|0
5857753|NCT02104583|20256674|P4|Overall Study|Randomized but Never Treated|1
5857754|NCT02104583|20256675|P3|Overall Study|Randomized but Never Treated|0
5857755|NCT02104583|20256676|P2|Overall Study|Randomized but Never Treated|0
5857756|NCT02104583|20256677|P1|Overall Study|Randomized but Never Treated|0
5857757|NCT02104583|20256673|P5|Overall Study|Lost to Follow-up|0
5857758|NCT02104583|20256674|P4|Overall Study|Lost to Follow-up|0
5857759|NCT02104583|20256675|P3|Overall Study|Lost to Follow-up|0
5857760|NCT02104583|20256676|P2|Overall Study|Lost to Follow-up|0
5857761|NCT02104583|20256677|P1|Overall Study|Lost to Follow-up|1
5857762|NCT02104583|20256673|P5|Overall Study|Adverse Event|1
5857763|NCT02104583|20256674|P4|Overall Study|Adverse Event|6
5857764|NCT02104583|20256675|P3|Overall Study|Adverse Event|6
5857765|NCT02104583|20256676|P2|Overall Study|Adverse Event|3
5857766|NCT02104583|20256677|P1|Overall Study|Adverse Event|3
5857767|NCT02104583|20256673|P5|Overall Study|Protocol Violation|0
5857768|NCT02104583|20256674|P4|Overall Study|Protocol Violation|0
5857769|NCT02104583|20256675|P3|Overall Study|Protocol Violation|1
5857770|NCT02104583|20256676|P2|Overall Study|Protocol Violation|0
5857771|NCT02104583|20256677|P1|Overall Study|Protocol Violation|0
5857772|NCT02104583|20256673|P5|Overall Study|Investigator's Discretion|0
5857773|NCT02104583|20256674|P4|Overall Study|Investigator's Discretion|0
5857774|NCT02104583|20256675|P3|Overall Study|Investigator's Discretion|0
5857775|NCT02104583|20256676|P2|Overall Study|Investigator's Discretion|0
5857776|NCT02104583|20256677|P1|Overall Study|Investigator's Discretion|1
5857777|NCT02104583|20256673|P5|Overall Study|Withdrew Consent|1
5857778|NCT02104583|20256674|P4|Overall Study|Withdrew Consent|2
5857779|NCT02104583|20256675|P3|Overall Study|Withdrew Consent|0
5857780|NCT02104583|20256676|P2|Overall Study|Withdrew Consent|2
5857781|NCT02104583|20256677|P1|Overall Study|Withdrew Consent|3
5857782|NCT02104583|20256673|P5|Overall Study|Subject required prohibited medication|1
5857783|NCT02104583|20256674|P4|Overall Study|Subject required prohibited medication|0
5857784|NCT02104583|20256675|P3|Overall Study|Subject required prohibited medication|1
5857785|NCT02104583|20256676|P2|Overall Study|Subject required prohibited medication|1
5857786|NCT02104583|20256677|P1|Overall Study|Subject required prohibited medication|0
5857787|NCT02104583|20256673|P5|Overall Study|Subject required cardiac ablation|4
5857788|NCT02104583|20256674|P4|Overall Study|Subject required cardiac ablation|5
5857789|NCT02104583|20256675|P3|Overall Study|Subject required cardiac ablation|4
5857790|NCT02104583|20256676|P2|Overall Study|Subject required cardiac ablation|4
5857791|NCT02104583|20256677|P1|Overall Study|Subject required cardiac ablation|6
5857792|NCT02104583|20256673|P5|Overall Study|Death|5
5857793|NCT02104583|20256674|P4|Overall Study|Death|3
5857794|NCT02104583|20256675|P3|Overall Study|Death|3
5857795|NCT02104583|20256676|P2|Overall Study|Death|1
5857796|NCT02104583|20256677|P1|Overall Study|Death|2
5857797|NCT02104583|20256673|P5|Overall Study|New ICD or CRT-D implanted|0
5857798|NCT02104583|20256674|P4|Overall Study|New ICD or CRT-D implanted|0
5857799|NCT02104583|20256675|P3|Overall Study|New ICD or CRT-D implanted|1
5857800|NCT02104583|20256676|P2|Overall Study|New ICD or CRT-D implanted|0
5857801|NCT02104583|20256677|P1|Overall Study|New ICD or CRT-D implanted|2
5857802|NCT02104505|20256740|P2|Second Intervention (14 Days)|Adverse Event|0
5857803|NCT02104505|20256741|P1|Second Intervention (14 Days)|Adverse Event|2
5857804|NCT02104505|20256740|P2|Second Intervention (14 Days)|Withdrawal by Subject|1
5857805|NCT02104505|20256741|P1|Second Intervention (14 Days)|Withdrawal by Subject|0
5857806|NCT02104505|20256740|P2|First Intervention (14 Days)|exclusionary condition|1
5857807|NCT02104505|20256741|P1|First Intervention (14 Days)|exclusionary condition|0
5857808|NCT02104505|20256740|P2|First Intervention (14 Days)|Lost to Follow-up|1
5857809|NCT02104505|20256741|P1|First Intervention (14 Days)|Lost to Follow-up|0
5857810|NCT02104505|20256740|P2|First Intervention (14 Days)|Withdrawal by Subject|1
5857811|NCT02104505|20256741|P1|First Intervention (14 Days)|Withdrawal by Subject|0
5857812|NCT02104505|20256740|P2|First Intervention (14 Days)|Adverse Event|0
5857813|NCT02104505|20256741|P1|First Intervention (14 Days)|Adverse Event|2
5857814|NCT02104180|20256813|P2|Overall Study|Protocol Violation|0
5857815|NCT02104180|20256814|P1|Overall Study|Protocol Violation|1
5857816|NCT02103478|20256855|P9|Overall Study|Other|2
5857817|NCT02103478|20256856|P8|Overall Study|Other|4
5857818|NCT02103478|20256857|P7|Overall Study|Other|8
5857819|NCT02103478|20256858|P6|Overall Study|Other|8
5857820|NCT02103478|20256859|P5|Overall Study|Other|3
5857821|NCT02103478|20256860|P4|Overall Study|Other|0
5857822|NCT02103478|20256861|P3|Overall Study|Other|2
5857823|NCT02103478|20256862|P2|Overall Study|Other|3
5857824|NCT02103478|20256863|P1|Overall Study|Other|1
5857825|NCT02103478|20256855|P9|Overall Study|Lost to Follow-up|0
5857826|NCT02103478|20256856|P8|Overall Study|Lost to Follow-up|1
5857827|NCT02103478|20256857|P7|Overall Study|Lost to Follow-up|0
5857828|NCT02103478|20256858|P6|Overall Study|Lost to Follow-up|0
5857829|NCT02103478|20256859|P5|Overall Study|Lost to Follow-up|0
5857830|NCT02103478|20256860|P4|Overall Study|Lost to Follow-up|0
5857831|NCT02103478|20256861|P3|Overall Study|Lost to Follow-up|0
5857832|NCT02103478|20256862|P2|Overall Study|Lost to Follow-up|0
5857833|NCT02103478|20256863|P1|Overall Study|Lost to Follow-up|0
5857834|NCT02103478|20256855|P9|Overall Study|Withdrawal by Subject|0
5857835|NCT02103478|20256856|P8|Overall Study|Withdrawal by Subject|1
5857836|NCT02103478|20256857|P7|Overall Study|Withdrawal by Subject|1
5857837|NCT02103478|20256858|P6|Overall Study|Withdrawal by Subject|0
5857838|NCT02103478|20256859|P5|Overall Study|Withdrawal by Subject|0
5857839|NCT02103478|20256860|P4|Overall Study|Withdrawal by Subject|4
5857840|NCT02103478|20256861|P3|Overall Study|Withdrawal by Subject|0
5857841|NCT02103478|20256862|P2|Overall Study|Withdrawal by Subject|0
5857842|NCT02103478|20256863|P1|Overall Study|Withdrawal by Subject|2
5857843|NCT02103478|20256855|P9|Overall Study|Progressive Disease|1
5857844|NCT02103478|20256856|P8|Overall Study|Progressive Disease|0
5857845|NCT02103478|20256857|P7|Overall Study|Progressive Disease|2
5857846|NCT02103478|20256858|P6|Overall Study|Progressive Disease|1
5857847|NCT02103478|20256859|P5|Overall Study|Progressive Disease|9
5857848|NCT02103478|20256860|P4|Overall Study|Progressive Disease|0
5857849|NCT02103478|20256861|P3|Overall Study|Progressive Disease|2
5857850|NCT02103478|20256862|P2|Overall Study|Progressive Disease|1
5857851|NCT02103478|20256863|P1|Overall Study|Progressive Disease|2
5857852|NCT02103478|20256855|P9|Overall Study|Death|11
5857853|NCT02103478|20256856|P8|Overall Study|Death|10
5857854|NCT02103478|20256857|P7|Overall Study|Death|14
5857855|NCT02103478|20256858|P6|Overall Study|Death|15
5857856|NCT02103478|20256859|P5|Overall Study|Death|5
5857857|NCT02103478|20256860|P4|Overall Study|Death|1
5857858|NCT02103478|20256861|P3|Overall Study|Death|1
5857859|NCT02103478|20256862|P2|Overall Study|Death|2
5857860|NCT02103478|20256863|P1|Overall Study|Death|2
5857861|NCT02103478|20256855|P9|Overall Study|Adverse Event|0
5857862|NCT02103478|20256856|P8|Overall Study|Adverse Event|0
5857863|NCT02103478|20256857|P7|Overall Study|Adverse Event|0
5857864|NCT02103478|20256858|P6|Overall Study|Adverse Event|1
5857865|NCT02103478|20256859|P5|Overall Study|Adverse Event|2
5857866|NCT02103478|20256860|P4|Overall Study|Adverse Event|1
5857867|NCT02103478|20256861|P3|Overall Study|Adverse Event|1
5857868|NCT02103478|20256862|P2|Overall Study|Adverse Event|0
5857869|NCT02103478|20256863|P1|Overall Study|Adverse Event|0
5857870|NCT02103439|20256972|P2|Overall Study|Withdrawal by Subject|1
5857871|NCT02103439|20256973|P1|Overall Study|Withdrawal by Subject|3
5857872|NCT02103439|20256972|P2|Overall Study|Adverse Event|2
5857873|NCT02103439|20256973|P1|Overall Study|Adverse Event|0
5857874|NCT02103062|20257139|P2|Overall Study|Death|1
5857875|NCT02103062|20257140|P1|Overall Study|Death|0
5857876|NCT02103062|20257139|P2|Overall Study|Progressive Disease|20
5857877|NCT02103062|20257140|P1|Overall Study|Progressive Disease|17
5857878|NCT02103062|20257139|P2|Overall Study|Adverse Event|2
5857879|NCT02103062|20257140|P1|Overall Study|Adverse Event|1
5857880|NCT02102724|20257233|P2|Overall Study|surgery for brain aneurysm|1
5857881|NCT02102724|20257234|P1|Overall Study|surgery for brain aneurysm|1
5857882|NCT02102724|20257233|P2|Overall Study|Lost to Follow-up|0
5857883|NCT02102724|20257234|P1|Overall Study|Lost to Follow-up|1
5857884|NCT02102490|20257240|P1|Overall Study|Lost to Follow-up|1
5857885|NCT02102490|20257240|P1|Overall Study|Death|6
5857886|NCT02102464|20257254|P3|Randomized Study|Withdrawal by Subject|0
5857887|NCT02102464|20257255|P2|Randomized Study|Withdrawal by Subject|1
5857888|NCT02102464|20257256|P1|Randomized Study|Withdrawal by Subject|0
5857889|NCT02102399|20257275|P2|Overall Study|Withdrawal by Subject|4
5857890|NCT02102399|20257276|P1|Overall Study|Withdrawal by Subject|6
5857891|NCT02102204|20257346|P1|Overall Study|Ongoing|5
5857892|NCT02102204|20257346|P1|Overall Study|Sponsor Decision|5
5857893|NCT02102204|20257346|P1|Overall Study|Lost to Follow-up|65
5857894|NCT02102204|20257346|P1|Overall Study|Death|92
5857895|NCT02102204|20257346|P1|Overall Study|Withdrawal by Subject|137
5857896|NCT02101983|20257366|P2|Overall Study|Physician Decision|0
5857897|NCT02101983|20257367|P1|Overall Study|Physician Decision|1
5857898|NCT02101554|20257413|P3|Overall Study|Withdrawl by Parents/Guardians|0
5857899|NCT02101554|20257414|P2|Overall Study|Withdrawl by Parents/Guardians|0
5857900|NCT02101554|20257415|P1|Overall Study|Withdrawl by Parents/Guardians|1
5857901|NCT02101554|20257413|P3|Overall Study|Lost to Follow-up|0
5857902|NCT02101554|20257414|P2|Overall Study|Lost to Follow-up|1
5857903|NCT02101554|20257415|P1|Overall Study|Lost to Follow-up|0
5857904|NCT02101554|20257413|P3|Overall Study|Adverse Event|1
5857905|NCT02101554|20257414|P2|Overall Study|Adverse Event|1
5857906|NCT02101554|20257415|P1|Overall Study|Adverse Event|2
5857907|NCT02101554|20257413|P3|Overall Study|Insufficient Clinical Response|0
5857908|NCT02101554|20257414|P2|Overall Study|Insufficient Clinical Response|2
5857909|NCT02101554|20257415|P1|Overall Study|Insufficient Clinical Response|0
5857910|NCT02101554|20257413|P3|Overall Study|Protocol Violation|0
5857911|NCT02101554|20257414|P2|Overall Study|Protocol Violation|1
5857912|NCT02101554|20257415|P1|Overall Study|Protocol Violation|0
5857913|NCT02101359|20257568|P2|Overall Study|Protocol Violation|2
5857914|NCT02101359|20257569|P1|Overall Study|Protocol Violation|0
5857915|NCT02101359|20257568|P2|Overall Study|Lost to Follow-up|0
5857916|NCT02101359|20257569|P1|Overall Study|Lost to Follow-up|1
5857917|NCT02101359|20257568|P2|Overall Study|Withdrawal by Subject|4
5857918|NCT02101359|20257569|P1|Overall Study|Withdrawal by Subject|5
5857919|NCT02101359|20257568|P2|Overall Study|Not included|13
5857920|NCT02101359|20257569|P1|Overall Study|Not included|23
5857921|NCT02101294|20257575|P1|Overall Study|Lost to Follow-up|6
5857922|NCT02101294|20257575|P1|Overall Study|Withdrawal by Subject|5
5857923|NCT02101281|20257584|P2|Overall Study|Adverse Event|1
5857924|NCT02101281|20257585|P1|Overall Study|Adverse Event|0
5857925|NCT02101112|20257638|P6|Overall Study|Withdrawal by Subject|0
5857926|NCT02101112|20257639|P5|Overall Study|Withdrawal by Subject|1
5857927|NCT02101112|20257640|P4|Overall Study|Withdrawal by Subject|0
5857928|NCT02101112|20257641|P3|Overall Study|Withdrawal by Subject|0
5857929|NCT02101112|20257642|P2|Overall Study|Withdrawal by Subject|0
5857930|NCT02101112|20257643|P1|Overall Study|Withdrawal by Subject|0
5857931|NCT02101112|20257638|P6|Overall Study|Adverse Event|0
5857932|NCT02101112|20257639|P5|Overall Study|Adverse Event|0
5857933|NCT02101112|20257640|P4|Overall Study|Adverse Event|0
5857934|NCT02101112|20257641|P3|Overall Study|Adverse Event|1
5857935|NCT02101112|20257642|P2|Overall Study|Adverse Event|0
5857936|NCT02101112|20257643|P1|Overall Study|Adverse Event|0
5857937|NCT02101021|20257673|P5|Overall Study|Study Terminated by Sponsor|1
5857938|NCT02101021|20257674|P4|Overall Study|Study Terminated by Sponsor|1
5857939|NCT02101021|20257675|P3|Overall Study|Study Terminated by Sponsor|1
5857940|NCT02101021|20257676|P2|Overall Study|Study Terminated by Sponsor|0
5857941|NCT02101021|20257677|P1|Overall Study|Study Terminated by Sponsor|1
5857942|NCT02101021|20257673|P5|Overall Study|Lost to Follow-up|0
5857943|NCT02101021|20257674|P4|Overall Study|Lost to Follow-up|0
5857944|NCT02101021|20257675|P3|Overall Study|Lost to Follow-up|0
5857945|NCT02101021|20257676|P2|Overall Study|Lost to Follow-up|0
5857946|NCT02101021|20257677|P1|Overall Study|Lost to Follow-up|1
5857947|NCT02101021|20257673|P5|Overall Study|Withdrew Consent from study|0
5857948|NCT02101021|20257674|P4|Overall Study|Withdrew Consent from study|2
5857949|NCT02101021|20257675|P3|Overall Study|Withdrew Consent from study|0
5857950|NCT02101021|20257676|P2|Overall Study|Withdrew Consent from study|1
5857951|NCT02101021|20257677|P1|Overall Study|Withdrew Consent from study|1
5857952|NCT02101021|20257673|P5|Overall Study|Death|3
5857953|NCT02101021|20257674|P4|Overall Study|Death|0
5857954|NCT02101021|20257675|P3|Overall Study|Death|6
5857955|NCT02101021|20257676|P2|Overall Study|Death|3
5857956|NCT02101021|20257677|P1|Overall Study|Death|4
5857957|NCT02100969|20257724|P1|Overall Study|Did not pass screening phase|1
5857958|NCT02100839|20257743|P2|Multiple Ascending Dose|Withdrawal by Subject|0
5857959|NCT02100839|20257744|P1|Multiple Ascending Dose|Withdrawal by Subject|2
5857960|NCT02100839|20257743|P2|Multiple Ascending Dose|Adverse Event|0
5857961|NCT02100839|20257744|P1|Multiple Ascending Dose|Adverse Event|2
5857962|NCT02100813|20257775|P8|Overall Study|Adverse Event|1
5857963|NCT02100813|20257776|P7|Overall Study|Adverse Event|0
5857964|NCT02100813|20257777|P6|Overall Study|Adverse Event|0
5857965|NCT02100813|20257778|P5|Overall Study|Adverse Event|0
5857966|NCT02100813|20257779|P4|Overall Study|Adverse Event|0
5857967|NCT02100813|20257780|P3|Overall Study|Adverse Event|0
5857968|NCT02100813|20257781|P2|Overall Study|Adverse Event|0
5857969|NCT02100813|20257782|P1|Overall Study|Adverse Event|0
5857970|NCT02100670|20257859|P4|Overall Study|Withdrawal by Subject|0
5857971|NCT02100670|20257860|P3|Overall Study|Withdrawal by Subject|0
5857972|NCT02100670|20257861|P2|Overall Study|Withdrawal by Subject|0
5857973|NCT02100670|20257862|P1|Overall Study|Withdrawal by Subject|1
5857974|NCT02100670|20257859|P4|Overall Study|Physician Decision|0
5857975|NCT02100670|20257860|P3|Overall Study|Physician Decision|0
5857976|NCT02100670|20257861|P2|Overall Study|Physician Decision|1
5857977|NCT02100670|20257862|P1|Overall Study|Physician Decision|0
5857978|NCT02100670|20257859|P4|Overall Study|Poor Efficacy|0
5857979|NCT02100670|20257860|P3|Overall Study|Poor Efficacy|0
5857980|NCT02100670|20257861|P2|Overall Study|Poor Efficacy|1
5857981|NCT02100670|20257862|P1|Overall Study|Poor Efficacy|0
5857982|NCT02100670|20257859|P4|Overall Study|No swelling no pain|0
5857983|NCT02100670|20257860|P3|Overall Study|No swelling no pain|0
5857984|NCT02100670|20257861|P2|Overall Study|No swelling no pain|0
5857985|NCT02100670|20257862|P1|Overall Study|No swelling no pain|1
5857986|NCT02100670|20257859|P4|Overall Study|Withdrawal of Consent|0
5857987|NCT02100670|20257860|P3|Overall Study|Withdrawal of Consent|1
5857988|NCT02100670|20257861|P2|Overall Study|Withdrawal of Consent|1
5857989|NCT02100670|20257862|P1|Overall Study|Withdrawal of Consent|0
5857990|NCT02100670|20257859|P4|Overall Study|Protocol Violation|1
5857991|NCT02100670|20257860|P3|Overall Study|Protocol Violation|0
5857992|NCT02100670|20257861|P2|Overall Study|Protocol Violation|1
5857993|NCT02100670|20257862|P1|Overall Study|Protocol Violation|0
5857994|NCT02100670|20257859|P4|Overall Study|Lost to Follow-up|0
5857995|NCT02100670|20257860|P3|Overall Study|Lost to Follow-up|0
5857996|NCT02100670|20257861|P2|Overall Study|Lost to Follow-up|0
5857997|NCT02100670|20257862|P1|Overall Study|Lost to Follow-up|1
5857998|NCT02100670|20257859|P4|Overall Study|Adverse Event|0
5857999|NCT02100670|20257860|P3|Overall Study|Adverse Event|3
5858000|NCT02100670|20257861|P2|Overall Study|Adverse Event|3
5858001|NCT02100670|20257862|P1|Overall Study|Adverse Event|10
5858002|NCT02100657|20257925|P3|Cohort 3: Dose Level 3|Withdrawal by Subject|3
5858003|NCT02100657|20257926|P2|Cohort 3: Dose Level 3|Withdrawal by Subject|0
5858004|NCT02100657|20257927|P1|Cohort 3: Dose Level 3|Withdrawal by Subject|0
5858005|NCT02100657|20257925|P3|Cohort 3: Dose Level 3|Treatment-related adverse event|3
5858006|NCT02100657|20257926|P2|Cohort 3: Dose Level 3|Treatment-related adverse event|0
5858007|NCT02100657|20257927|P1|Cohort 3: Dose Level 3|Treatment-related adverse event|0
5858008|NCT02100657|20257925|P3|Cohort 3: Dose Level 3|Never were treated|3
5858009|NCT02100657|20257926|P2|Cohort 3: Dose Level 3|Never were treated|0
5858010|NCT02100657|20257927|P1|Cohort 3: Dose Level 3|Never were treated|0
5858011|NCT02100657|20257925|P3|Cohort 3: Dose Level 3|Physician Decision|1
5858012|NCT02100657|20257926|P2|Cohort 3: Dose Level 3|Physician Decision|0
5858013|NCT02100657|20257927|P1|Cohort 3: Dose Level 3|Physician Decision|0
5858014|NCT02100657|20257925|P3|Cohort 3: Dose Level 3|Non-treatment related adverse event|1
5858015|NCT02100657|20257926|P2|Cohort 3: Dose Level 3|Non-treatment related adverse event|0
5858016|NCT02100657|20257927|P1|Cohort 3: Dose Level 3|Non-treatment related adverse event|0
5858017|NCT02100657|20257925|P3|Cohort 3: Dose Level 3|Death|1
5858018|NCT02100657|20257926|P2|Cohort 3: Dose Level 3|Death|0
5858019|NCT02100657|20257927|P1|Cohort 3: Dose Level 3|Death|0
5858020|NCT02100657|20257925|P3|Cohort 3: Dose Level 3|Progressive disease|15
5858021|NCT02100657|20257926|P2|Cohort 3: Dose Level 3|Progressive disease|0
5858022|NCT02100657|20257927|P1|Cohort 3: Dose Level 3|Progressive disease|0
5858023|NCT02100657|20257925|P3|Cohort 2: Dose Level 2|Treatment-related adverse event|0
5858024|NCT02100657|20257926|P2|Cohort 2: Dose Level 2|Treatment-related adverse event|1
5858025|NCT02100657|20257927|P1|Cohort 2: Dose Level 2|Treatment-related adverse event|0
5858026|NCT02100657|20257925|P3|Cohort 2: Dose Level 2|Physician Decision|0
5858027|NCT02100657|20257926|P2|Cohort 2: Dose Level 2|Physician Decision|1
5858028|NCT02100657|20257927|P1|Cohort 2: Dose Level 2|Physician Decision|0
5858029|NCT02100657|20257925|P3|Cohort 2: Dose Level 2|Progressive disease|0
5858030|NCT02100657|20257926|P2|Cohort 2: Dose Level 2|Progressive disease|2
5858031|NCT02100657|20257927|P1|Cohort 2: Dose Level 2|Progressive disease|0
5858032|NCT02100657|20257925|P3|Cohort 1: Dose Level 1|Withdrawal by Subject|0
5858033|NCT02100657|20257926|P2|Cohort 1: Dose Level 1|Withdrawal by Subject|0
5858034|NCT02100657|20257927|P1|Cohort 1: Dose Level 1|Withdrawal by Subject|1
5858035|NCT02100657|20257925|P3|Cohort 1: Dose Level 1|Treatment-related adverse event|0
5858036|NCT02100657|20257926|P2|Cohort 1: Dose Level 1|Treatment-related adverse event|0
5858037|NCT02100657|20257927|P1|Cohort 1: Dose Level 1|Treatment-related adverse event|1
5858038|NCT02100657|20257925|P3|Cohort 1: Dose Level 1|Progressive disease|0
5858039|NCT02100657|20257926|P2|Cohort 1: Dose Level 1|Progressive disease|0
5858040|NCT02100657|20257927|P1|Cohort 1: Dose Level 1|Progressive disease|6
5858041|NCT02100644|20257965|P3|LTG Escalation Phase|Withdrawal by Subject|0
5858042|NCT02100644|20257966|P2|LTG Escalation Phase|Withdrawal by Subject|0
5858043|NCT02100644|20257967|P1|LTG Escalation Phase|Withdrawal by Subject|3
5858044|NCT02100644|20257965|P3|LTG Escalation Phase|Protocol-defined Stopping Criteria|0
5858045|NCT02100644|20257966|P2|LTG Escalation Phase|Protocol-defined Stopping Criteria|0
5858046|NCT02100644|20257967|P1|LTG Escalation Phase|Protocol-defined Stopping Criteria|1
5858047|NCT02100644|20257965|P3|LTG Escalation Phase|Adverse Event|0
5858048|NCT02100644|20257966|P2|LTG Escalation Phase|Adverse Event|0
5858049|NCT02100644|20257967|P1|LTG Escalation Phase|Adverse Event|9
5858050|NCT02100514|20257992|P5|Extension Period|Withdrew consent|0
5858051|NCT02100514|20257993|P4|Extension Period|Withdrew consent|0
5858052|NCT02100514|20257994|P3|Extension Period|Withdrew consent|2
5858053|NCT02100514|20257995|P2|Extension Period|Withdrew consent|0
5858054|NCT02100514|20257996|P1|Extension Period|Withdrew consent|0
5858055|NCT02100514|20257992|P5|Treatment Period|Other|0
5858056|NCT02100514|20257993|P4|Treatment Period|Other|0
5858057|NCT02100514|20257994|P3|Treatment Period|Other|0
5858058|NCT02100514|20257995|P2|Treatment Period|Other|11
5858059|NCT02100514|20257996|P1|Treatment Period|Other|9
5858060|NCT02100514|20257992|P5|Treatment Period|Withdrawal by Subject|0
5858061|NCT02100514|20257993|P4|Treatment Period|Withdrawal by Subject|0
5858062|NCT02100514|20257994|P3|Treatment Period|Withdrawal by Subject|0
5858063|NCT02100514|20257995|P2|Treatment Period|Withdrawal by Subject|37
5858064|NCT02100514|20257996|P1|Treatment Period|Withdrawal by Subject|12
5858065|NCT02100514|20257992|P5|Treatment Period|Protocol Violation|0
5858066|NCT02100514|20257993|P4|Treatment Period|Protocol Violation|0
5858067|NCT02100514|20257994|P3|Treatment Period|Protocol Violation|0
5858068|NCT02100514|20257995|P2|Treatment Period|Protocol Violation|1
5858069|NCT02100514|20257996|P1|Treatment Period|Protocol Violation|1
5858070|NCT02100514|20257992|P5|Treatment Period|Did Not Meet Entrance Criteria|0
5858071|NCT02100514|20257993|P4|Treatment Period|Did Not Meet Entrance Criteria|0
5858072|NCT02100514|20257994|P3|Treatment Period|Did Not Meet Entrance Criteria|0
5858073|NCT02100514|20257995|P2|Treatment Period|Did Not Meet Entrance Criteria|1
5858074|NCT02100514|20257996|P1|Treatment Period|Did Not Meet Entrance Criteria|0
5858075|NCT02100514|20257992|P5|Treatment Period|Lost to Follow-up|0
5858076|NCT02100514|20257993|P4|Treatment Period|Lost to Follow-up|0
5858077|NCT02100514|20257994|P3|Treatment Period|Lost to Follow-up|0
5858078|NCT02100514|20257995|P2|Treatment Period|Lost to Follow-up|17
5858079|NCT02100514|20257996|P1|Treatment Period|Lost to Follow-up|5
5858080|NCT02100514|20257992|P5|Treatment Period|Death|0
5858081|NCT02100514|20257993|P4|Treatment Period|Death|0
5858082|NCT02100514|20257994|P3|Treatment Period|Death|0
5858083|NCT02100514|20257995|P2|Treatment Period|Death|2
5858084|NCT02100514|20257996|P1|Treatment Period|Death|2
5858085|NCT02100514|20257992|P5|Treatment Period|Adverse Event|0
5858086|NCT02100514|20257993|P4|Treatment Period|Adverse Event|0
5858087|NCT02100514|20257994|P3|Treatment Period|Adverse Event|0
5858088|NCT02100514|20257995|P2|Treatment Period|Adverse Event|5
5858089|NCT02100514|20257996|P1|Treatment Period|Adverse Event|0
5858090|NCT02100475|20258064|P2|Overall Study|Withdrawal criteria|0
5858091|NCT02100475|20258065|P1|Overall Study|Withdrawal criteria|1
5858092|NCT02100475|20258064|P2|Overall Study|Unclassified|2
5858093|NCT02100475|20258065|P1|Overall Study|Unclassified|1
5858094|NCT02100319|20258096|P1|Overall Study|Protocol Deviation|5
5858095|NCT02100319|20258096|P1|Overall Study|Case Report Forms Uncollected|11
5858096|NCT02100228|20258124|P2|Overall Study|Death|1
5858097|NCT02100228|20258125|P1|Overall Study|Death|1
5858098|NCT02100228|20258124|P2|Overall Study|Adverse Event|12
5858099|NCT02100228|20258125|P1|Overall Study|Adverse Event|16
5858100|NCT02100228|20258124|P2|Overall Study|Withdrawal by Subject|37
5858101|NCT02100228|20258125|P1|Overall Study|Withdrawal by Subject|27
5858102|NCT02100228|20258124|P2|Overall Study|Lost to Follow-up|1
5858103|NCT02100228|20258125|P1|Overall Study|Lost to Follow-up|0
5858104|NCT02100228|20258124|P2|Overall Study|Non-compliance|3
5858105|NCT02100228|20258125|P1|Overall Study|Non-compliance|0
5858106|NCT02100228|20258124|P2|Overall Study|Inclusion/Exclusion criteria not met|16
5858107|NCT02100228|20258125|P1|Overall Study|Inclusion/Exclusion criteria not met|12
5858108|NCT02100228|20258124|P2|Overall Study|Administrative reason|1
5858109|NCT02100228|20258125|P1|Overall Study|Administrative reason|0
5858110|NCT02100228|20258124|P2|Overall Study|Other|19
5858111|NCT02100228|20258125|P1|Overall Study|Other|19
5858112|NCT02100124|20258161|P3|Overall Study|Withdrawal by Subject|0
5858113|NCT02100124|20258162|P2|Overall Study|Withdrawal by Subject|0
5858114|NCT02100124|20258163|P1|Overall Study|Withdrawal by Subject|1
5858115|NCT02100124|20258161|P3|Overall Study|Lost to Follow-up|3
5858116|NCT02100124|20258162|P2|Overall Study|Lost to Follow-up|11
5858117|NCT02100124|20258163|P1|Overall Study|Lost to Follow-up|5
5858118|NCT02099838|20258220|P2|Overall Study|Withdrawal by Subject|1
5858119|NCT02099838|20258221|P1|Overall Study|Withdrawal by Subject|0
5858120|NCT02099838|20258220|P2|Overall Study|Lost to Follow-up|1
5858121|NCT02099838|20258221|P1|Overall Study|Lost to Follow-up|3
5858122|NCT02099838|20258220|P2|Overall Study|Death|0
5858123|NCT02099838|20258221|P1|Overall Study|Death|1
5858124|NCT02099708|20258304|P1|Overall Study|Other|29
5858125|NCT02099708|20258304|P1|Overall Study|Lost to Follow-up|141
5858126|NCT02099708|20258304|P1|Overall Study|Data Not Available|30
5858127|NCT02099682|20258315|P1|Overall Study|Other|29
5858128|NCT02099682|20258315|P1|Overall Study|Lost to Follow-up|31
5858129|NCT02099682|20258315|P1|Overall Study|Data Not Available|51
5858130|NCT02099344|20258341|P2|Overall Study|Physician Decision|0
5858131|NCT02099344|20258342|P1|Overall Study|Physician Decision|1
5858132|NCT02099110|20258379|P5|Overall Study|Physician Decision|1
5858133|NCT02099110|20258380|P4|Overall Study|Physician Decision|2
5858134|NCT02099110|20258381|P3|Overall Study|Physician Decision|1
5858135|NCT02099110|20258382|P2|Overall Study|Physician Decision|0
5858136|NCT02099110|20258383|P1|Overall Study|Physician Decision|3
5858137|NCT02099110|20258379|P5|Overall Study|Non-compliance with study drug|1
5858138|NCT02099110|20258380|P4|Overall Study|Non-compliance with study drug|0
5858139|NCT02099110|20258381|P3|Overall Study|Non-compliance with study drug|0
5858140|NCT02099110|20258382|P2|Overall Study|Non-compliance with study drug|0
5858141|NCT02099110|20258383|P1|Overall Study|Non-compliance with study drug|2
5858142|NCT02099110|20258379|P5|Overall Study|Screen failure|1
5858143|NCT02099110|20258380|P4|Overall Study|Screen failure|0
5858144|NCT02099110|20258381|P3|Overall Study|Screen failure|0
5858145|NCT02099110|20258382|P2|Overall Study|Screen failure|0
5858146|NCT02099110|20258383|P1|Overall Study|Screen failure|0
5858147|NCT02099110|20258379|P5|Overall Study|Death|0
5858148|NCT02099110|20258380|P4|Overall Study|Death|0
5858149|NCT02099110|20258381|P3|Overall Study|Death|0
5858150|NCT02099110|20258382|P2|Overall Study|Death|1
5858151|NCT02099110|20258383|P1|Overall Study|Death|0
5858152|NCT02099110|20258379|P5|Overall Study|Lost to Follow-up|6
5858153|NCT02099110|20258380|P4|Overall Study|Lost to Follow-up|5
5858154|NCT02099110|20258381|P3|Overall Study|Lost to Follow-up|11
5858155|NCT02099110|20258382|P2|Overall Study|Lost to Follow-up|12
5858156|NCT02099110|20258383|P1|Overall Study|Lost to Follow-up|6
5858157|NCT02099110|20258379|P5|Overall Study|Adverse Event|2
5858158|NCT02099110|20258380|P4|Overall Study|Adverse Event|3
5858159|NCT02099110|20258381|P3|Overall Study|Adverse Event|2
5858160|NCT02099110|20258382|P2|Overall Study|Adverse Event|5
5858161|NCT02099110|20258383|P1|Overall Study|Adverse Event|3
5858162|NCT02099110|20258379|P5|Overall Study|Withdrawal by Subject|13
5858163|NCT02099110|20258380|P4|Overall Study|Withdrawal by Subject|9
5858164|NCT02099110|20258381|P3|Overall Study|Withdrawal by Subject|13
5858165|NCT02099110|20258382|P2|Overall Study|Withdrawal by Subject|11
5858166|NCT02099110|20258383|P1|Overall Study|Withdrawal by Subject|7
5858167|NCT02099110|20258379|P5|Overall Study|Participant moved|2
5858168|NCT02099110|20258380|P4|Overall Study|Participant moved|0
5858169|NCT02099110|20258381|P3|Overall Study|Participant moved|1
5858170|NCT02099110|20258382|P2|Overall Study|Participant moved|1
5858171|NCT02099110|20258383|P1|Overall Study|Participant moved|1
5858172|NCT02099110|20258379|P5|Overall Study|Protocol Violation|1
5858173|NCT02099110|20258380|P4|Overall Study|Protocol Violation|3
5858174|NCT02099110|20258381|P3|Overall Study|Protocol Violation|0
5858175|NCT02099110|20258382|P2|Overall Study|Protocol Violation|1
5858176|NCT02099110|20258383|P1|Overall Study|Protocol Violation|2
5858177|NCT02098746|20258484|P1|Overall Study|Data Not Available After Treatment|1
5858178|NCT02098746|20258484|P1|Overall Study|Enrolled 15 Days After the First Dose|1
5858179|NCT02098746|20258484|P1|Overall Study|Other Miscellaneous Reasons|1
5858180|NCT02098746|20258484|P1|Overall Study|Changes of Investigator|2
5858181|NCT02098733|20258492|P1|Overall Study|Lost to Follow-up|5
5858182|NCT02098733|20258492|P1|Overall Study|Data Not Available|5
5858183|NCT02098395|20258506|P4|Overall Study|Unclassified|2
5858184|NCT02098395|20258507|P3|Overall Study|Unclassified|3
5858185|NCT02098395|20258508|P2|Overall Study|Unclassified|0
5858186|NCT02098395|20258509|P1|Overall Study|Unclassified|0
5858187|NCT02098395|20258506|P4|Overall Study|Lost to Follow-up|3
5858188|NCT02098395|20258507|P3|Overall Study|Lost to Follow-up|0
5858189|NCT02098395|20258508|P2|Overall Study|Lost to Follow-up|1
5858190|NCT02098395|20258509|P1|Overall Study|Lost to Follow-up|2
5858191|NCT02098395|20258506|P4|Overall Study|Adverse Event|2
5858192|NCT02098395|20258507|P3|Overall Study|Adverse Event|34
5858193|NCT02098395|20258508|P2|Overall Study|Adverse Event|19
5858194|NCT02098395|20258509|P1|Overall Study|Adverse Event|12
5858195|NCT02098395|20258506|P4|Overall Study|Withdrawal by Subject|13
5858196|NCT02098395|20258507|P3|Overall Study|Withdrawal by Subject|5
5858197|NCT02098395|20258508|P2|Overall Study|Withdrawal by Subject|10
5858198|NCT02098395|20258509|P1|Overall Study|Withdrawal by Subject|10
5858199|NCT02098395|20258506|P4|Overall Study|Protocol Violation|7
5858200|NCT02098395|20258507|P3|Overall Study|Protocol Violation|0
5858201|NCT02098395|20258508|P2|Overall Study|Protocol Violation|2
5858202|NCT02098395|20258509|P1|Overall Study|Protocol Violation|2
5858203|NCT02098369|20258530|P3|Overall Study|Other|1
5858204|NCT02098369|20258531|P2|Overall Study|Other|2
5858205|NCT02098369|20258532|P1|Overall Study|Other|0
5858206|NCT02098369|20258530|P3|Overall Study|Death|1
5858207|NCT02098369|20258531|P2|Overall Study|Death|1
5858208|NCT02098369|20258532|P1|Overall Study|Death|1
5858209|NCT02098369|20258530|P3|Overall Study|Lost to Follow-up|3
5858210|NCT02098369|20258531|P2|Overall Study|Lost to Follow-up|1
5858211|NCT02098369|20258532|P1|Overall Study|Lost to Follow-up|5
5858212|NCT02098369|20258530|P3|Overall Study|Withdrawal by Subject|0
5858213|NCT02098369|20258531|P2|Overall Study|Withdrawal by Subject|5
5858214|NCT02098369|20258532|P1|Overall Study|Withdrawal by Subject|1
5858215|NCT02098109|20258570|P2|Overall Study|Protocol Violation|0
5858216|NCT02098109|20258571|P1|Overall Study|Protocol Violation|3
5858217|NCT02097823|20258649|P2|Overall Study|Withdrawal by Subject|1
5858218|NCT02097823|20258650|P1|Overall Study|Withdrawal by Subject|1
5858219|NCT02097745|20258665|P1|Overall Study|Reason Not Specified|96
5858220|NCT02097745|20258665|P1|Overall Study|Administrative/Other|27
5858221|NCT02097745|20258665|P1|Overall Study|Failure to Return|14
5858222|NCT02097745|20258665|P1|Overall Study|Death|16
5858223|NCT02097745|20258665|P1|Overall Study|Adverse Event|25
5858224|NCT02097719|20258703|P2|Overall Study|Adverse Event|0
5858225|NCT02097719|20258704|P1|Overall Study|Adverse Event|2
5858226|NCT02097719|20258703|P2|Overall Study|Lost to Follow-up|1
5858227|NCT02097719|20258704|P1|Overall Study|Lost to Follow-up|0
5858228|NCT02097719|20258703|P2|Overall Study|Subject Withdrew Consent|0
5858229|NCT02097719|20258704|P1|Overall Study|Subject Withdrew Consent|1
5858230|NCT02097472|20258769|P8|Received Vaccination 2|Adverse Event|0
5858231|NCT02097472|20258770|P7|Received Vaccination 2|Adverse Event|1
5858232|NCT02097472|20258771|P6|Received Vaccination 2|Adverse Event|0
5858233|NCT02097472|20258772|P5|Received Vaccination 2|Adverse Event|0
5858234|NCT02097472|20258773|P4|Received Vaccination 2|Adverse Event|0
5858235|NCT02097472|20258774|P3|Received Vaccination 2|Adverse Event|0
5858236|NCT02097472|20258775|P2|Received Vaccination 2|Adverse Event|0
5858237|NCT02097472|20258776|P1|Received Vaccination 2|Adverse Event|0
5858238|NCT02097420|20259197|P1|Overall Study|Not reached 12-month visit|7
5858239|NCT02097420|20259197|P1|Overall Study|Device explanted|3
5858240|NCT02097420|20259197|P1|Overall Study|Death|4
5858241|NCT02097290|20259220|P1|Overall Study|Attempt|8
5858242|NCT02097290|20259220|P1|Overall Study|Total Withdrawals|3
5858243|NCT02097290|20259220|P1|Overall Study|Death|6
5858244|NCT02097277|20259235|P5|Overall Study|Adverse Event|0
5858245|NCT02097277|20259236|P4|Overall Study|Adverse Event|2
5858246|NCT02097277|20259237|P3|Overall Study|Adverse Event|1
5858247|NCT02097277|20259238|P2|Overall Study|Adverse Event|0
5858248|NCT02097277|20259239|P1|Overall Study|Adverse Event|0
5858249|NCT02097277|20259235|P5|Overall Study|Withdrawal by Subject|0
5858250|NCT02097277|20259236|P4|Overall Study|Withdrawal by Subject|1
5858251|NCT02097277|20259237|P3|Overall Study|Withdrawal by Subject|0
5858252|NCT02097277|20259238|P2|Overall Study|Withdrawal by Subject|1
5858253|NCT02097277|20259239|P1|Overall Study|Withdrawal by Subject|2
5858254|NCT02097277|20259235|P5|Overall Study|Lost to Follow-up|0
5858255|NCT02097277|20259236|P4|Overall Study|Lost to Follow-up|0
5858256|NCT02097277|20259237|P3|Overall Study|Lost to Follow-up|1
5858257|NCT02097277|20259238|P2|Overall Study|Lost to Follow-up|1
5858258|NCT02097277|20259239|P1|Overall Study|Lost to Follow-up|0
5858259|NCT02097277|20259235|P5|Overall Study|Subject request to discontinue treatment|1
5858260|NCT02097277|20259236|P4|Overall Study|Subject request to discontinue treatment|0
5858261|NCT02097277|20259237|P3|Overall Study|Subject request to discontinue treatment|0
5858262|NCT02097277|20259238|P2|Overall Study|Subject request to discontinue treatment|0
5858263|NCT02097277|20259239|P1|Overall Study|Subject request to discontinue treatment|0
5858264|NCT02097277|20259235|P5|Overall Study|Subject no longer meets study criteria|0
5858265|NCT02097277|20259236|P4|Overall Study|Subject no longer meets study criteria|1
5858266|NCT02097277|20259237|P3|Overall Study|Subject no longer meets study criteria|0
5858267|NCT02097277|20259238|P2|Overall Study|Subject no longer meets study criteria|1
5858268|NCT02097277|20259239|P1|Overall Study|Subject no longer meets study criteria|0
5858269|NCT02097238|20259322|P1|Overall Study|Progressive Disease|17
5858270|NCT02097238|20259322|P1|Overall Study|Physician Decision|1
5858271|NCT02097238|20259322|P1|Overall Study|Death|1
5858272|NCT02097134|20259331|P1|Overall Study|Refusal of Further Protocol Therapy|1
5858273|NCT02097134|20259331|P1|Overall Study|Progressive Disease|3
5858274|NCT02097134|20259331|P1|Overall Study|Non-Protocol Therapy|1
5858275|NCT02097134|20259331|P1|Overall Study|Physician Decision|4
5858276|NCT02097108|20259339|P1|Overall Study|patient was abroad for 6 months|1
5858277|NCT02097108|20259339|P1|Overall Study|Adverse Event|1
5858278|NCT02097056|20259346|P1|Overall Study|Other|2
5858279|NCT02097056|20259346|P1|Overall Study|Adverse Event|37
5858280|NCT02097056|20259346|P1|Overall Study|Lost to Follow-up|2
5858281|NCT02097056|20259346|P1|Overall Study|Withdrawal by Subject|15
5858282|NCT02097056|20259346|P1|Overall Study|Protocol Violation|2
5858283|NCT02097030|20259354|P2|First Intervention (3 Days)|Visual Acuity|1
5858284|NCT02097030|20259355|P1|First Intervention (3 Days)|Visual Acuity|0
5858285|NCT02097030|20259354|P2|First Intervention (3 Days)|Lost to Follow-up|0
5858286|NCT02097030|20259355|P1|First Intervention (3 Days)|Lost to Follow-up|1
5858287|NCT02096952|20259416|P1|Overall Study|Adverse Event|1
5858288|NCT02096900|20259422|P2|Overall Study|Surgery cancelled- medication received|1
5858289|NCT02096900|20259423|P1|Overall Study|Surgery cancelled- medication received|1
5858290|NCT02096900|20259422|P2|Overall Study|Did not receive medication|1
5858291|NCT02096900|20259423|P1|Overall Study|Did not receive medication|3
5858292|NCT02096835|20259475|P3|Overall Study|Lost to Follow-up|1
5858293|NCT02096835|20259476|P2|Overall Study|Lost to Follow-up|0
5858294|NCT02096835|20259477|P1|Overall Study|Lost to Follow-up|1
5858295|NCT02096835|20259475|P3|Overall Study|converted to open procedures|0
5858296|NCT02096835|20259476|P2|Overall Study|converted to open procedures|0
5858297|NCT02096835|20259477|P1|Overall Study|converted to open procedures|1
5858298|NCT02096835|20259475|P3|Overall Study|Withdrawal by Subject|0
5858299|NCT02096835|20259476|P2|Overall Study|Withdrawal by Subject|0
5858300|NCT02096835|20259477|P1|Overall Study|Withdrawal by Subject|1
5858301|NCT02096744|20259494|P2|Treatment Period 3 (7 Days)|Withdrawal by Subject|1
5858302|NCT02096744|20259495|P1|Treatment Period 3 (7 Days)|Withdrawal by Subject|0
5858303|NCT02096744|20259494|P2|Treatment Period 1(7 Days)|Non compliance with the site rule|0
5858304|NCT02096744|20259495|P1|Treatment Period 1(7 Days)|Non compliance with the site rule|1
5858305|NCT02096744|20259494|P2|Treatment Period 1(7 Days)|Accidental early removal of the patch|1
5858306|NCT02096744|20259495|P1|Treatment Period 1(7 Days)|Accidental early removal of the patch|0
5858307|NCT02096705|20259549|P2|Follow-up|Subjects not reporting status|2
5858308|NCT02096705|20259550|P1|Follow-up|Subjects not reporting status|1
5858309|NCT02096705|20259549|P2|Follow-up|Adverse Event|2
5858310|NCT02096705|20259550|P1|Follow-up|Adverse Event|2
5858311|NCT02096705|20259549|P2|Follow-up|Withdrawal by Subject|0
5858312|NCT02096705|20259550|P1|Follow-up|Withdrawal by Subject|1
5858313|NCT02096705|20259549|P2|Treatment|Other|1
5858314|NCT02096705|20259550|P1|Treatment|Other|1
5858315|NCT02096705|20259549|P2|Treatment|Withdrawal by Subject|0
5858316|NCT02096705|20259550|P1|Treatment|Withdrawal by Subject|1
5858317|NCT02096705|20259549|P2|Treatment|Subject request to discontinue treatment|1
5858318|NCT02096705|20259550|P1|Treatment|Subject request to discontinue treatment|1
5858319|NCT02096705|20259549|P2|Treatment|Adverse Event|3
5858320|NCT02096705|20259550|P1|Treatment|Adverse Event|6
5858321|NCT02096588|20259593|P2|Overall Study|Withdrawal by Subject|1
5858322|NCT02096588|20259594|P1|Overall Study|Withdrawal by Subject|0
5858323|NCT02096588|20259593|P2|Overall Study|Lack of Efficacy|0
5858324|NCT02096588|20259594|P1|Overall Study|Lack of Efficacy|2
5858325|NCT02096471|20259620|P1|Overall Study|Non-Compliant|2
5858326|NCT02096471|20259620|P1|Overall Study|Withdrawal by Subject|3
5858327|NCT02096471|20259620|P1|Overall Study|Lack of Efficacy|7
5858328|NCT02096471|20259620|P1|Overall Study|Adverse Event|1
5858329|NCT02096263|20259647|P3|Overall Study|Withdrawal by Subject|8
5858330|NCT02096263|20259648|P2|Overall Study|Withdrawal by Subject|7
5858331|NCT02096263|20259649|P1|Overall Study|Withdrawal by Subject|5
5858332|NCT02096263|20259647|P3|Overall Study|Protocol Violation|8
5858333|NCT02096263|20259648|P2|Overall Study|Protocol Violation|2
5858334|NCT02096263|20259649|P1|Overall Study|Protocol Violation|7
5858335|NCT02096263|20259647|P3|Overall Study|Sponsor study termination|1
5858336|NCT02096263|20259648|P2|Overall Study|Sponsor study termination|0
5858337|NCT02096263|20259649|P1|Overall Study|Sponsor study termination|0
5858338|NCT02096263|20259647|P3|Overall Study|Other|6
5858339|NCT02096263|20259648|P2|Overall Study|Other|9
5858340|NCT02096263|20259649|P1|Overall Study|Other|7
5858341|NCT02096263|20259647|P3|Overall Study|Lost to Follow-up|15
5858342|NCT02096263|20259648|P2|Overall Study|Lost to Follow-up|18
5858343|NCT02096263|20259649|P1|Overall Study|Lost to Follow-up|14
5858344|NCT02096263|20259647|P3|Overall Study|Adverse Event|1
5858345|NCT02096263|20259648|P2|Overall Study|Adverse Event|0
5858346|NCT02096263|20259649|P1|Overall Study|Adverse Event|1
5858347|NCT02096042|20259837|P3|Overall Study|Disease Progression|0
5858348|NCT02096042|20259838|P2|Overall Study|Disease Progression|0
5858349|NCT02096042|20259839|P1|Overall Study|Disease Progression|1
5858350|NCT02096003|20259861|P2|Overall Study|additional surgery|1
5858351|NCT02096003|20259862|P1|Overall Study|additional surgery|2
5858352|NCT02096003|20259861|P2|Overall Study|Protocol Violation|2
5858353|NCT02096003|20259862|P1|Overall Study|Protocol Violation|0
5858354|NCT02095951|20259878|P2|Overall Study|NO POSITIVE BLOOD CULTURE|6
5858355|NCT02095951|20259879|P1|Overall Study|NO POSITIVE BLOOD CULTURE|9
5858356|NCT02095873|20259899|P2|Second Intervention (8 Weeks)|Protocol Violation|0
5858357|NCT02095873|20259900|P1|Second Intervention (8 Weeks)|Protocol Violation|1
5858358|NCT02095873|20259899|P2|Second Intervention (8 Weeks)|Withdrawal by Subject|0
5858359|NCT02095873|20259900|P1|Second Intervention (8 Weeks)|Withdrawal by Subject|1
5858360|NCT02095873|20259899|P2|First Intervention (8 Weeks)|Withdrawal by Subject|0
5858361|NCT02095873|20259900|P1|First Intervention (8 Weeks)|Withdrawal by Subject|1
5858362|NCT02095691|20259912|P1|Overall Study|Physician Decision|1
5858375|NCT02095535|20259964|P1|Recruitment|Protocol Violation|2
5858376|NCT02095223|20259986|P2|Overall Study|Withdrawal by Subject|0
5858377|NCT02095223|20259987|P1|Overall Study|Withdrawal by Subject|1
5858378|NCT02095197|20259997|P2|Overall Study|Lost to Follow-up|3
5858379|NCT02095197|20259998|P1|Overall Study|Lost to Follow-up|0
5858380|NCT02095158|20260010|P1|Overall Study|Other Miscellaneous Reasons|1
5858381|NCT02095158|20260010|P1|Overall Study|Protocol Violation|1
5858382|NCT02095158|20260010|P1|Overall Study|Personal Reasons|35
5858383|NCT02095158|20260010|P1|Overall Study|Lost to Follow-up|20
5858384|NCT02095158|20260010|P1|Overall Study|Pregnancy|1
5858385|NCT02095158|20260010|P1|Overall Study|Lack of Efficacy|3
5858386|NCT02095158|20260010|P1|Overall Study|Adverse Event|14
5858387|NCT02095145|20260017|P2|Overall Study|Withdrawal by Subject|0
5858388|NCT02095145|20260018|P1|Overall Study|Withdrawal by Subject|1
5858389|NCT02095106|20260064|P2|Second Intervention (14 Days)|Withdrawal by Subject|1
5858390|NCT02095106|20260065|P1|Second Intervention (14 Days)|Withdrawal by Subject|0
5858391|NCT02094937|20260081|P4|12 Weeks in Period 2|Randomized incorrectly|0
5858392|NCT02094937|20260082|P3|12 Weeks in Period 2|Randomized incorrectly|0
5858393|NCT02094937|20260083|P2|12 Weeks in Period 2|Randomized incorrectly|1
5858394|NCT02094937|20260084|P1|12 Weeks in Period 2|Randomized incorrectly|0
5858395|NCT02094937|20260081|P4|12 Weeks in Period 2|Withdrawal by Subject|0
5858396|NCT02094937|20260082|P3|12 Weeks in Period 2|Withdrawal by Subject|2
5858397|NCT02094937|20260083|P2|12 Weeks in Period 2|Withdrawal by Subject|2
5858398|NCT02094937|20260084|P1|12 Weeks in Period 2|Withdrawal by Subject|0
5858399|NCT02094937|20260081|P4|12 Weeks in Period 2|Protocol defined stopping criteria|11
5858400|NCT02094937|20260082|P3|12 Weeks in Period 2|Protocol defined stopping criteria|6
5858401|NCT02094937|20260083|P2|12 Weeks in Period 2|Protocol defined stopping criteria|5
5858402|NCT02094937|20260084|P1|12 Weeks in Period 2|Protocol defined stopping criteria|0
5858403|NCT02094937|20260081|P4|12 Weeks in Period 2|Lack of Efficacy|0
5858404|NCT02094937|20260082|P3|12 Weeks in Period 2|Lack of Efficacy|0
5858405|NCT02094937|20260083|P2|12 Weeks in Period 2|Lack of Efficacy|1
5858406|NCT02094937|20260084|P1|12 Weeks in Period 2|Lack of Efficacy|0
5858407|NCT02094937|20260081|P4|12 Weeks in Period 2|Adverse Event|1
5858408|NCT02094937|20260082|P3|12 Weeks in Period 2|Adverse Event|4
5858409|NCT02094937|20260083|P2|12 Weeks in Period 2|Adverse Event|2
5858410|NCT02094937|20260084|P1|12 Weeks in Period 2|Adverse Event|0
5858411|NCT02094937|20260081|P4|8 Weeks in Period 1|Withdrawal by Subject|0
5858412|NCT02094937|20260082|P3|8 Weeks in Period 1|Withdrawal by Subject|0
5858413|NCT02094937|20260083|P2|8 Weeks in Period 1|Withdrawal by Subject|0
5858414|NCT02094937|20260084|P1|8 Weeks in Period 1|Withdrawal by Subject|4
5858415|NCT02094937|20260081|P4|8 Weeks in Period 1|Physician Decision|0
5858416|NCT02094937|20260082|P3|8 Weeks in Period 1|Physician Decision|0
5858417|NCT02094937|20260083|P2|8 Weeks in Period 1|Physician Decision|0
5858418|NCT02094937|20260084|P1|8 Weeks in Period 1|Physician Decision|1
5858419|NCT02094937|20260081|P4|8 Weeks in Period 1|Protocol defined stopping criteria|0
5858420|NCT02094937|20260082|P3|8 Weeks in Period 1|Protocol defined stopping criteria|0
5858421|NCT02094937|20260083|P2|8 Weeks in Period 1|Protocol defined stopping criteria|0
5858422|NCT02094937|20260084|P1|8 Weeks in Period 1|Protocol defined stopping criteria|41
5858423|NCT02094937|20260081|P4|8 Weeks in Period 1|Protocol Violation|0
5858424|NCT02094937|20260082|P3|8 Weeks in Period 1|Protocol Violation|0
5858425|NCT02094937|20260083|P2|8 Weeks in Period 1|Protocol Violation|0
5858426|NCT02094937|20260084|P1|8 Weeks in Period 1|Protocol Violation|2
5858427|NCT02094937|20260081|P4|8 Weeks in Period 1|Lack of Efficacy|0
5858428|NCT02094937|20260082|P3|8 Weeks in Period 1|Lack of Efficacy|0
5858429|NCT02094937|20260083|P2|8 Weeks in Period 1|Lack of Efficacy|0
5858430|NCT02094937|20260084|P1|8 Weeks in Period 1|Lack of Efficacy|3
5858431|NCT02094937|20260081|P4|8 Weeks in Period 1|Adverse Event|0
5858432|NCT02094937|20260082|P3|8 Weeks in Period 1|Adverse Event|0
5858433|NCT02094937|20260083|P2|8 Weeks in Period 1|Adverse Event|0
5858434|NCT02094937|20260084|P1|8 Weeks in Period 1|Adverse Event|9
5858435|NCT02094898|20260114|P1|Overall Study|Lack of Efficacy|1
5858436|NCT02094898|20260114|P1|Overall Study|Adverse Event|2
5858437|NCT02094898|20260114|P1|Overall Study|Clinical Worsening|2
5858438|NCT02094885|20260161|P2|Overall Study|Withdrawn due to age|0
5858439|NCT02094885|20260162|P1|Overall Study|Withdrawn due to age|1
5858440|NCT02094885|20260161|P2|Overall Study|Death|5
5858441|NCT02094885|20260162|P1|Overall Study|Death|1
5858442|NCT02094677|20260210|P2|Overall Study|Screening|1
5858443|NCT02094677|20260211|P1|Overall Study|Screening|3
5858444|NCT02094612|20260290|P2|Overall Study|Never started ADHD medication|23
5858445|NCT02094612|20260291|P1|Overall Study|Never started ADHD medication|32
5858446|NCT02094612|20260290|P2|Overall Study|Lost to Follow-up|47
5858447|NCT02094612|20260291|P1|Overall Study|Lost to Follow-up|47
5858448|NCT02094573|20260311|P2|Overall Study|Ongoing|76
5858449|NCT02094573|20260312|P1|Overall Study|Ongoing|64
5858450|NCT02094573|20260311|P2|Overall Study|Randomized but not treated|0
5858451|NCT02094573|20260312|P1|Overall Study|Randomized but not treated|3
5858452|NCT02094573|20260311|P2|Overall Study|Withdrawal by Subject|4
5858453|NCT02094573|20260312|P1|Overall Study|Withdrawal by Subject|2
5858454|NCT02094573|20260311|P2|Overall Study|Non-compliance with study drug|1
5858455|NCT02094573|20260312|P1|Overall Study|Non-compliance with study drug|0
5858456|NCT02094573|20260311|P2|Overall Study|Death|1
5858457|NCT02094573|20260312|P1|Overall Study|Death|7
5858458|NCT02094573|20260311|P2|Overall Study|Adverse Event|9
5858459|NCT02094573|20260312|P1|Overall Study|Adverse Event|3
5858460|NCT02094573|20260311|P2|Overall Study|Clinical Progressive Disease|3
5858461|NCT02094573|20260312|P1|Overall Study|Clinical Progressive Disease|4
5858462|NCT02094573|20260311|P2|Overall Study|Documented Progressive Disease|16
5858463|NCT02094573|20260312|P1|Overall Study|Documented Progressive Disease|29
5858464|NCT02094300|20260394|P1|Overall Study|Still be eligible for follow-up|3
5858465|NCT02094300|20260394|P1|Overall Study|Lost to Follow-up|10
5858466|NCT02094300|20260394|P1|Overall Study|Death|7
5858471|NCT02093923|20260440|P5|Overall Study|Screen failure after randomization|0
5858472|NCT02093923|20260441|P4|Overall Study|Screen failure after randomization|1
5858473|NCT02093923|20260442|P3|Overall Study|Screen failure after randomization|0
5858474|NCT02093923|20260443|P2|Overall Study|Screen failure after randomization|0
5858475|NCT02093923|20260444|P1|Overall Study|Screen failure after randomization|0
5858476|NCT02093923|20260440|P5|Overall Study|Lost to Follow-up|0
5858477|NCT02093923|20260441|P4|Overall Study|Lost to Follow-up|1
5858478|NCT02093923|20260442|P3|Overall Study|Lost to Follow-up|0
5858479|NCT02093923|20260443|P2|Overall Study|Lost to Follow-up|0
5858480|NCT02093923|20260444|P1|Overall Study|Lost to Follow-up|0
5858481|NCT02093897|20260499|P1|Overall Study|Adverse event, non-fatal|1
5858482|NCT02093897|20260499|P1|Overall Study|Planned age group closure - no's reached|17
5858483|NCT02093897|20260499|P1|Overall Study|Physician Decision|1
5858484|NCT02093689|20260615|P3|Overall Study|Physician Decision|0
5858485|NCT02093689|20260616|P2|Overall Study|Physician Decision|0
5858486|NCT02093689|20260617|P1|Overall Study|Physician Decision|4
5858487|NCT02093663|20260623|P5|Double Blind Maintenance Phase(26 Weeks)|Missing|1
5858488|NCT02093663|20260624|P4|Double Blind Maintenance Phase(26 Weeks)|Missing|0
5858489|NCT02093663|20260625|P3|Double Blind Maintenance Phase(26 Weeks)|Missing|0
5858490|NCT02093663|20260626|P2|Double Blind Maintenance Phase(26 Weeks)|Missing|0
5858491|NCT02093663|20260627|P1|Double Blind Maintenance Phase(26 Weeks)|Missing|0
5858492|NCT02093663|20260623|P5|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1
5858493|NCT02093663|20260624|P4|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1
5858494|NCT02093663|20260625|P3|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0
5858495|NCT02093663|20260626|P2|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0
5858496|NCT02093663|20260627|P1|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0
5858497|NCT02093663|20260623|P5|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|7
5858498|NCT02093663|20260624|P4|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|6
5858499|NCT02093663|20260625|P3|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0
5858500|NCT02093663|20260626|P2|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0
5858501|NCT02093663|20260627|P1|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0
5858502|NCT02093663|20260623|P5|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|2
5858503|NCT02093663|20260624|P4|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|3
5858504|NCT02093663|20260625|P3|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0
5858505|NCT02093663|20260626|P2|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0
5858506|NCT02093663|20260627|P1|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0
5858507|NCT02093663|20260623|P5|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0
5858508|NCT02093663|20260624|P4|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0
5858509|NCT02093663|20260625|P3|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|5
5858510|NCT02093663|20260626|P2|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0
5858511|NCT02093663|20260627|P1|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0
5858512|NCT02093663|20260623|P5|Open Label Acute Phase (8 Weeks)|Adverse Event|0
5858513|NCT02093663|20260624|P4|Open Label Acute Phase (8 Weeks)|Adverse Event|0
5858514|NCT02093663|20260625|P3|Open Label Acute Phase (8 Weeks)|Adverse Event|1
5858515|NCT02093663|20260626|P2|Open Label Acute Phase (8 Weeks)|Adverse Event|0
5858516|NCT02093663|20260627|P1|Open Label Acute Phase (8 Weeks)|Adverse Event|0
5858517|NCT02093663|20260623|P5|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0
5858518|NCT02093663|20260624|P4|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0
5858519|NCT02093663|20260625|P3|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0
5858520|NCT02093663|20260626|P2|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|4
5858521|NCT02093663|20260627|P1|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|2
5858522|NCT02093663|20260623|P5|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0
5858523|NCT02093663|20260624|P4|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0
5858524|NCT02093663|20260625|P3|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0
5858525|NCT02093663|20260626|P2|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0
5858526|NCT02093663|20260627|P1|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|5
5858527|NCT02093663|20260623|P5|Double Blind Acute Phase (8 Weeks)|Adverse Event|0
5858528|NCT02093663|20260624|P4|Double Blind Acute Phase (8 Weeks)|Adverse Event|0
5858529|NCT02093663|20260625|P3|Double Blind Acute Phase (8 Weeks)|Adverse Event|0
5858530|NCT02093663|20260626|P2|Double Blind Acute Phase (8 Weeks)|Adverse Event|0
5858531|NCT02093663|20260627|P1|Double Blind Acute Phase (8 Weeks)|Adverse Event|1
5858532|NCT02093520|20260656|P2|Overall Study|Not treated|22
5858533|NCT02093520|20260657|P1|Overall Study|Not treated|6
5858534|NCT02093390|20260669|P2|Overall Study|Withdrawal by Subject|1
5858535|NCT02093390|20260670|P1|Overall Study|Withdrawal by Subject|0
5858536|NCT02093351|20260709|P4|Part B|Death|1
5858537|NCT02093351|20260710|P3|Part B|Death|0
5858538|NCT02093351|20260711|P2|Part B|Death|0
5858539|NCT02093351|20260712|P1|Part B|Death|0
5858540|NCT02093351|20260709|P4|Part B|Adverse Event|2
5858541|NCT02093351|20260710|P3|Part B|Adverse Event|0
5858542|NCT02093351|20260711|P2|Part B|Adverse Event|0
5858543|NCT02093351|20260712|P1|Part B|Adverse Event|0
5858544|NCT02093351|20260709|P4|Part B|Condition under investigation worsened|39
5858545|NCT02093351|20260710|P3|Part B|Condition under investigation worsened|0
5858546|NCT02093351|20260711|P2|Part B|Condition under investigation worsened|0
5858547|NCT02093351|20260712|P1|Part B|Condition under investigation worsened|0
5858548|NCT02093351|20260709|P4|Part B|Lack of therapeutic response|12
5858549|NCT02093351|20260710|P3|Part B|Lack of therapeutic response|0
5858550|NCT02093351|20260711|P2|Part B|Lack of therapeutic response|0
5858551|NCT02093351|20260712|P1|Part B|Lack of therapeutic response|0
5858552|NCT02093351|20260709|P4|Part B|Adverse event + disease progression|1
5858553|NCT02093351|20260710|P3|Part B|Adverse event + disease progression|0
5858554|NCT02093351|20260711|P2|Part B|Adverse event + disease progression|0
5858555|NCT02093351|20260712|P1|Part B|Adverse event + disease progression|0
5858556|NCT02093351|20260709|P4|Part B|Complete response|1
5858557|NCT02093351|20260710|P3|Part B|Complete response|0
5858558|NCT02093351|20260711|P2|Part B|Complete response|0
5858559|NCT02093351|20260712|P1|Part B|Complete response|0
5858560|NCT02093351|20260709|P4|Part B|Disease progression|4
5858561|NCT02093351|20260710|P3|Part B|Disease progression|0
5858562|NCT02093351|20260711|P2|Part B|Disease progression|0
5858563|NCT02093351|20260712|P1|Part B|Disease progression|0
5858564|NCT02093351|20260709|P4|Part B|Patient decision|3
5858565|NCT02093351|20260710|P3|Part B|Patient decision|0
5858566|NCT02093351|20260711|P2|Part B|Patient decision|0
5858567|NCT02093351|20260712|P1|Part B|Patient decision|0
5858568|NCT02093351|20260709|P4|Part A|Death|0
5858569|NCT02093351|20260710|P3|Part A|Death|0
5858570|NCT02093351|20260711|P2|Part A|Death|1
5858571|NCT02093351|20260712|P1|Part A|Death|0
5858572|NCT02093351|20260709|P4|Part A|Condition under investigation worsened|0
5858573|NCT02093351|20260710|P3|Part A|Condition under investigation worsened|2
5858574|NCT02093351|20260711|P2|Part A|Condition under investigation worsened|0
5858575|NCT02093351|20260712|P1|Part A|Condition under investigation worsened|2
5858576|NCT02093351|20260709|P4|Part A|Adverse Event|0
5858577|NCT02093351|20260710|P3|Part A|Adverse Event|1
5858578|NCT02093351|20260711|P2|Part A|Adverse Event|1
5858579|NCT02093351|20260712|P1|Part A|Adverse Event|0
5858580|NCT02093221|20260769|P5|Overall Study|Study termination|7
5858581|NCT02093221|20260770|P4|Overall Study|Study termination|6
5858582|NCT02093221|20260771|P3|Overall Study|Study termination|4
5858583|NCT02093221|20260772|P2|Overall Study|Study termination|5
5858584|NCT02093221|20260773|P1|Overall Study|Study termination|6
5858585|NCT02093221|20260769|P5|Overall Study|Protocol Violation|0
5858586|NCT02093221|20260770|P4|Overall Study|Protocol Violation|0
5858587|NCT02093221|20260771|P3|Overall Study|Protocol Violation|0
5858588|NCT02093221|20260772|P2|Overall Study|Protocol Violation|1
5858589|NCT02093221|20260773|P1|Overall Study|Protocol Violation|0
5858590|NCT02093221|20260769|P5|Overall Study|Death|0
5858591|NCT02093221|20260770|P4|Overall Study|Death|0
5858592|NCT02093221|20260771|P3|Overall Study|Death|0
5858593|NCT02093221|20260772|P2|Overall Study|Death|1
5858594|NCT02093221|20260773|P1|Overall Study|Death|0
5858595|NCT02093221|20260769|P5|Overall Study|Lost to Follow-up|0
5858596|NCT02093221|20260770|P4|Overall Study|Lost to Follow-up|1
5858597|NCT02093221|20260771|P3|Overall Study|Lost to Follow-up|1
5858598|NCT02093221|20260772|P2|Overall Study|Lost to Follow-up|0
5858599|NCT02093221|20260773|P1|Overall Study|Lost to Follow-up|2
5858600|NCT02093221|20260769|P5|Overall Study|Withdrawal by Subject|1
5858601|NCT02093221|20260770|P4|Overall Study|Withdrawal by Subject|1
5858602|NCT02093221|20260771|P3|Overall Study|Withdrawal by Subject|4
5858603|NCT02093221|20260772|P2|Overall Study|Withdrawal by Subject|1
5858604|NCT02093221|20260773|P1|Overall Study|Withdrawal by Subject|1
5858605|NCT02093221|20260769|P5|Overall Study|Adverse Event|0
5858606|NCT02093221|20260770|P4|Overall Study|Adverse Event|0
5858607|NCT02093221|20260771|P3|Overall Study|Adverse Event|0
5858608|NCT02093221|20260772|P2|Overall Study|Adverse Event|0
5858609|NCT02093221|20260773|P1|Overall Study|Adverse Event|1
5858610|NCT02093026|20260810|P1|Overall Study|Other|157
5858611|NCT02093026|20260810|P1|Overall Study|Death|10
5858612|NCT02093026|20260810|P1|Overall Study|Adverse Event|26
5858613|NCT02092961|20260832|P3|Overall Study|Adverse Event|0
5858614|NCT02092961|20260833|P2|Overall Study|Adverse Event|4
5858615|NCT02092961|20260834|P1|Overall Study|Adverse Event|2
5858616|NCT02092961|20260832|P3|Overall Study|Dev. of study specific discont. criteria|0
5858617|NCT02092961|20260833|P2|Overall Study|Dev. of study specific discont. criteria|0
5858618|NCT02092961|20260834|P1|Overall Study|Dev. of study specific discont. criteria|3
5858619|NCT02092961|20260832|P3|Overall Study|Lack of therapeutic response|3
5858620|NCT02092961|20260833|P2|Overall Study|Lack of therapeutic response|1
5858621|NCT02092961|20260834|P1|Overall Study|Lack of therapeutic response|2
5858622|NCT02092961|20260832|P3|Overall Study|Study stopped|12
5858623|NCT02092961|20260833|P2|Overall Study|Study stopped|9
5858624|NCT02092961|20260834|P1|Overall Study|Study stopped|13
5858625|NCT02092961|20260832|P3|Overall Study|Not reported|1
5858626|NCT02092961|20260833|P2|Overall Study|Not reported|0
5858627|NCT02092961|20260834|P1|Overall Study|Not reported|1
5858628|NCT02092909|20260859|P4|Overall Study|Miscellaneous|1
5858629|NCT02092909|20260860|P3|Overall Study|Miscellaneous|2
5858630|NCT02092909|20260861|P2|Overall Study|Miscellaneous|1
5858631|NCT02092909|20260862|P1|Overall Study|Miscellaneous|1
5858632|NCT02092909|20260859|P4|Overall Study|Study terminated by Sponsor|2
5858633|NCT02092909|20260860|P3|Overall Study|Study terminated by Sponsor|0
5858634|NCT02092909|20260861|P2|Overall Study|Study terminated by Sponsor|0
5858635|NCT02092909|20260862|P1|Overall Study|Study terminated by Sponsor|0
5858636|NCT02092909|20260859|P4|Overall Study|Withdrawal by Subject|1
5858637|NCT02092909|20260860|P3|Overall Study|Withdrawal by Subject|2
5858638|NCT02092909|20260861|P2|Overall Study|Withdrawal by Subject|0
5858639|NCT02092909|20260862|P1|Overall Study|Withdrawal by Subject|0
5858640|NCT02092909|20260859|P4|Overall Study|Lack of Efficacy|0
5858641|NCT02092909|20260860|P3|Overall Study|Lack of Efficacy|1
5858642|NCT02092909|20260861|P2|Overall Study|Lack of Efficacy|2
5858643|NCT02092909|20260862|P1|Overall Study|Lack of Efficacy|0
5858644|NCT02092909|20260859|P4|Overall Study|Adverse Event|2
5858645|NCT02092909|20260860|P3|Overall Study|Adverse Event|4
5858646|NCT02092909|20260861|P2|Overall Study|Adverse Event|0
5858647|NCT02092909|20260862|P1|Overall Study|Adverse Event|0
5858648|NCT02092662|20260903|P2|Overall Study|Lost to Follow-up|0
5858649|NCT02092662|20260904|P1|Overall Study|Lost to Follow-up|13
5858650|NCT02092389|20260963|P1|Overall Study|Other|5
5858651|NCT02092389|20260963|P1|Overall Study|Adverse Event|1
5858652|NCT02092350|20260975|P2|Overall Study|Withdrawal by Subject|2
5858653|NCT02092350|20260976|P1|Overall Study|Withdrawal by Subject|2
5858654|NCT02092350|20260975|P2|Overall Study|Screen Failure|0
5858655|NCT02092350|20260976|P1|Overall Study|Screen Failure|1
5858656|NCT02092350|20260975|P2|Overall Study|Physician Decision|1
5858657|NCT02092350|20260976|P1|Overall Study|Physician Decision|1
5858658|NCT02092350|20260975|P2|Overall Study|Protocol Violation|0
5858659|NCT02092350|20260976|P1|Overall Study|Protocol Violation|1
5858660|NCT02092350|20260975|P2|Overall Study|Lost to Follow-up|1
5858661|NCT02092350|20260976|P1|Overall Study|Lost to Follow-up|3
5858662|NCT02092350|20260975|P2|Overall Study|Death|5
5858663|NCT02092350|20260976|P1|Overall Study|Death|2
5858664|NCT02092350|20260975|P2|Overall Study|Adverse Event|3
5858665|NCT02092350|20260976|P1|Overall Study|Adverse Event|0
5858666|NCT02092324|20260993|P1|Overall Study|Misdiagnosis|2
5858667|NCT02092324|20260993|P1|Overall Study|Physician Decision|7
5858668|NCT02092324|20260993|P1|Overall Study|Proceed to Transplant|3
5858669|NCT02092324|20260993|P1|Overall Study|Lack of Efficacy|6
5858670|NCT02092324|20260993|P1|Overall Study|Adverse Event|1
5858671|NCT02092285|20261024|P1|Maintenance Phase & Follow-up|Lack of Efficacy|23
5858672|NCT02092285|20261024|P1|Maintenance Phase & Follow-up|Withdrawal by Subject|11
5858673|NCT02092285|20261024|P1|Maintenance Phase & Follow-up|Relapse/recurrence|29
5858674|NCT02092285|20261024|P1|Maintenance Phase & Follow-up|Protocol Violation|11
5858675|NCT02092285|20261024|P1|Maintenance Phase & Follow-up|Pregnancy|1
5858676|NCT02092285|20261024|P1|Maintenance Phase & Follow-up|Physician Decision|10
5858677|NCT02092285|20261024|P1|Maintenance Phase & Follow-up|Non-compliance with study drug|2
5858678|NCT02092285|20261024|P1|Maintenance Phase & Follow-up|Lost to Follow-up|1
5858679|NCT02092285|20261024|P1|Maintenance Phase & Follow-up|Adverse Event|22
5858680|NCT02092285|20261024|P1|Induction Phase|Lack of Efficacy|14
5858681|NCT02092285|20261024|P1|Induction Phase|Withdrawal by Subject|2
5858682|NCT02092285|20261024|P1|Induction Phase|Relapse/Recurrence|7
5858683|NCT02092285|20261024|P1|Induction Phase|Pregnancy|1
5858684|NCT02092285|20261024|P1|Induction Phase|Physician Decision|4
5858685|NCT02092285|20261024|P1|Induction Phase|Adverse Event|7
5858686|NCT02092220|20261028|P2|Period 2|Nausea, Anxiety, Inconvenience|1
5858687|NCT02092220|20261029|P1|Period 2|Nausea, Anxiety, Inconvenience|0
5858688|NCT02092220|20261028|P2|Period 2|Severe Hypoglycaemia|0
5858689|NCT02092220|20261029|P1|Period 2|Severe Hypoglycaemia|1
5858690|NCT02092220|20261028|P2|Period 1|Unrelated Illness|2
5858691|NCT02092220|20261029|P1|Period 1|Unrelated Illness|0
5858692|NCT02092116|20261102|P2|Overall Study|Adverse Event|1
5858693|NCT02092116|20261103|P1|Overall Study|Adverse Event|0
5858694|NCT02092116|20261102|P2|Overall Study|Withdrawal by Subject|3
5858695|NCT02092116|20261103|P1|Overall Study|Withdrawal by Subject|0
5858696|NCT02092025|20261112|P1|Overall Study|Protocol Deviation|24
5858697|NCT02092025|20261112|P1|Overall Study|Case Report Forms Uncollected|44
5858698|NCT02091986|20261121|P3|Overall Study|Adverse Event|2
5858699|NCT02091986|20261122|P2|Overall Study|Adverse Event|0
5858700|NCT02091986|20261123|P1|Overall Study|Adverse Event|0
5858701|NCT02091986|20261121|P3|Overall Study|Withdrawal by Subject|3
5858702|NCT02091986|20261122|P2|Overall Study|Withdrawal by Subject|8
5858703|NCT02091986|20261123|P1|Overall Study|Withdrawal by Subject|4
5858704|NCT02091986|20261121|P3|Overall Study|Lost to Follow-up|0
5858705|NCT02091986|20261122|P2|Overall Study|Lost to Follow-up|0
5858706|NCT02091986|20261123|P1|Overall Study|Lost to Follow-up|1
5858707|NCT02091986|20261121|P3|Overall Study|7 rand in error 1 patient decision|3
5858708|NCT02091986|20261122|P2|Overall Study|7 rand in error 1 patient decision|3
5858709|NCT02091986|20261123|P1|Overall Study|7 rand in error 1 patient decision|2
5858710|NCT02091960|20261170|P1|Overall Study|On Study at Data Cut-off|12
5858711|NCT02091960|20261170|P1|Overall Study|Miscellaneous Reasons|31
5858712|NCT02091960|20261170|P1|Overall Study|Withdrawal by Subject|1
5858713|NCT02091960|20261170|P1|Overall Study|Death|7
5858714|NCT02091921|20261181|P1|Overall Study|Adverse Event|3
5858715|NCT02091869|20261190|P2|Overall Study|Withdrawal by Subject|3
5858716|NCT02091869|20261191|P1|Overall Study|Withdrawal by Subject|0
5858717|NCT02091752|20261232|P1|Overall Study|Adverse Event|1
5858718|NCT02091752|20261232|P1|Overall Study|Study terminated by Sponsor|2
5858719|NCT02091739|20261246|P5|EP: 48 Weeks|Withdrawal by Subject|6
5858720|NCT02091739|20261247|P4|EP: 48 Weeks|Withdrawal by Subject|2
5858721|NCT02091739|20261248|P3|EP: 48 Weeks|Withdrawal by Subject|0
5858722|NCT02091739|20261249|P2|EP: 48 Weeks|Withdrawal by Subject|0
5858723|NCT02091739|20261250|P1|EP: 48 Weeks|Withdrawal by Subject|0
5858724|NCT02091739|20261246|P5|EP: 48 Weeks|Adverse Event|6
5858725|NCT02091739|20261247|P4|EP: 48 Weeks|Adverse Event|2
5858726|NCT02091739|20261248|P3|EP: 48 Weeks|Adverse Event|0
5858727|NCT02091739|20261249|P2|EP: 48 Weeks|Adverse Event|0
5858728|NCT02091739|20261250|P1|EP: 48 Weeks|Adverse Event|0
5858729|NCT02091739|20261246|P5|EP: 48 Weeks|Death|2
5858730|NCT02091739|20261247|P4|EP: 48 Weeks|Death|3
5858731|NCT02091739|20261248|P3|EP: 48 Weeks|Death|0
5858732|NCT02091739|20261249|P2|EP: 48 Weeks|Death|0
5858733|NCT02091739|20261250|P1|EP: 48 Weeks|Death|0
5858734|NCT02091739|20261246|P5|EP: 48 Weeks|Other|0
5858735|NCT02091739|20261247|P4|EP: 48 Weeks|Other|1
5858736|NCT02091739|20261248|P3|EP: 48 Weeks|Other|0
5858737|NCT02091739|20261249|P2|EP: 48 Weeks|Other|0
5858738|NCT02091739|20261250|P1|EP: 48 Weeks|Other|0
5858739|NCT02091739|20261246|P5|MP: 16 Weeks|Lost to Follow-up|0
5858740|NCT02091739|20261247|P4|MP: 16 Weeks|Lost to Follow-up|0
5858741|NCT02091739|20261248|P3|MP: 16 Weeks|Lost to Follow-up|1
5858742|NCT02091739|20261249|P2|MP: 16 Weeks|Lost to Follow-up|0
5858743|NCT02091739|20261250|P1|MP: 16 Weeks|Lost to Follow-up|0
5858744|NCT02091739|20261246|P5|MP: 16 Weeks|Withdrawal by Subject|0
5858745|NCT02091739|20261247|P4|MP: 16 Weeks|Withdrawal by Subject|0
5858746|NCT02091739|20261248|P3|MP: 16 Weeks|Withdrawal by Subject|0
5858747|NCT02091739|20261249|P2|MP: 16 Weeks|Withdrawal by Subject|4
5858748|NCT02091739|20261250|P1|MP: 16 Weeks|Withdrawal by Subject|3
5858749|NCT02091739|20261246|P5|MP: 16 Weeks|Adverse Event|0
5858750|NCT02091739|20261247|P4|MP: 16 Weeks|Adverse Event|0
5858751|NCT02091739|20261248|P3|MP: 16 Weeks|Adverse Event|1
5858752|NCT02091739|20261249|P2|MP: 16 Weeks|Adverse Event|1
5858753|NCT02091739|20261250|P1|MP: 16 Weeks|Adverse Event|1
5858754|NCT02091726|20261269|P1|Overall Study|Lost to Follow-up|6
5858755|NCT02091440|20261292|P1|Overall Study|Death|2
5858756|NCT02091414|20261302|P1|Overall Study|Death|2
5858757|NCT02091414|20261302|P1|Overall Study|Withdrawal by Subject|2
5858758|NCT02091375|20261316|P2|Overall Study|Withdrawn by the investigator|0
5858759|NCT02091375|20261317|P1|Overall Study|Withdrawn by the investigator|1
5858760|NCT02091375|20261316|P2|Overall Study|Withdrawal by Subject|1
5858761|NCT02091375|20261317|P1|Overall Study|Withdrawal by Subject|0
5858762|NCT02091375|20261316|P2|Overall Study|Lost to Follow-up|1
5858763|NCT02091375|20261317|P1|Overall Study|Lost to Follow-up|0
5858764|NCT02091375|20261316|P2|Overall Study|Adverse Event|1
5858765|NCT02091375|20261317|P1|Overall Study|Adverse Event|8
5858766|NCT02091362|20261347|P2|Period 2|Withdrawal by Subject|1
5858767|NCT02091362|20261348|P1|Period 2|Withdrawal by Subject|1
5858768|NCT02091362|20261347|P2|Period 2|Lost to Follow-up|1
5858769|NCT02091362|20261348|P1|Period 2|Lost to Follow-up|0
5858770|NCT02091362|20261347|P2|Period 2|Adverse Event|0
5858771|NCT02091362|20261348|P1|Period 2|Adverse Event|1
5858772|NCT02091362|20261347|P2|Wash-out|Withdrawal by Subject|2
5858773|NCT02091362|20261348|P1|Wash-out|Withdrawal by Subject|0
5858774|NCT02091362|20261347|P2|Wash-out|Lost to Follow-up|1
5858775|NCT02091362|20261348|P1|Wash-out|Lost to Follow-up|1
5858776|NCT02091362|20261347|P2|Period 1|Adverse Event|0
5858777|NCT02091362|20261348|P1|Period 1|Adverse Event|2
5858778|NCT02091362|20261347|P2|Period 1|Lost to Follow-up|1
5858779|NCT02091362|20261348|P1|Period 1|Lost to Follow-up|0
5858780|NCT02091362|20261347|P2|Period 1|Withdrawal by Subject|3
5858781|NCT02091362|20261348|P1|Period 1|Withdrawal by Subject|2
5858782|NCT02091362|20261347|P2|Period 1|Protocol Violation|0
5858783|NCT02091362|20261348|P1|Period 1|Protocol Violation|1
5858784|NCT02091284|20261370|P2|Overall Study|unreliable data|0
5858785|NCT02091284|20261371|P1|Overall Study|unreliable data|1
5858786|NCT02091284|20261370|P2|Overall Study|Withdrawal by Subject|1
5858787|NCT02091284|20261371|P1|Overall Study|Withdrawal by Subject|2
5858788|NCT02091206|20261393|P4|Taper Period|Lost to Follow-up|1
5858789|NCT02091206|20261394|P3|Taper Period|Lost to Follow-up|0
5858790|NCT02091206|20261395|P2|Taper Period|Lost to Follow-up|0
5858791|NCT02091206|20261396|P1|Taper Period|Lost to Follow-up|0
5858792|NCT02091206|20261393|P4|Taper Period|Participant refused study drug|1
5858793|NCT02091206|20261394|P3|Taper Period|Participant refused study drug|0
5858794|NCT02091206|20261395|P2|Taper Period|Participant refused study drug|0
5858795|NCT02091206|20261396|P1|Taper Period|Participant refused study drug|1
5858796|NCT02091206|20261393|P4|Treatment Period|Met withdrawal criteria|0
5858797|NCT02091206|20261394|P3|Treatment Period|Met withdrawal criteria|1
5858798|NCT02091206|20261395|P2|Treatment Period|Met withdrawal criteria|0
5858799|NCT02091206|20261396|P1|Treatment Period|Met withdrawal criteria|0
5858800|NCT02091206|20261393|P4|Treatment Period|Adverse Event|0
5858801|NCT02091206|20261394|P3|Treatment Period|Adverse Event|0
5858802|NCT02091206|20261395|P2|Treatment Period|Adverse Event|1
5858803|NCT02091206|20261396|P1|Treatment Period|Adverse Event|0
5858804|NCT02091167|20261415|P2|Overall Study|Lost to Follow-up|2
5858805|NCT02091167|20261416|P1|Overall Study|Lost to Follow-up|0
5858806|NCT02091089|20261432|P1|Overall Study|Lost to Follow-up|2
5858807|NCT02090959|20261440|P1|Overall Study|Other than specified|2
5858808|NCT02090959|20261440|P1|Overall Study|Switched to commercial supply|88
5858809|NCT02090959|20261440|P1|Overall Study|Entered in to other study|34
5858810|NCT02090959|20261440|P1|Overall Study|Move to medical need program|3
5858811|NCT02090959|20261440|P1|Overall Study|Transfer for compassionate use medicine|4
5858812|NCT02090959|20261440|P1|Overall Study|Enrolled but not treated|1
5858813|NCT02090959|20261440|P1|Overall Study|Study termination|6
5858814|NCT02090959|20261440|P1|Overall Study|Investigator decision|2
5858815|NCT02090959|20261440|P1|Overall Study|Adverse Event|1
5858816|NCT02090959|20261440|P1|Overall Study|Withdrawal by Subject|10
5858817|NCT02090855|20261467|P1|Overall Study|no evaluable Standard of Truth results|2
5858818|NCT02090764|20261480|P2|Overall Study|Lost to Follow-up|2
5858819|NCT02090764|20261481|P1|Overall Study|Lost to Follow-up|2
5858820|NCT02090764|20261480|P2|Overall Study|Intercurrent illness and other|1
5858821|NCT02090764|20261481|P1|Overall Study|Intercurrent illness and other|1
5858822|NCT02090764|20261480|P2|Overall Study|Withdrawal by Subject|1
5858823|NCT02090764|20261481|P1|Overall Study|Withdrawal by Subject|2
5858824|NCT02090764|20261480|P2|Overall Study|Lack of Efficacy|13
5858825|NCT02090764|20261481|P1|Overall Study|Lack of Efficacy|0
5858826|NCT02090764|20261480|P2|Overall Study|Adverse Event|3
5858827|NCT02090764|20261481|P1|Overall Study|Adverse Event|1
5858828|NCT02090725|20261487|P1|Overall Study|participants moved from area|3
5858829|NCT02090725|20261487|P1|Overall Study|Withdrawal by Subject|1
5858830|NCT02090426|20261493|P2|Overall Study|Lost to Follow-up|6
5858831|NCT02090426|20261494|P1|Overall Study|Lost to Follow-up|12
5858832|NCT02090413|20261525|P3|Overall Study|Lost to Follow-up|0
5858833|NCT02090413|20261526|P2|Overall Study|Lost to Follow-up|1
5858834|NCT02090413|20261527|P1|Overall Study|Lost to Follow-up|1
5858835|NCT02090413|20261525|P3|Overall Study|Other|0
5858836|NCT02090413|20261526|P2|Overall Study|Other|1
5858837|NCT02090413|20261527|P1|Overall Study|Other|2
5858838|NCT02090413|20261525|P3|Overall Study|Investigator Decision|0
5858839|NCT02090413|20261526|P2|Overall Study|Investigator Decision|1
5858840|NCT02090413|20261527|P1|Overall Study|Investigator Decision|1
5858841|NCT02090413|20261525|P3|Overall Study|Withdrawal by Subject|2
5858842|NCT02090413|20261526|P2|Overall Study|Withdrawal by Subject|2
5858843|NCT02090413|20261527|P1|Overall Study|Withdrawal by Subject|2
5858844|NCT02090413|20261525|P3|Overall Study|Flushing event|1
5858845|NCT02090413|20261526|P2|Overall Study|Flushing event|0
5858846|NCT02090413|20261527|P1|Overall Study|Flushing event|2
5858847|NCT02090413|20261525|P3|Overall Study|Adverse Event|20
5858848|NCT02090413|20261526|P2|Overall Study|Adverse Event|15
5858849|NCT02090413|20261527|P1|Overall Study|Adverse Event|11
5858850|NCT02090283|20261604|P3|Overall Study|Protocol Violation|0
5858851|NCT02090283|20261605|P2|Overall Study|Protocol Violation|0
5858852|NCT02090283|20261606|P1|Overall Study|Protocol Violation|2
5858853|NCT02090283|20261604|P3|Overall Study|Adverse Event|0
5858854|NCT02090283|20261605|P2|Overall Study|Adverse Event|1
5858855|NCT02090283|20261606|P1|Overall Study|Adverse Event|1
5858856|NCT02090283|20261604|P3|Overall Study|Lost to Follow-up|3
5858857|NCT02090283|20261605|P2|Overall Study|Lost to Follow-up|2
5858858|NCT02090283|20261606|P1|Overall Study|Lost to Follow-up|2
5858859|NCT02090283|20261604|P3|Overall Study|Sponsor Terminated Study|1
5858860|NCT02090283|20261605|P2|Overall Study|Sponsor Terminated Study|6
5858861|NCT02090283|20261606|P1|Overall Study|Sponsor Terminated Study|6
5858862|NCT02090283|20261604|P3|Overall Study|Withdrawal by Subject|6
5858863|NCT02090283|20261605|P2|Overall Study|Withdrawal by Subject|6
5858864|NCT02090283|20261606|P1|Overall Study|Withdrawal by Subject|6
5858865|NCT02089997|20261640|P1|Overall Study|Protocol Violation|147
5858866|NCT02089997|20261640|P1|Overall Study|Case report forms uncollected|99
5858867|NCT02089737|20261655|P1|Overall Study|Not treated|1
5858868|NCT02089737|20261655|P1|Overall Study|Survey form not completed|5
5858869|NCT02089347|20261705|P2|Overall Study|Protocol Violation|0
5858870|NCT02089347|20261706|P1|Overall Study|Protocol Violation|1
5858871|NCT02089334|20261732|P4|Overall Study|Physician Decision|1
5858872|NCT02089334|20261733|P3|Overall Study|Physician Decision|1
5858873|NCT02089334|20261734|P2|Overall Study|Physician Decision|0
5858874|NCT02089334|20261735|P1|Overall Study|Physician Decision|0
5858875|NCT02089334|20261732|P4|Overall Study|Progressive disease|2
5858876|NCT02089334|20261733|P3|Overall Study|Progressive disease|0
5858877|NCT02089334|20261734|P2|Overall Study|Progressive disease|0
5858878|NCT02089334|20261735|P1|Overall Study|Progressive disease|0
5858879|NCT02089334|20261732|P4|Overall Study|Adverse Event|2
5858880|NCT02089334|20261733|P3|Overall Study|Adverse Event|0
5858881|NCT02089334|20261734|P2|Overall Study|Adverse Event|0
5858882|NCT02089334|20261735|P1|Overall Study|Adverse Event|0
5858883|NCT02089334|20261732|P4|Overall Study|Withdrawal by Subject|2
5858884|NCT02089334|20261733|P3|Overall Study|Withdrawal by Subject|0
5858885|NCT02089334|20261734|P2|Overall Study|Withdrawal by Subject|0
5858886|NCT02089334|20261735|P1|Overall Study|Withdrawal by Subject|0
5858887|NCT02088957|20261772|P2|Overall Study|Lack of Efficacy|0
5858888|NCT02088957|20261773|P1|Overall Study|Lack of Efficacy|1
5858889|NCT02088905|20261791|P2|Overall Study|Withdrawal by Subject|1
5858890|NCT02088905|20261792|P1|Overall Study|Withdrawal by Subject|5
5858891|NCT02088541|20261828|P5|Overall Study|Other|1
5858892|NCT02088541|20261829|P4|Overall Study|Other|1
5858893|NCT02088541|20261830|P3|Overall Study|Other|3
5858894|NCT02088541|20261831|P2|Overall Study|Other|1
5858895|NCT02088541|20261832|P1|Overall Study|Other|2
5858896|NCT02088541|20261828|P5|Overall Study|Withdrawal by Subject|10
5858897|NCT02088541|20261829|P4|Overall Study|Withdrawal by Subject|7
5858898|NCT02088541|20261830|P3|Overall Study|Withdrawal by Subject|9
5858899|NCT02088541|20261831|P2|Overall Study|Withdrawal by Subject|2
5858900|NCT02088541|20261832|P1|Overall Study|Withdrawal by Subject|3
5858901|NCT02088541|20261828|P5|Overall Study|Study terminated by sponsor|6
5858902|NCT02088541|20261829|P4|Overall Study|Study terminated by sponsor|2
5858903|NCT02088541|20261830|P3|Overall Study|Study terminated by sponsor|12
5858904|NCT02088541|20261831|P2|Overall Study|Study terminated by sponsor|1
5858905|NCT02088541|20261832|P1|Overall Study|Study terminated by sponsor|1
5858906|NCT02088541|20261828|P5|Overall Study|Disease progression|1
5858907|NCT02088541|20261829|P4|Overall Study|Disease progression|3
5858908|NCT02088541|20261830|P3|Overall Study|Disease progression|2
5858909|NCT02088541|20261831|P2|Overall Study|Disease progression|1
5858910|NCT02088541|20261832|P1|Overall Study|Disease progression|7
5858911|NCT02088541|20261828|P5|Overall Study|Physician Decision|2
5858912|NCT02088541|20261829|P4|Overall Study|Physician Decision|0
5858913|NCT02088541|20261830|P3|Overall Study|Physician Decision|2
5858914|NCT02088541|20261831|P2|Overall Study|Physician Decision|1
5858915|NCT02088541|20261832|P1|Overall Study|Physician Decision|2
5858916|NCT02088541|20261828|P5|Overall Study|Lost to Follow-up|0
5858917|NCT02088541|20261829|P4|Overall Study|Lost to Follow-up|0
5858918|NCT02088541|20261830|P3|Overall Study|Lost to Follow-up|1
5858919|NCT02088541|20261831|P2|Overall Study|Lost to Follow-up|0
5858920|NCT02088541|20261832|P1|Overall Study|Lost to Follow-up|2
5858921|NCT02088541|20261828|P5|Overall Study|Death|38
5858922|NCT02088541|20261829|P4|Overall Study|Death|28
5858923|NCT02088541|20261830|P3|Overall Study|Death|85
5858924|NCT02088541|20261831|P2|Overall Study|Death|21
5858925|NCT02088541|20261832|P1|Overall Study|Death|51
5858926|NCT02088541|20261828|P5|Overall Study|Adverse Event|0
5858927|NCT02088541|20261829|P4|Overall Study|Adverse Event|3
5858928|NCT02088541|20261830|P3|Overall Study|Adverse Event|3
5858929|NCT02088541|20261831|P2|Overall Study|Adverse Event|0
5858930|NCT02088541|20261832|P1|Overall Study|Adverse Event|3
5858931|NCT02088177|20261903|P1|Overall Study|Lost to Follow-up|3
5858932|NCT02088073|20261913|P5|Maintanance Phase|Subject compliance|0
5858933|NCT02088073|20261914|P4|Maintanance Phase|Subject compliance|0
5858934|NCT02088073|20261915|P3|Maintanance Phase|Subject compliance|0
5858935|NCT02088073|20261916|P2|Maintanance Phase|Subject compliance|1
5858936|NCT02088073|20261917|P1|Maintanance Phase|Subject compliance|0
5858937|NCT02088073|20261913|P5|Maintanance Phase|Met ECG withdrawal criteria|2
5858938|NCT02088073|20261914|P4|Maintanance Phase|Met ECG withdrawal criteria|0
5858939|NCT02088073|20261915|P3|Maintanance Phase|Met ECG withdrawal criteria|1
5858940|NCT02088073|20261916|P2|Maintanance Phase|Met ECG withdrawal criteria|0
5858941|NCT02088073|20261917|P1|Maintanance Phase|Met ECG withdrawal criteria|0
5858942|NCT02088073|20261913|P5|Maintanance Phase|Miscellaneous|1
5858943|NCT02088073|20261914|P4|Maintanance Phase|Miscellaneous|2
5858944|NCT02088073|20261915|P3|Maintanance Phase|Miscellaneous|1
5858945|NCT02088073|20261916|P2|Maintanance Phase|Miscellaneous|2
5858946|NCT02088073|20261917|P1|Maintanance Phase|Miscellaneous|0
5858947|NCT02088073|20261913|P5|Maintanance Phase|Hypo- or hyperkalemia|1
5858948|NCT02088073|20261914|P4|Maintanance Phase|Hypo- or hyperkalemia|3
5858949|NCT02088073|20261915|P3|Maintanance Phase|Hypo- or hyperkalemia|0
5858950|NCT02088073|20261916|P2|Maintanance Phase|Hypo- or hyperkalemia|3
5858951|NCT02088073|20261917|P1|Maintanance Phase|Hypo- or hyperkalemia|0
5858952|NCT02088073|20261913|P5|Maintanance Phase|Sponsor's decision|1
5858953|NCT02088073|20261914|P4|Maintanance Phase|Sponsor's decision|2
5858954|NCT02088073|20261915|P3|Maintanance Phase|Sponsor's decision|0
5858955|NCT02088073|20261916|P2|Maintanance Phase|Sponsor's decision|2
5858956|NCT02088073|20261917|P1|Maintanance Phase|Sponsor's decision|0
5858957|NCT02088073|20261913|P5|Maintanance Phase|Physician Decision|1
5858958|NCT02088073|20261914|P4|Maintanance Phase|Physician Decision|0
5858959|NCT02088073|20261915|P3|Maintanance Phase|Physician Decision|0
5858960|NCT02088073|20261916|P2|Maintanance Phase|Physician Decision|0
5858961|NCT02088073|20261917|P1|Maintanance Phase|Physician Decision|0
5858962|NCT02088073|20261913|P5|Maintanance Phase|Adverse Event|1
5858963|NCT02088073|20261914|P4|Maintanance Phase|Adverse Event|0
5858964|NCT02088073|20261915|P3|Maintanance Phase|Adverse Event|3
5858965|NCT02088073|20261916|P2|Maintanance Phase|Adverse Event|0
5858966|NCT02088073|20261917|P1|Maintanance Phase|Adverse Event|0
5858967|NCT02088073|20261913|P5|Maintanance Phase|Withdrawal by Subject|0
5858968|NCT02088073|20261914|P4|Maintanance Phase|Withdrawal by Subject|0
5858969|NCT02088073|20261915|P3|Maintanance Phase|Withdrawal by Subject|0
5858970|NCT02088073|20261916|P2|Maintanance Phase|Withdrawal by Subject|2
5858971|NCT02088073|20261917|P1|Maintanance Phase|Withdrawal by Subject|0
5858972|NCT02088073|20261913|P5|Acute Phase|Hyperkalemia|0
5858973|NCT02088073|20261914|P4|Acute Phase|Hyperkalemia|0
5858974|NCT02088073|20261915|P3|Acute Phase|Hyperkalemia|0
5858975|NCT02088073|20261916|P2|Acute Phase|Hyperkalemia|0
5858976|NCT02088073|20261917|P1|Acute Phase|Hyperkalemia|2
5858977|NCT02088073|20261913|P5|Acute Phase|Withdrawal by Subject|0
5858978|NCT02088073|20261914|P4|Acute Phase|Withdrawal by Subject|0
5858979|NCT02088073|20261915|P3|Acute Phase|Withdrawal by Subject|0
5858980|NCT02088073|20261916|P2|Acute Phase|Withdrawal by Subject|0
5858981|NCT02088073|20261917|P1|Acute Phase|Withdrawal by Subject|5
5858982|NCT02088047|20261971|P2|Overall Study|Withdrawal by Subject|0
5858983|NCT02088047|20261972|P1|Overall Study|Withdrawal by Subject|1
5858984|NCT02088034|20261981|P3|Overall Study|Pregnancy|2
5858985|NCT02088034|20261982|P2|Overall Study|Pregnancy|1
5858986|NCT02088034|20261983|P1|Overall Study|Pregnancy|2
5858987|NCT02088034|20261981|P3|Overall Study|Lost to Follow-up|0
5858988|NCT02088034|20261982|P2|Overall Study|Lost to Follow-up|1
5858989|NCT02088034|20261983|P1|Overall Study|Lost to Follow-up|1
5858990|NCT02087943|20262013|P5|Active Treatment Phase Week 12-24|Other-Unspecified|0
5858991|NCT02087943|20262014|P4|Active Treatment Phase Week 12-24|Other-Unspecified|1
5858992|NCT02087943|20262015|P3|Active Treatment Phase Week 12-24|Other-Unspecified|1
5858993|NCT02087943|20262016|P2|Active Treatment Phase Week 12-24|Other-Unspecified|0
5858994|NCT02087943|20262017|P1|Active Treatment Phase Week 12-24|Other-Unspecified|0
5858995|NCT02087943|20262013|P5|Active Treatment Phase Week 12-24|Lost to Follow-up|1
5858996|NCT02087943|20262014|P4|Active Treatment Phase Week 12-24|Lost to Follow-up|0
5858997|NCT02087943|20262015|P3|Active Treatment Phase Week 12-24|Lost to Follow-up|0
5858998|NCT02087943|20262016|P2|Active Treatment Phase Week 12-24|Lost to Follow-up|0
5858999|NCT02087943|20262017|P1|Active Treatment Phase Week 12-24|Lost to Follow-up|0
5859000|NCT02087943|20262013|P5|Active Treatment Phase Week 12-24|Withdrawal by Subject|0
5859001|NCT02087943|20262014|P4|Active Treatment Phase Week 12-24|Withdrawal by Subject|0
5859002|NCT02087943|20262015|P3|Active Treatment Phase Week 12-24|Withdrawal by Subject|1
5859003|NCT02087943|20262016|P2|Active Treatment Phase Week 12-24|Withdrawal by Subject|0
5859004|NCT02087943|20262017|P1|Active Treatment Phase Week 12-24|Withdrawal by Subject|0
5859005|NCT02087943|20262013|P5|Active Treatment Phase Week 12-24|Lack of Efficacy|0
5859006|NCT02087943|20262014|P4|Active Treatment Phase Week 12-24|Lack of Efficacy|1
5859007|NCT02087943|20262015|P3|Active Treatment Phase Week 12-24|Lack of Efficacy|1
5859008|NCT02087943|20262016|P2|Active Treatment Phase Week 12-24|Lack of Efficacy|3
5859009|NCT02087943|20262017|P1|Active Treatment Phase Week 12-24|Lack of Efficacy|0
5859010|NCT02087943|20262013|P5|Active Treatment Phase Week 12-24|Adverse Event|1
5859011|NCT02087943|20262014|P4|Active Treatment Phase Week 12-24|Adverse Event|0
5859012|NCT02087943|20262015|P3|Active Treatment Phase Week 12-24|Adverse Event|2
5859013|NCT02087943|20262016|P2|Active Treatment Phase Week 12-24|Adverse Event|1
5859014|NCT02087943|20262017|P1|Active Treatment Phase Week 12-24|Adverse Event|0
5859015|NCT02087943|20262013|P5|Placebo-Controlled Phase Week 0-12|Protocol Violation|0
5859016|NCT02087943|20262014|P4|Placebo-Controlled Phase Week 0-12|Protocol Violation|0
5859017|NCT02087943|20262015|P3|Placebo-Controlled Phase Week 0-12|Protocol Violation|0
5859018|NCT02087943|20262016|P2|Placebo-Controlled Phase Week 0-12|Protocol Violation|1
5859019|NCT02087943|20262017|P1|Placebo-Controlled Phase Week 0-12|Protocol Violation|0
5859020|NCT02087943|20262013|P5|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0
5859021|NCT02087943|20262014|P4|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0
5859022|NCT02087943|20262015|P3|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1
5859023|NCT02087943|20262016|P2|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0
5859024|NCT02087943|20262017|P1|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1
5859025|NCT02087943|20262013|P5|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0
5859026|NCT02087943|20262014|P4|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0
5859027|NCT02087943|20262015|P3|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2
5859028|NCT02087943|20262016|P2|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2
5859029|NCT02087943|20262017|P1|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|4
5859030|NCT02087943|20262013|P5|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0
5859031|NCT02087943|20262014|P4|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0
5859032|NCT02087943|20262015|P3|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|4
5859033|NCT02087943|20262016|P2|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|7
5859034|NCT02087943|20262017|P1|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|8
5859035|NCT02087943|20262013|P5|Placebo-Controlled Phase Week 0-12|Adverse Event|0
5859036|NCT02087943|20262014|P4|Placebo-Controlled Phase Week 0-12|Adverse Event|0
5859037|NCT02087943|20262015|P3|Placebo-Controlled Phase Week 0-12|Adverse Event|6
5859038|NCT02087943|20262016|P2|Placebo-Controlled Phase Week 0-12|Adverse Event|2
5859039|NCT02087943|20262017|P1|Placebo-Controlled Phase Week 0-12|Adverse Event|1
5859040|NCT02087904|20262045|P4|Overall Study|Lost to Follow-up|2
5859041|NCT02087904|20262046|P3|Overall Study|Lost to Follow-up|2
5859042|NCT02087904|20262047|P2|Overall Study|Lost to Follow-up|4
5859043|NCT02087904|20262048|P1|Overall Study|Lost to Follow-up|0
5859044|NCT02087904|20262045|P4|Overall Study|Withdrawal by Subject|4
5859045|NCT02087904|20262046|P3|Overall Study|Withdrawal by Subject|7
5859046|NCT02087904|20262047|P2|Overall Study|Withdrawal by Subject|3
5859047|NCT02087904|20262048|P1|Overall Study|Withdrawal by Subject|8
5859048|NCT02087904|20262045|P4|Overall Study|Other|4
5859049|NCT02087904|20262046|P3|Overall Study|Other|4
5859050|NCT02087904|20262047|P2|Overall Study|Other|2
5859051|NCT02087904|20262048|P1|Overall Study|Other|6
5859052|NCT02087904|20262045|P4|Overall Study|Lack of Efficacy|2
5859053|NCT02087904|20262046|P3|Overall Study|Lack of Efficacy|3
5859054|NCT02087904|20262047|P2|Overall Study|Lack of Efficacy|6
5859055|NCT02087904|20262048|P1|Overall Study|Lack of Efficacy|3
5859056|NCT02087904|20262045|P4|Overall Study|Adverse Event|12
5859057|NCT02087904|20262046|P3|Overall Study|Adverse Event|4
5859058|NCT02087904|20262047|P2|Overall Study|Adverse Event|4
5859059|NCT02087904|20262048|P1|Overall Study|Adverse Event|8
5859060|NCT02087904|20262045|P4|Overall Study|Did Not Receive Study Drug|1
5859061|NCT02087904|20262046|P3|Overall Study|Did Not Receive Study Drug|2
5859062|NCT02087904|20262047|P2|Overall Study|Did Not Receive Study Drug|0
5859063|NCT02087904|20262048|P1|Overall Study|Did Not Receive Study Drug|0
5859064|NCT02087774|20262164|P2|Overall Study|Were absent day of data collection|20
5859065|NCT02087774|20262165|P1|Overall Study|Were absent day of data collection|8
5859066|NCT02087670|20262185|P2|Overall Study|Withdrawal by Subject|2
5859067|NCT02087670|20262186|P1|Overall Study|Withdrawal by Subject|3
5859068|NCT02087423|20262222|P3|Overall Study|Terminated from study at final DCO|25
5859069|NCT02087423|20262223|P2|Overall Study|Terminated from study at final DCO|36
5859070|NCT02087423|20262224|P1|Overall Study|Terminated from study at final DCO|23
5859071|NCT02087423|20262222|P3|Overall Study|Lost to Follow-up|0
5859072|NCT02087423|20262223|P2|Overall Study|Lost to Follow-up|2
5859073|NCT02087423|20262224|P1|Overall Study|Lost to Follow-up|0
5859074|NCT02087423|20262222|P3|Overall Study|Death|40
5859075|NCT02087423|20262223|P2|Overall Study|Death|207
5859076|NCT02087423|20262224|P1|Overall Study|Death|68
5859077|NCT02087423|20262222|P3|Overall Study|Withdrawal by Subject|3
5859078|NCT02087423|20262223|P2|Overall Study|Withdrawal by Subject|20
5859079|NCT02087423|20262224|P1|Overall Study|Withdrawal by Subject|20
5859080|NCT02087241|20262253|P4|Overall Study|Study Terminated by Sponsor|4
5859081|NCT02087241|20262254|P3|Overall Study|Study Terminated by Sponsor|0
5859082|NCT02087241|20262255|P2|Overall Study|Study Terminated by Sponsor|2
5859083|NCT02087241|20262256|P1|Overall Study|Study Terminated by Sponsor|0
5859084|NCT02087241|20262253|P4|Overall Study|Progressive Disease|1
5859085|NCT02087241|20262254|P3|Overall Study|Progressive Disease|0
5859086|NCT02087241|20262255|P2|Overall Study|Progressive Disease|0
5859087|NCT02087241|20262256|P1|Overall Study|Progressive Disease|0
5859088|NCT02087241|20262253|P4|Overall Study|Withdrawal by Subject|1
5859089|NCT02087241|20262254|P3|Overall Study|Withdrawal by Subject|0
5859090|NCT02087241|20262255|P2|Overall Study|Withdrawal by Subject|0
5859091|NCT02087241|20262256|P1|Overall Study|Withdrawal by Subject|1
5859092|NCT02087241|20262253|P4|Overall Study|Death|1
5859093|NCT02087241|20262254|P3|Overall Study|Death|1
5859094|NCT02087241|20262255|P2|Overall Study|Death|1
5859095|NCT02087241|20262256|P1|Overall Study|Death|2
5859096|NCT02087176|20262282|P1|Overall Study|Study Terminated by Sponsor|2
5859097|NCT02087176|20262282|P1|Overall Study|Censored|19
5859098|NCT02087176|20262282|P1|Overall Study|Death|10
5859099|NCT02087176|20262282|P1|Overall Study|Withdrawal by Subject|1
5859100|NCT02087150|20262295|P3|Overall Study|Pt moved out of town|0
5859101|NCT02087150|20262296|P2|Overall Study|Pt moved out of town|1
5859102|NCT02087150|20262297|P1|Overall Study|Pt moved out of town|0
5859103|NCT02087150|20262295|P3|Overall Study|Other|0
5859104|NCT02087150|20262296|P2|Overall Study|Other|0
5859105|NCT02087150|20262297|P1|Overall Study|Other|1
5859106|NCT02087150|20262295|P3|Overall Study|F/U not completed w/in study window|1
5859107|NCT02087150|20262296|P2|Overall Study|F/U not completed w/in study window|0
5859108|NCT02087150|20262297|P1|Overall Study|F/U not completed w/in study window|0
5859109|NCT02087150|20262295|P3|Overall Study|Procedure not done|0
5859110|NCT02087150|20262296|P2|Overall Study|Procedure not done|13
5859111|NCT02087150|20262297|P1|Overall Study|Procedure not done|1
5859112|NCT02087150|20262295|P3|Overall Study|Physician Decision|0
5859113|NCT02087150|20262296|P2|Overall Study|Physician Decision|1
5859114|NCT02087150|20262297|P1|Overall Study|Physician Decision|0
5859115|NCT02087150|20262295|P3|Overall Study|Withdrawal by Subject|3
5859116|NCT02087150|20262296|P2|Overall Study|Withdrawal by Subject|5
5859117|NCT02087150|20262297|P1|Overall Study|Withdrawal by Subject|2
5859118|NCT02087150|20262295|P3|Overall Study|Lost to Follow-up|7
5859119|NCT02087150|20262296|P2|Overall Study|Lost to Follow-up|13
5859120|NCT02087150|20262297|P1|Overall Study|Lost to Follow-up|6
5859121|NCT02087150|20262295|P3|Overall Study|Death|0
5859122|NCT02087150|20262296|P2|Overall Study|Death|1
5859123|NCT02087150|20262297|P1|Overall Study|Death|0
5859124|NCT02087085|20262316|P2|Overall Study|Other Miscellaneous Reasons|4
5859125|NCT02087085|20262317|P1|Overall Study|Other Miscellaneous Reasons|3
5859126|NCT02087085|20262316|P2|Overall Study|Study Terminated by Sponsor|80
5859127|NCT02087085|20262317|P1|Overall Study|Study Terminated by Sponsor|87
5859128|NCT02087085|20262316|P2|Overall Study|Protocol Violation|0
5859129|NCT02087085|20262317|P1|Overall Study|Protocol Violation|1
5859130|NCT02087085|20262316|P2|Overall Study|Withdrawal by Subject|11
5859131|NCT02087085|20262317|P1|Overall Study|Withdrawal by Subject|9
5859132|NCT02087085|20262316|P2|Overall Study|Lost to Follow-up|4
5859133|NCT02087085|20262317|P1|Overall Study|Lost to Follow-up|6
5859134|NCT02087085|20262316|P2|Overall Study|Lack of Efficacy|3
5859135|NCT02087085|20262317|P1|Overall Study|Lack of Efficacy|4
5859136|NCT02087085|20262316|P2|Overall Study|Adverse Event|14
5859137|NCT02087085|20262317|P1|Overall Study|Adverse Event|10
5859138|NCT02087059|20262327|P1|Overall Study|Lost to Follow-up|1
5859139|NCT02087059|20262327|P1|Overall Study|Adverse Event|5
5859140|NCT02087059|20262327|P1|Overall Study|Disease Progression|1
5859141|NCT02086968|20262337|P2|Overall Study|Withdrawal by Subject|4
5859142|NCT02086968|20262338|P1|Overall Study|Withdrawal by Subject|1
5859143|NCT02086968|20262337|P2|Overall Study|Physician Decision|0
5859144|NCT02086968|20262338|P1|Overall Study|Physician Decision|4
5859145|NCT02086968|20262337|P2|Overall Study|Study drug received outside protocol|1
5859146|NCT02086968|20262338|P1|Overall Study|Study drug received outside protocol|0
5859147|NCT02086968|20262337|P2|Overall Study|Lost to Follow-up|3
5859148|NCT02086968|20262338|P1|Overall Study|Lost to Follow-up|2
5859149|NCT02086968|20262337|P2|Overall Study|Adverse Event|5
5859150|NCT02086968|20262338|P1|Overall Study|Adverse Event|1
5859151|NCT02086591|20262392|P1|Overall Study|protocol terminated|3
5859152|NCT02086591|20262392|P1|Overall Study|Withdrawal by Subject|1
5859153|NCT02086591|20262392|P1|Overall Study|Adverse Event|1
5859154|NCT02086565|20262400|P2|Overall Study|withdrawn by research team|2
5859155|NCT02086565|20262401|P1|Overall Study|withdrawn by research team|2
5859156|NCT02086565|20262400|P2|Overall Study|Death|2
5859157|NCT02086565|20262401|P1|Overall Study|Death|3
5859158|NCT02086565|20262400|P2|Overall Study|Withdrawal by Subject|1
5859159|NCT02086565|20262401|P1|Overall Study|Withdrawal by Subject|2
5859160|NCT02086565|20262400|P2|Overall Study|Lost to Follow-up|7
5859161|NCT02086565|20262401|P1|Overall Study|Lost to Follow-up|9
5859162|NCT02086552|20262415|P1|Overall Study|Withdrawal by Subject|1
5859163|NCT02086162|20262464|P2|Overall Study|Death|0
5859164|NCT02086162|20262465|P1|Overall Study|Death|1
5859165|NCT02086162|20262464|P2|Overall Study|Lost to Follow-up|2
5859166|NCT02086162|20262465|P1|Overall Study|Lost to Follow-up|4
5859167|NCT02086162|20262464|P2|Overall Study|moved|1
5859168|NCT02086162|20262465|P1|Overall Study|moved|1
5859169|NCT02086162|20262464|P2|Overall Study|Withdrawal by Subject|4
5859170|NCT02086162|20262465|P1|Overall Study|Withdrawal by Subject|4
5859171|NCT02086110|20262477|P2|Overall Study|Withdrawal by Subject|1
5859172|NCT02086110|20262478|P1|Overall Study|Withdrawal by Subject|1
5859173|NCT02085785|20262489|P2|Overall Study|Lost to Follow-up|1
5859174|NCT02085785|20262490|P1|Overall Study|Lost to Follow-up|0
5859175|NCT02085785|20262489|P2|Overall Study|Withdrawal by Subject|1
5859176|NCT02085785|20262490|P1|Overall Study|Withdrawal by Subject|2
5859177|NCT02085252|20262644|P2|Overall Study|Reason Unknown|1
5859178|NCT02085252|20262645|P1|Overall Study|Reason Unknown|0
5859179|NCT02085252|20262644|P2|Overall Study|Reason Not Specified|1
5859180|NCT02085252|20262645|P1|Overall Study|Reason Not Specified|0
5859181|NCT02085252|20262644|P2|Overall Study|Discontinuation Due to Patient Decision|1
5859182|NCT02085252|20262645|P1|Overall Study|Discontinuation Due to Patient Decision|0
5859183|NCT02085252|20262644|P2|Overall Study|Adverse Event|1
5859184|NCT02085252|20262645|P1|Overall Study|Adverse Event|0
5859185|NCT02085252|20262644|P2|Overall Study|Withdrawal of Consent|0
5859186|NCT02085252|20262645|P1|Overall Study|Withdrawal of Consent|1
5859187|NCT02085161|20262669|P4|Overall Study|Other Reason|1
5859188|NCT02085161|20262670|P3|Overall Study|Other Reason|1
5859189|NCT02085161|20262671|P2|Overall Study|Other Reason|0
5859190|NCT02085161|20262672|P1|Overall Study|Other Reason|1
5859191|NCT02085161|20262669|P4|Overall Study|Withdrawal by Subject|3
5859192|NCT02085161|20262670|P3|Overall Study|Withdrawal by Subject|0
5859193|NCT02085161|20262671|P2|Overall Study|Withdrawal by Subject|4
5859194|NCT02085161|20262672|P1|Overall Study|Withdrawal by Subject|2
5859195|NCT02085161|20262669|P4|Overall Study|Protocol Violation|1
5859196|NCT02085161|20262670|P3|Overall Study|Protocol Violation|0
5859197|NCT02085161|20262671|P2|Overall Study|Protocol Violation|1
5859198|NCT02085161|20262672|P1|Overall Study|Protocol Violation|0
5859199|NCT02085161|20262669|P4|Overall Study|Adverse Event|5
5859200|NCT02085161|20262670|P3|Overall Study|Adverse Event|4
5859201|NCT02085161|20262671|P2|Overall Study|Adverse Event|5
5859202|NCT02085161|20262672|P1|Overall Study|Adverse Event|8
5859203|NCT02085161|20262669|P4|Overall Study|Not Treated|0
5859204|NCT02085161|20262670|P3|Overall Study|Not Treated|0
5859205|NCT02085161|20262671|P2|Overall Study|Not Treated|0
5859206|NCT02085161|20262672|P1|Overall Study|Not Treated|1
5859207|NCT02085135|20262713|P2|Overall Study|Lack of Efficacy|0
5859208|NCT02085135|20262714|P1|Overall Study|Lack of Efficacy|2
5859209|NCT02085135|20262713|P2|Overall Study|Withdrawal by Subject|0
5859210|NCT02085135|20262714|P1|Overall Study|Withdrawal by Subject|3
5859211|NCT02085135|20262713|P2|Overall Study|Lost to Follow-up|2
5859212|NCT02085135|20262714|P1|Overall Study|Lost to Follow-up|2
5859213|NCT02085135|20262713|P2|Overall Study|Adverse Event|7
5859214|NCT02085135|20262714|P1|Overall Study|Adverse Event|4
5859215|NCT02084238|20262786|P1|Overall Study|Lost to Follow-up|2
5859216|NCT02084134|20262811|P2|Overall Study|Death|1
5859217|NCT02084134|20262812|P1|Overall Study|Death|0
5859218|NCT02084134|20262811|P2|Overall Study|Protocol Violation|2
5859219|NCT02084134|20262812|P1|Overall Study|Protocol Violation|4
5859220|NCT02084082|20262822|P4|Washout Period 1 (35 Days)|Withdrawal by Subject|1
5859221|NCT02084082|20262823|P3|Washout Period 1 (35 Days)|Withdrawal by Subject|0
5859222|NCT02084082|20262824|P2|Washout Period 1 (35 Days)|Withdrawal by Subject|0
5859223|NCT02084082|20262825|P1|Washout Period 1 (35 Days)|Withdrawal by Subject|0
5859224|NCT02084082|20262822|P4|Washout Period 1 (35 Days)|Adverse Event|1
5859225|NCT02084082|20262823|P3|Washout Period 1 (35 Days)|Adverse Event|1
5859226|NCT02084082|20262824|P2|Washout Period 1 (35 Days)|Adverse Event|0
5859227|NCT02084082|20262825|P1|Washout Period 1 (35 Days)|Adverse Event|0
5859228|NCT02084056|20262866|P4|Washout Period 1 (35 Days)|Withdrawal by Subject|0
5859229|NCT02084056|20262867|P3|Washout Period 1 (35 Days)|Withdrawal by Subject|0
5859230|NCT02084056|20262868|P2|Washout Period 1 (35 Days)|Withdrawal by Subject|0
5859231|NCT02084056|20262869|P1|Washout Period 1 (35 Days)|Withdrawal by Subject|1
5859232|NCT02084056|20262866|P4|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
5859233|NCT02084056|20262867|P3|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
5859234|NCT02084056|20262868|P2|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
5859235|NCT02084056|20262869|P1|Treatment Period 1 (4 Days)|Withdrawal by Subject|1
5859236|NCT02083965|20262901|P2|Treatment Period|Other|0
5859237|NCT02083965|20262902|P1|Treatment Period|Other|1
5859238|NCT02083783|20262984|P2|Overall Study|Withdrawal by Subject|0
5859239|NCT02083783|20262985|P1|Overall Study|Withdrawal by Subject|1
5859240|NCT02083653|20263017|P3|Overall Study|Reason Missing|4
5859241|NCT02083653|20263018|P2|Overall Study|Reason Missing|0
5859242|NCT02083653|20263019|P1|Overall Study|Reason Missing|0
5859243|NCT02083653|20263017|P3|Overall Study|Other Events|2
5859244|NCT02083653|20263018|P2|Overall Study|Other Events|2
5859245|NCT02083653|20263019|P1|Overall Study|Other Events|0
5859246|NCT02083653|20263017|P3|Overall Study|Withdrawal by Subject|2
5859247|NCT02083653|20263018|P2|Overall Study|Withdrawal by Subject|1
5859248|NCT02083653|20263019|P1|Overall Study|Withdrawal by Subject|2
5859249|NCT02083653|20263017|P3|Overall Study|Progressive Disease|63
5859250|NCT02083653|20263018|P2|Overall Study|Progressive Disease|73
5859251|NCT02083653|20263019|P1|Overall Study|Progressive Disease|65
5859252|NCT02083653|20263017|P3|Overall Study|Death|2
5859253|NCT02083653|20263018|P2|Overall Study|Death|2
5859254|NCT02083653|20263019|P1|Overall Study|Death|2
5859255|NCT02083653|20263017|P3|Overall Study|Lost to Follow-up|0
5859256|NCT02083653|20263018|P2|Overall Study|Lost to Follow-up|0
5859257|NCT02083653|20263019|P1|Overall Study|Lost to Follow-up|1
5859258|NCT02083653|20263017|P3|Overall Study|Adverse Event|4
5859259|NCT02083653|20263018|P2|Overall Study|Adverse Event|5
5859260|NCT02083653|20263019|P1|Overall Study|Adverse Event|12
5859261|NCT02083653|20263017|P3|Overall Study|Randomized but not Treated|7
5859262|NCT02083653|20263018|P2|Overall Study|Randomized but not Treated|2
5859263|NCT02083653|20263019|P1|Overall Study|Randomized but not Treated|0
5859264|NCT02083380|20263087|P3|Overall Study|Other|6
5859265|NCT02083380|20263088|P2|Overall Study|Other|4
5859266|NCT02083380|20263089|P1|Overall Study|Other|8
5859267|NCT02083380|20263087|P3|Overall Study|Lost to Follow-up|3
5859268|NCT02083380|20263088|P2|Overall Study|Lost to Follow-up|3
5859269|NCT02083380|20263089|P1|Overall Study|Lost to Follow-up|5
5859270|NCT02083380|20263087|P3|Overall Study|Adverse Event|1
5859271|NCT02083380|20263088|P2|Overall Study|Adverse Event|0
5859272|NCT02083380|20263089|P1|Overall Study|Adverse Event|0
5859273|NCT02083380|20263087|P3|Overall Study|Physician Decision|3
5859274|NCT02083380|20263088|P2|Overall Study|Physician Decision|6
5859275|NCT02083380|20263089|P1|Overall Study|Physician Decision|1
5859276|NCT02083380|20263087|P3|Overall Study|Withdrawal by Subject|7
5859277|NCT02083380|20263088|P2|Overall Study|Withdrawal by Subject|3
5859278|NCT02083380|20263089|P1|Overall Study|Withdrawal by Subject|9
5859279|NCT02083380|20263087|P3|Overall Study|Lack of Efficacy|64
5859280|NCT02083380|20263088|P2|Overall Study|Lack of Efficacy|79
5859281|NCT02083380|20263089|P1|Overall Study|Lack of Efficacy|68
5859282|NCT02083185|20263194|P3|Overall Study|Did not Receive Study Drug|0
5859283|NCT02083185|20263195|P2|Overall Study|Did not Receive Study Drug|2
5859284|NCT02083185|20263196|P1|Overall Study|Did not Receive Study Drug|0
5859285|NCT02083185|20263194|P3|Overall Study|Study Terminated by Sponsor|0
5859286|NCT02083185|20263195|P2|Overall Study|Study Terminated by Sponsor|1
5859287|NCT02083185|20263196|P1|Overall Study|Study Terminated by Sponsor|0
5859288|NCT02083185|20263194|P3|Overall Study|Reason not Specified|5
5859289|NCT02083185|20263195|P2|Overall Study|Reason not Specified|6
5859290|NCT02083185|20263196|P1|Overall Study|Reason not Specified|9
5859291|NCT02083185|20263194|P3|Overall Study|Death|1
5859292|NCT02083185|20263195|P2|Overall Study|Death|2
5859293|NCT02083185|20263196|P1|Overall Study|Death|2
5859294|NCT02083185|20263194|P3|Overall Study|Withdrawal by Subject|1
5859295|NCT02083185|20263195|P2|Overall Study|Withdrawal by Subject|15
5859296|NCT02083185|20263196|P1|Overall Study|Withdrawal by Subject|9
5859297|NCT02083185|20263194|P3|Overall Study|Lost to Follow-up|0
5859298|NCT02083185|20263195|P2|Overall Study|Lost to Follow-up|3
5859299|NCT02083185|20263196|P1|Overall Study|Lost to Follow-up|0
5859300|NCT02082977|20263301|P10|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
5859301|NCT02082977|20263302|P9|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
5859302|NCT02082977|20263303|P8|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|2
5859303|NCT02082977|20263304|P7|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
5859304|NCT02082977|20263305|P6|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
5859305|NCT02082977|20263306|P5|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
5859306|NCT02082977|20263307|P4|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
5859307|NCT02082977|20263308|P3|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
5859308|NCT02082977|20263309|P2|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
5859309|NCT02082977|20263310|P1|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
5859310|NCT02082977|20263301|P10|Part 1 (Up to 3.2 Years)|Physician Decision|0
5859311|NCT02082977|20263302|P9|Part 1 (Up to 3.2 Years)|Physician Decision|2
5859312|NCT02082977|20263303|P8|Part 1 (Up to 3.2 Years)|Physician Decision|1
5859313|NCT02082977|20263304|P7|Part 1 (Up to 3.2 Years)|Physician Decision|4
5859314|NCT02082977|20263305|P6|Part 1 (Up to 3.2 Years)|Physician Decision|1
5859315|NCT02082977|20263306|P5|Part 1 (Up to 3.2 Years)|Physician Decision|1
5859316|NCT02082977|20263307|P4|Part 1 (Up to 3.2 Years)|Physician Decision|0
5859317|NCT02082977|20263308|P3|Part 1 (Up to 3.2 Years)|Physician Decision|0
5859318|NCT02082977|20263309|P2|Part 1 (Up to 3.2 Years)|Physician Decision|0
5859319|NCT02082977|20263310|P1|Part 1 (Up to 3.2 Years)|Physician Decision|0
5859320|NCT02082977|20263301|P10|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
5859321|NCT02082977|20263302|P9|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
5859322|NCT02082977|20263303|P8|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
5859323|NCT02082977|20263304|P7|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
5859324|NCT02082977|20263305|P6|Part 1 (Up to 3.2 Years)|Lost to Follow-up|1
5859325|NCT02082977|20263306|P5|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
5859326|NCT02082977|20263307|P4|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
5859327|NCT02082977|20263308|P3|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
5859328|NCT02082977|20263309|P2|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
5859329|NCT02082977|20263310|P1|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
5859330|NCT02082977|20263301|P10|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
5859331|NCT02082977|20263302|P9|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
5859332|NCT02082977|20263303|P8|Part 1 (Up to 3.2 Years)|Study closed/terminated|2
5859333|NCT02082977|20263304|P7|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
5859334|NCT02082977|20263305|P6|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
5859335|NCT02082977|20263306|P5|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
5859336|NCT02082977|20263307|P4|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
5859337|NCT02082977|20263308|P3|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
5859338|NCT02082977|20263309|P2|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
5859339|NCT02082977|20263310|P1|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
5859340|NCT02082977|20263301|P10|Part 1 (Up to 3.2 Years)|Death|0
5859341|NCT02082977|20263302|P9|Part 1 (Up to 3.2 Years)|Death|1
5859342|NCT02082977|20263303|P8|Part 1 (Up to 3.2 Years)|Death|0
5859343|NCT02082977|20263304|P7|Part 1 (Up to 3.2 Years)|Death|2
5859344|NCT02082977|20263305|P6|Part 1 (Up to 3.2 Years)|Death|1
5859345|NCT02082977|20263306|P5|Part 1 (Up to 3.2 Years)|Death|0
5859346|NCT02082977|20263307|P4|Part 1 (Up to 3.2 Years)|Death|0
5859347|NCT02082977|20263308|P3|Part 1 (Up to 3.2 Years)|Death|0
5859348|NCT02082977|20263309|P2|Part 1 (Up to 3.2 Years)|Death|0
5859349|NCT02082977|20263310|P1|Part 1 (Up to 3.2 Years)|Death|1
5859350|NCT02082912|20263564|P2|Overall Study|Physician Decision|1
5859351|NCT02082912|20263565|P1|Overall Study|Physician Decision|0
5859352|NCT02082522|20263613|P2|Overall Study|Chemotherapy change|3
5859353|NCT02082522|20263614|P1|Overall Study|Chemotherapy change|1
5859354|NCT02082522|20263613|P2|Overall Study|Disease progression|2
5859355|NCT02082522|20263614|P1|Overall Study|Disease progression|2
5859356|NCT02082522|20263613|P2|Overall Study|Physician Decision|1
5859357|NCT02082522|20263614|P1|Overall Study|Physician Decision|3
5859358|NCT02082522|20263613|P2|Overall Study|Lost to Follow-up|0
5859359|NCT02082522|20263614|P1|Overall Study|Lost to Follow-up|1
5859360|NCT02082522|20263613|P2|Overall Study|Death|0
5859361|NCT02082522|20263614|P1|Overall Study|Death|1
5859362|NCT02082522|20263613|P2|Overall Study|Withdrawal by Subject|4
5859363|NCT02082522|20263614|P1|Overall Study|Withdrawal by Subject|2
5859364|NCT02082522|20263613|P2|Overall Study|Sponsor termination|3
5859365|NCT02082522|20263614|P1|Overall Study|Sponsor termination|5
5859366|NCT02082483|20263664|P2|Overall Study|Death|3
5859367|NCT02082483|20263665|P1|Overall Study|Death|2
5859368|NCT02082483|20263664|P2|Overall Study|Physician Decision|1
5859369|NCT02082483|20263665|P1|Overall Study|Physician Decision|1
5859370|NCT02082483|20263664|P2|Overall Study|Withdrawal by Subject|1
5859371|NCT02082483|20263665|P1|Overall Study|Withdrawal by Subject|2
5859372|NCT02082483|20263664|P2|Overall Study|Lost to Follow-up|1
5859373|NCT02082483|20263665|P1|Overall Study|Lost to Follow-up|1
5859374|NCT02082340|20263717|P2|Overall Study|Lost to Follow-up|1
5859375|NCT02082340|20263718|P1|Overall Study|Lost to Follow-up|1
5859376|NCT02082262|20263728|P1|Overall Study|Adverse Event|48
5859377|NCT02082262|20263728|P1|Overall Study|Withdrawal by Subject|3
5859378|NCT02082210|20263738|P6|Overall Study|Physician Decision|0
5859379|NCT02082210|20263739|P5|Overall Study|Physician Decision|0
5859380|NCT02082210|20263740|P4|Overall Study|Physician Decision|1
5859381|NCT02082210|20263741|P3|Overall Study|Physician Decision|1
5859382|NCT02082210|20263742|P2|Overall Study|Physician Decision|0
5859383|NCT02082210|20263743|P1|Overall Study|Physician Decision|0
5859384|NCT02082210|20263738|P6|Overall Study|No Post-Baseline Tumor Assesment|0
5859385|NCT02082210|20263739|P5|Overall Study|No Post-Baseline Tumor Assesment|0
5859386|NCT02082210|20263740|P4|Overall Study|No Post-Baseline Tumor Assesment|2
5859387|NCT02082210|20263741|P3|Overall Study|No Post-Baseline Tumor Assesment|1
5859388|NCT02082210|20263742|P2|Overall Study|No Post-Baseline Tumor Assesment|0
5859389|NCT02082210|20263743|P1|Overall Study|No Post-Baseline Tumor Assesment|0
5859390|NCT02082210|20263738|P6|Overall Study|Clinical Progression|0
5859391|NCT02082210|20263739|P5|Overall Study|Clinical Progression|0
5859392|NCT02082210|20263740|P4|Overall Study|Clinical Progression|1
5859393|NCT02082210|20263741|P3|Overall Study|Clinical Progression|0
5859394|NCT02082210|20263742|P2|Overall Study|Clinical Progression|0
5859395|NCT02082210|20263743|P1|Overall Study|Clinical Progression|0
5859396|NCT02082210|20263738|P6|Overall Study|Withdrawal by Subject|2
5859397|NCT02082210|20263739|P5|Overall Study|Withdrawal by Subject|2
5859398|NCT02082210|20263740|P4|Overall Study|Withdrawal by Subject|1
5859399|NCT02082210|20263741|P3|Overall Study|Withdrawal by Subject|0
5859400|NCT02082210|20263742|P2|Overall Study|Withdrawal by Subject|0
5859401|NCT02082210|20263743|P1|Overall Study|Withdrawal by Subject|0
5859402|NCT02082210|20263738|P6|Overall Study|Death|0
5859403|NCT02082210|20263739|P5|Overall Study|Death|1
5859404|NCT02082210|20263740|P4|Overall Study|Death|1
5859405|NCT02082210|20263741|P3|Overall Study|Death|1
5859406|NCT02082210|20263742|P2|Overall Study|Death|0
5859407|NCT02082210|20263743|P1|Overall Study|Death|0
5859408|NCT02082184|20263791|P2|Overall Study|Subject non-compliance|1
5859409|NCT02082184|20263792|P1|Overall Study|Subject non-compliance|0
5859410|NCT02082184|20263791|P2|Overall Study|Lost to Follow-up|2
5859411|NCT02082184|20263792|P1|Overall Study|Lost to Follow-up|0
5859412|NCT02082184|20263791|P2|Overall Study|Protocol Violation|6
5859413|NCT02082184|20263792|P1|Overall Study|Protocol Violation|0
5859414|NCT02082184|20263791|P2|Overall Study|Withdrawal by Subject|2
5859415|NCT02082184|20263792|P1|Overall Study|Withdrawal by Subject|3
5859416|NCT02082184|20263791|P2|Overall Study|Device associated symptoms|0
5859417|NCT02082184|20263792|P1|Overall Study|Device associated symptoms|5
5859418|NCT02082184|20263791|P2|Overall Study|Medical diagnosis|2
5859419|NCT02082184|20263792|P1|Overall Study|Medical diagnosis|1
5859420|NCT02082184|20263791|P2|Overall Study|Adverse Event|0
5859421|NCT02082184|20263792|P1|Overall Study|Adverse Event|1
5859422|NCT02082158|20263817|P6|Overall Study|Failed Fit-testing|7
5859423|NCT02082158|20263818|P5|Overall Study|Failed Fit-testing|3
5859424|NCT02082158|20263819|P4|Overall Study|Failed Fit-testing|4
5859425|NCT02082158|20263820|P3|Overall Study|Failed Fit-testing|14
5859426|NCT02082158|20263821|P2|Overall Study|Failed Fit-testing|8
5859427|NCT02082158|20263822|P1|Overall Study|Failed Fit-testing|8
5859428|NCT02082158|20263817|P6|Overall Study|Withdrawal by Subject|0
5859429|NCT02082158|20263818|P5|Overall Study|Withdrawal by Subject|1
5859430|NCT02082158|20263819|P4|Overall Study|Withdrawal by Subject|0
5859431|NCT02082158|20263820|P3|Overall Study|Withdrawal by Subject|0
5859432|NCT02082158|20263821|P2|Overall Study|Withdrawal by Subject|0
5859433|NCT02082158|20263822|P1|Overall Study|Withdrawal by Subject|0
5859434|NCT02081859|20263952|P2|Overall Study|Other reasons|0
5859435|NCT02081859|20263953|P1|Overall Study|Other reasons|2
5859436|NCT02081859|20263952|P2|Overall Study|< 4 embryos|23
5859437|NCT02081859|20263953|P1|Overall Study|< 4 embryos|27
5859438|NCT02081859|20263952|P2|Overall Study|Unanticipated freeze all cycle|6
5859439|NCT02081859|20263953|P1|Overall Study|Unanticipated freeze all cycle|2
5859440|NCT02081859|20263952|P2|Overall Study|No sperm|0
5859441|NCT02081859|20263953|P1|Overall Study|No sperm|1
5859442|NCT02081859|20263952|P2|Overall Study|No fertilization|2
5859443|NCT02081859|20263953|P1|Overall Study|No fertilization|2
5859444|NCT02081846|20263963|P2|Overall Study|invalid consent|0
5859445|NCT02081846|20263964|P1|Overall Study|invalid consent|1
5859446|NCT02081846|20263963|P2|Overall Study|Withdrawal by Subject|0
5859447|NCT02081846|20263964|P1|Overall Study|Withdrawal by Subject|1
5859448|NCT02081690|20264133|P1|Overall Study|Withdrawal by Subject|1
5859449|NCT02081690|20264133|P1|Overall Study|Physician Decision|3
5859450|NCT02081690|20264133|P1|Overall Study|Death|3
5859451|NCT02081677|20264144|P4|Overall Study|Unsatisfactory Lens Fitting|0
5859452|NCT02081677|20264145|P3|Overall Study|Unsatisfactory Lens Fitting|0
5859453|NCT02081677|20264146|P2|Overall Study|Unsatisfactory Lens Fitting|1
5859454|NCT02081677|20264147|P1|Overall Study|Unsatisfactory Lens Fitting|0
5859455|NCT02081677|20264144|P4|Overall Study|Not comfortable with lens care system|0
5859456|NCT02081677|20264145|P3|Overall Study|Not comfortable with lens care system|0
5859457|NCT02081677|20264146|P2|Overall Study|Not comfortable with lens care system|0
5859458|NCT02081677|20264147|P1|Overall Study|Not comfortable with lens care system|1
5859459|NCT02081677|20264144|P4|Overall Study|No Longer Meets Eligibility Criteria|0
5859460|NCT02081677|20264145|P3|Overall Study|No Longer Meets Eligibility Criteria|1
5859461|NCT02081677|20264146|P2|Overall Study|No Longer Meets Eligibility Criteria|0
5859462|NCT02081677|20264147|P1|Overall Study|No Longer Meets Eligibility Criteria|0
5859463|NCT02081677|20264144|P4|Overall Study|Adverse Event|0
5859464|NCT02081677|20264145|P3|Overall Study|Adverse Event|1
5859465|NCT02081677|20264146|P2|Overall Study|Adverse Event|0
5859466|NCT02081677|20264147|P1|Overall Study|Adverse Event|0
5859467|NCT02081599|20264252|P2|Period 2：Open-label Period|Withdrawal by Subject|0
5859468|NCT02081599|20264253|P1|Period 2：Open-label Period|Withdrawal by Subject|2
5859469|NCT02081599|20264252|P2|Period 2：Open-label Period|Physician Decision|0
5859470|NCT02081599|20264253|P1|Period 2：Open-label Period|Physician Decision|1
5859471|NCT02081599|20264252|P2|Period 2：Open-label Period|Lack of Efficacy|4
5859472|NCT02081599|20264253|P1|Period 2：Open-label Period|Lack of Efficacy|2
5859473|NCT02081599|20264252|P2|Period 2：Open-label Period|Adverse Event|0
5859474|NCT02081599|20264253|P1|Period 2：Open-label Period|Adverse Event|1
5859475|NCT02081599|20264252|P2|Period 1：Double-blind Period|stopping criteria|0
5859476|NCT02081599|20264253|P1|Period 1：Double-blind Period|stopping criteria|1
5859477|NCT02081599|20264252|P2|Period 1：Double-blind Period|Withdrawal by Subject|0
5859478|NCT02081599|20264253|P1|Period 1：Double-blind Period|Withdrawal by Subject|1
5859479|NCT02081599|20264252|P2|Period 1：Double-blind Period|Protocol Violation|1
5859480|NCT02081599|20264253|P1|Period 1：Double-blind Period|Protocol Violation|0
5859481|NCT02081599|20264252|P2|Period 1：Double-blind Period|Physician Decision|0
5859482|NCT02081599|20264253|P1|Period 1：Double-blind Period|Physician Decision|1
5859483|NCT02081599|20264252|P2|Period 1：Double-blind Period|Lack of Efficacy|1
5859484|NCT02081599|20264253|P1|Period 1：Double-blind Period|Lack of Efficacy|2
5859485|NCT02081599|20264252|P2|Period 1：Double-blind Period|Adverse Event|0
5859486|NCT02081599|20264253|P1|Period 1：Double-blind Period|Adverse Event|3
5859487|NCT02081586|20264271|P4|Overall Study|Head injury not related to study|0
5859488|NCT02081586|20264272|P3|Overall Study|Head injury not related to study|1
5859489|NCT02081586|20264273|P2|Overall Study|Head injury not related to study|0
5859490|NCT02081586|20264274|P1|Overall Study|Head injury not related to study|0
5859491|NCT02081586|20264271|P4|Overall Study|Lost to Follow-up|1
5859492|NCT02081586|20264272|P3|Overall Study|Lost to Follow-up|0
5859493|NCT02081586|20264273|P2|Overall Study|Lost to Follow-up|1
5859494|NCT02081586|20264274|P1|Overall Study|Lost to Follow-up|0
5859495|NCT02081534|20264317|P7|Overall Study|Lost to Follow-up|0
5859496|NCT02081534|20264318|P6|Overall Study|Lost to Follow-up|1
5859497|NCT02081534|20264319|P5|Overall Study|Lost to Follow-up|1
5859498|NCT02081534|20264320|P4|Overall Study|Lost to Follow-up|2
5859499|NCT02081534|20264321|P3|Overall Study|Lost to Follow-up|0
5859500|NCT02081534|20264322|P2|Overall Study|Lost to Follow-up|0
5859501|NCT02081534|20264323|P1|Overall Study|Lost to Follow-up|0
5859502|NCT02081534|20264317|P7|Overall Study|Protocol Violation|1
5859503|NCT02081534|20264318|P6|Overall Study|Protocol Violation|0
5859504|NCT02081534|20264319|P5|Overall Study|Protocol Violation|0
5859505|NCT02081534|20264320|P4|Overall Study|Protocol Violation|0
5859506|NCT02081534|20264321|P3|Overall Study|Protocol Violation|0
5859507|NCT02081534|20264322|P2|Overall Study|Protocol Violation|3
5859508|NCT02081534|20264323|P1|Overall Study|Protocol Violation|0
5859509|NCT02081534|20264317|P7|Overall Study|Withdrawal by Subject|1
5859510|NCT02081534|20264318|P6|Overall Study|Withdrawal by Subject|0
5859511|NCT02081534|20264319|P5|Overall Study|Withdrawal by Subject|1
5859512|NCT02081534|20264320|P4|Overall Study|Withdrawal by Subject|1
5859513|NCT02081534|20264321|P3|Overall Study|Withdrawal by Subject|1
5859514|NCT02081534|20264322|P2|Overall Study|Withdrawal by Subject|1
5859515|NCT02081534|20264323|P1|Overall Study|Withdrawal by Subject|0
5859516|NCT02081534|20264317|P7|Overall Study|Adverse Event|2
5859517|NCT02081534|20264318|P6|Overall Study|Adverse Event|8
5859518|NCT02081534|20264319|P5|Overall Study|Adverse Event|2
5859519|NCT02081534|20264320|P4|Overall Study|Adverse Event|10
5859520|NCT02081534|20264321|P3|Overall Study|Adverse Event|3
5859521|NCT02081534|20264322|P2|Overall Study|Adverse Event|4
5859522|NCT02081534|20264323|P1|Overall Study|Adverse Event|5
5859523|NCT02081417|20264376|P2|Overall Study|Did not start treatment|21
5859524|NCT02081417|20264377|P1|Overall Study|Did not start treatment|17
5859525|NCT02081417|20264376|P2|Overall Study|Admitted to Residential Treatment|0
5859526|NCT02081417|20264377|P1|Overall Study|Admitted to Residential Treatment|2
5859527|NCT02081417|20264376|P2|Overall Study|Withdrawal by Subject|0
5859528|NCT02081417|20264377|P1|Overall Study|Withdrawal by Subject|4
5859529|NCT02081417|20264376|P2|Overall Study|Death|3
5859530|NCT02081417|20264377|P1|Overall Study|Death|4
5859531|NCT02081417|20264376|P2|Overall Study|Incarcerated|2
5859532|NCT02081417|20264377|P1|Overall Study|Incarcerated|2
5859533|NCT02081417|20264376|P2|Overall Study|Moved Away|2
5859534|NCT02081417|20264377|P1|Overall Study|Moved Away|1
5859535|NCT02081417|20264376|P2|Overall Study|Lost to Follow-up|23
5859536|NCT02081417|20264377|P1|Overall Study|Lost to Follow-up|26
5859537|NCT02081391|20264397|P4|24-hour Treatment and Trial Completion|Further reasons|0
5859538|NCT02081391|20264398|P3|24-hour Treatment and Trial Completion|Further reasons|0
5859539|NCT02081391|20264399|P2|24-hour Treatment and Trial Completion|Further reasons|4
5859540|NCT02081391|20264400|P1|24-hour Treatment and Trial Completion|Further reasons|3
5859541|NCT02081391|20264397|P4|24-hour Treatment and Trial Completion|Technical Problems|0
5859542|NCT02081391|20264398|P3|24-hour Treatment and Trial Completion|Technical Problems|0
5859543|NCT02081391|20264399|P2|24-hour Treatment and Trial Completion|Technical Problems|1
5859544|NCT02081391|20264400|P1|24-hour Treatment and Trial Completion|Technical Problems|1
5859545|NCT02081391|20264397|P4|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|0
5859546|NCT02081391|20264398|P3|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|1
5859547|NCT02081391|20264399|P2|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|5
5859548|NCT02081391|20264400|P1|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|11
5859549|NCT02081391|20264397|P4|24-hour Treatment and Trial Completion|Adverse Event|0
5859550|NCT02081391|20264398|P3|24-hour Treatment and Trial Completion|Adverse Event|0
5859638|NCT02079909|20265050|P3|Overall Study|Lost to Follow-up|1
5859551|NCT02081391|20264399|P2|24-hour Treatment and Trial Completion|Adverse Event|0
5859552|NCT02081391|20264400|P1|24-hour Treatment and Trial Completion|Adverse Event|1
5859553|NCT02081391|20264397|P4|24-hour Treatment and Trial Completion|Lack of Efficacy|0
5859554|NCT02081391|20264398|P3|24-hour Treatment and Trial Completion|Lack of Efficacy|0
5859555|NCT02081391|20264399|P2|24-hour Treatment and Trial Completion|Lack of Efficacy|3
5859556|NCT02081391|20264400|P1|24-hour Treatment and Trial Completion|Lack of Efficacy|1
5859557|NCT02081391|20264397|P4|24-hour Treatment and Trial Completion|Physician Decision|0
5859558|NCT02081391|20264398|P3|24-hour Treatment and Trial Completion|Physician Decision|0
5859559|NCT02081391|20264399|P2|24-hour Treatment and Trial Completion|Physician Decision|5
5859560|NCT02081391|20264400|P1|24-hour Treatment and Trial Completion|Physician Decision|10
5859561|NCT02081391|20264397|P4|12-hour Treatment|Further reasons|0
5859562|NCT02081391|20264398|P3|12-hour Treatment|Further reasons|0
5859563|NCT02081391|20264399|P2|12-hour Treatment|Further reasons|1
5859564|NCT02081391|20264400|P1|12-hour Treatment|Further reasons|2
5859565|NCT02081391|20264397|P4|12-hour Treatment|Recovery (opioid no longer needed)|0
5859566|NCT02081391|20264398|P3|12-hour Treatment|Recovery (opioid no longer needed)|1
5859567|NCT02081391|20264399|P2|12-hour Treatment|Recovery (opioid no longer needed)|0
5859568|NCT02081391|20264400|P1|12-hour Treatment|Recovery (opioid no longer needed)|2
5859569|NCT02081391|20264397|P4|12-hour Treatment|Adverse Event|0
5859570|NCT02081391|20264398|P3|12-hour Treatment|Adverse Event|0
5859571|NCT02081391|20264399|P2|12-hour Treatment|Adverse Event|2
5859572|NCT02081391|20264400|P1|12-hour Treatment|Adverse Event|4
5859573|NCT02081391|20264397|P4|12-hour Treatment|Lack of Efficacy|0
5859574|NCT02081391|20264398|P3|12-hour Treatment|Lack of Efficacy|0
5859575|NCT02081391|20264399|P2|12-hour Treatment|Lack of Efficacy|0
5859576|NCT02081391|20264400|P1|12-hour Treatment|Lack of Efficacy|3
5859577|NCT02081391|20264397|P4|12-hour Treatment|Physician Decision|0
5859578|NCT02081391|20264398|P3|12-hour Treatment|Physician Decision|0
5859579|NCT02081391|20264399|P2|12-hour Treatment|Physician Decision|1
5859580|NCT02081391|20264400|P1|12-hour Treatment|Physician Decision|4
5859581|NCT02081391|20264397|P4|12-hour Treatment|Withdrawal by Subject|0
5859582|NCT02081391|20264398|P3|12-hour Treatment|Withdrawal by Subject|0
5859583|NCT02081391|20264399|P2|12-hour Treatment|Withdrawal by Subject|2
5859584|NCT02081391|20264400|P1|12-hour Treatment|Withdrawal by Subject|3
5859585|NCT02081183|20264494|P2|Overall Study|Other|3
5859586|NCT02081183|20264495|P1|Overall Study|Other|3
5859587|NCT02081183|20264494|P2|Overall Study|Protocol Violation|0
5859588|NCT02081183|20264495|P1|Overall Study|Protocol Violation|1
5859589|NCT02081183|20264494|P2|Overall Study|Lost to Follow-up|1
5859590|NCT02081183|20264495|P1|Overall Study|Lost to Follow-up|0
5859591|NCT02081079|20264511|P2|Overall Study|Lost to Follow-up|0
5859592|NCT02081079|20264512|P1|Overall Study|Lost to Follow-up|1
5859593|NCT02081079|20264511|P2|Overall Study|Lack of Efficacy|2
5859594|NCT02081079|20264512|P1|Overall Study|Lack of Efficacy|3
5859595|NCT02081001|20264585|P12|Overall Study|Adverse Event|0
5859596|NCT02081001|20264586|P11|Overall Study|Adverse Event|0
5859597|NCT02081001|20264587|P10|Overall Study|Adverse Event|0
5859598|NCT02081001|20264588|P9|Overall Study|Adverse Event|0
5859599|NCT02081001|20264589|P8|Overall Study|Adverse Event|0
5859600|NCT02081001|20264590|P7|Overall Study|Adverse Event|0
5859601|NCT02081001|20264591|P6|Overall Study|Adverse Event|0
5859602|NCT02081001|20264592|P5|Overall Study|Adverse Event|1
5859603|NCT02081001|20264593|P4|Overall Study|Adverse Event|0
5859604|NCT02081001|20264594|P3|Overall Study|Adverse Event|0
5859605|NCT02081001|20264595|P2|Overall Study|Adverse Event|0
5859606|NCT02081001|20264596|P1|Overall Study|Adverse Event|0
5859607|NCT02080871|20264660|P1|Overall Study|Lost to Follow-up|1
5859608|NCT02080871|20264660|P1|Overall Study|Death|1
5859609|NCT02080832|20264744|P3|Overall Study|Lost to Follow-up|2
5859610|NCT02080832|20264745|P2|Overall Study|Lost to Follow-up|2
5859611|NCT02080832|20264746|P1|Overall Study|Lost to Follow-up|0
5859612|NCT02080832|20264744|P3|Overall Study|Excluded from analysis by MRI|14
5859613|NCT02080832|20264745|P2|Overall Study|Excluded from analysis by MRI|10
5859614|NCT02080832|20264746|P1|Overall Study|Excluded from analysis by MRI|9
5859615|NCT02080481|20264818|P2|Overall Study|Never received a block.|0
5859616|NCT02080481|20264819|P1|Overall Study|Never received a block.|1
5859617|NCT02080260|20265005|P1|Overall Study|Withdrawal by Subject|1
5859618|NCT02080260|20265005|P1|Overall Study|Death|18
5859619|NCT02080091|20265022|P1|Overall Study|Other|1
5859620|NCT02080091|20265022|P1|Overall Study|Withdrawal by Subject|1
5859621|NCT02080091|20265022|P1|Overall Study|Death|1
5859622|NCT02080091|20265022|P1|Overall Study|Study Terminated|22
5859623|NCT02079909|20265050|P3|Overall Study|Relocation etc.|3
5859624|NCT02079909|20265051|P2|Overall Study|Relocation etc.|2
5859625|NCT02079909|20265052|P1|Overall Study|Relocation etc.|2
5859626|NCT02079909|20265050|P3|Overall Study|Physician Decision|1
5859627|NCT02079909|20265051|P2|Overall Study|Physician Decision|1
5859628|NCT02079909|20265052|P1|Overall Study|Physician Decision|0
5859629|NCT02079909|20265050|P3|Overall Study|Protocol Violation|1
5859630|NCT02079909|20265051|P2|Overall Study|Protocol Violation|1
5859631|NCT02079909|20265052|P1|Overall Study|Protocol Violation|0
5859632|NCT02079909|20265050|P3|Overall Study|Lack of Efficacy|1
5859633|NCT02079909|20265051|P2|Overall Study|Lack of Efficacy|0
5859634|NCT02079909|20265052|P1|Overall Study|Lack of Efficacy|0
5859635|NCT02079909|20265050|P3|Overall Study|Death|0
5859636|NCT02079909|20265051|P2|Overall Study|Death|2
5859637|NCT02079909|20265052|P1|Overall Study|Death|2
5859639|NCT02079909|20265051|P2|Overall Study|Lost to Follow-up|3
5859640|NCT02079909|20265052|P1|Overall Study|Lost to Follow-up|2
5859641|NCT02079909|20265050|P3|Overall Study|Withdrawal by Subject|4
5859642|NCT02079909|20265051|P2|Overall Study|Withdrawal by Subject|17
5859643|NCT02079909|20265052|P1|Overall Study|Withdrawal by Subject|9
5859644|NCT02079909|20265050|P3|Overall Study|Adverse Event|7
5859645|NCT02079909|20265051|P2|Overall Study|Adverse Event|23
5859646|NCT02079909|20265052|P1|Overall Study|Adverse Event|23
5859647|NCT02079844|20265069|P3|Treatment Period 2|Voluntary Withdrawal|0
5859648|NCT02079844|20265070|P2|Treatment Period 2|Voluntary Withdrawal|1
5859649|NCT02079844|20265071|P1|Treatment Period 2|Voluntary Withdrawal|0
5859650|NCT02079844|20265069|P3|Treatment Period 1|Voluntary Withdrawal|2
5859651|NCT02079844|20265070|P2|Treatment Period 1|Voluntary Withdrawal|0
5859652|NCT02079844|20265071|P1|Treatment Period 1|Voluntary Withdrawal|0
5859653|NCT02079805|20265129|P2|Overall Study|Voluntary Withdrawal|1
5859654|NCT02079805|20265130|P1|Overall Study|Voluntary Withdrawal|0
5859655|NCT02079805|20265129|P2|Overall Study|Pretreatment Event/Adverse Event|1
5859656|NCT02079805|20265130|P1|Overall Study|Pretreatment Event/Adverse Event|0
5859657|NCT02079766|20265150|P2|Overall Study|Withdrawal by Subject|0
5859658|NCT02079766|20265151|P1|Overall Study|Withdrawal by Subject|1
5859659|NCT02079766|20265150|P2|Overall Study|Physician Decision|0
5859660|NCT02079766|20265151|P1|Overall Study|Physician Decision|1
5859661|NCT02079649|20265162|P4|Overall Study|Randomization error (prior to treatment)|0
5859662|NCT02079649|20265163|P3|Overall Study|Randomization error (prior to treatment)|1
5859663|NCT02079649|20265164|P2|Overall Study|Randomization error (prior to treatment)|0
5859664|NCT02079649|20265165|P1|Overall Study|Randomization error (prior to treatment)|1
5859665|NCT02079649|20265162|P4|Overall Study|Withdrawal by Subject|1
5859666|NCT02079649|20265163|P3|Overall Study|Withdrawal by Subject|0
5859667|NCT02079649|20265164|P2|Overall Study|Withdrawal by Subject|0
5859668|NCT02079649|20265165|P1|Overall Study|Withdrawal by Subject|0
5859669|NCT02079649|20265162|P4|Overall Study|Lost to Follow-up|1
5859670|NCT02079649|20265163|P3|Overall Study|Lost to Follow-up|0
5859671|NCT02079649|20265164|P2|Overall Study|Lost to Follow-up|0
5859672|NCT02079649|20265165|P1|Overall Study|Lost to Follow-up|0
5859673|NCT02079636|20265195|P15|Overall Study|Lost to Follow-up|0
5859674|NCT02079636|20265196|P14|Overall Study|Lost to Follow-up|0
5859675|NCT02079636|20265197|P13|Overall Study|Lost to Follow-up|0
5859676|NCT02079636|20265198|P12|Overall Study|Lost to Follow-up|0
5859677|NCT02079636|20265199|P11|Overall Study|Lost to Follow-up|0
5859678|NCT02079636|20265200|P10|Overall Study|Lost to Follow-up|0
5859679|NCT02079636|20265201|P9|Overall Study|Lost to Follow-up|0
5859680|NCT02079636|20265202|P8|Overall Study|Lost to Follow-up|1
5859681|NCT02079636|20265203|P7|Overall Study|Lost to Follow-up|0
5859682|NCT02079636|20265204|P6|Overall Study|Lost to Follow-up|0
5859683|NCT02079636|20265205|P5|Overall Study|Lost to Follow-up|0
5859684|NCT02079636|20265206|P4|Overall Study|Lost to Follow-up|0
5859685|NCT02079636|20265207|P3|Overall Study|Lost to Follow-up|0
5859686|NCT02079636|20265208|P2|Overall Study|Lost to Follow-up|0
5859687|NCT02079636|20265209|P1|Overall Study|Lost to Follow-up|0
5859688|NCT02079636|20265195|P15|Overall Study|Physician Decision|1
5859689|NCT02079636|20265196|P14|Overall Study|Physician Decision|0
5859690|NCT02079636|20265197|P13|Overall Study|Physician Decision|0
5859691|NCT02079636|20265198|P12|Overall Study|Physician Decision|0
5859692|NCT02079636|20265199|P11|Overall Study|Physician Decision|1
5859693|NCT02079636|20265200|P10|Overall Study|Physician Decision|1
5859694|NCT02079636|20265201|P9|Overall Study|Physician Decision|0
5859695|NCT02079636|20265202|P8|Overall Study|Physician Decision|0
5859696|NCT02079636|20265203|P7|Overall Study|Physician Decision|0
5859697|NCT02079636|20265204|P6|Overall Study|Physician Decision|1
5859698|NCT02079636|20265205|P5|Overall Study|Physician Decision|0
5859699|NCT02079636|20265206|P4|Overall Study|Physician Decision|0
5859700|NCT02079636|20265207|P3|Overall Study|Physician Decision|0
5859701|NCT02079636|20265208|P2|Overall Study|Physician Decision|0
5859702|NCT02079636|20265209|P1|Overall Study|Physician Decision|0
5859703|NCT02079636|20265195|P15|Overall Study|Withdrawal by Subject|2
5859704|NCT02079636|20265196|P14|Overall Study|Withdrawal by Subject|0
5859705|NCT02079636|20265197|P13|Overall Study|Withdrawal by Subject|1
5859706|NCT02079636|20265198|P12|Overall Study|Withdrawal by Subject|1
5859707|NCT02079636|20265199|P11|Overall Study|Withdrawal by Subject|1
5859708|NCT02079636|20265200|P10|Overall Study|Withdrawal by Subject|2
5859709|NCT02079636|20265201|P9|Overall Study|Withdrawal by Subject|0
5859710|NCT02079636|20265202|P8|Overall Study|Withdrawal by Subject|0
5859711|NCT02079636|20265203|P7|Overall Study|Withdrawal by Subject|0
5859712|NCT02079636|20265204|P6|Overall Study|Withdrawal by Subject|1
5859713|NCT02079636|20265205|P5|Overall Study|Withdrawal by Subject|0
5859714|NCT02079636|20265206|P4|Overall Study|Withdrawal by Subject|4
5859715|NCT02079636|20265207|P3|Overall Study|Withdrawal by Subject|0
5859716|NCT02079636|20265208|P2|Overall Study|Withdrawal by Subject|0
5859717|NCT02079636|20265209|P1|Overall Study|Withdrawal by Subject|0
5859718|NCT02079636|20265195|P15|Overall Study|Progressive disease|0
5859719|NCT02079636|20265196|P14|Overall Study|Progressive disease|0
5859720|NCT02079636|20265197|P13|Overall Study|Progressive disease|1
5859721|NCT02079636|20265198|P12|Overall Study|Progressive disease|0
5859722|NCT02079636|20265199|P11|Overall Study|Progressive disease|0
5859723|NCT02079636|20265200|P10|Overall Study|Progressive disease|0
5859724|NCT02079636|20265201|P9|Overall Study|Progressive disease|0
5859725|NCT02079636|20265202|P8|Overall Study|Progressive disease|0
5859726|NCT02079636|20265203|P7|Overall Study|Progressive disease|0
5859727|NCT02079636|20265204|P6|Overall Study|Progressive disease|0
5859728|NCT02079636|20265205|P5|Overall Study|Progressive disease|0
5859729|NCT02079636|20265206|P4|Overall Study|Progressive disease|2
5859730|NCT02079636|20265207|P3|Overall Study|Progressive disease|0
5859731|NCT02079636|20265208|P2|Overall Study|Progressive disease|0
5859732|NCT02079636|20265209|P1|Overall Study|Progressive disease|0
5859733|NCT02079636|20265195|P15|Overall Study|Adverse Event|0
5859734|NCT02079636|20265196|P14|Overall Study|Adverse Event|0
5859735|NCT02079636|20265197|P13|Overall Study|Adverse Event|0
5859736|NCT02079636|20265198|P12|Overall Study|Adverse Event|0
5859737|NCT02079636|20265199|P11|Overall Study|Adverse Event|0
5859738|NCT02079636|20265200|P10|Overall Study|Adverse Event|0
5859739|NCT02079636|20265201|P9|Overall Study|Adverse Event|0
5859740|NCT02079636|20265202|P8|Overall Study|Adverse Event|0
5859741|NCT02079636|20265203|P7|Overall Study|Adverse Event|0
5859742|NCT02079636|20265204|P6|Overall Study|Adverse Event|2
5859743|NCT02079636|20265205|P5|Overall Study|Adverse Event|1
5859744|NCT02079636|20265206|P4|Overall Study|Adverse Event|1
5859745|NCT02079636|20265207|P3|Overall Study|Adverse Event|0
5859746|NCT02079636|20265208|P2|Overall Study|Adverse Event|1
5859747|NCT02079636|20265209|P1|Overall Study|Adverse Event|1
5859748|NCT02079636|20265195|P15|Overall Study|Death|2
5859749|NCT02079636|20265196|P14|Overall Study|Death|0
5859750|NCT02079636|20265197|P13|Overall Study|Death|1
5859751|NCT02079636|20265198|P12|Overall Study|Death|1
5859752|NCT02079636|20265199|P11|Overall Study|Death|0
5859753|NCT02079636|20265200|P10|Overall Study|Death|0
5859754|NCT02079636|20265201|P9|Overall Study|Death|0
5859755|NCT02079636|20265202|P8|Overall Study|Death|0
5859756|NCT02079636|20265203|P7|Overall Study|Death|1
5859757|NCT02079636|20265204|P6|Overall Study|Death|2
5859758|NCT02079636|20265205|P5|Overall Study|Death|1
5859759|NCT02079636|20265206|P4|Overall Study|Death|5
5859760|NCT02079636|20265207|P3|Overall Study|Death|0
5859761|NCT02079636|20265208|P2|Overall Study|Death|1
5859762|NCT02079636|20265209|P1|Overall Study|Death|2
5859763|NCT02079610|20265320|P2|Overall Study|Withdrawal by Subject|1
5859764|NCT02079610|20265321|P1|Overall Study|Withdrawal by Subject|1
5859765|NCT02079532|20265331|P1|Overall Study|Other|3
5859766|NCT02079532|20265331|P1|Overall Study|Inclusion into ReFIRST|3
5859767|NCT02079532|20265331|P1|Overall Study|Administrative problems|1
5859768|NCT02079532|20265331|P1|Overall Study|Withdrawal by Subject|1
5859769|NCT02079532|20265331|P1|Overall Study|Protocol Violation|3
5859770|NCT02079532|20265331|P1|Overall Study|Lack of Efficacy|9
5859771|NCT02079532|20265331|P1|Overall Study|Additional or changed therapy|2
5859772|NCT02079532|20265331|P1|Overall Study|Adverse Event|7
5859773|NCT02079519|20265353|P1|Overall Study|Adverse Event|1
5859774|NCT02079519|20265353|P1|Overall Study|Disease Progression|9
5859775|NCT02079246|20265366|P2|OLEX-MEM|Other: Moved to nursing home|3
5859776|NCT02079246|20265367|P1|OLEX-MEM|Other: Moved to nursing home|0
5859777|NCT02079246|20265366|P2|OLEX-MEM|Lost to Follow-up|1
5859778|NCT02079246|20265367|P1|OLEX-MEM|Lost to Follow-up|0
5859779|NCT02079246|20265366|P2|OLEX-MEM|Protocol Violation|2
5859780|NCT02079246|20265367|P1|OLEX-MEM|Protocol Violation|0
5859781|NCT02079246|20265366|P2|OLEX-MEM|Withdrawal by Subject|7
5859782|NCT02079246|20265367|P1|OLEX-MEM|Withdrawal by Subject|0
5859783|NCT02079246|20265366|P2|OLEX-MEM|Adverse Event|6
5859784|NCT02079246|20265367|P1|OLEX-MEM|Adverse Event|0
5859785|NCT02079246|20265366|P2|OLEX|Other: Withdrawal of caregiver consent|0
5859786|NCT02079246|20265367|P1|OLEX|Other: Withdrawal of caregiver consent|1
5859787|NCT02079246|20265366|P2|OLEX|Other: Moved to nursing home|0
5859788|NCT02079246|20265367|P1|OLEX|Other: Moved to nursing home|1
5859789|NCT02079246|20265366|P2|OLEX|Other: Worsening of condition|0
5859790|NCT02079246|20265367|P1|OLEX|Other: Worsening of condition|1
5859791|NCT02079246|20265366|P2|OLEX|Other: Coordinator decision|0
5859792|NCT02079246|20265367|P1|OLEX|Other: Coordinator decision|1
5859793|NCT02079246|20265366|P2|OLEX|Other: Caregiver unavailable|0
5859794|NCT02079246|20265367|P1|OLEX|Other: Caregiver unavailable|3
5859795|NCT02079246|20265366|P2|OLEX|Other: Insufficient compliance|0
5859796|NCT02079246|20265367|P1|OLEX|Other: Insufficient compliance|2
5859797|NCT02079246|20265366|P2|OLEX|Other: Disallowed medication|0
5859798|NCT02079246|20265367|P1|OLEX|Other: Disallowed medication|8
5859799|NCT02079246|20265366|P2|OLEX|Results of the lead-in studies|0
5859800|NCT02079246|20265367|P1|OLEX|Results of the lead-in studies|58
5859801|NCT02079246|20265366|P2|OLEX|Lack of Efficacy|0
5859802|NCT02079246|20265367|P1|OLEX|Lack of Efficacy|3
5859803|NCT02079246|20265366|P2|OLEX|Protocol Violation|0
5859804|NCT02079246|20265367|P1|OLEX|Protocol Violation|6
5859805|NCT02079246|20265366|P2|OLEX|Lost to Follow-up|0
5859806|NCT02079246|20265367|P1|OLEX|Lost to Follow-up|6
5859807|NCT02079246|20265366|P2|OLEX|Withdrawal by Subject|0
5859808|NCT02079246|20265367|P1|OLEX|Withdrawal by Subject|60
5859809|NCT02079246|20265366|P2|OLEX|Adverse Event|0
5859810|NCT02079246|20265367|P1|OLEX|Adverse Event|66
5859811|NCT02079246|20265366|P2|OLEX|Death|0
5859812|NCT02079246|20265367|P1|OLEX|Death|11
5859813|NCT02079246|20265366|P2|OLEX|Withdrawal before treatment|0
5859814|NCT02079246|20265367|P1|OLEX|Withdrawal before treatment|1
5859815|NCT02079077|20265386|P2|Overall Study|Became STIs Positive|2
5859816|NCT02079077|20265387|P1|Overall Study|Became STIs Positive|1
5859817|NCT02079077|20265386|P2|Overall Study|Lost to Follow-up|7
5859818|NCT02079077|20265387|P1|Overall Study|Lost to Follow-up|5
5859819|NCT02079038|20265397|P2|Completed 6 Months|Lost to Follow-up|1
5859820|NCT02079038|20265398|P1|Completed 6 Months|Lost to Follow-up|2
5859821|NCT02079038|20265397|P2|Modified Intent to Treat Population|Death|0
5859822|NCT02079038|20265398|P1|Modified Intent to Treat Population|Death|1
5859823|NCT02079038|20265397|P2|Modified Intent to Treat Population|Withdrawal by Subject|5
5859824|NCT02079038|20265398|P1|Modified Intent to Treat Population|Withdrawal by Subject|6
5859825|NCT02078960|20265419|P3|Follow-up Period|Lost to Follow-up|0
5859826|NCT02078960|20265420|P2|Follow-up Period|Lost to Follow-up|1
5859827|NCT02078960|20265421|P1|Follow-up Period|Lost to Follow-up|0
5859828|NCT02078960|20265419|P3|Follow-up Period|Death|0
5859829|NCT02078960|20265420|P2|Follow-up Period|Death|0
5859830|NCT02078960|20265421|P1|Follow-up Period|Death|2
5859831|NCT02078960|20265419|P3|Treatment Period|Death|1
5859832|NCT02078960|20265420|P2|Treatment Period|Death|0
5859833|NCT02078960|20265421|P1|Treatment Period|Death|0
5859834|NCT02078960|20265419|P3|Treatment Period|Adverse Event|0
5859835|NCT02078960|20265420|P2|Treatment Period|Adverse Event|0
5859836|NCT02078960|20265421|P1|Treatment Period|Adverse Event|1
5859837|NCT02078960|20265419|P3|Treatment Period|Withdrawal by Subject|1
5859838|NCT02078960|20265420|P2|Treatment Period|Withdrawal by Subject|1
5859839|NCT02078960|20265421|P1|Treatment Period|Withdrawal by Subject|0
5859840|NCT02078960|20265419|P3|Treatment Period|Disease progression - blast phase|0
5859841|NCT02078960|20265420|P2|Treatment Period|Disease progression - blast phase|0
5859842|NCT02078960|20265421|P1|Treatment Period|Disease progression - blast phase|1
5859843|NCT02078960|20265419|P3|Treatment Period|Disease progression - accelerated phase|0
5859844|NCT02078960|20265420|P2|Treatment Period|Disease progression - accelerated phase|1
5859845|NCT02078960|20265421|P1|Treatment Period|Disease progression - accelerated phase|0
5859846|NCT02078960|20265419|P3|Treatment Period|Lack of Efficacy|0
5859847|NCT02078960|20265420|P2|Treatment Period|Lack of Efficacy|1
5859848|NCT02078960|20265421|P1|Treatment Period|Lack of Efficacy|0
5859849|NCT02078960|20265419|P3|Treatment Period|Other|1
5859850|NCT02078960|20265420|P2|Treatment Period|Other|0
5859851|NCT02078960|20265421|P1|Treatment Period|Other|0
5859852|NCT02078817|20265455|P1|Overall Study|Withdrawal by Subject|1
5859853|NCT02078752|20265477|P10|Overall Study|Study terminated by sponsor|5
5859854|NCT02078752|20265478|P9|Overall Study|Study terminated by sponsor|0
5859855|NCT02078752|20265479|P8|Overall Study|Study terminated by sponsor|0
5859856|NCT02078752|20265480|P7|Overall Study|Study terminated by sponsor|0
5859857|NCT02078752|20265481|P6|Overall Study|Study terminated by sponsor|0
5859858|NCT02078752|20265482|P5|Overall Study|Study terminated by sponsor|0
5859859|NCT02078752|20265483|P4|Overall Study|Study terminated by sponsor|0
5859860|NCT02078752|20265484|P3|Overall Study|Study terminated by sponsor|0
5859861|NCT02078752|20265485|P2|Overall Study|Study terminated by sponsor|0
5859862|NCT02078752|20265486|P1|Overall Study|Study terminated by sponsor|0
5859863|NCT02078752|20265477|P10|Overall Study|Other|0
5859864|NCT02078752|20265478|P9|Overall Study|Other|0
5859865|NCT02078752|20265479|P8|Overall Study|Other|1
5859866|NCT02078752|20265480|P7|Overall Study|Other|0
5859867|NCT02078752|20265481|P6|Overall Study|Other|0
5859868|NCT02078752|20265482|P5|Overall Study|Other|1
5859869|NCT02078752|20265483|P4|Overall Study|Other|0
5859870|NCT02078752|20265484|P3|Overall Study|Other|0
5859871|NCT02078752|20265485|P2|Overall Study|Other|3
5859872|NCT02078752|20265486|P1|Overall Study|Other|0
5859873|NCT02078752|20265477|P10|Overall Study|Withdrawal by Subject|1
5859874|NCT02078752|20265478|P9|Overall Study|Withdrawal by Subject|0
5859875|NCT02078752|20265479|P8|Overall Study|Withdrawal by Subject|1
5859876|NCT02078752|20265480|P7|Overall Study|Withdrawal by Subject|2
5859877|NCT02078752|20265481|P6|Overall Study|Withdrawal by Subject|3
5859878|NCT02078752|20265482|P5|Overall Study|Withdrawal by Subject|0
5859879|NCT02078752|20265483|P4|Overall Study|Withdrawal by Subject|1
5859880|NCT02078752|20265484|P3|Overall Study|Withdrawal by Subject|1
5859881|NCT02078752|20265485|P2|Overall Study|Withdrawal by Subject|1
5859882|NCT02078752|20265486|P1|Overall Study|Withdrawal by Subject|1
5859883|NCT02078752|20265477|P10|Overall Study|Lost to Follow-up|0
5859884|NCT02078752|20265478|P9|Overall Study|Lost to Follow-up|0
5859885|NCT02078752|20265479|P8|Overall Study|Lost to Follow-up|0
5859886|NCT02078752|20265480|P7|Overall Study|Lost to Follow-up|0
5859887|NCT02078752|20265481|P6|Overall Study|Lost to Follow-up|0
5859888|NCT02078752|20265482|P5|Overall Study|Lost to Follow-up|0
5859889|NCT02078752|20265483|P4|Overall Study|Lost to Follow-up|1
5859890|NCT02078752|20265484|P3|Overall Study|Lost to Follow-up|0
5859891|NCT02078752|20265485|P2|Overall Study|Lost to Follow-up|0
5859892|NCT02078752|20265486|P1|Overall Study|Lost to Follow-up|1
5859893|NCT02078752|20265477|P10|Overall Study|Death|4
5859894|NCT02078752|20265478|P9|Overall Study|Death|0
5859895|NCT02078752|20265479|P8|Overall Study|Death|1
5859896|NCT02078752|20265480|P7|Overall Study|Death|0
5859897|NCT02078752|20265481|P6|Overall Study|Death|1
5859898|NCT02078752|20265482|P5|Overall Study|Death|0
5859899|NCT02078752|20265483|P4|Overall Study|Death|0
5859900|NCT02078752|20265484|P3|Overall Study|Death|0
5859901|NCT02078752|20265485|P2|Overall Study|Death|3
5859902|NCT02078752|20265486|P1|Overall Study|Death|0
5859903|NCT02078713|20265762|P4|Overall Study|Enrolled twice|0
5859904|NCT02078713|20265763|P3|Overall Study|Enrolled twice|0
5859905|NCT02078713|20265764|P2|Overall Study|Enrolled twice|1
5859906|NCT02078713|20265765|P1|Overall Study|Enrolled twice|0
5859907|NCT02078713|20265762|P4|Overall Study|Pregnant at baseline|0
5859908|NCT02078713|20265763|P3|Overall Study|Pregnant at baseline|0
5859909|NCT02078713|20265764|P2|Overall Study|Pregnant at baseline|5
5859910|NCT02078713|20265765|P1|Overall Study|Pregnant at baseline|3
5859911|NCT02078713|20265762|P4|Overall Study|Lost to Follow-up|0
5859912|NCT02078713|20265763|P3|Overall Study|Lost to Follow-up|0
5859913|NCT02078713|20265764|P2|Overall Study|Lost to Follow-up|55
5859914|NCT02078713|20265765|P1|Overall Study|Lost to Follow-up|49
5859915|NCT02078219|20265850|P5|Overall Study|Adverse Event|0
5859916|NCT02078219|20265851|P4|Overall Study|Adverse Event|1
5859917|NCT02078219|20265852|P3|Overall Study|Adverse Event|3
5859918|NCT02078219|20265853|P2|Overall Study|Adverse Event|1
5859919|NCT02078219|20265854|P1|Overall Study|Adverse Event|1
5859920|NCT02078219|20265850|P5|Overall Study|Death|0
5859921|NCT02078219|20265851|P4|Overall Study|Death|1
5859922|NCT02078219|20265852|P3|Overall Study|Death|0
5859923|NCT02078219|20265853|P2|Overall Study|Death|0
5859924|NCT02078219|20265854|P1|Overall Study|Death|0
5859925|NCT02078219|20265850|P5|Overall Study|Protocol Violation|0
5859926|NCT02078219|20265851|P4|Overall Study|Protocol Violation|1
5859927|NCT02078219|20265852|P3|Overall Study|Protocol Violation|0
5859928|NCT02078219|20265853|P2|Overall Study|Protocol Violation|0
5859929|NCT02078219|20265854|P1|Overall Study|Protocol Violation|0
5859930|NCT02078219|20265850|P5|Overall Study|Withdrawal by Subject|1
5859931|NCT02078219|20265851|P4|Overall Study|Withdrawal by Subject|1
5859932|NCT02078219|20265852|P3|Overall Study|Withdrawal by Subject|0
5859933|NCT02078219|20265853|P2|Overall Study|Withdrawal by Subject|1
5859934|NCT02078219|20265854|P1|Overall Study|Withdrawal by Subject|0
5859935|NCT02078219|20265850|P5|Overall Study|Other|1
5859936|NCT02078219|20265851|P4|Overall Study|Other|0
5859937|NCT02078219|20265852|P3|Overall Study|Other|3
5859938|NCT02078219|20265853|P2|Overall Study|Other|2
5859939|NCT02078219|20265854|P1|Overall Study|Other|2
5859940|NCT02077465|20265904|P2|Overall Study|Lost to Follow-up|0
5859941|NCT02077465|20265905|P1|Overall Study|Lost to Follow-up|1
5859942|NCT02077465|20265904|P2|Overall Study|Withdrew Consent|1
5859943|NCT02077465|20265905|P1|Overall Study|Withdrew Consent|0
5859944|NCT02077374|20265928|P2|Overall Study|Protocol Violation|1
5859945|NCT02077374|20265929|P1|Overall Study|Protocol Violation|0
5859946|NCT02077374|20265928|P2|Overall Study|Withdrawal by Subject|1
5859947|NCT02077374|20265929|P1|Overall Study|Withdrawal by Subject|0
5859948|NCT02077140|20265950|P5|Overall Study|Withdrawal by Subject|2
5859949|NCT02077140|20265951|P4|Overall Study|Withdrawal by Subject|2
5859950|NCT02077140|20265952|P3|Overall Study|Withdrawal by Subject|0
5859951|NCT02077140|20265953|P2|Overall Study|Withdrawal by Subject|1
5859952|NCT02077140|20265954|P1|Overall Study|Withdrawal by Subject|0
5859953|NCT02077140|20265950|P5|Overall Study|Lost to Follow-up|3
5859954|NCT02077140|20265951|P4|Overall Study|Lost to Follow-up|2
5859955|NCT02077140|20265952|P3|Overall Study|Lost to Follow-up|2
5859956|NCT02077140|20265953|P2|Overall Study|Lost to Follow-up|1
5859957|NCT02077140|20265954|P1|Overall Study|Lost to Follow-up|4
5859958|NCT02076334|20266232|P4|Overall Study|muscle soreness|1
5859959|NCT02076334|20266233|P3|Overall Study|muscle soreness|0
5859960|NCT02076334|20266234|P2|Overall Study|muscle soreness|0
5859961|NCT02076334|20266235|P1|Overall Study|muscle soreness|0
5859962|NCT02076334|20266232|P4|Overall Study|Lost to Follow-up|0
5859963|NCT02076334|20266233|P3|Overall Study|Lost to Follow-up|1
5859964|NCT02076334|20266234|P2|Overall Study|Lost to Follow-up|1
5859965|NCT02076334|20266235|P1|Overall Study|Lost to Follow-up|0
5859966|NCT02076334|20266232|P4|Overall Study|Protocol Violation|0
5859967|NCT02076334|20266233|P3|Overall Study|Protocol Violation|0
5859968|NCT02076334|20266234|P2|Overall Study|Protocol Violation|0
5859969|NCT02076334|20266235|P1|Overall Study|Protocol Violation|1
5859970|NCT02076178|20266268|P2|Injection Phase|Lost to Follow-up|1
5859971|NCT02076178|20266269|P1|Injection Phase|Lost to Follow-up|0
5859972|NCT02076178|20266268|P2|Injection Phase|Physician Decision|3
5859973|NCT02076178|20266269|P1|Injection Phase|Physician Decision|0
5859974|NCT02076178|20266268|P2|Injection Phase|Withdrawal by Subject|3
5859975|NCT02076178|20266269|P1|Injection Phase|Withdrawal by Subject|0
5859976|NCT02076178|20266268|P2|Injection Phase|Protocol defined stopping criteria|0
5859977|NCT02076178|20266269|P1|Injection Phase|Protocol defined stopping criteria|1
5859978|NCT02076178|20266268|P2|Oral Phase|Physician Decision|1
5859979|NCT02076178|20266269|P1|Oral Phase|Physician Decision|0
5859980|NCT02076178|20266268|P2|Oral Phase|Withdrawal by Subject|4
5859981|NCT02076178|20266269|P1|Oral Phase|Withdrawal by Subject|0
5859982|NCT02076178|20266268|P2|Oral Phase|Adverse Event|7
5859983|NCT02076178|20266269|P1|Oral Phase|Adverse Event|0
5859984|NCT02076165|20266303|P2|Overall Study|Refused follow-up assessment|1
5859985|NCT02076165|20266304|P1|Overall Study|Refused follow-up assessment|1
5859986|NCT02076165|20266303|P2|Overall Study|Lost to Follow-up|5
5859987|NCT02076165|20266304|P1|Overall Study|Lost to Follow-up|7
5859988|NCT02076022|20266374|P2|Overall Study|Withdrawal by Subject|0
5859989|NCT02076022|20266375|P1|Overall Study|Withdrawal by Subject|2
5860002|NCT02075840|20266410|P2|Overall Study|Ongoing at CCOD|82
5860003|NCT02075840|20266411|P1|Overall Study|Ongoing at CCOD|99
5860004|NCT02075840|20266410|P2|Overall Study|Physician Decision|3
5860005|NCT02075840|20266411|P1|Overall Study|Physician Decision|1
5860006|NCT02075840|20266410|P2|Overall Study|Lost to Follow-up|2
5860007|NCT02075840|20266411|P1|Overall Study|Lost to Follow-up|3
5860008|NCT02075840|20266410|P2|Overall Study|Death|40
5860009|NCT02075840|20266411|P1|Overall Study|Death|35
5860010|NCT02075840|20266410|P2|Overall Study|Adverse Event|2
5860011|NCT02075840|20266411|P1|Overall Study|Adverse Event|0
5860012|NCT02075840|20266410|P2|Overall Study|Reason not specified|0
5860013|NCT02075840|20266411|P1|Overall Study|Reason not specified|1
5860014|NCT02075840|20266410|P2|Overall Study|Withdrawal by Subject|22
5860015|NCT02075840|20266411|P1|Overall Study|Withdrawal by Subject|13
5860016|NCT02075658|20266467|P2|Overall Study|Physician Decision|2
5860017|NCT02075658|20266468|P1|Overall Study|Physician Decision|2
5860018|NCT02075632|20266478|P2|Overall Study|Withdrawal by Subject|1
5860019|NCT02075632|20266479|P1|Overall Study|Withdrawal by Subject|0
5860020|NCT02075632|20266478|P2|Overall Study|Lost to Follow-up|3
5860021|NCT02075632|20266479|P1|Overall Study|Lost to Follow-up|0
5860022|NCT02075632|20266478|P2|Overall Study|Adverse Event|1
5860023|NCT02075632|20266479|P1|Overall Study|Adverse Event|1
5860024|NCT02075606|20266489|P1|Overall Study|Increasing Symptoms|1
5860025|NCT02075606|20266489|P1|Overall Study|Symptom management|1
5860026|NCT02075606|20266489|P1|Overall Study|Investigator's decision|1
5860027|NCT02075606|20266489|P1|Overall Study|Death|1
5860028|NCT02075606|20266489|P1|Overall Study|Withdrawal by Subject|1
5860029|NCT02075606|20266489|P1|Overall Study|Adverse Event|5
5860030|NCT02075541|20266513|P2|Overall Study|Other- unable to perform study procedure|0
5860031|NCT02075541|20266514|P1|Overall Study|Other- unable to perform study procedure|1
5860032|NCT02075541|20266513|P2|Overall Study|Sponsor study termination|1
5860033|NCT02075541|20266514|P1|Overall Study|Sponsor study termination|0
5860034|NCT02075541|20266513|P2|Overall Study|Withdrawal by Subject|3
5860035|NCT02075541|20266514|P1|Overall Study|Withdrawal by Subject|1
5860036|NCT02075541|20266513|P2|Overall Study|Protocol Violation|0
5860037|NCT02075541|20266514|P1|Overall Study|Protocol Violation|1
5860038|NCT02075541|20266513|P2|Overall Study|Serious Adverse Event|4
5860039|NCT02075541|20266514|P1|Overall Study|Serious Adverse Event|1
5860040|NCT02075515|20266563|P3|Overall Study|Lost to Follow-up|6
5860041|NCT02075515|20266564|P2|Overall Study|Lost to Follow-up|3
5860042|NCT02075515|20266565|P1|Overall Study|Lost to Follow-up|1
5860043|NCT02075515|20266563|P3|Overall Study|Withdrawal by Subject|1
5860044|NCT02075515|20266564|P2|Overall Study|Withdrawal by Subject|0
5860045|NCT02075515|20266565|P1|Overall Study|Withdrawal by Subject|2
5860046|NCT02075515|20266563|P3|Overall Study|Non-Serious Adverse Event|0
5860047|NCT02075515|20266564|P2|Overall Study|Non-Serious Adverse Event|1
5860048|NCT02075515|20266565|P1|Overall Study|Non-Serious Adverse Event|0
5860049|NCT02075515|20266563|P3|Overall Study|Serious Adverse Event|1
5860050|NCT02075515|20266564|P2|Overall Study|Serious Adverse Event|1
5860051|NCT02075515|20266565|P1|Overall Study|Serious Adverse Event|1
5860052|NCT02075476|20266602|P2|Overall Study|Lost to Follow-up|3
5860053|NCT02075476|20266603|P1|Overall Study|Lost to Follow-up|1
5860054|NCT02075476|20266602|P2|Overall Study|Death|2
5860055|NCT02075476|20266603|P1|Overall Study|Death|2
5860056|NCT02075463|20266613|P1|Overall Study|Withdrawal by Subject|1
5860057|NCT02075463|20266613|P1|Overall Study|Par. reached stopping criteria|4
5860058|NCT02075463|20266613|P1|Overall Study|Adverse Event|3
5860059|NCT02075320|20266663|P1|Overall Study|Withdrawal by Subject|2
5860060|NCT02075255|20266673|P3|Overall Study|Death|0
5860061|NCT02075255|20266674|P2|Overall Study|Death|2
5860062|NCT02075255|20266675|P1|Overall Study|Death|0
5860063|NCT02075255|20266673|P3|Overall Study|Adverse Event|1
5860064|NCT02075255|20266674|P2|Overall Study|Adverse Event|0
5860065|NCT02075255|20266675|P1|Overall Study|Adverse Event|0
5860066|NCT02075255|20266673|P3|Overall Study|Lost to Follow-up|1
5860067|NCT02075255|20266674|P2|Overall Study|Lost to Follow-up|0
5860068|NCT02075255|20266675|P1|Overall Study|Lost to Follow-up|0
5860069|NCT02075255|20266673|P3|Overall Study|Withdrawal by Subject|0
5860070|NCT02075255|20266674|P2|Overall Study|Withdrawal by Subject|1
5860071|NCT02075255|20266675|P1|Overall Study|Withdrawal by Subject|4
5860072|NCT02075255|20266673|P3|Overall Study|Study specific withdrawal criteria|1
5860073|NCT02075255|20266674|P2|Overall Study|Study specific withdrawal criteria|1
5860074|NCT02075255|20266675|P1|Overall Study|Study specific withdrawal criteria|0
5860075|NCT02075203|20266785|P3|Overall Study|participant refused to use contraception|0
5860076|NCT02075203|20266786|P2|Overall Study|participant refused to use contraception|0
5860077|NCT02075203|20266787|P1|Overall Study|participant refused to use contraception|1
5860078|NCT02075203|20266785|P3|Overall Study|Adverse Event|0
5860079|NCT02075203|20266786|P2|Overall Study|Adverse Event|0
5860080|NCT02075203|20266787|P1|Overall Study|Adverse Event|1
5860081|NCT02075203|20266785|P3|Overall Study|Withdrawal by Subject|1
5860082|NCT02075203|20266786|P2|Overall Study|Withdrawal by Subject|0
5860083|NCT02075203|20266787|P1|Overall Study|Withdrawal by Subject|1
5860084|NCT02075073|20266828|P3|Overall Study|Withdrawal by Subject|0
5860085|NCT02075073|20266829|P2|Overall Study|Withdrawal by Subject|1
5860086|NCT02075073|20266830|P1|Overall Study|Withdrawal by Subject|0
5860087|NCT02075008|20266852|P1|Overall Study|Study terminated by Sponsor|159
5860088|NCT02075008|20266852|P1|Overall Study|Withdrawal by Subject|6
5860089|NCT02075008|20266852|P1|Overall Study|Adverse Event|5
5860090|NCT02075008|20266852|P1|Overall Study|Death|1
5860091|NCT02075008|20266852|P1|Overall Study|Lack of Efficacy|1
5860092|NCT02075008|20266852|P1|Overall Study|Lost to Follow-up|1
5860093|NCT02075008|20266852|P1|Overall Study|Physician Decision|1
5860094|NCT02075008|20266852|P1|Overall Study|Pregnancy|1
5860095|NCT02075008|20266852|P1|Overall Study|Technical problems|1
5860096|NCT02074982|20266875|P2|Overall Study|Death|2
5860097|NCT02074982|20266876|P1|Overall Study|Death|0
5860098|NCT02074982|20266875|P2|Overall Study|Subject/guardian decision|24
5860099|NCT02074982|20266876|P1|Overall Study|Subject/guardian decision|15
5860100|NCT02074982|20266875|P2|Overall Study|Technical problems|2
5860101|NCT02074982|20266876|P1|Overall Study|Technical problems|0
5860102|NCT02074982|20266875|P2|Overall Study|Protocol deviation|3
5860103|NCT02074982|20266876|P1|Overall Study|Protocol deviation|4
5860104|NCT02074982|20266875|P2|Overall Study|Pregnancy|2
5860105|NCT02074982|20266876|P1|Overall Study|Pregnancy|1
5860106|NCT02074982|20266875|P2|Overall Study|Physician Decision|1
5860107|NCT02074982|20266876|P1|Overall Study|Physician Decision|1
5860108|NCT02074982|20266875|P2|Overall Study|Non-compliance with study treatment|2
5860109|NCT02074982|20266876|P1|Overall Study|Non-compliance with study treatment|0
5860110|NCT02074982|20266875|P2|Overall Study|Lost to Follow-up|10
5860111|NCT02074982|20266876|P1|Overall Study|Lost to Follow-up|9
5860112|NCT02074982|20266875|P2|Overall Study|Lack of Efficacy|1
5860113|NCT02074982|20266876|P1|Overall Study|Lack of Efficacy|6
5860114|NCT02074982|20266875|P2|Overall Study|Adverse Event|7
5860115|NCT02074982|20266876|P1|Overall Study|Adverse Event|15
5860116|NCT02074553|20266923|P8|Washout Period 3|Physician Decision|1
5860117|NCT02074553|20266924|P7|Washout Period 3|Physician Decision|0
5860118|NCT02074553|20266925|P6|Washout Period 3|Physician Decision|0
5860119|NCT02074553|20266926|P5|Washout Period 3|Physician Decision|0
5860120|NCT02074553|20266927|P4|Washout Period 3|Physician Decision|0
5860121|NCT02074553|20266928|P3|Washout Period 3|Physician Decision|0
5860122|NCT02074553|20266929|P2|Washout Period 3|Physician Decision|0
5860123|NCT02074553|20266930|P1|Washout Period 3|Physician Decision|0
5860124|NCT02074553|20266923|P8|Washout Period 2|Lost to Follow-up|0
5860125|NCT02074553|20266924|P7|Washout Period 2|Lost to Follow-up|0
5860126|NCT02074553|20266925|P6|Washout Period 2|Lost to Follow-up|0
5860127|NCT02074553|20266926|P5|Washout Period 2|Lost to Follow-up|0
5860128|NCT02074553|20266927|P4|Washout Period 2|Lost to Follow-up|0
5860129|NCT02074553|20266928|P3|Washout Period 2|Lost to Follow-up|1
5860130|NCT02074553|20266929|P2|Washout Period 2|Lost to Follow-up|0
5860131|NCT02074553|20266930|P1|Washout Period 2|Lost to Follow-up|0
5860132|NCT02074553|20266923|P8|Washout Period 2|Physician Decision|0
5860133|NCT02074553|20266924|P7|Washout Period 2|Physician Decision|0
5860134|NCT02074553|20266925|P6|Washout Period 2|Physician Decision|1
5860135|NCT02074553|20266926|P5|Washout Period 2|Physician Decision|0
5860136|NCT02074553|20266927|P4|Washout Period 2|Physician Decision|0
5860137|NCT02074553|20266928|P3|Washout Period 2|Physician Decision|0
5860138|NCT02074553|20266929|P2|Washout Period 2|Physician Decision|0
5860139|NCT02074553|20266930|P1|Washout Period 2|Physician Decision|0
5860140|NCT02074553|20266923|P8|Washout Period 2|Adverse Event|0
5860141|NCT02074553|20266924|P7|Washout Period 2|Adverse Event|1
5860142|NCT02074553|20266925|P6|Washout Period 2|Adverse Event|0
5860143|NCT02074553|20266926|P5|Washout Period 2|Adverse Event|0
5860144|NCT02074553|20266927|P4|Washout Period 2|Adverse Event|0
5860145|NCT02074553|20266928|P3|Washout Period 2|Adverse Event|0
5860146|NCT02074553|20266929|P2|Washout Period 2|Adverse Event|0
5860147|NCT02074553|20266930|P1|Washout Period 2|Adverse Event|0
5860148|NCT02074553|20266923|P8|Washout Period 1|Other|0
5860149|NCT02074553|20266924|P7|Washout Period 1|Other|0
5860150|NCT02074553|20266925|P6|Washout Period 1|Other|1
5860151|NCT02074553|20266926|P5|Washout Period 1|Other|0
5860152|NCT02074553|20266927|P4|Washout Period 1|Other|0
5860153|NCT02074553|20266928|P3|Washout Period 1|Other|0
5860154|NCT02074553|20266929|P2|Washout Period 1|Other|0
5860155|NCT02074553|20266930|P1|Washout Period 1|Other|0
5860156|NCT02074553|20266923|P8|Washout Period 1|Physician Decision|0
5860157|NCT02074553|20266924|P7|Washout Period 1|Physician Decision|0
5860158|NCT02074553|20266925|P6|Washout Period 1|Physician Decision|0
5860159|NCT02074553|20266926|P5|Washout Period 1|Physician Decision|0
5860160|NCT02074553|20266927|P4|Washout Period 1|Physician Decision|1
5860161|NCT02074553|20266928|P3|Washout Period 1|Physician Decision|0
5860162|NCT02074553|20266929|P2|Washout Period 1|Physician Decision|0
5860163|NCT02074553|20266930|P1|Washout Period 1|Physician Decision|0
5860164|NCT02074553|20266923|P8|Washout Period 1|Adverse Event|0
5860165|NCT02074553|20266924|P7|Washout Period 1|Adverse Event|0
5860166|NCT02074553|20266925|P6|Washout Period 1|Adverse Event|0
5860167|NCT02074553|20266926|P5|Washout Period 1|Adverse Event|0
5860168|NCT02074553|20266927|P4|Washout Period 1|Adverse Event|0
5860169|NCT02074553|20266928|P3|Washout Period 1|Adverse Event|0
5860170|NCT02074553|20266929|P2|Washout Period 1|Adverse Event|0
5860171|NCT02074553|20266930|P1|Washout Period 1|Adverse Event|1
5860172|NCT02074553|20266923|P8|Intervention Period 1|Family Emergency|0
5860173|NCT02074553|20266924|P7|Intervention Period 1|Family Emergency|0
5860174|NCT02074553|20266925|P6|Intervention Period 1|Family Emergency|0
5860175|NCT02074553|20266926|P5|Intervention Period 1|Family Emergency|0
5860176|NCT02074553|20266927|P4|Intervention Period 1|Family Emergency|1
5860177|NCT02074553|20266928|P3|Intervention Period 1|Family Emergency|0
5860178|NCT02074553|20266929|P2|Intervention Period 1|Family Emergency|0
5860179|NCT02074553|20266930|P1|Intervention Period 1|Family Emergency|0
5860180|NCT02074514|20267112|P2|Overall Study|Withdrew Consent|1
5860181|NCT02074514|20267113|P1|Overall Study|Withdrew Consent|0
5860182|NCT02074514|20267112|P2|Overall Study|Lost to Follow-up|1
5860183|NCT02074514|20267113|P1|Overall Study|Lost to Follow-up|0
5860184|NCT02074514|20267112|P2|Overall Study|Lack of Efficacy|2
5860185|NCT02074514|20267113|P1|Overall Study|Lack of Efficacy|3
5860186|NCT02074059|20267254|P6|Overall Study|Death|1
5860187|NCT02074059|20267255|P5|Overall Study|Death|1
5860188|NCT02074059|20267256|P4|Overall Study|Death|0
5860189|NCT02074059|20267257|P3|Overall Study|Death|0
5860190|NCT02074059|20267258|P2|Overall Study|Death|0
5860191|NCT02074059|20267259|P1|Overall Study|Death|0
5860192|NCT02073929|20267303|P2|Overall Study|Withdrawal by Subject|1
5860193|NCT02073929|20267304|P1|Overall Study|Withdrawal by Subject|0
5860194|NCT02073929|20267303|P2|Overall Study|Adverse Event|1
5860195|NCT02073929|20267304|P1|Overall Study|Adverse Event|2
5860196|NCT02073929|20267303|P2|Overall Study|Lost to Follow-up|1
5860197|NCT02073929|20267304|P1|Overall Study|Lost to Follow-up|2
5860198|NCT02073682|20267341|P2|Overall Study|ID: Benefit/Risk Judgment|46
5860199|NCT02073682|20267342|P1|Overall Study|ID: Benefit/Risk Judgment|32
5860200|NCT02073682|20267341|P2|Overall Study|Lost to Follow-up|1
5860201|NCT02073682|20267342|P1|Overall Study|Lost to Follow-up|1
5860202|NCT02073682|20267341|P2|Overall Study|PD: Inconvenience of Dosing|78
5860203|NCT02073682|20267342|P1|Overall Study|PD: Inconvenience of Dosing|21
5860204|NCT02073682|20267341|P2|Overall Study|No reason provided|9
5860205|NCT02073682|20267342|P1|Overall Study|No reason provided|11
5860206|NCT02073682|20267341|P2|Overall Study|Adverse Event|62
5860207|NCT02073682|20267342|P1|Overall Study|Adverse Event|79
5860208|NCT02073682|20267341|P2|Overall Study|Protocol Violation|0
5860209|NCT02073682|20267342|P1|Overall Study|Protocol Violation|1
5860210|NCT02073682|20267341|P2|Overall Study|Cancer Progression|33
5860211|NCT02073682|20267342|P1|Overall Study|Cancer Progression|53
5860212|NCT02073682|20267341|P2|Overall Study|Start of New Chemotherapy Regimen|3
5860213|NCT02073682|20267342|P1|Overall Study|Start of New Chemotherapy Regimen|6
5860214|NCT02073682|20267341|P2|Overall Study|Withdrawal by Subject|8
5860215|NCT02073682|20267342|P1|Overall Study|Withdrawal by Subject|6
5860216|NCT02073682|20267341|P2|Overall Study|Surgery/Medical Procedure|1
5860217|NCT02073682|20267342|P1|Overall Study|Surgery/Medical Procedure|3
5860218|NCT02073682|20267341|P2|Overall Study|Platelet Count <50,000/mL|2
5860219|NCT02073682|20267342|P1|Overall Study|Platelet Count <50,000/mL|1
5860220|NCT02073682|20267341|P2|Overall Study|Prohibited Concomitant Medication Use|1
5860221|NCT02073682|20267342|P1|Overall Study|Prohibited Concomitant Medication Use|0
5860222|NCT02073682|20267341|P2|Overall Study|ID: Palliative Treatment Only|7
5860223|NCT02073682|20267342|P1|Overall Study|ID: Palliative Treatment Only|10
5860224|NCT02073682|20267341|P2|Overall Study|ID: Patient Noncompliance|2
5860225|NCT02073682|20267342|P1|Overall Study|ID: Patient Noncompliance|1
5860226|NCT02073682|20267341|P2|Overall Study|Cancer Cured|15
5860227|NCT02073682|20267342|P1|Overall Study|Cancer Cured|10
5860228|NCT02073682|20267341|P2|Overall Study|Death|100
5860229|NCT02073682|20267342|P1|Overall Study|Death|86
5860230|NCT02073682|20267341|P2|Overall Study|Low Creatinine Clearance|2
5860231|NCT02073682|20267342|P1|Overall Study|Low Creatinine Clearance|1
5860232|NCT02073656|20267360|P1|Primary Study|Withdrew Consent|1
5860233|NCT02073656|20267360|P1|Primary Study|Death|1
5860234|NCT02073656|20267360|P1|Primary Study|Lost to Follow-up|6
5860235|NCT02073643|20267376|P1|Overall Study|Lost to Follow-up|24
5860236|NCT02073565|20267387|P2|Cohort C|Lost to Follow-up|2
5860237|NCT02073565|20267388|P1|Cohort C|Lost to Follow-up|0
5860238|NCT02073565|20267387|P2|Cohort C|Withdrawal by Subject|2
5860239|NCT02073565|20267388|P1|Cohort C|Withdrawal by Subject|0
5860240|NCT02073565|20267387|P2|Cohort B|Withdrawal by Subject|2
5860241|NCT02073565|20267388|P1|Cohort B|Withdrawal by Subject|1
5860242|NCT02073565|20267387|P2|Cohort A|Withdrawal by Subject|0
5860243|NCT02073565|20267388|P1|Cohort A|Withdrawal by Subject|1
5860244|NCT02073279|20267479|P2|Open-label Extension Period|On-going in Study|13
5860245|NCT02073279|20267480|P1|Open-label Extension Period|On-going in Study|14
5860246|NCT02073279|20267479|P2|Open-label Extension Period|Reason Not Specified|1
5860247|NCT02073279|20267480|P1|Open-label Extension Period|Reason Not Specified|1
5860248|NCT02073279|20267479|P2|Open-label Extension Period|Withdrawal by Subject|1
5860249|NCT02073279|20267480|P1|Open-label Extension Period|Withdrawal by Subject|1
5860250|NCT02073279|20267479|P2|Open-label Extension Period|Refused Treatment/Did Not Cooperate|1
5860251|NCT02073279|20267480|P1|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0
5860252|NCT02073279|20267479|P2|Open-label Extension Period|Lack of Efficacy|0
5860253|NCT02073279|20267480|P1|Open-label Extension Period|Lack of Efficacy|1
5860254|NCT02073279|20267479|P2|Double-blind Period|On-going in Study|40
5860255|NCT02073279|20267480|P1|Double-blind Period|On-going in Study|11
5860256|NCT02073279|20267479|P2|Double-blind Period|Refused Treatment/Did Not Cooperate|1
5860257|NCT02073279|20267480|P1|Double-blind Period|Refused Treatment/Did Not Cooperate|0
5860258|NCT02073279|20267479|P2|Double-blind Period|Reason Not Specified|2
5860259|NCT02073279|20267480|P1|Double-blind Period|Reason Not Specified|1
5860260|NCT02073279|20267479|P2|Double-blind Period|Withdrawal by Subject|2
5860261|NCT02073279|20267480|P1|Double-blind Period|Withdrawal by Subject|2
5860262|NCT02073279|20267479|P2|Double-blind Period|Protocol Deviation|1
5860263|NCT02073279|20267480|P1|Double-blind Period|Protocol Deviation|0
5860264|NCT02073279|20267479|P2|Double-blind Period|Adverse Event|1
5860265|NCT02073279|20267480|P1|Double-blind Period|Adverse Event|1
5860266|NCT02072980|20267583|P2|Period 2, Second Wear|Adverse Event|1
5860267|NCT02072980|20267584|P1|Period 2, Second Wear|Adverse Event|0
5860268|NCT02072941|20267592|P2|Overall Study|Removed by Study Staff|2
5860269|NCT02072941|20267593|P1|Overall Study|Removed by Study Staff|2
5860270|NCT02072941|20267592|P2|Overall Study|Death|2
5860271|NCT02072941|20267593|P1|Overall Study|Death|3
5860272|NCT02072941|20267592|P2|Overall Study|Lost to Follow-up|4
5860273|NCT02072941|20267593|P1|Overall Study|Lost to Follow-up|4
5860274|NCT02072941|20267592|P2|Overall Study|Withdrawal by Subject|21
5860275|NCT02072941|20267593|P1|Overall Study|Withdrawal by Subject|29
5860276|NCT02072824|20267608|P3|Overall Study|Adverse Event|1
5860277|NCT02072824|20267609|P2|Overall Study|Adverse Event|0
5860278|NCT02072824|20267610|P1|Overall Study|Adverse Event|0
5860279|NCT02072824|20267608|P3|Overall Study|Medication error|0
5860280|NCT02072824|20267609|P2|Overall Study|Medication error|1
5860281|NCT02072824|20267610|P1|Overall Study|Medication error|0
5860282|NCT02072824|20267608|P3|Overall Study|No longer willing to participate|1
5860283|NCT02072824|20267609|P2|Overall Study|No longer willing to participate|0
5860284|NCT02072824|20267610|P1|Overall Study|No longer willing to participate|1
5860285|NCT02072824|20267608|P3|Overall Study|Insufficient clinical response|1
5860286|NCT02072824|20267609|P2|Overall Study|Insufficient clinical response|0
5860287|NCT02072824|20267610|P1|Overall Study|Insufficient clinical response|1
5860288|NCT02072668|20267645|P2|Second Intervention|Lost to Follow-up|0
5860289|NCT02072668|20267646|P1|Second Intervention|Lost to Follow-up|1
5860290|NCT02072434|20267686|P2|Overall Study|Lost to Follow-up|1
5860291|NCT02072434|20267687|P1|Overall Study|Lost to Follow-up|0
5860292|NCT02072434|20267686|P2|Overall Study|Other|29
5860293|NCT02072434|20267687|P1|Overall Study|Other|14
5860294|NCT02072434|20267686|P2|Overall Study|Withdrawal by Subject|29
5860295|NCT02072434|20267687|P1|Overall Study|Withdrawal by Subject|17
5860296|NCT02072434|20267686|P2|Overall Study|Adverse Event|6
5860297|NCT02072434|20267687|P1|Overall Study|Adverse Event|7
5860298|NCT02072434|20267686|P2|Overall Study|Adverse event, serious fatal|6
5860299|NCT02072434|20267687|P1|Overall Study|Adverse event, serious fatal|1
5860300|NCT02072434|20267686|P2|Overall Study|Physician Decision|10
5860301|NCT02072434|20267687|P1|Overall Study|Physician Decision|5
5860302|NCT02072434|20267686|P2|Overall Study|Protocol Violation|9
5860303|NCT02072434|20267687|P1|Overall Study|Protocol Violation|10
5860304|NCT02072226|20267707|P2|Overall Study|Patient Withdrawal of Consent|0
5860305|NCT02072226|20267708|P1|Overall Study|Patient Withdrawal of Consent|1
5860306|NCT02072226|20267707|P2|Overall Study|Death|0
5860307|NCT02072226|20267708|P1|Overall Study|Death|1
5860308|NCT02072226|20267707|P2|Overall Study|Patient Non-compliance|3
5860309|NCT02072226|20267708|P1|Overall Study|Patient Non-compliance|2
5860310|NCT02072226|20267707|P2|Overall Study|Lost to Follow-up|7
5860311|NCT02072226|20267708|P1|Overall Study|Lost to Follow-up|11
5860312|NCT02072174|20267738|P2|Overall Study|Non-compliance with protocol requirement|0
5860313|NCT02072174|20267739|P1|Overall Study|Non-compliance with protocol requirement|2
5860314|NCT02072174|20267738|P2|Overall Study|Physician Decision|1
5860315|NCT02072174|20267739|P1|Overall Study|Physician Decision|0
5860316|NCT02072174|20267738|P2|Overall Study|Protocol Violation|23
5860317|NCT02072174|20267739|P1|Overall Study|Protocol Violation|16
5860318|NCT02072174|20267738|P2|Overall Study|Did Not Meet In-/Exclusion Criteria|15
5860319|NCT02072174|20267739|P1|Overall Study|Did Not Meet In-/Exclusion Criteria|14
5860320|NCT02072096|20267763|P2|Overall Study|Lost to Follow-up|0
5860321|NCT02072096|20267764|P1|Overall Study|Lost to Follow-up|1
5860322|NCT02072096|20267763|P2|Overall Study|Study Terminated by Sponsor|30
5860323|NCT02072096|20267764|P1|Overall Study|Study Terminated by Sponsor|43
5860324|NCT02072096|20267763|P2|Overall Study|Physician Decision|1
5860325|NCT02072096|20267764|P1|Overall Study|Physician Decision|0
5860326|NCT02072096|20267763|P2|Overall Study|Death|0
5860327|NCT02072096|20267764|P1|Overall Study|Death|2
5860328|NCT02072096|20267763|P2|Overall Study|No Reason Provided|2
5860329|NCT02072096|20267764|P1|Overall Study|No Reason Provided|4
5860330|NCT02072096|20267763|P2|Overall Study|Adverse Event|2
5860331|NCT02072096|20267764|P1|Overall Study|Adverse Event|5
5860332|NCT02072096|20267763|P2|Overall Study|Withdrawal by Subject|7
5860333|NCT02072096|20267764|P1|Overall Study|Withdrawal by Subject|5
5860334|NCT02072096|20267763|P2|Overall Study|Protocol Violation|7
5860335|NCT02072096|20267764|P1|Overall Study|Protocol Violation|7
5860336|NCT02072096|20267763|P2|Overall Study|Lack of Efficacy|29
5860337|NCT02072096|20267764|P1|Overall Study|Lack of Efficacy|18
5860338|NCT02071849|20267815|P1|2-year Extended Follow-up|Adverse Event|1
5860339|NCT02071849|20267815|P1|6-month Primary Endpoint|Adverse Event|1
5860340|NCT02071849|20267815|P1|6-month Primary Endpoint|Did not receive device|4
5860341|NCT02071771|20267881|P2|Period 1: First 10 Days|Unavailable lens power|0
5860342|NCT02071771|20267882|P1|Period 1: First 10 Days|Unavailable lens power|1
5860343|NCT02071771|20267881|P2|Period 1: First 10 Days|Unacceptable lens fit|0
5860344|NCT02071771|20267882|P1|Period 1: First 10 Days|Unacceptable lens fit|1
5860345|NCT02071706|20267890|P1|Overall Study|Withdrawal by Subject|2
5860346|NCT02071706|20267890|P1|Overall Study|Adverse Event|1
5860347|NCT02071290|20267906|P2|Overall Study|Physician Decision|1
5860348|NCT02071290|20267907|P1|Overall Study|Physician Decision|0
5860349|NCT02071290|20267906|P2|Overall Study|Protocol Violation|5
5860350|NCT02071290|20267907|P1|Overall Study|Protocol Violation|3
5860351|NCT02071290|20267906|P2|Overall Study|Withdrawal by Subject|1
5860352|NCT02071290|20267907|P1|Overall Study|Withdrawal by Subject|0
5860353|NCT02071290|20267906|P2|Overall Study|Death|0
5860354|NCT02071290|20267907|P1|Overall Study|Death|1
5860355|NCT02071225|20267961|P1|Overall Study|Death|25
5860356|NCT02071225|20267961|P1|Overall Study|Lost to Follow-up|2
5860357|NCT02071225|20267961|P1|Overall Study|Protocol Deviation|1
5860358|NCT02071225|20267961|P1|Overall Study|Withdrawal of Consent|2
5860359|NCT02071082|20268036|P2|Overall Study|Lost to Follow-up|1
5860360|NCT02071082|20268037|P1|Overall Study|Lost to Follow-up|1
5860361|NCT02071082|20268036|P2|Overall Study|Withdrew Consent|4
5860362|NCT02071082|20268037|P1|Overall Study|Withdrew Consent|0
5860363|NCT02071082|20268036|P2|Overall Study|Adverse Event|1
5860364|NCT02071082|20268037|P1|Overall Study|Adverse Event|0
5860365|NCT02071082|20268036|P2|Overall Study|Enrolled and Never Treated|1
5860366|NCT02071082|20268037|P1|Overall Study|Enrolled and Never Treated|1
5860367|NCT02070991|20268067|P2|Overall Study|Withdrawal by Subject|0
5860368|NCT02070991|20268068|P1|Overall Study|Withdrawal by Subject|1
5860369|NCT02070991|20268067|P2|Overall Study|Death|0
5860370|NCT02070991|20268068|P1|Overall Study|Death|2
5860371|NCT02070978|20268091|P3|Overall Study|Terminated by Sponsor|39
5860372|NCT02070978|20268092|P2|Overall Study|Terminated by Sponsor|40
5860373|NCT02070978|20268093|P1|Overall Study|Terminated by Sponsor|33
5860374|NCT02070978|20268091|P3|Overall Study|Un-specified|2
5860375|NCT02070978|20268092|P2|Overall Study|Un-specified|2
5860376|NCT02070978|20268093|P1|Overall Study|Un-specified|3
5860377|NCT02070978|20268091|P3|Overall Study|Death|2
5860378|NCT02070978|20268092|P2|Overall Study|Death|0
5860379|NCT02070978|20268093|P1|Overall Study|Death|0
5860380|NCT02070978|20268091|P3|Overall Study|Lack of Efficacy|0
5860381|NCT02070978|20268092|P2|Overall Study|Lack of Efficacy|1
5860382|NCT02070978|20268093|P1|Overall Study|Lack of Efficacy|0
5860383|NCT02070978|20268091|P3|Overall Study|Protocol Violation|3
5860384|NCT02070978|20268092|P2|Overall Study|Protocol Violation|0
5860385|NCT02070978|20268093|P1|Overall Study|Protocol Violation|1
5860386|NCT02070978|20268091|P3|Overall Study|Withdrawal by Subject|3
5860387|NCT02070978|20268092|P2|Overall Study|Withdrawal by Subject|5
5860388|NCT02070978|20268093|P1|Overall Study|Withdrawal by Subject|3
5860389|NCT02070978|20268091|P3|Overall Study|Lost to Follow-up|4
5860390|NCT02070978|20268092|P2|Overall Study|Lost to Follow-up|3
5860391|NCT02070978|20268093|P1|Overall Study|Lost to Follow-up|1
5860392|NCT02070978|20268091|P3|Overall Study|Adverse Event|0
5860393|NCT02070978|20268092|P2|Overall Study|Adverse Event|2
5860394|NCT02070978|20268093|P1|Overall Study|Adverse Event|6
5860395|NCT02070965|20268155|P3|Overall Study|Subject moved|0
5860396|NCT02070965|20268156|P2|Overall Study|Subject moved|0
5860397|NCT02070965|20268157|P1|Overall Study|Subject moved|1
5860398|NCT02070965|20268155|P3|Overall Study|Withdrawal by Subject|1
5860399|NCT02070965|20268156|P2|Overall Study|Withdrawal by Subject|1
5860400|NCT02070965|20268157|P1|Overall Study|Withdrawal by Subject|1
5860401|NCT02070965|20268155|P3|Overall Study|Lost to Follow-up|0
5860402|NCT02070965|20268156|P2|Overall Study|Lost to Follow-up|1
5860403|NCT02070965|20268157|P1|Overall Study|Lost to Follow-up|0
5860404|NCT02070757|20268167|P2|Overall Study|Discharged from Study Hospital|2
5860405|NCT02070757|20268168|P1|Overall Study|Discharged from Study Hospital|2
5860406|NCT02070757|20268167|P2|Overall Study|Investigator Decision|2
5860407|NCT02070757|20268168|P1|Overall Study|Investigator Decision|0
5860408|NCT02070757|20268167|P2|Overall Study|Withdrawal by Subject|3
5860409|NCT02070757|20268168|P1|Overall Study|Withdrawal by Subject|1
5860410|NCT02070757|20268167|P2|Overall Study|Protocol Violation|4
5860411|NCT02070757|20268168|P1|Overall Study|Protocol Violation|0
5860412|NCT02070757|20268167|P2|Overall Study|Lost to Follow-up|4
5860413|NCT02070757|20268168|P1|Overall Study|Lost to Follow-up|7
5860414|NCT02070757|20268167|P2|Overall Study|Adverse Event|99
5860415|NCT02070757|20268168|P1|Overall Study|Adverse Event|107
5860416|NCT02070744|20268202|P5|OLE Phase (48 Weeks)|Other|1
5860417|NCT02070744|20268203|P4|OLE Phase (48 Weeks)|Other|0
5860418|NCT02070744|20268204|P3|OLE Phase (48 Weeks)|Other|0
5860419|NCT02070744|20268205|P2|OLE Phase (48 Weeks)|Other|0
5860420|NCT02070744|20268206|P1|OLE Phase (48 Weeks)|Other|0
5860421|NCT02070744|20268202|P5|OLE Phase (48 Weeks)|Withdrawal by Subject|2
5860422|NCT02070744|20268203|P4|OLE Phase (48 Weeks)|Withdrawal by Subject|0
5860423|NCT02070744|20268204|P3|OLE Phase (48 Weeks)|Withdrawal by Subject|0
5860424|NCT02070744|20268205|P2|OLE Phase (48 Weeks)|Withdrawal by Subject|0
5860425|NCT02070744|20268206|P1|OLE Phase (48 Weeks)|Withdrawal by Subject|0
5860426|NCT02070744|20268202|P5|PC Phase (12 Weeks)|Randomized, but not treated|0
5860427|NCT02070744|20268203|P4|PC Phase (12 Weeks)|Randomized, but not treated|1
5860428|NCT02070744|20268204|P3|PC Phase (12 Weeks)|Randomized, but not treated|0
5860429|NCT02070744|20268205|P2|PC Phase (12 Weeks)|Randomized, but not treated|0
5860430|NCT02070744|20268206|P1|PC Phase (12 Weeks)|Randomized, but not treated|0
5860431|NCT02070588|20268289|P3|Overall Study|Adverse Event|0
5860432|NCT02070588|20268290|P2|Overall Study|Adverse Event|0
5860433|NCT02070588|20268291|P1|Overall Study|Adverse Event|1
5860434|NCT02070588|20268289|P3|Overall Study|Writhdrawal due to early termination|0
5860435|NCT02070588|20268290|P2|Overall Study|Writhdrawal due to early termination|0
5860436|NCT02070588|20268291|P1|Overall Study|Writhdrawal due to early termination|9
5860437|NCT02070588|20268289|P3|Overall Study|Withdrawal by Subject|0
5860438|NCT02070588|20268290|P2|Overall Study|Withdrawal by Subject|1
5860439|NCT02070588|20268291|P1|Overall Study|Withdrawal by Subject|29
5860440|NCT02070484|20268307|P2|Overall Study|Withdrawal by Subject|0
5860441|NCT02070484|20268308|P1|Overall Study|Withdrawal by Subject|1
5860442|NCT02070380|20268330|P4|Second Injection|Protocol Violation|5
5860443|NCT02070380|20268331|P3|Second Injection|Protocol Violation|1
5860444|NCT02070380|20268332|P2|Second Injection|Protocol Violation|1
5860445|NCT02070380|20268333|P1|Second Injection|Protocol Violation|0
5860446|NCT02070380|20268330|P4|Second Injection|Image sets missing or technically inadeq|0
5860447|NCT02070380|20268331|P3|Second Injection|Image sets missing or technically inadeq|0
5860448|NCT02070380|20268332|P2|Second Injection|Image sets missing or technically inadeq|1
5860449|NCT02070380|20268333|P1|Second Injection|Image sets missing or technically inadeq|0
5860450|NCT02070380|20268330|P4|Washout (no Second Injection/MRI)|Withdrawal by Subject|3
5860451|NCT02070380|20268331|P3|Washout (no Second Injection/MRI)|Withdrawal by Subject|2
5860452|NCT02070380|20268332|P2|Washout (no Second Injection/MRI)|Withdrawal by Subject|5
5860453|NCT02070380|20268333|P1|Washout (no Second Injection/MRI)|Withdrawal by Subject|0
5860454|NCT02069392|20268475|P2|Overall Study|Withdrawal by Subject|2
5860455|NCT02069392|20268476|P1|Overall Study|Withdrawal by Subject|4
5860456|NCT02069379|20268500|P4|Second Treatment Arm|Lost to Follow-up|0
5860457|NCT02069379|20268501|P3|Second Treatment Arm|Lost to Follow-up|1
5860458|NCT02069379|20268502|P2|Second Treatment Arm|Lost to Follow-up|0
5860459|NCT02069379|20268503|P1|Second Treatment Arm|Lost to Follow-up|0
5860460|NCT02069379|20268500|P4|Washout Period (4 Weeks)|Unrelated event|0
5860461|NCT02069379|20268501|P3|Washout Period (4 Weeks)|Unrelated event|0
5860462|NCT02069379|20268502|P2|Washout Period (4 Weeks)|Unrelated event|1
5860463|NCT02069379|20268503|P1|Washout Period (4 Weeks)|Unrelated event|0
5860464|NCT02069379|20268500|P4|Washout Period (4 Weeks)|Lost to Follow-up|0
5860465|NCT02069379|20268501|P3|Washout Period (4 Weeks)|Lost to Follow-up|0
5860466|NCT02069379|20268502|P2|Washout Period (4 Weeks)|Lost to Follow-up|1
5860467|NCT02069379|20268503|P1|Washout Period (4 Weeks)|Lost to Follow-up|0
5860468|NCT02069379|20268500|P4|First Treatment Arm|Lost to Follow-up|0
5860469|NCT02069379|20268501|P3|First Treatment Arm|Lost to Follow-up|1
5860470|NCT02069379|20268502|P2|First Treatment Arm|Lost to Follow-up|1
5860471|NCT02069379|20268503|P1|First Treatment Arm|Lost to Follow-up|0
5860472|NCT02069379|20268500|P4|Baseline Measurements|Ineligible based on initial assessments|2
5860473|NCT02069379|20268501|P3|Baseline Measurements|Ineligible based on initial assessments|0
5860474|NCT02069379|20268502|P2|Baseline Measurements|Ineligible based on initial assessments|0
5860475|NCT02069379|20268503|P1|Baseline Measurements|Ineligible based on initial assessments|2
5860476|NCT02069379|20268500|P4|Baseline Measurements|Lost to Follow-up|0
5860477|NCT02069379|20268501|P3|Baseline Measurements|Lost to Follow-up|0
5860478|NCT02069379|20268502|P2|Baseline Measurements|Lost to Follow-up|0
5860479|NCT02069379|20268503|P1|Baseline Measurements|Lost to Follow-up|1
5860480|NCT02069093|20268590|P1|Overall Study|Adverse Event|10
5860481|NCT02069093|20268590|P1|Overall Study|Abnormal laboratory values|1
5860482|NCT02069093|20268590|P1|Overall Study|Withdrawal by Subject|2
5860483|NCT02069093|20268590|P1|Overall Study|Administrative problems|1
5860484|NCT02069093|20268590|P1|Overall Study|Death|1
5860485|NCT02069093|20268590|P1|Overall Study|New cancer therapy|1
5860486|NCT02069093|20268590|P1|Overall Study|Disease progression|14
5860487|NCT02069015|20268609|P2|Overall Study|Withdrawal by Subject|1
5860488|NCT02069015|20268610|P1|Overall Study|Withdrawal by Subject|1
5860489|NCT02069015|20268609|P2|Overall Study|Lost to Follow-up|32
5860490|NCT02069015|20268610|P1|Overall Study|Lost to Follow-up|39
5860494|NCT02068768|20268700|P1|Overall Study|Early Termination by Sponsor|2
5860495|NCT02068768|20268700|P1|Overall Study|Lost to Follow-up|5
5860496|NCT02068599|20268709|P3|Overall Study|Noncompliance|1
5860497|NCT02068599|20268710|P2|Overall Study|Noncompliance|0
5860498|NCT02068599|20268711|P1|Overall Study|Noncompliance|0
5860499|NCT02068599|20268709|P3|Overall Study|Lack of Efficacy|3
5860500|NCT02068599|20268710|P2|Overall Study|Lack of Efficacy|0
5860501|NCT02068599|20268711|P1|Overall Study|Lack of Efficacy|0
5860502|NCT02068599|20268709|P3|Overall Study|Lost to Follow-up|0
5860503|NCT02068599|20268710|P2|Overall Study|Lost to Follow-up|0
5860504|NCT02068599|20268711|P1|Overall Study|Lost to Follow-up|1
5860505|NCT02068599|20268709|P3|Overall Study|Protocol Violation|3
5860506|NCT02068599|20268710|P2|Overall Study|Protocol Violation|2
5860507|NCT02068599|20268711|P1|Overall Study|Protocol Violation|4
5860508|NCT02068599|20268709|P3|Overall Study|Withdrawal by Subject|5
5860509|NCT02068599|20268710|P2|Overall Study|Withdrawal by Subject|7
5860510|NCT02068599|20268711|P1|Overall Study|Withdrawal by Subject|2
5860511|NCT02068599|20268709|P3|Overall Study|Adverse Event|1
5860512|NCT02068599|20268710|P2|Overall Study|Adverse Event|1
5860513|NCT02068599|20268711|P1|Overall Study|Adverse Event|4
5860514|NCT02068547|20268751|P2|Overall Study|Physician Decision|0
5860515|NCT02068547|20268752|P1|Overall Study|Physician Decision|1
5860516|NCT02068547|20268751|P2|Overall Study|Lost to Follow-up|3
5860517|NCT02068547|20268752|P1|Overall Study|Lost to Follow-up|3
5860518|NCT02068508|20268762|P1|Overall Study|Protocol Violation|4
5860519|NCT02068508|20268762|P1|Overall Study|Patient did not visit the study site|1
5860520|NCT02068508|20268762|P1|Overall Study|Case report forms uncollected|27
5860521|NCT02068495|20268772|P1|Overall Study|Protocol Deviation|49
5860522|NCT02068495|20268772|P1|Overall Study|Case Report Forms Uncollected|60
5860523|NCT02068443|20268784|P3|Overall Study|Other Reason Not Specified|0
5860524|NCT02068443|20268785|P2|Overall Study|Other Reason Not Specified|0
5860525|NCT02068443|20268786|P1|Overall Study|Other Reason Not Specified|1
5860526|NCT02068443|20268784|P3|Overall Study|Lack of Efficacy|0
5860527|NCT02068443|20268785|P2|Overall Study|Lack of Efficacy|1
5860528|NCT02068443|20268786|P1|Overall Study|Lack of Efficacy|2
5860529|NCT02068443|20268784|P3|Overall Study|Voluntary Withdrawal|1
5860530|NCT02068443|20268785|P2|Overall Study|Voluntary Withdrawal|0
5860531|NCT02068443|20268786|P1|Overall Study|Voluntary Withdrawal|4
5860532|NCT02068443|20268784|P3|Overall Study|Pretreatment Event/Adverse Event|2
5860533|NCT02068443|20268785|P2|Overall Study|Pretreatment Event/Adverse Event|5
5860534|NCT02068443|20268786|P1|Overall Study|Pretreatment Event/Adverse Event|0
5860535|NCT02068222|20268821|P1|Overall Study|Lost to Follow-up|1
5860536|NCT02067728|20268852|P2|6 Month Measurements|Unable to attend|97
5860537|NCT02067728|20268853|P1|6 Month Measurements|Unable to attend|114
5860538|NCT02067728|20268852|P2|6 Month Follow up Survey|Lost to Follow-up|60
5860539|NCT02067728|20268853|P1|6 Month Follow up Survey|Lost to Follow-up|48
5860540|NCT02067728|20268852|P2|Baseline - 1 Month Follow up Survey|Lost to Follow-up|28
5860541|NCT02067728|20268853|P1|Baseline - 1 Month Follow up Survey|Lost to Follow-up|7
5860542|NCT02067676|20268887|P6|Overall Study|Withdrawal by Subject|0
5860543|NCT02067676|20268888|P5|Overall Study|Withdrawal by Subject|0
5860544|NCT02067676|20268889|P4|Overall Study|Withdrawal by Subject|0
5860545|NCT02067676|20268890|P3|Overall Study|Withdrawal by Subject|0
5860546|NCT02067676|20268891|P2|Overall Study|Withdrawal by Subject|0
5860547|NCT02067676|20268892|P1|Overall Study|Withdrawal by Subject|1
5860548|NCT02067663|20268932|P2|Overall Study|Lost to Follow-up|14
5860549|NCT02067663|20268933|P1|Overall Study|Lost to Follow-up|13
5860550|NCT02067533|20269032|P2|Overall Study|Lost to Follow-up|2
5860551|NCT02067533|20269033|P1|Overall Study|Lost to Follow-up|4
5860552|NCT02067104|20269084|P2|Overall Study|Study termination due to low accrual|5
5860553|NCT02067104|20269085|P1|Overall Study|Study termination due to low accrual|4
5860554|NCT02066922|20269114|P1|Overall Study|Adverse Event|1
5860555|NCT02066467|20269183|P1|Overall Study|Not defined|4
5860556|NCT02066467|20269183|P1|Overall Study|Physician Decision|2
5860557|NCT02066467|20269183|P1|Overall Study|Withdrawal by Subject|16
5860558|NCT02066467|20269183|P1|Overall Study|Adverse Event|20
5860559|NCT02066467|20269183|P1|Overall Study|Lost to Follow-up|51
5860560|NCT02066467|20269183|P1|Overall Study|Death|54
5860561|NCT02066467|20269183|P1|Overall Study|Consent ineligible|1
5860562|NCT02066467|20269183|P1|Overall Study|Attempted to implant withoput success|43
5860563|NCT02066467|20269183|P1|Overall Study|Did not undergo implant procedure|24
5860564|NCT02066415|20269192|P3|Overall Study|Lost to Follow-up|2
5860565|NCT02066415|20269193|P2|Overall Study|Lost to Follow-up|2
5860566|NCT02066415|20269194|P1|Overall Study|Lost to Follow-up|7
5860567|NCT02066415|20269192|P3|Overall Study|Withdrawal by Subject|4
5860568|NCT02066415|20269193|P2|Overall Study|Withdrawal by Subject|1
5860569|NCT02066415|20269194|P1|Overall Study|Withdrawal by Subject|9
5860570|NCT02066415|20269192|P3|Overall Study|Decision by Sponsor|2
5860571|NCT02066415|20269193|P2|Overall Study|Decision by Sponsor|4
5860572|NCT02066415|20269194|P1|Overall Study|Decision by Sponsor|5
5860573|NCT02066402|20269219|P2|Overall Study|Protocol driven decision point|1
5860574|NCT02066402|20269220|P1|Overall Study|Protocol driven decision point|0
5860575|NCT02066402|20269219|P2|Overall Study|Progressive disease-clinical progression|1
5860576|NCT02066402|20269220|P1|Overall Study|Progressive disease-clinical progression|0
5860577|NCT02066402|20269219|P2|Overall Study|Withdrawal by Subject|11
5860578|NCT02066402|20269220|P1|Overall Study|Withdrawal by Subject|14
5860579|NCT02066402|20269219|P2|Overall Study|Lost to Follow-up|8
5860580|NCT02066402|20269220|P1|Overall Study|Lost to Follow-up|11
5860581|NCT02066402|20269219|P2|Overall Study|Adverse Event|2
5860582|NCT02066402|20269220|P1|Overall Study|Adverse Event|1
5860583|NCT02066389|20269252|P6|Overall Study|Randomized in Error|1
5860584|NCT02066389|20269253|P5|Overall Study|Randomized in Error|0
5860585|NCT02066389|20269254|P4|Overall Study|Randomized in Error|0
5860586|NCT02066389|20269255|P3|Overall Study|Randomized in Error|0
5860587|NCT02066389|20269256|P2|Overall Study|Randomized in Error|0
5860588|NCT02066389|20269257|P1|Overall Study|Randomized in Error|0
5860589|NCT02066389|20269252|P6|Overall Study|Lost to Follow-up|1
5860590|NCT02066389|20269253|P5|Overall Study|Lost to Follow-up|1
5860591|NCT02066389|20269254|P4|Overall Study|Lost to Follow-up|1
5860592|NCT02066389|20269255|P3|Overall Study|Lost to Follow-up|0
5860593|NCT02066389|20269256|P2|Overall Study|Lost to Follow-up|0
5860594|NCT02066389|20269257|P1|Overall Study|Lost to Follow-up|0
5860595|NCT02066389|20269252|P6|Overall Study|Withdrawal by Subject|2
5860596|NCT02066389|20269253|P5|Overall Study|Withdrawal by Subject|1
5860597|NCT02066389|20269254|P4|Overall Study|Withdrawal by Subject|1
5860598|NCT02066389|20269255|P3|Overall Study|Withdrawal by Subject|5
5860599|NCT02066389|20269256|P2|Overall Study|Withdrawal by Subject|0
5860600|NCT02066389|20269257|P1|Overall Study|Withdrawal by Subject|4
5860601|NCT02066389|20269252|P6|Overall Study|Adverse Event|1
5860602|NCT02066389|20269253|P5|Overall Study|Adverse Event|5
5860603|NCT02066389|20269254|P4|Overall Study|Adverse Event|1
5860604|NCT02066389|20269255|P3|Overall Study|Adverse Event|1
5860605|NCT02066389|20269256|P2|Overall Study|Adverse Event|1
5860606|NCT02066389|20269257|P1|Overall Study|Adverse Event|1
5860607|NCT02066311|20269307|P1|Overall Study|Withdrawal by Subject|1
5860608|NCT02066311|20269307|P1|Overall Study|Adverse Event|4
5860609|NCT02066298|20269317|P6|Overall Study|Physician Decision|0
5860610|NCT02066298|20269318|P5|Overall Study|Physician Decision|1
5860611|NCT02066298|20269319|P4|Overall Study|Physician Decision|0
5860612|NCT02066298|20269320|P3|Overall Study|Physician Decision|1
5860613|NCT02066298|20269321|P2|Overall Study|Physician Decision|0
5860614|NCT02066298|20269322|P1|Overall Study|Physician Decision|0
5860615|NCT02066298|20269317|P6|Overall Study|Withdrawal by Subject|8
5860616|NCT02066298|20269318|P5|Overall Study|Withdrawal by Subject|5
5860617|NCT02066298|20269319|P4|Overall Study|Withdrawal by Subject|4
5860618|NCT02066298|20269320|P3|Overall Study|Withdrawal by Subject|6
5860619|NCT02066298|20269321|P2|Overall Study|Withdrawal by Subject|6
5860620|NCT02066298|20269322|P1|Overall Study|Withdrawal by Subject|6
5860621|NCT02066298|20269317|P6|Overall Study|Lost to Follow-up|4
5860622|NCT02066298|20269318|P5|Overall Study|Lost to Follow-up|3
5860623|NCT02066298|20269319|P4|Overall Study|Lost to Follow-up|2
5860624|NCT02066298|20269320|P3|Overall Study|Lost to Follow-up|3
5860625|NCT02066298|20269321|P2|Overall Study|Lost to Follow-up|2
5860626|NCT02066298|20269322|P1|Overall Study|Lost to Follow-up|3
5860627|NCT02066233|20269346|P2|EG Scan II (Day 1)|difficulty intubating subject|6
5860628|NCT02066233|20269347|P1|EG Scan II (Day 1)|difficulty intubating subject|6
5860629|NCT02066181|20269357|P2|Overall Study|Withdrawal by Subject|1
5860630|NCT02066181|20269358|P1|Overall Study|Withdrawal by Subject|1
5860631|NCT02066129|20269380|P2|Overall Study|Physician Decision|1
5860632|NCT02066129|20269381|P1|Overall Study|Physician Decision|1
5860633|NCT02066129|20269380|P2|Overall Study|Lack of Efficacy|10
5860634|NCT02066129|20269381|P1|Overall Study|Lack of Efficacy|8
5860635|NCT02066129|20269380|P2|Overall Study|Withdrawal by Subject|10
5860636|NCT02066129|20269381|P1|Overall Study|Withdrawal by Subject|7
5860637|NCT02066129|20269380|P2|Overall Study|Lost to Follow-up|12
5860638|NCT02066129|20269381|P1|Overall Study|Lost to Follow-up|13
5860639|NCT02066051|20269395|P1|Overall Study|Subject developed active GVHD|1
5860640|NCT02065895|20269400|P6|Overall Study|Scheduling conflicts|0
5860641|NCT02065895|20269401|P5|Overall Study|Scheduling conflicts|0
5860642|NCT02065895|20269402|P4|Overall Study|Scheduling conflicts|0
5860643|NCT02065895|20269403|P3|Overall Study|Scheduling conflicts|0
5860644|NCT02065895|20269404|P2|Overall Study|Scheduling conflicts|1
5860645|NCT02065895|20269405|P1|Overall Study|Scheduling conflicts|0
5860646|NCT02065895|20269400|P6|Overall Study|Protocol Violation|0
5860647|NCT02065895|20269401|P5|Overall Study|Protocol Violation|0
5860648|NCT02065895|20269402|P4|Overall Study|Protocol Violation|1
5860649|NCT02065895|20269403|P3|Overall Study|Protocol Violation|0
5860650|NCT02065895|20269404|P2|Overall Study|Protocol Violation|0
5860651|NCT02065895|20269405|P1|Overall Study|Protocol Violation|1
5860652|NCT02065791|20269424|P2|Overall Study|Lost to Follow-up|9
5860653|NCT02065791|20269425|P1|Overall Study|Lost to Follow-up|13
5860654|NCT02065791|20269424|P2|Overall Study|Withdrawal by Subject|5
5860655|NCT02065791|20269425|P1|Overall Study|Withdrawal by Subject|11
5860656|NCT02065791|20269424|P2|Overall Study|Closed Site|1
5860657|NCT02065791|20269425|P1|Overall Study|Closed Site|1
5860658|NCT02065713|20269447|P2|Overall Study|Unsatisfactory therapeutic effect|0
5860659|NCT02065713|20269448|P1|Overall Study|Unsatisfactory therapeutic effect|1
5860660|NCT02065713|20269447|P2|Overall Study|Adverse Event|1
5860661|NCT02065713|20269448|P1|Overall Study|Adverse Event|0
5860662|NCT02065622|20269479|P5|Maintenance Study|Unknown Reason|0
5860663|NCT02065622|20269480|P4|Maintenance Study|Unknown Reason|1
5860664|NCT02065622|20269481|P3|Maintenance Study|Unknown Reason|0
5860665|NCT02065622|20269482|P2|Maintenance Study|Unknown Reason|0
5860666|NCT02065622|20269483|P1|Maintenance Study|Unknown Reason|0
5860667|NCT02065622|20269479|P5|Maintenance Study|Other, Not Specified|2
5860668|NCT02065622|20269480|P4|Maintenance Study|Other, Not Specified|14
5860669|NCT02065622|20269481|P3|Maintenance Study|Other, Not Specified|6
5860670|NCT02065622|20269482|P2|Maintenance Study|Other, Not Specified|0
5860671|NCT02065622|20269483|P1|Maintenance Study|Other, Not Specified|0
5860672|NCT02065622|20269479|P5|Maintenance Study|Subject Non-Compliance|2
5860673|NCT02065622|20269480|P4|Maintenance Study|Subject Non-Compliance|3
5860674|NCT02065622|20269481|P3|Maintenance Study|Subject Non-Compliance|1
5860675|NCT02065622|20269482|P2|Maintenance Study|Subject Non-Compliance|0
5860676|NCT02065622|20269483|P1|Maintenance Study|Subject Non-Compliance|0
5860677|NCT02065622|20269479|P5|Maintenance Study|Requires Alternative/Prohibited Therapy|4
5860678|NCT02065622|20269480|P4|Maintenance Study|Requires Alternative/Prohibited Therapy|3
5860679|NCT02065622|20269481|P3|Maintenance Study|Requires Alternative/Prohibited Therapy|7
5860680|NCT02065622|20269482|P2|Maintenance Study|Requires Alternative/Prohibited Therapy|0
5860681|NCT02065622|20269483|P1|Maintenance Study|Requires Alternative/Prohibited Therapy|0
5860682|NCT02065622|20269479|P5|Maintenance Study|Lack of Efficacy|19
5860683|NCT02065622|20269480|P4|Maintenance Study|Lack of Efficacy|55
5860684|NCT02065622|20269481|P3|Maintenance Study|Lack of Efficacy|70
5860685|NCT02065622|20269482|P2|Maintenance Study|Lack of Efficacy|0
5860686|NCT02065622|20269483|P1|Maintenance Study|Lack of Efficacy|0
5860687|NCT02065622|20269479|P5|Maintenance Study|Lost to Follow-up|1
5860688|NCT02065622|20269480|P4|Maintenance Study|Lost to Follow-up|1
5860689|NCT02065622|20269481|P3|Maintenance Study|Lost to Follow-up|4
5860690|NCT02065622|20269482|P2|Maintenance Study|Lost to Follow-up|0
5860691|NCT02065622|20269483|P1|Maintenance Study|Lost to Follow-up|0
5860692|NCT02065622|20269479|P5|Maintenance Study|Withdrawal by Subject|7
5860693|NCT02065622|20269480|P4|Maintenance Study|Withdrawal by Subject|5
5860694|NCT02065622|20269481|P3|Maintenance Study|Withdrawal by Subject|11
5860695|NCT02065622|20269482|P2|Maintenance Study|Withdrawal by Subject|0
5860696|NCT02065622|20269483|P1|Maintenance Study|Withdrawal by Subject|0
5860697|NCT02065622|20269479|P5|Maintenance Study|Adverse Event|11
5860698|NCT02065622|20269480|P4|Maintenance Study|Adverse Event|22
5860699|NCT02065622|20269481|P3|Maintenance Study|Adverse Event|25
5860700|NCT02065622|20269482|P2|Maintenance Study|Adverse Event|0
5860701|NCT02065622|20269483|P1|Maintenance Study|Adverse Event|0
5860702|NCT02065622|20269479|P5|Induction Study|Other, Not Specified|0
5860703|NCT02065622|20269480|P4|Induction Study|Other, Not Specified|0
5860704|NCT02065622|20269481|P3|Induction Study|Other, Not Specified|0
5860705|NCT02065622|20269482|P2|Induction Study|Other, Not Specified|2
5860706|NCT02065622|20269483|P1|Induction Study|Other, Not Specified|3
5860707|NCT02065622|20269479|P5|Induction Study|Subject Noncompliance|0
5860708|NCT02065622|20269480|P4|Induction Study|Subject Noncompliance|0
5860709|NCT02065622|20269481|P3|Induction Study|Subject Noncompliance|0
5860710|NCT02065622|20269482|P2|Induction Study|Subject Noncompliance|1
5860711|NCT02065622|20269483|P1|Induction Study|Subject Noncompliance|1
5860712|NCT02065622|20269479|P5|Induction Study|Requires Alternative/Prohibited Therapy|0
5860713|NCT02065622|20269480|P4|Induction Study|Requires Alternative/Prohibited Therapy|0
5860714|NCT02065622|20269481|P3|Induction Study|Requires Alternative/Prohibited Therapy|0
5860715|NCT02065622|20269482|P2|Induction Study|Requires Alternative/Prohibited Therapy|5
5860716|NCT02065622|20269483|P1|Induction Study|Requires Alternative/Prohibited Therapy|4
5860717|NCT02065622|20269479|P5|Induction Study|Lack of Efficacy|0
5860718|NCT02065622|20269480|P4|Induction Study|Lack of Efficacy|0
5860719|NCT02065622|20269481|P3|Induction Study|Lack of Efficacy|0
5860720|NCT02065622|20269482|P2|Induction Study|Lack of Efficacy|27
5860721|NCT02065622|20269483|P1|Induction Study|Lack of Efficacy|22
5860722|NCT02065622|20269479|P5|Induction Study|Lost to Follow-up|0
5860723|NCT02065622|20269480|P4|Induction Study|Lost to Follow-up|0
5860724|NCT02065622|20269481|P3|Induction Study|Lost to Follow-up|0
5860725|NCT02065622|20269482|P2|Induction Study|Lost to Follow-up|0
5860726|NCT02065622|20269483|P1|Induction Study|Lost to Follow-up|1
5860727|NCT02065622|20269479|P5|Induction Study|Withdrawal by Subject|0
5860728|NCT02065622|20269480|P4|Induction Study|Withdrawal by Subject|0
5860729|NCT02065622|20269481|P3|Induction Study|Withdrawal by Subject|0
5860730|NCT02065622|20269482|P2|Induction Study|Withdrawal by Subject|5
5860731|NCT02065622|20269483|P1|Induction Study|Withdrawal by Subject|3
5860732|NCT02065622|20269479|P5|Induction Study|Adverse Event|0
5860733|NCT02065622|20269480|P4|Induction Study|Adverse Event|0
5860734|NCT02065622|20269481|P3|Induction Study|Adverse Event|0
5860735|NCT02065622|20269482|P2|Induction Study|Adverse Event|19
5860736|NCT02065622|20269483|P1|Induction Study|Adverse Event|13
5860737|NCT02065557|20269585|P6|Maintenance Period|Subject Non-Compliance|1
5860738|NCT02065557|20269586|P5|Maintenance Period|Subject Non-Compliance|0
5860739|NCT02065557|20269587|P4|Maintenance Period|Subject Non-Compliance|0
5860740|NCT02065557|20269588|P3|Maintenance Period|Subject Non-Compliance|0
5860741|NCT02065557|20269589|P2|Maintenance Period|Subject Non-Compliance|0
5860742|NCT02065557|20269590|P1|Maintenance Period|Subject Non-Compliance|0
5860743|NCT02065557|20269585|P6|Maintenance Period|Lack of Efficacy|2
5860744|NCT02065557|20269586|P5|Maintenance Period|Lack of Efficacy|5
5860745|NCT02065557|20269587|P4|Maintenance Period|Lack of Efficacy|0
5860746|NCT02065557|20269588|P3|Maintenance Period|Lack of Efficacy|0
5860747|NCT02065557|20269589|P2|Maintenance Period|Lack of Efficacy|0
5860748|NCT02065557|20269590|P1|Maintenance Period|Lack of Efficacy|0
5860749|NCT02065557|20269585|P6|Maintenance Period|Withdrawal by Subject|1
5860750|NCT02065557|20269586|P5|Maintenance Period|Withdrawal by Subject|2
5860751|NCT02065557|20269587|P4|Maintenance Period|Withdrawal by Subject|0
5860752|NCT02065557|20269588|P3|Maintenance Period|Withdrawal by Subject|0
5860753|NCT02065557|20269589|P2|Maintenance Period|Withdrawal by Subject|0
5860754|NCT02065557|20269590|P1|Maintenance Period|Withdrawal by Subject|0
5860755|NCT02065557|20269585|P6|Maintenance Period|Requires Alternative/Prohibited Therapy|0
5860756|NCT02065557|20269586|P5|Maintenance Period|Requires Alternative/Prohibited Therapy|1
5860757|NCT02065557|20269587|P4|Maintenance Period|Requires Alternative/Prohibited Therapy|1
5860758|NCT02065557|20269588|P3|Maintenance Period|Requires Alternative/Prohibited Therapy|0
5860759|NCT02065557|20269589|P2|Maintenance Period|Requires Alternative/Prohibited Therapy|0
5860760|NCT02065557|20269590|P1|Maintenance Period|Requires Alternative/Prohibited Therapy|0
5860761|NCT02065557|20269585|P6|Induction Period|Adverse Event|0
5860762|NCT02065557|20269586|P5|Induction Period|Adverse Event|0
5860763|NCT02065557|20269587|P4|Induction Period|Adverse Event|0
5860764|NCT02065557|20269588|P3|Induction Period|Adverse Event|0
5860765|NCT02065557|20269589|P2|Induction Period|Adverse Event|1
5860766|NCT02065557|20269590|P1|Induction Period|Adverse Event|1
5860767|NCT02065557|20269585|P6|Induction Period|Non-Responder at Week 8|0
5860768|NCT02065557|20269586|P5|Induction Period|Non-Responder at Week 8|0
5860769|NCT02065557|20269587|P4|Induction Period|Non-Responder at Week 8|0
5860770|NCT02065557|20269588|P3|Induction Period|Non-Responder at Week 8|0
5860771|NCT02065557|20269589|P2|Induction Period|Non-Responder at Week 8|4
5860772|NCT02065557|20269590|P1|Induction Period|Non-Responder at Week 8|4
5860773|NCT02065557|20269585|P6|Induction Period|Requires Alternative/Prohibited Therapy|0
5860774|NCT02065557|20269586|P5|Induction Period|Requires Alternative/Prohibited Therapy|0
5860775|NCT02065557|20269587|P4|Induction Period|Requires Alternative/Prohibited Therapy|0
5860776|NCT02065557|20269588|P3|Induction Period|Requires Alternative/Prohibited Therapy|1
5860777|NCT02065557|20269589|P2|Induction Period|Requires Alternative/Prohibited Therapy|1
5860778|NCT02065557|20269590|P1|Induction Period|Requires Alternative/Prohibited Therapy|1
5860779|NCT02065557|20269585|P6|Induction Period|Lack of Efficacy|0
5860780|NCT02065557|20269586|P5|Induction Period|Lack of Efficacy|0
5860781|NCT02065557|20269587|P4|Induction Period|Lack of Efficacy|0
5860782|NCT02065557|20269588|P3|Induction Period|Lack of Efficacy|1
5860783|NCT02065557|20269589|P2|Induction Period|Lack of Efficacy|1
5860784|NCT02065557|20269590|P1|Induction Period|Lack of Efficacy|2
5860785|NCT02065557|20269585|P6|Induction Period|Withdrawal by Subject|0
5860786|NCT02065557|20269586|P5|Induction Period|Withdrawal by Subject|0
5860787|NCT02065557|20269587|P4|Induction Period|Withdrawal by Subject|0
5860788|NCT02065557|20269588|P3|Induction Period|Withdrawal by Subject|0
5860789|NCT02065557|20269589|P2|Induction Period|Withdrawal by Subject|1
5860790|NCT02065557|20269590|P1|Induction Period|Withdrawal by Subject|2
5860791|NCT02065518|20269651|P4|Overall Study|Withdrawal by Subject|2
5860792|NCT02065518|20269652|P3|Overall Study|Withdrawal by Subject|9
5860793|NCT02065518|20269653|P2|Overall Study|Withdrawal by Subject|4
5860794|NCT02065518|20269654|P1|Overall Study|Withdrawal by Subject|3
5860795|NCT02065518|20269651|P4|Overall Study|Lost to Follow-up|3
5860796|NCT02065518|20269652|P3|Overall Study|Lost to Follow-up|0
5860797|NCT02065518|20269653|P2|Overall Study|Lost to Follow-up|4
5860798|NCT02065518|20269654|P1|Overall Study|Lost to Follow-up|3
5860799|NCT02065336|20269729|P10|Extension Phase|Study Terminated by Sponsor|8
5860800|NCT02065336|20269730|P9|Extension Phase|Study Terminated by Sponsor|2
5860801|NCT02065336|20269731|P8|Extension Phase|Study Terminated by Sponsor|0
5860802|NCT02065336|20269732|P7|Extension Phase|Study Terminated by Sponsor|0
5860803|NCT02065336|20269733|P6|Extension Phase|Study Terminated by Sponsor|0
5860804|NCT02065336|20269734|P5|Extension Phase|Study Terminated by Sponsor|0
5860805|NCT02065336|20269735|P4|Extension Phase|Study Terminated by Sponsor|0
5860806|NCT02065336|20269736|P3|Extension Phase|Study Terminated by Sponsor|0
5860807|NCT02065336|20269737|P2|Extension Phase|Study Terminated by Sponsor|0
5860808|NCT02065336|20269738|P1|Extension Phase|Study Terminated by Sponsor|0
5860809|NCT02064920|20270015|P2|Overall Study|Withdrawal by Subject|3
5860810|NCT02064920|20270016|P1|Overall Study|Withdrawal by Subject|1
5860811|NCT02064920|20270015|P2|Overall Study|Technical Problems|1
5860812|NCT02064920|20270016|P1|Overall Study|Technical Problems|0
5860813|NCT02064920|20270015|P2|Overall Study|Physician Decision|1
5860814|NCT02064920|20270016|P1|Overall Study|Physician Decision|0
5860815|NCT02064920|20270015|P2|Overall Study|Adverse Event|4
5860816|NCT02064920|20270016|P1|Overall Study|Adverse Event|0
5860817|NCT02064894|20270046|P3|Overall Study|Withdrawal by Subject|115
5860818|NCT02064894|20270047|P2|Overall Study|Withdrawal by Subject|102
5860819|NCT02064894|20270048|P1|Overall Study|Withdrawal by Subject|43
5860820|NCT02064868|20270061|P2|Overall Study|Technical Problems or Missing|2
5860821|NCT02064868|20270062|P1|Overall Study|Technical Problems or Missing|5
5860822|NCT02064868|20270061|P2|Overall Study|Withdrawal by Subject|3
5860823|NCT02064868|20270062|P1|Overall Study|Withdrawal by Subject|14
5860824|NCT02064868|20270061|P2|Overall Study|Physician Decision|0
5860825|NCT02064868|20270062|P1|Overall Study|Physician Decision|1
5860826|NCT02064868|20270061|P2|Overall Study|Lost to Follow-up|8
5860827|NCT02064868|20270062|P1|Overall Study|Lost to Follow-up|14
5860828|NCT02064816|20270082|P2|Overall Study|Other|3
5860829|NCT02064816|20270083|P1|Overall Study|Other|1
5860830|NCT02064816|20270082|P2|Overall Study|Therapeutic failure|1
5860831|NCT02064816|20270083|P1|Overall Study|Therapeutic failure|0
5860832|NCT02064816|20270082|P2|Overall Study|Lost to Follow-up|1
5860833|NCT02064816|20270083|P1|Overall Study|Lost to Follow-up|2
5860834|NCT02064816|20270082|P2|Overall Study|Withdrawal by Subject|1
5860835|NCT02064816|20270083|P1|Overall Study|Withdrawal by Subject|2
5860836|NCT02064816|20270082|P2|Overall Study|Adverse Event|2
5860837|NCT02064816|20270083|P1|Overall Study|Adverse Event|3
5860838|NCT02064439|20270129|P3|Overall Study|Other|7
5860839|NCT02064439|20270130|P2|Overall Study|Other|2
5860840|NCT02064439|20270131|P1|Overall Study|Other|2
5860841|NCT02064439|20270129|P3|Overall Study|Safety outcome reached|10
5860842|NCT02064439|20270130|P2|Overall Study|Safety outcome reached|20
5860843|NCT02064439|20270131|P1|Overall Study|Safety outcome reached|12
5860844|NCT02064439|20270129|P3|Overall Study|Efficacy outcome reached|57
5860845|NCT02064439|20270130|P2|Overall Study|Efficacy outcome reached|16
5860846|NCT02064439|20270131|P1|Overall Study|Efficacy outcome reached|18
5860847|NCT02064439|20270129|P3|Overall Study|Logistical difficulties|2
5860848|NCT02064439|20270130|P2|Overall Study|Logistical difficulties|5
5860849|NCT02064439|20270131|P1|Overall Study|Logistical difficulties|6
5860850|NCT02064439|20270129|P3|Overall Study|Physician Decision|1
5860851|NCT02064439|20270130|P2|Overall Study|Physician Decision|1
5860852|NCT02064439|20270131|P1|Overall Study|Physician Decision|0
5860853|NCT02064439|20270129|P3|Overall Study|Non-compliance with study medication|23
5860854|NCT02064439|20270130|P2|Overall Study|Non-compliance with study medication|19
5860855|NCT02064439|20270131|P1|Overall Study|Non-compliance with study medication|21
5860856|NCT02064439|20270129|P3|Overall Study|Lost to Follow-up|4
5860857|NCT02064439|20270130|P2|Overall Study|Lost to Follow-up|3
5860858|NCT02064439|20270131|P1|Overall Study|Lost to Follow-up|1
5860859|NCT02064439|20270129|P3|Overall Study|Protocol Violation|3
5860860|NCT02064439|20270130|P2|Overall Study|Protocol Violation|5
5860861|NCT02064439|20270131|P1|Overall Study|Protocol Violation|3
5860862|NCT02064439|20270129|P3|Overall Study|Withdrawal by Subject|26
5860863|NCT02064439|20270130|P2|Overall Study|Withdrawal by Subject|18
5860864|NCT02064439|20270131|P1|Overall Study|Withdrawal by Subject|29
5860865|NCT02064439|20270129|P3|Overall Study|Death|3
5860866|NCT02064439|20270130|P2|Overall Study|Death|2
5860867|NCT02064439|20270131|P1|Overall Study|Death|0
5860868|NCT02064439|20270129|P3|Overall Study|Adverse Event|46
5860869|NCT02064439|20270130|P2|Overall Study|Adverse Event|47
5860870|NCT02064439|20270131|P1|Overall Study|Adverse Event|51
5860871|NCT02064387|20270160|P12|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0
5860872|NCT02064387|20270161|P11|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|1
5860873|NCT02064387|20270162|P10|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0
5860874|NCT02064387|20270163|P9|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0
5860875|NCT02064387|20270164|P8|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0
5860876|NCT02064387|20270165|P7|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0
5860877|NCT02064387|20270166|P6|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0
5860878|NCT02064387|20270167|P5|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0
5860879|NCT02064387|20270168|P4|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0
5860880|NCT02064387|20270169|P3|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0
5860881|NCT02064387|20270170|P2|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0
5860882|NCT02064387|20270171|P1|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0
5860883|NCT02064387|20270160|P12|Part 2 Max 35 Months Followup Duration|Death|3
5860884|NCT02064387|20270161|P11|Part 2 Max 35 Months Followup Duration|Death|5
5860885|NCT02064387|20270162|P10|Part 2 Max 35 Months Followup Duration|Death|0
5860886|NCT02064387|20270163|P9|Part 2 Max 35 Months Followup Duration|Death|0
5860887|NCT02064387|20270164|P8|Part 2 Max 35 Months Followup Duration|Death|0
5860888|NCT02064387|20270165|P7|Part 2 Max 35 Months Followup Duration|Death|0
5860889|NCT02064387|20270166|P6|Part 2 Max 35 Months Followup Duration|Death|0
5860890|NCT02064387|20270167|P5|Part 2 Max 35 Months Followup Duration|Death|0
5860891|NCT02064387|20270168|P4|Part 2 Max 35 Months Followup Duration|Death|0
5860892|NCT02064387|20270169|P3|Part 2 Max 35 Months Followup Duration|Death|0
5860893|NCT02064387|20270170|P2|Part 2 Max 35 Months Followup Duration|Death|0
5860894|NCT02064387|20270171|P1|Part 2 Max 35 Months Followup Duration|Death|0
5860895|NCT02064387|20270160|P12|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0
5860896|NCT02064387|20270161|P11|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0
5860897|NCT02064387|20270162|P10|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0
5860898|NCT02064387|20270163|P9|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|1
5860899|NCT02064387|20270164|P8|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0
5860900|NCT02064387|20270165|P7|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0
5860901|NCT02064387|20270166|P6|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0
5860902|NCT02064387|20270167|P5|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0
5860903|NCT02064387|20270168|P4|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0
5860904|NCT02064387|20270169|P3|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0
5860905|NCT02064387|20270170|P2|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0
5860906|NCT02064387|20270171|P1|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0
5860907|NCT02064387|20270160|P12|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0
5860908|NCT02064387|20270161|P11|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0
5860909|NCT02064387|20270162|P10|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0
5860910|NCT02064387|20270163|P9|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0
5860911|NCT02064387|20270164|P8|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|1
5860912|NCT02064387|20270165|P7|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0
5860913|NCT02064387|20270166|P6|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0
5860914|NCT02064387|20270167|P5|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0
5860915|NCT02064387|20270168|P4|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0
5860916|NCT02064387|20270169|P3|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0
5860917|NCT02064387|20270170|P2|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0
5860918|NCT02064387|20270171|P1|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0
5860919|NCT02064387|20270160|P12|Part 1 Max 23.5 Months Followup Duration|Death|0
5860920|NCT02064387|20270161|P11|Part 1 Max 23.5 Months Followup Duration|Death|0
5860921|NCT02064387|20270162|P10|Part 1 Max 23.5 Months Followup Duration|Death|1
5860922|NCT02064387|20270163|P9|Part 1 Max 23.5 Months Followup Duration|Death|0
5860923|NCT02064387|20270164|P8|Part 1 Max 23.5 Months Followup Duration|Death|1
5860924|NCT02064387|20270165|P7|Part 1 Max 23.5 Months Followup Duration|Death|0
5860925|NCT02064387|20270166|P6|Part 1 Max 23.5 Months Followup Duration|Death|0
5860926|NCT02064387|20270167|P5|Part 1 Max 23.5 Months Followup Duration|Death|0
5860927|NCT02064387|20270168|P4|Part 1 Max 23.5 Months Followup Duration|Death|0
5860928|NCT02064387|20270169|P3|Part 1 Max 23.5 Months Followup Duration|Death|0
5860929|NCT02064387|20270170|P2|Part 1 Max 23.5 Months Followup Duration|Death|0
5860930|NCT02064387|20270171|P1|Part 1 Max 23.5 Months Followup Duration|Death|0
5860931|NCT02064231|20270500|P4|Second Test Period (Test B or Test D)|Lack of Efficacy|0
5860932|NCT02064231|20270501|P3|Second Test Period (Test B or Test D)|Lack of Efficacy|0
5860933|NCT02064231|20270502|P2|Second Test Period (Test B or Test D)|Lack of Efficacy|1
5860934|NCT02064231|20270503|P1|Second Test Period (Test B or Test D)|Lack of Efficacy|1
5860935|NCT02064231|20270500|P4|First Test Period (Test A or Test C)|Adverse Event|0
5860936|NCT02064231|20270501|P3|First Test Period (Test A or Test C)|Adverse Event|1
5860937|NCT02064231|20270502|P2|First Test Period (Test A or Test C)|Adverse Event|0
5860938|NCT02064231|20270503|P1|First Test Period (Test A or Test C)|Adverse Event|1
5860939|NCT02064231|20270500|P4|First Test Period (Test A or Test C)|Withdrawal by Subject|0
5860940|NCT02064231|20270501|P3|First Test Period (Test A or Test C)|Withdrawal by Subject|0
5860941|NCT02064231|20270502|P2|First Test Period (Test A or Test C)|Withdrawal by Subject|1
5860942|NCT02064231|20270503|P1|First Test Period (Test A or Test C)|Withdrawal by Subject|1
5860943|NCT02064231|20270500|P4|First Test Period (Test A or Test C)|Lack of Efficacy|0
5860944|NCT02064231|20270501|P3|First Test Period (Test A or Test C)|Lack of Efficacy|0
5860945|NCT02064231|20270502|P2|First Test Period (Test A or Test C)|Lack of Efficacy|3
5860946|NCT02064231|20270503|P1|First Test Period (Test A or Test C)|Lack of Efficacy|5
5860947|NCT02064205|20270515|P1|Overall Study|Withdrawal by Subject|1
5860948|NCT02064166|20270533|P2|Overall Study|Adverse Event|0
5860949|NCT02064166|20270534|P1|Overall Study|Adverse Event|1
5860950|NCT02063880|20270564|P2|Overall Study|Ineligible|2
5860951|NCT02063880|20270565|P1|Overall Study|Ineligible|0
5860952|NCT02063880|20270564|P2|Overall Study|Lost to Follow-up|7
5860953|NCT02063880|20270565|P1|Overall Study|Lost to Follow-up|7
5860954|NCT02063880|20270564|P2|Overall Study|Death|18
5860955|NCT02063880|20270565|P1|Overall Study|Death|21
5860956|NCT02063854|20270603|P7|Overall Study|Did Not Receive Study Drug|0
5860957|NCT02063854|20270604|P6|Overall Study|Did Not Receive Study Drug|1
5860958|NCT02063854|20270605|P5|Overall Study|Did Not Receive Study Drug|0
5860959|NCT02063854|20270606|P4|Overall Study|Did Not Receive Study Drug|0
5860960|NCT02063854|20270607|P3|Overall Study|Did Not Receive Study Drug|0
5860961|NCT02063854|20270608|P2|Overall Study|Did Not Receive Study Drug|0
5860962|NCT02063854|20270609|P1|Overall Study|Did Not Receive Study Drug|0
5860963|NCT02063854|20270603|P7|Overall Study|Reason Not Specified|0
5860964|NCT02063854|20270604|P6|Overall Study|Reason Not Specified|0
5860965|NCT02063854|20270605|P5|Overall Study|Reason Not Specified|0
5860966|NCT02063854|20270606|P4|Overall Study|Reason Not Specified|0
5860967|NCT02063854|20270607|P3|Overall Study|Reason Not Specified|0
5860968|NCT02063854|20270608|P2|Overall Study|Reason Not Specified|0
5860969|NCT02063854|20270609|P1|Overall Study|Reason Not Specified|1
5860970|NCT02063854|20270603|P7|Overall Study|Surgical Dental Work Performed/Planned|1
5860971|NCT02063854|20270604|P6|Overall Study|Surgical Dental Work Performed/Planned|6
5860972|NCT02063854|20270605|P5|Overall Study|Surgical Dental Work Performed/Planned|1
5860973|NCT02063854|20270606|P4|Overall Study|Surgical Dental Work Performed/Planned|1
5860974|NCT02063854|20270607|P3|Overall Study|Surgical Dental Work Performed/Planned|6
5860975|NCT02063854|20270608|P2|Overall Study|Surgical Dental Work Performed/Planned|2
5860976|NCT02063854|20270609|P1|Overall Study|Surgical Dental Work Performed/Planned|5
5860977|NCT02063854|20270603|P7|Overall Study|Voluntary Withdrawal|1
5860978|NCT02063854|20270604|P6|Overall Study|Voluntary Withdrawal|6
5860979|NCT02063854|20270605|P5|Overall Study|Voluntary Withdrawal|3
5860980|NCT02063854|20270606|P4|Overall Study|Voluntary Withdrawal|1
5860981|NCT02063854|20270607|P3|Overall Study|Voluntary Withdrawal|8
5860982|NCT02063854|20270608|P2|Overall Study|Voluntary Withdrawal|0
5860983|NCT02063854|20270609|P1|Overall Study|Voluntary Withdrawal|2
5860984|NCT02063854|20270603|P7|Overall Study|Major Protocol Deviation|0
5860985|NCT02063854|20270604|P6|Overall Study|Major Protocol Deviation|0
5860986|NCT02063854|20270605|P5|Overall Study|Major Protocol Deviation|0
5860987|NCT02063854|20270606|P4|Overall Study|Major Protocol Deviation|0
5860988|NCT02063854|20270607|P3|Overall Study|Major Protocol Deviation|3
5860989|NCT02063854|20270608|P2|Overall Study|Major Protocol Deviation|0
5860990|NCT02063854|20270609|P1|Overall Study|Major Protocol Deviation|0
5860991|NCT02063854|20270603|P7|Overall Study|Pretreatment Event/Adverse Event|4
5860992|NCT02063854|20270604|P6|Overall Study|Pretreatment Event/Adverse Event|18
5860993|NCT02063854|20270605|P5|Overall Study|Pretreatment Event/Adverse Event|7
5860994|NCT02063854|20270606|P4|Overall Study|Pretreatment Event/Adverse Event|8
5860995|NCT02063854|20270607|P3|Overall Study|Pretreatment Event/Adverse Event|13
5860996|NCT02063854|20270608|P2|Overall Study|Pretreatment Event/Adverse Event|10
5860997|NCT02063854|20270609|P1|Overall Study|Pretreatment Event/Adverse Event|13
5860998|NCT02063737|20270693|P2|Overall Study|Lost to Follow-up|4
5860999|NCT02063737|20270694|P1|Overall Study|Lost to Follow-up|11
5861001|NCT02063698|20270734|P2|Overall Study|did not complete booklet for days 2-8|2
5861002|NCT02063698|20270735|P1|Overall Study|did not complete booklet for days 2-8|1
5861003|NCT02063672|20270759|P2|Overall Study|Withdrawal by Subject|2
5861004|NCT02063672|20270760|P1|Overall Study|Withdrawal by Subject|2
5861005|NCT02063672|20270759|P2|Overall Study|Lost to Follow-up|3
5861006|NCT02063672|20270760|P1|Overall Study|Lost to Follow-up|1
5861007|NCT02063672|20270759|P2|Overall Study|Death|3
5861008|NCT02063672|20270760|P1|Overall Study|Death|5
5861009|NCT02063672|20270759|P2|Overall Study|Ongoing Follow-up|14
5861010|NCT02063672|20270760|P1|Overall Study|Ongoing Follow-up|27
5861011|NCT02063659|20270807|P4|Open-Label Extension Period (OLE)|Reason not Specified|2
5861012|NCT02063659|20270808|P3|Open-Label Extension Period (OLE)|Reason not Specified|0
5861013|NCT02063659|20270809|P2|Open-Label Extension Period (OLE)|Reason not Specified|0
5861014|NCT02063659|20270810|P1|Open-Label Extension Period (OLE)|Reason not Specified|0
5861015|NCT02063659|20270807|P4|Open-Label Extension Period (OLE)|Adverse Event|7
5861016|NCT02063659|20270808|P3|Open-Label Extension Period (OLE)|Adverse Event|0
5861017|NCT02063659|20270809|P2|Open-Label Extension Period (OLE)|Adverse Event|0
5861018|NCT02063659|20270810|P1|Open-Label Extension Period (OLE)|Adverse Event|0
5861019|NCT02063659|20270807|P4|Open-Label Extension Period (OLE)|Lack of Efficacy|1
5861020|NCT02063659|20270808|P3|Open-Label Extension Period (OLE)|Lack of Efficacy|0
5861021|NCT02063659|20270809|P2|Open-Label Extension Period (OLE)|Lack of Efficacy|0
5861022|NCT02063659|20270810|P1|Open-Label Extension Period (OLE)|Lack of Efficacy|0
5861023|NCT02063659|20270807|P4|Open-Label Extension Period (OLE)|Withdrawal of Consent|9
5861024|NCT02063659|20270808|P3|Open-Label Extension Period (OLE)|Withdrawal of Consent|0
5861025|NCT02063659|20270809|P2|Open-Label Extension Period (OLE)|Withdrawal of Consent|0
5861026|NCT02063659|20270810|P1|Open-Label Extension Period (OLE)|Withdrawal of Consent|0
5861027|NCT02063659|20270807|P4|Open-Label Extension Period (OLE)|Physician Decision|1
5861028|NCT02063659|20270808|P3|Open-Label Extension Period (OLE)|Physician Decision|0
5861029|NCT02063659|20270809|P2|Open-Label Extension Period (OLE)|Physician Decision|0
5861030|NCT02063659|20270810|P1|Open-Label Extension Period (OLE)|Physician Decision|0
5861031|NCT02063659|20270807|P4|Double-Blind Treatment Period|Withdrawal of consent|0
5861032|NCT02063659|20270808|P3|Double-Blind Treatment Period|Withdrawal of consent|3
5861033|NCT02063659|20270809|P2|Double-Blind Treatment Period|Withdrawal of consent|1
5861034|NCT02063659|20270810|P1|Double-Blind Treatment Period|Withdrawal of consent|0
5861035|NCT02063659|20270807|P4|Double-Blind Treatment Period|Physician Decision|0
5861036|NCT02063659|20270808|P3|Double-Blind Treatment Period|Physician Decision|0
5861037|NCT02063659|20270809|P2|Double-Blind Treatment Period|Physician Decision|0
5861038|NCT02063659|20270810|P1|Double-Blind Treatment Period|Physician Decision|1
5861039|NCT02063659|20270807|P4|Double-Blind Treatment Period|Adverse Event|0
5861040|NCT02063659|20270808|P3|Double-Blind Treatment Period|Adverse Event|0
5861041|NCT02063659|20270809|P2|Double-Blind Treatment Period|Adverse Event|2
5861042|NCT02063659|20270810|P1|Double-Blind Treatment Period|Adverse Event|1
5861043|NCT02063217|20270893|P3|Overall Study|Withdrawal by Subject|0
5861044|NCT02063217|20270894|P2|Overall Study|Withdrawal by Subject|0
5861045|NCT02063217|20270895|P1|Overall Study|Withdrawal by Subject|1
5861046|NCT02062879|20270971|P2|Overall Study|Withdrawal by Subject|1
5861047|NCT02062879|20270972|P1|Overall Study|Withdrawal by Subject|4
5861048|NCT02062658|20271008|P1|Overall Study|Lack of Efficacy|1
5861049|NCT02062658|20271008|P1|Overall Study|Withdrawal by Subject|1
5861050|NCT02062645|20271012|P1|Overall Study|Lost to Follow-up|5
5861051|NCT02062645|20271012|P1|Overall Study|Protocol Violation|8
5861052|NCT02062645|20271012|P1|Overall Study|Adverse Event|2
5861053|NCT02062632|20271020|P1|Overall Study|No treatment data|1
5861054|NCT02062450|20271061|P1|Overall Study|No follow-up visit|124
5861055|NCT02062437|20271075|P1|Overall Study|Pt. couldn't come due to med. condition|1
5861056|NCT02062437|20271075|P1|Overall Study|Death|2
5861057|NCT02062437|20271075|P1|Overall Study|Patient not available for the 2y visit|18
5861058|NCT02062437|20271075|P1|Overall Study|Pt. didn't want to come for the 2y visit|31
5861059|NCT02062398|20271084|P1|Overall Study|Implant removal|1
5861060|NCT02062385|20271096|P4|Overall Study|Lost to Follow-up|0
5861061|NCT02062385|20271097|P3|Overall Study|Lost to Follow-up|1
5861062|NCT02062385|20271098|P2|Overall Study|Lost to Follow-up|0
5861063|NCT02062385|20271099|P1|Overall Study|Lost to Follow-up|0
5861064|NCT02062385|20271096|P4|Overall Study|Death|1
5861065|NCT02062385|20271097|P3|Overall Study|Death|0
5861066|NCT02062385|20271098|P2|Overall Study|Death|0
5861067|NCT02062385|20271099|P1|Overall Study|Death|0
5861068|NCT02062385|20271096|P4|Overall Study|Withdrawn by parent/guardian|8
5861069|NCT02062385|20271097|P3|Overall Study|Withdrawn by parent/guardian|9
5861070|NCT02062385|20271098|P2|Overall Study|Withdrawn by parent/guardian|41
5861071|NCT02062385|20271099|P1|Overall Study|Withdrawn by parent/guardian|46
5861072|NCT02062385|20271096|P4|Overall Study|Moved|0
5861073|NCT02062385|20271097|P3|Overall Study|Moved|1
5861074|NCT02062385|20271098|P2|Overall Study|Moved|11
5861075|NCT02062385|20271099|P1|Overall Study|Moved|10
5861076|NCT02062385|20271096|P4|Overall Study|Incomplete EPI by database lock|0
5861077|NCT02062385|20271097|P3|Overall Study|Incomplete EPI by database lock|0
5861078|NCT02062385|20271098|P2|Overall Study|Incomplete EPI by database lock|0
5861079|NCT02062385|20271099|P1|Overall Study|Incomplete EPI by database lock|2
5861080|NCT02062385|20271096|P4|Overall Study|Protocol Violation|0
5861081|NCT02062385|20271097|P3|Overall Study|Protocol Violation|0
5861082|NCT02062385|20271098|P2|Overall Study|Protocol Violation|0
5861083|NCT02062385|20271099|P1|Overall Study|Protocol Violation|1
5861084|NCT02062385|20271096|P4|Overall Study|Adverse Event|0
5861085|NCT02062385|20271097|P3|Overall Study|Adverse Event|1
5861086|NCT02062385|20271098|P2|Overall Study|Adverse Event|13
5861087|NCT02062385|20271099|P1|Overall Study|Adverse Event|19
5861088|NCT02062151|20271143|P1|Overall Study|screen failure|1
5861089|NCT02061592|20271303|P2|Period 2|Lost to Follow-up|1
5861090|NCT02061592|20271304|P1|Period 2|Lost to Follow-up|0
5861091|NCT02061592|20271303|P2|Period 1|Protocol Violation|0
5861092|NCT02061592|20271304|P1|Period 1|Protocol Violation|1
5861093|NCT02061592|20271303|P2|Period 1|Withdrawal by Subject|0
5861094|NCT02061592|20271304|P1|Period 1|Withdrawal by Subject|1
5861095|NCT02061540|20271316|P1|Overall Study|Withdrawal by Subject|2
5861096|NCT02061540|20271316|P1|Overall Study|Adverse Event|2
5861097|NCT02061280|20271489|P2|Overall Study|Lost to Follow-up|1
5861098|NCT02061280|20271490|P1|Overall Study|Lost to Follow-up|5
5861099|NCT02061280|20271489|P2|Overall Study|Withdrawal by Subject|2
5861100|NCT02061280|20271490|P1|Overall Study|Withdrawal by Subject|1
5861101|NCT02061280|20271489|P2|Overall Study|moved out of state|1
5861102|NCT02061280|20271490|P1|Overall Study|moved out of state|0
5861103|NCT02061280|20271489|P2|Overall Study|Protocol Violation|8
5861104|NCT02061280|20271490|P1|Overall Study|Protocol Violation|12
5861105|NCT02061202|20271522|P2|Overall Study|Lost to Follow-up|1
5861106|NCT02061202|20271523|P1|Overall Study|Lost to Follow-up|1
5861107|NCT02060903|20271549|P2|Overall Study|Withdrawal by Subject|7
5861108|NCT02060903|20271550|P1|Overall Study|Withdrawal by Subject|0
5861109|NCT02060903|20271549|P2|Overall Study|Lost to Follow-up|0
5861110|NCT02060903|20271550|P1|Overall Study|Lost to Follow-up|4
5861111|NCT02060383|20271671|P5|Extension Phase|Protocol Violation|1
5861112|NCT02060383|20271672|P4|Extension Phase|Protocol Violation|0
5861113|NCT02060383|20271673|P3|Extension Phase|Protocol Violation|0
5861114|NCT02060383|20271674|P2|Extension Phase|Protocol Violation|0
5861115|NCT02060383|20271675|P1|Extension Phase|Protocol Violation|0
5861116|NCT02060383|20271671|P5|Extension Phase|Death|1
5861117|NCT02060383|20271672|P4|Extension Phase|Death|0
5861118|NCT02060383|20271673|P3|Extension Phase|Death|1
5861119|NCT02060383|20271674|P2|Extension Phase|Death|0
5861120|NCT02060383|20271675|P1|Extension Phase|Death|0
5861121|NCT02060383|20271671|P5|Extension Phase|Administrative problems|0
5861122|NCT02060383|20271672|P4|Extension Phase|Administrative problems|0
5861123|NCT02060383|20271673|P3|Extension Phase|Administrative problems|0
5861124|NCT02060383|20271674|P2|Extension Phase|Administrative problems|0
5861125|NCT02060383|20271675|P1|Extension Phase|Administrative problems|1
5861126|NCT02060383|20271671|P5|Extension Phase|Withdrawal by Subject|2
5861127|NCT02060383|20271672|P4|Extension Phase|Withdrawal by Subject|0
5861128|NCT02060383|20271673|P3|Extension Phase|Withdrawal by Subject|0
5861129|NCT02060383|20271674|P2|Extension Phase|Withdrawal by Subject|1
5861130|NCT02060383|20271675|P1|Extension Phase|Withdrawal by Subject|0
5861131|NCT02060383|20271671|P5|Extension Phase|Adverse Event|1
5861132|NCT02060383|20271672|P4|Extension Phase|Adverse Event|0
5861133|NCT02060383|20271673|P3|Extension Phase|Adverse Event|2
5861134|NCT02060383|20271674|P2|Extension Phase|Adverse Event|1
5861135|NCT02060383|20271675|P1|Extension Phase|Adverse Event|1
5861136|NCT02060383|20271671|P5|Extension Phase|Unsatisfactory therapeutic effect|2
5861137|NCT02060383|20271672|P4|Extension Phase|Unsatisfactory therapeutic effect|2
5861138|NCT02060383|20271673|P3|Extension Phase|Unsatisfactory therapeutic effect|0
5861139|NCT02060383|20271674|P2|Extension Phase|Unsatisfactory therapeutic effect|1
5861140|NCT02060383|20271675|P1|Extension Phase|Unsatisfactory therapeutic effect|1
5861141|NCT02060383|20271671|P5|Core Phase|Withdrawal by Subject|2
5861142|NCT02060383|20271672|P4|Core Phase|Withdrawal by Subject|4
5861143|NCT02060383|20271673|P3|Core Phase|Withdrawal by Subject|0
5861144|NCT02060383|20271674|P2|Core Phase|Withdrawal by Subject|0
5861145|NCT02060383|20271675|P1|Core Phase|Withdrawal by Subject|0
5861146|NCT02060383|20271671|P5|Core Phase|Protocol Violation|0
5861147|NCT02060383|20271672|P4|Core Phase|Protocol Violation|1
5861148|NCT02060383|20271673|P3|Core Phase|Protocol Violation|0
5861149|NCT02060383|20271674|P2|Core Phase|Protocol Violation|0
5861150|NCT02060383|20271675|P1|Core Phase|Protocol Violation|0
5861151|NCT02060383|20271671|P5|Core Phase|Administrative problems|0
5861152|NCT02060383|20271672|P4|Core Phase|Administrative problems|0
5861153|NCT02060383|20271673|P3|Core Phase|Administrative problems|0
5861154|NCT02060383|20271674|P2|Core Phase|Administrative problems|1
5861155|NCT02060383|20271675|P1|Core Phase|Administrative problems|0
5861156|NCT02060383|20271671|P5|Core Phase|Adverse Event|6
5861157|NCT02060383|20271672|P4|Core Phase|Adverse Event|2
5861158|NCT02060383|20271673|P3|Core Phase|Adverse Event|0
5861159|NCT02060383|20271674|P2|Core Phase|Adverse Event|0
5861160|NCT02060383|20271675|P1|Core Phase|Adverse Event|2
5861161|NCT02060383|20271671|P5|Core Phase|Unsatisfactory therapeutic effect|0
5861162|NCT02060383|20271672|P4|Core Phase|Unsatisfactory therapeutic effect|0
5861163|NCT02060383|20271673|P3|Core Phase|Unsatisfactory therapeutic effect|0
5861164|NCT02060383|20271674|P2|Core Phase|Unsatisfactory therapeutic effect|5
5861165|NCT02060383|20271675|P1|Core Phase|Unsatisfactory therapeutic effect|1
5861166|NCT02060370|20271701|P1|Overall Study|Physician Decision|1
5861167|NCT02059980|20271742|P2|Overall Study|Lost to Follow-up|1
5861168|NCT02059980|20271743|P1|Overall Study|Lost to Follow-up|2
5861169|NCT02059434|20271788|P9|Washout Between Periods 7 and 8|Withdrawal by Subject|1
5861170|NCT02059434|20271789|P8|Washout Between Periods 7 and 8|Withdrawal by Subject|0
5861171|NCT02059434|20271790|P7|Washout Between Periods 7 and 8|Withdrawal by Subject|0
5861172|NCT02059434|20271791|P6|Washout Between Periods 7 and 8|Withdrawal by Subject|0
5861173|NCT02059434|20271792|P5|Washout Between Periods 7 and 8|Withdrawal by Subject|0
5861174|NCT02059434|20271793|P4|Washout Between Periods 7 and 8|Withdrawal by Subject|0
5861175|NCT02059434|20271794|P3|Washout Between Periods 7 and 8|Withdrawal by Subject|0
5861176|NCT02059434|20271795|P2|Washout Between Periods 7 and 8|Withdrawal by Subject|0
5861177|NCT02059434|20271796|P1|Washout Between Periods 7 and 8|Withdrawal by Subject|0
5861178|NCT02059434|20271788|P9|Washout Between Periods 7 and 8|Adverse Event|1
5861179|NCT02059434|20271789|P8|Washout Between Periods 7 and 8|Adverse Event|0
5861180|NCT02059434|20271790|P7|Washout Between Periods 7 and 8|Adverse Event|0
5861181|NCT02059434|20271791|P6|Washout Between Periods 7 and 8|Adverse Event|0
5861182|NCT02059434|20271792|P5|Washout Between Periods 7 and 8|Adverse Event|0
5861183|NCT02059434|20271793|P4|Washout Between Periods 7 and 8|Adverse Event|0
5861184|NCT02059434|20271794|P3|Washout Between Periods 7 and 8|Adverse Event|0
5861185|NCT02059434|20271795|P2|Washout Between Periods 7 and 8|Adverse Event|0
5861186|NCT02059434|20271796|P1|Washout Between Periods 7 and 8|Adverse Event|0
5861187|NCT02059434|20271788|P9|Washout Between Periods 6 and 7|Physician Decision|1
5861188|NCT02059434|20271789|P8|Washout Between Periods 6 and 7|Physician Decision|0
5861189|NCT02059434|20271790|P7|Washout Between Periods 6 and 7|Physician Decision|0
5861190|NCT02059434|20271791|P6|Washout Between Periods 6 and 7|Physician Decision|0
5861191|NCT02059434|20271792|P5|Washout Between Periods 6 and 7|Physician Decision|0
5861192|NCT02059434|20271793|P4|Washout Between Periods 6 and 7|Physician Decision|0
5861193|NCT02059434|20271794|P3|Washout Between Periods 6 and 7|Physician Decision|0
5861194|NCT02059434|20271795|P2|Washout Between Periods 6 and 7|Physician Decision|0
5861195|NCT02059434|20271796|P1|Washout Between Periods 6 and 7|Physician Decision|0
5861196|NCT02059434|20271788|P9|Washout Between Periods 4 and 5|Adverse Event|1
5861197|NCT02059434|20271789|P8|Washout Between Periods 4 and 5|Adverse Event|0
5861198|NCT02059434|20271790|P7|Washout Between Periods 4 and 5|Adverse Event|0
5861199|NCT02059434|20271791|P6|Washout Between Periods 4 and 5|Adverse Event|0
5861200|NCT02059434|20271792|P5|Washout Between Periods 4 and 5|Adverse Event|0
5861201|NCT02059434|20271793|P4|Washout Between Periods 4 and 5|Adverse Event|0
5861202|NCT02059434|20271794|P3|Washout Between Periods 4 and 5|Adverse Event|0
5861203|NCT02059434|20271795|P2|Washout Between Periods 4 and 5|Adverse Event|0
5861204|NCT02059434|20271796|P1|Washout Between Periods 4 and 5|Adverse Event|0
5861205|NCT02059434|20271788|P9|Washout Between Periods 1 and 2|Physician Decision|0
5861206|NCT02059434|20271789|P8|Washout Between Periods 1 and 2|Physician Decision|1
5861207|NCT02059434|20271790|P7|Washout Between Periods 1 and 2|Physician Decision|0
5861208|NCT02059434|20271791|P6|Washout Between Periods 1 and 2|Physician Decision|0
5861209|NCT02059434|20271792|P5|Washout Between Periods 1 and 2|Physician Decision|0
5861210|NCT02059434|20271793|P4|Washout Between Periods 1 and 2|Physician Decision|0
5861211|NCT02059434|20271794|P3|Washout Between Periods 1 and 2|Physician Decision|0
5861212|NCT02059434|20271795|P2|Washout Between Periods 1 and 2|Physician Decision|0
5861213|NCT02059434|20271796|P1|Washout Between Periods 1 and 2|Physician Decision|0
5861214|NCT02059408|20271861|P3|Overall Study|Did not get tested|358
5861215|NCT02059408|20271862|P2|Overall Study|Did not get tested|330
5861216|NCT02059408|20271863|P1|Overall Study|Did not get tested|0
5861217|NCT02059395|20271882|P2|Overall Study|Lost to Follow-up|4
5861218|NCT02059395|20271883|P1|Overall Study|Lost to Follow-up|2
5861219|NCT02059291|20271898|P25|Epoch 4|Lack of Efficacy|0
5861220|NCT02059291|20271899|P24|Epoch 4|Lack of Efficacy|1
5861221|NCT02059291|20271900|P23|Epoch 4|Lack of Efficacy|0
5861222|NCT02059291|20271901|P22|Epoch 4|Lack of Efficacy|0
5861223|NCT02059291|20271902|P21|Epoch 4|Lack of Efficacy|0
5861224|NCT02059291|20271903|P20|Epoch 4|Lack of Efficacy|0
5861225|NCT02059291|20271904|P19|Epoch 4|Lack of Efficacy|0
5861226|NCT02059291|20271905|P18|Epoch 4|Lack of Efficacy|0
5861227|NCT02059291|20271906|P17|Epoch 4|Lack of Efficacy|0
5861228|NCT02059291|20271907|P16|Epoch 4|Lack of Efficacy|0
5861229|NCT02059291|20271908|P15|Epoch 4|Lack of Efficacy|0
5861230|NCT02059291|20271909|P14|Epoch 4|Lack of Efficacy|0
5861231|NCT02059291|20271910|P13|Epoch 4|Lack of Efficacy|0
5861232|NCT02059291|20271911|P12|Epoch 4|Lack of Efficacy|0
5861233|NCT02059291|20271912|P11|Epoch 4|Lack of Efficacy|0
5861234|NCT02059291|20271913|P10|Epoch 4|Lack of Efficacy|0
5861235|NCT02059291|20271914|P9|Epoch 4|Lack of Efficacy|0
5861236|NCT02059291|20271915|P8|Epoch 4|Lack of Efficacy|0
5861237|NCT02059291|20271916|P7|Epoch 4|Lack of Efficacy|0
5861238|NCT02059291|20271917|P6|Epoch 4|Lack of Efficacy|0
5861239|NCT02059291|20271918|P5|Epoch 4|Lack of Efficacy|0
5861240|NCT02059291|20271919|P4|Epoch 4|Lack of Efficacy|0
5861241|NCT02059291|20271920|P3|Epoch 4|Lack of Efficacy|0
5861242|NCT02059291|20271921|P2|Epoch 4|Lack of Efficacy|0
5861243|NCT02059291|20271922|P1|Epoch 4|Lack of Efficacy|0
5861244|NCT02059291|20271898|P25|Epoch 4|Withdrawal by Subject|0
5861245|NCT02059291|20271899|P24|Epoch 4|Withdrawal by Subject|0
5861246|NCT02059291|20271900|P23|Epoch 4|Withdrawal by Subject|0
5861247|NCT02059291|20271901|P22|Epoch 4|Withdrawal by Subject|0
5861248|NCT02059291|20271902|P21|Epoch 4|Withdrawal by Subject|1
5861249|NCT02059291|20271903|P20|Epoch 4|Withdrawal by Subject|0
5861250|NCT02059291|20271904|P19|Epoch 4|Withdrawal by Subject|0
5861251|NCT02059291|20271905|P18|Epoch 4|Withdrawal by Subject|0
5861252|NCT02059291|20271906|P17|Epoch 4|Withdrawal by Subject|0
5861253|NCT02059291|20271907|P16|Epoch 4|Withdrawal by Subject|0
5861254|NCT02059291|20271908|P15|Epoch 4|Withdrawal by Subject|0
5861255|NCT02059291|20271909|P14|Epoch 4|Withdrawal by Subject|0
5861256|NCT02059291|20271910|P13|Epoch 4|Withdrawal by Subject|0
5861257|NCT02059291|20271911|P12|Epoch 4|Withdrawal by Subject|0
5861258|NCT02059291|20271912|P11|Epoch 4|Withdrawal by Subject|0
5861259|NCT02059291|20271913|P10|Epoch 4|Withdrawal by Subject|0
5861260|NCT02059291|20271914|P9|Epoch 4|Withdrawal by Subject|0
5861261|NCT02059291|20271915|P8|Epoch 4|Withdrawal by Subject|0
5861262|NCT02059291|20271916|P7|Epoch 4|Withdrawal by Subject|0
5861263|NCT02059291|20271917|P6|Epoch 4|Withdrawal by Subject|0
5861264|NCT02059291|20271918|P5|Epoch 4|Withdrawal by Subject|0
5861265|NCT02059291|20271919|P4|Epoch 4|Withdrawal by Subject|0
5861266|NCT02059291|20271920|P3|Epoch 4|Withdrawal by Subject|0
5861267|NCT02059291|20271921|P2|Epoch 4|Withdrawal by Subject|0
5861268|NCT02059291|20271922|P1|Epoch 4|Withdrawal by Subject|0
5861269|NCT02059291|20271898|P25|Epoch 4|Pregnancy|0
5861270|NCT02059291|20271899|P24|Epoch 4|Pregnancy|0
5861271|NCT02059291|20271900|P23|Epoch 4|Pregnancy|0
5861272|NCT02059291|20271901|P22|Epoch 4|Pregnancy|0
5861273|NCT02059291|20271902|P21|Epoch 4|Pregnancy|0
5861274|NCT02059291|20271903|P20|Epoch 4|Pregnancy|0
5861275|NCT02059291|20271904|P19|Epoch 4|Pregnancy|0
5861276|NCT02059291|20271905|P18|Epoch 4|Pregnancy|0
5861277|NCT02059291|20271906|P17|Epoch 4|Pregnancy|1
5861278|NCT02059291|20271907|P16|Epoch 4|Pregnancy|0
5861279|NCT02059291|20271908|P15|Epoch 4|Pregnancy|0
5861280|NCT02059291|20271909|P14|Epoch 4|Pregnancy|0
5861281|NCT02059291|20271910|P13|Epoch 4|Pregnancy|0
5861282|NCT02059291|20271911|P12|Epoch 4|Pregnancy|0
5861283|NCT02059291|20271912|P11|Epoch 4|Pregnancy|0
5861284|NCT02059291|20271913|P10|Epoch 4|Pregnancy|0
5861285|NCT02059291|20271914|P9|Epoch 4|Pregnancy|0
5861286|NCT02059291|20271915|P8|Epoch 4|Pregnancy|0
5861287|NCT02059291|20271916|P7|Epoch 4|Pregnancy|0
5861288|NCT02059291|20271917|P6|Epoch 4|Pregnancy|0
5861289|NCT02059291|20271918|P5|Epoch 4|Pregnancy|0
5861290|NCT02059291|20271919|P4|Epoch 4|Pregnancy|0
5861291|NCT02059291|20271920|P3|Epoch 4|Pregnancy|0
5861292|NCT02059291|20271921|P2|Epoch 4|Pregnancy|0
5861293|NCT02059291|20271922|P1|Epoch 4|Pregnancy|0
5861294|NCT02059291|20271898|P25|Epoch 4|Adverse Event|0
5861295|NCT02059291|20271899|P24|Epoch 4|Adverse Event|0
5861296|NCT02059291|20271900|P23|Epoch 4|Adverse Event|1
5861297|NCT02059291|20271901|P22|Epoch 4|Adverse Event|0
5861298|NCT02059291|20271902|P21|Epoch 4|Adverse Event|0
5861299|NCT02059291|20271903|P20|Epoch 4|Adverse Event|0
5861300|NCT02059291|20271904|P19|Epoch 4|Adverse Event|0
5861301|NCT02059291|20271905|P18|Epoch 4|Adverse Event|0
5861302|NCT02059291|20271906|P17|Epoch 4|Adverse Event|1
5861303|NCT02059291|20271907|P16|Epoch 4|Adverse Event|0
5861304|NCT02059291|20271908|P15|Epoch 4|Adverse Event|0
5861305|NCT02059291|20271909|P14|Epoch 4|Adverse Event|0
5861306|NCT02059291|20271910|P13|Epoch 4|Adverse Event|0
5861307|NCT02059291|20271911|P12|Epoch 4|Adverse Event|0
5861308|NCT02059291|20271912|P11|Epoch 4|Adverse Event|0
5861309|NCT02059291|20271913|P10|Epoch 4|Adverse Event|0
5861310|NCT02059291|20271914|P9|Epoch 4|Adverse Event|0
5861311|NCT02059291|20271915|P8|Epoch 4|Adverse Event|0
5861312|NCT02059291|20271916|P7|Epoch 4|Adverse Event|0
5861313|NCT02059291|20271917|P6|Epoch 4|Adverse Event|0
5861314|NCT02059291|20271918|P5|Epoch 4|Adverse Event|0
5861315|NCT02059291|20271919|P4|Epoch 4|Adverse Event|0
5861316|NCT02059291|20271920|P3|Epoch 4|Adverse Event|0
5861317|NCT02059291|20271921|P2|Epoch 4|Adverse Event|0
5861318|NCT02059291|20271922|P1|Epoch 4|Adverse Event|0
5861319|NCT02059291|20271898|P25|Epoch 3|Withdrawal by Subject|0
5861320|NCT02059291|20271899|P24|Epoch 3|Withdrawal by Subject|0
5861321|NCT02059291|20271900|P23|Epoch 3|Withdrawal by Subject|0
5861322|NCT02059291|20271901|P22|Epoch 3|Withdrawal by Subject|0
5861323|NCT02059291|20271902|P21|Epoch 3|Withdrawal by Subject|0
5861324|NCT02059291|20271903|P20|Epoch 3|Withdrawal by Subject|0
5861325|NCT02059291|20271904|P19|Epoch 3|Withdrawal by Subject|0
5861326|NCT02059291|20271905|P18|Epoch 3|Withdrawal by Subject|0
5861327|NCT02059291|20271906|P17|Epoch 3|Withdrawal by Subject|0
5861328|NCT02059291|20271907|P16|Epoch 3|Withdrawal by Subject|1
5861329|NCT02059291|20271908|P15|Epoch 3|Withdrawal by Subject|0
5861330|NCT02059291|20271909|P14|Epoch 3|Withdrawal by Subject|0
5861331|NCT02059291|20271910|P13|Epoch 3|Withdrawal by Subject|0
5861332|NCT02059291|20271911|P12|Epoch 3|Withdrawal by Subject|0
5861333|NCT02059291|20271912|P11|Epoch 3|Withdrawal by Subject|0
5861334|NCT02059291|20271913|P10|Epoch 3|Withdrawal by Subject|0
5861335|NCT02059291|20271914|P9|Epoch 3|Withdrawal by Subject|0
5861336|NCT02059291|20271915|P8|Epoch 3|Withdrawal by Subject|0
5861337|NCT02059291|20271916|P7|Epoch 3|Withdrawal by Subject|0
5861338|NCT02059291|20271917|P6|Epoch 3|Withdrawal by Subject|0
5861339|NCT02059291|20271918|P5|Epoch 3|Withdrawal by Subject|0
5861340|NCT02059291|20271919|P4|Epoch 3|Withdrawal by Subject|0
5861341|NCT02059291|20271920|P3|Epoch 3|Withdrawal by Subject|0
5861342|NCT02059291|20271921|P2|Epoch 3|Withdrawal by Subject|0
5861343|NCT02059291|20271922|P1|Epoch 3|Withdrawal by Subject|0
5861344|NCT02059291|20271898|P25|Epoch 3|Lack of Efficacy|0
5861345|NCT02059291|20271899|P24|Epoch 3|Lack of Efficacy|0
5861346|NCT02059291|20271900|P23|Epoch 3|Lack of Efficacy|0
5861347|NCT02059291|20271901|P22|Epoch 3|Lack of Efficacy|0
5861348|NCT02059291|20271902|P21|Epoch 3|Lack of Efficacy|0
5861349|NCT02059291|20271903|P20|Epoch 3|Lack of Efficacy|0
5861350|NCT02059291|20271904|P19|Epoch 3|Lack of Efficacy|0
5861351|NCT02059291|20271905|P18|Epoch 3|Lack of Efficacy|0
5861352|NCT02059291|20271906|P17|Epoch 3|Lack of Efficacy|0
5861353|NCT02059291|20271907|P16|Epoch 3|Lack of Efficacy|3
5861354|NCT02059291|20271908|P15|Epoch 3|Lack of Efficacy|0
5861355|NCT02059291|20271909|P14|Epoch 3|Lack of Efficacy|0
5861356|NCT02059291|20271910|P13|Epoch 3|Lack of Efficacy|0
5861357|NCT02059291|20271911|P12|Epoch 3|Lack of Efficacy|0
5861358|NCT02059291|20271912|P11|Epoch 3|Lack of Efficacy|0
5861359|NCT02059291|20271913|P10|Epoch 3|Lack of Efficacy|0
5861360|NCT02059291|20271914|P9|Epoch 3|Lack of Efficacy|0
5861361|NCT02059291|20271915|P8|Epoch 3|Lack of Efficacy|0
5861362|NCT02059291|20271916|P7|Epoch 3|Lack of Efficacy|0
5861363|NCT02059291|20271917|P6|Epoch 3|Lack of Efficacy|0
5861364|NCT02059291|20271918|P5|Epoch 3|Lack of Efficacy|0
5861365|NCT02059291|20271919|P4|Epoch 3|Lack of Efficacy|0
5861366|NCT02059291|20271920|P3|Epoch 3|Lack of Efficacy|0
5861367|NCT02059291|20271921|P2|Epoch 3|Lack of Efficacy|0
5861368|NCT02059291|20271922|P1|Epoch 3|Lack of Efficacy|0
5861369|NCT02059291|20271898|P25|Epoch 3|Adverse Event|0
5861370|NCT02059291|20271899|P24|Epoch 3|Adverse Event|0
5861371|NCT02059291|20271900|P23|Epoch 3|Adverse Event|0
5861372|NCT02059291|20271901|P22|Epoch 3|Adverse Event|0
5861373|NCT02059291|20271902|P21|Epoch 3|Adverse Event|0
5861374|NCT02059291|20271903|P20|Epoch 3|Adverse Event|0
5861375|NCT02059291|20271904|P19|Epoch 3|Adverse Event|0
5861376|NCT02059291|20271905|P18|Epoch 3|Adverse Event|0
5861377|NCT02059291|20271906|P17|Epoch 3|Adverse Event|0
5861378|NCT02059291|20271907|P16|Epoch 3|Adverse Event|1
5861379|NCT02059291|20271908|P15|Epoch 3|Adverse Event|0
5861380|NCT02059291|20271909|P14|Epoch 3|Adverse Event|0
5861381|NCT02059291|20271910|P13|Epoch 3|Adverse Event|0
5861382|NCT02059291|20271911|P12|Epoch 3|Adverse Event|0
5861383|NCT02059291|20271912|P11|Epoch 3|Adverse Event|0
5861384|NCT02059291|20271913|P10|Epoch 3|Adverse Event|0
5861385|NCT02059291|20271914|P9|Epoch 3|Adverse Event|0
5861386|NCT02059291|20271915|P8|Epoch 3|Adverse Event|0
5861387|NCT02059291|20271916|P7|Epoch 3|Adverse Event|0
5861388|NCT02059291|20271917|P6|Epoch 3|Adverse Event|0
5861389|NCT02059291|20271918|P5|Epoch 3|Adverse Event|0
5861390|NCT02059291|20271919|P4|Epoch 3|Adverse Event|0
5861391|NCT02059291|20271920|P3|Epoch 3|Adverse Event|0
5861392|NCT02059291|20271921|P2|Epoch 3|Adverse Event|0
5861393|NCT02059291|20271922|P1|Epoch 3|Adverse Event|0
5861394|NCT02059291|20271898|P25|Epoch 3|Physician Decision|0
5861395|NCT02059291|20271899|P24|Epoch 3|Physician Decision|0
5861396|NCT02059291|20271900|P23|Epoch 3|Physician Decision|0
5861397|NCT02059291|20271901|P22|Epoch 3|Physician Decision|0
5861398|NCT02059291|20271902|P21|Epoch 3|Physician Decision|0
5861399|NCT02059291|20271903|P20|Epoch 3|Physician Decision|0
5861400|NCT02059291|20271904|P19|Epoch 3|Physician Decision|0
5861401|NCT02059291|20271905|P18|Epoch 3|Physician Decision|0
5861402|NCT02059291|20271906|P17|Epoch 3|Physician Decision|0
5861403|NCT02059291|20271907|P16|Epoch 3|Physician Decision|1
5861404|NCT02059291|20271908|P15|Epoch 3|Physician Decision|0
5861405|NCT02059291|20271909|P14|Epoch 3|Physician Decision|1
5861406|NCT02059291|20271910|P13|Epoch 3|Physician Decision|0
5861407|NCT02059291|20271911|P12|Epoch 3|Physician Decision|0
5861408|NCT02059291|20271912|P11|Epoch 3|Physician Decision|0
5861409|NCT02059291|20271913|P10|Epoch 3|Physician Decision|0
5861410|NCT02059291|20271914|P9|Epoch 3|Physician Decision|0
5861411|NCT02059291|20271915|P8|Epoch 3|Physician Decision|0
5861412|NCT02059291|20271916|P7|Epoch 3|Physician Decision|0
5861413|NCT02059291|20271917|P6|Epoch 3|Physician Decision|0
5861414|NCT02059291|20271918|P5|Epoch 3|Physician Decision|0
5861415|NCT02059291|20271919|P4|Epoch 3|Physician Decision|0
5861416|NCT02059291|20271920|P3|Epoch 3|Physician Decision|0
5861417|NCT02059291|20271921|P2|Epoch 3|Physician Decision|0
5861418|NCT02059291|20271922|P1|Epoch 3|Physician Decision|0
5861419|NCT02059291|20271898|P25|Epoch 2|Withdrawal by Subject|0
5861420|NCT02059291|20271899|P24|Epoch 2|Withdrawal by Subject|0
5861421|NCT02059291|20271900|P23|Epoch 2|Withdrawal by Subject|0
5861422|NCT02059291|20271901|P22|Epoch 2|Withdrawal by Subject|0
5861423|NCT02059291|20271902|P21|Epoch 2|Withdrawal by Subject|0
5861424|NCT02059291|20271903|P20|Epoch 2|Withdrawal by Subject|0
5861425|NCT02059291|20271904|P19|Epoch 2|Withdrawal by Subject|0
5861426|NCT02059291|20271905|P18|Epoch 2|Withdrawal by Subject|0
5861427|NCT02059291|20271906|P17|Epoch 2|Withdrawal by Subject|0
5861428|NCT02059291|20271907|P16|Epoch 2|Withdrawal by Subject|0
5861429|NCT02059291|20271908|P15|Epoch 2|Withdrawal by Subject|0
5861430|NCT02059291|20271909|P14|Epoch 2|Withdrawal by Subject|0
5861431|NCT02059291|20271910|P13|Epoch 2|Withdrawal by Subject|0
5861432|NCT02059291|20271911|P12|Epoch 2|Withdrawal by Subject|0
5861433|NCT02059291|20271912|P11|Epoch 2|Withdrawal by Subject|0
5861434|NCT02059291|20271913|P10|Epoch 2|Withdrawal by Subject|0
5861435|NCT02059291|20271914|P9|Epoch 2|Withdrawal by Subject|1
5861436|NCT02059291|20271915|P8|Epoch 2|Withdrawal by Subject|0
5861437|NCT02059291|20271916|P7|Epoch 2|Withdrawal by Subject|0
5861438|NCT02059291|20271917|P6|Epoch 2|Withdrawal by Subject|1
5861439|NCT02059291|20271918|P5|Epoch 2|Withdrawal by Subject|0
5861440|NCT02059291|20271919|P4|Epoch 2|Withdrawal by Subject|0
5861441|NCT02059291|20271920|P3|Epoch 2|Withdrawal by Subject|0
5861442|NCT02059291|20271921|P2|Epoch 2|Withdrawal by Subject|1
5861443|NCT02059291|20271922|P1|Epoch 2|Withdrawal by Subject|0
5861444|NCT02059291|20271898|P25|Epoch 2|Adverse Event|0
5861445|NCT02059291|20271899|P24|Epoch 2|Adverse Event|0
5861446|NCT02059291|20271900|P23|Epoch 2|Adverse Event|0
5861447|NCT02059291|20271901|P22|Epoch 2|Adverse Event|0
5861448|NCT02059291|20271902|P21|Epoch 2|Adverse Event|0
5861449|NCT02059291|20271903|P20|Epoch 2|Adverse Event|0
5861450|NCT02059291|20271904|P19|Epoch 2|Adverse Event|0
5861451|NCT02059291|20271905|P18|Epoch 2|Adverse Event|0
5861452|NCT02059291|20271906|P17|Epoch 2|Adverse Event|0
5861453|NCT02059291|20271907|P16|Epoch 2|Adverse Event|0
5861454|NCT02059291|20271908|P15|Epoch 2|Adverse Event|0
5861455|NCT02059291|20271909|P14|Epoch 2|Adverse Event|0
5861456|NCT02059291|20271910|P13|Epoch 2|Adverse Event|0
5861457|NCT02059291|20271911|P12|Epoch 2|Adverse Event|0
5861458|NCT02059291|20271912|P11|Epoch 2|Adverse Event|0
5861459|NCT02059291|20271913|P10|Epoch 2|Adverse Event|0
5861460|NCT02059291|20271914|P9|Epoch 2|Adverse Event|1
5861461|NCT02059291|20271915|P8|Epoch 2|Adverse Event|1
5861462|NCT02059291|20271916|P7|Epoch 2|Adverse Event|0
5861463|NCT02059291|20271917|P6|Epoch 2|Adverse Event|0
5861464|NCT02059291|20271918|P5|Epoch 2|Adverse Event|0
5861465|NCT02059291|20271919|P4|Epoch 2|Adverse Event|1
5861466|NCT02059291|20271920|P3|Epoch 2|Adverse Event|1
5861467|NCT02059291|20271921|P2|Epoch 2|Adverse Event|0
5861468|NCT02059291|20271922|P1|Epoch 2|Adverse Event|0
5861469|NCT02059291|20271898|P25|Epoch 2|Lack of Efficacy|0
5861470|NCT02059291|20271899|P24|Epoch 2|Lack of Efficacy|0
5861471|NCT02059291|20271900|P23|Epoch 2|Lack of Efficacy|0
5861472|NCT02059291|20271901|P22|Epoch 2|Lack of Efficacy|0
5861473|NCT02059291|20271902|P21|Epoch 2|Lack of Efficacy|0
5861474|NCT02059291|20271903|P20|Epoch 2|Lack of Efficacy|0
5861475|NCT02059291|20271904|P19|Epoch 2|Lack of Efficacy|0
5861476|NCT02059291|20271905|P18|Epoch 2|Lack of Efficacy|0
5861477|NCT02059291|20271906|P17|Epoch 2|Lack of Efficacy|0
5861478|NCT02059291|20271907|P16|Epoch 2|Lack of Efficacy|0
5861479|NCT02059291|20271908|P15|Epoch 2|Lack of Efficacy|0
5861480|NCT02059291|20271909|P14|Epoch 2|Lack of Efficacy|0
5861481|NCT02059291|20271910|P13|Epoch 2|Lack of Efficacy|0
5861482|NCT02059291|20271911|P12|Epoch 2|Lack of Efficacy|0
5861483|NCT02059291|20271912|P11|Epoch 2|Lack of Efficacy|0
5861484|NCT02059291|20271913|P10|Epoch 2|Lack of Efficacy|0
5861485|NCT02059291|20271914|P9|Epoch 2|Lack of Efficacy|0
5861486|NCT02059291|20271915|P8|Epoch 2|Lack of Efficacy|0
5861487|NCT02059291|20271916|P7|Epoch 2|Lack of Efficacy|0
5861488|NCT02059291|20271917|P6|Epoch 2|Lack of Efficacy|1
5861489|NCT02059291|20271918|P5|Epoch 2|Lack of Efficacy|0
5861490|NCT02059291|20271919|P4|Epoch 2|Lack of Efficacy|1
5861491|NCT02059291|20271920|P3|Epoch 2|Lack of Efficacy|0
5861492|NCT02059291|20271921|P2|Epoch 2|Lack of Efficacy|0
5861493|NCT02059291|20271922|P1|Epoch 2|Lack of Efficacy|0
5861494|NCT02059278|20271976|P2|Overall Study|Ran out of IP and decided to discontinue|0
5861495|NCT02059278|20271977|P1|Overall Study|Ran out of IP and decided to discontinue|1
5861496|NCT02059278|20271976|P2|Overall Study|Withdrawal by Subject|3
5861497|NCT02059278|20271977|P1|Overall Study|Withdrawal by Subject|0
5861498|NCT02059278|20271976|P2|Overall Study|Lost to Follow-up|0
5861499|NCT02059278|20271977|P1|Overall Study|Lost to Follow-up|1
5861500|NCT02059278|20271976|P2|Overall Study|Adverse Event|1
5861501|NCT02059278|20271977|P1|Overall Study|Adverse Event|1
5861502|NCT02059265|20271991|P1|Overall Study|Ineligible|4
5861503|NCT02059187|20272023|P2|Overall Study|Withdrawal by Subject|8
5861504|NCT02059187|20272024|P1|Overall Study|Withdrawal by Subject|12
5861505|NCT02059187|20272023|P2|Overall Study|Protocol Violation|0
5861506|NCT02059187|20272024|P1|Overall Study|Protocol Violation|1
5861507|NCT02059187|20272023|P2|Overall Study|Physician Decision|2
5861508|NCT02059187|20272024|P1|Overall Study|Physician Decision|1
5861509|NCT02059187|20272023|P2|Overall Study|Non-compliance with study drug|0
5861510|NCT02059187|20272024|P1|Overall Study|Non-compliance with study drug|1
5861511|NCT02059187|20272023|P2|Overall Study|Lost to Follow-up|8
5861512|NCT02059187|20272024|P1|Overall Study|Lost to Follow-up|9
5861513|NCT02059187|20272023|P2|Overall Study|Death|1
5861514|NCT02059187|20272024|P1|Overall Study|Death|1
5861515|NCT02059187|20272023|P2|Overall Study|Adverse Event|3
5861516|NCT02059187|20272024|P1|Overall Study|Adverse Event|0
5861517|NCT02059174|20272050|P2|Period 3|Physician Decision|0
5861518|NCT02059174|20272051|P1|Period 3|Physician Decision|1
5861519|NCT02059174|20272050|P2|Period 2|Protocol Violation|0
5861520|NCT02059174|20272051|P1|Period 2|Protocol Violation|1
5861521|NCT02059174|20272050|P2|Period 2|Withdrawal by Subject|2
5861522|NCT02059174|20272051|P1|Period 2|Withdrawal by Subject|0
5861523|NCT02059174|20272050|P2|Period 1|Withdrawal by Subject|2
5861524|NCT02059174|20272051|P1|Period 1|Withdrawal by Subject|0
5861525|NCT02059161|20272075|P2|Overall Study|Non-compliance with study drug|2
5861526|NCT02059161|20272076|P1|Overall Study|Non-compliance with study drug|6
5861527|NCT02059161|20272075|P2|Overall Study|Randomized in error, no study drug|1
5861528|NCT02059161|20272076|P1|Overall Study|Randomized in error, no study drug|0
5861529|NCT02059161|20272075|P2|Overall Study|Withdrawal by Subject|13
5861530|NCT02059161|20272076|P1|Overall Study|Withdrawal by Subject|16
5861531|NCT02059161|20272075|P2|Overall Study|Protocol Violation|1
5861532|NCT02059161|20272076|P1|Overall Study|Protocol Violation|1
5861533|NCT02059161|20272075|P2|Overall Study|Physician Decision|4
5861534|NCT02059161|20272076|P1|Overall Study|Physician Decision|4
5861535|NCT02059161|20272075|P2|Overall Study|Lost to Follow-up|12
5861536|NCT02059161|20272076|P1|Overall Study|Lost to Follow-up|20
5861537|NCT02059161|20272075|P2|Overall Study|Adverse Event|6
5861538|NCT02059161|20272076|P1|Overall Study|Adverse Event|2
5861539|NCT02059161|20272075|P2|Overall Study|Pregnancy|2
5861540|NCT02059161|20272076|P1|Overall Study|Pregnancy|0
5861541|NCT02059148|20272136|P6|Treatment 1|Protocol Violation|1
5861542|NCT02059148|20272137|P5|Treatment 1|Protocol Violation|0
5861543|NCT02059148|20272138|P4|Treatment 1|Protocol Violation|0
5861544|NCT02059148|20272139|P3|Treatment 1|Protocol Violation|0
5861545|NCT02059148|20272140|P2|Treatment 1|Protocol Violation|0
5861546|NCT02059148|20272141|P1|Treatment 1|Protocol Violation|0
5861547|NCT02059135|20272160|P2|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|1
5861548|NCT02059135|20272161|P1|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|0
5861549|NCT02059135|20272160|P2|Neonatal Follow-up (Safety Population)|delivered at another hospital|1
5861550|NCT02059135|20272161|P1|Neonatal Follow-up (Safety Population)|delivered at another hospital|0
5861551|NCT02059135|20272160|P2|Neonatal Follow-up (Safety Population)|Death|2
5861552|NCT02059135|20272161|P1|Neonatal Follow-up (Safety Population)|Death|3
5861553|NCT02059135|20272160|P2|Neonatal Follow-up (Safety Population)|Lost to Follow-up|0
5861554|NCT02059135|20272161|P1|Neonatal Follow-up (Safety Population)|Lost to Follow-up|1
5861555|NCT02059135|20272160|P2|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|1
5861556|NCT02059135|20272161|P1|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|0
5861557|NCT02059135|20272160|P2|Maternal Follow-up (ITT Population)|declined to see site staff|1
5861558|NCT02059135|20272161|P1|Maternal Follow-up (ITT Population)|declined to see site staff|0
5861559|NCT02059135|20272160|P2|Maternal Follow-up (ITT Population)|Lost to Follow-up|3
5861560|NCT02059135|20272161|P1|Maternal Follow-up (ITT Population)|Lost to Follow-up|0
5861561|NCT02059135|20272160|P2|Maternal Follow-up (ITT Population)|Withdrawal by Subject|2
5861562|NCT02059135|20272161|P1|Maternal Follow-up (ITT Population)|Withdrawal by Subject|3
5861563|NCT02059005|20272197|P2|Overall Study|Inpatient|1
5861564|NCT02059005|20272198|P1|Overall Study|Inpatient|0
5861565|NCT02059005|20272197|P2|Overall Study|Incarceration|1
5861566|NCT02059005|20272198|P1|Overall Study|Incarceration|0
5861567|NCT02059005|20272197|P2|Overall Study|Lost to Follow-up|19
5861568|NCT02059005|20272198|P1|Overall Study|Lost to Follow-up|19
5861569|NCT02059005|20272197|P2|Overall Study|Death|3
5861570|NCT02059005|20272198|P1|Overall Study|Death|1
5861571|NCT02058992|20272208|P1|Overall Study|CRF Uncollected|20
5861572|NCT02058992|20272208|P1|Overall Study|Protocol Violation|92
5861573|NCT02058992|20272208|P1|Overall Study|Lost to Follow-up|4
5861574|NCT02058966|20272217|P1|First Intervention|Withdrawal by Subject|1
5861575|NCT02058966|20272217|P1|Open-Label Methamphetamine|Adverse Event|1
5861576|NCT02058940|20272244|P1|Overall Study|Discharged from Critical Care Unit|1
5861577|NCT02058849|20272268|P2|Overall Study|Withdrawal by Subject|0
5861578|NCT02058849|20272269|P1|Overall Study|Withdrawal by Subject|4
5861579|NCT02058849|20272268|P2|Overall Study|Lost to Follow-up|0
5861580|NCT02058849|20272269|P1|Overall Study|Lost to Follow-up|1
5861581|NCT02058849|20272268|P2|Overall Study|Death|0
5861582|NCT02058849|20272269|P1|Overall Study|Death|1
5861583|NCT02058849|20272268|P2|Overall Study|Hospitalization|1
5861584|NCT02058849|20272269|P1|Overall Study|Hospitalization|1
5861585|NCT02058836|20272297|P2|Overall Study|Withdrawal by Subject|1
5861586|NCT02058836|20272298|P1|Overall Study|Withdrawal by Subject|1
5861587|NCT02058628|20272328|P2|Overall Study|Non compliance|0
5861588|NCT02058628|20272329|P1|Overall Study|Non compliance|1
5861589|NCT02058628|20272328|P2|Overall Study|A lot of time for study for participant|0
5861590|NCT02058628|20272329|P1|Overall Study|A lot of time for study for participant|1
5861591|NCT02058628|20272328|P2|Overall Study|The visit date was not in timeline|1
5861592|NCT02058628|20272329|P1|Overall Study|The visit date was not in timeline|0
5861593|NCT02058628|20272328|P2|Overall Study|Not in time schedule|1
5861594|NCT02058628|20272329|P1|Overall Study|Not in time schedule|0
5861595|NCT02058628|20272328|P2|Overall Study|Lost to Follow-up|4
5861596|NCT02058628|20272329|P1|Overall Study|Lost to Follow-up|2
5861597|NCT02058628|20272328|P2|Overall Study|Withdrawal by Subject|2
5861598|NCT02058628|20272329|P1|Overall Study|Withdrawal by Subject|2
5861599|NCT02058628|20272328|P2|Overall Study|Adverse Event|0
5861600|NCT02058628|20272329|P1|Overall Study|Adverse Event|1
5861601|NCT02058589|20272361|P2|Overall Study|Withdrawal by Subject|1
5861602|NCT02058589|20272362|P1|Overall Study|Withdrawal by Subject|0
5861603|NCT02058589|20272361|P2|Overall Study|Non-Serious Adverse Event|0
5861604|NCT02058589|20272362|P1|Overall Study|Non-Serious Adverse Event|1
5861605|NCT02058589|20272361|P2|Overall Study|Serious Adverse Event|1
5861606|NCT02058589|20272362|P1|Overall Study|Serious Adverse Event|1
5861607|NCT02058563|20272404|P2|Overall Study|Other (patient incarcerated)|1
5861608|NCT02058563|20272405|P1|Overall Study|Other (patient incarcerated)|0
5861609|NCT02058563|20272404|P2|Overall Study|Consent Withdrawal|1
5861610|NCT02058563|20272405|P1|Overall Study|Consent Withdrawal|1
5861611|NCT02058563|20272404|P2|Overall Study|Other (vaccinated later as new subject)|0
5861612|NCT02058563|20272405|P1|Overall Study|Other (vaccinated later as new subject)|1
5861613|NCT02058563|20272404|P2|Overall Study|Lost to Follow-up|22
5861614|NCT02058563|20272405|P1|Overall Study|Lost to Follow-up|26
5861615|NCT02058537|20272441|P1|Overall Study|Withdrawal by Subject|1
5861616|NCT02058498|20272452|P1|Overall Study|Withdrawal by Subject|4
5861617|NCT02058368|20272460|P2|Overall Study|Withdrawal by Subject|26
5861618|NCT02058368|20272461|P1|Overall Study|Withdrawal by Subject|22
5861619|NCT02058368|20272460|P2|Overall Study|Physician Decision|3
5861620|NCT02058368|20272461|P1|Overall Study|Physician Decision|2
5861621|NCT02058368|20272460|P2|Overall Study|Lost to Follow-up|0
5861622|NCT02058368|20272461|P1|Overall Study|Lost to Follow-up|2
5861623|NCT02058368|20272460|P2|Overall Study|Protocol Violation|4
5861624|NCT02058368|20272461|P1|Overall Study|Protocol Violation|0
5861625|NCT02058368|20272460|P2|Overall Study|Lack of Efficacy|1
5861626|NCT02058368|20272461|P1|Overall Study|Lack of Efficacy|0
5861627|NCT02058368|20272460|P2|Overall Study|Adverse Event|20
5861628|NCT02058368|20272461|P1|Overall Study|Adverse Event|15
5861629|NCT02058290|20272513|P2|Overall Study|Withdrawal by Subject|1
5861630|NCT02058290|20272514|P1|Overall Study|Withdrawal by Subject|0
5861631|NCT02058290|20272513|P2|Overall Study|Didn't meet intraoperative criteria|7
5861632|NCT02058290|20272514|P1|Overall Study|Didn't meet intraoperative criteria|8
5861633|NCT02058290|20272513|P2|Overall Study|Physician Decision|0
5861634|NCT02058290|20272514|P1|Overall Study|Physician Decision|1
5861635|NCT02058290|20272513|P2|Overall Study|Protocol Violation|1
5861636|NCT02058290|20272514|P1|Overall Study|Protocol Violation|2
5861637|NCT02058160|20272541|P2|Overall Study|Other than specified above|6
5861638|NCT02058160|20272542|P1|Overall Study|Other than specified above|12
5861639|NCT02058160|20272541|P2|Overall Study|Lost to Follow-up|0
5861640|NCT02058160|20272542|P1|Overall Study|Lost to Follow-up|1
5861641|NCT02058160|20272541|P2|Overall Study|Adverse Event|3
5861642|NCT02058160|20272542|P1|Overall Study|Adverse Event|12
5861643|NCT02058160|20272541|P2|Overall Study|Poor compliance to protocol|1
5861644|NCT02058160|20272542|P1|Overall Study|Poor compliance to protocol|4
5861645|NCT02058160|20272541|P2|Overall Study|Randomized but not treated|4
5861646|NCT02058160|20272542|P1|Overall Study|Randomized but not treated|2
5861647|NCT02058147|20272579|P3|Overall Study|Other than specified|0
5861648|NCT02058147|20272580|P2|Overall Study|Other than specified|9
5861649|NCT02058147|20272581|P1|Overall Study|Other than specified|8
5861650|NCT02058147|20272579|P3|Overall Study|Poor compliance to protocol|4
5861651|NCT02058147|20272580|P2|Overall Study|Poor compliance to protocol|9
5861652|NCT02058147|20272581|P1|Overall Study|Poor compliance to protocol|8
5861653|NCT02058147|20272579|P3|Overall Study|Lack of Efficacy|3
5861654|NCT02058147|20272580|P2|Overall Study|Lack of Efficacy|0
5861655|NCT02058147|20272581|P1|Overall Study|Lack of Efficacy|1
5861656|NCT02058147|20272579|P3|Overall Study|Adverse Event|21
5861657|NCT02058147|20272580|P2|Overall Study|Adverse Event|9
5861658|NCT02058147|20272581|P1|Overall Study|Adverse Event|12
5861659|NCT02058147|20272579|P3|Overall Study|Randomized but not treated|1
5861660|NCT02058147|20272580|P2|Overall Study|Randomized but not treated|0
5861661|NCT02058147|20272581|P1|Overall Study|Randomized but not treated|0
5861662|NCT02058108|20272632|P2|Overall Study|Protocol Violation|1
5861663|NCT02058108|20272633|P1|Overall Study|Protocol Violation|0
5861664|NCT02058108|20272632|P2|Overall Study|Administrative problems|3
5861665|NCT02058108|20272633|P1|Overall Study|Administrative problems|3
5861666|NCT02058108|20272632|P2|Overall Study|Withdrawal by Subject|0
5861667|NCT02058108|20272633|P1|Overall Study|Withdrawal by Subject|1
5861668|NCT02058108|20272632|P2|Overall Study|No longer requires study drug|1
5861669|NCT02058108|20272633|P1|Overall Study|No longer requires study drug|0
5861670|NCT02058108|20272632|P2|Overall Study|Unsatisfactory therapeutic effect|4
5861671|NCT02058108|20272633|P1|Overall Study|Unsatisfactory therapeutic effect|37
5861672|NCT02058108|20272632|P2|Overall Study|Abnormal Laboratory Values|1
5861673|NCT02058108|20272633|P1|Overall Study|Abnormal Laboratory Values|0
5861674|NCT02058095|20272659|P2|Overall Study|Adverse Event|0
5861675|NCT02058095|20272660|P1|Overall Study|Adverse Event|1
5861676|NCT02058069|20272670|P1|Overall Study|Withdrawal by Subject|6
5861677|NCT02058069|20272670|P1|Overall Study|Exclusion due to implant size|5
5861678|NCT02057874|20272729|P1|Overall Study|participant did not return for scan|1
5861679|NCT02057835|20272747|P10|Overall Study|Withdrawal by Subject|0
5861680|NCT02057835|20272748|P9|Overall Study|Withdrawal by Subject|0
5861681|NCT02057835|20272749|P8|Overall Study|Withdrawal by Subject|0
5861682|NCT02057835|20272750|P7|Overall Study|Withdrawal by Subject|0
5861683|NCT02057835|20272751|P6|Overall Study|Withdrawal by Subject|0
5861684|NCT02057835|20272752|P5|Overall Study|Withdrawal by Subject|0
5861685|NCT02057835|20272753|P4|Overall Study|Withdrawal by Subject|0
5861686|NCT02057835|20272754|P3|Overall Study|Withdrawal by Subject|0
5861687|NCT02057835|20272755|P2|Overall Study|Withdrawal by Subject|2
5861688|NCT02057835|20272756|P1|Overall Study|Withdrawal by Subject|0
5861689|NCT02057757|20272835|P2|Overall Study|Non-compliance|0
5861690|NCT02057757|20272836|P1|Overall Study|Non-compliance|1
5861691|NCT02057757|20272835|P2|Overall Study|Lost to Follow-up|3
5861692|NCT02057757|20272836|P1|Overall Study|Lost to Follow-up|8
5861693|NCT02057757|20272835|P2|Overall Study|Death|0
5861694|NCT02057757|20272836|P1|Overall Study|Death|2
5861695|NCT02057757|20272835|P2|Overall Study|Withdrawal by Subject|5
5861696|NCT02057757|20272836|P1|Overall Study|Withdrawal by Subject|3
5861697|NCT02057692|20272890|P4|Overall Study|Lost to Follow-up|1
5861698|NCT02057692|20272891|P3|Overall Study|Lost to Follow-up|0
5861699|NCT02057692|20272892|P2|Overall Study|Lost to Follow-up|0
5861700|NCT02057692|20272893|P1|Overall Study|Lost to Follow-up|0
5861701|NCT02057692|20272890|P4|Overall Study|Adverse Event|0
5861702|NCT02057692|20272891|P3|Overall Study|Adverse Event|0
5861703|NCT02057692|20272892|P2|Overall Study|Adverse Event|0
5861704|NCT02057692|20272893|P1|Overall Study|Adverse Event|1
5861705|NCT02057575|20272939|P4|Overall Study|Protocol Violation|0
5861706|NCT02057575|20272940|P3|Overall Study|Protocol Violation|0
5861707|NCT02057575|20272941|P2|Overall Study|Protocol Violation|1
5861708|NCT02057575|20272942|P1|Overall Study|Protocol Violation|0
5861709|NCT02057575|20272939|P4|Overall Study|Dissallowed Concurrent Medication|0
5861710|NCT02057575|20272940|P3|Overall Study|Dissallowed Concurrent Medication|0
5861711|NCT02057575|20272941|P2|Overall Study|Dissallowed Concurrent Medication|1
5861712|NCT02057575|20272942|P1|Overall Study|Dissallowed Concurrent Medication|0
5861713|NCT02057575|20272939|P4|Overall Study|Withdrawal by Subject|0
5861714|NCT02057575|20272940|P3|Overall Study|Withdrawal by Subject|0
5861715|NCT02057575|20272941|P2|Overall Study|Withdrawal by Subject|0
5861716|NCT02057575|20272942|P1|Overall Study|Withdrawal by Subject|1
5861717|NCT02057575|20272939|P4|Overall Study|Adverse Event|1
5861718|NCT02057575|20272940|P3|Overall Study|Adverse Event|0
5861719|NCT02057575|20272941|P2|Overall Study|Adverse Event|2
5861720|NCT02057575|20272942|P1|Overall Study|Adverse Event|0
5861721|NCT02057549|20272954|P2|Overall Study|Withdrawal by Subject|0
5861722|NCT02057549|20272955|P1|Overall Study|Withdrawal by Subject|1
5861723|NCT02057549|20272954|P2|Overall Study|Physician Decision|0
5861724|NCT02057549|20272955|P1|Overall Study|Physician Decision|1
5861725|NCT02057549|20272954|P2|Overall Study|Lost to Follow-up|0
5861726|NCT02057549|20272955|P1|Overall Study|Lost to Follow-up|1
5861727|NCT02057523|20272975|P1|Overall Study|Lack of Efficacy|1
5861728|NCT02057523|20272975|P1|Overall Study|Withdrawal by Subject|1
5861729|NCT02057458|20272980|P3|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0
5861730|NCT02057458|20272981|P2|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0
5861731|NCT02057458|20272982|P1|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|1
5861732|NCT02057458|20272980|P3|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0
5861733|NCT02057458|20272981|P2|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0
5861734|NCT02057458|20272982|P1|Acute Study (1 Hour): First Intervention|Lost to Follow-up|2
5861735|NCT02057458|20272980|P3|Met Inclusion Criteria|Prior history of migraine headaches|0
5861736|NCT02057458|20272981|P2|Met Inclusion Criteria|Prior history of migraine headaches|1
5861737|NCT02057458|20272982|P1|Met Inclusion Criteria|Prior history of migraine headaches|0
5861738|NCT02057406|20273020|P3|Overall Study|Patient transportation issues|1
5861739|NCT02057406|20273021|P2|Overall Study|Patient transportation issues|0
5861740|NCT02057406|20273022|P1|Overall Study|Patient transportation issues|0
5861741|NCT02057406|20273020|P3|Overall Study|Protocol Violation|0
5861742|NCT02057406|20273021|P2|Overall Study|Protocol Violation|1
5861743|NCT02057406|20273022|P1|Overall Study|Protocol Violation|0
5861744|NCT02057406|20273020|P3|Overall Study|Death|0
5861745|NCT02057406|20273021|P2|Overall Study|Death|0
5861746|NCT02057406|20273022|P1|Overall Study|Death|1
5861747|NCT02057406|20273020|P3|Overall Study|Lost to Follow-up|1
5861748|NCT02057406|20273021|P2|Overall Study|Lost to Follow-up|0
5861749|NCT02057406|20273022|P1|Overall Study|Lost to Follow-up|0
5861750|NCT02057406|20273020|P3|Overall Study|Withdrawal by Subject|0
5861751|NCT02057406|20273021|P2|Overall Study|Withdrawal by Subject|2
5861752|NCT02057406|20273022|P1|Overall Study|Withdrawal by Subject|0
5861753|NCT02057406|20273020|P3|Overall Study|Physician Decision|2
5861754|NCT02057406|20273021|P2|Overall Study|Physician Decision|0
5861755|NCT02057406|20273022|P1|Overall Study|Physician Decision|0
5861756|NCT02057393|20273033|P1|Overall Study|Patient did not meet criteria|1
5861757|NCT02057393|20273033|P1|Overall Study|Withdrawal by Subject|1
5861758|NCT02057250|20273054|P5|Extension Phase|Other than specified above|7
5861759|NCT02057250|20273055|P4|Extension Phase|Other than specified above|0
5861760|NCT02057250|20273056|P3|Extension Phase|Other than specified above|0
5861761|NCT02057250|20273057|P2|Extension Phase|Other than specified above|0
5861762|NCT02057250|20273058|P1|Extension Phase|Other than specified above|0
5861763|NCT02057250|20273054|P5|Extension Phase|Entered in this period but not treated|4
5861764|NCT02057250|20273055|P4|Extension Phase|Entered in this period but not treated|0
5861765|NCT02057250|20273056|P3|Extension Phase|Entered in this period but not treated|0
5861766|NCT02057250|20273057|P2|Extension Phase|Entered in this period but not treated|0
5861767|NCT02057250|20273058|P1|Extension Phase|Entered in this period but not treated|0
5861768|NCT02057250|20273054|P5|Extension Phase|Lack of Efficacy|10
5861769|NCT02057250|20273055|P4|Extension Phase|Lack of Efficacy|0
5861770|NCT02057250|20273056|P3|Extension Phase|Lack of Efficacy|0
5861771|NCT02057250|20273057|P2|Extension Phase|Lack of Efficacy|0
5861772|NCT02057250|20273058|P1|Extension Phase|Lack of Efficacy|0
5861773|NCT02057250|20273054|P5|Extension Phase|Adverse Event|15
5861774|NCT02057250|20273055|P4|Extension Phase|Adverse Event|0
5861775|NCT02057250|20273056|P3|Extension Phase|Adverse Event|0
5861776|NCT02057250|20273057|P2|Extension Phase|Adverse Event|0
5861777|NCT02057250|20273058|P1|Extension Phase|Adverse Event|0
5861778|NCT02057250|20273054|P5|AID Assessment Phase|Other than specified above|0
5861779|NCT02057250|20273055|P4|AID Assessment Phase|Other than specified above|1
5861780|NCT02057250|20273056|P3|AID Assessment Phase|Other than specified above|1
5861781|NCT02057250|20273057|P2|AID Assessment Phase|Other than specified above|1
5861782|NCT02057250|20273058|P1|AID Assessment Phase|Other than specified above|1
5861783|NCT02057250|20273054|P5|AID Assessment Phase|Adverse Event|0
5861784|NCT02057250|20273055|P4|AID Assessment Phase|Adverse Event|1
5861785|NCT02057250|20273056|P3|AID Assessment Phase|Adverse Event|6
5861786|NCT02057250|20273057|P2|AID Assessment Phase|Adverse Event|2
5861787|NCT02057250|20273058|P1|AID Assessment Phase|Adverse Event|3
5861788|NCT02057198|20273079|P3|Overall Study|Discharged early; lost to followup|0
5861789|NCT02057198|20273080|P2|Overall Study|Discharged early; lost to followup|1
5861790|NCT02057198|20273081|P1|Overall Study|Discharged early; lost to followup|0
5861791|NCT02057198|20273079|P3|Overall Study|Death|1
5861792|NCT02057198|20273080|P2|Overall Study|Death|0
5861793|NCT02057198|20273081|P1|Overall Study|Death|0
5861794|NCT02057068|20273117|P2|Overall Study|Lost to Follow-up|2
5861795|NCT02057068|20273118|P1|Overall Study|Lost to Follow-up|2
5861796|NCT02057068|20273117|P2|Overall Study|Carepartner (CP) Health|2
5861797|NCT02057068|20273118|P1|Overall Study|Carepartner (CP) Health|4
5861798|NCT02057068|20273117|P2|Overall Study|Caregiver (CG) Health|2
5861799|NCT02057068|20273118|P1|Overall Study|Caregiver (CG) Health|0
5861800|NCT02057068|20273117|P2|Overall Study|Withdrawal by Subject|2
5861801|NCT02057068|20273118|P1|Overall Study|Withdrawal by Subject|2
5861802|NCT02056834|20273147|P1|Overall Study|Lost to Follow-up|7
5861803|NCT02056652|20273168|P2|Overall Study|Lost to Follow-up|3
5861804|NCT02056652|20273169|P1|Overall Study|Lost to Follow-up|0
5861805|NCT02056652|20273168|P2|Overall Study|Withdrawal by Subject|0
5861806|NCT02056652|20273169|P1|Overall Study|Withdrawal by Subject|1
5861807|NCT02056626|20273206|P4|Overall Study|patient did not follow directions|0
5861808|NCT02056626|20273207|P3|Overall Study|patient did not follow directions|0
5861809|NCT02056626|20273208|P2|Overall Study|patient did not follow directions|1
5861810|NCT02056626|20273209|P1|Overall Study|patient did not follow directions|3
5861811|NCT02056392|20273244|P6|Overall Study|Withdrawal by Subject|0
5861812|NCT02056392|20273245|P5|Overall Study|Withdrawal by Subject|1
5861813|NCT02056392|20273246|P4|Overall Study|Withdrawal by Subject|0
5861814|NCT02056392|20273247|P3|Overall Study|Withdrawal by Subject|0
5861815|NCT02056392|20273248|P2|Overall Study|Withdrawal by Subject|0
5861816|NCT02056392|20273249|P1|Overall Study|Withdrawal by Subject|1
5861817|NCT02056392|20273244|P6|Overall Study|Protocol Violation|0
5861818|NCT02056392|20273245|P5|Overall Study|Protocol Violation|0
5861819|NCT02056392|20273246|P4|Overall Study|Protocol Violation|0
5861820|NCT02056392|20273247|P3|Overall Study|Protocol Violation|1
5861821|NCT02056392|20273248|P2|Overall Study|Protocol Violation|0
5861822|NCT02056392|20273249|P1|Overall Study|Protocol Violation|1
5861823|NCT02056392|20273244|P6|Overall Study|Lost to Follow-up|0
5861824|NCT02056392|20273245|P5|Overall Study|Lost to Follow-up|0
5861825|NCT02056392|20273246|P4|Overall Study|Lost to Follow-up|0
5861826|NCT02056392|20273247|P3|Overall Study|Lost to Follow-up|2
5861827|NCT02056392|20273248|P2|Overall Study|Lost to Follow-up|1
5861828|NCT02056392|20273249|P1|Overall Study|Lost to Follow-up|0
5861829|NCT02056340|20273286|P2|Overall Study|Withdrawal by Subject|6
5861830|NCT02056340|20273287|P1|Overall Study|Withdrawal by Subject|2
5861831|NCT02056340|20273286|P2|Overall Study|Lost to Follow-up|5
5861832|NCT02056340|20273287|P1|Overall Study|Lost to Follow-up|5
5861833|NCT02056301|20273297|P2|Overall Study|Issues with epidural|3
5861834|NCT02056301|20273298|P1|Overall Study|Issues with epidural|0
5861835|NCT02056301|20273297|P2|Overall Study|Withdrawal by Subject|1
5861836|NCT02056301|20273298|P1|Overall Study|Withdrawal by Subject|0
5861837|NCT02056301|20273297|P2|Overall Study|Surgical complications req. 2nd surgery|0
5861838|NCT02056301|20273298|P1|Overall Study|Surgical complications req. 2nd surgery|1
5861839|NCT02056301|20273297|P2|Overall Study|Protocol Violation|2
5861840|NCT02056301|20273298|P1|Overall Study|Protocol Violation|1
5861841|NCT02055976|20273330|P9|Overall Study|Lost to Follow-up|0
5861842|NCT02055976|20273331|P8|Overall Study|Lost to Follow-up|0
5861843|NCT02055976|20273332|P7|Overall Study|Lost to Follow-up|0
5861844|NCT02055976|20273333|P6|Overall Study|Lost to Follow-up|0
5861845|NCT02055976|20273334|P5|Overall Study|Lost to Follow-up|0
5861846|NCT02055976|20273335|P4|Overall Study|Lost to Follow-up|1
5861847|NCT02055976|20273336|P3|Overall Study|Lost to Follow-up|0
5861848|NCT02055976|20273337|P2|Overall Study|Lost to Follow-up|0
5861849|NCT02055976|20273338|P1|Overall Study|Lost to Follow-up|0
5861850|NCT02055976|20273330|P9|Overall Study|Does not meet entrance criteria|0
5861851|NCT02055976|20273331|P8|Overall Study|Does not meet entrance criteria|0
5861852|NCT02055976|20273332|P7|Overall Study|Does not meet entrance criteria|1
5861853|NCT02055976|20273333|P6|Overall Study|Does not meet entrance criteria|0
5861854|NCT02055976|20273334|P5|Overall Study|Does not meet entrance criteria|0
5861855|NCT02055976|20273335|P4|Overall Study|Does not meet entrance criteria|0
5861856|NCT02055976|20273336|P3|Overall Study|Does not meet entrance criteria|0
5861857|NCT02055976|20273337|P2|Overall Study|Does not meet entrance criteria|0
5861858|NCT02055976|20273338|P1|Overall Study|Does not meet entrance criteria|0
5861859|NCT02055976|20273330|P9|Overall Study|Adverse Event|0
5861860|NCT02055976|20273331|P8|Overall Study|Adverse Event|0
5861861|NCT02055976|20273332|P7|Overall Study|Adverse Event|1
5861862|NCT02055976|20273333|P6|Overall Study|Adverse Event|1
5861863|NCT02055976|20273334|P5|Overall Study|Adverse Event|0
5861864|NCT02055976|20273335|P4|Overall Study|Adverse Event|0
5861865|NCT02055976|20273336|P3|Overall Study|Adverse Event|0
5861866|NCT02055976|20273337|P2|Overall Study|Adverse Event|0
5861867|NCT02055976|20273338|P1|Overall Study|Adverse Event|0
5861868|NCT02055976|20273330|P9|Overall Study|Other|0
5861869|NCT02055976|20273331|P8|Overall Study|Other|0
5861870|NCT02055976|20273332|P7|Overall Study|Other|0
5861871|NCT02055976|20273333|P6|Overall Study|Other|0
5861872|NCT02055976|20273334|P5|Overall Study|Other|0
5861873|NCT02055976|20273335|P4|Overall Study|Other|0
5861874|NCT02055976|20273336|P3|Overall Study|Other|1
5861875|NCT02055976|20273337|P2|Overall Study|Other|0
5861876|NCT02055976|20273338|P1|Overall Study|Other|0
5861877|NCT02055898|20273759|P2|First Intervention (5 Days)|Withdrawal by Subject|1
5861878|NCT02055898|20273760|P1|First Intervention (5 Days)|Withdrawal by Subject|0
5861879|NCT02055898|20273759|P2|First Intervention (5 Days)|Physician Decision|0
5861880|NCT02055898|20273760|P1|First Intervention (5 Days)|Physician Decision|2
5861881|NCT02055820|20273782|P10|Phase II: Expansion|Withdrawal by Subject|0
5861882|NCT02055820|20273783|P9|Phase II: Expansion|Withdrawal by Subject|0
5861883|NCT02055820|20273784|P8|Phase II: Expansion|Withdrawal by Subject|0
5861884|NCT02055820|20273785|P7|Phase II: Expansion|Withdrawal by Subject|0
5861885|NCT02055820|20273786|P6|Phase II: Expansion|Withdrawal by Subject|0
5861886|NCT02055820|20273787|P5|Phase II: Expansion|Withdrawal by Subject|12
5861887|NCT02055820|20273788|P4|Phase II: Expansion|Withdrawal by Subject|0
5861888|NCT02055820|20273789|P3|Phase II: Expansion|Withdrawal by Subject|0
5861889|NCT02055820|20273790|P2|Phase II: Expansion|Withdrawal by Subject|0
5861890|NCT02055820|20273791|P1|Phase II: Expansion|Withdrawal by Subject|0
5861891|NCT02055820|20273782|P10|Phase II: Expansion|Lost to Follow-up|0
5861892|NCT02055820|20273783|P9|Phase II: Expansion|Lost to Follow-up|0
5861893|NCT02055820|20273784|P8|Phase II: Expansion|Lost to Follow-up|0
5861894|NCT02055820|20273785|P7|Phase II: Expansion|Lost to Follow-up|0
5861895|NCT02055820|20273786|P6|Phase II: Expansion|Lost to Follow-up|0
5861896|NCT02055820|20273787|P5|Phase II: Expansion|Lost to Follow-up|4
5861897|NCT02055820|20273788|P4|Phase II: Expansion|Lost to Follow-up|0
5861898|NCT02055820|20273789|P3|Phase II: Expansion|Lost to Follow-up|0
5861899|NCT02055820|20273790|P2|Phase II: Expansion|Lost to Follow-up|0
5861900|NCT02055820|20273791|P1|Phase II: Expansion|Lost to Follow-up|0
5861901|NCT02055820|20273782|P10|Phase II: Expansion|Death|0
5861902|NCT02055820|20273783|P9|Phase II: Expansion|Death|0
5861903|NCT02055820|20273784|P8|Phase II: Expansion|Death|0
5861904|NCT02055820|20273785|P7|Phase II: Expansion|Death|0
5861905|NCT02055820|20273786|P6|Phase II: Expansion|Death|0
5861906|NCT02055820|20273787|P5|Phase II: Expansion|Death|33
5861907|NCT02055820|20273788|P4|Phase II: Expansion|Death|0
5861908|NCT02055820|20273789|P3|Phase II: Expansion|Death|0
5861909|NCT02055820|20273790|P2|Phase II: Expansion|Death|0
5861910|NCT02055820|20273791|P1|Phase II: Expansion|Death|0
5861911|NCT02055820|20273782|P10|Phase I: Dose-Finding|Lost to Follow-up|0
5861912|NCT02055820|20273783|P9|Phase I: Dose-Finding|Lost to Follow-up|0
5861913|NCT02055820|20273784|P8|Phase I: Dose-Finding|Lost to Follow-up|0
5861914|NCT02055820|20273785|P7|Phase I: Dose-Finding|Lost to Follow-up|1
5861915|NCT02055820|20273786|P6|Phase I: Dose-Finding|Lost to Follow-up|0
5861916|NCT02055820|20273787|P5|Phase I: Dose-Finding|Lost to Follow-up|0
5861917|NCT02055820|20273788|P4|Phase I: Dose-Finding|Lost to Follow-up|1
5861918|NCT02055820|20273789|P3|Phase I: Dose-Finding|Lost to Follow-up|0
5861919|NCT02055820|20273790|P2|Phase I: Dose-Finding|Lost to Follow-up|0
5861920|NCT02055820|20273791|P1|Phase I: Dose-Finding|Lost to Follow-up|0
5861921|NCT02055820|20273782|P10|Phase I: Dose-Finding|Withdrawal by Subject|0
5861922|NCT02055820|20273783|P9|Phase I: Dose-Finding|Withdrawal by Subject|0
5861923|NCT02055820|20273784|P8|Phase I: Dose-Finding|Withdrawal by Subject|0
5861924|NCT02055820|20273785|P7|Phase I: Dose-Finding|Withdrawal by Subject|0
5861925|NCT02055820|20273786|P6|Phase I: Dose-Finding|Withdrawal by Subject|1
5861926|NCT02055820|20273787|P5|Phase I: Dose-Finding|Withdrawal by Subject|0
5861927|NCT02055820|20273788|P4|Phase I: Dose-Finding|Withdrawal by Subject|0
5861928|NCT02055820|20273789|P3|Phase I: Dose-Finding|Withdrawal by Subject|0
5861929|NCT02055820|20273790|P2|Phase I: Dose-Finding|Withdrawal by Subject|0
5861930|NCT02055820|20273791|P1|Phase I: Dose-Finding|Withdrawal by Subject|0
5861931|NCT02055820|20273782|P10|Phase I: Dose-Finding|Death|0
5861932|NCT02055820|20273783|P9|Phase I: Dose-Finding|Death|0
5861933|NCT02055820|20273784|P8|Phase I: Dose-Finding|Death|0
5861934|NCT02055820|20273785|P7|Phase I: Dose-Finding|Death|1
5861935|NCT02055820|20273786|P6|Phase I: Dose-Finding|Death|1
5861936|NCT02055820|20273787|P5|Phase I: Dose-Finding|Death|0
5861937|NCT02055820|20273788|P4|Phase I: Dose-Finding|Death|2
5861938|NCT02055820|20273789|P3|Phase I: Dose-Finding|Death|1
5861939|NCT02055820|20273790|P2|Phase I: Dose-Finding|Death|0
5861940|NCT02055820|20273791|P1|Phase I: Dose-Finding|Death|1
5861941|NCT02055547|20273902|P19|Overall Study|Lost to Follow-up|0
5861942|NCT02055547|20273903|P18|Overall Study|Lost to Follow-up|0
5861943|NCT02055547|20273904|P17|Overall Study|Lost to Follow-up|0
5861944|NCT02055547|20273905|P16|Overall Study|Lost to Follow-up|0
5861945|NCT02055547|20273906|P15|Overall Study|Lost to Follow-up|0
5861946|NCT02055547|20273907|P14|Overall Study|Lost to Follow-up|0
5861947|NCT02055547|20273908|P13|Overall Study|Lost to Follow-up|0
5861948|NCT02055547|20273909|P12|Overall Study|Lost to Follow-up|0
5861949|NCT02055547|20273910|P11|Overall Study|Lost to Follow-up|0
5861950|NCT02055547|20273911|P10|Overall Study|Lost to Follow-up|0
5861951|NCT02055547|20273912|P9|Overall Study|Lost to Follow-up|0
5861952|NCT02055547|20273913|P8|Overall Study|Lost to Follow-up|0
5861953|NCT02055547|20273914|P7|Overall Study|Lost to Follow-up|0
5861954|NCT02055547|20273915|P6|Overall Study|Lost to Follow-up|0
5861955|NCT02055547|20273916|P5|Overall Study|Lost to Follow-up|0
5861956|NCT02055547|20273917|P4|Overall Study|Lost to Follow-up|0
5861957|NCT02055547|20273918|P3|Overall Study|Lost to Follow-up|1
5861958|NCT02055547|20273919|P2|Overall Study|Lost to Follow-up|0
5861959|NCT02055547|20273920|P1|Overall Study|Lost to Follow-up|0
5861960|NCT02055547|20273902|P19|Overall Study|Withdrawal by Subject|0
5861961|NCT02055547|20273903|P18|Overall Study|Withdrawal by Subject|0
5861962|NCT02055547|20273904|P17|Overall Study|Withdrawal by Subject|0
5861963|NCT02055547|20273905|P16|Overall Study|Withdrawal by Subject|1
5861964|NCT02055547|20273906|P15|Overall Study|Withdrawal by Subject|0
5861965|NCT02055547|20273907|P14|Overall Study|Withdrawal by Subject|1
5861966|NCT02055547|20273908|P13|Overall Study|Withdrawal by Subject|0
5861967|NCT02055547|20273909|P12|Overall Study|Withdrawal by Subject|0
5861968|NCT02055547|20273910|P11|Overall Study|Withdrawal by Subject|0
5861969|NCT02055547|20273911|P10|Overall Study|Withdrawal by Subject|0
5861970|NCT02055547|20273912|P9|Overall Study|Withdrawal by Subject|1
5861971|NCT02055547|20273913|P8|Overall Study|Withdrawal by Subject|0
5861972|NCT02055547|20273914|P7|Overall Study|Withdrawal by Subject|0
5861973|NCT02055547|20273915|P6|Overall Study|Withdrawal by Subject|1
5861974|NCT02055547|20273916|P5|Overall Study|Withdrawal by Subject|0
5861975|NCT02055547|20273917|P4|Overall Study|Withdrawal by Subject|0
5861976|NCT02055547|20273918|P3|Overall Study|Withdrawal by Subject|0
5861977|NCT02055547|20273919|P2|Overall Study|Withdrawal by Subject|0
5861978|NCT02055547|20273920|P1|Overall Study|Withdrawal by Subject|0
5861979|NCT02055547|20273902|P19|Overall Study|Adverse Event|0
5861980|NCT02055547|20273903|P18|Overall Study|Adverse Event|0
5861981|NCT02055547|20273904|P17|Overall Study|Adverse Event|0
5861982|NCT02055547|20273905|P16|Overall Study|Adverse Event|0
5861983|NCT02055547|20273906|P15|Overall Study|Adverse Event|0
5861984|NCT02055547|20273907|P14|Overall Study|Adverse Event|0
5861985|NCT02055547|20273908|P13|Overall Study|Adverse Event|0
5861986|NCT02055547|20273909|P12|Overall Study|Adverse Event|0
5861987|NCT02055547|20273910|P11|Overall Study|Adverse Event|0
5861988|NCT02055547|20273911|P10|Overall Study|Adverse Event|0
5861989|NCT02055547|20273912|P9|Overall Study|Adverse Event|1
5861990|NCT02055547|20273913|P8|Overall Study|Adverse Event|0
5861991|NCT02055547|20273914|P7|Overall Study|Adverse Event|1
5861992|NCT02055547|20273915|P6|Overall Study|Adverse Event|0
5861993|NCT02055547|20273916|P5|Overall Study|Adverse Event|0
5861994|NCT02055547|20273917|P4|Overall Study|Adverse Event|0
5861995|NCT02055547|20273918|P3|Overall Study|Adverse Event|0
5861996|NCT02055547|20273919|P2|Overall Study|Adverse Event|0
5861997|NCT02055547|20273920|P1|Overall Study|Adverse Event|0
5861998|NCT02055547|20273902|P19|Overall Study|Physician Decision|0
5861999|NCT02055547|20273903|P18|Overall Study|Physician Decision|0
5862000|NCT02055547|20273904|P17|Overall Study|Physician Decision|0
5862001|NCT02055547|20273905|P16|Overall Study|Physician Decision|0
5862002|NCT02055547|20273906|P15|Overall Study|Physician Decision|0
5862003|NCT02055547|20273907|P14|Overall Study|Physician Decision|0
5862004|NCT02055547|20273908|P13|Overall Study|Physician Decision|0
5862005|NCT02055547|20273909|P12|Overall Study|Physician Decision|0
5862006|NCT02055547|20273910|P11|Overall Study|Physician Decision|1
5862007|NCT02055547|20273911|P10|Overall Study|Physician Decision|1
5862008|NCT02055547|20273912|P9|Overall Study|Physician Decision|0
5862009|NCT02055547|20273913|P8|Overall Study|Physician Decision|0
5862010|NCT02055547|20273914|P7|Overall Study|Physician Decision|0
5862011|NCT02055547|20273915|P6|Overall Study|Physician Decision|0
5862012|NCT02055547|20273916|P5|Overall Study|Physician Decision|1
5862013|NCT02055547|20273917|P4|Overall Study|Physician Decision|0
5862014|NCT02055547|20273918|P3|Overall Study|Physician Decision|1
5862015|NCT02055547|20273919|P2|Overall Study|Physician Decision|1
5862016|NCT02055547|20273920|P1|Overall Study|Physician Decision|0
5862017|NCT02055547|20273902|P19|Overall Study|Protocol Violation|0
5862018|NCT02055547|20273903|P18|Overall Study|Protocol Violation|0
5862019|NCT02055547|20273904|P17|Overall Study|Protocol Violation|0
5862020|NCT02055547|20273905|P16|Overall Study|Protocol Violation|0
5862021|NCT02055547|20273906|P15|Overall Study|Protocol Violation|0
5862022|NCT02055547|20273907|P14|Overall Study|Protocol Violation|0
5862023|NCT02055547|20273908|P13|Overall Study|Protocol Violation|0
5862024|NCT02055547|20273909|P12|Overall Study|Protocol Violation|0
5862025|NCT02055547|20273910|P11|Overall Study|Protocol Violation|0
5862026|NCT02055547|20273911|P10|Overall Study|Protocol Violation|0
5862027|NCT02055547|20273912|P9|Overall Study|Protocol Violation|0
5862028|NCT02055547|20273913|P8|Overall Study|Protocol Violation|0
5862029|NCT02055547|20273914|P7|Overall Study|Protocol Violation|1
5862030|NCT02055547|20273915|P6|Overall Study|Protocol Violation|0
5862031|NCT02055547|20273916|P5|Overall Study|Protocol Violation|0
5862032|NCT02055547|20273917|P4|Overall Study|Protocol Violation|0
5862033|NCT02055547|20273918|P3|Overall Study|Protocol Violation|1
5862034|NCT02055547|20273919|P2|Overall Study|Protocol Violation|0
5862035|NCT02055547|20273920|P1|Overall Study|Protocol Violation|0
5862036|NCT02055365|20274089|P1|Overall Study|Prematurely Withdrawn|1
5862037|NCT02055352|20274102|P2|Overall Study|Reason unknown|5
5862038|NCT02055352|20274103|P1|Overall Study|Reason unknown|1
5862039|NCT02055352|20274102|P2|Overall Study|Withdrawal of informed consent|0
5862040|NCT02055352|20274103|P1|Overall Study|Withdrawal of informed consent|1
5862041|NCT02055352|20274102|P2|Overall Study|AE, study drug would be detrimental|3
5862042|NCT02055352|20274103|P1|Overall Study|AE, study drug would be detrimental|1
5862043|NCT02055352|20274102|P2|Overall Study|Use of prohibited treatment|3
5862044|NCT02055352|20274103|P1|Overall Study|Use of prohibited treatment|0
5862045|NCT02055352|20274102|P2|Overall Study|Patient decision|1
5862046|NCT02055352|20274103|P1|Overall Study|Patient decision|1
5862047|NCT02055352|20274102|P2|Overall Study|Death|2
5862048|NCT02055352|20274103|P1|Overall Study|Death|1
5862049|NCT02055352|20274102|P2|Overall Study|Poor compliance|1
5862050|NCT02055352|20274103|P1|Overall Study|Poor compliance|1
5862051|NCT02055352|20274102|P2|Overall Study|Non-eligible|1
5862052|NCT02055352|20274103|P1|Overall Study|Non-eligible|0
5862053|NCT02055352|20274102|P2|Overall Study|Adverse Event|1
5862054|NCT02055352|20274103|P1|Overall Study|Adverse Event|0
5862055|NCT02055157|20274121|P4|18-month Extension|Subject discontinued due to NeedlePhobia|0
5862056|NCT02055157|20274122|P3|18-month Extension|Subject discontinued due to NeedlePhobia|0
5862057|NCT02055157|20274123|P2|18-month Extension|Subject discontinued due to NeedlePhobia|0
5862058|NCT02055157|20274124|P1|18-month Extension|Subject discontinued due to NeedlePhobia|1
5862059|NCT02055157|20274121|P4|18-month Extension|Investigator decision|0
5862060|NCT02055157|20274122|P3|18-month Extension|Investigator decision|0
5862061|NCT02055157|20274123|P2|18-month Extension|Investigator decision|1
5862062|NCT02055157|20274124|P1|18-month Extension|Investigator decision|0
5862063|NCT02055157|20274121|P4|Initial 6 Months|Consent withdrawn by subject|0
5862064|NCT02055157|20274122|P3|Initial 6 Months|Consent withdrawn by subject|0
5862065|NCT02055157|20274123|P2|Initial 6 Months|Consent withdrawn by subject|0
5862066|NCT02055157|20274124|P1|Initial 6 Months|Consent withdrawn by subject|1
5862067|NCT02055157|20274121|P4|Initial 6 Months|Adverse Event|1
5862068|NCT02055157|20274122|P3|Initial 6 Months|Adverse Event|0
5862069|NCT02055157|20274123|P2|Initial 6 Months|Adverse Event|0
5862070|NCT02055157|20274124|P1|Initial 6 Months|Adverse Event|0
5862071|NCT02055157|20274121|P4|Initial 6 Months|Subject discontinued due to NeedlePhobia|0
5862072|NCT02055157|20274122|P3|Initial 6 Months|Subject discontinued due to NeedlePhobia|0
5862073|NCT02055157|20274123|P2|Initial 6 Months|Subject discontinued due to NeedlePhobia|1
5862074|NCT02055157|20274124|P1|Initial 6 Months|Subject discontinued due to NeedlePhobia|0
5862075|NCT02055118|20274204|P3|Overall Study|Withdrawal by Subject|0
5862076|NCT02055118|20274205|P2|Overall Study|Withdrawal by Subject|2
5862077|NCT02055118|20274206|P1|Overall Study|Withdrawal by Subject|0
5862078|NCT02054910|20274276|P2|Overall Study|Lost to Follow-up|1
5862079|NCT02054910|20274277|P1|Overall Study|Lost to Follow-up|4
5862080|NCT02054897|20274296|P3|Overall Study|Randomized but not exposed|0
5862081|NCT02054897|20274297|P2|Overall Study|Randomized but not exposed|0
5862082|NCT02054897|20274298|P1|Overall Study|Randomized but not exposed|1
5862083|NCT02054897|20274296|P3|Overall Study|Lost to Follow-up|7
5862084|NCT02054897|20274297|P2|Overall Study|Lost to Follow-up|2
5862085|NCT02054897|20274298|P1|Overall Study|Lost to Follow-up|4
5862086|NCT02054897|20274296|P3|Overall Study|Missing follow-up information|3
5862087|NCT02054897|20274297|P2|Overall Study|Missing follow-up information|5
5862088|NCT02054897|20274298|P1|Overall Study|Missing follow-up information|3
5862089|NCT02054897|20274296|P3|Overall Study|Withdrawal by Subject|2
5862090|NCT02054897|20274297|P2|Overall Study|Withdrawal by Subject|0
5862091|NCT02054897|20274298|P1|Overall Study|Withdrawal by Subject|2
5862092|NCT02054715|20274345|P2|Follow-up 2|Treatment Change or Delay|0
5862093|NCT02054715|20274346|P1|Follow-up 2|Treatment Change or Delay|1
5862094|NCT02054715|20274345|P2|Follow-up 2|No Reason|0
5862095|NCT02054715|20274346|P1|Follow-up 2|No Reason|2
5862096|NCT02054715|20274345|P2|Follow-up 2|Changed Mind|1
5862097|NCT02054715|20274346|P1|Follow-up 2|Changed Mind|0
5862098|NCT02054715|20274345|P2|Follow-up 2|Changed MD/Facility|1
5862099|NCT02054715|20274346|P1|Follow-up 2|Changed MD/Facility|0
5862100|NCT02054715|20274345|P2|Follow-up 2|Hospitalization|2
5862101|NCT02054715|20274346|P1|Follow-up 2|Hospitalization|0
5862102|NCT02054715|20274345|P2|Follow-up 2|Death|3
5862103|NCT02054715|20274346|P1|Follow-up 2|Death|3
5862104|NCT02054715|20274345|P2|Follow-up 2|Ineligible|5
5862105|NCT02054715|20274346|P1|Follow-up 2|Ineligible|4
5862106|NCT02054715|20274345|P2|Follow-up 2|Followup Not Completed|4
5862107|NCT02054715|20274346|P1|Follow-up 2|Followup Not Completed|3
5862108|NCT02054715|20274345|P2|Follow-up 2|Refused|2
5862109|NCT02054715|20274346|P1|Follow-up 2|Refused|3
5862110|NCT02054715|20274345|P2|Follow-up 2|Lost to Followup|1
5862111|NCT02054715|20274346|P1|Follow-up 2|Lost to Followup|3
5862112|NCT02054715|20274345|P2|Baseline/Follow-up 1|Changed Mind|0
5862113|NCT02054715|20274346|P1|Baseline/Follow-up 1|Changed Mind|1
5862114|NCT02054715|20274345|P2|Baseline/Follow-up 1|Hospitalization|0
5862115|NCT02054715|20274346|P1|Baseline/Follow-up 1|Hospitalization|1
5862116|NCT02054715|20274345|P2|Baseline/Follow-up 1|Ineligible|0
5862117|NCT02054715|20274346|P1|Baseline/Follow-up 1|Ineligible|3
5862118|NCT02054715|20274345|P2|Baseline/Follow-up 1|Overwhelmed|0
5862119|NCT02054715|20274346|P1|Baseline/Follow-up 1|Overwhelmed|2
5862120|NCT02054715|20274345|P2|Baseline/Follow-up 1|No Reason|1
5862121|NCT02054715|20274346|P1|Baseline/Follow-up 1|No Reason|0
5862122|NCT02054715|20274345|P2|Baseline/Follow-up 1|Disliked Procedure|1
5862123|NCT02054715|20274346|P1|Baseline/Follow-up 1|Disliked Procedure|0
5862124|NCT02054715|20274345|P2|Baseline/Follow-up 1|Changed MD/Facility|1
5862125|NCT02054715|20274346|P1|Baseline/Follow-up 1|Changed MD/Facility|0
5862126|NCT02054715|20274345|P2|Baseline/Follow-up 1|Medical|1
5862127|NCT02054715|20274346|P1|Baseline/Follow-up 1|Medical|0
5862128|NCT02054715|20274345|P2|Baseline/Follow-up 1|Refused|3
5862129|NCT02054715|20274346|P1|Baseline/Follow-up 1|Refused|1
5862130|NCT02054702|20274360|P2|Overall Study|Withdrawal by Subject|4
5862131|NCT02054702|20274361|P1|Overall Study|Withdrawal by Subject|14
5862132|NCT02054702|20274360|P2|Overall Study|Physician Decision|1
5862133|NCT02054702|20274361|P1|Overall Study|Physician Decision|0
5862134|NCT02054702|20274360|P2|Overall Study|Met Withdrawal Criteria|1
5862135|NCT02054702|20274361|P1|Overall Study|Met Withdrawal Criteria|4
5862136|NCT02054702|20274360|P2|Overall Study|Adverse Event|1
5862137|NCT02054702|20274361|P1|Overall Study|Adverse Event|3
5862138|NCT02054702|20274360|P2|Overall Study|Lost to Follow-up|5
5862139|NCT02054702|20274361|P1|Overall Study|Lost to Follow-up|3
5862140|NCT02054520|20274418|P6|Overall Study|Study terminated by Sponsor|0
5862141|NCT02054520|20274419|P5|Overall Study|Study terminated by Sponsor|0
5862142|NCT02054520|20274420|P4|Overall Study|Study terminated by Sponsor|1
5862143|NCT02054520|20274421|P3|Overall Study|Study terminated by Sponsor|2
5862144|NCT02054520|20274422|P2|Overall Study|Study terminated by Sponsor|0
5862145|NCT02054520|20274423|P1|Overall Study|Study terminated by Sponsor|0
5862146|NCT02054520|20274418|P6|Overall Study|Physician Decision|1
5862147|NCT02054520|20274419|P5|Overall Study|Physician Decision|0
5862148|NCT02054520|20274420|P4|Overall Study|Physician Decision|1
5862149|NCT02054520|20274421|P3|Overall Study|Physician Decision|0
5862150|NCT02054520|20274422|P2|Overall Study|Physician Decision|1
5862151|NCT02054520|20274423|P1|Overall Study|Physician Decision|0
5862152|NCT02054520|20274418|P6|Overall Study|Withdrawal by Subject|0
5862153|NCT02054520|20274419|P5|Overall Study|Withdrawal by Subject|1
5862154|NCT02054520|20274420|P4|Overall Study|Withdrawal by Subject|2
5862155|NCT02054520|20274421|P3|Overall Study|Withdrawal by Subject|0
5862156|NCT02054520|20274422|P2|Overall Study|Withdrawal by Subject|0
5862157|NCT02054520|20274423|P1|Overall Study|Withdrawal by Subject|1
5862158|NCT02054520|20274418|P6|Overall Study|Lack of Efficacy|2
5862159|NCT02054520|20274419|P5|Overall Study|Lack of Efficacy|3
5862160|NCT02054520|20274420|P4|Overall Study|Lack of Efficacy|1
5862161|NCT02054520|20274421|P3|Overall Study|Lack of Efficacy|2
5862162|NCT02054520|20274422|P2|Overall Study|Lack of Efficacy|0
5862163|NCT02054520|20274423|P1|Overall Study|Lack of Efficacy|7
5862164|NCT02054520|20274418|P6|Overall Study|Adverse Event|0
5862165|NCT02054520|20274419|P5|Overall Study|Adverse Event|1
5862166|NCT02054520|20274420|P4|Overall Study|Adverse Event|1
5862167|NCT02054520|20274421|P3|Overall Study|Adverse Event|2
5862168|NCT02054520|20274422|P2|Overall Study|Adverse Event|4
5862169|NCT02054520|20274423|P1|Overall Study|Adverse Event|1
5862170|NCT02054481|20274447|P4|Overall Study|Other reason|0
5862171|NCT02054481|20274448|P3|Overall Study|Other reason|2
5862172|NCT02054481|20274449|P2|Overall Study|Other reason|1
5862173|NCT02054481|20274450|P1|Overall Study|Other reason|2
5862174|NCT02054481|20274447|P4|Overall Study|Lost to Follow-up|0
5862175|NCT02054481|20274448|P3|Overall Study|Lost to Follow-up|0
5862176|NCT02054481|20274449|P2|Overall Study|Lost to Follow-up|0
5862177|NCT02054481|20274450|P1|Overall Study|Lost to Follow-up|1
5862178|NCT02054481|20274447|P4|Overall Study|Adverse Event|1
5862179|NCT02054481|20274448|P3|Overall Study|Adverse Event|0
5862180|NCT02054481|20274449|P2|Overall Study|Adverse Event|1
5862181|NCT02054481|20274450|P1|Overall Study|Adverse Event|1
5862182|NCT02054325|20274511|P2|Overall Study|Lost to Follow-up|5
5862183|NCT02054325|20274512|P1|Overall Study|Lost to Follow-up|8
5862184|NCT02054130|20274539|P4|Overall Study|Missed dose|10
5862185|NCT02054130|20274540|P3|Overall Study|Missed dose|7
5862186|NCT02054130|20274541|P2|Overall Study|Missed dose|6
5862187|NCT02054130|20274542|P1|Overall Study|Missed dose|4
5862188|NCT02054130|20274539|P4|Overall Study|Lost to Follow-up|2
5862189|NCT02054130|20274540|P3|Overall Study|Lost to Follow-up|1
5862190|NCT02054130|20274541|P2|Overall Study|Lost to Follow-up|0
5862191|NCT02054130|20274542|P1|Overall Study|Lost to Follow-up|0
5862192|NCT02054130|20274539|P4|Overall Study|Death|0
5862193|NCT02054130|20274540|P3|Overall Study|Death|0
5862194|NCT02054130|20274541|P2|Overall Study|Death|1
5862195|NCT02054130|20274542|P1|Overall Study|Death|0
5862196|NCT02054130|20274539|P4|Overall Study|Withdrawal by Subject|10
5862197|NCT02054130|20274540|P3|Overall Study|Withdrawal by Subject|7
5862198|NCT02054130|20274541|P2|Overall Study|Withdrawal by Subject|4
5862199|NCT02054130|20274542|P1|Overall Study|Withdrawal by Subject|4
5862200|NCT02053753|20274636|P2|Overall Study|Lost to Follow-up|3
5862201|NCT02053753|20274637|P1|Overall Study|Lost to Follow-up|4
5862202|NCT02053753|20274636|P2|Overall Study|Decision by Sponsor|1
5862203|NCT02053753|20274637|P1|Overall Study|Decision by Sponsor|1
5862204|NCT02053753|20274636|P2|Overall Study|Withdrawal by Subject|4
5862205|NCT02053753|20274637|P1|Overall Study|Withdrawal by Subject|2
5862206|NCT02053610|20274661|P2|Overall Study|Violation of Selection Criteria|0
5862207|NCT02053610|20274662|P1|Overall Study|Violation of Selection Criteria|1
5862208|NCT02053610|20274661|P2|Overall Study|Insufficient Therapeutic Response|1
5862209|NCT02053610|20274662|P1|Overall Study|Insufficient Therapeutic Response|1
5862210|NCT02053610|20274661|P2|Overall Study|Did not Receive Treatment|2
5862211|NCT02053610|20274662|P1|Overall Study|Did not Receive Treatment|4
5862212|NCT02053610|20274661|P2|Overall Study|Refused treatment/Did not cooperate|3
5862213|NCT02053610|20274662|P1|Overall Study|Refused treatment/Did not cooperate|1
5862214|NCT02053610|20274661|P2|Overall Study|Disease Progression|3
5862215|NCT02053610|20274662|P1|Overall Study|Disease Progression|2
5862216|NCT02053610|20274661|P2|Overall Study|Administrative/Other|1
5862217|NCT02053610|20274662|P1|Overall Study|Administrative/Other|1
5862218|NCT02053610|20274661|P2|Overall Study|Death|5
5862219|NCT02053610|20274662|P1|Overall Study|Death|5
5862220|NCT02053610|20274661|P2|Overall Study|Withdrew Consent|9
5862221|NCT02053610|20274662|P1|Overall Study|Withdrew Consent|2
5862222|NCT02053610|20274661|P2|Overall Study|Adverse Event/Intercurrent Illness|43
5862223|NCT02053610|20274662|P1|Overall Study|Adverse Event/Intercurrent Illness|25
5862224|NCT02053493|20274694|P2|Overall Study|Withdrawal by Subject|1
5862225|NCT02053493|20274695|P1|Overall Study|Withdrawal by Subject|1
5862226|NCT02053168|20274761|P1|Overall Study|Lost to Follow-up|1
5862227|NCT02053168|20274761|P1|Overall Study|Physician Decision|1
5862228|NCT02053168|20274761|P1|Overall Study|Withdrawal by Subject|1
5862229|NCT02052596|20274840|P2|Safety Phase|Lost due to Crohn's disease|1
5862230|NCT02052596|20274841|P1|Safety Phase|Lost due to Crohn's disease|0
5862231|NCT02052596|20274840|P2|Safety Phase|Enrolled in error|0
5862232|NCT02052596|20274841|P1|Safety Phase|Enrolled in error|1
5862233|NCT02052596|20274840|P2|Safety Phase|Withdrawal by Subject|11
5862234|NCT02052596|20274841|P1|Safety Phase|Withdrawal by Subject|8
5862235|NCT02052596|20274840|P2|Safety Phase|Protocol Violation|2
5862236|NCT02052596|20274841|P1|Safety Phase|Protocol Violation|1
5862237|NCT02052596|20274840|P2|Safety Phase|Lost to Follow-up|18
5862238|NCT02052596|20274841|P1|Safety Phase|Lost to Follow-up|11
5862239|NCT02052596|20274840|P2|Safety Phase|Adverse Event|3
5862240|NCT02052596|20274841|P1|Safety Phase|Adverse Event|6
5862241|NCT02052596|20274840|P2|Active Phase|Lost due to Crohn's disease|1
5862242|NCT02052596|20274841|P1|Active Phase|Lost due to Crohn's disease|0
5862243|NCT02052596|20274840|P2|Active Phase|Enrolled in error|0
5862244|NCT02052596|20274841|P1|Active Phase|Enrolled in error|1
5862245|NCT02052596|20274840|P2|Active Phase|Withdrawal by Subject|4
5862246|NCT02052596|20274841|P1|Active Phase|Withdrawal by Subject|3
5862247|NCT02052596|20274840|P2|Active Phase|Protocol Violation|2
5862248|NCT02052596|20274841|P1|Active Phase|Protocol Violation|1
5862249|NCT02052596|20274840|P2|Active Phase|Lost to Follow-up|11
5862250|NCT02052596|20274841|P1|Active Phase|Lost to Follow-up|8
5862251|NCT02052596|20274840|P2|Active Phase|Adverse Event|2
5862252|NCT02052596|20274841|P1|Active Phase|Adverse Event|3
5862253|NCT02052466|20274906|P1|Overall Study|Acromial fracture|1
5862254|NCT02052466|20274906|P1|Overall Study|Withdrawal by Subject|1
5862255|NCT02052440|20274923|P2|Overall Study|Withdrawal by Subject|1
5862256|NCT02052440|20274924|P1|Overall Study|Withdrawal by Subject|0
5862257|NCT02052414|20274936|P1|Overall Study|Withdrawal by Subject|3
5862258|NCT02052414|20274936|P1|Overall Study|Lack of Efficacy|2
5862259|NCT02052414|20274936|P1|Overall Study|Adverse Event|12
5862260|NCT02052011|20274971|P2|Overall Study|Withdrawal by Subject|2
5862261|NCT02052011|20274972|P1|Overall Study|Withdrawal by Subject|1
5862262|NCT02052011|20274971|P2|Overall Study|Lost to Follow-up|0
5862263|NCT02052011|20274972|P1|Overall Study|Lost to Follow-up|3
5862264|NCT02051764|20275029|P2|Overall Study|Study terminated by sponsor|7
5862265|NCT02051764|20275030|P1|Overall Study|Study terminated by sponsor|0
5862266|NCT02051296|20275136|P2|Overall Study|withdraw prior to treatment|7
5862267|NCT02051296|20275137|P1|Overall Study|withdraw prior to treatment|7
5862268|NCT02051296|20275136|P2|Overall Study|Lost to Follow-up|2
5862269|NCT02051296|20275137|P1|Overall Study|Lost to Follow-up|1
5862270|NCT02050373|20275188|P2|Overall Study|Death|3
5862271|NCT02050373|20275189|P1|Overall Study|Death|3
5862272|NCT02050373|20275188|P2|Overall Study|Adverse Event|7
5862273|NCT02050373|20275189|P1|Overall Study|Adverse Event|4
5862274|NCT02050321|20275208|P1|Overall Study|Adverse Event|1
5862275|NCT02050321|20275208|P1|Overall Study|Withdrawal by Subject|1
5862276|NCT02050048|20275224|P2|Overall Study|Ineligible after ERCP|1
5862277|NCT02050048|20275225|P1|Overall Study|Ineligible after ERCP|4
5862278|NCT02050048|20275224|P2|Overall Study|Death|0
5862279|NCT02050048|20275225|P1|Overall Study|Death|1
5862280|NCT02050048|20275224|P2|Overall Study|Lost to Follow-up|1
5862281|NCT02050048|20275225|P1|Overall Study|Lost to Follow-up|0
5862282|NCT02049957|20275240|P9|Overall Study|Physician Decision|0
5862283|NCT02049957|20275241|P8|Overall Study|Physician Decision|0
5862284|NCT02049957|20275242|P7|Overall Study|Physician Decision|0
5862285|NCT02049957|20275243|P6|Overall Study|Physician Decision|1
5862286|NCT02049957|20275244|P5|Overall Study|Physician Decision|0
5862287|NCT02049957|20275245|P4|Overall Study|Physician Decision|0
5862288|NCT02049957|20275246|P3|Overall Study|Physician Decision|0
5862289|NCT02049957|20275247|P2|Overall Study|Physician Decision|0
5862290|NCT02049957|20275248|P1|Overall Study|Physician Decision|0
5862291|NCT02049957|20275240|P9|Overall Study|Withdrawal by Subject|1
5862292|NCT02049957|20275241|P8|Overall Study|Withdrawal by Subject|3
5862293|NCT02049957|20275242|P7|Overall Study|Withdrawal by Subject|0
5862294|NCT02049957|20275243|P6|Overall Study|Withdrawal by Subject|2
5862295|NCT02049957|20275244|P5|Overall Study|Withdrawal by Subject|0
5862296|NCT02049957|20275245|P4|Overall Study|Withdrawal by Subject|1
5862297|NCT02049957|20275246|P3|Overall Study|Withdrawal by Subject|0
5862298|NCT02049957|20275247|P2|Overall Study|Withdrawal by Subject|0
5862299|NCT02049957|20275248|P1|Overall Study|Withdrawal by Subject|0
5862300|NCT02049957|20275240|P9|Overall Study|Study Terminated by Sponsor|0
5862301|NCT02049957|20275241|P8|Overall Study|Study Terminated by Sponsor|0
5862302|NCT02049957|20275242|P7|Overall Study|Study Terminated by Sponsor|1
5862303|NCT02049957|20275243|P6|Overall Study|Study Terminated by Sponsor|0
5862304|NCT02049957|20275244|P5|Overall Study|Study Terminated by Sponsor|0
5862305|NCT02049957|20275245|P4|Overall Study|Study Terminated by Sponsor|0
5862306|NCT02049957|20275246|P3|Overall Study|Study Terminated by Sponsor|0
5862307|NCT02049957|20275247|P2|Overall Study|Study Terminated by Sponsor|1
5862308|NCT02049957|20275248|P1|Overall Study|Study Terminated by Sponsor|0
5862309|NCT02049957|20275240|P9|Overall Study|Adverse Event|1
5862310|NCT02049957|20275241|P8|Overall Study|Adverse Event|6
5862311|NCT02049957|20275242|P7|Overall Study|Adverse Event|0
5862312|NCT02049957|20275243|P6|Overall Study|Adverse Event|5
5862313|NCT02049957|20275244|P5|Overall Study|Adverse Event|0
5862314|NCT02049957|20275245|P4|Overall Study|Adverse Event|0
5862315|NCT02049957|20275246|P3|Overall Study|Adverse Event|1
5862316|NCT02049957|20275247|P2|Overall Study|Adverse Event|1
5862317|NCT02049957|20275248|P1|Overall Study|Adverse Event|1
5862318|NCT02049957|20275240|P9|Overall Study|Progressive Disease|6
5862319|NCT02049957|20275241|P8|Overall Study|Progressive Disease|26
5862320|NCT02049957|20275242|P7|Overall Study|Progressive Disease|7
5862321|NCT02049957|20275243|P6|Overall Study|Progressive Disease|35
5862322|NCT02049957|20275244|P5|Overall Study|Progressive Disease|6
5862323|NCT02049957|20275245|P4|Overall Study|Progressive Disease|2
5862324|NCT02049957|20275246|P3|Overall Study|Progressive Disease|2
5862325|NCT02049957|20275247|P2|Overall Study|Progressive Disease|4
5862326|NCT02049957|20275248|P1|Overall Study|Progressive Disease|5
5862327|NCT02049814|20275340|P2|Overall Study|Voluntary withdrawal|8
5862328|NCT02049814|20275341|P1|Overall Study|Voluntary withdrawal|9
5862329|NCT02049814|20275340|P2|Overall Study|Pretreatment event/Adverse Event (AE)|5
5862330|NCT02049814|20275341|P1|Overall Study|Pretreatment event/Adverse Event (AE)|8
5862331|NCT02049814|20275340|P2|Overall Study|Study Termination|1
5862332|NCT02049814|20275341|P1|Overall Study|Study Termination|0
5862333|NCT02049814|20275340|P2|Overall Study|Serious Protocol Violation|7
5862334|NCT02049814|20275341|P1|Overall Study|Serious Protocol Violation|5
5862335|NCT02049814|20275340|P2|Overall Study|Lost to Follow-up|3
5862336|NCT02049814|20275341|P1|Overall Study|Lost to Follow-up|2
5862337|NCT02049814|20275340|P2|Overall Study|Pregnancy|0
5862338|NCT02049814|20275341|P1|Overall Study|Pregnancy|1
5862339|NCT02049814|20275340|P2|Overall Study|Reason not Specified|3
5862340|NCT02049814|20275341|P1|Overall Study|Reason not Specified|4
5862341|NCT02049450|20275390|P1|Overall Study|Patients/guardian decision|1
5862342|NCT02049450|20275390|P1|Overall Study|Withdrawal by Subject|1
5862343|NCT02049450|20275390|P1|Overall Study|Adverse Event|2
5862344|NCT02049437|20275406|P2|Period 1|Adverse Event|0
5862345|NCT02049437|20275407|P1|Period 1|Adverse Event|1
5862346|NCT02049437|20275406|P2|Period 1|Adverse Event|1
5862347|NCT02049437|20275407|P1|Period 1|Adverse Event|1
5862348|NCT02048904|20275452|P1|Overall Study|Physician Decision|70
5862349|NCT02048904|20275452|P1|Overall Study|Withdrawal by Subject|7
5862350|NCT02048722|20275484|P1|Follow up for 5 Years|Still in follow up|4
5862351|NCT02048722|20275484|P1|Follow up for 5 Years|Withdrawal by Subject|3
5862352|NCT02048722|20275484|P1|Follow up for 5 Years|Death|22
5862353|NCT02048722|20275484|P1|Reached 1st Response/Continued Treatment|Progressive Disease|10
5862354|NCT02048722|20275484|P1|2 Cycles of Treatment|Progressive Disease|2
5862355|NCT02048722|20275484|P1|2 Cycles of Treatment|Withdrawal by Subject|4
5862356|NCT02048722|20275484|P1|2 Cycles of Treatment|Adverse Event|2
5862357|NCT02048241|20275507|P2|Overall Study|Withdrawal by Subject|1
5862358|NCT02048241|20275508|P1|Overall Study|Withdrawal by Subject|0
5862359|NCT02048072|20275514|P1|Overall Study|Lost to Follow-up|1
5862360|NCT02048072|20275514|P1|Overall Study|Adverse Event|3
5862361|NCT02047903|20275553|P1|Overall Study|Not Treated|9
5862362|NCT02047903|20275553|P1|Overall Study|Reason not listed|6
5862363|NCT02047903|20275553|P1|Overall Study|Lost to Follow-up|4
5862364|NCT02047903|20275553|P1|Overall Study|Withdrawal by Subject|16
5862365|NCT02047903|20275553|P1|Overall Study|Serious adverse event|10
5862366|NCT02047903|20275553|P1|Overall Study|Adverse Event|14
5862367|NCT02047253|20275608|P1|Overall Study|Lost to Follow-up|8
5862368|NCT02047227|20275618|P2|Overall Study|Other|9
5862369|NCT02047227|20275619|P1|Overall Study|Other|10
5862370|NCT02047227|20275618|P2|Overall Study|All embryos discarded|11
5862371|NCT02047227|20275619|P1|Overall Study|All embryos discarded|12
5862372|NCT02047227|20275618|P2|Overall Study|Intention to freeze all embryos|0
5862373|NCT02047227|20275619|P1|Overall Study|Intention to freeze all embryos|1
5862374|NCT02047227|20275618|P2|Overall Study|No fertilization|51
5862375|NCT02047227|20275619|P1|Overall Study|No fertilization|61
5862376|NCT02047227|20275618|P2|Overall Study|No oocytes retrieved|20
5862377|NCT02047227|20275619|P1|Overall Study|No oocytes retrieved|21
5862378|NCT02047227|20275618|P2|Overall Study|Lack of ovarian response to stimulation|32
5862379|NCT02047227|20275619|P1|Overall Study|Lack of ovarian response to stimulation|35
5862380|NCT02047227|20275618|P2|Overall Study|Spontaneous pregnancy|0
5862381|NCT02047227|20275619|P1|Overall Study|Spontaneous pregnancy|1
5862382|NCT02047227|20275618|P2|Overall Study|Protocol Violation|0
5862383|NCT02047227|20275619|P1|Overall Study|Protocol Violation|1
5862384|NCT02047227|20275618|P2|Overall Study|Lost to Follow-up|3
5862385|NCT02047227|20275619|P1|Overall Study|Lost to Follow-up|0
5862386|NCT02047227|20275618|P2|Overall Study|Adverse Event|4
5862387|NCT02047227|20275619|P1|Overall Study|Adverse Event|2
5862388|NCT02047110|20275639|P4|OLE Treatment Period|Other than specified|0
5862389|NCT02047110|20275640|P3|OLE Treatment Period|Other than specified|1
5862390|NCT02047110|20275641|P2|OLE Treatment Period|Other than specified|0
5862391|NCT02047110|20275642|P1|OLE Treatment Period|Other than specified|0
5862392|NCT02047110|20275639|P4|Escape Treatment Period|Other than specified|1
5862393|NCT02047110|20275640|P3|Escape Treatment Period|Other than specified|0
5862394|NCT02047110|20275641|P2|Escape Treatment Period|Other than specified|2
5862395|NCT02047110|20275642|P1|Escape Treatment Period|Other than specified|1
5862396|NCT02047110|20275639|P4|Escape Treatment Period|Adverse Event|0
5862397|NCT02047110|20275640|P3|Escape Treatment Period|Adverse Event|2
5862398|NCT02047110|20275641|P2|Escape Treatment Period|Adverse Event|2
5862399|NCT02047110|20275642|P1|Escape Treatment Period|Adverse Event|1
5862400|NCT02047110|20275639|P4|Escape Treatment Period|Withdrawal by Subject|1
5862401|NCT02047110|20275640|P3|Escape Treatment Period|Withdrawal by Subject|1
5862402|NCT02047110|20275641|P2|Escape Treatment Period|Withdrawal by Subject|2
5862403|NCT02047110|20275642|P1|Escape Treatment Period|Withdrawal by Subject|1
5862404|NCT02047110|20275639|P4|DB (Week 12 up to Week 24)|Other than specified|0
5862405|NCT02047110|20275640|P3|DB (Week 12 up to Week 24)|Other than specified|1
5862406|NCT02047110|20275641|P2|DB (Week 12 up to Week 24)|Other than specified|1
5862407|NCT02047110|20275642|P1|DB (Week 12 up to Week 24)|Other than specified|0
5862408|NCT02047110|20275639|P4|DB (Week 12 up to Week 24)|Withdrawal by Subject|0
5862409|NCT02047110|20275640|P3|DB (Week 12 up to Week 24)|Withdrawal by Subject|0
5862410|NCT02047110|20275641|P2|DB (Week 12 up to Week 24)|Withdrawal by Subject|1
5862411|NCT02047110|20275642|P1|DB (Week 12 up to Week 24)|Withdrawal by Subject|0
5862412|NCT02047110|20275639|P4|DB Treatment Period up to Week 24|Other than specified|1
5862413|NCT02047110|20275640|P3|DB Treatment Period up to Week 24|Other than specified|3
5862414|NCT02047110|20275641|P2|DB Treatment Period up to Week 24|Other than specified|2
5862415|NCT02047110|20275642|P1|DB Treatment Period up to Week 24|Other than specified|1
5862416|NCT02047110|20275639|P4|DB Treatment Period up to Week 24|Withdrawal by Subject|1
5862417|NCT02047110|20275640|P3|DB Treatment Period up to Week 24|Withdrawal by Subject|0
5862418|NCT02047110|20275641|P2|DB Treatment Period up to Week 24|Withdrawal by Subject|0
5862419|NCT02047110|20275642|P1|DB Treatment Period up to Week 24|Withdrawal by Subject|1
5862420|NCT02047110|20275639|P4|DB Treatment Period up to Week 24|Protocol Violation|0
5862421|NCT02047110|20275640|P3|DB Treatment Period up to Week 24|Protocol Violation|0
5862422|NCT02047110|20275641|P2|DB Treatment Period up to Week 24|Protocol Violation|0
5862423|NCT02047110|20275642|P1|DB Treatment Period up to Week 24|Protocol Violation|1
5862424|NCT02047110|20275639|P4|DB Treatment Period up to Week 24|Lost to Follow-up|0
5862425|NCT02047110|20275640|P3|DB Treatment Period up to Week 24|Lost to Follow-up|0
5862426|NCT02047110|20275641|P2|DB Treatment Period up to Week 24|Lost to Follow-up|0
5862427|NCT02047110|20275642|P1|DB Treatment Period up to Week 24|Lost to Follow-up|1
5862428|NCT02047110|20275639|P4|DB Treatment Period up to Week 24|Adverse Event|0
5862429|NCT02047110|20275640|P3|DB Treatment Period up to Week 24|Adverse Event|0
5862430|NCT02047110|20275641|P2|DB Treatment Period up to Week 24|Adverse Event|0
5862431|NCT02047110|20275642|P1|DB Treatment Period up to Week 24|Adverse Event|1
5862432|NCT02047045|20275685|P2|Treatment Period (8 Weeks )|Withdrawal by Subject|2
5862433|NCT02047045|20275686|P1|Treatment Period (8 Weeks )|Withdrawal by Subject|4
5862434|NCT02047045|20275685|P2|Treatment Period (8 Weeks )|Lost to Follow-up|0
5862435|NCT02047045|20275686|P1|Treatment Period (8 Weeks )|Lost to Follow-up|1
5862436|NCT02047045|20275685|P2|Treatment Period (8 Weeks )|Adverse Event|1
5862437|NCT02047045|20275686|P1|Treatment Period (8 Weeks )|Adverse Event|2
5862438|NCT02047045|20275685|P2|Baseline|Withdrawal by Subject|15
5862439|NCT02047045|20275686|P1|Baseline|Withdrawal by Subject|8
5862440|NCT02046993|20275750|P2|Overall Study|Lost to Follow-up|1
5862441|NCT02046993|20275751|P1|Overall Study|Lost to Follow-up|1
5862442|NCT02046993|20275750|P2|Overall Study|Withdrawal by Subject|10
5862443|NCT02046993|20275751|P1|Overall Study|Withdrawal by Subject|2
5862444|NCT02046616|20275823|P1|8-Week FU Period|Lost to Follow-up|1
5862445|NCT02046616|20275823|P1|24-Week Treatment Period|Other|1
5862446|NCT02046616|20275823|P1|24-Week Treatment Period|Physician Decision|3
5862447|NCT02046616|20275823|P1|24-Week Treatment Period|Insufficient Therapeutic Response|1
5862448|NCT02046616|20275823|P1|24-Week Treatment Period|Any Other Adverse Event|13
5862449|NCT02046616|20275823|P1|24-Week Treatment Period|Anaphylaxis/Serious Hypersensitivity|1
5862450|NCT02046603|20275845|P2|Overall Study|Adverse Event|1
5862451|NCT02046603|20275846|P1|Overall Study|Adverse Event|0
5862452|NCT02046603|20275845|P2|Overall Study|Death|1
5862453|NCT02046603|20275846|P1|Overall Study|Death|0
5862454|NCT02046603|20275845|P2|Overall Study|Lost to Follow-up|2
5862455|NCT02046603|20275846|P1|Overall Study|Lost to Follow-up|1
5862456|NCT02046603|20275845|P2|Overall Study|Physician Decision|1
5862457|NCT02046603|20275846|P1|Overall Study|Physician Decision|2
5862458|NCT02046603|20275845|P2|Overall Study|Participant/legal guardian decision|3
5862459|NCT02046603|20275846|P1|Overall Study|Participant/legal guardian decision|1
5862460|NCT02046603|20275845|P2|Overall Study|Protocol Violation|1
5862461|NCT02046603|20275846|P1|Overall Study|Protocol Violation|0
5862462|NCT02046603|20275845|P2|Overall Study|Other|66
5862463|NCT02046603|20275846|P1|Overall Study|Other|11
5862464|NCT02046564|20275925|P2|Overall Study|Subject met withdrawal criteria|5
5862465|NCT02046564|20275926|P1|Overall Study|Subject met withdrawal criteria|2
5862466|NCT02046564|20275925|P2|Overall Study|Withdrawal by Subject|10
5862467|NCT02046564|20275926|P1|Overall Study|Withdrawal by Subject|4
5862468|NCT02046564|20275925|P2|Overall Study|Protocol Violation|1
5862469|NCT02046564|20275926|P1|Overall Study|Protocol Violation|3
5862470|NCT02046564|20275925|P2|Overall Study|Physician Decision|1
5862471|NCT02046564|20275926|P1|Overall Study|Physician Decision|0
5862472|NCT02046564|20275925|P2|Overall Study|Adverse Event|3
5862473|NCT02046564|20275926|P1|Overall Study|Adverse Event|6
5862474|NCT02046369|20275974|P2|Overall Study|non compliance|0
5862475|NCT02046369|20275975|P1|Overall Study|non compliance|1
5862476|NCT02046369|20275974|P2|Overall Study|never received study drug|1
5862477|NCT02046369|20275975|P1|Overall Study|never received study drug|0
5862478|NCT02046369|20275974|P2|Overall Study|Withdrawal by Subject|6
5862479|NCT02046369|20275975|P1|Overall Study|Withdrawal by Subject|3
5862480|NCT02046369|20275974|P2|Overall Study|Protocol Violation|2
5862481|NCT02046369|20275975|P1|Overall Study|Protocol Violation|1
5862482|NCT02046369|20275974|P2|Overall Study|Lost to Follow-up|3
5862483|NCT02046369|20275975|P1|Overall Study|Lost to Follow-up|3
5862484|NCT02046369|20275974|P2|Overall Study|Lack of Efficacy|3
5862485|NCT02046369|20275975|P1|Overall Study|Lack of Efficacy|3
5862486|NCT02046369|20275974|P2|Overall Study|Adverse Event|3
5862487|NCT02046369|20275975|P1|Overall Study|Adverse Event|3
5862488|NCT02046226|20276019|P1|Overall Study|Lost to Follow-up|7
5862489|NCT02046148|20276067|P2|Overall Study|Withdrawal by Subject|2
5862490|NCT02046148|20276068|P1|Overall Study|Withdrawal by Subject|0
5862491|NCT02046148|20276067|P2|Overall Study|Lost to Follow-up|1
5862492|NCT02046148|20276068|P1|Overall Study|Lost to Follow-up|1
5862493|NCT02046122|20276145|P1|Overall Study|Withdrawal by Subject|1
5862494|NCT02046122|20276145|P1|Overall Study|Physician Decision|8
5862495|NCT02046070|20276159|P3|Overall Study|Reason not Specified|6
5862496|NCT02046070|20276160|P2|Overall Study|Reason not Specified|4
5862497|NCT02046070|20276161|P1|Overall Study|Reason not Specified|4
5862498|NCT02046070|20276159|P3|Overall Study|Study Terminated by Sponsor|1
5862499|NCT02046070|20276160|P2|Overall Study|Study Terminated by Sponsor|1
5862500|NCT02046070|20276161|P1|Overall Study|Study Terminated by Sponsor|1
5862501|NCT02046070|20276159|P3|Overall Study|Withdrawal by Subject|6
5862502|NCT02046070|20276160|P2|Overall Study|Withdrawal by Subject|2
5862503|NCT02046070|20276161|P1|Overall Study|Withdrawal by Subject|1
5862504|NCT02046070|20276159|P3|Overall Study|Adverse Event|17
5862505|NCT02046070|20276160|P2|Overall Study|Adverse Event|10
5862506|NCT02046070|20276161|P1|Overall Study|Adverse Event|8
5862507|NCT02046070|20276159|P3|Overall Study|Progressive Disease|40
5862508|NCT02046070|20276160|P2|Overall Study|Progressive Disease|11
5862509|NCT02046070|20276161|P1|Overall Study|Progressive Disease|18
5862510|NCT02045979|20276221|P3|Overall Study|not specified above|0
5862511|NCT02045979|20276222|P2|Overall Study|not specified above|1
5862512|NCT02045979|20276223|P1|Overall Study|not specified above|0
5862513|NCT02045979|20276221|P3|Overall Study|Informed Consent Withdrawn|1
5862514|NCT02045979|20276222|P2|Overall Study|Informed Consent Withdrawn|0
5862515|NCT02045979|20276223|P1|Overall Study|Informed Consent Withdrawn|2
5862516|NCT02045875|20276260|P2|Overall Study|Withdrawal by Subject|3
5862517|NCT02045875|20276261|P1|Overall Study|Withdrawal by Subject|4
5862518|NCT02045875|20276260|P2|Overall Study|Lost to Follow-up|0
5862519|NCT02045875|20276261|P1|Overall Study|Lost to Follow-up|3
5862520|NCT02045862|20276272|P3|Overall Study|Lost to Follow-up|6
5862521|NCT02045862|20276273|P2|Overall Study|Lost to Follow-up|2
5862522|NCT02045862|20276274|P1|Overall Study|Lost to Follow-up|1
5862523|NCT02045862|20276272|P3|Overall Study|Adverse Event|27
5862524|NCT02045862|20276273|P2|Overall Study|Adverse Event|5
5862525|NCT02045862|20276274|P1|Overall Study|Adverse Event|7
5862526|NCT02045862|20276272|P3|Overall Study|Randomized but not Received Study Drug|8
5862527|NCT02045862|20276273|P2|Overall Study|Randomized but not Received Study Drug|2
5862528|NCT02045862|20276274|P1|Overall Study|Randomized but not Received Study Drug|0
5862529|NCT02045862|20276272|P3|Overall Study|Lack of Efficacy|13
5862530|NCT02045862|20276273|P2|Overall Study|Lack of Efficacy|4
5862531|NCT02045862|20276274|P1|Overall Study|Lack of Efficacy|8
5862532|NCT02045862|20276272|P3|Overall Study|Protocol Violation|6
5862533|NCT02045862|20276273|P2|Overall Study|Protocol Violation|0
5862534|NCT02045862|20276274|P1|Overall Study|Protocol Violation|0
5862535|NCT02045862|20276272|P3|Overall Study|Withdrawal by Patient|57
5862536|NCT02045862|20276273|P2|Overall Study|Withdrawal by Patient|27
5862537|NCT02045862|20276274|P1|Overall Study|Withdrawal by Patient|18
5862538|NCT02045862|20276272|P3|Overall Study|Miscellaneous|8
5862539|NCT02045862|20276273|P2|Overall Study|Miscellaneous|0
5862540|NCT02045862|20276274|P1|Overall Study|Miscellaneous|5
5862541|NCT02045862|20276272|P3|Overall Study|Death|1
5862542|NCT02045862|20276273|P2|Overall Study|Death|0
5862543|NCT02045862|20276274|P1|Overall Study|Death|0
5862544|NCT02045836|20276455|P2|Overall Study|Migrated from study area|2
5862545|NCT02045836|20276456|P1|Overall Study|Migrated from study area|0
5862546|NCT02045836|20276455|P2|Overall Study|Lost to Follow-up|7
5862547|NCT02045836|20276456|P1|Overall Study|Lost to Follow-up|4
5862548|NCT02045836|20276455|P2|Overall Study|Withdrawal by Subject|1
5862549|NCT02045836|20276456|P1|Overall Study|Withdrawal by Subject|1
5862550|NCT02045836|20276455|P2|Overall Study|Adverse Event|4
5862551|NCT02045836|20276456|P1|Overall Study|Adverse Event|4
5862552|NCT02045797|20276488|P3|Overall Study|Withdrawal by Subject|0
5862553|NCT02045797|20276489|P2|Overall Study|Withdrawal by Subject|2
5862554|NCT02045797|20276490|P1|Overall Study|Withdrawal by Subject|1
5862555|NCT02045797|20276488|P3|Overall Study|Physician Decision|0
5862556|NCT02045797|20276489|P2|Overall Study|Physician Decision|1
5862557|NCT02045797|20276490|P1|Overall Study|Physician Decision|0
5862558|NCT02045797|20276488|P3|Overall Study|Lost to Follow-up|1
5862559|NCT02045797|20276489|P2|Overall Study|Lost to Follow-up|3
5862560|NCT02045797|20276490|P1|Overall Study|Lost to Follow-up|2
5862561|NCT02045797|20276488|P3|Overall Study|Lack of Efficacy|0
5862562|NCT02045797|20276489|P2|Overall Study|Lack of Efficacy|0
5862563|NCT02045797|20276490|P1|Overall Study|Lack of Efficacy|1
5862564|NCT02045797|20276488|P3|Overall Study|Adverse Event|0
5862565|NCT02045797|20276489|P2|Overall Study|Adverse Event|1
5862566|NCT02045797|20276490|P1|Overall Study|Adverse Event|3
5862567|NCT02045732|20276635|P2|Overall Study|At the discretion of the investigator|1
5862568|NCT02045732|20276636|P1|Overall Study|At the discretion of the investigator|1
5862569|NCT02045433|20276673|P1|Overall Study|Withdrawal by Subject|1
5862570|NCT02045212|20276726|P2|Overall Study|Finished 13 weeks, chose not to extend|0
5862571|NCT02045212|20276727|P1|Overall Study|Finished 13 weeks, chose not to extend|1
5862572|NCT02045212|20276726|P2|Overall Study|Withdrawal by Subject|0
5862573|NCT02045212|20276727|P1|Overall Study|Withdrawal by Subject|1
5862574|NCT02045212|20276726|P2|Overall Study|Adverse Event|1
5862575|NCT02045212|20276727|P1|Overall Study|Adverse Event|0
5862576|NCT02045095|20276792|P7|Overall Study|Adverse Event|0
5862577|NCT02045095|20276793|P6|Overall Study|Adverse Event|2
5862578|NCT02045095|20276794|P5|Overall Study|Adverse Event|0
5862579|NCT02045095|20276795|P4|Overall Study|Adverse Event|0
5862580|NCT02045095|20276796|P3|Overall Study|Adverse Event|1
5862581|NCT02045095|20276797|P2|Overall Study|Adverse Event|1
5862582|NCT02045095|20276798|P1|Overall Study|Adverse Event|0
5862583|NCT02045095|20276792|P7|Overall Study|Withdrawal by Subject|0
5862584|NCT02045095|20276793|P6|Overall Study|Withdrawal by Subject|0
5862585|NCT02045095|20276794|P5|Overall Study|Withdrawal by Subject|3
5862586|NCT02045095|20276795|P4|Overall Study|Withdrawal by Subject|0
5862587|NCT02045095|20276796|P3|Overall Study|Withdrawal by Subject|0
5862588|NCT02045095|20276797|P2|Overall Study|Withdrawal by Subject|0
5862589|NCT02045095|20276798|P1|Overall Study|Withdrawal by Subject|0
5862590|NCT02045095|20276792|P7|Overall Study|Progressive Disease|1
5862591|NCT02045095|20276793|P6|Overall Study|Progressive Disease|4
5862592|NCT02045095|20276794|P5|Overall Study|Progressive Disease|2
5862593|NCT02045095|20276795|P4|Overall Study|Progressive Disease|4
5862594|NCT02045095|20276796|P3|Overall Study|Progressive Disease|2
5862595|NCT02045095|20276797|P2|Overall Study|Progressive Disease|3
5862596|NCT02045095|20276798|P1|Overall Study|Progressive Disease|3
5862597|NCT02045095|20276792|P7|Overall Study|Other|0
5862598|NCT02045095|20276793|P6|Overall Study|Other|2
5862599|NCT02045095|20276794|P5|Overall Study|Other|0
5862600|NCT02045095|20276795|P4|Overall Study|Other|0
5862601|NCT02045095|20276796|P3|Overall Study|Other|1
5862602|NCT02045095|20276797|P2|Overall Study|Other|0
5862603|NCT02045095|20276798|P1|Overall Study|Other|0
5862604|NCT02044874|20276956|P3|Overall Study|Other|8
5862605|NCT02044874|20276957|P2|Overall Study|Other|3
5862606|NCT02044874|20276958|P1|Overall Study|Other|7
5862607|NCT02044874|20276956|P3|Overall Study|Sponsor Decision|1
5862608|NCT02044874|20276957|P2|Overall Study|Sponsor Decision|1
5862609|NCT02044874|20276958|P1|Overall Study|Sponsor Decision|0
5862610|NCT02044874|20276956|P3|Overall Study|Lost to Follow-up|21
5862611|NCT02044874|20276957|P2|Overall Study|Lost to Follow-up|27
5862612|NCT02044874|20276958|P1|Overall Study|Lost to Follow-up|10
5862613|NCT02044874|20276956|P3|Overall Study|Physician Decision|1
5862614|NCT02044874|20276957|P2|Overall Study|Physician Decision|2
5862615|NCT02044874|20276958|P1|Overall Study|Physician Decision|0
5862616|NCT02044874|20276956|P3|Overall Study|Withdrawal by Subject|23
5862617|NCT02044874|20276957|P2|Overall Study|Withdrawal by Subject|16
5862618|NCT02044874|20276958|P1|Overall Study|Withdrawal by Subject|8
5862619|NCT02044874|20276956|P3|Overall Study|Adverse Event|6
5862620|NCT02044874|20276957|P2|Overall Study|Adverse Event|6
5862621|NCT02044874|20276958|P1|Overall Study|Adverse Event|5
5862622|NCT02044848|20276980|P2|Overall Study|Administrative Problems|3
5862623|NCT02044848|20276981|P1|Overall Study|Administrative Problems|2
5862624|NCT02044822|20276987|P1|Overall Study|Lost to Follow-up|1
5862625|NCT02044822|20276987|P1|Overall Study|Initiation of Anti-Neoplastic Therapy|2
5862626|NCT02044822|20276987|P1|Overall Study|Withdrew Consent|3
5862627|NCT02044822|20276987|P1|Overall Study|Investigator's Discretion|10
5862628|NCT02044822|20276987|P1|Overall Study|Study Terminated by Sponsor|77
5862629|NCT02044510|20277029|P2|Overall Study|Adverse Event|2
5862630|NCT02044510|20277030|P1|Overall Study|Adverse Event|1
5862631|NCT02044458|20277038|P2|Overall Study|Protocol Violation|8
5862632|NCT02044458|20277039|P1|Overall Study|Protocol Violation|3
5862633|NCT02044302|20277125|P2|Overall Study|study terminated|0
5862634|NCT02044302|20277126|P1|Overall Study|study terminated|2
5862635|NCT02044159|20277134|P2|Overall Study|Nurse declined to give study drug|0
5862636|NCT02044159|20277135|P1|Overall Study|Nurse declined to give study drug|1
5862637|NCT02044159|20277134|P2|Overall Study|No longer eligible, drug not given|0
5862638|NCT02044159|20277135|P1|Overall Study|No longer eligible, drug not given|1
5862639|NCT02044159|20277134|P2|Overall Study|Consent declined (deferred consent)|4
5862640|NCT02044159|20277135|P1|Overall Study|Consent declined (deferred consent)|2
5862641|NCT02044094|20277148|P1|RBP-6000 Injection 2 (Day 29 to Week 12)|Noncompliance|1
5862642|NCT02044094|20277148|P1|RBP-6000 Injection 2 (Day 29 to Week 12)|Physician Decision|1
5862643|NCT02044094|20277148|P1|RBP-6000 Injection 2 (Day 29 to Week 12)|Withdrawal by Subject|2
5862644|NCT02044094|20277148|P1|RBP-6000 Injection 2 (Day 29 to Week 12)|Lost to Follow-up|5
5862645|NCT02044094|20277148|P1|RBP-6000 Injection 2 (Day 29 to Week 12)|Adverse Event|4
5862646|NCT02044094|20277148|P1|RBP-6000 Injection 1 (Day 1 to Day 28)|Withdrawal by Subject|3
5862647|NCT02044094|20277148|P1|RBP-6000 Injection 1 (Day 1 to Day 28)|Physician Decision|3
5862648|NCT02044094|20277148|P1|RBP-6000 Injection 1 (Day 1 to Day 28)|Lost to Follow-up|3
5862649|NCT02043938|20277205|P1|Overall Study|Investigator decision|1
5862650|NCT02043938|20277205|P1|Overall Study|No show by subject|1
5862651|NCT02043938|20277205|P1|Overall Study|Unable to place EEG sensors on patient|1
5862652|NCT02043938|20277205|P1|Overall Study|Withdrawal by Subject|7
5862653|NCT02043782|20277260|P6|Period 1|Adverse Event|0
5862654|NCT02043782|20277261|P5|Period 1|Adverse Event|0
5862655|NCT02043782|20277262|P4|Period 1|Adverse Event|0
5862656|NCT02043782|20277263|P3|Period 1|Adverse Event|1
5862657|NCT02043782|20277264|P2|Period 1|Adverse Event|0
5862658|NCT02043782|20277265|P1|Period 1|Adverse Event|0
5862679|NCT02043548|20277345|P2|Overall Study|Adverse Event|1
5862680|NCT02043548|20277346|P1|Overall Study|Adverse Event|0
5862681|NCT02043548|20277345|P2|Overall Study|Lack of Efficacy|0
5862682|NCT02043548|20277346|P1|Overall Study|Lack of Efficacy|1
5862683|NCT02043509|20277364|P2|Baseline to 2nd Follow-up|Withdrawal by Subject|5
5862684|NCT02043509|20277365|P1|Baseline to 2nd Follow-up|Withdrawal by Subject|7
5862685|NCT02043509|20277364|P2|Baseline to 2nd Follow-up|Lost to Follow-up|67
5862686|NCT02043509|20277365|P1|Baseline to 2nd Follow-up|Lost to Follow-up|67
5862687|NCT02043509|20277364|P2|Baseline to 1st Follow-up|Withdrawal by Subject|0
5862688|NCT02043509|20277365|P1|Baseline to 1st Follow-up|Withdrawal by Subject|4
5862689|NCT02043509|20277364|P2|Baseline to 1st Follow-up|Lost to Follow-up|47
5862690|NCT02043509|20277365|P1|Baseline to 1st Follow-up|Lost to Follow-up|61
5862691|NCT02043366|20277453|P6|Overall Study|Lost to Follow-up|2
5862692|NCT02043366|20277454|P5|Overall Study|Lost to Follow-up|2
5862693|NCT02043366|20277455|P4|Overall Study|Lost to Follow-up|2
5862694|NCT02043366|20277456|P3|Overall Study|Lost to Follow-up|2
5862695|NCT02043366|20277457|P2|Overall Study|Lost to Follow-up|2
5862696|NCT02043366|20277458|P1|Overall Study|Lost to Follow-up|2
5862697|NCT02043301|20277481|P3|Overall Study|Discontinued|0
5862698|NCT02043301|20277482|P2|Overall Study|Discontinued|1
5862699|NCT02043301|20277483|P1|Overall Study|Discontinued|0
5862700|NCT02043132|20277580|P2|Overall Study|screen failures|8
5862701|NCT02043132|20277581|P1|Overall Study|screen failures|4
5862702|NCT02043132|20277580|P2|Overall Study|Lost to Follow-up|1
5862703|NCT02043132|20277581|P1|Overall Study|Lost to Follow-up|1
5862704|NCT02043015|20277601|P1|Overall Study|Incarceration|1
5862705|NCT02043015|20277601|P1|Overall Study|Participant moved away from study city|4
5862706|NCT02043015|20277601|P1|Overall Study|Removed once target enrollment reached|15
5862707|NCT02043015|20277601|P1|Overall Study|Withdrawal by Subject|4
5862708|NCT02043015|20277601|P1|Overall Study|Lost to Follow-up|4
5862709|NCT02042950|20277614|P1|Overall Study|Progressive Disease|4
5862710|NCT02042924|20277620|P1|Overall Study|Early Death|1
5862711|NCT02042443|20277668|P2|Overall Study|Not eligible/not analyzable|6
5862712|NCT02042443|20277669|P1|Overall Study|Not eligible/not analyzable|3
5862713|NCT02042443|20277668|P2|Overall Study|not protocol specified|1
5862714|NCT02042443|20277669|P1|Overall Study|not protocol specified|1
5862715|NCT02042443|20277668|P2|Overall Study|Progression|17
5862716|NCT02042443|20277669|P1|Overall Study|Progression|21
5862717|NCT02042443|20277668|P2|Overall Study|Withdrawal by Subject|1
5862718|NCT02042443|20277669|P1|Overall Study|Withdrawal by Subject|0
5862719|NCT02042443|20277668|P2|Overall Study|Adverse Event|1
5862720|NCT02042443|20277669|P1|Overall Study|Adverse Event|2
5862721|NCT02042404|20277681|P2|Overall Study|Inability to meet time requirements|0
5862722|NCT02042404|20277682|P1|Overall Study|Inability to meet time requirements|1
5862723|NCT02042404|20277681|P2|Overall Study|Unrelated Adverse Event|0
5862724|NCT02042404|20277682|P1|Overall Study|Unrelated Adverse Event|3
5862725|NCT02042404|20277681|P2|Overall Study|Death|0
5862726|NCT02042404|20277682|P1|Overall Study|Death|1
5862727|NCT02042183|20277700|P2|Overall Study|Lost to Follow-up|2
5862728|NCT02042183|20277701|P1|Overall Study|Lost to Follow-up|9
5862729|NCT02042183|20277700|P2|Overall Study|Site Terminated by Sponsor|1
5862730|NCT02042183|20277701|P1|Overall Study|Site Terminated by Sponsor|2
5862731|NCT02042183|20277700|P2|Overall Study|Withdrawal by Subject|16
5862732|NCT02042183|20277701|P1|Overall Study|Withdrawal by Subject|21
5862733|NCT02042183|20277700|P2|Overall Study|Other|3
5862734|NCT02042183|20277701|P1|Overall Study|Other|3
5862735|NCT02042183|20277700|P2|Overall Study|Adverse Event|6
5862736|NCT02042183|20277701|P1|Overall Study|Adverse Event|17
5862737|NCT02042183|20277700|P2|Overall Study|Non-compliance with Study Drug|3
5862738|NCT02042183|20277701|P1|Overall Study|Non-compliance with Study Drug|2
5862739|NCT02042183|20277700|P2|Overall Study|Lack of Efficacy|3
5862740|NCT02042183|20277701|P1|Overall Study|Lack of Efficacy|4
5862741|NCT02042183|20277700|P2|Overall Study|Physician Decision|2
5862742|NCT02042183|20277701|P1|Overall Study|Physician Decision|7
5862743|NCT02042014|20277731|P1|Overall Study|Physician Decision|7
5862744|NCT02042014|20277731|P1|Overall Study|Adverse Event|1
5862745|NCT02041962|20277737|P2|Overall Study|Withdrawal by Subject|11
5862746|NCT02041962|20277738|P1|Overall Study|Withdrawal by Subject|0
5862747|NCT02041962|20277737|P2|Overall Study|Lost to Follow-up|32
5862748|NCT02041962|20277738|P1|Overall Study|Lost to Follow-up|37
5862749|NCT02041962|20277737|P2|Overall Study|Death|1
5862750|NCT02041962|20277738|P1|Overall Study|Death|1
5862751|NCT02041962|20277737|P2|Overall Study|Lost Aetna Coverage|40
5862752|NCT02041962|20277738|P1|Overall Study|Lost Aetna Coverage|43
5862753|NCT02041702|20277748|P2|Overall Study|Cardiac Resynchronization Therapy|0
5862754|NCT02041702|20277749|P1|Overall Study|Cardiac Resynchronization Therapy|1
5862755|NCT02041702|20277748|P2|Overall Study|Patient not confirmed as MRI compatible|0
5862756|NCT02041702|20277749|P1|Overall Study|Patient not confirmed as MRI compatible|1
5862757|NCT02041702|20277748|P2|Overall Study|Withdrawal by Subject|3
5862758|NCT02041702|20277749|P1|Overall Study|Withdrawal by Subject|4
5862759|NCT02041702|20277748|P2|Overall Study|Death|0
5862760|NCT02041702|20277749|P1|Overall Study|Death|4
5862761|NCT02041702|20277748|P2|Overall Study|Lost to Follow-up|6
5862762|NCT02041702|20277749|P1|Overall Study|Lost to Follow-up|1
5862763|NCT02041533|20277764|P2|Overall Study|Randomized, not treated|7
5862764|NCT02041533|20277765|P1|Overall Study|Randomized, not treated|4
5862765|NCT02041533|20277764|P2|Overall Study|Completed max number of chemo cycles|29
5862766|NCT02041533|20277765|P1|Overall Study|Completed max number of chemo cycles|0
5862767|NCT02041533|20277764|P2|Overall Study|Other reasons|1
5862768|NCT02041533|20277765|P1|Overall Study|Other reasons|0
5862769|NCT02041533|20277764|P2|Overall Study|Poor/non-compliance|0
5862770|NCT02041533|20277765|P1|Overall Study|Poor/non-compliance|1
5862771|NCT02041533|20277764|P2|Overall Study|Maximum clinical benefit|18
5862772|NCT02041533|20277765|P1|Overall Study|Maximum clinical benefit|0
5862773|NCT02041533|20277764|P2|Overall Study|Withdrawal by Subject|1
5862774|NCT02041533|20277765|P1|Overall Study|Withdrawal by Subject|2
5862775|NCT02041533|20277764|P2|Overall Study|Subject request to discontinue treatment|9
5862776|NCT02041533|20277765|P1|Overall Study|Subject request to discontinue treatment|5
5862777|NCT02041533|20277764|P2|Overall Study|Adverse Event unrelated to study drug|21
5862778|NCT02041533|20277765|P1|Overall Study|Adverse Event unrelated to study drug|20
5862779|NCT02041533|20277764|P2|Overall Study|Death|0
5862780|NCT02041533|20277765|P1|Overall Study|Death|1
5862781|NCT02041533|20277764|P2|Overall Study|Study drug toxicity|30
5862782|NCT02041533|20277765|P1|Overall Study|Study drug toxicity|27
5862783|NCT02041533|20277764|P2|Overall Study|Disease Progression|142
5862784|NCT02041533|20277765|P1|Overall Study|Disease Progression|168
5862785|NCT02041520|20277787|P2|Overall Study|Hypothiroidism identified during follow-|1
5862786|NCT02041520|20277788|P1|Overall Study|Hypothiroidism identified during follow-|0
5862787|NCT02041520|20277787|P2|Overall Study|Lost to Follow-up|1
5862788|NCT02041520|20277788|P1|Overall Study|Lost to Follow-up|0
5862789|NCT02041520|20277787|P2|Overall Study|Protocol Violation|0
5862790|NCT02041520|20277788|P1|Overall Study|Protocol Violation|1
5862791|NCT02041520|20277787|P2|Overall Study|Withdrawal by Subject|4
5862792|NCT02041520|20277788|P1|Overall Study|Withdrawal by Subject|3
5862793|NCT02041520|20277787|P2|Overall Study|Adverse Event|1
5862794|NCT02041520|20277788|P1|Overall Study|Adverse Event|2
5862795|NCT02041286|20277831|P1|Overall Study|Adverse Event|1
5862796|NCT02041104|20277866|P2|Overall Study|discomfort during OGTT|3
5862797|NCT02041104|20277867|P1|Overall Study|discomfort during OGTT|0
5862798|NCT02041104|20277866|P2|Overall Study|Lost to Follow-up|4
5862799|NCT02041104|20277867|P1|Overall Study|Lost to Follow-up|1
5862800|NCT02041091|20277907|P2|Optional Safety Extension Period|Lost to Follow-up|3
5862801|NCT02041091|20277908|P1|Optional Safety Extension Period|Lost to Follow-up|2
5862802|NCT02041091|20277907|P2|Optional Safety Extension Period|Sponsor Decision|74
5862803|NCT02041091|20277908|P1|Optional Safety Extension Period|Sponsor Decision|70
5862804|NCT02041091|20277907|P2|Optional Safety Extension Period|Physician Decision|1
5862805|NCT02041091|20277908|P1|Optional Safety Extension Period|Physician Decision|2
5862806|NCT02041091|20277907|P2|Optional Safety Extension Period|Protocol Violation|0
5862807|NCT02041091|20277908|P1|Optional Safety Extension Period|Protocol Violation|2
5862808|NCT02041091|20277907|P2|Optional Safety Extension Period|Withdrawal by Subject|2
5862809|NCT02041091|20277908|P1|Optional Safety Extension Period|Withdrawal by Subject|5
5862810|NCT02041091|20277907|P2|Optional Safety Extension Period|Adverse Event|2
5862811|NCT02041091|20277908|P1|Optional Safety Extension Period|Adverse Event|4
5862812|NCT02041091|20277907|P2|Treatment|Lost to Follow-up|0
5862813|NCT02041091|20277908|P1|Treatment|Lost to Follow-up|1
5862814|NCT02041091|20277907|P2|Treatment|Sponsor Decision|16
5862815|NCT02041091|20277908|P1|Treatment|Sponsor Decision|15
5862816|NCT02041091|20277907|P2|Treatment|Physician Decision|0
5862817|NCT02041091|20277908|P1|Treatment|Physician Decision|1
5862818|NCT02041091|20277907|P2|Treatment|Withdrawal by Subject|4
5862819|NCT02041091|20277908|P1|Treatment|Withdrawal by Subject|2
5862820|NCT02041091|20277907|P2|Treatment|Adverse Event|3
5862821|NCT02041091|20277908|P1|Treatment|Adverse Event|3
5862822|NCT02040870|20277930|P1|Overall Study|Death|13
5862823|NCT02040870|20277930|P1|Overall Study|Lost to Follow-up|3
5862824|NCT02040870|20277930|P1|Overall Study|Subject/guardian decision|10
5862825|NCT02040870|20277930|P1|Overall Study|Physician Decision|6
5862826|NCT02040870|20277930|P1|Overall Study|Progressive disease|58
5862827|NCT02040870|20277930|P1|Overall Study|Adverse Event|7
5862828|NCT02040870|20277930|P1|Overall Study|Completed treatment phase|6
5862829|NCT02040857|20277951|P1|Overall Study|ineligible|1
5862830|NCT02040857|20277951|P1|Overall Study|recurrence|4
5862831|NCT02040857|20277951|P1|Overall Study|Lost to Follow-up|2
5862832|NCT02040857|20277951|P1|Overall Study|patient non-compliance|3
5862833|NCT02040857|20277951|P1|Overall Study|Withdrawal by Subject|31
5862834|NCT02040857|20277951|P1|Overall Study|Physician Decision|5
5862835|NCT02040857|20277951|P1|Overall Study|Adverse Event|14
5862836|NCT02040844|20277964|P3|Overall Study|Concomitant medication|1
5862837|NCT02040844|20277965|P2|Overall Study|Concomitant medication|3
5862838|NCT02040844|20277966|P1|Overall Study|Concomitant medication|1
5862839|NCT02040844|20277964|P3|Overall Study|Non-specified|5
5862840|NCT02040844|20277965|P2|Overall Study|Non-specified|2
5862841|NCT02040844|20277966|P1|Overall Study|Non-specified|8
5862842|NCT02040844|20277964|P3|Overall Study|Missing|2
5862843|NCT02040844|20277965|P2|Overall Study|Missing|3
5862844|NCT02040844|20277966|P1|Overall Study|Missing|13
5862845|NCT02040844|20277964|P3|Overall Study|Lost to Follow-up|13
5862846|NCT02040844|20277965|P2|Overall Study|Lost to Follow-up|9
5862847|NCT02040844|20277966|P1|Overall Study|Lost to Follow-up|12
5862848|NCT02040844|20277964|P3|Overall Study|Withdrawal by Subject|25
5862849|NCT02040844|20277965|P2|Overall Study|Withdrawal by Subject|22
5862850|NCT02040844|20277966|P1|Overall Study|Withdrawal by Subject|16
5862851|NCT02040844|20277964|P3|Overall Study|Adverse Event|1
5862852|NCT02040844|20277965|P2|Overall Study|Adverse Event|0
5862853|NCT02040844|20277966|P1|Overall Study|Adverse Event|0
5862854|NCT02040805|20277991|P2|Overall Study|Withdrawal by Subject|41
5862855|NCT02040805|20277992|P1|Overall Study|Withdrawal by Subject|28
5862856|NCT02040805|20277991|P2|Overall Study|Lost to Follow-up|9
5862857|NCT02040805|20277992|P1|Overall Study|Lost to Follow-up|14
5862858|NCT02040779|20278028|P3|Overall Study|Lack of Efficacy|0
5862859|NCT02040779|20278029|P2|Overall Study|Lack of Efficacy|2
5862860|NCT02040779|20278030|P1|Overall Study|Lack of Efficacy|4
5862861|NCT02040779|20278028|P3|Overall Study|Lost to Follow-up|1
5862862|NCT02040779|20278029|P2|Overall Study|Lost to Follow-up|2
5862863|NCT02040779|20278030|P1|Overall Study|Lost to Follow-up|1
5862864|NCT02040779|20278028|P3|Overall Study|Protocol Violation|0
5862865|NCT02040779|20278029|P2|Overall Study|Protocol Violation|1
5862866|NCT02040779|20278030|P1|Overall Study|Protocol Violation|2
5862867|NCT02040779|20278028|P3|Overall Study|Non-compliance|0
5862868|NCT02040779|20278029|P2|Overall Study|Non-compliance|1
5862869|NCT02040779|20278030|P1|Overall Study|Non-compliance|0
5862870|NCT02040779|20278028|P3|Overall Study|Withdrawal by Subject|3
5862871|NCT02040779|20278029|P2|Overall Study|Withdrawal by Subject|1
5862872|NCT02040779|20278030|P1|Overall Study|Withdrawal by Subject|4
5862873|NCT02040779|20278028|P3|Overall Study|Adverse Event|0
5862874|NCT02040779|20278029|P2|Overall Study|Adverse Event|0
5862875|NCT02040779|20278030|P1|Overall Study|Adverse Event|1
5862876|NCT02040766|20278070|P5|Overall Study|Lack of Efficacy|5
5862877|NCT02040766|20278071|P4|Overall Study|Lack of Efficacy|6
5862878|NCT02040766|20278072|P3|Overall Study|Lack of Efficacy|4
5862879|NCT02040766|20278073|P2|Overall Study|Lack of Efficacy|3
5862880|NCT02040766|20278074|P1|Overall Study|Lack of Efficacy|6
5862881|NCT02040766|20278070|P5|Overall Study|Not reported|0
5862882|NCT02040766|20278071|P4|Overall Study|Not reported|0
5862883|NCT02040766|20278072|P3|Overall Study|Not reported|0
5862884|NCT02040766|20278073|P2|Overall Study|Not reported|0
5862885|NCT02040766|20278074|P1|Overall Study|Not reported|1
5862886|NCT02040766|20278070|P5|Overall Study|Lost to Follow-up|4
5862887|NCT02040766|20278071|P4|Overall Study|Lost to Follow-up|1
5862888|NCT02040766|20278072|P3|Overall Study|Lost to Follow-up|3
5862889|NCT02040766|20278073|P2|Overall Study|Lost to Follow-up|1
5862890|NCT02040766|20278074|P1|Overall Study|Lost to Follow-up|4
5862891|NCT02040766|20278070|P5|Overall Study|Protocol Violation|0
5862892|NCT02040766|20278071|P4|Overall Study|Protocol Violation|3
5862893|NCT02040766|20278072|P3|Overall Study|Protocol Violation|2
5862894|NCT02040766|20278073|P2|Overall Study|Protocol Violation|1
5862895|NCT02040766|20278074|P1|Overall Study|Protocol Violation|2
5862896|NCT02040766|20278070|P5|Overall Study|Non-compliance|0
5862897|NCT02040766|20278071|P4|Overall Study|Non-compliance|0
5862898|NCT02040766|20278072|P3|Overall Study|Non-compliance|0
5862899|NCT02040766|20278073|P2|Overall Study|Non-compliance|1
5862900|NCT02040766|20278074|P1|Overall Study|Non-compliance|0
5862901|NCT02040766|20278070|P5|Overall Study|Withdrawal by Subject|2
5862902|NCT02040766|20278071|P4|Overall Study|Withdrawal by Subject|3
5862903|NCT02040766|20278072|P3|Overall Study|Withdrawal by Subject|2
5862904|NCT02040766|20278073|P2|Overall Study|Withdrawal by Subject|3
5862905|NCT02040766|20278074|P1|Overall Study|Withdrawal by Subject|4
5862906|NCT02040766|20278070|P5|Overall Study|Adverse Event|2
5862907|NCT02040766|20278071|P4|Overall Study|Adverse Event|0
5862908|NCT02040766|20278072|P3|Overall Study|Adverse Event|1
5862909|NCT02040766|20278073|P2|Overall Study|Adverse Event|1
5862910|NCT02040766|20278074|P1|Overall Study|Adverse Event|1
5862911|NCT02040584|20278127|P2|Overall Study|Immunosuppressant/prohibited med use|10
5862912|NCT02040584|20278128|P1|Overall Study|Immunosuppressant/prohibited med use|7
5862913|NCT02040584|20278127|P2|Overall Study|Transplant rejection/retransplant|1
5862914|NCT02040584|20278128|P1|Overall Study|Transplant rejection/retransplant|0
5862915|NCT02040584|20278127|P2|Overall Study|Death|3
5862916|NCT02040584|20278128|P1|Overall Study|Death|6
5862917|NCT02040584|20278127|P2|Overall Study|Unsatisfactory therapeutic effect|1
5862918|NCT02040584|20278128|P1|Overall Study|Unsatisfactory therapeutic effect|0
5862919|NCT02040584|20278127|P2|Overall Study|Protocol Violation|11
5862920|NCT02040584|20278128|P1|Overall Study|Protocol Violation|9
5862921|NCT02040584|20278127|P2|Overall Study|Adverse Event|6
5862922|NCT02040584|20278128|P1|Overall Study|Adverse Event|13
5862923|NCT02040532|20278161|P1|Overall Study|Withdrawal by Subject|3
5862924|NCT02040532|20278161|P1|Overall Study|Adverse Event|4
5862925|NCT02040532|20278161|P1|Overall Study|Physician Decision|4
5862926|NCT02040532|20278161|P1|Overall Study|Lost to Follow-up|1
5862927|NCT02040428|20278174|P2|Overall Study|Withdrawal by Subject|1
5862928|NCT02040428|20278175|P1|Overall Study|Withdrawal by Subject|1
5862929|NCT02040428|20278174|P2|Overall Study|Death|3
5862930|NCT02040428|20278175|P1|Overall Study|Death|4
5862931|NCT02040259|20278187|P1|Overall Study|Withdrawal by Subject|4
5862932|NCT02040259|20278187|P1|Overall Study|Assessment not completed|3
5862933|NCT02040259|20278187|P1|Overall Study|Lost to Follow-up|76
5862934|NCT02040259|20278187|P1|Overall Study|Death|280
5862935|NCT02039908|20278261|P4|Phase 2-School Year|Withdrawal by Subject|5
5862936|NCT02039908|20278262|P3|Phase 2-School Year|Withdrawal by Subject|8
5862937|NCT02039908|20278263|P2|Phase 2-School Year|Withdrawal by Subject|0
5862938|NCT02039908|20278264|P1|Phase 2-School Year|Withdrawal by Subject|0
5862939|NCT02039908|20278261|P4|Phase 2-School Year|Protocol Violation|0
5862940|NCT02039908|20278262|P3|Phase 2-School Year|Protocol Violation|3
5862941|NCT02039908|20278263|P2|Phase 2-School Year|Protocol Violation|0
5862942|NCT02039908|20278264|P1|Phase 2-School Year|Protocol Violation|0
5862943|NCT02039908|20278261|P4|Phase 2-School Year|Lost to Follow-up|3
5862944|NCT02039908|20278262|P3|Phase 2-School Year|Lost to Follow-up|1
5862945|NCT02039908|20278263|P2|Phase 2-School Year|Lost to Follow-up|0
5862946|NCT02039908|20278264|P1|Phase 2-School Year|Lost to Follow-up|0
5862947|NCT02039908|20278261|P4|Phase 1-Summer|Protocol Violation|0
5862948|NCT02039908|20278262|P3|Phase 1-Summer|Protocol Violation|0
5862949|NCT02039908|20278263|P2|Phase 1-Summer|Protocol Violation|0
5862950|NCT02039908|20278264|P1|Phase 1-Summer|Protocol Violation|6
5862951|NCT02039908|20278261|P4|Phase 1-Summer|Withdrawal by Subject|0
5862952|NCT02039908|20278262|P3|Phase 1-Summer|Withdrawal by Subject|0
5862953|NCT02039908|20278263|P2|Phase 1-Summer|Withdrawal by Subject|6
5862954|NCT02039908|20278264|P1|Phase 1-Summer|Withdrawal by Subject|7
5862955|NCT02039856|20278278|P2|Overall Study|Withdrawal by Subject|618
5862956|NCT02039856|20278279|P1|Overall Study|Withdrawal by Subject|1573
5862957|NCT02039856|20278278|P2|Overall Study|Lost to Follow-up|206
5862958|NCT02039856|20278279|P1|Overall Study|Lost to Follow-up|388
5862959|NCT02039856|20278278|P2|Overall Study|Partial survey completion|26
5862960|NCT02039856|20278279|P1|Overall Study|Partial survey completion|61
5862961|NCT02039856|20278278|P2|Overall Study|Death|3
5862962|NCT02039856|20278279|P1|Overall Study|Death|5
5862963|NCT02039778|20278311|P1|Overall Study|Never started the protocol treatment|1
5862964|NCT02039778|20278311|P1|Overall Study|Withdrawal by Subject|1
5862965|NCT02039778|20278311|P1|Overall Study|Death|2
5862966|NCT02039687|20278334|P4|Overall Study|treatment assignment could not be confir|0
5862967|NCT02039687|20278335|P3|Overall Study|treatment assignment could not be confir|2
5862968|NCT02039687|20278336|P2|Overall Study|treatment assignment could not be confir|0
5862969|NCT02039687|20278337|P1|Overall Study|treatment assignment could not be confir|0
5862970|NCT02039687|20278334|P4|Overall Study|Withdrawal by Subject|0
5862971|NCT02039687|20278335|P3|Overall Study|Withdrawal by Subject|0
5862972|NCT02039687|20278336|P2|Overall Study|Withdrawal by Subject|1
5862973|NCT02039687|20278337|P1|Overall Study|Withdrawal by Subject|0
5862974|NCT02039687|20278334|P4|Overall Study|Adverse Event|0
5862975|NCT02039687|20278335|P3|Overall Study|Adverse Event|1
5862976|NCT02039687|20278336|P2|Overall Study|Adverse Event|0
5862977|NCT02039687|20278337|P1|Overall Study|Adverse Event|0
5862978|NCT02039674|20278377|P14|Overall Study|Ongoing in Study|3
5862979|NCT02039674|20278378|P13|Overall Study|Ongoing in Study|33
5862980|NCT02039674|20278379|P12|Overall Study|Ongoing in Study|34
5862981|NCT02039674|20278380|P11|Overall Study|Ongoing in Study|1
5862982|NCT02039674|20278381|P10|Overall Study|Ongoing in Study|6
5862983|NCT02039674|20278382|P9|Overall Study|Ongoing in Study|1
5862984|NCT02039674|20278383|P8|Overall Study|Ongoing in Study|0
5862985|NCT02039674|20278384|P7|Overall Study|Ongoing in Study|2
5862986|NCT02039674|20278385|P6|Overall Study|Ongoing in Study|1
5862987|NCT02039674|20278386|P5|Overall Study|Ongoing in Study|3
5862988|NCT02039674|20278387|P4|Overall Study|Ongoing in Study|2
5862989|NCT02039674|20278388|P3|Overall Study|Ongoing in Study|3
5862990|NCT02039674|20278389|P2|Overall Study|Ongoing in Study|2
5862991|NCT02039674|20278390|P1|Overall Study|Ongoing in Study|5
5862992|NCT02039674|20278377|P14|Overall Study|Withdrawal by Subject|2
5862993|NCT02039674|20278378|P13|Overall Study|Withdrawal by Subject|5
5862994|NCT02039674|20278379|P12|Overall Study|Withdrawal by Subject|3
5862995|NCT02039674|20278380|P11|Overall Study|Withdrawal by Subject|1
5862996|NCT02039674|20278381|P10|Overall Study|Withdrawal by Subject|2
5862997|NCT02039674|20278382|P9|Overall Study|Withdrawal by Subject|0
5862998|NCT02039674|20278383|P8|Overall Study|Withdrawal by Subject|0
5862999|NCT02039674|20278384|P7|Overall Study|Withdrawal by Subject|0
5863000|NCT02039674|20278385|P6|Overall Study|Withdrawal by Subject|0
5863001|NCT02039674|20278386|P5|Overall Study|Withdrawal by Subject|1
5863002|NCT02039674|20278387|P4|Overall Study|Withdrawal by Subject|0
5863003|NCT02039674|20278388|P3|Overall Study|Withdrawal by Subject|1
5863004|NCT02039674|20278389|P2|Overall Study|Withdrawal by Subject|2
5863005|NCT02039674|20278390|P1|Overall Study|Withdrawal by Subject|0
5863006|NCT02039674|20278377|P14|Overall Study|Progressive Disease|16
5863007|NCT02039674|20278378|P13|Overall Study|Progressive Disease|18
5863008|NCT02039674|20278379|P12|Overall Study|Progressive Disease|17
5863009|NCT02039674|20278380|P11|Overall Study|Progressive Disease|0
5863010|NCT02039674|20278381|P10|Overall Study|Progressive Disease|2
5863011|NCT02039674|20278382|P9|Overall Study|Progressive Disease|7
5863012|NCT02039674|20278383|P8|Overall Study|Progressive Disease|3
5863013|NCT02039674|20278384|P7|Overall Study|Progressive Disease|1
5863014|NCT02039674|20278385|P6|Overall Study|Progressive Disease|10
5863015|NCT02039674|20278386|P5|Overall Study|Progressive Disease|8
5863016|NCT02039674|20278387|P4|Overall Study|Progressive Disease|7
5863017|NCT02039674|20278388|P3|Overall Study|Progressive Disease|6
5863018|NCT02039674|20278389|P2|Overall Study|Progressive Disease|7
5863019|NCT02039674|20278390|P1|Overall Study|Progressive Disease|6
5863020|NCT02039674|20278377|P14|Overall Study|Physician Decision|0
5863021|NCT02039674|20278378|P13|Overall Study|Physician Decision|0
5863022|NCT02039674|20278379|P12|Overall Study|Physician Decision|1
5863023|NCT02039674|20278380|P11|Overall Study|Physician Decision|0
5863024|NCT02039674|20278381|P10|Overall Study|Physician Decision|0
5863025|NCT02039674|20278382|P9|Overall Study|Physician Decision|0
5863026|NCT02039674|20278383|P8|Overall Study|Physician Decision|0
5863027|NCT02039674|20278384|P7|Overall Study|Physician Decision|0
5863028|NCT02039674|20278385|P6|Overall Study|Physician Decision|0
5863029|NCT02039674|20278386|P5|Overall Study|Physician Decision|0
5863030|NCT02039674|20278387|P4|Overall Study|Physician Decision|0
5863031|NCT02039674|20278388|P3|Overall Study|Physician Decision|0
5863032|NCT02039674|20278389|P2|Overall Study|Physician Decision|0
5863033|NCT02039674|20278390|P1|Overall Study|Physician Decision|0
5863034|NCT02039674|20278377|P14|Overall Study|Lost to Follow-up|0
5863035|NCT02039674|20278378|P13|Overall Study|Lost to Follow-up|1
5863036|NCT02039674|20278379|P12|Overall Study|Lost to Follow-up|0
5863037|NCT02039674|20278380|P11|Overall Study|Lost to Follow-up|0
5863038|NCT02039674|20278381|P10|Overall Study|Lost to Follow-up|0
5863039|NCT02039674|20278382|P9|Overall Study|Lost to Follow-up|0
5863040|NCT02039674|20278383|P8|Overall Study|Lost to Follow-up|0
5863041|NCT02039674|20278384|P7|Overall Study|Lost to Follow-up|0
5863042|NCT02039674|20278385|P6|Overall Study|Lost to Follow-up|0
5863043|NCT02039674|20278386|P5|Overall Study|Lost to Follow-up|0
5863044|NCT02039674|20278387|P4|Overall Study|Lost to Follow-up|0
5863045|NCT02039674|20278388|P3|Overall Study|Lost to Follow-up|0
5863046|NCT02039674|20278389|P2|Overall Study|Lost to Follow-up|0
5863047|NCT02039674|20278390|P1|Overall Study|Lost to Follow-up|0
5863048|NCT02039674|20278377|P14|Overall Study|Excluded Medication|3
5863049|NCT02039674|20278378|P13|Overall Study|Excluded Medication|4
5863050|NCT02039674|20278379|P12|Overall Study|Excluded Medication|2
5863051|NCT02039674|20278380|P11|Overall Study|Excluded Medication|4
5863052|NCT02039674|20278381|P10|Overall Study|Excluded Medication|2
5863053|NCT02039674|20278382|P9|Overall Study|Excluded Medication|2
5863054|NCT02039674|20278383|P8|Overall Study|Excluded Medication|0
5863055|NCT02039674|20278384|P7|Overall Study|Excluded Medication|0
5863056|NCT02039674|20278385|P6|Overall Study|Excluded Medication|1
5863057|NCT02039674|20278386|P5|Overall Study|Excluded Medication|0
5863058|NCT02039674|20278387|P4|Overall Study|Excluded Medication|1
5863059|NCT02039674|20278388|P3|Overall Study|Excluded Medication|0
5863060|NCT02039674|20278389|P2|Overall Study|Excluded Medication|1
5863061|NCT02039674|20278390|P1|Overall Study|Excluded Medication|1
5863062|NCT02039674|20278377|P14|Overall Study|Death|8
5863063|NCT02039674|20278378|P13|Overall Study|Death|0
5863064|NCT02039674|20278379|P12|Overall Study|Death|1
5863065|NCT02039674|20278380|P11|Overall Study|Death|1
5863066|NCT02039674|20278381|P10|Overall Study|Death|0
5863067|NCT02039674|20278382|P9|Overall Study|Death|0
5863068|NCT02039674|20278383|P8|Overall Study|Death|0
5863069|NCT02039674|20278384|P7|Overall Study|Death|0
5863070|NCT02039674|20278385|P6|Overall Study|Death|0
5863071|NCT02039674|20278386|P5|Overall Study|Death|0
5863072|NCT02039674|20278387|P4|Overall Study|Death|2
5863073|NCT02039674|20278388|P3|Overall Study|Death|1
5863074|NCT02039674|20278389|P2|Overall Study|Death|0
5863075|NCT02039674|20278390|P1|Overall Study|Death|0
5863076|NCT02039674|20278377|P14|Overall Study|Adverse Event|1
5863077|NCT02039674|20278378|P13|Overall Study|Adverse Event|2
5863078|NCT02039674|20278379|P12|Overall Study|Adverse Event|2
5863079|NCT02039674|20278380|P11|Overall Study|Adverse Event|0
5863080|NCT02039674|20278381|P10|Overall Study|Adverse Event|0
5863081|NCT02039674|20278382|P9|Overall Study|Adverse Event|2
5863082|NCT02039674|20278383|P8|Overall Study|Adverse Event|0
5863083|NCT02039674|20278384|P7|Overall Study|Adverse Event|0
5863084|NCT02039674|20278385|P6|Overall Study|Adverse Event|0
5863085|NCT02039674|20278386|P5|Overall Study|Adverse Event|0
5863086|NCT02039674|20278387|P4|Overall Study|Adverse Event|1
5863087|NCT02039674|20278388|P3|Overall Study|Adverse Event|1
5863088|NCT02039674|20278389|P2|Overall Study|Adverse Event|0
5863089|NCT02039674|20278390|P1|Overall Study|Adverse Event|0
5863090|NCT02039505|20278432|P7|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|1
5863091|NCT02039505|20278433|P6|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0
5863092|NCT02039505|20278434|P5|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0
5863093|NCT02039505|20278435|P4|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0
5863094|NCT02039505|20278436|P3|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0
5863095|NCT02039505|20278437|P2|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0
5863096|NCT02039505|20278438|P1|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0
5863097|NCT02039505|20278432|P7|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|7
5863098|NCT02039505|20278433|P6|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0
5863099|NCT02039505|20278434|P5|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0
5863100|NCT02039505|20278435|P4|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0
5863101|NCT02039505|20278436|P3|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0
5863102|NCT02039505|20278437|P2|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0
5863103|NCT02039505|20278438|P1|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0
5863104|NCT02039505|20278432|P7|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|19
5863105|NCT02039505|20278433|P6|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0
5863106|NCT02039505|20278434|P5|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0
5863107|NCT02039505|20278435|P4|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0
5863108|NCT02039505|20278436|P3|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0
5863109|NCT02039505|20278437|P2|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0
5863110|NCT02039505|20278438|P1|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0
5863111|NCT02039505|20278432|P7|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|44
5863112|NCT02039505|20278433|P6|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0
5863113|NCT02039505|20278434|P5|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0
5863114|NCT02039505|20278435|P4|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0
5863115|NCT02039505|20278436|P3|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0
5863116|NCT02039505|20278437|P2|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0
5863117|NCT02039505|20278438|P1|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0
5863118|NCT02039505|20278432|P7|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0
5863119|NCT02039505|20278433|P6|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0
5863120|NCT02039505|20278434|P5|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0
5863121|NCT02039505|20278435|P4|Maintenance Phase (Week 14 to Week 60)|Pregnancy|2
5863122|NCT02039505|20278436|P3|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0
5863123|NCT02039505|20278437|P2|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0
5863124|NCT02039505|20278438|P1|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0
5863125|NCT02039505|20278432|P7|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0
5863126|NCT02039505|20278433|P6|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|1
5863127|NCT02039505|20278434|P5|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|2
5863128|NCT02039505|20278435|P4|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|3
5863129|NCT02039505|20278436|P3|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0
5863130|NCT02039505|20278437|P2|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0
5863131|NCT02039505|20278438|P1|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0
5863132|NCT02039505|20278432|P7|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0
5863133|NCT02039505|20278433|P6|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1
5863134|NCT02039505|20278434|P5|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1
5863135|NCT02039505|20278435|P4|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|6
5863136|NCT02039505|20278436|P3|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0
5863137|NCT02039505|20278437|P2|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0
5863138|NCT02039505|20278438|P1|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0
5863139|NCT02039505|20278432|P7|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0
5863140|NCT02039505|20278433|P6|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|12
5863141|NCT02039505|20278434|P5|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|8
5863142|NCT02039505|20278435|P4|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|13
5863143|NCT02039505|20278436|P3|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0
5863144|NCT02039505|20278437|P2|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0
5863145|NCT02039505|20278438|P1|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0
5863146|NCT02039505|20278432|P7|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0
5863147|NCT02039505|20278433|P6|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0
5863148|NCT02039505|20278434|P5|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0
5863149|NCT02039505|20278435|P4|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0
5863150|NCT02039505|20278436|P3|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0
5863151|NCT02039505|20278437|P2|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0
5863152|NCT02039505|20278438|P1|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|1
5863153|NCT02039505|20278432|P7|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0
5863154|NCT02039505|20278433|P6|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0
5863155|NCT02039505|20278434|P5|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0
5863156|NCT02039505|20278435|P4|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0
5863157|NCT02039505|20278436|P3|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|3
5863158|NCT02039505|20278437|P2|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1
5863159|NCT02039505|20278438|P1|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1
5863160|NCT02039505|20278432|P7|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0
5863161|NCT02039505|20278433|P6|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0
5863162|NCT02039505|20278434|P5|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0
5863163|NCT02039505|20278435|P4|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0
5863164|NCT02039505|20278436|P3|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|7
5863165|NCT02039505|20278437|P2|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|8
5863166|NCT02039505|20278438|P1|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|2
5863167|NCT02039427|20278514|P4|Overall Study|Steroid Use|0
5863168|NCT02039427|20278515|P3|Overall Study|Steroid Use|0
5863169|NCT02039427|20278516|P2|Overall Study|Steroid Use|0
5863170|NCT02039427|20278517|P1|Overall Study|Steroid Use|1
5863171|NCT02039427|20278514|P4|Overall Study|Loss of follow - up|4
5863172|NCT02039427|20278515|P3|Overall Study|Loss of follow - up|2
5863173|NCT02039427|20278516|P2|Overall Study|Loss of follow - up|0
5863174|NCT02039427|20278517|P1|Overall Study|Loss of follow - up|1
5863175|NCT02039427|20278514|P4|Overall Study|Cancellation of surgery|0
5863176|NCT02039427|20278515|P3|Overall Study|Cancellation of surgery|1
5863177|NCT02039427|20278516|P2|Overall Study|Cancellation of surgery|0
5863178|NCT02039427|20278517|P1|Overall Study|Cancellation of surgery|0
5863179|NCT02039427|20278514|P4|Overall Study|Withdrawal on concent|1
5863180|NCT02039427|20278515|P3|Overall Study|Withdrawal on concent|0
5863181|NCT02039427|20278516|P2|Overall Study|Withdrawal on concent|0
5863182|NCT02039427|20278517|P1|Overall Study|Withdrawal on concent|0
5863183|NCT02039427|20278514|P4|Overall Study|Duration of surgery > 3h|0
5863184|NCT02039427|20278515|P3|Overall Study|Duration of surgery > 3h|0
5863185|NCT02039427|20278516|P2|Overall Study|Duration of surgery > 3h|1
5863186|NCT02039427|20278517|P1|Overall Study|Duration of surgery > 3h|1
5863187|NCT02039414|20278537|P2|Overall Study|Protocol Violation|1
5863188|NCT02039414|20278538|P1|Overall Study|Protocol Violation|3
5863189|NCT02039414|20278537|P2|Overall Study|Lost to Follow-up|0
5863190|NCT02039414|20278538|P1|Overall Study|Lost to Follow-up|2
5863191|NCT02039414|20278537|P2|Overall Study|Delivered|1
5863192|NCT02039414|20278538|P1|Overall Study|Delivered|1
5863193|NCT02039375|20278550|P1|Overall Study|Lost to Follow-up|2
5863194|NCT02039219|20278561|P2|Follow up|Adverse Event|1
5863195|NCT02039219|20278562|P1|Follow up|Adverse Event|0
5863196|NCT02039219|20278561|P2|Treatment|Death|0
5863197|NCT02039219|20278562|P1|Treatment|Death|1
5863198|NCT02039219|20278561|P2|Treatment|Protocol Violation|0
5863199|NCT02039219|20278562|P1|Treatment|Protocol Violation|1
5863200|NCT02039219|20278561|P2|Treatment|Lost to Follow-up|1
5863201|NCT02039219|20278562|P1|Treatment|Lost to Follow-up|0
5863202|NCT02039219|20278561|P2|Treatment|Physician Decision|0
5863203|NCT02039219|20278562|P1|Treatment|Physician Decision|1
5863204|NCT02039219|20278561|P2|Treatment|Adverse Event|1
5863205|NCT02039219|20278562|P1|Treatment|Adverse Event|0
5863206|NCT02039219|20278561|P2|Treatment|Withdrawal by Subject|0
5863207|NCT02039219|20278562|P1|Treatment|Withdrawal by Subject|1
5863208|NCT02038959|20278611|P2|Overall Study|Withdrawal by Subject|8
5863209|NCT02038959|20278612|P1|Overall Study|Withdrawal by Subject|6
5863210|NCT02038946|20278638|P1|Overall Study|Other reasons|1
5863211|NCT02038946|20278638|P1|Overall Study|Lost to Follow-up|2
5863212|NCT02038946|20278638|P1|Overall Study|Withdrawal by Subject|3
5863213|NCT02038946|20278638|P1|Overall Study|Death|5
5863214|NCT02038933|20278649|P1|Follow-up|Disease Progression|2
5863215|NCT02038933|20278649|P1|Follow-up|Withdrawal by Subject|1
5863216|NCT02038933|20278649|P1|Follow-up|Lost to Follow-up|1
5863217|NCT02038933|20278649|P1|Follow-up|Adverse event unrelated to study drug|4
5863218|NCT02038933|20278649|P1|Follow-up|Death|11
5863219|NCT02038933|20278649|P1|Treatment|Withdrawal by Subject|1
5863220|NCT02038933|20278649|P1|Treatment|Disease Progression|101
5863221|NCT02038933|20278649|P1|Treatment|Study Drug Toxicity|4
5863222|NCT02038933|20278649|P1|Treatment|Adverse Event Unrelated to Study Drug|6
5863223|NCT02038933|20278649|P1|Treatment|Lost to Follow-up|1
5863224|NCT02038933|20278649|P1|Treatment|No longer meets study criteria|1
5863225|NCT02038920|20278670|P6|Open Label Cohort (Week 10 to 154)|Reason Not Specified|2
5863226|NCT02038920|20278671|P5|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0
5863227|NCT02038920|20278672|P4|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0
5863228|NCT02038920|20278673|P3|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0
5863229|NCT02038920|20278674|P2|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0
5863230|NCT02038920|20278675|P1|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0
5863231|NCT02038920|20278670|P6|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|23
5863232|NCT02038920|20278671|P5|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0
5863233|NCT02038920|20278672|P4|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0
5863234|NCT02038920|20278673|P3|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0
5863235|NCT02038920|20278674|P2|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0
5863236|NCT02038920|20278675|P1|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0
5863237|NCT02038920|20278670|P6|Open Label Cohort (Week 10 to 154)|Pregnancy|1
5863238|NCT02038920|20278671|P5|Open Label Cohort (Week 10 to 154)|Pregnancy|0
5863239|NCT02038920|20278672|P4|Open Label Cohort (Week 10 to 154)|Pregnancy|0
5863240|NCT02038920|20278673|P3|Open Label Cohort (Week 10 to 154)|Pregnancy|0
5863241|NCT02038920|20278674|P2|Open Label Cohort (Week 10 to 154)|Pregnancy|0
5863242|NCT02038920|20278675|P1|Open Label Cohort (Week 10 to 154)|Pregnancy|0
5863243|NCT02038920|20278670|P6|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|7
5863244|NCT02038920|20278671|P5|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0
5863245|NCT02038920|20278672|P4|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0
5863246|NCT02038920|20278673|P3|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0
5863247|NCT02038920|20278674|P2|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0
5863248|NCT02038920|20278675|P1|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0
5863249|NCT02038920|20278670|P6|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|1
5863250|NCT02038920|20278671|P5|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0
5863251|NCT02038920|20278672|P4|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0
5863252|NCT02038920|20278673|P3|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0
5863253|NCT02038920|20278674|P2|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0
5863254|NCT02038920|20278675|P1|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0
5863255|NCT02038920|20278670|P6|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|43
5863256|NCT02038920|20278671|P5|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0
5863257|NCT02038920|20278672|P4|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0
5863258|NCT02038920|20278673|P3|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0
5863259|NCT02038920|20278674|P2|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0
5863260|NCT02038920|20278675|P1|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0
5863261|NCT02038920|20278670|P6|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0
5863262|NCT02038920|20278671|P5|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|10
5863263|NCT02038920|20278672|P4|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|4
5863264|NCT02038920|20278673|P3|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|2
5863265|NCT02038920|20278674|P2|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0
5863266|NCT02038920|20278675|P1|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0
5863267|NCT02038920|20278670|P6|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0
5863268|NCT02038920|20278671|P5|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0
5863269|NCT02038920|20278672|P4|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0
5863270|NCT02038920|20278673|P3|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|1
5863271|NCT02038920|20278674|P2|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0
5863272|NCT02038920|20278675|P1|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0
5863273|NCT02038920|20278670|P6|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0
5863274|NCT02038920|20278671|P5|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2
5863275|NCT02038920|20278672|P4|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|4
5863276|NCT02038920|20278673|P3|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2
5863277|NCT02038920|20278674|P2|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0
5863278|NCT02038920|20278675|P1|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0
5863279|NCT02038920|20278670|P6|Induction Phase (Week 0 to 14)|Lack of Efficacy|0
5863280|NCT02038920|20278671|P5|Induction Phase (Week 0 to 14)|Lack of Efficacy|0
5863281|NCT02038920|20278672|P4|Induction Phase (Week 0 to 14)|Lack of Efficacy|0
5863282|NCT02038920|20278673|P3|Induction Phase (Week 0 to 14)|Lack of Efficacy|0
5863283|NCT02038920|20278674|P2|Induction Phase (Week 0 to 14)|Lack of Efficacy|1
5863284|NCT02038920|20278675|P1|Induction Phase (Week 0 to 14)|Lack of Efficacy|1
5863285|NCT02038920|20278670|P6|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0
5863286|NCT02038920|20278671|P5|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0
5863287|NCT02038920|20278672|P4|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0
5863288|NCT02038920|20278673|P3|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0
5863289|NCT02038920|20278674|P2|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0
5863290|NCT02038920|20278675|P1|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|2
5863291|NCT02038920|20278670|P6|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0
5863292|NCT02038920|20278671|P5|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0
5863293|NCT02038920|20278672|P4|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0
5863294|NCT02038920|20278673|P3|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0
5863295|NCT02038920|20278674|P2|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|11
5863296|NCT02038920|20278675|P1|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|3
5863297|NCT02038907|20278752|P14|Overall Study|Withdrawal by Subject|0
5863298|NCT02038907|20278753|P13|Overall Study|Withdrawal by Subject|0
5863299|NCT02038907|20278754|P12|Overall Study|Withdrawal by Subject|0
5863300|NCT02038907|20278755|P11|Overall Study|Withdrawal by Subject|1
5863301|NCT02038907|20278756|P10|Overall Study|Withdrawal by Subject|0
5863302|NCT02038907|20278757|P9|Overall Study|Withdrawal by Subject|0
5863303|NCT02038907|20278758|P8|Overall Study|Withdrawal by Subject|0
5863304|NCT02038907|20278759|P7|Overall Study|Withdrawal by Subject|0
5863305|NCT02038907|20278760|P6|Overall Study|Withdrawal by Subject|0
5863306|NCT02038907|20278761|P5|Overall Study|Withdrawal by Subject|0
5863307|NCT02038907|20278762|P4|Overall Study|Withdrawal by Subject|0
5863308|NCT02038907|20278763|P3|Overall Study|Withdrawal by Subject|0
5863309|NCT02038907|20278764|P2|Overall Study|Withdrawal by Subject|0
5863310|NCT02038907|20278765|P1|Overall Study|Withdrawal by Subject|0
5863311|NCT02038907|20278752|P14|Overall Study|Protocol Violation|0
5863312|NCT02038907|20278753|P13|Overall Study|Protocol Violation|0
5863313|NCT02038907|20278754|P12|Overall Study|Protocol Violation|0
5863314|NCT02038907|20278755|P11|Overall Study|Protocol Violation|1
5863315|NCT02038907|20278756|P10|Overall Study|Protocol Violation|0
5863316|NCT02038907|20278757|P9|Overall Study|Protocol Violation|0
5863317|NCT02038907|20278758|P8|Overall Study|Protocol Violation|0
5863318|NCT02038907|20278759|P7|Overall Study|Protocol Violation|0
5863319|NCT02038907|20278760|P6|Overall Study|Protocol Violation|0
5863320|NCT02038907|20278761|P5|Overall Study|Protocol Violation|0
5863321|NCT02038907|20278762|P4|Overall Study|Protocol Violation|0
5863322|NCT02038907|20278763|P3|Overall Study|Protocol Violation|0
5863323|NCT02038907|20278764|P2|Overall Study|Protocol Violation|0
5863324|NCT02038907|20278765|P1|Overall Study|Protocol Violation|0
5863325|NCT02038881|20279316|P3|Overall Study|incarcerated|0
5863326|NCT02038881|20279317|P2|Overall Study|incarcerated|0
5863327|NCT02038881|20279318|P1|Overall Study|incarcerated|1
5863328|NCT02038881|20279316|P3|Overall Study|Lost to Follow-up|0
5863329|NCT02038881|20279317|P2|Overall Study|Lost to Follow-up|0
5863330|NCT02038881|20279318|P1|Overall Study|Lost to Follow-up|2
5863331|NCT02038881|20279316|P3|Overall Study|Withdrawal by Subject|1
5863332|NCT02038881|20279317|P2|Overall Study|Withdrawal by Subject|0
5863333|NCT02038881|20279318|P1|Overall Study|Withdrawal by Subject|0
5863334|NCT02038829|20279391|P12|Treatment Period 6|Adverse Event|0
5863335|NCT02038829|20279392|P11|Treatment Period 6|Adverse Event|0
5863336|NCT02038829|20279393|P10|Treatment Period 6|Adverse Event|0
5863337|NCT02038829|20279394|P9|Treatment Period 6|Adverse Event|0
5863338|NCT02038829|20279395|P8|Treatment Period 6|Adverse Event|0
5863339|NCT02038829|20279396|P7|Treatment Period 6|Adverse Event|0
5863340|NCT02038829|20279397|P6|Treatment Period 6|Adverse Event|0
5863341|NCT02038829|20279398|P5|Treatment Period 6|Adverse Event|0
5863342|NCT02038829|20279399|P4|Treatment Period 6|Adverse Event|0
5863343|NCT02038829|20279400|P3|Treatment Period 6|Adverse Event|1
5863344|NCT02038829|20279401|P2|Treatment Period 6|Adverse Event|0
5863345|NCT02038829|20279402|P1|Treatment Period 6|Adverse Event|0
5863346|NCT02038829|20279391|P12|Washout Period 4|Adverse Event|0
5863347|NCT02038829|20279392|P11|Washout Period 4|Adverse Event|0
5863348|NCT02038829|20279393|P10|Washout Period 4|Adverse Event|0
5863349|NCT02038829|20279394|P9|Washout Period 4|Adverse Event|0
5863350|NCT02038829|20279395|P8|Washout Period 4|Adverse Event|0
5863351|NCT02038829|20279396|P7|Washout Period 4|Adverse Event|1
5863352|NCT02038829|20279397|P6|Washout Period 4|Adverse Event|0
5863353|NCT02038829|20279398|P5|Washout Period 4|Adverse Event|0
5863354|NCT02038829|20279399|P4|Washout Period 4|Adverse Event|0
5863355|NCT02038829|20279400|P3|Washout Period 4|Adverse Event|0
5863356|NCT02038829|20279401|P2|Washout Period 4|Adverse Event|0
5863357|NCT02038829|20279402|P1|Washout Period 4|Adverse Event|0
5863358|NCT02038829|20279391|P12|Treatment Period 4|Adverse Event|0
5863359|NCT02038829|20279392|P11|Treatment Period 4|Adverse Event|0
5863360|NCT02038829|20279393|P10|Treatment Period 4|Adverse Event|0
5863361|NCT02038829|20279394|P9|Treatment Period 4|Adverse Event|0
5863362|NCT02038829|20279395|P8|Treatment Period 4|Adverse Event|0
5863363|NCT02038829|20279396|P7|Treatment Period 4|Adverse Event|0
5863364|NCT02038829|20279397|P6|Treatment Period 4|Adverse Event|0
5863365|NCT02038829|20279398|P5|Treatment Period 4|Adverse Event|0
5863366|NCT02038829|20279399|P4|Treatment Period 4|Adverse Event|0
5863367|NCT02038829|20279400|P3|Treatment Period 4|Adverse Event|0
5863368|NCT02038829|20279401|P2|Treatment Period 4|Adverse Event|1
5863369|NCT02038829|20279402|P1|Treatment Period 4|Adverse Event|0
5863370|NCT02038829|20279391|P12|Washout Period 2|Withdrawal by Subject|0
5863371|NCT02038829|20279392|P11|Washout Period 2|Withdrawal by Subject|0
5863372|NCT02038829|20279393|P10|Washout Period 2|Withdrawal by Subject|0
5863373|NCT02038829|20279394|P9|Washout Period 2|Withdrawal by Subject|0
5863374|NCT02038829|20279395|P8|Washout Period 2|Withdrawal by Subject|0
5863375|NCT02038829|20279396|P7|Washout Period 2|Withdrawal by Subject|0
5863376|NCT02038829|20279397|P6|Washout Period 2|Withdrawal by Subject|1
5863377|NCT02038829|20279398|P5|Washout Period 2|Withdrawal by Subject|0
5863378|NCT02038829|20279399|P4|Washout Period 2|Withdrawal by Subject|0
5863379|NCT02038829|20279400|P3|Washout Period 2|Withdrawal by Subject|0
5863380|NCT02038829|20279401|P2|Washout Period 2|Withdrawal by Subject|0
5863381|NCT02038829|20279402|P1|Washout Period 2|Withdrawal by Subject|0
5863382|NCT02038829|20279391|P12|Washout Period 2|Adverse Event|0
5863383|NCT02038829|20279392|P11|Washout Period 2|Adverse Event|0
5863384|NCT02038829|20279393|P10|Washout Period 2|Adverse Event|0
5863385|NCT02038829|20279394|P9|Washout Period 2|Adverse Event|1
5863386|NCT02038829|20279395|P8|Washout Period 2|Adverse Event|0
5863387|NCT02038829|20279396|P7|Washout Period 2|Adverse Event|0
5863388|NCT02038829|20279397|P6|Washout Period 2|Adverse Event|0
5863389|NCT02038829|20279398|P5|Washout Period 2|Adverse Event|0
5863390|NCT02038829|20279399|P4|Washout Period 2|Adverse Event|0
5863391|NCT02038829|20279400|P3|Washout Period 2|Adverse Event|0
5863392|NCT02038829|20279401|P2|Washout Period 2|Adverse Event|0
5863393|NCT02038829|20279402|P1|Washout Period 2|Adverse Event|0
5863394|NCT02038829|20279391|P12|Treatment Period 2|Withdrawal by Subject|0
5863395|NCT02038829|20279392|P11|Treatment Period 2|Withdrawal by Subject|0
5863396|NCT02038829|20279393|P10|Treatment Period 2|Withdrawal by Subject|0
5863397|NCT02038829|20279394|P9|Treatment Period 2|Withdrawal by Subject|0
5863398|NCT02038829|20279395|P8|Treatment Period 2|Withdrawal by Subject|0
5863399|NCT02038829|20279396|P7|Treatment Period 2|Withdrawal by Subject|0
5863400|NCT02038829|20279397|P6|Treatment Period 2|Withdrawal by Subject|0
5863401|NCT02038829|20279398|P5|Treatment Period 2|Withdrawal by Subject|0
5863402|NCT02038829|20279399|P4|Treatment Period 2|Withdrawal by Subject|0
5863403|NCT02038829|20279400|P3|Treatment Period 2|Withdrawal by Subject|0
5863404|NCT02038829|20279401|P2|Treatment Period 2|Withdrawal by Subject|0
5863405|NCT02038829|20279402|P1|Treatment Period 2|Withdrawal by Subject|1
5863406|NCT02038829|20279391|P12|Treatment Period 2|Adverse Event|0
5863407|NCT02038829|20279392|P11|Treatment Period 2|Adverse Event|1
5863408|NCT02038829|20279393|P10|Treatment Period 2|Adverse Event|0
5863409|NCT02038829|20279394|P9|Treatment Period 2|Adverse Event|0
5863410|NCT02038829|20279395|P8|Treatment Period 2|Adverse Event|0
5863411|NCT02038829|20279396|P7|Treatment Period 2|Adverse Event|0
5863412|NCT02038829|20279397|P6|Treatment Period 2|Adverse Event|0
5863413|NCT02038829|20279398|P5|Treatment Period 2|Adverse Event|0
5863414|NCT02038829|20279399|P4|Treatment Period 2|Adverse Event|0
5863415|NCT02038829|20279400|P3|Treatment Period 2|Adverse Event|0
5863416|NCT02038829|20279401|P2|Treatment Period 2|Adverse Event|0
5863417|NCT02038829|20279402|P1|Treatment Period 2|Adverse Event|0
5863418|NCT02038829|20279391|P12|Washout Period 1|Death|0
5863419|NCT02038829|20279392|P11|Washout Period 1|Death|0
5863420|NCT02038829|20279393|P10|Washout Period 1|Death|0
5863421|NCT02038829|20279394|P9|Washout Period 1|Death|0
5863422|NCT02038829|20279395|P8|Washout Period 1|Death|0
5863423|NCT02038829|20279396|P7|Washout Period 1|Death|0
5863424|NCT02038829|20279397|P6|Washout Period 1|Death|0
5863425|NCT02038829|20279398|P5|Washout Period 1|Death|1
5863426|NCT02038829|20279399|P4|Washout Period 1|Death|0
5863427|NCT02038829|20279400|P3|Washout Period 1|Death|0
5863428|NCT02038829|20279401|P2|Washout Period 1|Death|0
5863429|NCT02038829|20279402|P1|Washout Period 1|Death|0
5863430|NCT02038790|20279436|P2|Day 0 - First Treatment|Withdrawal by Subject|1
5863431|NCT02038790|20279437|P1|Day 0 - First Treatment|Withdrawal by Subject|1
5863432|NCT02038764|20279473|P5|Overall Study|Other|0
5863433|NCT02038764|20279474|P4|Overall Study|Other|0
5863434|NCT02038764|20279475|P3|Overall Study|Other|1
5863435|NCT02038764|20279476|P2|Overall Study|Other|0
5863436|NCT02038764|20279477|P1|Overall Study|Other|1
5863437|NCT02038764|20279473|P5|Overall Study|Withdrawal by Subject|1
5863438|NCT02038764|20279474|P4|Overall Study|Withdrawal by Subject|0
5863439|NCT02038764|20279475|P3|Overall Study|Withdrawal by Subject|0
5863440|NCT02038764|20279476|P2|Overall Study|Withdrawal by Subject|0
5863441|NCT02038764|20279477|P1|Overall Study|Withdrawal by Subject|0
5863442|NCT02038764|20279473|P5|Overall Study|Lost to Follow-up|0
5863443|NCT02038764|20279474|P4|Overall Study|Lost to Follow-up|0
5863444|NCT02038764|20279475|P3|Overall Study|Lost to Follow-up|0
5863445|NCT02038764|20279476|P2|Overall Study|Lost to Follow-up|1
5863446|NCT02038764|20279477|P1|Overall Study|Lost to Follow-up|0
5863447|NCT02038764|20279473|P5|Overall Study|Adverse Event|0
5863448|NCT02038764|20279474|P4|Overall Study|Adverse Event|0
5863449|NCT02038764|20279475|P3|Overall Study|Adverse Event|1
5863450|NCT02038764|20279476|P2|Overall Study|Adverse Event|0
5863451|NCT02038764|20279477|P1|Overall Study|Adverse Event|0
5863452|NCT02038647|20279579|P2|Overall Study|Ongoing at Datacut|10
5863453|NCT02038647|20279580|P1|Overall Study|Ongoing at Datacut|9
5863454|NCT02038647|20279579|P2|Overall Study|Not Reported|1
5863455|NCT02038647|20279580|P1|Overall Study|Not Reported|0
5863456|NCT02038647|20279579|P2|Overall Study|Withdrawal by Subject|2
5863457|NCT02038647|20279580|P1|Overall Study|Withdrawal by Subject|5
5863458|NCT02038647|20279579|P2|Overall Study|Symptomatic Deterioration|7
5863459|NCT02038647|20279580|P1|Overall Study|Symptomatic Deterioration|7
5863460|NCT02038647|20279579|P2|Overall Study|Adverse Event|10
5863461|NCT02038647|20279580|P1|Overall Study|Adverse Event|18
5863462|NCT02038647|20279579|P2|Overall Study|Progressive Disease|59
5863463|NCT02038647|20279580|P1|Overall Study|Progressive Disease|50
5863464|NCT02038543|20279643|P4|Overall Study|Withdrawal by Subject|1
5863465|NCT02038543|20279644|P3|Overall Study|Withdrawal by Subject|0
5863466|NCT02038543|20279645|P2|Overall Study|Withdrawal by Subject|0
5863467|NCT02038543|20279646|P1|Overall Study|Withdrawal by Subject|0
5863468|NCT02038543|20279643|P4|Overall Study|Screen Failure|1
5863469|NCT02038543|20279644|P3|Overall Study|Screen Failure|0
5863470|NCT02038543|20279645|P2|Overall Study|Screen Failure|0
5863471|NCT02038543|20279646|P1|Overall Study|Screen Failure|0
5863472|NCT02038153|20279682|P1|Overall Study|Withdrawal by Subject|1
5863473|NCT02038075|20279689|P2|Overall Study|Withdrawal by Subject|0
5863474|NCT02038075|20279690|P1|Overall Study|Withdrawal by Subject|3
5863475|NCT02038049|20279698|P2|Overall Study|Lost to Follow-up|0
5863476|NCT02038049|20279699|P1|Overall Study|Lost to Follow-up|1
5863477|NCT02038010|20279728|P4|Follow Up|Other|0
5863478|NCT02038010|20279729|P3|Follow Up|Other|0
5863479|NCT02038010|20279730|P2|Follow Up|Other|0
5863480|NCT02038010|20279731|P1|Follow Up|Other|3
5863481|NCT02038010|20279728|P4|Follow Up|Death|0
5863482|NCT02038010|20279729|P3|Follow Up|Death|0
5863483|NCT02038010|20279730|P2|Follow Up|Death|3
5863484|NCT02038010|20279731|P1|Follow Up|Death|4
5863485|NCT02038010|20279728|P4|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0
5863486|NCT02038010|20279729|P3|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0
5863487|NCT02038010|20279730|P2|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1
5863488|NCT02038010|20279731|P1|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1
5863489|NCT02038010|20279728|P4|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0
5863490|NCT02038010|20279729|P3|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0
5863491|NCT02038010|20279730|P2|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|1
5863492|NCT02038010|20279731|P1|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0
5863493|NCT02038010|20279728|P4|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0
5863494|NCT02038010|20279729|P3|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0
5863495|NCT02038010|20279730|P2|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0
5863496|NCT02038010|20279731|P1|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|1
5863497|NCT02038010|20279728|P4|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0
5863498|NCT02038010|20279729|P3|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0
5863499|NCT02038010|20279730|P2|Completed 1st Cycle and Started Cycle 2|Progressive Disease|1
5863500|NCT02038010|20279731|P1|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0
5863501|NCT02037984|20279758|P8|Overall Study|Withdrawal by Subject|1
5863502|NCT02037984|20279759|P7|Overall Study|Withdrawal by Subject|0
5863503|NCT02037984|20279760|P6|Overall Study|Withdrawal by Subject|3
5863504|NCT02037984|20279761|P5|Overall Study|Withdrawal by Subject|1
5863505|NCT02037984|20279762|P4|Overall Study|Withdrawal by Subject|1
5863506|NCT02037984|20279763|P3|Overall Study|Withdrawal by Subject|0
5863507|NCT02037984|20279764|P2|Overall Study|Withdrawal by Subject|0
5863508|NCT02037984|20279765|P1|Overall Study|Withdrawal by Subject|0
5863509|NCT02037984|20279758|P8|Overall Study|Withdrawal by Parent/Guardian|2
5863510|NCT02037984|20279759|P7|Overall Study|Withdrawal by Parent/Guardian|4
5863511|NCT02037984|20279760|P6|Overall Study|Withdrawal by Parent/Guardian|1
5863512|NCT02037984|20279761|P5|Overall Study|Withdrawal by Parent/Guardian|5
5863513|NCT02037984|20279762|P4|Overall Study|Withdrawal by Parent/Guardian|2
5863514|NCT02037984|20279763|P3|Overall Study|Withdrawal by Parent/Guardian|3
5863515|NCT02037984|20279764|P2|Overall Study|Withdrawal by Parent/Guardian|0
5863516|NCT02037984|20279765|P1|Overall Study|Withdrawal by Parent/Guardian|0
5863517|NCT02037984|20279758|P8|Overall Study|Technical Problems|2
5863518|NCT02037984|20279759|P7|Overall Study|Technical Problems|4
5863519|NCT02037984|20279760|P6|Overall Study|Technical Problems|3
5863520|NCT02037984|20279761|P5|Overall Study|Technical Problems|2
5863521|NCT02037984|20279762|P4|Overall Study|Technical Problems|3
5863522|NCT02037984|20279763|P3|Overall Study|Technical Problems|3
5863523|NCT02037984|20279764|P2|Overall Study|Technical Problems|0
5863524|NCT02037984|20279765|P1|Overall Study|Technical Problems|0
5863525|NCT02037984|20279758|P8|Overall Study|Protocol Violation|0
5863526|NCT02037984|20279759|P7|Overall Study|Protocol Violation|2
5863527|NCT02037984|20279760|P6|Overall Study|Protocol Violation|1
5863528|NCT02037984|20279761|P5|Overall Study|Protocol Violation|0
5863529|NCT02037984|20279762|P4|Overall Study|Protocol Violation|0
5863530|NCT02037984|20279763|P3|Overall Study|Protocol Violation|0
5863531|NCT02037984|20279764|P2|Overall Study|Protocol Violation|0
5863532|NCT02037984|20279765|P1|Overall Study|Protocol Violation|0
5863533|NCT02037984|20279758|P8|Overall Study|Physician Decision|0
5863534|NCT02037984|20279759|P7|Overall Study|Physician Decision|1
5863535|NCT02037984|20279760|P6|Overall Study|Physician Decision|0
5863536|NCT02037984|20279761|P5|Overall Study|Physician Decision|0
5863537|NCT02037984|20279762|P4|Overall Study|Physician Decision|0
5863538|NCT02037984|20279763|P3|Overall Study|Physician Decision|0
5863539|NCT02037984|20279764|P2|Overall Study|Physician Decision|0
5863540|NCT02037984|20279765|P1|Overall Study|Physician Decision|0
5863541|NCT02037984|20279758|P8|Overall Study|Lost to Follow-up|4
5863542|NCT02037984|20279759|P7|Overall Study|Lost to Follow-up|2
5863543|NCT02037984|20279760|P6|Overall Study|Lost to Follow-up|2
5863544|NCT02037984|20279761|P5|Overall Study|Lost to Follow-up|2
5863545|NCT02037984|20279762|P4|Overall Study|Lost to Follow-up|5
5863546|NCT02037984|20279763|P3|Overall Study|Lost to Follow-up|3
5863547|NCT02037984|20279764|P2|Overall Study|Lost to Follow-up|0
5863548|NCT02037984|20279765|P1|Overall Study|Lost to Follow-up|1
5863549|NCT02037984|20279758|P8|Overall Study|Lack of Efficacy|3
5863550|NCT02037984|20279759|P7|Overall Study|Lack of Efficacy|4
5863551|NCT02037984|20279760|P6|Overall Study|Lack of Efficacy|2
5863552|NCT02037984|20279761|P5|Overall Study|Lack of Efficacy|2
5863553|NCT02037984|20279762|P4|Overall Study|Lack of Efficacy|10
5863554|NCT02037984|20279763|P3|Overall Study|Lack of Efficacy|3
5863555|NCT02037984|20279764|P2|Overall Study|Lack of Efficacy|0
5863556|NCT02037984|20279765|P1|Overall Study|Lack of Efficacy|0
5863557|NCT02037568|20279910|P2|Overall Study|Patient did not receive transplant|1
5863558|NCT02037568|20279911|P1|Overall Study|Patient did not receive transplant|0
5863559|NCT02037568|20279910|P2|Overall Study|Screen Failure|1
5863560|NCT02037568|20279911|P1|Overall Study|Screen Failure|3
5863561|NCT02037568|20279910|P2|Overall Study|Lost to Follow-up|13
5863562|NCT02037568|20279911|P1|Overall Study|Lost to Follow-up|16
5863563|NCT02037568|20279910|P2|Overall Study|Withdrawal by Subject|24
5863564|NCT02037568|20279911|P1|Overall Study|Withdrawal by Subject|17
5863565|NCT02037477|20279946|P4|Treatment Period 1|Pre-treatment Event/Adverse Event|0
5863566|NCT02037477|20279947|P3|Treatment Period 1|Pre-treatment Event/Adverse Event|1
5863567|NCT02037477|20279948|P2|Treatment Period 1|Pre-treatment Event/Adverse Event|0
5863568|NCT02037477|20279949|P1|Treatment Period 1|Pre-treatment Event/Adverse Event|0
5863569|NCT02037295|20280044|P4|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|1
5863570|NCT02037295|20280045|P3|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|0
5863571|NCT02037295|20280046|P2|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|0
5863572|NCT02037295|20280047|P1|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|1
5863573|NCT02037165|20280103|P5|Washout Period 4 (6 Days)|Withdrawal by Subject|1
5863574|NCT02037165|20280104|P4|Washout Period 4 (6 Days)|Withdrawal by Subject|0
5863575|NCT02037165|20280105|P3|Washout Period 4 (6 Days)|Withdrawal by Subject|0
5863576|NCT02037165|20280106|P2|Washout Period 4 (6 Days)|Withdrawal by Subject|0
5863577|NCT02037165|20280107|P1|Washout Period 4 (6 Days)|Withdrawal by Subject|0
5863578|NCT02036775|20280167|P6|Treatment Period 2 (6 Days)|Withdrawal by Subject|1
5863579|NCT02036775|20280168|P5|Treatment Period 2 (6 Days)|Withdrawal by Subject|0
5863580|NCT02036775|20280169|P4|Treatment Period 2 (6 Days)|Withdrawal by Subject|0
5863581|NCT02036775|20280170|P3|Treatment Period 2 (6 Days)|Withdrawal by Subject|0
5863582|NCT02036775|20280171|P2|Treatment Period 2 (6 Days)|Withdrawal by Subject|0
5863583|NCT02036775|20280172|P1|Treatment Period 2 (6 Days)|Withdrawal by Subject|0
5863584|NCT02036645|20280222|P12|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
5863585|NCT02036645|20280223|P11|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
5863586|NCT02036645|20280224|P10|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
5863587|NCT02036645|20280225|P9|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
5863588|NCT02036645|20280226|P8|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
5863589|NCT02036645|20280227|P7|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
5863590|NCT02036645|20280228|P6|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
5863591|NCT02036645|20280229|P5|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
5863592|NCT02036645|20280230|P4|SAD Cohorts : Study Part 1|Withdrawal by Subject|1
5863593|NCT02036645|20280231|P3|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
5863594|NCT02036645|20280232|P2|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
5863595|NCT02036645|20280233|P1|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
5863596|NCT02036645|20280222|P12|SAD Cohorts : Study Part 1|Lost to Follow-up|0
5863597|NCT02036645|20280223|P11|SAD Cohorts : Study Part 1|Lost to Follow-up|0
5863598|NCT02036645|20280224|P10|SAD Cohorts : Study Part 1|Lost to Follow-up|0
5863599|NCT02036645|20280225|P9|SAD Cohorts : Study Part 1|Lost to Follow-up|0
5863600|NCT02036645|20280226|P8|SAD Cohorts : Study Part 1|Lost to Follow-up|0
5863601|NCT02036645|20280227|P7|SAD Cohorts : Study Part 1|Lost to Follow-up|1
5863602|NCT02036645|20280228|P6|SAD Cohorts : Study Part 1|Lost to Follow-up|0
5863603|NCT02036645|20280229|P5|SAD Cohorts : Study Part 1|Lost to Follow-up|0
5863604|NCT02036645|20280230|P4|SAD Cohorts : Study Part 1|Lost to Follow-up|0
5863605|NCT02036645|20280231|P3|SAD Cohorts : Study Part 1|Lost to Follow-up|0
5863606|NCT02036645|20280232|P2|SAD Cohorts : Study Part 1|Lost to Follow-up|0
5863607|NCT02036645|20280233|P1|SAD Cohorts : Study Part 1|Lost to Follow-up|0
5863608|NCT02036580|20280338|P3|Overall Study|Adverse Event|0
5863609|NCT02036580|20280339|P2|Overall Study|Adverse Event|0
5863610|NCT02036580|20280340|P1|Overall Study|Adverse Event|1
5863611|NCT02036580|20280338|P3|Overall Study|Withdrawal by Subject|0
5863612|NCT02036580|20280339|P2|Overall Study|Withdrawal by Subject|1
5863613|NCT02036580|20280340|P1|Overall Study|Withdrawal by Subject|0
5863614|NCT02036515|20280361|P3|Overall Study|Hyperglycemia|1
5863615|NCT02036515|20280362|P2|Overall Study|Hyperglycemia|0
5863616|NCT02036515|20280363|P1|Overall Study|Hyperglycemia|0
5863617|NCT02036515|20280361|P3|Overall Study|Withdrawal by Subject|9
5863618|NCT02036515|20280362|P2|Overall Study|Withdrawal by Subject|7
5863619|NCT02036515|20280363|P1|Overall Study|Withdrawal by Subject|4
5863620|NCT02036515|20280361|P3|Overall Study|Screen failure|0
5863621|NCT02036515|20280362|P2|Overall Study|Screen failure|2
5863622|NCT02036515|20280363|P1|Overall Study|Screen failure|0
5863623|NCT02036515|20280361|P3|Overall Study|Non-compliance with study drug|2
5863624|NCT02036515|20280362|P2|Overall Study|Non-compliance with study drug|0
5863625|NCT02036515|20280363|P1|Overall Study|Non-compliance with study drug|0
5863626|NCT02036515|20280361|P3|Overall Study|Lost to Follow-up|0
5863627|NCT02036515|20280362|P2|Overall Study|Lost to Follow-up|2
5863628|NCT02036515|20280363|P1|Overall Study|Lost to Follow-up|0
5863629|NCT02036515|20280361|P3|Overall Study|Adverse Event|2
5863630|NCT02036515|20280362|P2|Overall Study|Adverse Event|1
5863631|NCT02036515|20280363|P1|Overall Study|Adverse Event|1
5863632|NCT02036294|20280464|P2|Overall Study|Withdrawal by Subject|3
5863633|NCT02036294|20280465|P1|Overall Study|Withdrawal by Subject|2
5863634|NCT02036294|20280464|P2|Overall Study|Death|8
5863635|NCT02036294|20280465|P1|Overall Study|Death|7
5863636|NCT02035748|20280481|P1|Overall Study|Progressive Disease|1
5863637|NCT02035748|20280481|P1|Overall Study|Withdrawal by Subject|6
5863638|NCT02035748|20280481|P1|Overall Study|Physician Decision|3
5863639|NCT02035748|20280481|P1|Overall Study|Lost to Follow-up|2
5863640|NCT02035748|20280481|P1|Overall Study|Death|3
5863641|NCT02035748|20280481|P1|Overall Study|Adverse Event|5
5863642|NCT02035696|20280495|P4|Overall Study|Withdrawal by Subject|1
5863643|NCT02035696|20280496|P3|Overall Study|Withdrawal by Subject|2
5863644|NCT02035696|20280497|P2|Overall Study|Withdrawal by Subject|0
5863645|NCT02035696|20280498|P1|Overall Study|Withdrawal by Subject|3
5863646|NCT02035696|20280495|P4|Overall Study|Lost to Follow-up|2
5863647|NCT02035696|20280496|P3|Overall Study|Lost to Follow-up|1
5863648|NCT02035696|20280497|P2|Overall Study|Lost to Follow-up|3
5863649|NCT02035696|20280498|P1|Overall Study|Lost to Follow-up|0
5863650|NCT02035553|20280554|P2|Overall Study|Other Reason|4
5863651|NCT02035553|20280555|P1|Overall Study|Other Reason|0
5863652|NCT02035553|20280554|P2|Overall Study|Lost to Follow-up|1
5863653|NCT02035553|20280555|P1|Overall Study|Lost to Follow-up|0
5863654|NCT02035553|20280554|P2|Overall Study|Non-compliance with Study Drug|1
5863655|NCT02035553|20280555|P1|Overall Study|Non-compliance with Study Drug|0
5863656|NCT02035553|20280554|P2|Overall Study|Withdrawal by Subject|7
5863657|NCT02035553|20280555|P1|Overall Study|Withdrawal by Subject|4
5863658|NCT02035553|20280554|P2|Overall Study|Lack of Efficacy|1
5863659|NCT02035553|20280555|P1|Overall Study|Lack of Efficacy|1
5863660|NCT02035553|20280554|P2|Overall Study|Physician Decision|2
5863661|NCT02035553|20280555|P1|Overall Study|Physician Decision|3
5863662|NCT02035553|20280554|P2|Overall Study|Adverse Event|6
5863663|NCT02035553|20280555|P1|Overall Study|Adverse Event|10
5863664|NCT02035553|20280554|P2|Overall Study|Death (See All-Cause Mortality Table)|1
5863665|NCT02035553|20280555|P1|Overall Study|Death (See All-Cause Mortality Table)|0
5863666|NCT02035475|20280561|P1|Overall Study|Equipment Error|1
5863667|NCT02035475|20280561|P1|Overall Study|Physician Decision|1
5863668|NCT02035475|20280561|P1|Overall Study|Withdrawal by Subject|4
5863669|NCT02035332|20280572|P1|Overall Study|Procedure Aborted due to Uterine Width|1
5863670|NCT02035267|20280582|P4|Overall Study|Other unspecified|0
5863671|NCT02035267|20280583|P3|Overall Study|Other unspecified|0
5863672|NCT02035267|20280584|P2|Overall Study|Other unspecified|1
5863673|NCT02035267|20280585|P1|Overall Study|Other unspecified|0
5863674|NCT02035267|20280582|P4|Overall Study|Lost to Follow-up|1
5863675|NCT02035267|20280583|P3|Overall Study|Lost to Follow-up|0
5863676|NCT02035267|20280584|P2|Overall Study|Lost to Follow-up|0
5863677|NCT02035267|20280585|P1|Overall Study|Lost to Follow-up|0
5863678|NCT02035267|20280582|P4|Overall Study|Adverse Event|0
5863679|NCT02035267|20280583|P3|Overall Study|Adverse Event|1
5863680|NCT02035267|20280584|P2|Overall Study|Adverse Event|0
5863681|NCT02035267|20280585|P1|Overall Study|Adverse Event|0
5863682|NCT02035267|20280582|P4|Overall Study|Withdrawal consent-subject convenience|0
5863683|NCT02035267|20280583|P3|Overall Study|Withdrawal consent-subject convenience|1
5863684|NCT02035267|20280584|P2|Overall Study|Withdrawal consent-subject convenience|0
5863685|NCT02035267|20280585|P1|Overall Study|Withdrawal consent-subject convenience|0
5863686|NCT02035202|20280616|P3|Overall Study|Lost to Follow-up|2
5863687|NCT02035202|20280617|P2|Overall Study|Lost to Follow-up|16
5863688|NCT02035202|20280618|P1|Overall Study|Lost to Follow-up|8
5863689|NCT02034916|20280634|P2|Overall Study|Study terminated by sponsor|5
5863690|NCT02034916|20280635|P1|Overall Study|Study terminated by sponsor|4
5863691|NCT02034916|20280634|P2|Overall Study|Lost to Follow-up|1
5863692|NCT02034916|20280635|P1|Overall Study|Lost to Follow-up|4
5863693|NCT02034916|20280634|P2|Overall Study|Withdrawal by Subject|1
5863694|NCT02034916|20280635|P1|Overall Study|Withdrawal by Subject|2
5863695|NCT02034916|20280634|P2|Overall Study|Death|28
5863696|NCT02034916|20280635|P1|Overall Study|Death|39
5863697|NCT02034877|20280672|P2|Overall Study|No Longer Willing to Participate|3
5863698|NCT02034877|20280673|P1|Overall Study|No Longer Willing to Participate|0
5863699|NCT02034877|20280672|P2|Overall Study|Lost to Follow-up|3
5863700|NCT02034877|20280673|P1|Overall Study|Lost to Follow-up|0
5863701|NCT02034799|20280691|P2|Overall Study|Death|1
5863702|NCT02034799|20280692|P1|Overall Study|Death|2
5863703|NCT02034799|20280691|P2|Overall Study|Lost to Follow-up|1
5863704|NCT02034799|20280692|P1|Overall Study|Lost to Follow-up|0
5863705|NCT02034799|20280691|P2|Overall Study|Withdrawal by Subject|2
5863706|NCT02034799|20280692|P1|Overall Study|Withdrawal by Subject|0
5863707|NCT02034708|20280706|P2|Wash-out (From 2 Days up to 14 Days)|other reason|2
5863708|NCT02034708|20280707|P1|Wash-out (From 2 Days up to 14 Days)|other reason|3
5863709|NCT02034708|20280706|P2|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3
5863710|NCT02034708|20280707|P1|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3
5863711|NCT02034708|20280706|P2|Wash-out (From 2 Days up to 14 Days)|Adverse Event|0
5863712|NCT02034708|20280707|P1|Wash-out (From 2 Days up to 14 Days)|Adverse Event|1
5863713|NCT02034708|20280706|P2|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|5
5863714|NCT02034708|20280707|P1|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|2
5863715|NCT02034591|20280718|P6|Overall Study|Withdrawal by Subject|0
5863716|NCT02034591|20280719|P5|Overall Study|Withdrawal by Subject|1
5863717|NCT02034591|20280720|P4|Overall Study|Withdrawal by Subject|0
5863718|NCT02034591|20280721|P3|Overall Study|Withdrawal by Subject|0
5863719|NCT02034591|20280722|P2|Overall Study|Withdrawal by Subject|0
5863720|NCT02034591|20280723|P1|Overall Study|Withdrawal by Subject|0
5863721|NCT02034565|20280778|P2|Overall Study|Adverse Event|0
5863722|NCT02034565|20280779|P1|Overall Study|Adverse Event|1
5863723|NCT02034552|20280796|P3|Overall Study|Clinical progression|9
5863724|NCT02034552|20280797|P2|Overall Study|Clinical progression|7
5863725|NCT02034552|20280798|P1|Overall Study|Clinical progression|5
5863726|NCT02034552|20280796|P3|Overall Study|Non-compliance with study drug|1
5863727|NCT02034552|20280797|P2|Overall Study|Non-compliance with study drug|0
5863728|NCT02034552|20280798|P1|Overall Study|Non-compliance with study drug|0
5863729|NCT02034552|20280796|P3|Overall Study|Withdrawal by Subject|1
5863730|NCT02034552|20280797|P2|Overall Study|Withdrawal by Subject|1
5863731|NCT02034552|20280798|P1|Overall Study|Withdrawal by Subject|2
5863732|NCT02034552|20280796|P3|Overall Study|AE associated with disease progression|0
5863733|NCT02034552|20280797|P2|Overall Study|AE associated with disease progression|1
5863734|NCT02034552|20280798|P1|Overall Study|AE associated with disease progression|0
5863735|NCT02034552|20280796|P3|Overall Study|AE not assoc. with disease progression|2
5863736|NCT02034552|20280797|P2|Overall Study|AE not assoc. with disease progression|4
5863737|NCT02034552|20280798|P1|Overall Study|AE not assoc. with disease progression|1
5863738|NCT02034552|20280796|P3|Overall Study|Radiological progression|4
5863739|NCT02034552|20280797|P2|Overall Study|Radiological progression|5
5863740|NCT02034552|20280798|P1|Overall Study|Radiological progression|3
5863741|NCT02034552|20280796|P3|Overall Study|Never treated|0
5863742|NCT02034552|20280797|P2|Overall Study|Never treated|2
5863743|NCT02034552|20280798|P1|Overall Study|Never treated|3
5863744|NCT02034513|20280829|P2|Overall Study|Unclassified|1
5863745|NCT02034513|20280830|P1|Overall Study|Unclassified|0
5863746|NCT02034513|20280829|P2|Overall Study|Withdrawal by Subject|25
5863747|NCT02034513|20280830|P1|Overall Study|Withdrawal by Subject|25
5863748|NCT02034513|20280829|P2|Overall Study|Protocol Violation|10
5863749|NCT02034513|20280830|P1|Overall Study|Protocol Violation|7
5863750|NCT02034513|20280829|P2|Overall Study|Pregnancy|3
5863751|NCT02034513|20280830|P1|Overall Study|Pregnancy|0
5863752|NCT02034513|20280829|P2|Overall Study|Lost to Follow-up|7
5863753|NCT02034513|20280830|P1|Overall Study|Lost to Follow-up|6
5863754|NCT02034513|20280829|P2|Overall Study|Lack of Efficacy|1
5863755|NCT02034513|20280830|P1|Overall Study|Lack of Efficacy|0
5863756|NCT02034513|20280829|P2|Overall Study|Adverse Event|10
5863757|NCT02034513|20280830|P1|Overall Study|Adverse Event|11
5863758|NCT02034474|20280848|P2|Overall Study|Withdrawal by Subject|2
5863759|NCT02034474|20280849|P1|Overall Study|Withdrawal by Subject|1
5863760|NCT02034474|20280848|P2|Overall Study|Adverse Event|2
5863761|NCT02034474|20280849|P1|Overall Study|Adverse Event|3
5863762|NCT02034435|20280861|P4|Overall Study|Inadequate IV access|1
5863763|NCT02034435|20280862|P3|Overall Study|Inadequate IV access|0
5863764|NCT02034435|20280863|P2|Overall Study|Inadequate IV access|0
5863765|NCT02034435|20280864|P1|Overall Study|Inadequate IV access|1
5863766|NCT02034435|20280861|P4|Overall Study|Illness|0
5863767|NCT02034435|20280862|P3|Overall Study|Illness|0
5863768|NCT02034435|20280863|P2|Overall Study|Illness|2
5863769|NCT02034435|20280864|P1|Overall Study|Illness|0
5863770|NCT02034435|20280861|P4|Overall Study|Withdrawal by Subject|0
5863771|NCT02034435|20280862|P3|Overall Study|Withdrawal by Subject|0
5863772|NCT02034435|20280863|P2|Overall Study|Withdrawal by Subject|0
5863773|NCT02034435|20280864|P1|Overall Study|Withdrawal by Subject|1
5863774|NCT02034162|20280884|P3|Double-blind|Withdrawal by Subject|0
5863775|NCT02034162|20280885|P2|Double-blind|Withdrawal by Subject|7
5863776|NCT02034162|20280886|P1|Double-blind|Withdrawal by Subject|5
5863777|NCT02034162|20280884|P3|Double-blind|Protocol Violation|0
5863778|NCT02034162|20280885|P2|Double-blind|Protocol Violation|1
5863779|NCT02034162|20280886|P1|Double-blind|Protocol Violation|0
5863780|NCT02034162|20280884|P3|Double-blind|Physician Decision|0
5863781|NCT02034162|20280885|P2|Double-blind|Physician Decision|0
5863782|NCT02034162|20280886|P1|Double-blind|Physician Decision|1
5863783|NCT02034162|20280884|P3|Double-blind|Lost to Follow-up|0
5863784|NCT02034162|20280885|P2|Double-blind|Lost to Follow-up|0
5863785|NCT02034162|20280886|P1|Double-blind|Lost to Follow-up|3
5863786|NCT02034123|20280932|P18|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
5863787|NCT02034123|20280933|P17|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
5863788|NCT02034123|20280934|P16|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
5863789|NCT02034123|20280935|P15|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
5863790|NCT02034123|20280936|P14|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
5863791|NCT02034123|20280937|P13|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
5863792|NCT02034123|20280938|P12|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
5863793|NCT02034123|20280939|P11|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
5863794|NCT02034123|20280940|P10|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
5863795|NCT02034123|20280941|P9|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
5863796|NCT02034123|20280942|P8|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
5863797|NCT02034123|20280943|P7|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
5863798|NCT02034123|20280944|P6|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
5863799|NCT02034123|20280945|P5|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1
5863800|NCT02034123|20280946|P4|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1
5863801|NCT02034123|20280947|P3|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
5863802|NCT02034123|20280948|P2|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
5863803|NCT02034123|20280949|P1|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
5863804|NCT02034123|20280932|P18|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
5863805|NCT02034123|20280933|P17|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
5863806|NCT02034123|20280934|P16|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
5863807|NCT02034123|20280935|P15|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
5863808|NCT02034123|20280936|P14|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
5863809|NCT02034123|20280937|P13|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
5863810|NCT02034123|20280938|P12|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
5863811|NCT02034123|20280939|P11|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
5863812|NCT02034123|20280940|P10|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
5863813|NCT02034123|20280941|P9|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|1
5863814|NCT02034123|20280942|P8|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
5863815|NCT02034123|20280943|P7|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
5863816|NCT02034123|20280944|P6|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
5863817|NCT02034123|20280945|P5|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
5863818|NCT02034123|20280946|P4|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
5863819|NCT02034123|20280947|P3|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
5863820|NCT02034123|20280948|P2|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
5863821|NCT02034123|20280949|P1|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
5863822|NCT02034123|20280932|P18|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
5863823|NCT02034123|20280933|P17|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
5863824|NCT02034123|20280934|P16|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
5863825|NCT02034123|20280935|P15|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
5863826|NCT02034123|20280936|P14|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
5863827|NCT02034123|20280937|P13|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
5863828|NCT02034123|20280938|P12|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
5863829|NCT02034123|20280939|P11|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
5863830|NCT02034123|20280940|P10|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
5863831|NCT02034123|20280941|P9|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
5863832|NCT02034123|20280942|P8|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
5863833|NCT02034123|20280943|P7|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
5863834|NCT02034123|20280944|P6|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
5863835|NCT02034123|20280945|P5|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
5863836|NCT02034123|20280946|P4|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|1
5863837|NCT02034123|20280947|P3|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
5863838|NCT02034123|20280948|P2|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
5863839|NCT02034123|20280949|P1|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
5863840|NCT02034123|20280932|P18|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
5863841|NCT02034123|20280933|P17|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
5863842|NCT02034123|20280934|P16|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
5863843|NCT02034123|20280935|P15|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
5863844|NCT02034123|20280936|P14|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
5863845|NCT02034123|20280937|P13|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
5863846|NCT02034123|20280938|P12|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
5863847|NCT02034123|20280939|P11|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
5863848|NCT02034123|20280940|P10|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
5863849|NCT02034123|20280941|P9|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1
5863850|NCT02034123|20280942|P8|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1
5863851|NCT02034123|20280943|P7|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
5863852|NCT02034123|20280944|P6|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
5863853|NCT02034123|20280945|P5|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1
5863854|NCT02034123|20280946|P4|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
5863855|NCT02034123|20280947|P3|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
5863856|NCT02034123|20280948|P2|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
5863857|NCT02034123|20280949|P1|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
5863858|NCT02034058|20281268|P1|Overall Study|Death|3
5863859|NCT02034006|20281289|P1|Overall Study|Pregnancy|1
5863860|NCT02034006|20281289|P1|Overall Study|Death|1
5863861|NCT02034006|20281289|P1|Overall Study|Lost to Follow-up|5
5863862|NCT02034006|20281289|P1|Overall Study|Withdrawal by Subject|7
5863863|NCT02033889|20281340|P3|Overall Study|Withdrawal by Subject|13
5863864|NCT02033889|20281341|P2|Overall Study|Withdrawal by Subject|10
5863865|NCT02033889|20281342|P1|Overall Study|Withdrawal by Subject|18
5863866|NCT02033889|20281340|P3|Overall Study|Participant moved|0
5863867|NCT02033889|20281341|P2|Overall Study|Participant moved|1
5863868|NCT02033889|20281342|P1|Overall Study|Participant moved|0
5863869|NCT02033889|20281340|P3|Overall Study|Physician Decision|1
5863870|NCT02033889|20281341|P2|Overall Study|Physician Decision|1
5863871|NCT02033889|20281342|P1|Overall Study|Physician Decision|0
5863872|NCT02033889|20281340|P3|Overall Study|Non-Compliance With Study Drug|0
5863873|NCT02033889|20281341|P2|Overall Study|Non-Compliance With Study Drug|0
5863874|NCT02033889|20281342|P1|Overall Study|Non-Compliance With Study Drug|1
5863875|NCT02033889|20281340|P3|Overall Study|Lost to Follow-up|6
5863876|NCT02033889|20281341|P2|Overall Study|Lost to Follow-up|5
5863877|NCT02033889|20281342|P1|Overall Study|Lost to Follow-up|8
5863878|NCT02033889|20281340|P3|Overall Study|Excluded Medication|0
5863879|NCT02033889|20281341|P2|Overall Study|Excluded Medication|1
5863880|NCT02033889|20281342|P1|Overall Study|Excluded Medication|1
5863881|NCT02033889|20281340|P3|Overall Study|Death|2
5863882|NCT02033889|20281341|P2|Overall Study|Death|1
5863883|NCT02033889|20281342|P1|Overall Study|Death|3
5863884|NCT02033889|20281340|P3|Overall Study|Adverse Event|3
5863885|NCT02033889|20281341|P2|Overall Study|Adverse Event|1
5863886|NCT02033889|20281342|P1|Overall Study|Adverse Event|3
5863887|NCT02033850|20281519|P2|Overall Study|unrelated medical reason|1
5863888|NCT02033850|20281520|P1|Overall Study|unrelated medical reason|1
5863889|NCT02033850|20281519|P2|Overall Study|Death|0
5863890|NCT02033850|20281520|P1|Overall Study|Death|1
5863891|NCT02033759|20281544|P2|Overall Study|Protocol Violation|1
5863892|NCT02033759|20281545|P1|Overall Study|Protocol Violation|1
5863893|NCT02033759|20281544|P2|Overall Study|Withdrawal by Subject|1
5863894|NCT02033759|20281545|P1|Overall Study|Withdrawal by Subject|2
5863895|NCT02033369|20281626|P2|Overall Study|Protocol Violation|0
5863896|NCT02033369|20281627|P1|Overall Study|Protocol Violation|2
5863897|NCT02033369|20281626|P2|Overall Study|Lost to Follow-up|0
5863898|NCT02033369|20281627|P1|Overall Study|Lost to Follow-up|1
5863899|NCT02033369|20281626|P2|Overall Study|Withdrawal by Subject|1
5863900|NCT02033369|20281627|P1|Overall Study|Withdrawal by Subject|1
5863901|NCT02033369|20281626|P2|Overall Study|Not a good demographic match|2
5863902|NCT02033369|20281627|P1|Overall Study|Not a good demographic match|0
5863903|NCT02033369|20281626|P2|Overall Study|Physician Decision|2
5863904|NCT02033369|20281627|P1|Overall Study|Physician Decision|1
5863905|NCT02032901|20281721|P2|Follow-Up Period (24 Weeks)|Lost to Follow-up|1
5863906|NCT02032901|20281722|P1|Follow-Up Period (24 Weeks)|Lost to Follow-up|0
5863907|NCT02032901|20281721|P2|Treatment Period (12 Weeks)|Pregnancy|0
5863908|NCT02032901|20281722|P1|Treatment Period (12 Weeks)|Pregnancy|1
5863909|NCT02032888|20281746|P3|Follow-up Period|Other|0
5863910|NCT02032888|20281747|P2|Follow-up Period|Other|0
5863911|NCT02032888|20281748|P1|Follow-up Period|Other|1
5863912|NCT02032888|20281746|P3|Follow-up Period|Death|0
5863913|NCT02032888|20281747|P2|Follow-up Period|Death|1
5863914|NCT02032888|20281748|P1|Follow-up Period|Death|1
5863915|NCT02032888|20281746|P3|Follow-up Period|Lost to Follow-up|0
5863916|NCT02032888|20281747|P2|Follow-up Period|Lost to Follow-up|1
5863917|NCT02032888|20281748|P1|Follow-up Period|Lost to Follow-up|1
5863918|NCT02032888|20281746|P3|Treatment Period|Other|0
5863919|NCT02032888|20281747|P2|Treatment Period|Other|1
5863920|NCT02032888|20281748|P1|Treatment Period|Other|1
5863921|NCT02032888|20281746|P3|Treatment Period|Poor compliance/noncompliance|0
5863922|NCT02032888|20281747|P2|Treatment Period|Poor compliance/noncompliance|1
5863923|NCT02032888|20281748|P1|Treatment Period|Poor compliance/noncompliance|1
5863924|NCT02032875|20281779|P2|Follow-up Period|Virologic Relapse|10
5863925|NCT02032875|20281780|P1|Follow-up Period|Virologic Relapse|3
5863926|NCT02032875|20281779|P2|Follow-up Period|Death|1
5863927|NCT02032875|20281780|P1|Follow-up Period|Death|0
5863928|NCT02032875|20281779|P2|Treatment Period|Liver transplant, Treatment extension|3
5863929|NCT02032875|20281780|P1|Treatment Period|Liver transplant, Treatment extension|0
5863930|NCT02032875|20281779|P2|Treatment Period|Liver transplant, No extension needed|1
5863931|NCT02032875|20281780|P1|Treatment Period|Liver transplant, No extension needed|0
5863932|NCT02032875|20281779|P2|Treatment Period|Adverse Event|0
5863933|NCT02032875|20281780|P1|Treatment Period|Adverse Event|1
5863934|NCT02032706|20281823|P1|Overall Study|Protocol Violation|1
5863935|NCT02032706|20281823|P1|Overall Study|Did not qualify|5
5863936|NCT02032407|20282006|P1|Overall Study|Other Miscellaneous Reasons|2
5863937|NCT02032407|20282006|P1|Overall Study|Pregnancy|1
5863938|NCT02032407|20282006|P1|Overall Study|Lost to Follow-up|2
5863939|NCT02032238|20282019|P2|Overall Study|Lost to Follow-up|0
5863940|NCT02032238|20282020|P1|Overall Study|Lost to Follow-up|2
5863941|NCT02032173|20282059|P1|Overall Study|Discontinuation due to sponsor decision|31
5863942|NCT02031679|20282081|P2|Overall Study|Lack of Efficacy|1
5863943|NCT02031679|20282082|P1|Overall Study|Lack of Efficacy|0
5863944|NCT02031679|20282081|P2|Overall Study|Protocol Violation|1
5863945|NCT02031679|20282082|P1|Overall Study|Protocol Violation|0
5863946|NCT02031640|20282097|P6|Double-blind Treatment Period|Lost to Follow-up|0
5863947|NCT02031640|20282098|P5|Double-blind Treatment Period|Lost to Follow-up|1
5863948|NCT02031640|20282099|P4|Double-blind Treatment Period|Lost to Follow-up|0
5863949|NCT02031640|20282100|P3|Double-blind Treatment Period|Lost to Follow-up|0
5863950|NCT02031640|20282101|P2|Double-blind Treatment Period|Lost to Follow-up|3
5863951|NCT02031640|20282102|P1|Double-blind Treatment Period|Lost to Follow-up|0
5863952|NCT02031640|20282097|P6|Double-blind Treatment Period|Withdrawal by Subject|1
5863953|NCT02031640|20282098|P5|Double-blind Treatment Period|Withdrawal by Subject|1
5863954|NCT02031640|20282099|P4|Double-blind Treatment Period|Withdrawal by Subject|1
5863955|NCT02031640|20282100|P3|Double-blind Treatment Period|Withdrawal by Subject|3
5863956|NCT02031640|20282101|P2|Double-blind Treatment Period|Withdrawal by Subject|2
5863957|NCT02031640|20282102|P1|Double-blind Treatment Period|Withdrawal by Subject|0
5863958|NCT02031640|20282097|P6|Double-blind Treatment Period|Adverse Event|0
5863959|NCT02031640|20282098|P5|Double-blind Treatment Period|Adverse Event|0
5863960|NCT02031640|20282099|P4|Double-blind Treatment Period|Adverse Event|2
5863961|NCT02031640|20282100|P3|Double-blind Treatment Period|Adverse Event|0
5863962|NCT02031640|20282101|P2|Double-blind Treatment Period|Adverse Event|0
5863963|NCT02031640|20282102|P1|Double-blind Treatment Period|Adverse Event|0
5863964|NCT02031640|20282097|P6|Double-blind Treatment Period|Non-compliance|0
5863965|NCT02031640|20282098|P5|Double-blind Treatment Period|Non-compliance|1
5863966|NCT02031640|20282099|P4|Double-blind Treatment Period|Non-compliance|1
5863967|NCT02031640|20282100|P3|Double-blind Treatment Period|Non-compliance|0
5863968|NCT02031640|20282101|P2|Double-blind Treatment Period|Non-compliance|1
5863969|NCT02031640|20282102|P1|Double-blind Treatment Period|Non-compliance|0
5863970|NCT02031640|20282097|P6|Double-blind Treatment Period|Lack of Efficacy|1
5863971|NCT02031640|20282098|P5|Double-blind Treatment Period|Lack of Efficacy|5
5863972|NCT02031640|20282099|P4|Double-blind Treatment Period|Lack of Efficacy|2
5863973|NCT02031640|20282100|P3|Double-blind Treatment Period|Lack of Efficacy|3
5863974|NCT02031640|20282101|P2|Double-blind Treatment Period|Lack of Efficacy|14
5863975|NCT02031640|20282102|P1|Double-blind Treatment Period|Lack of Efficacy|0
5863976|NCT02031640|20282097|P6|Double-blind Treatment Period|Protocol deviation|1
5863977|NCT02031640|20282098|P5|Double-blind Treatment Period|Protocol deviation|3
5863978|NCT02031640|20282099|P4|Double-blind Treatment Period|Protocol deviation|1
5863979|NCT02031640|20282100|P3|Double-blind Treatment Period|Protocol deviation|0
5863980|NCT02031640|20282101|P2|Double-blind Treatment Period|Protocol deviation|2
5863981|NCT02031640|20282102|P1|Double-blind Treatment Period|Protocol deviation|0
5863982|NCT02031640|20282097|P6|Run-In Period|Various administrative reasons|0
5863983|NCT02031640|20282098|P5|Run-In Period|Various administrative reasons|0
5863984|NCT02031640|20282099|P4|Run-In Period|Various administrative reasons|0
5863985|NCT02031640|20282100|P3|Run-In Period|Various administrative reasons|0
5863986|NCT02031640|20282101|P2|Run-In Period|Various administrative reasons|0
5863987|NCT02031640|20282102|P1|Run-In Period|Various administrative reasons|17
5863988|NCT02031640|20282097|P6|Run-In Period|Randomization criteria not met|0
5863989|NCT02031640|20282098|P5|Run-In Period|Randomization criteria not met|0
5863990|NCT02031640|20282099|P4|Run-In Period|Randomization criteria not met|0
5863991|NCT02031640|20282100|P3|Run-In Period|Randomization criteria not met|0
5863992|NCT02031640|20282101|P2|Run-In Period|Randomization criteria not met|0
5863993|NCT02031640|20282102|P1|Run-In Period|Randomization criteria not met|85
5863994|NCT02031640|20282097|P6|Run-In Period|Exclusion criteria met|0
5863995|NCT02031640|20282098|P5|Run-In Period|Exclusion criteria met|0
5863996|NCT02031640|20282099|P4|Run-In Period|Exclusion criteria met|0
5863997|NCT02031640|20282100|P3|Run-In Period|Exclusion criteria met|0
5863998|NCT02031640|20282101|P2|Run-In Period|Exclusion criteria met|0
5863999|NCT02031640|20282102|P1|Run-In Period|Exclusion criteria met|8
5864000|NCT02031640|20282097|P6|Run-In Period|Inclusion criteria not met|0
5864001|NCT02031640|20282098|P5|Run-In Period|Inclusion criteria not met|0
5864002|NCT02031640|20282099|P4|Run-In Period|Inclusion criteria not met|0
5864003|NCT02031640|20282100|P3|Run-In Period|Inclusion criteria not met|0
5864004|NCT02031640|20282101|P2|Run-In Period|Inclusion criteria not met|0
5864005|NCT02031640|20282102|P1|Run-In Period|Inclusion criteria not met|38
5864006|NCT02031640|20282097|P6|Run-In Period|Withdrawal by Subject|0
5864007|NCT02031640|20282098|P5|Run-In Period|Withdrawal by Subject|0
5864008|NCT02031640|20282099|P4|Run-In Period|Withdrawal by Subject|0
5864009|NCT02031640|20282100|P3|Run-In Period|Withdrawal by Subject|0
5864010|NCT02031640|20282101|P2|Run-In Period|Withdrawal by Subject|0
5864011|NCT02031640|20282102|P1|Run-In Period|Withdrawal by Subject|17
5864012|NCT02031640|20282097|P6|Run-In Period|Adverse Event|0
5864013|NCT02031640|20282098|P5|Run-In Period|Adverse Event|0
5864014|NCT02031640|20282099|P4|Run-In Period|Adverse Event|0
5864015|NCT02031640|20282100|P3|Run-In Period|Adverse Event|0
5864016|NCT02031640|20282101|P2|Run-In Period|Adverse Event|0
5864017|NCT02031640|20282102|P1|Run-In Period|Adverse Event|4
5864018|NCT02031640|20282097|P6|Screening Period|Enrollment closed|0
5864019|NCT02031640|20282098|P5|Screening Period|Enrollment closed|0
5864020|NCT02031640|20282099|P4|Screening Period|Enrollment closed|0
5864021|NCT02031640|20282100|P3|Screening Period|Enrollment closed|0
5864022|NCT02031640|20282101|P2|Screening Period|Enrollment closed|0
5864023|NCT02031640|20282102|P1|Screening Period|Enrollment closed|26
5864024|NCT02031640|20282097|P6|Screening Period|Lost to Follow-up|0
5864025|NCT02031640|20282098|P5|Screening Period|Lost to Follow-up|0
5864026|NCT02031640|20282099|P4|Screening Period|Lost to Follow-up|0
5864027|NCT02031640|20282100|P3|Screening Period|Lost to Follow-up|0
5864028|NCT02031640|20282101|P2|Screening Period|Lost to Follow-up|0
5864029|NCT02031640|20282102|P1|Screening Period|Lost to Follow-up|14
5864030|NCT02031640|20282097|P6|Screening Period|Exclusion criteria met|0
5864031|NCT02031640|20282098|P5|Screening Period|Exclusion criteria met|0
5864032|NCT02031640|20282099|P4|Screening Period|Exclusion criteria met|0
5864033|NCT02031640|20282100|P3|Screening Period|Exclusion criteria met|0
5864034|NCT02031640|20282101|P2|Screening Period|Exclusion criteria met|0
5864035|NCT02031640|20282102|P1|Screening Period|Exclusion criteria met|30
5864036|NCT02031640|20282097|P6|Screening Period|Inclusion criteria not met|0
5864037|NCT02031640|20282098|P5|Screening Period|Inclusion criteria not met|0
5864038|NCT02031640|20282099|P4|Screening Period|Inclusion criteria not met|0
5864039|NCT02031640|20282100|P3|Screening Period|Inclusion criteria not met|0
5864040|NCT02031640|20282101|P2|Screening Period|Inclusion criteria not met|0
5864041|NCT02031640|20282102|P1|Screening Period|Inclusion criteria not met|312
5864042|NCT02031640|20282097|P6|Screening Period|Withdrawal by Subject|0
5864043|NCT02031640|20282098|P5|Screening Period|Withdrawal by Subject|0
5864044|NCT02031640|20282099|P4|Screening Period|Withdrawal by Subject|0
5864045|NCT02031640|20282100|P3|Screening Period|Withdrawal by Subject|0
5864046|NCT02031640|20282101|P2|Screening Period|Withdrawal by Subject|0
5864047|NCT02031640|20282102|P1|Screening Period|Withdrawal by Subject|29
5864048|NCT02031640|20282097|P6|Screening Period|Adverse Event|0
5864049|NCT02031640|20282098|P5|Screening Period|Adverse Event|0
5864050|NCT02031640|20282099|P4|Screening Period|Adverse Event|0
5864051|NCT02031640|20282100|P3|Screening Period|Adverse Event|0
5864052|NCT02031640|20282101|P2|Screening Period|Adverse Event|0
5864053|NCT02031640|20282102|P1|Screening Period|Adverse Event|1
5864054|NCT02031536|20282147|P2|Overall Study|ineligible|0
5864055|NCT02031536|20282148|P1|Overall Study|ineligible|1
5864056|NCT02031471|20282156|P1|Long Term Extension (LTE) Period|Insufficient Therapeutic Response|1
5864057|NCT02031471|20282156|P1|Long Term Extension (LTE) Period|Adverse Event|1
5864058|NCT02031471|20282156|P1|24 Week Treatment Period|Hypersensitivity Reaction|1
5864059|NCT02031471|20282156|P1|24 Week Treatment Period|Insufficient Therapeutic Response|1
5864060|NCT02031471|20282156|P1|24 Week Treatment Period|Protocol Violation|1
5864061|NCT02031471|20282156|P1|24 Week Treatment Period|Participant Decision to Withdraw|2
5864062|NCT02031471|20282156|P1|24 Week Treatment Period|Adverse Event|6
5864063|NCT02031458|20282189|P3|Baseline to May 8, 2015|Lost to Follow-up|2
5864064|NCT02031458|20282190|P2|Baseline to May 8, 2015|Lost to Follow-up|1
5864065|NCT02031458|20282191|P1|Baseline to May 8, 2015|Lost to Follow-up|1
5864066|NCT02031458|20282189|P3|Baseline to May 8, 2015|On Treatment|73
5864067|NCT02031458|20282190|P2|Baseline to May 8, 2015|On Treatment|81
5864068|NCT02031458|20282191|P1|Baseline to May 8, 2015|On Treatment|43
5864069|NCT02031458|20282189|P3|Baseline to May 8, 2015|On Survival Follow-Up|73
5864070|NCT02031458|20282190|P2|Baseline to May 8, 2015|On Survival Follow-Up|83
5864071|NCT02031458|20282191|P1|Baseline to May 8, 2015|On Survival Follow-Up|46
5864072|NCT02031458|20282189|P3|Baseline to May 8, 2015|Withdrawal by Subject|3
5864073|NCT02031458|20282190|P2|Baseline to May 8, 2015|Withdrawal by Subject|9
5864074|NCT02031458|20282191|P1|Baseline to May 8, 2015|Withdrawal by Subject|6
5864075|NCT02031458|20282189|P3|Baseline to May 8, 2015|Unknown Reason|2
5864076|NCT02031458|20282190|P2|Baseline to May 8, 2015|Unknown Reason|1
5864077|NCT02031458|20282191|P1|Baseline to May 8, 2015|Unknown Reason|0
5864078|NCT02031458|20282189|P3|Baseline to May 8, 2015|Physician Decision|0
5864079|NCT02031458|20282190|P2|Baseline to May 8, 2015|Physician Decision|1
5864080|NCT02031458|20282191|P1|Baseline to May 8, 2015|Physician Decision|0
5864081|NCT02031458|20282189|P3|Baseline to May 8, 2015|Protocol Violation|0
5864082|NCT02031458|20282190|P2|Baseline to May 8, 2015|Protocol Violation|4
5864083|NCT02031458|20282191|P1|Baseline to May 8, 2015|Protocol Violation|7
5864084|NCT02031458|20282189|P3|Baseline to May 8, 2015|Death|100
5864085|NCT02031458|20282190|P2|Baseline to May 8, 2015|Death|87
5864086|NCT02031458|20282191|P1|Baseline to May 8, 2015|Death|36
5864087|NCT02031458|20282189|P3|May 8, 2015 to January 11, 2019|Withdrawal by Subject|14
5864088|NCT02031458|20282190|P2|May 8, 2015 to January 11, 2019|Withdrawal by Subject|16
5864089|NCT02031458|20282191|P1|May 8, 2015 to January 11, 2019|Withdrawal by Subject|13
5864090|NCT02031458|20282189|P3|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|23
5864091|NCT02031458|20282190|P2|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|42
5864092|NCT02031458|20282191|P1|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|24
5864093|NCT02031458|20282189|P3|May 8, 2015 to January 11, 2019|Protocol Violation|0
5864094|NCT02031458|20282190|P2|May 8, 2015 to January 11, 2019|Protocol Violation|4
5864095|NCT02031458|20282191|P1|May 8, 2015 to January 11, 2019|Protocol Violation|7
5864096|NCT02031458|20282189|P3|May 8, 2015 to January 11, 2019|Physician Decision|3
5864097|NCT02031458|20282190|P2|May 8, 2015 to January 11, 2019|Physician Decision|3
5864098|NCT02031458|20282191|P1|May 8, 2015 to January 11, 2019|Physician Decision|2
5864099|NCT02031458|20282189|P3|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6
5864100|NCT02031458|20282190|P2|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6
5864101|NCT02031458|20282191|P1|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|1
5864102|NCT02031458|20282189|P3|May 8, 2015 to January 11, 2019|Lost to Follow-up|8
5864103|NCT02031458|20282190|P2|May 8, 2015 to January 11, 2019|Lost to Follow-up|5
5864104|NCT02031458|20282191|P1|May 8, 2015 to January 11, 2019|Lost to Follow-up|2
5864105|NCT02031458|20282189|P3|May 8, 2015 to January 11, 2019|Death|198
5864106|NCT02031458|20282190|P2|May 8, 2015 to January 11, 2019|Death|193
5864107|NCT02031458|20282191|P1|May 8, 2015 to January 11, 2019|Death|89
5864108|NCT02031432|20282285|P1|Overall Study|Death|10
5864109|NCT02031432|20282285|P1|Overall Study|Inclusion/Exclusion criteria not met|5
5864110|NCT02031432|20282285|P1|Overall Study|Lost to Follow-up|1
5864111|NCT02031432|20282285|P1|Overall Study|Withdrawal by Subject|5
5864112|NCT02031432|20282285|P1|Overall Study|Adverse Event|8
5864113|NCT02031432|20282285|P1|Overall Study|Withdrawn as forbidden meds required|1
5864114|NCT02031432|20282285|P1|Overall Study|Cancer Progression|2
5864115|NCT02031432|20282285|P1|Overall Study|Lack of Efficacy|5
5864116|NCT02031432|20282285|P1|Overall Study|Protocol Violation|1
5864117|NCT02031302|20282312|P2|Overall Study|Lost to Follow-up|0
5864118|NCT02031302|20282313|P1|Overall Study|Lost to Follow-up|4
5864119|NCT02031302|20282312|P2|Overall Study|Missed Follow Up|0
5864120|NCT02031302|20282313|P1|Overall Study|Missed Follow Up|27
5864121|NCT02031302|20282312|P2|Overall Study|Not treated with study valve system|0
5864122|NCT02031302|20282313|P1|Overall Study|Not treated with study valve system|18
5864123|NCT02031302|20282312|P2|Overall Study|Death|0
5864124|NCT02031302|20282313|P1|Overall Study|Death|115
5864125|NCT02031276|20282334|P3|Period 3 Open-label Risankizumab SC|Other|1
5864126|NCT02031276|20282335|P2|Period 3 Open-label Risankizumab SC|Other|0
5864127|NCT02031276|20282336|P1|Period 3 Open-label Risankizumab SC|Other|0
5864128|NCT02031276|20282334|P3|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1
5864129|NCT02031276|20282335|P2|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1
5864130|NCT02031276|20282336|P1|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1
5864131|NCT02031276|20282334|P3|Period 3 Open-label Risankizumab SC|Protocol Violation|0
5864132|NCT02031276|20282335|P2|Period 3 Open-label Risankizumab SC|Protocol Violation|0
5864133|NCT02031276|20282336|P1|Period 3 Open-label Risankizumab SC|Protocol Violation|2
5864134|NCT02031276|20282334|P3|Period 3 Open-label Risankizumab SC|Adverse Event|0
5864135|NCT02031276|20282335|P2|Period 3 Open-label Risankizumab SC|Adverse Event|2
5864136|NCT02031276|20282336|P1|Period 3 Open-label Risankizumab SC|Adverse Event|0
5864137|NCT02031276|20282334|P3|Period 2 Open-label Risankizumab IV|Other|1
5864138|NCT02031276|20282335|P2|Period 2 Open-label Risankizumab IV|Other|2
5864139|NCT02031276|20282336|P1|Period 2 Open-label Risankizumab IV|Other|0
5864140|NCT02031276|20282334|P3|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0
5864141|NCT02031276|20282335|P2|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0
5864142|NCT02031276|20282336|P1|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|3
5864143|NCT02031276|20282334|P3|Period 2 Open-label Risankizumab IV|Adverse Event|0
5864144|NCT02031276|20282335|P2|Period 2 Open-label Risankizumab IV|Adverse Event|0
5864145|NCT02031276|20282336|P1|Period 2 Open-label Risankizumab IV|Adverse Event|1
5864146|NCT02031276|20282334|P3|Period 1 Double-blind IV|Other|0
5864147|NCT02031276|20282335|P2|Period 1 Double-blind IV|Other|1
5864148|NCT02031276|20282336|P1|Period 1 Double-blind IV|Other|0
5864149|NCT02031276|20282334|P3|Period 1 Double-blind IV|Adverse Event|1
5864150|NCT02031276|20282335|P2|Period 1 Double-blind IV|Adverse Event|5
5864151|NCT02031276|20282336|P1|Period 1 Double-blind IV|Adverse Event|6
5864152|NCT02031237|20282370|P3|Overall Study|Alternate Treatment Given|3
5864153|NCT02031237|20282371|P2|Overall Study|Alternate Treatment Given|0
5864154|NCT02031237|20282372|P1|Overall Study|Alternate Treatment Given|0
5864155|NCT02031237|20282370|P3|Overall Study|Protocol Violation|0
5864156|NCT02031237|20282371|P2|Overall Study|Protocol Violation|6
5864157|NCT02031237|20282372|P1|Overall Study|Protocol Violation|2
5864158|NCT02031237|20282370|P3|Overall Study|Withdrawal by Subject|0
5864159|NCT02031237|20282371|P2|Overall Study|Withdrawal by Subject|2
5864160|NCT02031237|20282372|P1|Overall Study|Withdrawal by Subject|2
5864161|NCT02031237|20282370|P3|Overall Study|Physician Decision|0
5864162|NCT02031237|20282371|P2|Overall Study|Physician Decision|1
5864163|NCT02031237|20282372|P1|Overall Study|Physician Decision|0
5864164|NCT02031237|20282370|P3|Overall Study|Death|0
5864165|NCT02031237|20282371|P2|Overall Study|Death|5
5864166|NCT02031237|20282372|P1|Overall Study|Death|1
5864167|NCT02030847|20282392|P1|Overall Study|Withdrawal by Subject|1
5864168|NCT02030847|20282392|P1|Overall Study|Physician Decision|3
5864169|NCT02030847|20282392|P1|Overall Study|New Cancer Therapy|8
5864170|NCT02030847|20282392|P1|Overall Study|Disease Progression|15
5864171|NCT02030847|20282392|P1|Overall Study|Death|10
5864172|NCT02030834|20282400|P3|Overall Study|Lack of funding|0
5864173|NCT02030834|20282401|P2|Overall Study|Lack of funding|0
5864174|NCT02030834|20282402|P1|Overall Study|Lack of funding|1
5864175|NCT02030834|20282400|P3|Overall Study|Withdrawal by Subject|0
5864176|NCT02030834|20282401|P2|Overall Study|Withdrawal by Subject|0
5864177|NCT02030834|20282402|P1|Overall Study|Withdrawal by Subject|1
5864178|NCT02030834|20282400|P3|Overall Study|Lost to Follow-up|0
5864179|NCT02030834|20282401|P2|Overall Study|Lost to Follow-up|0
5864180|NCT02030834|20282402|P1|Overall Study|Lost to Follow-up|1
5864181|NCT02030834|20282400|P3|Overall Study|Disease progression|2
5864182|NCT02030834|20282401|P2|Overall Study|Disease progression|0
5864183|NCT02030834|20282402|P1|Overall Study|Disease progression|2
5864184|NCT02030834|20282400|P3|Overall Study|Manufacturing failure|1
5864185|NCT02030834|20282401|P2|Overall Study|Manufacturing failure|0
5864186|NCT02030834|20282402|P1|Overall Study|Manufacturing failure|2
5864187|NCT02030834|20282400|P3|Overall Study|Death|0
5864188|NCT02030834|20282401|P2|Overall Study|Death|0
5864189|NCT02030834|20282402|P1|Overall Study|Death|4
5864190|NCT02030821|20282414|P4|Overall Study|Physician Decision|2
5864191|NCT02030821|20282415|P3|Overall Study|Physician Decision|5
5864192|NCT02030821|20282416|P2|Overall Study|Physician Decision|2
5864193|NCT02030821|20282417|P1|Overall Study|Physician Decision|2
5864194|NCT02030600|20282445|P2|Treatment Period 2|Unclassified|0
5864195|NCT02030600|20282446|P1|Treatment Period 2|Unclassified|1
5864196|NCT02030600|20282445|P2|Treatment Period 2|Withdrawal by Subject|9
5864197|NCT02030600|20282446|P1|Treatment Period 2|Withdrawal by Subject|13
5864198|NCT02030600|20282445|P2|Treatment Period 2|Protocol Violation|2
5864199|NCT02030600|20282446|P1|Treatment Period 2|Protocol Violation|1
5864200|NCT02030600|20282445|P2|Treatment Period 2|Lost to Follow-up|2
5864201|NCT02030600|20282446|P1|Treatment Period 2|Lost to Follow-up|4
5864202|NCT02030600|20282445|P2|Treatment Period 2|Lack of Efficacy|1
5864203|NCT02030600|20282446|P1|Treatment Period 2|Lack of Efficacy|2
5864204|NCT02030600|20282445|P2|Treatment Period 2|Adverse Event|4
5864205|NCT02030600|20282446|P1|Treatment Period 2|Adverse Event|4
5864206|NCT02030600|20282445|P2|Treatment Period 1|Unclassified|0
5864207|NCT02030600|20282446|P1|Treatment Period 1|Unclassified|1
5864208|NCT02030600|20282445|P2|Treatment Period 1|Casebook Unsigned|0
5864209|NCT02030600|20282446|P1|Treatment Period 1|Casebook Unsigned|1
5864210|NCT02030600|20282445|P2|Treatment Period 1|Withdrawal by Subject|17
5864211|NCT02030600|20282446|P1|Treatment Period 1|Withdrawal by Subject|13
5864212|NCT02030600|20282445|P2|Treatment Period 1|Protocol Violation|17
5864213|NCT02030600|20282446|P1|Treatment Period 1|Protocol Violation|22
5864214|NCT02030600|20282445|P2|Treatment Period 1|Lost to Follow-up|3
5864215|NCT02030600|20282446|P1|Treatment Period 1|Lost to Follow-up|11
5864216|NCT02030600|20282445|P2|Treatment Period 1|Lack of Efficacy|1
5864217|NCT02030600|20282446|P1|Treatment Period 1|Lack of Efficacy|0
5864218|NCT02030600|20282445|P2|Treatment Period 1|Adverse Event|7
5864219|NCT02030600|20282446|P1|Treatment Period 1|Adverse Event|5
5864220|NCT02030535|20282467|P1|Washout Period 1 (21 Days)|Adverse Event|1
5864221|NCT02030405|20282535|P1|Overall Study|Lost to Follow-up|1
5864222|NCT02030405|20282535|P1|Overall Study|Withdrawal by Subject|1
5864223|NCT02030119|20282561|P4|Overall Study|Ineligible (see Pre-assignment Details)|0
5864224|NCT02030119|20282562|P3|Overall Study|Ineligible (see Pre-assignment Details)|1
5864225|NCT02030119|20282563|P2|Overall Study|Ineligible (see Pre-assignment Details)|1
5864226|NCT02030119|20282564|P1|Overall Study|Ineligible (see Pre-assignment Details)|0
5864227|NCT02030119|20282561|P4|Overall Study|Withdrawal by Subject|3
5864228|NCT02030119|20282562|P3|Overall Study|Withdrawal by Subject|5
5864229|NCT02030119|20282563|P2|Overall Study|Withdrawal by Subject|1
5864230|NCT02030119|20282564|P1|Overall Study|Withdrawal by Subject|3
5864231|NCT02030041|20282602|P3|Overall Study|Withdrawal by Subject|1
5864232|NCT02030041|20282603|P2|Overall Study|Withdrawal by Subject|2
5864233|NCT02030041|20282604|P1|Overall Study|Withdrawal by Subject|2
5864234|NCT02030002|20282615|P1|Follow-up|Lost to Follow-up|2
5864235|NCT02030002|20282615|P1|Enrollment|Participants signed consent, but enrollment was completed before their treatment began.|4
5864236|NCT02030002|20282615|P1|Enrollment|Participant had change in treatment plan and no longer met the inclusion criteria|1
5864237|NCT02029989|20282629|P2|Overall Study|Protocol Violation|0
5864238|NCT02029989|20282630|P1|Overall Study|Protocol Violation|1
5864239|NCT02029989|20282629|P2|Overall Study|Death|1
5864240|NCT02029989|20282630|P1|Overall Study|Death|0
5864241|NCT02029989|20282629|P2|Overall Study|Lost to Follow-up|7
5864242|NCT02029989|20282630|P1|Overall Study|Lost to Follow-up|9
5864243|NCT02029989|20282629|P2|Overall Study|Physician Decision|0
5864244|NCT02029989|20282630|P1|Overall Study|Physician Decision|2
5864245|NCT02029989|20282629|P2|Overall Study|Change of location|3
5864246|NCT02029989|20282630|P1|Overall Study|Change of location|2
5864247|NCT02029989|20282629|P2|Overall Study|Withdrawal: Fear of needles|0
5864248|NCT02029989|20282630|P1|Overall Study|Withdrawal: Fear of needles|1
5864249|NCT02029989|20282629|P2|Overall Study|Withdrawal by Subject|0
5864250|NCT02029989|20282630|P1|Overall Study|Withdrawal by Subject|1
5864251|NCT02029976|20282638|P2|YR-2 Follow Up vs Baseline|Moved from area|2
5864252|NCT02029976|20282639|P1|YR-2 Follow Up vs Baseline|Moved from area|0
5864253|NCT02029976|20282638|P2|YR-2 Follow Up vs Baseline|Withdrawal by Subject|2
5864254|NCT02029976|20282639|P1|YR-2 Follow Up vs Baseline|Withdrawal by Subject|2
5864255|NCT02029976|20282638|P2|YR-2 Follow Up vs Baseline|Lost to Follow-up|4
5864256|NCT02029976|20282639|P1|YR-2 Follow Up vs Baseline|Lost to Follow-up|8
5864257|NCT02029976|20282638|P2|YR-1 Post Intervention vs Baseline|Lost to Follow-up|8
5864258|NCT02029976|20282639|P1|YR-1 Post Intervention vs Baseline|Lost to Follow-up|12
5864259|NCT02029846|20282668|P2|Overall Study|n=1 each arm|1
5864260|NCT02029846|20282669|P1|Overall Study|n=1 each arm|1
5864261|NCT02029638|20282707|P3|Overall Study|Decision by Study Sponsor or Regulatory|0
5864262|NCT02029638|20282708|P2|Overall Study|Decision by Study Sponsor or Regulatory|0
5864263|NCT02029638|20282709|P1|Overall Study|Decision by Study Sponsor or Regulatory|2
5864264|NCT02029638|20282707|P3|Overall Study|Death|1
5864265|NCT02029638|20282708|P2|Overall Study|Death|0
5864266|NCT02029638|20282709|P1|Overall Study|Death|0
5864267|NCT02029521|20282738|P2|Overall Study|Withdrawal by Subject|1
5864268|NCT02029521|20282739|P1|Overall Study|Withdrawal by Subject|1
5864269|NCT02029521|20282738|P2|Overall Study|Protocol Violation|0
5864270|NCT02029521|20282739|P1|Overall Study|Protocol Violation|1
5864271|NCT02029417|20282837|P1|Overall Study|Adverse Event|1
5864272|NCT02029417|20282837|P1|Overall Study|Death|1
5864273|NCT02029274|20282846|P4|Overall Study|Adverse Event|2
5864274|NCT02029274|20282847|P3|Overall Study|Adverse Event|2
5864275|NCT02029274|20282848|P2|Overall Study|Adverse Event|0
5864276|NCT02029274|20282849|P1|Overall Study|Adverse Event|1
5864277|NCT02029235|20282881|P2|Overall Study|Non-compliance with study meds or diary|1
5864278|NCT02029235|20282882|P1|Overall Study|Non-compliance with study meds or diary|4
5864279|NCT02028884|20282914|P2|Open-label Extension Period|On-going in Study|14
5864280|NCT02028884|20282915|P1|Open-label Extension Period|On-going in Study|19
5864281|NCT02028884|20282914|P2|Open-label Extension Period|Withdrawal by Subject|2
5864282|NCT02028884|20282915|P1|Open-label Extension Period|Withdrawal by Subject|0
5864283|NCT02028884|20282914|P2|Open-label Extension Period|Non-Compliance With Study Drug|1
5864284|NCT02028884|20282915|P1|Open-label Extension Period|Non-Compliance With Study Drug|0
5864285|NCT02028884|20282914|P2|Open-label Extension Period|Lack of Efficacy|0
5864286|NCT02028884|20282915|P1|Open-label Extension Period|Lack of Efficacy|3
5864287|NCT02028884|20282914|P2|Open-label Extension Period|Adverse Event|1
5864288|NCT02028884|20282915|P1|Open-label Extension Period|Adverse Event|2
5864289|NCT02028884|20282914|P2|Double-blind Period|On-going in Study|20
5864290|NCT02028884|20282915|P1|Double-blind Period|On-going in Study|8
5864291|NCT02028884|20282914|P2|Double-blind Period|Withdrawal by Subject|0
5864292|NCT02028884|20282915|P1|Double-blind Period|Withdrawal by Subject|2
5864293|NCT02028884|20282914|P2|Double-blind Period|Non-Compliance With Study Drug|0
5864294|NCT02028884|20282915|P1|Double-blind Period|Non-Compliance With Study Drug|2
5864295|NCT02028884|20282914|P2|Double-blind Period|Eligibility Violation|0
5864296|NCT02028884|20282915|P1|Double-blind Period|Eligibility Violation|1
5864297|NCT02028884|20282914|P2|Double-blind Period|Adverse Event|3
5864298|NCT02028884|20282915|P1|Double-blind Period|Adverse Event|5
5864299|NCT02028871|20282985|P2|Overall Study|Current Illness|0
5864300|NCT02028871|20282986|P1|Overall Study|Current Illness|1
5864301|NCT02028871|20282985|P2|Overall Study|IV placement difficulty|0
5864302|NCT02028871|20282986|P1|Overall Study|IV placement difficulty|1
5864303|NCT02028871|20282985|P2|Overall Study|Withdrawal by Subject|2
5864304|NCT02028871|20282986|P1|Overall Study|Withdrawal by Subject|1
5864305|NCT02028871|20282985|P2|Overall Study|Positive urine drug screen|1
5864306|NCT02028871|20282986|P1|Overall Study|Positive urine drug screen|1
5864307|NCT02028767|20283083|P2|Treatment Period 2|Reason other than those specified above|0
5864308|NCT02028767|20283084|P1|Treatment Period 2|Reason other than those specified above|1
5864309|NCT02028767|20283083|P2|Treatment Period 2|Non compliant with protocol|0
5864310|NCT02028767|20283084|P1|Treatment Period 2|Non compliant with protocol|1
5864311|NCT02028715|20283117|P2|Overall Study|Did not complete satisfaction surveys|2
5864312|NCT02028715|20283118|P1|Overall Study|Did not complete satisfaction surveys|2
5864313|NCT02028715|20283117|P2|Overall Study|Physician Decision|0
5864314|NCT02028715|20283118|P1|Overall Study|Physician Decision|1
5864315|NCT02028715|20283117|P2|Overall Study|Adverse Event|2
5864316|NCT02028715|20283118|P1|Overall Study|Adverse Event|2
5864317|NCT02028182|20283346|P1|Overall Study|Protocol Violation|2
5864318|NCT02028169|20283352|P1|Overall Study|Concomitant Medication Usage|1
5864319|NCT02028169|20283352|P1|Overall Study|Cessation of Drug|1
5864320|NCT02028169|20283352|P1|Overall Study|Adverse Event|1
5864321|NCT02028169|20283352|P1|Overall Study|Withdrawal by Subject|2
5864322|NCT02028169|20283352|P1|Overall Study|Lack of Efficacy|2
5864323|NCT02028169|20283352|P1|Overall Study|Lost to Follow-up|21
5864324|NCT02028065|20283378|P3|Treatment Through Study Completion|Adverse Event|5
5864325|NCT02028065|20283379|P2|Treatment Through Study Completion|Adverse Event|3
5864326|NCT02028065|20283380|P1|Treatment Through Study Completion|Adverse Event|3
5864327|NCT02028065|20283378|P3|Treatment Through Study Completion|Withdrawal by Subject|3
5864328|NCT02028065|20283379|P2|Treatment Through Study Completion|Withdrawal by Subject|4
5864329|NCT02028065|20283380|P1|Treatment Through Study Completion|Withdrawal by Subject|5
5864330|NCT02028065|20283378|P3|Treatment Through Study Completion|Protocol Violation|0
5864331|NCT02028065|20283379|P2|Treatment Through Study Completion|Protocol Violation|4
5864332|NCT02028065|20283380|P1|Treatment Through Study Completion|Protocol Violation|1
5864333|NCT02028065|20283378|P3|Treatment Through Study Completion|Physician Decision|0
5864334|NCT02028065|20283379|P2|Treatment Through Study Completion|Physician Decision|0
5864335|NCT02028065|20283380|P1|Treatment Through Study Completion|Physician Decision|1
5864336|NCT02028065|20283378|P3|Treatment Through Study Completion|Lost to Follow-up|6
5864337|NCT02028065|20283379|P2|Treatment Through Study Completion|Lost to Follow-up|4
5864338|NCT02028065|20283380|P1|Treatment Through Study Completion|Lost to Follow-up|2
5864339|NCT02028065|20283378|P3|Randomization Through Start Treatment|Not treated|3
5864340|NCT02028065|20283379|P2|Randomization Through Start Treatment|Not treated|3
5864341|NCT02028065|20283380|P1|Randomization Through Start Treatment|Not treated|1
5864342|NCT02027844|20283407|P3|Overall Study|Incomlete data|0
5864343|NCT02027844|20283408|P2|Overall Study|Incomlete data|0
5864344|NCT02027844|20283409|P1|Overall Study|Incomlete data|2
5864345|NCT02027844|20283407|P3|Overall Study|Protocol Violation|0
5864346|NCT02027844|20283408|P2|Overall Study|Protocol Violation|2
5864347|NCT02027844|20283409|P1|Overall Study|Protocol Violation|0
5864348|NCT02027844|20283407|P3|Overall Study|Lost to Follow-up|1
5864349|NCT02027844|20283408|P2|Overall Study|Lost to Follow-up|2
5864350|NCT02027844|20283409|P1|Overall Study|Lost to Follow-up|0
5864351|NCT02027844|20283407|P3|Overall Study|Withdrawal by Subject|1
5864352|NCT02027844|20283408|P2|Overall Study|Withdrawal by Subject|2
5864353|NCT02027844|20283409|P1|Overall Study|Withdrawal by Subject|3
5864354|NCT02027701|20283426|P1|Overall Study|Withdrawal by Subject|3
5864355|NCT02027701|20283426|P1|Overall Study|Physician Decision|2
5864356|NCT02027701|20283426|P1|Overall Study|Lack of Efficacy|8
5864357|NCT02027701|20283426|P1|Overall Study|Adverse Event|3
5864358|NCT02027623|20283444|P2|Overall Study|Withdrawal by Subject|9
5864359|NCT02027623|20283445|P1|Overall Study|Withdrawal by Subject|6
5864360|NCT02027623|20283444|P2|Overall Study|Lost to Follow-up|3
5864361|NCT02027623|20283445|P1|Overall Study|Lost to Follow-up|3
5864362|NCT02027558|20283541|P2|Overall Study|Refused assessment|0
5864363|NCT02027558|20283542|P1|Overall Study|Refused assessment|3
5864364|NCT02027558|20283541|P2|Overall Study|Lost to Follow-up|1
5864365|NCT02027558|20283542|P1|Overall Study|Lost to Follow-up|4
5864366|NCT02027558|20283541|P2|Overall Study|Withdrawal by Subject|0
5864367|NCT02027558|20283542|P1|Overall Study|Withdrawal by Subject|2
5864368|NCT02027558|20283541|P2|Overall Study|Death|1
5864369|NCT02027558|20283542|P1|Overall Study|Death|0
5864370|NCT02027545|20283560|P2|Overall Study|Failed to attend study visit|0
5864371|NCT02027545|20283561|P1|Overall Study|Failed to attend study visit|2
5864372|NCT02027545|20283560|P2|Overall Study|Failed to sign HIPAA|2
5864373|NCT02027545|20283561|P1|Overall Study|Failed to sign HIPAA|0
5864374|NCT02027428|20283573|P3|Survival Follow-up|Lost to Follow-up|1
5864375|NCT02027428|20283574|P2|Survival Follow-up|Lost to Follow-up|1
5864376|NCT02027428|20283575|P1|Survival Follow-up|Lost to Follow-up|0
5864377|NCT02027428|20283573|P3|Survival Follow-up|Death|45
5864378|NCT02027428|20283574|P2|Survival Follow-up|Death|78
5864379|NCT02027428|20283575|P1|Survival Follow-up|Death|0
5864380|NCT02027428|20283573|P3|Maintenance|Other|3
5864381|NCT02027428|20283574|P2|Maintenance|Other|6
5864382|NCT02027428|20283575|P1|Maintenance|Other|0
5864383|NCT02027428|20283573|P3|Maintenance|Protocol Violation|1
5864384|NCT02027428|20283574|P2|Maintenance|Protocol Violation|0
5864385|NCT02027428|20283575|P1|Maintenance|Protocol Violation|0
5864386|NCT02027428|20283573|P3|Maintenance|Withdrawal by Subject|5
5864387|NCT02027428|20283574|P2|Maintenance|Withdrawal by Subject|6
5864388|NCT02027428|20283575|P1|Maintenance|Withdrawal by Subject|0
5864389|NCT02027428|20283573|P3|Maintenance|Symptomatic deterioration|1
5864390|NCT02027428|20283574|P2|Maintenance|Symptomatic deterioration|4
5864391|NCT02027428|20283575|P1|Maintenance|Symptomatic deterioration|0
5864392|NCT02027428|20283573|P3|Maintenance|Progressive disease|47
5864393|NCT02027428|20283574|P2|Maintenance|Progressive disease|84
5864394|NCT02027428|20283575|P1|Maintenance|Progressive disease|0
5864395|NCT02027428|20283573|P3|Maintenance|Adverse Event|1
5864396|NCT02027428|20283574|P2|Maintenance|Adverse Event|21
5864397|NCT02027428|20283575|P1|Maintenance|Adverse Event|0
5864398|NCT02027428|20283573|P3|Maintenance|Death|2
5864399|NCT02027428|20283574|P2|Maintenance|Death|3
5864400|NCT02027428|20283575|P1|Maintenance|Death|0
5864401|NCT02027428|20283573|P3|Induction|Induction Treatment Ongoing|0
5864402|NCT02027428|20283574|P2|Induction|Induction Treatment Ongoing|0
5864403|NCT02027428|20283575|P1|Induction|Induction Treatment Ongoing|4
5864404|NCT02027428|20283573|P3|Induction|Miscellaneous|0
5864405|NCT02027428|20283574|P2|Induction|Miscellaneous|0
5864406|NCT02027428|20283575|P1|Induction|Miscellaneous|14
5864407|NCT02027428|20283573|P3|Induction|Protocol Violation|0
5864408|NCT02027428|20283574|P2|Induction|Protocol Violation|0
5864409|NCT02027428|20283575|P1|Induction|Protocol Violation|1
5864410|NCT02027428|20283573|P3|Induction|Study terminated by sponsor|0
5864411|NCT02027428|20283574|P2|Induction|Study terminated by sponsor|0
5864412|NCT02027428|20283575|P1|Induction|Study terminated by sponsor|12
5864413|NCT02027428|20283573|P3|Induction|Symptomatic deterioration|0
5864414|NCT02027428|20283574|P2|Induction|Symptomatic deterioration|0
5864415|NCT02027428|20283575|P1|Induction|Symptomatic deterioration|16
5864416|NCT02027428|20283573|P3|Induction|Death|0
5864417|NCT02027428|20283574|P2|Induction|Death|0
5864418|NCT02027428|20283575|P1|Induction|Death|21
5864419|NCT02027428|20283573|P3|Induction|Withdrawal by Subject|0
5864420|NCT02027428|20283574|P2|Induction|Withdrawal by Subject|0
5864421|NCT02027428|20283575|P1|Induction|Withdrawal by Subject|22
5864422|NCT02027428|20283573|P3|Induction|Adverse Event|0
5864423|NCT02027428|20283574|P2|Induction|Adverse Event|0
5864424|NCT02027428|20283575|P1|Induction|Adverse Event|51
5864425|NCT02027428|20283573|P3|Induction|Progressive disease|0
5864426|NCT02027428|20283574|P2|Induction|Progressive disease|0
5864427|NCT02027428|20283575|P1|Induction|Progressive disease|77
5864428|NCT02027428|20283573|P3|Induction|Never treated|0
5864429|NCT02027428|20283574|P2|Induction|Never treated|0
5864430|NCT02027428|20283575|P1|Induction|Never treated|7
5864431|NCT02027402|20283613|P2|Overall Study|Withdrawal by Subject|1
5864432|NCT02027402|20283614|P1|Overall Study|Withdrawal by Subject|4
5864433|NCT02027376|20283626|P3|Overall Study|Death|0
5864434|NCT02027376|20283627|P2|Overall Study|Death|0
5864435|NCT02027376|20283628|P1|Overall Study|Death|1
5864436|NCT02027311|20283654|P2|Overall Study|Protocol Violation|2
5864437|NCT02027311|20283655|P1|Overall Study|Protocol Violation|3
5864438|NCT02027025|20283675|P3|Overall Study|Sponsor's decision|0
5864439|NCT02027025|20283676|P2|Overall Study|Sponsor's decision|1
5864440|NCT02027025|20283677|P1|Overall Study|Sponsor's decision|0
5864441|NCT02027025|20283675|P3|Overall Study|Withdrawal by Subject|0
5864442|NCT02027025|20283676|P2|Overall Study|Withdrawal by Subject|1
5864443|NCT02027025|20283677|P1|Overall Study|Withdrawal by Subject|0
5864444|NCT02027025|20283675|P3|Overall Study|Lost to Follow-up|0
5864445|NCT02027025|20283676|P2|Overall Study|Lost to Follow-up|2
5864446|NCT02027025|20283677|P1|Overall Study|Lost to Follow-up|0
5864447|NCT02027025|20283675|P3|Overall Study|Protocol Violation|0
5864448|NCT02027025|20283676|P2|Overall Study|Protocol Violation|0
5864449|NCT02027025|20283677|P1|Overall Study|Protocol Violation|1
5864450|NCT02027025|20283675|P3|Overall Study|Adverse Event|1
5864451|NCT02027025|20283676|P2|Overall Study|Adverse Event|1
5864452|NCT02027025|20283677|P1|Overall Study|Adverse Event|0
5864453|NCT02026258|20283740|P2|Recieved Allocated Intervention|Lost to Follow-up|1
5864454|NCT02026258|20283741|P1|Recieved Allocated Intervention|Lost to Follow-up|0
5864455|NCT02026258|20283740|P2|Recieved Allocated Intervention|Withdrawal by Subject|1
5864456|NCT02026258|20283741|P1|Recieved Allocated Intervention|Withdrawal by Subject|1
5864457|NCT02026258|20283740|P2|Randomized|Presence of periodontal disease|1
5864458|NCT02026258|20283741|P1|Randomized|Presence of periodontal disease|1
5864459|NCT02026258|20283740|P2|Randomized|Change in treatment plan|0
5864460|NCT02026258|20283741|P1|Randomized|Change in treatment plan|1
5864461|NCT02026258|20283740|P2|Randomized|Did not start treatment|1
5864462|NCT02026258|20283741|P1|Randomized|Did not start treatment|2
5864463|NCT02026141|20283775|P2|Overall Study|Protocol Violation|1
5864464|NCT02026141|20283776|P1|Overall Study|Protocol Violation|0
5864465|NCT02026063|20283784|P2|Overall Study|Reason not Specified|7
5864466|NCT02026063|20283785|P1|Overall Study|Reason not Specified|2
5864467|NCT02026063|20283784|P2|Overall Study|Lost to Follow-up|1
5864468|NCT02026063|20283785|P1|Overall Study|Lost to Follow-up|0
5864469|NCT02026063|20283784|P2|Overall Study|Lack of Efficacy|4
5864470|NCT02026063|20283785|P1|Overall Study|Lack of Efficacy|0
5864471|NCT02026063|20283784|P2|Overall Study|Adverse Event|20
5864472|NCT02026063|20283785|P1|Overall Study|Adverse Event|5
5864473|NCT02026063|20283784|P2|Overall Study|Withdrawal of Consent|6
5864474|NCT02026063|20283785|P1|Overall Study|Withdrawal of Consent|1
5864475|NCT02026063|20283784|P2|Overall Study|Noncompliance with Study Drug|1
5864476|NCT02026063|20283785|P1|Overall Study|Noncompliance with Study Drug|1
5864477|NCT02026063|20283784|P2|Overall Study|Physician Decision|10
5864478|NCT02026063|20283785|P1|Overall Study|Physician Decision|0
5864479|NCT02026011|20283797|P2|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|2
5864480|NCT02026011|20283798|P1|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|1
5864481|NCT02026011|20283797|P2|Allocation 1 (First Set of Medication)|Investigator Withdrawal|0
5864482|NCT02026011|20283798|P1|Allocation 1 (First Set of Medication)|Investigator Withdrawal|1
5864483|NCT02026011|20283797|P2|Allocation 1 (First Set of Medication)|Withdrawal by Subject|2
5864484|NCT02026011|20283798|P1|Allocation 1 (First Set of Medication)|Withdrawal by Subject|1
5864485|NCT02026011|20283797|P2|Allocation 1 (First Set of Medication)|Side Effects|0
5864486|NCT02026011|20283798|P1|Allocation 1 (First Set of Medication)|Side Effects|6
5864487|NCT02025907|20283824|P2|Overall Study|Potential misconduct,GCPcompliance issue|1
5864488|NCT02025907|20283825|P1|Overall Study|Potential misconduct,GCPcompliance issue|2
5864489|NCT02025907|20283824|P2|Overall Study|Adverse Event|1
5864490|NCT02025907|20283825|P1|Overall Study|Adverse Event|3
5864491|NCT02025907|20283824|P2|Overall Study|Lost to Follow-up|2
5864492|NCT02025907|20283825|P1|Overall Study|Lost to Follow-up|2
5864493|NCT02025907|20283824|P2|Overall Study|Physician Decision|0
5864494|NCT02025907|20283825|P1|Overall Study|Physician Decision|2
5864495|NCT02025907|20283824|P2|Overall Study|Protocol Violation|0
5864496|NCT02025907|20283825|P1|Overall Study|Protocol Violation|2
5864497|NCT02025907|20283824|P2|Overall Study|Withdrawal by Subject|8
5864498|NCT02025907|20283825|P1|Overall Study|Withdrawal by Subject|15
5864499|NCT02025907|20283824|P2|Overall Study|Lack of Efficacy|0
5864500|NCT02025907|20283825|P1|Overall Study|Lack of Efficacy|1
5864501|NCT02025751|20283853|P2|Overall Study|Withdrawal by Subject|1
5864502|NCT02025751|20283854|P1|Overall Study|Withdrawal by Subject|0
5864503|NCT02025751|20283853|P2|Overall Study|Physician Decision|1
5864504|NCT02025751|20283854|P1|Overall Study|Physician Decision|0
5864505|NCT02025751|20283853|P2|Overall Study|Adverse Event|1
5864506|NCT02025751|20283854|P1|Overall Study|Adverse Event|0
5864507|NCT02025751|20283853|P2|Overall Study|Lost to Follow-up|0
5864508|NCT02025751|20283854|P1|Overall Study|Lost to Follow-up|1
5864509|NCT02025725|20283862|P2|Overall Study|Post-dose QTcB > 270 msec|1
5864510|NCT02025725|20283863|P1|Overall Study|Post-dose QTcB > 270 msec|0
5864511|NCT02025725|20283862|P2|Overall Study|Withdrawal by Subject|2
5864512|NCT02025725|20283863|P1|Overall Study|Withdrawal by Subject|3
5864513|NCT02025725|20283862|P2|Overall Study|Protocol Violation|1
5864514|NCT02025725|20283863|P1|Overall Study|Protocol Violation|1
5864515|NCT02025725|20283862|P2|Overall Study|Lost to Follow-up|0
5864516|NCT02025725|20283863|P1|Overall Study|Lost to Follow-up|2
5864517|NCT02025725|20283862|P2|Overall Study|Adverse Event|0
5864518|NCT02025725|20283863|P1|Overall Study|Adverse Event|5
5864519|NCT02025621|20283915|P2|Overall Study|Surgery initiated before infusion|3
5864520|NCT02025621|20283916|P1|Overall Study|Surgery initiated before infusion|3
5864521|NCT02025621|20283915|P2|Overall Study|No longer eligible|15
5864522|NCT02025621|20283916|P1|Overall Study|No longer eligible|10
5864523|NCT02025621|20283915|P2|Overall Study|Death|1
5864524|NCT02025621|20283916|P1|Overall Study|Death|0
5864525|NCT02025621|20283915|P2|Overall Study|Withdrawal by Subject|0
5864526|NCT02025621|20283916|P1|Overall Study|Withdrawal by Subject|1
5864527|NCT02025530|20283936|P2|Overall Study|No longer met elligibility criteria|1
5864528|NCT02025530|20283937|P1|Overall Study|No longer met elligibility criteria|5
5864529|NCT02025205|20283983|P2|Overall Study|Death|1
5864530|NCT02025205|20283984|P1|Overall Study|Death|0
5864531|NCT02025205|20283983|P2|Overall Study|Protocol Violation|1
5864532|NCT02025205|20283984|P1|Overall Study|Protocol Violation|2
5864533|NCT02025205|20283983|P2|Overall Study|Withdrawal by Subject|1
5864534|NCT02025205|20283984|P1|Overall Study|Withdrawal by Subject|1
5864535|NCT02025179|20284028|P3|Overall Study|Lost to Follow-up|1
5864536|NCT02025179|20284029|P2|Overall Study|Lost to Follow-up|0
5864537|NCT02025179|20284030|P1|Overall Study|Lost to Follow-up|0
5864538|NCT02024971|20284080|P1|Overall Study|Lost to Follow-up|6
5864539|NCT02024971|20284080|P1|Overall Study|Data Not Available|30
5864540|NCT02024932|20284093|P6|Overall Study|Abnormal laboratory value|0
5864541|NCT02024932|20284094|P5|Overall Study|Abnormal laboratory value|0
5864542|NCT02024932|20284095|P4|Overall Study|Abnormal laboratory value|2
5864543|NCT02024932|20284096|P3|Overall Study|Abnormal laboratory value|0
5864544|NCT02024932|20284097|P2|Overall Study|Abnormal laboratory value|0
5864545|NCT02024932|20284098|P1|Overall Study|Abnormal laboratory value|0
5864546|NCT02024932|20284093|P6|Overall Study|Adverse Event|0
5864547|NCT02024932|20284094|P5|Overall Study|Adverse Event|2
5864548|NCT02024932|20284095|P4|Overall Study|Adverse Event|0
5864549|NCT02024932|20284096|P3|Overall Study|Adverse Event|0
5864550|NCT02024932|20284097|P2|Overall Study|Adverse Event|3
5864551|NCT02024932|20284098|P1|Overall Study|Adverse Event|2
5864552|NCT02024867|20284157|P2|Overall Study|Lost to Follow-up|4
5864553|NCT02024867|20284158|P1|Overall Study|Lost to Follow-up|6
5864554|NCT02024867|20284157|P2|Overall Study|Protocol Violation|3
5864555|NCT02024867|20284158|P1|Overall Study|Protocol Violation|3
5864556|NCT02024750|20284176|P2|Overall Study|Withdrawal by Subject|1
5864557|NCT02024750|20284177|P1|Overall Study|Withdrawal by Subject|2
5864558|NCT02024698|20284213|P2|First Intervention (7 Days)|Withdrawal by Subject|1
5864559|NCT02024698|20284214|P1|First Intervention (7 Days)|Withdrawal by Subject|0
5864560|NCT02024555|20284255|P2|Overall Study|Withdrawal by Subject|1
5864561|NCT02024555|20284256|P1|Overall Study|Withdrawal by Subject|5
5864562|NCT02024555|20284255|P2|Overall Study|Lost to Follow-up|1
5864563|NCT02024555|20284256|P1|Overall Study|Lost to Follow-up|1
5864564|NCT02023879|20284383|P3|Extension Open Label Treatment|Other than specified above|2
5864565|NCT02023879|20284384|P2|Extension Open Label Treatment|Other than specified above|7
5864566|NCT02023879|20284385|P1|Extension Open Label Treatment|Other than specified above|2
5864567|NCT02023879|20284383|P3|Extension Open Label Treatment|Participant moved|0
5864568|NCT02023879|20284384|P2|Extension Open Label Treatment|Participant moved|2
5864569|NCT02023879|20284385|P1|Extension Open Label Treatment|Participant moved|1
5864570|NCT02023879|20284383|P3|Extension Open Label Treatment|Poor compliance to protocol|0
5864571|NCT02023879|20284384|P2|Extension Open Label Treatment|Poor compliance to protocol|1
5864572|NCT02023879|20284385|P1|Extension Open Label Treatment|Poor compliance to protocol|1
5864573|NCT02023879|20284383|P3|Extension Open Label Treatment|Adverse Event|3
5864574|NCT02023879|20284384|P2|Extension Open Label Treatment|Adverse Event|7
5864575|NCT02023879|20284385|P1|Extension Open Label Treatment|Adverse Event|1
5864576|NCT02023879|20284383|P3|Period 1: 24-Week Double-blind Treatment|Other than specified above|1
5864577|NCT02023879|20284384|P2|Period 1: 24-Week Double-blind Treatment|Other than specified above|3
5864578|NCT02023879|20284385|P1|Period 1: 24-Week Double-blind Treatment|Other than specified above|1
5864579|NCT02023879|20284383|P3|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1
5864580|NCT02023879|20284384|P2|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1
5864581|NCT02023879|20284385|P1|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|0
5864582|NCT02023879|20284383|P3|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1
5864583|NCT02023879|20284384|P2|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|0
5864584|NCT02023879|20284385|P1|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1
5864585|NCT02023879|20284383|P3|Period 1: 24-Week Double-blind Treatment|Physician Decision|0
5864586|NCT02023879|20284384|P2|Period 1: 24-Week Double-blind Treatment|Physician Decision|1
5864587|NCT02023879|20284385|P1|Period 1: 24-Week Double-blind Treatment|Physician Decision|0
5864588|NCT02023879|20284383|P3|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|1
5864589|NCT02023879|20284384|P2|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|2
5864590|NCT02023879|20284385|P1|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|0
5864591|NCT02023879|20284383|P3|Period 1: 24-Week Double-blind Treatment|Adverse Event|5
5864592|NCT02023879|20284384|P2|Period 1: 24-Week Double-blind Treatment|Adverse Event|2
5864593|NCT02023879|20284385|P1|Period 1: 24-Week Double-blind Treatment|Adverse Event|2
5864594|NCT02023866|20284474|P1|Overall Study|Withdrawal by Subject|1
5864595|NCT02023866|20284474|P1|Overall Study|Adverse Event|3
5864596|NCT02023866|20284474|P1|Overall Study|Non-compliance|2
5864597|NCT02023697|20284496|P3|Long-term Follow-up Period|Other unspecified|5
5864598|NCT02023697|20284497|P2|Long-term Follow-up Period|Other unspecified|3
5864599|NCT02023697|20284498|P1|Long-term Follow-up Period|Other unspecified|6
5864600|NCT02023697|20284496|P3|Long-term Follow-up Period|Technical problems|1
5864601|NCT02023697|20284497|P2|Long-term Follow-up Period|Technical problems|0
5864602|NCT02023697|20284498|P1|Long-term Follow-up Period|Technical problems|0
5864603|NCT02023697|20284496|P3|Long-term Follow-up Period|Entered the long-term follow-up study|6
5864604|NCT02023697|20284497|P2|Long-term Follow-up Period|Entered the long-term follow-up study|9
5864605|NCT02023697|20284498|P1|Long-term Follow-up Period|Entered the long-term follow-up study|6
5864606|NCT02023697|20284496|P3|Long-term Follow-up Period|Lost to Follow-up|1
5864607|NCT02023697|20284497|P2|Long-term Follow-up Period|Lost to Follow-up|0
5864608|NCT02023697|20284498|P1|Long-term Follow-up Period|Lost to Follow-up|1
5864609|NCT02023697|20284496|P3|Long-term Follow-up Period|Withdrawal by Subject|0
5864610|NCT02023697|20284497|P2|Long-term Follow-up Period|Withdrawal by Subject|3
5864611|NCT02023697|20284498|P1|Long-term Follow-up Period|Withdrawal by Subject|6
5864612|NCT02023697|20284496|P3|Long-term Follow-up Period|Death|4
5864613|NCT02023697|20284497|P2|Long-term Follow-up Period|Death|6
5864614|NCT02023697|20284498|P1|Long-term Follow-up Period|Death|9
5864615|NCT02023697|20284496|P3|Active Follow-up Period|Death|87
5864616|NCT02023697|20284497|P2|Active Follow-up Period|Death|82
5864617|NCT02023697|20284498|P1|Active Follow-up Period|Death|83
5864618|NCT02023697|20284496|P3|Active Follow-up Period|Radiological progression|1
5864619|NCT02023697|20284497|P2|Active Follow-up Period|Radiological progression|0
5864620|NCT02023697|20284498|P1|Active Follow-up Period|Radiological progression|0
5864621|NCT02023697|20284496|P3|Active Follow-up Period|Clinical progression|1
5864622|NCT02023697|20284497|P2|Active Follow-up Period|Clinical progression|2
5864623|NCT02023697|20284498|P1|Active Follow-up Period|Clinical progression|0
5864624|NCT02023697|20284496|P3|Active Follow-up Period|Other unspecified|1
5864625|NCT02023697|20284497|P2|Active Follow-up Period|Other unspecified|0
5864626|NCT02023697|20284498|P1|Active Follow-up Period|Other unspecified|2
5864627|NCT02023697|20284496|P3|Active Follow-up Period|Deterioration of general condition|1
5864628|NCT02023697|20284497|P2|Active Follow-up Period|Deterioration of general condition|1
5864629|NCT02023697|20284498|P1|Active Follow-up Period|Deterioration of general condition|1
5864630|NCT02023697|20284496|P3|Active Follow-up Period|Lost to Follow-up|1
5864631|NCT02023697|20284497|P2|Active Follow-up Period|Lost to Follow-up|1
5864632|NCT02023697|20284498|P1|Active Follow-up Period|Lost to Follow-up|1
5864633|NCT02023697|20284496|P3|Active Follow-up Period|Withdrawal by Subject|7
5864634|NCT02023697|20284497|P2|Active Follow-up Period|Withdrawal by Subject|13
5864635|NCT02023697|20284498|P1|Active Follow-up Period|Withdrawal by Subject|5
5864636|NCT02023697|20284496|P3|Treatment Period|Physician Decision|1
5864637|NCT02023697|20284497|P2|Treatment Period|Physician Decision|0
5864638|NCT02023697|20284498|P1|Treatment Period|Physician Decision|0
5864639|NCT02023697|20284496|P3|Treatment Period|Safety outcome reached|0
5864640|NCT02023697|20284497|P2|Treatment Period|Safety outcome reached|1
5864641|NCT02023697|20284498|P1|Treatment Period|Safety outcome reached|0
5864642|NCT02023697|20284496|P3|Treatment Period|Withdrawal by Subject|13
5864643|NCT02023697|20284497|P2|Treatment Period|Withdrawal by Subject|5
5864644|NCT02023697|20284498|P1|Treatment Period|Withdrawal by Subject|4
5864645|NCT02023697|20284496|P3|Treatment Period|Clinical progression|28
5864646|NCT02023697|20284497|P2|Treatment Period|Clinical progression|8
5864647|NCT02023697|20284498|P1|Treatment Period|Clinical progression|10
5864648|NCT02023697|20284496|P3|Treatment Period|Logistical difficulties|1
5864649|NCT02023697|20284497|P2|Treatment Period|Logistical difficulties|1
5864650|NCT02023697|20284498|P1|Treatment Period|Logistical difficulties|1
5864651|NCT02023697|20284496|P3|Treatment Period|Adverse Event|23
5864652|NCT02023697|20284497|P2|Treatment Period|Adverse Event|25
5864653|NCT02023697|20284498|P1|Treatment Period|Adverse Event|13
5864654|NCT02023697|20284496|P3|Treatment Period|Never Treated|10
5864655|NCT02023697|20284497|P2|Treatment Period|Never Treated|6
5864656|NCT02023697|20284498|P1|Treatment Period|Never Treated|5
5864657|NCT02023697|20284496|P3|Treatment Period|Radiological progression|26
5864658|NCT02023697|20284497|P2|Treatment Period|Radiological progression|17
5864659|NCT02023697|20284498|P1|Treatment Period|Radiological progression|13
5864660|NCT02023268|20284622|P2|Overall Study|Withdrawal by Subject|1
5864661|NCT02023268|20284623|P1|Overall Study|Withdrawal by Subject|0
5864662|NCT02023268|20284622|P2|Overall Study|Adverse Event|2
5864663|NCT02023268|20284623|P1|Overall Study|Adverse Event|0
5864664|NCT02023268|20284622|P2|Overall Study|Lack of Efficacy|1
5864665|NCT02023268|20284623|P1|Overall Study|Lack of Efficacy|0
5864666|NCT02023242|20284631|P2|Overall Study|Death|1
5864667|NCT02023242|20284632|P1|Overall Study|Death|0
5864668|NCT02023242|20284631|P2|Overall Study|Lost to Follow-up|1
5864669|NCT02023242|20284632|P1|Overall Study|Lost to Follow-up|3
5864670|NCT02023151|20284646|P1|Overall Study|Lost to Follow-up|4
5864671|NCT02023112|20284716|P2|Overall Study|Withdrawal by Subject|1
5864672|NCT02023112|20284717|P1|Overall Study|Withdrawal by Subject|2
5864673|NCT02023099|20284738|P3|Overall Study|Non-treatment-emergent Fatal AE|1
5864674|NCT02023099|20284739|P2|Overall Study|Non-treatment-emergent Fatal AE|0
5864675|NCT02023099|20284740|P1|Overall Study|Non-treatment-emergent Fatal AE|0
5864676|NCT02023099|20284738|P3|Overall Study|Withdrawn Consent|1
5864677|NCT02023099|20284739|P2|Overall Study|Withdrawn Consent|0
5864678|NCT02023099|20284740|P1|Overall Study|Withdrawn Consent|3
5864679|NCT02023099|20284738|P3|Overall Study|Non-fatal Adverse Event (AE)|1
5864680|NCT02023099|20284739|P2|Overall Study|Non-fatal Adverse Event (AE)|0
5864681|NCT02023099|20284740|P1|Overall Study|Non-fatal Adverse Event (AE)|0
5864682|NCT02022748|20284763|P3|Overall Study|Withdrawal by Subject|0
5864683|NCT02022748|20284764|P2|Overall Study|Withdrawal by Subject|1
5864684|NCT02022748|20284765|P1|Overall Study|Withdrawal by Subject|0
5864685|NCT02022748|20284763|P3|Overall Study|Adverse Event|0
5864686|NCT02022748|20284764|P2|Overall Study|Adverse Event|1
5864687|NCT02022748|20284765|P1|Overall Study|Adverse Event|1
5864688|NCT02022670|20284791|P3|Overall Study|Adverse Event|1
5864689|NCT02022670|20284792|P2|Overall Study|Adverse Event|0
5864690|NCT02022670|20284793|P1|Overall Study|Adverse Event|1
5864691|NCT02022657|20284807|P6|Overall Study|Physician Decision|1
5864692|NCT02022657|20284808|P5|Overall Study|Physician Decision|0
5864693|NCT02022657|20284809|P4|Overall Study|Physician Decision|0
5864694|NCT02022657|20284810|P3|Overall Study|Physician Decision|0
5864695|NCT02022657|20284811|P2|Overall Study|Physician Decision|0
5864696|NCT02022657|20284812|P1|Overall Study|Physician Decision|0
5864697|NCT02022657|20284807|P6|Overall Study|Withdrawal by Subject|0
5864698|NCT02022657|20284808|P5|Overall Study|Withdrawal by Subject|0
5864699|NCT02022657|20284809|P4|Overall Study|Withdrawal by Subject|0
5864700|NCT02022657|20284810|P3|Overall Study|Withdrawal by Subject|1
5864701|NCT02022657|20284811|P2|Overall Study|Withdrawal by Subject|0
5864702|NCT02022657|20284812|P1|Overall Study|Withdrawal by Subject|2
5864703|NCT02022007|20284862|P3|Overall Study|Noncompliant|1
5864704|NCT02022007|20284863|P2|Overall Study|Noncompliant|0
5864705|NCT02022007|20284864|P1|Overall Study|Noncompliant|0
5864706|NCT02022007|20284862|P3|Overall Study|Withdrawal by Subject|1
5864707|NCT02022007|20284863|P2|Overall Study|Withdrawal by Subject|1
5864708|NCT02022007|20284864|P1|Overall Study|Withdrawal by Subject|1
5864709|NCT02021656|20284947|P1|Overall Study|Withdrew Consent|2
5864710|NCT02021656|20284947|P1|Overall Study|Lost to Follow-up|1
5864711|NCT02021656|20284947|P1|Overall Study|Lack of Efficacy|2
5864712|NCT02021656|20284947|P1|Overall Study|Adverse Event|1
5864713|NCT02021643|20284967|P4|Overall Study|Withdrew Consent|0
5864714|NCT02021643|20284968|P3|Overall Study|Withdrew Consent|0
5864715|NCT02021643|20284969|P2|Overall Study|Withdrew Consent|1
5864716|NCT02021643|20284970|P1|Overall Study|Withdrew Consent|0
5864717|NCT02021643|20284967|P4|Overall Study|Lost to Follow-up|0
5864718|NCT02021643|20284968|P3|Overall Study|Lost to Follow-up|0
5864719|NCT02021643|20284969|P2|Overall Study|Lost to Follow-up|1
5864720|NCT02021643|20284970|P1|Overall Study|Lost to Follow-up|0
5864721|NCT02021643|20284967|P4|Overall Study|Lack of Efficacy|12
5864722|NCT02021643|20284968|P3|Overall Study|Lack of Efficacy|0
5864723|NCT02021643|20284969|P2|Overall Study|Lack of Efficacy|6
5864724|NCT02021643|20284970|P1|Overall Study|Lack of Efficacy|7
5864725|NCT02021643|20284967|P4|Overall Study|Investigator's Discretion|0
5864726|NCT02021643|20284968|P3|Overall Study|Investigator's Discretion|0
5864727|NCT02021643|20284969|P2|Overall Study|Investigator's Discretion|0
5864728|NCT02021643|20284970|P1|Overall Study|Investigator's Discretion|1
5864729|NCT02021643|20284967|P4|Overall Study|Death|0
5864730|NCT02021643|20284968|P3|Overall Study|Death|0
5864731|NCT02021643|20284969|P2|Overall Study|Death|1
5864732|NCT02021643|20284970|P1|Overall Study|Death|0
5864733|NCT02021643|20284967|P4|Overall Study|Adverse Event|0
5864734|NCT02021643|20284968|P3|Overall Study|Adverse Event|0
5864735|NCT02021643|20284969|P2|Overall Study|Adverse Event|1
5864736|NCT02021643|20284970|P1|Overall Study|Adverse Event|0
5864737|NCT02021643|20284967|P4|Overall Study|Enrolled but Never Treated|0
5864738|NCT02021643|20284968|P3|Overall Study|Enrolled but Never Treated|0
5864739|NCT02021643|20284969|P2|Overall Study|Enrolled but Never Treated|0
5864740|NCT02021643|20284970|P1|Overall Study|Enrolled but Never Treated|1
5864741|NCT02021565|20285012|P2|3-month Follow-up|Protocol Violation|2
5864742|NCT02021565|20285013|P1|3-month Follow-up|Protocol Violation|3
5864743|NCT02021565|20285012|P2|3-month Follow-up|Withdrawal by Subject|0
5864744|NCT02021565|20285013|P1|3-month Follow-up|Withdrawal by Subject|4
5864745|NCT02021565|20285012|P2|3-month Follow-up|Death|0
5864746|NCT02021565|20285013|P1|3-month Follow-up|Death|3
5864747|NCT02021565|20285012|P2|Baseline Through Intervention|Lost to Follow-up|2
5864748|NCT02021565|20285013|P1|Baseline Through Intervention|Lost to Follow-up|4
5864749|NCT02021565|20285012|P2|Baseline Through Intervention|Protocol Violation|7
5864750|NCT02021565|20285013|P1|Baseline Through Intervention|Protocol Violation|0
5864751|NCT02021565|20285012|P2|Baseline Through Intervention|Withdrawal by Subject|8
5864752|NCT02021565|20285013|P1|Baseline Through Intervention|Withdrawal by Subject|8
5864753|NCT02021565|20285012|P2|Baseline Through Intervention|Death|1
5864754|NCT02021565|20285013|P1|Baseline Through Intervention|Death|0
5864755|NCT02021331|20285033|P2|Overall Study|Adverse Event|2
5864756|NCT02021331|20285034|P1|Overall Study|Adverse Event|0
5864757|NCT02021292|20285046|P2|Overall Study|Death|1
5864758|NCT02021292|20285047|P1|Overall Study|Death|0
5864759|NCT02021292|20285046|P2|Overall Study|Lost to Follow-up|1
5864760|NCT02021292|20285047|P1|Overall Study|Lost to Follow-up|0
5864761|NCT02021292|20285046|P2|Overall Study|Physician Decision|1
5864762|NCT02021292|20285047|P1|Overall Study|Physician Decision|0
5864763|NCT02020941|20285077|P1|Overall Study|Disease Progression|4
5864764|NCT02020941|20285077|P1|Overall Study|Withdrawal by Subject|1
5864765|NCT02020941|20285077|P1|Overall Study|Physician Decision|2
5864766|NCT02020941|20285077|P1|Overall Study|Adverse Event|1
5864767|NCT02020889|20285088|P2|Overall Study|Withdrawal by Subject|2
5864768|NCT02020889|20285089|P1|Overall Study|Withdrawal by Subject|3
5864769|NCT02020889|20285088|P2|Overall Study|Physician Decision|0
5864770|NCT02020889|20285089|P1|Overall Study|Physician Decision|2
5864771|NCT02020889|20285088|P2|Overall Study|Lost to Follow-up|0
5864772|NCT02020889|20285089|P1|Overall Study|Lost to Follow-up|1
5864773|NCT02020889|20285088|P2|Overall Study|Lack of Efficacy|0
5864774|NCT02020889|20285089|P1|Overall Study|Lack of Efficacy|1
5864775|NCT02020889|20285088|P2|Overall Study|Adverse Event|1
5864776|NCT02020889|20285089|P1|Overall Study|Adverse Event|0
5864777|NCT02020863|20285143|P1|Overall Study|Team chose not to place an a line|1
5864778|NCT02020863|20285143|P1|Overall Study|Discovery of Metastatic disease|4
5864779|NCT02020616|20285173|P7|Overall Study|Lack of Efficacy|0
5864780|NCT02020616|20285174|P6|Overall Study|Lack of Efficacy|0
5864781|NCT02020616|20285175|P5|Overall Study|Lack of Efficacy|1
5864782|NCT02020616|20285176|P4|Overall Study|Lack of Efficacy|0
5864783|NCT02020616|20285177|P3|Overall Study|Lack of Efficacy|0
5864784|NCT02020616|20285178|P2|Overall Study|Lack of Efficacy|0
5864785|NCT02020616|20285179|P1|Overall Study|Lack of Efficacy|0
5864786|NCT02020616|20285173|P7|Overall Study|Randomized in Error|0
5864787|NCT02020616|20285174|P6|Overall Study|Randomized in Error|0
5864788|NCT02020616|20285175|P5|Overall Study|Randomized in Error|0
5864789|NCT02020616|20285176|P4|Overall Study|Randomized in Error|1
5864790|NCT02020616|20285177|P3|Overall Study|Randomized in Error|0
5864791|NCT02020616|20285178|P2|Overall Study|Randomized in Error|0
5864792|NCT02020616|20285179|P1|Overall Study|Randomized in Error|0
5864793|NCT02020616|20285173|P7|Overall Study|Early Termination Criteria Met|0
5864794|NCT02020616|20285174|P6|Overall Study|Early Termination Criteria Met|1
5864795|NCT02020616|20285175|P5|Overall Study|Early Termination Criteria Met|0
5864796|NCT02020616|20285176|P4|Overall Study|Early Termination Criteria Met|0
5864797|NCT02020616|20285177|P3|Overall Study|Early Termination Criteria Met|1
5864798|NCT02020616|20285178|P2|Overall Study|Early Termination Criteria Met|0
5864799|NCT02020616|20285179|P1|Overall Study|Early Termination Criteria Met|0
5864800|NCT02020616|20285173|P7|Overall Study|Lost to Follow-up|0
5864801|NCT02020616|20285174|P6|Overall Study|Lost to Follow-up|1
5864802|NCT02020616|20285175|P5|Overall Study|Lost to Follow-up|1
5864803|NCT02020616|20285176|P4|Overall Study|Lost to Follow-up|1
5864804|NCT02020616|20285177|P3|Overall Study|Lost to Follow-up|0
5864805|NCT02020616|20285178|P2|Overall Study|Lost to Follow-up|1
5864806|NCT02020616|20285179|P1|Overall Study|Lost to Follow-up|0
5864807|NCT02020616|20285173|P7|Overall Study|Withdrawal by Subject|1
5864808|NCT02020616|20285174|P6|Overall Study|Withdrawal by Subject|1
5864809|NCT02020616|20285175|P5|Overall Study|Withdrawal by Subject|0
5864810|NCT02020616|20285176|P4|Overall Study|Withdrawal by Subject|0
5864811|NCT02020616|20285177|P3|Overall Study|Withdrawal by Subject|1
5864812|NCT02020616|20285178|P2|Overall Study|Withdrawal by Subject|0
5864813|NCT02020616|20285179|P1|Overall Study|Withdrawal by Subject|0
5864814|NCT02020616|20285173|P7|Overall Study|Physician Decision|2
5864815|NCT02020616|20285174|P6|Overall Study|Physician Decision|1
5864816|NCT02020616|20285175|P5|Overall Study|Physician Decision|0
5864817|NCT02020616|20285176|P4|Overall Study|Physician Decision|0
5864818|NCT02020616|20285177|P3|Overall Study|Physician Decision|0
5864819|NCT02020616|20285178|P2|Overall Study|Physician Decision|0
5864820|NCT02020616|20285179|P1|Overall Study|Physician Decision|0
5864821|NCT02020616|20285173|P7|Overall Study|Adverse Event|1
5864822|NCT02020616|20285174|P6|Overall Study|Adverse Event|1
5864823|NCT02020616|20285175|P5|Overall Study|Adverse Event|0
5864824|NCT02020616|20285176|P4|Overall Study|Adverse Event|0
5864825|NCT02020616|20285177|P3|Overall Study|Adverse Event|0
5864826|NCT02020616|20285178|P2|Overall Study|Adverse Event|0
5864827|NCT02020616|20285179|P1|Overall Study|Adverse Event|0
5864828|NCT02020577|20285272|P2|Overall Study|Other than stated above|1
5864829|NCT02020577|20285273|P1|Overall Study|Other than stated above|0
5864830|NCT02020577|20285272|P2|Overall Study|Withdrawal by Subject|1
5864831|NCT02020577|20285273|P1|Overall Study|Withdrawal by Subject|0
5864832|NCT02020577|20285272|P2|Overall Study|Other AE or clinical progression|15
5864833|NCT02020577|20285273|P1|Overall Study|Other AE or clinical progression|0
5864834|NCT02020577|20285272|P2|Overall Study|Progressive disease|38
5864835|NCT02020577|20285273|P1|Overall Study|Progressive disease|3
5864836|NCT02020512|20285300|P1|Overall Study|Protocol Violation|4
5864837|NCT02020512|20285300|P1|Overall Study|Lost to Follow-up|3
5864838|NCT02020512|20285300|P1|Overall Study|Adverse Event|1
5864839|NCT02020031|20285379|P2|Overall Study|Physician Decision|1
5864840|NCT02020031|20285380|P1|Overall Study|Physician Decision|1
5864841|NCT02019979|20285401|P1|Overall Study|study terminated|14
5864842|NCT02019927|20285417|P6|Overall Study|Lost to Follow-up|1
5864843|NCT02019927|20285418|P5|Overall Study|Lost to Follow-up|3
5864844|NCT02019927|20285419|P4|Overall Study|Lost to Follow-up|2
5864845|NCT02019927|20285420|P3|Overall Study|Lost to Follow-up|1
5864846|NCT02019927|20285421|P2|Overall Study|Lost to Follow-up|4
5864847|NCT02019927|20285422|P1|Overall Study|Lost to Follow-up|2
5864848|NCT02019719|20285522|P5|Overall Study|Physician Decision|0
5864849|NCT02019719|20285523|P4|Overall Study|Physician Decision|0
5864850|NCT02019719|20285524|P3|Overall Study|Physician Decision|0
5864851|NCT02019719|20285525|P2|Overall Study|Physician Decision|0
5864852|NCT02019719|20285526|P1|Overall Study|Physician Decision|2
5864853|NCT02019719|20285522|P5|Overall Study|Protocol defined stopping criteria|1
5864854|NCT02019719|20285523|P4|Overall Study|Protocol defined stopping criteria|1
5864855|NCT02019719|20285524|P3|Overall Study|Protocol defined stopping criteria|0
5864856|NCT02019719|20285525|P2|Overall Study|Protocol defined stopping criteria|0
5864857|NCT02019719|20285526|P1|Overall Study|Protocol defined stopping criteria|2
5864858|NCT02019719|20285522|P5|Overall Study|Protocol Violation|0
5864859|NCT02019719|20285523|P4|Overall Study|Protocol Violation|0
5864860|NCT02019719|20285524|P3|Overall Study|Protocol Violation|0
5864861|NCT02019719|20285525|P2|Overall Study|Protocol Violation|1
5864862|NCT02019719|20285526|P1|Overall Study|Protocol Violation|1
5864863|NCT02019719|20285522|P5|Overall Study|Adverse Event|1
5864864|NCT02019719|20285523|P4|Overall Study|Adverse Event|1
5864865|NCT02019719|20285524|P3|Overall Study|Adverse Event|0
5864866|NCT02019719|20285525|P2|Overall Study|Adverse Event|0
5864867|NCT02019719|20285526|P1|Overall Study|Adverse Event|1
5864868|NCT02019667|20285623|P2|2nd Intervention (6 Months)|Physician Decision|1
5864869|NCT02019667|20285624|P1|2nd Intervention (6 Months)|Physician Decision|0
5864870|NCT02019667|20285623|P2|2nd Intervention (6 Months)|Adverse Event|1
5864871|NCT02019667|20285624|P1|2nd Intervention (6 Months)|Adverse Event|0
5864872|NCT02019667|20285623|P2|First Intervention (6 Months)|Adverse Event|1
5864873|NCT02019667|20285624|P1|First Intervention (6 Months)|Adverse Event|0
5864874|NCT02019602|20285644|P2|Screening Period|Adverse Event|0
5864875|NCT02019602|20285645|P1|Screening Period|Adverse Event|1
5864876|NCT02019602|20285644|P2|Screening Period|Ineligibility|0
5864877|NCT02019602|20285645|P1|Screening Period|Ineligibility|4
5864878|NCT02019550|20285674|P2|Treatment Period 1 (4 Weeks)|Adverse Event|1
5864879|NCT02019550|20285675|P1|Treatment Period 1 (4 Weeks)|Adverse Event|0
5864880|NCT02019472|20285716|P3|Overall Study|Other|6
5864881|NCT02019472|20285717|P2|Overall Study|Other|8
5864882|NCT02019472|20285718|P1|Overall Study|Other|3
5864883|NCT02019472|20285716|P3|Overall Study|Withdrawal by Subject|11
5864884|NCT02019472|20285717|P2|Overall Study|Withdrawal by Subject|10
5864885|NCT02019472|20285718|P1|Overall Study|Withdrawal by Subject|11
5864886|NCT02019472|20285716|P3|Overall Study|Pregnancy|2
5864887|NCT02019472|20285717|P2|Overall Study|Pregnancy|2
5864888|NCT02019472|20285718|P1|Overall Study|Pregnancy|1
5864889|NCT02019472|20285716|P3|Overall Study|Physician Decision|0
5864890|NCT02019472|20285717|P2|Overall Study|Physician Decision|2
5864891|NCT02019472|20285718|P1|Overall Study|Physician Decision|1
5864892|NCT02019472|20285716|P3|Overall Study|Lost to Follow-up|1
5864893|NCT02019472|20285717|P2|Overall Study|Lost to Follow-up|2
5864894|NCT02019472|20285718|P1|Overall Study|Lost to Follow-up|0
5864895|NCT02019472|20285716|P3|Overall Study|Lack of Efficacy|4
5864896|NCT02019472|20285717|P2|Overall Study|Lack of Efficacy|4
5864897|NCT02019472|20285718|P1|Overall Study|Lack of Efficacy|7
5864898|NCT02019472|20285716|P3|Overall Study|Death|1
5864899|NCT02019472|20285717|P2|Overall Study|Death|1
5864900|NCT02019472|20285718|P1|Overall Study|Death|0
5864901|NCT02019472|20285716|P3|Overall Study|Adverse Event|17
5864902|NCT02019472|20285717|P2|Overall Study|Adverse Event|23
5864903|NCT02019472|20285718|P1|Overall Study|Adverse Event|14
5864904|NCT02019420|20285741|P2|Overall Study|Transferred to other care facility|1
5864905|NCT02019420|20285742|P1|Overall Study|Transferred to other care facility|1
5864906|NCT02019420|20285741|P2|Overall Study|Death|99
5864907|NCT02019420|20285742|P1|Overall Study|Death|104
5864908|NCT02019420|20285741|P2|Overall Study|At request of sponsor or investigator|1
5864909|NCT02019420|20285742|P1|Overall Study|At request of sponsor or investigator|0
5864910|NCT02019420|20285741|P2|Overall Study|Withdrawal by Subject|3
5864911|NCT02019420|20285742|P1|Overall Study|Withdrawal by Subject|1
5864912|NCT02019420|20285741|P2|Overall Study|Did not receive study drug|2
5864913|NCT02019420|20285742|P1|Overall Study|Did not receive study drug|2
5864914|NCT02019277|20285770|P1|Overall Study|Adverse Event|1
5864915|NCT02019277|20285770|P1|Overall Study|Did no Cooperate|1
5864916|NCT02019277|20285770|P1|Overall Study|Death|7
5864917|NCT02019277|20285770|P1|Overall Study|Withdrawal by Subject|3
5864918|NCT02019264|20285789|P2|Overall Study|Missing|11
5864919|NCT02019264|20285790|P1|Overall Study|Missing|14
5864920|NCT02019264|20285789|P2|Overall Study|Administrative reason|28
5864921|NCT02019264|20285790|P1|Overall Study|Administrative reason|36
5864922|NCT02019264|20285789|P2|Overall Study|Withdrawal by Subject|117
5864923|NCT02019264|20285790|P1|Overall Study|Withdrawal by Subject|142
5864924|NCT02019264|20285789|P2|Overall Study|Lost to Follow-up|47
5864925|NCT02019264|20285790|P1|Overall Study|Lost to Follow-up|50
5864926|NCT02019264|20285789|P2|Overall Study|Not treated|4
5864927|NCT02019264|20285790|P1|Overall Study|Not treated|6
5864928|NCT02019108|20285826|P2|Overall Study|Lost to Follow-up|7
5864929|NCT02019108|20285827|P1|Overall Study|Lost to Follow-up|5
5864930|NCT02018887|20285869|P11|Part C: Cohort 8 Overall|Physician Decision|1
5864931|NCT02018887|20285870|P10|Part C: Cohort 8 Overall|Physician Decision|0
5864932|NCT02018887|20285871|P9|Part C: Cohort 8 Overall|Physician Decision|2
5864933|NCT02018887|20285872|P8|Part C: Cohort 8 Overall|Physician Decision|0
5864934|NCT02018887|20285873|P7|Part C: Cohort 8 Overall|Physician Decision|0
5864935|NCT02018887|20285874|P6|Part C: Cohort 8 Overall|Physician Decision|0
5864936|NCT02018887|20285875|P5|Part C: Cohort 8 Overall|Physician Decision|0
5864937|NCT02018887|20285876|P4|Part C: Cohort 8 Overall|Physician Decision|0
5864938|NCT02018887|20285877|P3|Part C: Cohort 8 Overall|Physician Decision|0
5864939|NCT02018887|20285878|P2|Part C: Cohort 8 Overall|Physician Decision|0
5864940|NCT02018887|20285879|P1|Part C: Cohort 8 Overall|Physician Decision|0
5864941|NCT02018887|20285869|P11|Part C: Cohort 8 Overall|Adverse Event|0
5864942|NCT02018887|20285870|P10|Part C: Cohort 8 Overall|Adverse Event|3
5864943|NCT02018887|20285871|P9|Part C: Cohort 8 Overall|Adverse Event|1
5864944|NCT02018887|20285872|P8|Part C: Cohort 8 Overall|Adverse Event|0
5864945|NCT02018887|20285873|P7|Part C: Cohort 8 Overall|Adverse Event|0
5864946|NCT02018887|20285874|P6|Part C: Cohort 8 Overall|Adverse Event|0
5864947|NCT02018887|20285875|P5|Part C: Cohort 8 Overall|Adverse Event|0
5864948|NCT02018887|20285876|P4|Part C: Cohort 8 Overall|Adverse Event|0
5864949|NCT02018887|20285877|P3|Part C: Cohort 8 Overall|Adverse Event|0
5864950|NCT02018887|20285878|P2|Part C: Cohort 8 Overall|Adverse Event|0
5864951|NCT02018887|20285879|P1|Part C: Cohort 8 Overall|Adverse Event|0
5864952|NCT02018887|20285869|P11|Part B: Cohorts 3-7 Overall|Adverse Event|0
5864953|NCT02018887|20285870|P10|Part B: Cohorts 3-7 Overall|Adverse Event|0
5864954|NCT02018887|20285871|P9|Part B: Cohorts 3-7 Overall|Adverse Event|0
5864955|NCT02018887|20285872|P8|Part B: Cohorts 3-7 Overall|Adverse Event|4
5864956|NCT02018887|20285873|P7|Part B: Cohorts 3-7 Overall|Adverse Event|1
5864957|NCT02018887|20285874|P6|Part B: Cohorts 3-7 Overall|Adverse Event|0
5864958|NCT02018887|20285875|P5|Part B: Cohorts 3-7 Overall|Adverse Event|1
5864959|NCT02018887|20285876|P4|Part B: Cohorts 3-7 Overall|Adverse Event|0
5864960|NCT02018887|20285877|P3|Part B: Cohorts 3-7 Overall|Adverse Event|0
5864961|NCT02018887|20285878|P2|Part B: Cohorts 3-7 Overall|Adverse Event|0
5864962|NCT02018887|20285879|P1|Part B: Cohorts 3-7 Overall|Adverse Event|0
5864963|NCT02018887|20285869|P11|Part A: Cohorts 1-2: Period 3|Adverse Event|0
5864964|NCT02018887|20285870|P10|Part A: Cohorts 1-2: Period 3|Adverse Event|0
5864965|NCT02018887|20285871|P9|Part A: Cohorts 1-2: Period 3|Adverse Event|0
5864966|NCT02018887|20285872|P8|Part A: Cohorts 1-2: Period 3|Adverse Event|0
5864967|NCT02018887|20285873|P7|Part A: Cohorts 1-2: Period 3|Adverse Event|0
5864968|NCT02018887|20285874|P6|Part A: Cohorts 1-2: Period 3|Adverse Event|0
5864969|NCT02018887|20285875|P5|Part A: Cohorts 1-2: Period 3|Adverse Event|0
5864970|NCT02018887|20285876|P4|Part A: Cohorts 1-2: Period 3|Adverse Event|0
5864971|NCT02018887|20285877|P3|Part A: Cohorts 1-2: Period 3|Adverse Event|0
5864972|NCT02018887|20285878|P2|Part A: Cohorts 1-2: Period 3|Adverse Event|0
5864973|NCT02018887|20285879|P1|Part A: Cohorts 1-2: Period 3|Adverse Event|1
5864974|NCT02018822|20285968|P3|Overall Study|Lost to Follow-up|5
5864975|NCT02018822|20285969|P2|Overall Study|Lost to Follow-up|6
5864976|NCT02018822|20285970|P1|Overall Study|Lost to Follow-up|6
5864977|NCT02018822|20285968|P3|Overall Study|Physician Decision|1
5864978|NCT02018822|20285969|P2|Overall Study|Physician Decision|1
5864979|NCT02018822|20285970|P1|Overall Study|Physician Decision|0
5864980|NCT02018822|20285968|P3|Overall Study|filling replaced by crown|0
5864981|NCT02018822|20285969|P2|Overall Study|filling replaced by crown|1
5864982|NCT02018822|20285970|P1|Overall Study|filling replaced by crown|0
5864983|NCT02018562|20286050|P2|Overall Study|Discharged prior to study completion|0
5864984|NCT02018562|20286051|P1|Overall Study|Discharged prior to study completion|1
5864985|NCT02018562|20286050|P2|Overall Study|Withdrawal by Subject|0
5864986|NCT02018562|20286051|P1|Overall Study|Withdrawal by Subject|2
5864987|NCT02018458|20286069|P1|Overall Study|Death|4
5864988|NCT02018042|20286096|P1|Overall Study|Withdrawal by Subject|1
5864989|NCT02017964|20286102|P1|Overall Study|Patient deemed ineligible|1
5864990|NCT02017899|20286116|P6|Overall Study|Withdrawal by Subject|0
5864991|NCT02017899|20286117|P5|Overall Study|Withdrawal by Subject|1
5864992|NCT02017899|20286118|P4|Overall Study|Withdrawal by Subject|1
5864993|NCT02017899|20286119|P3|Overall Study|Withdrawal by Subject|0
5864994|NCT02017899|20286120|P2|Overall Study|Withdrawal by Subject|0
5864995|NCT02017899|20286121|P1|Overall Study|Withdrawal by Subject|0
5864996|NCT02017860|20286195|P1|Overall Study|Withdrawal by Subject|1
5864997|NCT02017860|20286195|P1|Overall Study|Adverse Event|1
5864998|NCT02017535|20286214|P4|Overall Study|Withdrawal by Subject|0
5864999|NCT02017535|20286215|P3|Overall Study|Withdrawal by Subject|0
5865000|NCT02017535|20286216|P2|Overall Study|Withdrawal by Subject|0
5865001|NCT02017535|20286217|P1|Overall Study|Withdrawal by Subject|1
5865002|NCT02017522|20286239|P1|Overall Study|Withdrawal by Subject|1
5865003|NCT02017223|20286257|P1|Overall Study|Algorithm problems|2
5865004|NCT02017171|20286303|P2|Overall Study|Miscellaneous|3
5865005|NCT02017171|20286304|P1|Overall Study|Miscellaneous|2
5865006|NCT02017171|20286303|P2|Overall Study|ESKD|2
5865007|NCT02017171|20286304|P1|Overall Study|ESKD|6
5865008|NCT02017171|20286303|P2|Overall Study|Lost to Follow-up|20
5865009|NCT02017171|20286304|P1|Overall Study|Lost to Follow-up|21
5865010|NCT02017171|20286303|P2|Overall Study|Withdrawal by Subject|17
5865011|NCT02017171|20286304|P1|Overall Study|Withdrawal by Subject|23
5865012|NCT02017171|20286303|P2|Overall Study|Death|4
5865013|NCT02017171|20286304|P1|Overall Study|Death|10
5865014|NCT02017015|20286337|P1|Overall Study|Physician Decision|2
5865015|NCT02017015|20286337|P1|Overall Study|Non-compliance with study drug|2
5865016|NCT02017015|20286337|P1|Overall Study|Progressive Disease|31
5865017|NCT02017015|20286337|P1|Overall Study|Death|4
5865018|NCT02017015|20286337|P1|Overall Study|Withdrawal by Subject|21
5865019|NCT02017015|20286337|P1|Overall Study|Adverse Event|9
5865020|NCT02016898|20286362|P2|Overall Study|Lost to Follow-up|4
5865021|NCT02016898|20286363|P1|Overall Study|Lost to Follow-up|4
5865022|NCT02016898|20286362|P2|Overall Study|Death|1
5865023|NCT02016898|20286363|P1|Overall Study|Death|1
5865024|NCT02016755|20286417|P1|Overall Study|Death|2
5865025|NCT02016755|20286417|P1|Overall Study|Physician Decision|1
5865026|NCT02016755|20286417|P1|Overall Study|Adverse Event|2
5865027|NCT02016755|20286417|P1|Overall Study|Major amputation of index limb|2
5865028|NCT02016716|20286436|P3|Overall Study|Lost to Follow-up|1
5865029|NCT02016716|20286437|P2|Overall Study|Lost to Follow-up|2
5865030|NCT02016716|20286438|P1|Overall Study|Lost to Follow-up|1
5865031|NCT02016716|20286436|P3|Overall Study|Protocol-specified Criteria|0
5865032|NCT02016716|20286437|P2|Overall Study|Protocol-specified Criteria|1
5865033|NCT02016716|20286438|P1|Overall Study|Protocol-specified Criteria|0
5865034|NCT02016716|20286436|P3|Overall Study|Withdrawal by Subject|5
5865035|NCT02016716|20286437|P2|Overall Study|Withdrawal by Subject|5
5865036|NCT02016716|20286438|P1|Overall Study|Withdrawal by Subject|5
5865037|NCT02016690|20286459|P1|Overall Study|Hospitalized for RSV at study start|3
5865038|NCT02016690|20286459|P1|Overall Study|Did not meet inclusion criteria|13
5865039|NCT02016690|20286459|P1|Overall Study|Excluded from SAS: Ineligible for study|2
5865040|NCT02016690|20286459|P1|Overall Study|Excluded from SAS: Early treatment|2
5865041|NCT02016690|20286459|P1|Overall Study|Excluded from SAS: Duplication|2
5865042|NCT02016690|20286459|P1|Overall Study|Excluded from SAS: Enrollment violation|2
5865043|NCT02016625|20286472|P2|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|0
5865044|NCT02016625|20286473|P1|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|2
5865045|NCT02016625|20286472|P2|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|0
5865046|NCT02016625|20286473|P1|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|1
5865047|NCT02016625|20286472|P2|Cyclo or Tac (Single Dose, Day 1)|not treated|1
5865048|NCT02016625|20286473|P1|Cyclo or Tac (Single Dose, Day 1)|not treated|0
5865049|NCT02016482|20286561|P2|Period B|Required Alternative/Prohibited Therapy|2
5865050|NCT02016482|20286562|P1|Period B|Required Alternative/Prohibited Therapy|0
5865051|NCT02016482|20286561|P2|Period B|Other|0
5865052|NCT02016482|20286562|P1|Period B|Other|4
5865053|NCT02016482|20286561|P2|Period B|Lack of Efficacy|4
5865054|NCT02016482|20286562|P1|Period B|Lack of Efficacy|6
5865055|NCT02016482|20286561|P2|Period B|Lost to Follow-up|0
5865056|NCT02016482|20286562|P1|Period B|Lost to Follow-up|2
5865057|NCT02016482|20286561|P2|Period B|Withdrawal by Subject|1
5865058|NCT02016482|20286562|P1|Period B|Withdrawal by Subject|1
5865059|NCT02016482|20286561|P2|Period A|Required Alternative/Prohibited Therapy|1
5865060|NCT02016482|20286562|P1|Period A|Required Alternative/Prohibited Therapy|0
5865061|NCT02016482|20286561|P2|Period A|Protocol Violation|1
5865062|NCT02016482|20286562|P1|Period A|Protocol Violation|0
5865063|NCT02016482|20286561|P2|Period A|Other|0
5865064|NCT02016482|20286562|P1|Period A|Other|3
5865065|NCT02016482|20286561|P2|Period A|Lack of Efficacy|1
5865066|NCT02016482|20286562|P1|Period A|Lack of Efficacy|2
5865067|NCT02016482|20286561|P2|Period A|Lost to Follow-up|3
5865068|NCT02016482|20286562|P1|Period A|Lost to Follow-up|3
5865069|NCT02016482|20286561|P2|Period A|Withdrawal by Subject|4
5865070|NCT02016482|20286562|P1|Period A|Withdrawal by Subject|3
5865071|NCT02016482|20286561|P2|Period A|Adverse Event|5
5865072|NCT02016482|20286562|P1|Period A|Adverse Event|3
5865073|NCT02016300|20286652|P2|Overall Study|Lost to Follow-up|3
5865074|NCT02016300|20286653|P1|Overall Study|Lost to Follow-up|0
5865075|NCT02016183|20286684|P1|Overall Study|Protocol Violation|52
5865076|NCT02016183|20286684|P1|Overall Study|Case Report Forms Uncollected|13
5865077|NCT02016170|20286694|P3|Overall Study|Protocol Violation|0
5865078|NCT02016170|20286695|P2|Overall Study|Protocol Violation|0
5865079|NCT02016170|20286696|P1|Overall Study|Protocol Violation|1
5865080|NCT02016170|20286694|P3|Overall Study|Adverse Event|0
5865081|NCT02016170|20286695|P2|Overall Study|Adverse Event|1
5865082|NCT02016170|20286696|P1|Overall Study|Adverse Event|1
5865083|NCT02016105|20286707|P6|EXTENSION PERIOD|Lost to Follow-up|2
5865084|NCT02016105|20286708|P5|EXTENSION PERIOD|Lost to Follow-up|0
5865085|NCT02016105|20286709|P4|EXTENSION PERIOD|Lost to Follow-up|0
5865086|NCT02016105|20286710|P3|EXTENSION PERIOD|Lost to Follow-up|0
5865087|NCT02016105|20286711|P2|EXTENSION PERIOD|Lost to Follow-up|0
5865088|NCT02016105|20286712|P1|EXTENSION PERIOD|Lost to Follow-up|0
5865089|NCT02016105|20286707|P6|EXTENSION PERIOD|Non-compliance with study indication|0
5865090|NCT02016105|20286708|P5|EXTENSION PERIOD|Non-compliance with study indication|1
5865091|NCT02016105|20286709|P4|EXTENSION PERIOD|Non-compliance with study indication|0
5865092|NCT02016105|20286710|P3|EXTENSION PERIOD|Non-compliance with study indication|0
5865093|NCT02016105|20286711|P2|EXTENSION PERIOD|Non-compliance with study indication|0
5865094|NCT02016105|20286712|P1|EXTENSION PERIOD|Non-compliance with study indication|0
5865095|NCT02016105|20286707|P6|EXTENSION PERIOD|Withdrawal by Subject|2
5865096|NCT02016105|20286708|P5|EXTENSION PERIOD|Withdrawal by Subject|2
5865097|NCT02016105|20286709|P4|EXTENSION PERIOD|Withdrawal by Subject|2
5865098|NCT02016105|20286710|P3|EXTENSION PERIOD|Withdrawal by Subject|2
5865099|NCT02016105|20286711|P2|EXTENSION PERIOD|Withdrawal by Subject|0
5865100|NCT02016105|20286712|P1|EXTENSION PERIOD|Withdrawal by Subject|0
5865101|NCT02016105|20286707|P6|EXTENSION PERIOD|Adverse Event|0
5865102|NCT02016105|20286708|P5|EXTENSION PERIOD|Adverse Event|1
5865103|NCT02016105|20286709|P4|EXTENSION PERIOD|Adverse Event|0
5865104|NCT02016105|20286710|P3|EXTENSION PERIOD|Adverse Event|2
5865105|NCT02016105|20286711|P2|EXTENSION PERIOD|Adverse Event|0
5865106|NCT02016105|20286712|P1|EXTENSION PERIOD|Adverse Event|0
5865107|NCT02016105|20286707|P6|EXTENSION PERIOD|Lack of Efficacy|1
5865108|NCT02016105|20286708|P5|EXTENSION PERIOD|Lack of Efficacy|1
5865109|NCT02016105|20286709|P4|EXTENSION PERIOD|Lack of Efficacy|3
5865110|NCT02016105|20286710|P3|EXTENSION PERIOD|Lack of Efficacy|1
5865111|NCT02016105|20286711|P2|EXTENSION PERIOD|Lack of Efficacy|0
5865112|NCT02016105|20286712|P1|EXTENSION PERIOD|Lack of Efficacy|0
5865113|NCT02016105|20286707|P6|EXTENSION PERIOD|New therapy for study indication|1
5865114|NCT02016105|20286708|P5|EXTENSION PERIOD|New therapy for study indication|1
5865115|NCT02016105|20286709|P4|EXTENSION PERIOD|New therapy for study indication|0
5865116|NCT02016105|20286710|P3|EXTENSION PERIOD|New therapy for study indication|0
5865117|NCT02016105|20286711|P2|EXTENSION PERIOD|New therapy for study indication|0
5865118|NCT02016105|20286712|P1|EXTENSION PERIOD|New therapy for study indication|0
5865119|NCT02016105|20286707|P6|TREATMENT PERIOD 2|Lost to Follow-up|1
5865120|NCT02016105|20286708|P5|TREATMENT PERIOD 2|Lost to Follow-up|0
5865121|NCT02016105|20286709|P4|TREATMENT PERIOD 2|Lost to Follow-up|0
5865122|NCT02016105|20286710|P3|TREATMENT PERIOD 2|Lost to Follow-up|1
5865123|NCT02016105|20286711|P2|TREATMENT PERIOD 2|Lost to Follow-up|0
5865124|NCT02016105|20286712|P1|TREATMENT PERIOD 2|Lost to Follow-up|0
5865125|NCT02016105|20286707|P6|TREATMENT PERIOD 2|Withdrawal by Subject|7
5865126|NCT02016105|20286708|P5|TREATMENT PERIOD 2|Withdrawal by Subject|1
5865127|NCT02016105|20286709|P4|TREATMENT PERIOD 2|Withdrawal by Subject|1
5865128|NCT02016105|20286710|P3|TREATMENT PERIOD 2|Withdrawal by Subject|3
5865129|NCT02016105|20286711|P2|TREATMENT PERIOD 2|Withdrawal by Subject|0
5865130|NCT02016105|20286712|P1|TREATMENT PERIOD 2|Withdrawal by Subject|0
5865131|NCT02016105|20286707|P6|TREATMENT PERIOD 2|Adverse Event|1
5865132|NCT02016105|20286708|P5|TREATMENT PERIOD 2|Adverse Event|0
5865133|NCT02016105|20286709|P4|TREATMENT PERIOD 2|Adverse Event|4
5865134|NCT02016105|20286710|P3|TREATMENT PERIOD 2|Adverse Event|0
5865135|NCT02016105|20286711|P2|TREATMENT PERIOD 2|Adverse Event|0
5865136|NCT02016105|20286712|P1|TREATMENT PERIOD 2|Adverse Event|0
5865137|NCT02016105|20286707|P6|TREATMENT PERIOD 2|Death|1
5865138|NCT02016105|20286708|P5|TREATMENT PERIOD 2|Death|0
5865139|NCT02016105|20286709|P4|TREATMENT PERIOD 2|Death|0
5865140|NCT02016105|20286710|P3|TREATMENT PERIOD 2|Death|0
5865141|NCT02016105|20286711|P2|TREATMENT PERIOD 2|Death|0
5865142|NCT02016105|20286712|P1|TREATMENT PERIOD 2|Death|0
5865143|NCT02016105|20286707|P6|TREATMENT PERIOD 2|Pregnancy|1
5865144|NCT02016105|20286708|P5|TREATMENT PERIOD 2|Pregnancy|0
5865145|NCT02016105|20286709|P4|TREATMENT PERIOD 2|Pregnancy|0
5865146|NCT02016105|20286710|P3|TREATMENT PERIOD 2|Pregnancy|0
5865147|NCT02016105|20286711|P2|TREATMENT PERIOD 2|Pregnancy|0
5865148|NCT02016105|20286712|P1|TREATMENT PERIOD 2|Pregnancy|0
5865149|NCT02016105|20286707|P6|TREATMENT PERIOD 2|Lack of Efficacy|2
5865150|NCT02016105|20286708|P5|TREATMENT PERIOD 2|Lack of Efficacy|3
5865151|NCT02016105|20286709|P4|TREATMENT PERIOD 2|Lack of Efficacy|6
5865152|NCT02016105|20286710|P3|TREATMENT PERIOD 2|Lack of Efficacy|2
5865153|NCT02016105|20286711|P2|TREATMENT PERIOD 2|Lack of Efficacy|0
5865154|NCT02016105|20286712|P1|TREATMENT PERIOD 2|Lack of Efficacy|0
5865155|NCT02016105|20286707|P6|TREATMENT PERIOD 2|Non compliance study medication|1
5865156|NCT02016105|20286708|P5|TREATMENT PERIOD 2|Non compliance study medication|0
5865157|NCT02016105|20286709|P4|TREATMENT PERIOD 2|Non compliance study medication|0
5865158|NCT02016105|20286710|P3|TREATMENT PERIOD 2|Non compliance study medication|0
5865159|NCT02016105|20286711|P2|TREATMENT PERIOD 2|Non compliance study medication|0
5865160|NCT02016105|20286712|P1|TREATMENT PERIOD 2|Non compliance study medication|0
5865161|NCT02016105|20286707|P6|TREATMENT PERIOD 1|Lost to Follow-up|0
5865162|NCT02016105|20286708|P5|TREATMENT PERIOD 1|Lost to Follow-up|0
5865163|NCT02016105|20286709|P4|TREATMENT PERIOD 1|Lost to Follow-up|0
5865164|NCT02016105|20286710|P3|TREATMENT PERIOD 1|Lost to Follow-up|0
5865165|NCT02016105|20286711|P2|TREATMENT PERIOD 1|Lost to Follow-up|4
5865166|NCT02016105|20286712|P1|TREATMENT PERIOD 1|Lost to Follow-up|6
5865167|NCT02016105|20286707|P6|TREATMENT PERIOD 1|Withdrawal by Subject|0
5865168|NCT02016105|20286708|P5|TREATMENT PERIOD 1|Withdrawal by Subject|0
5865169|NCT02016105|20286709|P4|TREATMENT PERIOD 1|Withdrawal by Subject|0
5865170|NCT02016105|20286710|P3|TREATMENT PERIOD 1|Withdrawal by Subject|0
5865171|NCT02016105|20286711|P2|TREATMENT PERIOD 1|Withdrawal by Subject|11
5865172|NCT02016105|20286712|P1|TREATMENT PERIOD 1|Withdrawal by Subject|15
5865173|NCT02016105|20286707|P6|TREATMENT PERIOD 1|Adverse Event|0
5865174|NCT02016105|20286708|P5|TREATMENT PERIOD 1|Adverse Event|0
5865175|NCT02016105|20286709|P4|TREATMENT PERIOD 1|Adverse Event|0
5865176|NCT02016105|20286710|P3|TREATMENT PERIOD 1|Adverse Event|0
5865177|NCT02016105|20286711|P2|TREATMENT PERIOD 1|Adverse Event|5
5865178|NCT02016105|20286712|P1|TREATMENT PERIOD 1|Adverse Event|3
5865179|NCT02016105|20286707|P6|TREATMENT PERIOD 1|Pregnancy|0
5865180|NCT02016105|20286708|P5|TREATMENT PERIOD 1|Pregnancy|0
5865181|NCT02016105|20286709|P4|TREATMENT PERIOD 1|Pregnancy|0
5865182|NCT02016105|20286710|P3|TREATMENT PERIOD 1|Pregnancy|0
5865183|NCT02016105|20286711|P2|TREATMENT PERIOD 1|Pregnancy|1
5865184|NCT02016105|20286712|P1|TREATMENT PERIOD 1|Pregnancy|0
5865185|NCT02016105|20286707|P6|TREATMENT PERIOD 1|Lack of Efficacy|0
5865186|NCT02016105|20286708|P5|TREATMENT PERIOD 1|Lack of Efficacy|0
5865187|NCT02016105|20286709|P4|TREATMENT PERIOD 1|Lack of Efficacy|0
5865188|NCT02016105|20286710|P3|TREATMENT PERIOD 1|Lack of Efficacy|0
5865189|NCT02016105|20286711|P2|TREATMENT PERIOD 1|Lack of Efficacy|2
5865190|NCT02016105|20286712|P1|TREATMENT PERIOD 1|Lack of Efficacy|4
5865191|NCT02016105|20286707|P6|TREATMENT PERIOD 1|Physician Decision|0
5865192|NCT02016105|20286708|P5|TREATMENT PERIOD 1|Physician Decision|0
5865193|NCT02016105|20286709|P4|TREATMENT PERIOD 1|Physician Decision|0
5865194|NCT02016105|20286710|P3|TREATMENT PERIOD 1|Physician Decision|0
5865195|NCT02016105|20286711|P2|TREATMENT PERIOD 1|Physician Decision|2
5865196|NCT02016105|20286712|P1|TREATMENT PERIOD 1|Physician Decision|0
5865197|NCT02016105|20286707|P6|TREATMENT PERIOD 1|Protocol Violation|0
5865198|NCT02016105|20286708|P5|TREATMENT PERIOD 1|Protocol Violation|0
5865199|NCT02016105|20286709|P4|TREATMENT PERIOD 1|Protocol Violation|0
5865200|NCT02016105|20286710|P3|TREATMENT PERIOD 1|Protocol Violation|0
5865201|NCT02016105|20286711|P2|TREATMENT PERIOD 1|Protocol Violation|8
5865202|NCT02016105|20286712|P1|TREATMENT PERIOD 1|Protocol Violation|2
5865203|NCT02015793|20286771|P2|Overall Study|Withdrawal by Subject|1
5865204|NCT02015793|20286772|P1|Overall Study|Withdrawal by Subject|1
5865205|NCT02015793|20286771|P2|Overall Study|Adverse Event|3
5865206|NCT02015793|20286772|P1|Overall Study|Adverse Event|3
5865207|NCT02015754|20286802|P1|Overall Study|Lost to Follow-up|1
5865208|NCT02015754|20286802|P1|Overall Study|Change in treatment modality|5
5865209|NCT02015754|20286802|P1|Overall Study|Disease progression|5
5865210|NCT02015676|20286822|P3|Overall Study|Disease progression|1
5865211|NCT02015676|20286823|P2|Overall Study|Disease progression|1
5865212|NCT02015676|20286824|P1|Overall Study|Disease progression|3
5865213|NCT02015676|20286822|P3|Overall Study|Death|0
5865214|NCT02015676|20286823|P2|Overall Study|Death|1
5865215|NCT02015676|20286824|P1|Overall Study|Death|0
5865216|NCT02015676|20286822|P3|Overall Study|Administrative reasons|1
5865217|NCT02015676|20286823|P2|Overall Study|Administrative reasons|3
5865218|NCT02015676|20286824|P1|Overall Study|Administrative reasons|0
5865219|NCT02015676|20286822|P3|Overall Study|Withdrawal by Subject|1
5865220|NCT02015676|20286823|P2|Overall Study|Withdrawal by Subject|7
5865221|NCT02015676|20286824|P1|Overall Study|Withdrawal by Subject|1
5865222|NCT02015676|20286822|P3|Overall Study|Protocol Violation|0
5865223|NCT02015676|20286823|P2|Overall Study|Protocol Violation|0
5865224|NCT02015676|20286824|P1|Overall Study|Protocol Violation|1
5865225|NCT02015676|20286822|P3|Overall Study|Lack of Efficacy|0
5865226|NCT02015676|20286823|P2|Overall Study|Lack of Efficacy|4
5865227|NCT02015676|20286824|P1|Overall Study|Lack of Efficacy|2
5865228|NCT02015676|20286822|P3|Overall Study|Adverse Event|0
5865229|NCT02015676|20286823|P2|Overall Study|Adverse Event|18
5865230|NCT02015676|20286824|P1|Overall Study|Adverse Event|2
5865231|NCT02015663|20286840|P2|Overall Study|Administrative problems|11
5865232|NCT02015663|20286841|P1|Overall Study|Administrative problems|10
5865233|NCT02015663|20286840|P2|Overall Study|Adverse Event|0
5865234|NCT02015663|20286841|P1|Overall Study|Adverse Event|3
5865235|NCT02015663|20286840|P2|Overall Study|Protocol Violation|1
5865236|NCT02015663|20286841|P1|Overall Study|Protocol Violation|0
5865237|NCT02015663|20286840|P2|Overall Study|Withdrawal by Subject|0
5865238|NCT02015663|20286841|P1|Overall Study|Withdrawal by Subject|1
5865239|NCT02015663|20286840|P2|Overall Study|unsatisfactory therapeutic effect|0
5865240|NCT02015663|20286841|P1|Overall Study|unsatisfactory therapeutic effect|1
5865241|NCT02015637|20286872|P2|Overall Study|Did not take study drug|0
5865242|NCT02015637|20286873|P1|Overall Study|Did not take study drug|2
5865243|NCT02015637|20286872|P2|Overall Study|Adverse Event|0
5865244|NCT02015637|20286873|P1|Overall Study|Adverse Event|3
5865245|NCT02015637|20286872|P2|Overall Study|Lost to Follow-up|5
5865246|NCT02015637|20286873|P1|Overall Study|Lost to Follow-up|3
5865247|NCT02015546|20286884|P3|Overall Study|Screem Failure|3
5865248|NCT02015546|20286885|P2|Overall Study|Screem Failure|1
5865249|NCT02015546|20286886|P1|Overall Study|Screem Failure|2
5865250|NCT02015546|20286884|P3|Overall Study|Withdrawal by Subject|1
5865251|NCT02015546|20286885|P2|Overall Study|Withdrawal by Subject|1
5865252|NCT02015546|20286886|P1|Overall Study|Withdrawal by Subject|1
5865253|NCT02015481|20286918|P1|Overall Study|Death|1
5865254|NCT02015221|20286951|P2|Overall Study|Lost to Follow-up|0
5865255|NCT02015221|20286952|P1|Overall Study|Lost to Follow-up|1
5865256|NCT02015221|20286951|P2|Overall Study|Withdrawal by Subject|6
5865257|NCT02015221|20286952|P1|Overall Study|Withdrawal by Subject|8
5865258|NCT02015195|20286965|P7|Overall Study|Adverse Event|0
5865259|NCT02015195|20286966|P6|Overall Study|Adverse Event|0
5865260|NCT02015195|20286967|P5|Overall Study|Adverse Event|0
5865261|NCT02015195|20286968|P4|Overall Study|Adverse Event|1
5865262|NCT02015195|20286969|P3|Overall Study|Adverse Event|0
5865263|NCT02015195|20286970|P2|Overall Study|Adverse Event|0
5865264|NCT02015195|20286971|P1|Overall Study|Adverse Event|0
5865265|NCT02015104|20286994|P2|Overall Study|Withdrew consent prior to treatment|1
5865266|NCT02015104|20286995|P1|Overall Study|Withdrew consent prior to treatment|0
5865267|NCT02015104|20286994|P2|Overall Study|Withdrew consent after first dose drug|0
5865268|NCT02015104|20286995|P1|Overall Study|Withdrew consent after first dose drug|1
5865269|NCT02015065|20287012|P3|Overall Study|Death on study|1
5865270|NCT02015065|20287013|P2|Overall Study|Death on study|2
5865271|NCT02015065|20287014|P1|Overall Study|Death on study|1
5865272|NCT02015039|20287036|P2|Overall Study|Not eligible|1
5865273|NCT02015039|20287037|P1|Overall Study|Not eligible|0
5865274|NCT02014740|20287057|P2|Overall Study|Withdrawal by Subject|1
5865275|NCT02014740|20287058|P1|Overall Study|Withdrawal by Subject|2
5865276|NCT02014740|20287057|P2|Overall Study|Lost to Follow-up|4
5865277|NCT02014740|20287058|P1|Overall Study|Lost to Follow-up|4
5865278|NCT02014597|20287066|P2|Overall Study|Unable to record log contrast sensitivity|1
5865279|NCT02014597|20287067|P1|Overall Study|Unable to record log contrast sensitivity|2
5865280|NCT02014584|20287083|P6|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0
5865281|NCT02014584|20287084|P5|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|1
5865282|NCT02014584|20287085|P4|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0
5865283|NCT02014584|20287086|P3|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0
5865284|NCT02014584|20287087|P2|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0
5865285|NCT02014584|20287088|P1|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0
5865286|NCT02014584|20287083|P6|Open-Label Period (24 Weeks)|Withdrawal by Subject|0
5865287|NCT02014584|20287084|P5|Open-Label Period (24 Weeks)|Withdrawal by Subject|0
5865288|NCT02014584|20287085|P4|Open-Label Period (24 Weeks)|Withdrawal by Subject|1
5865289|NCT02014584|20287086|P3|Open-Label Period (24 Weeks)|Withdrawal by Subject|3
5865290|NCT02014584|20287087|P2|Open-Label Period (24 Weeks)|Withdrawal by Subject|0
5865291|NCT02014584|20287088|P1|Open-Label Period (24 Weeks)|Withdrawal by Subject|0
5865292|NCT02014584|20287083|P6|Open-Label Period (24 Weeks)|Lost to Follow-up|0
5865293|NCT02014584|20287084|P5|Open-Label Period (24 Weeks)|Lost to Follow-up|0
5865294|NCT02014584|20287085|P4|Open-Label Period (24 Weeks)|Lost to Follow-up|0
5865295|NCT02014584|20287086|P3|Open-Label Period (24 Weeks)|Lost to Follow-up|2
5865296|NCT02014584|20287087|P2|Open-Label Period (24 Weeks)|Lost to Follow-up|0
5865297|NCT02014584|20287088|P1|Open-Label Period (24 Weeks)|Lost to Follow-up|0
5865298|NCT02014584|20287083|P6|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0
5865299|NCT02014584|20287084|P5|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0
5865300|NCT02014584|20287085|P4|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0
5865301|NCT02014584|20287086|P3|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0
5865302|NCT02014584|20287087|P2|Double-Blind Period (24 Weeks)|Withdrawal by Subject|5
5865303|NCT02014584|20287088|P1|Double-Blind Period (24 Weeks)|Withdrawal by Subject|2
5865304|NCT02014584|20287083|P6|Double-Blind Period (24 Weeks)|Protocol Violation|0
5865305|NCT02014584|20287084|P5|Double-Blind Period (24 Weeks)|Protocol Violation|0
5865306|NCT02014584|20287085|P4|Double-Blind Period (24 Weeks)|Protocol Violation|0
5865307|NCT02014584|20287086|P3|Double-Blind Period (24 Weeks)|Protocol Violation|0
5865308|NCT02014584|20287087|P2|Double-Blind Period (24 Weeks)|Protocol Violation|1
5865309|NCT02014584|20287088|P1|Double-Blind Period (24 Weeks)|Protocol Violation|0
5865310|NCT02014558|20287218|P13|Overall Study|Miscellaneous|1
5865311|NCT02014558|20287219|P12|Overall Study|Miscellaneous|11
5865312|NCT02014558|20287220|P11|Overall Study|Miscellaneous|12
5865313|NCT02014558|20287221|P10|Overall Study|Miscellaneous|3
5865314|NCT02014558|20287222|P9|Overall Study|Miscellaneous|1
5865315|NCT02014558|20287223|P8|Overall Study|Miscellaneous|1
5865316|NCT02014558|20287224|P7|Overall Study|Miscellaneous|0
5865317|NCT02014558|20287225|P6|Overall Study|Miscellaneous|1
5865318|NCT02014558|20287226|P5|Overall Study|Miscellaneous|0
5865319|NCT02014558|20287227|P4|Overall Study|Miscellaneous|1
5865320|NCT02014558|20287228|P3|Overall Study|Miscellaneous|1
5865321|NCT02014558|20287229|P2|Overall Study|Miscellaneous|1
5865322|NCT02014558|20287230|P1|Overall Study|Miscellaneous|2
5865323|NCT02014558|20287218|P13|Overall Study|Withdrawal by Subject|0
5865324|NCT02014558|20287219|P12|Overall Study|Withdrawal by Subject|10
5865325|NCT02014558|20287220|P11|Overall Study|Withdrawal by Subject|6
5865326|NCT02014558|20287221|P10|Overall Study|Withdrawal by Subject|2
5865327|NCT02014558|20287222|P9|Overall Study|Withdrawal by Subject|0
5865328|NCT02014558|20287223|P8|Overall Study|Withdrawal by Subject|0
5865329|NCT02014558|20287224|P7|Overall Study|Withdrawal by Subject|0
5865330|NCT02014558|20287225|P6|Overall Study|Withdrawal by Subject|0
5865331|NCT02014558|20287226|P5|Overall Study|Withdrawal by Subject|1
5865332|NCT02014558|20287227|P4|Overall Study|Withdrawal by Subject|0
5865333|NCT02014558|20287228|P3|Overall Study|Withdrawal by Subject|0
5865334|NCT02014558|20287229|P2|Overall Study|Withdrawal by Subject|0
5865335|NCT02014558|20287230|P1|Overall Study|Withdrawal by Subject|0
5865336|NCT02014558|20287218|P13|Overall Study|Progressive Disease|6
5865337|NCT02014558|20287219|P12|Overall Study|Progressive Disease|31
5865338|NCT02014558|20287220|P11|Overall Study|Progressive Disease|22
5865339|NCT02014558|20287221|P10|Overall Study|Progressive Disease|6
5865340|NCT02014558|20287222|P9|Overall Study|Progressive Disease|5
5865341|NCT02014558|20287223|P8|Overall Study|Progressive Disease|6
5865342|NCT02014558|20287224|P7|Overall Study|Progressive Disease|1
5865343|NCT02014558|20287225|P6|Overall Study|Progressive Disease|2
5865344|NCT02014558|20287226|P5|Overall Study|Progressive Disease|1
5865345|NCT02014558|20287227|P4|Overall Study|Progressive Disease|1
5865346|NCT02014558|20287228|P3|Overall Study|Progressive Disease|1
5865347|NCT02014558|20287229|P2|Overall Study|Progressive Disease|0
5865348|NCT02014558|20287230|P1|Overall Study|Progressive Disease|1
5865349|NCT02014558|20287218|P13|Overall Study|Lost to Follow-up|0
5865350|NCT02014558|20287219|P12|Overall Study|Lost to Follow-up|0
5865351|NCT02014558|20287220|P11|Overall Study|Lost to Follow-up|1
5865352|NCT02014558|20287221|P10|Overall Study|Lost to Follow-up|0
5865353|NCT02014558|20287222|P9|Overall Study|Lost to Follow-up|0
5865354|NCT02014558|20287223|P8|Overall Study|Lost to Follow-up|0
5865355|NCT02014558|20287224|P7|Overall Study|Lost to Follow-up|0
5865356|NCT02014558|20287225|P6|Overall Study|Lost to Follow-up|0
5865357|NCT02014558|20287226|P5|Overall Study|Lost to Follow-up|0
5865358|NCT02014558|20287227|P4|Overall Study|Lost to Follow-up|0
5865359|NCT02014558|20287228|P3|Overall Study|Lost to Follow-up|0
5865360|NCT02014558|20287229|P2|Overall Study|Lost to Follow-up|0
5865361|NCT02014558|20287230|P1|Overall Study|Lost to Follow-up|0
5865362|NCT02014558|20287218|P13|Overall Study|Lack of Efficacy|5
5865363|NCT02014558|20287219|P12|Overall Study|Lack of Efficacy|8
5865364|NCT02014558|20287220|P11|Overall Study|Lack of Efficacy|16
5865365|NCT02014558|20287221|P10|Overall Study|Lack of Efficacy|3
5865366|NCT02014558|20287222|P9|Overall Study|Lack of Efficacy|3
5865367|NCT02014558|20287223|P8|Overall Study|Lack of Efficacy|3
5865368|NCT02014558|20287224|P7|Overall Study|Lack of Efficacy|1
5865369|NCT02014558|20287225|P6|Overall Study|Lack of Efficacy|0
5865370|NCT02014558|20287226|P5|Overall Study|Lack of Efficacy|0
5865371|NCT02014558|20287227|P4|Overall Study|Lack of Efficacy|1
5865372|NCT02014558|20287228|P3|Overall Study|Lack of Efficacy|1
5865373|NCT02014558|20287229|P2|Overall Study|Lack of Efficacy|2
5865374|NCT02014558|20287230|P1|Overall Study|Lack of Efficacy|1
5865375|NCT02014558|20287218|P13|Overall Study|Death|2
5865376|NCT02014558|20287219|P12|Overall Study|Death|19
5865377|NCT02014558|20287220|P11|Overall Study|Death|5
5865378|NCT02014558|20287221|P10|Overall Study|Death|5
5865379|NCT02014558|20287222|P9|Overall Study|Death|2
5865380|NCT02014558|20287223|P8|Overall Study|Death|1
5865381|NCT02014558|20287224|P7|Overall Study|Death|1
5865382|NCT02014558|20287225|P6|Overall Study|Death|0
5865383|NCT02014558|20287226|P5|Overall Study|Death|0
5865384|NCT02014558|20287227|P4|Overall Study|Death|0
5865385|NCT02014558|20287228|P3|Overall Study|Death|0
5865386|NCT02014558|20287229|P2|Overall Study|Death|0
5865387|NCT02014558|20287230|P1|Overall Study|Death|1
5865388|NCT02014558|20287218|P13|Overall Study|Adverse Event|3
5865389|NCT02014558|20287219|P12|Overall Study|Adverse Event|21
5865390|NCT02014558|20287220|P11|Overall Study|Adverse Event|5
5865391|NCT02014558|20287221|P10|Overall Study|Adverse Event|2
5865392|NCT02014558|20287222|P9|Overall Study|Adverse Event|2
5865393|NCT02014558|20287223|P8|Overall Study|Adverse Event|0
5865394|NCT02014558|20287224|P7|Overall Study|Adverse Event|0
5865395|NCT02014558|20287225|P6|Overall Study|Adverse Event|0
5865396|NCT02014558|20287226|P5|Overall Study|Adverse Event|1
5865397|NCT02014558|20287227|P4|Overall Study|Adverse Event|0
5865398|NCT02014558|20287228|P3|Overall Study|Adverse Event|0
5865399|NCT02014558|20287229|P2|Overall Study|Adverse Event|0
5865400|NCT02014558|20287230|P1|Overall Study|Adverse Event|0
5865401|NCT02014558|20287218|P13|Overall Study|Never Received Study Drug|0
5865402|NCT02014558|20287219|P12|Overall Study|Never Received Study Drug|2
5865403|NCT02014558|20287220|P11|Overall Study|Never Received Study Drug|2
5865404|NCT02014558|20287221|P10|Overall Study|Never Received Study Drug|0
5865405|NCT02014558|20287222|P9|Overall Study|Never Received Study Drug|2
5865406|NCT02014558|20287223|P8|Overall Study|Never Received Study Drug|0
5865407|NCT02014558|20287224|P7|Overall Study|Never Received Study Drug|1
5865408|NCT02014558|20287225|P6|Overall Study|Never Received Study Drug|0
5865409|NCT02014558|20287226|P5|Overall Study|Never Received Study Drug|1
5865410|NCT02014558|20287227|P4|Overall Study|Never Received Study Drug|0
5865411|NCT02014558|20287228|P3|Overall Study|Never Received Study Drug|0
5865412|NCT02014558|20287229|P2|Overall Study|Never Received Study Drug|0
5865413|NCT02014558|20287230|P1|Overall Study|Never Received Study Drug|0
5865414|NCT02014480|20287595|P6|Treatment Period 3 (14 Days)|Lack of Efficacy|1
5865415|NCT02014480|20287596|P5|Treatment Period 3 (14 Days)|Lack of Efficacy|0
5865416|NCT02014480|20287597|P4|Treatment Period 3 (14 Days)|Lack of Efficacy|0
5865417|NCT02014480|20287598|P3|Treatment Period 3 (14 Days)|Lack of Efficacy|0
5865418|NCT02014480|20287599|P2|Treatment Period 3 (14 Days)|Lack of Efficacy|0
5865419|NCT02014480|20287600|P1|Treatment Period 3 (14 Days)|Lack of Efficacy|0
5865420|NCT02014480|20287595|P6|Treatment Period 3 (14 Days)|Adverse Event|1
5865421|NCT02014480|20287596|P5|Treatment Period 3 (14 Days)|Adverse Event|0
5865422|NCT02014480|20287597|P4|Treatment Period 3 (14 Days)|Adverse Event|0
5865423|NCT02014480|20287598|P3|Treatment Period 3 (14 Days)|Adverse Event|1
5865424|NCT02014480|20287599|P2|Treatment Period 3 (14 Days)|Adverse Event|0
5865425|NCT02014480|20287600|P1|Treatment Period 3 (14 Days)|Adverse Event|0
5865426|NCT02014480|20287595|P6|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
5865427|NCT02014480|20287596|P5|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
5865428|NCT02014480|20287597|P4|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
5865429|NCT02014480|20287598|P3|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
5865430|NCT02014480|20287599|P2|Treatment Period 3 (14 Days)|Withdrawal by Subject|1
5865431|NCT02014480|20287600|P1|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
5865432|NCT02014480|20287595|P6|Treatment Period 2 (14 Days)|Protocol Violation|0
5865433|NCT02014480|20287596|P5|Treatment Period 2 (14 Days)|Protocol Violation|0
5865434|NCT02014480|20287597|P4|Treatment Period 2 (14 Days)|Protocol Violation|1
5865435|NCT02014480|20287598|P3|Treatment Period 2 (14 Days)|Protocol Violation|2
5865436|NCT02014480|20287599|P2|Treatment Period 2 (14 Days)|Protocol Violation|1
5865437|NCT02014480|20287600|P1|Treatment Period 2 (14 Days)|Protocol Violation|1
5865438|NCT02014480|20287595|P6|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
5865439|NCT02014480|20287596|P5|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
5865440|NCT02014480|20287597|P4|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
5865441|NCT02014480|20287598|P3|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1
5865442|NCT02014480|20287599|P2|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
5865443|NCT02014480|20287600|P1|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
5865444|NCT02014480|20287595|P6|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
5865445|NCT02014480|20287596|P5|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
5865446|NCT02014480|20287597|P4|Treatment Period 1 (14 Days)|Withdrawal by Subject|2
5865447|NCT02014480|20287598|P3|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
5865448|NCT02014480|20287599|P2|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
5865449|NCT02014480|20287600|P1|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
5865450|NCT02014480|20287595|P6|Treatment Period 1 (14 Days)|Lack of Efficacy|0
5865451|NCT02014480|20287596|P5|Treatment Period 1 (14 Days)|Lack of Efficacy|0
5865452|NCT02014480|20287597|P4|Treatment Period 1 (14 Days)|Lack of Efficacy|0
5865453|NCT02014480|20287598|P3|Treatment Period 1 (14 Days)|Lack of Efficacy|1
5865454|NCT02014480|20287599|P2|Treatment Period 1 (14 Days)|Lack of Efficacy|0
5865455|NCT02014480|20287600|P1|Treatment Period 1 (14 Days)|Lack of Efficacy|0
5865456|NCT02014467|20287619|P2|Overall Study|Withdrawal by Subject|4
5865457|NCT02014467|20287620|P1|Overall Study|Withdrawal by Subject|16
5865458|NCT02014467|20287619|P2|Overall Study|Physician Decision|3
5865459|NCT02014467|20287620|P1|Overall Study|Physician Decision|2
5865460|NCT02014467|20287619|P2|Overall Study|Protocol Violation|0
5865461|NCT02014467|20287620|P1|Overall Study|Protocol Violation|3
5865462|NCT02014467|20287619|P2|Overall Study|Adverse Event|0
5865463|NCT02014467|20287620|P1|Overall Study|Adverse Event|4
5865464|NCT02014441|20287680|P1|Overall Study|Withdrawal by Subject|12
5865465|NCT02014402|20287776|P4|Overall Study|Lost to Follow-up|2
5865466|NCT02014402|20287777|P3|Overall Study|Lost to Follow-up|1
5865467|NCT02014402|20287778|P2|Overall Study|Lost to Follow-up|0
5865468|NCT02014402|20287779|P1|Overall Study|Lost to Follow-up|0
5865469|NCT02014402|20287776|P4|Overall Study|Subject did not have transportation|0
5865470|NCT02014402|20287777|P3|Overall Study|Subject did not have transportation|0
5865471|NCT02014402|20287778|P2|Overall Study|Subject did not have transportation|1
5865472|NCT02014402|20287779|P1|Overall Study|Subject did not have transportation|0
5865473|NCT02014402|20287776|P4|Overall Study|Withdrawal by Subject|1
5865474|NCT02014402|20287777|P3|Overall Study|Withdrawal by Subject|2
5865475|NCT02014402|20287778|P2|Overall Study|Withdrawal by Subject|2
5865476|NCT02014402|20287779|P1|Overall Study|Withdrawal by Subject|1
5865477|NCT02014402|20287776|P4|Overall Study|Adverse Event|0
5865478|NCT02014402|20287777|P3|Overall Study|Adverse Event|0
5865479|NCT02014402|20287778|P2|Overall Study|Adverse Event|0
5865480|NCT02014402|20287779|P1|Overall Study|Adverse Event|1
5865481|NCT02014376|20287809|P3|Overall Study|Lost to Follow-up|0
5865482|NCT02014376|20287810|P2|Overall Study|Lost to Follow-up|0
5865483|NCT02014376|20287811|P1|Overall Study|Lost to Follow-up|2
5865484|NCT02014376|20287809|P3|Overall Study|Adverse Event|0
5865485|NCT02014376|20287810|P2|Overall Study|Adverse Event|1
5865486|NCT02014376|20287811|P1|Overall Study|Adverse Event|1
5865487|NCT02014272|20287847|P2|Intervention Period 1|Adverse Event|1
5865488|NCT02014272|20287848|P1|Intervention Period 1|Adverse Event|0
5865489|NCT02014272|20287847|P2|Intervention Period 1|Withdrawal by Subject|0
5865490|NCT02014272|20287848|P1|Intervention Period 1|Withdrawal by Subject|1
5865491|NCT02014116|20287897|P9|Overall Study|Physician Decision|1
5865492|NCT02014116|20287898|P8|Overall Study|Physician Decision|0
5865493|NCT02014116|20287899|P7|Overall Study|Physician Decision|0
5865494|NCT02014116|20287900|P6|Overall Study|Physician Decision|0
5865495|NCT02014116|20287901|P5|Overall Study|Physician Decision|0
5865496|NCT02014116|20287902|P4|Overall Study|Physician Decision|0
5865497|NCT02014116|20287903|P3|Overall Study|Physician Decision|0
5865498|NCT02014116|20287904|P2|Overall Study|Physician Decision|0
5865499|NCT02014116|20287905|P1|Overall Study|Physician Decision|0
5865500|NCT02014116|20287897|P9|Overall Study|Withdrawal Caregiver Decision|0
5865501|NCT02014116|20287898|P8|Overall Study|Withdrawal Caregiver Decision|0
5865502|NCT02014116|20287899|P7|Overall Study|Withdrawal Caregiver Decision|0
5865503|NCT02014116|20287900|P6|Overall Study|Withdrawal Caregiver Decision|1
5865504|NCT02014116|20287901|P5|Overall Study|Withdrawal Caregiver Decision|0
5865505|NCT02014116|20287902|P4|Overall Study|Withdrawal Caregiver Decision|0
5865506|NCT02014116|20287903|P3|Overall Study|Withdrawal Caregiver Decision|0
5865507|NCT02014116|20287904|P2|Overall Study|Withdrawal Caregiver Decision|0
5865508|NCT02014116|20287905|P1|Overall Study|Withdrawal Caregiver Decision|0
5865509|NCT02014116|20287897|P9|Overall Study|Withdrawal by Subject|0
5865510|NCT02014116|20287898|P8|Overall Study|Withdrawal by Subject|0
5865511|NCT02014116|20287899|P7|Overall Study|Withdrawal by Subject|0
5865512|NCT02014116|20287900|P6|Overall Study|Withdrawal by Subject|1
5865513|NCT02014116|20287901|P5|Overall Study|Withdrawal by Subject|0
5865514|NCT02014116|20287902|P4|Overall Study|Withdrawal by Subject|1
5865515|NCT02014116|20287903|P3|Overall Study|Withdrawal by Subject|1
5865516|NCT02014116|20287904|P2|Overall Study|Withdrawal by Subject|0
5865517|NCT02014116|20287905|P1|Overall Study|Withdrawal by Subject|0
5865518|NCT02014116|20287897|P9|Overall Study|Death|1
5865519|NCT02014116|20287898|P8|Overall Study|Death|1
5865520|NCT02014116|20287899|P7|Overall Study|Death|0
5865521|NCT02014116|20287900|P6|Overall Study|Death|0
5865522|NCT02014116|20287901|P5|Overall Study|Death|0
5865523|NCT02014116|20287902|P4|Overall Study|Death|0
5865524|NCT02014116|20287903|P3|Overall Study|Death|0
5865525|NCT02014116|20287904|P2|Overall Study|Death|0
5865526|NCT02014116|20287905|P1|Overall Study|Death|0
5865527|NCT02014116|20287897|P9|Overall Study|Lost to Follow-up|1
5865528|NCT02014116|20287898|P8|Overall Study|Lost to Follow-up|0
5865529|NCT02014116|20287899|P7|Overall Study|Lost to Follow-up|0
5865530|NCT02014116|20287900|P6|Overall Study|Lost to Follow-up|1
5865531|NCT02014116|20287901|P5|Overall Study|Lost to Follow-up|0
5865532|NCT02014116|20287902|P4|Overall Study|Lost to Follow-up|0
5865533|NCT02014116|20287903|P3|Overall Study|Lost to Follow-up|0
5865534|NCT02014116|20287904|P2|Overall Study|Lost to Follow-up|0
5865535|NCT02014116|20287905|P1|Overall Study|Lost to Follow-up|0
5865536|NCT02014116|20287897|P9|Overall Study|Adverse Event|0
5865537|NCT02014116|20287898|P8|Overall Study|Adverse Event|1
5865538|NCT02014116|20287899|P7|Overall Study|Adverse Event|0
5865539|NCT02014116|20287900|P6|Overall Study|Adverse Event|0
5865540|NCT02014116|20287901|P5|Overall Study|Adverse Event|1
5865541|NCT02014116|20287902|P4|Overall Study|Adverse Event|0
5865542|NCT02014116|20287903|P3|Overall Study|Adverse Event|0
5865543|NCT02014116|20287904|P2|Overall Study|Adverse Event|0
5865544|NCT02014116|20287905|P1|Overall Study|Adverse Event|0
5865545|NCT02014116|20287897|P9|Overall Study|Progressive Disease|7
5865546|NCT02014116|20287898|P8|Overall Study|Progressive Disease|3
5865547|NCT02014116|20287899|P7|Overall Study|Progressive Disease|1
5865548|NCT02014116|20287900|P6|Overall Study|Progressive Disease|13
5865549|NCT02014116|20287901|P5|Overall Study|Progressive Disease|1
5865550|NCT02014116|20287902|P4|Overall Study|Progressive Disease|6
5865551|NCT02014116|20287903|P3|Overall Study|Progressive Disease|2
5865552|NCT02014116|20287904|P2|Overall Study|Progressive Disease|4
5865553|NCT02014116|20287905|P1|Overall Study|Progressive Disease|3
5865554|NCT02013830|20287970|P1|Overall Study|Refused treatment|1
5865555|NCT02013830|20287970|P1|Overall Study|Insufficient therapeutic response|25
5865556|NCT02013830|20287970|P1|Overall Study|Death|1
5865557|NCT02013830|20287970|P1|Overall Study|Adverse Event|3
5865558|NCT02013817|20287981|P1|Overall Study|Other|9
5865559|NCT02013817|20287981|P1|Overall Study|Death|2
5865560|NCT02013817|20287981|P1|Overall Study|Withdrawal by Subject|4
5865561|NCT02013817|20287981|P1|Overall Study|Adverse Event|12
5865562|NCT02013791|20287999|P9|Period 1|Other Miscellaneous Reasons|0
5865563|NCT02013791|20288000|P8|Period 1|Other Miscellaneous Reasons|0
5865564|NCT02013791|20288001|P7|Period 1|Other Miscellaneous Reasons|0
5865565|NCT02013791|20288002|P6|Period 1|Other Miscellaneous Reasons|0
5865566|NCT02013791|20288003|P5|Period 1|Other Miscellaneous Reasons|0
5865567|NCT02013791|20288004|P4|Period 1|Other Miscellaneous Reasons|0
5865568|NCT02013791|20288005|P3|Period 1|Other Miscellaneous Reasons|0
5865569|NCT02013791|20288006|P2|Period 1|Other Miscellaneous Reasons|2
5865570|NCT02013791|20288007|P1|Period 1|Other Miscellaneous Reasons|0
5865571|NCT02013791|20287999|P9|Period 1|Lost to Follow-up|0
5865572|NCT02013791|20288000|P8|Period 1|Lost to Follow-up|1
5865573|NCT02013791|20288001|P7|Period 1|Lost to Follow-up|1
5865574|NCT02013791|20288002|P6|Period 1|Lost to Follow-up|0
5865575|NCT02013791|20288003|P5|Period 1|Lost to Follow-up|0
5865576|NCT02013791|20288004|P4|Period 1|Lost to Follow-up|1
5865577|NCT02013791|20288005|P3|Period 1|Lost to Follow-up|0
5865578|NCT02013791|20288006|P2|Period 1|Lost to Follow-up|0
5865579|NCT02013791|20288007|P1|Period 1|Lost to Follow-up|0
5865580|NCT02013778|20288028|P1|Overall Study|Adverse Event|1
5865581|NCT02013778|20288028|P1|Overall Study|Physician Decision|1
5865582|NCT02013778|20288028|P1|Overall Study|Withdrawal by Subject|1
5865583|NCT02013778|20288028|P1|Overall Study|Death|4
5865584|NCT02013765|20288032|P1|Overall Study|Trial was terminated by sponsor|1
5865585|NCT02013687|20288046|P4|Overall Study|Missed visits due to patient travel|0
5865586|NCT02013687|20288047|P3|Overall Study|Missed visits due to patient travel|1
5865587|NCT02013687|20288048|P2|Overall Study|Missed visits due to patient travel|0
5865588|NCT02013687|20288049|P1|Overall Study|Missed visits due to patient travel|0
5865589|NCT02013687|20288046|P4|Overall Study|Withdrawal by Subject|1
5865590|NCT02013687|20288047|P3|Overall Study|Withdrawal by Subject|0
5865591|NCT02013687|20288048|P2|Overall Study|Withdrawal by Subject|0
5865592|NCT02013687|20288049|P1|Overall Study|Withdrawal by Subject|0
5865593|NCT02013687|20288046|P4|Overall Study|Protocol Violation|1
5865594|NCT02013687|20288047|P3|Overall Study|Protocol Violation|0
5865595|NCT02013687|20288048|P2|Overall Study|Protocol Violation|0
5865596|NCT02013687|20288049|P1|Overall Study|Protocol Violation|0
5865597|NCT02013687|20288046|P4|Overall Study|Lost to Follow-up|0
5865598|NCT02013687|20288047|P3|Overall Study|Lost to Follow-up|1
5865599|NCT02013687|20288048|P2|Overall Study|Lost to Follow-up|0
5865600|NCT02013687|20288049|P1|Overall Study|Lost to Follow-up|0
5865601|NCT02013674|20288081|P2|Overall Study|Lost to Follow-up|0
5865602|NCT02013674|20288082|P1|Overall Study|Lost to Follow-up|1
5865603|NCT02013674|20288081|P2|Overall Study|Death|1
5865604|NCT02013674|20288082|P1|Overall Study|Death|0
5865605|NCT02013622|20288132|P1|Overall Study|Lack of Efficacy|1
5865606|NCT02013622|20288132|P1|Overall Study|Protocol Deviation|1
5865607|NCT02013622|20288132|P1|Overall Study|Withdrawal by Subject|6
5865608|NCT02013622|20288132|P1|Overall Study|Met Withdrawal Criteria|3
5865609|NCT02013622|20288132|P1|Overall Study|Adverse Event|3
5865610|NCT02013622|20288132|P1|Overall Study|Lost to Follow-up|10
5865611|NCT02013609|20288152|P1|Overall Study|Met Withdrawal Criteria|3
5865612|NCT02013609|20288152|P1|Overall Study|Adverse Event|3
5865613|NCT02013609|20288152|P1|Overall Study|Lost to Follow-up|3
5865614|NCT02013609|20288152|P1|Overall Study|Withdrawal by Subject|9
5865615|NCT02013544|20288177|P2|Overall Study|Entry criteria not met/non-compliance|3
5865616|NCT02013544|20288178|P1|Overall Study|Entry criteria not met/non-compliance|2
5865617|NCT02013544|20288177|P2|Overall Study|Physician Decision|1
5865618|NCT02013544|20288178|P1|Overall Study|Physician Decision|0
5865619|NCT02013544|20288177|P2|Overall Study|Withdrawal by Subject|8
5865620|NCT02013544|20288178|P1|Overall Study|Withdrawal by Subject|2
5865621|NCT02013544|20288177|P2|Overall Study|Lost to Follow-up|3
5865622|NCT02013544|20288178|P1|Overall Study|Lost to Follow-up|2
5865623|NCT02013544|20288177|P2|Overall Study|Adverse Event|5
5865624|NCT02013544|20288178|P1|Overall Study|Adverse Event|5
5865625|NCT02013531|20288200|P1|Overall Study|Withdrawal by Subject|1
5865626|NCT02013531|20288200|P1|Overall Study|Met Withdrawal Criteria|1
5865627|NCT02013531|20288200|P1|Overall Study|Lost to Follow-up|3
5865628|NCT02013388|20288236|P8|Overall Study|work emergency|0
5865629|NCT02013388|20288237|P7|Overall Study|work emergency|0
5865630|NCT02013388|20288238|P6|Overall Study|work emergency|0
5865631|NCT02013388|20288239|P5|Overall Study|work emergency|1
5865632|NCT02013388|20288240|P4|Overall Study|work emergency|0
5865633|NCT02013388|20288241|P3|Overall Study|work emergency|0
5865634|NCT02013388|20288242|P2|Overall Study|work emergency|0
5865635|NCT02013388|20288243|P1|Overall Study|work emergency|1
5865636|NCT02013375|20288277|P1|Overall Study|Did not engraft|1
5865637|NCT02013375|20288277|P1|Overall Study|Did not engraft|1
5865638|NCT02013206|20288307|P2|Overall Study|Other reasons off treatment|2
5865639|NCT02013206|20288308|P1|Overall Study|Other reasons off treatment|5
5865640|NCT02013206|20288307|P2|Overall Study|Death|2
5865641|NCT02013206|20288308|P1|Overall Study|Death|1
5865642|NCT02013206|20288307|P2|Overall Study|Patient non-compliance|0
5865643|NCT02013206|20288308|P1|Overall Study|Patient non-compliance|1
5865644|NCT02013206|20288307|P2|Overall Study|Patient refusal|0
5865645|NCT02013206|20288308|P1|Overall Study|Patient refusal|2
5865646|NCT02013206|20288307|P2|Overall Study|Adverse Event|0
5865647|NCT02013206|20288308|P1|Overall Study|Adverse Event|1
5865648|NCT02013206|20288307|P2|Overall Study|Symptomatic deterioration|1
5865649|NCT02013206|20288308|P1|Overall Study|Symptomatic deterioration|3
5865650|NCT02013206|20288307|P2|Overall Study|Progressive disease (PD)|17
5865651|NCT02013206|20288308|P1|Overall Study|Progressive disease (PD)|14
5865652|NCT02013167|20288339|P2|Overall Study|Death|160
5865653|NCT02013167|20288340|P1|Overall Study|Death|85
5865654|NCT02013167|20288339|P2|Overall Study|Lost to Follow-up|1
5865655|NCT02013167|20288340|P1|Overall Study|Lost to Follow-up|0
5865656|NCT02013167|20288339|P2|Overall Study|Sponsor Decision|3
5865657|NCT02013167|20288340|P1|Overall Study|Sponsor Decision|1
5865658|NCT02013167|20288339|P2|Overall Study|Withdrawal by Subject|14
5865659|NCT02013167|20288340|P1|Overall Study|Withdrawal by Subject|15
5865660|NCT02012959|20288416|P5|Treatment Phase A|Adverse Event|0
5865661|NCT02012959|20288417|P4|Treatment Phase A|Adverse Event|0
5865662|NCT02012959|20288418|P3|Treatment Phase A|Adverse Event|0
5865663|NCT02012959|20288419|P2|Treatment Phase A|Adverse Event|0
5865664|NCT02012959|20288420|P1|Treatment Phase A|Adverse Event|2
5865665|NCT02012686|20288433|P2|Overall Study|electrocardiography monitoring noise|1
5865666|NCT02012686|20288434|P1|Overall Study|electrocardiography monitoring noise|0
5865667|NCT02012686|20288433|P2|Overall Study|muscle contraction|1
5865668|NCT02012686|20288434|P1|Overall Study|muscle contraction|0
5865669|NCT02012491|20288496|P2|Overall Study|Withdrawal by Subject|0
5865670|NCT02012491|20288497|P1|Overall Study|Withdrawal by Subject|1
5865671|NCT02012491|20288496|P2|Overall Study|Protocol Violation|1
5865672|NCT02012491|20288497|P1|Overall Study|Protocol Violation|0
5865673|NCT02012491|20288496|P2|Overall Study|Lost to Follow-up|0
5865674|NCT02012491|20288497|P1|Overall Study|Lost to Follow-up|1
5865675|NCT02012452|20288515|P2|Overall Study|Withdrawal by Subject|0
5865676|NCT02012452|20288516|P1|Overall Study|Withdrawal by Subject|4
5865677|NCT02012452|20288515|P2|Overall Study|Lost to Follow-up|1
5865678|NCT02012452|20288516|P1|Overall Study|Lost to Follow-up|2
5865679|NCT02012218|20288559|P5|Overall Study|Protocol Deviation|0
5865680|NCT02012218|20288560|P4|Overall Study|Protocol Deviation|0
5865681|NCT02012218|20288561|P3|Overall Study|Protocol Deviation|0
5865682|NCT02012218|20288562|P2|Overall Study|Protocol Deviation|0
5865683|NCT02012218|20288563|P1|Overall Study|Protocol Deviation|1
5865684|NCT02012218|20288559|P5|Overall Study|Protocol Specified|0
5865685|NCT02012218|20288560|P4|Overall Study|Protocol Specified|0
5865686|NCT02012218|20288561|P3|Overall Study|Protocol Specified|0
5865687|NCT02012218|20288562|P2|Overall Study|Protocol Specified|0
5865688|NCT02012218|20288563|P1|Overall Study|Protocol Specified|1
5865689|NCT02012218|20288559|P5|Overall Study|Lost to Follow-up|0
5865690|NCT02012218|20288560|P4|Overall Study|Lost to Follow-up|0
5865691|NCT02012218|20288561|P3|Overall Study|Lost to Follow-up|1
5865692|NCT02012218|20288562|P2|Overall Study|Lost to Follow-up|1
5865693|NCT02012218|20288563|P1|Overall Study|Lost to Follow-up|0
5865694|NCT02012218|20288559|P5|Overall Study|Adverse Event|0
5865695|NCT02012218|20288560|P4|Overall Study|Adverse Event|1
5865696|NCT02012218|20288561|P3|Overall Study|Adverse Event|0
5865697|NCT02012218|20288562|P2|Overall Study|Adverse Event|0
5865698|NCT02012218|20288563|P1|Overall Study|Adverse Event|1
5865699|NCT02012218|20288559|P5|Overall Study|Withdrawal by Subject|1
5865700|NCT02012218|20288560|P4|Overall Study|Withdrawal by Subject|1
5865701|NCT02012218|20288561|P3|Overall Study|Withdrawal by Subject|1
5865702|NCT02012218|20288562|P2|Overall Study|Withdrawal by Subject|0
5865703|NCT02012218|20288563|P1|Overall Study|Withdrawal by Subject|1
5865704|NCT02011945|20288587|P3|Overall Study|Sub-Optimal Response to dasatinib|0
5865705|NCT02011945|20288588|P2|Overall Study|Sub-Optimal Response to dasatinib|0
5865706|NCT02011945|20288589|P1|Overall Study|Sub-Optimal Response to dasatinib|1
5865707|NCT02011945|20288587|P3|Overall Study|Proceeded to stem cell transplant|1
5865708|NCT02011945|20288588|P2|Overall Study|Proceeded to stem cell transplant|0
5865709|NCT02011945|20288589|P1|Overall Study|Proceeded to stem cell transplant|0
5865710|NCT02011945|20288587|P3|Overall Study|No Longer Meets Study Criteria|0
5865711|NCT02011945|20288588|P2|Overall Study|No Longer Meets Study Criteria|0
5865712|NCT02011945|20288589|P1|Overall Study|No Longer Meets Study Criteria|1
5865713|NCT02011945|20288587|P3|Overall Study|Treatment Failure|6
5865714|NCT02011945|20288588|P2|Overall Study|Treatment Failure|7
5865715|NCT02011945|20288589|P1|Overall Study|Treatment Failure|0
5865716|NCT02011945|20288587|P3|Overall Study|Study Drug Toxicity|1
5865717|NCT02011945|20288588|P2|Overall Study|Study Drug Toxicity|0
5865718|NCT02011945|20288589|P1|Overall Study|Study Drug Toxicity|0
5865719|NCT02011945|20288587|P3|Overall Study|Adverse Event unrelated to Drug|1
5865720|NCT02011945|20288588|P2|Overall Study|Adverse Event unrelated to Drug|2
5865721|NCT02011945|20288589|P1|Overall Study|Adverse Event unrelated to Drug|0
5865722|NCT02011945|20288587|P3|Overall Study|Participant requested to Discontinue|1
5865723|NCT02011945|20288588|P2|Overall Study|Participant requested to Discontinue|1
5865724|NCT02011945|20288589|P1|Overall Study|Participant requested to Discontinue|0
5865725|NCT02011893|20288666|P3|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|1
5865726|NCT02011893|20288667|P2|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0
5865727|NCT02011893|20288668|P1|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0
5865728|NCT02011893|20288666|P3|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|2
5865729|NCT02011893|20288667|P2|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0
5865730|NCT02011893|20288668|P1|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0
5865731|NCT02011893|20288666|P3|Period 1 (Randomization to 12 Weeks)|Physician Decision|1
5865732|NCT02011893|20288667|P2|Period 1 (Randomization to 12 Weeks)|Physician Decision|0
5865733|NCT02011893|20288668|P1|Period 1 (Randomization to 12 Weeks)|Physician Decision|0
5865734|NCT02011893|20288666|P3|Enrollment to Randomization|Insurance/Financial Reasons|0
5865735|NCT02011893|20288667|P2|Enrollment to Randomization|Insurance/Financial Reasons|0
5865736|NCT02011893|20288668|P1|Enrollment to Randomization|Insurance/Financial Reasons|2
5865737|NCT02011893|20288666|P3|Enrollment to Randomization|Temporary Trial Stimulation Failure|0
5865738|NCT02011893|20288667|P2|Enrollment to Randomization|Temporary Trial Stimulation Failure|0
5865739|NCT02011893|20288668|P1|Enrollment to Randomization|Temporary Trial Stimulation Failure|9
5865740|NCT02011893|20288666|P3|Enrollment to Randomization|Screening Failure|0
5865741|NCT02011893|20288667|P2|Enrollment to Randomization|Screening Failure|0
5865742|NCT02011893|20288668|P1|Enrollment to Randomization|Screening Failure|29
5865743|NCT02011893|20288666|P3|Enrollment to Randomization|Withdrawal by Subject|0
5865744|NCT02011893|20288667|P2|Enrollment to Randomization|Withdrawal by Subject|0
5865745|NCT02011893|20288668|P1|Enrollment to Randomization|Withdrawal by Subject|21
5865746|NCT02011893|20288666|P3|Enrollment to Randomization|Physician Decision|0
5865747|NCT02011893|20288667|P2|Enrollment to Randomization|Physician Decision|0
5865748|NCT02011893|20288668|P1|Enrollment to Randomization|Physician Decision|10
5865749|NCT02011893|20288666|P3|Enrollment to Randomization|Adverse Event|0
5865750|NCT02011893|20288667|P2|Enrollment to Randomization|Adverse Event|0
5865751|NCT02011893|20288668|P1|Enrollment to Randomization|Adverse Event|2
5865752|NCT02011542|20288679|P1|Overall Study|Physician Decision|1
5865753|NCT02011386|20288810|P1|Overall Study|Lack of Efficacy|3
5865754|NCT02011386|20288810|P1|Overall Study|Non-compliance|2
5865755|NCT02011113|20288824|P1|Overall Study|Study terminated by sponsor|11
5865756|NCT02011113|20288824|P1|Overall Study|Investigator's judgement- DP|3
5865757|NCT02011113|20288824|P1|Overall Study|Insufficient effect of Pomalidomide|1
5865758|NCT02011113|20288824|P1|Overall Study|Death|1
5865759|NCT02011113|20288824|P1|Overall Study|Disease Progression (DP)|16
5865760|NCT02011113|20288824|P1|Overall Study|Adverse Event|4
5865761|NCT02010775|20288856|P5|Overall Study|Personal Reasons|4
5865762|NCT02010775|20288857|P4|Overall Study|Personal Reasons|2
5865763|NCT02010775|20288858|P3|Overall Study|Personal Reasons|1
5865764|NCT02010775|20288859|P2|Overall Study|Personal Reasons|3
5865765|NCT02010775|20288860|P1|Overall Study|Personal Reasons|3
5865766|NCT02010775|20288856|P5|Overall Study|Lost to Follow-up|1
5865767|NCT02010775|20288857|P4|Overall Study|Lost to Follow-up|1
5865768|NCT02010775|20288858|P3|Overall Study|Lost to Follow-up|0
5865769|NCT02010775|20288859|P2|Overall Study|Lost to Follow-up|0
5865770|NCT02010775|20288860|P1|Overall Study|Lost to Follow-up|2
5865771|NCT02010775|20288856|P5|Overall Study|Pregnancy|0
5865772|NCT02010775|20288857|P4|Overall Study|Pregnancy|0
5865773|NCT02010775|20288858|P3|Overall Study|Pregnancy|2
5865774|NCT02010775|20288859|P2|Overall Study|Pregnancy|0
5865775|NCT02010775|20288860|P1|Overall Study|Pregnancy|0
5865776|NCT02010775|20288856|P5|Overall Study|Adverse Event|1
5865777|NCT02010775|20288857|P4|Overall Study|Adverse Event|0
5865778|NCT02010775|20288858|P3|Overall Study|Adverse Event|0
5865779|NCT02010775|20288859|P2|Overall Study|Adverse Event|0
5865780|NCT02010775|20288860|P1|Overall Study|Adverse Event|0
5865781|NCT02010684|20288901|P2|Overall Study|Withdrawal by Subject|5
5865782|NCT02010684|20288902|P1|Overall Study|Withdrawal by Subject|4
5865783|NCT02010684|20288901|P2|Overall Study|Lost to Follow-up|18
5865784|NCT02010684|20288902|P1|Overall Study|Lost to Follow-up|8
5865785|NCT02010632|20288924|P2|Second Intervention (7 Days)|Withdrawal by Subject|0
5865786|NCT02010632|20288925|P1|Second Intervention (7 Days)|Withdrawal by Subject|1
5865787|NCT02010567|20288936|P5|Overall Study|Adverse Event|1
5865788|NCT02010567|20288937|P4|Overall Study|Adverse Event|0
5865789|NCT02010567|20288938|P3|Overall Study|Adverse Event|1
5865790|NCT02010567|20288939|P2|Overall Study|Adverse Event|0
5865791|NCT02010567|20288940|P1|Overall Study|Adverse Event|0
5865792|NCT02010255|20288996|P14|Overall Study|Randomized but Not Treated|1
5865793|NCT02010255|20288997|P13|Overall Study|Randomized but Not Treated|0
5865794|NCT02010255|20288998|P12|Overall Study|Randomized but Not Treated|0
5865795|NCT02010255|20288999|P11|Overall Study|Randomized but Not Treated|0
5865796|NCT02010255|20289000|P10|Overall Study|Randomized but Not Treated|0
5865797|NCT02010255|20289001|P9|Overall Study|Randomized but Not Treated|0
5865798|NCT02010255|20289002|P8|Overall Study|Randomized but Not Treated|0
5865799|NCT02010255|20289003|P7|Overall Study|Randomized but Not Treated|0
5865800|NCT02010255|20289004|P6|Overall Study|Randomized but Not Treated|0
5865801|NCT02010255|20289005|P5|Overall Study|Randomized but Not Treated|0
5865802|NCT02010255|20289006|P4|Overall Study|Randomized but Not Treated|0
5865803|NCT02010255|20289007|P3|Overall Study|Randomized but Not Treated|0
5865804|NCT02010255|20289008|P2|Overall Study|Randomized but Not Treated|0
5865805|NCT02010255|20289009|P1|Overall Study|Randomized but Not Treated|0
5865806|NCT02010255|20288996|P14|Overall Study|Lost to Follow-up|0
5865807|NCT02010255|20288997|P13|Overall Study|Lost to Follow-up|0
5865808|NCT02010255|20288998|P12|Overall Study|Lost to Follow-up|0
5865809|NCT02010255|20288999|P11|Overall Study|Lost to Follow-up|0
5865810|NCT02010255|20289000|P10|Overall Study|Lost to Follow-up|0
5865811|NCT02010255|20289001|P9|Overall Study|Lost to Follow-up|0
5865812|NCT02010255|20289002|P8|Overall Study|Lost to Follow-up|0
5865813|NCT02010255|20289003|P7|Overall Study|Lost to Follow-up|0
5865814|NCT02010255|20289004|P6|Overall Study|Lost to Follow-up|0
5865815|NCT02010255|20289005|P5|Overall Study|Lost to Follow-up|1
5865816|NCT02010255|20289006|P4|Overall Study|Lost to Follow-up|0
5865817|NCT02010255|20289007|P3|Overall Study|Lost to Follow-up|1
5865818|NCT02010255|20289008|P2|Overall Study|Lost to Follow-up|0
5865819|NCT02010255|20289009|P1|Overall Study|Lost to Follow-up|0
5865820|NCT02010255|20288996|P14|Overall Study|Adverse Event|0
5865821|NCT02010255|20288997|P13|Overall Study|Adverse Event|0
5865822|NCT02010255|20288998|P12|Overall Study|Adverse Event|0
5865823|NCT02010255|20288999|P11|Overall Study|Adverse Event|0
5865824|NCT02010255|20289000|P10|Overall Study|Adverse Event|0
5865825|NCT02010255|20289001|P9|Overall Study|Adverse Event|0
5865826|NCT02010255|20289002|P8|Overall Study|Adverse Event|0
5865827|NCT02010255|20289003|P7|Overall Study|Adverse Event|0
5865828|NCT02010255|20289004|P6|Overall Study|Adverse Event|0
5865829|NCT02010255|20289005|P5|Overall Study|Adverse Event|0
5865830|NCT02010255|20289006|P4|Overall Study|Adverse Event|0
5865831|NCT02010255|20289007|P3|Overall Study|Adverse Event|0
5865832|NCT02010255|20289008|P2|Overall Study|Adverse Event|0
5865833|NCT02010255|20289009|P1|Overall Study|Adverse Event|1
5865834|NCT02010255|20288996|P14|Overall Study|Withdrew Consent|0
5865835|NCT02010255|20288997|P13|Overall Study|Withdrew Consent|0
5865836|NCT02010255|20288998|P12|Overall Study|Withdrew Consent|0
5865837|NCT02010255|20288999|P11|Overall Study|Withdrew Consent|0
5865838|NCT02010255|20289000|P10|Overall Study|Withdrew Consent|0
5865839|NCT02010255|20289001|P9|Overall Study|Withdrew Consent|0
5865840|NCT02010255|20289002|P8|Overall Study|Withdrew Consent|0
5865841|NCT02010255|20289003|P7|Overall Study|Withdrew Consent|0
5865842|NCT02010255|20289004|P6|Overall Study|Withdrew Consent|0
5865843|NCT02010255|20289005|P5|Overall Study|Withdrew Consent|0
5865844|NCT02010255|20289006|P4|Overall Study|Withdrew Consent|1
5865845|NCT02010255|20289007|P3|Overall Study|Withdrew Consent|0
5865846|NCT02010255|20289008|P2|Overall Study|Withdrew Consent|0
5865847|NCT02010255|20289009|P1|Overall Study|Withdrew Consent|1
5865848|NCT02010255|20288996|P14|Overall Study|Lack of Efficacy|0
5865849|NCT02010255|20288997|P13|Overall Study|Lack of Efficacy|0
5865850|NCT02010255|20288998|P12|Overall Study|Lack of Efficacy|0
5865851|NCT02010255|20288999|P11|Overall Study|Lack of Efficacy|1
5865852|NCT02010255|20289000|P10|Overall Study|Lack of Efficacy|0
5865853|NCT02010255|20289001|P9|Overall Study|Lack of Efficacy|0
5865854|NCT02010255|20289002|P8|Overall Study|Lack of Efficacy|0
5865855|NCT02010255|20289003|P7|Overall Study|Lack of Efficacy|0
5865856|NCT02010255|20289004|P6|Overall Study|Lack of Efficacy|0
5865857|NCT02010255|20289005|P5|Overall Study|Lack of Efficacy|1
5865858|NCT02010255|20289006|P4|Overall Study|Lack of Efficacy|1
5865859|NCT02010255|20289007|P3|Overall Study|Lack of Efficacy|2
5865860|NCT02010255|20289008|P2|Overall Study|Lack of Efficacy|1
5865861|NCT02010255|20289009|P1|Overall Study|Lack of Efficacy|4
5865862|NCT02010255|20288996|P14|Overall Study|Death|0
5865863|NCT02010255|20288997|P13|Overall Study|Death|0
5865864|NCT02010255|20288998|P12|Overall Study|Death|1
5865865|NCT02010255|20288999|P11|Overall Study|Death|1
5865866|NCT02010255|20289000|P10|Overall Study|Death|0
5865867|NCT02010255|20289001|P9|Overall Study|Death|1
5865868|NCT02010255|20289002|P8|Overall Study|Death|1
5865869|NCT02010255|20289003|P7|Overall Study|Death|1
5865870|NCT02010255|20289004|P6|Overall Study|Death|0
5865871|NCT02010255|20289005|P5|Overall Study|Death|2
5865872|NCT02010255|20289006|P4|Overall Study|Death|4
5865873|NCT02010255|20289007|P3|Overall Study|Death|4
5865874|NCT02010255|20289008|P2|Overall Study|Death|1
5865875|NCT02010255|20289009|P1|Overall Study|Death|0
5865876|NCT02009930|20289454|P1|Overall Study|withdrawn|5
5865877|NCT02009878|20289479|P3|Overall Study|Participant Met Withdrawal Criteria|0
5865878|NCT02009878|20289480|P2|Overall Study|Participant Met Withdrawal Criteria|1
5865879|NCT02009878|20289481|P1|Overall Study|Participant Met Withdrawal Criteria|0
5865880|NCT02009865|20289515|P2|Overall Study|Withdrawal by Subject|1
5865881|NCT02009865|20289516|P1|Overall Study|Withdrawal by Subject|1
5865882|NCT02009865|20289515|P2|Overall Study|Protocol Violation|2
5865883|NCT02009865|20289516|P1|Overall Study|Protocol Violation|0
5865884|NCT02009865|20289515|P2|Overall Study|Adverse Event|2
5865885|NCT02009865|20289516|P1|Overall Study|Adverse Event|0
5865886|NCT02009722|20289532|P2|Overall Study|Did not receive intervention|1
5865887|NCT02009722|20289533|P1|Overall Study|Did not receive intervention|0
5865888|NCT02009722|20289532|P2|Overall Study|Protocol Violation|2
5865889|NCT02009722|20289533|P1|Overall Study|Protocol Violation|1
5865890|NCT02009696|20289557|P1|Overall Study|Withdrawal by Subject|2
5865891|NCT02009163|20289574|P3|Randomized-withdrawal Period|Other|5
5865892|NCT02009163|20289575|P2|Randomized-withdrawal Period|Other|9
5865893|NCT02009163|20289576|P1|Randomized-withdrawal Period|Other|0
5865894|NCT02009163|20289574|P3|Randomized-withdrawal Period|Pregnancy|2
5865895|NCT02009163|20289575|P2|Randomized-withdrawal Period|Pregnancy|0
5865896|NCT02009163|20289576|P1|Randomized-withdrawal Period|Pregnancy|0
5865897|NCT02009163|20289574|P3|Randomized-withdrawal Period|Protocol Violation|2
5865898|NCT02009163|20289575|P2|Randomized-withdrawal Period|Protocol Violation|1
5865899|NCT02009163|20289576|P1|Randomized-withdrawal Period|Protocol Violation|0
5865900|NCT02009163|20289574|P3|Randomized-withdrawal Period|Relapse Criteria Met|5
5865901|NCT02009163|20289575|P2|Randomized-withdrawal Period|Relapse Criteria Met|40
5865902|NCT02009163|20289576|P1|Randomized-withdrawal Period|Relapse Criteria Met|0
5865903|NCT02009163|20289574|P3|Randomized-withdrawal Period|Adverse Event|6
5865904|NCT02009163|20289575|P2|Randomized-withdrawal Period|Adverse Event|0
5865905|NCT02009163|20289576|P1|Randomized-withdrawal Period|Adverse Event|0
5865906|NCT02009163|20289574|P3|Randomized-withdrawal Period|Lost to Follow-up|6
5865907|NCT02009163|20289575|P2|Randomized-withdrawal Period|Lost to Follow-up|13
5865908|NCT02009163|20289576|P1|Randomized-withdrawal Period|Lost to Follow-up|0
5865909|NCT02009163|20289574|P3|Randomized-withdrawal Period|Withdrawal by Subject|9
5865910|NCT02009163|20289575|P2|Randomized-withdrawal Period|Withdrawal by Subject|25
5865911|NCT02009163|20289576|P1|Randomized-withdrawal Period|Withdrawal by Subject|0
5865912|NCT02009163|20289574|P3|Open-label Period (Non-randomized)|Other|0
5865913|NCT02009163|20289575|P2|Open-label Period (Non-randomized)|Other|0
5865914|NCT02009163|20289576|P1|Open-label Period (Non-randomized)|Other|13
5865915|NCT02009163|20289574|P3|Open-label Period (Non-randomized)|Pregnancy|0
5865916|NCT02009163|20289575|P2|Open-label Period (Non-randomized)|Pregnancy|0
5865917|NCT02009163|20289576|P1|Open-label Period (Non-randomized)|Pregnancy|1
5865918|NCT02009163|20289574|P3|Open-label Period (Non-randomized)|Protocol Violation|0
5865919|NCT02009163|20289575|P2|Open-label Period (Non-randomized)|Protocol Violation|0
5865920|NCT02009163|20289576|P1|Open-label Period (Non-randomized)|Protocol Violation|10
5865921|NCT02009163|20289574|P3|Open-label Period (Non-randomized)|Lost to Follow-up|0
5865922|NCT02009163|20289575|P2|Open-label Period (Non-randomized)|Lost to Follow-up|0
5865923|NCT02009163|20289576|P1|Open-label Period (Non-randomized)|Lost to Follow-up|20
5865924|NCT02009163|20289574|P3|Open-label Period (Non-randomized)|Adverse Event|0
5865925|NCT02009163|20289575|P2|Open-label Period (Non-randomized)|Adverse Event|0
5865926|NCT02009163|20289576|P1|Open-label Period (Non-randomized)|Adverse Event|22
5865927|NCT02009163|20289574|P3|Open-label Period (Non-randomized)|Withdrawal by Subject|0
5865928|NCT02009163|20289575|P2|Open-label Period (Non-randomized)|Withdrawal by Subject|0
5865929|NCT02009163|20289576|P1|Open-label Period (Non-randomized)|Withdrawal by Subject|29
5865930|NCT02009163|20289574|P3|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0
5865931|NCT02009163|20289575|P2|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0
5865932|NCT02009163|20289576|P1|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|48
5865933|NCT02009046|20289611|P2|Overall Study|Lost to Follow-up|206
5865934|NCT02009046|20289612|P1|Overall Study|Lost to Follow-up|256
5865935|NCT02008916|20289672|P3|Week 16 - 156|Physician Decision|0
5865936|NCT02008916|20289673|P2|Week 16 - 156|Physician Decision|1
5865937|NCT02008916|20289674|P1|Week 16 - 156|Physician Decision|0
5865938|NCT02008916|20289672|P3|Week 16 - 156|Pregnancy|0
5865939|NCT02008916|20289673|P2|Week 16 - 156|Pregnancy|1
5865940|NCT02008916|20289674|P1|Week 16 - 156|Pregnancy|0
5865941|NCT02008916|20289672|P3|Week 16 - 156|Lack of Efficacy|2
5865942|NCT02008916|20289673|P2|Week 16 - 156|Lack of Efficacy|5
5865943|NCT02008916|20289674|P1|Week 16 - 156|Lack of Efficacy|3
5865944|NCT02008916|20289672|P3|Week 16 - 156|Lost to Follow-up|0
5865945|NCT02008916|20289673|P2|Week 16 - 156|Lost to Follow-up|0
5865946|NCT02008916|20289674|P1|Week 16 - 156|Lost to Follow-up|5
5865947|NCT02008916|20289672|P3|Week 16 - 156|No longer requires treatment|0
5865948|NCT02008916|20289673|P2|Week 16 - 156|No longer requires treatment|1
5865949|NCT02008916|20289674|P1|Week 16 - 156|No longer requires treatment|0
5865950|NCT02008916|20289672|P3|Week 16 - 156|Withdrawal by Subject|5
5865951|NCT02008916|20289673|P2|Week 16 - 156|Withdrawal by Subject|3
5865952|NCT02008916|20289674|P1|Week 16 - 156|Withdrawal by Subject|7
5865953|NCT02008916|20289672|P3|Week 16 - 156|Adverse Event|3
5865954|NCT02008916|20289673|P2|Week 16 - 156|Adverse Event|2
5865955|NCT02008916|20289674|P1|Week 16 - 156|Adverse Event|4
5865956|NCT02008916|20289672|P3|Primary Assessment (up to Week 16)|Withdrawal by Subject|3
5865957|NCT02008916|20289673|P2|Primary Assessment (up to Week 16)|Withdrawal by Subject|1
5865958|NCT02008916|20289674|P1|Primary Assessment (up to Week 16)|Withdrawal by Subject|0
5865959|NCT02008890|20289710|P5|Extension Period|Adverse Event|2
5865960|NCT02008890|20289711|P4|Extension Period|Adverse Event|0
5865961|NCT02008890|20289712|P3|Extension Period|Adverse Event|0
5865962|NCT02008890|20289713|P2|Extension Period|Adverse Event|3
5865963|NCT02008890|20289714|P1|Extension Period|Adverse Event|1
5865964|NCT02008890|20289710|P5|Extension Period|Lost to Follow-up|0
5865965|NCT02008890|20289711|P4|Extension Period|Lost to Follow-up|0
5865966|NCT02008890|20289712|P3|Extension Period|Lost to Follow-up|0
5865967|NCT02008890|20289713|P2|Extension Period|Lost to Follow-up|0
5865968|NCT02008890|20289714|P1|Extension Period|Lost to Follow-up|1
5865969|NCT02008890|20289710|P5|Extension Period|Withdrawal by Subject|2
5865970|NCT02008890|20289711|P4|Extension Period|Withdrawal by Subject|4
5865971|NCT02008890|20289712|P3|Extension Period|Withdrawal by Subject|0
5865972|NCT02008890|20289713|P2|Extension Period|Withdrawal by Subject|2
5865973|NCT02008890|20289714|P1|Extension Period|Withdrawal by Subject|3
5865974|NCT02008890|20289710|P5|Period 2|Lost to Follow-up|0
5865975|NCT02008890|20289711|P4|Period 2|Lost to Follow-up|0
5865976|NCT02008890|20289712|P3|Period 2|Lost to Follow-up|1
5865977|NCT02008890|20289713|P2|Period 2|Lost to Follow-up|0
5865978|NCT02008890|20289714|P1|Period 2|Lost to Follow-up|0
5865979|NCT02008890|20289710|P5|Period 2|Physician Decision|1
5865980|NCT02008890|20289711|P4|Period 2|Physician Decision|2
5865981|NCT02008890|20289712|P3|Period 2|Physician Decision|0
5865982|NCT02008890|20289713|P2|Period 2|Physician Decision|0
5865983|NCT02008890|20289714|P1|Period 2|Physician Decision|4
5865984|NCT02008890|20289710|P5|Period 2|Withdrawal by Subject|2
5865985|NCT02008890|20289711|P4|Period 2|Withdrawal by Subject|7
5865986|NCT02008890|20289712|P3|Period 2|Withdrawal by Subject|0
5865987|NCT02008890|20289713|P2|Period 2|Withdrawal by Subject|8
5865988|NCT02008890|20289714|P1|Period 2|Withdrawal by Subject|11
5865989|NCT02008890|20289710|P5|Period 2|Adverse Event|5
5865990|NCT02008890|20289711|P4|Period 2|Adverse Event|5
5865991|NCT02008890|20289712|P3|Period 2|Adverse Event|0
5865992|NCT02008890|20289713|P2|Period 2|Adverse Event|7
5865993|NCT02008890|20289714|P1|Period 2|Adverse Event|12
5865994|NCT02008890|20289710|P5|Period 1|Adverse Event|0
5865995|NCT02008890|20289711|P4|Period 1|Adverse Event|0
5865996|NCT02008890|20289712|P3|Period 1|Adverse Event|6
5865997|NCT02008890|20289713|P2|Period 1|Adverse Event|8
5865998|NCT02008890|20289714|P1|Period 1|Adverse Event|6
5865999|NCT02008890|20289710|P5|Period 1|Physician Decision|0
5866000|NCT02008890|20289711|P4|Period 1|Physician Decision|0
5866001|NCT02008890|20289712|P3|Period 1|Physician Decision|1
5866002|NCT02008890|20289713|P2|Period 1|Physician Decision|0
5866003|NCT02008890|20289714|P1|Period 1|Physician Decision|1
5866004|NCT02008890|20289710|P5|Period 1|Pregnancy|0
5866005|NCT02008890|20289711|P4|Period 1|Pregnancy|0
5866006|NCT02008890|20289712|P3|Period 1|Pregnancy|0
5866007|NCT02008890|20289713|P2|Period 1|Pregnancy|0
5866008|NCT02008890|20289714|P1|Period 1|Pregnancy|1
5866009|NCT02008890|20289710|P5|Period 1|Withdrawal by Subject|0
5866010|NCT02008890|20289711|P4|Period 1|Withdrawal by Subject|0
5866011|NCT02008890|20289712|P3|Period 1|Withdrawal by Subject|5
5866012|NCT02008890|20289713|P2|Period 1|Withdrawal by Subject|7
5866013|NCT02008890|20289714|P1|Period 1|Withdrawal by Subject|7
5866014|NCT02008877|20289750|P3|Overall Study|Inevaluable|0
5866015|NCT02008877|20289751|P2|Overall Study|Inevaluable|1
5866016|NCT02008877|20289752|P1|Overall Study|Inevaluable|0
5866017|NCT02008773|20289771|P4|Overall Study|Lost to Follow-up|2
5866018|NCT02008773|20289772|P3|Overall Study|Lost to Follow-up|3
5866019|NCT02008773|20289773|P2|Overall Study|Lost to Follow-up|1
5866020|NCT02008773|20289774|P1|Overall Study|Lost to Follow-up|0
5866021|NCT02008773|20289771|P4|Overall Study|Withdrawal by Subject|6
5866022|NCT02008773|20289772|P3|Overall Study|Withdrawal by Subject|7
5866023|NCT02008773|20289773|P2|Overall Study|Withdrawal by Subject|4
5866024|NCT02008773|20289774|P1|Overall Study|Withdrawal by Subject|8
5866025|NCT02008773|20289771|P4|Overall Study|Medication Non-compliance|2
5866026|NCT02008773|20289772|P3|Overall Study|Medication Non-compliance|3
5866027|NCT02008773|20289773|P2|Overall Study|Medication Non-compliance|1
5866028|NCT02008773|20289774|P1|Overall Study|Medication Non-compliance|2
5866029|NCT02008773|20289771|P4|Overall Study|Adverse Event|2
5866030|NCT02008773|20289772|P3|Overall Study|Adverse Event|1
5866031|NCT02008773|20289773|P2|Overall Study|Adverse Event|3
5866032|NCT02008773|20289774|P1|Overall Study|Adverse Event|3
5866033|NCT02008565|20289840|P4|Overall Study|Protocol Violation|0
5866034|NCT02008565|20289841|P3|Overall Study|Protocol Violation|2
5866035|NCT02008565|20289842|P2|Overall Study|Protocol Violation|1
5866036|NCT02008565|20289843|P1|Overall Study|Protocol Violation|1
5866037|NCT02008526|20289904|P3|Overall Study|Lost to Follow-up|6
5866038|NCT02008526|20289905|P2|Overall Study|Lost to Follow-up|9
5866039|NCT02008526|20289906|P1|Overall Study|Lost to Follow-up|5
5866040|NCT02008526|20289904|P3|Overall Study|Withdrawal by Subject|2
5866041|NCT02008526|20289905|P2|Overall Study|Withdrawal by Subject|3
5866042|NCT02008526|20289906|P1|Overall Study|Withdrawal by Subject|3
5866043|NCT02008526|20289904|P3|Overall Study|Death|1
5866044|NCT02008526|20289905|P2|Overall Study|Death|2
5866045|NCT02008526|20289906|P1|Overall Study|Death|0
5866046|NCT02008396|20289919|P2|Overall Study|Protocol Violation|1
5866047|NCT02008396|20289920|P1|Overall Study|Protocol Violation|0
5866048|NCT02008370|20289930|P1|Overall Study|Lost to Follow-up|7
5866049|NCT02008318|20289938|P2|Overall Study|Withdrawal by Subject|0
5866050|NCT02008318|20289939|P1|Overall Study|Withdrawal by Subject|3
5866051|NCT02008318|20289938|P2|Overall Study|Protocol Violation|1
5866052|NCT02008318|20289939|P1|Overall Study|Protocol Violation|1
5866053|NCT02008318|20289938|P2|Overall Study|Progressive Disease|0
5866054|NCT02008318|20289939|P1|Overall Study|Progressive Disease|2
5866055|NCT02008318|20289938|P2|Overall Study|Physician Decision|0
5866056|NCT02008318|20289939|P1|Overall Study|Physician Decision|2
5866057|NCT02008318|20289938|P2|Overall Study|Adverse Event|0
5866058|NCT02008318|20289939|P1|Overall Study|Adverse Event|4
5866059|NCT02008227|20289960|P2|Overall Study|Study Terminated By Sponsor|83
5866060|NCT02008227|20289961|P1|Overall Study|Study Terminated By Sponsor|44
5866061|NCT02008227|20289960|P2|Overall Study|Withdrawal by Subject|36
5866062|NCT02008227|20289961|P1|Overall Study|Withdrawal by Subject|67
5866063|NCT02008227|20289960|P2|Overall Study|Death|485
5866064|NCT02008227|20289961|P1|Overall Study|Death|494
5866065|NCT02008227|20289960|P2|Overall Study|Lost to Follow-up|9
5866066|NCT02008227|20289961|P1|Overall Study|Lost to Follow-up|7
5866067|NCT02007954|20290049|P1|Overall Study|Death|1
5866068|NCT02007954|20290049|P1|Overall Study|Disease progression and unrelated AE|1
5866069|NCT02007954|20290049|P1|Overall Study|Switch in treatment modality|2
5866070|NCT02007954|20290049|P1|Overall Study|Received liver transplant|3
5866071|NCT02007720|20290068|P2|Overall Study|patient followd less than 165 days|5
5866072|NCT02007720|20290069|P1|Overall Study|patient followd less than 165 days|11
5866073|NCT02007720|20290068|P2|Overall Study|technical problem|2
5866074|NCT02007720|20290069|P1|Overall Study|technical problem|4
5866075|NCT02007720|20290068|P2|Overall Study|study terminated by sponsor|54
5866076|NCT02007720|20290069|P1|Overall Study|study terminated by sponsor|58
5866077|NCT02007720|20290068|P2|Overall Study|Withdrawal by Subject|11
5866078|NCT02007720|20290069|P1|Overall Study|Withdrawal by Subject|9
5866079|NCT02007577|20290104|P2|Overall Study|Withdrawal by Subject|1
5866080|NCT02007577|20290105|P1|Overall Study|Withdrawal by Subject|0
5866081|NCT02007577|20290104|P2|Overall Study|Adverse Event|0
5866082|NCT02007577|20290105|P1|Overall Study|Adverse Event|1
5866083|NCT02007512|20290117|P4|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|0
5866084|NCT02007512|20290118|P3|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|0
5866085|NCT02007512|20290119|P2|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|3
5866086|NCT02007512|20290120|P1|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|0
5866087|NCT02007512|20290117|P4|Open Label Treatment Period|Disease progression|11
5866088|NCT02007512|20290118|P3|Open Label Treatment Period|Disease progression|0
5866089|NCT02007512|20290119|P2|Open Label Treatment Period|Disease progression|17
5866090|NCT02007512|20290120|P1|Open Label Treatment Period|Disease progression|0
5866091|NCT02007512|20290117|P4|Open Label Treatment Period|Other|1
5866092|NCT02007512|20290118|P3|Open Label Treatment Period|Other|0
5866093|NCT02007512|20290119|P2|Open Label Treatment Period|Other|0
5866094|NCT02007512|20290120|P1|Open Label Treatment Period|Other|0
5866095|NCT02007512|20290117|P4|Open Label Treatment Period|Adverse Event|0
5866096|NCT02007512|20290118|P3|Open Label Treatment Period|Adverse Event|0
5866097|NCT02007512|20290119|P2|Open Label Treatment Period|Adverse Event|1
5866098|NCT02007512|20290120|P1|Open Label Treatment Period|Adverse Event|0
5866099|NCT02007512|20290117|P4|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|1
5866100|NCT02007512|20290118|P3|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|5
5866101|NCT02007512|20290119|P2|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|11
5866102|NCT02007512|20290120|P1|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|10
5866103|NCT02007512|20290117|P4|Double Blind Treatment Period|Other|2
5866104|NCT02007512|20290118|P3|Double Blind Treatment Period|Other|1
5866105|NCT02007512|20290119|P2|Double Blind Treatment Period|Other|0
5866106|NCT02007512|20290120|P1|Double Blind Treatment Period|Other|0
5866107|NCT02007512|20290117|P4|Double Blind Treatment Period|Protocol Violation|1
5866108|NCT02007512|20290118|P3|Double Blind Treatment Period|Protocol Violation|0
5866109|NCT02007512|20290119|P2|Double Blind Treatment Period|Protocol Violation|0
5866110|NCT02007512|20290120|P1|Double Blind Treatment Period|Protocol Violation|0
5866111|NCT02007512|20290117|P4|Double Blind Treatment Period|Withdrawal by Subject|3
5866112|NCT02007512|20290118|P3|Double Blind Treatment Period|Withdrawal by Subject|3
5866113|NCT02007512|20290119|P2|Double Blind Treatment Period|Withdrawal by Subject|2
5866114|NCT02007512|20290120|P1|Double Blind Treatment Period|Withdrawal by Subject|4
5866115|NCT02007512|20290117|P4|Double Blind Treatment Period|Disease progression|51
5866116|NCT02007512|20290118|P3|Double Blind Treatment Period|Disease progression|45
5866117|NCT02007512|20290119|P2|Double Blind Treatment Period|Disease progression|49
5866118|NCT02007512|20290120|P1|Double Blind Treatment Period|Disease progression|44
5866119|NCT02007512|20290117|P4|Double Blind Treatment Period|Death|0
5866120|NCT02007512|20290118|P3|Double Blind Treatment Period|Death|0
5866121|NCT02007512|20290119|P2|Double Blind Treatment Period|Death|0
5866122|NCT02007512|20290120|P1|Double Blind Treatment Period|Death|1
5866123|NCT02007512|20290117|P4|Double Blind Treatment Period|Adverse Event|2
5866124|NCT02007512|20290118|P3|Double Blind Treatment Period|Adverse Event|6
5866125|NCT02007512|20290119|P2|Double Blind Treatment Period|Adverse Event|2
5866126|NCT02007512|20290120|P1|Double Blind Treatment Period|Adverse Event|4
5866127|NCT02007434|20290198|P8|Overall Study|Non-compliance|0
5866128|NCT02007434|20290199|P7|Overall Study|Non-compliance|0
5866129|NCT02007434|20290200|P6|Overall Study|Non-compliance|0
5866130|NCT02007434|20290201|P5|Overall Study|Non-compliance|0
5866131|NCT02007434|20290202|P4|Overall Study|Non-compliance|0
5866132|NCT02007434|20290203|P3|Overall Study|Non-compliance|1
5866133|NCT02007434|20290204|P2|Overall Study|Non-compliance|0
5866134|NCT02007434|20290205|P1|Overall Study|Non-compliance|1
5866135|NCT02007434|20290198|P8|Overall Study|Lost to Follow-up|0
5866136|NCT02007434|20290199|P7|Overall Study|Lost to Follow-up|0
5866137|NCT02007434|20290200|P6|Overall Study|Lost to Follow-up|0
5866138|NCT02007434|20290201|P5|Overall Study|Lost to Follow-up|0
5866139|NCT02007434|20290202|P4|Overall Study|Lost to Follow-up|0
5866140|NCT02007434|20290203|P3|Overall Study|Lost to Follow-up|0
5866141|NCT02007434|20290204|P2|Overall Study|Lost to Follow-up|1
5866142|NCT02007434|20290205|P1|Overall Study|Lost to Follow-up|0
5866143|NCT02007278|20290336|P2|Overall Study|Mis-randomization|1
5866144|NCT02007278|20290337|P1|Overall Study|Mis-randomization|1
5866145|NCT02007278|20290336|P2|Overall Study|Incorrect medication administration|0
5866146|NCT02007278|20290337|P1|Overall Study|Incorrect medication administration|1
5866147|NCT02007278|20290336|P2|Overall Study|Ingestion of drugs not allowed in study|1
5866148|NCT02007278|20290337|P1|Overall Study|Ingestion of drugs not allowed in study|0
5866149|NCT02007278|20290336|P2|Overall Study|Failure to comply with an eligibility|1
5866150|NCT02007278|20290337|P1|Overall Study|Failure to comply with an eligibility|0
5866151|NCT02007252|20290359|P2|Overall Study|Adverse Event|4
5866152|NCT02007252|20290360|P1|Overall Study|Adverse Event|7
5866153|NCT02007252|20290359|P2|Overall Study|Abnormal laboratory value(s)|0
5866154|NCT02007252|20290360|P1|Overall Study|Abnormal laboratory value(s)|1
5866155|NCT02007252|20290359|P2|Overall Study|Administrative problems|7
5866156|NCT02007252|20290360|P1|Overall Study|Administrative problems|3
5866157|NCT02007109|20290373|P1|Overall Study|Excluded - Age<7yo|9
5866158|NCT02007109|20290373|P1|Overall Study|Diary not returned or excluded|102
5866159|NCT02007096|20290382|P2|Overall Study|no mesh placed|1
5866160|NCT02007096|20290383|P1|Overall Study|no mesh placed|0
5866161|NCT02007096|20290382|P2|Overall Study|converted to open surgery|1
5866162|NCT02007096|20290383|P1|Overall Study|converted to open surgery|1
5866163|NCT02007096|20290382|P2|Overall Study|did not follow postoperative protocol|11
5866164|NCT02007096|20290383|P1|Overall Study|did not follow postoperative protocol|8
5866165|NCT02007096|20290382|P2|Overall Study|did not inject saline|3
5866166|NCT02007096|20290383|P1|Overall Study|did not inject saline|0
5866167|NCT02007096|20290382|P2|Overall Study|medication not available|0
5866168|NCT02007096|20290383|P1|Overall Study|medication not available|2
5866169|NCT02007070|20290395|P1|Overall Study|Progressive Disease|21
5866170|NCT02007070|20290395|P1|Overall Study|Physician Decision|1
5866171|NCT02007070|20290395|P1|Overall Study|Protocol Violation|2
5866172|NCT02007070|20290395|P1|Overall Study|Death|1
5866173|NCT02007070|20290395|P1|Overall Study|Clinical Progression|4
5866174|NCT02007070|20290395|P1|Overall Study|Adverse Event|4
5866175|NCT02006979|20290416|P2|Overall Study|Protocol Violation|1
5866176|NCT02006979|20290417|P1|Overall Study|Protocol Violation|0
5866177|NCT02006979|20290416|P2|Overall Study|Withdrawal by Subject|1
5866178|NCT02006979|20290417|P1|Overall Study|Withdrawal by Subject|1
5866179|NCT02006927|20290429|P1|Overall Study|Withdrawal by Subject|1
5866180|NCT02006927|20290429|P1|Overall Study|Adverse Event|2
5866181|NCT02006758|20290468|P1|Overall Study|Other|2
5866182|NCT02006758|20290468|P1|Overall Study|Procedurally excluded|1
5866183|NCT02006758|20290468|P1|Overall Study|Withdrawal by Subject|4
5866184|NCT02006758|20290468|P1|Overall Study|Lost to Follow-up|4
5866185|NCT02006758|20290468|P1|Overall Study|Death|1
5866186|NCT02006758|20290468|P1|Overall Study|Protocol Violation|1
5866187|NCT02006732|20290499|P4|Overall Study|Withdrawal by Subject|1
5866188|NCT02006732|20290500|P3|Overall Study|Withdrawal by Subject|4
5866189|NCT02006732|20290501|P2|Overall Study|Withdrawal by Subject|0
5866190|NCT02006732|20290502|P1|Overall Study|Withdrawal by Subject|3
5866191|NCT02006732|20290499|P4|Overall Study|Lost to Follow-up|0
5866192|NCT02006732|20290500|P3|Overall Study|Lost to Follow-up|0
5866193|NCT02006732|20290501|P2|Overall Study|Lost to Follow-up|1
5866194|NCT02006732|20290502|P1|Overall Study|Lost to Follow-up|0
5866195|NCT02006732|20290499|P4|Overall Study|Protocol Violation|0
5866196|NCT02006732|20290500|P3|Overall Study|Protocol Violation|0
5866197|NCT02006732|20290501|P2|Overall Study|Protocol Violation|1
5866198|NCT02006732|20290502|P1|Overall Study|Protocol Violation|1
5866199|NCT02006732|20290499|P4|Overall Study|Lack of Efficacy|1
5866200|NCT02006732|20290500|P3|Overall Study|Lack of Efficacy|1
5866201|NCT02006732|20290501|P2|Overall Study|Lack of Efficacy|3
5866202|NCT02006732|20290502|P1|Overall Study|Lack of Efficacy|6
5866203|NCT02006732|20290499|P4|Overall Study|Adverse Event|2
5866204|NCT02006732|20290500|P3|Overall Study|Adverse Event|4
5866205|NCT02006732|20290501|P2|Overall Study|Adverse Event|7
5866206|NCT02006732|20290502|P1|Overall Study|Adverse Event|10
5866207|NCT02006719|20290542|P2|Overall Study|Other/Unknown|1
5866208|NCT02006719|20290543|P1|Overall Study|Other/Unknown|0
5866209|NCT02006719|20290542|P2|Overall Study|Adverse Event|1
5866210|NCT02006719|20290543|P1|Overall Study|Adverse Event|1
5866211|NCT02006719|20290542|P2|Overall Study|Protocol Violation|0
5866212|NCT02006719|20290543|P1|Overall Study|Protocol Violation|2
5866213|NCT02006719|20290542|P2|Overall Study|Lost to Follow-up|1
5866214|NCT02006719|20290543|P1|Overall Study|Lost to Follow-up|5
5866215|NCT02006719|20290542|P2|Overall Study|Withdrawal by Subject|2
5866216|NCT02006719|20290543|P1|Overall Study|Withdrawal by Subject|10
5866217|NCT02006706|20290573|P1|Overall Study|Lost to Follow-up|1
5866218|NCT02006693|20290580|P2|Overall Study|Patient Decision|0
5866219|NCT02006693|20290581|P1|Overall Study|Patient Decision|4
5866220|NCT02006693|20290580|P2|Overall Study|Lost to Follow-up|1
5866221|NCT02006693|20290581|P1|Overall Study|Lost to Follow-up|4
5866222|NCT02006693|20290580|P2|Overall Study|Death|2
5866223|NCT02006693|20290581|P1|Overall Study|Death|2
5866224|NCT02006693|20290580|P2|Overall Study|XEN Implant Explantation|1
5866225|NCT02006693|20290581|P1|Overall Study|XEN Implant Explantation|0
5866226|NCT02006693|20290580|P2|Overall Study|Another Glaucoma-related Surgery|1
5866227|NCT02006693|20290581|P1|Overall Study|Another Glaucoma-related Surgery|12
5866228|NCT02006693|20290580|P2|Overall Study|No Reason Specified|8
5866229|NCT02006693|20290581|P1|Overall Study|No Reason Specified|6
5866230|NCT02006667|20290593|P1|Overall Study|Withdrawal by Subject|1
5866231|NCT02006667|20290593|P1|Overall Study|Death|2
5866232|NCT02006667|20290593|P1|Overall Study|Adverse Event|3
5866233|NCT02006654|20290605|P2|Overall Study|moving out of state|1
5866234|NCT02006654|20290606|P1|Overall Study|moving out of state|0
5866235|NCT02006654|20290605|P2|Overall Study|disallowed medication|0
5866236|NCT02006654|20290606|P1|Overall Study|disallowed medication|1
5866237|NCT02006654|20290605|P2|Overall Study|mood disorder|1
5866238|NCT02006654|20290606|P1|Overall Study|mood disorder|0
5866239|NCT02006654|20290605|P2|Overall Study|faecal incontinence|1
5866240|NCT02006654|20290606|P1|Overall Study|faecal incontinence|0
5866241|NCT02006654|20290605|P2|Overall Study|worsening cognitive condition|1
5866242|NCT02006654|20290606|P1|Overall Study|worsening cognitive condition|0
5866243|NCT02006654|20290605|P2|Overall Study|insufficient compliance|0
5866244|NCT02006654|20290606|P1|Overall Study|insufficient compliance|1
5866245|NCT02006654|20290605|P2|Overall Study|patient's will|1
5866246|NCT02006654|20290606|P1|Overall Study|patient's will|2
5866247|NCT02006654|20290605|P2|Overall Study|Lost to Follow-up|0
5866248|NCT02006654|20290606|P1|Overall Study|Lost to Follow-up|1
5866249|NCT02006654|20290605|P2|Overall Study|Protocol Violation|8
5866250|NCT02006654|20290606|P1|Overall Study|Protocol Violation|5
5866251|NCT02006654|20290605|P2|Overall Study|Withdrawal by Subject|12
5866252|NCT02006654|20290606|P1|Overall Study|Withdrawal by Subject|14
5866253|NCT02006654|20290605|P2|Overall Study|Death|0
5866254|NCT02006654|20290606|P1|Overall Study|Death|1
5866255|NCT02006654|20290605|P2|Overall Study|Adverse Event|17
5866256|NCT02006654|20290606|P1|Overall Study|Adverse Event|16
5866257|NCT02006654|20290605|P2|Overall Study|Withdrawal before treatment|2
5866258|NCT02006654|20290606|P1|Overall Study|Withdrawal before treatment|4
5866259|NCT02006641|20290635|P3|Overall Study|Other reason: protocol non-compliance|1
5866260|NCT02006641|20290636|P2|Overall Study|Other reason: protocol non-compliance|0
5866261|NCT02006641|20290637|P1|Overall Study|Other reason: protocol non-compliance|0
5866262|NCT02006641|20290635|P3|Overall Study|Other reason: caregiver impossibility|1
5866263|NCT02006641|20290636|P2|Overall Study|Other reason: caregiver impossibility|0
5866264|NCT02006641|20290637|P1|Overall Study|Other reason: caregiver impossibility|0
5866265|NCT02006641|20290635|P3|Overall Study|Other reason: hospitalisation|0
5866266|NCT02006641|20290636|P2|Overall Study|Other reason: hospitalisation|1
5866267|NCT02006641|20290637|P1|Overall Study|Other reason: hospitalisation|0
5866268|NCT02006641|20290635|P3|Overall Study|Other reason: patient's wife has died|1
5866269|NCT02006641|20290636|P2|Overall Study|Other reason: patient's wife has died|0
5866270|NCT02006641|20290637|P1|Overall Study|Other reason: patient's wife has died|0
5866271|NCT02006641|20290635|P3|Overall Study|Other reason: caregiver in hospital|0
5866272|NCT02006641|20290636|P2|Overall Study|Other reason: caregiver in hospital|1
5866273|NCT02006641|20290637|P1|Overall Study|Other reason: caregiver in hospital|0
5866274|NCT02006641|20290635|P3|Overall Study|Other reason: patient has moved|1
5866275|NCT02006641|20290636|P2|Overall Study|Other reason: patient has moved|0
5866276|NCT02006641|20290637|P1|Overall Study|Other reason: patient has moved|1
5866277|NCT02006641|20290635|P3|Overall Study|Other reason:patient didn't want to come|1
5866278|NCT02006641|20290636|P2|Overall Study|Other reason:patient didn't want to come|0
5866279|NCT02006641|20290637|P1|Overall Study|Other reason:patient didn't want to come|0
5866280|NCT02006641|20290635|P3|Overall Study|Other reason: patient didn't show up|0
5866281|NCT02006641|20290636|P2|Overall Study|Other reason: patient didn't show up|0
5866282|NCT02006641|20290637|P1|Overall Study|Other reason: patient didn't show up|1
5866283|NCT02006641|20290635|P3|Overall Study|Withdrawal by Subject|11
5866284|NCT02006641|20290636|P2|Overall Study|Withdrawal by Subject|12
5866285|NCT02006641|20290637|P1|Overall Study|Withdrawal by Subject|7
5866286|NCT02006641|20290635|P3|Overall Study|Lost to Follow-up|0
5866287|NCT02006641|20290636|P2|Overall Study|Lost to Follow-up|1
5866288|NCT02006641|20290637|P1|Overall Study|Lost to Follow-up|0
5866289|NCT02006641|20290635|P3|Overall Study|Protocol Violation|2
5866290|NCT02006641|20290636|P2|Overall Study|Protocol Violation|2
5866291|NCT02006641|20290637|P1|Overall Study|Protocol Violation|0
5866292|NCT02006641|20290635|P3|Overall Study|Adverse Event|15
5866293|NCT02006641|20290636|P2|Overall Study|Adverse Event|11
5866294|NCT02006641|20290637|P1|Overall Study|Adverse Event|15
5866295|NCT02006641|20290635|P3|Overall Study|Withdrawal before treatment|3
5866296|NCT02006641|20290636|P2|Overall Study|Withdrawal before treatment|5
5866297|NCT02006641|20290637|P1|Overall Study|Withdrawal before treatment|2
5866298|NCT02006628|20290677|P2|Overall Study|Withdrawal by Subject|1
5866299|NCT02006628|20290678|P1|Overall Study|Withdrawal by Subject|2
5866300|NCT02006628|20290677|P2|Overall Study|Adverse Event|1
5866301|NCT02006628|20290678|P1|Overall Study|Adverse Event|1
5866302|NCT02006576|20290703|P3|Overall Study|Screen Failure, too sick, other|13
5866303|NCT02006576|20290704|P2|Overall Study|Screen Failure, too sick, other|1
5866304|NCT02006576|20290705|P1|Overall Study|Screen Failure, too sick, other|13
5866305|NCT02006576|20290703|P3|Overall Study|Lost to Follow-up|1
5866306|NCT02006576|20290704|P2|Overall Study|Lost to Follow-up|0
5866307|NCT02006576|20290705|P1|Overall Study|Lost to Follow-up|1
5866308|NCT02006576|20290703|P3|Overall Study|Death|1
5866309|NCT02006576|20290704|P2|Overall Study|Death|0
5866310|NCT02006576|20290705|P1|Overall Study|Death|0
5866311|NCT02006576|20290703|P3|Overall Study|Withdrawal by Subject|2
5866312|NCT02006576|20290704|P2|Overall Study|Withdrawal by Subject|6
5866313|NCT02006576|20290705|P1|Overall Study|Withdrawal by Subject|4
5866314|NCT02006121|20290788|P2|Open Label Phase|Non-compliance with study drug|0
5866315|NCT02006121|20290789|P1|Open Label Phase|Non-compliance with study drug|3
5866316|NCT02006121|20290788|P2|Open Label Phase|Withdrawal by Subject|0
5866317|NCT02006121|20290789|P1|Open Label Phase|Withdrawal by Subject|3
5866318|NCT02006121|20290788|P2|Open Label Phase|Protocol Violation|0
5866319|NCT02006121|20290789|P1|Open Label Phase|Protocol Violation|2
5866320|NCT02006121|20290788|P2|Open Label Phase|Lack of Efficacy|0
5866321|NCT02006121|20290789|P1|Open Label Phase|Lack of Efficacy|2
5866322|NCT02006121|20290788|P2|Open Label Phase|Adverse Event|0
5866323|NCT02006121|20290789|P1|Open Label Phase|Adverse Event|15
5866324|NCT02006121|20290788|P2|Double Blind Phase|Inconvenience of infusion system|1
5866325|NCT02006121|20290789|P1|Double Blind Phase|Inconvenience of infusion system|0
5866326|NCT02006121|20290788|P2|Double Blind Phase|Minimum infusion rate poorly tolerated|0
5866412|NCT02004522|20291293|P1|Overall Study|Other is reason listed by PI.|4
5866327|NCT02006121|20290789|P1|Double Blind Phase|Minimum infusion rate poorly tolerated|1
5866328|NCT02006121|20290788|P2|Double Blind Phase|Non-compliance with study drug|3
5866329|NCT02006121|20290789|P1|Double Blind Phase|Non-compliance with study drug|1
5866330|NCT02006121|20290788|P2|Double Blind Phase|Withdrawal by Subject|4
5866331|NCT02006121|20290789|P1|Double Blind Phase|Withdrawal by Subject|3
5866332|NCT02006121|20290788|P2|Double Blind Phase|Lack of Efficacy|16
5866333|NCT02006121|20290789|P1|Double Blind Phase|Lack of Efficacy|1
5866334|NCT02006121|20290788|P2|Double Blind Phase|Adverse Event|0
5866335|NCT02006121|20290789|P1|Double Blind Phase|Adverse Event|6
5866336|NCT02005887|20290822|P2|Overall Study|Protocol Violation|2
5866337|NCT02005887|20290823|P1|Overall Study|Protocol Violation|0
5866338|NCT02005692|20290841|P1|Overall Study|Discharged earlier than anticipated|5
5866339|NCT02005692|20290841|P1|Overall Study|Withdrawal by Subject|1
5866340|NCT02005692|20290841|P1|Overall Study|Protocol Violation|1
5866341|NCT02005627|20290867|P2|Overall Study|Withdrawal by Subject|2
5866342|NCT02005627|20290868|P1|Overall Study|Withdrawal by Subject|1
5866343|NCT02005627|20290867|P2|Overall Study|Lost to Follow-up|2
5866344|NCT02005627|20290868|P1|Overall Study|Lost to Follow-up|1
5866345|NCT02005562|20290897|P2|Overall Study|Physician Decision|1
5866346|NCT02005562|20290898|P1|Overall Study|Physician Decision|0
5866347|NCT02005562|20290897|P2|Overall Study|No transplant|4
5866348|NCT02005562|20290898|P1|Overall Study|No transplant|1
5866349|NCT02005562|20290897|P2|Overall Study|Withdrawal by Subject|2
5866350|NCT02005562|20290898|P1|Overall Study|Withdrawal by Subject|2
5866351|NCT02005562|20290897|P2|Overall Study|Graft loss|6
5866352|NCT02005562|20290898|P1|Overall Study|Graft loss|7
5866353|NCT02005562|20290897|P2|Overall Study|Death|2
5866354|NCT02005562|20290898|P1|Overall Study|Death|2
5866355|NCT02005484|20290959|P1|Overall Study|Sponsor decision|1
5866356|NCT02005484|20290959|P1|Overall Study|Changed to a Different Study|1
5866357|NCT02005484|20290959|P1|Overall Study|Disease progression|1
5866358|NCT02005484|20290959|P1|Overall Study|Death|1
5866373|NCT02005445|20291027|P2|Overall Study|Dual study enrollment|1
5866374|NCT02005445|20291028|P1|Overall Study|Dual study enrollment|0
5866375|NCT02005276|20291051|P4|Overall Study|No longer interested|3
5866376|NCT02005276|20291052|P3|Overall Study|No longer interested|3
5866377|NCT02005276|20291053|P2|Overall Study|No longer interested|2
5866378|NCT02005276|20291054|P1|Overall Study|No longer interested|5
5866379|NCT02005250|20291070|P2|Overall Study|Lost to Follow-up|5
5866380|NCT02005250|20291071|P1|Overall Study|Lost to Follow-up|15
5866381|NCT02005211|20291084|P7|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
5866382|NCT02005211|20291085|P6|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
5866383|NCT02005211|20291086|P5|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|1
5866384|NCT02005211|20291087|P4|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
5866385|NCT02005211|20291088|P3|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
5866386|NCT02005211|20291089|P2|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
5866387|NCT02005211|20291090|P1|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
5866388|NCT02005029|20291125|P2|First Intervention (1 Day)|participant withdrawn for noncompliance|0
5866389|NCT02005029|20291126|P1|First Intervention (1 Day)|participant withdrawn for noncompliance|1
5866390|NCT02004886|20291183|P4|Overall Study|Unable to attend future visits|0
5866391|NCT02004886|20291184|P3|Overall Study|Unable to attend future visits|0
5866392|NCT02004886|20291185|P2|Overall Study|Unable to attend future visits|0
5866393|NCT02004886|20291186|P1|Overall Study|Unable to attend future visits|1
5866394|NCT02004886|20291183|P4|Overall Study|Adverse Event|0
5866395|NCT02004886|20291184|P3|Overall Study|Adverse Event|0
5866396|NCT02004886|20291185|P2|Overall Study|Adverse Event|1
5866397|NCT02004886|20291186|P1|Overall Study|Adverse Event|0
5866398|NCT02004873|20291236|P1|Overall Study|Withdrawal by Subject|1
5866399|NCT02004873|20291236|P1|Overall Study|Death|23
5866400|NCT02004873|20291236|P1|Overall Study|Missed 6-month visit|4
5866401|NCT02004873|20291236|P1|Overall Study|Awaiting 6-month visit|390
5866402|NCT02004873|20291236|P1|Overall Study|Implant unsuccessful|6
5866403|NCT02004847|20291245|P2|Overall Study|Protocol Violation|1
5866404|NCT02004847|20291246|P1|Overall Study|Protocol Violation|1
5866405|NCT02004522|20291292|P2|Overall Study|Completed Treatrment Cycles Per Protocol|103
5866406|NCT02004522|20291293|P1|Overall Study|Completed Treatrment Cycles Per Protocol|1
5866407|NCT02004522|20291292|P2|Overall Study|Disease Progression|31
5866408|NCT02004522|20291293|P1|Overall Study|Disease Progression|35
5866409|NCT02004522|20291292|P2|Overall Study|Never Dosed|4
5866410|NCT02004522|20291293|P1|Overall Study|Never Dosed|2
5866411|NCT02004522|20291292|P2|Overall Study|Other is reason listed by PI.|1
5866413|NCT02004522|20291292|P2|Overall Study|Protocol Violation|0
5866414|NCT02004522|20291293|P1|Overall Study|Protocol Violation|1
5866415|NCT02004522|20291292|P2|Overall Study|Physician Decision|4
5866416|NCT02004522|20291293|P1|Overall Study|Physician Decision|3
5866417|NCT02004522|20291292|P2|Overall Study|Death|3
5866418|NCT02004522|20291293|P1|Overall Study|Death|12
5866419|NCT02004522|20291292|P2|Overall Study|Withdrawal by Subject|7
5866420|NCT02004522|20291293|P1|Overall Study|Withdrawal by Subject|13
5866421|NCT02004522|20291292|P2|Overall Study|Adverse Event|6
5866422|NCT02004522|20291293|P1|Overall Study|Adverse Event|55
5866423|NCT02004262|20291414|P6|Overall Study|Study Terminated by Sponsor|5
5866424|NCT02004262|20291415|P5|Overall Study|Study Terminated by Sponsor|1
5866425|NCT02004262|20291416|P4|Overall Study|Study Terminated by Sponsor|1
5866426|NCT02004262|20291417|P3|Overall Study|Study Terminated by Sponsor|2
5866427|NCT02004262|20291418|P2|Overall Study|Study Terminated by Sponsor|3
5866428|NCT02004262|20291419|P1|Overall Study|Study Terminated by Sponsor|4
5866429|NCT02004262|20291414|P6|Overall Study|Lost to Follow-up|0
5866430|NCT02004262|20291415|P5|Overall Study|Lost to Follow-up|0
5866431|NCT02004262|20291416|P4|Overall Study|Lost to Follow-up|0
5866432|NCT02004262|20291417|P3|Overall Study|Lost to Follow-up|0
5866433|NCT02004262|20291418|P2|Overall Study|Lost to Follow-up|1
5866434|NCT02004262|20291419|P1|Overall Study|Lost to Follow-up|1
5866435|NCT02004262|20291414|P6|Overall Study|Withdrawal by Subject|3
5866436|NCT02004262|20291415|P5|Overall Study|Withdrawal by Subject|1
5866437|NCT02004262|20291416|P4|Overall Study|Withdrawal by Subject|0
5866438|NCT02004262|20291417|P3|Overall Study|Withdrawal by Subject|4
5866439|NCT02004262|20291418|P2|Overall Study|Withdrawal by Subject|0
5866440|NCT02004262|20291419|P1|Overall Study|Withdrawal by Subject|1
5866441|NCT02004262|20291414|P6|Overall Study|Death|22
5866442|NCT02004262|20291415|P5|Overall Study|Death|29
5866443|NCT02004262|20291416|P4|Overall Study|Death|28
5866444|NCT02004262|20291417|P3|Overall Study|Death|66
5866445|NCT02004262|20291418|P2|Overall Study|Death|64
5866446|NCT02004262|20291419|P1|Overall Study|Death|67
5866447|NCT02004236|20291439|P3|Overall Study|Lack of Efficacy|16
5866448|NCT02004236|20291440|P2|Overall Study|Lack of Efficacy|0
5866449|NCT02004236|20291441|P1|Overall Study|Lack of Efficacy|0
5866450|NCT02004093|20291501|P2|Overall Study|Other|1
5866451|NCT02004093|20291502|P1|Overall Study|Other|3
5866452|NCT02004093|20291501|P2|Overall Study|Withdrawal by Subject|7
5866453|NCT02004093|20291502|P1|Overall Study|Withdrawal by Subject|3
5866454|NCT02004093|20291501|P2|Overall Study|Lost to Follow-up|1
5866455|NCT02004093|20291502|P1|Overall Study|Lost to Follow-up|0
5866456|NCT02004093|20291501|P2|Overall Study|Protocol Violation|1
5866457|NCT02004093|20291502|P1|Overall Study|Protocol Violation|0
5866458|NCT02004093|20291501|P2|Overall Study|Lack of Efficacy|62
5866459|NCT02004093|20291502|P1|Overall Study|Lack of Efficacy|66
5866460|NCT02004093|20291501|P2|Overall Study|Death|1
5866461|NCT02004093|20291502|P1|Overall Study|Death|2
5866462|NCT02003963|20291534|P2|Overall Study|Lost to Follow-up|1
5866463|NCT02003963|20291535|P1|Overall Study|Lost to Follow-up|2
5866512|NCT02003898|20291681|P1|Overall Study|Withdrawal by Subject|52
5866513|NCT02003898|20291681|P1|Overall Study|Lost to Follow-up|12
5866514|NCT02003898|20291681|P1|Overall Study|Death|3
5866515|NCT02003638|20291690|P2|Overall Study|Withdrawal by Subject|0
5866516|NCT02003638|20291691|P1|Overall Study|Withdrawal by Subject|1
5866517|NCT02003573|20291721|P3|Overall Study|Other than specified|3
5866518|NCT02003573|20291722|P2|Overall Study|Other than specified|2
5866519|NCT02003573|20291723|P1|Overall Study|Other than specified|1
5866520|NCT02003573|20291721|P3|Overall Study|Refuse to take trial medication|1
5866521|NCT02003573|20291722|P2|Overall Study|Refuse to take trial medication|1
5866522|NCT02003573|20291723|P1|Overall Study|Refuse to take trial medication|0
5866523|NCT02003573|20291721|P3|Overall Study|Other Adverse event|1
5866524|NCT02003573|20291722|P2|Overall Study|Other Adverse event|1
5866525|NCT02003573|20291723|P1|Overall Study|Other Adverse event|0
5866526|NCT02003573|20291721|P3|Overall Study|Progressive disease|1
5866527|NCT02003573|20291722|P2|Overall Study|Progressive disease|0
5866528|NCT02003573|20291723|P1|Overall Study|Progressive disease|2
5866529|NCT02003534|20291733|P1|Overall Study|Lost to Follow-up|47
5866530|NCT02003391|20291754|P2|Overall Study|Adverse Event|0
5866531|NCT02003391|20291755|P1|Overall Study|Adverse Event|1
5866532|NCT02003391|20291754|P2|Overall Study|Protocol Violation|1
5866533|NCT02003391|20291755|P1|Overall Study|Protocol Violation|0
5866534|NCT02003391|20291754|P2|Overall Study|Withdrawal by Subject|1
5866535|NCT02003391|20291755|P1|Overall Study|Withdrawal by Subject|2
5866536|NCT02003365|20291768|P3|Overall Study|Lost to Follow-up|1
5866537|NCT02003365|20291769|P2|Overall Study|Lost to Follow-up|0
5866538|NCT02003365|20291770|P1|Overall Study|Lost to Follow-up|0
5866539|NCT02003183|20291787|P2|Overall Study|Lost to Follow-up|2
5866540|NCT02003183|20291788|P1|Overall Study|Lost to Follow-up|0
5866541|NCT02003014|20291803|P1|Overall Study|Investigator's transfer|4
5866542|NCT02003014|20291803|P1|Overall Study|Patient did not visit the study site|5
5866543|NCT02003014|20291803|P1|Overall Study|Treatment started after contract period|1
5866544|NCT02003014|20291803|P1|Overall Study|Case report forms uncollected|9
5866545|NCT02002975|20291813|P1|Overall Study|Protocol Deviation|437
5866546|NCT02002975|20291813|P1|Overall Study|Case Report Forms Uncollected|135
5866547|NCT02002884|20291841|P4|Open-Label Extension Period (OLEX)|Lost to Follow-up|10
5866548|NCT02002884|20291842|P3|Open-Label Extension Period (OLEX)|Lost to Follow-up|0
5866549|NCT02002884|20291843|P2|Open-Label Extension Period (OLEX)|Lost to Follow-up|0
5866550|NCT02002884|20291844|P1|Open-Label Extension Period (OLEX)|Lost to Follow-up|0
5866551|NCT02002884|20291841|P4|Open-Label Extension Period (OLEX)|Withdrawal by Subject|10
5866552|NCT02002884|20291842|P3|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0
5866553|NCT02002884|20291843|P2|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0
5866554|NCT02002884|20291844|P1|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0
5866555|NCT02002884|20291841|P4|Open-Label Extension Period (OLEX)|Adverse Event|5
5866556|NCT02002884|20291842|P3|Open-Label Extension Period (OLEX)|Adverse Event|0
5866557|NCT02002884|20291843|P2|Open-Label Extension Period (OLEX)|Adverse Event|0
5866558|NCT02002884|20291844|P1|Open-Label Extension Period (OLEX)|Adverse Event|0
5866559|NCT02002884|20291841|P4|Open-Label Extension Period (OLEX)|Physician Decision|1
5866560|NCT02002884|20291842|P3|Open-Label Extension Period (OLEX)|Physician Decision|0
5866561|NCT02002884|20291843|P2|Open-Label Extension Period (OLEX)|Physician Decision|0
5866562|NCT02002884|20291844|P1|Open-Label Extension Period (OLEX)|Physician Decision|0
5866563|NCT02002884|20291841|P4|Open-Label Extension Period (OLEX)|Other|24
5866564|NCT02002884|20291842|P3|Open-Label Extension Period (OLEX)|Other|0
5866565|NCT02002884|20291843|P2|Open-Label Extension Period (OLEX)|Other|0
5866566|NCT02002884|20291844|P1|Open-Label Extension Period (OLEX)|Other|0
5866567|NCT02002884|20291841|P4|Main Period (MP)|Lost to Follow-up|0
5866568|NCT02002884|20291842|P3|Main Period (MP)|Lost to Follow-up|2
5866569|NCT02002884|20291843|P2|Main Period (MP)|Lost to Follow-up|0
5866570|NCT02002884|20291844|P1|Main Period (MP)|Lost to Follow-up|0
5866571|NCT02002884|20291841|P4|Main Period (MP)|Withdrawal by Subject|0
5866572|NCT02002884|20291842|P3|Main Period (MP)|Withdrawal by Subject|2
5866573|NCT02002884|20291843|P2|Main Period (MP)|Withdrawal by Subject|2
5866574|NCT02002884|20291844|P1|Main Period (MP)|Withdrawal by Subject|6
5866575|NCT02002884|20291841|P4|Main Period (MP)|Adverse Event|0
5866576|NCT02002884|20291842|P3|Main Period (MP)|Adverse Event|1
5866577|NCT02002884|20291843|P2|Main Period (MP)|Adverse Event|1
5866578|NCT02002884|20291844|P1|Main Period (MP)|Adverse Event|0
5866579|NCT02002884|20291841|P4|Main Period (MP)|Other|0
5866580|NCT02002884|20291842|P3|Main Period (MP)|Other|3
5866581|NCT02002884|20291843|P2|Main Period (MP)|Other|3
5866582|NCT02002884|20291844|P1|Main Period (MP)|Other|0
5866583|NCT02002689|20291996|P1|Overall Study|Adverse Event|3
5866584|NCT02002689|20291996|P1|Overall Study|Disease Progression|7
5866585|NCT02002533|20292015|P2|Overall Study|Lost to Follow-up|1
5866586|NCT02002533|20292016|P1|Overall Study|Lost to Follow-up|0
5866587|NCT02002533|20292015|P2|Overall Study|Adverse Event|3
5866588|NCT02002533|20292016|P1|Overall Study|Adverse Event|0
5866589|NCT02002533|20292015|P2|Overall Study|Protocol Violation|1
5866590|NCT02002533|20292016|P1|Overall Study|Protocol Violation|0
5866591|NCT02002533|20292015|P2|Overall Study|Withdrawal by Subject|13
5866592|NCT02002533|20292016|P1|Overall Study|Withdrawal by Subject|6
5866593|NCT02002221|20292056|P2|Overall Study|Patient withdrew consent|1
5866594|NCT02002221|20292057|P1|Overall Study|Patient withdrew consent|0
5866595|NCT02002221|20292056|P2|Overall Study|Unsatisfactory therapeutic effect|1
5866596|NCT02002221|20292057|P1|Overall Study|Unsatisfactory therapeutic effect|0
5866597|NCT02002221|20292056|P2|Overall Study|Adverse Event|1
5866598|NCT02002221|20292057|P1|Overall Study|Adverse Event|2
5866599|NCT02002182|20292084|P2|Overall Study|Death|0
5866600|NCT02002182|20292085|P1|Overall Study|Death|1
5866601|NCT02002182|20292084|P2|Overall Study|Health Reasons|0
5866602|NCT02002182|20292085|P1|Overall Study|Health Reasons|1
5866603|NCT02002182|20292084|P2|Overall Study|Withdraw from study|1
5866604|NCT02002182|20292085|P1|Overall Study|Withdraw from study|3
5866605|NCT02002091|20292097|P2|Screening|Death|2
5866606|NCT02002091|20292098|P1|Screening|Death|3
5866607|NCT02002091|20292097|P2|Screening|Lost to Follow-up|12
5866608|NCT02002091|20292098|P1|Screening|Lost to Follow-up|10
5866609|NCT02001987|20292133|P1|LTE Period (52 Weeks)|Other|3
5866610|NCT02001987|20292133|P1|LTE Period (52 Weeks)|Lack of Efficacy|1
5866611|NCT02001987|20292133|P1|LTE Period (52 Weeks)|Withdrawal by Subject|1
5866612|NCT02001987|20292133|P1|LTE Period (52 Weeks)|Physician Decision|2
5866613|NCT02001987|20292133|P1|LTE Period (52 Weeks)|Lost to Follow-up|2
5866614|NCT02001987|20292133|P1|Core Study Period (24 Weeks)|Lack of Efficacy|3
5866615|NCT02001987|20292133|P1|Core Study Period (24 Weeks)|Protocol Violation|3
5866616|NCT02001987|20292133|P1|Core Study Period (24 Weeks)|Withdrawal by Subject|4
5866617|NCT02001987|20292133|P1|Core Study Period (24 Weeks)|Physician Decision|1
5866618|NCT02001987|20292133|P1|Core Study Period (24 Weeks)|Non-Serious Hypersensitivity Reaction|2
5866619|NCT02001987|20292133|P1|Core Study Period (24 Weeks)|Death|1
5866620|NCT02001987|20292133|P1|Core Study Period (24 Weeks)|Adverse Event|9
5866621|NCT02001688|20292219|P3|Overall Study|Adverse Event|0
5866622|NCT02001688|20292220|P2|Overall Study|Adverse Event|1
5866623|NCT02001688|20292221|P1|Overall Study|Adverse Event|0
5866624|NCT02001688|20292219|P3|Overall Study|Withdrawal by Subject|1
5866625|NCT02001688|20292220|P2|Overall Study|Withdrawal by Subject|0
5866626|NCT02001688|20292221|P1|Overall Study|Withdrawal by Subject|0
5866627|NCT02001558|20292240|P2|Overall Study|Lost to Follow-up|14
5866628|NCT02001558|20292241|P1|Overall Study|Lost to Follow-up|8
5866629|NCT02001194|20292277|P4|Follow-Up Period (13 Weeks)|No longer interested|0
5866630|NCT02001194|20292278|P3|Follow-Up Period (13 Weeks)|No longer interested|1
5866631|NCT02001194|20292279|P2|Follow-Up Period (13 Weeks)|No longer interested|2
5866632|NCT02001194|20292280|P1|Follow-Up Period (13 Weeks)|No longer interested|3
5866633|NCT02001194|20292277|P4|Intervention Period (13 Weeks)|No longer interested|2
5866634|NCT02001194|20292278|P3|Intervention Period (13 Weeks)|No longer interested|2
5866635|NCT02001194|20292279|P2|Intervention Period (13 Weeks)|No longer interested|0
5866636|NCT02001194|20292280|P1|Intervention Period (13 Weeks)|No longer interested|1
5866637|NCT02001181|20292296|P2|Overall Study|Withdrawal by Subject|1
5866638|NCT02001181|20292297|P1|Overall Study|Withdrawal by Subject|0
5866639|NCT02001181|20292296|P2|Overall Study|Lost to Follow-up|0
5866640|NCT02001181|20292297|P1|Overall Study|Lost to Follow-up|1
5866641|NCT02001181|20292296|P2|Overall Study|Adverse Event|2
5866642|NCT02001181|20292297|P1|Overall Study|Adverse Event|0
5866643|NCT02001051|20292313|P2|Overall Study|Deemed not eligible following enrollment|1
5866644|NCT02001051|20292314|P1|Overall Study|Deemed not eligible following enrollment|0
5866645|NCT02000921|20292366|P3|Overall Study|Physician Decision|0
5866646|NCT02000921|20292367|P2|Overall Study|Physician Decision|2
5866647|NCT02000921|20292368|P1|Overall Study|Physician Decision|0
5866648|NCT02000921|20292366|P3|Overall Study|Lost to Follow-up|5
5866649|NCT02000921|20292367|P2|Overall Study|Lost to Follow-up|4
5866650|NCT02000921|20292368|P1|Overall Study|Lost to Follow-up|2
5866651|NCT02000921|20292366|P3|Overall Study|Withdrawal by Subject|5
5866652|NCT02000921|20292367|P2|Overall Study|Withdrawal by Subject|10
5866653|NCT02000921|20292368|P1|Overall Study|Withdrawal by Subject|3
5866654|NCT02000817|20292398|P4|Overall Study|Lost to Follow-up|0
5866655|NCT02000817|20292399|P3|Overall Study|Lost to Follow-up|1
5866656|NCT02000817|20292400|P2|Overall Study|Lost to Follow-up|0
5866657|NCT02000817|20292401|P1|Overall Study|Lost to Follow-up|0
5866658|NCT02000817|20292398|P4|Overall Study|Adverse Event|0
5866659|NCT02000817|20292399|P3|Overall Study|Adverse Event|0
5866660|NCT02000817|20292400|P2|Overall Study|Adverse Event|1
5866661|NCT02000817|20292401|P1|Overall Study|Adverse Event|0
5866662|NCT02000817|20292398|P4|Overall Study|Withdrawal by Subject|0
5866663|NCT02000817|20292399|P3|Overall Study|Withdrawal by Subject|0
5866664|NCT02000817|20292400|P2|Overall Study|Withdrawal by Subject|0
5866665|NCT02000817|20292401|P1|Overall Study|Withdrawal by Subject|2
5866666|NCT02000752|20292496|P2|Overall Study|Shift Changes|5
5866667|NCT02000752|20292497|P1|Overall Study|Shift Changes|12
5866668|NCT02000752|20292496|P2|Overall Study|Dystocic delivery|8
5866669|NCT02000752|20292497|P1|Overall Study|Dystocic delivery|19
5866670|NCT02000622|20292511|P2|Overall Study|Withdrawn due to site closure|0
5866671|NCT02000622|20292512|P1|Overall Study|Withdrawn due to site closure|1
5866672|NCT02000622|20292511|P2|Overall Study|Death|73
5866673|NCT02000622|20292512|P1|Overall Study|Death|159
5866674|NCT02000622|20292511|P2|Overall Study|Lost to Follow-up|0
5866675|NCT02000622|20292512|P1|Overall Study|Lost to Follow-up|4
5866676|NCT02000622|20292511|P2|Overall Study|Withdrawal by Subject|7
5866677|NCT02000622|20292512|P1|Overall Study|Withdrawal by Subject|5
5866678|NCT02000531|20292555|P2|Overall Study|Discontinued due to data cut-off|8
5866679|NCT02000531|20292556|P1|Overall Study|Discontinued due to data cut-off|3
5866680|NCT02000531|20292555|P2|Overall Study|Lost to Follow-up|0
5866681|NCT02000531|20292556|P1|Overall Study|Lost to Follow-up|1
5866682|NCT02000440|20292564|P1|Overall Study|Other-Protocol-defined Stopping Criteria|1
5866683|NCT02000440|20292564|P1|Overall Study|Adverse Event|3
5866684|NCT02000427|20292584|P1|Overall Study|Death|22
5866685|NCT02000115|20292625|P4|Overall Study|Still on Study|53
5866686|NCT02000115|20292626|P3|Overall Study|Still on Study|0
5866687|NCT02000115|20292627|P2|Overall Study|Still on Study|0
5866688|NCT02000115|20292628|P1|Overall Study|Still on Study|0
5866689|NCT02000115|20292625|P4|Overall Study|Withdrawn on day of randomization|0
5866690|NCT02000115|20292626|P3|Overall Study|Withdrawn on day of randomization|0
5866691|NCT02000115|20292627|P2|Overall Study|Withdrawn on day of randomization|1
5866692|NCT02000115|20292628|P1|Overall Study|Withdrawn on day of randomization|0
5866693|NCT02000115|20292625|P4|Overall Study|Non-compliance|0
5866694|NCT02000115|20292626|P3|Overall Study|Non-compliance|0
5866695|NCT02000115|20292627|P2|Overall Study|Non-compliance|1
5866696|NCT02000115|20292628|P1|Overall Study|Non-compliance|2
5866697|NCT02000115|20292625|P4|Overall Study|Lost to Follow-up|0
5866698|NCT02000115|20292626|P3|Overall Study|Lost to Follow-up|0
5866699|NCT02000115|20292627|P2|Overall Study|Lost to Follow-up|1
5866700|NCT02000115|20292628|P1|Overall Study|Lost to Follow-up|0
5866701|NCT02000115|20292625|P4|Overall Study|Withdrawal by Subject|0
5866702|NCT02000115|20292626|P3|Overall Study|Withdrawal by Subject|0
5866703|NCT02000115|20292627|P2|Overall Study|Withdrawal by Subject|11
5866704|NCT02000115|20292628|P1|Overall Study|Withdrawal by Subject|11
5866705|NCT02000115|20292625|P4|Overall Study|Physician Decision|0
5866706|NCT02000115|20292626|P3|Overall Study|Physician Decision|0
5866707|NCT02000115|20292627|P2|Overall Study|Physician Decision|0
5866708|NCT02000115|20292628|P1|Overall Study|Physician Decision|2
5866709|NCT02000115|20292625|P4|Overall Study|Protocol Violation|0
5866710|NCT02000115|20292626|P3|Overall Study|Protocol Violation|0
5866711|NCT02000115|20292627|P2|Overall Study|Protocol Violation|1
5866712|NCT02000115|20292628|P1|Overall Study|Protocol Violation|2
5866713|NCT02000115|20292625|P4|Overall Study|Missed Visit|0
5866714|NCT02000115|20292626|P3|Overall Study|Missed Visit|1
5866715|NCT02000115|20292627|P2|Overall Study|Missed Visit|8
5866716|NCT02000115|20292628|P1|Overall Study|Missed Visit|6
5866717|NCT02000115|20292625|P4|Overall Study|Death|0
5866718|NCT02000115|20292626|P3|Overall Study|Death|0
5866719|NCT02000115|20292627|P2|Overall Study|Death|45
5866720|NCT02000115|20292628|P1|Overall Study|Death|56
5866721|NCT01999972|20292662|P6|Dose Expansion Part|Changed to standard of care|0
5866722|NCT01999972|20292663|P5|Dose Expansion Part|Changed to standard of care|1
5866723|NCT01999972|20292664|P4|Dose Expansion Part|Changed to standard of care|0
5866724|NCT01999972|20292665|P3|Dose Expansion Part|Changed to standard of care|0
5866725|NCT01999972|20292666|P2|Dose Expansion Part|Changed to standard of care|0
5866726|NCT01999972|20292667|P1|Dose Expansion Part|Changed to standard of care|0
5866727|NCT01999972|20292662|P6|Dose Expansion Part|Participant refused further follow-up|0
5866728|NCT01999972|20292663|P5|Dose Expansion Part|Participant refused further follow-up|4
5866729|NCT01999972|20292664|P4|Dose Expansion Part|Participant refused further follow-up|0
5866730|NCT01999972|20292665|P3|Dose Expansion Part|Participant refused further follow-up|0
5866731|NCT01999972|20292666|P2|Dose Expansion Part|Participant refused further follow-up|0
5866732|NCT01999972|20292667|P1|Dose Expansion Part|Participant refused further follow-up|0
5866733|NCT01999972|20292662|P6|Dose Expansion Part|Participant's non-compliance|1
5866734|NCT01999972|20292663|P5|Dose Expansion Part|Participant's non-compliance|0
5866735|NCT01999972|20292664|P4|Dose Expansion Part|Participant's non-compliance|0
5866736|NCT01999972|20292665|P3|Dose Expansion Part|Participant's non-compliance|0
5866737|NCT01999972|20292666|P2|Dose Expansion Part|Participant's non-compliance|0
5866738|NCT01999972|20292667|P1|Dose Expansion Part|Participant's non-compliance|0
5866739|NCT01999972|20292662|P6|Dose Expansion Part|Adverse Event|2
5866740|NCT01999972|20292663|P5|Dose Expansion Part|Adverse Event|4
5866741|NCT01999972|20292664|P4|Dose Expansion Part|Adverse Event|0
5866742|NCT01999972|20292665|P3|Dose Expansion Part|Adverse Event|0
5866743|NCT01999972|20292666|P2|Dose Expansion Part|Adverse Event|0
5866744|NCT01999972|20292667|P1|Dose Expansion Part|Adverse Event|0
5866745|NCT01999972|20292662|P6|Dose Expansion Part|Sponsor decision|0
5866746|NCT01999972|20292663|P5|Dose Expansion Part|Sponsor decision|1
5866747|NCT01999972|20292664|P4|Dose Expansion Part|Sponsor decision|0
5866748|NCT01999972|20292665|P3|Dose Expansion Part|Sponsor decision|0
5866749|NCT01999972|20292666|P2|Dose Expansion Part|Sponsor decision|0
5866750|NCT01999972|20292667|P1|Dose Expansion Part|Sponsor decision|0
5866751|NCT01999972|20292662|P6|Dose Expansion Part|Disease progression|3
5866752|NCT01999972|20292663|P5|Dose Expansion Part|Disease progression|9
5866753|NCT01999972|20292664|P4|Dose Expansion Part|Disease progression|0
5866754|NCT01999972|20292665|P3|Dose Expansion Part|Disease progression|0
5866755|NCT01999972|20292666|P2|Dose Expansion Part|Disease progression|0
5866756|NCT01999972|20292667|P1|Dose Expansion Part|Disease progression|0
5866757|NCT01999972|20292662|P6|Dose Expansion Part|Death|1
5866758|NCT01999972|20292663|P5|Dose Expansion Part|Death|2
5866759|NCT01999972|20292664|P4|Dose Expansion Part|Death|0
5866760|NCT01999972|20292665|P3|Dose Expansion Part|Death|0
5866761|NCT01999972|20292666|P2|Dose Expansion Part|Death|0
5866762|NCT01999972|20292667|P1|Dose Expansion Part|Death|0
5866763|NCT01999972|20292662|P6|Dose Escalation Part|Global deterioration of health status|0
5866764|NCT01999972|20292663|P5|Dose Escalation Part|Global deterioration of health status|0
5866765|NCT01999972|20292664|P4|Dose Escalation Part|Global deterioration of health status|1
5866766|NCT01999972|20292665|P3|Dose Escalation Part|Global deterioration of health status|0
5866767|NCT01999972|20292666|P2|Dose Escalation Part|Global deterioration of health status|0
5866768|NCT01999972|20292667|P1|Dose Escalation Part|Global deterioration of health status|1
5866769|NCT01999972|20292662|P6|Dose Escalation Part|Adverse Event|0
5866770|NCT01999972|20292663|P5|Dose Escalation Part|Adverse Event|0
5866771|NCT01999972|20292664|P4|Dose Escalation Part|Adverse Event|2
5866772|NCT01999972|20292665|P3|Dose Escalation Part|Adverse Event|0
5866773|NCT01999972|20292666|P2|Dose Escalation Part|Adverse Event|0
5866774|NCT01999972|20292667|P1|Dose Escalation Part|Adverse Event|0
5866775|NCT01999972|20292662|P6|Dose Escalation Part|Disease progression|0
5866776|NCT01999972|20292663|P5|Dose Escalation Part|Disease progression|0
5866777|NCT01999972|20292664|P4|Dose Escalation Part|Disease progression|6
5866778|NCT01999972|20292665|P3|Dose Escalation Part|Disease progression|3
5866779|NCT01999972|20292666|P2|Dose Escalation Part|Disease progression|2
5866780|NCT01999972|20292667|P1|Dose Escalation Part|Disease progression|3
5866781|NCT01999972|20292662|P6|Dose Escalation Part|Enrolled but not treated|0
5866782|NCT01999972|20292663|P5|Dose Escalation Part|Enrolled but not treated|0
5866783|NCT01999972|20292664|P4|Dose Escalation Part|Enrolled but not treated|1
5866784|NCT01999972|20292665|P3|Dose Escalation Part|Enrolled but not treated|1
5866785|NCT01999972|20292666|P2|Dose Escalation Part|Enrolled but not treated|0
5866786|NCT01999972|20292667|P1|Dose Escalation Part|Enrolled but not treated|0
5866787|NCT01999972|20292662|P6|Dose Escalation Part|Death|0
5866788|NCT01999972|20292663|P5|Dose Escalation Part|Death|0
5866789|NCT01999972|20292664|P4|Dose Escalation Part|Death|0
5866790|NCT01999972|20292665|P3|Dose Escalation Part|Death|0
5866791|NCT01999972|20292666|P2|Dose Escalation Part|Death|1
5866792|NCT01999972|20292667|P1|Dose Escalation Part|Death|0
5866793|NCT01999972|20292662|P6|Dose Escalation Part|Participant refused further follow-up|0
5866794|NCT01999972|20292663|P5|Dose Escalation Part|Participant refused further follow-up|0
5866795|NCT01999972|20292664|P4|Dose Escalation Part|Participant refused further follow-up|1
5866796|NCT01999972|20292665|P3|Dose Escalation Part|Participant refused further follow-up|1
5866797|NCT01999972|20292666|P2|Dose Escalation Part|Participant refused further follow-up|0
5866798|NCT01999972|20292667|P1|Dose Escalation Part|Participant refused further follow-up|1
5866799|NCT01999946|20292782|P3|Overall Study|Not included in primary outcome analysis|79
5866800|NCT01999946|20292783|P2|Overall Study|Not included in primary outcome analysis|0
5866801|NCT01999946|20292784|P1|Overall Study|Not included in primary outcome analysis|0
5866802|NCT01999946|20292782|P3|Overall Study|Participant not released from jail|0
5866803|NCT01999946|20292783|P2|Overall Study|Participant not released from jail|2
5866804|NCT01999946|20292784|P1|Overall Study|Participant not released from jail|2
5866805|NCT01999894|20292810|P1|Overall Study|Inclusion/exclusion criteria not met|1
5866806|NCT01999894|20292810|P1|Overall Study|Other Reason|3
5866807|NCT01999894|20292810|P1|Overall Study|Lost to Follow-up|10
5866808|NCT01999894|20292810|P1|Overall Study|Withdrawal by Subject|7
5866809|NCT01999894|20292810|P1|Overall Study|Protocol Violation|1
5866810|NCT01999894|20292810|P1|Overall Study|Lack of Efficacy|5
5866811|NCT01999894|20292810|P1|Overall Study|Adverse Event|9
5866812|NCT01999868|20292818|P3|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|0
5866813|NCT01999868|20292819|P2|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|4
5866814|NCT01999868|20292820|P1|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|12
5866815|NCT01999868|20292818|P3|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|0
5866816|NCT01999868|20292819|P2|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|2
5866817|NCT01999868|20292820|P1|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|0
5866818|NCT01999868|20292818|P3|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|0
5866819|NCT01999868|20292819|P2|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|19
5866820|NCT01999868|20292820|P1|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|10
5866821|NCT01999868|20292818|P3|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|0
5866822|NCT01999868|20292819|P2|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|2
5866823|NCT01999868|20292820|P1|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|1
5866824|NCT01999868|20292818|P3|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|0
5866825|NCT01999868|20292819|P2|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|1
5866826|NCT01999868|20292820|P1|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|0
5866827|NCT01999868|20292818|P3|Blinded Observation Phase (Week 40 - 88)|Adverse Event|0
5866828|NCT01999868|20292819|P2|Blinded Observation Phase (Week 40 - 88)|Adverse Event|1
5866829|NCT01999868|20292820|P1|Blinded Observation Phase (Week 40 - 88)|Adverse Event|0
5866830|NCT01999868|20292818|P3|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|0
5866913|NCT01999114|20293017|P5|Overall Study|Lost to Follow-up|0
5866831|NCT01999868|20292819|P2|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|0
5866832|NCT01999868|20292820|P1|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|4
5866833|NCT01999868|20292818|P3|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|0
5866834|NCT01999868|20292819|P2|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|0
5866835|NCT01999868|20292820|P1|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|1
5866836|NCT01999868|20292818|P3|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|0
5866837|NCT01999868|20292819|P2|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|1
5866838|NCT01999868|20292820|P1|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|8
5866839|NCT01999868|20292818|P3|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|0
5866840|NCT01999868|20292819|P2|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|2
5866841|NCT01999868|20292820|P1|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|1
5866842|NCT01999868|20292818|P3|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|0
5866843|NCT01999868|20292819|P2|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|2
5866844|NCT01999868|20292820|P1|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|0
5866845|NCT01999868|20292818|P3|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|0
5866846|NCT01999868|20292819|P2|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|1
5866847|NCT01999868|20292820|P1|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|0
5866848|NCT01999868|20292818|P3|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|0
5866849|NCT01999868|20292819|P2|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|4
5866850|NCT01999868|20292820|P1|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|3
5866851|NCT01999868|20292818|P3|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|0
5866852|NCT01999868|20292819|P2|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|1
5866853|NCT01999868|20292820|P1|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|1
5866854|NCT01999868|20292818|P3|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|5
5866855|NCT01999868|20292819|P2|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|0
5866856|NCT01999868|20292820|P1|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|0
5866857|NCT01999465|20292871|P2|Overall Study|Protocol Violation|1
5866858|NCT01999465|20292872|P1|Overall Study|Protocol Violation|0
5866859|NCT01999465|20292871|P2|Overall Study|Lost to Follow-up|2
5866860|NCT01999465|20292872|P1|Overall Study|Lost to Follow-up|0
5866861|NCT01999322|20292917|P2|Overall Study|Adverse Event|0
5866862|NCT01999322|20292918|P1|Overall Study|Adverse Event|1
5866863|NCT01999218|20292970|P3|Overall Study|Treated but excluded at 1 trial site|2
5866864|NCT01999218|20292971|P2|Overall Study|Treated but excluded at 1 trial site|5
5866865|NCT01999218|20292972|P1|Overall Study|Treated but excluded at 1 trial site|3
5866866|NCT01999218|20292970|P3|Overall Study|Adverse Event|7
5866867|NCT01999218|20292971|P2|Overall Study|Adverse Event|7
5866868|NCT01999218|20292972|P1|Overall Study|Adverse Event|9
5866869|NCT01999218|20292970|P3|Overall Study|Excluded Medication|2
5866870|NCT01999218|20292971|P2|Overall Study|Excluded Medication|1
5866871|NCT01999218|20292972|P1|Overall Study|Excluded Medication|1
5866872|NCT01999218|20292970|P3|Overall Study|Death|2
5866873|NCT01999218|20292971|P2|Overall Study|Death|1
5866874|NCT01999218|20292972|P1|Overall Study|Death|7
5866875|NCT01999218|20292970|P3|Overall Study|Creatinine/eGFR|1
5866876|NCT01999218|20292971|P2|Overall Study|Creatinine/eGFR|0
5866877|NCT01999218|20292972|P1|Overall Study|Creatinine/eGFR|0
5866878|NCT01999218|20292970|P3|Overall Study|Withdrawal by Subject|34
5866879|NCT01999218|20292971|P2|Overall Study|Withdrawal by Subject|29
5866880|NCT01999218|20292972|P1|Overall Study|Withdrawal by Subject|28
5866881|NCT01999218|20292970|P3|Overall Study|Participant moves|3
5866882|NCT01999218|20292971|P2|Overall Study|Participant moves|5
5866883|NCT01999218|20292972|P1|Overall Study|Participant moves|2
5866884|NCT01999218|20292970|P3|Overall Study|Study Terminated By Sponsor|12
5866885|NCT01999218|20292971|P2|Overall Study|Study Terminated By Sponsor|5
5866886|NCT01999218|20292972|P1|Overall Study|Study Terminated By Sponsor|7
5866887|NCT01999218|20292970|P3|Overall Study|Screen failure|0
5866888|NCT01999218|20292971|P2|Overall Study|Screen failure|1
5866889|NCT01999218|20292972|P1|Overall Study|Screen failure|0
5866890|NCT01999218|20292970|P3|Overall Study|Protocol Violation|4
5866891|NCT01999218|20292971|P2|Overall Study|Protocol Violation|5
5866892|NCT01999218|20292972|P1|Overall Study|Protocol Violation|4
5866893|NCT01999218|20292970|P3|Overall Study|Physician Decision|6
5866894|NCT01999218|20292971|P2|Overall Study|Physician Decision|4
5866895|NCT01999218|20292972|P1|Overall Study|Physician Decision|1
5866896|NCT01999218|20292970|P3|Overall Study|Non-Compliance With Study Drug|1
5866897|NCT01999218|20292971|P2|Overall Study|Non-Compliance With Study Drug|4
5866898|NCT01999218|20292972|P1|Overall Study|Non-Compliance With Study Drug|6
5866899|NCT01999218|20292970|P3|Overall Study|Lost to Follow-up|18
5866900|NCT01999218|20292971|P2|Overall Study|Lost to Follow-up|17
5866901|NCT01999218|20292972|P1|Overall Study|Lost to Follow-up|22
5866902|NCT01999218|20292970|P3|Overall Study|Lack of Efficacy|1
5866903|NCT01999218|20292971|P2|Overall Study|Lack of Efficacy|0
5866904|NCT01999218|20292972|P1|Overall Study|Lack of Efficacy|1
5866905|NCT01999218|20292970|P3|Overall Study|Hyperglycemia|17
5866906|NCT01999218|20292971|P2|Overall Study|Hyperglycemia|17
5866907|NCT01999218|20292972|P1|Overall Study|Hyperglycemia|18
5866908|NCT01999114|20293017|P5|Overall Study|Administrative|2
5866909|NCT01999114|20293018|P4|Overall Study|Administrative|1
5866910|NCT01999114|20293019|P3|Overall Study|Administrative|1
5866911|NCT01999114|20293020|P2|Overall Study|Administrative|0
5866912|NCT01999114|20293021|P1|Overall Study|Administrative|0
5866914|NCT01999114|20293018|P4|Overall Study|Lost to Follow-up|0
5866915|NCT01999114|20293019|P3|Overall Study|Lost to Follow-up|1
5866916|NCT01999114|20293020|P2|Overall Study|Lost to Follow-up|0
5866917|NCT01999114|20293021|P1|Overall Study|Lost to Follow-up|0
5866918|NCT01999114|20293017|P5|Overall Study|Withdrawal by Subject|1
5866919|NCT01999114|20293018|P4|Overall Study|Withdrawal by Subject|0
5866920|NCT01999114|20293019|P3|Overall Study|Withdrawal by Subject|1
5866921|NCT01999114|20293020|P2|Overall Study|Withdrawal by Subject|0
5866922|NCT01999114|20293021|P1|Overall Study|Withdrawal by Subject|0
5866923|NCT01999114|20293017|P5|Overall Study|Adverse Event|1
5866924|NCT01999114|20293018|P4|Overall Study|Adverse Event|2
5866925|NCT01999114|20293019|P3|Overall Study|Adverse Event|2
5866926|NCT01999114|20293020|P2|Overall Study|Adverse Event|7
5866927|NCT01999114|20293021|P1|Overall Study|Adverse Event|8
5866928|NCT01998984|20293089|P4|Overall Study|Other|1
5866929|NCT01998984|20293090|P3|Overall Study|Other|0
5866930|NCT01998984|20293091|P2|Overall Study|Other|0
5866931|NCT01998984|20293092|P1|Overall Study|Other|0
5866932|NCT01998984|20293089|P4|Overall Study|Withdrawal by Subject|0
5866933|NCT01998984|20293090|P3|Overall Study|Withdrawal by Subject|1
5866934|NCT01998984|20293091|P2|Overall Study|Withdrawal by Subject|0
5866935|NCT01998984|20293092|P1|Overall Study|Withdrawal by Subject|0
5866936|NCT01998984|20293089|P4|Overall Study|Lost to Follow-up|1
5866937|NCT01998984|20293090|P3|Overall Study|Lost to Follow-up|0
5866938|NCT01998984|20293091|P2|Overall Study|Lost to Follow-up|1
5866939|NCT01998984|20293092|P1|Overall Study|Lost to Follow-up|0
5866940|NCT01998984|20293089|P4|Overall Study|Adverse Event|1
5866941|NCT01998984|20293090|P3|Overall Study|Adverse Event|0
5866942|NCT01998984|20293091|P2|Overall Study|Adverse Event|0
5866943|NCT01998984|20293092|P1|Overall Study|Adverse Event|0
5866944|NCT01998958|20293117|P32|Open Label Phase (Optional)|Withdrawal by Subject|0
5866945|NCT01998958|20293118|P31|Open Label Phase (Optional)|Withdrawal by Subject|0
5866946|NCT01998958|20293119|P30|Open Label Phase (Optional)|Withdrawal by Subject|0
5866947|NCT01998958|20293120|P29|Open Label Phase (Optional)|Withdrawal by Subject|0
5866948|NCT01998958|20293121|P28|Open Label Phase (Optional)|Withdrawal by Subject|0
5866949|NCT01998958|20293122|P27|Open Label Phase (Optional)|Withdrawal by Subject|0
5866950|NCT01998958|20293123|P26|Open Label Phase (Optional)|Withdrawal by Subject|0
5866951|NCT01998958|20293124|P25|Open Label Phase (Optional)|Withdrawal by Subject|0
5866952|NCT01998958|20293125|P24|Open Label Phase (Optional)|Withdrawal by Subject|2
5866953|NCT01998958|20293126|P23|Open Label Phase (Optional)|Withdrawal by Subject|1
5866954|NCT01998958|20293127|P22|Open Label Phase (Optional)|Withdrawal by Subject|2
5866955|NCT01998958|20293128|P21|Open Label Phase (Optional)|Withdrawal by Subject|0
5866956|NCT01998958|20293129|P20|Open Label Phase (Optional)|Withdrawal by Subject|0
5866957|NCT01998958|20293130|P19|Open Label Phase (Optional)|Withdrawal by Subject|0
5866958|NCT01998958|20293131|P18|Open Label Phase (Optional)|Withdrawal by Subject|0
5866959|NCT01998958|20293132|P17|Open Label Phase (Optional)|Withdrawal by Subject|0
5866960|NCT01998958|20293133|P16|Open Label Phase (Optional)|Withdrawal by Subject|0
5866961|NCT01998958|20293134|P15|Open Label Phase (Optional)|Withdrawal by Subject|0
5866962|NCT01998958|20293135|P14|Open Label Phase (Optional)|Withdrawal by Subject|0
5866963|NCT01998958|20293136|P13|Open Label Phase (Optional)|Withdrawal by Subject|0
5866964|NCT01998958|20293137|P12|Open Label Phase (Optional)|Withdrawal by Subject|0
5866965|NCT01998958|20293138|P11|Open Label Phase (Optional)|Withdrawal by Subject|0
5866966|NCT01998958|20293139|P10|Open Label Phase (Optional)|Withdrawal by Subject|0
5866967|NCT01998958|20293140|P9|Open Label Phase (Optional)|Withdrawal by Subject|0
5866968|NCT01998958|20293141|P8|Open Label Phase (Optional)|Withdrawal by Subject|0
5866969|NCT01998958|20293142|P7|Open Label Phase (Optional)|Withdrawal by Subject|0
5866970|NCT01998958|20293143|P6|Open Label Phase (Optional)|Withdrawal by Subject|0
5866971|NCT01998958|20293144|P5|Open Label Phase (Optional)|Withdrawal by Subject|0
5866972|NCT01998958|20293145|P4|Open Label Phase (Optional)|Withdrawal by Subject|0
5866973|NCT01998958|20293146|P3|Open Label Phase (Optional)|Withdrawal by Subject|0
5866974|NCT01998958|20293147|P2|Open Label Phase (Optional)|Withdrawal by Subject|0
5866975|NCT01998958|20293148|P1|Open Label Phase (Optional)|Withdrawal by Subject|0
5866976|NCT01998958|20293117|P32|Open Label Phase (Optional)|Lack of Efficacy|0
5866977|NCT01998958|20293118|P31|Open Label Phase (Optional)|Lack of Efficacy|0
5866978|NCT01998958|20293119|P30|Open Label Phase (Optional)|Lack of Efficacy|0
5866979|NCT01998958|20293120|P29|Open Label Phase (Optional)|Lack of Efficacy|0
5866980|NCT01998958|20293121|P28|Open Label Phase (Optional)|Lack of Efficacy|0
5866981|NCT01998958|20293122|P27|Open Label Phase (Optional)|Lack of Efficacy|0
5866982|NCT01998958|20293123|P26|Open Label Phase (Optional)|Lack of Efficacy|0
5866983|NCT01998958|20293124|P25|Open Label Phase (Optional)|Lack of Efficacy|0
5866984|NCT01998958|20293125|P24|Open Label Phase (Optional)|Lack of Efficacy|0
5866985|NCT01998958|20293126|P23|Open Label Phase (Optional)|Lack of Efficacy|2
5866986|NCT01998958|20293127|P22|Open Label Phase (Optional)|Lack of Efficacy|1
5866987|NCT01998958|20293128|P21|Open Label Phase (Optional)|Lack of Efficacy|0
5866988|NCT01998958|20293129|P20|Open Label Phase (Optional)|Lack of Efficacy|0
5866989|NCT01998958|20293130|P19|Open Label Phase (Optional)|Lack of Efficacy|0
5866990|NCT01998958|20293131|P18|Open Label Phase (Optional)|Lack of Efficacy|0
5866991|NCT01998958|20293132|P17|Open Label Phase (Optional)|Lack of Efficacy|0
5866992|NCT01998958|20293133|P16|Open Label Phase (Optional)|Lack of Efficacy|0
5866993|NCT01998958|20293134|P15|Open Label Phase (Optional)|Lack of Efficacy|0
5866994|NCT01998958|20293135|P14|Open Label Phase (Optional)|Lack of Efficacy|0
5866995|NCT01998958|20293136|P13|Open Label Phase (Optional)|Lack of Efficacy|0
5866996|NCT01998958|20293137|P12|Open Label Phase (Optional)|Lack of Efficacy|0
5866997|NCT01998958|20293138|P11|Open Label Phase (Optional)|Lack of Efficacy|0
5866998|NCT01998958|20293139|P10|Open Label Phase (Optional)|Lack of Efficacy|0
5866999|NCT01998958|20293140|P9|Open Label Phase (Optional)|Lack of Efficacy|0
5867000|NCT01998958|20293141|P8|Open Label Phase (Optional)|Lack of Efficacy|0
5867001|NCT01998958|20293142|P7|Open Label Phase (Optional)|Lack of Efficacy|0
5867002|NCT01998958|20293143|P6|Open Label Phase (Optional)|Lack of Efficacy|0
5867003|NCT01998958|20293144|P5|Open Label Phase (Optional)|Lack of Efficacy|0
5867004|NCT01998958|20293145|P4|Open Label Phase (Optional)|Lack of Efficacy|0
5867005|NCT01998958|20293146|P3|Open Label Phase (Optional)|Lack of Efficacy|0
5867006|NCT01998958|20293147|P2|Open Label Phase (Optional)|Lack of Efficacy|0
5867007|NCT01998958|20293148|P1|Open Label Phase (Optional)|Lack of Efficacy|0
5867008|NCT01998958|20293117|P32|Open Label Phase (Optional)|Lost to Follow-up|0
5867009|NCT01998958|20293118|P31|Open Label Phase (Optional)|Lost to Follow-up|0
5867010|NCT01998958|20293119|P30|Open Label Phase (Optional)|Lost to Follow-up|0
5867011|NCT01998958|20293120|P29|Open Label Phase (Optional)|Lost to Follow-up|0
5867012|NCT01998958|20293121|P28|Open Label Phase (Optional)|Lost to Follow-up|0
5867013|NCT01998958|20293122|P27|Open Label Phase (Optional)|Lost to Follow-up|0
5867014|NCT01998958|20293123|P26|Open Label Phase (Optional)|Lost to Follow-up|0
5867015|NCT01998958|20293124|P25|Open Label Phase (Optional)|Lost to Follow-up|0
5867016|NCT01998958|20293125|P24|Open Label Phase (Optional)|Lost to Follow-up|0
5867017|NCT01998958|20293126|P23|Open Label Phase (Optional)|Lost to Follow-up|1
5867018|NCT01998958|20293127|P22|Open Label Phase (Optional)|Lost to Follow-up|0
5867019|NCT01998958|20293128|P21|Open Label Phase (Optional)|Lost to Follow-up|0
5867020|NCT01998958|20293129|P20|Open Label Phase (Optional)|Lost to Follow-up|0
5867021|NCT01998958|20293130|P19|Open Label Phase (Optional)|Lost to Follow-up|0
5867022|NCT01998958|20293131|P18|Open Label Phase (Optional)|Lost to Follow-up|0
5867023|NCT01998958|20293132|P17|Open Label Phase (Optional)|Lost to Follow-up|0
5867024|NCT01998958|20293133|P16|Open Label Phase (Optional)|Lost to Follow-up|0
5867025|NCT01998958|20293134|P15|Open Label Phase (Optional)|Lost to Follow-up|0
5867026|NCT01998958|20293135|P14|Open Label Phase (Optional)|Lost to Follow-up|0
5867027|NCT01998958|20293136|P13|Open Label Phase (Optional)|Lost to Follow-up|0
5867028|NCT01998958|20293137|P12|Open Label Phase (Optional)|Lost to Follow-up|0
5867029|NCT01998958|20293138|P11|Open Label Phase (Optional)|Lost to Follow-up|0
5867030|NCT01998958|20293139|P10|Open Label Phase (Optional)|Lost to Follow-up|0
5867031|NCT01998958|20293140|P9|Open Label Phase (Optional)|Lost to Follow-up|0
5867032|NCT01998958|20293141|P8|Open Label Phase (Optional)|Lost to Follow-up|0
5867033|NCT01998958|20293142|P7|Open Label Phase (Optional)|Lost to Follow-up|0
5867034|NCT01998958|20293143|P6|Open Label Phase (Optional)|Lost to Follow-up|0
5867035|NCT01998958|20293144|P5|Open Label Phase (Optional)|Lost to Follow-up|0
5867036|NCT01998958|20293145|P4|Open Label Phase (Optional)|Lost to Follow-up|0
5867037|NCT01998958|20293146|P3|Open Label Phase (Optional)|Lost to Follow-up|0
5867038|NCT01998958|20293147|P2|Open Label Phase (Optional)|Lost to Follow-up|0
5867039|NCT01998958|20293148|P1|Open Label Phase (Optional)|Lost to Follow-up|0
5867040|NCT01998958|20293117|P32|Open Label Phase (Optional)|Other|0
5867041|NCT01998958|20293118|P31|Open Label Phase (Optional)|Other|0
5867042|NCT01998958|20293119|P30|Open Label Phase (Optional)|Other|0
5867043|NCT01998958|20293120|P29|Open Label Phase (Optional)|Other|0
5867044|NCT01998958|20293121|P28|Open Label Phase (Optional)|Other|0
5867045|NCT01998958|20293122|P27|Open Label Phase (Optional)|Other|0
5867046|NCT01998958|20293123|P26|Open Label Phase (Optional)|Other|0
5867047|NCT01998958|20293124|P25|Open Label Phase (Optional)|Other|0
5867048|NCT01998958|20293125|P24|Open Label Phase (Optional)|Other|1
5867049|NCT01998958|20293126|P23|Open Label Phase (Optional)|Other|5
5867050|NCT01998958|20293127|P22|Open Label Phase (Optional)|Other|0
5867051|NCT01998958|20293128|P21|Open Label Phase (Optional)|Other|0
5867052|NCT01998958|20293129|P20|Open Label Phase (Optional)|Other|0
5867053|NCT01998958|20293130|P19|Open Label Phase (Optional)|Other|0
5867054|NCT01998958|20293131|P18|Open Label Phase (Optional)|Other|0
5867055|NCT01998958|20293132|P17|Open Label Phase (Optional)|Other|0
5867056|NCT01998958|20293133|P16|Open Label Phase (Optional)|Other|0
5867057|NCT01998958|20293134|P15|Open Label Phase (Optional)|Other|0
5867058|NCT01998958|20293135|P14|Open Label Phase (Optional)|Other|0
5867059|NCT01998958|20293136|P13|Open Label Phase (Optional)|Other|0
5867060|NCT01998958|20293137|P12|Open Label Phase (Optional)|Other|0
5867061|NCT01998958|20293138|P11|Open Label Phase (Optional)|Other|0
5867062|NCT01998958|20293139|P10|Open Label Phase (Optional)|Other|0
5867063|NCT01998958|20293140|P9|Open Label Phase (Optional)|Other|0
5867064|NCT01998958|20293141|P8|Open Label Phase (Optional)|Other|0
5867065|NCT01998958|20293142|P7|Open Label Phase (Optional)|Other|0
5867066|NCT01998958|20293143|P6|Open Label Phase (Optional)|Other|0
5867067|NCT01998958|20293144|P5|Open Label Phase (Optional)|Other|0
5867068|NCT01998958|20293145|P4|Open Label Phase (Optional)|Other|0
5867069|NCT01998958|20293146|P3|Open Label Phase (Optional)|Other|0
5867070|NCT01998958|20293147|P2|Open Label Phase (Optional)|Other|0
5867071|NCT01998958|20293148|P1|Open Label Phase (Optional)|Other|0
5867072|NCT01998958|20293117|P32|Open Label Phase (Optional)|Adverse Event|0
5867073|NCT01998958|20293118|P31|Open Label Phase (Optional)|Adverse Event|0
5867074|NCT01998958|20293119|P30|Open Label Phase (Optional)|Adverse Event|0
5867075|NCT01998958|20293120|P29|Open Label Phase (Optional)|Adverse Event|0
5867076|NCT01998958|20293121|P28|Open Label Phase (Optional)|Adverse Event|0
5867077|NCT01998958|20293122|P27|Open Label Phase (Optional)|Adverse Event|0
5867078|NCT01998958|20293123|P26|Open Label Phase (Optional)|Adverse Event|0
5867079|NCT01998958|20293124|P25|Open Label Phase (Optional)|Adverse Event|0
5867080|NCT01998958|20293125|P24|Open Label Phase (Optional)|Adverse Event|1
5867081|NCT01998958|20293126|P23|Open Label Phase (Optional)|Adverse Event|0
5867082|NCT01998958|20293127|P22|Open Label Phase (Optional)|Adverse Event|0
5867083|NCT01998958|20293128|P21|Open Label Phase (Optional)|Adverse Event|0
5867084|NCT01998958|20293129|P20|Open Label Phase (Optional)|Adverse Event|0
5867085|NCT01998958|20293130|P19|Open Label Phase (Optional)|Adverse Event|0
5867086|NCT01998958|20293131|P18|Open Label Phase (Optional)|Adverse Event|0
5867087|NCT01998958|20293132|P17|Open Label Phase (Optional)|Adverse Event|0
5867088|NCT01998958|20293133|P16|Open Label Phase (Optional)|Adverse Event|0
5867089|NCT01998958|20293134|P15|Open Label Phase (Optional)|Adverse Event|0
5867090|NCT01998958|20293135|P14|Open Label Phase (Optional)|Adverse Event|0
5867091|NCT01998958|20293136|P13|Open Label Phase (Optional)|Adverse Event|0
5867092|NCT01998958|20293137|P12|Open Label Phase (Optional)|Adverse Event|0
5867093|NCT01998958|20293138|P11|Open Label Phase (Optional)|Adverse Event|0
5867094|NCT01998958|20293139|P10|Open Label Phase (Optional)|Adverse Event|0
5867095|NCT01998958|20293140|P9|Open Label Phase (Optional)|Adverse Event|0
5867096|NCT01998958|20293141|P8|Open Label Phase (Optional)|Adverse Event|0
5867097|NCT01998958|20293142|P7|Open Label Phase (Optional)|Adverse Event|0
5867098|NCT01998958|20293143|P6|Open Label Phase (Optional)|Adverse Event|0
5867099|NCT01998958|20293144|P5|Open Label Phase (Optional)|Adverse Event|0
5867100|NCT01998958|20293145|P4|Open Label Phase (Optional)|Adverse Event|0
5867101|NCT01998958|20293146|P3|Open Label Phase (Optional)|Adverse Event|0
5867102|NCT01998958|20293147|P2|Open Label Phase (Optional)|Adverse Event|0
5867103|NCT01998958|20293148|P1|Open Label Phase (Optional)|Adverse Event|0
5867104|NCT01998958|20293117|P32|Period 2 (Panel A and B)|Withdrawal by Subject|0
5867105|NCT01998958|20293118|P31|Period 2 (Panel A and B)|Withdrawal by Subject|0
5867106|NCT01998958|20293119|P30|Period 2 (Panel A and B)|Withdrawal by Subject|0
5867107|NCT01998958|20293120|P29|Period 2 (Panel A and B)|Withdrawal by Subject|0
5867108|NCT01998958|20293121|P28|Period 2 (Panel A and B)|Withdrawal by Subject|0
5867109|NCT01998958|20293122|P27|Period 2 (Panel A and B)|Withdrawal by Subject|0
5867110|NCT01998958|20293123|P26|Period 2 (Panel A and B)|Withdrawal by Subject|0
5867111|NCT01998958|20293124|P25|Period 2 (Panel A and B)|Withdrawal by Subject|0
5867112|NCT01998958|20293125|P24|Period 2 (Panel A and B)|Withdrawal by Subject|0
5867113|NCT01998958|20293126|P23|Period 2 (Panel A and B)|Withdrawal by Subject|0
5867114|NCT01998958|20293127|P22|Period 2 (Panel A and B)|Withdrawal by Subject|0
5867115|NCT01998958|20293128|P21|Period 2 (Panel A and B)|Withdrawal by Subject|0
5867116|NCT01998958|20293129|P20|Period 2 (Panel A and B)|Withdrawal by Subject|0
5867117|NCT01998958|20293130|P19|Period 2 (Panel A and B)|Withdrawal by Subject|1
5867118|NCT01998958|20293131|P18|Period 2 (Panel A and B)|Withdrawal by Subject|0
5867119|NCT01998958|20293132|P17|Period 2 (Panel A and B)|Withdrawal by Subject|0
5867120|NCT01998958|20293133|P16|Period 2 (Panel A and B)|Withdrawal by Subject|0
5867121|NCT01998958|20293134|P15|Period 2 (Panel A and B)|Withdrawal by Subject|1
5867122|NCT01998958|20293135|P14|Period 2 (Panel A and B)|Withdrawal by Subject|0
5867123|NCT01998958|20293136|P13|Period 2 (Panel A and B)|Withdrawal by Subject|0
5867124|NCT01998958|20293137|P12|Period 2 (Panel A and B)|Withdrawal by Subject|0
5867125|NCT01998958|20293138|P11|Period 2 (Panel A and B)|Withdrawal by Subject|0
5867126|NCT01998958|20293139|P10|Period 2 (Panel A and B)|Withdrawal by Subject|0
5867127|NCT01998958|20293140|P9|Period 2 (Panel A and B)|Withdrawal by Subject|0
5867128|NCT01998958|20293141|P8|Period 2 (Panel A and B)|Withdrawal by Subject|0
5867129|NCT01998958|20293142|P7|Period 2 (Panel A and B)|Withdrawal by Subject|0
5867130|NCT01998958|20293143|P6|Period 2 (Panel A and B)|Withdrawal by Subject|0
5867131|NCT01998958|20293144|P5|Period 2 (Panel A and B)|Withdrawal by Subject|0
5867132|NCT01998958|20293145|P4|Period 2 (Panel A and B)|Withdrawal by Subject|0
5867133|NCT01998958|20293146|P3|Period 2 (Panel A and B)|Withdrawal by Subject|0
5867134|NCT01998958|20293147|P2|Period 2 (Panel A and B)|Withdrawal by Subject|0
5867135|NCT01998958|20293148|P1|Period 2 (Panel A and B)|Withdrawal by Subject|0
5867136|NCT01998958|20293117|P32|Period 2 (Panel A and B)|Adverse Event|0
5867137|NCT01998958|20293118|P31|Period 2 (Panel A and B)|Adverse Event|0
5867138|NCT01998958|20293119|P30|Period 2 (Panel A and B)|Adverse Event|0
5867139|NCT01998958|20293120|P29|Period 2 (Panel A and B)|Adverse Event|0
5867140|NCT01998958|20293121|P28|Period 2 (Panel A and B)|Adverse Event|0
5867141|NCT01998958|20293122|P27|Period 2 (Panel A and B)|Adverse Event|0
5867142|NCT01998958|20293123|P26|Period 2 (Panel A and B)|Adverse Event|0
5867143|NCT01998958|20293124|P25|Period 2 (Panel A and B)|Adverse Event|0
5867144|NCT01998958|20293125|P24|Period 2 (Panel A and B)|Adverse Event|0
5867145|NCT01998958|20293126|P23|Period 2 (Panel A and B)|Adverse Event|0
5867146|NCT01998958|20293127|P22|Period 2 (Panel A and B)|Adverse Event|0
5867147|NCT01998958|20293128|P21|Period 2 (Panel A and B)|Adverse Event|0
5867148|NCT01998958|20293129|P20|Period 2 (Panel A and B)|Adverse Event|0
5867149|NCT01998958|20293130|P19|Period 2 (Panel A and B)|Adverse Event|0
5867150|NCT01998958|20293131|P18|Period 2 (Panel A and B)|Adverse Event|0
5867151|NCT01998958|20293132|P17|Period 2 (Panel A and B)|Adverse Event|0
5867152|NCT01998958|20293133|P16|Period 2 (Panel A and B)|Adverse Event|0
5867153|NCT01998958|20293134|P15|Period 2 (Panel A and B)|Adverse Event|1
5867154|NCT01998958|20293135|P14|Period 2 (Panel A and B)|Adverse Event|0
5867155|NCT01998958|20293136|P13|Period 2 (Panel A and B)|Adverse Event|0
5867156|NCT01998958|20293137|P12|Period 2 (Panel A and B)|Adverse Event|0
5867157|NCT01998958|20293138|P11|Period 2 (Panel A and B)|Adverse Event|1
5867158|NCT01998958|20293139|P10|Period 2 (Panel A and B)|Adverse Event|0
5867159|NCT01998958|20293140|P9|Period 2 (Panel A and B)|Adverse Event|0
5867160|NCT01998958|20293141|P8|Period 2 (Panel A and B)|Adverse Event|0
5867161|NCT01998958|20293142|P7|Period 2 (Panel A and B)|Adverse Event|0
5867162|NCT01998958|20293143|P6|Period 2 (Panel A and B)|Adverse Event|0
5867163|NCT01998958|20293144|P5|Period 2 (Panel A and B)|Adverse Event|0
5867164|NCT01998958|20293145|P4|Period 2 (Panel A and B)|Adverse Event|0
5867165|NCT01998958|20293146|P3|Period 2 (Panel A and B)|Adverse Event|0
5867166|NCT01998958|20293147|P2|Period 2 (Panel A and B)|Adverse Event|0
5867167|NCT01998958|20293148|P1|Period 2 (Panel A and B)|Adverse Event|0
5867168|NCT01998958|20293117|P32|Period 1 (Panel A and B)|Other|0
5867169|NCT01998958|20293118|P31|Period 1 (Panel A and B)|Other|0
5867170|NCT01998958|20293119|P30|Period 1 (Panel A and B)|Other|0
5867171|NCT01998958|20293120|P29|Period 1 (Panel A and B)|Other|0
5867172|NCT01998958|20293121|P28|Period 1 (Panel A and B)|Other|0
5867173|NCT01998958|20293122|P27|Period 1 (Panel A and B)|Other|0
5867174|NCT01998958|20293123|P26|Period 1 (Panel A and B)|Other|0
5867175|NCT01998958|20293124|P25|Period 1 (Panel A and B)|Other|0
5867176|NCT01998958|20293125|P24|Period 1 (Panel A and B)|Other|0
5867177|NCT01998958|20293126|P23|Period 1 (Panel A and B)|Other|0
5867178|NCT01998958|20293127|P22|Period 1 (Panel A and B)|Other|0
5867179|NCT01998958|20293128|P21|Period 1 (Panel A and B)|Other|0
5867180|NCT01998958|20293129|P20|Period 1 (Panel A and B)|Other|0
5867181|NCT01998958|20293130|P19|Period 1 (Panel A and B)|Other|0
5867182|NCT01998958|20293131|P18|Period 1 (Panel A and B)|Other|0
5867183|NCT01998958|20293132|P17|Period 1 (Panel A and B)|Other|0
5867184|NCT01998958|20293133|P16|Period 1 (Panel A and B)|Other|0
5867185|NCT01998958|20293134|P15|Period 1 (Panel A and B)|Other|0
5867186|NCT01998958|20293135|P14|Period 1 (Panel A and B)|Other|0
5867187|NCT01998958|20293136|P13|Period 1 (Panel A and B)|Other|0
5867188|NCT01998958|20293137|P12|Period 1 (Panel A and B)|Other|0
5867189|NCT01998958|20293138|P11|Period 1 (Panel A and B)|Other|0
5867190|NCT01998958|20293139|P10|Period 1 (Panel A and B)|Other|0
5867191|NCT01998958|20293140|P9|Period 1 (Panel A and B)|Other|0
5867192|NCT01998958|20293141|P8|Period 1 (Panel A and B)|Other|0
5867193|NCT01998958|20293142|P7|Period 1 (Panel A and B)|Other|0
5867194|NCT01998958|20293143|P6|Period 1 (Panel A and B)|Other|0
5867195|NCT01998958|20293144|P5|Period 1 (Panel A and B)|Other|0
5867196|NCT01998958|20293145|P4|Period 1 (Panel A and B)|Other|0
5867197|NCT01998958|20293146|P3|Period 1 (Panel A and B)|Other|0
5867198|NCT01998958|20293147|P2|Period 1 (Panel A and B)|Other|0
5867199|NCT01998958|20293148|P1|Period 1 (Panel A and B)|Other|1
5867200|NCT01998958|20293117|P32|Period 1 (Panel A and B)|Adverse Event|0
5867201|NCT01998958|20293118|P31|Period 1 (Panel A and B)|Adverse Event|0
5867202|NCT01998958|20293119|P30|Period 1 (Panel A and B)|Adverse Event|0
5867203|NCT01998958|20293120|P29|Period 1 (Panel A and B)|Adverse Event|0
5867204|NCT01998958|20293121|P28|Period 1 (Panel A and B)|Adverse Event|0
5867205|NCT01998958|20293122|P27|Period 1 (Panel A and B)|Adverse Event|0
5867206|NCT01998958|20293123|P26|Period 1 (Panel A and B)|Adverse Event|0
5867207|NCT01998958|20293124|P25|Period 1 (Panel A and B)|Adverse Event|0
5867208|NCT01998958|20293125|P24|Period 1 (Panel A and B)|Adverse Event|0
5867209|NCT01998958|20293126|P23|Period 1 (Panel A and B)|Adverse Event|0
5867210|NCT01998958|20293127|P22|Period 1 (Panel A and B)|Adverse Event|0
5867211|NCT01998958|20293128|P21|Period 1 (Panel A and B)|Adverse Event|0
5867212|NCT01998958|20293129|P20|Period 1 (Panel A and B)|Adverse Event|0
5867213|NCT01998958|20293130|P19|Period 1 (Panel A and B)|Adverse Event|0
5867214|NCT01998958|20293131|P18|Period 1 (Panel A and B)|Adverse Event|0
5867215|NCT01998958|20293132|P17|Period 1 (Panel A and B)|Adverse Event|0
5867216|NCT01998958|20293133|P16|Period 1 (Panel A and B)|Adverse Event|0
5867217|NCT01998958|20293134|P15|Period 1 (Panel A and B)|Adverse Event|0
5867218|NCT01998958|20293135|P14|Period 1 (Panel A and B)|Adverse Event|0
5867219|NCT01998958|20293136|P13|Period 1 (Panel A and B)|Adverse Event|0
5867220|NCT01998958|20293137|P12|Period 1 (Panel A and B)|Adverse Event|0
5867221|NCT01998958|20293138|P11|Period 1 (Panel A and B)|Adverse Event|0
5867222|NCT01998958|20293139|P10|Period 1 (Panel A and B)|Adverse Event|0
5867223|NCT01998958|20293140|P9|Period 1 (Panel A and B)|Adverse Event|0
5867224|NCT01998958|20293141|P8|Period 1 (Panel A and B)|Adverse Event|0
5867225|NCT01998958|20293142|P7|Period 1 (Panel A and B)|Adverse Event|0
5867226|NCT01998958|20293143|P6|Period 1 (Panel A and B)|Adverse Event|0
5867227|NCT01998958|20293144|P5|Period 1 (Panel A and B)|Adverse Event|0
5867228|NCT01998958|20293145|P4|Period 1 (Panel A and B)|Adverse Event|0
5867229|NCT01998958|20293146|P3|Period 1 (Panel A and B)|Adverse Event|0
5867230|NCT01998958|20293147|P2|Period 1 (Panel A and B)|Adverse Event|1
5867231|NCT01998958|20293148|P1|Period 1 (Panel A and B)|Adverse Event|0
5867232|NCT01998958|20293117|P32|Period 1 (Panel A and B)|Lack of Efficacy|0
5867233|NCT01998958|20293118|P31|Period 1 (Panel A and B)|Lack of Efficacy|0
5867234|NCT01998958|20293119|P30|Period 1 (Panel A and B)|Lack of Efficacy|0
5867235|NCT01998958|20293120|P29|Period 1 (Panel A and B)|Lack of Efficacy|0
5867236|NCT01998958|20293121|P28|Period 1 (Panel A and B)|Lack of Efficacy|0
5867237|NCT01998958|20293122|P27|Period 1 (Panel A and B)|Lack of Efficacy|0
5867238|NCT01998958|20293123|P26|Period 1 (Panel A and B)|Lack of Efficacy|0
5867239|NCT01998958|20293124|P25|Period 1 (Panel A and B)|Lack of Efficacy|0
5867240|NCT01998958|20293125|P24|Period 1 (Panel A and B)|Lack of Efficacy|0
5867241|NCT01998958|20293126|P23|Period 1 (Panel A and B)|Lack of Efficacy|0
5867242|NCT01998958|20293127|P22|Period 1 (Panel A and B)|Lack of Efficacy|0
5867243|NCT01998958|20293128|P21|Period 1 (Panel A and B)|Lack of Efficacy|0
5867244|NCT01998958|20293129|P20|Period 1 (Panel A and B)|Lack of Efficacy|0
5867245|NCT01998958|20293130|P19|Period 1 (Panel A and B)|Lack of Efficacy|0
5867246|NCT01998958|20293131|P18|Period 1 (Panel A and B)|Lack of Efficacy|0
5867247|NCT01998958|20293132|P17|Period 1 (Panel A and B)|Lack of Efficacy|0
5867248|NCT01998958|20293133|P16|Period 1 (Panel A and B)|Lack of Efficacy|0
5867249|NCT01998958|20293134|P15|Period 1 (Panel A and B)|Lack of Efficacy|0
5867250|NCT01998958|20293135|P14|Period 1 (Panel A and B)|Lack of Efficacy|0
5867251|NCT01998958|20293136|P13|Period 1 (Panel A and B)|Lack of Efficacy|0
5867252|NCT01998958|20293137|P12|Period 1 (Panel A and B)|Lack of Efficacy|0
5867253|NCT01998958|20293138|P11|Period 1 (Panel A and B)|Lack of Efficacy|0
5867254|NCT01998958|20293139|P10|Period 1 (Panel A and B)|Lack of Efficacy|0
5867255|NCT01998958|20293140|P9|Period 1 (Panel A and B)|Lack of Efficacy|0
5867256|NCT01998958|20293141|P8|Period 1 (Panel A and B)|Lack of Efficacy|0
5867257|NCT01998958|20293142|P7|Period 1 (Panel A and B)|Lack of Efficacy|0
5867258|NCT01998958|20293143|P6|Period 1 (Panel A and B)|Lack of Efficacy|0
5867259|NCT01998958|20293144|P5|Period 1 (Panel A and B)|Lack of Efficacy|0
5867260|NCT01998958|20293145|P4|Period 1 (Panel A and B)|Lack of Efficacy|0
5867261|NCT01998958|20293146|P3|Period 1 (Panel A and B)|Lack of Efficacy|0
5867262|NCT01998958|20293147|P2|Period 1 (Panel A and B)|Lack of Efficacy|1
5867263|NCT01998958|20293148|P1|Period 1 (Panel A and B)|Lack of Efficacy|0
5867264|NCT01998958|20293117|P32|Period 1 (Panel A and B)|Withdrawal by Subject|0
5867265|NCT01998958|20293118|P31|Period 1 (Panel A and B)|Withdrawal by Subject|0
5867266|NCT01998958|20293119|P30|Period 1 (Panel A and B)|Withdrawal by Subject|0
5867267|NCT01998958|20293120|P29|Period 1 (Panel A and B)|Withdrawal by Subject|0
5867268|NCT01998958|20293121|P28|Period 1 (Panel A and B)|Withdrawal by Subject|0
5867269|NCT01998958|20293122|P27|Period 1 (Panel A and B)|Withdrawal by Subject|0
5867270|NCT01998958|20293123|P26|Period 1 (Panel A and B)|Withdrawal by Subject|0
5867271|NCT01998958|20293124|P25|Period 1 (Panel A and B)|Withdrawal by Subject|0
5867272|NCT01998958|20293125|P24|Period 1 (Panel A and B)|Withdrawal by Subject|0
5867273|NCT01998958|20293126|P23|Period 1 (Panel A and B)|Withdrawal by Subject|0
5867274|NCT01998958|20293127|P22|Period 1 (Panel A and B)|Withdrawal by Subject|0
5867275|NCT01998958|20293128|P21|Period 1 (Panel A and B)|Withdrawal by Subject|0
5867276|NCT01998958|20293129|P20|Period 1 (Panel A and B)|Withdrawal by Subject|0
5867277|NCT01998958|20293130|P19|Period 1 (Panel A and B)|Withdrawal by Subject|0
5867278|NCT01998958|20293131|P18|Period 1 (Panel A and B)|Withdrawal by Subject|0
5867279|NCT01998958|20293132|P17|Period 1 (Panel A and B)|Withdrawal by Subject|0
5867280|NCT01998958|20293133|P16|Period 1 (Panel A and B)|Withdrawal by Subject|0
5867281|NCT01998958|20293134|P15|Period 1 (Panel A and B)|Withdrawal by Subject|0
5867282|NCT01998958|20293135|P14|Period 1 (Panel A and B)|Withdrawal by Subject|0
5867283|NCT01998958|20293136|P13|Period 1 (Panel A and B)|Withdrawal by Subject|0
5867284|NCT01998958|20293137|P12|Period 1 (Panel A and B)|Withdrawal by Subject|0
5867285|NCT01998958|20293138|P11|Period 1 (Panel A and B)|Withdrawal by Subject|0
5867286|NCT01998958|20293139|P10|Period 1 (Panel A and B)|Withdrawal by Subject|0
5867287|NCT01998958|20293140|P9|Period 1 (Panel A and B)|Withdrawal by Subject|0
5867288|NCT01998958|20293141|P8|Period 1 (Panel A and B)|Withdrawal by Subject|0
5867289|NCT01998958|20293142|P7|Period 1 (Panel A and B)|Withdrawal by Subject|0
5867290|NCT01998958|20293143|P6|Period 1 (Panel A and B)|Withdrawal by Subject|0
5867291|NCT01998958|20293144|P5|Period 1 (Panel A and B)|Withdrawal by Subject|0
5867292|NCT01998958|20293145|P4|Period 1 (Panel A and B)|Withdrawal by Subject|0
5867293|NCT01998958|20293146|P3|Period 1 (Panel A and B)|Withdrawal by Subject|0
5867294|NCT01998958|20293147|P2|Period 1 (Panel A and B)|Withdrawal by Subject|1
5867295|NCT01998958|20293148|P1|Period 1 (Panel A and B)|Withdrawal by Subject|0
5867296|NCT01998919|20293287|P2|Overall Study|Other|2
5867297|NCT01998919|20293288|P1|Overall Study|Other|5
5867298|NCT01998919|20293287|P2|Overall Study|Lost to Follow-up|0
5867299|NCT01998919|20293288|P1|Overall Study|Lost to Follow-up|2
5867300|NCT01998919|20293287|P2|Overall Study|Withdrawal by Subject|4
5867301|NCT01998919|20293288|P1|Overall Study|Withdrawal by Subject|2
5867302|NCT01998919|20293287|P2|Overall Study|Disease progression|22
5867303|NCT01998919|20293288|P1|Overall Study|Disease progression|31
5867304|NCT01998919|20293287|P2|Overall Study|Adverse Event|5
5867305|NCT01998919|20293288|P1|Overall Study|Adverse Event|0
5867306|NCT01998919|20293287|P2|Overall Study|Death|2
5867307|NCT01998919|20293288|P1|Overall Study|Death|2
5867308|NCT01998906|20293309|P3|Overall Study|Other|4
5867309|NCT01998906|20293310|P2|Overall Study|Other|8
5867310|NCT01998906|20293311|P1|Overall Study|Other|3
5867311|NCT01998906|20293309|P3|Overall Study|Administrative/Other|3
5867312|NCT01998906|20293310|P2|Overall Study|Administrative/Other|1
5867313|NCT01998906|20293311|P1|Overall Study|Administrative/Other|2
5867314|NCT01998906|20293309|P3|Overall Study|Withdrawal by Subject|3
5867315|NCT01998906|20293310|P2|Overall Study|Withdrawal by Subject|4
5867316|NCT01998906|20293311|P1|Overall Study|Withdrawal by Subject|1
5867317|NCT01998906|20293309|P3|Overall Study|Violation of Selection Criteria|1
5867318|NCT01998906|20293310|P2|Overall Study|Violation of Selection Criteria|0
5867319|NCT01998906|20293311|P1|Overall Study|Violation of Selection Criteria|0
5867320|NCT01998906|20293309|P3|Overall Study|Failure to return|4
5867321|NCT01998906|20293310|P2|Overall Study|Failure to return|2
5867322|NCT01998906|20293311|P1|Overall Study|Failure to return|0
5867323|NCT01998906|20293309|P3|Overall Study|Lack of Efficacy|8
5867324|NCT01998906|20293310|P2|Overall Study|Lack of Efficacy|9
5867325|NCT01998906|20293311|P1|Overall Study|Lack of Efficacy|10
5867326|NCT01998906|20293309|P3|Overall Study|Death|17
5867327|NCT01998906|20293310|P2|Overall Study|Death|30
5867328|NCT01998906|20293311|P1|Overall Study|Death|21
5867329|NCT01998906|20293309|P3|Overall Study|Participants ongoing in follow-up|58
5867330|NCT01998906|20293310|P2|Overall Study|Participants ongoing in follow-up|60
5867331|NCT01998906|20293311|P1|Overall Study|Participants ongoing in follow-up|77
5867332|NCT01998893|20293355|P1|Overall Study|Transformation to high-grade lymphoma|1
5867333|NCT01998893|20293355|P1|Overall Study|Withdrawal by Subject|1
5867334|NCT01998893|20293355|P1|Overall Study|Protocol Violation|2
5867335|NCT01998893|20293355|P1|Overall Study|Physician Decision|2
5867336|NCT01998893|20293355|P1|Overall Study|Lost to Follow-up|8
5867337|NCT01998893|20293355|P1|Overall Study|Death|1
5867338|NCT01998893|20293355|P1|Overall Study|Adverse Event|2
5867339|NCT01998880|20293367|P2|Overall Study|Did Not Receive Treatment|2
5867340|NCT01998880|20293368|P1|Overall Study|Did Not Receive Treatment|3
5867341|NCT01998880|20293367|P2|Overall Study|Violation of Selection Criteria at Entry|1
5867342|NCT01998880|20293368|P1|Overall Study|Violation of Selection Criteria at Entry|0
5867343|NCT01998880|20293367|P2|Overall Study|Refused Treatment/Did Not Cooperate|0
5867344|NCT01998880|20293368|P1|Overall Study|Refused Treatment/Did Not Cooperate|1
5867345|NCT01998880|20293367|P2|Overall Study|Administrative/Other|1
5867346|NCT01998880|20293368|P1|Overall Study|Administrative/Other|1
5867347|NCT01998880|20293367|P2|Overall Study|Insufficient Therapeutic Response|5
5867348|NCT01998880|20293368|P1|Overall Study|Insufficient Therapeutic Response|1
5867349|NCT01998880|20293367|P2|Overall Study|Death|6
5867350|NCT01998880|20293368|P1|Overall Study|Death|3
5867351|NCT01998880|20293367|P2|Overall Study|Withdrew Consent|1
5867352|NCT01998880|20293368|P1|Overall Study|Withdrew Consent|2
5867353|NCT01998880|20293367|P2|Overall Study|Disease Progression|8
5867354|NCT01998880|20293368|P1|Overall Study|Disease Progression|1
5867355|NCT01998880|20293367|P2|Overall Study|Adverse Events or Intercurrent Illness|16
5867356|NCT01998880|20293368|P1|Overall Study|Adverse Events or Intercurrent Illness|16
5867357|NCT01998737|20293400|P2|Overall Study|Corrupted database|0
5867358|NCT01998737|20293401|P1|Overall Study|Corrupted database|23
5867359|NCT01998633|20293413|P1|Overall Study|Death|1
5867360|NCT01998581|20293431|P2|Overall Study|Randomized but withdrew before treatment|0
5867361|NCT01998581|20293432|P1|Overall Study|Randomized but withdrew before treatment|1
5867362|NCT01998581|20293431|P2|Overall Study|Other reasons|2
5867363|NCT01998581|20293432|P1|Overall Study|Other reasons|3
5867364|NCT01998581|20293431|P2|Overall Study|Adverse Event|1
5867365|NCT01998581|20293432|P1|Overall Study|Adverse Event|1
5867366|NCT01998581|20293431|P2|Overall Study|Lost to Follow-up|4
5867367|NCT01998581|20293432|P1|Overall Study|Lost to Follow-up|12
5867368|NCT01998581|20293431|P2|Overall Study|Withdrawal by Subject|1
5867369|NCT01998581|20293432|P1|Overall Study|Withdrawal by Subject|8
5867370|NCT01998581|20293431|P2|Overall Study|Protocol Violation|0
5867371|NCT01998581|20293432|P1|Overall Study|Protocol Violation|1
5867372|NCT01998581|20293431|P2|Overall Study|Refused repeat treatment|4
5867373|NCT01998581|20293432|P1|Overall Study|Refused repeat treatment|20
5867374|NCT01998477|20293445|P2|Overall Study|Withdrawal by Subject|0
5867375|NCT01998477|20293446|P1|Overall Study|Withdrawal by Subject|6
5867376|NCT01998477|20293445|P2|Overall Study|Lost to Follow-up|5
5867377|NCT01998477|20293446|P1|Overall Study|Lost to Follow-up|4
5867378|NCT01998399|20293492|P2|Overall Study|Withdrawal by Subject|1
5867379|NCT01998399|20293493|P1|Overall Study|Withdrawal by Subject|0
5867380|NCT01998399|20293492|P2|Overall Study|Study stopped before dosing completed|3
5867381|NCT01998399|20293493|P1|Overall Study|Study stopped before dosing completed|3
5867382|NCT01998399|20293492|P2|Overall Study|Death|2
5867383|NCT01998399|20293493|P1|Overall Study|Death|4
5867384|NCT01998399|20293492|P2|Overall Study|Lost to Follow-up|3
5867385|NCT01998399|20293493|P1|Overall Study|Lost to Follow-up|1
5867386|NCT01998243|20293548|P2|Overall Study|Withdrawal by Subject|4
5867387|NCT01998243|20293549|P1|Overall Study|Withdrawal by Subject|3
5867388|NCT01998243|20293548|P2|Overall Study|Protocol Violation|2
5867389|NCT01998243|20293549|P1|Overall Study|Protocol Violation|5
5867390|NCT01998243|20293548|P2|Overall Study|Pregnancy|1
5867391|NCT01998243|20293549|P1|Overall Study|Pregnancy|0
5867392|NCT01997892|20293572|P1|Overall Study|Study completion data not recorded|35
5867393|NCT01997892|20293572|P1|Overall Study|Other|3
5867394|NCT01997892|20293572|P1|Overall Study|Renal transplant|8
5867395|NCT01997892|20293572|P1|Overall Study|Death|14
5867396|NCT01997892|20293572|P1|Overall Study|Lost to Follow-up|6
5867397|NCT01997892|20293572|P1|Overall Study|Physician Decision|2
5867398|NCT01997333|20293746|P2|Survival Follow up|Various|2
5867399|NCT01997333|20293747|P1|Survival Follow up|Various|1
5867400|NCT01997333|20293746|P2|Survival Follow up|Lost to Follow-up|6
5867401|NCT01997333|20293747|P1|Survival Follow up|Lost to Follow-up|0
5867402|NCT01997333|20293746|P2|Survival Follow up|Withdrawal by Subject|6
5867403|NCT01997333|20293747|P1|Survival Follow up|Withdrawal by Subject|15
5867404|NCT01997333|20293746|P2|Randomization and Treatment|Did not receive treatment|5
5867405|NCT01997333|20293747|P1|Randomization and Treatment|Did not receive treatment|17
5867495|NCT01995838|20294120|P1|Overall Study|Adverse Event|0
5867406|NCT01997333|20293746|P2|Randomization and Treatment|Withdrawal by Subject|3
5867407|NCT01997333|20293747|P1|Randomization and Treatment|Withdrawal by Subject|6
5867408|NCT01997333|20293746|P2|Randomization and Treatment|Physician Decision|4
5867409|NCT01997333|20293747|P1|Randomization and Treatment|Physician Decision|0
5867410|NCT01997333|20293746|P2|Randomization and Treatment|Adverse Event|32
5867411|NCT01997333|20293747|P1|Randomization and Treatment|Adverse Event|10
5867412|NCT01997333|20293746|P2|Randomization and Treatment|Disease Progression|159
5867413|NCT01997333|20293747|P1|Randomization and Treatment|Disease Progression|70
5867414|NCT01997281|20293764|P2|Overall Study|Withdrawal by Subject|0
5867415|NCT01997281|20293765|P1|Overall Study|Withdrawal by Subject|1
5867416|NCT01996982|20293791|P1|Overall Study|PI/team left institution|7
5867417|NCT01996904|20293807|P2|Overall Study|Lost to Follow-up|27
5867418|NCT01996904|20293808|P1|Overall Study|Lost to Follow-up|38
5867419|NCT01996826|20293893|P2|Overall Study|Physician Decision|1
5867420|NCT01996826|20293894|P1|Overall Study|Physician Decision|1
5867421|NCT01996826|20293893|P2|Overall Study|Lost to Follow-up|2
5867422|NCT01996826|20293894|P1|Overall Study|Lost to Follow-up|6
5867423|NCT01996748|20293917|P2|Overall Study|Lost to Follow-up|1
5867424|NCT01996748|20293918|P1|Overall Study|Lost to Follow-up|4
5867425|NCT01996748|20293917|P2|Overall Study|Withdrawal by Subject|1
5867426|NCT01996748|20293918|P1|Overall Study|Withdrawal by Subject|0
5867427|NCT01996748|20293917|P2|Overall Study|Adverse Event|4
5867428|NCT01996748|20293918|P1|Overall Study|Adverse Event|1
5867429|NCT01996748|20293917|P2|Overall Study|Physician Decision|0
5867430|NCT01996748|20293918|P1|Overall Study|Physician Decision|2
5867431|NCT01996748|20293917|P2|Overall Study|Personal reason|0
5867432|NCT01996748|20293918|P1|Overall Study|Personal reason|1
5867433|NCT01996709|20293932|P2|Overall Study|Failed Inclusion/Exclusion Criteria|1
5867434|NCT01996709|20293933|P1|Overall Study|Failed Inclusion/Exclusion Criteria|0
5867435|NCT01996709|20293932|P2|Overall Study|Subject Non-Compliant|0
5867436|NCT01996709|20293933|P1|Overall Study|Subject Non-Compliant|1
5867437|NCT01996709|20293932|P2|Overall Study|Lost to Follow-up|0
5867438|NCT01996709|20293933|P1|Overall Study|Lost to Follow-up|3
5867439|NCT01996709|20293932|P2|Overall Study|Withdrawal by Subject|0
5867440|NCT01996709|20293933|P1|Overall Study|Withdrawal by Subject|1
5867441|NCT01996592|20293980|P1|Overall Study|change in mode of delivery|4
5867442|NCT01996592|20293980|P1|Overall Study|Withdrawal by Subject|5
5867443|NCT01996592|20293980|P1|Overall Study|change in surgical date|4
5867444|NCT01996592|20293980|P1|Overall Study|no response to text/no diary entry|32
5867445|NCT01996332|20294016|P1|Overall Study|Lost to Follow-up|34
5867446|NCT01996332|20294016|P1|Overall Study|Physician Decision|17
5867447|NCT01996332|20294016|P1|Overall Study|Clinical Deterioration|28
5867448|NCT01996332|20294016|P1|Overall Study|Other|20
5867449|NCT01996332|20294016|P1|Overall Study|Withdrawal by Subject|71
5867450|NCT01996332|20294016|P1|Overall Study|Protocol Violation|9
5867451|NCT01996332|20294016|P1|Overall Study|Death|264
5867452|NCT01996332|20294016|P1|Overall Study|Lack of Efficacy|1245
5867453|NCT01996332|20294016|P1|Overall Study|Adverse Event|117
5867454|NCT01996319|20294024|P2|Overall Study|Adverse Event|2
5867455|NCT01996319|20294025|P1|Overall Study|Adverse Event|2
5867456|NCT01996319|20294024|P2|Overall Study|Severe or moderate (COPD) Exacerbation|1
5867457|NCT01996319|20294025|P1|Overall Study|Severe or moderate (COPD) Exacerbation|5
5867458|NCT01996319|20294024|P2|Overall Study|Protocol Violation|0
5867459|NCT01996319|20294025|P1|Overall Study|Protocol Violation|1
5867460|NCT01996254|20294047|P3|Overall Study|Lost to Follow-up|4
5867461|NCT01996254|20294048|P2|Overall Study|Lost to Follow-up|0
5867462|NCT01996254|20294049|P1|Overall Study|Lost to Follow-up|1
5867463|NCT01996254|20294047|P3|Overall Study|Withdrawal by Subject|4
5867464|NCT01996254|20294048|P2|Overall Study|Withdrawal by Subject|3
5867465|NCT01996254|20294049|P1|Overall Study|Withdrawal by Subject|0
5867466|NCT01996254|20294047|P3|Overall Study|Change in Eligibility|0
5867467|NCT01996254|20294048|P2|Overall Study|Change in Eligibility|2
5867468|NCT01996254|20294049|P1|Overall Study|Change in Eligibility|0
5867469|NCT01996241|20294077|P2|Overall Study|Lost to Follow-up|235
5867470|NCT01996241|20294078|P1|Overall Study|Lost to Follow-up|252
5867471|NCT01996033|20294094|P1|Overall Study|Lost to Follow-up|3
5867472|NCT01996033|20294094|P1|Overall Study|Withdrawal by Subject|4
5867473|NCT01996033|20294094|P1|Overall Study|Physician Decision|1
5867474|NCT01996033|20294094|P1|Overall Study|Death|1
5867475|NCT01995838|20294114|P7|Overall Study|Other|2
5867476|NCT01995838|20294115|P6|Overall Study|Other|1
5867477|NCT01995838|20294116|P5|Overall Study|Other|1
5867478|NCT01995838|20294117|P4|Overall Study|Other|2
5867479|NCT01995838|20294118|P3|Overall Study|Other|0
5867480|NCT01995838|20294119|P2|Overall Study|Other|1
5867481|NCT01995838|20294120|P1|Overall Study|Other|3
5867482|NCT01995838|20294114|P7|Overall Study|Withdrawal by Subject|0
5867483|NCT01995838|20294115|P6|Overall Study|Withdrawal by Subject|0
5867484|NCT01995838|20294116|P5|Overall Study|Withdrawal by Subject|1
5867485|NCT01995838|20294117|P4|Overall Study|Withdrawal by Subject|0
5867486|NCT01995838|20294118|P3|Overall Study|Withdrawal by Subject|0
5867487|NCT01995838|20294119|P2|Overall Study|Withdrawal by Subject|0
5867488|NCT01995838|20294120|P1|Overall Study|Withdrawal by Subject|0
5867489|NCT01995838|20294114|P7|Overall Study|Adverse Event|1
5867490|NCT01995838|20294115|P6|Overall Study|Adverse Event|0
5867491|NCT01995838|20294116|P5|Overall Study|Adverse Event|0
5867492|NCT01995838|20294117|P4|Overall Study|Adverse Event|0
5867493|NCT01995838|20294118|P3|Overall Study|Adverse Event|0
5867494|NCT01995838|20294119|P2|Overall Study|Adverse Event|0
5867496|NCT01995838|20294114|P7|Overall Study|Participant choice|1
5867497|NCT01995838|20294115|P6|Overall Study|Participant choice|1
5867498|NCT01995838|20294116|P5|Overall Study|Participant choice|0
5867499|NCT01995838|20294117|P4|Overall Study|Participant choice|0
5867500|NCT01995838|20294118|P3|Overall Study|Participant choice|0
5867501|NCT01995838|20294119|P2|Overall Study|Participant choice|0
5867502|NCT01995838|20294120|P1|Overall Study|Participant choice|2
5867503|NCT01995838|20294114|P7|Overall Study|Lost to Follow-up|1
5867504|NCT01995838|20294115|P6|Overall Study|Lost to Follow-up|0
5867505|NCT01995838|20294116|P5|Overall Study|Lost to Follow-up|0
5867506|NCT01995838|20294117|P4|Overall Study|Lost to Follow-up|0
5867507|NCT01995838|20294118|P3|Overall Study|Lost to Follow-up|0
5867508|NCT01995838|20294119|P2|Overall Study|Lost to Follow-up|1
5867509|NCT01995838|20294120|P1|Overall Study|Lost to Follow-up|0
5867510|NCT01995825|20294221|P2|Overall Study|Withdrawal by Subject|0
5867511|NCT01995825|20294222|P1|Overall Study|Withdrawal by Subject|1
5867512|NCT01995552|20294230|P1|Overall Study|Death|1
5867513|NCT01995552|20294230|P1|Overall Study|Lack of Efficacy|15
5867514|NCT01995552|20294230|P1|Overall Study|Protocol Violation|1
5867515|NCT01995539|20294236|P1|Overall Study|Subject missed visit 3,4, came in for V5|1
5867516|NCT01995539|20294236|P1|Overall Study|Lost to Follow-up|5
5867517|NCT01995539|20294236|P1|Overall Study|Withdrawal by Subject|11
5867518|NCT01995539|20294236|P1|Overall Study|Withdrawal by Investigator|15
5867519|NCT01995539|20294236|P1|Overall Study|Screening Failure|1
5867520|NCT01995526|20294241|P1|Overall Study|Physician Decision|1
5867521|NCT01995513|20294249|P3|Double Blind Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|18
5867522|NCT01995513|20294250|P2|Double Blind Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|27
5867523|NCT01995513|20294251|P1|Double Blind Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|0
5867524|NCT01995513|20294249|P3|Double Blind Treatment Period|Disease Progression|93
5867525|NCT01995513|20294250|P2|Double Blind Treatment Period|Disease Progression|82
5867526|NCT01995513|20294251|P1|Double Blind Treatment Period|Disease Progression|0
5867527|NCT01995513|20294249|P3|Double Blind Treatment Period|Death|1
5867528|NCT01995513|20294250|P2|Double Blind Treatment Period|Death|0
5867529|NCT01995513|20294251|P1|Double Blind Treatment Period|Death|0
5867530|NCT01995513|20294249|P3|Double Blind Treatment Period|Withdrawal by Subject|6
5867531|NCT01995513|20294250|P2|Double Blind Treatment Period|Withdrawal by Subject|4
5867532|NCT01995513|20294251|P1|Double Blind Treatment Period|Withdrawal by Subject|0
5867533|NCT01995513|20294249|P3|Double Blind Treatment Period|Other|2
5867534|NCT01995513|20294250|P2|Double Blind Treatment Period|Other|1
5867535|NCT01995513|20294251|P1|Double Blind Treatment Period|Other|0
5867536|NCT01995513|20294249|P3|Double Blind Treatment Period|Adverse Event|5
5867537|NCT01995513|20294250|P2|Double Blind Treatment Period|Adverse Event|12
5867538|NCT01995513|20294251|P1|Double Blind Treatment Period|Adverse Event|0
5867539|NCT01995513|20294249|P3|Open Label Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|0
5867540|NCT01995513|20294250|P2|Open Label Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|0
5867541|NCT01995513|20294251|P1|Open Label Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|84
5867542|NCT01995513|20294249|P3|Open Label Treatment Period|Death|0
5867543|NCT01995513|20294250|P2|Open Label Treatment Period|Death|0
5867544|NCT01995513|20294251|P1|Open Label Treatment Period|Death|8
5867545|NCT01995513|20294249|P3|Open Label Treatment Period|Adverse Event|0
5867546|NCT01995513|20294250|P2|Open Label Treatment Period|Adverse Event|0
5867547|NCT01995513|20294251|P1|Open Label Treatment Period|Adverse Event|35
5867548|NCT01995513|20294249|P3|Open Label Treatment Period|No PSA response at week 13|0
5867549|NCT01995513|20294250|P2|Open Label Treatment Period|No PSA response at week 13|0
5867550|NCT01995513|20294251|P1|Open Label Treatment Period|No PSA response at week 13|43
5867551|NCT01995513|20294249|P3|Open Label Treatment Period|Disease Progression|0
5867552|NCT01995513|20294250|P2|Open Label Treatment Period|Disease Progression|0
5867553|NCT01995513|20294251|P1|Open Label Treatment Period|Disease Progression|64
5867554|NCT01995513|20294249|P3|Open Label Treatment Period|Protocol Violation|0
5867555|NCT01995513|20294250|P2|Open Label Treatment Period|Protocol Violation|0
5867556|NCT01995513|20294251|P1|Open Label Treatment Period|Protocol Violation|1
5867557|NCT01995513|20294249|P3|Open Label Treatment Period|Withdrawal by Subject|0
5867558|NCT01995513|20294250|P2|Open Label Treatment Period|Withdrawal by Subject|0
5867559|NCT01995513|20294251|P1|Open Label Treatment Period|Withdrawal by Subject|14
5867560|NCT01995513|20294249|P3|Open Label Treatment Period|Other|0
5867561|NCT01995513|20294250|P2|Open Label Treatment Period|Other|0
5867562|NCT01995513|20294251|P1|Open Label Treatment Period|Other|9
5867563|NCT01995461|20294294|P1|Overall Study|Withdrawal by Subject|2
5867564|NCT01995461|20294294|P1|Overall Study|Lost to Follow-up|2
5867565|NCT01995461|20294294|P1|Overall Study|Death|1
5867566|NCT01995357|20294300|P6|Period 5|Adverse Event|0
5867567|NCT01995357|20294301|P5|Period 5|Adverse Event|0
5867568|NCT01995357|20294302|P4|Period 5|Adverse Event|0
5867569|NCT01995357|20294303|P3|Period 5|Adverse Event|1
5867570|NCT01995357|20294304|P2|Period 5|Adverse Event|0
5867571|NCT01995357|20294305|P1|Period 5|Adverse Event|1
5867572|NCT01995357|20294300|P6|Period 5|Lack of Efficacy|0
5867573|NCT01995357|20294301|P5|Period 5|Lack of Efficacy|0
5867574|NCT01995357|20294302|P4|Period 5|Lack of Efficacy|0
5867575|NCT01995357|20294303|P3|Period 5|Lack of Efficacy|0
5867576|NCT01995357|20294304|P2|Period 5|Lack of Efficacy|0
5867577|NCT01995357|20294305|P1|Period 5|Lack of Efficacy|1
5867578|NCT01995266|20294321|P1|Overall Study|Adverse Event|2
5867579|NCT01995266|20294321|P1|Overall Study|Lack of Efficacy|6
5867580|NCT01995266|20294321|P1|Overall Study|Death|1
5867581|NCT01995201|20294336|P7|From Week 24 Until Week 48|Protocol Violation|0
5867582|NCT01995201|20294337|P6|From Week 24 Until Week 48|Protocol Violation|0
5867583|NCT01995201|20294338|P5|From Week 24 Until Week 48|Protocol Violation|2
5867584|NCT01995201|20294339|P4|From Week 24 Until Week 48|Protocol Violation|0
5867585|NCT01995201|20294340|P3|From Week 24 Until Week 48|Protocol Violation|1
5867586|NCT01995201|20294341|P2|From Week 24 Until Week 48|Protocol Violation|0
5867587|NCT01995201|20294342|P1|From Week 24 Until Week 48|Protocol Violation|0
5867588|NCT01995201|20294336|P7|From Week 24 Until Week 48|Physician Decision|0
5867589|NCT01995201|20294337|P6|From Week 24 Until Week 48|Physician Decision|0
5867590|NCT01995201|20294338|P5|From Week 24 Until Week 48|Physician Decision|1
5867591|NCT01995201|20294339|P4|From Week 24 Until Week 48|Physician Decision|0
5867592|NCT01995201|20294340|P3|From Week 24 Until Week 48|Physician Decision|0
5867593|NCT01995201|20294341|P2|From Week 24 Until Week 48|Physician Decision|0
5867594|NCT01995201|20294342|P1|From Week 24 Until Week 48|Physician Decision|0
5867595|NCT01995201|20294336|P7|From Week 24 Until Week 48|Withdrawal by Subject|0
5867596|NCT01995201|20294337|P6|From Week 24 Until Week 48|Withdrawal by Subject|0
5867597|NCT01995201|20294338|P5|From Week 24 Until Week 48|Withdrawal by Subject|1
5867598|NCT01995201|20294339|P4|From Week 24 Until Week 48|Withdrawal by Subject|0
5867599|NCT01995201|20294340|P3|From Week 24 Until Week 48|Withdrawal by Subject|1
5867600|NCT01995201|20294341|P2|From Week 24 Until Week 48|Withdrawal by Subject|0
5867601|NCT01995201|20294342|P1|From Week 24 Until Week 48|Withdrawal by Subject|0
5867602|NCT01995201|20294336|P7|From Week 24 Until Week 48|Lost to Follow-up|0
5867603|NCT01995201|20294337|P6|From Week 24 Until Week 48|Lost to Follow-up|1
5867604|NCT01995201|20294338|P5|From Week 24 Until Week 48|Lost to Follow-up|1
5867605|NCT01995201|20294339|P4|From Week 24 Until Week 48|Lost to Follow-up|0
5867606|NCT01995201|20294340|P3|From Week 24 Until Week 48|Lost to Follow-up|0
5867607|NCT01995201|20294341|P2|From Week 24 Until Week 48|Lost to Follow-up|0
5867608|NCT01995201|20294342|P1|From Week 24 Until Week 48|Lost to Follow-up|0
5867609|NCT01995201|20294336|P7|From Week 24 Until Week 48|Lack of Efficacy|1
5867610|NCT01995201|20294337|P6|From Week 24 Until Week 48|Lack of Efficacy|2
5867611|NCT01995201|20294338|P5|From Week 24 Until Week 48|Lack of Efficacy|0
5867612|NCT01995201|20294339|P4|From Week 24 Until Week 48|Lack of Efficacy|0
5867613|NCT01995201|20294340|P3|From Week 24 Until Week 48|Lack of Efficacy|1
5867614|NCT01995201|20294341|P2|From Week 24 Until Week 48|Lack of Efficacy|0
5867615|NCT01995201|20294342|P1|From Week 24 Until Week 48|Lack of Efficacy|0
5867616|NCT01995201|20294336|P7|From Week 24 Until Week 48|Death|0
5867617|NCT01995201|20294337|P6|From Week 24 Until Week 48|Death|2
5867618|NCT01995201|20294338|P5|From Week 24 Until Week 48|Death|0
5867619|NCT01995201|20294339|P4|From Week 24 Until Week 48|Death|0
5867620|NCT01995201|20294340|P3|From Week 24 Until Week 48|Death|0
5867621|NCT01995201|20294341|P2|From Week 24 Until Week 48|Death|0
5867622|NCT01995201|20294342|P1|From Week 24 Until Week 48|Death|0
5867623|NCT01995201|20294336|P7|From Week 24 Until Week 48|Adverse Event|1
5867624|NCT01995201|20294337|P6|From Week 24 Until Week 48|Adverse Event|3
5867625|NCT01995201|20294338|P5|From Week 24 Until Week 48|Adverse Event|1
5867626|NCT01995201|20294339|P4|From Week 24 Until Week 48|Adverse Event|1
5867627|NCT01995201|20294340|P3|From Week 24 Until Week 48|Adverse Event|2
5867628|NCT01995201|20294341|P2|From Week 24 Until Week 48|Adverse Event|0
5867629|NCT01995201|20294342|P1|From Week 24 Until Week 48|Adverse Event|0
5867630|NCT01995201|20294336|P7|From Baseline Until Week 24|Protocol Violation|0
5867631|NCT01995201|20294337|P6|From Baseline Until Week 24|Protocol Violation|0
5867632|NCT01995201|20294338|P5|From Baseline Until Week 24|Protocol Violation|0
5867633|NCT01995201|20294339|P4|From Baseline Until Week 24|Protocol Violation|0
5867634|NCT01995201|20294340|P3|From Baseline Until Week 24|Protocol Violation|0
5867635|NCT01995201|20294341|P2|From Baseline Until Week 24|Protocol Violation|9
5867636|NCT01995201|20294342|P1|From Baseline Until Week 24|Protocol Violation|0
5867637|NCT01995201|20294336|P7|From Baseline Until Week 24|Physician Decision|0
5867638|NCT01995201|20294337|P6|From Baseline Until Week 24|Physician Decision|0
5867639|NCT01995201|20294338|P5|From Baseline Until Week 24|Physician Decision|0
5867640|NCT01995201|20294339|P4|From Baseline Until Week 24|Physician Decision|0
5867641|NCT01995201|20294340|P3|From Baseline Until Week 24|Physician Decision|0
5867642|NCT01995201|20294341|P2|From Baseline Until Week 24|Physician Decision|2
5867643|NCT01995201|20294342|P1|From Baseline Until Week 24|Physician Decision|0
5867644|NCT01995201|20294336|P7|From Baseline Until Week 24|Withdrawal by Subject|0
5867645|NCT01995201|20294337|P6|From Baseline Until Week 24|Withdrawal by Subject|0
5867646|NCT01995201|20294338|P5|From Baseline Until Week 24|Withdrawal by Subject|0
5867647|NCT01995201|20294339|P4|From Baseline Until Week 24|Withdrawal by Subject|0
5867648|NCT01995201|20294340|P3|From Baseline Until Week 24|Withdrawal by Subject|0
5867649|NCT01995201|20294341|P2|From Baseline Until Week 24|Withdrawal by Subject|8
5867650|NCT01995201|20294342|P1|From Baseline Until Week 24|Withdrawal by Subject|2
5867651|NCT01995201|20294336|P7|From Baseline Until Week 24|Lost to Follow-up|0
5867652|NCT01995201|20294337|P6|From Baseline Until Week 24|Lost to Follow-up|0
5867653|NCT01995201|20294338|P5|From Baseline Until Week 24|Lost to Follow-up|0
5867654|NCT01995201|20294339|P4|From Baseline Until Week 24|Lost to Follow-up|0
5867655|NCT01995201|20294340|P3|From Baseline Until Week 24|Lost to Follow-up|0
5867656|NCT01995201|20294341|P2|From Baseline Until Week 24|Lost to Follow-up|3
5867657|NCT01995201|20294342|P1|From Baseline Until Week 24|Lost to Follow-up|2
5867658|NCT01995201|20294336|P7|From Baseline Until Week 24|Lack of Efficacy|0
5867659|NCT01995201|20294337|P6|From Baseline Until Week 24|Lack of Efficacy|0
5867660|NCT01995201|20294338|P5|From Baseline Until Week 24|Lack of Efficacy|0
5867661|NCT01995201|20294339|P4|From Baseline Until Week 24|Lack of Efficacy|0
5867662|NCT01995201|20294340|P3|From Baseline Until Week 24|Lack of Efficacy|0
5867663|NCT01995201|20294341|P2|From Baseline Until Week 24|Lack of Efficacy|5
5867664|NCT01995201|20294342|P1|From Baseline Until Week 24|Lack of Efficacy|2
5867665|NCT01995201|20294336|P7|From Baseline Until Week 24|Death|0
5867666|NCT01995201|20294337|P6|From Baseline Until Week 24|Death|0
5867667|NCT01995201|20294338|P5|From Baseline Until Week 24|Death|0
5867668|NCT01995201|20294339|P4|From Baseline Until Week 24|Death|0
5867669|NCT01995201|20294340|P3|From Baseline Until Week 24|Death|0
5867670|NCT01995201|20294341|P2|From Baseline Until Week 24|Death|1
5867671|NCT01995201|20294342|P1|From Baseline Until Week 24|Death|0
5867672|NCT01995201|20294336|P7|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0
5867673|NCT01995201|20294337|P6|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0
5867674|NCT01995201|20294338|P5|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0
5867675|NCT01995201|20294339|P4|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0
5867676|NCT01995201|20294340|P3|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0
5867677|NCT01995201|20294341|P2|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|3
5867678|NCT01995201|20294342|P1|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0
5867679|NCT01995201|20294336|P7|From Baseline Until Week 24|Adverse Event|0
5867680|NCT01995201|20294337|P6|From Baseline Until Week 24|Adverse Event|0
5867681|NCT01995201|20294338|P5|From Baseline Until Week 24|Adverse Event|0
5867682|NCT01995201|20294339|P4|From Baseline Until Week 24|Adverse Event|0
5867683|NCT01995201|20294340|P3|From Baseline Until Week 24|Adverse Event|0
5867684|NCT01995201|20294341|P2|From Baseline Until Week 24|Adverse Event|15
5867685|NCT01995201|20294342|P1|From Baseline Until Week 24|Adverse Event|4
5867690|NCT01995136|20294466|P1|Overall Study|Change in residence|1
5867691|NCT01995071|20294495|P12|Overall Study|Incarcerated|0
5867692|NCT01995071|20294496|P11|Overall Study|Incarcerated|0
5867693|NCT01995071|20294497|P10|Overall Study|Incarcerated|0
5867694|NCT01995071|20294498|P9|Overall Study|Incarcerated|0
5867695|NCT01995071|20294499|P8|Overall Study|Incarcerated|1
5867696|NCT01995071|20294500|P7|Overall Study|Incarcerated|0
5867697|NCT01995071|20294501|P6|Overall Study|Incarcerated|0
5867698|NCT01995071|20294502|P5|Overall Study|Incarcerated|0
5867699|NCT01995071|20294503|P4|Overall Study|Incarcerated|0
5867700|NCT01995071|20294504|P3|Overall Study|Incarcerated|0
5867701|NCT01995071|20294505|P2|Overall Study|Incarcerated|0
5867702|NCT01995071|20294506|P1|Overall Study|Incarcerated|0
5867703|NCT01995071|20294495|P12|Overall Study|Lost to Follow-up|0
5867704|NCT01995071|20294496|P11|Overall Study|Lost to Follow-up|0
5867705|NCT01995071|20294497|P10|Overall Study|Lost to Follow-up|0
5867706|NCT01995071|20294498|P9|Overall Study|Lost to Follow-up|1
5867707|NCT01995071|20294499|P8|Overall Study|Lost to Follow-up|1
5867708|NCT01995071|20294500|P7|Overall Study|Lost to Follow-up|0
5867709|NCT01995071|20294501|P6|Overall Study|Lost to Follow-up|0
5867710|NCT01995071|20294502|P5|Overall Study|Lost to Follow-up|0
5867711|NCT01995071|20294503|P4|Overall Study|Lost to Follow-up|0
5867712|NCT01995071|20294504|P3|Overall Study|Lost to Follow-up|0
5867713|NCT01995071|20294505|P2|Overall Study|Lost to Follow-up|0
5867714|NCT01995071|20294506|P1|Overall Study|Lost to Follow-up|1
5867715|NCT01995071|20294495|P12|Overall Study|Moved|0
5867716|NCT01995071|20294496|P11|Overall Study|Moved|1
5867717|NCT01995071|20294497|P10|Overall Study|Moved|0
5867718|NCT01995071|20294498|P9|Overall Study|Moved|0
5867719|NCT01995071|20294499|P8|Overall Study|Moved|0
5867720|NCT01995071|20294500|P7|Overall Study|Moved|0
5867721|NCT01995071|20294501|P6|Overall Study|Moved|0
5867722|NCT01995071|20294502|P5|Overall Study|Moved|1
5867723|NCT01995071|20294503|P4|Overall Study|Moved|0
5867724|NCT01995071|20294504|P3|Overall Study|Moved|1
5867725|NCT01995071|20294505|P2|Overall Study|Moved|0
5867726|NCT01995071|20294506|P1|Overall Study|Moved|0
5867727|NCT01995071|20294495|P12|Overall Study|Adverse Event|0
5867728|NCT01995071|20294496|P11|Overall Study|Adverse Event|0
5867729|NCT01995071|20294497|P10|Overall Study|Adverse Event|0
5867730|NCT01995071|20294498|P9|Overall Study|Adverse Event|0
5867731|NCT01995071|20294499|P8|Overall Study|Adverse Event|0
5867732|NCT01995071|20294500|P7|Overall Study|Adverse Event|1
5867733|NCT01995071|20294501|P6|Overall Study|Adverse Event|0
5867734|NCT01995071|20294502|P5|Overall Study|Adverse Event|0
5867735|NCT01995071|20294503|P4|Overall Study|Adverse Event|0
5867736|NCT01995071|20294504|P3|Overall Study|Adverse Event|0
5867737|NCT01995071|20294505|P2|Overall Study|Adverse Event|0
5867738|NCT01995071|20294506|P1|Overall Study|Adverse Event|0
5867739|NCT01994954|20294643|P2|Overall Study|6 Month Follow-up Not Complete|4
5867740|NCT01994954|20294644|P1|Overall Study|6 Month Follow-up Not Complete|5
5867741|NCT01994954|20294643|P2|Overall Study|Lost to Follow-up|10
5867742|NCT01994954|20294644|P1|Overall Study|Lost to Follow-up|8
5867743|NCT01994954|20294643|P2|Overall Study|Physician Decision|2
5867744|NCT01994954|20294644|P1|Overall Study|Physician Decision|2
5867745|NCT01994954|20294643|P2|Overall Study|Withdrawal by Subject|14
5867746|NCT01994954|20294644|P1|Overall Study|Withdrawal by Subject|9
5867747|NCT01994954|20294643|P2|Overall Study|Death|0
5867748|NCT01994954|20294644|P1|Overall Study|Death|1
5867749|NCT01994902|20294662|P2|Test Period 2|Other|3
5867750|NCT01994902|20294663|P1|Test Period 2|Other|0
5867751|NCT01994902|20294662|P2|Test Period 2|Lack of Efficacy|1
5867752|NCT01994902|20294663|P1|Test Period 2|Lack of Efficacy|0
5867753|NCT01994902|20294662|P2|Test Period 2|Withdrawal by Subject|2
5867754|NCT01994902|20294663|P1|Test Period 2|Withdrawal by Subject|0
5867755|NCT01994902|20294662|P2|Test Period 1|bag too small|0
5867756|NCT01994902|20294663|P1|Test Period 1|bag too small|1
5867757|NCT01994902|20294662|P2|Test Period 1|Lack of Efficacy|1
5867758|NCT01994902|20294663|P1|Test Period 1|Lack of Efficacy|0
5867759|NCT01994902|20294662|P2|Test Period 1|Adverse Event|1
5867760|NCT01994902|20294663|P1|Test Period 1|Adverse Event|2
5867761|NCT01994902|20294662|P2|Test Period 1|device deficiency with adverse event|1
5867762|NCT01994902|20294663|P1|Test Period 1|device deficiency with adverse event|0
5867763|NCT01994902|20294662|P2|Test Period 1|Withdrawal by Subject|0
5867764|NCT01994902|20294663|P1|Test Period 1|Withdrawal by Subject|3
5867765|NCT01994889|20294672|P3|Overall Study|Death|38
5867766|NCT01994889|20294673|P2|Overall Study|Death|25
5867767|NCT01994889|20294674|P1|Overall Study|Death|14
5867768|NCT01994889|20294672|P3|Overall Study|Protocol Violation|1
5867769|NCT01994889|20294673|P2|Overall Study|Protocol Violation|1
5867770|NCT01994889|20294674|P1|Overall Study|Protocol Violation|0
5867771|NCT01994889|20294672|P3|Overall Study|Lost to Follow-up|0
5867772|NCT01994889|20294673|P2|Overall Study|Lost to Follow-up|1
5867773|NCT01994889|20294674|P1|Overall Study|Lost to Follow-up|0
5867774|NCT01994889|20294672|P3|Overall Study|No longer willing to participate|37
5867775|NCT01994889|20294673|P2|Overall Study|No longer willing to participate|17
5867776|NCT01994889|20294674|P1|Overall Study|No longer willing to participate|8
5867777|NCT01994889|20294672|P3|Overall Study|Organ Transplantation|5
5867778|NCT01994889|20294673|P2|Overall Study|Organ Transplantation|5
5867779|NCT01994889|20294674|P1|Overall Study|Organ Transplantation|1
5867780|NCT01994889|20294672|P3|Overall Study|Cardiac Device Implantation|0
5867781|NCT01994889|20294673|P2|Overall Study|Cardiac Device Implantation|2
5867782|NCT01994889|20294674|P1|Overall Study|Cardiac Device Implantation|0
5867783|NCT01994889|20294672|P3|Overall Study|Adverse Event|11
5867784|NCT01994889|20294673|P2|Overall Study|Adverse Event|12
5867785|NCT01994889|20294674|P1|Overall Study|Adverse Event|5
5867786|NCT01994876|20294693|P2|Test Period 2|Protocol Violation|1
5867787|NCT01994876|20294694|P1|Test Period 2|Protocol Violation|0
5867788|NCT01994876|20294693|P2|Test Period 2|Adverse Event|0
5867789|NCT01994876|20294694|P1|Test Period 2|Adverse Event|1
5867790|NCT01994876|20294693|P2|Test Period 1|Adverse Event|1
5867791|NCT01994876|20294694|P1|Test Period 1|Adverse Event|0
5867792|NCT01994876|20294693|P2|Test Period 1|Withdrawal by Subject|1
5867793|NCT01994876|20294694|P1|Test Period 1|Withdrawal by Subject|0
5867794|NCT01994863|20294702|P2|Period 2|Withdrawal by Subject|1
5867795|NCT01994863|20294703|P1|Period 2|Withdrawal by Subject|1
5867796|NCT01994863|20294702|P2|Period 2|Lack of Efficacy|2
5867797|NCT01994863|20294703|P1|Period 2|Lack of Efficacy|0
5867798|NCT01994863|20294702|P2|Period 2|Adverse Event|1
5867799|NCT01994863|20294703|P1|Period 2|Adverse Event|0
5867800|NCT01994863|20294702|P2|Period 1|Lack of Efficacy|0
5867801|NCT01994863|20294703|P1|Period 1|Lack of Efficacy|1
5867802|NCT01994863|20294702|P2|Period 1|Trial stopped by sponsor|3
5867803|NCT01994863|20294703|P1|Period 1|Trial stopped by sponsor|1
5867804|NCT01994863|20294702|P2|Period 1|Withdrawal by Subject|0
5867805|NCT01994863|20294703|P1|Period 1|Withdrawal by Subject|1
5867806|NCT01994863|20294702|P2|Period 1|Adverse Event|0
5867807|NCT01994863|20294703|P1|Period 1|Adverse Event|4
5867808|NCT01994850|20294709|P1|Overall Study|Withdrawal by Subject|1
5867809|NCT01994850|20294709|P1|Overall Study|Physician Decision|1
5867810|NCT01994837|20294714|P1|Overall Study|Removed from study due to no response|1
5867811|NCT01994837|20294714|P1|Overall Study|Proceeded to transplant|1
5867812|NCT01994837|20294714|P1|Overall Study|Chose palliative care|1
5867813|NCT01994837|20294714|P1|Overall Study|Adverse event not related to progression|1
5867814|NCT01994837|20294714|P1|Overall Study|Fatal progressive disease|2
5867815|NCT01994837|20294714|P1|Overall Study|Adv event related to progressive disease|3
5867816|NCT01994837|20294714|P1|Overall Study|Progressive disease per protocol|23
5867817|NCT01994720|20294771|P2|Overall Study|Withdrawal by Subject|56
5867818|NCT01994720|20294772|P1|Overall Study|Withdrawal by Subject|46
5867819|NCT01994629|20294814|P2|Overall Study|Lost to Follow-up|3
5867820|NCT01994629|20294815|P1|Overall Study|Lost to Follow-up|0
5867821|NCT01994629|20294814|P2|Overall Study|Withdrawal by Subject|0
5867822|NCT01994629|20294815|P1|Overall Study|Withdrawal by Subject|1
5867823|NCT01994590|20294839|P1|Overall Study|Trial Terminated|1
5867824|NCT01994590|20294839|P1|Overall Study|Adverse Event|1
5867825|NCT01994395|20294867|P2|Overall Study|Withdrawal by Subject|2
5867826|NCT01994395|20294868|P1|Overall Study|Withdrawal by Subject|1
5867827|NCT01994291|20294893|P3|Overall Study|Other|0
5867828|NCT01994291|20294894|P2|Overall Study|Other|2
5867829|NCT01994291|20294895|P1|Overall Study|Other|1
5867830|NCT01994291|20294893|P3|Overall Study|Withdrawal by Subject|5
5867831|NCT01994291|20294894|P2|Overall Study|Withdrawal by Subject|3
5867832|NCT01994291|20294895|P1|Overall Study|Withdrawal by Subject|6
5867833|NCT01994291|20294893|P3|Overall Study|Protocol Violation|0
5867834|NCT01994291|20294894|P2|Overall Study|Protocol Violation|0
5867835|NCT01994291|20294895|P1|Overall Study|Protocol Violation|1
5867836|NCT01994291|20294893|P3|Overall Study|Medication error without associated AE|1
5867837|NCT01994291|20294894|P2|Overall Study|Medication error without associated AE|0
5867838|NCT01994291|20294895|P1|Overall Study|Medication error without associated AE|1
5867839|NCT01994291|20294893|P3|Overall Study|Does not meet entrance criteria|0
5867840|NCT01994291|20294894|P2|Overall Study|Does not meet entrance criteria|0
5867841|NCT01994291|20294895|P1|Overall Study|Does not meet entrance criteria|1
5867842|NCT01994291|20294893|P3|Overall Study|Lost to Follow-up|0
5867843|NCT01994291|20294894|P2|Overall Study|Lost to Follow-up|1
5867844|NCT01994291|20294895|P1|Overall Study|Lost to Follow-up|1
5867845|NCT01994291|20294893|P3|Overall Study|Adverse Event|3
5867846|NCT01994291|20294894|P2|Overall Study|Adverse Event|1
5867847|NCT01994291|20294895|P1|Overall Study|Adverse Event|4
5867848|NCT01994226|20294951|P2|Overall Study|Early Cessation of treatment|11
5867849|NCT01994226|20294952|P1|Overall Study|Early Cessation of treatment|6
5867850|NCT01994226|20294951|P2|Overall Study|Protocol Violation|10
5867851|NCT01994226|20294952|P1|Overall Study|Protocol Violation|13
5867852|NCT01993940|20294978|P2|Overall Study|Other - Miscellaneous|1
5867853|NCT01993940|20294979|P1|Overall Study|Other - Miscellaneous|1
5867854|NCT01993940|20294978|P2|Overall Study|Death|0
5867855|NCT01993940|20294979|P1|Overall Study|Death|1
5867856|NCT01993940|20294978|P2|Overall Study|Protocol Violation|8
5867857|NCT01993940|20294979|P1|Overall Study|Protocol Violation|5
5867858|NCT01993940|20294978|P2|Overall Study|Lost to Follow-up|5
5867859|NCT01993940|20294979|P1|Overall Study|Lost to Follow-up|2
5867860|NCT01993940|20294978|P2|Overall Study|Withdrawal by Subject|19
5867861|NCT01993940|20294979|P1|Overall Study|Withdrawal by Subject|15
5867862|NCT01993940|20294978|P2|Overall Study|Adverse Event|11
5867863|NCT01993940|20294979|P1|Overall Study|Adverse Event|16
5867864|NCT01993927|20294993|P1|Overall Study|Protocol Violation|11
5867865|NCT01993927|20294993|P1|Overall Study|Case Report Forms Uncollected|18
5867866|NCT01993888|20295001|P2|Overall Study|Withdrawal by Subject|1
5867867|NCT01993888|20295002|P1|Overall Study|Withdrawal by Subject|0
5867868|NCT01993888|20295001|P2|Overall Study|Lost to Follow-up|1
5867869|NCT01993888|20295002|P1|Overall Study|Lost to Follow-up|1
5867870|NCT01993888|20295001|P2|Overall Study|Death|1
5867871|NCT01993888|20295002|P1|Overall Study|Death|1
5867872|NCT01993836|20295051|P3|Overall Study|Withdrawal by Subject|5
5867873|NCT01993836|20295052|P2|Overall Study|Withdrawal by Subject|10
5867874|NCT01993836|20295053|P1|Overall Study|Withdrawal by Subject|12
5867875|NCT01993836|20295051|P3|Overall Study|Death|0
5867876|NCT01993836|20295052|P2|Overall Study|Death|2
5867877|NCT01993836|20295053|P1|Overall Study|Death|0
5867878|NCT01993836|20295051|P3|Overall Study|Physician Decision|0
5867879|NCT01993836|20295052|P2|Overall Study|Physician Decision|1
5867880|NCT01993836|20295053|P1|Overall Study|Physician Decision|2
5867881|NCT01993836|20295051|P3|Overall Study|Surgery Cancelled|0
5867882|NCT01993836|20295052|P2|Overall Study|Surgery Cancelled|0
5867883|NCT01993836|20295053|P1|Overall Study|Surgery Cancelled|3
5867884|NCT01993823|20295069|P2|Overall Study|Lost to Follow-up|4
5867885|NCT01993823|20295070|P1|Overall Study|Lost to Follow-up|1
5867886|NCT01993823|20295069|P2|Overall Study|Protocol Violation|1
5867887|NCT01993823|20295070|P1|Overall Study|Protocol Violation|0
5867888|NCT01993823|20295069|P2|Overall Study|Requested by the patient|11
5867889|NCT01993823|20295070|P1|Overall Study|Requested by the patient|6
5867890|NCT01993667|20295080|P2|Overall Study|Lost to Follow-up|2
5867891|NCT01993667|20295081|P1|Overall Study|Lost to Follow-up|2
5867892|NCT01993667|20295080|P2|Overall Study|Insufficient altitude reached|1
5867893|NCT01993667|20295081|P1|Overall Study|Insufficient altitude reached|3
5867894|NCT01993667|20295080|P2|Overall Study|Insufficient data to analyze|16
5867895|NCT01993667|20295081|P1|Overall Study|Insufficient data to analyze|16
5867896|NCT01993615|20295091|P2|Overall Study|Death|0
5867897|NCT01993615|20295092|P1|Overall Study|Death|1
5867898|NCT01993186|20295111|P2|Open-Label Extension Period|Subject Non-Compliance|0
5867899|NCT01993186|20295112|P1|Open-Label Extension Period|Subject Non-Compliance|1
5867900|NCT01993186|20295111|P2|Open-Label Extension Period|Withdrawal by Subject|5
5867901|NCT01993186|20295112|P1|Open-Label Extension Period|Withdrawal by Subject|4
5867902|NCT01993186|20295111|P2|Open-Label Extension Period|Principal Investigator Decision|0
5867903|NCT01993186|20295112|P1|Open-Label Extension Period|Principal Investigator Decision|1
5867904|NCT01993186|20295111|P2|Open-Label Extension Period|Adverse Event|0
5867905|NCT01993186|20295112|P1|Open-Label Extension Period|Adverse Event|1
5867906|NCT01993186|20295111|P2|Open-Label Extension Period|Other, Not Specified|1
5867907|NCT01993186|20295112|P1|Open-Label Extension Period|Other, Not Specified|0
5867908|NCT01993186|20295111|P2|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0
5867909|NCT01993186|20295112|P1|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|1
5867910|NCT01993186|20295111|P2|Double-Blind Placebo-Controlled Period|Protocol Violation|0
5867911|NCT01993186|20295112|P1|Double-Blind Placebo-Controlled Period|Protocol Violation|1
5867912|NCT01993030|20295189|P2|Overall Study|Adverse Event|4
5867913|NCT01993030|20295190|P1|Overall Study|Adverse Event|0
5867914|NCT01993017|20295207|P3|Overall Study|Ineligible after randomization|5
5867915|NCT01993017|20295208|P2|Overall Study|Ineligible after randomization|5
5867916|NCT01993017|20295209|P1|Overall Study|Ineligible after randomization|4
5867917|NCT01993017|20295207|P3|Overall Study|Other reasons|7
5867918|NCT01993017|20295208|P2|Overall Study|Other reasons|11
5867919|NCT01993017|20295209|P1|Overall Study|Other reasons|17
5867920|NCT01993017|20295207|P3|Overall Study|Dropped out|11
5867921|NCT01993017|20295208|P2|Overall Study|Dropped out|6
5867922|NCT01993017|20295209|P1|Overall Study|Dropped out|19
5867923|NCT01993017|20295207|P3|Overall Study|Could not be contacted|38
5867924|NCT01993017|20295208|P2|Overall Study|Could not be contacted|42
5867925|NCT01993017|20295209|P1|Overall Study|Could not be contacted|43
5867926|NCT01993017|20295207|P3|Overall Study|Death|18
5867927|NCT01993017|20295208|P2|Overall Study|Death|26
5867928|NCT01993017|20295209|P1|Overall Study|Death|23
5867929|NCT01992757|20295250|P1|Overall Study|2 patients excluded due to FFP given.|2
5867930|NCT01992653|20295263|P8|Overall Study|Disease Progression|0
5867931|NCT01992653|20295264|P7|Overall Study|Disease Progression|4
5867932|NCT01992653|20295265|P6|Overall Study|Disease Progression|0
5867933|NCT01992653|20295266|P5|Overall Study|Disease Progression|0
5867934|NCT01992653|20295267|P4|Overall Study|Disease Progression|0
5867935|NCT01992653|20295268|P3|Overall Study|Disease Progression|0
5867936|NCT01992653|20295269|P2|Overall Study|Disease Progression|0
5867937|NCT01992653|20295270|P1|Overall Study|Disease Progression|0
5867938|NCT01992653|20295263|P8|Overall Study|Study Completed|1
5867939|NCT01992653|20295264|P7|Overall Study|Study Completed|0
5867940|NCT01992653|20295265|P6|Overall Study|Study Completed|0
5867941|NCT01992653|20295266|P5|Overall Study|Study Completed|0
5867942|NCT01992653|20295267|P4|Overall Study|Study Completed|0
5867943|NCT01992653|20295268|P3|Overall Study|Study Completed|0
5867944|NCT01992653|20295269|P2|Overall Study|Study Completed|0
5867945|NCT01992653|20295270|P1|Overall Study|Study Completed|0
5867946|NCT01992653|20295263|P8|Overall Study|Lost to Follow-up|1
5867947|NCT01992653|20295264|P7|Overall Study|Lost to Follow-up|0
5867948|NCT01992653|20295265|P6|Overall Study|Lost to Follow-up|0
5867949|NCT01992653|20295266|P5|Overall Study|Lost to Follow-up|0
5867950|NCT01992653|20295267|P4|Overall Study|Lost to Follow-up|0
5867951|NCT01992653|20295268|P3|Overall Study|Lost to Follow-up|0
5867952|NCT01992653|20295269|P2|Overall Study|Lost to Follow-up|0
5867953|NCT01992653|20295270|P1|Overall Study|Lost to Follow-up|0
5867954|NCT01992653|20295263|P8|Overall Study|Death|2
5867955|NCT01992653|20295264|P7|Overall Study|Death|4
5867956|NCT01992653|20295265|P6|Overall Study|Death|0
5867957|NCT01992653|20295266|P5|Overall Study|Death|1
5867958|NCT01992653|20295267|P4|Overall Study|Death|0
5867959|NCT01992653|20295268|P3|Overall Study|Death|1
5867960|NCT01992653|20295269|P2|Overall Study|Death|0
5867961|NCT01992653|20295270|P1|Overall Study|Death|0
5867962|NCT01992549|20295496|P1|Overall Study|Product Switch to Extend Half Life|1
5867963|NCT01992549|20295496|P1|Overall Study|Serious Adverse Event|1
5867964|NCT01992549|20295496|P1|Overall Study|Lost to Follow-up|2
5867965|NCT01992536|20295516|P10|Overall Study|Withdrawal by Subject|0
5867966|NCT01992536|20295517|P9|Overall Study|Withdrawal by Subject|0
5867967|NCT01992536|20295518|P8|Overall Study|Withdrawal by Subject|0
5867968|NCT01992536|20295519|P7|Overall Study|Withdrawal by Subject|0
5867969|NCT01992536|20295520|P6|Overall Study|Withdrawal by Subject|0
5867970|NCT01992536|20295521|P5|Overall Study|Withdrawal by Subject|0
5867971|NCT01992536|20295522|P4|Overall Study|Withdrawal by Subject|2
5867972|NCT01992536|20295523|P3|Overall Study|Withdrawal by Subject|0
5867973|NCT01992536|20295524|P2|Overall Study|Withdrawal by Subject|1
5867974|NCT01992536|20295525|P1|Overall Study|Withdrawal by Subject|0
5867975|NCT01992536|20295516|P10|Overall Study|Lost to Follow-up|1
5867976|NCT01992536|20295517|P9|Overall Study|Lost to Follow-up|1
5867977|NCT01992536|20295518|P8|Overall Study|Lost to Follow-up|0
5867978|NCT01992536|20295519|P7|Overall Study|Lost to Follow-up|0
5867979|NCT01992536|20295520|P6|Overall Study|Lost to Follow-up|1
5867980|NCT01992536|20295521|P5|Overall Study|Lost to Follow-up|0
5867981|NCT01992536|20295522|P4|Overall Study|Lost to Follow-up|0
5867982|NCT01992536|20295523|P3|Overall Study|Lost to Follow-up|1
5867983|NCT01992536|20295524|P2|Overall Study|Lost to Follow-up|2
5867984|NCT01992536|20295525|P1|Overall Study|Lost to Follow-up|4
5867985|NCT01992536|20295516|P10|Overall Study|Administrative Reason|0
5867986|NCT01992536|20295517|P9|Overall Study|Administrative Reason|0
5867987|NCT01992536|20295518|P8|Overall Study|Administrative Reason|0
5867988|NCT01992536|20295519|P7|Overall Study|Administrative Reason|7
5867989|NCT01992536|20295520|P6|Overall Study|Administrative Reason|0
5867990|NCT01992536|20295521|P5|Overall Study|Administrative Reason|0
5867991|NCT01992536|20295522|P4|Overall Study|Administrative Reason|0
5867992|NCT01992536|20295523|P3|Overall Study|Administrative Reason|0
5867993|NCT01992536|20295524|P2|Overall Study|Administrative Reason|0
5867994|NCT01992536|20295525|P1|Overall Study|Administrative Reason|0
5867995|NCT01992159|20295794|P4|Overall Study|Death|0
5867996|NCT01992159|20295795|P3|Overall Study|Death|1
5867997|NCT01992159|20295796|P2|Overall Study|Death|0
5867998|NCT01992159|20295797|P1|Overall Study|Death|0
5867999|NCT01992159|20295794|P4|Overall Study|Adverse Event|1
5868000|NCT01992159|20295795|P3|Overall Study|Adverse Event|0
5868001|NCT01992159|20295796|P2|Overall Study|Adverse Event|1
5868002|NCT01992159|20295797|P1|Overall Study|Adverse Event|0
5868003|NCT01992159|20295794|P4|Overall Study|Withdrawal by Subject|3
5868004|NCT01992159|20295795|P3|Overall Study|Withdrawal by Subject|0
5868005|NCT01992159|20295796|P2|Overall Study|Withdrawal by Subject|7
5868006|NCT01992159|20295797|P1|Overall Study|Withdrawal by Subject|4
5868007|NCT01992107|20295850|P3|Overall Study|Withdrawal by Subject|8
5868008|NCT01992107|20295851|P2|Overall Study|Withdrawal by Subject|7
5868009|NCT01992107|20295852|P1|Overall Study|Withdrawal by Subject|13
5868010|NCT01992107|20295850|P3|Overall Study|noncompliance and were unavailable|2
5868011|NCT01992107|20295851|P2|Overall Study|noncompliance and were unavailable|3
5868012|NCT01992107|20295852|P1|Overall Study|noncompliance and were unavailable|7
5868013|NCT01992107|20295850|P3|Overall Study|Lost to Follow-up|26
5868014|NCT01992107|20295851|P2|Overall Study|Lost to Follow-up|22
5868015|NCT01992107|20295852|P1|Overall Study|Lost to Follow-up|46
5868016|NCT01992107|20295850|P3|Overall Study|Adverse Event|0
5868017|NCT01992107|20295851|P2|Overall Study|Adverse Event|1
5868018|NCT01992107|20295852|P1|Overall Study|Adverse Event|0
5868019|NCT01992107|20295850|P3|Overall Study|Administrative reasons|0
5868020|NCT01992107|20295851|P2|Overall Study|Administrative reasons|0
5868021|NCT01992107|20295852|P1|Overall Study|Administrative reasons|2
5868022|NCT01992094|20295908|P3|Overall Study|Withdrawal by Subject|4
5868023|NCT01992094|20295909|P2|Overall Study|Withdrawal by Subject|3
5868024|NCT01992094|20295910|P1|Overall Study|Withdrawal by Subject|7
5868025|NCT01992094|20295908|P3|Overall Study|Protocol Violation|1
5868026|NCT01992094|20295909|P2|Overall Study|Protocol Violation|0
5868027|NCT01992094|20295910|P1|Overall Study|Protocol Violation|1
5868028|NCT01992094|20295908|P3|Overall Study|OTHER|0
5868029|NCT01992094|20295909|P2|Overall Study|OTHER|0
5868030|NCT01992094|20295910|P1|Overall Study|OTHER|4
5868031|NCT01992094|20295908|P3|Overall Study|Lost to Follow-up|13
5868032|NCT01992094|20295909|P2|Overall Study|Lost to Follow-up|9
5868033|NCT01992094|20295910|P1|Overall Study|Lost to Follow-up|26
5868034|NCT01992094|20295908|P3|Overall Study|Death|2
5868035|NCT01992094|20295909|P2|Overall Study|Death|5
5868036|NCT01992094|20295910|P1|Overall Study|Death|5
5868037|NCT01992094|20295908|P3|Overall Study|Adverse Event|0
5868038|NCT01992094|20295909|P2|Overall Study|Adverse Event|0
5868039|NCT01992094|20295910|P1|Overall Study|Adverse Event|1
5868040|NCT01992094|20295908|P3|Overall Study|ADMINISTRATIVE REASON|1
5868041|NCT01992094|20295909|P2|Overall Study|ADMINISTRATIVE REASON|7
5868042|NCT01992094|20295910|P1|Overall Study|ADMINISTRATIVE REASON|6
5868043|NCT01991977|20296018|P1|Overall Study|Withdrew after start of treatment|5
5868044|NCT01991977|20296018|P1|Overall Study|Withdrew prior to receiving treatment|7
5868045|NCT01991795|20296070|P2|Overall Study|Site prematurely closed by sponsor|25
5868046|NCT01991795|20296071|P1|Overall Study|Site prematurely closed by sponsor|26
5868047|NCT01991795|20296070|P2|Overall Study|Withdrawal by Subject|94
5868048|NCT01991795|20296071|P1|Overall Study|Withdrawal by Subject|117
5868049|NCT01991795|20296070|P2|Overall Study|Lost to Follow-up|4
5868050|NCT01991795|20296071|P1|Overall Study|Lost to Follow-up|6
5868051|NCT01991743|20296097|P4|Overall Study|external cephalic version not performed|0
5868052|NCT01991743|20296098|P3|Overall Study|external cephalic version not performed|1
5868053|NCT01991743|20296099|P2|Overall Study|external cephalic version not performed|0
5868054|NCT01991743|20296100|P1|Overall Study|external cephalic version not performed|0
5868055|NCT01991483|20296145|P4|Dose Level 1000 mg|Protocol Violation|1
5868056|NCT01991483|20296146|P3|Dose Level 1000 mg|Protocol Violation|0
5868057|NCT01991483|20296147|P2|Dose Level 1000 mg|Protocol Violation|0
5868058|NCT01991483|20296148|P1|Dose Level 1000 mg|Protocol Violation|0
5868059|NCT01991483|20296145|P4|Dose Level 600 mg|Physician Decision|0
5868060|NCT01991483|20296146|P3|Dose Level 600 mg|Physician Decision|1
5868061|NCT01991483|20296147|P2|Dose Level 600 mg|Physician Decision|0
5868062|NCT01991483|20296148|P1|Dose Level 600 mg|Physician Decision|0
5868063|NCT01991483|20296145|P4|Dose Level 600 mg|Withdrawal by Subject|0
5868064|NCT01991483|20296146|P3|Dose Level 600 mg|Withdrawal by Subject|1
5868065|NCT01991483|20296147|P2|Dose Level 600 mg|Withdrawal by Subject|0
5868066|NCT01991483|20296148|P1|Dose Level 600 mg|Withdrawal by Subject|0
5868067|NCT01991470|20296214|P1|Enlite 3 Period|DUE TO MULTIPLE SENSOR ISSUES|1
5868068|NCT01991470|20296214|P1|Enlite 3 Period|Physician Decision|8
5868069|NCT01991470|20296214|P1|Enlite 3 Period|Physician Decision|2
5868070|NCT01991470|20296214|P1|Enlite 3 Period|Lost to Follow-up|1
5868071|NCT01991470|20296214|P1|Enlite 1 Period|Inclusion/Exclusion not met|1
5868072|NCT01991470|20296214|P1|Enlite 1 Period|Adverse Event|1
5868073|NCT01991470|20296214|P1|Enlite 1 Period|Withdrawal by Subject|18
5868074|NCT01991314|20296228|P2|Overall Study|Lost to Follow-up|10
5868075|NCT01991314|20296229|P1|Overall Study|Lost to Follow-up|6
5868076|NCT01991314|20296228|P2|Overall Study|Adverse Event|1
5868077|NCT01991314|20296229|P1|Overall Study|Adverse Event|5
5868078|NCT01991197|20296249|P2|Overall Study|Withdrawal by Subject|0
5868079|NCT01991197|20296250|P1|Overall Study|Withdrawal by Subject|2
5868080|NCT01991197|20296249|P2|Overall Study|Physician Decision|2
5868081|NCT01991197|20296250|P1|Overall Study|Physician Decision|0
5868082|NCT01991197|20296249|P2|Overall Study|Lost to Follow-up|1
5868083|NCT01991197|20296250|P1|Overall Study|Lost to Follow-up|1
5868084|NCT01991067|20296288|P2|Overall Study|Lost to Follow-up|5
5868085|NCT01991067|20296289|P1|Overall Study|Lost to Follow-up|6
5868086|NCT01990859|20296303|P1|Week 12 to Week 24 Post Dosing Follow Up|Disease Progression|17
5868087|NCT01990859|20296303|P1|Treatment (4 Doses Over 12 Weeks)|Progressive Disease|5
5868088|NCT01990768|20296438|P3|6-Month Follow-up|Patient at psychiatric hospital|0
5868089|NCT01990768|20296439|P2|6-Month Follow-up|Patient at psychiatric hospital|0
5868090|NCT01990768|20296440|P1|6-Month Follow-up|Patient at psychiatric hospital|1
5868091|NCT01990768|20296438|P3|6-Month Follow-up|Prisoner at time of follow-up|0
5868092|NCT01990768|20296439|P2|6-Month Follow-up|Prisoner at time of follow-up|2
5868093|NCT01990768|20296440|P1|6-Month Follow-up|Prisoner at time of follow-up|0
5868094|NCT01990768|20296438|P3|6-Month Follow-up|Prisoner at time of enrollment|1
5868095|NCT01990768|20296439|P2|6-Month Follow-up|Prisoner at time of enrollment|0
5868096|NCT01990768|20296440|P1|6-Month Follow-up|Prisoner at time of enrollment|0
5868097|NCT01990768|20296438|P3|6-Month Follow-up|Homeless|6
5868098|NCT01990768|20296439|P2|6-Month Follow-up|Homeless|3
5868099|NCT01990768|20296440|P1|6-Month Follow-up|Homeless|4
5868100|NCT01990768|20296438|P3|6-Month Follow-up|No contact information|5
5868101|NCT01990768|20296439|P2|6-Month Follow-up|No contact information|6
5868102|NCT01990768|20296440|P1|6-Month Follow-up|No contact information|5
5868103|NCT01990768|20296438|P3|6-Month Follow-up|Calls unreturned or refused contact|20
5868104|NCT01990768|20296439|P2|6-Month Follow-up|Calls unreturned or refused contact|15
5868105|NCT01990768|20296440|P1|6-Month Follow-up|Calls unreturned or refused contact|4
5868106|NCT01990768|20296438|P3|6-Month Follow-up|Withdrawal by Subject|26
5868107|NCT01990768|20296439|P2|6-Month Follow-up|Withdrawal by Subject|25
5868108|NCT01990768|20296440|P1|6-Month Follow-up|Withdrawal by Subject|25
5868109|NCT01990768|20296438|P3|In-Hospital Study Drug Infusion|Unknown if completed|1
5868110|NCT01990768|20296439|P2|In-Hospital Study Drug Infusion|Unknown if completed|0
5868111|NCT01990768|20296440|P1|In-Hospital Study Drug Infusion|Unknown if completed|0
5868112|NCT01990768|20296438|P3|In-Hospital Study Drug Infusion|Other procoagulant administered|2
5868113|NCT01990768|20296439|P2|In-Hospital Study Drug Infusion|Other procoagulant administered|1
5868114|NCT01990768|20296440|P1|In-Hospital Study Drug Infusion|Other procoagulant administered|0
5868115|NCT01990768|20296438|P3|In-Hospital Study Drug Infusion|Transfer to non-participating facility|0
5868116|NCT01990768|20296439|P2|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1
5868117|NCT01990768|20296440|P1|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1
5868118|NCT01990768|20296438|P3|In-Hospital Study Drug Infusion|Found not to be injured|1
5868119|NCT01990768|20296439|P2|In-Hospital Study Drug Infusion|Found not to be injured|1
5868120|NCT01990768|20296440|P1|In-Hospital Study Drug Infusion|Found not to be injured|1
5868121|NCT01990768|20296438|P3|In-Hospital Study Drug Infusion|Taken into police custody|3
5868122|NCT01990768|20296439|P2|In-Hospital Study Drug Infusion|Taken into police custody|0
5868123|NCT01990768|20296440|P1|In-Hospital Study Drug Infusion|Taken into police custody|4
5868124|NCT01990768|20296438|P3|In-Hospital Study Drug Infusion|Other safety concern|3
5868125|NCT01990768|20296439|P2|In-Hospital Study Drug Infusion|Other safety concern|2
5868126|NCT01990768|20296440|P1|In-Hospital Study Drug Infusion|Other safety concern|4
5868127|NCT01990768|20296438|P3|In-Hospital Study Drug Infusion|Required CPR|1
5868128|NCT01990768|20296439|P2|In-Hospital Study Drug Infusion|Required CPR|7
5868129|NCT01990768|20296440|P1|In-Hospital Study Drug Infusion|Required CPR|3
5868130|NCT01990768|20296438|P3|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|4
5868131|NCT01990768|20296439|P2|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5
5868132|NCT01990768|20296440|P1|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5
5868133|NCT01990768|20296438|P3|In-Hospital Study Drug Infusion|Seizure or concern for seizure|17
5868134|NCT01990768|20296439|P2|In-Hospital Study Drug Infusion|Seizure or concern for seizure|9
5868135|NCT01990768|20296440|P1|In-Hospital Study Drug Infusion|Seizure or concern for seizure|8
5868136|NCT01990768|20296438|P3|In-Hospital Study Drug Infusion|Emergency unblinding|7
5868137|NCT01990768|20296439|P2|In-Hospital Study Drug Infusion|Emergency unblinding|4
5868138|NCT01990768|20296440|P1|In-Hospital Study Drug Infusion|Emergency unblinding|11
5868139|NCT01990768|20296438|P3|In-Hospital Study Drug Infusion|Death or comfort care|6
5868140|NCT01990768|20296439|P2|In-Hospital Study Drug Infusion|Death or comfort care|11
5868141|NCT01990768|20296440|P1|In-Hospital Study Drug Infusion|Death or comfort care|12
5868142|NCT01990768|20296438|P3|In-Hospital Study Drug Infusion|Withdrawal by Subject|12
5868143|NCT01990768|20296439|P2|In-Hospital Study Drug Infusion|Withdrawal by Subject|7
5868144|NCT01990768|20296440|P1|In-Hospital Study Drug Infusion|Withdrawal by Subject|13
5868145|NCT01990768|20296438|P3|In-Hospital Study Drug Infusion|Protocol non-compliance|10
5868146|NCT01990768|20296439|P2|In-Hospital Study Drug Infusion|Protocol non-compliance|17
5868147|NCT01990768|20296440|P1|In-Hospital Study Drug Infusion|Protocol non-compliance|14
5868148|NCT01990768|20296438|P3|In-Hospital Study Drug Infusion|Discharged|13
5868149|NCT01990768|20296439|P2|In-Hospital Study Drug Infusion|Discharged|18
5868150|NCT01990768|20296440|P1|In-Hospital Study Drug Infusion|Discharged|19
5868151|NCT01990768|20296438|P3|Prehospital Study Drug Infusion|Unknown if completed|2
5868152|NCT01990768|20296439|P2|Prehospital Study Drug Infusion|Unknown if completed|4
5868153|NCT01990768|20296440|P1|Prehospital Study Drug Infusion|Unknown if completed|1
5868154|NCT01990768|20296438|P3|Prehospital Study Drug Infusion|Emergency unblinding|1
5868155|NCT01990768|20296439|P2|Prehospital Study Drug Infusion|Emergency unblinding|0
5868156|NCT01990768|20296440|P1|Prehospital Study Drug Infusion|Emergency unblinding|0
5868157|NCT01990768|20296438|P3|Prehospital Study Drug Infusion|Withdrawal by Subject|0
5868158|NCT01990768|20296439|P2|Prehospital Study Drug Infusion|Withdrawal by Subject|0
5868159|NCT01990768|20296440|P1|Prehospital Study Drug Infusion|Withdrawal by Subject|1
5868160|NCT01990768|20296438|P3|Prehospital Study Drug Infusion|Discharged|0
5868161|NCT01990768|20296439|P2|Prehospital Study Drug Infusion|Discharged|1
5868162|NCT01990768|20296440|P1|Prehospital Study Drug Infusion|Discharged|2
5868163|NCT01990768|20296438|P3|Prehospital Study Drug Infusion|Death|1
5868164|NCT01990768|20296439|P2|Prehospital Study Drug Infusion|Death|1
5868165|NCT01990768|20296440|P1|Prehospital Study Drug Infusion|Death|3
5868166|NCT01990768|20296438|P3|Prehospital Study Drug Infusion|Other safety concern|1
5868167|NCT01990768|20296439|P2|Prehospital Study Drug Infusion|Other safety concern|1
5868168|NCT01990768|20296440|P1|Prehospital Study Drug Infusion|Other safety concern|2
5868169|NCT01990768|20296438|P3|Prehospital Study Drug Infusion|Required CPR|0
5868170|NCT01990768|20296439|P2|Prehospital Study Drug Infusion|Required CPR|6
5868171|NCT01990768|20296440|P1|Prehospital Study Drug Infusion|Required CPR|2
5868172|NCT01990768|20296438|P3|Prehospital Study Drug Infusion|Seizure or concern for seizure|4
5868173|NCT01990768|20296439|P2|Prehospital Study Drug Infusion|Seizure or concern for seizure|3
5868174|NCT01990768|20296440|P1|Prehospital Study Drug Infusion|Seizure or concern for seizure|4
5868175|NCT01990768|20296438|P3|Prehospital Study Drug Infusion|Protocol non-compliance|10
5868176|NCT01990768|20296439|P2|Prehospital Study Drug Infusion|Protocol non-compliance|11
5868177|NCT01990768|20296440|P1|Prehospital Study Drug Infusion|Protocol non-compliance|4
5868178|NCT01990768|20296438|P3|Intervention Started|Discovered to be pregnant|0
5868179|NCT01990768|20296439|P2|Intervention Started|Discovered to be pregnant|1
5868180|NCT01990768|20296440|P1|Intervention Started|Discovered to be pregnant|0
5868181|NCT01990768|20296438|P3|Intervention Started|Seizure or hx of seizure|2
5868182|NCT01990768|20296439|P2|Intervention Started|Seizure or hx of seizure|0
5868183|NCT01990768|20296440|P1|Intervention Started|Seizure or hx of seizure|0
5868184|NCT01990768|20296438|P3|Intervention Started|Required CPR|0
5868185|NCT01990768|20296439|P2|Intervention Started|Required CPR|1
5868186|NCT01990768|20296440|P1|Intervention Started|Required CPR|1
5868187|NCT01990768|20296438|P3|Intervention Started|IV lost|2
5868188|NCT01990768|20296439|P2|Intervention Started|IV lost|2
5868189|NCT01990768|20296440|P1|Intervention Started|IV lost|2
5868190|NCT01990768|20296438|P3|Intervention Started|Patient care priority|3
5868191|NCT01990768|20296439|P2|Intervention Started|Patient care priority|2
5868192|NCT01990768|20296440|P1|Intervention Started|Patient care priority|1
5868193|NCT01990768|20296438|P3|Intervention Started|Not enough time for EMS to enroll|0
5868194|NCT01990768|20296439|P2|Intervention Started|Not enough time for EMS to enroll|3
5868195|NCT01990768|20296440|P1|Intervention Started|Not enough time for EMS to enroll|4
5868196|NCT01990768|20296438|P3|Intervention Started|Patient became ineligible due to vitals|2
5868197|NCT01990768|20296439|P2|Intervention Started|Patient became ineligible due to vitals|5
5868198|NCT01990768|20296440|P1|Intervention Started|Patient became ineligible due to vitals|5
5868199|NCT01990768|20296438|P3|Intervention Started|Study drug issue or kit malfunction|7
5868200|NCT01990768|20296439|P2|Intervention Started|Study drug issue or kit malfunction|6
5868201|NCT01990768|20296440|P1|Intervention Started|Study drug issue or kit malfunction|9
5868202|NCT01990768|20296438|P3|Intervention Started|Found to be ineligible|11
5868203|NCT01990768|20296439|P2|Intervention Started|Found to be ineligible|13
5868204|NCT01990768|20296440|P1|Intervention Started|Found to be ineligible|14
5868205|NCT01990742|20296505|P2|Overall Study|Facility closed|270
5868206|NCT01990742|20296506|P1|Overall Study|Facility closed|0
5868207|NCT01990742|20296505|P2|Overall Study|Withdrawal by facility|1083
5868208|NCT01990742|20296506|P1|Overall Study|Withdrawal by facility|407
5868209|NCT01990664|20296542|P2|Overall Study|Unsatisfactory Visual Response|1
5868210|NCT01990664|20296543|P1|Overall Study|Unsatisfactory Visual Response|0
5868211|NCT01990664|20296542|P2|Overall Study|Lens Handling Difficulties|0
5868212|NCT01990664|20296543|P1|Overall Study|Lens Handling Difficulties|1
5868213|NCT01990664|20296542|P2|Overall Study|Lens Discomfort|1
5868214|NCT01990664|20296543|P1|Overall Study|Lens Discomfort|1
5868215|NCT01990664|20296542|P2|Overall Study|Protocol Violation|0
5868216|NCT01990664|20296543|P1|Overall Study|Protocol Violation|1
5868217|NCT01990664|20296542|P2|Overall Study|Withdrawal by Subject|3
5868218|NCT01990664|20296543|P1|Overall Study|Withdrawal by Subject|2
5868219|NCT01990664|20296542|P2|Overall Study|Lost to Follow-up|6
5868220|NCT01990664|20296543|P1|Overall Study|Lost to Follow-up|2
5868221|NCT01990612|20296551|P2|Overall Study|Withdrawal by Subject|2
5868222|NCT01990612|20296552|P1|Overall Study|Withdrawal by Subject|5
5868223|NCT01990612|20296551|P2|Overall Study|Lost to Follow-up|1
5868224|NCT01990612|20296552|P1|Overall Study|Lost to Follow-up|2
5868225|NCT01990573|20296633|P3|Overall Study|Physician Decision|1
5868226|NCT01990573|20296634|P2|Overall Study|Physician Decision|0
5868227|NCT01990573|20296635|P1|Overall Study|Physician Decision|0
5868228|NCT01990560|20296648|P1|Overall Study|Withdrawal by Subject|1
5868229|NCT01990534|20296662|P1|Overall Study|Overall Survival Follow-up|25
5868230|NCT01990534|20296662|P1|Overall Study|Progression Free Survival Follow-up|11
5868231|NCT01990534|20296662|P1|Overall Study|Reason Not Specified|2
5868232|NCT01990534|20296662|P1|Overall Study|Withdrawal by Subject|3
5868233|NCT01990534|20296662|P1|Overall Study|Symptomatic Deterioration|1
5868234|NCT01990534|20296662|P1|Overall Study|Withdrawal of Informed Consent|2
5868235|NCT01990534|20296662|P1|Overall Study|Protocol Violation|1
5868236|NCT01990534|20296662|P1|Overall Study|Progressive disease|3
5868237|NCT01990534|20296662|P1|Overall Study|Death|12
5868238|NCT01990495|20296680|P2|Overall Study|Physician Decision|4
5868239|NCT01990495|20296681|P1|Overall Study|Physician Decision|5
5868240|NCT01990339|20296691|P1|Overall Study|Lost to Follow-up|861
5868241|NCT01990339|20296691|P1|Overall Study|Voluntary Withdrawal|1402
5868242|NCT01990339|20296691|P1|Overall Study|Data Not Available|49
5868243|NCT01990313|20296696|P1|Overall Study|Lost to Follow-up|1
5868244|NCT01990300|20296701|P1|Overall Study|Protocol Deviation|53
5868245|NCT01990300|20296701|P1|Overall Study|Case Report Forms Uncollected|89
5868246|NCT01990261|20296707|P1|Overall Study|Lost to Follow-up|2
5868247|NCT01990261|20296707|P1|Overall Study|Dossier not Approved|1
5868248|NCT01990261|20296707|P1|Overall Study|PD Before Treatment Start|1
5868249|NCT01990261|20296707|P1|Overall Study|Disease Progression (PD)|8
5868250|NCT01990261|20296707|P1|Overall Study|Death From other Causes|1
5868251|NCT01990261|20296707|P1|Overall Study|Death due to Disease Progression (PD)|10
5868252|NCT01990261|20296707|P1|Overall Study|Death Before Treatment Start|2
5868253|NCT01989754|20296764|P2|Overall Study|Closed Site|1
5868254|NCT01989754|20296765|P1|Overall Study|Closed Site|1
5868255|NCT01989754|20296764|P2|Overall Study|Lost to Follow-up|20
5868256|NCT01989754|20296765|P1|Overall Study|Lost to Follow-up|28
5868257|NCT01989754|20296764|P2|Overall Study|Withdrawal by Subject|14
5868258|NCT01989754|20296765|P1|Overall Study|Withdrawal by Subject|10
5868259|NCT01989689|20296777|P2|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|1
5868260|NCT01989689|20296778|P1|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|0
5868261|NCT01989689|20296777|P2|Treatment Period 1 ( 3 Months)|Lost to Follow-up|2
5868262|NCT01989689|20296778|P1|Treatment Period 1 ( 3 Months)|Lost to Follow-up|0
5868263|NCT01989676|20296790|P2|Overall Study|Discontinued|68
5868264|NCT01989676|20296791|P1|Overall Study|Discontinued|59
5868265|NCT01989676|20296790|P2|Overall Study|Ongoing at data cutoff|279
5868266|NCT01989676|20296791|P1|Overall Study|Ongoing at data cutoff|279
5868267|NCT01989572|20296817|P6|Overall Study|alternative therapy|3
5868268|NCT01989572|20296818|P5|Overall Study|alternative therapy|1
5868269|NCT01989572|20296819|P4|Overall Study|alternative therapy|0
5868270|NCT01989572|20296820|P3|Overall Study|alternative therapy|0
5868271|NCT01989572|20296821|P2|Overall Study|alternative therapy|0
5868272|NCT01989572|20296822|P1|Overall Study|alternative therapy|3
5868273|NCT01989572|20296817|P6|Overall Study|not start protocol therapy|18
5868274|NCT01989572|20296818|P5|Overall Study|not start protocol therapy|4
5868275|NCT01989572|20296819|P4|Overall Study|not start protocol therapy|3
5868276|NCT01989572|20296820|P3|Overall Study|not start protocol therapy|2
5868277|NCT01989572|20296821|P2|Overall Study|not start protocol therapy|1
5868278|NCT01989572|20296822|P1|Overall Study|not start protocol therapy|5
5868279|NCT01989572|20296817|P6|Overall Study|unknown/not specify|5
5868280|NCT01989572|20296818|P5|Overall Study|unknown/not specify|3
5868281|NCT01989572|20296819|P4|Overall Study|unknown/not specify|3
5868282|NCT01989572|20296820|P3|Overall Study|unknown/not specify|1
5868283|NCT01989572|20296821|P2|Overall Study|unknown/not specify|4
5868284|NCT01989572|20296822|P1|Overall Study|unknown/not specify|3
5868285|NCT01989572|20296817|P6|Overall Study|maximum dose reached|0
5868286|NCT01989572|20296818|P5|Overall Study|maximum dose reached|1
5868287|NCT01989572|20296819|P4|Overall Study|maximum dose reached|0
5868288|NCT01989572|20296820|P3|Overall Study|maximum dose reached|0
5868289|NCT01989572|20296821|P2|Overall Study|maximum dose reached|1
5868290|NCT01989572|20296822|P1|Overall Study|maximum dose reached|0
5868291|NCT01989572|20296817|P6|Overall Study|error|1
5868292|NCT01989572|20296818|P5|Overall Study|error|1
5868293|NCT01989572|20296819|P4|Overall Study|error|1
5868294|NCT01989572|20296820|P3|Overall Study|error|1
5868295|NCT01989572|20296821|P2|Overall Study|error|1
5868296|NCT01989572|20296822|P1|Overall Study|error|2
5868297|NCT01989572|20296817|P6|Overall Study|complicating disease|0
5868298|NCT01989572|20296818|P5|Overall Study|complicating disease|1
5868299|NCT01989572|20296819|P4|Overall Study|complicating disease|0
5868300|NCT01989572|20296820|P3|Overall Study|complicating disease|2
5868301|NCT01989572|20296821|P2|Overall Study|complicating disease|1
5868302|NCT01989572|20296822|P1|Overall Study|complicating disease|1
5868303|NCT01989572|20296817|P6|Overall Study|Withdrawal by Subject|4
5868304|NCT01989572|20296818|P5|Overall Study|Withdrawal by Subject|12
5868305|NCT01989572|20296819|P4|Overall Study|Withdrawal by Subject|1
5868306|NCT01989572|20296820|P3|Overall Study|Withdrawal by Subject|5
5868307|NCT01989572|20296821|P2|Overall Study|Withdrawal by Subject|1
5868308|NCT01989572|20296822|P1|Overall Study|Withdrawal by Subject|4
5868309|NCT01989572|20296817|P6|Overall Study|Death|0
5868310|NCT01989572|20296818|P5|Overall Study|Death|1
5868311|NCT01989572|20296819|P4|Overall Study|Death|0
5868312|NCT01989572|20296820|P3|Overall Study|Death|0
5868313|NCT01989572|20296821|P2|Overall Study|Death|0
5868314|NCT01989572|20296822|P1|Overall Study|Death|0
5868315|NCT01989572|20296817|P6|Overall Study|Adverse Event|0
5868316|NCT01989572|20296818|P5|Overall Study|Adverse Event|3
5868317|NCT01989572|20296819|P4|Overall Study|Adverse Event|0
5868318|NCT01989572|20296820|P3|Overall Study|Adverse Event|3
5868319|NCT01989572|20296821|P2|Overall Study|Adverse Event|1
5868320|NCT01989572|20296822|P1|Overall Study|Adverse Event|2
5868321|NCT01989572|20296817|P6|Overall Study|Lack of Efficacy|79
5868322|NCT01989572|20296818|P5|Overall Study|Lack of Efficacy|71
5868323|NCT01989572|20296819|P4|Overall Study|Lack of Efficacy|43
5868324|NCT01989572|20296820|P3|Overall Study|Lack of Efficacy|48
5868325|NCT01989572|20296821|P2|Overall Study|Lack of Efficacy|48
5868326|NCT01989572|20296822|P1|Overall Study|Lack of Efficacy|35
5868329|NCT01989468|20296859|P5|Overall Study|Death|0
5868330|NCT01989468|20296860|P4|Overall Study|Death|0
5868331|NCT01989468|20296861|P3|Overall Study|Death|1
5868332|NCT01989468|20296862|P2|Overall Study|Death|0
5868333|NCT01989468|20296863|P1|Overall Study|Death|3
5868334|NCT01989468|20296859|P5|Overall Study|Subject Guardian Decision|1
5868335|NCT01989468|20296860|P4|Overall Study|Subject Guardian Decision|4
5868336|NCT01989468|20296861|P3|Overall Study|Subject Guardian Decision|4
5868337|NCT01989468|20296862|P2|Overall Study|Subject Guardian Decision|6
5868338|NCT01989468|20296863|P1|Overall Study|Subject Guardian Decision|11
5868339|NCT01989468|20296859|P5|Overall Study|Technical Problems|0
5868340|NCT01989468|20296860|P4|Overall Study|Technical Problems|1
5868341|NCT01989468|20296861|P3|Overall Study|Technical Problems|3
5868342|NCT01989468|20296862|P2|Overall Study|Technical Problems|1
5868343|NCT01989468|20296863|P1|Overall Study|Technical Problems|3
5868344|NCT01989468|20296859|P5|Overall Study|Pregnancy|0
5868345|NCT01989468|20296860|P4|Overall Study|Pregnancy|0
5868346|NCT01989468|20296861|P3|Overall Study|Pregnancy|0
5868347|NCT01989468|20296862|P2|Overall Study|Pregnancy|1
5868348|NCT01989468|20296863|P1|Overall Study|Pregnancy|0
5868349|NCT01989468|20296859|P5|Overall Study|Physician Decision|0
5868350|NCT01989468|20296860|P4|Overall Study|Physician Decision|1
5868351|NCT01989468|20296861|P3|Overall Study|Physician Decision|0
5868352|NCT01989468|20296862|P2|Overall Study|Physician Decision|1
5868353|NCT01989468|20296863|P1|Overall Study|Physician Decision|4
5868354|NCT01989468|20296859|P5|Overall Study|Lost to Follow-up|1
5868355|NCT01989468|20296860|P4|Overall Study|Lost to Follow-up|1
5868356|NCT01989468|20296861|P3|Overall Study|Lost to Follow-up|0
5868357|NCT01989468|20296862|P2|Overall Study|Lost to Follow-up|2
5868358|NCT01989468|20296863|P1|Overall Study|Lost to Follow-up|5
5868359|NCT01989468|20296859|P5|Overall Study|Lack of Efficacy|2
5868360|NCT01989468|20296860|P4|Overall Study|Lack of Efficacy|4
5868361|NCT01989468|20296861|P3|Overall Study|Lack of Efficacy|7
5868362|NCT01989468|20296862|P2|Overall Study|Lack of Efficacy|11
5868363|NCT01989468|20296863|P1|Overall Study|Lack of Efficacy|11
5868364|NCT01989468|20296859|P5|Overall Study|Adverse Event|4
5868365|NCT01989468|20296860|P4|Overall Study|Adverse Event|5
5868366|NCT01989468|20296861|P3|Overall Study|Adverse Event|4
5868367|NCT01989468|20296862|P2|Overall Study|Adverse Event|15
5868368|NCT01989468|20296863|P1|Overall Study|Adverse Event|10
5868369|NCT01989455|20296905|P5|Overall Study|Technical problems with infusion|1
5868370|NCT01989455|20296906|P4|Overall Study|Technical problems with infusion|0
5868371|NCT01989455|20296907|P3|Overall Study|Technical problems with infusion|1
5868372|NCT01989455|20296908|P2|Overall Study|Technical problems with infusion|0
5868373|NCT01989455|20296909|P1|Overall Study|Technical problems with infusion|0
5868374|NCT01989455|20296905|P5|Overall Study|Withdrawal by Subject|0
5868375|NCT01989455|20296906|P4|Overall Study|Withdrawal by Subject|0
5868376|NCT01989455|20296907|P3|Overall Study|Withdrawal by Subject|0
5868377|NCT01989455|20296908|P2|Overall Study|Withdrawal by Subject|1
5868378|NCT01989455|20296909|P1|Overall Study|Withdrawal by Subject|0
5868379|NCT01989455|20296905|P5|Overall Study|Adverse Event|0
5868380|NCT01989455|20296906|P4|Overall Study|Adverse Event|0
5868381|NCT01989455|20296907|P3|Overall Study|Adverse Event|0
5868382|NCT01989455|20296908|P2|Overall Study|Adverse Event|1
5868383|NCT01989455|20296909|P1|Overall Study|Adverse Event|0
5868384|NCT01989208|20296945|P2|200 mg (7 Days)|Protocol Violation|1
5868385|NCT01989208|20296946|P1|200 mg (7 Days)|Protocol Violation|0
5868386|NCT01989169|20296974|P2|Period 2|Adverse Event|1
5868387|NCT01989169|20296975|P1|Period 2|Adverse Event|0
5868388|NCT01989156|20296988|P3|End of Study (Population at Day 90)|Employment Conflict|0
5868389|NCT01989156|20296989|P2|End of Study (Population at Day 90)|Employment Conflict|1
5868390|NCT01989156|20296990|P1|End of Study (Population at Day 90)|Employment Conflict|0
5868391|NCT01989156|20296988|P3|End of Study (Population at Day 90)|Moved out of state|0
5868392|NCT01989156|20296989|P2|End of Study (Population at Day 90)|Moved out of state|0
5868393|NCT01989156|20296990|P1|End of Study (Population at Day 90)|Moved out of state|1
5868394|NCT01989156|20296988|P3|End of Study (Population at Day 90)|Physician Decision|1
5868395|NCT01989156|20296989|P2|End of Study (Population at Day 90)|Physician Decision|0
5868396|NCT01989156|20296990|P1|End of Study (Population at Day 90)|Physician Decision|1
5868397|NCT01989156|20296988|P3|End of Study (Population at Day 90)|Lost to Follow-up|0
5868398|NCT01989156|20296989|P2|End of Study (Population at Day 90)|Lost to Follow-up|2
5868399|NCT01989156|20296990|P1|End of Study (Population at Day 90)|Lost to Follow-up|3
5868400|NCT01989156|20296988|P3|End of Study (Population at Day 90)|Withdrawal by Subject|2
5868401|NCT01989156|20296989|P2|End of Study (Population at Day 90)|Withdrawal by Subject|2
5868402|NCT01989156|20296990|P1|End of Study (Population at Day 90)|Withdrawal by Subject|2
5868403|NCT01989156|20296988|P3|Confinement Period (Population at Day 5)|Adverse Event|1
5868404|NCT01989156|20296989|P2|Confinement Period (Population at Day 5)|Adverse Event|0
5868405|NCT01989156|20296990|P1|Confinement Period (Population at Day 5)|Adverse Event|0
5868406|NCT01989156|20296988|P3|Confinement Period (Population at Day 5)|Patient Anxiety|1
5868407|NCT01989156|20296989|P2|Confinement Period (Population at Day 5)|Patient Anxiety|0
5868408|NCT01989156|20296990|P1|Confinement Period (Population at Day 5)|Patient Anxiety|0
5868409|NCT01989156|20296988|P3|Confinement Period (Population at Day 5)|Withdrawal by Subject|3
5868410|NCT01989156|20296989|P2|Confinement Period (Population at Day 5)|Withdrawal by Subject|1
5868411|NCT01989156|20296990|P1|Confinement Period (Population at Day 5)|Withdrawal by Subject|0
5868412|NCT01988779|20297050|P2|Overall Study|Protocol Violation|0
5868413|NCT01988779|20297051|P1|Overall Study|Protocol Violation|1
5868414|NCT01988779|20297050|P2|Overall Study|Withdrawal by Subject|2
5868415|NCT01988779|20297051|P1|Overall Study|Withdrawal by Subject|2
5868416|NCT01988662|20297067|P2|Overall Study|Adverse Event|1
5868417|NCT01988662|20297068|P1|Overall Study|Adverse Event|3
5868418|NCT01988662|20297067|P2|Overall Study|Subject/guardian decision|1
5868419|NCT01988662|20297068|P1|Overall Study|Subject/guardian decision|1
5868420|NCT01988493|20297090|P5|Overall Study|Ongoing|0
5868421|NCT01988493|20297091|P4|Overall Study|Ongoing|2
5868422|NCT01988493|20297092|P3|Overall Study|Ongoing|0
5868423|NCT01988493|20297093|P2|Overall Study|Ongoing|0
5868424|NCT01988493|20297094|P1|Overall Study|Ongoing|0
5868425|NCT01988493|20297090|P5|Overall Study|Randomized but not treated|1
5868426|NCT01988493|20297091|P4|Overall Study|Randomized but not treated|0
5868427|NCT01988493|20297092|P3|Overall Study|Randomized but not treated|0
5868428|NCT01988493|20297093|P2|Overall Study|Randomized but not treated|0
5868429|NCT01988493|20297094|P1|Overall Study|Randomized but not treated|0
5868430|NCT01988402|20297173|P2|Overall Study|Withdrawal by Subject|0
5868431|NCT01988402|20297174|P1|Overall Study|Withdrawal by Subject|1
5868432|NCT01988402|20297173|P2|Overall Study|Adverse Event|2
5868433|NCT01988402|20297174|P1|Overall Study|Adverse Event|1
5868434|NCT01988103|20297241|P5|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2
5868435|NCT01988103|20297242|P4|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0
5868436|NCT01988103|20297243|P3|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2
5868437|NCT01988103|20297244|P2|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|1
5868438|NCT01988103|20297245|P1|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0
5868439|NCT01988103|20297241|P5|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|1
5868440|NCT01988103|20297242|P4|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0
5868441|NCT01988103|20297243|P3|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|4
5868442|NCT01988103|20297244|P2|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|5
5868443|NCT01988103|20297245|P1|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0
5868444|NCT01988103|20297241|P5|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0
5868445|NCT01988103|20297242|P4|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0
5868446|NCT01988103|20297243|P3|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|2
5868447|NCT01988103|20297244|P2|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|1
5868448|NCT01988103|20297245|P1|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0
5868449|NCT01988103|20297241|P5|Active Treatment Phase (Weeks 16-68)|Adverse Event|2
5868450|NCT01988103|20297242|P4|Active Treatment Phase (Weeks 16-68)|Adverse Event|3
5868451|NCT01988103|20297243|P3|Active Treatment Phase (Weeks 16-68)|Adverse Event|3
5868452|NCT01988103|20297244|P2|Active Treatment Phase (Weeks 16-68)|Adverse Event|6
5868453|NCT01988103|20297245|P1|Active Treatment Phase (Weeks 16-68)|Adverse Event|0
5868454|NCT01988103|20297241|P5|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0
5868455|NCT01988103|20297242|P4|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0
5868456|NCT01988103|20297243|P3|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|1
5868457|NCT01988103|20297244|P2|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|4
5868458|NCT01988103|20297245|P1|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|8
5868459|NCT01988103|20297241|P5|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0
5868460|NCT01988103|20297242|P4|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0
5868461|NCT01988103|20297243|P3|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2
5868462|NCT01988103|20297244|P2|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2
5868463|NCT01988103|20297245|P1|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|1
5868464|NCT01988103|20297241|P5|Placebo-Controlled Phase Week 0-16|Adverse Event|0
5868465|NCT01988103|20297242|P4|Placebo-Controlled Phase Week 0-16|Adverse Event|0
5868466|NCT01988103|20297243|P3|Placebo-Controlled Phase Week 0-16|Adverse Event|6
5868467|NCT01988103|20297244|P2|Placebo-Controlled Phase Week 0-16|Adverse Event|10
5868468|NCT01988103|20297245|P1|Placebo-Controlled Phase Week 0-16|Adverse Event|3
5868469|NCT01988090|20297292|P2|Complete Study After Start|Protocol Violation|1
5868470|NCT01988090|20297293|P1|Complete Study After Start|Protocol Violation|1
5868471|NCT01988090|20297292|P2|Complete Study After Start|Withdrawal by Subject|0
5868472|NCT01988090|20297293|P1|Complete Study After Start|Withdrawal by Subject|2
5868473|NCT01988090|20297292|P2|Start Treament After Randomization|Protocol Violation|1
5868474|NCT01988090|20297293|P1|Start Treament After Randomization|Protocol Violation|0
5868475|NCT01988090|20297292|P2|Start Treament After Randomization|Withdrawal by Subject|3
5868476|NCT01988090|20297293|P1|Start Treament After Randomization|Withdrawal by Subject|2
5868477|NCT01988012|20297303|P1|Overall Study|Protocol Violation|1
5868478|NCT01988012|20297303|P1|Overall Study|Physician Decision|1
5868479|NCT01988012|20297303|P1|Overall Study|Lost to Follow-up|1
5868480|NCT01988012|20297303|P1|Overall Study|Patient Withdrawal of Consent|4
5868481|NCT01988012|20297303|P1|Overall Study|Insufficient Therapeutic Response|3
5868482|NCT01988012|20297303|P1|Overall Study|Adverse Event|5
5868483|NCT01987986|20297329|P4|Overall Study|Adverse Event|0
5868484|NCT01987986|20297330|P3|Overall Study|Adverse Event|2
5868485|NCT01987986|20297331|P2|Overall Study|Adverse Event|0
5868486|NCT01987986|20297332|P1|Overall Study|Adverse Event|1
5868487|NCT01987986|20297329|P4|Overall Study|Lost to Follow-up|0
5868488|NCT01987986|20297330|P3|Overall Study|Lost to Follow-up|0
5868489|NCT01987986|20297331|P2|Overall Study|Lost to Follow-up|0
5868490|NCT01987986|20297332|P1|Overall Study|Lost to Follow-up|1
5868491|NCT01987960|20297372|P4|Period 3|Administrative or other reason|43
5868492|NCT01987960|20297373|P3|Period 3|Administrative or other reason|0
5868493|NCT01987960|20297374|P2|Period 3|Administrative or other reason|0
5868494|NCT01987960|20297375|P1|Period 3|Administrative or other reason|0
5868495|NCT01987960|20297372|P4|Period 3|Lost to Follow-up|5
5868496|NCT01987960|20297373|P3|Period 3|Lost to Follow-up|0
5868497|NCT01987960|20297374|P2|Period 3|Lost to Follow-up|0
5868498|NCT01987960|20297375|P1|Period 3|Lost to Follow-up|0
5868499|NCT01987960|20297372|P4|Period 3|Withdrawal by Subject|9
5868500|NCT01987960|20297373|P3|Period 3|Withdrawal by Subject|0
5868501|NCT01987960|20297374|P2|Period 3|Withdrawal by Subject|0
5868502|NCT01987960|20297375|P1|Period 3|Withdrawal by Subject|0
5868503|NCT01987960|20297372|P4|Period 3|Protocol Violation|6
5868504|NCT01987960|20297373|P3|Period 3|Protocol Violation|0
5868505|NCT01987960|20297374|P2|Period 3|Protocol Violation|0
5868506|NCT01987960|20297375|P1|Period 3|Protocol Violation|0
5868507|NCT01987960|20297372|P4|Period 3|Non-compliance with IMP|1
5868508|NCT01987960|20297373|P3|Period 3|Non-compliance with IMP|0
5868509|NCT01987960|20297374|P2|Period 3|Non-compliance with IMP|0
5868510|NCT01987960|20297375|P1|Period 3|Non-compliance with IMP|0
5868511|NCT01987960|20297372|P4|Period 3|Adverse Event|7
5868512|NCT01987960|20297373|P3|Period 3|Adverse Event|0
5868513|NCT01987960|20297374|P2|Period 3|Adverse Event|0
5868514|NCT01987960|20297375|P1|Period 3|Adverse Event|0
5868515|NCT01987960|20297372|P4|Period 2|Administrative or other reason|0
5868516|NCT01987960|20297373|P3|Period 2|Administrative or other reason|7
5868517|NCT01987960|20297374|P2|Period 2|Administrative or other reason|5
5868518|NCT01987960|20297375|P1|Period 2|Administrative or other reason|0
5868519|NCT01987960|20297372|P4|Period 2|Withdrawal by Subject|0
5868520|NCT01987960|20297373|P3|Period 2|Withdrawal by Subject|1
5868521|NCT01987960|20297374|P2|Period 2|Withdrawal by Subject|0
5868522|NCT01987960|20297375|P1|Period 2|Withdrawal by Subject|0
5868523|NCT01987960|20297372|P4|Period 2|Adverse Event|0
5868524|NCT01987960|20297373|P3|Period 2|Adverse Event|1
5868525|NCT01987960|20297374|P2|Period 2|Adverse Event|0
5868526|NCT01987960|20297375|P1|Period 2|Adverse Event|0
5868527|NCT01987960|20297372|P4|Period 1|Withdrawal of consent before treatment|0
5868528|NCT01987960|20297373|P3|Period 1|Withdrawal of consent before treatment|0
5868529|NCT01987960|20297374|P2|Period 1|Withdrawal of consent before treatment|0
5868530|NCT01987960|20297375|P1|Period 1|Withdrawal of consent before treatment|4
5868531|NCT01987960|20297372|P4|Period 1|administrative or other reason|0
5868532|NCT01987960|20297373|P3|Period 1|administrative or other reason|0
5868533|NCT01987960|20297374|P2|Period 1|administrative or other reason|0
5868534|NCT01987960|20297375|P1|Period 1|administrative or other reason|75
5868535|NCT01987960|20297372|P4|Period 1|Lost to Follow-up|0
5868536|NCT01987960|20297373|P3|Period 1|Lost to Follow-up|0
5868537|NCT01987960|20297374|P2|Period 1|Lost to Follow-up|0
5868538|NCT01987960|20297375|P1|Period 1|Lost to Follow-up|40
5868539|NCT01987960|20297372|P4|Period 1|Withdrawal by Subject|0
5868540|NCT01987960|20297373|P3|Period 1|Withdrawal by Subject|0
5868541|NCT01987960|20297374|P2|Period 1|Withdrawal by Subject|0
5868542|NCT01987960|20297375|P1|Period 1|Withdrawal by Subject|21
5868543|NCT01987960|20297372|P4|Period 1|Protocol Violation|0
5868544|NCT01987960|20297373|P3|Period 1|Protocol Violation|0
5868545|NCT01987960|20297374|P2|Period 1|Protocol Violation|0
5868546|NCT01987960|20297375|P1|Period 1|Protocol Violation|12
5868547|NCT01987960|20297372|P4|Period 1|Non-compliance with IMP|0
5868548|NCT01987960|20297373|P3|Period 1|Non-compliance with IMP|0
5868549|NCT01987960|20297374|P2|Period 1|Non-compliance with IMP|0
5868550|NCT01987960|20297375|P1|Period 1|Non-compliance with IMP|6
5868551|NCT01987960|20297372|P4|Period 1|Lack of Efficacy|0
5868552|NCT01987960|20297373|P3|Period 1|Lack of Efficacy|0
5868553|NCT01987960|20297374|P2|Period 1|Lack of Efficacy|0
5868554|NCT01987960|20297375|P1|Period 1|Lack of Efficacy|4
5868555|NCT01987960|20297372|P4|Period 1|Adverse Event|0
5868556|NCT01987960|20297373|P3|Period 1|Adverse Event|0
5868557|NCT01987960|20297374|P2|Period 1|Adverse Event|0
5868558|NCT01987960|20297375|P1|Period 1|Adverse Event|24
5868559|NCT01987908|20297387|P3|Post-Treatment Observation Period|Other: Bad Veins|0
5868560|NCT01987908|20297388|P2|Post-Treatment Observation Period|Other: Bad Veins|1
5868561|NCT01987908|20297389|P1|Post-Treatment Observation Period|Other: Bad Veins|0
5868562|NCT01987908|20297387|P3|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0
5868563|NCT01987908|20297388|P2|Post-Treatment Observation Period|Other: Study Termination by Sponsor|2
5868564|NCT01987908|20297389|P1|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0
5868565|NCT01987908|20297387|P3|Treatment Period|Adverse Event|1
5868566|NCT01987908|20297388|P2|Treatment Period|Adverse Event|1
5868567|NCT01987908|20297389|P1|Treatment Period|Adverse Event|0
5868568|NCT01987908|20297387|P3|Placebo Lead-in Period|Other: Study Termination by Sponsor|0
5868569|NCT01987908|20297388|P2|Placebo Lead-in Period|Other: Study Termination by Sponsor|0
5868570|NCT01987908|20297389|P1|Placebo Lead-in Period|Other: Study Termination by Sponsor|4
5868571|NCT01987908|20297387|P3|Placebo Lead-in Period|Withdrawal by Subject|0
5868572|NCT01987908|20297388|P2|Placebo Lead-in Period|Withdrawal by Subject|0
5868573|NCT01987908|20297389|P1|Placebo Lead-in Period|Withdrawal by Subject|1
5868574|NCT01987908|20297387|P3|Placebo Lead-in Period|Physician Decision|0
5868575|NCT01987908|20297388|P2|Placebo Lead-in Period|Physician Decision|0
5868576|NCT01987908|20297389|P1|Placebo Lead-in Period|Physician Decision|2
5868577|NCT01987908|20297387|P3|Placebo Lead-in Period|Adverse Event|0
5868578|NCT01987908|20297388|P2|Placebo Lead-in Period|Adverse Event|0
5868579|NCT01987908|20297389|P1|Placebo Lead-in Period|Adverse Event|2
5868580|NCT01987895|20297472|P2|Overall Study|randomized before giving IC|1
5868581|NCT01987895|20297473|P1|Overall Study|randomized before giving IC|0
5868582|NCT01987895|20297472|P2|Overall Study|Lost to Follow-up|5
5868583|NCT01987895|20297473|P1|Overall Study|Lost to Follow-up|3
5868584|NCT01987895|20297472|P2|Overall Study|Death|7
5868585|NCT01987895|20297473|P1|Overall Study|Death|7
5868586|NCT01987895|20297472|P2|Overall Study|Physician Decision|10
5868587|NCT01987895|20297473|P1|Overall Study|Physician Decision|8
5868588|NCT01987895|20297472|P2|Overall Study|Withdrawal by Subject|7
5868589|NCT01987895|20297473|P1|Overall Study|Withdrawal by Subject|12
5868590|NCT01987830|20297497|P1|Overall Study|Never received baseline scan|1
5868591|NCT01987765|20297501|P1|Overall Study|Lost to Follow-up|37
5868592|NCT01987765|20297501|P1|Overall Study|Protocol Violation|65
5868593|NCT01987609|20297511|P1|Overall Study|Adverse Event|1
5868594|NCT01987596|20297544|P2|Overall Study|Progressive Disease; missing all period|1
5868595|NCT01987596|20297545|P1|Overall Study|Progressive Disease; missing all period|0
5868596|NCT01987596|20297544|P2|Overall Study|Physician Decision|0
5868597|NCT01987596|20297545|P1|Overall Study|Physician Decision|1
5868598|NCT01987557|20297571|P3|Overall Study|Adverse Event|0
5868599|NCT01987557|20297572|P2|Overall Study|Adverse Event|2
5868600|NCT01987557|20297573|P1|Overall Study|Adverse Event|0
5868601|NCT01987557|20297571|P3|Overall Study|Withdrawal by Subject|2
5868602|NCT01987557|20297572|P2|Overall Study|Withdrawal by Subject|1
5868603|NCT01987557|20297573|P1|Overall Study|Withdrawal by Subject|2
5868604|NCT01987557|20297571|P3|Overall Study|Protocol Violation|1
5868605|NCT01987557|20297572|P2|Overall Study|Protocol Violation|0
5868606|NCT01987557|20297573|P1|Overall Study|Protocol Violation|1
5868607|NCT01987505|20297583|P1|Overall Study|Death|4
5868608|NCT01987505|20297583|P1|Overall Study|Investigator Decision|2
5868609|NCT01987505|20297583|P1|Overall Study|Lost to Follow-up|15
5868610|NCT01987505|20297583|P1|Overall Study|Other Reason|2
5868611|NCT01987505|20297583|P1|Overall Study|Withdrawal by Subject|2
5868612|NCT01987505|20297583|P1|Overall Study|Other|9
5868613|NCT01987479|20297613|P1|Overall Study|Adverse Event|7
5868614|NCT01987479|20297613|P1|Overall Study|Lost to Follow-up|1
5868615|NCT01987479|20297613|P1|Overall Study|Other|5
5868616|NCT01987479|20297613|P1|Overall Study|Participant/legal guardian decision|1
5868617|NCT01987479|20297613|P1|Overall Study|Physician Decision|2
5868618|NCT01987479|20297613|P1|Overall Study|Protocol Violation|1
5868619|NCT01987453|20297641|P3|Overall Study|Lack of Efficacy|0
5868620|NCT01987453|20297642|P2|Overall Study|Lack of Efficacy|12
5868621|NCT01987453|20297643|P1|Overall Study|Lack of Efficacy|1
5868622|NCT01987453|20297641|P3|Overall Study|Death|1
5868623|NCT01987453|20297642|P2|Overall Study|Death|0
5868624|NCT01987453|20297643|P1|Overall Study|Death|0
5868625|NCT01987427|20297669|P3|Overall Study|Other|0
5868626|NCT01987427|20297670|P2|Overall Study|Other|1
5868627|NCT01987427|20297671|P1|Overall Study|Other|1
5868628|NCT01987427|20297669|P3|Overall Study|Lack of Efficacy|0
5868629|NCT01987427|20297670|P2|Overall Study|Lack of Efficacy|0
5868630|NCT01987427|20297671|P1|Overall Study|Lack of Efficacy|1
5868631|NCT01987427|20297669|P3|Overall Study|Withdrawal by Subject|3
5868632|NCT01987427|20297670|P2|Overall Study|Withdrawal by Subject|1
5868633|NCT01987427|20297671|P1|Overall Study|Withdrawal by Subject|2
5868634|NCT01987427|20297669|P3|Overall Study|Lost to Follow-up|9
5868635|NCT01987427|20297670|P2|Overall Study|Lost to Follow-up|6
5868636|NCT01987427|20297671|P1|Overall Study|Lost to Follow-up|6
5868637|NCT01987427|20297669|P3|Overall Study|Adverse Event|8
5868638|NCT01987427|20297670|P2|Overall Study|Adverse Event|2
5868639|NCT01987427|20297671|P1|Overall Study|Adverse Event|4
5868640|NCT01987232|20297808|P5|Overall Study|Ongoing in Study|0
5868641|NCT01987232|20297809|P4|Overall Study|Ongoing in Study|1
5868642|NCT01987232|20297810|P3|Overall Study|Ongoing in Study|0
5868643|NCT01987232|20297811|P2|Overall Study|Ongoing in Study|0
5868644|NCT01987232|20297812|P1|Overall Study|Ongoing in Study|0
5868645|NCT01987102|20297901|P2|2 Courses of HDMTX With MOD Rescue|Adverse Event|1
5868646|NCT01987102|20297902|P1|2 Courses of HDMTX With MOD Rescue|Adverse Event|0
5868647|NCT01987102|20297901|P2|2 Courses of HDMTX With SOC Rescue|Incorrectly included|1
5868648|NCT01987102|20297902|P1|2 Courses of HDMTX With SOC Rescue|Incorrectly included|0
5868649|NCT01987102|20297901|P2|2 Courses of HDMTX With SOC Rescue|Protocol Violation|1
5868650|NCT01987102|20297902|P1|2 Courses of HDMTX With SOC Rescue|Protocol Violation|0
5868651|NCT01987102|20297901|P2|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|0
5868652|NCT01987102|20297902|P1|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|1
5868653|NCT01987102|20297901|P2|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|2
5868654|NCT01987102|20297902|P1|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|1
5868655|NCT01987102|20297901|P2|2 Courses of HDMTX With SOC Rescue|Adverse Event|2
5868656|NCT01987102|20297902|P1|2 Courses of HDMTX With SOC Rescue|Adverse Event|2
5868657|NCT01986985|20297949|P1|Overall Study|Scan not completed due to malfunction|3
5868658|NCT01986985|20297949|P1|Overall Study|Withdrawal by Subject|4
5868659|NCT01986920|20297986|P4|Placebo|Withdrawal by Subject|1
5868660|NCT01986920|20297987|P3|Placebo|Withdrawal by Subject|0
5868661|NCT01986920|20297988|P2|Placebo|Withdrawal by Subject|0
5868662|NCT01986920|20297989|P1|Placebo|Withdrawal by Subject|0
5868663|NCT01986920|20297986|P4|A-101 40%|Withdrawal by Subject|0
5868664|NCT01986920|20297987|P3|A-101 40%|Withdrawal by Subject|1
5868665|NCT01986920|20297988|P2|A-101 40%|Withdrawal by Subject|0
5868666|NCT01986920|20297989|P1|A-101 40%|Withdrawal by Subject|0
5868667|NCT01986920|20297986|P4|A-101 32.5%|Withdrawal by Subject|0
5868668|NCT01986920|20297987|P3|A-101 32.5%|Withdrawal by Subject|0
5868669|NCT01986920|20297988|P2|A-101 32.5%|Withdrawal by Subject|1
5868670|NCT01986920|20297989|P1|A-101 32.5%|Withdrawal by Subject|0
5868671|NCT01986920|20297986|P4|A- 101 25%|Withdrawal by Subject|0
5868672|NCT01986920|20297987|P3|A- 101 25%|Withdrawal by Subject|0
5868673|NCT01986920|20297988|P2|A- 101 25%|Withdrawal by Subject|0
5868674|NCT01986920|20297989|P1|A- 101 25%|Withdrawal by Subject|1
5868675|NCT01986907|20298003|P1|Overall Study|Death|9
5868676|NCT01986907|20298003|P1|Overall Study|Lost to Follow-up|38
5868677|NCT01986907|20298003|P1|Overall Study|Withdrawal by Subject|76
5868678|NCT01986907|20298003|P1|Overall Study|Protocol Violation|4
5868679|NCT01986907|20298003|P1|Overall Study|Unsatisfactory therapeutic effect|24
5868680|NCT01986907|20298003|P1|Overall Study|Adverse Event|11
5868681|NCT01986855|20298016|P3|Overall Study|Withdrawal by Subject|5
5868682|NCT01986855|20298017|P2|Overall Study|Withdrawal by Subject|8
5868683|NCT01986855|20298018|P1|Overall Study|Withdrawal by Subject|7
5868684|NCT01986855|20298016|P3|Overall Study|Participant Moved|2
5868685|NCT01986855|20298017|P2|Overall Study|Participant Moved|0
5868686|NCT01986855|20298018|P1|Overall Study|Participant Moved|0
5868687|NCT01986855|20298016|P3|Overall Study|Screen Failure|0
5868688|NCT01986855|20298017|P2|Overall Study|Screen Failure|1
5868689|NCT01986855|20298018|P1|Overall Study|Screen Failure|0
5868690|NCT01986855|20298016|P3|Overall Study|Lost to Follow-up|0
5868691|NCT01986855|20298017|P2|Overall Study|Lost to Follow-up|1
5868692|NCT01986855|20298018|P1|Overall Study|Lost to Follow-up|2
5868693|NCT01986855|20298016|P3|Overall Study|Death|4
5868694|NCT01986855|20298017|P2|Overall Study|Death|4
5868695|NCT01986855|20298018|P1|Overall Study|Death|3
5868696|NCT01986855|20298016|P3|Overall Study|Adverse Event|0
5868697|NCT01986855|20298017|P2|Overall Study|Adverse Event|0
5868698|NCT01986855|20298018|P1|Overall Study|Adverse Event|1
5868699|NCT01986829|20298047|P1|Overall Study|Death|1
5868700|NCT01986751|20298095|P2|Overall Study|improperly consented|2
5868701|NCT01986751|20298096|P1|Overall Study|improperly consented|10
5868702|NCT01986647|20298129|P4|Overall Study|Health|4
5868703|NCT01986647|20298130|P3|Overall Study|Health|6
5868704|NCT01986647|20298131|P2|Overall Study|Health|3
5868705|NCT01986647|20298132|P1|Overall Study|Health|5
5868706|NCT01986647|20298129|P4|Overall Study|Withdrawal by Subject|3
5868707|NCT01986647|20298130|P3|Overall Study|Withdrawal by Subject|2
5868708|NCT01986647|20298131|P2|Overall Study|Withdrawal by Subject|3
5868709|NCT01986647|20298132|P1|Overall Study|Withdrawal by Subject|1
5868710|NCT01986647|20298129|P4|Overall Study|Lost to Follow-up|4
5868711|NCT01986647|20298130|P3|Overall Study|Lost to Follow-up|4
5868712|NCT01986647|20298131|P2|Overall Study|Lost to Follow-up|1
5868713|NCT01986647|20298132|P1|Overall Study|Lost to Follow-up|4
5868714|NCT01986231|20298227|P1|Overall Study|Adverse Event|1
5868715|NCT01986140|20298234|P2|Overall Study|progression disease|1
5868716|NCT01986140|20298235|P1|Overall Study|progression disease|0
5868717|NCT01986140|20298234|P2|Overall Study|Adverse Event|1
5868718|NCT01986140|20298235|P1|Overall Study|Adverse Event|0
5868719|NCT01986140|20298234|P2|Overall Study|found not eligible|0
5868720|NCT01986140|20298235|P1|Overall Study|found not eligible|3
5868721|NCT01986140|20298234|P2|Overall Study|alternative treatment|1
5868722|NCT01986140|20298235|P1|Overall Study|alternative treatment|1
5868723|NCT01986140|20298234|P2|Overall Study|Withdrawal by Subject|25
5868724|NCT01986140|20298235|P1|Overall Study|Withdrawal by Subject|31
5868725|NCT01986114|20298241|P1|Overall Study|Other reason|7
5868726|NCT01986114|20298241|P1|Overall Study|Lost to Follow-up|5
5868727|NCT01986114|20298241|P1|Overall Study|Protocol Violation|1
5868728|NCT01986114|20298241|P1|Overall Study|Noncompliance|3
5868729|NCT01986114|20298241|P1|Overall Study|Withdrawal by Subject|58
5868730|NCT01986114|20298241|P1|Overall Study|Lack of Efficacy|23
5868731|NCT01986114|20298241|P1|Overall Study|Adverse Event|59
5868732|NCT01986062|20298280|P2|Overall Study|Withdrawal by Subject|1
5868733|NCT01986062|20298281|P1|Overall Study|Withdrawal by Subject|0
5868734|NCT01986062|20298280|P2|Overall Study|Lost to Follow-up|0
5868735|NCT01986062|20298281|P1|Overall Study|Lost to Follow-up|1
5868736|NCT01985360|20298379|P2|Overall Study|Lost to Follow-up|3
5868737|NCT01985360|20298380|P1|Overall Study|Lost to Follow-up|5
5868738|NCT01985360|20298379|P2|Overall Study|Withdrawal by Subject|0
5868739|NCT01985360|20298380|P1|Overall Study|Withdrawal by Subject|4
5868740|NCT01985334|20298396|P8|Overall Study|Lost to Follow-up|3
5868741|NCT01985334|20298397|P7|Overall Study|Lost to Follow-up|0
5868742|NCT01985334|20298398|P6|Overall Study|Lost to Follow-up|4
5868743|NCT01985334|20298399|P5|Overall Study|Lost to Follow-up|1
5868744|NCT01985334|20298400|P4|Overall Study|Lost to Follow-up|3
5868745|NCT01985334|20298401|P3|Overall Study|Lost to Follow-up|0
5868746|NCT01985334|20298402|P2|Overall Study|Lost to Follow-up|2
5868747|NCT01985334|20298403|P1|Overall Study|Lost to Follow-up|0
5868748|NCT01985334|20298396|P8|Overall Study|Investigator decision|4
5868749|NCT01985334|20298397|P7|Overall Study|Investigator decision|0
5868750|NCT01985334|20298398|P6|Overall Study|Investigator decision|1
5868751|NCT01985334|20298399|P5|Overall Study|Investigator decision|1
5868752|NCT01985334|20298400|P4|Overall Study|Investigator decision|7
5868753|NCT01985334|20298401|P3|Overall Study|Investigator decision|0
5868754|NCT01985334|20298402|P2|Overall Study|Investigator decision|3
5868755|NCT01985334|20298403|P1|Overall Study|Investigator decision|0
5868756|NCT01985334|20298396|P8|Overall Study|Use of prohibited treatment|0
5868757|NCT01985334|20298397|P7|Overall Study|Use of prohibited treatment|2
5868758|NCT01985334|20298398|P6|Overall Study|Use of prohibited treatment|6
5868759|NCT01985334|20298399|P5|Overall Study|Use of prohibited treatment|1
5868760|NCT01985334|20298400|P4|Overall Study|Use of prohibited treatment|2
5868761|NCT01985334|20298401|P3|Overall Study|Use of prohibited treatment|1
5868762|NCT01985334|20298402|P2|Overall Study|Use of prohibited treatment|4
5868763|NCT01985334|20298403|P1|Overall Study|Use of prohibited treatment|1
5868764|NCT01985334|20298396|P8|Overall Study|Medication non-compliance|3
5868765|NCT01985334|20298397|P7|Overall Study|Medication non-compliance|1
5868766|NCT01985334|20298398|P6|Overall Study|Medication non-compliance|3
5868767|NCT01985334|20298399|P5|Overall Study|Medication non-compliance|2
5868768|NCT01985334|20298400|P4|Overall Study|Medication non-compliance|6
5868769|NCT01985334|20298401|P3|Overall Study|Medication non-compliance|1
5868770|NCT01985334|20298402|P2|Overall Study|Medication non-compliance|4
5868771|NCT01985334|20298403|P1|Overall Study|Medication non-compliance|0
5868772|NCT01985334|20298396|P8|Overall Study|Other|2
5868773|NCT01985334|20298397|P7|Overall Study|Other|2
5868774|NCT01985334|20298398|P6|Overall Study|Other|6
5868775|NCT01985334|20298399|P5|Overall Study|Other|1
5868776|NCT01985334|20298400|P4|Overall Study|Other|10
5868777|NCT01985334|20298401|P3|Overall Study|Other|3
5868778|NCT01985334|20298402|P2|Overall Study|Other|2
5868779|NCT01985334|20298403|P1|Overall Study|Other|4
5868780|NCT01985334|20298396|P8|Overall Study|Adverse Event|15
5868781|NCT01985334|20298397|P7|Overall Study|Adverse Event|3
5868782|NCT01985334|20298398|P6|Overall Study|Adverse Event|18
5868783|NCT01985334|20298399|P5|Overall Study|Adverse Event|3
5868784|NCT01985334|20298400|P4|Overall Study|Adverse Event|26
5868785|NCT01985334|20298401|P3|Overall Study|Adverse Event|2
5868786|NCT01985334|20298402|P2|Overall Study|Adverse Event|8
5868787|NCT01985334|20298403|P1|Overall Study|Adverse Event|0
5868788|NCT01985334|20298396|P8|Overall Study|Subject withdrawal of consent|20
5868789|NCT01985334|20298397|P7|Overall Study|Subject withdrawal of consent|0
5868790|NCT01985334|20298398|P6|Overall Study|Subject withdrawal of consent|19
5868791|NCT01985334|20298399|P5|Overall Study|Subject withdrawal of consent|4
5868792|NCT01985334|20298400|P4|Overall Study|Subject withdrawal of consent|28
5868793|NCT01985334|20298401|P3|Overall Study|Subject withdrawal of consent|2
5868794|NCT01985334|20298402|P2|Overall Study|Subject withdrawal of consent|6
5868795|NCT01985334|20298403|P1|Overall Study|Subject withdrawal of consent|3
5868796|NCT01985334|20298396|P8|Overall Study|Moderate / severe COPD exacerbation|19
5868797|NCT01985334|20298397|P7|Overall Study|Moderate / severe COPD exacerbation|8
5868798|NCT01985334|20298398|P6|Overall Study|Moderate / severe COPD exacerbation|40
5868799|NCT01985334|20298399|P5|Overall Study|Moderate / severe COPD exacerbation|6
5868800|NCT01985334|20298400|P4|Overall Study|Moderate / severe COPD exacerbation|40
5868801|NCT01985334|20298401|P3|Overall Study|Moderate / severe COPD exacerbation|12
5868802|NCT01985334|20298402|P2|Overall Study|Moderate / severe COPD exacerbation|14
5868803|NCT01985334|20298403|P1|Overall Study|Moderate / severe COPD exacerbation|5
5868804|NCT01985334|20298396|P8|Overall Study|Protocol deviation|42
5868805|NCT01985334|20298397|P7|Overall Study|Protocol deviation|15
5868806|NCT01985334|20298398|P6|Overall Study|Protocol deviation|47
5868807|NCT01985334|20298399|P5|Overall Study|Protocol deviation|17
5868808|NCT01985334|20298400|P4|Overall Study|Protocol deviation|84
5868809|NCT01985334|20298401|P3|Overall Study|Protocol deviation|25
5868810|NCT01985334|20298402|P2|Overall Study|Protocol deviation|31
5868811|NCT01985334|20298403|P1|Overall Study|Protocol deviation|6
5868812|NCT01985334|20298396|P8|Overall Study|Other|7
5868813|NCT01985334|20298397|P7|Overall Study|Other|4
5868814|NCT01985334|20298398|P6|Overall Study|Other|8
5868815|NCT01985334|20298399|P5|Overall Study|Other|4
5868816|NCT01985334|20298400|P4|Overall Study|Other|17
5868817|NCT01985334|20298401|P3|Overall Study|Other|7
5868818|NCT01985334|20298402|P2|Overall Study|Other|9
5868819|NCT01985334|20298403|P1|Overall Study|Other|2
5868820|NCT01985334|20298396|P8|Overall Study|Worsening of disease|1
5868821|NCT01985334|20298397|P7|Overall Study|Worsening of disease|0
5868822|NCT01985334|20298398|P6|Overall Study|Worsening of disease|3
5868823|NCT01985334|20298399|P5|Overall Study|Worsening of disease|0
5868824|NCT01985334|20298400|P4|Overall Study|Worsening of disease|1
5868825|NCT01985334|20298401|P3|Overall Study|Worsening of disease|0
5868826|NCT01985334|20298402|P2|Overall Study|Worsening of disease|0
5868827|NCT01985334|20298403|P1|Overall Study|Worsening of disease|0
5868828|NCT01985334|20298396|P8|Overall Study|Death|2
5868829|NCT01985334|20298397|P7|Overall Study|Death|1
5868830|NCT01985334|20298398|P6|Overall Study|Death|0
5868831|NCT01985334|20298399|P5|Overall Study|Death|0
5868832|NCT01985334|20298400|P4|Overall Study|Death|3
5868833|NCT01985334|20298401|P3|Overall Study|Death|0
5868834|NCT01985334|20298402|P2|Overall Study|Death|0
5868835|NCT01985334|20298403|P1|Overall Study|Death|1
5868836|NCT01985334|20298396|P8|Overall Study|Administrative problems|3
5868837|NCT01985334|20298397|P7|Overall Study|Administrative problems|1
5868838|NCT01985334|20298398|P6|Overall Study|Administrative problems|1
5868839|NCT01985334|20298399|P5|Overall Study|Administrative problems|0
5868840|NCT01985334|20298400|P4|Overall Study|Administrative problems|2
5868841|NCT01985334|20298401|P3|Overall Study|Administrative problems|0
5868842|NCT01985334|20298402|P2|Overall Study|Administrative problems|1
5868843|NCT01985334|20298403|P1|Overall Study|Administrative problems|1
5868844|NCT01985321|20298471|P2|Overall Study|Subject treated wrong type of sore|0
5868845|NCT01985321|20298472|P1|Overall Study|Subject treated wrong type of sore|1
5868846|NCT01985321|20298471|P2|Overall Study|Lost to Follow-up|2
5868847|NCT01985321|20298472|P1|Overall Study|Lost to Follow-up|5
5868848|NCT01985321|20298471|P2|Overall Study|Withdrawal by Subject|0
5868849|NCT01985321|20298472|P1|Overall Study|Withdrawal by Subject|1
5868850|NCT01985321|20298471|P2|Overall Study|Protocol Violation|3
5868851|NCT01985321|20298472|P1|Overall Study|Protocol Violation|4
5868852|NCT01985126|20298482|P2|Overall Study|Withdrawal by Subject|7
5868853|NCT01985126|20298483|P1|Overall Study|Withdrawal by Subject|2
5868854|NCT01985126|20298482|P2|Overall Study|Study Terminated By Sponsor|22
5868855|NCT01985126|20298483|P1|Overall Study|Study Terminated By Sponsor|1
5868856|NCT01985126|20298482|P2|Overall Study|Lost to Follow-up|8
5868857|NCT01985126|20298483|P1|Overall Study|Lost to Follow-up|0
5868858|NCT01985126|20298482|P2|Overall Study|Death|69
5868859|NCT01985126|20298483|P1|Overall Study|Death|15
5868860|NCT01984892|20298501|P1|Overall Study|Progressive disease|7
5868861|NCT01984697|20298512|P5|Overall Study|Pregnancy|1
5868862|NCT01984697|20298513|P4|Overall Study|Pregnancy|0
5868863|NCT01984697|20298514|P3|Overall Study|Pregnancy|1
5868864|NCT01984697|20298515|P2|Overall Study|Pregnancy|0
5868865|NCT01984697|20298516|P1|Overall Study|Pregnancy|2
5868866|NCT01984697|20298512|P5|Overall Study|Death|0
5868867|NCT01984697|20298513|P4|Overall Study|Death|1
5868868|NCT01984697|20298514|P3|Overall Study|Death|0
5868869|NCT01984697|20298515|P2|Overall Study|Death|0
5868870|NCT01984697|20298516|P1|Overall Study|Death|0
5868871|NCT01984697|20298512|P5|Overall Study|Missed last follow-up visit|0
5868872|NCT01984697|20298513|P4|Overall Study|Missed last follow-up visit|0
5868873|NCT01984697|20298514|P3|Overall Study|Missed last follow-up visit|0
5868874|NCT01984697|20298515|P2|Overall Study|Missed last follow-up visit|0
5868875|NCT01984697|20298516|P1|Overall Study|Missed last follow-up visit|1
5868876|NCT01984697|20298512|P5|Overall Study|Withdrawal by Subject|13
5868877|NCT01984697|20298513|P4|Overall Study|Withdrawal by Subject|11
5868878|NCT01984697|20298514|P3|Overall Study|Withdrawal by Subject|13
5868879|NCT01984697|20298515|P2|Overall Study|Withdrawal by Subject|21
5868880|NCT01984697|20298516|P1|Overall Study|Withdrawal by Subject|15
5868881|NCT01984697|20298512|P5|Overall Study|Protocol Violation|0
5868882|NCT01984697|20298513|P4|Overall Study|Protocol Violation|2
5868883|NCT01984697|20298514|P3|Overall Study|Protocol Violation|3
5868884|NCT01984697|20298515|P2|Overall Study|Protocol Violation|5
5868885|NCT01984697|20298516|P1|Overall Study|Protocol Violation|8
5868886|NCT01984697|20298512|P5|Overall Study|Physician Decision|0
5868887|NCT01984697|20298513|P4|Overall Study|Physician Decision|1
5868888|NCT01984697|20298514|P3|Overall Study|Physician Decision|0
5868889|NCT01984697|20298515|P2|Overall Study|Physician Decision|0
5868890|NCT01984697|20298516|P1|Overall Study|Physician Decision|3
5868891|NCT01984697|20298512|P5|Overall Study|Lost to Follow-up|21
5868892|NCT01984697|20298513|P4|Overall Study|Lost to Follow-up|6
5868893|NCT01984697|20298514|P3|Overall Study|Lost to Follow-up|10
5868894|NCT01984697|20298515|P2|Overall Study|Lost to Follow-up|5
5868895|NCT01984697|20298516|P1|Overall Study|Lost to Follow-up|14
5868896|NCT01984697|20298512|P5|Overall Study|Adverse Event|0
5868897|NCT01984697|20298513|P4|Overall Study|Adverse Event|0
5868898|NCT01984697|20298514|P3|Overall Study|Adverse Event|2
5868899|NCT01984697|20298515|P2|Overall Study|Adverse Event|0
5868900|NCT01984697|20298516|P1|Overall Study|Adverse Event|0
5868901|NCT01984684|20298635|P2|Overall Study|Subject had inadequate IV access|1
5868902|NCT01984684|20298636|P1|Overall Study|Subject had inadequate IV access|0
5868903|NCT01984684|20298635|P2|Overall Study|Study drug not available at site|1
5868904|NCT01984684|20298636|P1|Overall Study|Study drug not available at site|1
5868905|NCT01984684|20298635|P2|Overall Study|Subject incarcerated|0
5868906|NCT01984684|20298636|P1|Overall Study|Subject incarcerated|1
5868907|NCT01984684|20298635|P2|Overall Study|Noncompliance with study drug|1
5868908|NCT01984684|20298636|P1|Overall Study|Noncompliance with study drug|2
5868909|NCT01984684|20298635|P2|Overall Study|Death|1
5868910|NCT01984684|20298636|P1|Overall Study|Death|0
5868911|NCT01984684|20298635|P2|Overall Study|Protocol Violation|2
5868912|NCT01984684|20298636|P1|Overall Study|Protocol Violation|4
5868913|NCT01984684|20298635|P2|Overall Study|Physician Decision|2
5868914|NCT01984684|20298636|P1|Overall Study|Physician Decision|4
5868915|NCT01984684|20298635|P2|Overall Study|Lack of Efficacy|6
5868916|NCT01984684|20298636|P1|Overall Study|Lack of Efficacy|3
5868917|NCT01984684|20298635|P2|Overall Study|Withdrawal by Subject|9
5868918|NCT01984684|20298636|P1|Overall Study|Withdrawal by Subject|9
5868919|NCT01984684|20298635|P2|Overall Study|Adverse Event|12
5868920|NCT01984684|20298636|P1|Overall Study|Adverse Event|8
5868921|NCT01984684|20298635|P2|Overall Study|Lost to Follow-up|24
5868922|NCT01984684|20298636|P1|Overall Study|Lost to Follow-up|25
5868923|NCT01984424|20298654|P2|Overall Study|Lost to Follow-up|1
5868924|NCT01984424|20298655|P1|Overall Study|Lost to Follow-up|0
5868925|NCT01984424|20298654|P2|Overall Study|Sponsor Decision|1
5868926|NCT01984424|20298655|P1|Overall Study|Sponsor Decision|0
5868927|NCT01984424|20298654|P2|Overall Study|Withdrawal by Subject|5
5868928|NCT01984424|20298655|P1|Overall Study|Withdrawal by Subject|3
5868929|NCT01984294|20298725|P3|Overall Study|Adverse Event|0
5868930|NCT01984294|20298726|P2|Overall Study|Adverse Event|1
5868931|NCT01984294|20298727|P1|Overall Study|Adverse Event|0
5868932|NCT01984294|20298725|P3|Overall Study|Lack of Efficacy|6
5868933|NCT01984294|20298726|P2|Overall Study|Lack of Efficacy|2
5868934|NCT01984294|20298727|P1|Overall Study|Lack of Efficacy|4
5868935|NCT01984294|20298725|P3|Overall Study|Randomized but Never Treated|1
5868936|NCT01984294|20298726|P2|Overall Study|Randomized but Never Treated|0
5868937|NCT01984294|20298727|P1|Overall Study|Randomized but Never Treated|0
5868938|NCT01984268|20298747|P1|Overall Study|Study Terminated|15
5868939|NCT01984242|20298759|P3|Overall Study|Disease Progression|1
5868940|NCT01984242|20298760|P2|Overall Study|Disease Progression|0
5868941|NCT01984242|20298761|P1|Overall Study|Disease Progression|0
5868942|NCT01984242|20298759|P3|Overall Study|Study terminated by Sponsor|34
5868943|NCT01984242|20298760|P2|Overall Study|Study terminated by Sponsor|50
5868944|NCT01984242|20298761|P1|Overall Study|Study terminated by Sponsor|38
5868945|NCT01984242|20298759|P3|Overall Study|Non-Compliance|0
5868946|NCT01984242|20298760|P2|Overall Study|Non-Compliance|0
5868947|NCT01984242|20298761|P1|Overall Study|Non-Compliance|1
5868948|NCT01984242|20298759|P3|Overall Study|Sponsor Decision|0
5868949|NCT01984242|20298760|P2|Overall Study|Sponsor Decision|0
5868950|NCT01984242|20298761|P1|Overall Study|Sponsor Decision|1
5868951|NCT01984242|20298759|P3|Overall Study|Lost to Follow-up|3
5868952|NCT01984242|20298760|P2|Overall Study|Lost to Follow-up|0
5868953|NCT01984242|20298761|P1|Overall Study|Lost to Follow-up|4
5868954|NCT01984242|20298759|P3|Overall Study|Physician Decision|1
5868955|NCT01984242|20298760|P2|Overall Study|Physician Decision|0
5868956|NCT01984242|20298761|P1|Overall Study|Physician Decision|0
5868957|NCT01984242|20298759|P3|Overall Study|Withdrawal by Subject|10
5868958|NCT01984242|20298760|P2|Overall Study|Withdrawal by Subject|3
5868959|NCT01984242|20298761|P1|Overall Study|Withdrawal by Subject|5
5868960|NCT01984242|20298759|P3|Overall Study|Death|52
5868961|NCT01984242|20298760|P2|Overall Study|Death|50
5868962|NCT01984242|20298761|P1|Overall Study|Death|52
5868963|NCT01984229|20298911|P2|Safety Follow-up Period|Lost to Follow-up|0
5868964|NCT01984229|20298912|P1|Safety Follow-up Period|Lost to Follow-up|1
5868965|NCT01984229|20298911|P2|Safety Follow-up Period|Adverse Event|1
5868966|NCT01984229|20298912|P1|Safety Follow-up Period|Adverse Event|1
5868967|NCT01983969|20298965|P3|Overall Study|Disease Progression|0
5868968|NCT01983969|20298966|P2|Overall Study|Disease Progression|1
5868969|NCT01983969|20298967|P1|Overall Study|Disease Progression|0
5868970|NCT01983930|20298981|P2|Overall Study|Adverse Event|1
5868971|NCT01983930|20298982|P1|Overall Study|Adverse Event|0
5868972|NCT01983930|20298981|P2|Overall Study|Withdrawal by Subject|8
5868973|NCT01983930|20298982|P1|Overall Study|Withdrawal by Subject|9
5868974|NCT01983683|20299056|P2|Overall Study|Sponsor Decision|1
5868975|NCT01983683|20299057|P1|Overall Study|Sponsor Decision|1
5868976|NCT01983683|20299056|P2|Overall Study|Lost to Follow-up|8
5868977|NCT01983683|20299057|P1|Overall Study|Lost to Follow-up|4
5868978|NCT01983683|20299056|P2|Overall Study|Physician Decision|9
5868979|NCT01983683|20299057|P1|Overall Study|Physician Decision|8
5868980|NCT01983683|20299056|P2|Overall Study|Death|15
5868981|NCT01983683|20299057|P1|Overall Study|Death|11
5868982|NCT01983683|20299056|P2|Overall Study|Withdrawal by Subject|18
5868983|NCT01983683|20299057|P1|Overall Study|Withdrawal by Subject|14
5868984|NCT01983293|20299144|P2|Overall Study|Missing NYHA/Patient Global Assessment|1
5868985|NCT01983293|20299145|P1|Overall Study|Missing NYHA/Patient Global Assessment|1
5868986|NCT01983293|20299144|P2|Overall Study|Missing 12-month visit|3
5868987|NCT01983293|20299145|P1|Overall Study|Missing 12-month visit|3
5868988|NCT01983293|20299144|P2|Overall Study|Withdrawal by Subject|15
5868989|NCT01983293|20299145|P1|Overall Study|Withdrawal by Subject|29
5868990|NCT01983254|20299153|P2|Overall Study|too ill|8
5868991|NCT01983254|20299154|P1|Overall Study|too ill|11
5868992|NCT01983254|20299153|P2|Overall Study|Lost to Follow-up|16
5868993|NCT01983254|20299154|P1|Overall Study|Lost to Follow-up|17
5868994|NCT01983254|20299153|P2|Overall Study|Death|6
5868995|NCT01983254|20299154|P1|Overall Study|Death|6
5868996|NCT01983111|20299166|P2|Overall Study|Protocol Violation|1
5868997|NCT01983111|20299167|P1|Overall Study|Protocol Violation|0
5868998|NCT01983111|20299166|P2|Overall Study|Adverse Event|0
5868999|NCT01983111|20299167|P1|Overall Study|Adverse Event|4
5869000|NCT01983111|20299166|P2|Overall Study|Withdrawal by Subject|6
5869001|NCT01983111|20299167|P1|Overall Study|Withdrawal by Subject|8
5869002|NCT01982955|20299205|P5|Overall Study|Ongoing|0
5869003|NCT01982955|20299206|P4|Overall Study|Ongoing|0
5869004|NCT01982955|20299207|P3|Overall Study|Ongoing|4
5869005|NCT01982955|20299208|P2|Overall Study|Ongoing|0
5869006|NCT01982955|20299209|P1|Overall Study|Ongoing|0
5869007|NCT01982955|20299205|P5|Overall Study|Randomized but not treated|0
5869008|NCT01982955|20299206|P4|Overall Study|Randomized but not treated|1
5869009|NCT01982955|20299207|P3|Overall Study|Randomized but not treated|0
5869010|NCT01982955|20299208|P2|Overall Study|Randomized but not treated|0
5869011|NCT01982955|20299209|P1|Overall Study|Randomized but not treated|0
5869012|NCT01982942|20299311|P2|Overall Study|Subject bedridden, rapidly declining|1
5869013|NCT01982942|20299312|P1|Overall Study|Subject bedridden, rapidly declining|0
5869014|NCT01982942|20299311|P2|Overall Study|Chose to join a stem cell trial|1
5869015|NCT01982942|20299312|P1|Overall Study|Chose to join a stem cell trial|0
5869016|NCT01982942|20299311|P2|Overall Study|MS Relapse|1
5869017|NCT01982942|20299312|P1|Overall Study|MS Relapse|0
5869018|NCT01982942|20299311|P2|Overall Study|Too many pills|0
5869019|NCT01982942|20299312|P1|Overall Study|Too many pills|1
5869020|NCT01982942|20299311|P2|Overall Study|Left geographical area|0
5869021|NCT01982942|20299312|P1|Overall Study|Left geographical area|2
5869022|NCT01982942|20299311|P2|Overall Study|Subject declined future visits|1
5869023|NCT01982942|20299312|P1|Overall Study|Subject declined future visits|0
5869024|NCT01982942|20299311|P2|Overall Study|Wanted to try therapy not permitted|0
5869025|NCT01982942|20299312|P1|Overall Study|Wanted to try therapy not permitted|1
5869026|NCT01982942|20299311|P2|Overall Study|Multiple sclerosis progression|2
5869027|NCT01982942|20299312|P1|Overall Study|Multiple sclerosis progression|3
5869028|NCT01982942|20299311|P2|Overall Study|Lost to Follow-up|3
5869029|NCT01982942|20299312|P1|Overall Study|Lost to Follow-up|4
5869030|NCT01982942|20299311|P2|Overall Study|Adverse Event|5
5869031|NCT01982942|20299312|P1|Overall Study|Adverse Event|10
5869032|NCT01982812|20299330|P2|Overall Study|Adverse Event|5
5869033|NCT01982812|20299331|P1|Overall Study|Adverse Event|0
5869034|NCT01982812|20299330|P2|Overall Study|Death|5
5869035|NCT01982812|20299331|P1|Overall Study|Death|1
5869036|NCT01982773|20299360|P2|Overall Study|Lost to Follow-up|1
5869037|NCT01982773|20299361|P1|Overall Study|Lost to Follow-up|7
5869038|NCT01982773|20299360|P2|Overall Study|Withdrawal by Subject|3
5869039|NCT01982773|20299361|P1|Overall Study|Withdrawal by Subject|1
5869040|NCT01982682|20299382|P1|Overall Study|Physician Decision|1
5869041|NCT01982435|20299402|P2|Overall Study|Adverse Event|0
5869042|NCT01982435|20299403|P1|Overall Study|Adverse Event|1
5869043|NCT01982331|20299442|P2|Completed Study (Day 112)|Withdrawal by Subject|0
5869044|NCT01982331|20299443|P1|Completed Study (Day 112)|Withdrawal by Subject|2
5869045|NCT01982331|20299442|P2|Received Vaccination 2|Withdrawal by Subject|1
5869046|NCT01982331|20299443|P1|Received Vaccination 2|Withdrawal by Subject|0
5869047|NCT01982331|20299442|P2|Received Vaccination 2|Adverse Event|2
5869048|NCT01982331|20299443|P1|Received Vaccination 2|Adverse Event|1
5869049|NCT01982292|20299479|P2|Overall Study|Technical Problems|0
5869050|NCT01982292|20299480|P1|Overall Study|Technical Problems|2
5869051|NCT01982292|20299479|P2|Overall Study|Patient/Guardian Decision|1
5869052|NCT01982292|20299480|P1|Overall Study|Patient/Guardian Decision|3
5869053|NCT01982292|20299479|P2|Overall Study|Protocol Deviation|0
5869054|NCT01982292|20299480|P1|Overall Study|Protocol Deviation|1
5869055|NCT01982292|20299479|P2|Overall Study|Non-Compliance With Study Treatment|0
5869056|NCT01982292|20299480|P1|Overall Study|Non-Compliance With Study Treatment|1
5869057|NCT01982292|20299479|P2|Overall Study|Lost to Follow-up|0
5869058|NCT01982292|20299480|P1|Overall Study|Lost to Follow-up|2
5869059|NCT01982292|20299479|P2|Overall Study|Death|0
5869060|NCT01982292|20299480|P1|Overall Study|Death|1
5869061|NCT01982292|20299479|P2|Overall Study|Adverse Event|0
5869062|NCT01982292|20299480|P1|Overall Study|Adverse Event|2
5869063|NCT01982253|20299501|P3|Overall Study|Study terminated by sponsor|4
5869064|NCT01982253|20299502|P2|Overall Study|Study terminated by sponsor|4
5869065|NCT01982253|20299503|P1|Overall Study|Study terminated by sponsor|1
5869066|NCT01982253|20299501|P3|Overall Study|Withdrawal by Subject|0
5869067|NCT01982253|20299502|P2|Overall Study|Withdrawal by Subject|0
5869068|NCT01982253|20299503|P1|Overall Study|Withdrawal by Subject|1
5869069|NCT01981954|20299557|P1|Fixed-Dose Assessment Period|Lack of Efficacy|1
5869070|NCT01981954|20299557|P1|Titration Period|Protocol Deviation|1
5869071|NCT01981616|20299641|P2|Overall Study|Protocol Violation|0
5869072|NCT01981616|20299642|P1|Overall Study|Protocol Violation|1
5869073|NCT01981616|20299641|P2|Overall Study|Adverse Event|1
5869074|NCT01981616|20299642|P1|Overall Study|Adverse Event|0
5869075|NCT01981551|20299672|P1|Overall Study|Adverse Event|1
5869076|NCT01981551|20299672|P1|Overall Study|Refused further treatment|8
5869077|NCT01981473|20299682|P3|Overall Study|Received treatment for >24 months|6
5869078|NCT01981473|20299683|P2|Overall Study|Received treatment for >24 months|0
5869079|NCT01981473|20299684|P1|Overall Study|Received treatment for >24 months|2
5869080|NCT01981473|20299682|P3|Overall Study|Received treatment for < 6 months|1
5869081|NCT01981473|20299683|P2|Overall Study|Received treatment for < 6 months|0
5869082|NCT01981473|20299684|P1|Overall Study|Received treatment for < 6 months|0
5869083|NCT01981473|20299682|P3|Overall Study|Incorrect diagnosis of RA|1
5869084|NCT01981473|20299683|P2|Overall Study|Incorrect diagnosis of RA|0
5869085|NCT01981473|20299684|P1|Overall Study|Incorrect diagnosis of RA|0
5869086|NCT01981356|20299725|P2|Overall Study|Protocol Violation|0
5869087|NCT01981356|20299726|P1|Overall Study|Protocol Violation|2
5869088|NCT01981356|20299725|P2|Overall Study|Withdrawal by Subject|1
5869089|NCT01981356|20299726|P1|Overall Study|Withdrawal by Subject|1
5869090|NCT01981356|20299725|P2|Overall Study|Lost to Follow-up|1
5869091|NCT01981356|20299726|P1|Overall Study|Lost to Follow-up|4
5869092|NCT01981122|20299753|P2|Overall Study|Death|15
5869093|NCT01981122|20299754|P1|Overall Study|Death|14
5869094|NCT01981122|20299753|P2|Overall Study|Investigator Or Dendreon Discretion|1
5869095|NCT01981122|20299754|P1|Overall Study|Investigator Or Dendreon Discretion|0
5869096|NCT01981122|20299753|P2|Overall Study|Lost to Follow-up|1
5869097|NCT01981122|20299754|P1|Overall Study|Lost to Follow-up|0
5869098|NCT01981122|20299753|P2|Overall Study|Protocol Violation|1
5869099|NCT01981122|20299754|P1|Overall Study|Protocol Violation|0
5869100|NCT01981122|20299753|P2|Overall Study|Withdrawal by Subject|2
5869101|NCT01981122|20299754|P1|Overall Study|Withdrawal by Subject|0
5869102|NCT01981109|20299760|P1|Overall Study|No data available|2
5869103|NCT01981109|20299760|P1|Overall Study|Study Termination|100
5869104|NCT01981109|20299760|P1|Overall Study|No Discontinuation Documentation|37
5869105|NCT01981109|20299760|P1|Overall Study|Lost to Follow-up|9
5869106|NCT01981109|20299760|P1|Overall Study|Withdrawal by Subject|40
5869107|NCT01981109|20299760|P1|Overall Study|Death|36
5869108|NCT01981096|20299767|P2|Overall Study|Lost to Follow-up|0
5869109|NCT01981096|20299768|P1|Overall Study|Lost to Follow-up|2
5869110|NCT01981096|20299767|P2|Overall Study|Withdrawal by Subject|1
5869111|NCT01981096|20299768|P1|Overall Study|Withdrawal by Subject|0
5869112|NCT01981096|20299767|P2|Overall Study|Parent illness|0
5869113|NCT01981096|20299768|P1|Overall Study|Parent illness|1
5869114|NCT01980992|20299789|P2|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|1
5869115|NCT01980992|20299790|P1|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|0
5869116|NCT01980992|20299789|P2|52 Weeks Open Label Active Wheat OIT|Non-compliance|0
5869117|NCT01980992|20299790|P1|52 Weeks Open Label Active Wheat OIT|Non-compliance|1
5869118|NCT01980992|20299789|P2|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|0
5869119|NCT01980992|20299790|P1|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|2
5869120|NCT01980992|20299789|P2|52 Weeks Blinded Study Treatment|Non-compliance|0
5869121|NCT01980992|20299790|P1|52 Weeks Blinded Study Treatment|Non-compliance|1
5869122|NCT01980992|20299789|P2|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1
5869123|NCT01980992|20299790|P1|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1
5869124|NCT01980992|20299789|P2|52 Weeks Blinded Study Treatment|Dosing Symptoms|3
5869125|NCT01980992|20299790|P1|52 Weeks Blinded Study Treatment|Dosing Symptoms|0
5869126|NCT01980940|20299815|P8|Overall Study|Protocol Violation|0
5869127|NCT01980940|20299816|P7|Overall Study|Protocol Violation|0
5869128|NCT01980940|20299817|P6|Overall Study|Protocol Violation|2
5869129|NCT01980940|20299818|P5|Overall Study|Protocol Violation|0
5869130|NCT01980940|20299819|P4|Overall Study|Protocol Violation|0
5869131|NCT01980940|20299820|P3|Overall Study|Protocol Violation|0
5869132|NCT01980940|20299821|P2|Overall Study|Protocol Violation|0
5869133|NCT01980940|20299822|P1|Overall Study|Protocol Violation|0
5869134|NCT01980888|20299881|P2|Overall Study|Non-Compliance with Study Drug|2
5869135|NCT01980888|20299882|P1|Overall Study|Non-Compliance with Study Drug|3
5869136|NCT01980888|20299881|P2|Overall Study|Investigator's Discretion|3
5869137|NCT01980888|20299882|P1|Overall Study|Investigator's Discretion|8
5869138|NCT01980888|20299881|P2|Overall Study|Withdrew Consent|6
5869139|NCT01980888|20299882|P1|Overall Study|Withdrew Consent|17
5869140|NCT01980888|20299881|P2|Overall Study|Study Terminated by Sponsor|122
5869141|NCT01980888|20299882|P1|Overall Study|Study Terminated by Sponsor|116
5869142|NCT01980875|20299901|P3|Overall Study|Lost to Follow-up|1
5869143|NCT01980875|20299902|P2|Overall Study|Lost to Follow-up|0
5869144|NCT01980875|20299903|P1|Overall Study|Lost to Follow-up|0
5869145|NCT01980875|20299901|P3|Overall Study|Study Terminated by Sponsor|22
5869146|NCT01980875|20299902|P2|Overall Study|Study Terminated by Sponsor|24
5869147|NCT01980875|20299903|P1|Overall Study|Study Terminated by Sponsor|7
5869148|NCT01980875|20299901|P3|Overall Study|Withdrew Consent|1
5869149|NCT01980875|20299902|P2|Overall Study|Withdrew Consent|1
5869150|NCT01980875|20299903|P1|Overall Study|Withdrew Consent|1
5869151|NCT01980706|20299938|P3|Overall Study|miscellaneous|3
5869152|NCT01980706|20299939|P2|Overall Study|miscellaneous|5
5869153|NCT01980706|20299940|P1|Overall Study|miscellaneous|4
5869154|NCT01980706|20299938|P3|Overall Study|Lost to Follow-up|3
5869155|NCT01980706|20299939|P2|Overall Study|Lost to Follow-up|4
5869156|NCT01980706|20299940|P1|Overall Study|Lost to Follow-up|3
5869157|NCT01980706|20299938|P3|Overall Study|Adverse Event|5
5869158|NCT01980706|20299939|P2|Overall Study|Adverse Event|2
5869159|NCT01980706|20299940|P1|Overall Study|Adverse Event|1
5869160|NCT01980706|20299938|P3|Overall Study|Withdrawal by Subject|2
5869161|NCT01980706|20299939|P2|Overall Study|Withdrawal by Subject|6
5869162|NCT01980706|20299940|P1|Overall Study|Withdrawal by Subject|9
5869163|NCT01980628|20299980|P1|Overall Study|PD, Subj non-Compliant,Study Terminated|42
5869164|NCT01980628|20299980|P1|Overall Study|Withdrawal by Subject|4
5869165|NCT01980628|20299980|P1|Overall Study|Physician Decision|5
5869166|NCT01980628|20299980|P1|Overall Study|Adverse Event|12
5869167|NCT01980095|20300039|P2|Overall Study|Randomized by mistake|0
5869168|NCT01980095|20300040|P1|Overall Study|Randomized by mistake|1
5869169|NCT01980095|20300039|P2|Overall Study|Study drug discontinued|0
5869170|NCT01980095|20300040|P1|Overall Study|Study drug discontinued|1
5869171|NCT01980095|20300039|P2|Overall Study|Safety issue|1
5869172|NCT01980095|20300040|P1|Overall Study|Safety issue|0
5869173|NCT01980095|20300039|P2|Overall Study|Poor compliance|0
5869174|NCT01980095|20300040|P1|Overall Study|Poor compliance|5
5869175|NCT01980095|20300039|P2|Overall Study|Withdrawal by Subject|3
5869176|NCT01980095|20300040|P1|Overall Study|Withdrawal by Subject|2
5869177|NCT01980095|20300039|P2|Overall Study|Lost to Follow-up|7
5869178|NCT01980095|20300040|P1|Overall Study|Lost to Follow-up|6
5869179|NCT01980056|20300051|P3|Overall Study|Death|0
5869180|NCT01980056|20300052|P2|Overall Study|Death|1
5869181|NCT01980056|20300053|P1|Overall Study|Death|1
5869182|NCT01979952|20300067|P2|Overall Study|Other than specified above|0
5869183|NCT01979952|20300068|P1|Overall Study|Other than specified above|1
5869184|NCT01979952|20300067|P2|Overall Study|Withdrawal by Subject|1
5869185|NCT01979952|20300068|P1|Overall Study|Withdrawal by Subject|2
5869186|NCT01979952|20300067|P2|Overall Study|Protocol Violation|0
5869187|NCT01979952|20300068|P1|Overall Study|Protocol Violation|1
5869188|NCT01979952|20300067|P2|Overall Study|Adverse Event|5
5869189|NCT01979952|20300068|P1|Overall Study|Adverse Event|4
5869190|NCT01979835|20300096|P1|Follow-up|Lost to Follow-up|32
5869191|NCT01979835|20300096|P1|Primary Outcome SA Measurment|failed insertion|18
5869192|NCT01979614|20300103|P2|Overall Study|Adverse Event|1
5869193|NCT01979614|20300104|P1|Overall Study|Adverse Event|1
5869194|NCT01979523|20300126|P2|Overall Study|Withdrawal by Subject|0
5869195|NCT01979523|20300127|P1|Overall Study|Withdrawal by Subject|1
5869196|NCT01979185|20300187|P2|Period 2|Other|1
5869197|NCT01979185|20300188|P1|Period 2|Other|0
5869198|NCT01979016|20300236|P2|Overall Study|Adverse Event|1
5869199|NCT01979016|20300237|P1|Overall Study|Adverse Event|0
5869200|NCT01979016|20300236|P2|Overall Study|Withdrawal by Subject|0
5869201|NCT01979016|20300237|P1|Overall Study|Withdrawal by Subject|2
5869202|NCT01978938|20300271|P2|Overall Study|Previously scheduled procedure|1
5869203|NCT01978938|20300272|P1|Overall Study|Previously scheduled procedure|0
5869204|NCT01978938|20300271|P2|Overall Study|Did not meet inclusion criteria|1
5869205|NCT01978938|20300272|P1|Overall Study|Did not meet inclusion criteria|0
5869206|NCT01978938|20300271|P2|Overall Study|Participant noncompliance|1
5869207|NCT01978938|20300272|P1|Overall Study|Participant noncompliance|1
5869208|NCT01978938|20300271|P2|Overall Study|Adverse Event, non-fatal|1
5869209|NCT01978938|20300272|P1|Overall Study|Adverse Event, non-fatal|2
5869210|NCT01978938|20300271|P2|Overall Study|Withdrawal by Subject|4
5869211|NCT01978938|20300272|P1|Overall Study|Withdrawal by Subject|8
5869212|NCT01978938|20300271|P2|Overall Study|Lost to Follow-up|6
5869213|NCT01978938|20300272|P1|Overall Study|Lost to Follow-up|12
5869214|NCT01978912|20300286|P4|Overall Study|Intradiscal Steroid Injection|0
5869215|NCT01978912|20300287|P3|Overall Study|Intradiscal Steroid Injection|0
5869216|NCT01978912|20300288|P2|Overall Study|Intradiscal Steroid Injection|1
5869217|NCT01978912|20300289|P1|Overall Study|Intradiscal Steroid Injection|0
5869218|NCT01978912|20300286|P4|Overall Study|Lumbar Surgery|0
5869219|NCT01978912|20300287|P3|Overall Study|Lumbar Surgery|1
5869220|NCT01978912|20300288|P2|Overall Study|Lumbar Surgery|0
5869221|NCT01978912|20300289|P1|Overall Study|Lumbar Surgery|1
5869222|NCT01978912|20300286|P4|Overall Study|Withdrawal by Subject|2
5869223|NCT01978912|20300287|P3|Overall Study|Withdrawal by Subject|2
5869224|NCT01978912|20300288|P2|Overall Study|Withdrawal by Subject|0
5869225|NCT01978912|20300289|P1|Overall Study|Withdrawal by Subject|1
5869226|NCT01978912|20300286|P4|Overall Study|Lost to Follow-up|1
5869227|NCT01978912|20300287|P3|Overall Study|Lost to Follow-up|0
5869228|NCT01978912|20300288|P2|Overall Study|Lost to Follow-up|1
5869229|NCT01978912|20300289|P1|Overall Study|Lost to Follow-up|1
5869230|NCT01978912|20300286|P4|Overall Study|Adverse Event|0
5869231|NCT01978912|20300287|P3|Overall Study|Adverse Event|0
5869232|NCT01978912|20300288|P2|Overall Study|Adverse Event|1
5869233|NCT01978912|20300289|P1|Overall Study|Adverse Event|0
5869234|NCT01978262|20300482|P1|Overall Study|Lost to Follow-up|2
5869235|NCT01978262|20300482|P1|Overall Study|Withdrawal by Subject|9
5869236|NCT01978236|20300487|P1|Overall Study|Discontinued due to study close|2
5869237|NCT01978184|20300508|P2|Overall Study|Withdrew- toxicities or physical decline|8
5869238|NCT01978184|20300509|P1|Overall Study|Withdrew- toxicities or physical decline|4
5869239|NCT01978184|20300508|P2|Overall Study|Death|0
5869240|NCT01978184|20300509|P1|Overall Study|Death|1
5869241|NCT01978184|20300508|P2|Overall Study|Noncompliance|2
5869242|NCT01978184|20300509|P1|Overall Study|Noncompliance|1
5869243|NCT01978184|20300508|P2|Overall Study|Physician Decision|3
5869244|NCT01978184|20300509|P1|Overall Study|Physician Decision|0
5869245|NCT01978184|20300508|P2|Overall Study|Other than PDA|2
5869246|NCT01978184|20300509|P1|Overall Study|Other than PDA|2
5869247|NCT01978184|20300508|P2|Overall Study|Progressive disease|5
5869248|NCT01978184|20300509|P1|Overall Study|Progressive disease|5
5869249|NCT01978145|20300535|P2|Treatment Period 2|Par. reached defined stopping criteria|5
5869250|NCT01978145|20300536|P1|Treatment Period 2|Par. reached defined stopping criteria|8
5869251|NCT01978145|20300535|P2|Treatment Period 2|Withdrawal by Subject|4
5869252|NCT01978145|20300536|P1|Treatment Period 2|Withdrawal by Subject|7
5869253|NCT01978145|20300535|P2|Treatment Period 2|Lost to Follow-up|1
5869254|NCT01978145|20300536|P1|Treatment Period 2|Lost to Follow-up|1
5869255|NCT01978145|20300535|P2|Treatment Period 2|Protocol Violation|1
5869256|NCT01978145|20300536|P1|Treatment Period 2|Protocol Violation|0
5869257|NCT01978145|20300535|P2|Treatment Period 2|Adverse Event|3
5869258|NCT01978145|20300536|P1|Treatment Period 2|Adverse Event|3
5869259|NCT01978145|20300535|P2|Washout Period 1|Par. reached defined stopping criteria|1
5869260|NCT01978145|20300536|P1|Washout Period 1|Par. reached defined stopping criteria|0
5869261|NCT01978145|20300535|P2|Washout Period 1|Withdrawal by Subject|1
5869262|NCT01978145|20300536|P1|Washout Period 1|Withdrawal by Subject|1
5869263|NCT01978145|20300535|P2|Washout Period 1|Adverse Event|1
5869264|NCT01978145|20300536|P1|Washout Period 1|Adverse Event|0
5869265|NCT01978145|20300535|P2|Treatment Period 1|Par. reached defined stopping criteria|3
5869266|NCT01978145|20300536|P1|Treatment Period 1|Par. reached defined stopping criteria|2
5869267|NCT01978145|20300535|P2|Treatment Period 1|Withdrawal by Subject|4
5869268|NCT01978145|20300536|P1|Treatment Period 1|Withdrawal by Subject|5
5869269|NCT01978145|20300535|P2|Treatment Period 1|Physician Decision|0
5869270|NCT01978145|20300536|P1|Treatment Period 1|Physician Decision|1
5869271|NCT01978145|20300535|P2|Treatment Period 1|Adverse Event|9
5869272|NCT01978145|20300536|P1|Treatment Period 1|Adverse Event|1
5869273|NCT01978119|20300552|P2|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2
5869274|NCT01978119|20300553|P1|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
5869275|NCT01978119|20300552|P2|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
5869276|NCT01978119|20300553|P1|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1
5869277|NCT01978119|20300552|P2|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|0
5869278|NCT01978119|20300553|P1|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|1
5869279|NCT01978093|20300579|P2|Overall Study|N/A for vaccine administration|1
5869280|NCT01978093|20300580|P1|Overall Study|N/A for vaccine administration|0
5869281|NCT01978093|20300579|P2|Overall Study|Child was in care of grandmother|1
5869282|NCT01978093|20300580|P1|Overall Study|Child was in care of grandmother|0
5869283|NCT01978093|20300579|P2|Overall Study|Mother lost custody of child|1
5869284|NCT01978093|20300580|P1|Overall Study|Mother lost custody of child|0
5869285|NCT01978093|20300579|P2|Overall Study|Lost kaiser health plan unable to contac|0
5869286|NCT01978093|20300580|P1|Overall Study|Lost kaiser health plan unable to contac|1
5869287|NCT01978093|20300579|P2|Overall Study|Loss of kaiser coverage|10
5869288|NCT01978093|20300580|P1|Overall Study|Loss of kaiser coverage|4
5869289|NCT01978093|20300579|P2|Overall Study|Migrated/moved from study area|13
5869290|NCT01978093|20300580|P1|Overall Study|Migrated/moved from study area|11
5869291|NCT01978093|20300579|P2|Overall Study|Lost to Follow-up|15
5869292|NCT01978093|20300580|P1|Overall Study|Lost to Follow-up|11
5869293|NCT01978093|20300579|P2|Overall Study|Withdrawal by Subject|25
5869294|NCT01978093|20300580|P1|Overall Study|Withdrawal by Subject|29
5869295|NCT01978093|20300579|P2|Overall Study|Protocol Violation|2
5869296|NCT01978093|20300580|P1|Overall Study|Protocol Violation|8
5869297|NCT01978093|20300579|P2|Overall Study|Adverse Event|5
5869298|NCT01978093|20300580|P1|Overall Study|Adverse Event|0
5869299|NCT01978093|20300579|P2|Overall Study|Death|0
5869300|NCT01978093|20300580|P1|Overall Study|Death|1
5869301|NCT01977937|20300624|P2|Overall Study|Physician Decision|1
5869302|NCT01977937|20300625|P1|Overall Study|Physician Decision|0
5869303|NCT01977937|20300624|P2|Overall Study|Adverse Event|0
5869304|NCT01977937|20300625|P1|Overall Study|Adverse Event|1
5869305|NCT01977937|20300624|P2|Overall Study|Withdrawal by Subject|1
5869306|NCT01977937|20300625|P1|Overall Study|Withdrawal by Subject|2
5869307|NCT01977846|20300635|P2|Total Study - Prospective|Protocol Violation|1
5869308|NCT01977846|20300636|P1|Total Study - Prospective|Protocol Violation|0
5869309|NCT01977846|20300635|P2|Total Study - Prospective|No show|1
5869310|NCT01977846|20300636|P1|Total Study - Prospective|No show|0
5869311|NCT01977846|20300635|P2|Total Study - Prospective|Not available at time of visit|5
5869312|NCT01977846|20300636|P1|Total Study - Prospective|Not available at time of visit|0
5869313|NCT01977846|20300635|P2|Total Study - Prospective|Withdrawal by Subject|13
5869314|NCT01977846|20300636|P1|Total Study - Prospective|Withdrawal by Subject|0
5869315|NCT01977846|20300635|P2|Total Study - Prospective|Lost to Follow-up|8
5869316|NCT01977846|20300636|P1|Total Study - Prospective|Lost to Follow-up|0
5869317|NCT01977846|20300635|P2|Total Study - Prospective|Death|1
5869318|NCT01977846|20300636|P1|Total Study - Prospective|Death|0
5869319|NCT01977820|20300654|P2|Overall Study|Sponsor terminated the study|1
5869320|NCT01977820|20300655|P1|Overall Study|Sponsor terminated the study|1
5869321|NCT01977794|20300663|P2|Overall Study|Other|1
5869322|NCT01977794|20300664|P1|Overall Study|Other|0
5869323|NCT01977794|20300663|P2|Overall Study|Withdrew consent|1
5869324|NCT01977794|20300664|P1|Overall Study|Withdrew consent|2
5869325|NCT01977794|20300663|P2|Overall Study|Death|1
5869326|NCT01977794|20300664|P1|Overall Study|Death|1
5869327|NCT01977794|20300663|P2|Overall Study|Protocol Violation|0
5869328|NCT01977794|20300664|P1|Overall Study|Protocol Violation|1
5869329|NCT01977794|20300663|P2|Overall Study|Lost to Follow-up|1
5869330|NCT01977794|20300664|P1|Overall Study|Lost to Follow-up|2
5869331|NCT01977794|20300663|P2|Overall Study|Adverse Event|2
5869332|NCT01977794|20300664|P1|Overall Study|Adverse Event|2
5869333|NCT01977729|20300699|P1|Overall Study|Study terminated|1
5869334|NCT01977690|20300711|P2|Overall Study|Withdrawal by Subject|4
5869335|NCT01977690|20300712|P1|Overall Study|Withdrawal by Subject|0
5869336|NCT01977677|20300721|P3|Overall Study|Unrelated Adverse Event|1
5869337|NCT01977677|20300722|P2|Overall Study|Unrelated Adverse Event|0
5869338|NCT01977677|20300723|P1|Overall Study|Unrelated Adverse Event|0
5869339|NCT01977651|20300734|P1|Post 1 Year Extension Period|Miscellaneous|49
5869340|NCT01977651|20300734|P1|Post 1 Year Extension Period|Physician Decision|4
5869341|NCT01977651|20300734|P1|Post 1 Year Extension Period|Withdrawal by Subject|13
5869342|NCT01977651|20300734|P1|Post 1 Year Extension Period|Progressive Disease|60
5869343|NCT01977651|20300734|P1|Post 1 Year Extension Period|Death|13
5869344|NCT01977651|20300734|P1|Post 1 Year Extension Period|Adverse Event|5
5869345|NCT01977651|20300734|P1|1 Year Extension Period|Miscellaneous|1
5869346|NCT01977651|20300734|P1|1 Year Extension Period|Physician Decision|6
5869347|NCT01977651|20300734|P1|1 Year Extension Period|Withdrawal by Subject|11
5869348|NCT01977651|20300734|P1|1 Year Extension Period|Progressive Disease|86
5869349|NCT01977651|20300734|P1|1 Year Extension Period|Lost to Follow-up|2
5869350|NCT01977651|20300734|P1|1 Year Extension Period|Death|10
5869351|NCT01977651|20300734|P1|1 Year Extension Period|Adverse Event|14
5869352|NCT01977651|20300734|P1|4 Month Treatment Period|Physician Decision|4
5869353|NCT01977651|20300734|P1|4 Month Treatment Period|Withdrawal by Subject|17
5869354|NCT01977651|20300734|P1|4 Month Treatment Period|Progressive Disease|43
5869355|NCT01977651|20300734|P1|4 Month Treatment Period|Death|3
5869356|NCT01977651|20300734|P1|4 Month Treatment Period|Adverse Event|34
5869357|NCT01977625|20300738|P2|Second Intervention (4 Weeks)|Withdrawal by Subject|0
5869358|NCT01977625|20300739|P1|Second Intervention (4 Weeks)|Withdrawal by Subject|1
5869359|NCT01977625|20300738|P2|First Intervention (4 Weeks)|Withdrawal by Subject|0
5869360|NCT01977625|20300739|P1|First Intervention (4 Weeks)|Withdrawal by Subject|3
5869361|NCT01977612|20300749|P2|Overall Study|Lost to Follow-up|1
5869362|NCT01977612|20300750|P1|Overall Study|Lost to Follow-up|1
5869363|NCT01977573|20300772|P4|Overall Study|Withdrawal by Subject|1
5869364|NCT01977573|20300773|P3|Overall Study|Withdrawal by Subject|1
5869365|NCT01977573|20300774|P2|Overall Study|Withdrawal by Subject|1
5869366|NCT01977573|20300775|P1|Overall Study|Withdrawal by Subject|6
5869367|NCT01977573|20300772|P4|Overall Study|Reached Defined Stopping Criteria|0
5869368|NCT01977573|20300773|P3|Overall Study|Reached Defined Stopping Criteria|1
5869369|NCT01977573|20300774|P2|Overall Study|Reached Defined Stopping Criteria|1
5869370|NCT01977573|20300775|P1|Overall Study|Reached Defined Stopping Criteria|2
5869371|NCT01977573|20300772|P4|Overall Study|Protocol Violation|0
5869372|NCT01977573|20300773|P3|Overall Study|Protocol Violation|0
5869373|NCT01977573|20300774|P2|Overall Study|Protocol Violation|1
5869374|NCT01977573|20300775|P1|Overall Study|Protocol Violation|3
5869375|NCT01977573|20300772|P4|Overall Study|Physician Decision|0
5869376|NCT01977573|20300773|P3|Overall Study|Physician Decision|0
5869377|NCT01977573|20300774|P2|Overall Study|Physician Decision|0
5869378|NCT01977573|20300775|P1|Overall Study|Physician Decision|1
5869379|NCT01977573|20300772|P4|Overall Study|Lost to Follow-up|1
5869380|NCT01977573|20300773|P3|Overall Study|Lost to Follow-up|0
5869381|NCT01977573|20300774|P2|Overall Study|Lost to Follow-up|0
5869382|NCT01977573|20300775|P1|Overall Study|Lost to Follow-up|1
5869383|NCT01977573|20300772|P4|Overall Study|Adverse Event|1
5869384|NCT01977573|20300773|P3|Overall Study|Adverse Event|2
5869385|NCT01977573|20300774|P2|Overall Study|Adverse Event|0
5869386|NCT01977573|20300775|P1|Overall Study|Adverse Event|7
5869387|NCT01977482|20300889|P6|Overall Study|Withdrawal by Subject|5
5869388|NCT01977482|20300890|P5|Overall Study|Withdrawal by Subject|1
5869389|NCT01977482|20300891|P4|Overall Study|Withdrawal by Subject|3
5869390|NCT01977482|20300892|P3|Overall Study|Withdrawal by Subject|1
5869391|NCT01977482|20300893|P2|Overall Study|Withdrawal by Subject|4
5869392|NCT01977482|20300894|P1|Overall Study|Withdrawal by Subject|2
5869393|NCT01977482|20300889|P6|Overall Study|Other-Protocol-defined Stopping Criteria|0
5869394|NCT01977482|20300890|P5|Overall Study|Other-Protocol-defined Stopping Criteria|0
5869395|NCT01977482|20300891|P4|Overall Study|Other-Protocol-defined Stopping Criteria|1
5869396|NCT01977482|20300892|P3|Overall Study|Other-Protocol-defined Stopping Criteria|2
5869397|NCT01977482|20300893|P2|Overall Study|Other-Protocol-defined Stopping Criteria|3
5869398|NCT01977482|20300894|P1|Overall Study|Other-Protocol-defined Stopping Criteria|0
5869399|NCT01977482|20300889|P6|Overall Study|Protocol Violation|0
5869400|NCT01977482|20300890|P5|Overall Study|Protocol Violation|0
5869401|NCT01977482|20300891|P4|Overall Study|Protocol Violation|0
5869402|NCT01977482|20300892|P3|Overall Study|Protocol Violation|1
5869403|NCT01977482|20300893|P2|Overall Study|Protocol Violation|0
5869404|NCT01977482|20300894|P1|Overall Study|Protocol Violation|0
5869405|NCT01977482|20300889|P6|Overall Study|Physician Decision|0
5869406|NCT01977482|20300890|P5|Overall Study|Physician Decision|0
5869407|NCT01977482|20300891|P4|Overall Study|Physician Decision|0
5869408|NCT01977482|20300892|P3|Overall Study|Physician Decision|0
5869409|NCT01977482|20300893|P2|Overall Study|Physician Decision|1
5869410|NCT01977482|20300894|P1|Overall Study|Physician Decision|0
5869411|NCT01977482|20300889|P6|Overall Study|Lost to Follow-up|0
5869412|NCT01977482|20300890|P5|Overall Study|Lost to Follow-up|0
5869413|NCT01977482|20300891|P4|Overall Study|Lost to Follow-up|0
5869414|NCT01977482|20300892|P3|Overall Study|Lost to Follow-up|0
5869415|NCT01977482|20300893|P2|Overall Study|Lost to Follow-up|0
5869416|NCT01977482|20300894|P1|Overall Study|Lost to Follow-up|1
5869417|NCT01977482|20300889|P6|Overall Study|Adverse Event|0
5869418|NCT01977482|20300890|P5|Overall Study|Adverse Event|2
5869419|NCT01977482|20300891|P4|Overall Study|Adverse Event|0
5869420|NCT01977482|20300892|P3|Overall Study|Adverse Event|1
5869421|NCT01977482|20300893|P2|Overall Study|Adverse Event|1
5869422|NCT01977482|20300894|P1|Overall Study|Adverse Event|0
5869423|NCT01977456|20301009|P1|Overall Study|Death|5
5869424|NCT01977352|20301018|P2|Overall Study|Lost to Follow-up|2
5869425|NCT01977352|20301019|P1|Overall Study|Lost to Follow-up|1
5869426|NCT01977222|20301037|P1|Overall Study|Withdrawal by Subject|1
5869427|NCT01977092|20301050|P2|Overall Study|In prison|11
5869428|NCT01977092|20301051|P1|Overall Study|In prison|3
5869429|NCT01977092|20301050|P2|Overall Study|Withdrawal by Subject|1
5869430|NCT01977092|20301051|P1|Overall Study|Withdrawal by Subject|2
5869431|NCT01977092|20301050|P2|Overall Study|Lost to Follow-up|14
5869432|NCT01977092|20301051|P1|Overall Study|Lost to Follow-up|23
5869433|NCT01977092|20301050|P2|Overall Study|Death|4
5869434|NCT01977092|20301051|P1|Overall Study|Death|3
5869435|NCT01977040|20301061|P1|Overall Study|Vasa previa not confirmed|2
5869436|NCT01976845|20301115|P3|Overall Study|Physician Decision|3
5869437|NCT01976845|20301116|P2|Overall Study|Physician Decision|8
5869438|NCT01976845|20301117|P1|Overall Study|Physician Decision|8
5869439|NCT01976806|20301142|P2|Overall Study|Withdrawal by Subject|1
5869440|NCT01976806|20301143|P1|Overall Study|Withdrawal by Subject|1
5869441|NCT01976806|20301142|P2|Overall Study|Adverse Event|1
5869442|NCT01976806|20301143|P1|Overall Study|Adverse Event|1
5869443|NCT01976806|20301142|P2|Overall Study|Lost to Follow-up|4
5869444|NCT01976806|20301143|P1|Overall Study|Lost to Follow-up|1
5869445|NCT01976741|20301181|P10|Overall Study|Adverse Event|4
5869446|NCT01976741|20301182|P9|Overall Study|Adverse Event|1
5869447|NCT01976741|20301183|P8|Overall Study|Adverse Event|8
5869448|NCT01976741|20301184|P7|Overall Study|Adverse Event|3
5869449|NCT01976741|20301185|P6|Overall Study|Adverse Event|0
5869450|NCT01976741|20301186|P5|Overall Study|Adverse Event|0
5869451|NCT01976741|20301187|P4|Overall Study|Adverse Event|0
5869452|NCT01976741|20301188|P3|Overall Study|Adverse Event|2
5869453|NCT01976741|20301189|P2|Overall Study|Adverse Event|0
5869454|NCT01976741|20301190|P1|Overall Study|Adverse Event|0
5869455|NCT01976741|20301181|P10|Overall Study|Withdrawal by Subject|0
5869456|NCT01976741|20301182|P9|Overall Study|Withdrawal by Subject|0
5869457|NCT01976741|20301183|P8|Overall Study|Withdrawal by Subject|4
5869458|NCT01976741|20301184|P7|Overall Study|Withdrawal by Subject|1
5869459|NCT01976741|20301185|P6|Overall Study|Withdrawal by Subject|0
5869460|NCT01976741|20301186|P5|Overall Study|Withdrawal by Subject|0
5869461|NCT01976741|20301187|P4|Overall Study|Withdrawal by Subject|1
5869462|NCT01976741|20301188|P3|Overall Study|Withdrawal by Subject|1
5869463|NCT01976741|20301189|P2|Overall Study|Withdrawal by Subject|0
5869464|NCT01976741|20301190|P1|Overall Study|Withdrawal by Subject|1
5869465|NCT01976663|20301428|P1|Overall Study|Lost to Follow-up|3
5869466|NCT01976663|20301428|P1|Overall Study|Adverse Event|2
5869467|NCT01976663|20301428|P1|Overall Study|Screen Failure|3
5869468|NCT01976663|20301428|P1|Overall Study|Withdrawal by Subject|4
5869469|NCT01976663|20301428|P1|Overall Study|Personal Reasons|6
5869470|NCT01976663|20301428|P1|Overall Study|Completed 18 mos but no repeat treatment|24
5869471|NCT01976624|20301447|P1|Overall Study|Participants age less than 19 years|12
5869472|NCT01976624|20301447|P1|Overall Study|Participants contraindicated|2
5869473|NCT01976507|20301475|P1|Overall Study|ablation not done, drug not given|1
5869474|NCT01976507|20301475|P1|Overall Study|Adverse Event|6
5869475|NCT01976364|20301506|P3|Sub-study (12 Months)|Adverse Event|3
5869476|NCT01976364|20301507|P2|Sub-study (12 Months)|Adverse Event|4
5869477|NCT01976364|20301508|P1|Sub-study (12 Months)|Adverse Event|0
5869478|NCT01976364|20301506|P3|Sub-study (12 Months)|Protocol Violation|1
5869479|NCT01976364|20301507|P2|Sub-study (12 Months)|Protocol Violation|1
5869480|NCT01976364|20301508|P1|Sub-study (12 Months)|Protocol Violation|0
5869481|NCT01976364|20301506|P3|Sub-study (12 Months)|Withdrawal by Subject|1
5869482|NCT01976364|20301507|P2|Sub-study (12 Months)|Withdrawal by Subject|0
5869483|NCT01976364|20301508|P1|Sub-study (12 Months)|Withdrawal by Subject|0
5869484|NCT01976364|20301506|P3|Sub-study (12 Months)|Lost to Follow-up|0
5869485|NCT01976364|20301507|P2|Sub-study (12 Months)|Lost to Follow-up|1
5869486|NCT01976364|20301508|P1|Sub-study (12 Months)|Lost to Follow-up|0
5869487|NCT01976364|20301506|P3|Main Study (36 Months)|Death|0
5869488|NCT01976364|20301507|P2|Main Study (36 Months)|Death|0
5869489|NCT01976364|20301508|P1|Main Study (36 Months)|Death|5
5869490|NCT01976364|20301506|P3|Main Study (36 Months)|Withdrawal by Subject|0
5869491|NCT01976364|20301507|P2|Main Study (36 Months)|Withdrawal by Subject|0
5869492|NCT01976364|20301508|P1|Main Study (36 Months)|Withdrawal by Subject|69
5869493|NCT01976364|20301506|P3|Main Study (36 Months)|Protocol Violation|0
5869494|NCT01976364|20301507|P2|Main Study (36 Months)|Protocol Violation|0
5869495|NCT01976364|20301508|P1|Main Study (36 Months)|Protocol Violation|13
5869496|NCT01976364|20301506|P3|Main Study (36 Months)|Lack of Efficacy|0
5869497|NCT01976364|20301507|P2|Main Study (36 Months)|Lack of Efficacy|0
5869498|NCT01976364|20301508|P1|Main Study (36 Months)|Lack of Efficacy|40
5869499|NCT01976364|20301506|P3|Main Study (36 Months)|Lost to Follow-up|0
5869500|NCT01976364|20301507|P2|Main Study (36 Months)|Lost to Follow-up|0
5869501|NCT01976364|20301508|P1|Main Study (36 Months)|Lost to Follow-up|10
5869502|NCT01976364|20301506|P3|Main Study (36 Months)|Medication error|0
5869503|NCT01976364|20301507|P2|Main Study (36 Months)|Medication error|0
5869504|NCT01976364|20301508|P1|Main Study (36 Months)|Medication error|1
5869505|NCT01976364|20301506|P3|Main Study (36 Months)|No longer met eligibility criteria|0
5869506|NCT01976364|20301507|P2|Main Study (36 Months)|No longer met eligibility criteria|0
5869507|NCT01976364|20301508|P1|Main Study (36 Months)|No longer met eligibility criteria|2
5869508|NCT01976364|20301506|P3|Main Study (36 Months)|Other|0
5869509|NCT01976364|20301507|P2|Main Study (36 Months)|Other|0
5869510|NCT01976364|20301508|P1|Main Study (36 Months)|Other|13
5869511|NCT01976364|20301506|P3|Main Study (36 Months)|Withdrawn due to pregnancy|0
5869512|NCT01976364|20301507|P2|Main Study (36 Months)|Withdrawn due to pregnancy|0
5869513|NCT01976364|20301508|P1|Main Study (36 Months)|Withdrawn due to pregnancy|5
5869514|NCT01976364|20301506|P3|Main Study (36 Months)|Adverse Event|0
5869515|NCT01976364|20301507|P2|Main Study (36 Months)|Adverse Event|0
5869516|NCT01976364|20301508|P1|Main Study (36 Months)|Adverse Event|63
5869517|NCT01976338|20301628|P2|Overall Study|Adverse Event|1
5869518|NCT01976338|20301629|P1|Overall Study|Adverse Event|5
5869519|NCT01976338|20301628|P2|Overall Study|Withdrawal by Subject|2
5869520|NCT01976338|20301629|P1|Overall Study|Withdrawal by Subject|5
5869521|NCT01976338|20301628|P2|Overall Study|Lost to Follow-up|0
5869522|NCT01976338|20301629|P1|Overall Study|Lost to Follow-up|3
5869523|NCT01976338|20301628|P2|Overall Study|Physician Decision|1
5869524|NCT01976338|20301629|P1|Overall Study|Physician Decision|0
5869525|NCT01976312|20301656|P2|Overall Study|Protocol Violation|0
5869526|NCT01976312|20301657|P1|Overall Study|Protocol Violation|2
5869527|NCT01976312|20301656|P2|Overall Study|Adverse Event|6
5869528|NCT01976312|20301657|P1|Overall Study|Adverse Event|6
5869529|NCT01976312|20301656|P2|Overall Study|Withdrawal by Subject|2
5869530|NCT01976312|20301657|P1|Overall Study|Withdrawal by Subject|7
5869531|NCT01976312|20301656|P2|Overall Study|Lost to Follow-up|0
5869532|NCT01976312|20301657|P1|Overall Study|Lost to Follow-up|2
5869533|NCT01976312|20301656|P2|Overall Study|Pregnancy|1
5869534|NCT01976312|20301657|P1|Overall Study|Pregnancy|0
5869535|NCT01976299|20301678|P2|Overall Study|See clarification above in comments|2
5869536|NCT01976299|20301679|P1|Overall Study|See clarification above in comments|9
5869537|NCT01976299|20301678|P2|Overall Study|Lost to Follow-up|1
5869538|NCT01976299|20301679|P1|Overall Study|Lost to Follow-up|7
5869539|NCT01976299|20301678|P2|Overall Study|Death|2
5869540|NCT01976299|20301679|P1|Overall Study|Death|4
5869541|NCT01976299|20301678|P2|Overall Study|Withdrawal by Subject|1
5869542|NCT01976299|20301679|P1|Overall Study|Withdrawal by Subject|3
5869543|NCT01976104|20301706|P4|Overall Study|Other|0
5869544|NCT01976104|20301707|P3|Overall Study|Other|0
5869545|NCT01976104|20301708|P2|Overall Study|Other|1
5869546|NCT01976104|20301709|P1|Overall Study|Other|0
5869547|NCT01976104|20301706|P4|Overall Study|Withdrawal by Subject|1
5869548|NCT01976104|20301707|P3|Overall Study|Withdrawal by Subject|0
5869549|NCT01976104|20301708|P2|Overall Study|Withdrawal by Subject|0
5869550|NCT01976104|20301709|P1|Overall Study|Withdrawal by Subject|3
5869551|NCT01976104|20301706|P4|Overall Study|Subject Choice|1
5869552|NCT01976104|20301707|P3|Overall Study|Subject Choice|0
5869553|NCT01976104|20301708|P2|Overall Study|Subject Choice|1
5869554|NCT01976104|20301709|P1|Overall Study|Subject Choice|0
5869555|NCT01976104|20301706|P4|Overall Study|Lost to Follow-up|1
5869556|NCT01976104|20301707|P3|Overall Study|Lost to Follow-up|1
5869557|NCT01976104|20301708|P2|Overall Study|Lost to Follow-up|0
5869558|NCT01976104|20301709|P1|Overall Study|Lost to Follow-up|3
5869559|NCT01976104|20301706|P4|Overall Study|Adverse Event|0
5869560|NCT01976104|20301707|P3|Overall Study|Adverse Event|1
5869561|NCT01976104|20301708|P2|Overall Study|Adverse Event|0
5869562|NCT01976104|20301709|P1|Overall Study|Adverse Event|0
5869563|NCT01975948|20301743|P4|Overall Study|Withdrawal by Subject|6
5869564|NCT01975948|20301744|P3|Overall Study|Withdrawal by Subject|7
5869565|NCT01975948|20301745|P2|Overall Study|Withdrawal by Subject|21
5869566|NCT01975948|20301746|P1|Overall Study|Withdrawal by Subject|17
5869567|NCT01975831|20301822|P9|Overall Study|Unable to Treat Within Protocol Windows|1
5869568|NCT01975831|20301823|P8|Overall Study|Unable to Treat Within Protocol Windows|0
5869569|NCT01975831|20301824|P7|Overall Study|Unable to Treat Within Protocol Windows|1
5869570|NCT01975831|20301825|P6|Overall Study|Unable to Treat Within Protocol Windows|0
5869571|NCT01975831|20301826|P5|Overall Study|Unable to Treat Within Protocol Windows|0
5869572|NCT01975831|20301827|P4|Overall Study|Unable to Treat Within Protocol Windows|0
5869573|NCT01975831|20301828|P3|Overall Study|Unable to Treat Within Protocol Windows|0
5869574|NCT01975831|20301829|P2|Overall Study|Unable to Treat Within Protocol Windows|0
5869575|NCT01975831|20301830|P1|Overall Study|Unable to Treat Within Protocol Windows|0
5869576|NCT01975831|20301822|P9|Overall Study|Entered Hospice|0
5869577|NCT01975831|20301823|P8|Overall Study|Entered Hospice|0
5869578|NCT01975831|20301824|P7|Overall Study|Entered Hospice|0
5869579|NCT01975831|20301825|P6|Overall Study|Entered Hospice|1
5869580|NCT01975831|20301826|P5|Overall Study|Entered Hospice|0
5869581|NCT01975831|20301827|P4|Overall Study|Entered Hospice|0
5869582|NCT01975831|20301828|P3|Overall Study|Entered Hospice|0
5869583|NCT01975831|20301829|P2|Overall Study|Entered Hospice|0
5869584|NCT01975831|20301830|P1|Overall Study|Entered Hospice|0
5869585|NCT01975831|20301822|P9|Overall Study|Initiation of Subsequent Therapy|0
5869586|NCT01975831|20301823|P8|Overall Study|Initiation of Subsequent Therapy|2
5869587|NCT01975831|20301824|P7|Overall Study|Initiation of Subsequent Therapy|0
5869588|NCT01975831|20301825|P6|Overall Study|Initiation of Subsequent Therapy|1
5869589|NCT01975831|20301826|P5|Overall Study|Initiation of Subsequent Therapy|0
5869590|NCT01975831|20301827|P4|Overall Study|Initiation of Subsequent Therapy|0
5869591|NCT01975831|20301828|P3|Overall Study|Initiation of Subsequent Therapy|0
5869592|NCT01975831|20301829|P2|Overall Study|Initiation of Subsequent Therapy|0
5869593|NCT01975831|20301830|P1|Overall Study|Initiation of Subsequent Therapy|0
5869594|NCT01975831|20301822|P9|Overall Study|Physician Decision|0
5869595|NCT01975831|20301823|P8|Overall Study|Physician Decision|1
5869596|NCT01975831|20301824|P7|Overall Study|Physician Decision|0
5869597|NCT01975831|20301825|P6|Overall Study|Physician Decision|1
5869598|NCT01975831|20301826|P5|Overall Study|Physician Decision|0
5869599|NCT01975831|20301827|P4|Overall Study|Physician Decision|0
5869600|NCT01975831|20301828|P3|Overall Study|Physician Decision|0
5869601|NCT01975831|20301829|P2|Overall Study|Physician Decision|0
5869602|NCT01975831|20301830|P1|Overall Study|Physician Decision|0
5869603|NCT01975831|20301822|P9|Overall Study|Withdrawal by Subject|0
5869604|NCT01975831|20301823|P8|Overall Study|Withdrawal by Subject|0
5869605|NCT01975831|20301824|P7|Overall Study|Withdrawal by Subject|1
5869606|NCT01975831|20301825|P6|Overall Study|Withdrawal by Subject|1
5869607|NCT01975831|20301826|P5|Overall Study|Withdrawal by Subject|3
5869608|NCT01975831|20301827|P4|Overall Study|Withdrawal by Subject|0
5869609|NCT01975831|20301828|P3|Overall Study|Withdrawal by Subject|0
5869610|NCT01975831|20301829|P2|Overall Study|Withdrawal by Subject|3
5869611|NCT01975831|20301830|P1|Overall Study|Withdrawal by Subject|0
5869612|NCT01975831|20301822|P9|Overall Study|Progressive Disease|10
5869613|NCT01975831|20301823|P8|Overall Study|Progressive Disease|8
5869614|NCT01975831|20301824|P7|Overall Study|Progressive Disease|10
5869615|NCT01975831|20301825|P6|Overall Study|Progressive Disease|9
5869616|NCT01975831|20301826|P5|Overall Study|Progressive Disease|13
5869617|NCT01975831|20301827|P4|Overall Study|Progressive Disease|4
5869618|NCT01975831|20301828|P3|Overall Study|Progressive Disease|2
5869619|NCT01975831|20301829|P2|Overall Study|Progressive Disease|3
5869620|NCT01975831|20301830|P1|Overall Study|Progressive Disease|1
5869621|NCT01975831|20301822|P9|Overall Study|Death|0
5869622|NCT01975831|20301823|P8|Overall Study|Death|0
5869623|NCT01975831|20301824|P7|Overall Study|Death|1
5869624|NCT01975831|20301825|P6|Overall Study|Death|0
5869625|NCT01975831|20301826|P5|Overall Study|Death|1
5869626|NCT01975831|20301827|P4|Overall Study|Death|0
5869627|NCT01975831|20301828|P3|Overall Study|Death|0
5869628|NCT01975831|20301829|P2|Overall Study|Death|1
5869629|NCT01975831|20301830|P1|Overall Study|Death|1
5869630|NCT01975831|20301822|P9|Overall Study|Adverse Event|1
5869631|NCT01975831|20301823|P8|Overall Study|Adverse Event|4
5869632|NCT01975831|20301824|P7|Overall Study|Adverse Event|3
5869633|NCT01975831|20301825|P6|Overall Study|Adverse Event|1
5869634|NCT01975831|20301826|P5|Overall Study|Adverse Event|1
5869635|NCT01975831|20301827|P4|Overall Study|Adverse Event|0
5869636|NCT01975831|20301828|P3|Overall Study|Adverse Event|2
5869637|NCT01975831|20301829|P2|Overall Study|Adverse Event|2
5869638|NCT01975831|20301830|P1|Overall Study|Adverse Event|1
5869639|NCT01975701|20301895|P1|Overall Study|Physician Decision|1
5869640|NCT01975701|20301895|P1|Overall Study|Death|23
5869641|NCT01975701|20301895|P1|Overall Study|Lost to Follow-up|1
5869642|NCT01975675|20301906|P4|Overall Study|Death|0
5869643|NCT01975675|20301907|P3|Overall Study|Death|0
5869644|NCT01975675|20301908|P2|Overall Study|Death|1
5869645|NCT01975675|20301909|P1|Overall Study|Death|0
5869646|NCT01975389|20301960|P2|Overall Study|Randomized, not treated|5
5869647|NCT01975389|20301961|P1|Overall Study|Randomized, not treated|4
5869648|NCT01975389|20301960|P2|Overall Study|Other|9
5869649|NCT01975389|20301961|P1|Overall Study|Other|6
5869650|NCT01975389|20301960|P2|Overall Study|Withdrawal by Subject|76
5869651|NCT01975389|20301961|P1|Overall Study|Withdrawal by Subject|90
5869652|NCT01975389|20301960|P2|Overall Study|Lost to Follow-up|86
5869653|NCT01975389|20301961|P1|Overall Study|Lost to Follow-up|81
5869654|NCT01975389|20301960|P2|Overall Study|Death|54
5869655|NCT01975389|20301961|P1|Overall Study|Death|61
5869656|NCT01975389|20301960|P2|Overall Study|Adverse Event|6
5869657|NCT01975389|20301961|P1|Overall Study|Adverse Event|10
5869658|NCT01975376|20302021|P2|Overall Study|Randomized, Not Treated|8
5869659|NCT01975376|20302022|P1|Overall Study|Randomized, Not Treated|16
5869660|NCT01975376|20302021|P2|Overall Study|Other|4
5869661|NCT01975376|20302022|P1|Overall Study|Other|2
5869662|NCT01975376|20302021|P2|Overall Study|Withdrew consent|62
5869663|NCT01975376|20302022|P1|Overall Study|Withdrew consent|68
5869664|NCT01975376|20302021|P2|Overall Study|Lost to Follow-up|66
5869665|NCT01975376|20302022|P1|Overall Study|Lost to Follow-up|70
5869666|NCT01975376|20302021|P2|Overall Study|Death|72
5869667|NCT01975376|20302022|P1|Overall Study|Death|65
5869668|NCT01975376|20302021|P2|Overall Study|Adverse Event|5
5869669|NCT01975376|20302022|P1|Overall Study|Adverse Event|5
5869670|NCT01975285|20302082|P2|Overall Study|Failed Block and follow up|2
5869671|NCT01975285|20302083|P1|Overall Study|Failed Block and follow up|2
5869672|NCT01975246|20302099|P2|Overall Study|Other than stated|1
5869673|NCT01975246|20302100|P1|Overall Study|Other than stated|0
5869674|NCT01975246|20302099|P2|Overall Study|Protocol Violation|0
5869675|NCT01975246|20302100|P1|Overall Study|Protocol Violation|1
5869676|NCT01975246|20302099|P2|Overall Study|Lack of Efficacy|0
5869677|NCT01975246|20302100|P1|Overall Study|Lack of Efficacy|1
5869678|NCT01975246|20302099|P2|Overall Study|Adverse Event|1
5869679|NCT01975246|20302100|P1|Overall Study|Adverse Event|2
5869680|NCT01975220|20302113|P6|Test Period 1|Not treated|0
5869681|NCT01975220|20302114|P5|Test Period 1|Not treated|0
5869682|NCT01975220|20302115|P4|Test Period 1|Not treated|0
5869683|NCT01975220|20302116|P3|Test Period 1|Not treated|0
5869684|NCT01975220|20302117|P2|Test Period 1|Not treated|1
5869685|NCT01975220|20302118|P1|Test Period 1|Not treated|0
5869686|NCT01974895|20302174|P2|Overall Study|Other (Reason unknown)|8
5869687|NCT01974895|20302175|P1|Overall Study|Other (Reason unknown)|9
5869688|NCT01974895|20302174|P2|Overall Study|Other (Missed Visit)|0
5869689|NCT01974895|20302175|P1|Overall Study|Other (Missed Visit)|1
5869690|NCT01974895|20302174|P2|Overall Study|Withdrawal by Subject|1
5869691|NCT01974895|20302175|P1|Overall Study|Withdrawal by Subject|0
5869692|NCT01974895|20302174|P2|Overall Study|Lost to Follow-up|6
5869693|NCT01974895|20302175|P1|Overall Study|Lost to Follow-up|4
5869694|NCT01974895|20302174|P2|Overall Study|Protocol Violation|0
5869695|NCT01974895|20302175|P1|Overall Study|Protocol Violation|1
5869696|NCT01974817|20302205|P1|Overall Study|Protocol Violation|2
5869697|NCT01974817|20302205|P1|Overall Study|Lost to Follow-up|2
5869698|NCT01974817|20302205|P1|Overall Study|Death|4
5869699|NCT01974752|20302211|P2|Overall Study|Other Eligibility Criteria|1
5869700|NCT01974752|20302212|P1|Overall Study|Other Eligibility Criteria|0
5869701|NCT01974752|20302211|P2|Overall Study|Withdrawal by Subject|3
5869702|NCT01974752|20302212|P1|Overall Study|Withdrawal by Subject|2
5869703|NCT01974752|20302211|P2|Overall Study|Lost to Follow-up|0
5869704|NCT01974752|20302212|P1|Overall Study|Lost to Follow-up|2
5869705|NCT01974752|20302211|P2|Overall Study|Death|11
5869706|NCT01974752|20302212|P1|Overall Study|Death|33
5869707|NCT01974323|20302640|P2|Overall Study|Adverse Event|2
5869708|NCT01974323|20302641|P1|Overall Study|Adverse Event|2
5869709|NCT01974323|20302640|P2|Overall Study|Lack of Efficacy|1
5869710|NCT01974323|20302641|P1|Overall Study|Lack of Efficacy|1
5869711|NCT01974323|20302640|P2|Overall Study|Pregnancy|1
5869712|NCT01974323|20302641|P1|Overall Study|Pregnancy|2
5869713|NCT01974323|20302640|P2|Overall Study|Lost to Follow-up|40
5869714|NCT01974323|20302641|P1|Overall Study|Lost to Follow-up|45
5869715|NCT01974323|20302640|P2|Overall Study|Personal Reasons|19
5869716|NCT01974323|20302641|P1|Overall Study|Personal Reasons|15
5869717|NCT01974323|20302640|P2|Overall Study|Protocol Violation|2
5869718|NCT01974323|20302641|P1|Overall Study|Protocol Violation|2
5869719|NCT01974323|20302640|P2|Overall Study|Other Reasons|28
5869720|NCT01974323|20302641|P1|Overall Study|Other Reasons|25
5869721|NCT01974141|20302681|P2|Overall Study|Adverse Event|5
5869722|NCT01974141|20302682|P1|Overall Study|Adverse Event|4
5869723|NCT01974141|20302681|P2|Overall Study|Lack of Efficacy|1
5869724|NCT01974141|20302682|P1|Overall Study|Lack of Efficacy|0
5869725|NCT01974141|20302681|P2|Overall Study|Pregnancy|3
5869726|NCT01974141|20302682|P1|Overall Study|Pregnancy|3
5869727|NCT01974141|20302681|P2|Overall Study|Lost to Follow-up|29
5869728|NCT01974141|20302682|P1|Overall Study|Lost to Follow-up|38
5869729|NCT01974141|20302681|P2|Overall Study|Personal Reasons|20
5869730|NCT01974141|20302682|P1|Overall Study|Personal Reasons|21
5869731|NCT01974141|20302681|P2|Overall Study|Protocol Violation|6
5869732|NCT01974141|20302682|P1|Overall Study|Protocol Violation|2
5869733|NCT01974141|20302681|P2|Overall Study|Other Reasons|18
5869734|NCT01974141|20302682|P1|Overall Study|Other Reasons|28
5869735|NCT01973998|20302726|P2|Overall Study|Death|2
5869736|NCT01973998|20302727|P1|Overall Study|Death|2
5869737|NCT01973595|20302789|P4|Washout|Withdrawal by Subject|0
5869738|NCT01973595|20302790|P3|Washout|Withdrawal by Subject|1
5869739|NCT01973595|20302791|P2|Washout|Withdrawal by Subject|0
5869740|NCT01973595|20302792|P1|Washout|Withdrawal by Subject|1
5869741|NCT01973569|20302809|P3|Overall Study|Did not receive study drug|3
5869742|NCT01973569|20302810|P2|Overall Study|Did not receive study drug|3
5869743|NCT01973569|20302811|P1|Overall Study|Did not receive study drug|6
5869744|NCT01973569|20302809|P3|Overall Study|Other|0
5869745|NCT01973569|20302810|P2|Overall Study|Other|1
5869746|NCT01973569|20302811|P1|Overall Study|Other|1
5869747|NCT01973569|20302809|P3|Overall Study|Disease progression|0
5869748|NCT01973569|20302810|P2|Overall Study|Disease progression|3
5869749|NCT01973569|20302811|P1|Overall Study|Disease progression|0
5869750|NCT01973569|20302809|P3|Overall Study|Prohibited concomitant d|0
5869751|NCT01973569|20302810|P2|Overall Study|Prohibited concomitant d|5
5869752|NCT01973569|20302811|P1|Overall Study|Prohibited concomitant d|1
5869753|NCT01973569|20302809|P3|Overall Study|Invasive dental treatment|6
5869754|NCT01973569|20302810|P2|Overall Study|Invasive dental treatment|5
5869755|NCT01973569|20302811|P1|Overall Study|Invasive dental treatment|3
5869756|NCT01973569|20302809|P3|Overall Study|Withdrawal by Subject|2
5869757|NCT01973569|20302810|P2|Overall Study|Withdrawal by Subject|5
5869758|NCT01973569|20302811|P1|Overall Study|Withdrawal by Subject|7
5869759|NCT01973569|20302809|P3|Overall Study|Protocol Violation|3
5869760|NCT01973569|20302810|P2|Overall Study|Protocol Violation|1
5869761|NCT01973569|20302811|P1|Overall Study|Protocol Violation|2
5869762|NCT01973569|20302809|P3|Overall Study|Adverse Event|4
5869763|NCT01973569|20302810|P2|Overall Study|Adverse Event|2
5869764|NCT01973569|20302811|P1|Overall Study|Adverse Event|9
5869765|NCT01973491|20302837|P1|Treatment Period (16 Weeks)|Adverse Event|1
5869766|NCT01973491|20302837|P1|Baseline Control Period (8 Weeks)|Withdrawal by Subject|1
5869767|NCT01973491|20302837|P1|Baseline Control Period (8 Weeks)|Did not meet Eligibility Criteria|17
5869768|NCT01973439|20302853|P1|Overall Study|PK curve incomplete|2
5869769|NCT01973439|20302853|P1|Overall Study|Vomiting after commencing once daily|1
5869770|NCT01973439|20302853|P1|Overall Study|Lost samples from one PK Day|2
5869771|NCT01973387|20302875|P2|Overall Study|Randomized, not treated|2
5869772|NCT01973387|20302876|P1|Overall Study|Randomized, not treated|2
5869773|NCT01973387|20302875|P2|Overall Study|Death|3
5869774|NCT01973387|20302876|P1|Overall Study|Death|4
5869775|NCT01973387|20302875|P2|Overall Study|Progressive disease or relapse|5
5869776|NCT01973387|20302876|P1|Overall Study|Progressive disease or relapse|16
5869777|NCT01973387|20302875|P2|Overall Study|Study terminated by sponsor|0
5869778|NCT01973387|20302876|P1|Overall Study|Study terminated by sponsor|63
5869779|NCT01973387|20302875|P2|Overall Study|Withdrawal by Subject|4
5869780|NCT01973387|20302876|P1|Overall Study|Withdrawal by Subject|7
5869781|NCT01973387|20302875|P2|Overall Study|Adverse Event|4
5869782|NCT01973387|20302876|P1|Overall Study|Adverse Event|14
5869783|NCT01973231|20302958|P2|Overall Study|Withdrawal by Subject|9
5869784|NCT01973231|20302959|P1|Overall Study|Withdrawal by Subject|7
5869785|NCT01973231|20302958|P2|Overall Study|unclassified|1
5869786|NCT01973231|20302959|P1|Overall Study|unclassified|2
5869787|NCT01973231|20302958|P2|Overall Study|Lost to Follow-up|1
5869788|NCT01973231|20302959|P1|Overall Study|Lost to Follow-up|1
5869789|NCT01973231|20302958|P2|Overall Study|Protocol Violation|1
5869790|NCT01973231|20302959|P1|Overall Study|Protocol Violation|1
5869791|NCT01973218|20302979|P2|Overall Study|Withdrawal by Subject|0
5869792|NCT01973218|20302980|P1|Overall Study|Withdrawal by Subject|1
5869793|NCT01973218|20302979|P2|Overall Study|Adverse Event|0
5869794|NCT01973218|20302980|P1|Overall Study|Adverse Event|1
5869795|NCT01972841|20303073|P6|Overall Study|Did not have end of treatment page|0
5869796|NCT01972841|20303074|P5|Overall Study|Did not have end of treatment page|1
5869797|NCT01972841|20303075|P4|Overall Study|Did not have end of treatment page|0
5869798|NCT01972841|20303076|P3|Overall Study|Did not have end of treatment page|0
5869799|NCT01972841|20303077|P2|Overall Study|Did not have end of treatment page|0
5869800|NCT01972841|20303078|P1|Overall Study|Did not have end of treatment page|0
5869801|NCT01972841|20303073|P6|Overall Study|Miscellaneous|4
5869802|NCT01972841|20303074|P5|Overall Study|Miscellaneous|0
5869803|NCT01972841|20303075|P4|Overall Study|Miscellaneous|1
5869804|NCT01972841|20303076|P3|Overall Study|Miscellaneous|4
5869805|NCT01972841|20303077|P2|Overall Study|Miscellaneous|0
5869806|NCT01972841|20303078|P1|Overall Study|Miscellaneous|0
5869807|NCT01972841|20303073|P6|Overall Study|Withdrawal by participants|34
5869808|NCT01972841|20303074|P5|Overall Study|Withdrawal by participants|33
5869809|NCT01972841|20303075|P4|Overall Study|Withdrawal by participants|16
5869810|NCT01972841|20303076|P3|Overall Study|Withdrawal by participants|23
5869811|NCT01972841|20303077|P2|Overall Study|Withdrawal by participants|27
5869812|NCT01972841|20303078|P1|Overall Study|Withdrawal by participants|21
5869813|NCT01972841|20303073|P6|Overall Study|Protocol Violation|4
5869814|NCT01972841|20303074|P5|Overall Study|Protocol Violation|9
5869815|NCT01972841|20303075|P4|Overall Study|Protocol Violation|5
5869816|NCT01972841|20303076|P3|Overall Study|Protocol Violation|3
5869817|NCT01972841|20303077|P2|Overall Study|Protocol Violation|2
5869818|NCT01972841|20303078|P1|Overall Study|Protocol Violation|2
5869819|NCT01972841|20303073|P6|Overall Study|Lost to Follow-up|3
5869820|NCT01972841|20303074|P5|Overall Study|Lost to Follow-up|9
5869821|NCT01972841|20303075|P4|Overall Study|Lost to Follow-up|2
5869822|NCT01972841|20303076|P3|Overall Study|Lost to Follow-up|4
5869823|NCT01972841|20303077|P2|Overall Study|Lost to Follow-up|2
5869824|NCT01972841|20303078|P1|Overall Study|Lost to Follow-up|4
5869825|NCT01972841|20303073|P6|Overall Study|Lack of Efficacy|1
5869826|NCT01972841|20303074|P5|Overall Study|Lack of Efficacy|4
5869827|NCT01972841|20303075|P4|Overall Study|Lack of Efficacy|2
5869828|NCT01972841|20303076|P3|Overall Study|Lack of Efficacy|0
5869829|NCT01972841|20303077|P2|Overall Study|Lack of Efficacy|0
5869830|NCT01972841|20303078|P1|Overall Study|Lack of Efficacy|1
5869831|NCT01972841|20303073|P6|Overall Study|Adverse Event|26
5869832|NCT01972841|20303074|P5|Overall Study|Adverse Event|21
5869833|NCT01972841|20303075|P4|Overall Study|Adverse Event|9
5869834|NCT01972841|20303076|P3|Overall Study|Adverse Event|12
5869835|NCT01972841|20303077|P2|Overall Study|Adverse Event|8
5869836|NCT01972841|20303078|P1|Overall Study|Adverse Event|13
5869837|NCT01972841|20303073|P6|Overall Study|Randomized but Never Received Treatment|13
5869838|NCT01972841|20303074|P5|Overall Study|Randomized but Never Received Treatment|6
5869839|NCT01972841|20303075|P4|Overall Study|Randomized but Never Received Treatment|2
5869840|NCT01972841|20303076|P3|Overall Study|Randomized but Never Received Treatment|4
5869841|NCT01972841|20303077|P2|Overall Study|Randomized but Never Received Treatment|5
5869842|NCT01972841|20303078|P1|Overall Study|Randomized but Never Received Treatment|2
5869843|NCT01972789|20303508|P2|Overall Study|Physician Decision|2
5869844|NCT01972789|20303509|P1|Overall Study|Physician Decision|3
5869845|NCT01972789|20303508|P2|Overall Study|Protocol deviation|0
5869846|NCT01972789|20303509|P1|Overall Study|Protocol deviation|1
5869847|NCT01972789|20303508|P2|Overall Study|Death|5
5869848|NCT01972789|20303509|P1|Overall Study|Death|7
5869849|NCT01972789|20303508|P2|Overall Study|Lost to Follow-up|7
5869850|NCT01972789|20303509|P1|Overall Study|Lost to Follow-up|4
5869851|NCT01972789|20303508|P2|Overall Study|Subject withdrew consent|12
5869852|NCT01972789|20303509|P1|Overall Study|Subject withdrew consent|14
5869853|NCT01972789|20303508|P2|Overall Study|Adverse Event|4
5869854|NCT01972789|20303509|P1|Overall Study|Adverse Event|11
5869855|NCT01972776|20303543|P6|Part 2|Administrative problems|7
5869856|NCT01972776|20303544|P5|Part 2|Administrative problems|10
5869857|NCT01972776|20303545|P4|Part 2|Administrative problems|0
5869858|NCT01972776|20303546|P3|Part 2|Administrative problems|0
5869859|NCT01972776|20303547|P2|Part 2|Administrative problems|0
5869860|NCT01972776|20303548|P1|Part 2|Administrative problems|0
5869861|NCT01972776|20303543|P6|Part 2|Adverse Event|0
5869862|NCT01972776|20303544|P5|Part 2|Adverse Event|3
5869863|NCT01972776|20303545|P4|Part 2|Adverse Event|0
5869864|NCT01972776|20303546|P3|Part 2|Adverse Event|0
5869865|NCT01972776|20303547|P2|Part 2|Adverse Event|0
5869866|NCT01972776|20303548|P1|Part 2|Adverse Event|0
5869867|NCT01972776|20303543|P6|Part 1|Adverse Event|0
5869868|NCT01972776|20303544|P5|Part 1|Adverse Event|0
5869869|NCT01972776|20303545|P4|Part 1|Adverse Event|1
5869870|NCT01972776|20303546|P3|Part 1|Adverse Event|1
5869871|NCT01972776|20303547|P2|Part 1|Adverse Event|0
5869872|NCT01972776|20303548|P1|Part 1|Adverse Event|0
5869873|NCT01972776|20303543|P6|Part 1|Withdrawal by Subject|0
5869874|NCT01972776|20303544|P5|Part 1|Withdrawal by Subject|0
5869875|NCT01972776|20303545|P4|Part 1|Withdrawal by Subject|0
5869876|NCT01972776|20303546|P3|Part 1|Withdrawal by Subject|1
5869877|NCT01972776|20303547|P2|Part 1|Withdrawal by Subject|0
5869878|NCT01972776|20303548|P1|Part 1|Withdrawal by Subject|0
5869879|NCT01972724|20303619|P3|Open-Label|Significant Protocol Deviation|2
5869880|NCT01972724|20303620|P2|Open-Label|Significant Protocol Deviation|0
5869881|NCT01972724|20303621|P1|Open-Label|Significant Protocol Deviation|0
5869882|NCT01972724|20303619|P3|Open-Label|Withdrew Consent|3
5869883|NCT01972724|20303620|P2|Open-Label|Withdrew Consent|0
5869884|NCT01972724|20303621|P1|Open-Label|Withdrew Consent|0
5869885|NCT01972724|20303619|P3|Double-Blind|Significant Protocol Deviation|0
5869886|NCT01972724|20303620|P2|Double-Blind|Significant Protocol Deviation|8
5869887|NCT01972724|20303621|P1|Double-Blind|Significant Protocol Deviation|5
5869888|NCT01972724|20303619|P3|Double-Blind|Withdrawal of Consent|0
5869889|NCT01972724|20303620|P2|Double-Blind|Withdrawal of Consent|1
5869890|NCT01972724|20303621|P1|Double-Blind|Withdrawal of Consent|2
5869891|NCT01972724|20303619|P3|Double-Blind|Adverse Event|0
5869892|NCT01972724|20303620|P2|Double-Blind|Adverse Event|0
5869893|NCT01972724|20303621|P1|Double-Blind|Adverse Event|1
5869894|NCT01972724|20303619|P3|Double-Blind|Rescue Criteria Met|0
5869895|NCT01972724|20303620|P2|Double-Blind|Rescue Criteria Met|0
5869896|NCT01972724|20303621|P1|Double-Blind|Rescue Criteria Met|1
5869897|NCT01972659|20303634|P2|Overall Study|problems realted to acceleromyograph|1
5869898|NCT01972659|20303635|P1|Overall Study|problems realted to acceleromyograph|2
5869899|NCT01972659|20303634|P2|Overall Study|Protocol Violation|2
5869900|NCT01972659|20303635|P1|Overall Study|Protocol Violation|2
5869901|NCT01972568|20303644|P3|Overall Study|Adverse Event|5
5869902|NCT01972568|20303645|P2|Overall Study|Adverse Event|6
5869903|NCT01972568|20303646|P1|Overall Study|Adverse Event|5
5869904|NCT01972568|20303644|P3|Overall Study|Lost to Follow-up|0
5869905|NCT01972568|20303645|P2|Overall Study|Lost to Follow-up|0
5869906|NCT01972568|20303646|P1|Overall Study|Lost to Follow-up|1
5869907|NCT01972568|20303644|P3|Overall Study|Withdrawal by Subject|7
5869908|NCT01972568|20303645|P2|Overall Study|Withdrawal by Subject|3
5869909|NCT01972568|20303646|P1|Overall Study|Withdrawal by Subject|6
5869910|NCT01972568|20303644|P3|Overall Study|Protocol Violation|2
5869911|NCT01972568|20303645|P2|Overall Study|Protocol Violation|2
5869912|NCT01972568|20303646|P1|Overall Study|Protocol Violation|1
5869913|NCT01972568|20303644|P3|Overall Study|Lack of Efficacy|2
5869914|NCT01972568|20303645|P2|Overall Study|Lack of Efficacy|1
5869915|NCT01972568|20303646|P1|Overall Study|Lack of Efficacy|0
5869916|NCT01972568|20303644|P3|Overall Study|Other events|0
5869917|NCT01972568|20303645|P2|Overall Study|Other events|0
5869918|NCT01972568|20303646|P1|Overall Study|Other events|3
5869919|NCT01972529|20303685|P4|Overall Study|Not treated|1
5869920|NCT01972529|20303686|P3|Overall Study|Not treated|2
5869921|NCT01972529|20303687|P2|Overall Study|Not treated|1
5869922|NCT01972529|20303688|P1|Overall Study|Not treated|0
5869923|NCT01972529|20303685|P4|Overall Study|Other|2
5869924|NCT01972529|20303686|P3|Overall Study|Other|0
5869925|NCT01972529|20303687|P2|Overall Study|Other|0
5869926|NCT01972529|20303688|P1|Overall Study|Other|0
5869927|NCT01972529|20303685|P4|Overall Study|Withdrawl of Consent|1
5869928|NCT01972529|20303686|P3|Overall Study|Withdrawl of Consent|0
5869929|NCT01972529|20303687|P2|Overall Study|Withdrawl of Consent|2
5869930|NCT01972529|20303688|P1|Overall Study|Withdrawl of Consent|1
5869931|NCT01972529|20303685|P4|Overall Study|Participant Choice|0
5869932|NCT01972529|20303686|P3|Overall Study|Participant Choice|0
5869933|NCT01972529|20303687|P2|Overall Study|Participant Choice|1
5869934|NCT01972529|20303688|P1|Overall Study|Participant Choice|0
5869935|NCT01972529|20303685|P4|Overall Study|Lost to Follow-up|0
5869936|NCT01972529|20303686|P3|Overall Study|Lost to Follow-up|0
5869937|NCT01972529|20303687|P2|Overall Study|Lost to Follow-up|0
5869938|NCT01972529|20303688|P1|Overall Study|Lost to Follow-up|1
5869939|NCT01972529|20303685|P4|Overall Study|Adverse Event|0
5869940|NCT01972529|20303686|P3|Overall Study|Adverse Event|0
5869941|NCT01972529|20303687|P2|Overall Study|Adverse Event|1
5869942|NCT01972529|20303688|P1|Overall Study|Adverse Event|0
5869943|NCT01972464|20303733|P2|3-Month Follow-Up (Week 20)|Lost to Follow-up|1
5869944|NCT01972464|20303734|P1|3-Month Follow-Up (Week 20)|Lost to Follow-up|1
5869945|NCT01972464|20303733|P2|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|1
5869946|NCT01972464|20303734|P1|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|0
5869947|NCT01972464|20303733|P2|Treatment Period (Week 1 Through Week 8)|Patient Relocated|0
5869948|NCT01972464|20303734|P1|Treatment Period (Week 1 Through Week 8)|Patient Relocated|1
5869949|NCT01972464|20303733|P2|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|3
5869950|NCT01972464|20303734|P1|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|2
5869951|NCT01972438|20303750|P2|Post Month 12 Study Period|Early Study Closure|4
5869952|NCT01972438|20303751|P1|Post Month 12 Study Period|Early Study Closure|3
5869953|NCT01972438|20303750|P2|Months 6-12 Study Period|Early Study Closure|2
5869954|NCT01972438|20303751|P1|Months 6-12 Study Period|Early Study Closure|2
5869955|NCT01972438|20303750|P2|Months 6-12 Study Period|Death|0
5869956|NCT01972438|20303751|P1|Months 6-12 Study Period|Death|1
5869957|NCT01972438|20303750|P2|Months 3-6 Crossover Period|Early Study Closure|1
5869958|NCT01972438|20303751|P1|Months 3-6 Crossover Period|Early Study Closure|0
5869959|NCT01972438|20303750|P2|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|2
5869960|NCT01972438|20303751|P1|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|1
5869961|NCT01972438|20303750|P2|Baseline-Month 3 Crossover Period|Unable to donate blood|1
5869962|NCT01972438|20303751|P1|Baseline-Month 3 Crossover Period|Unable to donate blood|0
5869963|NCT01972438|20303750|P2|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|0
5869964|NCT01972438|20303751|P1|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|1
5869965|NCT01972438|20303750|P2|Baseline-Month 3 Crossover Period|Death|0
5869966|NCT01972438|20303751|P1|Baseline-Month 3 Crossover Period|Death|1
5869967|NCT01972308|20303805|P2|Overall Study|Death|1
5869968|NCT01972308|20303806|P1|Overall Study|Death|4
5869969|NCT01972308|20303805|P2|Overall Study|Lost to Follow-up|6
5869970|NCT01972308|20303806|P1|Overall Study|Lost to Follow-up|4
5869971|NCT01972308|20303805|P2|Overall Study|Withdrawal by Subject|1
5869972|NCT01972308|20303806|P1|Overall Study|Withdrawal by Subject|0
5869973|NCT01972217|20303832|P4|Part B Double-blind, Randomised Period|Withdrawal by Subject|1
5869974|NCT01972217|20303833|P3|Part B Double-blind, Randomised Period|Withdrawal by Subject|0
5869975|NCT01972217|20303834|P2|Part B Double-blind, Randomised Period|Withdrawal by Subject|0
5869976|NCT01972217|20303835|P1|Part B Double-blind, Randomised Period|Withdrawal by Subject|0
5869977|NCT01972217|20303832|P4|Part B Double-blind, Randomised Period|Lost to Follow-up|1
5869978|NCT01972217|20303833|P3|Part B Double-blind, Randomised Period|Lost to Follow-up|2
5869979|NCT01972217|20303834|P2|Part B Double-blind, Randomised Period|Lost to Follow-up|0
5869980|NCT01972217|20303835|P1|Part B Double-blind, Randomised Period|Lost to Follow-up|0
5869981|NCT01972217|20303832|P4|Part B Double-blind, Randomised Period|Screen failure|1
5869982|NCT01972217|20303833|P3|Part B Double-blind, Randomised Period|Screen failure|0
5869983|NCT01972217|20303834|P2|Part B Double-blind, Randomised Period|Screen failure|0
5869984|NCT01972217|20303835|P1|Part B Double-blind, Randomised Period|Screen failure|0
5869985|NCT01972217|20303832|P4|Part B Double-blind, Randomised Period|Reason not recorded|0
5869986|NCT01972217|20303833|P3|Part B Double-blind, Randomised Period|Reason not recorded|1
5869987|NCT01972217|20303834|P2|Part B Double-blind, Randomised Period|Reason not recorded|0
5869988|NCT01972217|20303835|P1|Part B Double-blind, Randomised Period|Reason not recorded|0
5869989|NCT01972217|20303832|P4|Part B Double-blind, Randomised Period|Death|44
5869990|NCT01972217|20303833|P3|Part B Double-blind, Randomised Period|Death|43
5869991|NCT01972217|20303834|P2|Part B Double-blind, Randomised Period|Death|0
5869992|NCT01972217|20303835|P1|Part B Double-blind, Randomised Period|Death|0
5869993|NCT01972217|20303832|P4|Part A: Open-label Safety Run-in Period|Death|0
5869994|NCT01972217|20303833|P3|Part A: Open-label Safety Run-in Period|Death|0
5869995|NCT01972217|20303834|P2|Part A: Open-label Safety Run-in Period|Death|1
5869996|NCT01972217|20303835|P1|Part A: Open-label Safety Run-in Period|Death|0
5869997|NCT01972217|20303832|P4|Part A: Open-label Safety Run-in Period|Adverse Event|0
5869998|NCT01972217|20303833|P3|Part A: Open-label Safety Run-in Period|Adverse Event|0
5869999|NCT01972217|20303834|P2|Part A: Open-label Safety Run-in Period|Adverse Event|1
5870000|NCT01972217|20303835|P1|Part A: Open-label Safety Run-in Period|Adverse Event|0
5870001|NCT01972217|20303832|P4|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0
5870002|NCT01972217|20303833|P3|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0
5870003|NCT01972217|20303834|P2|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|9
5870004|NCT01972217|20303835|P1|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|1
5870005|NCT01972217|20303832|P4|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0
5870006|NCT01972217|20303833|P3|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0
5870007|NCT01972217|20303834|P2|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|1
5870008|NCT01972217|20303835|P1|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0
5870009|NCT01972152|20303896|P6|Second Treatment Visit|Protocol Violation|0
5870010|NCT01972152|20303897|P5|Second Treatment Visit|Protocol Violation|0
5870011|NCT01972152|20303898|P4|Second Treatment Visit|Protocol Violation|0
5870012|NCT01972152|20303899|P3|Second Treatment Visit|Protocol Violation|0
5870013|NCT01972152|20303900|P2|Second Treatment Visit|Protocol Violation|1
5870014|NCT01972152|20303901|P1|Second Treatment Visit|Protocol Violation|0
5870015|NCT01972152|20303896|P6|First Treatment Visit|Lost to Follow-up|0
5870016|NCT01972152|20303897|P5|First Treatment Visit|Lost to Follow-up|0
5870017|NCT01972152|20303898|P4|First Treatment Visit|Lost to Follow-up|0
5870018|NCT01972152|20303899|P3|First Treatment Visit|Lost to Follow-up|0
5870019|NCT01972152|20303900|P2|First Treatment Visit|Lost to Follow-up|1
5870020|NCT01972152|20303901|P1|First Treatment Visit|Lost to Follow-up|0
5870021|NCT01972074|20303939|P3|Overall Study|Scanner Unavailable|1
5870022|NCT01972074|20303940|P2|Overall Study|Scanner Unavailable|0
5870023|NCT01972074|20303941|P1|Overall Study|Scanner Unavailable|0
5870024|NCT01972074|20303939|P3|Overall Study|Withdrawal by Subject|1
5870025|NCT01972074|20303940|P2|Overall Study|Withdrawal by Subject|1
5870026|NCT01972074|20303941|P1|Overall Study|Withdrawal by Subject|1
5870027|NCT01972074|20303939|P3|Overall Study|Lost to Follow-up|1
5870028|NCT01972074|20303940|P2|Overall Study|Lost to Follow-up|1
5870029|NCT01972074|20303941|P1|Overall Study|Lost to Follow-up|0
5870030|NCT01972074|20303939|P3|Overall Study|Lack of Efficacy|0
5870031|NCT01972074|20303940|P2|Overall Study|Lack of Efficacy|1
5870032|NCT01972074|20303941|P1|Overall Study|Lack of Efficacy|1
5870033|NCT01972074|20303939|P3|Overall Study|Adverse Event|0
5870034|NCT01972074|20303940|P2|Overall Study|Adverse Event|1
5870035|NCT01972074|20303941|P1|Overall Study|Adverse Event|4
5870036|NCT01971723|20303986|P2|Overall Study|Protocol Violation|2
5870037|NCT01971723|20303987|P1|Overall Study|Protocol Violation|1
5870038|NCT01971723|20303986|P2|Overall Study|Withdrawal by Subject|1
5870039|NCT01971723|20303987|P1|Overall Study|Withdrawal by Subject|1
5870040|NCT01971645|20304020|P3|Overall Study|Protocol Violation|1
5870041|NCT01971645|20304021|P2|Overall Study|Protocol Violation|0
5870042|NCT01971645|20304022|P1|Overall Study|Protocol Violation|0
5870043|NCT01971645|20304020|P3|Overall Study|Lost to Follow-up|1
5870044|NCT01971645|20304021|P2|Overall Study|Lost to Follow-up|0
5870045|NCT01971645|20304022|P1|Overall Study|Lost to Follow-up|1
5870046|NCT01971645|20304020|P3|Overall Study|Adverse Event|0
5870047|NCT01971645|20304021|P2|Overall Study|Adverse Event|0
5870048|NCT01971645|20304022|P1|Overall Study|Adverse Event|1
5870049|NCT01971567|20304056|P2|Overall Study|Lost to Follow-up|0
5870050|NCT01971567|20304057|P1|Overall Study|Lost to Follow-up|1
5870051|NCT01971567|20304056|P2|Overall Study|Withdrawal by Subject|2
5870052|NCT01971567|20304057|P1|Overall Study|Withdrawal by Subject|3
5870053|NCT01971554|20304083|P4|Overall Study|Lost to Follow-up|0
5870054|NCT01971554|20304084|P3|Overall Study|Lost to Follow-up|0
5870055|NCT01971554|20304085|P2|Overall Study|Lost to Follow-up|0
5870056|NCT01971554|20304086|P1|Overall Study|Lost to Follow-up|1
5870057|NCT01971476|20304123|P3|Cohort 2: 12 to <18 Years|Adverse Event|0
5870058|NCT01971476|20304124|P2|Cohort 2: 12 to <18 Years|Adverse Event|1
5870059|NCT01971476|20304125|P1|Cohort 2: 12 to <18 Years|Adverse Event|0
5870060|NCT01971476|20304123|P3|Cohort 2: 12 to <18 Years|Other not defined|0
5870061|NCT01971476|20304124|P2|Cohort 2: 12 to <18 Years|Other not defined|3
5870062|NCT01971476|20304125|P1|Cohort 2: 12 to <18 Years|Other not defined|6
5870063|NCT01971476|20304123|P3|Cohort 1: 2 to <12 Years|Other not defined|6
5870064|NCT01971476|20304124|P2|Cohort 1: 2 to <12 Years|Other not defined|3
5870065|NCT01971476|20304125|P1|Cohort 1: 2 to <12 Years|Other not defined|3
5870066|NCT01971346|20304219|P1|Overall Study|Physician Decision|1
5870067|NCT01971346|20304219|P1|Overall Study|Withdrawal by Subject|2
5870068|NCT01971346|20304219|P1|Overall Study|Lost to Follow-up|2
5870069|NCT01971346|20304219|P1|Overall Study|Protocol Violation|3
5870070|NCT01971203|20304252|P2|Overall Study|Adverse Event|0
5870071|NCT01971203|20304253|P1|Overall Study|Adverse Event|1
5870072|NCT01971203|20304252|P2|Overall Study|Withdrawal by Subject|6
5870073|NCT01971203|20304253|P1|Overall Study|Withdrawal by Subject|5
5870074|NCT01971203|20304252|P2|Overall Study|Protocol Violation|2
5870075|NCT01971203|20304253|P1|Overall Study|Protocol Violation|3
5870076|NCT01970995|20304280|P3|End of Study (Population at Day 90)|Withdrawal by Subject|1
5870077|NCT01970995|20304281|P2|End of Study (Population at Day 90)|Withdrawal by Subject|0
5870078|NCT01970995|20304282|P1|End of Study (Population at Day 90)|Withdrawal by Subject|1
5870079|NCT01970995|20304280|P3|Confinement Period (Population at Day 5)|Withdrawal by Subject|1
5870080|NCT01970995|20304281|P2|Confinement Period (Population at Day 5)|Withdrawal by Subject|1
5870081|NCT01970995|20304282|P1|Confinement Period (Population at Day 5)|Withdrawal by Subject|1
5870082|NCT01970982|20304305|P3|Overall Study|Withdrawal by Subject|2
5870083|NCT01970982|20304306|P2|Overall Study|Withdrawal by Subject|0
5870084|NCT01970982|20304307|P1|Overall Study|Withdrawal by Subject|0
5870085|NCT01970878|20304342|P4|Overall Study|No Completion Status|0
5870086|NCT01970878|20304343|P3|Overall Study|No Completion Status|0
5870087|NCT01970878|20304344|P2|Overall Study|No Completion Status|1
5870088|NCT01970878|20304345|P1|Overall Study|No Completion Status|0
5870089|NCT01970878|20304342|P4|Overall Study|Physician Decision|0
5870090|NCT01970878|20304343|P3|Overall Study|Physician Decision|1
5870091|NCT01970878|20304344|P2|Overall Study|Physician Decision|1
5870092|NCT01970878|20304345|P1|Overall Study|Physician Decision|0
5870093|NCT01970878|20304342|P4|Overall Study|Protocol Specified Criteria|6
5870094|NCT01970878|20304343|P3|Overall Study|Protocol Specified Criteria|3
5870095|NCT01970878|20304344|P2|Overall Study|Protocol Specified Criteria|4
5870096|NCT01970878|20304345|P1|Overall Study|Protocol Specified Criteria|10
5870097|NCT01970878|20304342|P4|Overall Study|Adverse Event|3
5870098|NCT01970878|20304343|P3|Overall Study|Adverse Event|4
5870099|NCT01970878|20304344|P2|Overall Study|Adverse Event|7
5870100|NCT01970878|20304345|P1|Overall Study|Adverse Event|12
5870101|NCT01970878|20304342|P4|Overall Study|Lack of Efficacy|0
5870102|NCT01970878|20304343|P3|Overall Study|Lack of Efficacy|2
5870103|NCT01970878|20304344|P2|Overall Study|Lack of Efficacy|1
5870104|NCT01970878|20304345|P1|Overall Study|Lack of Efficacy|2
5870105|NCT01970878|20304342|P4|Overall Study|Administrative Reasons|4
5870106|NCT01970878|20304343|P3|Overall Study|Administrative Reasons|0
5870107|NCT01970878|20304344|P2|Overall Study|Administrative Reasons|0
5870108|NCT01970878|20304345|P1|Overall Study|Administrative Reasons|1
5870109|NCT01970878|20304342|P4|Overall Study|Lost to Follow-up|4
5870110|NCT01970878|20304343|P3|Overall Study|Lost to Follow-up|2
5870111|NCT01970878|20304344|P2|Overall Study|Lost to Follow-up|3
5870112|NCT01970878|20304345|P1|Overall Study|Lost to Follow-up|1
5870113|NCT01970878|20304342|P4|Overall Study|Withdrawal by Subject|7
5870114|NCT01970878|20304343|P3|Overall Study|Withdrawal by Subject|14
5870115|NCT01970878|20304344|P2|Overall Study|Withdrawal by Subject|10
5870116|NCT01970878|20304345|P1|Overall Study|Withdrawal by Subject|11
5870202|NCT01970592|20304836|P1|Overall Study|Adverse Event|1
5870203|NCT01970592|20304836|P1|Overall Study|Physician Decision|1
5870204|NCT01970592|20304836|P1|Overall Study|Withdrawal by Subject|4
5870205|NCT01970540|20304844|P3|Overall Study|Clinical deterioration|0
5870206|NCT01970540|20304845|P2|Overall Study|Clinical deterioration|0
5870207|NCT01970540|20304846|P1|Overall Study|Clinical deterioration|1
5870208|NCT01970540|20304844|P3|Overall Study|Withdrawal by Subject|1
5870209|NCT01970540|20304845|P2|Overall Study|Withdrawal by Subject|0
5870210|NCT01970540|20304846|P1|Overall Study|Withdrawal by Subject|4
5870211|NCT01970540|20304844|P3|Overall Study|Treatment-related AE|2
5870212|NCT01970540|20304845|P2|Overall Study|Treatment-related AE|0
5870213|NCT01970540|20304846|P1|Overall Study|Treatment-related AE|4
5870214|NCT01970540|20304844|P3|Overall Study|Adverse Event|1
5870215|NCT01970540|20304845|P2|Overall Study|Adverse Event|2
5870216|NCT01970540|20304846|P1|Overall Study|Adverse Event|0
5870217|NCT01970540|20304844|P3|Overall Study|End of study|2
5870218|NCT01970540|20304845|P2|Overall Study|End of study|0
5870219|NCT01970540|20304846|P1|Overall Study|End of study|2
5870220|NCT01970540|20304844|P3|Overall Study|Clinical progression|1
5870221|NCT01970540|20304845|P2|Overall Study|Clinical progression|1
5870222|NCT01970540|20304846|P1|Overall Study|Clinical progression|0
5870223|NCT01970540|20304844|P3|Overall Study|Physician Decision|0
5870224|NCT01970540|20304845|P2|Overall Study|Physician Decision|2
5870225|NCT01970540|20304846|P1|Overall Study|Physician Decision|7
5870226|NCT01970540|20304844|P3|Overall Study|Treatment delay over protocol|1
5870227|NCT01970540|20304845|P2|Overall Study|Treatment delay over protocol|0
5870228|NCT01970540|20304846|P1|Overall Study|Treatment delay over protocol|0
5870229|NCT01970540|20304844|P3|Overall Study|Progressive disease|10
5870230|NCT01970540|20304845|P2|Overall Study|Progressive disease|23
5870231|NCT01970540|20304846|P1|Overall Study|Progressive disease|55
5870232|NCT01970540|20304844|P3|Overall Study|Non-treatment-related AE|1
5870233|NCT01970540|20304845|P2|Overall Study|Non-treatment-related AE|0
5870234|NCT01970540|20304846|P1|Overall Study|Non-treatment-related AE|0
5870235|NCT01970527|20304877|P2|Follow-up Clinic Visit|Lost to Follow-up|1
5870236|NCT01970527|20304878|P1|Follow-up Clinic Visit|Lost to Follow-up|0
5870237|NCT01970527|20304877|P2|Follow-up Clinic Visit|Withdrawal by Subject|1
5870238|NCT01970527|20304878|P1|Follow-up Clinic Visit|Withdrawal by Subject|0
5870239|NCT01970527|20304877|P2|Follow-up Clinic Visit|Disease progression|1
5870240|NCT01970527|20304878|P1|Follow-up Clinic Visit|Disease progression|1
5870241|NCT01970527|20304877|P2|Treatment|Death|1
5870242|NCT01970527|20304878|P1|Treatment|Death|0
5870243|NCT01970527|20304877|P2|Treatment|Participant did not tolerate Ipilimumab|1
5870244|NCT01970527|20304878|P1|Treatment|Participant did not tolerate Ipilimumab|0
5870245|NCT01970527|20304877|P2|Treatment|Disease progression|1
5870246|NCT01970527|20304878|P1|Treatment|Disease progression|0
5870247|NCT01970527|20304877|P2|Pre-treatment/Baseline|Screen fail- participant had brain mets|0
5870248|NCT01970527|20304878|P1|Pre-treatment/Baseline|Screen fail- participant had brain mets|1
5870249|NCT01970488|20304891|P5|Part 2: Post Week 16|Lost to Follow-up|2
5870250|NCT01970488|20304892|P4|Part 2: Post Week 16|Lost to Follow-up|1
5870251|NCT01970488|20304893|P3|Part 2: Post Week 16|Lost to Follow-up|1
5870252|NCT01970488|20304894|P2|Part 2: Post Week 16|Lost to Follow-up|0
5870253|NCT01970488|20304895|P1|Part 2: Post Week 16|Lost to Follow-up|0
5870254|NCT01970488|20304891|P5|Part 2: Post Week 16|Withdrawal by Subject|3
5870255|NCT01970488|20304892|P4|Part 2: Post Week 16|Withdrawal by Subject|3
5870256|NCT01970488|20304893|P3|Part 2: Post Week 16|Withdrawal by Subject|8
5870257|NCT01970488|20304894|P2|Part 2: Post Week 16|Withdrawal by Subject|0
5870258|NCT01970488|20304895|P1|Part 2: Post Week 16|Withdrawal by Subject|0
5870259|NCT01970488|20304891|P5|Part 2: Post Week 16|Adverse Event|1
5870260|NCT01970488|20304892|P4|Part 2: Post Week 16|Adverse Event|1
5870261|NCT01970488|20304893|P3|Part 2: Post Week 16|Adverse Event|5
5870262|NCT01970488|20304894|P2|Part 2: Post Week 16|Adverse Event|0
5870263|NCT01970488|20304895|P1|Part 2: Post Week 16|Adverse Event|0
5870264|NCT01970488|20304891|P5|Part 2: Post Week 16|Lack of Efficacy|1
5870265|NCT01970488|20304892|P4|Part 2: Post Week 16|Lack of Efficacy|3
5870266|NCT01970488|20304893|P3|Part 2: Post Week 16|Lack of Efficacy|2
5870267|NCT01970488|20304894|P2|Part 2: Post Week 16|Lack of Efficacy|0
5870268|NCT01970488|20304895|P1|Part 2: Post Week 16|Lack of Efficacy|0
5870269|NCT01970488|20304891|P5|Part 2: Post Week 16|Non-compliance|0
5870270|NCT01970488|20304892|P4|Part 2: Post Week 16|Non-compliance|0
5870271|NCT01970488|20304893|P3|Part 2: Post Week 16|Non-compliance|1
5870272|NCT01970488|20304894|P2|Part 2: Post Week 16|Non-compliance|0
5870273|NCT01970488|20304895|P1|Part 2: Post Week 16|Non-compliance|0
5870274|NCT01970488|20304891|P5|Part 2: Post Week 16|Physician Decision|1
5870275|NCT01970488|20304892|P4|Part 2: Post Week 16|Physician Decision|0
5870276|NCT01970488|20304893|P3|Part 2: Post Week 16|Physician Decision|0
5870277|NCT01970488|20304894|P2|Part 2: Post Week 16|Physician Decision|0
5870278|NCT01970488|20304895|P1|Part 2: Post Week 16|Physician Decision|0
5870279|NCT01970488|20304891|P5|Part 1: Through Week 16|Lost to Follow-up|0
5870280|NCT01970488|20304892|P4|Part 1: Through Week 16|Lost to Follow-up|0
5870281|NCT01970488|20304893|P3|Part 1: Through Week 16|Lost to Follow-up|0
5870282|NCT01970488|20304894|P2|Part 1: Through Week 16|Lost to Follow-up|2
5870283|NCT01970488|20304895|P1|Part 1: Through Week 16|Lost to Follow-up|0
5870284|NCT01970488|20304891|P5|Part 1: Through Week 16|Withdrawal by Subject|0
5870285|NCT01970488|20304892|P4|Part 1: Through Week 16|Withdrawal by Subject|0
5870286|NCT01970488|20304893|P3|Part 1: Through Week 16|Withdrawal by Subject|0
5870287|NCT01970488|20304894|P2|Part 1: Through Week 16|Withdrawal by Subject|2
5870288|NCT01970488|20304895|P1|Part 1: Through Week 16|Withdrawal by Subject|3
5870289|NCT01970488|20304891|P5|Part 1: Through Week 16|Adverse Event|0
5870290|NCT01970488|20304892|P4|Part 1: Through Week 16|Adverse Event|0
5870291|NCT01970488|20304893|P3|Part 1: Through Week 16|Adverse Event|0
5870292|NCT01970488|20304894|P2|Part 1: Through Week 16|Adverse Event|5
5870293|NCT01970488|20304895|P1|Part 1: Through Week 16|Adverse Event|6
5870294|NCT01970488|20304891|P5|Part 1: Through Week 16|Protocol Violation|0
5870295|NCT01970488|20304892|P4|Part 1: Through Week 16|Protocol Violation|0
5870296|NCT01970488|20304893|P3|Part 1: Through Week 16|Protocol Violation|0
5870297|NCT01970488|20304894|P2|Part 1: Through Week 16|Protocol Violation|2
5870298|NCT01970488|20304895|P1|Part 1: Through Week 16|Protocol Violation|1
5870299|NCT01970488|20304891|P5|Part 1: Through Week 16|Protocol-specified Criteria|0
5870300|NCT01970488|20304892|P4|Part 1: Through Week 16|Protocol-specified Criteria|0
5870301|NCT01970488|20304893|P3|Part 1: Through Week 16|Protocol-specified Criteria|0
5870302|NCT01970488|20304894|P2|Part 1: Through Week 16|Protocol-specified Criteria|2
5870303|NCT01970488|20304895|P1|Part 1: Through Week 16|Protocol-specified Criteria|1
5870304|NCT01970475|20304962|P2|Overall Study|Protocol Violation|0
5870305|NCT01970475|20304963|P1|Overall Study|Protocol Violation|1
5870306|NCT01970475|20304962|P2|Overall Study|Lost to Follow-up|2
5870307|NCT01970475|20304963|P1|Overall Study|Lost to Follow-up|2
5870308|NCT01970475|20304962|P2|Overall Study|Adverse Event|3
5870309|NCT01970475|20304963|P1|Overall Study|Adverse Event|7
5870310|NCT01970475|20304962|P2|Overall Study|Withdrawal by Subject|6
5870311|NCT01970475|20304963|P1|Overall Study|Withdrawal by Subject|11
5870312|NCT01970462|20304983|P2|Overall Study|Lost to Follow-up|2
5870313|NCT01970462|20304984|P1|Overall Study|Lost to Follow-up|0
5870314|NCT01970397|20304998|P2|Overall Study|Protocol Violation|1
5870315|NCT01970397|20304999|P1|Overall Study|Protocol Violation|1
5870316|NCT01970397|20304998|P2|Overall Study|Personal Reasons|2
5870317|NCT01970397|20304999|P1|Overall Study|Personal Reasons|1
5870318|NCT01970397|20304998|P2|Overall Study|Lost to Follow-up|1
5870319|NCT01970397|20304999|P1|Overall Study|Lost to Follow-up|0
5870320|NCT01970397|20304998|P2|Overall Study|Adverse Event|1
5870321|NCT01970397|20304999|P1|Overall Study|Adverse Event|0
5870322|NCT01970371|20305012|P3|Overall Study|Lost to Follow-up|1
5870323|NCT01970371|20305013|P2|Overall Study|Lost to Follow-up|0
5870324|NCT01970371|20305014|P1|Overall Study|Lost to Follow-up|0
5870325|NCT01970371|20305012|P3|Overall Study|Death|12
5870326|NCT01970371|20305013|P2|Overall Study|Death|13
5870327|NCT01970371|20305014|P1|Overall Study|Death|8
5870328|NCT01970241|20305039|P2|Overall Study|Steroid d/c;discharge<48 hrs.|8
5870329|NCT01970241|20305040|P1|Overall Study|Steroid d/c;discharge<48 hrs.|15
5870330|NCT01970241|20305039|P2|Overall Study|Withdrawal by Subject|0
5870331|NCT01970241|20305040|P1|Overall Study|Withdrawal by Subject|2
5870332|NCT01969851|20305100|P3|Overall Study|Sponsor decision|1
5870333|NCT01969851|20305101|P2|Overall Study|Sponsor decision|0
5870334|NCT01969851|20305102|P1|Overall Study|Sponsor decision|0
5870335|NCT01969851|20305100|P3|Overall Study|No effective dose in Titration period|1
5870336|NCT01969851|20305101|P2|Overall Study|No effective dose in Titration period|0
5870337|NCT01969851|20305102|P1|Overall Study|No effective dose in Titration period|0
5870338|NCT01969851|20305100|P3|Overall Study|Withdrawal by Subject|1
5870339|NCT01969851|20305101|P2|Overall Study|Withdrawal by Subject|0
5870340|NCT01969851|20305102|P1|Overall Study|Withdrawal by Subject|1
5870341|NCT01969851|20305100|P3|Overall Study|Lack of Efficacy|1
5870342|NCT01969851|20305101|P2|Overall Study|Lack of Efficacy|3
5870343|NCT01969851|20305102|P1|Overall Study|Lack of Efficacy|0
5870344|NCT01969851|20305100|P3|Overall Study|Adverse Event|3
5870345|NCT01969851|20305101|P2|Overall Study|Adverse Event|0
5870346|NCT01969851|20305102|P1|Overall Study|Adverse Event|0
5870347|NCT01969799|20305124|P2|Overall Study|Physician Decision|0
5870348|NCT01969799|20305125|P1|Overall Study|Physician Decision|1
5870349|NCT01969799|20305124|P2|Overall Study|Lost to Follow-up|2
5870350|NCT01969799|20305125|P1|Overall Study|Lost to Follow-up|0
5870351|NCT01969799|20305124|P2|Overall Study|Death|11
5870352|NCT01969799|20305125|P1|Overall Study|Death|16
5870353|NCT01969799|20305124|P2|Overall Study|Adverse Event|1
5870354|NCT01969799|20305125|P1|Overall Study|Adverse Event|0
5870355|NCT01969721|20305162|P4|Overall Study|Discontinued during washout periods.|2
5870356|NCT01969721|20305163|P3|Overall Study|Discontinued during washout periods.|1
5870357|NCT01969721|20305164|P2|Overall Study|Discontinued during washout periods.|1
5870358|NCT01969721|20305165|P1|Overall Study|Discontinued during washout periods.|0
5870359|NCT01969721|20305162|P4|Overall Study|Other not defined above|0
5870360|NCT01969721|20305163|P3|Overall Study|Other not defined above|0
5870361|NCT01969721|20305164|P2|Overall Study|Other not defined above|2
5870362|NCT01969721|20305165|P1|Overall Study|Other not defined above|0
5870363|NCT01969721|20305162|P4|Overall Study|Non compliant with protocol|2
5870364|NCT01969721|20305163|P3|Overall Study|Non compliant with protocol|0
5870365|NCT01969721|20305164|P2|Overall Study|Non compliant with protocol|1
5870366|NCT01969721|20305165|P1|Overall Study|Non compliant with protocol|1
5870367|NCT01969721|20305162|P4|Overall Study|Lack of Efficacy|0
5870368|NCT01969721|20305163|P3|Overall Study|Lack of Efficacy|1
5870369|NCT01969721|20305164|P2|Overall Study|Lack of Efficacy|0
5870370|NCT01969721|20305165|P1|Overall Study|Lack of Efficacy|0
5870371|NCT01969721|20305162|P4|Overall Study|Adverse Event|2
5870372|NCT01969721|20305163|P3|Overall Study|Adverse Event|3
5870373|NCT01969721|20305164|P2|Overall Study|Adverse Event|8
5870374|NCT01969721|20305165|P1|Overall Study|Adverse Event|3
5870375|NCT01969565|20305210|P1|Overall Study|Withdrawal by Subject|1
5870376|NCT01969500|20305224|P2|Overall Study|extended hospitalization|1
5870377|NCT01969500|20305225|P1|Overall Study|extended hospitalization|1
5870378|NCT01969500|20305224|P2|Overall Study|Death|1
5870379|NCT01969500|20305225|P1|Overall Study|Death|0
5870380|NCT01969084|20305346|P2|Overall Study|Adverse Event|1
5870381|NCT01969084|20305347|P1|Overall Study|Adverse Event|0
5870382|NCT01969058|20305363|P2|Overall Study|Adverse Event|0
5870383|NCT01969058|20305364|P1|Overall Study|Adverse Event|1
5870384|NCT01969058|20305363|P2|Overall Study|Withdrawal by Subject|0
5870385|NCT01969058|20305364|P1|Overall Study|Withdrawal by Subject|2
5870386|NCT01968980|20305408|P2|Overall Study|Other unspecified|2
5870387|NCT01968980|20305409|P1|Overall Study|Other unspecified|1
5870388|NCT01968980|20305408|P2|Overall Study|Withdrawal by Subject|5
5870389|NCT01968980|20305409|P1|Overall Study|Withdrawal by Subject|13
5870390|NCT01968980|20305408|P2|Overall Study|Does not meet entry criteria|3
5870391|NCT01968980|20305409|P1|Overall Study|Does not meet entry criteria|1
5870392|NCT01968980|20305408|P2|Overall Study|Adverse Event|3
5870393|NCT01968980|20305409|P1|Overall Study|Adverse Event|1
5870394|NCT01968980|20305408|P2|Overall Study|Death|1
5870395|NCT01968980|20305409|P1|Overall Study|Death|0
5870396|NCT01968967|20305471|P5|Extension Period|Withdrew Consent|5
5870397|NCT01968967|20305472|P4|Extension Period|Withdrew Consent|0
5870398|NCT01968967|20305473|P3|Extension Period|Withdrew Consent|2
5870399|NCT01968967|20305474|P2|Extension Period|Withdrew Consent|0
5870400|NCT01968967|20305475|P1|Extension Period|Withdrew Consent|0
5870401|NCT01968967|20305471|P5|Treatment Period|Randomized Not Treated|0
5870402|NCT01968967|20305472|P4|Treatment Period|Randomized Not Treated|0
5870403|NCT01968967|20305473|P3|Treatment Period|Randomized Not Treated|0
5870404|NCT01968967|20305474|P2|Treatment Period|Randomized Not Treated|5
5870405|NCT01968967|20305475|P1|Treatment Period|Randomized Not Treated|6
5870406|NCT01968967|20305471|P5|Treatment Period|Death|0
5870407|NCT01968967|20305472|P4|Treatment Period|Death|0
5870408|NCT01968967|20305473|P3|Treatment Period|Death|0
5870409|NCT01968967|20305474|P2|Treatment Period|Death|2
5870410|NCT01968967|20305475|P1|Treatment Period|Death|9
5870411|NCT01968967|20305471|P5|Treatment Period|Adverse Event|0
5870412|NCT01968967|20305472|P4|Treatment Period|Adverse Event|0
5870413|NCT01968967|20305473|P3|Treatment Period|Adverse Event|0
5870414|NCT01968967|20305474|P2|Treatment Period|Adverse Event|8
5870415|NCT01968967|20305475|P1|Treatment Period|Adverse Event|9
5870416|NCT01968967|20305471|P5|Treatment Period|Protocol Violation|0
5870417|NCT01968967|20305472|P4|Treatment Period|Protocol Violation|0
5870418|NCT01968967|20305473|P3|Treatment Period|Protocol Violation|0
5870419|NCT01968967|20305474|P2|Treatment Period|Protocol Violation|2
5870420|NCT01968967|20305475|P1|Treatment Period|Protocol Violation|1
5870421|NCT01968967|20305471|P5|Treatment Period|Lost to Follow-up|0
5870422|NCT01968967|20305472|P4|Treatment Period|Lost to Follow-up|0
5870423|NCT01968967|20305473|P3|Treatment Period|Lost to Follow-up|0
5870424|NCT01968967|20305474|P2|Treatment Period|Lost to Follow-up|31
5870425|NCT01968967|20305475|P1|Treatment Period|Lost to Follow-up|26
5870426|NCT01968967|20305471|P5|Treatment Period|Did Not Meet Entrance Criteria|0
5870427|NCT01968967|20305472|P4|Treatment Period|Did Not Meet Entrance Criteria|0
5870428|NCT01968967|20305473|P3|Treatment Period|Did Not Meet Entrance Criteria|0
5870429|NCT01968967|20305474|P2|Treatment Period|Did Not Meet Entrance Criteria|3
5870430|NCT01968967|20305475|P1|Treatment Period|Did Not Meet Entrance Criteria|2
5870431|NCT01968967|20305471|P5|Treatment Period|Withdrawal by Subject|0
5870432|NCT01968967|20305472|P4|Treatment Period|Withdrawal by Subject|0
5870433|NCT01968967|20305473|P3|Treatment Period|Withdrawal by Subject|0
5870434|NCT01968967|20305474|P2|Treatment Period|Withdrawal by Subject|61
5870435|NCT01968967|20305475|P1|Treatment Period|Withdrawal by Subject|71
5870436|NCT01968967|20305471|P5|Treatment Period|Other|0
5870437|NCT01968967|20305472|P4|Treatment Period|Other|0
5870438|NCT01968967|20305473|P3|Treatment Period|Other|0
5870439|NCT01968967|20305474|P2|Treatment Period|Other|22
5870440|NCT01968967|20305475|P1|Treatment Period|Other|22
5870441|NCT01968954|20305544|P2|Overall Study|Did not met inclusion criteria|2
5870442|NCT01968954|20305545|P1|Overall Study|Did not met inclusion criteria|0
5870443|NCT01968954|20305544|P2|Overall Study|Protocol Violation|1
5870444|NCT01968954|20305545|P1|Overall Study|Protocol Violation|0
5870445|NCT01968954|20305544|P2|Overall Study|Other|8
5870446|NCT01968954|20305545|P1|Overall Study|Other|7
5870447|NCT01968954|20305544|P2|Overall Study|Withdrawal by Subject|23
5870448|NCT01968954|20305545|P1|Overall Study|Withdrawal by Subject|20
5870449|NCT01968954|20305544|P2|Overall Study|Lost to Follow-up|4
5870450|NCT01968954|20305545|P1|Overall Study|Lost to Follow-up|6
5870451|NCT01968954|20305544|P2|Overall Study|Death|2
5870452|NCT01968954|20305545|P1|Overall Study|Death|1
5870453|NCT01968954|20305544|P2|Overall Study|Adverse Event|3
5870454|NCT01968954|20305545|P1|Overall Study|Adverse Event|6
5870455|NCT01968811|20305609|P1|Overall Study|post op.ref. of subject to other hospita|1
5870456|NCT01968811|20305609|P1|Overall Study|Protocol Violation|4
5870457|NCT01968694|20305616|P2|Washout (1 Month)|Lost to Follow-up|1
5870458|NCT01968694|20305617|P1|Washout (1 Month)|Lost to Follow-up|0
5870459|NCT01968551|20305634|P3|Extension Phase|Lost to Follow-up|1
5870460|NCT01968551|20305635|P2|Extension Phase|Lost to Follow-up|0
5870461|NCT01968551|20305636|P1|Extension Phase|Lost to Follow-up|1
5870462|NCT01968551|20305634|P3|Extension Phase|Withdrew Consent|1
5870463|NCT01968551|20305635|P2|Extension Phase|Withdrew Consent|0
5870464|NCT01968551|20305636|P1|Extension Phase|Withdrew Consent|0
5870465|NCT01968551|20305634|P3|Extension Phase|Death|0
5870466|NCT01968551|20305635|P2|Extension Phase|Death|1
5870467|NCT01968551|20305636|P1|Extension Phase|Death|0
5870468|NCT01968551|20305634|P3|Extension Phase|Adverse Event|2
5870469|NCT01968551|20305635|P2|Extension Phase|Adverse Event|0
5870470|NCT01968551|20305636|P1|Extension Phase|Adverse Event|0
5870471|NCT01968551|20305634|P3|Open Label Phase (48 Weeks)|Lost to Follow-up|2
5870472|NCT01968551|20305635|P2|Open Label Phase (48 Weeks)|Lost to Follow-up|0
5870473|NCT01968551|20305636|P1|Open Label Phase (48 Weeks)|Lost to Follow-up|0
5870474|NCT01968551|20305634|P3|Open Label Phase (48 Weeks)|Withdrew Consent|3
5870475|NCT01968551|20305635|P2|Open Label Phase (48 Weeks)|Withdrew Consent|1
5870476|NCT01968551|20305636|P1|Open Label Phase (48 Weeks)|Withdrew Consent|1
5870477|NCT01968551|20305634|P3|Open Label Phase (48 Weeks)|Investigator's Discretion|0
5870478|NCT01968551|20305635|P2|Open Label Phase (48 Weeks)|Investigator's Discretion|1
5870479|NCT01968551|20305636|P1|Open Label Phase (48 Weeks)|Investigator's Discretion|0
5870480|NCT01968551|20305634|P3|Open Label Phase (48 Weeks)|Randomized but Never Treated|0
5870481|NCT01968551|20305635|P2|Open Label Phase (48 Weeks)|Randomized but Never Treated|1
5870482|NCT01968551|20305636|P1|Open Label Phase (48 Weeks)|Randomized but Never Treated|1
5870483|NCT01968434|20305673|P2|Overall Study|Lost to Follow-up|6
5870484|NCT01968434|20305674|P1|Overall Study|Lost to Follow-up|3
5870485|NCT01968226|20305742|P1|Overall Study|[F-18] RDG-K5 was not available|2
5870486|NCT01968213|20305748|P2|Overall Study|Ongoing|9
5870487|NCT01968213|20305749|P1|Overall Study|Ongoing|90
5870488|NCT01968070|20305791|P18|Period 2|Withdrawal by Subject|0
5870489|NCT01968070|20305792|P17|Period 2|Withdrawal by Subject|0
5870490|NCT01968070|20305793|P16|Period 2|Withdrawal by Subject|0
5870491|NCT01968070|20305794|P15|Period 2|Withdrawal by Subject|0
5870492|NCT01968070|20305795|P14|Period 2|Withdrawal by Subject|0
5870493|NCT01968070|20305796|P13|Period 2|Withdrawal by Subject|0
5870494|NCT01968070|20305797|P12|Period 2|Withdrawal by Subject|0
5870495|NCT01968070|20305798|P11|Period 2|Withdrawal by Subject|0
5870496|NCT01968070|20305799|P10|Period 2|Withdrawal by Subject|0
5870497|NCT01968070|20305800|P9|Period 2|Withdrawal by Subject|0
5870498|NCT01968070|20305801|P8|Period 2|Withdrawal by Subject|0
5870499|NCT01968070|20305802|P7|Period 2|Withdrawal by Subject|0
5870500|NCT01968070|20305803|P6|Period 2|Withdrawal by Subject|0
5870501|NCT01968070|20305804|P5|Period 2|Withdrawal by Subject|1
5870502|NCT01968070|20305805|P4|Period 2|Withdrawal by Subject|0
5870503|NCT01968070|20305806|P3|Period 2|Withdrawal by Subject|0
5870504|NCT01968070|20305807|P2|Period 2|Withdrawal by Subject|0
5870505|NCT01968070|20305808|P1|Period 2|Withdrawal by Subject|0
5870506|NCT01968070|20305791|P18|Period 1|Physician Decision|0
5870507|NCT01968070|20305792|P17|Period 1|Physician Decision|0
5870508|NCT01968070|20305793|P16|Period 1|Physician Decision|0
5870509|NCT01968070|20305794|P15|Period 1|Physician Decision|0
5870510|NCT01968070|20305795|P14|Period 1|Physician Decision|0
5870511|NCT01968070|20305796|P13|Period 1|Physician Decision|0
5870512|NCT01968070|20305797|P12|Period 1|Physician Decision|1
5870513|NCT01968070|20305798|P11|Period 1|Physician Decision|0
5870514|NCT01968070|20305799|P10|Period 1|Physician Decision|0
5870515|NCT01968070|20305800|P9|Period 1|Physician Decision|0
5870516|NCT01968070|20305801|P8|Period 1|Physician Decision|0
5870517|NCT01968070|20305802|P7|Period 1|Physician Decision|0
5870518|NCT01968070|20305803|P6|Period 1|Physician Decision|0
5870519|NCT01968070|20305804|P5|Period 1|Physician Decision|0
5870520|NCT01968070|20305805|P4|Period 1|Physician Decision|0
5870521|NCT01968070|20305806|P3|Period 1|Physician Decision|0
5870522|NCT01968070|20305807|P2|Period 1|Physician Decision|0
5870523|NCT01968070|20305808|P1|Period 1|Physician Decision|0
5870524|NCT01968070|20305791|P18|Period 1|Adverse Event|0
5870525|NCT01968070|20305792|P17|Period 1|Adverse Event|0
5870526|NCT01968070|20305793|P16|Period 1|Adverse Event|0
5870527|NCT01968070|20305794|P15|Period 1|Adverse Event|0
5870528|NCT01968070|20305795|P14|Period 1|Adverse Event|0
5870529|NCT01968070|20305796|P13|Period 1|Adverse Event|0
5870530|NCT01968070|20305797|P12|Period 1|Adverse Event|0
5870531|NCT01968070|20305798|P11|Period 1|Adverse Event|0
5870532|NCT01968070|20305799|P10|Period 1|Adverse Event|0
5870533|NCT01968070|20305800|P9|Period 1|Adverse Event|0
5870534|NCT01968070|20305801|P8|Period 1|Adverse Event|0
5870535|NCT01968070|20305802|P7|Period 1|Adverse Event|1
5870536|NCT01968070|20305803|P6|Period 1|Adverse Event|0
5870537|NCT01968070|20305804|P5|Period 1|Adverse Event|0
5870538|NCT01968070|20305805|P4|Period 1|Adverse Event|0
5870539|NCT01968070|20305806|P3|Period 1|Adverse Event|0
5870540|NCT01968070|20305807|P2|Period 1|Adverse Event|0
5870541|NCT01968070|20305808|P1|Period 1|Adverse Event|0
5870542|NCT01968070|20305791|P18|Period 1|Lost to Follow-up|0
5870543|NCT01968070|20305792|P17|Period 1|Lost to Follow-up|0
5870544|NCT01968070|20305793|P16|Period 1|Lost to Follow-up|0
5870545|NCT01968070|20305794|P15|Period 1|Lost to Follow-up|0
5870546|NCT01968070|20305795|P14|Period 1|Lost to Follow-up|0
5870547|NCT01968070|20305796|P13|Period 1|Lost to Follow-up|0
5870548|NCT01968070|20305797|P12|Period 1|Lost to Follow-up|0
5870549|NCT01968070|20305798|P11|Period 1|Lost to Follow-up|0
5870550|NCT01968070|20305799|P10|Period 1|Lost to Follow-up|0
5870551|NCT01968070|20305800|P9|Period 1|Lost to Follow-up|0
5870552|NCT01968070|20305801|P8|Period 1|Lost to Follow-up|0
5870553|NCT01968070|20305802|P7|Period 1|Lost to Follow-up|0
5870554|NCT01968070|20305803|P6|Period 1|Lost to Follow-up|0
5870555|NCT01968070|20305804|P5|Period 1|Lost to Follow-up|0
5870556|NCT01968070|20305805|P4|Period 1|Lost to Follow-up|1
5870557|NCT01968070|20305806|P3|Period 1|Lost to Follow-up|0
5870558|NCT01968070|20305807|P2|Period 1|Lost to Follow-up|0
5870559|NCT01968070|20305808|P1|Period 1|Lost to Follow-up|0
5870560|NCT01968070|20305791|P18|Period 1|Protocol Violation|0
5870561|NCT01968070|20305792|P17|Period 1|Protocol Violation|0
5870562|NCT01968070|20305793|P16|Period 1|Protocol Violation|0
5870563|NCT01968070|20305794|P15|Period 1|Protocol Violation|0
5870564|NCT01968070|20305795|P14|Period 1|Protocol Violation|0
5870565|NCT01968070|20305796|P13|Period 1|Protocol Violation|0
5870566|NCT01968070|20305797|P12|Period 1|Protocol Violation|0
5870567|NCT01968070|20305798|P11|Period 1|Protocol Violation|0
5870568|NCT01968070|20305799|P10|Period 1|Protocol Violation|0
5870569|NCT01968070|20305800|P9|Period 1|Protocol Violation|0
5870570|NCT01968070|20305801|P8|Period 1|Protocol Violation|0
5870571|NCT01968070|20305802|P7|Period 1|Protocol Violation|0
5870572|NCT01968070|20305803|P6|Period 1|Protocol Violation|0
5870573|NCT01968070|20305804|P5|Period 1|Protocol Violation|1
5870574|NCT01968070|20305805|P4|Period 1|Protocol Violation|1
5870575|NCT01968070|20305806|P3|Period 1|Protocol Violation|0
5870576|NCT01968070|20305807|P2|Period 1|Protocol Violation|0
5870577|NCT01968070|20305808|P1|Period 1|Protocol Violation|0
5870578|NCT01968070|20305791|P18|Period 1|Withdrawal by Subject|0
5870579|NCT01968070|20305792|P17|Period 1|Withdrawal by Subject|0
5870580|NCT01968070|20305793|P16|Period 1|Withdrawal by Subject|1
5870581|NCT01968070|20305794|P15|Period 1|Withdrawal by Subject|0
5870582|NCT01968070|20305795|P14|Period 1|Withdrawal by Subject|0
5870583|NCT01968070|20305796|P13|Period 1|Withdrawal by Subject|0
5870584|NCT01968070|20305797|P12|Period 1|Withdrawal by Subject|0
5870585|NCT01968070|20305798|P11|Period 1|Withdrawal by Subject|0
5870586|NCT01968070|20305799|P10|Period 1|Withdrawal by Subject|0
5870587|NCT01968070|20305800|P9|Period 1|Withdrawal by Subject|0
5870588|NCT01968070|20305801|P8|Period 1|Withdrawal by Subject|0
5870589|NCT01968070|20305802|P7|Period 1|Withdrawal by Subject|1
5870590|NCT01968070|20305803|P6|Period 1|Withdrawal by Subject|0
5870591|NCT01968070|20305804|P5|Period 1|Withdrawal by Subject|0
5870592|NCT01968070|20305805|P4|Period 1|Withdrawal by Subject|0
5870593|NCT01968070|20305806|P3|Period 1|Withdrawal by Subject|0
5870594|NCT01968070|20305807|P2|Period 1|Withdrawal by Subject|1
5870595|NCT01968070|20305808|P1|Period 1|Withdrawal by Subject|0
5870596|NCT01968031|20305879|P3|Overall Study|Prohibited concomitant medication|0
5870597|NCT01968031|20305880|P2|Overall Study|Prohibited concomitant medication|0
5870598|NCT01968031|20305881|P1|Overall Study|Prohibited concomitant medication|1
5870599|NCT01968031|20305879|P3|Overall Study|Death|1
5870600|NCT01968031|20305880|P2|Overall Study|Death|0
5870601|NCT01968031|20305881|P1|Overall Study|Death|0
5870602|NCT01968031|20305879|P3|Overall Study|Failed inclusion criteria|0
5870603|NCT01968031|20305880|P2|Overall Study|Failed inclusion criteria|2
5870604|NCT01968031|20305881|P1|Overall Study|Failed inclusion criteria|0
5870605|NCT01968031|20305879|P3|Overall Study|Noncompliance|2
5870606|NCT01968031|20305880|P2|Overall Study|Noncompliance|0
5870607|NCT01968031|20305881|P1|Overall Study|Noncompliance|0
5870608|NCT01968031|20305879|P3|Overall Study|Did not meet entry criteria|1
5870609|NCT01968031|20305880|P2|Overall Study|Did not meet entry criteria|1
5870610|NCT01968031|20305881|P1|Overall Study|Did not meet entry criteria|1
5870611|NCT01968031|20305879|P3|Overall Study|Withdrawal by Subject|3
5870612|NCT01968031|20305880|P2|Overall Study|Withdrawal by Subject|7
5870613|NCT01968031|20305881|P1|Overall Study|Withdrawal by Subject|3
5870614|NCT01968031|20305879|P3|Overall Study|Adverse Event|22
5870615|NCT01968031|20305880|P2|Overall Study|Adverse Event|10
5870616|NCT01968031|20305881|P1|Overall Study|Adverse Event|13
5870617|NCT01967940|20305925|P4|Part 2|Unknown Reason|1
5870618|NCT01967940|20305926|P3|Part 2|Unknown Reason|0
5870619|NCT01967940|20305927|P2|Part 2|Unknown Reason|0
5870620|NCT01967940|20305928|P1|Part 2|Unknown Reason|0
5870621|NCT01967940|20305925|P4|Part 2|Adverse Event|1
5870622|NCT01967940|20305926|P3|Part 2|Adverse Event|0
5870623|NCT01967940|20305927|P2|Part 2|Adverse Event|0
5870624|NCT01967940|20305928|P1|Part 2|Adverse Event|0
5870625|NCT01967940|20305925|P4|Part 2|Enrolled in Part 2 and Never Treated|1
5870626|NCT01967940|20305926|P3|Part 2|Enrolled in Part 2 and Never Treated|0
5870627|NCT01967940|20305927|P2|Part 2|Enrolled in Part 2 and Never Treated|0
5870628|NCT01967940|20305928|P1|Part 2|Enrolled in Part 2 and Never Treated|0
5870629|NCT01967888|20305956|P2|Overall Study|Subject Unable To Comply With Final Day|1
5870630|NCT01967888|20305957|P1|Overall Study|Subject Unable To Comply With Final Day|0
5870631|NCT01967888|20305956|P2|Overall Study|Patient didn't proceed to pancreatectomy|1
5870632|NCT01967888|20305957|P1|Overall Study|Patient didn't proceed to pancreatectomy|0
5870633|NCT01967888|20305956|P2|Overall Study|Subject excluded after randomization|0
5870634|NCT01967888|20305957|P1|Overall Study|Subject excluded after randomization|1
5870635|NCT01967888|20305956|P2|Overall Study|Research visit not done, data recorded|0
5870636|NCT01967888|20305957|P1|Overall Study|Research visit not done, data recorded|1
5870637|NCT01967888|20305956|P2|Overall Study|Did Not Have Transplant|0
5870638|NCT01967888|20305957|P1|Overall Study|Did Not Have Transplant|1
5870639|NCT01967888|20305956|P2|Overall Study|Withdrawal by Subject|1
5870640|NCT01967888|20305957|P1|Overall Study|Withdrawal by Subject|1
5870641|NCT01967888|20305956|P2|Overall Study|Lost to Follow-up|4
5870642|NCT01967888|20305957|P1|Overall Study|Lost to Follow-up|6
5870643|NCT01967732|20306045|P4|First Intervention (Day 1)|Poor venous access|0
5870644|NCT01967732|20306046|P3|First Intervention (Day 1)|Poor venous access|0
5870645|NCT01967732|20306047|P2|First Intervention (Day 1)|Poor venous access|1
5870646|NCT01967732|20306048|P1|First Intervention (Day 1)|Poor venous access|0
5870647|NCT01967732|20306045|P4|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0
5870648|NCT01967732|20306046|P3|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0
5870649|NCT01967732|20306047|P2|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|1
5870650|NCT01967732|20306048|P1|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0
5870651|NCT01967719|20306062|P4|Second Intervention (Day 3)|Withdrawal by Subject|0
5870652|NCT01967719|20306063|P3|Second Intervention (Day 3)|Withdrawal by Subject|0
5870653|NCT01967719|20306064|P2|Second Intervention (Day 3)|Withdrawal by Subject|1
5870654|NCT01967719|20306065|P1|Second Intervention (Day 3)|Withdrawal by Subject|0
5870655|NCT01967719|20306062|P4|First Intervention (Day 1)|Withdrawal by Subject|1
5870656|NCT01967719|20306063|P3|First Intervention (Day 1)|Withdrawal by Subject|0
5870657|NCT01967719|20306064|P2|First Intervention (Day 1)|Withdrawal by Subject|1
5870658|NCT01967719|20306065|P1|First Intervention (Day 1)|Withdrawal by Subject|0
5870659|NCT01967706|20306080|P4|First Intervention (Day 1)|Withdrawal by Subject|0
5870660|NCT01967706|20306081|P3|First Intervention (Day 1)|Withdrawal by Subject|0
5870661|NCT01967706|20306082|P2|First Intervention (Day 1)|Withdrawal by Subject|0
5870662|NCT01967706|20306083|P1|First Intervention (Day 1)|Withdrawal by Subject|1
5870663|NCT01967628|20306104|P2|Overall Study|Low protein concentration in sample|25
5870664|NCT01967628|20306105|P1|Overall Study|Low protein concentration in sample|20
5870665|NCT01967628|20306104|P2|Overall Study|Lost to Follow-up|0
5870666|NCT01967628|20306105|P1|Overall Study|Lost to Follow-up|1
5870667|NCT01967628|20306104|P2|Overall Study|Unable to complete bronchoscopy|6
5870668|NCT01967628|20306105|P1|Overall Study|Unable to complete bronchoscopy|4
5870669|NCT01967628|20306104|P2|Overall Study|Withdrawal by Subject|0
5870670|NCT01967628|20306105|P1|Overall Study|Withdrawal by Subject|2
5870671|NCT01967576|20306111|P1|Overall Study|Refused further treatment|1
5870672|NCT01967576|20306111|P1|Overall Study|Adverse Event|1
5870673|NCT01967576|20306111|P1|Overall Study|Study closing at site|1
5870674|NCT01967576|20306111|P1|Overall Study|Progressed/Removed from treatment|1
5870675|NCT01967576|20306111|P1|Overall Study|Withdrawal by Subject|3
5870676|NCT01967550|20306122|P2|Overall Study|Non Compliance|1
5870677|NCT01967550|20306123|P1|Overall Study|Non Compliance|0
5870678|NCT01967550|20306122|P2|Overall Study|Protocol Violation|1
5870679|NCT01967550|20306123|P1|Overall Study|Protocol Violation|2
5870680|NCT01967550|20306122|P2|Overall Study|Adverse Event|0
5870681|NCT01967550|20306123|P1|Overall Study|Adverse Event|2
5870682|NCT01967550|20306122|P2|Overall Study|Withdrawal by Subject|0
5870683|NCT01967550|20306123|P1|Overall Study|Withdrawal by Subject|1
5870684|NCT01967537|20306129|P1|Overall Study|Lost to Follow-up|6
5870685|NCT01967537|20306129|P1|Overall Study|Refuse treatment|2
5870686|NCT01967537|20306129|P1|Overall Study|Withdrawal by Subject|52
5870687|NCT01967277|20306183|P2|Overall Study|Unrelated illness|1
5870688|NCT01967277|20306184|P1|Overall Study|Unrelated illness|0
5870689|NCT01967277|20306183|P2|Overall Study|Lost to Follow-up|2
5870690|NCT01967277|20306184|P1|Overall Study|Lost to Follow-up|1
5870691|NCT01967225|20306196|P2|Overall Study|Protocol Violation|0
5870692|NCT01967225|20306197|P1|Overall Study|Protocol Violation|2
5870693|NCT01967225|20306196|P2|Overall Study|Logistical difficulties|0
5870694|NCT01967225|20306197|P1|Overall Study|Logistical difficulties|1
5870695|NCT01967225|20306196|P2|Overall Study|Protocol driven decision point|0
5870696|NCT01967225|20306197|P1|Overall Study|Protocol driven decision point|1
5870697|NCT01967225|20306196|P2|Overall Study|Switching to other therapy|0
5870698|NCT01967225|20306197|P1|Overall Study|Switching to other therapy|2
5870699|NCT01967225|20306196|P2|Overall Study|Lack of Efficacy|1
5870700|NCT01967225|20306197|P1|Overall Study|Lack of Efficacy|1
5870701|NCT01967225|20306196|P2|Overall Study|Withdrawal by Subject|1
5870702|NCT01967225|20306197|P1|Overall Study|Withdrawal by Subject|2
5870703|NCT01967225|20306196|P2|Overall Study|Adverse Event|1
5870704|NCT01967225|20306197|P1|Overall Study|Adverse Event|3
5870705|NCT01967173|20306229|P8|Overall Study|Withdrawal by Subject|12
5870706|NCT01967173|20306230|P7|Overall Study|Withdrawal by Subject|10
5870707|NCT01967173|20306231|P6|Overall Study|Withdrawal by Subject|9
5870708|NCT01967173|20306232|P5|Overall Study|Withdrawal by Subject|8
5870709|NCT01967173|20306233|P4|Overall Study|Withdrawal by Subject|7
5870710|NCT01967173|20306234|P3|Overall Study|Withdrawal by Subject|10
5870711|NCT01967173|20306235|P2|Overall Study|Withdrawal by Subject|14
5870712|NCT01967173|20306236|P1|Overall Study|Withdrawal by Subject|15
5870713|NCT01967173|20306229|P8|Overall Study|Adverse Event|1
5870714|NCT01967173|20306230|P7|Overall Study|Adverse Event|0
5870715|NCT01967173|20306231|P6|Overall Study|Adverse Event|0
5870716|NCT01967173|20306232|P5|Overall Study|Adverse Event|0
5870717|NCT01967173|20306233|P4|Overall Study|Adverse Event|0
5870718|NCT01967173|20306234|P3|Overall Study|Adverse Event|0
5870719|NCT01967173|20306235|P2|Overall Study|Adverse Event|0
5870720|NCT01967173|20306236|P1|Overall Study|Adverse Event|0
5870721|NCT01967173|20306229|P8|Overall Study|Pregnancy|1
5870722|NCT01967173|20306230|P7|Overall Study|Pregnancy|1
5870723|NCT01967173|20306231|P6|Overall Study|Pregnancy|0
5870724|NCT01967173|20306232|P5|Overall Study|Pregnancy|0
5870725|NCT01967173|20306233|P4|Overall Study|Pregnancy|0
5870726|NCT01967173|20306234|P3|Overall Study|Pregnancy|0
5870727|NCT01967173|20306235|P2|Overall Study|Pregnancy|0
5870728|NCT01967173|20306236|P1|Overall Study|Pregnancy|0
5870729|NCT01967173|20306229|P8|Overall Study|Lack of Efficacy|2
5870730|NCT01967173|20306230|P7|Overall Study|Lack of Efficacy|0
5870731|NCT01967173|20306231|P6|Overall Study|Lack of Efficacy|1
5870732|NCT01967173|20306232|P5|Overall Study|Lack of Efficacy|0
5870733|NCT01967173|20306233|P4|Overall Study|Lack of Efficacy|2
5870734|NCT01967173|20306234|P3|Overall Study|Lack of Efficacy|2
5870735|NCT01967173|20306235|P2|Overall Study|Lack of Efficacy|0
5870736|NCT01967173|20306236|P1|Overall Study|Lack of Efficacy|2
5870737|NCT01967173|20306229|P8|Overall Study|Physician Decision|0
5870738|NCT01967173|20306230|P7|Overall Study|Physician Decision|1
5870739|NCT01967173|20306231|P6|Overall Study|Physician Decision|1
5870740|NCT01967173|20306232|P5|Overall Study|Physician Decision|1
5870741|NCT01967173|20306233|P4|Overall Study|Physician Decision|1
5870742|NCT01967173|20306234|P3|Overall Study|Physician Decision|2
5870743|NCT01967173|20306235|P2|Overall Study|Physician Decision|0
5870744|NCT01967173|20306236|P1|Overall Study|Physician Decision|2
5870745|NCT01967173|20306229|P8|Overall Study|Lost to Follow-up|8
5870746|NCT01967173|20306230|P7|Overall Study|Lost to Follow-up|6
5870747|NCT01967173|20306231|P6|Overall Study|Lost to Follow-up|12
5870748|NCT01967173|20306232|P5|Overall Study|Lost to Follow-up|8
5870749|NCT01967173|20306233|P4|Overall Study|Lost to Follow-up|4
5870750|NCT01967173|20306234|P3|Overall Study|Lost to Follow-up|2
5870751|NCT01967173|20306235|P2|Overall Study|Lost to Follow-up|3
5870752|NCT01967173|20306236|P1|Overall Study|Lost to Follow-up|5
5870753|NCT01967147|20306250|P2|Overall Study|Other|5
5870754|NCT01967147|20306251|P1|Overall Study|Other|4
5870755|NCT01967147|20306250|P2|Overall Study|Non-compliance with Study Drug|3
5870756|NCT01967147|20306251|P1|Overall Study|Non-compliance with Study Drug|0
5870757|NCT01967147|20306250|P2|Overall Study|Withdrawal by Subject|4
5870758|NCT01967147|20306251|P1|Overall Study|Withdrawal by Subject|2
5870759|NCT01967147|20306250|P2|Overall Study|Lost to Follow-up|2
5870760|NCT01967147|20306251|P1|Overall Study|Lost to Follow-up|1
5870761|NCT01967147|20306250|P2|Overall Study|Lack of Efficacy|4
5870762|NCT01967147|20306251|P1|Overall Study|Lack of Efficacy|1
5870763|NCT01967147|20306250|P2|Overall Study|Adverse Event|2
5870764|NCT01967147|20306251|P1|Overall Study|Adverse Event|5
5870765|NCT01967134|20306269|P3|Overall Study|Lost to Follow-up|0
5870766|NCT01967134|20306270|P2|Overall Study|Lost to Follow-up|1
5870767|NCT01967134|20306271|P1|Overall Study|Lost to Follow-up|0
5870768|NCT01967069|20306306|P2|Overall Study|Lack of Efficacy|1
5870769|NCT01967069|20306307|P1|Overall Study|Lack of Efficacy|0
5870770|NCT01967069|20306306|P2|Overall Study|Withdrawal by Subject|3
5870771|NCT01967069|20306307|P1|Overall Study|Withdrawal by Subject|1
5870772|NCT01967069|20306306|P2|Overall Study|Lost to Follow-up|2
5870773|NCT01967069|20306307|P1|Overall Study|Lost to Follow-up|5
5870774|NCT01967069|20306306|P2|Overall Study|Adverse Event|2
5870775|NCT01967069|20306307|P1|Overall Study|Adverse Event|2
5870776|NCT01966731|20306505|P1|Overall Study|Found to be ineligible|1
5870777|NCT01966731|20306505|P1|Overall Study|Screening Failure|29
5870778|NCT01966731|20306505|P1|Overall Study|Follow up is not complete|600
5870779|NCT01966731|20306505|P1|Overall Study|Physician Decision|2
5870780|NCT01966731|20306505|P1|Overall Study|Lost to Follow-up|1
5870781|NCT01966731|20306505|P1|Overall Study|Death|2
5870782|NCT01966471|20306519|P2|Overall Study|Withdrawal by Subject|43
5870783|NCT01966471|20306520|P1|Overall Study|Withdrawal by Subject|48
5870784|NCT01966471|20306519|P2|Overall Study|Physician Decision|5
5870785|NCT01966471|20306520|P1|Overall Study|Physician Decision|5
5870786|NCT01966471|20306519|P2|Overall Study|Other|5
5870787|NCT01966471|20306520|P1|Overall Study|Other|3
5870788|NCT01966471|20306519|P2|Overall Study|Lost to Follow-up|16
5870789|NCT01966471|20306520|P1|Overall Study|Lost to Follow-up|14
5870790|NCT01966471|20306519|P2|Overall Study|Death|44
5870791|NCT01966471|20306520|P1|Overall Study|Death|33
5870792|NCT01966445|20306554|P7|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|2
5870793|NCT01966445|20306555|P6|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0
5870794|NCT01966445|20306556|P5|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0
5870795|NCT01966445|20306557|P4|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0
5870796|NCT01966445|20306558|P3|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0
5870797|NCT01966445|20306559|P2|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0
5870798|NCT01966445|20306560|P1|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0
5870799|NCT01966445|20306554|P7|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|3
5870800|NCT01966445|20306555|P6|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0
5870801|NCT01966445|20306556|P5|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0
5870802|NCT01966445|20306557|P4|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0
5870803|NCT01966445|20306558|P3|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0
5870804|NCT01966445|20306559|P2|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0
5870805|NCT01966445|20306560|P1|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0
5870806|NCT01966445|20306554|P7|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0
5870807|NCT01966445|20306555|P6|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0
5870808|NCT01966445|20306556|P5|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|2
5870809|NCT01966445|20306557|P4|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0
5870810|NCT01966445|20306558|P3|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1
5870811|NCT01966445|20306559|P2|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1
5870812|NCT01966445|20306560|P1|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0
5870813|NCT01966445|20306554|P7|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0
5870814|NCT01966445|20306555|P6|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0
5870815|NCT01966445|20306556|P5|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1
5870816|NCT01966445|20306557|P4|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1
5870817|NCT01966445|20306558|P3|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0
5870818|NCT01966445|20306559|P2|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1
5870819|NCT01966445|20306560|P1|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0
5870820|NCT01966445|20306554|P7|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0
5870821|NCT01966445|20306555|P6|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|1
5870822|NCT01966445|20306556|P5|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0
5870823|NCT01966445|20306557|P4|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|2
5870824|NCT01966445|20306558|P3|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0
5870825|NCT01966445|20306559|P2|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0
5870826|NCT01966445|20306560|P1|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0
5870827|NCT01966432|20306670|P3|Overall Study|SBIRT program ended|20
5870828|NCT01966432|20306671|P2|Overall Study|SBIRT program ended|8
5870829|NCT01966432|20306672|P1|Overall Study|SBIRT program ended|1
5870830|NCT01966432|20306670|P3|Overall Study|Subject Incarcerated|1
5870831|NCT01966432|20306671|P2|Overall Study|Subject Incarcerated|0
5870832|NCT01966432|20306672|P1|Overall Study|Subject Incarcerated|0
5870833|NCT01966432|20306670|P3|Overall Study|Withdrawal by Subject|0
5870834|NCT01966432|20306671|P2|Overall Study|Withdrawal by Subject|3
5870835|NCT01966432|20306672|P1|Overall Study|Withdrawal by Subject|1
5870836|NCT01966432|20306670|P3|Overall Study|Lost to Follow-up|5
5870837|NCT01966432|20306671|P2|Overall Study|Lost to Follow-up|2
5870838|NCT01966432|20306672|P1|Overall Study|Lost to Follow-up|3
5870839|NCT01966120|20306742|P2|Overall Study|Lost to Follow-up|1
5870840|NCT01966120|20306743|P1|Overall Study|Lost to Follow-up|1
5870841|NCT01966120|20306742|P2|Overall Study|Withdrawal by Subject|5
5870842|NCT01966120|20306743|P1|Overall Study|Withdrawal by Subject|0
5870843|NCT01966107|20306767|P2|Overall Study|withdrew from the study|303
5870844|NCT01966107|20306768|P1|Overall Study|withdrew from the study|272
5870845|NCT01966107|20306767|P2|Overall Study|due to study closure|186
5870846|NCT01966107|20306768|P1|Overall Study|due to study closure|164
5870847|NCT01966107|20306767|P2|Overall Study|discontinued treatment|372
5870848|NCT01966107|20306768|P1|Overall Study|discontinued treatment|345
5870849|NCT01966107|20306767|P2|Overall Study|excluded from FAS|20
5870850|NCT01966107|20306768|P1|Overall Study|excluded from FAS|21
5870851|NCT01966068|20306782|P1|Overall Study|Lost to Follow-up|81
5870852|NCT01966068|20306782|P1|Overall Study|Withdrawal by Subject|57
5870853|NCT01966042|20306787|P1|Overall Study|Death|2
5870854|NCT01966003|20306796|P2|Overall Study|Other|1
5870855|NCT01966003|20306797|P1|Overall Study|Other|1
5870856|NCT01966003|20306796|P2|Overall Study|Plan to Receive Commercial Bevacizumab|67
5870857|NCT01966003|20306797|P1|Overall Study|Plan to Receive Commercial Bevacizumab|44
5870858|NCT01966003|20306796|P2|Overall Study|Plan to Receive Other Anticancer Therapy|127
5870859|NCT01966003|20306797|P1|Overall Study|Plan to Receive Other Anticancer Therapy|131
5870860|NCT01966003|20306796|P2|Overall Study|Withdrawal by Subject|19
5870861|NCT01966003|20306797|P1|Overall Study|Withdrawal by Subject|29
5870862|NCT01966003|20306796|P2|Overall Study|Physician Decision|13
5870863|NCT01966003|20306797|P1|Overall Study|Physician Decision|12
5870864|NCT01966003|20306796|P2|Overall Study|Lost to Follow-up|3
5870865|NCT01966003|20306797|P1|Overall Study|Lost to Follow-up|4
5870866|NCT01966003|20306796|P2|Overall Study|Protocol Violation|4
5870867|NCT01966003|20306797|P1|Overall Study|Protocol Violation|6
5870868|NCT01966003|20306796|P2|Overall Study|Death|36
5870869|NCT01966003|20306797|P1|Overall Study|Death|43
5870870|NCT01965938|20306815|P2|Overall Study|Withdrawal by Subject|0
5870871|NCT01965938|20306816|P1|Overall Study|Withdrawal by Subject|1
5870872|NCT01965834|20306847|P1|Overall Study|Lack of Efficacy|4
5870873|NCT01965652|20306888|P2|Overall Study|Pregnancy|1
5870874|NCT01965652|20306889|P1|Overall Study|Pregnancy|0
5870875|NCT01965652|20306888|P2|Overall Study|Other - Miscellaneous|21
5870876|NCT01965652|20306889|P1|Overall Study|Other - Miscellaneous|18
5870877|NCT01965652|20306888|P2|Overall Study|Death|4
5870878|NCT01965652|20306889|P1|Overall Study|Death|3
5870879|NCT01965652|20306888|P2|Overall Study|Protocol Violation|38
5870880|NCT01965652|20306889|P1|Overall Study|Protocol Violation|34
5870881|NCT01965652|20306888|P2|Overall Study|Lost to Follow-up|40
5870882|NCT01965652|20306889|P1|Overall Study|Lost to Follow-up|53
5870883|NCT01965652|20306888|P2|Overall Study|Withdrawal by Subject|69
5870884|NCT01965652|20306889|P1|Overall Study|Withdrawal by Subject|62
5870885|NCT01965652|20306888|P2|Overall Study|Adverse Event|37
5870886|NCT01965652|20306889|P1|Overall Study|Adverse Event|40
5870887|NCT01965600|20306919|P4|Second Intervention|Study terminated by Sponsor|2
5870888|NCT01965600|20306920|P3|Second Intervention|Study terminated by Sponsor|2
5870889|NCT01965600|20306921|P2|Second Intervention|Study terminated by Sponsor|0
5870890|NCT01965600|20306922|P1|Second Intervention|Study terminated by Sponsor|0
5870891|NCT01965600|20306919|P4|Washout Period of Approximately 15 Days|Adverse Event|1
5870892|NCT01965600|20306920|P3|Washout Period of Approximately 15 Days|Adverse Event|0
5870893|NCT01965600|20306921|P2|Washout Period of Approximately 15 Days|Adverse Event|0
5870894|NCT01965600|20306922|P1|Washout Period of Approximately 15 Days|Adverse Event|0
5870895|NCT01965600|20306919|P4|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0
5870896|NCT01965600|20306920|P3|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0
5870897|NCT01965600|20306921|P2|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0
5870898|NCT01965600|20306922|P1|Washout Period of Approximately 15 Days|Did not meet entrance criteria|1
5870899|NCT01965600|20306919|P4|Washout Period of Approximately 15 Days|Withdrawal by Subject|0
5870900|NCT01965600|20306920|P3|Washout Period of Approximately 15 Days|Withdrawal by Subject|0
5870901|NCT01965600|20306921|P2|Washout Period of Approximately 15 Days|Withdrawal by Subject|1
5870902|NCT01965600|20306922|P1|Washout Period of Approximately 15 Days|Withdrawal by Subject|0
5870903|NCT01965600|20306919|P4|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1
5870904|NCT01965600|20306920|P3|Washout Period of Approximately 15 Days|Study terminated by Sponsor|2
5870905|NCT01965600|20306921|P2|Washout Period of Approximately 15 Days|Study terminated by Sponsor|3
5870906|NCT01965600|20306922|P1|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1
5870907|NCT01965535|20306979|P2|Overall Study|Lack of Efficacy|1
5870908|NCT01965535|20306980|P1|Overall Study|Lack of Efficacy|2
5870909|NCT01965431|20306994|P6|Overall Study|Other than stated above|6
5870910|NCT01965431|20306995|P5|Overall Study|Other than stated above|6
5870911|NCT01965431|20306996|P4|Overall Study|Other than stated above|6
5870912|NCT01965431|20306997|P3|Overall Study|Other than stated above|6
5870913|NCT01965431|20306998|P2|Overall Study|Other than stated above|5
5870914|NCT01965431|20306999|P1|Overall Study|Other than stated above|6
5870915|NCT01965431|20306994|P6|Overall Study|Adverse Event|0
5870916|NCT01965431|20306995|P5|Overall Study|Adverse Event|0
5870917|NCT01965431|20306996|P4|Overall Study|Adverse Event|0
5870918|NCT01965431|20306997|P3|Overall Study|Adverse Event|0
5870919|NCT01965431|20306998|P2|Overall Study|Adverse Event|1
5870920|NCT01965431|20306999|P1|Overall Study|Adverse Event|0
5870921|NCT01965327|20307023|P1|Overall Study|Physician Decision|2
5870922|NCT01965262|20307237|P2|Second Intervention (7 Days)|Poor visual acuity|0
5870923|NCT01965262|20307238|P1|Second Intervention (7 Days)|Poor visual acuity|1
5870924|NCT01965262|20307237|P2|Second Intervention (7 Days)|Poor lens fit|9
5870925|NCT01965262|20307238|P1|Second Intervention (7 Days)|Poor lens fit|0
5870926|NCT01965262|20307237|P2|Second Intervention (7 Days)|Discontinued|1
5870927|NCT01965262|20307238|P1|Second Intervention (7 Days)|Discontinued|0
5870928|NCT01965158|20307302|P2|Overall Study|Other - Miscellaneous|0
5870929|NCT01965158|20307303|P1|Overall Study|Other - Miscellaneous|3
5870930|NCT01965158|20307302|P2|Overall Study|Protocol Violation|1
5870931|NCT01965158|20307303|P1|Overall Study|Protocol Violation|1
5870932|NCT01965158|20307302|P2|Overall Study|Lost to Follow-up|5
5870933|NCT01965158|20307303|P1|Overall Study|Lost to Follow-up|7
5870934|NCT01965158|20307302|P2|Overall Study|Withdrawal by Subject|24
5870935|NCT01965158|20307303|P1|Overall Study|Withdrawal by Subject|16
5870936|NCT01965158|20307302|P2|Overall Study|Adverse Event|5
5870937|NCT01965158|20307303|P1|Overall Study|Adverse Event|14
5870938|NCT01964976|20307344|P1|Overall Study|Protocol Violation|31
5870939|NCT01964963|20307356|P1|Overall Study|Data Reliability was not Assured|5
5870940|NCT01964963|20307356|P1|Overall Study|Protocol Deviation|50
5870941|NCT01964963|20307356|P1|Overall Study|Case Report Forms Uncollected|888
5870942|NCT01964950|20307364|P1|Overall Study|Protocol Violation|25
5870943|NCT01964924|20307376|P2|Trametinib Monotherapy|Progression|0
5870944|NCT01964924|20307377|P1|Trametinib Monotherapy|Progression|19
5870945|NCT01964898|20307401|P2|Overall Study|Withdrawal by Subject|0
5870946|NCT01964898|20307402|P1|Overall Study|Withdrawal by Subject|1
5870947|NCT01964898|20307401|P2|Overall Study|Lost to Follow-up|5
5870948|NCT01964898|20307402|P1|Overall Study|Lost to Follow-up|3
5870949|NCT01964898|20307401|P2|Overall Study|did not receive the allocated interventi|1
5870950|NCT01964898|20307402|P1|Overall Study|did not receive the allocated interventi|2
5870951|NCT01964898|20307401|P2|Overall Study|ineligible post-randomization|1
5870952|NCT01964898|20307402|P1|Overall Study|ineligible post-randomization|1
5870953|NCT01964755|20307422|P1|Overall Study|Death|2
5870954|NCT01964716|20307437|P2|Overall Study|Death|0
5870955|NCT01964716|20307438|P1|Overall Study|Death|1
5870956|NCT01964716|20307437|P2|Overall Study|No longer met eligibility criteria|1
5870957|NCT01964716|20307438|P1|Overall Study|No longer met eligibility criteria|1
5870958|NCT01964716|20307437|P2|Overall Study|Lost to Follow-up|2
5870959|NCT01964716|20307438|P1|Overall Study|Lost to Follow-up|1
5870960|NCT01964716|20307437|P2|Overall Study|Withdrawal by Subject|3
5870961|NCT01964716|20307438|P1|Overall Study|Withdrawal by Subject|2
5870962|NCT01964547|20307476|P2|Overall Study|Withdrawal by Investigator|1
5870963|NCT01964547|20307477|P1|Overall Study|Withdrawal by Investigator|0
5870964|NCT01964547|20307476|P2|Overall Study|Lost to Follow-up|1
5870965|NCT01964547|20307477|P1|Overall Study|Lost to Follow-up|0
5870966|NCT01964547|20307476|P2|Overall Study|Withdrawal by Subject|7
5870967|NCT01964547|20307477|P1|Overall Study|Withdrawal by Subject|4
5870968|NCT01964547|20307476|P2|Overall Study|Adverse Event|2
5870969|NCT01964547|20307477|P1|Overall Study|Adverse Event|8
5870970|NCT01964521|20307501|P1|Overall Study|Lost to Follow-up|4
5870971|NCT01964430|20307508|P2|Overall Study|Randomized but not Treated|11
5870972|NCT01964430|20307509|P1|Overall Study|Randomized but not Treated|3
5870973|NCT01964430|20307508|P2|Overall Study|Miscellaneous|3
5870974|NCT01964430|20307509|P1|Overall Study|Miscellaneous|1
5870975|NCT01964430|20307508|P2|Overall Study|Disease Relapse|38
5870976|NCT01964430|20307509|P1|Overall Study|Disease Relapse|28
5870977|NCT01964430|20307508|P2|Overall Study|Physician Decision|4
5870978|NCT01964430|20307509|P1|Overall Study|Physician Decision|5
5870979|NCT01964430|20307508|P2|Overall Study|Protocol Deviation|1
5870980|NCT01964430|20307509|P1|Overall Study|Protocol Deviation|0
5870981|NCT01964430|20307508|P2|Overall Study|Death|3
5870982|NCT01964430|20307509|P1|Overall Study|Death|1
5870983|NCT01964430|20307508|P2|Overall Study|Withdrawal by Subject|27
5870984|NCT01964430|20307509|P1|Overall Study|Withdrawal by Subject|36
5870985|NCT01964430|20307508|P2|Overall Study|Adverse Event|37
5870986|NCT01964430|20307509|P1|Overall Study|Adverse Event|71
5870987|NCT01964378|20307521|P2|Overall Study|Other|2
5870988|NCT01964378|20307522|P1|Overall Study|Other|1
5870989|NCT01964378|20307521|P2|Overall Study|Inclusion/exclusion criteria not met|3
5870990|NCT01964378|20307522|P1|Overall Study|Inclusion/exclusion criteria not met|1
5870991|NCT01964378|20307521|P2|Overall Study|Withdrawal by Subject|5
5870992|NCT01964378|20307522|P1|Overall Study|Withdrawal by Subject|7
5870993|NCT01964378|20307521|P2|Overall Study|Lost to Follow-up|1
5870994|NCT01964378|20307522|P1|Overall Study|Lost to Follow-up|0
5870995|NCT01964378|20307521|P2|Overall Study|Protocol Violation|1
5870996|NCT01964378|20307522|P1|Overall Study|Protocol Violation|0
5870997|NCT01964378|20307521|P2|Overall Study|Lack of Efficacy|1
5870998|NCT01964378|20307522|P1|Overall Study|Lack of Efficacy|0
5870999|NCT01964378|20307521|P2|Overall Study|Adverse Event|5
5871000|NCT01964378|20307522|P1|Overall Study|Adverse Event|12
5871001|NCT01964378|20307521|P2|Overall Study|Death|2
5871002|NCT01964378|20307522|P1|Overall Study|Death|3
5871003|NCT01964378|20307521|P2|Overall Study|Disc. due to AE before first dosing|0
5871004|NCT01964378|20307522|P1|Overall Study|Disc. due to AE before first dosing|1
5871005|NCT01964378|20307521|P2|Overall Study|Disc. due to death before first dosing|1
5871006|NCT01964378|20307522|P1|Overall Study|Disc. due to death before first dosing|0
5871007|NCT01964352|20307558|P4|Overall Study|Other than stated above|2
5871008|NCT01964352|20307559|P3|Overall Study|Other than stated above|1
5871009|NCT01964352|20307560|P2|Overall Study|Other than stated above|2
5871010|NCT01964352|20307561|P1|Overall Study|Other than stated above|0
5871011|NCT01964352|20307558|P4|Overall Study|Withdrawal by Subject|0
5871012|NCT01964352|20307559|P3|Overall Study|Withdrawal by Subject|1
5871013|NCT01964352|20307560|P2|Overall Study|Withdrawal by Subject|2
5871014|NCT01964352|20307561|P1|Overall Study|Withdrawal by Subject|4
5871015|NCT01964352|20307558|P4|Overall Study|Lost to Follow-up|1
5871016|NCT01964352|20307559|P3|Overall Study|Lost to Follow-up|0
5871017|NCT01964352|20307560|P2|Overall Study|Lost to Follow-up|0
5871018|NCT01964352|20307561|P1|Overall Study|Lost to Follow-up|1
5871019|NCT01964352|20307558|P4|Overall Study|Protocol Violation|2
5871020|NCT01964352|20307559|P3|Overall Study|Protocol Violation|0
5871021|NCT01964352|20307560|P2|Overall Study|Protocol Violation|4
5871022|NCT01964352|20307561|P1|Overall Study|Protocol Violation|2
5871023|NCT01964352|20307558|P4|Overall Study|Lack of Efficacy|0
5871024|NCT01964352|20307559|P3|Overall Study|Lack of Efficacy|0
5871025|NCT01964352|20307560|P2|Overall Study|Lack of Efficacy|0
5871026|NCT01964352|20307561|P1|Overall Study|Lack of Efficacy|6
5871027|NCT01964352|20307558|P4|Overall Study|Adverse Event|3
5871028|NCT01964352|20307559|P3|Overall Study|Adverse Event|4
5871029|NCT01964352|20307560|P2|Overall Study|Adverse Event|3
5871030|NCT01964352|20307561|P1|Overall Study|Adverse Event|13
5871042|NCT01964300|20307600|P2|Overall Study|Weight criteria not met|1
5871043|NCT01964300|20307601|P1|Overall Study|Weight criteria not met|0
5871044|NCT01964300|20307600|P2|Overall Study|Enlargement of cyst requiring drainage|0
5871045|NCT01964300|20307601|P1|Overall Study|Enlargement of cyst requiring drainage|1
5871046|NCT01964300|20307600|P2|Overall Study|To receive alternative therapy|2
5871047|NCT01964300|20307601|P1|Overall Study|To receive alternative therapy|1
5871048|NCT01964300|20307600|P2|Overall Study|Withdrawal by Subject|1
5871049|NCT01964300|20307601|P1|Overall Study|Withdrawal by Subject|0
5871050|NCT01964300|20307600|P2|Overall Study|Lack of Efficacy|5
5871051|NCT01964300|20307601|P1|Overall Study|Lack of Efficacy|3
5871052|NCT01964300|20307600|P2|Overall Study|Adverse Event|1
5871053|NCT01964300|20307601|P1|Overall Study|Adverse Event|1
5871054|NCT01964300|20307600|P2|Overall Study|Ineligible after enrollment|1
5871055|NCT01964300|20307601|P1|Overall Study|Ineligible after enrollment|0
5871056|NCT01964222|20307615|P2|Overall Study|Screening Failure|0
5871057|NCT01964222|20307616|P1|Overall Study|Screening Failure|2
5871058|NCT01964222|20307615|P2|Overall Study|Withdrawal by Subject|6
5871059|NCT01964222|20307616|P1|Overall Study|Withdrawal by Subject|6
5871060|NCT01964222|20307615|P2|Overall Study|Lost to Follow-up|5
5871061|NCT01964222|20307616|P1|Overall Study|Lost to Follow-up|7
5871062|NCT01964105|20307633|P3|Overall Study|Lost to Follow-up|0
5871063|NCT01964105|20307634|P2|Overall Study|Lost to Follow-up|13
5871064|NCT01964105|20307635|P1|Overall Study|Lost to Follow-up|2
5871065|NCT01963767|20307694|P2|Overall Study|Adverse Event|0
5871066|NCT01963767|20307695|P1|Overall Study|Adverse Event|2
5871067|NCT01963767|20307694|P2|Overall Study|Withdrawal by Subject|2
5871068|NCT01963767|20307695|P1|Overall Study|Withdrawal by Subject|4
5871069|NCT01963676|20307705|P2|Overall Study|Withdrawal by Subject|0
5871070|NCT01963676|20307706|P1|Overall Study|Withdrawal by Subject|1
5871071|NCT01963611|20307719|P5|Overall Study|Other|45
5871072|NCT01963611|20307720|P4|Overall Study|Other|45
5871073|NCT01963611|20307721|P3|Overall Study|Other|48
5871074|NCT01963611|20307722|P2|Overall Study|Other|46
5871075|NCT01963611|20307723|P1|Overall Study|Other|47
5871076|NCT01963611|20307719|P5|Overall Study|Withdrawal by Subject|3
5871077|NCT01963611|20307720|P4|Overall Study|Withdrawal by Subject|1
5871078|NCT01963611|20307721|P3|Overall Study|Withdrawal by Subject|1
5871079|NCT01963611|20307722|P2|Overall Study|Withdrawal by Subject|2
5871080|NCT01963611|20307723|P1|Overall Study|Withdrawal by Subject|3
5871081|NCT01963611|20307719|P5|Overall Study|Lack of Efficacy|0
5871082|NCT01963611|20307720|P4|Overall Study|Lack of Efficacy|1
5871083|NCT01963611|20307721|P3|Overall Study|Lack of Efficacy|0
5871084|NCT01963611|20307722|P2|Overall Study|Lack of Efficacy|0
5871085|NCT01963611|20307723|P1|Overall Study|Lack of Efficacy|0
5871086|NCT01963611|20307719|P5|Overall Study|Protocol Violation|0
5871087|NCT01963611|20307720|P4|Overall Study|Protocol Violation|1
5871088|NCT01963611|20307721|P3|Overall Study|Protocol Violation|0
5871089|NCT01963611|20307722|P2|Overall Study|Protocol Violation|0
5871090|NCT01963611|20307723|P1|Overall Study|Protocol Violation|0
5871091|NCT01963611|20307719|P5|Overall Study|Adverse Event|3
5871092|NCT01963611|20307720|P4|Overall Study|Adverse Event|4
5871093|NCT01963611|20307721|P3|Overall Study|Adverse Event|3
5871094|NCT01963611|20307722|P2|Overall Study|Adverse Event|1
5871095|NCT01963611|20307723|P1|Overall Study|Adverse Event|1
5871096|NCT01963403|20307788|P2|Overall Study|Implant removal|1
5871097|NCT01963403|20307789|P1|Overall Study|Implant removal|0
5871098|NCT01963403|20307788|P2|Overall Study|Lost to Follow-up|3
5871099|NCT01963403|20307789|P1|Overall Study|Lost to Follow-up|2
5871100|NCT01963260|20307811|P10|Overall Study|Withdrawal by Subject|0
5871101|NCT01963260|20307812|P9|Overall Study|Withdrawal by Subject|0
5871102|NCT01963260|20307813|P8|Overall Study|Withdrawal by Subject|0
5871103|NCT01963260|20307814|P7|Overall Study|Withdrawal by Subject|0
5871104|NCT01963260|20307815|P6|Overall Study|Withdrawal by Subject|0
5871105|NCT01963260|20307816|P5|Overall Study|Withdrawal by Subject|2
5871106|NCT01963260|20307817|P4|Overall Study|Withdrawal by Subject|1
5871107|NCT01963260|20307818|P3|Overall Study|Withdrawal by Subject|0
5871108|NCT01963260|20307819|P2|Overall Study|Withdrawal by Subject|0
5871109|NCT01963260|20307820|P1|Overall Study|Withdrawal by Subject|2
5871110|NCT01963117|20307934|P1|Overall Study|Death|1
5871111|NCT01962987|20307976|P3|Overall Study|Randomized in Error|2
5871112|NCT01962987|20307977|P2|Overall Study|Randomized in Error|2
5871113|NCT01962987|20307978|P1|Overall Study|Randomized in Error|4
5871114|NCT01962987|20307976|P3|Overall Study|Withdrawal by Subject|6
5871115|NCT01962987|20307977|P2|Overall Study|Withdrawal by Subject|10
5871116|NCT01962987|20307978|P1|Overall Study|Withdrawal by Subject|11
5871117|NCT01962987|20307976|P3|Overall Study|Serious Adverse Event|0
5871118|NCT01962987|20307977|P2|Overall Study|Serious Adverse Event|0
5871119|NCT01962987|20307978|P1|Overall Study|Serious Adverse Event|1
5871120|NCT01962987|20307976|P3|Overall Study|Restricted medication|1
5871121|NCT01962987|20307977|P2|Overall Study|Restricted medication|1
5871122|NCT01962987|20307978|P1|Overall Study|Restricted medication|5
5871123|NCT01962987|20307976|P3|Overall Study|Miscellaneous|2
5871124|NCT01962987|20307977|P2|Overall Study|Miscellaneous|9
5871125|NCT01962987|20307978|P1|Overall Study|Miscellaneous|1
5871126|NCT01962987|20307976|P3|Overall Study|Non compliance with dosing requirements|0
5871127|NCT01962987|20307977|P2|Overall Study|Non compliance with dosing requirements|2
5871128|NCT01962987|20307978|P1|Overall Study|Non compliance with dosing requirements|4
5871129|NCT01962987|20307976|P3|Overall Study|Lost to Follow-up|1
5871130|NCT01962987|20307977|P2|Overall Study|Lost to Follow-up|0
5871131|NCT01962987|20307978|P1|Overall Study|Lost to Follow-up|0
5871132|NCT01962987|20307976|P3|Overall Study|Adverse Event|0
5871133|NCT01962987|20307977|P2|Overall Study|Adverse Event|4
5871134|NCT01962987|20307978|P1|Overall Study|Adverse Event|4
5871135|NCT01962974|20307986|P1|Overall Study|Study termination|7
5871136|NCT01962922|20308013|P2|Extendion Portion (up to Month 6)|Physician Decision|0
5871137|NCT01962922|20308014|P1|Extendion Portion (up to Month 6)|Physician Decision|1
5871138|NCT01962922|20308013|P2|Extendion Portion (up to Month 6)|no longer wished to participate in study|3
5871139|NCT01962922|20308014|P1|Extendion Portion (up to Month 6)|no longer wished to participate in study|4
5871140|NCT01962922|20308013|P2|PK Portion Day 7|non-compliance|0
5871141|NCT01962922|20308014|P1|PK Portion Day 7|non-compliance|1
5871142|NCT01962922|20308013|P2|PK Portion Day 7|Withdrawal by Subject|0
5871143|NCT01962922|20308014|P1|PK Portion Day 7|Withdrawal by Subject|3
5871144|NCT01962896|20308036|P1|Overall Study|Lack of Efficacy|4
5871145|NCT01962493|20308158|P2|Overall Study|Withdrawal by Subject|2
5871146|NCT01962493|20308159|P1|Overall Study|Withdrawal by Subject|4
5871147|NCT01962493|20308158|P2|Overall Study|Protocol Violation|1
5871148|NCT01962493|20308159|P1|Overall Study|Protocol Violation|0
5871149|NCT01962493|20308158|P2|Overall Study|Adverse Event|2
5871150|NCT01962493|20308159|P1|Overall Study|Adverse Event|1
5871151|NCT01962441|20308182|P3|Retreatment Substudy|Lost to Follow-up|0
5871152|NCT01962441|20308183|P2|Retreatment Substudy|Lost to Follow-up|0
5871153|NCT01962441|20308184|P1|Retreatment Substudy|Lost to Follow-up|1
5871154|NCT01962441|20308182|P3|Retreatment Substudy|Lack of Efficacy|0
5871155|NCT01962441|20308183|P2|Retreatment Substudy|Lack of Efficacy|0
5871156|NCT01962441|20308184|P1|Retreatment Substudy|Lack of Efficacy|1
5871157|NCT01962441|20308182|P3|Randomized Period|Protocol Violation|0
5871158|NCT01962441|20308183|P2|Randomized Period|Protocol Violation|1
5871159|NCT01962441|20308184|P1|Randomized Period|Protocol Violation|0
5871160|NCT01962441|20308182|P3|Randomized Period|Death|2
5871161|NCT01962441|20308183|P2|Randomized Period|Death|0
5871162|NCT01962441|20308184|P1|Randomized Period|Death|0
5871163|NCT01962441|20308182|P3|Randomized Period|Adverse Event|0
5871164|NCT01962441|20308183|P2|Randomized Period|Adverse Event|1
5871165|NCT01962441|20308184|P1|Randomized Period|Adverse Event|1
5871166|NCT01962441|20308182|P3|Randomized Period|Withdrew Consent|2
5871167|NCT01962441|20308183|P2|Randomized Period|Withdrew Consent|3
5871168|NCT01962441|20308184|P1|Randomized Period|Withdrew Consent|3
5871169|NCT01962441|20308182|P3|Randomized Period|Lost to Follow-up|4
5871170|NCT01962441|20308183|P2|Randomized Period|Lost to Follow-up|4
5871171|NCT01962441|20308184|P1|Randomized Period|Lost to Follow-up|2
5871172|NCT01962441|20308182|P3|Randomized Period|Randomized but Never Treated|3
5871173|NCT01962441|20308183|P2|Randomized Period|Randomized but Never Treated|2
5871174|NCT01962441|20308184|P1|Randomized Period|Randomized but Never Treated|4
5871175|NCT01962298|20308228|P5|Overall Study|Physician Decision|1
5871176|NCT01962298|20308229|P4|Overall Study|Physician Decision|0
5871177|NCT01962298|20308230|P3|Overall Study|Physician Decision|0
5871178|NCT01962298|20308231|P2|Overall Study|Physician Decision|1
5871179|NCT01962298|20308232|P1|Overall Study|Physician Decision|0
5871180|NCT01962298|20308228|P5|Overall Study|Incorrect data recorded|0
5871181|NCT01962298|20308229|P4|Overall Study|Incorrect data recorded|0
5871182|NCT01962298|20308230|P3|Overall Study|Incorrect data recorded|0
5871183|NCT01962298|20308231|P2|Overall Study|Incorrect data recorded|1
5871184|NCT01962298|20308232|P1|Overall Study|Incorrect data recorded|0
5871185|NCT01962298|20308228|P5|Overall Study|Insufficient data|1
5871186|NCT01962298|20308229|P4|Overall Study|Insufficient data|0
5871187|NCT01962298|20308230|P3|Overall Study|Insufficient data|1
5871188|NCT01962298|20308231|P2|Overall Study|Insufficient data|2
5871189|NCT01962298|20308232|P1|Overall Study|Insufficient data|0
5871190|NCT01962298|20308228|P5|Overall Study|Data quality insufficient|4
5871191|NCT01962298|20308229|P4|Overall Study|Data quality insufficient|1
5871192|NCT01962298|20308230|P3|Overall Study|Data quality insufficient|3
5871193|NCT01962298|20308231|P2|Overall Study|Data quality insufficient|0
5871194|NCT01962298|20308232|P1|Overall Study|Data quality insufficient|2
5871195|NCT01962298|20308228|P5|Overall Study|Protocol Violation|0
5871196|NCT01962298|20308229|P4|Overall Study|Protocol Violation|1
5871197|NCT01962298|20308230|P3|Overall Study|Protocol Violation|1
5871198|NCT01962298|20308231|P2|Overall Study|Protocol Violation|0
5871199|NCT01962298|20308232|P1|Overall Study|Protocol Violation|1
5871200|NCT01962207|20308253|P4|Persistence Phase (5 Years)|Missed at least 1 persistence visit|5
5871201|NCT01962207|20308254|P3|Persistence Phase (5 Years)|Missed at least 1 persistence visit|13
5871202|NCT01962207|20308255|P2|Persistence Phase (5 Years)|Missed at least 1 persistence visit|7
5871203|NCT01962207|20308256|P1|Persistence Phase (5 Years)|Missed at least 1 persistence visit|21
5871204|NCT01962207|20308253|P4|Persistence Phase (5 Years)|Adverse Event|0
5871205|NCT01962207|20308254|P3|Persistence Phase (5 Years)|Adverse Event|1
5871206|NCT01962207|20308255|P2|Persistence Phase (5 Years)|Adverse Event|0
5871207|NCT01962207|20308256|P1|Persistence Phase (5 Years)|Adverse Event|0
5871208|NCT01962207|20308253|P4|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|1
5871209|NCT01962207|20308254|P3|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|3
5871210|NCT01962207|20308255|P2|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0
5871211|NCT01962207|20308256|P1|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0
5871212|NCT01962207|20308253|P4|Persistence Phase (5 Years)|Withdrawal by Subject|4
5871213|NCT01962207|20308254|P3|Persistence Phase (5 Years)|Withdrawal by Subject|18
5871214|NCT01962207|20308255|P2|Persistence Phase (5 Years)|Withdrawal by Subject|5
5871215|NCT01962207|20308256|P1|Persistence Phase (5 Years)|Withdrawal by Subject|4
5871216|NCT01962207|20308253|P4|Persistence Phase (5 Years)|Migrated/moved from study area|0
5871217|NCT01962207|20308254|P3|Persistence Phase (5 Years)|Migrated/moved from study area|4
5871218|NCT01962207|20308255|P2|Persistence Phase (5 Years)|Migrated/moved from study area|0
5871219|NCT01962207|20308256|P1|Persistence Phase (5 Years)|Migrated/moved from study area|2
5871220|NCT01962207|20308253|P4|Persistence Phase (5 Years)|Lost to Follow-up|2
5871221|NCT01962207|20308254|P3|Persistence Phase (5 Years)|Lost to Follow-up|5
5871222|NCT01962207|20308255|P2|Persistence Phase (5 Years)|Lost to Follow-up|1
5871223|NCT01962207|20308256|P1|Persistence Phase (5 Years)|Lost to Follow-up|2
5871224|NCT01962103|20308367|P9|Phase 2|Symptomatic Deterioration|0
5871225|NCT01962103|20308368|P8|Phase 2|Symptomatic Deterioration|2
5871226|NCT01962103|20308369|P7|Phase 2|Symptomatic Deterioration|2
5871227|NCT01962103|20308370|P6|Phase 2|Symptomatic Deterioration|0
5871228|NCT01962103|20308371|P5|Phase 2|Symptomatic Deterioration|0
5871229|NCT01962103|20308372|P4|Phase 2|Symptomatic Deterioration|0
5871230|NCT01962103|20308373|P3|Phase 2|Symptomatic Deterioration|0
5871231|NCT01962103|20308374|P2|Phase 2|Symptomatic Deterioration|0
5871232|NCT01962103|20308375|P1|Phase 2|Symptomatic Deterioration|0
5871233|NCT01962103|20308367|P9|Phase 2|Progressive Disease|11
5871234|NCT01962103|20308368|P8|Phase 2|Progressive Disease|12
5871235|NCT01962103|20308369|P7|Phase 2|Progressive Disease|11
5871236|NCT01962103|20308370|P6|Phase 2|Progressive Disease|0
5871237|NCT01962103|20308371|P5|Phase 2|Progressive Disease|0
5871238|NCT01962103|20308372|P4|Phase 2|Progressive Disease|0
5871239|NCT01962103|20308373|P3|Phase 2|Progressive Disease|0
5871240|NCT01962103|20308374|P2|Phase 2|Progressive Disease|0
5871241|NCT01962103|20308375|P1|Phase 2|Progressive Disease|0
5871242|NCT01962103|20308367|P9|Phase 2|Adverse Event|3
5871243|NCT01962103|20308368|P8|Phase 2|Adverse Event|0
5871244|NCT01962103|20308369|P7|Phase 2|Adverse Event|1
5871245|NCT01962103|20308370|P6|Phase 2|Adverse Event|0
5871246|NCT01962103|20308371|P5|Phase 2|Adverse Event|0
5871247|NCT01962103|20308372|P4|Phase 2|Adverse Event|0
5871248|NCT01962103|20308373|P3|Phase 2|Adverse Event|0
5871249|NCT01962103|20308374|P2|Phase 2|Adverse Event|0
5871250|NCT01962103|20308375|P1|Phase 2|Adverse Event|0
5871251|NCT01962103|20308367|P9|Phase 1|Miscellaneous|0
5871252|NCT01962103|20308368|P8|Phase 1|Miscellaneous|0
5871253|NCT01962103|20308369|P7|Phase 1|Miscellaneous|0
5871254|NCT01962103|20308370|P6|Phase 1|Miscellaneous|0
5871255|NCT01962103|20308371|P5|Phase 1|Miscellaneous|0
5871256|NCT01962103|20308372|P4|Phase 1|Miscellaneous|0
5871257|NCT01962103|20308373|P3|Phase 1|Miscellaneous|0
5871258|NCT01962103|20308374|P2|Phase 1|Miscellaneous|0
5871259|NCT01962103|20308375|P1|Phase 1|Miscellaneous|1
5871260|NCT01962103|20308367|P9|Phase 1|Symptomatic Deterioration|0
5871261|NCT01962103|20308368|P8|Phase 1|Symptomatic Deterioration|0
5871262|NCT01962103|20308369|P7|Phase 1|Symptomatic Deterioration|0
5871263|NCT01962103|20308370|P6|Phase 1|Symptomatic Deterioration|1
5871264|NCT01962103|20308371|P5|Phase 1|Symptomatic Deterioration|1
5871265|NCT01962103|20308372|P4|Phase 1|Symptomatic Deterioration|2
5871266|NCT01962103|20308373|P3|Phase 1|Symptomatic Deterioration|2
5871267|NCT01962103|20308374|P2|Phase 1|Symptomatic Deterioration|2
5871268|NCT01962103|20308375|P1|Phase 1|Symptomatic Deterioration|3
5871269|NCT01962103|20308367|P9|Phase 1|Physician Decision|0
5871270|NCT01962103|20308368|P8|Phase 1|Physician Decision|0
5871271|NCT01962103|20308369|P7|Phase 1|Physician Decision|0
5871272|NCT01962103|20308370|P6|Phase 1|Physician Decision|0
5871273|NCT01962103|20308371|P5|Phase 1|Physician Decision|0
5871274|NCT01962103|20308372|P4|Phase 1|Physician Decision|1
5871275|NCT01962103|20308373|P3|Phase 1|Physician Decision|0
5871276|NCT01962103|20308374|P2|Phase 1|Physician Decision|0
5871277|NCT01962103|20308375|P1|Phase 1|Physician Decision|0
5871278|NCT01962103|20308367|P9|Phase 1|Withdrawal by Parent/Guardian|0
5871279|NCT01962103|20308368|P8|Phase 1|Withdrawal by Parent/Guardian|0
5871280|NCT01962103|20308369|P7|Phase 1|Withdrawal by Parent/Guardian|0
5871281|NCT01962103|20308370|P6|Phase 1|Withdrawal by Parent/Guardian|0
5871282|NCT01962103|20308371|P5|Phase 1|Withdrawal by Parent/Guardian|0
5871283|NCT01962103|20308372|P4|Phase 1|Withdrawal by Parent/Guardian|1
5871284|NCT01962103|20308373|P3|Phase 1|Withdrawal by Parent/Guardian|2
5871285|NCT01962103|20308374|P2|Phase 1|Withdrawal by Parent/Guardian|0
5871286|NCT01962103|20308375|P1|Phase 1|Withdrawal by Parent/Guardian|0
5871287|NCT01962103|20308367|P9|Phase 1|Withdrawal by Subject|0
5871288|NCT01962103|20308368|P8|Phase 1|Withdrawal by Subject|0
5871289|NCT01962103|20308369|P7|Phase 1|Withdrawal by Subject|0
5871290|NCT01962103|20308370|P6|Phase 1|Withdrawal by Subject|0
5871291|NCT01962103|20308371|P5|Phase 1|Withdrawal by Subject|0
5871292|NCT01962103|20308372|P4|Phase 1|Withdrawal by Subject|2
5871293|NCT01962103|20308373|P3|Phase 1|Withdrawal by Subject|0
5871294|NCT01962103|20308374|P2|Phase 1|Withdrawal by Subject|0
5871295|NCT01962103|20308375|P1|Phase 1|Withdrawal by Subject|0
5871296|NCT01962103|20308367|P9|Phase 1|Progressive Disease|0
5871297|NCT01962103|20308368|P8|Phase 1|Progressive Disease|0
5871298|NCT01962103|20308369|P7|Phase 1|Progressive Disease|0
5871299|NCT01962103|20308370|P6|Phase 1|Progressive Disease|4
5871300|NCT01962103|20308371|P5|Phase 1|Progressive Disease|5
5871301|NCT01962103|20308372|P4|Phase 1|Progressive Disease|4
5871302|NCT01962103|20308373|P3|Phase 1|Progressive Disease|8
5871303|NCT01962103|20308374|P2|Phase 1|Progressive Disease|6
5871304|NCT01962103|20308375|P1|Phase 1|Progressive Disease|8
5871305|NCT01962103|20308367|P9|Phase 1|Adverse Event|0
5871306|NCT01962103|20308368|P8|Phase 1|Adverse Event|0
5871307|NCT01962103|20308369|P7|Phase 1|Adverse Event|0
5871308|NCT01962103|20308370|P6|Phase 1|Adverse Event|2
5871309|NCT01962103|20308371|P5|Phase 1|Adverse Event|2
5871310|NCT01962103|20308372|P4|Phase 1|Adverse Event|1
5871311|NCT01962103|20308373|P3|Phase 1|Adverse Event|2
5871312|NCT01962103|20308374|P2|Phase 1|Adverse Event|0
5871313|NCT01962103|20308375|P1|Phase 1|Adverse Event|4
5871314|NCT01961687|20308502|P1|Overall Study|Unable to meet follow-up requirements|1
5871315|NCT01961687|20308502|P1|Overall Study|Physician Decision|1
5871316|NCT01961687|20308502|P1|Overall Study|Sponsor decision|2
5871317|NCT01961687|20308502|P1|Overall Study|Moved to area without study site|2
5871318|NCT01961687|20308502|P1|Overall Study|Adverse Event|6
5871319|NCT01961687|20308502|P1|Overall Study|Withdrawal by Subject|6
5871320|NCT01961687|20308502|P1|Overall Study|Death|7
5871321|NCT01961687|20308502|P1|Overall Study|Re-operation|17
5871322|NCT01961687|20308502|P1|Overall Study|Lost to Follow-up|19
5871323|NCT01961609|20308516|P4|Maintanence 2 (Weeks 49 - 72)|Adverse Event|2
5871324|NCT01961609|20308517|P3|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0
5871325|NCT01961609|20308518|P2|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0
5871326|NCT01961609|20308519|P1|Maintanence 2 (Weeks 49 - 72)|Adverse Event|1
5871327|NCT01961609|20308516|P4|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|1
5871328|NCT01961609|20308517|P3|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3
5871329|NCT01961609|20308518|P2|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|0
5871330|NCT01961609|20308519|P1|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3
5871331|NCT01961609|20308516|P4|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0
5871332|NCT01961609|20308517|P3|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0
5871333|NCT01961609|20308518|P2|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|1
5871334|NCT01961609|20308519|P1|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0
5871335|NCT01961609|20308516|P4|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0
5871336|NCT01961609|20308517|P3|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0
5871337|NCT01961609|20308518|P2|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0
5871338|NCT01961609|20308519|P1|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|1
5871339|NCT01961609|20308516|P4|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0
5871340|NCT01961609|20308517|P3|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|1
5871341|NCT01961609|20308518|P2|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0
5871342|NCT01961609|20308519|P1|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0
5871343|NCT01961609|20308516|P4|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|4
5871344|NCT01961609|20308517|P3|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|0
5871345|NCT01961609|20308518|P2|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|5
5871346|NCT01961609|20308519|P1|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|7
5871347|NCT01961609|20308516|P4|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0
5871348|NCT01961609|20308517|P3|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|1
5871349|NCT01961609|20308518|P2|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0
5871350|NCT01961609|20308519|P1|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0
5871351|NCT01961609|20308516|P4|Maintenance 1 (Weeks 17 - 48)|Adverse Event|0
5871352|NCT01961609|20308517|P3|Maintenance 1 (Weeks 17 - 48)|Adverse Event|3
5871353|NCT01961609|20308518|P2|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6
5871354|NCT01961609|20308519|P1|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6
5871355|NCT01961609|20308516|P4|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|0
5871356|NCT01961609|20308517|P3|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|10
5871357|NCT01961609|20308518|P2|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|4
5871358|NCT01961609|20308519|P1|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|13
5871359|NCT01961609|20308516|P4|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0
5871360|NCT01961609|20308517|P3|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1
5871361|NCT01961609|20308518|P2|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1
5871362|NCT01961609|20308519|P1|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0
5871363|NCT01961609|20308516|P4|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0
5871364|NCT01961609|20308517|P3|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|1
5871365|NCT01961609|20308518|P2|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0
5871366|NCT01961609|20308519|P1|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|3
5871367|NCT01961609|20308516|P4|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0
5871368|NCT01961609|20308517|P3|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|3
5871369|NCT01961609|20308518|P2|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0
5871370|NCT01961609|20308519|P1|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|1
5871371|NCT01961609|20308516|P4|Initiation|Randomized but not treated|0
5871372|NCT01961609|20308517|P3|Initiation|Randomized but not treated|0
5871373|NCT01961609|20308518|P2|Initiation|Randomized but not treated|1
5871374|NCT01961609|20308519|P1|Initiation|Randomized but not treated|1
5871375|NCT01961609|20308516|P4|Initiation|Adverse Event|0
5871376|NCT01961609|20308517|P3|Initiation|Adverse Event|0
5871377|NCT01961609|20308518|P2|Initiation|Adverse Event|5
5871378|NCT01961609|20308519|P1|Initiation|Adverse Event|3
5871379|NCT01961609|20308516|P4|Initiation|Abnormal lab values|0
5871380|NCT01961609|20308517|P3|Initiation|Abnormal lab values|0
5871381|NCT01961609|20308518|P2|Initiation|Abnormal lab values|1
5871382|NCT01961609|20308519|P1|Initiation|Abnormal lab values|0
5871383|NCT01961609|20308516|P4|Initiation|Lack of Efficacy|0
5871384|NCT01961609|20308517|P3|Initiation|Lack of Efficacy|0
5871385|NCT01961609|20308518|P2|Initiation|Lack of Efficacy|1
5871386|NCT01961609|20308519|P1|Initiation|Lack of Efficacy|2
5871387|NCT01961609|20308516|P4|Initiation|Withdrawal by Subject|0
5871388|NCT01961609|20308517|P3|Initiation|Withdrawal by Subject|0
5871389|NCT01961609|20308518|P2|Initiation|Withdrawal by Subject|2
5871390|NCT01961609|20308519|P1|Initiation|Withdrawal by Subject|1
5871391|NCT01961609|20308516|P4|Initiation|Administrative problems|0
5871392|NCT01961609|20308517|P3|Initiation|Administrative problems|0
5871393|NCT01961609|20308518|P2|Initiation|Administrative problems|0
5871394|NCT01961609|20308519|P1|Initiation|Administrative problems|1
5871395|NCT01961609|20308516|P4|Initiation|Death|0
5871396|NCT01961609|20308517|P3|Initiation|Death|0
5871397|NCT01961609|20308518|P2|Initiation|Death|1
5871398|NCT01961609|20308519|P1|Initiation|Death|0
5871399|NCT01961609|20308516|P4|Initiation|Protocol deviation|0
5871400|NCT01961609|20308517|P3|Initiation|Protocol deviation|0
5871401|NCT01961609|20308518|P2|Initiation|Protocol deviation|0
5871402|NCT01961609|20308519|P1|Initiation|Protocol deviation|1
5871403|NCT01961609|20308516|P4|Initiation|Missing|0
5871404|NCT01961609|20308517|P3|Initiation|Missing|0
5871405|NCT01961609|20308518|P2|Initiation|Missing|2
5871406|NCT01961609|20308519|P1|Initiation|Missing|3
5871407|NCT01961544|20308571|P1|Overall Study|Aggravation of Steral Pain|1
5871408|NCT01961544|20308571|P1|Overall Study|Poor Tolerance|1
5871409|NCT01961544|20308571|P1|Overall Study|Physician Decision|2
5871410|NCT01961544|20308571|P1|Overall Study|Adverse Event|1
5871411|NCT01961544|20308571|P1|Overall Study|Withdrawal by Subject|7
5871412|NCT01961544|20308571|P1|Overall Study|Protocol Violation|1
5871413|NCT01961349|20308590|P3|Overall Study|registration error, personal reason etc|1
5871414|NCT01961349|20308591|P2|Overall Study|registration error, personal reason etc|2
5871415|NCT01961349|20308592|P1|Overall Study|registration error, personal reason etc|2
5871416|NCT01961349|20308590|P3|Overall Study|Adverse Event|1
5871417|NCT01961349|20308591|P2|Overall Study|Adverse Event|0
5871418|NCT01961349|20308592|P1|Overall Study|Adverse Event|0
5871419|NCT01961349|20308590|P3|Overall Study|Withdrawal by Subject|0
5871420|NCT01961349|20308591|P2|Overall Study|Withdrawal by Subject|4
5871421|NCT01961349|20308592|P1|Overall Study|Withdrawal by Subject|1
5871422|NCT01961323|20308603|P1|Overall Study|screen failure|34
5871423|NCT01961323|20308603|P1|Overall Study|Lost to Follow-up|8
5871424|NCT01961323|20308603|P1|Overall Study|Withdrawal by Subject|7
5871425|NCT01961297|20308611|P2|Overall Study|unconfirmed diagnosis of SD|1
5871426|NCT01961297|20308612|P1|Overall Study|unconfirmed diagnosis of SD|2
5871427|NCT01961115|20308676|P3|Overall Study|Adverse Event|1
5871428|NCT01961115|20308677|P2|Overall Study|Adverse Event|0
5871429|NCT01961115|20308678|P1|Overall Study|Adverse Event|1
5871430|NCT01961115|20308676|P3|Overall Study|Disease Progression|3
5871431|NCT01961115|20308677|P2|Overall Study|Disease Progression|0
5871432|NCT01961115|20308678|P1|Overall Study|Disease Progression|1
5871433|NCT01960907|20308721|P2|Overall Study|Withdrawal by Subject|42
5871434|NCT01960907|20308722|P1|Overall Study|Withdrawal by Subject|32
5871435|NCT01960907|20308721|P2|Overall Study|Death|3
5871436|NCT01960907|20308722|P1|Overall Study|Death|4
5871437|NCT01960855|20308737|P5|Overall Study|Lost to Follow-up|2
5871438|NCT01960855|20308738|P4|Overall Study|Lost to Follow-up|0
5871439|NCT01960855|20308739|P3|Overall Study|Lost to Follow-up|0
5871440|NCT01960855|20308740|P2|Overall Study|Lost to Follow-up|1
5871441|NCT01960855|20308741|P1|Overall Study|Lost to Follow-up|2
5871442|NCT01960855|20308737|P5|Overall Study|Consent withdrawn by subject|1
5871443|NCT01960855|20308738|P4|Overall Study|Consent withdrawn by subject|1
5871444|NCT01960855|20308739|P3|Overall Study|Consent withdrawn by subject|2
5871445|NCT01960855|20308740|P2|Overall Study|Consent withdrawn by subject|1
5871446|NCT01960855|20308741|P1|Overall Study|Consent withdrawn by subject|3
5871447|NCT01960855|20308737|P5|Overall Study|Other|0
5871448|NCT01960855|20308738|P4|Overall Study|Other|1
5871449|NCT01960855|20308739|P3|Overall Study|Other|1
5871450|NCT01960855|20308740|P2|Overall Study|Other|1
5871451|NCT01960855|20308741|P1|Overall Study|Other|2
5871452|NCT01960855|20308737|P5|Overall Study|Lack of Efficacy|0
5871453|NCT01960855|20308738|P4|Overall Study|Lack of Efficacy|0
5871454|NCT01960855|20308739|P3|Overall Study|Lack of Efficacy|0
5871455|NCT01960855|20308740|P2|Overall Study|Lack of Efficacy|1
5871456|NCT01960855|20308741|P1|Overall Study|Lack of Efficacy|1
5871457|NCT01960855|20308737|P5|Overall Study|Adverse Event|2
5871458|NCT01960855|20308738|P4|Overall Study|Adverse Event|2
5871459|NCT01960855|20308739|P3|Overall Study|Adverse Event|6
5871460|NCT01960855|20308740|P2|Overall Study|Adverse Event|0
5871461|NCT01960855|20308741|P1|Overall Study|Adverse Event|2
5871462|NCT01960855|20308737|P5|Overall Study|Subject noncompliant|0
5871463|NCT01960855|20308738|P4|Overall Study|Subject noncompliant|0
5871464|NCT01960855|20308739|P3|Overall Study|Subject noncompliant|0
5871465|NCT01960855|20308740|P2|Overall Study|Subject noncompliant|0
5871466|NCT01960855|20308741|P1|Overall Study|Subject noncompliant|1
5871467|NCT01960842|20308773|P1|Overall Study|Withdrawal by Subject|2
5871468|NCT01960842|20308773|P1|Overall Study|Adverse Event|1
5871469|NCT01960816|20308796|P1|Overall Study|Lost to Follow-up|1
5871470|NCT01960790|20308802|P1|Overall Study|Unevaluable for safety|1
5871471|NCT01960790|20308802|P1|Overall Study|Transferred to another hospital|4
5871472|NCT01960790|20308802|P1|Overall Study|Treat with Humira outside survey period|3
5871473|NCT01960790|20308802|P1|Overall Study|Survey forms could not be recovered|3
5871474|NCT01960725|20308814|P2|Overall Study|unable to obtain blood sample|2
5871475|NCT01960725|20308815|P1|Overall Study|unable to obtain blood sample|1
5871476|NCT01960725|20308814|P2|Overall Study|Withdrawal by Subject|0
5871477|NCT01960725|20308815|P1|Overall Study|Withdrawal by Subject|1
5871478|NCT01960725|20308814|P2|Overall Study|Lost to Follow-up|3
5871479|NCT01960725|20308815|P1|Overall Study|Lost to Follow-up|4
5871480|NCT01960413|20308885|P2|Overall Study|Lost to Follow-up|0
5871481|NCT01960413|20308886|P1|Overall Study|Lost to Follow-up|2
5871482|NCT01960413|20308885|P2|Overall Study|Physician Decision|0
5871483|NCT01960413|20308886|P1|Overall Study|Physician Decision|1
5871484|NCT01960413|20308885|P2|Overall Study|Withdrawal by Subject|1
5871485|NCT01960413|20308886|P1|Overall Study|Withdrawal by Subject|1
5871486|NCT01960348|20308916|P2|Overall Study|Protocol Violation|0
5871487|NCT01960348|20308917|P1|Overall Study|Protocol Violation|1
5871488|NCT01960348|20308916|P2|Overall Study|Physician Decision|1
5871489|NCT01960348|20308917|P1|Overall Study|Physician Decision|0
5871490|NCT01960348|20308916|P2|Overall Study|Withdrawal by Subject|11
5871491|NCT01960348|20308917|P1|Overall Study|Withdrawal by Subject|1
5871492|NCT01960348|20308916|P2|Overall Study|Adverse event, serious non-fatal|3
5871493|NCT01960348|20308917|P1|Overall Study|Adverse event, serious non-fatal|0
5871494|NCT01960348|20308916|P2|Overall Study|Adverse event, serious fatal|5
5871495|NCT01960348|20308917|P1|Overall Study|Adverse event, serious fatal|6
5871496|NCT01960348|20308916|P2|Overall Study|Adverse event, not serious|2
5871497|NCT01960348|20308917|P1|Overall Study|Adverse event, not serious|2
5871498|NCT01960296|20308937|P2|Overall Study|Received different procedure|3
5871499|NCT01960296|20308938|P1|Overall Study|Received different procedure|1
5871500|NCT01960296|20308937|P2|Overall Study|Postponed surgery|0
5871501|NCT01960296|20308938|P1|Overall Study|Postponed surgery|1
5871502|NCT01960140|20308958|P1|Period 2 (Days 3-18)|Adverse Event|2
5871503|NCT01960114|20308969|P2|Overall Study|Could not swallow study medication|1
5871504|NCT01960114|20308970|P1|Overall Study|Could not swallow study medication|0
5871505|NCT01960114|20308969|P2|Overall Study|Adverse Event|0
5871506|NCT01960114|20308970|P1|Overall Study|Adverse Event|1
5871507|NCT01959932|20309077|P3|Overall Study|Withdrawal by Subject|0
5871508|NCT01959932|20309078|P2|Overall Study|Withdrawal by Subject|0
5871509|NCT01959932|20309079|P1|Overall Study|Withdrawal by Subject|1
5871510|NCT01959919|20309097|P1|Overall Study|Did not meet the eligibility criteria|2
5871511|NCT01959880|20309111|P4|Overall Study|Study completed early-FDA approved|152
5871512|NCT01959880|20309112|P3|Overall Study|Study completed early-FDA approved|179
5871513|NCT01959880|20309113|P2|Overall Study|Study completed early-FDA approved|311
5871514|NCT01959880|20309114|P1|Overall Study|Study completed early-FDA approved|1003
5871515|NCT01959880|20309111|P4|Overall Study|Explantation w/o study device reimplant.|12
5871516|NCT01959880|20309112|P3|Overall Study|Explantation w/o study device reimplant.|5
5871517|NCT01959880|20309113|P2|Overall Study|Explantation w/o study device reimplant.|17
5871518|NCT01959880|20309114|P1|Overall Study|Explantation w/o study device reimplant.|22
5871519|NCT01959880|20309111|P4|Overall Study|Lost to Follow-up|8
5871520|NCT01959880|20309112|P3|Overall Study|Lost to Follow-up|15
5871521|NCT01959880|20309113|P2|Overall Study|Lost to Follow-up|18
5871522|NCT01959880|20309114|P1|Overall Study|Lost to Follow-up|95
5871523|NCT01959880|20309111|P4|Overall Study|Death|2
5871524|NCT01959880|20309112|P3|Overall Study|Death|1
5871525|NCT01959880|20309113|P2|Overall Study|Death|10
5871526|NCT01959880|20309114|P1|Overall Study|Death|1
5871527|NCT01959880|20309111|P4|Overall Study|Withdrawal by Subject|7
5871528|NCT01959880|20309112|P3|Overall Study|Withdrawal by Subject|8
5871529|NCT01959880|20309113|P2|Overall Study|Withdrawal by Subject|13
5871530|NCT01959880|20309114|P1|Overall Study|Withdrawal by Subject|11
5871531|NCT01959841|20309139|P3|Overall Study|Platelet count below on day1 or 4|11
5871532|NCT01959841|20309140|P2|Overall Study|Platelet count below on day1 or 4|15
5871533|NCT01959841|20309141|P1|Overall Study|Platelet count below on day1 or 4|11
5871534|NCT01959841|20309139|P3|Overall Study|Clinical laboratory value|6
5871535|NCT01959841|20309140|P2|Overall Study|Clinical laboratory value|6
5871536|NCT01959841|20309141|P1|Overall Study|Clinical laboratory value|2
5871537|NCT01959841|20309139|P3|Overall Study|Withdrawal by Subject|5
5871538|NCT01959841|20309140|P2|Overall Study|Withdrawal by Subject|7
5871539|NCT01959841|20309141|P1|Overall Study|Withdrawal by Subject|7
5871540|NCT01959841|20309139|P3|Overall Study|Protocol Violation|16
5871541|NCT01959841|20309140|P2|Overall Study|Protocol Violation|23
5871542|NCT01959841|20309141|P1|Overall Study|Protocol Violation|16
5871543|NCT01959841|20309139|P3|Overall Study|Physician Decision|3
5871544|NCT01959841|20309140|P2|Overall Study|Physician Decision|2
5871545|NCT01959841|20309141|P1|Overall Study|Physician Decision|0
5871546|NCT01959841|20309139|P3|Overall Study|Lost to Follow-up|0
5871547|NCT01959841|20309140|P2|Overall Study|Lost to Follow-up|1
5871548|NCT01959841|20309141|P1|Overall Study|Lost to Follow-up|1
5871549|NCT01959841|20309139|P3|Overall Study|Lack of Efficacy|0
5871550|NCT01959841|20309140|P2|Overall Study|Lack of Efficacy|0
5871551|NCT01959841|20309141|P1|Overall Study|Lack of Efficacy|5
5871552|NCT01959841|20309139|P3|Overall Study|Adverse Event|2
5871553|NCT01959841|20309140|P2|Overall Study|Adverse Event|3
5871554|NCT01959841|20309141|P1|Overall Study|Adverse Event|1
5871555|NCT01959672|20309169|P1|Overall Study|Death|1
5871556|NCT01959607|20309180|P4|First Intervention (Day 1)|Withdrawal by Subject|0
5871557|NCT01959607|20309181|P3|First Intervention (Day 1)|Withdrawal by Subject|0
5871558|NCT01959607|20309182|P2|First Intervention (Day 1)|Withdrawal by Subject|1
5871559|NCT01959607|20309183|P1|First Intervention (Day 1)|Withdrawal by Subject|1
5871560|NCT01959581|20309196|P1|Overall Study|Lost to Follow-up|5
5871561|NCT01959529|20309207|P2|Overall Study|Lack of glycaemic control|1
5871562|NCT01959529|20309208|P1|Overall Study|Lack of glycaemic control|1
5871563|NCT01959529|20309207|P2|Overall Study|Hypoglycaemia|1
5871564|NCT01959529|20309208|P1|Overall Study|Hypoglycaemia|1
5871565|NCT01959529|20309207|P2|Overall Study|Other|68
5871566|NCT01959529|20309208|P1|Overall Study|Other|70
5871567|NCT01959529|20309207|P2|Overall Study|Lost to Follow-up|1
5871568|NCT01959529|20309208|P1|Overall Study|Lost to Follow-up|4
5871569|NCT01959529|20309207|P2|Overall Study|Adverse event (not hypoglycaemia)|1
5871570|NCT01959529|20309208|P1|Overall Study|Adverse event (not hypoglycaemia)|0
5871571|NCT01959516|20309220|P2|Epoch 2|Moderate or severe COPD exacerbation|1
5871572|NCT01959516|20309221|P1|Epoch 2|Moderate or severe COPD exacerbation|0
5871573|NCT01959516|20309220|P2|Epoch 2|Subject withdrew consent|0
5871574|NCT01959516|20309221|P1|Epoch 2|Subject withdrew consent|1
5871575|NCT01959516|20309220|P2|Epoch 2|unsatisfactory therapeutic effect|0
5871576|NCT01959516|20309221|P1|Epoch 2|unsatisfactory therapeutic effect|1
5871577|NCT01959516|20309220|P2|Epoch 1|Protocol deviation|1
5871578|NCT01959516|20309221|P1|Epoch 1|Protocol deviation|0
5871579|NCT01959516|20309220|P2|Epoch 1|Moderate or severe COPD exacerbation|1
5871580|NCT01959516|20309221|P1|Epoch 1|Moderate or severe COPD exacerbation|0
5871581|NCT01959516|20309220|P2|Epoch 1|Use of prohibited treatment|0
5871582|NCT01959516|20309221|P1|Epoch 1|Use of prohibited treatment|1
5871583|NCT01959516|20309220|P2|Epoch 1|Administrative problems|0
5871584|NCT01959516|20309221|P1|Epoch 1|Administrative problems|1
5871585|NCT01959516|20309220|P2|Epoch 1|Subject withdrew consent|2
5871586|NCT01959516|20309221|P1|Epoch 1|Subject withdrew consent|3
5871587|NCT01959516|20309220|P2|Epoch 1|unsatisfactory therapeutic effect|0
5871588|NCT01959516|20309221|P1|Epoch 1|unsatisfactory therapeutic effect|1
5871589|NCT01959516|20309220|P2|Epoch 1|Adverse Event|1
5871590|NCT01959516|20309221|P1|Epoch 1|Adverse Event|4
5871591|NCT01959503|20309231|P2|Overall Study|Randomized but not treated|1
5871592|NCT01959503|20309232|P1|Overall Study|Randomized but not treated|1
5871593|NCT01959503|20309231|P2|Overall Study|Death|1
5871594|NCT01959503|20309232|P1|Overall Study|Death|2
5871595|NCT01959425|20309285|P2|Overall Study|Discontinued Subjects|4
5871596|NCT01959425|20309286|P1|Overall Study|Discontinued Subjects|6
5871597|NCT01959425|20309285|P2|Overall Study|Lost to Follow-up|0
5871598|NCT01959425|20309286|P1|Overall Study|Lost to Follow-up|1
5871599|NCT01959425|20309285|P2|Overall Study|Withdrawal by Subject|4
5871600|NCT01959425|20309286|P1|Overall Study|Withdrawal by Subject|5
5871601|NCT01959412|20309306|P6|Overall Study|Adverse Event|0
5871602|NCT01959412|20309307|P5|Overall Study|Adverse Event|0
5871603|NCT01959412|20309308|P4|Overall Study|Adverse Event|1
5871604|NCT01959412|20309309|P3|Overall Study|Adverse Event|0
5871605|NCT01959412|20309310|P2|Overall Study|Adverse Event|0
5871606|NCT01959412|20309311|P1|Overall Study|Adverse Event|0
5871607|NCT01959412|20309306|P6|Overall Study|Protocol deviation|0
5871608|NCT01959412|20309307|P5|Overall Study|Protocol deviation|3
5871609|NCT01959412|20309308|P4|Overall Study|Protocol deviation|1
5871610|NCT01959412|20309309|P3|Overall Study|Protocol deviation|0
5871611|NCT01959412|20309310|P2|Overall Study|Protocol deviation|1
5871612|NCT01959412|20309311|P1|Overall Study|Protocol deviation|1
5871613|NCT01959347|20309351|P2|Overall Study|Protocol Violation|7
5871614|NCT01959347|20309352|P1|Overall Study|Protocol Violation|9
5871615|NCT01959334|20309458|P2|Third Dose|Adverse Event|1
5871616|NCT01959334|20309459|P1|Third Dose|Adverse Event|0
5871617|NCT01959334|20309458|P2|Second Dose|Adverse Event|0
5871618|NCT01959334|20309459|P1|Second Dose|Adverse Event|1
5871619|NCT01959243|20309471|P2|Overall Study|Lost to Follow-up|1
5871620|NCT01959243|20309472|P1|Overall Study|Lost to Follow-up|3
5871621|NCT01959243|20309471|P2|Overall Study|Administrative reasons|1
5871622|NCT01959243|20309472|P1|Overall Study|Administrative reasons|2
5871623|NCT01959243|20309471|P2|Overall Study|Adverse Event|2
5871624|NCT01959243|20309472|P1|Overall Study|Adverse Event|5
5871625|NCT01959243|20309471|P2|Overall Study|Investigator Decision|0
5871626|NCT01959243|20309472|P1|Overall Study|Investigator Decision|3
5871627|NCT01959230|20309484|P2|Overall Study|Withdrawal by Subject|0
5871628|NCT01959230|20309485|P1|Overall Study|Withdrawal by Subject|2
5871629|NCT01959230|20309484|P2|Overall Study|Administrative reasons|0
5871630|NCT01959230|20309485|P1|Overall Study|Administrative reasons|2
5871631|NCT01959230|20309484|P2|Overall Study|Failure to follow study procedures|1
5871632|NCT01959230|20309485|P1|Overall Study|Failure to follow study procedures|0
5871633|NCT01959165|20309508|P4|Overall Study|Welfare recipient|0
5871634|NCT01959165|20309509|P3|Overall Study|Welfare recipient|0
5871635|NCT01959165|20309510|P2|Overall Study|Welfare recipient|1
5871636|NCT01959165|20309511|P1|Overall Study|Welfare recipient|0
5871637|NCT01959165|20309508|P4|Overall Study|overdose|1
5871638|NCT01959165|20309509|P3|Overall Study|overdose|0
5871639|NCT01959165|20309510|P2|Overall Study|overdose|0
5871640|NCT01959165|20309511|P1|Overall Study|overdose|0
5871641|NCT01959165|20309508|P4|Overall Study|Lack of Efficacy|0
5871642|NCT01959165|20309509|P3|Overall Study|Lack of Efficacy|0
5871643|NCT01959165|20309510|P2|Overall Study|Lack of Efficacy|0
5871644|NCT01959165|20309511|P1|Overall Study|Lack of Efficacy|1
5871645|NCT01959165|20309508|P4|Overall Study|Adverse Event|1
5871646|NCT01959165|20309509|P3|Overall Study|Adverse Event|0
5871647|NCT01959165|20309510|P2|Overall Study|Adverse Event|0
5871648|NCT01959165|20309511|P1|Overall Study|Adverse Event|0
5871649|NCT01959139|20309537|P4|Phase II|On treatment|0
5871650|NCT01959139|20309538|P3|Phase II|On treatment|4
5871651|NCT01959139|20309539|P2|Phase II|On treatment|0
5871652|NCT01959139|20309540|P1|Phase II|On treatment|0
5871653|NCT01959139|20309537|P4|Phase II|Other/Unknown|5
5871654|NCT01959139|20309538|P3|Phase II|Other/Unknown|8
5871655|NCT01959139|20309539|P2|Phase II|Other/Unknown|0
5871656|NCT01959139|20309540|P1|Phase II|Other/Unknown|0
5871657|NCT01959139|20309537|P4|Phase II|Death|1
5871658|NCT01959139|20309538|P3|Phase II|Death|3
5871659|NCT01959139|20309539|P2|Phase II|Death|0
5871660|NCT01959139|20309540|P1|Phase II|Death|0
5871661|NCT01959139|20309537|P4|Phase II|Patient Refusal|4
5871662|NCT01959139|20309538|P3|Phase II|Patient Refusal|5
5871663|NCT01959139|20309539|P2|Phase II|Patient Refusal|0
5871664|NCT01959139|20309540|P1|Phase II|Patient Refusal|0
5871665|NCT01959139|20309537|P4|Phase II|Adverse Event|11
5871666|NCT01959139|20309538|P3|Phase II|Adverse Event|10
5871667|NCT01959139|20309539|P2|Phase II|Adverse Event|0
5871668|NCT01959139|20309540|P1|Phase II|Adverse Event|0
5871669|NCT01959139|20309537|P4|Phase II|Disease progression|34
5871670|NCT01959139|20309538|P3|Phase II|Disease progression|26
5871671|NCT01959139|20309539|P2|Phase II|Disease progression|0
5871672|NCT01959139|20309540|P1|Phase II|Disease progression|0
5871673|NCT01959035|20309573|P1|Overall Study|Other (no primary reason given)|1
5871674|NCT01959035|20309573|P1|Overall Study|Lost to Follow-up|1
5871675|NCT01959035|20309573|P1|Overall Study|Withdrawal by Subject|4
5871676|NCT01959035|20309573|P1|Overall Study|Adverse Event|5
5871677|NCT01958918|20309601|P2|Overall Study|administrative problems|2
5871678|NCT01958918|20309602|P1|Overall Study|administrative problems|0
5871679|NCT01958918|20309601|P2|Overall Study|Adverse Event|12
5871680|NCT01958918|20309602|P1|Overall Study|Adverse Event|12
5871681|NCT01958918|20309601|P2|Overall Study|Lack of Efficacy|10
5871682|NCT01958918|20309602|P1|Overall Study|Lack of Efficacy|13
5871683|NCT01958918|20309601|P2|Overall Study|Withdrawal by Subject|8
5871684|NCT01958918|20309602|P1|Overall Study|Withdrawal by Subject|13
5871685|NCT01958918|20309601|P2|Overall Study|Lost to Follow-up|7
5871686|NCT01958918|20309602|P1|Overall Study|Lost to Follow-up|4
5871687|NCT01958918|20309601|P2|Overall Study|Death|3
5871688|NCT01958918|20309602|P1|Overall Study|Death|1
5871689|NCT01958827|20309616|P1|Overall Study|Concomitant Prohibited Medicine for AE|1
5871690|NCT01958827|20309616|P1|Overall Study|Lack of Efficacy|6
5871691|NCT01958827|20309616|P1|Overall Study|Adverse Event|3
5871692|NCT01958671|20309647|P3|Overall Study|Withdrawal by Subject|13
5871693|NCT01958671|20309648|P2|Overall Study|Withdrawal by Subject|10
5871694|NCT01958671|20309649|P1|Overall Study|Withdrawal by Subject|8
5871695|NCT01958671|20309647|P3|Overall Study|Participant moved|1
5871696|NCT01958671|20309648|P2|Overall Study|Participant moved|0
5871697|NCT01958671|20309649|P1|Overall Study|Participant moved|0
5871698|NCT01958671|20309647|P3|Overall Study|Study site terminated by sponsor|1
5871699|NCT01958671|20309648|P2|Overall Study|Study site terminated by sponsor|0
5871700|NCT01958671|20309649|P1|Overall Study|Study site terminated by sponsor|1
5871701|NCT01958671|20309647|P3|Overall Study|Protocol Violation|0
5871702|NCT01958671|20309648|P2|Overall Study|Protocol Violation|1
5871703|NCT01958671|20309649|P1|Overall Study|Protocol Violation|0
5871704|NCT01958671|20309647|P3|Overall Study|Pregnancy|1
5871705|NCT01958671|20309648|P2|Overall Study|Pregnancy|0
5871706|NCT01958671|20309649|P1|Overall Study|Pregnancy|0
5871707|NCT01958671|20309647|P3|Overall Study|Non-compliance with study drug|1
5871708|NCT01958671|20309648|P2|Overall Study|Non-compliance with study drug|1
5871709|NCT01958671|20309649|P1|Overall Study|Non-compliance with study drug|1
5871710|NCT01958671|20309647|P3|Overall Study|Lost to Follow-up|7
5871711|NCT01958671|20309648|P2|Overall Study|Lost to Follow-up|11
5871712|NCT01958671|20309649|P1|Overall Study|Lost to Follow-up|7
5871713|NCT01958671|20309647|P3|Overall Study|Hyperglycemia|2
5871714|NCT01958671|20309648|P2|Overall Study|Hyperglycemia|0
5871715|NCT01958671|20309649|P1|Overall Study|Hyperglycemia|0
5871716|NCT01958671|20309647|P3|Overall Study|Excluded medication|1
5871717|NCT01958671|20309648|P2|Overall Study|Excluded medication|0
5871718|NCT01958671|20309649|P1|Overall Study|Excluded medication|0
5871719|NCT01958671|20309647|P3|Overall Study|Death|0
5871720|NCT01958671|20309648|P2|Overall Study|Death|0
5871721|NCT01958671|20309649|P1|Overall Study|Death|1
5871722|NCT01958671|20309647|P3|Overall Study|Adverse Event|5
5871723|NCT01958671|20309648|P2|Overall Study|Adverse Event|1
5871724|NCT01958671|20309649|P1|Overall Study|Adverse Event|1
5871725|NCT01958619|20309723|P4|Overall Study|Protocol Violation|0
5871726|NCT01958619|20309724|P3|Overall Study|Protocol Violation|1
5871727|NCT01958619|20309725|P2|Overall Study|Protocol Violation|0
5871728|NCT01958619|20309726|P1|Overall Study|Protocol Violation|2
5871729|NCT01958489|20309787|P2|Period 2|Adverse Event|1
5871730|NCT01958489|20309788|P1|Period 2|Adverse Event|0
5871731|NCT01958476|20309804|P2|Overall Study|Parent requested exclusion from analysis|0
5871732|NCT01958476|20309805|P1|Overall Study|Parent requested exclusion from analysis|1
5871733|NCT01958437|20309835|P4|Overall Study|Incidental MRI findings|1
5871734|NCT01958437|20309836|P3|Overall Study|Incidental MRI findings|1
5871735|NCT01958437|20309837|P2|Overall Study|Incidental MRI findings|0
5871736|NCT01958437|20309838|P1|Overall Study|Incidental MRI findings|0
5871737|NCT01958294|20309902|P1|Overall Study|Clinical Circumstances|2
5871738|NCT01958281|20309911|P3|Overall Study|Withdrew Consent|0
5871739|NCT01958281|20309912|P2|Overall Study|Withdrew Consent|0
5871740|NCT01958281|20309913|P1|Overall Study|Withdrew Consent|1
5871741|NCT01958281|20309911|P3|Overall Study|Adverse Event|0
5871742|NCT01958281|20309912|P2|Overall Study|Adverse Event|2
5871743|NCT01958281|20309913|P1|Overall Study|Adverse Event|0
5871744|NCT01958281|20309911|P3|Overall Study|Lack of Efficacy|0
5871745|NCT01958281|20309912|P2|Overall Study|Lack of Efficacy|2
5871746|NCT01958281|20309913|P1|Overall Study|Lack of Efficacy|5
5871747|NCT01958164|20309989|P2|Overall Study|Lost to Follow-up|3
5871748|NCT01958164|20309990|P1|Overall Study|Lost to Follow-up|2
5871749|NCT01958164|20309989|P2|Overall Study|Adverse Event|2
5871750|NCT01958164|20309990|P1|Overall Study|Adverse Event|0
5871751|NCT01958125|20310005|P2|Overall Study|No headache attacks|2
5871752|NCT01958125|20310006|P1|Overall Study|No headache attacks|0
5871753|NCT01958125|20310005|P2|Overall Study|Missing diary data|6
5871754|NCT01958125|20310006|P1|Overall Study|Missing diary data|2
5871755|NCT01958060|20310069|P6|Overall Study|Not treated|0
5871756|NCT01958060|20310070|P5|Overall Study|Not treated|1
5871757|NCT01958060|20310071|P4|Overall Study|Not treated|0
5871758|NCT01958060|20310072|P3|Overall Study|Not treated|0
5871759|NCT01958060|20310073|P2|Overall Study|Not treated|0
5871760|NCT01958060|20310074|P1|Overall Study|Not treated|2
5871761|NCT01958021|20310099|P2|Overall Study|Death|0
5871762|NCT01958021|20310100|P1|Overall Study|Death|2
5871763|NCT01958021|20310099|P2|Overall Study|Protocol Violation|1
5871764|NCT01958021|20310100|P1|Overall Study|Protocol Violation|3
5871765|NCT01958021|20310099|P2|Overall Study|Physician Decision|13
5871766|NCT01958021|20310100|P1|Overall Study|Physician Decision|10
5871767|NCT01958021|20310099|P2|Overall Study|Subject/guardian decision|13
5871768|NCT01958021|20310100|P1|Overall Study|Subject/guardian decision|12
5871769|NCT01958021|20310099|P2|Overall Study|Adverse Event|7
5871770|NCT01958021|20310100|P1|Overall Study|Adverse Event|25
5871771|NCT01958021|20310099|P2|Overall Study|Progressive disease|146
5871772|NCT01958021|20310100|P1|Overall Study|Progressive disease|87
5871773|NCT01958008|20310112|P4|Overall Study|Other adverse event|0
5871774|NCT01958008|20310113|P3|Overall Study|Other adverse event|0
5871775|NCT01958008|20310114|P2|Overall Study|Other adverse event|0
5871776|NCT01958008|20310115|P1|Overall Study|Other adverse event|1
5871777|NCT01958008|20310112|P4|Overall Study|Worsening of disease under study|0
5871778|NCT01958008|20310113|P3|Overall Study|Worsening of disease under study|1
5871779|NCT01958008|20310114|P2|Overall Study|Worsening of disease under study|0
5871780|NCT01958008|20310115|P1|Overall Study|Worsening of disease under study|0
5871781|NCT01957865|20310158|P3|Overall Study|Lost to Follow-up|2
5871782|NCT01957865|20310159|P2|Overall Study|Lost to Follow-up|2
5871783|NCT01957865|20310160|P1|Overall Study|Lost to Follow-up|0
5871784|NCT01957865|20310158|P3|Overall Study|Found HIV negative|1
5871785|NCT01957865|20310159|P2|Overall Study|Found HIV negative|0
5871786|NCT01957865|20310160|P1|Overall Study|Found HIV negative|0
5871787|NCT01957787|20310171|P1|Overall Study|Local therapy, not cryoablation|6
5871788|NCT01957787|20310171|P1|Overall Study|Index Tumor was Primary Lung Cancer|2
5871789|NCT01957787|20310171|P1|Overall Study|Index Tumor(s) Resected|2
5871790|NCT01957787|20310171|P1|Overall Study|Entered Hospice or Similar Program|2
5871791|NCT01957787|20310171|P1|Overall Study|Withdrawal by Subject|3
5871792|NCT01957787|20310171|P1|Overall Study|Lost to Follow-up|3
5871793|NCT01957787|20310171|P1|Overall Study|Death|18
5871794|NCT01957709|20310190|P1|Overall Study|Patient refused to complete post-tx bx|1
5871795|NCT01957644|20310215|P5|Overall Study|Protocol Violation|0
5871796|NCT01957644|20310216|P4|Overall Study|Protocol Violation|0
5871797|NCT01957644|20310217|P3|Overall Study|Protocol Violation|0
5871798|NCT01957644|20310218|P2|Overall Study|Protocol Violation|1
5871799|NCT01957644|20310219|P1|Overall Study|Protocol Violation|0
5871800|NCT01957644|20310215|P5|Overall Study|Withdrawal by Subject|0
5871801|NCT01957644|20310216|P4|Overall Study|Withdrawal by Subject|0
5871802|NCT01957644|20310217|P3|Overall Study|Withdrawal by Subject|0
5871803|NCT01957644|20310218|P2|Overall Study|Withdrawal by Subject|0
5871804|NCT01957644|20310219|P1|Overall Study|Withdrawal by Subject|1
5871805|NCT01957644|20310215|P5|Overall Study|Other reason|0
5871806|NCT01957644|20310216|P4|Overall Study|Other reason|1
5871807|NCT01957644|20310217|P3|Overall Study|Other reason|1
5871808|NCT01957644|20310218|P2|Overall Study|Other reason|2
5871809|NCT01957644|20310219|P1|Overall Study|Other reason|1
5871810|NCT01957644|20310215|P5|Overall Study|Progressive disease / relapse|0
5871811|NCT01957644|20310216|P4|Overall Study|Progressive disease / relapse|1
5871812|NCT01957644|20310217|P3|Overall Study|Progressive disease / relapse|0
5871813|NCT01957644|20310218|P2|Overall Study|Progressive disease / relapse|1
5871814|NCT01957644|20310219|P1|Overall Study|Progressive disease / relapse|0
5871815|NCT01957644|20310215|P5|Overall Study|Adverse Event|1
5871816|NCT01957644|20310216|P4|Overall Study|Adverse Event|0
5871817|NCT01957644|20310217|P3|Overall Study|Adverse Event|0
5871818|NCT01957644|20310218|P2|Overall Study|Adverse Event|2
5871819|NCT01957644|20310219|P1|Overall Study|Adverse Event|4
5871820|NCT01957579|20310243|P4|Overall Study|Death|0
5871821|NCT01957579|20310244|P3|Overall Study|Death|2
5871822|NCT01957579|20310245|P2|Overall Study|Death|0
5871823|NCT01957579|20310246|P1|Overall Study|Death|0
5871824|NCT01957579|20310243|P4|Overall Study|Withdrawal of concent|0
5871825|NCT01957579|20310244|P3|Overall Study|Withdrawal of concent|0
5871826|NCT01957579|20310245|P2|Overall Study|Withdrawal of concent|1
5871827|NCT01957579|20310246|P1|Overall Study|Withdrawal of concent|0
5871828|NCT01957553|20310313|P2|Test Period 2 (21 +- 1 Days)|Other|0
5871829|NCT01957553|20310314|P1|Test Period 2 (21 +- 1 Days)|Other|1
5871830|NCT01957553|20310313|P2|Test Period 2 (21 +- 1 Days)|device deficiency without AE|1
5871831|NCT01957553|20310314|P1|Test Period 2 (21 +- 1 Days)|device deficiency without AE|0
5871832|NCT01957553|20310313|P2|Test Period 2 (21 +- 1 Days)|completed early by mistake|1
5871833|NCT01957553|20310314|P1|Test Period 2 (21 +- 1 Days)|completed early by mistake|0
5871834|NCT01957553|20310313|P2|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|2
5871835|NCT01957553|20310314|P1|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|1
5871836|NCT01957553|20310313|P2|Test Period 2 (21 +- 1 Days)|Adverse Event|3
5871837|NCT01957553|20310314|P1|Test Period 2 (21 +- 1 Days)|Adverse Event|1
5871838|NCT01957553|20310313|P2|Test Period 1 (21 +- 1 Days)|screen failure|0
5871839|NCT01957553|20310314|P1|Test Period 1 (21 +- 1 Days)|screen failure|1
5871840|NCT01957553|20310313|P2|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|0
5871841|NCT01957553|20310314|P1|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|2
5871842|NCT01957553|20310313|P2|Test Period 1 (21 +- 1 Days)|Adverse Event|0
5871843|NCT01957553|20310314|P1|Test Period 1 (21 +- 1 Days)|Adverse Event|2
5871844|NCT01957553|20310313|P2|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|3
5871845|NCT01957553|20310314|P1|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|2
5871846|NCT01957488|20310320|P6|Test Period 3 (2 Weeks)|Lack of Efficacy|0
5871847|NCT01957488|20310321|P5|Test Period 3 (2 Weeks)|Lack of Efficacy|0
5871848|NCT01957488|20310322|P4|Test Period 3 (2 Weeks)|Lack of Efficacy|0
5871849|NCT01957488|20310323|P3|Test Period 3 (2 Weeks)|Lack of Efficacy|0
5871850|NCT01957488|20310324|P2|Test Period 3 (2 Weeks)|Lack of Efficacy|1
5871851|NCT01957488|20310325|P1|Test Period 3 (2 Weeks)|Lack of Efficacy|0
5871852|NCT01957488|20310320|P6|Test Period 3 (2 Weeks)|Withdrawal by Subject|0
5871853|NCT01957488|20310321|P5|Test Period 3 (2 Weeks)|Withdrawal by Subject|0
5871854|NCT01957488|20310322|P4|Test Period 3 (2 Weeks)|Withdrawal by Subject|0
5871855|NCT01957488|20310323|P3|Test Period 3 (2 Weeks)|Withdrawal by Subject|0
5871856|NCT01957488|20310324|P2|Test Period 3 (2 Weeks)|Withdrawal by Subject|0
5871857|NCT01957488|20310325|P1|Test Period 3 (2 Weeks)|Withdrawal by Subject|1
5871858|NCT01957488|20310320|P6|Test Period 2 (2 Weeks)|Discontinue due to personal problems|1
5871859|NCT01957488|20310321|P5|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0
5871860|NCT01957488|20310322|P4|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0
5871861|NCT01957488|20310323|P3|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0
5871862|NCT01957488|20310324|P2|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0
5871863|NCT01957488|20310325|P1|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0
5871864|NCT01957488|20310320|P6|Test Period 2 (2 Weeks)|Adverse Event|0
5871865|NCT01957488|20310321|P5|Test Period 2 (2 Weeks)|Adverse Event|2
5871866|NCT01957488|20310322|P4|Test Period 2 (2 Weeks)|Adverse Event|0
5871867|NCT01957488|20310323|P3|Test Period 2 (2 Weeks)|Adverse Event|0
5871868|NCT01957488|20310324|P2|Test Period 2 (2 Weeks)|Adverse Event|0
5871869|NCT01957488|20310325|P1|Test Period 2 (2 Weeks)|Adverse Event|0
5871870|NCT01957488|20310320|P6|Test Period 2 (2 Weeks)|Withdrawal by Subject|0
5871871|NCT01957488|20310321|P5|Test Period 2 (2 Weeks)|Withdrawal by Subject|0
5871872|NCT01957488|20310322|P4|Test Period 2 (2 Weeks)|Withdrawal by Subject|0
5871873|NCT01957488|20310323|P3|Test Period 2 (2 Weeks)|Withdrawal by Subject|0
5871874|NCT01957488|20310324|P2|Test Period 2 (2 Weeks)|Withdrawal by Subject|1
5871875|NCT01957488|20310325|P1|Test Period 2 (2 Weeks)|Withdrawal by Subject|0
5871876|NCT01957488|20310320|P6|Test Period 2 (2 Weeks)|Other|0
5871877|NCT01957488|20310321|P5|Test Period 2 (2 Weeks)|Other|0
5871878|NCT01957488|20310322|P4|Test Period 2 (2 Weeks)|Other|0
5871879|NCT01957488|20310323|P3|Test Period 2 (2 Weeks)|Other|0
5871880|NCT01957488|20310324|P2|Test Period 2 (2 Weeks)|Other|0
5871881|NCT01957488|20310325|P1|Test Period 2 (2 Weeks)|Other|1
5871882|NCT01957488|20310320|P6|Test Period 2 (2 Weeks)|Protocol Violation|0
5871883|NCT01957488|20310321|P5|Test Period 2 (2 Weeks)|Protocol Violation|0
5871884|NCT01957488|20310322|P4|Test Period 2 (2 Weeks)|Protocol Violation|1
5871885|NCT01957488|20310323|P3|Test Period 2 (2 Weeks)|Protocol Violation|1
5871886|NCT01957488|20310324|P2|Test Period 2 (2 Weeks)|Protocol Violation|0
5871887|NCT01957488|20310325|P1|Test Period 2 (2 Weeks)|Protocol Violation|2
5871888|NCT01957488|20310320|P6|Test Period 1 (2 Weeks)|screen failure|1
5871889|NCT01957488|20310321|P5|Test Period 1 (2 Weeks)|screen failure|0
5871890|NCT01957488|20310322|P4|Test Period 1 (2 Weeks)|screen failure|0
5871891|NCT01957488|20310323|P3|Test Period 1 (2 Weeks)|screen failure|0
5871892|NCT01957488|20310324|P2|Test Period 1 (2 Weeks)|screen failure|0
5871893|NCT01957488|20310325|P1|Test Period 1 (2 Weeks)|screen failure|0
5871894|NCT01957488|20310320|P6|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0
5871895|NCT01957488|20310321|P5|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|1
5871896|NCT01957488|20310322|P4|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0
5871897|NCT01957488|20310323|P3|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0
5871898|NCT01957488|20310324|P2|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0
5871899|NCT01957488|20310325|P1|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0
5871900|NCT01957488|20310320|P6|Test Period 1 (2 Weeks)|Withdrawal by Subject|2
5871901|NCT01957488|20310321|P5|Test Period 1 (2 Weeks)|Withdrawal by Subject|1
5871902|NCT01957488|20310322|P4|Test Period 1 (2 Weeks)|Withdrawal by Subject|1
5871903|NCT01957488|20310323|P3|Test Period 1 (2 Weeks)|Withdrawal by Subject|0
5871904|NCT01957488|20310324|P2|Test Period 1 (2 Weeks)|Withdrawal by Subject|0
5871905|NCT01957488|20310325|P1|Test Period 1 (2 Weeks)|Withdrawal by Subject|0
5871906|NCT01957488|20310320|P6|Test Period 1 (2 Weeks)|Adverse Event|0
5871907|NCT01957488|20310321|P5|Test Period 1 (2 Weeks)|Adverse Event|1
5871908|NCT01957488|20310322|P4|Test Period 1 (2 Weeks)|Adverse Event|0
5871909|NCT01957488|20310323|P3|Test Period 1 (2 Weeks)|Adverse Event|1
5871910|NCT01957488|20310324|P2|Test Period 1 (2 Weeks)|Adverse Event|1
5871911|NCT01957488|20310325|P1|Test Period 1 (2 Weeks)|Adverse Event|0
5871912|NCT01957488|20310320|P6|Test Period 1 (2 Weeks)|Protocol Violation|3
5871913|NCT01957488|20310321|P5|Test Period 1 (2 Weeks)|Protocol Violation|0
5871914|NCT01957488|20310322|P4|Test Period 1 (2 Weeks)|Protocol Violation|1
5871915|NCT01957488|20310323|P3|Test Period 1 (2 Weeks)|Protocol Violation|2
5871916|NCT01957488|20310324|P2|Test Period 1 (2 Weeks)|Protocol Violation|2
5871917|NCT01957488|20310325|P1|Test Period 1 (2 Weeks)|Protocol Violation|1
5871918|NCT01957488|20310320|P6|Test Period 1 (2 Weeks)|Lost to Follow-up|0
5871919|NCT01957488|20310321|P5|Test Period 1 (2 Weeks)|Lost to Follow-up|0
5871920|NCT01957488|20310322|P4|Test Period 1 (2 Weeks)|Lost to Follow-up|1
5871921|NCT01957488|20310323|P3|Test Period 1 (2 Weeks)|Lost to Follow-up|1
5871922|NCT01957488|20310324|P2|Test Period 1 (2 Weeks)|Lost to Follow-up|0
5871923|NCT01957488|20310325|P1|Test Period 1 (2 Weeks)|Lost to Follow-up|2
5871924|NCT01957475|20310333|P2|Test Period 2|Adverse Event|0
5871925|NCT01957475|20310334|P1|Test Period 2|Adverse Event|1
5871926|NCT01957475|20310333|P2|Test Period 1|Lack of Efficacy|1
5871927|NCT01957475|20310334|P1|Test Period 1|Lack of Efficacy|0
5871928|NCT01957475|20310333|P2|Test Period 1|Other|0
5871929|NCT01957475|20310334|P1|Test Period 1|Other|1
5871930|NCT01957475|20310333|P2|Test Period 1|Withdrawal by Subject|0
5871931|NCT01957475|20310334|P1|Test Period 1|Withdrawal by Subject|1
5871932|NCT01957462|20310340|P2|Test Period 1|Adverse Event|0
5871933|NCT01957462|20310341|P1|Test Period 1|Adverse Event|1
5871934|NCT01957462|20310340|P2|Test Period 1|Withdrawal by Subject|0
5871935|NCT01957462|20310341|P1|Test Period 1|Withdrawal by Subject|1
5871936|NCT01957397|20310352|P2|Test Period 3|the adhesive did not work|0
5871937|NCT01957397|20310353|P1|Test Period 3|the adhesive did not work|1
5871938|NCT01957397|20310352|P2|Test Period 3|Adverse Event|2
5871939|NCT01957397|20310353|P1|Test Period 3|Adverse Event|1
5871940|NCT01957397|20310352|P2|Test Period 2|Adverse Event|1
5871941|NCT01957397|20310353|P1|Test Period 2|Adverse Event|0
5871942|NCT01957397|20310352|P2|Test Period 1|Withdrawal by Subject|0
5871943|NCT01957397|20310353|P1|Test Period 1|Withdrawal by Subject|1
5871944|NCT01957397|20310352|P2|Test Period 1|sudden leakage/small bag|1
5871945|NCT01957397|20310353|P1|Test Period 1|sudden leakage/small bag|1
5871946|NCT01957215|20310378|P2|Overall Study|Withdrawal by Subject|5
5871947|NCT01957215|20310379|P1|Overall Study|Withdrawal by Subject|7
5871948|NCT01957215|20310378|P2|Overall Study|Protocol Violation|2
5871949|NCT01957215|20310379|P1|Overall Study|Protocol Violation|1
5871950|NCT01957215|20310378|P2|Overall Study|Lost to Follow-up|3
5871951|NCT01957215|20310379|P1|Overall Study|Lost to Follow-up|3
5871952|NCT01957215|20310378|P2|Overall Study|Adverse Event|2
5871953|NCT01957215|20310379|P1|Overall Study|Adverse Event|2
5871954|NCT01957202|20310407|P18|Treatment Period 3 (8 Days)|Adverse Event|0
5871955|NCT01957202|20310408|P17|Treatment Period 3 (8 Days)|Adverse Event|1
5871956|NCT01957202|20310409|P16|Treatment Period 3 (8 Days)|Adverse Event|0
5871957|NCT01957202|20310410|P15|Treatment Period 3 (8 Days)|Adverse Event|0
5871958|NCT01957202|20310411|P14|Treatment Period 3 (8 Days)|Adverse Event|0
5871959|NCT01957202|20310412|P13|Treatment Period 3 (8 Days)|Adverse Event|0
5871960|NCT01957202|20310413|P12|Treatment Period 3 (8 Days)|Adverse Event|0
5871961|NCT01957202|20310414|P11|Treatment Period 3 (8 Days)|Adverse Event|0
5871962|NCT01957202|20310415|P10|Treatment Period 3 (8 Days)|Adverse Event|0
5871963|NCT01957202|20310416|P9|Treatment Period 3 (8 Days)|Adverse Event|0
5871964|NCT01957202|20310417|P8|Treatment Period 3 (8 Days)|Adverse Event|0
5871965|NCT01957202|20310418|P7|Treatment Period 3 (8 Days)|Adverse Event|0
5871966|NCT01957202|20310419|P6|Treatment Period 3 (8 Days)|Adverse Event|0
5871967|NCT01957202|20310420|P5|Treatment Period 3 (8 Days)|Adverse Event|0
5871968|NCT01957202|20310421|P4|Treatment Period 3 (8 Days)|Adverse Event|0
5871969|NCT01957202|20310422|P3|Treatment Period 3 (8 Days)|Adverse Event|0
5871970|NCT01957202|20310423|P2|Treatment Period 3 (8 Days)|Adverse Event|0
5871971|NCT01957202|20310424|P1|Treatment Period 3 (8 Days)|Adverse Event|0
5871972|NCT01957202|20310407|P18|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
5871973|NCT01957202|20310408|P17|Treatment Period 2 (8 Days)|Withdrawal by Subject|1
5871974|NCT01957202|20310409|P16|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
5871975|NCT01957202|20310410|P15|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
5871976|NCT01957202|20310411|P14|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
5871977|NCT01957202|20310412|P13|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
5871978|NCT01957202|20310413|P12|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
5871979|NCT01957202|20310414|P11|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
5871980|NCT01957202|20310415|P10|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
5871981|NCT01957202|20310416|P9|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
5871982|NCT01957202|20310417|P8|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
5871983|NCT01957202|20310418|P7|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
5871984|NCT01957202|20310419|P6|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
5871985|NCT01957202|20310420|P5|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
5871986|NCT01957202|20310421|P4|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
5871987|NCT01957202|20310422|P3|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
5871988|NCT01957202|20310423|P2|Treatment Period 2 (8 Days)|Withdrawal by Subject|1
5871989|NCT01957202|20310424|P1|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
5871990|NCT01957163|20310449|P3|Overall Study|Withdrawal by Subject|4
5871991|NCT01957163|20310450|P2|Overall Study|Withdrawal by Subject|2
5871992|NCT01957163|20310451|P1|Overall Study|Withdrawal by Subject|4
5871993|NCT01957163|20310449|P3|Overall Study|Lost to Follow-up|0
5871994|NCT01957163|20310450|P2|Overall Study|Lost to Follow-up|1
5871995|NCT01957163|20310451|P1|Overall Study|Lost to Follow-up|0
5871996|NCT01957163|20310449|P3|Overall Study|Met Protocol-Defined Stopping Criteria|1
5871997|NCT01957163|20310450|P2|Overall Study|Met Protocol-Defined Stopping Criteria|0
5871998|NCT01957163|20310451|P1|Overall Study|Met Protocol-Defined Stopping Criteria|0
5871999|NCT01957163|20310449|P3|Overall Study|Protocol Violation|0
5872000|NCT01957163|20310450|P2|Overall Study|Protocol Violation|2
5872001|NCT01957163|20310451|P1|Overall Study|Protocol Violation|1
5872002|NCT01957163|20310449|P3|Overall Study|Lack of Efficacy|9
5872003|NCT01957163|20310450|P2|Overall Study|Lack of Efficacy|4
5872004|NCT01957163|20310451|P1|Overall Study|Lack of Efficacy|5
5872005|NCT01957163|20310449|P3|Overall Study|Adverse Event|4
5872006|NCT01957163|20310450|P2|Overall Study|Adverse Event|2
5872007|NCT01957163|20310451|P1|Overall Study|Adverse Event|5
5872008|NCT01957150|20310464|P2|Overall Study|Lack of Efficacy|11
5872009|NCT01957150|20310465|P1|Overall Study|Lack of Efficacy|11
5872010|NCT01957150|20310464|P2|Overall Study|Protocol Violation|0
5872011|NCT01957150|20310465|P1|Overall Study|Protocol Violation|1
5872012|NCT01957150|20310464|P2|Overall Study|Lost to Follow-up|4
5872013|NCT01957150|20310465|P1|Overall Study|Lost to Follow-up|4
5872014|NCT01957150|20310464|P2|Overall Study|Physician Decision|6
5872015|NCT01957150|20310465|P1|Overall Study|Physician Decision|3
5872016|NCT01957150|20310464|P2|Overall Study|Withdrawal by Subject|17
5872017|NCT01957150|20310465|P1|Overall Study|Withdrawal by Subject|13
5872018|NCT01957150|20310464|P2|Overall Study|Adverse Event|20
5872019|NCT01957150|20310465|P1|Overall Study|Adverse Event|23
5872020|NCT01957137|20310481|P1|Randomized Portion|Withdrawal by Subject|1
5872021|NCT01957137|20310481|P1|Randomized Portion|Adverse Event|1
5872022|NCT01957111|20310511|P2|Overall Study|Withdrawal by Subject|1
5872023|NCT01957111|20310512|P1|Overall Study|Withdrawal by Subject|1
5872024|NCT01956773|20310531|P2|Overall Study|Lost to Follow-up|1
5872025|NCT01956773|20310532|P1|Overall Study|Lost to Follow-up|628
5872026|NCT01956669|20310550|P7|Overall Study|Withdrawal by Subject|1
5872027|NCT01956669|20310551|P6|Overall Study|Withdrawal by Subject|0
5872028|NCT01956669|20310552|P5|Overall Study|Withdrawal by Subject|0
5872029|NCT01956669|20310553|P4|Overall Study|Withdrawal by Subject|1
5872030|NCT01956669|20310554|P3|Overall Study|Withdrawal by Subject|1
5872031|NCT01956669|20310555|P2|Overall Study|Withdrawal by Subject|0
5872032|NCT01956669|20310556|P1|Overall Study|Withdrawal by Subject|0
5872033|NCT01956669|20310550|P7|Overall Study|Physician Decision|0
5872034|NCT01956669|20310551|P6|Overall Study|Physician Decision|1
5872035|NCT01956669|20310552|P5|Overall Study|Physician Decision|0
5872036|NCT01956669|20310553|P4|Overall Study|Physician Decision|0
5872037|NCT01956669|20310554|P3|Overall Study|Physician Decision|0
5872038|NCT01956669|20310555|P2|Overall Study|Physician Decision|2
5872039|NCT01956669|20310556|P1|Overall Study|Physician Decision|0
5872040|NCT01956669|20310550|P7|Overall Study|Adverse Event|0
5872041|NCT01956669|20310551|P6|Overall Study|Adverse Event|0
5872042|NCT01956669|20310552|P5|Overall Study|Adverse Event|0
5872043|NCT01956669|20310553|P4|Overall Study|Adverse Event|1
5872044|NCT01956669|20310554|P3|Overall Study|Adverse Event|2
5872045|NCT01956669|20310555|P2|Overall Study|Adverse Event|2
5872046|NCT01956669|20310556|P1|Overall Study|Adverse Event|0
5872047|NCT01956669|20310550|P7|Overall Study|Disease Progression|5
5872048|NCT01956669|20310551|P6|Overall Study|Disease Progression|3
5872049|NCT01956669|20310552|P5|Overall Study|Disease Progression|4
5872050|NCT01956669|20310553|P4|Overall Study|Disease Progression|8
5872051|NCT01956669|20310554|P3|Overall Study|Disease Progression|7
5872052|NCT01956669|20310555|P2|Overall Study|Disease Progression|7
5872053|NCT01956669|20310556|P1|Overall Study|Disease Progression|12
5872054|NCT01956240|20310678|P2|Overall Study|Adverse Event|4
5872055|NCT01956240|20310679|P1|Overall Study|Adverse Event|17
5872056|NCT01956240|20310678|P2|Overall Study|Lost to Follow-up|20
5872057|NCT01956240|20310679|P1|Overall Study|Lost to Follow-up|6
5872058|NCT01956123|20310689|P4|COS Cycle 3|Withdrawal by Subject|1
5872059|NCT01956123|20310690|P3|COS Cycle 3|Withdrawal by Subject|0
5872060|NCT01956123|20310691|P2|COS Cycle 3|Withdrawal by Subject|0
5872061|NCT01956123|20310692|P1|COS Cycle 3|Withdrawal by Subject|0
5872062|NCT01956123|20310689|P4|COS Cycle 3|Personal Reasons|0
5872063|NCT01956123|20310690|P3|COS Cycle 3|Personal Reasons|1
5872064|NCT01956123|20310691|P2|COS Cycle 3|Personal Reasons|0
5872065|NCT01956123|20310692|P1|COS Cycle 3|Personal Reasons|0
5872066|NCT01956123|20310689|P4|COS Cycle 3|Adverse Event|0
5872067|NCT01956123|20310690|P3|COS Cycle 3|Adverse Event|3
5872068|NCT01956123|20310691|P2|COS Cycle 3|Adverse Event|0
5872069|NCT01956123|20310692|P1|COS Cycle 3|Adverse Event|0
5872070|NCT01956123|20310689|P4|COS Cycle 3|Protocol Violation|1
5872071|NCT01956123|20310690|P3|COS Cycle 3|Protocol Violation|2
5872072|NCT01956123|20310691|P2|COS Cycle 3|Protocol Violation|0
5872073|NCT01956123|20310692|P1|COS Cycle 3|Protocol Violation|0
5872074|NCT01956123|20310689|P4|COS Cycle 2|Withdrawal by Subject|0
5872075|NCT01956123|20310690|P3|COS Cycle 2|Withdrawal by Subject|0
5872076|NCT01956123|20310691|P2|COS Cycle 2|Withdrawal by Subject|0
5872077|NCT01956123|20310692|P1|COS Cycle 2|Withdrawal by Subject|1
5872078|NCT01956123|20310689|P4|COS Cycle 2|Personal Reasons|0
5872079|NCT01956123|20310690|P3|COS Cycle 2|Personal Reasons|0
5872080|NCT01956123|20310691|P2|COS Cycle 2|Personal Reasons|0
5872081|NCT01956123|20310692|P1|COS Cycle 2|Personal Reasons|2
5872082|NCT01956123|20310689|P4|COS Cycle 2|Adverse Event|0
5872083|NCT01956123|20310690|P3|COS Cycle 2|Adverse Event|0
5872084|NCT01956123|20310691|P2|COS Cycle 2|Adverse Event|4
5872085|NCT01956123|20310692|P1|COS Cycle 2|Adverse Event|3
5872086|NCT01956123|20310689|P4|COS Cycle 2|Protocol Violation|0
5872087|NCT01956123|20310690|P3|COS Cycle 2|Protocol Violation|0
5872088|NCT01956123|20310691|P2|COS Cycle 2|Protocol Violation|3
5872089|NCT01956123|20310692|P1|COS Cycle 2|Protocol Violation|8
5872090|NCT01956110|20310744|P2|Overall Study|Personal reasons|1
5872091|NCT01956110|20310745|P1|Overall Study|Personal reasons|1
5872092|NCT01956110|20310744|P2|Overall Study|Adverse Event|10
5872093|NCT01956110|20310745|P1|Overall Study|Adverse Event|9
5872094|NCT01956110|20310744|P2|Overall Study|Protocol Violation|11
5872095|NCT01956110|20310745|P1|Overall Study|Protocol Violation|25
5872096|NCT01955733|20310911|P3|Period 2|Other not defined above|2
5872097|NCT01955733|20310912|P2|Period 2|Other not defined above|2
5872098|NCT01955733|20310913|P1|Period 2|Other not defined above|0
5872099|NCT01955733|20310911|P3|Period 2|Lost to Follow-up|0
5872100|NCT01955733|20310912|P2|Period 2|Lost to Follow-up|0
5872101|NCT01955733|20310913|P1|Period 2|Lost to Follow-up|2
5872102|NCT01955733|20310911|P3|Period 2|Study terminated by sponsor|16
5872103|NCT01955733|20310912|P2|Period 2|Study terminated by sponsor|14
5872104|NCT01955733|20310913|P1|Period 2|Study terminated by sponsor|8
5872105|NCT01955733|20310911|P3|Period 2|Withdrawal by Subject|2
5872106|NCT01955733|20310912|P2|Period 2|Withdrawal by Subject|3
5872107|NCT01955733|20310913|P1|Period 2|Withdrawal by Subject|1
5872108|NCT01955733|20310911|P3|Period 2|Physician Decision|1
5872109|NCT01955733|20310912|P2|Period 2|Physician Decision|0
5872110|NCT01955733|20310913|P1|Period 2|Physician Decision|0
5872111|NCT01955733|20310911|P3|Period 2|Adverse Event|0
5872112|NCT01955733|20310912|P2|Period 2|Adverse Event|0
5872113|NCT01955733|20310913|P1|Period 2|Adverse Event|1
5872114|NCT01955733|20310911|P3|Period 1|Lost to Follow-up|0
5872115|NCT01955733|20310912|P2|Period 1|Lost to Follow-up|0
5872116|NCT01955733|20310913|P1|Period 1|Lost to Follow-up|1
5872117|NCT01955707|20311006|P2|Overall Study|Other|2
5872118|NCT01955707|20311007|P1|Overall Study|Other|4
5872119|NCT01955707|20311006|P2|Overall Study|Death|14
5872120|NCT01955707|20311007|P1|Overall Study|Death|13
5872121|NCT01955707|20311006|P2|Overall Study|Withdrawal by Subject|3
5872122|NCT01955707|20311007|P1|Overall Study|Withdrawal by Subject|0
5872123|NCT01955707|20311006|P2|Overall Study|Lost to Follow-up|1
5872124|NCT01955707|20311007|P1|Overall Study|Lost to Follow-up|2
5872125|NCT01955707|20311006|P2|Overall Study|Adverse Event|2
5872126|NCT01955707|20311007|P1|Overall Study|Adverse Event|1
5872127|NCT01955161|20311275|P3|Overall Study|Other reason: patient's will|1
5872128|NCT01955161|20311276|P2|Overall Study|Other reason: patient's will|0
5872129|NCT01955161|20311277|P1|Overall Study|Other reason: patient's will|0
5872130|NCT01955161|20311275|P3|Overall Study|Other reason: primary biliary cirrhosis|0
5872131|NCT01955161|20311276|P2|Overall Study|Other reason: primary biliary cirrhosis|0
5872132|NCT01955161|20311277|P1|Overall Study|Other reason: primary biliary cirrhosis|1
5872133|NCT01955161|20311275|P3|Overall Study|Other reason: insufficient compliance|1
5872134|NCT01955161|20311276|P2|Overall Study|Other reason: insufficient compliance|0
5872135|NCT01955161|20311277|P1|Overall Study|Other reason: insufficient compliance|0
5872136|NCT01955161|20311275|P3|Overall Study|Other reason: moved to nursing home|0
5872137|NCT01955161|20311276|P2|Overall Study|Other reason: moved to nursing home|1
5872138|NCT01955161|20311277|P1|Overall Study|Other reason: moved to nursing home|0
5872139|NCT01955161|20311275|P3|Overall Study|Other reason: caregiver unavailable|0
5872140|NCT01955161|20311276|P2|Overall Study|Other reason: caregiver unavailable|0
5872141|NCT01955161|20311277|P1|Overall Study|Other reason: caregiver unavailable|1
5872142|NCT01955161|20311275|P3|Overall Study|Other reason: disallowed medication|1
5872143|NCT01955161|20311276|P2|Overall Study|Other reason: disallowed medication|0
5872144|NCT01955161|20311277|P1|Overall Study|Other reason: disallowed medication|1
5872145|NCT01955161|20311275|P3|Overall Study|Other reason: physician decision|1
5872146|NCT01955161|20311276|P2|Overall Study|Other reason: physician decision|1
5872147|NCT01955161|20311277|P1|Overall Study|Other reason: physician decision|0
5872148|NCT01955161|20311275|P3|Overall Study|Protocol Violation|0
5872149|NCT01955161|20311276|P2|Overall Study|Protocol Violation|0
5872150|NCT01955161|20311277|P1|Overall Study|Protocol Violation|2
5872151|NCT01955161|20311275|P3|Overall Study|Withdrawal by Subject|12
5872152|NCT01955161|20311276|P2|Overall Study|Withdrawal by Subject|8
5872153|NCT01955161|20311277|P1|Overall Study|Withdrawal by Subject|9
5872154|NCT01955161|20311275|P3|Overall Study|Death|3
5872155|NCT01955161|20311276|P2|Overall Study|Death|1
5872156|NCT01955161|20311277|P1|Overall Study|Death|1
5872157|NCT01955161|20311275|P3|Overall Study|Adverse Event|15
5872158|NCT01955161|20311276|P2|Overall Study|Adverse Event|14
5872159|NCT01955161|20311277|P1|Overall Study|Adverse Event|10
5872160|NCT01955161|20311275|P3|Overall Study|Withdrawal before treatment|1
5872161|NCT01955161|20311276|P2|Overall Study|Withdrawal before treatment|0
5872162|NCT01955161|20311277|P1|Overall Study|Withdrawal before treatment|2
5872163|NCT01955122|20311317|P2|Overall Study|Physician Decision|5
5872164|NCT01955122|20311318|P1|Overall Study|Physician Decision|5
5872165|NCT01955083|20311338|P2|Overall Study|Lost to Follow-up|1
5872166|NCT01955083|20311339|P1|Overall Study|Lost to Follow-up|1
5872167|NCT01955044|20311372|P3|Overall Study|Death|0
5872168|NCT01955044|20311373|P2|Overall Study|Death|1
5872169|NCT01955044|20311374|P1|Overall Study|Death|1
5872170|NCT01955005|20311387|P2|Overall Study|Withdrawal by Subject|5
5872171|NCT01955005|20311388|P1|Overall Study|Withdrawal by Subject|3
5872172|NCT01954927|20311400|P2|Overall Study|Withdrawal by Subject|1
5872173|NCT01954927|20311401|P1|Overall Study|Withdrawal by Subject|3
5872174|NCT01954771|20311422|P3|Overall Study|Missing HbA1c and CGMS of end-point|3
5872175|NCT01954771|20311423|P2|Overall Study|Missing HbA1c and CGMS of end-point|1
5872176|NCT01954771|20311424|P1|Overall Study|Missing HbA1c and CGMS of end-point|5
5872177|NCT01954771|20311422|P3|Overall Study|Missing CGMS of end-point|0
5872178|NCT01954771|20311423|P2|Overall Study|Missing CGMS of end-point|1
5872179|NCT01954771|20311424|P1|Overall Study|Missing CGMS of end-point|1
5872180|NCT01954771|20311422|P3|Overall Study|Missing HbA1c of end-point|0
5872181|NCT01954771|20311423|P2|Overall Study|Missing HbA1c of end-point|1
5872182|NCT01954771|20311424|P1|Overall Study|Missing HbA1c of end-point|1
5872183|NCT01954745|20311441|P1|Overall Study|Death|1
5872184|NCT01954745|20311441|P1|Overall Study|Adverse Event|2
5872185|NCT01954745|20311441|P1|Overall Study|Clinical Progression|5
5872186|NCT01954745|20311441|P1|Overall Study|Radiological Progression|11
5872187|NCT01954394|20311472|P2|Overall Study|Other than specified above|21
5872188|NCT01954394|20311473|P1|Overall Study|Other than specified above|10
5872189|NCT01954394|20311472|P2|Overall Study|Related to Study Drug administration|2
5872190|NCT01954394|20311473|P1|Overall Study|Related to Study Drug administration|2
5872191|NCT01954394|20311472|P2|Overall Study|Participant Moved|4
5872192|NCT01954394|20311473|P1|Overall Study|Participant Moved|0
5872193|NCT01954394|20311472|P2|Overall Study|Poor compliance to protocol|7
5872194|NCT01954394|20311473|P1|Overall Study|Poor compliance to protocol|7
5872195|NCT01954394|20311472|P2|Overall Study|Adverse Event|23
5872196|NCT01954394|20311473|P1|Overall Study|Adverse Event|10
5872197|NCT01954394|20311472|P2|Overall Study|Enrolled but not treated|0
5872198|NCT01954394|20311473|P1|Overall Study|Enrolled but not treated|1
5872199|NCT01954342|20311527|P4|Overall Study|Unreliable Data|2
5872200|NCT01954342|20311528|P3|Overall Study|Unreliable Data|0
5872201|NCT01954342|20311529|P2|Overall Study|Unreliable Data|0
5872202|NCT01954342|20311530|P1|Overall Study|Unreliable Data|0
5872203|NCT01954342|20311527|P4|Overall Study|Pre-eclampsia|4
5872204|NCT01954342|20311528|P3|Overall Study|Pre-eclampsia|0
5872205|NCT01954342|20311529|P2|Overall Study|Pre-eclampsia|0
5872206|NCT01954342|20311530|P1|Overall Study|Pre-eclampsia|0
5872207|NCT01954342|20311527|P4|Overall Study|Preterm delivery|3
5872208|NCT01954342|20311528|P3|Overall Study|Preterm delivery|0
5872209|NCT01954342|20311529|P2|Overall Study|Preterm delivery|0
5872210|NCT01954342|20311530|P1|Overall Study|Preterm delivery|0
5872211|NCT01954342|20311527|P4|Overall Study|Lost to Follow-up|5
5872212|NCT01954342|20311528|P3|Overall Study|Lost to Follow-up|0
5872213|NCT01954342|20311529|P2|Overall Study|Lost to Follow-up|0
5872214|NCT01954342|20311530|P1|Overall Study|Lost to Follow-up|0
5872215|NCT01954342|20311527|P4|Overall Study|Miscarriage|3
5872216|NCT01954342|20311528|P3|Overall Study|Miscarriage|0
5872217|NCT01954342|20311529|P2|Overall Study|Miscarriage|0
5872218|NCT01954342|20311530|P1|Overall Study|Miscarriage|0
5872219|NCT01954342|20311527|P4|Overall Study|Missing data from 13-16week study visit|1
5872220|NCT01954342|20311528|P3|Overall Study|Missing data from 13-16week study visit|0
5872221|NCT01954342|20311529|P2|Overall Study|Missing data from 13-16week study visit|0
5872222|NCT01954342|20311530|P1|Overall Study|Missing data from 13-16week study visit|0
5872223|NCT01954251|20311632|P2|Overall Study|Withdrawal by Subject|6
5872224|NCT01954251|20311633|P1|Overall Study|Withdrawal by Subject|2
5872225|NCT01954251|20311632|P2|Overall Study|Lost to Follow-up|6
5872226|NCT01954251|20311633|P1|Overall Study|Lost to Follow-up|6
5872227|NCT01954251|20311632|P2|Overall Study|Adverse Event|7
5872228|NCT01954251|20311633|P1|Overall Study|Adverse Event|5
5872229|NCT01954121|20311730|P2|Overall Study|Subject did not follow instructions|2
5872230|NCT01954121|20311731|P1|Overall Study|Subject did not follow instructions|0
5872231|NCT01954121|20311730|P2|Overall Study|Non-compliant patient|1
5872232|NCT01954121|20311731|P1|Overall Study|Non-compliant patient|1
5872233|NCT01954121|20311730|P2|Overall Study|Non-compliant with study procedures|0
5872234|NCT01954121|20311731|P1|Overall Study|Non-compliant with study procedures|1
5872235|NCT01954121|20311730|P2|Overall Study|SAE, non-fatal|4
5872236|NCT01954121|20311731|P1|Overall Study|SAE, non-fatal|1
5872237|NCT01954121|20311730|P2|Overall Study|AE, non-serious non-fatal|22
5872238|NCT01954121|20311731|P1|Overall Study|AE, non-serious non-fatal|5
5872239|NCT01954121|20311730|P2|Overall Study|AE, serious fatal|0
5872240|NCT01954121|20311731|P1|Overall Study|AE, serious fatal|1
5872241|NCT01954121|20311730|P2|Overall Study|Pregnancy|1
5872242|NCT01954121|20311731|P1|Overall Study|Pregnancy|1
5872243|NCT01954121|20311730|P2|Overall Study|Withdrawal by Subject|12
5872244|NCT01954121|20311731|P1|Overall Study|Withdrawal by Subject|18
5872245|NCT01954121|20311730|P2|Overall Study|Lost to Follow-up|6
5872246|NCT01954121|20311731|P1|Overall Study|Lost to Follow-up|5
5872247|NCT01954121|20311730|P2|Overall Study|Protocol Violation|2
5872248|NCT01954121|20311731|P1|Overall Study|Protocol Violation|0
5872249|NCT01954121|20311730|P2|Overall Study|Lack of Efficacy|41
5872250|NCT01954121|20311731|P1|Overall Study|Lack of Efficacy|94
5872251|NCT01954082|20311747|P2|Overall Study|Randomized not Treated|2
5872252|NCT01954082|20311748|P1|Overall Study|Randomized not Treated|4
5872253|NCT01954082|20311747|P2|Overall Study|Infant Moved|1
5872254|NCT01954082|20311748|P1|Overall Study|Infant Moved|0
5872255|NCT01954082|20311747|P2|Overall Study|Comfort Care|1
5872256|NCT01954082|20311748|P1|Overall Study|Comfort Care|0
5872257|NCT01954082|20311747|P2|Overall Study|Miscalculation of Final Dose Day|3
5872258|NCT01954082|20311748|P1|Overall Study|Miscalculation of Final Dose Day|0
5872259|NCT01954082|20311747|P2|Overall Study|Redirection of Care|2
5872260|NCT01954082|20311748|P1|Overall Study|Redirection of Care|0
5872261|NCT01954082|20311747|P2|Overall Study|Discontinued Early Prior to Transfer|2
5872262|NCT01954082|20311748|P1|Overall Study|Discontinued Early Prior to Transfer|3
5872263|NCT01954082|20311747|P2|Overall Study|Withdrawal by Subject|1
5872264|NCT01954082|20311748|P1|Overall Study|Withdrawal by Subject|0
5872265|NCT01954082|20311747|P2|Overall Study|Parent Decision|0
5872266|NCT01954082|20311748|P1|Overall Study|Parent Decision|1
5872267|NCT01954082|20311747|P2|Overall Study|Physician Decision|0
5872268|NCT01954082|20311748|P1|Overall Study|Physician Decision|2
5872269|NCT01954082|20311747|P2|Overall Study|Non-compliance|4
5872270|NCT01954082|20311748|P1|Overall Study|Non-compliance|6
5872271|NCT01954082|20311747|P2|Overall Study|Intolerance|1
5872272|NCT01954082|20311748|P1|Overall Study|Intolerance|0
5872273|NCT01954082|20311747|P2|Overall Study|Adverse Event|4
5872274|NCT01954082|20311748|P1|Overall Study|Adverse Event|10
5872275|NCT01954082|20311747|P2|Overall Study|Study Suspension|36
5872276|NCT01954082|20311748|P1|Overall Study|Study Suspension|42
5872277|NCT01954056|20311768|P2|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|0
5872278|NCT01954056|20311769|P1|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|1
5872279|NCT01954017|20311814|P3|Overall Study|All other reasons|7
5872280|NCT01954017|20311815|P2|Overall Study|All other reasons|2
5872281|NCT01954017|20311816|P1|Overall Study|All other reasons|2
5872282|NCT01954017|20311814|P3|Overall Study|Enteral intake stopped >7 days|1
5872283|NCT01954017|20311815|P2|Overall Study|Enteral intake stopped >7 days|1
5872284|NCT01954017|20311816|P1|Overall Study|Enteral intake stopped >7 days|0
5872285|NCT01954017|20311814|P3|Overall Study|Necrotizing enterocolitis|1
5872286|NCT01954017|20311815|P2|Overall Study|Necrotizing enterocolitis|0
5872287|NCT01954017|20311816|P1|Overall Study|Necrotizing enterocolitis|1
5872288|NCT01954017|20311814|P3|Overall Study|Protocol Violation|2
5872289|NCT01954017|20311815|P2|Overall Study|Protocol Violation|3
5872290|NCT01954017|20311816|P1|Overall Study|Protocol Violation|0
5872291|NCT01954017|20311814|P3|Overall Study|Withdrawal by Subject|0
5872292|NCT01954017|20311815|P2|Overall Study|Withdrawal by Subject|1
5872293|NCT01954017|20311816|P1|Overall Study|Withdrawal by Subject|0
5872294|NCT01954017|20311814|P3|Overall Study|Death|1
5872295|NCT01954017|20311815|P2|Overall Study|Death|1
5872296|NCT01954017|20311816|P1|Overall Study|Death|2
5872297|NCT01954017|20311814|P3|Overall Study|Adverse Event|1
5872298|NCT01954017|20311815|P2|Overall Study|Adverse Event|0
5872299|NCT01954017|20311816|P1|Overall Study|Adverse Event|0
5872300|NCT01953913|20312042|P1|Overall Study|Not Treated|1
5872301|NCT01953913|20312042|P1|Overall Study|Other than listed|108
5872302|NCT01953913|20312042|P1|Overall Study|Withdrawal by Subject|32
5872303|NCT01953913|20312042|P1|Overall Study|Lost to Follow-up|4
5872304|NCT01953913|20312042|P1|Overall Study|Protocol Violation|6
5872305|NCT01953913|20312042|P1|Overall Study|Adverse Event|20
5872306|NCT01953913|20312042|P1|Overall Study|Worsening of underlying cancer|22
5872307|NCT01953913|20312042|P1|Overall Study|Disease Progression|349
5872308|NCT01953783|20312094|P1|Overall Study|Progressive disease|2
5872309|NCT01953601|20312119|P3|Part 2 (Extension Study)|Withdrawal by Subject|2
5872310|NCT01953601|20312120|P2|Part 2 (Extension Study)|Withdrawal by Subject|4
5872311|NCT01953601|20312121|P1|Part 2 (Extension Study)|Withdrawal by Subject|5
5872312|NCT01953601|20312119|P3|Part 2 (Extension Study)|Subject moved|1
5872313|NCT01953601|20312120|P2|Part 2 (Extension Study)|Subject moved|0
5872314|NCT01953601|20312121|P1|Part 2 (Extension Study)|Subject moved|0
5872315|NCT01953601|20312119|P3|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|0
5872316|NCT01953601|20312120|P2|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|3
5872317|NCT01953601|20312121|P1|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|1
5872318|NCT01953601|20312119|P3|Part 2 (Extension Study)|Study terminated by sponsor|187
5872319|NCT01953601|20312120|P2|Part 2 (Extension Study)|Study terminated by sponsor|178
5872320|NCT01953601|20312121|P1|Part 2 (Extension Study)|Study terminated by sponsor|185
5872321|NCT01953601|20312119|P3|Part 2 (Extension Study)|Site discontinued study participation|1
5872322|NCT01953601|20312120|P2|Part 2 (Extension Study)|Site discontinued study participation|1
5872323|NCT01953601|20312121|P1|Part 2 (Extension Study)|Site discontinued study participation|0
5872324|NCT01953601|20312119|P3|Part 2 (Extension Study)|Physician Decision|2
5872325|NCT01953601|20312120|P2|Part 2 (Extension Study)|Physician Decision|0
5872326|NCT01953601|20312121|P1|Part 2 (Extension Study)|Physician Decision|2
5872327|NCT01953601|20312119|P3|Part 2 (Extension Study)|Lost to Follow-up|1
5872328|NCT01953601|20312120|P2|Part 2 (Extension Study)|Lost to Follow-up|1
5872329|NCT01953601|20312121|P1|Part 2 (Extension Study)|Lost to Follow-up|2
5872330|NCT01953601|20312119|P3|Part 2 (Extension Study)|Lack of Efficacy|0
5872331|NCT01953601|20312120|P2|Part 2 (Extension Study)|Lack of Efficacy|0
5872332|NCT01953601|20312121|P1|Part 2 (Extension Study)|Lack of Efficacy|2
5872333|NCT01953601|20312119|P3|Part 2 (Extension Study)|Death|0
5872334|NCT01953601|20312120|P2|Part 2 (Extension Study)|Death|3
5872335|NCT01953601|20312121|P1|Part 2 (Extension Study)|Death|0
5872336|NCT01953601|20312119|P3|Part 2 (Extension Study)|Adverse Event|10
5872337|NCT01953601|20312120|P2|Part 2 (Extension Study)|Adverse Event|1
5872338|NCT01953601|20312121|P1|Part 2 (Extension Study)|Adverse Event|1
5872339|NCT01953601|20312119|P3|Part 1 (Base Study)|Withdrawal by Subject|22
5872340|NCT01953601|20312120|P2|Part 1 (Base Study)|Withdrawal by Subject|23
5872341|NCT01953601|20312121|P1|Part 1 (Base Study)|Withdrawal by Subject|32
5872342|NCT01953601|20312119|P3|Part 1 (Base Study)|Subject moved|1
5872343|NCT01953601|20312120|P2|Part 1 (Base Study)|Subject moved|2
5872344|NCT01953601|20312121|P1|Part 1 (Base Study)|Subject moved|2
5872345|NCT01953601|20312119|P3|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|10
5872346|NCT01953601|20312120|P2|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|8
5872347|NCT01953601|20312121|P1|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|7
5872348|NCT01953601|20312119|P3|Part 1 (Base Study)|Study terminated by sponsor|179
5872349|NCT01953601|20312120|P2|Part 1 (Base Study)|Study terminated by sponsor|169
5872350|NCT01953601|20312121|P1|Part 1 (Base Study)|Study terminated by sponsor|174
5872351|NCT01953601|20312119|P3|Part 1 (Base Study)|Site discontinued study participation|0
5872352|NCT01953601|20312120|P2|Part 1 (Base Study)|Site discontinued study participation|0
5872353|NCT01953601|20312121|P1|Part 1 (Base Study)|Site discontinued study participation|2
5872354|NCT01953601|20312119|P3|Part 1 (Base Study)|Screen failure|1
5872355|NCT01953601|20312120|P2|Part 1 (Base Study)|Screen failure|0
5872356|NCT01953601|20312121|P1|Part 1 (Base Study)|Screen failure|1
5872357|NCT01953601|20312119|P3|Part 1 (Base Study)|Physician Decision|4
5872358|NCT01953601|20312120|P2|Part 1 (Base Study)|Physician Decision|7
5872359|NCT01953601|20312121|P1|Part 1 (Base Study)|Physician Decision|3
5872360|NCT01953601|20312119|P3|Part 1 (Base Study)|Non-compliance with study drug|1
5872361|NCT01953601|20312120|P2|Part 1 (Base Study)|Non-compliance with study drug|3
5872362|NCT01953601|20312121|P1|Part 1 (Base Study)|Non-compliance with study drug|0
5872363|NCT01953601|20312119|P3|Part 1 (Base Study)|Lost to Follow-up|6
5872364|NCT01953601|20312120|P2|Part 1 (Base Study)|Lost to Follow-up|3
5872365|NCT01953601|20312121|P1|Part 1 (Base Study)|Lost to Follow-up|1
5872366|NCT01953601|20312119|P3|Part 1 (Base Study)|Lack of Efficacy|4
5872367|NCT01953601|20312120|P2|Part 1 (Base Study)|Lack of Efficacy|1
5872368|NCT01953601|20312121|P1|Part 1 (Base Study)|Lack of Efficacy|3
5872369|NCT01953601|20312119|P3|Part 1 (Base Study)|Death|3
5872370|NCT01953601|20312120|P2|Part 1 (Base Study)|Death|0
5872371|NCT01953601|20312121|P1|Part 1 (Base Study)|Death|2
5872372|NCT01953601|20312119|P3|Part 1 (Base Study)|Adverse Event|15
5872373|NCT01953601|20312120|P2|Part 1 (Base Study)|Adverse Event|37
5872374|NCT01953601|20312121|P1|Part 1 (Base Study)|Adverse Event|24
5872375|NCT01953354|20312192|P2|Overall Study|Disease Exacerbation|0
5872376|NCT01953354|20312193|P1|Overall Study|Disease Exacerbation|1
5872377|NCT01953354|20312192|P2|Overall Study|Decision of Sponsor|1
5872378|NCT01953354|20312193|P1|Overall Study|Decision of Sponsor|0
5872379|NCT01953354|20312192|P2|Overall Study|Withdrawal by Subject|1
5872380|NCT01953354|20312193|P1|Overall Study|Withdrawal by Subject|0
5872381|NCT01953328|20312221|P8|Overall Study|Lost to Follow-up|0
5872382|NCT01953328|20312222|P7|Overall Study|Lost to Follow-up|0
5872383|NCT01953328|20312223|P6|Overall Study|Lost to Follow-up|0
5872384|NCT01953328|20312224|P5|Overall Study|Lost to Follow-up|1
5872385|NCT01953328|20312225|P4|Overall Study|Lost to Follow-up|0
5872386|NCT01953328|20312226|P3|Overall Study|Lost to Follow-up|0
5872387|NCT01953328|20312227|P2|Overall Study|Lost to Follow-up|0
5872388|NCT01953328|20312228|P1|Overall Study|Lost to Follow-up|0
5872389|NCT01953328|20312221|P8|Overall Study|Withdrawal by Subject|0
5872390|NCT01953328|20312222|P7|Overall Study|Withdrawal by Subject|0
5872391|NCT01953328|20312223|P6|Overall Study|Withdrawal by Subject|0
5872392|NCT01953328|20312224|P5|Overall Study|Withdrawal by Subject|1
5872393|NCT01953328|20312225|P4|Overall Study|Withdrawal by Subject|0
5872394|NCT01953328|20312226|P3|Overall Study|Withdrawal by Subject|0
5872395|NCT01953328|20312227|P2|Overall Study|Withdrawal by Subject|0
5872396|NCT01953328|20312228|P1|Overall Study|Withdrawal by Subject|0
5872397|NCT01953224|20312441|P2|Overall Study|Withdrawal by Subject|2
5872398|NCT01953224|20312442|P1|Overall Study|Withdrawal by Subject|1
5872399|NCT01953224|20312441|P2|Overall Study|Lost to Follow-up|1
5872400|NCT01953224|20312442|P1|Overall Study|Lost to Follow-up|1
5872401|NCT01953003|20312491|P2|Overall Study|Withdrawal by Subject|4
5872402|NCT01953003|20312492|P1|Overall Study|Withdrawal by Subject|14
5872403|NCT01953003|20312491|P2|Overall Study|Protocol Violation|1
5872404|NCT01953003|20312492|P1|Overall Study|Protocol Violation|0
5872405|NCT01953003|20312491|P2|Overall Study|Non-related adverse events|2
5872406|NCT01953003|20312492|P1|Overall Study|Non-related adverse events|0
5872407|NCT01953003|20312491|P2|Overall Study|Related Adverse events|2
5872408|NCT01953003|20312492|P1|Overall Study|Related Adverse events|7
5872409|NCT01953003|20312491|P2|Overall Study|Progressive disease|45
5872410|NCT01953003|20312492|P1|Overall Study|Progressive disease|35
5872411|NCT01953003|20312491|P2|Overall Study|Not treated|1
5872412|NCT01953003|20312492|P1|Overall Study|Not treated|0
5872413|NCT01952834|20312498|P1|Overall Study|Adverse Event|1
5872414|NCT01952691|20312505|P1|Overall Study|Lost to Follow-up|2
5872415|NCT01952665|20312532|P2|Overall Study|Protocol Violation|1
5872416|NCT01952665|20312533|P1|Overall Study|Protocol Violation|0
5872417|NCT01952665|20312532|P2|Overall Study|Adverse Event|1
5872418|NCT01952665|20312533|P1|Overall Study|Adverse Event|2
5872419|NCT01952665|20312532|P2|Overall Study|Lost to Follow-up|2
5872420|NCT01952665|20312533|P1|Overall Study|Lost to Follow-up|1
5872421|NCT01952665|20312532|P2|Overall Study|Physician Decision|2
5872422|NCT01952665|20312533|P1|Overall Study|Physician Decision|3
5872423|NCT01952574|20312688|P7|Clinical Home Use Substudy|Decision by Sponsor|1
5872424|NCT01952574|20312689|P6|Clinical Home Use Substudy|Decision by Sponsor|2
5872425|NCT01952574|20312690|P5|Clinical Home Use Substudy|Decision by Sponsor|0
5872426|NCT01952574|20312691|P4|Clinical Home Use Substudy|Decision by Sponsor|0
5872427|NCT01952574|20312692|P3|Clinical Home Use Substudy|Decision by Sponsor|0
5872428|NCT01952574|20312693|P2|Clinical Home Use Substudy|Decision by Sponsor|0
5872429|NCT01952574|20312694|P1|Clinical Home Use Substudy|Decision by Sponsor|0
5872430|NCT01952574|20312688|P7|Clinical Home Use Substudy|Withdrawal by Subject|0
5872431|NCT01952574|20312689|P6|Clinical Home Use Substudy|Withdrawal by Subject|1
5872432|NCT01952574|20312690|P5|Clinical Home Use Substudy|Withdrawal by Subject|0
5872433|NCT01952574|20312691|P4|Clinical Home Use Substudy|Withdrawal by Subject|0
5872434|NCT01952574|20312692|P3|Clinical Home Use Substudy|Withdrawal by Subject|0
5872435|NCT01952574|20312693|P2|Clinical Home Use Substudy|Withdrawal by Subject|0
5872436|NCT01952574|20312694|P1|Clinical Home Use Substudy|Withdrawal by Subject|0
5872437|NCT01952574|20312688|P7|Open-label Treatment Phase|Death|0
5872438|NCT01952574|20312689|P6|Open-label Treatment Phase|Death|0
5872439|NCT01952574|20312690|P5|Open-label Treatment Phase|Death|1
5872440|NCT01952574|20312691|P4|Open-label Treatment Phase|Death|0
5872441|NCT01952574|20312692|P3|Open-label Treatment Phase|Death|0
5872442|NCT01952574|20312693|P2|Open-label Treatment Phase|Death|0
5872443|NCT01952574|20312694|P1|Open-label Treatment Phase|Death|0
5872444|NCT01952574|20312688|P7|Open-label Treatment Phase|Lost to Follow-up|0
5872445|NCT01952574|20312689|P6|Open-label Treatment Phase|Lost to Follow-up|0
5872446|NCT01952574|20312690|P5|Open-label Treatment Phase|Lost to Follow-up|19
5872447|NCT01952574|20312691|P4|Open-label Treatment Phase|Lost to Follow-up|0
5872448|NCT01952574|20312692|P3|Open-label Treatment Phase|Lost to Follow-up|0
5872449|NCT01952574|20312693|P2|Open-label Treatment Phase|Lost to Follow-up|0
5872450|NCT01952574|20312694|P1|Open-label Treatment Phase|Lost to Follow-up|0
5872451|NCT01952574|20312688|P7|Open-label Treatment Phase|Missing|0
5872452|NCT01952574|20312689|P6|Open-label Treatment Phase|Missing|0
5872453|NCT01952574|20312690|P5|Open-label Treatment Phase|Missing|4
5872454|NCT01952574|20312691|P4|Open-label Treatment Phase|Missing|0
5872455|NCT01952574|20312692|P3|Open-label Treatment Phase|Missing|0
5872456|NCT01952574|20312693|P2|Open-label Treatment Phase|Missing|0
5872457|NCT01952574|20312694|P1|Open-label Treatment Phase|Missing|0
5872458|NCT01952574|20312688|P7|Open-label Treatment Phase|Decision by Sponsor|0
5872459|NCT01952574|20312689|P6|Open-label Treatment Phase|Decision by Sponsor|0
5872460|NCT01952574|20312690|P5|Open-label Treatment Phase|Decision by Sponsor|17
5872461|NCT01952574|20312691|P4|Open-label Treatment Phase|Decision by Sponsor|0
5872462|NCT01952574|20312692|P3|Open-label Treatment Phase|Decision by Sponsor|0
5872463|NCT01952574|20312693|P2|Open-label Treatment Phase|Decision by Sponsor|0
5872464|NCT01952574|20312694|P1|Open-label Treatment Phase|Decision by Sponsor|0
5872465|NCT01952574|20312688|P7|Open-label Treatment Phase|Withdrawal by Subject|0
5872466|NCT01952574|20312689|P6|Open-label Treatment Phase|Withdrawal by Subject|0
5872467|NCT01952574|20312690|P5|Open-label Treatment Phase|Withdrawal by Subject|121
5872468|NCT01952574|20312691|P4|Open-label Treatment Phase|Withdrawal by Subject|0
5872469|NCT01952574|20312692|P3|Open-label Treatment Phase|Withdrawal by Subject|0
5872470|NCT01952574|20312693|P2|Open-label Treatment Phase|Withdrawal by Subject|0
5872471|NCT01952574|20312694|P1|Open-label Treatment Phase|Withdrawal by Subject|0
5872472|NCT01952574|20312688|P7|Double-blind Treatment Phase|Lost to Follow-up|0
5872473|NCT01952574|20312689|P6|Double-blind Treatment Phase|Lost to Follow-up|0
5872474|NCT01952574|20312690|P5|Double-blind Treatment Phase|Lost to Follow-up|0
5872475|NCT01952574|20312691|P4|Double-blind Treatment Phase|Lost to Follow-up|0
5872476|NCT01952574|20312692|P3|Double-blind Treatment Phase|Lost to Follow-up|1
5872477|NCT01952574|20312693|P2|Double-blind Treatment Phase|Lost to Follow-up|0
5872478|NCT01952574|20312694|P1|Double-blind Treatment Phase|Lost to Follow-up|2
5872479|NCT01952574|20312688|P7|Double-blind Treatment Phase|Sponsor Decision|0
5872480|NCT01952574|20312689|P6|Double-blind Treatment Phase|Sponsor Decision|0
5872481|NCT01952574|20312690|P5|Double-blind Treatment Phase|Sponsor Decision|0
5872482|NCT01952574|20312691|P4|Double-blind Treatment Phase|Sponsor Decision|2
5872483|NCT01952574|20312692|P3|Double-blind Treatment Phase|Sponsor Decision|5
5872484|NCT01952574|20312693|P2|Double-blind Treatment Phase|Sponsor Decision|0
5872485|NCT01952574|20312694|P1|Double-blind Treatment Phase|Sponsor Decision|6
5872486|NCT01952574|20312688|P7|Double-blind Treatment Phase|Withdrawal by Subject|0
5872487|NCT01952574|20312689|P6|Double-blind Treatment Phase|Withdrawal by Subject|0
5872488|NCT01952574|20312690|P5|Double-blind Treatment Phase|Withdrawal by Subject|0
5872489|NCT01952574|20312691|P4|Double-blind Treatment Phase|Withdrawal by Subject|4
5872490|NCT01952574|20312692|P3|Double-blind Treatment Phase|Withdrawal by Subject|3
5872491|NCT01952574|20312693|P2|Double-blind Treatment Phase|Withdrawal by Subject|3
5872492|NCT01952574|20312694|P1|Double-blind Treatment Phase|Withdrawal by Subject|9
5872493|NCT01952366|20312818|P1|Overall Study|Withdrawal by Subject|9
5872494|NCT01952366|20312818|P1|Overall Study|Death|22
5872495|NCT01952145|20312833|P2|Overall Study|Unclassified|1
5872496|NCT01952145|20312834|P1|Overall Study|Unclassified|1
5872497|NCT01952145|20312833|P2|Overall Study|Withdrawal Criteria|11
5872498|NCT01952145|20312834|P1|Overall Study|Withdrawal Criteria|16
5872499|NCT01952145|20312833|P2|Overall Study|Adverse Event|0
5872500|NCT01952145|20312834|P1|Overall Study|Adverse Event|9
5872501|NCT01952145|20312833|P2|Overall Study|Death|1
5872502|NCT01952145|20312834|P1|Overall Study|Death|0
5872503|NCT01952145|20312833|P2|Overall Study|Protocol Violation|1
5872504|NCT01952145|20312834|P1|Overall Study|Protocol Violation|2
5872505|NCT01952080|20312848|P4|Overall Study|Protocol Non-compliance|0
5872506|NCT01952080|20312849|P3|Overall Study|Protocol Non-compliance|0
5872507|NCT01952080|20312850|P2|Overall Study|Protocol Non-compliance|1
5872508|NCT01952080|20312851|P1|Overall Study|Protocol Non-compliance|0
5872509|NCT01952080|20312848|P4|Overall Study|Withdrawal by Subject|1
5872510|NCT01952080|20312849|P3|Overall Study|Withdrawal by Subject|0
5872511|NCT01952080|20312850|P2|Overall Study|Withdrawal by Subject|0
5872512|NCT01952080|20312851|P1|Overall Study|Withdrawal by Subject|0
5872513|NCT01952054|20312897|P1|Overall Study|Physician Decision|1
5872514|NCT01952041|20312905|P2|Overall Study|Death|0
5872515|NCT01952041|20312906|P1|Overall Study|Death|1
5872516|NCT01952041|20312905|P2|Overall Study|Withdrawal by Subject|5
5872517|NCT01952041|20312906|P1|Overall Study|Withdrawal by Subject|7
5872518|NCT01952041|20312905|P2|Overall Study|Lost to Follow-up|16
5872519|NCT01952041|20312906|P1|Overall Study|Lost to Follow-up|9
5872520|NCT01952015|20312920|P1|Treatment Period 3|Physician Decision|9
5872521|NCT01952015|20312920|P1|Maintenance|Adverse Event|2
5872522|NCT01952015|20312920|P1|Induction|Protocol Violation|1
5872523|NCT01951703|20312987|P2|Second Intervention|Unsatisfactory Lens fitting|1
5872524|NCT01951703|20312988|P1|Second Intervention|Unsatisfactory Lens fitting|0
5872525|NCT01951703|20312987|P2|Second Intervention|Protocol Violation|1
5872526|NCT01951703|20312988|P1|Second Intervention|Protocol Violation|0
5872527|NCT01951703|20312987|P2|First Intervention|Physician Decision|0
5872528|NCT01951703|20312988|P1|First Intervention|Physician Decision|1
5872529|NCT01951703|20312987|P2|First Intervention|Subject was not compliant|1
5872530|NCT01951703|20312988|P1|First Intervention|Subject was not compliant|1
5872531|NCT01951703|20312987|P2|First Intervention|Withdrawal by Subject|0
5872532|NCT01951703|20312988|P1|First Intervention|Withdrawal by Subject|1
5872533|NCT01951586|20313013|P2|Overall Study|Sponsor Decision|10
5872534|NCT01951586|20313014|P1|Overall Study|Sponsor Decision|9
5872535|NCT01951586|20313013|P2|Overall Study|Lost to Follow-up|1
5872536|NCT01951586|20313014|P1|Overall Study|Lost to Follow-up|0
5872537|NCT01951586|20313013|P2|Overall Study|Withdrawal by Subject|17
5872538|NCT01951586|20313014|P1|Overall Study|Withdrawal by Subject|8
5872539|NCT01951586|20313013|P2|Overall Study|Death|120
5872540|NCT01951586|20313014|P1|Overall Study|Death|61
5872541|NCT01951573|20313038|P2|Washout Period|Adverse Event|1
5872542|NCT01951573|20313039|P1|Washout Period|Adverse Event|0
5872543|NCT01951417|20313049|P1|Overall Study|Lost to Follow-up|6
5872544|NCT01951417|20313049|P1|Overall Study|Protocol Violation|2
5872545|NCT01951417|20313049|P1|Overall Study|Withdrawal by Subject|1
5872546|NCT01951378|20313085|P2|Overall Study|Study Terminated-Not completed|17
5872547|NCT01951378|20313086|P1|Overall Study|Study Terminated-Not completed|23
5872548|NCT01951261|20313163|P2|Overall Study|Protocol Violation|3
5872549|NCT01951261|20313164|P1|Overall Study|Protocol Violation|4
5872550|NCT01951261|20313163|P2|Overall Study|Lost to Follow-up|3
5872551|NCT01951261|20313164|P1|Overall Study|Lost to Follow-up|4
5872552|NCT01951261|20313163|P2|Overall Study|Death|0
5872553|NCT01951261|20313164|P1|Overall Study|Death|1
5872554|NCT01951170|20313182|P1|Overall Study|Investigator decision|1
5872555|NCT01951157|20313208|P3|Overall Study|Treatment-related death|0
5872556|NCT01951157|20313209|P2|Overall Study|Treatment-related death|2
5872557|NCT01951157|20313210|P1|Overall Study|Treatment-related death|0
5872558|NCT01951157|20313208|P3|Overall Study|Consent withdrawn by subject|3
5872559|NCT01951157|20313209|P2|Overall Study|Consent withdrawn by subject|1
5872560|NCT01951157|20313210|P1|Overall Study|Consent withdrawn by subject|0
5872561|NCT01951157|20313208|P3|Overall Study|Treatment-related AE|4
5872562|NCT01951157|20313209|P2|Overall Study|Treatment-related AE|0
5872563|NCT01951157|20313210|P1|Overall Study|Treatment-related AE|2
5872564|NCT01951157|20313208|P3|Overall Study|No treated|0
5872565|NCT01951157|20313209|P2|Overall Study|No treated|1
5872566|NCT01951157|20313210|P1|Overall Study|No treated|0
5872567|NCT01951157|20313208|P3|Overall Study|Non-treatmentrelated death|2
5872568|NCT01951157|20313209|P2|Overall Study|Non-treatmentrelated death|2
5872569|NCT01951157|20313210|P1|Overall Study|Non-treatmentrelated death|2
5872570|NCT01951157|20313208|P3|Overall Study|Physician Decision|2
5872571|NCT01951157|20313209|P2|Overall Study|Physician Decision|3
5872572|NCT01951157|20313210|P1|Overall Study|Physician Decision|5
5872573|NCT01951157|20313208|P3|Overall Study|Study Termination|1
5872574|NCT01951157|20313209|P2|Overall Study|Study Termination|0
5872575|NCT01951157|20313210|P1|Overall Study|Study Termination|0
5872576|NCT01951157|20313208|P3|Overall Study|Treatment-unrelated AE|3
5872577|NCT01951157|20313209|P2|Overall Study|Treatment-unrelated AE|0
5872578|NCT01951157|20313210|P1|Overall Study|Treatment-unrelated AE|1
5872579|NCT01951157|20313208|P3|Overall Study|Progressive Disease|10
5872580|NCT01951157|20313209|P2|Overall Study|Progressive Disease|13
5872581|NCT01951157|20313210|P1|Overall Study|Progressive Disease|12
5872582|NCT01951105|20313261|P3|Overall Study|Withdrawal by Subject|1
5872583|NCT01951105|20313262|P2|Overall Study|Withdrawal by Subject|3
5872584|NCT01951105|20313263|P1|Overall Study|Withdrawal by Subject|0
5872585|NCT01951105|20313261|P3|Overall Study|Protocol Violation|1
5872586|NCT01951105|20313262|P2|Overall Study|Protocol Violation|1
5872587|NCT01951105|20313263|P1|Overall Study|Protocol Violation|1
5872588|NCT01951105|20313261|P3|Overall Study|Lost to Follow-up|0
5872589|NCT01951105|20313262|P2|Overall Study|Lost to Follow-up|1
5872590|NCT01951105|20313263|P1|Overall Study|Lost to Follow-up|0
5872591|NCT01951105|20313261|P3|Overall Study|Adverse Event|0
5872592|NCT01951105|20313262|P2|Overall Study|Adverse Event|5
5872593|NCT01951105|20313263|P1|Overall Study|Adverse Event|0
5872594|NCT01951092|20313277|P1|Overall Study|Transfer of Care|1
5872595|NCT01951092|20313277|P1|Overall Study|Incarceration|1
5872596|NCT01951092|20313277|P1|Overall Study|Lost to Follow-up|10
5872597|NCT01950819|20313290|P2|Overall Study|Lost to Follow-up|17
5872598|NCT01950819|20313291|P1|Overall Study|Lost to Follow-up|9
5872599|NCT01950819|20313290|P2|Overall Study|Pregnancy|2
5872600|NCT01950819|20313291|P1|Overall Study|Pregnancy|0
5872601|NCT01950819|20313290|P2|Overall Study|technical problems|0
5872602|NCT01950819|20313291|P1|Overall Study|technical problems|2
5872603|NCT01950819|20313290|P2|Overall Study|Subject / Gardian decision|51
5872604|NCT01950819|20313291|P1|Overall Study|Subject / Gardian decision|54
5872605|NCT01950819|20313290|P2|Overall Study|Death|34
5872606|NCT01950819|20313291|P1|Overall Study|Death|29
5872607|NCT01950819|20313290|P2|Overall Study|Graft Loss|30
5872608|NCT01950819|20313291|P1|Overall Study|Graft Loss|35
5872609|NCT01950741|20313344|P1|Overall Study|Withdrawal by Subject|1
5872610|NCT01950741|20313344|P1|Overall Study|Death|1
5872611|NCT01950741|20313344|P1|Overall Study|Lost to Follow-up|1
5872612|NCT01950364|20313359|P2|Overall Study|Protocol Violation|1
5872613|NCT01950364|20313360|P1|Overall Study|Protocol Violation|0
5872614|NCT01950364|20313359|P2|Overall Study|Withdrawal by Subject|1
5872615|NCT01950364|20313360|P1|Overall Study|Withdrawal by Subject|0
5872616|NCT01950364|20313359|P2|Overall Study|Disease Progression|2
5872617|NCT01950364|20313360|P1|Overall Study|Disease Progression|5
5872618|NCT01950364|20313359|P2|Overall Study|Stem Cell Transplant|6
5872619|NCT01950364|20313360|P1|Overall Study|Stem Cell Transplant|2
5872620|NCT01950364|20313359|P2|Overall Study|Adverse Event|0
5872621|NCT01950364|20313360|P1|Overall Study|Adverse Event|3
5872622|NCT01950273|20313482|P2|Overall Study|Other not defined above|0
5872623|NCT01950273|20313483|P1|Overall Study|Other not defined above|1
5872624|NCT01950273|20313482|P2|Overall Study|Withdrawal by Subject|0
5872625|NCT01950273|20313483|P1|Overall Study|Withdrawal by Subject|2
5872626|NCT01950273|20313482|P2|Overall Study|Protocol Violation|0
5872627|NCT01950273|20313483|P1|Overall Study|Protocol Violation|1
5872628|NCT01950013|20313530|P3|Overall Study|Withdrawal by Subject|0
5872629|NCT01950013|20313531|P2|Overall Study|Withdrawal by Subject|2
5872630|NCT01950013|20313532|P1|Overall Study|Withdrawal by Subject|0
5872631|NCT01949870|20313543|P1|Overall Study|Eligibility requirements not fulfilled|2
5872632|NCT01949870|20313543|P1|Overall Study|Study termination|1
5872633|NCT01949870|20313543|P1|Overall Study|Adverse Event|1
5872634|NCT01949870|20313543|P1|Overall Study|Lack of Efficacy|2
5872635|NCT01949662|20313559|P2|Overall Study|Ineligible|1
5872636|NCT01949662|20313560|P1|Overall Study|Ineligible|0
5872637|NCT01949662|20313559|P2|Overall Study|Dropped out|3
5872638|NCT01949662|20313560|P1|Overall Study|Dropped out|1
5872639|NCT01949662|20313559|P2|Overall Study|Discharged before an agitation event|3
5872640|NCT01949662|20313560|P1|Overall Study|Discharged before an agitation event|8
5872641|NCT01949662|20313559|P2|Overall Study|Death|7
5872642|NCT01949662|20313560|P1|Overall Study|Death|9
5872643|NCT01949532|20313727|P2|Overall Study|On-study at the Data Cut-off Date|3
5872644|NCT01949532|20313728|P1|Overall Study|On-study at the Data Cut-off Date|3
5872645|NCT01949480|20313798|P2|Overall Study|Physician Decision|8
5872646|NCT01949480|20313799|P1|Overall Study|Physician Decision|5
5872647|NCT01949155|20313845|P2|Overall Study|Protocol Violation|0
5872648|NCT01949155|20313846|P1|Overall Study|Protocol Violation|1
5872649|NCT01949155|20313845|P2|Overall Study|Lost to Follow-up|0
5872650|NCT01949155|20313846|P1|Overall Study|Lost to Follow-up|1
5872651|NCT01949142|20313858|P2|Overall Study|Parent changed their mind|0
5872652|NCT01949142|20313859|P1|Overall Study|Parent changed their mind|1
5872653|NCT01949142|20313858|P2|Overall Study|Lost to Follow-up|1
5872654|NCT01949142|20313859|P1|Overall Study|Lost to Follow-up|1
5872655|NCT01949142|20313858|P2|Overall Study|Withdrawal of consent|0
5872656|NCT01949142|20313859|P1|Overall Study|Withdrawal of consent|1
5872657|NCT01949116|20313871|P2|Overall Study|Withdrawal by Subject|3
5872658|NCT01949116|20313872|P1|Overall Study|Withdrawal by Subject|5
5872659|NCT01949116|20313871|P2|Overall Study|Lost to Follow-up|3
5872660|NCT01949116|20313872|P1|Overall Study|Lost to Follow-up|1
5872661|NCT01949116|20313871|P2|Overall Study|Death|0
5872662|NCT01949116|20313872|P1|Overall Study|Death|2
5872663|NCT01949090|20313909|P5|Overall Study|Lost to Follow-up|1
5872664|NCT01949090|20313910|P4|Overall Study|Lost to Follow-up|1
5872665|NCT01949090|20313911|P3|Overall Study|Lost to Follow-up|0
5872666|NCT01949090|20313912|P2|Overall Study|Lost to Follow-up|1
5872667|NCT01949090|20313913|P1|Overall Study|Lost to Follow-up|2
5872668|NCT01949090|20313909|P5|Overall Study|Protocol non-compliance|1
5872669|NCT01949090|20313910|P4|Overall Study|Protocol non-compliance|0
5872670|NCT01949090|20313911|P3|Overall Study|Protocol non-compliance|0
5872671|NCT01949090|20313912|P2|Overall Study|Protocol non-compliance|0
5872672|NCT01949090|20313913|P1|Overall Study|Protocol non-compliance|0
5872673|NCT01949090|20313909|P5|Overall Study|Withdrawal by Subject|1
5872674|NCT01949090|20313910|P4|Overall Study|Withdrawal by Subject|0
5872675|NCT01949090|20313911|P3|Overall Study|Withdrawal by Subject|0
5872676|NCT01949090|20313912|P2|Overall Study|Withdrawal by Subject|0
5872677|NCT01949090|20313913|P1|Overall Study|Withdrawal by Subject|2
5872678|NCT01949090|20313909|P5|Overall Study|Serious Adverse Event|1
5872679|NCT01949090|20313910|P4|Overall Study|Serious Adverse Event|0
5872680|NCT01949090|20313911|P3|Overall Study|Serious Adverse Event|2
5872681|NCT01949090|20313912|P2|Overall Study|Serious Adverse Event|1
5872682|NCT01949090|20313913|P1|Overall Study|Serious Adverse Event|0
5872683|NCT01949051|20314090|P6|Treatment Period 2 (7 Days)|Withdrawal by Subject|0
5872684|NCT01949051|20314091|P5|Treatment Period 2 (7 Days)|Withdrawal by Subject|0
5872685|NCT01949051|20314092|P4|Treatment Period 2 (7 Days)|Withdrawal by Subject|0
5872686|NCT01949051|20314093|P3|Treatment Period 2 (7 Days)|Withdrawal by Subject|1
5872687|NCT01949051|20314094|P2|Treatment Period 2 (7 Days)|Withdrawal by Subject|0
5872688|NCT01949051|20314095|P1|Treatment Period 2 (7 Days)|Withdrawal by Subject|0
5872689|NCT01949051|20314090|P6|Treatment Period 2 (7 Days)|Lost to Follow-up|0
5872690|NCT01949051|20314091|P5|Treatment Period 2 (7 Days)|Lost to Follow-up|0
5872691|NCT01949051|20314092|P4|Treatment Period 2 (7 Days)|Lost to Follow-up|0
5872692|NCT01949051|20314093|P3|Treatment Period 2 (7 Days)|Lost to Follow-up|0
5872693|NCT01949051|20314094|P2|Treatment Period 2 (7 Days)|Lost to Follow-up|1
5872694|NCT01949051|20314095|P1|Treatment Period 2 (7 Days)|Lost to Follow-up|0
5872695|NCT01949051|20314090|P6|Treatment Period 2 (7 Days)|Protocol Violation|1
5872696|NCT01949051|20314091|P5|Treatment Period 2 (7 Days)|Protocol Violation|0
5872697|NCT01949051|20314092|P4|Treatment Period 2 (7 Days)|Protocol Violation|0
5872698|NCT01949051|20314093|P3|Treatment Period 2 (7 Days)|Protocol Violation|0
5872699|NCT01949051|20314094|P2|Treatment Period 2 (7 Days)|Protocol Violation|0
5872700|NCT01949051|20314095|P1|Treatment Period 2 (7 Days)|Protocol Violation|0
5872701|NCT01949051|20314090|P6|Treatment Period 1 (7 Days)|Lost to Follow-up|0
5872702|NCT01949051|20314091|P5|Treatment Period 1 (7 Days)|Lost to Follow-up|0
5872703|NCT01949051|20314092|P4|Treatment Period 1 (7 Days)|Lost to Follow-up|0
5872704|NCT01949051|20314093|P3|Treatment Period 1 (7 Days)|Lost to Follow-up|0
5872705|NCT01949051|20314094|P2|Treatment Period 1 (7 Days)|Lost to Follow-up|0
5872706|NCT01949051|20314095|P1|Treatment Period 1 (7 Days)|Lost to Follow-up|1
5872707|NCT01949051|20314090|P6|Treatment Period 1 (7 Days)|Protocol Violation|0
5872708|NCT01949051|20314091|P5|Treatment Period 1 (7 Days)|Protocol Violation|0
5872709|NCT01949051|20314092|P4|Treatment Period 1 (7 Days)|Protocol Violation|1
5872710|NCT01949051|20314093|P3|Treatment Period 1 (7 Days)|Protocol Violation|0
5872711|NCT01949051|20314094|P2|Treatment Period 1 (7 Days)|Protocol Violation|0
5872712|NCT01949051|20314095|P1|Treatment Period 1 (7 Days)|Protocol Violation|1
5872713|NCT01948908|20314290|P3|Overall Study|Protocol Violation|2
5872714|NCT01948908|20314291|P2|Overall Study|Protocol Violation|0
5872715|NCT01948908|20314292|P1|Overall Study|Protocol Violation|1
5872716|NCT01948830|20314308|P2|Overall Study|Death|4
5872717|NCT01948830|20314309|P1|Overall Study|Death|3
5872718|NCT01948830|20314308|P2|Overall Study|Adverse Event|2
5872719|NCT01948830|20314309|P1|Overall Study|Adverse Event|9
5872720|NCT01948830|20314308|P2|Overall Study|Withdrawal by Subject|17
5872721|NCT01948830|20314309|P1|Overall Study|Withdrawal by Subject|14
5872722|NCT01948830|20314308|P2|Overall Study|Lost to Follow-up|4
5872723|NCT01948830|20314309|P1|Overall Study|Lost to Follow-up|5
5872724|NCT01948830|20314308|P2|Overall Study|Protocol deviation|2
5872725|NCT01948830|20314309|P1|Overall Study|Protocol deviation|1
5872726|NCT01948830|20314308|P2|Overall Study|Physician Decision|3
5872727|NCT01948830|20314309|P1|Overall Study|Physician Decision|1
5872728|NCT01948791|20314341|P1|Overall Study|Screening failure|35
5872729|NCT01948791|20314341|P1|Overall Study|Others|7
5872730|NCT01948791|20314341|P1|Overall Study|Management issues|1
5872731|NCT01948791|20314341|P1|Overall Study|Lost to Follow-up|6
5872732|NCT01948791|20314341|P1|Overall Study|Withdrawal by Subject|5
5872733|NCT01948791|20314341|P1|Overall Study|Protocol Violation|2
5872734|NCT01948791|20314341|P1|Overall Study|Lack of Efficacy|3
5872735|NCT01948791|20314341|P1|Overall Study|Adverse Event|12
5872736|NCT01948258|20314401|P1|Overall Study|Removed from statistical analysis|2
5872737|NCT01948258|20314401|P1|Overall Study|Health Care Professional|43
5872738|NCT01948258|20314401|P1|Overall Study|Withdrawal by Subject|6
5872739|NCT01948258|20314401|P1|Overall Study|Withdrawal by SPD|8
5872740|NCT01948258|20314401|P1|Overall Study|Lost to Follow-up|27
5872741|NCT01948258|20314401|P1|Overall Study|Did not complete by cut-off date|35
5872742|NCT01948258|20314401|P1|Overall Study|Pregnancy|41
5872743|NCT01948193|20314407|P1|Overall Study|Lost to Follow-up|7
5872744|NCT01948193|20314407|P1|Overall Study|Serious event|2
5872745|NCT01948076|20314429|P2|Overall Study|Withdrawal by Subject|1
5872746|NCT01948076|20314430|P1|Overall Study|Withdrawal by Subject|0
5872747|NCT01948063|20314440|P2|Overall Study|Blood samples were accidentally thawed|0
5872748|NCT01948063|20314441|P1|Overall Study|Blood samples were accidentally thawed|1
5872749|NCT01948063|20314440|P2|Overall Study|Discovered an enrollment in other study|1
5872750|NCT01948063|20314441|P1|Overall Study|Discovered an enrollment in other study|0
5872751|NCT01948063|20314440|P2|Overall Study|Boston MCI halted research protocol|1
5872752|NCT01948063|20314441|P1|Overall Study|Boston MCI halted research protocol|0
5872753|NCT01948050|20314449|P2|Overall Study|Withdrawal by Subject|1
5872754|NCT01948050|20314450|P1|Overall Study|Withdrawal by Subject|0
5872755|NCT01947894|20314518|P3|Overall Study|Switched to other growth hormone brand|23
5872756|NCT01947894|20314519|P2|Overall Study|Switched to other growth hormone brand|8
5872757|NCT01947894|20314520|P1|Overall Study|Switched to other growth hormone brand|53
5872758|NCT01947894|20314518|P3|Overall Study|Adverse Event|0
5872759|NCT01947894|20314519|P2|Overall Study|Adverse Event|1
5872760|NCT01947894|20314520|P1|Overall Study|Adverse Event|5
5872761|NCT01947894|20314518|P3|Overall Study|Physician Decision|0
5872762|NCT01947894|20314519|P2|Overall Study|Physician Decision|0
5872763|NCT01947894|20314520|P1|Overall Study|Physician Decision|2
5872764|NCT01947894|20314518|P3|Overall Study|Death|0
5872765|NCT01947894|20314519|P2|Overall Study|Death|1
5872766|NCT01947894|20314520|P1|Overall Study|Death|12
5872767|NCT01947894|20314518|P3|Overall Study|Withdrawal by Subject|1
5872768|NCT01947894|20314519|P2|Overall Study|Withdrawal by Subject|4
5872769|NCT01947894|20314520|P1|Overall Study|Withdrawal by Subject|12
5872770|NCT01947894|20314518|P3|Overall Study|Other|3
5872771|NCT01947894|20314519|P2|Overall Study|Other|4
5872772|NCT01947894|20314520|P1|Overall Study|Other|3
5872773|NCT01947855|20314585|P3|Overall Study|Withdrawal by Subject|0
5872774|NCT01947855|20314586|P2|Overall Study|Withdrawal by Subject|0
5872775|NCT01947855|20314587|P1|Overall Study|Withdrawal by Subject|1
5872776|NCT01947582|20314622|P1|Overall Study|Withdrawal by Subject|1
5872777|NCT01947517|20314631|P2|Overall Study|Withdrawal by Subject|1
5872778|NCT01947517|20314632|P1|Overall Study|Withdrawal by Subject|1
5872779|NCT01947491|20314650|P4|Overall Study|Adverse Event|2
5872780|NCT01947491|20314651|P3|Overall Study|Adverse Event|0
5872781|NCT01947491|20314652|P2|Overall Study|Adverse Event|1
5872782|NCT01947491|20314653|P1|Overall Study|Adverse Event|0
5872783|NCT01947491|20314650|P4|Overall Study|Worsening of condition|0
5872784|NCT01947491|20314651|P3|Overall Study|Worsening of condition|0
5872785|NCT01947491|20314652|P2|Overall Study|Worsening of condition|1
5872786|NCT01947491|20314653|P1|Overall Study|Worsening of condition|0
5872787|NCT01947491|20314650|P4|Overall Study|Withdrawal by Subject|0
5872788|NCT01947491|20314651|P3|Overall Study|Withdrawal by Subject|1
5872789|NCT01947491|20314652|P2|Overall Study|Withdrawal by Subject|1
5872790|NCT01947491|20314653|P1|Overall Study|Withdrawal by Subject|1
5872791|NCT01947491|20314650|P4|Overall Study|Protocol Violation|0
5872792|NCT01947491|20314651|P3|Overall Study|Protocol Violation|0
5872793|NCT01947491|20314652|P2|Overall Study|Protocol Violation|0
5872794|NCT01947491|20314653|P1|Overall Study|Protocol Violation|1
5872795|NCT01947491|20314650|P4|Overall Study|Lack of Efficacy|1
5872796|NCT01947491|20314651|P3|Overall Study|Lack of Efficacy|0
5872797|NCT01947491|20314652|P2|Overall Study|Lack of Efficacy|0
5872798|NCT01947491|20314653|P1|Overall Study|Lack of Efficacy|1
5872799|NCT01947491|20314650|P4|Overall Study|Lost to Follow-up|2
5872800|NCT01947491|20314651|P3|Overall Study|Lost to Follow-up|1
5872801|NCT01947491|20314652|P2|Overall Study|Lost to Follow-up|3
5872802|NCT01947491|20314653|P1|Overall Study|Lost to Follow-up|5
5872803|NCT01947283|20314683|P7|Overall Study|No patients were enrolled in study|1
5872804|NCT01947283|20314684|P6|Overall Study|No patients were enrolled in study|3
5872805|NCT01947283|20314685|P5|Overall Study|No patients were enrolled in study|0
5872806|NCT01947283|20314686|P4|Overall Study|No patients were enrolled in study|0
5872807|NCT01947283|20314687|P3|Overall Study|No patients were enrolled in study|0
5872808|NCT01947283|20314688|P2|Overall Study|No patients were enrolled in study|0
5872809|NCT01947283|20314689|P1|Overall Study|No patients were enrolled in study|0
5872810|NCT01947283|20314683|P7|Overall Study|Missing Follow-up Assessment|0
5872811|NCT01947283|20314684|P6|Overall Study|Missing Follow-up Assessment|2
5872812|NCT01947283|20314685|P5|Overall Study|Missing Follow-up Assessment|0
5872813|NCT01947283|20314686|P4|Overall Study|Missing Follow-up Assessment|0
5872814|NCT01947283|20314687|P3|Overall Study|Missing Follow-up Assessment|3
5872815|NCT01947283|20314688|P2|Overall Study|Missing Follow-up Assessment|2
5872816|NCT01947283|20314689|P1|Overall Study|Missing Follow-up Assessment|2
5872817|NCT01947283|20314683|P7|Overall Study|Non-coding Clinical Recording language|0
5872818|NCT01947283|20314684|P6|Overall Study|Non-coding Clinical Recording language|0
5872819|NCT01947283|20314685|P5|Overall Study|Non-coding Clinical Recording language|0
5872820|NCT01947283|20314686|P4|Overall Study|Non-coding Clinical Recording language|1
5872821|NCT01947283|20314687|P3|Overall Study|Non-coding Clinical Recording language|0
5872822|NCT01947283|20314688|P2|Overall Study|Non-coding Clinical Recording language|0
5872823|NCT01947283|20314689|P1|Overall Study|Non-coding Clinical Recording language|0
5872824|NCT01947283|20314683|P7|Overall Study|No Clinical Recording|0
5872825|NCT01947283|20314684|P6|Overall Study|No Clinical Recording|0
5872826|NCT01947283|20314685|P5|Overall Study|No Clinical Recording|0
5872827|NCT01947283|20314686|P4|Overall Study|No Clinical Recording|10
5872828|NCT01947283|20314687|P3|Overall Study|No Clinical Recording|8
5872829|NCT01947283|20314688|P2|Overall Study|No Clinical Recording|6
5872830|NCT01947283|20314689|P1|Overall Study|No Clinical Recording|12
5872831|NCT01947283|20314683|P7|Overall Study|Withdrawal by Subject|2
5872832|NCT01947283|20314684|P6|Overall Study|Withdrawal by Subject|0
5872833|NCT01947283|20314685|P5|Overall Study|Withdrawal by Subject|0
5872834|NCT01947283|20314686|P4|Overall Study|Withdrawal by Subject|1
5872835|NCT01947283|20314687|P3|Overall Study|Withdrawal by Subject|4
5872836|NCT01947283|20314688|P2|Overall Study|Withdrawal by Subject|8
5872837|NCT01947283|20314689|P1|Overall Study|Withdrawal by Subject|10
5872838|NCT01947283|20314683|P7|Overall Study|Lost to Follow-up|5
5872839|NCT01947283|20314684|P6|Overall Study|Lost to Follow-up|2
5872840|NCT01947283|20314685|P5|Overall Study|Lost to Follow-up|0
5872841|NCT01947283|20314686|P4|Overall Study|Lost to Follow-up|5
5872842|NCT01947283|20314687|P3|Overall Study|Lost to Follow-up|5
5872843|NCT01947283|20314688|P2|Overall Study|Lost to Follow-up|6
5872844|NCT01947283|20314689|P1|Overall Study|Lost to Follow-up|4
5872845|NCT01947283|20314683|P7|Overall Study|Death|0
5872846|NCT01947283|20314684|P6|Overall Study|Death|0
5872847|NCT01947283|20314685|P5|Overall Study|Death|0
5872848|NCT01947283|20314686|P4|Overall Study|Death|0
5872849|NCT01947283|20314687|P3|Overall Study|Death|1
5872850|NCT01947283|20314688|P2|Overall Study|Death|1
5872851|NCT01947283|20314689|P1|Overall Study|Death|1
5872852|NCT01947127|20314761|P2|Overall Study|Data loss|4
5872853|NCT01947127|20314762|P1|Overall Study|Data loss|4
5872854|NCT01947127|20314761|P2|Overall Study|Withdrawal by Subject|1
5872855|NCT01947127|20314762|P1|Overall Study|Withdrawal by Subject|1
5872856|NCT01947127|20314761|P2|Overall Study|Protocol Violation|38
5872857|NCT01947127|20314762|P1|Overall Study|Protocol Violation|18
5872858|NCT01946880|20314774|P2|Overall Study|Personal and Family Issues|0
5872859|NCT01946880|20314775|P1|Overall Study|Personal and Family Issues|1
5872860|NCT01946880|20314774|P2|Overall Study|Met Primary Endpoint|0
5872861|NCT01946880|20314775|P1|Overall Study|Met Primary Endpoint|1
5872862|NCT01946880|20314774|P2|Overall Study|Withdrawal by Subject|2
5872863|NCT01946880|20314775|P1|Overall Study|Withdrawal by Subject|3
5872864|NCT01946880|20314774|P2|Overall Study|Physician Decision|1
5872865|NCT01946880|20314775|P1|Overall Study|Physician Decision|1
5872866|NCT01946880|20314774|P2|Overall Study|Lost to Follow-up|0
5872867|NCT01946880|20314775|P1|Overall Study|Lost to Follow-up|1
5872868|NCT01946529|20314865|P3|Completion of All Therapy|Some pts. still receiving study therapy|6
5872869|NCT01946529|20314866|P2|Completion of All Therapy|Some pts. still receiving study therapy|16
5872870|NCT01946529|20314867|P1|Completion of All Therapy|Some pts. still receiving study therapy|1
5872871|NCT01946529|20314865|P3|End of Window Therapy (2 Courses)|Physician Decision|0
5872872|NCT01946529|20314866|P2|End of Window Therapy (2 Courses)|Physician Decision|1
5872873|NCT01946529|20314867|P1|End of Window Therapy (2 Courses)|Physician Decision|0
5872874|NCT01946438|20314878|P4|Overall Study|Withdrawal by Subject|0
5872875|NCT01946438|20314879|P3|Overall Study|Withdrawal by Subject|0
5872876|NCT01946438|20314880|P2|Overall Study|Withdrawal by Subject|0
5872877|NCT01946438|20314881|P1|Overall Study|Withdrawal by Subject|1
5872878|NCT01946438|20314878|P4|Overall Study|Protocol Violation|0
5872879|NCT01946438|20314879|P3|Overall Study|Protocol Violation|1
5872880|NCT01946438|20314880|P2|Overall Study|Protocol Violation|0
5872881|NCT01946438|20314881|P1|Overall Study|Protocol Violation|0
5872882|NCT01946438|20314878|P4|Overall Study|Serious Adverse event|0
5872883|NCT01946438|20314879|P3|Overall Study|Serious Adverse event|0
5872884|NCT01946438|20314880|P2|Overall Study|Serious Adverse event|0
5872885|NCT01946438|20314881|P1|Overall Study|Serious Adverse event|1
5872886|NCT01946438|20314878|P4|Overall Study|Adverse Event|1
5872887|NCT01946438|20314879|P3|Overall Study|Adverse Event|0
5872888|NCT01946438|20314880|P2|Overall Study|Adverse Event|0
5872889|NCT01946438|20314881|P1|Overall Study|Adverse Event|0
5872890|NCT01946425|20314909|P2|Overall Study|Withdrawal by Subject|0
5872891|NCT01946425|20314910|P1|Overall Study|Withdrawal by Subject|1
5872892|NCT01946425|20314909|P2|Overall Study|Protocol Violation|0
5872893|NCT01946425|20314910|P1|Overall Study|Protocol Violation|1
5872894|NCT01946412|20314924|P1|Overall Study|Difficulty in swallowing|1
5872895|NCT01946412|20314924|P1|Overall Study|Continued with commercial Kalydeco|2
5872896|NCT01946412|20314924|P1|Overall Study|Non-Compliance|1
5872897|NCT01946412|20314924|P1|Overall Study|Adverse Event|1
5872898|NCT01946282|20314949|P3|Year 3|Did not return FIT kit|30
5872899|NCT01946282|20314950|P2|Year 3|Did not return FIT kit|43
5872900|NCT01946282|20314951|P1|Year 3|Did not return FIT kit|288
5872901|NCT01946282|20314949|P3|Year 2|Did not return FIT kit|115
5872902|NCT01946282|20314950|P2|Year 2|Did not return FIT kit|131
5872903|NCT01946282|20314951|P1|Year 2|Did not return FIT kit|803
5872904|NCT01946282|20314949|P3|Year 1|Did not return FIT kit|654
5872905|NCT01946282|20314950|P2|Year 1|Did not return FIT kit|608
5872906|NCT01946282|20314951|P1|Year 1|Did not return FIT kit|4186
5872907|NCT01946204|20314984|P2|Overall Study|Other|3
5872908|NCT01946204|20314985|P1|Overall Study|Other|7
5872909|NCT01946204|20314984|P2|Overall Study|Ongoing|687
5872910|NCT01946204|20314985|P1|Overall Study|Ongoing|316
5872911|NCT01946204|20314984|P2|Overall Study|Lost to Follow-up|7
5872912|NCT01946204|20314985|P1|Overall Study|Lost to Follow-up|3
5872913|NCT01946204|20314984|P2|Overall Study|Withdrawal by Subject|50
5872914|NCT01946204|20314985|P1|Overall Study|Withdrawal by Subject|37
5872915|NCT01946204|20314984|P2|Overall Study|Death|59
5872916|NCT01946204|20314985|P1|Overall Study|Death|38
5872917|NCT01946191|20315003|P2|Follow-Up, 24-mo Endpoint|Lost to Follow-up|15
5872918|NCT01946191|20315004|P1|Follow-Up, 24-mo Endpoint|Lost to Follow-up|13
5872919|NCT01946191|20315003|P2|Follow-Up, 24-mo Endpoint|Protocol Violation|1
5872920|NCT01946191|20315004|P1|Follow-Up, 24-mo Endpoint|Protocol Violation|0
5872921|NCT01946191|20315003|P2|Follow-Up, 24-mo Endpoint|Withdrawal by Subject|2
5872922|NCT01946191|20315004|P1|Follow-Up, 24-mo Endpoint|Withdrawal by Subject|4
5872923|NCT01946191|20315003|P2|Allocation|Did not complete orientation|1
5872924|NCT01946191|20315004|P1|Allocation|Did not complete orientation|1
5872925|NCT01946178|20315030|P1|Overall Study|Lost to Follow-up|1
5872926|NCT01946178|20315030|P1|Overall Study|Pregnancy|1
5872927|NCT01946165|20315040|P2|Overall Study|Withdrawal by Subject|2
5872928|NCT01946165|20315041|P1|Overall Study|Withdrawal by Subject|0
5872929|NCT01946165|20315040|P2|Overall Study|Physician Decision|0
5872930|NCT01946165|20315041|P1|Overall Study|Physician Decision|2
5872931|NCT01945996|20315068|P2|Overall Study|Lost to Follow-up|5
5872932|NCT01945996|20315069|P1|Overall Study|Lost to Follow-up|3
5872933|NCT01945944|20315145|P2|Overall Study|Withdrawal by Subject|1
5872934|NCT01945944|20315146|P1|Overall Study|Withdrawal by Subject|0
5872935|NCT01945944|20315145|P2|Overall Study|Physician Decision|0
5872936|NCT01945944|20315146|P1|Overall Study|Physician Decision|1
5872937|NCT01945944|20315145|P2|Overall Study|Adverse Event|2
5872938|NCT01945944|20315146|P1|Overall Study|Adverse Event|0
5872939|NCT01945866|20315170|P2|Overall Study|Eyes did not complete or were dropped|0
5872940|NCT01945866|20315171|P1|Overall Study|Eyes did not complete or were dropped|2
5872949|NCT01945710|20315229|P7|Overall Study|Withdrawal by Subject|0
5872950|NCT01945710|20315230|P6|Overall Study|Withdrawal by Subject|0
5872951|NCT01945710|20315231|P5|Overall Study|Withdrawal by Subject|1
5872952|NCT01945710|20315232|P4|Overall Study|Withdrawal by Subject|0
5872953|NCT01945710|20315233|P3|Overall Study|Withdrawal by Subject|1
5872954|NCT01945710|20315234|P2|Overall Study|Withdrawal by Subject|1
5872955|NCT01945710|20315235|P1|Overall Study|Withdrawal by Subject|0
5872956|NCT01945710|20315229|P7|Overall Study|Other|4
5872957|NCT01945710|20315230|P6|Overall Study|Other|0
5872958|NCT01945710|20315231|P5|Overall Study|Other|1
5872959|NCT01945710|20315232|P4|Overall Study|Other|1
5872960|NCT01945710|20315233|P3|Overall Study|Other|3
5872961|NCT01945710|20315234|P2|Overall Study|Other|0
5872962|NCT01945710|20315235|P1|Overall Study|Other|2
5872963|NCT01945710|20315229|P7|Overall Study|Adverse Event|0
5872964|NCT01945710|20315230|P6|Overall Study|Adverse Event|0
5872965|NCT01945710|20315231|P5|Overall Study|Adverse Event|0
5872966|NCT01945710|20315232|P4|Overall Study|Adverse Event|0
5872967|NCT01945710|20315233|P3|Overall Study|Adverse Event|0
5872968|NCT01945710|20315234|P2|Overall Study|Adverse Event|1
5872969|NCT01945710|20315235|P1|Overall Study|Adverse Event|0
5872970|NCT01945710|20315229|P7|Overall Study|Progressive Disease|19
5872971|NCT01945710|20315230|P6|Overall Study|Progressive Disease|3
5872972|NCT01945710|20315231|P5|Overall Study|Progressive Disease|7
5872973|NCT01945710|20315232|P4|Overall Study|Progressive Disease|2
5872974|NCT01945710|20315233|P3|Overall Study|Progressive Disease|3
5872975|NCT01945710|20315234|P2|Overall Study|Progressive Disease|4
5872976|NCT01945710|20315235|P1|Overall Study|Progressive Disease|5
5872977|NCT01945593|20315354|P4|Overall Study|Other: Screen Failure|0
5872978|NCT01945593|20315355|P3|Overall Study|Other: Screen Failure|0
5872979|NCT01945593|20315356|P2|Overall Study|Other: Screen Failure|2
5872980|NCT01945593|20315357|P1|Overall Study|Other: Screen Failure|0
5872981|NCT01945593|20315354|P4|Overall Study|Other: Surgical Procedure|6
5872982|NCT01945593|20315355|P3|Overall Study|Other: Surgical Procedure|0
5872983|NCT01945593|20315356|P2|Overall Study|Other: Surgical Procedure|2
5872984|NCT01945593|20315357|P1|Overall Study|Other: Surgical Procedure|0
5872985|NCT01945593|20315354|P4|Overall Study|Other: Terminated|1
5872986|NCT01945593|20315355|P3|Overall Study|Other: Terminated|0
5872987|NCT01945593|20315356|P2|Overall Study|Other: Terminated|0
5872988|NCT01945593|20315357|P1|Overall Study|Other: Terminated|0
5872989|NCT01945593|20315354|P4|Overall Study|Death|0
5872990|NCT01945593|20315355|P3|Overall Study|Death|1
5872991|NCT01945593|20315356|P2|Overall Study|Death|0
5872992|NCT01945593|20315357|P1|Overall Study|Death|0
5872993|NCT01945593|20315354|P4|Overall Study|Protocol Violation|3
5872994|NCT01945593|20315355|P3|Overall Study|Protocol Violation|1
5872995|NCT01945593|20315356|P2|Overall Study|Protocol Violation|2
5872996|NCT01945593|20315357|P1|Overall Study|Protocol Violation|0
5872997|NCT01945593|20315354|P4|Overall Study|Withdrawal by Subject|4
5872998|NCT01945593|20315355|P3|Overall Study|Withdrawal by Subject|0
5872999|NCT01945593|20315356|P2|Overall Study|Withdrawal by Subject|2
5873000|NCT01945593|20315357|P1|Overall Study|Withdrawal by Subject|0
5873001|NCT01945593|20315354|P4|Overall Study|Physician Decision|1
5873002|NCT01945593|20315355|P3|Overall Study|Physician Decision|1
5873003|NCT01945593|20315356|P2|Overall Study|Physician Decision|0
5873004|NCT01945593|20315357|P1|Overall Study|Physician Decision|0
5873005|NCT01945593|20315354|P4|Overall Study|Adverse Event|5
5873006|NCT01945593|20315355|P3|Overall Study|Adverse Event|0
5873007|NCT01945593|20315356|P2|Overall Study|Adverse Event|0
5873008|NCT01945593|20315357|P1|Overall Study|Adverse Event|0
5873009|NCT01945489|20315439|P2|Cycle 2|Lost to Follow-up|1
5873010|NCT01945489|20315440|P1|Cycle 2|Lost to Follow-up|0
5873011|NCT01945489|20315439|P2|Cycle 2|Adverse Event|0
5873012|NCT01945489|20315440|P1|Cycle 2|Adverse Event|1
5873013|NCT01945489|20315439|P2|Cycle 1|Other Miscellaneous Reasons|1
5873014|NCT01945489|20315440|P1|Cycle 1|Other Miscellaneous Reasons|3
5873015|NCT01945489|20315439|P2|Cycle 1|Protocol Violation|1
5873016|NCT01945489|20315440|P1|Cycle 1|Protocol Violation|0
5873017|NCT01945489|20315439|P2|Cycle 1|Personal Reasons|2
5873018|NCT01945489|20315440|P1|Cycle 1|Personal Reasons|4
5873019|NCT01945489|20315439|P2|Cycle 1|Lost to Follow-up|0
5873020|NCT01945489|20315440|P1|Cycle 1|Lost to Follow-up|4
5873021|NCT01945489|20315439|P2|Cycle 1|Adverse Event|0
5873022|NCT01945489|20315440|P1|Cycle 1|Adverse Event|2
5873023|NCT01945281|20315494|P2|Overall Study|Technical Problems|0
5873024|NCT01945281|20315495|P1|Overall Study|Technical Problems|1
5873025|NCT01945281|20315494|P2|Overall Study|Physician Decision|1
5873026|NCT01945281|20315495|P1|Overall Study|Physician Decision|1
5873027|NCT01945281|20315494|P2|Overall Study|Death|3
5873028|NCT01945281|20315495|P1|Overall Study|Death|3
5873029|NCT01945281|20315494|P2|Overall Study|Adverse Event|0
5873030|NCT01945281|20315495|P1|Overall Study|Adverse Event|1
5873031|NCT01945242|20315507|P2|Overall Study|Physician Decision|3
5873032|NCT01945242|20315508|P1|Overall Study|Physician Decision|3
5873033|NCT01945216|20315523|P1|Overall Study|CRF not assured by investigators|5
5873034|NCT01945216|20315523|P1|Overall Study|Protocol Violation|42
5873035|NCT01945216|20315523|P1|Overall Study|Case report forms (CRF) uncollected|52
5873036|NCT01945086|20315581|P3|Overall Study|Adverse Event|1
5873037|NCT01945086|20315582|P2|Overall Study|Adverse Event|0
5873038|NCT01945086|20315583|P1|Overall Study|Adverse Event|0
5873039|NCT01945086|20315581|P3|Overall Study|Withdrawal by Subject|1
5873040|NCT01945086|20315582|P2|Overall Study|Withdrawal by Subject|0
5873041|NCT01945086|20315583|P1|Overall Study|Withdrawal by Subject|1
5873042|NCT01945034|20315627|P3|Overall Study|Protocol Violation|1
5873043|NCT01945034|20315628|P2|Overall Study|Protocol Violation|0
5873044|NCT01945034|20315629|P1|Overall Study|Protocol Violation|1
5873045|NCT01945034|20315627|P3|Overall Study|Lost to Follow-up|2
5873046|NCT01945034|20315628|P2|Overall Study|Lost to Follow-up|0
5873047|NCT01945034|20315629|P1|Overall Study|Lost to Follow-up|0
5873048|NCT01945034|20315627|P3|Overall Study|Other|3
5873049|NCT01945034|20315628|P2|Overall Study|Other|1
5873050|NCT01945034|20315629|P1|Overall Study|Other|0
5873051|NCT01945034|20315627|P3|Overall Study|Withdrawal by Subject|1
5873052|NCT01945034|20315628|P2|Overall Study|Withdrawal by Subject|3
5873053|NCT01945034|20315629|P1|Overall Study|Withdrawal by Subject|0
5873054|NCT01945034|20315627|P3|Overall Study|Medication Error|0
5873055|NCT01945034|20315628|P2|Overall Study|Medication Error|1
5873056|NCT01945034|20315629|P1|Overall Study|Medication Error|0
5873065|NCT01944969|20315693|P1|Overall Study|Administrative or other reasons|23
5873066|NCT01944969|20315693|P1|Overall Study|Non-compliance with IMP|1
5873067|NCT01944969|20315693|P1|Overall Study|Lack of Efficacy|1
5873068|NCT01944969|20315693|P1|Overall Study|Adverse Event|1
5873069|NCT01944839|20315726|P2|Overall Study|Subject non-compliance|3
5873070|NCT01944839|20315727|P1|Overall Study|Subject non-compliance|0
5873071|NCT01944839|20315726|P2|Overall Study|Lost to Follow-up|0
5873072|NCT01944839|20315727|P1|Overall Study|Lost to Follow-up|1
5873073|NCT01944839|20315726|P2|Overall Study|Withdrawal by Subject|17
5873074|NCT01944839|20315727|P1|Overall Study|Withdrawal by Subject|9
5873075|NCT01944839|20315726|P2|Overall Study|Adverse Event|5
5873076|NCT01944839|20315727|P1|Overall Study|Adverse Event|10
5873077|NCT01944839|20315726|P2|Overall Study|Protocol Violation|1
5873078|NCT01944839|20315727|P1|Overall Study|Protocol Violation|0
5873079|NCT01944839|20315726|P2|Overall Study|Physician Decision|2
5873080|NCT01944839|20315727|P1|Overall Study|Physician Decision|2
5873081|NCT01944774|20315736|P3|Overall Study|Lost to Follow-up|0
5873082|NCT01944774|20315737|P2|Overall Study|Lost to Follow-up|1
5873083|NCT01944774|20315738|P1|Overall Study|Lost to Follow-up|0
5873084|NCT01944774|20315736|P3|Overall Study|Lack of Efficacy|2
5873085|NCT01944774|20315737|P2|Overall Study|Lack of Efficacy|2
5873086|NCT01944774|20315738|P1|Overall Study|Lack of Efficacy|1
5873087|NCT01944774|20315736|P3|Overall Study|Adverse Event|3
5873088|NCT01944774|20315737|P2|Overall Study|Adverse Event|2
5873089|NCT01944774|20315738|P1|Overall Study|Adverse Event|3
5873090|NCT01944774|20315736|P3|Overall Study|Withdrawal by Subject|3
5873091|NCT01944774|20315737|P2|Overall Study|Withdrawal by Subject|3
5873092|NCT01944774|20315738|P1|Overall Study|Withdrawal by Subject|2
5873093|NCT01944722|20315781|P1|Overall Study|>ASCUS Cytology|1122
5873094|NCT01944722|20315781|P1|Overall Study|Unsatisfactory Cytology Result|63
5873095|NCT01944722|20315781|P1|Overall Study|NILM Subjects <30 years old|8106
5873096|NCT01944722|20315781|P1|Overall Study|Withdrawal by Subject|8
5873097|NCT01944722|20315781|P1|Overall Study|Specimens Mislabeled|2
5873098|NCT01944722|20315781|P1|Overall Study|Missing Specimens|3
5873099|NCT01944722|20315781|P1|Overall Study|Insufficient Volume for Test|1
5873100|NCT01944722|20315781|P1|Overall Study|Improper Storage/Transport|5
5873101|NCT01944722|20315781|P1|Overall Study|Specimen Shipping Issues|34
5873102|NCT01944722|20315781|P1|Overall Study|Didn't meet Inclusion/Exclusion Criteria|171
5873103|NCT01944670|20315815|P1|Overall Study|Lost to Follow-up|2
5873104|NCT01944631|20315837|P2|Overall Study|Withdrawal by Subject|1
5873105|NCT01944631|20315838|P1|Overall Study|Withdrawal by Subject|0
5873106|NCT01944631|20315837|P2|Overall Study|Lost to Follow-up|1
5873107|NCT01944631|20315838|P1|Overall Study|Lost to Follow-up|3
5873108|NCT01944631|20315837|P2|Overall Study|Adverse Event|0
5873109|NCT01944631|20315838|P1|Overall Study|Adverse Event|1
5873110|NCT01944462|20315854|P1|PPPP Educational Program|Lost to Follow-up|60
5873111|NCT01944098|20315917|P2|Overall Study|Physician Decision|0
5873112|NCT01944098|20315918|P1|Overall Study|Physician Decision|1
5873113|NCT01944059|20315930|P1|Overall Study|Adverse Event|2
5873114|NCT01944059|20315930|P1|Overall Study|Withdrawal by Subject|1
5873115|NCT01944059|20315930|P1|Overall Study|Physician Decision|3
5873116|NCT01944059|20315930|P1|Overall Study|Lost to Follow-up|1
5873117|NCT01944046|20315941|P2|Open Label Eligible and Consented|Withdrawal by Subject|0
5873118|NCT01944046|20315942|P1|Open Label Eligible and Consented|Withdrawal by Subject|1
5873119|NCT01944046|20315941|P2|Open Label Eligible and Consented|Clinical Worsening|2
5873120|NCT01944046|20315942|P1|Open Label Eligible and Consented|Clinical Worsening|4
5873121|NCT01944046|20315941|P2|Open Label Eligible and Consented|Adverse Event|1
5873122|NCT01944046|20315942|P1|Open Label Eligible and Consented|Adverse Event|6
5873123|NCT01944046|20315941|P2|Open Label Eligible and Consented|Lost to Follow-up|5
5873124|NCT01944046|20315942|P1|Open Label Eligible and Consented|Lost to Follow-up|3
5873125|NCT01944046|20315941|P2|Randomized to DB|Did not have a postbaseline ABC SW|6
5873126|NCT01944046|20315942|P1|Randomized to DB|Did not have a postbaseline ABC SW|5
5873127|NCT01944046|20315941|P2|Randomized to DB|Did not have baseline ABC-SW|0
5873128|NCT01944046|20315942|P1|Randomized to DB|Did not have baseline ABC-SW|2
5873129|NCT01944046|20315941|P2|Randomized to DB|Physician Decision|2
5873130|NCT01944046|20315942|P1|Randomized to DB|Physician Decision|1
5873131|NCT01944046|20315941|P2|Randomized to DB|Withdrawal by Subject|4
5873132|NCT01944046|20315942|P1|Randomized to DB|Withdrawal by Subject|2
5873133|NCT01944046|20315941|P2|Randomized to DB|Lost to Follow-up|3
5873134|NCT01944046|20315942|P1|Randomized to DB|Lost to Follow-up|3
5873135|NCT01944046|20315941|P2|Randomized to DB|Clinical Worsening|2
5873136|NCT01944046|20315942|P1|Randomized to DB|Clinical Worsening|3
5873137|NCT01944046|20315941|P2|Randomized to DB|Adverse Event|2
5873138|NCT01944046|20315942|P1|Randomized to DB|Adverse Event|5
5873139|NCT01943825|20316012|P4|Overall Study|Other than specified above|1
5873140|NCT01943825|20316013|P3|Overall Study|Other than specified above|0
5873141|NCT01943825|20316014|P2|Overall Study|Other than specified above|1
5873142|NCT01943825|20316015|P1|Overall Study|Other than specified above|0
5873143|NCT01943825|20316012|P4|Overall Study|Withdrawal by Subject|2
5873144|NCT01943825|20316013|P3|Overall Study|Withdrawal by Subject|3
5873145|NCT01943825|20316014|P2|Overall Study|Withdrawal by Subject|0
5873146|NCT01943825|20316015|P1|Overall Study|Withdrawal by Subject|1
5873147|NCT01943825|20316012|P4|Overall Study|Lost to Follow-up|8
5873148|NCT01943825|20316013|P3|Overall Study|Lost to Follow-up|12
5873149|NCT01943825|20316014|P2|Overall Study|Lost to Follow-up|3
5873150|NCT01943825|20316015|P1|Overall Study|Lost to Follow-up|9
5873151|NCT01943799|20316057|P4|Overall Study|Withdrawal by Subject|0
5873152|NCT01943799|20316058|P3|Overall Study|Withdrawal by Subject|1
5873153|NCT01943799|20316059|P2|Overall Study|Withdrawal by Subject|2
5873154|NCT01943799|20316060|P1|Overall Study|Withdrawal by Subject|4
5873155|NCT01943799|20316057|P4|Overall Study|Protocol Violation|0
5873156|NCT01943799|20316058|P3|Overall Study|Protocol Violation|0
5873157|NCT01943799|20316059|P2|Overall Study|Protocol Violation|0
5873158|NCT01943799|20316060|P1|Overall Study|Protocol Violation|1
5873159|NCT01943799|20316057|P4|Overall Study|Lost to Follow-up|0
5873160|NCT01943799|20316058|P3|Overall Study|Lost to Follow-up|1
5873161|NCT01943799|20316059|P2|Overall Study|Lost to Follow-up|1
5873162|NCT01943799|20316060|P1|Overall Study|Lost to Follow-up|0
5873163|NCT01943591|20316100|P2|Overall Study|Death|7
5873164|NCT01943591|20316101|P1|Overall Study|Death|2
5873165|NCT01943591|20316100|P2|Overall Study|Lost to Follow-up|4
5873166|NCT01943591|20316101|P1|Overall Study|Lost to Follow-up|3
5873167|NCT01943552|20316159|P2|Overall Study|Other Reasons|17
5873168|NCT01943552|20316160|P1|Overall Study|Other Reasons|16
5873169|NCT01943552|20316159|P2|Overall Study|Withdrawal by Subject|6
5873170|NCT01943552|20316160|P1|Overall Study|Withdrawal by Subject|6
5873171|NCT01943552|20316159|P2|Overall Study|Adverse Event|2
5873172|NCT01943552|20316160|P1|Overall Study|Adverse Event|3
5873173|NCT01943539|20316176|P2|Overall Study|Non-compliance with at-home intervention|0
5873174|NCT01943539|20316177|P1|Overall Study|Non-compliance with at-home intervention|4
5873175|NCT01943435|20316274|P3|6 Month Follow up|Lost to Follow-up|15
5873176|NCT01943435|20316275|P2|6 Month Follow up|Lost to Follow-up|7
5873177|NCT01943435|20316276|P1|6 Month Follow up|Lost to Follow-up|12
5873178|NCT01943435|20316274|P3|2 Month Follow up|Lost to Follow-up|0
5873179|NCT01943435|20316275|P2|2 Month Follow up|Lost to Follow-up|3
5873180|NCT01943435|20316276|P1|2 Month Follow up|Lost to Follow-up|2
5873181|NCT01943435|20316274|P3|Intervention Period|Withdrawal by Subject|4
5873182|NCT01943435|20316275|P2|Intervention Period|Withdrawal by Subject|3
5873183|NCT01943435|20316276|P1|Intervention Period|Withdrawal by Subject|3
5873184|NCT01943435|20316274|P3|Baseline Eligibility and Randomization|Withdrawal by Subject|3
5873185|NCT01943435|20316275|P2|Baseline Eligibility and Randomization|Withdrawal by Subject|12
5873186|NCT01943435|20316276|P1|Baseline Eligibility and Randomization|Withdrawal by Subject|4
5873187|NCT01943292|20316299|P3|Overall Study|Withdrawal by Subject|0
5873188|NCT01943292|20316300|P2|Overall Study|Withdrawal by Subject|0
5873189|NCT01943292|20316301|P1|Overall Study|Withdrawal by Subject|1
5873190|NCT01942993|20316337|P1|Overall Study|Physician Decision|1
5873191|NCT01942993|20316337|P1|Overall Study|Lost to Follow-up|1
5873192|NCT01942785|20316354|P1|Overall Study|Protocol Violation|1
5873193|NCT01942785|20316354|P1|Overall Study|Withdrawal by Subject|1
5873194|NCT01942785|20316354|P1|Overall Study|Adverse Event|2
5873195|NCT01942733|20316383|P1|Overall Study|Administrative|1
5873196|NCT01942733|20316383|P1|Overall Study|Non-compliance with IMP|1
5873197|NCT01942733|20316383|P1|Overall Study|Lost to Follow-up|1
5873198|NCT01942590|20317524|P2|Overall Study|Adverse Event|0
5873199|NCT01942590|20317525|P1|Overall Study|Adverse Event|1
5873200|NCT01942590|20317524|P2|Overall Study|Withdrawal by Subject|1
5873201|NCT01942590|20317525|P1|Overall Study|Withdrawal by Subject|0
5873202|NCT01942486|20317555|P1|Overall Study|Lost to Follow-up|27
5873203|NCT01942161|20317562|P3|Overall Study|Withdrawal by Subject|1
5873204|NCT01942161|20317563|P2|Overall Study|Withdrawal by Subject|3
5873205|NCT01942161|20317564|P1|Overall Study|Withdrawal by Subject|3
5873206|NCT01942161|20317562|P3|Overall Study|Protocol Violation|0
5873207|NCT01942161|20317563|P2|Overall Study|Protocol Violation|0
5873208|NCT01942161|20317564|P1|Overall Study|Protocol Violation|1
5873209|NCT01942161|20317562|P3|Overall Study|Physician Decision|0
5873210|NCT01942161|20317563|P2|Overall Study|Physician Decision|1
5873211|NCT01942161|20317564|P1|Overall Study|Physician Decision|3
5873212|NCT01942161|20317562|P3|Overall Study|Adverse Event|5
5873213|NCT01942161|20317563|P2|Overall Study|Adverse Event|2
5873214|NCT01942161|20317564|P1|Overall Study|Adverse Event|1
5873215|NCT01942148|20317584|P1|Overall Study|Use of the prohibition medicine|1
5873216|NCT01942148|20317584|P1|Overall Study|Withdrawal by Subject|8
5873217|NCT01942148|20317584|P1|Overall Study|Protocol Violation|1
5873218|NCT01942148|20317584|P1|Overall Study|Physician Decision|11
5873219|NCT01942148|20317584|P1|Overall Study|Lack of Efficacy|2
5873220|NCT01942148|20317584|P1|Overall Study|Adverse Event|4
5873221|NCT01942135|20317592|P2|Overall Study|Ongoing at date of cut-off (05 Dec 2014)|75
5873222|NCT01942135|20317593|P1|Overall Study|Ongoing at date of cut-off (05 Dec 2014)|238
5873223|NCT01942135|20317592|P2|Overall Study|Withdrawal by Subject|2
5873224|NCT01942135|20317593|P1|Overall Study|Withdrawal by Subject|4
5873225|NCT01942135|20317592|P2|Overall Study|Participant Refused toContinue Treatment|1
5873226|NCT01942135|20317593|P1|Overall Study|Participant Refused toContinue Treatment|1
5873227|NCT01942135|20317592|P2|Overall Study|ObjectiveProgression+Progressive Disease|87
5873228|NCT01942135|20317593|P1|Overall Study|ObjectiveProgression+Progressive Disease|85
5873229|NCT01942135|20317592|P2|Overall Study|Death|1
5873230|NCT01942135|20317593|P1|Overall Study|Death|0
5873231|NCT01942135|20317592|P2|Overall Study|Randomized Not Treated|2
5873232|NCT01942135|20317593|P1|Overall Study|Randomized Not Treated|2
5873233|NCT01942135|20317592|P2|Overall Study|Global deterioration of health status|3
5873234|NCT01942135|20317593|P1|Overall Study|Global deterioration of health status|8
5873235|NCT01942135|20317592|P2|Overall Study|Adverse Event|3
5873236|NCT01942135|20317593|P1|Overall Study|Adverse Event|9
5873237|NCT01941940|20317630|P1|Overall Study|Other|1
5873238|NCT01941940|20317630|P1|Overall Study|Other|1
5873239|NCT01941940|20317630|P1|Overall Study|Death|1
5873240|NCT01941940|20317630|P1|Overall Study|Withdrawal by Subject|15
5873241|NCT01941940|20317630|P1|Overall Study|Physician Decision|2
5873242|NCT01941940|20317630|P1|Overall Study|Lost to Follow-up|2
5873243|NCT01941940|20317630|P1|Overall Study|Adverse Event|11
5873244|NCT01941537|20317738|P2|Overall Study|Withdrawal by Subject|1
5873245|NCT01941537|20317739|P1|Overall Study|Withdrawal by Subject|0
5873246|NCT01941537|20317738|P2|Overall Study|Adverse Event|0
5873247|NCT01941537|20317739|P1|Overall Study|Adverse Event|1
5873248|NCT01941537|20317738|P2|Overall Study|Pregnancy|0
5873249|NCT01941537|20317739|P1|Overall Study|Pregnancy|1
5873250|NCT01941537|20317738|P2|Overall Study|Lost to Follow-up|0
5873251|NCT01941537|20317739|P1|Overall Study|Lost to Follow-up|1
5873252|NCT01941537|20317738|P2|Overall Study|Lack of Efficacy|2
5873253|NCT01941537|20317739|P1|Overall Study|Lack of Efficacy|1
5873254|NCT01941498|20317751|P1|Overall Study|Relocated out of state|1
5873255|NCT01941186|20317869|P2|Follow-up|Lost to Follow-up|0
5873256|NCT01941186|20317870|P1|Follow-up|Lost to Follow-up|1
5873257|NCT01941095|20317896|P1|Overall Study|Lost to Follow-up|10
5873258|NCT01941095|20317896|P1|Overall Study|Withdrawal by Subject|17
5873259|NCT01941095|20317896|P1|Overall Study|Physician Decision|3
5873260|NCT01941095|20317896|P1|Overall Study|Adverse Event|11
5873261|NCT01941095|20317896|P1|Overall Study|Anaphylaxis or serious hypersensitivity|2
5873262|NCT01941095|20317896|P1|Overall Study|Insufficient therapeutic response|13
5873263|NCT01941030|20317921|P2|Overall Study|Withdrawal by Subject|6
5873264|NCT01941030|20317922|P1|Overall Study|Withdrawal by Subject|4
5873265|NCT01941030|20317921|P2|Overall Study|Lost to Follow-up|5
5873266|NCT01941030|20317922|P1|Overall Study|Lost to Follow-up|6
5873267|NCT01941030|20317921|P2|Overall Study|Death|2
5873268|NCT01941030|20317922|P1|Overall Study|Death|3
5873269|NCT01940939|20317944|P2|Overall Study|Withdrawal by Subject|8
5873270|NCT01940939|20317945|P1|Overall Study|Withdrawal by Subject|2
5873271|NCT01940900|20317957|P2|Overall Study|other|0
5873272|NCT01940900|20317958|P1|Overall Study|other|1
5873273|NCT01940900|20317957|P2|Overall Study|subject non-compliance|1
5873274|NCT01940900|20317958|P1|Overall Study|subject non-compliance|1
5873275|NCT01940900|20317957|P2|Overall Study|Sponsor Decision|0
5873276|NCT01940900|20317958|P1|Overall Study|Sponsor Decision|1
5873277|NCT01940900|20317957|P2|Overall Study|Lost to Follow-up|0
5873278|NCT01940900|20317958|P1|Overall Study|Lost to Follow-up|1
5873279|NCT01940900|20317957|P2|Overall Study|Withdrawal by Subject|15
5873280|NCT01940900|20317958|P1|Overall Study|Withdrawal by Subject|11
5873281|NCT01940900|20317957|P2|Overall Study|Adverse Event|15
5873282|NCT01940900|20317958|P1|Overall Study|Adverse Event|10
5873283|NCT01940900|20317957|P2|Overall Study|Physician Decision|0
5873284|NCT01940900|20317958|P1|Overall Study|Physician Decision|4
5873285|NCT01940887|20317966|P2|Year 2|Lost to Follow-up|6
5873286|NCT01940887|20317967|P1|Year 2|Lost to Follow-up|1
5873287|NCT01940887|20317966|P2|Year 2|Withdrawal by Subject|8
5873288|NCT01940887|20317967|P1|Year 2|Withdrawal by Subject|8
5873289|NCT01940887|20317966|P2|Year 2|Adverse Event|2
5873290|NCT01940887|20317967|P1|Year 2|Adverse Event|8
5873291|NCT01940887|20317966|P2|Year 2|Sponsor Decision, early termination|203
5873292|NCT01940887|20317967|P1|Year 2|Sponsor Decision, early termination|192
5873293|NCT01940887|20317966|P2|Year 2|Death|2
5873294|NCT01940887|20317967|P1|Year 2|Death|0
5873295|NCT01940887|20317966|P2|Year 2|Physician Decision|1
5873296|NCT01940887|20317967|P1|Year 2|Physician Decision|8
5873297|NCT01940887|20317966|P2|Year 1|Lost to Follow-up|1
5873298|NCT01940887|20317967|P1|Year 1|Lost to Follow-up|2
5873299|NCT01940887|20317966|P2|Year 1|Withdrawal by Subject|9
5873300|NCT01940887|20317967|P1|Year 1|Withdrawal by Subject|18
5873301|NCT01940887|20317966|P2|Year 1|Adverse Event|6
5873302|NCT01940887|20317967|P1|Year 1|Adverse Event|7
5873303|NCT01940887|20317966|P2|Year 1|Death|3
5873304|NCT01940887|20317967|P1|Year 1|Death|5
5873305|NCT01940887|20317966|P2|Year 1|Physician Decision|3
5873306|NCT01940887|20317967|P1|Year 1|Physician Decision|7
5873307|NCT01940887|20317966|P2|Year 1|Protocol Violation|1
5873308|NCT01940887|20317967|P1|Year 1|Protocol Violation|0
5873309|NCT01940705|20317977|P4|Overall Study|Withdrawal by team - hearing aid change|0
5873310|NCT01940705|20317978|P3|Overall Study|Withdrawal by team - hearing aid change|0
5873311|NCT01940705|20317979|P2|Overall Study|Withdrawal by team - hearing aid change|0
5873312|NCT01940705|20317980|P1|Overall Study|Withdrawal by team - hearing aid change|1
5873313|NCT01940705|20317977|P4|Overall Study|Intervention not given|0
5873314|NCT01940705|20317978|P3|Overall Study|Intervention not given|3
5873315|NCT01940705|20317979|P2|Overall Study|Intervention not given|3
5873316|NCT01940705|20317980|P1|Overall Study|Intervention not given|0
5873317|NCT01940705|20317977|P4|Overall Study|Withdrawal by Subject|2
5873318|NCT01940705|20317978|P3|Overall Study|Withdrawal by Subject|3
5873319|NCT01940705|20317979|P2|Overall Study|Withdrawal by Subject|2
5873320|NCT01940705|20317980|P1|Overall Study|Withdrawal by Subject|2
5873321|NCT01940705|20317977|P4|Overall Study|Lost to Follow-up|2
5873322|NCT01940705|20317978|P3|Overall Study|Lost to Follow-up|2
5873323|NCT01940705|20317979|P2|Overall Study|Lost to Follow-up|3
5873324|NCT01940705|20317980|P1|Overall Study|Lost to Follow-up|1
5873325|NCT01940497|20318044|P2|Overall Study|Administrative/Other|1
5873326|NCT01940497|20318045|P1|Overall Study|Administrative/Other|1
5873327|NCT01940497|20318044|P2|Overall Study|Withdrew Consent|2
5873328|NCT01940497|20318045|P1|Overall Study|Withdrew Consent|6
5873329|NCT01940497|20318044|P2|Overall Study|Refused Treatment|3
5873330|NCT01940497|20318045|P1|Overall Study|Refused Treatment|1
5873331|NCT01940497|20318044|P2|Overall Study|Violation of Entry Criteria|1
5873332|NCT01940497|20318045|P1|Overall Study|Violation of Entry Criteria|1
5873333|NCT01940497|20318044|P2|Overall Study|Recurrence of Disease Postsurgery|3
5873334|NCT01940497|20318045|P1|Overall Study|Recurrence of Disease Postsurgery|1
5873335|NCT01940497|20318044|P2|Overall Study|Adverse Event/Intercurrent Illness|8
5873336|NCT01940497|20318045|P1|Overall Study|Adverse Event/Intercurrent Illness|11
5873337|NCT01940484|20318086|P1|Overall Study|Adverse Event|1
5873338|NCT01940484|20318086|P1|Overall Study|Death|2
5873339|NCT01940484|20318086|P1|Overall Study|Underwent transplantation|4
5873340|NCT01940484|20318086|P1|Overall Study|Withdrawal by Subject|3
5873367|NCT01940354|20318125|P2|Overall Study|Withdrawal by Subject|2
5873368|NCT01940354|20318126|P1|Overall Study|Withdrawal by Subject|4
5873369|NCT01940341|20318138|P2|Open-label Extension Phase|Still on Study|1
5873370|NCT01940341|20318139|P1|Open-label Extension Phase|Still on Study|4
5873371|NCT01940341|20318138|P2|Double-Blind Phase|Still on Double-Blind Treatment|132
5873372|NCT01940341|20318139|P1|Double-Blind Phase|Still on Double-Blind Treatment|269
5873373|NCT01940341|20318138|P2|Double-Blind Phase|Protocol Specified Criteria|0
5873374|NCT01940341|20318139|P1|Double-Blind Phase|Protocol Specified Criteria|1
5873375|NCT01940341|20318138|P2|Double-Blind Phase|Non-Compliance with Study Drug|1
5873376|NCT01940341|20318139|P1|Double-Blind Phase|Non-Compliance with Study Drug|0
5873377|NCT01940341|20318138|P2|Double-Blind Phase|Investigator's Discretion|0
5873378|NCT01940341|20318139|P1|Double-Blind Phase|Investigator's Discretion|1
5873379|NCT01940341|20318138|P2|Double-Blind Phase|Pregnancy|1
5873380|NCT01940341|20318139|P1|Double-Blind Phase|Pregnancy|0
5873381|NCT01940341|20318138|P2|Double-Blind Phase|Lost to Follow-up|1
5873382|NCT01940341|20318139|P1|Double-Blind Phase|Lost to Follow-up|4
5873383|NCT01940341|20318138|P2|Double-Blind Phase|Withdrew Consent|2
5873384|NCT01940341|20318139|P1|Double-Blind Phase|Withdrew Consent|3
5873385|NCT01940341|20318138|P2|Double-Blind Phase|Adverse Event|2
5873386|NCT01940341|20318139|P1|Double-Blind Phase|Adverse Event|3
5873387|NCT01940341|20318138|P2|Double-Blind Phase|Randomized but Never Treated|1
5873388|NCT01940341|20318139|P1|Double-Blind Phase|Randomized but Never Treated|0
5873389|NCT01940120|20318189|P1|Overall Study|Withdrawal by Subject|8
5873390|NCT01940120|20318189|P1|Overall Study|Death|40
5873391|NCT01939977|20318345|P2|Overall Study|Did not receive study medication|1
5873392|NCT01939977|20318346|P1|Overall Study|Did not receive study medication|0
5873393|NCT01939977|20318345|P2|Overall Study|Did not meet inclusion criteria|0
5873394|NCT01939977|20318346|P1|Overall Study|Did not meet inclusion criteria|1
5873395|NCT01939977|20318345|P2|Overall Study|Withdrawal by Subject|2
5873396|NCT01939977|20318346|P1|Overall Study|Withdrawal by Subject|0
5873397|NCT01939977|20318345|P2|Overall Study|Physician Decision|1
5873398|NCT01939977|20318346|P1|Overall Study|Physician Decision|1
5873399|NCT01939977|20318345|P2|Overall Study|Lack of Efficacy|0
5873400|NCT01939977|20318346|P1|Overall Study|Lack of Efficacy|3
5873401|NCT01939977|20318345|P2|Overall Study|Adverse Event|3
5873402|NCT01939977|20318346|P1|Overall Study|Adverse Event|4
5873403|NCT01939899|20318393|P5|Phase 2|Disease Progression|1
5873404|NCT01939899|20318394|P4|Phase 2|Disease Progression|9
5873405|NCT01939899|20318395|P3|Phase 2|Disease Progression|0
5873406|NCT01939899|20318396|P2|Phase 2|Disease Progression|0
5873407|NCT01939899|20318397|P1|Phase 2|Disease Progression|0
5873408|NCT01939899|20318393|P5|Phase 2|Withdrawal by Subject|0
5873409|NCT01939899|20318394|P4|Phase 2|Withdrawal by Subject|2
5873410|NCT01939899|20318395|P3|Phase 2|Withdrawal by Subject|0
5873411|NCT01939899|20318396|P2|Phase 2|Withdrawal by Subject|0
5873412|NCT01939899|20318397|P1|Phase 2|Withdrawal by Subject|0
5873413|NCT01939899|20318393|P5|Lead-in Dose Finding Phase|Other|0
5873414|NCT01939899|20318394|P4|Lead-in Dose Finding Phase|Other|0
5873415|NCT01939899|20318395|P3|Lead-in Dose Finding Phase|Other|1
5873416|NCT01939899|20318396|P2|Lead-in Dose Finding Phase|Other|0
5873417|NCT01939899|20318397|P1|Lead-in Dose Finding Phase|Other|0
5873418|NCT01939899|20318393|P5|Lead-in Dose Finding Phase|Disease Progression|0
5873419|NCT01939899|20318394|P4|Lead-in Dose Finding Phase|Disease Progression|0
5873420|NCT01939899|20318395|P3|Lead-in Dose Finding Phase|Disease Progression|3
5873421|NCT01939899|20318396|P2|Lead-in Dose Finding Phase|Disease Progression|4
5873422|NCT01939899|20318397|P1|Lead-in Dose Finding Phase|Disease Progression|2
5873423|NCT01939899|20318393|P5|Lead-in Dose Finding Phase|Death|0
5873424|NCT01939899|20318394|P4|Lead-in Dose Finding Phase|Death|0
5873425|NCT01939899|20318395|P3|Lead-in Dose Finding Phase|Death|1
5873426|NCT01939899|20318396|P2|Lead-in Dose Finding Phase|Death|3
5873427|NCT01939899|20318397|P1|Lead-in Dose Finding Phase|Death|0
5873428|NCT01939548|20318444|P3|Overall Study|Did not complete follow-up|0
5873429|NCT01939548|20318445|P2|Overall Study|Did not complete follow-up|1
5873430|NCT01939548|20318446|P1|Overall Study|Did not complete follow-up|0
5873431|NCT01939548|20318444|P3|Overall Study|Participant withdrew consent|0
5873432|NCT01939548|20318445|P2|Overall Study|Participant withdrew consent|2
5873433|NCT01939548|20318446|P1|Overall Study|Participant withdrew consent|0
5873434|NCT01939548|20318444|P3|Overall Study|Participant unwilling to continue|0
5873435|NCT01939548|20318445|P2|Overall Study|Participant unwilling to continue|1
5873436|NCT01939548|20318446|P1|Overall Study|Participant unwilling to continue|0
5873437|NCT01939548|20318444|P3|Overall Study|Participant dropped|1
5873438|NCT01939548|20318445|P2|Overall Study|Participant dropped|0
5873439|NCT01939548|20318446|P1|Overall Study|Participant dropped|0
5873440|NCT01939548|20318444|P3|Overall Study|Death|1
5873441|NCT01939548|20318445|P2|Overall Study|Death|0
5873442|NCT01939548|20318446|P1|Overall Study|Death|0
5873443|NCT01939548|20318444|P3|Overall Study|Adverse Event|7
5873444|NCT01939548|20318445|P2|Overall Study|Adverse Event|9
5873445|NCT01939548|20318446|P1|Overall Study|Adverse Event|2
5873446|NCT01939548|20318444|P3|Overall Study|Lost to Follow-up|3
5873447|NCT01939548|20318445|P2|Overall Study|Lost to Follow-up|5
5873448|NCT01939548|20318446|P1|Overall Study|Lost to Follow-up|5
5873449|NCT01939548|20318444|P3|Overall Study|Protocol Violation|5
5873450|NCT01939548|20318445|P2|Overall Study|Protocol Violation|6
5873451|NCT01939548|20318446|P1|Overall Study|Protocol Violation|7
5873452|NCT01939548|20318444|P3|Overall Study|Withdrawal by Subject|1
5873453|NCT01939548|20318445|P2|Overall Study|Withdrawal by Subject|4
5873454|NCT01939548|20318446|P1|Overall Study|Withdrawal by Subject|4
5873455|NCT01939548|20318444|P3|Overall Study|Did Not Meet Entrance Criteria|0
5873456|NCT01939548|20318445|P2|Overall Study|Did Not Meet Entrance Criteria|0
5873457|NCT01939548|20318446|P1|Overall Study|Did Not Meet Entrance Criteria|1
5873458|NCT01939548|20318444|P3|Overall Study|Insufficient Clinical Response|0
5873459|NCT01939548|20318445|P2|Overall Study|Insufficient Clinical Response|0
5873460|NCT01939548|20318446|P1|Overall Study|Insufficient Clinical Response|1
5873461|NCT01939548|20318444|P3|Overall Study|Study Terminated by Sponsor|12
5873462|NCT01939548|20318445|P2|Overall Study|Study Terminated by Sponsor|19
5873463|NCT01939548|20318446|P1|Overall Study|Study Terminated by Sponsor|17
5873464|NCT01939548|20318444|P3|Overall Study|Non compliance|0
5873465|NCT01939548|20318445|P2|Overall Study|Non compliance|2
5873466|NCT01939548|20318446|P1|Overall Study|Non compliance|0
5873467|NCT01939496|20318520|P3|Overall Study|Other|1
5873468|NCT01939496|20318521|P2|Overall Study|Other|0
5873469|NCT01939496|20318522|P1|Overall Study|Other|2
5873470|NCT01939496|20318520|P3|Overall Study|Blood Pressure Withdrawal Criteria|0
5873471|NCT01939496|20318521|P2|Overall Study|Blood Pressure Withdrawal Criteria|1
5873472|NCT01939496|20318522|P1|Overall Study|Blood Pressure Withdrawal Criteria|0
5873473|NCT01939496|20318520|P3|Overall Study|Withdrawal by Subject|1
5873474|NCT01939496|20318521|P2|Overall Study|Withdrawal by Subject|1
5873475|NCT01939496|20318522|P1|Overall Study|Withdrawal by Subject|0
5873476|NCT01939496|20318520|P3|Overall Study|Protocol Violation|0
5873477|NCT01939496|20318521|P2|Overall Study|Protocol Violation|0
5873478|NCT01939496|20318522|P1|Overall Study|Protocol Violation|3
5873479|NCT01939496|20318520|P3|Overall Study|Physician Decision|0
5873480|NCT01939496|20318521|P2|Overall Study|Physician Decision|0
5873481|NCT01939496|20318522|P1|Overall Study|Physician Decision|1
5873482|NCT01939496|20318520|P3|Overall Study|Lost to Follow-up|0
5873483|NCT01939496|20318521|P2|Overall Study|Lost to Follow-up|1
5873484|NCT01939496|20318522|P1|Overall Study|Lost to Follow-up|1
5873485|NCT01939496|20318520|P3|Overall Study|Adverse Event|0
5873486|NCT01939496|20318521|P2|Overall Study|Adverse Event|0
5873487|NCT01939496|20318522|P1|Overall Study|Adverse Event|2
5873488|NCT01939366|20318592|P5|Overall Study|GCP non-compliance at site|3
5873489|NCT01939366|20318593|P4|Overall Study|GCP non-compliance at site|3
5873490|NCT01939366|20318594|P3|Overall Study|GCP non-compliance at site|2
5873491|NCT01939366|20318595|P2|Overall Study|GCP non-compliance at site|3
5873492|NCT01939366|20318596|P1|Overall Study|GCP non-compliance at site|2
5873493|NCT01939366|20318592|P5|Overall Study|Sponsor decision|2
5873494|NCT01939366|20318593|P4|Overall Study|Sponsor decision|0
5873495|NCT01939366|20318594|P3|Overall Study|Sponsor decision|0
5873496|NCT01939366|20318595|P2|Overall Study|Sponsor decision|0
5873497|NCT01939366|20318596|P1|Overall Study|Sponsor decision|0
5873498|NCT01939366|20318592|P5|Overall Study|Protocol Violation|0
5873499|NCT01939366|20318593|P4|Overall Study|Protocol Violation|1
5873500|NCT01939366|20318594|P3|Overall Study|Protocol Violation|0
5873501|NCT01939366|20318595|P2|Overall Study|Protocol Violation|0
5873502|NCT01939366|20318596|P1|Overall Study|Protocol Violation|0
5873503|NCT01939366|20318592|P5|Overall Study|Other|1
5873504|NCT01939366|20318593|P4|Overall Study|Other|2
5873505|NCT01939366|20318594|P3|Overall Study|Other|2
5873506|NCT01939366|20318595|P2|Overall Study|Other|0
5873507|NCT01939366|20318596|P1|Overall Study|Other|0
5873508|NCT01939366|20318592|P5|Overall Study|Inclusion criteria not met|1
5873509|NCT01939366|20318593|P4|Overall Study|Inclusion criteria not met|0
5873510|NCT01939366|20318594|P3|Overall Study|Inclusion criteria not met|1
5873511|NCT01939366|20318595|P2|Overall Study|Inclusion criteria not met|1
5873512|NCT01939366|20318596|P1|Overall Study|Inclusion criteria not met|0
5873513|NCT01939366|20318592|P5|Overall Study|Withdrawal by Subject|3
5873514|NCT01939366|20318593|P4|Overall Study|Withdrawal by Subject|2
5873515|NCT01939366|20318594|P3|Overall Study|Withdrawal by Subject|2
5873516|NCT01939366|20318595|P2|Overall Study|Withdrawal by Subject|0
5873517|NCT01939366|20318596|P1|Overall Study|Withdrawal by Subject|1
5873518|NCT01939366|20318592|P5|Overall Study|Lost to Follow-up|0
5873519|NCT01939366|20318593|P4|Overall Study|Lost to Follow-up|0
5873520|NCT01939366|20318594|P3|Overall Study|Lost to Follow-up|0
5873521|NCT01939366|20318595|P2|Overall Study|Lost to Follow-up|1
5873522|NCT01939366|20318596|P1|Overall Study|Lost to Follow-up|1
5873523|NCT01939366|20318592|P5|Overall Study|Lack of Efficacy|3
5873524|NCT01939366|20318593|P4|Overall Study|Lack of Efficacy|1
5873525|NCT01939366|20318594|P3|Overall Study|Lack of Efficacy|1
5873526|NCT01939366|20318595|P2|Overall Study|Lack of Efficacy|1
5873527|NCT01939366|20318596|P1|Overall Study|Lack of Efficacy|2
5873528|NCT01939366|20318592|P5|Overall Study|Adverse Event|5
5873529|NCT01939366|20318593|P4|Overall Study|Adverse Event|8
5873530|NCT01939366|20318594|P3|Overall Study|Adverse Event|30
5873531|NCT01939366|20318595|P2|Overall Study|Adverse Event|17
5873532|NCT01939366|20318596|P1|Overall Study|Adverse Event|8
5873533|NCT01939314|20318610|P2|Overall Study|Lost to Follow-up|6
5873534|NCT01939314|20318611|P1|Overall Study|Lost to Follow-up|5
5873535|NCT01939314|20318610|P2|Overall Study|Pregnancy|1
5873536|NCT01939314|20318611|P1|Overall Study|Pregnancy|0
5873537|NCT01939314|20318610|P2|Overall Study|Protocol Violation|0
5873538|NCT01939314|20318611|P1|Overall Study|Protocol Violation|1
5873539|NCT01939314|20318610|P2|Overall Study|Withdrawal by Subject|1
5873540|NCT01939314|20318611|P1|Overall Study|Withdrawal by Subject|3
5873541|NCT01939223|20318645|P2|Overall Study|Withdrawal by Subject|0
5873542|NCT01939223|20318646|P1|Overall Study|Withdrawal by Subject|6
5873543|NCT01939223|20318645|P2|Overall Study|Study stopped by Sponsor|7
5873544|NCT01939223|20318646|P1|Overall Study|Study stopped by Sponsor|5
5873545|NCT01939223|20318645|P2|Overall Study|Disease recurrence (radiological)|3
5873546|NCT01939223|20318646|P1|Overall Study|Disease recurrence (radiological)|1
5873547|NCT01939223|20318645|P2|Overall Study|AE not assoc. with disease recurrence|1
5873548|NCT01939223|20318646|P1|Overall Study|AE not assoc. with disease recurrence|1
5873549|NCT01939197|20318661|P7|Overall Study|Lost to Follow-up|2
5873550|NCT01939197|20318662|P6|Overall Study|Lost to Follow-up|1
5873551|NCT01939197|20318663|P5|Overall Study|Lost to Follow-up|3
5873552|NCT01939197|20318664|P4|Overall Study|Lost to Follow-up|1
5873553|NCT01939197|20318665|P3|Overall Study|Lost to Follow-up|0
5873554|NCT01939197|20318666|P2|Overall Study|Lost to Follow-up|1
5873555|NCT01939197|20318667|P1|Overall Study|Lost to Follow-up|0
5873556|NCT01939197|20318661|P7|Overall Study|Withdrawal by Subject|0
5873557|NCT01939197|20318662|P6|Overall Study|Withdrawal by Subject|0
5873558|NCT01939197|20318663|P5|Overall Study|Withdrawal by Subject|1
5873559|NCT01939197|20318664|P4|Overall Study|Withdrawal by Subject|0
5873560|NCT01939197|20318665|P3|Overall Study|Withdrawal by Subject|0
5873561|NCT01939197|20318666|P2|Overall Study|Withdrawal by Subject|0
5873562|NCT01939197|20318667|P1|Overall Study|Withdrawal by Subject|1
5873563|NCT01939028|20318736|P1|Overall Study|Physician Decision|7
5873564|NCT01939028|20318736|P1|Overall Study|Withdrawal by Subject|5
5873565|NCT01939002|20318749|P2|Overall Study|Other|2
5873566|NCT01939002|20318750|P1|Overall Study|Other|1
5873567|NCT01939002|20318749|P2|Overall Study|Withdrawal by Subject|3
5873568|NCT01939002|20318750|P1|Overall Study|Withdrawal by Subject|5
5873569|NCT01939002|20318749|P2|Overall Study|Adverse Event|13
5873570|NCT01939002|20318750|P1|Overall Study|Adverse Event|13
5873571|NCT01938846|20318826|P3|Overall Study|Other than listed|4
5873572|NCT01938846|20318827|P2|Overall Study|Other than listed|1
5873573|NCT01938846|20318828|P1|Overall Study|Other than listed|5
5873574|NCT01938846|20318826|P3|Overall Study|Withdrawal by Subject|1
5873575|NCT01938846|20318827|P2|Overall Study|Withdrawal by Subject|2
5873576|NCT01938846|20318828|P1|Overall Study|Withdrawal by Subject|2
5873577|NCT01938846|20318826|P3|Overall Study|Adverse Event|3
5873578|NCT01938846|20318827|P2|Overall Study|Adverse Event|4
5873579|NCT01938846|20318828|P1|Overall Study|Adverse Event|8
5873580|NCT01938846|20318826|P3|Overall Study|Progressive disease|16
5873581|NCT01938846|20318827|P2|Overall Study|Progressive disease|18
5873582|NCT01938846|20318828|P1|Overall Study|Progressive disease|26
5873583|NCT01938716|20319028|P1|Overall Study|Withdrawal by Subject|2
5873584|NCT01938716|20319028|P1|Overall Study|Physician Decision|2
5873585|NCT01938625|20319051|P2|Overall Study|Adverse Event|1
5873586|NCT01938625|20319052|P1|Overall Study|Adverse Event|0
5873587|NCT01938625|20319051|P2|Overall Study|Withdrawal by Subject|1
5873588|NCT01938625|20319052|P1|Overall Study|Withdrawal by Subject|0
5873589|NCT01938573|20319072|P2|Overall Study|Operation at other hospital|0
5873590|NCT01938573|20319073|P1|Overall Study|Operation at other hospital|1
5873591|NCT01938573|20319072|P2|Overall Study|Lack of Efficacy|0
5873592|NCT01938573|20319073|P1|Overall Study|Lack of Efficacy|1
5873593|NCT01938430|20319093|P14|Overall Study|Withdrew Consent|0
5873594|NCT01938430|20319094|P13|Overall Study|Withdrew Consent|0
5873595|NCT01938430|20319095|P12|Overall Study|Withdrew Consent|0
5873596|NCT01938430|20319096|P11|Overall Study|Withdrew Consent|0
5873597|NCT01938430|20319097|P10|Overall Study|Withdrew Consent|0
5873598|NCT01938430|20319098|P9|Overall Study|Withdrew Consent|1
5873599|NCT01938430|20319099|P8|Overall Study|Withdrew Consent|0
5873600|NCT01938430|20319100|P7|Overall Study|Withdrew Consent|0
5873601|NCT01938430|20319101|P6|Overall Study|Withdrew Consent|0
5873602|NCT01938430|20319102|P5|Overall Study|Withdrew Consent|0
5873603|NCT01938430|20319103|P4|Overall Study|Withdrew Consent|0
5873604|NCT01938430|20319104|P3|Overall Study|Withdrew Consent|0
5873605|NCT01938430|20319105|P2|Overall Study|Withdrew Consent|0
5873606|NCT01938430|20319106|P1|Overall Study|Withdrew Consent|0
5873607|NCT01938430|20319093|P14|Overall Study|Lost to Follow-up|0
5873608|NCT01938430|20319094|P13|Overall Study|Lost to Follow-up|0
5873609|NCT01938430|20319095|P12|Overall Study|Lost to Follow-up|0
5873610|NCT01938430|20319096|P11|Overall Study|Lost to Follow-up|0
5873611|NCT01938430|20319097|P10|Overall Study|Lost to Follow-up|0
5873612|NCT01938430|20319098|P9|Overall Study|Lost to Follow-up|0
5873613|NCT01938430|20319099|P8|Overall Study|Lost to Follow-up|0
5873614|NCT01938430|20319100|P7|Overall Study|Lost to Follow-up|0
5873615|NCT01938430|20319101|P6|Overall Study|Lost to Follow-up|1
5873616|NCT01938430|20319102|P5|Overall Study|Lost to Follow-up|0
5873617|NCT01938430|20319103|P4|Overall Study|Lost to Follow-up|0
5873618|NCT01938430|20319104|P3|Overall Study|Lost to Follow-up|1
5873619|NCT01938430|20319105|P2|Overall Study|Lost to Follow-up|0
5873620|NCT01938430|20319106|P1|Overall Study|Lost to Follow-up|0
5873621|NCT01938430|20319093|P14|Overall Study|Lack of Efficacy|0
5873622|NCT01938430|20319094|P13|Overall Study|Lack of Efficacy|0
5873623|NCT01938430|20319095|P12|Overall Study|Lack of Efficacy|1
5873624|NCT01938430|20319096|P11|Overall Study|Lack of Efficacy|2
5873625|NCT01938430|20319097|P10|Overall Study|Lack of Efficacy|0
5873626|NCT01938430|20319098|P9|Overall Study|Lack of Efficacy|1
5873627|NCT01938430|20319099|P8|Overall Study|Lack of Efficacy|0
5873628|NCT01938430|20319100|P7|Overall Study|Lack of Efficacy|0
5873629|NCT01938430|20319101|P6|Overall Study|Lack of Efficacy|0
5873630|NCT01938430|20319102|P5|Overall Study|Lack of Efficacy|0
5873631|NCT01938430|20319103|P4|Overall Study|Lack of Efficacy|1
5873632|NCT01938430|20319104|P3|Overall Study|Lack of Efficacy|1
5873633|NCT01938430|20319105|P2|Overall Study|Lack of Efficacy|1
5873634|NCT01938430|20319106|P1|Overall Study|Lack of Efficacy|3
5873635|NCT01938430|20319093|P14|Overall Study|Investigator's Discretion|0
5873636|NCT01938430|20319094|P13|Overall Study|Investigator's Discretion|0
5873637|NCT01938430|20319095|P12|Overall Study|Investigator's Discretion|0
5873638|NCT01938430|20319096|P11|Overall Study|Investigator's Discretion|0
5873639|NCT01938430|20319097|P10|Overall Study|Investigator's Discretion|0
5873640|NCT01938430|20319098|P9|Overall Study|Investigator's Discretion|0
5873641|NCT01938430|20319099|P8|Overall Study|Investigator's Discretion|0
5873642|NCT01938430|20319100|P7|Overall Study|Investigator's Discretion|0
5873643|NCT01938430|20319101|P6|Overall Study|Investigator's Discretion|0
5873644|NCT01938430|20319102|P5|Overall Study|Investigator's Discretion|0
5873645|NCT01938430|20319103|P4|Overall Study|Investigator's Discretion|0
5873646|NCT01938430|20319104|P3|Overall Study|Investigator's Discretion|1
5873647|NCT01938430|20319105|P2|Overall Study|Investigator's Discretion|0
5873648|NCT01938430|20319106|P1|Overall Study|Investigator's Discretion|0
5873649|NCT01938430|20319093|P14|Overall Study|Death|0
5873650|NCT01938430|20319094|P13|Overall Study|Death|0
5873651|NCT01938430|20319095|P12|Overall Study|Death|0
5873652|NCT01938430|20319096|P11|Overall Study|Death|0
5873653|NCT01938430|20319097|P10|Overall Study|Death|3
5873654|NCT01938430|20319098|P9|Overall Study|Death|2
5873655|NCT01938430|20319099|P8|Overall Study|Death|1
5873656|NCT01938430|20319100|P7|Overall Study|Death|1
5873657|NCT01938430|20319101|P6|Overall Study|Death|0
5873658|NCT01938430|20319102|P5|Overall Study|Death|0
5873659|NCT01938430|20319103|P4|Overall Study|Death|1
5873660|NCT01938430|20319104|P3|Overall Study|Death|2
5873661|NCT01938430|20319105|P2|Overall Study|Death|2
5873662|NCT01938430|20319106|P1|Overall Study|Death|1
5873663|NCT01938430|20319093|P14|Overall Study|Adverse Event|0
5873664|NCT01938430|20319094|P13|Overall Study|Adverse Event|0
5873665|NCT01938430|20319095|P12|Overall Study|Adverse Event|0
5873666|NCT01938430|20319096|P11|Overall Study|Adverse Event|0
5873667|NCT01938430|20319097|P10|Overall Study|Adverse Event|0
5873668|NCT01938430|20319098|P9|Overall Study|Adverse Event|0
5873669|NCT01938430|20319099|P8|Overall Study|Adverse Event|0
5873670|NCT01938430|20319100|P7|Overall Study|Adverse Event|1
5873671|NCT01938430|20319101|P6|Overall Study|Adverse Event|0
5873672|NCT01938430|20319102|P5|Overall Study|Adverse Event|0
5873673|NCT01938430|20319103|P4|Overall Study|Adverse Event|0
5873674|NCT01938430|20319104|P3|Overall Study|Adverse Event|0
5873675|NCT01938430|20319105|P2|Overall Study|Adverse Event|0
5873676|NCT01938430|20319106|P1|Overall Study|Adverse Event|0
5873677|NCT01938430|20319093|P14|Overall Study|Randomized but Not Treated|1
5873678|NCT01938430|20319094|P13|Overall Study|Randomized but Not Treated|0
5873679|NCT01938430|20319095|P12|Overall Study|Randomized but Not Treated|0
5873680|NCT01938430|20319096|P11|Overall Study|Randomized but Not Treated|1
5873681|NCT01938430|20319097|P10|Overall Study|Randomized but Not Treated|0
5873682|NCT01938430|20319098|P9|Overall Study|Randomized but Not Treated|0
5873683|NCT01938430|20319099|P8|Overall Study|Randomized but Not Treated|0
5873684|NCT01938430|20319100|P7|Overall Study|Randomized but Not Treated|0
5873685|NCT01938430|20319101|P6|Overall Study|Randomized but Not Treated|0
5873686|NCT01938430|20319102|P5|Overall Study|Randomized but Not Treated|0
5873687|NCT01938430|20319103|P4|Overall Study|Randomized but Not Treated|0
5873688|NCT01938430|20319104|P3|Overall Study|Randomized but Not Treated|0
5873689|NCT01938430|20319105|P2|Overall Study|Randomized but Not Treated|0
5873690|NCT01938430|20319106|P1|Overall Study|Randomized but Not Treated|0
5873691|NCT01938391|20319431|P1|12 Month Follow up|Withdrawal by Subject|1
5873692|NCT01938391|20319431|P1|12 Month Follow up|Physician Decision|1
5873693|NCT01938391|20319431|P1|6 Month Follow up|Withdrawal by Subject|1
5873704|NCT01937871|20319645|P3|Overall Study|Entry Criteria Not Met|1
5873705|NCT01937871|20319646|P2|Overall Study|Entry Criteria Not Met|2
5873706|NCT01937871|20319647|P1|Overall Study|Entry Criteria Not Met|1
5873707|NCT01937871|20319645|P3|Overall Study|Physician Decision|0
5873708|NCT01937871|20319646|P2|Overall Study|Physician Decision|1
5873709|NCT01937871|20319647|P1|Overall Study|Physician Decision|0
5873710|NCT01937871|20319645|P3|Overall Study|Withdrawal by Subject|4
5873711|NCT01937871|20319646|P2|Overall Study|Withdrawal by Subject|6
5873712|NCT01937871|20319647|P1|Overall Study|Withdrawal by Subject|9
5873713|NCT01937871|20319645|P3|Overall Study|Lost to Follow-up|4
5873714|NCT01937871|20319646|P2|Overall Study|Lost to Follow-up|2
5873715|NCT01937871|20319647|P1|Overall Study|Lost to Follow-up|8
5873716|NCT01937871|20319645|P3|Overall Study|Adverse Event|2
5873717|NCT01937871|20319646|P2|Overall Study|Adverse Event|6
5873718|NCT01937871|20319647|P1|Overall Study|Adverse Event|6
5873719|NCT01937715|20319723|P5|Overall Study|Other|0
5873720|NCT01937715|20319724|P4|Overall Study|Other|3
5873721|NCT01937715|20319725|P3|Overall Study|Other|0
5873722|NCT01937715|20319726|P2|Overall Study|Other|0
5873723|NCT01937715|20319727|P1|Overall Study|Other|0
5873724|NCT01937715|20319723|P5|Overall Study|Withdrawal by Subject|2
5873725|NCT01937715|20319724|P4|Overall Study|Withdrawal by Subject|0
5873726|NCT01937715|20319725|P3|Overall Study|Withdrawal by Subject|0
5873727|NCT01937715|20319726|P2|Overall Study|Withdrawal by Subject|1
5873728|NCT01937715|20319727|P1|Overall Study|Withdrawal by Subject|0
5873729|NCT01937715|20319723|P5|Overall Study|Death|0
5873730|NCT01937715|20319724|P4|Overall Study|Death|1
5873731|NCT01937715|20319725|P3|Overall Study|Death|0
5873732|NCT01937715|20319726|P2|Overall Study|Death|0
5873733|NCT01937715|20319727|P1|Overall Study|Death|0
5873734|NCT01937559|20319879|P3|Overall Study|screen fail|0
5873735|NCT01937559|20319880|P2|Overall Study|screen fail|4
5873736|NCT01937559|20319881|P1|Overall Study|screen fail|2
5873737|NCT01937559|20319879|P3|Overall Study|Withdrawal by Subject|0
5873738|NCT01937559|20319880|P2|Overall Study|Withdrawal by Subject|4
5873739|NCT01937559|20319881|P1|Overall Study|Withdrawal by Subject|6
5873740|NCT01937559|20319879|P3|Overall Study|Physician Decision|0
5873741|NCT01937559|20319880|P2|Overall Study|Physician Decision|3
5873742|NCT01937559|20319881|P1|Overall Study|Physician Decision|3
5873743|NCT01937390|20319951|P1|Overall Study|Fail to return|21
5873744|NCT01937390|20319951|P1|Overall Study|Withdrawal by Subject|5
5873745|NCT01937390|20319951|P1|Overall Study|Lost to Follow-up|7
5873746|NCT01937390|20319951|P1|Overall Study|Death|2
5873747|NCT01937364|20319961|P2|Overall Study|Adverse Event|1
5873748|NCT01937364|20319962|P1|Overall Study|Adverse Event|2
5873749|NCT01937351|20319974|P2|Overall Study|Not treated w device, per protocol fail|0
5873750|NCT01937351|20319975|P1|Overall Study|Not treated w device, per protocol fail|4
5873751|NCT01937351|20319974|P2|Overall Study|Death|0
5873752|NCT01937351|20319975|P1|Overall Study|Death|1
5873753|NCT01937351|20319974|P2|Overall Study|Withdrawal by Subject|2
5873754|NCT01937351|20319975|P1|Overall Study|Withdrawal by Subject|4
5873755|NCT01937312|20319983|P2|Overall Study|Withdrawal of subject prior to treatment|1
5873756|NCT01937312|20319984|P1|Overall Study|Withdrawal of subject prior to treatment|1
5873757|NCT01937312|20319983|P2|Overall Study|Lack of Efficacy|1
5873758|NCT01937312|20319984|P1|Overall Study|Lack of Efficacy|0
5873759|NCT01937312|20319983|P2|Overall Study|Adverse Event|1
5873760|NCT01937312|20319984|P1|Overall Study|Adverse Event|10
5873761|NCT01937299|20319999|P2|Overall Study|Withdrawal by Subject|0
5873762|NCT01937299|20320000|P1|Overall Study|Withdrawal by Subject|1
5873763|NCT01937299|20319999|P2|Overall Study|Lack of Efficacy|4
5873764|NCT01937299|20320000|P1|Overall Study|Lack of Efficacy|0
5873765|NCT01937299|20319999|P2|Overall Study|Adverse Event|0
5873766|NCT01937299|20320000|P1|Overall Study|Adverse Event|13
5873767|NCT01937130|20320035|P4|Overall Study|Patient lost to FU due to death|0
5873768|NCT01937130|20320036|P3|Overall Study|Patient lost to FU due to death|0
5873769|NCT01937130|20320037|P2|Overall Study|Patient lost to FU due to death|0
5873770|NCT01937130|20320038|P1|Overall Study|Patient lost to FU due to death|2
5873771|NCT01937130|20320035|P4|Overall Study|Patients unable to swallow|0
5873772|NCT01937130|20320036|P3|Overall Study|Patients unable to swallow|0
5873773|NCT01937130|20320037|P2|Overall Study|Patients unable to swallow|1
5873774|NCT01937130|20320038|P1|Overall Study|Patients unable to swallow|0
5873775|NCT01937130|20320035|P4|Overall Study|Physician Decision|0
5873776|NCT01937130|20320036|P3|Overall Study|Physician Decision|0
5873777|NCT01937130|20320037|P2|Overall Study|Physician Decision|1
5873778|NCT01937130|20320038|P1|Overall Study|Physician Decision|0
5873779|NCT01937130|20320035|P4|Overall Study|Lost to Follow-up|0
5873780|NCT01937130|20320036|P3|Overall Study|Lost to Follow-up|2
5873781|NCT01937130|20320037|P2|Overall Study|Lost to Follow-up|0
5873782|NCT01937130|20320038|P1|Overall Study|Lost to Follow-up|2
5873783|NCT01937130|20320035|P4|Overall Study|Death|0
5873784|NCT01937130|20320036|P3|Overall Study|Death|1
5873785|NCT01937130|20320037|P2|Overall Study|Death|1
5873786|NCT01937130|20320038|P1|Overall Study|Death|1
5873787|NCT01937130|20320035|P4|Overall Study|Adverse Event|1
5873788|NCT01937130|20320036|P3|Overall Study|Adverse Event|0
5873789|NCT01937130|20320037|P2|Overall Study|Adverse Event|1
5873790|NCT01937130|20320038|P1|Overall Study|Adverse Event|0
5873791|NCT01937130|20320035|P4|Overall Study|Withdrawal by Subject|1
5873792|NCT01937130|20320036|P3|Overall Study|Withdrawal by Subject|0
5873793|NCT01937130|20320037|P2|Overall Study|Withdrawal by Subject|0
5873794|NCT01937130|20320038|P1|Overall Study|Withdrawal by Subject|0
5873795|NCT01937117|20320065|P1|Overall Study|Adverse Event|2
5873796|NCT01937117|20320065|P1|Overall Study|Physician Decision|4
5873797|NCT01937117|20320065|P1|Overall Study|Disease Progression|7
5873798|NCT01936974|20320080|P2|Overall Study|Physician Decision|5
5873799|NCT01936974|20320081|P1|Overall Study|Physician Decision|2
5873800|NCT01936870|20320111|P1|Overall Study|No Drug Administration|1
5873801|NCT01936870|20320111|P1|Overall Study|Protocol Violation|12
5873802|NCT01936870|20320111|P1|Overall Study|No Visit After Treatment|176
5873803|NCT01936857|20320126|P2|Overall Study|Other|2
5873804|NCT01936857|20320127|P1|Overall Study|Other|2
5873805|NCT01936857|20320126|P2|Overall Study|Side effect of medication|0
5873806|NCT01936857|20320127|P1|Overall Study|Side effect of medication|1
5873807|NCT01936857|20320126|P2|Overall Study|Withdrawal by Subject|0
5873808|NCT01936857|20320127|P1|Overall Study|Withdrawal by Subject|1
5873809|NCT01936857|20320126|P2|Overall Study|Moved|1
5873810|NCT01936857|20320127|P1|Overall Study|Moved|2
5873811|NCT01936857|20320126|P2|Overall Study|Death|3
5873812|NCT01936857|20320127|P1|Overall Study|Death|7
5873813|NCT01936857|20320126|P2|Overall Study|Lost to Follow-up|7
5873814|NCT01936857|20320127|P1|Overall Study|Lost to Follow-up|10
5873815|NCT01936857|20320126|P2|Overall Study|Sent to prison or 06 center|12
5873816|NCT01936857|20320127|P1|Overall Study|Sent to prison or 06 center|11
5873817|NCT01936649|20320157|P1|Overall Study|Other than specified above|5
5873818|NCT01936649|20320157|P1|Overall Study|Protocol Violation|2
5873819|NCT01936649|20320157|P1|Overall Study|Physician Decision|2
5873820|NCT01936649|20320157|P1|Overall Study|Withdrawal by Subject|4
5873821|NCT01936623|20320164|P2|Overall Study|Lost to Follow-up|5
5873822|NCT01936623|20320165|P1|Overall Study|Lost to Follow-up|0
5873823|NCT01936181|20320273|P4|Transition-extension|Withdrawal by Subject|1
5873824|NCT01936181|20320274|P3|Transition-extension|Withdrawal by Subject|2
5873825|NCT01936181|20320275|P2|Transition-extension|Withdrawal by Subject|0
5873826|NCT01936181|20320276|P1|Transition-extension|Withdrawal by Subject|7
5873827|NCT01936181|20320273|P4|Transition-extension|Physician Decision|1
5873828|NCT01936181|20320274|P3|Transition-extension|Physician Decision|0
5873829|NCT01936181|20320275|P2|Transition-extension|Physician Decision|0
5873830|NCT01936181|20320276|P1|Transition-extension|Physician Decision|2
5873831|NCT01936181|20320273|P4|Transition-extension|Lost to Follow-up|2
5873832|NCT01936181|20320274|P3|Transition-extension|Lost to Follow-up|1
5873833|NCT01936181|20320275|P2|Transition-extension|Lost to Follow-up|0
5873834|NCT01936181|20320276|P1|Transition-extension|Lost to Follow-up|3
5873835|NCT01936181|20320273|P4|Transition-extension|Adverse Event|1
5873836|NCT01936181|20320274|P3|Transition-extension|Adverse Event|3
5873837|NCT01936181|20320275|P2|Transition-extension|Adverse Event|0
5873838|NCT01936181|20320276|P1|Transition-extension|Adverse Event|3
5873839|NCT01936181|20320273|P4|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0
5873840|NCT01936181|20320274|P3|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0
5873841|NCT01936181|20320275|P2|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4
5873842|NCT01936181|20320276|P1|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4
5873843|NCT01936181|20320273|P4|Randomised, Double-blind|Withdrawal by Subject|0
5873844|NCT01936181|20320274|P3|Randomised, Double-blind|Withdrawal by Subject|0
5873845|NCT01936181|20320275|P2|Randomised, Double-blind|Withdrawal by Subject|26
5873846|NCT01936181|20320276|P1|Randomised, Double-blind|Withdrawal by Subject|23
5873847|NCT01936181|20320273|P4|Randomised, Double-blind|Physician Decision|0
5873848|NCT01936181|20320274|P3|Randomised, Double-blind|Physician Decision|0
5873849|NCT01936181|20320275|P2|Randomised, Double-blind|Physician Decision|4
5873850|NCT01936181|20320276|P1|Randomised, Double-blind|Physician Decision|4
5873851|NCT01936181|20320273|P4|Randomised, Double-blind|Pregnancy|0
5873852|NCT01936181|20320274|P3|Randomised, Double-blind|Pregnancy|0
5873853|NCT01936181|20320275|P2|Randomised, Double-blind|Pregnancy|1
5873854|NCT01936181|20320276|P1|Randomised, Double-blind|Pregnancy|0
5873855|NCT01936181|20320273|P4|Randomised, Double-blind|Lost to Follow-up|0
5873856|NCT01936181|20320274|P3|Randomised, Double-blind|Lost to Follow-up|0
5873857|NCT01936181|20320275|P2|Randomised, Double-blind|Lost to Follow-up|1
5873858|NCT01936181|20320276|P1|Randomised, Double-blind|Lost to Follow-up|0
5873859|NCT01936181|20320273|P4|Randomised, Double-blind|Lack of Efficacy|0
5873860|NCT01936181|20320274|P3|Randomised, Double-blind|Lack of Efficacy|0
5873861|NCT01936181|20320275|P2|Randomised, Double-blind|Lack of Efficacy|6
5873862|NCT01936181|20320276|P1|Randomised, Double-blind|Lack of Efficacy|5
5873863|NCT01936181|20320273|P4|Randomised, Double-blind|Protocol Violation|0
5873864|NCT01936181|20320274|P3|Randomised, Double-blind|Protocol Violation|0
5873865|NCT01936181|20320275|P2|Randomised, Double-blind|Protocol Violation|5
5873866|NCT01936181|20320276|P1|Randomised, Double-blind|Protocol Violation|1
5873867|NCT01936181|20320273|P4|Randomised, Double-blind|Adverse Event|0
5873868|NCT01936181|20320274|P3|Randomised, Double-blind|Adverse Event|0
5873869|NCT01936181|20320275|P2|Randomised, Double-blind|Adverse Event|21
5873870|NCT01936181|20320276|P1|Randomised, Double-blind|Adverse Event|27
5873871|NCT01935947|20320290|P3|Overall Study|Death|0
5873872|NCT01935947|20320291|P2|Overall Study|Death|0
5873873|NCT01935947|20320292|P1|Overall Study|Death|1
5873874|NCT01935947|20320290|P3|Overall Study|Diease Progression|2
5873875|NCT01935947|20320291|P2|Overall Study|Diease Progression|2
5873876|NCT01935947|20320292|P1|Overall Study|Diease Progression|2
5873877|NCT01935947|20320290|P3|Overall Study|Adverse Event|0
5873878|NCT01935947|20320291|P2|Overall Study|Adverse Event|2
5873879|NCT01935947|20320292|P1|Overall Study|Adverse Event|0
5873880|NCT01935700|20320327|P2|Overall Study|Physician Decision|0
5873881|NCT01935700|20320328|P1|Overall Study|Physician Decision|4
5873882|NCT01935700|20320327|P2|Overall Study|Withdrawal by Subject|0
5873883|NCT01935700|20320328|P1|Overall Study|Withdrawal by Subject|1
5873884|NCT01934972|20320372|P2|Overall Study|Withdrawal by Subject|6
5873885|NCT01934972|20320373|P1|Overall Study|Withdrawal by Subject|9
5873886|NCT01934894|20320403|P2|Overall Study|Progressive Disease|2
5873887|NCT01934894|20320404|P1|Overall Study|Progressive Disease|3
5873888|NCT01934894|20320403|P2|Overall Study|Withdrawal by Subject|1
5873889|NCT01934894|20320404|P1|Overall Study|Withdrawal by Subject|0
5873890|NCT01934894|20320403|P2|Overall Study|Death|0
5873891|NCT01934894|20320404|P1|Overall Study|Death|2
5873892|NCT01934894|20320403|P2|Overall Study|Adverse Event|2
5873893|NCT01934894|20320404|P1|Overall Study|Adverse Event|1
5873894|NCT01934790|20320419|P1|Active Follow up|Other reason|1
5873895|NCT01934790|20320419|P1|Active Follow up|Progressive disease|1
5873896|NCT01934790|20320419|P1|Active Follow up|Physician Decision|2
5873897|NCT01934790|20320419|P1|Active Follow up|Death|20
5873898|NCT01934790|20320419|P1|Treatment|Study drug never administered|1
5873899|NCT01934790|20320419|P1|Treatment|Withdrawal by Subject|2
5873900|NCT01934790|20320419|P1|Treatment|Radiological progression|4
5873901|NCT01934790|20320419|P1|Treatment|Clinical progression|6
5873902|NCT01934790|20320419|P1|Treatment|Adverse Event|3
5873903|NCT01934556|20320477|P3|Overall Study|Death|2
5873904|NCT01934556|20320478|P2|Overall Study|Death|5
5873905|NCT01934556|20320479|P1|Overall Study|Death|1
5873906|NCT01934556|20320477|P3|Overall Study|Lost to Follow-up|7
5873907|NCT01934556|20320478|P2|Overall Study|Lost to Follow-up|10
5873908|NCT01934556|20320479|P1|Overall Study|Lost to Follow-up|4
5873909|NCT01934556|20320477|P3|Overall Study|Withdrawal by Subject|1
5873910|NCT01934556|20320478|P2|Overall Study|Withdrawal by Subject|1
5873911|NCT01934556|20320479|P1|Overall Study|Withdrawal by Subject|0
5873912|NCT01934504|20320523|P4|Overall Study|Study Terminated by Sponsor|5
5873913|NCT01934504|20320524|P3|Overall Study|Study Terminated by Sponsor|5
5873914|NCT01934504|20320525|P2|Overall Study|Study Terminated by Sponsor|0
5873915|NCT01934504|20320526|P1|Overall Study|Study Terminated by Sponsor|1
5873916|NCT01934504|20320523|P4|Overall Study|Protocol Deviation|2
5873917|NCT01934504|20320524|P3|Overall Study|Protocol Deviation|0
5873918|NCT01934504|20320525|P2|Overall Study|Protocol Deviation|0
5873919|NCT01934504|20320526|P1|Overall Study|Protocol Deviation|0
5873920|NCT01934218|20320559|P2|Open-Label Phase|Failure to Exam Primary Evaluation|1
5873921|NCT01934218|20320560|P1|Open-Label Phase|Failure to Exam Primary Evaluation|0
5873922|NCT01934218|20320559|P2|Open-Label Phase|Noncompliance with Study Protocol|2
5873923|NCT01934218|20320560|P1|Open-Label Phase|Noncompliance with Study Protocol|4
5873924|NCT01934218|20320559|P2|Open-Label Phase|Withdrawal by Subject|11
5873925|NCT01934218|20320560|P1|Open-Label Phase|Withdrawal by Subject|13
5873926|NCT01934218|20320559|P2|Open-Label Phase|Protocol Violation|0
5873927|NCT01934218|20320560|P1|Open-Label Phase|Protocol Violation|1
5873928|NCT01934218|20320559|P2|Open-Label Phase|Physician Decision|0
5873929|NCT01934218|20320560|P1|Open-Label Phase|Physician Decision|1
5873930|NCT01934218|20320559|P2|Open-Label Phase|Lost to Follow-up|2
5873931|NCT01934218|20320560|P1|Open-Label Phase|Lost to Follow-up|4
5873932|NCT01934218|20320559|P2|Open-Label Phase|Lack of Efficacy|4
5873933|NCT01934218|20320560|P1|Open-Label Phase|Lack of Efficacy|1
5873934|NCT01934218|20320559|P2|Open-Label Phase|Adverse Event|4
5873935|NCT01934218|20320560|P1|Open-Label Phase|Adverse Event|2
5873936|NCT01934218|20320559|P2|Double-blind Phase|Protocol Violation of Study Eligibility|2
5873937|NCT01934218|20320560|P1|Double-blind Phase|Protocol Violation of Study Eligibility|1
5873938|NCT01934218|20320559|P2|Double-blind Phase|Noncompliance with Study Protocol|8
5873939|NCT01934218|20320560|P1|Double-blind Phase|Noncompliance with Study Protocol|5
5873940|NCT01934218|20320559|P2|Double-blind Phase|Withdrawal by Subject|13
5873941|NCT01934218|20320560|P1|Double-blind Phase|Withdrawal by Subject|16
5873942|NCT01934218|20320559|P2|Double-blind Phase|Protocol Violation|0
5873943|NCT01934218|20320560|P1|Double-blind Phase|Protocol Violation|4
5873944|NCT01934218|20320559|P2|Double-blind Phase|Physician Decision|2
5873945|NCT01934218|20320560|P1|Double-blind Phase|Physician Decision|1
5873946|NCT01934218|20320559|P2|Double-blind Phase|Lost to Follow-up|14
5873947|NCT01934218|20320560|P1|Double-blind Phase|Lost to Follow-up|7
5873948|NCT01934218|20320559|P2|Double-blind Phase|Lack of Efficacy|7
5873949|NCT01934218|20320560|P1|Double-blind Phase|Lack of Efficacy|6
5873950|NCT01934218|20320559|P2|Double-blind Phase|Adverse Event|8
5873951|NCT01934218|20320560|P1|Double-blind Phase|Adverse Event|8
5873952|NCT01934192|20320571|P4|Overall Study|Physician Decision|0
5873953|NCT01934192|20320572|P3|Overall Study|Physician Decision|0
5873954|NCT01934192|20320573|P2|Overall Study|Physician Decision|2
5873955|NCT01934192|20320574|P1|Overall Study|Physician Decision|3
5873956|NCT01934192|20320571|P4|Overall Study|Other: reached stopping criteria|0
5873957|NCT01934192|20320572|P3|Overall Study|Other: reached stopping criteria|1
5873958|NCT01934192|20320573|P2|Overall Study|Other: reached stopping criteria|5
5873959|NCT01934192|20320574|P1|Overall Study|Other: reached stopping criteria|6
5873960|NCT01934192|20320571|P4|Overall Study|Protocol Violation|1
5873961|NCT01934192|20320572|P3|Overall Study|Protocol Violation|0
5873962|NCT01934192|20320573|P2|Overall Study|Protocol Violation|0
5873963|NCT01934192|20320574|P1|Overall Study|Protocol Violation|0
5873964|NCT01934140|20320710|P2|Booster Phase (6 Months)|Migrated/moved from study area|2
5873965|NCT01934140|20320711|P1|Booster Phase (6 Months)|Migrated/moved from study area|2
5873966|NCT01934140|20320710|P2|Booster Phase (6 Months)|Missed at least 1 booster visit|1
5873967|NCT01934140|20320711|P1|Booster Phase (6 Months)|Missed at least 1 booster visit|2
5873968|NCT01934140|20320710|P2|Booster Phase (6 Months)|Lost to Follow-up|0
5873969|NCT01934140|20320711|P1|Booster Phase (6 Months)|Lost to Follow-up|1
5873970|NCT01934140|20320710|P2|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|7
5873971|NCT01934140|20320711|P1|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|21
5873972|NCT01934140|20320710|P2|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|0
5873973|NCT01934140|20320711|P1|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|2
5873974|NCT01934140|20320710|P2|Persistence Phase (Year 6-10)|Migrated/moved from study area|10
5873975|NCT01934140|20320711|P1|Persistence Phase (Year 6-10)|Migrated/moved from study area|31
5873976|NCT01934140|20320710|P2|Persistence Phase (Year 6-10)|Lost to Follow-up|2
5873977|NCT01934140|20320711|P1|Persistence Phase (Year 6-10)|Lost to Follow-up|5
5873978|NCT01934140|20320710|P2|Persistence Phase (Year 6-10)|Other|6
5873979|NCT01934140|20320711|P1|Persistence Phase (Year 6-10)|Other|24
5873980|NCT01934010|20320762|P3|Overall Study|Lost to Follow-up|0
5873981|NCT01934010|20320763|P2|Overall Study|Lost to Follow-up|4
5873982|NCT01934010|20320764|P1|Overall Study|Lost to Follow-up|7
5873983|NCT01934010|20320762|P3|Overall Study|Withdrawal by Subject|2
5873984|NCT01934010|20320763|P2|Overall Study|Withdrawal by Subject|6
5873985|NCT01934010|20320764|P1|Overall Study|Withdrawal by Subject|15
5873986|NCT01934010|20320762|P3|Overall Study|Adverse Event|0
5873987|NCT01934010|20320763|P2|Overall Study|Adverse Event|1
5873988|NCT01934010|20320764|P1|Overall Study|Adverse Event|1
5873989|NCT01933932|20320806|P2|Overall Study|Eligibility criteria not fulfilled|1
5873990|NCT01933932|20320807|P1|Overall Study|Eligibility criteria not fulfilled|0
5873991|NCT01933932|20320806|P2|Overall Study|Withdrawal by Subject|14
5873992|NCT01933932|20320807|P1|Overall Study|Withdrawal by Subject|11
5873993|NCT01933932|20320806|P2|Overall Study|Death|163
5873994|NCT01933932|20320807|P1|Overall Study|Death|173
5873995|NCT01933919|20320825|P2|Open-label Long-term Phase|Other|2
5873996|NCT01933919|20320826|P1|Open-label Long-term Phase|Other|1
5873997|NCT01933919|20320825|P2|Open-label Long-term Phase|Lost to Follow-up|0
5873998|NCT01933919|20320826|P1|Open-label Long-term Phase|Lost to Follow-up|1
5873999|NCT01933919|20320825|P2|Open-label Long-term Phase|Withdrawal by Subject|4
5874000|NCT01933919|20320826|P1|Open-label Long-term Phase|Withdrawal by Subject|3
5874001|NCT01933919|20320825|P2|Open-label Long-term Phase|Adverse Event|0
5874002|NCT01933919|20320826|P1|Open-label Long-term Phase|Adverse Event|2
5874003|NCT01933919|20320825|P2|Double-blind Placebo-controlled Phase|Lack of Efficacy|2
5874004|NCT01933919|20320826|P1|Double-blind Placebo-controlled Phase|Lack of Efficacy|0
5874005|NCT01933919|20320825|P2|Double-blind Placebo-controlled Phase|Withdrawal by Subject|1
5874006|NCT01933919|20320826|P1|Double-blind Placebo-controlled Phase|Withdrawal by Subject|0
5874007|NCT01933919|20320825|P2|Double-blind Placebo-controlled Phase|Adverse Event|1
5874008|NCT01933919|20320826|P1|Double-blind Placebo-controlled Phase|Adverse Event|0
5874009|NCT01933880|20320862|P2|Overall Study|Protocol Violation|0
5874010|NCT01933880|20320863|P1|Overall Study|Protocol Violation|1
5874011|NCT01933880|20320862|P2|Overall Study|Other|0
5874012|NCT01933880|20320863|P1|Overall Study|Other|4
5874013|NCT01933880|20320862|P2|Overall Study|Followup exceeded 4 days to visit window|0
5874014|NCT01933880|20320863|P1|Overall Study|Followup exceeded 4 days to visit window|19
5874015|NCT01933880|20320862|P2|Overall Study|Concomitant medication Interference|1
5874016|NCT01933880|20320863|P1|Overall Study|Concomitant medication Interference|0
5874017|NCT01933880|20320862|P2|Overall Study|Lack of Efficacy|0
5874018|NCT01933880|20320863|P1|Overall Study|Lack of Efficacy|1
5874019|NCT01933880|20320862|P2|Overall Study|Withdrawal by Subject|0
5874020|NCT01933880|20320863|P1|Overall Study|Withdrawal by Subject|5
5874021|NCT01933789|20320937|P9|Overall Study|Became Ineligible|0
5874022|NCT01933789|20320938|P8|Overall Study|Became Ineligible|6
5874023|NCT01933789|20320939|P7|Overall Study|Became Ineligible|13
5874024|NCT01933789|20320940|P6|Overall Study|Became Ineligible|10
5874025|NCT01933789|20320941|P5|Overall Study|Became Ineligible|13
5874026|NCT01933789|20320942|P4|Overall Study|Became Ineligible|0
5874027|NCT01933789|20320943|P3|Overall Study|Became Ineligible|0
5874028|NCT01933789|20320944|P2|Overall Study|Became Ineligible|0
5874029|NCT01933789|20320945|P1|Overall Study|Became Ineligible|4
5874030|NCT01933789|20320937|P9|Overall Study|Withdrawal by Subject|0
5874031|NCT01933789|20320938|P8|Overall Study|Withdrawal by Subject|4
5874032|NCT01933789|20320939|P7|Overall Study|Withdrawal by Subject|1
5874033|NCT01933789|20320940|P6|Overall Study|Withdrawal by Subject|16
5874034|NCT01933789|20320941|P5|Overall Study|Withdrawal by Subject|17
5874035|NCT01933789|20320942|P4|Overall Study|Withdrawal by Subject|0
5874036|NCT01933789|20320943|P3|Overall Study|Withdrawal by Subject|0
5874037|NCT01933789|20320944|P2|Overall Study|Withdrawal by Subject|1
5874038|NCT01933789|20320945|P1|Overall Study|Withdrawal by Subject|2
5874039|NCT01933789|20320937|P9|Overall Study|Lost to Follow-up|0
5874040|NCT01933789|20320938|P8|Overall Study|Lost to Follow-up|4
5874041|NCT01933789|20320939|P7|Overall Study|Lost to Follow-up|1
5874042|NCT01933789|20320940|P6|Overall Study|Lost to Follow-up|9
5874043|NCT01933789|20320941|P5|Overall Study|Lost to Follow-up|8
5874044|NCT01933789|20320942|P4|Overall Study|Lost to Follow-up|1
5874045|NCT01933789|20320943|P3|Overall Study|Lost to Follow-up|0
5874046|NCT01933789|20320944|P2|Overall Study|Lost to Follow-up|0
5874047|NCT01933789|20320945|P1|Overall Study|Lost to Follow-up|0
5874048|NCT01933789|20320937|P9|Overall Study|Death|0
5874049|NCT01933789|20320938|P8|Overall Study|Death|0
5874050|NCT01933789|20320939|P7|Overall Study|Death|0
5874051|NCT01933789|20320940|P6|Overall Study|Death|32
5874052|NCT01933789|20320941|P5|Overall Study|Death|21
5874053|NCT01933789|20320942|P4|Overall Study|Death|0
5874054|NCT01933789|20320943|P3|Overall Study|Death|0
5874055|NCT01933789|20320944|P2|Overall Study|Death|0
5874056|NCT01933789|20320945|P1|Overall Study|Death|0
5874057|NCT01933672|20321255|P7|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
5874058|NCT01933672|20321256|P6|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
5874059|NCT01933672|20321257|P5|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
5874060|NCT01933672|20321258|P4|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
5874061|NCT01933672|20321259|P3|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
5874062|NCT01933672|20321260|P2|Third Intervention Period (12-16 Days)|Withdrawal by Subject|1
5874063|NCT01933672|20321261|P1|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
5874064|NCT01933672|20321255|P7|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
5874065|NCT01933672|20321256|P6|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
5874066|NCT01933672|20321257|P5|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
5874067|NCT01933672|20321258|P4|Third Intervention Period (12-16 Days)|Lost to Follow-up|1
5874068|NCT01933672|20321259|P3|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
5874069|NCT01933672|20321260|P2|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
5874070|NCT01933672|20321261|P1|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
5874071|NCT01933672|20321255|P7|Second Intervention Period (12-16 Days)|Other|0
5874072|NCT01933672|20321256|P6|Second Intervention Period (12-16 Days)|Other|0
5874073|NCT01933672|20321257|P5|Second Intervention Period (12-16 Days)|Other|0
5874074|NCT01933672|20321258|P4|Second Intervention Period (12-16 Days)|Other|0
5874075|NCT01933672|20321259|P3|Second Intervention Period (12-16 Days)|Other|1
5874076|NCT01933672|20321260|P2|Second Intervention Period (12-16 Days)|Other|1
5874077|NCT01933672|20321261|P1|Second Intervention Period (12-16 Days)|Other|0
5874078|NCT01933672|20321255|P7|First Intervention Period (12-16 Days)|Other|0
5874079|NCT01933672|20321256|P6|First Intervention Period (12-16 Days)|Other|1
5874080|NCT01933672|20321257|P5|First Intervention Period (12-16 Days)|Other|0
5874081|NCT01933672|20321258|P4|First Intervention Period (12-16 Days)|Other|0
5874082|NCT01933672|20321259|P3|First Intervention Period (12-16 Days)|Other|1
5874083|NCT01933672|20321260|P2|First Intervention Period (12-16 Days)|Other|0
5874084|NCT01933672|20321261|P1|First Intervention Period (12-16 Days)|Other|0
5874085|NCT01933672|20321255|P7|First Intervention Period (12-16 Days)|Lost to Follow-up|0
5874086|NCT01933672|20321256|P6|First Intervention Period (12-16 Days)|Lost to Follow-up|0
5874087|NCT01933672|20321257|P5|First Intervention Period (12-16 Days)|Lost to Follow-up|1
5874088|NCT01933672|20321258|P4|First Intervention Period (12-16 Days)|Lost to Follow-up|0
5874089|NCT01933672|20321259|P3|First Intervention Period (12-16 Days)|Lost to Follow-up|0
5874090|NCT01933672|20321260|P2|First Intervention Period (12-16 Days)|Lost to Follow-up|0
5874091|NCT01933672|20321261|P1|First Intervention Period (12-16 Days)|Lost to Follow-up|0
5874092|NCT01933672|20321255|P7|Metformin Run-in Period|Other|0
5874093|NCT01933672|20321256|P6|Metformin Run-in Period|Other|0
5874094|NCT01933672|20321257|P5|Metformin Run-in Period|Other|0
5874095|NCT01933672|20321258|P4|Metformin Run-in Period|Other|0
5874096|NCT01933672|20321259|P3|Metformin Run-in Period|Other|0
5874097|NCT01933672|20321260|P2|Metformin Run-in Period|Other|0
5874098|NCT01933672|20321261|P1|Metformin Run-in Period|Other|5
5874099|NCT01933672|20321255|P7|Metformin Run-in Period|No longer meets eligibility criteria|0
5874100|NCT01933672|20321256|P6|Metformin Run-in Period|No longer meets eligibility criteria|0
5874101|NCT01933672|20321257|P5|Metformin Run-in Period|No longer meets eligibility criteria|0
5874102|NCT01933672|20321258|P4|Metformin Run-in Period|No longer meets eligibility criteria|0
5874103|NCT01933672|20321259|P3|Metformin Run-in Period|No longer meets eligibility criteria|0
5874104|NCT01933672|20321260|P2|Metformin Run-in Period|No longer meets eligibility criteria|0
5874105|NCT01933672|20321261|P1|Metformin Run-in Period|No longer meets eligibility criteria|4
5874106|NCT01933672|20321255|P7|Metformin Run-in Period|Adverse Event|0
5874107|NCT01933672|20321256|P6|Metformin Run-in Period|Adverse Event|0
5874108|NCT01933672|20321257|P5|Metformin Run-in Period|Adverse Event|0
5874109|NCT01933672|20321258|P4|Metformin Run-in Period|Adverse Event|0
5874110|NCT01933672|20321259|P3|Metformin Run-in Period|Adverse Event|0
5874111|NCT01933672|20321260|P2|Metformin Run-in Period|Adverse Event|0
5874112|NCT01933672|20321261|P1|Metformin Run-in Period|Adverse Event|1
5874113|NCT01933594|20321313|P6|Overall Study|Ineligible for subsequent study step|0
5874114|NCT01933594|20321314|P5|Overall Study|Ineligible for subsequent study step|1
5874115|NCT01933594|20321315|P4|Overall Study|Ineligible for subsequent study step|0
5874116|NCT01933594|20321316|P3|Overall Study|Ineligible for subsequent study step|0
5874117|NCT01933594|20321317|P2|Overall Study|Ineligible for subsequent study step|0
5874118|NCT01933594|20321318|P1|Overall Study|Ineligible for subsequent study step|0
5874119|NCT01933594|20321313|P6|Overall Study|Lost to Follow-up|0
5874120|NCT01933594|20321314|P5|Overall Study|Lost to Follow-up|1
5874121|NCT01933594|20321315|P4|Overall Study|Lost to Follow-up|0
5874122|NCT01933594|20321316|P3|Overall Study|Lost to Follow-up|0
5874123|NCT01933594|20321317|P2|Overall Study|Lost to Follow-up|0
5874124|NCT01933594|20321318|P1|Overall Study|Lost to Follow-up|1
5874125|NCT01933334|20321452|P2|Overall Study|Withdrawal by Subject|1
5874126|NCT01933334|20321453|P1|Overall Study|Withdrawal by Subject|0
5874127|NCT01933334|20321452|P2|Overall Study|Adverse Event|1
5874128|NCT01933334|20321453|P1|Overall Study|Adverse Event|5
5874129|NCT01933217|20321482|P2|Randomization (4 Weeks)|Lost to Follow-up|1
5874130|NCT01933217|20321483|P1|Randomization (4 Weeks)|Lost to Follow-up|1
5874131|NCT01933217|20321482|P2|Randomization (4 Weeks)|Withdrawal by Subject|3
5874132|NCT01933217|20321483|P1|Randomization (4 Weeks)|Withdrawal by Subject|1
5874133|NCT01933113|20321495|P1|Overall Study|Fractured nonfunctioning lead.|1
5874134|NCT01933048|20321501|P2|Overall Study|unknown reasons|1
5874135|NCT01933048|20321502|P1|Overall Study|unknown reasons|1
5874136|NCT01933048|20321501|P2|Overall Study|Physician Decision|0
5874137|NCT01933048|20321502|P1|Overall Study|Physician Decision|1
5874138|NCT01933048|20321501|P2|Overall Study|Protocol Violation|8
5874139|NCT01933048|20321502|P1|Overall Study|Protocol Violation|7
5874140|NCT01933048|20321501|P2|Overall Study|personal reasons|1
5874141|NCT01933048|20321502|P1|Overall Study|personal reasons|1
5874142|NCT01933048|20321501|P2|Overall Study|Lost to Follow-up|18
5874143|NCT01933048|20321502|P1|Overall Study|Lost to Follow-up|15
5874144|NCT01932996|20321517|P2|Overall Study|Protocol Violation|0
5874145|NCT01932996|20321518|P1|Overall Study|Protocol Violation|2
5874146|NCT01932970|20321528|P1|Overall Study|Protocol Specified Criteria|10
5874147|NCT01932970|20321528|P1|Overall Study|Lost to Follow-up|2
5874148|NCT01932970|20321528|P1|Overall Study|Death|1
5874149|NCT01932970|20321528|P1|Overall Study|Withdrawal by Subject|5
5874150|NCT01932788|20321538|P2|Overall Study|Withdrawal by Subject|5
5874151|NCT01932788|20321539|P1|Overall Study|Withdrawal by Subject|0
5874152|NCT01932788|20321538|P2|Overall Study|Lack of Efficacy|0
5874153|NCT01932788|20321539|P1|Overall Study|Lack of Efficacy|2
5874154|NCT01932788|20321538|P2|Overall Study|Lost to Follow-up|46
5874155|NCT01932788|20321539|P1|Overall Study|Lost to Follow-up|18
5874156|NCT01932788|20321538|P2|Overall Study|Protocol Violation|0
5874157|NCT01932788|20321539|P1|Overall Study|Protocol Violation|18
5874170|NCT01932697|20321588|P2|Overall Study|Ineligible|0
5874171|NCT01932697|20321589|P1|Overall Study|Ineligible|1
5874172|NCT01932697|20321588|P2|Overall Study|Received a different amount of tx|0
5874173|NCT01932697|20321589|P1|Overall Study|Received a different amount of tx|1
5874174|NCT01932437|20321656|P6|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|1
5874175|NCT01932437|20321657|P5|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0
5874176|NCT01932437|20321658|P4|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0
5874177|NCT01932437|20321659|P3|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0
5874178|NCT01932437|20321660|P2|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0
5874179|NCT01932437|20321661|P1|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0
5874180|NCT01932294|20321711|P1|Overall Study|Transferred to other hospitals|12
5874181|NCT01932294|20321711|P1|Overall Study|Heart Transplantation|16
5874182|NCT01932294|20321711|P1|Overall Study|VAD Implantation|20
5874183|NCT01932294|20321711|P1|Overall Study|Lost to Follow-up|8
5874184|NCT01932294|20321711|P1|Overall Study|Death|43
5874185|NCT01931956|20321788|P4|Overall Study|Not due|0
5874186|NCT01931956|20321789|P3|Overall Study|Not due|21
5874187|NCT01931956|20321790|P2|Overall Study|Not due|0
5874188|NCT01931956|20321791|P1|Overall Study|Not due|0
5874189|NCT01931956|20321788|P4|Overall Study|Expected|0
5874190|NCT01931956|20321789|P3|Overall Study|Expected|6
5874191|NCT01931956|20321790|P2|Overall Study|Expected|0
5874192|NCT01931956|20321791|P1|Overall Study|Expected|2
5874193|NCT01931956|20321788|P4|Overall Study|Lost to Follow-up|7
5874194|NCT01931956|20321789|P3|Overall Study|Lost to Follow-up|11
5874195|NCT01931956|20321790|P2|Overall Study|Lost to Follow-up|0
5874196|NCT01931956|20321791|P1|Overall Study|Lost to Follow-up|2
5874197|NCT01931956|20321788|P4|Overall Study|Withdrawal by Subject|30
5874198|NCT01931956|20321789|P3|Overall Study|Withdrawal by Subject|70
5874199|NCT01931956|20321790|P2|Overall Study|Withdrawal by Subject|0
5874200|NCT01931956|20321791|P1|Overall Study|Withdrawal by Subject|5
5874201|NCT01931956|20321788|P4|Overall Study|Death|96
5874202|NCT01931956|20321789|P3|Overall Study|Death|379
5874203|NCT01931956|20321790|P2|Overall Study|Death|7
5874204|NCT01931956|20321791|P1|Overall Study|Death|42
5874205|NCT01931865|20322158|P1|Overall Study|Withdrawal by Subject|2
5874206|NCT01931865|20322158|P1|Overall Study|Lost to Follow-up|2
5874207|NCT01931839|20322171|P7|Overall Study|Other|0
5874208|NCT01931839|20322172|P6|Overall Study|Other|0
5874209|NCT01931839|20322173|P5|Overall Study|Other|0
5874210|NCT01931839|20322174|P4|Overall Study|Other|0
5874211|NCT01931839|20322175|P3|Overall Study|Other|6
5874212|NCT01931839|20322176|P2|Overall Study|Other|2
5874213|NCT01931839|20322177|P1|Overall Study|Other|4
5874214|NCT01931839|20322171|P7|Overall Study|Lost to Follow-up|0
5874215|NCT01931839|20322172|P6|Overall Study|Lost to Follow-up|0
5874216|NCT01931839|20322173|P5|Overall Study|Lost to Follow-up|0
5874217|NCT01931839|20322174|P4|Overall Study|Lost to Follow-up|5
5874218|NCT01931839|20322175|P3|Overall Study|Lost to Follow-up|4
5874219|NCT01931839|20322176|P2|Overall Study|Lost to Follow-up|2
5874220|NCT01931839|20322177|P1|Overall Study|Lost to Follow-up|1
5874221|NCT01931839|20322171|P7|Overall Study|Other non-compliance|0
5874222|NCT01931839|20322172|P6|Overall Study|Other non-compliance|3
5874223|NCT01931839|20322173|P5|Overall Study|Other non-compliance|0
5874224|NCT01931839|20322174|P4|Overall Study|Other non-compliance|3
5874225|NCT01931839|20322175|P3|Overall Study|Other non-compliance|12
5874226|NCT01931839|20322176|P2|Overall Study|Other non-compliance|9
5874227|NCT01931839|20322177|P1|Overall Study|Other non-compliance|15
5874228|NCT01931839|20322171|P7|Overall Study|Withdrawal of consent (not due to AE)|2
5874229|NCT01931839|20322172|P6|Overall Study|Withdrawal of consent (not due to AE)|2
5874230|NCT01931839|20322173|P5|Overall Study|Withdrawal of consent (not due to AE)|0
5874231|NCT01931839|20322174|P4|Overall Study|Withdrawal of consent (not due to AE)|3
5874232|NCT01931839|20322175|P3|Overall Study|Withdrawal of consent (not due to AE)|13
5874233|NCT01931839|20322176|P2|Overall Study|Withdrawal of consent (not due to AE)|8
5874234|NCT01931839|20322177|P1|Overall Study|Withdrawal of consent (not due to AE)|11
5874235|NCT01931839|20322171|P7|Overall Study|Adverse Event|1
5874236|NCT01931839|20322172|P6|Overall Study|Adverse Event|0
5874237|NCT01931839|20322173|P5|Overall Study|Adverse Event|0
5874238|NCT01931839|20322174|P4|Overall Study|Adverse Event|3
5874239|NCT01931839|20322175|P3|Overall Study|Adverse Event|1
5874240|NCT01931839|20322176|P2|Overall Study|Adverse Event|4
5874241|NCT01931839|20322177|P1|Overall Study|Adverse Event|9
5874242|NCT01931839|20322171|P7|Overall Study|Withdrawal of consent|0
5874243|NCT01931839|20322172|P6|Overall Study|Withdrawal of consent|0
5874244|NCT01931839|20322173|P5|Overall Study|Withdrawal of consent|1
5874245|NCT01931839|20322174|P4|Overall Study|Withdrawal of consent|0
5874246|NCT01931839|20322175|P3|Overall Study|Withdrawal of consent|0
5874247|NCT01931839|20322176|P2|Overall Study|Withdrawal of consent|0
5874248|NCT01931839|20322177|P1|Overall Study|Withdrawal of consent|0
5874249|NCT01931839|20322171|P7|Overall Study|Physician Decision|1
5874250|NCT01931839|20322172|P6|Overall Study|Physician Decision|0
5874251|NCT01931839|20322173|P5|Overall Study|Physician Decision|0
5874252|NCT01931839|20322174|P4|Overall Study|Physician Decision|0
5874253|NCT01931839|20322175|P3|Overall Study|Physician Decision|1
5874254|NCT01931839|20322176|P2|Overall Study|Physician Decision|0
5874255|NCT01931839|20322177|P1|Overall Study|Physician Decision|1
5874256|NCT01931839|20322171|P7|Overall Study|Death|0
5874257|NCT01931839|20322172|P6|Overall Study|Death|0
5874258|NCT01931839|20322173|P5|Overall Study|Death|0
5874259|NCT01931839|20322174|P4|Overall Study|Death|0
5874260|NCT01931839|20322175|P3|Overall Study|Death|2
5874261|NCT01931839|20322176|P2|Overall Study|Death|1
5874262|NCT01931839|20322177|P1|Overall Study|Death|0
5874263|NCT01931735|20322249|P4|Observational Non-Randomized Phase|Withdrawal by Subject|1
5874264|NCT01931735|20322250|P3|Observational Non-Randomized Phase|Withdrawal by Subject|0
5874265|NCT01931735|20322251|P2|Observational Non-Randomized Phase|Withdrawal by Subject|0
5874266|NCT01931735|20322252|P1|Observational Non-Randomized Phase|Withdrawal by Subject|0
5874267|NCT01931735|20322249|P4|Observational Non-Randomized Phase|Adverse Event|1
5874268|NCT01931735|20322250|P3|Observational Non-Randomized Phase|Adverse Event|0
5874269|NCT01931735|20322251|P2|Observational Non-Randomized Phase|Adverse Event|0
5874270|NCT01931735|20322252|P1|Observational Non-Randomized Phase|Adverse Event|0
5874271|NCT01931735|20322249|P4|Randomized Phase|Lost to Follow-up|0
5874272|NCT01931735|20322250|P3|Randomized Phase|Lost to Follow-up|5
5874273|NCT01931735|20322251|P2|Randomized Phase|Lost to Follow-up|2
5874274|NCT01931735|20322252|P1|Randomized Phase|Lost to Follow-up|2
5874275|NCT01931670|20322299|P3|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|2
5874276|NCT01931670|20322300|P2|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0
5874277|NCT01931670|20322301|P1|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0
5874278|NCT01931670|20322299|P3|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|13
5874279|NCT01931670|20322300|P2|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|3
5874280|NCT01931670|20322301|P1|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|6
5874281|NCT01931670|20322299|P3|Post-Treatment Follow-Up (PTFU) Period|Other|3
5874282|NCT01931670|20322300|P2|Post-Treatment Follow-Up (PTFU) Period|Other|3
5874283|NCT01931670|20322301|P1|Post-Treatment Follow-Up (PTFU) Period|Other|6
5874284|NCT01931670|20322299|P3|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|2
5874285|NCT01931670|20322300|P2|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4
5874286|NCT01931670|20322301|P1|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4
5874287|NCT01931670|20322299|P3|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|1
5874288|NCT01931670|20322300|P2|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|2
5874289|NCT01931670|20322301|P1|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|0
5874290|NCT01931670|20322299|P3|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0
5874291|NCT01931670|20322300|P2|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0
5874292|NCT01931670|20322301|P1|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|3
5874293|NCT01931670|20322299|P3|Treatment Period|Lost to Follow-up|7
5874294|NCT01931670|20322300|P2|Treatment Period|Lost to Follow-up|5
5874295|NCT01931670|20322301|P1|Treatment Period|Lost to Follow-up|19
5874296|NCT01931670|20322299|P3|Treatment Period|Consent Withdrawn by Subject|7
5874297|NCT01931670|20322300|P2|Treatment Period|Consent Withdrawn by Subject|12
5874298|NCT01931670|20322301|P1|Treatment Period|Consent Withdrawn by Subject|17
5874299|NCT01931670|20322299|P3|Treatment Period|Other|2
5874300|NCT01931670|20322300|P2|Treatment Period|Other|7
5874301|NCT01931670|20322301|P1|Treatment Period|Other|8
5874302|NCT01931670|20322299|P3|Treatment Period|Pregnancy|0
5874303|NCT01931670|20322300|P2|Treatment Period|Pregnancy|2
5874304|NCT01931670|20322301|P1|Treatment Period|Pregnancy|7
5874305|NCT01931670|20322299|P3|Treatment Period|Lack of Efficacy|2
5874306|NCT01931670|20322300|P2|Treatment Period|Lack of Efficacy|2
5874307|NCT01931670|20322301|P1|Treatment Period|Lack of Efficacy|11
5874308|NCT01931670|20322299|P3|Treatment Period|Adverse Event|21
5874309|NCT01931670|20322300|P2|Treatment Period|Adverse Event|8
5874310|NCT01931670|20322301|P1|Treatment Period|Adverse Event|19
5874311|NCT01931670|20322299|P3|Treatment Period|Subject Noncompliant|5
5874312|NCT01931670|20322300|P2|Treatment Period|Subject Noncompliant|9
5874313|NCT01931670|20322301|P1|Treatment Period|Subject Noncompliant|4
5874314|NCT01931670|20322299|P3|Treatment Period|Surgery/Invasive Intervention|0
5874315|NCT01931670|20322300|P2|Treatment Period|Surgery/Invasive Intervention|2
5874316|NCT01931670|20322301|P1|Treatment Period|Surgery/Invasive Intervention|4
5874317|NCT01931670|20322299|P3|Treatment Period|Exclusionary Medication Received|1
5874318|NCT01931670|20322300|P2|Treatment Period|Exclusionary Medication Received|1
5874319|NCT01931670|20322301|P1|Treatment Period|Exclusionary Medication Received|1
5874320|NCT01931566|20322402|P3|Overall Study|Missing|1
5874321|NCT01931566|20322403|P2|Overall Study|Missing|0
5874322|NCT01931566|20322404|P1|Overall Study|Missing|0
5874323|NCT01931566|20322402|P3|Overall Study|Reason Not Specified|53
5874324|NCT01931566|20322403|P2|Overall Study|Reason Not Specified|47
5874325|NCT01931566|20322404|P1|Overall Study|Reason Not Specified|11
5874326|NCT01931566|20322402|P3|Overall Study|Study Termination|1037
5874327|NCT01931566|20322403|P2|Overall Study|Study Termination|968
5874328|NCT01931566|20322404|P1|Overall Study|Study Termination|289
5874329|NCT01931566|20322402|P3|Overall Study|Voluntary Withdrawal|225
5874330|NCT01931566|20322403|P2|Overall Study|Voluntary Withdrawal|245
5874331|NCT01931566|20322404|P1|Overall Study|Voluntary Withdrawal|78
5874332|NCT01931566|20322402|P3|Overall Study|Lost to Follow-up|23
5874333|NCT01931566|20322403|P2|Overall Study|Lost to Follow-up|26
5874334|NCT01931566|20322404|P1|Overall Study|Lost to Follow-up|3
5874335|NCT01931566|20322402|P3|Overall Study|Major Protocol Deviation|21
5874336|NCT01931566|20322403|P2|Overall Study|Major Protocol Deviation|14
5874337|NCT01931566|20322404|P1|Overall Study|Major Protocol Deviation|5
5874338|NCT01931566|20322402|P3|Overall Study|Adverse Event|132
5874339|NCT01931566|20322403|P2|Overall Study|Adverse Event|167
5874340|NCT01931566|20322404|P1|Overall Study|Adverse Event|37
5874341|NCT01931566|20322402|P3|Overall Study|Randomized But Not Treated|14
5874342|NCT01931566|20322403|P2|Overall Study|Randomized But Not Treated|9
5874343|NCT01931566|20322404|P1|Overall Study|Randomized But Not Treated|6
5874344|NCT01931475|20322442|P2|Period 2: Extension Treatment Phase|Lack of Efficacy|1
5874345|NCT01931475|20322443|P1|Period 2: Extension Treatment Phase|Lack of Efficacy|1
5874346|NCT01931475|20322442|P2|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|0
5874347|NCT01931475|20322443|P1|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|1
5874348|NCT01931475|20322442|P2|Period 2: Extension Treatment Phase|Physician Decision|1
5874349|NCT01931475|20322443|P1|Period 2: Extension Treatment Phase|Physician Decision|1
5874350|NCT01931475|20322442|P2|Period 2: Extension Treatment Phase|Withdrawal by Subject|9
5874351|NCT01931475|20322443|P1|Period 2: Extension Treatment Phase|Withdrawal by Subject|0
5874352|NCT01931475|20322442|P2|Period 2: Extension Treatment Phase|Protocol Violation|0
5874353|NCT01931475|20322443|P1|Period 2: Extension Treatment Phase|Protocol Violation|1
5874354|NCT01931475|20322442|P2|Period 2: Extension Treatment Phase|Adverse Event|8
5874355|NCT01931475|20322443|P1|Period 2: Extension Treatment Phase|Adverse Event|0
5874356|NCT01931475|20322442|P2|Period 1: Double-Blind Treatment Phase|Physician Decision|1
5874357|NCT01931475|20322443|P1|Period 1: Double-Blind Treatment Phase|Physician Decision|0
5874358|NCT01931475|20322442|P2|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|3
5874359|NCT01931475|20322443|P1|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|2
5874360|NCT01931475|20322442|P2|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|12
5874361|NCT01931475|20322443|P1|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|16
5874362|NCT01931475|20322442|P2|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|0
5874363|NCT01931475|20322443|P1|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|1
5874364|NCT01931475|20322442|P2|Period 1: Double-Blind Treatment Phase|Adverse Event|10
5874365|NCT01931475|20322443|P1|Period 1: Double-Blind Treatment Phase|Adverse Event|20
5874366|NCT01931462|20322470|P1|Overall Study|Withdrawal by Subject|1
5874367|NCT01931397|20322481|P1|Overall Study|moved out of state|1
5874368|NCT01931397|20322481|P1|Overall Study|Withdrawal by Subject|8
5874369|NCT01931397|20322481|P1|Overall Study|Physician Decision|2
5874370|NCT01931202|20322493|P3|Overall Study|Lost to Follow-up|2
5874371|NCT01931202|20322494|P2|Overall Study|Lost to Follow-up|5
5874372|NCT01931202|20322495|P1|Overall Study|Lost to Follow-up|0
5874373|NCT01931202|20322493|P3|Overall Study|Withdrawal by Subject|2
5874374|NCT01931202|20322494|P2|Overall Study|Withdrawal by Subject|0
5874375|NCT01931202|20322495|P1|Overall Study|Withdrawal by Subject|0
5874376|NCT01931150|20322541|P2|Overall Study|Withdrawal by Subject|2
5874377|NCT01931150|20322542|P1|Overall Study|Withdrawal by Subject|1
5874378|NCT01931098|20322550|P2|Overall Study|Refused further treatment|1
5874379|NCT01931098|20322551|P1|Overall Study|Refused further treatment|0
5874380|NCT01931098|20322550|P2|Overall Study|Unable to begin trmt:active infection|1
5874381|NCT01931098|20322551|P1|Overall Study|Unable to begin trmt:active infection|0
5874382|NCT01931098|20322550|P2|Overall Study|Enrolled in different protocol|1
5874383|NCT01931098|20322551|P1|Overall Study|Enrolled in different protocol|0
5874384|NCT01931098|20322550|P2|Overall Study|Withdrawal by Subject|1
5874385|NCT01931098|20322551|P1|Overall Study|Withdrawal by Subject|0
5874386|NCT01931059|20322567|P2|Day3|Lost to Follow-up|0
5874387|NCT01931059|20322568|P1|Day3|Lost to Follow-up|1
5874388|NCT01931059|20322567|P2|Day 1|Pregnancy|1
5874389|NCT01931059|20322568|P1|Day 1|Pregnancy|0
5874390|NCT01930890|20322584|P4|Overall Study|Adverse Event|0
5874391|NCT01930890|20322585|P3|Overall Study|Adverse Event|0
5874392|NCT01930890|20322586|P2|Overall Study|Adverse Event|1
5874393|NCT01930890|20322587|P1|Overall Study|Adverse Event|0
5874394|NCT01930890|20322584|P4|Overall Study|Consent Withdrawn|1
5874395|NCT01930890|20322585|P3|Overall Study|Consent Withdrawn|0
5874396|NCT01930890|20322586|P2|Overall Study|Consent Withdrawn|3
5874397|NCT01930890|20322587|P1|Overall Study|Consent Withdrawn|0
5874398|NCT01930890|20322584|P4|Overall Study|Investigator Decision|0
5874399|NCT01930890|20322585|P3|Overall Study|Investigator Decision|0
5874400|NCT01930890|20322586|P2|Overall Study|Investigator Decision|1
5874401|NCT01930890|20322587|P1|Overall Study|Investigator Decision|0
5874402|NCT01930890|20322584|P4|Overall Study|Death|1
5874403|NCT01930890|20322585|P3|Overall Study|Death|0
5874404|NCT01930890|20322586|P2|Overall Study|Death|0
5874405|NCT01930890|20322587|P1|Overall Study|Death|0
5874406|NCT01930890|20322584|P4|Overall Study|Study Termination|25
5874407|NCT01930890|20322585|P3|Overall Study|Study Termination|13
5874408|NCT01930890|20322586|P2|Overall Study|Study Termination|28
5874409|NCT01930890|20322587|P1|Overall Study|Study Termination|14
5874410|NCT01930799|20322601|P1|Overall Study|Lost to Follow-up|5
5874411|NCT01930799|20322601|P1|Overall Study|Withdrawal by Subject|3
5874412|NCT01930214|20322740|P3|Overall Study|Physician Decision|0
5874413|NCT01930214|20322741|P2|Overall Study|Physician Decision|0
5874414|NCT01930214|20322742|P1|Overall Study|Physician Decision|2
5874415|NCT01930214|20322740|P3|Overall Study|Voluntary withdrawal of infomed consent|2
5874416|NCT01930214|20322741|P2|Overall Study|Voluntary withdrawal of infomed consent|4
5874417|NCT01930214|20322742|P1|Overall Study|Voluntary withdrawal of infomed consent|2
5874418|NCT01930214|20322740|P3|Overall Study|Lost to Follow-up|12
5874419|NCT01930214|20322741|P2|Overall Study|Lost to Follow-up|13
5874420|NCT01930214|20322742|P1|Overall Study|Lost to Follow-up|12
5874421|NCT01930214|20322740|P3|Overall Study|Death|11
5874422|NCT01930214|20322741|P2|Overall Study|Death|4
5874423|NCT01930214|20322742|P1|Overall Study|Death|4
5874424|NCT01930188|20322762|P3|Overall Study|Withdrawal by Subject|8
5874425|NCT01930188|20322763|P2|Overall Study|Withdrawal by Subject|11
5874426|NCT01930188|20322764|P1|Overall Study|Withdrawal by Subject|9
5874427|NCT01930188|20322762|P3|Overall Study|Death|3
5874428|NCT01930188|20322763|P2|Overall Study|Death|1
5874429|NCT01930188|20322764|P1|Overall Study|Death|2
5874430|NCT01930188|20322762|P3|Overall Study|Lost to Follow-up|2
5874431|NCT01930188|20322763|P2|Overall Study|Lost to Follow-up|2
5874432|NCT01930188|20322764|P1|Overall Study|Lost to Follow-up|5
5874433|NCT01930188|20322762|P3|Overall Study|Missing follow-up information|3
5874434|NCT01930188|20322763|P2|Overall Study|Missing follow-up information|2
5874435|NCT01930188|20322764|P1|Overall Study|Missing follow-up information|2
5874436|NCT01930188|20322762|P3|Overall Study|unclassified|3
5874437|NCT01930188|20322763|P2|Overall Study|unclassified|5
5874438|NCT01930188|20322764|P1|Overall Study|unclassified|4
5874439|NCT01930175|20322791|P3|Core Study|Adverse Event|1
5874440|NCT01930175|20322792|P2|Core Study|Adverse Event|0
5874441|NCT01930175|20322793|P1|Core Study|Adverse Event|0
5874442|NCT01930175|20322791|P3|Core Study|Lost to Follow-up|0
5874443|NCT01930175|20322792|P2|Core Study|Lost to Follow-up|1
5874444|NCT01930175|20322793|P1|Core Study|Lost to Follow-up|0
5874445|NCT01930162|20322823|P1|Overall Study|Death|1
5874446|NCT01930162|20322823|P1|Overall Study|Abnormal test procedure result(s)|4
5874447|NCT01930045|20322859|P6|Pause (up to 37 Days)|Protocol Violation|1
5874448|NCT01930045|20322860|P5|Pause (up to 37 Days)|Protocol Violation|0
5874449|NCT01930045|20322861|P4|Pause (up to 37 Days)|Protocol Violation|0
5874450|NCT01930045|20322862|P3|Pause (up to 37 Days)|Protocol Violation|0
5874451|NCT01930045|20322863|P2|Pause (up to 37 Days)|Protocol Violation|0
5874452|NCT01930045|20322864|P1|Pause (up to 37 Days)|Protocol Violation|0
5874453|NCT01930045|20322859|P6|Pause (up to 37 Days)|Withdrawal by Subject|1
5874454|NCT01930045|20322860|P5|Pause (up to 37 Days)|Withdrawal by Subject|0
5874455|NCT01930045|20322861|P4|Pause (up to 37 Days)|Withdrawal by Subject|0
5874456|NCT01930045|20322862|P3|Pause (up to 37 Days)|Withdrawal by Subject|0
5874457|NCT01930045|20322863|P2|Pause (up to 37 Days)|Withdrawal by Subject|0
5874458|NCT01930045|20322864|P1|Pause (up to 37 Days)|Withdrawal by Subject|0
5874459|NCT01929993|20322891|P2|Overall Study|Absent CIN, invasion present or artifact|22
5874460|NCT01929993|20322892|P1|Overall Study|Absent CIN, invasion present or artifact|26
5874461|NCT01929993|20322891|P2|Overall Study|Protocol Violation|6
5874462|NCT01929993|20322892|P1|Overall Study|Protocol Violation|4
5874463|NCT01929980|20322898|P1|Overall Study|Physician Decision|1
5874464|NCT01929876|20322906|P1|Period 2|Non-Compliance|1
5874465|NCT01929863|20322919|P2|Period 3:Intervention Period 2 (7 Days)|Adverse Event|1
5874466|NCT01929863|20322920|P1|Period 3:Intervention Period 2 (7 Days)|Adverse Event|0
5874467|NCT01929863|20322919|P2|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|1
5874468|NCT01929863|20322920|P1|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|0
5874469|NCT01929863|20322919|P2|Period 1:Intervention Period 1 (7 Days)|Adverse Event|0
5874470|NCT01929863|20322920|P1|Period 1:Intervention Period 1 (7 Days)|Adverse Event|1
5874471|NCT01929707|20322975|P8|Intervention Period 2|Withdrawal by Subject|0
5874472|NCT01929707|20322976|P7|Intervention Period 2|Withdrawal by Subject|0
5874473|NCT01929707|20322977|P6|Intervention Period 2|Withdrawal by Subject|2
5874474|NCT01929707|20322978|P5|Intervention Period 2|Withdrawal by Subject|0
5874475|NCT01929707|20322979|P4|Intervention Period 2|Withdrawal by Subject|0
5874476|NCT01929707|20322980|P3|Intervention Period 2|Withdrawal by Subject|0
5874477|NCT01929707|20322981|P2|Intervention Period 2|Withdrawal by Subject|0
5874478|NCT01929707|20322982|P1|Intervention Period 2|Withdrawal by Subject|0
5874479|NCT01929707|20322975|P8|Intervention Period 1|Withdrawal by Subject|0
5874480|NCT01929707|20322976|P7|Intervention Period 1|Withdrawal by Subject|0
5874481|NCT01929707|20322977|P6|Intervention Period 1|Withdrawal by Subject|0
5874482|NCT01929707|20322978|P5|Intervention Period 1|Withdrawal by Subject|0
5874483|NCT01929707|20322979|P4|Intervention Period 1|Withdrawal by Subject|2
5874484|NCT01929707|20322980|P3|Intervention Period 1|Withdrawal by Subject|0
5874485|NCT01929707|20322981|P2|Intervention Period 1|Withdrawal by Subject|0
5874486|NCT01929707|20322982|P1|Intervention Period 1|Withdrawal by Subject|0
5874487|NCT01929707|20322975|P8|Intervention Period 1|Lost to Follow-up|0
5874488|NCT01929707|20322976|P7|Intervention Period 1|Lost to Follow-up|0
5874489|NCT01929707|20322977|P6|Intervention Period 1|Lost to Follow-up|0
5874490|NCT01929707|20322978|P5|Intervention Period 1|Lost to Follow-up|0
5874491|NCT01929707|20322979|P4|Intervention Period 1|Lost to Follow-up|1
5874492|NCT01929707|20322980|P3|Intervention Period 1|Lost to Follow-up|0
5874493|NCT01929707|20322981|P2|Intervention Period 1|Lost to Follow-up|0
5874494|NCT01929707|20322982|P1|Intervention Period 1|Lost to Follow-up|0
5874495|NCT01929681|20323014|P2|Overall Study|Physician Decision|1
5874496|NCT01929681|20323015|P1|Overall Study|Physician Decision|1
5874497|NCT01929681|20323014|P2|Overall Study|Withdrawal by Subject|0
5874498|NCT01929681|20323015|P1|Overall Study|Withdrawal by Subject|1
5874499|NCT01929408|20323058|P1|Overall Study|received HCT as initial treatment|8
5874500|NCT01929395|20323066|P3|Overall Study|Screen Fail|1
5874501|NCT01929395|20323067|P2|Overall Study|Screen Fail|0
5874502|NCT01929395|20323068|P1|Overall Study|Screen Fail|0
5874503|NCT01929395|20323066|P3|Overall Study|Withdrawal by Subject|0
5874504|NCT01929395|20323067|P2|Overall Study|Withdrawal by Subject|1
5874505|NCT01929395|20323068|P1|Overall Study|Withdrawal by Subject|0
5874506|NCT01929395|20323066|P3|Overall Study|Did not complete - non-related toxicity|0
5874507|NCT01929395|20323067|P2|Overall Study|Did not complete - non-related toxicity|0
5874508|NCT01929395|20323068|P1|Overall Study|Did not complete - non-related toxicity|1
5874509|NCT01929343|20323081|P3|Overall Study|Withdrawal by Subject|0
5874510|NCT01929343|20323082|P2|Overall Study|Withdrawal by Subject|0
5874511|NCT01929343|20323083|P1|Overall Study|Withdrawal by Subject|1
5874512|NCT01929343|20323081|P3|Overall Study|Physician Decision|0
5874513|NCT01929343|20323082|P2|Overall Study|Physician Decision|2
5874514|NCT01929343|20323083|P1|Overall Study|Physician Decision|0
5874515|NCT01929317|20323111|P2|Long-term Phase|Study Closed/Terminated|3
5874516|NCT01929317|20323112|P1|Long-term Phase|Study Closed/Terminated|5
5874517|NCT01929317|20323111|P2|Long-term Phase|Protocol-defined Stopping Criteria|0
5874518|NCT01929317|20323112|P1|Long-term Phase|Protocol-defined Stopping Criteria|1
5874519|NCT01929317|20323111|P2|Long-term Phase|Protocol Violation|0
5874520|NCT01929317|20323112|P1|Long-term Phase|Protocol Violation|1
5874521|NCT01929317|20323111|P2|Long-term Phase|Withdrawal by Subject|0
5874522|NCT01929317|20323112|P1|Long-term Phase|Withdrawal by Subject|4
5874523|NCT01929317|20323111|P2|Long-term Phase|Physician Decision|0
5874524|NCT01929317|20323112|P1|Long-term Phase|Physician Decision|3
5874525|NCT01929317|20323111|P2|Long-term Phase|Adverse Event|1
5874526|NCT01929317|20323112|P1|Long-term Phase|Adverse Event|5
5874527|NCT01929317|20323111|P2|Dose Increase Effect Verification Phase|Withdrawal by Subject|0
5874528|NCT01929317|20323112|P1|Dose Increase Effect Verification Phase|Withdrawal by Subject|3
5874529|NCT01929317|20323111|P2|Dose Increase Effect Verification Phase|Physician Decision|0
5874530|NCT01929317|20323112|P1|Dose Increase Effect Verification Phase|Physician Decision|1
5874531|NCT01929317|20323111|P2|Dose Increase Effect Verification Phase|Adverse Event|1
5874532|NCT01929317|20323112|P1|Dose Increase Effect Verification Phase|Adverse Event|5
5874533|NCT01929226|20323187|P2|Overall Study|Withdrawal by Subject|1
5874534|NCT01929226|20323188|P1|Overall Study|Withdrawal by Subject|1
5874535|NCT01929226|20323187|P2|Overall Study|Lost to Follow-up|0
5874536|NCT01929226|20323188|P1|Overall Study|Lost to Follow-up|4
5874537|NCT01929135|20323214|P2|Overall Study|Lost to Follow-up|1
5874538|NCT01929135|20323215|P1|Overall Study|Lost to Follow-up|1
5874539|NCT01929109|20323234|P5|Period 1 (All Groups)|Deviation from protocol|0
5874540|NCT01929109|20323235|P4|Period 1 (All Groups)|Deviation from protocol|0
5874541|NCT01929109|20323236|P3|Period 1 (All Groups)|Deviation from protocol|1
5874542|NCT01929109|20323237|P2|Period 1 (All Groups)|Deviation from protocol|0
5874543|NCT01929109|20323238|P1|Period 1 (All Groups)|Deviation from protocol|0
5874544|NCT01929083|20323257|P2|Intervention 2|Adverse Event|1
5874545|NCT01929083|20323258|P1|Intervention 2|Adverse Event|0
5874546|NCT01929083|20323257|P2|Intervention 1|Nonadherent to study medications|0
5874547|NCT01929083|20323258|P1|Intervention 1|Nonadherent to study medications|1
5874548|NCT01929083|20323257|P2|Intervention 1|Lost to Follow-up|0
5874549|NCT01929083|20323258|P1|Intervention 1|Lost to Follow-up|2
5874550|NCT01929044|20323295|P2|Overall Study|Not Treated|3
5874551|NCT01929044|20323296|P1|Overall Study|Not Treated|1
5874552|NCT01929044|20323295|P2|Overall Study|Protocol Violation|14
5874553|NCT01929044|20323296|P1|Overall Study|Protocol Violation|9
5874554|NCT01929044|20323295|P2|Overall Study|Adverse Event|0
5874555|NCT01929044|20323296|P1|Overall Study|Adverse Event|1
5874556|NCT01929031|20323318|P6|Overall Study|Reason other than specified above|0
5874557|NCT01929031|20323319|P5|Overall Study|Reason other than specified above|1
5874558|NCT01929031|20323320|P4|Overall Study|Reason other than specified above|0
5874559|NCT01929031|20323321|P3|Overall Study|Reason other than specified above|0
5874560|NCT01929031|20323322|P2|Overall Study|Reason other than specified above|1
5874561|NCT01929031|20323323|P1|Overall Study|Reason other than specified above|0
5874562|NCT01929031|20323318|P6|Overall Study|Protocol Violation|1
5874563|NCT01929031|20323319|P5|Overall Study|Protocol Violation|0
5874564|NCT01929031|20323320|P4|Overall Study|Protocol Violation|0
5874565|NCT01929031|20323321|P3|Overall Study|Protocol Violation|0
5874566|NCT01929031|20323322|P2|Overall Study|Protocol Violation|0
5874567|NCT01929031|20323323|P1|Overall Study|Protocol Violation|1
5874568|NCT01929031|20323318|P6|Overall Study|Adverse Event|0
5874569|NCT01929031|20323319|P5|Overall Study|Adverse Event|0
5874570|NCT01929031|20323320|P4|Overall Study|Adverse Event|0
5874571|NCT01929031|20323321|P3|Overall Study|Adverse Event|1
5874572|NCT01929031|20323322|P2|Overall Study|Adverse Event|1
5874573|NCT01929031|20323323|P1|Overall Study|Adverse Event|3
5874574|NCT01929018|20323347|P2|Overall Study|Hospitalization|1
5874575|NCT01929018|20323348|P1|Overall Study|Hospitalization|0
5874576|NCT01929018|20323347|P2|Overall Study|Lost to Follow-up|0
5874577|NCT01929018|20323348|P1|Overall Study|Lost to Follow-up|1
5874578|NCT01928940|20323372|P2|Overall Study|Adverse Event|1
5874579|NCT01928940|20323373|P1|Overall Study|Adverse Event|0
5874580|NCT01928927|20323416|P2|Overall Study|Withdrawal by Subject|1
5874581|NCT01928927|20323417|P1|Overall Study|Withdrawal by Subject|1
5874582|NCT01928927|20323416|P2|Overall Study|Lost to Follow-up|0
5874583|NCT01928927|20323417|P1|Overall Study|Lost to Follow-up|1
5874584|NCT01928862|20323558|P5|Overall Study|Lost to Follow-up|1
5874585|NCT01928862|20323559|P4|Overall Study|Lost to Follow-up|0
5874586|NCT01928862|20323560|P3|Overall Study|Lost to Follow-up|0
5874587|NCT01928862|20323561|P2|Overall Study|Lost to Follow-up|0
5874588|NCT01928862|20323562|P1|Overall Study|Lost to Follow-up|1
5874589|NCT01928771|20323636|P3|Overall Study|Severe Non-Compliance to Protocol|2
5874590|NCT01928771|20323637|P2|Overall Study|Severe Non-Compliance to Protocol|2
5874591|NCT01928771|20323638|P1|Overall Study|Severe Non-Compliance to Protocol|4
5874592|NCT01928771|20323636|P3|Overall Study|Other Reasons|14
5874593|NCT01928771|20323637|P2|Overall Study|Other Reasons|9
5874594|NCT01928771|20323638|P1|Overall Study|Other Reasons|9
5874595|NCT01928771|20323636|P3|Overall Study|Study-Specific Withdrawal Criteria|1
5874596|NCT01928771|20323637|P2|Overall Study|Study-Specific Withdrawal Criteria|1
5874597|NCT01928771|20323638|P1|Overall Study|Study-Specific Withdrawal Criteria|0
5874598|NCT01928771|20323636|P3|Overall Study|Withdrawal by Subject|17
5874599|NCT01928771|20323637|P2|Overall Study|Withdrawal by Subject|15
5874600|NCT01928771|20323638|P1|Overall Study|Withdrawal by Subject|20
5874601|NCT01928771|20323636|P3|Overall Study|Lost to Follow-up|3
5874602|NCT01928771|20323637|P2|Overall Study|Lost to Follow-up|6
5874603|NCT01928771|20323638|P1|Overall Study|Lost to Follow-up|5
5874604|NCT01928771|20323636|P3|Overall Study|Death|2
5874605|NCT01928771|20323637|P2|Overall Study|Death|2
5874606|NCT01928771|20323638|P1|Overall Study|Death|2
5874607|NCT01928771|20323636|P3|Overall Study|Adverse Event|1
5874608|NCT01928771|20323637|P2|Overall Study|Adverse Event|5
5874609|NCT01928771|20323638|P1|Overall Study|Adverse Event|6
5874610|NCT01928758|20323717|P2|Overall Study|Protocol Violation|4
5874611|NCT01928758|20323718|P1|Overall Study|Protocol Violation|3
5874612|NCT01928758|20323717|P2|Overall Study|Adverse Event|5
5874613|NCT01928758|20323718|P1|Overall Study|Adverse Event|3
5874614|NCT01928758|20323717|P2|Overall Study|Withdrawal by Subject|2
5874615|NCT01928758|20323718|P1|Overall Study|Withdrawal by Subject|5
5874616|NCT01928758|20323717|P2|Overall Study|Lost to Follow-up|9
5874617|NCT01928758|20323718|P1|Overall Study|Lost to Follow-up|14
5874618|NCT01928719|20323736|P2|Overall Study|Adverse Event|0
5874619|NCT01928719|20323737|P1|Overall Study|Adverse Event|1
5874620|NCT01928719|20323736|P2|Overall Study|Protocol Violation|1
5874621|NCT01928719|20323737|P1|Overall Study|Protocol Violation|3
5874622|NCT01928719|20323736|P2|Overall Study|Withdrawal by Subject|7
5874623|NCT01928719|20323737|P1|Overall Study|Withdrawal by Subject|22
5874624|NCT01928719|20323736|P2|Overall Study|Lost to Follow-up|11
5874625|NCT01928719|20323737|P1|Overall Study|Lost to Follow-up|26
5874626|NCT01928615|20323789|P1|Overall Study|Study Terminated by Sponsor|2
5874627|NCT01928485|20323806|P2|Overall Study|Physician Decision|1
5874628|NCT01928485|20323807|P1|Overall Study|Physician Decision|0
5874629|NCT01928472|20323859|P4|Overall Study|Unclassified|0
5874630|NCT01928472|20323860|P3|Overall Study|Unclassified|1
5874631|NCT01928472|20323861|P2|Overall Study|Unclassified|0
5874632|NCT01928472|20323862|P1|Overall Study|Unclassified|0
5874633|NCT01928472|20323859|P4|Overall Study|Administrative Reason|0
5874634|NCT01928472|20323860|P3|Overall Study|Administrative Reason|0
5874635|NCT01928472|20323861|P2|Overall Study|Administrative Reason|1
5874636|NCT01928472|20323862|P1|Overall Study|Administrative Reason|2
5874637|NCT01928472|20323859|P4|Overall Study|Lost to Follow-up|0
5874638|NCT01928472|20323860|P3|Overall Study|Lost to Follow-up|4
5874639|NCT01928472|20323861|P2|Overall Study|Lost to Follow-up|3
5874640|NCT01928472|20323862|P1|Overall Study|Lost to Follow-up|2
5874641|NCT01928472|20323859|P4|Overall Study|Withdrawal by Subject|2
5874642|NCT01928472|20323860|P3|Overall Study|Withdrawal by Subject|1
5874643|NCT01928472|20323861|P2|Overall Study|Withdrawal by Subject|4
5874644|NCT01928472|20323862|P1|Overall Study|Withdrawal by Subject|4
5874645|NCT01928472|20323859|P4|Overall Study|Death|0
5874646|NCT01928472|20323860|P3|Overall Study|Death|1
5874647|NCT01928472|20323861|P2|Overall Study|Death|0
5874648|NCT01928472|20323862|P1|Overall Study|Death|0
5874649|NCT01928433|20323932|P3|Overall Study|Other reasons|4
5874650|NCT01928433|20323933|P2|Overall Study|Other reasons|3
5874651|NCT01928433|20323934|P1|Overall Study|Other reasons|3
5874652|NCT01928433|20323932|P3|Overall Study|Lost to Follow-up|3
5874653|NCT01928433|20323933|P2|Overall Study|Lost to Follow-up|2
5874654|NCT01928433|20323934|P1|Overall Study|Lost to Follow-up|0
5874655|NCT01928433|20323932|P3|Overall Study|Negative screening urine culture|10
5874656|NCT01928433|20323933|P2|Overall Study|Negative screening urine culture|6
5874657|NCT01928433|20323934|P1|Overall Study|Negative screening urine culture|7
5874658|NCT01928433|20323932|P3|Overall Study|Withdrawal by Subject|0
5874659|NCT01928433|20323933|P2|Overall Study|Withdrawal by Subject|4
5874660|NCT01928433|20323934|P1|Overall Study|Withdrawal by Subject|0
5874661|NCT01928433|20323932|P3|Overall Study|Lack of Efficacy|4
5874662|NCT01928433|20323933|P2|Overall Study|Lack of Efficacy|4
5874663|NCT01928433|20323934|P1|Overall Study|Lack of Efficacy|5
5874664|NCT01928433|20323932|P3|Overall Study|Protocol Violation|2
5874665|NCT01928433|20323933|P2|Overall Study|Protocol Violation|0
5874666|NCT01928433|20323934|P1|Overall Study|Protocol Violation|0
5874667|NCT01928433|20323932|P3|Overall Study|Adverse Event|5
5874668|NCT01928433|20323933|P2|Overall Study|Adverse Event|2
5874669|NCT01928433|20323934|P1|Overall Study|Adverse Event|5
5874670|NCT01928394|20323980|P23|Follow-up Period|Lost to Follow-up|1
5874671|NCT01928394|20323981|P22|Follow-up Period|Lost to Follow-up|0
5874672|NCT01928394|20323982|P21|Follow-up Period|Lost to Follow-up|0
5874673|NCT01928394|20323983|P20|Follow-up Period|Lost to Follow-up|0
5874674|NCT01928394|20323984|P19|Follow-up Period|Lost to Follow-up|0
5874675|NCT01928394|20323985|P18|Follow-up Period|Lost to Follow-up|0
5874676|NCT01928394|20323986|P17|Follow-up Period|Lost to Follow-up|1
5874677|NCT01928394|20323987|P16|Follow-up Period|Lost to Follow-up|0
5874678|NCT01928394|20323988|P15|Follow-up Period|Lost to Follow-up|1
5874679|NCT01928394|20323989|P14|Follow-up Period|Lost to Follow-up|0
5874680|NCT01928394|20323990|P13|Follow-up Period|Lost to Follow-up|1
5874681|NCT01928394|20323991|P12|Follow-up Period|Lost to Follow-up|1
5874682|NCT01928394|20323992|P11|Follow-up Period|Lost to Follow-up|0
5874683|NCT01928394|20323993|P10|Follow-up Period|Lost to Follow-up|0
5874684|NCT01928394|20323994|P9|Follow-up Period|Lost to Follow-up|0
5874685|NCT01928394|20323995|P8|Follow-up Period|Lost to Follow-up|0
5874686|NCT01928394|20323996|P7|Follow-up Period|Lost to Follow-up|0
5874687|NCT01928394|20323997|P6|Follow-up Period|Lost to Follow-up|0
5874688|NCT01928394|20323998|P5|Follow-up Period|Lost to Follow-up|0
5874689|NCT01928394|20323999|P4|Follow-up Period|Lost to Follow-up|0
5874690|NCT01928394|20324000|P3|Follow-up Period|Lost to Follow-up|0
5874691|NCT01928394|20324001|P2|Follow-up Period|Lost to Follow-up|0
5874692|NCT01928394|20324002|P1|Follow-up Period|Lost to Follow-up|0
5874693|NCT01928394|20323980|P23|Follow-up Period|other reason|1
5874694|NCT01928394|20323981|P22|Follow-up Period|other reason|0
5874695|NCT01928394|20323982|P21|Follow-up Period|other reason|0
5874696|NCT01928394|20323983|P20|Follow-up Period|other reason|1
5874697|NCT01928394|20323984|P19|Follow-up Period|other reason|1
5874698|NCT01928394|20323985|P18|Follow-up Period|other reason|0
5874699|NCT01928394|20323986|P17|Follow-up Period|other reason|2
5874700|NCT01928394|20323987|P16|Follow-up Period|other reason|0
5874701|NCT01928394|20323988|P15|Follow-up Period|other reason|4
5874702|NCT01928394|20323989|P14|Follow-up Period|other reason|1
5874703|NCT01928394|20323990|P13|Follow-up Period|other reason|0
5874704|NCT01928394|20323991|P12|Follow-up Period|other reason|1
5874705|NCT01928394|20323992|P11|Follow-up Period|other reason|2
5874706|NCT01928394|20323993|P10|Follow-up Period|other reason|0
5874707|NCT01928394|20323994|P9|Follow-up Period|other reason|0
5874708|NCT01928394|20323995|P8|Follow-up Period|other reason|3
5874709|NCT01928394|20323996|P7|Follow-up Period|other reason|1
5874710|NCT01928394|20323997|P6|Follow-up Period|other reason|0
5874711|NCT01928394|20323998|P5|Follow-up Period|other reason|0
5874712|NCT01928394|20323999|P4|Follow-up Period|other reason|0
5874713|NCT01928394|20324000|P3|Follow-up Period|other reason|0
5874714|NCT01928394|20324001|P2|Follow-up Period|other reason|0
5874715|NCT01928394|20324002|P1|Follow-up Period|other reason|0
5874716|NCT01928394|20323980|P23|Follow-up Period|Death|2
5874717|NCT01928394|20323981|P22|Follow-up Period|Death|3
5874718|NCT01928394|20323982|P21|Follow-up Period|Death|5
5874719|NCT01928394|20323983|P20|Follow-up Period|Death|13
5874720|NCT01928394|20323984|P19|Follow-up Period|Death|13
5874721|NCT01928394|20323985|P18|Follow-up Period|Death|5
5874722|NCT01928394|20323986|P17|Follow-up Period|Death|6
5874723|NCT01928394|20323987|P16|Follow-up Period|Death|0
5874724|NCT01928394|20323988|P15|Follow-up Period|Death|18
5874725|NCT01928394|20323989|P14|Follow-up Period|Death|25
5874726|NCT01928394|20323990|P13|Follow-up Period|Death|11
5874727|NCT01928394|20323991|P12|Follow-up Period|Death|12
5874728|NCT01928394|20323992|P11|Follow-up Period|Death|4
5874729|NCT01928394|20323993|P10|Follow-up Period|Death|2
5874730|NCT01928394|20323994|P9|Follow-up Period|Death|1
5874731|NCT01928394|20323995|P8|Follow-up Period|Death|2
5874732|NCT01928394|20323996|P7|Follow-up Period|Death|6
5874733|NCT01928394|20323997|P6|Follow-up Period|Death|6
5874734|NCT01928394|20323998|P5|Follow-up Period|Death|0
5874735|NCT01928394|20323999|P4|Follow-up Period|Death|6
5874736|NCT01928394|20324000|P3|Follow-up Period|Death|2
5874737|NCT01928394|20324001|P2|Follow-up Period|Death|0
5874738|NCT01928394|20324002|P1|Follow-up Period|Death|0
5874739|NCT01928394|20323980|P23|Follow-up Period|Participant withdrew consent|2
5874740|NCT01928394|20323981|P22|Follow-up Period|Participant withdrew consent|6
5874741|NCT01928394|20323982|P21|Follow-up Period|Participant withdrew consent|4
5874742|NCT01928394|20323983|P20|Follow-up Period|Participant withdrew consent|7
5874743|NCT01928394|20323984|P19|Follow-up Period|Participant withdrew consent|2
5874744|NCT01928394|20323985|P18|Follow-up Period|Participant withdrew consent|3
5874745|NCT01928394|20323986|P17|Follow-up Period|Participant withdrew consent|5
5874746|NCT01928394|20323987|P16|Follow-up Period|Participant withdrew consent|0
5874747|NCT01928394|20323988|P15|Follow-up Period|Participant withdrew consent|7
5874748|NCT01928394|20323989|P14|Follow-up Period|Participant withdrew consent|12
5874749|NCT01928394|20323990|P13|Follow-up Period|Participant withdrew consent|2
5874750|NCT01928394|20323991|P12|Follow-up Period|Participant withdrew consent|8
5874751|NCT01928394|20323992|P11|Follow-up Period|Participant withdrew consent|5
5874752|NCT01928394|20323993|P10|Follow-up Period|Participant withdrew consent|0
5874753|NCT01928394|20323994|P9|Follow-up Period|Participant withdrew consent|0
5874754|NCT01928394|20323995|P8|Follow-up Period|Participant withdrew consent|1
5874755|NCT01928394|20323996|P7|Follow-up Period|Participant withdrew consent|5
5874756|NCT01928394|20323997|P6|Follow-up Period|Participant withdrew consent|2
5874757|NCT01928394|20323998|P5|Follow-up Period|Participant withdrew consent|0
5874758|NCT01928394|20323999|P4|Follow-up Period|Participant withdrew consent|4
5874759|NCT01928394|20324000|P3|Follow-up Period|Participant withdrew consent|1
5874760|NCT01928394|20324001|P2|Follow-up Period|Participant withdrew consent|0
5874761|NCT01928394|20324002|P1|Follow-up Period|Participant withdrew consent|3
5874762|NCT01928394|20323980|P23|Treatment Period|Death|0
5874763|NCT01928394|20323981|P22|Treatment Period|Death|0
5874764|NCT01928394|20323982|P21|Treatment Period|Death|0
5874765|NCT01928394|20323983|P20|Treatment Period|Death|0
5874766|NCT01928394|20323984|P19|Treatment Period|Death|0
5874767|NCT01928394|20323985|P18|Treatment Period|Death|0
5874768|NCT01928394|20323986|P17|Treatment Period|Death|0
5874769|NCT01928394|20323987|P16|Treatment Period|Death|0
5874770|NCT01928394|20323988|P15|Treatment Period|Death|2
5874771|NCT01928394|20323989|P14|Treatment Period|Death|1
5874772|NCT01928394|20323990|P13|Treatment Period|Death|0
5874773|NCT01928394|20323991|P12|Treatment Period|Death|0
5874774|NCT01928394|20323992|P11|Treatment Period|Death|0
5874775|NCT01928394|20323993|P10|Treatment Period|Death|0
5874776|NCT01928394|20323994|P9|Treatment Period|Death|0
5874777|NCT01928394|20323995|P8|Treatment Period|Death|0
5874778|NCT01928394|20323996|P7|Treatment Period|Death|0
5874779|NCT01928394|20323997|P6|Treatment Period|Death|0
5874780|NCT01928394|20323998|P5|Treatment Period|Death|0
5874781|NCT01928394|20323999|P4|Treatment Period|Death|0
5874782|NCT01928394|20324000|P3|Treatment Period|Death|0
5874783|NCT01928394|20324001|P2|Treatment Period|Death|0
5874784|NCT01928394|20324002|P1|Treatment Period|Death|0
5874785|NCT01928394|20323980|P23|Treatment Period|Lost to Follow-up|1
5874786|NCT01928394|20323981|P22|Treatment Period|Lost to Follow-up|0
5874787|NCT01928394|20323982|P21|Treatment Period|Lost to Follow-up|0
5874788|NCT01928394|20323983|P20|Treatment Period|Lost to Follow-up|0
5874789|NCT01928394|20323984|P19|Treatment Period|Lost to Follow-up|0
5874790|NCT01928394|20323985|P18|Treatment Period|Lost to Follow-up|0
5874791|NCT01928394|20323986|P17|Treatment Period|Lost to Follow-up|0
5874792|NCT01928394|20323987|P16|Treatment Period|Lost to Follow-up|0
5874793|NCT01928394|20323988|P15|Treatment Period|Lost to Follow-up|0
5874794|NCT01928394|20323989|P14|Treatment Period|Lost to Follow-up|0
5874795|NCT01928394|20323990|P13|Treatment Period|Lost to Follow-up|0
5874796|NCT01928394|20323991|P12|Treatment Period|Lost to Follow-up|0
5874797|NCT01928394|20323992|P11|Treatment Period|Lost to Follow-up|0
5874798|NCT01928394|20323993|P10|Treatment Period|Lost to Follow-up|0
5874799|NCT01928394|20323994|P9|Treatment Period|Lost to Follow-up|0
5874800|NCT01928394|20323995|P8|Treatment Period|Lost to Follow-up|0
5874801|NCT01928394|20323996|P7|Treatment Period|Lost to Follow-up|0
5874802|NCT01928394|20323997|P6|Treatment Period|Lost to Follow-up|0
5874803|NCT01928394|20323998|P5|Treatment Period|Lost to Follow-up|0
5874804|NCT01928394|20323999|P4|Treatment Period|Lost to Follow-up|0
5874805|NCT01928394|20324000|P3|Treatment Period|Lost to Follow-up|0
5874806|NCT01928394|20324001|P2|Treatment Period|Lost to Follow-up|0
5874807|NCT01928394|20324002|P1|Treatment Period|Lost to Follow-up|0
5874808|NCT01928394|20323980|P23|Treatment Period|Maximum clinical benefit|0
5874809|NCT01928394|20323981|P22|Treatment Period|Maximum clinical benefit|0
5874810|NCT01928394|20323982|P21|Treatment Period|Maximum clinical benefit|2
5874811|NCT01928394|20323983|P20|Treatment Period|Maximum clinical benefit|0
5874812|NCT01928394|20323984|P19|Treatment Period|Maximum clinical benefit|1
5874813|NCT01928394|20323985|P18|Treatment Period|Maximum clinical benefit|1
5874814|NCT01928394|20323986|P17|Treatment Period|Maximum clinical benefit|0
5874815|NCT01928394|20323987|P16|Treatment Period|Maximum clinical benefit|0
5874816|NCT01928394|20323988|P15|Treatment Period|Maximum clinical benefit|1
5874817|NCT01928394|20323989|P14|Treatment Period|Maximum clinical benefit|0
5874818|NCT01928394|20323990|P13|Treatment Period|Maximum clinical benefit|0
5874819|NCT01928394|20323991|P12|Treatment Period|Maximum clinical benefit|1
5874820|NCT01928394|20323992|P11|Treatment Period|Maximum clinical benefit|1
5874821|NCT01928394|20323993|P10|Treatment Period|Maximum clinical benefit|0
5874822|NCT01928394|20323994|P9|Treatment Period|Maximum clinical benefit|0
5874823|NCT01928394|20323995|P8|Treatment Period|Maximum clinical benefit|0
5874824|NCT01928394|20323996|P7|Treatment Period|Maximum clinical benefit|0
5874825|NCT01928394|20323997|P6|Treatment Period|Maximum clinical benefit|0
5874826|NCT01928394|20323998|P5|Treatment Period|Maximum clinical benefit|0
5874827|NCT01928394|20323999|P4|Treatment Period|Maximum clinical benefit|0
5874828|NCT01928394|20324000|P3|Treatment Period|Maximum clinical benefit|0
5874829|NCT01928394|20324001|P2|Treatment Period|Maximum clinical benefit|0
5874830|NCT01928394|20324002|P1|Treatment Period|Maximum clinical benefit|0
5874831|NCT01928394|20323980|P23|Treatment Period|other reason|0
5874832|NCT01928394|20323981|P22|Treatment Period|other reason|0
5874833|NCT01928394|20323982|P21|Treatment Period|other reason|0
5874834|NCT01928394|20323983|P20|Treatment Period|other reason|2
5874835|NCT01928394|20323984|P19|Treatment Period|other reason|2
5874836|NCT01928394|20323985|P18|Treatment Period|other reason|0
5874837|NCT01928394|20323986|P17|Treatment Period|other reason|0
5874838|NCT01928394|20323987|P16|Treatment Period|other reason|0
5874839|NCT01928394|20323988|P15|Treatment Period|other reason|1
5874840|NCT01928394|20323989|P14|Treatment Period|other reason|0
5874841|NCT01928394|20323990|P13|Treatment Period|other reason|1
5874842|NCT01928394|20323991|P12|Treatment Period|other reason|1
5874843|NCT01928394|20323992|P11|Treatment Period|other reason|1
5874844|NCT01928394|20323993|P10|Treatment Period|other reason|0
5874845|NCT01928394|20323994|P9|Treatment Period|other reason|0
5874846|NCT01928394|20323995|P8|Treatment Period|other reason|0
5874847|NCT01928394|20323996|P7|Treatment Period|other reason|0
5874848|NCT01928394|20323997|P6|Treatment Period|other reason|0
5874849|NCT01928394|20323998|P5|Treatment Period|other reason|0
5874850|NCT01928394|20323999|P4|Treatment Period|other reason|0
5874851|NCT01928394|20324000|P3|Treatment Period|other reason|0
5874852|NCT01928394|20324001|P2|Treatment Period|other reason|0
5874853|NCT01928394|20324002|P1|Treatment Period|other reason|0
5874854|NCT01928394|20323980|P23|Treatment Period|Poor/non-compliance|0
5874855|NCT01928394|20323981|P22|Treatment Period|Poor/non-compliance|0
5874856|NCT01928394|20323982|P21|Treatment Period|Poor/non-compliance|0
5874857|NCT01928394|20323983|P20|Treatment Period|Poor/non-compliance|1
5874858|NCT01928394|20323984|P19|Treatment Period|Poor/non-compliance|0
5874859|NCT01928394|20323985|P18|Treatment Period|Poor/non-compliance|1
5874860|NCT01928394|20323986|P17|Treatment Period|Poor/non-compliance|0
5874861|NCT01928394|20323987|P16|Treatment Period|Poor/non-compliance|0
5874862|NCT01928394|20323988|P15|Treatment Period|Poor/non-compliance|1
5874863|NCT01928394|20323989|P14|Treatment Period|Poor/non-compliance|0
5874864|NCT01928394|20323990|P13|Treatment Period|Poor/non-compliance|1
5874865|NCT01928394|20323991|P12|Treatment Period|Poor/non-compliance|0
5874866|NCT01928394|20323992|P11|Treatment Period|Poor/non-compliance|0
5874867|NCT01928394|20323993|P10|Treatment Period|Poor/non-compliance|0
5874868|NCT01928394|20323994|P9|Treatment Period|Poor/non-compliance|0
5874869|NCT01928394|20323995|P8|Treatment Period|Poor/non-compliance|0
5874870|NCT01928394|20323996|P7|Treatment Period|Poor/non-compliance|0
5874871|NCT01928394|20323997|P6|Treatment Period|Poor/non-compliance|0
5874872|NCT01928394|20323998|P5|Treatment Period|Poor/non-compliance|0
5874873|NCT01928394|20323999|P4|Treatment Period|Poor/non-compliance|1
5874874|NCT01928394|20324000|P3|Treatment Period|Poor/non-compliance|0
5874875|NCT01928394|20324001|P2|Treatment Period|Poor/non-compliance|0
5874876|NCT01928394|20324002|P1|Treatment Period|Poor/non-compliance|0
5874877|NCT01928394|20323980|P23|Treatment Period|Participant withdrew consent|0
5874878|NCT01928394|20323981|P22|Treatment Period|Participant withdrew consent|2
5874879|NCT01928394|20323982|P21|Treatment Period|Participant withdrew consent|0
5874880|NCT01928394|20323983|P20|Treatment Period|Participant withdrew consent|1
5874881|NCT01928394|20323984|P19|Treatment Period|Participant withdrew consent|1
5874882|NCT01928394|20323985|P18|Treatment Period|Participant withdrew consent|1
5874883|NCT01928394|20323986|P17|Treatment Period|Participant withdrew consent|2
5874884|NCT01928394|20323987|P16|Treatment Period|Participant withdrew consent|0
5874885|NCT01928394|20323988|P15|Treatment Period|Participant withdrew consent|2
5874886|NCT01928394|20323989|P14|Treatment Period|Participant withdrew consent|0
5874887|NCT01928394|20323990|P13|Treatment Period|Participant withdrew consent|1
5874888|NCT01928394|20323991|P12|Treatment Period|Participant withdrew consent|1
5874889|NCT01928394|20323992|P11|Treatment Period|Participant withdrew consent|1
5874890|NCT01928394|20323993|P10|Treatment Period|Participant withdrew consent|0
5874891|NCT01928394|20323994|P9|Treatment Period|Participant withdrew consent|0
5874892|NCT01928394|20323995|P8|Treatment Period|Participant withdrew consent|1
5874893|NCT01928394|20323996|P7|Treatment Period|Participant withdrew consent|0
5874894|NCT01928394|20323997|P6|Treatment Period|Participant withdrew consent|1
5874895|NCT01928394|20323998|P5|Treatment Period|Participant withdrew consent|0
5874896|NCT01928394|20323999|P4|Treatment Period|Participant withdrew consent|1
5874897|NCT01928394|20324000|P3|Treatment Period|Participant withdrew consent|1
5874898|NCT01928394|20324001|P2|Treatment Period|Participant withdrew consent|0
5874899|NCT01928394|20324002|P1|Treatment Period|Participant withdrew consent|0
5874900|NCT01928394|20323980|P23|Treatment Period|Participant request to stop therapy|3
5874901|NCT01928394|20323981|P22|Treatment Period|Participant request to stop therapy|1
5874902|NCT01928394|20323982|P21|Treatment Period|Participant request to stop therapy|3
5874903|NCT01928394|20323983|P20|Treatment Period|Participant request to stop therapy|1
5874904|NCT01928394|20323984|P19|Treatment Period|Participant request to stop therapy|1
5874905|NCT01928394|20323985|P18|Treatment Period|Participant request to stop therapy|3
5874906|NCT01928394|20323986|P17|Treatment Period|Participant request to stop therapy|1
5874907|NCT01928394|20323987|P16|Treatment Period|Participant request to stop therapy|0
5874908|NCT01928394|20323988|P15|Treatment Period|Participant request to stop therapy|4
5874909|NCT01928394|20323989|P14|Treatment Period|Participant request to stop therapy|2
5874910|NCT01928394|20323990|P13|Treatment Period|Participant request to stop therapy|1
5874911|NCT01928394|20323991|P12|Treatment Period|Participant request to stop therapy|2
5874912|NCT01928394|20323992|P11|Treatment Period|Participant request to stop therapy|3
5874913|NCT01928394|20323993|P10|Treatment Period|Participant request to stop therapy|0
5874914|NCT01928394|20323994|P9|Treatment Period|Participant request to stop therapy|0
5874915|NCT01928394|20323995|P8|Treatment Period|Participant request to stop therapy|0
5874916|NCT01928394|20323996|P7|Treatment Period|Participant request to stop therapy|3
5874917|NCT01928394|20323997|P6|Treatment Period|Participant request to stop therapy|3
5874918|NCT01928394|20323998|P5|Treatment Period|Participant request to stop therapy|0
5874919|NCT01928394|20323999|P4|Treatment Period|Participant request to stop therapy|0
5874920|NCT01928394|20324000|P3|Treatment Period|Participant request to stop therapy|0
5874921|NCT01928394|20324001|P2|Treatment Period|Participant request to stop therapy|0
5874922|NCT01928394|20324002|P1|Treatment Period|Participant request to stop therapy|0
5874923|NCT01928394|20323980|P23|Treatment Period|AE unrelated to study drug|0
5874924|NCT01928394|20323981|P22|Treatment Period|AE unrelated to study drug|1
5874925|NCT01928394|20323982|P21|Treatment Period|AE unrelated to study drug|1
5874926|NCT01928394|20323983|P20|Treatment Period|AE unrelated to study drug|5
5874927|NCT01928394|20323984|P19|Treatment Period|AE unrelated to study drug|3
5874928|NCT01928394|20323985|P18|Treatment Period|AE unrelated to study drug|6
5874929|NCT01928394|20323986|P17|Treatment Period|AE unrelated to study drug|1
5874930|NCT01928394|20323987|P16|Treatment Period|AE unrelated to study drug|1
5874931|NCT01928394|20323988|P15|Treatment Period|AE unrelated to study drug|6
5874932|NCT01928394|20323989|P14|Treatment Period|AE unrelated to study drug|13
5874933|NCT01928394|20323990|P13|Treatment Period|AE unrelated to study drug|6
5874934|NCT01928394|20323991|P12|Treatment Period|AE unrelated to study drug|12
5874935|NCT01928394|20323992|P11|Treatment Period|AE unrelated to study drug|0
5874936|NCT01928394|20323993|P10|Treatment Period|AE unrelated to study drug|2
5874937|NCT01928394|20323994|P9|Treatment Period|AE unrelated to study drug|0
5874938|NCT01928394|20323995|P8|Treatment Period|AE unrelated to study drug|0
5874939|NCT01928394|20323996|P7|Treatment Period|AE unrelated to study drug|1
5874940|NCT01928394|20323997|P6|Treatment Period|AE unrelated to study drug|5
5874941|NCT01928394|20323998|P5|Treatment Period|AE unrelated to study drug|0
5874942|NCT01928394|20323999|P4|Treatment Period|AE unrelated to study drug|3
5874943|NCT01928394|20324000|P3|Treatment Period|AE unrelated to study drug|2
5874944|NCT01928394|20324001|P2|Treatment Period|AE unrelated to study drug|0
5874945|NCT01928394|20324002|P1|Treatment Period|AE unrelated to study drug|0
5874946|NCT01928394|20323980|P23|Treatment Period|Study drug toxicity|4
5874947|NCT01928394|20323981|P22|Treatment Period|Study drug toxicity|7
5874948|NCT01928394|20323982|P21|Treatment Period|Study drug toxicity|4
5874949|NCT01928394|20323983|P20|Treatment Period|Study drug toxicity|15
5874950|NCT01928394|20323984|P19|Treatment Period|Study drug toxicity|12
5874951|NCT01928394|20323985|P18|Treatment Period|Study drug toxicity|3
5874952|NCT01928394|20323986|P17|Treatment Period|Study drug toxicity|3
5874953|NCT01928394|20323987|P16|Treatment Period|Study drug toxicity|0
5874954|NCT01928394|20323988|P15|Treatment Period|Study drug toxicity|12
5874955|NCT01928394|20323989|P14|Treatment Period|Study drug toxicity|5
5874956|NCT01928394|20323990|P13|Treatment Period|Study drug toxicity|7
5874957|NCT01928394|20323991|P12|Treatment Period|Study drug toxicity|3
5874958|NCT01928394|20323992|P11|Treatment Period|Study drug toxicity|2
5874959|NCT01928394|20323993|P10|Treatment Period|Study drug toxicity|5
5874960|NCT01928394|20323994|P9|Treatment Period|Study drug toxicity|0
5874961|NCT01928394|20323995|P8|Treatment Period|Study drug toxicity|1
5874962|NCT01928394|20323996|P7|Treatment Period|Study drug toxicity|7
5874963|NCT01928394|20323997|P6|Treatment Period|Study drug toxicity|9
5874964|NCT01928394|20323998|P5|Treatment Period|Study drug toxicity|0
5874965|NCT01928394|20323999|P4|Treatment Period|Study drug toxicity|3
5874966|NCT01928394|20324000|P3|Treatment Period|Study drug toxicity|3
5874967|NCT01928394|20324001|P2|Treatment Period|Study drug toxicity|1
5874968|NCT01928394|20324002|P1|Treatment Period|Study drug toxicity|1
5874969|NCT01928394|20323980|P23|Treatment Period|Disease progression|31
5874970|NCT01928394|20323981|P22|Treatment Period|Disease progression|31
5874971|NCT01928394|20323982|P21|Treatment Period|Disease progression|30
5874972|NCT01928394|20323983|P20|Treatment Period|Disease progression|71
5874973|NCT01928394|20323984|P19|Treatment Period|Disease progression|50
5874974|NCT01928394|20323985|P18|Treatment Period|Disease progression|56
5874975|NCT01928394|20323986|P17|Treatment Period|Disease progression|43
5874976|NCT01928394|20323987|P16|Treatment Period|Disease progression|1
5874977|NCT01928394|20323988|P15|Treatment Period|Disease progression|59
5874978|NCT01928394|20323989|P14|Treatment Period|Disease progression|118
5874979|NCT01928394|20323990|P13|Treatment Period|Disease progression|38
5874980|NCT01928394|20323991|P12|Treatment Period|Disease progression|73
5874981|NCT01928394|20323992|P11|Treatment Period|Disease progression|22
5874982|NCT01928394|20323993|P10|Treatment Period|Disease progression|11
5874983|NCT01928394|20323994|P9|Treatment Period|Disease progression|3
5874984|NCT01928394|20323995|P8|Treatment Period|Disease progression|16
5874985|NCT01928394|20323996|P7|Treatment Period|Disease progression|38
5874986|NCT01928394|20323997|P6|Treatment Period|Disease progression|25
5874987|NCT01928394|20323998|P5|Treatment Period|Disease progression|3
5874988|NCT01928394|20323999|P4|Treatment Period|Disease progression|48
5874989|NCT01928394|20324000|P3|Treatment Period|Disease progression|12
5874990|NCT01928394|20324001|P2|Treatment Period|Disease progression|2
5874991|NCT01928394|20324002|P1|Treatment Period|Disease progression|17
5874992|NCT01928381|20324050|P7|Part 2 - Post Third Intervention|Protocol Violation|0
5874993|NCT01928381|20324051|P6|Part 2 - Post Third Intervention|Protocol Violation|0
5874994|NCT01928381|20324052|P5|Part 2 - Post Third Intervention|Protocol Violation|0
5874995|NCT01928381|20324053|P4|Part 2 - Post Third Intervention|Protocol Violation|0
5874996|NCT01928381|20324054|P3|Part 2 - Post Third Intervention|Protocol Violation|1
5874997|NCT01928381|20324055|P2|Part 2 - Post Third Intervention|Protocol Violation|0
5874998|NCT01928381|20324056|P1|Part 2 - Post Third Intervention|Protocol Violation|0
5874999|NCT01928381|20324050|P7|Part 2 - Second Intervention|Lost to Follow-up|0
5875000|NCT01928381|20324051|P6|Part 2 - Second Intervention|Lost to Follow-up|0
5875001|NCT01928381|20324052|P5|Part 2 - Second Intervention|Lost to Follow-up|0
5875002|NCT01928381|20324053|P4|Part 2 - Second Intervention|Lost to Follow-up|1
5875003|NCT01928381|20324054|P3|Part 2 - Second Intervention|Lost to Follow-up|0
5875004|NCT01928381|20324055|P2|Part 2 - Second Intervention|Lost to Follow-up|1
5875005|NCT01928381|20324056|P1|Part 2 - Second Intervention|Lost to Follow-up|0
5875006|NCT01928381|20324050|P7|Washout First Intervention|Protocol Violation|0
5875007|NCT01928381|20324051|P6|Washout First Intervention|Protocol Violation|0
5875008|NCT01928381|20324052|P5|Washout First Intervention|Protocol Violation|1
5875009|NCT01928381|20324053|P4|Washout First Intervention|Protocol Violation|0
5875010|NCT01928381|20324054|P3|Washout First Intervention|Protocol Violation|0
5875011|NCT01928381|20324055|P2|Washout First Intervention|Protocol Violation|0
5875012|NCT01928381|20324056|P1|Washout First Intervention|Protocol Violation|0
5875013|NCT01928381|20324050|P7|Part 2 - First Intervention|Lost to Follow-up|0
5875014|NCT01928381|20324051|P6|Part 2 - First Intervention|Lost to Follow-up|0
5875015|NCT01928381|20324052|P5|Part 2 - First Intervention|Lost to Follow-up|0
5875016|NCT01928381|20324053|P4|Part 2 - First Intervention|Lost to Follow-up|1
5875017|NCT01928381|20324054|P3|Part 2 - First Intervention|Lost to Follow-up|0
5875018|NCT01928381|20324055|P2|Part 2 - First Intervention|Lost to Follow-up|0
5875019|NCT01928381|20324056|P1|Part 2 - First Intervention|Lost to Follow-up|0
5875020|NCT01928381|20324050|P7|Part 2 - First Intervention|Eligibility criterion not met|1
5875021|NCT01928381|20324051|P6|Part 2 - First Intervention|Eligibility criterion not met|1
5875022|NCT01928381|20324052|P5|Part 2 - First Intervention|Eligibility criterion not met|0
5875023|NCT01928381|20324053|P4|Part 2 - First Intervention|Eligibility criterion not met|0
5875024|NCT01928381|20324054|P3|Part 2 - First Intervention|Eligibility criterion not met|0
5875025|NCT01928381|20324055|P2|Part 2 - First Intervention|Eligibility criterion not met|0
5875026|NCT01928381|20324056|P1|Part 2 - First Intervention|Eligibility criterion not met|0
5875027|NCT01928381|20324050|P7|Part 2 - First Intervention|Study specific withdrawal criteria|0
5875028|NCT01928381|20324051|P6|Part 2 - First Intervention|Study specific withdrawal criteria|0
5875029|NCT01928381|20324052|P5|Part 2 - First Intervention|Study specific withdrawal criteria|0
5875030|NCT01928381|20324053|P4|Part 2 - First Intervention|Study specific withdrawal criteria|0
5875031|NCT01928381|20324054|P3|Part 2 - First Intervention|Study specific withdrawal criteria|1
5875032|NCT01928381|20324055|P2|Part 2 - First Intervention|Study specific withdrawal criteria|0
5875033|NCT01928381|20324056|P1|Part 2 - First Intervention|Study specific withdrawal criteria|0
5875034|NCT01928381|20324050|P7|Part 2 - First Intervention|Withdrawal by Subject|0
5875035|NCT01928381|20324051|P6|Part 2 - First Intervention|Withdrawal by Subject|0
5875036|NCT01928381|20324052|P5|Part 2 - First Intervention|Withdrawal by Subject|0
5875037|NCT01928381|20324053|P4|Part 2 - First Intervention|Withdrawal by Subject|0
5875038|NCT01928381|20324054|P3|Part 2 - First Intervention|Withdrawal by Subject|1
5875039|NCT01928381|20324055|P2|Part 2 - First Intervention|Withdrawal by Subject|0
5875040|NCT01928381|20324056|P1|Part 2 - First Intervention|Withdrawal by Subject|0
5875041|NCT01928381|20324050|P7|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
5875042|NCT01928381|20324051|P6|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
5875043|NCT01928381|20324052|P5|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
5875044|NCT01928381|20324053|P4|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
5875045|NCT01928381|20324054|P3|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
5875046|NCT01928381|20324055|P2|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
5875047|NCT01928381|20324056|P1|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|10
5875048|NCT01928381|20324050|P7|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
5875049|NCT01928381|20324051|P6|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
5875050|NCT01928381|20324052|P5|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
5875051|NCT01928381|20324053|P4|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
5875052|NCT01928381|20324054|P3|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
5875053|NCT01928381|20324055|P2|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
5875054|NCT01928381|20324056|P1|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|1
5875055|NCT01928381|20324050|P7|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
5875056|NCT01928381|20324051|P6|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
5875057|NCT01928381|20324052|P5|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
5875058|NCT01928381|20324053|P4|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
5875059|NCT01928381|20324054|P3|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
5875060|NCT01928381|20324055|P2|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
5875061|NCT01928381|20324056|P1|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|2
5875062|NCT01928381|20324050|P7|Placebo run-in & Part 2 Eligibility|Adverse Event|0
5875063|NCT01928381|20324051|P6|Placebo run-in & Part 2 Eligibility|Adverse Event|0
5875064|NCT01928381|20324052|P5|Placebo run-in & Part 2 Eligibility|Adverse Event|0
5875065|NCT01928381|20324053|P4|Placebo run-in & Part 2 Eligibility|Adverse Event|0
5875066|NCT01928381|20324054|P3|Placebo run-in & Part 2 Eligibility|Adverse Event|0
5875067|NCT01928381|20324055|P2|Placebo run-in & Part 2 Eligibility|Adverse Event|0
5875068|NCT01928381|20324056|P1|Placebo run-in & Part 2 Eligibility|Adverse Event|1
5875069|NCT01928381|20324050|P7|Part 1 - Pain Training|Protocol Violation|0
5875070|NCT01928381|20324051|P6|Part 1 - Pain Training|Protocol Violation|0
5875071|NCT01928381|20324052|P5|Part 1 - Pain Training|Protocol Violation|0
5875072|NCT01928381|20324053|P4|Part 1 - Pain Training|Protocol Violation|0
5875073|NCT01928381|20324054|P3|Part 1 - Pain Training|Protocol Violation|0
5875074|NCT01928381|20324055|P2|Part 1 - Pain Training|Protocol Violation|0
5875075|NCT01928381|20324056|P1|Part 1 - Pain Training|Protocol Violation|1
5875076|NCT01928381|20324050|P7|Part 1 - Pain Training|Lost to Follow-up|0
5875077|NCT01928381|20324051|P6|Part 1 - Pain Training|Lost to Follow-up|0
5875078|NCT01928381|20324052|P5|Part 1 - Pain Training|Lost to Follow-up|0
5875079|NCT01928381|20324053|P4|Part 1 - Pain Training|Lost to Follow-up|0
5875080|NCT01928381|20324054|P3|Part 1 - Pain Training|Lost to Follow-up|0
5875081|NCT01928381|20324055|P2|Part 1 - Pain Training|Lost to Follow-up|0
5875082|NCT01928381|20324056|P1|Part 1 - Pain Training|Lost to Follow-up|4
5875083|NCT01928381|20324050|P7|Part 1 - Pain Training|Withdrawal by Subject|0
5875084|NCT01928381|20324051|P6|Part 1 - Pain Training|Withdrawal by Subject|0
5875085|NCT01928381|20324052|P5|Part 1 - Pain Training|Withdrawal by Subject|0
5875086|NCT01928381|20324053|P4|Part 1 - Pain Training|Withdrawal by Subject|0
5875087|NCT01928381|20324054|P3|Part 1 - Pain Training|Withdrawal by Subject|0
5875088|NCT01928381|20324055|P2|Part 1 - Pain Training|Withdrawal by Subject|0
5875089|NCT01928381|20324056|P1|Part 1 - Pain Training|Withdrawal by Subject|1
5875090|NCT01928381|20324050|P7|Part 1 - Pain Training|Pain training criteria not met|0
5875091|NCT01928381|20324051|P6|Part 1 - Pain Training|Pain training criteria not met|0
5875092|NCT01928381|20324052|P5|Part 1 - Pain Training|Pain training criteria not met|0
5875093|NCT01928381|20324053|P4|Part 1 - Pain Training|Pain training criteria not met|0
5875094|NCT01928381|20324054|P3|Part 1 - Pain Training|Pain training criteria not met|0
5875095|NCT01928381|20324055|P2|Part 1 - Pain Training|Pain training criteria not met|0
5875096|NCT01928381|20324056|P1|Part 1 - Pain Training|Pain training criteria not met|29
5875097|NCT01928381|20324050|P7|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
5875098|NCT01928381|20324051|P6|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
5875099|NCT01928381|20324052|P5|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
5875100|NCT01928381|20324053|P4|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
5875101|NCT01928381|20324054|P3|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
5875102|NCT01928381|20324055|P2|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
5875103|NCT01928381|20324056|P1|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|60
5875104|NCT01928329|20324071|P2|Overall Study|Physician Decision|1
5875105|NCT01928329|20324072|P1|Overall Study|Physician Decision|1
5875106|NCT01928329|20324071|P2|Overall Study|Withdrawal by Subject|5
5875107|NCT01928329|20324072|P1|Overall Study|Withdrawal by Subject|1
5875108|NCT01928329|20324071|P2|Overall Study|Stopping Rule: Lost Greater than 5kg|1
5875109|NCT01928329|20324072|P1|Overall Study|Stopping Rule: Lost Greater than 5kg|4
5875110|NCT01928329|20324071|P2|Overall Study|Adverse Event|3
5875111|NCT01928329|20324072|P1|Overall Study|Adverse Event|5
5875112|NCT01928329|20324071|P2|Overall Study|Removed from Study Prior to Receiving Dr|1
5875113|NCT01928329|20324072|P1|Overall Study|Removed from Study Prior to Receiving Dr|0
5875114|NCT01928329|20324071|P2|Overall Study|Withdrew Consent Prior to Receiving Drug|3
5875115|NCT01928329|20324072|P1|Overall Study|Withdrew Consent Prior to Receiving Drug|1
5875116|NCT01928225|20324107|P2|Overall Study|Lost to Follow-up|3
5875117|NCT01928225|20324108|P1|Overall Study|Lost to Follow-up|1
5875118|NCT01928225|20324107|P2|Overall Study|basaloid cervical cancer|0
5875119|NCT01928225|20324108|P1|Overall Study|basaloid cervical cancer|1
5875120|NCT01928225|20324107|P2|Overall Study|Pregnancy|0
5875121|NCT01928225|20324108|P1|Overall Study|Pregnancy|1
5875122|NCT01928082|20324130|P1|Overall Study|Study terminated.|1
5875123|NCT01927861|20324164|P2|Extension Phase (104 Weeks)|Unclassified|1
5875124|NCT01927861|20324165|P1|Extension Phase (104 Weeks)|Unclassified|0
5875125|NCT01927861|20324164|P2|Extension Phase (104 Weeks)|Adverse Event|2
5875126|NCT01927861|20324165|P1|Extension Phase (104 Weeks)|Adverse Event|0
5875127|NCT01927757|20324303|P1|Overall Study|Ethical Reasons|4
5875128|NCT01927757|20324303|P1|Overall Study|Other|1
5875129|NCT01927757|20324303|P1|Overall Study|Decision by Sponsor|2
5875130|NCT01927757|20324303|P1|Overall Study|Lost to Follow-up|2
5875131|NCT01927757|20324303|P1|Overall Study|Withdrawal by Subject|14
5875132|NCT01927627|20324325|P1|Overall Study|Financial Concerns|1
5875133|NCT01927627|20324325|P1|Overall Study|Lack of Efficacy|1
5875134|NCT01927627|20324325|P1|Overall Study|Adverse Event|3
5875135|NCT01927562|20324338|P1|Overall Study|Physician Decision|5
5875136|NCT01927562|20324338|P1|Overall Study|Withdrawal by Subject|3
5875137|NCT01927562|20324338|P1|Overall Study|Lost to Follow-up|30
5875138|NCT01927419|20324344|P2|Overall Study|Not reported|0
5875139|NCT01927419|20324345|P1|Overall Study|Not reported|1
5875140|NCT01927419|20324344|P2|Overall Study|Other|1
5875141|NCT01927419|20324345|P1|Overall Study|Other|2
5875142|NCT01927419|20324344|P2|Overall Study|Withdrawal by Subject|1
5875143|NCT01927419|20324345|P1|Overall Study|Withdrawal by Subject|3
5875144|NCT01927419|20324344|P2|Overall Study|Adverse event unrelated to study drug|1
5875145|NCT01927419|20324345|P1|Overall Study|Adverse event unrelated to study drug|6
5875146|NCT01927419|20324344|P2|Overall Study|Death|1
5875147|NCT01927419|20324345|P1|Overall Study|Death|0
5875148|NCT01927419|20324344|P2|Overall Study|Study drug toxicity|7
5875149|NCT01927419|20324345|P1|Overall Study|Study drug toxicity|43
5875150|NCT01927419|20324344|P2|Overall Study|Disease progression|17
5875151|NCT01927419|20324345|P1|Overall Study|Disease progression|15
5875156|NCT01927055|20324396|P3|Double-Blind|Extended Vacation|0
5875157|NCT01927055|20324397|P2|Double-Blind|Extended Vacation|1
5875158|NCT01927055|20324398|P1|Double-Blind|Extended Vacation|0
5875159|NCT01927055|20324396|P3|Double-Blind|Supine Hypertension|1
5875160|NCT01927055|20324397|P2|Double-Blind|Supine Hypertension|0
5875161|NCT01927055|20324398|P1|Double-Blind|Supine Hypertension|0
5875162|NCT01927055|20324396|P3|Double-Blind|Study Stopped|7
5875163|NCT01927055|20324397|P2|Double-Blind|Study Stopped|7
5875164|NCT01927055|20324398|P1|Double-Blind|Study Stopped|0
5875165|NCT01927055|20324396|P3|Double-Blind|Withdrawal by Subject|3
5875166|NCT01927055|20324397|P2|Double-Blind|Withdrawal by Subject|2
5875167|NCT01927055|20324398|P1|Double-Blind|Withdrawal by Subject|0
5875168|NCT01927055|20324396|P3|Double-Blind|Protocol Violation|1
5875169|NCT01927055|20324397|P2|Double-Blind|Protocol Violation|0
5875170|NCT01927055|20324398|P1|Double-Blind|Protocol Violation|0
5875171|NCT01927055|20324396|P3|Double-Blind|Adverse Event|1
5875172|NCT01927055|20324397|P2|Double-Blind|Adverse Event|1
5875173|NCT01927055|20324398|P1|Double-Blind|Adverse Event|0
5875174|NCT01927055|20324396|P3|Open-label|Difficulty attending study visits|0
5875175|NCT01927055|20324397|P2|Open-label|Difficulty attending study visits|0
5875176|NCT01927055|20324398|P1|Open-label|Difficulty attending study visits|1
5875177|NCT01927055|20324396|P3|Open-label|Supine Hypertension|0
5875178|NCT01927055|20324397|P2|Open-label|Supine Hypertension|0
5875179|NCT01927055|20324398|P1|Open-label|Supine Hypertension|4
5875180|NCT01927055|20324396|P3|Open-label|Study Stopped|0
5875181|NCT01927055|20324397|P2|Open-label|Study Stopped|0
5875182|NCT01927055|20324398|P1|Open-label|Study Stopped|4
5875183|NCT01927055|20324396|P3|Open-label|Withdrawal by Subject|0
5875184|NCT01927055|20324397|P2|Open-label|Withdrawal by Subject|0
5875185|NCT01927055|20324398|P1|Open-label|Withdrawal by Subject|1
5875186|NCT01927055|20324396|P3|Open-label|Adverse Event|0
5875187|NCT01927055|20324397|P2|Open-label|Adverse Event|0
5875188|NCT01927055|20324398|P1|Open-label|Adverse Event|6
5875189|NCT01926886|20324416|P2|Overall Study|Did not cooperate|0
5875190|NCT01926886|20324417|P1|Overall Study|Did not cooperate|1
5875191|NCT01926886|20324416|P2|Overall Study|Death|0
5875192|NCT01926886|20324417|P1|Overall Study|Death|1
5875193|NCT01926886|20324416|P2|Overall Study|Progression of disease|0
5875194|NCT01926886|20324417|P1|Overall Study|Progression of disease|2
5875195|NCT01926886|20324416|P2|Overall Study|Recurrence of disease|0
5875196|NCT01926886|20324417|P1|Overall Study|Recurrence of disease|1
5875197|NCT01926886|20324416|P2|Overall Study|Failure to return|0
5875198|NCT01926886|20324417|P1|Overall Study|Failure to return|3
5875199|NCT01926886|20324416|P2|Overall Study|Withdrawal by Subject|0
5875200|NCT01926886|20324417|P1|Overall Study|Withdrawal by Subject|15
5875201|NCT01926886|20324416|P2|Overall Study|Disease progression/recurrence|0
5875202|NCT01926886|20324417|P1|Overall Study|Disease progression/recurrence|4
5875203|NCT01926886|20324416|P2|Overall Study|Adverse event/intercurrent illness|0
5875204|NCT01926886|20324417|P1|Overall Study|Adverse event/intercurrent illness|4
5875205|NCT01926886|20324416|P2|Overall Study|Administrative/other|0
5875206|NCT01926886|20324417|P1|Overall Study|Administrative/other|1
5875207|NCT01926782|20324436|P6|Overall Study|Related to study drug administration|2
5875208|NCT01926782|20324437|P5|Overall Study|Related to study drug administration|0
5875209|NCT01926782|20324438|P4|Overall Study|Related to study drug administration|0
5875210|NCT01926782|20324439|P3|Overall Study|Related to study drug administration|0
5875211|NCT01926782|20324440|P2|Overall Study|Related to study drug administration|0
5875212|NCT01926782|20324441|P1|Overall Study|Related to study drug administration|0
5875213|NCT01926782|20324436|P6|Overall Study|Withdrawal by Subject|5
5875214|NCT01926782|20324437|P5|Overall Study|Withdrawal by Subject|0
5875215|NCT01926782|20324438|P4|Overall Study|Withdrawal by Subject|1
5875216|NCT01926782|20324439|P3|Overall Study|Withdrawal by Subject|8
5875217|NCT01926782|20324440|P2|Overall Study|Withdrawal by Subject|1
5875218|NCT01926782|20324441|P1|Overall Study|Withdrawal by Subject|6
5875219|NCT01926782|20324436|P6|Overall Study|Randomized and not treated|0
5875220|NCT01926782|20324437|P5|Overall Study|Randomized and not treated|0
5875221|NCT01926782|20324438|P4|Overall Study|Randomized and not treated|1
5875222|NCT01926782|20324439|P3|Overall Study|Randomized and not treated|0
5875223|NCT01926782|20324440|P2|Overall Study|Randomized and not treated|0
5875224|NCT01926782|20324441|P1|Overall Study|Randomized and not treated|0
5875225|NCT01926782|20324436|P6|Overall Study|Poor compliance to protocol|6
5875226|NCT01926782|20324437|P5|Overall Study|Poor compliance to protocol|1
5875227|NCT01926782|20324438|P4|Overall Study|Poor compliance to protocol|0
5875228|NCT01926782|20324439|P3|Overall Study|Poor compliance to protocol|8
5875229|NCT01926782|20324440|P2|Overall Study|Poor compliance to protocol|3
5875230|NCT01926782|20324441|P1|Overall Study|Poor compliance to protocol|5
5875231|NCT01926782|20324436|P6|Overall Study|Adverse Event|14
5875232|NCT01926782|20324437|P5|Overall Study|Adverse Event|3
5875233|NCT01926782|20324438|P4|Overall Study|Adverse Event|4
5875234|NCT01926782|20324439|P3|Overall Study|Adverse Event|17
5875235|NCT01926782|20324440|P2|Overall Study|Adverse Event|4
5875236|NCT01926782|20324441|P1|Overall Study|Adverse Event|13
5875237|NCT01926782|20324436|P6|Overall Study|Other than specified|11
5875238|NCT01926782|20324437|P5|Overall Study|Other than specified|4
5875239|NCT01926782|20324438|P4|Overall Study|Other than specified|12
5875240|NCT01926782|20324439|P3|Overall Study|Other than specified|5
5875241|NCT01926782|20324440|P2|Overall Study|Other than specified|3
5875242|NCT01926782|20324441|P1|Overall Study|Other than specified|2
5875243|NCT01926782|20324436|P6|Overall Study|Physician Decision|0
5875244|NCT01926782|20324437|P5|Overall Study|Physician Decision|0
5875245|NCT01926782|20324438|P4|Overall Study|Physician Decision|1
5875246|NCT01926782|20324439|P3|Overall Study|Physician Decision|1
5875247|NCT01926782|20324440|P2|Overall Study|Physician Decision|2
5875248|NCT01926782|20324441|P1|Overall Study|Physician Decision|0
5875249|NCT01926782|20324436|P6|Overall Study|Participant moved|3
5875250|NCT01926782|20324437|P5|Overall Study|Participant moved|0
5875251|NCT01926782|20324438|P4|Overall Study|Participant moved|1
5875252|NCT01926782|20324439|P3|Overall Study|Participant moved|1
5875253|NCT01926782|20324440|P2|Overall Study|Participant moved|0
5875254|NCT01926782|20324441|P1|Overall Study|Participant moved|2
5875255|NCT01926626|20324590|P1|Overall Study|Lost to Follow-up|7
5875256|NCT01926626|20324590|P1|Overall Study|Withdrawal by Subject|15
5875257|NCT01926509|20324604|P4|Overall Study|vital sign met discontinuation criteria|0
5875258|NCT01926509|20324605|P3|Overall Study|vital sign met discontinuation criteria|0
5875259|NCT01926509|20324606|P2|Overall Study|vital sign met discontinuation criteria|0
5875260|NCT01926509|20324607|P1|Overall Study|vital sign met discontinuation criteria|1
5875261|NCT01926444|20324647|P4|Overall Study|Colonoscopy not performed|2
5875262|NCT01926444|20324648|P3|Overall Study|Colonoscopy not performed|4
5875263|NCT01926444|20324649|P2|Overall Study|Colonoscopy not performed|0
5875264|NCT01926444|20324650|P1|Overall Study|Colonoscopy not performed|0
5875265|NCT01926119|20324692|P1|Overall Study|Withdrawal by Subject|1
5875266|NCT01926028|20324705|P3|Overall Study|Non compliance or other reasons|0
5875267|NCT01926028|20324706|P2|Overall Study|Non compliance or other reasons|2
5875268|NCT01926028|20324707|P1|Overall Study|Non compliance or other reasons|4
5875269|NCT01926028|20324705|P3|Overall Study|Withdrawal by Subject|2
5875270|NCT01926028|20324706|P2|Overall Study|Withdrawal by Subject|9
5875271|NCT01926028|20324707|P1|Overall Study|Withdrawal by Subject|9
5875272|NCT01926028|20324705|P3|Overall Study|Physician Decision|0
5875273|NCT01926028|20324706|P2|Overall Study|Physician Decision|5
5875274|NCT01926028|20324707|P1|Overall Study|Physician Decision|1
5875275|NCT01926028|20324705|P3|Overall Study|Lost to Follow-up|0
5875276|NCT01926028|20324706|P2|Overall Study|Lost to Follow-up|6
5875277|NCT01926028|20324707|P1|Overall Study|Lost to Follow-up|7
5875278|NCT01926015|20324743|P2|Overall Study|Randomized not treated|0
5875279|NCT01926015|20324744|P1|Overall Study|Randomized not treated|2
5875280|NCT01926015|20324743|P2|Overall Study|Withdrawal by parent/guardian|1
5875281|NCT01926015|20324744|P1|Overall Study|Withdrawal by parent/guardian|0
5875282|NCT01925989|20324776|P3|Period 1|Withdrawal by Subject|0
5875283|NCT01925989|20324777|P2|Period 1|Withdrawal by Subject|1
5875284|NCT01925989|20324778|P1|Period 1|Withdrawal by Subject|0
5875285|NCT01925989|20324776|P3|Period 1|Sponsor Decision|0
5875286|NCT01925989|20324777|P2|Period 1|Sponsor Decision|1
5875287|NCT01925989|20324778|P1|Period 1|Sponsor Decision|1
5875288|NCT01925950|20324798|P2|Part 2|Withdrawal by Subject|0
5875289|NCT01925950|20324799|P1|Part 2|Withdrawal by Subject|1
5875290|NCT01925768|20324818|P2|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|1
5875291|NCT01925768|20324819|P1|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|5
5875292|NCT01925768|20324818|P2|ActiveTreatment/Extension (Weeks 24-104)|Death|1
5875293|NCT01925768|20324819|P1|ActiveTreatment/Extension (Weeks 24-104)|Death|0
5875294|NCT01925768|20324818|P2|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|1
5875295|NCT01925768|20324819|P1|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|2
5875296|NCT01925768|20324818|P2|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|9
5875297|NCT01925768|20324819|P1|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|7
5875298|NCT01925768|20324818|P2|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6
5875299|NCT01925768|20324819|P1|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6
5875300|NCT01925768|20324818|P2|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|1
5875301|NCT01925768|20324819|P1|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|0
5875302|NCT01925768|20324818|P2|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4
5875303|NCT01925768|20324819|P1|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1
5875304|NCT01925768|20324818|P2|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6
5875305|NCT01925768|20324819|P1|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3
5875306|NCT01925768|20324818|P2|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10
5875307|NCT01925768|20324819|P1|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5
5875308|NCT01925768|20324818|P2|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|2
5875309|NCT01925768|20324819|P1|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1
5875310|NCT01925768|20324818|P2|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
5875311|NCT01925768|20324819|P1|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1
5875312|NCT01925703|20324867|P1|Overall Study|Discharge prior to full iron repletion|1
5875313|NCT01925703|20324867|P1|Overall Study|Lost to Follow-up|2
5875314|NCT01925703|20324867|P1|Overall Study|Physician Decision|1
5875315|NCT01925612|20324885|P5|Overall Study|Adverse Event|2
5875316|NCT01925612|20324886|P4|Overall Study|Adverse Event|1
5875317|NCT01925612|20324887|P3|Overall Study|Adverse Event|0
5875318|NCT01925612|20324888|P2|Overall Study|Adverse Event|3
5875319|NCT01925612|20324889|P1|Overall Study|Adverse Event|3
5875320|NCT01925612|20324885|P5|Overall Study|Progressive Disease|0
5875321|NCT01925612|20324886|P4|Overall Study|Progressive Disease|0
5875322|NCT01925612|20324887|P3|Overall Study|Progressive Disease|1
5875323|NCT01925612|20324888|P2|Overall Study|Progressive Disease|1
5875324|NCT01925612|20324889|P1|Overall Study|Progressive Disease|1
5875325|NCT01925417|20324939|P1|Overall Study|Death|1
5875326|NCT01925417|20324939|P1|Overall Study|Withdrawal by Subject|2
5875327|NCT01925339|20324970|P2|Overall Study|Adverse Event|0
5875328|NCT01925339|20324971|P1|Overall Study|Adverse Event|2
5875329|NCT01925274|20324982|P3|Overall Study|Protocol amendment|6
5875330|NCT01925274|20324983|P2|Overall Study|Protocol amendment|3
5875331|NCT01925274|20324984|P1|Overall Study|Protocol amendment|1
5875332|NCT01925274|20324982|P3|Overall Study|Study terminated by sponsor|0
5875333|NCT01925274|20324983|P2|Overall Study|Study terminated by sponsor|0
5875334|NCT01925274|20324984|P1|Overall Study|Study terminated by sponsor|4
5875335|NCT01925274|20324982|P3|Overall Study|Withdrawal by Subject|0
5875336|NCT01925274|20324983|P2|Overall Study|Withdrawal by Subject|2
5875337|NCT01925274|20324984|P1|Overall Study|Withdrawal by Subject|1
5875338|NCT01925274|20324982|P3|Overall Study|Lost to Follow-up|0
5875339|NCT01925274|20324983|P2|Overall Study|Lost to Follow-up|1
5875340|NCT01925274|20324984|P1|Overall Study|Lost to Follow-up|0
5875341|NCT01925274|20324982|P3|Overall Study|Death|0
5875342|NCT01925274|20324983|P2|Overall Study|Death|0
5875343|NCT01925274|20324984|P1|Overall Study|Death|1
5875344|NCT01925209|20325065|P4|Follow-up|Withdrawal by Subject|2
5875345|NCT01925209|20325066|P3|Follow-up|Withdrawal by Subject|0
5875346|NCT01925209|20325067|P2|Follow-up|Withdrawal by Subject|2
5875347|NCT01925209|20325068|P1|Follow-up|Withdrawal by Subject|0
5875348|NCT01925209|20325065|P4|Follow-up|Non-compliance with study treatment|1
5875349|NCT01925209|20325066|P3|Follow-up|Non-compliance with study treatment|0
5875350|NCT01925209|20325067|P2|Follow-up|Non-compliance with study treatment|0
5875351|NCT01925209|20325068|P1|Follow-up|Non-compliance with study treatment|0
5875352|NCT01925209|20325065|P4|Follow-up|Physician Decision|0
5875353|NCT01925209|20325066|P3|Follow-up|Physician Decision|1
5875354|NCT01925209|20325067|P2|Follow-up|Physician Decision|0
5875355|NCT01925209|20325068|P1|Follow-up|Physician Decision|0
5875356|NCT01925209|20325065|P4|Follow-up|Adverse Event|1
5875357|NCT01925209|20325066|P3|Follow-up|Adverse Event|0
5875358|NCT01925209|20325067|P2|Follow-up|Adverse Event|4
5875359|NCT01925209|20325068|P1|Follow-up|Adverse Event|1
5875360|NCT01925209|20325065|P4|Maintenance Treatment Epoch|Adverse Event|0
5875361|NCT01925209|20325066|P3|Maintenance Treatment Epoch|Adverse Event|1
5875362|NCT01925209|20325067|P2|Maintenance Treatment Epoch|Adverse Event|0
5875363|NCT01925209|20325068|P1|Maintenance Treatment Epoch|Adverse Event|0
5875364|NCT01925209|20325065|P4|Maintenance Treatment Epoch|Withdrawal by Subject|2
5875365|NCT01925209|20325066|P3|Maintenance Treatment Epoch|Withdrawal by Subject|1
5875366|NCT01925209|20325067|P2|Maintenance Treatment Epoch|Withdrawal by Subject|1
5875367|NCT01925209|20325068|P1|Maintenance Treatment Epoch|Withdrawal by Subject|0
5875368|NCT01925209|20325065|P4|Treatment Epoch|Adverse Event|1
5875369|NCT01925209|20325066|P3|Treatment Epoch|Adverse Event|3
5875370|NCT01925209|20325067|P2|Treatment Epoch|Adverse Event|5
5875371|NCT01925209|20325068|P1|Treatment Epoch|Adverse Event|3
5875372|NCT01925209|20325065|P4|Treatment Epoch|Withdrawal by Subject|2
5875373|NCT01925209|20325066|P3|Treatment Epoch|Withdrawal by Subject|3
5875374|NCT01925209|20325067|P2|Treatment Epoch|Withdrawal by Subject|3
5875375|NCT01925209|20325068|P1|Treatment Epoch|Withdrawal by Subject|4
5875376|NCT01925209|20325065|P4|Treatment Epoch|Protocol deviation|1
5875377|NCT01925209|20325066|P3|Treatment Epoch|Protocol deviation|1
5875378|NCT01925209|20325067|P2|Treatment Epoch|Protocol deviation|0
5875379|NCT01925209|20325068|P1|Treatment Epoch|Protocol deviation|0
5875380|NCT01925209|20325065|P4|Treatment Epoch|Death|0
5875381|NCT01925209|20325066|P3|Treatment Epoch|Death|0
5875382|NCT01925209|20325067|P2|Treatment Epoch|Death|0
5875383|NCT01925209|20325068|P1|Treatment Epoch|Death|1
5875384|NCT01925209|20325065|P4|Treatment Epoch|Non-compliance with study treatment|1
5875385|NCT01925209|20325066|P3|Treatment Epoch|Non-compliance with study treatment|0
5875386|NCT01925209|20325067|P2|Treatment Epoch|Non-compliance with study treatment|0
5875387|NCT01925209|20325068|P1|Treatment Epoch|Non-compliance with study treatment|0
5875388|NCT01925209|20325065|P4|Treatment Epoch|Physician Decision|0
5875389|NCT01925209|20325066|P3|Treatment Epoch|Physician Decision|0
5875390|NCT01925209|20325067|P2|Treatment Epoch|Physician Decision|0
5875391|NCT01925209|20325068|P1|Treatment Epoch|Physician Decision|1
5875392|NCT01925183|20325100|P2|Overall Study|Adverse Event|0
5875393|NCT01925183|20325101|P1|Overall Study|Adverse Event|1
5875394|NCT01925170|20325109|P1|Overall Study|Unverified cancer status|53
5875395|NCT01925014|20325140|P2|Overall Study|Withdrawal by Subject|13
5875396|NCT01925014|20325141|P1|Overall Study|Withdrawal by Subject|5
5875397|NCT01925014|20325140|P2|Overall Study|Inappropriate enrollment|6
5875398|NCT01925014|20325141|P1|Overall Study|Inappropriate enrollment|4
5875399|NCT01924845|20325216|P1|Overall Study|Protocol Violation|1
5875400|NCT01924845|20325216|P1|Overall Study|Withdrawal by Subject|2
5875401|NCT01924845|20325216|P1|Overall Study|Adverse Event|3
5875402|NCT01924806|20325226|P2|Overall Study|Physician Decision|1
5875403|NCT01924806|20325227|P1|Overall Study|Physician Decision|2
5875404|NCT01924767|20325244|P5|Overall Study|Adverse Event|0
5875405|NCT01924767|20325245|P4|Overall Study|Adverse Event|0
5875406|NCT01924767|20325246|P3|Overall Study|Adverse Event|1
5875407|NCT01924767|20325247|P2|Overall Study|Adverse Event|0
5875408|NCT01924767|20325248|P1|Overall Study|Adverse Event|1
5875409|NCT01924689|20325354|P6|Overall Study|Other|0
5875410|NCT01924689|20325355|P5|Overall Study|Other|1
5875411|NCT01924689|20325356|P4|Overall Study|Other|0
5875412|NCT01924689|20325357|P3|Overall Study|Other|0
5875413|NCT01924689|20325358|P2|Overall Study|Other|0
5875414|NCT01924689|20325359|P1|Overall Study|Other|0
5875415|NCT01924689|20325354|P6|Overall Study|Withdrawal of consent|0
5875416|NCT01924689|20325355|P5|Overall Study|Withdrawal of consent|0
5875417|NCT01924689|20325356|P4|Overall Study|Withdrawal of consent|1
5875418|NCT01924689|20325357|P3|Overall Study|Withdrawal of consent|1
5875419|NCT01924689|20325358|P2|Overall Study|Withdrawal of consent|0
5875420|NCT01924689|20325359|P1|Overall Study|Withdrawal of consent|0
5875421|NCT01924689|20325354|P6|Overall Study|New therapy or study|0
5875422|NCT01924689|20325355|P5|Overall Study|New therapy or study|2
5875423|NCT01924689|20325356|P4|Overall Study|New therapy or study|4
5875424|NCT01924689|20325357|P3|Overall Study|New therapy or study|1
5875425|NCT01924689|20325358|P2|Overall Study|New therapy or study|2
5875426|NCT01924689|20325359|P1|Overall Study|New therapy or study|3
5875427|NCT01924689|20325354|P6|Overall Study|Disease progression|2
5875428|NCT01924689|20325355|P5|Overall Study|Disease progression|3
5875429|NCT01924689|20325356|P4|Overall Study|Disease progression|0
5875430|NCT01924689|20325357|P3|Overall Study|Disease progression|2
5875431|NCT01924689|20325358|P2|Overall Study|Disease progression|0
5875432|NCT01924689|20325359|P1|Overall Study|Disease progression|0
5875433|NCT01924689|20325354|P6|Overall Study|Death|0
5875434|NCT01924689|20325355|P5|Overall Study|Death|0
5875435|NCT01924689|20325356|P4|Overall Study|Death|1
5875436|NCT01924689|20325357|P3|Overall Study|Death|0
5875437|NCT01924689|20325358|P2|Overall Study|Death|1
5875438|NCT01924689|20325359|P1|Overall Study|Death|0
5875439|NCT01924533|20325433|P2|Overall Study|Other Eligibility criteria|1
5875440|NCT01924533|20325434|P1|Overall Study|Other Eligibility criteria|1
5875441|NCT01924533|20325433|P2|Overall Study|Withdrawal by Subject|3
5875442|NCT01924533|20325434|P1|Overall Study|Withdrawal by Subject|7
5875443|NCT01924533|20325433|P2|Overall Study|Lost to Follow-up|1
5875444|NCT01924533|20325434|P1|Overall Study|Lost to Follow-up|0
5875445|NCT01924533|20325433|P2|Overall Study|Death|200
5875446|NCT01924533|20325434|P1|Overall Study|Death|181
5875447|NCT01924429|20325475|P2|Washout Period (2 Weeks)|Withdrawal by Subject|2
5875448|NCT01924429|20325476|P1|Washout Period (2 Weeks)|Withdrawal by Subject|3
5875449|NCT01924364|20325519|P1|Overall Study|Physician Decision|3
5875450|NCT01924299|20325536|P2|Period 2|Adverse Event|1
5875451|NCT01924299|20325537|P1|Period 2|Adverse Event|0
5875452|NCT01924299|20325536|P2|Period 2|Withdrawal by Subject|0
5875453|NCT01924299|20325537|P1|Period 2|Withdrawal by Subject|1
5875454|NCT01924182|20325559|P2|Overall Study|Withdrawal by Subject|0
5875455|NCT01924182|20325560|P1|Overall Study|Withdrawal by Subject|1
5875456|NCT01923896|20325601|P2|Overall Study|Adverse Event|0
5875457|NCT01923896|20325602|P1|Overall Study|Adverse Event|1
5875458|NCT01923740|20325625|P2|Overall Study|Withdrawal by Subject|0
5875459|NCT01923740|20325626|P1|Overall Study|Withdrawal by Subject|2
5875460|NCT01923740|20325625|P2|Overall Study|Lost to Follow-up|9
5875461|NCT01923740|20325626|P1|Overall Study|Lost to Follow-up|4
5875462|NCT01923467|20326051|P1|Overall Study|Subject non-interest|479
5875463|NCT01923467|20326051|P1|Overall Study|Lost to Follow-up|62
5875464|NCT01923428|20326059|P4|Overall Study|Lack of Efficacy|1
5875465|NCT01923428|20326060|P3|Overall Study|Lack of Efficacy|1
5875466|NCT01923428|20326061|P2|Overall Study|Lack of Efficacy|0
5875467|NCT01923428|20326062|P1|Overall Study|Lack of Efficacy|0
5875468|NCT01923428|20326059|P4|Overall Study|Non Compliance to treatment|1
5875469|NCT01923428|20326060|P3|Overall Study|Non Compliance to treatment|0
5875470|NCT01923428|20326061|P2|Overall Study|Non Compliance to treatment|2
5875471|NCT01923428|20326062|P1|Overall Study|Non Compliance to treatment|1
5875472|NCT01923428|20326059|P4|Overall Study|Protocol Violation|1
5875473|NCT01923428|20326060|P3|Overall Study|Protocol Violation|2
5875474|NCT01923428|20326061|P2|Overall Study|Protocol Violation|0
5875475|NCT01923428|20326062|P1|Overall Study|Protocol Violation|3
5875476|NCT01923428|20326059|P4|Overall Study|Lost to Follow-up|0
5875477|NCT01923428|20326060|P3|Overall Study|Lost to Follow-up|5
5875478|NCT01923428|20326061|P2|Overall Study|Lost to Follow-up|1
5875479|NCT01923428|20326062|P1|Overall Study|Lost to Follow-up|2
5875480|NCT01923428|20326059|P4|Overall Study|Withdrawal by Subject|4
5875481|NCT01923428|20326060|P3|Overall Study|Withdrawal by Subject|0
5875482|NCT01923428|20326061|P2|Overall Study|Withdrawal by Subject|3
5875483|NCT01923428|20326062|P1|Overall Study|Withdrawal by Subject|5
5875484|NCT01923428|20326059|P4|Overall Study|Adverse Event|3
5875485|NCT01923428|20326060|P3|Overall Study|Adverse Event|3
5875486|NCT01923428|20326061|P2|Overall Study|Adverse Event|6
5875487|NCT01923428|20326062|P1|Overall Study|Adverse Event|8
5875488|NCT01923389|20326074|P2|Overall Study|Protocol Violation|0
5875489|NCT01923389|20326075|P1|Overall Study|Protocol Violation|1
5875490|NCT01923363|20326097|P1|Overall Study|Protocol Violation|1
5875491|NCT01923311|20326106|P2|Overall Study|Study Terminated by Sponsor|0
5875492|NCT01923311|20326107|P1|Overall Study|Study Terminated by Sponsor|12
5875493|NCT01923311|20326106|P2|Overall Study|Withdrew Consent|0
5875494|NCT01923311|20326107|P1|Overall Study|Withdrew Consent|1
5875495|NCT01923311|20326106|P2|Overall Study|Non-Compliance with Study Drug|1
5875496|NCT01923311|20326107|P1|Overall Study|Non-Compliance with Study Drug|2
5875497|NCT01923311|20326106|P2|Overall Study|Investigator's Discretion|0
5875498|NCT01923311|20326107|P1|Overall Study|Investigator's Discretion|1
5875499|NCT01923311|20326106|P2|Overall Study|Pregnancy|0
5875500|NCT01923311|20326107|P1|Overall Study|Pregnancy|1
5875501|NCT01923285|20326152|P2|Overall Study|Withdrawal by Subject|6
5875502|NCT01923285|20326153|P1|Overall Study|Withdrawal by Subject|7
5875503|NCT01923181|20326174|P9|Overall Study|Lost to Follow-up|1
5875504|NCT01923181|20326175|P8|Overall Study|Lost to Follow-up|3
5875505|NCT01923181|20326176|P7|Overall Study|Lost to Follow-up|3
5875506|NCT01923181|20326177|P6|Overall Study|Lost to Follow-up|1
5875507|NCT01923181|20326178|P5|Overall Study|Lost to Follow-up|2
5875508|NCT01923181|20326179|P4|Overall Study|Lost to Follow-up|1
5875509|NCT01923181|20326180|P3|Overall Study|Lost to Follow-up|2
5875510|NCT01923181|20326181|P2|Overall Study|Lost to Follow-up|3
5875511|NCT01923181|20326182|P1|Overall Study|Lost to Follow-up|0
5875512|NCT01923181|20326174|P9|Overall Study|Other|0
5875513|NCT01923181|20326175|P8|Overall Study|Other|0
5875514|NCT01923181|20326176|P7|Overall Study|Other|0
5875515|NCT01923181|20326177|P6|Overall Study|Other|0
5875516|NCT01923181|20326178|P5|Overall Study|Other|0
5875517|NCT01923181|20326179|P4|Overall Study|Other|1
5875518|NCT01923181|20326180|P3|Overall Study|Other|0
5875519|NCT01923181|20326181|P2|Overall Study|Other|0
5875520|NCT01923181|20326182|P1|Overall Study|Other|1
5875521|NCT01923181|20326174|P9|Overall Study|Withdrawal by Subject|1
5875522|NCT01923181|20326175|P8|Overall Study|Withdrawal by Subject|3
5875523|NCT01923181|20326176|P7|Overall Study|Withdrawal by Subject|4
5875524|NCT01923181|20326177|P6|Overall Study|Withdrawal by Subject|2
5875525|NCT01923181|20326178|P5|Overall Study|Withdrawal by Subject|4
5875526|NCT01923181|20326179|P4|Overall Study|Withdrawal by Subject|1
5875527|NCT01923181|20326180|P3|Overall Study|Withdrawal by Subject|0
5875528|NCT01923181|20326181|P2|Overall Study|Withdrawal by Subject|1
5875529|NCT01923181|20326182|P1|Overall Study|Withdrawal by Subject|0
5875530|NCT01923181|20326174|P9|Overall Study|Protocol Violation|1
5875531|NCT01923181|20326175|P8|Overall Study|Protocol Violation|2
5875532|NCT01923181|20326176|P7|Overall Study|Protocol Violation|1
5875533|NCT01923181|20326177|P6|Overall Study|Protocol Violation|1
5875534|NCT01923181|20326178|P5|Overall Study|Protocol Violation|2
5875535|NCT01923181|20326179|P4|Overall Study|Protocol Violation|2
5875536|NCT01923181|20326180|P3|Overall Study|Protocol Violation|0
5875537|NCT01923181|20326181|P2|Overall Study|Protocol Violation|2
5875538|NCT01923181|20326182|P1|Overall Study|Protocol Violation|2
5875539|NCT01923168|20326260|P3|Overall Study|Death|1
5875540|NCT01923168|20326261|P2|Overall Study|Death|0
5875541|NCT01923168|20326262|P1|Overall Study|Death|0
5875542|NCT01923168|20326260|P3|Overall Study|Progressive disease|7
5875543|NCT01923168|20326261|P2|Overall Study|Progressive disease|3
5875544|NCT01923168|20326262|P1|Overall Study|Progressive disease|4
5875545|NCT01923168|20326260|P3|Overall Study|Physician Decision|5
5875546|NCT01923168|20326261|P2|Overall Study|Physician Decision|9
5875547|NCT01923168|20326262|P1|Overall Study|Physician Decision|6
5875548|NCT01923168|20326260|P3|Overall Study|Adverse Event|0
5875549|NCT01923168|20326261|P2|Overall Study|Adverse Event|12
5875550|NCT01923168|20326262|P1|Overall Study|Adverse Event|12
5875551|NCT01923168|20326260|P3|Overall Study|Subject/guardian decision|4
5875552|NCT01923168|20326261|P2|Overall Study|Subject/guardian decision|14
5875553|NCT01923168|20326262|P1|Overall Study|Subject/guardian decision|14
5875554|NCT01923168|20326260|P3|Overall Study|Protocol Violation|0
5875555|NCT01923168|20326261|P2|Overall Study|Protocol Violation|1
5875556|NCT01923168|20326262|P1|Overall Study|Protocol Violation|1
5875557|NCT01922934|20326345|P2|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|1284
5875558|NCT01922934|20326346|P1|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|21
5875559|NCT01922934|20326345|P2|Visit 0 - Patient Contacted & Consented|No response or could not reach|0
5875560|NCT01922934|20326346|P1|Visit 0 - Patient Contacted & Consented|No response or could not reach|66
5875561|NCT01922934|20326345|P2|Visit 0 - Patient Contacted & Consented|Patient declined to participate|0
5875562|NCT01922934|20326346|P1|Visit 0 - Patient Contacted & Consented|Patient declined to participate|169
5875563|NCT01922934|20326345|P2|Eligible Patients|Did not meet inclusion criteria|81
5875564|NCT01922934|20326346|P1|Eligible Patients|Did not meet inclusion criteria|36
5875565|NCT01922934|20326345|P2|Eligible Patients|Physician Decision|0
5875566|NCT01922934|20326346|P1|Eligible Patients|Physician Decision|17
5875567|NCT01922934|20326345|P2|Eligible Patients|Death|7
5875568|NCT01922934|20326346|P1|Eligible Patients|Death|0
5875569|NCT01922739|20326358|P1|Open-label Treatment Period|Sponsor request - investigator leaving|1
5875570|NCT01922739|20326358|P1|Open-label Treatment Period|Physician Decision|1
5875571|NCT01922739|20326358|P1|Open-label Treatment Period|Lost to Follow-up|2
5875572|NCT01922739|20326358|P1|Open-label Treatment Period|Noncompliance to study procedures|1
5875573|NCT01922739|20326358|P1|Open-label Treatment Period|Pregnancy|1
5875574|NCT01922739|20326358|P1|Open-label Treatment Period|Protocol Violation|5
5875575|NCT01922739|20326358|P1|Open-label Treatment Period|Noncompliance to study medication|3
5875576|NCT01922739|20326358|P1|Open-label Treatment Period|Withdrawal by Subject|14
5875577|NCT01922739|20326358|P1|Open-label Treatment Period|Adverse Event|6
5875578|NCT01922739|20326358|P1|Titration/Adjustment Period|Lack of Efficacy|3
5875579|NCT01922739|20326358|P1|Titration/Adjustment Period|Lost to Follow-up|1
5875580|NCT01922739|20326358|P1|Titration/Adjustment Period|Withdrawal by Subject|5
5875581|NCT01922739|20326358|P1|Titration/Adjustment Period|Adverse Event|3
5875582|NCT01922349|20326387|P4|Multiple Rising Dose (MRD) Period|Adverse Event|1
5875583|NCT01922349|20326388|P3|Multiple Rising Dose (MRD) Period|Adverse Event|0
5875584|NCT01922349|20326389|P2|Multiple Rising Dose (MRD) Period|Adverse Event|0
5875585|NCT01922349|20326390|P1|Multiple Rising Dose (MRD) Period|Adverse Event|0
5875586|NCT01922271|20326519|P2|WASHOUT Period|Withdrawal by Subject|0
5875587|NCT01922271|20326520|P1|WASHOUT Period|Withdrawal by Subject|1
5875588|NCT01922258|20326540|P2|Overall Study|Withdrawal by participant|5
5875589|NCT01922258|20326541|P1|Overall Study|Withdrawal by participant|5
5875590|NCT01922258|20326540|P2|Overall Study|Withdrawn by the Investigator|4
5875591|NCT01922258|20326541|P1|Overall Study|Withdrawn by the Investigator|1
5875592|NCT01922258|20326540|P2|Overall Study|Met Withdrawal Criteria|4
5875593|NCT01922258|20326541|P1|Overall Study|Met Withdrawal Criteria|0
5875594|NCT01922258|20326540|P2|Overall Study|Adverse Event|2
5875595|NCT01922258|20326541|P1|Overall Study|Adverse Event|9
5875596|NCT01922258|20326540|P2|Overall Study|Lost to Follow-up|1
5875597|NCT01922258|20326541|P1|Overall Study|Lost to Follow-up|1
5875598|NCT01922102|20326573|P3|Overall Study|Administrative problems|0
5875599|NCT01922102|20326574|P2|Overall Study|Administrative problems|2
5875600|NCT01922102|20326575|P1|Overall Study|Administrative problems|0
5875601|NCT01922102|20326573|P3|Overall Study|Lost to Follow-up|0
5875602|NCT01922102|20326574|P2|Overall Study|Lost to Follow-up|0
5875603|NCT01922102|20326575|P1|Overall Study|Lost to Follow-up|1
5875604|NCT01922102|20326573|P3|Overall Study|Adverse Event|0
5875605|NCT01922102|20326574|P2|Overall Study|Adverse Event|2
5875606|NCT01922102|20326575|P1|Overall Study|Adverse Event|1
5875607|NCT01922102|20326573|P3|Overall Study|Physician Decision|1
5875608|NCT01922102|20326574|P2|Overall Study|Physician Decision|2
5875609|NCT01922102|20326575|P1|Overall Study|Physician Decision|0
5875610|NCT01922102|20326573|P3|Overall Study|Withdrawal by Subject|7
5875611|NCT01922102|20326574|P2|Overall Study|Withdrawal by Subject|3
5875612|NCT01922102|20326575|P1|Overall Study|Withdrawal by Subject|7
5875613|NCT01922089|20326611|P2|Overall Study|Lost to Follow-up|1
5875614|NCT01922089|20326612|P1|Overall Study|Lost to Follow-up|0
5875615|NCT01922089|20326611|P2|Overall Study|Death|1
5875616|NCT01922089|20326612|P1|Overall Study|Death|2
5875617|NCT01922089|20326611|P2|Overall Study|Physician Decision|3
5875618|NCT01922089|20326612|P1|Overall Study|Physician Decision|2
5875619|NCT01922089|20326611|P2|Overall Study|administrative problems|1
5875620|NCT01922089|20326612|P1|Overall Study|administrative problems|4
5875621|NCT01922089|20326611|P2|Overall Study|Withdrawal by Subject|4
5875622|NCT01922089|20326612|P1|Overall Study|Withdrawal by Subject|3
5875623|NCT01922089|20326611|P2|Overall Study|Protocol Deviation|7
5875624|NCT01922089|20326612|P1|Overall Study|Protocol Deviation|10
5875625|NCT01922089|20326611|P2|Overall Study|Adverse Event|13
5875626|NCT01922089|20326612|P1|Overall Study|Adverse Event|18
5875627|NCT01922037|20326689|P2|Overall Study|Other unspecified|66
5875628|NCT01922037|20326690|P1|Overall Study|Other unspecified|2
5875629|NCT01922037|20326689|P2|Overall Study|Investigator/Sponsor decision|4
5875630|NCT01922037|20326690|P1|Overall Study|Investigator/Sponsor decision|1
5875631|NCT01922037|20326689|P2|Overall Study|Participant non-compliance|46
5875632|NCT01922037|20326690|P1|Overall Study|Participant non-compliance|4
5875633|NCT01922037|20326689|P2|Overall Study|Pregnancy|2
5875634|NCT01922037|20326690|P1|Overall Study|Pregnancy|0
5875635|NCT01922037|20326689|P2|Overall Study|Death|5
5875636|NCT01922037|20326690|P1|Overall Study|Death|0
5875637|NCT01922037|20326689|P2|Overall Study|Adverse Event|7
5875638|NCT01922037|20326690|P1|Overall Study|Adverse Event|1
5875639|NCT01922037|20326689|P2|Overall Study|Withdrawal by Subject|44
5875640|NCT01922037|20326690|P1|Overall Study|Withdrawal by Subject|2
5875641|NCT01922011|20326793|P2|Overall Study|Randomized in error|0
5875642|NCT01922011|20326794|P1|Overall Study|Randomized in error|1
5875643|NCT01922011|20326793|P2|Overall Study|Lack of willing home health agency|0
5875644|NCT01922011|20326794|P1|Overall Study|Lack of willing home health agency|1
5875645|NCT01922011|20326793|P2|Overall Study|Not Treated|0
5875646|NCT01922011|20326794|P1|Overall Study|Not Treated|1
5875647|NCT01922011|20326793|P2|Overall Study|Missed Test-of-Cure Visit|2
5875648|NCT01922011|20326794|P1|Overall Study|Missed Test-of-Cure Visit|0
5875649|NCT01922011|20326793|P2|Overall Study|Lost to Follow-up|1
5875650|NCT01922011|20326794|P1|Overall Study|Lost to Follow-up|0
5875651|NCT01922011|20326793|P2|Overall Study|Parent/Guardian Decision|0
5875652|NCT01922011|20326794|P1|Overall Study|Parent/Guardian Decision|3
5875653|NCT01922011|20326793|P2|Overall Study|Physician Decision|1
5875654|NCT01922011|20326794|P1|Overall Study|Physician Decision|0
5875655|NCT01922011|20326793|P2|Overall Study|Protocol Violation|1
5875656|NCT01922011|20326794|P1|Overall Study|Protocol Violation|0
5875657|NCT01921829|20326861|P2|Overall Study|Withdrawal by Subject|1
5875658|NCT01921829|20326862|P1|Overall Study|Withdrawal by Subject|0
5875659|NCT01921517|20326938|P2|Overall Study|Subject missed final imaging|4
5875660|NCT01921517|20326939|P1|Overall Study|Subject missed final imaging|1
5875661|NCT01921517|20326938|P2|Overall Study|Withdrawal by Subject|3
5875662|NCT01921517|20326939|P1|Overall Study|Withdrawal by Subject|7
5875663|NCT01921517|20326938|P2|Overall Study|Physician Decision|2
5875664|NCT01921517|20326939|P1|Overall Study|Physician Decision|0
5875665|NCT01921517|20326938|P2|Overall Study|Newly diagnosed health concern|0
5875666|NCT01921517|20326939|P1|Overall Study|Newly diagnosed health concern|2
5875667|NCT01921517|20326938|P2|Overall Study|Lost to Follow-up|0
5875668|NCT01921517|20326939|P1|Overall Study|Lost to Follow-up|5
5875669|NCT01921387|20326950|P1|Overall Study|Adverse Event|1
5875670|NCT01921348|20326959|P2|Overall Study|Lost to Follow-up|2
5875671|NCT01921348|20326960|P1|Overall Study|Lost to Follow-up|0
5875672|NCT01921348|20326959|P2|Overall Study|Withdrawal by Subject|0
5875673|NCT01921348|20326960|P1|Overall Study|Withdrawal by Subject|1
5875674|NCT01921270|20326989|P1|Overall Study|Withdrawal by Subject|1
5875675|NCT01921257|20327005|P1|Overall Study|Withdrawal by Subject|1
5875676|NCT01921257|20327005|P1|Overall Study|Protocol Violation|1
5875677|NCT01921257|20327005|P1|Overall Study|Adverse Event|1
5875678|NCT01921218|20327012|P2|Overall Study|Kidney transplant|1
5875679|NCT01921218|20327013|P1|Overall Study|Kidney transplant|1
5875680|NCT01921218|20327012|P2|Overall Study|Withdrawal by Subject|2
5875681|NCT01921218|20327013|P1|Overall Study|Withdrawal by Subject|0
5875682|NCT01921218|20327012|P2|Overall Study|Death|1
5875683|NCT01921218|20327013|P1|Overall Study|Death|2
5875684|NCT01921205|20327029|P2|Overall Study|Non Compliance Of Child|1
5875685|NCT01921205|20327030|P1|Overall Study|Non Compliance Of Child|0
5875686|NCT01921205|20327029|P2|Overall Study|Non Compliance Of The Parent|1
5875687|NCT01921205|20327030|P1|Overall Study|Non Compliance Of The Parent|0
5875688|NCT01921205|20327029|P2|Overall Study|The Excessive Use Of Rescue Medication|1
5875689|NCT01921205|20327030|P1|Overall Study|The Excessive Use Of Rescue Medication|0
5875690|NCT01921205|20327029|P2|Overall Study|Use Of Prohibited Medication|1
5875691|NCT01921205|20327030|P1|Overall Study|Use Of Prohibited Medication|0
5875692|NCT01921205|20327029|P2|Overall Study|Withdrawal by Subject|5
5875693|NCT01921205|20327030|P1|Overall Study|Withdrawal by Subject|6
5875694|NCT01921205|20327029|P2|Overall Study|Lost to Follow-up|1
5875695|NCT01921205|20327030|P1|Overall Study|Lost to Follow-up|1
5875696|NCT01921205|20327029|P2|Overall Study|Protocol Violation|3
5875697|NCT01921205|20327030|P1|Overall Study|Protocol Violation|1
5875698|NCT01921205|20327029|P2|Overall Study|Lack of Efficacy|0
5875699|NCT01921205|20327030|P1|Overall Study|Lack of Efficacy|1
5875700|NCT01921205|20327029|P2|Overall Study|Adverse Event|7
5875701|NCT01921205|20327030|P1|Overall Study|Adverse Event|12
5875702|NCT01921179|20327060|P2|Long Term Follow-up After GOALS Training|Lost to Follow-up|0
5875703|NCT01921179|20327061|P1|Long Term Follow-up After GOALS Training|Lost to Follow-up|2
5875704|NCT01921179|20327060|P2|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3
5875705|NCT01921179|20327061|P1|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3
5875706|NCT01921101|20327098|P2|Overall Study|Death|6
5875707|NCT01921101|20327099|P1|Overall Study|Death|16
5875708|NCT01920958|20327107|P1|Overall Study|Did Not Fulfill Inclusion Criteria|5
5875709|NCT01920893|20327125|P2|Overall Study|Lack of Efficacy|0
5875710|NCT01920893|20327126|P1|Overall Study|Lack of Efficacy|2
5875711|NCT01920893|20327125|P2|Overall Study|Adverse Event|2
5875712|NCT01920893|20327126|P1|Overall Study|Adverse Event|5
5875713|NCT01920854|20327159|P7|Overall Study|Withdrawal by Subject|1
5875714|NCT01920854|20327160|P6|Overall Study|Withdrawal by Subject|0
5875715|NCT01920854|20327161|P5|Overall Study|Withdrawal by Subject|1
5875716|NCT01920854|20327162|P4|Overall Study|Withdrawal by Subject|0
5875717|NCT01920854|20327163|P3|Overall Study|Withdrawal by Subject|0
5875718|NCT01920854|20327164|P2|Overall Study|Withdrawal by Subject|0
5875719|NCT01920854|20327165|P1|Overall Study|Withdrawal by Subject|1
5875720|NCT01920711|20327325|P2|Overall Study|Withdrawal by Subject|3
5875721|NCT01920711|20327326|P1|Overall Study|Withdrawal by Subject|4
5875722|NCT01920711|20327325|P2|Overall Study|Lost to Follow-up|14
5875723|NCT01920711|20327326|P1|Overall Study|Lost to Follow-up|13
5875724|NCT01920711|20327325|P2|Overall Study|Death|356
5875725|NCT01920711|20327326|P1|Overall Study|Death|347
5875726|NCT01920594|20327343|P2|Overall Study|Investigator discretion|1
5875727|NCT01920594|20327344|P1|Overall Study|Investigator discretion|0
5875728|NCT01920594|20327343|P2|Overall Study|Recovery|0
5875729|NCT01920594|20327344|P1|Overall Study|Recovery|2
5875730|NCT01920594|20327343|P2|Overall Study|Lost to Follow-up|0
5875731|NCT01920594|20327344|P1|Overall Study|Lost to Follow-up|1
5875732|NCT01920594|20327343|P2|Overall Study|Adverse Event|2
5875733|NCT01920594|20327344|P1|Overall Study|Adverse Event|4
5875734|NCT01920568|20327394|P2|Overall Study|Death due to disease progression|12
5875735|NCT01920568|20327395|P1|Overall Study|Death due to disease progression|25
5875736|NCT01920568|20327394|P2|Overall Study|Withdrawal by Subject|55
5875737|NCT01920568|20327395|P1|Overall Study|Withdrawal by Subject|79
5875738|NCT01920568|20327394|P2|Overall Study|Physician Decision|4
5875739|NCT01920568|20327395|P1|Overall Study|Physician Decision|13
5875740|NCT01920568|20327394|P2|Overall Study|Lost to Follow-up|2
5875741|NCT01920568|20327395|P1|Overall Study|Lost to Follow-up|2
5875742|NCT01920568|20327394|P2|Overall Study|Protocol Violation|3
5875743|NCT01920568|20327395|P1|Overall Study|Protocol Violation|5
5875744|NCT01920568|20327394|P2|Overall Study|Adverse Event|8
5875745|NCT01920568|20327395|P1|Overall Study|Adverse Event|27
5875746|NCT01920555|20327421|P5|Overall Study|Lost to Follow-up|0
5875747|NCT01920555|20327422|P4|Overall Study|Lost to Follow-up|1
5875748|NCT01920555|20327423|P3|Overall Study|Lost to Follow-up|0
5875749|NCT01920555|20327424|P2|Overall Study|Lost to Follow-up|1
5875750|NCT01920555|20327425|P1|Overall Study|Lost to Follow-up|0
5875751|NCT01920555|20327421|P5|Overall Study|Travel Difficulties|1
5875752|NCT01920555|20327422|P4|Overall Study|Travel Difficulties|0
5875753|NCT01920555|20327423|P3|Overall Study|Travel Difficulties|0
5875754|NCT01920555|20327424|P2|Overall Study|Travel Difficulties|1
5875755|NCT01920555|20327425|P1|Overall Study|Travel Difficulties|1
5875756|NCT01920555|20327421|P5|Overall Study|Lack of Efficacy|0
5875757|NCT01920555|20327422|P4|Overall Study|Lack of Efficacy|0
5875758|NCT01920555|20327423|P3|Overall Study|Lack of Efficacy|0
5875759|NCT01920555|20327424|P2|Overall Study|Lack of Efficacy|0
5875760|NCT01920555|20327425|P1|Overall Study|Lack of Efficacy|2
5875761|NCT01920555|20327421|P5|Overall Study|Physician Decision|0
5875762|NCT01920555|20327422|P4|Overall Study|Physician Decision|2
5875763|NCT01920555|20327423|P3|Overall Study|Physician Decision|1
5875764|NCT01920555|20327424|P2|Overall Study|Physician Decision|2
5875765|NCT01920555|20327425|P1|Overall Study|Physician Decision|1
5875766|NCT01920477|20327484|P2|Overall Study|Withdrawal by Subject|1
5875767|NCT01920477|20327485|P1|Overall Study|Withdrawal by Subject|0
5875768|NCT01920477|20327484|P2|Overall Study|Study closed/terminated|15
5875769|NCT01920477|20327485|P1|Overall Study|Study closed/terminated|14
5875770|NCT01920477|20327484|P2|Overall Study|Lack of Efficacy|0
5875771|NCT01920477|20327485|P1|Overall Study|Lack of Efficacy|1
5875772|NCT01920477|20327484|P2|Overall Study|Adverse Event|1
5875773|NCT01920477|20327485|P1|Overall Study|Adverse Event|0
5875774|NCT01920178|20327534|P2|Overall Study|Lost to Follow-up|1
5875775|NCT01920178|20327535|P1|Overall Study|Lost to Follow-up|2
5875778|NCT01919970|20327592|P2|Overall Study|Withdrawal by Subject|0
5875779|NCT01919970|20327593|P1|Overall Study|Withdrawal by Subject|3
5875780|NCT01919814|20327601|P2|Overall Study|Withdrawal by Subject|0
5875781|NCT01919814|20327602|P1|Overall Study|Withdrawal by Subject|1
5875782|NCT01919814|20327601|P2|Overall Study|Protocol Violation|0
5875783|NCT01919814|20327602|P1|Overall Study|Protocol Violation|1
5875784|NCT01919814|20327601|P2|Overall Study|Adverse Event|0
5875785|NCT01919814|20327602|P1|Overall Study|Adverse Event|1
5875786|NCT01919801|20327614|P2|Overall Study|Other|1
5875787|NCT01919801|20327615|P1|Overall Study|Other|0
5875788|NCT01919801|20327614|P2|Overall Study|Lost to Follow-up|1
5875789|NCT01919801|20327615|P1|Overall Study|Lost to Follow-up|0
5875790|NCT01919801|20327614|P2|Overall Study|Physician Decision|1
5875791|NCT01919801|20327615|P1|Overall Study|Physician Decision|0
5875792|NCT01919801|20327614|P2|Overall Study|Withdrawal by Subject|0
5875793|NCT01919801|20327615|P1|Overall Study|Withdrawal by Subject|1
5875794|NCT01919723|20327640|P2|Overall Study|Blood Samples Hemolyzed|2
5875795|NCT01919723|20327641|P1|Overall Study|Blood Samples Hemolyzed|2
5875796|NCT01919411|20327714|P2|Overall Study|Protocol Violation|1
5875797|NCT01919411|20327715|P1|Overall Study|Protocol Violation|2
5875798|NCT01919411|20327714|P2|Overall Study|Physician Decision|0
5875799|NCT01919411|20327715|P1|Overall Study|Physician Decision|1
5875800|NCT01919411|20327714|P2|Overall Study|Lost to Follow-up|4
5875801|NCT01919411|20327715|P1|Overall Study|Lost to Follow-up|2
5875802|NCT01919398|20327734|P3|Overall Study|Progressive Disease|4
5875803|NCT01919398|20327735|P2|Overall Study|Progressive Disease|0
5875804|NCT01919398|20327736|P1|Overall Study|Progressive Disease|0
5875805|NCT01919307|20327756|P1|Overall Study|Withdrawal by Subject|9
5875806|NCT01919229|20327766|P3|Overall Study|Subject/guardian decision|1
5875807|NCT01919229|20327767|P2|Overall Study|Subject/guardian decision|0
5875808|NCT01919229|20327768|P1|Overall Study|Subject/guardian decision|0
5875809|NCT01919164|20327815|P5|Overall Study|Other Un-specified|15
5875810|NCT01919164|20327816|P4|Overall Study|Other Un-specified|7
5875811|NCT01919164|20327817|P3|Overall Study|Other Un-specified|8
5875812|NCT01919164|20327818|P2|Overall Study|Other Un-specified|9
5875813|NCT01919164|20327819|P1|Overall Study|Other Un-specified|13
5875814|NCT01919164|20327815|P5|Overall Study|Withdrew consent|9
5875815|NCT01919164|20327816|P4|Overall Study|Withdrew consent|14
5875816|NCT01919164|20327817|P3|Overall Study|Withdrew consent|14
5875817|NCT01919164|20327818|P2|Overall Study|Withdrew consent|13
5875818|NCT01919164|20327819|P1|Overall Study|Withdrew consent|13
5875819|NCT01919164|20327815|P5|Overall Study|Disease progression|1
5875820|NCT01919164|20327816|P4|Overall Study|Disease progression|2
5875821|NCT01919164|20327817|P3|Overall Study|Disease progression|1
5875822|NCT01919164|20327818|P2|Overall Study|Disease progression|2
5875823|NCT01919164|20327819|P1|Overall Study|Disease progression|2
5875824|NCT01919164|20327815|P5|Overall Study|Protocol Violation|2
5875825|NCT01919164|20327816|P4|Overall Study|Protocol Violation|2
5875826|NCT01919164|20327817|P3|Overall Study|Protocol Violation|3
5875827|NCT01919164|20327818|P2|Overall Study|Protocol Violation|0
5875828|NCT01919164|20327819|P1|Overall Study|Protocol Violation|6
5875829|NCT01919164|20327815|P5|Overall Study|Death|0
5875830|NCT01919164|20327816|P4|Overall Study|Death|0
5875831|NCT01919164|20327817|P3|Overall Study|Death|0
5875832|NCT01919164|20327818|P2|Overall Study|Death|0
5875833|NCT01919164|20327819|P1|Overall Study|Death|1
5875834|NCT01919164|20327815|P5|Overall Study|Lost to Follow-up|4
5875835|NCT01919164|20327816|P4|Overall Study|Lost to Follow-up|0
5875836|NCT01919164|20327817|P3|Overall Study|Lost to Follow-up|2
5875837|NCT01919164|20327818|P2|Overall Study|Lost to Follow-up|2
5875838|NCT01919164|20327819|P1|Overall Study|Lost to Follow-up|2
5875839|NCT01919164|20327815|P5|Overall Study|Adverse Event|2
5875840|NCT01919164|20327816|P4|Overall Study|Adverse Event|3
5875841|NCT01919164|20327817|P3|Overall Study|Adverse Event|9
5875842|NCT01919164|20327818|P2|Overall Study|Adverse Event|4
5875843|NCT01919164|20327819|P1|Overall Study|Adverse Event|6
5875844|NCT01919112|20327874|P3|Secondary Analysis-day 30|Lost to Follow-up|0
5875845|NCT01919112|20327875|P2|Secondary Analysis-day 30|Lost to Follow-up|0
5875846|NCT01919112|20327876|P1|Secondary Analysis-day 30|Lost to Follow-up|1
5875847|NCT01919112|20327874|P3|Secondary Analysis-day 30|Death|1
5875848|NCT01919112|20327875|P2|Secondary Analysis-day 30|Death|1
5875849|NCT01919112|20327876|P1|Secondary Analysis-day 30|Death|1
5875850|NCT01918774|20327935|P1|Overall Study|Lost to Follow-up|1
5875851|NCT01918774|20327935|P1|Overall Study|Lost prior to first CBTw session|4
5875852|NCT01918371|20327959|P2|Overall Study|Missing Data|1
5875853|NCT01918371|20327960|P1|Overall Study|Missing Data|1
5875854|NCT01918332|20328038|P4|Overall Study|lipid result by central lab did not meet|0
5875855|NCT01918332|20328039|P3|Overall Study|lipid result by central lab did not meet|1
5875856|NCT01918332|20328040|P2|Overall Study|lipid result by central lab did not meet|0
5875857|NCT01918332|20328041|P1|Overall Study|lipid result by central lab did not meet|0
5875858|NCT01918332|20328038|P4|Overall Study|Protocol Violation|3
5875859|NCT01918332|20328039|P3|Overall Study|Protocol Violation|6
5875860|NCT01918332|20328040|P2|Overall Study|Protocol Violation|2
5875861|NCT01918332|20328041|P1|Overall Study|Protocol Violation|6
5875862|NCT01918332|20328038|P4|Overall Study|Withdrawal by Subject|3
5875863|NCT01918332|20328039|P3|Overall Study|Withdrawal by Subject|2
5875864|NCT01918332|20328040|P2|Overall Study|Withdrawal by Subject|3
5875865|NCT01918332|20328041|P1|Overall Study|Withdrawal by Subject|2
5875866|NCT01918332|20328038|P4|Overall Study|Adverse Event|1
5875867|NCT01918332|20328039|P3|Overall Study|Adverse Event|0
5875868|NCT01918332|20328040|P2|Overall Study|Adverse Event|0
5875869|NCT01918332|20328041|P1|Overall Study|Adverse Event|0
5875870|NCT01918306|20328053|P4|Overall Study|progress disease, crossover|0
5875871|NCT01918306|20328054|P3|Overall Study|progress disease, crossover|1
5875872|NCT01918306|20328055|P2|Overall Study|progress disease, crossover|0
5875873|NCT01918306|20328056|P1|Overall Study|progress disease, crossover|0
5875874|NCT01918306|20328053|P4|Overall Study|Lack of Efficacy|0
5875875|NCT01918306|20328054|P3|Overall Study|Lack of Efficacy|0
5875876|NCT01918306|20328055|P2|Overall Study|Lack of Efficacy|0
5875877|NCT01918306|20328056|P1|Overall Study|Lack of Efficacy|1
5875878|NCT01918306|20328053|P4|Overall Study|neutropenia|0
5875879|NCT01918306|20328054|P3|Overall Study|neutropenia|0
5875880|NCT01918306|20328055|P2|Overall Study|neutropenia|0
5875881|NCT01918306|20328056|P1|Overall Study|neutropenia|1
5875882|NCT01918306|20328053|P4|Overall Study|Withdrawal by Subject|2
5875883|NCT01918306|20328054|P3|Overall Study|Withdrawal by Subject|0
5875884|NCT01918306|20328055|P2|Overall Study|Withdrawal by Subject|0
5875885|NCT01918306|20328056|P1|Overall Study|Withdrawal by Subject|0
5875886|NCT01918306|20328053|P4|Overall Study|progresive disease|1
5875887|NCT01918306|20328054|P3|Overall Study|progresive disease|1
5875888|NCT01918306|20328055|P2|Overall Study|progresive disease|0
5875889|NCT01918306|20328056|P1|Overall Study|progresive disease|4
5875890|NCT01918085|20328087|P2|Test Period 1: Strata Strip|Adverse Event|1
5875891|NCT01918085|20328088|P1|Test Period 1: Strata Strip|Adverse Event|0
5875892|NCT01918033|20328112|P3|Overall Study|Withdrawal by Subject|0
5875893|NCT01918033|20328113|P2|Overall Study|Withdrawal by Subject|1
5875894|NCT01918033|20328114|P1|Overall Study|Withdrawal by Subject|2
5875895|NCT01918033|20328112|P3|Overall Study|Protocol Violation|1
5875896|NCT01918033|20328113|P2|Overall Study|Protocol Violation|0
5875897|NCT01918033|20328114|P1|Overall Study|Protocol Violation|2
5875898|NCT01918033|20328112|P3|Overall Study|Lost to Follow-up|0
5875899|NCT01918033|20328113|P2|Overall Study|Lost to Follow-up|1
5875900|NCT01918033|20328114|P1|Overall Study|Lost to Follow-up|0
5875901|NCT01918033|20328112|P3|Overall Study|Adverse Event|2
5875902|NCT01918033|20328113|P2|Overall Study|Adverse Event|0
5875903|NCT01918033|20328114|P1|Overall Study|Adverse Event|1
5875904|NCT01917747|20328185|P2|Overall Study|Lost to Follow-up|9
5875905|NCT01917747|20328186|P1|Overall Study|Lost to Follow-up|18
5875906|NCT01917747|20328185|P2|Overall Study|Withdrawal by Subject|2
5875907|NCT01917747|20328186|P1|Overall Study|Withdrawal by Subject|1
5875908|NCT01917656|20328215|P2|Overall Study|Lost to Follow-up|4
5875909|NCT01917656|20328216|P1|Overall Study|Lost to Follow-up|3
5875910|NCT01917656|20328215|P2|Overall Study|Withdrawal by Subject|3
5875911|NCT01917656|20328216|P1|Overall Study|Withdrawal by Subject|4
5875912|NCT01917656|20328215|P2|Overall Study|Unclassified|3
5875913|NCT01917656|20328216|P1|Overall Study|Unclassified|0
5875914|NCT01917656|20328215|P2|Overall Study|Withdrawal criteria|14
5875915|NCT01917656|20328216|P1|Overall Study|Withdrawal criteria|8
5875916|NCT01917656|20328215|P2|Overall Study|Adverse Event|0
5875917|NCT01917656|20328216|P1|Overall Study|Adverse Event|11
5875918|NCT01917526|20328242|P2|Overall Study|Protocol Violation|1
5875919|NCT01917526|20328243|P1|Overall Study|Protocol Violation|1
5875920|NCT01917344|20328260|P1|Overall Study|Withdrawal by Subject|1
5875921|NCT01917318|20328266|P2|First Treatment|Withdrawal by Subject|1
5875922|NCT01917318|20328267|P1|First Treatment|Withdrawal by Subject|0
5875923|NCT01917084|20328313|P1|Overall Study|Withdrawal by Subject|1
5875924|NCT01917006|20328326|P8|Open-label Period|Lost to Follow-up|1
5875925|NCT01917006|20328327|P7|Open-label Period|Lost to Follow-up|0
5875926|NCT01917006|20328328|P6|Open-label Period|Lost to Follow-up|0
5875927|NCT01917006|20328329|P5|Open-label Period|Lost to Follow-up|0
5875928|NCT01917006|20328330|P4|Open-label Period|Lost to Follow-up|0
5875929|NCT01917006|20328331|P3|Open-label Period|Lost to Follow-up|0
5875930|NCT01917006|20328332|P2|Open-label Period|Lost to Follow-up|0
5875931|NCT01917006|20328333|P1|Open-label Period|Lost to Follow-up|0
5875932|NCT01917006|20328326|P8|Open-label Period|Adverse Event|1
5875933|NCT01917006|20328327|P7|Open-label Period|Adverse Event|0
5875934|NCT01917006|20328328|P6|Open-label Period|Adverse Event|0
5875935|NCT01917006|20328329|P5|Open-label Period|Adverse Event|0
5875936|NCT01917006|20328330|P4|Open-label Period|Adverse Event|0
5875937|NCT01917006|20328331|P3|Open-label Period|Adverse Event|0
5875938|NCT01917006|20328332|P2|Open-label Period|Adverse Event|0
5875939|NCT01917006|20328333|P1|Open-label Period|Adverse Event|0
5875940|NCT01917006|20328326|P8|Randomized-treatment Period|Other Miscellaneous Reasons|0
5875941|NCT01917006|20328327|P7|Randomized-treatment Period|Other Miscellaneous Reasons|1
5875942|NCT01917006|20328328|P6|Randomized-treatment Period|Other Miscellaneous Reasons|0
5875943|NCT01917006|20328329|P5|Randomized-treatment Period|Other Miscellaneous Reasons|0
5875944|NCT01917006|20328330|P4|Randomized-treatment Period|Other Miscellaneous Reasons|0
5875945|NCT01917006|20328331|P3|Randomized-treatment Period|Other Miscellaneous Reasons|0
5875946|NCT01917006|20328332|P2|Randomized-treatment Period|Other Miscellaneous Reasons|0
5875947|NCT01917006|20328333|P1|Randomized-treatment Period|Other Miscellaneous Reasons|0
5875948|NCT01917006|20328326|P8|Randomized-treatment Period|Protocol Violation|0
5875949|NCT01917006|20328327|P7|Randomized-treatment Period|Protocol Violation|0
5875950|NCT01917006|20328328|P6|Randomized-treatment Period|Protocol Violation|0
5875951|NCT01917006|20328329|P5|Randomized-treatment Period|Protocol Violation|0
5875952|NCT01917006|20328330|P4|Randomized-treatment Period|Protocol Violation|0
5875953|NCT01917006|20328331|P3|Randomized-treatment Period|Protocol Violation|0
5875954|NCT01917006|20328332|P2|Randomized-treatment Period|Protocol Violation|0
5875955|NCT01917006|20328333|P1|Randomized-treatment Period|Protocol Violation|1
5875956|NCT01917006|20328326|P8|Randomized-treatment Period|Personal Reasons|0
5875957|NCT01917006|20328327|P7|Randomized-treatment Period|Personal Reasons|0
5875958|NCT01917006|20328328|P6|Randomized-treatment Period|Personal Reasons|1
5875959|NCT01917006|20328329|P5|Randomized-treatment Period|Personal Reasons|0
5875960|NCT01917006|20328330|P4|Randomized-treatment Period|Personal Reasons|0
5875961|NCT01917006|20328331|P3|Randomized-treatment Period|Personal Reasons|0
5875962|NCT01917006|20328332|P2|Randomized-treatment Period|Personal Reasons|0
5875963|NCT01917006|20328333|P1|Randomized-treatment Period|Personal Reasons|0
5875964|NCT01917006|20328326|P8|Randomized-treatment Period|Lost to Follow-up|0
5875965|NCT01917006|20328327|P7|Randomized-treatment Period|Lost to Follow-up|0
5875966|NCT01917006|20328328|P6|Randomized-treatment Period|Lost to Follow-up|0
5875967|NCT01917006|20328329|P5|Randomized-treatment Period|Lost to Follow-up|0
5875968|NCT01917006|20328330|P4|Randomized-treatment Period|Lost to Follow-up|1
5875969|NCT01917006|20328331|P3|Randomized-treatment Period|Lost to Follow-up|0
5875970|NCT01917006|20328332|P2|Randomized-treatment Period|Lost to Follow-up|0
5875971|NCT01917006|20328333|P1|Randomized-treatment Period|Lost to Follow-up|1
5875972|NCT01916980|20328366|P2|Overall Study|Withdrawal by Subject|0
5875973|NCT01916980|20328367|P1|Overall Study|Withdrawal by Subject|1
5875974|NCT01916980|20328366|P2|Overall Study|Lack of Efficacy|2
5875975|NCT01916980|20328367|P1|Overall Study|Lack of Efficacy|2
5875976|NCT01916980|20328366|P2|Overall Study|Adverse Event|2
5875977|NCT01916980|20328367|P1|Overall Study|Adverse Event|4
5875978|NCT01916967|20328386|P3|Overall Study|Protocol Violation|0
5875979|NCT01916967|20328387|P2|Overall Study|Protocol Violation|1
5875980|NCT01916967|20328388|P1|Overall Study|Protocol Violation|0
5875981|NCT01916967|20328386|P3|Overall Study|Physician Decision|1
5875982|NCT01916967|20328387|P2|Overall Study|Physician Decision|0
5875983|NCT01916967|20328388|P1|Overall Study|Physician Decision|0
5875984|NCT01916967|20328386|P3|Overall Study|Lack of Efficacy|6
5875985|NCT01916967|20328387|P2|Overall Study|Lack of Efficacy|0
5875986|NCT01916967|20328388|P1|Overall Study|Lack of Efficacy|0
5875987|NCT01916967|20328386|P3|Overall Study|Adverse Event|2
5875988|NCT01916967|20328387|P2|Overall Study|Adverse Event|0
5875989|NCT01916967|20328388|P1|Overall Study|Adverse Event|0
5875990|NCT01916824|20328444|P2|Overall Study|Withdrawal by Subject|3
5875991|NCT01916824|20328445|P1|Overall Study|Withdrawal by Subject|2
5875992|NCT01916824|20328444|P2|Overall Study|Physician Decision|0
5875993|NCT01916824|20328445|P1|Overall Study|Physician Decision|2
5875994|NCT01916824|20328444|P2|Overall Study|Lost to Follow-up|6
5875995|NCT01916824|20328445|P1|Overall Study|Lost to Follow-up|3
5875996|NCT01916304|20328527|P1|Overall Study|Screening failure|17
5875997|NCT01916226|20328539|P4|Overall Study|Physician Decision|1
5875998|NCT01916226|20328540|P3|Overall Study|Physician Decision|0
5875999|NCT01916226|20328541|P2|Overall Study|Physician Decision|0
5876000|NCT01916226|20328542|P1|Overall Study|Physician Decision|0
5876001|NCT01916226|20328539|P4|Overall Study|Protocol Violation|1
5876002|NCT01916226|20328540|P3|Overall Study|Protocol Violation|0
5876003|NCT01916226|20328541|P2|Overall Study|Protocol Violation|1
5876004|NCT01916226|20328542|P1|Overall Study|Protocol Violation|0
5876005|NCT01916226|20328539|P4|Overall Study|Lack of Efficacy|1
5876006|NCT01916226|20328540|P3|Overall Study|Lack of Efficacy|2
5876007|NCT01916226|20328541|P2|Overall Study|Lack of Efficacy|0
5876008|NCT01916226|20328542|P1|Overall Study|Lack of Efficacy|0
5876009|NCT01916226|20328539|P4|Overall Study|Adverse Event|1
5876010|NCT01916226|20328540|P3|Overall Study|Adverse Event|1
5876011|NCT01916226|20328541|P2|Overall Study|Adverse Event|0
5876012|NCT01916226|20328542|P1|Overall Study|Adverse Event|1
5876013|NCT01916109|20328576|P1|Overall Study|Withdrawal by Subject|1
5876014|NCT01915940|20328582|P3|Treatment Period|Other Miscellaneous Reasons|0
5876015|NCT01915940|20328583|P2|Treatment Period|Other Miscellaneous Reasons|1
5876016|NCT01915940|20328584|P1|Treatment Period|Other Miscellaneous Reasons|0
5876017|NCT01915940|20328582|P3|Treatment Period|Adverse Event|1
5876018|NCT01915940|20328583|P2|Treatment Period|Adverse Event|9
5876019|NCT01915940|20328584|P1|Treatment Period|Adverse Event|0
5876020|NCT01915940|20328582|P3|Treatment Period|Decision of Participant|3
5876021|NCT01915940|20328583|P2|Treatment Period|Decision of Participant|1
5876022|NCT01915940|20328584|P1|Treatment Period|Decision of Participant|0
5876023|NCT01915940|20328582|P3|Pre-randomization Washout Period|Not Qualified for Randomization|0
5876024|NCT01915940|20328583|P2|Pre-randomization Washout Period|Not Qualified for Randomization|0
5876025|NCT01915940|20328584|P1|Pre-randomization Washout Period|Not Qualified for Randomization|39
5876026|NCT01915914|20328600|P4|Follow-up Phase|Physician Decision|1
5876027|NCT01915914|20328601|P3|Follow-up Phase|Physician Decision|0
5876028|NCT01915914|20328602|P2|Follow-up Phase|Physician Decision|0
5876029|NCT01915914|20328603|P1|Follow-up Phase|Physician Decision|0
5876030|NCT01915914|20328600|P4|Follow-up Phase|Withdrawal by Subject|1
5876031|NCT01915914|20328601|P3|Follow-up Phase|Withdrawal by Subject|0
5876032|NCT01915914|20328602|P2|Follow-up Phase|Withdrawal by Subject|0
5876033|NCT01915914|20328603|P1|Follow-up Phase|Withdrawal by Subject|0
5876034|NCT01915914|20328600|P4|Maintenance Phase|Missing|0
5876035|NCT01915914|20328601|P3|Maintenance Phase|Missing|0
5876036|NCT01915914|20328602|P2|Maintenance Phase|Missing|1
5876037|NCT01915914|20328603|P1|Maintenance Phase|Missing|0
5876038|NCT01915914|20328600|P4|Maintenance Phase|Lost to Follow-up|0
5876039|NCT01915914|20328601|P3|Maintenance Phase|Lost to Follow-up|1
5876040|NCT01915914|20328602|P2|Maintenance Phase|Lost to Follow-up|4
5876041|NCT01915914|20328603|P1|Maintenance Phase|Lost to Follow-up|0
5876042|NCT01915914|20328600|P4|Maintenance Phase|Withdrawal by Subject|0
5876043|NCT01915914|20328601|P3|Maintenance Phase|Withdrawal by Subject|1
5876044|NCT01915914|20328602|P2|Maintenance Phase|Withdrawal by Subject|1
5876045|NCT01915914|20328603|P1|Maintenance Phase|Withdrawal by Subject|0
5876046|NCT01915914|20328600|P4|Acute Phase|Missing|0
5876047|NCT01915914|20328601|P3|Acute Phase|Missing|0
5876048|NCT01915914|20328602|P2|Acute Phase|Missing|0
5876049|NCT01915914|20328603|P1|Acute Phase|Missing|1
5876050|NCT01915914|20328600|P4|Acute Phase|"Not Achieved treatment success"|0
5876051|NCT01915914|20328601|P3|Acute Phase|"Not Achieved treatment success"|0
5876052|NCT01915914|20328602|P2|Acute Phase|"Not Achieved treatment success"|0
5876053|NCT01915914|20328603|P1|Acute Phase|"Not Achieved treatment success"|1
5876054|NCT01915914|20328600|P4|Acute Phase|Accepted Other Topic Therapies|0
5876055|NCT01915914|20328601|P3|Acute Phase|Accepted Other Topic Therapies|0
5876056|NCT01915914|20328602|P2|Acute Phase|Accepted Other Topic Therapies|0
5876057|NCT01915914|20328603|P1|Acute Phase|Accepted Other Topic Therapies|1
5876058|NCT01915914|20328600|P4|Acute Phase|Physician Decision|0
5876059|NCT01915914|20328601|P3|Acute Phase|Physician Decision|0
5876060|NCT01915914|20328602|P2|Acute Phase|Physician Decision|0
5876061|NCT01915914|20328603|P1|Acute Phase|Physician Decision|1
5876062|NCT01915914|20328600|P4|Acute Phase|Lost to Follow-up|0
5876063|NCT01915914|20328601|P3|Acute Phase|Lost to Follow-up|0
5876064|NCT01915914|20328602|P2|Acute Phase|Lost to Follow-up|0
5876065|NCT01915914|20328603|P1|Acute Phase|Lost to Follow-up|4
5876066|NCT01915914|20328600|P4|Acute Phase|Withdrawal by Subject|0
5876067|NCT01915914|20328601|P3|Acute Phase|Withdrawal by Subject|0
5876068|NCT01915914|20328602|P2|Acute Phase|Withdrawal by Subject|0
5876069|NCT01915914|20328603|P1|Acute Phase|Withdrawal by Subject|4
5876070|NCT01915849|20328635|P4|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
5876071|NCT01915849|20328636|P3|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
5876072|NCT01915849|20328637|P2|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
5876073|NCT01915849|20328638|P1|Treatment Period 1 (4 Days)|Withdrawal by Subject|1
5876074|NCT01915849|20328635|P4|Treatment Period 1 (4 Days)|Protocol Violation|0
5876075|NCT01915849|20328636|P3|Treatment Period 1 (4 Days)|Protocol Violation|0
5876076|NCT01915849|20328637|P2|Treatment Period 1 (4 Days)|Protocol Violation|0
5876077|NCT01915849|20328638|P1|Treatment Period 1 (4 Days)|Protocol Violation|1
5876078|NCT01915771|20328661|P1|Day 15|Withdrawal by Subject|1
5876079|NCT01915771|20328661|P1|Day 1|Withdrawal by Subject|1
5876080|NCT01915732|20328685|P2|Overall Study|Poor Conscious Effect|1
5876081|NCT01915732|20328686|P1|Overall Study|Poor Conscious Effect|0
5876082|NCT01915732|20328685|P2|Overall Study|Improper Facial Procedure|1
5876083|NCT01915732|20328686|P1|Overall Study|Improper Facial Procedure|0
5876084|NCT01915732|20328685|P2|Overall Study|Job Transfer|1
5876085|NCT01915732|20328686|P1|Overall Study|Job Transfer|0
5876086|NCT01915732|20328685|P2|Overall Study|Par. Refused to Hospital Visits|1
5876087|NCT01915732|20328686|P1|Overall Study|Par. Refused to Hospital Visits|0
5876088|NCT01915732|20328685|P2|Overall Study|Par. not Willing to Continue Treatment|1
5876089|NCT01915732|20328686|P1|Overall Study|Par. not Willing to Continue Treatment|0
5876090|NCT01915732|20328685|P2|Overall Study|Got Well|1
5876091|NCT01915732|20328686|P1|Overall Study|Got Well|0
5876092|NCT01915732|20328685|P2|Overall Study|Par. Unable to Come to the Hospital|1
5876093|NCT01915732|20328686|P1|Overall Study|Par. Unable to Come to the Hospital|0
5876094|NCT01915732|20328685|P2|Overall Study|Poor Perceived Efficacy|0
5876095|NCT01915732|20328686|P1|Overall Study|Poor Perceived Efficacy|1
5876096|NCT01915732|20328685|P2|Overall Study|Pregnancy|0
5876097|NCT01915732|20328686|P1|Overall Study|Pregnancy|1
5876098|NCT01915732|20328685|P2|Overall Study|Recovered|0
5876099|NCT01915732|20328686|P1|Overall Study|Recovered|1
5876100|NCT01915732|20328685|P2|Overall Study|Drug Release Error|0
5876101|NCT01915732|20328686|P1|Overall Study|Drug Release Error|1
5876102|NCT01915732|20328685|P2|Overall Study|Par. Conscious Ineffective Vol Exit|0
5876103|NCT01915732|20328686|P1|Overall Study|Par. Conscious Ineffective Vol Exit|1
5876104|NCT01915732|20328685|P2|Overall Study|Par. Improved, Voluntary (Vol) exit|0
5876105|NCT01915732|20328686|P1|Overall Study|Par. Improved, Voluntary (Vol) exit|1
5876106|NCT01915732|20328685|P2|Overall Study|Lost to Follow-up|26
5876107|NCT01915732|20328686|P1|Overall Study|Lost to Follow-up|22
5876108|NCT01915732|20328685|P2|Overall Study|Lack of Efficacy|11
5876109|NCT01915732|20328686|P1|Overall Study|Lack of Efficacy|6
5876110|NCT01915732|20328685|P2|Overall Study|Protocol Violation|5
5876111|NCT01915732|20328686|P1|Overall Study|Protocol Violation|5
5876112|NCT01915732|20328685|P2|Overall Study|Adverse Event|4
5876113|NCT01915732|20328686|P1|Overall Study|Adverse Event|12
5876114|NCT01915732|20328685|P2|Overall Study|Failure to Meet Randomization Criteria|0
5876115|NCT01915732|20328686|P1|Overall Study|Failure to Meet Randomization Criteria|1
5876116|NCT01915732|20328685|P2|Overall Study|Withdrawal by Subject|18
5876117|NCT01915732|20328686|P1|Overall Study|Withdrawal by Subject|18
5876118|NCT01915498|20328739|P19|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|2
5876119|NCT01915498|20328740|P18|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
5876120|NCT01915498|20328741|P17|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
5876121|NCT01915498|20328742|P16|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
5876122|NCT01915498|20328743|P15|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
5876123|NCT01915498|20328744|P14|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
5876124|NCT01915498|20328745|P13|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
5876125|NCT01915498|20328746|P12|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
5876126|NCT01915498|20328747|P11|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
5876127|NCT01915498|20328748|P10|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
5876128|NCT01915498|20328749|P9|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
5876129|NCT01915498|20328750|P8|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
5876130|NCT01915498|20328751|P7|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
5876131|NCT01915498|20328752|P6|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
5876132|NCT01915498|20328753|P5|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
5876133|NCT01915498|20328754|P4|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
5876134|NCT01915498|20328755|P3|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
5876135|NCT01915498|20328756|P2|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
5876136|NCT01915498|20328757|P1|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
5876137|NCT01915498|20328739|P19|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0
5876138|NCT01915498|20328740|P18|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2
5876139|NCT01915498|20328741|P17|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2
5876140|NCT01915498|20328742|P16|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1
5876141|NCT01915498|20328743|P15|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2
5876142|NCT01915498|20328744|P14|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1
5876143|NCT01915498|20328745|P13|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0
5876144|NCT01915498|20328746|P12|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0
5876145|NCT01915498|20328747|P11|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0
5876146|NCT01915498|20328748|P10|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2
5876147|NCT01915498|20328749|P9|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0
5876148|NCT01915498|20328750|P8|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0
5876149|NCT01915498|20328751|P7|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0
5876150|NCT01915498|20328752|P6|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1
5876151|NCT01915498|20328753|P5|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0
5876152|NCT01915498|20328754|P4|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0
5876153|NCT01915498|20328755|P3|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0
5876154|NCT01915498|20328756|P2|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0
5876155|NCT01915498|20328757|P1|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0
5876156|NCT01915498|20328739|P19|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
5876157|NCT01915498|20328740|P18|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|2
5876158|NCT01915498|20328741|P17|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
5876159|NCT01915498|20328742|P16|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
5876160|NCT01915498|20328743|P15|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|1
5876161|NCT01915498|20328744|P14|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
5876162|NCT01915498|20328745|P13|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
5876163|NCT01915498|20328746|P12|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
5876164|NCT01915498|20328747|P11|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
5876165|NCT01915498|20328748|P10|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
5876166|NCT01915498|20328749|P9|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
5876167|NCT01915498|20328750|P8|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
5876168|NCT01915498|20328751|P7|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
5876169|NCT01915498|20328752|P6|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|1
5876170|NCT01915498|20328753|P5|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
5876171|NCT01915498|20328754|P4|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
5876172|NCT01915498|20328755|P3|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
5876173|NCT01915498|20328756|P2|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
5876174|NCT01915498|20328757|P1|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|1
5876175|NCT01915498|20328739|P19|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
5876176|NCT01915498|20328740|P18|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1
5876177|NCT01915498|20328741|P17|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1
5876178|NCT01915498|20328742|P16|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
5876179|NCT01915498|20328743|P15|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
5876180|NCT01915498|20328744|P14|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1
5876181|NCT01915498|20328745|P13|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
5876182|NCT01915498|20328746|P12|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
5876183|NCT01915498|20328747|P11|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1
5876184|NCT01915498|20328748|P10|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
5876185|NCT01915498|20328749|P9|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
5876186|NCT01915498|20328750|P8|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
5876187|NCT01915498|20328751|P7|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
5876188|NCT01915498|20328752|P6|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
5876189|NCT01915498|20328753|P5|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
5876190|NCT01915498|20328754|P4|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
5876191|NCT01915498|20328755|P3|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
5876192|NCT01915498|20328756|P2|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
5876193|NCT01915498|20328757|P1|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
5876194|NCT01915498|20328739|P19|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0
5876195|NCT01915498|20328740|P18|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|9
5876196|NCT01915498|20328741|P17|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2
5876197|NCT01915498|20328742|P16|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2
5876198|NCT01915498|20328743|P15|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|5
5876199|NCT01915498|20328744|P14|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|6
5876200|NCT01915498|20328745|P13|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1
5876201|NCT01915498|20328746|P12|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0
5876202|NCT01915498|20328747|P11|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1
5876203|NCT01915498|20328748|P10|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0
5876204|NCT01915498|20328749|P9|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0
5876205|NCT01915498|20328750|P8|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0
5876206|NCT01915498|20328751|P7|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1
5876207|NCT01915498|20328752|P6|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0
5876208|NCT01915498|20328753|P5|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0
5876209|NCT01915498|20328754|P4|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1
5876210|NCT01915498|20328755|P3|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0
5876211|NCT01915498|20328756|P2|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2
5876212|NCT01915498|20328757|P1|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1
5876213|NCT01915498|20328739|P19|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0
5876214|NCT01915498|20328740|P18|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|8
5876215|NCT01915498|20328741|P17|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|4
5876216|NCT01915498|20328742|P16|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1
5876217|NCT01915498|20328743|P15|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0
5876218|NCT01915498|20328744|P14|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1
5876219|NCT01915498|20328745|P13|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0
5876220|NCT01915498|20328746|P12|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1
5876221|NCT01915498|20328747|P11|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0
5876222|NCT01915498|20328748|P10|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1
5876223|NCT01915498|20328749|P9|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1
5876224|NCT01915498|20328750|P8|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1
5876225|NCT01915498|20328751|P7|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0
5876226|NCT01915498|20328752|P6|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0
5876227|NCT01915498|20328753|P5|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0
5876228|NCT01915498|20328754|P4|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0
5876229|NCT01915498|20328755|P3|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|2
5876230|NCT01915498|20328756|P2|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1
5876231|NCT01915498|20328757|P1|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0
5876232|NCT01915498|20328739|P19|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
5876233|NCT01915498|20328740|P18|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
5876234|NCT01915498|20328741|P17|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
5876235|NCT01915498|20328742|P16|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
5876236|NCT01915498|20328743|P15|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
5876237|NCT01915498|20328744|P14|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
5876238|NCT01915498|20328745|P13|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
5876239|NCT01915498|20328746|P12|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
5876240|NCT01915498|20328747|P11|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
5876241|NCT01915498|20328748|P10|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|1
5876242|NCT01915498|20328749|P9|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
5876243|NCT01915498|20328750|P8|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
5876244|NCT01915498|20328751|P7|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
5876245|NCT01915498|20328752|P6|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
5876246|NCT01915498|20328753|P5|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|1
5876247|NCT01915498|20328754|P4|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
5876248|NCT01915498|20328755|P3|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
5876249|NCT01915498|20328756|P2|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
5876250|NCT01915498|20328757|P1|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
5876251|NCT01915498|20328739|P19|Main Analysis (Sept 2013 - Sept 2017)|Death|0
5876252|NCT01915498|20328740|P18|Main Analysis (Sept 2013 - Sept 2017)|Death|16
5876253|NCT01915498|20328741|P17|Main Analysis (Sept 2013 - Sept 2017)|Death|3
5876254|NCT01915498|20328742|P16|Main Analysis (Sept 2013 - Sept 2017)|Death|4
5876255|NCT01915498|20328743|P15|Main Analysis (Sept 2013 - Sept 2017)|Death|1
5876256|NCT01915498|20328744|P14|Main Analysis (Sept 2013 - Sept 2017)|Death|4
5876257|NCT01915498|20328745|P13|Main Analysis (Sept 2013 - Sept 2017)|Death|0
5876258|NCT01915498|20328746|P12|Main Analysis (Sept 2013 - Sept 2017)|Death|0
5876259|NCT01915498|20328747|P11|Main Analysis (Sept 2013 - Sept 2017)|Death|2
5876260|NCT01915498|20328748|P10|Main Analysis (Sept 2013 - Sept 2017)|Death|0
5876261|NCT01915498|20328749|P9|Main Analysis (Sept 2013 - Sept 2017)|Death|0
5876262|NCT01915498|20328750|P8|Main Analysis (Sept 2013 - Sept 2017)|Death|1
5876263|NCT01915498|20328751|P7|Main Analysis (Sept 2013 - Sept 2017)|Death|0
5876264|NCT01915498|20328752|P6|Main Analysis (Sept 2013 - Sept 2017)|Death|2
5876265|NCT01915498|20328753|P5|Main Analysis (Sept 2013 - Sept 2017)|Death|1
5876266|NCT01915498|20328754|P4|Main Analysis (Sept 2013 - Sept 2017)|Death|1
5876267|NCT01915498|20328755|P3|Main Analysis (Sept 2013 - Sept 2017)|Death|1
5876268|NCT01915498|20328756|P2|Main Analysis (Sept 2013 - Sept 2017)|Death|1
5876269|NCT01915498|20328757|P1|Main Analysis (Sept 2013 - Sept 2017)|Death|2
5876270|NCT01915498|20328739|P19|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
5876271|NCT01915498|20328740|P18|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
5876272|NCT01915498|20328741|P17|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
5876273|NCT01915498|20328742|P16|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
5876274|NCT01915498|20328743|P15|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
5876275|NCT01915498|20328744|P14|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
5876276|NCT01915498|20328745|P13|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
5876277|NCT01915498|20328746|P12|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
5876278|NCT01915498|20328747|P11|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|1
5876279|NCT01915498|20328748|P10|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
5876280|NCT01915498|20328749|P9|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
5876281|NCT01915498|20328750|P8|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
5876282|NCT01915498|20328751|P7|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
5876283|NCT01915498|20328752|P6|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
5876284|NCT01915498|20328753|P5|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
5876285|NCT01915498|20328754|P4|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
5876286|NCT01915498|20328755|P3|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
5876287|NCT01915498|20328756|P2|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
5876288|NCT01915498|20328757|P1|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
5876289|NCT01915498|20328739|P19|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|0
5876290|NCT01915498|20328740|P18|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|41
5876291|NCT01915498|20328741|P17|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|8
5876292|NCT01915498|20328742|P16|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|9
5876293|NCT01915498|20328743|P15|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|14
5876294|NCT01915498|20328744|P14|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|24
5876295|NCT01915498|20328745|P13|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3
5876296|NCT01915498|20328746|P12|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|2
5876297|NCT01915498|20328747|P11|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3
5876298|NCT01915498|20328748|P10|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|7
5876299|NCT01915498|20328749|P9|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|4
5876300|NCT01915498|20328750|P8|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|15
5876301|NCT01915498|20328751|P7|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|5
5876302|NCT01915498|20328752|P6|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|5
5876303|NCT01915498|20328753|P5|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|2
5876304|NCT01915498|20328754|P4|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|4
5876305|NCT01915498|20328755|P3|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3
5876306|NCT01915498|20328756|P2|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3
5876307|NCT01915498|20328757|P1|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|1
5876308|NCT01915498|20328739|P19|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0
5876309|NCT01915498|20328740|P18|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|16
5876310|NCT01915498|20328741|P17|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2
5876311|NCT01915498|20328742|P16|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4
5876312|NCT01915498|20328743|P15|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1
5876313|NCT01915498|20328744|P14|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4
5876314|NCT01915498|20328745|P13|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2
5876315|NCT01915498|20328746|P12|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1
5876316|NCT01915498|20328747|P11|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1
5876317|NCT01915498|20328748|P10|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2
5876318|NCT01915498|20328749|P9|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1
5876319|NCT01915498|20328750|P8|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4
5876320|NCT01915498|20328751|P7|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1
5876321|NCT01915498|20328752|P6|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0
5876322|NCT01915498|20328753|P5|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0
5876323|NCT01915498|20328754|P4|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1
5876324|NCT01915498|20328755|P3|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1
5876325|NCT01915498|20328756|P2|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0
5876326|NCT01915498|20328757|P1|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2
5876327|NCT01915498|20328739|P19|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0
5876328|NCT01915498|20328740|P18|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|5
5876329|NCT01915498|20328741|P17|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|2
5876330|NCT01915498|20328742|P16|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|2
5876331|NCT01915498|20328743|P15|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1
5876332|NCT01915498|20328744|P14|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|5
5876333|NCT01915498|20328745|P13|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1
5876334|NCT01915498|20328746|P12|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0
5876335|NCT01915498|20328747|P11|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0
5876336|NCT01915498|20328748|P10|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1
5876337|NCT01915498|20328749|P9|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0
5876338|NCT01915498|20328750|P8|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0
5876339|NCT01915498|20328751|P7|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0
5876340|NCT01915498|20328752|P6|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0
5876341|NCT01915498|20328753|P5|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1
5876342|NCT01915498|20328754|P4|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1
5876343|NCT01915498|20328755|P3|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0
5876344|NCT01915498|20328756|P2|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0
5876345|NCT01915498|20328757|P1|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0
5876346|NCT01915303|20329281|P1|Extension Phase|Protocol Violation|1
5876347|NCT01915303|20329281|P1|Extension Phase|Death|1
5876348|NCT01915303|20329281|P1|Extension Phase|Adverse Event|3
5876349|NCT01915303|20329281|P1|Extension Phase|Withdrawal by Subject|4
5876350|NCT01915303|20329281|P1|Extension Phase|Unsatisfactory therapeutic effect|8
5876351|NCT01915303|20329281|P1|Core Phase|Withdrawal by Subject|1
5876352|NCT01915303|20329281|P1|Core Phase|Abnormal lab value|1
5876353|NCT01915303|20329281|P1|Core Phase|Protocol Violation|2
5876354|NCT01915303|20329281|P1|Core Phase|Death|2
5876355|NCT01915303|20329281|P1|Core Phase|Unsatisfactory therapeutic effect|3
5876356|NCT01915303|20329281|P1|Core Phase|Adverse Event|7
5876357|NCT01915095|20329355|P5|Overall Study|Some subjects were unable to commit to the training study.|6
5876358|NCT01915095|20329356|P4|Overall Study|Some subjects were unable to commit to the training study.|4
5876359|NCT01915095|20329357|P3|Overall Study|Some subjects were unable to commit to the training study.|0
5876360|NCT01915095|20329358|P2|Overall Study|Some subjects were unable to commit to the training study.|0
5876361|NCT01915095|20329359|P1|Overall Study|Some subjects were unable to commit to the training study.|0
5876362|NCT01914926|20329382|P2|Overall Study|uncooperative, agitated and removed|1
5876363|NCT01914926|20329383|P1|Overall Study|uncooperative, agitated and removed|0
5876364|NCT01914926|20329382|P2|Overall Study|Adverse Event|0
5876365|NCT01914926|20329383|P1|Overall Study|Adverse Event|1
5876366|NCT01914757|20329392|P3|Overall Study|Other reasons|4
5876367|NCT01914757|20329393|P2|Overall Study|Other reasons|9
5876368|NCT01914757|20329394|P1|Overall Study|Other reasons|5
5876369|NCT01914757|20329392|P3|Overall Study|Eligibility criteria not fulfilled|2
5876370|NCT01914757|20329393|P2|Overall Study|Eligibility criteria not fulfilled|0
5876371|NCT01914757|20329394|P1|Overall Study|Eligibility criteria not fulfilled|2
5876372|NCT01914757|20329392|P3|Overall Study|Study specific withdrawal criteria|0
5876373|NCT01914757|20329393|P2|Overall Study|Study specific withdrawal criteria|1
5876374|NCT01914757|20329394|P1|Overall Study|Study specific withdrawal criteria|0
5876375|NCT01914757|20329392|P3|Overall Study|Adverse Event|4
5876376|NCT01914757|20329393|P2|Overall Study|Adverse Event|3
5876377|NCT01914757|20329394|P1|Overall Study|Adverse Event|4
5876378|NCT01914757|20329392|P3|Overall Study|Death|1
5876379|NCT01914757|20329393|P2|Overall Study|Death|2
5876380|NCT01914757|20329394|P1|Overall Study|Death|2
5876381|NCT01914757|20329392|P3|Overall Study|Withdrawal by Subject|19
5876382|NCT01914757|20329393|P2|Overall Study|Withdrawal by Subject|27
5876383|NCT01914757|20329394|P1|Overall Study|Withdrawal by Subject|15
5876384|NCT01914757|20329392|P3|Overall Study|Lost to Follow-up|6
5876385|NCT01914757|20329393|P2|Overall Study|Lost to Follow-up|8
5876386|NCT01914757|20329394|P1|Overall Study|Lost to Follow-up|5
5876387|NCT01914757|20329392|P3|Overall Study|Severe non-compliance to protocol|2
5876388|NCT01914757|20329393|P2|Overall Study|Severe non-compliance to protocol|1
5876389|NCT01914757|20329394|P1|Overall Study|Severe non-compliance to protocol|3
5876390|NCT01914679|20329468|P1|Overall Study|Sponsor terminated study|4
5876391|NCT01914679|20329468|P1|Overall Study|Lack of Efficacy|1
5876392|NCT01914666|20329475|P3|Treatment Period|Physician Decision|2
5876393|NCT01914666|20329476|P2|Treatment Period|Physician Decision|0
5876394|NCT01914666|20329477|P1|Treatment Period|Physician Decision|0
5876395|NCT01914666|20329475|P3|Treatment Period|Withdrawal by Subject|2
5876396|NCT01914666|20329476|P2|Treatment Period|Withdrawal by Subject|2
5876397|NCT01914666|20329477|P1|Treatment Period|Withdrawal by Subject|3
5876398|NCT01914666|20329475|P3|Treatment Period|Adverse Event|2
5876399|NCT01914666|20329476|P2|Treatment Period|Adverse Event|4
5876400|NCT01914666|20329477|P1|Treatment Period|Adverse Event|10
5876401|NCT01914666|20329475|P3|Treatment Period|Lack of Efficacy|2
5876402|NCT01914666|20329476|P2|Treatment Period|Lack of Efficacy|0
5876403|NCT01914666|20329477|P1|Treatment Period|Lack of Efficacy|0
5876404|NCT01914393|20329520|P3|Overall Study|subject never dosed|1
5876405|NCT01914393|20329521|P2|Overall Study|subject never dosed|0
5876406|NCT01914393|20329522|P1|Overall Study|subject never dosed|0
5876407|NCT01914393|20329520|P3|Overall Study|Lost to Follow-up|19
5876408|NCT01914393|20329521|P2|Overall Study|Lost to Follow-up|6
5876409|NCT01914393|20329522|P1|Overall Study|Lost to Follow-up|12
5876410|NCT01914393|20329520|P3|Overall Study|Withdrawal by Subject|47
5876411|NCT01914393|20329521|P2|Overall Study|Withdrawal by Subject|20
5876412|NCT01914393|20329522|P1|Overall Study|Withdrawal by Subject|38
5876413|NCT01914393|20329520|P3|Overall Study|Adverse Event|31
5876414|NCT01914393|20329521|P2|Overall Study|Adverse Event|18
5876415|NCT01914393|20329522|P1|Overall Study|Adverse Event|29
5876416|NCT01914393|20329520|P3|Overall Study|no reason given|16
5876417|NCT01914393|20329521|P2|Overall Study|no reason given|8
5876418|NCT01914393|20329522|P1|Overall Study|no reason given|14
5876419|NCT01914393|20329520|P3|Overall Study|Lack of Efficacy|5
5876420|NCT01914393|20329521|P2|Overall Study|Lack of Efficacy|16
5876421|NCT01914393|20329522|P1|Overall Study|Lack of Efficacy|11
5876422|NCT01914393|20329520|P3|Overall Study|Protocol Violation|19
5876423|NCT01914393|20329521|P2|Overall Study|Protocol Violation|3
5876424|NCT01914393|20329522|P1|Overall Study|Protocol Violation|11
5876425|NCT01913639|20329590|P1|Overall Study|Not Eligible|3
5876426|NCT01913483|20329656|P2|Overall Study|Death|17
5876427|NCT01913483|20329657|P1|Overall Study|Death|14
5876428|NCT01913483|20329656|P2|Overall Study|Lost to Follow-up|3
5876429|NCT01913483|20329657|P1|Overall Study|Lost to Follow-up|6
5876430|NCT01913483|20329656|P2|Overall Study|Withdrawal by Subject|2
5876431|NCT01913483|20329657|P1|Overall Study|Withdrawal by Subject|1
5876432|NCT01913470|20329669|P2|Overall Study|Withdrawal by Subject|1
5876433|NCT01913470|20329670|P1|Overall Study|Withdrawal by Subject|0
5876434|NCT01913470|20329669|P2|Overall Study|Physician Decision|1
5876435|NCT01913470|20329670|P1|Overall Study|Physician Decision|0
5876436|NCT01913470|20329669|P2|Overall Study|Lost to Follow-up|1
5876437|NCT01913470|20329670|P1|Overall Study|Lost to Follow-up|0
5876438|NCT01913405|20329688|P1|Overall Study|Adverse Event|1
5876439|NCT01913405|20329688|P1|Overall Study|Withdrawal by Subject|1
5876440|NCT01913353|20329744|P2|Overall Study|multiple reasons|7
5876441|NCT01913353|20329745|P1|Overall Study|multiple reasons|10
5876442|NCT01913353|20329744|P2|Overall Study|Withdrawal by Subject|6
5876443|NCT01913353|20329745|P1|Overall Study|Withdrawal by Subject|20
5876444|NCT01913353|20329744|P2|Overall Study|Physician Decision|2
5876445|NCT01913353|20329745|P1|Overall Study|Physician Decision|0
5876446|NCT01913353|20329744|P2|Overall Study|Adverse Event|0
5876447|NCT01913353|20329745|P1|Overall Study|Adverse Event|2
5876448|NCT01913340|20329815|P2|Overall Study|Lost to Follow-up|1
5876449|NCT01913340|20329816|P1|Overall Study|Lost to Follow-up|1
5876450|NCT01913340|20329815|P2|Overall Study|Death|5
5876451|NCT01913340|20329816|P1|Overall Study|Death|2
5876452|NCT01913327|20329840|P2|Overall Study|Withdrawal by Subject|1
5876453|NCT01913327|20329841|P1|Overall Study|Withdrawal by Subject|0
5876454|NCT01913041|20329866|P1|Overall Study|Physician Decision|1
5876455|NCT01913041|20329866|P1|Overall Study|Withdrawal by Subject|3
5876456|NCT01913041|20329866|P1|Overall Study|Protocol Violation|35
5876457|NCT01912963|20329873|P3|Overall Study|Sought treatment locally|0
5876458|NCT01912963|20329874|P2|Overall Study|Sought treatment locally|1
5876459|NCT01912963|20329875|P1|Overall Study|Sought treatment locally|0
5876460|NCT01912963|20329873|P3|Overall Study|Withdrawal by Subject|0
5876461|NCT01912963|20329874|P2|Overall Study|Withdrawal by Subject|1
5876462|NCT01912963|20329875|P1|Overall Study|Withdrawal by Subject|0
5876463|NCT01912963|20329873|P3|Overall Study|Adverse Event|1
5876464|NCT01912963|20329874|P2|Overall Study|Adverse Event|1
5876465|NCT01912963|20329875|P1|Overall Study|Adverse Event|0
5876466|NCT01912963|20329873|P3|Overall Study|Disease Progression (not RECIST1.1)|1
5876467|NCT01912963|20329874|P2|Overall Study|Disease Progression (not RECIST1.1)|7
5876468|NCT01912963|20329875|P1|Overall Study|Disease Progression (not RECIST1.1)|0
5876469|NCT01912963|20329873|P3|Overall Study|Disease Progression (RECIST1.1)|5
5876470|NCT01912963|20329874|P2|Overall Study|Disease Progression (RECIST1.1)|9
5876471|NCT01912963|20329875|P1|Overall Study|Disease Progression (RECIST1.1)|6
5876472|NCT01912872|20329898|P4|Overall Study|Missing|1
5876473|NCT01912872|20329899|P3|Overall Study|Missing|0
5876474|NCT01912872|20329900|P2|Overall Study|Missing|0
5876475|NCT01912872|20329901|P1|Overall Study|Missing|0
5876476|NCT01912872|20329898|P4|Overall Study|Withdrawal of study medication|2
5876477|NCT01912872|20329899|P3|Overall Study|Withdrawal of study medication|0
5876478|NCT01912872|20329900|P2|Overall Study|Withdrawal of study medication|0
5876479|NCT01912872|20329901|P1|Overall Study|Withdrawal of study medication|0
5876480|NCT01912872|20329898|P4|Overall Study|Unsatisfactory therapeutic effect|2
5876481|NCT01912872|20329899|P3|Overall Study|Unsatisfactory therapeutic effect|0
5876482|NCT01912872|20329900|P2|Overall Study|Unsatisfactory therapeutic effect|0
5876483|NCT01912872|20329901|P1|Overall Study|Unsatisfactory therapeutic effect|0
5876484|NCT01912872|20329898|P4|Overall Study|Protocol Violation|0
5876485|NCT01912872|20329899|P3|Overall Study|Protocol Violation|1
5876486|NCT01912872|20329900|P2|Overall Study|Protocol Violation|0
5876487|NCT01912872|20329901|P1|Overall Study|Protocol Violation|0
5876488|NCT01912872|20329898|P4|Overall Study|Non-compliance with lab inc/exclusion|1
5876489|NCT01912872|20329899|P3|Overall Study|Non-compliance with lab inc/exclusion|0
5876490|NCT01912872|20329900|P2|Overall Study|Non-compliance with lab inc/exclusion|0
5876491|NCT01912872|20329901|P1|Overall Study|Non-compliance with lab inc/exclusion|0
5876492|NCT01912872|20329898|P4|Overall Study|Informed consent withdrawn|1
5876493|NCT01912872|20329899|P3|Overall Study|Informed consent withdrawn|1
5876494|NCT01912872|20329900|P2|Overall Study|Informed consent withdrawn|0
5876495|NCT01912872|20329901|P1|Overall Study|Informed consent withdrawn|0
5876496|NCT01912872|20329898|P4|Overall Study|Other unspecified|0
5876497|NCT01912872|20329899|P3|Overall Study|Other unspecified|3
5876498|NCT01912872|20329900|P2|Overall Study|Other unspecified|1
5876499|NCT01912872|20329901|P1|Overall Study|Other unspecified|3
5876500|NCT01912872|20329898|P4|Overall Study|Lost to Follow-up|5
5876501|NCT01912872|20329899|P3|Overall Study|Lost to Follow-up|5
5876502|NCT01912872|20329900|P2|Overall Study|Lost to Follow-up|3
5876503|NCT01912872|20329901|P1|Overall Study|Lost to Follow-up|2
5876504|NCT01912781|20329945|P2|Overall Study|Withdrawal by Subject|0
5876505|NCT01912781|20329946|P1|Overall Study|Withdrawal by Subject|2
5876506|NCT01912768|20329977|P2|Overall Study|Randomized in error|0
5876507|NCT01912768|20329978|P1|Overall Study|Randomized in error|1
5876508|NCT01912768|20329977|P2|Overall Study|Withdrawal by Subject|3
5876509|NCT01912768|20329978|P1|Overall Study|Withdrawal by Subject|5
5876510|NCT01912768|20329977|P2|Overall Study|Lost to Follow-up|1
5876511|NCT01912768|20329978|P1|Overall Study|Lost to Follow-up|2
5876512|NCT01912768|20329977|P2|Overall Study|Adverse Event|0
5876513|NCT01912768|20329978|P1|Overall Study|Adverse Event|2
5876514|NCT01912729|20330009|P2|Overall Study|Withdrawal by Subject|1
5876515|NCT01912729|20330010|P1|Overall Study|Withdrawal by Subject|0
5876516|NCT01912612|20330033|P3|Overall Study|Study design change|3
5876517|NCT01912612|20330034|P2|Overall Study|Study design change|0
5876518|NCT01912612|20330035|P1|Overall Study|Study design change|0
5876519|NCT01912612|20330033|P3|Overall Study|Withdrew consent|0
5876520|NCT01912612|20330034|P2|Overall Study|Withdrew consent|0
5876521|NCT01912612|20330035|P1|Overall Study|Withdrew consent|1
5876522|NCT01912612|20330033|P3|Overall Study|Adverse Event|0
5876523|NCT01912612|20330034|P2|Overall Study|Adverse Event|0
5876524|NCT01912612|20330035|P1|Overall Study|Adverse Event|4
5876525|NCT01912599|20330079|P2|Overall Study|Withdrawal by Subject|1
5876526|NCT01912599|20330080|P1|Overall Study|Withdrawal by Subject|0
5876527|NCT01912404|20330105|P2|Overall Study|Due to personal reasons|0
5876528|NCT01912404|20330106|P1|Overall Study|Due to personal reasons|1
5876529|NCT01912339|20330119|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|46
5876530|NCT01912339|20330120|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|0
5876531|NCT01912339|20330121|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|120
5876532|NCT01912339|20330119|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|1
5876533|NCT01912339|20330120|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0
5876534|NCT01912339|20330121|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0
5876535|NCT01912339|20330119|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|1
5876536|NCT01912339|20330120|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0
5876537|NCT01912339|20330121|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0
5876538|NCT01912339|20330119|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Death|1
5876539|NCT01912339|20330120|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0
5876540|NCT01912339|20330121|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0
5876541|NCT01912339|20330119|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|1
5876542|NCT01912339|20330120|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0
5876543|NCT01912339|20330121|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0
5876544|NCT01912339|20330119|P3|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0
5876545|NCT01912339|20330120|P2|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0
5876546|NCT01912339|20330121|P1|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|1
5876547|NCT01912339|20330119|P3|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0
5876548|NCT01912339|20330120|P2|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0
5876549|NCT01912339|20330121|P1|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|1
5876550|NCT01912339|20330119|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|3
5876551|NCT01912339|20330120|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|0
5876552|NCT01912339|20330121|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|1
5876553|NCT01912339|20330119|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0
5876554|NCT01912339|20330120|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0
5876555|NCT01912339|20330121|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|5
5876556|NCT01912339|20330119|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0
5876557|NCT01912339|20330120|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0
5876558|NCT01912339|20330121|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|5
5876559|NCT01912339|20330119|P3|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0
5876560|NCT01912339|20330120|P2|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0
5876561|NCT01912339|20330121|P1|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|1
5876562|NCT01912339|20330119|P3|Blinded (0 to 3 Months)|Open Prostatectomy|0
5876563|NCT01912339|20330120|P2|Blinded (0 to 3 Months)|Open Prostatectomy|0
5876564|NCT01912339|20330121|P1|Blinded (0 to 3 Months)|Open Prostatectomy|1
5876565|NCT01912339|20330119|P3|Blinded (0 to 3 Months)|Declined to participate|0
5876566|NCT01912339|20330120|P2|Blinded (0 to 3 Months)|Declined to participate|0
5876567|NCT01912339|20330121|P1|Blinded (0 to 3 Months)|Declined to participate|1
5876568|NCT01912287|20330138|P3|Overall Study|Scheduling/change in availability|8
5876569|NCT01912287|20330139|P2|Overall Study|Scheduling/change in availability|10
5876570|NCT01912287|20330140|P1|Overall Study|Scheduling/change in availability|17
5876571|NCT01912287|20330138|P3|Overall Study|Missed Assesment|1
5876572|NCT01912287|20330139|P2|Overall Study|Missed Assesment|1
5876573|NCT01912287|20330140|P1|Overall Study|Missed Assesment|1
5876574|NCT01912287|20330138|P3|Overall Study|Uknown reason - subject drop out|3
5876575|NCT01912287|20330139|P2|Overall Study|Uknown reason - subject drop out|7
5876576|NCT01912287|20330140|P1|Overall Study|Uknown reason - subject drop out|5
5876577|NCT01912287|20330138|P3|Overall Study|Lost Interest|0
5876578|NCT01912287|20330139|P2|Overall Study|Lost Interest|0
5876579|NCT01912287|20330140|P1|Overall Study|Lost Interest|1
5876580|NCT01912287|20330138|P3|Overall Study|Life circumstances|0
5876581|NCT01912287|20330139|P2|Overall Study|Life circumstances|2
5876582|NCT01912287|20330140|P1|Overall Study|Life circumstances|4
5876583|NCT01912287|20330138|P3|Overall Study|Felt treatment no longer needed|0
5876584|NCT01912287|20330139|P2|Overall Study|Felt treatment no longer needed|1
5876585|NCT01912287|20330140|P1|Overall Study|Felt treatment no longer needed|0
5876586|NCT01912287|20330138|P3|Overall Study|Dissatisfaction with assigned treatment|1
5876587|NCT01912287|20330139|P2|Overall Study|Dissatisfaction with assigned treatment|2
5876588|NCT01912287|20330140|P1|Overall Study|Dissatisfaction with assigned treatment|4
5876589|NCT01912287|20330138|P3|Overall Study|No-show|1
5876590|NCT01912287|20330139|P2|Overall Study|No-show|0
5876591|NCT01912287|20330140|P1|Overall Study|No-show|0
5876592|NCT01912287|20330138|P3|Overall Study|Ineligible|1
5876593|NCT01912287|20330139|P2|Overall Study|Ineligible|0
5876594|NCT01912287|20330140|P1|Overall Study|Ineligible|1
5876595|NCT01912222|20330151|P3|Part B: Treatment Period|Withdrawal by Subject|2
5876596|NCT01912222|20330152|P2|Part B: Treatment Period|Withdrawal by Subject|1
5876597|NCT01912222|20330153|P1|Part B: Treatment Period|Withdrawal by Subject|2
5876598|NCT01912222|20330151|P3|Part B: Treatment Period|Adverse Event|3
5876599|NCT01912222|20330152|P2|Part B: Treatment Period|Adverse Event|2
5876600|NCT01912222|20330153|P1|Part B: Treatment Period|Adverse Event|1
5876601|NCT01912222|20330151|P3|Part B: Treatment Period|Progressive disease|15
5876602|NCT01912222|20330152|P2|Part B: Treatment Period|Progressive disease|12
5876603|NCT01912222|20330153|P1|Part B: Treatment Period|Progressive disease|10
5876604|NCT01912222|20330151|P3|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2
5876605|NCT01912222|20330152|P2|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2
5876606|NCT01912222|20330153|P1|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|1
5876607|NCT01911845|20330211|P1|Overall Study|Other (not specified)|3
5876608|NCT01911845|20330211|P1|Overall Study|Lost to Follow-up|1
5876609|NCT01911845|20330211|P1|Overall Study|Adverse Event|2
5876610|NCT01911819|20330228|P3|Overall Study|Withdrawal by Subject|0
5876611|NCT01911819|20330229|P2|Overall Study|Withdrawal by Subject|1
5876612|NCT01911819|20330230|P1|Overall Study|Withdrawal by Subject|1
5876613|NCT01911819|20330228|P3|Overall Study|Adverse Event|0
5876614|NCT01911819|20330229|P2|Overall Study|Adverse Event|1
5876615|NCT01911819|20330230|P1|Overall Study|Adverse Event|0
5876616|NCT01911793|20330243|P2|Overall Study|Physician Decision|5
5876617|NCT01911793|20330244|P1|Overall Study|Physician Decision|1
5876618|NCT01911780|20330268|P2|Extension Period (52 Weeks)|Personal reason|1
5876619|NCT01911780|20330269|P1|Extension Period (52 Weeks)|Personal reason|1
5876620|NCT01911780|20330268|P2|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|2
5876621|NCT01911780|20330269|P1|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|0
5876622|NCT01911780|20330268|P2|Extension Period (52 Weeks)|Adverse Event|0
5876623|NCT01911780|20330269|P1|Extension Period (52 Weeks)|Adverse Event|3
5876624|NCT01911780|20330268|P2|Double-blind Period (8 Weeks)|Personal reason|0
5876625|NCT01911780|20330269|P1|Double-blind Period (8 Weeks)|Personal reason|1
5876626|NCT01911780|20330268|P2|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1
5876627|NCT01911780|20330269|P1|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1
5876628|NCT01911780|20330268|P2|Double-blind Period (8 Weeks)|Adverse Event|2
5876629|NCT01911780|20330269|P1|Double-blind Period (8 Weeks)|Adverse Event|1
5876630|NCT01911546|20330303|P1|Overall Study|Everolimus was discontinued|5
5876631|NCT01911546|20330303|P1|Overall Study|Lost to Follow-up|1
5876632|NCT01911442|20330313|P3|Overall Study|Mother's Work Schedule|0
5876633|NCT01911442|20330314|P2|Overall Study|Mother's Work Schedule|1
5876634|NCT01911442|20330315|P1|Overall Study|Mother's Work Schedule|0
5876635|NCT01911442|20330313|P3|Overall Study|Withdrawal by Subject|6
5876636|NCT01911442|20330314|P2|Overall Study|Withdrawal by Subject|0
5876637|NCT01911442|20330315|P1|Overall Study|Withdrawal by Subject|1
5876638|NCT01911442|20330313|P3|Overall Study|Lost to Follow-up|1
5876639|NCT01911442|20330314|P2|Overall Study|Lost to Follow-up|0
5876640|NCT01911442|20330315|P1|Overall Study|Lost to Follow-up|2
5876641|NCT01911442|20330313|P3|Overall Study|Lack of Efficacy|1
5876642|NCT01911442|20330314|P2|Overall Study|Lack of Efficacy|1
5876643|NCT01911442|20330315|P1|Overall Study|Lack of Efficacy|1
5876644|NCT01911442|20330313|P3|Overall Study|Adverse Event|4
5876645|NCT01911442|20330314|P2|Overall Study|Adverse Event|2
5876646|NCT01911442|20330315|P1|Overall Study|Adverse Event|2
5876647|NCT01911429|20330344|P3|Overall Study|subject left study|0
5876648|NCT01911429|20330345|P2|Overall Study|subject left study|0
5876649|NCT01911429|20330346|P1|Overall Study|subject left study|1
5876650|NCT01911429|20330344|P3|Overall Study|Accidental randomization|1
5876651|NCT01911429|20330345|P2|Overall Study|Accidental randomization|0
5876652|NCT01911429|20330346|P1|Overall Study|Accidental randomization|0
5876653|NCT01911429|20330344|P3|Overall Study|Withdrawal by Subject|4
5876654|NCT01911429|20330345|P2|Overall Study|Withdrawal by Subject|5
5876655|NCT01911429|20330346|P1|Overall Study|Withdrawal by Subject|5
5876656|NCT01911429|20330344|P3|Overall Study|Protocol Violation|1
5876657|NCT01911429|20330345|P2|Overall Study|Protocol Violation|0
5876658|NCT01911429|20330346|P1|Overall Study|Protocol Violation|0
5876659|NCT01911429|20330344|P3|Overall Study|Lost to Follow-up|1
5876660|NCT01911429|20330345|P2|Overall Study|Lost to Follow-up|0
5876661|NCT01911429|20330346|P1|Overall Study|Lost to Follow-up|0
5876662|NCT01911429|20330344|P3|Overall Study|Lack of Efficacy|4
5876663|NCT01911429|20330345|P2|Overall Study|Lack of Efficacy|2
5876664|NCT01911429|20330346|P1|Overall Study|Lack of Efficacy|1
5876665|NCT01911429|20330344|P3|Overall Study|Adverse Event|9
5876666|NCT01911429|20330345|P2|Overall Study|Adverse Event|3
5876667|NCT01911429|20330346|P1|Overall Study|Adverse Event|5
5876668|NCT01911273|20330438|P2|Overall Study|Withdrawal by Subject|2
5876669|NCT01911273|20330439|P1|Overall Study|Withdrawal by Subject|0
5876670|NCT01911273|20330438|P2|Overall Study|Progression of Disease|0
5876671|NCT01911273|20330439|P1|Overall Study|Progression of Disease|1
5876672|NCT01911260|20330473|P4|Follow-up Period|transference or evasion of school|12
5876673|NCT01911260|20330474|P3|Follow-up Period|transference or evasion of school|15
5876674|NCT01911260|20330475|P2|Follow-up Period|transference or evasion of school|20
5876675|NCT01911260|20330476|P1|Follow-up Period|transference or evasion of school|13
5876676|NCT01911260|20330473|P4|Supplementation Period|less than 12 weeks supplementation|2
5876677|NCT01911260|20330474|P3|Supplementation Period|less than 12 weeks supplementation|1
5876678|NCT01911260|20330475|P2|Supplementation Period|less than 12 weeks supplementation|3
5876679|NCT01911260|20330476|P1|Supplementation Period|less than 12 weeks supplementation|0
5876680|NCT01911260|20330473|P4|Supplementation Period|refused to receive supplement|0
5876681|NCT01911260|20330474|P3|Supplementation Period|refused to receive supplement|1
5876682|NCT01911260|20330475|P2|Supplementation Period|refused to receive supplement|0
5876683|NCT01911260|20330476|P1|Supplementation Period|refused to receive supplement|1
5876684|NCT01911260|20330473|P4|Supplementation Period|Adverse Event|0
5876685|NCT01911260|20330474|P3|Supplementation Period|Adverse Event|1
5876686|NCT01911260|20330475|P2|Supplementation Period|Adverse Event|0
5876687|NCT01911260|20330476|P1|Supplementation Period|Adverse Event|2
5876688|NCT01911260|20330473|P4|Supplementation Period|transference or evasion of school|6
5876689|NCT01911260|20330474|P3|Supplementation Period|transference or evasion of school|7
5876690|NCT01911260|20330475|P2|Supplementation Period|transference or evasion of school|9
5876691|NCT01911260|20330476|P1|Supplementation Period|transference or evasion of school|7
5876692|NCT01910519|20330562|P2|Overall Study|Adverse Event|0
5876693|NCT01910519|20330563|P1|Overall Study|Adverse Event|2
5876694|NCT01910519|20330562|P2|Overall Study|Withdrawal by Subject|0
5876695|NCT01910519|20330563|P1|Overall Study|Withdrawal by Subject|2
5876696|NCT01910441|20330589|P2|Overall Study|Physician Decision|1
5876697|NCT01910441|20330590|P1|Overall Study|Physician Decision|0
5876698|NCT01910441|20330589|P2|Overall Study|Adverse Event|0
5876699|NCT01910441|20330590|P1|Overall Study|Adverse Event|1
5876700|NCT01910441|20330589|P2|Overall Study|Non-compliance|1
5876701|NCT01910441|20330590|P1|Overall Study|Non-compliance|0
5876702|NCT01910441|20330589|P2|Overall Study|Withdrawal by Subject|1
5876703|NCT01910441|20330590|P1|Overall Study|Withdrawal by Subject|0
5876704|NCT01910441|20330589|P2|Overall Study|Lost to Follow-up|5
5876705|NCT01910441|20330590|P1|Overall Study|Lost to Follow-up|6
5876706|NCT01910441|20330589|P2|Overall Study|Sponsor decision|2
5876707|NCT01910441|20330590|P1|Overall Study|Sponsor decision|0
5876708|NCT01910402|20330598|P2|Continuation Phase|Withdrawal by Subject|0
5876709|NCT01910402|20330599|P1|Continuation Phase|Withdrawal by Subject|2
5876710|NCT01910402|20330598|P2|Continuation Phase|Protocol Violation|0
5876711|NCT01910402|20330599|P1|Continuation Phase|Protocol Violation|3
5876712|NCT01910402|20330598|P2|Continuation Phase|Adverse Event|0
5876713|NCT01910402|20330599|P1|Continuation Phase|Adverse Event|1
5876714|NCT01910402|20330598|P2|Continuation Phase|Ongoing|0
5876715|NCT01910402|20330599|P1|Continuation Phase|Ongoing|84
5876716|NCT01910402|20330598|P2|Randomized Phase|Withdrawal by Subject|7
5876717|NCT01910402|20330599|P1|Randomized Phase|Withdrawal by Subject|5
5876718|NCT01910402|20330598|P2|Randomized Phase|Protocol Violation|13
5876719|NCT01910402|20330599|P1|Randomized Phase|Protocol Violation|10
5876720|NCT01910402|20330598|P2|Randomized Phase|Lost to Follow-up|13
5876721|NCT01910402|20330599|P1|Randomized Phase|Lost to Follow-up|11
5876722|NCT01910402|20330598|P2|Randomized Phase|Lack of Efficacy|4
5876723|NCT01910402|20330599|P1|Randomized Phase|Lack of Efficacy|5
5876724|NCT01910402|20330598|P2|Randomized Phase|Physician Decision|0
5876725|NCT01910402|20330599|P1|Randomized Phase|Physician Decision|1
5876726|NCT01910402|20330598|P2|Randomized Phase|Adverse Event|18
5876727|NCT01910402|20330599|P1|Randomized Phase|Adverse Event|10
5876728|NCT01910389|20330669|P2|Overall Study|Study Closed|8
5876729|NCT01910389|20330670|P1|Overall Study|Study Closed|13
5876730|NCT01910389|20330669|P2|Overall Study|Withdrawal by Subject|0
5876731|NCT01910389|20330670|P1|Overall Study|Withdrawal by Subject|2
5876732|NCT01910298|20330713|P2|Overall Study|Other Miscellaneous Reasons|2
5876733|NCT01910298|20330714|P1|Overall Study|Other Miscellaneous Reasons|0
5876734|NCT01910298|20330713|P2|Overall Study|Study Terminated by Sponsor|17
5876735|NCT01910298|20330714|P1|Overall Study|Study Terminated by Sponsor|1
5876736|NCT01910298|20330713|P2|Overall Study|Lost to Follow-up|1
5876737|NCT01910298|20330714|P1|Overall Study|Lost to Follow-up|1
5876738|NCT01910298|20330713|P2|Overall Study|Protocol Deviation|5
5876739|NCT01910298|20330714|P1|Overall Study|Protocol Deviation|0
5876740|NCT01910298|20330713|P2|Overall Study|Withdrawal by Subject|7
5876741|NCT01910298|20330714|P1|Overall Study|Withdrawal by Subject|2
5876742|NCT01910298|20330713|P2|Overall Study|Adverse Event|0
5876743|NCT01910298|20330714|P1|Overall Study|Adverse Event|1
5876744|NCT01910181|20330732|P1|Overall Study|Study Terminated by Sponsor|6
5876745|NCT01910181|20330732|P1|Overall Study|Lost to Follow-up|3
5876746|NCT01910181|20330732|P1|Overall Study|Death|37
5876747|NCT01910129|20330759|P3|Randomized Phase 3|Withdrawal by Subject|0
5876748|NCT01910129|20330760|P2|Randomized Phase 3|Withdrawal by Subject|1
5876749|NCT01910129|20330761|P1|Randomized Phase 3|Withdrawal by Subject|0
5876750|NCT01910129|20330759|P3|Randomized Phase 2|Withdrawal by Subject|0
5876751|NCT01910129|20330760|P2|Randomized Phase 2|Withdrawal by Subject|1
5876752|NCT01910129|20330761|P1|Randomized Phase 2|Withdrawal by Subject|2
5876753|NCT01910116|20330785|P2|Overall Study|incomplete data|1
5876754|NCT01910116|20330786|P1|Overall Study|incomplete data|0
5876755|NCT01910116|20330785|P2|Overall Study|uncertain allocation|3
5876756|NCT01910116|20330786|P1|Overall Study|uncertain allocation|1
5876757|NCT01910116|20330785|P2|Overall Study|Withdrawal by Subject|3
5876758|NCT01910116|20330786|P1|Overall Study|Withdrawal by Subject|8
5876759|NCT01910116|20330785|P2|Overall Study|Protocol Violation|2
5876760|NCT01910116|20330786|P1|Overall Study|Protocol Violation|1
5876761|NCT01910116|20330785|P2|Overall Study|Lost to Follow-up|0
5876762|NCT01910116|20330786|P1|Overall Study|Lost to Follow-up|1
5876763|NCT01910116|20330785|P2|Overall Study|Lack of Efficacy|4
5876764|NCT01910116|20330786|P1|Overall Study|Lack of Efficacy|3
5876765|NCT01910116|20330785|P2|Overall Study|Adverse Event|3
5876766|NCT01910116|20330786|P1|Overall Study|Adverse Event|0
5876767|NCT01909973|20330873|P2|Overall Study|Lost to Follow-up|0
5876768|NCT01909973|20330874|P1|Overall Study|Lost to Follow-up|1
5876769|NCT01909804|20330894|P12|Overall Study|Protocol Violation|1
5876770|NCT01909804|20330895|P11|Overall Study|Protocol Violation|0
5876771|NCT01909804|20330896|P10|Overall Study|Protocol Violation|0
5876772|NCT01909804|20330897|P9|Overall Study|Protocol Violation|0
5876773|NCT01909804|20330898|P8|Overall Study|Protocol Violation|0
5876774|NCT01909804|20330899|P7|Overall Study|Protocol Violation|0
5876775|NCT01909804|20330900|P6|Overall Study|Protocol Violation|0
5876776|NCT01909804|20330901|P5|Overall Study|Protocol Violation|0
5876777|NCT01909804|20330902|P4|Overall Study|Protocol Violation|0
5876778|NCT01909804|20330903|P3|Overall Study|Protocol Violation|0
5876779|NCT01909804|20330904|P2|Overall Study|Protocol Violation|0
5876780|NCT01909804|20330905|P1|Overall Study|Protocol Violation|0
5876781|NCT01909804|20330894|P12|Overall Study|Withdrew Consent|0
5876782|NCT01909804|20330895|P11|Overall Study|Withdrew Consent|0
5876783|NCT01909804|20330896|P10|Overall Study|Withdrew Consent|0
5876784|NCT01909804|20330897|P9|Overall Study|Withdrew Consent|0
5876785|NCT01909804|20330898|P8|Overall Study|Withdrew Consent|0
5876786|NCT01909804|20330899|P7|Overall Study|Withdrew Consent|0
5876787|NCT01909804|20330900|P6|Overall Study|Withdrew Consent|1
5876788|NCT01909804|20330901|P5|Overall Study|Withdrew Consent|1
5876789|NCT01909804|20330902|P4|Overall Study|Withdrew Consent|0
5876790|NCT01909804|20330903|P3|Overall Study|Withdrew Consent|0
5876791|NCT01909804|20330904|P2|Overall Study|Withdrew Consent|0
5876792|NCT01909804|20330905|P1|Overall Study|Withdrew Consent|0
5876793|NCT01909804|20330894|P12|Overall Study|Lack of Efficacy|1
5876794|NCT01909804|20330895|P11|Overall Study|Lack of Efficacy|0
5876795|NCT01909804|20330896|P10|Overall Study|Lack of Efficacy|1
5876796|NCT01909804|20330897|P9|Overall Study|Lack of Efficacy|0
5876797|NCT01909804|20330898|P8|Overall Study|Lack of Efficacy|1
5876798|NCT01909804|20330899|P7|Overall Study|Lack of Efficacy|1
5876799|NCT01909804|20330900|P6|Overall Study|Lack of Efficacy|3
5876800|NCT01909804|20330901|P5|Overall Study|Lack of Efficacy|7
5876801|NCT01909804|20330902|P4|Overall Study|Lack of Efficacy|0
5876802|NCT01909804|20330903|P3|Overall Study|Lack of Efficacy|0
5876803|NCT01909804|20330904|P2|Overall Study|Lack of Efficacy|1
5876804|NCT01909804|20330905|P1|Overall Study|Lack of Efficacy|4
5876805|NCT01909804|20330894|P12|Overall Study|Death|0
5876806|NCT01909804|20330895|P11|Overall Study|Death|1
5876807|NCT01909804|20330896|P10|Overall Study|Death|0
5876808|NCT01909804|20330897|P9|Overall Study|Death|0
5876809|NCT01909804|20330898|P8|Overall Study|Death|0
5876810|NCT01909804|20330899|P7|Overall Study|Death|0
5876811|NCT01909804|20330900|P6|Overall Study|Death|0
5876812|NCT01909804|20330901|P5|Overall Study|Death|0
5876813|NCT01909804|20330902|P4|Overall Study|Death|0
5876814|NCT01909804|20330903|P3|Overall Study|Death|0
5876815|NCT01909804|20330904|P2|Overall Study|Death|0
5876816|NCT01909804|20330905|P1|Overall Study|Death|0
5876817|NCT01909804|20330894|P12|Overall Study|Randomized but Never Treated|1
5876818|NCT01909804|20330895|P11|Overall Study|Randomized but Never Treated|0
5876819|NCT01909804|20330896|P10|Overall Study|Randomized but Never Treated|0
5876820|NCT01909804|20330897|P9|Overall Study|Randomized but Never Treated|0
5876821|NCT01909804|20330898|P8|Overall Study|Randomized but Never Treated|0
5876822|NCT01909804|20330899|P7|Overall Study|Randomized but Never Treated|1
5876823|NCT01909804|20330900|P6|Overall Study|Randomized but Never Treated|0
5876824|NCT01909804|20330901|P5|Overall Study|Randomized but Never Treated|0
5876825|NCT01909804|20330902|P4|Overall Study|Randomized but Never Treated|0
5876826|NCT01909804|20330903|P3|Overall Study|Randomized but Never Treated|0
5876827|NCT01909804|20330904|P2|Overall Study|Randomized but Never Treated|0
5876828|NCT01909804|20330905|P1|Overall Study|Randomized but Never Treated|0
5876829|NCT01909791|20330954|P3|Overall Study|Missed Visit|1
5876830|NCT01909791|20330955|P2|Overall Study|Missed Visit|0
5876831|NCT01909791|20330956|P1|Overall Study|Missed Visit|2
5876832|NCT01909791|20330954|P3|Overall Study|Lost to Follow-up|10
5876833|NCT01909791|20330955|P2|Overall Study|Lost to Follow-up|11
5876834|NCT01909791|20330956|P1|Overall Study|Lost to Follow-up|5
5876835|NCT01909791|20330954|P3|Overall Study|Withdrawal by Subject|13
5876836|NCT01909791|20330955|P2|Overall Study|Withdrawal by Subject|9
5876837|NCT01909791|20330956|P1|Overall Study|Withdrawal by Subject|5
5876838|NCT01909791|20330954|P3|Overall Study|Death|4
5876839|NCT01909791|20330955|P2|Overall Study|Death|8
5876840|NCT01909791|20330956|P1|Overall Study|Death|9
5876841|NCT01909778|20331014|P1|Overall Study|failed screening|1
5876842|NCT01909674|20331093|P2|Overall Study|Withdrawal by Subject|2
5876843|NCT01909674|20331094|P1|Overall Study|Withdrawal by Subject|5
5876844|NCT01909466|20331113|P2|Overall Study|Lack of Efficacy|0
5876845|NCT01909466|20331114|P1|Overall Study|Lack of Efficacy|1
5876846|NCT01909466|20331113|P2|Overall Study|Withdrawal by Subject|9
5876847|NCT01909466|20331114|P1|Overall Study|Withdrawal by Subject|11
5876848|NCT01909466|20331113|P2|Overall Study|Physician Decision|0
5876849|NCT01909466|20331114|P1|Overall Study|Physician Decision|2
5876850|NCT01909466|20331113|P2|Overall Study|Met Withdrawal Criteria|3
5876851|NCT01909466|20331114|P1|Overall Study|Met Withdrawal Criteria|0
5876852|NCT01909466|20331113|P2|Overall Study|Adverse Event|4
5876853|NCT01909466|20331114|P1|Overall Study|Adverse Event|3
5876854|NCT01909466|20331113|P2|Overall Study|Lost to Follow-up|7
5876855|NCT01909466|20331114|P1|Overall Study|Lost to Follow-up|5
5876856|NCT01909336|20331137|P3|Overall Study|Physician Decision|1
5876857|NCT01909336|20331138|P2|Overall Study|Physician Decision|1
5876858|NCT01909336|20331139|P1|Overall Study|Physician Decision|0
5876859|NCT01909336|20331137|P3|Overall Study|Lost to Follow-up|2
5876860|NCT01909336|20331138|P2|Overall Study|Lost to Follow-up|2
5876861|NCT01909336|20331139|P1|Overall Study|Lost to Follow-up|4
5876862|NCT01908907|20331237|P2|Overall Study|Protocol Violation|0
5876863|NCT01908907|20331238|P1|Overall Study|Protocol Violation|1
5876864|NCT01908907|20331237|P2|Overall Study|Physician Decision|0
5876865|NCT01908907|20331238|P1|Overall Study|Physician Decision|1
5876866|NCT01908829|20331282|P3|Overall Study|Withdrawal by Subject|22
5876867|NCT01908829|20331283|P2|Overall Study|Withdrawal by Subject|29
5876868|NCT01908829|20331284|P1|Overall Study|Withdrawal by Subject|26
5876869|NCT01908829|20331282|P3|Overall Study|Lack of Efficacy|2
5876870|NCT01908829|20331283|P2|Overall Study|Lack of Efficacy|3
5876871|NCT01908829|20331284|P1|Overall Study|Lack of Efficacy|1
5876872|NCT01908829|20331282|P3|Overall Study|Protocol Violation|0
5876873|NCT01908829|20331283|P2|Overall Study|Protocol Violation|2
5876874|NCT01908829|20331284|P1|Overall Study|Protocol Violation|2
5876875|NCT01908829|20331282|P3|Overall Study|Miscellaneous|0
5876876|NCT01908829|20331283|P2|Overall Study|Miscellaneous|2
5876877|NCT01908829|20331284|P1|Overall Study|Miscellaneous|0
5876878|NCT01908829|20331282|P3|Overall Study|Discontinued (no EoT page)|0
5876879|NCT01908829|20331283|P2|Overall Study|Discontinued (no EoT page)|0
5876880|NCT01908829|20331284|P1|Overall Study|Discontinued (no EoT page)|2
5876881|NCT01908829|20331282|P3|Overall Study|Randomized no double-blind drug received|1
5876882|NCT01908829|20331283|P2|Overall Study|Randomized no double-blind drug received|0
5876883|NCT01908829|20331284|P1|Overall Study|Randomized no double-blind drug received|1
5876884|NCT01908829|20331282|P3|Overall Study|Lost to Follow-up|1
5876885|NCT01908829|20331283|P2|Overall Study|Lost to Follow-up|2
5876886|NCT01908829|20331284|P1|Overall Study|Lost to Follow-up|4
5876887|NCT01908829|20331282|P3|Overall Study|Adverse Event|13
5876888|NCT01908829|20331283|P2|Overall Study|Adverse Event|11
5876889|NCT01908829|20331284|P1|Overall Study|Adverse Event|13
5876890|NCT01908816|20331401|P4|Overall Study|Early termination|28
5876891|NCT01908816|20331402|P3|Overall Study|Early termination|43
5876892|NCT01908816|20331403|P2|Overall Study|Early termination|60
5876893|NCT01908816|20331404|P1|Overall Study|Early termination|87
5876894|NCT01908816|20331401|P4|Overall Study|Unsatisfactory therapeutic effect|0
5876895|NCT01908816|20331402|P3|Overall Study|Unsatisfactory therapeutic effect|1
5876896|NCT01908816|20331403|P2|Overall Study|Unsatisfactory therapeutic effect|13
5876897|NCT01908816|20331404|P1|Overall Study|Unsatisfactory therapeutic effect|1
5876898|NCT01908816|20331401|P4|Overall Study|Death|1
5876899|NCT01908816|20331402|P3|Overall Study|Death|7
5876900|NCT01908816|20331403|P2|Overall Study|Death|0
5876901|NCT01908816|20331404|P1|Overall Study|Death|1
5876902|NCT01908816|20331401|P4|Overall Study|Lost to Follow-up|2
5876903|NCT01908816|20331402|P3|Overall Study|Lost to Follow-up|4
5876904|NCT01908816|20331403|P2|Overall Study|Lost to Follow-up|5
5876905|NCT01908816|20331404|P1|Overall Study|Lost to Follow-up|3
5876906|NCT01908816|20331401|P4|Overall Study|Withdrawal by Subject|2
5876907|NCT01908816|20331402|P3|Overall Study|Withdrawal by Subject|2
5876908|NCT01908816|20331403|P2|Overall Study|Withdrawal by Subject|4
5876909|NCT01908816|20331404|P1|Overall Study|Withdrawal by Subject|0
5876910|NCT01908816|20331401|P4|Overall Study|Protocol deviation|1
5876911|NCT01908816|20331402|P3|Overall Study|Protocol deviation|1
5876912|NCT01908816|20331403|P2|Overall Study|Protocol deviation|2
5876913|NCT01908816|20331404|P1|Overall Study|Protocol deviation|1
5876914|NCT01908816|20331401|P4|Overall Study|Subject's no longer requires study drug|1
5876915|NCT01908816|20331402|P3|Overall Study|Subject's no longer requires study drug|0
5876916|NCT01908816|20331403|P2|Overall Study|Subject's no longer requires study drug|0
5876917|NCT01908816|20331404|P1|Overall Study|Subject's no longer requires study drug|0
5876918|NCT01908803|20331429|P2|Overall Study|Adverse Event (pre-treatment)|0
5876919|NCT01908803|20331430|P1|Overall Study|Adverse Event (pre-treatment)|1
5876920|NCT01908803|20331429|P2|Overall Study|Randomization Error|0
5876921|NCT01908803|20331430|P1|Overall Study|Randomization Error|1
5876922|NCT01908803|20331429|P2|Overall Study|Withdrawal by Subject|0
5876923|NCT01908803|20331430|P1|Overall Study|Withdrawal by Subject|1
5876924|NCT01908803|20331429|P2|Overall Study|Physician Decision|1
5876925|NCT01908803|20331430|P1|Overall Study|Physician Decision|0
5876926|NCT01908803|20331429|P2|Overall Study|Adverse Event|0
5876927|NCT01908803|20331430|P1|Overall Study|Adverse Event|1
5876928|NCT01908699|20331484|P2|Overall Study|Progressive Disease|29
5876929|NCT01908699|20331485|P1|Overall Study|Progressive Disease|30
5876930|NCT01908699|20331484|P2|Overall Study|Death|12
5876931|NCT01908699|20331485|P1|Overall Study|Death|9
5876932|NCT01908699|20331484|P2|Overall Study|Randomized in Error|0
5876933|NCT01908699|20331485|P1|Overall Study|Randomized in Error|1
5876934|NCT01908699|20331484|P2|Overall Study|Pregnancy|1
5876935|NCT01908699|20331485|P1|Overall Study|Pregnancy|0
5876936|NCT01908699|20331484|P2|Overall Study|Withdrawal by Subject|10
5876937|NCT01908699|20331485|P1|Overall Study|Withdrawal by Subject|15
5876938|NCT01908699|20331484|P2|Overall Study|Physician Decision|8
5876939|NCT01908699|20331485|P1|Overall Study|Physician Decision|8
5876940|NCT01908699|20331484|P2|Overall Study|Lost to Follow-up|4
5876941|NCT01908699|20331485|P1|Overall Study|Lost to Follow-up|2
5876942|NCT01908699|20331484|P2|Overall Study|Lack of Efficacy|2
5876943|NCT01908699|20331485|P1|Overall Study|Lack of Efficacy|2
5876944|NCT01908699|20331484|P2|Overall Study|Adverse Event|12
5876945|NCT01908699|20331485|P1|Overall Study|Adverse Event|8
5876946|NCT01908582|20331501|P1|Period 2|Withdrawal by Subject|1
5876947|NCT01908582|20331501|P1|Period 2|Physician Decision|1
5876948|NCT01908426|20331545|P2|Overall Study|No Study Treatment Given|0
5876949|NCT01908426|20331546|P1|Overall Study|No Study Treatment Given|3
5876950|NCT01908426|20331545|P2|Overall Study|Protocol Violation|0
5876951|NCT01908426|20331546|P1|Overall Study|Protocol Violation|1
5876952|NCT01908426|20331545|P2|Overall Study|Progressive Disease|152
5876953|NCT01908426|20331546|P1|Overall Study|Progressive Disease|206
5876954|NCT01908426|20331545|P2|Overall Study|Withdrawal by Subject|6
5876955|NCT01908426|20331546|P1|Overall Study|Withdrawal by Subject|11
5876956|NCT01908426|20331545|P2|Overall Study|Physician Decision|3
5876957|NCT01908426|20331546|P1|Overall Study|Physician Decision|3
5876958|NCT01908426|20331545|P2|Overall Study|Lost to Follow-up|1
5876959|NCT01908426|20331546|P1|Overall Study|Lost to Follow-up|0
5876960|NCT01908426|20331545|P2|Overall Study|Lack of Efficacy|0
5876961|NCT01908426|20331546|P1|Overall Study|Lack of Efficacy|3
5876962|NCT01908426|20331545|P2|Overall Study|Clinical Deterioration|38
5876963|NCT01908426|20331546|P1|Overall Study|Clinical Deterioration|72
5876964|NCT01908426|20331545|P2|Overall Study|Adverse Event|11
5876965|NCT01908426|20331546|P1|Overall Study|Adverse Event|98
5876966|NCT01908205|20331558|P2|Overall Study|Withdrawal by Subject|1
5876967|NCT01908205|20331559|P1|Overall Study|Withdrawal by Subject|3
5876968|NCT01908205|20331558|P2|Overall Study|Lost to Follow-up|0
5876969|NCT01908205|20331559|P1|Overall Study|Lost to Follow-up|2
5876970|NCT01908140|20331587|P2|Overall Study|Adverse Event|23
5876971|NCT01908140|20331588|P1|Overall Study|Adverse Event|22
5876972|NCT01908140|20331587|P2|Overall Study|Protocol Violation|9
5876973|NCT01908140|20331588|P1|Overall Study|Protocol Violation|8
5876974|NCT01908140|20331587|P2|Overall Study|Lost to Follow-up|6
5876975|NCT01908140|20331588|P1|Overall Study|Lost to Follow-up|1
5876976|NCT01908140|20331587|P2|Overall Study|Withdrawal by Subject|24
5876977|NCT01908140|20331588|P1|Overall Study|Withdrawal by Subject|23
5876978|NCT01908140|20331587|P2|Overall Study|Lack of Efficacy|5
5876979|NCT01908140|20331588|P1|Overall Study|Lack of Efficacy|7
5876980|NCT01908140|20331587|P2|Overall Study|Other or Progressive Disease|12
5876981|NCT01908140|20331588|P1|Overall Study|Other or Progressive Disease|5
5876982|NCT01908101|20331607|P1|Overall Study|Did not complete the first cycle|4
5876983|NCT01908101|20331607|P1|Overall Study|Incorrect Starting Dose|1
5876984|NCT01908101|20331607|P1|Overall Study|Incorrect Diagnosis|2
5876985|NCT01908101|20331607|P1|Overall Study|Withdrawal by Subject|1
5876986|NCT01908101|20331607|P1|Overall Study|Physician Decision|1
5876987|NCT01907906|20331641|P2|Overall Study|Physician Decision|1
5876988|NCT01907906|20331642|P1|Overall Study|Physician Decision|3
5876989|NCT01907906|20331641|P2|Overall Study|Withdrawal by Subject|0
5876990|NCT01907906|20331642|P1|Overall Study|Withdrawal by Subject|1
5876991|NCT01907854|20331722|P2|Overall Study|Unclassified|3
5876992|NCT01907854|20331723|P1|Overall Study|Unclassified|4
5876993|NCT01907854|20331722|P2|Overall Study|Lost to Follow-up|2
5876994|NCT01907854|20331723|P1|Overall Study|Lost to Follow-up|2
5876995|NCT01907854|20331722|P2|Overall Study|Withdrawal by Subject|7
5876996|NCT01907854|20331723|P1|Overall Study|Withdrawal by Subject|9
5876997|NCT01907854|20331722|P2|Overall Study|Protocol Violation|1
5876998|NCT01907854|20331723|P1|Overall Study|Protocol Violation|1
5876999|NCT01907828|20331743|P2|Overall Study|Participant met exclusion criteria|1
5877000|NCT01907828|20331744|P1|Overall Study|Participant met exclusion criteria|0
5877001|NCT01907828|20331743|P2|Overall Study|Participant refused 24-month follow-up|0
5877002|NCT01907828|20331744|P1|Overall Study|Participant refused 24-month follow-up|1
5877003|NCT01907828|20331743|P2|Overall Study|Lost to Follow-up|0
5877004|NCT01907828|20331744|P1|Overall Study|Lost to Follow-up|3
5877005|NCT01907828|20331743|P2|Overall Study|Withdrawal by Subject|4
5877006|NCT01907828|20331744|P1|Overall Study|Withdrawal by Subject|3
5877007|NCT01907828|20331743|P2|Overall Study|Exclusion criteria not met|1
5877008|NCT01907828|20331744|P1|Overall Study|Exclusion criteria not met|0
5877009|NCT01907815|20331772|P2|Overall Study|Withdrawal by Subject|0
5877010|NCT01907815|20331773|P1|Overall Study|Withdrawal by Subject|1
5877011|NCT01907737|20331787|P1|Overall Study|Withdrawal by Subject|1
5877012|NCT01907516|20331806|P2|First Intervention (3 Weeks)|Developed DKA during study|0
5877013|NCT01907516|20331807|P1|First Intervention (3 Weeks)|Developed DKA during study|1
5877014|NCT01907516|20331806|P2|First Intervention (3 Weeks)|Delivered before second arm|4
5877015|NCT01907516|20331807|P1|First Intervention (3 Weeks)|Delivered before second arm|3
5877016|NCT01907516|20331806|P2|First Intervention (3 Weeks)|Lost to Follow-up|3
5877017|NCT01907516|20331807|P1|First Intervention (3 Weeks)|Lost to Follow-up|1
5877018|NCT01907516|20331806|P2|First Intervention (3 Weeks)|Withdrawal by Subject|9
5877019|NCT01907516|20331807|P1|First Intervention (3 Weeks)|Withdrawal by Subject|5
5877020|NCT01907217|20331851|P2|Overall Study|Withdrawal by Subject|2
5877021|NCT01907217|20331852|P1|Overall Study|Withdrawal by Subject|0
5877022|NCT01907100|20331964|P4|Overall Study|Worsening/AE underlying cancer disease|8
5877023|NCT01907100|20331965|P3|Overall Study|Worsening/AE underlying cancer disease|8
5877024|NCT01907100|20331966|P2|Overall Study|Worsening/AE underlying cancer disease|0
5877025|NCT01907100|20331967|P1|Overall Study|Worsening/AE underlying cancer disease|0
5877026|NCT01907100|20331964|P4|Overall Study|Adverse event (AE)|23
5877027|NCT01907100|20331965|P3|Overall Study|Adverse event (AE)|22
5877028|NCT01907100|20331966|P2|Overall Study|Adverse event (AE)|3
5877029|NCT01907100|20331967|P1|Overall Study|Adverse event (AE)|6
5877030|NCT01907100|20331964|P4|Overall Study|Other than reasons specified|6
5877031|NCT01907100|20331965|P3|Overall Study|Other than reasons specified|10
5877032|NCT01907100|20331966|P2|Overall Study|Other than reasons specified|0
5877033|NCT01907100|20331967|P1|Overall Study|Other than reasons specified|1
5877034|NCT01907100|20331964|P4|Overall Study|Not treated|2
5877035|NCT01907100|20331965|P3|Overall Study|Not treated|1
5877036|NCT01907100|20331966|P2|Overall Study|Not treated|0
5877037|NCT01907100|20331967|P1|Overall Study|Not treated|2
5877038|NCT01907100|20331964|P4|Overall Study|Lost to Follow-up|1
5877039|NCT01907100|20331965|P3|Overall Study|Lost to Follow-up|0
5877040|NCT01907100|20331966|P2|Overall Study|Lost to Follow-up|0
5877041|NCT01907100|20331967|P1|Overall Study|Lost to Follow-up|0
5877042|NCT01907100|20331964|P4|Overall Study|Protocol Violation|1
5877043|NCT01907100|20331965|P3|Overall Study|Protocol Violation|1
5877044|NCT01907100|20331966|P2|Overall Study|Protocol Violation|0
5877045|NCT01907100|20331967|P1|Overall Study|Protocol Violation|0
5877046|NCT01907100|20331964|P4|Overall Study|Withdrawal by Subject|13
5877047|NCT01907100|20331965|P3|Overall Study|Withdrawal by Subject|10
5877048|NCT01907100|20331966|P2|Overall Study|Withdrawal by Subject|5
5877049|NCT01907100|20331967|P1|Overall Study|Withdrawal by Subject|2
5877050|NCT01907100|20331964|P4|Overall Study|PD based on modified RECIST criteria|92
5877051|NCT01907100|20331965|P3|Overall Study|PD based on modified RECIST criteria|95
5877052|NCT01907100|20331966|P2|Overall Study|PD based on modified RECIST criteria|32
5877053|NCT01907100|20331967|P1|Overall Study|PD based on modified RECIST criteria|31
5877054|NCT01907087|20331981|P1|Overall Study|Withdrawal by Subject|1
5877055|NCT01906476|20332044|P2|Overall Study|Lost to Follow-up|16
5877056|NCT01906476|20332045|P1|Overall Study|Lost to Follow-up|17
5877057|NCT01906372|20332053|P1|Overall Study|Withdrawal by Subject|2
5877058|NCT01906346|20332058|P1|Overall Study|AEs|1
5877059|NCT01906008|20332066|P2|Overall Study|Adverse Event|3
5877060|NCT01906008|20332067|P1|Overall Study|Adverse Event|0
5877061|NCT01906008|20332066|P2|Overall Study|Lack of compliance of study med|3
5877062|NCT01906008|20332067|P1|Overall Study|Lack of compliance of study med|5
5877063|NCT01906008|20332066|P2|Overall Study|Physician Decision|3
5877064|NCT01906008|20332067|P1|Overall Study|Physician Decision|3
5877065|NCT01906008|20332066|P2|Overall Study|Hospice|0
5877066|NCT01906008|20332067|P1|Overall Study|Hospice|1
5877067|NCT01906008|20332066|P2|Overall Study|Oxaliplatin stops|8
5877068|NCT01906008|20332067|P1|Overall Study|Oxaliplatin stops|10
5877069|NCT01906008|20332066|P2|Overall Study|Did not start study med|4
5877070|NCT01906008|20332067|P1|Overall Study|Did not start study med|3
5877071|NCT01906008|20332066|P2|Overall Study|Withdrawal by Subject|5
5877072|NCT01906008|20332067|P1|Overall Study|Withdrawal by Subject|1
5877073|NCT01906008|20332066|P2|Overall Study|Protocol Violation|1
5877074|NCT01906008|20332067|P1|Overall Study|Protocol Violation|0
5877075|NCT01906008|20332066|P2|Overall Study|Oxaliplatin toxicity|0
5877076|NCT01906008|20332067|P1|Overall Study|Oxaliplatin toxicity|2
5877077|NCT01906008|20332066|P2|Overall Study|Lost to Follow-up|0
5877078|NCT01906008|20332067|P1|Overall Study|Lost to Follow-up|2
5877079|NCT01905943|20332100|P1|Overall Study|Other|12
5877080|NCT01905943|20332100|P1|Overall Study|Adverse Event|3
5877081|NCT01905943|20332100|P1|Overall Study|Death|186
5877082|NCT01905943|20332100|P1|Overall Study|Investigator discretion|7
5877083|NCT01905943|20332100|P1|Overall Study|Lost to Follow-up|16
5877084|NCT01905943|20332100|P1|Overall Study|Withdrawal of consent|90
5877085|NCT01905683|20332217|P1|Overall Study|Lost to Follow-up|4
5877086|NCT01905683|20332217|P1|Overall Study|Adverse Event|4
5877087|NCT01905683|20332217|P1|Overall Study|Withdrawal by Subject|20
5877088|NCT01905683|20332217|P1|Overall Study|Lack of Efficacy|8
5877089|NCT01905683|20332217|P1|Overall Study|Physician Decision|1
5877090|NCT01905683|20332217|P1|Overall Study|Re-injection criteria not met; others|13
5877091|NCT01905683|20332217|P1|Overall Study|Protocol Violation|1
5877092|NCT01905657|20332233|P3|Overall Study|Excluded from Efficacy Analysis|0
5877093|NCT01905657|20332234|P2|Overall Study|Excluded from Efficacy Analysis|0
5877094|NCT01905657|20332235|P1|Overall Study|Excluded from Efficacy Analysis|1
5877095|NCT01905657|20332233|P3|Overall Study|Continuing in Study|11
5877096|NCT01905657|20332234|P2|Overall Study|Continuing in Study|74
5877097|NCT01905657|20332235|P1|Overall Study|Continuing in Study|74
5877098|NCT01905657|20332233|P3|Overall Study|Withdrawal by Subject|45
5877099|NCT01905657|20332234|P2|Overall Study|Withdrawal by Subject|10
5877100|NCT01905657|20332235|P1|Overall Study|Withdrawal by Subject|5
5877101|NCT01905657|20332233|P3|Overall Study|Protocol Violation|1
5877102|NCT01905657|20332234|P2|Overall Study|Protocol Violation|1
5877103|NCT01905657|20332235|P1|Overall Study|Protocol Violation|2
5877104|NCT01905657|20332233|P3|Overall Study|Progressive Disease|89
5877105|NCT01905657|20332234|P2|Overall Study|Progressive Disease|126
5877106|NCT01905657|20332235|P1|Overall Study|Progressive Disease|124
5877107|NCT01905657|20332233|P3|Overall Study|Physician Decision|113
5877108|NCT01905657|20332234|P2|Overall Study|Physician Decision|74
5877109|NCT01905657|20332235|P1|Overall Study|Physician Decision|82
5877110|NCT01905657|20332233|P3|Overall Study|Other|1
5877111|NCT01905657|20332234|P2|Overall Study|Other|7
5877112|NCT01905657|20332235|P1|Overall Study|Other|3
5877113|NCT01905657|20332233|P3|Overall Study|Death|21
5877114|NCT01905657|20332234|P2|Overall Study|Death|21
5877115|NCT01905657|20332235|P1|Overall Study|Death|21
5877116|NCT01905657|20332233|P3|Overall Study|Adverse Event|47
5877117|NCT01905657|20332234|P2|Overall Study|Adverse Event|32
5877118|NCT01905657|20332235|P1|Overall Study|Adverse Event|33
5877119|NCT01905657|20332233|P3|Overall Study|Not Treated|0
5877120|NCT01905657|20332234|P2|Overall Study|Not Treated|1
5877121|NCT01905657|20332235|P1|Overall Study|Not Treated|0
5877122|NCT01905592|20332260|P2|Overall Study|Withdrawal by Subject|2
5877123|NCT01905592|20332261|P1|Overall Study|Withdrawal by Subject|10
5877124|NCT01905592|20332260|P2|Overall Study|Ongoing in Study|7
5877125|NCT01905592|20332261|P1|Overall Study|Ongoing in Study|0
5877126|NCT01905592|20332260|P2|Overall Study|Not treated|3
5877127|NCT01905592|20332261|P1|Overall Study|Not treated|7
5877128|NCT01905592|20332260|P2|Overall Study|Sponsor's decision|0
5877129|NCT01905592|20332261|P1|Overall Study|Sponsor's decision|1
5877130|NCT01905592|20332260|P2|Overall Study|Protocol Violation|1
5877131|NCT01905592|20332261|P1|Overall Study|Protocol Violation|0
5877132|NCT01905592|20332260|P2|Overall Study|New anti-cancer|0
5877133|NCT01905592|20332261|P1|Overall Study|New anti-cancer|1
5877134|NCT01905592|20332260|P2|Overall Study|Physician Decision|2
5877135|NCT01905592|20332261|P1|Overall Study|Physician Decision|0
5877136|NCT01905592|20332260|P2|Overall Study|Toxicity|16
5877137|NCT01905592|20332261|P1|Overall Study|Toxicity|1
5877138|NCT01905592|20332260|P2|Overall Study|Disease Progression|104
5877139|NCT01905592|20332261|P1|Overall Study|Disease Progression|51
5877140|NCT01905553|20332275|P2|Period 2|Adverse Event|0
5877141|NCT01905553|20332276|P1|Period 2|Adverse Event|1
5877142|NCT01905540|20332290|P4|Period 3|Other|1
5877143|NCT01905540|20332291|P3|Period 3|Other|1
5877144|NCT01905540|20332292|P2|Period 3|Other|0
5877145|NCT01905540|20332293|P1|Period 3|Other|1
5877146|NCT01905267|20332359|P2|Overall Study|Physician Decision|2
5877147|NCT01905267|20332360|P1|Overall Study|Physician Decision|2
5877148|NCT01904773|20332381|P9|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
5877149|NCT01904773|20332382|P8|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
5877150|NCT01904773|20332383|P7|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
5877151|NCT01904773|20332384|P6|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
5877152|NCT01904773|20332385|P5|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
5877153|NCT01904773|20332386|P4|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
5877154|NCT01904773|20332387|P3|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
5877155|NCT01904773|20332388|P2|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|1
5877156|NCT01904773|20332389|P1|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
5877157|NCT01904773|20332381|P9|Fifth Intervention|Adverse Event|0
5877158|NCT01904773|20332382|P8|Fifth Intervention|Adverse Event|1
5877159|NCT01904773|20332383|P7|Fifth Intervention|Adverse Event|0
5877160|NCT01904773|20332384|P6|Fifth Intervention|Adverse Event|0
5877161|NCT01904773|20332385|P5|Fifth Intervention|Adverse Event|0
5877162|NCT01904773|20332386|P4|Fifth Intervention|Adverse Event|0
5877163|NCT01904773|20332387|P3|Fifth Intervention|Adverse Event|0
5877164|NCT01904773|20332388|P2|Fifth Intervention|Adverse Event|0
5877165|NCT01904773|20332389|P1|Fifth Intervention|Adverse Event|0
5877166|NCT01904773|20332381|P9|Placebo Washout First Intervention|Condition worsened|0
5877167|NCT01904773|20332382|P8|Placebo Washout First Intervention|Condition worsened|0
5877168|NCT01904773|20332383|P7|Placebo Washout First Intervention|Condition worsened|0
5877169|NCT01904773|20332384|P6|Placebo Washout First Intervention|Condition worsened|0
5877170|NCT01904773|20332385|P5|Placebo Washout First Intervention|Condition worsened|0
5877171|NCT01904773|20332386|P4|Placebo Washout First Intervention|Condition worsened|0
5877172|NCT01904773|20332387|P3|Placebo Washout First Intervention|Condition worsened|0
5877173|NCT01904773|20332388|P2|Placebo Washout First Intervention|Condition worsened|1
5877174|NCT01904773|20332389|P1|Placebo Washout First Intervention|Condition worsened|0
5877175|NCT01904773|20332381|P9|First Intervention|Adverse Event|0
5877176|NCT01904773|20332382|P8|First Intervention|Adverse Event|0
5877177|NCT01904773|20332383|P7|First Intervention|Adverse Event|1
5877178|NCT01904773|20332384|P6|First Intervention|Adverse Event|0
5877179|NCT01904773|20332385|P5|First Intervention|Adverse Event|0
5877180|NCT01904773|20332386|P4|First Intervention|Adverse Event|0
5877181|NCT01904773|20332387|P3|First Intervention|Adverse Event|0
5877182|NCT01904773|20332388|P2|First Intervention|Adverse Event|0
5877183|NCT01904773|20332389|P1|First Intervention|Adverse Event|0
5877184|NCT01904773|20332381|P9|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
5877185|NCT01904773|20332382|P8|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
5877186|NCT01904773|20332383|P7|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
5877187|NCT01904773|20332384|P6|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
5877188|NCT01904773|20332385|P5|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
5877189|NCT01904773|20332386|P4|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
5877190|NCT01904773|20332387|P3|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
5877191|NCT01904773|20332388|P2|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
5877192|NCT01904773|20332389|P1|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|1
5877193|NCT01904773|20332381|P9|Screen|Withdrawal by Subject|0
5877194|NCT01904773|20332382|P8|Screen|Withdrawal by Subject|0
5877195|NCT01904773|20332383|P7|Screen|Withdrawal by Subject|0
5877196|NCT01904773|20332384|P6|Screen|Withdrawal by Subject|0
5877197|NCT01904773|20332385|P5|Screen|Withdrawal by Subject|0
5877198|NCT01904773|20332386|P4|Screen|Withdrawal by Subject|0
5877199|NCT01904773|20332387|P3|Screen|Withdrawal by Subject|0
5877200|NCT01904773|20332388|P2|Screen|Withdrawal by Subject|0
5877201|NCT01904773|20332389|P1|Screen|Withdrawal by Subject|1
5877202|NCT01904773|20332381|P9|Screen|Screen failure|0
5877203|NCT01904773|20332382|P8|Screen|Screen failure|0
5877204|NCT01904773|20332383|P7|Screen|Screen failure|0
5877205|NCT01904773|20332384|P6|Screen|Screen failure|0
5877206|NCT01904773|20332385|P5|Screen|Screen failure|0
5877207|NCT01904773|20332386|P4|Screen|Screen failure|0
5877208|NCT01904773|20332387|P3|Screen|Screen failure|0
5877209|NCT01904773|20332388|P2|Screen|Screen failure|0
5877210|NCT01904773|20332389|P1|Screen|Screen failure|3
5877211|NCT01904760|20332406|P2|Overall Study|Protocol Violation|0
5877212|NCT01904760|20332407|P1|Overall Study|Protocol Violation|1
5877213|NCT01904721|20332422|P7|Overall Study|Adverse Event|0
5877214|NCT01904721|20332423|P6|Overall Study|Adverse Event|1
5877215|NCT01904721|20332424|P5|Overall Study|Adverse Event|3
5877216|NCT01904721|20332425|P4|Overall Study|Adverse Event|0
5877217|NCT01904721|20332426|P3|Overall Study|Adverse Event|0
5877218|NCT01904721|20332427|P2|Overall Study|Adverse Event|0
5877219|NCT01904721|20332428|P1|Overall Study|Adverse Event|0
5877220|NCT01904721|20332422|P7|Overall Study|Lack of Efficacy|1
5877221|NCT01904721|20332423|P6|Overall Study|Lack of Efficacy|0
5877222|NCT01904721|20332424|P5|Overall Study|Lack of Efficacy|0
5877223|NCT01904721|20332425|P4|Overall Study|Lack of Efficacy|0
5877224|NCT01904721|20332426|P3|Overall Study|Lack of Efficacy|0
5877225|NCT01904721|20332427|P2|Overall Study|Lack of Efficacy|0
5877226|NCT01904721|20332428|P1|Overall Study|Lack of Efficacy|0
5877227|NCT01904721|20332422|P7|Overall Study|Lost to Follow-up|1
5877228|NCT01904721|20332423|P6|Overall Study|Lost to Follow-up|3
5877229|NCT01904721|20332424|P5|Overall Study|Lost to Follow-up|1
5877230|NCT01904721|20332425|P4|Overall Study|Lost to Follow-up|0
5877231|NCT01904721|20332426|P3|Overall Study|Lost to Follow-up|0
5877232|NCT01904721|20332427|P2|Overall Study|Lost to Follow-up|0
5877233|NCT01904721|20332428|P1|Overall Study|Lost to Follow-up|0
5877234|NCT01904721|20332422|P7|Overall Study|Personal Reasons|3
5877235|NCT01904721|20332423|P6|Overall Study|Personal Reasons|3
5877236|NCT01904721|20332424|P5|Overall Study|Personal Reasons|2
5877237|NCT01904721|20332425|P4|Overall Study|Personal Reasons|0
5877238|NCT01904721|20332426|P3|Overall Study|Personal Reasons|0
5877239|NCT01904721|20332427|P2|Overall Study|Personal Reasons|0
5877240|NCT01904721|20332428|P1|Overall Study|Personal Reasons|0
5877241|NCT01904721|20332422|P7|Overall Study|Other Reasons|2
5877242|NCT01904721|20332423|P6|Overall Study|Other Reasons|2
5877243|NCT01904721|20332424|P5|Overall Study|Other Reasons|2
5877244|NCT01904721|20332425|P4|Overall Study|Other Reasons|1
5877245|NCT01904721|20332426|P3|Overall Study|Other Reasons|1
5877246|NCT01904721|20332427|P2|Overall Study|Other Reasons|0
5877247|NCT01904721|20332428|P1|Overall Study|Other Reasons|0
5877248|NCT01904604|20332458|P3|Overall Study|Lost to Follow-up|1
5877249|NCT01904604|20332459|P2|Overall Study|Lost to Follow-up|0
5877250|NCT01904604|20332460|P1|Overall Study|Lost to Follow-up|0
5877251|NCT01904604|20332458|P3|Overall Study|Participant Relocated|1
5877252|NCT01904604|20332459|P2|Overall Study|Participant Relocated|1
5877253|NCT01904604|20332460|P1|Overall Study|Participant Relocated|1
5877254|NCT01904604|20332458|P3|Overall Study|Withdrawal by Subject|0
5877255|NCT01904604|20332459|P2|Overall Study|Withdrawal by Subject|2
5877256|NCT01904604|20332460|P1|Overall Study|Withdrawal by Subject|1
5877257|NCT01904604|20332458|P3|Overall Study|Passed Week 52 OFC|0
5877258|NCT01904604|20332459|P2|Overall Study|Passed Week 52 OFC|0
5877259|NCT01904604|20332460|P1|Overall Study|Passed Week 52 OFC|1
5877260|NCT01904604|20332458|P3|Overall Study|Unrelated illness|0
5877261|NCT01904604|20332459|P2|Overall Study|Unrelated illness|1
5877262|NCT01904604|20332460|P1|Overall Study|Unrelated illness|0
5877263|NCT01904604|20332458|P3|Overall Study|Increased syncope|0
5877264|NCT01904604|20332459|P2|Overall Study|Increased syncope|1
5877265|NCT01904604|20332460|P1|Overall Study|Increased syncope|0
5877266|NCT01904604|20332458|P3|Overall Study|Patch site reactions|0
5877267|NCT01904604|20332459|P2|Overall Study|Patch site reactions|1
5877268|NCT01904604|20332460|P1|Overall Study|Patch site reactions|1
5877269|NCT01904604|20332458|P3|Overall Study|Anxiety about OFC/Refused OFC|0
5877270|NCT01904604|20332459|P2|Overall Study|Anxiety about OFC/Refused OFC|0
5877271|NCT01904604|20332460|P1|Overall Study|Anxiety about OFC/Refused OFC|2
5877272|NCT01904604|20332458|P3|Overall Study|Non-compliance|0
5877273|NCT01904604|20332459|P2|Overall Study|Non-compliance|0
5877274|NCT01904604|20332460|P1|Overall Study|Non-compliance|1
5877275|NCT01904604|20332458|P3|Overall Study|Withdrew before receiving dosing|0
5877276|NCT01904604|20332459|P2|Overall Study|Withdrew before receiving dosing|1
5877277|NCT01904604|20332460|P1|Overall Study|Withdrew before receiving dosing|0
5877278|NCT01904383|20332525|P1|Overall Study|No patient visit after entry|54
5877279|NCT01904383|20332525|P1|Overall Study|Adverse Event|271
5877280|NCT01904383|20332525|P1|Overall Study|Improvement|141
5877281|NCT01904383|20332525|P1|Overall Study|Lack of Efficacy|370
5877282|NCT01904383|20332525|P1|Overall Study|Lost to Follow-up|674
5877283|NCT01904383|20332525|P1|Overall Study|Reason not listed|147
5877284|NCT01904383|20332525|P1|Overall Study|CRF not collected|117
5877285|NCT01904279|20332532|P2|Overall Study|Withdrawal by Subject|0
5877286|NCT01904279|20332533|P1|Overall Study|Withdrawal by Subject|1
5877287|NCT01904279|20332532|P2|Overall Study|Lack of Efficacy|3
5877288|NCT01904279|20332533|P1|Overall Study|Lack of Efficacy|2
5877289|NCT01904149|20332559|P6|Overall Study|non compliance with study drug|0
5877290|NCT01904149|20332560|P5|Overall Study|non compliance with study drug|0
5877291|NCT01904149|20332561|P4|Overall Study|non compliance with study drug|0
5877292|NCT01904149|20332562|P3|Overall Study|non compliance with study drug|0
5877293|NCT01904149|20332563|P2|Overall Study|non compliance with study drug|0
5877294|NCT01904149|20332564|P1|Overall Study|non compliance with study drug|1
5877295|NCT01904149|20332559|P6|Overall Study|Protocol Violation|0
5877296|NCT01904149|20332560|P5|Overall Study|Protocol Violation|0
5877297|NCT01904149|20332561|P4|Overall Study|Protocol Violation|0
5877298|NCT01904149|20332562|P3|Overall Study|Protocol Violation|0
5877299|NCT01904149|20332563|P2|Overall Study|Protocol Violation|1
5877300|NCT01904149|20332564|P1|Overall Study|Protocol Violation|0
5877301|NCT01904149|20332559|P6|Overall Study|Withdrawal by Subject|0
5877302|NCT01904149|20332560|P5|Overall Study|Withdrawal by Subject|1
5877303|NCT01904149|20332561|P4|Overall Study|Withdrawal by Subject|0
5877304|NCT01904149|20332562|P3|Overall Study|Withdrawal by Subject|1
5877305|NCT01904149|20332563|P2|Overall Study|Withdrawal by Subject|3
5877306|NCT01904149|20332564|P1|Overall Study|Withdrawal by Subject|1
5877307|NCT01904149|20332559|P6|Overall Study|Lack of Efficacy|1
5877308|NCT01904149|20332560|P5|Overall Study|Lack of Efficacy|3
5877309|NCT01904149|20332561|P4|Overall Study|Lack of Efficacy|3
5877310|NCT01904149|20332562|P3|Overall Study|Lack of Efficacy|1
5877311|NCT01904149|20332563|P2|Overall Study|Lack of Efficacy|3
5877312|NCT01904149|20332564|P1|Overall Study|Lack of Efficacy|0
5877313|NCT01904149|20332559|P6|Overall Study|Adverse Event|2
5877314|NCT01904149|20332560|P5|Overall Study|Adverse Event|1
5877315|NCT01904149|20332561|P4|Overall Study|Adverse Event|1
5877316|NCT01904149|20332562|P3|Overall Study|Adverse Event|0
5877317|NCT01904149|20332563|P2|Overall Study|Adverse Event|4
5877318|NCT01904149|20332564|P1|Overall Study|Adverse Event|3
5877319|NCT01904058|20332615|P4|Overall Study|Pregnancy|1
5877320|NCT01904058|20332616|P3|Overall Study|Pregnancy|0
5877321|NCT01904058|20332617|P2|Overall Study|Pregnancy|0
5877322|NCT01904058|20332618|P1|Overall Study|Pregnancy|0
5877323|NCT01904058|20332615|P4|Overall Study|Withdrawal by Subject|0
5877324|NCT01904058|20332616|P3|Overall Study|Withdrawal by Subject|1
5877325|NCT01904058|20332617|P2|Overall Study|Withdrawal by Subject|0
5877326|NCT01904058|20332618|P1|Overall Study|Withdrawal by Subject|1
5877327|NCT01904058|20332615|P4|Overall Study|Adverse Event|0
5877328|NCT01904058|20332616|P3|Overall Study|Adverse Event|0
5877329|NCT01904058|20332617|P2|Overall Study|Adverse Event|0
5877330|NCT01904058|20332618|P1|Overall Study|Adverse Event|2
5877331|NCT01903993|20332658|P2|Overall Study|Terminated by Sponsor After 31 Aug 2018|2
5877332|NCT01903993|20332659|P1|Overall Study|Terminated by Sponsor After 31 Aug 2018|0
5877333|NCT01903993|20332658|P2|Overall Study|Study Terminated by Sponsor|14
5877334|NCT01903993|20332659|P1|Overall Study|Study Terminated by Sponsor|8
5877335|NCT01903993|20332658|P2|Overall Study|Lost to Follow-up|3
5877336|NCT01903993|20332659|P1|Overall Study|Lost to Follow-up|2
5877337|NCT01903993|20332658|P2|Overall Study|Withdrawal by Subject|4
5877338|NCT01903993|20332659|P1|Overall Study|Withdrawal by Subject|15
5877339|NCT01903993|20332658|P2|Overall Study|Death|121
5877340|NCT01903993|20332659|P1|Overall Study|Death|118
5877341|NCT01903876|20332676|P2|Six-Month Follow-up Period|Lost to Follow-up|145
5877342|NCT01903876|20332677|P1|Six-Month Follow-up Period|Lost to Follow-up|91
5877343|NCT01903876|20332676|P2|Baseline to Post-Intervention Period|Lost to Follow-up|108
5877344|NCT01903876|20332677|P1|Baseline to Post-Intervention Period|Lost to Follow-up|184
5877345|NCT01903863|20332687|P2|Overall Study|Physician Decision|0
5877346|NCT01903863|20332688|P1|Overall Study|Physician Decision|2
5877347|NCT01903811|20332710|P2|Overall Study|Withdrawal by Subject|1
5877348|NCT01903811|20332711|P1|Overall Study|Withdrawal by Subject|0
5877349|NCT01903811|20332710|P2|Overall Study|Baseline lab missing/incomplete/untimely|11
5877350|NCT01903811|20332711|P1|Overall Study|Baseline lab missing/incomplete/untimely|6
5877351|NCT01903811|20332710|P2|Overall Study|Incomplete/discontinued prior therapy|1
5877352|NCT01903811|20332711|P1|Overall Study|Incomplete/discontinued prior therapy|1
5877353|NCT01903811|20332710|P2|Overall Study|No measurable disease|1
5877354|NCT01903811|20332711|P1|Overall Study|No measurable disease|1
5877355|NCT01903720|20332745|P1|Overall Study|Treatment with alternative drug|1
5877356|NCT01903720|20332745|P1|Overall Study|Lost to Follow-up|2
5877357|NCT01903720|20332745|P1|Overall Study|Rescinding of informed consent|2
5877358|NCT01903720|20332745|P1|Overall Study|Adverse Event|1
5877359|NCT01903720|20332745|P1|Overall Study|Inclusion / exclusion criteria not met|6
5877360|NCT01903525|20332781|P2|Overall Study|Adverse Event|1
5877361|NCT01903525|20332782|P1|Overall Study|Adverse Event|0
5877362|NCT01903525|20332781|P2|Overall Study|Lost to Follow-up|9
5877363|NCT01903525|20332782|P1|Overall Study|Lost to Follow-up|5
5877364|NCT01903460|20332798|P4|Overall Study|Adverse Event|1
5877365|NCT01903460|20332799|P3|Overall Study|Adverse Event|0
5877366|NCT01903460|20332800|P2|Overall Study|Adverse Event|0
5877367|NCT01903460|20332801|P1|Overall Study|Adverse Event|0
5877368|NCT01903434|20332818|P2|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|2
5877369|NCT01903434|20332819|P1|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|0
5877370|NCT01903434|20332818|P2|Washout Period 1 (at Least 14 Days)|Adverse Event|0
5877371|NCT01903434|20332819|P1|Washout Period 1 (at Least 14 Days)|Adverse Event|1
5877372|NCT01903356|20332827|P1|Overall Study|Violated the dosage and administration|3
5877373|NCT01903356|20332827|P1|Overall Study|Violated inclusion/exclusion criteria|5
5877374|NCT01903356|20332827|P1|Overall Study|Lost to Follow-up|7
5877375|NCT01903252|20332854|P6|Maintenance, Open-Label|Other|2
5877376|NCT01903252|20332855|P5|Maintenance, Open-Label|Other|6
5877377|NCT01903252|20332856|P4|Maintenance, Open-Label|Other|2
5877378|NCT01903252|20332857|P3|Maintenance, Open-Label|Other|0
5877379|NCT01903252|20332858|P2|Maintenance, Open-Label|Other|0
5877380|NCT01903252|20332859|P1|Maintenance, Open-Label|Other|0
5877381|NCT01903252|20332854|P6|Maintenance, Open-Label|Withdrawal by Subject|2
5877382|NCT01903252|20332855|P5|Maintenance, Open-Label|Withdrawal by Subject|6
5877383|NCT01903252|20332856|P4|Maintenance, Open-Label|Withdrawal by Subject|1
5877384|NCT01903252|20332857|P3|Maintenance, Open-Label|Withdrawal by Subject|0
5877385|NCT01903252|20332858|P2|Maintenance, Open-Label|Withdrawal by Subject|0
5877386|NCT01903252|20332859|P1|Maintenance, Open-Label|Withdrawal by Subject|0
5877387|NCT01903252|20332854|P6|Maintenance, Open-Label|Adverse Event|14
5877388|NCT01903252|20332855|P5|Maintenance, Open-Label|Adverse Event|9
5877389|NCT01903252|20332856|P4|Maintenance, Open-Label|Adverse Event|3
5877390|NCT01903252|20332857|P3|Maintenance, Open-Label|Adverse Event|0
5877391|NCT01903252|20332858|P2|Maintenance, Open-Label|Adverse Event|0
5877392|NCT01903252|20332859|P1|Maintenance, Open-Label|Adverse Event|0
5877393|NCT01903252|20332854|P6|Extended Induction, Open-Label|Physician Decision|0
5877394|NCT01903252|20332855|P5|Extended Induction, Open-Label|Physician Decision|0
5877395|NCT01903252|20332856|P4|Extended Induction, Open-Label|Physician Decision|0
5877396|NCT01903252|20332857|P3|Extended Induction, Open-Label|Physician Decision|1
5877397|NCT01903252|20332858|P2|Extended Induction, Open-Label|Physician Decision|0
5877398|NCT01903252|20332859|P1|Extended Induction, Open-Label|Physician Decision|0
5877399|NCT01903252|20332854|P6|Extended Induction, Open-Label|Withdrawal by Subject|0
5877400|NCT01903252|20332855|P5|Extended Induction, Open-Label|Withdrawal by Subject|0
5877401|NCT01903252|20332856|P4|Extended Induction, Open-Label|Withdrawal by Subject|0
5877402|NCT01903252|20332857|P3|Extended Induction, Open-Label|Withdrawal by Subject|5
5877403|NCT01903252|20332858|P2|Extended Induction, Open-Label|Withdrawal by Subject|0
5877404|NCT01903252|20332859|P1|Extended Induction, Open-Label|Withdrawal by Subject|0
5877405|NCT01903252|20332854|P6|Extended Induction, Open-Label|Adverse Event|0
5877406|NCT01903252|20332855|P5|Extended Induction, Open-Label|Adverse Event|0
5877407|NCT01903252|20332856|P4|Extended Induction, Open-Label|Adverse Event|0
5877408|NCT01903252|20332857|P3|Extended Induction, Open-Label|Adverse Event|17
5877409|NCT01903252|20332858|P2|Extended Induction, Open-Label|Adverse Event|0
5877410|NCT01903252|20332859|P1|Extended Induction, Open-Label|Adverse Event|0
5877411|NCT01903252|20332854|P6|Double-Blind Induction|non-compliance,|0
5877412|NCT01903252|20332855|P5|Double-Blind Induction|non-compliance,|0
5877413|NCT01903252|20332856|P4|Double-Blind Induction|non-compliance,|0
5877414|NCT01903252|20332857|P3|Double-Blind Induction|non-compliance,|0
5877415|NCT01903252|20332858|P2|Double-Blind Induction|non-compliance,|7
5877416|NCT01903252|20332859|P1|Double-Blind Induction|non-compliance,|7
5877417|NCT01903252|20332854|P6|Double-Blind Induction|Physician Decision|0
5877418|NCT01903252|20332855|P5|Double-Blind Induction|Physician Decision|0
5877419|NCT01903252|20332856|P4|Double-Blind Induction|Physician Decision|0
5877420|NCT01903252|20332857|P3|Double-Blind Induction|Physician Decision|0
5877421|NCT01903252|20332858|P2|Double-Blind Induction|Physician Decision|3
5877422|NCT01903252|20332859|P1|Double-Blind Induction|Physician Decision|2
5877423|NCT01903252|20332854|P6|Double-Blind Induction|Withdrawal by Subject|0
5877424|NCT01903252|20332855|P5|Double-Blind Induction|Withdrawal by Subject|0
5877425|NCT01903252|20332856|P4|Double-Blind Induction|Withdrawal by Subject|0
5877426|NCT01903252|20332857|P3|Double-Blind Induction|Withdrawal by Subject|0
5877427|NCT01903252|20332858|P2|Double-Blind Induction|Withdrawal by Subject|13
5877428|NCT01903252|20332859|P1|Double-Blind Induction|Withdrawal by Subject|10
5877429|NCT01903252|20332854|P6|Double-Blind Induction|Adverse Event|0
5877430|NCT01903252|20332855|P5|Double-Blind Induction|Adverse Event|0
5877431|NCT01903252|20332856|P4|Double-Blind Induction|Adverse Event|0
5877432|NCT01903252|20332857|P3|Double-Blind Induction|Adverse Event|0
5877433|NCT01903252|20332858|P2|Double-Blind Induction|Adverse Event|18
5877434|NCT01903252|20332859|P1|Double-Blind Induction|Adverse Event|20
5877435|NCT01903031|20332972|P3|Overall Study|NuvaRing removed prior to Day 21 visit|1
5877436|NCT01903031|20332973|P2|Overall Study|NuvaRing removed prior to Day 21 visit|0
5877437|NCT01903031|20332974|P1|Overall Study|NuvaRing removed prior to Day 21 visit|0
5877438|NCT01903031|20332972|P3|Overall Study|Lost to Follow-up|1
5877439|NCT01903031|20332973|P2|Overall Study|Lost to Follow-up|0
5877440|NCT01903031|20332974|P1|Overall Study|Lost to Follow-up|0
5877441|NCT01903031|20332972|P3|Overall Study|Protocol Violation|2
5877442|NCT01903031|20332973|P2|Overall Study|Protocol Violation|0
5877443|NCT01903031|20332974|P1|Overall Study|Protocol Violation|0
5877444|NCT01903031|20332972|P3|Overall Study|Withdrawal by Subject|1
5877445|NCT01903031|20332973|P2|Overall Study|Withdrawal by Subject|1
5877446|NCT01903031|20332974|P1|Overall Study|Withdrawal by Subject|0
5877447|NCT01903031|20332972|P3|Overall Study|Adverse Event|0
5877448|NCT01903031|20332973|P2|Overall Study|Adverse Event|1
5877449|NCT01903031|20332974|P1|Overall Study|Adverse Event|0
5877450|NCT01903031|20332972|P3|Overall Study|Missed Day 21 Primary Endpoint Visit|0
5877451|NCT01903031|20332973|P2|Overall Study|Missed Day 21 Primary Endpoint Visit|0
5877452|NCT01903031|20332974|P1|Overall Study|Missed Day 21 Primary Endpoint Visit|1
5877453|NCT01903031|20332972|P3|Overall Study|Not Able to Attend Clinic|0
5877454|NCT01903031|20332973|P2|Overall Study|Not Able to Attend Clinic|1
5877455|NCT01903031|20332974|P1|Overall Study|Not Able to Attend Clinic|1
5877456|NCT01902888|20333048|P1|Overall Study|Study Terminated|3
5877457|NCT01902628|20333062|P1|Overall Study|Lost to Follow-up|35
5877458|NCT01902628|20333062|P1|Overall Study|Adverse Event|41
5877459|NCT01902628|20333062|P1|Overall Study|Withdrawal of participant's consent|7
5877460|NCT01902303|20333090|P2|Overall Study|Did not develop a cold sore|19
5877461|NCT01902303|20333091|P1|Overall Study|Did not develop a cold sore|21
5877462|NCT01902303|20333090|P2|Overall Study|subject lost investigational product|1
5877463|NCT01902303|20333091|P1|Overall Study|subject lost investigational product|0
5877464|NCT01902303|20333090|P2|Overall Study|Protocol Violation|2
5877465|NCT01902303|20333091|P1|Overall Study|Protocol Violation|2
5877466|NCT01902303|20333090|P2|Overall Study|Lost to Follow-up|1
5877467|NCT01902303|20333091|P1|Overall Study|Lost to Follow-up|0
5877468|NCT01902303|20333090|P2|Overall Study|Adverse Event|1
5877469|NCT01902303|20333091|P1|Overall Study|Adverse Event|0
5877470|NCT01902173|20333105|P6|Phase 1 Triplet Regimen Cohort 4|Death|1
5877471|NCT01902173|20333106|P5|Phase 1 Triplet Regimen Cohort 4|Death|0
5877472|NCT01902173|20333107|P4|Phase 1 Triplet Regimen Cohort 4|Death|0
5877473|NCT01902173|20333108|P3|Phase 1 Triplet Regimen Cohort 4|Death|0
5877474|NCT01902173|20333109|P2|Phase 1 Triplet Regimen Cohort 4|Death|0
5877475|NCT01902173|20333110|P1|Phase 1 Triplet Regimen Cohort 4|Death|0
5877476|NCT01902173|20333105|P6|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|3
5877477|NCT01902173|20333106|P5|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0
5877478|NCT01902173|20333107|P4|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0
5877479|NCT01902173|20333108|P3|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0
5877480|NCT01902173|20333109|P2|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0
5877481|NCT01902173|20333110|P1|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0
5877482|NCT01902173|20333105|P6|Phase 1 Triplet Regimen Cohort 4|Adverse Event|1
5877483|NCT01902173|20333106|P5|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0
5877484|NCT01902173|20333107|P4|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0
5877485|NCT01902173|20333108|P3|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0
5877486|NCT01902173|20333109|P2|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0
5877487|NCT01902173|20333110|P1|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0
5877488|NCT01902173|20333105|P6|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0
5877489|NCT01902173|20333106|P5|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|2
5877490|NCT01902173|20333107|P4|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0
5877491|NCT01902173|20333108|P3|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0
5877492|NCT01902173|20333109|P2|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0
5877493|NCT01902173|20333110|P1|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0
5877494|NCT01902173|20333105|P6|Phase 1 Triplet Regimen Cohort 3|Ongoing|0
5877495|NCT01902173|20333106|P5|Phase 1 Triplet Regimen Cohort 3|Ongoing|1
5877496|NCT01902173|20333107|P4|Phase 1 Triplet Regimen Cohort 3|Ongoing|0
5877497|NCT01902173|20333108|P3|Phase 1 Triplet Regimen Cohort 3|Ongoing|0
5877498|NCT01902173|20333109|P2|Phase 1 Triplet Regimen Cohort 3|Ongoing|0
5877499|NCT01902173|20333110|P1|Phase 1 Triplet Regimen Cohort 3|Ongoing|0
5877500|NCT01902173|20333105|P6|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0
5877501|NCT01902173|20333106|P5|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0
5877502|NCT01902173|20333107|P4|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|2
5877503|NCT01902173|20333108|P3|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0
5877504|NCT01902173|20333109|P2|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0
5877505|NCT01902173|20333110|P1|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0
5877506|NCT01902173|20333105|P6|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0
5877507|NCT01902173|20333106|P5|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0
5877508|NCT01902173|20333107|P4|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|1
5877509|NCT01902173|20333108|P3|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0
5877510|NCT01902173|20333109|P2|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0
5877511|NCT01902173|20333110|P1|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0
5877512|NCT01902173|20333105|P6|Phase 1 Triplet Regimen Cohort 1|Ineligible|0
5877513|NCT01902173|20333106|P5|Phase 1 Triplet Regimen Cohort 1|Ineligible|0
5877514|NCT01902173|20333107|P4|Phase 1 Triplet Regimen Cohort 1|Ineligible|0
5877515|NCT01902173|20333108|P3|Phase 1 Triplet Regimen Cohort 1|Ineligible|1
5877516|NCT01902173|20333109|P2|Phase 1 Triplet Regimen Cohort 1|Ineligible|0
5877517|NCT01902173|20333110|P1|Phase 1 Triplet Regimen Cohort 1|Ineligible|0
5877518|NCT01902173|20333105|P6|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0
5877519|NCT01902173|20333106|P5|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0
5877520|NCT01902173|20333107|P4|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0
5877521|NCT01902173|20333108|P3|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|3
5877522|NCT01902173|20333109|P2|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0
5877523|NCT01902173|20333110|P1|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0
5877524|NCT01902173|20333105|P6|Phase 1 Doublet Regimen Cohort 2|No treated|0
5877525|NCT01902173|20333106|P5|Phase 1 Doublet Regimen Cohort 2|No treated|0
5877526|NCT01902173|20333107|P4|Phase 1 Doublet Regimen Cohort 2|No treated|0
5877527|NCT01902173|20333108|P3|Phase 1 Doublet Regimen Cohort 2|No treated|0
5877528|NCT01902173|20333109|P2|Phase 1 Doublet Regimen Cohort 2|No treated|3
5877529|NCT01902173|20333110|P1|Phase 1 Doublet Regimen Cohort 2|No treated|0
5877530|NCT01902173|20333105|P6|Phase 1 Doublet Regimen Cohort 2|Ineligible|0
5877531|NCT01902173|20333106|P5|Phase 1 Doublet Regimen Cohort 2|Ineligible|0
5877532|NCT01902173|20333107|P4|Phase 1 Doublet Regimen Cohort 2|Ineligible|0
5877533|NCT01902173|20333108|P3|Phase 1 Doublet Regimen Cohort 2|Ineligible|0
5877534|NCT01902173|20333109|P2|Phase 1 Doublet Regimen Cohort 2|Ineligible|1
5877535|NCT01902173|20333110|P1|Phase 1 Doublet Regimen Cohort 2|Ineligible|0
5877536|NCT01902173|20333105|P6|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0
5877537|NCT01902173|20333106|P5|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0
5877538|NCT01902173|20333107|P4|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0
5877539|NCT01902173|20333108|P3|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0
5877540|NCT01902173|20333109|P2|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|5
5877541|NCT01902173|20333110|P1|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0
5877542|NCT01902173|20333105|P6|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0
5877543|NCT01902173|20333106|P5|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0
5877544|NCT01902173|20333107|P4|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0
5877545|NCT01902173|20333108|P3|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0
5877546|NCT01902173|20333109|P2|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0
5877547|NCT01902173|20333110|P1|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|2
5877548|NCT01902173|20333105|P6|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0
5877549|NCT01902173|20333106|P5|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0
5877550|NCT01902173|20333107|P4|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0
5877551|NCT01902173|20333108|P3|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0
5877552|NCT01902173|20333109|P2|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0
5877553|NCT01902173|20333110|P1|Phase 1 Doublet Regimen Cohort 1|Adverse Event|1
5877554|NCT01902134|20333133|P6|Overall Study|Other|0
5877555|NCT01902134|20333134|P5|Overall Study|Other|1
5877556|NCT01902134|20333135|P4|Overall Study|Other|0
5877557|NCT01902134|20333136|P3|Overall Study|Other|2
5877558|NCT01902134|20333137|P2|Overall Study|Other|1
5877559|NCT01902134|20333138|P1|Overall Study|Other|0
5877560|NCT01902134|20333133|P6|Overall Study|no compliance|0
5877561|NCT01902134|20333134|P5|Overall Study|no compliance|0
5877562|NCT01902134|20333135|P4|Overall Study|no compliance|0
5877563|NCT01902134|20333136|P3|Overall Study|no compliance|0
5877564|NCT01902134|20333137|P2|Overall Study|no compliance|0
5877565|NCT01902134|20333138|P1|Overall Study|no compliance|1
5877566|NCT01902134|20333133|P6|Overall Study|Withdrawal by Subject|4
5877567|NCT01902134|20333134|P5|Overall Study|Withdrawal by Subject|5
5877568|NCT01902134|20333135|P4|Overall Study|Withdrawal by Subject|1
5877569|NCT01902134|20333136|P3|Overall Study|Withdrawal by Subject|9
5877570|NCT01902134|20333137|P2|Overall Study|Withdrawal by Subject|8
5877571|NCT01902134|20333138|P1|Overall Study|Withdrawal by Subject|4
5877572|NCT01902134|20333133|P6|Overall Study|Protocol Violation|1
5877573|NCT01902134|20333134|P5|Overall Study|Protocol Violation|0
5877574|NCT01902134|20333135|P4|Overall Study|Protocol Violation|0
5877575|NCT01902134|20333136|P3|Overall Study|Protocol Violation|0
5877576|NCT01902134|20333137|P2|Overall Study|Protocol Violation|0
5877577|NCT01902134|20333138|P1|Overall Study|Protocol Violation|0
5877578|NCT01902134|20333133|P6|Overall Study|Physician Decision|0
5877579|NCT01902134|20333134|P5|Overall Study|Physician Decision|0
5877580|NCT01902134|20333135|P4|Overall Study|Physician Decision|0
5877581|NCT01902134|20333136|P3|Overall Study|Physician Decision|0
5877582|NCT01902134|20333137|P2|Overall Study|Physician Decision|1
5877583|NCT01902134|20333138|P1|Overall Study|Physician Decision|0
5877584|NCT01902134|20333133|P6|Overall Study|Lack of Efficacy|1
5877585|NCT01902134|20333134|P5|Overall Study|Lack of Efficacy|0
5877586|NCT01902134|20333135|P4|Overall Study|Lack of Efficacy|0
5877587|NCT01902134|20333136|P3|Overall Study|Lack of Efficacy|2
5877588|NCT01902134|20333137|P2|Overall Study|Lack of Efficacy|0
5877589|NCT01902134|20333138|P1|Overall Study|Lack of Efficacy|0
5877590|NCT01902134|20333133|P6|Overall Study|Adverse Event|3
5877591|NCT01902134|20333134|P5|Overall Study|Adverse Event|1
5877592|NCT01902134|20333135|P4|Overall Study|Adverse Event|1
5877593|NCT01902134|20333136|P3|Overall Study|Adverse Event|2
5877594|NCT01902134|20333137|P2|Overall Study|Adverse Event|1
5877595|NCT01902134|20333138|P1|Overall Study|Adverse Event|3
5877596|NCT01901874|20333175|P1|1-Year (365-Day) MAE Evaluation|Insufficient Follow-up|6
5877597|NCT01901874|20333175|P1|1-Year (365-Day) MAE Evaluation|Withdrawal by Subject|2
5877598|NCT01901874|20333175|P1|1-Year (365-Day) MAE Evaluation|Lost to Follow-up|5
5877599|NCT01901874|20333175|P1|1-Year (365-Day) MAE Evaluation|Death|7
5877600|NCT01901874|20333175|P1|30-Day MAE Evaluation|Insufficient Follow-up|1
5877601|NCT01901874|20333175|P1|Screening Committee Retrospective Review|Protocol Violation|47
5877602|NCT01901848|20333190|P2|Removed From Analyses|CPT practice cases to establish fidelity|0
5877603|NCT01901848|20333191|P1|Removed From Analyses|CPT practice cases to establish fidelity|10
5877604|NCT01901848|20333190|P2|Randomized and Treated|Lost to Follow-up|6
5877605|NCT01901848|20333191|P1|Randomized and Treated|Lost to Follow-up|3
5877606|NCT01901653|20333233|P13|Overall Study|Alive at Study Termination by Sponsor|1
5877607|NCT01901653|20333234|P12|Overall Study|Alive at Study Termination by Sponsor|1
5877608|NCT01901653|20333235|P11|Overall Study|Alive at Study Termination by Sponsor|0
5877609|NCT01901653|20333236|P10|Overall Study|Alive at Study Termination by Sponsor|2
5877610|NCT01901653|20333237|P9|Overall Study|Alive at Study Termination by Sponsor|0
5877611|NCT01901653|20333238|P8|Overall Study|Alive at Study Termination by Sponsor|0
5877612|NCT01901653|20333239|P7|Overall Study|Alive at Study Termination by Sponsor|0
5877613|NCT01901653|20333240|P6|Overall Study|Alive at Study Termination by Sponsor|0
5877614|NCT01901653|20333241|P5|Overall Study|Alive at Study Termination by Sponsor|0
5877615|NCT01901653|20333242|P4|Overall Study|Alive at Study Termination by Sponsor|0
5877616|NCT01901653|20333243|P3|Overall Study|Alive at Study Termination by Sponsor|1
5877617|NCT01901653|20333244|P2|Overall Study|Alive at Study Termination by Sponsor|0
5877618|NCT01901653|20333245|P1|Overall Study|Alive at Study Termination by Sponsor|0
5877619|NCT01901653|20333233|P13|Overall Study|Withdrawal by Subject|0
5877620|NCT01901653|20333234|P12|Overall Study|Withdrawal by Subject|0
5877621|NCT01901653|20333235|P11|Overall Study|Withdrawal by Subject|0
5877622|NCT01901653|20333236|P10|Overall Study|Withdrawal by Subject|0
5877623|NCT01901653|20333237|P9|Overall Study|Withdrawal by Subject|0
5877624|NCT01901653|20333238|P8|Overall Study|Withdrawal by Subject|0
5877625|NCT01901653|20333239|P7|Overall Study|Withdrawal by Subject|1
5877626|NCT01901653|20333240|P6|Overall Study|Withdrawal by Subject|0
5877627|NCT01901653|20333241|P5|Overall Study|Withdrawal by Subject|0
5877628|NCT01901653|20333242|P4|Overall Study|Withdrawal by Subject|0
5877629|NCT01901653|20333243|P3|Overall Study|Withdrawal by Subject|0
5877630|NCT01901653|20333244|P2|Overall Study|Withdrawal by Subject|0
5877631|NCT01901653|20333245|P1|Overall Study|Withdrawal by Subject|0
5877632|NCT01901653|20333233|P13|Overall Study|Lost to Follow-up|0
5877633|NCT01901653|20333234|P12|Overall Study|Lost to Follow-up|0
5877634|NCT01901653|20333235|P11|Overall Study|Lost to Follow-up|0
5877635|NCT01901653|20333236|P10|Overall Study|Lost to Follow-up|0
5877636|NCT01901653|20333237|P9|Overall Study|Lost to Follow-up|0
5877637|NCT01901653|20333238|P8|Overall Study|Lost to Follow-up|1
5877638|NCT01901653|20333239|P7|Overall Study|Lost to Follow-up|0
5877639|NCT01901653|20333240|P6|Overall Study|Lost to Follow-up|1
5877640|NCT01901653|20333241|P5|Overall Study|Lost to Follow-up|0
5877641|NCT01901653|20333242|P4|Overall Study|Lost to Follow-up|0
5877642|NCT01901653|20333243|P3|Overall Study|Lost to Follow-up|2
5877643|NCT01901653|20333244|P2|Overall Study|Lost to Follow-up|0
5877644|NCT01901653|20333245|P1|Overall Study|Lost to Follow-up|1
5877645|NCT01901653|20333233|P13|Overall Study|Death|4
5877646|NCT01901653|20333234|P12|Overall Study|Death|15
5877647|NCT01901653|20333235|P11|Overall Study|Death|2
5877648|NCT01901653|20333236|P10|Overall Study|Death|16
5877649|NCT01901653|20333237|P9|Overall Study|Death|1
5877650|NCT01901653|20333238|P8|Overall Study|Death|9
5877651|NCT01901653|20333239|P7|Overall Study|Death|6
5877652|NCT01901653|20333240|P6|Overall Study|Death|2
5877653|NCT01901653|20333241|P5|Overall Study|Death|2
5877654|NCT01901653|20333242|P4|Overall Study|Death|3
5877655|NCT01901653|20333243|P3|Overall Study|Death|8
5877656|NCT01901653|20333244|P2|Overall Study|Death|1
5877657|NCT01901653|20333245|P1|Overall Study|Death|2
5877658|NCT01901614|20333289|P2|Overall Study|Screen Fail|0
5877659|NCT01901614|20333290|P1|Overall Study|Screen Fail|1
5877660|NCT01901614|20333289|P2|Overall Study|Lost to Follow-up|0
5877661|NCT01901614|20333290|P1|Overall Study|Lost to Follow-up|1
5877662|NCT01901614|20333289|P2|Overall Study|Adverse Event|1
5877663|NCT01901614|20333290|P1|Overall Study|Adverse Event|0
5877664|NCT01901432|20333325|P5|Overall Study|Patient decision to stop study drug|1
5877665|NCT01901432|20333326|P4|Overall Study|Patient decision to stop study drug|0
5877666|NCT01901432|20333327|P3|Overall Study|Patient decision to stop study drug|0
5877667|NCT01901432|20333328|P2|Overall Study|Patient decision to stop study drug|0
5877668|NCT01901432|20333329|P1|Overall Study|Patient decision to stop study drug|0
5877669|NCT01901432|20333325|P5|Overall Study|Physician Decision|2
5877670|NCT01901432|20333326|P4|Overall Study|Physician Decision|0
5877671|NCT01901432|20333327|P3|Overall Study|Physician Decision|0
5877672|NCT01901432|20333328|P2|Overall Study|Physician Decision|0
5877673|NCT01901432|20333329|P1|Overall Study|Physician Decision|0
5877674|NCT01901432|20333325|P5|Overall Study|Withdrawal by Subject|5
5877675|NCT01901432|20333326|P4|Overall Study|Withdrawal by Subject|0
5877676|NCT01901432|20333327|P3|Overall Study|Withdrawal by Subject|1
5877677|NCT01901432|20333328|P2|Overall Study|Withdrawal by Subject|0
5877678|NCT01901432|20333329|P1|Overall Study|Withdrawal by Subject|0
5877679|NCT01901432|20333325|P5|Overall Study|Adverse Event|1
5877680|NCT01901432|20333326|P4|Overall Study|Adverse Event|0
5877681|NCT01901432|20333327|P3|Overall Study|Adverse Event|1
5877682|NCT01901432|20333328|P2|Overall Study|Adverse Event|1
5877683|NCT01901432|20333329|P1|Overall Study|Adverse Event|0
5877684|NCT01901419|20333381|P2|Overall Study|unavailable researchers|3
5877685|NCT01901419|20333382|P1|Overall Study|unavailable researchers|6
5877686|NCT01901419|20333381|P2|Overall Study|Protocol Violation|6
5877687|NCT01901419|20333382|P1|Overall Study|Protocol Violation|2
5877688|NCT01901393|20333448|P2|Overall Study|Adverse Event|0
5877689|NCT01901393|20333449|P1|Overall Study|Adverse Event|1
5877690|NCT01901341|20333467|P2|Overall Study|Withdrawal by Subject|1
5877691|NCT01901341|20333468|P1|Overall Study|Withdrawal by Subject|1
5877692|NCT01901341|20333467|P2|Overall Study|Study Terminated by Sponsor|15
5877693|NCT01901341|20333468|P1|Overall Study|Study Terminated by Sponsor|13
5877694|NCT01901341|20333467|P2|Overall Study|Protocol Violation|0
5877695|NCT01901341|20333468|P1|Overall Study|Protocol Violation|2
5877696|NCT01901341|20333467|P2|Overall Study|Lost to Follow-up|1
5877697|NCT01901341|20333468|P1|Overall Study|Lost to Follow-up|0
5877698|NCT01901341|20333467|P2|Overall Study|Lack of Efficacy|2
5877699|NCT01901341|20333468|P1|Overall Study|Lack of Efficacy|0
5877700|NCT01901341|20333467|P2|Overall Study|Adverse Event|2
5877701|NCT01901341|20333468|P1|Overall Study|Adverse Event|4
5877702|NCT01901328|20333482|P2|Overall Study|Lack of Efficacy|1
5877703|NCT01901328|20333483|P1|Overall Study|Lack of Efficacy|0
5877704|NCT01901328|20333482|P2|Overall Study|Withdrawal by Subject|2
5877705|NCT01901328|20333483|P1|Overall Study|Withdrawal by Subject|1
5877706|NCT01901328|20333482|P2|Overall Study|Study Terminated by Sponsor|16
5877707|NCT01901328|20333483|P1|Overall Study|Study Terminated by Sponsor|19
5877708|NCT01901328|20333482|P2|Overall Study|Protocol Violation|1
5877709|NCT01901328|20333483|P1|Overall Study|Protocol Violation|1
5877710|NCT01901328|20333482|P2|Overall Study|Physician Decision|1
5877711|NCT01901328|20333483|P1|Overall Study|Physician Decision|0
5877712|NCT01901328|20333482|P2|Overall Study|Lost to Follow-up|0
5877713|NCT01901328|20333483|P1|Overall Study|Lost to Follow-up|1
5877714|NCT01901302|20333497|P2|Overall Study|Withdrawal by Subject|0
5877715|NCT01901302|20333498|P1|Overall Study|Withdrawal by Subject|2
5877716|NCT01901302|20333497|P2|Overall Study|Study Terminated by Sponsor|20
5877717|NCT01901302|20333498|P1|Overall Study|Study Terminated by Sponsor|23
5877718|NCT01901302|20333497|P2|Overall Study|Lack of Efficacy|2
5877719|NCT01901302|20333498|P1|Overall Study|Lack of Efficacy|0
5877720|NCT01901302|20333497|P2|Overall Study|Adverse Event|1
5877721|NCT01901302|20333498|P1|Overall Study|Adverse Event|2
5877722|NCT01901224|20333523|P1|Overall Study|study was not funded and terminated|2
5877723|NCT01901185|20333558|P1|Overall Study|Withdrawal by Subject|2
5877724|NCT01901146|20333567|P5|Adjuvant Phase|Withdrawal by Subject|4
5877725|NCT01901146|20333568|P4|Adjuvant Phase|Withdrawal by Subject|1
5877726|NCT01901146|20333569|P3|Adjuvant Phase|Withdrawal by Subject|4
5877727|NCT01901146|20333570|P2|Adjuvant Phase|Withdrawal by Subject|0
5877728|NCT01901146|20333571|P1|Adjuvant Phase|Withdrawal by Subject|0
5877729|NCT01901146|20333567|P5|Adjuvant Phase|Physician Decision|4
5877730|NCT01901146|20333568|P4|Adjuvant Phase|Physician Decision|2
5877731|NCT01901146|20333569|P3|Adjuvant Phase|Physician Decision|9
5877732|NCT01901146|20333570|P2|Adjuvant Phase|Physician Decision|0
5877733|NCT01901146|20333571|P1|Adjuvant Phase|Physician Decision|0
5877734|NCT01901146|20333567|P5|Adjuvant Phase|Disease Progression or Recurrence|3
5877735|NCT01901146|20333568|P4|Adjuvant Phase|Disease Progression or Recurrence|4
5877736|NCT01901146|20333569|P3|Adjuvant Phase|Disease Progression or Recurrence|12
5877737|NCT01901146|20333570|P2|Adjuvant Phase|Disease Progression or Recurrence|0
5877738|NCT01901146|20333571|P1|Adjuvant Phase|Disease Progression or Recurrence|0
5877739|NCT01901146|20333567|P5|Adjuvant Phase|Death|3
5877740|NCT01901146|20333568|P4|Adjuvant Phase|Death|0
5877741|NCT01901146|20333569|P3|Adjuvant Phase|Death|0
5877742|NCT01901146|20333570|P2|Adjuvant Phase|Death|0
5877743|NCT01901146|20333571|P1|Adjuvant Phase|Death|0
5877744|NCT01901146|20333567|P5|Adjuvant Phase|Other|0
5877745|NCT01901146|20333568|P4|Adjuvant Phase|Other|0
5877746|NCT01901146|20333569|P3|Adjuvant Phase|Other|1
5877747|NCT01901146|20333570|P2|Adjuvant Phase|Other|0
5877748|NCT01901146|20333571|P1|Adjuvant Phase|Other|0
5877749|NCT01901146|20333567|P5|Neoadjuvant Phase|Requirement for Alternative Therapy|0
5877750|NCT01901146|20333568|P4|Neoadjuvant Phase|Requirement for Alternative Therapy|0
5877751|NCT01901146|20333569|P3|Neoadjuvant Phase|Requirement for Alternative Therapy|0
5877752|NCT01901146|20333570|P2|Neoadjuvant Phase|Requirement for Alternative Therapy|1
5877753|NCT01901146|20333571|P1|Neoadjuvant Phase|Requirement for Alternative Therapy|0
5877754|NCT01901146|20333567|P5|Neoadjuvant Phase|Withdrawal by Subject|0
5877755|NCT01901146|20333568|P4|Neoadjuvant Phase|Withdrawal by Subject|0
5877756|NCT01901146|20333569|P3|Neoadjuvant Phase|Withdrawal by Subject|0
5877757|NCT01901146|20333570|P2|Neoadjuvant Phase|Withdrawal by Subject|5
5877758|NCT01901146|20333571|P1|Neoadjuvant Phase|Withdrawal by Subject|2
5877759|NCT01901146|20333567|P5|Neoadjuvant Phase|Physician Decision|0
5877760|NCT01901146|20333568|P4|Neoadjuvant Phase|Physician Decision|0
5877761|NCT01901146|20333569|P3|Neoadjuvant Phase|Physician Decision|0
5877762|NCT01901146|20333570|P2|Neoadjuvant Phase|Physician Decision|2
5877763|NCT01901146|20333571|P1|Neoadjuvant Phase|Physician Decision|1
5877764|NCT01901146|20333567|P5|Neoadjuvant Phase|Lost to Follow-up|0
5877765|NCT01901146|20333568|P4|Neoadjuvant Phase|Lost to Follow-up|0
5877766|NCT01901146|20333569|P3|Neoadjuvant Phase|Lost to Follow-up|0
5877767|NCT01901146|20333570|P2|Neoadjuvant Phase|Lost to Follow-up|1
5877768|NCT01901146|20333571|P1|Neoadjuvant Phase|Lost to Follow-up|0
5877769|NCT01901146|20333567|P5|Neoadjuvant Phase|Disease Progression or Recurrence|0
5877770|NCT01901146|20333568|P4|Neoadjuvant Phase|Disease Progression or Recurrence|0
5877771|NCT01901146|20333569|P3|Neoadjuvant Phase|Disease Progression or Recurrence|0
5877772|NCT01901146|20333570|P2|Neoadjuvant Phase|Disease Progression or Recurrence|3
5877773|NCT01901146|20333571|P1|Neoadjuvant Phase|Disease Progression or Recurrence|2
5877774|NCT01901146|20333567|P5|Neoadjuvant Phase|Death|0
5877775|NCT01901146|20333568|P4|Neoadjuvant Phase|Death|0
5877776|NCT01901146|20333569|P3|Neoadjuvant Phase|Death|0
5877777|NCT01901146|20333570|P2|Neoadjuvant Phase|Death|2
5877778|NCT01901146|20333571|P1|Neoadjuvant Phase|Death|1
5877779|NCT01900899|20333586|P2|Overall Study|Migrated from study area|0
5877780|NCT01900899|20333587|P1|Overall Study|Migrated from study area|2
5877781|NCT01900899|20333586|P2|Overall Study|Withdrawal by Subject|1
5877782|NCT01900899|20333587|P1|Overall Study|Withdrawal by Subject|7
5877783|NCT01900730|20333613|P2|Overall Study|Screen Failure|0
5877784|NCT01900730|20333614|P1|Overall Study|Screen Failure|1
5877785|NCT01900730|20333613|P2|Overall Study|Withdrawal by Subject|0
5877786|NCT01900730|20333614|P1|Overall Study|Withdrawal by Subject|1
5877787|NCT01900665|20333638|P2|Open Label Period|Withdrawal by Subject|28
5877788|NCT01900665|20333639|P1|Open Label Period|Withdrawal by Subject|20
5877789|NCT01900665|20333638|P2|Open Label Period|Sponsor Decision|765
5877790|NCT01900665|20333639|P1|Open Label Period|Sponsor Decision|802
5877791|NCT01900665|20333638|P2|Open Label Period|Protocol Violation|1
5877792|NCT01900665|20333639|P1|Open Label Period|Protocol Violation|0
5877793|NCT01900665|20333638|P2|Open Label Period|Physician Decision|4
5877794|NCT01900665|20333639|P1|Open Label Period|Physician Decision|4
5877795|NCT01900665|20333638|P2|Open Label Period|Parent/Caregiver Decision|34
5877796|NCT01900665|20333639|P1|Open Label Period|Parent/Caregiver Decision|33
5877797|NCT01900665|20333638|P2|Open Label Period|Lost to Follow-up|1
5877798|NCT01900665|20333639|P1|Open Label Period|Lost to Follow-up|1
5877799|NCT01900665|20333638|P2|Open Label Period|Death|6
5877800|NCT01900665|20333639|P1|Open Label Period|Death|5
5877801|NCT01900665|20333638|P2|Open Label Period|Adverse Event|20
5877802|NCT01900665|20333639|P1|Open Label Period|Adverse Event|16
5877803|NCT01900665|20333638|P2|Placebo Controlled Period|Entry Criteria Not Met|9
5877804|NCT01900665|20333639|P1|Placebo Controlled Period|Entry Criteria Not Met|5
5877805|NCT01900665|20333638|P2|Placebo Controlled Period|Caregiver Decision|41
5877806|NCT01900665|20333639|P1|Placebo Controlled Period|Caregiver Decision|33
5877807|NCT01900665|20333638|P2|Placebo Controlled Period|Lost to Follow-up|0
5877808|NCT01900665|20333639|P1|Placebo Controlled Period|Lost to Follow-up|3
5877809|NCT01900665|20333638|P2|Placebo Controlled Period|Physician Decision|7
5877810|NCT01900665|20333639|P1|Placebo Controlled Period|Physician Decision|11
5877811|NCT01900665|20333638|P2|Placebo Controlled Period|Withdrawal by Subject|45
5877812|NCT01900665|20333639|P1|Placebo Controlled Period|Withdrawal by Subject|33
5877813|NCT01900665|20333638|P2|Placebo Controlled Period|Protocol Violation|7
5877814|NCT01900665|20333639|P1|Placebo Controlled Period|Protocol Violation|1
5877815|NCT01900665|20333638|P2|Placebo Controlled Period|Adverse Event|39
5877816|NCT01900665|20333639|P1|Placebo Controlled Period|Adverse Event|48
5877817|NCT01900665|20333638|P2|Placebo Controlled Period|Death|16
5877818|NCT01900665|20333639|P1|Placebo Controlled Period|Death|9
5877819|NCT01900652|20333682|P2|Overall Study|Physician Decision|1
5877820|NCT01900652|20333683|P1|Overall Study|Physician Decision|1
5877821|NCT01900652|20333682|P2|Overall Study|Adverse Event|1
5877822|NCT01900652|20333683|P1|Overall Study|Adverse Event|2
5877823|NCT01900652|20333682|P2|Overall Study|Death|0
5877824|NCT01900652|20333683|P1|Overall Study|Death|3
5877825|NCT01900652|20333682|P2|Overall Study|Consent withdrawn by subject|1
5877826|NCT01900652|20333683|P1|Overall Study|Consent withdrawn by subject|1
5877827|NCT01900652|20333682|P2|Overall Study|Progressive Disease|0
5877828|NCT01900652|20333683|P1|Overall Study|Progressive Disease|1
5877829|NCT01900626|20333719|P2|Overall Study|study was closed due to low enrollment|1
5877830|NCT01900626|20333720|P1|Overall Study|study was closed due to low enrollment|1
5877831|NCT01900444|20333799|P1|Overall Study|Lost to Follow-up|1
5877832|NCT01900444|20333799|P1|Overall Study|Protocol Violation|2
5877833|NCT01900431|20333812|P3|Open-Label Treatment Period (Part C)|Withdrawal by Subject|3
5877834|NCT01900431|20333813|P2|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0
5877835|NCT01900431|20333814|P1|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0
5877836|NCT01900431|20333812|P3|Open-Label Treatment Period (Part C)|Lack of Efficacy|3
5877837|NCT01900431|20333813|P2|Open-Label Treatment Period (Part C)|Lack of Efficacy|0
5877838|NCT01900431|20333814|P1|Open-Label Treatment Period (Part C)|Lack of Efficacy|0
5877839|NCT01900431|20333812|P3|Open-Label Treatment Period (Part C)|Adverse Event|2
5877840|NCT01900431|20333813|P2|Open-Label Treatment Period (Part C)|Adverse Event|0
5877841|NCT01900431|20333814|P1|Open-Label Treatment Period (Part C)|Adverse Event|0
5877842|NCT01900431|20333812|P3|Extended Treatment Period (Part B)|Other than specified above|0
5877843|NCT01900431|20333813|P2|Extended Treatment Period (Part B)|Other than specified above|1
5877844|NCT01900431|20333814|P1|Extended Treatment Period (Part B)|Other than specified above|0
5877845|NCT01900431|20333812|P3|Extended Treatment Period (Part B)|Lack of Efficacy|0
5877846|NCT01900431|20333813|P2|Extended Treatment Period (Part B)|Lack of Efficacy|7
5877847|NCT01900431|20333814|P1|Extended Treatment Period (Part B)|Lack of Efficacy|1
5877848|NCT01900431|20333812|P3|Extended Treatment Period (Part B)|Adverse Event|0
5877849|NCT01900431|20333813|P2|Extended Treatment Period (Part B)|Adverse Event|2
5877850|NCT01900431|20333814|P1|Extended Treatment Period (Part B)|Adverse Event|0
5877851|NCT01900431|20333812|P3|Principal Treatment Period (Part A)|Other than specified above|0
5877852|NCT01900431|20333813|P2|Principal Treatment Period (Part A)|Other than specified above|1
5877853|NCT01900431|20333814|P1|Principal Treatment Period (Part A)|Other than specified above|0
5877854|NCT01900431|20333812|P3|Principal Treatment Period (Part A)|Lack of Efficacy|0
5877855|NCT01900431|20333813|P2|Principal Treatment Period (Part A)|Lack of Efficacy|6
5877856|NCT01900431|20333814|P1|Principal Treatment Period (Part A)|Lack of Efficacy|6
5877857|NCT01900431|20333812|P3|Principal Treatment Period (Part A)|Adverse Event|0
5877858|NCT01900431|20333813|P2|Principal Treatment Period (Part A)|Adverse Event|3
5877859|NCT01900431|20333814|P1|Principal Treatment Period (Part A)|Adverse Event|1
5877860|NCT01900314|20333856|P2|Overall Study|Withdrawal by Subject|3
5877861|NCT01900314|20333857|P1|Overall Study|Withdrawal by Subject|3
5877862|NCT01900314|20333856|P2|Overall Study|Protocol Violation|1
5877863|NCT01900314|20333857|P1|Overall Study|Protocol Violation|0
5877864|NCT01900314|20333856|P2|Overall Study|Lost to Follow-up|0
5877865|NCT01900314|20333857|P1|Overall Study|Lost to Follow-up|1
5877866|NCT01900054|20333887|P1|Overall Study|Withdrawal by Subject|1
5877867|NCT01900054|20333887|P1|Overall Study|Physician Decision|1
5877868|NCT01899768|20333896|P1|Part B|Withdrawal by Subject|1
5877869|NCT01899768|20333896|P1|Part B|Adverse Event|1
5877870|NCT01899768|20333896|P1|Part A|Withdrawal by Subject|1
5877871|NCT01899768|20333896|P1|Part A|Adverse Event|2
5877872|NCT01899742|20333970|P2|Overall Study|Withdrawal by Subject|5
5877873|NCT01899742|20333971|P1|Overall Study|Withdrawal by Subject|9
5877874|NCT01899742|20333970|P2|Overall Study|Protocol Violation|2
5877875|NCT01899742|20333971|P1|Overall Study|Protocol Violation|2
5877876|NCT01899742|20333970|P2|Overall Study|Lack of Efficacy|5
5877877|NCT01899742|20333971|P1|Overall Study|Lack of Efficacy|1
5877878|NCT01899742|20333970|P2|Overall Study|Adverse Event|4
5877879|NCT01899742|20333971|P1|Overall Study|Adverse Event|5
5877880|NCT01899729|20333984|P5|Overall Study|Lack of Efficacy|1
5877881|NCT01899729|20333985|P4|Overall Study|Lack of Efficacy|0
5877882|NCT01899729|20333986|P3|Overall Study|Lack of Efficacy|2
5877883|NCT01899729|20333987|P2|Overall Study|Lack of Efficacy|0
5877884|NCT01899729|20333988|P1|Overall Study|Lack of Efficacy|0
5877885|NCT01899729|20333984|P5|Overall Study|Withdrawal by Subject|0
5877886|NCT01899729|20333985|P4|Overall Study|Withdrawal by Subject|0
5877887|NCT01899729|20333986|P3|Overall Study|Withdrawal by Subject|0
5877888|NCT01899729|20333987|P2|Overall Study|Withdrawal by Subject|2
5877889|NCT01899729|20333988|P1|Overall Study|Withdrawal by Subject|1
5877890|NCT01899729|20333984|P5|Overall Study|Adverse Event|1
5877891|NCT01899729|20333985|P4|Overall Study|Adverse Event|0
5877892|NCT01899729|20333986|P3|Overall Study|Adverse Event|0
5877893|NCT01899729|20333987|P2|Overall Study|Adverse Event|0
5877894|NCT01899729|20333988|P1|Overall Study|Adverse Event|1
5877895|NCT01899144|20334035|P1|Treatment Period 5|Other|1
5877896|NCT01899144|20334035|P1|Treatment Period 3|Other|2
5877897|NCT01899144|20334035|P1|Treatment Period 2|Other|1
5877898|NCT01899053|20334071|P14|Overall Study|Symptomatic Deterioration|0
5877899|NCT01899053|20334072|P13|Overall Study|Symptomatic Deterioration|2
5877900|NCT01899053|20334073|P12|Overall Study|Symptomatic Deterioration|1
5877901|NCT01899053|20334074|P11|Overall Study|Symptomatic Deterioration|0
5877902|NCT01899053|20334075|P10|Overall Study|Symptomatic Deterioration|0
5877903|NCT01899053|20334076|P9|Overall Study|Symptomatic Deterioration|0
5877904|NCT01899053|20334077|P8|Overall Study|Symptomatic Deterioration|1
5877905|NCT01899053|20334078|P7|Overall Study|Symptomatic Deterioration|0
5877906|NCT01899053|20334079|P6|Overall Study|Symptomatic Deterioration|1
5877907|NCT01899053|20334080|P5|Overall Study|Symptomatic Deterioration|0
5877908|NCT01899053|20334081|P4|Overall Study|Symptomatic Deterioration|0
5877909|NCT01899053|20334082|P3|Overall Study|Symptomatic Deterioration|0
5877910|NCT01899053|20334083|P2|Overall Study|Symptomatic Deterioration|0
5877911|NCT01899053|20334084|P1|Overall Study|Symptomatic Deterioration|0
5877912|NCT01899053|20334071|P14|Overall Study|Unsatisfactory Therapeutic Response|0
5877913|NCT01899053|20334072|P13|Overall Study|Unsatisfactory Therapeutic Response|0
5877914|NCT01899053|20334073|P12|Overall Study|Unsatisfactory Therapeutic Response|0
5877915|NCT01899053|20334074|P11|Overall Study|Unsatisfactory Therapeutic Response|1
5877916|NCT01899053|20334075|P10|Overall Study|Unsatisfactory Therapeutic Response|0
5877917|NCT01899053|20334076|P9|Overall Study|Unsatisfactory Therapeutic Response|0
5877918|NCT01899053|20334077|P8|Overall Study|Unsatisfactory Therapeutic Response|0
5877919|NCT01899053|20334078|P7|Overall Study|Unsatisfactory Therapeutic Response|0
5877920|NCT01899053|20334079|P6|Overall Study|Unsatisfactory Therapeutic Response|0
5877921|NCT01899053|20334080|P5|Overall Study|Unsatisfactory Therapeutic Response|0
5877922|NCT01899053|20334081|P4|Overall Study|Unsatisfactory Therapeutic Response|0
5877923|NCT01899053|20334082|P3|Overall Study|Unsatisfactory Therapeutic Response|0
5877924|NCT01899053|20334083|P2|Overall Study|Unsatisfactory Therapeutic Response|1
5877925|NCT01899053|20334084|P1|Overall Study|Unsatisfactory Therapeutic Response|1
5877926|NCT01899053|20334071|P14|Overall Study|Protocol Violation|0
5877927|NCT01899053|20334072|P13|Overall Study|Protocol Violation|0
5877928|NCT01899053|20334073|P12|Overall Study|Protocol Violation|0
5877929|NCT01899053|20334074|P11|Overall Study|Protocol Violation|0
5877930|NCT01899053|20334075|P10|Overall Study|Protocol Violation|0
5877931|NCT01899053|20334076|P9|Overall Study|Protocol Violation|0
5877932|NCT01899053|20334077|P8|Overall Study|Protocol Violation|0
5877933|NCT01899053|20334078|P7|Overall Study|Protocol Violation|0
5877934|NCT01899053|20334079|P6|Overall Study|Protocol Violation|0
5877935|NCT01899053|20334080|P5|Overall Study|Protocol Violation|0
5877936|NCT01899053|20334081|P4|Overall Study|Protocol Violation|0
5877937|NCT01899053|20334082|P3|Overall Study|Protocol Violation|1
5877938|NCT01899053|20334083|P2|Overall Study|Protocol Violation|0
5877939|NCT01899053|20334084|P1|Overall Study|Protocol Violation|0
5877940|NCT01899053|20334071|P14|Overall Study|Withdrawal by Subject|1
5877941|NCT01899053|20334072|P13|Overall Study|Withdrawal by Subject|1
5877942|NCT01899053|20334073|P12|Overall Study|Withdrawal by Subject|0
5877943|NCT01899053|20334074|P11|Overall Study|Withdrawal by Subject|0
5877944|NCT01899053|20334075|P10|Overall Study|Withdrawal by Subject|0
5877945|NCT01899053|20334076|P9|Overall Study|Withdrawal by Subject|0
5877946|NCT01899053|20334077|P8|Overall Study|Withdrawal by Subject|1
5877947|NCT01899053|20334078|P7|Overall Study|Withdrawal by Subject|0
5877948|NCT01899053|20334079|P6|Overall Study|Withdrawal by Subject|0
5877949|NCT01899053|20334080|P5|Overall Study|Withdrawal by Subject|2
5877950|NCT01899053|20334081|P4|Overall Study|Withdrawal by Subject|0
5877951|NCT01899053|20334082|P3|Overall Study|Withdrawal by Subject|2
5877952|NCT01899053|20334083|P2|Overall Study|Withdrawal by Subject|1
5877953|NCT01899053|20334084|P1|Overall Study|Withdrawal by Subject|1
5877954|NCT01899053|20334071|P14|Overall Study|Reason Not Specified|0
5877955|NCT01899053|20334072|P13|Overall Study|Reason Not Specified|1
5877956|NCT01899053|20334073|P12|Overall Study|Reason Not Specified|0
5877957|NCT01899053|20334074|P11|Overall Study|Reason Not Specified|0
5877958|NCT01899053|20334075|P10|Overall Study|Reason Not Specified|0
5877959|NCT01899053|20334076|P9|Overall Study|Reason Not Specified|0
5877960|NCT01899053|20334077|P8|Overall Study|Reason Not Specified|0
5877961|NCT01899053|20334078|P7|Overall Study|Reason Not Specified|1
5877962|NCT01899053|20334079|P6|Overall Study|Reason Not Specified|0
5877963|NCT01899053|20334080|P5|Overall Study|Reason Not Specified|0
5877964|NCT01899053|20334081|P4|Overall Study|Reason Not Specified|0
5877965|NCT01899053|20334082|P3|Overall Study|Reason Not Specified|0
5877966|NCT01899053|20334083|P2|Overall Study|Reason Not Specified|0
5877967|NCT01899053|20334084|P1|Overall Study|Reason Not Specified|0
5877968|NCT01899053|20334071|P14|Overall Study|Adverse Event|2
5877969|NCT01899053|20334072|P13|Overall Study|Adverse Event|2
5877970|NCT01899053|20334073|P12|Overall Study|Adverse Event|1
5877971|NCT01899053|20334074|P11|Overall Study|Adverse Event|3
5877972|NCT01899053|20334075|P10|Overall Study|Adverse Event|0
5877973|NCT01899053|20334076|P9|Overall Study|Adverse Event|2
5877974|NCT01899053|20334077|P8|Overall Study|Adverse Event|0
5877975|NCT01899053|20334078|P7|Overall Study|Adverse Event|1
5877976|NCT01899053|20334079|P6|Overall Study|Adverse Event|1
5877977|NCT01899053|20334080|P5|Overall Study|Adverse Event|1
5877978|NCT01899053|20334081|P4|Overall Study|Adverse Event|3
5877979|NCT01899053|20334082|P3|Overall Study|Adverse Event|1
5877980|NCT01899053|20334083|P2|Overall Study|Adverse Event|1
5877981|NCT01899053|20334084|P1|Overall Study|Adverse Event|1
5877982|NCT01899053|20334071|P14|Overall Study|Progressive Disease|17
5877983|NCT01899053|20334072|P13|Overall Study|Progressive Disease|8
5877984|NCT01899053|20334073|P12|Overall Study|Progressive Disease|5
5877985|NCT01899053|20334074|P11|Overall Study|Progressive Disease|12
5877986|NCT01899053|20334075|P10|Overall Study|Progressive Disease|3
5877987|NCT01899053|20334076|P9|Overall Study|Progressive Disease|4
5877988|NCT01899053|20334077|P8|Overall Study|Progressive Disease|1
5877989|NCT01899053|20334078|P7|Overall Study|Progressive Disease|1
5877990|NCT01899053|20334079|P6|Overall Study|Progressive Disease|1
5877991|NCT01899053|20334080|P5|Overall Study|Progressive Disease|3
5877992|NCT01899053|20334081|P4|Overall Study|Progressive Disease|0
5877993|NCT01899053|20334082|P3|Overall Study|Progressive Disease|3
5877994|NCT01899053|20334083|P2|Overall Study|Progressive Disease|0
5877995|NCT01899053|20334084|P1|Overall Study|Progressive Disease|4
5877996|NCT01898884|20334341|P9|Multiple Dose Period|Randomized Not Treated|1
5877997|NCT01898884|20334342|P8|Multiple Dose Period|Randomized Not Treated|0
5877998|NCT01898884|20334343|P7|Multiple Dose Period|Randomized Not Treated|0
5877999|NCT01898884|20334344|P6|Multiple Dose Period|Randomized Not Treated|0
5878000|NCT01898884|20334345|P5|Multiple Dose Period|Randomized Not Treated|0
5878001|NCT01898884|20334346|P4|Multiple Dose Period|Randomized Not Treated|0
5878002|NCT01898884|20334347|P3|Multiple Dose Period|Randomized Not Treated|0
5878003|NCT01898884|20334348|P2|Multiple Dose Period|Randomized Not Treated|0
5878004|NCT01898884|20334349|P1|Multiple Dose Period|Randomized Not Treated|0
5878005|NCT01898884|20334341|P9|Multiple Dose Period|Adverse Event|0
5878006|NCT01898884|20334342|P8|Multiple Dose Period|Adverse Event|0
5878007|NCT01898884|20334343|P7|Multiple Dose Period|Adverse Event|1
5878008|NCT01898884|20334344|P6|Multiple Dose Period|Adverse Event|0
5878009|NCT01898884|20334345|P5|Multiple Dose Period|Adverse Event|0
5878010|NCT01898884|20334346|P4|Multiple Dose Period|Adverse Event|0
5878011|NCT01898884|20334347|P3|Multiple Dose Period|Adverse Event|0
5878012|NCT01898884|20334348|P2|Multiple Dose Period|Adverse Event|0
5878013|NCT01898884|20334349|P1|Multiple Dose Period|Adverse Event|0
5878014|NCT01898806|20334499|P1|Overall Study|Physician Decision|1
5878015|NCT01898806|20334499|P1|Overall Study|Withdrawal by Subject|2
5878016|NCT01898598|20334529|P2|Overall Study|Other|1
5878017|NCT01898598|20334530|P1|Overall Study|Other|0
5878018|NCT01898598|20334529|P2|Overall Study|Lost to Follow-up|1
5878019|NCT01898598|20334530|P1|Overall Study|Lost to Follow-up|0
5878020|NCT01898598|20334529|P2|Overall Study|Withdrawal by Subject|0
5878021|NCT01898598|20334530|P1|Overall Study|Withdrawal by Subject|3
5878022|NCT01898598|20334529|P2|Overall Study|Adverse Event|0
5878023|NCT01898598|20334530|P1|Overall Study|Adverse Event|1
5878024|NCT01898442|20334549|P3|Overall Study|Patient vomited pills|1
5878025|NCT01898442|20334550|P2|Overall Study|Patient vomited pills|0
5878026|NCT01898442|20334551|P1|Overall Study|Patient vomited pills|0
5878027|NCT01898442|20334549|P3|Overall Study|Hemolysis/technical problems|2
5878028|NCT01898442|20334550|P2|Overall Study|Hemolysis/technical problems|2
5878029|NCT01898442|20334551|P1|Overall Study|Hemolysis/technical problems|1
5878030|NCT01898299|20334588|P2|Post Treatment (One Month)|Lost to Follow-up|4
5878031|NCT01898299|20334589|P1|Post Treatment (One Month)|Lost to Follow-up|3
5878032|NCT01898286|20334595|P1|Overall Study|Lost to Follow-up|1
5878033|NCT01898286|20334595|P1|Overall Study|Protocol Violation|1
5878034|NCT01898286|20334595|P1|Overall Study|Withdrawal by Subject|1
5878035|NCT01898208|20334605|P3|Overall Study|Lost to Follow-up|1
5878036|NCT01898208|20334606|P2|Overall Study|Lost to Follow-up|1
5878037|NCT01898208|20334607|P1|Overall Study|Lost to Follow-up|3
5878038|NCT01898208|20334605|P3|Overall Study|System/Technical Error|3
5878039|NCT01898208|20334606|P2|Overall Study|System/Technical Error|2
5878040|NCT01898208|20334607|P1|Overall Study|System/Technical Error|1
5878041|NCT01898208|20334605|P3|Overall Study|Non-Blood Specimens in Bottles|4
5878042|NCT01898208|20334606|P2|Overall Study|Non-Blood Specimens in Bottles|5
5878043|NCT01898208|20334607|P1|Overall Study|Non-Blood Specimens in Bottles|3
5878044|NCT01898208|20334605|P3|Overall Study|Negative Gram Stain|6
5878045|NCT01898208|20334606|P2|Overall Study|Negative Gram Stain|9
5878046|NCT01898208|20334607|P1|Overall Study|Negative Gram Stain|6
5878047|NCT01898208|20334605|P3|Overall Study|Death/comfort care within 24 hours|8
5878048|NCT01898208|20334606|P2|Overall Study|Death/comfort care within 24 hours|9
5878049|NCT01898208|20334607|P1|Overall Study|Death/comfort care within 24 hours|10
5878050|NCT01898208|20334605|P3|Overall Study|Positive blood culture|15
5878051|NCT01898208|20334606|P2|Overall Study|Positive blood culture|23
5878052|NCT01898208|20334607|P1|Overall Study|Positive blood culture|17
5878053|NCT01898195|20334654|P3|Smoking Abstinence|Did not have good measurements|36
5878054|NCT01898195|20334655|P2|Smoking Abstinence|Did not have good measurements|38
5878055|NCT01898195|20334656|P1|Smoking Abstinence|Did not have good measurements|35
5878056|NCT01898130|20334667|P1|Follow up Until PD or Death|Lost to Follow-up|1
5878057|NCT01898130|20334667|P1|Treatment|Progressive Disease|4
5878058|NCT01898130|20334667|P1|Treatment|Withdrawal by Subject|2
5878059|NCT01898091|20334682|P2|Overall Study|Withdrawal by Subject|5
5878060|NCT01898091|20334683|P1|Overall Study|Withdrawal by Subject|1
5878061|NCT01898091|20334682|P2|Overall Study|Lost to Follow-up|1
5878062|NCT01898091|20334683|P1|Overall Study|Lost to Follow-up|1
5878063|NCT01898078|20334691|P2|Overall Study|Reason not Specified|1
5878064|NCT01898078|20334692|P1|Overall Study|Reason not Specified|0
5878065|NCT01898078|20334691|P2|Overall Study|Symptomatic Deterioration|0
5878066|NCT01898078|20334692|P1|Overall Study|Symptomatic Deterioration|2
5878067|NCT01898078|20334691|P2|Overall Study|Withdrawal by Subject|1
5878068|NCT01898078|20334692|P1|Overall Study|Withdrawal by Subject|1
5878069|NCT01898078|20334691|P2|Overall Study|Adverse Event|1
5878070|NCT01898078|20334692|P1|Overall Study|Adverse Event|2
5878071|NCT01898078|20334691|P2|Overall Study|Progressive Disease|5
5878072|NCT01898078|20334692|P1|Overall Study|Progressive Disease|1
5878073|NCT01897896|20334729|P2|Overall Study|Other than specified|1
5878074|NCT01897896|20334730|P1|Overall Study|Other than specified|2
5878075|NCT01897896|20334729|P2|Overall Study|Caregiver can no longer participate|2
5878076|NCT01897896|20334730|P1|Overall Study|Caregiver can no longer participate|0
5878077|NCT01897896|20334729|P2|Overall Study|Withdrawal per Investigator's judgement|1
5878078|NCT01897896|20334730|P1|Overall Study|Withdrawal per Investigator's judgement|1
5878079|NCT01897896|20334729|P2|Overall Study|Protocol Violation|1
5878080|NCT01897896|20334730|P1|Overall Study|Protocol Violation|1
5878081|NCT01897896|20334729|P2|Overall Study|Require drug that interfere with study|4
5878082|NCT01897896|20334730|P1|Overall Study|Require drug that interfere with study|1
5878083|NCT01897896|20334729|P2|Overall Study|Withdrawal by Subject|1
5878084|NCT01897896|20334730|P1|Overall Study|Withdrawal by Subject|7
5878085|NCT01897896|20334729|P2|Overall Study|Non-compliance with study drug dosing|1
5878086|NCT01897896|20334730|P1|Overall Study|Non-compliance with study drug dosing|1
5878087|NCT01897896|20334729|P2|Overall Study|Lost to Follow-up|0
5878088|NCT01897896|20334730|P1|Overall Study|Lost to Follow-up|1
5878089|NCT01897896|20334729|P2|Overall Study|Adverse Event|1
5878090|NCT01897896|20334730|P1|Overall Study|Adverse Event|11
5878091|NCT01897896|20334729|P2|Overall Study|Death|0
5878092|NCT01897896|20334730|P1|Overall Study|Death|1
5878093|NCT01897727|20334862|P2|Overall Study|Exclusion: central sleep apnea|1
5878094|NCT01897727|20334863|P1|Overall Study|Exclusion: central sleep apnea|0
5878095|NCT01897714|20334875|P6|Phase II (MTD)|Other|0
5878096|NCT01897714|20334876|P5|Phase II (MTD)|Other|3
5878097|NCT01897714|20334877|P4|Phase II (MTD)|Other|0
5878098|NCT01897714|20334878|P3|Phase II (MTD)|Other|0
5878099|NCT01897714|20334879|P2|Phase II (MTD)|Other|0
5878100|NCT01897714|20334880|P1|Phase II (MTD)|Other|0
5878101|NCT01897714|20334875|P6|Phase II (MTD)|Study terminated with patient alive|0
5878102|NCT01897714|20334876|P5|Phase II (MTD)|Study terminated with patient alive|1
5878103|NCT01897714|20334877|P4|Phase II (MTD)|Study terminated with patient alive|0
5878104|NCT01897714|20334878|P3|Phase II (MTD)|Study terminated with patient alive|0
5878105|NCT01897714|20334879|P2|Phase II (MTD)|Study terminated with patient alive|0
5878106|NCT01897714|20334880|P1|Phase II (MTD)|Study terminated with patient alive|0
5878107|NCT01897714|20334875|P6|Phase II (MTD)|Death|10
5878108|NCT01897714|20334876|P5|Phase II (MTD)|Death|25
5878109|NCT01897714|20334877|P4|Phase II (MTD)|Death|0
5878110|NCT01897714|20334878|P3|Phase II (MTD)|Death|0
5878111|NCT01897714|20334879|P2|Phase II (MTD)|Death|0
5878112|NCT01897714|20334880|P1|Phase II (MTD)|Death|0
5878113|NCT01897714|20334875|P6|Phase II (MTD)|Lost to Follow-up|0
5878114|NCT01897714|20334876|P5|Phase II (MTD)|Lost to Follow-up|1
5878115|NCT01897714|20334877|P4|Phase II (MTD)|Lost to Follow-up|0
5878116|NCT01897714|20334878|P3|Phase II (MTD)|Lost to Follow-up|0
5878117|NCT01897714|20334879|P2|Phase II (MTD)|Lost to Follow-up|0
5878118|NCT01897714|20334880|P1|Phase II (MTD)|Lost to Follow-up|0
5878119|NCT01897714|20334875|P6|Phase II (MTD)|Withdrawal by Subject|1
5878120|NCT01897714|20334876|P5|Phase II (MTD)|Withdrawal by Subject|0
5878121|NCT01897714|20334877|P4|Phase II (MTD)|Withdrawal by Subject|0
5878122|NCT01897714|20334878|P3|Phase II (MTD)|Withdrawal by Subject|0
5878123|NCT01897714|20334879|P2|Phase II (MTD)|Withdrawal by Subject|0
5878124|NCT01897714|20334880|P1|Phase II (MTD)|Withdrawal by Subject|0
5878125|NCT01897714|20334875|P6|Phase I (Dose Escalation)|Other|0
5878126|NCT01897714|20334876|P5|Phase I (Dose Escalation)|Other|0
5878127|NCT01897714|20334877|P4|Phase I (Dose Escalation)|Other|0
5878128|NCT01897714|20334878|P3|Phase I (Dose Escalation)|Other|0
5878129|NCT01897714|20334879|P2|Phase I (Dose Escalation)|Other|1
5878130|NCT01897714|20334880|P1|Phase I (Dose Escalation)|Other|0
5878131|NCT01897714|20334875|P6|Phase I (Dose Escalation)|Adverse Event|0
5878132|NCT01897714|20334876|P5|Phase I (Dose Escalation)|Adverse Event|0
5878133|NCT01897714|20334877|P4|Phase I (Dose Escalation)|Adverse Event|3
5878134|NCT01897714|20334878|P3|Phase I (Dose Escalation)|Adverse Event|4
5878135|NCT01897714|20334879|P2|Phase I (Dose Escalation)|Adverse Event|1
5878136|NCT01897714|20334880|P1|Phase I (Dose Escalation)|Adverse Event|0
5878137|NCT01897714|20334875|P6|Phase I (Dose Escalation)|Disease progression|0
5878138|NCT01897714|20334876|P5|Phase I (Dose Escalation)|Disease progression|0
5878139|NCT01897714|20334877|P4|Phase I (Dose Escalation)|Disease progression|3
5878140|NCT01897714|20334878|P3|Phase I (Dose Escalation)|Disease progression|1
5878141|NCT01897714|20334879|P2|Phase I (Dose Escalation)|Disease progression|5
5878142|NCT01897714|20334880|P1|Phase I (Dose Escalation)|Disease progression|3
5878143|NCT01897532|20334926|P2|Discontinuation From Trial|Patient lost to follow-up for MACE|36
5878144|NCT01897532|20334927|P1|Discontinuation From Trial|Patient lost to follow-up for MACE|55
5878145|NCT01897532|20334926|P2|Discontinuation From Trial|Not Treated|5
5878146|NCT01897532|20334927|P1|Discontinuation From Trial|Not Treated|7
5878147|NCT01897532|20334926|P2|Discontinuation From Treatment|Adverse event/ CV outcome event|362
5878148|NCT01897532|20334927|P1|Discontinuation From Treatment|Adverse event/ CV outcome event|402
5878149|NCT01897532|20334926|P2|Discontinuation From Treatment|Non compliance|15
5878150|NCT01897532|20334927|P1|Discontinuation From Treatment|Non compliance|24
5878151|NCT01897532|20334926|P2|Discontinuation From Treatment|Withdrawal by Subject|281
5878152|NCT01897532|20334927|P1|Discontinuation From Treatment|Withdrawal by Subject|333
5878153|NCT01897532|20334926|P2|Discontinuation From Treatment|Other reason than specified|176
5878154|NCT01897532|20334927|P1|Discontinuation From Treatment|Other reason than specified|196
5878155|NCT01897532|20334926|P2|Discontinuation From Treatment|Not Treated|5
5878156|NCT01897532|20334927|P1|Discontinuation From Treatment|Not Treated|7
5878157|NCT01897493|20334935|P1|Period 1 (Day 1 Through Day 6 Predose)|Withdrawal by Subject|1
5878158|NCT01897233|20334971|P1|Part B (24 Weeks)|Physician Decision|1
5878159|NCT01897233|20334971|P1|Part B (24 Weeks)|Withdrawal by Subject|2
5878160|NCT01897233|20334971|P1|Part B (24 Weeks)|Adverse Event|1
5878161|NCT01896986|20335023|P2|Overall Study|samples lost|23
5878162|NCT01896986|20335024|P1|Overall Study|samples lost|14
5878163|NCT01896934|20335030|P1|Overall Study|Withdrawal by Subject|1
5878164|NCT01896934|20335030|P1|Overall Study|Adverse Event|1
5878165|NCT01896895|20335043|P4|Double-blind MP|Lost to Follow-up|0
5878166|NCT01896895|20335044|P3|Double-blind MP|Lost to Follow-up|1
5878167|NCT01896895|20335045|P2|Double-blind MP|Lost to Follow-up|0
5878168|NCT01896895|20335046|P1|Double-blind MP|Lost to Follow-up|1
5878169|NCT01896895|20335043|P4|Double-blind MP|Withdrawal by Subject|0
5878170|NCT01896895|20335044|P3|Double-blind MP|Withdrawal by Subject|1
5878171|NCT01896895|20335045|P2|Double-blind MP|Withdrawal by Subject|2
5878172|NCT01896895|20335046|P1|Double-blind MP|Withdrawal by Subject|0
5878173|NCT01896895|20335043|P4|Double-blind MP|Physician Decision|0
5878174|NCT01896895|20335044|P3|Double-blind MP|Physician Decision|1
5878175|NCT01896895|20335045|P2|Double-blind MP|Physician Decision|0
5878176|NCT01896895|20335046|P1|Double-blind MP|Physician Decision|0
5878177|NCT01896869|20335063|P2|Overall Study|Lost to Follow-up|0
5878178|NCT01896869|20335064|P1|Overall Study|Lost to Follow-up|1
5878179|NCT01896869|20335063|P2|Overall Study|Withdrawal by Subject|6
5878180|NCT01896869|20335064|P1|Overall Study|Withdrawal by Subject|0
5878181|NCT01896856|20335089|P6|Overall Study|Transportation issues / Non-compliance|0
5878182|NCT01896856|20335090|P5|Overall Study|Transportation issues / Non-compliance|0
5878183|NCT01896856|20335091|P4|Overall Study|Transportation issues / Non-compliance|0
5878184|NCT01896856|20335092|P3|Overall Study|Transportation issues / Non-compliance|1
5878185|NCT01896856|20335093|P2|Overall Study|Transportation issues / Non-compliance|0
5878186|NCT01896856|20335094|P1|Overall Study|Transportation issues / Non-compliance|0
5878187|NCT01896726|20335113|P1|Treatment Period 2 (Days 23-31)|Lost to Follow-up|1
5878188|NCT01896726|20335113|P1|Treatment Period 2 (Days 23-31)|Adverse Event|1
5878189|NCT01896700|20335128|P2|Overall Study|Withdrawal by Subject|1
5878190|NCT01896700|20335129|P1|Overall Study|Withdrawal by Subject|0
5878191|NCT01896700|20335128|P2|Overall Study|Adverse Event|5
5878192|NCT01896700|20335129|P1|Overall Study|Adverse Event|4
5878193|NCT01896557|20335160|P2|Clopidogrel + GI Protector|Reading error|3
5878194|NCT01896557|20335161|P1|Clopidogrel + GI Protector|Reading error|1
5878195|NCT01896557|20335160|P2|Clopidogrel + GI Protector|low adherence|1
5878196|NCT01896557|20335161|P1|Clopidogrel + GI Protector|low adherence|1
5878197|NCT01896557|20335160|P2|Clopidogrel Alone|Adverse Event|0
5878198|NCT01896557|20335161|P1|Clopidogrel Alone|Adverse Event|1
5878199|NCT01896297|20335198|P1|Overall Study|Died in post treatment phase|1
5878200|NCT01896232|20335205|P2|Overall Study|Lost to Follow-up|12
5878201|NCT01896232|20335206|P1|Overall Study|Lost to Follow-up|9
5878202|NCT01896232|20335205|P2|Overall Study|Sponsor Decision|0
5878203|NCT01896232|20335206|P1|Overall Study|Sponsor Decision|2
5878204|NCT01896232|20335205|P2|Overall Study|Withdrawal by Subject|31
5878205|NCT01896232|20335206|P1|Overall Study|Withdrawal by Subject|32
5878206|NCT01896232|20335205|P2|Overall Study|Death|10
5878207|NCT01896232|20335206|P1|Overall Study|Death|6
5878208|NCT01896193|20335234|P2|Overall Study|Withdrew Consent|0
5878209|NCT01896193|20335235|P1|Overall Study|Withdrew Consent|1
5878210|NCT01896193|20335234|P2|Overall Study|Protocol Violation|1
5878211|NCT01896193|20335235|P1|Overall Study|Protocol Violation|0
5878212|NCT01896193|20335234|P2|Overall Study|Lack of Efficacy|11
5878213|NCT01896193|20335235|P1|Overall Study|Lack of Efficacy|20
5878214|NCT01896128|20335261|P2|Overall Study|Withdrawal by Subject|3
5878215|NCT01896128|20335262|P1|Overall Study|Withdrawal by Subject|3
5878216|NCT01896050|20335304|P2|Overall Study|Death|0
5878217|NCT01896050|20335305|P1|Overall Study|Death|1
5878218|NCT01896050|20335304|P2|Overall Study|Adverse Event|2
5878219|NCT01896050|20335305|P1|Overall Study|Adverse Event|37
5878220|NCT01895777|20335349|P2|Overall Study|Non-compliance with the CTP|1
5878221|NCT01895777|20335350|P1|Overall Study|Non-compliance with the CTP|2
5878222|NCT01895777|20335349|P2|Overall Study|Other reasons|2
5878223|NCT01895777|20335350|P1|Overall Study|Other reasons|3
5878224|NCT01895777|20335349|P2|Overall Study|Not treated|0
5878225|NCT01895777|20335350|P1|Overall Study|Not treated|1
5878226|NCT01895777|20335349|P2|Overall Study|Lost to Follow-up|0
5878227|NCT01895777|20335350|P1|Overall Study|Lost to Follow-up|2
5878228|NCT01895777|20335349|P2|Overall Study|Adverse Event|2
5878229|NCT01895777|20335350|P1|Overall Study|Adverse Event|1
5878230|NCT01895608|20335406|P4|Overall Study|Withdrawal by Subject|0
5878231|NCT01895608|20335407|P3|Overall Study|Withdrawal by Subject|2
5878232|NCT01895608|20335408|P2|Overall Study|Withdrawal by Subject|0
5878233|NCT01895608|20335409|P1|Overall Study|Withdrawal by Subject|0
5878234|NCT01895608|20335406|P4|Overall Study|change in health status|0
5878235|NCT01895608|20335407|P3|Overall Study|change in health status|1
5878236|NCT01895608|20335408|P2|Overall Study|change in health status|1
5878237|NCT01895608|20335409|P1|Overall Study|change in health status|0
5878238|NCT01895543|20335439|P1|Overall Study|Other (Not fulfilling above criteria)|24
5878239|NCT01895543|20335439|P1|Overall Study|Physician Decision|2
5878240|NCT01895543|20335439|P1|Overall Study|Protocol Violation|1
5878241|NCT01895543|20335439|P1|Overall Study|Subject's substantial non-compliance|6
5878242|NCT01895543|20335439|P1|Overall Study|Adverse Event|28
5878243|NCT01895543|20335439|P1|Overall Study|Lost to Follow-up|25
5878244|NCT01895543|20335439|P1|Overall Study|Withdrawal by Subject|43
5878245|NCT01895452|20335455|P2|Overall Study|Noncompliance with study drug|1
5878246|NCT01895452|20335456|P1|Overall Study|Noncompliance with study drug|0
5878247|NCT01895452|20335455|P2|Overall Study|Underlying disease|3
5878248|NCT01895452|20335456|P1|Overall Study|Underlying disease|0
5878249|NCT01895452|20335455|P2|Overall Study|Withdrawal by Subject|14
5878250|NCT01895452|20335456|P1|Overall Study|Withdrawal by Subject|2
5878251|NCT01895452|20335455|P2|Overall Study|Pregnancy|1
5878252|NCT01895452|20335456|P1|Overall Study|Pregnancy|0
5878253|NCT01895452|20335455|P2|Overall Study|Lost to Follow-up|5
5878254|NCT01895452|20335456|P1|Overall Study|Lost to Follow-up|1
5878255|NCT01895452|20335455|P2|Overall Study|Adverse Event|4
5878256|NCT01895452|20335456|P1|Overall Study|Adverse Event|1
5878257|NCT01895361|20335469|P3|Overall Study|Reasons different from categories above|4
5878258|NCT01895361|20335470|P2|Overall Study|Reasons different from categories above|3
5878259|NCT01895361|20335471|P1|Overall Study|Reasons different from categories above|7
5878260|NCT01895361|20335469|P3|Overall Study|Lack of Efficacy|0
5878261|NCT01895361|20335470|P2|Overall Study|Lack of Efficacy|1
5878262|NCT01895361|20335471|P1|Overall Study|Lack of Efficacy|0
5878263|NCT01895361|20335469|P3|Overall Study|Withdrawal by Subject|6
5878264|NCT01895361|20335470|P2|Overall Study|Withdrawal by Subject|6
5878265|NCT01895361|20335471|P1|Overall Study|Withdrawal by Subject|7
5878266|NCT01895361|20335469|P3|Overall Study|Physician Decision|2
5878267|NCT01895361|20335470|P2|Overall Study|Physician Decision|2
5878268|NCT01895361|20335471|P1|Overall Study|Physician Decision|2
5878269|NCT01895361|20335469|P3|Overall Study|Non-compliance with study|1
5878270|NCT01895361|20335470|P2|Overall Study|Non-compliance with study|3
5878271|NCT01895361|20335471|P1|Overall Study|Non-compliance with study|1
5878272|NCT01895361|20335469|P3|Overall Study|Lost to Follow-up|6
5878273|NCT01895361|20335470|P2|Overall Study|Lost to Follow-up|4
5878274|NCT01895361|20335471|P1|Overall Study|Lost to Follow-up|4
5878275|NCT01895361|20335469|P3|Overall Study|Death|2
5878276|NCT01895361|20335470|P2|Overall Study|Death|1
5878277|NCT01895361|20335471|P1|Overall Study|Death|2
5878278|NCT01895361|20335469|P3|Overall Study|Adverse Event|3
5878279|NCT01895361|20335470|P2|Overall Study|Adverse Event|1
5878280|NCT01895361|20335471|P1|Overall Study|Adverse Event|1
5878281|NCT01895335|20335500|P1|Overall Study|Other than Specified Above|44
5878282|NCT01895335|20335500|P1|Overall Study|Included But Not treated|1
5878283|NCT01895335|20335500|P1|Overall Study|Poor Compliance to Protocol|11
5878284|NCT01895335|20335500|P1|Overall Study|Lack of Efficacy|53
5878285|NCT01895335|20335500|P1|Overall Study|Adverse Event|106
5878286|NCT01895322|20335517|P1|Overall Study|Protocol Violation|10
5878287|NCT01895322|20335517|P1|Overall Study|Withdrawal by Subject|2
5878288|NCT01895322|20335517|P1|Overall Study|Adverse Event|1
5878289|NCT01895309|20335526|P2|Overall Study|Withdrawal by Subject|18
5878290|NCT01895309|20335527|P1|Overall Study|Withdrawal by Subject|9
5878291|NCT01895309|20335526|P2|Overall Study|Physician Decision|10
5878292|NCT01895309|20335527|P1|Overall Study|Physician Decision|15
5878293|NCT01895309|20335526|P2|Overall Study|Lost to Follow-up|3
5878294|NCT01895309|20335527|P1|Overall Study|Lost to Follow-up|1
5878295|NCT01895309|20335526|P2|Overall Study|Lack of Efficacy|3
5878296|NCT01895309|20335527|P1|Overall Study|Lack of Efficacy|1
5878297|NCT01895309|20335526|P2|Overall Study|Protocol Violation|0
5878298|NCT01895309|20335527|P1|Overall Study|Protocol Violation|1
5878299|NCT01895309|20335526|P2|Overall Study|Adverse Event|17
5878300|NCT01895309|20335527|P1|Overall Study|Adverse Event|13
5878301|NCT01895270|20335541|P2|Isradipine Taper (W7-8)|Withdrawal by Subject|1
5878302|NCT01895270|20335542|P1|Isradipine Taper (W7-8)|Withdrawal by Subject|0
5878303|NCT01895270|20335541|P2|Isradipine Taper (W7-8)|Lost to Follow-up|1
5878304|NCT01895270|20335542|P1|Isradipine Taper (W7-8)|Lost to Follow-up|0
5878305|NCT01895270|20335541|P2|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|5
5878306|NCT01895270|20335542|P1|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|3
5878307|NCT01895270|20335541|P2|Study Medications Induction (W1-4)|Blood pressure issues|1
5878308|NCT01895270|20335542|P1|Study Medications Induction (W1-4)|Blood pressure issues|0
5878309|NCT01895270|20335541|P2|Study Medications Induction (W1-4)|noncompliance- missed medications|1
5878310|NCT01895270|20335542|P1|Study Medications Induction (W1-4)|noncompliance- missed medications|3
5878311|NCT01895270|20335541|P2|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|2
5878312|NCT01895270|20335542|P1|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|3
5878313|NCT01895270|20335541|P2|Study Medications Induction (W1-4)|Withdrawal by Subject|2
5878314|NCT01895270|20335542|P1|Study Medications Induction (W1-4)|Withdrawal by Subject|0
5878315|NCT01895101|20335561|P3|Overall Study|coagulation disorder|0
5878316|NCT01895101|20335562|P2|Overall Study|coagulation disorder|1
5878317|NCT01895101|20335563|P1|Overall Study|coagulation disorder|0
5878318|NCT01895101|20335561|P3|Overall Study|Death|0
5878319|NCT01895101|20335562|P2|Overall Study|Death|1
5878320|NCT01895101|20335563|P1|Overall Study|Death|0
5878321|NCT01895101|20335561|P3|Overall Study|another study, enrolled in other study|0
5878322|NCT01895101|20335562|P2|Overall Study|another study, enrolled in other study|1
5878323|NCT01895101|20335563|P1|Overall Study|another study, enrolled in other study|0
5878324|NCT01895101|20335561|P3|Overall Study|Withdrawal by Subject|2
5878325|NCT01895101|20335562|P2|Overall Study|Withdrawal by Subject|1
5878326|NCT01895101|20335563|P1|Overall Study|Withdrawal by Subject|0
5878327|NCT01895101|20335561|P3|Overall Study|OPCAB procedure|3
5878328|NCT01895101|20335562|P2|Overall Study|OPCAB procedure|1
5878329|NCT01895101|20335563|P1|Overall Study|OPCAB procedure|1
5878330|NCT01894984|20335598|P2|Overall Study|Other|175
5878331|NCT01894984|20335599|P1|Overall Study|Other|314
5878332|NCT01894919|20335628|P13|Overall Study|Lost to Follow-up|0
5878333|NCT01894919|20335629|P12|Overall Study|Lost to Follow-up|0
5878334|NCT01894919|20335630|P11|Overall Study|Lost to Follow-up|0
5878335|NCT01894919|20335631|P10|Overall Study|Lost to Follow-up|0
5878336|NCT01894919|20335632|P9|Overall Study|Lost to Follow-up|0
5878337|NCT01894919|20335633|P8|Overall Study|Lost to Follow-up|0
5878338|NCT01894919|20335634|P7|Overall Study|Lost to Follow-up|0
5878339|NCT01894919|20335635|P6|Overall Study|Lost to Follow-up|0
5878340|NCT01894919|20335636|P5|Overall Study|Lost to Follow-up|2
5878341|NCT01894919|20335637|P4|Overall Study|Lost to Follow-up|0
5878342|NCT01894919|20335638|P3|Overall Study|Lost to Follow-up|0
5878343|NCT01894919|20335639|P2|Overall Study|Lost to Follow-up|0
5878344|NCT01894919|20335640|P1|Overall Study|Lost to Follow-up|0
5878345|NCT01894919|20335628|P13|Overall Study|Other-Unspecified|0
5878346|NCT01894919|20335629|P12|Overall Study|Other-Unspecified|0
5878347|NCT01894919|20335630|P11|Overall Study|Other-Unspecified|0
5878348|NCT01894919|20335631|P10|Overall Study|Other-Unspecified|0
5878349|NCT01894919|20335632|P9|Overall Study|Other-Unspecified|0
5878350|NCT01894919|20335633|P8|Overall Study|Other-Unspecified|0
5878351|NCT01894919|20335634|P7|Overall Study|Other-Unspecified|0
5878352|NCT01894919|20335635|P6|Overall Study|Other-Unspecified|0
5878353|NCT01894919|20335636|P5|Overall Study|Other-Unspecified|0
5878354|NCT01894919|20335637|P4|Overall Study|Other-Unspecified|0
5878355|NCT01894919|20335638|P3|Overall Study|Other-Unspecified|0
5878356|NCT01894919|20335639|P2|Overall Study|Other-Unspecified|0
5878357|NCT01894919|20335640|P1|Overall Study|Other-Unspecified|1
5878358|NCT01894919|20335628|P13|Overall Study|Adverse Event|0
5878359|NCT01894919|20335629|P12|Overall Study|Adverse Event|0
5878360|NCT01894919|20335630|P11|Overall Study|Adverse Event|1
5878361|NCT01894919|20335631|P10|Overall Study|Adverse Event|0
5878362|NCT01894919|20335632|P9|Overall Study|Adverse Event|0
5878363|NCT01894919|20335633|P8|Overall Study|Adverse Event|0
5878364|NCT01894919|20335634|P7|Overall Study|Adverse Event|0
5878365|NCT01894919|20335635|P6|Overall Study|Adverse Event|0
5878366|NCT01894919|20335636|P5|Overall Study|Adverse Event|0
5878367|NCT01894919|20335637|P4|Overall Study|Adverse Event|0
5878368|NCT01894919|20335638|P3|Overall Study|Adverse Event|0
5878369|NCT01894919|20335639|P2|Overall Study|Adverse Event|0
5878370|NCT01894919|20335640|P1|Overall Study|Adverse Event|0
5878371|NCT01894919|20335628|P13|Overall Study|Withdrawal by Subject|0
5878372|NCT01894919|20335629|P12|Overall Study|Withdrawal by Subject|0
5878373|NCT01894919|20335630|P11|Overall Study|Withdrawal by Subject|1
5878374|NCT01894919|20335631|P10|Overall Study|Withdrawal by Subject|1
5878375|NCT01894919|20335632|P9|Overall Study|Withdrawal by Subject|0
5878376|NCT01894919|20335633|P8|Overall Study|Withdrawal by Subject|0
5878377|NCT01894919|20335634|P7|Overall Study|Withdrawal by Subject|0
5878378|NCT01894919|20335635|P6|Overall Study|Withdrawal by Subject|0
5878379|NCT01894919|20335636|P5|Overall Study|Withdrawal by Subject|1
5878380|NCT01894919|20335637|P4|Overall Study|Withdrawal by Subject|0
5878381|NCT01894919|20335638|P3|Overall Study|Withdrawal by Subject|0
5878382|NCT01894919|20335639|P2|Overall Study|Withdrawal by Subject|0
5878383|NCT01894919|20335640|P1|Overall Study|Withdrawal by Subject|1
5878384|NCT01894841|20335795|P2|Overall Study|Lost to Follow-up|3
5878385|NCT01894841|20335796|P1|Overall Study|Lost to Follow-up|7
5878386|NCT01894841|20335795|P2|Overall Study|Withdrawn by investigator|2
5878387|NCT01894841|20335796|P1|Overall Study|Withdrawn by investigator|2
5878388|NCT01894841|20335795|P2|Overall Study|Withdrawal by Subject|4
5878389|NCT01894841|20335796|P1|Overall Study|Withdrawal by Subject|9
5878390|NCT01894776|20335812|P1|Overall Study|Withdrawal by Subject|1
5878393|NCT01894607|20335835|P1|Overall Study|Ineligible|1
5878394|NCT01894581|20335842|P2|Overall Study|Screen Failure|4
5878395|NCT01894581|20335843|P1|Overall Study|Screen Failure|3
5878396|NCT01894581|20335842|P2|Overall Study|Withdrawal by Subject|3
5878397|NCT01894581|20335843|P1|Overall Study|Withdrawal by Subject|2
5878398|NCT01894568|20335851|P2|Overall Study|Lost to Follow-up|1
5878399|NCT01894568|20335852|P1|Overall Study|Lost to Follow-up|0
5878400|NCT01894568|20335851|P2|Overall Study|Physician Decision|0
5878401|NCT01894568|20335852|P1|Overall Study|Physician Decision|1
5878402|NCT01894568|20335851|P2|Overall Study|Withdrawal by Subject|5
5878403|NCT01894568|20335852|P1|Overall Study|Withdrawal by Subject|5
5878404|NCT01894568|20335851|P2|Overall Study|Protocol required discontinuation|1
5878405|NCT01894568|20335852|P1|Overall Study|Protocol required discontinuation|2
5878406|NCT01894568|20335851|P2|Overall Study|Adverse Event|3
5878407|NCT01894568|20335852|P1|Overall Study|Adverse Event|2
5878408|NCT01894516|20335900|P4|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0
5878409|NCT01894516|20335901|P3|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|2
5878410|NCT01894516|20335902|P2|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0
5878411|NCT01894516|20335903|P1|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0
5878412|NCT01894516|20335900|P4|Period 2 (Week 13 to Week 24)|Adverse Event|1
5878413|NCT01894516|20335901|P3|Period 2 (Week 13 to Week 24)|Adverse Event|3
5878414|NCT01894516|20335902|P2|Period 2 (Week 13 to Week 24)|Adverse Event|2
5878415|NCT01894516|20335903|P1|Period 2 (Week 13 to Week 24)|Adverse Event|0
5878416|NCT01894516|20335900|P4|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2
5878417|NCT01894516|20335901|P3|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|1
5878418|NCT01894516|20335902|P2|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3
5878419|NCT01894516|20335903|P1|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2
5878420|NCT01894516|20335900|P4|Period 1 (Baseline up to Week 12)|Adverse Event|1
5878421|NCT01894516|20335901|P3|Period 1 (Baseline up to Week 12)|Adverse Event|0
5878422|NCT01894516|20335902|P2|Period 1 (Baseline up to Week 12)|Adverse Event|0
5878423|NCT01894516|20335903|P1|Period 1 (Baseline up to Week 12)|Adverse Event|2
5878424|NCT01894516|20335900|P4|Period 1 (Baseline up to Week 12)|Treatment failure|0
5878425|NCT01894516|20335901|P3|Period 1 (Baseline up to Week 12)|Treatment failure|1
5878426|NCT01894516|20335902|P2|Period 1 (Baseline up to Week 12)|Treatment failure|0
5878427|NCT01894516|20335903|P1|Period 1 (Baseline up to Week 12)|Treatment failure|0
5878428|NCT01894516|20335900|P4|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|0
5878429|NCT01894516|20335901|P3|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|0
5878430|NCT01894516|20335902|P2|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|1
5878431|NCT01894516|20335903|P1|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|1
5878432|NCT01894516|20335900|P4|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0
5878433|NCT01894516|20335901|P3|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0
5878434|NCT01894516|20335902|P2|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0
5878435|NCT01894516|20335903|P1|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|2
5878436|NCT01894516|20335900|P4|Period 1 (Baseline up to Week 12)|Other|0
5878437|NCT01894516|20335901|P3|Period 1 (Baseline up to Week 12)|Other|1
5878438|NCT01894516|20335902|P2|Period 1 (Baseline up to Week 12)|Other|1
5878439|NCT01894516|20335903|P1|Period 1 (Baseline up to Week 12)|Other|0
5878440|NCT01894477|20335959|P2|Overall Study|protocol changed due SC changed to cord|1
5878441|NCT01894477|20335960|P1|Overall Study|protocol changed due SC changed to cord|0
5878442|NCT01894477|20335959|P2|Overall Study|Protocol Violation|1
5878443|NCT01894477|20335960|P1|Overall Study|Protocol Violation|0
5878444|NCT01894256|20335971|P3|Part B|Lack of Efficacy|13
5878445|NCT01894256|20335972|P2|Part B|Lack of Efficacy|12
5878446|NCT01894256|20335973|P1|Part B|Lack of Efficacy|15
5878447|NCT01894256|20335971|P3|Part B|Withdrawal by Subject|0
5878448|NCT01894256|20335972|P2|Part B|Withdrawal by Subject|1
5878449|NCT01894256|20335973|P1|Part B|Withdrawal by Subject|0
5878450|NCT01894256|20335971|P3|Part B|Death|1
5878451|NCT01894256|20335972|P2|Part B|Death|1
5878452|NCT01894256|20335973|P1|Part B|Death|0
5878453|NCT01894256|20335971|P3|Part A|Adverse Event|0
5878454|NCT01894256|20335972|P2|Part A|Adverse Event|1
5878455|NCT01894256|20335973|P1|Part A|Adverse Event|0
5878456|NCT01894243|20336020|P3|Overall Study|Other|0
5878457|NCT01894243|20336021|P2|Overall Study|Other|0
5878458|NCT01894243|20336022|P1|Overall Study|Other|1
5878459|NCT01894243|20336020|P3|Overall Study|Subject decision|0
5878460|NCT01894243|20336021|P2|Overall Study|Subject decision|0
5878461|NCT01894243|20336022|P1|Overall Study|Subject decision|1
5878462|NCT01894243|20336020|P3|Overall Study|Condition under investigation worsened|2
5878463|NCT01894243|20336021|P2|Overall Study|Condition under investigation worsened|6
5878464|NCT01894243|20336022|P1|Overall Study|Condition under investigation worsened|8
5878465|NCT01894243|20336020|P3|Overall Study|Lack of Efficacy|1
5878466|NCT01894243|20336021|P2|Overall Study|Lack of Efficacy|3
5878467|NCT01894243|20336022|P1|Overall Study|Lack of Efficacy|3
5878468|NCT01894243|20336020|P3|Overall Study|Death|3
5878469|NCT01894243|20336021|P2|Overall Study|Death|0
5878470|NCT01894243|20336022|P1|Overall Study|Death|0
5878471|NCT01894243|20336020|P3|Overall Study|Adverse Event|2
5878472|NCT01894243|20336021|P2|Overall Study|Adverse Event|1
5878473|NCT01894243|20336022|P1|Overall Study|Adverse Event|0
5878474|NCT01894230|20336061|P2|Overall Study|Death|0
5878475|NCT01894230|20336062|P1|Overall Study|Death|1
5878476|NCT01894230|20336061|P2|Overall Study|Non-adherent|1
5878477|NCT01894230|20336062|P1|Overall Study|Non-adherent|0
5878478|NCT01894230|20336061|P2|Overall Study|Withdrawal by Subject|4
5878479|NCT01894230|20336062|P1|Overall Study|Withdrawal by Subject|4
5878480|NCT01894230|20336061|P2|Overall Study|Lost to Follow-up|2
5878481|NCT01894230|20336062|P1|Overall Study|Lost to Follow-up|2
5878482|NCT01894152|20336097|P1|Overall Study|No DMR and no Stent thrombosis|151
5878483|NCT01894100|20336140|P2|Overall Study|Withdrawal by Subject|0
5878484|NCT01894100|20336141|P1|Overall Study|Withdrawal by Subject|3
5878485|NCT01894100|20336140|P2|Overall Study|Lost to Follow-up|1
5878486|NCT01894100|20336141|P1|Overall Study|Lost to Follow-up|0
5878487|NCT01894022|20336166|P2|Overall Study|Study Closed/terminated|10
5878488|NCT01894022|20336167|P1|Overall Study|Study Closed/terminated|7
5878489|NCT01894022|20336166|P2|Overall Study|Adverse Event, non-fatal|0
5878490|NCT01894022|20336167|P1|Overall Study|Adverse Event, non-fatal|1
5878491|NCT01894022|20336166|P2|Overall Study|Death|0
5878492|NCT01894022|20336167|P1|Overall Study|Death|1
5878493|NCT01893905|20336236|P2|Overall Study|Other reason|3
5878494|NCT01893905|20336237|P1|Overall Study|Other reason|1
5878495|NCT01893905|20336236|P2|Overall Study|Lack of adherence to treatment|0
5878496|NCT01893905|20336237|P1|Overall Study|Lack of adherence to treatment|2
5878497|NCT01893905|20336236|P2|Overall Study|Protocol Violation|1
5878498|NCT01893905|20336237|P1|Overall Study|Protocol Violation|6
5878499|NCT01893905|20336236|P2|Overall Study|Lost to Follow-up|0
5878500|NCT01893905|20336237|P1|Overall Study|Lost to Follow-up|1
5878501|NCT01893905|20336236|P2|Overall Study|Lack of Efficacy|7
5878502|NCT01893905|20336237|P1|Overall Study|Lack of Efficacy|5
5878503|NCT01893905|20336236|P2|Overall Study|Adverse Event|3
5878504|NCT01893905|20336237|P1|Overall Study|Adverse Event|9
5878505|NCT01893905|20336236|P2|Overall Study|Withdrawal by Subject|0
5878506|NCT01893905|20336237|P1|Overall Study|Withdrawal by Subject|1
5878507|NCT01893827|20336254|P2|Overall Study|Lost to Follow-up|26
5878508|NCT01893827|20336255|P1|Overall Study|Lost to Follow-up|19
5878509|NCT01893411|20336285|P3|Overall Study|Lost to Follow-up|1
5878510|NCT01893411|20336286|P2|Overall Study|Lost to Follow-up|0
5878511|NCT01893411|20336287|P1|Overall Study|Lost to Follow-up|2
5878512|NCT01893411|20336285|P3|Overall Study|Withdrawal by Subject|3
5878513|NCT01893411|20336286|P2|Overall Study|Withdrawal by Subject|4
5878514|NCT01893411|20336287|P1|Overall Study|Withdrawal by Subject|7
5878515|NCT01893411|20336285|P3|Overall Study|Adverse Event|0
5878516|NCT01893411|20336286|P2|Overall Study|Adverse Event|0
5878517|NCT01893411|20336287|P1|Overall Study|Adverse Event|1
5878518|NCT01893411|20336285|P3|Overall Study|Other|3
5878519|NCT01893411|20336286|P2|Overall Study|Other|1
5878520|NCT01893411|20336287|P1|Overall Study|Other|3
5878521|NCT01893411|20336285|P3|Overall Study|Lack of Efficacy|0
5878522|NCT01893411|20336286|P2|Overall Study|Lack of Efficacy|1
5878523|NCT01893411|20336287|P1|Overall Study|Lack of Efficacy|2
5878524|NCT01893411|20336285|P3|Overall Study|Physician Decision|2
5878525|NCT01893411|20336286|P2|Overall Study|Physician Decision|1
5878526|NCT01893411|20336287|P1|Overall Study|Physician Decision|1
5878527|NCT01893411|20336285|P3|Overall Study|Protocol Violation|0
5878528|NCT01893411|20336286|P2|Overall Study|Protocol Violation|0
5878529|NCT01893411|20336287|P1|Overall Study|Protocol Violation|1
5878530|NCT01893346|20336384|P4|Overall Study|Withdrawal by Subject|0
5878531|NCT01893346|20336385|P3|Overall Study|Withdrawal by Subject|0
5878532|NCT01893346|20336386|P2|Overall Study|Withdrawal by Subject|0
5878533|NCT01893346|20336387|P1|Overall Study|Withdrawal by Subject|2
5878534|NCT01893346|20336384|P4|Overall Study|Protocol Violation|0
5878535|NCT01893346|20336385|P3|Overall Study|Protocol Violation|0
5878536|NCT01893346|20336386|P2|Overall Study|Protocol Violation|0
5878537|NCT01893346|20336387|P1|Overall Study|Protocol Violation|1
5878538|NCT01893346|20336384|P4|Overall Study|Lost to Follow-up|0
5878539|NCT01893346|20336385|P3|Overall Study|Lost to Follow-up|0
5878540|NCT01893346|20336386|P2|Overall Study|Lost to Follow-up|1
5878541|NCT01893346|20336387|P1|Overall Study|Lost to Follow-up|0
5878542|NCT01893281|20336401|P1|Overall Study|Withdrawal by Subject|1
5878543|NCT01893281|20336401|P1|Overall Study|Protocol Violation|1
5878544|NCT01893281|20336401|P1|Overall Study|Adverse Event|1
5878545|NCT01893203|20336408|P1|Overall Study|Withdrawal by Subject|1
5878546|NCT01892722|20336432|P2|Overall Study|Withdrawal by Subject|5
5878547|NCT01892722|20336433|P1|Overall Study|Withdrawal by Subject|3
5878548|NCT01892722|20336432|P2|Overall Study|Lack of Efficacy|7
5878549|NCT01892722|20336433|P1|Overall Study|Lack of Efficacy|0
5878550|NCT01892722|20336432|P2|Overall Study|Adverse Event|2
5878551|NCT01892722|20336433|P1|Overall Study|Adverse Event|3
5878552|NCT01892722|20336432|P2|Overall Study|Physician Decision|2
5878553|NCT01892722|20336433|P1|Overall Study|Physician Decision|1
5878554|NCT01892722|20336432|P2|Overall Study|Patient/guardian decision|2
5878555|NCT01892722|20336433|P1|Overall Study|Patient/guardian decision|0
5878556|NCT01892722|20336432|P2|Overall Study|Administrative problems|1
5878557|NCT01892722|20336433|P1|Overall Study|Administrative problems|0
5878558|NCT01892722|20336432|P2|Overall Study|Protocol deviation|1
5878559|NCT01892722|20336433|P1|Overall Study|Protocol deviation|0
5878560|NCT01892657|20336449|P1|Overall Study|Protocol Violation|12
5878561|NCT01892657|20336449|P1|Overall Study|Withdrawal by Subject|6
5878562|NCT01892540|20336468|P3|Overall Study|Did not fit in scanner|1
5878563|NCT01892540|20336469|P2|Overall Study|Did not fit in scanner|0
5878564|NCT01892540|20336470|P1|Overall Study|Did not fit in scanner|0
5878565|NCT01892540|20336468|P3|Overall Study|Did not complete PET/MRI|2
5878566|NCT01892540|20336469|P2|Overall Study|Did not complete PET/MRI|0
5878567|NCT01892540|20336470|P1|Overall Study|Did not complete PET/MRI|0
5878568|NCT01892436|20336491|P4|Overall Study|Adverse Event|3
5878569|NCT01892436|20336492|P3|Overall Study|Adverse Event|2
5878570|NCT01892436|20336493|P2|Overall Study|Adverse Event|6
5878571|NCT01892436|20336494|P1|Overall Study|Adverse Event|7
5878572|NCT01892436|20336491|P4|Overall Study|non-compliance with treatment|0
5878573|NCT01892436|20336492|P3|Overall Study|non-compliance with treatment|0
5878574|NCT01892436|20336493|P2|Overall Study|non-compliance with treatment|0
5878575|NCT01892436|20336494|P1|Overall Study|non-compliance with treatment|1
5878576|NCT01892436|20336491|P4|Overall Study|Lost to Follow-up|3
5878577|NCT01892436|20336492|P3|Overall Study|Lost to Follow-up|1
5878578|NCT01892436|20336493|P2|Overall Study|Lost to Follow-up|1
5878579|NCT01892436|20336494|P1|Overall Study|Lost to Follow-up|1
5878580|NCT01892436|20336491|P4|Overall Study|Lack of Efficacy|2
5878581|NCT01892436|20336492|P3|Overall Study|Lack of Efficacy|2
5878582|NCT01892436|20336493|P2|Overall Study|Lack of Efficacy|2
5878583|NCT01892436|20336494|P1|Overall Study|Lack of Efficacy|1
5878584|NCT01892436|20336491|P4|Overall Study|Technical problems|1
5878585|NCT01892436|20336492|P3|Overall Study|Technical problems|1
5878586|NCT01892436|20336493|P2|Overall Study|Technical problems|1
5878587|NCT01892436|20336494|P1|Overall Study|Technical problems|2
5878588|NCT01892436|20336491|P4|Overall Study|Pregnancy|0
5878589|NCT01892436|20336492|P3|Overall Study|Pregnancy|1
5878590|NCT01892436|20336493|P2|Overall Study|Pregnancy|2
5878591|NCT01892436|20336494|P1|Overall Study|Pregnancy|0
5878592|NCT01892436|20336491|P4|Overall Study|Physician Decision|1
5878593|NCT01892436|20336492|P3|Overall Study|Physician Decision|0
5878594|NCT01892436|20336493|P2|Overall Study|Physician Decision|1
5878595|NCT01892436|20336494|P1|Overall Study|Physician Decision|2
5878596|NCT01892436|20336491|P4|Overall Study|Death|0
5878597|NCT01892436|20336492|P3|Overall Study|Death|0
5878598|NCT01892436|20336493|P2|Overall Study|Death|1
5878599|NCT01892436|20336494|P1|Overall Study|Death|1
5878600|NCT01892436|20336491|P4|Overall Study|Withdrawal by Subject|4
5878601|NCT01892436|20336492|P3|Overall Study|Withdrawal by Subject|4
5878602|NCT01892436|20336493|P2|Overall Study|Withdrawal by Subject|15
5878603|NCT01892436|20336494|P1|Overall Study|Withdrawal by Subject|8
5878604|NCT01892345|20336534|P2|Overall Study|Withdrawal by Subject|1
5878605|NCT01892345|20336535|P1|Overall Study|Withdrawal by Subject|12
5878606|NCT01892345|20336534|P2|Overall Study|Lost to Follow-up|0
5878607|NCT01892345|20336535|P1|Overall Study|Lost to Follow-up|3
5878608|NCT01892345|20336534|P2|Overall Study|Death|0
5878609|NCT01892345|20336535|P1|Overall Study|Death|1
5878610|NCT01892345|20336534|P2|Overall Study|Adverse Event|2
5878611|NCT01892345|20336535|P1|Overall Study|Adverse Event|0
5878612|NCT01892293|20336576|P1|Overall Study|Apheresed but not treated|4
5878613|NCT01892189|20336620|P9|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
5878614|NCT01892189|20336621|P8|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
5878615|NCT01892189|20336622|P7|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
5878616|NCT01892189|20336623|P6|Washout Period 1 (7 Days)|Noncompliance, Irritability|1
5878617|NCT01892189|20336624|P5|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
5878618|NCT01892189|20336625|P4|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
5878619|NCT01892189|20336626|P3|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
5878620|NCT01892189|20336627|P2|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
5878621|NCT01892189|20336628|P1|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
5878622|NCT01892189|20336620|P9|Washout Period 1 (7 Days)|Withdrawal by Subject|1
5878623|NCT01892189|20336621|P8|Washout Period 1 (7 Days)|Withdrawal by Subject|0
5878624|NCT01892189|20336622|P7|Washout Period 1 (7 Days)|Withdrawal by Subject|1
5878625|NCT01892189|20336623|P6|Washout Period 1 (7 Days)|Withdrawal by Subject|0
5878626|NCT01892189|20336624|P5|Washout Period 1 (7 Days)|Withdrawal by Subject|0
5878627|NCT01892189|20336625|P4|Washout Period 1 (7 Days)|Withdrawal by Subject|1
5878628|NCT01892189|20336626|P3|Washout Period 1 (7 Days)|Withdrawal by Subject|2
5878629|NCT01892189|20336627|P2|Washout Period 1 (7 Days)|Withdrawal by Subject|0
5878630|NCT01892189|20336628|P1|Washout Period 1 (7 Days)|Withdrawal by Subject|0
5878631|NCT01892189|20336620|P9|Washout Period 1 (7 Days)|Adverse Event|1
5878632|NCT01892189|20336621|P8|Washout Period 1 (7 Days)|Adverse Event|0
5878633|NCT01892189|20336622|P7|Washout Period 1 (7 Days)|Adverse Event|0
5878634|NCT01892189|20336623|P6|Washout Period 1 (7 Days)|Adverse Event|0
5878635|NCT01892189|20336624|P5|Washout Period 1 (7 Days)|Adverse Event|0
5878636|NCT01892189|20336625|P4|Washout Period 1 (7 Days)|Adverse Event|0
5878637|NCT01892189|20336626|P3|Washout Period 1 (7 Days)|Adverse Event|0
5878638|NCT01892189|20336627|P2|Washout Period 1 (7 Days)|Adverse Event|0
5878639|NCT01892189|20336628|P1|Washout Period 1 (7 Days)|Adverse Event|0
5878640|NCT01892163|20336670|P2|Overall Study|Lost to Follow-up|0
5878641|NCT01892163|20336671|P1|Overall Study|Lost to Follow-up|1
5878642|NCT01892163|20336670|P2|Overall Study|Death|1
5878643|NCT01892163|20336671|P1|Overall Study|Death|1
5878644|NCT01892020|20336683|P2|Period 2|Protocol Violation|0
5878645|NCT01892020|20336684|P1|Period 2|Protocol Violation|1
5878646|NCT01892020|20336683|P2|Period 1|Unclassified|1
5878647|NCT01892020|20336684|P1|Period 1|Unclassified|0
5878648|NCT01892020|20336683|P2|Period 1|Protocol Violation|4
5878649|NCT01892020|20336684|P1|Period 1|Protocol Violation|2
5878650|NCT01892020|20336683|P2|Period 1|Adverse Event|1
5878651|NCT01892020|20336684|P1|Period 1|Adverse Event|1
5878652|NCT01891890|20336742|P3|Overall Study|Study ended before endpoint reached|6
5878653|NCT01891890|20336743|P2|Overall Study|Study ended before endpoint reached|3
5878654|NCT01891890|20336744|P1|Overall Study|Study ended before endpoint reached|7
5878655|NCT01891890|20336742|P3|Overall Study|Lost to Follow-up|1
5878656|NCT01891890|20336743|P2|Overall Study|Lost to Follow-up|0
5878657|NCT01891890|20336744|P1|Overall Study|Lost to Follow-up|0
5878658|NCT01891864|20336787|P6|Extension Period|Lost to Follow-up|0
5878659|NCT01891864|20336788|P5|Extension Period|Lost to Follow-up|0
5878660|NCT01891864|20336789|P4|Extension Period|Lost to Follow-up|0
5878661|NCT01891864|20336790|P3|Extension Period|Lost to Follow-up|2
5878662|NCT01891864|20336791|P2|Extension Period|Lost to Follow-up|0
5878663|NCT01891864|20336792|P1|Extension Period|Lost to Follow-up|0
5878664|NCT01891864|20336787|P6|Extension Period|Withdrawal by Subject|0
5878665|NCT01891864|20336788|P5|Extension Period|Withdrawal by Subject|4
5878666|NCT01891864|20336789|P4|Extension Period|Withdrawal by Subject|2
5878667|NCT01891864|20336790|P3|Extension Period|Withdrawal by Subject|1
5878668|NCT01891864|20336791|P2|Extension Period|Withdrawal by Subject|0
5878669|NCT01891864|20336792|P1|Extension Period|Withdrawal by Subject|0
5878670|NCT01891864|20336787|P6|Extension Period|Adverse Event|0
5878671|NCT01891864|20336788|P5|Extension Period|Adverse Event|2
5878672|NCT01891864|20336789|P4|Extension Period|Adverse Event|2
5878673|NCT01891864|20336790|P3|Extension Period|Adverse Event|4
5878674|NCT01891864|20336791|P2|Extension Period|Adverse Event|0
5878675|NCT01891864|20336792|P1|Extension Period|Adverse Event|0
5878676|NCT01891864|20336787|P6|Extension Period|Pregnancy|0
5878677|NCT01891864|20336788|P5|Extension Period|Pregnancy|0
5878678|NCT01891864|20336789|P4|Extension Period|Pregnancy|0
5878679|NCT01891864|20336790|P3|Extension Period|Pregnancy|1
5878680|NCT01891864|20336791|P2|Extension Period|Pregnancy|0
5878681|NCT01891864|20336792|P1|Extension Period|Pregnancy|0
5878682|NCT01891864|20336787|P6|Extension Period|Lack of Efficacy|0
5878683|NCT01891864|20336788|P5|Extension Period|Lack of Efficacy|1
5878684|NCT01891864|20336789|P4|Extension Period|Lack of Efficacy|1
5878685|NCT01891864|20336790|P3|Extension Period|Lack of Efficacy|0
5878686|NCT01891864|20336791|P2|Extension Period|Lack of Efficacy|0
5878687|NCT01891864|20336792|P1|Extension Period|Lack of Efficacy|0
5878688|NCT01891864|20336787|P6|Treatment Period 2|Withdrawal by Subject|1
5878689|NCT01891864|20336788|P5|Treatment Period 2|Withdrawal by Subject|1
5878690|NCT01891864|20336789|P4|Treatment Period 2|Withdrawal by Subject|4
5878691|NCT01891864|20336790|P3|Treatment Period 2|Withdrawal by Subject|3
5878692|NCT01891864|20336791|P2|Treatment Period 2|Withdrawal by Subject|0
5878693|NCT01891864|20336792|P1|Treatment Period 2|Withdrawal by Subject|0
5878694|NCT01891864|20336787|P6|Treatment Period 2|Termination of Site|0
5878695|NCT01891864|20336788|P5|Treatment Period 2|Termination of Site|2
5878696|NCT01891864|20336789|P4|Treatment Period 2|Termination of Site|0
5878697|NCT01891864|20336790|P3|Treatment Period 2|Termination of Site|0
5878698|NCT01891864|20336791|P2|Treatment Period 2|Termination of Site|0
5878699|NCT01891864|20336792|P1|Treatment Period 2|Termination of Site|0
5878700|NCT01891864|20336787|P6|Treatment Period 2|Adverse Event|4
5878701|NCT01891864|20336788|P5|Treatment Period 2|Adverse Event|0
5878702|NCT01891864|20336789|P4|Treatment Period 2|Adverse Event|2
5878703|NCT01891864|20336790|P3|Treatment Period 2|Adverse Event|1
5878704|NCT01891864|20336791|P2|Treatment Period 2|Adverse Event|0
5878705|NCT01891864|20336792|P1|Treatment Period 2|Adverse Event|0
5878706|NCT01891864|20336787|P6|Treatment Period 2|Lack of Efficacy|0
5878707|NCT01891864|20336788|P5|Treatment Period 2|Lack of Efficacy|1
5878708|NCT01891864|20336789|P4|Treatment Period 2|Lack of Efficacy|0
5878709|NCT01891864|20336790|P3|Treatment Period 2|Lack of Efficacy|1
5878710|NCT01891864|20336791|P2|Treatment Period 2|Lack of Efficacy|0
5878711|NCT01891864|20336792|P1|Treatment Period 2|Lack of Efficacy|0
5878712|NCT01891864|20336787|P6|Treatment Period 2|Site Termination|0
5878713|NCT01891864|20336788|P5|Treatment Period 2|Site Termination|0
5878714|NCT01891864|20336789|P4|Treatment Period 2|Site Termination|2
5878715|NCT01891864|20336790|P3|Treatment Period 2|Site Termination|1
5878716|NCT01891864|20336791|P2|Treatment Period 2|Site Termination|0
5878717|NCT01891864|20336792|P1|Treatment Period 2|Site Termination|0
5878718|NCT01891864|20336787|P6|Treatment Period 2|Physician Decision|0
5878719|NCT01891864|20336788|P5|Treatment Period 2|Physician Decision|0
5878720|NCT01891864|20336789|P4|Treatment Period 2|Physician Decision|0
5878721|NCT01891864|20336790|P3|Treatment Period 2|Physician Decision|1
5878722|NCT01891864|20336791|P2|Treatment Period 2|Physician Decision|0
5878723|NCT01891864|20336792|P1|Treatment Period 2|Physician Decision|0
5878724|NCT01891864|20336787|P6|Treatment Period 2|Protocol Violation|0
5878725|NCT01891864|20336788|P5|Treatment Period 2|Protocol Violation|0
5878726|NCT01891864|20336789|P4|Treatment Period 2|Protocol Violation|1
5878727|NCT01891864|20336790|P3|Treatment Period 2|Protocol Violation|0
5878728|NCT01891864|20336791|P2|Treatment Period 2|Protocol Violation|0
5878729|NCT01891864|20336792|P1|Treatment Period 2|Protocol Violation|0
5878730|NCT01891864|20336787|P6|Treatment Period 1|Lost to Follow-up|0
5878731|NCT01891864|20336788|P5|Treatment Period 1|Lost to Follow-up|0
5878732|NCT01891864|20336789|P4|Treatment Period 1|Lost to Follow-up|0
5878733|NCT01891864|20336790|P3|Treatment Period 1|Lost to Follow-up|0
5878734|NCT01891864|20336791|P2|Treatment Period 1|Lost to Follow-up|0
5878735|NCT01891864|20336792|P1|Treatment Period 1|Lost to Follow-up|1
5878736|NCT01891864|20336787|P6|Treatment Period 1|Withdrawal by Subject|0
5878737|NCT01891864|20336788|P5|Treatment Period 1|Withdrawal by Subject|0
5878738|NCT01891864|20336789|P4|Treatment Period 1|Withdrawal by Subject|0
5878739|NCT01891864|20336790|P3|Treatment Period 1|Withdrawal by Subject|0
5878740|NCT01891864|20336791|P2|Treatment Period 1|Withdrawal by Subject|5
5878741|NCT01891864|20336792|P1|Treatment Period 1|Withdrawal by Subject|2
5878742|NCT01891864|20336787|P6|Treatment Period 1|Adverse Event / Injection Site Reaction|0
5878743|NCT01891864|20336788|P5|Treatment Period 1|Adverse Event / Injection Site Reaction|0
5878744|NCT01891864|20336789|P4|Treatment Period 1|Adverse Event / Injection Site Reaction|0
5878745|NCT01891864|20336790|P3|Treatment Period 1|Adverse Event / Injection Site Reaction|0
5878746|NCT01891864|20336791|P2|Treatment Period 1|Adverse Event / Injection Site Reaction|4
5878747|NCT01891864|20336792|P1|Treatment Period 1|Adverse Event / Injection Site Reaction|4
5878748|NCT01891864|20336787|P6|Treatment Period 1|Adverse Event, Serious, Fatal|0
5878749|NCT01891864|20336788|P5|Treatment Period 1|Adverse Event, Serious, Fatal|0
5878750|NCT01891864|20336789|P4|Treatment Period 1|Adverse Event, Serious, Fatal|0
5878751|NCT01891864|20336790|P3|Treatment Period 1|Adverse Event, Serious, Fatal|0
5878752|NCT01891864|20336791|P2|Treatment Period 1|Adverse Event, Serious, Fatal|1
5878753|NCT01891864|20336792|P1|Treatment Period 1|Adverse Event, Serious, Fatal|0
5878754|NCT01891864|20336787|P6|Treatment Period 1|Physician Decision|0
5878755|NCT01891864|20336788|P5|Treatment Period 1|Physician Decision|0
5878756|NCT01891864|20336789|P4|Treatment Period 1|Physician Decision|0
5878757|NCT01891864|20336790|P3|Treatment Period 1|Physician Decision|0
5878758|NCT01891864|20336791|P2|Treatment Period 1|Physician Decision|1
5878759|NCT01891864|20336792|P1|Treatment Period 1|Physician Decision|0
5878760|NCT01891864|20336787|P6|Treatment Period 1|Protocol Violation / IMP non-compliance|0
5878761|NCT01891864|20336788|P5|Treatment Period 1|Protocol Violation / IMP non-compliance|0
5878762|NCT01891864|20336789|P4|Treatment Period 1|Protocol Violation / IMP non-compliance|0
5878763|NCT01891864|20336790|P3|Treatment Period 1|Protocol Violation / IMP non-compliance|0
5878764|NCT01891864|20336791|P2|Treatment Period 1|Protocol Violation / IMP non-compliance|1
5878765|NCT01891864|20336792|P1|Treatment Period 1|Protocol Violation / IMP non-compliance|1
5878766|NCT01891721|20336828|P3|Overall Study|Lost to Follow-up|1
5878767|NCT01891721|20336829|P2|Overall Study|Lost to Follow-up|5
5878768|NCT01891721|20336830|P1|Overall Study|Lost to Follow-up|10
5878769|NCT01891669|20336854|P10|Overall Study|Other|0
5878770|NCT01891669|20336855|P9|Overall Study|Other|0
5878771|NCT01891669|20336856|P8|Overall Study|Other|1
5878772|NCT01891669|20336857|P7|Overall Study|Other|0
5878773|NCT01891669|20336858|P6|Overall Study|Other|0
5878774|NCT01891669|20336859|P5|Overall Study|Other|0
5878775|NCT01891669|20336860|P4|Overall Study|Other|0
5878776|NCT01891669|20336861|P3|Overall Study|Other|0
5878777|NCT01891669|20336862|P2|Overall Study|Other|0
5878778|NCT01891669|20336863|P1|Overall Study|Other|1
5878779|NCT01891669|20336854|P10|Overall Study|Withdrawal by Subject|1
5878780|NCT01891669|20336855|P9|Overall Study|Withdrawal by Subject|1
5878781|NCT01891669|20336856|P8|Overall Study|Withdrawal by Subject|2
5878782|NCT01891669|20336857|P7|Overall Study|Withdrawal by Subject|1
5878783|NCT01891669|20336858|P6|Overall Study|Withdrawal by Subject|0
5878784|NCT01891669|20336859|P5|Overall Study|Withdrawal by Subject|0
5878785|NCT01891669|20336860|P4|Overall Study|Withdrawal by Subject|0
5878786|NCT01891669|20336861|P3|Overall Study|Withdrawal by Subject|0
5878787|NCT01891669|20336862|P2|Overall Study|Withdrawal by Subject|1
5878788|NCT01891669|20336863|P1|Overall Study|Withdrawal by Subject|1
5878789|NCT01891669|20336854|P10|Overall Study|Death|1
5878790|NCT01891669|20336855|P9|Overall Study|Death|0
5878791|NCT01891669|20336856|P8|Overall Study|Death|1
5878792|NCT01891669|20336857|P7|Overall Study|Death|0
5878793|NCT01891669|20336858|P6|Overall Study|Death|0
5878794|NCT01891669|20336859|P5|Overall Study|Death|0
5878795|NCT01891669|20336860|P4|Overall Study|Death|0
5878796|NCT01891669|20336861|P3|Overall Study|Death|0
5878797|NCT01891669|20336862|P2|Overall Study|Death|0
5878798|NCT01891669|20336863|P1|Overall Study|Death|0
5878799|NCT01891357|20337014|P1|Overall Study|Protocol Violation|3
5878800|NCT01890967|20337061|P6|Overall Study|Withdrawal by Subject|1
5878801|NCT01890967|20337062|P5|Overall Study|Withdrawal by Subject|3
5878802|NCT01890967|20337063|P4|Overall Study|Withdrawal by Subject|3
5878803|NCT01890967|20337064|P3|Overall Study|Withdrawal by Subject|2
5878804|NCT01890967|20337065|P2|Overall Study|Withdrawal by Subject|4
5878805|NCT01890967|20337066|P1|Overall Study|Withdrawal by Subject|3
5878806|NCT01890967|20337061|P6|Overall Study|Sponsor Decision|3
5878807|NCT01890967|20337062|P5|Overall Study|Sponsor Decision|2
5878808|NCT01890967|20337063|P4|Overall Study|Sponsor Decision|3
5878809|NCT01890967|20337064|P3|Overall Study|Sponsor Decision|1
5878810|NCT01890967|20337065|P2|Overall Study|Sponsor Decision|0
5878811|NCT01890967|20337066|P1|Overall Study|Sponsor Decision|2
5878812|NCT01890967|20337061|P6|Overall Study|Protocol Violation|1
5878813|NCT01890967|20337062|P5|Overall Study|Protocol Violation|4
5878814|NCT01890967|20337063|P4|Overall Study|Protocol Violation|2
5878815|NCT01890967|20337064|P3|Overall Study|Protocol Violation|3
5878816|NCT01890967|20337065|P2|Overall Study|Protocol Violation|3
5878817|NCT01890967|20337066|P1|Overall Study|Protocol Violation|0
5878818|NCT01890967|20337061|P6|Overall Study|Lost to Follow-up|1
5878819|NCT01890967|20337062|P5|Overall Study|Lost to Follow-up|0
5878820|NCT01890967|20337063|P4|Overall Study|Lost to Follow-up|1
5878821|NCT01890967|20337064|P3|Overall Study|Lost to Follow-up|1
5878822|NCT01890967|20337065|P2|Overall Study|Lost to Follow-up|1
5878823|NCT01890967|20337066|P1|Overall Study|Lost to Follow-up|1
5878824|NCT01890967|20337061|P6|Overall Study|Death|0
5878825|NCT01890967|20337062|P5|Overall Study|Death|0
5878826|NCT01890967|20337063|P4|Overall Study|Death|0
5878827|NCT01890967|20337064|P3|Overall Study|Death|0
5878828|NCT01890967|20337065|P2|Overall Study|Death|0
5878829|NCT01890967|20337066|P1|Overall Study|Death|1
5878830|NCT01890967|20337061|P6|Overall Study|Adverse Event|7
5878831|NCT01890967|20337062|P5|Overall Study|Adverse Event|1
5878832|NCT01890967|20337063|P4|Overall Study|Adverse Event|2
5878833|NCT01890967|20337064|P3|Overall Study|Adverse Event|3
5878834|NCT01890967|20337065|P2|Overall Study|Adverse Event|3
5878835|NCT01890967|20337066|P1|Overall Study|Adverse Event|3
5878836|NCT01890915|20337144|P2|Overall Study|Equipment Malfunction|1
5878837|NCT01890915|20337145|P1|Overall Study|Equipment Malfunction|0
5878838|NCT01890915|20337144|P2|Overall Study|Protocol Violation|0
5878839|NCT01890915|20337145|P1|Overall Study|Protocol Violation|2
5878840|NCT01890915|20337144|P2|Overall Study|Adverse Event|0
5878841|NCT01890915|20337145|P1|Overall Study|Adverse Event|1
5878842|NCT01890785|20337161|P6|Third Intervention|Withdrawal by Subject|0
5878843|NCT01890785|20337162|P5|Third Intervention|Withdrawal by Subject|0
5878844|NCT01890785|20337163|P4|Third Intervention|Withdrawal by Subject|0
5878845|NCT01890785|20337164|P3|Third Intervention|Withdrawal by Subject|0
5878846|NCT01890785|20337165|P2|Third Intervention|Withdrawal by Subject|1
5878847|NCT01890785|20337166|P1|Third Intervention|Withdrawal by Subject|0
5878848|NCT01890759|20337185|P2|Overall Study|Withdrawal by Subject|8
5878849|NCT01890759|20337186|P1|Overall Study|Withdrawal by Subject|2
5878850|NCT01890759|20337185|P2|Overall Study|Lost to Follow-up|2
5878851|NCT01890759|20337186|P1|Overall Study|Lost to Follow-up|0
5878852|NCT01890759|20337185|P2|Overall Study|Protocol Violation|2
5878853|NCT01890759|20337186|P1|Overall Study|Protocol Violation|0
5878854|NCT01890746|20337220|P2|Overall Study|Withdrawal by Subject|8
5878855|NCT01890746|20337221|P1|Overall Study|Withdrawal by Subject|5
5878856|NCT01890746|20337220|P2|Overall Study|Physician Decision|2
5878857|NCT01890746|20337221|P1|Overall Study|Physician Decision|3
5878858|NCT01890746|20337220|P2|Overall Study|Lost to Follow-up|1
5878859|NCT01890746|20337221|P1|Overall Study|Lost to Follow-up|4
5878860|NCT01890746|20337220|P2|Overall Study|Adverse Event|0
5878861|NCT01890746|20337221|P1|Overall Study|Adverse Event|1
5878862|NCT01890746|20337220|P2|Overall Study|Death|30
5878863|NCT01890746|20337221|P1|Overall Study|Death|39
5878864|NCT01890707|20337307|P2|Overall Study|Lost to Follow-up|1
5878865|NCT01890707|20337308|P1|Overall Study|Lost to Follow-up|1
5878866|NCT01890512|20337387|P1|Overall Study|Protocol Violation|1
5878867|NCT01890512|20337387|P1|Overall Study|Withdrawal by Subject|1
5878868|NCT01890512|20337387|P1|Overall Study|Physician Decision|1
5878869|NCT01890473|20337393|P2|Overall Study|Poor/non-compliance|0
5878870|NCT01890473|20337394|P1|Overall Study|Poor/non-compliance|1
5878871|NCT01890473|20337393|P2|Overall Study|Lost to Follow-up|0
5878872|NCT01890473|20337394|P1|Overall Study|Lost to Follow-up|1
5878873|NCT01890434|20337420|P1|Overall Study|Withdrawal by PI for ICA not performed|2
5878874|NCT01890434|20337420|P1|Overall Study|Unable to contact|1
5878875|NCT01890434|20337420|P1|Overall Study|Moved out of position|1
5878876|NCT01890434|20337420|P1|Overall Study|Uncontactable by phone|1
5878877|NCT01890434|20337420|P1|Overall Study|Participant didn't complete MRI|1
5878878|NCT01890434|20337420|P1|Overall Study|GSPECT at rest was not done|1
5878879|NCT01890434|20337420|P1|Overall Study|Decline to return for GSPECT|1
5878880|NCT01890434|20337420|P1|Overall Study|Could not get whole set of images|1
5878881|NCT01890434|20337420|P1|Overall Study|CRC didn't contact participant for FU|1
5878882|NCT01890434|20337420|P1|Overall Study|Assessment discrepancy|1
5878883|NCT01890434|20337420|P1|Overall Study|PCI at external hospital|1
5878884|NCT01890434|20337420|P1|Overall Study|Adverse Event|8
5878885|NCT01890421|20337450|P1|Overall Study|Other reason|10
5878886|NCT01890421|20337450|P1|Overall Study|Adverse Event|1
5878887|NCT01890265|20337495|P6|Overall Study|Withdrawal by Subject|0
5878888|NCT01890265|20337496|P5|Overall Study|Withdrawal by Subject|2
5878889|NCT01890265|20337497|P4|Overall Study|Withdrawal by Subject|0
5878890|NCT01890265|20337498|P3|Overall Study|Withdrawal by Subject|3
5878891|NCT01890265|20337499|P2|Overall Study|Withdrawal by Subject|2
5878892|NCT01890265|20337500|P1|Overall Study|Withdrawal by Subject|0
5878893|NCT01890265|20337495|P6|Overall Study|Death|0
5878894|NCT01890265|20337496|P5|Overall Study|Death|0
5878895|NCT01890265|20337497|P4|Overall Study|Death|0
5878896|NCT01890265|20337498|P3|Overall Study|Death|1
5878897|NCT01890265|20337499|P2|Overall Study|Death|3
5878898|NCT01890265|20337500|P1|Overall Study|Death|2
5878899|NCT01890265|20337495|P6|Overall Study|Adverse Event|0
5878900|NCT01890265|20337496|P5|Overall Study|Adverse Event|0
5878901|NCT01890265|20337497|P4|Overall Study|Adverse Event|0
5878902|NCT01890265|20337498|P3|Overall Study|Adverse Event|0
5878903|NCT01890265|20337499|P2|Overall Study|Adverse Event|1
5878904|NCT01890265|20337500|P1|Overall Study|Adverse Event|2
5878905|NCT01890265|20337495|P6|Overall Study|Progressive disease|0
5878906|NCT01890265|20337496|P5|Overall Study|Progressive disease|0
5878907|NCT01890265|20337497|P4|Overall Study|Progressive disease|0
5878908|NCT01890265|20337498|P3|Overall Study|Progressive disease|0
5878909|NCT01890265|20337499|P2|Overall Study|Progressive disease|6
5878910|NCT01890265|20337500|P1|Overall Study|Progressive disease|6
5878911|NCT01890265|20337495|P6|Overall Study|Other (Unspecified reason)|0
5878912|NCT01890265|20337496|P5|Overall Study|Other (Unspecified reason)|0
5878913|NCT01890265|20337497|P4|Overall Study|Other (Unspecified reason)|0
5878914|NCT01890265|20337498|P3|Overall Study|Other (Unspecified reason)|0
5878915|NCT01890265|20337499|P2|Overall Study|Other (Unspecified reason)|1
5878916|NCT01890265|20337500|P1|Overall Study|Other (Unspecified reason)|0
5878917|NCT01890148|20337537|P1|Overall Study|Adverse Event|1
5878918|NCT01890122|20337557|P4|Overall Study|Randomized but not Treated|0
5878919|NCT01890122|20337558|P3|Overall Study|Randomized but not Treated|0
5878920|NCT01890122|20337559|P2|Overall Study|Randomized but not Treated|1
5878921|NCT01890122|20337560|P1|Overall Study|Randomized but not Treated|1
5878922|NCT01890122|20337557|P4|Overall Study|Reason not Specified|2
5878923|NCT01890122|20337558|P3|Overall Study|Reason not Specified|1
5878924|NCT01890122|20337559|P2|Overall Study|Reason not Specified|1
5878925|NCT01890122|20337560|P1|Overall Study|Reason not Specified|0
5878926|NCT01890122|20337557|P4|Overall Study|Lack of Efficacy|41
5878927|NCT01890122|20337558|P3|Overall Study|Lack of Efficacy|7
5878928|NCT01890122|20337559|P2|Overall Study|Lack of Efficacy|24
5878929|NCT01890122|20337560|P1|Overall Study|Lack of Efficacy|14
5878930|NCT01890122|20337557|P4|Overall Study|Voluntary Withdrawal|11
5878931|NCT01890122|20337558|P3|Overall Study|Voluntary Withdrawal|2
5878932|NCT01890122|20337559|P2|Overall Study|Voluntary Withdrawal|8
5878933|NCT01890122|20337560|P1|Overall Study|Voluntary Withdrawal|8
5878934|NCT01890122|20337557|P4|Overall Study|Lost to Follow-up|2
5878935|NCT01890122|20337558|P3|Overall Study|Lost to Follow-up|2
5878936|NCT01890122|20337559|P2|Overall Study|Lost to Follow-up|1
5878937|NCT01890122|20337560|P1|Overall Study|Lost to Follow-up|0
5878938|NCT01890122|20337557|P4|Overall Study|Major Protocol Deviation|1
5878939|NCT01890122|20337558|P3|Overall Study|Major Protocol Deviation|0
5878940|NCT01890122|20337559|P2|Overall Study|Major Protocol Deviation|1
5878941|NCT01890122|20337560|P1|Overall Study|Major Protocol Deviation|3
5878942|NCT01890122|20337557|P4|Overall Study|Adverse Event|2
5878943|NCT01890122|20337558|P3|Overall Study|Adverse Event|1
5878944|NCT01890122|20337559|P2|Overall Study|Adverse Event|1
5878945|NCT01890122|20337560|P1|Overall Study|Adverse Event|1
5878946|NCT01890109|20337624|P2|Overall Study|Lost to Follow-up|2
5878947|NCT01890109|20337625|P1|Overall Study|Lost to Follow-up|1
5878948|NCT01890109|20337624|P2|Overall Study|Withdrawal by Subject|3
5878949|NCT01890109|20337625|P1|Overall Study|Withdrawal by Subject|0
5878950|NCT01889602|20337730|P3|Third Intervention|Withdrawal by Subject|0
5878951|NCT01889602|20337731|P2|Third Intervention|Withdrawal by Subject|2
5878952|NCT01889602|20337732|P1|Third Intervention|Withdrawal by Subject|2
5878953|NCT01889602|20337730|P3|Third Intervention|Protocol Violation|0
5878954|NCT01889602|20337731|P2|Third Intervention|Protocol Violation|0
5878955|NCT01889602|20337732|P1|Third Intervention|Protocol Violation|1
5878956|NCT01889602|20337730|P3|Second Intervention|Withdrawal by Subject|1
5878957|NCT01889602|20337731|P2|Second Intervention|Withdrawal by Subject|0
5878958|NCT01889602|20337732|P1|Second Intervention|Withdrawal by Subject|0
5878959|NCT01889602|20337730|P3|Second Intervention|Study ending|0
5878960|NCT01889602|20337731|P2|Second Intervention|Study ending|0
5878961|NCT01889602|20337732|P1|Second Intervention|Study ending|1
5878962|NCT01889602|20337730|P3|Second Intervention|Adverse Event|1
5878963|NCT01889602|20337731|P2|Second Intervention|Adverse Event|0
5878964|NCT01889602|20337732|P1|Second Intervention|Adverse Event|0
5878965|NCT01889602|20337730|P3|First Intervention|Study ending|0
5878966|NCT01889602|20337731|P2|First Intervention|Study ending|1
5878967|NCT01889602|20337732|P1|First Intervention|Study ending|0
5878968|NCT01889602|20337730|P3|First Intervention|Protocol Violation|1
5878969|NCT01889602|20337731|P2|First Intervention|Protocol Violation|1
5878970|NCT01889602|20337732|P1|First Intervention|Protocol Violation|0
5878971|NCT01889602|20337730|P3|First Intervention|Adverse Event|1
5878972|NCT01889602|20337731|P2|First Intervention|Adverse Event|1
5878973|NCT01889602|20337732|P1|First Intervention|Adverse Event|1
5878974|NCT01889251|20337780|P2|Overall Study|Adverse Event|0
5878975|NCT01889251|20337781|P1|Overall Study|Adverse Event|1
5878976|NCT01889238|20337787|P1|Overall Study|Treatment ongoing|9
5878977|NCT01889069|20337806|P1|Overall Study|Consent Withdrawal|3
5878978|NCT01889069|20337806|P1|Overall Study|Other|4
5878979|NCT01889069|20337806|P1|Overall Study|Lost to Follow-up|6
5878980|NCT01889069|20337806|P1|Overall Study|Progression of Disease|14
5878981|NCT01889069|20337806|P1|Overall Study|Death|18
5878982|NCT01888965|20337851|P1|Overall Study|Lack of Efficacy|4
5878983|NCT01888965|20337851|P1|Overall Study|Adverse Event|5
5878984|NCT01888900|20337863|P2|Overall Study|failed treatment|2
5878985|NCT01888900|20337864|P1|Overall Study|failed treatment|0
5878986|NCT01888874|20337891|P7|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0
5878987|NCT01888874|20337892|P6|Period 2 (Week 13 to Week 24)|Lost to Follow-up|1
5878988|NCT01888874|20337893|P5|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0
5878989|NCT01888874|20337894|P4|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0
5878990|NCT01888874|20337895|P3|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0
5878991|NCT01888874|20337896|P2|Period 2 (Week 13 to Week 24)|Lost to Follow-up|1
5878992|NCT01888874|20337897|P1|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0
5878993|NCT01888874|20337891|P7|Period 2 (Week 13 to Week 24)|Adverse Event|3
5878994|NCT01888874|20337892|P6|Period 2 (Week 13 to Week 24)|Adverse Event|1
5878995|NCT01888874|20337893|P5|Period 2 (Week 13 to Week 24)|Adverse Event|1
5878996|NCT01888874|20337894|P4|Period 2 (Week 13 to Week 24)|Adverse Event|2
5878997|NCT01888874|20337895|P3|Period 2 (Week 13 to Week 24)|Adverse Event|3
5878998|NCT01888874|20337896|P2|Period 2 (Week 13 to Week 24)|Adverse Event|0
5878999|NCT01888874|20337897|P1|Period 2 (Week 13 to Week 24)|Adverse Event|2
5879000|NCT01888874|20337891|P7|Period 2 (Week 13 to Week 24)|Treatment failure|0
5879001|NCT01888874|20337892|P6|Period 2 (Week 13 to Week 24)|Treatment failure|0
5879002|NCT01888874|20337893|P5|Period 2 (Week 13 to Week 24)|Treatment failure|0
5879003|NCT01888874|20337894|P4|Period 2 (Week 13 to Week 24)|Treatment failure|0
5879004|NCT01888874|20337895|P3|Period 2 (Week 13 to Week 24)|Treatment failure|1
5879005|NCT01888874|20337896|P2|Period 2 (Week 13 to Week 24)|Treatment failure|0
5879006|NCT01888874|20337897|P1|Period 2 (Week 13 to Week 24)|Treatment failure|0
5879007|NCT01888874|20337891|P7|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0
5879008|NCT01888874|20337892|P6|Period 2 (Week 13 to Week 24)|Non compliance with study medication|1
5879009|NCT01888874|20337893|P5|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0
5879010|NCT01888874|20337894|P4|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0
5879011|NCT01888874|20337895|P3|Period 2 (Week 13 to Week 24)|Non compliance with study medication|2
5879012|NCT01888874|20337896|P2|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0
5879013|NCT01888874|20337897|P1|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0
5879014|NCT01888874|20337891|P7|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0
5879015|NCT01888874|20337892|P6|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0
5879016|NCT01888874|20337893|P5|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|1
5879017|NCT01888874|20337894|P4|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0
5879018|NCT01888874|20337895|P3|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0
5879019|NCT01888874|20337896|P2|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0
5879020|NCT01888874|20337897|P1|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0
5879021|NCT01888874|20337891|P7|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0
5879022|NCT01888874|20337892|P6|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0
5879023|NCT01888874|20337893|P5|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1
5879024|NCT01888874|20337894|P4|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0
5879025|NCT01888874|20337895|P3|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|2
5879026|NCT01888874|20337896|P2|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1
5879027|NCT01888874|20337897|P1|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1
5879028|NCT01888874|20337891|P7|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0
5879029|NCT01888874|20337892|P6|Period 1 (Baseline up to Week 12)|Lost to Follow-up|1
5879030|NCT01888874|20337893|P5|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0
5879031|NCT01888874|20337894|P4|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0
5879032|NCT01888874|20337895|P3|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0
5879033|NCT01888874|20337896|P2|Period 1 (Baseline up to Week 12)|Lost to Follow-up|1
5879034|NCT01888874|20337897|P1|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0
5879035|NCT01888874|20337891|P7|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0
5879036|NCT01888874|20337892|P6|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0
5879037|NCT01888874|20337893|P5|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0
5879038|NCT01888874|20337894|P4|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0
5879039|NCT01888874|20337895|P3|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0
5879040|NCT01888874|20337896|P2|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|1
5879041|NCT01888874|20337897|P1|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0
5879042|NCT01888874|20337891|P7|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0
5879043|NCT01888874|20337892|P6|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0
5879044|NCT01888874|20337893|P5|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|1
5879045|NCT01888874|20337894|P4|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0
5879046|NCT01888874|20337895|P3|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0
5879047|NCT01888874|20337896|P2|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0
5879048|NCT01888874|20337897|P1|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0
5879049|NCT01888874|20337891|P7|Period 1 (Baseline up to Week 12)|Adverse Event|0
5879050|NCT01888874|20337892|P6|Period 1 (Baseline up to Week 12)|Adverse Event|1
5879051|NCT01888874|20337893|P5|Period 1 (Baseline up to Week 12)|Adverse Event|2
5879052|NCT01888874|20337894|P4|Period 1 (Baseline up to Week 12)|Adverse Event|1
5879053|NCT01888874|20337895|P3|Period 1 (Baseline up to Week 12)|Adverse Event|3
5879054|NCT01888874|20337896|P2|Period 1 (Baseline up to Week 12)|Adverse Event|2
5879055|NCT01888874|20337897|P1|Period 1 (Baseline up to Week 12)|Adverse Event|0
5879056|NCT01888874|20337891|P7|Period 1 (Baseline up to Week 12)|Physician Decision|1
5879057|NCT01888874|20337892|P6|Period 1 (Baseline up to Week 12)|Physician Decision|0
5879058|NCT01888874|20337893|P5|Period 1 (Baseline up to Week 12)|Physician Decision|0
5879059|NCT01888874|20337894|P4|Period 1 (Baseline up to Week 12)|Physician Decision|0
5879060|NCT01888874|20337895|P3|Period 1 (Baseline up to Week 12)|Physician Decision|0
5879061|NCT01888874|20337896|P2|Period 1 (Baseline up to Week 12)|Physician Decision|0
5879062|NCT01888874|20337897|P1|Period 1 (Baseline up to Week 12)|Physician Decision|0
5879063|NCT01888874|20337891|P7|Period 1 (Baseline up to Week 12)|Other|0
5879064|NCT01888874|20337892|P6|Period 1 (Baseline up to Week 12)|Other|3
5879065|NCT01888874|20337893|P5|Period 1 (Baseline up to Week 12)|Other|3
5879066|NCT01888874|20337894|P4|Period 1 (Baseline up to Week 12)|Other|1
5879067|NCT01888874|20337895|P3|Period 1 (Baseline up to Week 12)|Other|1
5879068|NCT01888874|20337896|P2|Period 1 (Baseline up to Week 12)|Other|0
5879069|NCT01888874|20337897|P1|Period 1 (Baseline up to Week 12)|Other|1
5879070|NCT01888874|20337891|P7|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|0
5879071|NCT01888874|20337892|P6|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|0
5879072|NCT01888874|20337893|P5|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3
5879073|NCT01888874|20337894|P4|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|4
5879074|NCT01888874|20337895|P3|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3
5879075|NCT01888874|20337896|P2|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2
5879076|NCT01888874|20337897|P1|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2
5879077|NCT01888640|20337986|P3|Overall Study|Researcher Termination of Participant|1
5879078|NCT01888640|20337987|P2|Overall Study|Researcher Termination of Participant|1
5879079|NCT01888640|20337988|P1|Overall Study|Researcher Termination of Participant|0
5879080|NCT01888640|20337986|P3|Overall Study|Excluded for prior TENS|0
5879081|NCT01888640|20337987|P2|Overall Study|Excluded for prior TENS|1
5879082|NCT01888640|20337988|P1|Overall Study|Excluded for prior TENS|0
5879083|NCT01888640|20337986|P3|Overall Study|Given wrong unit (placebo)|0
5879084|NCT01888640|20337987|P2|Overall Study|Given wrong unit (placebo)|0
5879085|NCT01888640|20337988|P1|Overall Study|Given wrong unit (placebo)|1
5879086|NCT01888640|20337986|P3|Overall Study|Minimum dose not met|0
5879087|NCT01888640|20337987|P2|Overall Study|Minimum dose not met|16
5879088|NCT01888640|20337988|P1|Overall Study|Minimum dose not met|10
5879089|NCT01888640|20337986|P3|Overall Study|Withdrawal by Subject|4
5879090|NCT01888640|20337987|P2|Overall Study|Withdrawal by Subject|11
5879091|NCT01888640|20337988|P1|Overall Study|Withdrawal by Subject|15
5879092|NCT01888640|20337986|P3|Overall Study|Lost to Follow-up|0
5879093|NCT01888640|20337987|P2|Overall Study|Lost to Follow-up|2
5879094|NCT01888640|20337988|P1|Overall Study|Lost to Follow-up|1
5879095|NCT01888432|20338044|P2|36-month Analysis (Extension)|Death|0
5879096|NCT01888432|20338045|P1|36-month Analysis (Extension)|Death|1
5879097|NCT01888432|20338044|P2|24-month Analysis (FAS)|Death|4
5879098|NCT01888432|20338045|P1|24-month Analysis (FAS)|Death|8
5879099|NCT01888432|20338044|P2|24-month Analysis (FAS)|Withdrawal by Subject|6
5879100|NCT01888432|20338045|P1|24-month Analysis (FAS)|Withdrawal by Subject|7
5879101|NCT01888432|20338044|P2|24-month Analysis (FAS)|Physician Decision|4
5879102|NCT01888432|20338045|P1|24-month Analysis (FAS)|Physician Decision|2
5879103|NCT01888432|20338044|P2|24-month Analysis (FAS)|Lost to Follow-up|2
5879104|NCT01888432|20338045|P1|24-month Analysis (FAS)|Lost to Follow-up|0
5879105|NCT01888432|20338044|P2|24-month Analysis (FAS)|Graft loss|1
5879106|NCT01888432|20338045|P1|24-month Analysis (FAS)|Graft loss|0
5879107|NCT01888432|20338044|P2|12-month Analysis (FAS)|Death|3
5879108|NCT01888432|20338045|P1|12-month Analysis (FAS)|Death|4
5879109|NCT01888432|20338044|P2|12-month Analysis (FAS)|Withdrawal by Subject|3
5879110|NCT01888432|20338045|P1|12-month Analysis (FAS)|Withdrawal by Subject|6
5879111|NCT01888432|20338044|P2|12-month Analysis (FAS)|Physician Decision|1
5879112|NCT01888432|20338045|P1|12-month Analysis (FAS)|Physician Decision|1
5879113|NCT01888432|20338044|P2|12-month Analysis (FAS)|Lost to Follow-up|2
5879114|NCT01888432|20338045|P1|12-month Analysis (FAS)|Lost to Follow-up|0
5879115|NCT01888367|20338086|P3|Overall Study|30-Day Visit Too Early (< 28 Days)|0
5879116|NCT01888367|20338087|P2|Overall Study|30-Day Visit Too Early (< 28 Days)|0
5879117|NCT01888367|20338088|P1|Overall Study|30-Day Visit Too Early (< 28 Days)|1
5879118|NCT01888367|20338086|P3|Overall Study|Protocol Violation|1
5879119|NCT01888367|20338087|P2|Overall Study|Protocol Violation|0
5879120|NCT01888367|20338088|P1|Overall Study|Protocol Violation|0
5879121|NCT01888367|20338086|P3|Overall Study|Lost to Follow-up|0
5879122|NCT01888367|20338087|P2|Overall Study|Lost to Follow-up|1
5879123|NCT01888367|20338088|P1|Overall Study|Lost to Follow-up|1
5879124|NCT01888367|20338086|P3|Overall Study|Withdrawal by Subject|1
5879125|NCT01888367|20338087|P2|Overall Study|Withdrawal by Subject|0
5879126|NCT01888367|20338088|P1|Overall Study|Withdrawal by Subject|1
5879127|NCT01888367|20338086|P3|Overall Study|Death|1
5879128|NCT01888367|20338087|P2|Overall Study|Death|0
5879129|NCT01888367|20338088|P1|Overall Study|Death|2
5879130|NCT01888367|20338086|P3|Overall Study|Physician Decision|2
5879131|NCT01888367|20338087|P2|Overall Study|Physician Decision|4
5879132|NCT01888367|20338088|P1|Overall Study|Physician Decision|3
5879133|NCT01888003|20338108|P3|Overall Study|Study Terminated|40
5879134|NCT01888003|20338109|P2|Overall Study|Study Terminated|6
5879135|NCT01888003|20338110|P1|Overall Study|Study Terminated|5
5879136|NCT01887912|20338150|P2|Overall Study|Other|58
5879137|NCT01887912|20338151|P1|Overall Study|Other|122
5879138|NCT01887912|20338150|P2|Overall Study|Withdrawal by Subject|349
5879139|NCT01887912|20338151|P1|Overall Study|Withdrawal by Subject|606
5879140|NCT01887912|20338150|P2|Overall Study|Lost to Follow-up|74
5879141|NCT01887912|20338151|P1|Overall Study|Lost to Follow-up|163
5879142|NCT01887912|20338150|P2|Overall Study|Protocol Violation|37
5879143|NCT01887912|20338151|P1|Overall Study|Protocol Violation|67
5879144|NCT01887912|20338150|P2|Overall Study|Other Adverse Event|15
5879145|NCT01887912|20338151|P1|Overall Study|Other Adverse Event|34
5879146|NCT01887912|20338150|P2|Overall Study|Serious adverse event|198
5879147|NCT01887912|20338151|P1|Overall Study|Serious adverse event|400
5879148|NCT01887717|20338179|P2|Overall Study|Administrative reasons|2
5879149|NCT01887717|20338180|P1|Overall Study|Administrative reasons|5
5879150|NCT01887717|20338179|P2|Overall Study|Physician Decision|2
5879151|NCT01887717|20338180|P1|Overall Study|Physician Decision|0
5879152|NCT01887717|20338179|P2|Overall Study|Withdrawal by Subject|7
5879153|NCT01887717|20338180|P1|Overall Study|Withdrawal by Subject|1
5879154|NCT01887678|20338202|P2|Overall Study|Specified|2
5879155|NCT01887678|20338203|P1|Overall Study|Specified|1
5879156|NCT01887678|20338202|P2|Overall Study|Non-compliance|3
5879157|NCT01887678|20338203|P1|Overall Study|Non-compliance|0
5879158|NCT01887678|20338202|P2|Overall Study|Lack of Efficacy|2
5879159|NCT01887678|20338203|P1|Overall Study|Lack of Efficacy|1
5879160|NCT01887678|20338202|P2|Overall Study|Deterioration of clinical condition|4
5879161|NCT01887678|20338203|P1|Overall Study|Deterioration of clinical condition|0
5879162|NCT01887678|20338202|P2|Overall Study|Lost to Follow-up|2
5879163|NCT01887678|20338203|P1|Overall Study|Lost to Follow-up|4
5879164|NCT01887678|20338202|P2|Overall Study|Withdrawal of consent|4
5879165|NCT01887678|20338203|P1|Overall Study|Withdrawal of consent|3
5879166|NCT01887678|20338202|P2|Overall Study|Exceeded rescue medication dosage|5
5879167|NCT01887678|20338203|P1|Overall Study|Exceeded rescue medication dosage|4
5879168|NCT01887678|20338202|P2|Overall Study|Adverse Event|6
5879169|NCT01887678|20338203|P1|Overall Study|Adverse Event|4
5879190|NCT01887418|20338389|P3|Overall Study|Travelling difficulties|1
5879191|NCT01887418|20338390|P2|Overall Study|Travelling difficulties|0
5879192|NCT01887418|20338391|P1|Overall Study|Travelling difficulties|0
5879193|NCT01887353|20338410|P2|Overall Study|Study stopped early|3
5879194|NCT01887353|20338411|P1|Overall Study|Study stopped early|4
5879195|NCT01887288|20338439|P1|Overall Study|The study was terminated and the PI has|16
5879196|NCT01887210|20338446|P2|Overall Study|Lost to Follow-up|1
5879197|NCT01887210|20338447|P1|Overall Study|Lost to Follow-up|0
5879198|NCT01887210|20338446|P2|Overall Study|Withdrawal by Subject|3
5879199|NCT01887210|20338447|P1|Overall Study|Withdrawal by Subject|1
5879200|NCT01886872|20338494|P3|Overall Study|Ineligible|12
5879201|NCT01886872|20338495|P2|Overall Study|Ineligible|4
5879202|NCT01886872|20338496|P1|Overall Study|Ineligible|7
5879203|NCT01886833|20338529|P1|Overall Study|IgA not available from both periods|204
5879204|NCT01886781|20338561|P2|Overall Study|Worsening of symptoms|1
5879205|NCT01886781|20338562|P1|Overall Study|Worsening of symptoms|1
5879206|NCT01886781|20338561|P2|Overall Study|Withdrawal by Subject|1
5879207|NCT01886781|20338562|P1|Overall Study|Withdrawal by Subject|2
5879208|NCT01886781|20338561|P2|Overall Study|Lost to Follow-up|0
5879209|NCT01886781|20338562|P1|Overall Study|Lost to Follow-up|5
5879210|NCT01886781|20338561|P2|Overall Study|Adverse Event|0
5879211|NCT01886781|20338562|P1|Overall Study|Adverse Event|1
5879212|NCT01886781|20338561|P2|Overall Study|Protocol Violation|0
5879213|NCT01886781|20338562|P1|Overall Study|Protocol Violation|5
5879214|NCT01886716|20338572|P4|Week 3|Lost to Follow-up|1
5879215|NCT01886716|20338573|P3|Week 3|Lost to Follow-up|0
5879216|NCT01886716|20338574|P2|Week 3|Lost to Follow-up|1
5879217|NCT01886716|20338575|P1|Week 3|Lost to Follow-up|1
5879218|NCT01886716|20338572|P4|Week 2|Lost to Follow-up|3
5879219|NCT01886716|20338573|P3|Week 2|Lost to Follow-up|1
5879220|NCT01886716|20338574|P2|Week 2|Lost to Follow-up|2
5879221|NCT01886716|20338575|P1|Week 2|Lost to Follow-up|3
5879222|NCT01886716|20338572|P4|Week 1|Lost to Follow-up|2
5879223|NCT01886716|20338573|P3|Week 1|Lost to Follow-up|2
5879224|NCT01886716|20338574|P2|Week 1|Lost to Follow-up|0
5879225|NCT01886716|20338575|P1|Week 1|Lost to Follow-up|0
5879226|NCT01886690|20338591|P2|Overall Study|Personal Reasons|1
5879227|NCT01886690|20338592|P1|Overall Study|Personal Reasons|0
5879228|NCT01886690|20338591|P2|Overall Study|Protocol Violation|1
5879229|NCT01886690|20338592|P1|Overall Study|Protocol Violation|0
5879230|NCT01886313|20338608|P2|Overall Study|Adverse Event|1
5879231|NCT01886313|20338609|P1|Overall Study|Adverse Event|1
5879232|NCT01886300|20338615|P1|Overall Study|Trial terminated by sponsor|16
5879233|NCT01886287|20338626|P1|Overall Study|Clinical progression due to disease|1
5879234|NCT01886287|20338626|P1|Overall Study|Radiographic disease progression|1
5879235|NCT01886105|20338642|P1|Overall Study|Lack of Efficacy|3
5879236|NCT01885936|20338649|P2|Overall Study|Withdrawal by Subject|0
5879237|NCT01885936|20338650|P1|Overall Study|Withdrawal by Subject|1
5879238|NCT01885559|20338733|P2|Overall Study|Protocol Violation|1
5879239|NCT01885559|20338734|P1|Overall Study|Protocol Violation|0
5879240|NCT01885559|20338733|P2|Overall Study|Less than full participation|19
5879241|NCT01885559|20338734|P1|Overall Study|Less than full participation|9
5879242|NCT01885559|20338733|P2|Overall Study|Lost to Follow-up|16
5879243|NCT01885559|20338734|P1|Overall Study|Lost to Follow-up|15
5879244|NCT01885208|20338756|P2|Overall Study|Unclassified|38
5879245|NCT01885208|20338757|P1|Overall Study|Unclassified|32
5879246|NCT01885182|20338775|P2|Overall Study|Lack of Efficacy|1
5879247|NCT01885182|20338776|P1|Overall Study|Lack of Efficacy|8
5879248|NCT01885182|20338775|P2|Overall Study|Lost to Follow-up|2
5879249|NCT01885182|20338776|P1|Overall Study|Lost to Follow-up|2
5879250|NCT01885182|20338775|P2|Overall Study|Withdrawal by Subject|6
5879251|NCT01885182|20338776|P1|Overall Study|Withdrawal by Subject|13
5879252|NCT01885182|20338775|P2|Overall Study|Adverse Event|13
5879253|NCT01885182|20338776|P1|Overall Study|Adverse Event|11
5879254|NCT01885104|20338823|P2|Overall Study|Physician Decision|0
5879255|NCT01885104|20338824|P1|Overall Study|Physician Decision|1
5879256|NCT01885104|20338823|P2|Overall Study|Lost to Follow-up|1
5879257|NCT01885104|20338824|P1|Overall Study|Lost to Follow-up|0
5879258|NCT01885104|20338823|P2|Overall Study|Withdrawal of Consent|0
5879259|NCT01885104|20338824|P1|Overall Study|Withdrawal of Consent|1
5879260|NCT01885000|20338834|P2|Overall Study|Protocol Violation|1
5879261|NCT01885000|20338835|P1|Overall Study|Protocol Violation|0
5879262|NCT01885000|20338834|P2|Overall Study|Withdrawal by Subject|1
5879263|NCT01885000|20338835|P1|Overall Study|Withdrawal by Subject|1
5879264|NCT01885000|20338834|P2|Overall Study|Adverse Event|0
5879265|NCT01885000|20338835|P1|Overall Study|Adverse Event|1
5879266|NCT01884688|20338856|P1|Overall Study|Screen Failure|2
5879267|NCT01884675|20338862|P2|Overall Study|Study closed/terminated|2
5879268|NCT01884675|20338863|P1|Overall Study|Study closed/terminated|3
5879269|NCT01884597|20338906|P3|Overall Study|Death|0
5879270|NCT01884597|20338907|P2|Overall Study|Death|1
5879271|NCT01884597|20338908|P1|Overall Study|Death|0
5879272|NCT01884597|20338906|P3|Overall Study|Lack of Efficacy|0
5879273|NCT01884597|20338907|P2|Overall Study|Lack of Efficacy|0
5879274|NCT01884597|20338908|P1|Overall Study|Lack of Efficacy|1
5879275|NCT01884597|20338906|P3|Overall Study|Adverse Event|1
5879276|NCT01884597|20338907|P2|Overall Study|Adverse Event|0
5879277|NCT01884597|20338908|P1|Overall Study|Adverse Event|0
5879278|NCT01884571|20338937|P1|Overall Study|Disease progression|3
5879279|NCT01884571|20338937|P1|Overall Study|Withdrawal by Subject|2
5879280|NCT01884571|20338937|P1|Overall Study|Death|2
5879281|NCT01884571|20338937|P1|Overall Study|Adverse Event|1
5879282|NCT01884545|20338952|P4|Overall Study|Non-adherence|0
5879283|NCT01884545|20338953|P3|Overall Study|Non-adherence|0
5879284|NCT01884545|20338954|P2|Overall Study|Non-adherence|2
5879285|NCT01884545|20338955|P1|Overall Study|Non-adherence|0
5879286|NCT01884545|20338952|P4|Overall Study|Patient withdrawn|5
5879287|NCT01884545|20338953|P3|Overall Study|Patient withdrawn|5
5879288|NCT01884545|20338954|P2|Overall Study|Patient withdrawn|12
5879289|NCT01884545|20338955|P1|Overall Study|Patient withdrawn|7
5879290|NCT01884545|20338952|P4|Overall Study|Lost to Follow-up|4
5879291|NCT01884545|20338953|P3|Overall Study|Lost to Follow-up|9
5879292|NCT01884545|20338954|P2|Overall Study|Lost to Follow-up|4
5879293|NCT01884545|20338955|P1|Overall Study|Lost to Follow-up|6
5879294|NCT01884350|20339108|P3|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0
5879295|NCT01884350|20339109|P2|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0
5879296|NCT01884350|20339110|P1|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|2
5879297|NCT01884350|20339108|P3|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0
5879298|NCT01884350|20339109|P2|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0
5879299|NCT01884350|20339110|P1|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|1
5879300|NCT01884350|20339108|P3|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|0
5879301|NCT01884350|20339109|P2|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|1
5879302|NCT01884350|20339110|P1|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|4
5879303|NCT01884350|20339108|P3|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0
5879304|NCT01884350|20339109|P2|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0
5879305|NCT01884350|20339110|P1|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|3
5879306|NCT01884350|20339108|P3|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0
5879307|NCT01884350|20339109|P2|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0
5879308|NCT01884350|20339110|P1|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|4
5879309|NCT01884350|20339108|P3|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|2
5879310|NCT01884350|20339109|P2|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|0
5879311|NCT01884350|20339110|P1|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|3
5879312|NCT01884350|20339108|P3|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|0
5879313|NCT01884350|20339109|P2|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|3
5879314|NCT01884350|20339110|P1|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|17
5879315|NCT01884350|20339108|P3|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|3
5879316|NCT01884350|20339109|P2|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|6
5879317|NCT01884350|20339110|P1|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|17
5879318|NCT01884350|20339108|P3|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1
5879319|NCT01884350|20339109|P2|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|0
5879320|NCT01884350|20339110|P1|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1
5879321|NCT01884350|20339108|P3|Primary Efficacy Analysis Set (48 Weeks)|Death|3
5879322|NCT01884350|20339109|P2|Primary Efficacy Analysis Set (48 Weeks)|Death|3
5879323|NCT01884350|20339110|P1|Primary Efficacy Analysis Set (48 Weeks)|Death|7
5879324|NCT01884350|20339108|P3|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|2
5879325|NCT01884350|20339109|P2|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|0
5879326|NCT01884350|20339110|P1|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|21
5879327|NCT01884350|20339108|P3|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|0
5879328|NCT01884350|20339109|P2|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3
5879329|NCT01884350|20339110|P1|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3
5879330|NCT01884350|20339108|P3|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|0
5879331|NCT01884350|20339109|P2|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1
5879332|NCT01884350|20339110|P1|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1
5879333|NCT01884350|20339108|P3|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|0
5879334|NCT01884350|20339109|P2|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1
5879335|NCT01884350|20339110|P1|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1
5879336|NCT01884350|20339108|P3|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0
5879337|NCT01884350|20339109|P2|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0
5879338|NCT01884350|20339110|P1|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|2
5879339|NCT01884350|20339108|P3|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|0
5879340|NCT01884350|20339109|P2|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|5
5879341|NCT01884350|20339110|P1|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|2
5879342|NCT01884350|20339108|P3|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0
5879343|NCT01884350|20339109|P2|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|2
5879344|NCT01884350|20339110|P1|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0
5879345|NCT01884350|20339108|P3|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|0
5879346|NCT01884350|20339109|P2|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|11
5879347|NCT01884350|20339110|P1|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|15
5879348|NCT01884350|20339108|P3|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|0
5879349|NCT01884350|20339109|P2|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|6
5879350|NCT01884350|20339110|P1|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|7
5879351|NCT01884350|20339108|P3|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0
5879352|NCT01884350|20339109|P2|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|1
5879353|NCT01884350|20339110|P1|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0
5879354|NCT01884350|20339108|P3|Primary Efficacy Analysis Set (24 Weeks)|Death|0
5879355|NCT01884350|20339109|P2|Primary Efficacy Analysis Set (24 Weeks)|Death|4
5879356|NCT01884350|20339110|P1|Primary Efficacy Analysis Set (24 Weeks)|Death|6
5879357|NCT01884350|20339108|P3|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|0
5879358|NCT01884350|20339109|P2|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|20
5879359|NCT01884350|20339110|P1|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|17
5879360|NCT01884337|20339133|P2|Follow-up Period|Lost to Follow-up|1
5879361|NCT01884337|20339134|P1|Follow-up Period|Lost to Follow-up|1
5879362|NCT01884337|20339133|P2|Treatment|Subj. request to discont. treatment|0
5879363|NCT01884337|20339134|P1|Treatment|Subj. request to discont. treatment|2
5879364|NCT01884337|20339133|P2|Treatment|Adverse Event|2
5879365|NCT01884337|20339134|P1|Treatment|Adverse Event|2
5879366|NCT01884311|20339142|P1|Overall Study|Precautionary measure|1
5879367|NCT01884311|20339142|P1|Overall Study|withdrew consent due to AEs|1
5879368|NCT01884311|20339142|P1|Overall Study|Withdrawal by Subject|3
5879369|NCT01884077|20339152|P2|Overall Study|study closed|4
5879370|NCT01884077|20339153|P1|Overall Study|study closed|6
5879371|NCT01884077|20339152|P2|Overall Study|Lost to Follow-up|4
5879372|NCT01884077|20339153|P1|Overall Study|Lost to Follow-up|0
5879373|NCT01884077|20339152|P2|Overall Study|canceled surgery|0
5879374|NCT01884077|20339153|P1|Overall Study|canceled surgery|2
5879375|NCT01884077|20339152|P2|Overall Study|screen fail|2
5879376|NCT01884077|20339153|P1|Overall Study|screen fail|0
5879377|NCT01884025|20339174|P2|Overall Study|Lost to Follow-up|4
5879378|NCT01884025|20339175|P1|Overall Study|Lost to Follow-up|3
5879379|NCT01883895|20339235|P1|Overall Study|Lost to Follow-up|2
5879380|NCT01883635|20339262|P2|Overall Study|Withdrawal by Subject|0
5879381|NCT01883635|20339263|P1|Overall Study|Withdrawal by Subject|4
5879382|NCT01883492|20339277|P2|Overall Study|bone anatomy did not meet study criteria|1
5879383|NCT01883492|20339278|P1|Overall Study|bone anatomy did not meet study criteria|1
5879384|NCT01883492|20339277|P2|Overall Study|inappropriate implant used|1
5879385|NCT01883492|20339278|P1|Overall Study|inappropriate implant used|1
5879386|NCT01883492|20339277|P2|Overall Study|Withdrawal by Subject|0
5879387|NCT01883492|20339278|P1|Overall Study|Withdrawal by Subject|1
5879388|NCT01883492|20339277|P2|Overall Study|Poor X-ray quality|4
5879389|NCT01883492|20339278|P1|Overall Study|Poor X-ray quality|7
5879390|NCT01883492|20339277|P2|Overall Study|Surgery on contra-lateral hip|1
5879391|NCT01883492|20339278|P1|Overall Study|Surgery on contra-lateral hip|0
5879392|NCT01883492|20339277|P2|Overall Study|Lost to Follow-up|4
5879393|NCT01883492|20339278|P1|Overall Study|Lost to Follow-up|3
5879394|NCT01883453|20339310|P2|Overall Study|No episode of common cold|23
5879395|NCT01883453|20339311|P1|Overall Study|No episode of common cold|25
5879396|NCT01882985|20339346|P1|Overall Study|Withdrawal by Subject|1
5879397|NCT01882985|20339346|P1|Overall Study|Lost to Follow-up|1
5879398|NCT01882907|20339355|P2|Overall Study|Withdrawal by Subject|6
5879399|NCT01882907|20339356|P1|Overall Study|Withdrawal by Subject|0
5879400|NCT01882907|20339355|P2|Overall Study|Protocol Violation|14
5879401|NCT01882907|20339356|P1|Overall Study|Protocol Violation|10
5879402|NCT01882907|20339355|P2|Overall Study|Lost to Follow-up|4
5879403|NCT01882907|20339356|P1|Overall Study|Lost to Follow-up|1
5879404|NCT01882907|20339355|P2|Overall Study|Lack of Efficacy|3
5879405|NCT01882907|20339356|P1|Overall Study|Lack of Efficacy|0
5879406|NCT01882907|20339355|P2|Overall Study|Adverse Event|1
5879407|NCT01882907|20339356|P1|Overall Study|Adverse Event|3
5879408|NCT01882829|20339402|P1|Overall Study|Withdrawal by Subject|1
5879409|NCT01882829|20339402|P1|Overall Study|Protocol Violation|1
5879410|NCT01882829|20339402|P1|Overall Study|Adverse Event|4
5879411|NCT01882803|20339416|P1|Overall Study|Withdrawal by Subject|4
5879412|NCT01882803|20339416|P1|Overall Study|Protocol Violation|1
5879413|NCT01882803|20339416|P1|Overall Study|Physician Decision|7
5879414|NCT01882803|20339416|P1|Overall Study|Death|7
5879415|NCT01882803|20339416|P1|Overall Study|Adverse Event|22
5879416|NCT01882803|20339416|P1|Overall Study|Disease Progression|53
5879417|NCT01882647|20339443|P2|Overall Study|Withdrawal by Subject|4
5879418|NCT01882647|20339444|P1|Overall Study|Withdrawal by Subject|0
5879419|NCT01882647|20339443|P2|Overall Study|Lost to Follow-up|2
5879420|NCT01882647|20339444|P1|Overall Study|Lost to Follow-up|2
5879421|NCT01882465|20339484|P7|Period 2|Protocol Violation|0
5879422|NCT01882465|20339485|P6|Period 2|Protocol Violation|0
5879423|NCT01882465|20339486|P5|Period 2|Protocol Violation|1
5879424|NCT01882465|20339487|P4|Period 2|Protocol Violation|0
5879425|NCT01882465|20339488|P3|Period 2|Protocol Violation|0
5879426|NCT01882465|20339489|P2|Period 2|Protocol Violation|0
5879427|NCT01882465|20339490|P1|Period 2|Protocol Violation|0
5879428|NCT01882465|20339484|P7|Period 1|Withdrawal by Subject|1
5879429|NCT01882465|20339485|P6|Period 1|Withdrawal by Subject|0
5879430|NCT01882465|20339486|P5|Period 1|Withdrawal by Subject|0
5879431|NCT01882465|20339487|P4|Period 1|Withdrawal by Subject|0
5879432|NCT01882465|20339488|P3|Period 1|Withdrawal by Subject|0
5879433|NCT01882465|20339489|P2|Period 1|Withdrawal by Subject|0
5879434|NCT01882465|20339490|P1|Period 1|Withdrawal by Subject|0
5879435|NCT01882465|20339484|P7|Period 1|Lens Discomfort|0
5879436|NCT01882465|20339485|P6|Period 1|Lens Discomfort|0
5879437|NCT01882465|20339486|P5|Period 1|Lens Discomfort|0
5879438|NCT01882465|20339487|P4|Period 1|Lens Discomfort|1
5879439|NCT01882465|20339488|P3|Period 1|Lens Discomfort|0
5879440|NCT01882465|20339489|P2|Period 1|Lens Discomfort|0
5879441|NCT01882465|20339490|P1|Period 1|Lens Discomfort|0
5879442|NCT01882439|20339502|P4|Overall Study|Adverse event unrelated to study drug|1
5879443|NCT01882439|20339503|P3|Overall Study|Adverse event unrelated to study drug|1
5879444|NCT01882439|20339504|P2|Overall Study|Adverse event unrelated to study drug|2
5879445|NCT01882439|20339505|P1|Overall Study|Adverse event unrelated to study drug|2
5879446|NCT01882439|20339502|P4|Overall Study|Insufficient clinical response|2
5879447|NCT01882439|20339503|P3|Overall Study|Insufficient clinical response|4
5879448|NCT01882439|20339504|P2|Overall Study|Insufficient clinical response|4
5879449|NCT01882439|20339505|P1|Overall Study|Insufficient clinical response|1
5879450|NCT01882439|20339502|P4|Overall Study|Medication error with no associated AE|0
5879451|NCT01882439|20339503|P3|Overall Study|Medication error with no associated AE|2
5879452|NCT01882439|20339504|P2|Overall Study|Medication error with no associated AE|0
5879453|NCT01882439|20339505|P1|Overall Study|Medication error with no associated AE|0
5879454|NCT01882439|20339502|P4|Overall Study|No longer willing to participate|3
5879455|NCT01882439|20339503|P3|Overall Study|No longer willing to participate|2
5879456|NCT01882439|20339504|P2|Overall Study|No longer willing to participate|4
5879457|NCT01882439|20339505|P1|Overall Study|No longer willing to participate|1
5879458|NCT01882439|20339502|P4|Overall Study|Protocol Violation|1
5879459|NCT01882439|20339503|P3|Overall Study|Protocol Violation|0
5879460|NCT01882439|20339504|P2|Overall Study|Protocol Violation|2
5879461|NCT01882439|20339505|P1|Overall Study|Protocol Violation|2
5879462|NCT01882439|20339502|P4|Overall Study|Pregnancy|0
5879463|NCT01882439|20339503|P3|Overall Study|Pregnancy|0
5879464|NCT01882439|20339504|P2|Overall Study|Pregnancy|1
5879465|NCT01882439|20339505|P1|Overall Study|Pregnancy|0
5879466|NCT01882439|20339502|P4|Overall Study|Adverse event related to study drug|2
5879467|NCT01882439|20339503|P3|Overall Study|Adverse event related to study drug|1
5879468|NCT01882439|20339504|P2|Overall Study|Adverse event related to study drug|8
5879469|NCT01882439|20339505|P1|Overall Study|Adverse event related to study drug|3
5879470|NCT01882257|20339702|P3|Therapy Portion of Study (12 Months)|Withdrawal by Subject|4
5879471|NCT01882257|20339703|P2|Therapy Portion of Study (12 Months)|Withdrawal by Subject|11
5879472|NCT01882257|20339704|P1|Therapy Portion of Study (12 Months)|Withdrawal by Subject|0
5879473|NCT01882257|20339702|P3|Study Origination to Beginning Therapy|Withdrawal by Subject|1
5879474|NCT01882257|20339703|P2|Study Origination to Beginning Therapy|Withdrawal by Subject|2
5879475|NCT01882257|20339704|P1|Study Origination to Beginning Therapy|Withdrawal by Subject|0
5879476|NCT01882088|20339711|P1|Overall Study|inadequate pH-impedance tracings|2
5879477|NCT01882088|20339711|P1|Overall Study|Protocol Violation|1
5879478|NCT01882088|20339711|P1|Overall Study|no possibility to place the catheter|1
5879479|NCT01882088|20339711|P1|Overall Study|Intolerance of esophageal manometry|1
5879480|NCT01881776|20339793|P3|Overall Study|Protocol Violation|1
5879481|NCT01881776|20339794|P2|Overall Study|Protocol Violation|2
5879482|NCT01881776|20339795|P1|Overall Study|Protocol Violation|0
5879483|NCT01881776|20339793|P3|Overall Study|Lost to Follow-up|1
5879484|NCT01881776|20339794|P2|Overall Study|Lost to Follow-up|2
5879485|NCT01881776|20339795|P1|Overall Study|Lost to Follow-up|1
5879486|NCT01881750|20339823|P2|Overall Study|Lost to Follow-up|1
5879487|NCT01881750|20339824|P1|Overall Study|Lost to Follow-up|0
5879488|NCT01881750|20339823|P2|Overall Study|Changes in concomitant therapies|3
5879489|NCT01881750|20339824|P1|Overall Study|Changes in concomitant therapies|2
5879490|NCT01881737|20339842|P1|Overall Study|Worsening of baseline behavior|1
5879491|NCT01881737|20339842|P1|Overall Study|Withdrawal by Subject|1
5879492|NCT01881737|20339842|P1|Overall Study|Inclusion/Exclusion Criteria Not Met|3
5879493|NCT01881620|20339851|P1|Overall Study|Protocol Violation|4
5879494|NCT01881230|20339931|P3|Overall Study|Untreated: Withdrawal Before Study Start|0
5879495|NCT01881230|20339932|P2|Overall Study|Untreated: Withdrawal Before Study Start|0
5879496|NCT01881230|20339933|P1|Overall Study|Untreated: Withdrawal Before Study Start|1
5879497|NCT01881230|20339931|P3|Overall Study|Untreated: Death|1
5879498|NCT01881230|20339932|P2|Overall Study|Untreated: Death|0
5879499|NCT01881230|20339933|P1|Overall Study|Untreated: Death|0
5879500|NCT01881230|20339931|P3|Overall Study|Untreated: Other|1
5879501|NCT01881230|20339932|P2|Overall Study|Untreated: Other|0
5879502|NCT01881230|20339933|P1|Overall Study|Untreated: Other|0
5879503|NCT01881230|20339931|P3|Overall Study|Miscellaneous|0
5879504|NCT01881230|20339932|P2|Overall Study|Miscellaneous|3
5879505|NCT01881230|20339933|P1|Overall Study|Miscellaneous|3
5879506|NCT01881230|20339931|P3|Overall Study|Protocol Violation|0
5879507|NCT01881230|20339932|P2|Overall Study|Protocol Violation|1
5879508|NCT01881230|20339933|P1|Overall Study|Protocol Violation|1
5879509|NCT01881230|20339931|P3|Overall Study|Given Commercially Available Drug|2
5879510|NCT01881230|20339932|P2|Overall Study|Given Commercially Available Drug|0
5879511|NCT01881230|20339933|P1|Overall Study|Given Commercially Available Drug|0
5879512|NCT01881230|20339931|P3|Overall Study|Non-Compliance with Study Drug|0
5879513|NCT01881230|20339932|P2|Overall Study|Non-Compliance with Study Drug|2
5879514|NCT01881230|20339933|P1|Overall Study|Non-Compliance with Study Drug|1
5879515|NCT01881230|20339931|P3|Overall Study|Physician Decision|6
5879516|NCT01881230|20339932|P2|Overall Study|Physician Decision|3
5879517|NCT01881230|20339933|P1|Overall Study|Physician Decision|4
5879518|NCT01881230|20339931|P3|Overall Study|Withdrawal by Subject|6
5879519|NCT01881230|20339932|P2|Overall Study|Withdrawal by Subject|4
5879520|NCT01881230|20339933|P1|Overall Study|Withdrawal by Subject|6
5879521|NCT01881230|20339931|P3|Overall Study|Symptomatic Deterioration|1
5879522|NCT01881230|20339932|P2|Overall Study|Symptomatic Deterioration|3
5879523|NCT01881230|20339933|P1|Overall Study|Symptomatic Deterioration|3
5879524|NCT01881230|20339931|P3|Overall Study|Progressive Disease|36
5879525|NCT01881230|20339932|P2|Overall Study|Progressive Disease|35
5879526|NCT01881230|20339933|P1|Overall Study|Progressive Disease|31
5879527|NCT01881230|20339931|P3|Overall Study|Adverse Event|12
5879528|NCT01881230|20339932|P2|Overall Study|Adverse Event|13
5879529|NCT01881230|20339933|P1|Overall Study|Adverse Event|9
5879530|NCT01881230|20339931|P3|Overall Study|Death|1
5879531|NCT01881230|20339932|P2|Overall Study|Death|0
5879532|NCT01881230|20339933|P1|Overall Study|Death|2
5879533|NCT01881126|20339961|P2|Overall Study|Adverse Event|1
5879534|NCT01881126|20339962|P1|Overall Study|Adverse Event|0
5879535|NCT01881126|20339961|P2|Overall Study|Non-compliance|1
5879536|NCT01881126|20339962|P1|Overall Study|Non-compliance|1
5879537|NCT01881009|20340043|P2|Summer Camp Session (6 Days)|Unable to wear device|1
5879538|NCT01881009|20340044|P1|Summer Camp Session (6 Days)|Unable to wear device|0
5879539|NCT01880736|20340066|P4|Overall Study|Withdrawal Criteria|5
5879540|NCT01880736|20340067|P3|Overall Study|Withdrawal Criteria|1
5879541|NCT01880736|20340068|P2|Overall Study|Withdrawal Criteria|2
5879542|NCT01880736|20340069|P1|Overall Study|Withdrawal Criteria|1
5879543|NCT01880736|20340066|P4|Overall Study|Adverse Event|1
5879544|NCT01880736|20340067|P3|Overall Study|Adverse Event|0
5879545|NCT01880736|20340068|P2|Overall Study|Adverse Event|0
5879546|NCT01880736|20340069|P1|Overall Study|Adverse Event|0
5879547|NCT01880593|20340153|P2|Overall Study|Withdrawal by Subject|1
5879548|NCT01880593|20340154|P1|Overall Study|Withdrawal by Subject|6
5879549|NCT01880593|20340153|P2|Overall Study|Lack of Efficacy|5
5879550|NCT01880593|20340154|P1|Overall Study|Lack of Efficacy|1
5879551|NCT01880593|20340153|P2|Overall Study|Adverse Event|0
5879552|NCT01880593|20340154|P1|Overall Study|Adverse Event|1
5879553|NCT01880528|20340174|P2|Overall Study|Other|1
5879554|NCT01880528|20340175|P1|Overall Study|Other|1
5879555|NCT01880515|20340191|P2|Overall Study|Disease Progression|7
5879556|NCT01880515|20340192|P1|Overall Study|Disease Progression|5
5879557|NCT01880515|20340191|P2|Overall Study|Lost to Follow-up|2
5879558|NCT01880515|20340192|P1|Overall Study|Lost to Follow-up|3
5879559|NCT01880437|20340203|P3|Overall Study|Study terminated by Sponsor|2
5879560|NCT01880437|20340204|P2|Overall Study|Study terminated by Sponsor|0
5879561|NCT01880437|20340205|P1|Overall Study|Study terminated by Sponsor|3
5879562|NCT01880437|20340203|P3|Overall Study|Death|17
5879563|NCT01880437|20340204|P2|Overall Study|Death|4
5879564|NCT01880437|20340205|P1|Overall Study|Death|12
5879565|NCT01880424|20340231|P2|Overall Study|Other|0
5879566|NCT01880424|20340232|P1|Overall Study|Other|1
5879567|NCT01880424|20340231|P2|Overall Study|Withdrawal by Subject|30
5879568|NCT01880424|20340232|P1|Overall Study|Withdrawal by Subject|10
5879569|NCT01880424|20340231|P2|Overall Study|Protocol Violation|13
5879570|NCT01880424|20340232|P1|Overall Study|Protocol Violation|11
5879571|NCT01880424|20340231|P2|Overall Study|Lost to Follow-up|2
5879572|NCT01880424|20340232|P1|Overall Study|Lost to Follow-up|3
5879573|NCT01880424|20340231|P2|Overall Study|Lack of Efficacy|4
5879574|NCT01880424|20340232|P1|Overall Study|Lack of Efficacy|1
5879575|NCT01880424|20340231|P2|Overall Study|Adverse Event|6
5879576|NCT01880424|20340232|P1|Overall Study|Adverse Event|7
5879577|NCT01880086|20340288|P2|Overall Study|Lost to Follow-up|1
5879578|NCT01880086|20340289|P1|Overall Study|Lost to Follow-up|1
5879579|NCT01879852|20340344|P2|Overall Study|Withdrawal by Subject|0
5879580|NCT01879852|20340345|P1|Overall Study|Withdrawal by Subject|2
5879581|NCT01879722|20340400|P10|Overall Study|Voluntary Withdrawal|0
5879582|NCT01879722|20340401|P9|Overall Study|Voluntary Withdrawal|1
5879583|NCT01879722|20340402|P8|Overall Study|Voluntary Withdrawal|0
5879584|NCT01879722|20340403|P7|Overall Study|Voluntary Withdrawal|0
5879585|NCT01879722|20340404|P6|Overall Study|Voluntary Withdrawal|0
5879586|NCT01879722|20340405|P5|Overall Study|Voluntary Withdrawal|0
5879587|NCT01879722|20340406|P4|Overall Study|Voluntary Withdrawal|0
5879588|NCT01879722|20340407|P3|Overall Study|Voluntary Withdrawal|0
5879589|NCT01879722|20340408|P2|Overall Study|Voluntary Withdrawal|0
5879590|NCT01879722|20340409|P1|Overall Study|Voluntary Withdrawal|0
5879591|NCT01879722|20340400|P10|Overall Study|Pretreatment Event/Adverse Event|0
5879592|NCT01879722|20340401|P9|Overall Study|Pretreatment Event/Adverse Event|1
5879593|NCT01879722|20340402|P8|Overall Study|Pretreatment Event/Adverse Event|1
5879594|NCT01879722|20340403|P7|Overall Study|Pretreatment Event/Adverse Event|0
5879595|NCT01879722|20340404|P6|Overall Study|Pretreatment Event/Adverse Event|0
5879596|NCT01879722|20340405|P5|Overall Study|Pretreatment Event/Adverse Event|1
5879597|NCT01879722|20340406|P4|Overall Study|Pretreatment Event/Adverse Event|1
5879598|NCT01879722|20340407|P3|Overall Study|Pretreatment Event/Adverse Event|0
5879599|NCT01879722|20340408|P2|Overall Study|Pretreatment Event/Adverse Event|1
5879600|NCT01879722|20340409|P1|Overall Study|Pretreatment Event/Adverse Event|0
5879601|NCT01879683|20340557|P1|Overall Study|Did not Complete 4-week Follow-up Visit|1
5879602|NCT01879618|20340564|P1|Overall Study|Adverse Event|5
5879603|NCT01879618|20340564|P1|Overall Study|Protocol Violation|6
5879604|NCT01879618|20340564|P1|Overall Study|Surgery;changed schedule; not available|8
5879605|NCT01879618|20340564|P1|Overall Study|Withdrawal by Subject|1
5879606|NCT01879618|20340564|P1|Overall Study|Does not meet entrance criteria|1
5879607|NCT01879579|20340571|P2|Overall Study|Discontinued insulin - possible allergy|1
5879608|NCT01879579|20340572|P1|Overall Study|Discontinued insulin - possible allergy|0
5879609|NCT01879579|20340571|P2|Overall Study|Phenotypic type 1 diabetes|1
5879610|NCT01879579|20340572|P1|Overall Study|Phenotypic type 1 diabetes|0
5879611|NCT01879579|20340571|P2|Overall Study|Did not initiate insulin treatment|0
5879612|NCT01879579|20340572|P1|Overall Study|Did not initiate insulin treatment|1
5879613|NCT01879579|20340571|P2|Overall Study|Did not enroll in texting platform|0
5879614|NCT01879579|20340572|P1|Overall Study|Did not enroll in texting platform|1
5879615|NCT01879579|20340571|P2|Overall Study|Phone incompatible with texting platform|0
5879616|NCT01879579|20340572|P1|Overall Study|Phone incompatible with texting platform|3
5879617|NCT01879553|20340602|P2|Overall Study|Withdrawal by Subject|0
5879618|NCT01879553|20340603|P1|Overall Study|Withdrawal by Subject|1
5879619|NCT01879410|20340637|P2|Overall Study|Randomised in Error|2
5879620|NCT01879410|20340638|P1|Overall Study|Randomised in Error|1
5879621|NCT01879410|20340637|P2|Overall Study|Withdrawal by Subject|8
5879622|NCT01879410|20340638|P1|Overall Study|Withdrawal by Subject|7
5879623|NCT01879410|20340637|P2|Overall Study|Lost to Follow-up|1
5879624|NCT01879410|20340638|P1|Overall Study|Lost to Follow-up|2
5879625|NCT01879410|20340637|P2|Overall Study|Protocol Violation|7
5879626|NCT01879410|20340638|P1|Overall Study|Protocol Violation|1
5879627|NCT01879410|20340637|P2|Overall Study|Lack of Efficacy|6
5879628|NCT01879410|20340638|P1|Overall Study|Lack of Efficacy|4
5879629|NCT01879410|20340637|P2|Overall Study|Adverse Event|14
5879630|NCT01879410|20340638|P1|Overall Study|Adverse Event|9
5879631|NCT01879319|20340705|P2|Overall Study|Lost to Follow-up|5
5879632|NCT01879319|20340706|P1|Overall Study|Lost to Follow-up|1
5879633|NCT01879319|20340705|P2|Overall Study|Withdrawal by Subject|0
5879634|NCT01879319|20340706|P1|Overall Study|Withdrawal by Subject|1
5879635|NCT01879072|20340723|P1|Overall Study|Not Transplanted|30
5879636|NCT01879072|20340723|P1|Overall Study|Withdrawal by Subject|121
5879637|NCT01878890|20340735|P4|Overall Study|Protocol Violation|0
5879638|NCT01878890|20340736|P3|Overall Study|Protocol Violation|0
5879639|NCT01878890|20340737|P2|Overall Study|Protocol Violation|1
5879640|NCT01878890|20340738|P1|Overall Study|Protocol Violation|0
5879641|NCT01878383|20340887|P2|Overall Study|Lost to Follow-up|1499
5879642|NCT01878383|20340888|P1|Overall Study|Lost to Follow-up|0
5879643|NCT01878292|20340898|P3|Double-blind Down-Taper Period|Withdrawal by Subject|4
5879644|NCT01878292|20340899|P2|Double-blind Down-Taper Period|Withdrawal by Subject|8
5879645|NCT01878292|20340900|P1|Double-blind Down-Taper Period|Withdrawal by Subject|5
5879646|NCT01878292|20340898|P3|Double-blind Treatment Period|Adverse Event|8
5879647|NCT01878292|20340899|P2|Double-blind Treatment Period|Adverse Event|9
5879648|NCT01878292|20340900|P1|Double-blind Treatment Period|Adverse Event|4
5879649|NCT01878292|20340898|P3|Double-blind Treatment Period|Lack of Efficacy|0
5879650|NCT01878292|20340899|P2|Double-blind Treatment Period|Lack of Efficacy|3
5879651|NCT01878292|20340900|P1|Double-blind Treatment Period|Lack of Efficacy|5
5879652|NCT01878292|20340898|P3|Double-blind Treatment Period|Protocol Violation|2
5879653|NCT01878292|20340899|P2|Double-blind Treatment Period|Protocol Violation|4
5879654|NCT01878292|20340900|P1|Double-blind Treatment Period|Protocol Violation|3
5879655|NCT01878292|20340898|P3|Double-blind Treatment Period|Withdrawal by Subject|8
5879656|NCT01878292|20340899|P2|Double-blind Treatment Period|Withdrawal by Subject|7
5879657|NCT01878292|20340900|P1|Double-blind Treatment Period|Withdrawal by Subject|9
5879658|NCT01878292|20340898|P3|Double-blind Treatment Period|Lost to Follow-up|1
5879659|NCT01878292|20340899|P2|Double-blind Treatment Period|Lost to Follow-up|3
5879660|NCT01878292|20340900|P1|Double-blind Treatment Period|Lost to Follow-up|6
5879661|NCT01878292|20340898|P3|Double-blind Treatment Period|Other Reasons|0
5879662|NCT01878292|20340899|P2|Double-blind Treatment Period|Other Reasons|0
5879663|NCT01878292|20340900|P1|Double-blind Treatment Period|Other Reasons|2
5879664|NCT01878292|20340898|P3|Randomized|Adverse Event|0
5879665|NCT01878292|20340899|P2|Randomized|Adverse Event|0
5879666|NCT01878292|20340900|P1|Randomized|Adverse Event|1
5879667|NCT01878292|20340898|P3|Randomized|Lost to Follow-up|0
5879668|NCT01878292|20340899|P2|Randomized|Lost to Follow-up|0
5879669|NCT01878292|20340900|P1|Randomized|Lost to Follow-up|1
5879670|NCT01878292|20340898|P3|Randomized|Protocol Violation|0
5879671|NCT01878292|20340899|P2|Randomized|Protocol Violation|0
5879672|NCT01878292|20340900|P1|Randomized|Protocol Violation|1
5879673|NCT01878253|20340911|P1|Overall Study|Completed Study w/o Follow-up Data|2
5879674|NCT01878253|20340911|P1|Overall Study|Lost to Follow-up|2
5879675|NCT01878253|20340911|P1|Overall Study|Withdrawal by Subject|1
5879676|NCT01878253|20340911|P1|Overall Study|SIdus System Removal|3
5879677|NCT01878253|20340911|P1|Overall Study|Death|1
5879678|NCT01878214|20340922|P2|Overall Study|Lost to Follow-up|36
5879679|NCT01878214|20340923|P1|Overall Study|Lost to Follow-up|35
5879680|NCT01878214|20340922|P2|Overall Study|Death|1
5879681|NCT01878214|20340923|P1|Overall Study|Death|0
5879682|NCT01878214|20340922|P2|Overall Study|Withdrawal by Subject|7
5879683|NCT01878214|20340923|P1|Overall Study|Withdrawal by Subject|18
5879684|NCT01878175|20340937|P1|Overall Study|Developed contraindicated health problem|2
5879685|NCT01878149|20340956|P2|Overall Study|Did Not Meet Eligibility Criteria|2
5879686|NCT01878149|20340957|P1|Overall Study|Did Not Meet Eligibility Criteria|2
5879687|NCT01878097|20340965|P2|Implementation Year 4|Surveys not fully completed|3007
5879688|NCT01878097|20340966|P1|Implementation Year 4|Surveys not fully completed|3604
5879689|NCT01878097|20340965|P2|Implementation Year 3|Surveys not fully completed|2980
5879690|NCT01878097|20340966|P1|Implementation Year 3|Surveys not fully completed|3494
5879691|NCT01878097|20340965|P2|Implementation Year 2|Surveys not fully completed|2841
5879692|NCT01878097|20340966|P1|Implementation Year 2|Surveys not fully completed|3281
5879693|NCT01878097|20340965|P2|Implementation Year 1|Surveys not fully completed|2549
5879694|NCT01878097|20340966|P1|Implementation Year 1|Surveys not fully completed|3202
5879695|NCT01878097|20340965|P2|Baseline|Surveys not fully completed|1800
5879696|NCT01878097|20340966|P1|Baseline|Surveys not fully completed|2497
5879697|NCT01878084|20340974|P1|Overall Study|Physician Decision|2
5879698|NCT01877915|20341008|P2|Overall Study|Other|4
5879699|NCT01877915|20341009|P1|Overall Study|Other|2
5879700|NCT01877915|20341008|P2|Overall Study|Withdrawal by Subject|55
5879701|NCT01877915|20341009|P1|Overall Study|Withdrawal by Subject|42
5879702|NCT01877915|20341008|P2|Overall Study|Lost to Follow-up|9
5879703|NCT01877915|20341009|P1|Overall Study|Lost to Follow-up|10
5879704|NCT01877720|20341031|P2|Overall Study|Adverse Event|0
5879705|NCT01877720|20341032|P1|Overall Study|Adverse Event|1
5879706|NCT01877668|20341061|P5|Overall Study|Adverse event unrelated to study drug|1
5879707|NCT01877668|20341062|P4|Overall Study|Adverse event unrelated to study drug|0
5879708|NCT01877668|20341063|P3|Overall Study|Adverse event unrelated to study drug|2
5879709|NCT01877668|20341064|P2|Overall Study|Adverse event unrelated to study drug|1
5879710|NCT01877668|20341065|P1|Overall Study|Adverse event unrelated to study drug|4
5879711|NCT01877668|20341061|P5|Overall Study|Adverse event related to study drug|1
5879712|NCT01877668|20341062|P4|Overall Study|Adverse event related to study drug|2
5879713|NCT01877668|20341063|P3|Overall Study|Adverse event related to study drug|2
5879714|NCT01877668|20341064|P2|Overall Study|Adverse event related to study drug|2
5879715|NCT01877668|20341065|P1|Overall Study|Adverse event related to study drug|2
5879716|NCT01877668|20341061|P5|Overall Study|Protocol Violation|3
5879717|NCT01877668|20341062|P4|Overall Study|Protocol Violation|0
5879718|NCT01877668|20341063|P3|Overall Study|Protocol Violation|0
5879719|NCT01877668|20341064|P2|Overall Study|Protocol Violation|1
5879720|NCT01877668|20341065|P1|Overall Study|Protocol Violation|1
5879721|NCT01877668|20341061|P5|Overall Study|Other|3
5879722|NCT01877668|20341062|P4|Overall Study|Other|1
5879723|NCT01877668|20341063|P3|Overall Study|Other|1
5879724|NCT01877668|20341064|P2|Overall Study|Other|1
5879725|NCT01877668|20341065|P1|Overall Study|Other|1
5879726|NCT01877668|20341061|P5|Overall Study|Withdrawal by Subject|2
5879727|NCT01877668|20341062|P4|Overall Study|Withdrawal by Subject|2
5879728|NCT01877668|20341063|P3|Overall Study|Withdrawal by Subject|3
5879729|NCT01877668|20341064|P2|Overall Study|Withdrawal by Subject|0
5879730|NCT01877668|20341065|P1|Overall Study|Withdrawal by Subject|2
5879731|NCT01877668|20341061|P5|Overall Study|Lost to Follow-up|0
5879732|NCT01877668|20341062|P4|Overall Study|Lost to Follow-up|0
5879733|NCT01877668|20341063|P3|Overall Study|Lost to Follow-up|1
5879734|NCT01877668|20341064|P2|Overall Study|Lost to Follow-up|2
5879735|NCT01877668|20341065|P1|Overall Study|Lost to Follow-up|0
5879736|NCT01877668|20341061|P5|Overall Study|Insufficient clinical response|0
5879737|NCT01877668|20341062|P4|Overall Study|Insufficient clinical response|2
5879738|NCT01877668|20341063|P3|Overall Study|Insufficient clinical response|2
5879739|NCT01877668|20341064|P2|Overall Study|Insufficient clinical response|1
5879740|NCT01877668|20341065|P1|Overall Study|Insufficient clinical response|0
5879741|NCT01877668|20341061|P5|Overall Study|No longer met study criteria|0
5879742|NCT01877668|20341062|P4|Overall Study|No longer met study criteria|0
5879743|NCT01877668|20341063|P3|Overall Study|No longer met study criteria|1
5879744|NCT01877668|20341064|P2|Overall Study|No longer met study criteria|0
5879745|NCT01877668|20341065|P1|Overall Study|No longer met study criteria|1
5879746|NCT01877668|20341061|P5|Overall Study|Death|0
5879747|NCT01877668|20341062|P4|Overall Study|Death|1
5879748|NCT01877668|20341063|P3|Overall Study|Death|0
5879749|NCT01877668|20341064|P2|Overall Study|Death|0
5879750|NCT01877668|20341065|P1|Overall Study|Death|0
5879751|NCT01877655|20341296|P2|Overall Study|Randomized but Never Received Drug|5
5879752|NCT01877655|20341297|P1|Overall Study|Randomized but Never Received Drug|8
5879753|NCT01877655|20341296|P2|Overall Study|Miscellaneous|4
5879754|NCT01877655|20341297|P1|Overall Study|Miscellaneous|4
5879755|NCT01877655|20341296|P2|Overall Study|Physician Decision|10
5879756|NCT01877655|20341297|P1|Overall Study|Physician Decision|11
5879757|NCT01877655|20341296|P2|Overall Study|Withdrawal by Subject|26
5879758|NCT01877655|20341297|P1|Overall Study|Withdrawal by Subject|18
5879759|NCT01877655|20341296|P2|Overall Study|Death|52
5879760|NCT01877655|20341297|P1|Overall Study|Death|57
5879761|NCT01877551|20341353|P2|Overall Study|Physician Decision|1
5879762|NCT01877551|20341354|P1|Overall Study|Physician Decision|0
5879763|NCT01877421|20341403|P18|Phase 2|Protocol Violation|0
5879764|NCT01877421|20341404|P17|Phase 2|Protocol Violation|0
5879765|NCT01877421|20341405|P16|Phase 2|Protocol Violation|0
5879766|NCT01877421|20341406|P15|Phase 2|Protocol Violation|0
5879767|NCT01877421|20341407|P14|Phase 2|Protocol Violation|0
5879768|NCT01877421|20341408|P13|Phase 2|Protocol Violation|0
5879769|NCT01877421|20341409|P12|Phase 2|Protocol Violation|0
5879770|NCT01877421|20341410|P11|Phase 2|Protocol Violation|1
5879771|NCT01877421|20341411|P10|Phase 2|Protocol Violation|0
5879772|NCT01877421|20341412|P9|Phase 2|Protocol Violation|0
5879773|NCT01877421|20341413|P8|Phase 2|Protocol Violation|0
5879774|NCT01877421|20341414|P7|Phase 2|Protocol Violation|0
5879775|NCT01877421|20341415|P6|Phase 2|Protocol Violation|0
5879776|NCT01877421|20341416|P5|Phase 2|Protocol Violation|0
5879777|NCT01877421|20341417|P4|Phase 2|Protocol Violation|0
5879778|NCT01877421|20341418|P3|Phase 2|Protocol Violation|0
5879779|NCT01877421|20341419|P2|Phase 2|Protocol Violation|0
5879780|NCT01877421|20341420|P1|Phase 2|Protocol Violation|0
5879781|NCT01877421|20341403|P18|Phase 2|Withdrawal by Subject|0
5879782|NCT01877421|20341404|P17|Phase 2|Withdrawal by Subject|0
5879783|NCT01877421|20341405|P16|Phase 2|Withdrawal by Subject|1
5879784|NCT01877421|20341406|P15|Phase 2|Withdrawal by Subject|0
5879785|NCT01877421|20341407|P14|Phase 2|Withdrawal by Subject|0
5879786|NCT01877421|20341408|P13|Phase 2|Withdrawal by Subject|1
5879787|NCT01877421|20341409|P12|Phase 2|Withdrawal by Subject|0
5879788|NCT01877421|20341410|P11|Phase 2|Withdrawal by Subject|1
5879789|NCT01877421|20341411|P10|Phase 2|Withdrawal by Subject|0
5879790|NCT01877421|20341412|P9|Phase 2|Withdrawal by Subject|1
5879791|NCT01877421|20341413|P8|Phase 2|Withdrawal by Subject|0
5879792|NCT01877421|20341414|P7|Phase 2|Withdrawal by Subject|0
5879793|NCT01877421|20341415|P6|Phase 2|Withdrawal by Subject|0
5879794|NCT01877421|20341416|P5|Phase 2|Withdrawal by Subject|0
5879795|NCT01877421|20341417|P4|Phase 2|Withdrawal by Subject|0
5879796|NCT01877421|20341418|P3|Phase 2|Withdrawal by Subject|0
5879797|NCT01877421|20341419|P2|Phase 2|Withdrawal by Subject|0
5879798|NCT01877421|20341420|P1|Phase 2|Withdrawal by Subject|0
5879799|NCT01877421|20341403|P18|Phase 2|Lost to Follow-up|0
5879800|NCT01877421|20341404|P17|Phase 2|Lost to Follow-up|0
5879801|NCT01877421|20341405|P16|Phase 2|Lost to Follow-up|0
5879802|NCT01877421|20341406|P15|Phase 2|Lost to Follow-up|0
5879803|NCT01877421|20341407|P14|Phase 2|Lost to Follow-up|0
5879804|NCT01877421|20341408|P13|Phase 2|Lost to Follow-up|0
5879805|NCT01877421|20341409|P12|Phase 2|Lost to Follow-up|0
5879806|NCT01877421|20341410|P11|Phase 2|Lost to Follow-up|0
5879807|NCT01877421|20341411|P10|Phase 2|Lost to Follow-up|0
5879808|NCT01877421|20341412|P9|Phase 2|Lost to Follow-up|0
5879809|NCT01877421|20341413|P8|Phase 2|Lost to Follow-up|0
5879810|NCT01877421|20341414|P7|Phase 2|Lost to Follow-up|1
5879811|NCT01877421|20341415|P6|Phase 2|Lost to Follow-up|0
5879812|NCT01877421|20341416|P5|Phase 2|Lost to Follow-up|0
5879813|NCT01877421|20341417|P4|Phase 2|Lost to Follow-up|0
5879814|NCT01877421|20341418|P3|Phase 2|Lost to Follow-up|0
5879815|NCT01877421|20341419|P2|Phase 2|Lost to Follow-up|0
5879816|NCT01877421|20341420|P1|Phase 2|Lost to Follow-up|0
5879817|NCT01877408|20341530|P2|Overall Study|Lost to Follow-up|2
5879818|NCT01877408|20341531|P1|Overall Study|Lost to Follow-up|0
5879819|NCT01877278|20341564|P2|Overall Study|Lost to Follow-up|3
5879820|NCT01877278|20341565|P1|Overall Study|Lost to Follow-up|3
5879821|NCT01877265|20341573|P6|Treatment Period 3|Lost to Follow-up|0
5879822|NCT01877265|20341574|P5|Treatment Period 3|Lost to Follow-up|0
5879823|NCT01877265|20341575|P4|Treatment Period 3|Lost to Follow-up|0
5879824|NCT01877265|20341576|P3|Treatment Period 3|Lost to Follow-up|0
5879825|NCT01877265|20341577|P2|Treatment Period 3|Lost to Follow-up|0
5879826|NCT01877265|20341578|P1|Treatment Period 3|Lost to Follow-up|1
5879827|NCT01877265|20341573|P6|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|1
5879828|NCT01877265|20341574|P5|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0
5879829|NCT01877265|20341575|P4|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0
5879830|NCT01877265|20341576|P3|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0
5879831|NCT01877265|20341577|P2|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0
5879832|NCT01877265|20341578|P1|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0
5879833|NCT01877265|20341573|P6|Treatment Period 1|Sponsor Decision|0
5879834|NCT01877265|20341574|P5|Treatment Period 1|Sponsor Decision|0
5879835|NCT01877265|20341575|P4|Treatment Period 1|Sponsor Decision|0
5879836|NCT01877265|20341576|P3|Treatment Period 1|Sponsor Decision|1
5879837|NCT01877265|20341577|P2|Treatment Period 1|Sponsor Decision|0
5879838|NCT01877265|20341578|P1|Treatment Period 1|Sponsor Decision|0
5879839|NCT01877239|20341595|P1|Overall Study|Data not available|35
5879840|NCT01877239|20341595|P1|Overall Study|Lack of Efficacy|4
5879841|NCT01877239|20341595|P1|Overall Study|Other|2
5879842|NCT01877239|20341595|P1|Overall Study|Withdrawal by Subject|4
5879843|NCT01877239|20341595|P1|Overall Study|Disease Remission|1
5879844|NCT01877239|20341595|P1|Overall Study|Adverse Event|4
5879845|NCT01877187|20341601|P1|Overall Study|Liver transplant|2
5879846|NCT01877187|20341601|P1|Overall Study|Declining clinical status|11
5879847|NCT01877187|20341601|P1|Overall Study|Lost to Follow-up|3
5879848|NCT01877187|20341601|P1|Overall Study|Withdrawal by Subject|4
5879849|NCT01877187|20341601|P1|Overall Study|Death|2
5879850|NCT01877083|20341653|P1|Extension Phase|Adverse Event|2
5879851|NCT01877083|20341653|P1|Extension Phase|Disease Progression|3
5879852|NCT01877083|20341653|P1|Treatment Phase|Lost to Follow-up|1
5879853|NCT01877083|20341653|P1|Treatment Phase|Withdrawal by Subject|2
5879854|NCT01877083|20341653|P1|Treatment Phase|Adverse Event|6
5879855|NCT01877083|20341653|P1|Treatment Phase|Clinical Progression|1
5879856|NCT01877083|20341653|P1|Treatment Phase|Disease Progression|10
5879857|NCT01876979|20341677|P2|Overall Study|Physician Decision|3
5879858|NCT01876979|20341678|P1|Overall Study|Physician Decision|2
5879859|NCT01876823|20341684|P1|Overall Study|Patients moved|2
5879860|NCT01876823|20341684|P1|Overall Study|Physician Decision|2
5879861|NCT01876823|20341684|P1|Overall Study|Withdrawal by Subject|5
5879862|NCT01876810|20341697|P2|Overall Study|Physician Decision|1
5879863|NCT01876810|20341698|P1|Overall Study|Physician Decision|0
5879864|NCT01876784|20341710|P2|Overall Study|Ongoing|40
5879865|NCT01876784|20341711|P1|Overall Study|Ongoing|41
5879866|NCT01876784|20341710|P2|Overall Study|Other than specified above|6
5879867|NCT01876784|20341711|P1|Overall Study|Other than specified above|5
5879868|NCT01876784|20341710|P2|Overall Study|Randomized but not treated|1
5879869|NCT01876784|20341711|P1|Overall Study|Randomized but not treated|2
5879870|NCT01876784|20341710|P2|Overall Study|Death|0
5879871|NCT01876784|20341711|P1|Overall Study|Death|1
5879872|NCT01876784|20341710|P2|Overall Study|Lost to Follow-up|1
5879873|NCT01876784|20341711|P1|Overall Study|Lost to Follow-up|0
5879874|NCT01876784|20341710|P2|Overall Study|Disease progression|67
5879875|NCT01876784|20341711|P1|Overall Study|Disease progression|37
5879876|NCT01876784|20341710|P2|Overall Study|Protocol Violation|0
5879877|NCT01876784|20341711|P1|Overall Study|Protocol Violation|1
5879878|NCT01876784|20341710|P2|Overall Study|Adverse Event|2
5879879|NCT01876784|20341711|P1|Overall Study|Adverse Event|15
5879880|NCT01876784|20341710|P2|Overall Study|Withdrawal by Subject|2
5879881|NCT01876784|20341711|P1|Overall Study|Withdrawal by Subject|17
5879882|NCT01876732|20341717|P1|Overall Study|MMA was not over 800mg/dL|75
5879883|NCT01876706|20341722|P1|Overall Study|Death|3
5879884|NCT01876706|20341722|P1|Overall Study|Withdrawals|6
5879885|NCT01876706|20341722|P1|Overall Study|Lost to Follow-up|7
5879886|NCT01876706|20341722|P1|Overall Study|BPH Intervention|9
5879887|NCT01876511|20341742|P3|Overall Study|Physician Decision|1
5879888|NCT01876511|20341743|P2|Overall Study|Physician Decision|0
5879889|NCT01876511|20341744|P1|Overall Study|Physician Decision|1
5879890|NCT01876511|20341742|P3|Overall Study|Patient Decision|6
5879891|NCT01876511|20341743|P2|Overall Study|Patient Decision|0
5879892|NCT01876511|20341744|P1|Overall Study|Patient Decision|3
5879893|NCT01876511|20341742|P3|Overall Study|Drug-related Toxicity|6
5879894|NCT01876511|20341743|P2|Overall Study|Drug-related Toxicity|1
5879895|NCT01876511|20341744|P1|Overall Study|Drug-related Toxicity|5
5879896|NCT01876511|20341742|P3|Overall Study|Death (unrelated)|2
5879897|NCT01876511|20341743|P2|Overall Study|Death (unrelated)|0
5879898|NCT01876511|20341744|P1|Overall Study|Death (unrelated)|3
5879899|NCT01876511|20341742|P3|Overall Study|Disease Progression-clinical/radiologic|16
5879900|NCT01876511|20341743|P2|Overall Study|Disease Progression-clinical/radiologic|24
5879901|NCT01876511|20341744|P1|Overall Study|Disease Progression-clinical/radiologic|11
5879902|NCT01876446|20341792|P2|Overall Study|Physician Decision|3
5879903|NCT01876446|20341793|P1|Overall Study|Physician Decision|1
5879904|NCT01876446|20341792|P2|Overall Study|Withdrawal by Subject|2
5879905|NCT01876446|20341793|P1|Overall Study|Withdrawal by Subject|1
5879906|NCT01876446|20341792|P2|Overall Study|Death|1
5879907|NCT01876446|20341793|P1|Overall Study|Death|0
5879908|NCT01876420|20341809|P1|Overall Study|Missed 30 day visit|1
5879909|NCT01876381|20341821|P1|Overall Study|Withdrawal by Subject|1
5879910|NCT01876381|20341821|P1|Overall Study|Physician Decision|1
5879911|NCT01876381|20341821|P1|Overall Study|Lack of Efficacy|5
5879912|NCT01876368|20341828|P2|Overall Study|Subject/guardian decision|1
5879913|NCT01876368|20341829|P1|Overall Study|Subject/guardian decision|3
5879914|NCT01876368|20341828|P2|Overall Study|Protocol deviation|3
5879915|NCT01876368|20341829|P1|Overall Study|Protocol deviation|3
5879916|NCT01876368|20341828|P2|Overall Study|Physician Decision|2
5879917|NCT01876368|20341829|P1|Overall Study|Physician Decision|0
5879918|NCT01876368|20341828|P2|Overall Study|Non-compliance with study treatment|1
5879919|NCT01876368|20341829|P1|Overall Study|Non-compliance with study treatment|0
5879920|NCT01876368|20341828|P2|Overall Study|Lost to Follow-up|1
5879921|NCT01876368|20341829|P1|Overall Study|Lost to Follow-up|0
5879922|NCT01876368|20341828|P2|Overall Study|Lack of Efficacy|0
5879923|NCT01876368|20341829|P1|Overall Study|Lack of Efficacy|1
5879924|NCT01876368|20341828|P2|Overall Study|Adverse Event|5
5879925|NCT01876368|20341829|P1|Overall Study|Adverse Event|2
5879926|NCT01876251|20341874|P3|Overall Study|Objective progression or relapse|8
5879927|NCT01876251|20341875|P2|Overall Study|Objective progression or relapse|3
5879928|NCT01876251|20341876|P1|Overall Study|Objective progression or relapse|10
5879929|NCT01876251|20341874|P3|Overall Study|Study terminated|0
5879930|NCT01876251|20341875|P2|Overall Study|Study terminated|0
5879931|NCT01876251|20341876|P1|Overall Study|Study terminated|1
5879932|NCT01876251|20341874|P3|Overall Study|Participant refused further follow-up|1
5879933|NCT01876251|20341875|P2|Overall Study|Participant refused further follow-up|0
5879934|NCT01876251|20341876|P1|Overall Study|Participant refused further follow-up|0
5879935|NCT01876251|20341874|P3|Overall Study|Participant started new treatment|1
5879936|NCT01876251|20341875|P2|Overall Study|Participant started new treatment|0
5879937|NCT01876251|20341876|P1|Overall Study|Participant started new treatment|1
5879938|NCT01876251|20341874|P3|Overall Study|Death|1
5879939|NCT01876251|20341875|P2|Overall Study|Death|0
5879940|NCT01876251|20341876|P1|Overall Study|Death|2
5879941|NCT01876251|20341874|P3|Overall Study|Clinical progression|0
5879942|NCT01876251|20341875|P2|Overall Study|Clinical progression|0
5879943|NCT01876251|20341876|P1|Overall Study|Clinical progression|1
5879944|NCT01876043|20341980|P1|Overall Study|Withdrawal by Subject|1
5879945|NCT01876043|20341980|P1|Overall Study|Death|1
5879946|NCT01875991|20341992|P2|Overall Study|Sponsor Decision|0
5879947|NCT01875991|20341993|P1|Overall Study|Sponsor Decision|1
5879948|NCT01875991|20341992|P2|Overall Study|Withdrawal by Subject|6
5879949|NCT01875991|20341993|P1|Overall Study|Withdrawal by Subject|6
5879950|NCT01875874|20342029|P1|Overall Study|Death|3
5879951|NCT01875848|20342049|P2|Overall Study|Withdrawal by Subject|0
5879952|NCT01875848|20342050|P1|Overall Study|Withdrawal by Subject|2
5879953|NCT01875731|20342067|P2|Overall Study|Fail to obtain lab sample|0
5879954|NCT01875731|20342068|P1|Overall Study|Fail to obtain lab sample|1
5879955|NCT01875471|20342087|P2|Overall Study|Unsatisfactory Lens Fitting|0
5879956|NCT01875471|20342088|P1|Overall Study|Unsatisfactory Lens Fitting|1
5879957|NCT01875471|20342087|P2|Overall Study|Adverse Event|1
5879958|NCT01875471|20342088|P1|Overall Study|Adverse Event|0
5879959|NCT01875445|20342096|P2|Overall Study|Withdrawal by Subject|0
5879960|NCT01875445|20342097|P1|Overall Study|Withdrawal by Subject|2
5879961|NCT01875445|20342096|P2|Overall Study|Lost to Follow-up|0
5879962|NCT01875445|20342097|P1|Overall Study|Lost to Follow-up|5
5879963|NCT01875250|20342107|P2|Overall Study|Adverse Event|0
5879964|NCT01875250|20342108|P1|Overall Study|Adverse Event|2
5879965|NCT01875237|20342123|P2|Overall Study|DLI cells could not be produced|0
5879966|NCT01875237|20342124|P1|Overall Study|DLI cells could not be produced|1
5879967|NCT01875237|20342123|P2|Overall Study|GVDH before DLI|0
5879968|NCT01875237|20342124|P1|Overall Study|GVDH before DLI|1
5879969|NCT01875185|20342150|P2|Overall Study|study was terminated|48
5879970|NCT01875185|20342151|P1|Overall Study|study was terminated|52
5879971|NCT01874665|20342236|P2|Overall Study|Other|0
5879972|NCT01874665|20342237|P1|Overall Study|Other|2
5879973|NCT01874665|20342236|P2|Overall Study|Documented Progressive Disease|7
5879974|NCT01874665|20342237|P1|Overall Study|Documented Progressive Disease|11
5879975|NCT01874665|20342236|P2|Overall Study|Study Terminated by Sponsor|2
5879976|NCT01874665|20342237|P1|Overall Study|Study Terminated by Sponsor|0
5879977|NCT01874665|20342236|P2|Overall Study|Clinical Progressive Disease|3
5879978|NCT01874665|20342237|P1|Overall Study|Clinical Progressive Disease|4
5879979|NCT01874665|20342236|P2|Overall Study|Physician Decision|0
5879980|NCT01874665|20342237|P1|Overall Study|Physician Decision|3
5879981|NCT01874665|20342236|P2|Overall Study|Withdrawal by Subject|1
5879982|NCT01874665|20342237|P1|Overall Study|Withdrawal by Subject|4
5879983|NCT01874665|20342236|P2|Overall Study|Adverse Event|2
5879984|NCT01874665|20342237|P1|Overall Study|Adverse Event|6
5879985|NCT01874535|20342265|P2|Overall Study|incomplete symptom resolution|35
5879986|NCT01874535|20342266|P1|Overall Study|incomplete symptom resolution|45
5879987|NCT01874535|20342265|P2|Overall Study|Lost to Follow-up|9
5879988|NCT01874535|20342266|P1|Overall Study|Lost to Follow-up|10
5879997|NCT01874340|20342302|P4|Overall Study|Withdrawal by Subject|1
5879998|NCT01874340|20342303|P3|Overall Study|Withdrawal by Subject|0
5879999|NCT01874340|20342304|P2|Overall Study|Withdrawal by Subject|0
5880000|NCT01874340|20342305|P1|Overall Study|Withdrawal by Subject|0
5880001|NCT01874340|20342302|P4|Overall Study|Study terminated by Sponsor|4
5880002|NCT01874340|20342303|P3|Overall Study|Study terminated by Sponsor|8
5880003|NCT01874340|20342304|P2|Overall Study|Study terminated by Sponsor|8
5880004|NCT01874340|20342305|P1|Overall Study|Study terminated by Sponsor|6
5880005|NCT01874288|20342336|P5|Overall Study|Progressive disease|1
5880006|NCT01874288|20342337|P4|Overall Study|Progressive disease|5
5880007|NCT01874288|20342338|P3|Overall Study|Progressive disease|3
5880008|NCT01874288|20342339|P2|Overall Study|Progressive disease|0
5880009|NCT01874288|20342340|P1|Overall Study|Progressive disease|2
5880010|NCT01874288|20342336|P5|Overall Study|Physician Decision|0
5880011|NCT01874288|20342337|P4|Overall Study|Physician Decision|1
5880012|NCT01874288|20342338|P3|Overall Study|Physician Decision|0
5880013|NCT01874288|20342339|P2|Overall Study|Physician Decision|0
5880014|NCT01874288|20342340|P1|Overall Study|Physician Decision|0
5880015|NCT01874288|20342336|P5|Overall Study|Withdrawal by Subject|1
5880016|NCT01874288|20342337|P4|Overall Study|Withdrawal by Subject|1
5880017|NCT01874288|20342338|P3|Overall Study|Withdrawal by Subject|2
5880018|NCT01874288|20342339|P2|Overall Study|Withdrawal by Subject|0
5880019|NCT01874288|20342340|P1|Overall Study|Withdrawal by Subject|1
5880020|NCT01874275|20342375|P2|Overall Study|Lost to Follow-up|0
5880021|NCT01874275|20342376|P1|Overall Study|Lost to Follow-up|1
5880022|NCT01874145|20342399|P2|Extension Period|Lost to Follow-up|1
5880023|NCT01874145|20342400|P1|Extension Period|Lost to Follow-up|1
5880024|NCT01874145|20342399|P2|Extension Period|Withdrawal by Subject|1
5880025|NCT01874145|20342400|P1|Extension Period|Withdrawal by Subject|2
5880026|NCT01874145|20342399|P2|Extension Period|Adverse Event|2
5880027|NCT01874145|20342400|P1|Extension Period|Adverse Event|3
5880028|NCT01874145|20342399|P2|Core Period|Withdrawal by Subject|4
5880029|NCT01874145|20342400|P1|Core Period|Withdrawal by Subject|0
5880030|NCT01874145|20342399|P2|Core Period|Adverse Event|1
5880031|NCT01874145|20342400|P1|Core Period|Adverse Event|0
5880032|NCT01874145|20342399|P2|Core Period|Physician Decision|1
5880033|NCT01874145|20342400|P1|Core Period|Physician Decision|1
5880034|NCT01874145|20342399|P2|Core Period|Protocol Violation|1
5880035|NCT01874145|20342400|P1|Core Period|Protocol Violation|1
5880036|NCT01874145|20342399|P2|Core Period|Non-compliance|0
5880037|NCT01874145|20342400|P1|Core Period|Non-compliance|1
5880038|NCT01874054|20342459|P1|Overall Study|Death|5
5880039|NCT01874054|20342459|P1|Overall Study|Lost to Follow-up|5
5880040|NCT01874054|20342459|P1|Overall Study|Study Termination by Sponsor|42
5880041|NCT01874054|20342459|P1|Overall Study|Withdrawal by Subject|3
5880042|NCT01873950|20342481|P5|Period 5|Withdrawal by Subject|0
5880043|NCT01873950|20342482|P4|Period 5|Withdrawal by Subject|1
5880044|NCT01873950|20342483|P3|Period 5|Withdrawal by Subject|0
5880045|NCT01873950|20342484|P2|Period 5|Withdrawal by Subject|0
5880046|NCT01873950|20342485|P1|Period 5|Withdrawal by Subject|0
5880047|NCT01873859|20342522|P2|Overall Study|Withdrawal by Subject|4
5880048|NCT01873859|20342523|P1|Overall Study|Withdrawal by Subject|0
5880049|NCT01873742|20342541|P2|Overall Study|Lost to Follow-up|76
5880050|NCT01873742|20342542|P1|Overall Study|Lost to Follow-up|68
5880051|NCT01873729|20342548|P1|Overall Study|Withdrawal by Subject|1
5880052|NCT01873586|20342553|P1|Overall Study|Lost to Follow-up|3
5880053|NCT01873495|20342566|P1|Overall Study|AML (Acute Myelogenous Leukemia) Relapse|1
5880054|NCT01873495|20342566|P1|Overall Study|Removed for Transplantation|1
5880055|NCT01873495|20342566|P1|Overall Study|Adverse Event|1
5880056|NCT01873495|20342566|P1|Overall Study|Physician Decision|3
5880057|NCT01873495|20342566|P1|Overall Study|Withdrawal by Subject|1
5880058|NCT01873417|20342574|P1|Overall Study|Physician Decision|3
5880059|NCT01873417|20342574|P1|Overall Study|Withdrawal by Subject|2
5880060|NCT01873417|20342574|P1|Overall Study|Lost to Follow-up|2
5880061|NCT01873417|20342574|P1|Overall Study|Adverse Event|24
5880062|NCT01873417|20342574|P1|Overall Study|Did Not Receive Any Study Drug|4
5880063|NCT01872910|20342602|P6|Overall Study|Lost to Follow-up|0
5880064|NCT01872910|20342603|P5|Overall Study|Lost to Follow-up|0
5880065|NCT01872910|20342604|P4|Overall Study|Lost to Follow-up|0
5880066|NCT01872910|20342605|P3|Overall Study|Lost to Follow-up|2
5880067|NCT01872910|20342606|P2|Overall Study|Lost to Follow-up|0
5880068|NCT01872910|20342607|P1|Overall Study|Lost to Follow-up|2
5880069|NCT01872715|20342652|P1|Overall Study|Withdrawal by Subject|2
5880070|NCT01872715|20342652|P1|Overall Study|Protocol Violation|1
5880071|NCT01872715|20342652|P1|Overall Study|Adverse Event|1
5880072|NCT01872689|20342671|P4|Open-Label Period (Only For Monotherapy)|Adverse Event|0
5880073|NCT01872689|20342672|P3|Open-Label Period (Only For Monotherapy)|Adverse Event|0
5880074|NCT01872689|20342673|P2|Open-Label Period (Only For Monotherapy)|Adverse Event|1
5880075|NCT01872689|20342674|P1|Open-Label Period (Only For Monotherapy)|Adverse Event|2
5880076|NCT01872689|20342671|P4|Open-Label Period (Only For Monotherapy)|Death|0
5880077|NCT01872689|20342672|P3|Open-Label Period (Only For Monotherapy)|Death|0
5880078|NCT01872689|20342673|P2|Open-Label Period (Only For Monotherapy)|Death|3
5880079|NCT01872689|20342674|P1|Open-Label Period (Only For Monotherapy)|Death|5
5880080|NCT01872689|20342671|P4|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0
5880081|NCT01872689|20342672|P3|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0
5880082|NCT01872689|20342673|P2|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|3
5880083|NCT01872689|20342674|P1|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|1
5880084|NCT01872689|20342671|P4|Open-Label Period (Only For Monotherapy)|Physician Decision|0
5880085|NCT01872689|20342672|P3|Open-Label Period (Only For Monotherapy)|Physician Decision|0
5880086|NCT01872689|20342673|P2|Open-Label Period (Only For Monotherapy)|Physician Decision|1
5880087|NCT01872689|20342674|P1|Open-Label Period (Only For Monotherapy)|Physician Decision|0
5880088|NCT01872689|20342671|P4|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0
5880089|NCT01872689|20342672|P3|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0
5880090|NCT01872689|20342673|P2|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|12
5880091|NCT01872689|20342674|P1|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|11
5880092|NCT01872689|20342671|P4|Open-Label Period (Only For Monotherapy)|Other|0
5880093|NCT01872689|20342672|P3|Open-Label Period (Only For Monotherapy)|Other|0
5880094|NCT01872689|20342673|P2|Open-Label Period (Only For Monotherapy)|Other|3
5880095|NCT01872689|20342674|P1|Open-Label Period (Only For Monotherapy)|Other|2
5880096|NCT01872689|20342671|P4|Double-Blind/Placebo-Controlled Period|Adverse Event|7
5880097|NCT01872689|20342672|P3|Double-Blind/Placebo-Controlled Period|Adverse Event|10
5880098|NCT01872689|20342673|P2|Double-Blind/Placebo-Controlled Period|Adverse Event|3
5880099|NCT01872689|20342674|P1|Double-Blind/Placebo-Controlled Period|Adverse Event|6
5880100|NCT01872689|20342671|P4|Double-Blind/Placebo-Controlled Period|Death|9
5880101|NCT01872689|20342672|P3|Double-Blind/Placebo-Controlled Period|Death|14
5880102|NCT01872689|20342673|P2|Double-Blind/Placebo-Controlled Period|Death|4
5880103|NCT01872689|20342674|P1|Double-Blind/Placebo-Controlled Period|Death|3
5880104|NCT01872689|20342671|P4|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1
5880105|NCT01872689|20342672|P3|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0
5880106|NCT01872689|20342673|P2|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0
5880107|NCT01872689|20342674|P1|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1
5880108|NCT01872689|20342671|P4|Double-Blind/Placebo-Controlled Period|Physician Decision|1
5880109|NCT01872689|20342672|P3|Double-Blind/Placebo-Controlled Period|Physician Decision|3
5880110|NCT01872689|20342673|P2|Double-Blind/Placebo-Controlled Period|Physician Decision|3
5880111|NCT01872689|20342674|P1|Double-Blind/Placebo-Controlled Period|Physician Decision|0
5880112|NCT01872689|20342671|P4|Double-Blind/Placebo-Controlled Period|Protocol Violation|1
5880113|NCT01872689|20342672|P3|Double-Blind/Placebo-Controlled Period|Protocol Violation|1
5880114|NCT01872689|20342673|P2|Double-Blind/Placebo-Controlled Period|Protocol Violation|0
5880115|NCT01872689|20342674|P1|Double-Blind/Placebo-Controlled Period|Protocol Violation|0
5880116|NCT01872689|20342671|P4|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|16
5880117|NCT01872689|20342672|P3|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|14
5880118|NCT01872689|20342673|P2|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|8
5880119|NCT01872689|20342674|P1|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|9
5880120|NCT01872689|20342671|P4|Double-Blind/Placebo-Controlled Period|Other|3
5880121|NCT01872689|20342672|P3|Double-Blind/Placebo-Controlled Period|Other|6
5880122|NCT01872689|20342673|P2|Double-Blind/Placebo-Controlled Period|Other|1
5880123|NCT01872689|20342674|P1|Double-Blind/Placebo-Controlled Period|Other|1
5880124|NCT01872689|20342671|P4|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0
5880125|NCT01872689|20342672|P3|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0
5880126|NCT01872689|20342673|P2|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|1
5880127|NCT01872689|20342674|P1|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0
5880128|NCT01872611|20342750|P2|Overall Study|Reason not provided|6
5880129|NCT01872611|20342751|P1|Overall Study|Reason not provided|6
5880130|NCT01872611|20342750|P2|Overall Study|Withdrawal by Subject|1
5880131|NCT01872611|20342751|P1|Overall Study|Withdrawal by Subject|6
5880132|NCT01872611|20342750|P2|Overall Study|Physician Decision|0
5880133|NCT01872611|20342751|P1|Overall Study|Physician Decision|1
5880134|NCT01872611|20342750|P2|Overall Study|Lost to Follow-up|1
5880135|NCT01872611|20342751|P1|Overall Study|Lost to Follow-up|8
5880136|NCT01872611|20342750|P2|Overall Study|Death, prior to treatment|1
5880137|NCT01872611|20342751|P1|Overall Study|Death, prior to treatment|0
5880138|NCT01872611|20342750|P2|Overall Study|Death|1
5880139|NCT01872611|20342751|P1|Overall Study|Death|0
5880140|NCT01872611|20342750|P2|Overall Study|Adverse Event, prior to treatment|1
5880141|NCT01872611|20342751|P1|Overall Study|Adverse Event, prior to treatment|0
5880142|NCT01872611|20342750|P2|Overall Study|Adverse Event|1
5880143|NCT01872611|20342751|P1|Overall Study|Adverse Event|3
5880144|NCT01872078|20342803|P4|Overall Study|Patient met exclusion criterion 16.|1
5880145|NCT01872078|20342804|P3|Overall Study|Patient met exclusion criterion 16.|0
5880146|NCT01872078|20342805|P2|Overall Study|Patient met exclusion criterion 16.|0
5880147|NCT01872078|20342806|P1|Overall Study|Patient met exclusion criterion 16.|0
5880148|NCT01872078|20342803|P4|Overall Study|Withdrawal by Subject|0
5880149|NCT01872078|20342804|P3|Overall Study|Withdrawal by Subject|1
5880150|NCT01872078|20342805|P2|Overall Study|Withdrawal by Subject|0
5880151|NCT01872078|20342806|P1|Overall Study|Withdrawal by Subject|0
5880152|NCT01872078|20342803|P4|Overall Study|Protocol Violation|0
5880153|NCT01872078|20342804|P3|Overall Study|Protocol Violation|1
5880154|NCT01872078|20342805|P2|Overall Study|Protocol Violation|0
5880155|NCT01872078|20342806|P1|Overall Study|Protocol Violation|0
5880156|NCT01872078|20342803|P4|Overall Study|Dose administration non-compliance|1
5880157|NCT01872078|20342804|P3|Overall Study|Dose administration non-compliance|0
5880158|NCT01872078|20342805|P2|Overall Study|Dose administration non-compliance|0
5880159|NCT01872078|20342806|P1|Overall Study|Dose administration non-compliance|0
5880160|NCT01872078|20342803|P4|Overall Study|Adverse Event|0
5880161|NCT01872078|20342804|P3|Overall Study|Adverse Event|1
5880162|NCT01872078|20342805|P2|Overall Study|Adverse Event|0
5880163|NCT01872078|20342806|P1|Overall Study|Adverse Event|0
5880164|NCT01871870|20342816|P1|Overall Study|hyperglycemia|2
5880165|NCT01871870|20342816|P1|Overall Study|Hardware issues|7
5880166|NCT01871805|20342827|P6|Phase II|Lost to Follow-up|13
5880167|NCT01871805|20342828|P5|Phase II|Lost to Follow-up|0
5880168|NCT01871805|20342829|P4|Phase II|Lost to Follow-up|0
5880169|NCT01871805|20342830|P3|Phase II|Lost to Follow-up|0
5880170|NCT01871805|20342831|P2|Phase II|Lost to Follow-up|0
5880171|NCT01871805|20342832|P1|Phase II|Lost to Follow-up|0
5880172|NCT01871805|20342827|P6|Phase II|Alive in Survival Follow-up|29
5880173|NCT01871805|20342828|P5|Phase II|Alive in Survival Follow-up|0
5880174|NCT01871805|20342829|P4|Phase II|Alive in Survival Follow-up|0
5880175|NCT01871805|20342830|P3|Phase II|Alive in Survival Follow-up|0
5880176|NCT01871805|20342831|P2|Phase II|Alive in Survival Follow-up|0
5880177|NCT01871805|20342832|P1|Phase II|Alive in Survival Follow-up|0
5880178|NCT01871805|20342827|P6|Phase II|Death|45
5880179|NCT01871805|20342828|P5|Phase II|Death|0
5880180|NCT01871805|20342829|P4|Phase II|Death|0
5880181|NCT01871805|20342830|P3|Phase II|Death|0
5880182|NCT01871805|20342831|P2|Phase II|Death|0
5880183|NCT01871805|20342832|P1|Phase II|Death|0
5880184|NCT01871805|20342827|P6|Phase I|Lost to Follow-up|0
5880185|NCT01871805|20342828|P5|Phase I|Lost to Follow-up|0
5880186|NCT01871805|20342829|P4|Phase I|Lost to Follow-up|0
5880187|NCT01871805|20342830|P3|Phase I|Lost to Follow-up|3
5880188|NCT01871805|20342831|P2|Phase I|Lost to Follow-up|1
5880189|NCT01871805|20342832|P1|Phase I|Lost to Follow-up|0
5880190|NCT01871805|20342827|P6|Phase I|Alive in Survival Follow-up|0
5880191|NCT01871805|20342828|P5|Phase I|Alive in Survival Follow-up|4
5880192|NCT01871805|20342829|P4|Phase I|Alive in Survival Follow-up|5
5880193|NCT01871805|20342830|P3|Phase I|Alive in Survival Follow-up|4
5880194|NCT01871805|20342831|P2|Phase I|Alive in Survival Follow-up|2
5880195|NCT01871805|20342832|P1|Phase I|Alive in Survival Follow-up|0
5880196|NCT01871805|20342827|P6|Phase I|Death|0
5880197|NCT01871805|20342828|P5|Phase I|Death|9
5880198|NCT01871805|20342829|P4|Phase I|Death|2
5880199|NCT01871805|20342830|P3|Phase I|Death|6
5880200|NCT01871805|20342831|P2|Phase I|Death|4
5880201|NCT01871805|20342832|P1|Phase I|Death|7
5880202|NCT01871558|20342904|P2|Overall Study|Withdrawal by Subject|0
5880203|NCT01871558|20342905|P1|Overall Study|Withdrawal by Subject|2
5880204|NCT01871558|20342904|P2|Overall Study|antidiabetic drug prematurely stopped|1
5880205|NCT01871558|20342905|P1|Overall Study|antidiabetic drug prematurely stopped|1
5880206|NCT01871558|20342904|P2|Overall Study|Other reason|1
5880207|NCT01871558|20342905|P1|Overall Study|Other reason|0
5880208|NCT01871545|20342925|P2|Overall Study|Withdrawal by Subject|1
5880209|NCT01871545|20342926|P1|Overall Study|Withdrawal by Subject|0
5880210|NCT01871545|20342925|P2|Overall Study|Physician Decision|0
5880211|NCT01871545|20342926|P1|Overall Study|Physician Decision|4
5880212|NCT01871545|20342925|P2|Overall Study|Lack of Efficacy|2
5880213|NCT01871545|20342926|P1|Overall Study|Lack of Efficacy|11
5880214|NCT01871545|20342925|P2|Overall Study|Death|0
5880215|NCT01871545|20342926|P1|Overall Study|Death|2
5880216|NCT01871532|20342967|P2|Overall Study|Withdrawal by Subject|2
5880217|NCT01871532|20342968|P1|Overall Study|Withdrawal by Subject|1
5880218|NCT01871519|20343002|P1|Overall Study|Withdrawal by Subject|49
5880219|NCT01871519|20343002|P1|Overall Study|Lost to Follow-up|15
5880220|NCT01871519|20343002|P1|Overall Study|Death|26
5880221|NCT01871402|20343059|P2|Overall Study|Non-compliance|1
5880222|NCT01871402|20343060|P1|Overall Study|Non-compliance|0
5880223|NCT01871402|20343059|P2|Overall Study|Withdrawal by Subject|2
5880224|NCT01871402|20343060|P1|Overall Study|Withdrawal by Subject|0
5880225|NCT01871402|20343059|P2|Overall Study|Lost to Follow-up|0
5880226|NCT01871402|20343060|P1|Overall Study|Lost to Follow-up|1
5880227|NCT01871285|20343078|P4|First Intervention (1 Day)|Lost to Follow-up|0
5880228|NCT01871285|20343079|P3|First Intervention (1 Day)|Lost to Follow-up|1
5880229|NCT01871285|20343080|P2|First Intervention (1 Day)|Lost to Follow-up|1
5880230|NCT01871285|20343081|P1|First Intervention (1 Day)|Lost to Follow-up|0
5880231|NCT01871285|20343078|P4|First Intervention (1 Day)|Adverse Event|0
5880232|NCT01871285|20343079|P3|First Intervention (1 Day)|Adverse Event|0
5880233|NCT01871285|20343080|P2|First Intervention (1 Day)|Adverse Event|0
5880234|NCT01871285|20343081|P1|First Intervention (1 Day)|Adverse Event|1
5880235|NCT01871142|20343107|P1|Overall Study|Adverse Event|1
5880236|NCT01871090|20343123|P2|Overall Study|Subject Non-Compliance|1
5880237|NCT01871090|20343124|P1|Overall Study|Subject Non-Compliance|0
5880238|NCT01871090|20343123|P2|Overall Study|Interrogation not completed correctly|0
5880239|NCT01871090|20343124|P1|Overall Study|Interrogation not completed correctly|1
5880240|NCT01871090|20343123|P2|Overall Study|Interrogation not done in Emergency Room|22
5880241|NCT01871090|20343124|P1|Overall Study|Interrogation not done in Emergency Room|1
5880242|NCT01870999|20343144|P3|Overall Study|Protocol Violation|1
5880243|NCT01870999|20343145|P2|Overall Study|Protocol Violation|0
5880244|NCT01870999|20343146|P1|Overall Study|Protocol Violation|0
5880245|NCT01870999|20343144|P3|Overall Study|Withdrawal by Subject|5
5880246|NCT01870999|20343145|P2|Overall Study|Withdrawal by Subject|2
5880247|NCT01870999|20343146|P1|Overall Study|Withdrawal by Subject|0
5880248|NCT01870999|20343144|P3|Overall Study|Subject withdrawn by Investigator|0
5880249|NCT01870999|20343145|P2|Overall Study|Subject withdrawn by Investigator|0
5880250|NCT01870999|20343146|P1|Overall Study|Subject withdrawn by Investigator|1
5880251|NCT01870999|20343144|P3|Overall Study|Subject met withdrawal criteria|0
5880252|NCT01870999|20343145|P2|Overall Study|Subject met withdrawal criteria|2
5880253|NCT01870999|20343146|P1|Overall Study|Subject met withdrawal criteria|3
5880254|NCT01870999|20343144|P3|Overall Study|Adverse Event|1
5880255|NCT01870999|20343145|P2|Overall Study|Adverse Event|4
5880256|NCT01870999|20343146|P1|Overall Study|Adverse Event|0
5880257|NCT01870973|20343204|P2|Overall Study|Lost to Follow-up|3
5880258|NCT01870973|20343205|P1|Overall Study|Lost to Follow-up|10
5880259|NCT01870921|20343211|P1|Overall Study|Other|1
5880260|NCT01870921|20343211|P1|Overall Study|Subject Lost to Follow up|2
5880261|NCT01870921|20343211|P1|Overall Study|Severe non-compliance to protocol|7
5880262|NCT01870921|20343211|P1|Overall Study|Subject decision|80
5880263|NCT01870869|20343221|P4|Overall Study|Not evaluable|10
5880264|NCT01870869|20343222|P3|Overall Study|Not evaluable|42
5880265|NCT01870869|20343223|P2|Overall Study|Not evaluable|5
5880266|NCT01870869|20343224|P1|Overall Study|Not evaluable|10
5880267|NCT01870869|20343221|P4|Overall Study|Reason not Specified|4
5880268|NCT01870869|20343222|P3|Overall Study|Reason not Specified|20
5880269|NCT01870869|20343223|P2|Overall Study|Reason not Specified|2
5880270|NCT01870869|20343224|P1|Overall Study|Reason not Specified|1
5880271|NCT01870869|20343221|P4|Overall Study|Lost to Follow-up|3
5880272|NCT01870869|20343222|P3|Overall Study|Lost to Follow-up|25
5880273|NCT01870869|20343223|P2|Overall Study|Lost to Follow-up|2
5880274|NCT01870869|20343224|P1|Overall Study|Lost to Follow-up|10
5880275|NCT01870869|20343221|P4|Overall Study|Subject choice|8
5880276|NCT01870869|20343222|P3|Overall Study|Subject choice|22
5880277|NCT01870869|20343223|P2|Overall Study|Subject choice|2
5880278|NCT01870869|20343224|P1|Overall Study|Subject choice|6
5880279|NCT01870869|20343221|P4|Overall Study|Death|1
5880280|NCT01870869|20343222|P3|Overall Study|Death|7
5880281|NCT01870869|20343223|P2|Overall Study|Death|0
5880282|NCT01870869|20343224|P1|Overall Study|Death|0
5880283|NCT01870869|20343221|P4|Overall Study|Implanted with nonstudy device|4
5880284|NCT01870869|20343222|P3|Overall Study|Implanted with nonstudy device|14
5880285|NCT01870869|20343223|P2|Overall Study|Implanted with nonstudy device|3
5880286|NCT01870869|20343224|P1|Overall Study|Implanted with nonstudy device|1
5880287|NCT01870843|20343263|P1|Overall Study|Withdrawal by Subject|18
5880288|NCT01870843|20343263|P1|Overall Study|Death|1
5880289|NCT01870843|20343263|P1|Overall Study|Lost to Follow-up|24
5880290|NCT01870843|20343263|P1|Overall Study|Adverse Event|10
5880291|NCT01870778|20343278|P2|Overall Study|Lost to Follow-up|2
5880292|NCT01870778|20343279|P1|Overall Study|Lost to Follow-up|0
5880293|NCT01870778|20343278|P2|Overall Study|Withdrawal by Subject|7
5880294|NCT01870778|20343279|P1|Overall Study|Withdrawal by Subject|8
5880295|NCT01870739|20343305|P2|Add-on Period (40 Weeks)|Patient withdrew consent|0
5880296|NCT01870739|20343306|P1|Add-on Period (40 Weeks)|Patient withdrew consent|1
5880297|NCT01870739|20343305|P2|Add-on Period (40 Weeks)|Protocol deviation|1
5880298|NCT01870739|20343306|P1|Add-on Period (40 Weeks)|Protocol deviation|1
5880299|NCT01870739|20343305|P2|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|0
5880300|NCT01870739|20343306|P1|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|1
5880301|NCT01870739|20343305|P2|Add-on Period (40 Weeks)|Adverse Event|1
5880302|NCT01870739|20343306|P1|Add-on Period (40 Weeks)|Adverse Event|0
5880303|NCT01870739|20343305|P2|Single Drug Treatment (12 Weeks)|Administrative problems|2
5880304|NCT01870739|20343306|P1|Single Drug Treatment (12 Weeks)|Administrative problems|3
5880305|NCT01870739|20343305|P2|Single Drug Treatment (12 Weeks)|Adverse Event|1
5880306|NCT01870739|20343306|P1|Single Drug Treatment (12 Weeks)|Adverse Event|0
5880307|NCT01870739|20343305|P2|Single Drug Treatment (12 Weeks)|Protocol deviation|1
5880308|NCT01870739|20343306|P1|Single Drug Treatment (12 Weeks)|Protocol deviation|0
5880309|NCT01870726|20343345|P7|Overall Study|Progressive disease|10
5880310|NCT01870726|20343346|P6|Overall Study|Progressive disease|4
5880311|NCT01870726|20343347|P5|Overall Study|Progressive disease|6
5880312|NCT01870726|20343348|P4|Overall Study|Progressive disease|5
5880313|NCT01870726|20343349|P3|Overall Study|Progressive disease|4
5880314|NCT01870726|20343350|P2|Overall Study|Progressive disease|5
5880315|NCT01870726|20343351|P1|Overall Study|Progressive disease|5
5880316|NCT01870726|20343345|P7|Overall Study|Adverse Event|0
5880317|NCT01870726|20343346|P6|Overall Study|Adverse Event|1
5880318|NCT01870726|20343347|P5|Overall Study|Adverse Event|1
5880319|NCT01870726|20343348|P4|Overall Study|Adverse Event|0
5880320|NCT01870726|20343349|P3|Overall Study|Adverse Event|0
5880321|NCT01870726|20343350|P2|Overall Study|Adverse Event|0
5880322|NCT01870726|20343351|P1|Overall Study|Adverse Event|0
5880323|NCT01870726|20343345|P7|Overall Study|Withdrawal by Subject|0
5880324|NCT01870726|20343346|P6|Overall Study|Withdrawal by Subject|0
5880325|NCT01870726|20343347|P5|Overall Study|Withdrawal by Subject|0
5880326|NCT01870726|20343348|P4|Overall Study|Withdrawal by Subject|0
5880327|NCT01870726|20343349|P3|Overall Study|Withdrawal by Subject|0
5880328|NCT01870726|20343350|P2|Overall Study|Withdrawal by Subject|1
5880329|NCT01870726|20343351|P1|Overall Study|Withdrawal by Subject|0
5880330|NCT01870726|20343345|P7|Overall Study|Withdrawal of informed consent|0
5880331|NCT01870726|20343346|P6|Overall Study|Withdrawal of informed consent|0
5880332|NCT01870726|20343347|P5|Overall Study|Withdrawal of informed consent|0
5880333|NCT01870726|20343348|P4|Overall Study|Withdrawal of informed consent|1
5880334|NCT01870726|20343349|P3|Overall Study|Withdrawal of informed consent|0
5880335|NCT01870726|20343350|P2|Overall Study|Withdrawal of informed consent|0
5880336|NCT01870726|20343351|P1|Overall Study|Withdrawal of informed consent|0
5880337|NCT01870583|20343446|P3|Overall Study|Lost to Follow-up|5
5880338|NCT01870583|20343447|P2|Overall Study|Lost to Follow-up|13
5880339|NCT01870583|20343448|P1|Overall Study|Lost to Follow-up|11
5880340|NCT01870583|20343446|P3|Overall Study|Protocol Violation|3
5880341|NCT01870583|20343447|P2|Overall Study|Protocol Violation|5
5880342|NCT01870583|20343448|P1|Overall Study|Protocol Violation|0
5880343|NCT01870401|20343458|P2|Overall Study|On-going in the Study|25
5880344|NCT01870401|20343459|P1|Overall Study|On-going in the Study|35
5880345|NCT01870401|20343458|P2|Overall Study|Other|7
5880346|NCT01870401|20343459|P1|Overall Study|Other|9
5880347|NCT01870401|20343458|P2|Overall Study|Lost to Follow-up|14
5880348|NCT01870401|20343459|P1|Overall Study|Lost to Follow-up|19
5880349|NCT01870401|20343458|P2|Overall Study|Withdrawal by Subject|26
5880350|NCT01870401|20343459|P1|Overall Study|Withdrawal by Subject|39
5880351|NCT01870401|20343458|P2|Overall Study|Death|24
5880352|NCT01870401|20343459|P1|Overall Study|Death|48
5880353|NCT01870297|20343535|P7|Overall Study|Sponsor Decision|1
5880354|NCT01870297|20343536|P6|Overall Study|Sponsor Decision|0
5880355|NCT01870297|20343537|P5|Overall Study|Sponsor Decision|0
5880356|NCT01870297|20343538|P4|Overall Study|Sponsor Decision|0
5880357|NCT01870297|20343539|P3|Overall Study|Sponsor Decision|0
5880358|NCT01870297|20343540|P2|Overall Study|Sponsor Decision|6
5880359|NCT01870297|20343541|P1|Overall Study|Sponsor Decision|0
5880360|NCT01870297|20343535|P7|Overall Study|Withdrawal by Subject|1
5880361|NCT01870297|20343536|P6|Overall Study|Withdrawal by Subject|1
5880362|NCT01870297|20343537|P5|Overall Study|Withdrawal by Subject|1
5880363|NCT01870297|20343538|P4|Overall Study|Withdrawal by Subject|0
5880364|NCT01870297|20343539|P3|Overall Study|Withdrawal by Subject|0
5880365|NCT01870297|20343540|P2|Overall Study|Withdrawal by Subject|0
5880366|NCT01870297|20343541|P1|Overall Study|Withdrawal by Subject|0
5880367|NCT01870297|20343535|P7|Overall Study|Lost to Follow-up|0
5880368|NCT01870297|20343536|P6|Overall Study|Lost to Follow-up|0
5880369|NCT01870297|20343537|P5|Overall Study|Lost to Follow-up|0
5880370|NCT01870297|20343538|P4|Overall Study|Lost to Follow-up|0
5880371|NCT01870297|20343539|P3|Overall Study|Lost to Follow-up|1
5880372|NCT01870297|20343540|P2|Overall Study|Lost to Follow-up|1
5880373|NCT01870297|20343541|P1|Overall Study|Lost to Follow-up|0
5880374|NCT01870297|20343535|P7|Overall Study|Adverse Event|0
5880375|NCT01870297|20343536|P6|Overall Study|Adverse Event|0
5880376|NCT01870297|20343537|P5|Overall Study|Adverse Event|2
5880377|NCT01870297|20343538|P4|Overall Study|Adverse Event|0
5880378|NCT01870297|20343539|P3|Overall Study|Adverse Event|0
5880379|NCT01870297|20343540|P2|Overall Study|Adverse Event|0
5880380|NCT01870297|20343541|P1|Overall Study|Adverse Event|0
5880381|NCT01870076|20343585|P4|Overall Study|Withdrawal by Subject|0
5880382|NCT01870076|20343586|P3|Overall Study|Withdrawal by Subject|1
5880383|NCT01870076|20343587|P2|Overall Study|Withdrawal by Subject|0
5880384|NCT01870076|20343588|P1|Overall Study|Withdrawal by Subject|1
5880385|NCT01869959|20343606|P5|Treatment Period|Withdrawal by Subject|0
5880386|NCT01869959|20343607|P4|Treatment Period|Withdrawal by Subject|0
5880387|NCT01869959|20343608|P3|Treatment Period|Withdrawal by Subject|0
5880388|NCT01869959|20343609|P2|Treatment Period|Withdrawal by Subject|1
5880389|NCT01869959|20343610|P1|Treatment Period|Withdrawal by Subject|0
5880390|NCT01869959|20343606|P5|Treatment Period|Sponsor decision|0
5880391|NCT01869959|20343607|P4|Treatment Period|Sponsor decision|1
5880392|NCT01869959|20343608|P3|Treatment Period|Sponsor decision|0
5880393|NCT01869959|20343609|P2|Treatment Period|Sponsor decision|1
5880394|NCT01869959|20343610|P1|Treatment Period|Sponsor decision|0
5880395|NCT01869959|20343606|P5|Treatment Period|Adverse Event|0
5880396|NCT01869959|20343607|P4|Treatment Period|Adverse Event|1
5880397|NCT01869959|20343608|P3|Treatment Period|Adverse Event|3
5880398|NCT01869959|20343609|P2|Treatment Period|Adverse Event|0
5880399|NCT01869959|20343610|P1|Treatment Period|Adverse Event|1
5880400|NCT01869959|20343606|P5|Randomization Period|Physician Decision|1
5880401|NCT01869959|20343607|P4|Randomization Period|Physician Decision|0
5880402|NCT01869959|20343608|P3|Randomization Period|Physician Decision|0
5880403|NCT01869959|20343609|P2|Randomization Period|Physician Decision|0
5880404|NCT01869959|20343610|P1|Randomization Period|Physician Decision|0
5880405|NCT01869777|20343678|P1|Overall Study|Excluded from the analysis, ineligible|1
5880406|NCT01869764|20343691|P2|Overall Study|Withdrawal by Subject|2
5880407|NCT01869764|20343692|P1|Overall Study|Withdrawal by Subject|0
5880408|NCT01869699|20343710|P2|Overall Study|Withdrawal by Subject|0
5880409|NCT01869699|20343711|P1|Overall Study|Withdrawal by Subject|1
5880410|NCT01869348|20343796|P2|Overall Study|Withdrawal by Subject|1
5880411|NCT01869348|20343797|P1|Overall Study|Withdrawal by Subject|1
5880412|NCT01869192|20343805|P2|Postoperative Chemotherapy|Physician Decision|2
5880413|NCT01869192|20343806|P1|Postoperative Chemotherapy|Physician Decision|0
5880414|NCT01869192|20343805|P2|Preoperative Chemotherapy to Surgery|patient choice|1
5880415|NCT01869192|20343806|P1|Preoperative Chemotherapy to Surgery|patient choice|2
5880416|NCT01868997|20343841|P2|Overall Study|Other|1
5880417|NCT01868997|20343842|P1|Overall Study|Other|3
5880418|NCT01868997|20343841|P2|Overall Study|Lack of Efficacy|0
5880419|NCT01868997|20343842|P1|Overall Study|Lack of Efficacy|2
5880420|NCT01868997|20343841|P2|Overall Study|Adverse Event|5
5880421|NCT01868997|20343842|P1|Overall Study|Adverse Event|2
5880422|NCT01868893|20343858|P1|Overall Study|Neutropenia|1
5880423|NCT01868893|20343858|P1|Overall Study|Commercial availability of study drug|17
5880424|NCT01868893|20343858|P1|Overall Study|Adverse Event|2
5880425|NCT01868646|20343889|P2|Overall Study|Do not meet inclusion criteria|5
5880426|NCT01868646|20343890|P1|Overall Study|Do not meet inclusion criteria|3
5880427|NCT01868594|20343935|P2|Overall Study|Do not meet inclusion criteria|3
5880428|NCT01868594|20343936|P1|Overall Study|Do not meet inclusion criteria|4
5880429|NCT01868542|20343956|P2|Overall Study|Unclassified|1
5880430|NCT01868542|20343957|P1|Overall Study|Unclassified|0
5880431|NCT01868542|20343956|P2|Overall Study|Protocol Violation|1
5880432|NCT01868542|20343957|P1|Overall Study|Protocol Violation|0
5880433|NCT01868503|20343975|P1|Overall Study|Protocol Violation|1
5880434|NCT01868503|20343975|P1|Overall Study|Withdrawal by Subject|1
5880435|NCT01868477|20343985|P2|Overall Study|Withdrawal by Subject|0
5880436|NCT01868477|20343986|P1|Overall Study|Withdrawal by Subject|1
5880437|NCT01868477|20343985|P2|Overall Study|Disease progression|1
5880438|NCT01868477|20343986|P1|Overall Study|Disease progression|1
5880439|NCT01868477|20343985|P2|Overall Study|Adverse Event|4
5880440|NCT01868477|20343986|P1|Overall Study|Adverse Event|2
5880441|NCT01868243|20344090|P2|Overall Study|Death|1
5880442|NCT01868243|20344091|P1|Overall Study|Death|0
5880443|NCT01868165|20344099|P1|Overall Study|Death|4
5880444|NCT01868165|20344099|P1|Overall Study|Lost to Follow-up|3
5880445|NCT01868165|20344099|P1|Overall Study|Physician Decision|2
5880446|NCT01868165|20344099|P1|Overall Study|Withdrawal by Subject|36
5880447|NCT01868074|20344115|P2|Overall Study|Withdrawal by Subject|2
5880448|NCT01868074|20344116|P1|Overall Study|Withdrawal by Subject|4
5880449|NCT01868074|20344115|P2|Overall Study|Lost to Follow-up|2
5880450|NCT01868074|20344116|P1|Overall Study|Lost to Follow-up|3
5880451|NCT01868035|20344126|P1|Overall Study|Non-compliance|1
5880452|NCT01868035|20344126|P1|Overall Study|Progressive Disease|2
5880453|NCT01868035|20344126|P1|Overall Study|Withdrawal by Subject|1
5880454|NCT01868035|20344126|P1|Overall Study|Lost to Follow-up|3
5880455|NCT01868022|20344151|P9|Overall Study|Ongoing|0
5880456|NCT01868022|20344152|P8|Overall Study|Ongoing|3
5880457|NCT01868022|20344153|P7|Overall Study|Ongoing|0
5880458|NCT01868022|20344154|P6|Overall Study|Ongoing|0
5880459|NCT01868022|20344155|P5|Overall Study|Ongoing|0
5880460|NCT01868022|20344156|P4|Overall Study|Ongoing|0
5880461|NCT01868022|20344157|P3|Overall Study|Ongoing|0
5880462|NCT01868022|20344158|P2|Overall Study|Ongoing|0
5880463|NCT01868022|20344159|P1|Overall Study|Ongoing|0
5880464|NCT01868022|20344151|P9|Overall Study|Study closed/terminated|0
5880465|NCT01868022|20344152|P8|Overall Study|Study closed/terminated|1
5880466|NCT01868022|20344153|P7|Overall Study|Study closed/terminated|0
5880467|NCT01868022|20344154|P6|Overall Study|Study closed/terminated|0
5880468|NCT01868022|20344155|P5|Overall Study|Study closed/terminated|0
5880469|NCT01868022|20344156|P4|Overall Study|Study closed/terminated|0
5880470|NCT01868022|20344157|P3|Overall Study|Study closed/terminated|0
5880471|NCT01868022|20344158|P2|Overall Study|Study closed/terminated|0
5880472|NCT01868022|20344159|P1|Overall Study|Study closed/terminated|0
5880473|NCT01868022|20344151|P9|Overall Study|Physician Decision|0
5880474|NCT01868022|20344152|P8|Overall Study|Physician Decision|2
5880475|NCT01868022|20344153|P7|Overall Study|Physician Decision|0
5880476|NCT01868022|20344154|P6|Overall Study|Physician Decision|1
5880477|NCT01868022|20344155|P5|Overall Study|Physician Decision|0
5880478|NCT01868022|20344156|P4|Overall Study|Physician Decision|0
5880479|NCT01868022|20344157|P3|Overall Study|Physician Decision|0
5880480|NCT01868022|20344158|P2|Overall Study|Physician Decision|0
5880481|NCT01868022|20344159|P1|Overall Study|Physician Decision|0
5880482|NCT01868022|20344151|P9|Overall Study|Adverse Event|2
5880483|NCT01868022|20344152|P8|Overall Study|Adverse Event|2
5880484|NCT01868022|20344153|P7|Overall Study|Adverse Event|0
5880485|NCT01868022|20344154|P6|Overall Study|Adverse Event|0
5880486|NCT01868022|20344155|P5|Overall Study|Adverse Event|2
5880487|NCT01868022|20344156|P4|Overall Study|Adverse Event|0
5880488|NCT01868022|20344157|P3|Overall Study|Adverse Event|0
5880489|NCT01868022|20344158|P2|Overall Study|Adverse Event|0
5880490|NCT01868022|20344159|P1|Overall Study|Adverse Event|0
5880491|NCT01868022|20344151|P9|Overall Study|Withdrawal by Subject|0
5880492|NCT01868022|20344152|P8|Overall Study|Withdrawal by Subject|1
5880493|NCT01868022|20344153|P7|Overall Study|Withdrawal by Subject|0
5880494|NCT01868022|20344154|P6|Overall Study|Withdrawal by Subject|0
5880495|NCT01868022|20344155|P5|Overall Study|Withdrawal by Subject|0
5880496|NCT01868022|20344156|P4|Overall Study|Withdrawal by Subject|1
5880497|NCT01868022|20344157|P3|Overall Study|Withdrawal by Subject|1
5880498|NCT01868022|20344158|P2|Overall Study|Withdrawal by Subject|0
5880499|NCT01868022|20344159|P1|Overall Study|Withdrawal by Subject|0
5880500|NCT01868009|20344365|P2|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|0
5880501|NCT01868009|20344366|P1|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|1
5880502|NCT01868009|20344365|P2|Period 2 (5-9 Days)|Adverse Event|0
5880503|NCT01868009|20344366|P1|Period 2 (5-9 Days)|Adverse Event|1
5880504|NCT01868009|20344365|P2|Period 1 (5-9 Days)|Adverse Event|2
5880505|NCT01868009|20344366|P1|Period 1 (5-9 Days)|Adverse Event|0
5880506|NCT01867710|20344380|P4|Overall Study|Study medication no longer effective|0
5880507|NCT01867710|20344381|P3|Overall Study|Study medication no longer effective|0
5880508|NCT01867710|20344382|P2|Overall Study|Study medication no longer effective|1
5880509|NCT01867710|20344383|P1|Overall Study|Study medication no longer effective|0
5880510|NCT01867710|20344380|P4|Overall Study|PSA-progression|0
5880511|NCT01867710|20344381|P3|Overall Study|PSA-progression|0
5880512|NCT01867710|20344382|P2|Overall Study|PSA-progression|1
5880513|NCT01867710|20344383|P1|Overall Study|PSA-progression|0
5880514|NCT01867710|20344380|P4|Overall Study|Protocol Violation|1
5880515|NCT01867710|20344381|P3|Overall Study|Protocol Violation|0
5880516|NCT01867710|20344382|P2|Overall Study|Protocol Violation|0
5880517|NCT01867710|20344383|P1|Overall Study|Protocol Violation|0
5880518|NCT01867710|20344380|P4|Overall Study|Progressive disease|0
5880519|NCT01867710|20344381|P3|Overall Study|Progressive disease|0
5880520|NCT01867710|20344382|P2|Overall Study|Progressive disease|0
5880521|NCT01867710|20344383|P1|Overall Study|Progressive disease|1
5880522|NCT01867710|20344380|P4|Overall Study|Patient to follow subsequent treatment|0
5880523|NCT01867710|20344381|P3|Overall Study|Patient to follow subsequent treatment|0
5880524|NCT01867710|20344382|P2|Overall Study|Patient to follow subsequent treatment|1
5880525|NCT01867710|20344383|P1|Overall Study|Patient to follow subsequent treatment|0
5880526|NCT01867710|20344380|P4|Overall Study|Patient decision|1
5880527|NCT01867710|20344381|P3|Overall Study|Patient decision|0
5880528|NCT01867710|20344382|P2|Overall Study|Patient decision|0
5880529|NCT01867710|20344383|P1|Overall Study|Patient decision|0
5880530|NCT01867710|20344380|P4|Overall Study|Disease progression|0
5880531|NCT01867710|20344381|P3|Overall Study|Disease progression|0
5880532|NCT01867710|20344382|P2|Overall Study|Disease progression|0
5880533|NCT01867710|20344383|P1|Overall Study|Disease progression|1
5880534|NCT01867710|20344380|P4|Overall Study|Clinical progression|0
5880535|NCT01867710|20344381|P3|Overall Study|Clinical progression|1
5880536|NCT01867710|20344382|P2|Overall Study|Clinical progression|0
5880537|NCT01867710|20344383|P1|Overall Study|Clinical progression|0
5880538|NCT01867710|20344380|P4|Overall Study|Biochemical progression|0
5880539|NCT01867710|20344381|P3|Overall Study|Biochemical progression|0
5880540|NCT01867710|20344382|P2|Overall Study|Biochemical progression|1
5880541|NCT01867710|20344383|P1|Overall Study|Biochemical progression|0
5880542|NCT01867710|20344380|P4|Overall Study|Study Terminated by Sponsor|16
5880543|NCT01867710|20344381|P3|Overall Study|Study Terminated by Sponsor|8
5880544|NCT01867710|20344382|P2|Overall Study|Study Terminated by Sponsor|13
5880545|NCT01867710|20344383|P1|Overall Study|Study Terminated by Sponsor|9
5880546|NCT01867710|20344380|P4|Overall Study|Withdrawal of consent|2
5880547|NCT01867710|20344381|P3|Overall Study|Withdrawal of consent|1
5880548|NCT01867710|20344382|P2|Overall Study|Withdrawal of consent|5
5880549|NCT01867710|20344383|P1|Overall Study|Withdrawal of consent|2
5880550|NCT01867710|20344380|P4|Overall Study|Lost to Follow-up|2
5880551|NCT01867710|20344381|P3|Overall Study|Lost to Follow-up|3
5880552|NCT01867710|20344382|P2|Overall Study|Lost to Follow-up|4
5880553|NCT01867710|20344383|P1|Overall Study|Lost to Follow-up|3
5880554|NCT01867710|20344380|P4|Overall Study|Death|20
5880555|NCT01867710|20344381|P3|Overall Study|Death|27
5880556|NCT01867710|20344382|P2|Overall Study|Death|15
5880557|NCT01867710|20344383|P1|Overall Study|Death|25
5880558|NCT01867671|20344451|P2|Overall Study|Withdrawal by Subject|21
5880559|NCT01867671|20344452|P1|Overall Study|Withdrawal by Subject|21
5880560|NCT01867671|20344451|P2|Overall Study|Non-compliance with Study Drug|2
5880561|NCT01867671|20344452|P1|Overall Study|Non-compliance with Study Drug|1
5880562|NCT01867671|20344451|P2|Overall Study|Lost to Follow-up|1
5880563|NCT01867671|20344452|P1|Overall Study|Lost to Follow-up|0
5880564|NCT01867671|20344451|P2|Overall Study|Inability to reach 3 mg peanut/placebo|0
5880565|NCT01867671|20344452|P1|Overall Study|Inability to reach 3 mg peanut/placebo|2
5880566|NCT01867671|20344451|P2|Overall Study|Anaphylaxis|1
5880567|NCT01867671|20344452|P1|Overall Study|Anaphylaxis|0
5880568|NCT01867671|20344451|P2|Overall Study|Adverse Event|3
5880569|NCT01867671|20344452|P1|Overall Study|Adverse Event|5
5880570|NCT01867658|20344465|P1|Overall Study|Subject could not be contacted|1
5880571|NCT01867658|20344465|P1|Overall Study|Death|2
5880572|NCT01867658|20344465|P1|Overall Study|Withdrawal by Subject|6
5880573|NCT01867606|20344489|P2|Overall Study|Protocol Violation|1
5880574|NCT01867606|20344490|P1|Overall Study|Protocol Violation|0
5880575|NCT01867606|20344489|P2|Overall Study|Withdrawal by Subject|14
5880576|NCT01867606|20344490|P1|Overall Study|Withdrawal by Subject|10
5880577|NCT01867580|20344508|P2|Overall Study|Wound recurrence|1
5880578|NCT01867580|20344509|P1|Overall Study|Wound recurrence|0
5880579|NCT01867580|20344508|P2|Overall Study|Continuation of therapy|1
5880580|NCT01867580|20344509|P1|Overall Study|Continuation of therapy|0
5880581|NCT01867580|20344508|P2|Overall Study|Osteomyelitis|1
5880582|NCT01867580|20344509|P1|Overall Study|Osteomyelitis|0
5880583|NCT01867580|20344508|P2|Overall Study|Interruption to therapy|0
5880584|NCT01867580|20344509|P1|Overall Study|Interruption to therapy|3
5880585|NCT01867580|20344508|P2|Overall Study|Missed follow-up assessment|1
5880586|NCT01867580|20344509|P1|Overall Study|Missed follow-up assessment|2
5880587|NCT01867580|20344508|P2|Overall Study|Sponsor terminated study|0
5880588|NCT01867580|20344509|P1|Overall Study|Sponsor terminated study|1
5880589|NCT01867580|20344508|P2|Overall Study|Lost to Follow-up|5
5880590|NCT01867580|20344509|P1|Overall Study|Lost to Follow-up|3
5880591|NCT01867580|20344508|P2|Overall Study|Physician Decision|12
5880592|NCT01867580|20344509|P1|Overall Study|Physician Decision|17
5880593|NCT01867580|20344508|P2|Overall Study|Withdrawal by Subject|3
5880594|NCT01867580|20344509|P1|Overall Study|Withdrawal by Subject|2
5880595|NCT01867424|20344534|P2|Overall Study|Patient noncompliance|1
5880596|NCT01867424|20344535|P1|Overall Study|Patient noncompliance|2
5880597|NCT01867307|20344549|P2|Overall Study|Other Adverse Event|3
5880598|NCT01867307|20344550|P1|Overall Study|Other Adverse Event|1
5880599|NCT01867307|20344549|P2|Overall Study|Protocol Violation|0
5880600|NCT01867307|20344550|P1|Overall Study|Protocol Violation|2
5880601|NCT01867294|20344560|P4|Overall Study|Withdrawal by Subject|0
5880602|NCT01867294|20344561|P3|Overall Study|Withdrawal by Subject|0
5880603|NCT01867294|20344562|P2|Overall Study|Withdrawal by Subject|1
5880604|NCT01867294|20344563|P1|Overall Study|Withdrawal by Subject|1
5880605|NCT01867216|20344610|P7|Overall Study|Unable to Place Catheter for Blood Draws|0
5880606|NCT01867216|20344611|P6|Overall Study|Unable to Place Catheter for Blood Draws|0
5880607|NCT01867216|20344612|P5|Overall Study|Unable to Place Catheter for Blood Draws|0
5880608|NCT01867216|20344613|P4|Overall Study|Unable to Place Catheter for Blood Draws|0
5880609|NCT01867216|20344614|P3|Overall Study|Unable to Place Catheter for Blood Draws|0
5880610|NCT01867216|20344615|P2|Overall Study|Unable to Place Catheter for Blood Draws|0
5880611|NCT01867216|20344616|P1|Overall Study|Unable to Place Catheter for Blood Draws|1
5880612|NCT01867216|20344610|P7|Overall Study|Physician Decision|0
5880613|NCT01867216|20344611|P6|Overall Study|Physician Decision|0
5880614|NCT01867216|20344612|P5|Overall Study|Physician Decision|0
5880615|NCT01867216|20344613|P4|Overall Study|Physician Decision|0
5880616|NCT01867216|20344614|P3|Overall Study|Physician Decision|0
5880617|NCT01867216|20344615|P2|Overall Study|Physician Decision|0
5880618|NCT01867216|20344616|P1|Overall Study|Physician Decision|1
5880619|NCT01867216|20344610|P7|Overall Study|Withdrawal by Subject|1
5880620|NCT01867216|20344611|P6|Overall Study|Withdrawal by Subject|0
5880621|NCT01867216|20344612|P5|Overall Study|Withdrawal by Subject|1
5880622|NCT01867216|20344613|P4|Overall Study|Withdrawal by Subject|0
5880623|NCT01867216|20344614|P3|Overall Study|Withdrawal by Subject|0
5880624|NCT01867216|20344615|P2|Overall Study|Withdrawal by Subject|0
5880625|NCT01867216|20344616|P1|Overall Study|Withdrawal by Subject|2
5880626|NCT01867086|20344688|P1|Overall Study|Disease Progression|1
5880627|NCT01867047|20344697|P2|Overall Study|surgery not indicated in protocol|2
5880628|NCT01867047|20344698|P1|Overall Study|surgery not indicated in protocol|1
5880629|NCT01867047|20344697|P2|Overall Study|Physician Decision|0
5880630|NCT01867047|20344698|P1|Overall Study|Physician Decision|2
5880631|NCT01867047|20344697|P2|Overall Study|Withdrawal by Subject|0
5880632|NCT01867047|20344698|P1|Overall Study|Withdrawal by Subject|2
5880633|NCT01867047|20344697|P2|Overall Study|Lost to Follow-up|3
5880634|NCT01867047|20344698|P1|Overall Study|Lost to Follow-up|3
5880635|NCT01867021|20344718|P2|Overall Study|Withdrawal by Subject|6
5880636|NCT01867021|20344719|P1|Overall Study|Withdrawal by Subject|1
5880637|NCT01867021|20344718|P2|Overall Study|Lost to Follow-up|2
5880638|NCT01867021|20344719|P1|Overall Study|Lost to Follow-up|0
5880639|NCT01867021|20344718|P2|Overall Study|Death|0
5880640|NCT01867021|20344719|P1|Overall Study|Death|1
5880641|NCT01867021|20344718|P2|Overall Study|Not Eligible|1
5880642|NCT01867021|20344719|P1|Overall Study|Not Eligible|0
5880643|NCT01867021|20344718|P2|Overall Study|Adverse Event|1
5880644|NCT01867021|20344719|P1|Overall Study|Adverse Event|0
5880645|NCT01867008|20344738|P1|Overall Study|Withdrawal by Subject|1
5880646|NCT01866917|20344754|P2|Overall Study|Pharmacist stopped dispensing treatment|6
5880647|NCT01866917|20344755|P1|Overall Study|Pharmacist stopped dispensing treatment|4
5880648|NCT01866826|20344779|P2|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|1
5880649|NCT01866826|20344780|P1|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|0
5880650|NCT01866826|20344779|P2|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|2
5880651|NCT01866826|20344780|P1|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|0
5880652|NCT01866826|20344779|P2|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|0
5880653|NCT01866826|20344780|P1|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|1
5880654|NCT01866709|20344796|P2|Overall Study|Adverse Event|0
5880655|NCT01866709|20344797|P1|Overall Study|Adverse Event|1
5880656|NCT01866423|20344838|P1|Overall Study|Sponsor Decision|1
5880657|NCT01866423|20344838|P1|Overall Study|Lack of Efficacy|3
5880658|NCT01866319|20344866|P3|Overall Study|Withdrawal by Subject|12
5880659|NCT01866319|20344867|P2|Overall Study|Withdrawal by Subject|14
5880660|NCT01866319|20344868|P1|Overall Study|Withdrawal by Subject|32
5880661|NCT01866319|20344866|P3|Overall Study|Protocol Violation|1
5880662|NCT01866319|20344867|P2|Overall Study|Protocol Violation|0
5880663|NCT01866319|20344868|P1|Overall Study|Protocol Violation|0
5880664|NCT01866319|20344866|P3|Overall Study|Physician Decision|1
5880665|NCT01866319|20344867|P2|Overall Study|Physician Decision|0
5880666|NCT01866319|20344868|P1|Overall Study|Physician Decision|1
5880667|NCT01866319|20344866|P3|Overall Study|Lost to Follow-up|8
5880668|NCT01866319|20344867|P2|Overall Study|Lost to Follow-up|3
5880669|NCT01866319|20344868|P1|Overall Study|Lost to Follow-up|6
5880670|NCT01866319|20344866|P3|Overall Study|Death|147
5880671|NCT01866319|20344867|P2|Overall Study|Death|154
5880672|NCT01866319|20344868|P1|Overall Study|Death|153
5880673|NCT01866319|20344866|P3|Overall Study|Clinical progression|2
5880674|NCT01866319|20344867|P2|Overall Study|Clinical progression|2
5880675|NCT01866319|20344868|P1|Overall Study|Clinical progression|3
5880676|NCT01866319|20344866|P3|Overall Study|Adverse Event|9
5880677|NCT01866319|20344867|P2|Overall Study|Adverse Event|5
5880678|NCT01866319|20344868|P1|Overall Study|Adverse Event|12
5880679|NCT01866293|20344967|P1|Overall Study|Adverse Event|2
5880680|NCT01866098|20345012|P3|Overall Study|Death|0
5880681|NCT01866098|20345013|P2|Overall Study|Death|1
5880682|NCT01866098|20345014|P1|Overall Study|Death|0
5880683|NCT01866098|20345012|P3|Overall Study|Pregnancy|0
5880684|NCT01866098|20345013|P2|Overall Study|Pregnancy|0
5880685|NCT01866098|20345014|P1|Overall Study|Pregnancy|2
5880686|NCT01866098|20345012|P3|Overall Study|Non-compliance|1
5880687|NCT01866098|20345013|P2|Overall Study|Non-compliance|0
5880688|NCT01866098|20345014|P1|Overall Study|Non-compliance|1
5880689|NCT01866098|20345012|P3|Overall Study|Unrelated Hospitalization|1
5880690|NCT01866098|20345013|P2|Overall Study|Unrelated Hospitalization|0
5880691|NCT01866098|20345014|P1|Overall Study|Unrelated Hospitalization|2
5880692|NCT01866098|20345012|P3|Overall Study|Withdrawal by Subject|0
5880693|NCT01866098|20345013|P2|Overall Study|Withdrawal by Subject|2
5880694|NCT01866098|20345014|P1|Overall Study|Withdrawal by Subject|1
5880695|NCT01866098|20345012|P3|Overall Study|Protocol Violation|0
5880696|NCT01866098|20345013|P2|Overall Study|Protocol Violation|0
5880697|NCT01866098|20345014|P1|Overall Study|Protocol Violation|1
5880698|NCT01866098|20345012|P3|Overall Study|Adverse Event|4
5880699|NCT01866098|20345013|P2|Overall Study|Adverse Event|5
5880700|NCT01866098|20345014|P1|Overall Study|Adverse Event|1
5880701|NCT01866098|20345012|P3|Overall Study|Physician Decision|2
5880702|NCT01866098|20345013|P2|Overall Study|Physician Decision|1
5880703|NCT01866098|20345014|P1|Overall Study|Physician Decision|0
5880704|NCT01866098|20345012|P3|Overall Study|Lost to Follow-up|13
5880705|NCT01866098|20345013|P2|Overall Study|Lost to Follow-up|18
5880706|NCT01866098|20345014|P1|Overall Study|Lost to Follow-up|11
5880707|NCT01865812|20345043|P1|Overall Study|Adverse Event|2
5880708|NCT01865747|20345051|P2|Primary Intent to Treat (PITT)|Other|1
5880709|NCT01865747|20345052|P1|Primary Intent to Treat (PITT)|Other|0
5880710|NCT01865747|20345051|P2|Primary Intent to Treat (PITT)|Progressive Disease|92
5880711|NCT01865747|20345052|P1|Primary Intent to Treat (PITT)|Progressive Disease|82
5880712|NCT01865747|20345051|P2|Primary Intent to Treat (PITT)|Withdrawal by Subject|7
5880713|NCT01865747|20345052|P1|Primary Intent to Treat (PITT)|Withdrawal by Subject|3
5880714|NCT01865747|20345051|P2|Primary Intent to Treat (PITT)|Physician Decision|2
5880715|NCT01865747|20345052|P1|Primary Intent to Treat (PITT)|Physician Decision|4
5880716|NCT01865747|20345051|P2|Primary Intent to Treat (PITT)|Protocol Violation|1
5880717|NCT01865747|20345052|P1|Primary Intent to Treat (PITT)|Protocol Violation|1
5880718|NCT01865747|20345051|P2|Primary Intent to Treat (PITT)|Lack of Efficacy|0
5880719|NCT01865747|20345052|P1|Primary Intent to Treat (PITT)|Lack of Efficacy|2
5880720|NCT01865747|20345051|P2|Primary Intent to Treat (PITT)|Clinical Deterioration|29
5880721|NCT01865747|20345052|P1|Primary Intent to Treat (PITT)|Clinical Deterioration|18
5880722|NCT01865747|20345051|P2|Primary Intent to Treat (PITT)|Adverse Event|20
5880723|NCT01865747|20345052|P1|Primary Intent to Treat (PITT)|Adverse Event|21
5880724|NCT01865747|20345051|P2|Overall Study (ITT)|Reason Not Provided|1
5880725|NCT01865747|20345052|P1|Overall Study (ITT)|Reason Not Provided|0
5880726|NCT01865747|20345051|P2|Overall Study (ITT)|Progressive Disease|158
5880727|NCT01865747|20345052|P1|Overall Study (ITT)|Progressive Disease|122
5880728|NCT01865747|20345051|P2|Overall Study (ITT)|Sponsor Decision|1
5880729|NCT01865747|20345052|P1|Overall Study (ITT)|Sponsor Decision|0
5880730|NCT01865747|20345051|P2|Overall Study (ITT)|Withdrawal by Subject|11
5880731|NCT01865747|20345052|P1|Overall Study (ITT)|Withdrawal by Subject|6
5880732|NCT01865747|20345051|P2|Overall Study (ITT)|Physician Decision|2
5880733|NCT01865747|20345052|P1|Overall Study (ITT)|Physician Decision|5
5880734|NCT01865747|20345051|P2|Overall Study (ITT)|Protocol Violation|1
5880735|NCT01865747|20345052|P1|Overall Study (ITT)|Protocol Violation|1
5880736|NCT01865747|20345051|P2|Overall Study (ITT)|Lack of Efficacy|0
5880737|NCT01865747|20345052|P1|Overall Study (ITT)|Lack of Efficacy|3
5880738|NCT01865747|20345051|P2|Overall Study (ITT)|Clinical Deterioration|50
5880739|NCT01865747|20345052|P1|Overall Study (ITT)|Clinical Deterioration|29
5880740|NCT01865747|20345051|P2|Overall Study (ITT)|Adverse Event|31
5880741|NCT01865747|20345052|P1|Overall Study (ITT)|Adverse Event|32
5880742|NCT01865552|20345073|P6|Period 1|Other|0
5880743|NCT01865552|20345074|P5|Period 1|Other|1
5880744|NCT01865552|20345075|P4|Period 1|Other|0
5880745|NCT01865552|20345076|P3|Period 1|Other|0
5880746|NCT01865552|20345077|P2|Period 1|Other|0
5880747|NCT01865552|20345078|P1|Period 1|Other|0
5880748|NCT01865552|20345073|P6|Period 1|Pathological lab|0
5880749|NCT01865552|20345074|P5|Period 1|Pathological lab|1
5880750|NCT01865552|20345075|P4|Period 1|Pathological lab|0
5880751|NCT01865552|20345076|P3|Period 1|Pathological lab|0
5880752|NCT01865552|20345077|P2|Period 1|Pathological lab|0
5880753|NCT01865552|20345078|P1|Period 1|Pathological lab|0
5880754|NCT01865552|20345073|P6|Period 1|Adverse Event|1
5880755|NCT01865552|20345074|P5|Period 1|Adverse Event|1
5880756|NCT01865552|20345075|P4|Period 1|Adverse Event|1
5880757|NCT01865552|20345076|P3|Period 1|Adverse Event|0
5880758|NCT01865552|20345077|P2|Period 1|Adverse Event|0
5880759|NCT01865552|20345078|P1|Period 1|Adverse Event|1
5880760|NCT01865487|20345116|P10|Overall Study|Withdrawal by Subject|0
5880761|NCT01865487|20345117|P9|Overall Study|Withdrawal by Subject|0
5880762|NCT01865487|20345118|P8|Overall Study|Withdrawal by Subject|0
5880763|NCT01865487|20345119|P7|Overall Study|Withdrawal by Subject|0
5880764|NCT01865487|20345120|P6|Overall Study|Withdrawal by Subject|0
5880765|NCT01865487|20345121|P5|Overall Study|Withdrawal by Subject|1
5880766|NCT01865487|20345122|P4|Overall Study|Withdrawal by Subject|0
5880767|NCT01865487|20345123|P3|Overall Study|Withdrawal by Subject|0
5880768|NCT01865487|20345124|P2|Overall Study|Withdrawal by Subject|0
5880769|NCT01865487|20345125|P1|Overall Study|Withdrawal by Subject|0
5880770|NCT01865487|20345116|P10|Overall Study|Lost to Follow-up|0
5880771|NCT01865487|20345117|P9|Overall Study|Lost to Follow-up|0
5880772|NCT01865487|20345118|P8|Overall Study|Lost to Follow-up|0
5880773|NCT01865487|20345119|P7|Overall Study|Lost to Follow-up|1
5880774|NCT01865487|20345120|P6|Overall Study|Lost to Follow-up|0
5880775|NCT01865487|20345121|P5|Overall Study|Lost to Follow-up|0
5880776|NCT01865487|20345122|P4|Overall Study|Lost to Follow-up|1
5880777|NCT01865487|20345123|P3|Overall Study|Lost to Follow-up|0
5880778|NCT01865487|20345124|P2|Overall Study|Lost to Follow-up|0
5880779|NCT01865487|20345125|P1|Overall Study|Lost to Follow-up|0
5880780|NCT01865448|20345164|P2|Overall Study|dropout unrelated to study|1
5880781|NCT01865448|20345165|P1|Overall Study|dropout unrelated to study|1
5880782|NCT01865448|20345164|P2|Overall Study|Pregnancy|1
5880783|NCT01865448|20345165|P1|Overall Study|Pregnancy|0
5880784|NCT01865448|20345164|P2|Overall Study|Adverse Event|1
5880785|NCT01865448|20345165|P1|Overall Study|Adverse Event|1
5880786|NCT01865084|20345276|P3|Open Label Extension (OLE) Period|Withdrawal by Subject|2
5880787|NCT01865084|20345277|P2|Open Label Extension (OLE) Period|Withdrawal by Subject|2
5880788|NCT01865084|20345278|P1|Open Label Extension (OLE) Period|Withdrawal by Subject|0
5880789|NCT01865084|20345276|P3|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|2
5880790|NCT01865084|20345277|P2|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|8
5880791|NCT01865084|20345278|P1|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|0
5880792|NCT01865084|20345276|P3|Open Label Extension (OLE) Period|Lost to Follow-up|0
5880793|NCT01865084|20345277|P2|Open Label Extension (OLE) Period|Lost to Follow-up|1
5880794|NCT01865084|20345278|P1|Open Label Extension (OLE) Period|Lost to Follow-up|0
5880795|NCT01865084|20345276|P3|Open Label Extension (OLE) Period|Lack of Efficacy|2
5880796|NCT01865084|20345277|P2|Open Label Extension (OLE) Period|Lack of Efficacy|0
5880797|NCT01865084|20345278|P1|Open Label Extension (OLE) Period|Lack of Efficacy|0
5880798|NCT01865084|20345276|P3|Open Label Extension (OLE) Period|Adverse Event|1
5880799|NCT01865084|20345277|P2|Open Label Extension (OLE) Period|Adverse Event|0
5880800|NCT01865084|20345278|P1|Open Label Extension (OLE) Period|Adverse Event|0
5880801|NCT01865084|20345276|P3|Double Blind Period (DB)|Withdrawal by Subject|0
5880802|NCT01865084|20345277|P2|Double Blind Period (DB)|Withdrawal by Subject|0
5880803|NCT01865084|20345278|P1|Double Blind Period (DB)|Withdrawal by Subject|1
5880804|NCT01865084|20345276|P3|Double Blind Period (DB)|Withdrawal by Parent/Guardian|4
5880805|NCT01865084|20345277|P2|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2
5880806|NCT01865084|20345278|P1|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2
5880807|NCT01865084|20345276|P3|Double Blind Period (DB)|Protocol Violation|1
5880808|NCT01865084|20345277|P2|Double Blind Period (DB)|Protocol Violation|0
5880809|NCT01865084|20345278|P1|Double Blind Period (DB)|Protocol Violation|0
5880810|NCT01865084|20345276|P3|Double Blind Period (DB)|Adverse Event|1
5880811|NCT01865084|20345277|P2|Double Blind Period (DB)|Adverse Event|2
5880812|NCT01865084|20345278|P1|Double Blind Period (DB)|Adverse Event|2
5880813|NCT01864564|20345306|P2|Overall Study|not reported|34
5880814|NCT01864564|20345307|P1|Overall Study|not reported|0
5880815|NCT01864564|20345306|P2|Overall Study|Protocol Violation|27
5880816|NCT01864564|20345307|P1|Overall Study|Protocol Violation|0
5880817|NCT01864564|20345306|P2|Overall Study|Withdrawal by Subject|11
5880818|NCT01864564|20345307|P1|Overall Study|Withdrawal by Subject|20
5880819|NCT01864564|20345306|P2|Overall Study|Lost to Follow-up|23
5880820|NCT01864564|20345307|P1|Overall Study|Lost to Follow-up|17
5880821|NCT01864525|20345339|P2|Overall Study|Adverse Event|0
5880822|NCT01864525|20345340|P1|Overall Study|Adverse Event|1
5880823|NCT01864291|20345361|P1|Overall Study|need for revision surgery|2
5880824|NCT01864200|20345369|P2|Overall Study|Protocol Violation|0
5880825|NCT01864200|20345370|P1|Overall Study|Protocol Violation|1
5880826|NCT01864200|20345369|P2|Overall Study|Lost to Follow-up|3
5880827|NCT01864200|20345370|P1|Overall Study|Lost to Follow-up|1
5880828|NCT01864174|20345378|P2|Off Treatment Follow-Up|Subject Withdrew Consent|0
5880829|NCT01864174|20345379|P1|Off Treatment Follow-Up|Subject Withdrew Consent|1
5880830|NCT01864174|20345378|P2|Off Treatment Follow-Up|Other|0
5880831|NCT01864174|20345379|P1|Off Treatment Follow-Up|Other|2
5880832|NCT01864174|20345378|P2|Double Blind - Compliant Randomized|Other|10
5880833|NCT01864174|20345379|P1|Double Blind - Compliant Randomized|Other|6
5880834|NCT01864174|20345378|P2|Double Blind - Compliant Randomized|Poor/Non-compliance|0
5880835|NCT01864174|20345379|P1|Double Blind - Compliant Randomized|Poor/Non-compliance|1
5880836|NCT01864174|20345378|P2|Double Blind - Compliant Randomized|Lost to Follow-up|10
5880837|NCT01864174|20345379|P1|Double Blind - Compliant Randomized|Lost to Follow-up|3
5880838|NCT01864174|20345378|P2|Double Blind - Compliant Randomized|Death|0
5880839|NCT01864174|20345379|P1|Double Blind - Compliant Randomized|Death|1
5880840|NCT01864174|20345378|P2|Double Blind - Compliant Randomized|Subject Withdrew Consent|5
5880841|NCT01864174|20345379|P1|Double Blind - Compliant Randomized|Subject Withdrew Consent|4
5880842|NCT01864174|20345378|P2|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|0
5880843|NCT01864174|20345379|P1|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|2
5880844|NCT01864174|20345378|P2|Double Blind - Compliant Randomized|Adverse Event|1
5880845|NCT01864174|20345379|P1|Double Blind - Compliant Randomized|Adverse Event|6
5880846|NCT01864174|20345378|P2|Double Blind Treatment - All Treated|Removed due to site non-compliance|14
5880847|NCT01864174|20345379|P1|Double Blind Treatment - All Treated|Removed due to site non-compliance|15
5880848|NCT01864148|20345398|P5|Overall Study|Not Dosed|0
5880849|NCT01864148|20345399|P4|Overall Study|Not Dosed|1
5880850|NCT01864148|20345400|P3|Overall Study|Not Dosed|0
5880851|NCT01864148|20345401|P2|Overall Study|Not Dosed|0
5880852|NCT01864148|20345402|P1|Overall Study|Not Dosed|0
5880853|NCT01864148|20345398|P5|Overall Study|Adverse Event|7
5880854|NCT01864148|20345399|P4|Overall Study|Adverse Event|7
5880855|NCT01864148|20345400|P3|Overall Study|Adverse Event|4
5880856|NCT01864148|20345401|P2|Overall Study|Adverse Event|2
5880857|NCT01864148|20345402|P1|Overall Study|Adverse Event|4
5880858|NCT01864148|20345398|P5|Overall Study|Lost to Follow-up|1
5880859|NCT01864148|20345399|P4|Overall Study|Lost to Follow-up|2
5880860|NCT01864148|20345400|P3|Overall Study|Lost to Follow-up|0
5880861|NCT01864148|20345401|P2|Overall Study|Lost to Follow-up|0
5880862|NCT01864148|20345402|P1|Overall Study|Lost to Follow-up|0
5880863|NCT01864148|20345398|P5|Overall Study|Withdrawal by Subject|8
5880864|NCT01864148|20345399|P4|Overall Study|Withdrawal by Subject|8
5880865|NCT01864148|20345400|P3|Overall Study|Withdrawal by Subject|6
5880866|NCT01864148|20345401|P2|Overall Study|Withdrawal by Subject|2
5880867|NCT01864148|20345402|P1|Overall Study|Withdrawal by Subject|9
5880868|NCT01864148|20345398|P5|Overall Study|Investigator Decision|6
5880869|NCT01864148|20345399|P4|Overall Study|Investigator Decision|4
5880870|NCT01864148|20345400|P3|Overall Study|Investigator Decision|0
5880871|NCT01864148|20345401|P2|Overall Study|Investigator Decision|0
5880872|NCT01864148|20345402|P1|Overall Study|Investigator Decision|5
5880873|NCT01864148|20345398|P5|Overall Study|Death|0
5880874|NCT01864148|20345399|P4|Overall Study|Death|1
5880875|NCT01864148|20345400|P3|Overall Study|Death|0
5880876|NCT01864148|20345401|P2|Overall Study|Death|0
5880877|NCT01864148|20345402|P1|Overall Study|Death|0
5880878|NCT01864148|20345398|P5|Overall Study|Other|1
5880879|NCT01864148|20345399|P4|Overall Study|Other|3
5880880|NCT01864148|20345400|P3|Overall Study|Other|1
5880881|NCT01864148|20345401|P2|Overall Study|Other|1
5880882|NCT01864148|20345402|P1|Overall Study|Other|2
5880883|NCT01864005|20345431|P2|Overall Study|Need GP IIb/IIIa|3
5880884|NCT01864005|20345432|P1|Overall Study|Need GP IIb/IIIa|1
5880885|NCT01864005|20345431|P2|Overall Study|Disease need|1
5880886|NCT01864005|20345432|P1|Overall Study|Disease need|1
5880887|NCT01864005|20345431|P2|Overall Study|Incorrect enrolment|0
5880888|NCT01864005|20345432|P1|Overall Study|Incorrect enrolment|1
5880889|NCT01864005|20345431|P2|Overall Study|Withdrawal by Subject|1
5880890|NCT01864005|20345432|P1|Overall Study|Withdrawal by Subject|0
5880891|NCT01864005|20345431|P2|Overall Study|Protocol Violation|1
5880892|NCT01864005|20345432|P1|Overall Study|Protocol Violation|0
5880893|NCT01863953|20345449|P3|Overall Study|Adverse Event|1
5880894|NCT01863953|20345450|P2|Overall Study|Adverse Event|0
5880895|NCT01863953|20345451|P1|Overall Study|Adverse Event|0
5880896|NCT01863771|20345465|P4|Maintenance Phase|Withdrawal by Subject|3
5880897|NCT01863771|20345466|P3|Maintenance Phase|Withdrawal by Subject|2
5880898|NCT01863771|20345467|P2|Maintenance Phase|Withdrawal by Subject|1
5880899|NCT01863771|20345468|P1|Maintenance Phase|Withdrawal by Subject|0
5880900|NCT01863771|20345465|P4|Maintenance Phase|Pregnancy|0
5880901|NCT01863771|20345466|P3|Maintenance Phase|Pregnancy|0
5880902|NCT01863771|20345467|P2|Maintenance Phase|Pregnancy|1
5880903|NCT01863771|20345468|P1|Maintenance Phase|Pregnancy|0
5880904|NCT01863771|20345465|P4|Maintenance Phase|Physician Decision|1
5880905|NCT01863771|20345466|P3|Maintenance Phase|Physician Decision|2
5880906|NCT01863771|20345467|P2|Maintenance Phase|Physician Decision|0
5880907|NCT01863771|20345468|P1|Maintenance Phase|Physician Decision|0
5880908|NCT01863771|20345465|P4|Maintenance Phase|Lack of Efficacy|38
5880909|NCT01863771|20345466|P3|Maintenance Phase|Lack of Efficacy|7
5880910|NCT01863771|20345467|P2|Maintenance Phase|Lack of Efficacy|3
5880911|NCT01863771|20345468|P1|Maintenance Phase|Lack of Efficacy|0
5880912|NCT01863771|20345465|P4|Maintenance Phase|Adverse Event|1
5880913|NCT01863771|20345466|P3|Maintenance Phase|Adverse Event|1
5880914|NCT01863771|20345467|P2|Maintenance Phase|Adverse Event|0
5880915|NCT01863771|20345468|P1|Maintenance Phase|Adverse Event|0
5880916|NCT01863771|20345465|P4|Induction Phase|Withdrawal by Subject|0
5880917|NCT01863771|20345466|P3|Induction Phase|Withdrawal by Subject|0
5880918|NCT01863771|20345467|P2|Induction Phase|Withdrawal by Subject|0
5880919|NCT01863771|20345468|P1|Induction Phase|Withdrawal by Subject|2
5880920|NCT01863771|20345465|P4|Induction Phase|Lack of Efficacy|0
5880921|NCT01863771|20345466|P3|Induction Phase|Lack of Efficacy|0
5880922|NCT01863771|20345467|P2|Induction Phase|Lack of Efficacy|0
5880923|NCT01863771|20345468|P1|Induction Phase|Lack of Efficacy|10
5880924|NCT01863771|20345465|P4|Induction Phase|Adverse Event|0
5880925|NCT01863771|20345466|P3|Induction Phase|Adverse Event|0
5880926|NCT01863771|20345467|P2|Induction Phase|Adverse Event|0
5880927|NCT01863771|20345468|P1|Induction Phase|Adverse Event|9
5880928|NCT01863758|20345480|P1|Prophylactic Treatment-Phase II|Lost to Follow-up|1
5880929|NCT01863758|20345480|P1|Prophylactic Treatment-Phase II|investigator Error of Early Termination|1
5880930|NCT01863732|20345492|P4|Overall Study|Death|1
5880931|NCT01863732|20345493|P3|Overall Study|Death|0
5880932|NCT01863732|20345494|P2|Overall Study|Death|0
5880933|NCT01863732|20345495|P1|Overall Study|Death|1
5880934|NCT01863732|20345492|P4|Overall Study|Subject/guardian decision|1
5880935|NCT01863732|20345493|P3|Overall Study|Subject/guardian decision|3
5880936|NCT01863732|20345494|P2|Overall Study|Subject/guardian decision|9
5880937|NCT01863732|20345495|P1|Overall Study|Subject/guardian decision|6
5880938|NCT01863732|20345492|P4|Overall Study|Technical problems|0
5880939|NCT01863732|20345493|P3|Overall Study|Technical problems|1
5880940|NCT01863732|20345494|P2|Overall Study|Technical problems|1
5880941|NCT01863732|20345495|P1|Overall Study|Technical problems|0
5880942|NCT01863732|20345492|P4|Overall Study|Pregnancy|1
5880943|NCT01863732|20345493|P3|Overall Study|Pregnancy|0
5880944|NCT01863732|20345494|P2|Overall Study|Pregnancy|0
5880945|NCT01863732|20345495|P1|Overall Study|Pregnancy|0
5880946|NCT01863732|20345492|P4|Overall Study|Physician Decision|0
5880947|NCT01863732|20345493|P3|Overall Study|Physician Decision|1
5880948|NCT01863732|20345494|P2|Overall Study|Physician Decision|0
5880949|NCT01863732|20345495|P1|Overall Study|Physician Decision|1
5880950|NCT01863732|20345492|P4|Overall Study|Lost to Follow-up|1
5880951|NCT01863732|20345493|P3|Overall Study|Lost to Follow-up|1
5880952|NCT01863732|20345494|P2|Overall Study|Lost to Follow-up|2
5880953|NCT01863732|20345495|P1|Overall Study|Lost to Follow-up|2
5880954|NCT01863732|20345492|P4|Overall Study|Lack of Efficacy|1
5880955|NCT01863732|20345493|P3|Overall Study|Lack of Efficacy|2
5880956|NCT01863732|20345494|P2|Overall Study|Lack of Efficacy|0
5880957|NCT01863732|20345495|P1|Overall Study|Lack of Efficacy|1
5880958|NCT01863732|20345492|P4|Overall Study|Adverse Event|3
5880959|NCT01863732|20345493|P3|Overall Study|Adverse Event|3
5880960|NCT01863732|20345494|P2|Overall Study|Adverse Event|0
5880961|NCT01863732|20345495|P1|Overall Study|Adverse Event|2
5880962|NCT01863680|20345508|P1|Overall Study|Other|6
5880963|NCT01863680|20345508|P1|Overall Study|Did not undergo IVF/ET|14
5880964|NCT01863680|20345508|P1|Overall Study|Withdrawal by Subject|1
5880965|NCT01863680|20345508|P1|Overall Study|Spontaneous pregnancy|2
5880966|NCT01863680|20345508|P1|Overall Study|Risk of OHSS|17
5880967|NCT01863680|20345508|P1|Overall Study|Adverse Event|17
5880968|NCT01863667|20345516|P2|Overall Study|Withdrawal by Subject|2
5880969|NCT01863667|20345517|P1|Overall Study|Withdrawal by Subject|2
5880970|NCT01863667|20345516|P2|Overall Study|Study terminated by Sponsor|30
5880971|NCT01863667|20345517|P1|Overall Study|Study terminated by Sponsor|30
5880972|NCT01863667|20345516|P2|Overall Study|Adverse Event|0
5880973|NCT01863667|20345517|P1|Overall Study|Adverse Event|1
5880974|NCT01863433|20345554|P1|Overall Study|Protocol Violation|1
5880975|NCT01863368|20345564|P2|Phase II, Day 35 to Day 90|Lost to Follow-up|0
5880976|NCT01863368|20345565|P1|Phase II, Day 35 to Day 90|Lost to Follow-up|1
5880977|NCT01863368|20345564|P2|Phase II, Day 35 to Day 90|Adverse Event|0
5880978|NCT01863368|20345565|P1|Phase II, Day 35 to Day 90|Adverse Event|1
5880979|NCT01863368|20345564|P2|Phase I, Day 0 to Day 35|Withdrawal by Subject|2
5880980|NCT01863368|20345565|P1|Phase I, Day 0 to Day 35|Withdrawal by Subject|0
5880981|NCT01863368|20345564|P2|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|1
5880982|NCT01863368|20345565|P1|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|0
5880983|NCT01863368|20345564|P2|Phase I, Day 0 to Day 35|Lost to Follow-up|0
5880984|NCT01863368|20345565|P1|Phase I, Day 0 to Day 35|Lost to Follow-up|1
5880985|NCT01863368|20345564|P2|Phase I, Day 0 to Day 35|Adverse Event|4
5880986|NCT01863368|20345565|P1|Phase I, Day 0 to Day 35|Adverse Event|2
5880987|NCT01862991|20345619|P3|Overall Study|Protocol Violation|0
5880988|NCT01862991|20345620|P2|Overall Study|Protocol Violation|0
5880989|NCT01862991|20345621|P1|Overall Study|Protocol Violation|1
5880990|NCT01862991|20345619|P3|Overall Study|Lost to Follow-up|1
5880991|NCT01862991|20345620|P2|Overall Study|Lost to Follow-up|1
5880992|NCT01862991|20345621|P1|Overall Study|Lost to Follow-up|2
5880993|NCT01862874|20345634|P2|Overall Study|Death|1
5880994|NCT01862874|20345635|P1|Overall Study|Death|0
5880995|NCT01862874|20345634|P2|Overall Study|Withdrawal by Subject|40
5880996|NCT01862874|20345635|P1|Overall Study|Withdrawal by Subject|46
5880997|NCT01862874|20345634|P2|Overall Study|Withdrawn by parent/guardian|1
5880998|NCT01862874|20345635|P1|Overall Study|Withdrawn by parent/guardian|1
5880999|NCT01862874|20345634|P2|Overall Study|Physician Decision|3
5881000|NCT01862874|20345635|P1|Overall Study|Physician Decision|5
5881001|NCT01862874|20345634|P2|Overall Study|Lost to Follow-up|29
5881002|NCT01862874|20345635|P1|Overall Study|Lost to Follow-up|26
5881003|NCT01862874|20345634|P2|Overall Study|Adverse Event|3
5881004|NCT01862874|20345635|P1|Overall Study|Adverse Event|0
5881005|NCT01862874|20345634|P2|Overall Study|Randomized not treated|0
5881006|NCT01862874|20345635|P1|Overall Study|Randomized not treated|1
5881007|NCT01862796|20345654|P3|Overall Study|Prohibited medications|1
5881008|NCT01862796|20345655|P2|Overall Study|Prohibited medications|0
5881009|NCT01862796|20345656|P1|Overall Study|Prohibited medications|0
5881010|NCT01862640|20345671|P4|Overall Study|Protocol Deviation|0
5881011|NCT01862640|20345672|P3|Overall Study|Protocol Deviation|1
5881012|NCT01862640|20345673|P2|Overall Study|Protocol Deviation|0
5881013|NCT01862640|20345674|P1|Overall Study|Protocol Deviation|0
5881014|NCT01862640|20345671|P4|Overall Study|Withdrawal by Subject|5
5881015|NCT01862640|20345672|P3|Overall Study|Withdrawal by Subject|8
5881016|NCT01862640|20345673|P2|Overall Study|Withdrawal by Subject|4
5881017|NCT01862640|20345674|P1|Overall Study|Withdrawal by Subject|2
5881018|NCT01862640|20345671|P4|Overall Study|Participant Withdrawn by Investigator|1
5881019|NCT01862640|20345672|P3|Overall Study|Participant Withdrawn by Investigator|1
5881020|NCT01862640|20345673|P2|Overall Study|Participant Withdrawn by Investigator|1
5881021|NCT01862640|20345674|P1|Overall Study|Participant Withdrawn by Investigator|0
5881022|NCT01862640|20345671|P4|Overall Study|Participant Met Withdrawal Criteria|1
5881023|NCT01862640|20345672|P3|Overall Study|Participant Met Withdrawal Criteria|2
5881024|NCT01862640|20345673|P2|Overall Study|Participant Met Withdrawal Criteria|1
5881025|NCT01862640|20345674|P1|Overall Study|Participant Met Withdrawal Criteria|1
5881026|NCT01862640|20345671|P4|Overall Study|Adverse Event|8
5881027|NCT01862640|20345672|P3|Overall Study|Adverse Event|6
5881028|NCT01862640|20345673|P2|Overall Study|Adverse Event|10
5881029|NCT01862640|20345674|P1|Overall Study|Adverse Event|4
5881030|NCT01862484|20345695|P2|Overall Study|Withdrawal by Subject|3
5881031|NCT01862484|20345696|P1|Overall Study|Withdrawal by Subject|0
5881032|NCT01862484|20345695|P2|Overall Study|Protocol Violation|2
5881033|NCT01862484|20345696|P1|Overall Study|Protocol Violation|0
5881034|NCT01862484|20345695|P2|Overall Study|Lost to Follow-up|2
5881035|NCT01862484|20345696|P1|Overall Study|Lost to Follow-up|1
5881036|NCT01862484|20345695|P2|Overall Study|Lack of Efficacy|1
5881037|NCT01862484|20345696|P1|Overall Study|Lack of Efficacy|1
5881038|NCT01862328|20345722|P7|Overall Study|Symptomatic Deterioration|1
5881039|NCT01862328|20345723|P6|Overall Study|Symptomatic Deterioration|0
5881040|NCT01862328|20345724|P5|Overall Study|Symptomatic Deterioration|0
5881041|NCT01862328|20345725|P4|Overall Study|Symptomatic Deterioration|0
5881042|NCT01862328|20345726|P3|Overall Study|Symptomatic Deterioration|0
5881043|NCT01862328|20345727|P2|Overall Study|Symptomatic Deterioration|0
5881044|NCT01862328|20345728|P1|Overall Study|Symptomatic Deterioration|0
5881045|NCT01862328|20345722|P7|Overall Study|Withdrawal by Subject|1
5881046|NCT01862328|20345723|P6|Overall Study|Withdrawal by Subject|1
5881047|NCT01862328|20345724|P5|Overall Study|Withdrawal by Subject|1
5881048|NCT01862328|20345725|P4|Overall Study|Withdrawal by Subject|0
5881049|NCT01862328|20345726|P3|Overall Study|Withdrawal by Subject|0
5881050|NCT01862328|20345727|P2|Overall Study|Withdrawal by Subject|1
5881051|NCT01862328|20345728|P1|Overall Study|Withdrawal by Subject|1
5881052|NCT01862328|20345722|P7|Overall Study|Other|1
5881053|NCT01862328|20345723|P6|Overall Study|Other|0
5881054|NCT01862328|20345724|P5|Overall Study|Other|4
5881055|NCT01862328|20345725|P4|Overall Study|Other|0
5881056|NCT01862328|20345726|P3|Overall Study|Other|1
5881057|NCT01862328|20345727|P2|Overall Study|Other|2
5881058|NCT01862328|20345728|P1|Overall Study|Other|0
5881059|NCT01862328|20345722|P7|Overall Study|Adverse Event|4
5881060|NCT01862328|20345723|P6|Overall Study|Adverse Event|2
5881061|NCT01862328|20345724|P5|Overall Study|Adverse Event|0
5881062|NCT01862328|20345725|P4|Overall Study|Adverse Event|1
5881063|NCT01862328|20345726|P3|Overall Study|Adverse Event|0
5881064|NCT01862328|20345727|P2|Overall Study|Adverse Event|4
5881065|NCT01862328|20345728|P1|Overall Study|Adverse Event|0
5881066|NCT01862328|20345722|P7|Overall Study|Progressive Disease|3
5881067|NCT01862328|20345723|P6|Overall Study|Progressive Disease|4
5881068|NCT01862328|20345724|P5|Overall Study|Progressive Disease|7
5881069|NCT01862328|20345725|P4|Overall Study|Progressive Disease|6
5881070|NCT01862328|20345726|P3|Overall Study|Progressive Disease|5
5881071|NCT01862328|20345727|P2|Overall Study|Progressive Disease|11
5881072|NCT01862328|20345728|P1|Overall Study|Progressive Disease|3
5881073|NCT01862250|20345780|P1|Overall Study|Adverse Event|4
5881074|NCT01862029|20345801|P1|Overall Study|Physician Decision|1
5881075|NCT01861522|20345904|P2|Overall Study|Withdrawal by Subject|0
5881076|NCT01861522|20345905|P1|Overall Study|Withdrawal by Subject|2
5881077|NCT01861522|20345904|P2|Overall Study|Adverse Event|0
5881078|NCT01861522|20345905|P1|Overall Study|Adverse Event|1
5881079|NCT01860989|20345934|P1|Overall Study|Unsatisfactory therapeutic|5
5881080|NCT01860976|20345940|P2|Long Term Extension|Ongoing treatment at time of analysis|100
5881081|NCT01860976|20345941|P1|Long Term Extension|Ongoing treatment at time of analysis|106
5881082|NCT01860976|20345940|P2|Long Term Extension|Withdrawal by Subject|0
5881083|NCT01860976|20345941|P1|Long Term Extension|Withdrawal by Subject|1
5881084|NCT01860976|20345940|P2|Long Term Extension|Subject request to discontinue treatment|0
5881085|NCT01860976|20345941|P1|Long Term Extension|Subject request to discontinue treatment|2
5881086|NCT01860976|20345940|P2|Long Term Extension|Lack of Efficacy|7
5881087|NCT01860976|20345941|P1|Long Term Extension|Lack of Efficacy|3
5881088|NCT01860976|20345940|P2|Long Term Extension|Adverse Event|0
5881089|NCT01860976|20345941|P1|Long Term Extension|Adverse Event|1
5881090|NCT01860976|20345940|P2|Open-Label|Ongoing OL treatment at time of analysis|45
5881091|NCT01860976|20345941|P1|Open-Label|Ongoing OL treatment at time of analysis|46
5881092|NCT01860976|20345940|P2|Open-Label|Other Reasons|1
5881093|NCT01860976|20345941|P1|Open-Label|Other Reasons|1
5881094|NCT01860976|20345940|P2|Open-Label|Withdrawal by Subject|1
5881095|NCT01860976|20345941|P1|Open-Label|Withdrawal by Subject|4
5881096|NCT01860976|20345940|P2|Open-Label|Subject request discontinue treatment|3
5881097|NCT01860976|20345941|P1|Open-Label|Subject request discontinue treatment|4
5881098|NCT01860976|20345940|P2|Open-Label|Lost to Follow-up|2
5881099|NCT01860976|20345941|P1|Open-Label|Lost to Follow-up|1
5881100|NCT01860976|20345940|P2|Open-Label|Lack of Efficacy|8
5881101|NCT01860976|20345941|P1|Open-Label|Lack of Efficacy|16
5881102|NCT01860976|20345940|P2|Open-Label|Adverse Event|4
5881103|NCT01860976|20345941|P1|Open-Label|Adverse Event|2
5881104|NCT01860976|20345940|P2|Blinded Treatment|Early Escape: Transitioned to OL period|89
5881105|NCT01860976|20345941|P1|Blinded Treatment|Early Escape: Transitioned to OL period|76
5881106|NCT01860976|20345940|P2|Blinded Treatment|Entered Open-Label in error|1
5881107|NCT01860976|20345941|P1|Blinded Treatment|Entered Open-Label in error|0
5881108|NCT01860976|20345940|P2|Blinded Treatment|Subject no longer met criteria|0
5881109|NCT01860976|20345941|P1|Blinded Treatment|Subject no longer met criteria|1
5881110|NCT01860976|20345940|P2|Blinded Treatment|Withdrawal by Subject|5
5881111|NCT01860976|20345941|P1|Blinded Treatment|Withdrawal by Subject|3
5881112|NCT01860976|20345940|P2|Blinded Treatment|Subject request to discontinue treatment|3
5881113|NCT01860976|20345941|P1|Blinded Treatment|Subject request to discontinue treatment|2
5881114|NCT01860976|20345940|P2|Blinded Treatment|Lack of Efficacy|12
5881115|NCT01860976|20345941|P1|Blinded Treatment|Lack of Efficacy|5
5881116|NCT01860976|20345940|P2|Blinded Treatment|Adverse Event|3
5881117|NCT01860976|20345941|P1|Blinded Treatment|Adverse Event|1
5881118|NCT01860846|20345995|P1|Overall Study|Lost to Follow-up|33
5881119|NCT01860703|20346015|P4|Overall Study|Personal reason|0
5881120|NCT01860703|20346016|P3|Overall Study|Personal reason|1
5881121|NCT01860703|20346017|P2|Overall Study|Personal reason|0
5881122|NCT01860703|20346018|P1|Overall Study|Personal reason|1
5881123|NCT01860703|20346015|P4|Overall Study|Withdrawal by Subject|0
5881124|NCT01860703|20346016|P3|Overall Study|Withdrawal by Subject|0
5881125|NCT01860703|20346017|P2|Overall Study|Withdrawal by Subject|1
5881126|NCT01860703|20346018|P1|Overall Study|Withdrawal by Subject|0
5881127|NCT01860703|20346015|P4|Overall Study|Adverse Event|2
5881128|NCT01860703|20346016|P3|Overall Study|Adverse Event|0
5881129|NCT01860703|20346017|P2|Overall Study|Adverse Event|4
5881130|NCT01860703|20346018|P1|Overall Study|Adverse Event|1
5881131|NCT01860677|20346050|P2|Second Intervention (1 Day)|Lost to Follow-up|0
5881132|NCT01860677|20346051|P1|Second Intervention (1 Day)|Lost to Follow-up|7
5881133|NCT01860534|20346108|P2|ROP #2|discharged prior to ROP #2|0
5881134|NCT01860534|20346109|P1|ROP #2|discharged prior to ROP #2|1
5881135|NCT01860534|20346108|P2|ROP #1|Needed treatment for ROP|1
5881136|NCT01860534|20346109|P1|ROP #1|Needed treatment for ROP|0
5881137|NCT01860079|20346170|P2|Overall Study|Physician Decision|22
5881138|NCT01860079|20346171|P1|Overall Study|Physician Decision|14
5881139|NCT01860040|20346179|P2|Overall Study|Withdrawal by Subject|0
5881140|NCT01860040|20346180|P1|Overall Study|Withdrawal by Subject|1
5881141|NCT01859988|20346191|P6|Overall Study|Other than specified above|3
5881142|NCT01859988|20346192|P5|Overall Study|Other than specified above|5
5881143|NCT01859988|20346193|P4|Overall Study|Other than specified above|3
5881144|NCT01859988|20346194|P3|Overall Study|Other than specified above|11
5881145|NCT01859988|20346195|P2|Overall Study|Other than specified above|2
5881146|NCT01859988|20346196|P1|Overall Study|Other than specified above|0
5881147|NCT01859988|20346191|P6|Overall Study|Protocol Violation|0
5881148|NCT01859988|20346192|P5|Overall Study|Protocol Violation|0
5881149|NCT01859988|20346193|P4|Overall Study|Protocol Violation|0
5881150|NCT01859988|20346194|P3|Overall Study|Protocol Violation|1
5881151|NCT01859988|20346195|P2|Overall Study|Protocol Violation|0
5881152|NCT01859988|20346196|P1|Overall Study|Protocol Violation|0
5881153|NCT01859988|20346191|P6|Overall Study|Lost to Follow-up|2
5881154|NCT01859988|20346192|P5|Overall Study|Lost to Follow-up|3
5881155|NCT01859988|20346193|P4|Overall Study|Lost to Follow-up|0
5881156|NCT01859988|20346194|P3|Overall Study|Lost to Follow-up|3
5881157|NCT01859988|20346195|P2|Overall Study|Lost to Follow-up|2
5881158|NCT01859988|20346196|P1|Overall Study|Lost to Follow-up|1
5881159|NCT01859988|20346191|P6|Overall Study|Adverse Event|2
5881160|NCT01859988|20346192|P5|Overall Study|Adverse Event|2
5881161|NCT01859988|20346193|P4|Overall Study|Adverse Event|1
5881162|NCT01859988|20346194|P3|Overall Study|Adverse Event|3
5881163|NCT01859988|20346195|P2|Overall Study|Adverse Event|1
5881164|NCT01859988|20346196|P1|Overall Study|Adverse Event|2
5881165|NCT01859988|20346191|P6|Overall Study|Physician Decision|1
5881166|NCT01859988|20346192|P5|Overall Study|Physician Decision|4
5881167|NCT01859988|20346193|P4|Overall Study|Physician Decision|3
5881168|NCT01859988|20346194|P3|Overall Study|Physician Decision|1
5881169|NCT01859988|20346195|P2|Overall Study|Physician Decision|3
5881170|NCT01859988|20346196|P1|Overall Study|Physician Decision|1
5881171|NCT01859988|20346191|P6|Overall Study|Lack of Efficacy|9
5881172|NCT01859988|20346192|P5|Overall Study|Lack of Efficacy|7
5881173|NCT01859988|20346193|P4|Overall Study|Lack of Efficacy|0
5881174|NCT01859988|20346194|P3|Overall Study|Lack of Efficacy|5
5881175|NCT01859988|20346195|P2|Overall Study|Lack of Efficacy|1
5881176|NCT01859988|20346196|P1|Overall Study|Lack of Efficacy|1
5881177|NCT01859988|20346191|P6|Overall Study|Withdrawal by Subject|2
5881178|NCT01859988|20346192|P5|Overall Study|Withdrawal by Subject|2
5881179|NCT01859988|20346193|P4|Overall Study|Withdrawal by Subject|3
5881180|NCT01859988|20346194|P3|Overall Study|Withdrawal by Subject|4
5881181|NCT01859988|20346195|P2|Overall Study|Withdrawal by Subject|3
5881182|NCT01859988|20346196|P1|Overall Study|Withdrawal by Subject|6
5881183|NCT01859949|20346290|P2|Overall Study|Adverse Event|1
5881184|NCT01859949|20346291|P1|Overall Study|Adverse Event|0
5881185|NCT01859949|20346290|P2|Overall Study|Protocol Violation|1
5881186|NCT01859949|20346291|P1|Overall Study|Protocol Violation|1
5881187|NCT01859949|20346290|P2|Overall Study|Withdrawal by Subject|10
5881188|NCT01859949|20346291|P1|Overall Study|Withdrawal by Subject|11
5881189|NCT01859949|20346290|P2|Overall Study|Physician Decision|4
5881190|NCT01859949|20346291|P1|Overall Study|Physician Decision|2
5881191|NCT01859949|20346290|P2|Overall Study|Family Matters|1
5881192|NCT01859949|20346291|P1|Overall Study|Family Matters|0
5881193|NCT01859923|20346311|P4|Overall Study|Adverse Event|1
5881194|NCT01859923|20346312|P3|Overall Study|Adverse Event|1
5881195|NCT01859923|20346313|P2|Overall Study|Adverse Event|0
5881196|NCT01859923|20346314|P1|Overall Study|Adverse Event|0
5881197|NCT01859793|20346368|P2|Washout Period (4 Weeks)|Lost to Follow-up|1
5881198|NCT01859793|20346369|P1|Washout Period (4 Weeks)|Lost to Follow-up|1
5881199|NCT01859793|20346368|P2|First Intervention (8 Weeks)|Withdrawal by Subject|1
5881200|NCT01859793|20346369|P1|First Intervention (8 Weeks)|Withdrawal by Subject|2
5881201|NCT01859793|20346368|P2|First Intervention (8 Weeks)|Adverse Event|0
5881202|NCT01859793|20346369|P1|First Intervention (8 Weeks)|Adverse Event|1
5881203|NCT01859793|20346368|P2|First Intervention (8 Weeks)|Protocol Violation|0
5881204|NCT01859793|20346369|P1|First Intervention (8 Weeks)|Protocol Violation|2
5881205|NCT01859741|20346387|P8|Overall Study|Other|0
5881206|NCT01859741|20346388|P7|Overall Study|Other|2
5881207|NCT01859741|20346389|P6|Overall Study|Other|0
5881208|NCT01859741|20346390|P5|Overall Study|Other|0
5881209|NCT01859741|20346391|P4|Overall Study|Other|0
5881210|NCT01859741|20346392|P3|Overall Study|Other|0
5881211|NCT01859741|20346393|P2|Overall Study|Other|0
5881212|NCT01859741|20346394|P1|Overall Study|Other|0
5881213|NCT01859741|20346387|P8|Overall Study|Study Terminated by Sponsor|14
5881214|NCT01859741|20346388|P7|Overall Study|Study Terminated by Sponsor|16
5881215|NCT01859741|20346389|P6|Overall Study|Study Terminated by Sponsor|0
5881216|NCT01859741|20346390|P5|Overall Study|Study Terminated by Sponsor|1
5881217|NCT01859741|20346391|P4|Overall Study|Study Terminated by Sponsor|0
5881218|NCT01859741|20346392|P3|Overall Study|Study Terminated by Sponsor|0
5881219|NCT01859741|20346393|P2|Overall Study|Study Terminated by Sponsor|0
5881220|NCT01859741|20346394|P1|Overall Study|Study Terminated by Sponsor|0
5881221|NCT01859741|20346387|P8|Overall Study|Withdrawal by Subject|1
5881222|NCT01859741|20346388|P7|Overall Study|Withdrawal by Subject|1
5881223|NCT01859741|20346389|P6|Overall Study|Withdrawal by Subject|1
5881224|NCT01859741|20346390|P5|Overall Study|Withdrawal by Subject|0
5881225|NCT01859741|20346391|P4|Overall Study|Withdrawal by Subject|0
5881226|NCT01859741|20346392|P3|Overall Study|Withdrawal by Subject|2
5881227|NCT01859741|20346393|P2|Overall Study|Withdrawal by Subject|1
5881228|NCT01859741|20346394|P1|Overall Study|Withdrawal by Subject|0
5881229|NCT01859741|20346387|P8|Overall Study|Lost to Follow-up|4
5881230|NCT01859741|20346388|P7|Overall Study|Lost to Follow-up|0
5881231|NCT01859741|20346389|P6|Overall Study|Lost to Follow-up|1
5881232|NCT01859741|20346390|P5|Overall Study|Lost to Follow-up|0
5881233|NCT01859741|20346391|P4|Overall Study|Lost to Follow-up|0
5881234|NCT01859741|20346392|P3|Overall Study|Lost to Follow-up|0
5881235|NCT01859741|20346393|P2|Overall Study|Lost to Follow-up|0
5881236|NCT01859741|20346394|P1|Overall Study|Lost to Follow-up|0
5881237|NCT01859741|20346387|P8|Overall Study|Death|51
5881238|NCT01859741|20346388|P7|Overall Study|Death|51
5881239|NCT01859741|20346389|P6|Overall Study|Death|4
5881240|NCT01859741|20346390|P5|Overall Study|Death|5
5881241|NCT01859741|20346391|P4|Overall Study|Death|3
5881242|NCT01859741|20346392|P3|Overall Study|Death|4
5881243|NCT01859741|20346393|P2|Overall Study|Death|2
5881244|NCT01859741|20346394|P1|Overall Study|Death|3
5881245|NCT01859715|20346423|P3|Overall Study|No 2nd VAS|23
5881246|NCT01859715|20346424|P2|Overall Study|No 2nd VAS|8
5881247|NCT01859715|20346425|P1|Overall Study|No 2nd VAS|16
5881248|NCT01859702|20346436|P1|Overall Study|Adverse Event|2
5881249|NCT01859702|20346436|P1|Overall Study|Protocol deviation|3
5881250|NCT01859598|20346450|P1|Visit 2 at 3 Months|Lost to Follow-up|1742
5881251|NCT01859507|20346458|P1|Overall Study|left the country|4
5881252|NCT01859494|20346463|P1|Overall Study|Adverse Event|1
5881253|NCT01859390|20346474|P2|Overall Study|Shipment Error|1
5881254|NCT01859390|20346475|P1|Overall Study|Shipment Error|0
5881255|NCT01859390|20346474|P2|Overall Study|Tube Cracked|2
5881256|NCT01859390|20346475|P1|Overall Study|Tube Cracked|0
5881257|NCT01859390|20346474|P2|Overall Study|Sample Missing Collection Date|1
5881258|NCT01859390|20346475|P1|Overall Study|Sample Missing Collection Date|0
5881259|NCT01859390|20346474|P2|Overall Study|Insufficient Sputum Collected|3
5881260|NCT01859390|20346475|P1|Overall Study|Insufficient Sputum Collected|1
5881261|NCT01859143|20346609|P2|Overall Study|Lost to Follow-up|0
5881262|NCT01859143|20346610|P1|Overall Study|Lost to Follow-up|2
5881263|NCT01858766|20346666|P19|Overall Study|Withdrew Consent|0
5881264|NCT01858766|20346667|P18|Overall Study|Withdrew Consent|0
5881265|NCT01858766|20346668|P17|Overall Study|Withdrew Consent|0
5881266|NCT01858766|20346669|P16|Overall Study|Withdrew Consent|0
5881267|NCT01858766|20346670|P15|Overall Study|Withdrew Consent|0
5881268|NCT01858766|20346671|P14|Overall Study|Withdrew Consent|0
5881269|NCT01858766|20346672|P13|Overall Study|Withdrew Consent|0
5881270|NCT01858766|20346673|P12|Overall Study|Withdrew Consent|1
5881271|NCT01858766|20346674|P11|Overall Study|Withdrew Consent|0
5881272|NCT01858766|20346675|P10|Overall Study|Withdrew Consent|0
5881273|NCT01858766|20346676|P9|Overall Study|Withdrew Consent|0
5881274|NCT01858766|20346677|P8|Overall Study|Withdrew Consent|0
5881275|NCT01858766|20346678|P7|Overall Study|Withdrew Consent|0
5881276|NCT01858766|20346679|P6|Overall Study|Withdrew Consent|0
5881277|NCT01858766|20346680|P5|Overall Study|Withdrew Consent|0
5881278|NCT01858766|20346681|P4|Overall Study|Withdrew Consent|0
5881279|NCT01858766|20346682|P3|Overall Study|Withdrew Consent|0
5881280|NCT01858766|20346683|P2|Overall Study|Withdrew Consent|0
5881281|NCT01858766|20346684|P1|Overall Study|Withdrew Consent|0
5881282|NCT01858766|20346666|P19|Overall Study|Lost to Follow-up|1
5881283|NCT01858766|20346667|P18|Overall Study|Lost to Follow-up|0
5881284|NCT01858766|20346668|P17|Overall Study|Lost to Follow-up|1
5881285|NCT01858766|20346669|P16|Overall Study|Lost to Follow-up|1
5881286|NCT01858766|20346670|P15|Overall Study|Lost to Follow-up|3
5881287|NCT01858766|20346671|P14|Overall Study|Lost to Follow-up|0
5881288|NCT01858766|20346672|P13|Overall Study|Lost to Follow-up|0
5881289|NCT01858766|20346673|P12|Overall Study|Lost to Follow-up|1
5881290|NCT01858766|20346674|P11|Overall Study|Lost to Follow-up|0
5881291|NCT01858766|20346675|P10|Overall Study|Lost to Follow-up|0
5881292|NCT01858766|20346676|P9|Overall Study|Lost to Follow-up|0
5881293|NCT01858766|20346677|P8|Overall Study|Lost to Follow-up|2
5881294|NCT01858766|20346678|P7|Overall Study|Lost to Follow-up|0
5881295|NCT01858766|20346679|P6|Overall Study|Lost to Follow-up|1
5881296|NCT01858766|20346680|P5|Overall Study|Lost to Follow-up|0
5881297|NCT01858766|20346681|P4|Overall Study|Lost to Follow-up|0
5881298|NCT01858766|20346682|P3|Overall Study|Lost to Follow-up|0
5881299|NCT01858766|20346683|P2|Overall Study|Lost to Follow-up|0
5881300|NCT01858766|20346684|P1|Overall Study|Lost to Follow-up|0
5881301|NCT01858766|20346666|P19|Overall Study|Lack of Efficacy|3
5881302|NCT01858766|20346667|P18|Overall Study|Lack of Efficacy|3
5881303|NCT01858766|20346668|P17|Overall Study|Lack of Efficacy|2
5881304|NCT01858766|20346669|P16|Overall Study|Lack of Efficacy|5
5881305|NCT01858766|20346670|P15|Overall Study|Lack of Efficacy|5
5881306|NCT01858766|20346671|P14|Overall Study|Lack of Efficacy|3
5881307|NCT01858766|20346672|P13|Overall Study|Lack of Efficacy|5
5881308|NCT01858766|20346673|P12|Overall Study|Lack of Efficacy|3
5881309|NCT01858766|20346674|P11|Overall Study|Lack of Efficacy|0
5881310|NCT01858766|20346675|P10|Overall Study|Lack of Efficacy|0
5881311|NCT01858766|20346676|P9|Overall Study|Lack of Efficacy|0
5881312|NCT01858766|20346677|P8|Overall Study|Lack of Efficacy|0
5881313|NCT01858766|20346678|P7|Overall Study|Lack of Efficacy|0
5881314|NCT01858766|20346679|P6|Overall Study|Lack of Efficacy|2
5881315|NCT01858766|20346680|P5|Overall Study|Lack of Efficacy|1
5881316|NCT01858766|20346681|P4|Overall Study|Lack of Efficacy|0
5881317|NCT01858766|20346682|P3|Overall Study|Lack of Efficacy|0
5881318|NCT01858766|20346683|P2|Overall Study|Lack of Efficacy|0
5881319|NCT01858766|20346684|P1|Overall Study|Lack of Efficacy|1
5881320|NCT01858766|20346666|P19|Overall Study|Death|0
5881321|NCT01858766|20346667|P18|Overall Study|Death|0
5881322|NCT01858766|20346668|P17|Overall Study|Death|0
5881323|NCT01858766|20346669|P16|Overall Study|Death|0
5881324|NCT01858766|20346670|P15|Overall Study|Death|0
5881325|NCT01858766|20346671|P14|Overall Study|Death|0
5881326|NCT01858766|20346672|P13|Overall Study|Death|0
5881327|NCT01858766|20346673|P12|Overall Study|Death|0
5881328|NCT01858766|20346674|P11|Overall Study|Death|0
5881329|NCT01858766|20346675|P10|Overall Study|Death|0
5881330|NCT01858766|20346676|P9|Overall Study|Death|0
5881331|NCT01858766|20346677|P8|Overall Study|Death|0
5881332|NCT01858766|20346678|P7|Overall Study|Death|0
5881333|NCT01858766|20346679|P6|Overall Study|Death|0
5881334|NCT01858766|20346680|P5|Overall Study|Death|0
5881335|NCT01858766|20346681|P4|Overall Study|Death|0
5881336|NCT01858766|20346682|P3|Overall Study|Death|1
5881337|NCT01858766|20346683|P2|Overall Study|Death|0
5881338|NCT01858766|20346684|P1|Overall Study|Death|0
5881339|NCT01858766|20346666|P19|Overall Study|Randomized but Never Treated|0
5881340|NCT01858766|20346667|P18|Overall Study|Randomized but Never Treated|1
5881341|NCT01858766|20346668|P17|Overall Study|Randomized but Never Treated|0
5881342|NCT01858766|20346669|P16|Overall Study|Randomized but Never Treated|0
5881343|NCT01858766|20346670|P15|Overall Study|Randomized but Never Treated|0
5881344|NCT01858766|20346671|P14|Overall Study|Randomized but Never Treated|0
5881345|NCT01858766|20346672|P13|Overall Study|Randomized but Never Treated|0
5881346|NCT01858766|20346673|P12|Overall Study|Randomized but Never Treated|0
5881347|NCT01858766|20346674|P11|Overall Study|Randomized but Never Treated|0
5881348|NCT01858766|20346675|P10|Overall Study|Randomized but Never Treated|0
5881349|NCT01858766|20346676|P9|Overall Study|Randomized but Never Treated|0
5881350|NCT01858766|20346677|P8|Overall Study|Randomized but Never Treated|0
5881351|NCT01858766|20346678|P7|Overall Study|Randomized but Never Treated|0
5881352|NCT01858766|20346679|P6|Overall Study|Randomized but Never Treated|1
5881353|NCT01858766|20346680|P5|Overall Study|Randomized but Never Treated|0
5881354|NCT01858766|20346681|P4|Overall Study|Randomized but Never Treated|0
5881355|NCT01858766|20346682|P3|Overall Study|Randomized but Never Treated|0
5881356|NCT01858766|20346683|P2|Overall Study|Randomized but Never Treated|0
5881357|NCT01858766|20346684|P1|Overall Study|Randomized but Never Treated|0
5881358|NCT01858701|20346755|P2|Period 2, Second 30 Days of Wear|Comfort|1
5881359|NCT01858701|20346756|P1|Period 2, Second 30 Days of Wear|Comfort|0
5881360|NCT01858701|20346755|P2|Washout Period, 1-13 Days|Withdrawal by Subject|2
5881361|NCT01858701|20346756|P1|Washout Period, 1-13 Days|Withdrawal by Subject|1
5881362|NCT01858701|20346755|P2|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|0
5881363|NCT01858701|20346756|P1|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|1
5881364|NCT01858701|20346755|P2|Period 1, First 30 Days of Wear|Withdrawal by Subject|1
5881365|NCT01858701|20346756|P1|Period 1, First 30 Days of Wear|Withdrawal by Subject|0
5881366|NCT01858636|20346762|P1|Overall Study|Withdrawal by Subject|1
5881367|NCT01858636|20346762|P1|Overall Study|Lost to Follow-up|1
5881368|NCT01858636|20346762|P1|Overall Study|Death|1
5881369|NCT01858636|20346762|P1|Overall Study|Physician Decision|1
5881370|NCT01858636|20346762|P1|Overall Study|No Device Deployment Attempted|24
5881371|NCT01858558|20346769|P2|Overall Study|Failed expansion of cell product|0
5881372|NCT01858558|20346770|P1|Overall Study|Failed expansion of cell product|2
5881373|NCT01858558|20346769|P2|Overall Study|Product contamination|0
5881374|NCT01858558|20346770|P1|Overall Study|Product contamination|2
5881375|NCT01858558|20346769|P2|Overall Study|Disease progression|1
5881376|NCT01858558|20346770|P1|Overall Study|Disease progression|3
5881377|NCT01858558|20346769|P2|Overall Study|Lost to Follow-up|0
5881378|NCT01858558|20346770|P1|Overall Study|Lost to Follow-up|1
5881379|NCT01858558|20346769|P2|Overall Study|Death|1
5881380|NCT01858558|20346770|P1|Overall Study|Death|1
5881381|NCT01858532|20346792|P4|Overall Study|Other, not specified|11
5881382|NCT01858532|20346793|P3|Overall Study|Other, not specified|13
5881383|NCT01858532|20346794|P2|Overall Study|Other, not specified|15
5881384|NCT01858532|20346795|P1|Overall Study|Other, not specified|29
5881385|NCT01858532|20346792|P4|Overall Study|Investigator request|6
5881386|NCT01858532|20346793|P3|Overall Study|Investigator request|2
5881387|NCT01858532|20346794|P2|Overall Study|Investigator request|4
5881388|NCT01858532|20346795|P1|Overall Study|Investigator request|3
5881389|NCT01858532|20346792|P4|Overall Study|Deterioration of medical status|7
5881390|NCT01858532|20346793|P3|Overall Study|Deterioration of medical status|3
5881391|NCT01858532|20346794|P2|Overall Study|Deterioration of medical status|4
5881392|NCT01858532|20346795|P1|Overall Study|Deterioration of medical status|3
5881393|NCT01858532|20346792|P4|Overall Study|Lost to Follow-up|14
5881394|NCT01858532|20346793|P3|Overall Study|Lost to Follow-up|11
5881395|NCT01858532|20346794|P2|Overall Study|Lost to Follow-up|26
5881396|NCT01858532|20346795|P1|Overall Study|Lost to Follow-up|17
5881397|NCT01858532|20346792|P4|Overall Study|Withdrew consent|27
5881398|NCT01858532|20346793|P3|Overall Study|Withdrew consent|46
5881399|NCT01858532|20346794|P2|Overall Study|Withdrew consent|93
5881400|NCT01858532|20346795|P1|Overall Study|Withdrew consent|71
5881401|NCT01858532|20346792|P4|Overall Study|Adverse Event|28
5881402|NCT01858532|20346793|P3|Overall Study|Adverse Event|23
5881403|NCT01858532|20346794|P2|Overall Study|Adverse Event|50
5881404|NCT01858532|20346795|P1|Overall Study|Adverse Event|58
5881405|NCT01858389|20346849|P2|Overall Study|Did not receive treatment|3
5881406|NCT01858389|20346850|P1|Overall Study|Did not receive treatment|0
5881407|NCT01858389|20346849|P2|Overall Study|Adverse Event|1
5881408|NCT01858389|20346850|P1|Overall Study|Adverse Event|3
5881409|NCT01858389|20346849|P2|Overall Study|Other|4
5881410|NCT01858389|20346850|P1|Overall Study|Other|2
5881411|NCT01858389|20346849|P2|Overall Study|Progressive disease|11
5881412|NCT01858389|20346850|P1|Overall Study|Progressive disease|10
5881413|NCT01858389|20346849|P2|Overall Study|Withdrawal by Subject|1
5881414|NCT01858389|20346850|P1|Overall Study|Withdrawal by Subject|0
5881415|NCT01858389|20346849|P2|Overall Study|Study terminated by sponsor|2
5881416|NCT01858389|20346850|P1|Overall Study|Study terminated by sponsor|0
5881417|NCT01858389|20346849|P2|Overall Study|Death|3
5881418|NCT01858389|20346850|P1|Overall Study|Death|1
5881419|NCT01858376|20346865|P1|Overall Study|Dropped d/t lab work not fitting criter|4
5881420|NCT01858194|20346874|P2|Overall Study|Lost to Follow-up|1
5881421|NCT01858194|20346875|P1|Overall Study|Lost to Follow-up|0
5881422|NCT01858194|20346874|P2|Overall Study|Total Artificial Heart Implant|1
5881423|NCT01858194|20346875|P1|Overall Study|Total Artificial Heart Implant|0
5881424|NCT01857973|20346928|P1|Overall Study|Physician Decision|1
5881425|NCT01857973|20346928|P1|Overall Study|drop out after 3 failed attempts|1
5881426|NCT01857973|20346928|P1|Overall Study|Subject did not meet required BG range|3
5881427|NCT01857869|20346958|P10|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
5881428|NCT01857869|20346959|P9|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
5881429|NCT01857869|20346960|P8|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
5881430|NCT01857869|20346961|P7|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
5881431|NCT01857869|20346962|P6|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
5881432|NCT01857869|20346963|P5|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
5881433|NCT01857869|20346964|P4|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|1
5881434|NCT01857869|20346965|P3|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
5881435|NCT01857869|20346966|P2|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
5881436|NCT01857869|20346967|P1|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
5881437|NCT01857869|20346958|P10|Booster/Rechallenge Phase|Withdrawal by Subject|0
5881438|NCT01857869|20346959|P9|Booster/Rechallenge Phase|Withdrawal by Subject|0
5881439|NCT01857869|20346960|P8|Booster/Rechallenge Phase|Withdrawal by Subject|0
5881440|NCT01857869|20346961|P7|Booster/Rechallenge Phase|Withdrawal by Subject|0
5881441|NCT01857869|20346962|P6|Booster/Rechallenge Phase|Withdrawal by Subject|0
5881442|NCT01857869|20346963|P5|Booster/Rechallenge Phase|Withdrawal by Subject|0
5881443|NCT01857869|20346964|P4|Booster/Rechallenge Phase|Withdrawal by Subject|1
5881444|NCT01857869|20346965|P3|Booster/Rechallenge Phase|Withdrawal by Subject|0
5881445|NCT01857869|20346966|P2|Booster/Rechallenge Phase|Withdrawal by Subject|0
5881446|NCT01857869|20346967|P1|Booster/Rechallenge Phase|Withdrawal by Subject|0
5881447|NCT01857869|20346958|P10|Primary/Challenge Phase|Other|0
5881448|NCT01857869|20346959|P9|Primary/Challenge Phase|Other|0
5881449|NCT01857869|20346960|P8|Primary/Challenge Phase|Other|0
5881450|NCT01857869|20346961|P7|Primary/Challenge Phase|Other|0
5881451|NCT01857869|20346962|P6|Primary/Challenge Phase|Other|0
5881452|NCT01857869|20346963|P5|Primary/Challenge Phase|Other|0
5881453|NCT01857869|20346964|P4|Primary/Challenge Phase|Other|0
5881454|NCT01857869|20346965|P3|Primary/Challenge Phase|Other|0
5881455|NCT01857869|20346966|P2|Primary/Challenge Phase|Other|1
5881456|NCT01857869|20346967|P1|Primary/Challenge Phase|Other|1
5881457|NCT01857869|20346958|P10|Primary/Challenge Phase|Protocol Violation|0
5881458|NCT01857869|20346959|P9|Primary/Challenge Phase|Protocol Violation|0
5881459|NCT01857869|20346960|P8|Primary/Challenge Phase|Protocol Violation|0
5881460|NCT01857869|20346961|P7|Primary/Challenge Phase|Protocol Violation|0
5881461|NCT01857869|20346962|P6|Primary/Challenge Phase|Protocol Violation|0
5881462|NCT01857869|20346963|P5|Primary/Challenge Phase|Protocol Violation|0
5881463|NCT01857869|20346964|P4|Primary/Challenge Phase|Protocol Violation|0
5881464|NCT01857869|20346965|P3|Primary/Challenge Phase|Protocol Violation|0
5881465|NCT01857869|20346966|P2|Primary/Challenge Phase|Protocol Violation|0
5881466|NCT01857869|20346967|P1|Primary/Challenge Phase|Protocol Violation|1
5881467|NCT01857869|20346958|P10|Primary/Challenge Phase|Pregnancy|0
5881468|NCT01857869|20346959|P9|Primary/Challenge Phase|Pregnancy|0
5881469|NCT01857869|20346960|P8|Primary/Challenge Phase|Pregnancy|0
5881470|NCT01857869|20346961|P7|Primary/Challenge Phase|Pregnancy|0
5881471|NCT01857869|20346962|P6|Primary/Challenge Phase|Pregnancy|0
5881472|NCT01857869|20346963|P5|Primary/Challenge Phase|Pregnancy|0
5881473|NCT01857869|20346964|P4|Primary/Challenge Phase|Pregnancy|0
5881474|NCT01857869|20346965|P3|Primary/Challenge Phase|Pregnancy|0
5881475|NCT01857869|20346966|P2|Primary/Challenge Phase|Pregnancy|0
5881476|NCT01857869|20346967|P1|Primary/Challenge Phase|Pregnancy|1
5881477|NCT01857869|20346958|P10|Primary/Challenge Phase|Lost to Follow-up|0
5881478|NCT01857869|20346959|P9|Primary/Challenge Phase|Lost to Follow-up|0
5881479|NCT01857869|20346960|P8|Primary/Challenge Phase|Lost to Follow-up|0
5881480|NCT01857869|20346961|P7|Primary/Challenge Phase|Lost to Follow-up|0
5881481|NCT01857869|20346962|P6|Primary/Challenge Phase|Lost to Follow-up|0
5881482|NCT01857869|20346963|P5|Primary/Challenge Phase|Lost to Follow-up|0
5881483|NCT01857869|20346964|P4|Primary/Challenge Phase|Lost to Follow-up|0
5881484|NCT01857869|20346965|P3|Primary/Challenge Phase|Lost to Follow-up|0
5881485|NCT01857869|20346966|P2|Primary/Challenge Phase|Lost to Follow-up|0
5881486|NCT01857869|20346967|P1|Primary/Challenge Phase|Lost to Follow-up|2
5881487|NCT01857622|20347057|P3|Overall Study|Withdrawal by Subject|0
5881488|NCT01857622|20347058|P2|Overall Study|Withdrawal by Subject|0
5881489|NCT01857622|20347059|P1|Overall Study|Withdrawal by Subject|1
5881490|NCT01857622|20347057|P3|Overall Study|Protocol Violation|0
5881491|NCT01857622|20347058|P2|Overall Study|Protocol Violation|1
5881492|NCT01857622|20347059|P1|Overall Study|Protocol Violation|4
5881493|NCT01857622|20347057|P3|Overall Study|Physician Decision|0
5881494|NCT01857622|20347058|P2|Overall Study|Physician Decision|0
5881495|NCT01857622|20347059|P1|Overall Study|Physician Decision|1
5881496|NCT01857622|20347057|P3|Overall Study|Adverse Event|2
5881497|NCT01857622|20347058|P2|Overall Study|Adverse Event|0
5881498|NCT01857622|20347059|P1|Overall Study|Adverse Event|5
5881499|NCT01857583|20347071|P4|Overall Study|Withdrawal by Subject|2
5881500|NCT01857583|20347072|P3|Overall Study|Withdrawal by Subject|1
5881501|NCT01857583|20347073|P2|Overall Study|Withdrawal by Subject|0
5881502|NCT01857583|20347074|P1|Overall Study|Withdrawal by Subject|1
5881503|NCT01857583|20347071|P4|Overall Study|Physician Decision|1
5881504|NCT01857583|20347072|P3|Overall Study|Physician Decision|0
5881505|NCT01857583|20347073|P2|Overall Study|Physician Decision|0
5881506|NCT01857583|20347074|P1|Overall Study|Physician Decision|0
5881507|NCT01857583|20347071|P4|Overall Study|Death|0
5881508|NCT01857583|20347072|P3|Overall Study|Death|1
5881509|NCT01857583|20347073|P2|Overall Study|Death|1
5881510|NCT01857583|20347074|P1|Overall Study|Death|0
5881511|NCT01857583|20347071|P4|Overall Study|Adverse Event|1
5881512|NCT01857583|20347072|P3|Overall Study|Adverse Event|1
5881513|NCT01857583|20347073|P2|Overall Study|Adverse Event|0
5881514|NCT01857583|20347074|P1|Overall Study|Adverse Event|0
5881515|NCT01857531|20347084|P1|Overall Study|Withdrawal by Subject|4
5881516|NCT01857323|20347102|P1|Overall Study|Did not complete 180 doses|48
5881517|NCT01857323|20347102|P1|Overall Study|Other|4
5881518|NCT01857323|20347102|P1|Overall Study|Lost to Follow-up|1
5881519|NCT01857323|20347102|P1|Overall Study|Protocol Violation|6
5881520|NCT01857323|20347102|P1|Overall Study|Non-compliance|1
5881521|NCT01857323|20347102|P1|Overall Study|Withdrawal by Subject|3
5881522|NCT01857323|20347102|P1|Overall Study|Adverse Event|1
5881523|NCT01857310|20347113|P2|Secondary Analysis: Semen Quality at 6m|Lost to Follow-up|282
5881524|NCT01857310|20347114|P1|Secondary Analysis: Semen Quality at 6m|Lost to Follow-up|315
5881525|NCT01857271|20347209|P1|Overall Study|Lost to Follow-up|1
5881526|NCT01857206|20347262|P2|Overall Study|Withdrawal by Subject|0
5881527|NCT01857206|20347263|P1|Overall Study|Withdrawal by Subject|1
5881528|NCT01857206|20347262|P2|Overall Study|Unclassified|3
5881529|NCT01857206|20347263|P1|Overall Study|Unclassified|3
5881530|NCT01857206|20347262|P2|Overall Study|Lost to Follow-up|6
5881531|NCT01857206|20347263|P1|Overall Study|Lost to Follow-up|9
5881532|NCT01857206|20347262|P2|Overall Study|ADMINISTRATIVE REASON|1
5881533|NCT01857206|20347263|P1|Overall Study|ADMINISTRATIVE REASON|0
5881534|NCT01857102|20347281|P2|Period 2|Unsatisfactory Lens Fit|0
5881535|NCT01857102|20347282|P1|Period 2|Unsatisfactory Lens Fit|1
5881536|NCT01857102|20347281|P2|Period 2|Lens Discomfort|0
5881537|NCT01857102|20347282|P1|Period 2|Lens Discomfort|1
5881538|NCT01857102|20347281|P2|Period 1|Physician Decision|0
5881539|NCT01857102|20347282|P1|Period 1|Physician Decision|1
5881540|NCT01857102|20347281|P2|Period 1|Unsatisfactory Visual Response|0
5881541|NCT01857102|20347282|P1|Period 1|Unsatisfactory Visual Response|1
5881542|NCT01857102|20347281|P2|Period 1|Unsatisfactory Lens Fit|0
5881543|NCT01857102|20347282|P1|Period 1|Unsatisfactory Lens Fit|1
5881544|NCT01857102|20347281|P2|Period 1|Lost to Follow-up|3
5881545|NCT01857102|20347282|P1|Period 1|Lost to Follow-up|0
5881546|NCT01857102|20347281|P2|Period 1|No longer meets Eligibility Criteria|2
5881547|NCT01857102|20347282|P1|Period 1|No longer meets Eligibility Criteria|0
5881548|NCT01857063|20347292|P2|Period 2 (7 Days)|Withdrawal by Subject|0
5881549|NCT01857063|20347293|P1|Period 2 (7 Days)|Withdrawal by Subject|1
5881550|NCT01857063|20347292|P2|Period 2 (7 Days)|Physician Decision|1
5881551|NCT01857063|20347293|P1|Period 2 (7 Days)|Physician Decision|1
5881552|NCT01857063|20347292|P2|Period 2 (7 Days)|Adverse Event|1
5881553|NCT01857063|20347293|P1|Period 2 (7 Days)|Adverse Event|2
5881554|NCT01857063|20347292|P2|Period 1 (7 Days)|Withdrawal by Subject|3
5881555|NCT01857063|20347293|P1|Period 1 (7 Days)|Withdrawal by Subject|1
5881556|NCT01857063|20347292|P2|Period 1 (7 Days)|Physician Decision|0
5881557|NCT01857063|20347293|P1|Period 1 (7 Days)|Physician Decision|1
5881558|NCT01857063|20347292|P2|Period 1 (7 Days)|Adverse Event|1
5881559|NCT01857063|20347293|P1|Period 1 (7 Days)|Adverse Event|0
5881560|NCT01856907|20347327|P3|Overall Study|Withdrawal by Subject|0
5881561|NCT01856907|20347328|P2|Overall Study|Withdrawal by Subject|1
5881562|NCT01856907|20347329|P1|Overall Study|Withdrawal by Subject|0
5881563|NCT01856907|20347327|P3|Overall Study|Pregnancy|0
5881564|NCT01856907|20347328|P2|Overall Study|Pregnancy|1
5881565|NCT01856907|20347329|P1|Overall Study|Pregnancy|0
5881566|NCT01856907|20347327|P3|Overall Study|Pregnancy|0
5881567|NCT01856907|20347328|P2|Overall Study|Pregnancy|1
5881568|NCT01856907|20347329|P1|Overall Study|Pregnancy|0
5881569|NCT01856790|20347367|P1|Closed Loop Control + Liraglutide|Withdrawal by Subject|2
5881570|NCT01856790|20347367|P1|Closed Loop Control|Withdrawal by Subject|2
5881571|NCT01856686|20347421|P2|Overall Study|Lost to Follow-up|11
5881572|NCT01856686|20347422|P1|Overall Study|Lost to Follow-up|5
5881573|NCT01856673|20347465|P3|Overall Study|Protocol Violation|1
5881574|NCT01856673|20347466|P2|Overall Study|Protocol Violation|0
5881575|NCT01856673|20347467|P1|Overall Study|Protocol Violation|1
5881576|NCT01856673|20347465|P3|Overall Study|Death|0
5881577|NCT01856673|20347466|P2|Overall Study|Death|1
5881578|NCT01856673|20347467|P1|Overall Study|Death|2
5881579|NCT01856673|20347465|P3|Overall Study|Paperwork errors|0
5881580|NCT01856673|20347466|P2|Overall Study|Paperwork errors|0
5881581|NCT01856673|20347467|P1|Overall Study|Paperwork errors|4
5881582|NCT01856673|20347465|P3|Overall Study|Psychologist decision|0
5881583|NCT01856673|20347466|P2|Overall Study|Psychologist decision|0
5881584|NCT01856673|20347467|P1|Overall Study|Psychologist decision|3
5881585|NCT01856673|20347465|P3|Overall Study|Unknown reasons|0
5881586|NCT01856673|20347466|P2|Overall Study|Unknown reasons|0
5881587|NCT01856673|20347467|P1|Overall Study|Unknown reasons|20
5881588|NCT01856673|20347465|P3|Overall Study|Lost to Follow-up|0
5881589|NCT01856673|20347466|P2|Overall Study|Lost to Follow-up|34
5881590|NCT01856673|20347467|P1|Overall Study|Lost to Follow-up|22
5881591|NCT01856673|20347465|P3|Overall Study|Withdrawal by Subject|33
5881592|NCT01856673|20347466|P2|Overall Study|Withdrawal by Subject|50
5881593|NCT01856673|20347467|P1|Overall Study|Withdrawal by Subject|46
5881594|NCT01856595|20347487|P9|Overall Study|Withdrawal by Subject|0
5881595|NCT01856595|20347488|P8|Overall Study|Withdrawal by Subject|0
5881596|NCT01856595|20347489|P7|Overall Study|Withdrawal by Subject|1
5881597|NCT01856595|20347490|P6|Overall Study|Withdrawal by Subject|0
5881598|NCT01856595|20347491|P5|Overall Study|Withdrawal by Subject|0
5881599|NCT01856595|20347492|P4|Overall Study|Withdrawal by Subject|0
5881600|NCT01856595|20347493|P3|Overall Study|Withdrawal by Subject|0
5881601|NCT01856595|20347494|P2|Overall Study|Withdrawal by Subject|1
5881602|NCT01856595|20347495|P1|Overall Study|Withdrawal by Subject|0
5881603|NCT01856582|20347728|P1|Overall Study|Died prior to Boost infusion|1
5881604|NCT01856569|20347732|P1|Overall Study|Did not met inclusion criteria|8
5881605|NCT01856569|20347732|P1|Overall Study|Lost to Follow-up|3
5881606|NCT01856569|20347732|P1|Overall Study|Changed Site/Structure|1
5881607|NCT01856569|20347732|P1|Overall Study|Other|1
5881608|NCT01856543|20347743|P2|Overall Study|Withdrawn before start|3
5881609|NCT01856543|20347744|P1|Overall Study|Withdrawn before start|7
5881610|NCT01856543|20347743|P2|Overall Study|Treatment discontinued|3
5881611|NCT01856543|20347744|P1|Overall Study|Treatment discontinued|6
5881612|NCT01856322|20347802|P3|Overall Study|off study due to lack of accrual|3
5881613|NCT01856322|20347803|P2|Overall Study|off study due to lack of accrual|0
5881614|NCT01856322|20347804|P1|Overall Study|off study due to lack of accrual|0
5881615|NCT01856309|20347815|P4|Overall Study|Noncompliance With Study Drug|1
5881616|NCT01856309|20347816|P3|Overall Study|Noncompliance With Study Drug|4
5881617|NCT01856309|20347817|P2|Overall Study|Noncompliance With Study Drug|1
5881618|NCT01856309|20347818|P1|Overall Study|Noncompliance With Study Drug|0
5881619|NCT01856309|20347815|P4|Overall Study|Physician Decision|8
5881620|NCT01856309|20347816|P3|Overall Study|Physician Decision|6
5881621|NCT01856309|20347817|P2|Overall Study|Physician Decision|1
5881622|NCT01856309|20347818|P1|Overall Study|Physician Decision|6
5881623|NCT01856309|20347815|P4|Overall Study|Pregnancy|1
5881624|NCT01856309|20347816|P3|Overall Study|Pregnancy|0
5881625|NCT01856309|20347817|P2|Overall Study|Pregnancy|0
5881626|NCT01856309|20347818|P1|Overall Study|Pregnancy|0
5881627|NCT01856309|20347815|P4|Overall Study|Adverse Event|65
5881628|NCT01856309|20347816|P3|Overall Study|Adverse Event|55
5881629|NCT01856309|20347817|P2|Overall Study|Adverse Event|31
5881630|NCT01856309|20347818|P1|Overall Study|Adverse Event|31
5881631|NCT01856309|20347815|P4|Overall Study|Lack of Efficacy|25
5881632|NCT01856309|20347816|P3|Overall Study|Lack of Efficacy|40
5881633|NCT01856309|20347817|P2|Overall Study|Lack of Efficacy|9
5881634|NCT01856309|20347818|P1|Overall Study|Lack of Efficacy|14
5881635|NCT01856309|20347815|P4|Overall Study|Other|469
5881636|NCT01856309|20347816|P3|Overall Study|Other|447
5881637|NCT01856309|20347817|P2|Overall Study|Other|225
5881638|NCT01856309|20347818|P1|Overall Study|Other|227
5881639|NCT01856309|20347815|P4|Overall Study|Withdrawal by Subject|26
5881640|NCT01856309|20347816|P3|Overall Study|Withdrawal by Subject|28
5881641|NCT01856309|20347817|P2|Overall Study|Withdrawal by Subject|13
5881642|NCT01856309|20347818|P1|Overall Study|Withdrawal by Subject|11
5881643|NCT01856309|20347815|P4|Overall Study|Lost to Follow-up|8
5881644|NCT01856309|20347816|P3|Overall Study|Lost to Follow-up|4
5881645|NCT01856309|20347817|P2|Overall Study|Lost to Follow-up|2
5881646|NCT01856309|20347818|P1|Overall Study|Lost to Follow-up|6
5881647|NCT01856309|20347815|P4|Overall Study|Death|6
5881648|NCT01856309|20347816|P3|Overall Study|Death|11
5881649|NCT01856309|20347817|P2|Overall Study|Death|6
5881650|NCT01856309|20347818|P1|Overall Study|Death|4
5881651|NCT01856257|20347942|P4|Overall Study|Donor complication|1
5881652|NCT01856257|20347943|P3|Overall Study|Donor complication|0
5881653|NCT01856257|20347944|P2|Overall Study|Donor complication|0
5881654|NCT01856257|20347945|P1|Overall Study|Donor complication|0
5881655|NCT01856257|20347942|P4|Overall Study|Withdrawal by Subject|0
5881656|NCT01856257|20347943|P3|Overall Study|Withdrawal by Subject|0
5881657|NCT01856257|20347944|P2|Overall Study|Withdrawal by Subject|1
5881658|NCT01856257|20347945|P1|Overall Study|Withdrawal by Subject|1
5881659|NCT01856257|20347942|P4|Overall Study|Physician Decision|1
5881660|NCT01856257|20347943|P3|Overall Study|Physician Decision|0
5881661|NCT01856257|20347944|P2|Overall Study|Physician Decision|0
5881662|NCT01856257|20347945|P1|Overall Study|Physician Decision|0
5881663|NCT01856257|20347942|P4|Overall Study|Death|0
5881664|NCT01856257|20347943|P3|Overall Study|Death|0
5881665|NCT01856257|20347944|P2|Overall Study|Death|0
5881666|NCT01856257|20347945|P1|Overall Study|Death|2
5881667|NCT01856114|20348060|P2|Overall Study|Adverse Event|0
5881668|NCT01856114|20348061|P1|Overall Study|Adverse Event|1
5881669|NCT01856114|20348060|P2|Overall Study|Withdrawal by Subject|0
5881670|NCT01856114|20348061|P1|Overall Study|Withdrawal by Subject|1
5881671|NCT01855958|20348126|P2|Overall Study|Withdrawal by Subject|0
5881672|NCT01855958|20348127|P1|Overall Study|Withdrawal by Subject|1
5881673|NCT01855945|20348157|P12|Overall Study|Withdrawal by Subject|1
5881674|NCT01855945|20348158|P11|Overall Study|Withdrawal by Subject|4
5881675|NCT01855945|20348159|P10|Overall Study|Withdrawal by Subject|2
5881676|NCT01855945|20348160|P9|Overall Study|Withdrawal by Subject|0
5881677|NCT01855945|20348161|P8|Overall Study|Withdrawal by Subject|0
5881678|NCT01855945|20348162|P7|Overall Study|Withdrawal by Subject|1
5881679|NCT01855945|20348163|P6|Overall Study|Withdrawal by Subject|0
5881680|NCT01855945|20348164|P5|Overall Study|Withdrawal by Subject|1
5881681|NCT01855945|20348165|P4|Overall Study|Withdrawal by Subject|1
5881682|NCT01855945|20348166|P3|Overall Study|Withdrawal by Subject|4
5881683|NCT01855945|20348167|P2|Overall Study|Withdrawal by Subject|0
5881684|NCT01855945|20348168|P1|Overall Study|Withdrawal by Subject|4
5881685|NCT01855945|20348157|P12|Overall Study|Other - Unclassified|0
5881686|NCT01855945|20348158|P11|Overall Study|Other - Unclassified|1
5881687|NCT01855945|20348159|P10|Overall Study|Other - Unclassified|0
5881688|NCT01855945|20348160|P9|Overall Study|Other - Unclassified|0
5881689|NCT01855945|20348161|P8|Overall Study|Other - Unclassified|1
5881690|NCT01855945|20348162|P7|Overall Study|Other - Unclassified|2
5881691|NCT01855945|20348163|P6|Overall Study|Other - Unclassified|0
5881692|NCT01855945|20348164|P5|Overall Study|Other - Unclassified|0
5881693|NCT01855945|20348165|P4|Overall Study|Other - Unclassified|0
5881694|NCT01855945|20348166|P3|Overall Study|Other - Unclassified|1
5881695|NCT01855945|20348167|P2|Overall Study|Other - Unclassified|1
5881696|NCT01855945|20348168|P1|Overall Study|Other - Unclassified|1
5881697|NCT01855945|20348157|P12|Overall Study|Lost to Follow-up|2
5881698|NCT01855945|20348158|P11|Overall Study|Lost to Follow-up|0
5881699|NCT01855945|20348159|P10|Overall Study|Lost to Follow-up|0
5881700|NCT01855945|20348160|P9|Overall Study|Lost to Follow-up|2
5881701|NCT01855945|20348161|P8|Overall Study|Lost to Follow-up|7
5881702|NCT01855945|20348162|P7|Overall Study|Lost to Follow-up|4
5881703|NCT01855945|20348163|P6|Overall Study|Lost to Follow-up|3
5881704|NCT01855945|20348164|P5|Overall Study|Lost to Follow-up|0
5881705|NCT01855945|20348165|P4|Overall Study|Lost to Follow-up|3
5881706|NCT01855945|20348166|P3|Overall Study|Lost to Follow-up|7
5881707|NCT01855945|20348167|P2|Overall Study|Lost to Follow-up|10
5881708|NCT01855945|20348168|P1|Overall Study|Lost to Follow-up|11
5881709|NCT01855945|20348157|P12|Overall Study|Death|0
5881710|NCT01855945|20348158|P11|Overall Study|Death|0
5881711|NCT01855945|20348159|P10|Overall Study|Death|0
5881712|NCT01855945|20348160|P9|Overall Study|Death|0
5881713|NCT01855945|20348161|P8|Overall Study|Death|0
5881714|NCT01855945|20348162|P7|Overall Study|Death|2
5881715|NCT01855945|20348163|P6|Overall Study|Death|0
5881716|NCT01855945|20348164|P5|Overall Study|Death|0
5881717|NCT01855945|20348165|P4|Overall Study|Death|0
5881718|NCT01855945|20348166|P3|Overall Study|Death|0
5881719|NCT01855945|20348167|P2|Overall Study|Death|0
5881720|NCT01855945|20348168|P1|Overall Study|Death|0
5881721|NCT01855945|20348157|P12|Overall Study|Adverse Event|0
5881722|NCT01855945|20348158|P11|Overall Study|Adverse Event|0
5881723|NCT01855945|20348159|P10|Overall Study|Adverse Event|0
5881724|NCT01855945|20348160|P9|Overall Study|Adverse Event|0
5881725|NCT01855945|20348161|P8|Overall Study|Adverse Event|0
5881726|NCT01855945|20348162|P7|Overall Study|Adverse Event|1
5881727|NCT01855945|20348163|P6|Overall Study|Adverse Event|0
5881728|NCT01855945|20348164|P5|Overall Study|Adverse Event|0
5881729|NCT01855945|20348165|P4|Overall Study|Adverse Event|0
5881730|NCT01855945|20348166|P3|Overall Study|Adverse Event|0
5881731|NCT01855945|20348167|P2|Overall Study|Adverse Event|0
5881732|NCT01855945|20348168|P1|Overall Study|Adverse Event|0
5881733|NCT01855919|20348304|P2|Overall Study|Protocol Violation|4
5881734|NCT01855919|20348305|P1|Overall Study|Protocol Violation|1
5881735|NCT01855919|20348304|P2|Overall Study|Entry Criteria Not Met|1
5881736|NCT01855919|20348305|P1|Overall Study|Entry Criteria Not Met|1
5881737|NCT01855919|20348304|P2|Overall Study|Withdrawal by Subject|10
5881738|NCT01855919|20348305|P1|Overall Study|Withdrawal by Subject|4
5881739|NCT01855919|20348304|P2|Overall Study|Lack of Efficacy|3
5881740|NCT01855919|20348305|P1|Overall Study|Lack of Efficacy|1
5881741|NCT01855919|20348304|P2|Overall Study|Adverse Event|8
5881742|NCT01855919|20348305|P1|Overall Study|Adverse Event|16
5881743|NCT01855828|20348337|P1|Overall Study|Withdrawal by Subject|1
5881744|NCT01855828|20348337|P1|Overall Study|Adverse Event|1
5881745|NCT01855789|20348347|P4|2) Week 24 up to End of Study|Other|1
5881746|NCT01855789|20348348|P3|2) Week 24 up to End of Study|Other|0
5881747|NCT01855789|20348349|P2|2) Week 24 up to End of Study|Other|0
5881748|NCT01855789|20348350|P1|2) Week 24 up to End of Study|Other|0
5881749|NCT01855789|20348347|P4|2) Week 24 up to End of Study|Sponsor Decision|1
5881750|NCT01855789|20348348|P3|2) Week 24 up to End of Study|Sponsor Decision|0
5881751|NCT01855789|20348349|P2|2) Week 24 up to End of Study|Sponsor Decision|0
5881752|NCT01855789|20348350|P1|2) Week 24 up to End of Study|Sponsor Decision|0
5881753|NCT01855789|20348347|P4|2) Week 24 up to End of Study|Participant Non-compliance|1
5881754|NCT01855789|20348348|P3|2) Week 24 up to End of Study|Participant Non-compliance|0
5881755|NCT01855789|20348349|P2|2) Week 24 up to End of Study|Participant Non-compliance|1
5881756|NCT01855789|20348350|P1|2) Week 24 up to End of Study|Participant Non-compliance|0
5881757|NCT01855789|20348347|P4|2) Week 24 up to End of Study|Physician Decision|4
5881758|NCT01855789|20348348|P3|2) Week 24 up to End of Study|Physician Decision|2
5881759|NCT01855789|20348349|P2|2) Week 24 up to End of Study|Physician Decision|0
5881760|NCT01855789|20348350|P1|2) Week 24 up to End of Study|Physician Decision|0
5881761|NCT01855789|20348347|P4|2) Week 24 up to End of Study|Withdrawal by Subject|8
5881762|NCT01855789|20348348|P3|2) Week 24 up to End of Study|Withdrawal by Subject|5
5881763|NCT01855789|20348349|P2|2) Week 24 up to End of Study|Withdrawal by Subject|7
5881764|NCT01855789|20348350|P1|2) Week 24 up to End of Study|Withdrawal by Subject|0
5881765|NCT01855789|20348347|P4|2) Week 24 up to End of Study|Protocol Violation|1
5881766|NCT01855789|20348348|P3|2) Week 24 up to End of Study|Protocol Violation|0
5881767|NCT01855789|20348349|P2|2) Week 24 up to End of Study|Protocol Violation|0
5881768|NCT01855789|20348350|P1|2) Week 24 up to End of Study|Protocol Violation|0
5881769|NCT01855789|20348347|P4|2) Week 24 up to End of Study|Lost to Follow-up|4
5881770|NCT01855789|20348348|P3|2) Week 24 up to End of Study|Lost to Follow-up|1
5881771|NCT01855789|20348349|P2|2) Week 24 up to End of Study|Lost to Follow-up|1
5881772|NCT01855789|20348350|P1|2) Week 24 up to End of Study|Lost to Follow-up|0
5881773|NCT01855789|20348347|P4|2) Week 24 up to End of Study|Lack of Efficacy|16
5881774|NCT01855789|20348348|P3|2) Week 24 up to End of Study|Lack of Efficacy|5
5881775|NCT01855789|20348349|P2|2) Week 24 up to End of Study|Lack of Efficacy|2
5881776|NCT01855789|20348350|P1|2) Week 24 up to End of Study|Lack of Efficacy|0
5881777|NCT01855789|20348347|P4|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|1
5881778|NCT01855789|20348348|P3|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0
5881779|NCT01855789|20348349|P2|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0
5881780|NCT01855789|20348350|P1|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0
5881781|NCT01855789|20348347|P4|2) Week 24 up to End of Study|Adverse Event|21
5881782|NCT01855789|20348348|P3|2) Week 24 up to End of Study|Adverse Event|5
5881783|NCT01855789|20348349|P2|2) Week 24 up to End of Study|Adverse Event|4
5881784|NCT01855789|20348350|P1|2) Week 24 up to End of Study|Adverse Event|0
5881785|NCT01855789|20348347|P4|1) Baseline up to Week 24|Other|0
5881786|NCT01855789|20348348|P3|1) Baseline up to Week 24|Other|0
5881787|NCT01855789|20348349|P2|1) Baseline up to Week 24|Other|0
5881788|NCT01855789|20348350|P1|1) Baseline up to Week 24|Other|4
5881789|NCT01855789|20348347|P4|1) Baseline up to Week 24|Sponsor Decision|0
5881790|NCT01855789|20348348|P3|1) Baseline up to Week 24|Sponsor Decision|0
5881791|NCT01855789|20348349|P2|1) Baseline up to Week 24|Sponsor Decision|0
5881792|NCT01855789|20348350|P1|1) Baseline up to Week 24|Sponsor Decision|3
5881793|NCT01855789|20348347|P4|1) Baseline up to Week 24|Participant Non-compliance|0
5881794|NCT01855789|20348348|P3|1) Baseline up to Week 24|Participant Non-compliance|0
5881795|NCT01855789|20348349|P2|1) Baseline up to Week 24|Participant Non-compliance|0
5881796|NCT01855789|20348350|P1|1) Baseline up to Week 24|Participant Non-compliance|3
5881797|NCT01855789|20348347|P4|1) Baseline up to Week 24|Pregnancy|0
5881798|NCT01855789|20348348|P3|1) Baseline up to Week 24|Pregnancy|0
5881799|NCT01855789|20348349|P2|1) Baseline up to Week 24|Pregnancy|0
5881800|NCT01855789|20348350|P1|1) Baseline up to Week 24|Pregnancy|1
5881801|NCT01855789|20348347|P4|1) Baseline up to Week 24|Physician Decision|0
5881802|NCT01855789|20348348|P3|1) Baseline up to Week 24|Physician Decision|0
5881803|NCT01855789|20348349|P2|1) Baseline up to Week 24|Physician Decision|0
5881804|NCT01855789|20348350|P1|1) Baseline up to Week 24|Physician Decision|4
5881805|NCT01855789|20348347|P4|1) Baseline up to Week 24|Withdrawal by Subject|0
5881806|NCT01855789|20348348|P3|1) Baseline up to Week 24|Withdrawal by Subject|0
5881807|NCT01855789|20348349|P2|1) Baseline up to Week 24|Withdrawal by Subject|0
5881808|NCT01855789|20348350|P1|1) Baseline up to Week 24|Withdrawal by Subject|31
5881809|NCT01855789|20348347|P4|1) Baseline up to Week 24|Protocol Violation|0
5881810|NCT01855789|20348348|P3|1) Baseline up to Week 24|Protocol Violation|0
5881811|NCT01855789|20348349|P2|1) Baseline up to Week 24|Protocol Violation|0
5881812|NCT01855789|20348350|P1|1) Baseline up to Week 24|Protocol Violation|4
5881813|NCT01855789|20348347|P4|1) Baseline up to Week 24|Lost to Follow-up|0
5881814|NCT01855789|20348348|P3|1) Baseline up to Week 24|Lost to Follow-up|0
5881815|NCT01855789|20348349|P2|1) Baseline up to Week 24|Lost to Follow-up|0
5881816|NCT01855789|20348350|P1|1) Baseline up to Week 24|Lost to Follow-up|11
5881817|NCT01855789|20348347|P4|1) Baseline up to Week 24|Lack of Efficacy|0
5881818|NCT01855789|20348348|P3|1) Baseline up to Week 24|Lack of Efficacy|0
5881819|NCT01855789|20348349|P2|1) Baseline up to Week 24|Lack of Efficacy|0
5881820|NCT01855789|20348350|P1|1) Baseline up to Week 24|Lack of Efficacy|16
5881821|NCT01855789|20348347|P4|1) Baseline up to Week 24|Death|0
5881822|NCT01855789|20348348|P3|1) Baseline up to Week 24|Death|0
5881823|NCT01855789|20348349|P2|1) Baseline up to Week 24|Death|0
5881824|NCT01855789|20348350|P1|1) Baseline up to Week 24|Death|2
5881825|NCT01855789|20348347|P4|1) Baseline up to Week 24|Adverse Event|0
5881826|NCT01855789|20348348|P3|1) Baseline up to Week 24|Adverse Event|0
5881827|NCT01855789|20348349|P2|1) Baseline up to Week 24|Adverse Event|0
5881828|NCT01855789|20348350|P1|1) Baseline up to Week 24|Adverse Event|37
5881829|NCT01855750|20348374|P2|Overall Study|Sponsor ends the study|290
5881830|NCT01855750|20348375|P1|Overall Study|Sponsor ends the study|297
5881831|NCT01855750|20348374|P2|Overall Study|Withdrawal by Subject|28
5881832|NCT01855750|20348375|P1|Overall Study|Withdrawal by Subject|35
5881833|NCT01855750|20348374|P2|Overall Study|Lost to Follow-up|23
5881834|NCT01855750|20348375|P1|Overall Study|Lost to Follow-up|9
5881835|NCT01855750|20348374|P2|Overall Study|Death|78
5881836|NCT01855750|20348375|P1|Overall Study|Death|78
5881837|NCT01855425|20348391|P1|Overall Study|Physician Decision|20
5881838|NCT01855399|20348397|P2|12 Month|Lost to Follow-up|11
5881839|NCT01855399|20348398|P1|12 Month|Lost to Follow-up|7
5881840|NCT01855399|20348397|P2|6 Month|Withdrawal by Subject|6
5881841|NCT01855399|20348398|P1|6 Month|Withdrawal by Subject|8
5881842|NCT01855399|20348397|P2|6 Month|Lost to Follow-up|9
5881843|NCT01855399|20348398|P1|6 Month|Lost to Follow-up|12
5881844|NCT01855243|20348412|P3|Overall Study|develpoed diabetic ketoacidosis|0
5881845|NCT01855243|20348413|P2|Overall Study|develpoed diabetic ketoacidosis|0
5881846|NCT01855243|20348414|P1|Overall Study|develpoed diabetic ketoacidosis|1
5881847|NCT01855126|20348436|P2|Second Intervention (8 Weeks)|Withdrawal by Subject|2
5881848|NCT01855126|20348437|P1|Second Intervention (8 Weeks)|Withdrawal by Subject|2
5881849|NCT01855126|20348436|P2|First Intervention (8 Weeks)|Withdrawal by Subject|6
5881850|NCT01855126|20348437|P1|First Intervention (8 Weeks)|Withdrawal by Subject|4
5881851|NCT01855074|20348449|P1|Overall Study|Started but not treated|1
5881852|NCT01855074|20348449|P1|Overall Study|Withdrawal by Subject|8
5881853|NCT01855074|20348449|P1|Overall Study|Lost to Follow-up|4
5881854|NCT01855074|20348449|P1|Overall Study|Adverse Event|1
5881855|NCT01854944|20348461|P3|Overall Study|Withdrawal by Subject|1
5881856|NCT01854944|20348462|P2|Overall Study|Withdrawal by Subject|0
5881857|NCT01854944|20348463|P1|Overall Study|Withdrawal by Subject|0
5881858|NCT01854918|20348515|P2|All-IP Period (Years 2 and 3)|Death|16
5881859|NCT01854918|20348516|P1|All-IP Period (Years 2 and 3)|Death|5
5881860|NCT01854918|20348515|P2|All-IP Period (Years 2 and 3)|Lost to Follow-up|51
5881861|NCT01854918|20348516|P1|All-IP Period (Years 2 and 3)|Lost to Follow-up|27
5881862|NCT01854918|20348515|P2|All-IP Period (Years 2 and 3)|Decision by Sponsor|11
5881863|NCT01854918|20348516|P1|All-IP Period (Years 2 and 3)|Decision by Sponsor|8
5881864|NCT01854918|20348515|P2|All-IP Period (Years 2 and 3)|Withdrawal by Subject|117
5881865|NCT01854918|20348516|P1|All-IP Period (Years 2 and 3)|Withdrawal by Subject|78
5881866|NCT01854918|20348515|P2|SOC-controlled Period (Year 1)|Death|5
5881867|NCT01854918|20348516|P1|SOC-controlled Period (Year 1)|Death|5
5881868|NCT01854918|20348515|P2|SOC-controlled Period (Year 1)|Lost to Follow-up|8
5881869|NCT01854918|20348516|P1|SOC-controlled Period (Year 1)|Lost to Follow-up|3
5881870|NCT01854918|20348515|P2|SOC-controlled Period (Year 1)|Decision by Sponsor|1
5881871|NCT01854918|20348516|P1|SOC-controlled Period (Year 1)|Decision by Sponsor|2
5881872|NCT01854918|20348515|P2|SOC-controlled Period (Year 1)|Withdrawal by Subject|49
5881873|NCT01854918|20348516|P1|SOC-controlled Period (Year 1)|Withdrawal by Subject|20
5881874|NCT01854879|20348535|P1|Overall Study|incomplete data set|1
5881875|NCT01854879|20348535|P1|Overall Study|screen fail|3
5881876|NCT01854879|20348535|P1|Overall Study|Could not complete testing within the scheduled time.|1
5881877|NCT01854827|20348539|P1|Overall Study|Death|1
5881878|NCT01854710|20348551|P6|Overall Study|CRI procedural error|2
5881879|NCT01854710|20348552|P5|Overall Study|CRI procedural error|2
5881880|NCT01854710|20348553|P4|Overall Study|CRI procedural error|2
5881881|NCT01854710|20348554|P3|Overall Study|CRI procedural error|2
5881882|NCT01854710|20348555|P2|Overall Study|CRI procedural error|2
5881883|NCT01854710|20348556|P1|Overall Study|CRI procedural error|2
5881884|NCT01854710|20348551|P6|Overall Study|Withdrawal by Subject|0
5881885|NCT01854710|20348552|P5|Overall Study|Withdrawal by Subject|0
5881886|NCT01854710|20348553|P4|Overall Study|Withdrawal by Subject|0
5881887|NCT01854710|20348554|P3|Overall Study|Withdrawal by Subject|0
5881888|NCT01854710|20348555|P2|Overall Study|Withdrawal by Subject|1
5881889|NCT01854710|20348556|P1|Overall Study|Withdrawal by Subject|2
5881890|NCT01854697|20348577|P5|Overall Study|Other|0
5881891|NCT01854697|20348578|P4|Overall Study|Other|0
5881892|NCT01854697|20348579|P3|Overall Study|Other|1
5881893|NCT01854697|20348580|P2|Overall Study|Other|1
5881894|NCT01854697|20348581|P1|Overall Study|Other|0
5881895|NCT01854697|20348577|P5|Overall Study|Withdrew Consent|0
5881896|NCT01854697|20348578|P4|Overall Study|Withdrew Consent|1
5881897|NCT01854697|20348579|P3|Overall Study|Withdrew Consent|0
5881898|NCT01854697|20348580|P2|Overall Study|Withdrew Consent|1
5881899|NCT01854697|20348581|P1|Overall Study|Withdrew Consent|0
5881900|NCT01854697|20348577|P5|Overall Study|To enter another AbbVie study|1
5881901|NCT01854697|20348578|P4|Overall Study|To enter another AbbVie study|0
5881902|NCT01854697|20348579|P3|Overall Study|To enter another AbbVie study|0
5881903|NCT01854697|20348580|P2|Overall Study|To enter another AbbVie study|0
5881904|NCT01854697|20348581|P1|Overall Study|To enter another AbbVie study|1
5881905|NCT01854697|20348577|P5|Overall Study|Lost to Follow-up|0
5881906|NCT01854697|20348578|P4|Overall Study|Lost to Follow-up|2
5881907|NCT01854697|20348579|P3|Overall Study|Lost to Follow-up|1
5881908|NCT01854697|20348580|P2|Overall Study|Lost to Follow-up|1
5881909|NCT01854697|20348581|P1|Overall Study|Lost to Follow-up|4
5881910|NCT01854697|20348577|P5|Overall Study|Adverse Event|1
5881911|NCT01854697|20348578|P4|Overall Study|Adverse Event|0
5881912|NCT01854697|20348579|P3|Overall Study|Adverse Event|0
5881913|NCT01854697|20348580|P2|Overall Study|Adverse Event|0
5881914|NCT01854697|20348581|P1|Overall Study|Adverse Event|1
5881915|NCT01854658|20348625|P4|Overall Study|Administrative reasons|2
5881916|NCT01854658|20348626|P3|Overall Study|Administrative reasons|2
5881917|NCT01854658|20348627|P2|Overall Study|Administrative reasons|1
5881918|NCT01854658|20348628|P1|Overall Study|Administrative reasons|5
5881919|NCT01854658|20348625|P4|Overall Study|Adverse Event|19
5881920|NCT01854658|20348626|P3|Overall Study|Adverse Event|23
5881921|NCT01854658|20348627|P2|Overall Study|Adverse Event|14
5881922|NCT01854658|20348628|P1|Overall Study|Adverse Event|21
5881923|NCT01854658|20348625|P4|Overall Study|Lack of Efficacy|7
5881924|NCT01854658|20348626|P3|Overall Study|Lack of Efficacy|4
5881925|NCT01854658|20348627|P2|Overall Study|Lack of Efficacy|8
5881926|NCT01854658|20348628|P1|Overall Study|Lack of Efficacy|3
5881927|NCT01854658|20348625|P4|Overall Study|Protocol-specified criteria|7
5881928|NCT01854658|20348626|P3|Overall Study|Protocol-specified criteria|10
5881929|NCT01854658|20348627|P2|Overall Study|Protocol-specified criteria|15
5881930|NCT01854658|20348628|P1|Overall Study|Protocol-specified criteria|15
5881931|NCT01854658|20348625|P4|Overall Study|Withdrawal by Subject|15
5881932|NCT01854658|20348626|P3|Overall Study|Withdrawal by Subject|29
5881933|NCT01854658|20348627|P2|Overall Study|Withdrawal by Subject|21
5881934|NCT01854658|20348628|P1|Overall Study|Withdrawal by Subject|28
5881935|NCT01854658|20348625|P4|Overall Study|Lost to Follow-up|4
5881936|NCT01854658|20348626|P3|Overall Study|Lost to Follow-up|8
5881937|NCT01854658|20348627|P2|Overall Study|Lost to Follow-up|9
5881938|NCT01854658|20348628|P1|Overall Study|Lost to Follow-up|8
5881939|NCT01854658|20348625|P4|Overall Study|Physician Decision|4
5881940|NCT01854658|20348626|P3|Overall Study|Physician Decision|2
5881941|NCT01854658|20348627|P2|Overall Study|Physician Decision|5
5881942|NCT01854658|20348628|P1|Overall Study|Physician Decision|7
5881943|NCT01854658|20348625|P4|Overall Study|Protocol Violation|1
5881944|NCT01854658|20348626|P3|Overall Study|Protocol Violation|2
5881945|NCT01854658|20348627|P2|Overall Study|Protocol Violation|2
5881946|NCT01854658|20348628|P1|Overall Study|Protocol Violation|6
5881947|NCT01854645|20348663|P5|Overall Study|Adverse Event|11
5881948|NCT01854645|20348664|P4|Overall Study|Adverse Event|20
5881949|NCT01854645|20348665|P3|Overall Study|Adverse Event|19
5881950|NCT01854645|20348666|P2|Overall Study|Adverse Event|31
5881951|NCT01854645|20348667|P1|Overall Study|Adverse Event|33
5881952|NCT01854645|20348663|P5|Overall Study|Lack of Efficacy|9
5881953|NCT01854645|20348664|P4|Overall Study|Lack of Efficacy|3
5881954|NCT01854645|20348665|P3|Overall Study|Lack of Efficacy|9
5881955|NCT01854645|20348666|P2|Overall Study|Lack of Efficacy|12
5881956|NCT01854645|20348667|P1|Overall Study|Lack of Efficacy|7
5881957|NCT01854645|20348663|P5|Overall Study|Withdrawal by Subject|24
5881958|NCT01854645|20348664|P4|Overall Study|Withdrawal by Subject|21
5881959|NCT01854645|20348665|P3|Overall Study|Withdrawal by Subject|30
5881960|NCT01854645|20348666|P2|Overall Study|Withdrawal by Subject|41
5881961|NCT01854645|20348667|P1|Overall Study|Withdrawal by Subject|31
5881962|NCT01854645|20348663|P5|Overall Study|Physician Decision|7
5881963|NCT01854645|20348664|P4|Overall Study|Physician Decision|3
5881964|NCT01854645|20348665|P3|Overall Study|Physician Decision|3
5881965|NCT01854645|20348666|P2|Overall Study|Physician Decision|5
5881966|NCT01854645|20348667|P1|Overall Study|Physician Decision|1
5881967|NCT01854645|20348663|P5|Overall Study|Lost to Follow-up|0
5881968|NCT01854645|20348664|P4|Overall Study|Lost to Follow-up|5
5881969|NCT01854645|20348665|P3|Overall Study|Lost to Follow-up|8
5881970|NCT01854645|20348666|P2|Overall Study|Lost to Follow-up|7
5881971|NCT01854645|20348667|P1|Overall Study|Lost to Follow-up|10
5881972|NCT01854645|20348663|P5|Overall Study|Protocol Violation|1
5881973|NCT01854645|20348664|P4|Overall Study|Protocol Violation|4
5881974|NCT01854645|20348665|P3|Overall Study|Protocol Violation|5
5881975|NCT01854645|20348666|P2|Overall Study|Protocol Violation|0
5881976|NCT01854645|20348667|P1|Overall Study|Protocol Violation|3
5881977|NCT01854645|20348663|P5|Overall Study|Administrative Reasons / Missing|1
5881978|NCT01854645|20348664|P4|Overall Study|Administrative Reasons / Missing|1
5881979|NCT01854645|20348665|P3|Overall Study|Administrative Reasons / Missing|0
5881980|NCT01854645|20348666|P2|Overall Study|Administrative Reasons / Missing|0
5881981|NCT01854645|20348667|P1|Overall Study|Administrative Reasons / Missing|0
5881982|NCT01854645|20348663|P5|Overall Study|Protocol-Specified Criteria|7
5881983|NCT01854645|20348664|P4|Overall Study|Protocol-Specified Criteria|5
5881984|NCT01854645|20348665|P3|Overall Study|Protocol-Specified Criteria|8
5881985|NCT01854645|20348666|P2|Overall Study|Protocol-Specified Criteria|10
5881986|NCT01854645|20348667|P1|Overall Study|Protocol-Specified Criteria|13
5881987|NCT01854528|20348748|P2|Overall Study|Virologic Failure|9
5881988|NCT01854528|20348749|P1|Overall Study|Virologic Failure|0
5881989|NCT01854528|20348748|P2|Overall Study|Withdrawal by Subject|2
5881990|NCT01854528|20348749|P1|Overall Study|Withdrawal by Subject|0
5881991|NCT01854528|20348748|P2|Overall Study|Adverse Event|4
5881992|NCT01854528|20348749|P1|Overall Study|Adverse Event|0
5881993|NCT01854047|20348820|P5|Overall Study|Other than specified above|8
5881994|NCT01854047|20348821|P4|Overall Study|Other than specified above|5
5881995|NCT01854047|20348822|P3|Overall Study|Other than specified above|3
5881996|NCT01854047|20348823|P2|Overall Study|Other than specified above|3
5881997|NCT01854047|20348824|P1|Overall Study|Other than specified above|3
5881998|NCT01854047|20348820|P5|Overall Study|Randomized but not treated|4
5881999|NCT01854047|20348821|P4|Overall Study|Randomized but not treated|0
5882000|NCT01854047|20348822|P3|Overall Study|Randomized but not treated|2
5882001|NCT01854047|20348823|P2|Overall Study|Randomized but not treated|1
5882002|NCT01854047|20348824|P1|Overall Study|Randomized but not treated|0
5882003|NCT01854047|20348820|P5|Overall Study|Adverse Event|7
5882004|NCT01854047|20348821|P4|Overall Study|Adverse Event|10
5882005|NCT01854047|20348822|P3|Overall Study|Adverse Event|6
5882006|NCT01854047|20348823|P2|Overall Study|Adverse Event|4
5882007|NCT01854047|20348824|P1|Overall Study|Adverse Event|5
5882008|NCT01854047|20348820|P5|Overall Study|Poor compliance to protocol|0
5882009|NCT01854047|20348821|P4|Overall Study|Poor compliance to protocol|0
5882010|NCT01854047|20348822|P3|Overall Study|Poor compliance to protocol|2
5882011|NCT01854047|20348823|P2|Overall Study|Poor compliance to protocol|0
5882012|NCT01854047|20348824|P1|Overall Study|Poor compliance to protocol|3
5882013|NCT01854047|20348820|P5|Overall Study|Lack of Efficacy|0
5882014|NCT01854047|20348821|P4|Overall Study|Lack of Efficacy|0
5882015|NCT01854047|20348822|P3|Overall Study|Lack of Efficacy|0
5882016|NCT01854047|20348823|P2|Overall Study|Lack of Efficacy|0
5882017|NCT01854047|20348824|P1|Overall Study|Lack of Efficacy|1
5882018|NCT01853982|20348955|P2|Overall Study|Lost to Follow-up|1
5882019|NCT01853982|20348956|P1|Overall Study|Lost to Follow-up|0
5882020|NCT01853982|20348955|P2|Overall Study|Death|0
5882021|NCT01853982|20348956|P1|Overall Study|Death|1
5882022|NCT01853982|20348955|P2|Overall Study|Withdrawal by Subject|0
5882023|NCT01853982|20348956|P1|Overall Study|Withdrawal by Subject|1
5882024|NCT01853878|20348973|P2|Overall Study|Other|43
5882025|NCT01853878|20348974|P1|Overall Study|Other|55
5882026|NCT01853878|20348973|P2|Overall Study|Migrated/moved from the study area|0
5882027|NCT01853878|20348974|P1|Overall Study|Migrated/moved from the study area|1
5882028|NCT01853878|20348973|P2|Overall Study|Withdrawal by Subject|1
5882029|NCT01853878|20348974|P1|Overall Study|Withdrawal by Subject|3
5882030|NCT01853878|20348973|P2|Overall Study|Adverse Event|0
5882031|NCT01853878|20348974|P1|Overall Study|Adverse Event|2
5882032|NCT01853878|20348973|P2|Overall Study|Recurrence|0
5882033|NCT01853878|20348974|P1|Overall Study|Recurrence|2
5882034|NCT01853839|20348998|P1|Overall Study|Lost to follow-up or no valid BP measure|336
5882035|NCT01853839|20348998|P1|Overall Study|End of treatment visit too early|33
5882036|NCT01853839|20348998|P1|Overall Study|Not meet ITT population definition|58
5882037|NCT01853839|20348998|P1|Overall Study|Violated inclusion criteria|2
5882038|NCT01853696|20349031|P2|Overall Study|Lost to Follow-up|4
5882039|NCT01853696|20349032|P1|Overall Study|Lost to Follow-up|5
5882040|NCT01853696|20349031|P2|Overall Study|Withdrawal by Subject|1
5882041|NCT01853696|20349032|P1|Overall Study|Withdrawal by Subject|1
5882042|NCT01853644|20349040|P1|Follow up for 3 Years or Until Death|Still in the follow up period|3
5882043|NCT01853644|20349040|P1|Continued Treatment After First Response|Progressive Diseaes|10
5882044|NCT01853644|20349040|P1|Continued Treatment After First Response|Adverse Event|2
5882045|NCT01853644|20349040|P1|Reached First Response/Complete 2 Cycles|Progressive Disease|2
5882046|NCT01853644|20349040|P1|Reached First Response/Complete 2 Cycles|Other|1
5882047|NCT01853644|20349040|P1|Reached First Response/Complete 2 Cycles|Withdrawal by Subject|1
5882048|NCT01853644|20349040|P1|Reached First Response/Complete 2 Cycles|Adverse Event|2
5882049|NCT01853644|20349040|P1|Registration and Treatment Start|Did not start treatment|1
5882050|NCT01853618|20349054|P5|Overall Study|Refused further treatment|1
5882051|NCT01853618|20349055|P4|Overall Study|Refused further treatment|0
5882052|NCT01853618|20349056|P3|Overall Study|Refused further treatment|0
5882053|NCT01853618|20349057|P2|Overall Study|Refused further treatment|0
5882054|NCT01853618|20349058|P1|Overall Study|Refused further treatment|0
5882055|NCT01853618|20349054|P5|Overall Study|Physician Decision|0
5882056|NCT01853618|20349055|P4|Overall Study|Physician Decision|0
5882057|NCT01853618|20349056|P3|Overall Study|Physician Decision|1
5882058|NCT01853618|20349057|P2|Overall Study|Physician Decision|1
5882059|NCT01853618|20349058|P1|Overall Study|Physician Decision|0
5882060|NCT01853618|20349054|P5|Overall Study|Progressive disease|2
5882061|NCT01853618|20349055|P4|Overall Study|Progressive disease|1
5882062|NCT01853618|20349056|P3|Overall Study|Progressive disease|1
5882063|NCT01853618|20349057|P2|Overall Study|Progressive disease|1
5882064|NCT01853618|20349058|P1|Overall Study|Progressive disease|1
5882065|NCT01853618|20349054|P5|Overall Study|Bile duct stent blockage/progressive dis|0
5882066|NCT01853618|20349055|P4|Overall Study|Bile duct stent blockage/progressive dis|0
5882067|NCT01853618|20349056|P3|Overall Study|Bile duct stent blockage/progressive dis|0
5882068|NCT01853618|20349057|P2|Overall Study|Bile duct stent blockage/progressive dis|0
5882069|NCT01853618|20349058|P1|Overall Study|Bile duct stent blockage/progressive dis|1
5882070|NCT01853475|20349124|P3|Overall Study|Withdrawal by Subject|0
5882071|NCT01853475|20349125|P2|Overall Study|Withdrawal by Subject|1
5882072|NCT01853475|20349126|P1|Overall Study|Withdrawal by Subject|0
5882073|NCT01853462|20349145|P2|Overall Study|Withdrawal by Subject|1
5882074|NCT01853462|20349146|P1|Overall Study|Withdrawal by Subject|1
5882075|NCT01853397|20349216|P4|Overall Study|Subject Noncompliance|1
5882076|NCT01853397|20349217|P3|Overall Study|Subject Noncompliance|0
5882077|NCT01853397|20349218|P2|Overall Study|Subject Noncompliance|0
5882078|NCT01853397|20349219|P1|Overall Study|Subject Noncompliance|0
5882079|NCT01853397|20349216|P4|Overall Study|Withdrawal by Subject|1
5882080|NCT01853397|20349217|P3|Overall Study|Withdrawal by Subject|0
5882081|NCT01853397|20349218|P2|Overall Study|Withdrawal by Subject|0
5882082|NCT01853397|20349219|P1|Overall Study|Withdrawal by Subject|0
5882083|NCT01853384|20349247|P2|Completed Follow up Visit 2|Lost to Follow-up|1
5882084|NCT01853384|20349248|P1|Completed Follow up Visit 2|Lost to Follow-up|0
5882085|NCT01853384|20349247|P2|Completed Follow up Visit 2|Death|0
5882086|NCT01853384|20349248|P1|Completed Follow up Visit 2|Death|1
5882087|NCT01853384|20349247|P2|Completed Follow up Visit 2|Withdrawal by Subject|2
5882088|NCT01853384|20349248|P1|Completed Follow up Visit 2|Withdrawal by Subject|1
5882089|NCT01853384|20349247|P2|Completed Follow up Visit 2|Adverse Event|0
5882090|NCT01853384|20349248|P1|Completed Follow up Visit 2|Adverse Event|1
5882091|NCT01853384|20349247|P2|Completed Follow up Visit 1|Withdrawal by Subject|0
5882092|NCT01853384|20349248|P1|Completed Follow up Visit 1|Withdrawal by Subject|1
5882093|NCT01853384|20349247|P2|Completed Follow up Visit 1|Early Termination|9
5882094|NCT01853384|20349248|P1|Completed Follow up Visit 1|Early Termination|13
5882095|NCT01853384|20349247|P2|Randomized|Other|3
5882096|NCT01853384|20349248|P1|Randomized|Other|3
5882097|NCT01853384|20349247|P2|Randomized|Sponsor Decision|34
5882098|NCT01853384|20349248|P1|Randomized|Sponsor Decision|47
5882099|NCT01853384|20349247|P2|Randomized|Withdrawal by Subject|3
5882100|NCT01853384|20349248|P1|Randomized|Withdrawal by Subject|5
5882101|NCT01853384|20349247|P2|Randomized|Lost to Follow-up|1
5882102|NCT01853384|20349248|P1|Randomized|Lost to Follow-up|1
5882103|NCT01853384|20349247|P2|Randomized|Death|2
5882104|NCT01853384|20349248|P1|Randomized|Death|1
5882105|NCT01853384|20349247|P2|Randomized|Adverse Event|3
5882106|NCT01853384|20349248|P1|Randomized|Adverse Event|5
5882107|NCT01853280|20349288|P2|Overall Study|Ineligible|1
5882108|NCT01853280|20349289|P1|Overall Study|Ineligible|0
5882109|NCT01853280|20349288|P2|Overall Study|Withdrawal by Subject|1
5882110|NCT01853280|20349289|P1|Overall Study|Withdrawal by Subject|0
5882111|NCT01853280|20349288|P2|Overall Study|Physician Decision|1
5882112|NCT01853280|20349289|P1|Overall Study|Physician Decision|0
5882113|NCT01853280|20349288|P2|Overall Study|Lost to Follow-up|1
5882114|NCT01853280|20349289|P1|Overall Study|Lost to Follow-up|0
5882115|NCT01853280|20349288|P2|Overall Study|Lack of Efficacy|2
5882116|NCT01853280|20349289|P1|Overall Study|Lack of Efficacy|2
5882117|NCT01853254|20349295|P1|Overall Study|Administrative/Other|16
5882118|NCT01853254|20349295|P1|Overall Study|Withdrawal of Consent|16
5882119|NCT01853254|20349295|P1|Overall Study|Other Protocol Violation|1
5882120|NCT01853254|20349295|P1|Overall Study|Refusal of Treatment|1
5882121|NCT01853254|20349295|P1|Overall Study|Insufficient Therapeutic Response|22
5882122|NCT01853254|20349295|P1|Overall Study|Failure to Return|43
5882123|NCT01853254|20349295|P1|Overall Study|Death|1
5882124|NCT01853254|20349295|P1|Overall Study|Adverse Event/Intercurrent Illness|3
5882125|NCT01853254|20349295|P1|Overall Study|Abnormal Laboratory Test|1
5882126|NCT01853228|20349299|P2|Phase 2|Lack of Efficacy|4
5882127|NCT01853228|20349300|P1|Phase 2|Lack of Efficacy|0
5882128|NCT01853228|20349299|P2|Phase 2|Proceed To Transplant|3
5882129|NCT01853228|20349300|P1|Phase 2|Proceed To Transplant|0
5882130|NCT01853228|20349299|P2|Phase 2|Physician Decision|1
5882131|NCT01853228|20349300|P1|Phase 2|Physician Decision|0
5882132|NCT01853228|20349299|P2|Phase 1|Other|0
5882133|NCT01853228|20349300|P1|Phase 1|Other|1
5882134|NCT01853228|20349299|P2|Phase 1|Lack of Efficacy|0
5882135|NCT01853228|20349300|P1|Phase 1|Lack of Efficacy|8
5882136|NCT01853176|20349330|P2|Overall Study|Study terminated|0
5882137|NCT01853176|20349331|P1|Overall Study|Study terminated|4
5882138|NCT01853137|20349339|P2|Overall Study|Lost to Follow-up|1
5882139|NCT01853137|20349340|P1|Overall Study|Lost to Follow-up|4
5882140|NCT01853072|20349361|P2|Overall Study|Reason not specified|6
5882141|NCT01853072|20349362|P1|Overall Study|Reason not specified|9
5882142|NCT01853072|20349361|P2|Overall Study|Withdrawal by Subject|2
5882143|NCT01853072|20349362|P1|Overall Study|Withdrawal by Subject|1
5882144|NCT01853072|20349361|P2|Overall Study|Physician Decision|1
5882145|NCT01853072|20349362|P1|Overall Study|Physician Decision|1
5882146|NCT01853072|20349361|P2|Overall Study|Non-compliance with study drug|1
5882147|NCT01853072|20349362|P1|Overall Study|Non-compliance with study drug|0
5882148|NCT01853072|20349361|P2|Overall Study|Lost to Follow-up|3
5882149|NCT01853072|20349362|P1|Overall Study|Lost to Follow-up|0
5882150|NCT01853072|20349361|P2|Overall Study|Death|4
5882151|NCT01853072|20349362|P1|Overall Study|Death|1
5882152|NCT01853072|20349361|P2|Overall Study|Adverse Event|3
5882153|NCT01853072|20349362|P1|Overall Study|Adverse Event|0
5882154|NCT01853072|20349361|P2|Overall Study|Adverse event prior to treatment|1
5882155|NCT01853072|20349362|P1|Overall Study|Adverse event prior to treatment|0
5882156|NCT01853046|20349382|P2|Overall Study|Disease progression|3
5882157|NCT01853046|20349383|P1|Overall Study|Disease progression|13
5882158|NCT01853046|20349382|P2|Overall Study|Adverse Event|2
5882159|NCT01853046|20349383|P1|Overall Study|Adverse Event|4
5882160|NCT01853046|20349382|P2|Overall Study|Withdrawal by Subject|1
5882161|NCT01853046|20349383|P1|Overall Study|Withdrawal by Subject|1
5882162|NCT01852942|20349450|P2|Overall Study|Lost to Follow-up|2
5882163|NCT01852942|20349451|P1|Overall Study|Lost to Follow-up|1
5882164|NCT01852942|20349450|P2|Overall Study|Withdrawal by Subject|3
5882165|NCT01852942|20349451|P1|Overall Study|Withdrawal by Subject|2
5882166|NCT01852942|20349450|P2|Overall Study|Death|1
5882167|NCT01852942|20349451|P1|Overall Study|Death|1
5882168|NCT01852942|20349450|P2|Overall Study|Physician Decision|0
5882169|NCT01852942|20349451|P1|Overall Study|Physician Decision|1
5882170|NCT01852825|20349546|P3|Overall Study|Withdrawal by Subject|0
5882171|NCT01852825|20349547|P2|Overall Study|Withdrawal by Subject|0
5882172|NCT01852825|20349548|P1|Overall Study|Withdrawal by Subject|2
5882173|NCT01852812|20349574|P3|Overall Study|Non-compliance With Study Drug|0
5882174|NCT01852812|20349575|P2|Overall Study|Non-compliance With Study Drug|1
5882175|NCT01852812|20349576|P1|Overall Study|Non-compliance With Study Drug|0
5882176|NCT01852812|20349574|P3|Overall Study|Adverse Event|1
5882177|NCT01852812|20349575|P2|Overall Study|Adverse Event|0
5882178|NCT01852812|20349576|P1|Overall Study|Adverse Event|0
5882179|NCT01852591|20349614|P1|Overall Study|Not Evaluable at Time of Analysis|1
5882180|NCT01852591|20349614|P1|Overall Study|Withdrawal by Subject|2
5882181|NCT01852292|20349668|P2|Overall Study|Progressive disease|52
5882182|NCT01852292|20349669|P1|Overall Study|Progressive disease|42
5882183|NCT01852292|20349668|P2|Overall Study|Study terminated by Sponsor|1
5882184|NCT01852292|20349669|P1|Overall Study|Study terminated by Sponsor|0
5882185|NCT01852292|20349668|P2|Overall Study|Non-compliance with study treatment|0
5882186|NCT01852292|20349669|P1|Overall Study|Non-compliance with study treatment|1
5882187|NCT01852292|20349668|P2|Overall Study|Protocol Violation|0
5882188|NCT01852292|20349669|P1|Overall Study|Protocol Violation|2
5882189|NCT01852292|20349668|P2|Overall Study|Physician Decision|2
5882190|NCT01852292|20349669|P1|Overall Study|Physician Decision|6
5882191|NCT01852292|20349668|P2|Overall Study|Adverse Event|11
5882192|NCT01852292|20349669|P1|Overall Study|Adverse Event|8
5882193|NCT01852292|20349668|P2|Overall Study|Patient/guardian decision|4
5882194|NCT01852292|20349669|P1|Overall Study|Patient/guardian decision|8
5882195|NCT01852292|20349668|P2|Overall Study|Death|8
5882196|NCT01852292|20349669|P1|Overall Study|Death|9
5882197|NCT01852292|20349668|P2|Overall Study|Untreated - did not receive study drug|1
5882198|NCT01852292|20349669|P1|Overall Study|Untreated - did not receive study drug|3
5882199|NCT01852214|20349693|P2|Washout Period|Withdrawal by Subject|1
5882200|NCT01852214|20349694|P1|Washout Period|Withdrawal by Subject|0
5882201|NCT01852214|20349693|P2|Period 1|Withdrawal by Subject|1
5882202|NCT01852214|20349694|P1|Period 1|Withdrawal by Subject|0
5882203|NCT01852214|20349693|P2|Period 1|Adverse Event|2
5882204|NCT01852214|20349694|P1|Period 1|Adverse Event|1
5882205|NCT01852162|20349746|P2|Overall Study|Withdrawal by Subject|1
5882206|NCT01852162|20349747|P1|Overall Study|Withdrawal by Subject|3
5882207|NCT01852162|20349746|P2|Overall Study|Adverse Event|0
5882208|NCT01852162|20349747|P1|Overall Study|Adverse Event|1
5882209|NCT01852110|20349763|P6|Overall Study|Withdrawal by Subject|0
5882210|NCT01852110|20349764|P5|Overall Study|Withdrawal by Subject|0
5882211|NCT01852110|20349765|P4|Overall Study|Withdrawal by Subject|0
5882212|NCT01852110|20349766|P3|Overall Study|Withdrawal by Subject|0
5882213|NCT01852110|20349767|P2|Overall Study|Withdrawal by Subject|4
5882214|NCT01852110|20349768|P1|Overall Study|Withdrawal by Subject|4
5882215|NCT01852110|20349763|P6|Overall Study|Study Terminated by Sponsor|0
5882216|NCT01852110|20349764|P5|Overall Study|Study Terminated by Sponsor|0
5882217|NCT01852110|20349765|P4|Overall Study|Study Terminated by Sponsor|0
5882218|NCT01852110|20349766|P3|Overall Study|Study Terminated by Sponsor|0
5882219|NCT01852110|20349767|P2|Overall Study|Study Terminated by Sponsor|32
5882220|NCT01852110|20349768|P1|Overall Study|Study Terminated by Sponsor|30
5882221|NCT01852110|20349763|P6|Overall Study|Protocol Violation|0
5882222|NCT01852110|20349764|P5|Overall Study|Protocol Violation|0
5882223|NCT01852110|20349765|P4|Overall Study|Protocol Violation|0
5882224|NCT01852110|20349766|P3|Overall Study|Protocol Violation|0
5882225|NCT01852110|20349767|P2|Overall Study|Protocol Violation|1
5882226|NCT01852110|20349768|P1|Overall Study|Protocol Violation|0
5882227|NCT01852110|20349763|P6|Overall Study|Physician Decision|0
5882228|NCT01852110|20349764|P5|Overall Study|Physician Decision|0
5882229|NCT01852110|20349765|P4|Overall Study|Physician Decision|0
5882230|NCT01852110|20349766|P3|Overall Study|Physician Decision|0
5882231|NCT01852110|20349767|P2|Overall Study|Physician Decision|0
5882232|NCT01852110|20349768|P1|Overall Study|Physician Decision|1
5882233|NCT01852110|20349763|P6|Overall Study|Non-compliance with Study Drug|0
5882234|NCT01852110|20349764|P5|Overall Study|Non-compliance with Study Drug|0
5882235|NCT01852110|20349765|P4|Overall Study|Non-compliance with Study Drug|0
5882236|NCT01852110|20349766|P3|Overall Study|Non-compliance with Study Drug|0
5882237|NCT01852110|20349767|P2|Overall Study|Non-compliance with Study Drug|1
5882238|NCT01852110|20349768|P1|Overall Study|Non-compliance with Study Drug|2
5882239|NCT01852110|20349763|P6|Overall Study|Lost to Follow-up|0
5882240|NCT01852110|20349764|P5|Overall Study|Lost to Follow-up|0
5882241|NCT01852110|20349765|P4|Overall Study|Lost to Follow-up|0
5882242|NCT01852110|20349766|P3|Overall Study|Lost to Follow-up|0
5882243|NCT01852110|20349767|P2|Overall Study|Lost to Follow-up|3
5882244|NCT01852110|20349768|P1|Overall Study|Lost to Follow-up|1
5882245|NCT01852110|20349763|P6|Overall Study|Adverse Event|0
5882246|NCT01852110|20349764|P5|Overall Study|Adverse Event|0
5882247|NCT01852110|20349765|P4|Overall Study|Adverse Event|0
5882248|NCT01852110|20349766|P3|Overall Study|Adverse Event|0
5882249|NCT01852110|20349767|P2|Overall Study|Adverse Event|5
5882250|NCT01852110|20349768|P1|Overall Study|Adverse Event|12
5882251|NCT01852058|20349832|P12|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0
5882252|NCT01852058|20349833|P11|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0
5882253|NCT01852058|20349834|P10|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0
5882254|NCT01852058|20349835|P9|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|1
5882255|NCT01852058|20349836|P8|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0
5882256|NCT01852058|20349837|P7|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0
5882257|NCT01852058|20349838|P6|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0
5882258|NCT01852058|20349839|P5|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0
5882259|NCT01852058|20349840|P4|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0
5882260|NCT01852058|20349841|P3|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0
5882261|NCT01852058|20349842|P2|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0
5882262|NCT01852058|20349843|P1|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0
5882263|NCT01852058|20349832|P12|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0
5882264|NCT01852058|20349833|P11|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0
5882265|NCT01852058|20349834|P10|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0
5882266|NCT01852058|20349835|P9|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0
5882267|NCT01852058|20349836|P8|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|1
5882268|NCT01852058|20349837|P7|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0
5882269|NCT01852058|20349838|P6|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0
5882270|NCT01852058|20349839|P5|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0
5882271|NCT01852058|20349840|P4|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0
5882272|NCT01852058|20349841|P3|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0
5882273|NCT01852058|20349842|P2|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0
5882274|NCT01852058|20349843|P1|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0
5882275|NCT01852058|20349832|P12|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0
5882276|NCT01852058|20349833|P11|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0
5882277|NCT01852058|20349834|P10|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0
5882278|NCT01852058|20349835|P9|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0
5882279|NCT01852058|20349836|P8|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0
5882280|NCT01852058|20349837|P7|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0
5882435|NCT01850615|20350182|P1|Overall Study|Withdrawal by Subject|3
5882281|NCT01852058|20349838|P6|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|7
5882282|NCT01852058|20349839|P5|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|1
5882283|NCT01852058|20349840|P4|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0
5882284|NCT01852058|20349841|P3|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0
5882285|NCT01852058|20349842|P2|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0
5882286|NCT01852058|20349843|P1|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0
5882287|NCT01852058|20349832|P12|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0
5882288|NCT01852058|20349833|P11|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0
5882289|NCT01852058|20349834|P10|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0
5882290|NCT01852058|20349835|P9|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0
5882291|NCT01852058|20349836|P8|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0
5882292|NCT01852058|20349837|P7|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0
5882293|NCT01852058|20349838|P6|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0
5882294|NCT01852058|20349839|P5|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0
5882295|NCT01852058|20349840|P4|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|1
5882296|NCT01852058|20349841|P3|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0
5882297|NCT01852058|20349842|P2|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0
5882298|NCT01852058|20349843|P1|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0
5882299|NCT01852058|20349832|P12|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0
5882300|NCT01852058|20349833|P11|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0
5882301|NCT01852058|20349834|P10|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0
5882302|NCT01852058|20349835|P9|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0
5882303|NCT01852058|20349836|P8|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0
5882304|NCT01852058|20349837|P7|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0
5882305|NCT01852058|20349838|P6|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|1
5882306|NCT01852058|20349839|P5|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|3
5882307|NCT01852058|20349840|P4|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0
5882308|NCT01852058|20349841|P3|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0
5882309|NCT01852058|20349842|P2|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0
5882310|NCT01852058|20349843|P1|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0
5882311|NCT01852058|20349832|P12|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0
5882312|NCT01852058|20349833|P11|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0
5882313|NCT01852058|20349834|P10|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0
5882314|NCT01852058|20349835|P9|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0
5882315|NCT01852058|20349836|P8|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0
5882316|NCT01852058|20349837|P7|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0
5882317|NCT01852058|20349838|P6|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0
5882318|NCT01852058|20349839|P5|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|1
5882319|NCT01852058|20349840|P4|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0
5882320|NCT01852058|20349841|P3|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0
5882321|NCT01852058|20349842|P2|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0
5882322|NCT01852058|20349843|P1|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0
5882323|NCT01852058|20349832|P12|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0
5882324|NCT01852058|20349833|P11|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0
5882325|NCT01852058|20349834|P10|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0
5882326|NCT01852058|20349835|P9|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0
5882327|NCT01852058|20349836|P8|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0
5882328|NCT01852058|20349837|P7|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0
5882329|NCT01852058|20349838|P6|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1
5882330|NCT01852058|20349839|P5|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1
5882331|NCT01852058|20349840|P4|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0
5882332|NCT01852058|20349841|P3|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0
5882333|NCT01852058|20349842|P2|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0
5882334|NCT01852058|20349843|P1|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0
5882335|NCT01852058|20349832|P12|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0
5882336|NCT01852058|20349833|P11|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0
5882337|NCT01852058|20349834|P10|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0
5882338|NCT01852058|20349835|P9|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0
5882339|NCT01852058|20349836|P8|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0
5882340|NCT01852058|20349837|P7|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0
5882341|NCT01852058|20349838|P6|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0
5882342|NCT01852058|20349839|P5|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|1
5882343|NCT01852058|20349840|P4|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0
5882344|NCT01852058|20349841|P3|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0
5882345|NCT01852058|20349842|P2|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0
5882346|NCT01852058|20349843|P1|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0
5882347|NCT01852058|20349832|P12|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0
5882348|NCT01852058|20349833|P11|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0
5882349|NCT01852058|20349834|P10|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0
5882350|NCT01852058|20349835|P9|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0
5882351|NCT01852058|20349836|P8|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0
5882352|NCT01852058|20349837|P7|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0
5882353|NCT01852058|20349838|P6|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0
5882354|NCT01852058|20349839|P5|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0
5882355|NCT01852058|20349840|P4|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0
5882356|NCT01852058|20349841|P3|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0
5882357|NCT01852058|20349842|P2|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0
5882358|NCT01852058|20349843|P1|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|1
5882359|NCT01852045|20349923|P3|Overall Study|Other Miscellaneous Reasons|2
5882360|NCT01852045|20349924|P2|Overall Study|Other Miscellaneous Reasons|3
5882361|NCT01852045|20349925|P1|Overall Study|Other Miscellaneous Reasons|1
5882362|NCT01852045|20349923|P3|Overall Study|Withdrawal by Subject|1
5882363|NCT01852045|20349924|P2|Overall Study|Withdrawal by Subject|0
5882364|NCT01852045|20349925|P1|Overall Study|Withdrawal by Subject|1
5882365|NCT01852045|20349923|P3|Overall Study|Lost to Follow-up|1
5882366|NCT01852045|20349924|P2|Overall Study|Lost to Follow-up|1
5882367|NCT01852045|20349925|P1|Overall Study|Lost to Follow-up|0
5882368|NCT01852045|20349923|P3|Overall Study|Lack of Efficacy|0
5882369|NCT01852045|20349924|P2|Overall Study|Lack of Efficacy|0
5882370|NCT01852045|20349925|P1|Overall Study|Lack of Efficacy|3
5882371|NCT01852045|20349923|P3|Overall Study|Adverse Event|0
5882372|NCT01852045|20349924|P2|Overall Study|Adverse Event|0
5882373|NCT01852045|20349925|P1|Overall Study|Adverse Event|1
5882374|NCT01851863|20350009|P4|Overall Study|Lost to Follow-up|3
5882375|NCT01851863|20350010|P3|Overall Study|Lost to Follow-up|2
5882376|NCT01851863|20350011|P2|Overall Study|Lost to Follow-up|4
5882377|NCT01851863|20350012|P1|Overall Study|Lost to Follow-up|3
5882378|NCT01851863|20350009|P4|Overall Study|Did not receive study medication|0
5882379|NCT01851863|20350010|P3|Overall Study|Did not receive study medication|3
5882380|NCT01851863|20350011|P2|Overall Study|Did not receive study medication|5
5882381|NCT01851863|20350012|P1|Overall Study|Did not receive study medication|2
5882382|NCT01851720|20350041|P2|Overall Study|Lost to Follow-up|1
5882383|NCT01851720|20350042|P1|Overall Study|Lost to Follow-up|0
5882384|NCT01851590|20350072|P3|Overall Study|Lack of Efficacy|0
5882385|NCT01851590|20350073|P2|Overall Study|Lack of Efficacy|1
5882386|NCT01851590|20350074|P1|Overall Study|Lack of Efficacy|0
5882387|NCT01851590|20350072|P3|Overall Study|Adverse Event|2
5882388|NCT01851590|20350073|P2|Overall Study|Adverse Event|0
5882389|NCT01851590|20350074|P1|Overall Study|Adverse Event|0
5882390|NCT01851590|20350072|P3|Overall Study|Withdrawal by Subject|1
5882391|NCT01851590|20350073|P2|Overall Study|Withdrawal by Subject|0
5882392|NCT01851590|20350074|P1|Overall Study|Withdrawal by Subject|0
5882393|NCT01851330|20350097|P3|Overall Study|Investigator's Discretion|1
5882394|NCT01851330|20350098|P2|Overall Study|Investigator's Discretion|0
5882395|NCT01851330|20350099|P1|Overall Study|Investigator's Discretion|0
5882396|NCT01851330|20350097|P3|Overall Study|Withdrew Consent|0
5882397|NCT01851330|20350098|P2|Overall Study|Withdrew Consent|1
5882398|NCT01851330|20350099|P1|Overall Study|Withdrew Consent|2
5882399|NCT01851330|20350097|P3|Overall Study|Lost to Follow-up|9
5882400|NCT01851330|20350098|P2|Overall Study|Lost to Follow-up|6
5882401|NCT01851330|20350099|P1|Overall Study|Lost to Follow-up|1
5882402|NCT01851330|20350097|P3|Overall Study|Lack of Efficacy|2
5882403|NCT01851330|20350098|P2|Overall Study|Lack of Efficacy|9
5882404|NCT01851330|20350099|P1|Overall Study|Lack of Efficacy|10
5882405|NCT01850823|20350142|P3|Overall Study|Withdrawal by Subject|1
5882406|NCT01850823|20350143|P2|Overall Study|Withdrawal by Subject|0
5882407|NCT01850823|20350144|P1|Overall Study|Withdrawal by Subject|2
5882408|NCT01850823|20350142|P3|Overall Study|Significant worstening of SAR|0
5882409|NCT01850823|20350143|P2|Overall Study|Significant worstening of SAR|1
5882410|NCT01850823|20350144|P1|Overall Study|Significant worstening of SAR|0
5882411|NCT01850823|20350142|P3|Overall Study|Restricted Medication|2
5882412|NCT01850823|20350143|P2|Overall Study|Restricted Medication|0
5882413|NCT01850823|20350144|P1|Overall Study|Restricted Medication|0
5882414|NCT01850823|20350142|P3|Overall Study|Lost to Follow-up|1
5882415|NCT01850823|20350143|P2|Overall Study|Lost to Follow-up|0
5882416|NCT01850823|20350144|P1|Overall Study|Lost to Follow-up|0
5882417|NCT01850823|20350142|P3|Overall Study|Lack of Efficacy|0
5882418|NCT01850823|20350143|P2|Overall Study|Lack of Efficacy|0
5882419|NCT01850823|20350144|P1|Overall Study|Lack of Efficacy|1
5882420|NCT01850823|20350142|P3|Overall Study|Enrolled in Error|2
5882421|NCT01850823|20350143|P2|Overall Study|Enrolled in Error|1
5882422|NCT01850823|20350144|P1|Overall Study|Enrolled in Error|0
5882423|NCT01850823|20350142|P3|Overall Study|Early Visit Window|4
5882424|NCT01850823|20350143|P2|Overall Study|Early Visit Window|1
5882425|NCT01850823|20350144|P1|Overall Study|Early Visit Window|0
5882426|NCT01850641|20350167|P1|Overall Study|Increase in serum ferritin|1
5882427|NCT01850641|20350167|P1|Overall Study|Decrease in serum calcium|2
5882428|NCT01850641|20350167|P1|Overall Study|Decrease in serum phosphorus|1
5882429|NCT01850641|20350167|P1|Overall Study|Physician Decision|1
5882430|NCT01850615|20350181|P2|Overall Study|Unclassified|1
5882431|NCT01850615|20350182|P1|Overall Study|Unclassified|0
5882432|NCT01850615|20350181|P2|Overall Study|Lost to Follow-up|1
5882433|NCT01850615|20350182|P1|Overall Study|Lost to Follow-up|0
5882434|NCT01850615|20350181|P2|Overall Study|Withdrawal by Subject|1
5882436|NCT01850615|20350181|P2|Overall Study|Adverse Event|1
5882437|NCT01850615|20350182|P1|Overall Study|Adverse Event|2
5882438|NCT01850615|20350181|P2|Overall Study|Protocol Violation|1
5882439|NCT01850615|20350182|P1|Overall Study|Protocol Violation|4
5882440|NCT01850602|20350200|P2|Overall Study|Increase in serum ferritin|0
5882441|NCT01850602|20350201|P1|Overall Study|Increase in serum ferritin|1
5882442|NCT01850602|20350200|P2|Overall Study|Decrease in serum calcium|3
5882443|NCT01850602|20350201|P1|Overall Study|Decrease in serum calcium|2
5882444|NCT01850602|20350200|P2|Overall Study|Withdrawal by Subject|4
5882445|NCT01850602|20350201|P1|Overall Study|Withdrawal by Subject|2
5882446|NCT01850602|20350200|P2|Overall Study|Physician Decision|1
5882447|NCT01850602|20350201|P1|Overall Study|Physician Decision|2
5882448|NCT01850602|20350200|P2|Overall Study|Adverse Event|10
5882449|NCT01850602|20350201|P1|Overall Study|Adverse Event|7
5882450|NCT01850589|20350215|P2|Overall Study|Withdrawal by Subject|0
5882451|NCT01850589|20350216|P1|Overall Study|Withdrawal by Subject|8
5882452|NCT01850446|20350256|P2|Overall Study|Protocol Violation|2
5882453|NCT01850446|20350257|P1|Overall Study|Protocol Violation|0
5882454|NCT01850446|20350256|P2|Overall Study|Withdrawal by Subject|0
5882455|NCT01850446|20350257|P1|Overall Study|Withdrawal by Subject|4
5882456|NCT01850446|20350256|P2|Overall Study|Lack of Efficacy|0
5882457|NCT01850446|20350257|P1|Overall Study|Lack of Efficacy|1
5882458|NCT01850030|20350316|P2|Overall Study|pregnancy not confirmed at visit 4|249
5882459|NCT01850030|20350317|P1|Overall Study|pregnancy not confirmed at visit 4|248
5882460|NCT01850030|20350316|P2|Overall Study|Protocol Violation|28
5882461|NCT01850030|20350317|P1|Overall Study|Protocol Violation|24
5882462|NCT01850030|20350316|P2|Overall Study|Withdrawal by Subject|4
5882463|NCT01850030|20350317|P1|Overall Study|Withdrawal by Subject|3
5882464|NCT01850030|20350316|P2|Overall Study|Lost to Follow-up|5
5882465|NCT01850030|20350317|P1|Overall Study|Lost to Follow-up|5
5882466|NCT01850030|20350316|P2|Overall Study|Lack of Efficacy|1
5882467|NCT01850030|20350317|P1|Overall Study|Lack of Efficacy|3
5882468|NCT01850030|20350316|P2|Overall Study|Adverse Event|82
5882469|NCT01850030|20350317|P1|Overall Study|Adverse Event|64
5882470|NCT01850004|20350329|P1|Overall Study|AE Unrelated to Study Drug|1
5882471|NCT01850004|20350329|P1|Overall Study|Subject Request to Discontinue Treatment|1
5882472|NCT01850004|20350329|P1|Overall Study|Subject Withdrew Consent|4
5882473|NCT01850004|20350329|P1|Overall Study|Poor/Non-compliance|1
5882474|NCT01850004|20350329|P1|Overall Study|Subject Moved|1
5882475|NCT01849848|20350336|P1|Overall Study|Progression of the primary disease|3
5882476|NCT01849848|20350336|P1|Overall Study|Physician Decision|1
5882477|NCT01849588|20350434|P1|Overall Study|Lack of Efficacy|3
5882478|NCT01849562|20350453|P3|Overall Study|Non-compliance with Study Drug|0
5882479|NCT01849562|20350454|P2|Overall Study|Non-compliance with Study Drug|0
5882480|NCT01849562|20350455|P1|Overall Study|Non-compliance with Study Drug|1
5882481|NCT01849562|20350453|P3|Overall Study|Lost to Follow-up|0
5882482|NCT01849562|20350454|P2|Overall Study|Lost to Follow-up|0
5882483|NCT01849562|20350455|P1|Overall Study|Lost to Follow-up|1
5882484|NCT01849497|20350468|P2|Overall Study|Lost to Follow-up|1
5882485|NCT01849497|20350469|P1|Overall Study|Lost to Follow-up|0
5882486|NCT01849497|20350468|P2|Overall Study|Sponsor Decision|1
5882487|NCT01849497|20350469|P1|Overall Study|Sponsor Decision|0
5882488|NCT01849497|20350468|P2|Overall Study|Withdrawal by Subject|2
5882489|NCT01849497|20350469|P1|Overall Study|Withdrawal by Subject|1
5882490|NCT01849458|20350477|P1|Overall Study|Lost to Follow-up|4
5882491|NCT01849289|20350516|P2|Overall Study|Unclassified|18
5882492|NCT01849289|20350517|P1|Overall Study|Unclassified|25
5882493|NCT01849289|20350516|P2|Overall Study|Withdrawal criteria|0
5882494|NCT01849289|20350517|P1|Overall Study|Withdrawal criteria|1
5882495|NCT01849289|20350516|P2|Overall Study|Protocol Violation|3
5882496|NCT01849289|20350517|P1|Overall Study|Protocol Violation|3
5882497|NCT01849289|20350516|P2|Overall Study|Adverse Event|3
5882498|NCT01849289|20350517|P1|Overall Study|Adverse Event|3
5882499|NCT01849276|20350533|P1|Followed for Survival for 5 Years|Early termination of the study|1
5882500|NCT01849276|20350533|P1|Followed for Survival for 5 Years|Death|1
5882501|NCT01849055|20350615|P6|Overall Study|Withdrawal by Subject|0
5882502|NCT01849055|20350616|P5|Overall Study|Withdrawal by Subject|0
5882503|NCT01849055|20350617|P4|Overall Study|Withdrawal by Subject|0
5882504|NCT01849055|20350618|P3|Overall Study|Withdrawal by Subject|1
5882505|NCT01849055|20350619|P2|Overall Study|Withdrawal by Subject|0
5882506|NCT01849055|20350620|P1|Overall Study|Withdrawal by Subject|0
5882507|NCT01848990|20350655|P3|Overall Study|Other|2
5882508|NCT01848990|20350656|P2|Overall Study|Other|4
5882509|NCT01848990|20350657|P1|Overall Study|Other|1
5882510|NCT01848990|20350655|P3|Overall Study|Death|1
5882511|NCT01848990|20350656|P2|Overall Study|Death|0
5882512|NCT01848990|20350657|P1|Overall Study|Death|1
5882513|NCT01848990|20350655|P3|Overall Study|Non Compliance|0
5882514|NCT01848990|20350656|P2|Overall Study|Non Compliance|0
5882515|NCT01848990|20350657|P1|Overall Study|Non Compliance|1
5882516|NCT01848990|20350655|P3|Overall Study|Physician Decision|0
5882517|NCT01848990|20350656|P2|Overall Study|Physician Decision|1
5882518|NCT01848990|20350657|P1|Overall Study|Physician Decision|1
5882519|NCT01848990|20350655|P3|Overall Study|Withdrawal by Subject|11
5882520|NCT01848990|20350656|P2|Overall Study|Withdrawal by Subject|10
5882521|NCT01848990|20350657|P1|Overall Study|Withdrawal by Subject|29
5882522|NCT01848990|20350655|P3|Overall Study|Protocol Violation|0
5882523|NCT01848990|20350656|P2|Overall Study|Protocol Violation|1
5882524|NCT01848990|20350657|P1|Overall Study|Protocol Violation|1
5882525|NCT01848990|20350655|P3|Overall Study|Lost to Follow-up|2
5882526|NCT01848990|20350656|P2|Overall Study|Lost to Follow-up|2
5882527|NCT01848990|20350657|P1|Overall Study|Lost to Follow-up|6
5882528|NCT01848990|20350655|P3|Overall Study|Adverse Event|0
5882529|NCT01848990|20350656|P2|Overall Study|Adverse Event|2
5882530|NCT01848990|20350657|P1|Overall Study|Adverse Event|6
5882531|NCT01848938|20350727|P2|Overall Study|Lost to Follow-up|1
5882532|NCT01848938|20350728|P1|Overall Study|Lost to Follow-up|1
5882533|NCT01848834|20350777|P5|Overall Study|Not Treated|0
5882534|NCT01848834|20350778|P4|Overall Study|Not Treated|0
5882535|NCT01848834|20350779|P3|Overall Study|Not Treated|0
5882536|NCT01848834|20350780|P2|Overall Study|Not Treated|1
5882537|NCT01848834|20350781|P1|Overall Study|Not Treated|0
5882538|NCT01848834|20350777|P5|Overall Study|Withdrawal by Subject|7
5882539|NCT01848834|20350778|P4|Overall Study|Withdrawal by Subject|0
5882540|NCT01848834|20350779|P3|Overall Study|Withdrawal by Subject|3
5882541|NCT01848834|20350780|P2|Overall Study|Withdrawal by Subject|2
5882542|NCT01848834|20350781|P1|Overall Study|Withdrawal by Subject|0
5882543|NCT01848834|20350777|P5|Overall Study|Protocol Violation|2
5882544|NCT01848834|20350778|P4|Overall Study|Protocol Violation|0
5882545|NCT01848834|20350779|P3|Overall Study|Protocol Violation|1
5882546|NCT01848834|20350780|P2|Overall Study|Protocol Violation|0
5882547|NCT01848834|20350781|P1|Overall Study|Protocol Violation|0
5882548|NCT01848834|20350777|P5|Overall Study|Progressive Disease|78
5882549|NCT01848834|20350778|P4|Overall Study|Progressive Disease|36
5882550|NCT01848834|20350779|P3|Overall Study|Progressive Disease|21
5882551|NCT01848834|20350780|P2|Overall Study|Progressive Disease|41
5882552|NCT01848834|20350781|P1|Overall Study|Progressive Disease|27
5882553|NCT01848834|20350777|P5|Overall Study|Death|3
5882554|NCT01848834|20350778|P4|Overall Study|Death|0
5882555|NCT01848834|20350779|P3|Overall Study|Death|0
5882556|NCT01848834|20350780|P2|Overall Study|Death|1
5882557|NCT01848834|20350781|P1|Overall Study|Death|0
5882558|NCT01848834|20350777|P5|Overall Study|Complete Response|0
5882559|NCT01848834|20350778|P4|Overall Study|Complete Response|0
5882560|NCT01848834|20350779|P3|Overall Study|Complete Response|0
5882561|NCT01848834|20350780|P2|Overall Study|Complete Response|1
5882562|NCT01848834|20350781|P1|Overall Study|Complete Response|0
5882563|NCT01848834|20350777|P5|Overall Study|Adverse Event|15
5882564|NCT01848834|20350778|P4|Overall Study|Adverse Event|1
5882565|NCT01848834|20350779|P3|Overall Study|Adverse Event|6
5882566|NCT01848834|20350780|P2|Overall Study|Adverse Event|8
5882567|NCT01848834|20350781|P1|Overall Study|Adverse Event|3
5882568|NCT01848834|20350777|P5|Overall Study|Physician Decision|1
5882569|NCT01848834|20350778|P4|Overall Study|Physician Decision|0
5882570|NCT01848834|20350779|P3|Overall Study|Physician Decision|0
5882571|NCT01848834|20350780|P2|Overall Study|Physician Decision|0
5882572|NCT01848834|20350781|P1|Overall Study|Physician Decision|0
5882573|NCT01848834|20350777|P5|Overall Study|Ongoing in Study|26
5882574|NCT01848834|20350778|P4|Overall Study|Ongoing in Study|0
5882575|NCT01848834|20350779|P3|Overall Study|Ongoing in Study|1
5882576|NCT01848834|20350780|P2|Overall Study|Ongoing in Study|6
5882577|NCT01848834|20350781|P1|Overall Study|Ongoing in Study|0
5882578|NCT01848756|20350829|P1|Overall Study|Enrolled in Error|1
5882579|NCT01848756|20350829|P1|Overall Study|Withdrawal by Subject|1
5882580|NCT01848756|20350829|P1|Overall Study|Adverse Event|1
5882581|NCT01848483|20350841|P2|Overall Study|Incarceration|2
5882582|NCT01848483|20350842|P1|Overall Study|Incarceration|2
5882583|NCT01848483|20350841|P2|Overall Study|Withdrawal by Subject|0
5882584|NCT01848483|20350842|P1|Overall Study|Withdrawal by Subject|1
5882585|NCT01848483|20350841|P2|Overall Study|Lost to Follow-up|8
5882586|NCT01848483|20350842|P1|Overall Study|Lost to Follow-up|6
5882587|NCT01848483|20350841|P2|Overall Study|Death|1
5882588|NCT01848483|20350842|P1|Overall Study|Death|2
5882589|NCT01848457|20350860|P4|Overall Study|Death|0
5882590|NCT01848457|20350861|P3|Overall Study|Death|0
5882591|NCT01848457|20350862|P2|Overall Study|Death|0
5882592|NCT01848457|20350863|P1|Overall Study|Death|1
5882593|NCT01848353|20350895|P4|Phase 3|Withdrawal by Subject|0
5882594|NCT01848353|20350896|P3|Phase 3|Withdrawal by Subject|0
5882595|NCT01848353|20350897|P2|Phase 3|Withdrawal by Subject|1
5882596|NCT01848353|20350898|P1|Phase 3|Withdrawal by Subject|1
5882597|NCT01848353|20350895|P4|Phase 2|Withdrawal by Subject|0
5882598|NCT01848353|20350896|P3|Phase 2|Withdrawal by Subject|0
5882599|NCT01848353|20350897|P2|Phase 2|Withdrawal by Subject|2
5882600|NCT01848353|20350898|P1|Phase 2|Withdrawal by Subject|3
5882601|NCT01848353|20350895|P4|Phase 1|Withdrawal by Subject|0
5882602|NCT01848353|20350896|P3|Phase 1|Withdrawal by Subject|0
5882603|NCT01848353|20350897|P2|Phase 1|Withdrawal by Subject|1
5882604|NCT01848353|20350898|P1|Phase 1|Withdrawal by Subject|3
5882605|NCT01848288|20350954|P1|Overall Study|Withdrawal by Subject|1
5882606|NCT01848288|20350954|P1|Overall Study|Protocol Violation|1
5882607|NCT01848288|20350954|P1|Overall Study|Death|1
5882608|NCT01848210|20350965|P2|Overall Study|Administrative|0
5882609|NCT01848210|20350966|P1|Overall Study|Administrative|1
5882610|NCT01848210|20350965|P2|Overall Study|Chronic Venous Insufficiency Course|2
5882611|NCT01848210|20350966|P1|Overall Study|Chronic Venous Insufficiency Course|1
5882612|NCT01848210|20350965|P2|Overall Study|Hepatic Function Alteration|0
5882613|NCT01848210|20350966|P1|Overall Study|Hepatic Function Alteration|4
5882614|NCT01848210|20350965|P2|Overall Study|Hypesensitivity|0
5882615|NCT01848210|20350966|P1|Overall Study|Hypesensitivity|1
5882616|NCT01848210|20350965|P2|Overall Study|Discontinuation Criterion|7
5882617|NCT01848210|20350966|P1|Overall Study|Discontinuation Criterion|5
5882618|NCT01848210|20350965|P2|Overall Study|Adverse Event|9
5882619|NCT01848210|20350966|P1|Overall Study|Adverse Event|7
5882620|NCT01848210|20350965|P2|Overall Study|Impedition Condition|9
5882621|NCT01848210|20350966|P1|Overall Study|Impedition Condition|5
5882622|NCT01848210|20350965|P2|Overall Study|Use of Forbidden Drugs|10
5882623|NCT01848210|20350966|P1|Overall Study|Use of Forbidden Drugs|9
5882624|NCT01848210|20350965|P2|Overall Study|Protocol Violation|5
5882625|NCT01848210|20350966|P1|Overall Study|Protocol Violation|3
5882626|NCT01848210|20350965|P2|Overall Study|Lost to Follow-up|12
5882627|NCT01848210|20350966|P1|Overall Study|Lost to Follow-up|24
5882628|NCT01848210|20350965|P2|Overall Study|Informed Consent Form Withdrawal|24
5882629|NCT01848210|20350966|P1|Overall Study|Informed Consent Form Withdrawal|28
5882630|NCT01848145|20351015|P1|Subsequent Infusions: Weeks 3-8|Death|1
5882631|NCT01848145|20351015|P1|Subsequent Infusions: Weeks 3-8|Withdrawal by Subject|3
5882632|NCT01848145|20351015|P1|Subsequent Infusions: Weeks 3-8|Disease Progression|6
5882633|NCT01848145|20351015|P1|Infusion 3: Week 2, Day 1 - 120 Minutes|Adverse Event|1
5882634|NCT01848145|20351015|P1|Infusion 2: Week 1, Day 3 - 167 Minutes|Disease Progression|1
5882635|NCT01848145|20351015|P1|Infusion 2: Week 1, Day 3 - 167 Minutes|Adverse Event|1
5882636|NCT01848145|20351015|P1|Infusion 1: Week 1, Day 1 - 226 Minutes|Adverse Event|1
5882637|NCT01847885|20351055|P3|Randomization|Screen Failure|0
5882638|NCT01847885|20351056|P2|Randomization|Screen Failure|3
5882639|NCT01847885|20351057|P1|Randomization|Screen Failure|0
5882640|NCT01847885|20351055|P3|Randomization|Withdrawal by Subject|2
5882641|NCT01847885|20351056|P2|Randomization|Withdrawal by Subject|0
5882642|NCT01847885|20351057|P1|Randomization|Withdrawal by Subject|0
5882643|NCT01847885|20351055|P3|Randomization|Protocol Violation|0
5882644|NCT01847885|20351056|P2|Randomization|Protocol Violation|1
5882645|NCT01847885|20351057|P1|Randomization|Protocol Violation|0
5882646|NCT01847885|20351055|P3|Initial Enrollment (Consented)|Pending prior to enrollment stop|0
5882647|NCT01847885|20351056|P2|Initial Enrollment (Consented)|Pending prior to enrollment stop|0
5882648|NCT01847885|20351057|P1|Initial Enrollment (Consented)|Pending prior to enrollment stop|6
5882649|NCT01847885|20351055|P3|Initial Enrollment (Consented)|Screen failure|0
5882650|NCT01847885|20351056|P2|Initial Enrollment (Consented)|Screen failure|0
5882651|NCT01847885|20351057|P1|Initial Enrollment (Consented)|Screen failure|39
5882652|NCT01847885|20351055|P3|Initial Enrollment (Consented)|Withdrawal by Subject|0
5882653|NCT01847885|20351056|P2|Initial Enrollment (Consented)|Withdrawal by Subject|0
5882654|NCT01847885|20351057|P1|Initial Enrollment (Consented)|Withdrawal by Subject|2
5882655|NCT01847885|20351055|P3|Initial Enrollment (Consented)|Protocol Violation|0
5882656|NCT01847885|20351056|P2|Initial Enrollment (Consented)|Protocol Violation|0
5882657|NCT01847885|20351057|P1|Initial Enrollment (Consented)|Protocol Violation|1
5882658|NCT01847443|20351221|P4|Washout Period Before Study Period 4|Positive alcohol test|0
5882659|NCT01847443|20351222|P3|Washout Period Before Study Period 4|Positive alcohol test|0
5882660|NCT01847443|20351223|P2|Washout Period Before Study Period 4|Positive alcohol test|0
5882661|NCT01847443|20351224|P1|Washout Period Before Study Period 4|Positive alcohol test|1
5882662|NCT01847443|20351221|P4|Washout Period Before Study Period 4|Withdrawal by Subject|0
5882663|NCT01847443|20351222|P3|Washout Period Before Study Period 4|Withdrawal by Subject|0
5882664|NCT01847443|20351223|P2|Washout Period Before Study Period 4|Withdrawal by Subject|0
5882665|NCT01847443|20351224|P1|Washout Period Before Study Period 4|Withdrawal by Subject|1
5882666|NCT01847443|20351221|P4|Washout Period Before Study Period 3|Other reason|0
5882667|NCT01847443|20351222|P3|Washout Period Before Study Period 3|Other reason|0
5882668|NCT01847443|20351223|P2|Washout Period Before Study Period 3|Other reason|0
5882669|NCT01847443|20351224|P1|Washout Period Before Study Period 3|Other reason|1
5882670|NCT01847443|20351221|P4|Washout Period Before Study Period 2|Other reason|0
5882671|NCT01847443|20351222|P3|Washout Period Before Study Period 2|Other reason|0
5882672|NCT01847443|20351223|P2|Washout Period Before Study Period 2|Other reason|0
5882673|NCT01847443|20351224|P1|Washout Period Before Study Period 2|Other reason|1
5882674|NCT01847443|20351221|P4|Washout Period Before Study Period 2|Adverse Event|0
5882675|NCT01847443|20351222|P3|Washout Period Before Study Period 2|Adverse Event|0
5882676|NCT01847443|20351223|P2|Washout Period Before Study Period 2|Adverse Event|1
5882677|NCT01847443|20351224|P1|Washout Period Before Study Period 2|Adverse Event|1
5882678|NCT01847443|20351221|P4|Study Period 1|Withdrawal by Subject|0
5882679|NCT01847443|20351222|P3|Study Period 1|Withdrawal by Subject|0
5882680|NCT01847443|20351223|P2|Study Period 1|Withdrawal by Subject|1
5882681|NCT01847443|20351224|P1|Study Period 1|Withdrawal by Subject|0
5882682|NCT01847313|20351267|P2|Overall Study|Withdrawal by Subject|1
5882683|NCT01847313|20351268|P1|Overall Study|Withdrawal by Subject|0
5882684|NCT01847313|20351267|P2|Overall Study|Death|1
5882685|NCT01847313|20351268|P1|Overall Study|Death|0
5882686|NCT01847274|20351284|P4|Overall Study|Non Compliance|0
5882687|NCT01847274|20351285|P3|Overall Study|Non Compliance|2
5882688|NCT01847274|20351286|P2|Overall Study|Non Compliance|0
5882689|NCT01847274|20351287|P1|Overall Study|Non Compliance|0
5882690|NCT01847274|20351284|P4|Overall Study|Other Reasons|3
5882691|NCT01847274|20351285|P3|Overall Study|Other Reasons|11
5882692|NCT01847274|20351286|P2|Overall Study|Other Reasons|1
5882693|NCT01847274|20351287|P1|Overall Study|Other Reasons|3
5882694|NCT01847274|20351284|P4|Overall Study|Treatment Associated Risk|0
5882695|NCT01847274|20351285|P3|Overall Study|Treatment Associated Risk|2
5882696|NCT01847274|20351286|P2|Overall Study|Treatment Associated Risk|2
5882697|NCT01847274|20351287|P1|Overall Study|Treatment Associated Risk|0
5882698|NCT01847274|20351284|P4|Overall Study|Disease Progression|98
5882699|NCT01847274|20351285|P3|Overall Study|Disease Progression|129
5882700|NCT01847274|20351286|P2|Overall Study|Disease Progression|49
5882701|NCT01847274|20351287|P1|Overall Study|Disease Progression|63
5882702|NCT01847274|20351284|P4|Overall Study|Withdrawal by Subject|1
5882703|NCT01847274|20351285|P3|Overall Study|Withdrawal by Subject|11
5882704|NCT01847274|20351286|P2|Overall Study|Withdrawal by Subject|8
5882705|NCT01847274|20351287|P1|Overall Study|Withdrawal by Subject|8
5882706|NCT01847274|20351284|P4|Overall Study|Adverse Event|2
5882707|NCT01847274|20351285|P3|Overall Study|Adverse Event|33
5882708|NCT01847274|20351286|P2|Overall Study|Adverse Event|1
5882709|NCT01847274|20351287|P1|Overall Study|Adverse Event|17
5882710|NCT01847209|20351341|P1|Overall Study|No lung nodule found on intraop CT scan|1
5882711|NCT01847209|20351341|P1|Overall Study|Withdrawal by Subject|1
5882712|NCT01847092|20351364|P2|Overall Study|Protocol Violation|2
5882713|NCT01847092|20351365|P1|Overall Study|Protocol Violation|0
5882714|NCT01847092|20351364|P2|Overall Study|Physician Decision|1
5882715|NCT01847092|20351365|P1|Overall Study|Physician Decision|1
5882716|NCT01847092|20351364|P2|Overall Study|Protocol Specified|0
5882717|NCT01847092|20351365|P1|Overall Study|Protocol Specified|8
5882718|NCT01847092|20351364|P2|Overall Study|Withdrawal by Subject|5
5882719|NCT01847092|20351365|P1|Overall Study|Withdrawal by Subject|5
5882720|NCT01847092|20351364|P2|Overall Study|Adverse Event|3
5882721|NCT01847092|20351365|P1|Overall Study|Adverse Event|12
5882722|NCT01846741|20351419|P1|Baseline Visit|Subject did not meet entry criteria|2
5882723|NCT01846624|20351575|P1|Overall Study|Died during induction, no midostaurin|1
5882724|NCT01846611|20351585|P2|Overall Study|Other|18
5882725|NCT01846611|20351586|P1|Overall Study|Other|19
5882726|NCT01846611|20351585|P2|Overall Study|Withdrawal by Subject|19
5882727|NCT01846611|20351586|P1|Overall Study|Withdrawal by Subject|15
5882728|NCT01846611|20351585|P2|Overall Study|Lost to Follow-up|6
5882729|NCT01846611|20351586|P1|Overall Study|Lost to Follow-up|4
5882730|NCT01846507|20351596|P1|Overall Study|Missing data|2
5882731|NCT01846507|20351596|P1|Overall Study|Protocol Violation|1
5882732|NCT01846507|20351596|P1|Overall Study|Lost to Follow-up|4
5882733|NCT01846442|20351694|P4|Overall Study|Left the city/Lost medication|1
5882734|NCT01846442|20351695|P3|Overall Study|Left the city/Lost medication|1
5882735|NCT01846442|20351696|P2|Overall Study|Left the city/Lost medication|0
5882736|NCT01846442|20351697|P1|Overall Study|Left the city/Lost medication|1
5882737|NCT01846442|20351694|P4|Overall Study|Withdrawal by Subject|1
5882738|NCT01846442|20351695|P3|Overall Study|Withdrawal by Subject|0
5882739|NCT01846442|20351696|P2|Overall Study|Withdrawal by Subject|2
5882740|NCT01846442|20351697|P1|Overall Study|Withdrawal by Subject|3
5882741|NCT01846442|20351694|P4|Overall Study|Lost to Follow-up|0
5882742|NCT01846442|20351695|P3|Overall Study|Lost to Follow-up|1
5882743|NCT01846442|20351696|P2|Overall Study|Lost to Follow-up|0
5882744|NCT01846442|20351697|P1|Overall Study|Lost to Follow-up|0
5882745|NCT01846442|20351694|P4|Overall Study|Adverse Event|1
5882746|NCT01846442|20351695|P3|Overall Study|Adverse Event|2
5882747|NCT01846442|20351696|P2|Overall Study|Adverse Event|4
5882748|NCT01846442|20351697|P1|Overall Study|Adverse Event|2
5882749|NCT01846416|20351738|P3|Survival Follow-up|Other|1
5882750|NCT01846416|20351739|P2|Survival Follow-up|Other|1
5882751|NCT01846416|20351740|P1|Survival Follow-up|Other|3
5882752|NCT01846416|20351738|P3|Survival Follow-up|Study Terminated by Sponsor|0
5882753|NCT01846416|20351739|P2|Survival Follow-up|Study Terminated by Sponsor|8
5882754|NCT01846416|20351740|P1|Survival Follow-up|Study Terminated by Sponsor|2
5882755|NCT01846416|20351738|P3|Survival Follow-up|Withdrawal by Subject|0
5882756|NCT01846416|20351739|P2|Survival Follow-up|Withdrawal by Subject|7
5882757|NCT01846416|20351740|P1|Survival Follow-up|Withdrawal by Subject|2
5882758|NCT01846416|20351738|P3|Survival Follow-up|Lost to Follow-up|2
5882759|NCT01846416|20351739|P2|Survival Follow-up|Lost to Follow-up|2
5882760|NCT01846416|20351740|P1|Survival Follow-up|Lost to Follow-up|0
5882761|NCT01846416|20351738|P3|Survival Follow-up|Death|9
5882762|NCT01846416|20351739|P2|Survival Follow-up|Death|62
5882763|NCT01846416|20351740|P1|Survival Follow-up|Death|21
5882764|NCT01846416|20351738|P3|Treatment Phase|Progressive Disease|9
5882765|NCT01846416|20351739|P2|Treatment Phase|Progressive Disease|63
5882766|NCT01846416|20351740|P1|Treatment Phase|Progressive Disease|21
5882767|NCT01846416|20351738|P3|Treatment Phase|Study Terminated by Sponsor|0
5882768|NCT01846416|20351739|P2|Treatment Phase|Study Terminated by Sponsor|4
5882769|NCT01846416|20351740|P1|Treatment Phase|Study Terminated by Sponsor|1
5882770|NCT01846416|20351738|P3|Treatment Phase|Non-compliance|0
5882771|NCT01846416|20351739|P2|Treatment Phase|Non-compliance|2
5882772|NCT01846416|20351740|P1|Treatment Phase|Non-compliance|0
5882773|NCT01846416|20351738|P3|Treatment Phase|Adverse Event|0
5882774|NCT01846416|20351739|P2|Treatment Phase|Adverse Event|4
5882775|NCT01846416|20351740|P1|Treatment Phase|Adverse Event|3
5882776|NCT01846416|20351738|P3|Treatment Phase|Physician Decision|0
5882777|NCT01846416|20351739|P2|Treatment Phase|Physician Decision|2
5882778|NCT01846416|20351740|P1|Treatment Phase|Physician Decision|1
5882779|NCT01846416|20351738|P3|Treatment Phase|Other|1
5882780|NCT01846416|20351739|P2|Treatment Phase|Other|5
5882781|NCT01846416|20351740|P1|Treatment Phase|Other|1
5882782|NCT01846416|20351738|P3|Treatment Phase|Withdrawal by Subject|2
5882783|NCT01846416|20351739|P2|Treatment Phase|Withdrawal by Subject|4
5882784|NCT01846416|20351740|P1|Treatment Phase|Withdrawal by Subject|2
5882785|NCT01846416|20351738|P3|Treatment Phase|Death|1
5882786|NCT01846416|20351739|P2|Treatment Phase|Death|9
5882787|NCT01846416|20351740|P1|Treatment Phase|Death|2
5882788|NCT01846299|20351785|P2|Overall Study|Adverse Event|0
5882789|NCT01846299|20351786|P1|Overall Study|Adverse Event|2
5882790|NCT01846299|20351785|P2|Overall Study|Withdrawal by Subject|6
5882791|NCT01846299|20351786|P1|Overall Study|Withdrawal by Subject|1
5882792|NCT01846299|20351785|P2|Overall Study|Lost to Follow-up|0
5882793|NCT01846299|20351786|P1|Overall Study|Lost to Follow-up|3
5882794|NCT01846299|20351785|P2|Overall Study|Death|2
5882795|NCT01846299|20351786|P1|Overall Study|Death|1
5882796|NCT01846299|20351785|P2|Overall Study|Protocol deviation|0
5882797|NCT01846299|20351786|P1|Overall Study|Protocol deviation|1
5882798|NCT01846299|20351785|P2|Overall Study|Physician Decision|2
5882799|NCT01846299|20351786|P1|Overall Study|Physician Decision|4
5882800|NCT01846273|20351825|P3|Overall Study|Physician Decision|0
5882801|NCT01846273|20351826|P2|Overall Study|Physician Decision|2
5882802|NCT01846273|20351827|P1|Overall Study|Physician Decision|1
5882803|NCT01846273|20351825|P3|Overall Study|Protocol Deviation|0
5882804|NCT01846273|20351826|P2|Overall Study|Protocol Deviation|3
5882805|NCT01846273|20351827|P1|Overall Study|Protocol Deviation|2
5882806|NCT01846273|20351825|P3|Overall Study|Disease Progression|0
5882807|NCT01846273|20351826|P2|Overall Study|Disease Progression|4
5882808|NCT01846273|20351827|P1|Overall Study|Disease Progression|0
5882809|NCT01846273|20351825|P3|Overall Study|Death|0
5882810|NCT01846273|20351826|P2|Overall Study|Death|1
5882811|NCT01846273|20351827|P1|Overall Study|Death|2
5882812|NCT01846273|20351825|P3|Overall Study|Administrative problems|0
5882813|NCT01846273|20351826|P2|Overall Study|Administrative problems|0
5882814|NCT01846273|20351827|P1|Overall Study|Administrative problems|1
5882815|NCT01846273|20351825|P3|Overall Study|Lost to Follow-up|0
5882816|NCT01846273|20351826|P2|Overall Study|Lost to Follow-up|1
5882817|NCT01846273|20351827|P1|Overall Study|Lost to Follow-up|2
5882818|NCT01846273|20351825|P3|Overall Study|Subject withdrew consent|0
5882819|NCT01846273|20351826|P2|Overall Study|Subject withdrew consent|8
5882820|NCT01846273|20351827|P1|Overall Study|Subject withdrew consent|5
5882821|NCT01846273|20351825|P3|Overall Study|Adverse Event|0
5882822|NCT01846273|20351826|P2|Overall Study|Adverse Event|7
5882823|NCT01846273|20351827|P1|Overall Study|Adverse Event|9
5882824|NCT01846221|20351883|P2|Overall Study|Age Exclusion|0
5882825|NCT01846221|20351884|P1|Overall Study|Age Exclusion|1
5882826|NCT01846221|20351883|P2|Overall Study|Catheter Failure|0
5882827|NCT01846221|20351884|P1|Overall Study|Catheter Failure|2
5882828|NCT01846208|20351901|P3|Overall Study|Refused SU OFC|1
5882829|NCT01846208|20351902|P2|Overall Study|Refused SU OFC|0
5882830|NCT01846208|20351903|P1|Overall Study|Refused SU OFC|0
5882831|NCT01846208|20351901|P3|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0
5882832|NCT01846208|20351902|P2|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0
5882833|NCT01846208|20351903|P1|Overall Study|Developed Eosinophilic Esophagitis (EoE)|1
5882834|NCT01846208|20351901|P3|Overall Study|Non-compliance|0
5882835|NCT01846208|20351902|P2|Overall Study|Non-compliance|1
5882836|NCT01846208|20351903|P1|Overall Study|Non-compliance|1
5882837|NCT01846208|20351901|P3|Overall Study|Withdrawal by Subject|0
5882838|NCT01846208|20351902|P2|Overall Study|Withdrawal by Subject|0
5882839|NCT01846208|20351903|P1|Overall Study|Withdrawal by Subject|5
5882840|NCT01846208|20351901|P3|Overall Study|Dosing Symptoms|6
5882841|NCT01846208|20351902|P2|Overall Study|Dosing Symptoms|2
5882842|NCT01846208|20351903|P1|Overall Study|Dosing Symptoms|1
5882843|NCT01846208|20351901|P3|Overall Study|Withdrew prior to treatment|1
5882844|NCT01846208|20351902|P2|Overall Study|Withdrew prior to treatment|1
5882845|NCT01846208|20351903|P1|Overall Study|Withdrew prior to treatment|1
5882846|NCT01846104|20351923|P1|Overall Study|Withdrawal by Subject|1
5882847|NCT01846039|20351929|P1|Overall Study|Subject Withdrew Consent|1
5882848|NCT01846039|20351929|P1|Overall Study|Protocol Violation|1
5882849|NCT01845974|20351941|P2|Overall Study|screen failure|0
5882850|NCT01845974|20351942|P1|Overall Study|screen failure|1
5882851|NCT01845831|20351950|P5|Inpatient Phase|Withdrawal by Subject|0
5882852|NCT01845831|20351951|P4|Inpatient Phase|Withdrawal by Subject|0
5882853|NCT01845831|20351952|P3|Inpatient Phase|Withdrawal by Subject|0
5882854|NCT01845831|20351953|P2|Inpatient Phase|Withdrawal by Subject|1
5882855|NCT01845831|20351954|P1|Inpatient Phase|Withdrawal by Subject|1
5882856|NCT01845818|20351983|P2|Overall Study|No Follow-Up Data Available|1
5882857|NCT01845818|20351984|P1|Overall Study|No Follow-Up Data Available|4
5882858|NCT01845818|20351983|P2|Overall Study|Did Not Receive Any Dose of Adalimumab|0
5882859|NCT01845818|20351984|P1|Overall Study|Did Not Receive Any Dose of Adalimumab|5
5882860|NCT01845818|20351983|P2|Overall Study|Other|8
5882861|NCT01845818|20351984|P1|Overall Study|Other|25
5882862|NCT01845818|20351983|P2|Overall Study|Serious Adverse Event|1
5882863|NCT01845818|20351984|P1|Overall Study|Serious Adverse Event|1
5882864|NCT01845818|20351983|P2|Overall Study|Administrative Reasons|1
5882865|NCT01845818|20351984|P1|Overall Study|Administrative Reasons|3
5882866|NCT01845818|20351983|P2|Overall Study|Lost to Follow-up|5
5882867|NCT01845818|20351984|P1|Overall Study|Lost to Follow-up|7
5882868|NCT01845818|20351983|P2|Overall Study|Withdrawal by Subject|1
5882869|NCT01845818|20351984|P1|Overall Study|Withdrawal by Subject|0
5882870|NCT01845077|20352068|P6|Washout Period|Protocol Violation|0
5882871|NCT01845077|20352069|P5|Washout Period|Protocol Violation|1
5882872|NCT01845077|20352070|P4|Washout Period|Protocol Violation|1
5882873|NCT01845077|20352071|P3|Washout Period|Protocol Violation|0
5882874|NCT01845077|20352072|P2|Washout Period|Protocol Violation|0
5882875|NCT01845077|20352073|P1|Washout Period|Protocol Violation|0
5882876|NCT01845077|20352068|P6|Washout Period|elevated lab values (not clinic. sign.)|0
5882877|NCT01845077|20352069|P5|Washout Period|elevated lab values (not clinic. sign.)|0
5882878|NCT01845077|20352070|P4|Washout Period|elevated lab values (not clinic. sign.)|0
5882879|NCT01845077|20352071|P3|Washout Period|elevated lab values (not clinic. sign.)|1
5882880|NCT01845077|20352072|P2|Washout Period|elevated lab values (not clinic. sign.)|0
5882881|NCT01845077|20352073|P1|Washout Period|elevated lab values (not clinic. sign.)|0
5882882|NCT01845077|20352068|P6|Washout Period|Adverse Event|0
5882883|NCT01845077|20352069|P5|Washout Period|Adverse Event|0
5882884|NCT01845077|20352070|P4|Washout Period|Adverse Event|0
5882885|NCT01845077|20352071|P3|Washout Period|Adverse Event|0
5882886|NCT01845077|20352072|P2|Washout Period|Adverse Event|0
5882887|NCT01845077|20352073|P1|Washout Period|Adverse Event|1
5882888|NCT01845077|20352068|P6|Washout Period|Lost to Follow-up|1
5882889|NCT01845077|20352069|P5|Washout Period|Lost to Follow-up|0
5882890|NCT01845077|20352070|P4|Washout Period|Lost to Follow-up|1
5882891|NCT01845077|20352071|P3|Washout Period|Lost to Follow-up|0
5882892|NCT01845077|20352072|P2|Washout Period|Lost to Follow-up|1
5882893|NCT01845077|20352073|P1|Washout Period|Lost to Follow-up|0
5882894|NCT01845025|20352119|P2|Overall Study|Missing|1
5882895|NCT01845025|20352120|P1|Overall Study|Missing|1
5882896|NCT01845025|20352119|P2|Overall Study|Protocol deviation|6
5882897|NCT01845025|20352120|P1|Overall Study|Protocol deviation|3
5882898|NCT01845025|20352119|P2|Overall Study|Death|0
5882899|NCT01845025|20352120|P1|Overall Study|Death|2
5882900|NCT01845025|20352119|P2|Overall Study|Administrative problems|8
5882901|NCT01845025|20352120|P1|Overall Study|Administrative problems|8
5882902|NCT01845025|20352119|P2|Overall Study|Lost to Follow-up|13
5882903|NCT01845025|20352120|P1|Overall Study|Lost to Follow-up|13
5882904|NCT01845025|20352119|P2|Overall Study|Withdrawal by Subject|44
5882905|NCT01845025|20352120|P1|Overall Study|Withdrawal by Subject|48
5882906|NCT01845025|20352119|P2|Overall Study|Unsatisfactory therapeutic effect|2
5882907|NCT01845025|20352120|P1|Overall Study|Unsatisfactory therapeutic effect|4
5882908|NCT01845025|20352119|P2|Overall Study|Adverse Event|3
5882909|NCT01845025|20352120|P1|Overall Study|Adverse Event|6
5882916|NCT01844895|20352167|P1|Day 29 - Day113 - Autoinjector|planned surgery|1
5882917|NCT01844895|20352167|P1|Day 29 - Day113 - Autoinjector|Difficulty using device|3
5882918|NCT01844895|20352167|P1|Day 29 - Day113 - Autoinjector|Withdrawal by Subject|1
5882919|NCT01844895|20352167|P1|Day 29 - Day113 - Autoinjector|Adverse Event|1
5882920|NCT01844895|20352167|P1|Day 1 to Day 28 - Pre-filled Syringe|Clinic Closed|1
5882921|NCT01844895|20352167|P1|Day 1 to Day 28 - Pre-filled Syringe|Withdrawal by Subject|1
5882922|NCT01844895|20352167|P1|Day 1 to Day 28 - Pre-filled Syringe|Adverse Event|1
5882923|NCT01844856|20352185|P2|Overall Study|Randomized but was a Screen Failure|1
5882924|NCT01844856|20352186|P1|Overall Study|Randomized but was a Screen Failure|0
5882925|NCT01844856|20352185|P2|Overall Study|Inadvertently Not Scheduled|0
5882926|NCT01844856|20352186|P1|Overall Study|Inadvertently Not Scheduled|1
5882927|NCT01844856|20352185|P2|Overall Study|Enterococcus Resistant|1
5882928|NCT01844856|20352186|P1|Overall Study|Enterococcus Resistant|0
5882929|NCT01844856|20352185|P2|Overall Study|Noncompliance|3
5882930|NCT01844856|20352186|P1|Overall Study|Noncompliance|2
5882931|NCT01844856|20352185|P2|Overall Study|Withdrawal by Subject|2
5882932|NCT01844856|20352186|P1|Overall Study|Withdrawal by Subject|3
5882933|NCT01844856|20352185|P2|Overall Study|Adverse Event|6
5882934|NCT01844856|20352186|P1|Overall Study|Adverse Event|3
5882935|NCT01844856|20352185|P2|Overall Study|Lost to Follow-up|3
5882936|NCT01844856|20352186|P1|Overall Study|Lost to Follow-up|15
5882937|NCT01844830|20352198|P2|Overall Study|Withdrawal by Subject|0
5882938|NCT01844830|20352199|P1|Overall Study|Withdrawal by Subject|1
5882939|NCT01844817|20352229|P2|Treatment|Other|3
5882940|NCT01844817|20352230|P1|Treatment|Other|0
5882941|NCT01844817|20352229|P2|Treatment|Lost to Follow-up|1
5882942|NCT01844817|20352230|P1|Treatment|Lost to Follow-up|0
5882943|NCT01844817|20352229|P2|Treatment|Death|8
5882944|NCT01844817|20352230|P1|Treatment|Death|10
5882945|NCT01844817|20352229|P2|Treatment|Withdrawal by Subject|6
5882946|NCT01844817|20352230|P1|Treatment|Withdrawal by Subject|10
5882947|NCT01844817|20352229|P2|Treatment|Adverse Event|9
5882948|NCT01844817|20352230|P1|Treatment|Adverse Event|17
5882949|NCT01844817|20352229|P2|Treatment|Progressive Disease|36
5882950|NCT01844817|20352230|P1|Treatment|Progressive Disease|27
5882951|NCT01844817|20352229|P2|Enrolled and Randomized|Withdrawal by Subject|3
5882952|NCT01844817|20352230|P1|Enrolled and Randomized|Withdrawal by Subject|2
5882953|NCT01844778|20352243|P3|Overall Study|Adverse Event|2
5882954|NCT01844778|20352244|P2|Overall Study|Adverse Event|2
5882955|NCT01844778|20352245|P1|Overall Study|Adverse Event|0
5882956|NCT01844778|20352243|P3|Overall Study|Withdrawal by Subject|0
5882957|NCT01844778|20352244|P2|Overall Study|Withdrawal by Subject|0
5882958|NCT01844778|20352245|P1|Overall Study|Withdrawal by Subject|2
5882959|NCT01844778|20352243|P3|Overall Study|Protocol deviation|2
5882960|NCT01844778|20352244|P2|Overall Study|Protocol deviation|1
5882961|NCT01844778|20352245|P1|Overall Study|Protocol deviation|0
5882962|NCT01844765|20352271|P2|Overall Study|Untreated|0
5882963|NCT01844765|20352272|P1|Overall Study|Untreated|1
5882964|NCT01844765|20352271|P2|Overall Study|Protocol Violation|0
5882965|NCT01844765|20352272|P1|Overall Study|Protocol Violation|1
5882966|NCT01844765|20352271|P2|Overall Study|Disease progression|0
5882967|NCT01844765|20352272|P1|Overall Study|Disease progression|1
5882968|NCT01844765|20352271|P2|Overall Study|Administrative problems|1
5882969|NCT01844765|20352272|P1|Overall Study|Administrative problems|1
5882970|NCT01844765|20352271|P2|Overall Study|Withdrawal by Subject|1
5882971|NCT01844765|20352272|P1|Overall Study|Withdrawal by Subject|0
5882972|NCT01844765|20352271|P2|Overall Study|Adverse Event|4
5882973|NCT01844765|20352272|P1|Overall Study|Adverse Event|5
5882974|NCT01844700|20352292|P2|Overall Study|stopped taking meds|1
5882975|NCT01844700|20352293|P1|Overall Study|stopped taking meds|0
5882976|NCT01844700|20352292|P2|Overall Study|Withdrawal by Subject|0
5882977|NCT01844700|20352293|P1|Overall Study|Withdrawal by Subject|1
5882978|NCT01844700|20352292|P2|Overall Study|refused medication switch|0
5882979|NCT01844700|20352293|P1|Overall Study|refused medication switch|1
5882980|NCT01844700|20352292|P2|Overall Study|Lack of Efficacy|0
5882981|NCT01844700|20352293|P1|Overall Study|Lack of Efficacy|1
5882982|NCT01844687|20352305|P1|Visit 4|Withdrawal by Subject|2
5882983|NCT01844687|20352305|P1|Visit 4|Lost to Follow-up|1
5882984|NCT01844687|20352305|P1|Visit 4|Pregnancy|1
5882985|NCT01844687|20352305|P1|Visit 3|child care problems|1
5882986|NCT01844687|20352305|P1|Visit 3|Withdrawal by Subject|3
5882987|NCT01844687|20352305|P1|Visit 3|Lost to Follow-up|1
5882988|NCT01844687|20352305|P1|Visit 2|Protocol Violation|1
5882989|NCT01844687|20352305|P1|Visit 2|Withdrawal by Subject|1
5882990|NCT01844687|20352305|P1|Visit 1|Lost to Follow-up|5
5882991|NCT01844687|20352305|P1|Visit 1|Protocol Violation|3
5882992|NCT01844583|20352366|P2|Overall Study|Didn't complete dosing;PK/ECG assessment|10
5882993|NCT01844583|20352367|P1|Overall Study|Didn't complete dosing;PK/ECG assessment|8
5882994|NCT01844531|20352399|P4|Overall Study|Withdrawal by Subject|0
5882995|NCT01844531|20352400|P3|Overall Study|Withdrawal by Subject|0
5882996|NCT01844531|20352401|P2|Overall Study|Withdrawal by Subject|1
5882997|NCT01844531|20352402|P1|Overall Study|Withdrawal by Subject|0
5882998|NCT01844518|20352432|P1|Long-Term Extension|Still in On-Going Study|149
5882999|NCT01844518|20352432|P1|Long-Term Extension|No Longer Met Study Criteria|1
5883000|NCT01844518|20352432|P1|Long-Term Extension|Adverse Event|1
5883001|NCT01844518|20352432|P1|Long-Term Extension|Lack of Efficacy|6
5883002|NCT01844518|20352432|P1|Short-Term (ST) Period|Poor/Non-Compliance|1
5883003|NCT01844518|20352432|P1|Short-Term (ST) Period|Withdrawal of Consent|2
5883004|NCT01844518|20352432|P1|Short-Term (ST) Period|Lack of Efficacy|3
5883005|NCT01844518|20352432|P1|Short-Term (ST) Period|Adverse Event|3
5883006|NCT01844505|20352449|P3|Overall Study|Not Reported|1
5883007|NCT01844505|20352450|P2|Overall Study|Not Reported|0
5883008|NCT01844505|20352451|P1|Overall Study|Not Reported|0
5883009|NCT01844505|20352449|P3|Overall Study|Other Reasons|2
5883010|NCT01844505|20352450|P2|Overall Study|Other Reasons|2
5883011|NCT01844505|20352451|P1|Overall Study|Other Reasons|4
5883012|NCT01844505|20352449|P3|Overall Study|Subject no longer meets criteria|0
5883013|NCT01844505|20352450|P2|Overall Study|Subject no longer meets criteria|1
5883014|NCT01844505|20352451|P1|Overall Study|Subject no longer meets criteria|0
5883015|NCT01844505|20352449|P3|Overall Study|Poor/non-compliance|1
5883016|NCT01844505|20352450|P2|Overall Study|Poor/non-compliance|1
5883017|NCT01844505|20352451|P1|Overall Study|Poor/non-compliance|1
5883018|NCT01844505|20352449|P3|Overall Study|Maximum clinical benefit|2
5883019|NCT01844505|20352450|P2|Overall Study|Maximum clinical benefit|11
5883020|NCT01844505|20352451|P1|Overall Study|Maximum clinical benefit|8
5883021|NCT01844505|20352449|P3|Overall Study|Lost to Follow-up|0
5883022|NCT01844505|20352450|P2|Overall Study|Lost to Follow-up|0
5883023|NCT01844505|20352451|P1|Overall Study|Lost to Follow-up|1
5883024|NCT01844505|20352449|P3|Overall Study|Withdrawal by Subject|0
5883025|NCT01844505|20352450|P2|Overall Study|Withdrawal by Subject|3
5883026|NCT01844505|20352451|P1|Overall Study|Withdrawal by Subject|0
5883027|NCT01844505|20352449|P3|Overall Study|Subject request discontinue treatment|8
5883028|NCT01844505|20352450|P2|Overall Study|Subject request discontinue treatment|14
5883029|NCT01844505|20352451|P1|Overall Study|Subject request discontinue treatment|17
5883030|NCT01844505|20352449|P3|Overall Study|Adverse event unrelated to study drug|6
5883031|NCT01844505|20352450|P2|Overall Study|Adverse event unrelated to study drug|15
5883032|NCT01844505|20352451|P1|Overall Study|Adverse event unrelated to study drug|7
5883033|NCT01844505|20352449|P3|Overall Study|Death|1
5883034|NCT01844505|20352450|P2|Overall Study|Death|3
5883035|NCT01844505|20352451|P1|Overall Study|Death|1
5883036|NCT01844505|20352449|P3|Overall Study|Study drug toxicity|50
5883037|NCT01844505|20352450|P2|Overall Study|Study drug toxicity|131
5883038|NCT01844505|20352451|P1|Overall Study|Study drug toxicity|40
5883039|NCT01844505|20352449|P3|Overall Study|Disease progression|224
5883040|NCT01844505|20352450|P2|Overall Study|Disease progression|88
5883041|NCT01844505|20352451|P1|Overall Study|Disease progression|170
5883042|NCT01844375|20352545|P2|Overall Study|Protocol Violation|1
5883043|NCT01844375|20352546|P1|Overall Study|Protocol Violation|1
5883044|NCT01844284|20352558|P2|Overall Study|Lost to Follow-up|7
5883045|NCT01844284|20352559|P1|Overall Study|Lost to Follow-up|12
5883046|NCT01844115|20352778|P2|Overall Study|Pregnancy|1
5883047|NCT01844115|20352779|P1|Overall Study|Pregnancy|0
5883048|NCT01844115|20352778|P2|Overall Study|Lost to Follow-up|10
5883049|NCT01844115|20352779|P1|Overall Study|Lost to Follow-up|11
5883050|NCT01844115|20352778|P2|Overall Study|Withdrawal by Subject|11
5883051|NCT01844115|20352779|P1|Overall Study|Withdrawal by Subject|11
5883052|NCT01844115|20352778|P2|Overall Study|Protocol Violation|10
5883053|NCT01844115|20352779|P1|Overall Study|Protocol Violation|12
5883054|NCT01844115|20352778|P2|Overall Study|Lack of Efficacy|4
5883055|NCT01844115|20352779|P1|Overall Study|Lack of Efficacy|1
5883056|NCT01844115|20352778|P2|Overall Study|Adverse Event|22
5883057|NCT01844115|20352779|P1|Overall Study|Adverse Event|4
5883058|NCT01843972|20352797|P10|Overall Study|Withdrawal by Subject|0
5883059|NCT01843972|20352798|P9|Overall Study|Withdrawal by Subject|0
5883060|NCT01843972|20352799|P8|Overall Study|Withdrawal by Subject|0
5883061|NCT01843972|20352800|P7|Overall Study|Withdrawal by Subject|0
5883062|NCT01843972|20352801|P6|Overall Study|Withdrawal by Subject|0
5883063|NCT01843972|20352802|P5|Overall Study|Withdrawal by Subject|1
5883064|NCT01843972|20352803|P4|Overall Study|Withdrawal by Subject|0
5883065|NCT01843972|20352804|P3|Overall Study|Withdrawal by Subject|0
5883066|NCT01843972|20352805|P2|Overall Study|Withdrawal by Subject|0
5883067|NCT01843972|20352806|P1|Overall Study|Withdrawal by Subject|0
5883068|NCT01843933|20352876|P2|Overall Study|Data lost|4
5883069|NCT01843933|20352877|P1|Overall Study|Data lost|6
5883070|NCT01843842|20352896|P2|Overall Study|Do not meet inclusion criteria|1
5883071|NCT01843842|20352897|P1|Overall Study|Do not meet inclusion criteria|1
5883072|NCT01843803|20352919|P2|Overall Study|not a Veteran, did not see provider|3
5883073|NCT01843803|20352920|P1|Overall Study|not a Veteran, did not see provider|1
5883074|NCT01843777|20352934|P2|Overall Study|Withdrawal by Subject|0
5883075|NCT01843777|20352935|P1|Overall Study|Withdrawal by Subject|1
5883076|NCT01843673|20352960|P1|Overall Study|Withdrawal by Subject|4
5883077|NCT01843673|20352960|P1|Overall Study|Lack of Efficacy|2
5883078|NCT01843660|20352972|P1|Overall Study|Other|30
5883085|NCT01843348|20353041|P3|Overall Study|Various reasons|6
5883086|NCT01843348|20353042|P2|Overall Study|Various reasons|9
5883087|NCT01843348|20353043|P1|Overall Study|Various reasons|4
5883088|NCT01843348|20353041|P3|Overall Study|Graft loss/retransplantation|11
5883089|NCT01843348|20353042|P2|Overall Study|Graft loss/retransplantation|8
5883090|NCT01843348|20353043|P1|Overall Study|Graft loss/retransplantation|5
5883091|NCT01843348|20353041|P3|Overall Study|Death|4
5883092|NCT01843348|20353042|P2|Overall Study|Death|3
5883093|NCT01843348|20353043|P1|Overall Study|Death|5
5883094|NCT01843348|20353041|P3|Overall Study|Lost to Follow-up|2
5883095|NCT01843348|20353042|P2|Overall Study|Lost to Follow-up|4
5883096|NCT01843348|20353043|P1|Overall Study|Lost to Follow-up|5
5883097|NCT01843348|20353041|P3|Overall Study|Withdrawal by Subject|18
5883098|NCT01843348|20353042|P2|Overall Study|Withdrawal by Subject|16
5883099|NCT01843348|20353043|P1|Overall Study|Withdrawal by Subject|4
5883100|NCT01843205|20353083|P2|First Treatment (11 Days)|Withdrawal by Subject|0
5883101|NCT01843205|20353084|P1|First Treatment (11 Days)|Withdrawal by Subject|1
5883102|NCT01843192|20353145|P3|Overall Study|Intra-operative exclusions per protocol|2
5883103|NCT01843192|20353146|P2|Overall Study|Intra-operative exclusions per protocol|6
5883104|NCT01843192|20353147|P1|Overall Study|Intra-operative exclusions per protocol|2
5883105|NCT01843062|20353178|P2|Overall Study|Lost to Follow-up|4
5883106|NCT01843062|20353179|P1|Overall Study|Lost to Follow-up|2
5883107|NCT01843062|20353178|P2|Overall Study|Death|2
5883108|NCT01843062|20353179|P1|Overall Study|Death|1
5883109|NCT01843062|20353178|P2|Overall Study|Withdrawal by Subject|3
5883110|NCT01843062|20353179|P1|Overall Study|Withdrawal by Subject|12
5883111|NCT01843062|20353178|P2|Overall Study|Incorrect randomisation|0
5883112|NCT01843062|20353179|P1|Overall Study|Incorrect randomisation|1
5883113|NCT01843062|20353178|P2|Overall Study|Adverse Event|0
5883114|NCT01843062|20353179|P1|Overall Study|Adverse Event|2
5883115|NCT01843062|20353178|P2|Overall Study|Pregnancy|0
5883116|NCT01843062|20353179|P1|Overall Study|Pregnancy|1
5883117|NCT01843062|20353178|P2|Overall Study|New treatment following progression|0
5883118|NCT01843062|20353179|P1|Overall Study|New treatment following progression|2
5883119|NCT01843062|20353178|P2|Overall Study|Protocol Violation|0
5883120|NCT01843062|20353179|P1|Overall Study|Protocol Violation|1
5883121|NCT01842958|20353193|P2|Overall Study|Lost to Follow-up|1
5883122|NCT01842958|20353194|P1|Overall Study|Lost to Follow-up|1
5883123|NCT01842633|20353278|P3|Overall Study|Technical issues|0
5883124|NCT01842633|20353279|P2|Overall Study|Technical issues|0
5883125|NCT01842633|20353280|P1|Overall Study|Technical issues|1
5883126|NCT01842633|20353278|P3|Overall Study|Withdrawal by Subject|0
5883127|NCT01842633|20353279|P2|Overall Study|Withdrawal by Subject|1
5883128|NCT01842633|20353280|P1|Overall Study|Withdrawal by Subject|0
5883129|NCT01842633|20353278|P3|Overall Study|Adverse Event|0
5883130|NCT01842633|20353279|P2|Overall Study|Adverse Event|1
5883131|NCT01842633|20353280|P1|Overall Study|Adverse Event|1
5883132|NCT01842633|20353278|P3|Overall Study|Screen Failure|0
5883133|NCT01842633|20353279|P2|Overall Study|Screen Failure|0
5883134|NCT01842633|20353280|P1|Overall Study|Screen Failure|1
5883135|NCT01842620|20353327|P2|Period 1|Withdrawal by Subject|0
5883136|NCT01842620|20353328|P1|Period 1|Withdrawal by Subject|1
5883137|NCT01842607|20353344|P1|Overall Study|Withdrawal by Subject|14
5883138|NCT01842607|20353344|P1|Overall Study|Physician Decision|9
5883139|NCT01842607|20353344|P1|Overall Study|Lost to Follow-up|3
5883140|NCT01842607|20353344|P1|Overall Study|Protocol defined stopping criteria|2
5883141|NCT01842607|20353344|P1|Overall Study|Protocol Violation|8
5883142|NCT01842607|20353344|P1|Overall Study|Lack of Efficacy|19
5883143|NCT01842607|20353344|P1|Overall Study|Adverse Event|11
5883144|NCT01842581|20353370|P2|Overall Study|Other than specified|1
5883145|NCT01842581|20353371|P1|Overall Study|Other than specified|3
5883146|NCT01842581|20353370|P2|Overall Study|Withdrawal by Subject|7
5883147|NCT01842581|20353371|P1|Overall Study|Withdrawal by Subject|5
5883148|NCT01842581|20353370|P2|Overall Study|Lost to Follow-up|5
5883149|NCT01842581|20353371|P1|Overall Study|Lost to Follow-up|2
5883150|NCT01842581|20353370|P2|Overall Study|Liver transplant|0
5883151|NCT01842581|20353371|P1|Overall Study|Liver transplant|2
5883152|NCT01842581|20353370|P2|Overall Study|HE breakthrough|13
5883153|NCT01842581|20353371|P1|Overall Study|HE breakthrough|26
5883154|NCT01842581|20353370|P2|Overall Study|Adverse Event|4
5883155|NCT01842581|20353371|P1|Overall Study|Adverse Event|6
5883156|NCT01842438|20353395|P2|T2: 6month Follow-up|Death|1
5883157|NCT01842438|20353396|P1|T2: 6month Follow-up|Death|0
5883158|NCT01842438|20353395|P2|T2: 6month Follow-up|Withdrawal by Subject|3
5883159|NCT01842438|20353396|P1|T2: 6month Follow-up|Withdrawal by Subject|4
5883160|NCT01842438|20353395|P2|T1: Immediately After the Intervention|Withdrawal by Subject|8
5883161|NCT01842438|20353396|P1|T1: Immediately After the Intervention|Withdrawal by Subject|6
5883162|NCT01842334|20353410|P2|Overall Study|Moved away mid-study|1
5883163|NCT01842334|20353411|P1|Overall Study|Moved away mid-study|0
5883164|NCT01842334|20353410|P2|Overall Study|Withdrawal by Subject|3
5883165|NCT01842334|20353411|P1|Overall Study|Withdrawal by Subject|3
5883166|NCT01842308|20353422|P5|Overall Study|Withdrawal by Subject|1
5883167|NCT01842308|20353423|P4|Overall Study|Withdrawal by Subject|0
5883168|NCT01842308|20353424|P3|Overall Study|Withdrawal by Subject|0
5883169|NCT01842308|20353425|P2|Overall Study|Withdrawal by Subject|0
5883170|NCT01842308|20353426|P1|Overall Study|Withdrawal by Subject|0
5883171|NCT01841970|20353445|P1|Overall Study|Lost to Follow-up|8
5883172|NCT01841970|20353445|P1|Overall Study|Physician Decision|2
5883173|NCT01841970|20353445|P1|Overall Study|Withdrawal by Subject|1
5883174|NCT01841762|20353469|P1|Post-Treatment Safety Follow-Up Period|Other, administrative error|1
5883175|NCT01841762|20353469|P1|Post-Treatment Safety Follow-Up Period|Lost to Follow-up|6
5883176|NCT01841762|20353469|P1|Post-Treatment Safety Follow-Up Period|Withdrawal by Subject|7
5883177|NCT01841762|20353469|P1|Post-Treatment Safety Follow-Up Period|Death|1
5883178|NCT01841762|20353469|P1|Treatment Period|Other, including non-compliance|5
5883179|NCT01841762|20353469|P1|Treatment Period|Physician Decision|2
5883180|NCT01841762|20353469|P1|Treatment Period|Lost to Follow-up|1
5883181|NCT01841762|20353469|P1|Treatment Period|Withdrawal by Subject|7
5883182|NCT01841762|20353469|P1|Treatment Period|Death|1
5883183|NCT01841762|20353469|P1|Treatment Period|Adverse Event|16
5883184|NCT01841762|20353469|P1|Screening Period|Other, 2 PAH-SYMPACT cycles not complete|51
5883185|NCT01841697|20353493|P2|Overall Study|Withdrawal by Subject|16
5883186|NCT01841697|20353494|P1|Overall Study|Withdrawal by Subject|16
5883187|NCT01841697|20353493|P2|Overall Study|Lost to Follow-up|1
5883188|NCT01841697|20353494|P1|Overall Study|Lost to Follow-up|4
5883189|NCT01841697|20353493|P2|Overall Study|Death|1
5883190|NCT01841697|20353494|P1|Overall Study|Death|0
5883191|NCT01841593|20353534|P2|Second Intervention (Days 8 to 14)|Adverse Event|0
5883192|NCT01841593|20353535|P1|Second Intervention (Days 8 to 14)|Adverse Event|1
5883193|NCT01841593|20353534|P2|First Intervention (Days 1 to 7)|Protocol Violation|1
5883194|NCT01841593|20353535|P1|First Intervention (Days 1 to 7)|Protocol Violation|0
5883195|NCT01841567|20353551|P1|Overall Study|Adverse Event|3
5883196|NCT01841554|20353556|P1|Overall Study|Study exit due to secondary intervention|6
5883197|NCT01841554|20353556|P1|Overall Study|Discontinued Follow Up|5
5883198|NCT01841554|20353556|P1|Overall Study|No Implantation|1
5883199|NCT01841554|20353556|P1|Overall Study|Death|7
5883200|NCT01841073|20353605|P2|Overall Study|Lost to Follow-up|2
5883201|NCT01841073|20353606|P1|Overall Study|Lost to Follow-up|0
5883202|NCT01841073|20353605|P2|Overall Study|Physician Decision|0
5883203|NCT01841073|20353606|P1|Overall Study|Physician Decision|1
5883204|NCT01841073|20353605|P2|Overall Study|Adverse Event|1
5883205|NCT01841073|20353606|P1|Overall Study|Adverse Event|1
5883206|NCT01841060|20353616|P1|Overall Study|Protocol Violation|10
5883207|NCT01840943|20353635|P2|Overall Study|Lost to Follow-up|4
5883208|NCT01840943|20353636|P1|Overall Study|Lost to Follow-up|4
5883209|NCT01840943|20353635|P2|Overall Study|Physician Decision|2
5883210|NCT01840943|20353636|P1|Overall Study|Physician Decision|4
5883211|NCT01840943|20353635|P2|Overall Study|Withdrawal by Subject|6
5883212|NCT01840943|20353636|P1|Overall Study|Withdrawal by Subject|5
5883213|NCT01840605|20353685|P2|Overall Study|Physician Decision|1
5883214|NCT01840605|20353686|P1|Overall Study|Physician Decision|2
5883215|NCT01840605|20353685|P2|Overall Study|Adverse Event|1
5883216|NCT01840605|20353686|P1|Overall Study|Adverse Event|0
5883217|NCT01840410|20353700|P2|Overall Study|Adverse Event|1
5883218|NCT01840410|20353701|P1|Overall Study|Adverse Event|1
5883219|NCT01840410|20353700|P2|Overall Study|Withdrawal by Subject|1
5883220|NCT01840410|20353701|P1|Overall Study|Withdrawal by Subject|2
5883221|NCT01840410|20353700|P2|Overall Study|Lost to Follow-up|0
5883222|NCT01840410|20353701|P1|Overall Study|Lost to Follow-up|1
5883223|NCT01840410|20353700|P2|Overall Study|Protocol deviation|0
5883224|NCT01840410|20353701|P1|Overall Study|Protocol deviation|1
5883225|NCT01840410|20353700|P2|Overall Study|Pregnancy|0
5883226|NCT01840410|20353701|P1|Overall Study|Pregnancy|1
5883227|NCT01840410|20353700|P2|Overall Study|Physician Decision|2
5883228|NCT01840410|20353701|P1|Overall Study|Physician Decision|1
5883229|NCT01840228|20353750|P2|Overall Study|Lost to Follow-up|1
5883230|NCT01840228|20353751|P1|Overall Study|Lost to Follow-up|1
5883231|NCT01840163|20353779|P2|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|35
5883232|NCT01840163|20353780|P1|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|43
5883233|NCT01840163|20353779|P2|Systemic Follow Up-secondary Outcome|Lost to Follow-up|40
5883234|NCT01840163|20353780|P1|Systemic Follow Up-secondary Outcome|Lost to Follow-up|48
5883235|NCT01840163|20353779|P2|First Follow up -Primary Outcome|Lost to Follow-up|16
5883236|NCT01840163|20353780|P1|First Follow up -Primary Outcome|Lost to Follow-up|19
5883237|NCT01839916|20353825|P1|Overall Study|Graft Failure|1
5883238|NCT01839916|20353825|P1|Overall Study|GVHD|2
5883239|NCT01839916|20353825|P1|Overall Study|Relapse|12
5883240|NCT01839916|20353825|P1|Overall Study|Physician Decision|17
5883241|NCT01839916|20353825|P1|Overall Study|Death|9
5883250|NCT01839487|20353937|P6|Phase 2 (Maximum Exposure:935 Days)|Other than specified|1
5883251|NCT01839487|20353938|P5|Phase 2 (Maximum Exposure:935 Days)|Other than specified|2
5883252|NCT01839487|20353939|P4|Phase 2 (Maximum Exposure:935 Days)|Other than specified|3
5883253|NCT01839487|20353940|P3|Phase 2 (Maximum Exposure:935 Days)|Other than specified|1
5883254|NCT01839487|20353941|P2|Phase 2 (Maximum Exposure:935 Days)|Other than specified|0
5883255|NCT01839487|20353942|P1|Phase 2 (Maximum Exposure:935 Days)|Other than specified|0
5883256|NCT01839487|20353937|P6|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|3
5883257|NCT01839487|20353938|P5|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|10
5883258|NCT01839487|20353939|P4|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|1
5883259|NCT01839487|20353940|P3|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0
5883260|NCT01839487|20353941|P2|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0
5883261|NCT01839487|20353942|P1|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0
5883262|NCT01839487|20353937|P6|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0
5883263|NCT01839487|20353938|P5|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|1
5883264|NCT01839487|20353939|P4|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0
5883265|NCT01839487|20353940|P3|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|2
5883266|NCT01839487|20353941|P2|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0
5883267|NCT01839487|20353942|P1|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0
5883268|NCT01839487|20353937|P6|Phase 2 (Maximum Exposure:935 Days)|Death|32
5883269|NCT01839487|20353938|P5|Phase 2 (Maximum Exposure:935 Days)|Death|71
5883270|NCT01839487|20353939|P4|Phase 2 (Maximum Exposure:935 Days)|Death|49
5883271|NCT01839487|20353940|P3|Phase 2 (Maximum Exposure:935 Days)|Death|46
5883272|NCT01839487|20353941|P2|Phase 2 (Maximum Exposure:935 Days)|Death|0
5883273|NCT01839487|20353942|P1|Phase 2 (Maximum Exposure:935 Days)|Death|0
5883274|NCT01839487|20353937|P6|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|8
5883275|NCT01839487|20353938|P5|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|4
5883276|NCT01839487|20353939|P4|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|9
5883277|NCT01839487|20353940|P3|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|12
5883278|NCT01839487|20353941|P2|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|0
5883279|NCT01839487|20353942|P1|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|0
5883280|NCT01839487|20353937|P6|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0
5883281|NCT01839487|20353938|P5|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0
5883282|NCT01839487|20353939|P4|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0
5883283|NCT01839487|20353940|P3|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0
5883284|NCT01839487|20353941|P2|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0
5883285|NCT01839487|20353942|P1|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|1
5883286|NCT01839487|20353937|P6|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0
5883287|NCT01839487|20353938|P5|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0
5883288|NCT01839487|20353939|P4|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0
5883289|NCT01839487|20353940|P3|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0
5883290|NCT01839487|20353941|P2|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|1
5883291|NCT01839487|20353942|P1|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0
5883292|NCT01839487|20353937|P6|Run-in Phase (Maximum Exposure:295 Days)|Death|0
5883293|NCT01839487|20353938|P5|Run-in Phase (Maximum Exposure:295 Days)|Death|0
5883294|NCT01839487|20353939|P4|Run-in Phase (Maximum Exposure:295 Days)|Death|0
5883295|NCT01839487|20353940|P3|Run-in Phase (Maximum Exposure:295 Days)|Death|0
5883296|NCT01839487|20353941|P2|Run-in Phase (Maximum Exposure:295 Days)|Death|6
5883297|NCT01839487|20353942|P1|Run-in Phase (Maximum Exposure:295 Days)|Death|14
5883298|NCT01839487|20353937|P6|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0
5883299|NCT01839487|20353938|P5|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0
5883300|NCT01839487|20353939|P4|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0
5883301|NCT01839487|20353940|P3|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0
5883302|NCT01839487|20353941|P2|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0
5883303|NCT01839487|20353942|P1|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|1
5883304|NCT01839279|20353993|P3|Overall Study|Classified as 'Other'|0
5883305|NCT01839279|20353994|P2|Overall Study|Classified as 'Other'|0
5883306|NCT01839279|20353995|P1|Overall Study|Classified as 'Other'|5
5883307|NCT01839279|20353993|P3|Overall Study|Withdrawal by Subject|1
5883308|NCT01839279|20353994|P2|Overall Study|Withdrawal by Subject|1
5883309|NCT01839279|20353995|P1|Overall Study|Withdrawal by Subject|4
5883310|NCT01839279|20353993|P3|Overall Study|Adverse Event|1
5883311|NCT01839279|20353994|P2|Overall Study|Adverse Event|1
5883312|NCT01839279|20353995|P1|Overall Study|Adverse Event|4
5883313|NCT01839188|20354014|P1|Overall Study|Withdrawal by Subject|1
5883314|NCT01838941|20354086|P1|Overall Study|Withdrawal by Subject|1
5883315|NCT01838941|20354086|P1|Overall Study|Adverse Event|1
5883316|NCT01838876|20354091|P1|Overall Study|Did not meet eligibility criteria|78
5883317|NCT01838876|20354091|P1|Overall Study|Reason not Specified|7
5883318|NCT01838876|20354091|P1|Overall Study|Study or Site Terminated by Sponsor|1
5883319|NCT01838876|20354091|P1|Overall Study|Lost to Follow-up|21
5883320|NCT01838876|20354091|P1|Overall Study|Withdrawal of Consent|33
5883321|NCT01838876|20354091|P1|Overall Study|Protocol Violation|34
5883322|NCT01838876|20354091|P1|Overall Study|Insufficient Therapeutic Response|10
5883323|NCT01838876|20354091|P1|Overall Study|Adverse Event|49
5883324|NCT01838694|20354200|P2|Overall Study|Adverse Event|1
5883325|NCT01838694|20354201|P1|Overall Study|Adverse Event|0
5883326|NCT01838681|20354210|P4|Period B/A+|Administrative or other reasons|28
5883327|NCT01838681|20354211|P3|Period B/A+|Administrative or other reasons|10
5883328|NCT01838681|20354212|P2|Period B/A+|Administrative or other reasons|6
5883329|NCT01838681|20354213|P1|Period B/A+|Administrative or other reasons|0
5883330|NCT01838681|20354210|P4|Period B/A+|Withdrawal before treatment|0
5883331|NCT01838681|20354211|P3|Period B/A+|Withdrawal before treatment|0
5883332|NCT01838681|20354212|P2|Period B/A+|Withdrawal before treatment|1
5883333|NCT01838681|20354213|P1|Period B/A+|Withdrawal before treatment|0
5883334|NCT01838681|20354210|P4|Period B/A+|Lost to Follow-up|11
5883335|NCT01838681|20354211|P3|Period B/A+|Lost to Follow-up|5
5883336|NCT01838681|20354212|P2|Period B/A+|Lost to Follow-up|2
5883337|NCT01838681|20354213|P1|Period B/A+|Lost to Follow-up|0
5883338|NCT01838681|20354210|P4|Period B/A+|Non-compliance with IMP|3
5883339|NCT01838681|20354211|P3|Period B/A+|Non-compliance with IMP|3
5883340|NCT01838681|20354212|P2|Period B/A+|Non-compliance with IMP|2
5883341|NCT01838681|20354213|P1|Period B/A+|Non-compliance with IMP|0
5883342|NCT01838681|20354210|P4|Period B/A+|Protocol Violation|6
5883343|NCT01838681|20354211|P3|Period B/A+|Protocol Violation|4
5883344|NCT01838681|20354212|P2|Period B/A+|Protocol Violation|1
5883345|NCT01838681|20354213|P1|Period B/A+|Protocol Violation|0
5883346|NCT01838681|20354210|P4|Period B/A+|Withdrawal by Subject|47
5883347|NCT01838681|20354211|P3|Period B/A+|Withdrawal by Subject|35
5883348|NCT01838681|20354212|P2|Period B/A+|Withdrawal by Subject|28
5883349|NCT01838681|20354213|P1|Period B/A+|Withdrawal by Subject|0
5883350|NCT01838681|20354210|P4|Period B/A+|Lack of Efficacy|6
5883351|NCT01838681|20354211|P3|Period B/A+|Lack of Efficacy|11
5883352|NCT01838681|20354212|P2|Period B/A+|Lack of Efficacy|9
5883353|NCT01838681|20354213|P1|Period B/A+|Lack of Efficacy|0
5883354|NCT01838681|20354210|P4|Period B/A+|Adverse Event|16
5883355|NCT01838681|20354211|P3|Period B/A+|Adverse Event|27
5883356|NCT01838681|20354212|P2|Period B/A+|Adverse Event|13
5883357|NCT01838681|20354213|P1|Period B/A+|Adverse Event|0
5883358|NCT01838681|20354210|P4|Period A|Administrative or other reasons|0
5883359|NCT01838681|20354211|P3|Period A|Administrative or other reasons|0
5883360|NCT01838681|20354212|P2|Period A|Administrative or other reasons|0
5883361|NCT01838681|20354213|P1|Period A|Administrative or other reasons|17
5883362|NCT01838681|20354210|P4|Period A|Withdrawal before treatment|0
5883363|NCT01838681|20354211|P3|Period A|Withdrawal before treatment|0
5883364|NCT01838681|20354212|P2|Period A|Withdrawal before treatment|0
5883365|NCT01838681|20354213|P1|Period A|Withdrawal before treatment|4
5883366|NCT01838681|20354210|P4|Period A|Lost to Follow-up|0
5883367|NCT01838681|20354211|P3|Period A|Lost to Follow-up|0
5883368|NCT01838681|20354212|P2|Period A|Lost to Follow-up|0
5883369|NCT01838681|20354213|P1|Period A|Lost to Follow-up|4
5883370|NCT01838681|20354210|P4|Period A|Non-compliance with IMP|0
5883371|NCT01838681|20354211|P3|Period A|Non-compliance with IMP|0
5883372|NCT01838681|20354212|P2|Period A|Non-compliance with IMP|0
5883373|NCT01838681|20354213|P1|Period A|Non-compliance with IMP|6
5883374|NCT01838681|20354210|P4|Period A|Protocol Violation|0
5883375|NCT01838681|20354211|P3|Period A|Protocol Violation|0
5883376|NCT01838681|20354212|P2|Period A|Protocol Violation|0
5883377|NCT01838681|20354213|P1|Period A|Protocol Violation|16
5883378|NCT01838681|20354210|P4|Period A|Withdrawal by Subject|0
5883379|NCT01838681|20354211|P3|Period A|Withdrawal by Subject|0
5883380|NCT01838681|20354212|P2|Period A|Withdrawal by Subject|0
5883381|NCT01838681|20354213|P1|Period A|Withdrawal by Subject|70
5883382|NCT01838681|20354210|P4|Period A|Early response|0
5883383|NCT01838681|20354211|P3|Period A|Early response|0
5883384|NCT01838681|20354212|P2|Period A|Early response|0
5883385|NCT01838681|20354213|P1|Period A|Early response|148
5883386|NCT01838681|20354210|P4|Period A|Lack of Efficacy|0
5883387|NCT01838681|20354211|P3|Period A|Lack of Efficacy|0
5883388|NCT01838681|20354212|P2|Period A|Lack of Efficacy|0
5883389|NCT01838681|20354213|P1|Period A|Lack of Efficacy|21
5883390|NCT01838681|20354210|P4|Period A|Adverse Event|0
5883391|NCT01838681|20354211|P3|Period A|Adverse Event|0
5883392|NCT01838681|20354212|P2|Period A|Adverse Event|0
5883393|NCT01838681|20354213|P1|Period A|Adverse Event|39
5883394|NCT01838642|20354321|P1|Overall Study|Died on study|1
5883395|NCT01838616|20354334|P2|Pick-up Arm|Technical problems|0
5883396|NCT01838616|20354335|P1|Pick-up Arm|Technical problems|1
5883397|NCT01838616|20354334|P2|Pick-up Arm|Withdrawal by Subject|0
5883398|NCT01838616|20354335|P1|Pick-up Arm|Withdrawal by Subject|1
5883399|NCT01838616|20354334|P2|Pick-up Arm|Adverse Event|0
5883400|NCT01838616|20354335|P1|Pick-up Arm|Adverse Event|9
5883401|NCT01838616|20354334|P2|Pick-up Arm|Lack of Efficacy|0
5883402|NCT01838616|20354335|P1|Pick-up Arm|Lack of Efficacy|4
5883403|NCT01838616|20354334|P2|Continuation Period|Technical problems|1
5883404|NCT01838616|20354335|P1|Continuation Period|Technical problems|0
5883405|NCT01838616|20354334|P2|Continuation Period|Withdrawal by Subject|4
5883406|NCT01838616|20354335|P1|Continuation Period|Withdrawal by Subject|0
5883407|NCT01838616|20354334|P2|Continuation Period|Lost to Follow-up|0
5883408|NCT01838616|20354335|P1|Continuation Period|Lost to Follow-up|1
5883409|NCT01838616|20354334|P2|Continuation Period|Protocol Violation|0
5883410|NCT01838616|20354335|P1|Continuation Period|Protocol Violation|2
5883411|NCT01838616|20354334|P2|Continuation Period|Adverse Event|4
5883412|NCT01838616|20354335|P1|Continuation Period|Adverse Event|8
5883413|NCT01838616|20354334|P2|Continuation Period|Lack of Efficacy|5
5883414|NCT01838616|20354335|P1|Continuation Period|Lack of Efficacy|3
5883415|NCT01838616|20354334|P2|Titration Period|Protocol Violation|1
5883416|NCT01838616|20354335|P1|Titration Period|Protocol Violation|0
5883417|NCT01838616|20354334|P2|Titration Period|Other|0
5883418|NCT01838616|20354335|P1|Titration Period|Other|1
5883419|NCT01838616|20354334|P2|Titration Period|Technical problems|0
5883420|NCT01838616|20354335|P1|Titration Period|Technical problems|1
5883421|NCT01838616|20354334|P2|Titration Period|Withdrawal by Subject|5
5883422|NCT01838616|20354335|P1|Titration Period|Withdrawal by Subject|5
5883423|NCT01838616|20354334|P2|Titration Period|Lack of Efficacy|12
5883424|NCT01838616|20354335|P1|Titration Period|Lack of Efficacy|5
5883425|NCT01838616|20354334|P2|Titration Period|Adverse Event|48
5883426|NCT01838616|20354335|P1|Titration Period|Adverse Event|18
5883427|NCT01838590|20354406|P2|Overall Study|Lost to Follow-up|1
5883428|NCT01838590|20354407|P1|Overall Study|Lost to Follow-up|0
5883429|NCT01838590|20354406|P2|Overall Study|Lack of Efficacy|4
5883430|NCT01838590|20354407|P1|Overall Study|Lack of Efficacy|12
5883431|NCT01838499|20354431|P2|Overall Study|Withdrawal by Subject|9
5883432|NCT01838499|20354432|P1|Overall Study|Withdrawal by Subject|19
5883433|NCT01838499|20354431|P2|Overall Study|Adverse Event|1
5883434|NCT01838499|20354432|P1|Overall Study|Adverse Event|2
5883435|NCT01838499|20354431|P2|Overall Study|Lack of Efficacy|2
5883436|NCT01838499|20354432|P1|Overall Study|Lack of Efficacy|1
5883437|NCT01838499|20354431|P2|Overall Study|Lost to Follow-up|4
5883438|NCT01838499|20354432|P1|Overall Study|Lost to Follow-up|2
5883439|NCT01838499|20354431|P2|Overall Study|Protocol Violation|1
5883440|NCT01838499|20354432|P1|Overall Study|Protocol Violation|0
5883441|NCT01838447|20354444|P2|Overall Study|Withdrawal by Subject|1
5883442|NCT01838447|20354445|P1|Overall Study|Withdrawal by Subject|1
5883443|NCT01838447|20354444|P2|Overall Study|Change in surgical plan|2
5883444|NCT01838447|20354445|P1|Overall Study|Change in surgical plan|1
5883445|NCT01838213|20354493|P2|Overall Study|Ineligible|191
5883446|NCT01838213|20354494|P1|Overall Study|Ineligible|166
5883447|NCT01838200|20354502|P2|Overall Study|Progressive disease|0
5883448|NCT01838200|20354503|P1|Overall Study|Progressive disease|3
5883449|NCT01838200|20354502|P2|Overall Study|Adverse Event|2
5883450|NCT01838200|20354503|P1|Overall Study|Adverse Event|0
5883451|NCT01837966|20354515|P2|Overall Study|Withdrawal by Subject|1
5883452|NCT01837966|20354516|P1|Overall Study|Withdrawal by Subject|2
5883453|NCT01837823|20354522|P1|Overall Study|Lost to Follow-up|6
5883454|NCT01837797|20354553|P5|Period 3|Other|2
5883455|NCT01837797|20354554|P4|Period 3|Other|0
5883456|NCT01837797|20354555|P3|Period 3|Other|0
5883457|NCT01837797|20354556|P2|Period 3|Other|0
5883458|NCT01837797|20354557|P1|Period 3|Other|0
5883459|NCT01837797|20354553|P5|Period 3|Administrative reasons|20
5883460|NCT01837797|20354554|P4|Period 3|Administrative reasons|0
5883461|NCT01837797|20354555|P3|Period 3|Administrative reasons|0
5883462|NCT01837797|20354556|P2|Period 3|Administrative reasons|0
5883463|NCT01837797|20354557|P1|Period 3|Administrative reasons|0
5883464|NCT01837797|20354553|P5|Period 3|Adverse Event|1
5883465|NCT01837797|20354554|P4|Period 3|Adverse Event|0
5883466|NCT01837797|20354555|P3|Period 3|Adverse Event|0
5883467|NCT01837797|20354556|P2|Period 3|Adverse Event|0
5883468|NCT01837797|20354557|P1|Period 3|Adverse Event|0
5883469|NCT01837797|20354553|P5|Period 2|Adverse Event|0
5883470|NCT01837797|20354554|P4|Period 2|Adverse Event|1
5883471|NCT01837797|20354555|P3|Period 2|Adverse Event|0
5883472|NCT01837797|20354556|P2|Period 2|Adverse Event|0
5883473|NCT01837797|20354557|P1|Period 2|Adverse Event|0
5883474|NCT01837797|20354553|P5|Period 2|Administrative or other reasons|0
5883475|NCT01837797|20354554|P4|Period 2|Administrative or other reasons|4
5883476|NCT01837797|20354555|P3|Period 2|Administrative or other reasons|2
5883477|NCT01837797|20354556|P2|Period 2|Administrative or other reasons|5
5883478|NCT01837797|20354557|P1|Period 2|Administrative or other reasons|0
5883479|NCT01837797|20354553|P5|Period 1|Other|0
5883480|NCT01837797|20354554|P4|Period 1|Other|0
5883481|NCT01837797|20354555|P3|Period 1|Other|0
5883482|NCT01837797|20354556|P2|Period 1|Other|0
5883483|NCT01837797|20354557|P1|Period 1|Other|10
5883484|NCT01837797|20354553|P5|Period 1|Withdrawal of consent before treatment|0
5883485|NCT01837797|20354554|P4|Period 1|Withdrawal of consent before treatment|0
5883486|NCT01837797|20354555|P3|Period 1|Withdrawal of consent before treatment|0
5883487|NCT01837797|20354556|P2|Period 1|Withdrawal of consent before treatment|0
5883488|NCT01837797|20354557|P1|Period 1|Withdrawal of consent before treatment|1
5883489|NCT01837797|20354553|P5|Period 1|Administrative reasons|0
5883490|NCT01837797|20354554|P4|Period 1|Administrative reasons|0
5883491|NCT01837797|20354555|P3|Period 1|Administrative reasons|0
5883492|NCT01837797|20354556|P2|Period 1|Administrative reasons|0
5883493|NCT01837797|20354557|P1|Period 1|Administrative reasons|76
5883494|NCT01837797|20354553|P5|Period 1|Withdrawal by Subject|0
5883495|NCT01837797|20354554|P4|Period 1|Withdrawal by Subject|0
5883496|NCT01837797|20354555|P3|Period 1|Withdrawal by Subject|0
5883497|NCT01837797|20354556|P2|Period 1|Withdrawal by Subject|0
5883498|NCT01837797|20354557|P1|Period 1|Withdrawal by Subject|6
5883499|NCT01837797|20354553|P5|Period 1|Adverse Event|0
5883500|NCT01837797|20354554|P4|Period 1|Adverse Event|0
5883501|NCT01837797|20354555|P3|Period 1|Adverse Event|0
5883502|NCT01837797|20354556|P2|Period 1|Adverse Event|0
5883503|NCT01837797|20354557|P1|Period 1|Adverse Event|9
5883504|NCT01837719|20354592|P1|Period 5: Days 29-31 (Treatment E)|Poor compliance/noncompliance|1
5883505|NCT01837719|20354592|P1|Period 2: Days 8-14 (Treatment B or A)|Withdrawal by Subject|1
5883506|NCT01837680|20354661|P2|Overall Study|switched to oral hypoglycemic or diet|4
5883507|NCT01837680|20354662|P1|Overall Study|switched to oral hypoglycemic or diet|2
5883508|NCT01837680|20354661|P2|Overall Study|allergic reaction|0
5883509|NCT01837680|20354662|P1|Overall Study|allergic reaction|6
5883510|NCT01837680|20354661|P2|Overall Study|lack of insurance|2
5883511|NCT01837680|20354662|P1|Overall Study|lack of insurance|0
5883512|NCT01837680|20354661|P2|Overall Study|Lost to Follow-up|2
5883513|NCT01837680|20354662|P1|Overall Study|Lost to Follow-up|2
5883514|NCT01836549|20354796|P7|Overall Study|Patient inevaluable to start therapy|1
5883515|NCT01836549|20354797|P6|Overall Study|Patient inevaluable to start therapy|0
5883516|NCT01836549|20354798|P5|Overall Study|Patient inevaluable to start therapy|0
5883517|NCT01836549|20354799|P4|Overall Study|Patient inevaluable to start therapy|0
5883518|NCT01836549|20354800|P3|Overall Study|Patient inevaluable to start therapy|0
5883519|NCT01836549|20354801|P2|Overall Study|Patient inevaluable to start therapy|0
5883520|NCT01836549|20354802|P1|Overall Study|Patient inevaluable to start therapy|0
5883521|NCT01836549|20354796|P7|Overall Study|Patient declared ineligible|0
5883522|NCT01836549|20354797|P6|Overall Study|Patient declared ineligible|0
5883523|NCT01836549|20354798|P5|Overall Study|Patient declared ineligible|0
5883524|NCT01836549|20354799|P4|Overall Study|Patient declared ineligible|1
5883525|NCT01836549|20354800|P3|Overall Study|Patient declared ineligible|0
5883526|NCT01836549|20354801|P2|Overall Study|Patient declared ineligible|0
5883527|NCT01836549|20354802|P1|Overall Study|Patient declared ineligible|0
5883528|NCT01836549|20354796|P7|Overall Study|Did not receive study drug|0
5883529|NCT01836549|20354797|P6|Overall Study|Did not receive study drug|0
5883530|NCT01836549|20354798|P5|Overall Study|Did not receive study drug|0
5883531|NCT01836549|20354799|P4|Overall Study|Did not receive study drug|0
5883532|NCT01836549|20354800|P3|Overall Study|Did not receive study drug|1
5883533|NCT01836549|20354801|P2|Overall Study|Did not receive study drug|0
5883534|NCT01836549|20354802|P1|Overall Study|Did not receive study drug|0
5883535|NCT01836523|20354826|P4|Overall Study|Unclassified|29
5883536|NCT01836523|20354827|P3|Overall Study|Unclassified|19
5883537|NCT01836523|20354828|P2|Overall Study|Unclassified|28
5883538|NCT01836523|20354829|P1|Overall Study|Unclassified|17
5883539|NCT01836523|20354826|P4|Overall Study|Met Withdrawal Criteria|27
5883540|NCT01836523|20354827|P3|Overall Study|Met Withdrawal Criteria|21
5883541|NCT01836523|20354828|P2|Overall Study|Met Withdrawal Criteria|13
5883542|NCT01836523|20354829|P1|Overall Study|Met Withdrawal Criteria|13
5883543|NCT01836523|20354826|P4|Overall Study|Protocol Violation|4
5883544|NCT01836523|20354827|P3|Overall Study|Protocol Violation|2
5883545|NCT01836523|20354828|P2|Overall Study|Protocol Violation|3
5883546|NCT01836523|20354829|P1|Overall Study|Protocol Violation|6
5883547|NCT01836523|20354826|P4|Overall Study|Adverse Event|14
5883548|NCT01836523|20354827|P3|Overall Study|Adverse Event|49
5883549|NCT01836523|20354828|P2|Overall Study|Adverse Event|41
5883550|NCT01836523|20354829|P1|Overall Study|Adverse Event|15
5883551|NCT01836471|20354856|P5|Overall Study|Non compliance with tx|0
5883552|NCT01836471|20354857|P4|Overall Study|Non compliance with tx|0
5883553|NCT01836471|20354858|P3|Overall Study|Non compliance with tx|0
5883554|NCT01836471|20354859|P2|Overall Study|Non compliance with tx|1
5883555|NCT01836471|20354860|P1|Overall Study|Non compliance with tx|1
5883556|NCT01836471|20354856|P5|Overall Study|Adverse Event|2
5883557|NCT01836471|20354857|P4|Overall Study|Adverse Event|1
5883558|NCT01836471|20354858|P3|Overall Study|Adverse Event|1
5883559|NCT01836471|20354859|P2|Overall Study|Adverse Event|3
5883560|NCT01836471|20354860|P1|Overall Study|Adverse Event|6
5883561|NCT01836471|20354856|P5|Overall Study|Lost to Follow-up|1
5883562|NCT01836471|20354857|P4|Overall Study|Lost to Follow-up|1
5883563|NCT01836471|20354858|P3|Overall Study|Lost to Follow-up|0
5883564|NCT01836471|20354859|P2|Overall Study|Lost to Follow-up|0
5883565|NCT01836471|20354860|P1|Overall Study|Lost to Follow-up|0
5883566|NCT01836471|20354856|P5|Overall Study|Physician Decision|0
5883567|NCT01836471|20354857|P4|Overall Study|Physician Decision|0
5883568|NCT01836471|20354858|P3|Overall Study|Physician Decision|0
5883569|NCT01836471|20354859|P2|Overall Study|Physician Decision|1
5883570|NCT01836471|20354860|P1|Overall Study|Physician Decision|0
5883571|NCT01836471|20354856|P5|Overall Study|Withdrawal by Subject|2
5883572|NCT01836471|20354857|P4|Overall Study|Withdrawal by Subject|0
5883573|NCT01836471|20354858|P3|Overall Study|Withdrawal by Subject|1
5883574|NCT01836471|20354859|P2|Overall Study|Withdrawal by Subject|4
5883575|NCT01836471|20354860|P1|Overall Study|Withdrawal by Subject|3
5883576|NCT01836471|20354856|P5|Overall Study|Pregnancy|0
5883577|NCT01836471|20354857|P4|Overall Study|Pregnancy|0
5883578|NCT01836471|20354858|P3|Overall Study|Pregnancy|0
5883579|NCT01836471|20354859|P2|Overall Study|Pregnancy|0
5883580|NCT01836471|20354860|P1|Overall Study|Pregnancy|1
5883581|NCT01836458|20354889|P4|Overall Study|Unsatisfactory therapeutic effect|6
5883582|NCT01836458|20354890|P3|Overall Study|Unsatisfactory therapeutic effect|5
5883583|NCT01836458|20354891|P2|Overall Study|Unsatisfactory therapeutic effect|2
5883584|NCT01836458|20354892|P1|Overall Study|Unsatisfactory therapeutic effect|3
5883585|NCT01836276|20354977|P2|Overall Study|Lost to Follow-up|51
5883586|NCT01836276|20354978|P1|Overall Study|Lost to Follow-up|28
5883587|NCT01836198|20354986|P3|Part A, Period 2|Protocol Violation|0
5883588|NCT01836198|20354987|P2|Part A, Period 2|Protocol Violation|1
5883589|NCT01836198|20354988|P1|Part A, Period 2|Protocol Violation|0
5883590|NCT01835899|20355090|P3|Overall Study|Other than stated above|0
5883591|NCT01835899|20355091|P2|Overall Study|Other than stated above|1
5883592|NCT01835899|20355092|P1|Overall Study|Other than stated above|0
5883593|NCT01835899|20355090|P3|Overall Study|Adverse Event|1
5883594|NCT01835899|20355091|P2|Overall Study|Adverse Event|0
5883595|NCT01835899|20355092|P1|Overall Study|Adverse Event|0
5883596|NCT01835587|20355149|P4|Overall Study|Miscellaneous|0
5883597|NCT01835587|20355150|P3|Overall Study|Miscellaneous|0
5883598|NCT01835587|20355151|P2|Overall Study|Miscellaneous|1
5883599|NCT01835587|20355152|P1|Overall Study|Miscellaneous|0
5883600|NCT01835587|20355149|P4|Overall Study|Death|1
5883601|NCT01835587|20355150|P3|Overall Study|Death|0
5883602|NCT01835587|20355151|P2|Overall Study|Death|0
5883603|NCT01835587|20355152|P1|Overall Study|Death|0
5883604|NCT01835587|20355149|P4|Overall Study|Adverse Event|2
5883605|NCT01835587|20355150|P3|Overall Study|Adverse Event|2
5883606|NCT01835587|20355151|P2|Overall Study|Adverse Event|0
5883607|NCT01835587|20355152|P1|Overall Study|Adverse Event|0
5883608|NCT01835587|20355149|P4|Overall Study|Withdrawal by Subject|3
5883609|NCT01835587|20355150|P3|Overall Study|Withdrawal by Subject|0
5883610|NCT01835587|20355151|P2|Overall Study|Withdrawal by Subject|0
5883611|NCT01835587|20355152|P1|Overall Study|Withdrawal by Subject|2
5883612|NCT01835587|20355149|P4|Overall Study|Disease Recurrence or Relapse|3
5883613|NCT01835587|20355150|P3|Overall Study|Disease Recurrence or Relapse|0
5883614|NCT01835587|20355151|P2|Overall Study|Disease Recurrence or Relapse|3
5883615|NCT01835587|20355152|P1|Overall Study|Disease Recurrence or Relapse|0
5883616|NCT01835548|20355213|P3|Double-Blind Treatment Period|Withdrawal by Subject|0
5883617|NCT01835548|20355214|P2|Double-Blind Treatment Period|Withdrawal by Subject|1
5883618|NCT01835548|20355215|P1|Double-Blind Treatment Period|Withdrawal by Subject|0
5883619|NCT01835548|20355213|P3|Double-Blind Treatment Period|Adverse Event|0
5883620|NCT01835548|20355214|P2|Double-Blind Treatment Period|Adverse Event|1
5883621|NCT01835548|20355215|P1|Double-Blind Treatment Period|Adverse Event|0
5883622|NCT01835548|20355213|P3|Dose Optimization Period|Withdrawal by Subject|1
5883623|NCT01835548|20355214|P2|Dose Optimization Period|Withdrawal by Subject|0
5883624|NCT01835548|20355215|P1|Dose Optimization Period|Withdrawal by Subject|0
5883625|NCT01835548|20355213|P3|Dose Optimization Period|Adverse Event|1
5883626|NCT01835548|20355214|P2|Dose Optimization Period|Adverse Event|0
5883627|NCT01835548|20355215|P1|Dose Optimization Period|Adverse Event|0
5883630|NCT01835431|20355256|P2|Overall Study|Protocol Violation|0
5883631|NCT01835431|20355257|P1|Overall Study|Protocol Violation|1
5883632|NCT01835431|20355256|P2|Overall Study|Withdrawal by Subject|10
5883633|NCT01835431|20355257|P1|Overall Study|Withdrawal by Subject|6
5883634|NCT01835431|20355256|P2|Overall Study|other|2
5883635|NCT01835431|20355257|P1|Overall Study|other|0
5883636|NCT01835431|20355256|P2|Overall Study|Adverse Event|0
5883637|NCT01835431|20355257|P1|Overall Study|Adverse Event|1
5883638|NCT01835223|20355297|P2|Overall Study|Became Inelligible|0
5883639|NCT01835223|20355298|P1|Overall Study|Became Inelligible|4
5883640|NCT01835223|20355297|P2|Overall Study|Disease progression|1
5883641|NCT01835223|20355298|P1|Overall Study|Disease progression|2
5883642|NCT01835223|20355297|P2|Overall Study|Withdrawal by Subject|0
5883643|NCT01835223|20355298|P1|Overall Study|Withdrawal by Subject|2
5883644|NCT01835223|20355297|P2|Overall Study|Adverse Event|0
5883645|NCT01835223|20355298|P1|Overall Study|Adverse Event|1
5883648|NCT01835145|20355331|P2|Overall Study|Ineligible prior to treatment|0
5883649|NCT01835145|20355332|P1|Overall Study|Ineligible prior to treatment|1
5883650|NCT01835132|20355347|P1|Initial Phase|Insufficient Therapeutic Response|2
5883651|NCT01835015|20355392|P5|Overall Study|Adverse Event|0
5883652|NCT01835015|20355393|P4|Overall Study|Adverse Event|0
5883653|NCT01835015|20355394|P3|Overall Study|Adverse Event|1
5883654|NCT01835015|20355395|P2|Overall Study|Adverse Event|0
5883655|NCT01835015|20355396|P1|Overall Study|Adverse Event|0
5883656|NCT01834729|20355473|P4|Overall Study|Adverse Event|2
5883657|NCT01834729|20355474|P3|Overall Study|Adverse Event|0
5883658|NCT01834729|20355475|P2|Overall Study|Adverse Event|0
5883659|NCT01834729|20355476|P1|Overall Study|Adverse Event|0
5883660|NCT01834729|20355473|P4|Overall Study|Withdrawal by Subject|0
5883661|NCT01834729|20355474|P3|Overall Study|Withdrawal by Subject|0
5883662|NCT01834729|20355475|P2|Overall Study|Withdrawal by Subject|1
5883663|NCT01834729|20355476|P1|Overall Study|Withdrawal by Subject|1
5883664|NCT01834729|20355473|P4|Overall Study|Did not return bowel diaries|0
5883665|NCT01834729|20355474|P3|Overall Study|Did not return bowel diaries|3
5883666|NCT01834729|20355475|P2|Overall Study|Did not return bowel diaries|0
5883667|NCT01834729|20355476|P1|Overall Study|Did not return bowel diaries|0
5883668|NCT01834586|20355509|P1|Overall Study|Adverse Event|1
5883669|NCT01834274|20355549|P2|Overall Study|Other|1
5883670|NCT01834274|20355550|P1|Overall Study|Other|2
5883671|NCT01834274|20355549|P2|Overall Study|Lost to Follow-up|1
5883672|NCT01834274|20355550|P1|Overall Study|Lost to Follow-up|3
5883673|NCT01834274|20355549|P2|Overall Study|Withdrawal by Subject|1
5883674|NCT01834274|20355550|P1|Overall Study|Withdrawal by Subject|1
5883675|NCT01834274|20355549|P2|Overall Study|Study Termination|38
5883676|NCT01834274|20355550|P1|Overall Study|Study Termination|41
5883677|NCT01834222|20355573|P1|Overall Study|Not meet inclusion/exclusion criteria|1
5883678|NCT01833897|20355668|P1|Overall Study|Lack of Efficacy|1
5883679|NCT01833832|20355680|P1|Overall Study|Pt could not be cytoreduced for HIPEC|1
5883680|NCT01833533|20355835|P2|Overall Study|Other|7
5883681|NCT01833533|20355836|P1|Overall Study|Other|2
5883682|NCT01833533|20355835|P2|Overall Study|To Enter an Extension Study|4
5883683|NCT01833533|20355836|P1|Overall Study|To Enter an Extension Study|0
5883684|NCT01833533|20355835|P2|Overall Study|Lost to Follow-up|9
5883685|NCT01833533|20355836|P1|Overall Study|Lost to Follow-up|4
5883686|NCT01833533|20355835|P2|Overall Study|Adverse Event|1
5883687|NCT01833533|20355836|P1|Overall Study|Adverse Event|0
5883688|NCT01833494|20355850|P1|Overall Study|Increase in serum ferritin|1
5883689|NCT01833494|20355850|P1|Overall Study|Decrease in serum calcium|4
5883690|NCT01833494|20355850|P1|Overall Study|Decrease in serum phosphorus|4
5883691|NCT01833494|20355850|P1|Overall Study|Withdrawal by Subject|6
5883692|NCT01833494|20355850|P1|Overall Study|Physician Decision|6
5883693|NCT01833494|20355850|P1|Overall Study|Adverse Event|24
5883694|NCT01833455|20355878|P2|Overall Study|Withdrawal by Subject|0
5883695|NCT01833455|20355879|P1|Overall Study|Withdrawal by Subject|1
5883696|NCT01833169|20355908|P1|Overall Study|Physician Decision|2
5883697|NCT01833169|20355908|P1|Overall Study|Death|3
5883698|NCT01833169|20355908|P1|Overall Study|Withdrawal by Subject|9
5883699|NCT01833169|20355908|P1|Overall Study|Adverse Event|33
5883700|NCT01833169|20355908|P1|Overall Study|Disease Progression|99
5883701|NCT01833143|20355919|P1|Overall Study|Not Treated|1
5883702|NCT01833065|20355984|P5|Overall Study|Others|4
5883703|NCT01833065|20355985|P4|Overall Study|Others|1
5883704|NCT01833065|20355986|P3|Overall Study|Others|1
5883705|NCT01833065|20355987|P2|Overall Study|Others|1
5883706|NCT01833065|20355988|P1|Overall Study|Others|2
5883707|NCT01833065|20355984|P5|Overall Study|Trial terminated by sponsor|13
5883708|NCT01833065|20355985|P4|Overall Study|Trial terminated by sponsor|3
5883709|NCT01833065|20355986|P3|Overall Study|Trial terminated by sponsor|7
5883710|NCT01833065|20355987|P2|Overall Study|Trial terminated by sponsor|8
5883711|NCT01833065|20355988|P1|Overall Study|Trial terminated by sponsor|8
5883712|NCT01833065|20355984|P5|Overall Study|Subject's substantial non-compliance|0
5883713|NCT01833065|20355985|P4|Overall Study|Subject's substantial non-compliance|0
5883714|NCT01833065|20355986|P3|Overall Study|Subject's substantial non-compliance|0
5883715|NCT01833065|20355987|P2|Overall Study|Subject's substantial non-compliance|1
5883716|NCT01833065|20355988|P1|Overall Study|Subject's substantial non-compliance|0
5883717|NCT01833065|20355984|P5|Overall Study|Withdrawal by Subject|11
5883718|NCT01833065|20355985|P4|Overall Study|Withdrawal by Subject|3
5883719|NCT01833065|20355986|P3|Overall Study|Withdrawal by Subject|4
5883720|NCT01833065|20355987|P2|Overall Study|Withdrawal by Subject|2
5883721|NCT01833065|20355988|P1|Overall Study|Withdrawal by Subject|6
5883722|NCT01833065|20355984|P5|Overall Study|Lost to Follow-up|3
5883723|NCT01833065|20355985|P4|Overall Study|Lost to Follow-up|0
5883724|NCT01833065|20355986|P3|Overall Study|Lost to Follow-up|0
5883725|NCT01833065|20355987|P2|Overall Study|Lost to Follow-up|0
5883726|NCT01833065|20355988|P1|Overall Study|Lost to Follow-up|1
5883727|NCT01833065|20355984|P5|Overall Study|Protocol Violation|2
5883728|NCT01833065|20355985|P4|Overall Study|Protocol Violation|0
5883729|NCT01833065|20355986|P3|Overall Study|Protocol Violation|0
5883730|NCT01833065|20355987|P2|Overall Study|Protocol Violation|0
5883731|NCT01833065|20355988|P1|Overall Study|Protocol Violation|1
5883732|NCT01833065|20355984|P5|Overall Study|Adverse Event|3
5883733|NCT01833065|20355985|P4|Overall Study|Adverse Event|2
5883734|NCT01833065|20355986|P3|Overall Study|Adverse Event|0
5883735|NCT01833065|20355987|P2|Overall Study|Adverse Event|1
5883736|NCT01833065|20355988|P1|Overall Study|Adverse Event|6
5883737|NCT01832818|20356057|P1|Overall Study|Lost to Follow-up|6
5883738|NCT01832766|20356066|P2|Washout|Lost to Follow-up|1
5883739|NCT01832766|20356067|P1|Washout|Lost to Follow-up|0
5883740|NCT01832727|20356103|P9|Overall Study|Study terminated by sponsor|1
5883741|NCT01832727|20356104|P8|Overall Study|Study terminated by sponsor|1
5883742|NCT01832727|20356105|P7|Overall Study|Study terminated by sponsor|0
5883743|NCT01832727|20356106|P6|Overall Study|Study terminated by sponsor|0
5883744|NCT01832727|20356107|P5|Overall Study|Study terminated by sponsor|0
5883745|NCT01832727|20356108|P4|Overall Study|Study terminated by sponsor|0
5883746|NCT01832727|20356109|P3|Overall Study|Study terminated by sponsor|0
5883747|NCT01832727|20356110|P2|Overall Study|Study terminated by sponsor|0
5883748|NCT01832727|20356111|P1|Overall Study|Study terminated by sponsor|0
5883749|NCT01832727|20356103|P9|Overall Study|Withdrawal by Subject|1
5883750|NCT01832727|20356104|P8|Overall Study|Withdrawal by Subject|2
5883751|NCT01832727|20356105|P7|Overall Study|Withdrawal by Subject|0
5883752|NCT01832727|20356106|P6|Overall Study|Withdrawal by Subject|1
5883753|NCT01832727|20356107|P5|Overall Study|Withdrawal by Subject|0
5883754|NCT01832727|20356108|P4|Overall Study|Withdrawal by Subject|1
5883755|NCT01832727|20356109|P3|Overall Study|Withdrawal by Subject|0
5883756|NCT01832727|20356110|P2|Overall Study|Withdrawal by Subject|1
5883757|NCT01832727|20356111|P1|Overall Study|Withdrawal by Subject|1
5883758|NCT01832727|20356103|P9|Overall Study|Physician Decision|0
5883759|NCT01832727|20356104|P8|Overall Study|Physician Decision|0
5883760|NCT01832727|20356105|P7|Overall Study|Physician Decision|0
5883761|NCT01832727|20356106|P6|Overall Study|Physician Decision|1
5883762|NCT01832727|20356107|P5|Overall Study|Physician Decision|0
5883763|NCT01832727|20356108|P4|Overall Study|Physician Decision|1
5883764|NCT01832727|20356109|P3|Overall Study|Physician Decision|0
5883765|NCT01832727|20356110|P2|Overall Study|Physician Decision|0
5883766|NCT01832727|20356111|P1|Overall Study|Physician Decision|1
5883767|NCT01832727|20356103|P9|Overall Study|Lost to Follow-up|0
5883768|NCT01832727|20356104|P8|Overall Study|Lost to Follow-up|0
5883769|NCT01832727|20356105|P7|Overall Study|Lost to Follow-up|0
5883770|NCT01832727|20356106|P6|Overall Study|Lost to Follow-up|0
5883771|NCT01832727|20356107|P5|Overall Study|Lost to Follow-up|0
5883772|NCT01832727|20356108|P4|Overall Study|Lost to Follow-up|1
5883773|NCT01832727|20356109|P3|Overall Study|Lost to Follow-up|0
5883774|NCT01832727|20356110|P2|Overall Study|Lost to Follow-up|0
5883775|NCT01832727|20356111|P1|Overall Study|Lost to Follow-up|0
5883776|NCT01832727|20356103|P9|Overall Study|Disease progression|7
5883777|NCT01832727|20356104|P8|Overall Study|Disease progression|2
5883778|NCT01832727|20356105|P7|Overall Study|Disease progression|6
5883779|NCT01832727|20356106|P6|Overall Study|Disease progression|3
5883780|NCT01832727|20356107|P5|Overall Study|Disease progression|3
5883781|NCT01832727|20356108|P4|Overall Study|Disease progression|1
5883782|NCT01832727|20356109|P3|Overall Study|Disease progression|2
5883783|NCT01832727|20356110|P2|Overall Study|Disease progression|0
5883784|NCT01832727|20356111|P1|Overall Study|Disease progression|3
5883785|NCT01832727|20356103|P9|Overall Study|Adverse Event|9
5883786|NCT01832727|20356104|P8|Overall Study|Adverse Event|1
5883787|NCT01832727|20356105|P7|Overall Study|Adverse Event|2
5883788|NCT01832727|20356106|P6|Overall Study|Adverse Event|1
5883789|NCT01832727|20356107|P5|Overall Study|Adverse Event|1
5883790|NCT01832727|20356108|P4|Overall Study|Adverse Event|0
5883791|NCT01832727|20356109|P3|Overall Study|Adverse Event|1
5883792|NCT01832727|20356110|P2|Overall Study|Adverse Event|6
5883793|NCT01832727|20356111|P1|Overall Study|Adverse Event|4
5883794|NCT01832532|20356224|P2|Overall Study|Withdrawal by Subject|2
5883795|NCT01832532|20356225|P1|Overall Study|Withdrawal by Subject|5
5883796|NCT01832493|20356287|P1|Overall Study|Unable to place LV lead|2
5883797|NCT01832493|20356287|P1|Overall Study|Protocol Violation|4
5883798|NCT01832493|20356287|P1|Overall Study|Physician Decision|2
5883799|NCT01832480|20356296|P2|Overall Study|post randomization ineligible|10
5883800|NCT01832480|20356297|P1|Overall Study|post randomization ineligible|8
5883801|NCT01832480|20356296|P2|Overall Study|Withdrawal by Subject|2
5883802|NCT01832480|20356297|P1|Overall Study|Withdrawal by Subject|0
5883803|NCT01832480|20356296|P2|Overall Study|Lost to Follow-up|30
5883804|NCT01832480|20356297|P1|Overall Study|Lost to Follow-up|33
5883805|NCT01832402|20356305|P2|Overall Study|Declining Performance status|1
5883806|NCT01832402|20356306|P1|Overall Study|Declining Performance status|2
5883807|NCT01832402|20356305|P2|Overall Study|Withdrawal by Subject|3
5883808|NCT01832402|20356306|P1|Overall Study|Withdrawal by Subject|3
5883809|NCT01832402|20356305|P2|Overall Study|Lost to Follow-up|0
5883810|NCT01832402|20356306|P1|Overall Study|Lost to Follow-up|2
5883811|NCT01832155|20356333|P2|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|0
5883812|NCT01832155|20356334|P1|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|1
5883813|NCT01832155|20356333|P2|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|0
5883814|NCT01832155|20356334|P1|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|1
5883815|NCT01832038|20356401|P1|Overall Study|Subject considered the efficacy was poor|1
5883816|NCT01832038|20356401|P1|Overall Study|Pregnancy and abortion in EP0008 study|1
5883817|NCT01832038|20356401|P1|Overall Study|Prohibited concomitant medication|1
5883818|NCT01832038|20356401|P1|Overall Study|Bad mood and has suicidal thought|1
5883819|NCT01832038|20356401|P1|Overall Study|Plan to pregnancy|7
5883820|NCT01832038|20356401|P1|Overall Study|Changes of implementation system|3
5883821|NCT01832038|20356401|P1|Overall Study|Not possible to visit the hospital|1
5883822|NCT01832038|20356401|P1|Overall Study|Prohibit procedure|2
5883823|NCT01832038|20356401|P1|Overall Study|Low compliance|3
5883824|NCT01832038|20356401|P1|Overall Study|Pregnancy|1
5883825|NCT01832038|20356401|P1|Overall Study|Back home|1
5883826|NCT01832038|20356401|P1|Overall Study|Participant was asked to quit|5
5883827|NCT01832038|20356401|P1|Overall Study|Not convenient to come back to site|2
5883828|NCT01832038|20356401|P1|Overall Study|Subject refused to return visit|2
5883829|NCT01832038|20356401|P1|Overall Study|Visit non-compliance|2
5883830|NCT01832038|20356401|P1|Overall Study|Withdrawal by Subject|49
5883831|NCT01832038|20356401|P1|Overall Study|Lost to Follow-up|10
5883832|NCT01832038|20356401|P1|Overall Study|Protocol Violation|7
5883833|NCT01832038|20356401|P1|Overall Study|Lack of Efficacy|81
5883834|NCT01832038|20356401|P1|Overall Study|Adverse Event|50
5883835|NCT01832038|20356401|P1|Overall Study|Death|5
5883836|NCT01831856|20356459|P2|Overall Study|Unsuccessful Electrical Cardioversion|18
5883837|NCT01831856|20356460|P1|Overall Study|Unsuccessful Electrical Cardioversion|16
5883838|NCT01831856|20356459|P2|Overall Study|Lack of Efficacy|11
5883839|NCT01831856|20356460|P1|Overall Study|Lack of Efficacy|13
5883840|NCT01831856|20356459|P2|Overall Study|Adverse Event|8
5883841|NCT01831856|20356460|P1|Overall Study|Adverse Event|5
5883842|NCT01831817|20356470|P4|Overall Study|Withdrawl of Consent|0
5883843|NCT01831817|20356471|P3|Overall Study|Withdrawl of Consent|0
5883844|NCT01831817|20356472|P2|Overall Study|Withdrawl of Consent|0
5883845|NCT01831817|20356473|P1|Overall Study|Withdrawl of Consent|3
5883846|NCT01831817|20356470|P4|Overall Study|Lost to Follow-up|0
5883847|NCT01831817|20356471|P3|Overall Study|Lost to Follow-up|0
5883848|NCT01831817|20356472|P2|Overall Study|Lost to Follow-up|0
5883849|NCT01831817|20356473|P1|Overall Study|Lost to Follow-up|1
5883850|NCT01831804|20356520|P9|Overall Study|Withdrew Consent|0
5883851|NCT01831804|20356521|P8|Overall Study|Withdrew Consent|2
5883852|NCT01831804|20356522|P7|Overall Study|Withdrew Consent|0
5883853|NCT01831804|20356523|P6|Overall Study|Withdrew Consent|0
5883854|NCT01831804|20356524|P5|Overall Study|Withdrew Consent|0
5883855|NCT01831804|20356525|P4|Overall Study|Withdrew Consent|0
5883856|NCT01831804|20356526|P3|Overall Study|Withdrew Consent|0
5883857|NCT01831804|20356527|P2|Overall Study|Withdrew Consent|1
5883858|NCT01831804|20356528|P1|Overall Study|Withdrew Consent|0
5883859|NCT01831804|20356520|P9|Overall Study|Investigator discretion|0
5883860|NCT01831804|20356521|P8|Overall Study|Investigator discretion|1
5883861|NCT01831804|20356522|P7|Overall Study|Investigator discretion|0
5883862|NCT01831804|20356523|P6|Overall Study|Investigator discretion|0
5883863|NCT01831804|20356524|P5|Overall Study|Investigator discretion|1
5883864|NCT01831804|20356525|P4|Overall Study|Investigator discretion|0
5883865|NCT01831804|20356526|P3|Overall Study|Investigator discretion|0
5883866|NCT01831804|20356527|P2|Overall Study|Investigator discretion|0
5883867|NCT01831804|20356528|P1|Overall Study|Investigator discretion|0
5883868|NCT01831804|20356520|P9|Overall Study|Lost to Follow-up|1
5883869|NCT01831804|20356521|P8|Overall Study|Lost to Follow-up|0
5883870|NCT01831804|20356522|P7|Overall Study|Lost to Follow-up|0
5883871|NCT01831804|20356523|P6|Overall Study|Lost to Follow-up|0
5883872|NCT01831804|20356524|P5|Overall Study|Lost to Follow-up|0
5883873|NCT01831804|20356525|P4|Overall Study|Lost to Follow-up|0
5883874|NCT01831804|20356526|P3|Overall Study|Lost to Follow-up|1
5883875|NCT01831804|20356527|P2|Overall Study|Lost to Follow-up|0
5883876|NCT01831804|20356528|P1|Overall Study|Lost to Follow-up|0
5883877|NCT01831804|20356520|P9|Overall Study|Protocol defined stopping criteria|0
5883878|NCT01831804|20356521|P8|Overall Study|Protocol defined stopping criteria|0
5883879|NCT01831804|20356522|P7|Overall Study|Protocol defined stopping criteria|0
5883880|NCT01831804|20356523|P6|Overall Study|Protocol defined stopping criteria|0
5883881|NCT01831804|20356524|P5|Overall Study|Protocol defined stopping criteria|1
5883882|NCT01831804|20356525|P4|Overall Study|Protocol defined stopping criteria|0
5883883|NCT01831804|20356526|P3|Overall Study|Protocol defined stopping criteria|3
5883884|NCT01831804|20356527|P2|Overall Study|Protocol defined stopping criteria|1
5883885|NCT01831804|20356528|P1|Overall Study|Protocol defined stopping criteria|1
5883886|NCT01831804|20356520|P9|Overall Study|Protocol Violation|0
5883887|NCT01831804|20356521|P8|Overall Study|Protocol Violation|0
5883888|NCT01831804|20356522|P7|Overall Study|Protocol Violation|0
5883889|NCT01831804|20356523|P6|Overall Study|Protocol Violation|0
5883890|NCT01831804|20356524|P5|Overall Study|Protocol Violation|0
5883891|NCT01831804|20356525|P4|Overall Study|Protocol Violation|0
5883892|NCT01831804|20356526|P3|Overall Study|Protocol Violation|2
5883893|NCT01831804|20356527|P2|Overall Study|Protocol Violation|0
5883894|NCT01831804|20356528|P1|Overall Study|Protocol Violation|0
5883895|NCT01831804|20356520|P9|Overall Study|Adverse Event|1
5883896|NCT01831804|20356521|P8|Overall Study|Adverse Event|0
5883897|NCT01831804|20356522|P7|Overall Study|Adverse Event|1
5883898|NCT01831804|20356523|P6|Overall Study|Adverse Event|0
5883899|NCT01831804|20356524|P5|Overall Study|Adverse Event|0
5883900|NCT01831804|20356525|P4|Overall Study|Adverse Event|0
5883901|NCT01831804|20356526|P3|Overall Study|Adverse Event|0
5883902|NCT01831804|20356527|P2|Overall Study|Adverse Event|0
5883903|NCT01831804|20356528|P1|Overall Study|Adverse Event|0
5883904|NCT01831791|20356623|P1|Overall Study|Withdrawal by Subject|10
5883905|NCT01831765|20356652|P3|Overall Study|Lost to Follow-up|3
5883906|NCT01831765|20356653|P2|Overall Study|Lost to Follow-up|3
5883907|NCT01831765|20356654|P1|Overall Study|Lost to Follow-up|2
5883908|NCT01831765|20356652|P3|Overall Study|Withdrawal criteria|16
5883909|NCT01831765|20356653|P2|Overall Study|Withdrawal criteria|10
5883910|NCT01831765|20356654|P1|Overall Study|Withdrawal criteria|12
5883911|NCT01831765|20356652|P3|Overall Study|Withdrawal by Subject|17
5883912|NCT01831765|20356653|P2|Overall Study|Withdrawal by Subject|7
5883913|NCT01831765|20356654|P1|Overall Study|Withdrawal by Subject|22
5883914|NCT01831765|20356652|P3|Overall Study|Adverse Event|3
5883915|NCT01831765|20356653|P2|Overall Study|Adverse Event|3
5883916|NCT01831765|20356654|P1|Overall Study|Adverse Event|5
5883917|NCT01831765|20356652|P3|Overall Study|Other, site closed|0
5883918|NCT01831765|20356653|P2|Overall Study|Other, site closed|1
5883919|NCT01831765|20356654|P1|Overall Study|Other, site closed|1
5883920|NCT01831765|20356652|P3|Overall Study|Death|1
5883921|NCT01831765|20356653|P2|Overall Study|Death|1
5883922|NCT01831765|20356654|P1|Overall Study|Death|0
5883923|NCT01831765|20356652|P3|Overall Study|Pregnancy|2
5883924|NCT01831765|20356653|P2|Overall Study|Pregnancy|1
5883925|NCT01831765|20356654|P1|Overall Study|Pregnancy|1
5883926|NCT01831765|20356652|P3|Overall Study|Other, sponsor withdrew subject|0
5883927|NCT01831765|20356653|P2|Overall Study|Other, sponsor withdrew subject|1
5883928|NCT01831765|20356654|P1|Overall Study|Other, sponsor withdrew subject|0
5883929|NCT01831765|20356652|P3|Overall Study|Lack of Efficacy|0
5883930|NCT01831765|20356653|P2|Overall Study|Lack of Efficacy|0
5883931|NCT01831765|20356654|P1|Overall Study|Lack of Efficacy|1
5883932|NCT01831726|20356680|P1|Overall Study|Subject/guardian decision|7
5883933|NCT01831726|20356680|P1|Overall Study|Physician Decision|1
5883934|NCT01831726|20356680|P1|Overall Study|Disease Progression|49
5883935|NCT01831726|20356680|P1|Overall Study|Death|7
5883936|NCT01831726|20356680|P1|Overall Study|Adverse Event|16
5883937|NCT01831596|20356687|P1|Overall Study|Other|8
5883938|NCT01831544|20356691|P1|Overall Study|Still on original MVAD device|2
5883939|NCT01831544|20356691|P1|Overall Study|Death|1
5883940|NCT01831466|20356720|P12|Overall Study|Adverse Event|2
5883941|NCT01831466|20356721|P11|Overall Study|Adverse Event|0
5883942|NCT01831466|20356722|P10|Overall Study|Adverse Event|1
5883943|NCT01831466|20356723|P9|Overall Study|Adverse Event|1
5883944|NCT01831466|20356724|P8|Overall Study|Adverse Event|1
5883945|NCT01831466|20356725|P7|Overall Study|Adverse Event|0
5883946|NCT01831466|20356726|P6|Overall Study|Adverse Event|7
5883947|NCT01831466|20356727|P5|Overall Study|Adverse Event|3
5883948|NCT01831466|20356728|P4|Overall Study|Adverse Event|6
5883949|NCT01831466|20356729|P3|Overall Study|Adverse Event|4
5883950|NCT01831466|20356730|P2|Overall Study|Adverse Event|0
5883951|NCT01831466|20356731|P1|Overall Study|Adverse Event|0
5883952|NCT01831466|20356720|P12|Overall Study|Lack of Efficacy|0
5883953|NCT01831466|20356721|P11|Overall Study|Lack of Efficacy|2
5883954|NCT01831466|20356722|P10|Overall Study|Lack of Efficacy|2
5883955|NCT01831466|20356723|P9|Overall Study|Lack of Efficacy|2
5883956|NCT01831466|20356724|P8|Overall Study|Lack of Efficacy|1
5883957|NCT01831466|20356725|P7|Overall Study|Lack of Efficacy|1
5883958|NCT01831466|20356726|P6|Overall Study|Lack of Efficacy|8
5883959|NCT01831466|20356727|P5|Overall Study|Lack of Efficacy|9
5883960|NCT01831466|20356728|P4|Overall Study|Lack of Efficacy|6
5883961|NCT01831466|20356729|P3|Overall Study|Lack of Efficacy|7
5883962|NCT01831466|20356730|P2|Overall Study|Lack of Efficacy|8
5883963|NCT01831466|20356731|P1|Overall Study|Lack of Efficacy|5
5883964|NCT01831466|20356720|P12|Overall Study|Lost to Follow-up|1
5883965|NCT01831466|20356721|P11|Overall Study|Lost to Follow-up|0
5883966|NCT01831466|20356722|P10|Overall Study|Lost to Follow-up|1
5883967|NCT01831466|20356723|P9|Overall Study|Lost to Follow-up|0
5883968|NCT01831466|20356724|P8|Overall Study|Lost to Follow-up|0
5883969|NCT01831466|20356725|P7|Overall Study|Lost to Follow-up|0
5883970|NCT01831466|20356726|P6|Overall Study|Lost to Follow-up|3
5883971|NCT01831466|20356727|P5|Overall Study|Lost to Follow-up|0
5883972|NCT01831466|20356728|P4|Overall Study|Lost to Follow-up|2
5883973|NCT01831466|20356729|P3|Overall Study|Lost to Follow-up|4
5883974|NCT01831466|20356730|P2|Overall Study|Lost to Follow-up|1
5883975|NCT01831466|20356731|P1|Overall Study|Lost to Follow-up|0
5883976|NCT01831466|20356720|P12|Overall Study|Withdrawal by Subject|1
5883977|NCT01831466|20356721|P11|Overall Study|Withdrawal by Subject|0
5883978|NCT01831466|20356722|P10|Overall Study|Withdrawal by Subject|1
5883979|NCT01831466|20356723|P9|Overall Study|Withdrawal by Subject|0
5883980|NCT01831466|20356724|P8|Overall Study|Withdrawal by Subject|0
5883981|NCT01831466|20356725|P7|Overall Study|Withdrawal by Subject|0
5883982|NCT01831466|20356726|P6|Overall Study|Withdrawal by Subject|5
5883983|NCT01831466|20356727|P5|Overall Study|Withdrawal by Subject|3
5883984|NCT01831466|20356728|P4|Overall Study|Withdrawal by Subject|3
5883985|NCT01831466|20356729|P3|Overall Study|Withdrawal by Subject|3
5883986|NCT01831466|20356730|P2|Overall Study|Withdrawal by Subject|3
5883987|NCT01831466|20356731|P1|Overall Study|Withdrawal by Subject|6
5883988|NCT01831466|20356720|P12|Overall Study|Death|0
5883989|NCT01831466|20356721|P11|Overall Study|Death|0
5883990|NCT01831466|20356722|P10|Overall Study|Death|0
5883991|NCT01831466|20356723|P9|Overall Study|Death|0
5883992|NCT01831466|20356724|P8|Overall Study|Death|0
5883993|NCT01831466|20356725|P7|Overall Study|Death|0
5883994|NCT01831466|20356726|P6|Overall Study|Death|0
5883995|NCT01831466|20356727|P5|Overall Study|Death|0
5883996|NCT01831466|20356728|P4|Overall Study|Death|0
5883997|NCT01831466|20356729|P3|Overall Study|Death|0
5883998|NCT01831466|20356730|P2|Overall Study|Death|1
5883999|NCT01831466|20356731|P1|Overall Study|Death|0
5884000|NCT01831466|20356720|P12|Overall Study|Non-compliance with study treatment|0
5884001|NCT01831466|20356721|P11|Overall Study|Non-compliance with study treatment|0
5884002|NCT01831466|20356722|P10|Overall Study|Non-compliance with study treatment|0
5884003|NCT01831466|20356723|P9|Overall Study|Non-compliance with study treatment|0
5884004|NCT01831466|20356724|P8|Overall Study|Non-compliance with study treatment|0
5884005|NCT01831466|20356725|P7|Overall Study|Non-compliance with study treatment|0
5884006|NCT01831466|20356726|P6|Overall Study|Non-compliance with study treatment|1
5884007|NCT01831466|20356727|P5|Overall Study|Non-compliance with study treatment|0
5884008|NCT01831466|20356728|P4|Overall Study|Non-compliance with study treatment|0
5884009|NCT01831466|20356729|P3|Overall Study|Non-compliance with study treatment|1
5884010|NCT01831466|20356730|P2|Overall Study|Non-compliance with study treatment|1
5884011|NCT01831466|20356731|P1|Overall Study|Non-compliance with study treatment|2
5884012|NCT01831466|20356720|P12|Overall Study|Other|0
5884013|NCT01831466|20356721|P11|Overall Study|Other|0
5884014|NCT01831466|20356722|P10|Overall Study|Other|0
5884015|NCT01831466|20356723|P9|Overall Study|Other|0
5884016|NCT01831466|20356724|P8|Overall Study|Other|0
5884017|NCT01831466|20356725|P7|Overall Study|Other|0
5884018|NCT01831466|20356726|P6|Overall Study|Other|1
5884019|NCT01831466|20356727|P5|Overall Study|Other|2
5884020|NCT01831466|20356728|P4|Overall Study|Other|2
5884021|NCT01831466|20356729|P3|Overall Study|Other|2
5884022|NCT01831466|20356730|P2|Overall Study|Other|3
5884023|NCT01831466|20356731|P1|Overall Study|Other|2
5884024|NCT01831466|20356720|P12|Overall Study|Protocol Violation|0
5884025|NCT01831466|20356721|P11|Overall Study|Protocol Violation|0
5884026|NCT01831466|20356722|P10|Overall Study|Protocol Violation|0
5884027|NCT01831466|20356723|P9|Overall Study|Protocol Violation|0
5884028|NCT01831466|20356724|P8|Overall Study|Protocol Violation|0
5884029|NCT01831466|20356725|P7|Overall Study|Protocol Violation|0
5884030|NCT01831466|20356726|P6|Overall Study|Protocol Violation|1
5884031|NCT01831466|20356727|P5|Overall Study|Protocol Violation|0
5884032|NCT01831466|20356728|P4|Overall Study|Protocol Violation|0
5884033|NCT01831466|20356729|P3|Overall Study|Protocol Violation|2
5884034|NCT01831466|20356730|P2|Overall Study|Protocol Violation|1
5884035|NCT01831466|20356731|P1|Overall Study|Protocol Violation|1
5884036|NCT01831258|20356853|P2|Overall Study|Lost to Follow-up|2
5884037|NCT01831258|20356854|P1|Overall Study|Lost to Follow-up|3
5884038|NCT01831258|20356853|P2|Overall Study|Withdrawal by Subject|1
5884039|NCT01831258|20356854|P1|Overall Study|Withdrawal by Subject|2
5884040|NCT01831089|20356944|P6|Cohort B: Arm B|Global end of study|1
5884041|NCT01831089|20356945|P5|Cohort B: Arm B|Global end of study|0
5884042|NCT01831089|20356946|P4|Cohort B: Arm B|Global end of study|0
5884043|NCT01831089|20356947|P3|Cohort B: Arm B|Global end of study|0
5884044|NCT01831089|20356948|P2|Cohort B: Arm B|Global end of study|0
5884045|NCT01831089|20356949|P1|Cohort B: Arm B|Global end of study|0
5884046|NCT01831089|20356944|P6|Cohort B: Arm B|Adverse Event|1
5884047|NCT01831089|20356945|P5|Cohort B: Arm B|Adverse Event|0
5884048|NCT01831089|20356946|P4|Cohort B: Arm B|Adverse Event|0
5884049|NCT01831089|20356947|P3|Cohort B: Arm B|Adverse Event|0
5884050|NCT01831089|20356948|P2|Cohort B: Arm B|Adverse Event|0
5884051|NCT01831089|20356949|P1|Cohort B: Arm B|Adverse Event|0
5884052|NCT01831089|20356944|P6|Cohort B: Arm B|Never treated|2
5884053|NCT01831089|20356945|P5|Cohort B: Arm B|Never treated|0
5884054|NCT01831089|20356946|P4|Cohort B: Arm B|Never treated|0
5884055|NCT01831089|20356947|P3|Cohort B: Arm B|Never treated|0
5884056|NCT01831089|20356948|P2|Cohort B: Arm B|Never treated|0
5884057|NCT01831089|20356949|P1|Cohort B: Arm B|Never treated|0
5884058|NCT01831089|20356944|P6|Cohort B: Arm B|Physician Decision|2
5884059|NCT01831089|20356945|P5|Cohort B: Arm B|Physician Decision|0
5884060|NCT01831089|20356946|P4|Cohort B: Arm B|Physician Decision|0
5884061|NCT01831089|20356947|P3|Cohort B: Arm B|Physician Decision|0
5884062|NCT01831089|20356948|P2|Cohort B: Arm B|Physician Decision|0
5884063|NCT01831089|20356949|P1|Cohort B: Arm B|Physician Decision|0
5884064|NCT01831089|20356944|P6|Cohort B: Arm B|Progressive disease|8
5884065|NCT01831089|20356945|P5|Cohort B: Arm B|Progressive disease|0
5884066|NCT01831089|20356946|P4|Cohort B: Arm B|Progressive disease|0
5884067|NCT01831089|20356947|P3|Cohort B: Arm B|Progressive disease|0
5884068|NCT01831089|20356948|P2|Cohort B: Arm B|Progressive disease|0
5884069|NCT01831089|20356949|P1|Cohort B: Arm B|Progressive disease|0
5884070|NCT01831089|20356944|P6|Cohort V: Dose Level 5|Lost to Follow-up|0
5884071|NCT01831089|20356945|P5|Cohort V: Dose Level 5|Lost to Follow-up|1
5884072|NCT01831089|20356946|P4|Cohort V: Dose Level 5|Lost to Follow-up|0
5884073|NCT01831089|20356947|P3|Cohort V: Dose Level 5|Lost to Follow-up|0
5884074|NCT01831089|20356948|P2|Cohort V: Dose Level 5|Lost to Follow-up|0
5884075|NCT01831089|20356949|P1|Cohort V: Dose Level 5|Lost to Follow-up|0
5884076|NCT01831089|20356944|P6|Cohort V: Dose Level 5|Global end of study|0
5884077|NCT01831089|20356945|P5|Cohort V: Dose Level 5|Global end of study|2
5884078|NCT01831089|20356946|P4|Cohort V: Dose Level 5|Global end of study|0
5884079|NCT01831089|20356947|P3|Cohort V: Dose Level 5|Global end of study|0
5884080|NCT01831089|20356948|P2|Cohort V: Dose Level 5|Global end of study|0
5884081|NCT01831089|20356949|P1|Cohort V: Dose Level 5|Global end of study|0
5884082|NCT01831089|20356944|P6|Cohort V: Dose Level 5|Death|0
5884083|NCT01831089|20356945|P5|Cohort V: Dose Level 5|Death|1
5884084|NCT01831089|20356946|P4|Cohort V: Dose Level 5|Death|0
5884085|NCT01831089|20356947|P3|Cohort V: Dose Level 5|Death|0
5884086|NCT01831089|20356948|P2|Cohort V: Dose Level 5|Death|0
5884087|NCT01831089|20356949|P1|Cohort V: Dose Level 5|Death|0
5884088|NCT01831089|20356944|P6|Cohort V: Dose Level 5|Withdrawal by Subject|0
5884089|NCT01831089|20356945|P5|Cohort V: Dose Level 5|Withdrawal by Subject|3
5884090|NCT01831089|20356946|P4|Cohort V: Dose Level 5|Withdrawal by Subject|0
5884091|NCT01831089|20356947|P3|Cohort V: Dose Level 5|Withdrawal by Subject|0
5884092|NCT01831089|20356948|P2|Cohort V: Dose Level 5|Withdrawal by Subject|0
5884093|NCT01831089|20356949|P1|Cohort V: Dose Level 5|Withdrawal by Subject|0
5884094|NCT01831089|20356944|P6|Cohort V: Dose Level 5|Progressive disease|0
5884095|NCT01831089|20356945|P5|Cohort V: Dose Level 5|Progressive disease|30
5884096|NCT01831089|20356946|P4|Cohort V: Dose Level 5|Progressive disease|0
5884097|NCT01831089|20356947|P3|Cohort V: Dose Level 5|Progressive disease|0
5884098|NCT01831089|20356948|P2|Cohort V: Dose Level 5|Progressive disease|0
5884099|NCT01831089|20356949|P1|Cohort V: Dose Level 5|Progressive disease|0
5884100|NCT01831089|20356944|P6|Cohort IV: Dose Level 4|Progressive disease|0
5884101|NCT01831089|20356945|P5|Cohort IV: Dose Level 4|Progressive disease|0
5884102|NCT01831089|20356946|P4|Cohort IV: Dose Level 4|Progressive disease|6
5884103|NCT01831089|20356947|P3|Cohort IV: Dose Level 4|Progressive disease|0
5884104|NCT01831089|20356948|P2|Cohort IV: Dose Level 4|Progressive disease|0
5884105|NCT01831089|20356949|P1|Cohort IV: Dose Level 4|Progressive disease|0
5884106|NCT01831089|20356944|P6|Cohort III: Dose Level 3|Global end of study|0
5884107|NCT01831089|20356945|P5|Cohort III: Dose Level 3|Global end of study|0
5884108|NCT01831089|20356946|P4|Cohort III: Dose Level 3|Global end of study|0
5884109|NCT01831089|20356947|P3|Cohort III: Dose Level 3|Global end of study|1
5884110|NCT01831089|20356948|P2|Cohort III: Dose Level 3|Global end of study|0
5884111|NCT01831089|20356949|P1|Cohort III: Dose Level 3|Global end of study|0
5884112|NCT01831089|20356944|P6|Cohort III: Dose Level 3|Adverse Event|0
5884113|NCT01831089|20356945|P5|Cohort III: Dose Level 3|Adverse Event|0
5884114|NCT01831089|20356946|P4|Cohort III: Dose Level 3|Adverse Event|0
5884115|NCT01831089|20356947|P3|Cohort III: Dose Level 3|Adverse Event|1
5884116|NCT01831089|20356948|P2|Cohort III: Dose Level 3|Adverse Event|0
5884117|NCT01831089|20356949|P1|Cohort III: Dose Level 3|Adverse Event|0
5884118|NCT01831089|20356944|P6|Cohort III: Dose Level 3|Withdrawal by Subject|0
5884119|NCT01831089|20356945|P5|Cohort III: Dose Level 3|Withdrawal by Subject|0
5884120|NCT01831089|20356946|P4|Cohort III: Dose Level 3|Withdrawal by Subject|0
5884121|NCT01831089|20356947|P3|Cohort III: Dose Level 3|Withdrawal by Subject|1
5884122|NCT01831089|20356948|P2|Cohort III: Dose Level 3|Withdrawal by Subject|0
5884123|NCT01831089|20356949|P1|Cohort III: Dose Level 3|Withdrawal by Subject|0
5884124|NCT01831089|20356944|P6|Cohort III: Dose Level 3|Progressive disease|0
5884125|NCT01831089|20356945|P5|Cohort III: Dose Level 3|Progressive disease|0
5884126|NCT01831089|20356946|P4|Cohort III: Dose Level 3|Progressive disease|0
5884127|NCT01831089|20356947|P3|Cohort III: Dose Level 3|Progressive disease|3
5884128|NCT01831089|20356948|P2|Cohort III: Dose Level 3|Progressive disease|0
5884129|NCT01831089|20356949|P1|Cohort III: Dose Level 3|Progressive disease|0
5884130|NCT01831089|20356944|P6|Cohort II: Dose Level 2|Clinical progressive disease|0
5884131|NCT01831089|20356945|P5|Cohort II: Dose Level 2|Clinical progressive disease|0
5884132|NCT01831089|20356946|P4|Cohort II: Dose Level 2|Clinical progressive disease|0
5884133|NCT01831089|20356947|P3|Cohort II: Dose Level 2|Clinical progressive disease|0
5884134|NCT01831089|20356948|P2|Cohort II: Dose Level 2|Clinical progressive disease|1
5884135|NCT01831089|20356949|P1|Cohort II: Dose Level 2|Clinical progressive disease|0
5884136|NCT01831089|20356944|P6|Cohort II: Dose Level 2|Progressive disease|0
5884137|NCT01831089|20356945|P5|Cohort II: Dose Level 2|Progressive disease|0
5884138|NCT01831089|20356946|P4|Cohort II: Dose Level 2|Progressive disease|0
5884139|NCT01831089|20356947|P3|Cohort II: Dose Level 2|Progressive disease|0
5884140|NCT01831089|20356948|P2|Cohort II: Dose Level 2|Progressive disease|2
5884141|NCT01831089|20356949|P1|Cohort II: Dose Level 2|Progressive disease|0
5884142|NCT01831089|20356944|P6|Cohort I: Dose Level 1|Progressive disease|0
5884143|NCT01831089|20356945|P5|Cohort I: Dose Level 1|Progressive disease|0
5884144|NCT01831089|20356946|P4|Cohort I: Dose Level 1|Progressive disease|0
5884145|NCT01831089|20356947|P3|Cohort I: Dose Level 1|Progressive disease|0
5884146|NCT01831089|20356948|P2|Cohort I: Dose Level 1|Progressive disease|0
5884147|NCT01831089|20356949|P1|Cohort I: Dose Level 1|Progressive disease|3
5884148|NCT01830972|20357000|P2|Part IV|Non-Compliance|0
5884149|NCT01830972|20357001|P1|Part IV|Non-Compliance|1
5884150|NCT01830972|20357000|P2|Part IV|Withdrawal by Subject|1
5884151|NCT01830972|20357001|P1|Part IV|Withdrawal by Subject|2
5884152|NCT01830972|20357000|P2|Part III|Noncompliance|0
5884153|NCT01830972|20357001|P1|Part III|Noncompliance|1
5884154|NCT01830972|20357000|P2|Part III|Withdrawal by Subject|0
5884155|NCT01830972|20357001|P1|Part III|Withdrawal by Subject|1
5884156|NCT01830972|20357000|P2|Part II|Withdrawal by Subject|2
5884157|NCT01830972|20357001|P1|Part II|Withdrawal by Subject|2
5884158|NCT01830920|20357045|P5|Overall Study|Other|3
5884159|NCT01830920|20357046|P4|Overall Study|Other|5
5884160|NCT01830920|20357047|P3|Overall Study|Other|1
5884161|NCT01830920|20357048|P2|Overall Study|Other|1
5884162|NCT01830920|20357049|P1|Overall Study|Other|15
5884163|NCT01830920|20357045|P5|Overall Study|Death|4
5884164|NCT01830920|20357046|P4|Overall Study|Death|4
5884165|NCT01830920|20357047|P3|Overall Study|Death|5
5884166|NCT01830920|20357048|P2|Overall Study|Death|3
5884167|NCT01830920|20357049|P1|Overall Study|Death|3
5884168|NCT01830920|20357045|P5|Overall Study|Withdrawal by Subject|1
5884169|NCT01830920|20357046|P4|Overall Study|Withdrawal by Subject|7
5884170|NCT01830920|20357047|P3|Overall Study|Withdrawal by Subject|1
5884171|NCT01830920|20357048|P2|Overall Study|Withdrawal by Subject|2
5884172|NCT01830920|20357049|P1|Overall Study|Withdrawal by Subject|2
5884173|NCT01830920|20357045|P5|Overall Study|Adverse Event|0
5884174|NCT01830920|20357046|P4|Overall Study|Adverse Event|0
5884175|NCT01830920|20357047|P3|Overall Study|Adverse Event|1
5884176|NCT01830920|20357048|P2|Overall Study|Adverse Event|0
5884177|NCT01830920|20357049|P1|Overall Study|Adverse Event|1
5884178|NCT01830881|20357088|P2|Overall Study|Changed decision to have an abortion|1
5884179|NCT01830881|20357089|P1|Overall Study|Changed decision to have an abortion|0
5884180|NCT01830855|20357137|P4|Overall Study|Lost to Follow-up|33
5884181|NCT01830855|20357138|P3|Overall Study|Lost to Follow-up|23
5884182|NCT01830855|20357139|P2|Overall Study|Lost to Follow-up|20
5884183|NCT01830855|20357140|P1|Overall Study|Lost to Follow-up|47
5884184|NCT01830855|20357137|P4|Overall Study|No longer willing to participate|17
5884185|NCT01830855|20357138|P3|Overall Study|No longer willing to participate|12
5884186|NCT01830855|20357139|P2|Overall Study|No longer willing to participate|13
5884187|NCT01830855|20357140|P1|Overall Study|No longer willing to participate|32
5884188|NCT01830855|20357137|P4|Overall Study|Withdrawal by Subject|12
5884189|NCT01830855|20357138|P3|Overall Study|Withdrawal by Subject|10
5884190|NCT01830855|20357139|P2|Overall Study|Withdrawal by Subject|14
5884191|NCT01830855|20357140|P1|Overall Study|Withdrawal by Subject|33
5884192|NCT01830855|20357137|P4|Overall Study|Protocol deviation|6
5884193|NCT01830855|20357138|P3|Overall Study|Protocol deviation|6
5884194|NCT01830855|20357139|P2|Overall Study|Protocol deviation|5
5884195|NCT01830855|20357140|P1|Overall Study|Protocol deviation|10
5884196|NCT01830855|20357137|P4|Overall Study|Adverse Event|3
5884197|NCT01830855|20357138|P3|Overall Study|Adverse Event|6
5884198|NCT01830855|20357139|P2|Overall Study|Adverse Event|5
5884199|NCT01830855|20357140|P1|Overall Study|Adverse Event|11
5884200|NCT01830855|20357137|P4|Overall Study|No longer meets eligibility criteria|5
5884201|NCT01830855|20357138|P3|Overall Study|No longer meets eligibility criteria|3
5884202|NCT01830855|20357139|P2|Overall Study|No longer meets eligibility criteria|2
5884203|NCT01830855|20357140|P1|Overall Study|No longer meets eligibility criteria|11
5884204|NCT01830855|20357137|P4|Overall Study|Pregnancy|1
5884205|NCT01830855|20357138|P3|Overall Study|Pregnancy|2
5884206|NCT01830855|20357139|P2|Overall Study|Pregnancy|1
5884207|NCT01830855|20357140|P1|Overall Study|Pregnancy|3
5884208|NCT01830855|20357137|P4|Overall Study|Medication error without associated AE|1
5884209|NCT01830855|20357138|P3|Overall Study|Medication error without associated AE|0
5884210|NCT01830855|20357139|P2|Overall Study|Medication error without associated AE|0
5884211|NCT01830855|20357140|P1|Overall Study|Medication error without associated AE|1
5884212|NCT01830855|20357137|P4|Overall Study|Other|4
5884213|NCT01830855|20357138|P3|Overall Study|Other|4
5884214|NCT01830855|20357139|P2|Overall Study|Other|1
5884215|NCT01830855|20357140|P1|Overall Study|Other|7
5884216|NCT01830816|20357256|P3|Overall Study|Reason not Specified|0
5884217|NCT01830816|20357257|P2|Overall Study|Reason not Specified|0
5884218|NCT01830816|20357258|P1|Overall Study|Reason not Specified|2
5884219|NCT01830816|20357256|P3|Overall Study|Symptomatic Deterioration|0
5884220|NCT01830816|20357257|P2|Overall Study|Symptomatic Deterioration|0
5884221|NCT01830816|20357258|P1|Overall Study|Symptomatic Deterioration|1
5884222|NCT01830816|20357256|P3|Overall Study|Lost to Follow-up|0
5884223|NCT01830816|20357257|P2|Overall Study|Lost to Follow-up|1
5884224|NCT01830816|20357258|P1|Overall Study|Lost to Follow-up|0
5884225|NCT01830816|20357256|P3|Overall Study|Withdrawal by Subject|0
5884226|NCT01830816|20357257|P2|Overall Study|Withdrawal by Subject|1
5884227|NCT01830816|20357258|P1|Overall Study|Withdrawal by Subject|1
5884228|NCT01830816|20357256|P3|Overall Study|Study Terminated by Sponsor|0
5884229|NCT01830816|20357257|P2|Overall Study|Study Terminated by Sponsor|1
5884230|NCT01830816|20357258|P1|Overall Study|Study Terminated by Sponsor|1
5884231|NCT01830816|20357256|P3|Overall Study|Adverse Event|0
5884232|NCT01830816|20357257|P2|Overall Study|Adverse Event|4
5884233|NCT01830816|20357258|P1|Overall Study|Adverse Event|3
5884234|NCT01830816|20357256|P3|Overall Study|Progressive Disease|7
5884235|NCT01830816|20357257|P2|Overall Study|Progressive Disease|7
5884236|NCT01830816|20357258|P1|Overall Study|Progressive Disease|12
5884237|NCT01830595|20357322|P2|Washout|Withdrawal by Subject|2
5884238|NCT01830595|20357323|P1|Washout|Withdrawal by Subject|2
5884239|NCT01830595|20357322|P2|First Period|Withdrawal by Subject|3
5884240|NCT01830595|20357323|P1|First Period|Withdrawal by Subject|1
5884241|NCT01830543|20357340|P3|Overall Study|Other|37
5884242|NCT01830543|20357341|P2|Overall Study|Other|17
5884243|NCT01830543|20357342|P1|Overall Study|Other|12
5884244|NCT01830543|20357340|P3|Overall Study|Withdrawal by consent|3
5884245|NCT01830543|20357341|P2|Overall Study|Withdrawal by consent|3
5884246|NCT01830543|20357342|P1|Overall Study|Withdrawal by consent|3
5884247|NCT01830543|20357340|P3|Overall Study|Physician Decision|12
5884248|NCT01830543|20357341|P2|Overall Study|Physician Decision|5
5884249|NCT01830543|20357342|P1|Overall Study|Physician Decision|11
5884250|NCT01830543|20357340|P3|Overall Study|Protocol Violation|7
5884251|NCT01830543|20357341|P2|Overall Study|Protocol Violation|7
5884252|NCT01830543|20357342|P1|Overall Study|Protocol Violation|3
5884253|NCT01830543|20357340|P3|Overall Study|Death|22
5884254|NCT01830543|20357341|P2|Overall Study|Death|22
5884255|NCT01830543|20357342|P1|Overall Study|Death|20
5884256|NCT01830543|20357340|P3|Overall Study|Adverse Event|76
5884257|NCT01830543|20357341|P2|Overall Study|Adverse Event|77
5884258|NCT01830543|20357342|P1|Overall Study|Adverse Event|91
5884259|NCT01830543|20357340|P3|Overall Study|Subject Decision|57
5884260|NCT01830543|20357341|P2|Overall Study|Subject Decision|21
5884261|NCT01830543|20357342|P1|Overall Study|Subject Decision|19
5884262|NCT01830127|20357474|P2|Overall Study|Other reason not defined above|2
5884263|NCT01830127|20357475|P1|Overall Study|Other reason not defined above|0
5884264|NCT01830127|20357474|P2|Overall Study|Withdrawal by Subject|1
5884265|NCT01830127|20357475|P1|Overall Study|Withdrawal by Subject|1
5884266|NCT01830127|20357474|P2|Overall Study|Lack of Efficacy|0
5884267|NCT01830127|20357475|P1|Overall Study|Lack of Efficacy|3
5884268|NCT01830127|20357474|P2|Overall Study|Adverse Event|6
5884269|NCT01830127|20357475|P1|Overall Study|Adverse Event|1
5884270|NCT01829711|20357508|P1|Overall Study|Due to lack of response|1
5884271|NCT01829711|20357508|P1|Overall Study|Due to progression of disease|13
5884272|NCT01829711|20357508|P1|Overall Study|Adverse Event|3
5884273|NCT01829711|20357508|P1|Overall Study|Started new therapies|17
5884274|NCT01829711|20357508|P1|Overall Study|Death|4
5884275|NCT01829711|20357508|P1|Overall Study|Withdrawal by Subject|3
5884276|NCT01829711|20357508|P1|Overall Study|Lost to Follow-up|2
5884277|NCT01829477|20357565|P2|Overall Study|Withdrawal by Subject|0
5884278|NCT01829477|20357566|P1|Overall Study|Withdrawal by Subject|1
5884279|NCT01829477|20357565|P2|Overall Study|Study Terminated by Sponsor|15
5884280|NCT01829477|20357566|P1|Overall Study|Study Terminated by Sponsor|15
5884281|NCT01829464|20357579|P3|Overall Study|Lack of Efficacy|0
5884282|NCT01829464|20357580|P2|Overall Study|Lack of Efficacy|1
5884283|NCT01829464|20357581|P1|Overall Study|Lack of Efficacy|0
5884284|NCT01829464|20357579|P3|Overall Study|Study terminated by sponsor|25
5884285|NCT01829464|20357580|P2|Overall Study|Study terminated by sponsor|28
5884286|NCT01829464|20357581|P1|Overall Study|Study terminated by sponsor|25
5884287|NCT01829464|20357579|P3|Overall Study|Withdrawal by Subject|0
5884288|NCT01829464|20357580|P2|Overall Study|Withdrawal by Subject|0
5884289|NCT01829464|20357581|P1|Overall Study|Withdrawal by Subject|2
5884290|NCT01829464|20357579|P3|Overall Study|Lost to Follow-up|1
5884291|NCT01829464|20357580|P2|Overall Study|Lost to Follow-up|0
5884292|NCT01829464|20357581|P1|Overall Study|Lost to Follow-up|0
5884293|NCT01829464|20357579|P3|Overall Study|Adverse Event|0
5884294|NCT01829464|20357580|P2|Overall Study|Adverse Event|0
5884295|NCT01829464|20357581|P1|Overall Study|Adverse Event|1
5884296|NCT01829425|20357597|P2|Overall Study|Lost to Follow-up|1
5884297|NCT01829425|20357598|P1|Overall Study|Lost to Follow-up|2
5884298|NCT01829425|20357597|P2|Overall Study|Withdrawal by Subject|3
5884299|NCT01829425|20357598|P1|Overall Study|Withdrawal by Subject|4
5884300|NCT01829360|20357641|P4|Overall Study|Protocol Violation|0
5884301|NCT01829360|20357642|P3|Overall Study|Protocol Violation|1
5884302|NCT01829360|20357643|P2|Overall Study|Protocol Violation|0
5884303|NCT01829360|20357644|P1|Overall Study|Protocol Violation|0
5884304|NCT01829347|20357664|P2|VTI-210E|Study terminated prematurely|5
5884305|NCT01829347|20357665|P1|VTI-210E|Study terminated prematurely|1
5884306|NCT01829347|20357664|P2|VTI-210E|Death|1
5884307|NCT01829347|20357665|P1|VTI-210E|Death|2
5884308|NCT01829347|20357664|P2|VTI-210|Withdrawal by Subject|0
5884309|NCT01829347|20357665|P1|VTI-210|Withdrawal by Subject|1
5884310|NCT01829347|20357664|P2|VTI-210|Death|3
5884311|NCT01829347|20357665|P1|VTI-210|Death|5
5884312|NCT01829295|20357675|P4|6-12 Months|Withdrawal by Subject|0
5884313|NCT01829295|20357676|P3|6-12 Months|Withdrawal by Subject|0
5884314|NCT01829295|20357677|P2|6-12 Months|Withdrawal by Subject|2
5884315|NCT01829295|20357678|P1|6-12 Months|Withdrawal by Subject|2
5884316|NCT01829295|20357675|P4|6-12 Months|Lost to Follow-up|0
5884317|NCT01829295|20357676|P3|6-12 Months|Lost to Follow-up|0
5884318|NCT01829295|20357677|P2|6-12 Months|Lost to Follow-up|0
5884319|NCT01829295|20357678|P1|6-12 Months|Lost to Follow-up|2
5884320|NCT01829295|20357675|P4|6-12 Months|Adverse Event|2
5884321|NCT01829295|20357676|P3|6-12 Months|Adverse Event|3
5884322|NCT01829295|20357677|P2|6-12 Months|Adverse Event|0
5884323|NCT01829295|20357678|P1|6-12 Months|Adverse Event|0
5884324|NCT01829295|20357675|P4|6-12 Months|Did not want to switch antimetabolites|11
5884325|NCT01829295|20357676|P3|6-12 Months|Did not want to switch antimetabolites|9
5884326|NCT01829295|20357677|P2|6-12 Months|Did not want to switch antimetabolites|0
5884327|NCT01829295|20357678|P1|6-12 Months|Did not want to switch antimetabolites|0
5884328|NCT01829243|20357688|P2|First Intervention|Screen Failure|2
5884329|NCT01829243|20357689|P1|First Intervention|Screen Failure|4
5884330|NCT01829230|20357703|P2|Overall Study|Lost to Follow-up|1
5884331|NCT01829230|20357704|P1|Overall Study|Lost to Follow-up|1
5884332|NCT01829230|20357703|P2|Overall Study|Withdrawal by Subject|1
5884333|NCT01829230|20357704|P1|Overall Study|Withdrawal by Subject|0
5884334|NCT01829230|20357703|P2|Overall Study|Protocol Violation|2
5884335|NCT01829230|20357704|P1|Overall Study|Protocol Violation|0
5884336|NCT01829191|20357718|P2|Overall Study|Subject was fit for ortho - k|1
5884337|NCT01829191|20357719|P1|Overall Study|Subject was fit for ortho - k|0
5884338|NCT01829191|20357718|P2|Overall Study|Lost to Follow-up|1
5884339|NCT01829191|20357719|P1|Overall Study|Lost to Follow-up|0
5884340|NCT01829191|20357718|P2|Overall Study|Withdrawal by Subject|3
5884341|NCT01829191|20357719|P1|Overall Study|Withdrawal by Subject|2
5884342|NCT01829191|20357718|P2|Overall Study|Protocol Violation|1
5884343|NCT01829191|20357719|P1|Overall Study|Protocol Violation|4
5884344|NCT01829191|20357718|P2|Overall Study|Lens handling difficulty|4
5884345|NCT01829191|20357719|P1|Overall Study|Lens handling difficulty|1
5884346|NCT01829191|20357718|P2|Overall Study|Lens discomfort|3
5884347|NCT01829191|20357719|P1|Overall Study|Lens discomfort|0
5884348|NCT01829191|20357718|P2|Overall Study|Relocation|1
5884349|NCT01829191|20357719|P1|Overall Study|Relocation|0
5884350|NCT01829165|20357728|P2|Overall Study|Did not complete intervention|0
5884351|NCT01829165|20357729|P1|Overall Study|Did not complete intervention|2
5884352|NCT01829113|20357737|P2|Overall Study|Physician Decision|1
5884353|NCT01829113|20357738|P1|Overall Study|Physician Decision|1
5884354|NCT01829113|20357737|P2|Overall Study|No Study Treatment Received|2
5884355|NCT01829113|20357738|P1|Overall Study|No Study Treatment Received|3
5884356|NCT01829113|20357737|P2|Overall Study|Sponsor Decision|1
5884357|NCT01829113|20357738|P1|Overall Study|Sponsor Decision|1
5884358|NCT01829113|20357737|P2|Overall Study|Death|6
5884359|NCT01829113|20357738|P1|Overall Study|Death|4
5884360|NCT01829113|20357737|P2|Overall Study|Withdrawal by Subject|10
5884361|NCT01829113|20357738|P1|Overall Study|Withdrawal by Subject|17
5884362|NCT01829113|20357737|P2|Overall Study|Adverse Event|10
5884363|NCT01829113|20357738|P1|Overall Study|Adverse Event|14
5884364|NCT01829113|20357737|P2|Overall Study|Disease Progression|48
5884365|NCT01829113|20357738|P1|Overall Study|Disease Progression|37
5884366|NCT01829048|20357755|P5|Overall Study|Withdrawal by Subject|0
5884367|NCT01829048|20357756|P4|Overall Study|Withdrawal by Subject|2
5884368|NCT01829048|20357757|P3|Overall Study|Withdrawal by Subject|0
5884369|NCT01829048|20357758|P2|Overall Study|Withdrawal by Subject|0
5884370|NCT01829048|20357759|P1|Overall Study|Withdrawal by Subject|0
5884371|NCT01828567|20357872|P2|Overall Study|Excluded - did not meet criteria|1
5884372|NCT01828567|20357873|P1|Overall Study|Excluded - did not meet criteria|4
5884373|NCT01828567|20357872|P2|Overall Study|Lost to Follow-up|9
5884374|NCT01828567|20357873|P1|Overall Study|Lost to Follow-up|27
5884375|NCT01828281|20357928|P2|Overall Study|Withdrawal by Subject|0
5884376|NCT01828281|20357929|P1|Overall Study|Withdrawal by Subject|1
5884377|NCT01828112|20357979|P2|Overall Study|Subject/guardian decision|8
5884378|NCT01828112|20357980|P1|Overall Study|Subject/guardian decision|6
5884379|NCT01828112|20357979|P2|Overall Study|Progressive disease|82
5884380|NCT01828112|20357980|P1|Overall Study|Progressive disease|56
5884381|NCT01828112|20357979|P2|Overall Study|Physician Decision|5
5884382|NCT01828112|20357980|P1|Overall Study|Physician Decision|5
5884383|NCT01828112|20357979|P2|Overall Study|Death|5
5884384|NCT01828112|20357980|P1|Overall Study|Death|9
5884385|NCT01828112|20357979|P2|Overall Study|Adverse Event|8
5884386|NCT01828112|20357980|P1|Overall Study|Adverse Event|6
5884387|NCT01828099|20357988|P2|Overall Study|Subject/guardian decision|23
5884388|NCT01828099|20357989|P1|Overall Study|Subject/guardian decision|7
5884389|NCT01828099|20357988|P2|Overall Study|Protocol Violation|0
5884390|NCT01828099|20357989|P1|Overall Study|Protocol Violation|1
5884391|NCT01828099|20357988|P2|Overall Study|Progressive disease|94
5884392|NCT01828099|20357989|P1|Overall Study|Progressive disease|51
5884393|NCT01828099|20357988|P2|Overall Study|Physician Decision|11
5884394|NCT01828099|20357989|P1|Overall Study|Physician Decision|7
5884395|NCT01828099|20357988|P2|Overall Study|Non-compliance with study treatment|0
5884396|NCT01828099|20357989|P1|Overall Study|Non-compliance with study treatment|2
5884397|NCT01828099|20357988|P2|Overall Study|Lost to Follow-up|0
5884398|NCT01828099|20357989|P1|Overall Study|Lost to Follow-up|2
5884399|NCT01828099|20357988|P2|Overall Study|Death|11
5884400|NCT01828099|20357989|P1|Overall Study|Death|9
5884401|NCT01828099|20357988|P2|Overall Study|Adverse Event|18
5884402|NCT01828099|20357989|P1|Overall Study|Adverse Event|15
5884403|NCT01828073|20357997|P2|Overall Study|Lost to Follow-up|2
5884404|NCT01828073|20357998|P1|Overall Study|Lost to Follow-up|1
5884405|NCT01828034|20358022|P4|Overall Study|Withdrawal by Subject|1
5884406|NCT01828034|20358023|P3|Overall Study|Withdrawal by Subject|0
5884407|NCT01828034|20358024|P2|Overall Study|Withdrawal by Subject|0
5884408|NCT01828034|20358025|P1|Overall Study|Withdrawal by Subject|0
5884409|NCT01828021|20358037|P1|Overall Study|Ileal obstruction, unrelated|1
5884410|NCT01828021|20358037|P1|Overall Study|Withdrawal by Subject|2
5884411|NCT01828021|20358037|P1|Overall Study|Lack of Efficacy|17
5884412|NCT01828021|20358037|P1|Overall Study|Adverse Event|5
5884413|NCT01827839|20358076|P1|Overall Study|Consent Withdrawal|2
5884414|NCT01827839|20358076|P1|Overall Study|Adverse Event|1
5884415|NCT01827670|20358121|P2|Overall Study|Lost to Follow-up|1
5884416|NCT01827670|20358122|P1|Overall Study|Lost to Follow-up|0
5884417|NCT01827670|20358121|P2|Overall Study|Withdrawal of Consent|2
5884418|NCT01827670|20358122|P1|Overall Study|Withdrawal of Consent|3
5884419|NCT01827592|20358141|P3|Overall Study|Others|3
5884420|NCT01827592|20358142|P2|Overall Study|Others|1
5884421|NCT01827592|20358143|P1|Overall Study|Others|0
5884422|NCT01827592|20358141|P3|Overall Study|Trial terminated by Sponsor|51
5884423|NCT01827592|20358142|P2|Overall Study|Trial terminated by Sponsor|53
5884424|NCT01827592|20358143|P1|Overall Study|Trial terminated by Sponsor|47
5884425|NCT01827592|20358141|P3|Overall Study|Patient's substantial non-compliance|6
5884426|NCT01827592|20358142|P2|Overall Study|Patient's substantial non-compliance|1
5884427|NCT01827592|20358143|P1|Overall Study|Patient's substantial non-compliance|1
5884428|NCT01827592|20358141|P3|Overall Study|Withdrawal by Subject|11
5884429|NCT01827592|20358142|P2|Overall Study|Withdrawal by Subject|11
5884430|NCT01827592|20358143|P1|Overall Study|Withdrawal by Subject|12
5884431|NCT01827592|20358141|P3|Overall Study|Lost to Follow-up|2
5884432|NCT01827592|20358142|P2|Overall Study|Lost to Follow-up|2
5884433|NCT01827592|20358143|P1|Overall Study|Lost to Follow-up|1
5884434|NCT01827592|20358141|P3|Overall Study|Protocol Violation|0
5884435|NCT01827592|20358142|P2|Overall Study|Protocol Violation|1
5884436|NCT01827592|20358143|P1|Overall Study|Protocol Violation|2
5884437|NCT01827592|20358141|P3|Overall Study|Physician Decision|1
5884438|NCT01827592|20358142|P2|Overall Study|Physician Decision|2
5884439|NCT01827592|20358143|P1|Overall Study|Physician Decision|0
5884440|NCT01827592|20358141|P3|Overall Study|Adverse Event|2
5884441|NCT01827592|20358142|P2|Overall Study|Adverse Event|9
5884442|NCT01827592|20358143|P1|Overall Study|Adverse Event|11
5884443|NCT01827371|20358208|P4|Overall Study|Temporary study halt to vaccinations|13
5884444|NCT01827371|20358209|P3|Overall Study|Temporary study halt to vaccinations|5
5884445|NCT01827371|20358210|P2|Overall Study|Temporary study halt to vaccinations|2
5884446|NCT01827371|20358211|P1|Overall Study|Temporary study halt to vaccinations|11
5884447|NCT01827371|20358208|P4|Overall Study|Physician Decision|1
5884448|NCT01827371|20358209|P3|Overall Study|Physician Decision|0
5884449|NCT01827371|20358210|P2|Overall Study|Physician Decision|1
5884450|NCT01827371|20358211|P1|Overall Study|Physician Decision|0
5884451|NCT01827371|20358208|P4|Overall Study|Withdrawal by Subject|3
5884452|NCT01827371|20358209|P3|Overall Study|Withdrawal by Subject|2
5884453|NCT01827371|20358210|P2|Overall Study|Withdrawal by Subject|2
5884454|NCT01827371|20358211|P1|Overall Study|Withdrawal by Subject|1
5884455|NCT01827371|20358208|P4|Overall Study|Protocol Violation|0
5884456|NCT01827371|20358209|P3|Overall Study|Protocol Violation|0
5884457|NCT01827371|20358210|P2|Overall Study|Protocol Violation|0
5884458|NCT01827371|20358211|P1|Overall Study|Protocol Violation|1
5884459|NCT01827371|20358208|P4|Overall Study|Lost to Follow-up|4
5884460|NCT01827371|20358209|P3|Overall Study|Lost to Follow-up|0
5884461|NCT01827371|20358210|P2|Overall Study|Lost to Follow-up|2
5884462|NCT01827371|20358211|P1|Overall Study|Lost to Follow-up|0
5884463|NCT01827371|20358208|P4|Overall Study|Adverse Event|2
5884464|NCT01827371|20358209|P3|Overall Study|Adverse Event|4
5884465|NCT01827371|20358210|P2|Overall Study|Adverse Event|0
5884466|NCT01827371|20358211|P1|Overall Study|Adverse Event|0
5884467|NCT01827332|20358270|P2|Overall Study|Lost to Follow-up|1
5884468|NCT01827332|20358271|P1|Overall Study|Lost to Follow-up|2
5884469|NCT01827319|20358279|P1|Overall Study|Lost to Follow-up|3
5884470|NCT01827267|20358302|P2|Overall Study|Still on study|2
5884471|NCT01827267|20358303|P1|Overall Study|Still on study|0
5884472|NCT01827267|20358302|P2|Overall Study|Sponsor Discontinued Study|8
5884473|NCT01827267|20358303|P1|Overall Study|Sponsor Discontinued Study|2
5884474|NCT01827267|20358302|P2|Overall Study|Disease Progression|1
5884475|NCT01827267|20358303|P1|Overall Study|Disease Progression|1
5884476|NCT01827267|20358302|P2|Overall Study|Physician Decision|0
5884477|NCT01827267|20358303|P1|Overall Study|Physician Decision|1
5884478|NCT01827267|20358302|P2|Overall Study|Did not receive study drug|1
5884479|NCT01827267|20358303|P1|Overall Study|Did not receive study drug|1
5884480|NCT01827254|20358318|P1|Overall Study|Intolerance to treatment|4
5884481|NCT01827254|20358318|P1|Overall Study|Disease progression|36
5884482|NCT01827254|20358318|P1|Overall Study|Did not complete re-challenge|1
5884483|NCT01827254|20358318|P1|Overall Study|Discontinued prior initiation: sunitinib|1
5884484|NCT01827254|20358318|P1|Overall Study|Invalidated centre|3
5884485|NCT01827254|20358318|P1|Overall Study|Case report form not completed|4
5884486|NCT01827254|20358318|P1|Overall Study|Death|10
5884487|NCT01827163|20358328|P1|Overall Study|Adverse Event|9
5884488|NCT01827163|20358328|P1|Overall Study|Hypersensitivity reaction to Paclitaxel|2
5884489|NCT01827046|20358335|P2|Overall Study|Withdrawal by Subject|4
5884490|NCT01827046|20358336|P1|Overall Study|Withdrawal by Subject|0
5884491|NCT01827046|20358335|P2|Overall Study|Lost to Follow-up|5
5884492|NCT01827046|20358336|P1|Overall Study|Lost to Follow-up|1
5884493|NCT01826981|20358391|P15|Overall Study|Enrolled/Randomized but Not Treated|0
5884494|NCT01826981|20358392|P14|Overall Study|Enrolled/Randomized but Not Treated|0
5884495|NCT01826981|20358393|P13|Overall Study|Enrolled/Randomized but Not Treated|0
5884496|NCT01826981|20358394|P12|Overall Study|Enrolled/Randomized but Not Treated|0
5884497|NCT01826981|20358395|P11|Overall Study|Enrolled/Randomized but Not Treated|0
5884498|NCT01826981|20358396|P10|Overall Study|Enrolled/Randomized but Not Treated|0
5884499|NCT01826981|20358397|P9|Overall Study|Enrolled/Randomized but Not Treated|0
5884500|NCT01826981|20358398|P8|Overall Study|Enrolled/Randomized but Not Treated|1
5884501|NCT01826981|20358399|P7|Overall Study|Enrolled/Randomized but Not Treated|0
5884502|NCT01826981|20358400|P6|Overall Study|Enrolled/Randomized but Not Treated|0
5884503|NCT01826981|20358401|P5|Overall Study|Enrolled/Randomized but Not Treated|0
5884504|NCT01826981|20358402|P4|Overall Study|Enrolled/Randomized but Not Treated|0
5884505|NCT01826981|20358403|P3|Overall Study|Enrolled/Randomized but Not Treated|0
5884506|NCT01826981|20358404|P2|Overall Study|Enrolled/Randomized but Not Treated|0
5884507|NCT01826981|20358405|P1|Overall Study|Enrolled/Randomized but Not Treated|0
5884508|NCT01826981|20358391|P15|Overall Study|Upper G-I Haemorrhage|0
5884509|NCT01826981|20358392|P14|Overall Study|Upper G-I Haemorrhage|1
5884510|NCT01826981|20358393|P13|Overall Study|Upper G-I Haemorrhage|0
5884511|NCT01826981|20358394|P12|Overall Study|Upper G-I Haemorrhage|0
5884512|NCT01826981|20358395|P11|Overall Study|Upper G-I Haemorrhage|0
5884513|NCT01826981|20358396|P10|Overall Study|Upper G-I Haemorrhage|0
5884514|NCT01826981|20358397|P9|Overall Study|Upper G-I Haemorrhage|0
5884515|NCT01826981|20358398|P8|Overall Study|Upper G-I Haemorrhage|0
5884516|NCT01826981|20358399|P7|Overall Study|Upper G-I Haemorrhage|0
5884517|NCT01826981|20358400|P6|Overall Study|Upper G-I Haemorrhage|0
5884518|NCT01826981|20358401|P5|Overall Study|Upper G-I Haemorrhage|0
5884519|NCT01826981|20358402|P4|Overall Study|Upper G-I Haemorrhage|0
5884520|NCT01826981|20358403|P3|Overall Study|Upper G-I Haemorrhage|0
5884521|NCT01826981|20358404|P2|Overall Study|Upper G-I Haemorrhage|0
5884522|NCT01826981|20358405|P1|Overall Study|Upper G-I Haemorrhage|0
5884523|NCT01826981|20358391|P15|Overall Study|Adverse Event|0
5884524|NCT01826981|20358392|P14|Overall Study|Adverse Event|0
5884525|NCT01826981|20358393|P13|Overall Study|Adverse Event|0
5884526|NCT01826981|20358394|P12|Overall Study|Adverse Event|0
5884527|NCT01826981|20358395|P11|Overall Study|Adverse Event|0
5884528|NCT01826981|20358396|P10|Overall Study|Adverse Event|0
5884529|NCT01826981|20358397|P9|Overall Study|Adverse Event|0
5884530|NCT01826981|20358398|P8|Overall Study|Adverse Event|0
5884531|NCT01826981|20358399|P7|Overall Study|Adverse Event|0
5884532|NCT01826981|20358400|P6|Overall Study|Adverse Event|0
5884533|NCT01826981|20358401|P5|Overall Study|Adverse Event|1
5884534|NCT01826981|20358402|P4|Overall Study|Adverse Event|0
5884535|NCT01826981|20358403|P3|Overall Study|Adverse Event|0
5884536|NCT01826981|20358404|P2|Overall Study|Adverse Event|0
5884537|NCT01826981|20358405|P1|Overall Study|Adverse Event|0
5884538|NCT01826981|20358391|P15|Overall Study|Withdrew Consent|0
5884539|NCT01826981|20358392|P14|Overall Study|Withdrew Consent|1
5884540|NCT01826981|20358393|P13|Overall Study|Withdrew Consent|0
5884541|NCT01826981|20358394|P12|Overall Study|Withdrew Consent|1
5884542|NCT01826981|20358395|P11|Overall Study|Withdrew Consent|0
5884543|NCT01826981|20358396|P10|Overall Study|Withdrew Consent|0
5884544|NCT01826981|20358397|P9|Overall Study|Withdrew Consent|0
5884545|NCT01826981|20358398|P8|Overall Study|Withdrew Consent|1
5884546|NCT01826981|20358399|P7|Overall Study|Withdrew Consent|1
5884547|NCT01826981|20358400|P6|Overall Study|Withdrew Consent|0
5884548|NCT01826981|20358401|P5|Overall Study|Withdrew Consent|0
5884549|NCT01826981|20358402|P4|Overall Study|Withdrew Consent|0
5884550|NCT01826981|20358403|P3|Overall Study|Withdrew Consent|0
5884551|NCT01826981|20358404|P2|Overall Study|Withdrew Consent|0
5884552|NCT01826981|20358405|P1|Overall Study|Withdrew Consent|0
5884553|NCT01826981|20358391|P15|Overall Study|Lost to Follow-up|0
5884554|NCT01826981|20358392|P14|Overall Study|Lost to Follow-up|0
5884555|NCT01826981|20358393|P13|Overall Study|Lost to Follow-up|1
5884556|NCT01826981|20358394|P12|Overall Study|Lost to Follow-up|1
5884557|NCT01826981|20358395|P11|Overall Study|Lost to Follow-up|1
5884558|NCT01826981|20358396|P10|Overall Study|Lost to Follow-up|1
5884559|NCT01826981|20358397|P9|Overall Study|Lost to Follow-up|0
5884560|NCT01826981|20358398|P8|Overall Study|Lost to Follow-up|1
5884561|NCT01826981|20358399|P7|Overall Study|Lost to Follow-up|0
5884562|NCT01826981|20358400|P6|Overall Study|Lost to Follow-up|1
5884563|NCT01826981|20358401|P5|Overall Study|Lost to Follow-up|1
5884564|NCT01826981|20358402|P4|Overall Study|Lost to Follow-up|0
5884565|NCT01826981|20358403|P3|Overall Study|Lost to Follow-up|0
5884566|NCT01826981|20358404|P2|Overall Study|Lost to Follow-up|0
5884567|NCT01826981|20358405|P1|Overall Study|Lost to Follow-up|0
5884568|NCT01826981|20358391|P15|Overall Study|Lack of Efficacy|0
5884569|NCT01826981|20358392|P14|Overall Study|Lack of Efficacy|3
5884570|NCT01826981|20358393|P13|Overall Study|Lack of Efficacy|0
5884571|NCT01826981|20358394|P12|Overall Study|Lack of Efficacy|0
5884572|NCT01826981|20358395|P11|Overall Study|Lack of Efficacy|1
5884573|NCT01826981|20358396|P10|Overall Study|Lack of Efficacy|0
5884574|NCT01826981|20358397|P9|Overall Study|Lack of Efficacy|7
5884575|NCT01826981|20358398|P8|Overall Study|Lack of Efficacy|8
5884576|NCT01826981|20358399|P7|Overall Study|Lack of Efficacy|0
5884577|NCT01826981|20358400|P6|Overall Study|Lack of Efficacy|0
5884578|NCT01826981|20358401|P5|Overall Study|Lack of Efficacy|5
5884579|NCT01826981|20358402|P4|Overall Study|Lack of Efficacy|0
5884580|NCT01826981|20358403|P3|Overall Study|Lack of Efficacy|0
5884581|NCT01826981|20358404|P2|Overall Study|Lack of Efficacy|1
5884582|NCT01826981|20358405|P1|Overall Study|Lack of Efficacy|0
5884583|NCT01826604|20358591|P2|Overall Study|Lost to Follow-up|9
5884584|NCT01826604|20358592|P1|Overall Study|Lost to Follow-up|8
5884585|NCT01826487|20358636|P2|Overall Study|Protocol Violation|1
5884586|NCT01826487|20358637|P1|Overall Study|Protocol Violation|1
5884587|NCT01826487|20358636|P2|Overall Study|Withdrawal by Subject|3
5884588|NCT01826487|20358637|P1|Overall Study|Withdrawal by Subject|1
5884589|NCT01826487|20358636|P2|Overall Study|Lost to Follow-up|0
5884590|NCT01826487|20358637|P1|Overall Study|Lost to Follow-up|1
5884591|NCT01826487|20358636|P2|Overall Study|Adverse Event|1
5884592|NCT01826487|20358637|P1|Overall Study|Adverse Event|1
5884593|NCT01826448|20358664|P2|Overall Study|2 active cancers|1
5884594|NCT01826448|20358665|P1|Overall Study|2 active cancers|0
5884595|NCT01826448|20358664|P2|Overall Study|Physician Decision|1
5884596|NCT01826448|20358665|P1|Overall Study|Physician Decision|0
5884597|NCT01826448|20358664|P2|Overall Study|Withdrawal by Subject|0
5884598|NCT01826448|20358665|P1|Overall Study|Withdrawal by Subject|1
5884599|NCT01826448|20358664|P2|Overall Study|Disease progression|4
5884600|NCT01826448|20358665|P1|Overall Study|Disease progression|2
5884601|NCT01826448|20358664|P2|Overall Study|Adverse Event|3
5884602|NCT01826448|20358665|P1|Overall Study|Adverse Event|1
5884603|NCT01826422|20358673|P2|Overall Study|Withdrawal by Subject|3
5884604|NCT01826422|20358674|P1|Overall Study|Withdrawal by Subject|1
5884605|NCT01826370|20358718|P1|Overall Study|Other reason not defined above|2
5884606|NCT01826370|20358718|P1|Overall Study|Lost to Follow-up|12
5884607|NCT01826370|20358718|P1|Overall Study|Protocol Violation|6
5884608|NCT01826214|20358730|P2|Overall Study|Subject/guardian decision|3
5884609|NCT01826214|20358731|P1|Overall Study|Subject/guardian decision|2
5884610|NCT01826214|20358730|P2|Overall Study|Study terminated by Sponsor|1
5884611|NCT01826214|20358731|P1|Overall Study|Study terminated by Sponsor|0
5884612|NCT01826214|20358730|P2|Overall Study|Progressive disease|21
5884613|NCT01826214|20358731|P1|Overall Study|Progressive disease|22
5884614|NCT01826214|20358730|P2|Overall Study|Physician Decision|2
5884615|NCT01826214|20358731|P1|Overall Study|Physician Decision|0
5884616|NCT01826214|20358730|P2|Overall Study|Lost to Follow-up|0
5884617|NCT01826214|20358731|P1|Overall Study|Lost to Follow-up|1
5884618|NCT01826214|20358730|P2|Overall Study|Death|1
5884619|NCT01826214|20358731|P1|Overall Study|Death|3
5884620|NCT01826214|20358730|P2|Overall Study|Adverse Event|6
5884621|NCT01826214|20358731|P1|Overall Study|Adverse Event|7
5884622|NCT01826201|20358749|P1|Overall Study|Non compliance with protocol|4
5884623|NCT01825941|20358757|P2|Overall Study|Lost to Follow-up|1
5884624|NCT01825941|20358758|P1|Overall Study|Lost to Follow-up|4
5884625|NCT01825876|20358777|P2|Period 2|Withdrawal by Subject|1
5884626|NCT01825876|20358778|P1|Period 2|Withdrawal by Subject|0
5884627|NCT01825837|20358799|P4|PART II|reason unspecified|0
5884628|NCT01825837|20358800|P3|PART II|reason unspecified|2
5884629|NCT01825837|20358801|P2|PART II|reason unspecified|2
5884630|NCT01825837|20358802|P1|PART II|reason unspecified|2
5884631|NCT01825837|20358799|P4|PART II|Treatment failure|0
5884632|NCT01825837|20358800|P3|PART II|Treatment failure|5
5884633|NCT01825837|20358801|P2|PART II|Treatment failure|4
5884634|NCT01825837|20358802|P1|PART II|Treatment failure|6
5884635|NCT01825837|20358799|P4|PART II|Adverse Event|0
5884636|NCT01825837|20358800|P3|PART II|Adverse Event|1
5884637|NCT01825837|20358801|P2|PART II|Adverse Event|3
5884638|NCT01825837|20358802|P1|PART II|Adverse Event|3
5884639|NCT01825837|20358799|P4|PART II|Patient non-compliance|0
5884640|NCT01825837|20358800|P3|PART II|Patient non-compliance|4
5884641|NCT01825837|20358801|P2|PART II|Patient non-compliance|2
5884642|NCT01825837|20358802|P1|PART II|Patient non-compliance|5
5884643|NCT01825837|20358799|P4|PART II|Withdrawal by Subject|0
5884644|NCT01825837|20358800|P3|PART II|Withdrawal by Subject|7
5884645|NCT01825837|20358801|P2|PART II|Withdrawal by Subject|3
5884646|NCT01825837|20358802|P1|PART II|Withdrawal by Subject|3
5884647|NCT01825837|20358799|P4|PART I|reason unspecified|3
5884648|NCT01825837|20358800|P3|PART I|reason unspecified|0
5884649|NCT01825837|20358801|P2|PART I|reason unspecified|0
5884650|NCT01825837|20358802|P1|PART I|reason unspecified|0
5884651|NCT01825837|20358799|P4|PART I|Treatment failure|7
5884652|NCT01825837|20358800|P3|PART I|Treatment failure|0
5884653|NCT01825837|20358801|P2|PART I|Treatment failure|0
5884654|NCT01825837|20358802|P1|PART I|Treatment failure|0
5884655|NCT01825837|20358799|P4|PART I|Patient non-compliance|1
5884656|NCT01825837|20358800|P3|PART I|Patient non-compliance|0
5884657|NCT01825837|20358801|P2|PART I|Patient non-compliance|0
5884658|NCT01825837|20358802|P1|PART I|Patient non-compliance|0
5884659|NCT01825837|20358799|P4|PART I|Withdrawal by Subject|6
5884660|NCT01825837|20358800|P3|PART I|Withdrawal by Subject|0
5884661|NCT01825837|20358801|P2|PART I|Withdrawal by Subject|0
5884662|NCT01825837|20358802|P1|PART I|Withdrawal by Subject|0
5884663|NCT01825798|20358812|P2|Overall Study|Lost to Follow-up|0
5884664|NCT01825798|20358813|P1|Overall Study|Lost to Follow-up|1
5884665|NCT01825798|20358812|P2|Overall Study|Adverse Event|5
5884666|NCT01825798|20358813|P1|Overall Study|Adverse Event|1
5884667|NCT01825785|20358848|P7|Overall Study|Withdrawal by Subject|0
5884668|NCT01825785|20358849|P6|Overall Study|Withdrawal by Subject|1
5884669|NCT01825785|20358850|P5|Overall Study|Withdrawal by Subject|1
5884670|NCT01825785|20358851|P4|Overall Study|Withdrawal by Subject|0
5884671|NCT01825785|20358852|P3|Overall Study|Withdrawal by Subject|0
5884672|NCT01825785|20358853|P2|Overall Study|Withdrawal by Subject|0
5884673|NCT01825785|20358854|P1|Overall Study|Withdrawal by Subject|0
5884674|NCT01825785|20358848|P7|Overall Study|Adverse Event|0
5884675|NCT01825785|20358849|P6|Overall Study|Adverse Event|0
5884676|NCT01825785|20358850|P5|Overall Study|Adverse Event|1
5884677|NCT01825785|20358851|P4|Overall Study|Adverse Event|0
5884678|NCT01825785|20358852|P3|Overall Study|Adverse Event|0
5884679|NCT01825785|20358853|P2|Overall Study|Adverse Event|0
5884680|NCT01825785|20358854|P1|Overall Study|Adverse Event|0
5884681|NCT01825577|20359007|P1|Overall Study|Lack of Efficacy|3
5884682|NCT01825577|20359007|P1|Overall Study|Withdrawn by family members|2
5884683|NCT01825577|20359007|P1|Overall Study|Withdrawal by Subject|1
5884684|NCT01825577|20359007|P1|Overall Study|Physician Decision|2
5884685|NCT01825200|20359031|P2|Overall Study|Withdrawal by Subject|1
5884686|NCT01825200|20359032|P1|Overall Study|Withdrawal by Subject|0
5884687|NCT01825200|20359031|P2|Overall Study|Lost to Follow-up|6
5884688|NCT01825200|20359032|P1|Overall Study|Lost to Follow-up|5
5884689|NCT01824979|20359055|P2|Overall Study|Protocol Violation|13
5884690|NCT01824979|20359056|P1|Overall Study|Protocol Violation|6
5884691|NCT01824979|20359055|P2|Overall Study|Physician Decision|0
5884692|NCT01824979|20359056|P1|Overall Study|Physician Decision|2
5884693|NCT01824979|20359055|P2|Overall Study|Withdrawal by Subject|0
5884694|NCT01824979|20359056|P1|Overall Study|Withdrawal by Subject|5
5884695|NCT01824823|20359073|P2|Overall Study|Off-treatment reason not submitted|0
5884696|NCT01824823|20359074|P1|Overall Study|Off-treatment reason not submitted|1
5884697|NCT01824823|20359073|P2|Overall Study|Lack of Efficacy|1
5884698|NCT01824823|20359074|P1|Overall Study|Lack of Efficacy|1
5884699|NCT01824693|20359083|P3|Overall Study|No Transplant Planned|10
5884700|NCT01824693|20359084|P2|Overall Study|No Transplant Planned|0
5884701|NCT01824693|20359085|P1|Overall Study|No Transplant Planned|0
5884702|NCT01824693|20359083|P3|Overall Study|Ineligible|3
5884703|NCT01824693|20359084|P2|Overall Study|Ineligible|0
5884704|NCT01824693|20359085|P1|Overall Study|Ineligible|0
5884705|NCT01824693|20359083|P3|Overall Study|Progressive Disease|0
5884706|NCT01824693|20359084|P2|Overall Study|Progressive Disease|5
5884707|NCT01824693|20359085|P1|Overall Study|Progressive Disease|0
5884708|NCT01824693|20359083|P3|Overall Study|Withdrawal by Subject|1
5884709|NCT01824693|20359084|P2|Overall Study|Withdrawal by Subject|0
5884710|NCT01824693|20359085|P1|Overall Study|Withdrawal by Subject|0
5884711|NCT01824693|20359083|P3|Overall Study|Physician Decision|1
5884712|NCT01824693|20359084|P2|Overall Study|Physician Decision|1
5884713|NCT01824693|20359085|P1|Overall Study|Physician Decision|1
5884714|NCT01824693|20359083|P3|Overall Study|Death|0
5884715|NCT01824693|20359084|P2|Overall Study|Death|1
5884716|NCT01824693|20359085|P1|Overall Study|Death|0
5884717|NCT01824602|20359102|P4|Overall Study|Treatment failure|1
5884718|NCT01824602|20359103|P3|Overall Study|Treatment failure|0
5884719|NCT01824602|20359104|P2|Overall Study|Treatment failure|0
5884720|NCT01824602|20359105|P1|Overall Study|Treatment failure|0
5884721|NCT01824602|20359102|P4|Overall Study|Adverse Event|2
5884722|NCT01824602|20359103|P3|Overall Study|Adverse Event|2
5884723|NCT01824602|20359104|P2|Overall Study|Adverse Event|0
5884724|NCT01824602|20359105|P1|Overall Study|Adverse Event|1
5884725|NCT01824602|20359102|P4|Overall Study|Patient non-compliance|0
5884726|NCT01824602|20359103|P3|Overall Study|Patient non-compliance|1
5884727|NCT01824602|20359104|P2|Overall Study|Patient non-compliance|0
5884728|NCT01824602|20359105|P1|Overall Study|Patient non-compliance|0
5884729|NCT01824602|20359102|P4|Overall Study|Withdrawal by Subject|2
5884730|NCT01824602|20359103|P3|Overall Study|Withdrawal by Subject|1
5884731|NCT01824602|20359104|P2|Overall Study|Withdrawal by Subject|0
5884732|NCT01824602|20359105|P1|Overall Study|Withdrawal by Subject|0
5884733|NCT01824576|20359144|P1|Overall Study|Device deficiency|2
5884734|NCT01824498|20359162|P6|Washout (8 Weeks)|Withdrawal by Subject|0
5884735|NCT01824498|20359163|P5|Washout (8 Weeks)|Withdrawal by Subject|1
5884736|NCT01824498|20359164|P4|Washout (8 Weeks)|Withdrawal by Subject|1
5884737|NCT01824498|20359165|P3|Washout (8 Weeks)|Withdrawal by Subject|2
5884738|NCT01824498|20359166|P2|Washout (8 Weeks)|Withdrawal by Subject|0
5884739|NCT01824498|20359167|P1|Washout (8 Weeks)|Withdrawal by Subject|2
5884740|NCT01824472|20359178|P3|Overall Study|Ineligible post randomization&screening|0
5884741|NCT01824472|20359179|P2|Overall Study|Ineligible post randomization&screening|2
5884742|NCT01824472|20359180|P1|Overall Study|Ineligible post randomization&screening|0
5884743|NCT01824472|20359178|P3|Overall Study|Withdrawal by Subject|3
5884744|NCT01824472|20359179|P2|Overall Study|Withdrawal by Subject|5
5884745|NCT01824472|20359180|P1|Overall Study|Withdrawal by Subject|1
5884746|NCT01824472|20359178|P3|Overall Study|Lost to Follow-up|1
5884747|NCT01824472|20359179|P2|Overall Study|Lost to Follow-up|0
5884748|NCT01824472|20359180|P1|Overall Study|Lost to Follow-up|0
5884749|NCT01824394|20359214|P3|Overall Study|Excluded Subjects(No catheter inserted)|21
5884750|NCT01824394|20359215|P2|Overall Study|Excluded Subjects(No catheter inserted)|20
5884751|NCT01824394|20359216|P1|Overall Study|Excluded Subjects(No catheter inserted)|23
5884752|NCT01824394|20359214|P3|Overall Study|Discontinued Subjects|2
5884753|NCT01824394|20359215|P2|Overall Study|Discontinued Subjects|1
5884754|NCT01824394|20359216|P1|Overall Study|Discontinued Subjects|1
5884755|NCT01824394|20359214|P3|Overall Study|Death|4
5884756|NCT01824394|20359215|P2|Overall Study|Death|2
5884757|NCT01824394|20359216|P1|Overall Study|Death|3
5884758|NCT01824394|20359214|P3|Overall Study|Lost to Follow-up|3
5884759|NCT01824394|20359215|P2|Overall Study|Lost to Follow-up|9
5884760|NCT01824394|20359216|P1|Overall Study|Lost to Follow-up|0
5884761|NCT01824394|20359214|P3|Overall Study|Withdrawn due to Study Termination|41
5884762|NCT01824394|20359215|P2|Overall Study|Withdrawn due to Study Termination|83
5884763|NCT01824394|20359216|P1|Overall Study|Withdrawn due to Study Termination|91
5884764|NCT01824394|20359214|P3|Overall Study|Early Termination|3
5884765|NCT01824394|20359215|P2|Overall Study|Early Termination|1
5884766|NCT01824394|20359216|P1|Overall Study|Early Termination|1
5884767|NCT01824355|20359226|P1|Overall Study|unevaluable reference method results per|1
5884768|NCT01824355|20359226|P1|Overall Study|Adverse Event|2
5884769|NCT01824342|20359237|P2|Overall Study|Death|0
5884770|NCT01824342|20359238|P1|Overall Study|Death|2
5884771|NCT01824342|20359237|P2|Overall Study|Physician Decision|0
5884772|NCT01824342|20359238|P1|Overall Study|Physician Decision|5
5884773|NCT01824342|20359237|P2|Overall Study|Disease Progression|1
5884774|NCT01824342|20359238|P1|Overall Study|Disease Progression|1
5884775|NCT01824342|20359237|P2|Overall Study|Adverse Event|1
5884776|NCT01824342|20359238|P1|Overall Study|Adverse Event|1
5884777|NCT01824342|20359237|P2|Overall Study|Withdrawal by Subject|3
5884778|NCT01824342|20359238|P1|Overall Study|Withdrawal by Subject|0
5884779|NCT01824303|20359252|P2|Randomized Study|Other Miscellaneous Reasons|0
5884780|NCT01824303|20359253|P1|Randomized Study|Other Miscellaneous Reasons|1
5884781|NCT01824303|20359252|P2|Randomized Study|Withdrawal by Subject|1
5884782|NCT01824303|20359253|P1|Randomized Study|Withdrawal by Subject|1
5884783|NCT01824290|20359279|P2|Overall Study|Investigator Reported Clinical Worsening|1
5884784|NCT01824290|20359280|P1|Overall Study|Investigator Reported Clinical Worsening|1
5884785|NCT01824290|20359279|P2|Overall Study|Parent/Caregiver Decision|1
5884786|NCT01824290|20359280|P1|Overall Study|Parent/Caregiver Decision|1
5884787|NCT01824290|20359279|P2|Overall Study|Entry Criteria Not Met|0
5884788|NCT01824290|20359280|P1|Overall Study|Entry Criteria Not Met|1
5884789|NCT01823991|20359298|P2|Overall Study|Withdrawal by Subject|5
5884790|NCT01823991|20359299|P1|Overall Study|Withdrawal by Subject|8
5884791|NCT01823679|20359340|P1|Overall Study|Death|1
5884792|NCT01823536|20359393|P6|Overall Study|Subject moved out of the state|0
5884793|NCT01823536|20359394|P5|Overall Study|Subject moved out of the state|1
5884794|NCT01823536|20359395|P4|Overall Study|Subject moved out of the state|0
5884795|NCT01823536|20359396|P3|Overall Study|Subject moved out of the state|0
5884796|NCT01823536|20359397|P2|Overall Study|Subject moved out of the state|0
5884797|NCT01823536|20359398|P1|Overall Study|Subject moved out of the state|0
5884798|NCT01823536|20359393|P6|Overall Study|Met exclusion criterion No 6|0
5884799|NCT01823536|20359394|P5|Overall Study|Met exclusion criterion No 6|0
5884800|NCT01823536|20359395|P4|Overall Study|Met exclusion criterion No 6|1
5884801|NCT01823536|20359396|P3|Overall Study|Met exclusion criterion No 6|0
5884802|NCT01823536|20359397|P2|Overall Study|Met exclusion criterion No 6|0
5884803|NCT01823536|20359398|P1|Overall Study|Met exclusion criterion No 6|0
5884804|NCT01823536|20359393|P6|Overall Study|Visit 1 delayed, unable to reschedule|0
5884805|NCT01823536|20359394|P5|Overall Study|Visit 1 delayed, unable to reschedule|0
5884806|NCT01823536|20359395|P4|Overall Study|Visit 1 delayed, unable to reschedule|0
5884807|NCT01823536|20359396|P3|Overall Study|Visit 1 delayed, unable to reschedule|1
5884808|NCT01823536|20359397|P2|Overall Study|Visit 1 delayed, unable to reschedule|0
5884809|NCT01823536|20359398|P1|Overall Study|Visit 1 delayed, unable to reschedule|0
5884810|NCT01823536|20359393|P6|Overall Study|Withdrawal by Subject|0
5884811|NCT01823536|20359394|P5|Overall Study|Withdrawal by Subject|0
5884812|NCT01823536|20359395|P4|Overall Study|Withdrawal by Subject|0
5884813|NCT01823536|20359396|P3|Overall Study|Withdrawal by Subject|0
5884814|NCT01823536|20359397|P2|Overall Study|Withdrawal by Subject|1
5884815|NCT01823536|20359398|P1|Overall Study|Withdrawal by Subject|1
5884816|NCT01823536|20359393|P6|Overall Study|Protocol Violation|0
5884817|NCT01823536|20359394|P5|Overall Study|Protocol Violation|0
5884818|NCT01823536|20359395|P4|Overall Study|Protocol Violation|0
5884819|NCT01823536|20359396|P3|Overall Study|Protocol Violation|0
5884820|NCT01823536|20359397|P2|Overall Study|Protocol Violation|1
5884821|NCT01823536|20359398|P1|Overall Study|Protocol Violation|0
5884822|NCT01823536|20359393|P6|Overall Study|Lost to Follow-up|0
5884823|NCT01823536|20359394|P5|Overall Study|Lost to Follow-up|1
5884824|NCT01823536|20359395|P4|Overall Study|Lost to Follow-up|1
5884825|NCT01823536|20359396|P3|Overall Study|Lost to Follow-up|0
5884826|NCT01823536|20359397|P2|Overall Study|Lost to Follow-up|0
5884827|NCT01823536|20359398|P1|Overall Study|Lost to Follow-up|1
5884828|NCT01823341|20359460|P1|Overall Study|Adverse Event|1
5884829|NCT01823341|20359460|P1|Overall Study|Withdrawal by Subject|7
5884830|NCT01823341|20359460|P1|Overall Study|Failed run-in|7
5884831|NCT01823328|20359505|P2|Overall Study|Withdrawal by Subject|6
5884832|NCT01823328|20359506|P1|Overall Study|Withdrawal by Subject|8
5884833|NCT01823289|20359526|P1|Overall Study|Creatinine clearance<30milliliter/minute|1
5884834|NCT01823289|20359526|P1|Overall Study|Drug affected efficacy and safety|1
5884835|NCT01823289|20359526|P1|Overall Study|Transaminase increased more than 3 times|1
5884836|NCT01823289|20359526|P1|Overall Study|Administered contraindicated medicine|1
5884837|NCT01823289|20359526|P1|Overall Study|Physician Decision|9
5884838|NCT01823289|20359526|P1|Overall Study|Lack of Efficacy|1
5884839|NCT01823289|20359526|P1|Overall Study|Adverse Event|5
5884840|NCT01823289|20359526|P1|Overall Study|Lost to Follow-up|5
5884841|NCT01823224|20359534|P2|Overall Study|Withdrawal by Subject|1
5884842|NCT01823224|20359535|P1|Overall Study|Withdrawal by Subject|0
5884843|NCT01823224|20359534|P2|Overall Study|missed med dose|1
5884844|NCT01823224|20359535|P1|Overall Study|missed med dose|0
5884845|NCT01823224|20359534|P2|Overall Study|pharmacy error|1
5884846|NCT01823224|20359535|P1|Overall Study|pharmacy error|0
5884847|NCT01823224|20359534|P2|Overall Study|didn't qualify|2
5884848|NCT01823224|20359535|P1|Overall Study|didn't qualify|1
5884849|NCT01823224|20359534|P2|Overall Study|Lost to Follow-up|6
5884850|NCT01823224|20359535|P1|Overall Study|Lost to Follow-up|5
5884851|NCT01823146|20359545|P2|Overall Study|Lost to Follow-up|1
5884852|NCT01823146|20359546|P1|Overall Study|Lost to Follow-up|2
5884853|NCT01823146|20359545|P2|Overall Study|Withdrawal by Subject|1
5884854|NCT01823146|20359546|P1|Overall Study|Withdrawal by Subject|0
5884855|NCT01823107|20359556|P1|Overall Study|Withdrawal by Subject|1
5884856|NCT01822925|20359566|P4|Overall Study|Taking prohibited medication|1
5884857|NCT01822925|20359567|P3|Overall Study|Taking prohibited medication|0
5884858|NCT01822925|20359568|P2|Overall Study|Taking prohibited medication|0
5884859|NCT01822925|20359569|P1|Overall Study|Taking prohibited medication|2
5884860|NCT01822925|20359566|P4|Overall Study|Withdrawal by Subject|2
5884861|NCT01822925|20359567|P3|Overall Study|Withdrawal by Subject|2
5884862|NCT01822925|20359568|P2|Overall Study|Withdrawal by Subject|0
5884863|NCT01822925|20359569|P1|Overall Study|Withdrawal by Subject|2
5884864|NCT01822925|20359566|P4|Overall Study|Protocol Violation|1
5884865|NCT01822925|20359567|P3|Overall Study|Protocol Violation|0
5884866|NCT01822925|20359568|P2|Overall Study|Protocol Violation|0
5884867|NCT01822925|20359569|P1|Overall Study|Protocol Violation|1
5884868|NCT01822925|20359566|P4|Overall Study|Lost to Follow-up|0
5884869|NCT01822925|20359567|P3|Overall Study|Lost to Follow-up|0
5884870|NCT01822925|20359568|P2|Overall Study|Lost to Follow-up|1
5884871|NCT01822925|20359569|P1|Overall Study|Lost to Follow-up|0
5884872|NCT01822925|20359566|P4|Overall Study|Adverse Event|1
5884873|NCT01822925|20359567|P3|Overall Study|Adverse Event|1
5884874|NCT01822925|20359568|P2|Overall Study|Adverse Event|1
5884875|NCT01822925|20359569|P1|Overall Study|Adverse Event|1
5884876|NCT01822899|20359621|P2|Overall Study|Withdrawal by Subject|7
5884877|NCT01822899|20359622|P1|Overall Study|Withdrawal by Subject|5
5884878|NCT01822899|20359621|P2|Overall Study|Lost to Follow-up|0
5884879|NCT01822899|20359622|P1|Overall Study|Lost to Follow-up|1
5884880|NCT01822899|20359621|P2|Overall Study|Protocol Violation|3
5884881|NCT01822899|20359622|P1|Overall Study|Protocol Violation|6
5884882|NCT01822899|20359621|P2|Overall Study|Lack of Efficacy|3
5884883|NCT01822899|20359622|P1|Overall Study|Lack of Efficacy|6
5884884|NCT01822899|20359621|P2|Overall Study|Adverse Event|5
5884885|NCT01822899|20359622|P1|Overall Study|Adverse Event|6
5884886|NCT01822821|20359640|P2|Overall Study|Other reasons|0
5884887|NCT01822821|20359641|P1|Overall Study|Other reasons|1
5884888|NCT01822821|20359640|P2|Overall Study|Eligible surgery cancelled|1
5884889|NCT01822821|20359641|P1|Overall Study|Eligible surgery cancelled|1
5884890|NCT01822756|20359670|P5|Overall Study|disease progression & patient preference|0
5884891|NCT01822756|20359671|P4|Overall Study|disease progression & patient preference|0
5884892|NCT01822756|20359672|P3|Overall Study|disease progression & patient preference|1
5884893|NCT01822756|20359673|P2|Overall Study|disease progression & patient preference|0
5884894|NCT01822756|20359674|P1|Overall Study|disease progression & patient preference|2
5884895|NCT01822756|20359670|P5|Overall Study|Physician Decision|0
5884896|NCT01822756|20359671|P4|Overall Study|Physician Decision|0
5884897|NCT01822756|20359672|P3|Overall Study|Physician Decision|0
5884898|NCT01822756|20359673|P2|Overall Study|Physician Decision|1
5884899|NCT01822756|20359674|P1|Overall Study|Physician Decision|0
5884900|NCT01822756|20359670|P5|Overall Study|Lost to Follow-up|1
5884901|NCT01822756|20359671|P4|Overall Study|Lost to Follow-up|0
5884902|NCT01822756|20359672|P3|Overall Study|Lost to Follow-up|1
5884903|NCT01822756|20359673|P2|Overall Study|Lost to Follow-up|0
5884904|NCT01822756|20359674|P1|Overall Study|Lost to Follow-up|1
5884905|NCT01822756|20359670|P5|Overall Study|Death|0
5884906|NCT01822756|20359671|P4|Overall Study|Death|0
5884907|NCT01822756|20359672|P3|Overall Study|Death|1
5884908|NCT01822756|20359673|P2|Overall Study|Death|2
5884909|NCT01822756|20359674|P1|Overall Study|Death|2
5884910|NCT01822756|20359670|P5|Overall Study|Disease progression|6
5884911|NCT01822756|20359671|P4|Overall Study|Disease progression|2
5884912|NCT01822756|20359672|P3|Overall Study|Disease progression|7
5884913|NCT01822756|20359673|P2|Overall Study|Disease progression|1
5884914|NCT01822756|20359674|P1|Overall Study|Disease progression|11
5884915|NCT01822756|20359670|P5|Overall Study|Adverse Event|0
5884916|NCT01822756|20359671|P4|Overall Study|Adverse Event|2
5884917|NCT01822756|20359672|P3|Overall Study|Adverse Event|0
5884918|NCT01822756|20359673|P2|Overall Study|Adverse Event|0
5884919|NCT01822756|20359674|P1|Overall Study|Adverse Event|0
5884920|NCT01822691|20359716|P1|Overall Study|Withdrawal by Subject|2
5884921|NCT01822678|20359727|P3|Overall Study|Lost to Follow-up|1
5884922|NCT01822678|20359728|P2|Overall Study|Lost to Follow-up|2
5884923|NCT01822678|20359729|P1|Overall Study|Lost to Follow-up|0
5884924|NCT01822678|20359727|P3|Overall Study|Lack of Efficacy|5
5884925|NCT01822678|20359728|P2|Overall Study|Lack of Efficacy|6
5884926|NCT01822678|20359729|P1|Overall Study|Lack of Efficacy|3
5884927|NCT01822678|20359727|P3|Overall Study|Adverse Event|1
5884928|NCT01822678|20359728|P2|Overall Study|Adverse Event|3
5884929|NCT01822678|20359729|P1|Overall Study|Adverse Event|4
5884930|NCT01822678|20359727|P3|Overall Study|Withdrawal by Subject|4
5884931|NCT01822678|20359728|P2|Overall Study|Withdrawal by Subject|4
5884932|NCT01822678|20359729|P1|Overall Study|Withdrawal by Subject|5
5884933|NCT01822665|20359737|P1|Overall Study|Other Reason|5
5884934|NCT01822665|20359737|P1|Overall Study|Adverse Event|3
5884935|NCT01822587|20359764|P3|Overall Study|Physician Decision|6
5884936|NCT01822587|20359765|P2|Overall Study|Physician Decision|6
5884937|NCT01822587|20359766|P1|Overall Study|Physician Decision|9
5884938|NCT01822587|20359764|P3|Overall Study|Lost to Follow-up|12
5884939|NCT01822587|20359765|P2|Overall Study|Lost to Follow-up|9
5884940|NCT01822587|20359766|P1|Overall Study|Lost to Follow-up|7
5884941|NCT01822561|20359805|P1|Overall Study|Withdrawal by Subject|2
5884942|NCT01822535|20359826|P2|Visit 2 - Tetraplegia Only - Drug|Adverse Event|0
5884943|NCT01822535|20359827|P1|Visit 2 - Tetraplegia Only - Drug|Adverse Event|1
5884944|NCT01822535|20359826|P2|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|2
5884945|NCT01822535|20359827|P1|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|4
5884946|NCT01822535|20359826|P2|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|0
5884947|NCT01822535|20359827|P1|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|2
5884948|NCT01822496|20359843|P4|Overall Study|Withdrawal by Subject|3
5884949|NCT01822496|20359844|P3|Overall Study|Withdrawal by Subject|0
5884950|NCT01822496|20359845|P2|Overall Study|Withdrawal by Subject|0
5884951|NCT01822496|20359846|P1|Overall Study|Withdrawal by Subject|0
5884952|NCT01822496|20359843|P4|Overall Study|Protocol Violation|1
5884953|NCT01822496|20359844|P3|Overall Study|Protocol Violation|0
5884954|NCT01822496|20359845|P2|Overall Study|Protocol Violation|2
5884955|NCT01822496|20359846|P1|Overall Study|Protocol Violation|2
5884956|NCT01822366|20359899|P4|Overall Study|Partial Intervention Completion|15
5884957|NCT01822366|20359900|P3|Overall Study|Partial Intervention Completion|0
5884958|NCT01822366|20359901|P2|Overall Study|Partial Intervention Completion|15
5884959|NCT01822366|20359902|P1|Overall Study|Partial Intervention Completion|0
5884960|NCT01822366|20359899|P4|Overall Study|Withdrawal by Subject|6
5884961|NCT01822366|20359900|P3|Overall Study|Withdrawal by Subject|0
5884962|NCT01822366|20359901|P2|Overall Study|Withdrawal by Subject|6
5884963|NCT01822366|20359902|P1|Overall Study|Withdrawal by Subject|0
5884964|NCT01822366|20359899|P4|Overall Study|Lost to Follow-up|1
5884965|NCT01822366|20359900|P3|Overall Study|Lost to Follow-up|5
5884966|NCT01822366|20359901|P2|Overall Study|Lost to Follow-up|1
5884967|NCT01822366|20359902|P1|Overall Study|Lost to Follow-up|5
5884977|NCT01822223|20359955|P2|Overall Study|Death|1
5884978|NCT01822223|20359956|P1|Overall Study|Death|0
5884979|NCT01822132|20359980|P2|Overall Study|Lost to Follow-up|2
5884980|NCT01822132|20359981|P1|Overall Study|Lost to Follow-up|4
5884981|NCT01821963|20360018|P1|Overall Study|Adverse Event|1
5884982|NCT01821937|20360024|P2|Overall Study|Adverse Event|3
5884983|NCT01821937|20360025|P1|Overall Study|Adverse Event|0
5884984|NCT01821898|20360045|P2|Overall Study|Withdrawal by Subject|1
5884985|NCT01821898|20360046|P1|Overall Study|Withdrawal by Subject|2
5884986|NCT01821807|20360064|P2|Overall Study|Lost to Follow-up|1
5884987|NCT01821807|20360065|P1|Overall Study|Lost to Follow-up|3
5884988|NCT01821729|20360073|P1|Overall Study|Withdrawal by Subject|1
5884989|NCT01821625|20360078|P1|Overall Study|Medical contraindication|1
5884990|NCT01821625|20360078|P1|Overall Study|Adverse Event|1
5884991|NCT01821625|20360078|P1|Overall Study|Lack of Efficacy|2
5884992|NCT01821625|20360078|P1|Overall Study|Withdrawal by Subject|2
5884993|NCT01821560|20360084|P2|Overall Study|Protocol Violation|1
5884994|NCT01821560|20360085|P1|Overall Study|Protocol Violation|0
5884995|NCT01821560|20360084|P2|Overall Study|Withdrawal by Subject|1
5884996|NCT01821560|20360085|P1|Overall Study|Withdrawal by Subject|1
5884997|NCT01821560|20360084|P2|Overall Study|Lost to Follow-up|5
5884998|NCT01821560|20360085|P1|Overall Study|Lost to Follow-up|5
5885001|NCT01821118|20360217|P2|Overall Study|Death|1
5885002|NCT01821118|20360218|P1|Overall Study|Death|0
5885003|NCT01820637|20360265|P1|Overall Study|Withdrawal by Subject|1
5885004|NCT01820637|20360265|P1|Overall Study|Death|2
5885005|NCT01820585|20360274|P4|Overall Study|Pregnancy|0
5885006|NCT01820585|20360275|P3|Overall Study|Pregnancy|0
5885007|NCT01820585|20360276|P2|Overall Study|Pregnancy|1
5885008|NCT01820585|20360277|P1|Overall Study|Pregnancy|0
5885009|NCT01820585|20360274|P4|Overall Study|at sponsor request|0
5885010|NCT01820585|20360275|P3|Overall Study|at sponsor request|1
5885011|NCT01820585|20360276|P2|Overall Study|at sponsor request|0
5885012|NCT01820585|20360277|P1|Overall Study|at sponsor request|0
5885013|NCT01820585|20360274|P4|Overall Study|Subject non-compliance|2
5885014|NCT01820585|20360275|P3|Overall Study|Subject non-compliance|1
5885015|NCT01820585|20360276|P2|Overall Study|Subject non-compliance|0
5885016|NCT01820585|20360277|P1|Overall Study|Subject non-compliance|0
5885017|NCT01820585|20360274|P4|Overall Study|Protocol Violation|1
5885018|NCT01820585|20360275|P3|Overall Study|Protocol Violation|1
5885019|NCT01820585|20360276|P2|Overall Study|Protocol Violation|1
5885020|NCT01820585|20360277|P1|Overall Study|Protocol Violation|3
5885021|NCT01820585|20360274|P4|Overall Study|Lost to Follow-up|3
5885022|NCT01820585|20360275|P3|Overall Study|Lost to Follow-up|0
5885023|NCT01820585|20360276|P2|Overall Study|Lost to Follow-up|3
5885024|NCT01820585|20360277|P1|Overall Study|Lost to Follow-up|3
5885025|NCT01820585|20360274|P4|Overall Study|Withdrawal by Subject|8
5885026|NCT01820585|20360275|P3|Overall Study|Withdrawal by Subject|3
5885027|NCT01820585|20360276|P2|Overall Study|Withdrawal by Subject|7
5885028|NCT01820585|20360277|P1|Overall Study|Withdrawal by Subject|3
5885029|NCT01820585|20360274|P4|Overall Study|Lack of Efficacy|1
5885030|NCT01820585|20360275|P3|Overall Study|Lack of Efficacy|5
5885031|NCT01820585|20360276|P2|Overall Study|Lack of Efficacy|7
5885032|NCT01820585|20360277|P1|Overall Study|Lack of Efficacy|9
5885033|NCT01820585|20360274|P4|Overall Study|Adverse Event|34
5885034|NCT01820585|20360275|P3|Overall Study|Adverse Event|23
5885035|NCT01820585|20360276|P2|Overall Study|Adverse Event|13
5885036|NCT01820585|20360277|P1|Overall Study|Adverse Event|9
5885037|NCT01820572|20360289|P2|Treatment Period|withdrew consent|2
5885038|NCT01820572|20360290|P1|Treatment Period|withdrew consent|1
5885039|NCT01820572|20360289|P2|Treatment Period|No longer meets study criteria|10
5885040|NCT01820572|20360290|P1|Treatment Period|No longer meets study criteria|3
5885041|NCT01820572|20360289|P2|Treatment Period|request to discontinue|11
5885042|NCT01820572|20360290|P1|Treatment Period|request to discontinue|6
5885043|NCT01820572|20360289|P2|Treatment Period|poor/non compliance|3
5885044|NCT01820572|20360290|P1|Treatment Period|poor/non compliance|0
5885045|NCT01820572|20360289|P2|Treatment Period|Lack of Efficacy|0
5885046|NCT01820572|20360290|P1|Treatment Period|Lack of Efficacy|1
5885047|NCT01820572|20360289|P2|Treatment Period|Death|3
5885048|NCT01820572|20360290|P1|Treatment Period|Death|3
5885049|NCT01820572|20360289|P2|Treatment Period|Adverse Event|7
5885050|NCT01820572|20360290|P1|Treatment Period|Adverse Event|12
5885051|NCT01820572|20360289|P2|Randomization|Not Treated|1
5885052|NCT01820572|20360290|P1|Randomization|Not Treated|2
5885053|NCT01820559|20360333|P3|Overall Study|Lack of Efficacy|3
5885054|NCT01820559|20360334|P2|Overall Study|Lack of Efficacy|2
5885055|NCT01820559|20360335|P1|Overall Study|Lack of Efficacy|3
5885056|NCT01820559|20360333|P3|Overall Study|At sponsor request|1
5885057|NCT01820559|20360334|P2|Overall Study|At sponsor request|0
5885058|NCT01820559|20360335|P1|Overall Study|At sponsor request|0
5885059|NCT01820559|20360333|P3|Overall Study|Lost to Follow-up|2
5885060|NCT01820559|20360334|P2|Overall Study|Lost to Follow-up|2
5885061|NCT01820559|20360335|P1|Overall Study|Lost to Follow-up|3
5885062|NCT01820559|20360333|P3|Overall Study|Subject's non-compliance|2
5885063|NCT01820559|20360334|P2|Overall Study|Subject's non-compliance|0
5885064|NCT01820559|20360335|P1|Overall Study|Subject's non-compliance|1
5885065|NCT01820559|20360333|P3|Overall Study|Protocol Violation|3
5885066|NCT01820559|20360334|P2|Overall Study|Protocol Violation|1
5885067|NCT01820559|20360335|P1|Overall Study|Protocol Violation|2
5885068|NCT01820559|20360333|P3|Overall Study|Withdrawal by Subject|5
5885069|NCT01820559|20360334|P2|Overall Study|Withdrawal by Subject|2
5885070|NCT01820559|20360335|P1|Overall Study|Withdrawal by Subject|1
5885071|NCT01820559|20360333|P3|Overall Study|Adverse Event|13
5885072|NCT01820559|20360334|P2|Overall Study|Adverse Event|6
5885073|NCT01820559|20360335|P1|Overall Study|Adverse Event|4
5885074|NCT01820364|20360356|P2|Part II: LGX818 + MEK162|Study Termination|1
5885075|NCT01820364|20360357|P1|Part II: LGX818 + MEK162|Study Termination|0
5885076|NCT01820364|20360356|P2|Part I: LGX818|Disease Progression|0
5885077|NCT01820364|20360357|P1|Part I: LGX818|Disease Progression|4
5885078|NCT01820364|20360356|P2|Part I: LGX818|Adverse Event|0
5885079|NCT01820364|20360357|P1|Part I: LGX818|Adverse Event|6
5885080|NCT01820364|20360356|P2|Part I: LGX818|Administrative Problems|0
5885081|NCT01820364|20360357|P1|Part I: LGX818|Administrative Problems|3
5885082|NCT01820364|20360356|P2|Part I: LGX818|Death|0
5885083|NCT01820364|20360357|P1|Part I: LGX818|Death|1
5885084|NCT01819727|20360501|P2|Overall Study|Quit due to lack of health benifits|1
5885085|NCT01819727|20360502|P1|Overall Study|Quit due to lack of health benifits|0
5885086|NCT01819727|20360501|P2|Overall Study|Unable to demostrate ability self-inject|1
5885087|NCT01819727|20360502|P1|Overall Study|Unable to demostrate ability self-inject|0
5885088|NCT01819727|20360501|P2|Overall Study|Withdrawal by Subject|11
5885089|NCT01819727|20360502|P1|Overall Study|Withdrawal by Subject|6
5885090|NCT01819727|20360501|P2|Overall Study|Study Terminated by Sponsor|1
5885091|NCT01819727|20360502|P1|Overall Study|Study Terminated by Sponsor|0
5885092|NCT01819727|20360501|P2|Overall Study|Protocol Violation|2
5885093|NCT01819727|20360502|P1|Overall Study|Protocol Violation|0
5885094|NCT01819727|20360501|P2|Overall Study|Pregnancy|0
5885095|NCT01819727|20360502|P1|Overall Study|Pregnancy|1
5885096|NCT01819727|20360501|P2|Overall Study|Physician Decision|2
5885097|NCT01819727|20360502|P1|Overall Study|Physician Decision|3
5885098|NCT01819727|20360501|P2|Overall Study|Lost to Follow-up|1
5885099|NCT01819727|20360502|P1|Overall Study|Lost to Follow-up|1
5885100|NCT01819727|20360501|P2|Overall Study|Death|0
5885101|NCT01819727|20360502|P1|Overall Study|Death|1
5885102|NCT01819727|20360501|P2|Overall Study|Adverse Event|9
5885103|NCT01819727|20360502|P1|Overall Study|Adverse Event|8
5885104|NCT01819506|20360524|P2|Overall Study|Withdrawal by Subject|3
5885105|NCT01819506|20360525|P1|Overall Study|Withdrawal by Subject|3
5885106|NCT01819506|20360524|P2|Overall Study|Physician Decision|2
5885107|NCT01819506|20360525|P1|Overall Study|Physician Decision|5
5885108|NCT01819272|20360577|P6|Overall Study|Loss of Glucose Control|0
5885109|NCT01819272|20360578|P5|Overall Study|Loss of Glucose Control|2
5885110|NCT01819272|20360579|P4|Overall Study|Loss of Glucose Control|1
5885111|NCT01819272|20360580|P3|Overall Study|Loss of Glucose Control|0
5885112|NCT01819272|20360581|P2|Overall Study|Loss of Glucose Control|1
5885113|NCT01819272|20360582|P1|Overall Study|Loss of Glucose Control|2
5885114|NCT01819272|20360577|P6|Overall Study|Withdrawal of Consent|1
5885115|NCT01819272|20360578|P5|Overall Study|Withdrawal of Consent|0
5885116|NCT01819272|20360579|P4|Overall Study|Withdrawal of Consent|1
5885117|NCT01819272|20360580|P3|Overall Study|Withdrawal of Consent|2
5885118|NCT01819272|20360581|P2|Overall Study|Withdrawal of Consent|1
5885119|NCT01819272|20360582|P1|Overall Study|Withdrawal of Consent|0
5885120|NCT01819272|20360577|P6|Overall Study|Physician Decision|0
5885121|NCT01819272|20360578|P5|Overall Study|Physician Decision|0
5885122|NCT01819272|20360579|P4|Overall Study|Physician Decision|0
5885123|NCT01819272|20360580|P3|Overall Study|Physician Decision|0
5885124|NCT01819272|20360581|P2|Overall Study|Physician Decision|1
5885125|NCT01819272|20360582|P1|Overall Study|Physician Decision|0
5885126|NCT01819272|20360577|P6|Overall Study|Protocol Violation|3
5885127|NCT01819272|20360578|P5|Overall Study|Protocol Violation|2
5885128|NCT01819272|20360579|P4|Overall Study|Protocol Violation|1
5885129|NCT01819272|20360580|P3|Overall Study|Protocol Violation|0
5885130|NCT01819272|20360581|P2|Overall Study|Protocol Violation|0
5885131|NCT01819272|20360582|P1|Overall Study|Protocol Violation|0
5885132|NCT01819272|20360577|P6|Overall Study|Lost to Follow-up|3
5885133|NCT01819272|20360578|P5|Overall Study|Lost to Follow-up|0
5885134|NCT01819272|20360579|P4|Overall Study|Lost to Follow-up|0
5885135|NCT01819272|20360580|P3|Overall Study|Lost to Follow-up|1
5885136|NCT01819272|20360581|P2|Overall Study|Lost to Follow-up|0
5885137|NCT01819272|20360582|P1|Overall Study|Lost to Follow-up|3
5885138|NCT01819272|20360577|P6|Overall Study|Adverse Event|0
5885139|NCT01819272|20360578|P5|Overall Study|Adverse Event|0
5885140|NCT01819272|20360579|P4|Overall Study|Adverse Event|2
5885141|NCT01819272|20360580|P3|Overall Study|Adverse Event|0
5885142|NCT01819272|20360581|P2|Overall Study|Adverse Event|0
5885143|NCT01819272|20360582|P1|Overall Study|Adverse Event|1
5885144|NCT01819194|20360620|P1|Overall Study|Loss of study articles|2
5885145|NCT01819129|20360627|P2|Overall Study|Withdrawal Criteria|15
5885146|NCT01819129|20360628|P1|Overall Study|Withdrawal Criteria|20
5885147|NCT01819129|20360627|P2|Overall Study|Death|1
5885148|NCT01819129|20360628|P1|Overall Study|Death|1
5885149|NCT01819129|20360627|P2|Overall Study|Adverse Event|4
5885150|NCT01819129|20360628|P1|Overall Study|Adverse Event|1
5885151|NCT01819129|20360627|P2|Overall Study|Lack of Efficacy|1
5885152|NCT01819129|20360628|P1|Overall Study|Lack of Efficacy|0
5885153|NCT01819129|20360627|P2|Overall Study|Lost to Follow-up|2
5885154|NCT01819129|20360628|P1|Overall Study|Lost to Follow-up|5
5885155|NCT01819129|20360627|P2|Overall Study|Withdrawal by Subject|15
5885156|NCT01819129|20360628|P1|Overall Study|Withdrawal by Subject|15
5885157|NCT01819129|20360627|P2|Overall Study|Other, Subject moved out of the country|1
5885158|NCT01819129|20360628|P1|Overall Study|Other, Subject moved out of the country|0
5885159|NCT01819129|20360627|P2|Overall Study|Other, weight gain, hypoglycaemic events|0
5885160|NCT01819129|20360628|P1|Overall Study|Other, weight gain, hypoglycaemic events|1
5885161|NCT01819129|20360627|P2|Overall Study|Other, Subject wanted HbA1c to be > 7%|0
5885162|NCT01819129|20360628|P1|Overall Study|Other, Subject wanted HbA1c to be > 7%|1
5885163|NCT01818765|20360653|P1|Overall Study|Death|2
5885164|NCT01818752|20360666|P2|Overall Study|Randomized but not Dosed|4
5885165|NCT01818752|20360667|P1|Overall Study|Randomized but not Dosed|7
5885166|NCT01818752|20360666|P2|Overall Study|Continuing Treatment|4
5885167|NCT01818752|20360667|P1|Overall Study|Continuing Treatment|1
5885168|NCT01818752|20360666|P2|Overall Study|Other|8
5885169|NCT01818752|20360667|P1|Overall Study|Other|7
5885170|NCT01818752|20360666|P2|Overall Study|Disease Progression|48
5885171|NCT01818752|20360667|P1|Overall Study|Disease Progression|54
5885172|NCT01818752|20360666|P2|Overall Study|Physician Decision|8
5885173|NCT01818752|20360667|P1|Overall Study|Physician Decision|9
5885174|NCT01818752|20360666|P2|Overall Study|Withdrawal by Subject|14
5885175|NCT01818752|20360667|P1|Overall Study|Withdrawal by Subject|15
5885176|NCT01818752|20360666|P2|Overall Study|Non-compliance|20
5885177|NCT01818752|20360667|P1|Overall Study|Non-compliance|16
5885178|NCT01818752|20360666|P2|Overall Study|Death|18
5885179|NCT01818752|20360667|P1|Overall Study|Death|14
5885180|NCT01818752|20360666|P2|Overall Study|Adverse Event|74
5885181|NCT01818752|20360667|P1|Overall Study|Adverse Event|64
5885182|NCT01818726|20360687|P2|Overall Study|Decision to perform 2nd course of trtmnt|0
5885183|NCT01818726|20360688|P1|Overall Study|Decision to perform 2nd course of trtmnt|1
5885184|NCT01818726|20360687|P2|Overall Study|Withdrawal by Subject|1
5885185|NCT01818726|20360688|P1|Overall Study|Withdrawal by Subject|0
5885186|NCT01818726|20360687|P2|Overall Study|Administrative reasons|1
5885187|NCT01818726|20360688|P1|Overall Study|Administrative reasons|5
5885188|NCT01818700|20360698|P1|Overall Study|Other|1
5885189|NCT01818700|20360698|P1|Overall Study|Protocol Violation|2
5885190|NCT01818700|20360698|P1|Overall Study|Withdrawal by Subject|27
5885191|NCT01818700|20360698|P1|Overall Study|Lost to Follow-up|5
5885192|NCT01818700|20360698|P1|Overall Study|Lack of Efficacy|2
5885193|NCT01818700|20360698|P1|Overall Study|Adverse Event|67
5885194|NCT01818596|20360709|P2|Overall Study|Lost to Follow-up|0
5885195|NCT01818596|20360710|P1|Overall Study|Lost to Follow-up|7
5885196|NCT01818596|20360709|P2|Overall Study|Withdrew Consent|0
5885197|NCT01818596|20360710|P1|Overall Study|Withdrew Consent|5
5885198|NCT01818596|20360709|P2|Overall Study|Protocol Violation|0
5885199|NCT01818596|20360710|P1|Overall Study|Protocol Violation|1
5885200|NCT01818596|20360709|P2|Overall Study|Investigator's Discretion|0
5885201|NCT01818596|20360710|P1|Overall Study|Investigator's Discretion|4
5885202|NCT01818596|20360709|P2|Overall Study|Death|0
5885203|NCT01818596|20360710|P1|Overall Study|Death|3
5885204|NCT01818596|20360709|P2|Overall Study|Adverse Event|0
5885205|NCT01818596|20360710|P1|Overall Study|Adverse Event|7
5885206|NCT01818596|20360709|P2|Overall Study|Enrolled but Not Treated|0
5885207|NCT01818596|20360710|P1|Overall Study|Enrolled but Not Treated|4
5885208|NCT01818531|20360749|P2|Overall Study|Withdrawn for failure to place block|1
5885209|NCT01818531|20360750|P1|Overall Study|Withdrawn for failure to place block|0
5885210|NCT01818531|20360749|P2|Overall Study|Withdrawn for long-acting opioid patch|1
5885211|NCT01818531|20360750|P1|Overall Study|Withdrawn for long-acting opioid patch|0
5885212|NCT01818531|20360749|P2|Overall Study|Withdrawn for case delay after block|0
5885213|NCT01818531|20360750|P1|Overall Study|Withdrawn for case delay after block|1
5885214|NCT01818492|20360789|P1|Overall Study|Additional therapy when not allowed PP|4
5885215|NCT01818492|20360789|P1|Overall Study|Withdrawal by Subject|1
5885216|NCT01818492|20360789|P1|Overall Study|Death|3
5885217|NCT01818492|20360789|P1|Overall Study|Adverse Event|2
5885218|NCT01818336|20360838|P2|Overall Study|Lost to Follow-up|1
5885219|NCT01818336|20360839|P1|Overall Study|Lost to Follow-up|0
5885220|NCT01818336|20360838|P2|Overall Study|Declined retest visit|11
5885221|NCT01818336|20360839|P1|Overall Study|Declined retest visit|0
5885222|NCT01818297|20360847|P2|Open Label Phase (3-12 Months)|Early study closure|10
5885223|NCT01818297|20360848|P1|Open Label Phase (3-12 Months)|Early study closure|17
5885224|NCT01818297|20360847|P2|Open Label Phase (3-12 Months)|Physician Decision|0
5885225|NCT01818297|20360848|P1|Open Label Phase (3-12 Months)|Physician Decision|1
5885226|NCT01818297|20360847|P2|Blinded Phase (Randomization - 3 Months)|Adverse Event|1
5885227|NCT01818297|20360848|P1|Blinded Phase (Randomization - 3 Months)|Adverse Event|0
5885228|NCT01818284|20360866|P2|Overall Study|Death|2
5885229|NCT01818284|20360867|P1|Overall Study|Death|0
5885230|NCT01818284|20360866|P2|Overall Study|Not eligible due to White Blood Counts|4
5885231|NCT01818284|20360867|P1|Overall Study|Not eligible due to White Blood Counts|4
5885232|NCT01818141|20360900|P2|Overall Study|Lost to Follow-up|2
5885233|NCT01818141|20360901|P1|Overall Study|Lost to Follow-up|0
5885234|NCT01818141|20360900|P2|Overall Study|No baseline C.diff colonies|1
5885235|NCT01818141|20360901|P1|Overall Study|No baseline C.diff colonies|1
5885236|NCT01818141|20360900|P2|Overall Study|Withdrawal by Subject|0
5885237|NCT01818141|20360901|P1|Overall Study|Withdrawal by Subject|2
5885246|NCT01817790|20361017|P2|Overall Study|Other: Could not attend appointment|1
5885247|NCT01817790|20361018|P1|Overall Study|Other: Could not attend appointment|1
5885248|NCT01817790|20361017|P2|Overall Study|Withdrawal by Subject|3
5885249|NCT01817790|20361018|P1|Overall Study|Withdrawal by Subject|1
5885250|NCT01817790|20361017|P2|Overall Study|Protocol Violation|1
5885251|NCT01817790|20361018|P1|Overall Study|Protocol Violation|2
5885252|NCT01817790|20361017|P2|Overall Study|Lost to Follow-up|1
5885253|NCT01817790|20361018|P1|Overall Study|Lost to Follow-up|0
5885254|NCT01817790|20361017|P2|Overall Study|Adverse Event|2
5885255|NCT01817790|20361018|P1|Overall Study|Adverse Event|0
5885256|NCT01817777|20361062|P3|Interventional Phase (20 Weeks)|Early Study Termination|3
5885257|NCT01817777|20361063|P2|Interventional Phase (20 Weeks)|Early Study Termination|1
5885258|NCT01817777|20361064|P1|Interventional Phase (20 Weeks)|Early Study Termination|0
5885259|NCT01817777|20361062|P3|Interventional Phase (20 Weeks)|Lost to Follow-up|2
5885260|NCT01817777|20361063|P2|Interventional Phase (20 Weeks)|Lost to Follow-up|1
5885261|NCT01817777|20361064|P1|Interventional Phase (20 Weeks)|Lost to Follow-up|0
5885262|NCT01817777|20361062|P3|Interventional Phase (20 Weeks)|Withdrawal by Subject|0
5885263|NCT01817777|20361063|P2|Interventional Phase (20 Weeks)|Withdrawal by Subject|3
5885264|NCT01817777|20361064|P1|Interventional Phase (20 Weeks)|Withdrawal by Subject|0
5885265|NCT01817777|20361062|P3|Observational Phase (8 Weeks)|Early Study Termination|0
5885266|NCT01817777|20361063|P2|Observational Phase (8 Weeks)|Early Study Termination|0
5885267|NCT01817777|20361064|P1|Observational Phase (8 Weeks)|Early Study Termination|2
5885268|NCT01817777|20361062|P3|Observational Phase (8 Weeks)|Lost to Follow-up|0
5885269|NCT01817777|20361063|P2|Observational Phase (8 Weeks)|Lost to Follow-up|0
5885270|NCT01817777|20361064|P1|Observational Phase (8 Weeks)|Lost to Follow-up|3
5885271|NCT01817764|20361088|P2|Overall Study|Withdrawal by Subject|12
5885272|NCT01817764|20361089|P1|Overall Study|Withdrawal by Subject|10
5885273|NCT01817764|20361088|P2|Overall Study|Lost to Follow-up|4
5885274|NCT01817764|20361089|P1|Overall Study|Lost to Follow-up|1
5885275|NCT01817764|20361088|P2|Overall Study|Protocol Violation|5
5885276|NCT01817764|20361089|P1|Overall Study|Protocol Violation|7
5885277|NCT01817764|20361088|P2|Overall Study|Lack of Efficacy|7
5885278|NCT01817764|20361089|P1|Overall Study|Lack of Efficacy|9
5885279|NCT01817764|20361088|P2|Overall Study|Adverse Event|10
5885280|NCT01817764|20361089|P1|Overall Study|Adverse Event|7
5885281|NCT01817725|20361097|P1|Overall Study|Withdrawal by Subject|1
5885282|NCT01817582|20361118|P3|Overall Study|Randomized but exclusion criteria met|0
5885283|NCT01817582|20361119|P2|Overall Study|Randomized but exclusion criteria met|0
5885284|NCT01817582|20361120|P1|Overall Study|Randomized but exclusion criteria met|1
5885285|NCT01817582|20361118|P3|Overall Study|Participant revealed masked treatment|0
5885286|NCT01817582|20361119|P2|Overall Study|Participant revealed masked treatment|0
5885287|NCT01817582|20361120|P1|Overall Study|Participant revealed masked treatment|1
5885288|NCT01817582|20361118|P3|Overall Study|Withdrawal by Subject|0
5885289|NCT01817582|20361119|P2|Overall Study|Withdrawal by Subject|1
5885290|NCT01817582|20361120|P1|Overall Study|Withdrawal by Subject|0
5885291|NCT01817530|20361190|P8|Overall Study|Lost to Follow-up|4
5885292|NCT01817530|20361191|P7|Overall Study|Lost to Follow-up|8
5885293|NCT01817530|20361192|P6|Overall Study|Lost to Follow-up|2
5885294|NCT01817530|20361193|P5|Overall Study|Lost to Follow-up|3
5885295|NCT01817530|20361194|P4|Overall Study|Lost to Follow-up|1
5885296|NCT01817530|20361195|P3|Overall Study|Lost to Follow-up|2
5885297|NCT01817530|20361196|P2|Overall Study|Lost to Follow-up|4
5885298|NCT01817530|20361197|P1|Overall Study|Lost to Follow-up|1
5885299|NCT01817530|20361190|P8|Overall Study|Consent Withdrawn by Subject|10
5885300|NCT01817530|20361191|P7|Overall Study|Consent Withdrawn by Subject|3
5885301|NCT01817530|20361192|P6|Overall Study|Consent Withdrawn by Subject|3
5885302|NCT01817530|20361193|P5|Overall Study|Consent Withdrawn by Subject|5
5885303|NCT01817530|20361194|P4|Overall Study|Consent Withdrawn by Subject|3
5885304|NCT01817530|20361195|P3|Overall Study|Consent Withdrawn by Subject|7
5885305|NCT01817530|20361196|P2|Overall Study|Consent Withdrawn by Subject|4
5885306|NCT01817530|20361197|P1|Overall Study|Consent Withdrawn by Subject|3
5885307|NCT01817530|20361190|P8|Overall Study|Surgery or Invasive Intervention|0
5885308|NCT01817530|20361191|P7|Overall Study|Surgery or Invasive Intervention|1
5885309|NCT01817530|20361192|P6|Overall Study|Surgery or Invasive Intervention|1
5885310|NCT01817530|20361193|P5|Overall Study|Surgery or Invasive Intervention|1
5885311|NCT01817530|20361194|P4|Overall Study|Surgery or Invasive Intervention|0
5885312|NCT01817530|20361195|P3|Overall Study|Surgery or Invasive Intervention|0
5885313|NCT01817530|20361196|P2|Overall Study|Surgery or Invasive Intervention|0
5885314|NCT01817530|20361197|P1|Overall Study|Surgery or Invasive Intervention|1
5885315|NCT01817530|20361190|P8|Overall Study|Other|0
5885316|NCT01817530|20361191|P7|Overall Study|Other|5
5885317|NCT01817530|20361192|P6|Overall Study|Other|0
5885318|NCT01817530|20361193|P5|Overall Study|Other|1
5885319|NCT01817530|20361194|P4|Overall Study|Other|0
5885320|NCT01817530|20361195|P3|Overall Study|Other|0
5885321|NCT01817530|20361196|P2|Overall Study|Other|1
5885322|NCT01817530|20361197|P1|Overall Study|Other|0
5885323|NCT01817530|20361190|P8|Overall Study|Pregnancy|0
5885324|NCT01817530|20361191|P7|Overall Study|Pregnancy|0
5885325|NCT01817530|20361192|P6|Overall Study|Pregnancy|1
5885326|NCT01817530|20361193|P5|Overall Study|Pregnancy|0
5885327|NCT01817530|20361194|P4|Overall Study|Pregnancy|0
5885328|NCT01817530|20361195|P3|Overall Study|Pregnancy|0
5885329|NCT01817530|20361196|P2|Overall Study|Pregnancy|0
5885330|NCT01817530|20361197|P1|Overall Study|Pregnancy|0
5885331|NCT01817530|20361190|P8|Overall Study|Lack of Efficacy|1
5885332|NCT01817530|20361191|P7|Overall Study|Lack of Efficacy|0
5885333|NCT01817530|20361192|P6|Overall Study|Lack of Efficacy|1
5885334|NCT01817530|20361193|P5|Overall Study|Lack of Efficacy|0
5885335|NCT01817530|20361194|P4|Overall Study|Lack of Efficacy|0
5885336|NCT01817530|20361195|P3|Overall Study|Lack of Efficacy|0
5885337|NCT01817530|20361196|P2|Overall Study|Lack of Efficacy|0
5885338|NCT01817530|20361197|P1|Overall Study|Lack of Efficacy|1
5885339|NCT01817530|20361190|P8|Overall Study|Subject Noncompliant|1
5885340|NCT01817530|20361191|P7|Overall Study|Subject Noncompliant|1
5885341|NCT01817530|20361192|P6|Overall Study|Subject Noncompliant|1
5885342|NCT01817530|20361193|P5|Overall Study|Subject Noncompliant|0
5885343|NCT01817530|20361194|P4|Overall Study|Subject Noncompliant|4
5885344|NCT01817530|20361195|P3|Overall Study|Subject Noncompliant|0
5885345|NCT01817530|20361196|P2|Overall Study|Subject Noncompliant|1
5885346|NCT01817530|20361197|P1|Overall Study|Subject Noncompliant|3
5885347|NCT01817530|20361190|P8|Overall Study|Adverse Event|8
5885348|NCT01817530|20361191|P7|Overall Study|Adverse Event|5
5885349|NCT01817530|20361192|P6|Overall Study|Adverse Event|10
5885350|NCT01817530|20361193|P5|Overall Study|Adverse Event|0
5885351|NCT01817530|20361194|P4|Overall Study|Adverse Event|5
5885352|NCT01817530|20361195|P3|Overall Study|Adverse Event|2
5885353|NCT01817530|20361196|P2|Overall Study|Adverse Event|3
5885354|NCT01817530|20361197|P1|Overall Study|Adverse Event|6
5885355|NCT01817530|20361190|P8|Overall Study|Exclusionary Medication Received|0
5885356|NCT01817530|20361191|P7|Overall Study|Exclusionary Medication Received|0
5885357|NCT01817530|20361192|P6|Overall Study|Exclusionary Medication Received|0
5885358|NCT01817530|20361193|P5|Overall Study|Exclusionary Medication Received|1
5885359|NCT01817530|20361194|P4|Overall Study|Exclusionary Medication Received|0
5885360|NCT01817530|20361195|P3|Overall Study|Exclusionary Medication Received|0
5885361|NCT01817530|20361196|P2|Overall Study|Exclusionary Medication Received|0
5885362|NCT01817530|20361197|P1|Overall Study|Exclusionary Medication Received|0
5885363|NCT01817075|20361422|P2|Overall Study|Ineligible|2
5885364|NCT01817075|20361423|P1|Overall Study|Ineligible|0
5885365|NCT01817075|20361422|P2|Overall Study|Received Sorafenib after enrollment|1
5885366|NCT01817075|20361423|P1|Overall Study|Received Sorafenib after enrollment|0
5885367|NCT01817075|20361422|P2|Overall Study|Withdrawal by Subject|15
5885368|NCT01817075|20361423|P1|Overall Study|Withdrawal by Subject|31
5885369|NCT01817075|20361422|P2|Overall Study|Physician Decision|12
5885370|NCT01817075|20361423|P1|Overall Study|Physician Decision|9
5885371|NCT01817075|20361422|P2|Overall Study|Adverse Event|5
5885372|NCT01817075|20361423|P1|Overall Study|Adverse Event|7
5885373|NCT01816984|20361435|P1|Overall Study|declining health status|1
5885374|NCT01816906|20361448|P2|12 Months|Lost to Follow-up|1
5885375|NCT01816906|20361449|P1|12 Months|Lost to Follow-up|2
5885376|NCT01816906|20361448|P2|12 Months|Death|2
5885377|NCT01816906|20361449|P1|12 Months|Death|0
5885378|NCT01816906|20361448|P2|12 Months|Adverse Event|2
5885379|NCT01816906|20361449|P1|12 Months|Adverse Event|2
5885380|NCT01816906|20361448|P2|Six Months|Lost to Follow-up|16
5885381|NCT01816906|20361449|P1|Six Months|Lost to Follow-up|14
5885382|NCT01816906|20361448|P2|Six Months|Did Not Show Up for Baseline Measurement|6
5885383|NCT01816906|20361449|P1|Six Months|Did Not Show Up for Baseline Measurement|7
5885384|NCT01816893|20361467|P2|Washout Period|Withdrawal by Subject|0
5885385|NCT01816893|20361468|P1|Washout Period|Withdrawal by Subject|2
5885386|NCT01816763|20361504|P3|Overall Study|The main reason for an incomplete survey|11
5885387|NCT01816763|20361505|P2|Overall Study|The main reason for an incomplete survey|15
5885388|NCT01816763|20361506|P1|Overall Study|The main reason for an incomplete survey|4
5885389|NCT01816685|20361531|P2|Overall Study|Surgery Cancelled|2
5885390|NCT01816685|20361532|P1|Overall Study|Surgery Cancelled|3
5885391|NCT01816685|20361531|P2|Overall Study|Lost to Follow-up|9
5885392|NCT01816685|20361532|P1|Overall Study|Lost to Follow-up|7
5885393|NCT01816594|20361542|P2|Overall Study|Physician Decision|0
5885394|NCT01816594|20361543|P1|Overall Study|Physician Decision|1
5885395|NCT01816594|20361542|P2|Overall Study|Withdrawal by Subject|0
5885396|NCT01816594|20361543|P1|Overall Study|Withdrawal by Subject|1
5885397|NCT01816594|20361542|P2|Overall Study|Adverse Event|0
5885398|NCT01816594|20361543|P1|Overall Study|Adverse Event|9
5885399|NCT01816594|20361542|P2|Overall Study|Local Progress|2
5885400|NCT01816594|20361543|P1|Overall Study|Local Progress|0
5885401|NCT01816477|20361581|P2|Overall Study|Unable to tolerate catheter placement|0
5885402|NCT01816477|20361582|P1|Overall Study|Unable to tolerate catheter placement|3
5885403|NCT01816477|20361581|P2|Overall Study|Withdrawal by Subject|1
5885404|NCT01816477|20361582|P1|Overall Study|Withdrawal by Subject|13
5885405|NCT01816295|20361636|P2|OLE Phase|Lack of Efficacy|7
5885406|NCT01816295|20361637|P1|OLE Phase|Lack of Efficacy|3
5885407|NCT01816295|20361636|P2|OLE Phase|Withdrawal by Subject|10
5885408|NCT01816295|20361637|P1|OLE Phase|Withdrawal by Subject|10
5885409|NCT01816295|20361636|P2|OLE Phase|Sponsor Decision|9
5885410|NCT01816295|20361637|P1|OLE Phase|Sponsor Decision|7
5885411|NCT01816295|20361636|P2|OLE Phase|Protocol Violation|4
5885412|NCT01816295|20361637|P1|OLE Phase|Protocol Violation|4
5885413|NCT01816295|20361636|P2|OLE Phase|Physician Decision|1
5885414|NCT01816295|20361637|P1|OLE Phase|Physician Decision|3
5885415|NCT01816295|20361636|P2|OLE Phase|Lost to Follow-up|5
5885416|NCT01816295|20361637|P1|OLE Phase|Lost to Follow-up|5
5885417|NCT01816295|20361636|P2|OLE Phase|Entry Criteria Not Met|5
5885418|NCT01816295|20361637|P1|OLE Phase|Entry Criteria Not Met|3
5885419|NCT01816295|20361636|P2|OLE Phase|Death|0
5885420|NCT01816295|20361637|P1|OLE Phase|Death|1
5885421|NCT01816295|20361636|P2|OLE Phase|Adverse Event|15
5885422|NCT01816295|20361637|P1|OLE Phase|Adverse Event|17
5885423|NCT01816295|20361636|P2|Double Blind Phase|Withdrawal by Subject|20
5885424|NCT01816295|20361637|P1|Double Blind Phase|Withdrawal by Subject|22
5885425|NCT01816295|20361636|P2|Double Blind Phase|Sponsor Decision|8
5885426|NCT01816295|20361637|P1|Double Blind Phase|Sponsor Decision|8
5885427|NCT01816295|20361636|P2|Double Blind Phase|Protocol Violation|11
5885428|NCT01816295|20361637|P1|Double Blind Phase|Protocol Violation|17
5885429|NCT01816295|20361636|P2|Double Blind Phase|Physician Decision|2
5885430|NCT01816295|20361637|P1|Double Blind Phase|Physician Decision|2
5885431|NCT01816295|20361636|P2|Double Blind Phase|Lost to Follow-up|5
5885432|NCT01816295|20361637|P1|Double Blind Phase|Lost to Follow-up|3
5885433|NCT01816295|20361636|P2|Double Blind Phase|Entry Criteria Not Met|2
5885434|NCT01816295|20361637|P1|Double Blind Phase|Entry Criteria Not Met|0
5885435|NCT01816295|20361636|P2|Double Blind Phase|Adverse Event|8
5885436|NCT01816295|20361637|P1|Double Blind Phase|Adverse Event|11
5885437|NCT01816243|20361652|P1|Overall Study|Amputation|3
5885438|NCT01816243|20361652|P1|Overall Study|Not eligible for the study|1
5885439|NCT01816243|20361652|P1|Overall Study|Lack of Efficacy|1
5885440|NCT01816243|20361652|P1|Overall Study|Lost to Follow-up|1
5885441|NCT01816243|20361652|P1|Overall Study|Adverse Event|6
5885442|NCT01816074|20361667|P4|Phase 2|Withdrawal by Subject|0
5885443|NCT01816074|20361668|P3|Phase 2|Withdrawal by Subject|0
5885444|NCT01816074|20361669|P2|Phase 2|Withdrawal by Subject|0
5885445|NCT01816074|20361670|P1|Phase 2|Withdrawal by Subject|1
5885446|NCT01816074|20361667|P4|Phase 2|Physician Decision|1
5885447|NCT01816074|20361668|P3|Phase 2|Physician Decision|0
5885448|NCT01816074|20361669|P2|Phase 2|Physician Decision|0
5885449|NCT01816074|20361670|P1|Phase 2|Physician Decision|0
5885450|NCT01816074|20361667|P4|Phase 2|Unsatisfied with Randomization assignmen|0
5885451|NCT01816074|20361668|P3|Phase 2|Unsatisfied with Randomization assignmen|0
5885452|NCT01816074|20361669|P2|Phase 2|Unsatisfied with Randomization assignmen|0
5885453|NCT01816074|20361670|P1|Phase 2|Unsatisfied with Randomization assignmen|1
5885454|NCT01816074|20361667|P4|Phase 2|Time commitment Issues|0
5885455|NCT01816074|20361668|P3|Phase 2|Time commitment Issues|0
5885456|NCT01816074|20361669|P2|Phase 2|Time commitment Issues|2
5885457|NCT01816074|20361670|P1|Phase 2|Time commitment Issues|0
5885458|NCT01816074|20361667|P4|Phase 1|Time commitment issues|0
5885459|NCT01816074|20361668|P3|Phase 1|Time commitment issues|1
5885460|NCT01816074|20361669|P2|Phase 1|Time commitment issues|0
5885461|NCT01816074|20361670|P1|Phase 1|Time commitment issues|0
5885462|NCT01816061|20361700|P2|Overall Study|Lost to Follow-up|24
5885463|NCT01816061|20361701|P1|Overall Study|Lost to Follow-up|13
5885464|NCT01816048|20361709|P1|Overall Study|Disease Progression|3
5885465|NCT01816048|20361709|P1|Overall Study|Withdrawal by Subject|1
5885466|NCT01816048|20361709|P1|Overall Study|Death|1
5885467|NCT01816048|20361709|P1|Overall Study|Adverse Event|1
5885468|NCT01815918|20361724|P2|Overall Study|Lack of Efficacy|15
5885469|NCT01815918|20361725|P1|Overall Study|Lack of Efficacy|15
5885470|NCT01815918|20361724|P2|Overall Study|Patient samples not analyzable|4
5885471|NCT01815918|20361725|P1|Overall Study|Patient samples not analyzable|3
5885472|NCT01815840|20361741|P2|Overall Study|Sponsor Termination Treatment|0
5885473|NCT01815840|20361742|P1|Overall Study|Sponsor Termination Treatment|1
5885474|NCT01815840|20361741|P2|Overall Study|Refused Treatment|1
5885475|NCT01815840|20361742|P1|Overall Study|Refused Treatment|5
5885476|NCT01815840|20361741|P2|Overall Study|Lost to Follow-up|6
5885477|NCT01815840|20361742|P1|Overall Study|Lost to Follow-up|3
5885478|NCT01815840|20361741|P2|Overall Study|Investigators Decision|3
5885479|NCT01815840|20361742|P1|Overall Study|Investigators Decision|2
5885480|NCT01815840|20361741|P2|Overall Study|Disease progression|2
5885481|NCT01815840|20361742|P1|Overall Study|Disease progression|3
5885482|NCT01815840|20361741|P2|Overall Study|Death|2
5885483|NCT01815840|20361742|P1|Overall Study|Death|2
5885484|NCT01815840|20361741|P2|Overall Study|Adverse Event|16
5885485|NCT01815840|20361742|P1|Overall Study|Adverse Event|10
5885486|NCT01815840|20361741|P2|Overall Study|Administrative/Other|3
5885487|NCT01815840|20361742|P1|Overall Study|Administrative/Other|1
5885488|NCT01815840|20361741|P2|Overall Study|Withdrew Consent|30
5885489|NCT01815840|20361742|P1|Overall Study|Withdrew Consent|31
5885490|NCT01815840|20361741|P2|Overall Study|Missing|0
5885491|NCT01815840|20361742|P1|Overall Study|Missing|1
5885492|NCT01815736|20361772|P2|Overall Study|Still on Study|449
5885493|NCT01815736|20361773|P1|Overall Study|Still on Study|929
5885494|NCT01815736|20361772|P2|Overall Study|Lost to Follow-up|7
5885495|NCT01815736|20361773|P1|Overall Study|Lost to Follow-up|6
5885496|NCT01815736|20361772|P2|Overall Study|Withdrew Consent|15
5885497|NCT01815736|20361773|P1|Overall Study|Withdrew Consent|7
5885498|NCT01815736|20361772|P2|Overall Study|Investigator's Discretion|0
5885499|NCT01815736|20361773|P1|Overall Study|Investigator's Discretion|4
5885500|NCT01815736|20361772|P2|Overall Study|Death|0
5885501|NCT01815736|20361773|P1|Overall Study|Death|4
5885502|NCT01815736|20361772|P2|Overall Study|Adverse Event|4
5885503|NCT01815736|20361773|P1|Overall Study|Adverse Event|7
5885504|NCT01815736|20361772|P2|Overall Study|Randomized but Not Treated|3
5885505|NCT01815736|20361773|P1|Overall Study|Randomized but Not Treated|4
5885506|NCT01815424|20361842|P5|Week 16 to 52|Withdrawal by Subject|0
5885507|NCT01815424|20361843|P4|Week 16 to 52|Withdrawal by Subject|0
5885508|NCT01815424|20361844|P3|Week 16 to 52|Withdrawal by Subject|0
5885509|NCT01815424|20361845|P2|Week 16 to 52|Withdrawal by Subject|2
5885510|NCT01815424|20361846|P1|Week 16 to 52|Withdrawal by Subject|1
5885511|NCT01815424|20361842|P5|Week 16 to 52|Lost to Follow-up|1
5885512|NCT01815424|20361843|P4|Week 16 to 52|Lost to Follow-up|2
5885513|NCT01815424|20361844|P3|Week 16 to 52|Lost to Follow-up|0
5885514|NCT01815424|20361845|P2|Week 16 to 52|Lost to Follow-up|2
5885515|NCT01815424|20361846|P1|Week 16 to 52|Lost to Follow-up|0
5885516|NCT01815424|20361842|P5|Week 16 to 52|Insufficient Clinical Response|1
5885517|NCT01815424|20361843|P4|Week 16 to 52|Insufficient Clinical Response|1
5885518|NCT01815424|20361844|P3|Week 16 to 52|Insufficient Clinical Response|0
5885519|NCT01815424|20361845|P2|Week 16 to 52|Insufficient Clinical Response|0
5885520|NCT01815424|20361846|P1|Week 16 to 52|Insufficient Clinical Response|1
5885521|NCT01815424|20361842|P5|Week 16 to 52|Adverse Event|1
5885522|NCT01815424|20361843|P4|Week 16 to 52|Adverse Event|0
5885523|NCT01815424|20361844|P3|Week 16 to 52|Adverse Event|0
5885524|NCT01815424|20361845|P2|Week 16 to 52|Adverse Event|0
5885525|NCT01815424|20361846|P1|Week 16 to 52|Adverse Event|0
5885526|NCT01815424|20361842|P5|Week 16 to 52|Other|0
5885527|NCT01815424|20361843|P4|Week 16 to 52|Other|0
5885528|NCT01815424|20361844|P3|Week 16 to 52|Other|0
5885529|NCT01815424|20361845|P2|Week 16 to 52|Other|1
5885530|NCT01815424|20361846|P1|Week 16 to 52|Other|0
5885531|NCT01815424|20361842|P5|Week 0 to 16|Insufficient Clinical Response|0
5885532|NCT01815424|20361843|P4|Week 0 to 16|Insufficient Clinical Response|0
5885533|NCT01815424|20361844|P3|Week 0 to 16|Insufficient Clinical Response|4
5885534|NCT01815424|20361845|P2|Week 0 to 16|Insufficient Clinical Response|0
5885535|NCT01815424|20361846|P1|Week 0 to 16|Insufficient Clinical Response|2
5885536|NCT01815424|20361842|P5|Week 0 to 16|Protocol Violation|0
5885537|NCT01815424|20361843|P4|Week 0 to 16|Protocol Violation|0
5885538|NCT01815424|20361844|P3|Week 0 to 16|Protocol Violation|0
5885539|NCT01815424|20361845|P2|Week 0 to 16|Protocol Violation|0
5885540|NCT01815424|20361846|P1|Week 0 to 16|Protocol Violation|1
5885541|NCT01815424|20361842|P5|Week 0 to 16|Other|0
5885542|NCT01815424|20361843|P4|Week 0 to 16|Other|0
5885543|NCT01815424|20361844|P3|Week 0 to 16|Other|3
5885544|NCT01815424|20361845|P2|Week 0 to 16|Other|0
5885545|NCT01815424|20361846|P1|Week 0 to 16|Other|1
5885546|NCT01815424|20361842|P5|Week 0 to 16|Withdrawal by Subject|0
5885547|NCT01815424|20361843|P4|Week 0 to 16|Withdrawal by Subject|0
5885548|NCT01815424|20361844|P3|Week 0 to 16|Withdrawal by Subject|1
5885549|NCT01815424|20361845|P2|Week 0 to 16|Withdrawal by Subject|0
5885550|NCT01815424|20361846|P1|Week 0 to 16|Withdrawal by Subject|0
5885551|NCT01815424|20361842|P5|Week 0 to 16|Lost to Follow-up|0
5885552|NCT01815424|20361843|P4|Week 0 to 16|Lost to Follow-up|0
5885553|NCT01815424|20361844|P3|Week 0 to 16|Lost to Follow-up|0
5885554|NCT01815424|20361845|P2|Week 0 to 16|Lost to Follow-up|1
5885555|NCT01815424|20361846|P1|Week 0 to 16|Lost to Follow-up|0
5885556|NCT01815424|20361842|P5|Week 0 to 16|Does Not Meet Entrance Criteria|0
5885557|NCT01815424|20361843|P4|Week 0 to 16|Does Not Meet Entrance Criteria|0
5885558|NCT01815424|20361844|P3|Week 0 to 16|Does Not Meet Entrance Criteria|0
5885559|NCT01815424|20361845|P2|Week 0 to 16|Does Not Meet Entrance Criteria|0
5885560|NCT01815424|20361846|P1|Week 0 to 16|Does Not Meet Entrance Criteria|2
5885561|NCT01815424|20361842|P5|Week 0 to 16|Adverse Event|0
5885562|NCT01815424|20361843|P4|Week 0 to 16|Adverse Event|0
5885563|NCT01815424|20361844|P3|Week 0 to 16|Adverse Event|3
5885564|NCT01815424|20361845|P2|Week 0 to 16|Adverse Event|3
5885565|NCT01815424|20361846|P1|Week 0 to 16|Adverse Event|1
5885566|NCT01815138|20362062|P2|Overall Study|Physician Decision|5
5885567|NCT01815138|20362063|P1|Overall Study|Physician Decision|8
5885568|NCT01815138|20362062|P2|Overall Study|Withdrawal by Subject|1
5885569|NCT01815138|20362063|P1|Overall Study|Withdrawal by Subject|0
5885570|NCT01815099|20362075|P1|Overall Study|unable to attend study visits|1
5885571|NCT01815099|20362075|P1|Overall Study|Lack of Efficacy|1
5885572|NCT01814878|20362089|P2|Overall Study|Other|0
5885573|NCT01814878|20362090|P1|Overall Study|Other|2
5885574|NCT01814878|20362089|P2|Overall Study|Screening failure (drop-out)|3
5885575|NCT01814878|20362090|P1|Overall Study|Screening failure (drop-out)|0
5885576|NCT01814878|20362089|P2|Overall Study|Physician Decision|1
5885577|NCT01814878|20362090|P1|Overall Study|Physician Decision|3
5885578|NCT01814878|20362089|P2|Overall Study|Protocol Violation|5
5885579|NCT01814878|20362090|P1|Overall Study|Protocol Violation|5
5885580|NCT01814878|20362089|P2|Overall Study|Withdrawal by Subject|16
5885581|NCT01814878|20362090|P1|Overall Study|Withdrawal by Subject|20
5885582|NCT01814878|20362089|P2|Overall Study|Adverse Event|5
5885583|NCT01814878|20362090|P1|Overall Study|Adverse Event|16
5885584|NCT01814826|20362113|P3|Overall Study|Death|3
5885585|NCT01814826|20362114|P2|Overall Study|Death|24
5885586|NCT01814826|20362115|P1|Overall Study|Death|29
5885587|NCT01814826|20362113|P3|Overall Study|Other|0
5885588|NCT01814826|20362114|P2|Overall Study|Other|5
5885589|NCT01814826|20362115|P1|Overall Study|Other|3
5885590|NCT01814800|20362207|P1|Overall Study|Subject relocation|1
5885591|NCT01814800|20362207|P1|Overall Study|Sponsor decision|1
5885592|NCT01814800|20362207|P1|Overall Study|Pregnancy|1
5885593|NCT01814800|20362207|P1|Overall Study|Adverse Event|2
5885594|NCT01814761|20362267|P2|Overall Study|Lost to Follow-up|5
5885595|NCT01814761|20362268|P1|Overall Study|Lost to Follow-up|1
5885596|NCT01814761|20362267|P2|Overall Study|Ocular Adverse Event|15
5885597|NCT01814761|20362268|P1|Overall Study|Ocular Adverse Event|6
5885598|NCT01814761|20362267|P2|Overall Study|Other Reasons|10
5885599|NCT01814761|20362268|P1|Overall Study|Other Reasons|1
5885600|NCT01814748|20362282|P2|Overall Study|Withdrawal by Subject|4
5885601|NCT01814748|20362283|P1|Overall Study|Withdrawal by Subject|6
5885602|NCT01814748|20362282|P2|Overall Study|Study site terminated by sponsor|1
5885603|NCT01814748|20362283|P1|Overall Study|Study site terminated by sponsor|1
5885604|NCT01814748|20362282|P2|Overall Study|Lost to Follow-up|2
5885605|NCT01814748|20362283|P1|Overall Study|Lost to Follow-up|1
5885606|NCT01814696|20362327|P2|Overall Study|Randomized to wrong group|0
5885607|NCT01814696|20362328|P1|Overall Study|Randomized to wrong group|1
5885608|NCT01814696|20362327|P2|Overall Study|Withdrawal by Subject|0
5885609|NCT01814696|20362328|P1|Overall Study|Withdrawal by Subject|1
5885610|NCT01814670|20362346|P1|Overall Study|Protocol Violation|12
5885611|NCT01814553|20362356|P2|Overall Study|Other than stated|8
5885612|NCT01814553|20362357|P1|Overall Study|Other than stated|7
5885613|NCT01814553|20362356|P2|Overall Study|Withdrawal by Subject|1
5885614|NCT01814553|20362357|P1|Overall Study|Withdrawal by Subject|1
5885615|NCT01814553|20362356|P2|Overall Study|Other Adverse Event|5
5885616|NCT01814553|20362357|P1|Overall Study|Other Adverse Event|4
5885617|NCT01814553|20362356|P2|Overall Study|PD per clinical progression|8
5885618|NCT01814553|20362357|P1|Overall Study|PD per clinical progression|6
5885619|NCT01814397|20362371|P1|Overall Study|Withdrawal by Subject|7
5885620|NCT01814397|20362371|P1|Overall Study|Adverse Event|7
5885621|NCT01814371|20362380|P2|Overall Study|Lost to Follow-up|27
5885622|NCT01814371|20362381|P1|Overall Study|Lost to Follow-up|30
5885623|NCT01814332|20362416|P2|Overall Study|Lost to Follow-up|1
5885624|NCT01814332|20362417|P1|Overall Study|Lost to Follow-up|5
5885625|NCT01814332|20362416|P2|Overall Study|Protocol Violation|4
5885626|NCT01814332|20362417|P1|Overall Study|Protocol Violation|0
5885627|NCT01814332|20362416|P2|Overall Study|Withdrawal by Subject|8
5885628|NCT01814332|20362417|P1|Overall Study|Withdrawal by Subject|3
5885629|NCT01814332|20362416|P2|Overall Study|Adverse Event|3
5885630|NCT01814332|20362417|P1|Overall Study|Adverse Event|8
5885631|NCT01814137|20362439|P2|Overall Study|Unclassified|1
5885632|NCT01814137|20362440|P1|Overall Study|Unclassified|2
5885633|NCT01814137|20362439|P2|Overall Study|Physician Decision|1
5885634|NCT01814137|20362440|P1|Overall Study|Physician Decision|1
5885635|NCT01814137|20362439|P2|Overall Study|Withdrawal by Subject|2
5885636|NCT01814137|20362440|P1|Overall Study|Withdrawal by Subject|2
5885637|NCT01814137|20362439|P2|Overall Study|Adverse Event|1
5885638|NCT01814137|20362440|P1|Overall Study|Adverse Event|0
5885639|NCT01814072|20362486|P32|Overall Study|Withdrawal by Subject|0
5885640|NCT01814072|20362487|P31|Overall Study|Withdrawal by Subject|0
5885641|NCT01814072|20362488|P30|Overall Study|Withdrawal by Subject|0
5885642|NCT01814072|20362489|P29|Overall Study|Withdrawal by Subject|1
5885643|NCT01814072|20362490|P28|Overall Study|Withdrawal by Subject|2
5885644|NCT01814072|20362491|P27|Overall Study|Withdrawal by Subject|1
5885645|NCT01814072|20362492|P26|Overall Study|Withdrawal by Subject|1
5885646|NCT01814072|20362493|P25|Overall Study|Withdrawal by Subject|2
5885647|NCT01814072|20362494|P24|Overall Study|Withdrawal by Subject|0
5885648|NCT01814072|20362495|P23|Overall Study|Withdrawal by Subject|1
5885649|NCT01814072|20362496|P22|Overall Study|Withdrawal by Subject|0
5885650|NCT01814072|20362497|P21|Overall Study|Withdrawal by Subject|0
5885651|NCT01814072|20362498|P20|Overall Study|Withdrawal by Subject|2
5885652|NCT01814072|20362499|P19|Overall Study|Withdrawal by Subject|0
5885653|NCT01814072|20362500|P18|Overall Study|Withdrawal by Subject|0
5885654|NCT01814072|20362501|P17|Overall Study|Withdrawal by Subject|0
5885655|NCT01814072|20362502|P16|Overall Study|Withdrawal by Subject|1
5885656|NCT01814072|20362503|P15|Overall Study|Withdrawal by Subject|1
5885657|NCT01814072|20362504|P14|Overall Study|Withdrawal by Subject|1
5885658|NCT01814072|20362505|P13|Overall Study|Withdrawal by Subject|1
5885659|NCT01814072|20362506|P12|Overall Study|Withdrawal by Subject|0
5885660|NCT01814072|20362507|P11|Overall Study|Withdrawal by Subject|0
5885661|NCT01814072|20362508|P10|Overall Study|Withdrawal by Subject|2
5885662|NCT01814072|20362509|P9|Overall Study|Withdrawal by Subject|1
5885663|NCT01814072|20362510|P8|Overall Study|Withdrawal by Subject|0
5885664|NCT01814072|20362511|P7|Overall Study|Withdrawal by Subject|1
5885665|NCT01814072|20362512|P6|Overall Study|Withdrawal by Subject|3
5885666|NCT01814072|20362513|P5|Overall Study|Withdrawal by Subject|2
5885667|NCT01814072|20362514|P4|Overall Study|Withdrawal by Subject|0
5885668|NCT01814072|20362515|P3|Overall Study|Withdrawal by Subject|1
5885669|NCT01814072|20362516|P2|Overall Study|Withdrawal by Subject|0
5885670|NCT01814072|20362517|P1|Overall Study|Withdrawal by Subject|2
5885671|NCT01814072|20362486|P32|Overall Study|Lost to Follow-up|0
5885672|NCT01814072|20362487|P31|Overall Study|Lost to Follow-up|2
5885673|NCT01814072|20362488|P30|Overall Study|Lost to Follow-up|3
5885674|NCT01814072|20362489|P29|Overall Study|Lost to Follow-up|3
5885675|NCT01814072|20362490|P28|Overall Study|Lost to Follow-up|2
5885676|NCT01814072|20362491|P27|Overall Study|Lost to Follow-up|1
5885677|NCT01814072|20362492|P26|Overall Study|Lost to Follow-up|1
5885678|NCT01814072|20362493|P25|Overall Study|Lost to Follow-up|4
5885679|NCT01814072|20362494|P24|Overall Study|Lost to Follow-up|1
5885680|NCT01814072|20362495|P23|Overall Study|Lost to Follow-up|3
5885681|NCT01814072|20362496|P22|Overall Study|Lost to Follow-up|1
5885682|NCT01814072|20362497|P21|Overall Study|Lost to Follow-up|2
5885683|NCT01814072|20362498|P20|Overall Study|Lost to Follow-up|3
5885684|NCT01814072|20362499|P19|Overall Study|Lost to Follow-up|3
5885685|NCT01814072|20362500|P18|Overall Study|Lost to Follow-up|1
5885686|NCT01814072|20362501|P17|Overall Study|Lost to Follow-up|3
5885687|NCT01814072|20362502|P16|Overall Study|Lost to Follow-up|1
5885688|NCT01814072|20362503|P15|Overall Study|Lost to Follow-up|2
5885689|NCT01814072|20362504|P14|Overall Study|Lost to Follow-up|1
5885690|NCT01814072|20362505|P13|Overall Study|Lost to Follow-up|2
5885691|NCT01814072|20362506|P12|Overall Study|Lost to Follow-up|2
5885692|NCT01814072|20362507|P11|Overall Study|Lost to Follow-up|1
5885693|NCT01814072|20362508|P10|Overall Study|Lost to Follow-up|3
5885694|NCT01814072|20362509|P9|Overall Study|Lost to Follow-up|2
5885695|NCT01814072|20362510|P8|Overall Study|Lost to Follow-up|1
5885696|NCT01814072|20362511|P7|Overall Study|Lost to Follow-up|3
5885697|NCT01814072|20362512|P6|Overall Study|Lost to Follow-up|3
5885698|NCT01814072|20362513|P5|Overall Study|Lost to Follow-up|2
5885699|NCT01814072|20362514|P4|Overall Study|Lost to Follow-up|0
5885700|NCT01814072|20362515|P3|Overall Study|Lost to Follow-up|2
5885701|NCT01814072|20362516|P2|Overall Study|Lost to Follow-up|2
5885702|NCT01814072|20362517|P1|Overall Study|Lost to Follow-up|2
5885703|NCT01814046|20362559|P3|Drug Administration|Death due to complications of RSV|0
5885704|NCT01814046|20362560|P2|Drug Administration|Death due to complications of RSV|0
5885705|NCT01814046|20362561|P1|Drug Administration|Death due to complications of RSV|1
5885706|NCT01814007|20362572|P1|Overall Study|Withdrawal by Subject|1
5885707|NCT01813890|20362585|P3|Overall Study|Lack of Efficacy|2
5885708|NCT01813890|20362586|P2|Overall Study|Lack of Efficacy|1
5885709|NCT01813890|20362587|P1|Overall Study|Lack of Efficacy|9
5885710|NCT01813890|20362585|P3|Overall Study|Adverse Event|4
5885711|NCT01813890|20362586|P2|Overall Study|Adverse Event|3
5885712|NCT01813890|20362587|P1|Overall Study|Adverse Event|0
5885713|NCT01813721|20362624|P1|Overall Study|Withdrawal by Subject|1
5885714|NCT01813721|20362624|P1|Overall Study|Ineligibility determined|63
5885715|NCT01813474|20362679|P3|Overall Study|Death|1
5885716|NCT01813474|20362680|P2|Overall Study|Death|0
5885717|NCT01813474|20362681|P1|Overall Study|Death|0
5885718|NCT01813474|20362679|P3|Overall Study|Lack of Efficacy|9
5885719|NCT01813474|20362680|P2|Overall Study|Lack of Efficacy|6
5885720|NCT01813474|20362681|P1|Overall Study|Lack of Efficacy|2
5885721|NCT01813474|20362679|P3|Overall Study|Adverse Event|0
5885722|NCT01813474|20362680|P2|Overall Study|Adverse Event|1
5885723|NCT01813474|20362681|P1|Overall Study|Adverse Event|1
5885724|NCT01813474|20362679|P3|Overall Study|Withdrawal by Subject|1
5885725|NCT01813474|20362680|P2|Overall Study|Withdrawal by Subject|0
5885726|NCT01813474|20362681|P1|Overall Study|Withdrawal by Subject|0
5885727|NCT01813435|20362705|P2|Overall Study|Lost to Follow-up|237
5885728|NCT01813435|20362706|P1|Overall Study|Lost to Follow-up|268
5885729|NCT01813435|20362705|P2|Overall Study|did not finish experimental regimen|770
5885730|NCT01813435|20362706|P1|Overall Study|did not finish experimental regimen|1902
5885731|NCT01813422|20362730|P2|Overall Study|Lost to Follow-up|4
5885732|NCT01813422|20362731|P1|Overall Study|Lost to Follow-up|2
5885733|NCT01813422|20362730|P2|Overall Study|Sponsor Decision|1
5885734|NCT01813422|20362731|P1|Overall Study|Sponsor Decision|2
5885735|NCT01813422|20362730|P2|Overall Study|Death|3
5885736|NCT01813422|20362731|P1|Overall Study|Death|2
5885737|NCT01813422|20362730|P2|Overall Study|Withdrawal by Subject|8
5885738|NCT01813422|20362731|P1|Overall Study|Withdrawal by Subject|14
5885739|NCT01813357|20362745|P2|Overall Study|Lost to Follow-up|6
5885740|NCT01813357|20362746|P1|Overall Study|Lost to Follow-up|5
5885741|NCT01813071|20362802|P9|Overall Study|Met inc/exc criteria|1
5885742|NCT01813071|20362803|P8|Overall Study|Met inc/exc criteria|1
5885743|NCT01813071|20362804|P7|Overall Study|Met inc/exc criteria|0
5885744|NCT01813071|20362805|P6|Overall Study|Met inc/exc criteria|1
5885745|NCT01813071|20362806|P5|Overall Study|Met inc/exc criteria|0
5885746|NCT01813071|20362807|P4|Overall Study|Met inc/exc criteria|0
5885747|NCT01813071|20362808|P3|Overall Study|Met inc/exc criteria|0
5885748|NCT01813071|20362809|P2|Overall Study|Met inc/exc criteria|0
5885749|NCT01813071|20362810|P1|Overall Study|Met inc/exc criteria|0
5885750|NCT01813071|20362802|P9|Overall Study|Physician Decision|0
5885751|NCT01813071|20362803|P8|Overall Study|Physician Decision|0
5885752|NCT01813071|20362804|P7|Overall Study|Physician Decision|1
5885753|NCT01813071|20362805|P6|Overall Study|Physician Decision|0
5885754|NCT01813071|20362806|P5|Overall Study|Physician Decision|0
5885755|NCT01813071|20362807|P4|Overall Study|Physician Decision|0
5885756|NCT01813071|20362808|P3|Overall Study|Physician Decision|0
5885757|NCT01813071|20362809|P2|Overall Study|Physician Decision|0
5885758|NCT01813071|20362810|P1|Overall Study|Physician Decision|0
5885759|NCT01813071|20362802|P9|Overall Study|Adverse Event|0
5885760|NCT01813071|20362803|P8|Overall Study|Adverse Event|0
5885761|NCT01813071|20362804|P7|Overall Study|Adverse Event|0
5885762|NCT01813071|20362805|P6|Overall Study|Adverse Event|1
5885763|NCT01813071|20362806|P5|Overall Study|Adverse Event|0
5885764|NCT01813071|20362807|P4|Overall Study|Adverse Event|0
5885765|NCT01813071|20362808|P3|Overall Study|Adverse Event|0
5885766|NCT01813071|20362809|P2|Overall Study|Adverse Event|0
5885767|NCT01813071|20362810|P1|Overall Study|Adverse Event|0
5885768|NCT01813071|20362802|P9|Overall Study|Withdrawal by Subject|0
5885769|NCT01813071|20362803|P8|Overall Study|Withdrawal by Subject|0
5885770|NCT01813071|20362804|P7|Overall Study|Withdrawal by Subject|0
5885771|NCT01813071|20362805|P6|Overall Study|Withdrawal by Subject|1
5885772|NCT01813071|20362806|P5|Overall Study|Withdrawal by Subject|0
5885773|NCT01813071|20362807|P4|Overall Study|Withdrawal by Subject|0
5885774|NCT01813071|20362808|P3|Overall Study|Withdrawal by Subject|0
5885775|NCT01813071|20362809|P2|Overall Study|Withdrawal by Subject|0
5885776|NCT01813071|20362810|P1|Overall Study|Withdrawal by Subject|0
5885777|NCT01813071|20362802|P9|Overall Study|Protocol Violation|2
5885778|NCT01813071|20362803|P8|Overall Study|Protocol Violation|4
5885779|NCT01813071|20362804|P7|Overall Study|Protocol Violation|2
5885780|NCT01813071|20362805|P6|Overall Study|Protocol Violation|4
5885781|NCT01813071|20362806|P5|Overall Study|Protocol Violation|1
5885782|NCT01813071|20362807|P4|Overall Study|Protocol Violation|0
5885783|NCT01813071|20362808|P3|Overall Study|Protocol Violation|0
5885784|NCT01813071|20362809|P2|Overall Study|Protocol Violation|0
5885785|NCT01813071|20362810|P1|Overall Study|Protocol Violation|0
5885786|NCT01813058|20363277|P2|Overall Study|Withdrawal by Subject|4
5885787|NCT01813058|20363278|P1|Overall Study|Withdrawal by Subject|5
5885788|NCT01813019|20363286|P2|Overall Study|Protocol Deviation|1
5885789|NCT01813019|20363287|P1|Overall Study|Protocol Deviation|2
5885790|NCT01813019|20363286|P2|Overall Study|administrative problems|0
5885791|NCT01813019|20363287|P1|Overall Study|administrative problems|2
5885792|NCT01813019|20363286|P2|Overall Study|Withdrawal by Subject|2
5885793|NCT01813019|20363287|P1|Overall Study|Withdrawal by Subject|3
5885794|NCT01813019|20363286|P2|Overall Study|Adverse Event|3
5885795|NCT01813019|20363287|P1|Overall Study|Adverse Event|0
5885796|NCT01812837|20363298|P3|Overall Study|Protocol Violation|0
5885797|NCT01812837|20363299|P2|Overall Study|Protocol Violation|0
5885798|NCT01812837|20363300|P1|Overall Study|Protocol Violation|1
5885799|NCT01812837|20363298|P3|Overall Study|Lost to Follow-up|0
5885800|NCT01812837|20363299|P2|Overall Study|Lost to Follow-up|1
5885801|NCT01812837|20363300|P1|Overall Study|Lost to Follow-up|1
5885802|NCT01812759|20363311|P3|Overall Study|Physician Decision|1
5885803|NCT01812759|20363312|P2|Overall Study|Physician Decision|0
5885804|NCT01812759|20363313|P1|Overall Study|Physician Decision|0
5885805|NCT01812707|20363325|P4|Overall Study|Consent withdrawn by participant|0
5885806|NCT01812707|20363326|P3|Overall Study|Consent withdrawn by participant|0
5885807|NCT01812707|20363327|P2|Overall Study|Consent withdrawn by participant|0
5885808|NCT01812707|20363328|P1|Overall Study|Consent withdrawn by participant|1
5885809|NCT01812707|20363325|P4|Overall Study|Poor compliance to protocol|0
5885810|NCT01812707|20363326|P3|Overall Study|Poor compliance to protocol|0
5885811|NCT01812707|20363327|P2|Overall Study|Poor compliance to protocol|0
5885812|NCT01812707|20363328|P1|Overall Study|Poor compliance to protocol|1
5885813|NCT01812707|20363325|P4|Overall Study|Adverse Event|2
5885814|NCT01812707|20363326|P3|Overall Study|Adverse Event|0
5885815|NCT01812707|20363327|P2|Overall Study|Adverse Event|0
5885816|NCT01812707|20363328|P1|Overall Study|Adverse Event|0
5885817|NCT01812655|20363376|P3|Overall Study|Protocol Violation|0
5885818|NCT01812655|20363377|P2|Overall Study|Protocol Violation|1
5885819|NCT01812655|20363378|P1|Overall Study|Protocol Violation|1
5885820|NCT01812057|20363403|P2|Overall Study|Physician Decision|0
5885821|NCT01812057|20363404|P1|Overall Study|Physician Decision|1
5885822|NCT01812057|20363403|P2|Overall Study|Protocol Violation|0
5885823|NCT01812057|20363404|P1|Overall Study|Protocol Violation|1
5885824|NCT01811953|20363507|P6|Overall Study|Protocol Violation|0
5885825|NCT01811953|20363508|P5|Overall Study|Protocol Violation|1
5885826|NCT01811953|20363509|P4|Overall Study|Protocol Violation|0
5885827|NCT01811953|20363510|P3|Overall Study|Protocol Violation|0
5885828|NCT01811953|20363511|P2|Overall Study|Protocol Violation|0
5885829|NCT01811953|20363512|P1|Overall Study|Protocol Violation|0
5885830|NCT01811953|20363507|P6|Overall Study|Adverse Event|1
5885831|NCT01811953|20363508|P5|Overall Study|Adverse Event|0
5885832|NCT01811953|20363509|P4|Overall Study|Adverse Event|1
5885833|NCT01811953|20363510|P3|Overall Study|Adverse Event|0
5885834|NCT01811953|20363511|P2|Overall Study|Adverse Event|0
5885835|NCT01811953|20363512|P1|Overall Study|Adverse Event|0
5885836|NCT01811732|20363569|P2|Overall Study|Correct study drug not available on site|0
5885837|NCT01811732|20363570|P1|Overall Study|Correct study drug not available on site|1
5885838|NCT01811732|20363569|P2|Overall Study|Admitted to another facility|0
5885839|NCT01811732|20363570|P1|Overall Study|Admitted to another facility|1
5885840|NCT01811732|20363569|P2|Overall Study|Subject incarcerated|2
5885841|NCT01811732|20363570|P1|Overall Study|Subject incarcerated|1
5885842|NCT01811732|20363569|P2|Overall Study|Protocol Violation|1
5885843|NCT01811732|20363570|P1|Overall Study|Protocol Violation|0
5885844|NCT01811732|20363569|P2|Overall Study|Insufficient venous access|1
5885845|NCT01811732|20363570|P1|Overall Study|Insufficient venous access|0
5885846|NCT01811732|20363569|P2|Overall Study|Death|1
5885847|NCT01811732|20363570|P1|Overall Study|Death|1
5885848|NCT01811732|20363569|P2|Overall Study|Physician Decision|0
5885849|NCT01811732|20363570|P1|Overall Study|Physician Decision|2
5885850|NCT01811732|20363569|P2|Overall Study|Non-compliance with study drug/procedure|3
5885851|NCT01811732|20363570|P1|Overall Study|Non-compliance with study drug/procedure|3
5885852|NCT01811732|20363569|P2|Overall Study|Lack of Efficacy|1
5885853|NCT01811732|20363570|P1|Overall Study|Lack of Efficacy|3
5885854|NCT01811732|20363569|P2|Overall Study|Adverse Event|9
5885855|NCT01811732|20363570|P1|Overall Study|Adverse Event|3
5885856|NCT01811732|20363569|P2|Overall Study|Withdrawal by Subject|10
5885857|NCT01811732|20363570|P1|Overall Study|Withdrawal by Subject|16
5885858|NCT01811732|20363569|P2|Overall Study|Lost to Follow-up|30
5885859|NCT01811732|20363570|P1|Overall Study|Lost to Follow-up|24
5885860|NCT01811706|20363580|P2|First Intervention ( 4 Weeks)|Adverse Event|0
5885861|NCT01811706|20363581|P1|First Intervention ( 4 Weeks)|Adverse Event|1
5885862|NCT01811563|20363621|P2|Overall Study|Incorrect Randomization procedure|1
5885863|NCT01811563|20363622|P1|Overall Study|Incorrect Randomization procedure|0
5885864|NCT01811563|20363621|P2|Overall Study|Lost to Follow-up|2
5885865|NCT01811563|20363622|P1|Overall Study|Lost to Follow-up|5
5885866|NCT01811485|20363651|P3|Overall Study|Protocol Deviation|0
5885867|NCT01811485|20363652|P2|Overall Study|Protocol Deviation|1
5885868|NCT01811485|20363653|P1|Overall Study|Protocol Deviation|0
5885869|NCT01811485|20363651|P3|Overall Study|Administrative problems|0
5885870|NCT01811485|20363652|P2|Overall Study|Administrative problems|0
5885871|NCT01811485|20363653|P1|Overall Study|Administrative problems|1
5885872|NCT01811485|20363651|P3|Overall Study|Unsatisfactory therapeutic effect|3
5885873|NCT01811485|20363652|P2|Overall Study|Unsatisfactory therapeutic effect|0
5885874|NCT01811485|20363653|P1|Overall Study|Unsatisfactory therapeutic effect|0
5885875|NCT01811485|20363651|P3|Overall Study|Adverse Event|2
5885876|NCT01811485|20363652|P2|Overall Study|Adverse Event|3
5885877|NCT01811485|20363653|P1|Overall Study|Adverse Event|1
5885878|NCT01811472|20363673|P3|Overall Study|Subject/guardian decision|0
5885879|NCT01811472|20363674|P2|Overall Study|Subject/guardian decision|0
5885880|NCT01811472|20363675|P1|Overall Study|Subject/guardian decision|1
5885881|NCT01811472|20363673|P3|Overall Study|Lost to Follow-up|1
5885882|NCT01811472|20363674|P2|Overall Study|Lost to Follow-up|0
5885883|NCT01811472|20363675|P1|Overall Study|Lost to Follow-up|0
5885884|NCT01811472|20363673|P3|Overall Study|Adverse Event|4
5885885|NCT01811472|20363674|P2|Overall Study|Adverse Event|0
5885886|NCT01811472|20363675|P1|Overall Study|Adverse Event|1
5885887|NCT01811238|20363762|P1|Overall Study|subject refused study medication|6
5885888|NCT01811238|20363762|P1|Overall Study|Lack of Efficacy|4
5885889|NCT01811238|20363762|P1|Overall Study|Protocol Violation|4
5885890|NCT01811238|20363762|P1|Overall Study|Adverse Event|25
5885891|NCT01811238|20363762|P1|Overall Study|Withdrawal by Subject|42
5885892|NCT01811225|20363771|P2|Treatment Period 2|unable to remain smoke free overnight|4
5885893|NCT01811225|20363772|P1|Treatment Period 2|unable to remain smoke free overnight|3
5885894|NCT01811225|20363771|P2|Treatment Period 2|Lost to Follow-up|2
5885895|NCT01811225|20363772|P1|Treatment Period 2|Lost to Follow-up|1
5885896|NCT01811225|20363771|P2|Treatment Period 1|unable to remain smoke free overnight|6
5885897|NCT01811225|20363772|P1|Treatment Period 1|unable to remain smoke free overnight|10
5885898|NCT01811225|20363771|P2|Treatment Period 1|transporation|0
5885899|NCT01811225|20363772|P1|Treatment Period 1|transporation|1
5885900|NCT01811225|20363771|P2|Treatment Period 1|Lost to Follow-up|8
5885901|NCT01811225|20363772|P1|Treatment Period 1|Lost to Follow-up|12
5885902|NCT01811225|20363771|P2|Treatment Period 1|Adverse Event|3
5885903|NCT01811225|20363772|P1|Treatment Period 1|Adverse Event|2
5885904|NCT01811186|20363797|P2|Overall Study|Lost to Follow-up|2
5885905|NCT01811186|20363798|P1|Overall Study|Lost to Follow-up|4
5885906|NCT01811186|20363797|P2|Overall Study|Lack of Efficacy|6
5885907|NCT01811186|20363798|P1|Overall Study|Lack of Efficacy|3
5885908|NCT01811186|20363797|P2|Overall Study|Withdrawal by Subject|10
5885909|NCT01811186|20363798|P1|Overall Study|Withdrawal by Subject|5
5885910|NCT01811186|20363797|P2|Overall Study|Protocol Violation|6
5885911|NCT01811186|20363798|P1|Overall Study|Protocol Violation|5
5885912|NCT01811186|20363797|P2|Overall Study|Adverse Event|38
5885913|NCT01811186|20363798|P1|Overall Study|Adverse Event|54
5885914|NCT01810939|20363882|P3|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0
5885915|NCT01810939|20363883|P2|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|1
5885916|NCT01810939|20363884|P1|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0
5885917|NCT01810939|20363882|P3|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|1
5885918|NCT01810939|20363883|P2|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|2
5885919|NCT01810939|20363884|P1|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|0
5885920|NCT01810939|20363882|P3|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|14
5885921|NCT01810939|20363883|P2|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|2
5885922|NCT01810939|20363884|P1|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|0
5885923|NCT01810939|20363882|P3|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|2
5885924|NCT01810939|20363883|P2|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|1
5885925|NCT01810939|20363884|P1|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|0
5885926|NCT01810939|20363882|P3|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1
5885927|NCT01810939|20363883|P2|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1
5885928|NCT01810939|20363884|P1|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|0
5885929|NCT01810939|20363882|P3|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|1
5885930|NCT01810939|20363883|P2|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0
5885931|NCT01810939|20363884|P1|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0
5885932|NCT01810939|20363882|P3|Part B Placebo-Controlled Withdrawal|Death|1
5885933|NCT01810939|20363883|P2|Part B Placebo-Controlled Withdrawal|Death|0
5885934|NCT01810939|20363884|P1|Part B Placebo-Controlled Withdrawal|Death|0
5885935|NCT01810939|20363882|P3|Part B Placebo-Controlled Withdrawal|Adverse Event|1
5885936|NCT01810939|20363883|P2|Part B Placebo-Controlled Withdrawal|Adverse Event|1
5885937|NCT01810939|20363884|P1|Part B Placebo-Controlled Withdrawal|Adverse Event|0
5885938|NCT01810939|20363882|P3|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0
5885939|NCT01810939|20363883|P2|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|1
5885940|NCT01810939|20363884|P1|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0
5885941|NCT01810939|20363882|P3|Part B Placebo-Controlled Withdrawal|Physician Decision|1
5885942|NCT01810939|20363883|P2|Part B Placebo-Controlled Withdrawal|Physician Decision|1
5885943|NCT01810939|20363884|P1|Part B Placebo-Controlled Withdrawal|Physician Decision|0
5885944|NCT01810939|20363882|P3|Part A Treatment Period|Protocol-specified (Low K+)|0
5885945|NCT01810939|20363883|P2|Part A Treatment Period|Protocol-specified (Low K+)|0
5885946|NCT01810939|20363884|P1|Part A Treatment Period|Protocol-specified (Low K+)|1
5885947|NCT01810939|20363882|P3|Part A Treatment Period|Protocol-specified (High K+)|0
5885948|NCT01810939|20363883|P2|Part A Treatment Period|Protocol-specified (High K+)|0
5885949|NCT01810939|20363884|P1|Part A Treatment Period|Protocol-specified (High K+)|3
5885950|NCT01810939|20363882|P3|Part A Treatment Period|Protocol-specified (eGFR)|0
5885951|NCT01810939|20363883|P2|Part A Treatment Period|Protocol-specified (eGFR)|0
5885952|NCT01810939|20363884|P1|Part A Treatment Period|Protocol-specified (eGFR)|2
5885953|NCT01810939|20363882|P3|Part A Treatment Period|Withdrawal by Subject|0
5885954|NCT01810939|20363883|P2|Part A Treatment Period|Withdrawal by Subject|0
5885955|NCT01810939|20363884|P1|Part A Treatment Period|Withdrawal by Subject|5
5885956|NCT01810939|20363882|P3|Part A Treatment Period|Adverse Event|0
5885957|NCT01810939|20363883|P2|Part A Treatment Period|Adverse Event|0
5885958|NCT01810939|20363884|P1|Part A Treatment Period|Adverse Event|10
5885959|NCT01810939|20363882|P3|Part A Treatment Period|Protocol Violation|0
5885960|NCT01810939|20363883|P2|Part A Treatment Period|Protocol Violation|0
5885961|NCT01810939|20363884|P1|Part A Treatment Period|Protocol Violation|2
5885962|NCT01810939|20363882|P3|Part A Treatment Period|Non-compliance with Study Drug|0
5885963|NCT01810939|20363883|P2|Part A Treatment Period|Non-compliance with Study Drug|0
5885964|NCT01810939|20363884|P1|Part A Treatment Period|Non-compliance with Study Drug|1
5885965|NCT01810783|20363897|P1|Overall Study|Enrolled, not treated|1
5885966|NCT01810783|20363897|P1|Overall Study|Adminstrative or other reason(s)|23
5885967|NCT01810783|20363897|P1|Overall Study|Non-compliance with IMP|4
5885968|NCT01810783|20363897|P1|Overall Study|Protocol Violation|5
5885969|NCT01810783|20363897|P1|Overall Study|Lost to Follow-up|10
5885970|NCT01810783|20363897|P1|Overall Study|Lack of Efficacy|12
5885971|NCT01810783|20363897|P1|Overall Study|Withdrawal by Subject|22
5885972|NCT01810783|20363897|P1|Overall Study|Adverse Event|32
5885973|NCT01810432|20363922|P2|Period 2|Lost to Follow-up|1
5885974|NCT01810432|20363923|P1|Period 2|Lost to Follow-up|1
5885975|NCT01810432|20363922|P2|Period 2|Physician Decision|0
5885976|NCT01810432|20363923|P1|Period 2|Physician Decision|1
5885977|NCT01810432|20363922|P2|Period 2|Withdrawal by Subject|1
5885978|NCT01810432|20363923|P1|Period 2|Withdrawal by Subject|2
5885979|NCT01810432|20363922|P2|Washout|Adverse Event|0
5885980|NCT01810432|20363923|P1|Washout|Adverse Event|1
5885981|NCT01810432|20363922|P2|Washout|Protocol Violation|1
5885982|NCT01810432|20363923|P1|Washout|Protocol Violation|0
5885983|NCT01810380|20363936|P3|Overall Study|Administrative or other reasons|9
5885984|NCT01810380|20363937|P2|Overall Study|Administrative or other reasons|13
5885985|NCT01810380|20363938|P1|Overall Study|Administrative or other reasons|11
5885986|NCT01810380|20363936|P3|Overall Study|Withdrawal by Subject|6
5885987|NCT01810380|20363937|P2|Overall Study|Withdrawal by Subject|0
5885988|NCT01810380|20363938|P1|Overall Study|Withdrawal by Subject|6
5885989|NCT01810380|20363936|P3|Overall Study|Protocol Violation|1
5885990|NCT01810380|20363937|P2|Overall Study|Protocol Violation|0
5885991|NCT01810380|20363938|P1|Overall Study|Protocol Violation|1
5885992|NCT01810380|20363936|P3|Overall Study|Lack of Efficacy|11
5885993|NCT01810380|20363937|P2|Overall Study|Lack of Efficacy|10
5885994|NCT01810380|20363938|P1|Overall Study|Lack of Efficacy|24
5885995|NCT01810380|20363936|P3|Overall Study|Adverse Event|4
5885996|NCT01810380|20363937|P2|Overall Study|Adverse Event|14
5885997|NCT01810380|20363938|P1|Overall Study|Adverse Event|11
5885998|NCT01810380|20363936|P3|Overall Study|Randomised not treated|1
5885999|NCT01810380|20363937|P2|Overall Study|Randomised not treated|1
5886000|NCT01810380|20363938|P1|Overall Study|Randomised not treated|2
5886001|NCT01810302|20363999|P2|Overall Study|Physician Decision|1
5886002|NCT01810302|20364000|P1|Overall Study|Physician Decision|0
5886003|NCT01810302|20363999|P2|Overall Study|Death|0
5886004|NCT01810302|20364000|P1|Overall Study|Death|1
5886005|NCT01810263|20364027|P2|Overall Study|Lost to Follow-up|7
5886006|NCT01810263|20364028|P1|Overall Study|Lost to Follow-up|8
5886007|NCT01810042|20364034|P1|Overall Study|Lost to Follow-up|10
5886008|NCT01810016|20364044|P3|Overall Study|Death|1
5886009|NCT01810016|20364045|P2|Overall Study|Death|0
5886010|NCT01810016|20364046|P1|Overall Study|Death|0
5886011|NCT01810016|20364044|P3|Overall Study|Progressive disease|0
5886012|NCT01810016|20364045|P2|Overall Study|Progressive disease|1
5886013|NCT01810016|20364046|P1|Overall Study|Progressive disease|1
5886014|NCT01809327|20364116|P5|Overall Study|Other|9
5886015|NCT01809327|20364117|P4|Overall Study|Other|4
5886016|NCT01809327|20364118|P3|Overall Study|Other|7
5886017|NCT01809327|20364119|P2|Overall Study|Other|15
5886018|NCT01809327|20364120|P1|Overall Study|Other|14
5886019|NCT01809327|20364116|P5|Overall Study|Pregnancy|0
5886020|NCT01809327|20364117|P4|Overall Study|Pregnancy|0
5886021|NCT01809327|20364118|P3|Overall Study|Pregnancy|0
5886022|NCT01809327|20364119|P2|Overall Study|Pregnancy|0
5886023|NCT01809327|20364120|P1|Overall Study|Pregnancy|1
5886024|NCT01809327|20364116|P5|Overall Study|Physician Decision|0
5886025|NCT01809327|20364117|P4|Overall Study|Physician Decision|0
5886026|NCT01809327|20364118|P3|Overall Study|Physician Decision|0
5886027|NCT01809327|20364119|P2|Overall Study|Physician Decision|1
5886028|NCT01809327|20364120|P1|Overall Study|Physician Decision|1
5886029|NCT01809327|20364116|P5|Overall Study|Protocol Violation|0
5886030|NCT01809327|20364117|P4|Overall Study|Protocol Violation|0
5886031|NCT01809327|20364118|P3|Overall Study|Protocol Violation|0
5886032|NCT01809327|20364119|P2|Overall Study|Protocol Violation|1
5886033|NCT01809327|20364120|P1|Overall Study|Protocol Violation|0
5886034|NCT01809327|20364116|P5|Overall Study|Death|0
5886035|NCT01809327|20364117|P4|Overall Study|Death|0
5886036|NCT01809327|20364118|P3|Overall Study|Death|0
5886037|NCT01809327|20364119|P2|Overall Study|Death|0
5886038|NCT01809327|20364120|P1|Overall Study|Death|1
5886039|NCT01809327|20364116|P5|Overall Study|Adverse Event|8
5886040|NCT01809327|20364117|P4|Overall Study|Adverse Event|4
5886041|NCT01809327|20364118|P3|Overall Study|Adverse Event|7
5886042|NCT01809327|20364119|P2|Overall Study|Adverse Event|3
5886043|NCT01809327|20364120|P1|Overall Study|Adverse Event|4
5886044|NCT01809327|20364116|P5|Overall Study|Withdrawal by Subject|5
5886045|NCT01809327|20364117|P4|Overall Study|Withdrawal by Subject|2
5886046|NCT01809327|20364118|P3|Overall Study|Withdrawal by Subject|4
5886047|NCT01809327|20364119|P2|Overall Study|Withdrawal by Subject|4
5886048|NCT01809327|20364120|P1|Overall Study|Withdrawal by Subject|6
5886049|NCT01809327|20364116|P5|Overall Study|Lost to Follow-up|3
5886050|NCT01809327|20364117|P4|Overall Study|Lost to Follow-up|2
5886051|NCT01809327|20364118|P3|Overall Study|Lost to Follow-up|4
5886052|NCT01809327|20364119|P2|Overall Study|Lost to Follow-up|2
5886053|NCT01809327|20364120|P1|Overall Study|Lost to Follow-up|5
5886054|NCT01809314|20364162|P1|Overall Study|Lost to Follow-up|724
5886055|NCT01809314|20364162|P1|Overall Study|Insufficient Therapeutic Response|14
5886056|NCT01809314|20364162|P1|Overall Study|Adverse Event|6
5886057|NCT01809314|20364162|P1|Overall Study|Withdrawal Prior to Treatment|1
5886058|NCT01809262|20364168|P10|Period 3 (Third Dose + Washout)|Adverse Event|0
5886059|NCT01809262|20364169|P9|Period 3 (Third Dose + Washout)|Adverse Event|0
5886060|NCT01809262|20364170|P8|Period 3 (Third Dose + Washout)|Adverse Event|0
5886061|NCT01809262|20364171|P7|Period 3 (Third Dose + Washout)|Adverse Event|0
5886062|NCT01809262|20364172|P6|Period 3 (Third Dose + Washout)|Adverse Event|0
5886063|NCT01809262|20364173|P5|Period 3 (Third Dose + Washout)|Adverse Event|0
5886064|NCT01809262|20364174|P4|Period 3 (Third Dose + Washout)|Adverse Event|0
5886065|NCT01809262|20364175|P3|Period 3 (Third Dose + Washout)|Adverse Event|0
5886066|NCT01809262|20364176|P2|Period 3 (Third Dose + Washout)|Adverse Event|1
5886067|NCT01809262|20364177|P1|Period 3 (Third Dose + Washout)|Adverse Event|0
5886068|NCT01809262|20364168|P10|Period 1 (First Dose + Washout)|Adverse Event|0
5886069|NCT01809262|20364169|P9|Period 1 (First Dose + Washout)|Adverse Event|0
5886070|NCT01809262|20364170|P8|Period 1 (First Dose + Washout)|Adverse Event|0
5886071|NCT01809262|20364171|P7|Period 1 (First Dose + Washout)|Adverse Event|0
5886072|NCT01809262|20364172|P6|Period 1 (First Dose + Washout)|Adverse Event|0
5886073|NCT01809262|20364173|P5|Period 1 (First Dose + Washout)|Adverse Event|1
5886074|NCT01809262|20364174|P4|Period 1 (First Dose + Washout)|Adverse Event|0
5886075|NCT01809262|20364175|P3|Period 1 (First Dose + Washout)|Adverse Event|0
5886076|NCT01809262|20364176|P2|Period 1 (First Dose + Washout)|Adverse Event|0
5886077|NCT01809262|20364177|P1|Period 1 (First Dose + Washout)|Adverse Event|0
5886078|NCT01809210|20364251|P7|Overall Study|Death|1
5886079|NCT01809210|20364252|P6|Overall Study|Death|3
5886080|NCT01809210|20364253|P5|Overall Study|Death|1
5886081|NCT01809210|20364254|P4|Overall Study|Death|0
5886082|NCT01809210|20364255|P3|Overall Study|Death|2
5886083|NCT01809210|20364256|P2|Overall Study|Death|1
5886084|NCT01809210|20364257|P1|Overall Study|Death|1
5886085|NCT01809210|20364251|P7|Overall Study|Withdrawal by Subject|4
5886086|NCT01809210|20364252|P6|Overall Study|Withdrawal by Subject|0
5886087|NCT01809210|20364253|P5|Overall Study|Withdrawal by Subject|1
5886088|NCT01809210|20364254|P4|Overall Study|Withdrawal by Subject|1
5886089|NCT01809210|20364255|P3|Overall Study|Withdrawal by Subject|1
5886090|NCT01809210|20364256|P2|Overall Study|Withdrawal by Subject|0
5886091|NCT01809210|20364257|P1|Overall Study|Withdrawal by Subject|0
5886092|NCT01809197|20364331|P2|Overall Study|Product not available|1
5886093|NCT01809197|20364332|P1|Overall Study|Product not available|0
5886094|NCT01809197|20364331|P2|Overall Study|Withdrawal by Subject|1
5886095|NCT01809197|20364332|P1|Overall Study|Withdrawal by Subject|1
5886096|NCT01809197|20364331|P2|Overall Study|Decision Unrelated to an Adverse Event|0
5886097|NCT01809197|20364332|P1|Overall Study|Decision Unrelated to an Adverse Event|1
5886098|NCT01809197|20364331|P2|Overall Study|Non-Compliance|1
5886099|NCT01809197|20364332|P1|Overall Study|Non-Compliance|1
5886100|NCT01809197|20364331|P2|Overall Study|Failed slit lamp exam|0
5886101|NCT01809197|20364332|P1|Overall Study|Failed slit lamp exam|1
5886102|NCT01809197|20364331|P2|Overall Study|Adverse Event|3
5886103|NCT01809197|20364332|P1|Overall Study|Adverse Event|2
5886104|NCT01809197|20364331|P2|Overall Study|Lost to Follow-up|2
5886105|NCT01809197|20364332|P1|Overall Study|Lost to Follow-up|4
5886106|NCT01809132|20364341|P3|Overall Study|Withdrawal by Subject|1
5886107|NCT01809132|20364342|P2|Overall Study|Withdrawal by Subject|0
5886108|NCT01809132|20364343|P1|Overall Study|Withdrawal by Subject|0
5886109|NCT01808690|20364435|P2|Overall Study|Withdrawal by Subject|2
5886110|NCT01808690|20364436|P1|Overall Study|Withdrawal by Subject|1
5886111|NCT01808651|20364455|P3|Study Period 1|Participant Decision|3
5886112|NCT01808651|20364456|P2|Study Period 1|Participant Decision|7
5886113|NCT01808651|20364457|P1|Study Period 1|Participant Decision|9
5886114|NCT01808651|20364455|P3|Study Period 1|Adverse Event|1
5886115|NCT01808651|20364456|P2|Study Period 1|Adverse Event|4
5886116|NCT01808651|20364457|P1|Study Period 1|Adverse Event|10
5886117|NCT01808651|20364455|P3|Study Period 1|Lack of Efficacy|0
5886118|NCT01808651|20364456|P2|Study Period 1|Lack of Efficacy|1
5886119|NCT01808651|20364457|P1|Study Period 1|Lack of Efficacy|2
5886120|NCT01808651|20364455|P3|Study Period 1|Physician Decision|0
5886121|NCT01808651|20364456|P2|Study Period 1|Physician Decision|2
5886122|NCT01808651|20364457|P1|Study Period 1|Physician Decision|3
5886123|NCT01808651|20364455|P3|Study Period 1|Protocol Violation|1
5886124|NCT01808651|20364456|P2|Study Period 1|Protocol Violation|0
5886125|NCT01808651|20364457|P1|Study Period 1|Protocol Violation|1
5886126|NCT01808651|20364455|P3|Study Period 1|Lost to Follow-up|0
5886127|NCT01808651|20364456|P2|Study Period 1|Lost to Follow-up|3
5886128|NCT01808651|20364457|P1|Study Period 1|Lost to Follow-up|1
5886129|NCT01808612|20364492|P3|Discontinuation Period|Lost to Follow-up|0
5886130|NCT01808612|20364493|P2|Discontinuation Period|Lost to Follow-up|1
5886131|NCT01808612|20364494|P1|Discontinuation Period|Lost to Follow-up|0
5886132|NCT01808612|20364492|P3|Discontinuation Period|Physician Decision|0
5886133|NCT01808612|20364493|P2|Discontinuation Period|Physician Decision|0
5886134|NCT01808612|20364494|P1|Discontinuation Period|Physician Decision|1
5886135|NCT01808612|20364492|P3|Discontinuation Period|Adverse Event|0
5886136|NCT01808612|20364493|P2|Discontinuation Period|Adverse Event|0
5886137|NCT01808612|20364494|P1|Discontinuation Period|Adverse Event|1
5886138|NCT01808612|20364492|P3|Treatment Period|Lack of Efficacy|2
5886139|NCT01808612|20364493|P2|Treatment Period|Lack of Efficacy|1
5886140|NCT01808612|20364494|P1|Treatment Period|Lack of Efficacy|1
5886141|NCT01808612|20364492|P3|Treatment Period|Sponsor Decision|0
5886142|NCT01808612|20364493|P2|Treatment Period|Sponsor Decision|0
5886143|NCT01808612|20364494|P1|Treatment Period|Sponsor Decision|1
5886144|NCT01808612|20364492|P3|Treatment Period|Physician Decision|4
5886145|NCT01808612|20364493|P2|Treatment Period|Physician Decision|0
5886146|NCT01808612|20364494|P1|Treatment Period|Physician Decision|1
5886147|NCT01808612|20364492|P3|Treatment Period|Withdrawal by Subject|4
5886148|NCT01808612|20364493|P2|Treatment Period|Withdrawal by Subject|0
5886149|NCT01808612|20364494|P1|Treatment Period|Withdrawal by Subject|1
5886150|NCT01808612|20364492|P3|Treatment Period|Protocol Violation|0
5886151|NCT01808612|20364493|P2|Treatment Period|Protocol Violation|0
5886152|NCT01808612|20364494|P1|Treatment Period|Protocol Violation|1
5886153|NCT01808612|20364492|P3|Treatment Period|Lost to Follow-up|1
5886154|NCT01808612|20364493|P2|Treatment Period|Lost to Follow-up|2
5886155|NCT01808612|20364494|P1|Treatment Period|Lost to Follow-up|2
5886156|NCT01808612|20364492|P3|Treatment Period|Adverse Event|3
5886157|NCT01808612|20364493|P2|Treatment Period|Adverse Event|4
5886158|NCT01808612|20364494|P1|Treatment Period|Adverse Event|8
5886159|NCT01808573|20364525|P2|Overall Study|Randomized in Error|0
5886160|NCT01808573|20364526|P1|Overall Study|Randomized in Error|1
5886161|NCT01808573|20364525|P2|Overall Study|Discontinuation of study by sponsor|64
5886162|NCT01808573|20364526|P1|Overall Study|Discontinuation of study by sponsor|79
5886163|NCT01808573|20364525|P2|Overall Study|Lost to Follow-up|0
5886164|NCT01808573|20364526|P1|Overall Study|Lost to Follow-up|3
5886165|NCT01808573|20364525|P2|Overall Study|Withdrawal by Subject|10
5886166|NCT01808573|20364526|P1|Overall Study|Withdrawal by Subject|12
5886167|NCT01808573|20364525|P2|Overall Study|Death|240
5886168|NCT01808573|20364526|P1|Overall Study|Death|212
5886169|NCT01808534|20364581|P1|Overall Study|Physician Decision|1
5886170|NCT01808534|20364581|P1|Overall Study|Disease progression|3
5886171|NCT01808508|20364592|P3|Overall Study|Lost to Follow-up|0
5886172|NCT01808508|20364593|P2|Overall Study|Lost to Follow-up|0
5886173|NCT01808508|20364594|P1|Overall Study|Lost to Follow-up|1
5886174|NCT01808339|20364611|P6|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0
5886175|NCT01808339|20364612|P5|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0
5886176|NCT01808339|20364613|P4|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0
5886177|NCT01808339|20364614|P3|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|1
5886178|NCT01808339|20364615|P2|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0
5886179|NCT01808339|20364616|P1|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0
5886180|NCT01808339|20364611|P6|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
5886181|NCT01808339|20364612|P5|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
5886182|NCT01808339|20364613|P4|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
5886183|NCT01808339|20364614|P3|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
5886184|NCT01808339|20364615|P2|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
5886185|NCT01808339|20364616|P1|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
5886186|NCT01808339|20364611|P6|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1
5886187|NCT01808339|20364612|P5|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|2
5886188|NCT01808339|20364613|P4|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1
5886189|NCT01808339|20364614|P3|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0
5886190|NCT01808339|20364615|P2|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0
5886191|NCT01808339|20364616|P1|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0
5886192|NCT01808313|20364660|P1|Overall Study|Physician Decision|1
5886193|NCT01808313|20364660|P1|Overall Study|Lost to Follow-up|1
5886194|NCT01808313|20364660|P1|Overall Study|Met Protocol-defined Stopping Criteria|1
5886195|NCT01808313|20364660|P1|Overall Study|Protocol Violation|2
5886196|NCT01808313|20364660|P1|Overall Study|Adverse Event|5
5886197|NCT01808261|20364690|P2|Overall Study|Lost to Follow-up|1
5886198|NCT01808261|20364691|P1|Overall Study|Lost to Follow-up|3
5886199|NCT01808261|20364690|P2|Overall Study|Consent withdrawn by subject|7
5886200|NCT01808261|20364691|P1|Overall Study|Consent withdrawn by subject|6
5886201|NCT01808261|20364690|P2|Overall Study|Adverse event, non-fatal|0
5886202|NCT01808261|20364691|P1|Overall Study|Adverse event, non-fatal|2
5886203|NCT01808261|20364690|P2|Overall Study|Study Closed/Terminated|23
5886204|NCT01808261|20364691|P1|Overall Study|Study Closed/Terminated|25
5886205|NCT01808261|20364690|P2|Overall Study|Physician Decision|2
5886206|NCT01808261|20364691|P1|Overall Study|Physician Decision|0
5886207|NCT01808248|20364747|P1|Overall Study|Lost to Follow-up|1
5886208|NCT01808248|20364747|P1|Overall Study|Withdrawal by Subject|1
5886209|NCT01808248|20364747|P1|Overall Study|Lack of Efficacy|3
5886210|NCT01808222|20364759|P1|Overall Study|mpMR scan was not performed|1
5886211|NCT01808209|20364766|P2|Overall Study|Lost to Follow-up|1
5886212|NCT01808209|20364767|P1|Overall Study|Lost to Follow-up|0
5886213|NCT01808196|20364809|P1|Overall Study|Lost to Follow-up|1
5886214|NCT01808144|20364817|P2|Overall Study|Adverse Event|15
5886215|NCT01808144|20364818|P1|Overall Study|Adverse Event|11
5886216|NCT01808144|20364817|P2|Overall Study|Gout flare|1
5886217|NCT01808144|20364818|P1|Overall Study|Gout flare|0
5886218|NCT01808144|20364817|P2|Overall Study|Protocol Violation|6
5886219|NCT01808144|20364818|P1|Overall Study|Protocol Violation|6
5886220|NCT01808144|20364817|P2|Overall Study|Lost to Follow-up|3
5886221|NCT01808144|20364818|P1|Overall Study|Lost to Follow-up|6
5886222|NCT01808144|20364817|P2|Overall Study|Withdrawal by Subject|23
5886223|NCT01808144|20364818|P1|Overall Study|Withdrawal by Subject|16
5886224|NCT01808144|20364817|P2|Overall Study|Death|0
5886225|NCT01808144|20364818|P1|Overall Study|Death|1
5886226|NCT01808118|20364826|P3|Period 2|Switched to other therapy|0
5886227|NCT01808118|20364827|P2|Period 2|Switched to other therapy|1
5886228|NCT01808118|20364828|P1|Period 2|Switched to other therapy|0
5886229|NCT01808118|20364826|P3|Period 2|Investigator no longer conducting trials|0
5886230|NCT01808118|20364827|P2|Period 2|Investigator no longer conducting trials|1
5886231|NCT01808118|20364828|P1|Period 2|Investigator no longer conducting trials|0
5886232|NCT01808118|20364826|P3|Period 2|Lost to Follow-up|2
5886233|NCT01808118|20364827|P2|Period 2|Lost to Follow-up|0
5886234|NCT01808118|20364828|P1|Period 2|Lost to Follow-up|0
5886235|NCT01808118|20364826|P3|Period 2|Withdrew consent|6
5886236|NCT01808118|20364827|P2|Period 2|Withdrew consent|7
5886237|NCT01808118|20364828|P1|Period 2|Withdrew consent|0
5886238|NCT01808118|20364826|P3|Period 2|Adverse Event|0
5886239|NCT01808118|20364827|P2|Period 2|Adverse Event|4
5886240|NCT01808118|20364828|P1|Period 2|Adverse Event|0
5886241|NCT01808118|20364826|P3|Period 1|Lack of Efficacy|0
5886242|NCT01808118|20364827|P2|Period 1|Lack of Efficacy|0
5886243|NCT01808118|20364828|P1|Period 1|Lack of Efficacy|1
5886244|NCT01808118|20364826|P3|Period 1|Non-compliance per sponsor|0
5886245|NCT01808118|20364827|P2|Period 1|Non-compliance per sponsor|0
5886246|NCT01808118|20364828|P1|Period 1|Non-compliance per sponsor|1
5886247|NCT01808118|20364826|P3|Period 1|Investigator decision: site closure|0
5886248|NCT01808118|20364827|P2|Period 1|Investigator decision: site closure|0
5886249|NCT01808118|20364828|P1|Period 1|Investigator decision: site closure|2
5886250|NCT01808118|20364826|P3|Period 1|Non-conformance with inclusion criteria|0
5886251|NCT01808118|20364827|P2|Period 1|Non-conformance with inclusion criteria|0
5886252|NCT01808118|20364828|P1|Period 1|Non-conformance with inclusion criteria|3
5886253|NCT01808118|20364826|P3|Period 1|Did not meet inclusion criteria|0
5886254|NCT01808118|20364827|P2|Period 1|Did not meet inclusion criteria|0
5886255|NCT01808118|20364828|P1|Period 1|Did not meet inclusion criteria|3
5886256|NCT01808118|20364826|P3|Period 1|Enrolled in error|0
5886257|NCT01808118|20364827|P2|Period 1|Enrolled in error|0
5886258|NCT01808118|20364828|P1|Period 1|Enrolled in error|7
5886259|NCT01808118|20364826|P3|Period 1|Did not meet criteria for remission|0
5886260|NCT01808118|20364827|P2|Period 1|Did not meet criteria for remission|0
5886261|NCT01808118|20364828|P1|Period 1|Did not meet criteria for remission|303
5886262|NCT01808118|20364826|P3|Period 1|Lost to Follow-up|0
5886263|NCT01808118|20364827|P2|Period 1|Lost to Follow-up|0
5886264|NCT01808118|20364828|P1|Period 1|Lost to Follow-up|9
5886265|NCT01808118|20364826|P3|Period 1|Withdrew consent|0
5886266|NCT01808118|20364827|P2|Period 1|Withdrew consent|0
5886267|NCT01808118|20364828|P1|Period 1|Withdrew consent|24
5886268|NCT01808118|20364826|P3|Period 1|Adverse Event|0
5886269|NCT01808118|20364827|P2|Period 1|Adverse Event|0
5886270|NCT01808118|20364828|P1|Period 1|Adverse Event|15
5886271|NCT01808092|20364891|P2|Overall Study|Other Eligibility criteria|5
5886272|NCT01808092|20364892|P1|Overall Study|Other Eligibility criteria|3
5886273|NCT01808092|20364891|P2|Overall Study|Withdrawal by Subject|4
5886274|NCT01808092|20364892|P1|Overall Study|Withdrawal by Subject|9
5886275|NCT01808092|20364891|P2|Overall Study|Lost to Follow-up|7
5886276|NCT01808092|20364892|P1|Overall Study|Lost to Follow-up|3
5886277|NCT01808092|20364891|P2|Overall Study|Death|29
5886278|NCT01808092|20364892|P1|Overall Study|Death|39
5886279|NCT01808066|20364994|P1|Overall Study|Withdrawal by Subject|15
5886280|NCT01807949|20365005|P3|Overall Study|Randomized But Not Treated|2
5886281|NCT01807949|20365006|P2|Overall Study|Randomized But Not Treated|2
5886282|NCT01807949|20365007|P1|Overall Study|Randomized But Not Treated|0
5886283|NCT01807949|20365005|P3|Overall Study|Undefined|2
5886284|NCT01807949|20365006|P2|Overall Study|Undefined|1
5886285|NCT01807949|20365007|P1|Overall Study|Undefined|0
5886286|NCT01807949|20365005|P3|Overall Study|Non-Compliance|1
5886287|NCT01807949|20365006|P2|Overall Study|Non-Compliance|0
5886288|NCT01807949|20365007|P1|Overall Study|Non-Compliance|0
5886289|NCT01807949|20365005|P3|Overall Study|Withdrawal by Subject|2
5886290|NCT01807949|20365006|P2|Overall Study|Withdrawal by Subject|2
5886291|NCT01807949|20365007|P1|Overall Study|Withdrawal by Subject|1
5886292|NCT01807949|20365005|P3|Overall Study|Adverse Event|2
5886293|NCT01807949|20365006|P2|Overall Study|Adverse Event|2
5886294|NCT01807949|20365007|P1|Overall Study|Adverse Event|1
5886295|NCT01807923|20365059|P3|Overall Study|Randomized But Not Treated|5
5886296|NCT01807923|20365060|P2|Overall Study|Randomized But Not Treated|2
5886297|NCT01807923|20365061|P1|Overall Study|Randomized But Not Treated|3
5886298|NCT01807923|20365059|P3|Overall Study|Not Eligible (Genotype)|1
5886299|NCT01807923|20365060|P2|Overall Study|Not Eligible (Genotype)|0
5886300|NCT01807923|20365061|P1|Overall Study|Not Eligible (Genotype)|0
5886301|NCT01807923|20365059|P3|Overall Study|Physician Decision|1
5886302|NCT01807923|20365060|P2|Overall Study|Physician Decision|0
5886303|NCT01807923|20365061|P1|Overall Study|Physician Decision|0
5886304|NCT01807923|20365059|P3|Overall Study|Withdrawal of Consent (not due to AE)|2
5886305|NCT01807923|20365060|P2|Overall Study|Withdrawal of Consent (not due to AE)|3
5886306|NCT01807923|20365061|P1|Overall Study|Withdrawal of Consent (not due to AE)|0
5886307|NCT01807923|20365059|P3|Overall Study|Adverse Event|2
5886308|NCT01807923|20365060|P2|Overall Study|Adverse Event|1
5886309|NCT01807923|20365061|P1|Overall Study|Adverse Event|2
5886310|NCT01807650|20365123|P1|Overall Study|Other|2
5886311|NCT01807650|20365123|P1|Overall Study|Adverse Event|5
5886312|NCT01807650|20365123|P1|Overall Study|Lack of Full Wound Closure at Day 28|13
5886313|NCT01807598|20365209|P1|Overall Study|Other Physician Decision|1
5886314|NCT01807598|20365209|P1|Overall Study|Adverse Event|1
5886315|NCT01807598|20365209|P1|Overall Study|Withdrawal by Subject|4
5886316|NCT01807520|20365241|P7|Follow-up Period (132-140 Weeks)|Lost to Follow-up|1
5886317|NCT01807520|20365242|P6|Follow-up Period (132-140 Weeks)|Lost to Follow-up|2
5886318|NCT01807520|20365243|P5|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0
5886319|NCT01807520|20365244|P4|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0
5886320|NCT01807520|20365245|P3|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0
5886321|NCT01807520|20365246|P2|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0
5886322|NCT01807520|20365247|P1|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0
5886323|NCT01807520|20365241|P7|Follow-up Period (132-140 Weeks)|Study terminated|0
5886324|NCT01807520|20365242|P6|Follow-up Period (132-140 Weeks)|Study terminated|1
5886325|NCT01807520|20365243|P5|Follow-up Period (132-140 Weeks)|Study terminated|0
5886326|NCT01807520|20365244|P4|Follow-up Period (132-140 Weeks)|Study terminated|0
5886327|NCT01807520|20365245|P3|Follow-up Period (132-140 Weeks)|Study terminated|0
5886328|NCT01807520|20365246|P2|Follow-up Period (132-140 Weeks)|Study terminated|0
5886329|NCT01807520|20365247|P1|Follow-up Period (132-140 Weeks)|Study terminated|0
5886330|NCT01807520|20365241|P7|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0
5886331|NCT01807520|20365242|P6|Follow-up Period (132-140 Weeks)|Lack of Efficacy|1
5886332|NCT01807520|20365243|P5|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0
5886333|NCT01807520|20365244|P4|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0
5886334|NCT01807520|20365245|P3|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0
5886335|NCT01807520|20365246|P2|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0
5886336|NCT01807520|20365247|P1|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0
5886337|NCT01807520|20365241|P7|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0
5886338|NCT01807520|20365242|P6|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0
5886339|NCT01807520|20365243|P5|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2
5886340|NCT01807520|20365244|P4|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2
5886341|NCT01807520|20365245|P3|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0
5886342|NCT01807520|20365246|P2|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|6
5886343|NCT01807520|20365247|P1|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|5
5886344|NCT01807520|20365241|P7|Treatment Period 2 (16-132 Weeks)|Adverse Event|0
5886345|NCT01807520|20365242|P6|Treatment Period 2 (16-132 Weeks)|Adverse Event|0
5886346|NCT01807520|20365243|P5|Treatment Period 2 (16-132 Weeks)|Adverse Event|0
5886347|NCT01807520|20365244|P4|Treatment Period 2 (16-132 Weeks)|Adverse Event|3
5886348|NCT01807520|20365245|P3|Treatment Period 2 (16-132 Weeks)|Adverse Event|0
5886349|NCT01807520|20365246|P2|Treatment Period 2 (16-132 Weeks)|Adverse Event|3
5886350|NCT01807520|20365247|P1|Treatment Period 2 (16-132 Weeks)|Adverse Event|3
5886351|NCT01807520|20365241|P7|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0
5886352|NCT01807520|20365242|P6|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0
5886353|NCT01807520|20365243|P5|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|1
5886354|NCT01807520|20365244|P4|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0
5886355|NCT01807520|20365245|P3|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0
5886356|NCT01807520|20365246|P2|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|3
5886357|NCT01807520|20365247|P1|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|5
5886358|NCT01807520|20365241|P7|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0
5886359|NCT01807520|20365242|P6|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0
5886360|NCT01807520|20365243|P5|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0
5886361|NCT01807520|20365244|P4|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|1
5886362|NCT01807520|20365245|P3|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0
5886363|NCT01807520|20365246|P2|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0
5886364|NCT01807520|20365247|P1|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|4
5886365|NCT01807520|20365241|P7|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0
5886366|NCT01807520|20365242|P6|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0
5886367|NCT01807520|20365243|P5|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0
5886368|NCT01807520|20365244|P4|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0
5886369|NCT01807520|20365245|P3|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0
5886370|NCT01807520|20365246|P2|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|2
5886371|NCT01807520|20365247|P1|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0
5886372|NCT01807520|20365241|P7|Treatment Period 2 (16-132 Weeks)|Pregnancy|0
5886373|NCT01807520|20365242|P6|Treatment Period 2 (16-132 Weeks)|Pregnancy|0
5886374|NCT01807520|20365243|P5|Treatment Period 2 (16-132 Weeks)|Pregnancy|0
5886375|NCT01807520|20365244|P4|Treatment Period 2 (16-132 Weeks)|Pregnancy|0
5886376|NCT01807520|20365245|P3|Treatment Period 2 (16-132 Weeks)|Pregnancy|0
5886377|NCT01807520|20365246|P2|Treatment Period 2 (16-132 Weeks)|Pregnancy|0
5886378|NCT01807520|20365247|P1|Treatment Period 2 (16-132 Weeks)|Pregnancy|1
5886379|NCT01807520|20365241|P7|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0
5886380|NCT01807520|20365242|P6|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0
5886381|NCT01807520|20365243|P5|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0
5886382|NCT01807520|20365244|P4|Treatment Period 2 (16-132 Weeks)|Protocol deviation|1
5886383|NCT01807520|20365245|P3|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0
5886384|NCT01807520|20365246|P2|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0
5886385|NCT01807520|20365247|P1|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0
5886386|NCT01807520|20365241|P7|Treatment Period 2 (16-132 Weeks)|Study terminated|0
5886387|NCT01807520|20365242|P6|Treatment Period 2 (16-132 Weeks)|Study terminated|0
5886388|NCT01807520|20365243|P5|Treatment Period 2 (16-132 Weeks)|Study terminated|2
5886389|NCT01807520|20365244|P4|Treatment Period 2 (16-132 Weeks)|Study terminated|0
5886390|NCT01807520|20365245|P3|Treatment Period 2 (16-132 Weeks)|Study terminated|0
5886391|NCT01807520|20365246|P2|Treatment Period 2 (16-132 Weeks)|Study terminated|4
5886392|NCT01807520|20365247|P1|Treatment Period 2 (16-132 Weeks)|Study terminated|7
5886393|NCT01807520|20365241|P7|Treatment Period 1 (0-16 Weeks)|Adverse Event|0
5886394|NCT01807520|20365242|P6|Treatment Period 1 (0-16 Weeks)|Adverse Event|0
5886395|NCT01807520|20365243|P5|Treatment Period 1 (0-16 Weeks)|Adverse Event|0
5886396|NCT01807520|20365244|P4|Treatment Period 1 (0-16 Weeks)|Adverse Event|0
5886397|NCT01807520|20365245|P3|Treatment Period 1 (0-16 Weeks)|Adverse Event|0
5886398|NCT01807520|20365246|P2|Treatment Period 1 (0-16 Weeks)|Adverse Event|0
5886399|NCT01807520|20365247|P1|Treatment Period 1 (0-16 Weeks)|Adverse Event|2
5886400|NCT01807520|20365241|P7|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0
5886401|NCT01807520|20365242|P6|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0
5886402|NCT01807520|20365243|P5|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0
5886403|NCT01807520|20365244|P4|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0
5886404|NCT01807520|20365245|P3|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|2
5886405|NCT01807520|20365246|P2|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0
5886406|NCT01807520|20365247|P1|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0
5886407|NCT01807520|20365241|P7|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0
5886408|NCT01807520|20365242|P6|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0
5886409|NCT01807520|20365243|P5|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0
5886410|NCT01807520|20365244|P4|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0
5886411|NCT01807520|20365245|P3|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0
5886412|NCT01807520|20365246|P2|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0
5886413|NCT01807520|20365247|P1|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|1
5886414|NCT01807520|20365241|P7|Treatment Period 1 (0-16 Weeks)|Physician Decision|0
5886415|NCT01807520|20365242|P6|Treatment Period 1 (0-16 Weeks)|Physician Decision|0
5886416|NCT01807520|20365243|P5|Treatment Period 1 (0-16 Weeks)|Physician Decision|0
5886417|NCT01807520|20365244|P4|Treatment Period 1 (0-16 Weeks)|Physician Decision|0
5886418|NCT01807520|20365245|P3|Treatment Period 1 (0-16 Weeks)|Physician Decision|1
5886419|NCT01807520|20365246|P2|Treatment Period 1 (0-16 Weeks)|Physician Decision|0
5886420|NCT01807520|20365247|P1|Treatment Period 1 (0-16 Weeks)|Physician Decision|0
5886421|NCT01807520|20365241|P7|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0
5886422|NCT01807520|20365242|P6|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0
5886423|NCT01807520|20365243|P5|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0
5886424|NCT01807520|20365244|P4|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0
5886425|NCT01807520|20365245|P3|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1
5886426|NCT01807520|20365246|P2|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0
5886427|NCT01807520|20365247|P1|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1
5886428|NCT01807520|20365241|P7|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0
5886429|NCT01807520|20365242|P6|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0
5886430|NCT01807520|20365243|P5|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0
5886431|NCT01807520|20365244|P4|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0
5886432|NCT01807520|20365245|P3|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|3
5886433|NCT01807520|20365246|P2|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|1
5886434|NCT01807520|20365247|P1|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0
5886435|NCT01807299|20365278|P4|Overall Study|Protocol Violation|2
5886436|NCT01807299|20365279|P3|Overall Study|Protocol Violation|0
5886437|NCT01807299|20365280|P2|Overall Study|Protocol Violation|1
5886438|NCT01807299|20365281|P1|Overall Study|Protocol Violation|3
5886439|NCT01807234|20365297|P6|Overall Study|Lack of Efficacy|1
5886440|NCT01807234|20365298|P5|Overall Study|Lack of Efficacy|1
5886441|NCT01807234|20365299|P4|Overall Study|Lack of Efficacy|0
5886442|NCT01807234|20365300|P3|Overall Study|Lack of Efficacy|0
5886443|NCT01807234|20365301|P2|Overall Study|Lack of Efficacy|0
5886444|NCT01807234|20365302|P1|Overall Study|Lack of Efficacy|0
5886445|NCT01807234|20365297|P6|Overall Study|Withdrawal by Subject|1
5886446|NCT01807234|20365298|P5|Overall Study|Withdrawal by Subject|2
5886447|NCT01807234|20365299|P4|Overall Study|Withdrawal by Subject|1
5886448|NCT01807234|20365300|P3|Overall Study|Withdrawal by Subject|1
5886449|NCT01807234|20365301|P2|Overall Study|Withdrawal by Subject|1
5886450|NCT01807234|20365302|P1|Overall Study|Withdrawal by Subject|3
5886451|NCT01807234|20365297|P6|Overall Study|Lost to Follow-up|2
5886452|NCT01807234|20365298|P5|Overall Study|Lost to Follow-up|1
5886453|NCT01807234|20365299|P4|Overall Study|Lost to Follow-up|1
5886454|NCT01807234|20365300|P3|Overall Study|Lost to Follow-up|1
5886455|NCT01807234|20365301|P2|Overall Study|Lost to Follow-up|5
5886456|NCT01807234|20365302|P1|Overall Study|Lost to Follow-up|2
5886457|NCT01807156|20365337|P1|Overall Study|Physician Decision|1
5886458|NCT01807065|20365353|P2|Overall Study|Receive no sip-T due to IV access|1
5886459|NCT01807065|20365354|P1|Overall Study|Receive no sip-T due to IV access|1
5886460|NCT01806961|20365420|P1|Overall Study|sponsor decision|16
5886461|NCT01806896|20365426|P2|Overall Study|Other|0
5886462|NCT01806896|20365427|P1|Overall Study|Other|1
5886463|NCT01806896|20365426|P2|Overall Study|Adverse Event|0
5886464|NCT01806896|20365427|P1|Overall Study|Adverse Event|2
5886465|NCT01806779|20365494|P3|Overall Study|Withdrawal by Subject|22
5886466|NCT01806779|20365495|P2|Overall Study|Withdrawal by Subject|23
5886467|NCT01806779|20365496|P1|Overall Study|Withdrawal by Subject|20
5886468|NCT01806779|20365494|P3|Overall Study|Lost to Follow-up|0
5886469|NCT01806779|20365495|P2|Overall Study|Lost to Follow-up|20
5886470|NCT01806779|20365496|P1|Overall Study|Lost to Follow-up|19
5886471|NCT01806779|20365494|P3|Overall Study|Lack of Efficacy|0
5886472|NCT01806779|20365495|P2|Overall Study|Lack of Efficacy|1
5886473|NCT01806779|20365496|P1|Overall Study|Lack of Efficacy|1
5886474|NCT01806779|20365494|P3|Overall Study|Physician Decision|1
5886475|NCT01806779|20365495|P2|Overall Study|Physician Decision|0
5886476|NCT01806779|20365496|P1|Overall Study|Physician Decision|2
5886477|NCT01806740|20365509|P1|Overall Study|Patient's refusal of treatment|1
5886478|NCT01806740|20365509|P1|Overall Study|Physician Decision|1
5886479|NCT01806740|20365509|P1|Overall Study|Withdrawal by Subject|4
5886480|NCT01806714|20365520|P2|Overall Study|No functioning phone number|170
5886481|NCT01806714|20365521|P1|Overall Study|No functioning phone number|200
5886482|NCT01806662|20365556|P2|Second Intervention (Weeks 16-32)|Lost to Follow-up|1
5886483|NCT01806662|20365557|P1|Second Intervention (Weeks 16-32)|Lost to Follow-up|0
5886484|NCT01806662|20365556|P2|Second Intervention (Weeks 16-32)|Lack of Efficacy|3
5886485|NCT01806662|20365557|P1|Second Intervention (Weeks 16-32)|Lack of Efficacy|2
5886486|NCT01806662|20365556|P2|First Intervention (Weeks 0-16)|Adverse Event|1
5886487|NCT01806662|20365557|P1|First Intervention (Weeks 0-16)|Adverse Event|0
5886488|NCT01806662|20365556|P2|First Intervention (Weeks 0-16)|Withdrawal by Subject|0
5886489|NCT01806662|20365557|P1|First Intervention (Weeks 0-16)|Withdrawal by Subject|4
5886490|NCT01806597|20365566|P6|Follow-up Period (Week 132 to Week 140)|Physician Decision|1
5886491|NCT01806597|20365567|P5|Follow-up Period (Week 132 to Week 140)|Physician Decision|0
5886492|NCT01806597|20365568|P4|Follow-up Period (Week 132 to Week 140)|Physician Decision|0
5886493|NCT01806597|20365569|P3|Follow-up Period (Week 132 to Week 140)|Physician Decision|0
5886494|NCT01806597|20365570|P2|Follow-up Period (Week 132 to Week 140)|Physician Decision|0
5886495|NCT01806597|20365571|P1|Follow-up Period (Week 132 to Week 140)|Physician Decision|0
5886496|NCT01806597|20365566|P6|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|2
5886497|NCT01806597|20365567|P5|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0
5886498|NCT01806597|20365568|P4|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0
5886499|NCT01806597|20365569|P3|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0
5886500|NCT01806597|20365570|P2|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0
5886501|NCT01806597|20365571|P1|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0
5886502|NCT01806597|20365566|P6|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|2
5886503|NCT01806597|20365567|P5|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0
5886504|NCT01806597|20365568|P4|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0
5886505|NCT01806597|20365569|P3|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0
5886506|NCT01806597|20365570|P2|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0
5886507|NCT01806597|20365571|P1|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0
5886508|NCT01806597|20365566|P6|Follow-up Period (Week 132 to Week 140)|Adverse Event|2
5886509|NCT01806597|20365567|P5|Follow-up Period (Week 132 to Week 140)|Adverse Event|0
5886510|NCT01806597|20365568|P4|Follow-up Period (Week 132 to Week 140)|Adverse Event|0
5886511|NCT01806597|20365569|P3|Follow-up Period (Week 132 to Week 140)|Adverse Event|0
5886512|NCT01806597|20365570|P2|Follow-up Period (Week 132 to Week 140)|Adverse Event|0
5886513|NCT01806597|20365571|P1|Follow-up Period (Week 132 to Week 140)|Adverse Event|0
5886514|NCT01806597|20365566|P6|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|5
5886515|NCT01806597|20365567|P5|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0
5886516|NCT01806597|20365568|P4|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0
5886517|NCT01806597|20365569|P3|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0
5886518|NCT01806597|20365570|P2|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0
5886519|NCT01806597|20365571|P1|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0
5886520|NCT01806597|20365566|P6|Treatment Period 2 (Week 16 to Week 132)|Death|0
5886521|NCT01806597|20365567|P5|Treatment Period 2 (Week 16 to Week 132)|Death|0
5886522|NCT01806597|20365568|P4|Treatment Period 2 (Week 16 to Week 132)|Death|0
5886523|NCT01806597|20365569|P3|Treatment Period 2 (Week 16 to Week 132)|Death|0
5886524|NCT01806597|20365570|P2|Treatment Period 2 (Week 16 to Week 132)|Death|0
5886525|NCT01806597|20365571|P1|Treatment Period 2 (Week 16 to Week 132)|Death|1
5886526|NCT01806597|20365566|P6|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0
5886527|NCT01806597|20365567|P5|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0
5886528|NCT01806597|20365568|P4|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1
5886529|NCT01806597|20365569|P3|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1
5886530|NCT01806597|20365570|P2|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2
5886531|NCT01806597|20365571|P1|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2
5886532|NCT01806597|20365566|P6|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0
5886533|NCT01806597|20365567|P5|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0
5886534|NCT01806597|20365568|P4|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5
5886535|NCT01806597|20365569|P3|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|6
5886536|NCT01806597|20365570|P2|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5
5886537|NCT01806597|20365571|P1|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|10
5886538|NCT01806597|20365566|P6|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0
5886539|NCT01806597|20365567|P5|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0
5886540|NCT01806597|20365568|P4|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1
5886541|NCT01806597|20365569|P3|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0
5886542|NCT01806597|20365570|P2|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1
5886543|NCT01806597|20365571|P1|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0
5886544|NCT01806597|20365566|P6|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0
5886545|NCT01806597|20365567|P5|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0
5886546|NCT01806597|20365568|P4|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0
5886547|NCT01806597|20365569|P3|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0
5886548|NCT01806597|20365570|P2|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0
5886549|NCT01806597|20365571|P1|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|2
5886550|NCT01806597|20365566|P6|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0
5886551|NCT01806597|20365567|P5|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0
5886552|NCT01806597|20365568|P4|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0
5886553|NCT01806597|20365569|P3|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0
5886554|NCT01806597|20365570|P2|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1
5886555|NCT01806597|20365571|P1|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1
5886556|NCT01806597|20365566|P6|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0
5886557|NCT01806597|20365567|P5|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0
5886558|NCT01806597|20365568|P4|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0
5886559|NCT01806597|20365569|P3|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0
5886560|NCT01806597|20365570|P2|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0
5886561|NCT01806597|20365571|P1|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|2
5886562|NCT01806597|20365566|P6|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0
5886563|NCT01806597|20365567|P5|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0
5886564|NCT01806597|20365568|P4|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|1
5886565|NCT01806597|20365569|P3|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|3
5886566|NCT01806597|20365570|P2|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|5
5886567|NCT01806597|20365571|P1|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|12
5886568|NCT01806597|20365566|P6|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|0
5886569|NCT01806597|20365567|P5|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|1
5886570|NCT01806597|20365568|P4|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|3
5886571|NCT01806597|20365569|P3|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|4
5886572|NCT01806597|20365570|P2|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|6
5886573|NCT01806597|20365571|P1|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|9
5886574|NCT01806597|20365566|P6|Period 1 (Baseline to Week 16)|Physician Decision|0
5886575|NCT01806597|20365567|P5|Period 1 (Baseline to Week 16)|Physician Decision|0
5886576|NCT01806597|20365568|P4|Period 1 (Baseline to Week 16)|Physician Decision|0
5886577|NCT01806597|20365569|P3|Period 1 (Baseline to Week 16)|Physician Decision|0
5886578|NCT01806597|20365570|P2|Period 1 (Baseline to Week 16)|Physician Decision|1
5886579|NCT01806597|20365571|P1|Period 1 (Baseline to Week 16)|Physician Decision|0
5886580|NCT01806597|20365566|P6|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0
5886581|NCT01806597|20365567|P5|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2
5886582|NCT01806597|20365568|P4|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0
5886583|NCT01806597|20365569|P3|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0
5886584|NCT01806597|20365570|P2|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2
5886585|NCT01806597|20365571|P1|Period 1 (Baseline to Week 16)|Withdrawal by Subject|3
5886586|NCT01806597|20365566|P6|Period 1 (Baseline to Week 16)|Protocol Violation|0
5886587|NCT01806597|20365567|P5|Period 1 (Baseline to Week 16)|Protocol Violation|0
5886588|NCT01806597|20365568|P4|Period 1 (Baseline to Week 16)|Protocol Violation|0
5886589|NCT01806597|20365569|P3|Period 1 (Baseline to Week 16)|Protocol Violation|0
5886590|NCT01806597|20365570|P2|Period 1 (Baseline to Week 16)|Protocol Violation|1
5886591|NCT01806597|20365571|P1|Period 1 (Baseline to Week 16)|Protocol Violation|0
5886592|NCT01806597|20365566|P6|Period 1 (Baseline to Week 16)|Lack of Efficacy|0
5886593|NCT01806597|20365567|P5|Period 1 (Baseline to Week 16)|Lack of Efficacy|1
5886594|NCT01806597|20365568|P4|Period 1 (Baseline to Week 16)|Lack of Efficacy|0
5886595|NCT01806597|20365569|P3|Period 1 (Baseline to Week 16)|Lack of Efficacy|0
5886596|NCT01806597|20365570|P2|Period 1 (Baseline to Week 16)|Lack of Efficacy|0
5886597|NCT01806597|20365571|P1|Period 1 (Baseline to Week 16)|Lack of Efficacy|1
5886598|NCT01806597|20365566|P6|Period 1 (Baseline to Week 16)|Adverse Event|0
5886599|NCT01806597|20365567|P5|Period 1 (Baseline to Week 16)|Adverse Event|2
5886600|NCT01806597|20365568|P4|Period 1 (Baseline to Week 16)|Adverse Event|0
5886601|NCT01806597|20365569|P3|Period 1 (Baseline to Week 16)|Adverse Event|0
5886602|NCT01806597|20365570|P2|Period 1 (Baseline to Week 16)|Adverse Event|1
5886603|NCT01806597|20365571|P1|Period 1 (Baseline to Week 16)|Adverse Event|1
5886604|NCT01806584|20365607|P2|Overall Study|Other unspecified|0
5886605|NCT01806584|20365608|P1|Overall Study|Other unspecified|1
5886606|NCT01806584|20365607|P2|Overall Study|Withdrawal by Subject|1
5886607|NCT01806584|20365608|P1|Overall Study|Withdrawal by Subject|1
5886608|NCT01806584|20365607|P2|Overall Study|Study terminated by sponsor|14
5886609|NCT01806584|20365608|P1|Overall Study|Study terminated by sponsor|9
5886610|NCT01806584|20365607|P2|Overall Study|Lost to Follow-up|2
5886611|NCT01806584|20365608|P1|Overall Study|Lost to Follow-up|0
5886612|NCT01806584|20365607|P2|Overall Study|Death|0
5886613|NCT01806584|20365608|P1|Overall Study|Death|1
5886614|NCT01806584|20365607|P2|Overall Study|Adverse Event|1
5886615|NCT01806584|20365608|P1|Overall Study|Adverse Event|2
5886616|NCT01806545|20365630|P2|Overall Study|Withdrawal by Subject|2
5886617|NCT01806545|20365631|P1|Overall Study|Withdrawal by Subject|3
5886618|NCT01806545|20365630|P2|Overall Study|Lost to Follow-up|0
5886619|NCT01806545|20365631|P1|Overall Study|Lost to Follow-up|1
5886620|NCT01806545|20365630|P2|Overall Study|Adverse Event|3
5886621|NCT01806545|20365631|P1|Overall Study|Adverse Event|2
5886622|NCT01806506|20365655|P2|Overall Study|Lost to Follow-up|1
5886623|NCT01806506|20365656|P1|Overall Study|Lost to Follow-up|2
5886624|NCT01806389|20365662|P1|Overall Study|Withdrawal by Subject|4
5886625|NCT01806298|20365676|P1|Overall Study|Other|5
5886626|NCT01806298|20365676|P1|Overall Study|Withdrawal by Subject|1
5886627|NCT01806298|20365676|P1|Overall Study|Protocol Non-compliance|1
5886628|NCT01806298|20365676|P1|Overall Study|Adverse Event|3
5886629|NCT01806064|20365702|P5|Overall Study|Randomized Not Enrolled|2
5886630|NCT01806064|20365703|P4|Overall Study|Randomized Not Enrolled|1
5886631|NCT01806064|20365704|P3|Overall Study|Randomized Not Enrolled|0
5886632|NCT01806064|20365705|P2|Overall Study|Randomized Not Enrolled|0
5886633|NCT01806064|20365706|P1|Overall Study|Randomized Not Enrolled|0
5886634|NCT01806051|20365731|P1|Overall Study|Withdrawal by Subject|6
5886635|NCT01805180|20365848|P3|Lead-in Donor Phase|screen failure|0
5886636|NCT01805180|20365849|P2|Lead-in Donor Phase|screen failure|0
5886637|NCT01805180|20365850|P1|Lead-in Donor Phase|screen failure|1
5886638|NCT01805037|20365894|P2|Follow Up (up to 3 Years)|Lost to Follow-up|1
5886639|NCT01805037|20365895|P1|Follow Up (up to 3 Years)|Lost to Follow-up|0
5886640|NCT01805037|20365894|P2|Follow Up (up to 3 Years)|Withdrawal by Subject|3
5886641|NCT01805037|20365895|P1|Follow Up (up to 3 Years)|Withdrawal by Subject|0
5886642|NCT01805037|20365894|P2|Follow Up (up to 3 Years)|Death|2
5886643|NCT01805037|20365895|P1|Follow Up (up to 3 Years)|Death|0
5886644|NCT01805037|20365894|P2|2nd Cycle of Maintenance and Beyond|Withdrawal by Subject|1
5886645|NCT01805037|20365895|P1|2nd Cycle of Maintenance and Beyond|Withdrawal by Subject|0
5886646|NCT01805037|20365894|P2|2nd Cycle of Maintenance and Beyond|Progressive Disease|1
5886647|NCT01805037|20365895|P1|2nd Cycle of Maintenance and Beyond|Progressive Disease|0
5886648|NCT01805037|20365894|P2|2nd Cycle of Maintenance and Beyond|Adverse Event|10
5886649|NCT01805037|20365895|P1|2nd Cycle of Maintenance and Beyond|Adverse Event|0
5886650|NCT01805037|20365894|P2|1st Cycle of Maintenance (3 Weeks)|Death|1
5886651|NCT01805037|20365895|P1|1st Cycle of Maintenance (3 Weeks)|Death|0
5886652|NCT01805037|20365894|P2|1st Cycle of Maintenance (3 Weeks)|Adverse Event|1
5886653|NCT01805037|20365895|P1|1st Cycle of Maintenance (3 Weeks)|Adverse Event|0
5886654|NCT01805037|20365894|P2|1st Cycle of Maintenance (3 Weeks)|Withdrawal by Subject|2
5886655|NCT01805037|20365895|P1|1st Cycle of Maintenance (3 Weeks)|Withdrawal by Subject|0
5886656|NCT01805037|20365894|P2|1st Cycle of Maintenance (3 Weeks)|Lack of Efficacy|2
5886657|NCT01805037|20365895|P1|1st Cycle of Maintenance (3 Weeks)|Lack of Efficacy|0
5886658|NCT01804946|20365940|P2|Overall Study|Do not meet inclusion criteria|2
5886659|NCT01804946|20365941|P1|Overall Study|Do not meet inclusion criteria|1
5886660|NCT01804946|20365940|P2|Overall Study|Insufficient data available|1
5886661|NCT01804946|20365941|P1|Overall Study|Insufficient data available|0
5886662|NCT01804946|20365940|P2|Overall Study|Adverse Event|1
5886663|NCT01804946|20365941|P1|Overall Study|Adverse Event|0
5886664|NCT01804946|20365940|P2|Overall Study|Protocol Violation|0
5886665|NCT01804946|20365941|P1|Overall Study|Protocol Violation|1
5886666|NCT01804842|20365979|P3|Overall Study|Personal Reason|1
5886667|NCT01804842|20365980|P2|Overall Study|Personal Reason|0
5886668|NCT01804842|20365981|P1|Overall Study|Personal Reason|0
5886669|NCT01804842|20365979|P3|Overall Study|Non-Compliance|0
5886670|NCT01804842|20365980|P2|Overall Study|Non-Compliance|1
5886671|NCT01804842|20365981|P1|Overall Study|Non-Compliance|1
5886672|NCT01804842|20365979|P3|Overall Study|Lost to Follow-up|0
5886673|NCT01804842|20365980|P2|Overall Study|Lost to Follow-up|0
5886674|NCT01804842|20365981|P1|Overall Study|Lost to Follow-up|1
5886675|NCT01804842|20365979|P3|Overall Study|Adverse Event|0
5886676|NCT01804842|20365980|P2|Overall Study|Adverse Event|1
5886677|NCT01804842|20365981|P1|Overall Study|Adverse Event|1
5886680|NCT01804673|20366010|P1|Overall Study|Other|4
5886681|NCT01804673|20366010|P1|Overall Study|Use of Prohibited Medication|1
5886682|NCT01804673|20366010|P1|Overall Study|No Further Therapy Required|84
5886683|NCT01804673|20366010|P1|Overall Study|Change to Oral Therapy|37
5886684|NCT01804673|20366010|P1|Overall Study|Lack of Efficacy|9
5886685|NCT01804673|20366010|P1|Overall Study|Withdrawal by Subject|1
5886686|NCT01804673|20366010|P1|Overall Study|Adverse Event|4
5886687|NCT01804582|20366028|P2|Overall Study|Physician Decision|0
5886688|NCT01804582|20366029|P1|Overall Study|Physician Decision|2
5886689|NCT01804582|20366028|P2|Overall Study|Lost to Follow-up|56
5886690|NCT01804582|20366029|P1|Overall Study|Lost to Follow-up|47
5886691|NCT01804140|20366060|P1|Overall Study|No sampling or biopsy procedures done|114
5886692|NCT01804049|20366094|P2|Overall Study|Enrollment in dual studies|1
5886693|NCT01804049|20366095|P1|Overall Study|Enrollment in dual studies|0
5886694|NCT01804049|20366094|P2|Overall Study|other MD recommended|1
5886695|NCT01804049|20366095|P1|Overall Study|other MD recommended|1
5886696|NCT01804049|20366094|P2|Overall Study|Moved out of area|7
5886697|NCT01804049|20366095|P1|Overall Study|Moved out of area|0
5886698|NCT01804049|20366094|P2|Overall Study|Other health concerns|7
5886699|NCT01804049|20366095|P1|Overall Study|Other health concerns|2
5886700|NCT01804049|20366094|P2|Overall Study|Decreased interest/personal|5
5886701|NCT01804049|20366095|P1|Overall Study|Decreased interest/personal|4
5886702|NCT01804049|20366094|P2|Overall Study|Lost to Follow-up|1
5886703|NCT01804049|20366095|P1|Overall Study|Lost to Follow-up|2
5886704|NCT01804049|20366094|P2|Overall Study|Adverse Event|10
5886705|NCT01804049|20366095|P1|Overall Study|Adverse Event|2
5886706|NCT01803880|20366143|P3|Overall Study|Incomplete data entry by sites|0
5886707|NCT01803880|20366144|P2|Overall Study|Incomplete data entry by sites|0
5886708|NCT01803880|20366145|P1|Overall Study|Incomplete data entry by sites|2
5886709|NCT01803880|20366143|P3|Overall Study|Early study termination|5
5886710|NCT01803880|20366144|P2|Overall Study|Early study termination|6
5886711|NCT01803880|20366145|P1|Overall Study|Early study termination|0
5886712|NCT01803880|20366143|P3|Overall Study|Protocol Violation|0
5886713|NCT01803880|20366144|P2|Overall Study|Protocol Violation|0
5886714|NCT01803880|20366145|P1|Overall Study|Protocol Violation|1
5886715|NCT01803880|20366143|P3|Overall Study|Lost to Follow-up|3
5886716|NCT01803880|20366144|P2|Overall Study|Lost to Follow-up|2
5886717|NCT01803880|20366145|P1|Overall Study|Lost to Follow-up|1
5886718|NCT01803880|20366143|P3|Overall Study|Unable to return for follow-up visits|2
5886719|NCT01803880|20366144|P2|Overall Study|Unable to return for follow-up visits|1
5886720|NCT01803880|20366145|P1|Overall Study|Unable to return for follow-up visits|0
5886721|NCT01803880|20366143|P3|Overall Study|Physician Decision|1
5886722|NCT01803880|20366144|P2|Overall Study|Physician Decision|0
5886723|NCT01803880|20366145|P1|Overall Study|Physician Decision|0
5886724|NCT01803880|20366143|P3|Overall Study|Withdrawal by Subject|4
5886725|NCT01803880|20366144|P2|Overall Study|Withdrawal by Subject|1
5886726|NCT01803880|20366145|P1|Overall Study|Withdrawal by Subject|1
5886727|NCT01803880|20366143|P3|Overall Study|Adverse Event|0
5886728|NCT01803880|20366144|P2|Overall Study|Adverse Event|0
5886729|NCT01803880|20366145|P1|Overall Study|Adverse Event|1
5886730|NCT01803737|20366181|P2|Overall Study|Lost to Follow-up|2
5886731|NCT01803737|20366182|P1|Overall Study|Lost to Follow-up|0
5886732|NCT01803737|20366181|P2|Overall Study|Medical Reason|1
5886733|NCT01803737|20366182|P1|Overall Study|Medical Reason|0
5886734|NCT01803737|20366181|P2|Overall Study|Lack of Time|0
5886735|NCT01803737|20366182|P1|Overall Study|Lack of Time|1
5886736|NCT01803711|20366206|P2|Overall Study|Adverse Event|1
5886737|NCT01803711|20366207|P1|Overall Study|Adverse Event|1
5886738|NCT01803646|20366225|P2|Overall Study|Lost to Follow-up|1
5886739|NCT01803646|20366226|P1|Overall Study|Lost to Follow-up|5
5886740|NCT01803646|20366225|P2|Overall Study|Randomization error|2
5886741|NCT01803646|20366226|P1|Overall Study|Randomization error|1
5886742|NCT01803646|20366225|P2|Overall Study|Withdrawal by Subject|6
5886743|NCT01803646|20366226|P1|Overall Study|Withdrawal by Subject|9
5886744|NCT01803646|20366225|P2|Overall Study|Adverse Event|1
5886745|NCT01803646|20366226|P1|Overall Study|Adverse Event|1
5886746|NCT01803646|20366225|P2|Overall Study|Protocol Violation|0
5886747|NCT01803646|20366226|P1|Overall Study|Protocol Violation|1
5886748|NCT01803607|20366238|P2|Overall Study|Withdrawal by Subject|5
5886749|NCT01803607|20366239|P1|Overall Study|Withdrawal by Subject|6
5886750|NCT01803607|20366238|P2|Overall Study|Study terminated by sponsor|56
5886751|NCT01803607|20366239|P1|Overall Study|Study terminated by sponsor|54
5886752|NCT01803607|20366238|P2|Overall Study|Protocol Violation|2
5886753|NCT01803607|20366239|P1|Overall Study|Protocol Violation|3
5886754|NCT01803607|20366238|P2|Overall Study|Lack of Efficacy|1
5886755|NCT01803607|20366239|P1|Overall Study|Lack of Efficacy|0
5886756|NCT01803607|20366238|P2|Overall Study|Adverse Event|3
5886757|NCT01803607|20366239|P1|Overall Study|Adverse Event|5
5886758|NCT01803464|20366263|P4|Overall Study|Withdrawal by Subject|0
5886759|NCT01803464|20366264|P3|Overall Study|Withdrawal by Subject|0
5886760|NCT01803464|20366265|P2|Overall Study|Withdrawal by Subject|0
5886761|NCT01803464|20366266|P1|Overall Study|Withdrawal by Subject|1
5886762|NCT01803464|20366263|P4|Overall Study|Incomplete data|0
5886763|NCT01803464|20366264|P3|Overall Study|Incomplete data|4
5886764|NCT01803464|20366265|P2|Overall Study|Incomplete data|0
5886765|NCT01803464|20366266|P1|Overall Study|Incomplete data|0
5886766|NCT01803282|20366296|P12|Overall Study|Enrolled but Never Treated|0
5886767|NCT01803282|20366297|P11|Overall Study|Enrolled but Never Treated|0
5886768|NCT01803282|20366298|P10|Overall Study|Enrolled but Never Treated|1
5886769|NCT01803282|20366299|P9|Overall Study|Enrolled but Never Treated|0
5886770|NCT01803282|20366300|P8|Overall Study|Enrolled but Never Treated|1
5886771|NCT01803282|20366301|P7|Overall Study|Enrolled but Never Treated|1
5886772|NCT01803282|20366302|P6|Overall Study|Enrolled but Never Treated|0
5886773|NCT01803282|20366303|P5|Overall Study|Enrolled but Never Treated|1
5886774|NCT01803282|20366304|P4|Overall Study|Enrolled but Never Treated|0
5886775|NCT01803282|20366305|P3|Overall Study|Enrolled but Never Treated|0
5886776|NCT01803282|20366306|P2|Overall Study|Enrolled but Never Treated|0
5886777|NCT01803282|20366307|P1|Overall Study|Enrolled but Never Treated|0
5886778|NCT01803282|20366296|P12|Overall Study|Specified Criteria for Withdrawal|0
5886779|NCT01803282|20366297|P11|Overall Study|Specified Criteria for Withdrawal|1
5886780|NCT01803282|20366298|P10|Overall Study|Specified Criteria for Withdrawal|1
5886781|NCT01803282|20366299|P9|Overall Study|Specified Criteria for Withdrawal|0
5886782|NCT01803282|20366300|P8|Overall Study|Specified Criteria for Withdrawal|0
5886783|NCT01803282|20366301|P7|Overall Study|Specified Criteria for Withdrawal|0
5886784|NCT01803282|20366302|P6|Overall Study|Specified Criteria for Withdrawal|0
5886785|NCT01803282|20366303|P5|Overall Study|Specified Criteria for Withdrawal|0
5886786|NCT01803282|20366304|P4|Overall Study|Specified Criteria for Withdrawal|0
5886787|NCT01803282|20366305|P3|Overall Study|Specified Criteria for Withdrawal|0
5886788|NCT01803282|20366306|P2|Overall Study|Specified Criteria for Withdrawal|0
5886789|NCT01803282|20366307|P1|Overall Study|Specified Criteria for Withdrawal|0
5886790|NCT01803282|20366296|P12|Overall Study|Unknown Reason|0
5886791|NCT01803282|20366297|P11|Overall Study|Unknown Reason|0
5886792|NCT01803282|20366298|P10|Overall Study|Unknown Reason|0
5886793|NCT01803282|20366299|P9|Overall Study|Unknown Reason|0
5886794|NCT01803282|20366300|P8|Overall Study|Unknown Reason|1
5886795|NCT01803282|20366301|P7|Overall Study|Unknown Reason|0
5886796|NCT01803282|20366302|P6|Overall Study|Unknown Reason|0
5886797|NCT01803282|20366303|P5|Overall Study|Unknown Reason|0
5886798|NCT01803282|20366304|P4|Overall Study|Unknown Reason|0
5886799|NCT01803282|20366305|P3|Overall Study|Unknown Reason|0
5886800|NCT01803282|20366306|P2|Overall Study|Unknown Reason|0
5886801|NCT01803282|20366307|P1|Overall Study|Unknown Reason|0
5886802|NCT01803282|20366296|P12|Overall Study|Non-Compliance with Study Drug|0
5886803|NCT01803282|20366297|P11|Overall Study|Non-Compliance with Study Drug|0
5886804|NCT01803282|20366298|P10|Overall Study|Non-Compliance with Study Drug|0
5886805|NCT01803282|20366299|P9|Overall Study|Non-Compliance with Study Drug|0
5886806|NCT01803282|20366300|P8|Overall Study|Non-Compliance with Study Drug|0
5886807|NCT01803282|20366301|P7|Overall Study|Non-Compliance with Study Drug|0
5886808|NCT01803282|20366302|P6|Overall Study|Non-Compliance with Study Drug|0
5886809|NCT01803282|20366303|P5|Overall Study|Non-Compliance with Study Drug|0
5886810|NCT01803282|20366304|P4|Overall Study|Non-Compliance with Study Drug|1
5886811|NCT01803282|20366305|P3|Overall Study|Non-Compliance with Study Drug|0
5886812|NCT01803282|20366306|P2|Overall Study|Non-Compliance with Study Drug|0
5886813|NCT01803282|20366307|P1|Overall Study|Non-Compliance with Study Drug|0
5886814|NCT01803282|20366296|P12|Overall Study|Adverse Event|3
5886815|NCT01803282|20366297|P11|Overall Study|Adverse Event|0
5886816|NCT01803282|20366298|P10|Overall Study|Adverse Event|1
5886817|NCT01803282|20366299|P9|Overall Study|Adverse Event|0
5886818|NCT01803282|20366300|P8|Overall Study|Adverse Event|2
5886819|NCT01803282|20366301|P7|Overall Study|Adverse Event|1
5886820|NCT01803282|20366302|P6|Overall Study|Adverse Event|0
5886821|NCT01803282|20366303|P5|Overall Study|Adverse Event|0
5886822|NCT01803282|20366304|P4|Overall Study|Adverse Event|0
5886823|NCT01803282|20366305|P3|Overall Study|Adverse Event|0
5886824|NCT01803282|20366306|P2|Overall Study|Adverse Event|0
5886825|NCT01803282|20366307|P1|Overall Study|Adverse Event|0
5886826|NCT01803282|20366296|P12|Overall Study|Investigator's Discretion|0
5886827|NCT01803282|20366297|P11|Overall Study|Investigator's Discretion|1
5886828|NCT01803282|20366298|P10|Overall Study|Investigator's Discretion|7
5886829|NCT01803282|20366299|P9|Overall Study|Investigator's Discretion|6
5886830|NCT01803282|20366300|P8|Overall Study|Investigator's Discretion|10
5886831|NCT01803282|20366301|P7|Overall Study|Investigator's Discretion|7
5886832|NCT01803282|20366302|P6|Overall Study|Investigator's Discretion|1
5886833|NCT01803282|20366303|P5|Overall Study|Investigator's Discretion|2
5886834|NCT01803282|20366304|P4|Overall Study|Investigator's Discretion|7
5886835|NCT01803282|20366305|P3|Overall Study|Investigator's Discretion|0
5886836|NCT01803282|20366306|P2|Overall Study|Investigator's Discretion|0
5886837|NCT01803282|20366307|P1|Overall Study|Investigator's Discretion|0
5886838|NCT01803282|20366296|P12|Overall Study|Withdrew Consent|1
5886839|NCT01803282|20366297|P11|Overall Study|Withdrew Consent|0
5886840|NCT01803282|20366298|P10|Overall Study|Withdrew Consent|5
5886841|NCT01803282|20366299|P9|Overall Study|Withdrew Consent|1
5886842|NCT01803282|20366300|P8|Overall Study|Withdrew Consent|3
5886843|NCT01803282|20366301|P7|Overall Study|Withdrew Consent|8
5886844|NCT01803282|20366302|P6|Overall Study|Withdrew Consent|0
5886845|NCT01803282|20366303|P5|Overall Study|Withdrew Consent|1
5886846|NCT01803282|20366304|P4|Overall Study|Withdrew Consent|6
5886847|NCT01803282|20366305|P3|Overall Study|Withdrew Consent|0
5886848|NCT01803282|20366306|P2|Overall Study|Withdrew Consent|0
5886849|NCT01803282|20366307|P1|Overall Study|Withdrew Consent|0
5886850|NCT01803282|20366296|P12|Overall Study|Death|0
5886851|NCT01803282|20366297|P11|Overall Study|Death|0
5886852|NCT01803282|20366298|P10|Overall Study|Death|1
5886853|NCT01803282|20366299|P9|Overall Study|Death|1
5886854|NCT01803282|20366300|P8|Overall Study|Death|5
5886855|NCT01803282|20366301|P7|Overall Study|Death|1
5886856|NCT01803282|20366302|P6|Overall Study|Death|1
5886857|NCT01803282|20366303|P5|Overall Study|Death|2
5886858|NCT01803282|20366304|P4|Overall Study|Death|0
5886859|NCT01803282|20366305|P3|Overall Study|Death|0
5886860|NCT01803282|20366306|P2|Overall Study|Death|0
5886861|NCT01803282|20366307|P1|Overall Study|Death|0
5886862|NCT01803282|20366296|P12|Overall Study|Progressive Disease|11
5886863|NCT01803282|20366297|P11|Overall Study|Progressive Disease|6
5886864|NCT01803282|20366298|P10|Overall Study|Progressive Disease|29
5886865|NCT01803282|20366299|P9|Overall Study|Progressive Disease|3
5886866|NCT01803282|20366300|P8|Overall Study|Progressive Disease|24
5886867|NCT01803282|20366301|P7|Overall Study|Progressive Disease|23
5886868|NCT01803282|20366302|P6|Overall Study|Progressive Disease|8
5886869|NCT01803282|20366303|P5|Overall Study|Progressive Disease|5
5886870|NCT01803282|20366304|P4|Overall Study|Progressive Disease|22
5886871|NCT01803282|20366305|P3|Overall Study|Progressive Disease|6
5886872|NCT01803282|20366306|P2|Overall Study|Progressive Disease|3
5886873|NCT01803282|20366307|P1|Overall Study|Progressive Disease|4
5886874|NCT01803269|20366348|P3|Overall Study|Withdrawal by Subject|0
5886875|NCT01803269|20366349|P2|Overall Study|Withdrawal by Subject|0
5886876|NCT01803269|20366350|P1|Overall Study|Withdrawal by Subject|3
5886877|NCT01802879|20366664|P1|Overall Study|Disease progression|6
5886878|NCT01802879|20366664|P1|Overall Study|Administrative problems|2
5886879|NCT01802775|20366671|P2|Overall Study|Lost to Follow-up|2
5886880|NCT01802775|20366672|P1|Overall Study|Lost to Follow-up|1
5886881|NCT01802775|20366671|P2|Overall Study|Withdrawal by Subject|5
5886882|NCT01802775|20366672|P1|Overall Study|Withdrawal by Subject|3
5886883|NCT01802775|20366671|P2|Overall Study|Adverse Event|1
5886884|NCT01802775|20366672|P1|Overall Study|Adverse Event|1
5886885|NCT01802775|20366671|P2|Overall Study|Physician Decision|0
5886886|NCT01802775|20366672|P1|Overall Study|Physician Decision|1
5886887|NCT01802775|20366671|P2|Overall Study|Reason not provided|1
5886888|NCT01802775|20366672|P1|Overall Study|Reason not provided|0
5886889|NCT01802775|20366671|P2|Overall Study|Death|3
5886890|NCT01802775|20366672|P1|Overall Study|Death|0
5886921|NCT01802580|20366728|P2|Overall Study|Lack of Efficacy|2
5886922|NCT01802580|20366729|P1|Overall Study|Lack of Efficacy|0
5886923|NCT01802580|20366728|P2|Overall Study|Other|3
5886924|NCT01802580|20366729|P1|Overall Study|Other|1
5886925|NCT01802580|20366728|P2|Overall Study|Withdrawal by Subject|6
5886926|NCT01802580|20366729|P1|Overall Study|Withdrawal by Subject|5
5886927|NCT01802580|20366728|P2|Overall Study|Protocol Violation|0
5886928|NCT01802580|20366729|P1|Overall Study|Protocol Violation|2
5886929|NCT01802580|20366728|P2|Overall Study|Physician Decision|0
5886930|NCT01802580|20366729|P1|Overall Study|Physician Decision|1
5886931|NCT01802515|20366760|P3|Overall Study|Withdrawal by Subject|0
5886932|NCT01802515|20366761|P2|Overall Study|Withdrawal by Subject|0
5886933|NCT01802515|20366762|P1|Overall Study|Withdrawal by Subject|3
5886934|NCT01802437|20366775|P2|Overall Study|Withdrawal by Subject|4
5886935|NCT01802437|20366776|P1|Overall Study|Withdrawal by Subject|3
5886936|NCT01802437|20366775|P2|Overall Study|Lost to Follow-up|0
5886937|NCT01802437|20366776|P1|Overall Study|Lost to Follow-up|1
5886938|NCT01802411|20366788|P2|Overall Study|Proc changed to video-asst thorascopic|1
5886939|NCT01802411|20366789|P1|Overall Study|Proc changed to video-asst thorascopic|0
5886940|NCT01802411|20366788|P2|Overall Study|Surgery aborted after bronchoscopy|0
5886941|NCT01802411|20366789|P1|Overall Study|Surgery aborted after bronchoscopy|1
5886942|NCT01802411|20366788|P2|Overall Study|Planned pleurodesis as part of the proc|0
5886943|NCT01802411|20366789|P1|Overall Study|Planned pleurodesis as part of the proc|1
5886944|NCT01802411|20366788|P2|Overall Study|Withdrawal by Subject|2
5886945|NCT01802411|20366789|P1|Overall Study|Withdrawal by Subject|0
5886946|NCT01802411|20366788|P2|Overall Study|Lack of Efficacy|10
5886947|NCT01802411|20366789|P1|Overall Study|Lack of Efficacy|8
5886948|NCT01802411|20366788|P2|Overall Study|Adverse Event|7
5886949|NCT01802411|20366789|P1|Overall Study|Adverse Event|2
5886950|NCT01802411|20366788|P2|Overall Study|Death|1
5886951|NCT01802411|20366789|P1|Overall Study|Death|2
5886952|NCT01802385|20366801|P2|Overall Study|Death|120
5886953|NCT01802385|20366802|P1|Overall Study|Death|106
5886954|NCT01802333|20366825|P3|Overall Study|Did not start treatment|5
5886955|NCT01802333|20366826|P2|Overall Study|Did not start treatment|2
5886956|NCT01802333|20366827|P1|Overall Study|Did not start treatment|0
5886957|NCT01802333|20366825|P3|Overall Study|Other - not protocol specified|24
5886958|NCT01802333|20366826|P2|Overall Study|Other - not protocol specified|22
5886959|NCT01802333|20366827|P1|Overall Study|Other - not protocol specified|32
5886960|NCT01802333|20366825|P3|Overall Study|Death|13
5886961|NCT01802333|20366826|P2|Overall Study|Death|14
5886962|NCT01802333|20366827|P1|Overall Study|Death|7
5886963|NCT01802333|20366825|P3|Overall Study|Progression/relapse|0
5886964|NCT01802333|20366826|P2|Overall Study|Progression/relapse|3
5886965|NCT01802333|20366827|P1|Overall Study|Progression/relapse|1
5886966|NCT01802333|20366825|P3|Overall Study|Withdrawal by Subject|5
5886967|NCT01802333|20366826|P2|Overall Study|Withdrawal by Subject|6
5886968|NCT01802333|20366827|P1|Overall Study|Withdrawal by Subject|6
5886969|NCT01802333|20366825|P3|Overall Study|Adverse Event|8
5886970|NCT01802333|20366826|P2|Overall Study|Adverse Event|8
5886971|NCT01802333|20366827|P1|Overall Study|Adverse Event|1
5886972|NCT01802333|20366825|P3|Overall Study|Ineligible|8
5886973|NCT01802333|20366826|P2|Overall Study|Ineligible|6
5886974|NCT01802333|20366827|P1|Overall Study|Ineligible|2
5886975|NCT01802320|20366854|P1|Overall Study|Withdrawal by Subject|1
5886976|NCT01802320|20366854|P1|Overall Study|Death|1
5886977|NCT01802216|20366864|P2|12 Month Visit|Participant did not show to visit|4
5886978|NCT01802216|20366865|P1|12 Month Visit|Participant did not show to visit|3
5886979|NCT01802216|20366864|P2|8 Month Visit|Participant did not show to visit|5
5886980|NCT01802216|20366865|P1|8 Month Visit|Participant did not show to visit|3
5886981|NCT01802216|20366864|P2|4 Month Visit|Participant did not show to visit|4
5886982|NCT01802216|20366865|P1|4 Month Visit|Participant did not show to visit|3
5886983|NCT01802073|20366944|P2|Overall Study|Physician Decision|7
5886984|NCT01802073|20366945|P1|Overall Study|Physician Decision|0
5886985|NCT01802073|20366944|P2|Overall Study|Withdrawal by Subject|1
5886986|NCT01802073|20366945|P1|Overall Study|Withdrawal by Subject|1
5886987|NCT01802073|20366944|P2|Overall Study|Non-compliant|2
5886988|NCT01802073|20366945|P1|Overall Study|Non-compliant|4
5886989|NCT01802073|20366944|P2|Overall Study|Lost to Follow-up|1
5886990|NCT01802073|20366945|P1|Overall Study|Lost to Follow-up|0
5886992|NCT01801917|20366975|P4|Period 1 - Randomized|Adverse Event|0
5886993|NCT01801917|20366976|P3|Period 1 - Randomized|Adverse Event|1
5886994|NCT01801917|20366977|P2|Period 1 - Randomized|Adverse Event|0
5886995|NCT01801917|20366978|P1|Period 1 - Randomized|Adverse Event|1
5886996|NCT01801865|20366998|P1|Overall Study|Physician Decision|7
5886997|NCT01801865|20366998|P1|Overall Study|Patients scanned on another MRI scanner|35
5886998|NCT01801735|20367003|P1|Overall Study|Other, including site closure|19
5886999|NCT01801735|20367003|P1|Overall Study|Death|1
5887000|NCT01801735|20367003|P1|Overall Study|Physician Decision|3
5887001|NCT01801735|20367003|P1|Overall Study|Non-compliance with Trial Drug|13
5887002|NCT01801735|20367003|P1|Overall Study|Lost to Follow-up|15
5887003|NCT01801735|20367003|P1|Overall Study|Protocol Violation|25
5887004|NCT01801735|20367003|P1|Overall Study|Withdrawal by Subject|27
5887005|NCT01801735|20367003|P1|Overall Study|Lack of Efficacy|28
5887006|NCT01801735|20367003|P1|Overall Study|Adverse Event|79
5887007|NCT01801475|20367010|P5|Overall Study|Withdrawal by Subject|1
5887008|NCT01801475|20367011|P4|Overall Study|Withdrawal by Subject|0
5887009|NCT01801475|20367012|P3|Overall Study|Withdrawal by Subject|0
5887010|NCT01801475|20367013|P2|Overall Study|Withdrawal by Subject|0
5887011|NCT01801475|20367014|P1|Overall Study|Withdrawal by Subject|0
5887012|NCT01801436|20367039|P1|Overall Study|Progressive disease|4
5887013|NCT01801436|20367039|P1|Overall Study|Adverse Event|2
5887014|NCT01801436|20367039|P1|Overall Study|Withdrawal by Subject|3
5887015|NCT01801358|20367077|P6|Overall Study|Withdrawal by Subject|2
5887016|NCT01801358|20367078|P5|Overall Study|Withdrawal by Subject|0
5887017|NCT01801358|20367079|P4|Overall Study|Withdrawal by Subject|1
5887018|NCT01801358|20367080|P3|Overall Study|Withdrawal by Subject|0
5887019|NCT01801358|20367081|P2|Overall Study|Withdrawal by Subject|0
5887020|NCT01801358|20367082|P1|Overall Study|Withdrawal by Subject|0
5887021|NCT01801358|20367077|P6|Overall Study|Progressive Disease|5
5887022|NCT01801358|20367078|P5|Overall Study|Progressive Disease|6
5887023|NCT01801358|20367079|P4|Overall Study|Progressive Disease|5
5887024|NCT01801358|20367080|P3|Overall Study|Progressive Disease|4
5887025|NCT01801358|20367081|P2|Overall Study|Progressive Disease|4
5887026|NCT01801358|20367082|P1|Overall Study|Progressive Disease|6
5887027|NCT01801358|20367077|P6|Overall Study|Physician Decision|0
5887028|NCT01801358|20367078|P5|Overall Study|Physician Decision|0
5887029|NCT01801358|20367079|P4|Overall Study|Physician Decision|0
5887030|NCT01801358|20367080|P3|Overall Study|Physician Decision|1
5887031|NCT01801358|20367081|P2|Overall Study|Physician Decision|0
5887032|NCT01801358|20367082|P1|Overall Study|Physician Decision|0
5887033|NCT01801358|20367077|P6|Overall Study|Adverse Event|1
5887034|NCT01801358|20367078|P5|Overall Study|Adverse Event|0
5887035|NCT01801358|20367079|P4|Overall Study|Adverse Event|0
5887036|NCT01801358|20367080|P3|Overall Study|Adverse Event|1
5887037|NCT01801358|20367081|P2|Overall Study|Adverse Event|2
5887038|NCT01801358|20367082|P1|Overall Study|Adverse Event|0
5887039|NCT01801280|20367204|P4|Period 4|Protocol Violation|0
5887040|NCT01801280|20367205|P3|Period 4|Protocol Violation|1
5887041|NCT01801280|20367206|P2|Period 4|Protocol Violation|0
5887042|NCT01801280|20367207|P1|Period 4|Protocol Violation|0
5887043|NCT01801280|20367204|P4|Period 2|Withdrawal by Subject|0
5887044|NCT01801280|20367205|P3|Period 2|Withdrawal by Subject|0
5887045|NCT01801280|20367206|P2|Period 2|Withdrawal by Subject|0
5887046|NCT01801280|20367207|P1|Period 2|Withdrawal by Subject|1
5887047|NCT01801280|20367204|P4|Period 1|Withdrawal by Subject|0
5887048|NCT01801280|20367205|P3|Period 1|Withdrawal by Subject|0
5887049|NCT01801280|20367206|P2|Period 1|Withdrawal by Subject|1
5887050|NCT01801280|20367207|P1|Period 1|Withdrawal by Subject|0
5887051|NCT01801111|20367222|P1|Overall Study|Progressive Disease|81
5887052|NCT01801111|20367222|P1|Overall Study|Study Terminated by Sponsor|27
5887053|NCT01801111|20367222|P1|Overall Study|Withdrawal by Subject|4
5887054|NCT01801111|20367222|P1|Overall Study|Other|1
5887055|NCT01801111|20367222|P1|Overall Study|Physician Decision|5
5887056|NCT01801111|20367222|P1|Overall Study|Death|8
5887057|NCT01801111|20367222|P1|Overall Study|Adverse Event|12
5887058|NCT01801007|20367261|P1|Overall Study|Withdrawal by Subject|5
5887059|NCT01801007|20367261|P1|Overall Study|Lost to Follow-up|4
5887060|NCT01801007|20367261|P1|Overall Study|Adverse Event|2
5887061|NCT01800968|20367274|P2|Overall Study|Physician Decision|0
5887062|NCT01800968|20367275|P1|Overall Study|Physician Decision|1
5887063|NCT01800968|20367274|P2|Overall Study|Withdrawal by Subject|9
5887064|NCT01800968|20367275|P1|Overall Study|Withdrawal by Subject|7
5887065|NCT01800968|20367274|P2|Overall Study|Lost to Follow-up|7
5887066|NCT01800968|20367275|P1|Overall Study|Lost to Follow-up|5
5887067|NCT01800968|20367274|P2|Overall Study|Death|16
5887068|NCT01800968|20367275|P1|Overall Study|Death|23
5887069|NCT01800916|20367317|P9|Test Period 1 (1 Week)|Adverse Event|0
5887070|NCT01800916|20367318|P8|Test Period 1 (1 Week)|Adverse Event|0
5887071|NCT01800916|20367319|P7|Test Period 1 (1 Week)|Adverse Event|0
5887072|NCT01800916|20367320|P6|Test Period 1 (1 Week)|Adverse Event|0
5887073|NCT01800916|20367321|P5|Test Period 1 (1 Week)|Adverse Event|1
5887074|NCT01800916|20367322|P4|Test Period 1 (1 Week)|Adverse Event|0
5887075|NCT01800916|20367323|P3|Test Period 1 (1 Week)|Adverse Event|0
5887076|NCT01800916|20367324|P2|Test Period 1 (1 Week)|Adverse Event|0
5887077|NCT01800916|20367325|P1|Test Period 1 (1 Week)|Adverse Event|0
5887078|NCT01800916|20367317|P9|Test Period 1 (1 Week)|Convex product user|0
5887079|NCT01800916|20367318|P8|Test Period 1 (1 Week)|Convex product user|0
5887080|NCT01800916|20367319|P7|Test Period 1 (1 Week)|Convex product user|0
5887081|NCT01800916|20367320|P6|Test Period 1 (1 Week)|Convex product user|0
5887082|NCT01800916|20367321|P5|Test Period 1 (1 Week)|Convex product user|0
5887083|NCT01800916|20367322|P4|Test Period 1 (1 Week)|Convex product user|1
5887084|NCT01800916|20367323|P3|Test Period 1 (1 Week)|Convex product user|0
5887085|NCT01800916|20367324|P2|Test Period 1 (1 Week)|Convex product user|0
5887086|NCT01800916|20367325|P1|Test Period 1 (1 Week)|Convex product user|0
5887087|NCT01800903|20367335|P6|Second Test Period|unable to catheterise|0
5887088|NCT01800903|20367336|P5|Second Test Period|unable to catheterise|0
5887089|NCT01800903|20367337|P4|Second Test Period|unable to catheterise|0
5887090|NCT01800903|20367338|P3|Second Test Period|unable to catheterise|0
5887091|NCT01800903|20367339|P2|Second Test Period|unable to catheterise|0
5887092|NCT01800903|20367340|P1|Second Test Period|unable to catheterise|1
5887093|NCT01800201|20367429|P2|Overall Study|PI withdrawal, cognitive concerns|1
5887179|NCT01799889|20367593|P2|Overall Study|Study Terminated By Sponsor|0
5887094|NCT01800201|20367430|P1|Overall Study|PI withdrawal, cognitive concerns|0
5887095|NCT01800201|20367429|P2|Overall Study|did not want to use device|1
5887096|NCT01800201|20367430|P1|Overall Study|did not want to use device|0
5887097|NCT01800201|20367429|P2|Overall Study|patient privacy concerns|1
5887098|NCT01800201|20367430|P1|Overall Study|patient privacy concerns|1
5887099|NCT01800201|20367429|P2|Overall Study|Withdrawal by Subject|0
5887100|NCT01800201|20367430|P1|Overall Study|Withdrawal by Subject|2
5887101|NCT01800058|20367471|P1|Overall Study|Lost to Follow-up|1
5887102|NCT01799993|20367484|P2|Overall Study|Subject didn't return for follow-up|1
5887103|NCT01799993|20367485|P1|Overall Study|Subject didn't return for follow-up|0
5887104|NCT01799993|20367484|P2|Overall Study|Other|0
5887105|NCT01799993|20367485|P1|Overall Study|Other|1
5887106|NCT01799993|20367484|P2|Overall Study|Withdrawal by parent/guardian|1
5887107|NCT01799993|20367485|P1|Overall Study|Withdrawal by parent/guardian|0
5887108|NCT01799993|20367484|P2|Overall Study|Non-compliance with medical device|0
5887109|NCT01799993|20367485|P1|Overall Study|Non-compliance with medical device|1
5887110|NCT01799993|20367484|P2|Overall Study|Protocol deviation|0
5887111|NCT01799993|20367485|P1|Overall Study|Protocol deviation|1
5887112|NCT01799993|20367484|P2|Overall Study|Logistical difficulties|0
5887113|NCT01799993|20367485|P1|Overall Study|Logistical difficulties|1
5887114|NCT01799993|20367484|P2|Overall Study|Recovery|1
5887115|NCT01799993|20367485|P1|Overall Study|Recovery|0
5887116|NCT01799993|20367484|P2|Overall Study|Lack of Efficacy|0
5887117|NCT01799993|20367485|P1|Overall Study|Lack of Efficacy|1
5887118|NCT01799993|20367484|P2|Overall Study|Adverse Event|0
5887119|NCT01799993|20367485|P1|Overall Study|Adverse Event|1
5887120|NCT01799993|20367484|P2|Overall Study|Screen failure|1
5887121|NCT01799993|20367485|P1|Overall Study|Screen failure|0
5887122|NCT01799993|20367484|P2|Overall Study|Deterioration of general conditions|0
5887123|NCT01799993|20367485|P1|Overall Study|Deterioration of general conditions|2
5887124|NCT01799993|20367484|P2|Overall Study|Protocol Violation|1
5887125|NCT01799993|20367485|P1|Overall Study|Protocol Violation|1
5887126|NCT01799993|20367484|P2|Overall Study|Protocol driven decision point|3
5887127|NCT01799993|20367485|P1|Overall Study|Protocol driven decision point|0
5887128|NCT01799993|20367484|P2|Overall Study|Withdrawal by parent/guardian/LAR|3
5887129|NCT01799993|20367485|P1|Overall Study|Withdrawal by parent/guardian/LAR|5
5887130|NCT01799993|20367484|P2|Overall Study|Lost to Follow-up|8
5887131|NCT01799993|20367485|P1|Overall Study|Lost to Follow-up|5
5887132|NCT01799993|20367484|P2|Overall Study|Withdrawal by Subject|24
5887133|NCT01799993|20367485|P1|Overall Study|Withdrawal by Subject|23
5887134|NCT01799993|20367484|P2|Overall Study|Death|45
5887135|NCT01799993|20367485|P1|Overall Study|Death|61
5887136|NCT01799993|20367484|P2|Overall Study|"Didn't complete CRF page End of FU"|40
5887137|NCT01799993|20367485|P1|Overall Study|"Didn't complete CRF page End of FU"|30
5887138|NCT01799941|20367517|P1|Overall Study|Other|15
5887139|NCT01799941|20367517|P1|Overall Study|Lost to Follow-up|17
5887140|NCT01799941|20367517|P1|Overall Study|Lack of Efficacy|3
5887141|NCT01799941|20367517|P1|Overall Study|Investigator Decision|4
5887142|NCT01799941|20367517|P1|Overall Study|Death|2
5887143|NCT01799941|20367517|P1|Overall Study|Withdrawal by Subject|21
5887144|NCT01799941|20367517|P1|Overall Study|Adverse Event|34
5887145|NCT01799889|20367583|P12|Overall Study|Non-Compliance With Study Drug|0
5887146|NCT01799889|20367584|P11|Overall Study|Non-Compliance With Study Drug|0
5887147|NCT01799889|20367585|P10|Overall Study|Non-Compliance With Study Drug|0
5887148|NCT01799889|20367586|P9|Overall Study|Non-Compliance With Study Drug|0
5887149|NCT01799889|20367587|P8|Overall Study|Non-Compliance With Study Drug|0
5887150|NCT01799889|20367588|P7|Overall Study|Non-Compliance With Study Drug|0
5887151|NCT01799889|20367589|P6|Overall Study|Non-Compliance With Study Drug|1
5887152|NCT01799889|20367590|P5|Overall Study|Non-Compliance With Study Drug|0
5887153|NCT01799889|20367591|P4|Overall Study|Non-Compliance With Study Drug|0
5887154|NCT01799889|20367592|P3|Overall Study|Non-Compliance With Study Drug|0
5887155|NCT01799889|20367593|P2|Overall Study|Non-Compliance With Study Drug|0
5887156|NCT01799889|20367594|P1|Overall Study|Non-Compliance With Study Drug|0
5887157|NCT01799889|20367583|P12|Overall Study|Withdrawal by Subject|1
5887158|NCT01799889|20367584|P11|Overall Study|Withdrawal by Subject|1
5887159|NCT01799889|20367585|P10|Overall Study|Withdrawal by Subject|1
5887160|NCT01799889|20367586|P9|Overall Study|Withdrawal by Subject|2
5887161|NCT01799889|20367587|P8|Overall Study|Withdrawal by Subject|1
5887162|NCT01799889|20367588|P7|Overall Study|Withdrawal by Subject|3
5887163|NCT01799889|20367589|P6|Overall Study|Withdrawal by Subject|1
5887164|NCT01799889|20367590|P5|Overall Study|Withdrawal by Subject|5
5887165|NCT01799889|20367591|P4|Overall Study|Withdrawal by Subject|0
5887166|NCT01799889|20367592|P3|Overall Study|Withdrawal by Subject|4
5887167|NCT01799889|20367593|P2|Overall Study|Withdrawal by Subject|6
5887168|NCT01799889|20367594|P1|Overall Study|Withdrawal by Subject|1
5887169|NCT01799889|20367583|P12|Overall Study|Study Terminated By Sponsor|0
5887170|NCT01799889|20367584|P11|Overall Study|Study Terminated By Sponsor|0
5887171|NCT01799889|20367585|P10|Overall Study|Study Terminated By Sponsor|1
5887172|NCT01799889|20367586|P9|Overall Study|Study Terminated By Sponsor|1
5887173|NCT01799889|20367587|P8|Overall Study|Study Terminated By Sponsor|2
5887174|NCT01799889|20367588|P7|Overall Study|Study Terminated By Sponsor|0
5887175|NCT01799889|20367589|P6|Overall Study|Study Terminated By Sponsor|1
5887176|NCT01799889|20367590|P5|Overall Study|Study Terminated By Sponsor|2
5887177|NCT01799889|20367591|P4|Overall Study|Study Terminated By Sponsor|0
5887178|NCT01799889|20367592|P3|Overall Study|Study Terminated By Sponsor|0
5887180|NCT01799889|20367594|P1|Overall Study|Study Terminated By Sponsor|1
5887181|NCT01799889|20367583|P12|Overall Study|Specified Criteria for Withdrawal|0
5887182|NCT01799889|20367584|P11|Overall Study|Specified Criteria for Withdrawal|0
5887183|NCT01799889|20367585|P10|Overall Study|Specified Criteria for Withdrawal|0
5887184|NCT01799889|20367586|P9|Overall Study|Specified Criteria for Withdrawal|0
5887185|NCT01799889|20367587|P8|Overall Study|Specified Criteria for Withdrawal|0
5887186|NCT01799889|20367588|P7|Overall Study|Specified Criteria for Withdrawal|0
5887187|NCT01799889|20367589|P6|Overall Study|Specified Criteria for Withdrawal|0
5887188|NCT01799889|20367590|P5|Overall Study|Specified Criteria for Withdrawal|0
5887189|NCT01799889|20367591|P4|Overall Study|Specified Criteria for Withdrawal|0
5887190|NCT01799889|20367592|P3|Overall Study|Specified Criteria for Withdrawal|1
5887191|NCT01799889|20367593|P2|Overall Study|Specified Criteria for Withdrawal|1
5887192|NCT01799889|20367594|P1|Overall Study|Specified Criteria for Withdrawal|0
5887193|NCT01799889|20367583|P12|Overall Study|Progressive Disease|1
5887194|NCT01799889|20367584|P11|Overall Study|Progressive Disease|3
5887195|NCT01799889|20367585|P10|Overall Study|Progressive Disease|5
5887196|NCT01799889|20367586|P9|Overall Study|Progressive Disease|18
5887197|NCT01799889|20367587|P8|Overall Study|Progressive Disease|13
5887198|NCT01799889|20367588|P7|Overall Study|Progressive Disease|8
5887199|NCT01799889|20367589|P6|Overall Study|Progressive Disease|9
5887200|NCT01799889|20367590|P5|Overall Study|Progressive Disease|23
5887201|NCT01799889|20367591|P4|Overall Study|Progressive Disease|30
5887202|NCT01799889|20367592|P3|Overall Study|Progressive Disease|25
5887203|NCT01799889|20367593|P2|Overall Study|Progressive Disease|26
5887204|NCT01799889|20367594|P1|Overall Study|Progressive Disease|30
5887205|NCT01799889|20367583|P12|Overall Study|Physician Decision|1
5887206|NCT01799889|20367584|P11|Overall Study|Physician Decision|0
5887207|NCT01799889|20367585|P10|Overall Study|Physician Decision|0
5887208|NCT01799889|20367586|P9|Overall Study|Physician Decision|6
5887209|NCT01799889|20367587|P8|Overall Study|Physician Decision|2
5887210|NCT01799889|20367588|P7|Overall Study|Physician Decision|5
5887211|NCT01799889|20367589|P6|Overall Study|Physician Decision|5
5887212|NCT01799889|20367590|P5|Overall Study|Physician Decision|5
5887213|NCT01799889|20367591|P4|Overall Study|Physician Decision|4
5887214|NCT01799889|20367592|P3|Overall Study|Physician Decision|4
5887215|NCT01799889|20367593|P2|Overall Study|Physician Decision|2
5887216|NCT01799889|20367594|P1|Overall Study|Physician Decision|3
5887217|NCT01799889|20367583|P12|Overall Study|Lost to Follow-up|0
5887218|NCT01799889|20367584|P11|Overall Study|Lost to Follow-up|0
5887219|NCT01799889|20367585|P10|Overall Study|Lost to Follow-up|0
5887220|NCT01799889|20367586|P9|Overall Study|Lost to Follow-up|0
5887221|NCT01799889|20367587|P8|Overall Study|Lost to Follow-up|0
5887222|NCT01799889|20367588|P7|Overall Study|Lost to Follow-up|0
5887223|NCT01799889|20367589|P6|Overall Study|Lost to Follow-up|0
5887224|NCT01799889|20367590|P5|Overall Study|Lost to Follow-up|0
5887225|NCT01799889|20367591|P4|Overall Study|Lost to Follow-up|0
5887226|NCT01799889|20367592|P3|Overall Study|Lost to Follow-up|0
5887227|NCT01799889|20367593|P2|Overall Study|Lost to Follow-up|1
5887228|NCT01799889|20367594|P1|Overall Study|Lost to Follow-up|0
5887229|NCT01799889|20367583|P12|Overall Study|Lack of Efficacy|0
5887230|NCT01799889|20367584|P11|Overall Study|Lack of Efficacy|1
5887231|NCT01799889|20367585|P10|Overall Study|Lack of Efficacy|0
5887232|NCT01799889|20367586|P9|Overall Study|Lack of Efficacy|2
5887233|NCT01799889|20367587|P8|Overall Study|Lack of Efficacy|0
5887234|NCT01799889|20367588|P7|Overall Study|Lack of Efficacy|0
5887235|NCT01799889|20367589|P6|Overall Study|Lack of Efficacy|2
5887236|NCT01799889|20367590|P5|Overall Study|Lack of Efficacy|2
5887237|NCT01799889|20367591|P4|Overall Study|Lack of Efficacy|1
5887238|NCT01799889|20367592|P3|Overall Study|Lack of Efficacy|0
5887239|NCT01799889|20367593|P2|Overall Study|Lack of Efficacy|1
5887240|NCT01799889|20367594|P1|Overall Study|Lack of Efficacy|1
5887241|NCT01799889|20367583|P12|Overall Study|Death|0
5887242|NCT01799889|20367584|P11|Overall Study|Death|1
5887243|NCT01799889|20367585|P10|Overall Study|Death|0
5887244|NCT01799889|20367586|P9|Overall Study|Death|1
5887245|NCT01799889|20367587|P8|Overall Study|Death|0
5887246|NCT01799889|20367588|P7|Overall Study|Death|0
5887247|NCT01799889|20367589|P6|Overall Study|Death|0
5887248|NCT01799889|20367590|P5|Overall Study|Death|1
5887249|NCT01799889|20367591|P4|Overall Study|Death|3
5887250|NCT01799889|20367592|P3|Overall Study|Death|5
5887251|NCT01799889|20367593|P2|Overall Study|Death|0
5887252|NCT01799889|20367594|P1|Overall Study|Death|1
5887253|NCT01799889|20367583|P12|Overall Study|Adverse Event|0
5887254|NCT01799889|20367584|P11|Overall Study|Adverse Event|1
5887255|NCT01799889|20367585|P10|Overall Study|Adverse Event|1
5887256|NCT01799889|20367586|P9|Overall Study|Adverse Event|3
5887257|NCT01799889|20367587|P8|Overall Study|Adverse Event|2
5887258|NCT01799889|20367588|P7|Overall Study|Adverse Event|5
5887259|NCT01799889|20367589|P6|Overall Study|Adverse Event|1
5887260|NCT01799889|20367590|P5|Overall Study|Adverse Event|11
5887261|NCT01799889|20367591|P4|Overall Study|Adverse Event|1
5887262|NCT01799889|20367592|P3|Overall Study|Adverse Event|5
5887263|NCT01799889|20367593|P2|Overall Study|Adverse Event|4
5887264|NCT01799889|20367594|P1|Overall Study|Adverse Event|4
5887265|NCT01799720|20367695|P3|Overall Study|Pregnancy|1
5887266|NCT01799720|20367696|P2|Overall Study|Pregnancy|0
5887267|NCT01799720|20367697|P1|Overall Study|Pregnancy|0
5887268|NCT01799720|20367695|P3|Overall Study|Protocol Violation|0
5887269|NCT01799720|20367696|P2|Overall Study|Protocol Violation|1
5887270|NCT01799720|20367697|P1|Overall Study|Protocol Violation|0
5887271|NCT01799720|20367695|P3|Overall Study|Withdrawal by Subject|0
5887272|NCT01799720|20367696|P2|Overall Study|Withdrawal by Subject|0
5887273|NCT01799720|20367697|P1|Overall Study|Withdrawal by Subject|3
5887274|NCT01799590|20367735|P3|Overall Study|Other|1
5887275|NCT01799590|20367736|P2|Overall Study|Other|0
5887276|NCT01799590|20367737|P1|Overall Study|Other|3
5887277|NCT01799590|20367735|P3|Overall Study|Use of prohibited concomitant drugs|0
5887278|NCT01799590|20367736|P2|Overall Study|Use of prohibited concomitant drugs|0
5887279|NCT01799590|20367737|P1|Overall Study|Use of prohibited concomitant drugs|1
5887280|NCT01799590|20367735|P3|Overall Study|Using drugs with restricted days of use|2
5887281|NCT01799590|20367736|P2|Overall Study|Using drugs with restricted days of use|3
5887282|NCT01799590|20367737|P1|Overall Study|Using drugs with restricted days of use|0
5887283|NCT01799590|20367735|P3|Overall Study|Aggravation of complications|1
5887284|NCT01799590|20367736|P2|Overall Study|Aggravation of complications|1
5887285|NCT01799590|20367737|P1|Overall Study|Aggravation of complications|0
5887286|NCT01799590|20367735|P3|Overall Study|Participants convenience|2
5887287|NCT01799590|20367736|P2|Overall Study|Participants convenience|4
5887288|NCT01799590|20367737|P1|Overall Study|Participants convenience|4
5887289|NCT01799590|20367735|P3|Overall Study|Lack of Efficacy|3
5887290|NCT01799590|20367736|P2|Overall Study|Lack of Efficacy|1
5887291|NCT01799590|20367737|P1|Overall Study|Lack of Efficacy|3
5887292|NCT01799590|20367735|P3|Overall Study|Pregnancy|0
5887293|NCT01799590|20367736|P2|Overall Study|Pregnancy|0
5887294|NCT01799590|20367737|P1|Overall Study|Pregnancy|2
5887295|NCT01799590|20367735|P3|Overall Study|Adverse Event|5
5887296|NCT01799590|20367736|P2|Overall Study|Adverse Event|7
5887297|NCT01799590|20367737|P1|Overall Study|Adverse Event|13
5887298|NCT01799239|20367780|P2|Period 2 (7 Days)|Protocol Violation|0
5887299|NCT01799239|20367781|P1|Period 2 (7 Days)|Protocol Violation|1
5887300|NCT01799239|20367780|P2|Period 2 (7 Days)|Withdrawal by Subject|1
5887301|NCT01799239|20367781|P1|Period 2 (7 Days)|Withdrawal by Subject|1
5887302|NCT01799239|20367780|P2|Period 1 (7 Days)|Protocol Violation|1
5887303|NCT01799239|20367781|P1|Period 1 (7 Days)|Protocol Violation|0
5887304|NCT01799239|20367780|P2|Period 1 (7 Days)|Withdrawal by Subject|0
5887305|NCT01799239|20367781|P1|Period 1 (7 Days)|Withdrawal by Subject|2
5887306|NCT01799239|20367780|P2|Period 1 (7 Days)|Lack of Efficacy|0
5887307|NCT01799239|20367781|P1|Period 1 (7 Days)|Lack of Efficacy|1
5887308|NCT01799226|20367789|P2|Overall Study|Disqualified at Day 14|0
5887309|NCT01799226|20367790|P1|Overall Study|Disqualified at Day 14|1
5887310|NCT01799226|20367789|P2|Overall Study|Withdrawal by Subject|0
5887311|NCT01799226|20367790|P1|Overall Study|Withdrawal by Subject|1
5887312|NCT01798992|20367821|P4|Overall Study|Insufficient biopsy tissue|0
5887313|NCT01798992|20367822|P3|Overall Study|Insufficient biopsy tissue|1
5887314|NCT01798992|20367823|P2|Overall Study|Insufficient biopsy tissue|0
5887315|NCT01798992|20367824|P1|Overall Study|Insufficient biopsy tissue|0
5887316|NCT01798992|20367821|P4|Overall Study|Lost to Follow-up|0
5887317|NCT01798992|20367822|P3|Overall Study|Lost to Follow-up|1
5887318|NCT01798992|20367823|P2|Overall Study|Lost to Follow-up|1
5887319|NCT01798992|20367824|P1|Overall Study|Lost to Follow-up|0
5887320|NCT01798992|20367821|P4|Overall Study|Administrative withdrawal|1
5887321|NCT01798992|20367822|P3|Overall Study|Administrative withdrawal|0
5887322|NCT01798992|20367823|P2|Overall Study|Administrative withdrawal|1
5887323|NCT01798992|20367824|P1|Overall Study|Administrative withdrawal|0
5887324|NCT01798927|20367844|P1|Overall Study|Withdrawal by Subject|1
5887325|NCT01798849|20367853|P3|Overall Study|Physician Decision|1
5887326|NCT01798849|20367854|P2|Overall Study|Physician Decision|0
5887327|NCT01798849|20367855|P1|Overall Study|Physician Decision|0
5887328|NCT01798706|20368045|P2|Overall Study|Other than specified above|9
5887329|NCT01798706|20368046|P1|Overall Study|Other than specified above|5
5887330|NCT01798706|20368045|P2|Overall Study|Poor compliance to protocol|0
5887331|NCT01798706|20368046|P1|Overall Study|Poor compliance to protocol|1
5887332|NCT01798706|20368045|P2|Overall Study|Lack of Efficacy|2
5887333|NCT01798706|20368046|P1|Overall Study|Lack of Efficacy|0
5887334|NCT01798706|20368045|P2|Overall Study|Adverse Event|10
5887335|NCT01798706|20368046|P1|Overall Study|Adverse Event|15
5887336|NCT01798485|20368117|P2|Overall Study|Clinical Progression|24
5887337|NCT01798485|20368118|P1|Overall Study|Clinical Progression|35
5887338|NCT01798485|20368117|P2|Overall Study|Sponsor Decision|54
5887339|NCT01798485|20368118|P1|Overall Study|Sponsor Decision|61
5887340|NCT01798485|20368117|P2|Overall Study|Death|22
5887341|NCT01798485|20368118|P1|Overall Study|Death|25
5887342|NCT01798485|20368117|P2|Overall Study|Objective Disease Progression|106
5887343|NCT01798485|20368118|P1|Overall Study|Objective Disease Progression|152
5887344|NCT01798485|20368117|P2|Overall Study|Physician Decision|10
5887345|NCT01798485|20368118|P1|Overall Study|Physician Decision|14
5887346|NCT01798485|20368117|P2|Overall Study|Lost to Follow-up|3
5887347|NCT01798485|20368118|P1|Overall Study|Lost to Follow-up|0
5887348|NCT01798485|20368117|P2|Overall Study|Withdrawal by Subject|31
5887349|NCT01798485|20368118|P1|Overall Study|Withdrawal by Subject|27
5887350|NCT01798485|20368117|P2|Overall Study|Adverse Event|40
5887351|NCT01798485|20368118|P1|Overall Study|Adverse Event|32
5887352|NCT01798134|20368255|P1|Overall Study|Liver transplant/surgery|4
5887353|NCT01798134|20368255|P1|Overall Study|Physician Decision|3
5887354|NCT01798134|20368255|P1|Overall Study|Adverse Event|3
5887355|NCT01798134|20368255|P1|Overall Study|Death|2
5887356|NCT01798134|20368255|P1|Overall Study|Withdrawal by Subject|3
5887357|NCT01798134|20368255|P1|Overall Study|Lost to Follow-up|1
5887358|NCT01798056|20368264|P2|Overall Study|Other|2
5887359|NCT01798056|20368265|P1|Overall Study|Other|0
5887360|NCT01798056|20368264|P2|Overall Study|Lost to Follow-up|1
5887361|NCT01798056|20368265|P1|Overall Study|Lost to Follow-up|1
5887362|NCT01798056|20368264|P2|Overall Study|Migrated/moved from study area|1
5887363|NCT01798056|20368265|P1|Overall Study|Migrated/moved from study area|1
5887364|NCT01798056|20368264|P2|Overall Study|Withdrawal by Subject|9
5887365|NCT01798056|20368265|P1|Overall Study|Withdrawal by Subject|12
5887366|NCT01798056|20368264|P2|Overall Study|Serious Adverse Event|12
5887367|NCT01798056|20368265|P1|Overall Study|Serious Adverse Event|13
5887368|NCT01798004|20368299|P1|Overall Study|Enrollment another COG therapeutic trial|32
5887369|NCT01798004|20368299|P1|Overall Study|Initiation of other non-protocol therapy|5
5887370|NCT01798004|20368299|P1|Overall Study|Patient/parent refusal|7
5887371|NCT01798004|20368299|P1|Overall Study|Ineligible|4
5887372|NCT01798004|20368299|P1|Overall Study|Withdrawal by Subject|4
5887373|NCT01798004|20368299|P1|Overall Study|Physician Decision|25
5887374|NCT01798004|20368299|P1|Overall Study|Lack of Efficacy|8
5887375|NCT01798004|20368299|P1|Overall Study|Death|2
5887376|NCT01797965|20368307|P4|Overall Study|Reason Not Specified|15
5887377|NCT01797965|20368308|P3|Overall Study|Reason Not Specified|0
5887378|NCT01797965|20368309|P2|Overall Study|Reason Not Specified|295
5887379|NCT01797965|20368310|P1|Overall Study|Reason Not Specified|280
5887380|NCT01797965|20368307|P4|Overall Study|Disease progression, defined by protocol|0
5887381|NCT01797965|20368308|P3|Overall Study|Disease progression, defined by protocol|0
5887382|NCT01797965|20368309|P2|Overall Study|Disease progression, defined by protocol|1
5887383|NCT01797965|20368310|P1|Overall Study|Disease progression, defined by protocol|3
5887384|NCT01797965|20368307|P4|Overall Study|Death|0
5887385|NCT01797965|20368308|P3|Overall Study|Death|0
5887386|NCT01797965|20368309|P2|Overall Study|Death|4
5887387|NCT01797965|20368310|P1|Overall Study|Death|2
5887388|NCT01797965|20368307|P4|Overall Study|Investigator decision|0
5887389|NCT01797965|20368308|P3|Overall Study|Investigator decision|0
5887390|NCT01797965|20368309|P2|Overall Study|Investigator decision|15
5887391|NCT01797965|20368310|P1|Overall Study|Investigator decision|21
5887392|NCT01797965|20368307|P4|Overall Study|Consent withdrawn|35
5887393|NCT01797965|20368308|P3|Overall Study|Consent withdrawn|3
5887394|NCT01797965|20368309|P2|Overall Study|Consent withdrawn|117
5887395|NCT01797965|20368310|P1|Overall Study|Consent withdrawn|130
5887396|NCT01797965|20368307|P4|Overall Study|Lost to Follow-up|2
5887397|NCT01797965|20368308|P3|Overall Study|Lost to Follow-up|1
5887398|NCT01797965|20368309|P2|Overall Study|Lost to Follow-up|8
5887399|NCT01797965|20368310|P1|Overall Study|Lost to Follow-up|9
5887400|NCT01797965|20368307|P4|Overall Study|Adverse Event|21
5887401|NCT01797965|20368308|P3|Overall Study|Adverse Event|4
5887402|NCT01797965|20368309|P2|Overall Study|Adverse Event|129
5887403|NCT01797965|20368310|P1|Overall Study|Adverse Event|104
5887404|NCT01797835|20368444|P2|Overall Study|Lost to Follow-up|27
5887405|NCT01797835|20368445|P1|Overall Study|Lost to Follow-up|31
5887406|NCT01797783|20368461|P2|Overall Study|Withdrawal by Subject|0
5887407|NCT01797783|20368462|P1|Overall Study|Withdrawal by Subject|1
5887408|NCT01797783|20368461|P2|Overall Study|Adverse Event|1
5887409|NCT01797783|20368462|P1|Overall Study|Adverse Event|1
5887410|NCT01797731|20368486|P2|Overall Study|Didn't have proper radiographs required|3
5887411|NCT01797731|20368487|P1|Overall Study|Didn't have proper radiographs required|3
5887412|NCT01797705|20368495|P1|Overall Study|Withdrawal by Subject|1
5887413|NCT01797705|20368495|P1|Overall Study|Equipment anomalies during sleep studies|4
5887414|NCT01797562|20368556|P1|Overall Study|Protocol Violation|5
5887415|NCT01797536|20368565|P4|Overall Study|Adverse Event|0
5887416|NCT01797536|20368566|P3|Overall Study|Adverse Event|0
5887417|NCT01797536|20368567|P2|Overall Study|Adverse Event|1
5887418|NCT01797536|20368568|P1|Overall Study|Adverse Event|0
5887419|NCT01797445|20368640|P2|Open-Label Extension Phase|Investigator's Discretion|0
5887420|NCT01797445|20368641|P1|Open-Label Extension Phase|Investigator's Discretion|1
5887421|NCT01797445|20368640|P2|Double-Blind Phase|Lost to Follow-up|26
5887422|NCT01797445|20368641|P1|Double-Blind Phase|Lost to Follow-up|34
5887423|NCT01797445|20368640|P2|Double-Blind Phase|Withdrew Consent|35
5887424|NCT01797445|20368641|P1|Double-Blind Phase|Withdrew Consent|20
5887425|NCT01797445|20368640|P2|Double-Blind Phase|Protocol Violation|1
5887426|NCT01797445|20368641|P1|Double-Blind Phase|Protocol Violation|0
5887427|NCT01797445|20368640|P2|Double-Blind Phase|Noncompliance with Study Drug|1
5887428|NCT01797445|20368641|P1|Double-Blind Phase|Noncompliance with Study Drug|5
5887429|NCT01797445|20368640|P2|Double-Blind Phase|Investigator's Discretion|17
5887430|NCT01797445|20368641|P1|Double-Blind Phase|Investigator's Discretion|15
5887431|NCT01797445|20368640|P2|Double-Blind Phase|Lack of Efficacy|2
5887432|NCT01797445|20368641|P1|Double-Blind Phase|Lack of Efficacy|1
5887433|NCT01797445|20368640|P2|Double-Blind Phase|Pregnancy|1
5887434|NCT01797445|20368641|P1|Double-Blind Phase|Pregnancy|0
5887435|NCT01797445|20368640|P2|Double-Blind Phase|Death|4
5887436|NCT01797445|20368641|P1|Double-Blind Phase|Death|5
5887437|NCT01797445|20368640|P2|Double-Blind Phase|Adverse Event|0
5887438|NCT01797445|20368641|P1|Double-Blind Phase|Adverse Event|3
5887439|NCT01797445|20368640|P2|Double-Blind Phase|Randomized but Not Treated|2
5887440|NCT01797445|20368641|P1|Double-Blind Phase|Randomized but Not Treated|4
5887441|NCT01797432|20368681|P1|Overall Study|lived too far from study site|1
5887442|NCT01797432|20368681|P1|Overall Study|Withdrawal by Subject|1
5887443|NCT01797432|20368681|P1|Overall Study|Adverse Event|1
5887444|NCT01797432|20368681|P1|Overall Study|Lost to Follow-up|1
5887445|NCT01797302|20368707|P3|Overall Study|Withdrawal by Subject|4
5887446|NCT01797302|20368708|P2|Overall Study|Withdrawal by Subject|3
5887447|NCT01797302|20368709|P1|Overall Study|Withdrawal by Subject|1
5887448|NCT01797302|20368707|P3|Overall Study|Lost to Follow-up|22
5887449|NCT01797302|20368708|P2|Overall Study|Lost to Follow-up|23
5887450|NCT01797302|20368709|P1|Overall Study|Lost to Follow-up|16
5887451|NCT01797263|20368746|P2|Overall Study|Lost to Follow-up|15
5887452|NCT01797263|20368747|P1|Overall Study|Lost to Follow-up|15
5887453|NCT01797263|20368746|P2|Overall Study|Death|0
5887454|NCT01797263|20368747|P1|Overall Study|Death|1
5887455|NCT01797263|20368746|P2|Overall Study|Withdrawal by Subject|25
5887456|NCT01797263|20368747|P1|Overall Study|Withdrawal by Subject|21
5887457|NCT01797185|20368782|P3|Overall Study|Protocol Violation|0
5887458|NCT01797185|20368783|P2|Overall Study|Protocol Violation|1
5887459|NCT01797185|20368784|P1|Overall Study|Protocol Violation|1
5887460|NCT01797185|20368782|P3|Overall Study|Physician Decision|0
5887461|NCT01797185|20368783|P2|Overall Study|Physician Decision|3
5887462|NCT01797185|20368784|P1|Overall Study|Physician Decision|1
5887463|NCT01797185|20368782|P3|Overall Study|Withdrawn per sponsor|0
5887464|NCT01797185|20368783|P2|Overall Study|Withdrawn per sponsor|0
5887465|NCT01797185|20368784|P1|Overall Study|Withdrawn per sponsor|5
5887466|NCT01797185|20368782|P3|Overall Study|Lost to Follow-up|1
5887467|NCT01797185|20368783|P2|Overall Study|Lost to Follow-up|6
5887468|NCT01797185|20368784|P1|Overall Study|Lost to Follow-up|2
5887469|NCT01797185|20368782|P3|Overall Study|Site terminated|0
5887470|NCT01797185|20368783|P2|Overall Study|Site terminated|4
5887471|NCT01797185|20368784|P1|Overall Study|Site terminated|8
5887472|NCT01797185|20368782|P3|Overall Study|Withdrawal by Subject|5
5887473|NCT01797185|20368783|P2|Overall Study|Withdrawal by Subject|9
5887474|NCT01797185|20368784|P1|Overall Study|Withdrawal by Subject|6
5887475|NCT01797185|20368782|P3|Overall Study|Adverse Event|6
5887476|NCT01797185|20368783|P2|Overall Study|Adverse Event|15
5887477|NCT01797185|20368784|P1|Overall Study|Adverse Event|5
5887478|NCT01797120|20368808|P2|Overall Study|never start protocol therapy|0
5887479|NCT01797120|20368809|P1|Overall Study|never start protocol therapy|2
5887480|NCT01797120|20368808|P2|Overall Study|still on treatment|4
5887481|NCT01797120|20368809|P1|Overall Study|still on treatment|2
5887482|NCT01797120|20368808|P2|Overall Study|Physician Decision|0
5887483|NCT01797120|20368809|P1|Overall Study|Physician Decision|3
5887484|NCT01797120|20368808|P2|Overall Study|Non-compliance|0
5887485|NCT01797120|20368809|P1|Overall Study|Non-compliance|1
5887486|NCT01797120|20368808|P2|Overall Study|Symptomatic progression|1
5887487|NCT01797120|20368809|P1|Overall Study|Symptomatic progression|2
5887488|NCT01797120|20368808|P2|Overall Study|Withdrawal by Subject|6
5887489|NCT01797120|20368809|P1|Overall Study|Withdrawal by Subject|6
5887490|NCT01797120|20368808|P2|Overall Study|Adverse Event|5
5887491|NCT01797120|20368809|P1|Overall Study|Adverse Event|13
5887492|NCT01797120|20368808|P2|Overall Study|Disesae progression|49
5887493|NCT01797120|20368809|P1|Overall Study|Disesae progression|37
5887494|NCT01797094|20368823|P2|Overall Study|Other Miscellaneous Reasons|0
5887495|NCT01797094|20368824|P1|Overall Study|Other Miscellaneous Reasons|1
5887496|NCT01797094|20368823|P2|Overall Study|Protocol Violation|1
5887497|NCT01797094|20368824|P1|Overall Study|Protocol Violation|0
5887498|NCT01797094|20368823|P2|Overall Study|Personal Reasons|0
5887499|NCT01797094|20368824|P1|Overall Study|Personal Reasons|4
5887500|NCT01797094|20368823|P2|Overall Study|Adverse Event|1
5887501|NCT01797094|20368824|P1|Overall Study|Adverse Event|1
5887502|NCT01797081|20368846|P4|Overall Study|Protocol Violation|1
5887503|NCT01797081|20368847|P3|Overall Study|Protocol Violation|0
5887504|NCT01797081|20368848|P2|Overall Study|Protocol Violation|0
5887505|NCT01797081|20368849|P1|Overall Study|Protocol Violation|0
5887506|NCT01797081|20368846|P4|Overall Study|Personal Reasons|8
5887507|NCT01797081|20368847|P3|Overall Study|Personal Reasons|4
5887508|NCT01797081|20368848|P2|Overall Study|Personal Reasons|4
5887509|NCT01797081|20368849|P1|Overall Study|Personal Reasons|12
5887510|NCT01797081|20368846|P4|Overall Study|Pregnancy|0
5887511|NCT01797081|20368847|P3|Overall Study|Pregnancy|0
5887512|NCT01797081|20368848|P2|Overall Study|Pregnancy|0
5887513|NCT01797081|20368849|P1|Overall Study|Pregnancy|1
5887514|NCT01797081|20368846|P4|Overall Study|Adverse Event|0
5887515|NCT01797081|20368847|P3|Overall Study|Adverse Event|1
5887516|NCT01797081|20368848|P2|Overall Study|Adverse Event|0
5887517|NCT01797081|20368849|P1|Overall Study|Adverse Event|1
5887518|NCT01796964|20368890|P2|Overall Study|Withdrawal by Subject|1
5887519|NCT01796964|20368891|P1|Overall Study|Withdrawal by Subject|1
5887520|NCT01796964|20368890|P2|Overall Study|Protocol Violation|1
5887521|NCT01796964|20368891|P1|Overall Study|Protocol Violation|0
5887522|NCT01796964|20368890|P2|Overall Study|Death|0
5887523|NCT01796964|20368891|P1|Overall Study|Death|1
5887524|NCT01796964|20368890|P2|Overall Study|Adverse Event|1
5887525|NCT01796964|20368891|P1|Overall Study|Adverse Event|1
5887526|NCT01796860|20368932|P1|Overall Study|Withdrawal by Subject|3
5887527|NCT01796548|20368957|P1|Overall Study|Other|2
5887528|NCT01796548|20368957|P1|Overall Study|Lost to Follow-up|1
5887529|NCT01796470|20368974|P5|Overall Study|Withdrawal by Subject|1
5887530|NCT01796470|20368975|P4|Overall Study|Withdrawal by Subject|0
5887531|NCT01796470|20368976|P3|Overall Study|Withdrawal by Subject|0
5887532|NCT01796470|20368977|P2|Overall Study|Withdrawal by Subject|0
5887533|NCT01796470|20368978|P1|Overall Study|Withdrawal by Subject|7
5887534|NCT01796470|20368974|P5|Overall Study|Protocol Criteria for Withdrawal|0
5887535|NCT01796470|20368975|P4|Overall Study|Protocol Criteria for Withdrawal|0
5887536|NCT01796470|20368976|P3|Overall Study|Protocol Criteria for Withdrawal|0
5887537|NCT01796470|20368977|P2|Overall Study|Protocol Criteria for Withdrawal|0
5887538|NCT01796470|20368978|P1|Overall Study|Protocol Criteria for Withdrawal|1
5887539|NCT01796470|20368974|P5|Overall Study|Progressive Disease|0
5887540|NCT01796470|20368975|P4|Overall Study|Progressive Disease|2
5887541|NCT01796470|20368976|P3|Overall Study|Progressive Disease|3
5887542|NCT01796470|20368977|P2|Overall Study|Progressive Disease|7
5887543|NCT01796470|20368978|P1|Overall Study|Progressive Disease|7
5887544|NCT01796470|20368974|P5|Overall Study|Physician Decision|1
5887545|NCT01796470|20368975|P4|Overall Study|Physician Decision|0
5887546|NCT01796470|20368976|P3|Overall Study|Physician Decision|1
5887547|NCT01796470|20368977|P2|Overall Study|Physician Decision|4
5887548|NCT01796470|20368978|P1|Overall Study|Physician Decision|5
5887549|NCT01796470|20368974|P5|Overall Study|Lost to Follow-up|0
5887550|NCT01796470|20368975|P4|Overall Study|Lost to Follow-up|0
5887551|NCT01796470|20368976|P3|Overall Study|Lost to Follow-up|0
5887552|NCT01796470|20368977|P2|Overall Study|Lost to Follow-up|1
5887553|NCT01796470|20368978|P1|Overall Study|Lost to Follow-up|0
5887554|NCT01796470|20368974|P5|Overall Study|Initiated New Therapy|2
5887555|NCT01796470|20368975|P4|Overall Study|Initiated New Therapy|0
5887556|NCT01796470|20368976|P3|Overall Study|Initiated New Therapy|0
5887557|NCT01796470|20368977|P2|Overall Study|Initiated New Therapy|0
5887558|NCT01796470|20368978|P1|Overall Study|Initiated New Therapy|9
5887559|NCT01796470|20368974|P5|Overall Study|Death|1
5887560|NCT01796470|20368975|P4|Overall Study|Death|0
5887561|NCT01796470|20368976|P3|Overall Study|Death|0
5887562|NCT01796470|20368977|P2|Overall Study|Death|0
5887563|NCT01796470|20368978|P1|Overall Study|Death|2
5887564|NCT01796470|20368974|P5|Overall Study|Adverse Event|3
5887565|NCT01796470|20368975|P4|Overall Study|Adverse Event|1
5887566|NCT01796470|20368976|P3|Overall Study|Adverse Event|2
5887567|NCT01796470|20368977|P2|Overall Study|Adverse Event|2
5887568|NCT01796470|20368978|P1|Overall Study|Adverse Event|4
5887569|NCT01796392|20369022|P2|Overall Study|Lost to Follow-up|0
5887570|NCT01796392|20369023|P1|Overall Study|Lost to Follow-up|1
5887571|NCT01796392|20369022|P2|Overall Study|Excluded for medical reasons|2
5887572|NCT01796392|20369023|P1|Overall Study|Excluded for medical reasons|1
5887573|NCT01796392|20369022|P2|Overall Study|Death|1
5887574|NCT01796392|20369023|P1|Overall Study|Death|5
5887575|NCT01796392|20369022|P2|Overall Study|Withdrawal by Subject|0
5887576|NCT01796392|20369023|P1|Overall Study|Withdrawal by Subject|2
5887577|NCT01796301|20369037|P2|Overall Study|Decision by Sponsor|1
5887578|NCT01796301|20369038|P1|Overall Study|Decision by Sponsor|0
5887579|NCT01796301|20369037|P2|Overall Study|Death|1
5887580|NCT01796301|20369038|P1|Overall Study|Death|0
5887581|NCT01796301|20369037|P2|Overall Study|Lost to Follow-up|3
5887582|NCT01796301|20369038|P1|Overall Study|Lost to Follow-up|3
5887583|NCT01796301|20369037|P2|Overall Study|Withdrawal by Subject|15
5887584|NCT01796301|20369038|P1|Overall Study|Withdrawal by Subject|15
5887585|NCT01795937|20369124|P3|Overall Study|Physician Decision|0
5887586|NCT01795937|20369125|P2|Overall Study|Physician Decision|1
5887587|NCT01795937|20369126|P1|Overall Study|Physician Decision|0
5887588|NCT01795937|20369124|P3|Overall Study|Withdrawal by Subject|0
5887589|NCT01795937|20369125|P2|Overall Study|Withdrawal by Subject|0
5887590|NCT01795937|20369126|P1|Overall Study|Withdrawal by Subject|1
5887591|NCT01795898|20369155|P1|Overall Study|Physician Decision|1
5887592|NCT01795898|20369155|P1|Overall Study|Withdrew consent & had adverse events|3
5887593|NCT01795898|20369155|P1|Overall Study|Death|1
5887594|NCT01795898|20369155|P1|Overall Study|No pain|1
5887595|NCT01795898|20369155|P1|Overall Study|Diagnosed with metastasis|1
5887596|NCT01795898|20369155|P1|Overall Study|Withdrawal of consent|6
5887597|NCT01795898|20369155|P1|Overall Study|Lost to Follow-up|20
5887598|NCT01795898|20369155|P1|Overall Study|Adverse Event|27
5887599|NCT01795638|20369214|P2|Overall Study|Withdrawal by Subject|0
5887600|NCT01795638|20369215|P1|Overall Study|Withdrawal by Subject|1
5887601|NCT01795638|20369214|P2|Overall Study|discharged from hospital|5
5887602|NCT01795638|20369215|P1|Overall Study|discharged from hospital|7
5887603|NCT01795638|20369214|P2|Overall Study|Protocol Violation|0
5887604|NCT01795638|20369215|P1|Overall Study|Protocol Violation|3
5887605|NCT01795638|20369214|P2|Overall Study|transferred to quaternary hospital|3
5887606|NCT01795638|20369215|P1|Overall Study|transferred to quaternary hospital|2
5887607|NCT01795638|20369214|P2|Overall Study|Death|3
5887608|NCT01795638|20369215|P1|Overall Study|Death|0
5887609|NCT01795547|20369241|P2|Overall Study|Not stated|1
5887610|NCT01795547|20369242|P1|Overall Study|Not stated|0
5887611|NCT01795547|20369241|P2|Overall Study|Others|1
5887612|NCT01795547|20369242|P1|Overall Study|Others|4
5887613|NCT01795547|20369241|P2|Overall Study|Non-compliance with IMP|1
5887614|NCT01795547|20369242|P1|Overall Study|Non-compliance with IMP|1
5887615|NCT01795547|20369241|P2|Overall Study|Not Treated|10
5887616|NCT01795547|20369242|P1|Overall Study|Not Treated|4
5887617|NCT01795547|20369241|P2|Overall Study|Withdrawal of consent|12
5887618|NCT01795547|20369242|P1|Overall Study|Withdrawal of consent|7
5887619|NCT01795547|20369241|P2|Overall Study|Lost to Follow-up|5
5887620|NCT01795547|20369242|P1|Overall Study|Lost to Follow-up|2
5887621|NCT01795547|20369241|P2|Overall Study|Protocol Violation|4
5887622|NCT01795547|20369242|P1|Overall Study|Protocol Violation|6
5887623|NCT01795547|20369241|P2|Overall Study|Lack of Efficacy|3
5887624|NCT01795547|20369242|P1|Overall Study|Lack of Efficacy|8
5887625|NCT01795547|20369241|P2|Overall Study|Adverse Event|27
5887626|NCT01795547|20369242|P1|Overall Study|Adverse Event|16
5887627|NCT01795495|20369274|P3|Overall Study|Physician Decision|1
5887628|NCT01795495|20369275|P2|Overall Study|Physician Decision|0
5887629|NCT01795495|20369276|P1|Overall Study|Physician Decision|0
5887630|NCT01795495|20369274|P3|Overall Study|Protocol Violation|1
5887631|NCT01795495|20369275|P2|Overall Study|Protocol Violation|0
5887632|NCT01795495|20369276|P1|Overall Study|Protocol Violation|1
5887633|NCT01794949|20369296|P2|Overall Study|Lost to Follow-up|0
5887634|NCT01794949|20369297|P1|Overall Study|Lost to Follow-up|1
5887635|NCT01794845|20369308|P1|Overall Study|Withdrawal by Subject|1
5887636|NCT01794780|20369336|P8|Overall Study|Other|1
5887637|NCT01794780|20369337|P7|Overall Study|Other|4
5887638|NCT01794780|20369338|P6|Overall Study|Other|24
5887639|NCT01794780|20369339|P5|Overall Study|Other|1
5887640|NCT01794780|20369340|P4|Overall Study|Other|20
5887641|NCT01794780|20369341|P3|Overall Study|Other|25
5887642|NCT01794780|20369342|P2|Overall Study|Other|12
5887643|NCT01794780|20369343|P1|Overall Study|Other|0
5887644|NCT01794780|20369336|P8|Overall Study|Withdrew informed consent|3
5887645|NCT01794780|20369337|P7|Overall Study|Withdrew informed consent|4
5887646|NCT01794780|20369338|P6|Overall Study|Withdrew informed consent|48
5887647|NCT01794780|20369339|P5|Overall Study|Withdrew informed consent|0
5887648|NCT01794780|20369340|P4|Overall Study|Withdrew informed consent|9
5887649|NCT01794780|20369341|P3|Overall Study|Withdrew informed consent|36
5887650|NCT01794780|20369342|P2|Overall Study|Withdrew informed consent|17
5887651|NCT01794780|20369343|P1|Overall Study|Withdrew informed consent|7
5887652|NCT01794780|20369336|P8|Overall Study|Lost to Follow-up|5
5887653|NCT01794780|20369337|P7|Overall Study|Lost to Follow-up|30
5887654|NCT01794780|20369338|P6|Overall Study|Lost to Follow-up|99
5887655|NCT01794780|20369339|P5|Overall Study|Lost to Follow-up|2
5887656|NCT01794780|20369340|P4|Overall Study|Lost to Follow-up|53
5887657|NCT01794780|20369341|P3|Overall Study|Lost to Follow-up|165
5887658|NCT01794780|20369342|P2|Overall Study|Lost to Follow-up|64
5887659|NCT01794780|20369343|P1|Overall Study|Lost to Follow-up|10
5887660|NCT01794780|20369336|P8|Overall Study|Death|0
5887661|NCT01794780|20369337|P7|Overall Study|Death|4
5887662|NCT01794780|20369338|P6|Overall Study|Death|9
5887663|NCT01794780|20369339|P5|Overall Study|Death|0
5887664|NCT01794780|20369340|P4|Overall Study|Death|1
5887665|NCT01794780|20369341|P3|Overall Study|Death|14
5887666|NCT01794780|20369342|P2|Overall Study|Death|2
5887667|NCT01794780|20369343|P1|Overall Study|Death|0
5887668|NCT01794780|20369336|P8|Overall Study|Adverse Event|0
5887669|NCT01794780|20369337|P7|Overall Study|Adverse Event|0
5887670|NCT01794780|20369338|P6|Overall Study|Adverse Event|0
5887671|NCT01794780|20369339|P5|Overall Study|Adverse Event|0
5887672|NCT01794780|20369340|P4|Overall Study|Adverse Event|0
5887673|NCT01794780|20369341|P3|Overall Study|Adverse Event|2
5887674|NCT01794780|20369342|P2|Overall Study|Adverse Event|1
5887675|NCT01794780|20369343|P1|Overall Study|Adverse Event|0
5887676|NCT01794689|20369419|P4|Intervention 1 (2 Nights)|Adverse Event|0
5887677|NCT01794689|20369420|P3|Intervention 1 (2 Nights)|Adverse Event|0
5887678|NCT01794689|20369421|P2|Intervention 1 (2 Nights)|Adverse Event|1
5887679|NCT01794689|20369422|P1|Intervention 1 (2 Nights)|Adverse Event|0
5887680|NCT01794689|20369419|P4|Intervention 1 (2 Nights)|Physician Decision|0
5887681|NCT01794689|20369420|P3|Intervention 1 (2 Nights)|Physician Decision|0
5887682|NCT01794689|20369421|P2|Intervention 1 (2 Nights)|Physician Decision|1
5887683|NCT01794689|20369422|P1|Intervention 1 (2 Nights)|Physician Decision|1
5887684|NCT01794689|20369419|P4|Intervention 1 (2 Nights)|Protocol Violation|0
5887685|NCT01794689|20369420|P3|Intervention 1 (2 Nights)|Protocol Violation|1
5887686|NCT01794689|20369421|P2|Intervention 1 (2 Nights)|Protocol Violation|0
5887687|NCT01794689|20369422|P1|Intervention 1 (2 Nights)|Protocol Violation|1
5887688|NCT01794689|20369419|P4|Intervention 1 (2 Nights)|Withdrawal by Subject|4
5887689|NCT01794689|20369420|P3|Intervention 1 (2 Nights)|Withdrawal by Subject|2
5887690|NCT01794689|20369421|P2|Intervention 1 (2 Nights)|Withdrawal by Subject|0
5887691|NCT01794689|20369422|P1|Intervention 1 (2 Nights)|Withdrawal by Subject|3
5887692|NCT01794299|20369476|P1|Overall Study|Relapse and rejection of ATIR batch|1
5887693|NCT01794299|20369476|P1|Overall Study|Discontinued from active follow-up|1
5887694|NCT01794299|20369476|P1|Overall Study|Relapse|2
5887695|NCT01794299|20369476|P1|Overall Study|ATIR batch rejected|2
5887696|NCT01794299|20369476|P1|Overall Study|Graft failure|1
5887697|NCT01794299|20369476|P1|Overall Study|Death|14
5887698|NCT01794299|20369476|P1|Overall Study|ATIR manufacturing not possible|1
5887699|NCT01794000|20369495|P2|Open-Label Extension Phase (OLE)|Sponsor Decision|0
5887700|NCT01794000|20369496|P1|Open-Label Extension Phase (OLE)|Sponsor Decision|3
5887701|NCT01794000|20369495|P2|Double-Blind Phase (DBP)|Withdrawal by Subject|11
5887702|NCT01794000|20369496|P1|Double-Blind Phase (DBP)|Withdrawal by Subject|6
5887703|NCT01794000|20369495|P2|Double-Blind Phase (DBP)|Sponsor Decision|149
5887704|NCT01794000|20369496|P1|Double-Blind Phase (DBP)|Sponsor Decision|148
5887705|NCT01794000|20369495|P2|Double-Blind Phase (DBP)|Physician Decision|0
5887706|NCT01794000|20369496|P1|Double-Blind Phase (DBP)|Physician Decision|2
5887707|NCT01794000|20369495|P2|Double-Blind Phase (DBP)|Parent/Caregiver Decision|2
5887708|NCT01794000|20369496|P1|Double-Blind Phase (DBP)|Parent/Caregiver Decision|5
5887709|NCT01794000|20369495|P2|Double-Blind Phase (DBP)|Entry Criteria Not Met|0
5887710|NCT01794000|20369496|P1|Double-Blind Phase (DBP)|Entry Criteria Not Met|2
5887711|NCT01794000|20369495|P2|Double-Blind Phase (DBP)|Death|2
5887712|NCT01794000|20369496|P1|Double-Blind Phase (DBP)|Death|1
5887713|NCT01794000|20369495|P2|Double-Blind Phase (DBP)|Adverse Event|2
5887714|NCT01794000|20369496|P1|Double-Blind Phase (DBP)|Adverse Event|5
5887715|NCT01793935|20369529|P2|Overall Study|Lost to Follow-up|1
5887716|NCT01793935|20369530|P1|Overall Study|Lost to Follow-up|0
5887717|NCT01793935|20369529|P2|Overall Study|Patient did not take study medication|1
5887718|NCT01793935|20369530|P1|Overall Study|Patient did not take study medication|1
5887719|NCT01793935|20369529|P2|Overall Study|Adverse Event|0
5887720|NCT01793935|20369530|P1|Overall Study|Adverse Event|2
5887721|NCT01793935|20369529|P2|Overall Study|Protocol Violation|1
5887722|NCT01793935|20369530|P1|Overall Study|Protocol Violation|2
5887723|NCT01793935|20369529|P2|Overall Study|Pregnancy|0
5887724|NCT01793935|20369530|P1|Overall Study|Pregnancy|1
5887725|NCT01793883|20369576|P3|Overall Study|Respiratory distress during spirometry|1
5887726|NCT01793883|20369577|P2|Overall Study|Respiratory distress during spirometry|0
5887727|NCT01793883|20369578|P1|Overall Study|Respiratory distress during spirometry|0
5887728|NCT01793883|20369576|P3|Overall Study|Dosing error|0
5887729|NCT01793883|20369577|P2|Overall Study|Dosing error|1
5887730|NCT01793883|20369578|P1|Overall Study|Dosing error|0
5887731|NCT01793883|20369576|P3|Overall Study|Met exclusion criteria|0
5887732|NCT01793883|20369577|P2|Overall Study|Met exclusion criteria|0
5887733|NCT01793883|20369578|P1|Overall Study|Met exclusion criteria|1
5887734|NCT01793883|20369576|P3|Overall Study|Unable to complete measurements|0
5887735|NCT01793883|20369577|P2|Overall Study|Unable to complete measurements|0
5887736|NCT01793883|20369578|P1|Overall Study|Unable to complete measurements|1
5887737|NCT01793883|20369576|P3|Overall Study|Unable to complete spriometry|0
5887738|NCT01793883|20369577|P2|Overall Study|Unable to complete spriometry|0
5887739|NCT01793883|20369578|P1|Overall Study|Unable to complete spriometry|1
5887740|NCT01793883|20369576|P3|Overall Study|Randomized in error|0
5887741|NCT01793883|20369577|P2|Overall Study|Randomized in error|0
5887742|NCT01793883|20369578|P1|Overall Study|Randomized in error|1
5887743|NCT01793883|20369576|P3|Overall Study|Lost to Follow-up|3
5887744|NCT01793883|20369577|P2|Overall Study|Lost to Follow-up|1
5887745|NCT01793883|20369578|P1|Overall Study|Lost to Follow-up|5
5887746|NCT01793883|20369576|P3|Overall Study|Subject noncompliance|1
5887747|NCT01793883|20369577|P2|Overall Study|Subject noncompliance|1
5887748|NCT01793883|20369578|P1|Overall Study|Subject noncompliance|0
5887749|NCT01793883|20369576|P3|Overall Study|Withdrawal by Subject|3
5887750|NCT01793883|20369577|P2|Overall Study|Withdrawal by Subject|7
5887751|NCT01793883|20369578|P1|Overall Study|Withdrawal by Subject|3
5887752|NCT01793792|20369586|P1|Overall Study|Device Not Implanted|1
5887753|NCT01793792|20369586|P1|Overall Study|Withdrawal by Subject|1
5887754|NCT01793792|20369586|P1|Overall Study|Lost to Follow-up|5
5887755|NCT01793792|20369586|P1|Overall Study|Death|5
5887756|NCT01793688|20369591|P1|Overall Study|Protocol Violation|2
5887757|NCT01793610|20369601|P3|Overall Study|Withdrawal by Subject|1
5887758|NCT01793610|20369602|P2|Overall Study|Withdrawal by Subject|0
5887759|NCT01793610|20369603|P1|Overall Study|Withdrawal by Subject|1
5887760|NCT01793142|20369649|P1|Overall Study|Randomized not treated|7
5887761|NCT01792830|20369679|P11|Overall Study|Adverse Event|0
5887762|NCT01792830|20369680|P10|Overall Study|Adverse Event|0
5887763|NCT01792830|20369681|P9|Overall Study|Adverse Event|1
5887764|NCT01792830|20369682|P8|Overall Study|Adverse Event|0
5887765|NCT01792830|20369683|P7|Overall Study|Adverse Event|0
5887766|NCT01792830|20369684|P6|Overall Study|Adverse Event|0
5887767|NCT01792830|20369685|P5|Overall Study|Adverse Event|0
5887768|NCT01792830|20369686|P4|Overall Study|Adverse Event|0
5887769|NCT01792830|20369687|P3|Overall Study|Adverse Event|0
5887770|NCT01792830|20369688|P2|Overall Study|Adverse Event|0
5887771|NCT01792830|20369689|P1|Overall Study|Adverse Event|0
5887772|NCT01792830|20369679|P11|Overall Study|Death|1
5887773|NCT01792830|20369680|P10|Overall Study|Death|0
5887774|NCT01792830|20369681|P9|Overall Study|Death|1
5887775|NCT01792830|20369682|P8|Overall Study|Death|0
5887776|NCT01792830|20369683|P7|Overall Study|Death|1
5887777|NCT01792830|20369684|P6|Overall Study|Death|0
5887778|NCT01792830|20369685|P5|Overall Study|Death|0
5887779|NCT01792830|20369686|P4|Overall Study|Death|1
5887780|NCT01792830|20369687|P3|Overall Study|Death|0
5887781|NCT01792830|20369688|P2|Overall Study|Death|0
5887782|NCT01792830|20369689|P1|Overall Study|Death|3
5887783|NCT01792830|20369679|P11|Overall Study|Withdrawal by Subject|2
5887784|NCT01792830|20369680|P10|Overall Study|Withdrawal by Subject|0
5887785|NCT01792830|20369681|P9|Overall Study|Withdrawal by Subject|7
5887786|NCT01792830|20369682|P8|Overall Study|Withdrawal by Subject|1
5887787|NCT01792830|20369683|P7|Overall Study|Withdrawal by Subject|1
5887788|NCT01792830|20369684|P6|Overall Study|Withdrawal by Subject|1
5887789|NCT01792830|20369685|P5|Overall Study|Withdrawal by Subject|1
5887790|NCT01792830|20369686|P4|Overall Study|Withdrawal by Subject|2
5887791|NCT01792830|20369687|P3|Overall Study|Withdrawal by Subject|0
5887792|NCT01792830|20369688|P2|Overall Study|Withdrawal by Subject|0
5887793|NCT01792830|20369689|P1|Overall Study|Withdrawal by Subject|22
5887794|NCT01792635|20369776|P3|Part B|Study terminated|3
5887795|NCT01792635|20369777|P2|Part B|Study terminated|4
5887796|NCT01792635|20369778|P1|Part B|Study terminated|0
5887797|NCT01792635|20369776|P3|Part B|Adverse Event|1
5887798|NCT01792635|20369777|P2|Part B|Adverse Event|0
5887799|NCT01792635|20369778|P1|Part B|Adverse Event|0
5887800|NCT01792518|20369806|P2|Overall Study|Other Reason|1
5887801|NCT01792518|20369807|P1|Overall Study|Other Reason|0
5887802|NCT01792518|20369806|P2|Overall Study|Withdrawal by Subject|0
5887803|NCT01792518|20369807|P1|Overall Study|Withdrawal by Subject|2
5887804|NCT01792518|20369806|P2|Overall Study|Lost to Follow-up|1
5887805|NCT01792518|20369807|P1|Overall Study|Lost to Follow-up|3
5887806|NCT01792518|20369806|P2|Overall Study|Protocol Violation|1
5887807|NCT01792518|20369807|P1|Overall Study|Protocol Violation|0
5887808|NCT01792518|20369806|P2|Overall Study|Adverse Event|4
5887809|NCT01792518|20369807|P1|Overall Study|Adverse Event|3
5887810|NCT01792284|20369817|P3|Randomization Period 2|Withdrawal by Subject|0
5887811|NCT01792284|20369818|P2|Randomization Period 2|Withdrawal by Subject|2
5887812|NCT01792284|20369819|P1|Randomization Period 2|Withdrawal by Subject|0
5887813|NCT01792284|20369817|P3|Randomization Period 2|Protocol Violation|0
5887814|NCT01792284|20369818|P2|Randomization Period 2|Protocol Violation|1
5887815|NCT01792284|20369819|P1|Randomization Period 2|Protocol Violation|0
5887816|NCT01792284|20369817|P3|Randomization Period 1|Lost to Follow-up|1
5887817|NCT01792284|20369818|P2|Randomization Period 1|Lost to Follow-up|0
5887818|NCT01792284|20369819|P1|Randomization Period 1|Lost to Follow-up|0
5887819|NCT01792284|20369817|P3|Randomization Period 1|Adverse Event|2
5887820|NCT01792284|20369818|P2|Randomization Period 1|Adverse Event|0
5887821|NCT01792284|20369819|P1|Randomization Period 1|Adverse Event|0
5887822|NCT01792284|20369817|P3|Randomization Period 1|Physician Decision|1
5887823|NCT01792284|20369818|P2|Randomization Period 1|Physician Decision|1
5887824|NCT01792284|20369819|P1|Randomization Period 1|Physician Decision|0
5887825|NCT01792284|20369817|P3|Randomization Period 1|Withdrawal by Subject|1
5887826|NCT01792284|20369818|P2|Randomization Period 1|Withdrawal by Subject|1
5887827|NCT01792284|20369819|P1|Randomization Period 1|Withdrawal by Subject|0
5887828|NCT01792284|20369817|P3|Lead-in Period|Protocol Required Discontinuation|0
5887829|NCT01792284|20369818|P2|Lead-in Period|Protocol Required Discontinuation|0
5887830|NCT01792284|20369819|P1|Lead-in Period|Protocol Required Discontinuation|1
5887831|NCT01792284|20369817|P3|Lead-in Period|Physician Decision|0
5887832|NCT01792284|20369818|P2|Lead-in Period|Physician Decision|0
5887833|NCT01792284|20369819|P1|Lead-in Period|Physician Decision|1
5887834|NCT01792284|20369817|P3|Lead-in Period|Withdrawal by Subject|0
5887835|NCT01792284|20369818|P2|Lead-in Period|Withdrawal by Subject|0
5887836|NCT01792284|20369819|P1|Lead-in Period|Withdrawal by Subject|10
5887837|NCT01792284|20369817|P3|Lead-in Period|Protocol Violation|0
5887838|NCT01792284|20369818|P2|Lead-in Period|Protocol Violation|0
5887839|NCT01792284|20369819|P1|Lead-in Period|Protocol Violation|1
5887840|NCT01792284|20369817|P3|Lead-in Period|Lost to Follow-up|0
5887841|NCT01792284|20369818|P2|Lead-in Period|Lost to Follow-up|0
5887842|NCT01792284|20369819|P1|Lead-in Period|Lost to Follow-up|2
5887843|NCT01792284|20369817|P3|Lead-in Period|Adverse Event|0
5887844|NCT01792284|20369818|P2|Lead-in Period|Adverse Event|0
5887845|NCT01792284|20369819|P1|Lead-in Period|Adverse Event|15
5887846|NCT01792115|20369860|P3|Overall Study|Lost to Follow-up|0
5887847|NCT01792115|20369861|P2|Overall Study|Lost to Follow-up|1
5887848|NCT01792115|20369862|P1|Overall Study|Lost to Follow-up|0
5887849|NCT01791894|20369912|P1|Overall Study|Adverse Event|1
5887850|NCT01791803|20369923|P4|Overall Study|Death|2
5887851|NCT01791803|20369924|P3|Overall Study|Death|2
5887852|NCT01791803|20369925|P2|Overall Study|Death|0
5887853|NCT01791803|20369926|P1|Overall Study|Death|0
5887854|NCT01791803|20369923|P4|Overall Study|Physician Decision|1
5887855|NCT01791803|20369924|P3|Overall Study|Physician Decision|0
5887856|NCT01791803|20369925|P2|Overall Study|Physician Decision|2
5887857|NCT01791803|20369926|P1|Overall Study|Physician Decision|0
5887858|NCT01791803|20369923|P4|Overall Study|Withdrawal by Subject|2
5887859|NCT01791803|20369924|P3|Overall Study|Withdrawal by Subject|0
5887860|NCT01791803|20369925|P2|Overall Study|Withdrawal by Subject|0
5887861|NCT01791803|20369926|P1|Overall Study|Withdrawal by Subject|0
5887862|NCT01791725|20369944|P3|Overall Study|Withdrawal by Subject|0
5887863|NCT01791725|20369945|P2|Overall Study|Withdrawal by Subject|1
5887864|NCT01791725|20369946|P1|Overall Study|Withdrawal by Subject|0
5887865|NCT01791517|20369969|P12|Phase II|Pre-Existing Ocular Issue|1
5887866|NCT01791517|20369970|P11|Phase II|Pre-Existing Ocular Issue|0
5887867|NCT01791517|20369971|P10|Phase II|Pre-Existing Ocular Issue|0
5887868|NCT01791517|20369972|P9|Phase II|Pre-Existing Ocular Issue|0
5887869|NCT01791517|20369973|P8|Phase II|Pre-Existing Ocular Issue|0
5887870|NCT01791517|20369974|P7|Phase II|Pre-Existing Ocular Issue|0
5887871|NCT01791517|20369975|P6|Phase II|Pre-Existing Ocular Issue|0
5887872|NCT01791517|20369976|P5|Phase II|Pre-Existing Ocular Issue|0
5887873|NCT01791517|20369977|P4|Phase II|Pre-Existing Ocular Issue|0
5887874|NCT01791517|20369978|P3|Phase II|Pre-Existing Ocular Issue|0
5887875|NCT01791517|20369979|P2|Phase II|Pre-Existing Ocular Issue|0
5887876|NCT01791517|20369980|P1|Phase II|Pre-Existing Ocular Issue|0
5887877|NCT01791517|20369969|P12|Phase II|Unsatisfactory Lens Fitting|0
5887878|NCT01791517|20369970|P11|Phase II|Unsatisfactory Lens Fitting|0
5887879|NCT01791517|20369971|P10|Phase II|Unsatisfactory Lens Fitting|1
5887880|NCT01791517|20369972|P9|Phase II|Unsatisfactory Lens Fitting|0
5887881|NCT01791517|20369973|P8|Phase II|Unsatisfactory Lens Fitting|0
5887882|NCT01791517|20369974|P7|Phase II|Unsatisfactory Lens Fitting|0
5887883|NCT01791517|20369975|P6|Phase II|Unsatisfactory Lens Fitting|0
5887884|NCT01791517|20369976|P5|Phase II|Unsatisfactory Lens Fitting|0
5887885|NCT01791517|20369977|P4|Phase II|Unsatisfactory Lens Fitting|0
5887886|NCT01791517|20369978|P3|Phase II|Unsatisfactory Lens Fitting|0
5887887|NCT01791517|20369979|P2|Phase II|Unsatisfactory Lens Fitting|0
5887888|NCT01791517|20369980|P1|Phase II|Unsatisfactory Lens Fitting|0
5887889|NCT01791517|20369969|P12|Phase II|Lens Handling Difficulties|0
5887890|NCT01791517|20369970|P11|Phase II|Lens Handling Difficulties|0
5887891|NCT01791517|20369971|P10|Phase II|Lens Handling Difficulties|0
5887892|NCT01791517|20369972|P9|Phase II|Lens Handling Difficulties|1
5887893|NCT01791517|20369973|P8|Phase II|Lens Handling Difficulties|0
5887894|NCT01791517|20369974|P7|Phase II|Lens Handling Difficulties|0
5887895|NCT01791517|20369975|P6|Phase II|Lens Handling Difficulties|0
5887896|NCT01791517|20369976|P5|Phase II|Lens Handling Difficulties|0
5887897|NCT01791517|20369977|P4|Phase II|Lens Handling Difficulties|0
5887898|NCT01791517|20369978|P3|Phase II|Lens Handling Difficulties|0
5887899|NCT01791517|20369979|P2|Phase II|Lens Handling Difficulties|0
5887900|NCT01791517|20369980|P1|Phase II|Lens Handling Difficulties|0
5887901|NCT01791517|20369969|P12|Phase II|Adverse Event|0
5887902|NCT01791517|20369970|P11|Phase II|Adverse Event|0
5887903|NCT01791517|20369971|P10|Phase II|Adverse Event|1
5887904|NCT01791517|20369972|P9|Phase II|Adverse Event|0
5887905|NCT01791517|20369973|P8|Phase II|Adverse Event|1
5887906|NCT01791517|20369974|P7|Phase II|Adverse Event|2
5887907|NCT01791517|20369975|P6|Phase II|Adverse Event|0
5887908|NCT01791517|20369976|P5|Phase II|Adverse Event|0
5887909|NCT01791517|20369977|P4|Phase II|Adverse Event|0
5887910|NCT01791517|20369978|P3|Phase II|Adverse Event|0
5887911|NCT01791517|20369979|P2|Phase II|Adverse Event|0
5887912|NCT01791517|20369980|P1|Phase II|Adverse Event|0
5887913|NCT01791517|20369969|P12|Phase II|Lack of Efficacy|0
5887914|NCT01791517|20369970|P11|Phase II|Lack of Efficacy|0
5887915|NCT01791517|20369971|P10|Phase II|Lack of Efficacy|0
5887916|NCT01791517|20369972|P9|Phase II|Lack of Efficacy|0
5887917|NCT01791517|20369973|P8|Phase II|Lack of Efficacy|0
5887918|NCT01791517|20369974|P7|Phase II|Lack of Efficacy|0
5887919|NCT01791517|20369975|P6|Phase II|Lack of Efficacy|0
5887920|NCT01791517|20369976|P5|Phase II|Lack of Efficacy|1
5887921|NCT01791517|20369977|P4|Phase II|Lack of Efficacy|0
5887922|NCT01791517|20369978|P3|Phase II|Lack of Efficacy|0
5887923|NCT01791517|20369979|P2|Phase II|Lack of Efficacy|0
5887924|NCT01791517|20369980|P1|Phase II|Lack of Efficacy|0
5887925|NCT01791517|20369969|P12|Phase II|Withdrawal by Subject|0
5887926|NCT01791517|20369970|P11|Phase II|Withdrawal by Subject|1
5887927|NCT01791517|20369971|P10|Phase II|Withdrawal by Subject|0
5887928|NCT01791517|20369972|P9|Phase II|Withdrawal by Subject|0
5887929|NCT01791517|20369973|P8|Phase II|Withdrawal by Subject|1
5887930|NCT01791517|20369974|P7|Phase II|Withdrawal by Subject|0
5887931|NCT01791517|20369975|P6|Phase II|Withdrawal by Subject|2
5887932|NCT01791517|20369976|P5|Phase II|Withdrawal by Subject|0
5887933|NCT01791517|20369977|P4|Phase II|Withdrawal by Subject|0
5887934|NCT01791517|20369978|P3|Phase II|Withdrawal by Subject|0
5887935|NCT01791517|20369979|P2|Phase II|Withdrawal by Subject|0
5887936|NCT01791517|20369980|P1|Phase II|Withdrawal by Subject|1
5887937|NCT01791517|20369969|P12|Phase II|Lost to Follow-up|0
5887938|NCT01791517|20369970|P11|Phase II|Lost to Follow-up|0
5887939|NCT01791517|20369971|P10|Phase II|Lost to Follow-up|1
5887940|NCT01791517|20369972|P9|Phase II|Lost to Follow-up|1
5887941|NCT01791517|20369973|P8|Phase II|Lost to Follow-up|1
5887942|NCT01791517|20369974|P7|Phase II|Lost to Follow-up|0
5887943|NCT01791517|20369975|P6|Phase II|Lost to Follow-up|2
5887944|NCT01791517|20369976|P5|Phase II|Lost to Follow-up|1
5887945|NCT01791517|20369977|P4|Phase II|Lost to Follow-up|0
5887946|NCT01791517|20369978|P3|Phase II|Lost to Follow-up|1
5887947|NCT01791517|20369979|P2|Phase II|Lost to Follow-up|0
5887948|NCT01791517|20369980|P1|Phase II|Lost to Follow-up|1
5887949|NCT01791517|20369969|P12|Phase I: Period 3|Adverse Event|0
5887950|NCT01791517|20369970|P11|Phase I: Period 3|Adverse Event|0
5887951|NCT01791517|20369971|P10|Phase I: Period 3|Adverse Event|0
5887952|NCT01791517|20369972|P9|Phase I: Period 3|Adverse Event|0
5887953|NCT01791517|20369973|P8|Phase I: Period 3|Adverse Event|0
5887954|NCT01791517|20369974|P7|Phase I: Period 3|Adverse Event|0
5887955|NCT01791517|20369975|P6|Phase I: Period 3|Adverse Event|0
5887956|NCT01791517|20369976|P5|Phase I: Period 3|Adverse Event|0
5887957|NCT01791517|20369977|P4|Phase I: Period 3|Adverse Event|1
5887958|NCT01791517|20369978|P3|Phase I: Period 3|Adverse Event|0
5887959|NCT01791517|20369979|P2|Phase I: Period 3|Adverse Event|0
5887960|NCT01791517|20369980|P1|Phase I: Period 3|Adverse Event|0
5887961|NCT01791517|20369969|P12|Phase I: Period 3|Lost to Follow-up|0
5887962|NCT01791517|20369970|P11|Phase I: Period 3|Lost to Follow-up|0
5887963|NCT01791517|20369971|P10|Phase I: Period 3|Lost to Follow-up|0
5887964|NCT01791517|20369972|P9|Phase I: Period 3|Lost to Follow-up|0
5887965|NCT01791517|20369973|P8|Phase I: Period 3|Lost to Follow-up|0
5887966|NCT01791517|20369974|P7|Phase I: Period 3|Lost to Follow-up|0
5887967|NCT01791517|20369975|P6|Phase I: Period 3|Lost to Follow-up|0
5887968|NCT01791517|20369976|P5|Phase I: Period 3|Lost to Follow-up|1
5887969|NCT01791517|20369977|P4|Phase I: Period 3|Lost to Follow-up|0
5887970|NCT01791517|20369978|P3|Phase I: Period 3|Lost to Follow-up|0
5887971|NCT01791517|20369979|P2|Phase I: Period 3|Lost to Follow-up|1
5887972|NCT01791517|20369980|P1|Phase I: Period 3|Lost to Follow-up|0
5887973|NCT01791517|20369969|P12|Phase I: Period 3|Lens Discomfort|1
5887974|NCT01791517|20369970|P11|Phase I: Period 3|Lens Discomfort|0
5887975|NCT01791517|20369971|P10|Phase I: Period 3|Lens Discomfort|0
5887976|NCT01791517|20369972|P9|Phase I: Period 3|Lens Discomfort|0
5887977|NCT01791517|20369973|P8|Phase I: Period 3|Lens Discomfort|0
5887978|NCT01791517|20369974|P7|Phase I: Period 3|Lens Discomfort|0
5887979|NCT01791517|20369975|P6|Phase I: Period 3|Lens Discomfort|0
5887980|NCT01791517|20369976|P5|Phase I: Period 3|Lens Discomfort|0
5887981|NCT01791517|20369977|P4|Phase I: Period 3|Lens Discomfort|0
5887982|NCT01791517|20369978|P3|Phase I: Period 3|Lens Discomfort|0
5887983|NCT01791517|20369979|P2|Phase I: Period 3|Lens Discomfort|0
5887984|NCT01791517|20369980|P1|Phase I: Period 3|Lens Discomfort|0
5887985|NCT01791517|20369969|P12|Phase I: Period 2|Lost to Follow-up|0
5887986|NCT01791517|20369970|P11|Phase I: Period 2|Lost to Follow-up|0
5887987|NCT01791517|20369971|P10|Phase I: Period 2|Lost to Follow-up|0
5887988|NCT01791517|20369972|P9|Phase I: Period 2|Lost to Follow-up|0
5887989|NCT01791517|20369973|P8|Phase I: Period 2|Lost to Follow-up|0
5887990|NCT01791517|20369974|P7|Phase I: Period 2|Lost to Follow-up|0
5887991|NCT01791517|20369975|P6|Phase I: Period 2|Lost to Follow-up|0
5887992|NCT01791517|20369976|P5|Phase I: Period 2|Lost to Follow-up|0
5887993|NCT01791517|20369977|P4|Phase I: Period 2|Lost to Follow-up|0
5887994|NCT01791517|20369978|P3|Phase I: Period 2|Lost to Follow-up|2
5887995|NCT01791517|20369979|P2|Phase I: Period 2|Lost to Follow-up|3
5887996|NCT01791517|20369980|P1|Phase I: Period 2|Lost to Follow-up|0
5887997|NCT01791517|20369969|P12|Phase I: Period 2|Lens Discomfort|0
5887998|NCT01791517|20369970|P11|Phase I: Period 2|Lens Discomfort|0
5887999|NCT01791517|20369971|P10|Phase I: Period 2|Lens Discomfort|0
5888000|NCT01791517|20369972|P9|Phase I: Period 2|Lens Discomfort|0
5888001|NCT01791517|20369973|P8|Phase I: Period 2|Lens Discomfort|0
5888002|NCT01791517|20369974|P7|Phase I: Period 2|Lens Discomfort|0
5888003|NCT01791517|20369975|P6|Phase I: Period 2|Lens Discomfort|1
5888004|NCT01791517|20369976|P5|Phase I: Period 2|Lens Discomfort|0
5888005|NCT01791517|20369977|P4|Phase I: Period 2|Lens Discomfort|0
5888006|NCT01791517|20369978|P3|Phase I: Period 2|Lens Discomfort|0
5888007|NCT01791517|20369979|P2|Phase I: Period 2|Lens Discomfort|0
5888008|NCT01791517|20369980|P1|Phase I: Period 2|Lens Discomfort|0
5888009|NCT01791517|20369969|P12|Phase I: Period 2|Unsatisfactory Visual Response|0
5888010|NCT01791517|20369970|P11|Phase I: Period 2|Unsatisfactory Visual Response|1
5888011|NCT01791517|20369971|P10|Phase I: Period 2|Unsatisfactory Visual Response|0
5888012|NCT01791517|20369972|P9|Phase I: Period 2|Unsatisfactory Visual Response|0
5888013|NCT01791517|20369973|P8|Phase I: Period 2|Unsatisfactory Visual Response|0
5888014|NCT01791517|20369974|P7|Phase I: Period 2|Unsatisfactory Visual Response|0
5888015|NCT01791517|20369975|P6|Phase I: Period 2|Unsatisfactory Visual Response|0
5888016|NCT01791517|20369976|P5|Phase I: Period 2|Unsatisfactory Visual Response|0
5888017|NCT01791517|20369977|P4|Phase I: Period 2|Unsatisfactory Visual Response|0
5888018|NCT01791517|20369978|P3|Phase I: Period 2|Unsatisfactory Visual Response|0
5888019|NCT01791517|20369979|P2|Phase I: Period 2|Unsatisfactory Visual Response|0
5888020|NCT01791517|20369980|P1|Phase I: Period 2|Unsatisfactory Visual Response|0
5888021|NCT01791517|20369969|P12|Phase I: Period 2|Withdrawal by Subject|0
5888022|NCT01791517|20369970|P11|Phase I: Period 2|Withdrawal by Subject|1
5888023|NCT01791517|20369971|P10|Phase I: Period 2|Withdrawal by Subject|1
5888024|NCT01791517|20369972|P9|Phase I: Period 2|Withdrawal by Subject|0
5888025|NCT01791517|20369973|P8|Phase I: Period 2|Withdrawal by Subject|0
5888026|NCT01791517|20369974|P7|Phase I: Period 2|Withdrawal by Subject|0
5888027|NCT01791517|20369975|P6|Phase I: Period 2|Withdrawal by Subject|0
5888028|NCT01791517|20369976|P5|Phase I: Period 2|Withdrawal by Subject|0
5888029|NCT01791517|20369977|P4|Phase I: Period 2|Withdrawal by Subject|0
5888030|NCT01791517|20369978|P3|Phase I: Period 2|Withdrawal by Subject|0
5888031|NCT01791517|20369979|P2|Phase I: Period 2|Withdrawal by Subject|0
5888032|NCT01791517|20369980|P1|Phase I: Period 2|Withdrawal by Subject|0
5888033|NCT01791517|20369969|P12|Phase I: Period 2|Protocol Violation|0
5888034|NCT01791517|20369970|P11|Phase I: Period 2|Protocol Violation|0
5888035|NCT01791517|20369971|P10|Phase I: Period 2|Protocol Violation|0
5888036|NCT01791517|20369972|P9|Phase I: Period 2|Protocol Violation|0
5888037|NCT01791517|20369973|P8|Phase I: Period 2|Protocol Violation|0
5888038|NCT01791517|20369974|P7|Phase I: Period 2|Protocol Violation|0
5888039|NCT01791517|20369975|P6|Phase I: Period 2|Protocol Violation|0
5888040|NCT01791517|20369976|P5|Phase I: Period 2|Protocol Violation|0
5888041|NCT01791517|20369977|P4|Phase I: Period 2|Protocol Violation|1
5888042|NCT01791517|20369978|P3|Phase I: Period 2|Protocol Violation|0
5888043|NCT01791517|20369979|P2|Phase I: Period 2|Protocol Violation|0
5888044|NCT01791517|20369980|P1|Phase I: Period 2|Protocol Violation|0
5888045|NCT01791517|20369969|P12|Phase I: Period 2|Unsatisfactory Lens Fit|0
5888046|NCT01791517|20369970|P11|Phase I: Period 2|Unsatisfactory Lens Fit|0
5888047|NCT01791517|20369971|P10|Phase I: Period 2|Unsatisfactory Lens Fit|0
5888048|NCT01791517|20369972|P9|Phase I: Period 2|Unsatisfactory Lens Fit|0
5888049|NCT01791517|20369973|P8|Phase I: Period 2|Unsatisfactory Lens Fit|0
5888050|NCT01791517|20369974|P7|Phase I: Period 2|Unsatisfactory Lens Fit|0
5888051|NCT01791517|20369975|P6|Phase I: Period 2|Unsatisfactory Lens Fit|0
5888052|NCT01791517|20369976|P5|Phase I: Period 2|Unsatisfactory Lens Fit|0
5888053|NCT01791517|20369977|P4|Phase I: Period 2|Unsatisfactory Lens Fit|0
5888054|NCT01791517|20369978|P3|Phase I: Period 2|Unsatisfactory Lens Fit|0
5888055|NCT01791517|20369979|P2|Phase I: Period 2|Unsatisfactory Lens Fit|0
5888056|NCT01791517|20369980|P1|Phase I: Period 2|Unsatisfactory Lens Fit|1
5888057|NCT01791517|20369969|P12|Phase I: Period 1|Lens Handling DIfficulties|1
5888058|NCT01791517|20369970|P11|Phase I: Period 1|Lens Handling DIfficulties|0
5888059|NCT01791517|20369971|P10|Phase I: Period 1|Lens Handling DIfficulties|0
5888060|NCT01791517|20369972|P9|Phase I: Period 1|Lens Handling DIfficulties|0
5888061|NCT01791517|20369973|P8|Phase I: Period 1|Lens Handling DIfficulties|0
5888062|NCT01791517|20369974|P7|Phase I: Period 1|Lens Handling DIfficulties|0
5888063|NCT01791517|20369975|P6|Phase I: Period 1|Lens Handling DIfficulties|0
5888064|NCT01791517|20369976|P5|Phase I: Period 1|Lens Handling DIfficulties|0
5888065|NCT01791517|20369977|P4|Phase I: Period 1|Lens Handling DIfficulties|0
5888066|NCT01791517|20369978|P3|Phase I: Period 1|Lens Handling DIfficulties|0
5888067|NCT01791517|20369979|P2|Phase I: Period 1|Lens Handling DIfficulties|0
5888068|NCT01791517|20369980|P1|Phase I: Period 1|Lens Handling DIfficulties|0
5888069|NCT01791517|20369969|P12|Phase I: Period 1|Lost to Follow-up|0
5888070|NCT01791517|20369970|P11|Phase I: Period 1|Lost to Follow-up|0
5888071|NCT01791517|20369971|P10|Phase I: Period 1|Lost to Follow-up|1
5888072|NCT01791517|20369972|P9|Phase I: Period 1|Lost to Follow-up|1
5888073|NCT01791517|20369973|P8|Phase I: Period 1|Lost to Follow-up|0
5888074|NCT01791517|20369974|P7|Phase I: Period 1|Lost to Follow-up|1
5888075|NCT01791517|20369975|P6|Phase I: Period 1|Lost to Follow-up|0
5888076|NCT01791517|20369976|P5|Phase I: Period 1|Lost to Follow-up|0
5888077|NCT01791517|20369977|P4|Phase I: Period 1|Lost to Follow-up|1
5888078|NCT01791517|20369978|P3|Phase I: Period 1|Lost to Follow-up|0
5888079|NCT01791517|20369979|P2|Phase I: Period 1|Lost to Follow-up|0
5888080|NCT01791517|20369980|P1|Phase I: Period 1|Lost to Follow-up|0
5888081|NCT01791517|20369969|P12|Phase I: Period 1|Protocol Violation|0
5888082|NCT01791517|20369970|P11|Phase I: Period 1|Protocol Violation|0
5888083|NCT01791517|20369971|P10|Phase I: Period 1|Protocol Violation|0
5888084|NCT01791517|20369972|P9|Phase I: Period 1|Protocol Violation|0
5888085|NCT01791517|20369973|P8|Phase I: Period 1|Protocol Violation|0
5888086|NCT01791517|20369974|P7|Phase I: Period 1|Protocol Violation|0
5888087|NCT01791517|20369975|P6|Phase I: Period 1|Protocol Violation|0
5888088|NCT01791517|20369976|P5|Phase I: Period 1|Protocol Violation|0
5888089|NCT01791517|20369977|P4|Phase I: Period 1|Protocol Violation|0
5888090|NCT01791517|20369978|P3|Phase I: Period 1|Protocol Violation|0
5888091|NCT01791517|20369979|P2|Phase I: Period 1|Protocol Violation|1
5888092|NCT01791517|20369980|P1|Phase I: Period 1|Protocol Violation|0
5888093|NCT01791517|20369969|P12|Phase I: Period 1|Unsatisfactory Lens Fitting|0
5888094|NCT01791517|20369970|P11|Phase I: Period 1|Unsatisfactory Lens Fitting|0
5888095|NCT01791517|20369971|P10|Phase I: Period 1|Unsatisfactory Lens Fitting|0
5888096|NCT01791517|20369972|P9|Phase I: Period 1|Unsatisfactory Lens Fitting|0
5888097|NCT01791517|20369973|P8|Phase I: Period 1|Unsatisfactory Lens Fitting|0
5888098|NCT01791517|20369974|P7|Phase I: Period 1|Unsatisfactory Lens Fitting|0
5888099|NCT01791517|20369975|P6|Phase I: Period 1|Unsatisfactory Lens Fitting|0
5888100|NCT01791517|20369976|P5|Phase I: Period 1|Unsatisfactory Lens Fitting|0
5888101|NCT01791517|20369977|P4|Phase I: Period 1|Unsatisfactory Lens Fitting|0
5888102|NCT01791517|20369978|P3|Phase I: Period 1|Unsatisfactory Lens Fitting|0
5888103|NCT01791517|20369979|P2|Phase I: Period 1|Unsatisfactory Lens Fitting|0
5888104|NCT01791517|20369980|P1|Phase I: Period 1|Unsatisfactory Lens Fitting|1
5888105|NCT01791517|20369969|P12|Phase I: Period 1|Adverse Event|0
5888106|NCT01791517|20369970|P11|Phase I: Period 1|Adverse Event|0
5888107|NCT01791517|20369971|P10|Phase I: Period 1|Adverse Event|0
5888108|NCT01791517|20369972|P9|Phase I: Period 1|Adverse Event|0
5888109|NCT01791517|20369973|P8|Phase I: Period 1|Adverse Event|0
5888110|NCT01791517|20369974|P7|Phase I: Period 1|Adverse Event|0
5888111|NCT01791517|20369975|P6|Phase I: Period 1|Adverse Event|0
5888112|NCT01791517|20369976|P5|Phase I: Period 1|Adverse Event|0
5888113|NCT01791517|20369977|P4|Phase I: Period 1|Adverse Event|1
5888114|NCT01791517|20369978|P3|Phase I: Period 1|Adverse Event|1
5888115|NCT01791517|20369979|P2|Phase I: Period 1|Adverse Event|0
5888116|NCT01791517|20369980|P1|Phase I: Period 1|Adverse Event|0
5888117|NCT01791517|20369969|P12|Phase I: Period 1|Withdrawal by Subject|0
5888118|NCT01791517|20369970|P11|Phase I: Period 1|Withdrawal by Subject|0
5888119|NCT01791517|20369971|P10|Phase I: Period 1|Withdrawal by Subject|0
5888120|NCT01791517|20369972|P9|Phase I: Period 1|Withdrawal by Subject|0
5888121|NCT01791517|20369973|P8|Phase I: Period 1|Withdrawal by Subject|0
5888122|NCT01791517|20369974|P7|Phase I: Period 1|Withdrawal by Subject|0
5888123|NCT01791517|20369975|P6|Phase I: Period 1|Withdrawal by Subject|1
5888124|NCT01791517|20369976|P5|Phase I: Period 1|Withdrawal by Subject|1
5888125|NCT01791517|20369977|P4|Phase I: Period 1|Withdrawal by Subject|0
5888126|NCT01791517|20369978|P3|Phase I: Period 1|Withdrawal by Subject|1
5888127|NCT01791517|20369979|P2|Phase I: Period 1|Withdrawal by Subject|1
5888128|NCT01791517|20369980|P1|Phase I: Period 1|Withdrawal by Subject|0
5888129|NCT01791413|20370044|P2|Overall Study|Lost to Follow-up|1
5888130|NCT01791413|20370045|P1|Overall Study|Lost to Follow-up|5
5888131|NCT01791244|20370054|P2|Overall Study|Laboratory Abnormality|1
5888132|NCT01791244|20370055|P1|Overall Study|Laboratory Abnormality|0
5888133|NCT01791244|20370054|P2|Overall Study|Insufficient clinical response|10
5888134|NCT01791244|20370055|P1|Overall Study|Insufficient clinical response|10
5888135|NCT01791244|20370054|P2|Overall Study|Adverse Event|7
5888136|NCT01791244|20370055|P1|Overall Study|Adverse Event|5
5888137|NCT01791205|20370091|P2|Phase II|Physician's decision|0
5888138|NCT01791205|20370092|P1|Phase II|Physician's decision|1
5888139|NCT01791205|20370091|P2|Phase II|Remission of disease|0
5888140|NCT01791205|20370092|P1|Phase II|Remission of disease|1
5888141|NCT01791205|20370091|P2|Phase II|Lost to Follow-up|0
5888142|NCT01791205|20370092|P1|Phase II|Lost to Follow-up|1
5888143|NCT01791205|20370091|P2|Phase II|Safety|0
5888144|NCT01791205|20370092|P1|Phase II|Safety|1
5888145|NCT01791205|20370091|P2|Phase II|Adverse Event|0
5888146|NCT01791205|20370092|P1|Phase II|Adverse Event|2
5888147|NCT01791205|20370091|P2|Phase II|Lack of Efficacy|0
5888148|NCT01791205|20370092|P1|Phase II|Lack of Efficacy|6
5888149|NCT01791153|20370176|P8|Part 2: Open-label Period|Physician Decision|0
5888150|NCT01791153|20370177|P7|Part 2: Open-label Period|Physician Decision|0
5888151|NCT01791153|20370178|P6|Part 2: Open-label Period|Physician Decision|1
5888152|NCT01791153|20370179|P5|Part 2: Open-label Period|Physician Decision|1
5888153|NCT01791153|20370180|P4|Part 2: Open-label Period|Physician Decision|0
5888154|NCT01791153|20370181|P3|Part 2: Open-label Period|Physician Decision|0
5888155|NCT01791153|20370182|P2|Part 2: Open-label Period|Physician Decision|0
5888156|NCT01791153|20370183|P1|Part 2: Open-label Period|Physician Decision|0
5888157|NCT01791153|20370176|P8|Part 2: Open-label Period|Withdrawal by Subject|2
5888158|NCT01791153|20370177|P7|Part 2: Open-label Period|Withdrawal by Subject|3
5888159|NCT01791153|20370178|P6|Part 2: Open-label Period|Withdrawal by Subject|1
5888160|NCT01791153|20370179|P5|Part 2: Open-label Period|Withdrawal by Subject|1
5888161|NCT01791153|20370180|P4|Part 2: Open-label Period|Withdrawal by Subject|0
5888162|NCT01791153|20370181|P3|Part 2: Open-label Period|Withdrawal by Subject|0
5888163|NCT01791153|20370182|P2|Part 2: Open-label Period|Withdrawal by Subject|0
5888164|NCT01791153|20370183|P1|Part 2: Open-label Period|Withdrawal by Subject|0
5888165|NCT01791153|20370176|P8|Part 2: Open-label Period|Lack of Efficacy|1
5888166|NCT01791153|20370177|P7|Part 2: Open-label Period|Lack of Efficacy|0
5888167|NCT01791153|20370178|P6|Part 2: Open-label Period|Lack of Efficacy|0
5888168|NCT01791153|20370179|P5|Part 2: Open-label Period|Lack of Efficacy|0
5888169|NCT01791153|20370180|P4|Part 2: Open-label Period|Lack of Efficacy|0
5888170|NCT01791153|20370181|P3|Part 2: Open-label Period|Lack of Efficacy|0
5888171|NCT01791153|20370182|P2|Part 2: Open-label Period|Lack of Efficacy|0
5888172|NCT01791153|20370183|P1|Part 2: Open-label Period|Lack of Efficacy|0
5888173|NCT01791153|20370176|P8|Part 2: Open-label Period|Lost to Follow-up|0
5888174|NCT01791153|20370177|P7|Part 2: Open-label Period|Lost to Follow-up|1
5888175|NCT01791153|20370178|P6|Part 2: Open-label Period|Lost to Follow-up|0
5888176|NCT01791153|20370179|P5|Part 2: Open-label Period|Lost to Follow-up|0
5888177|NCT01791153|20370180|P4|Part 2: Open-label Period|Lost to Follow-up|0
5888178|NCT01791153|20370181|P3|Part 2: Open-label Period|Lost to Follow-up|0
5888179|NCT01791153|20370182|P2|Part 2: Open-label Period|Lost to Follow-up|0
5888180|NCT01791153|20370183|P1|Part 2: Open-label Period|Lost to Follow-up|0
5888181|NCT01791153|20370176|P8|Part 2: Open-label Period|Death|1
5888182|NCT01791153|20370177|P7|Part 2: Open-label Period|Death|1
5888183|NCT01791153|20370178|P6|Part 2: Open-label Period|Death|1
5888184|NCT01791153|20370179|P5|Part 2: Open-label Period|Death|0
5888185|NCT01791153|20370180|P4|Part 2: Open-label Period|Death|0
5888186|NCT01791153|20370181|P3|Part 2: Open-label Period|Death|0
5888187|NCT01791153|20370182|P2|Part 2: Open-label Period|Death|0
5888188|NCT01791153|20370183|P1|Part 2: Open-label Period|Death|0
5888189|NCT01791153|20370176|P8|Part 2: Open-label Period|Adverse Event|2
5888190|NCT01791153|20370177|P7|Part 2: Open-label Period|Adverse Event|1
5888191|NCT01791153|20370178|P6|Part 2: Open-label Period|Adverse Event|1
5888192|NCT01791153|20370179|P5|Part 2: Open-label Period|Adverse Event|0
5888193|NCT01791153|20370180|P4|Part 2: Open-label Period|Adverse Event|0
5888194|NCT01791153|20370181|P3|Part 2: Open-label Period|Adverse Event|0
5888195|NCT01791153|20370182|P2|Part 2: Open-label Period|Adverse Event|0
5888196|NCT01791153|20370183|P1|Part 2: Open-label Period|Adverse Event|0
5888197|NCT01791153|20370176|P8|Part 1: Blinded Period|Withdrawal by Subject|0
5888198|NCT01791153|20370177|P7|Part 1: Blinded Period|Withdrawal by Subject|0
5888199|NCT01791153|20370178|P6|Part 1: Blinded Period|Withdrawal by Subject|0
5888200|NCT01791153|20370179|P5|Part 1: Blinded Period|Withdrawal by Subject|0
5888201|NCT01791153|20370180|P4|Part 1: Blinded Period|Withdrawal by Subject|1
5888202|NCT01791153|20370181|P3|Part 1: Blinded Period|Withdrawal by Subject|2
5888203|NCT01791153|20370182|P2|Part 1: Blinded Period|Withdrawal by Subject|2
5888204|NCT01791153|20370183|P1|Part 1: Blinded Period|Withdrawal by Subject|6
5888205|NCT01791153|20370176|P8|Part 1: Blinded Period|Protocol Violation|0
5888206|NCT01791153|20370177|P7|Part 1: Blinded Period|Protocol Violation|0
5888207|NCT01791153|20370178|P6|Part 1: Blinded Period|Protocol Violation|0
5888208|NCT01791153|20370179|P5|Part 1: Blinded Period|Protocol Violation|0
5888209|NCT01791153|20370180|P4|Part 1: Blinded Period|Protocol Violation|1
5888210|NCT01791153|20370181|P3|Part 1: Blinded Period|Protocol Violation|0
5888211|NCT01791153|20370182|P2|Part 1: Blinded Period|Protocol Violation|0
5888212|NCT01791153|20370183|P1|Part 1: Blinded Period|Protocol Violation|0
5888213|NCT01791153|20370176|P8|Part 1: Blinded Period|Physician Decision|0
5888214|NCT01791153|20370177|P7|Part 1: Blinded Period|Physician Decision|0
5888215|NCT01791153|20370178|P6|Part 1: Blinded Period|Physician Decision|0
5888216|NCT01791153|20370179|P5|Part 1: Blinded Period|Physician Decision|0
5888217|NCT01791153|20370180|P4|Part 1: Blinded Period|Physician Decision|1
5888218|NCT01791153|20370181|P3|Part 1: Blinded Period|Physician Decision|0
5888219|NCT01791153|20370182|P2|Part 1: Blinded Period|Physician Decision|0
5888220|NCT01791153|20370183|P1|Part 1: Blinded Period|Physician Decision|0
5888221|NCT01791153|20370176|P8|Part 1: Blinded Period|Non-Compliance|0
5888222|NCT01791153|20370177|P7|Part 1: Blinded Period|Non-Compliance|0
5888223|NCT01791153|20370178|P6|Part 1: Blinded Period|Non-Compliance|0
5888224|NCT01791153|20370179|P5|Part 1: Blinded Period|Non-Compliance|0
5888225|NCT01791153|20370180|P4|Part 1: Blinded Period|Non-Compliance|0
5888226|NCT01791153|20370181|P3|Part 1: Blinded Period|Non-Compliance|0
5888227|NCT01791153|20370182|P2|Part 1: Blinded Period|Non-Compliance|0
5888228|NCT01791153|20370183|P1|Part 1: Blinded Period|Non-Compliance|1
5888229|NCT01791153|20370176|P8|Part 1: Blinded Period|Lack of Efficacy|0
5888230|NCT01791153|20370177|P7|Part 1: Blinded Period|Lack of Efficacy|0
5888231|NCT01791153|20370178|P6|Part 1: Blinded Period|Lack of Efficacy|0
5888232|NCT01791153|20370179|P5|Part 1: Blinded Period|Lack of Efficacy|0
5888233|NCT01791153|20370180|P4|Part 1: Blinded Period|Lack of Efficacy|2
5888234|NCT01791153|20370181|P3|Part 1: Blinded Period|Lack of Efficacy|2
5888235|NCT01791153|20370182|P2|Part 1: Blinded Period|Lack of Efficacy|3
5888236|NCT01791153|20370183|P1|Part 1: Blinded Period|Lack of Efficacy|1
5888237|NCT01791153|20370176|P8|Part 1: Blinded Period|Adverse Event|0
5888238|NCT01791153|20370177|P7|Part 1: Blinded Period|Adverse Event|0
5888239|NCT01791153|20370178|P6|Part 1: Blinded Period|Adverse Event|0
5888240|NCT01791153|20370179|P5|Part 1: Blinded Period|Adverse Event|0
5888241|NCT01791153|20370180|P4|Part 1: Blinded Period|Adverse Event|0
5888242|NCT01791153|20370181|P3|Part 1: Blinded Period|Adverse Event|2
5888243|NCT01791153|20370182|P2|Part 1: Blinded Period|Adverse Event|3
5888244|NCT01791153|20370183|P1|Part 1: Blinded Period|Adverse Event|7
5888245|NCT01791127|20370243|P1|Overall Study|Study terminated for EP Passion|749
5888246|NCT01791127|20370243|P1|Overall Study|Completion of 30 day safety registry|1
5888247|NCT01791127|20370243|P1|Overall Study|All Siello leads are explanted|31
5888248|NCT01791127|20370243|P1|Overall Study|Lost to Follow-up|42
5888249|NCT01791127|20370243|P1|Overall Study|Patient has withdrawn from study|293
5888250|NCT01791127|20370243|P1|Overall Study|Death|356
5888251|NCT01790932|20370267|P1|Overall Study|Withdrawal by Subject|1
5888252|NCT01790932|20370267|P1|Overall Study|Physician Decision|1
5888253|NCT01790932|20370267|P1|Overall Study|Adverse Event|7
5888254|NCT01790932|20370267|P1|Overall Study|Disease Progression|41
5888255|NCT01790828|20370273|P1|Overall Study|Other|34
5888256|NCT01790633|20370331|P2|Overall Study|RT failure and no follow-up ELISA|3
5888257|NCT01790633|20370332|P1|Overall Study|RT failure and no follow-up ELISA|0
5888258|NCT01790633|20370331|P2|Overall Study|Did not have serology performed|0
5888259|NCT01790633|20370332|P1|Overall Study|Did not have serology performed|47
5888260|NCT01790633|20370331|P2|Overall Study|Protocol Violation|2
5888261|NCT01790633|20370332|P1|Overall Study|Protocol Violation|1
5888262|NCT01790594|20370345|P3|Overall Study|Terminated prior to week 76|0
5888263|NCT01790594|20370346|P2|Overall Study|Terminated prior to week 76|2
5888264|NCT01790594|20370347|P1|Overall Study|Terminated prior to week 76|0
5888265|NCT01790594|20370345|P3|Overall Study|Transplant was not done|3
5888266|NCT01790594|20370346|P2|Overall Study|Transplant was not done|0
5888267|NCT01790594|20370347|P1|Overall Study|Transplant was not done|0
5888268|NCT01790594|20370345|P3|Overall Study|Withdrawal by Subject|0
5888269|NCT01790594|20370346|P2|Overall Study|Withdrawal by Subject|0
5888270|NCT01790594|20370347|P1|Overall Study|Withdrawal by Subject|2
5888271|NCT01790594|20370345|P3|Overall Study|Physician Decision|0
5888272|NCT01790594|20370346|P2|Overall Study|Physician Decision|1
5888273|NCT01790594|20370347|P1|Overall Study|Physician Decision|2
5888274|NCT01790594|20370345|P3|Overall Study|Death|0
5888275|NCT01790594|20370346|P2|Overall Study|Death|0
5888276|NCT01790594|20370347|P1|Overall Study|Death|1
5888277|NCT01790568|20370424|P2|Overall Study|Progression prior to transplant|1
5888278|NCT01790568|20370425|P1|Overall Study|Progression prior to transplant|0
5888279|NCT01790516|20370433|P2|Overall Study|Physician Decision|0
5888280|NCT01790516|20370434|P1|Overall Study|Physician Decision|1
5888281|NCT01790503|20370451|P11|Overall Study|Other|0
5888282|NCT01790503|20370452|P10|Overall Study|Other|2
5888283|NCT01790503|20370453|P9|Overall Study|Other|1
5888284|NCT01790503|20370454|P8|Overall Study|Other|0
5888285|NCT01790503|20370455|P7|Overall Study|Other|0
5888286|NCT01790503|20370456|P6|Overall Study|Other|0
5888287|NCT01790503|20370457|P5|Overall Study|Other|1
5888288|NCT01790503|20370458|P4|Overall Study|Other|0
5888289|NCT01790503|20370459|P3|Overall Study|Other|0
5888290|NCT01790503|20370460|P2|Overall Study|Other|0
5888291|NCT01790503|20370461|P1|Overall Study|Other|0
5888292|NCT01790503|20370451|P11|Overall Study|Non Compliance|0
5888293|NCT01790503|20370452|P10|Overall Study|Non Compliance|0
5888294|NCT01790503|20370453|P9|Overall Study|Non Compliance|0
5888295|NCT01790503|20370454|P8|Overall Study|Non Compliance|0
5888296|NCT01790503|20370455|P7|Overall Study|Non Compliance|0
5888297|NCT01790503|20370456|P6|Overall Study|Non Compliance|0
5888298|NCT01790503|20370457|P5|Overall Study|Non Compliance|1
5888299|NCT01790503|20370458|P4|Overall Study|Non Compliance|0
5888300|NCT01790503|20370459|P3|Overall Study|Non Compliance|0
5888301|NCT01790503|20370460|P2|Overall Study|Non Compliance|0
5888302|NCT01790503|20370461|P1|Overall Study|Non Compliance|0
5888303|NCT01790503|20370451|P11|Overall Study|Death|0
5888304|NCT01790503|20370452|P10|Overall Study|Death|1
5888305|NCT01790503|20370453|P9|Overall Study|Death|0
5888306|NCT01790503|20370454|P8|Overall Study|Death|0
5888307|NCT01790503|20370455|P7|Overall Study|Death|0
5888308|NCT01790503|20370456|P6|Overall Study|Death|0
5888309|NCT01790503|20370457|P5|Overall Study|Death|0
5888310|NCT01790503|20370458|P4|Overall Study|Death|0
5888311|NCT01790503|20370459|P3|Overall Study|Death|0
5888312|NCT01790503|20370460|P2|Overall Study|Death|0
5888313|NCT01790503|20370461|P1|Overall Study|Death|0
5888314|NCT01790503|20370451|P11|Overall Study|Physician Decision|1
5888315|NCT01790503|20370452|P10|Overall Study|Physician Decision|1
5888316|NCT01790503|20370453|P9|Overall Study|Physician Decision|0
5888317|NCT01790503|20370454|P8|Overall Study|Physician Decision|0
5888318|NCT01790503|20370455|P7|Overall Study|Physician Decision|0
5888319|NCT01790503|20370456|P6|Overall Study|Physician Decision|0
5888320|NCT01790503|20370457|P5|Overall Study|Physician Decision|0
5888321|NCT01790503|20370458|P4|Overall Study|Physician Decision|0
5888322|NCT01790503|20370459|P3|Overall Study|Physician Decision|0
5888323|NCT01790503|20370460|P2|Overall Study|Physician Decision|0
5888324|NCT01790503|20370461|P1|Overall Study|Physician Decision|0
5888325|NCT01790503|20370451|P11|Overall Study|Protocol Violation|0
5888326|NCT01790503|20370452|P10|Overall Study|Protocol Violation|1
5888327|NCT01790503|20370453|P9|Overall Study|Protocol Violation|0
5888328|NCT01790503|20370454|P8|Overall Study|Protocol Violation|0
5888329|NCT01790503|20370455|P7|Overall Study|Protocol Violation|0
5888330|NCT01790503|20370456|P6|Overall Study|Protocol Violation|0
5888331|NCT01790503|20370457|P5|Overall Study|Protocol Violation|0
5888332|NCT01790503|20370458|P4|Overall Study|Protocol Violation|0
5888333|NCT01790503|20370459|P3|Overall Study|Protocol Violation|0
5888334|NCT01790503|20370460|P2|Overall Study|Protocol Violation|0
5888335|NCT01790503|20370461|P1|Overall Study|Protocol Violation|0
5888336|NCT01790503|20370451|P11|Overall Study|Disease progression|7
5888337|NCT01790503|20370452|P10|Overall Study|Disease progression|17
5888338|NCT01790503|20370453|P9|Overall Study|Disease progression|0
5888339|NCT01790503|20370454|P8|Overall Study|Disease progression|1
5888340|NCT01790503|20370455|P7|Overall Study|Disease progression|0
5888341|NCT01790503|20370456|P6|Overall Study|Disease progression|1
5888342|NCT01790503|20370457|P5|Overall Study|Disease progression|2
5888343|NCT01790503|20370458|P4|Overall Study|Disease progression|1
5888344|NCT01790503|20370459|P3|Overall Study|Disease progression|0
5888345|NCT01790503|20370460|P2|Overall Study|Disease progression|1
5888346|NCT01790503|20370461|P1|Overall Study|Disease progression|2
5888347|NCT01790503|20370451|P11|Overall Study|Withdrawal by Subject|1
5888348|NCT01790503|20370452|P10|Overall Study|Withdrawal by Subject|0
5888349|NCT01790503|20370453|P9|Overall Study|Withdrawal by Subject|0
5888350|NCT01790503|20370454|P8|Overall Study|Withdrawal by Subject|0
5888351|NCT01790503|20370455|P7|Overall Study|Withdrawal by Subject|1
5888352|NCT01790503|20370456|P6|Overall Study|Withdrawal by Subject|2
5888353|NCT01790503|20370457|P5|Overall Study|Withdrawal by Subject|1
5888354|NCT01790503|20370458|P4|Overall Study|Withdrawal by Subject|1
5888355|NCT01790503|20370459|P3|Overall Study|Withdrawal by Subject|1
5888356|NCT01790503|20370460|P2|Overall Study|Withdrawal by Subject|0
5888357|NCT01790503|20370461|P1|Overall Study|Withdrawal by Subject|0
5888358|NCT01790503|20370451|P11|Overall Study|Adverse Event|7
5888359|NCT01790503|20370452|P10|Overall Study|Adverse Event|4
5888360|NCT01790503|20370453|P9|Overall Study|Adverse Event|2
5888361|NCT01790503|20370454|P8|Overall Study|Adverse Event|0
5888362|NCT01790503|20370455|P7|Overall Study|Adverse Event|0
5888363|NCT01790503|20370456|P6|Overall Study|Adverse Event|2
5888364|NCT01790503|20370457|P5|Overall Study|Adverse Event|0
5888365|NCT01790503|20370458|P4|Overall Study|Adverse Event|0
5888366|NCT01790503|20370459|P3|Overall Study|Adverse Event|0
5888367|NCT01790503|20370460|P2|Overall Study|Adverse Event|0
5888368|NCT01790503|20370461|P1|Overall Study|Adverse Event|1
5888369|NCT01790438|20370531|P2|Overall Study|Protocol Required Discontinuation|1
5888370|NCT01790438|20370532|P1|Overall Study|Protocol Required Discontinuation|7
5888371|NCT01790438|20370531|P2|Overall Study|Sponsor Decision|3
5888372|NCT01790438|20370532|P1|Overall Study|Sponsor Decision|0
5888373|NCT01790438|20370531|P2|Overall Study|Physician Decision|1
5888374|NCT01790438|20370532|P1|Overall Study|Physician Decision|3
5888375|NCT01790438|20370531|P2|Overall Study|Withdrawal by Subject|2
5888376|NCT01790438|20370532|P1|Overall Study|Withdrawal by Subject|13
5888377|NCT01790438|20370531|P2|Overall Study|Lost to Follow-up|2
5888378|NCT01790438|20370532|P1|Overall Study|Lost to Follow-up|5
5888379|NCT01790438|20370531|P2|Overall Study|Death|0
5888380|NCT01790438|20370532|P1|Overall Study|Death|4
5888381|NCT01790438|20370531|P2|Overall Study|Adverse Event|2
5888382|NCT01790438|20370532|P1|Overall Study|Adverse Event|3
5888383|NCT01790295|20370582|P1|Overall Study|Study closure|4
5888384|NCT01790295|20370582|P1|Overall Study|Lack of Efficacy|2
5888385|NCT01790295|20370582|P1|Overall Study|Death|4
5888386|NCT01790295|20370582|P1|Overall Study|Adverse Event|1
5888387|NCT01790126|20370652|P3|Overall Study|Radiographic Progression|0
5888388|NCT01790126|20370653|P2|Overall Study|Radiographic Progression|1
5888389|NCT01790126|20370654|P1|Overall Study|Radiographic Progression|3
5888390|NCT01790126|20370652|P3|Overall Study|Death|0
5888391|NCT01790126|20370653|P2|Overall Study|Death|0
5888392|NCT01790126|20370654|P1|Overall Study|Death|2
5888393|NCT01790126|20370652|P3|Overall Study|Adverse Event|0
5888394|NCT01790126|20370653|P2|Overall Study|Adverse Event|2
5888395|NCT01790126|20370654|P1|Overall Study|Adverse Event|0
5888396|NCT01790126|20370652|P3|Overall Study|Lost to Follow-up|1
5888397|NCT01790126|20370653|P2|Overall Study|Lost to Follow-up|0
5888398|NCT01790126|20370654|P1|Overall Study|Lost to Follow-up|1
5888399|NCT01790126|20370652|P3|Overall Study|Withdrawal by Subject|2
5888400|NCT01790126|20370653|P2|Overall Study|Withdrawal by Subject|1
5888401|NCT01790126|20370654|P1|Overall Study|Withdrawal by Subject|3
5888402|NCT01790126|20370652|P3|Overall Study|Withdrawal by Physician|2
5888403|NCT01790126|20370653|P2|Overall Study|Withdrawal by Physician|1
5888404|NCT01790126|20370654|P1|Overall Study|Withdrawal by Physician|1
5888405|NCT01790126|20370652|P3|Overall Study|Initiation of Non-Protocol Therapy|2
5888406|NCT01790126|20370653|P2|Overall Study|Initiation of Non-Protocol Therapy|4
5888407|NCT01790126|20370654|P1|Overall Study|Initiation of Non-Protocol Therapy|3
5888408|NCT01790126|20370652|P3|Overall Study|Other|8
5888409|NCT01790126|20370653|P2|Overall Study|Other|4
5888410|NCT01790126|20370654|P1|Overall Study|Other|5
5888411|NCT01790126|20370652|P3|Overall Study|PSA Progression|16
5888412|NCT01790126|20370653|P2|Overall Study|PSA Progression|16
5888413|NCT01790126|20370654|P1|Overall Study|PSA Progression|12
5888414|NCT01790048|20370711|P2|Overall Study|Measurement error|0
5888415|NCT01790048|20370712|P1|Overall Study|Measurement error|1
5888416|NCT01790048|20370711|P2|Overall Study|SAM at Enrollment|0
5888417|NCT01790048|20370712|P1|Overall Study|SAM at Enrollment|2
5888418|NCT01790048|20370711|P2|Overall Study|Other|2
5888419|NCT01790048|20370712|P1|Overall Study|Other|0
5888420|NCT01790048|20370711|P2|Overall Study|data entry error|1
5888421|NCT01790048|20370712|P1|Overall Study|data entry error|0
5888422|NCT01790048|20370711|P2|Overall Study|Incorrect Age|14
5888423|NCT01790048|20370712|P1|Overall Study|Incorrect Age|9
5888424|NCT01789970|20370730|P3|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0
5888425|NCT01789970|20370731|P2|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|1
5888426|NCT01789970|20370732|P1|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0
5888427|NCT01789970|20370730|P3|Double-blind Treatment Period (12 Weeks)|Other|3
5888428|NCT01789970|20370731|P2|Double-blind Treatment Period (12 Weeks)|Other|1
5888429|NCT01789970|20370732|P1|Double-blind Treatment Period (12 Weeks)|Other|0
5888430|NCT01789970|20370730|P3|Double-blind Treatment Period (12 Weeks)|Pregnancy|0
5888431|NCT01789970|20370731|P2|Double-blind Treatment Period (12 Weeks)|Pregnancy|1
5888432|NCT01789970|20370732|P1|Double-blind Treatment Period (12 Weeks)|Pregnancy|0
5888433|NCT01789970|20370730|P3|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|2
5888434|NCT01789970|20370731|P2|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|1
5888435|NCT01789970|20370732|P1|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|0
5888436|NCT01789970|20370730|P3|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|1
5888437|NCT01789970|20370731|P2|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|2
5888438|NCT01789970|20370732|P1|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|0
5888439|NCT01789970|20370730|P3|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2
5888440|NCT01789970|20370731|P2|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2
5888441|NCT01789970|20370732|P1|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0
5888442|NCT01789970|20370730|P3|Double-blind Treatment Period (12 Weeks)|Protocol Violation|7
5888443|NCT01789970|20370731|P2|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9
5888444|NCT01789970|20370732|P1|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0
5888445|NCT01789970|20370730|P3|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|9
5888446|NCT01789970|20370731|P2|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|7
5888447|NCT01789970|20370732|P1|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0
5888448|NCT01789970|20370730|P3|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5
5888449|NCT01789970|20370731|P2|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17
5888450|NCT01789970|20370732|P1|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0
5888451|NCT01789970|20370730|P3|Double-blind Treatment Period (12 Weeks)|Adverse Event|15
5888452|NCT01789970|20370731|P2|Double-blind Treatment Period (12 Weeks)|Adverse Event|9
5888453|NCT01789970|20370732|P1|Double-blind Treatment Period (12 Weeks)|Adverse Event|0
5888454|NCT01789970|20370730|P3|Open-label Titration Period|Dropped out prior to dosing|0
5888455|NCT01789970|20370731|P2|Open-label Titration Period|Dropped out prior to dosing|0
5888456|NCT01789970|20370732|P1|Open-label Titration Period|Dropped out prior to dosing|2
5888457|NCT01789970|20370730|P3|Open-label Titration Period|Other|0
5888458|NCT01789970|20370731|P2|Open-label Titration Period|Other|0
5888459|NCT01789970|20370732|P1|Open-label Titration Period|Other|76
5888460|NCT01789970|20370730|P3|Open-label Titration Period|Pregnancy|0
5888461|NCT01789970|20370731|P2|Open-label Titration Period|Pregnancy|0
5888462|NCT01789970|20370732|P1|Open-label Titration Period|Pregnancy|2
5888463|NCT01789970|20370730|P3|Open-label Titration Period|Noncompliance with study procedures|0
5888464|NCT01789970|20370731|P2|Open-label Titration Period|Noncompliance with study procedures|0
5888465|NCT01789970|20370732|P1|Open-label Titration Period|Noncompliance with study procedures|8
5888466|NCT01789970|20370730|P3|Open-label Titration Period|Noncompliance with study rescue meds|0
5888467|NCT01789970|20370731|P2|Open-label Titration Period|Noncompliance with study rescue meds|0
5888468|NCT01789970|20370732|P1|Open-label Titration Period|Noncompliance with study rescue meds|2
5888469|NCT01789970|20370730|P3|Open-label Titration Period|Noncompliance to study drug admin|0
5888470|NCT01789970|20370731|P2|Open-label Titration Period|Noncompliance to study drug admin|0
5888471|NCT01789970|20370732|P1|Open-label Titration Period|Noncompliance to study drug admin|11
5888472|NCT01789970|20370730|P3|Open-label Titration Period|Lost to Follow-up|0
5888473|NCT01789970|20370731|P2|Open-label Titration Period|Lost to Follow-up|0
5888474|NCT01789970|20370732|P1|Open-label Titration Period|Lost to Follow-up|5
5888475|NCT01789970|20370730|P3|Open-label Titration Period|Protocol Violation|0
5888476|NCT01789970|20370731|P2|Open-label Titration Period|Protocol Violation|0
5888477|NCT01789970|20370732|P1|Open-label Titration Period|Protocol Violation|18
5888478|NCT01789970|20370730|P3|Open-label Titration Period|Withdrawal by Subject|0
5888479|NCT01789970|20370731|P2|Open-label Titration Period|Withdrawal by Subject|0
5888480|NCT01789970|20370732|P1|Open-label Titration Period|Withdrawal by Subject|31
5888481|NCT01789970|20370730|P3|Open-label Titration Period|Lack of Efficacy|0
5888482|NCT01789970|20370731|P2|Open-label Titration Period|Lack of Efficacy|0
5888483|NCT01789970|20370732|P1|Open-label Titration Period|Lack of Efficacy|31
5888484|NCT01789970|20370730|P3|Open-label Titration Period|Adverse Event|0
5888485|NCT01789970|20370731|P2|Open-label Titration Period|Adverse Event|0
5888486|NCT01789970|20370732|P1|Open-label Titration Period|Adverse Event|68
5888487|NCT01789606|20370790|P2|Overall Study|Ineligible or not Willing to Continue|348
5888488|NCT01789606|20370791|P1|Overall Study|Ineligible or not Willing to Continue|0
5888489|NCT01789606|20370790|P2|Overall Study|Lost to Follow-up|14
5888490|NCT01789606|20370791|P1|Overall Study|Lost to Follow-up|0
5888491|NCT01789606|20370790|P2|Overall Study|Adverse Event|3
5888492|NCT01789606|20370791|P1|Overall Study|Adverse Event|0
5888493|NCT01789606|20370790|P2|Overall Study|Protocol Violation|55
5888494|NCT01789606|20370791|P1|Overall Study|Protocol Violation|0
5888495|NCT01789606|20370790|P2|Overall Study|No Study Medication Taken|1
5888496|NCT01789606|20370791|P1|Overall Study|No Study Medication Taken|0
5888497|NCT01789606|20370790|P2|Overall Study|Administrative Reasons|6
5888498|NCT01789606|20370791|P1|Overall Study|Administrative Reasons|17
5888499|NCT01789606|20370790|P2|Overall Study|Ineligible|2
5888500|NCT01789606|20370791|P1|Overall Study|Ineligible|6
5888501|NCT01789606|20370790|P2|Overall Study|Withdrawal by Subject|1
5888502|NCT01789606|20370791|P1|Overall Study|Withdrawal by Subject|0
5888503|NCT01789606|20370790|P2|Overall Study|Participant not Purchased the Product|20
5888504|NCT01789606|20370791|P1|Overall Study|Participant not Purchased the Product|0
5888505|NCT01789567|20370809|P1|Overall Study|Death|6
5888506|NCT01789476|20370818|P2|Overall Study|Unable to get IV access|0
5888507|NCT01789476|20370819|P1|Overall Study|Unable to get IV access|1
5888508|NCT01789476|20370818|P2|Overall Study|Adverse Event|0
5888509|NCT01789476|20370819|P1|Overall Study|Adverse Event|1
5888510|NCT01789476|20370818|P2|Overall Study|Lack of Efficacy|2
5888511|NCT01789476|20370819|P1|Overall Study|Lack of Efficacy|6
5888512|NCT01789203|20370841|P2|Overall Study|patient non-adherent|0
5888513|NCT01789203|20370842|P1|Overall Study|patient non-adherent|2
5888514|NCT01789203|20370841|P2|Overall Study|Other|1
5888515|NCT01789203|20370842|P1|Overall Study|Other|1
5888516|NCT01789203|20370841|P2|Overall Study|Protocol Violation|1
5888517|NCT01789203|20370842|P1|Overall Study|Protocol Violation|2
5888518|NCT01789203|20370841|P2|Overall Study|Death|0
5888519|NCT01789203|20370842|P1|Overall Study|Death|1
5888520|NCT01789203|20370841|P2|Overall Study|Withdrawal by Subject|0
5888521|NCT01789203|20370842|P1|Overall Study|Withdrawal by Subject|1
5888522|NCT01789203|20370841|P2|Overall Study|Adverse Event|2
5888523|NCT01789203|20370842|P1|Overall Study|Adverse Event|2
5888524|NCT01789047|20370883|P2|Overall Study|Withdrawal by Subject|2
5888525|NCT01789047|20370884|P1|Overall Study|Withdrawal by Subject|1
5888526|NCT01789047|20370883|P2|Overall Study|Adverse Event|2
5888527|NCT01789047|20370884|P1|Overall Study|Adverse Event|3
5888528|NCT01788943|20370892|P2|Overall Study|Withdrawal by Subject|0
5888529|NCT01788943|20370893|P1|Overall Study|Withdrawal by Subject|1
5888530|NCT01788566|20370922|P1|Overall Study|Clinical Progressive Disease|3
5888531|NCT01788566|20370922|P1|Overall Study|Adverse Event|1
5888532|NCT01788566|20370922|P1|Overall Study|Death|4
5888533|NCT01788423|20370960|P3|Overall Study|See Comments in Completed (above)|5
5888534|NCT01788423|20370961|P2|Overall Study|See Comments in Completed (above)|4
5888535|NCT01788423|20370962|P1|Overall Study|See Comments in Completed (above)|0
5888536|NCT01788358|20370973|P1|Overall Study|Adverse Event|51
5888537|NCT01788358|20370973|P1|Overall Study|Lack of Efficacy|1
5888538|NCT01788358|20370973|P1|Overall Study|Withdrawal by Subject|26
5888539|NCT01788358|20370973|P1|Overall Study|Protocol Violation|3
5888540|NCT01788358|20370973|P1|Overall Study|Lost to Follow-up|5
5888541|NCT01788358|20370973|P1|Overall Study|Logistical difficulties|1
5888542|NCT01788358|20370973|P1|Overall Study|Other|11
5888543|NCT01788228|20370987|P2|Overall Study|Migrated/moved from study area|0
5888544|NCT01788228|20370988|P1|Overall Study|Migrated/moved from study area|1
5888545|NCT01788215|20371021|P2|Overall Study|Lost to Follow-up|0
5888546|NCT01788215|20371022|P1|Overall Study|Lost to Follow-up|2
5888547|NCT01788215|20371021|P2|Overall Study|Withdrawal by Subject|1
5888548|NCT01788215|20371022|P1|Overall Study|Withdrawal by Subject|0
5888549|NCT01788163|20371051|P9|Overall Study|Withdrawal by Subject|1
5888550|NCT01788163|20371052|P8|Overall Study|Withdrawal by Subject|0
5888551|NCT01788163|20371053|P7|Overall Study|Withdrawal by Subject|0
5888552|NCT01788163|20371054|P6|Overall Study|Withdrawal by Subject|0
5888553|NCT01788163|20371055|P5|Overall Study|Withdrawal by Subject|0
5888554|NCT01788163|20371056|P4|Overall Study|Withdrawal by Subject|0
5888555|NCT01788163|20371057|P3|Overall Study|Withdrawal by Subject|0
5888556|NCT01788163|20371058|P2|Overall Study|Withdrawal by Subject|0
5888557|NCT01788163|20371059|P1|Overall Study|Withdrawal by Subject|2
5888558|NCT01788163|20371051|P9|Overall Study|Other|15
5888559|NCT01788163|20371052|P8|Overall Study|Other|48
5888560|NCT01788163|20371053|P7|Overall Study|Other|1
5888561|NCT01788163|20371054|P6|Overall Study|Other|7
5888562|NCT01788163|20371055|P5|Overall Study|Other|0
5888563|NCT01788163|20371056|P4|Overall Study|Other|0
5888564|NCT01788163|20371057|P3|Overall Study|Other|0
5888565|NCT01788163|20371058|P2|Overall Study|Other|0
5888566|NCT01788163|20371059|P1|Overall Study|Other|53
5888567|NCT01788046|20371222|P2|Overall Study|Protocol Specified Criteria|1
5888568|NCT01788046|20371223|P1|Overall Study|Protocol Specified Criteria|25
5888569|NCT01788046|20371222|P2|Overall Study|Death|5
5888570|NCT01788046|20371223|P1|Overall Study|Death|7
5888571|NCT01788046|20371222|P2|Overall Study|Lost to Follow-up|19
5888572|NCT01788046|20371223|P1|Overall Study|Lost to Follow-up|12
5888573|NCT01788046|20371222|P2|Overall Study|Withdrawal by Subject|12
5888574|NCT01788046|20371223|P1|Overall Study|Withdrawal by Subject|12
5888575|NCT01787838|20371246|P1|Overall Study|refused|1413
5888576|NCT01787825|20371250|P2|Overall Study|Data Not Analyzable|1
5888577|NCT01787825|20371251|P1|Overall Study|Data Not Analyzable|5
5888578|NCT01787825|20371250|P2|Overall Study|Subject Did Not Ingest Capsules|0
5888579|NCT01787825|20371251|P1|Overall Study|Subject Did Not Ingest Capsules|1
5888580|NCT01787760|20371269|P3|Overall Study|Near vision blur|0
5888581|NCT01787760|20371270|P2|Overall Study|Near vision blur|0
5888582|NCT01787760|20371271|P1|Overall Study|Near vision blur|1
5888583|NCT01787760|20371269|P3|Overall Study|Unsatisfactory visual response|0
5888584|NCT01787760|20371270|P2|Overall Study|Unsatisfactory visual response|1
5888585|NCT01787760|20371271|P1|Overall Study|Unsatisfactory visual response|1
5888586|NCT01787760|20371269|P3|Overall Study|Unsatisfactory physiological response|0
5888587|NCT01787760|20371270|P2|Overall Study|Unsatisfactory physiological response|4
5888588|NCT01787760|20371271|P1|Overall Study|Unsatisfactory physiological response|2
5888589|NCT01787760|20371269|P3|Overall Study|Unsatisfactory lens fitting performance|0
5888590|NCT01787760|20371270|P2|Overall Study|Unsatisfactory lens fitting performance|6
5888591|NCT01787760|20371271|P1|Overall Study|Unsatisfactory lens fitting performance|3
5888592|NCT01787760|20371269|P3|Overall Study|Stroke|0
5888593|NCT01787760|20371270|P2|Overall Study|Stroke|0
5888594|NCT01787760|20371271|P1|Overall Study|Stroke|1
5888595|NCT01787760|20371269|P3|Overall Study|Lost to Follow-up|1
5888596|NCT01787760|20371270|P2|Overall Study|Lost to Follow-up|0
5888597|NCT01787760|20371271|P1|Overall Study|Lost to Follow-up|1
5888598|NCT01787760|20371269|P3|Overall Study|Withdrawal by Subject|2
5888599|NCT01787760|20371270|P2|Overall Study|Withdrawal by Subject|1
5888600|NCT01787760|20371271|P1|Overall Study|Withdrawal by Subject|5
5888601|NCT01787760|20371269|P3|Overall Study|Protocol Violation|1
5888602|NCT01787760|20371270|P2|Overall Study|Protocol Violation|0
5888603|NCT01787760|20371271|P1|Overall Study|Protocol Violation|6
5888604|NCT01787760|20371269|P3|Overall Study|Lens handling difficulty|0
5888605|NCT01787760|20371270|P2|Overall Study|Lens handling difficulty|2
5888606|NCT01787760|20371271|P1|Overall Study|Lens handling difficulty|1
5888607|NCT01787760|20371269|P3|Overall Study|Lens discomfort|0
5888608|NCT01787760|20371270|P2|Overall Study|Lens discomfort|0
5888609|NCT01787760|20371271|P1|Overall Study|Lens discomfort|3
5888610|NCT01787760|20371269|P3|Overall Study|Relocation|0
5888611|NCT01787760|20371270|P2|Overall Study|Relocation|1
5888612|NCT01787760|20371271|P1|Overall Study|Relocation|1
5888613|NCT01787760|20371269|P3|Overall Study|Dryness|0
5888614|NCT01787760|20371270|P2|Overall Study|Dryness|1
5888615|NCT01787760|20371271|P1|Overall Study|Dryness|0
5888616|NCT01787760|20371269|P3|Overall Study|Decompensated on left exotropia|1
5888617|NCT01787760|20371270|P2|Overall Study|Decompensated on left exotropia|0
5888618|NCT01787760|20371271|P1|Overall Study|Decompensated on left exotropia|0
5888619|NCT01787760|20371269|P3|Overall Study|Anisometropia > -1.00D in spherical equi|0
5888620|NCT01787760|20371270|P2|Overall Study|Anisometropia > -1.00D in spherical equi|0
5888621|NCT01787760|20371271|P1|Overall Study|Anisometropia > -1.00D in spherical equi|1
5888622|NCT01787591|20371296|P4|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|1
5888623|NCT01787591|20371297|P3|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0
5888624|NCT01787591|20371298|P2|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0
5888625|NCT01787591|20371299|P1|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0
5888626|NCT01787552|20371329|P4|Overall Study|Progressive Disease|1
5888627|NCT01787552|20371330|P3|Overall Study|Progressive Disease|1
5888628|NCT01787552|20371331|P2|Overall Study|Progressive Disease|2
5888629|NCT01787552|20371332|P1|Overall Study|Progressive Disease|2
5888630|NCT01787552|20371329|P4|Overall Study|Study terminated by Sponsor|3
5888631|NCT01787552|20371330|P3|Overall Study|Study terminated by Sponsor|1
5888632|NCT01787552|20371331|P2|Overall Study|Study terminated by Sponsor|0
5888633|NCT01787552|20371332|P1|Overall Study|Study terminated by Sponsor|0
5888634|NCT01787552|20371329|P4|Overall Study|Adverse Event|16
5888635|NCT01787552|20371330|P3|Overall Study|Adverse Event|2
5888636|NCT01787552|20371331|P2|Overall Study|Adverse Event|5
5888637|NCT01787552|20371332|P1|Overall Study|Adverse Event|2
5888638|NCT01787552|20371329|P4|Overall Study|Death|1
5888639|NCT01787552|20371330|P3|Overall Study|Death|0
5888640|NCT01787552|20371331|P2|Overall Study|Death|0
5888641|NCT01787552|20371332|P1|Overall Study|Death|0
5888642|NCT01787552|20371329|P4|Overall Study|Physician Decision|2
5888643|NCT01787552|20371330|P3|Overall Study|Physician Decision|1
5888644|NCT01787552|20371331|P2|Overall Study|Physician Decision|2
5888645|NCT01787552|20371332|P1|Overall Study|Physician Decision|2
5888646|NCT01787552|20371329|P4|Overall Study|Withdrawal by Subject|4
5888647|NCT01787552|20371330|P3|Overall Study|Withdrawal by Subject|0
5888648|NCT01787552|20371331|P2|Overall Study|Withdrawal by Subject|0
5888649|NCT01787552|20371332|P1|Overall Study|Withdrawal by Subject|2
5888650|NCT01787461|20371402|P2|Overall Study|Protocol Violation|0
5888651|NCT01787461|20371403|P1|Overall Study|Protocol Violation|3
5888652|NCT01787461|20371402|P2|Overall Study|Withdrawal by Subject|4
5888653|NCT01787461|20371403|P1|Overall Study|Withdrawal by Subject|3
5888654|NCT01787461|20371402|P2|Overall Study|No longer met eligibility criteria|0
5888655|NCT01787461|20371403|P1|Overall Study|No longer met eligibility criteria|1
5888656|NCT01787461|20371402|P2|Overall Study|Lost to Follow-up|2
5888657|NCT01787461|20371403|P1|Overall Study|Lost to Follow-up|3
5888658|NCT01787461|20371402|P2|Overall Study|Adverse Event|3
5888659|NCT01787461|20371403|P1|Overall Study|Adverse Event|4
5888660|NCT01787331|20371452|P1|Overall Study|Withdrawal by Subject|1
5888661|NCT01787331|20371452|P1|Overall Study|Physician Decision|1
5888662|NCT01787292|20371464|P2|Home Based Exercise Program|Withdrawal by Subject|1
5888663|NCT01787292|20371465|P1|Home Based Exercise Program|Withdrawal by Subject|3
5888664|NCT01787292|20371464|P2|Crossover Exercise Interventions|Withdrawal by Subject|2
5888665|NCT01787292|20371465|P1|Crossover Exercise Interventions|Withdrawal by Subject|2
5888666|NCT01787279|20371482|P1|Overall Study|Lack of Efficacy|1
5888667|NCT01787279|20371482|P1|Overall Study|Lost to Follow-up|2
5888668|NCT01787188|20371508|P3|Overall Study|Other, including patient moved|0
5888669|NCT01787188|20371509|P2|Overall Study|Other, including patient moved|3
5888670|NCT01787188|20371510|P1|Overall Study|Other, including patient moved|0
5888671|NCT01787188|20371508|P3|Overall Study|Lost to Follow-up|2
5888672|NCT01787188|20371509|P2|Overall Study|Lost to Follow-up|2
5888673|NCT01787188|20371510|P1|Overall Study|Lost to Follow-up|1
5888674|NCT01787188|20371508|P3|Overall Study|Protocol Violation|3
5888675|NCT01787188|20371509|P2|Overall Study|Protocol Violation|2
5888676|NCT01787188|20371510|P1|Overall Study|Protocol Violation|3
5888677|NCT01787188|20371508|P3|Overall Study|Withdrawal by Subject|2
5888678|NCT01787188|20371509|P2|Overall Study|Withdrawal by Subject|3
5888679|NCT01787188|20371510|P1|Overall Study|Withdrawal by Subject|4
5888680|NCT01787188|20371508|P3|Overall Study|Non-compliance with Study Drug|0
5888681|NCT01787188|20371509|P2|Overall Study|Non-compliance with Study Drug|1
5888682|NCT01787188|20371510|P1|Overall Study|Non-compliance with Study Drug|0
5888683|NCT01787188|20371508|P3|Overall Study|Lack of Efficacy|5
5888684|NCT01787188|20371509|P2|Overall Study|Lack of Efficacy|3
5888685|NCT01787188|20371510|P1|Overall Study|Lack of Efficacy|7
5888686|NCT01787188|20371508|P3|Overall Study|Adverse Event|6
5888687|NCT01787188|20371509|P2|Overall Study|Adverse Event|4
5888688|NCT01787188|20371510|P1|Overall Study|Adverse Event|2
5888689|NCT01787097|20371576|P4|Overall Study|Withdrawal by Subject|0
5888690|NCT01787097|20371577|P3|Overall Study|Withdrawal by Subject|0
5888691|NCT01787097|20371578|P2|Overall Study|Withdrawal by Subject|0
5888692|NCT01787097|20371579|P1|Overall Study|Withdrawal by Subject|1
5888693|NCT01787032|20371611|P6|Overall Study|Protocol Violation|1
5888694|NCT01787032|20371612|P5|Overall Study|Protocol Violation|1
5888695|NCT01787032|20371613|P4|Overall Study|Protocol Violation|0
5888696|NCT01787032|20371614|P3|Overall Study|Protocol Violation|0
5888697|NCT01787032|20371615|P2|Overall Study|Protocol Violation|0
5888698|NCT01787032|20371616|P1|Overall Study|Protocol Violation|0
5888699|NCT01786993|20371669|P2|Overall Study|Hospice Admission|0
5888700|NCT01786993|20371670|P1|Overall Study|Hospice Admission|1
5888701|NCT01786993|20371669|P2|Overall Study|System Explant|0
5888702|NCT01786993|20371670|P1|Overall Study|System Explant|1
5888703|NCT01786993|20371669|P2|Overall Study|Subject Non-Compliance|0
5888704|NCT01786993|20371670|P1|Overall Study|Subject Non-Compliance|1
5888705|NCT01786993|20371669|P2|Overall Study|Lost to Follow-up|1
5888706|NCT01786993|20371670|P1|Overall Study|Lost to Follow-up|0
5888707|NCT01786993|20371669|P2|Overall Study|Withdrawal by Subject|2
5888708|NCT01786993|20371670|P1|Overall Study|Withdrawal by Subject|3
5888709|NCT01786993|20371669|P2|Overall Study|Death|7
5888710|NCT01786993|20371670|P1|Overall Study|Death|6
5888711|NCT01786707|20371729|P2|Overall Study|Lost to Follow-up|1
5888712|NCT01786707|20371730|P1|Overall Study|Lost to Follow-up|1
5888713|NCT01786668|20371742|P4|Overall Study|Lost to Follow-up|0
5888714|NCT01786668|20371743|P3|Overall Study|Lost to Follow-up|1
5888715|NCT01786668|20371744|P2|Overall Study|Lost to Follow-up|0
5888716|NCT01786668|20371745|P1|Overall Study|Lost to Follow-up|1
5888717|NCT01786668|20371742|P4|Overall Study|Pregnancy|1
5888718|NCT01786668|20371743|P3|Overall Study|Pregnancy|0
5888719|NCT01786668|20371744|P2|Overall Study|Pregnancy|0
5888720|NCT01786668|20371745|P1|Overall Study|Pregnancy|0
5888721|NCT01786668|20371742|P4|Overall Study|Withdrawal by Subject|1
5888722|NCT01786668|20371743|P3|Overall Study|Withdrawal by Subject|3
5888723|NCT01786668|20371744|P2|Overall Study|Withdrawal by Subject|0
5888724|NCT01786668|20371745|P1|Overall Study|Withdrawal by Subject|0
5888725|NCT01786668|20371742|P4|Overall Study|Adverse Event|2
5888726|NCT01786668|20371743|P3|Overall Study|Adverse Event|1
5888727|NCT01786668|20371744|P2|Overall Study|Adverse Event|1
5888728|NCT01786668|20371745|P1|Overall Study|Adverse Event|0
5888729|NCT01786629|20371845|P2|Overall Study|Adverse Event|1
5888730|NCT01786629|20371846|P1|Overall Study|Adverse Event|0
5888731|NCT01786629|20371845|P2|Overall Study|Lack of Efficacy|4
5888732|NCT01786629|20371846|P1|Overall Study|Lack of Efficacy|0
5888733|NCT01786603|20371854|P2|Overall Study|Lost to Follow-up|2
5888734|NCT01786603|20371855|P1|Overall Study|Lost to Follow-up|1
5888735|NCT01786603|20371854|P2|Overall Study|Physician decision to withdraw|7
5888736|NCT01786603|20371855|P1|Overall Study|Physician decision to withdraw|6
5888737|NCT01786603|20371854|P2|Overall Study|Adverse Event|2
5888738|NCT01786603|20371855|P1|Overall Study|Adverse Event|6
5888739|NCT01786603|20371854|P2|Overall Study|Death|1
5888740|NCT01786603|20371855|P1|Overall Study|Death|5
5888741|NCT01786564|20371873|P1|Overall Study|Ineligible|17
5888742|NCT01786564|20371873|P1|Overall Study|Lost to Follow-up|47
5888743|NCT01786551|20371877|P1|Overall Study|Participant withdrew consent|2
5888744|NCT01786330|20371898|P2|Overall Study|Protocol Violation|0
5888745|NCT01786330|20371899|P1|Overall Study|Protocol Violation|1
5888746|NCT01786330|20371898|P2|Overall Study|Excluded intraoperatively|1
5888747|NCT01786330|20371899|P1|Overall Study|Excluded intraoperatively|0
5888748|NCT01786330|20371898|P2|Overall Study|Lost to Follow-up|1
5888749|NCT01786330|20371899|P1|Overall Study|Lost to Follow-up|0
5888750|NCT01786330|20371898|P2|Overall Study|Withdrawal by Subject|1
5888751|NCT01786330|20371899|P1|Overall Study|Withdrawal by Subject|0
5888752|NCT01786174|20371951|P2|Overall Study|Discontinued Study Drug|0
5888753|NCT01786174|20371952|P1|Overall Study|Discontinued Study Drug|2
5888754|NCT01786148|20371981|P2|Overall Study|Incarceration|1
5888755|NCT01786148|20371982|P1|Overall Study|Incarceration|1
5888756|NCT01786148|20371981|P2|Overall Study|Withdrawal by Subject|7
5888757|NCT01786148|20371982|P1|Overall Study|Withdrawal by Subject|0
5888758|NCT01786148|20371981|P2|Overall Study|Death|1
5888759|NCT01786148|20371982|P1|Overall Study|Death|0
5888760|NCT01786148|20371981|P2|Overall Study|Lost to Follow-up|13
5888761|NCT01786148|20371982|P1|Overall Study|Lost to Follow-up|21
5888762|NCT01786109|20371997|P3|Overall Study|adverse effects colon preparation|1
5888763|NCT01786109|20371998|P2|Overall Study|adverse effects colon preparation|0
5888764|NCT01786109|20371999|P1|Overall Study|adverse effects colon preparation|0
5888765|NCT01786109|20371997|P3|Overall Study|unrelated illness|1
5888766|NCT01786109|20371998|P2|Overall Study|unrelated illness|0
5888767|NCT01786109|20371999|P1|Overall Study|unrelated illness|0
5888768|NCT01786109|20371997|P3|Overall Study|fail manometry barostat tube placement|0
5888769|NCT01786109|20371998|P2|Overall Study|fail manometry barostat tube placement|0
5888770|NCT01786109|20371999|P1|Overall Study|fail manometry barostat tube placement|1
5888771|NCT01785875|20372028|P3|Overall Study|Missing|3
5888772|NCT01785875|20372029|P2|Overall Study|Missing|1
5888773|NCT01785875|20372030|P1|Overall Study|Missing|0
5888774|NCT01785875|20372028|P3|Overall Study|Protocol Specified Criteria|55
5888775|NCT01785875|20372029|P2|Overall Study|Protocol Specified Criteria|214
5888776|NCT01785875|20372030|P1|Overall Study|Protocol Specified Criteria|207
5888777|NCT01785875|20372028|P3|Overall Study|Sponsor Decision|0
5888778|NCT01785875|20372029|P2|Overall Study|Sponsor Decision|2
5888779|NCT01785875|20372030|P1|Overall Study|Sponsor Decision|0
5888780|NCT01785875|20372028|P3|Overall Study|Death|7
5888781|NCT01785875|20372029|P2|Overall Study|Death|16
5888782|NCT01785875|20372030|P1|Overall Study|Death|27
5888783|NCT01785875|20372028|P3|Overall Study|Lost to Follow-up|6
5888784|NCT01785875|20372029|P2|Overall Study|Lost to Follow-up|22
5888785|NCT01785875|20372030|P1|Overall Study|Lost to Follow-up|19
5888786|NCT01785875|20372028|P3|Overall Study|Withdrawal by Subject|36
5888787|NCT01785875|20372029|P2|Overall Study|Withdrawal by Subject|34
5888788|NCT01785875|20372030|P1|Overall Study|Withdrawal by Subject|41
5888789|NCT01785849|20372099|P2|Overall Study|Lost to Follow-up|11
5888790|NCT01785849|20372100|P1|Overall Study|Lost to Follow-up|10
5888791|NCT01785849|20372099|P2|Overall Study|Sponsor Decision|1
5888792|NCT01785849|20372100|P1|Overall Study|Sponsor Decision|0
5888793|NCT01785849|20372099|P2|Overall Study|Withdrawal by Subject|12
5888794|NCT01785849|20372100|P1|Overall Study|Withdrawal by Subject|15
5888795|NCT01785849|20372099|P2|Overall Study|Protocol Specified Criteria|1
5888796|NCT01785849|20372100|P1|Overall Study|Protocol Specified Criteria|29
5888797|NCT01785849|20372099|P2|Overall Study|Death|9
5888798|NCT01785849|20372100|P1|Overall Study|Death|7
5888799|NCT01785628|20372137|P2|Overall Study|Lost to Follow-up|3
5888800|NCT01785628|20372138|P1|Overall Study|Lost to Follow-up|2
5888801|NCT01785615|20372161|P4|Dietary Phase|Lost to Follow-up|24
5888802|NCT01785615|20372162|P3|Dietary Phase|Lost to Follow-up|0
5888803|NCT01785615|20372163|P2|Dietary Phase|Lost to Follow-up|0
5888804|NCT01785615|20372164|P1|Dietary Phase|Lost to Follow-up|0
5888805|NCT01785602|20372236|P2|Overall Study|Administrative problems|3
5888806|NCT01785602|20372237|P1|Overall Study|Administrative problems|7
5888807|NCT01785602|20372236|P2|Overall Study|Adverse Event|5
5888808|NCT01785602|20372237|P1|Overall Study|Adverse Event|3
5888809|NCT01785602|20372236|P2|Overall Study|Lost to Follow-up|1
5888810|NCT01785602|20372237|P1|Overall Study|Lost to Follow-up|1
5888811|NCT01785602|20372236|P2|Overall Study|Withdrawal by Subject|0
5888812|NCT01785602|20372237|P1|Overall Study|Withdrawal by Subject|2
5888813|NCT01785524|20372247|P2|Overall Study|Withdrawal by Subject|2
5888814|NCT01785524|20372248|P1|Overall Study|Withdrawal by Subject|2
5888815|NCT01785472|20372267|P3|Overall Study|Technical problems|1
5888816|NCT01785472|20372268|P2|Overall Study|Technical problems|0
5888817|NCT01785472|20372269|P1|Overall Study|Technical problems|0
5888818|NCT01785472|20372267|P3|Overall Study|Subject/guardian decision|11
5888819|NCT01785472|20372268|P2|Overall Study|Subject/guardian decision|10
5888820|NCT01785472|20372269|P1|Overall Study|Subject/guardian decision|15
5888821|NCT01785472|20372267|P3|Overall Study|Protocol deviation|2
5888822|NCT01785472|20372268|P2|Overall Study|Protocol deviation|2
5888823|NCT01785472|20372269|P1|Overall Study|Protocol deviation|0
5888824|NCT01785472|20372267|P3|Overall Study|Physician Decision|1
5888825|NCT01785472|20372268|P2|Overall Study|Physician Decision|1
5888826|NCT01785472|20372269|P1|Overall Study|Physician Decision|1
5888827|NCT01785472|20372267|P3|Overall Study|Lost to Follow-up|0
5888828|NCT01785472|20372268|P2|Overall Study|Lost to Follow-up|2
5888829|NCT01785472|20372269|P1|Overall Study|Lost to Follow-up|1
5888830|NCT01785472|20372267|P3|Overall Study|Lack of Efficacy|1
5888831|NCT01785472|20372268|P2|Overall Study|Lack of Efficacy|0
5888832|NCT01785472|20372269|P1|Overall Study|Lack of Efficacy|2
5888833|NCT01785472|20372267|P3|Overall Study|Adverse Event|6
5888834|NCT01785472|20372268|P2|Overall Study|Adverse Event|4
5888835|NCT01785472|20372269|P1|Overall Study|Adverse Event|5
5888836|NCT01785160|20372355|P1|Washout Period of at Least 7 Days|Consent withdrawn|1
5888837|NCT01785160|20372355|P1|Treatment Period 1: Raltegravir|Not treated|1
5888838|NCT01785069|20372392|P4|Overall Study|Not evaluable|8
5888839|NCT01785069|20372393|P3|Overall Study|Not evaluable|5
5888840|NCT01785069|20372394|P2|Overall Study|Not evaluable|4
5888841|NCT01785069|20372395|P1|Overall Study|Not evaluable|7
5888842|NCT01785069|20372392|P4|Overall Study|Reason not Specified|4
5888843|NCT01785069|20372393|P3|Overall Study|Reason not Specified|1
5888844|NCT01785069|20372394|P2|Overall Study|Reason not Specified|2
5888845|NCT01785069|20372395|P1|Overall Study|Reason not Specified|1
5888846|NCT01785069|20372392|P4|Overall Study|Lost to Follow-up|1
5888847|NCT01785069|20372393|P3|Overall Study|Lost to Follow-up|4
5888848|NCT01785069|20372394|P2|Overall Study|Lost to Follow-up|2
5888849|NCT01785069|20372395|P1|Overall Study|Lost to Follow-up|1
5888850|NCT01785069|20372392|P4|Overall Study|Subject choice|1
5888851|NCT01785069|20372393|P3|Overall Study|Subject choice|0
5888852|NCT01785069|20372394|P2|Overall Study|Subject choice|2
5888853|NCT01785069|20372395|P1|Overall Study|Subject choice|2
5888854|NCT01785069|20372392|P4|Overall Study|Death|0
5888855|NCT01785069|20372393|P3|Overall Study|Death|2
5888856|NCT01785069|20372394|P2|Overall Study|Death|0
5888857|NCT01785069|20372395|P1|Overall Study|Death|0
5888858|NCT01785069|20372392|P4|Overall Study|Implanted with nonstudy device|0
5888859|NCT01785069|20372393|P3|Overall Study|Implanted with nonstudy device|1
5888860|NCT01785069|20372394|P2|Overall Study|Implanted with nonstudy device|2
5888861|NCT01785069|20372395|P1|Overall Study|Implanted with nonstudy device|1
5888862|NCT01784965|20372444|P2|Overall Study|Adverse Event|8
5888863|NCT01784965|20372445|P1|Overall Study|Adverse Event|0
5888864|NCT01784965|20372444|P2|Overall Study|Withdrawal by Subject|3
5888865|NCT01784965|20372445|P1|Overall Study|Withdrawal by Subject|6
5888866|NCT01784419|20372566|P1|Overall Study|Adverse Event|3
5888867|NCT01784211|20372574|P6|Part A (Days 1-15)|Withdrawal by Subject|0
5888868|NCT01784211|20372575|P5|Part A (Days 1-15)|Withdrawal by Subject|0
5888869|NCT01784211|20372576|P4|Part A (Days 1-15)|Withdrawal by Subject|0
5888870|NCT01784211|20372577|P3|Part A (Days 1-15)|Withdrawal by Subject|0
5888871|NCT01784211|20372578|P2|Part A (Days 1-15)|Withdrawal by Subject|1
5888872|NCT01784211|20372579|P1|Part A (Days 1-15)|Withdrawal by Subject|2
5888873|NCT01784211|20372574|P6|Part A (Days 1-15)|Adverse Event|0
5888874|NCT01784211|20372575|P5|Part A (Days 1-15)|Adverse Event|0
5888875|NCT01784211|20372576|P4|Part A (Days 1-15)|Adverse Event|0
5888876|NCT01784211|20372577|P3|Part A (Days 1-15)|Adverse Event|0
5888877|NCT01784211|20372578|P2|Part A (Days 1-15)|Adverse Event|1
5888878|NCT01784211|20372579|P1|Part A (Days 1-15)|Adverse Event|1
5888897|NCT01784029|20372616|P3|Overall Study|Lost to Follow-up|22
5888898|NCT01784029|20372617|P2|Overall Study|Lost to Follow-up|20
5888899|NCT01784029|20372618|P1|Overall Study|Lost to Follow-up|19
5888900|NCT01783938|20372647|P2|Overall Study|Other|0
5888901|NCT01783938|20372648|P1|Overall Study|Other|1
5888902|NCT01783938|20372647|P2|Overall Study|Withdrew Consent|0
5888903|NCT01783938|20372648|P1|Overall Study|Withdrew Consent|3
5888904|NCT01783938|20372647|P2|Overall Study|Request to Discontinue Study Treatment|2
5888905|NCT01783938|20372648|P1|Overall Study|Request to Discontinue Study Treatment|1
5888906|NCT01783938|20372647|P2|Overall Study|Adverse Event Unrelated to Study Drug|2
5888907|NCT01783938|20372648|P1|Overall Study|Adverse Event Unrelated to Study Drug|2
5888908|NCT01783938|20372647|P2|Overall Study|Study Drug Toxicity|10
5888909|NCT01783938|20372648|P1|Overall Study|Study Drug Toxicity|22
5888910|NCT01783938|20372647|P2|Overall Study|Disease Progression|39
5888911|NCT01783938|20372648|P1|Overall Study|Disease Progression|18
5888912|NCT01783886|20372676|P3|Overall Study|Adverse Event|4
5888913|NCT01783886|20372677|P2|Overall Study|Adverse Event|5
5888914|NCT01783886|20372678|P1|Overall Study|Adverse Event|4
5888915|NCT01783886|20372676|P3|Overall Study|Withdrawal of consent by participant|4
5888916|NCT01783886|20372677|P2|Overall Study|Withdrawal of consent by participant|3
5888917|NCT01783886|20372678|P1|Overall Study|Withdrawal of consent by participant|1
5888918|NCT01783886|20372676|P3|Overall Study|Protocol deviation|2
5888919|NCT01783886|20372677|P2|Overall Study|Protocol deviation|0
5888920|NCT01783886|20372678|P1|Overall Study|Protocol deviation|0
5888921|NCT01783886|20372676|P3|Overall Study|Lost to Follow-up|0
5888922|NCT01783886|20372677|P2|Overall Study|Lost to Follow-up|3
5888923|NCT01783886|20372678|P1|Overall Study|Lost to Follow-up|0
5888924|NCT01783821|20372741|P2|Overall Study|Screen Failure|1
5888925|NCT01783821|20372742|P1|Overall Study|Screen Failure|1
5889011|NCT01782872|20373214|P1|Overall Study|Withdrawal by Subject|0
5888926|NCT01783743|20372760|P2|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10236
5888927|NCT01783743|20372761|P1|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10305
5888928|NCT01783743|20372760|P2|Rescreening of Subjects by Senior Grader|Lost to Follow-up|684
5888929|NCT01783743|20372761|P1|Rescreening of Subjects by Senior Grader|Lost to Follow-up|591
5888930|NCT01783743|20372760|P2|Screening of Subjects by CTA During MDA|Absent at MDA|4439
5888931|NCT01783743|20372761|P1|Screening of Subjects by CTA During MDA|Absent at MDA|3427
5888932|NCT01783730|20372775|P1|Overall Study|Failed to meet inclusion criteria|6
5888933|NCT01783678|20372800|P6|Overall Study|Withdrew Consent|0
5888934|NCT01783678|20372801|P5|Overall Study|Withdrew Consent|0
5888935|NCT01783678|20372802|P4|Overall Study|Withdrew Consent|2
5888936|NCT01783678|20372803|P3|Overall Study|Withdrew Consent|0
5888937|NCT01783678|20372804|P2|Overall Study|Withdrew Consent|1
5888938|NCT01783678|20372805|P1|Overall Study|Withdrew Consent|1
5888939|NCT01783678|20372800|P6|Overall Study|Lost to Follow-up|0
5888940|NCT01783678|20372801|P5|Overall Study|Lost to Follow-up|1
5888941|NCT01783678|20372802|P4|Overall Study|Lost to Follow-up|2
5888942|NCT01783678|20372803|P3|Overall Study|Lost to Follow-up|0
5888943|NCT01783678|20372804|P2|Overall Study|Lost to Follow-up|4
5888944|NCT01783678|20372805|P1|Overall Study|Lost to Follow-up|0
5888945|NCT01783678|20372800|P6|Overall Study|Lack of Efficacy|5
5888946|NCT01783678|20372801|P5|Overall Study|Lack of Efficacy|6
5888947|NCT01783678|20372802|P4|Overall Study|Lack of Efficacy|3
5888948|NCT01783678|20372803|P3|Overall Study|Lack of Efficacy|1
5888949|NCT01783678|20372804|P2|Overall Study|Lack of Efficacy|13
5888950|NCT01783678|20372805|P1|Overall Study|Lack of Efficacy|1
5888951|NCT01783678|20372800|P6|Overall Study|Randomized but Not Treated|0
5888952|NCT01783678|20372801|P5|Overall Study|Randomized but Not Treated|0
5888953|NCT01783678|20372802|P4|Overall Study|Randomized but Not Treated|1
5888954|NCT01783678|20372803|P3|Overall Study|Randomized but Not Treated|0
5888955|NCT01783678|20372804|P2|Overall Study|Randomized but Not Treated|0
5888956|NCT01783678|20372805|P1|Overall Study|Randomized but Not Treated|0
5888957|NCT01783548|20372909|P2|Overall Study|Lack of Efficacy|1
5888958|NCT01783548|20372910|P1|Overall Study|Lack of Efficacy|1
5888959|NCT01783548|20372909|P2|Overall Study|Lost to Follow-up|3
5888960|NCT01783548|20372910|P1|Overall Study|Lost to Follow-up|8
5888961|NCT01783548|20372909|P2|Overall Study|Protocol Violation|2
5888962|NCT01783548|20372910|P1|Overall Study|Protocol Violation|2
5888963|NCT01783548|20372909|P2|Overall Study|Non-compliance|0
5888964|NCT01783548|20372910|P1|Overall Study|Non-compliance|4
5888965|NCT01783548|20372909|P2|Overall Study|Withdrawal by Subject|8
5888966|NCT01783548|20372910|P1|Overall Study|Withdrawal by Subject|11
5888967|NCT01783548|20372909|P2|Overall Study|Adverse Event|4
5888968|NCT01783548|20372910|P1|Overall Study|Adverse Event|8
5888969|NCT01783496|20372943|P6|Overall Study|Withdrawal by Subject|0
5888970|NCT01783496|20372944|P5|Overall Study|Withdrawal by Subject|0
5888971|NCT01783496|20372945|P4|Overall Study|Withdrawal by Subject|0
5888972|NCT01783496|20372946|P3|Overall Study|Withdrawal by Subject|0
5888973|NCT01783496|20372947|P2|Overall Study|Withdrawal by Subject|0
5888974|NCT01783496|20372948|P1|Overall Study|Withdrawal by Subject|1
5888975|NCT01783496|20372943|P6|Overall Study|Lost to Follow-up|1
5888976|NCT01783496|20372944|P5|Overall Study|Lost to Follow-up|0
5888977|NCT01783496|20372945|P4|Overall Study|Lost to Follow-up|2
5888978|NCT01783496|20372946|P3|Overall Study|Lost to Follow-up|0
5888979|NCT01783496|20372947|P2|Overall Study|Lost to Follow-up|0
5888980|NCT01783496|20372948|P1|Overall Study|Lost to Follow-up|0
5888981|NCT01783483|20372976|P2|Overall Study|Physician Decision|1
5888982|NCT01783483|20372977|P1|Overall Study|Physician Decision|1
5888983|NCT01783483|20372976|P2|Overall Study|Withdrawal by Subject|1
5888984|NCT01783483|20372977|P1|Overall Study|Withdrawal by Subject|2
5888985|NCT01783483|20372976|P2|Overall Study|Lost to Follow-up|10
5888986|NCT01783483|20372977|P1|Overall Study|Lost to Follow-up|14
5888987|NCT01783483|20372976|P2|Overall Study|Death|3
5888988|NCT01783483|20372977|P1|Overall Study|Death|3
5888989|NCT01783418|20373015|P2|Overall Study|Withdrawal by Subject|0
5888990|NCT01783418|20373016|P1|Overall Study|Withdrawal by Subject|1
5888991|NCT01783015|20373069|P3|Open Label Treatment|Study Terminated by Sponsor|6
5888992|NCT01783015|20373070|P2|Open Label Treatment|Study Terminated by Sponsor|0
5888993|NCT01783015|20373071|P1|Open Label Treatment|Study Terminated by Sponsor|0
5888994|NCT01783015|20373069|P3|Blinded Treatment|Study Terminated by Sponsor|0
5888995|NCT01783015|20373070|P2|Blinded Treatment|Study Terminated by Sponsor|0
5888996|NCT01783015|20373071|P1|Blinded Treatment|Study Terminated by Sponsor|2
5888997|NCT01783015|20373069|P3|Blinded Treatment|Withdrawal by Subject|0
5888998|NCT01783015|20373070|P2|Blinded Treatment|Withdrawal by Subject|1
5888999|NCT01783015|20373071|P1|Blinded Treatment|Withdrawal by Subject|0
5889000|NCT01783015|20373069|P3|Blinded Treatment|Protocol Violation|0
5889001|NCT01783015|20373070|P2|Blinded Treatment|Protocol Violation|1
5889002|NCT01783015|20373071|P1|Blinded Treatment|Protocol Violation|0
5889003|NCT01783015|20373069|P3|Blinded Treatment|Adverse Event|0
5889004|NCT01783015|20373070|P2|Blinded Treatment|Adverse Event|1
5889005|NCT01783015|20373071|P1|Blinded Treatment|Adverse Event|0
5889006|NCT01782885|20373184|P2|Overall Study|Lost to Follow-up|6
5889007|NCT01782885|20373185|P1|Overall Study|Lost to Follow-up|4
5889008|NCT01782872|20373211|P4|Overall Study|Withdrawal by Subject|0
5889009|NCT01782872|20373212|P3|Overall Study|Withdrawal by Subject|0
5889010|NCT01782872|20373213|P2|Overall Study|Withdrawal by Subject|1
5889012|NCT01782872|20373211|P4|Overall Study|Protocol Violation|1
5889013|NCT01782872|20373212|P3|Overall Study|Protocol Violation|0
5889014|NCT01782872|20373213|P2|Overall Study|Protocol Violation|0
5889015|NCT01782872|20373214|P1|Overall Study|Protocol Violation|0
5889016|NCT01782859|20373238|P2|Overall Study|Withdrawal by Subject|1
5889017|NCT01782859|20373239|P1|Overall Study|Withdrawal by Subject|0
5889018|NCT01782859|20373238|P2|Overall Study|Protocol Violation|6
5889019|NCT01782859|20373239|P1|Overall Study|Protocol Violation|6
5889020|NCT01782742|20373261|P2|Double-blind Treatment Phase|Adverse Event|0
5889021|NCT01782742|20373262|P1|Double-blind Treatment Phase|Adverse Event|1
5889022|NCT01782690|20373295|P1|Overall Study|Study completion unknown|7
5889023|NCT01782690|20373295|P1|Overall Study|Death|133
5889024|NCT01782690|20373295|P1|Overall Study|Tumor progression|74
5889025|NCT01782690|20373295|P1|Overall Study|Patient's wish|21
5889026|NCT01782690|20373295|P1|Overall Study|Physician Decision|13
5889027|NCT01782690|20373295|P1|Overall Study|Absent rash|9
5889028|NCT01782690|20373295|P1|Overall Study|Withdrawal of informed consent|2
5889029|NCT01782690|20373295|P1|Overall Study|Lost to Follow-up|31
5889030|NCT01782690|20373295|P1|Overall Study|Toxicity of erlotinib|1
5889031|NCT01782690|20373295|P1|Overall Study|Toxicity of gemcitabine|1
5889032|NCT01782690|20373295|P1|Overall Study|Not reported|7
5889033|NCT01782664|20373317|P6|Overall Study|Withdrawal by Subject|0
5889034|NCT01782664|20373318|P5|Overall Study|Withdrawal by Subject|0
5889035|NCT01782664|20373319|P4|Overall Study|Withdrawal by Subject|0
5889036|NCT01782664|20373320|P3|Overall Study|Withdrawal by Subject|0
5889037|NCT01782664|20373321|P2|Overall Study|Withdrawal by Subject|2
5889038|NCT01782664|20373322|P1|Overall Study|Withdrawal by Subject|2
5889039|NCT01782664|20373317|P6|Overall Study|Protocol Violation|0
5889040|NCT01782664|20373318|P5|Overall Study|Protocol Violation|0
5889041|NCT01782664|20373319|P4|Overall Study|Protocol Violation|1
5889042|NCT01782664|20373320|P3|Overall Study|Protocol Violation|0
5889043|NCT01782664|20373321|P2|Overall Study|Protocol Violation|1
5889044|NCT01782664|20373322|P1|Overall Study|Protocol Violation|0
5889045|NCT01782664|20373317|P6|Overall Study|Lack of Efficacy|0
5889046|NCT01782664|20373318|P5|Overall Study|Lack of Efficacy|0
5889047|NCT01782664|20373319|P4|Overall Study|Lack of Efficacy|2
5889048|NCT01782664|20373320|P3|Overall Study|Lack of Efficacy|2
5889049|NCT01782664|20373321|P2|Overall Study|Lack of Efficacy|0
5889050|NCT01782664|20373322|P1|Overall Study|Lack of Efficacy|2
5889051|NCT01782664|20373317|P6|Overall Study|Adverse Event|0
5889052|NCT01782664|20373318|P5|Overall Study|Adverse Event|0
5889053|NCT01782664|20373319|P4|Overall Study|Adverse Event|2
5889054|NCT01782664|20373320|P3|Overall Study|Adverse Event|2
5889055|NCT01782664|20373321|P2|Overall Study|Adverse Event|2
5889056|NCT01782664|20373322|P1|Overall Study|Adverse Event|2
5889057|NCT01782495|20373479|P11|Overall Study|Withdrew Consent|0
5889058|NCT01782495|20373480|P10|Overall Study|Withdrew Consent|0
5889059|NCT01782495|20373481|P9|Overall Study|Withdrew Consent|0
5889060|NCT01782495|20373482|P8|Overall Study|Withdrew Consent|1
5889061|NCT01782495|20373483|P7|Overall Study|Withdrew Consent|0
5889062|NCT01782495|20373484|P6|Overall Study|Withdrew Consent|0
5889063|NCT01782495|20373485|P5|Overall Study|Withdrew Consent|0
5889064|NCT01782495|20373486|P4|Overall Study|Withdrew Consent|0
5889065|NCT01782495|20373487|P3|Overall Study|Withdrew Consent|0
5889066|NCT01782495|20373488|P2|Overall Study|Withdrew Consent|1
5889067|NCT01782495|20373489|P1|Overall Study|Withdrew Consent|0
5889068|NCT01782495|20373479|P11|Overall Study|Adverse Event|0
5889069|NCT01782495|20373480|P10|Overall Study|Adverse Event|0
5889070|NCT01782495|20373481|P9|Overall Study|Adverse Event|0
5889071|NCT01782495|20373482|P8|Overall Study|Adverse Event|2
5889072|NCT01782495|20373483|P7|Overall Study|Adverse Event|0
5889073|NCT01782495|20373484|P6|Overall Study|Adverse Event|0
5889074|NCT01782495|20373485|P5|Overall Study|Adverse Event|0
5889075|NCT01782495|20373486|P4|Overall Study|Adverse Event|0
5889076|NCT01782495|20373487|P3|Overall Study|Adverse Event|0
5889077|NCT01782495|20373488|P2|Overall Study|Adverse Event|0
5889078|NCT01782495|20373489|P1|Overall Study|Adverse Event|0
5889079|NCT01782482|20373548|P2|Overall Study|Habitually wearing toric lens OS|1
5889080|NCT01782482|20373549|P1|Overall Study|Habitually wearing toric lens OS|0
5889081|NCT01782482|20373548|P2|Overall Study|Randomized in Error|2
5889082|NCT01782482|20373549|P1|Overall Study|Randomized in Error|2
5889083|NCT01782482|20373548|P2|Overall Study|Withdrawal by Subject|3
5889084|NCT01782482|20373549|P1|Overall Study|Withdrawal by Subject|2
5889085|NCT01782482|20373548|P2|Overall Study|Protocol Violation|0
5889086|NCT01782482|20373549|P1|Overall Study|Protocol Violation|1
5889087|NCT01782482|20373548|P2|Overall Study|Physician Decision|0
5889088|NCT01782482|20373549|P1|Overall Study|Physician Decision|1
5889089|NCT01782482|20373548|P2|Overall Study|Lost to Follow-up|3
5889090|NCT01782482|20373549|P1|Overall Study|Lost to Follow-up|2
5889091|NCT01782482|20373548|P2|Overall Study|Adverse Event|1
5889092|NCT01782482|20373549|P1|Overall Study|Adverse Event|2
5889093|NCT01782469|20373557|P1|Overall Study|Lost to Follow-up|1
5889094|NCT01782378|20373567|P2|Second Series|Did not choose to complete S2 Optional|0
5889095|NCT01782378|20373568|P1|Second Series|Did not choose to complete S2 Optional|18
5889096|NCT01782378|20373567|P2|Second Series|Lost to Follow-up|7
5889097|NCT01782378|20373568|P1|Second Series|Lost to Follow-up|8
5889098|NCT01782378|20373567|P2|Second Series|Partial Crossover Design- no Sham 2nd|25
5889099|NCT01782378|20373568|P1|Second Series|Partial Crossover Design- no Sham 2nd|0
5889100|NCT01782378|20373567|P2|First Series|Lost to Follow-up|8
5889101|NCT01782378|20373568|P1|First Series|Lost to Follow-up|7
5889102|NCT01782326|20373634|P2|Double-blind Treatment|Technical problems|5
5889103|NCT01782326|20373635|P1|Double-blind Treatment|Technical problems|0
5889104|NCT01782326|20373634|P2|Double-blind Treatment|Protocol deviation|7
5889105|NCT01782326|20373635|P1|Double-blind Treatment|Protocol deviation|8
5889106|NCT01782326|20373634|P2|Double-blind Treatment|Physician Decision|16
5889107|NCT01782326|20373635|P1|Double-blind Treatment|Physician Decision|13
5889108|NCT01782326|20373634|P2|Double-blind Treatment|Lack of Efficacy|22
5889109|NCT01782326|20373635|P1|Double-blind Treatment|Lack of Efficacy|17
5889110|NCT01782326|20373634|P2|Double-blind Treatment|Subject/guardian decision|125
5889111|NCT01782326|20373635|P1|Double-blind Treatment|Subject/guardian decision|111
5889112|NCT01782326|20373634|P2|Double-blind Treatment|Adverse Event|145
5889113|NCT01782326|20373635|P1|Double-blind Treatment|Adverse Event|129
5889114|NCT01782326|20373634|P2|Planned Treatment Epoch|Technical problems|4
5889115|NCT01782326|20373635|P1|Planned Treatment Epoch|Technical problems|0
5889116|NCT01782326|20373634|P2|Planned Treatment Epoch|Lost to Follow-up|4
5889117|NCT01782326|20373635|P1|Planned Treatment Epoch|Lost to Follow-up|4
5889118|NCT01782326|20373634|P2|Planned Treatment Epoch|Protocol deviation|3
5889119|NCT01782326|20373635|P1|Planned Treatment Epoch|Protocol deviation|2
5889120|NCT01782326|20373634|P2|Planned Treatment Epoch|Physician Decision|16
5889121|NCT01782326|20373635|P1|Planned Treatment Epoch|Physician Decision|18
5889122|NCT01782326|20373634|P2|Planned Treatment Epoch|Death|30
5889123|NCT01782326|20373635|P1|Planned Treatment Epoch|Death|29
5889124|NCT01782326|20373634|P2|Planned Treatment Epoch|Subject/guardian decision|151
5889125|NCT01782326|20373635|P1|Planned Treatment Epoch|Subject/guardian decision|149
5889126|NCT01782313|20373695|P1|Survival Follow up|Lost to Follow-up|1
5889127|NCT01782313|20373695|P1|Continued Treatment After 16 Weeks|Withdrawal by Subject|1
5889128|NCT01782313|20373695|P1|Continued Treatment After 16 Weeks|Progressive Disease|6
5889129|NCT01782313|20373695|P1|Treated Cycle 4/Reached 16 Week Response|Adverse Event|1
5889130|NCT01782313|20373695|P1|Treated Cycle 4/Reached 16 Week Response|Progressive Disease|5
5889131|NCT01782313|20373695|P1|Treated Cycle 3|Progressive Disease|21
5889132|NCT01782313|20373695|P1|Reached First Response/Completed 2 Cycle|Progressive Disease|3
5889133|NCT01782313|20373695|P1|Reached First Response/Completed 2 Cycle|Adverse Event|3
5889134|NCT01782222|20373709|P3|Overall Study|Moved to other state|0
5889135|NCT01782222|20373710|P2|Overall Study|Moved to other state|1
5889136|NCT01782222|20373711|P1|Overall Study|Moved to other state|0
5889137|NCT01782222|20373709|P3|Overall Study|Withdrawal by Subject|1
5889138|NCT01782222|20373710|P2|Overall Study|Withdrawal by Subject|4
5889139|NCT01782222|20373711|P1|Overall Study|Withdrawal by Subject|1
5889140|NCT01782222|20373709|P3|Overall Study|Protocol Violation|0
5889141|NCT01782222|20373710|P2|Overall Study|Protocol Violation|0
5889142|NCT01782222|20373711|P1|Overall Study|Protocol Violation|1
5889143|NCT01782222|20373709|P3|Overall Study|Lack of Efficacy|0
5889144|NCT01782222|20373710|P2|Overall Study|Lack of Efficacy|1
5889145|NCT01782222|20373711|P1|Overall Study|Lack of Efficacy|2
5889146|NCT01782222|20373709|P3|Overall Study|Adverse Event|3
5889147|NCT01782222|20373710|P2|Overall Study|Adverse Event|5
5889148|NCT01782222|20373711|P1|Overall Study|Adverse Event|4
5889149|NCT01782131|20373749|P2|Overall Study|Reason not provided|1
5889150|NCT01782131|20373750|P1|Overall Study|Reason not provided|0
5889151|NCT01782131|20373749|P2|Overall Study|Randomized but not treated|5
5889152|NCT01782131|20373750|P1|Overall Study|Randomized but not treated|5
5889153|NCT01782131|20373749|P2|Overall Study|Withdrawal by Subject|10
5889154|NCT01782131|20373750|P1|Overall Study|Withdrawal by Subject|10
5889155|NCT01782131|20373749|P2|Overall Study|Lost to Follow-up|3
5889156|NCT01782131|20373750|P1|Overall Study|Lost to Follow-up|1
5889157|NCT01782131|20373749|P2|Overall Study|Death|96
5889158|NCT01782131|20373750|P1|Overall Study|Death|93
5889159|NCT01781975|20373787|P2|Overall Study|Withdrawal by Subject|1
5889160|NCT01781975|20373788|P1|Overall Study|Withdrawal by Subject|1
5889161|NCT01781975|20373787|P2|Overall Study|Death|0
5889162|NCT01781975|20373788|P1|Overall Study|Death|1
5889163|NCT01781962|20373804|P1|Overall Study|Other Miscellaneous Reasons|5
5889164|NCT01781832|20373810|P1|Overall Study|Withdrawal by Subject|1
5889165|NCT01781637|20373830|P2|Overall Study|Withdrawal by Subject|0
5889166|NCT01781637|20373831|P1|Overall Study|Withdrawal by Subject|1
5889167|NCT01781637|20373830|P2|Overall Study|Lack of Efficacy|6
5889168|NCT01781637|20373831|P1|Overall Study|Lack of Efficacy|2
5889169|NCT01781637|20373830|P2|Overall Study|Adverse Event|0
5889170|NCT01781637|20373831|P1|Overall Study|Adverse Event|1
5889171|NCT01781611|20373841|P2|Overall Study|Adverse Event|0
5889172|NCT01781611|20373842|P1|Overall Study|Adverse Event|4
5889173|NCT01781572|20373863|P3|MEK162 45mg LEE011 600mg|Progressive Disease|0
5889174|NCT01781572|20373864|P2|MEK162 45mg LEE011 600mg|Progressive Disease|5
5889175|NCT01781572|20373865|P1|MEK162 45mg LEE011 600mg|Progressive Disease|0
5889176|NCT01781572|20373863|P3|MEK162 45mg LEE011 600mg|Adverse Event|0
5889177|NCT01781572|20373864|P2|MEK162 45mg LEE011 600mg|Adverse Event|1
5889178|NCT01781572|20373865|P1|MEK162 45mg LEE011 600mg|Adverse Event|0
5889179|NCT01781572|20373863|P3|MEK162 45mg LEE011 450mg|Progressive Disease|0
5889180|NCT01781572|20373864|P2|MEK162 45mg LEE011 450mg|Progressive Disease|6
5889181|NCT01781572|20373865|P1|MEK162 45mg LEE011 450mg|Progressive Disease|0
5889182|NCT01781572|20373863|P3|MEK162 45mg LEE011 450mg|Physician Decision|0
5889183|NCT01781572|20373864|P2|MEK162 45mg LEE011 450mg|Physician Decision|2
5889184|NCT01781572|20373865|P1|MEK162 45mg LEE011 450mg|Physician Decision|0
5889185|NCT01781572|20373863|P3|MEK162 45mg LEE011 450mg|Adverse Event|0
5889186|NCT01781572|20373864|P2|MEK162 45mg LEE011 450mg|Adverse Event|1
5889187|NCT01781572|20373865|P1|MEK162 45mg LEE011 450mg|Adverse Event|0
5889188|NCT01781572|20373863|P3|MEK162 30mg LEE011 200mg|Progressive Disease|0
5889189|NCT01781572|20373864|P2|MEK162 30mg LEE011 200mg|Progressive Disease|5
5889190|NCT01781572|20373865|P1|MEK162 30mg LEE011 200mg|Progressive Disease|0
5889191|NCT01781572|20373863|P3|MEK162 45mg BID+LEE011 300mg|Death|0
5889192|NCT01781572|20373864|P2|MEK162 45mg BID+LEE011 300mg|Death|0
5889193|NCT01781572|20373865|P1|MEK162 45mg BID+LEE011 300mg|Death|1
5889194|NCT01781572|20373863|P3|MEK162 45mg BID+LEE011 300mg|Progressive Disease|0
5889195|NCT01781572|20373864|P2|MEK162 45mg BID+LEE011 300mg|Progressive Disease|3
5889196|NCT01781572|20373865|P1|MEK162 45mg BID+LEE011 300mg|Progressive Disease|4
5889197|NCT01781572|20373863|P3|MEK162 45mg BID+LEE011 300mg|Adverse Event|0
5889198|NCT01781572|20373864|P2|MEK162 45mg BID+LEE011 300mg|Adverse Event|1
5889199|NCT01781572|20373865|P1|MEK162 45mg BID+LEE011 300mg|Adverse Event|1
5889200|NCT01781572|20373863|P3|MEK162 30mg BID+LEE011 300mg|Progressive Disease|0
5889201|NCT01781572|20373864|P2|MEK162 30mg BID+LEE011 300mg|Progressive Disease|2
5889202|NCT01781572|20373865|P1|MEK162 30mg BID+LEE011 300mg|Progressive Disease|3
5889203|NCT01781572|20373863|P3|MEK162 30mg BID+LEE011 300mg|Adverse Event|0
5889204|NCT01781572|20373864|P2|MEK162 30mg BID+LEE011 300mg|Adverse Event|0
5889205|NCT01781572|20373865|P1|MEK162 30mg BID+LEE011 300mg|Adverse Event|1
5889206|NCT01781572|20373863|P3|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|0
5889207|NCT01781572|20373864|P2|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|0
5889208|NCT01781572|20373865|P1|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|1
5889209|NCT01781572|20373863|P3|MEK162 45mg BID+LEE011 250mg|Progressive Disease|0
5889210|NCT01781572|20373864|P2|MEK162 45mg BID+LEE011 250mg|Progressive Disease|0
5889211|NCT01781572|20373865|P1|MEK162 45mg BID+LEE011 250mg|Progressive Disease|2
5889212|NCT01781572|20373863|P3|MEK162 45mg BID+LEE011 200mg|Death|1
5889213|NCT01781572|20373864|P2|MEK162 45mg BID+LEE011 200mg|Death|0
5889214|NCT01781572|20373865|P1|MEK162 45mg BID+LEE011 200mg|Death|0
5889215|NCT01781572|20373863|P3|MEK162 45mg BID+LEE011 200mg|Physician Decision|4
5889216|NCT01781572|20373864|P2|MEK162 45mg BID+LEE011 200mg|Physician Decision|0
5889217|NCT01781572|20373865|P1|MEK162 45mg BID+LEE011 200mg|Physician Decision|0
5889218|NCT01781572|20373863|P3|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|2
5889219|NCT01781572|20373864|P2|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|0
5889220|NCT01781572|20373865|P1|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|1
5889221|NCT01781572|20373863|P3|MEK162 45mg BID+LEE011 200mg|Progressive disease|23
5889222|NCT01781572|20373864|P2|MEK162 45mg BID+LEE011 200mg|Progressive disease|6
5889223|NCT01781572|20373865|P1|MEK162 45mg BID+LEE011 200mg|Progressive disease|8
5889224|NCT01781572|20373863|P3|MEK162 45mg BID+LEE011 200mg|Adverse Event|11
5889225|NCT01781572|20373864|P2|MEK162 45mg BID+LEE011 200mg|Adverse Event|0
5889226|NCT01781572|20373865|P1|MEK162 45mg BID+LEE011 200mg|Adverse Event|7
5889227|NCT01781429|20374206|P16|Overall Study|Enrolled, but not treated|0
5889228|NCT01781429|20374207|P15|Overall Study|Enrolled, but not treated|0
5889229|NCT01781429|20374208|P14|Overall Study|Enrolled, but not treated|0
5889230|NCT01781429|20374209|P13|Overall Study|Enrolled, but not treated|0
5889231|NCT01781429|20374210|P12|Overall Study|Enrolled, but not treated|0
5889232|NCT01781429|20374211|P11|Overall Study|Enrolled, but not treated|1
5889233|NCT01781429|20374212|P10|Overall Study|Enrolled, but not treated|0
5889234|NCT01781429|20374213|P9|Overall Study|Enrolled, but not treated|0
5889235|NCT01781429|20374214|P8|Overall Study|Enrolled, but not treated|0
5889236|NCT01781429|20374215|P7|Overall Study|Enrolled, but not treated|0
5889237|NCT01781429|20374216|P6|Overall Study|Enrolled, but not treated|0
5889238|NCT01781429|20374217|P5|Overall Study|Enrolled, but not treated|0
5889239|NCT01781429|20374218|P4|Overall Study|Enrolled, but not treated|0
5889240|NCT01781429|20374219|P3|Overall Study|Enrolled, but not treated|0
5889241|NCT01781429|20374220|P2|Overall Study|Enrolled, but not treated|0
5889242|NCT01781429|20374221|P1|Overall Study|Enrolled, but not treated|0
5889243|NCT01781429|20374206|P16|Overall Study|Other - as entered by PI in eCRF|0
5889244|NCT01781429|20374207|P15|Overall Study|Other - as entered by PI in eCRF|1
5889245|NCT01781429|20374208|P14|Overall Study|Other - as entered by PI in eCRF|1
5889246|NCT01781429|20374209|P13|Overall Study|Other - as entered by PI in eCRF|1
5889247|NCT01781429|20374210|P12|Overall Study|Other - as entered by PI in eCRF|2
5889248|NCT01781429|20374211|P11|Overall Study|Other - as entered by PI in eCRF|1
5889249|NCT01781429|20374212|P10|Overall Study|Other - as entered by PI in eCRF|1
5889250|NCT01781429|20374213|P9|Overall Study|Other - as entered by PI in eCRF|0
5889251|NCT01781429|20374214|P8|Overall Study|Other - as entered by PI in eCRF|0
5889252|NCT01781429|20374215|P7|Overall Study|Other - as entered by PI in eCRF|0
5889253|NCT01781429|20374216|P6|Overall Study|Other - as entered by PI in eCRF|0
5889254|NCT01781429|20374217|P5|Overall Study|Other - as entered by PI in eCRF|0
5889255|NCT01781429|20374218|P4|Overall Study|Other - as entered by PI in eCRF|0
5889256|NCT01781429|20374219|P3|Overall Study|Other - as entered by PI in eCRF|0
5889257|NCT01781429|20374220|P2|Overall Study|Other - as entered by PI in eCRF|1
5889258|NCT01781429|20374221|P1|Overall Study|Other - as entered by PI in eCRF|0
5889259|NCT01781429|20374206|P16|Overall Study|Patient Condition Changed|0
5889260|NCT01781429|20374207|P15|Overall Study|Patient Condition Changed|0
5889261|NCT01781429|20374208|P14|Overall Study|Patient Condition Changed|1
5889262|NCT01781429|20374209|P13|Overall Study|Patient Condition Changed|0
5889263|NCT01781429|20374210|P12|Overall Study|Patient Condition Changed|1
5889264|NCT01781429|20374211|P11|Overall Study|Patient Condition Changed|0
5889265|NCT01781429|20374212|P10|Overall Study|Patient Condition Changed|4
5889266|NCT01781429|20374213|P9|Overall Study|Patient Condition Changed|0
5889267|NCT01781429|20374214|P8|Overall Study|Patient Condition Changed|0
5889268|NCT01781429|20374215|P7|Overall Study|Patient Condition Changed|0
5889269|NCT01781429|20374216|P6|Overall Study|Patient Condition Changed|0
5889270|NCT01781429|20374217|P5|Overall Study|Patient Condition Changed|0
5889271|NCT01781429|20374218|P4|Overall Study|Patient Condition Changed|0
5889272|NCT01781429|20374219|P3|Overall Study|Patient Condition Changed|0
5889273|NCT01781429|20374220|P2|Overall Study|Patient Condition Changed|0
5889274|NCT01781429|20374221|P1|Overall Study|Patient Condition Changed|0
5889275|NCT01781429|20374206|P16|Overall Study|Unacceptable Toxicity|0
5889276|NCT01781429|20374207|P15|Overall Study|Unacceptable Toxicity|0
5889277|NCT01781429|20374208|P14|Overall Study|Unacceptable Toxicity|0
5889278|NCT01781429|20374209|P13|Overall Study|Unacceptable Toxicity|0
5889279|NCT01781429|20374210|P12|Overall Study|Unacceptable Toxicity|2
5889280|NCT01781429|20374211|P11|Overall Study|Unacceptable Toxicity|0
5889281|NCT01781429|20374212|P10|Overall Study|Unacceptable Toxicity|0
5889282|NCT01781429|20374213|P9|Overall Study|Unacceptable Toxicity|0
5889283|NCT01781429|20374214|P8|Overall Study|Unacceptable Toxicity|0
5889284|NCT01781429|20374215|P7|Overall Study|Unacceptable Toxicity|0
5889285|NCT01781429|20374216|P6|Overall Study|Unacceptable Toxicity|0
5889286|NCT01781429|20374217|P5|Overall Study|Unacceptable Toxicity|0
5889287|NCT01781429|20374218|P4|Overall Study|Unacceptable Toxicity|0
5889288|NCT01781429|20374219|P3|Overall Study|Unacceptable Toxicity|0
5889289|NCT01781429|20374220|P2|Overall Study|Unacceptable Toxicity|0
5889290|NCT01781429|20374221|P1|Overall Study|Unacceptable Toxicity|0
5889291|NCT01781429|20374206|P16|Overall Study|Disease Progression|0
5889292|NCT01781429|20374207|P15|Overall Study|Disease Progression|11
5889293|NCT01781429|20374208|P14|Overall Study|Disease Progression|4
5889294|NCT01781429|20374209|P13|Overall Study|Disease Progression|15
5889295|NCT01781429|20374210|P12|Overall Study|Disease Progression|15
5889296|NCT01781429|20374211|P11|Overall Study|Disease Progression|15
5889297|NCT01781429|20374212|P10|Overall Study|Disease Progression|15
5889298|NCT01781429|20374213|P9|Overall Study|Disease Progression|6
5889299|NCT01781429|20374214|P8|Overall Study|Disease Progression|4
5889300|NCT01781429|20374215|P7|Overall Study|Disease Progression|7
5889301|NCT01781429|20374216|P6|Overall Study|Disease Progression|4
5889302|NCT01781429|20374217|P5|Overall Study|Disease Progression|1
5889303|NCT01781429|20374218|P4|Overall Study|Disease Progression|1
5889304|NCT01781429|20374219|P3|Overall Study|Disease Progression|1
5889305|NCT01781429|20374220|P2|Overall Study|Disease Progression|0
5889306|NCT01781429|20374221|P1|Overall Study|Disease Progression|1
5889307|NCT01781429|20374206|P16|Overall Study|Withdrawal by Subject|0
5889308|NCT01781429|20374207|P15|Overall Study|Withdrawal by Subject|3
5889309|NCT01781429|20374208|P14|Overall Study|Withdrawal by Subject|2
5889310|NCT01781429|20374209|P13|Overall Study|Withdrawal by Subject|5
5889311|NCT01781429|20374210|P12|Overall Study|Withdrawal by Subject|1
5889312|NCT01781429|20374211|P11|Overall Study|Withdrawal by Subject|1
5889313|NCT01781429|20374212|P10|Overall Study|Withdrawal by Subject|3
5889314|NCT01781429|20374213|P9|Overall Study|Withdrawal by Subject|1
5889315|NCT01781429|20374214|P8|Overall Study|Withdrawal by Subject|0
5889316|NCT01781429|20374215|P7|Overall Study|Withdrawal by Subject|0
5889317|NCT01781429|20374216|P6|Overall Study|Withdrawal by Subject|0
5889318|NCT01781429|20374217|P5|Overall Study|Withdrawal by Subject|0
5889319|NCT01781429|20374218|P4|Overall Study|Withdrawal by Subject|0
5889320|NCT01781429|20374219|P3|Overall Study|Withdrawal by Subject|0
5889321|NCT01781429|20374220|P2|Overall Study|Withdrawal by Subject|0
5889322|NCT01781429|20374221|P1|Overall Study|Withdrawal by Subject|0
5889323|NCT01781429|20374206|P16|Overall Study|Death|0
5889324|NCT01781429|20374207|P15|Overall Study|Death|1
5889325|NCT01781429|20374208|P14|Overall Study|Death|0
5889326|NCT01781429|20374209|P13|Overall Study|Death|1
5889327|NCT01781429|20374210|P12|Overall Study|Death|0
5889328|NCT01781429|20374211|P11|Overall Study|Death|0
5889329|NCT01781429|20374212|P10|Overall Study|Death|1
5889330|NCT01781429|20374213|P9|Overall Study|Death|0
5889331|NCT01781429|20374214|P8|Overall Study|Death|0
5889332|NCT01781429|20374215|P7|Overall Study|Death|0
5889333|NCT01781429|20374216|P6|Overall Study|Death|0
5889334|NCT01781429|20374217|P5|Overall Study|Death|0
5889335|NCT01781429|20374218|P4|Overall Study|Death|0
5889336|NCT01781429|20374219|P3|Overall Study|Death|0
5889337|NCT01781429|20374220|P2|Overall Study|Death|0
5889338|NCT01781429|20374221|P1|Overall Study|Death|0
5889339|NCT01781299|20374298|P2|Overall Study|Withdrawal by Subject|1
5889340|NCT01781299|20374299|P1|Overall Study|Withdrawal by Subject|0
5889341|NCT01781286|20374307|P6|Overall Study|Noncompliance|0
5889342|NCT01781286|20374308|P5|Overall Study|Noncompliance|0
5889343|NCT01781286|20374309|P4|Overall Study|Noncompliance|1
5889344|NCT01781286|20374310|P3|Overall Study|Noncompliance|0
5889345|NCT01781286|20374311|P2|Overall Study|Noncompliance|0
5889346|NCT01781286|20374312|P1|Overall Study|Noncompliance|0
5889347|NCT01781286|20374307|P6|Overall Study|Time Constraints|0
5889348|NCT01781286|20374308|P5|Overall Study|Time Constraints|0
5889349|NCT01781286|20374309|P4|Overall Study|Time Constraints|0
5889350|NCT01781286|20374310|P3|Overall Study|Time Constraints|2
5889351|NCT01781286|20374311|P2|Overall Study|Time Constraints|0
5889352|NCT01781286|20374312|P1|Overall Study|Time Constraints|2
5889353|NCT01781286|20374307|P6|Overall Study|Lost to Follow-up|1
5889354|NCT01781286|20374308|P5|Overall Study|Lost to Follow-up|0
5889355|NCT01781286|20374309|P4|Overall Study|Lost to Follow-up|0
5889356|NCT01781286|20374310|P3|Overall Study|Lost to Follow-up|0
5889357|NCT01781286|20374311|P2|Overall Study|Lost to Follow-up|0
5889358|NCT01781286|20374312|P1|Overall Study|Lost to Follow-up|0
5889359|NCT01781234|20374337|P2|Overall Study|Withdrawal by Subject|3
5889360|NCT01781234|20374338|P1|Overall Study|Withdrawal by Subject|4
5889361|NCT01781234|20374337|P2|Overall Study|Protocol Violation|0
5889362|NCT01781234|20374338|P1|Overall Study|Protocol Violation|3
5889363|NCT01781234|20374337|P2|Overall Study|Adverse Event|0
5889364|NCT01781234|20374338|P1|Overall Study|Adverse Event|2
5889365|NCT01781026|20374376|P1|Overall Study|Lack of Efficacy|2
5889366|NCT01780987|20374382|P2|Overall Study|Not Receiving any Study Medication|1
5889367|NCT01780987|20374383|P1|Overall Study|Not Receiving any Study Medication|0
5889368|NCT01780987|20374382|P2|Overall Study|Changing Residence|0
5889369|NCT01780987|20374383|P1|Overall Study|Changing Residence|1
5889370|NCT01780987|20374382|P2|Overall Study|Request of Changing Hospital|1
5889371|NCT01780987|20374383|P1|Overall Study|Request of Changing Hospital|0
5889372|NCT01780987|20374382|P2|Overall Study|Withdrawal by Subject|0
5889373|NCT01780987|20374383|P1|Overall Study|Withdrawal by Subject|2
5889374|NCT01780987|20374382|P2|Overall Study|Adverse Event|4
5889375|NCT01780987|20374383|P1|Overall Study|Adverse Event|0
5889376|NCT01780974|20374401|P2|Overall Study|Adverse Event|3
5889377|NCT01780974|20374402|P1|Overall Study|Adverse Event|1
5889378|NCT01780974|20374401|P2|Overall Study|Death|0
5889379|NCT01780974|20374402|P1|Overall Study|Death|1
5889380|NCT01780935|20374412|P2|Overall Study|Patient withdrew consent|9
5889381|NCT01780935|20374413|P1|Overall Study|Patient withdrew consent|8
5889382|NCT01780935|20374412|P2|Overall Study|Protocol deviation|1
5889383|NCT01780935|20374413|P1|Overall Study|Protocol deviation|0
5889384|NCT01780935|20374412|P2|Overall Study|Physician Decision|1
5889385|NCT01780935|20374413|P1|Overall Study|Physician Decision|1
5889386|NCT01780935|20374412|P2|Overall Study|Lost to Follow-up|6
5889387|NCT01780935|20374413|P1|Overall Study|Lost to Follow-up|2
5889388|NCT01780935|20374412|P2|Overall Study|Death|6
5889389|NCT01780935|20374413|P1|Overall Study|Death|1
5889390|NCT01780935|20374412|P2|Overall Study|Adverse Event|4
5889391|NCT01780935|20374413|P1|Overall Study|Adverse Event|2
5889392|NCT01780935|20374412|P2|Overall Study|Admin problems due to early termination|309
5889393|NCT01780935|20374413|P1|Overall Study|Admin problems due to early termination|321
5889394|NCT01780831|20374518|P4|Overall Study|Lost to Follow-up|1
5889395|NCT01780831|20374519|P3|Overall Study|Lost to Follow-up|0
5889396|NCT01780831|20374520|P2|Overall Study|Lost to Follow-up|0
5889397|NCT01780831|20374521|P1|Overall Study|Lost to Follow-up|0
5889398|NCT01780831|20374518|P4|Overall Study|Withdrawal by Subject|0
5889399|NCT01780831|20374519|P3|Overall Study|Withdrawal by Subject|4
5889400|NCT01780831|20374520|P2|Overall Study|Withdrawal by Subject|0
5889401|NCT01780831|20374521|P1|Overall Study|Withdrawal by Subject|0
5889402|NCT01780662|20374589|P3|Overall Study|Ineligible|1
5889403|NCT01780662|20374590|P2|Overall Study|Ineligible|0
5889404|NCT01780662|20374591|P1|Overall Study|Ineligible|0
5889405|NCT01780662|20374589|P3|Overall Study|Protocol Violation|0
5889406|NCT01780662|20374590|P2|Overall Study|Protocol Violation|1
5889407|NCT01780662|20374591|P1|Overall Study|Protocol Violation|0
5889408|NCT01780662|20374589|P3|Overall Study|Physician Decision|7
5889409|NCT01780662|20374590|P2|Overall Study|Physician Decision|5
5889410|NCT01780662|20374591|P1|Overall Study|Physician Decision|0
5889411|NCT01780662|20374589|P3|Overall Study|Adverse Event|2
5889412|NCT01780662|20374590|P2|Overall Study|Adverse Event|0
5889413|NCT01780662|20374591|P1|Overall Study|Adverse Event|1
5889414|NCT01780584|20374608|P3|Overall Study|Protocol Violation|1
5889415|NCT01780584|20374609|P2|Overall Study|Protocol Violation|0
5889416|NCT01780584|20374610|P1|Overall Study|Protocol Violation|0
5889417|NCT01780584|20374608|P3|Overall Study|Adverse Event|0
5889418|NCT01780584|20374609|P2|Overall Study|Adverse Event|1
5889419|NCT01780584|20374610|P1|Overall Study|Adverse Event|0
5889420|NCT01780584|20374608|P3|Overall Study|Death|1
5889421|NCT01780584|20374609|P2|Overall Study|Death|0
5889422|NCT01780584|20374610|P1|Overall Study|Death|1
5889423|NCT01780545|20374632|P2|Overall Study|Lost to Follow-up|1
5889424|NCT01780545|20374633|P1|Overall Study|Lost to Follow-up|1
5889425|NCT01780545|20374632|P2|Overall Study|Withdrawal by Subject|1
5889426|NCT01780545|20374633|P1|Overall Study|Withdrawal by Subject|3
5889427|NCT01780506|20374651|P2|Open-Label Extension Phase|Enrolled but not Treated|1
5889428|NCT01780506|20374652|P1|Open-Label Extension Phase|Enrolled but not Treated|0
5889429|NCT01780506|20374651|P2|Double-Blind Phase|Lost to Follow-up|26
5889430|NCT01780506|20374652|P1|Double-Blind Phase|Lost to Follow-up|23
5889431|NCT01780506|20374651|P2|Double-Blind Phase|Withdrew Consent|24
5889432|NCT01780506|20374652|P1|Double-Blind Phase|Withdrew Consent|23
5889433|NCT01780506|20374651|P2|Double-Blind Phase|Protocol Violation|3
5889434|NCT01780506|20374652|P1|Double-Blind Phase|Protocol Violation|4
5889435|NCT01780506|20374651|P2|Double-Blind Phase|Non-Compliance with Study Drug|3
5889436|NCT01780506|20374652|P1|Double-Blind Phase|Non-Compliance with Study Drug|4
5889437|NCT01780506|20374651|P2|Double-Blind Phase|Investigator's Discretion|2
5889438|NCT01780506|20374652|P1|Double-Blind Phase|Investigator's Discretion|5
5889439|NCT01780506|20374651|P2|Double-Blind Phase|Lack of Efficacy|1
5889440|NCT01780506|20374652|P1|Double-Blind Phase|Lack of Efficacy|1
5889441|NCT01780506|20374651|P2|Double-Blind Phase|Pregnancy|1
5889442|NCT01780506|20374652|P1|Double-Blind Phase|Pregnancy|2
5889443|NCT01780506|20374651|P2|Double-Blind Phase|Death|2
5889444|NCT01780506|20374652|P1|Double-Blind Phase|Death|1
5889445|NCT01780506|20374651|P2|Double-Blind Phase|Adverse Event|14
5889446|NCT01780506|20374652|P1|Double-Blind Phase|Adverse Event|4
5889447|NCT01780506|20374651|P2|Double-Blind Phase|Randomized but not Treated|2
5889448|NCT01780506|20374652|P1|Double-Blind Phase|Randomized but not Treated|3
5889449|NCT01780389|20374710|P1|Overall Study|Adverse Event|1
5889450|NCT01779869|20374748|P1|Overall Study|Physician Decision|2
5889451|NCT01779700|20374754|P2|Overall Study|Withdrawal by Subject|2
5889452|NCT01779700|20374755|P1|Overall Study|Withdrawal by Subject|0
5889453|NCT01779700|20374754|P2|Overall Study|Adverse Event|3
5889454|NCT01779700|20374755|P1|Overall Study|Adverse Event|4
5889455|NCT01779648|20374795|P2|Overall Study|Protocol Violation|0
5889456|NCT01779648|20374796|P1|Overall Study|Protocol Violation|1
5889457|NCT01779440|20374826|P2|Overall Study|Withdrawal by Subject|5
5889458|NCT01779440|20374827|P1|Overall Study|Withdrawal by Subject|3
5889459|NCT01778985|20374892|P2|Overall Study|Protocol Violation|1
5889460|NCT01778985|20374893|P1|Overall Study|Protocol Violation|4
5889461|NCT01778985|20374892|P2|Overall Study|Physician Decision|2
5889462|NCT01778985|20374893|P1|Overall Study|Physician Decision|2
5889463|NCT01778985|20374892|P2|Overall Study|Lost to Follow-up|0
5889464|NCT01778985|20374893|P1|Overall Study|Lost to Follow-up|1
5889465|NCT01778855|20374939|P2|Overall Study|Death|1
5889466|NCT01778855|20374940|P1|Overall Study|Death|0
5889467|NCT01778751|20374948|P2|Overall Study|Transfered care|0
5889468|NCT01778751|20374949|P1|Overall Study|Transfered care|1
5889469|NCT01778751|20374948|P2|Overall Study|Withdrawal by Subject|2
5889470|NCT01778751|20374949|P1|Overall Study|Withdrawal by Subject|0
5889471|NCT01778751|20374948|P2|Overall Study|Lost to Follow-up|0
5889472|NCT01778751|20374949|P1|Overall Study|Lost to Follow-up|1
5889473|NCT01778556|20375006|P2|Long-term Follow-up|noncompliance with metreleptin|0
5889474|NCT01778556|20375007|P1|Long-term Follow-up|noncompliance with metreleptin|1
5889475|NCT01778556|20375006|P2|Intervention 2 (14 Days)|Protocol Violation|0
5889476|NCT01778556|20375007|P1|Intervention 2 (14 Days)|Protocol Violation|1
5889477|NCT01778556|20375006|P2|Intervention 1 (5 Days)|Withdrawal by Subject|1
5889478|NCT01778556|20375007|P1|Intervention 1 (5 Days)|Withdrawal by Subject|0
5889479|NCT01778556|20375006|P2|Intervention 1 (5 Days)|Protocol Violation|1
5889480|NCT01778556|20375007|P1|Intervention 1 (5 Days)|Protocol Violation|0
5889481|NCT01778530|20375020|P1|Overall Study|Adverse event/side effect|1
5889482|NCT01778530|20375020|P1|Overall Study|Progression on study|1
5889483|NCT01778127|20375062|P3|Overall Study|Withdrawal by Subject|4
5889484|NCT01778127|20375063|P2|Overall Study|Withdrawal by Subject|1
5889485|NCT01778127|20375064|P1|Overall Study|Withdrawal by Subject|3
5889486|NCT01778127|20375062|P3|Overall Study|Lost to Follow-up|2
5889487|NCT01778127|20375063|P2|Overall Study|Lost to Follow-up|1
5889488|NCT01778127|20375064|P1|Overall Study|Lost to Follow-up|5
5889489|NCT01778062|20375107|P2|Overall Study|major protocol deviation|3
5889490|NCT01778062|20375108|P1|Overall Study|major protocol deviation|4
5889491|NCT01778062|20375107|P2|Overall Study|Consent Withdrawal|5
5889492|NCT01778062|20375108|P1|Overall Study|Consent Withdrawal|1
5889493|NCT01778062|20375107|P2|Overall Study|Adverse Event|3
5889494|NCT01778062|20375108|P1|Overall Study|Adverse Event|1
5889495|NCT01778049|20375122|P6|Double Blind Treatment Period|Other reason not defined above|1
5889496|NCT01778049|20375123|P5|Double Blind Treatment Period|Other reason not defined above|2
5889497|NCT01778049|20375124|P4|Double Blind Treatment Period|Other reason not defined above|2
5889498|NCT01778049|20375125|P3|Double Blind Treatment Period|Other reason not defined above|4
5889499|NCT01778049|20375126|P2|Double Blind Treatment Period|Other reason not defined above|0
5889500|NCT01778049|20375127|P1|Double Blind Treatment Period|Other reason not defined above|0
5889501|NCT01778049|20375122|P6|Double Blind Treatment Period|Not treated|0
5889502|NCT01778049|20375123|P5|Double Blind Treatment Period|Not treated|2
5889503|NCT01778049|20375124|P4|Double Blind Treatment Period|Not treated|2
5889504|NCT01778049|20375125|P3|Double Blind Treatment Period|Not treated|0
5889505|NCT01778049|20375126|P2|Double Blind Treatment Period|Not treated|0
5889506|NCT01778049|20375127|P1|Double Blind Treatment Period|Not treated|0
5889507|NCT01778049|20375122|P6|Double Blind Treatment Period|Withdrawal by Subject|1
5889508|NCT01778049|20375123|P5|Double Blind Treatment Period|Withdrawal by Subject|0
5889509|NCT01778049|20375124|P4|Double Blind Treatment Period|Withdrawal by Subject|2
5889510|NCT01778049|20375125|P3|Double Blind Treatment Period|Withdrawal by Subject|1
5889511|NCT01778049|20375126|P2|Double Blind Treatment Period|Withdrawal by Subject|0
5889512|NCT01778049|20375127|P1|Double Blind Treatment Period|Withdrawal by Subject|0
5889513|NCT01778049|20375122|P6|Double Blind Treatment Period|Lost to Follow-up|2
5889514|NCT01778049|20375123|P5|Double Blind Treatment Period|Lost to Follow-up|5
5889515|NCT01778049|20375124|P4|Double Blind Treatment Period|Lost to Follow-up|1
5889516|NCT01778049|20375125|P3|Double Blind Treatment Period|Lost to Follow-up|4
5889517|NCT01778049|20375126|P2|Double Blind Treatment Period|Lost to Follow-up|0
5889518|NCT01778049|20375127|P1|Double Blind Treatment Period|Lost to Follow-up|0
5889519|NCT01778049|20375122|P6|Double Blind Treatment Period|Protocol Violation|0
5889520|NCT01778049|20375123|P5|Double Blind Treatment Period|Protocol Violation|0
5889521|NCT01778049|20375124|P4|Double Blind Treatment Period|Protocol Violation|0
5889522|NCT01778049|20375125|P3|Double Blind Treatment Period|Protocol Violation|2
5889523|NCT01778049|20375126|P2|Double Blind Treatment Period|Protocol Violation|0
5889524|NCT01778049|20375127|P1|Double Blind Treatment Period|Protocol Violation|0
5889525|NCT01778049|20375122|P6|Double Blind Treatment Period|Lack of Efficacy|1
5889526|NCT01778049|20375123|P5|Double Blind Treatment Period|Lack of Efficacy|0
5889527|NCT01778049|20375124|P4|Double Blind Treatment Period|Lack of Efficacy|0
5889528|NCT01778049|20375125|P3|Double Blind Treatment Period|Lack of Efficacy|0
5889529|NCT01778049|20375126|P2|Double Blind Treatment Period|Lack of Efficacy|0
5889530|NCT01778049|20375127|P1|Double Blind Treatment Period|Lack of Efficacy|0
5889531|NCT01778049|20375122|P6|Double Blind Treatment Period|Adverse Event|2
5889532|NCT01778049|20375123|P5|Double Blind Treatment Period|Adverse Event|3
5889533|NCT01778049|20375124|P4|Double Blind Treatment Period|Adverse Event|5
5889534|NCT01778049|20375125|P3|Double Blind Treatment Period|Adverse Event|4
5889535|NCT01778049|20375126|P2|Double Blind Treatment Period|Adverse Event|0
5889536|NCT01778049|20375127|P1|Double Blind Treatment Period|Adverse Event|0
5889537|NCT01778049|20375122|P6|Open Label Treatment Period|Other reason not defined above|0
5889538|NCT01778049|20375123|P5|Open Label Treatment Period|Other reason not defined above|0
5889539|NCT01778049|20375124|P4|Open Label Treatment Period|Other reason not defined above|0
5889540|NCT01778049|20375125|P3|Open Label Treatment Period|Other reason not defined above|0
5889541|NCT01778049|20375126|P2|Open Label Treatment Period|Other reason not defined above|94
5889542|NCT01778049|20375127|P1|Open Label Treatment Period|Other reason not defined above|77
5889543|NCT01778049|20375122|P6|Open Label Treatment Period|Not treated|0
5889544|NCT01778049|20375123|P5|Open Label Treatment Period|Not treated|0
5889545|NCT01778049|20375124|P4|Open Label Treatment Period|Not treated|0
5889546|NCT01778049|20375125|P3|Open Label Treatment Period|Not treated|0
5889547|NCT01778049|20375126|P2|Open Label Treatment Period|Not treated|1
5889548|NCT01778049|20375127|P1|Open Label Treatment Period|Not treated|2
5889549|NCT01778049|20375122|P6|Open Label Treatment Period|Withdrawal by Subject|0
5889550|NCT01778049|20375123|P5|Open Label Treatment Period|Withdrawal by Subject|0
5889551|NCT01778049|20375124|P4|Open Label Treatment Period|Withdrawal by Subject|0
5889552|NCT01778049|20375125|P3|Open Label Treatment Period|Withdrawal by Subject|0
5889553|NCT01778049|20375126|P2|Open Label Treatment Period|Withdrawal by Subject|10
5889554|NCT01778049|20375127|P1|Open Label Treatment Period|Withdrawal by Subject|4
5889555|NCT01778049|20375122|P6|Open Label Treatment Period|Lost to Follow-up|0
5889556|NCT01778049|20375123|P5|Open Label Treatment Period|Lost to Follow-up|0
5889557|NCT01778049|20375124|P4|Open Label Treatment Period|Lost to Follow-up|0
5889558|NCT01778049|20375125|P3|Open Label Treatment Period|Lost to Follow-up|0
5889559|NCT01778049|20375126|P2|Open Label Treatment Period|Lost to Follow-up|3
5889560|NCT01778049|20375127|P1|Open Label Treatment Period|Lost to Follow-up|4
5889561|NCT01778049|20375122|P6|Open Label Treatment Period|Protocol Violation|0
5889562|NCT01778049|20375123|P5|Open Label Treatment Period|Protocol Violation|0
5889563|NCT01778049|20375124|P4|Open Label Treatment Period|Protocol Violation|0
5889564|NCT01778049|20375125|P3|Open Label Treatment Period|Protocol Violation|0
5889565|NCT01778049|20375126|P2|Open Label Treatment Period|Protocol Violation|5
5889566|NCT01778049|20375127|P1|Open Label Treatment Period|Protocol Violation|5
5889567|NCT01778049|20375122|P6|Open Label Treatment Period|Lack of Efficacy|0
5889568|NCT01778049|20375123|P5|Open Label Treatment Period|Lack of Efficacy|0
5889569|NCT01778049|20375124|P4|Open Label Treatment Period|Lack of Efficacy|0
5889570|NCT01778049|20375125|P3|Open Label Treatment Period|Lack of Efficacy|0
5889571|NCT01778049|20375126|P2|Open Label Treatment Period|Lack of Efficacy|1
5889572|NCT01778049|20375127|P1|Open Label Treatment Period|Lack of Efficacy|1
5889573|NCT01778049|20375122|P6|Open Label Treatment Period|Adverse Event|0
5889574|NCT01778049|20375123|P5|Open Label Treatment Period|Adverse Event|0
5889575|NCT01778049|20375124|P4|Open Label Treatment Period|Adverse Event|0
5889576|NCT01778049|20375125|P3|Open Label Treatment Period|Adverse Event|0
5889577|NCT01778049|20375126|P2|Open Label Treatment Period|Adverse Event|15
5889578|NCT01778049|20375127|P1|Open Label Treatment Period|Adverse Event|5
5889579|NCT01778023|20375145|P2|Overall Study|Withdrawal by Subject|3
5889580|NCT01778023|20375146|P1|Overall Study|Withdrawal by Subject|0
5889581|NCT01778010|20375163|P1|Overall Study|rash while on placebo|1
5889582|NCT01778010|20375163|P1|Overall Study|Arrested|1
5889583|NCT01778010|20375163|P1|Overall Study|abnormal ECG before meds|1
5889584|NCT01778010|20375163|P1|Overall Study|Withdrawal by Subject|2
5889585|NCT01777997|20375204|P1|Weeks 48 to 72/96 on ART|Took prohibited/precautionary meds|1
5889586|NCT01777997|20375204|P1|Weeks 48 to 72/96 on ART|Death|1
5889587|NCT01777997|20375204|P1|Weeks 0 to 24/48 on ART|Participant felt treatment not working|1
5889588|NCT01777997|20375204|P1|12 Week lead-in of no ART|Severe debilitation|2
5889589|NCT01777932|20375226|P1|Overall Study|Patient refused further treatment|10
5889590|NCT01777932|20375226|P1|Overall Study|Reimbursement limit|9
5889591|NCT01777932|20375226|P1|Overall Study|Investigator decision|10
5889592|NCT01777932|20375226|P1|Overall Study|Lost to Follow-up|3
5889593|NCT01777932|20375226|P1|Overall Study|Adverse Event|34
5889594|NCT01777932|20375226|P1|Overall Study|Death|3
5889595|NCT01777932|20375226|P1|Overall Study|Disease progression|136
5889596|NCT01777854|20375240|P2|Overall Study|Physician Decision|3
5889597|NCT01777854|20375241|P1|Overall Study|Physician Decision|3
5889598|NCT01777776|20375249|P4|Overall Study|Withdrawal by Subject|1
5889599|NCT01777776|20375250|P3|Overall Study|Withdrawal by Subject|0
5889600|NCT01777776|20375251|P2|Overall Study|Withdrawal by Subject|0
5889601|NCT01777776|20375252|P1|Overall Study|Withdrawal by Subject|0
5889602|NCT01777776|20375249|P4|Overall Study|Disease Progression|3
5889603|NCT01777776|20375250|P3|Overall Study|Disease Progression|6
5889604|NCT01777776|20375251|P2|Overall Study|Disease Progression|8
5889605|NCT01777776|20375252|P1|Overall Study|Disease Progression|4
5889606|NCT01777776|20375249|P4|Overall Study|Adverse Event|0
5889607|NCT01777776|20375250|P3|Overall Study|Adverse Event|0
5889608|NCT01777776|20375251|P2|Overall Study|Adverse Event|4
5889609|NCT01777776|20375252|P1|Overall Study|Adverse Event|2
5889610|NCT01777763|20375311|P2|Overall Study|Treatment Failure|6
5889611|NCT01777763|20375312|P1|Overall Study|Treatment Failure|1
5889612|NCT01777763|20375311|P2|Overall Study|Withdrawal by Subject|2
5889613|NCT01777763|20375312|P1|Overall Study|Withdrawal by Subject|0
5889614|NCT01777763|20375311|P2|Overall Study|Protocol Violation|7
5889615|NCT01777763|20375312|P1|Overall Study|Protocol Violation|1
5889616|NCT01777763|20375311|P2|Overall Study|Adverse Event|32
5889617|NCT01777763|20375312|P1|Overall Study|Adverse Event|2
5889618|NCT01777620|20375336|P2|Overall Study|Subject Withdrawal|0
5889619|NCT01777620|20375337|P1|Overall Study|Subject Withdrawal|1
5889620|NCT01777581|20375363|P2|Overall Study|Lack of Efficacy|1
5889621|NCT01777581|20375364|P1|Overall Study|Lack of Efficacy|0
5889622|NCT01777581|20375363|P2|Overall Study|Adverse Event|0
5889623|NCT01777581|20375364|P1|Overall Study|Adverse Event|2
5889624|NCT01777581|20375363|P2|Overall Study|Lost to Follow-up|1
5889625|NCT01777581|20375364|P1|Overall Study|Lost to Follow-up|1
5889626|NCT01777542|20375393|P2|Second Intervention (20 Weeks)|Adverse Event|1
5889627|NCT01777542|20375394|P1|Second Intervention (20 Weeks)|Adverse Event|0
5889628|NCT01777490|20375437|P4|Overall Study|Dyad withdrew with data use prohibition|1
5889629|NCT01777490|20375438|P3|Overall Study|Dyad withdrew with data use prohibition|1
5889630|NCT01777490|20375439|P2|Overall Study|Dyad withdrew with data use prohibition|0
5889631|NCT01777490|20375440|P1|Overall Study|Dyad withdrew with data use prohibition|0
5889632|NCT01777334|20375485|P2|Overall Study|Withdrawal by Subject|11
5889633|NCT01777334|20375486|P1|Overall Study|Withdrawal by Subject|14
5889634|NCT01777334|20375485|P2|Overall Study|Lost to Follow-up|2
5889635|NCT01777334|20375486|P1|Overall Study|Lost to Follow-up|3
5889636|NCT01777334|20375485|P2|Overall Study|Protocol Violation|7
5889637|NCT01777334|20375486|P1|Overall Study|Protocol Violation|3
5889638|NCT01777334|20375485|P2|Overall Study|Lack of Efficacy|29
5889639|NCT01777334|20375486|P1|Overall Study|Lack of Efficacy|15
5889640|NCT01777334|20375485|P2|Overall Study|Adverse Event|14
5889641|NCT01777334|20375486|P1|Overall Study|Adverse Event|18
5889642|NCT01777321|20375496|P2|Overall Study|Withdrawal by Subject|1
5889643|NCT01777321|20375497|P1|Overall Study|Withdrawal by Subject|0
5889644|NCT01777308|20375535|P2|Overall Study|Blood draw refusal at Visit 3|0
5889645|NCT01777308|20375536|P1|Overall Study|Blood draw refusal at Visit 3|1
5889646|NCT01777308|20375535|P2|Overall Study|Lost to Follow-up|2
5889647|NCT01777308|20375536|P1|Overall Study|Lost to Follow-up|7
5889648|NCT01777308|20375535|P2|Overall Study|Migrated/moved from study area|0
5889649|NCT01777308|20375536|P1|Overall Study|Migrated/moved from study area|1
5889650|NCT01777308|20375535|P2|Overall Study|Withdrawal by Subject|1
5889651|NCT01777308|20375536|P1|Overall Study|Withdrawal by Subject|5
5889652|NCT01777295|20375568|P2|Overall Study|Investigator call for AEs check|0
5889653|NCT01777295|20375569|P1|Overall Study|Investigator call for AEs check|1
5889654|NCT01777295|20375568|P2|Overall Study|Personal problem|0
5889655|NCT01777295|20375569|P1|Overall Study|Personal problem|1
5889656|NCT01777295|20375568|P2|Overall Study|Pregnancy|1
5889657|NCT01777295|20375569|P1|Overall Study|Pregnancy|0
5889658|NCT01777295|20375568|P2|Overall Study|Withdrawal by Subject|2
5889659|NCT01777295|20375569|P1|Overall Study|Withdrawal by Subject|2
5889660|NCT01777282|20375776|P5|Overall Study|Moved, transfer abroad, did not enter FU|0
5889661|NCT01777282|20375777|P4|Overall Study|Moved, transfer abroad, did not enter FU|0
5889662|NCT01777282|20375778|P3|Overall Study|Moved, transfer abroad, did not enter FU|1
5889663|NCT01777282|20375779|P2|Overall Study|Moved, transfer abroad, did not enter FU|0
5889664|NCT01777282|20375780|P1|Overall Study|Moved, transfer abroad, did not enter FU|1
5889665|NCT01777282|20375776|P5|Overall Study|Protocol Violation|2
5889666|NCT01777282|20375777|P4|Overall Study|Protocol Violation|0
5889667|NCT01777282|20375778|P3|Overall Study|Protocol Violation|1
5889668|NCT01777282|20375779|P2|Overall Study|Protocol Violation|0
5889669|NCT01777282|20375780|P1|Overall Study|Protocol Violation|2
5889670|NCT01777282|20375776|P5|Overall Study|Withdrawal by Subject|2
5889671|NCT01777282|20375777|P4|Overall Study|Withdrawal by Subject|1
5889672|NCT01777282|20375778|P3|Overall Study|Withdrawal by Subject|0
5889673|NCT01777282|20375779|P2|Overall Study|Withdrawal by Subject|0
5889674|NCT01777282|20375780|P1|Overall Study|Withdrawal by Subject|4
5889675|NCT01777282|20375776|P5|Overall Study|Adverse Event|3
5889676|NCT01777282|20375777|P4|Overall Study|Adverse Event|1
5889677|NCT01777282|20375778|P3|Overall Study|Adverse Event|2
5889678|NCT01777282|20375779|P2|Overall Study|Adverse Event|4
5889679|NCT01777282|20375780|P1|Overall Study|Adverse Event|4
5889680|NCT01777282|20375776|P5|Overall Study|New Antidiabetic Medication|0
5889681|NCT01777282|20375777|P4|Overall Study|New Antidiabetic Medication|0
5889682|NCT01777282|20375778|P3|Overall Study|New Antidiabetic Medication|1
5889683|NCT01777282|20375779|P2|Overall Study|New Antidiabetic Medication|0
5889684|NCT01777282|20375780|P1|Overall Study|New Antidiabetic Medication|0
5889685|NCT01777282|20375776|P5|Overall Study|Persistent Hyperglycemia|0
5889686|NCT01777282|20375777|P4|Overall Study|Persistent Hyperglycemia|0
5889687|NCT01777282|20375778|P3|Overall Study|Persistent Hyperglycemia|1
5889688|NCT01777282|20375779|P2|Overall Study|Persistent Hyperglycemia|0
5889689|NCT01777282|20375780|P1|Overall Study|Persistent Hyperglycemia|0
5889690|NCT01777269|20375824|P2|Overall Study|Withdrawal by Subject|9
5889691|NCT01777269|20375825|P1|Overall Study|Withdrawal by Subject|9
5889692|NCT01777269|20375824|P2|Overall Study|Physician Decision|2
5889693|NCT01777269|20375825|P1|Overall Study|Physician Decision|5
5889694|NCT01777269|20375824|P2|Overall Study|Lost to Follow-up|0
5889695|NCT01777269|20375825|P1|Overall Study|Lost to Follow-up|4
5889696|NCT01777269|20375824|P2|Overall Study|Participants reached stopping criteria|1
5889697|NCT01777269|20375825|P1|Overall Study|Participants reached stopping criteria|1
5889698|NCT01777269|20375824|P2|Overall Study|Protocol Violation|4
5889699|NCT01777269|20375825|P1|Overall Study|Protocol Violation|4
5889700|NCT01777269|20375824|P2|Overall Study|Lack of Efficacy|10
5889701|NCT01777269|20375825|P1|Overall Study|Lack of Efficacy|8
5889702|NCT01777269|20375824|P2|Overall Study|Adverse Event|33
5889703|NCT01777269|20375825|P1|Overall Study|Adverse Event|24
5889704|NCT01777191|20375862|P2|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|3
5889705|NCT01777191|20375863|P1|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|1
5889706|NCT01777191|20375862|P2|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|2
5889707|NCT01777191|20375863|P1|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|1
5889708|NCT01777191|20375862|P2|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4
5889709|NCT01777191|20375863|P1|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4
5889710|NCT01777191|20375862|P2|Safety Extension Per (Week 12-Week 48)|Death|1
5889711|NCT01777191|20375863|P1|Safety Extension Per (Week 12-Week 48)|Death|0
5889712|NCT01777191|20375862|P2|Safety Extension Per (Week 12-Week 48)|Adverse Event|3
5889713|NCT01777191|20375863|P1|Safety Extension Per (Week 12-Week 48)|Adverse Event|3
5889714|NCT01777191|20375862|P2|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|0
5889715|NCT01777191|20375863|P1|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|1
5889716|NCT01777191|20375862|P2|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1
5889717|NCT01777191|20375863|P1|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1
5889718|NCT01777191|20375862|P2|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|3
5889719|NCT01777191|20375863|P1|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|0
5889720|NCT01777191|20375862|P2|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|2
5889721|NCT01777191|20375863|P1|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|1
5889722|NCT01777191|20375862|P2|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1
5889723|NCT01777191|20375863|P1|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1
5889724|NCT01777191|20375862|P2|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|1
5889725|NCT01777191|20375863|P1|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|2
5889726|NCT01777152|20375893|P2|Overall Study|Change of diagnosis|0
5889727|NCT01777152|20375894|P1|Overall Study|Change of diagnosis|1
5889728|NCT01777152|20375893|P2|Overall Study|Not eligible, no study drug received|0
5889729|NCT01777152|20375894|P1|Overall Study|Not eligible, no study drug received|1
5889730|NCT01777152|20375893|P2|Overall Study|Death|73
5889731|NCT01777152|20375894|P1|Overall Study|Death|51
5889732|NCT01777152|20375893|P2|Overall Study|Lost to Follow-up|4
5889733|NCT01777152|20375894|P1|Overall Study|Lost to Follow-up|0
5889734|NCT01777152|20375893|P2|Overall Study|Withdrawal by Subject|10
5889735|NCT01777152|20375894|P1|Overall Study|Withdrawal by Subject|16
5889736|NCT01777152|20375893|P2|Overall Study|In Follow Up|139
5889737|NCT01777152|20375894|P1|Overall Study|In Follow Up|157
5889738|NCT01777139|20375910|P2|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|3
5889739|NCT01777139|20375911|P1|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|0
5889740|NCT01777139|20375910|P2|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|1
5889741|NCT01777139|20375911|P1|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|0
5889742|NCT01777139|20375910|P2|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|0
5889743|NCT01777139|20375911|P1|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|4
5889744|NCT01777139|20375910|P2|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|0
5889745|NCT01777139|20375911|P1|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|2
5889746|NCT01777139|20375910|P2|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|0
5889747|NCT01777139|20375911|P1|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|3
5889748|NCT01777139|20375910|P2|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|0
5889749|NCT01777139|20375911|P1|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|8
5889750|NCT01777139|20375910|P2|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|0
5889751|NCT01777139|20375911|P1|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|6
5889752|NCT01777139|20375910|P2|Primary Reporting Phase (Up to 4 Years)|Adverse Event|0
5889753|NCT01777139|20375911|P1|Primary Reporting Phase (Up to 4 Years)|Adverse Event|7
5889754|NCT01776554|20376025|P2|Overall Study|Unclassified|1
5889755|NCT01776554|20376026|P1|Overall Study|Unclassified|4
5889756|NCT01776554|20376025|P2|Overall Study|Protocol Violation|0
5889757|NCT01776554|20376026|P1|Overall Study|Protocol Violation|1
5889758|NCT01776554|20376025|P2|Overall Study|Administrative Reason|5
5889759|NCT01776554|20376026|P1|Overall Study|Administrative Reason|2
5889760|NCT01776554|20376025|P2|Overall Study|Lost to Follow-up|9
5889761|NCT01776554|20376026|P1|Overall Study|Lost to Follow-up|6
5889762|NCT01776554|20376025|P2|Overall Study|Withdrawal by Subject|8
5889763|NCT01776554|20376026|P1|Overall Study|Withdrawal by Subject|3
5889764|NCT01776554|20376025|P2|Overall Study|Adverse Event|0
5889765|NCT01776554|20376026|P1|Overall Study|Adverse Event|1
5889766|NCT01776541|20376069|P2|Overall Study|Withdrawal by Subject|20
5889767|NCT01776541|20376070|P1|Overall Study|Withdrawal by Subject|12
5889768|NCT01776541|20376069|P2|Overall Study|Protocol Violation|1
5889769|NCT01776541|20376070|P1|Overall Study|Protocol Violation|2
5889770|NCT01776541|20376069|P2|Overall Study|Unclassified|4
5889771|NCT01776541|20376070|P1|Overall Study|Unclassified|5
5889772|NCT01776541|20376069|P2|Overall Study|Lost to Follow-up|48
5889773|NCT01776541|20376070|P1|Overall Study|Lost to Follow-up|27
5889774|NCT01776541|20376069|P2|Overall Study|Death|0
5889775|NCT01776541|20376070|P1|Overall Study|Death|4
5889776|NCT01776541|20376069|P2|Overall Study|Administrative Reason|2
5889777|NCT01776541|20376070|P1|Overall Study|Administrative Reason|6
5889784|NCT01776008|20376125|P1|Overall Study|ineligible|2
5889785|NCT01775995|20376139|P2|Overall Study|Lost to Follow-up|1
5889786|NCT01775995|20376140|P1|Overall Study|Lost to Follow-up|1
5889787|NCT01775930|20376200|P1|Overall Study|Futility stopping boundary met|1
5889788|NCT01775904|20376208|P1|LY2886721 ODT (Water, Fasting)|Adverse Event|1
5889789|NCT01775904|20376208|P1|LY2886721 Capsule (Water, Fasting)|Adverse Event|1
5889790|NCT01775787|20376274|P2|Second 7-10 Days|concerns with using IV|1
5889791|NCT01775787|20376275|P1|Second 7-10 Days|concerns with using IV|0
5889792|NCT01775787|20376274|P2|Second 7-10 Days|time commitment|1
5889793|NCT01775787|20376275|P1|Second 7-10 Days|time commitment|0
5889794|NCT01775787|20376274|P2|First 7-10 Days|concerns with using IV|2
5889795|NCT01775787|20376275|P1|First 7-10 Days|concerns with using IV|1
5889796|NCT01775787|20376274|P2|First 7-10 Days|time commitment|2
5889797|NCT01775787|20376275|P1|First 7-10 Days|time commitment|0
5889798|NCT01775787|20376274|P2|First 7-10 Days|family emergency|1
5889799|NCT01775787|20376275|P1|First 7-10 Days|family emergency|0
5889800|NCT01775787|20376274|P2|First 7-10 Days|Adverse Event|1
5889801|NCT01775787|20376275|P1|First 7-10 Days|Adverse Event|0
5889802|NCT01775670|20376331|P2|Overall Study|Lost to Follow-up|1
5889803|NCT01775670|20376332|P1|Overall Study|Lost to Follow-up|1
5889804|NCT01775553|20376358|P1|Overall Study|Disease Progression|12
5889805|NCT01775553|20376358|P1|Overall Study|Adverse Event|1
5889806|NCT01775501|20376366|P1|Overall Study|Discontinued prior to treatment|1
5889807|NCT01775189|20376390|P7|Treatment Phase: Washout Period 3|Protocol Violation|1
5889808|NCT01775189|20376391|P6|Treatment Phase: Washout Period 3|Protocol Violation|0
5889809|NCT01775189|20376392|P5|Treatment Phase: Washout Period 3|Protocol Violation|0
5889810|NCT01775189|20376393|P4|Treatment Phase: Washout Period 3|Protocol Violation|1
5889811|NCT01775189|20376394|P3|Treatment Phase: Washout Period 3|Protocol Violation|0
5889812|NCT01775189|20376395|P2|Treatment Phase: Washout Period 3|Protocol Violation|0
5889813|NCT01775189|20376396|P1|Treatment Phase: Washout Period 3|Protocol Violation|0
5889814|NCT01775189|20376390|P7|Treatment Phase: Washout Period 2|Protocol Violation|0
5889815|NCT01775189|20376391|P6|Treatment Phase: Washout Period 2|Protocol Violation|0
5889816|NCT01775189|20376392|P5|Treatment Phase: Washout Period 2|Protocol Violation|0
5889817|NCT01775189|20376393|P4|Treatment Phase: Washout Period 2|Protocol Violation|1
5889818|NCT01775189|20376394|P3|Treatment Phase: Washout Period 2|Protocol Violation|0
5889819|NCT01775189|20376395|P2|Treatment Phase: Washout Period 2|Protocol Violation|0
5889820|NCT01775189|20376396|P1|Treatment Phase: Washout Period 2|Protocol Violation|0
5889821|NCT01775189|20376390|P7|Treatment Phase: Washout Period 1|Protocol Violation|0
5889822|NCT01775189|20376391|P6|Treatment Phase: Washout Period 1|Protocol Violation|1
5889823|NCT01775189|20376392|P5|Treatment Phase: Washout Period 1|Protocol Violation|0
5889824|NCT01775189|20376393|P4|Treatment Phase: Washout Period 1|Protocol Violation|0
5889825|NCT01775189|20376394|P3|Treatment Phase: Washout Period 1|Protocol Violation|0
5889826|NCT01775189|20376395|P2|Treatment Phase: Washout Period 1|Protocol Violation|0
5889827|NCT01775189|20376396|P1|Treatment Phase: Washout Period 1|Protocol Violation|0
5889828|NCT01775189|20376390|P7|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0
5889829|NCT01775189|20376391|P6|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0
5889830|NCT01775189|20376392|P5|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0
5889831|NCT01775189|20376393|P4|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0
5889832|NCT01775189|20376394|P3|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|7
5889833|NCT01775189|20376395|P2|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|2
5889834|NCT01775189|20376396|P1|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0
5889835|NCT01775189|20376390|P7|Drug Discrimination Phase: Day 2|Protocol Violation|0
5889836|NCT01775189|20376391|P6|Drug Discrimination Phase: Day 2|Protocol Violation|0
5889837|NCT01775189|20376392|P5|Drug Discrimination Phase: Day 2|Protocol Violation|0
5889838|NCT01775189|20376393|P4|Drug Discrimination Phase: Day 2|Protocol Violation|0
5889839|NCT01775189|20376394|P3|Drug Discrimination Phase: Day 2|Protocol Violation|0
5889840|NCT01775189|20376395|P2|Drug Discrimination Phase: Day 2|Protocol Violation|1
5889841|NCT01775189|20376396|P1|Drug Discrimination Phase: Day 2|Protocol Violation|0
5889842|NCT01775189|20376390|P7|Drug Discrimination Phase: Day 1|Adverse Event|0
5889843|NCT01775189|20376391|P6|Drug Discrimination Phase: Day 1|Adverse Event|0
5889844|NCT01775189|20376392|P5|Drug Discrimination Phase: Day 1|Adverse Event|0
5889845|NCT01775189|20376393|P4|Drug Discrimination Phase: Day 1|Adverse Event|0
5889846|NCT01775189|20376394|P3|Drug Discrimination Phase: Day 1|Adverse Event|0
5889847|NCT01775189|20376395|P2|Drug Discrimination Phase: Day 1|Adverse Event|3
5889848|NCT01775189|20376396|P1|Drug Discrimination Phase: Day 1|Adverse Event|0
5889849|NCT01775137|20376615|P1|Overall Study|Withdrawal by participants|5
5889850|NCT01775137|20376615|P1|Overall Study|Adverse Event|1
5889851|NCT01775137|20376615|P1|Overall Study|Unsatisfactory therapeutic effect|2
5889852|NCT01775137|20376615|P1|Overall Study|Protocol deviation|2
5889853|NCT01775137|20376615|P1|Overall Study|Death|1
5889854|NCT01775124|20376642|P2|Extension Period|Withdrawal by Subject|12
5889855|NCT01775124|20376643|P1|Extension Period|Withdrawal by Subject|9
5889856|NCT01775124|20376642|P2|Extension Period|Lost to Follow-up|1
5889857|NCT01775124|20376643|P1|Extension Period|Lost to Follow-up|0
5889858|NCT01775124|20376642|P2|Extension Period|Administrative problems|1
5889859|NCT01775124|20376643|P1|Extension Period|Administrative problems|0
5889860|NCT01775124|20376642|P2|Extension Period|Physician Decision|2
5889861|NCT01775124|20376643|P1|Extension Period|Physician Decision|0
5889862|NCT01775124|20376642|P2|Extension Period|Adverse Event|2
5889863|NCT01775124|20376643|P1|Extension Period|Adverse Event|3
5889864|NCT01775124|20376642|P2|Core Period|Adverse Event|5
5889865|NCT01775124|20376643|P1|Core Period|Adverse Event|5
5889866|NCT01775124|20376642|P2|Core Period|Withdrawal by Subject|2
5889867|NCT01775124|20376643|P1|Core Period|Withdrawal by Subject|4
5889868|NCT01775124|20376642|P2|Core Period|Administrative problems|0
5889869|NCT01775124|20376643|P1|Core Period|Administrative problems|1
5889870|NCT01775124|20376642|P2|Core Period|Death|1
5889871|NCT01775124|20376643|P1|Core Period|Death|0
5889872|NCT01775124|20376642|P2|Core Period|Physician Decision|1
5889873|NCT01775124|20376643|P1|Core Period|Physician Decision|1
5889874|NCT01775124|20376642|P2|Core Period|Disease Progression|1
5889875|NCT01775124|20376643|P1|Core Period|Disease Progression|0
5889876|NCT01774981|20376678|P8|Overall Study|Death|0
5889877|NCT01774981|20376679|P7|Overall Study|Death|0
5889878|NCT01774981|20376680|P6|Overall Study|Death|0
5889879|NCT01774981|20376681|P5|Overall Study|Death|1
5889880|NCT01774981|20376682|P4|Overall Study|Death|0
5889881|NCT01774981|20376683|P3|Overall Study|Death|0
5889882|NCT01774981|20376684|P2|Overall Study|Death|0
5889883|NCT01774981|20376685|P1|Overall Study|Death|0
5889884|NCT01774981|20376678|P8|Overall Study|Withdrawal by Subject|1
5889885|NCT01774981|20376679|P7|Overall Study|Withdrawal by Subject|0
5889886|NCT01774981|20376680|P6|Overall Study|Withdrawal by Subject|0
5889887|NCT01774981|20376681|P5|Overall Study|Withdrawal by Subject|0
5889888|NCT01774981|20376682|P4|Overall Study|Withdrawal by Subject|0
5889889|NCT01774981|20376683|P3|Overall Study|Withdrawal by Subject|0
5889890|NCT01774981|20376684|P2|Overall Study|Withdrawal by Subject|0
5889891|NCT01774981|20376685|P1|Overall Study|Withdrawal by Subject|0
5889892|NCT01774981|20376678|P8|Overall Study|Adverse Event|0
5889893|NCT01774981|20376679|P7|Overall Study|Adverse Event|0
5889894|NCT01774981|20376680|P6|Overall Study|Adverse Event|1
5889895|NCT01774981|20376681|P5|Overall Study|Adverse Event|0
5889896|NCT01774981|20376682|P4|Overall Study|Adverse Event|0
5889897|NCT01774981|20376683|P3|Overall Study|Adverse Event|0
5889898|NCT01774981|20376684|P2|Overall Study|Adverse Event|0
5889899|NCT01774981|20376685|P1|Overall Study|Adverse Event|0
5889900|NCT01774968|20376717|P2|Overall Study|Withdrawal by Subject|11
5889901|NCT01774968|20376718|P1|Overall Study|Withdrawal by Subject|6
5889902|NCT01774968|20376717|P2|Overall Study|Sponsor Decision|2
5889903|NCT01774968|20376718|P1|Overall Study|Sponsor Decision|0
5889904|NCT01774968|20376717|P2|Overall Study|Protocol Violation|13
5889905|NCT01774968|20376718|P1|Overall Study|Protocol Violation|14
5889906|NCT01774968|20376717|P2|Overall Study|Physician Decision|1
5889907|NCT01774968|20376718|P1|Overall Study|Physician Decision|5
5889908|NCT01774968|20376717|P2|Overall Study|Lost to Follow-up|3
5889909|NCT01774968|20376718|P1|Overall Study|Lost to Follow-up|1
5889910|NCT01774968|20376717|P2|Overall Study|Death|1
5889911|NCT01774968|20376718|P1|Overall Study|Death|0
5889912|NCT01774968|20376717|P2|Overall Study|Adverse Event|4
5889913|NCT01774968|20376718|P1|Overall Study|Adverse Event|4
5889914|NCT01774929|20376752|P1|Overall Study|Adverse Event|3
5889915|NCT01774903|20376758|P1|Overall Study|Ineligible to continue the trial|1
5889916|NCT01774903|20376758|P1|Overall Study|Lack of Efficacy|1
5889917|NCT01774903|20376758|P1|Overall Study|Withdrawal by Subject|2
5889918|NCT01774903|20376758|P1|Overall Study|Adverse Event|7
5889919|NCT01774799|20376778|P4|Overall Study|Lost to Follow-up|0
5889920|NCT01774799|20376779|P3|Overall Study|Lost to Follow-up|0
5889921|NCT01774799|20376780|P2|Overall Study|Lost to Follow-up|1
5889922|NCT01774799|20376781|P1|Overall Study|Lost to Follow-up|1
5889923|NCT01774786|20376797|P2|Overall Study|Reason Not Specified|5
5889924|NCT01774786|20376798|P1|Overall Study|Reason Not Specified|2
5889925|NCT01774786|20376797|P2|Overall Study|Non-compliance|1
5889926|NCT01774786|20376798|P1|Overall Study|Non-compliance|0
5889927|NCT01774786|20376797|P2|Overall Study|Physician Decision|0
5889928|NCT01774786|20376798|P1|Overall Study|Physician Decision|2
5889929|NCT01774786|20376797|P2|Overall Study|Withdrawal by Subject|14
5889930|NCT01774786|20376798|P1|Overall Study|Withdrawal by Subject|18
5889931|NCT01774786|20376797|P2|Overall Study|Lost to Follow-up|7
5889932|NCT01774786|20376798|P1|Overall Study|Lost to Follow-up|6
5889933|NCT01774786|20376797|P2|Overall Study|Death|319
5889934|NCT01774786|20376798|P1|Overall Study|Death|300
5889935|NCT01774721|20376834|P2|Overall Study|Ongoing in study|120
5889936|NCT01774721|20376835|P1|Overall Study|Ongoing in study|136
5889937|NCT01774721|20376834|P2|Overall Study|Did not meet eligibility criteria|3
5889938|NCT01774721|20376835|P1|Overall Study|Did not meet eligibility criteria|0
5889939|NCT01774721|20376834|P2|Overall Study|Lost to Follow-up|1
5889940|NCT01774721|20376835|P1|Overall Study|Lost to Follow-up|1
5889941|NCT01774721|20376834|P2|Overall Study|Withdrawal by Subject|10
5889942|NCT01774721|20376835|P1|Overall Study|Withdrawal by Subject|14
5889943|NCT01774721|20376834|P2|Overall Study|Death|91
5889944|NCT01774721|20376835|P1|Overall Study|Death|76
5889945|NCT01774591|20376900|P2|Overall Study|Adverse Event|2
5889946|NCT01774591|20376901|P1|Overall Study|Adverse Event|0
5889947|NCT01774591|20376900|P2|Overall Study|Withdrawal by Subject|1
5889948|NCT01774591|20376901|P1|Overall Study|Withdrawal by Subject|0
5889949|NCT01774591|20376900|P2|Overall Study|Physician Decision|1
5889950|NCT01774591|20376901|P1|Overall Study|Physician Decision|1
5889951|NCT01774370|20376911|P1|Overall Study|Follow-up failure|34
5889952|NCT01774370|20376911|P1|Overall Study|Violated inclusion/exclusion criteria|53
5889953|NCT01774370|20376911|P1|Overall Study|Subjects of contraindications|34
5889954|NCT01774370|20376911|P1|Overall Study|Administered prior to the contract date|4
5889955|NCT01774370|20376911|P1|Overall Study|Never taken the PRADAXA during the study|4
5889956|NCT01774344|20376919|P2|Overall Study|Did not enter Survival Follow up|83
5889957|NCT01774344|20376920|P1|Overall Study|Did not enter Survival Follow up|49
5889958|NCT01774344|20376919|P2|Overall Study|Other|1
5889959|NCT01774344|20376920|P1|Overall Study|Other|0
5889960|NCT01774344|20376919|P2|Overall Study|Data collection finished|14
5889961|NCT01774344|20376920|P1|Overall Study|Data collection finished|4
5889962|NCT01774344|20376919|P2|Overall Study|End of survival follow-up not available|2
5889963|NCT01774344|20376920|P1|Overall Study|End of survival follow-up not available|2
5889964|NCT01774344|20376919|P2|Overall Study|Lost to Follow-up|10
5889965|NCT01774344|20376920|P1|Overall Study|Lost to Follow-up|4
5889966|NCT01774344|20376919|P2|Overall Study|Protocol Violation|1
5889967|NCT01774344|20376920|P1|Overall Study|Protocol Violation|0
5889968|NCT01774344|20376919|P2|Overall Study|Withdrawal by Subject|10
5889969|NCT01774344|20376920|P1|Overall Study|Withdrawal by Subject|3
5889970|NCT01774305|20376938|P2|Overall Study|Physician Decision|0
5889971|NCT01774305|20376939|P1|Overall Study|Physician Decision|1
5889972|NCT01774253|20376947|P1|Overall Study|Death|1
5889973|NCT01774253|20376947|P1|Overall Study|Withdrawal by Subject|2
5889974|NCT01774253|20376947|P1|Overall Study|Physician Decision|2
5889975|NCT01774253|20376947|P1|Overall Study|Lack of Efficacy|4
5889976|NCT01774110|20376966|P1|Overall Study|Lost to Follow-up|7
5889977|NCT01774097|20376974|P2|Overall Study|Adverse Event|1
5889978|NCT01774097|20376975|P1|Overall Study|Adverse Event|1
5889979|NCT01774097|20376974|P2|Overall Study|Withdrawal by Subject|1
5889980|NCT01774097|20376975|P1|Overall Study|Withdrawal by Subject|1
5889981|NCT01774084|20377005|P2|Overall Study|Personal reasons|0
5889982|NCT01774084|20377006|P1|Overall Study|Personal reasons|1
5889983|NCT01773993|20377031|P1|Overall Study|No Visit After Treatment|35
5889984|NCT01773967|20377050|P2|Overall Study|Lost to Follow-up|13
5889985|NCT01773967|20377051|P1|Overall Study|Lost to Follow-up|15
5889986|NCT01773889|20377066|P1|Overall Study|lack of funding|2
5889987|NCT01773473|20377072|P2|Overall Study|Lost to Follow-up|0
5889988|NCT01773473|20377073|P1|Overall Study|Lost to Follow-up|2
5889989|NCT01773473|20377072|P2|Overall Study|Withdrawal by Subject|3
5889990|NCT01773473|20377073|P1|Overall Study|Withdrawal by Subject|5
5889991|NCT01773473|20377072|P2|Overall Study|Non-Compliance with study drug|4
5889992|NCT01773473|20377073|P1|Overall Study|Non-Compliance with study drug|1
5889993|NCT01773473|20377072|P2|Overall Study|Lack of Efficacy|1
5889994|NCT01773473|20377073|P1|Overall Study|Lack of Efficacy|0
5889995|NCT01773473|20377072|P2|Overall Study|Sponsor Decision|0
5889996|NCT01773473|20377073|P1|Overall Study|Sponsor Decision|2
5889997|NCT01773473|20377072|P2|Overall Study|Physician Decision|5
5889998|NCT01773473|20377073|P1|Overall Study|Physician Decision|3
5889999|NCT01773473|20377072|P2|Overall Study|Protocol Violation|4
5890000|NCT01773473|20377073|P1|Overall Study|Protocol Violation|0
5890001|NCT01773473|20377072|P2|Overall Study|Adverse Event|2
5890002|NCT01773473|20377073|P1|Overall Study|Adverse Event|3
5890003|NCT01773421|20377095|P7|Extension Phase|Adverse Event|0
5890004|NCT01773421|20377096|P6|Extension Phase|Adverse Event|0
5890005|NCT01773421|20377097|P5|Extension Phase|Adverse Event|2
5890006|NCT01773421|20377098|P4|Extension Phase|Adverse Event|0
5890007|NCT01773421|20377099|P3|Extension Phase|Adverse Event|0
5890008|NCT01773421|20377100|P2|Extension Phase|Adverse Event|0
5890009|NCT01773421|20377101|P1|Extension Phase|Adverse Event|0
5890010|NCT01773421|20377095|P7|Extension Phase|Other|0
5890011|NCT01773421|20377096|P6|Extension Phase|Other|2
5890012|NCT01773421|20377097|P5|Extension Phase|Other|1
5890013|NCT01773421|20377098|P4|Extension Phase|Other|0
5890014|NCT01773421|20377099|P3|Extension Phase|Other|0
5890015|NCT01773421|20377100|P2|Extension Phase|Other|0
5890016|NCT01773421|20377101|P1|Extension Phase|Other|0
5890017|NCT01773421|20377095|P7|Treatment Phase|Withdrawal by Subject|0
5890018|NCT01773421|20377096|P6|Treatment Phase|Withdrawal by Subject|0
5890019|NCT01773421|20377097|P5|Treatment Phase|Withdrawal by Subject|0
5890020|NCT01773421|20377098|P4|Treatment Phase|Withdrawal by Subject|1
5890021|NCT01773421|20377099|P3|Treatment Phase|Withdrawal by Subject|1
5890022|NCT01773421|20377100|P2|Treatment Phase|Withdrawal by Subject|0
5890023|NCT01773421|20377101|P1|Treatment Phase|Withdrawal by Subject|0
5890024|NCT01773421|20377095|P7|Treatment Phase|Adverse Event|0
5890025|NCT01773421|20377096|P6|Treatment Phase|Adverse Event|0
5890026|NCT01773421|20377097|P5|Treatment Phase|Adverse Event|0
5890027|NCT01773421|20377098|P4|Treatment Phase|Adverse Event|1
5890028|NCT01773421|20377099|P3|Treatment Phase|Adverse Event|3
5890029|NCT01773421|20377100|P2|Treatment Phase|Adverse Event|0
5890030|NCT01773421|20377101|P1|Treatment Phase|Adverse Event|0
5890031|NCT01773421|20377095|P7|Treatment Phase|Other|0
5890032|NCT01773421|20377096|P6|Treatment Phase|Other|0
5890033|NCT01773421|20377097|P5|Treatment Phase|Other|0
5890034|NCT01773421|20377098|P4|Treatment Phase|Other|0
5890035|NCT01773421|20377099|P3|Treatment Phase|Other|2
5890036|NCT01773421|20377100|P2|Treatment Phase|Other|0
5890037|NCT01773421|20377101|P1|Treatment Phase|Other|0
5890038|NCT01773291|20377132|P3|Overall Study|Withdrawal by Subject|1
5890039|NCT01773291|20377133|P2|Overall Study|Withdrawal by Subject|0
5890040|NCT01773291|20377134|P1|Overall Study|Withdrawal by Subject|0
5890041|NCT01773291|20377132|P3|Overall Study|Protocol Violation|0
5890042|NCT01773291|20377133|P2|Overall Study|Protocol Violation|0
5890043|NCT01773291|20377134|P1|Overall Study|Protocol Violation|1
5890044|NCT01773226|20377145|P1|Overall Study|Withdrawal by Subject|1
5890045|NCT01773122|20377175|P4|Overall Study|Due to amended age eligibility criteria|1
5890046|NCT01773122|20377176|P3|Overall Study|Due to amended age eligibility criteria|0
5890047|NCT01773122|20377177|P2|Overall Study|Due to amended age eligibility criteria|1
5890048|NCT01773122|20377178|P1|Overall Study|Due to amended age eligibility criteria|3
5890049|NCT01773109|20377192|P1|Overall Study|Death|1
5890050|NCT01773109|20377192|P1|Overall Study|Symptomatic Progression|2
5890051|NCT01773070|20377196|P1|Overall Study|Death (unrelated to study procedures)|3
5890052|NCT01773070|20377196|P1|Overall Study|Other|15
5890053|NCT01773070|20377196|P1|Overall Study|Lost to Follow-up|39
5890054|NCT01773070|20377196|P1|Overall Study|Withdrawal by Subject|24
5890055|NCT01772823|20377206|P2|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|0
5890056|NCT01772823|20377207|P1|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|1
5890057|NCT01772823|20377206|P2|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2
5890058|NCT01772823|20377207|P1|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2
5890059|NCT01772823|20377206|P2|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|2
5890060|NCT01772823|20377207|P1|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|1
5890061|NCT01772823|20377206|P2|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|5
5890062|NCT01772823|20377207|P1|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|6
5890063|NCT01772823|20377206|P2|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1
5890064|NCT01772823|20377207|P1|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1
5890065|NCT01772823|20377206|P2|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|0
5890066|NCT01772823|20377207|P1|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|1
5890067|NCT01772823|20377206|P2|Treatment Phase (Week 0- Week 48)|Incarcerated|0
5890068|NCT01772823|20377207|P1|Treatment Phase (Week 0- Week 48)|Incarcerated|1
5890069|NCT01772823|20377206|P2|Treatment Phase (Week 0- Week 48)|Moved out of area|3
5890070|NCT01772823|20377207|P1|Treatment Phase (Week 0- Week 48)|Moved out of area|4
5890071|NCT01772823|20377206|P2|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|1
5890072|NCT01772823|20377207|P1|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|6
5890073|NCT01772823|20377206|P2|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|13
5890074|NCT01772823|20377207|P1|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|15
5890075|NCT01772823|20377206|P2|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|0
5890076|NCT01772823|20377207|P1|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|1
5890077|NCT01772823|20377206|P2|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|0
5890078|NCT01772823|20377207|P1|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|6
5890079|NCT01772823|20377206|P2|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|1
5890080|NCT01772823|20377207|P1|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|2
5890081|NCT01772823|20377206|P2|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|0
5890082|NCT01772823|20377207|P1|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|1
5890083|NCT01772823|20377206|P2|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1
5890084|NCT01772823|20377207|P1|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1
5890085|NCT01772823|20377206|P2|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|0
5890086|NCT01772823|20377207|P1|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|1
5890087|NCT01772719|20377320|P1|Overall Study|Lost to Follow-up|1
5890088|NCT01772719|20377320|P1|Overall Study|Protocol Violation|1
5890089|NCT01772719|20377320|P1|Overall Study|Adverse Event|2
5890090|NCT01772719|20377320|P1|Overall Study|Withdrawal by Subject|3
5890091|NCT01772693|20377333|P2|Overall Study|Alternative Treatment|0
5890092|NCT01772693|20377334|P1|Overall Study|Alternative Treatment|2
5890093|NCT01772693|20377333|P2|Overall Study|Withdrawal by Subject|0
5890094|NCT01772693|20377334|P1|Overall Study|Withdrawal by Subject|2
5890095|NCT01772693|20377333|P2|Overall Study|Health Concerns Unrelated to Study|1
5890096|NCT01772693|20377334|P1|Overall Study|Health Concerns Unrelated to Study|2
5890097|NCT01772576|20377355|P1|Overall Study|Withdrawal by Subject|6
5890098|NCT01772576|20377355|P1|Overall Study|Adverse Event|6
5890099|NCT01772576|20377355|P1|Overall Study|Study device not used|3
5890100|NCT01772576|20377355|P1|Overall Study|Lost to Follow-up|3
5890101|NCT01772576|20377355|P1|Overall Study|Protocol Violation|1
5890102|NCT01772576|20377355|P1|Overall Study|Death|15
5890103|NCT01772550|20377367|P3|Overall Study|Adverse Event|1
5890104|NCT01772550|20377368|P2|Overall Study|Adverse Event|0
5890105|NCT01772550|20377369|P1|Overall Study|Adverse Event|0
5890106|NCT01772550|20377367|P3|Overall Study|Unable to insert IV in antecubital vein|5
5890107|NCT01772550|20377368|P2|Overall Study|Unable to insert IV in antecubital vein|1
5890108|NCT01772550|20377369|P1|Overall Study|Unable to insert IV in antecubital vein|1
5890109|NCT01772537|20377410|P3|Overall Study|unsuccessful lumbar drain placement|0
5890110|NCT01772537|20377411|P2|Overall Study|unsuccessful lumbar drain placement|0
5890111|NCT01772537|20377412|P1|Overall Study|unsuccessful lumbar drain placement|1
5890112|NCT01772472|20377428|P2|Overall Study|Ongoing|635
5890113|NCT01772472|20377429|P1|Overall Study|Ongoing|597
5890114|NCT01772472|20377428|P2|Overall Study|Withdrawal by Subject|50
5890115|NCT01772472|20377429|P1|Overall Study|Withdrawal by Subject|72
5890116|NCT01772472|20377428|P2|Overall Study|Lost to Follow-up|8
5890117|NCT01772472|20377429|P1|Overall Study|Lost to Follow-up|12
5890118|NCT01772472|20377428|P2|Overall Study|Other|5
5890119|NCT01772472|20377429|P1|Overall Study|Other|5
5890120|NCT01772472|20377428|P2|Overall Study|Physician Decision|3
5890121|NCT01772472|20377429|P1|Overall Study|Physician Decision|1
5890122|NCT01772472|20377428|P2|Overall Study|Death|42
5890123|NCT01772472|20377429|P1|Overall Study|Death|56
5890124|NCT01772368|20377441|P1|Overall Study|Other|1
5890125|NCT01772368|20377441|P1|Overall Study|Protocol Violation|2
5890126|NCT01772368|20377441|P1|Overall Study|Withdrawal by Subject|3
5890127|NCT01772368|20377441|P1|Overall Study|Adverse Event|1
5890128|NCT01772316|20377487|P1|Overall Study|Withdrawn by sponsor decision|5
5890129|NCT01772316|20377487|P1|Overall Study|Inform consent withdrawn|1
5890130|NCT01772316|20377487|P1|Overall Study|Serious adverse event|1
5890131|NCT01772160|20377505|P1|Overall Study|Other|5
5890132|NCT01772160|20377505|P1|Overall Study|Lost to Follow-up|30
5890133|NCT01772160|20377505|P1|Overall Study|Migrated / moved from the study area|4
5890134|NCT01772160|20377505|P1|Overall Study|Consent withdrawal|3
5890135|NCT01772160|20377505|P1|Overall Study|Eligibility criteria not fulfilled|3
5890136|NCT01772160|20377505|P1|Overall Study|Death|3
5890137|NCT01772147|20377528|P3|Overall Study|Lack of Efficacy|6
5890138|NCT01772147|20377529|P2|Overall Study|Lack of Efficacy|6
5890139|NCT01772147|20377530|P1|Overall Study|Lack of Efficacy|8
5890140|NCT01772147|20377528|P3|Overall Study|Protocol Deviation|1
5890141|NCT01772147|20377529|P2|Overall Study|Protocol Deviation|1
5890142|NCT01772147|20377530|P1|Overall Study|Protocol Deviation|2
5890143|NCT01772147|20377528|P3|Overall Study|Lost to Follow-up|1
5890144|NCT01772147|20377529|P2|Overall Study|Lost to Follow-up|0
5890145|NCT01772147|20377530|P1|Overall Study|Lost to Follow-up|1
5890146|NCT01772147|20377528|P3|Overall Study|Withdrew Consent|4
5890147|NCT01772147|20377529|P2|Overall Study|Withdrew Consent|8
5890148|NCT01772147|20377530|P1|Overall Study|Withdrew Consent|7
5890149|NCT01772147|20377528|P3|Overall Study|Adverse Event|6
5890150|NCT01772147|20377529|P2|Overall Study|Adverse Event|10
5890151|NCT01772147|20377530|P1|Overall Study|Adverse Event|13
5890152|NCT01772134|20377550|P3|Overall Study|Randomized Study Medication Not Received|1
5890153|NCT01772134|20377551|P2|Overall Study|Randomized Study Medication Not Received|0
5890154|NCT01772134|20377552|P1|Overall Study|Randomized Study Medication Not Received|2
5890155|NCT01772134|20377550|P3|Overall Study|Protocol-defined Stopping Criteria|0
5890156|NCT01772134|20377551|P2|Overall Study|Protocol-defined Stopping Criteria|0
5890157|NCT01772134|20377552|P1|Overall Study|Protocol-defined Stopping Criteria|1
5890158|NCT01772134|20377550|P3|Overall Study|Lack of Efficacy|3
5890159|NCT01772134|20377551|P2|Overall Study|Lack of Efficacy|5
5890160|NCT01772134|20377552|P1|Overall Study|Lack of Efficacy|11
5890161|NCT01772134|20377550|P3|Overall Study|Protocol Deviation|3
5890162|NCT01772134|20377551|P2|Overall Study|Protocol Deviation|3
5890163|NCT01772134|20377552|P1|Overall Study|Protocol Deviation|4
5890164|NCT01772134|20377550|P3|Overall Study|Lost to Follow-up|0
5890165|NCT01772134|20377551|P2|Overall Study|Lost to Follow-up|0
5890166|NCT01772134|20377552|P1|Overall Study|Lost to Follow-up|2
5890167|NCT01772134|20377550|P3|Overall Study|Withdrew Consent|5
5890168|NCT01772134|20377551|P2|Overall Study|Withdrew Consent|1
5890169|NCT01772134|20377552|P1|Overall Study|Withdrew Consent|3
5890170|NCT01772134|20377550|P3|Overall Study|Adverse Event|10
5890171|NCT01772134|20377551|P2|Overall Study|Adverse Event|5
5890172|NCT01772134|20377552|P1|Overall Study|Adverse Event|6
5890173|NCT01771913|20377608|P2|Overall Study|Withdrawal by Subject|0
5890174|NCT01771913|20377609|P1|Overall Study|Withdrawal by Subject|1
5890175|NCT01771809|20377621|P2|Overall Study|Other (other)|5
5890176|NCT01771809|20377622|P1|Overall Study|Other (other)|9
5890177|NCT01771809|20377621|P2|Overall Study|Death|0
5890178|NCT01771809|20377622|P1|Overall Study|Death|1
5890179|NCT01771809|20377621|P2|Overall Study|Other (Insufficient clinical response)|20
5890180|NCT01771809|20377622|P1|Overall Study|Other (Insufficient clinical response)|22
5890181|NCT01771809|20377621|P2|Overall Study|Lost to Follow-up|3
5890182|NCT01771809|20377622|P1|Overall Study|Lost to Follow-up|1
5890183|NCT01771809|20377621|P2|Overall Study|Withdrawal by Subject|42
5890184|NCT01771809|20377622|P1|Overall Study|Withdrawal by Subject|34
5890185|NCT01771809|20377621|P2|Overall Study|Protocol Violation|1
5890186|NCT01771809|20377622|P1|Overall Study|Protocol Violation|0
5890187|NCT01771809|20377621|P2|Overall Study|Adverse Event|12
5890188|NCT01771809|20377622|P1|Overall Study|Adverse Event|4
5890189|NCT01771731|20377638|P2|Overall Study|Adverse event: Pain Crisis|1
5890190|NCT01771731|20377639|P1|Overall Study|Adverse event: Pain Crisis|1
5890191|NCT01771731|20377638|P2|Overall Study|Protocol Violation|1
5890192|NCT01771731|20377639|P1|Overall Study|Protocol Violation|0
5890193|NCT01771731|20377638|P2|Overall Study|Physician Decision|0
5890194|NCT01771731|20377639|P1|Overall Study|Physician Decision|1
5890195|NCT01771250|20377659|P2|Period 1|Met exclusion criteria|0
5890196|NCT01771250|20377660|P1|Period 1|Met exclusion criteria|1
5890197|NCT01770912|20377678|P2|Overall Study|Lost to Follow-up|0
5890198|NCT01770912|20377679|P1|Overall Study|Lost to Follow-up|2
5890199|NCT01770860|20377713|P1|Overall Study|Administrative decision made by the PI|1
5890200|NCT01770860|20377713|P1|Overall Study|Lost to Follow-up|1
5890201|NCT01770860|20377713|P1|Overall Study|Withdrawal by Subject|4
5890202|NCT01770743|20377761|P5|Overall Study|Moving Out of State|0
5890203|NCT01770743|20377762|P4|Overall Study|Moving Out of State|0
5890204|NCT01770743|20377763|P3|Overall Study|Moving Out of State|0
5890205|NCT01770743|20377764|P2|Overall Study|Moving Out of State|1
5890206|NCT01770743|20377765|P1|Overall Study|Moving Out of State|0
5890207|NCT01770743|20377761|P5|Overall Study|Sponsor Terminated Subject|0
5890208|NCT01770743|20377762|P4|Overall Study|Sponsor Terminated Subject|1
5890209|NCT01770743|20377763|P3|Overall Study|Sponsor Terminated Subject|0
5890210|NCT01770743|20377764|P2|Overall Study|Sponsor Terminated Subject|0
5890211|NCT01770743|20377765|P1|Overall Study|Sponsor Terminated Subject|1
5890212|NCT01770743|20377761|P5|Overall Study|Lost to Follow-up|1
5890213|NCT01770743|20377762|P4|Overall Study|Lost to Follow-up|0
5890214|NCT01770743|20377763|P3|Overall Study|Lost to Follow-up|0
5890215|NCT01770743|20377764|P2|Overall Study|Lost to Follow-up|2
5890216|NCT01770743|20377765|P1|Overall Study|Lost to Follow-up|0
5890217|NCT01770743|20377761|P5|Overall Study|Withdrawal by Subject|1
5890218|NCT01770743|20377762|P4|Overall Study|Withdrawal by Subject|1
5890219|NCT01770743|20377763|P3|Overall Study|Withdrawal by Subject|1
5890220|NCT01770743|20377764|P2|Overall Study|Withdrawal by Subject|0
5890221|NCT01770743|20377765|P1|Overall Study|Withdrawal by Subject|0
5890222|NCT01770743|20377761|P5|Overall Study|Adverse Event|0
5890223|NCT01770743|20377762|P4|Overall Study|Adverse Event|0
5890224|NCT01770743|20377763|P3|Overall Study|Adverse Event|0
5890225|NCT01770743|20377764|P2|Overall Study|Adverse Event|0
5890226|NCT01770743|20377765|P1|Overall Study|Adverse Event|1
5890227|NCT01770509|20377867|P2|Overall Study|Lost to Follow-up|2
5890228|NCT01770509|20377868|P1|Overall Study|Lost to Follow-up|1
5890229|NCT01770509|20377867|P2|Overall Study|Injury|1
5890230|NCT01770509|20377868|P1|Overall Study|Injury|0
5890231|NCT01770392|20377904|P1|Washout Period of at Least 14 Days|Adverse Event|1
5890232|NCT01770379|20377919|P3|Overall Study|Adverse Event|2
5890233|NCT01770379|20377920|P2|Overall Study|Adverse Event|3
5890234|NCT01770379|20377921|P1|Overall Study|Adverse Event|1
5890235|NCT01770379|20377919|P3|Overall Study|Lack of Efficacy|6
5890236|NCT01770379|20377920|P2|Overall Study|Lack of Efficacy|6
5890237|NCT01770379|20377921|P1|Overall Study|Lack of Efficacy|8
5890238|NCT01770379|20377919|P3|Overall Study|Lost to Follow-up|2
5890239|NCT01770379|20377920|P2|Overall Study|Lost to Follow-up|0
5890240|NCT01770379|20377921|P1|Overall Study|Lost to Follow-up|0
5890241|NCT01770379|20377919|P3|Overall Study|Physician Decision|2
5890242|NCT01770379|20377920|P2|Overall Study|Physician Decision|1
5890243|NCT01770379|20377921|P1|Overall Study|Physician Decision|0
5890244|NCT01770379|20377919|P3|Overall Study|Protocol Violation|1
5890245|NCT01770379|20377920|P2|Overall Study|Protocol Violation|1
5890246|NCT01770379|20377921|P1|Overall Study|Protocol Violation|0
5890247|NCT01770379|20377919|P3|Overall Study|study terminated by sponsor|22
5890248|NCT01770379|20377920|P2|Overall Study|study terminated by sponsor|23
5890249|NCT01770379|20377921|P1|Overall Study|study terminated by sponsor|22
5890250|NCT01770379|20377919|P3|Overall Study|Withdrawal by Subject|7
5890251|NCT01770379|20377920|P2|Overall Study|Withdrawal by Subject|10
5890252|NCT01770379|20377921|P1|Overall Study|Withdrawal by Subject|7
5890253|NCT01770379|20377919|P3|Overall Study|Technical issues|0
5890254|NCT01770379|20377920|P2|Overall Study|Technical issues|0
5890255|NCT01770379|20377921|P1|Overall Study|Technical issues|1
5890256|NCT01770353|20377949|P2|Overall Study|Toxicity related diarrhoea + progression|1
5890257|NCT01770353|20377950|P1|Overall Study|Toxicity related diarrhoea + progression|0
5890258|NCT01770353|20377949|P2|Overall Study|Clinical deterioration|6
5890259|NCT01770353|20377950|P1|Overall Study|Clinical deterioration|3
5890260|NCT01770353|20377949|P2|Overall Study|Physician Decision|3
5890261|NCT01770353|20377950|P1|Overall Study|Physician Decision|0
5890262|NCT01770353|20377949|P2|Overall Study|Protocol Violation|0
5890263|NCT01770353|20377950|P1|Overall Study|Protocol Violation|1
5890264|NCT01770353|20377949|P2|Overall Study|Adverse Event|1
5890265|NCT01770353|20377950|P1|Overall Study|Adverse Event|0
5890266|NCT01770353|20377949|P2|Overall Study|Progressive disease|1
5890267|NCT01770353|20377950|P1|Overall Study|Progressive disease|2
5890268|NCT01770145|20378009|P1|Treatment|Withdrawal by Subject|1
5890269|NCT01770145|20378009|P1|Treatment|Adverse Event|3
5890270|NCT01770145|20378009|P1|Baseline|Unable to define optimal dose|4
5890271|NCT01770145|20378009|P1|Baseline|Lost to Follow-up|1
5890272|NCT01770145|20378009|P1|Baseline|Withdrawal by Subject|1
5890273|NCT01770145|20378009|P1|Baseline|Adverse Event|20
5890274|NCT01769508|20378065|P1|Overall Study|Lost to Follow-up|1
5890275|NCT01769508|20378065|P1|Overall Study|Adverse Event|1
5890276|NCT01769508|20378065|P1|Overall Study|Withdrawal by Subject|1
5890277|NCT01769508|20378065|P1|Overall Study|Death|3
5890278|NCT01769469|20378074|P1|Overall Study|Subject Confirmed HIV Positive|3
5890279|NCT01769469|20378074|P1|Overall Study|Prem D/C from ATN 110/113 For Any Reason|7
5890280|NCT01769469|20378074|P1|Overall Study|Lost to Follow-up|17
5890281|NCT01769469|20378074|P1|Overall Study|Moved Out Of Area|3
5890282|NCT01769469|20378074|P1|Overall Study|Consent Withdrawn|5
5890283|NCT01769456|20378234|P1|Overall Study|Parental request to youth to withdraw|1
5890284|NCT01769456|20378234|P1|Overall Study|No wk 0 visit w/in 30 days of screening|5
5890285|NCT01769456|20378234|P1|Overall Study|Moved out of the area|3
5890286|NCT01769456|20378234|P1|Overall Study|Did not receive PCC intervention|6
5890287|NCT01769456|20378234|P1|Overall Study|Withdrawal by Subject|3
5890288|NCT01769456|20378234|P1|Overall Study|Lost to Follow-up|19
5890289|NCT01769443|20378255|P2|Overall Study|Study closure|0
5890290|NCT01769443|20378256|P1|Overall Study|Study closure|1
5890291|NCT01769404|20378298|P2|Treatment Period 2|Sponsor decision|0
5890292|NCT01769404|20378299|P1|Treatment Period 2|Sponsor decision|7
5890293|NCT01769404|20378298|P2|Treatment Period 1|Sponsor decision|0
5890294|NCT01769404|20378299|P1|Treatment Period 1|Sponsor decision|1
5890295|NCT01769404|20378298|P2|Treatment Period 1|Withdrawal by Subject|0
5890296|NCT01769404|20378299|P1|Treatment Period 1|Withdrawal by Subject|3
5890297|NCT01769404|20378298|P2|Treatment Period 1|Did not meet eligibility criteria|0
5890298|NCT01769404|20378299|P1|Treatment Period 1|Did not meet eligibility criteria|1
5890299|NCT01769391|20378321|P2|Overall Study|Investigator Decision|0
5890300|NCT01769391|20378322|P1|Overall Study|Investigator Decision|2
5890301|NCT01769391|20378321|P2|Overall Study|Withdrawal by Subject|3
5890302|NCT01769391|20378322|P1|Overall Study|Withdrawal by Subject|4
5890303|NCT01769391|20378321|P2|Overall Study|Progressive Disease|2
5890304|NCT01769391|20378322|P1|Overall Study|Progressive Disease|1
5890305|NCT01769391|20378321|P2|Overall Study|Adverse Event|3
5890306|NCT01769391|20378322|P1|Overall Study|Adverse Event|0
5890307|NCT01769391|20378321|P2|Overall Study|Death|1
5890308|NCT01769391|20378322|P1|Overall Study|Death|10
5890309|NCT01769378|20378341|P2|Overall Study|Lost to Follow-up|0
5890310|NCT01769378|20378342|P1|Overall Study|Lost to Follow-up|2
5890311|NCT01769378|20378341|P2|Overall Study|Sponsor Decision|0
5890312|NCT01769378|20378342|P1|Overall Study|Sponsor Decision|1
5890313|NCT01769378|20378341|P2|Overall Study|Withdrawal by Subject|3
5890314|NCT01769378|20378342|P1|Overall Study|Withdrawal by Subject|10
5890315|NCT01769378|20378341|P2|Overall Study|Protocol Violation|1
5890316|NCT01769378|20378342|P1|Overall Study|Protocol Violation|1
5890317|NCT01769378|20378341|P2|Overall Study|Entry criteria not met|0
5890318|NCT01769378|20378342|P1|Overall Study|Entry criteria not met|1
5890319|NCT01769378|20378341|P2|Overall Study|Adverse Event|0
5890320|NCT01769378|20378342|P1|Overall Study|Adverse Event|10
5890321|NCT01769339|20378422|P1|Overall Study|Adverse Event|1
5890322|NCT01769339|20378422|P1|Overall Study|Lost to Follow-up|42
5890323|NCT01769326|20378433|P4|Overall Study|Got sick and could not complete study|0
5890324|NCT01769326|20378434|P3|Overall Study|Got sick and could not complete study|1
5890325|NCT01769326|20378435|P2|Overall Study|Got sick and could not complete study|0
5890326|NCT01769326|20378436|P1|Overall Study|Got sick and could not complete study|0
5890327|NCT01769326|20378433|P4|Overall Study|got a job|0
5890328|NCT01769326|20378434|P3|Overall Study|got a job|0
5890329|NCT01769326|20378435|P2|Overall Study|got a job|1
5890330|NCT01769326|20378436|P1|Overall Study|got a job|0
5890331|NCT01769326|20378433|P4|Overall Study|unrelated injry|0
5890332|NCT01769326|20378434|P3|Overall Study|unrelated injry|0
5890333|NCT01769326|20378435|P2|Overall Study|unrelated injry|1
5890334|NCT01769326|20378436|P1|Overall Study|unrelated injry|1
5890335|NCT01769326|20378433|P4|Overall Study|Lost to Follow-up|0
5890336|NCT01769326|20378434|P3|Overall Study|Lost to Follow-up|0
5890337|NCT01769326|20378435|P2|Overall Study|Lost to Follow-up|2
5890338|NCT01769326|20378436|P1|Overall Study|Lost to Follow-up|1
5890339|NCT01769196|20378581|P2|Overall Study|Withdrew consent|40
5890340|NCT01769196|20378582|P1|Overall Study|Withdrew consent|36
5890341|NCT01769196|20378581|P2|Overall Study|Participant never dosed with study drug|0
5890342|NCT01769196|20378582|P1|Overall Study|Participant never dosed with study drug|1
5890343|NCT01769196|20378581|P2|Overall Study|Study terminated by sponsor|161
5890344|NCT01769196|20378582|P1|Overall Study|Study terminated by sponsor|160
5890345|NCT01769196|20378581|P2|Overall Study|Protocol Violation|3
5890346|NCT01769196|20378582|P1|Overall Study|Protocol Violation|0
5890347|NCT01769196|20378581|P2|Overall Study|Protocol defined criteria for withdrawal|11
5890348|NCT01769196|20378582|P1|Overall Study|Protocol defined criteria for withdrawal|9
5890349|NCT01769196|20378581|P2|Overall Study|Progressive disease|6
5890350|NCT01769196|20378582|P1|Overall Study|Progressive disease|11
5890351|NCT01769196|20378581|P2|Overall Study|Lack of Efficacy|2
5890352|NCT01769196|20378582|P1|Overall Study|Lack of Efficacy|3
5890353|NCT01769196|20378581|P2|Overall Study|Investigator Discretion|3
5890354|NCT01769196|20378582|P1|Overall Study|Investigator Discretion|7
5890355|NCT01769196|20378581|P2|Overall Study|Death|26
5890356|NCT01769196|20378582|P1|Overall Study|Death|21
5890357|NCT01769196|20378581|P2|Overall Study|Adverse Event|20
5890358|NCT01769196|20378582|P1|Overall Study|Adverse Event|24
5890359|NCT01769105|20378623|P2|Cross-over|Lost to Follow-up|0
5890360|NCT01769105|20378624|P1|Cross-over|Lost to Follow-up|5
5890361|NCT01769105|20378623|P2|First Intervention|Protocol Violation|2
5890362|NCT01769105|20378624|P1|First Intervention|Protocol Violation|2
5890363|NCT01768858|20378643|P1|Overall Study|Withdrawal by Subject|1
5890364|NCT01768858|20378643|P1|Overall Study|Exanthema|1
5890365|NCT01768858|20378643|P1|Overall Study|Aggravation of NY Heart Assoc 3 status|1
5890366|NCT01768858|20378643|P1|Overall Study|Participant moved to Germany|1
5890367|NCT01768858|20378643|P1|Overall Study|Serious Adverse Event|1
5890368|NCT01768858|20378643|P1|Overall Study|Lack of Efficacy|8
5890369|NCT01768858|20378643|P1|Overall Study|Lost to Follow-up|9
5890370|NCT01768676|20378694|P2|Overall Study|Withdrawal by Subject|10
5890371|NCT01768676|20378695|P1|Overall Study|Withdrawal by Subject|3
5890372|NCT01768676|20378694|P2|Overall Study|Physician Decision|1
5890373|NCT01768676|20378695|P1|Overall Study|Physician Decision|4
5890374|NCT01768676|20378694|P2|Overall Study|Protocol Violation|1
5890375|NCT01768676|20378695|P1|Overall Study|Protocol Violation|1
5890376|NCT01768676|20378694|P2|Overall Study|Lost to Follow-up|16
5890377|NCT01768676|20378695|P1|Overall Study|Lost to Follow-up|13
5890378|NCT01768676|20378694|P2|Overall Study|Adverse Event|3
5890379|NCT01768676|20378695|P1|Overall Study|Adverse Event|3
5890380|NCT01768637|20378711|P2|Overall Study|Difficult blood draw|0
5890381|NCT01768637|20378712|P1|Overall Study|Difficult blood draw|1
5890382|NCT01768637|20378711|P2|Overall Study|Lost to Follow-up|7
5890383|NCT01768637|20378712|P1|Overall Study|Lost to Follow-up|2
5890384|NCT01768572|20378725|P3|Overall Study|Other, Not due to an adverse event|1
5890385|NCT01768572|20378726|P2|Overall Study|Other, Not due to an adverse event|1
5890386|NCT01768572|20378727|P1|Overall Study|Other, Not due to an adverse event|1
5890387|NCT01768572|20378725|P3|Overall Study|Lack of Efficacy|1
5890388|NCT01768572|20378726|P2|Overall Study|Lack of Efficacy|3
5890389|NCT01768572|20378727|P1|Overall Study|Lack of Efficacy|1
5890390|NCT01768572|20378725|P3|Overall Study|Adverse Event|4
5890391|NCT01768572|20378726|P2|Overall Study|Adverse Event|8
5890392|NCT01768572|20378727|P1|Overall Study|Adverse Event|7
5890393|NCT01768559|20378738|P3|Overall Study|Other than specified|5
5890394|NCT01768559|20378739|P2|Overall Study|Other than specified|8
5890395|NCT01768559|20378740|P1|Overall Study|Other than specified|9
5890396|NCT01768559|20378738|P3|Overall Study|Poor compliance to protocol|2
5890397|NCT01768559|20378739|P2|Overall Study|Poor compliance to protocol|3
5890398|NCT01768559|20378740|P1|Overall Study|Poor compliance to protocol|0
5890399|NCT01768559|20378738|P3|Overall Study|Lack of Efficacy|0
5890400|NCT01768559|20378739|P2|Overall Study|Lack of Efficacy|4
5890401|NCT01768559|20378740|P1|Overall Study|Lack of Efficacy|6
5890402|NCT01768559|20378738|P3|Overall Study|Adverse Event|5
5890403|NCT01768559|20378739|P2|Overall Study|Adverse Event|2
5890404|NCT01768559|20378740|P1|Overall Study|Adverse Event|15
5890405|NCT01768559|20378738|P3|Overall Study|Randomized but not treated|1
5890406|NCT01768559|20378739|P2|Overall Study|Randomized but not treated|0
5890407|NCT01768559|20378740|P1|Overall Study|Randomized but not treated|0
5890408|NCT01768286|20378821|P4|Overall Study|Withdrew Consent|0
5890409|NCT01768286|20378822|P3|Overall Study|Withdrew Consent|1
5890410|NCT01768286|20378823|P2|Overall Study|Withdrew Consent|0
5890411|NCT01768286|20378824|P1|Overall Study|Withdrew Consent|0
5890412|NCT01768286|20378821|P4|Overall Study|Lack of Efficacy|1
5890413|NCT01768286|20378822|P3|Overall Study|Lack of Efficacy|0
5890414|NCT01768286|20378823|P2|Overall Study|Lack of Efficacy|4
5890415|NCT01768286|20378824|P1|Overall Study|Lack of Efficacy|7
5890416|NCT01768286|20378821|P4|Overall Study|Randomized But Not Treated|0
5890417|NCT01768286|20378822|P3|Overall Study|Randomized But Not Treated|1
5890418|NCT01768286|20378823|P2|Overall Study|Randomized But Not Treated|0
5890419|NCT01768286|20378824|P1|Overall Study|Randomized But Not Treated|0
5890420|NCT01768117|20378886|P1|Overall Study|Protocol Violation|3
5890421|NCT01768117|20378886|P1|Overall Study|Withdrawal by Subject|2
5890422|NCT01768117|20378886|P1|Overall Study|Lost to Follow-up|1
5890423|NCT01767987|20378950|P2|Overall Study|Physician Decision|1
5890424|NCT01767987|20378951|P1|Overall Study|Physician Decision|4
5890425|NCT01767909|20378983|P2|Overall Study|LP uncessessful|1
5890426|NCT01767909|20378984|P1|Overall Study|LP uncessessful|0
5890427|NCT01767909|20378983|P2|Overall Study|Lost to Follow-up|1
5890428|NCT01767909|20378984|P1|Overall Study|Lost to Follow-up|0
5890429|NCT01767909|20378983|P2|Overall Study|Investigator Recommendation|1
5890430|NCT01767909|20378984|P1|Overall Study|Investigator Recommendation|0
5890431|NCT01767909|20378983|P2|Overall Study|Perceived Lack of Efficacy|0
5890432|NCT01767909|20378984|P1|Overall Study|Perceived Lack of Efficacy|1
5890433|NCT01767909|20378983|P2|Overall Study|Non-Compliance|0
5890434|NCT01767909|20378984|P1|Overall Study|Non-Compliance|2
5890435|NCT01767909|20378983|P2|Overall Study|Withdrawal by Study Partner|1
5890436|NCT01767909|20378984|P1|Overall Study|Withdrawal by Study Partner|3
5890437|NCT01767909|20378983|P2|Overall Study|Adverse Event|1
5890438|NCT01767909|20378984|P1|Overall Study|Adverse Event|3
5890439|NCT01767909|20378983|P2|Overall Study|Withdrawal by Subject|7
5890440|NCT01767909|20378984|P1|Overall Study|Withdrawal by Subject|4
5890441|NCT01767597|20379054|P2|Overall Study|Withdrawal by Subject|0
5890442|NCT01767597|20379055|P1|Overall Study|Withdrawal by Subject|1
5890443|NCT01767597|20379054|P2|Overall Study|Incomplete intervention|1
5890444|NCT01767597|20379055|P1|Overall Study|Incomplete intervention|3
5890445|NCT01767519|20379064|P3|Overall Study|Adverse Event|1
5890446|NCT01767519|20379065|P2|Overall Study|Adverse Event|5
5890447|NCT01767519|20379066|P1|Overall Study|Adverse Event|5
5890448|NCT01767519|20379064|P3|Overall Study|Lack of Efficacy|0
5890449|NCT01767519|20379065|P2|Overall Study|Lack of Efficacy|0
5890450|NCT01767519|20379066|P1|Overall Study|Lack of Efficacy|1
5890451|NCT01767519|20379064|P3|Overall Study|Lost to Follow-up|2
5890452|NCT01767519|20379065|P2|Overall Study|Lost to Follow-up|1
5890453|NCT01767519|20379066|P1|Overall Study|Lost to Follow-up|3
5890454|NCT01767519|20379064|P3|Overall Study|Personal Reasons|0
5890455|NCT01767519|20379065|P2|Overall Study|Personal Reasons|0
5890456|NCT01767519|20379066|P1|Overall Study|Personal Reasons|1
5890457|NCT01767519|20379064|P3|Overall Study|Protocol Violation|0
5890458|NCT01767519|20379065|P2|Overall Study|Protocol Violation|3
5890459|NCT01767519|20379066|P1|Overall Study|Protocol Violation|0
5890460|NCT01767519|20379064|P3|Overall Study|Other Reasons|2
5890461|NCT01767519|20379065|P2|Overall Study|Other Reasons|4
5890462|NCT01767519|20379066|P1|Overall Study|Other Reasons|4
5890463|NCT01767467|20379107|P2|End of Study Phase (up to Month 13)|Subject Unavailable|2
5890464|NCT01767467|20379108|P1|End of Study Phase (up to Month 13)|Subject Unavailable|0
5890465|NCT01767467|20379107|P2|End of Study Phase (up to Month 13)|Physician Decision|0
5890466|NCT01767467|20379108|P1|End of Study Phase (up to Month 13)|Physician Decision|1
5890467|NCT01767467|20379107|P2|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|1
5890468|NCT01767467|20379108|P1|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|0
5890469|NCT01767467|20379107|P2|End of Study Phase (up to Month 13)|Lost to Follow-up|4
5890470|NCT01767467|20379108|P1|End of Study Phase (up to Month 13)|Lost to Follow-up|6
5890471|NCT01767467|20379107|P2|End of Study Phase (up to Month 13)|Migrated/Moved from study area|3
5890472|NCT01767467|20379108|P1|End of Study Phase (up to Month 13)|Migrated/Moved from study area|0
5890473|NCT01767467|20379107|P2|End of Study Phase (up to Month 13)|Withdrawal by Subject|14
5890474|NCT01767467|20379108|P1|End of Study Phase (up to Month 13)|Withdrawal by Subject|9
5890475|NCT01767467|20379107|P2|End of Study Phase (up to Month 13)|Protocol Violation|0
5890476|NCT01767467|20379108|P1|End of Study Phase (up to Month 13)|Protocol Violation|2
5890477|NCT01767467|20379107|P2|End of Study Phase (up to Month 13)|Adverse Event|39
5890478|NCT01767467|20379108|P1|End of Study Phase (up to Month 13)|Adverse Event|29
5890479|NCT01767467|20379107|P2|Vaccination Phase (up to Month 2)|Subject unavailable|1
5890480|NCT01767467|20379108|P1|Vaccination Phase (up to Month 2)|Subject unavailable|0
5890481|NCT01767467|20379107|P2|Vaccination Phase (up to Month 2)|Physician Decision|0
5890482|NCT01767467|20379108|P1|Vaccination Phase (up to Month 2)|Physician Decision|1
5890483|NCT01767467|20379107|P2|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|1
5890484|NCT01767467|20379108|P1|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|0
5890485|NCT01767467|20379107|P2|Vaccination Phase (up to Month 2)|Withdrawal by Subject|10
5890486|NCT01767467|20379108|P1|Vaccination Phase (up to Month 2)|Withdrawal by Subject|7
5890487|NCT01767467|20379107|P2|Vaccination Phase (up to Month 2)|Protocol Violation|0
5890488|NCT01767467|20379108|P1|Vaccination Phase (up to Month 2)|Protocol Violation|1
5890489|NCT01767467|20379107|P2|Vaccination Phase (up to Month 2)|Adverse Event|8
5890490|NCT01767467|20379108|P1|Vaccination Phase (up to Month 2)|Adverse Event|8
5890491|NCT01767376|20379164|P3|Overall Study|Withdrawal by Subject|0
5890492|NCT01767376|20379165|P2|Overall Study|Withdrawal by Subject|1
5890493|NCT01767376|20379166|P1|Overall Study|Withdrawal by Subject|1
5890494|NCT01767376|20379164|P3|Overall Study|Lost to Follow-up|0
5890495|NCT01767376|20379165|P2|Overall Study|Lost to Follow-up|2
5890496|NCT01767376|20379166|P1|Overall Study|Lost to Follow-up|3
5890497|NCT01767194|20379232|P2|Overall Study|Criteria not met on time for next cycle|1
5890498|NCT01767194|20379233|P1|Overall Study|Criteria not met on time for next cycle|0
5890499|NCT01767194|20379232|P2|Overall Study|Refusal by patient/parent|4
5890500|NCT01767194|20379233|P1|Overall Study|Refusal by patient/parent|2
5890501|NCT01767194|20379232|P2|Overall Study|Ineligible|1
5890502|NCT01767194|20379233|P1|Overall Study|Ineligible|1
5890503|NCT01767194|20379232|P2|Overall Study|Withdrawal by Subject|1
5890504|NCT01767194|20379233|P1|Overall Study|Withdrawal by Subject|0
5890505|NCT01767194|20379232|P2|Overall Study|Physician Decision|23
5890506|NCT01767194|20379233|P1|Overall Study|Physician Decision|2
5890507|NCT01767194|20379232|P2|Overall Study|Lack of Efficacy|11
5890508|NCT01767194|20379233|P1|Overall Study|Lack of Efficacy|12
5890509|NCT01767194|20379232|P2|Overall Study|Death|1
5890510|NCT01767194|20379233|P1|Overall Study|Death|0
5890511|NCT01767194|20379232|P2|Overall Study|Adverse Event|1
5890512|NCT01767194|20379233|P1|Overall Study|Adverse Event|1
5890513|NCT01767142|20379255|P1|Overall Study|Lost to Follow-up|3
5890514|NCT01767116|20379264|P2|Overall Study|Lost to Follow-up|2
5890515|NCT01767116|20379265|P1|Overall Study|Lost to Follow-up|2
5890516|NCT01766921|20379336|P2|Overall Study|Withdrawal by Subject|5
5890517|NCT01766921|20379337|P1|Overall Study|Withdrawal by Subject|14
5890518|NCT01766921|20379336|P2|Overall Study|Protocol Violation|1
5890519|NCT01766921|20379337|P1|Overall Study|Protocol Violation|1
5890520|NCT01766921|20379336|P2|Overall Study|Unclassified|2
5890521|NCT01766921|20379337|P1|Overall Study|Unclassified|2
5890522|NCT01766921|20379336|P2|Overall Study|Lost to Follow-up|3
5890523|NCT01766921|20379337|P1|Overall Study|Lost to Follow-up|1
5890524|NCT01766921|20379336|P2|Overall Study|Death|1
5890525|NCT01766921|20379337|P1|Overall Study|Death|1
5890526|NCT01766921|20379336|P2|Overall Study|Administrative Reason|5
5890527|NCT01766921|20379337|P1|Overall Study|Administrative Reason|5
5890528|NCT01766817|20379359|P3|Overall Study|Other|0
5890529|NCT01766817|20379360|P2|Overall Study|Other|0
5890530|NCT01766817|20379361|P1|Overall Study|Other|1
5890531|NCT01766817|20379359|P3|Overall Study|Physician Decision|4
5890532|NCT01766817|20379360|P2|Overall Study|Physician Decision|3
5890533|NCT01766817|20379361|P1|Overall Study|Physician Decision|3
5890534|NCT01766817|20379359|P3|Overall Study|Subject non-compliance|2
5890535|NCT01766817|20379360|P2|Overall Study|Subject non-compliance|1
5890536|NCT01766817|20379361|P1|Overall Study|Subject non-compliance|0
5890537|NCT01766817|20379359|P3|Overall Study|Withdrawal by Subject|3
5890538|NCT01766817|20379360|P2|Overall Study|Withdrawal by Subject|0
5890539|NCT01766817|20379361|P1|Overall Study|Withdrawal by Subject|2
5890540|NCT01766817|20379359|P3|Overall Study|Unable to take study drug|0
5890541|NCT01766817|20379360|P2|Overall Study|Unable to take study drug|1
5890542|NCT01766817|20379361|P1|Overall Study|Unable to take study drug|0
5890543|NCT01766817|20379359|P3|Overall Study|Death|0
5890544|NCT01766817|20379360|P2|Overall Study|Death|1
5890545|NCT01766817|20379361|P1|Overall Study|Death|1
5890546|NCT01766817|20379359|P3|Overall Study|Drug-unrelated adverse event|3
5890547|NCT01766817|20379360|P2|Overall Study|Drug-unrelated adverse event|3
5890548|NCT01766817|20379361|P1|Overall Study|Drug-unrelated adverse event|3
5890549|NCT01766817|20379359|P3|Overall Study|Drug-related adverse event|1
5890550|NCT01766817|20379360|P2|Overall Study|Drug-related adverse event|2
5890551|NCT01766817|20379361|P1|Overall Study|Drug-related adverse event|1
5890552|NCT01766778|20379412|P2|Overall Study|Withdrawal by Subject|0
5890553|NCT01766778|20379413|P1|Overall Study|Withdrawal by Subject|1
5890554|NCT01766778|20379412|P2|Overall Study|Adverse Event|4
5890555|NCT01766778|20379413|P1|Overall Study|Adverse Event|4
5890556|NCT01766401|20379467|P2|Overall Study|Pregnancy|1
5890557|NCT01766401|20379468|P1|Overall Study|Pregnancy|1
5890558|NCT01766401|20379467|P2|Overall Study|Lost to Follow-up|11
5890559|NCT01766401|20379468|P1|Overall Study|Lost to Follow-up|10
5890560|NCT01766401|20379467|P2|Overall Study|Withdrawal by Subject|12
5890561|NCT01766401|20379468|P1|Overall Study|Withdrawal by Subject|15
5890562|NCT01766401|20379467|P2|Overall Study|Protocol Violation|8
5890563|NCT01766401|20379468|P1|Overall Study|Protocol Violation|3
5890564|NCT01766401|20379467|P2|Overall Study|Lack of Efficacy|2
5890565|NCT01766401|20379468|P1|Overall Study|Lack of Efficacy|1
5890566|NCT01766401|20379467|P2|Overall Study|Adverse Event|22
5890567|NCT01766401|20379468|P1|Overall Study|Adverse Event|7
5890568|NCT01766336|20379478|P2|Overall Study|Withdrawal by Subject|15
5890569|NCT01766336|20379479|P1|Overall Study|Withdrawal by Subject|18
5890570|NCT01766336|20379478|P2|Overall Study|Sponsor Decision|43
5890571|NCT01766336|20379479|P1|Overall Study|Sponsor Decision|52
5890572|NCT01766336|20379478|P2|Overall Study|Protocol Violation|1
5890573|NCT01766336|20379479|P1|Overall Study|Protocol Violation|0
5890574|NCT01766336|20379478|P2|Overall Study|Physician Decision|2
5890575|NCT01766336|20379479|P1|Overall Study|Physician Decision|4
5890576|NCT01766336|20379478|P2|Overall Study|Lost to Follow-up|3
5890577|NCT01766336|20379479|P1|Overall Study|Lost to Follow-up|1
5890578|NCT01766336|20379478|P2|Overall Study|Death|3
5890579|NCT01766336|20379479|P1|Overall Study|Death|4
5890580|NCT01766336|20379478|P2|Overall Study|Adverse Event|8
5890581|NCT01766336|20379479|P1|Overall Study|Adverse Event|11
5890582|NCT01766310|20379487|P2|Overall Study|Lost to Follow-up|3
5890583|NCT01766310|20379488|P1|Overall Study|Lost to Follow-up|1
5890584|NCT01766206|20379518|P1|Overall Study|Withdrawal and inappropriate enrollment|1
5890585|NCT01766206|20379518|P1|Overall Study|Inappropriate enrollment|18
5890586|NCT01766206|20379518|P1|Overall Study|Lost to Follow-up|10
5890587|NCT01766206|20379518|P1|Overall Study|Withdrawal by Subject|22
5890588|NCT01766050|20379545|P1|Overall Study|Withdrawal by Subject|2
5890589|NCT01766050|20379545|P1|Overall Study|Lost to Follow-up|1
5890590|NCT01766050|20379545|P1|Overall Study|Adverse Event|1
5890591|NCT01766037|20379680|P2|Overall Study|nausea / discomfort|0
5890592|NCT01766037|20379681|P1|Overall Study|nausea / discomfort|3
5890593|NCT01766037|20379680|P2|Overall Study|medical - unrelated|2
5890594|NCT01766037|20379681|P1|Overall Study|medical - unrelated|1
5890595|NCT01766037|20379680|P2|Overall Study|Moved from area|0
5890596|NCT01766037|20379681|P1|Overall Study|Moved from area|5
5890597|NCT01766037|20379680|P2|Overall Study|Withdrawal by Subject|16
5890598|NCT01766037|20379681|P1|Overall Study|Withdrawal by Subject|18
5890599|NCT01766037|20379680|P2|Overall Study|Physician Decision|1
5890600|NCT01766037|20379681|P1|Overall Study|Physician Decision|0
5890601|NCT01766037|20379680|P2|Overall Study|Lost to Follow-up|10
5890602|NCT01766037|20379681|P1|Overall Study|Lost to Follow-up|0
5890603|NCT01766037|20379680|P2|Overall Study|Lack of Efficacy|0
5890604|NCT01766037|20379681|P1|Overall Study|Lack of Efficacy|1
5890605|NCT01766037|20379680|P2|Overall Study|Adverse Event|0
5890606|NCT01766037|20379681|P1|Overall Study|Adverse Event|1
5890607|NCT01765920|20379744|P2|Overall Study|Patient code disclosure|1
5890608|NCT01765920|20379745|P1|Overall Study|Patient code disclosure|0
5890609|NCT01765920|20379744|P2|Overall Study|Incorrect inclusion ineligible patient|5
5890610|NCT01765920|20379745|P1|Overall Study|Incorrect inclusion ineligible patient|2
5890611|NCT01765764|20379767|P3|Treatment Period|Other Miscellaneous Reasons|2
5890612|NCT01765764|20379768|P2|Treatment Period|Other Miscellaneous Reasons|2
5890613|NCT01765764|20379769|P1|Treatment Period|Other Miscellaneous Reasons|1
5890614|NCT01765764|20379767|P3|Treatment Period|Personal Reasons|1
5890615|NCT01765764|20379768|P2|Treatment Period|Personal Reasons|2
5890616|NCT01765764|20379769|P1|Treatment Period|Personal Reasons|1
5890617|NCT01765764|20379767|P3|Treatment Period|Lost to Follow-up|2
5890618|NCT01765764|20379768|P2|Treatment Period|Lost to Follow-up|3
5890619|NCT01765764|20379769|P1|Treatment Period|Lost to Follow-up|0
5890620|NCT01765764|20379767|P3|Treatment Period|Adverse Event|1
5890621|NCT01765764|20379768|P2|Treatment Period|Adverse Event|2
5890622|NCT01765764|20379769|P1|Treatment Period|Adverse Event|1
5890623|NCT01765751|20379789|P3|Overall Study|Lost to Follow-up|1
5890624|NCT01765751|20379790|P2|Overall Study|Lost to Follow-up|2
5890625|NCT01765751|20379791|P1|Overall Study|Lost to Follow-up|0
5890626|NCT01765673|20379823|P1|Overall Study|No transportation for 2nd/3rd visits|1
5890627|NCT01765582|20379856|P3|Overall Study|Withdrawal of Consent|10
5890628|NCT01765582|20379857|P2|Overall Study|Withdrawal of Consent|6
5890629|NCT01765582|20379858|P1|Overall Study|Withdrawal of Consent|11
5890630|NCT01765582|20379856|P3|Overall Study|Sponsor Decision|42
5890631|NCT01765582|20379857|P2|Overall Study|Sponsor Decision|42
5890632|NCT01765582|20379858|P1|Overall Study|Sponsor Decision|46
5890633|NCT01765582|20379856|P3|Overall Study|Death|33
5890634|NCT01765582|20379857|P2|Overall Study|Death|36
5890635|NCT01765582|20379858|P1|Overall Study|Death|31
5890636|NCT01765582|20379856|P3|Overall Study|Lost to Follow-up|1
5890637|NCT01765582|20379857|P2|Overall Study|Lost to Follow-up|2
5890638|NCT01765582|20379858|P1|Overall Study|Lost to Follow-up|2
5890639|NCT01765582|20379856|P3|Overall Study|Other|9
5890640|NCT01765582|20379857|P2|Overall Study|Other|6
5890641|NCT01765582|20379858|P1|Overall Study|Other|3
5890642|NCT01765569|20379891|P1|Period C|Death|1
5890643|NCT01765569|20379891|P1|Period B|Withdrawal by Subject|1
5890644|NCT01765543|20379912|P1|Overall Study|Withdrawal by Subject|2
5890645|NCT01765543|20379912|P1|Overall Study|Death|1
5890646|NCT01765426|20379964|P4|Overall Study|Lost to Follow-up|0
5890647|NCT01765426|20379965|P3|Overall Study|Lost to Follow-up|0
5890648|NCT01765426|20379966|P2|Overall Study|Lost to Follow-up|1
5890649|NCT01765426|20379967|P1|Overall Study|Lost to Follow-up|0
5890650|NCT01765270|20380023|P2|Overall Study|Withdrawal by Subject|1
5890651|NCT01765270|20380024|P1|Overall Study|Withdrawal by Subject|0
5890652|NCT01765270|20380023|P2|Overall Study|Physician Decision|0
5890653|NCT01765270|20380024|P1|Overall Study|Physician Decision|1
5890654|NCT01765192|20380046|P2|End of Treatment Period 2 to Final Visit|Adverse Event|1
5890655|NCT01765192|20380047|P1|End of Treatment Period 2 to Final Visit|Adverse Event|0
5890656|NCT01765192|20380046|P2|Treatment Period 2|Reason not specified|2
5890657|NCT01765192|20380047|P1|Treatment Period 2|Reason not specified|0
5890658|NCT01765192|20380046|P2|Washout Period|Reason not specified|0
5890659|NCT01765192|20380047|P1|Washout Period|Reason not specified|1
5890660|NCT01765192|20380046|P2|Washout Period|Voluntary Withdrawal|1
5890661|NCT01765192|20380047|P1|Washout Period|Voluntary Withdrawal|1
5890662|NCT01765192|20380046|P2|Treatment Period 1|Adverse Event|1
5890663|NCT01765192|20380047|P1|Treatment Period 1|Adverse Event|0
5890664|NCT01765179|20380065|P1|Overall Study|Ca elevated 10.6|1
5890665|NCT01765179|20380065|P1|Overall Study|work conflict|1
5890666|NCT01765179|20380065|P1|Overall Study|lack of venous access|1
5890667|NCT01765179|20380065|P1|Overall Study|Out of country unable to finish study|1
5890668|NCT01765179|20380065|P1|Overall Study|prohibited med|1
5890669|NCT01765179|20380065|P1|Overall Study|Hematocrit >54%|3
5890670|NCT01765179|20380065|P1|Overall Study|Withdrawal by Subject|8
5890671|NCT01765179|20380065|P1|Overall Study|Protocol Violation|1
5890672|NCT01765179|20380065|P1|Overall Study|Non-compliance with study drug|2
5890673|NCT01765179|20380065|P1|Overall Study|Lost to Follow-up|5
5890674|NCT01765179|20380065|P1|Overall Study|Adverse Event|3
5890675|NCT01765153|20380072|P2|Rest Phase 2|Lost to Follow-up|1
5890676|NCT01765153|20380073|P1|Rest Phase 2|Lost to Follow-up|2
5890677|NCT01765153|20380072|P2|Training Phase 2|Withdrawal by Subject|1
5890678|NCT01765153|20380073|P1|Training Phase 2|Withdrawal by Subject|0
5890679|NCT01765153|20380072|P2|Rest Phase 1|Withdrawal by Subject|1
5890680|NCT01765153|20380073|P1|Rest Phase 1|Withdrawal by Subject|0
5890681|NCT01765153|20380072|P2|Training Phase 1|Poor participation in intervention|1
5890682|NCT01765153|20380073|P1|Training Phase 1|Poor participation in intervention|0
5890683|NCT01765153|20380072|P2|Training Phase 1|Format of intervention differed|0
5890684|NCT01765153|20380073|P1|Training Phase 1|Format of intervention differed|1
5890685|NCT01764997|20380180|P5|Study Drug Treatment Period|Other than specified above|10
5890686|NCT01764997|20380181|P4|Study Drug Treatment Period|Other than specified above|0
5890687|NCT01764997|20380182|P3|Study Drug Treatment Period|Other than specified above|0
5890688|NCT01764997|20380183|P2|Study Drug Treatment Period|Other than specified above|0
5890689|NCT01764997|20380184|P1|Study Drug Treatment Period|Other than specified above|0
5890690|NCT01764997|20380180|P5|Study Drug Treatment Period|Lack of Efficacy|2
5890691|NCT01764997|20380181|P4|Study Drug Treatment Period|Lack of Efficacy|0
5890692|NCT01764997|20380182|P3|Study Drug Treatment Period|Lack of Efficacy|0
5890693|NCT01764997|20380183|P2|Study Drug Treatment Period|Lack of Efficacy|0
5890694|NCT01764997|20380184|P1|Study Drug Treatment Period|Lack of Efficacy|0
5890695|NCT01764997|20380180|P5|Study Drug Treatment Period|Adverse Event|24
5890696|NCT01764997|20380181|P4|Study Drug Treatment Period|Adverse Event|0
5890697|NCT01764997|20380182|P3|Study Drug Treatment Period|Adverse Event|0
5890698|NCT01764997|20380183|P2|Study Drug Treatment Period|Adverse Event|1
5890699|NCT01764997|20380184|P1|Study Drug Treatment Period|Adverse Event|0
5890700|NCT01764997|20380180|P5|Run-in Period|Other than specified above|0
5890701|NCT01764997|20380181|P4|Run-in Period|Other than specified above|0
5890702|NCT01764997|20380182|P3|Run-in Period|Other than specified above|0
5890703|NCT01764997|20380183|P2|Run-in Period|Other than specified above|0
5890704|NCT01764997|20380184|P1|Run-in Period|Other than specified above|17
5890705|NCT01764997|20380180|P5|Run-in Period|Poor compliance to protocol|0
5890706|NCT01764997|20380181|P4|Run-in Period|Poor compliance to protocol|0
5890707|NCT01764997|20380182|P3|Run-in Period|Poor compliance to protocol|0
5890708|NCT01764997|20380183|P2|Run-in Period|Poor compliance to protocol|0
5890709|NCT01764997|20380184|P1|Run-in Period|Poor compliance to protocol|1
5890710|NCT01764997|20380180|P5|Run-in Period|Lack of Efficacy|0
5890711|NCT01764997|20380181|P4|Run-in Period|Lack of Efficacy|0
5890712|NCT01764997|20380182|P3|Run-in Period|Lack of Efficacy|0
5890713|NCT01764997|20380183|P2|Run-in Period|Lack of Efficacy|0
5890714|NCT01764997|20380184|P1|Run-in Period|Lack of Efficacy|5
5890715|NCT01764997|20380180|P5|Run-in Period|Adverse Event|0
5890716|NCT01764997|20380181|P4|Run-in Period|Adverse Event|0
5890717|NCT01764997|20380182|P3|Run-in Period|Adverse Event|0
5890718|NCT01764997|20380183|P2|Run-in Period|Adverse Event|0
5890719|NCT01764997|20380184|P1|Run-in Period|Adverse Event|15
5890720|NCT01764945|20380211|P8|Overall Study|Adverse Event|0
5890721|NCT01764945|20380212|P7|Overall Study|Adverse Event|1
5890722|NCT01764945|20380213|P6|Overall Study|Adverse Event|0
5890723|NCT01764945|20380214|P5|Overall Study|Adverse Event|0
5890724|NCT01764945|20380215|P4|Overall Study|Adverse Event|0
5890725|NCT01764945|20380216|P3|Overall Study|Adverse Event|0
5890726|NCT01764945|20380217|P2|Overall Study|Adverse Event|1
5890727|NCT01764945|20380218|P1|Overall Study|Adverse Event|0
5890728|NCT01764854|20380264|P4|Overall Study|Protocol Violation|2
5890729|NCT01764854|20380265|P3|Overall Study|Protocol Violation|1
5890730|NCT01764854|20380266|P2|Overall Study|Protocol Violation|0
5890731|NCT01764854|20380267|P1|Overall Study|Protocol Violation|0
5890732|NCT01764854|20380264|P4|Overall Study|relocation|0
5890733|NCT01764854|20380265|P3|Overall Study|relocation|2
5890734|NCT01764854|20380266|P2|Overall Study|relocation|0
5890735|NCT01764854|20380267|P1|Overall Study|relocation|0
5890736|NCT01764854|20380264|P4|Overall Study|Withdrawal by Subject|0
5890737|NCT01764854|20380265|P3|Overall Study|Withdrawal by Subject|1
5890738|NCT01764854|20380266|P2|Overall Study|Withdrawal by Subject|0
5890739|NCT01764854|20380267|P1|Overall Study|Withdrawal by Subject|0
5890740|NCT01764854|20380264|P4|Overall Study|Adverse Event|0
5890741|NCT01764854|20380265|P3|Overall Study|Adverse Event|2
5890742|NCT01764854|20380266|P2|Overall Study|Adverse Event|0
5890743|NCT01764854|20380267|P1|Overall Study|Adverse Event|0
5890744|NCT01764841|20380281|P4|Overall Study|Lost to Follow-up|0
5890745|NCT01764841|20380282|P3|Overall Study|Lost to Follow-up|1
5890746|NCT01764841|20380283|P2|Overall Study|Lost to Follow-up|0
5890747|NCT01764841|20380284|P1|Overall Study|Lost to Follow-up|3
5890748|NCT01764841|20380281|P4|Overall Study|Withdrawal by Subject|15
5890749|NCT01764841|20380282|P3|Overall Study|Withdrawal by Subject|11
5890750|NCT01764841|20380283|P2|Overall Study|Withdrawal by Subject|24
5890751|NCT01764841|20380284|P1|Overall Study|Withdrawal by Subject|16
5890752|NCT01764841|20380281|P4|Overall Study|Protocol Violation|0
5890753|NCT01764841|20380282|P3|Overall Study|Protocol Violation|0
5890754|NCT01764841|20380283|P2|Overall Study|Protocol Violation|1
5890755|NCT01764841|20380284|P1|Overall Study|Protocol Violation|0
5890756|NCT01764841|20380281|P4|Overall Study|No Follow Up|0
5890757|NCT01764841|20380282|P3|Overall Study|No Follow Up|1
5890758|NCT01764841|20380283|P2|Overall Study|No Follow Up|0
5890759|NCT01764841|20380284|P1|Overall Study|No Follow Up|1
5890760|NCT01764841|20380281|P4|Overall Study|Death|4
5890761|NCT01764841|20380282|P3|Overall Study|Death|1
5890762|NCT01764841|20380283|P2|Overall Study|Death|0
5890763|NCT01764841|20380284|P1|Overall Study|Death|3
5890764|NCT01764841|20380281|P4|Overall Study|Logistical Difficulties|0
5890765|NCT01764841|20380282|P3|Overall Study|Logistical Difficulties|0
5890766|NCT01764841|20380283|P2|Overall Study|Logistical Difficulties|1
5890767|NCT01764841|20380284|P1|Overall Study|Logistical Difficulties|0
5890768|NCT01764659|20380325|P1|Overall Study|Physician Decision|1
5890769|NCT01764659|20380325|P1|Overall Study|Death|1
5890770|NCT01764633|20380339|P2|Overall Study|Lost to Follow-up|5
5890771|NCT01764633|20380340|P1|Overall Study|Lost to Follow-up|13
5890772|NCT01764633|20380339|P2|Overall Study|Withdrawal by Subject|88
5890773|NCT01764633|20380340|P1|Overall Study|Withdrawal by Subject|105
5890774|NCT01764464|20380369|P2|Second Intervention (Cross-over)|Adverse Event|0
5890775|NCT01764464|20380370|P1|Second Intervention (Cross-over)|Adverse Event|2
5890776|NCT01764464|20380369|P2|First Intervention|did not receive study drug|1
5890777|NCT01764464|20380370|P1|First Intervention|did not receive study drug|0
5890778|NCT01764464|20380369|P2|First Intervention|Adverse Event|2
5890779|NCT01764464|20380370|P1|First Intervention|Adverse Event|0
5890780|NCT01764464|20380369|P2|First Intervention|Lost to Follow-up|0
5890781|NCT01764464|20380370|P1|First Intervention|Lost to Follow-up|1
5890782|NCT01764464|20380369|P2|First Intervention|Withdrawal by Subject|0
5890783|NCT01764464|20380370|P1|First Intervention|Withdrawal by Subject|1
5890784|NCT01764386|20380388|P2|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5
5890785|NCT01764386|20380389|P1|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5
5890786|NCT01764386|20380388|P2|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9
5890787|NCT01764386|20380389|P1|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9
5890788|NCT01764386|20380388|P2|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|26
5890789|NCT01764386|20380389|P1|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|0
5890790|NCT01764386|20380388|P2|Uncontrolled Treatment Period (UTP)|Adverse Event|13
5890791|NCT01764386|20380389|P1|Uncontrolled Treatment Period (UTP)|Adverse Event|2
5890792|NCT01764386|20380388|P2|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|2
5890793|NCT01764386|20380389|P1|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|6
5890794|NCT01764386|20380388|P2|Controlled Treatment Period (CTP)|Lost to Follow-up|5
5890795|NCT01764386|20380389|P1|Controlled Treatment Period (CTP)|Lost to Follow-up|9
5890796|NCT01764386|20380388|P2|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|0
5890797|NCT01764386|20380389|P1|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|32
5890798|NCT01764386|20380388|P2|Controlled Treatment Period (CTP)|Adverse Event|0
5890890|NCT01763866|20380806|P8|Overall Study|Lost to Follow-up|0
5890799|NCT01764386|20380389|P1|Controlled Treatment Period (CTP)|Adverse Event|35
5890800|NCT01764256|20380434|P4|Completed Study|Lost to Follow-up|1
5890801|NCT01764256|20380435|P3|Completed Study|Lost to Follow-up|0
5890802|NCT01764256|20380436|P2|Completed Study|Lost to Follow-up|0
5890803|NCT01764256|20380437|P1|Completed Study|Lost to Follow-up|0
5890804|NCT01764256|20380434|P4|Received All Vaccinations|Lost to Follow-up|0
5890805|NCT01764256|20380435|P3|Received All Vaccinations|Lost to Follow-up|0
5890806|NCT01764256|20380436|P2|Received All Vaccinations|Lost to Follow-up|0
5890807|NCT01764256|20380437|P1|Received All Vaccinations|Lost to Follow-up|1
5890808|NCT01764256|20380434|P4|Received All Vaccinations|Did not meet inclusion criteria|0
5890809|NCT01764256|20380435|P3|Received All Vaccinations|Did not meet inclusion criteria|1
5890810|NCT01764256|20380436|P2|Received All Vaccinations|Did not meet inclusion criteria|0
5890811|NCT01764256|20380437|P1|Received All Vaccinations|Did not meet inclusion criteria|0
5890812|NCT01764256|20380434|P4|Received All Vaccinations|Adverse Event|0
5890813|NCT01764256|20380435|P3|Received All Vaccinations|Adverse Event|0
5890814|NCT01764256|20380436|P2|Received All Vaccinations|Adverse Event|1
5890815|NCT01764256|20380437|P1|Received All Vaccinations|Adverse Event|1
5890816|NCT01764022|20380480|P2|Overall Study|Protocol Violation|0
5890817|NCT01764022|20380481|P1|Overall Study|Protocol Violation|1
5890818|NCT01764022|20380480|P2|Overall Study|Lost to Follow-up|0
5890819|NCT01764022|20380481|P1|Overall Study|Lost to Follow-up|2
5890820|NCT01764022|20380480|P2|Overall Study|Physician Decision|2
5890821|NCT01764022|20380481|P1|Overall Study|Physician Decision|0
5890822|NCT01764022|20380480|P2|Overall Study|Lack of Efficacy|1
5890823|NCT01764022|20380481|P1|Overall Study|Lack of Efficacy|0
5890824|NCT01764022|20380480|P2|Overall Study|Withdrawal by Subject|6
5890825|NCT01764022|20380481|P1|Overall Study|Withdrawal by Subject|2
5890826|NCT01764022|20380480|P2|Overall Study|Death|5
5890827|NCT01764022|20380481|P1|Overall Study|Death|3
5890828|NCT01763996|20380513|P2|Treatment Period 2|Adverse Event|1
5890829|NCT01763996|20380514|P1|Treatment Period 2|Adverse Event|0
5890830|NCT01763918|20380568|P4|Overall Study|Sponsor Decision|0
5890831|NCT01763918|20380569|P3|Overall Study|Sponsor Decision|9
5890832|NCT01763918|20380570|P2|Overall Study|Sponsor Decision|0
5890833|NCT01763918|20380571|P1|Overall Study|Sponsor Decision|4
5890834|NCT01763918|20380568|P4|Overall Study|Withdrawal by Subject|2
5890835|NCT01763918|20380569|P3|Overall Study|Withdrawal by Subject|1
5890836|NCT01763918|20380570|P2|Overall Study|Withdrawal by Subject|1
5890837|NCT01763918|20380571|P1|Overall Study|Withdrawal by Subject|2
5890838|NCT01763905|20380669|P4|Overall Study|Lost to Follow-up|0
5890839|NCT01763905|20380670|P3|Overall Study|Lost to Follow-up|1
5890840|NCT01763905|20380671|P2|Overall Study|Lost to Follow-up|0
5890841|NCT01763905|20380672|P1|Overall Study|Lost to Follow-up|0
5890842|NCT01763905|20380669|P4|Overall Study|Decision by sponsor|0
5890843|NCT01763905|20380670|P3|Overall Study|Decision by sponsor|8
5890844|NCT01763905|20380671|P2|Overall Study|Decision by sponsor|0
5890845|NCT01763905|20380672|P1|Overall Study|Decision by sponsor|5
5890846|NCT01763905|20380669|P4|Overall Study|Withdrawal by Subject|1
5890847|NCT01763905|20380670|P3|Overall Study|Withdrawal by Subject|0
5890848|NCT01763905|20380671|P2|Overall Study|Withdrawal by Subject|1
5890849|NCT01763905|20380672|P1|Overall Study|Withdrawal by Subject|1
5890850|NCT01763866|20380790|P24|Overall Study|Death|0
5890851|NCT01763866|20380791|P23|Overall Study|Death|0
5890852|NCT01763866|20380792|P22|Overall Study|Death|0
5890853|NCT01763866|20380793|P21|Overall Study|Death|0
5890854|NCT01763866|20380794|P20|Overall Study|Death|0
5890855|NCT01763866|20380795|P19|Overall Study|Death|0
5890856|NCT01763866|20380796|P18|Overall Study|Death|0
5890857|NCT01763866|20380797|P17|Overall Study|Death|1
5890858|NCT01763866|20380798|P16|Overall Study|Death|0
5890859|NCT01763866|20380799|P15|Overall Study|Death|0
5890860|NCT01763866|20380800|P14|Overall Study|Death|0
5890861|NCT01763866|20380801|P13|Overall Study|Death|0
5890862|NCT01763866|20380802|P12|Overall Study|Death|0
5890863|NCT01763866|20380803|P11|Overall Study|Death|0
5890864|NCT01763866|20380804|P10|Overall Study|Death|0
5890865|NCT01763866|20380805|P9|Overall Study|Death|0
5890866|NCT01763866|20380806|P8|Overall Study|Death|0
5890867|NCT01763866|20380807|P7|Overall Study|Death|0
5890868|NCT01763866|20380808|P6|Overall Study|Death|0
5890869|NCT01763866|20380809|P5|Overall Study|Death|0
5890870|NCT01763866|20380810|P4|Overall Study|Death|0
5890871|NCT01763866|20380811|P3|Overall Study|Death|0
5890872|NCT01763866|20380812|P2|Overall Study|Death|0
5890873|NCT01763866|20380813|P1|Overall Study|Death|0
5890874|NCT01763866|20380790|P24|Overall Study|Lost to Follow-up|1
5890875|NCT01763866|20380791|P23|Overall Study|Lost to Follow-up|0
5890876|NCT01763866|20380792|P22|Overall Study|Lost to Follow-up|0
5890877|NCT01763866|20380793|P21|Overall Study|Lost to Follow-up|0
5890878|NCT01763866|20380794|P20|Overall Study|Lost to Follow-up|1
5890879|NCT01763866|20380795|P19|Overall Study|Lost to Follow-up|1
5890880|NCT01763866|20380796|P18|Overall Study|Lost to Follow-up|0
5890881|NCT01763866|20380797|P17|Overall Study|Lost to Follow-up|0
5890882|NCT01763866|20380798|P16|Overall Study|Lost to Follow-up|0
5890883|NCT01763866|20380799|P15|Overall Study|Lost to Follow-up|1
5890884|NCT01763866|20380800|P14|Overall Study|Lost to Follow-up|0
5890885|NCT01763866|20380801|P13|Overall Study|Lost to Follow-up|1
5890886|NCT01763866|20380802|P12|Overall Study|Lost to Follow-up|0
5890887|NCT01763866|20380803|P11|Overall Study|Lost to Follow-up|0
5890888|NCT01763866|20380804|P10|Overall Study|Lost to Follow-up|0
5890889|NCT01763866|20380805|P9|Overall Study|Lost to Follow-up|0
5890891|NCT01763866|20380807|P7|Overall Study|Lost to Follow-up|1
5890892|NCT01763866|20380808|P6|Overall Study|Lost to Follow-up|0
5890893|NCT01763866|20380809|P5|Overall Study|Lost to Follow-up|0
5890894|NCT01763866|20380810|P4|Overall Study|Lost to Follow-up|0
5890895|NCT01763866|20380811|P3|Overall Study|Lost to Follow-up|0
5890896|NCT01763866|20380812|P2|Overall Study|Lost to Follow-up|0
5890897|NCT01763866|20380813|P1|Overall Study|Lost to Follow-up|0
5890898|NCT01763866|20380790|P24|Overall Study|Decision by sponsor|0
5890899|NCT01763866|20380791|P23|Overall Study|Decision by sponsor|1
5890900|NCT01763866|20380792|P22|Overall Study|Decision by sponsor|0
5890901|NCT01763866|20380793|P21|Overall Study|Decision by sponsor|2
5890902|NCT01763866|20380794|P20|Overall Study|Decision by sponsor|0
5890903|NCT01763866|20380795|P19|Overall Study|Decision by sponsor|4
5890904|NCT01763866|20380796|P18|Overall Study|Decision by sponsor|0
5890905|NCT01763866|20380797|P17|Overall Study|Decision by sponsor|0
5890906|NCT01763866|20380798|P16|Overall Study|Decision by sponsor|0
5890907|NCT01763866|20380799|P15|Overall Study|Decision by sponsor|5
5890908|NCT01763866|20380800|P14|Overall Study|Decision by sponsor|0
5890909|NCT01763866|20380801|P13|Overall Study|Decision by sponsor|1
5890910|NCT01763866|20380802|P12|Overall Study|Decision by sponsor|0
5890911|NCT01763866|20380803|P11|Overall Study|Decision by sponsor|6
5890912|NCT01763866|20380804|P10|Overall Study|Decision by sponsor|0
5890913|NCT01763866|20380805|P9|Overall Study|Decision by sponsor|2
5890914|NCT01763866|20380806|P8|Overall Study|Decision by sponsor|0
5890915|NCT01763866|20380807|P7|Overall Study|Decision by sponsor|2
5890916|NCT01763866|20380808|P6|Overall Study|Decision by sponsor|0
5890917|NCT01763866|20380809|P5|Overall Study|Decision by sponsor|2
5890918|NCT01763866|20380810|P4|Overall Study|Decision by sponsor|0
5890919|NCT01763866|20380811|P3|Overall Study|Decision by sponsor|1
5890920|NCT01763866|20380812|P2|Overall Study|Decision by sponsor|0
5890921|NCT01763866|20380813|P1|Overall Study|Decision by sponsor|0
5890922|NCT01763866|20380790|P24|Overall Study|Withdrawal by Subject|1
5890923|NCT01763866|20380791|P23|Overall Study|Withdrawal by Subject|2
5890924|NCT01763866|20380792|P22|Overall Study|Withdrawal by Subject|1
5890925|NCT01763866|20380793|P21|Overall Study|Withdrawal by Subject|2
5890926|NCT01763866|20380794|P20|Overall Study|Withdrawal by Subject|1
5890927|NCT01763866|20380795|P19|Overall Study|Withdrawal by Subject|1
5890928|NCT01763866|20380796|P18|Overall Study|Withdrawal by Subject|1
5890929|NCT01763866|20380797|P17|Overall Study|Withdrawal by Subject|0
5890930|NCT01763866|20380798|P16|Overall Study|Withdrawal by Subject|3
5890931|NCT01763866|20380799|P15|Overall Study|Withdrawal by Subject|6
5890932|NCT01763866|20380800|P14|Overall Study|Withdrawal by Subject|0
5890933|NCT01763866|20380801|P13|Overall Study|Withdrawal by Subject|2
5890934|NCT01763866|20380802|P12|Overall Study|Withdrawal by Subject|2
5890935|NCT01763866|20380803|P11|Overall Study|Withdrawal by Subject|2
5890936|NCT01763866|20380804|P10|Overall Study|Withdrawal by Subject|1
5890937|NCT01763866|20380805|P9|Overall Study|Withdrawal by Subject|1
5890938|NCT01763866|20380806|P8|Overall Study|Withdrawal by Subject|0
5890939|NCT01763866|20380807|P7|Overall Study|Withdrawal by Subject|4
5890940|NCT01763866|20380808|P6|Overall Study|Withdrawal by Subject|3
5890941|NCT01763866|20380809|P5|Overall Study|Withdrawal by Subject|0
5890942|NCT01763866|20380810|P4|Overall Study|Withdrawal by Subject|0
5890943|NCT01763866|20380811|P3|Overall Study|Withdrawal by Subject|4
5890944|NCT01763866|20380812|P2|Overall Study|Withdrawal by Subject|1
5890945|NCT01763866|20380813|P1|Overall Study|Withdrawal by Subject|2
5890946|NCT01763827|20381373|P6|Overall Study|Lost to Follow-up|1
5890947|NCT01763827|20381374|P5|Overall Study|Lost to Follow-up|2
5890948|NCT01763827|20381375|P4|Overall Study|Lost to Follow-up|1
5890949|NCT01763827|20381376|P3|Overall Study|Lost to Follow-up|1
5890950|NCT01763827|20381377|P2|Overall Study|Lost to Follow-up|1
5890951|NCT01763827|20381378|P1|Overall Study|Lost to Follow-up|0
5890952|NCT01763827|20381373|P6|Overall Study|Decision by sponsor|1
5890953|NCT01763827|20381374|P5|Overall Study|Decision by sponsor|2
5890954|NCT01763827|20381375|P4|Overall Study|Decision by sponsor|0
5890955|NCT01763827|20381376|P3|Overall Study|Decision by sponsor|3
5890956|NCT01763827|20381377|P2|Overall Study|Decision by sponsor|0
5890957|NCT01763827|20381378|P1|Overall Study|Decision by sponsor|2
5890958|NCT01763827|20381373|P6|Overall Study|Withdrawal by Subject|0
5890959|NCT01763827|20381374|P5|Overall Study|Withdrawal by Subject|2
5890960|NCT01763827|20381375|P4|Overall Study|Withdrawal by Subject|0
5890961|NCT01763827|20381376|P3|Overall Study|Withdrawal by Subject|0
5890962|NCT01763827|20381377|P2|Overall Study|Withdrawal by Subject|0
5890963|NCT01763827|20381378|P1|Overall Study|Withdrawal by Subject|1
5890964|NCT01763788|20381522|P4|Overall Study|Lost to Follow-up|0
5890965|NCT01763788|20381523|P3|Overall Study|Lost to Follow-up|1
5890966|NCT01763788|20381524|P2|Overall Study|Lost to Follow-up|0
5890967|NCT01763788|20381525|P1|Overall Study|Lost to Follow-up|0
5890968|NCT01763203|20381746|P2|Overall Study|Physician Decision|1
5890969|NCT01763203|20381747|P1|Overall Study|Physician Decision|2
5890970|NCT01763203|20381746|P2|Overall Study|Moved out of study region|10
5890971|NCT01763203|20381747|P1|Overall Study|Moved out of study region|7
5890972|NCT01763203|20381746|P2|Overall Study|Withdrawal by Subject|12
5890973|NCT01763203|20381747|P1|Overall Study|Withdrawal by Subject|8
5890974|NCT01763203|20381746|P2|Overall Study|Lost to Follow-up|12
5890975|NCT01763203|20381747|P1|Overall Study|Lost to Follow-up|12
5890976|NCT01763203|20381746|P2|Overall Study|Death|7
5890977|NCT01763203|20381747|P1|Overall Study|Death|4
5890978|NCT01763047|20381793|P2|Period 2|Unsatisfactory lens Fitting|1
5890979|NCT01763047|20381794|P1|Period 2|Unsatisfactory lens Fitting|0
5890980|NCT01763047|20381793|P2|Period 2|Protocol Violation|2
5890981|NCT01763047|20381794|P1|Period 2|Protocol Violation|0
5890982|NCT01763047|20381793|P2|Period 2|Unsatisfactory Visual Response|1
5890983|NCT01763047|20381794|P1|Period 2|Unsatisfactory Visual Response|1
5890984|NCT01763047|20381793|P2|Period 2|Study Site office Closed|1
5890985|NCT01763047|20381794|P1|Period 2|Study Site office Closed|1
5890986|NCT01763047|20381793|P2|Period 2|No longer meets Eligibility Criteria|0
5890987|NCT01763047|20381794|P1|Period 2|No longer meets Eligibility Criteria|1
5890988|NCT01763047|20381793|P2|Period 2|Lens Discomfort|0
5890989|NCT01763047|20381794|P1|Period 2|Lens Discomfort|1
5890990|NCT01763047|20381793|P2|Period 1|Study Site office Closed|1
5890991|NCT01763047|20381794|P1|Period 1|Study Site office Closed|0
5890992|NCT01763047|20381793|P2|Period 1|Lens Power Not Available|1
5890993|NCT01763047|20381794|P1|Period 1|Lens Power Not Available|0
5890994|NCT01763047|20381793|P2|Period 1|Unsatisfactory Visual Response|3
5890995|NCT01763047|20381794|P1|Period 1|Unsatisfactory Visual Response|0
5890996|NCT01763047|20381793|P2|Period 1|Adverse Event|1
5890997|NCT01763047|20381794|P1|Period 1|Adverse Event|0
5890998|NCT01763047|20381793|P2|Period 1|No Longer Meets Eligibility criteria|0
5890999|NCT01763047|20381794|P1|Period 1|No Longer Meets Eligibility criteria|1
5891000|NCT01763047|20381793|P2|Period 1|Protocol Violation|4
5891001|NCT01763047|20381794|P1|Period 1|Protocol Violation|4
5891002|NCT01763047|20381793|P2|Period 1|Test Article Not Available|1
5891003|NCT01763047|20381794|P1|Period 1|Test Article Not Available|4
5891004|NCT01762943|20381833|P2|Overall Study|Withdrawal by Subject|1
5891005|NCT01762943|20381834|P1|Overall Study|Withdrawal by Subject|2
5891006|NCT01762943|20381833|P2|Overall Study|Protocol Violation|0
5891007|NCT01762943|20381834|P1|Overall Study|Protocol Violation|1
5891008|NCT01762943|20381833|P2|Overall Study|Physician Decision|1
5891009|NCT01762943|20381834|P1|Overall Study|Physician Decision|1
5891010|NCT01762800|20381851|P2|Overall Study|Withdrawal by Subject|4
5891011|NCT01762800|20381852|P1|Overall Study|Withdrawal by Subject|7
5891012|NCT01762800|20381851|P2|Overall Study|Physician Decision|1
5891013|NCT01762800|20381852|P1|Overall Study|Physician Decision|1
5891014|NCT01762800|20381851|P2|Overall Study|Study Closed/Terminated|1
5891015|NCT01762800|20381852|P1|Overall Study|Study Closed/Terminated|0
5891016|NCT01762800|20381851|P2|Overall Study|Lack of Efficacy|2
5891017|NCT01762800|20381852|P1|Overall Study|Lack of Efficacy|3
5891018|NCT01762800|20381851|P2|Overall Study|Adverse Event|13
5891019|NCT01762800|20381852|P1|Overall Study|Adverse Event|8
5891020|NCT01762761|20381926|P2|Overall Study|Withdrawal by Subject|8
5891021|NCT01762761|20381927|P1|Overall Study|Withdrawal by Subject|7
5891022|NCT01762761|20381926|P2|Overall Study|Physician Decision|6
5891023|NCT01762761|20381927|P1|Overall Study|Physician Decision|4
5891024|NCT01762761|20381926|P2|Overall Study|Lost to Follow-up|6
5891025|NCT01762761|20381927|P1|Overall Study|Lost to Follow-up|3
5891026|NCT01762761|20381926|P2|Overall Study|Study closed/terminated|2
5891027|NCT01762761|20381927|P1|Overall Study|Study closed/terminated|0
5891028|NCT01762761|20381926|P2|Overall Study|Protocol Violation|1
5891029|NCT01762761|20381927|P1|Overall Study|Protocol Violation|1
5891030|NCT01762761|20381926|P2|Overall Study|Lack of Efficacy|25
5891031|NCT01762761|20381927|P1|Overall Study|Lack of Efficacy|9
5891032|NCT01762761|20381926|P2|Overall Study|Adverse Event|17
5891033|NCT01762761|20381927|P1|Overall Study|Adverse Event|15
5891034|NCT01762345|20382026|P1|Overall Study|Protocol Violation|2
5891035|NCT01762345|20382026|P1|Overall Study|Adverse Event|5
5891036|NCT01761565|20382087|P1|40 Consecutive Doses of SUF 15 mcg|Adverse Event|1
5891037|NCT01761292|20382099|P1|Extension 1|Withdrawal by Subject|1
5891038|NCT01761292|20382099|P1|Part 1|not receiving treatment in Part 1|1
5891039|NCT01761292|20382099|P1|Part 1|Adverse Event|1
5891040|NCT01761266|20382133|P2|Overall Study|Ongoing as of data-cut off|107
5891041|NCT01761266|20382134|P1|Overall Study|Ongoing as of data-cut off|109
5891042|NCT01761266|20382133|P2|Overall Study|Withdrawal by Subject|8
5891043|NCT01761266|20382134|P1|Overall Study|Withdrawal by Subject|13
5891044|NCT01761266|20382133|P2|Overall Study|Lost to Follow-up|11
5891045|NCT01761266|20382134|P1|Overall Study|Lost to Follow-up|5
5891046|NCT01761266|20382133|P2|Overall Study|Death|350
5891047|NCT01761266|20382134|P1|Overall Study|Death|351
5891048|NCT01761162|20382191|P1|Overall Study|Withdrawal by Subject|3
5891049|NCT01760954|20382280|P4|Post-treatment Follow-up (12 Months)|Other|6
5891050|NCT01760954|20382281|P3|Post-treatment Follow-up (12 Months)|Other|9
5891051|NCT01760954|20382282|P2|Post-treatment Follow-up (12 Months)|Other|8
5891052|NCT01760954|20382283|P1|Post-treatment Follow-up (12 Months)|Other|13
5891053|NCT01760954|20382280|P4|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0
5891054|NCT01760954|20382281|P3|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|1
5891055|NCT01760954|20382282|P2|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0
5891056|NCT01760954|20382283|P1|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0
5891057|NCT01760954|20382280|P4|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0
5891058|NCT01760954|20382281|P3|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0
5891059|NCT01760954|20382282|P2|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|4
5891060|NCT01760954|20382283|P1|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|1
5891061|NCT01760954|20382280|P4|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5
5891140|NCT01760447|20382465|P4|Weeks 0-20|Withdrawal by Subject|0
5891062|NCT01760954|20382281|P3|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5
5891063|NCT01760954|20382282|P2|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|10
5891064|NCT01760954|20382283|P1|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|6
5891065|NCT01760954|20382280|P4|Post-treatment Follow-up (12 Months)|Lost to Follow-up|0
5891066|NCT01760954|20382281|P3|Post-treatment Follow-up (12 Months)|Lost to Follow-up|2
5891067|NCT01760954|20382282|P2|Post-treatment Follow-up (12 Months)|Lost to Follow-up|7
5891068|NCT01760954|20382283|P1|Post-treatment Follow-up (12 Months)|Lost to Follow-up|4
5891069|NCT01760954|20382280|P4|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|9
5891070|NCT01760954|20382281|P3|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4
5891071|NCT01760954|20382282|P2|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6
5891072|NCT01760954|20382283|P1|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6
5891073|NCT01760954|20382280|P4|Treatment Period (6 Months)|Exclusionary Medication|0
5891074|NCT01760954|20382281|P3|Treatment Period (6 Months)|Exclusionary Medication|0
5891075|NCT01760954|20382282|P2|Treatment Period (6 Months)|Exclusionary Medication|0
5891076|NCT01760954|20382283|P1|Treatment Period (6 Months)|Exclusionary Medication|1
5891077|NCT01760954|20382280|P4|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0
5891078|NCT01760954|20382281|P3|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0
5891079|NCT01760954|20382282|P2|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|6
5891080|NCT01760954|20382283|P1|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|1
5891081|NCT01760954|20382280|P4|Treatment Period (6 Months)|Other|1
5891082|NCT01760954|20382281|P3|Treatment Period (6 Months)|Other|3
5891083|NCT01760954|20382282|P2|Treatment Period (6 Months)|Other|3
5891084|NCT01760954|20382283|P1|Treatment Period (6 Months)|Other|0
5891085|NCT01760954|20382280|P4|Treatment Period (6 Months)|Non-compliance|3
5891086|NCT01760954|20382281|P3|Treatment Period (6 Months)|Non-compliance|0
5891087|NCT01760954|20382282|P2|Treatment Period (6 Months)|Non-compliance|4
5891088|NCT01760954|20382283|P1|Treatment Period (6 Months)|Non-compliance|1
5891089|NCT01760954|20382280|P4|Treatment Period (6 Months)|Pregnancy|2
5891090|NCT01760954|20382281|P3|Treatment Period (6 Months)|Pregnancy|3
5891091|NCT01760954|20382282|P2|Treatment Period (6 Months)|Pregnancy|0
5891092|NCT01760954|20382283|P1|Treatment Period (6 Months)|Pregnancy|5
5891093|NCT01760954|20382280|P4|Treatment Period (6 Months)|Surgery or invasive intervention for end|2
5891094|NCT01760954|20382281|P3|Treatment Period (6 Months)|Surgery or invasive intervention for end|3
5891095|NCT01760954|20382282|P2|Treatment Period (6 Months)|Surgery or invasive intervention for end|3
5891096|NCT01760954|20382283|P1|Treatment Period (6 Months)|Surgery or invasive intervention for end|3
5891097|NCT01760954|20382280|P4|Treatment Period (6 Months)|Lost to Follow-up|3
5891098|NCT01760954|20382281|P3|Treatment Period (6 Months)|Lost to Follow-up|4
5891099|NCT01760954|20382282|P2|Treatment Period (6 Months)|Lost to Follow-up|1
5891100|NCT01760954|20382283|P1|Treatment Period (6 Months)|Lost to Follow-up|9
5891101|NCT01760954|20382280|P4|Treatment Period (6 Months)|Adverse Event|10
5891102|NCT01760954|20382281|P3|Treatment Period (6 Months)|Adverse Event|4
5891103|NCT01760954|20382282|P2|Treatment Period (6 Months)|Adverse Event|3
5891104|NCT01760954|20382283|P1|Treatment Period (6 Months)|Adverse Event|5
5891105|NCT01760954|20382280|P4|Treatment Period (6 Months)|Withdrawal by Subject|5
5891106|NCT01760954|20382281|P3|Treatment Period (6 Months)|Withdrawal by Subject|4
5891107|NCT01760954|20382282|P2|Treatment Period (6 Months)|Withdrawal by Subject|8
5891108|NCT01760954|20382283|P1|Treatment Period (6 Months)|Withdrawal by Subject|8
5891109|NCT01760876|20382420|P1|Overall Study|Very poor baseline OCT quality|2
5891110|NCT01760876|20382420|P1|Overall Study|Major depression|1
5891111|NCT01760876|20382420|P1|Overall Study|Impaired renal function|1
5891112|NCT01760876|20382420|P1|Overall Study|Carcinoma of prostate|1
5891113|NCT01760876|20382420|P1|Overall Study|Non-cardiac death (head injury)|1
5891114|NCT01760733|20382435|P1|Transplanted|Graft loss|7
5891115|NCT01760733|20382435|P1|Transplanted|Death|26
5891116|NCT01760733|20382435|P1|Transplanted|Not reached 10 years post transplant|184
5891117|NCT01760733|20382435|P1|Waiting List|Not received a transplant yet|13
5891118|NCT01760733|20382435|P1|Waiting List|Removed from waiting list|41
5891119|NCT01760733|20382435|P1|Waiting List|Death|18
5891120|NCT01760447|20382465|P4|Weeks 20-54|Lost to Follow-up|2
5891121|NCT01760447|20382466|P3|Weeks 20-54|Lost to Follow-up|1
5891122|NCT01760447|20382467|P2|Weeks 20-54|Lost to Follow-up|0
5891123|NCT01760447|20382468|P1|Weeks 20-54|Lost to Follow-up|0
5891124|NCT01760447|20382465|P4|Weeks 20-54|Withdrawal by Subject|2
5891125|NCT01760447|20382466|P3|Weeks 20-54|Withdrawal by Subject|1
5891126|NCT01760447|20382467|P2|Weeks 20-54|Withdrawal by Subject|1
5891127|NCT01760447|20382468|P1|Weeks 20-54|Withdrawal by Subject|2
5891128|NCT01760447|20382465|P4|Weeks 20-54|Consent withdrawn by Parent/Guardian|0
5891129|NCT01760447|20382466|P3|Weeks 20-54|Consent withdrawn by Parent/Guardian|1
5891130|NCT01760447|20382467|P2|Weeks 20-54|Consent withdrawn by Parent/Guardian|1
5891131|NCT01760447|20382468|P1|Weeks 20-54|Consent withdrawn by Parent/Guardian|1
5891132|NCT01760447|20382465|P4|Weeks 0-20|Randomized but not treated|0
5891133|NCT01760447|20382466|P3|Weeks 0-20|Randomized but not treated|2
5891134|NCT01760447|20382467|P2|Weeks 0-20|Randomized but not treated|0
5891135|NCT01760447|20382468|P1|Weeks 0-20|Randomized but not treated|0
5891136|NCT01760447|20382465|P4|Weeks 0-20|Lost to Follow-up|1
5891137|NCT01760447|20382466|P3|Weeks 0-20|Lost to Follow-up|1
5891138|NCT01760447|20382467|P2|Weeks 0-20|Lost to Follow-up|0
5891139|NCT01760447|20382468|P1|Weeks 0-20|Lost to Follow-up|1
5891141|NCT01760447|20382466|P3|Weeks 0-20|Withdrawal by Subject|1
5891142|NCT01760447|20382467|P2|Weeks 0-20|Withdrawal by Subject|0
5891143|NCT01760447|20382468|P1|Weeks 0-20|Withdrawal by Subject|2
5891144|NCT01760447|20382465|P4|Weeks 0-20|Consent withdrawn by Parent/Guardian|3
5891145|NCT01760447|20382466|P3|Weeks 0-20|Consent withdrawn by Parent/Guardian|1
5891146|NCT01760447|20382467|P2|Weeks 0-20|Consent withdrawn by Parent/Guardian|0
5891147|NCT01760447|20382468|P1|Weeks 0-20|Consent withdrawn by Parent/Guardian|0
5891148|NCT01759862|20382796|P2|Overall Study|Adverse Event|1
5891149|NCT01759862|20382797|P1|Overall Study|Adverse Event|0
5891150|NCT01759862|20382796|P2|Overall Study|Physician Decision|1
5891151|NCT01759862|20382797|P1|Overall Study|Physician Decision|3
5891152|NCT01759511|20382815|P1|Overall Study|Withdrawal by Subject|3
5891153|NCT01759511|20382815|P1|Overall Study|Study Terminated by Sponsor|13
5891154|NCT01759511|20382815|P1|Overall Study|Protocol-Specified Criteria for Withdraw|4
5891155|NCT01759511|20382815|P1|Overall Study|Progressive Disease|5
5891156|NCT01759511|20382815|P1|Overall Study|Physician Decision|1
5891157|NCT01759511|20382815|P1|Overall Study|Lack of Efficacy|2
5891158|NCT01759511|20382815|P1|Overall Study|Death|2
5891159|NCT01759511|20382815|P1|Overall Study|Adverse Event|4
5891160|NCT01759446|20382828|P5|Overall Study|Withdrawal by Subject|0
5891161|NCT01759446|20382829|P4|Overall Study|Withdrawal by Subject|1
5891162|NCT01759446|20382830|P3|Overall Study|Withdrawal by Subject|0
5891163|NCT01759446|20382831|P2|Overall Study|Withdrawal by Subject|1
5891164|NCT01759446|20382832|P1|Overall Study|Withdrawal by Subject|0
5891165|NCT01759446|20382828|P5|Overall Study|Protocol Violation|0
5891166|NCT01759446|20382829|P4|Overall Study|Protocol Violation|0
5891167|NCT01759446|20382830|P3|Overall Study|Protocol Violation|1
5891168|NCT01759446|20382831|P2|Overall Study|Protocol Violation|0
5891169|NCT01759446|20382832|P1|Overall Study|Protocol Violation|1
5891170|NCT01759420|20382844|P1|Overall Study|Inaccurate EKG machine readings|1
5891171|NCT01759420|20382844|P1|Overall Study|Screen failure|5
5891172|NCT01759407|20382851|P2|Overall Study|Protocol Violation|2
5891173|NCT01759407|20382852|P1|Overall Study|Protocol Violation|0
5891174|NCT01759381|20382864|P2|Overall Study|Death|0
5891175|NCT01759381|20382865|P1|Overall Study|Death|1
5891176|NCT01759368|20382873|P2|Overall Study|Lost to Follow-up|0
5891177|NCT01759368|20382874|P1|Overall Study|Lost to Follow-up|1
5891178|NCT01759290|20382892|P1|Overall Study|Unknown reason|4
5891179|NCT01759290|20382892|P1|Overall Study|Lost to Follow-up|53
5891180|NCT01759290|20382892|P1|Overall Study|Death|17
5891181|NCT01759290|20382892|P1|Overall Study|Physician Decision|2
5891182|NCT01759290|20382892|P1|Overall Study|Subjects withdrawn consent|5
5891183|NCT01759264|20382961|P1|Overall Study|Discontinued Humira Due to Business Trip|1
5891184|NCT01759264|20382961|P1|Overall Study|Withdrawal by Subject|3
5891185|NCT01759264|20382961|P1|Overall Study|Lost to Follow-up|2
5891186|NCT01759264|20382961|P1|Overall Study|Other|2
5891187|NCT01759264|20382961|P1|Overall Study|Adverse Event|1
5891188|NCT01759264|20382961|P1|Overall Study|Serious Adverse Events (SAEs)|1
5891189|NCT01758900|20382989|P2|Overall Study|difficulty for further intubation|8
5891190|NCT01758900|20382990|P1|Overall Study|difficulty for further intubation|7
5891191|NCT01758731|20383008|P1|Overall Study|Physician Decision|1
5891192|NCT01758523|20383027|P2|Overall Study|Withdrawal by Subject|7
5891193|NCT01758523|20383028|P1|Overall Study|Withdrawal by Subject|12
5891194|NCT01758523|20383027|P2|Overall Study|Lost to Follow-up|4
5891195|NCT01758523|20383028|P1|Overall Study|Lost to Follow-up|3
5891196|NCT01758523|20383027|P2|Overall Study|Lack of Efficacy|2
5891197|NCT01758523|20383028|P1|Overall Study|Lack of Efficacy|4
5891198|NCT01758523|20383027|P2|Overall Study|Adverse Event|1
5891199|NCT01758523|20383028|P1|Overall Study|Adverse Event|2
5891200|NCT01758289|20383131|P1|Overall Study|Adverse Event|9
5891201|NCT01758289|20383131|P1|Overall Study|Premature Study Termination|44
5891202|NCT01757847|20383157|P2|Overall Study|Withdrawal by Subject|4
5891203|NCT01757847|20383158|P1|Overall Study|Withdrawal by Subject|3
5891204|NCT01757821|20383166|P1|Overall Study|Adverse Event|1
5891205|NCT01757704|20383181|P2|Overall Study|Protocol Violation|3
5891206|NCT01757704|20383182|P1|Overall Study|Protocol Violation|1
5891207|NCT01757691|20383200|P2|Overall Study|Administrative problems|0
5891208|NCT01757691|20383201|P1|Overall Study|Administrative problems|2
5891209|NCT01757665|20383228|P2|Overall Study|Not Implanted with Device|1
5891210|NCT01757665|20383229|P1|Overall Study|Not Implanted with Device|5
5891211|NCT01757665|20383228|P2|Overall Study|Lost to Follow-up|1
5891212|NCT01757665|20383229|P1|Overall Study|Lost to Follow-up|1
5891213|NCT01757665|20383228|P2|Overall Study|Withdrawal by Subject|0
5891214|NCT01757665|20383229|P1|Overall Study|Withdrawal by Subject|10
5891215|NCT01757665|20383228|P2|Overall Study|Explant|2
5891216|NCT01757665|20383229|P1|Overall Study|Explant|1
5891217|NCT01757665|20383228|P2|Overall Study|Death|8
5891218|NCT01757665|20383229|P1|Overall Study|Death|25
5891219|NCT01757665|20383228|P2|Overall Study|Still on Study - Missed Visit|1
5891220|NCT01757665|20383229|P1|Overall Study|Still on Study - Missed Visit|14
5891221|NCT01757665|20383228|P2|Overall Study|Still on Study - Visit Pending|40
5891222|NCT01757665|20383229|P1|Overall Study|Still on Study - Visit Pending|398
5891223|NCT01757665|20383228|P2|Overall Study|Still on Study - Visit Completed|30
5891224|NCT01757665|20383229|P1|Overall Study|Still on Study - Visit Completed|240
5891225|NCT01757535|20383401|P2|Overall Study|Death|2
5891226|NCT01757535|20383402|P1|Overall Study|Death|1
5891227|NCT01757535|20383401|P2|Overall Study|Physician Decision|0
5891228|NCT01757535|20383402|P1|Overall Study|Physician Decision|6
5891229|NCT01757535|20383401|P2|Overall Study|Miscellaneous|2
5891230|NCT01757535|20383402|P1|Overall Study|Miscellaneous|5
5891231|NCT01757535|20383401|P2|Overall Study|Withdrawal by Subject|13
5891232|NCT01757535|20383402|P1|Overall Study|Withdrawal by Subject|9
5891233|NCT01757535|20383401|P2|Overall Study|Adverse Event|11
5891234|NCT01757535|20383402|P1|Overall Study|Adverse Event|29
5891235|NCT01757535|20383401|P2|Overall Study|Disease Relapse|180
5891236|NCT01757535|20383402|P1|Overall Study|Disease Relapse|143
5891237|NCT01757405|20383434|P2|Overall Study|Withdrawal by Subject|1
5891238|NCT01757405|20383435|P1|Overall Study|Withdrawal by Subject|0
5891239|NCT01757405|20383434|P2|Overall Study|Lost to Follow-up|1
5891240|NCT01757405|20383435|P1|Overall Study|Lost to Follow-up|1
5891244|NCT01757275|20383478|P2|Overall Study|Not treated|4
5891245|NCT01757275|20383479|P1|Overall Study|Not treated|3
5891246|NCT01757275|20383478|P2|Overall Study|Withdrawal by Subject|4
5891247|NCT01757275|20383479|P1|Overall Study|Withdrawal by Subject|2
5891248|NCT01757275|20383478|P2|Overall Study|Adverse Event|3
5891249|NCT01757275|20383479|P1|Overall Study|Adverse Event|3
5891250|NCT01757275|20383478|P2|Overall Study|Lost to Follow-up|2
5891251|NCT01757275|20383479|P1|Overall Study|Lost to Follow-up|1
5891252|NCT01757197|20383501|P1|Overall Study|Death|2
5891253|NCT01757184|20383510|P4|Open-label Period|Discontinued by Sponsor|2
5891254|NCT01757184|20383511|P3|Open-label Period|Discontinued by Sponsor|1
5891255|NCT01757184|20383512|P2|Open-label Period|Discontinued by Sponsor|0
5891256|NCT01757184|20383513|P1|Open-label Period|Discontinued by Sponsor|0
5891257|NCT01757184|20383510|P4|Open-label Period|Withdrawal by Subject|1
5891258|NCT01757184|20383511|P3|Open-label Period|Withdrawal by Subject|1
5891259|NCT01757184|20383512|P2|Open-label Period|Withdrawal by Subject|0
5891260|NCT01757184|20383513|P1|Open-label Period|Withdrawal by Subject|0
5891261|NCT01757184|20383510|P4|Open-label Period|Lost to Follow-up|0
5891262|NCT01757184|20383511|P3|Open-label Period|Lost to Follow-up|2
5891263|NCT01757184|20383512|P2|Open-label Period|Lost to Follow-up|0
5891264|NCT01757184|20383513|P1|Open-label Period|Lost to Follow-up|0
5891265|NCT01757184|20383510|P4|Double-blind Period|Adverse Event|0
5891266|NCT01757184|20383511|P3|Double-blind Period|Adverse Event|0
5891267|NCT01757184|20383512|P2|Double-blind Period|Adverse Event|0
5891268|NCT01757184|20383513|P1|Double-blind Period|Adverse Event|1
5891269|NCT01757171|20383557|P2|Overall Study|ECOG decline|0
5891270|NCT01757171|20383558|P1|Overall Study|ECOG decline|1
5891271|NCT01757171|20383557|P2|Overall Study|Hospitalization|0
5891272|NCT01757171|20383558|P1|Overall Study|Hospitalization|1
5891273|NCT01757171|20383557|P2|Overall Study|Disease Progression|0
5891274|NCT01757171|20383558|P1|Overall Study|Disease Progression|1
5891275|NCT01757171|20383557|P2|Overall Study|Adverse Event|1
5891276|NCT01757171|20383558|P1|Overall Study|Adverse Event|5
5891277|NCT01756846|20383594|P2|Overall Study|Withdrawal by Subject|2
5891278|NCT01756846|20383595|P1|Overall Study|Withdrawal by Subject|1
5891279|NCT01756846|20383594|P2|Overall Study|Lost to Follow-up|10
5891280|NCT01756846|20383595|P1|Overall Study|Lost to Follow-up|5
5891281|NCT01756456|20383640|P6|Follow Up Period Phase I/II|Other causes|5
5891282|NCT01756456|20383641|P5|Follow Up Period Phase I/II|Other causes|3
5891283|NCT01756456|20383642|P4|Follow Up Period Phase I/II|Other causes|1
5891284|NCT01756456|20383643|P3|Follow Up Period Phase I/II|Other causes|0
5891285|NCT01756456|20383644|P2|Follow Up Period Phase I/II|Other causes|0
5891286|NCT01756456|20383645|P1|Follow Up Period Phase I/II|Other causes|0
5891287|NCT01756456|20383640|P6|Follow Up Period Phase I/II|Lost to Follow-up|1
5891288|NCT01756456|20383641|P5|Follow Up Period Phase I/II|Lost to Follow-up|0
5891289|NCT01756456|20383642|P4|Follow Up Period Phase I/II|Lost to Follow-up|2
5891290|NCT01756456|20383643|P3|Follow Up Period Phase I/II|Lost to Follow-up|1
5891291|NCT01756456|20383644|P2|Follow Up Period Phase I/II|Lost to Follow-up|0
5891292|NCT01756456|20383645|P1|Follow Up Period Phase I/II|Lost to Follow-up|0
5891293|NCT01756456|20383640|P6|Follow Up Period Phase I/II|Adverse Event|1
5891294|NCT01756456|20383641|P5|Follow Up Period Phase I/II|Adverse Event|0
5891295|NCT01756456|20383642|P4|Follow Up Period Phase I/II|Adverse Event|5
5891296|NCT01756456|20383643|P3|Follow Up Period Phase I/II|Adverse Event|0
5891297|NCT01756456|20383644|P2|Follow Up Period Phase I/II|Adverse Event|0
5891298|NCT01756456|20383645|P1|Follow Up Period Phase I/II|Adverse Event|1
5891299|NCT01756456|20383640|P6|Follow Up Period Phase I/II|Lack of Efficacy|1
5891300|NCT01756456|20383641|P5|Follow Up Period Phase I/II|Lack of Efficacy|0
5891301|NCT01756456|20383642|P4|Follow Up Period Phase I/II|Lack of Efficacy|0
5891302|NCT01756456|20383643|P3|Follow Up Period Phase I/II|Lack of Efficacy|0
5891303|NCT01756456|20383644|P2|Follow Up Period Phase I/II|Lack of Efficacy|0
5891304|NCT01756456|20383645|P1|Follow Up Period Phase I/II|Lack of Efficacy|0
5891305|NCT01756456|20383640|P6|Follow Up Period Phase I/II|parent withdrew the consent to continue|0
5891306|NCT01756456|20383641|P5|Follow Up Period Phase I/II|parent withdrew the consent to continue|0
5891307|NCT01756456|20383642|P4|Follow Up Period Phase I/II|parent withdrew the consent to continue|0
5891308|NCT01756456|20383643|P3|Follow Up Period Phase I/II|parent withdrew the consent to continue|0
5891309|NCT01756456|20383644|P2|Follow Up Period Phase I/II|parent withdrew the consent to continue|1
5891310|NCT01756456|20383645|P1|Follow Up Period Phase I/II|parent withdrew the consent to continue|0
5891311|NCT01756456|20383640|P6|Follow Up Period Phase I/II|still in study after week 20|25
5891312|NCT01756456|20383641|P5|Follow Up Period Phase I/II|still in study after week 20|23
5891313|NCT01756456|20383642|P4|Follow Up Period Phase I/II|still in study after week 20|25
5891314|NCT01756456|20383643|P3|Follow Up Period Phase I/II|still in study after week 20|0
5891315|NCT01756456|20383644|P2|Follow Up Period Phase I/II|still in study after week 20|0
5891316|NCT01756456|20383645|P1|Follow Up Period Phase I/II|still in study after week 20|0
5891317|NCT01756456|20383640|P6|Treatment Period: Phase I/II|Other causes|2
5891318|NCT01756456|20383641|P5|Treatment Period: Phase I/II|Other causes|2
5891319|NCT01756456|20383642|P4|Treatment Period: Phase I/II|Other causes|1
5891320|NCT01756456|20383643|P3|Treatment Period: Phase I/II|Other causes|0
5891321|NCT01756456|20383644|P2|Treatment Period: Phase I/II|Other causes|0
5891322|NCT01756456|20383645|P1|Treatment Period: Phase I/II|Other causes|0
5891323|NCT01756456|20383640|P6|Treatment Period: Phase I/II|Adverse Event|1
5891324|NCT01756456|20383641|P5|Treatment Period: Phase I/II|Adverse Event|9
5891325|NCT01756456|20383642|P4|Treatment Period: Phase I/II|Adverse Event|3
5891326|NCT01756456|20383643|P3|Treatment Period: Phase I/II|Adverse Event|2
5891327|NCT01756456|20383644|P2|Treatment Period: Phase I/II|Adverse Event|0
5891328|NCT01756456|20383645|P1|Treatment Period: Phase I/II|Adverse Event|1
5891329|NCT01756456|20383640|P6|Treatment Period: Phase I/II|Withdrawal by Subject|0
5891330|NCT01756456|20383641|P5|Treatment Period: Phase I/II|Withdrawal by Subject|0
5891331|NCT01756456|20383642|P4|Treatment Period: Phase I/II|Withdrawal by Subject|0
5891332|NCT01756456|20383643|P3|Treatment Period: Phase I/II|Withdrawal by Subject|0
5891333|NCT01756456|20383644|P2|Treatment Period: Phase I/II|Withdrawal by Subject|1
5891334|NCT01756456|20383645|P1|Treatment Period: Phase I/II|Withdrawal by Subject|0
5891335|NCT01756456|20383640|P6|Treatment Period: Phase I/II|Lack of Efficacy|0
5891336|NCT01756456|20383641|P5|Treatment Period: Phase I/II|Lack of Efficacy|1
5891337|NCT01756456|20383642|P4|Treatment Period: Phase I/II|Lack of Efficacy|2
5891338|NCT01756456|20383643|P3|Treatment Period: Phase I/II|Lack of Efficacy|0
5891339|NCT01756456|20383644|P2|Treatment Period: Phase I/II|Lack of Efficacy|0
5891340|NCT01756456|20383645|P1|Treatment Period: Phase I/II|Lack of Efficacy|0
5891341|NCT01756456|20383640|P6|Treatment Period: Phase I/II|decision unrelated to adverse event|1
5891342|NCT01756456|20383641|P5|Treatment Period: Phase I/II|decision unrelated to adverse event|1
5891343|NCT01756456|20383642|P4|Treatment Period: Phase I/II|decision unrelated to adverse event|1
5891344|NCT01756456|20383643|P3|Treatment Period: Phase I/II|decision unrelated to adverse event|0
5891345|NCT01756456|20383644|P2|Treatment Period: Phase I/II|decision unrelated to adverse event|0
5891346|NCT01756456|20383645|P1|Treatment Period: Phase I/II|decision unrelated to adverse event|0
5891347|NCT01756352|20383747|P1|Overall Study|moved away and lost to followup|1
5891348|NCT01756300|20383752|P1|Overall Study|Withdrawal by Subject|1
5891349|NCT01756300|20383752|P1|Overall Study|Death|1
5891350|NCT01756274|20383774|P1|Overall Study|Laboratory error|1
5891351|NCT01756274|20383774|P1|Overall Study|Protocol Violation|2
5891352|NCT01756235|20383781|P1|Overall Study|Adalimumab Treatment was not Documented|2
5891353|NCT01756157|20383819|P2|First Intervention Period|Lost to Follow-up|2
5891354|NCT01756157|20383820|P1|First Intervention Period|Lost to Follow-up|0
5891355|NCT01756157|20383819|P2|First Intervention Period|Withdrawal by Subject|0
5891356|NCT01756157|20383820|P1|First Intervention Period|Withdrawal by Subject|1
5891357|NCT01756079|20383834|P1|Treatment / Follow-up: Week 4 to Week 72|No boceprevir during Treatment Period|4
5891358|NCT01756079|20383834|P1|Treatment / Follow-up: Week 4 to Week 72|Lack of Efficacy|20
5891359|NCT01756079|20383834|P1|Treatment / Follow-up: Week 4 to Week 72|No information available|2
5891360|NCT01756079|20383834|P1|Treatment / Follow-up: Week 4 to Week 72|Adverse Event|5
5891361|NCT01756079|20383834|P1|Treatment / Follow-up: Week 4 to Week 72|Withdrawal by Subject|4
5891362|NCT01756053|20383840|P2|Period 2 (10 Days)|Protocol Violation|2
5891363|NCT01756053|20383841|P1|Period 2 (10 Days)|Protocol Violation|0
5891364|NCT01756053|20383840|P2|Period 1 (10 Days)|Protocol Violation|1
5891365|NCT01756053|20383841|P1|Period 1 (10 Days)|Protocol Violation|1
5891366|NCT01755858|20383900|P2|Overall Study|Adverse Event|1
5891367|NCT01755858|20383901|P1|Overall Study|Adverse Event|1
5891368|NCT01755767|20383927|P4|Overall Study|Ongoing Treatment as of 06 Jan 2017|2
5891369|NCT01755767|20383928|P3|Overall Study|Ongoing Treatment as of 06 Jan 2017|5
5891370|NCT01755767|20383929|P2|Overall Study|Ongoing Treatment as of 06 Jan 2017|0
5891371|NCT01755767|20383930|P1|Overall Study|Ongoing Treatment as of 06 Jan 2017|0
5891372|NCT01755767|20383927|P4|Overall Study|Other|3
5891373|NCT01755767|20383928|P3|Overall Study|Other|2
5891374|NCT01755767|20383929|P2|Overall Study|Other|0
5891375|NCT01755767|20383930|P1|Overall Study|Other|0
5891376|NCT01755767|20383927|P4|Overall Study|Withdrawal by Subject|1
5891377|NCT01755767|20383928|P3|Overall Study|Withdrawal by Subject|2
5891378|NCT01755767|20383929|P2|Overall Study|Withdrawal by Subject|0
5891379|NCT01755767|20383930|P1|Overall Study|Withdrawal by Subject|0
5891380|NCT01755767|20383927|P4|Overall Study|Subject Decision|3
5891381|NCT01755767|20383928|P3|Overall Study|Subject Decision|10
5891382|NCT01755767|20383929|P2|Overall Study|Subject Decision|0
5891383|NCT01755767|20383930|P1|Overall Study|Subject Decision|0
5891384|NCT01755767|20383927|P4|Overall Study|Death|4
5891385|NCT01755767|20383928|P3|Overall Study|Death|15
5891386|NCT01755767|20383929|P2|Overall Study|Death|2
5891387|NCT01755767|20383930|P1|Overall Study|Death|1
5891388|NCT01755767|20383927|P4|Overall Study|Adverse Event|11
5891389|NCT01755767|20383928|P3|Overall Study|Adverse Event|28
5891390|NCT01755767|20383929|P2|Overall Study|Adverse Event|0
5891391|NCT01755767|20383930|P1|Overall Study|Adverse Event|6
5891392|NCT01755767|20383927|P4|Overall Study|Radiographic Disease Progression|27
5891393|NCT01755767|20383928|P3|Overall Study|Radiographic Disease Progression|44
5891394|NCT01755767|20383929|P2|Overall Study|Radiographic Disease Progression|4
5891395|NCT01755767|20383930|P1|Overall Study|Radiographic Disease Progression|9
5891396|NCT01755767|20383927|P4|Overall Study|Clinical Disease Progression|20
5891397|NCT01755767|20383928|P3|Overall Study|Clinical Disease Progression|29
5891398|NCT01755767|20383929|P2|Overall Study|Clinical Disease Progression|2
5891399|NCT01755767|20383930|P1|Overall Study|Clinical Disease Progression|4
5891400|NCT01755767|20383927|P4|Overall Study|Progressive Disease|43
5891401|NCT01755767|20383928|P3|Overall Study|Progressive Disease|91
5891402|NCT01755767|20383929|P2|Overall Study|Progressive Disease|7
5891403|NCT01755767|20383930|P1|Overall Study|Progressive Disease|8
5891404|NCT01755702|20383946|P1|Washout Period II|Other Reason|5
5891405|NCT01755702|20383946|P1|Wash Out Period I|Other Reason|3
5891406|NCT01755689|20383993|P5|Overall Study|Pregnancy|2
5891407|NCT01755689|20383994|P4|Overall Study|Pregnancy|4
5891408|NCT01755689|20383995|P3|Overall Study|Pregnancy|2
5891409|NCT01755689|20383996|P2|Overall Study|Pregnancy|1
5891410|NCT01755689|20383997|P1|Overall Study|Pregnancy|1
5891411|NCT01755689|20383993|P5|Overall Study|Lost to Follow-up|2
5891412|NCT01755689|20383994|P4|Overall Study|Lost to Follow-up|0
5891413|NCT01755689|20383995|P3|Overall Study|Lost to Follow-up|1
5891414|NCT01755689|20383996|P2|Overall Study|Lost to Follow-up|0
5891415|NCT01755689|20383997|P1|Overall Study|Lost to Follow-up|1
5891416|NCT01755689|20383993|P5|Overall Study|Migrated/moved from study area|1
5891417|NCT01755689|20383994|P4|Overall Study|Migrated/moved from study area|1
5891418|NCT01755689|20383995|P3|Overall Study|Migrated/moved from study area|1
5891419|NCT01755689|20383996|P2|Overall Study|Migrated/moved from study area|1
5891420|NCT01755689|20383997|P1|Overall Study|Migrated/moved from study area|0
5891421|NCT01755689|20383993|P5|Overall Study|Withdrawal by Subject|1
5891422|NCT01755689|20383994|P4|Overall Study|Withdrawal by Subject|1
5891423|NCT01755689|20383995|P3|Overall Study|Withdrawal by Subject|2
5891424|NCT01755689|20383996|P2|Overall Study|Withdrawal by Subject|3
5891425|NCT01755689|20383997|P1|Overall Study|Withdrawal by Subject|1
5891426|NCT01755637|20384072|P2|Period 1|Adverse Event|1
5891427|NCT01755637|20384073|P1|Period 1|Adverse Event|0
5891428|NCT01755598|20384093|P2|Overall Study|Adverse Event|28
5891429|NCT01755598|20384094|P1|Overall Study|Adverse Event|19
5891430|NCT01755598|20384093|P2|Overall Study|Protocol Violation|7
5891431|NCT01755598|20384094|P1|Overall Study|Protocol Violation|7
5891432|NCT01755598|20384093|P2|Overall Study|Withdrawal by Subject|31
5891433|NCT01755598|20384094|P1|Overall Study|Withdrawal by Subject|22
5891434|NCT01755598|20384093|P2|Overall Study|Migrated/moved from study area|65
5891435|NCT01755598|20384094|P1|Overall Study|Migrated/moved from study area|76
5891436|NCT01755598|20384093|P2|Overall Study|Lost to Follow-up|43
5891437|NCT01755598|20384094|P1|Overall Study|Lost to Follow-up|32
5891438|NCT01755598|20384093|P2|Overall Study|Other|109
5891439|NCT01755598|20384094|P1|Overall Study|Other|109
5891440|NCT01755546|20384128|P1|Long Term Treatment|other and ongoing|41
5891441|NCT01755546|20384128|P1|Long Term Treatment|Lost to Follow-up|17
5891442|NCT01755546|20384128|P1|Long Term Treatment|Withdrawal by Subject|35
5891443|NCT01755546|20384128|P1|Long Term Treatment|Protocol Violation|10
5891444|NCT01755546|20384128|P1|Long Term Treatment|Lack of Efficacy|6
5891445|NCT01755546|20384128|P1|Long Term Treatment|Adverse Event|12
5891446|NCT01755546|20384128|P1|Titration Phase|Withdrawal by Subject|8
5891447|NCT01755546|20384128|P1|Titration Phase|Other and Continuing|22
5891448|NCT01755546|20384128|P1|Titration Phase|Lost to Follow-up|2
5891449|NCT01755546|20384128|P1|Titration Phase|Protocol Violation|9
5891450|NCT01755546|20384128|P1|Titration Phase|Lack of Efficacy|18
5891451|NCT01755546|20384128|P1|Titration Phase|Adverse Event|11
5891452|NCT01755546|20384128|P1|Screened and Taper (Rollover and DeNovo)|Any other reason and screen failures|5
5891453|NCT01755546|20384128|P1|Screened and Taper (Rollover and DeNovo)|Lost to Follow-up|1
5891454|NCT01755546|20384128|P1|Screened and Taper (Rollover and DeNovo)|Withdrawal by Subject|3
5891455|NCT01755546|20384128|P1|Screened and Taper (Rollover and DeNovo)|Protocol Violation|1
5891456|NCT01755416|20384145|P2|First Intervention ( Upto 2 Days)|Withdrawal by Subject|2
5891457|NCT01755416|20384146|P1|First Intervention ( Upto 2 Days)|Withdrawal by Subject|1
5891458|NCT01755234|20384154|P2|Overall Study|unblinded|0
5891459|NCT01755234|20384155|P1|Overall Study|unblinded|1
5891460|NCT01755234|20384154|P2|Overall Study|Withdrawal by Subject|1
5891461|NCT01755234|20384155|P1|Overall Study|Withdrawal by Subject|0
5891462|NCT01755234|20384154|P2|Overall Study|case cancelled|0
5891463|NCT01755234|20384155|P1|Overall Study|case cancelled|1
5891464|NCT01755234|20384154|P2|Overall Study|Change in surgical case|1
5891465|NCT01755234|20384155|P1|Overall Study|Change in surgical case|2
5891466|NCT01755234|20384154|P2|Overall Study|Lost to Follow-up|6
5891467|NCT01755234|20384155|P1|Overall Study|Lost to Follow-up|11
5891468|NCT01755156|20384186|P2|Phase B (Weeks 24-104)|Withdrawal by Subject|31
5891469|NCT01755156|20384187|P1|Phase B (Weeks 24-104)|Withdrawal by Subject|27
5891470|NCT01755156|20384186|P2|Phase B (Weeks 24-104)|Lost to Follow-up|5
5891471|NCT01755156|20384187|P1|Phase B (Weeks 24-104)|Lost to Follow-up|12
5891472|NCT01755156|20384186|P2|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1
5891473|NCT01755156|20384187|P1|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1
5891474|NCT01755156|20384186|P2|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|2
5891475|NCT01755156|20384187|P1|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|0
5891476|NCT01755156|20384186|P2|Phase A (Weeks 0-24)|Withdrawal by Subject|13
5891477|NCT01755156|20384187|P1|Phase A (Weeks 0-24)|Withdrawal by Subject|6
5891478|NCT01755156|20384186|P2|Phase A (Weeks 0-24)|Protocol Violation|1
5891479|NCT01755156|20384187|P1|Phase A (Weeks 0-24)|Protocol Violation|1
5891480|NCT01755156|20384186|P2|Phase A (Weeks 0-24)|Physician Decision|1
5891481|NCT01755156|20384187|P1|Phase A (Weeks 0-24)|Physician Decision|0
5891482|NCT01755156|20384186|P2|Phase A (Weeks 0-24)|Non-compliance with study drug|0
5891483|NCT01755156|20384187|P1|Phase A (Weeks 0-24)|Non-compliance with study drug|1
5891484|NCT01755156|20384186|P2|Phase A (Weeks 0-24)|Lost to Follow-up|3
5891485|NCT01755156|20384187|P1|Phase A (Weeks 0-24)|Lost to Follow-up|5
5891486|NCT01755156|20384186|P2|Phase A (Weeks 0-24)|Lack of Efficacy|0
5891487|NCT01755156|20384187|P1|Phase A (Weeks 0-24)|Lack of Efficacy|1
5891488|NCT01755156|20384186|P2|Phase A (Weeks 0-24)|Adverse Event|3
5891489|NCT01755156|20384187|P1|Phase A (Weeks 0-24)|Adverse Event|2
5891490|NCT01755091|20384251|P3|Overall Study|Physician Decision|2
5891491|NCT01755091|20384252|P2|Overall Study|Physician Decision|1
5891492|NCT01755091|20384253|P1|Overall Study|Physician Decision|1
5891493|NCT01755091|20384251|P3|Overall Study|Lost to Follow-up|1
5891494|NCT01755091|20384252|P2|Overall Study|Lost to Follow-up|0
5891495|NCT01755091|20384253|P1|Overall Study|Lost to Follow-up|1
5891496|NCT01755091|20384251|P3|Overall Study|Adverse Event|1
5891497|NCT01755091|20384252|P2|Overall Study|Adverse Event|1
5891498|NCT01755091|20384253|P1|Overall Study|Adverse Event|1
5891499|NCT01755091|20384251|P3|Overall Study|Withdrawal by Subject|3
5891500|NCT01755091|20384252|P2|Overall Study|Withdrawal by Subject|1
5891501|NCT01755091|20384253|P1|Overall Study|Withdrawal by Subject|6
5891502|NCT01755026|20384278|P2|Overall Study|Withdrawal by Subject|1
5891503|NCT01755026|20384279|P1|Overall Study|Withdrawal by Subject|1
5891504|NCT01755026|20384278|P2|Overall Study|Adverse Event|0
5891505|NCT01755026|20384279|P1|Overall Study|Adverse Event|1
5891506|NCT01754922|20384302|P2|Overall Study|Adverse Event|1
5891507|NCT01754922|20384303|P1|Overall Study|Adverse Event|0
5891508|NCT01754766|20384329|P3|Overall Study|Personal reasons|0
5891509|NCT01754766|20384330|P2|Overall Study|Personal reasons|1
5891510|NCT01754766|20384331|P1|Overall Study|Personal reasons|1
5891511|NCT01754727|20384345|P1|Overall Study|Adalimumab Treatment was not Documented|2
5891512|NCT01754493|20384477|P1|Overall Study|Scheduling conflict|1
5891513|NCT01754493|20384477|P1|Overall Study|Moved out of town|1
5891514|NCT01754493|20384477|P1|Overall Study|Withdrawal by Subject|1
5891515|NCT01754493|20384477|P1|Overall Study|Lost to Follow-up|3
5891516|NCT01754493|20384477|P1|Overall Study|Adverse Event|1
5891517|NCT01754467|20384502|P1|Overall Study|Lost to Follow-up|1
5891518|NCT01754402|20384512|P3|Overall Study|Lack of Efficacy|1
5891519|NCT01754402|20384513|P2|Overall Study|Lack of Efficacy|0
5891520|NCT01754402|20384514|P1|Overall Study|Lack of Efficacy|0
5891521|NCT01754402|20384512|P3|Overall Study|Withdrawal by Subject|1
5891522|NCT01754402|20384513|P2|Overall Study|Withdrawal by Subject|0
5891523|NCT01754402|20384514|P1|Overall Study|Withdrawal by Subject|0
5891524|NCT01754402|20384512|P3|Overall Study|Adverse Event|1
5891525|NCT01754402|20384513|P2|Overall Study|Adverse Event|2
5891526|NCT01754402|20384514|P1|Overall Study|Adverse Event|2
5891527|NCT01754402|20384512|P3|Overall Study|Death|1
5891528|NCT01754402|20384513|P2|Overall Study|Death|0
5891529|NCT01754402|20384514|P1|Overall Study|Death|0
5891530|NCT01754376|20384548|P1|Overall Study|Lack of Efficacy|2
5891531|NCT01754376|20384548|P1|Overall Study|Adverse Event|1
5891532|NCT01754259|20384559|P2|Overall Study|Lost to Follow-up|1
5891533|NCT01754259|20384560|P1|Overall Study|Lost to Follow-up|0
5891534|NCT01754259|20384559|P2|Overall Study|Adverse Event|1
5891535|NCT01754259|20384560|P1|Overall Study|Adverse Event|3
5891536|NCT01754259|20384559|P2|Overall Study|Withdrawal by Subject|4
5891537|NCT01754259|20384560|P1|Overall Study|Withdrawal by Subject|2
5891538|NCT01754194|20384574|P2|Overall Study|Other|8
5891539|NCT01754194|20384575|P1|Overall Study|Other|9
5891540|NCT01754194|20384574|P2|Overall Study|Withdrawal by Subject|5
5891541|NCT01754194|20384575|P1|Overall Study|Withdrawal by Subject|4
5891542|NCT01754194|20384574|P2|Overall Study|Lost to Follow-up|14
5891543|NCT01754194|20384575|P1|Overall Study|Lost to Follow-up|39
5891544|NCT01754129|20384595|P1|Overall Study|Inclusion/exclusion criteria violation|3
5891545|NCT01754129|20384595|P1|Overall Study|Withdrew consent|1
5891546|NCT01754129|20384595|P1|Overall Study|Lost to Follow-up|7
5891547|NCT01754129|20384595|P1|Overall Study|Duodopa discontinuation|9
5891548|NCT01754129|20384595|P1|Overall Study|Death|13
5891549|NCT01753999|20384618|P2|Period 2 -Cross to Alternate Arm|Physician Decision|1
5891550|NCT01753999|20384619|P1|Period 2 -Cross to Alternate Arm|Physician Decision|1
5891551|NCT01753999|20384618|P2|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|5
5891552|NCT01753999|20384619|P1|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|3
5891553|NCT01753999|20384618|P2|Period 2 -Cross to Alternate Arm|Lost to Follow-up|17
5891554|NCT01753999|20384619|P1|Period 2 -Cross to Alternate Arm|Lost to Follow-up|13
5891555|NCT01753999|20384618|P2|Period 1 - Initial Assignment|Lost to Follow-up|27
5891556|NCT01753999|20384619|P1|Period 1 - Initial Assignment|Lost to Follow-up|18
5891557|NCT01753999|20384618|P2|Period 1 - Initial Assignment|Withdrawal by Subject|20
5891558|NCT01753999|20384619|P1|Period 1 - Initial Assignment|Withdrawal by Subject|19
5891559|NCT01753999|20384618|P2|Period 1 - Initial Assignment|Physician Decision|3
5891560|NCT01753999|20384619|P1|Period 1 - Initial Assignment|Physician Decision|2
5891561|NCT01753856|20384637|P2|Overall Study|Sponsor Decision|0
5891562|NCT01753856|20384638|P1|Overall Study|Sponsor Decision|2
5891563|NCT01753856|20384637|P2|Overall Study|Withdrawal by Subject|2
5891564|NCT01753856|20384638|P1|Overall Study|Withdrawal by Subject|0
5891565|NCT01753856|20384637|P2|Overall Study|Adverse Event|0
5891566|NCT01753856|20384638|P1|Overall Study|Adverse Event|1
5891567|NCT01753570|20384750|P3|Overall Study|Withdrawal by Subject|0
5891568|NCT01753570|20384751|P2|Overall Study|Withdrawal by Subject|4
5891569|NCT01753570|20384752|P1|Overall Study|Withdrawal by Subject|1
5891570|NCT01753570|20384750|P3|Overall Study|Physician Decision|0
5891571|NCT01753570|20384751|P2|Overall Study|Physician Decision|1
5891572|NCT01753570|20384752|P1|Overall Study|Physician Decision|0
5891573|NCT01753570|20384750|P3|Overall Study|Adverse Event|1
5891574|NCT01753570|20384751|P2|Overall Study|Adverse Event|0
5891575|NCT01753570|20384752|P1|Overall Study|Adverse Event|1
5891576|NCT01753518|20384795|P2|Postpartum Follow-up|Lost to Follow-up|15
5891577|NCT01753518|20384796|P1|Postpartum Follow-up|Lost to Follow-up|22
5891578|NCT01753518|20384795|P2|Intention-to-Treat Analysis|Body Mass Index>50|1
5891579|NCT01753518|20384796|P1|Intention-to-Treat Analysis|Body Mass Index>50|0
5891580|NCT01753518|20384795|P2|Intention-to-Treat Analysis|Multifetal gestation|3
5891581|NCT01753518|20384796|P1|Intention-to-Treat Analysis|Multifetal gestation|2
5891582|NCT01753518|20384795|P2|Intention-to-Treat Analysis|Missing consent form|3
5891583|NCT01753518|20384796|P1|Intention-to-Treat Analysis|Missing consent form|5
5891584|NCT01753401|20384820|P4|Open Label Period (44 Weeks)|Reason not provided|2
5891585|NCT01753401|20384821|P3|Open Label Period (44 Weeks)|Reason not provided|0
5891586|NCT01753401|20384822|P2|Open Label Period (44 Weeks)|Reason not provided|0
5891587|NCT01753401|20384823|P1|Open Label Period (44 Weeks)|Reason not provided|0
5891588|NCT01753401|20384820|P4|Open Label Period (44 Weeks)|Lack of Efficacy|1
5891589|NCT01753401|20384821|P3|Open Label Period (44 Weeks)|Lack of Efficacy|1
5891590|NCT01753401|20384822|P2|Open Label Period (44 Weeks)|Lack of Efficacy|0
5891591|NCT01753401|20384823|P1|Open Label Period (44 Weeks)|Lack of Efficacy|0
5891592|NCT01753401|20384820|P4|Open Label Period (44 Weeks)|Withdrawal by Subject|2
5891593|NCT01753401|20384821|P3|Open Label Period (44 Weeks)|Withdrawal by Subject|0
5891594|NCT01753401|20384822|P2|Open Label Period (44 Weeks)|Withdrawal by Subject|0
5891595|NCT01753401|20384823|P1|Open Label Period (44 Weeks)|Withdrawal by Subject|0
5891596|NCT01753401|20384820|P4|Open Label Period (44 Weeks)|Adverse Event|4
5891597|NCT01753401|20384821|P3|Open Label Period (44 Weeks)|Adverse Event|3
5891598|NCT01753401|20384822|P2|Open Label Period (44 Weeks)|Adverse Event|0
5891599|NCT01753401|20384823|P1|Open Label Period (44 Weeks)|Adverse Event|0
5891600|NCT01753401|20384820|P4|Double-blind Period (8 Weeks)|Protocol Violation|0
5891601|NCT01753401|20384821|P3|Double-blind Period (8 Weeks)|Protocol Violation|0
5891602|NCT01753401|20384822|P2|Double-blind Period (8 Weeks)|Protocol Violation|1
5891603|NCT01753401|20384823|P1|Double-blind Period (8 Weeks)|Protocol Violation|0
5891604|NCT01753401|20384820|P4|Double-blind Period (8 Weeks)|Withdrawal by Subject|0
5891605|NCT01753401|20384821|P3|Double-blind Period (8 Weeks)|Withdrawal by Subject|0
5891606|NCT01753401|20384822|P2|Double-blind Period (8 Weeks)|Withdrawal by Subject|1
5891607|NCT01753401|20384823|P1|Double-blind Period (8 Weeks)|Withdrawal by Subject|1
5891608|NCT01753401|20384820|P4|Double-blind Period (8 Weeks)|Adverse Event|0
5891609|NCT01753401|20384821|P3|Double-blind Period (8 Weeks)|Adverse Event|0
5891610|NCT01753401|20384822|P2|Double-blind Period (8 Weeks)|Adverse Event|2
5891611|NCT01753401|20384823|P1|Double-blind Period (8 Weeks)|Adverse Event|0
5891612|NCT01753336|20384882|P1|Overall Study|Withdrawal by Subject|1
5891613|NCT01753336|20384882|P1|Overall Study|Sponsor's decision|2
5891614|NCT01753336|20384882|P1|Overall Study|Physician Decision|2
5891615|NCT01753336|20384882|P1|Overall Study|Lost to Follow-up|3
5891616|NCT01753336|20384882|P1|Overall Study|Patient decision|12
5891617|NCT01753323|20384894|P3|Overall Study|Adverse Event|1
5891618|NCT01753323|20384895|P2|Overall Study|Adverse Event|0
5891619|NCT01753323|20384896|P1|Overall Study|Adverse Event|0
5891620|NCT01753323|20384894|P3|Overall Study|Protocol deviation|0
5891621|NCT01753323|20384895|P2|Overall Study|Protocol deviation|0
5891622|NCT01753323|20384896|P1|Overall Study|Protocol deviation|1
5891623|NCT01753323|20384894|P3|Overall Study|Lack of Efficacy|8
5891624|NCT01753323|20384895|P2|Overall Study|Lack of Efficacy|0
5891625|NCT01753323|20384896|P1|Overall Study|Lack of Efficacy|0
5891626|NCT01753310|20384934|P2|Overall Study|Withdrawal by Subject|0
5891627|NCT01753310|20384935|P1|Overall Study|Withdrawal by Subject|1
5891628|NCT01753310|20384934|P2|Overall Study|Sponsor decision|0
5891629|NCT01753310|20384935|P1|Overall Study|Sponsor decision|1
5891630|NCT01753310|20384934|P2|Overall Study|Subject decision|2
5891631|NCT01753310|20384935|P1|Overall Study|Subject decision|2
5891632|NCT01753310|20384934|P2|Overall Study|Lost to Follow-up|0
5891633|NCT01753310|20384935|P1|Overall Study|Lost to Follow-up|2
5891634|NCT01753310|20384934|P2|Overall Study|Adverse Event|0
5891635|NCT01753310|20384935|P1|Overall Study|Adverse Event|1
5891636|NCT01753310|20384934|P2|Overall Study|Entered into open label extension study|22
5891637|NCT01753310|20384935|P1|Overall Study|Entered into open label extension study|25
5891638|NCT01753297|20384957|P2|Overall Study|Did not attend end of study visit|8
5891639|NCT01753297|20384958|P1|Overall Study|Did not attend end of study visit|7
5891640|NCT01753297|20384957|P2|Overall Study|Death|2
5891641|NCT01753297|20384958|P1|Overall Study|Death|0
5891642|NCT01753297|20384957|P2|Overall Study|Adverse Event (up to Month 36)|1
5891643|NCT01753297|20384958|P1|Overall Study|Adverse Event (up to Month 36)|1
5891644|NCT01753297|20384957|P2|Overall Study|Withdrawal by Subject|23
5891645|NCT01753297|20384958|P1|Overall Study|Withdrawal by Subject|26
5891646|NCT01753297|20384957|P2|Overall Study|Lost to Follow-up|2
5891647|NCT01753297|20384958|P1|Overall Study|Lost to Follow-up|7
5891648|NCT01753193|20384990|P1|Overall Study|Other|16
5891649|NCT01753193|20384990|P1|Overall Study|Death|1
5891650|NCT01753193|20384990|P1|Overall Study|Lost to Follow-up|6
5891651|NCT01753193|20384990|P1|Overall Study|Withdrawal by Subject|23
5891652|NCT01753115|20385005|P3|Overall Study|Used excluded drug|0
5891653|NCT01753115|20385006|P2|Overall Study|Used excluded drug|1
5891654|NCT01753115|20385007|P1|Overall Study|Used excluded drug|0
5891655|NCT01753115|20385005|P3|Overall Study|Subject non-compliant|0
5891656|NCT01753115|20385006|P2|Overall Study|Subject non-compliant|3
5891657|NCT01753115|20385007|P1|Overall Study|Subject non-compliant|3
5891658|NCT01753115|20385005|P3|Overall Study|Withdrawal by Subject|6
5891659|NCT01753115|20385006|P2|Overall Study|Withdrawal by Subject|5
5891660|NCT01753115|20385007|P1|Overall Study|Withdrawal by Subject|6
5891661|NCT01753115|20385005|P3|Overall Study|Lost to Follow-up|8
5891662|NCT01753115|20385006|P2|Overall Study|Lost to Follow-up|6
5891663|NCT01753115|20385007|P1|Overall Study|Lost to Follow-up|3
5891664|NCT01753076|20385017|P2|Overall Study|Other-Reached Protocol-defined Stopping|0
5891665|NCT01753076|20385018|P1|Overall Study|Other-Reached Protocol-defined Stopping|1
5891666|NCT01753076|20385017|P2|Overall Study|Withdrawal by Subject|24
5891667|NCT01753076|20385018|P1|Overall Study|Withdrawal by Subject|14
5891668|NCT01753076|20385017|P2|Overall Study|Physician Decision|2
5891669|NCT01753076|20385018|P1|Overall Study|Physician Decision|4
5891670|NCT01753076|20385017|P2|Overall Study|Lost to Follow-up|1
5891671|NCT01753076|20385018|P1|Overall Study|Lost to Follow-up|2
5891672|NCT01753076|20385017|P2|Overall Study|Lack of Efficacy|1
5891673|NCT01753076|20385018|P1|Overall Study|Lack of Efficacy|3
5891674|NCT01753076|20385017|P2|Overall Study|Adverse Event|18
5891675|NCT01753076|20385018|P1|Overall Study|Adverse Event|17
5891676|NCT01752985|20385045|P3|Treatment Period|Lost to Follow-up|1
5891677|NCT01752985|20385046|P2|Treatment Period|Lost to Follow-up|0
5891678|NCT01752985|20385047|P1|Treatment Period|Lost to Follow-up|0
5891679|NCT01752985|20385045|P3|Treatment Period|Withdrawal by Subject|0
5891680|NCT01752985|20385046|P2|Treatment Period|Withdrawal by Subject|1
5891681|NCT01752985|20385047|P1|Treatment Period|Withdrawal by Subject|1
5891682|NCT01752985|20385045|P3|Treatment Period|Adverse Event|2
5891683|NCT01752985|20385046|P2|Treatment Period|Adverse Event|1
5891684|NCT01752985|20385047|P1|Treatment Period|Adverse Event|2
5891685|NCT01752985|20385045|P3|Treatment Period|Subject no longer meets study criteria|1
5891686|NCT01752985|20385046|P2|Treatment Period|Subject no longer meets study criteria|1
5891687|NCT01752985|20385047|P1|Treatment Period|Subject no longer meets study criteria|0
5891688|NCT01752985|20385045|P3|Treatment Period|Subject request to discontinue treatment|1
5891689|NCT01752985|20385046|P2|Treatment Period|Subject request to discontinue treatment|0
5891690|NCT01752985|20385047|P1|Treatment Period|Subject request to discontinue treatment|1
5891691|NCT01752933|20385075|P2|Overall Study and Follow-up|Lost to Follow-up|2
5891692|NCT01752933|20385076|P1|Overall Study and Follow-up|Lost to Follow-up|0
5891693|NCT01752933|20385075|P2|Overall Study and Follow-up|Withdrawal by Subject|3
5891694|NCT01752933|20385076|P1|Overall Study and Follow-up|Withdrawal by Subject|0
5891695|NCT01752933|20385075|P2|Overall Study and Follow-up|Sponsor terminated study/Database lock|7
5891696|NCT01752933|20385076|P1|Overall Study and Follow-up|Sponsor terminated study/Database lock|0
5891697|NCT01752933|20385075|P2|Overall Study and Follow-up|Death|34
5891698|NCT01752933|20385076|P1|Overall Study and Follow-up|Death|4
5891699|NCT01752933|20385075|P2|Treatment|Patient unable to travel to appointments|1
5891700|NCT01752933|20385076|P1|Treatment|Patient unable to travel to appointments|0
5891701|NCT01752933|20385075|P2|Treatment|Patient noncompliant|1
5891702|NCT01752933|20385076|P1|Treatment|Patient noncompliant|0
5891703|NCT01752933|20385075|P2|Treatment|Hepatocellular carcinoma not confirmed|1
5891704|NCT01752933|20385076|P1|Treatment|Hepatocellular carcinoma not confirmed|0
5891705|NCT01752933|20385075|P2|Treatment|Death|2
5891706|NCT01752933|20385076|P1|Treatment|Death|0
5891707|NCT01752933|20385075|P2|Treatment|Physician Decision|3
5891708|NCT01752933|20385076|P1|Treatment|Physician Decision|0
5891709|NCT01752933|20385075|P2|Treatment|Adverse Event|4
5891710|NCT01752933|20385076|P1|Treatment|Adverse Event|1
5891711|NCT01752933|20385075|P2|Treatment|Withdrawal by Subject|5
5891712|NCT01752933|20385076|P1|Treatment|Withdrawal by Subject|0
5891713|NCT01752933|20385075|P2|Treatment|Disease Progression|29
5891714|NCT01752933|20385076|P1|Treatment|Disease Progression|3
5891715|NCT01752907|20385094|P2|Overall Study|Decision by Sponsor|9
5891716|NCT01752907|20385095|P1|Overall Study|Decision by Sponsor|6
5891717|NCT01752907|20385094|P2|Overall Study|Lost to Follow-up|1
5891718|NCT01752907|20385095|P1|Overall Study|Lost to Follow-up|2
5891719|NCT01752907|20385094|P2|Overall Study|Withdrawal by Subject|10
5891720|NCT01752907|20385095|P1|Overall Study|Withdrawal by Subject|4
5891721|NCT01752855|20385115|P2|Overall Study|Lack of Efficacy|2
5891722|NCT01752855|20385116|P1|Overall Study|Lack of Efficacy|0
5891723|NCT01752855|20385115|P2|Overall Study|Withdrew Consent|2
5891724|NCT01752855|20385116|P1|Overall Study|Withdrew Consent|0
5891725|NCT01752855|20385115|P2|Overall Study|Adverse Event|0
5891726|NCT01752855|20385116|P1|Overall Study|Adverse Event|1
5891727|NCT01752842|20385132|P2|Overall Study|Withdrawal by Subject|2
5891728|NCT01752842|20385133|P1|Overall Study|Withdrawal by Subject|0
5891729|NCT01752842|20385132|P2|Overall Study|Adverse Event|0
5891730|NCT01752842|20385133|P1|Overall Study|Adverse Event|3
5891731|NCT01752634|20385168|P6|Week 24 to Week 260|Adverse Event|0
5891732|NCT01752634|20385169|P5|Week 24 to Week 260|Adverse Event|2
5891733|NCT01752634|20385170|P4|Week 24 to Week 260|Adverse Event|4
5891734|NCT01752634|20385171|P3|Week 24 to Week 260|Adverse Event|8
5891735|NCT01752634|20385172|P2|Week 24 to Week 260|Adverse Event|8
5891736|NCT01752634|20385173|P1|Week 24 to Week 260|Adverse Event|4
5891737|NCT01752634|20385168|P6|Week 24 to Week 260|Lost to Follow-up|0
5891738|NCT01752634|20385169|P5|Week 24 to Week 260|Lost to Follow-up|2
5891739|NCT01752634|20385170|P4|Week 24 to Week 260|Lost to Follow-up|0
5891740|NCT01752634|20385171|P3|Week 24 to Week 260|Lost to Follow-up|3
5891741|NCT01752634|20385172|P2|Week 24 to Week 260|Lost to Follow-up|2
5891742|NCT01752634|20385173|P1|Week 24 to Week 260|Lost to Follow-up|2
5891743|NCT01752634|20385168|P6|Week 24 to Week 260|Noncompliance with study treatment|0
5891744|NCT01752634|20385169|P5|Week 24 to Week 260|Noncompliance with study treatment|0
5891745|NCT01752634|20385170|P4|Week 24 to Week 260|Noncompliance with study treatment|0
5891746|NCT01752634|20385171|P3|Week 24 to Week 260|Noncompliance with study treatment|1
5891747|NCT01752634|20385172|P2|Week 24 to Week 260|Noncompliance with study treatment|0
5891748|NCT01752634|20385173|P1|Week 24 to Week 260|Noncompliance with study treatment|0
5891749|NCT01752634|20385168|P6|Week 24 to Week 260|Pregnancy|0
5891750|NCT01752634|20385169|P5|Week 24 to Week 260|Pregnancy|0
5891751|NCT01752634|20385170|P4|Week 24 to Week 260|Pregnancy|0
5891752|NCT01752634|20385171|P3|Week 24 to Week 260|Pregnancy|1
5891753|NCT01752634|20385172|P2|Week 24 to Week 260|Pregnancy|0
5891754|NCT01752634|20385173|P1|Week 24 to Week 260|Pregnancy|0
5891755|NCT01752634|20385168|P6|Week 24 to Week 260|Death|0
5891756|NCT01752634|20385169|P5|Week 24 to Week 260|Death|0
5891757|NCT01752634|20385170|P4|Week 24 to Week 260|Death|0
5891758|NCT01752634|20385171|P3|Week 24 to Week 260|Death|0
5891759|NCT01752634|20385172|P2|Week 24 to Week 260|Death|1
5891760|NCT01752634|20385173|P1|Week 24 to Week 260|Death|0
5891761|NCT01752634|20385168|P6|Week 24 to Week 260|Physician Decision|0
5891762|NCT01752634|20385169|P5|Week 24 to Week 260|Physician Decision|1
5891763|NCT01752634|20385170|P4|Week 24 to Week 260|Physician Decision|2
5891764|NCT01752634|20385171|P3|Week 24 to Week 260|Physician Decision|4
5891765|NCT01752634|20385172|P2|Week 24 to Week 260|Physician Decision|2
5891766|NCT01752634|20385173|P1|Week 24 to Week 260|Physician Decision|1
5891767|NCT01752634|20385168|P6|Week 24 to Week 260|Subject/guardian decision|0
5891768|NCT01752634|20385169|P5|Week 24 to Week 260|Subject/guardian decision|5
5891769|NCT01752634|20385170|P4|Week 24 to Week 260|Subject/guardian decision|5
5891770|NCT01752634|20385171|P3|Week 24 to Week 260|Subject/guardian decision|9
5891771|NCT01752634|20385172|P2|Week 24 to Week 260|Subject/guardian decision|10
5891772|NCT01752634|20385173|P1|Week 24 to Week 260|Subject/guardian decision|12
5891773|NCT01752634|20385168|P6|Week 24 to Week 260|Lack of Efficacy|0
5891774|NCT01752634|20385169|P5|Week 24 to Week 260|Lack of Efficacy|4
5891775|NCT01752634|20385170|P4|Week 24 to Week 260|Lack of Efficacy|3
5891776|NCT01752634|20385171|P3|Week 24 to Week 260|Lack of Efficacy|7
5891777|NCT01752634|20385172|P2|Week 24 to Week 260|Lack of Efficacy|7
5891778|NCT01752634|20385173|P1|Week 24 to Week 260|Lack of Efficacy|15
5891779|NCT01752634|20385168|P6|Up to Week 24 (Primary Analysis)|Adverse Event|4
5891780|NCT01752634|20385169|P5|Up to Week 24 (Primary Analysis)|Adverse Event|0
5891781|NCT01752634|20385170|P4|Up to Week 24 (Primary Analysis)|Adverse Event|0
5891782|NCT01752634|20385171|P3|Up to Week 24 (Primary Analysis)|Adverse Event|2
5891783|NCT01752634|20385172|P2|Up to Week 24 (Primary Analysis)|Adverse Event|0
5891784|NCT01752634|20385173|P1|Up to Week 24 (Primary Analysis)|Adverse Event|3
5891785|NCT01752634|20385168|P6|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3
5891786|NCT01752634|20385169|P5|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0
5891787|NCT01752634|20385170|P4|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0
5891788|NCT01752634|20385171|P3|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0
5891789|NCT01752634|20385172|P2|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3
5891790|NCT01752634|20385173|P1|Up to Week 24 (Primary Analysis)|Lack of Efficacy|2
5891791|NCT01752634|20385168|P6|Up to Week 24 (Primary Analysis)|Physician Decision|0
5891792|NCT01752634|20385169|P5|Up to Week 24 (Primary Analysis)|Physician Decision|0
5891793|NCT01752634|20385170|P4|Up to Week 24 (Primary Analysis)|Physician Decision|0
5891794|NCT01752634|20385171|P3|Up to Week 24 (Primary Analysis)|Physician Decision|0
5891795|NCT01752634|20385172|P2|Up to Week 24 (Primary Analysis)|Physician Decision|1
5891796|NCT01752634|20385173|P1|Up to Week 24 (Primary Analysis)|Physician Decision|0
5891797|NCT01752634|20385168|P6|Up to Week 24 (Primary Analysis)|Subject/guardian decision|3
5891798|NCT01752634|20385169|P5|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0
5891799|NCT01752634|20385170|P4|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0
5891800|NCT01752634|20385171|P3|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1
5891801|NCT01752634|20385172|P2|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1
5891802|NCT01752634|20385173|P1|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1
5891803|NCT01752036|20385231|P1|Overall Study|Death|2
5891804|NCT01752023|20385244|P2|Overall Study|Physician Decision|1
5891805|NCT01752023|20385245|P1|Overall Study|Physician Decision|2
5891816|NCT01751867|20385392|P2|Overall Study|Randomized but not treated.|1
5891817|NCT01751867|20385393|P1|Overall Study|Randomized but not treated.|2
5891818|NCT01751867|20385392|P2|Overall Study|Other|37
5891819|NCT01751867|20385393|P1|Overall Study|Other|11
5891820|NCT01751867|20385392|P2|Overall Study|Death|5
5891821|NCT01751867|20385393|P1|Overall Study|Death|0
5891822|NCT01751867|20385392|P2|Overall Study|Protocol Violation|2
5891823|NCT01751867|20385393|P1|Overall Study|Protocol Violation|0
5891824|NCT01751867|20385392|P2|Overall Study|Physician Decision|7
5891825|NCT01751867|20385393|P1|Overall Study|Physician Decision|4
5891826|NCT01751867|20385392|P2|Overall Study|Withdrawal by Subject|1
5891827|NCT01751867|20385393|P1|Overall Study|Withdrawal by Subject|3
5891828|NCT01751867|20385392|P2|Overall Study|Poor Compliance|5
5891829|NCT01751867|20385393|P1|Overall Study|Poor Compliance|0
5891830|NCT01751867|20385392|P2|Overall Study|Adverse Event|15
5891831|NCT01751867|20385393|P1|Overall Study|Adverse Event|8
5891832|NCT01751867|20385392|P2|Overall Study|Diease Progression|18
5891833|NCT01751867|20385393|P1|Overall Study|Diease Progression|4
5891834|NCT01751867|20385392|P2|Overall Study|Completed treatment,dropped in follow-up|8
5891835|NCT01751867|20385393|P1|Overall Study|Completed treatment,dropped in follow-up|4
5891836|NCT01751802|20385413|P2|Overall Study|Adverse Event|2
5891837|NCT01751802|20385414|P1|Overall Study|Adverse Event|4
5891838|NCT01751724|20385428|P2|Overall Study|withdrawn by parent|2
5891839|NCT01751724|20385429|P1|Overall Study|withdrawn by parent|0
5891840|NCT01751724|20385428|P2|Overall Study|extubated bef.start assigned treatment|0
5891841|NCT01751724|20385429|P1|Overall Study|extubated bef.start assigned treatment|1
5891842|NCT01751646|20385457|P2|Overall Study|Childcare issues|1
5891843|NCT01751646|20385458|P1|Overall Study|Childcare issues|1
5891844|NCT01751646|20385457|P2|Overall Study|Fails to comply with study requirements|1
5891845|NCT01751646|20385458|P1|Overall Study|Fails to comply with study requirements|0
5891846|NCT01751646|20385457|P2|Overall Study|Off study due to multiple obligations|1
5891847|NCT01751646|20385458|P1|Overall Study|Off study due to multiple obligations|0
5891848|NCT01751646|20385457|P2|Overall Study|Inability to attend required visits|1
5891849|NCT01751646|20385458|P1|Overall Study|Inability to attend required visits|0
5891850|NCT01751646|20385457|P2|Overall Study|Moved out of the area|5
5891851|NCT01751646|20385458|P1|Overall Study|Moved out of the area|1
5891852|NCT01751646|20385457|P2|Overall Study|Inadvertent enrollment|1
5891853|NCT01751646|20385458|P1|Overall Study|Inadvertent enrollment|1
5891854|NCT01751646|20385457|P2|Overall Study|Missed 4 or more consecutive DOT visits|3
5891855|NCT01751646|20385458|P1|Overall Study|Missed 4 or more consecutive DOT visits|2
5891856|NCT01751646|20385457|P2|Overall Study|Starting hormone therapy|0
5891857|NCT01751646|20385458|P1|Overall Study|Starting hormone therapy|1
5891858|NCT01751646|20385457|P2|Overall Study|Withdrawal by Subject|4
5891859|NCT01751646|20385458|P1|Overall Study|Withdrawal by Subject|0
5891860|NCT01751646|20385457|P2|Overall Study|Lost to Follow-up|1
5891861|NCT01751646|20385458|P1|Overall Study|Lost to Follow-up|5
5891862|NCT01751568|20385609|P3|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|0
5891863|NCT01751568|20385610|P2|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|0
5891864|NCT01751568|20385611|P1|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|1
5891865|NCT01751412|20385640|P1|Overall Study|Disease Progression Before Treatment|1
5891866|NCT01751178|20385750|P3|Overall Study|Other Reason (unknown)|2
5891867|NCT01751178|20385751|P2|Overall Study|Other Reason (unknown)|0
5891868|NCT01751178|20385752|P1|Overall Study|Other Reason (unknown)|1
5891869|NCT01751178|20385750|P3|Overall Study|Adverse Event|0
5891870|NCT01751178|20385751|P2|Overall Study|Adverse Event|0
5891871|NCT01751178|20385752|P1|Overall Study|Adverse Event|2
5891872|NCT01751165|20385772|P3|Overall Study|Lost to Follow-up|1
5891873|NCT01751165|20385773|P2|Overall Study|Lost to Follow-up|1
5891874|NCT01751165|20385774|P1|Overall Study|Lost to Follow-up|1
5891875|NCT01751165|20385772|P3|Overall Study|Serious adverse event|0
5891876|NCT01751165|20385773|P2|Overall Study|Serious adverse event|2
5891877|NCT01751165|20385774|P1|Overall Study|Serious adverse event|0
5891878|NCT01751165|20385772|P3|Overall Study|Withdrawal by Subject|1
5891879|NCT01751165|20385773|P2|Overall Study|Withdrawal by Subject|0
5891880|NCT01751165|20385774|P1|Overall Study|Withdrawal by Subject|0
5891881|NCT01751165|20385772|P3|Overall Study|Adverse event, serious fatal|1
5891882|NCT01751165|20385773|P2|Overall Study|Adverse event, serious fatal|0
5891883|NCT01751165|20385774|P1|Overall Study|Adverse event, serious fatal|1
5891884|NCT01751139|20385814|P1|Overall Study|Death|31
5891885|NCT01751139|20385814|P1|Overall Study|Adverse Event|1
5891886|NCT01751139|20385814|P1|Overall Study|Withdrawal by Subject|251
5891887|NCT01751139|20385814|P1|Overall Study|Lost to Follow-up|240
5891888|NCT01751139|20385814|P1|Overall Study|Sponsor study termination|1609
5891889|NCT01751139|20385814|P1|Overall Study|Other|135
5891890|NCT01751113|20385832|P6|Treatment Period 3 (4 Weeks)|Adverse Event|1
5891891|NCT01751113|20385833|P5|Treatment Period 3 (4 Weeks)|Adverse Event|0
5891892|NCT01751113|20385834|P4|Treatment Period 3 (4 Weeks)|Adverse Event|0
5891893|NCT01751113|20385835|P3|Treatment Period 3 (4 Weeks)|Adverse Event|0
5891894|NCT01751113|20385836|P2|Treatment Period 3 (4 Weeks)|Adverse Event|0
5891895|NCT01751113|20385837|P1|Treatment Period 3 (4 Weeks)|Adverse Event|0
5891896|NCT01751113|20385832|P6|Treatment Period 1 (4 Weeks)|Adverse Event|0
5891897|NCT01751113|20385833|P5|Treatment Period 1 (4 Weeks)|Adverse Event|1
5891898|NCT01751113|20385834|P4|Treatment Period 1 (4 Weeks)|Adverse Event|1
5891899|NCT01751113|20385835|P3|Treatment Period 1 (4 Weeks)|Adverse Event|0
5891900|NCT01751113|20385836|P2|Treatment Period 1 (4 Weeks)|Adverse Event|0
5891901|NCT01751113|20385837|P1|Treatment Period 1 (4 Weeks)|Adverse Event|0
5891902|NCT01751087|20385878|P3|Overall Study|Physician Decision|1
5891903|NCT01751087|20385879|P2|Overall Study|Physician Decision|0
5891904|NCT01751087|20385880|P1|Overall Study|Physician Decision|0
5891905|NCT01751087|20385878|P3|Overall Study|Withdrawal by Subject|0
5891906|NCT01751087|20385879|P2|Overall Study|Withdrawal by Subject|0
5891907|NCT01751087|20385880|P1|Overall Study|Withdrawal by Subject|1
5891908|NCT01751061|20385914|P2|Overall Study|Physician Decision|0
5891909|NCT01751061|20385915|P1|Overall Study|Physician Decision|2
5891910|NCT01751061|20385914|P2|Overall Study|Withdrawal by Subject|1
5891911|NCT01751061|20385915|P1|Overall Study|Withdrawal by Subject|4
5891912|NCT01751061|20385914|P2|Overall Study|patient regained decisional capacity|8
5891913|NCT01751061|20385915|P1|Overall Study|patient regained decisional capacity|4
5891914|NCT01751061|20385914|P2|Overall Study|Lost to Follow-up|25
5891915|NCT01751061|20385915|P1|Overall Study|Lost to Follow-up|40
5891916|NCT01751061|20385914|P2|Overall Study|patient death|0
5891917|NCT01751061|20385915|P1|Overall Study|patient death|5
5891918|NCT01751061|20385914|P2|Overall Study|Death|0
5891919|NCT01751061|20385915|P1|Overall Study|Death|1
5891920|NCT01750840|20385989|P1|Overall Study|Lost to Follow-up|4
5891921|NCT01750697|20385994|P1|Overall Study|Withdrawal by Subject|1
5891922|NCT01750697|20385994|P1|Overall Study|Physician Decision|1
5891923|NCT01750697|20385994|P1|Overall Study|Transferred to Adult Services|5
5891924|NCT01750697|20385994|P1|Overall Study|Physician and Family Decision|1
5891925|NCT01750697|20385994|P1|Overall Study|Transferred Back to Local Hospital|1
5891926|NCT01750684|20386006|P2|Overall Study|Protocol Violation|0
5891927|NCT01750684|20386007|P1|Overall Study|Protocol Violation|1
5891928|NCT01750684|20386006|P2|Overall Study|Withdrawn by Sponsor|1
5891929|NCT01750684|20386007|P1|Overall Study|Withdrawn by Sponsor|0
5891930|NCT01750684|20386006|P2|Overall Study|Non-compliance with Study Drug|1
5891931|NCT01750684|20386007|P1|Overall Study|Non-compliance with Study Drug|0
5891932|NCT01750684|20386006|P2|Overall Study|Death|0
5891933|NCT01750684|20386007|P1|Overall Study|Death|1
5891934|NCT01750346|20386044|P3|Overall Study|Adverse Event|0
5891935|NCT01750346|20386045|P2|Overall Study|Adverse Event|0
5891936|NCT01750346|20386046|P1|Overall Study|Adverse Event|1
5891937|NCT01750294|20386072|P1|Overall Study|Safety Endpoint|1
5891938|NCT01750294|20386072|P1|Overall Study|Withdrawal by Subject|1
5891939|NCT01750281|20386079|P3|Overall Study|Did not receive treatment|0
5891940|NCT01750281|20386080|P2|Overall Study|Did not receive treatment|1
5891941|NCT01750281|20386081|P1|Overall Study|Did not receive treatment|0
5891942|NCT01750281|20386079|P3|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|9
5891943|NCT01750281|20386080|P2|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|7
5891944|NCT01750281|20386081|P1|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|6
5891945|NCT01750281|20386079|P3|Overall Study|Discontinued Selumetinib/Placebo|75
5891946|NCT01750281|20386080|P2|Overall Study|Discontinued Selumetinib/Placebo|77
5891947|NCT01750281|20386081|P1|Overall Study|Discontinued Selumetinib/Placebo|37
5891948|NCT01750268|20386094|P2|Overall Study|Withdrawal by Subject|0
5891949|NCT01750268|20386095|P1|Overall Study|Withdrawal by Subject|2
5891950|NCT01750268|20386094|P2|Overall Study|Physician Decision|3
5891951|NCT01750268|20386095|P1|Overall Study|Physician Decision|0
5891952|NCT01750268|20386094|P2|Overall Study|Lost to Follow-up|2
5891953|NCT01750268|20386095|P1|Overall Study|Lost to Follow-up|0
5891954|NCT01750242|20386122|P1|Overall Study|Unreadable Images|3
5891955|NCT01750229|20386127|P1|Long-term Follow-up Phase|Withdrawal by Subject|1
5891956|NCT01750229|20386127|P1|Long-term Follow-up Phase|Adverse Event|2
5891957|NCT01750229|20386127|P1|Randomized Crossover Phase|Withdrawal by Subject|1
5891958|NCT01750229|20386127|P1|Randomized Crossover Phase|Adverse Event|1
5891959|NCT01749982|20386154|P4|Overall Study|Withdrawal by Subject|1
5891960|NCT01749982|20386155|P3|Overall Study|Withdrawal by Subject|0
5891961|NCT01749982|20386156|P2|Overall Study|Withdrawal by Subject|0
5891962|NCT01749982|20386157|P1|Overall Study|Withdrawal by Subject|0
5891963|NCT01749982|20386154|P4|Overall Study|Lost to Follow-up|1
5891964|NCT01749982|20386155|P3|Overall Study|Lost to Follow-up|0
5891965|NCT01749982|20386156|P2|Overall Study|Lost to Follow-up|0
5891966|NCT01749982|20386157|P1|Overall Study|Lost to Follow-up|0
5891967|NCT01749982|20386154|P4|Overall Study|Physician Decision|1
5891968|NCT01749982|20386155|P3|Overall Study|Physician Decision|0
5891969|NCT01749982|20386156|P2|Overall Study|Physician Decision|0
5891970|NCT01749982|20386157|P1|Overall Study|Physician Decision|0
5891971|NCT01749826|20386221|P2|Overall Study|Study Terminated|0
5891972|NCT01749826|20386222|P1|Overall Study|Study Terminated|20
5891973|NCT01749800|20386237|P3|Overall Study|Withdrawal by Subject|0
5891974|NCT01749800|20386238|P2|Overall Study|Withdrawal by Subject|1
5891975|NCT01749800|20386239|P1|Overall Study|Withdrawal by Subject|0
5891976|NCT01749800|20386237|P3|Overall Study|not meeting inclusion criteria|0
5891977|NCT01749800|20386238|P2|Overall Study|not meeting inclusion criteria|0
5891978|NCT01749800|20386239|P1|Overall Study|not meeting inclusion criteria|3
5891979|NCT01749735|20386249|P2|Overall Study|Withdrawal by Subject|0
5891980|NCT01749735|20386250|P1|Overall Study|Withdrawal by Subject|1
5891981|NCT01749033|20386301|P3|Overall Study|Lost to Follow-up|1
5891982|NCT01749033|20386302|P2|Overall Study|Lost to Follow-up|2
5891983|NCT01749033|20386303|P1|Overall Study|Lost to Follow-up|0
5891984|NCT01749033|20386301|P3|Overall Study|Did not receive allocated intervention|0
5891985|NCT01749033|20386302|P2|Overall Study|Did not receive allocated intervention|3
5891986|NCT01749033|20386303|P1|Overall Study|Did not receive allocated intervention|3
5891987|NCT01748890|20386373|P1|Overall Study|Insufficient recruitment for analysis|4
5891988|NCT01748760|20386428|P2|Overall Study|Lost to Follow-up|1
5891989|NCT01748760|20386429|P1|Overall Study|Lost to Follow-up|5
5891990|NCT01748760|20386428|P2|Overall Study|Withdrawal by Subject|1
5891991|NCT01748760|20386429|P1|Overall Study|Withdrawal by Subject|1
5891992|NCT01748552|20386475|P12|Intervention Period 2 and Washout|Contingency dose not tested|0
5891993|NCT01748552|20386476|P11|Intervention Period 2 and Washout|Contingency dose not tested|0
5891994|NCT01748552|20386477|P10|Intervention Period 2 and Washout|Contingency dose not tested|0
5891995|NCT01748552|20386478|P9|Intervention Period 2 and Washout|Contingency dose not tested|3
5891996|NCT01748552|20386479|P8|Intervention Period 2 and Washout|Contingency dose not tested|3
5891997|NCT01748552|20386480|P7|Intervention Period 2 and Washout|Contingency dose not tested|3
5891998|NCT01748552|20386481|P6|Intervention Period 2 and Washout|Contingency dose not tested|0
5891999|NCT01748552|20386482|P5|Intervention Period 2 and Washout|Contingency dose not tested|0
5892000|NCT01748552|20386483|P4|Intervention Period 2 and Washout|Contingency dose not tested|0
5892001|NCT01748552|20386484|P3|Intervention Period 2 and Washout|Contingency dose not tested|0
5892002|NCT01748552|20386485|P2|Intervention Period 2 and Washout|Contingency dose not tested|0
5892003|NCT01748552|20386486|P1|Intervention Period 2 and Washout|Contingency dose not tested|0
5892004|NCT01748552|20386475|P12|Intervention Period 2 and Washout|Physician Decision|0
5892005|NCT01748552|20386476|P11|Intervention Period 2 and Washout|Physician Decision|0
5892006|NCT01748552|20386477|P10|Intervention Period 2 and Washout|Physician Decision|0
5892007|NCT01748552|20386478|P9|Intervention Period 2 and Washout|Physician Decision|0
5892008|NCT01748552|20386479|P8|Intervention Period 2 and Washout|Physician Decision|0
5892009|NCT01748552|20386480|P7|Intervention Period 2 and Washout|Physician Decision|0
5892010|NCT01748552|20386481|P6|Intervention Period 2 and Washout|Physician Decision|0
5892011|NCT01748552|20386482|P5|Intervention Period 2 and Washout|Physician Decision|0
5892012|NCT01748552|20386483|P4|Intervention Period 2 and Washout|Physician Decision|0
5892013|NCT01748552|20386484|P3|Intervention Period 2 and Washout|Physician Decision|1
5892014|NCT01748552|20386485|P2|Intervention Period 2 and Washout|Physician Decision|0
5892015|NCT01748552|20386486|P1|Intervention Period 2 and Washout|Physician Decision|0
5892016|NCT01748292|20386556|P2|Overall Study|Withdrawal by Subject|2
5892017|NCT01748292|20386557|P1|Overall Study|Withdrawal by Subject|0
5892018|NCT01748292|20386556|P2|Overall Study|Death|3
5892019|NCT01748292|20386557|P1|Overall Study|Death|0
5892020|NCT01748292|20386556|P2|Overall Study|Lost to Follow-up|3
5892021|NCT01748292|20386557|P1|Overall Study|Lost to Follow-up|0
5892022|NCT01748292|20386556|P2|Overall Study|Adverse Event|4
5892023|NCT01748292|20386557|P1|Overall Study|Adverse Event|2
5892024|NCT01748162|20386591|P2|Overall Study|reasons not available|2
5892025|NCT01748162|20386592|P1|Overall Study|reasons not available|3
5892026|NCT01748162|20386591|P2|Overall Study|participant consented but did not begin|1
5892027|NCT01748162|20386592|P1|Overall Study|participant consented but did not begin|0
5892028|NCT01748162|20386591|P2|Overall Study|no additional croup episodes to evaluate|2
5892029|NCT01748162|20386592|P1|Overall Study|no additional croup episodes to evaluate|2
5892030|NCT01748071|20386603|P3|Overall Study|Adverse Event|0
5892031|NCT01748071|20386604|P2|Overall Study|Adverse Event|2
5892032|NCT01748071|20386605|P1|Overall Study|Adverse Event|2
5892033|NCT01747915|20386868|P3|Overall Study|Pregnancy|1
5892034|NCT01747915|20386869|P2|Overall Study|Pregnancy|0
5892035|NCT01747915|20386870|P1|Overall Study|Pregnancy|0
5892036|NCT01747915|20386868|P3|Overall Study|Protocol Violation|0
5892037|NCT01747915|20386869|P2|Overall Study|Protocol Violation|0
5892038|NCT01747915|20386870|P1|Overall Study|Protocol Violation|1
5892039|NCT01747915|20386868|P3|Overall Study|Withdrawal by Subject|1
5892040|NCT01747915|20386869|P2|Overall Study|Withdrawal by Subject|4
5892041|NCT01747915|20386870|P1|Overall Study|Withdrawal by Subject|4
5892042|NCT01747915|20386868|P3|Overall Study|Lost to Follow-up|0
5892043|NCT01747915|20386869|P2|Overall Study|Lost to Follow-up|0
5892044|NCT01747915|20386870|P1|Overall Study|Lost to Follow-up|1
5892045|NCT01747915|20386868|P3|Overall Study|Lack of Efficacy|0
5892046|NCT01747915|20386869|P2|Overall Study|Lack of Efficacy|1
5892047|NCT01747915|20386870|P1|Overall Study|Lack of Efficacy|0
5892048|NCT01747915|20386868|P3|Overall Study|Death|1
5892049|NCT01747915|20386869|P2|Overall Study|Death|0
5892050|NCT01747915|20386870|P1|Overall Study|Death|0
5892051|NCT01747915|20386868|P3|Overall Study|Adverse Event|2
5892052|NCT01747915|20386869|P2|Overall Study|Adverse Event|5
5892053|NCT01747915|20386870|P1|Overall Study|Adverse Event|8
5892054|NCT01747915|20386868|P3|Overall Study|Other|1
5892055|NCT01747915|20386869|P2|Overall Study|Other|1
5892056|NCT01747915|20386870|P1|Overall Study|Other|1
5892057|NCT01747876|20386884|P3|Overall Study|Trtment duration compl. as per protocol|1
5892058|NCT01747876|20386885|P2|Overall Study|Trtment duration compl. as per protocol|1
5892059|NCT01747876|20386886|P1|Overall Study|Trtment duration compl. as per protocol|0
5892060|NCT01747876|20386884|P3|Overall Study|Disease progression|8
5892061|NCT01747876|20386885|P2|Overall Study|Disease progression|13
5892062|NCT01747876|20386886|P1|Overall Study|Disease progression|4
5892063|NCT01747876|20386884|P3|Overall Study|Withdrawal by Subject|1
5892064|NCT01747876|20386885|P2|Overall Study|Withdrawal by Subject|1
5892065|NCT01747876|20386886|P1|Overall Study|Withdrawal by Subject|0
5892066|NCT01747876|20386884|P3|Overall Study|Adverse Event|2
5892067|NCT01747876|20386885|P2|Overall Study|Adverse Event|0
5892068|NCT01747876|20386886|P1|Overall Study|Adverse Event|1
5892069|NCT01747837|20386939|P2|Overall Study|Death|4
5892070|NCT01747837|20386940|P1|Overall Study|Death|4
5892071|NCT01747837|20386939|P2|Overall Study|Lost to Follow-up|2
5892072|NCT01747837|20386940|P1|Overall Study|Lost to Follow-up|5
5892073|NCT01747811|20386970|P2|Overall Study|Lack of Efficacy|4
5892074|NCT01747811|20386971|P1|Overall Study|Lack of Efficacy|2
5892075|NCT01747772|20386987|P1|Overall Study|SWE Data Not Obtainable Prior to Biopsy|9
5892076|NCT01747655|20386995|P2|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|0
5892077|NCT01747655|20386996|P1|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|1
5892078|NCT01747655|20386995|P2|PEG-J Period (Duodopa Treatment)|Patient Decision|0
5892079|NCT01747655|20386996|P1|PEG-J Period (Duodopa Treatment)|Patient Decision|8
5892080|NCT01747655|20386995|P2|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|0
5892081|NCT01747655|20386996|P1|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|5
5892082|NCT01747629|20387026|P2|Overall Study|Other|1
5892083|NCT01747629|20387027|P1|Overall Study|Other|2
5892084|NCT01747629|20387026|P2|Overall Study|Not treated|0
5892085|NCT01747629|20387027|P1|Overall Study|Not treated|1
5892086|NCT01747629|20387026|P2|Overall Study|Inclusion criteria not met|0
5892087|NCT01747629|20387027|P1|Overall Study|Inclusion criteria not met|1
5892088|NCT01747629|20387026|P2|Overall Study|Noncompliance|1
5892089|NCT01747629|20387027|P1|Overall Study|Noncompliance|1
5892090|NCT01747629|20387026|P2|Overall Study|Withdrawal by Subject|2
5892091|NCT01747629|20387027|P1|Overall Study|Withdrawal by Subject|2
5892092|NCT01747629|20387026|P2|Overall Study|Adverse Event|2
5892093|NCT01747629|20387027|P1|Overall Study|Adverse Event|1
5892094|NCT01747551|20387061|P2|Overall Study|Other|0
5892095|NCT01747551|20387062|P1|Overall Study|Other|2
5892096|NCT01747551|20387061|P2|Overall Study|Physician Decision|1
5892097|NCT01747551|20387062|P1|Overall Study|Physician Decision|2
5892098|NCT01747551|20387061|P2|Overall Study|Withdrawal by Subject|1
5892099|NCT01747551|20387062|P1|Overall Study|Withdrawal by Subject|3
5892100|NCT01747551|20387061|P2|Overall Study|Prolonged Treatment Delay|0
5892101|NCT01747551|20387062|P1|Overall Study|Prolonged Treatment Delay|2
5892102|NCT01747551|20387061|P2|Overall Study|Adverse Event|1
5892103|NCT01747551|20387062|P1|Overall Study|Adverse Event|7
5892104|NCT01747551|20387061|P2|Overall Study|Death|1
5892105|NCT01747551|20387062|P1|Overall Study|Death|3
5892106|NCT01747551|20387061|P2|Overall Study|Progressive Disease|17
5892107|NCT01747551|20387062|P1|Overall Study|Progressive Disease|24
5892108|NCT01747499|20387079|P5|Overall Study|Determined not to be eligible|1
5892109|NCT01747499|20387080|P4|Overall Study|Determined not to be eligible|0
5892110|NCT01747499|20387081|P3|Overall Study|Determined not to be eligible|0
5892111|NCT01747499|20387082|P2|Overall Study|Determined not to be eligible|0
5892112|NCT01747499|20387083|P1|Overall Study|Determined not to be eligible|0
5892113|NCT01747499|20387079|P5|Overall Study|Developed AML and death|1
5892114|NCT01747499|20387080|P4|Overall Study|Developed AML and death|0
5892115|NCT01747499|20387081|P3|Overall Study|Developed AML and death|0
5892116|NCT01747499|20387082|P2|Overall Study|Developed AML and death|0
5892117|NCT01747499|20387083|P1|Overall Study|Developed AML and death|0
5892118|NCT01747499|20387079|P5|Overall Study|Withdrawal by Subject|6
5892119|NCT01747499|20387080|P4|Overall Study|Withdrawal by Subject|0
5892120|NCT01747499|20387081|P3|Overall Study|Withdrawal by Subject|0
5892121|NCT01747499|20387082|P2|Overall Study|Withdrawal by Subject|0
5892122|NCT01747499|20387083|P1|Overall Study|Withdrawal by Subject|0
5892123|NCT01747499|20387079|P5|Overall Study|Death|1
5892124|NCT01747499|20387080|P4|Overall Study|Death|1
5892125|NCT01747499|20387081|P3|Overall Study|Death|0
5892126|NCT01747499|20387082|P2|Overall Study|Death|0
5892127|NCT01747499|20387083|P1|Overall Study|Death|0
5892128|NCT01747499|20387079|P5|Overall Study|Physician Decision|2
5892129|NCT01747499|20387080|P4|Overall Study|Physician Decision|0
5892130|NCT01747499|20387081|P3|Overall Study|Physician Decision|0
5892131|NCT01747499|20387082|P2|Overall Study|Physician Decision|1
5892132|NCT01747499|20387083|P1|Overall Study|Physician Decision|0
5892133|NCT01747499|20387079|P5|Overall Study|Steroid refractory aGvHD|4
5892134|NCT01747499|20387080|P4|Overall Study|Steroid refractory aGvHD|1
5892135|NCT01747499|20387081|P3|Overall Study|Steroid refractory aGvHD|0
5892136|NCT01747499|20387082|P2|Overall Study|Steroid refractory aGvHD|0
5892137|NCT01747499|20387083|P1|Overall Study|Steroid refractory aGvHD|1
5892138|NCT01747486|20387119|P2|Stage 2|Disease Progression|0
5892139|NCT01747486|20387120|P1|Stage 2|Disease Progression|3
5892140|NCT01747486|20387119|P2|Stage 2|New Cancer Therapy|0
5892141|NCT01747486|20387120|P1|Stage 2|New Cancer Therapy|3
5892142|NCT01747486|20387119|P2|Stage 2|Withdrawal by Subject|0
5892143|NCT01747486|20387120|P1|Stage 2|Withdrawal by Subject|1
5892144|NCT01747486|20387119|P2|Stage 2|Physician Decision|0
5892145|NCT01747486|20387120|P1|Stage 2|Physician Decision|2
5892146|NCT01747486|20387119|P2|Stage 1|Death|1
5892147|NCT01747486|20387120|P1|Stage 1|Death|1
5892148|NCT01747486|20387119|P2|Stage 1|Disease progression|9
5892149|NCT01747486|20387120|P1|Stage 1|Disease progression|4
5892150|NCT01747486|20387119|P2|Stage 1|Withdrawal by Subject|3
5892151|NCT01747486|20387120|P1|Stage 1|Withdrawal by Subject|4
5892152|NCT01747486|20387119|P2|Stage 1|Physician Decision|0
5892153|NCT01747486|20387120|P1|Stage 1|Physician Decision|3
5892154|NCT01746901|20387170|P9|Treatment Phase: Fourth Intervention|Protocol Violation|1
5892155|NCT01746901|20387171|P8|Treatment Phase: Fourth Intervention|Protocol Violation|0
5892156|NCT01746901|20387172|P7|Treatment Phase: Fourth Intervention|Protocol Violation|1
5892157|NCT01746901|20387173|P6|Treatment Phase: Fourth Intervention|Protocol Violation|0
5892158|NCT01746901|20387174|P5|Treatment Phase: Fourth Intervention|Protocol Violation|0
5892159|NCT01746901|20387175|P4|Treatment Phase: Fourth Intervention|Protocol Violation|0
5892160|NCT01746901|20387176|P3|Treatment Phase: Fourth Intervention|Protocol Violation|0
5892161|NCT01746901|20387177|P2|Treatment Phase: Fourth Intervention|Protocol Violation|0
5892162|NCT01746901|20387178|P1|Treatment Phase: Fourth Intervention|Protocol Violation|0
5892163|NCT01746901|20387170|P9|Treatment Phase: Fourth Intervention|Adverse Event|1
5892164|NCT01746901|20387171|P8|Treatment Phase: Fourth Intervention|Adverse Event|0
5892165|NCT01746901|20387172|P7|Treatment Phase: Fourth Intervention|Adverse Event|0
5892166|NCT01746901|20387173|P6|Treatment Phase: Fourth Intervention|Adverse Event|1
5892167|NCT01746901|20387174|P5|Treatment Phase: Fourth Intervention|Adverse Event|0
5892168|NCT01746901|20387175|P4|Treatment Phase: Fourth Intervention|Adverse Event|0
5892169|NCT01746901|20387176|P3|Treatment Phase: Fourth Intervention|Adverse Event|0
5892170|NCT01746901|20387177|P2|Treatment Phase: Fourth Intervention|Adverse Event|0
5892171|NCT01746901|20387178|P1|Treatment Phase: Fourth Intervention|Adverse Event|0
5892172|NCT01746901|20387170|P9|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
5892173|NCT01746901|20387171|P8|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
5892174|NCT01746901|20387172|P7|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
5892175|NCT01746901|20387173|P6|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
5892176|NCT01746901|20387174|P5|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
5892177|NCT01746901|20387175|P4|Treatment Phase: Fourth Intervention|Lost to Follow-up|1
5892178|NCT01746901|20387176|P3|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
5892179|NCT01746901|20387177|P2|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
5892180|NCT01746901|20387178|P1|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
5892181|NCT01746901|20387170|P9|Treatment Phase: Third Intervention|Protocol Violation|0
5892182|NCT01746901|20387171|P8|Treatment Phase: Third Intervention|Protocol Violation|0
5892183|NCT01746901|20387172|P7|Treatment Phase: Third Intervention|Protocol Violation|1
5892184|NCT01746901|20387173|P6|Treatment Phase: Third Intervention|Protocol Violation|1
5892185|NCT01746901|20387174|P5|Treatment Phase: Third Intervention|Protocol Violation|0
5892186|NCT01746901|20387175|P4|Treatment Phase: Third Intervention|Protocol Violation|0
5892187|NCT01746901|20387176|P3|Treatment Phase: Third Intervention|Protocol Violation|0
5892188|NCT01746901|20387177|P2|Treatment Phase: Third Intervention|Protocol Violation|0
5892189|NCT01746901|20387178|P1|Treatment Phase: Third Intervention|Protocol Violation|0
5892190|NCT01746901|20387170|P9|Treatment Phase: Second Intervention|Withdrawal by Subject|0
5892191|NCT01746901|20387171|P8|Treatment Phase: Second Intervention|Withdrawal by Subject|1
5892192|NCT01746901|20387172|P7|Treatment Phase: Second Intervention|Withdrawal by Subject|0
5892193|NCT01746901|20387173|P6|Treatment Phase: Second Intervention|Withdrawal by Subject|0
5892194|NCT01746901|20387174|P5|Treatment Phase: Second Intervention|Withdrawal by Subject|0
5892195|NCT01746901|20387175|P4|Treatment Phase: Second Intervention|Withdrawal by Subject|0
5892196|NCT01746901|20387176|P3|Treatment Phase: Second Intervention|Withdrawal by Subject|0
5892197|NCT01746901|20387177|P2|Treatment Phase: Second Intervention|Withdrawal by Subject|0
5892198|NCT01746901|20387178|P1|Treatment Phase: Second Intervention|Withdrawal by Subject|0
5892199|NCT01746901|20387170|P9|Treatment Phase: First Intervention|Protocol Violation|0
5892200|NCT01746901|20387171|P8|Treatment Phase: First Intervention|Protocol Violation|0
5892201|NCT01746901|20387172|P7|Treatment Phase: First Intervention|Protocol Violation|1
5892202|NCT01746901|20387173|P6|Treatment Phase: First Intervention|Protocol Violation|0
5892203|NCT01746901|20387174|P5|Treatment Phase: First Intervention|Protocol Violation|0
5892204|NCT01746901|20387175|P4|Treatment Phase: First Intervention|Protocol Violation|0
5892205|NCT01746901|20387176|P3|Treatment Phase: First Intervention|Protocol Violation|0
5892206|NCT01746901|20387177|P2|Treatment Phase: First Intervention|Protocol Violation|0
5892207|NCT01746901|20387178|P1|Treatment Phase: First Intervention|Protocol Violation|0
5892208|NCT01746901|20387170|P9|Drug Discrimination Phase: Day 2|Protocol Violation|0
5892209|NCT01746901|20387171|P8|Drug Discrimination Phase: Day 2|Protocol Violation|0
5892210|NCT01746901|20387172|P7|Drug Discrimination Phase: Day 2|Protocol Violation|0
5892211|NCT01746901|20387173|P6|Drug Discrimination Phase: Day 2|Protocol Violation|0
5892212|NCT01746901|20387174|P5|Drug Discrimination Phase: Day 2|Protocol Violation|0
5892213|NCT01746901|20387175|P4|Drug Discrimination Phase: Day 2|Protocol Violation|0
5892214|NCT01746901|20387176|P3|Drug Discrimination Phase: Day 2|Protocol Violation|3
5892215|NCT01746901|20387177|P2|Drug Discrimination Phase: Day 2|Protocol Violation|3
5892216|NCT01746901|20387178|P1|Drug Discrimination Phase: Day 2|Protocol Violation|0
5892217|NCT01746901|20387170|P9|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0
5892218|NCT01746901|20387171|P8|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0
5892219|NCT01746901|20387172|P7|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0
5892220|NCT01746901|20387173|P6|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0
5892221|NCT01746901|20387174|P5|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0
5892222|NCT01746901|20387175|P4|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0
5892223|NCT01746901|20387176|P3|Drug Discrimination Phase: Day 2|Did not met entrance criteria|10
5892224|NCT01746901|20387177|P2|Drug Discrimination Phase: Day 2|Did not met entrance criteria|9
5892225|NCT01746901|20387178|P1|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0
5892226|NCT01746901|20387170|P9|Drug Discrimination Phase: Day 2|Adverse Event|0
5892227|NCT01746901|20387171|P8|Drug Discrimination Phase: Day 2|Adverse Event|0
5892228|NCT01746901|20387172|P7|Drug Discrimination Phase: Day 2|Adverse Event|0
5892229|NCT01746901|20387173|P6|Drug Discrimination Phase: Day 2|Adverse Event|0
5892230|NCT01746901|20387174|P5|Drug Discrimination Phase: Day 2|Adverse Event|0
5892231|NCT01746901|20387175|P4|Drug Discrimination Phase: Day 2|Adverse Event|0
5892232|NCT01746901|20387176|P3|Drug Discrimination Phase: Day 2|Adverse Event|1
5892233|NCT01746901|20387177|P2|Drug Discrimination Phase: Day 2|Adverse Event|2
5892234|NCT01746901|20387178|P1|Drug Discrimination Phase: Day 2|Adverse Event|0
5892235|NCT01746901|20387170|P9|Drug Discrimination Phase: Day 1|Adverse Event|0
5892236|NCT01746901|20387171|P8|Drug Discrimination Phase: Day 1|Adverse Event|0
5892237|NCT01746901|20387172|P7|Drug Discrimination Phase: Day 1|Adverse Event|0
5892238|NCT01746901|20387173|P6|Drug Discrimination Phase: Day 1|Adverse Event|0
5892239|NCT01746901|20387174|P5|Drug Discrimination Phase: Day 1|Adverse Event|0
5892240|NCT01746901|20387175|P4|Drug Discrimination Phase: Day 1|Adverse Event|0
5892241|NCT01746901|20387176|P3|Drug Discrimination Phase: Day 1|Adverse Event|0
5892242|NCT01746901|20387177|P2|Drug Discrimination Phase: Day 1|Adverse Event|3
5892243|NCT01746901|20387178|P1|Drug Discrimination Phase: Day 1|Adverse Event|0
5892244|NCT01746901|20387170|P9|Naloxone Challenge Phase|Did not meet entrance criteria|0
5892245|NCT01746901|20387171|P8|Naloxone Challenge Phase|Did not meet entrance criteria|0
5892246|NCT01746901|20387172|P7|Naloxone Challenge Phase|Did not meet entrance criteria|0
5892247|NCT01746901|20387173|P6|Naloxone Challenge Phase|Did not meet entrance criteria|0
5892248|NCT01746901|20387174|P5|Naloxone Challenge Phase|Did not meet entrance criteria|0
5892249|NCT01746901|20387175|P4|Naloxone Challenge Phase|Did not meet entrance criteria|0
5892250|NCT01746901|20387176|P3|Naloxone Challenge Phase|Did not meet entrance criteria|0
5892251|NCT01746901|20387177|P2|Naloxone Challenge Phase|Did not meet entrance criteria|0
5892252|NCT01746901|20387178|P1|Naloxone Challenge Phase|Did not meet entrance criteria|1
5892253|NCT01746901|20387170|P9|Naloxone Challenge Phase|Adverse Event|0
5892254|NCT01746901|20387171|P8|Naloxone Challenge Phase|Adverse Event|0
5892255|NCT01746901|20387172|P7|Naloxone Challenge Phase|Adverse Event|0
5892256|NCT01746901|20387173|P6|Naloxone Challenge Phase|Adverse Event|0
5892257|NCT01746901|20387174|P5|Naloxone Challenge Phase|Adverse Event|0
5892258|NCT01746901|20387175|P4|Naloxone Challenge Phase|Adverse Event|0
5892259|NCT01746901|20387176|P3|Naloxone Challenge Phase|Adverse Event|0
5892260|NCT01746901|20387177|P2|Naloxone Challenge Phase|Adverse Event|0
5892261|NCT01746901|20387178|P1|Naloxone Challenge Phase|Adverse Event|2
5892262|NCT01746862|20387501|P2|Overall Study|Entered puberty during the study|0
5892263|NCT01746862|20387502|P1|Overall Study|Entered puberty during the study|1
5892264|NCT01746862|20387501|P2|Overall Study|Consent withdrawal by parent's guardian|2
5892265|NCT01746862|20387502|P1|Overall Study|Consent withdrawal by parent's guardian|5
5892266|NCT01746862|20387501|P2|Overall Study|Protocol Violation|0
5892267|NCT01746862|20387502|P1|Overall Study|Protocol Violation|1
5892268|NCT01746862|20387501|P2|Overall Study|Withdrawal by Subject|1
5892269|NCT01746862|20387502|P1|Overall Study|Withdrawal by Subject|1
5892270|NCT01746732|20387566|P3|Period 2|Lost to Follow-up|1
5892271|NCT01746732|20387567|P2|Period 2|Lost to Follow-up|0
5892272|NCT01746732|20387568|P1|Period 2|Lost to Follow-up|0
5892273|NCT01746732|20387566|P3|Period 2|Adverse Event|1
5892274|NCT01746732|20387567|P2|Period 2|Adverse Event|0
5892275|NCT01746732|20387568|P1|Period 2|Adverse Event|0
5892276|NCT01746732|20387566|P3|Period 2|Withdrawal by Subject|2
5892277|NCT01746732|20387567|P2|Period 2|Withdrawal by Subject|0
5892278|NCT01746732|20387568|P1|Period 2|Withdrawal by Subject|0
5892279|NCT01746732|20387566|P3|Period 1|Physician Decision|0
5892280|NCT01746732|20387567|P2|Period 1|Physician Decision|1
5892281|NCT01746732|20387568|P1|Period 1|Physician Decision|0
5892282|NCT01746732|20387566|P3|Lead-In Period|Withdrawal by Subject|0
5892283|NCT01746732|20387567|P2|Lead-In Period|Withdrawal by Subject|0
5892284|NCT01746732|20387568|P1|Lead-In Period|Withdrawal by Subject|1
5892285|NCT01746368|20387649|P2|Overall Study|Withdrawal by Subject|1
5892286|NCT01746368|20387650|P1|Overall Study|Withdrawal by Subject|0
5892287|NCT01746368|20387649|P2|Overall Study|Lost to Follow-up|0
5892288|NCT01746368|20387650|P1|Overall Study|Lost to Follow-up|2
5892289|NCT01746225|20387680|P3|Overall Study|Continuing Treatment|3
5892290|NCT01746225|20387681|P2|Overall Study|Continuing Treatment|8
5892291|NCT01746225|20387682|P1|Overall Study|Continuing Treatment|5
5892292|NCT01746225|20387680|P3|Overall Study|Adverse Event|17
5892293|NCT01746225|20387681|P2|Overall Study|Adverse Event|12
5892294|NCT01746225|20387682|P1|Overall Study|Adverse Event|15
5892295|NCT01746225|20387680|P3|Overall Study|Physician Decision|3
5892296|NCT01746225|20387681|P2|Overall Study|Physician Decision|11
5892297|NCT01746225|20387682|P1|Overall Study|Physician Decision|14
5892298|NCT01746225|20387680|P3|Overall Study|Withdrawal by Subject|19
5892299|NCT01746225|20387681|P2|Overall Study|Withdrawal by Subject|15
5892300|NCT01746225|20387682|P1|Overall Study|Withdrawal by Subject|5
5892301|NCT01746225|20387680|P3|Overall Study|Death|1
5892302|NCT01746225|20387681|P2|Overall Study|Death|0
5892303|NCT01746225|20387682|P1|Overall Study|Death|1
5892304|NCT01746173|20387705|P1|Overall Study|Disease Progression|2
5892305|NCT01746108|20387713|P3|Overall Study|Lost to Follow-up|0
5892306|NCT01746108|20387714|P2|Overall Study|Lost to Follow-up|1
5892307|NCT01746108|20387715|P1|Overall Study|Lost to Follow-up|0
5892308|NCT01746108|20387713|P3|Overall Study|Withdrawal by Subject|0
5892309|NCT01746108|20387714|P2|Overall Study|Withdrawal by Subject|1
5892310|NCT01746108|20387715|P1|Overall Study|Withdrawal by Subject|0
5892311|NCT01746108|20387713|P3|Overall Study|Adverse event, non-fatal|0
5892312|NCT01746108|20387714|P2|Overall Study|Adverse event, non-fatal|1
5892313|NCT01746108|20387715|P1|Overall Study|Adverse event, non-fatal|0
5892314|NCT01746108|20387713|P3|Overall Study|Migrated /moved from study area|0
5892315|NCT01746108|20387714|P2|Overall Study|Migrated /moved from study area|1
5892316|NCT01746108|20387715|P1|Overall Study|Migrated /moved from study area|0
5892317|NCT01746017|20387832|P11|Period 3|Withdrawal by Subject|0
5892318|NCT01746017|20387833|P10|Period 3|Withdrawal by Subject|0
5892319|NCT01746017|20387834|P9|Period 3|Withdrawal by Subject|0
5892320|NCT01746017|20387835|P8|Period 3|Withdrawal by Subject|0
5892321|NCT01746017|20387836|P7|Period 3|Withdrawal by Subject|0
5892322|NCT01746017|20387837|P6|Period 3|Withdrawal by Subject|1
5892323|NCT01746017|20387838|P5|Period 3|Withdrawal by Subject|0
5892324|NCT01746017|20387839|P4|Period 3|Withdrawal by Subject|0
5892325|NCT01746017|20387840|P3|Period 3|Withdrawal by Subject|0
5892326|NCT01746017|20387841|P2|Period 3|Withdrawal by Subject|0
5892327|NCT01746017|20387842|P1|Period 3|Withdrawal by Subject|0
5892328|NCT01746017|20387832|P11|Period 1|Withdrawal by Subject|0
5892329|NCT01746017|20387833|P10|Period 1|Withdrawal by Subject|0
5892330|NCT01746017|20387834|P9|Period 1|Withdrawal by Subject|0
5892331|NCT01746017|20387835|P8|Period 1|Withdrawal by Subject|0
5892332|NCT01746017|20387836|P7|Period 1|Withdrawal by Subject|1
5892333|NCT01746017|20387837|P6|Period 1|Withdrawal by Subject|0
5892334|NCT01746017|20387838|P5|Period 1|Withdrawal by Subject|0
5892335|NCT01746017|20387839|P4|Period 1|Withdrawal by Subject|0
5892336|NCT01746017|20387840|P3|Period 1|Withdrawal by Subject|0
5892337|NCT01746017|20387841|P2|Period 1|Withdrawal by Subject|0
5892338|NCT01746017|20387842|P1|Period 1|Withdrawal by Subject|0
5892339|NCT01745848|20387963|P1|Overall Study|Adverse Event|6
5892340|NCT01745393|20387975|P2|12-month Follow-up|Lost to Follow-up|5
5892341|NCT01745393|20387976|P1|12-month Follow-up|Lost to Follow-up|6
5892342|NCT01745393|20387975|P2|Treatment to End-of-treatment Assessment|Withdrawal by Subject|0
5892343|NCT01745393|20387976|P1|Treatment to End-of-treatment Assessment|Withdrawal by Subject|1
5892344|NCT01745393|20387975|P2|Treatment to End-of-treatment Assessment|Lost to Follow-up|8
5892345|NCT01745393|20387976|P1|Treatment to End-of-treatment Assessment|Lost to Follow-up|20
5892346|NCT01745380|20387988|P2|Overall Study|Lack of Efficacy|1
5892347|NCT01745380|20387989|P1|Overall Study|Lack of Efficacy|0
5892348|NCT01745380|20387988|P2|Overall Study|Lost to Follow-up|0
5892349|NCT01745380|20387989|P1|Overall Study|Lost to Follow-up|1
5892350|NCT01745367|20388027|P2|Overall Study|Other Reasons Unspecified|2
5892351|NCT01745367|20388028|P1|Overall Study|Other Reasons Unspecified|0
5892352|NCT01745367|20388027|P2|Overall Study|Termination of The Study by The Sponsor|18
5892353|NCT01745367|20388028|P1|Overall Study|Termination of The Study by The Sponsor|6
5892354|NCT01745367|20388027|P2|Overall Study|Withdrawal by Subject|2
5892355|NCT01745367|20388028|P1|Overall Study|Withdrawal by Subject|1
5892356|NCT01745367|20388027|P2|Overall Study|Death|0
5892357|NCT01745367|20388028|P1|Overall Study|Death|1
5892358|NCT01745146|20388048|P2|Overall Study|Lost to Follow-up|0
5892359|NCT01745146|20388049|P1|Overall Study|Lost to Follow-up|2
5892360|NCT01745146|20388048|P2|Overall Study|Withdrawal by Subject|3
5892361|NCT01745146|20388049|P1|Overall Study|Withdrawal by Subject|1
5892362|NCT01745120|20388071|P2|Overall Study|Investigator decision|0
5892363|NCT01745120|20388072|P1|Overall Study|Investigator decision|1
5892364|NCT01745094|20388130|P4|Overall Study|Untenable Due to Recurrent Cystitis|0
5892365|NCT01745094|20388131|P3|Overall Study|Untenable Due to Recurrent Cystitis|0
5892366|NCT01745094|20388132|P2|Overall Study|Untenable Due to Recurrent Cystitis|0
5892367|NCT01745094|20388133|P1|Overall Study|Untenable Due to Recurrent Cystitis|1
5892368|NCT01745094|20388130|P4|Overall Study|Show no Stable Solifenacin Intake|0
5892369|NCT01745094|20388131|P3|Overall Study|Show no Stable Solifenacin Intake|1
5892370|NCT01745094|20388132|P2|Overall Study|Show no Stable Solifenacin Intake|0
5892371|NCT01745094|20388133|P1|Overall Study|Show no Stable Solifenacin Intake|0
5892372|NCT01745094|20388130|P4|Overall Study|Need Further Examinations Due to Biopsy|0
5892373|NCT01745094|20388131|P3|Overall Study|Need Further Examinations Due to Biopsy|1
5892374|NCT01745094|20388132|P2|Overall Study|Need Further Examinations Due to Biopsy|0
5892375|NCT01745094|20388133|P1|Overall Study|Need Further Examinations Due to Biopsy|0
5892376|NCT01745094|20388130|P4|Overall Study|Protocol Violation|1
5892377|NCT01745094|20388131|P3|Overall Study|Protocol Violation|3
5892378|NCT01745094|20388132|P2|Overall Study|Protocol Violation|0
5892379|NCT01745094|20388133|P1|Overall Study|Protocol Violation|1
5892380|NCT01745094|20388130|P4|Overall Study|Withdrawal by Subject|2
5892381|NCT01745094|20388131|P3|Overall Study|Withdrawal by Subject|1
5892382|NCT01745094|20388132|P2|Overall Study|Withdrawal by Subject|0
5892383|NCT01745094|20388133|P1|Overall Study|Withdrawal by Subject|2
5892384|NCT01745094|20388130|P4|Overall Study|Adverse Event|0
5892385|NCT01745094|20388131|P3|Overall Study|Adverse Event|3
5892386|NCT01745094|20388132|P2|Overall Study|Adverse Event|0
5892387|NCT01745094|20388133|P1|Overall Study|Adverse Event|0
5892388|NCT01745094|20388130|P4|Overall Study|Not Meeting the Eligibility Criteria|0
5892389|NCT01745094|20388131|P3|Overall Study|Not Meeting the Eligibility Criteria|3
5892390|NCT01745094|20388132|P2|Overall Study|Not Meeting the Eligibility Criteria|0
5892391|NCT01745094|20388133|P1|Overall Study|Not Meeting the Eligibility Criteria|1
5892392|NCT01744977|20388234|P2|Overall Study|No longer meets inclusion|0
5892393|NCT01744977|20388235|P1|Overall Study|No longer meets inclusion|6
5892394|NCT01744977|20388234|P2|Overall Study|Lost to Follow-up|0
5892395|NCT01744977|20388235|P1|Overall Study|Lost to Follow-up|2
5892396|NCT01744977|20388234|P2|Overall Study|Death|3
5892397|NCT01744977|20388235|P1|Overall Study|Death|2
5892398|NCT01744977|20388234|P2|Overall Study|Withdrawal by Subject|2
5892399|NCT01744977|20388235|P1|Overall Study|Withdrawal by Subject|1
5892400|NCT01744782|20388306|P1|Overall Study|Death|1
5892401|NCT01744691|20388467|P1|Overall Study|Physician Decision|4
5892402|NCT01744691|20388467|P1|Overall Study|Withdrawal of consent for treatment|3
5892403|NCT01744691|20388467|P1|Overall Study|Unacceptable toxicity, AE or death|18
5892404|NCT01744691|20388467|P1|Overall Study|Progressive Disease|18
5892405|NCT01744665|20388472|P1|Re-initiation Phase|Withdrawal by Subject|1
5892406|NCT01744665|20388472|P1|Re-initiation Phase|No longer required treatment|1
5892407|NCT01744665|20388472|P1|Re-initiation Phase|Adverse Event|1
5892408|NCT01744665|20388472|P1|Re-initiation Phase|Administrative problems|10
5892409|NCT01744665|20388472|P1|Consolidation Phase|Administrative problems|9
5892410|NCT01744665|20388472|P1|Consolidation Phase|Withdrawal by Subject|4
5892411|NCT01744665|20388472|P1|Consolidation Phase|Unsatisfactory therapeutic effect|4
5892412|NCT01744665|20388472|P1|Consolidation Phase|Adverse Event|2
5892413|NCT01744665|20388472|P1|Monitoring Phase|Did not achieve MR4.5|1
5892414|NCT01744665|20388472|P1|Monitoring Phase|Withdrawal by Subject|5
5892415|NCT01744665|20388472|P1|Monitoring Phase|Unsatisfactory therapeutic effect|7
5892416|NCT01744665|20388472|P1|Monitoring Phase|Abnormal laboratory value(s)|1
5892417|NCT01744665|20388472|P1|Monitoring Phase|Adverse Event|4
5892418|NCT01744496|20388542|P2|Maintenance Period|Subject left town|0
5892419|NCT01744496|20388543|P1|Maintenance Period|Subject left town|1
5892420|NCT01744496|20388542|P2|Maintenance Period|Withdrawal by Subject|1
5892421|NCT01744496|20388543|P1|Maintenance Period|Withdrawal by Subject|1
5892422|NCT01744496|20388542|P2|Maintenance Period|Protocol Violation|0
5892423|NCT01744496|20388543|P1|Maintenance Period|Protocol Violation|1
5892424|NCT01744496|20388542|P2|Maintenance Period|Adverse Event|3
5892425|NCT01744496|20388543|P1|Maintenance Period|Adverse Event|1
5892426|NCT01744496|20388542|P2|Titration Period|Personal reasons|1
5892427|NCT01744496|20388543|P1|Titration Period|Personal reasons|0
5892428|NCT01744496|20388542|P2|Titration Period|Adverse Event|1
5892429|NCT01744496|20388543|P1|Titration Period|Adverse Event|2
5892430|NCT01744483|20388564|P3|Overall Study|Routed to OSH|1
5892431|NCT01744483|20388565|P2|Overall Study|Routed to OSH|0
5892432|NCT01744483|20388566|P1|Overall Study|Routed to OSH|2
5892433|NCT01744483|20388564|P3|Overall Study|No ICU Admit|2
5892434|NCT01744483|20388565|P2|Overall Study|No ICU Admit|1
5892435|NCT01744483|20388566|P1|Overall Study|No ICU Admit|5
5892436|NCT01744483|20388564|P3|Overall Study|Withdrawal by Subject|2
5892437|NCT01744483|20388565|P2|Overall Study|Withdrawal by Subject|6
5892438|NCT01744483|20388566|P1|Overall Study|Withdrawal by Subject|4
5892439|NCT01744483|20388564|P3|Overall Study|Protocol Violation|1
5892440|NCT01744483|20388565|P2|Overall Study|Protocol Violation|2
5892441|NCT01744483|20388566|P1|Overall Study|Protocol Violation|1
5892442|NCT01744483|20388564|P3|Overall Study|Lost to Follow-up|11
5892443|NCT01744483|20388565|P2|Overall Study|Lost to Follow-up|9
5892444|NCT01744483|20388566|P1|Overall Study|Lost to Follow-up|8
5892445|NCT01744483|20388564|P3|Overall Study|Death|11
5892446|NCT01744483|20388565|P2|Overall Study|Death|4
5892447|NCT01744483|20388566|P1|Overall Study|Death|9
5892448|NCT01744392|20388574|P1|Overall Study|Physician Decision|1
5892449|NCT01744197|20388614|P2|Overall Study|No patch received|2
5892450|NCT01744197|20388615|P1|Overall Study|No patch received|2
5892451|NCT01744197|20388614|P2|Overall Study|Received 1 patch|1
5892452|NCT01744197|20388615|P1|Overall Study|Received 1 patch|2
5892453|NCT01743560|20388721|P1|Overall Study|>1 dose of study drug|3
5892454|NCT01743560|20388721|P1|Overall Study|Protocol Violation|1
5892455|NCT01743560|20388721|P1|Overall Study|Withdrawal by Subject|2
5892456|NCT01743560|20388721|P1|Overall Study|Death|3
5892457|NCT01743560|20388721|P1|Overall Study|Adverse Event|8
5892458|NCT01743560|20388721|P1|Overall Study|Disease progression|26
5892459|NCT01743469|20388805|P4|Follow-up Period - Post-Treatment|Lost to Follow-up|0
5892460|NCT01743469|20388806|P3|Follow-up Period - Post-Treatment|Lost to Follow-up|0
5892461|NCT01743469|20388807|P2|Follow-up Period - Post-Treatment|Lost to Follow-up|1
5892462|NCT01743469|20388808|P1|Follow-up Period - Post-Treatment|Lost to Follow-up|1
5892463|NCT01743469|20388805|P4|Follow-up Period - Post-Treatment|Death|16
5892464|NCT01743469|20388806|P3|Follow-up Period - Post-Treatment|Death|22
5892465|NCT01743469|20388807|P2|Follow-up Period - Post-Treatment|Death|47
5892466|NCT01743469|20388808|P1|Follow-up Period - Post-Treatment|Death|43
5892467|NCT01743469|20388805|P4|Follow-up Period - Post-Treatment|Withdrawal by Subject|0
5892468|NCT01743469|20388806|P3|Follow-up Period - Post-Treatment|Withdrawal by Subject|1
5892469|NCT01743469|20388807|P2|Follow-up Period - Post-Treatment|Withdrawal by Subject|0
5892470|NCT01743469|20388808|P1|Follow-up Period - Post-Treatment|Withdrawal by Subject|1
5892471|NCT01743469|20388805|P4|Active Treatment Phase|Missing|0
5892472|NCT01743469|20388806|P3|Active Treatment Phase|Missing|0
5892473|NCT01743469|20388807|P2|Active Treatment Phase|Missing|0
5892474|NCT01743469|20388808|P1|Active Treatment Phase|Missing|1
5892475|NCT01743469|20388805|P4|Active Treatment Phase|Withdrawal by Subject|0
5892476|NCT01743469|20388806|P3|Active Treatment Phase|Withdrawal by Subject|0
5892477|NCT01743469|20388807|P2|Active Treatment Phase|Withdrawal by Subject|3
5892478|NCT01743469|20388808|P1|Active Treatment Phase|Withdrawal by Subject|2
5892479|NCT01743469|20388805|P4|Active Treatment Phase|Disease Progression|20
5892480|NCT01743469|20388806|P3|Active Treatment Phase|Disease Progression|30
5892481|NCT01743469|20388807|P2|Active Treatment Phase|Disease Progression|47
5892482|NCT01743469|20388808|P1|Active Treatment Phase|Disease Progression|40
5892483|NCT01743469|20388805|P4|Active Treatment Phase|Adverse Event|1
5892484|NCT01743469|20388806|P3|Active Treatment Phase|Adverse Event|8
5892485|NCT01743469|20388807|P2|Active Treatment Phase|Adverse Event|5
5892486|NCT01743469|20388808|P1|Active Treatment Phase|Adverse Event|10
5892487|NCT01743092|20388873|P2|Overall Study|Lost to Follow-up|15
5892488|NCT01743092|20388874|P1|Overall Study|Lost to Follow-up|14
5892489|NCT01743040|20388882|P1|Overall Study|Withdrawal by Subject|121
5892490|NCT01743040|20388882|P1|Overall Study|Protocol Violation|1
5892491|NCT01743040|20388882|P1|Overall Study|Physician Decision|40
5892492|NCT01743040|20388882|P1|Overall Study|Lost to Follow-up|66
5892493|NCT01743040|20388882|P1|Overall Study|Death|1
5892494|NCT01743027|20388890|P4|Overall Study|Withdrawal by Subject|1
5892495|NCT01743027|20388891|P3|Overall Study|Withdrawal by Subject|3
5892496|NCT01743027|20388892|P2|Overall Study|Withdrawal by Subject|0
5892497|NCT01743027|20388893|P1|Overall Study|Withdrawal by Subject|1
5892498|NCT01743027|20388890|P4|Overall Study|Protocol Violation|0
5892499|NCT01743027|20388891|P3|Overall Study|Protocol Violation|1
5892500|NCT01743027|20388892|P2|Overall Study|Protocol Violation|1
5892501|NCT01743027|20388893|P1|Overall Study|Protocol Violation|1
5892502|NCT01743027|20388890|P4|Overall Study|Progressive Disease|0
5892503|NCT01743027|20388891|P3|Overall Study|Progressive Disease|3
5892504|NCT01743027|20388892|P2|Overall Study|Progressive Disease|4
5892505|NCT01743027|20388893|P1|Overall Study|Progressive Disease|1
5892506|NCT01743027|20388890|P4|Overall Study|Lost to Follow-up|0
5892507|NCT01743027|20388891|P3|Overall Study|Lost to Follow-up|2
5892508|NCT01743027|20388892|P2|Overall Study|Lost to Follow-up|0
5892509|NCT01743027|20388893|P1|Overall Study|Lost to Follow-up|0
5892510|NCT01743027|20388890|P4|Overall Study|Adverse Event|0
5892511|NCT01743027|20388891|P3|Overall Study|Adverse Event|0
5892512|NCT01743027|20388892|P2|Overall Study|Adverse Event|0
5892513|NCT01743027|20388893|P1|Overall Study|Adverse Event|2
5892514|NCT01743001|20388933|P2|Overall Study|Death|0
5892515|NCT01743001|20388934|P1|Overall Study|Death|1
5892516|NCT01743001|20388933|P2|Overall Study|Pregnancy|0
5892517|NCT01743001|20388934|P1|Overall Study|Pregnancy|1
5892518|NCT01743001|20388933|P2|Overall Study|Physician Decision|0
5892519|NCT01743001|20388934|P1|Overall Study|Physician Decision|1
5892520|NCT01742897|20388977|P1|Overall Study|Other|1
5892521|NCT01742897|20388977|P1|Overall Study|Withdrawal by Subject|1
5892522|NCT01742897|20388977|P1|Overall Study|Adverse Event|3
5892523|NCT01742286|20389030|P7|Expansion Phase|Withdrawal by Subject|1
5892524|NCT01742286|20389031|P6|Expansion Phase|Withdrawal by Subject|0
5892525|NCT01742286|20389032|P5|Expansion Phase|Withdrawal by Subject|0
5892526|NCT01742286|20389033|P4|Expansion Phase|Withdrawal by Subject|0
5892527|NCT01742286|20389034|P3|Expansion Phase|Withdrawal by Subject|0
5892528|NCT01742286|20389035|P2|Expansion Phase|Withdrawal by Subject|0
5892529|NCT01742286|20389036|P1|Expansion Phase|Withdrawal by Subject|0
5892530|NCT01742286|20389030|P7|Expansion Phase|Disease progression|15
5892531|NCT01742286|20389031|P6|Expansion Phase|Disease progression|0
5892532|NCT01742286|20389032|P5|Expansion Phase|Disease progression|0
5892533|NCT01742286|20389033|P4|Expansion Phase|Disease progression|0
5892534|NCT01742286|20389034|P3|Expansion Phase|Disease progression|3
5892535|NCT01742286|20389035|P2|Expansion Phase|Disease progression|0
5892536|NCT01742286|20389036|P1|Expansion Phase|Disease progression|0
5892537|NCT01742286|20389030|P7|Expansion Phase|Adverse Event|6
5892538|NCT01742286|20389031|P6|Expansion Phase|Adverse Event|0
5892539|NCT01742286|20389032|P5|Expansion Phase|Adverse Event|0
5892540|NCT01742286|20389033|P4|Expansion Phase|Adverse Event|0
5892541|NCT01742286|20389034|P3|Expansion Phase|Adverse Event|0
5892542|NCT01742286|20389035|P2|Expansion Phase|Adverse Event|0
5892543|NCT01742286|20389036|P1|Expansion Phase|Adverse Event|0
5892544|NCT01742286|20389030|P7|Expansion Phase|Physician Decision|9
5892545|NCT01742286|20389031|P6|Expansion Phase|Physician Decision|0
5892546|NCT01742286|20389032|P5|Expansion Phase|Physician Decision|0
5892547|NCT01742286|20389033|P4|Expansion Phase|Physician Decision|0
5892548|NCT01742286|20389034|P3|Expansion Phase|Physician Decision|4
5892549|NCT01742286|20389035|P2|Expansion Phase|Physician Decision|0
5892550|NCT01742286|20389036|P1|Expansion Phase|Physician Decision|0
5892551|NCT01742286|20389030|P7|Expansion Phase|Administrative problems|5
5892552|NCT01742286|20389031|P6|Expansion Phase|Administrative problems|0
5892553|NCT01742286|20389032|P5|Expansion Phase|Administrative problems|0
5892554|NCT01742286|20389033|P4|Expansion Phase|Administrative problems|0
5892555|NCT01742286|20389034|P3|Expansion Phase|Administrative problems|0
5892556|NCT01742286|20389035|P2|Expansion Phase|Administrative problems|0
5892557|NCT01742286|20389036|P1|Expansion Phase|Administrative problems|0
5892558|NCT01742286|20389030|P7|Escalation Phase|Subject/guardian decision|0
5892559|NCT01742286|20389031|P6|Escalation Phase|Subject/guardian decision|0
5892560|NCT01742286|20389032|P5|Escalation Phase|Subject/guardian decision|0
5892561|NCT01742286|20389033|P4|Escalation Phase|Subject/guardian decision|0
5892562|NCT01742286|20389034|P3|Escalation Phase|Subject/guardian decision|0
5892563|NCT01742286|20389035|P2|Escalation Phase|Subject/guardian decision|0
5892564|NCT01742286|20389036|P1|Escalation Phase|Subject/guardian decision|1
5892565|NCT01742286|20389030|P7|Escalation Phase|Physician Decision|2
5892566|NCT01742286|20389031|P6|Escalation Phase|Physician Decision|0
5892567|NCT01742286|20389032|P5|Escalation Phase|Physician Decision|0
5892568|NCT01742286|20389033|P4|Escalation Phase|Physician Decision|1
5892569|NCT01742286|20389034|P3|Escalation Phase|Physician Decision|0
5892570|NCT01742286|20389035|P2|Escalation Phase|Physician Decision|3
5892571|NCT01742286|20389036|P1|Escalation Phase|Physician Decision|0
5892572|NCT01742286|20389030|P7|Escalation Phase|Death|0
5892573|NCT01742286|20389031|P6|Escalation Phase|Death|1
5892574|NCT01742286|20389032|P5|Escalation Phase|Death|0
5892575|NCT01742286|20389033|P4|Escalation Phase|Death|0
5892576|NCT01742286|20389034|P3|Escalation Phase|Death|0
5892577|NCT01742286|20389035|P2|Escalation Phase|Death|0
5892578|NCT01742286|20389036|P1|Escalation Phase|Death|0
5892579|NCT01742286|20389030|P7|Escalation Phase|Disease progression|2
5892580|NCT01742286|20389031|P6|Escalation Phase|Disease progression|3
5892581|NCT01742286|20389032|P5|Escalation Phase|Disease progression|4
5892582|NCT01742286|20389033|P4|Escalation Phase|Disease progression|1
5892583|NCT01742286|20389034|P3|Escalation Phase|Disease progression|4
5892584|NCT01742286|20389035|P2|Escalation Phase|Disease progression|7
5892585|NCT01742286|20389036|P1|Escalation Phase|Disease progression|3
5892586|NCT01742286|20389030|P7|Escalation Phase|Adverse Event|0
5892587|NCT01742286|20389031|P6|Escalation Phase|Adverse Event|1
5892588|NCT01742286|20389032|P5|Escalation Phase|Adverse Event|0
5892589|NCT01742286|20389033|P4|Escalation Phase|Adverse Event|0
5892590|NCT01742286|20389034|P3|Escalation Phase|Adverse Event|2
5892591|NCT01742286|20389035|P2|Escalation Phase|Adverse Event|1
5892592|NCT01742286|20389036|P1|Escalation Phase|Adverse Event|0
5892593|NCT01742286|20389030|P7|Escalation Phase|Administrative problems|2
5892594|NCT01742286|20389031|P6|Escalation Phase|Administrative problems|0
5892595|NCT01742286|20389032|P5|Escalation Phase|Administrative problems|0
5892596|NCT01742286|20389033|P4|Escalation Phase|Administrative problems|0
5892597|NCT01742286|20389034|P3|Escalation Phase|Administrative problems|0
5892598|NCT01742286|20389035|P2|Escalation Phase|Administrative problems|1
5892599|NCT01742286|20389036|P1|Escalation Phase|Administrative problems|1
5892600|NCT01742091|20389169|P6|Overall Study|Lost to Follow-up|1
5892601|NCT01742091|20389170|P5|Overall Study|Lost to Follow-up|0
5892602|NCT01742091|20389171|P4|Overall Study|Lost to Follow-up|0
5892603|NCT01742091|20389172|P3|Overall Study|Lost to Follow-up|0
5892604|NCT01742091|20389173|P2|Overall Study|Lost to Follow-up|0
5892605|NCT01742091|20389174|P1|Overall Study|Lost to Follow-up|0
5892606|NCT01742091|20389169|P6|Overall Study|Withdrawal by Subject|0
5892607|NCT01742091|20389170|P5|Overall Study|Withdrawal by Subject|0
5892608|NCT01742091|20389171|P4|Overall Study|Withdrawal by Subject|1
5892609|NCT01742091|20389172|P3|Overall Study|Withdrawal by Subject|0
5892610|NCT01742091|20389173|P2|Overall Study|Withdrawal by Subject|0
5892611|NCT01742091|20389174|P1|Overall Study|Withdrawal by Subject|0
5892612|NCT01742091|20389169|P6|Overall Study|Physician Decision|1
5892613|NCT01742091|20389170|P5|Overall Study|Physician Decision|0
5892614|NCT01742091|20389171|P4|Overall Study|Physician Decision|0
5892615|NCT01742091|20389172|P3|Overall Study|Physician Decision|0
5892616|NCT01742091|20389173|P2|Overall Study|Physician Decision|0
5892617|NCT01742091|20389174|P1|Overall Study|Physician Decision|0
5892618|NCT01742091|20389169|P6|Overall Study|Adverse Event|0
5892619|NCT01742091|20389170|P5|Overall Study|Adverse Event|1
5892620|NCT01742091|20389171|P4|Overall Study|Adverse Event|0
5892621|NCT01742091|20389172|P3|Overall Study|Adverse Event|0
5892622|NCT01742091|20389173|P2|Overall Study|Adverse Event|0
5892623|NCT01742091|20389174|P1|Overall Study|Adverse Event|0
5892624|NCT01742078|20389220|P9|Overall Study|Withdrawal by Subject|0
5892625|NCT01742078|20389221|P8|Overall Study|Withdrawal by Subject|0
5892626|NCT01742078|20389222|P7|Overall Study|Withdrawal by Subject|0
5892627|NCT01742078|20389223|P6|Overall Study|Withdrawal by Subject|0
5892628|NCT01742078|20389224|P5|Overall Study|Withdrawal by Subject|0
5892629|NCT01742078|20389225|P4|Overall Study|Withdrawal by Subject|1
5892630|NCT01742078|20389226|P3|Overall Study|Withdrawal by Subject|0
5892631|NCT01742078|20389227|P2|Overall Study|Withdrawal by Subject|0
5892632|NCT01742078|20389228|P1|Overall Study|Withdrawal by Subject|0
5892633|NCT01741792|20389297|P3|Overall Study|Death|12
5892634|NCT01741792|20389298|P2|Overall Study|Death|1
5892635|NCT01741792|20389299|P1|Overall Study|Death|6
5892636|NCT01741701|20389366|P2|Overall Study|Withdrawal by Subject|1
5892637|NCT01741701|20389367|P1|Overall Study|Withdrawal by Subject|0
5892638|NCT01741701|20389366|P2|Overall Study|Adverse Event|1
5892639|NCT01741701|20389367|P1|Overall Study|Adverse Event|5
5892640|NCT01741688|20389383|P1|Overall Study|Withdrawal by Subject|1
5892641|NCT01741688|20389383|P1|Overall Study|Lack of insurance coverage|2
5892642|NCT01741545|20389402|P2|Follow-up Period (24 Weeks)|Withdrawal by Subject|1
5892643|NCT01741545|20389403|P1|Follow-up Period (24 Weeks)|Withdrawal by Subject|1
5892644|NCT01741545|20389402|P2|Follow-up Period (24 Weeks)|Other than specified|1
5892645|NCT01741545|20389403|P1|Follow-up Period (24 Weeks)|Other than specified|0
5892646|NCT01741545|20389402|P2|Treatment Period|Adverse event, non-fatal|3
5892647|NCT01741545|20389403|P1|Treatment Period|Adverse event, non-fatal|1
5892648|NCT01741545|20389402|P2|Treatment Period|Lack of Efficacy|1
5892649|NCT01741545|20389403|P1|Treatment Period|Lack of Efficacy|0
5892650|NCT01741532|20389427|P2|Overall Study|Medical event|0
5892651|NCT01741532|20389428|P1|Overall Study|Medical event|1
5892652|NCT01741532|20389427|P2|Overall Study|Sponsor decision|0
5892653|NCT01741532|20389428|P1|Overall Study|Sponsor decision|1
5892654|NCT01741532|20389427|P2|Overall Study|Worsening of the disease|1
5892655|NCT01741532|20389428|P1|Overall Study|Worsening of the disease|3
5892656|NCT01741532|20389427|P2|Overall Study|Protocol Violation|1
5892657|NCT01741532|20389428|P1|Overall Study|Protocol Violation|0
5892658|NCT01741532|20389427|P2|Overall Study|Withdrawal by Subject|1
5892659|NCT01741532|20389428|P1|Overall Study|Withdrawal by Subject|1
5892660|NCT01741532|20389427|P2|Overall Study|Adverse Event|0
5892661|NCT01741532|20389428|P1|Overall Study|Adverse Event|4
5892662|NCT01741259|20389642|P2|Overall Study|Withdrawal by Subject|2
5892663|NCT01741259|20389643|P1|Overall Study|Withdrawal by Subject|0
5892664|NCT01741259|20389642|P2|Overall Study|Protocol Violation|4
5892665|NCT01741259|20389643|P1|Overall Study|Protocol Violation|6
5892666|NCT01741012|20389697|P1|Overall Study|Withdrawal by Subject|2
5892667|NCT01741012|20389697|P1|Overall Study|Lost to Follow-up|1
5892668|NCT01740791|20389721|P6|Overall Study|Adverse Event|1
5892669|NCT01740791|20389722|P5|Overall Study|Adverse Event|0
5892670|NCT01740791|20389723|P4|Overall Study|Adverse Event|0
5892671|NCT01740791|20389724|P3|Overall Study|Adverse Event|0
5892672|NCT01740791|20389725|P2|Overall Study|Adverse Event|0
5892673|NCT01740791|20389726|P1|Overall Study|Adverse Event|0
5892674|NCT01740791|20389721|P6|Overall Study|Investigator's discretion|1
5892675|NCT01740791|20389722|P5|Overall Study|Investigator's discretion|0
5892676|NCT01740791|20389723|P4|Overall Study|Investigator's discretion|0
5892677|NCT01740791|20389724|P3|Overall Study|Investigator's discretion|1
5892678|NCT01740791|20389725|P2|Overall Study|Investigator's discretion|0
5892679|NCT01740791|20389726|P1|Overall Study|Investigator's discretion|1
5892680|NCT01740791|20389721|P6|Overall Study|Withdrew Consent|3
5892681|NCT01740791|20389722|P5|Overall Study|Withdrew Consent|0
5892682|NCT01740791|20389723|P4|Overall Study|Withdrew Consent|2
5892683|NCT01740791|20389724|P3|Overall Study|Withdrew Consent|1
5892684|NCT01740791|20389725|P2|Overall Study|Withdrew Consent|0
5892685|NCT01740791|20389726|P1|Overall Study|Withdrew Consent|4
5892686|NCT01740791|20389721|P6|Overall Study|Lost to Follow-up|3
5892687|NCT01740791|20389722|P5|Overall Study|Lost to Follow-up|2
5892688|NCT01740791|20389723|P4|Overall Study|Lost to Follow-up|3
5892689|NCT01740791|20389724|P3|Overall Study|Lost to Follow-up|2
5892690|NCT01740791|20389725|P2|Overall Study|Lost to Follow-up|0
5892691|NCT01740791|20389726|P1|Overall Study|Lost to Follow-up|2
5892692|NCT01740791|20389721|P6|Overall Study|Randomized but never treated|3
5892693|NCT01740791|20389722|P5|Overall Study|Randomized but never treated|1
5892694|NCT01740791|20389723|P4|Overall Study|Randomized but never treated|2
5892695|NCT01740791|20389724|P3|Overall Study|Randomized but never treated|2
5892696|NCT01740791|20389725|P2|Overall Study|Randomized but never treated|3
5892697|NCT01740791|20389726|P1|Overall Study|Randomized but never treated|5
5892698|NCT01740440|20389909|P1|Overall Study|Lost to Follow-up|3
5892699|NCT01740427|20389917|P2|Overall Study|Study terminated by Sponsor|0
5892700|NCT01740427|20389918|P1|Overall Study|Study terminated by Sponsor|1
5892701|NCT01740427|20389917|P2|Overall Study|Lost to Follow-up|0
5892702|NCT01740427|20389918|P1|Overall Study|Lost to Follow-up|1
5892703|NCT01740427|20389917|P2|Overall Study|Protocol Violation|3
5892704|NCT01740427|20389918|P1|Overall Study|Protocol Violation|5
5892705|NCT01740427|20389917|P2|Overall Study|Death|2
5892706|NCT01740427|20389918|P1|Overall Study|Death|6
5892707|NCT01740427|20389917|P2|Overall Study|Unspecified reasons|4
5892708|NCT01740427|20389918|P1|Overall Study|Unspecified reasons|6
5892709|NCT01740427|20389917|P2|Overall Study|Subject refused continued treatment|9
5892710|NCT01740427|20389918|P1|Overall Study|Subject refused continued treatment|12
5892711|NCT01740427|20389917|P2|Overall Study|Global deterioration of health status|9
5892712|NCT01740427|20389918|P1|Overall Study|Global deterioration of health status|16
5892713|NCT01740427|20389917|P2|Overall Study|Adverse Event|9
5892714|NCT01740427|20389918|P1|Overall Study|Adverse Event|20
5892715|NCT01740427|20389917|P2|Overall Study|Objective progression or relapse|125
5892716|NCT01740427|20389918|P1|Overall Study|Objective progression or relapse|172
5892717|NCT01740427|20389917|P2|Overall Study|Ongoing at date of cutoff (26 Feb 2016)|61
5892718|NCT01740427|20389918|P1|Overall Study|Ongoing at date of cutoff (26 Feb 2016)|205
5892719|NCT01740401|20389970|P1|Overall Study|Did not reach primary endpoint|2
5892720|NCT01740401|20389970|P1|Overall Study|Adverse Event|2
5892721|NCT01740401|20389970|P1|Overall Study|Progression of disease|6
5892722|NCT01740388|20389979|P2|Overall Study|Subjects missing data, completed|36
5892723|NCT01740388|20389980|P1|Overall Study|Subjects missing data, completed|41
5892724|NCT01740388|20389979|P2|Overall Study|Physician Decision|6
5892725|NCT01740388|20389980|P1|Overall Study|Physician Decision|2
5892726|NCT01740388|20389979|P2|Overall Study|Lost to Follow-up|0
5892727|NCT01740388|20389980|P1|Overall Study|Lost to Follow-up|2
5892728|NCT01740388|20389979|P2|Overall Study|Withdrawal by Subject|2
5892729|NCT01740388|20389980|P1|Overall Study|Withdrawal by Subject|1
5892730|NCT01740323|20390031|P2|Overall Study|Randomized but did not take study drug|0
5892731|NCT01740323|20390032|P1|Overall Study|Randomized but did not take study drug|1
5892732|NCT01740323|20390031|P2|Overall Study|Adverse Event|0
5892733|NCT01740323|20390032|P1|Overall Study|Adverse Event|1
5892734|NCT01740297|20390053|P3|Overall Study|Sponsor Decision|0
5892735|NCT01740297|20390054|P2|Overall Study|Sponsor Decision|1
5892736|NCT01740297|20390055|P1|Overall Study|Sponsor Decision|0
5892737|NCT01740297|20390053|P3|Overall Study|Death|19
5892738|NCT01740297|20390054|P2|Overall Study|Death|23
5892739|NCT01740297|20390055|P1|Overall Study|Death|8
5892740|NCT01740297|20390053|P3|Overall Study|Withdrawal by Subject|11
5892741|NCT01740297|20390054|P2|Overall Study|Withdrawal by Subject|9
5892742|NCT01740297|20390055|P1|Overall Study|Withdrawal by Subject|1
5892743|NCT01740297|20390053|P3|Overall Study|Continuing Study|68
5892744|NCT01740297|20390054|P2|Overall Study|Continuing Study|67
5892745|NCT01740297|20390055|P1|Overall Study|Continuing Study|10
5892746|NCT01740154|20390110|P1|Overall Study|Adverse Event|1
5892747|NCT01740128|20390118|P2|Overall Study|Insufficient protocol compliance|2
5892748|NCT01740128|20390119|P1|Overall Study|Insufficient protocol compliance|2
5892749|NCT01740128|20390118|P2|Overall Study|Withdrawal by Subject|0
5892750|NCT01740128|20390119|P1|Overall Study|Withdrawal by Subject|1
5892751|NCT01740128|20390118|P2|Overall Study|Lost to Follow-up|2
5892752|NCT01740128|20390119|P1|Overall Study|Lost to Follow-up|2
5892753|NCT01740128|20390118|P2|Overall Study|Protocol Violation|2
5892754|NCT01740128|20390119|P1|Overall Study|Protocol Violation|1
5892755|NCT01740128|20390118|P2|Overall Study|Pregnancy|1
5892756|NCT01740128|20390119|P1|Overall Study|Pregnancy|0
5892757|NCT01740089|20390148|P3|After 12 Weeks|Withdrawal by Subject|1
5892758|NCT01740089|20390149|P2|After 12 Weeks|Withdrawal by Subject|1
5892759|NCT01740089|20390150|P1|After 12 Weeks|Withdrawal by Subject|1
5892760|NCT01740089|20390148|P3|After 12 Weeks|Protocol Violation|1
5892761|NCT01740089|20390149|P2|After 12 Weeks|Protocol Violation|1
5892762|NCT01740089|20390150|P1|After 12 Weeks|Protocol Violation|1
5892763|NCT01740089|20390148|P3|After 12 Weeks|Adverse Event|5
5892764|NCT01740089|20390149|P2|After 12 Weeks|Adverse Event|0
5892765|NCT01740089|20390150|P1|After 12 Weeks|Adverse Event|2
5892766|NCT01740089|20390148|P3|After 12 Weeks|Lack of Efficacy|4
5892767|NCT01740089|20390149|P2|After 12 Weeks|Lack of Efficacy|1
5892768|NCT01740089|20390150|P1|After 12 Weeks|Lack of Efficacy|3
5892769|NCT01740089|20390148|P3|First 12 Weeks of Treatment|Withdrawal by Subject|0
5892770|NCT01740089|20390149|P2|First 12 Weeks of Treatment|Withdrawal by Subject|1
5892771|NCT01740089|20390150|P1|First 12 Weeks of Treatment|Withdrawal by Subject|0
5892772|NCT01740089|20390148|P3|First 12 Weeks of Treatment|Adverse Event|2
5892773|NCT01740089|20390149|P2|First 12 Weeks of Treatment|Adverse Event|1
5892774|NCT01740089|20390150|P1|First 12 Weeks of Treatment|Adverse Event|0
5892775|NCT01739803|20390168|P2|Overall Study|Lost to Follow-up|6
5892776|NCT01739803|20390169|P1|Overall Study|Lost to Follow-up|9
5892777|NCT01739790|20390181|P2|Overall Study|Early Trial Termination|4
5892778|NCT01739790|20390182|P1|Overall Study|Early Trial Termination|2
5892779|NCT01739764|20390191|P3|Overall Study|Withdrawal by Subject|27
5892780|NCT01739764|20390192|P2|Overall Study|Withdrawal by Subject|5
5892781|NCT01739764|20390193|P1|Overall Study|Withdrawal by Subject|6
5892782|NCT01739764|20390191|P3|Overall Study|Study Terminated by Sponsor|26
5892783|NCT01739764|20390192|P2|Overall Study|Study Terminated by Sponsor|13
5892784|NCT01739764|20390193|P1|Overall Study|Study Terminated by Sponsor|8
5892785|NCT01739764|20390191|P3|Overall Study|Protocol Violation|2
5892786|NCT01739764|20390192|P2|Overall Study|Protocol Violation|0
5892787|NCT01739764|20390193|P1|Overall Study|Protocol Violation|0
5892788|NCT01739764|20390191|P3|Overall Study|Progressive Disease|16
5892789|NCT01739764|20390192|P2|Overall Study|Progressive Disease|5
5892790|NCT01739764|20390193|P1|Overall Study|Progressive Disease|3
5892791|NCT01739764|20390191|P3|Overall Study|Physician Decision|4
5892792|NCT01739764|20390192|P2|Overall Study|Physician Decision|2
5892793|NCT01739764|20390193|P1|Overall Study|Physician Decision|2
5892794|NCT01739764|20390191|P3|Overall Study|Multiple Reasons|3
5892795|NCT01739764|20390192|P2|Overall Study|Multiple Reasons|2
5892796|NCT01739764|20390193|P1|Overall Study|Multiple Reasons|3
5892797|NCT01739764|20390191|P3|Overall Study|Non-Compliance|1
5892798|NCT01739764|20390192|P2|Overall Study|Non-Compliance|0
5892799|NCT01739764|20390193|P1|Overall Study|Non-Compliance|0
5892800|NCT01739764|20390191|P3|Overall Study|Lost to Follow-up|5
5892801|NCT01739764|20390192|P2|Overall Study|Lost to Follow-up|0
5892802|NCT01739764|20390193|P1|Overall Study|Lost to Follow-up|0
5892803|NCT01739764|20390191|P3|Overall Study|Death|38
5892804|NCT01739764|20390192|P2|Overall Study|Death|6
5892805|NCT01739764|20390193|P1|Overall Study|Death|4
5892806|NCT01739764|20390191|P3|Overall Study|Adverse Event|4
5892807|NCT01739764|20390192|P2|Overall Study|Adverse Event|3
5892808|NCT01739764|20390193|P1|Overall Study|Adverse Event|0
5892809|NCT01739595|20390207|P3|Overall Study|Drug discrepancy|0
5892810|NCT01739595|20390208|P2|Overall Study|Drug discrepancy|0
5892811|NCT01739595|20390209|P1|Overall Study|Drug discrepancy|1
5892812|NCT01739595|20390207|P3|Overall Study|Lab assessment|0
5892813|NCT01739595|20390208|P2|Overall Study|Lab assessment|0
5892814|NCT01739595|20390209|P1|Overall Study|Lab assessment|1
5892815|NCT01739595|20390207|P3|Overall Study|Protocol Violation|0
5892816|NCT01739595|20390208|P2|Overall Study|Protocol Violation|0
5892817|NCT01739595|20390209|P1|Overall Study|Protocol Violation|1
5892818|NCT01739595|20390207|P3|Overall Study|Eligibility issue|0
5892819|NCT01739595|20390208|P2|Overall Study|Eligibility issue|0
5892820|NCT01739595|20390209|P1|Overall Study|Eligibility issue|3
5892821|NCT01739595|20390207|P3|Overall Study|Withdrawal by Subject|2
5892822|NCT01739595|20390208|P2|Overall Study|Withdrawal by Subject|1
5892823|NCT01739595|20390209|P1|Overall Study|Withdrawal by Subject|2
5892824|NCT01739595|20390207|P3|Overall Study|Lost to Follow-up|0
5892825|NCT01739595|20390208|P2|Overall Study|Lost to Follow-up|0
5892826|NCT01739595|20390209|P1|Overall Study|Lost to Follow-up|2
5892827|NCT01739595|20390207|P3|Overall Study|Adverse Event|0
5892828|NCT01739595|20390208|P2|Overall Study|Adverse Event|0
5892829|NCT01739595|20390209|P1|Overall Study|Adverse Event|3
5892830|NCT01739400|20390219|P2|Overall Study|Withdrawal by Subject|7
5892831|NCT01739400|20390220|P1|Overall Study|Withdrawal by Subject|7
5892832|NCT01739400|20390219|P2|Overall Study|Death|2
5892833|NCT01739400|20390220|P1|Overall Study|Death|5
5892834|NCT01739400|20390219|P2|Overall Study|Lost to Follow-up|0
5892835|NCT01739400|20390220|P1|Overall Study|Lost to Follow-up|2
5892836|NCT01739400|20390219|P2|Overall Study|Physician Decision|0
5892837|NCT01739400|20390220|P1|Overall Study|Physician Decision|3
5892838|NCT01739348|20390248|P4|Part II (Extension Study)|Withdrawal by Subject|7
5892839|NCT01739348|20390249|P3|Part II (Extension Study)|Withdrawal by Subject|4
5892840|NCT01739348|20390250|P2|Part II (Extension Study)|Withdrawal by Subject|2
5892841|NCT01739348|20390251|P1|Part II (Extension Study)|Withdrawal by Subject|5
5892842|NCT01739348|20390248|P4|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|16
5892843|NCT01739348|20390249|P3|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|8
5892844|NCT01739348|20390250|P2|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|12
5892845|NCT01739348|20390251|P1|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|18
5892846|NCT01739348|20390248|P4|Part II (Extension Study)|Participant Moved|3
5892847|NCT01739348|20390249|P3|Part II (Extension Study)|Participant Moved|0
5892848|NCT01739348|20390250|P2|Part II (Extension Study)|Participant Moved|3
5892849|NCT01739348|20390251|P1|Part II (Extension Study)|Participant Moved|3
5892850|NCT01739348|20390248|P4|Part II (Extension Study)|Study Terminated by Sponsor|323
5892851|NCT01739348|20390249|P3|Part II (Extension Study)|Study Terminated by Sponsor|34
5892852|NCT01739348|20390250|P2|Part II (Extension Study)|Study Terminated by Sponsor|315
5892853|NCT01739348|20390251|P1|Part II (Extension Study)|Study Terminated by Sponsor|329
5892854|NCT01739348|20390248|P4|Part II (Extension Study)|Physician Decision|12
5892855|NCT01739348|20390249|P3|Part II (Extension Study)|Physician Decision|6
5892856|NCT01739348|20390250|P2|Part II (Extension Study)|Physician Decision|11
5892857|NCT01739348|20390251|P1|Part II (Extension Study)|Physician Decision|7
5892858|NCT01739348|20390248|P4|Part II (Extension Study)|Non-Compliance with Study Drug|1
5892859|NCT01739348|20390249|P3|Part II (Extension Study)|Non-Compliance with Study Drug|0
5892860|NCT01739348|20390250|P2|Part II (Extension Study)|Non-Compliance with Study Drug|0
5892861|NCT01739348|20390251|P1|Part II (Extension Study)|Non-Compliance with Study Drug|0
5892862|NCT01739348|20390248|P4|Part II (Extension Study)|Lost to Follow-up|1
5892863|NCT01739348|20390249|P3|Part II (Extension Study)|Lost to Follow-up|0
5892864|NCT01739348|20390250|P2|Part II (Extension Study)|Lost to Follow-up|4
5892865|NCT01739348|20390251|P1|Part II (Extension Study)|Lost to Follow-up|3
5892866|NCT01739348|20390248|P4|Part II (Extension Study)|Lack of Efficacy|1
5892867|NCT01739348|20390249|P3|Part II (Extension Study)|Lack of Efficacy|0
5892868|NCT01739348|20390250|P2|Part II (Extension Study)|Lack of Efficacy|5
5892869|NCT01739348|20390251|P1|Part II (Extension Study)|Lack of Efficacy|1
5892870|NCT01739348|20390248|P4|Part II (Extension Study)|Death|6
5892871|NCT01739348|20390249|P3|Part II (Extension Study)|Death|2
5892872|NCT01739348|20390250|P2|Part II (Extension Study)|Death|3
5892873|NCT01739348|20390251|P1|Part II (Extension Study)|Death|3
5892874|NCT01739348|20390248|P4|Part II (Extension Study)|Adverse Event|26
5892875|NCT01739348|20390249|P3|Part II (Extension Study)|Adverse Event|7
5892876|NCT01739348|20390250|P2|Part II (Extension Study)|Adverse Event|11
5892877|NCT01739348|20390251|P1|Part II (Extension Study)|Adverse Event|10
5892878|NCT01739348|20390248|P4|Part I (Base Study)|Withdrawal by Subject|20
5892879|NCT01739348|20390249|P3|Part I (Base Study)|Withdrawal by Subject|7
5892880|NCT01739348|20390250|P2|Part I (Base Study)|Withdrawal by Subject|21
5892881|NCT01739348|20390251|P1|Part I (Base Study)|Withdrawal by Subject|23
5892882|NCT01739348|20390248|P4|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|18
5892883|NCT01739348|20390249|P3|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|2
5892884|NCT01739348|20390250|P2|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|25
5892885|NCT01739348|20390251|P1|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|27
5892886|NCT01739348|20390248|P4|Part I (Base Study)|Participant Moved|7
5892887|NCT01739348|20390249|P3|Part I (Base Study)|Participant Moved|1
5892888|NCT01739348|20390250|P2|Part I (Base Study)|Participant Moved|3
5892889|NCT01739348|20390251|P1|Part I (Base Study)|Participant Moved|4
5892890|NCT01739348|20390248|P4|Part I (Base Study)|Study Terminated by Sponsor|86
5892891|NCT01739348|20390249|P3|Part I (Base Study)|Study Terminated by Sponsor|0
5892892|NCT01739348|20390250|P2|Part I (Base Study)|Study Terminated by Sponsor|73
5892893|NCT01739348|20390251|P1|Part I (Base Study)|Study Terminated by Sponsor|72
5892894|NCT01739348|20390248|P4|Part I (Base Study)|Site Discontinued Study Participation|0
5892895|NCT01739348|20390249|P3|Part I (Base Study)|Site Discontinued Study Participation|0
5892896|NCT01739348|20390250|P2|Part I (Base Study)|Site Discontinued Study Participation|3
5892897|NCT01739348|20390251|P1|Part I (Base Study)|Site Discontinued Study Participation|1
5892898|NCT01739348|20390248|P4|Part I (Base Study)|Screen Failure|0
5892899|NCT01739348|20390249|P3|Part I (Base Study)|Screen Failure|0
5892900|NCT01739348|20390250|P2|Part I (Base Study)|Screen Failure|0
5892901|NCT01739348|20390251|P1|Part I (Base Study)|Screen Failure|2
5892902|NCT01739348|20390248|P4|Part I (Base Study)|Protocol Violation|2
5892903|NCT01739348|20390249|P3|Part I (Base Study)|Protocol Violation|1
5892904|NCT01739348|20390250|P2|Part I (Base Study)|Protocol Violation|0
5892905|NCT01739348|20390251|P1|Part I (Base Study)|Protocol Violation|2
5892906|NCT01739348|20390248|P4|Part I (Base Study)|Physician Decision|4
5892907|NCT01739348|20390249|P3|Part I (Base Study)|Physician Decision|1
5892908|NCT01739348|20390250|P2|Part I (Base Study)|Physician Decision|7
5892909|NCT01739348|20390251|P1|Part I (Base Study)|Physician Decision|10
5892910|NCT01739348|20390248|P4|Part I (Base Study)|Non-Compliance with Study Drug|0
5892911|NCT01739348|20390249|P3|Part I (Base Study)|Non-Compliance with Study Drug|0
5892912|NCT01739348|20390250|P2|Part I (Base Study)|Non-Compliance with Study Drug|2
5892913|NCT01739348|20390251|P1|Part I (Base Study)|Non-Compliance with Study Drug|3
5892914|NCT01739348|20390248|P4|Part I (Base Study)|Lost to Follow-up|4
5892915|NCT01739348|20390249|P3|Part I (Base Study)|Lost to Follow-up|4
5892916|NCT01739348|20390250|P2|Part I (Base Study)|Lost to Follow-up|2
5892917|NCT01739348|20390251|P1|Part I (Base Study)|Lost to Follow-up|4
5892918|NCT01739348|20390248|P4|Part I (Base Study)|Lack of Efficacy|7
5892919|NCT01739348|20390249|P3|Part I (Base Study)|Lack of Efficacy|0
5892920|NCT01739348|20390250|P2|Part I (Base Study)|Lack of Efficacy|8
5892921|NCT01739348|20390251|P1|Part I (Base Study)|Lack of Efficacy|3
5892922|NCT01739348|20390248|P4|Part I (Base Study)|Death|8
5892923|NCT01739348|20390249|P3|Part I (Base Study)|Death|2
5892924|NCT01739348|20390250|P2|Part I (Base Study)|Death|7
5892925|NCT01739348|20390251|P1|Part I (Base Study)|Death|10
5892926|NCT01739348|20390248|P4|Part I (Base Study)|Adverse Event|33
5892927|NCT01739348|20390249|P3|Part I (Base Study)|Adverse Event|8
5892928|NCT01739348|20390250|P2|Part I (Base Study)|Adverse Event|52
5892929|NCT01739348|20390251|P1|Part I (Base Study)|Adverse Event|41
5892930|NCT01739335|20390323|P2|Overall Study|Ineligible patient randomized|1
5892931|NCT01739335|20390324|P1|Overall Study|Ineligible patient randomized|0
5892932|NCT01739335|20390323|P2|Overall Study|Lost to Follow-up|4
5892933|NCT01739335|20390324|P1|Overall Study|Lost to Follow-up|7
5892934|NCT01739309|20390356|P1|Overall Study|On study treatment|3
5892935|NCT01738984|20390551|P2|Overall Study|Lost to Follow-up|39
5892936|NCT01738984|20390552|P1|Overall Study|Lost to Follow-up|59
5892937|NCT01738984|20390551|P2|Overall Study|Withdrawal by Subject|0
5892938|NCT01738984|20390552|P1|Overall Study|Withdrawal by Subject|1
5892939|NCT01738984|20390551|P2|Overall Study|Pregnancy|0
5892940|NCT01738984|20390552|P1|Overall Study|Pregnancy|4
5892941|NCT01738971|20390565|P3|Overall Study|Lost to Follow-up|17
5892942|NCT01738971|20390566|P2|Overall Study|Lost to Follow-up|30
5892943|NCT01738971|20390567|P1|Overall Study|Lost to Follow-up|19
5892944|NCT01738919|20390583|P2|Overall Study|Not treated in accordance to guidelines|1
5892945|NCT01738919|20390584|P1|Overall Study|Not treated in accordance to guidelines|0
5892946|NCT01738919|20390583|P2|Overall Study|Withdrawal by Subject|1
5892947|NCT01738919|20390584|P1|Overall Study|Withdrawal by Subject|0
5892948|NCT01738919|20390583|P2|Overall Study|Immigrated|1
5892949|NCT01738919|20390584|P1|Overall Study|Immigrated|0
5892950|NCT01738919|20390583|P2|Overall Study|Lost to Follow-up|0
5892951|NCT01738919|20390584|P1|Overall Study|Lost to Follow-up|1
5892952|NCT01738646|20390734|P1|Overall Study|Still Receiving Treatment|2
5892953|NCT01738594|20390745|P8|Follow up for 1 Year|Other|0
5892954|NCT01738594|20390746|P7|Follow up for 1 Year|Other|0
5892955|NCT01738594|20390747|P6|Follow up for 1 Year|Other|2
5892956|NCT01738594|20390748|P5|Follow up for 1 Year|Other|0
5892957|NCT01738594|20390749|P4|Follow up for 1 Year|Other|0
5892958|NCT01738594|20390750|P3|Follow up for 1 Year|Other|0
5892959|NCT01738594|20390751|P2|Follow up for 1 Year|Other|0
5892960|NCT01738594|20390752|P1|Follow up for 1 Year|Other|0
5892961|NCT01738594|20390745|P8|Follow up for 1 Year|Death|0
5892962|NCT01738594|20390746|P7|Follow up for 1 Year|Death|0
5892963|NCT01738594|20390747|P6|Follow up for 1 Year|Death|1
5892964|NCT01738594|20390748|P5|Follow up for 1 Year|Death|0
5892965|NCT01738594|20390749|P4|Follow up for 1 Year|Death|0
5892966|NCT01738594|20390750|P3|Follow up for 1 Year|Death|0
5892967|NCT01738594|20390751|P2|Follow up for 1 Year|Death|0
5892968|NCT01738594|20390752|P1|Follow up for 1 Year|Death|0
5892969|NCT01738594|20390745|P8|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0
5892970|NCT01738594|20390746|P7|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0
5892971|NCT01738594|20390747|P6|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0
5892972|NCT01738594|20390748|P5|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|1
5892973|NCT01738594|20390749|P4|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0
5892974|NCT01738594|20390750|P3|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0
5892975|NCT01738594|20390751|P2|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0
5892976|NCT01738594|20390752|P1|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0
5892977|NCT01738594|20390745|P8|Went on to Continue Treatment Cycle 5|Progressive Disease|0
5892978|NCT01738594|20390746|P7|Went on to Continue Treatment Cycle 5|Progressive Disease|0
5892979|NCT01738594|20390747|P6|Went on to Continue Treatment Cycle 5|Progressive Disease|1
5892980|NCT01738594|20390748|P5|Went on to Continue Treatment Cycle 5|Progressive Disease|0
5892981|NCT01738594|20390749|P4|Went on to Continue Treatment Cycle 5|Progressive Disease|0
5892982|NCT01738594|20390750|P3|Went on to Continue Treatment Cycle 5|Progressive Disease|0
5892983|NCT01738594|20390751|P2|Went on to Continue Treatment Cycle 5|Progressive Disease|0
5892984|NCT01738594|20390752|P1|Went on to Continue Treatment Cycle 5|Progressive Disease|0
5892985|NCT01738594|20390745|P8|Completed 4 Cycles of Treatment|No response/patient benefit|0
5892986|NCT01738594|20390746|P7|Completed 4 Cycles of Treatment|No response/patient benefit|0
5892987|NCT01738594|20390747|P6|Completed 4 Cycles of Treatment|No response/patient benefit|1
5892988|NCT01738594|20390748|P5|Completed 4 Cycles of Treatment|No response/patient benefit|0
5892989|NCT01738594|20390749|P4|Completed 4 Cycles of Treatment|No response/patient benefit|0
5892990|NCT01738594|20390750|P3|Completed 4 Cycles of Treatment|No response/patient benefit|0
5892991|NCT01738594|20390751|P2|Completed 4 Cycles of Treatment|No response/patient benefit|0
5892992|NCT01738594|20390752|P1|Completed 4 Cycles of Treatment|No response/patient benefit|0
5892993|NCT01738594|20390745|P8|Completed 4 Cycles of Treatment|Progressive disease|0
5892994|NCT01738594|20390746|P7|Completed 4 Cycles of Treatment|Progressive disease|0
5892995|NCT01738594|20390747|P6|Completed 4 Cycles of Treatment|Progressive disease|0
5892996|NCT01738594|20390748|P5|Completed 4 Cycles of Treatment|Progressive disease|0
5892997|NCT01738594|20390749|P4|Completed 4 Cycles of Treatment|Progressive disease|0
5892998|NCT01738594|20390750|P3|Completed 4 Cycles of Treatment|Progressive disease|0
5892999|NCT01738594|20390751|P2|Completed 4 Cycles of Treatment|Progressive disease|2
5893000|NCT01738594|20390752|P1|Completed 4 Cycles of Treatment|Progressive disease|0
5893001|NCT01738594|20390745|P8|Completed 2 Cycles/Reached 1st Response|Physician Decision|0
5893002|NCT01738594|20390746|P7|Completed 2 Cycles/Reached 1st Response|Physician Decision|0
5893003|NCT01738594|20390747|P6|Completed 2 Cycles/Reached 1st Response|Physician Decision|1
5893004|NCT01738594|20390748|P5|Completed 2 Cycles/Reached 1st Response|Physician Decision|0
5893005|NCT01738594|20390749|P4|Completed 2 Cycles/Reached 1st Response|Physician Decision|0
5893006|NCT01738594|20390750|P3|Completed 2 Cycles/Reached 1st Response|Physician Decision|0
5893007|NCT01738594|20390751|P2|Completed 2 Cycles/Reached 1st Response|Physician Decision|0
5893008|NCT01738594|20390752|P1|Completed 2 Cycles/Reached 1st Response|Physician Decision|0
5893009|NCT01738594|20390745|P8|Registration and Treatment Start|Adverse Event|0
5893010|NCT01738594|20390746|P7|Registration and Treatment Start|Adverse Event|0
5893011|NCT01738594|20390747|P6|Registration and Treatment Start|Adverse Event|0
5893012|NCT01738594|20390748|P5|Registration and Treatment Start|Adverse Event|0
5893013|NCT01738594|20390749|P4|Registration and Treatment Start|Adverse Event|0
5893014|NCT01738594|20390750|P3|Registration and Treatment Start|Adverse Event|0
5893015|NCT01738594|20390751|P2|Registration and Treatment Start|Adverse Event|1
5893016|NCT01738594|20390752|P1|Registration and Treatment Start|Adverse Event|0
5893017|NCT01738581|20390770|P2|Overall Study|Lost to Follow-up|0
5893018|NCT01738581|20390771|P1|Overall Study|Lost to Follow-up|1
5893019|NCT01738503|20390795|P7|PET Imaging Sub-study|Scheduling issues with imaging facility|1
5893020|NCT01738503|20390796|P6|PET Imaging Sub-study|Scheduling issues with imaging facility|1
5893021|NCT01738503|20390797|P5|PET Imaging Sub-study|Scheduling issues with imaging facility|0
5893022|NCT01738503|20390798|P4|PET Imaging Sub-study|Scheduling issues with imaging facility|0
5893023|NCT01738503|20390799|P3|PET Imaging Sub-study|Scheduling issues with imaging facility|0
5893024|NCT01738503|20390800|P2|PET Imaging Sub-study|Scheduling issues with imaging facility|0
5893025|NCT01738503|20390801|P1|PET Imaging Sub-study|Scheduling issues with imaging facility|0
5893026|NCT01738503|20390795|P7|PET Imaging Sub-study|Adverse Event|0
5893027|NCT01738503|20390796|P6|PET Imaging Sub-study|Adverse Event|1
5893028|NCT01738503|20390797|P5|PET Imaging Sub-study|Adverse Event|0
5893029|NCT01738503|20390798|P4|PET Imaging Sub-study|Adverse Event|0
5893030|NCT01738503|20390799|P3|PET Imaging Sub-study|Adverse Event|0
5893031|NCT01738503|20390800|P2|PET Imaging Sub-study|Adverse Event|0
5893032|NCT01738503|20390801|P1|PET Imaging Sub-study|Adverse Event|0
5893033|NCT01738503|20390795|P7|Treatment Period|Other|0
5893034|NCT01738503|20390796|P6|Treatment Period|Other|0
5893035|NCT01738503|20390797|P5|Treatment Period|Other|0
5893036|NCT01738503|20390798|P4|Treatment Period|Other|0
5893037|NCT01738503|20390799|P3|Treatment Period|Other|1
5893038|NCT01738503|20390800|P2|Treatment Period|Other|0
5893039|NCT01738503|20390801|P1|Treatment Period|Other|0
5893040|NCT01738503|20390795|P7|Treatment Period|Protocol Violation|0
5893041|NCT01738503|20390796|P6|Treatment Period|Protocol Violation|2
5893042|NCT01738503|20390797|P5|Treatment Period|Protocol Violation|4
5893043|NCT01738503|20390798|P4|Treatment Period|Protocol Violation|0
5893044|NCT01738503|20390799|P3|Treatment Period|Protocol Violation|1
5893045|NCT01738503|20390800|P2|Treatment Period|Protocol Violation|3
5893046|NCT01738503|20390801|P1|Treatment Period|Protocol Violation|0
5893047|NCT01738503|20390795|P7|Treatment Period|Withdrawal by Subject|1
5893048|NCT01738503|20390796|P6|Treatment Period|Withdrawal by Subject|1
5893049|NCT01738503|20390797|P5|Treatment Period|Withdrawal by Subject|1
5893050|NCT01738503|20390798|P4|Treatment Period|Withdrawal by Subject|1
5893051|NCT01738503|20390799|P3|Treatment Period|Withdrawal by Subject|0
5893052|NCT01738503|20390800|P2|Treatment Period|Withdrawal by Subject|1
5893053|NCT01738503|20390801|P1|Treatment Period|Withdrawal by Subject|0
5893054|NCT01738503|20390795|P7|Treatment Period|Lost to Follow-up|5
5893055|NCT01738503|20390796|P6|Treatment Period|Lost to Follow-up|1
5893056|NCT01738503|20390797|P5|Treatment Period|Lost to Follow-up|1
5893057|NCT01738503|20390798|P4|Treatment Period|Lost to Follow-up|4
5893058|NCT01738503|20390799|P3|Treatment Period|Lost to Follow-up|3
5893059|NCT01738503|20390800|P2|Treatment Period|Lost to Follow-up|0
5893060|NCT01738503|20390801|P1|Treatment Period|Lost to Follow-up|0
5893061|NCT01738503|20390795|P7|Treatment Period|Adverse Event|2
5893062|NCT01738503|20390796|P6|Treatment Period|Adverse Event|2
5893063|NCT01738503|20390797|P5|Treatment Period|Adverse Event|2
5893064|NCT01738503|20390798|P4|Treatment Period|Adverse Event|1
5893065|NCT01738503|20390799|P3|Treatment Period|Adverse Event|0
5893066|NCT01738503|20390800|P2|Treatment Period|Adverse Event|1
5893067|NCT01738503|20390801|P1|Treatment Period|Adverse Event|0
5893068|NCT01738503|20390795|P7|Induction/Stabilization (Days -14 to -1)|Other|0
5893069|NCT01738503|20390796|P6|Induction/Stabilization (Days -14 to -1)|Other|0
5893070|NCT01738503|20390797|P5|Induction/Stabilization (Days -14 to -1)|Other|0
5893071|NCT01738503|20390798|P4|Induction/Stabilization (Days -14 to -1)|Other|0
5893072|NCT01738503|20390799|P3|Induction/Stabilization (Days -14 to -1)|Other|0
5893073|NCT01738503|20390800|P2|Induction/Stabilization (Days -14 to -1)|Other|0
5893074|NCT01738503|20390801|P1|Induction/Stabilization (Days -14 to -1)|Other|35
5893075|NCT01738477|20390999|P2|Overall Study|Lost to Follow-up|4
5893076|NCT01738477|20391000|P1|Overall Study|Lost to Follow-up|1
5893077|NCT01738438|20391028|P1|Overall Study|Adverse Event|3
5893078|NCT01738438|20391028|P1|Overall Study|Disease Progression|32
5893079|NCT01738191|20391045|P2|Overall Study|Withdrawal by Subject|1
5893080|NCT01738191|20391046|P1|Overall Study|Withdrawal by Subject|4
5893081|NCT01737996|20391069|P3|Overall Study|Withdrawal by Subject|1
5893082|NCT01737996|20391070|P2|Overall Study|Withdrawal by Subject|0
5893083|NCT01737996|20391071|P1|Overall Study|Withdrawal by Subject|0
5893084|NCT01737996|20391069|P3|Overall Study|Adverse Event|1
5893085|NCT01737996|20391070|P2|Overall Study|Adverse Event|1
5893086|NCT01737996|20391071|P1|Overall Study|Adverse Event|0
5893087|NCT01737931|20391133|P3|Overall Study|Physician Decision|0
5893088|NCT01737931|20391134|P2|Overall Study|Physician Decision|1
5893089|NCT01737931|20391135|P1|Overall Study|Physician Decision|0
5893090|NCT01737931|20391133|P3|Overall Study|Withdrawal by Subject|1
5893091|NCT01737931|20391134|P2|Overall Study|Withdrawal by Subject|1
5893092|NCT01737931|20391135|P1|Overall Study|Withdrawal by Subject|0
5893093|NCT01737879|20391150|P1|Overall Study|Sponsor decision|40
5893094|NCT01737879|20391150|P1|Overall Study|Death|1
5893095|NCT01737840|20391159|P2|Overall Study|Diagnosed with an other pathology|2
5893096|NCT01737840|20391160|P1|Overall Study|Diagnosed with an other pathology|2
5893097|NCT01737762|20391170|P2|Overall Study|Trial termination|9
5893098|NCT01737762|20391171|P1|Overall Study|Trial termination|11
5893099|NCT01737762|20391170|P2|Overall Study|Moved from area|1
5893100|NCT01737762|20391171|P1|Overall Study|Moved from area|2
5893101|NCT01737762|20391170|P2|Overall Study|Physician Decision|1
5893102|NCT01737762|20391171|P1|Overall Study|Physician Decision|1
5893103|NCT01737762|20391170|P2|Overall Study|Progressive disease|2
5893104|NCT01737762|20391171|P1|Overall Study|Progressive disease|1
5893105|NCT01737762|20391170|P2|Overall Study|Withdrawal by Subject|2
5893106|NCT01737762|20391171|P1|Overall Study|Withdrawal by Subject|2
5893107|NCT01737762|20391170|P2|Overall Study|Lost to Follow-up|0
5893108|NCT01737762|20391171|P1|Overall Study|Lost to Follow-up|1
5893109|NCT01737762|20391170|P2|Overall Study|Adverse Event|2
5893110|NCT01737762|20391171|P1|Overall Study|Adverse Event|2
5893111|NCT01737710|20391184|P5|Overall Study|Vaccinated in Error/Ineligible|0
5893112|NCT01737710|20391185|P4|Overall Study|Vaccinated in Error/Ineligible|0
5893113|NCT01737710|20391186|P3|Overall Study|Vaccinated in Error/Ineligible|0
5893114|NCT01737710|20391187|P2|Overall Study|Vaccinated in Error/Ineligible|1
5893115|NCT01737710|20391188|P1|Overall Study|Vaccinated in Error/Ineligible|1
5893116|NCT01737710|20391184|P5|Overall Study|Withdrawal by Subject|0
5893117|NCT01737710|20391185|P4|Overall Study|Withdrawal by Subject|0
5893118|NCT01737710|20391186|P3|Overall Study|Withdrawal by Subject|1
5893119|NCT01737710|20391187|P2|Overall Study|Withdrawal by Subject|1
5893120|NCT01737710|20391188|P1|Overall Study|Withdrawal by Subject|1
5893121|NCT01737710|20391184|P5|Overall Study|Lost to Follow-up|0
5893122|NCT01737710|20391185|P4|Overall Study|Lost to Follow-up|0
5893123|NCT01737710|20391186|P3|Overall Study|Lost to Follow-up|2
5893124|NCT01737710|20391187|P2|Overall Study|Lost to Follow-up|2
5893125|NCT01737710|20391188|P1|Overall Study|Lost to Follow-up|0
5893126|NCT01737697|20391230|P15|Subacute Phase|Death|0
5893127|NCT01737697|20391231|P14|Subacute Phase|Death|0
5893128|NCT01737697|20391232|P13|Subacute Phase|Death|0
5893129|NCT01737697|20391233|P12|Subacute Phase|Death|0
5893130|NCT01737697|20391234|P11|Subacute Phase|Death|1
5893131|NCT01737697|20391235|P10|Subacute Phase|Death|0
5893132|NCT01737697|20391236|P9|Subacute Phase|Death|0
5893133|NCT01737697|20391237|P8|Subacute Phase|Death|0
5893134|NCT01737697|20391238|P7|Subacute Phase|Death|0
5893135|NCT01737697|20391239|P6|Subacute Phase|Death|0
5893136|NCT01737697|20391240|P5|Subacute Phase|Death|0
5893137|NCT01737697|20391241|P4|Subacute Phase|Death|0
5893138|NCT01737697|20391242|P3|Subacute Phase|Death|0
5893139|NCT01737697|20391243|P2|Subacute Phase|Death|0
5893140|NCT01737697|20391244|P1|Subacute Phase|Death|0
5893141|NCT01737697|20391230|P15|Subacute Phase|Physician Decision|0
5893142|NCT01737697|20391231|P14|Subacute Phase|Physician Decision|0
5893143|NCT01737697|20391232|P13|Subacute Phase|Physician Decision|0
5893144|NCT01737697|20391233|P12|Subacute Phase|Physician Decision|0
5893145|NCT01737697|20391234|P11|Subacute Phase|Physician Decision|0
5893146|NCT01737697|20391235|P10|Subacute Phase|Physician Decision|0
5893147|NCT01737697|20391236|P9|Subacute Phase|Physician Decision|1
5893148|NCT01737697|20391237|P8|Subacute Phase|Physician Decision|0
5893149|NCT01737697|20391238|P7|Subacute Phase|Physician Decision|0
5893150|NCT01737697|20391239|P6|Subacute Phase|Physician Decision|0
5893151|NCT01737697|20391240|P5|Subacute Phase|Physician Decision|0
5893152|NCT01737697|20391241|P4|Subacute Phase|Physician Decision|0
5893153|NCT01737697|20391242|P3|Subacute Phase|Physician Decision|0
5893154|NCT01737697|20391243|P2|Subacute Phase|Physician Decision|0
5893155|NCT01737697|20391244|P1|Subacute Phase|Physician Decision|0
5893156|NCT01737697|20391230|P15|Subacute Phase|Protocol Violation|0
5893157|NCT01737697|20391231|P14|Subacute Phase|Protocol Violation|0
5893158|NCT01737697|20391232|P13|Subacute Phase|Protocol Violation|0
5893159|NCT01737697|20391233|P12|Subacute Phase|Protocol Violation|0
5893160|NCT01737697|20391234|P11|Subacute Phase|Protocol Violation|1
5893161|NCT01737697|20391235|P10|Subacute Phase|Protocol Violation|0
5893162|NCT01737697|20391236|P9|Subacute Phase|Protocol Violation|0
5893163|NCT01737697|20391237|P8|Subacute Phase|Protocol Violation|0
5893164|NCT01737697|20391238|P7|Subacute Phase|Protocol Violation|0
5893165|NCT01737697|20391239|P6|Subacute Phase|Protocol Violation|1
5893166|NCT01737697|20391240|P5|Subacute Phase|Protocol Violation|0
5893167|NCT01737697|20391241|P4|Subacute Phase|Protocol Violation|0
5893168|NCT01737697|20391242|P3|Subacute Phase|Protocol Violation|0
5893169|NCT01737697|20391243|P2|Subacute Phase|Protocol Violation|0
5893170|NCT01737697|20391244|P1|Subacute Phase|Protocol Violation|0
5893171|NCT01737697|20391230|P15|Subacute Phase|Hypo-or hyperkalemia|0
5893172|NCT01737697|20391231|P14|Subacute Phase|Hypo-or hyperkalemia|1
5893173|NCT01737697|20391232|P13|Subacute Phase|Hypo-or hyperkalemia|0
5893174|NCT01737697|20391233|P12|Subacute Phase|Hypo-or hyperkalemia|1
5893175|NCT01737697|20391234|P11|Subacute Phase|Hypo-or hyperkalemia|0
5893176|NCT01737697|20391235|P10|Subacute Phase|Hypo-or hyperkalemia|0
5893177|NCT01737697|20391236|P9|Subacute Phase|Hypo-or hyperkalemia|0
5893178|NCT01737697|20391237|P8|Subacute Phase|Hypo-or hyperkalemia|0
5893179|NCT01737697|20391238|P7|Subacute Phase|Hypo-or hyperkalemia|0
5893180|NCT01737697|20391239|P6|Subacute Phase|Hypo-or hyperkalemia|0
5893181|NCT01737697|20391240|P5|Subacute Phase|Hypo-or hyperkalemia|0
5893182|NCT01737697|20391241|P4|Subacute Phase|Hypo-or hyperkalemia|0
5893183|NCT01737697|20391242|P3|Subacute Phase|Hypo-or hyperkalemia|0
5893184|NCT01737697|20391243|P2|Subacute Phase|Hypo-or hyperkalemia|0
5893185|NCT01737697|20391244|P1|Subacute Phase|Hypo-or hyperkalemia|0
5893186|NCT01737697|20391230|P15|Subacute Phase|Lost to Follow-up|1
5893187|NCT01737697|20391231|P14|Subacute Phase|Lost to Follow-up|0
5893188|NCT01737697|20391232|P13|Subacute Phase|Lost to Follow-up|0
5893189|NCT01737697|20391233|P12|Subacute Phase|Lost to Follow-up|0
5893190|NCT01737697|20391234|P11|Subacute Phase|Lost to Follow-up|0
5893191|NCT01737697|20391235|P10|Subacute Phase|Lost to Follow-up|0
5893192|NCT01737697|20391236|P9|Subacute Phase|Lost to Follow-up|0
5893193|NCT01737697|20391237|P8|Subacute Phase|Lost to Follow-up|0
5893194|NCT01737697|20391238|P7|Subacute Phase|Lost to Follow-up|0
5893195|NCT01737697|20391239|P6|Subacute Phase|Lost to Follow-up|0
5893196|NCT01737697|20391240|P5|Subacute Phase|Lost to Follow-up|0
5893197|NCT01737697|20391241|P4|Subacute Phase|Lost to Follow-up|0
5893198|NCT01737697|20391242|P3|Subacute Phase|Lost to Follow-up|0
5893199|NCT01737697|20391243|P2|Subacute Phase|Lost to Follow-up|0
5893200|NCT01737697|20391244|P1|Subacute Phase|Lost to Follow-up|0
5893201|NCT01737697|20391230|P15|Subacute Phase|Withdrawal by Subject|0
5893202|NCT01737697|20391231|P14|Subacute Phase|Withdrawal by Subject|1
5893203|NCT01737697|20391232|P13|Subacute Phase|Withdrawal by Subject|1
5893204|NCT01737697|20391233|P12|Subacute Phase|Withdrawal by Subject|1
5893205|NCT01737697|20391234|P11|Subacute Phase|Withdrawal by Subject|0
5893206|NCT01737697|20391235|P10|Subacute Phase|Withdrawal by Subject|1
5893207|NCT01737697|20391236|P9|Subacute Phase|Withdrawal by Subject|0
5893208|NCT01737697|20391237|P8|Subacute Phase|Withdrawal by Subject|2
5893209|NCT01737697|20391238|P7|Subacute Phase|Withdrawal by Subject|0
5893210|NCT01737697|20391239|P6|Subacute Phase|Withdrawal by Subject|1
5893211|NCT01737697|20391240|P5|Subacute Phase|Withdrawal by Subject|0
5893212|NCT01737697|20391241|P4|Subacute Phase|Withdrawal by Subject|0
5893213|NCT01737697|20391242|P3|Subacute Phase|Withdrawal by Subject|0
5893214|NCT01737697|20391243|P2|Subacute Phase|Withdrawal by Subject|0
5893215|NCT01737697|20391244|P1|Subacute Phase|Withdrawal by Subject|0
5893216|NCT01737697|20391230|P15|Subacute Phase|Adverse Event|0
5893217|NCT01737697|20391231|P14|Subacute Phase|Adverse Event|0
5893218|NCT01737697|20391232|P13|Subacute Phase|Adverse Event|1
5893219|NCT01737697|20391233|P12|Subacute Phase|Adverse Event|1
5893220|NCT01737697|20391234|P11|Subacute Phase|Adverse Event|4
5893221|NCT01737697|20391235|P10|Subacute Phase|Adverse Event|1
5893222|NCT01737697|20391236|P9|Subacute Phase|Adverse Event|1
5893223|NCT01737697|20391237|P8|Subacute Phase|Adverse Event|1
5893224|NCT01737697|20391238|P7|Subacute Phase|Adverse Event|1
5893225|NCT01737697|20391239|P6|Subacute Phase|Adverse Event|1
5893226|NCT01737697|20391240|P5|Subacute Phase|Adverse Event|0
5893227|NCT01737697|20391241|P4|Subacute Phase|Adverse Event|0
5893228|NCT01737697|20391242|P3|Subacute Phase|Adverse Event|0
5893229|NCT01737697|20391243|P2|Subacute Phase|Adverse Event|0
5893230|NCT01737697|20391244|P1|Subacute Phase|Adverse Event|0
5893231|NCT01737697|20391230|P15|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
5893232|NCT01737697|20391231|P14|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
5893233|NCT01737697|20391232|P13|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
5893234|NCT01737697|20391233|P12|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
5893235|NCT01737697|20391234|P11|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
5893236|NCT01737697|20391235|P10|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
5893237|NCT01737697|20391236|P9|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
5893238|NCT01737697|20391237|P8|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
5893239|NCT01737697|20391238|P7|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
5893240|NCT01737697|20391239|P6|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
5893241|NCT01737697|20391240|P5|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1
5893242|NCT01737697|20391241|P4|Acute Phase-Initial 48 Hours|Withdrawal by Subject|4
5893243|NCT01737697|20391242|P3|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1
5893244|NCT01737697|20391243|P2|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1
5893245|NCT01737697|20391244|P1|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
5893246|NCT01737697|20391230|P15|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
5893247|NCT01737697|20391231|P14|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
5893248|NCT01737697|20391232|P13|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
5893249|NCT01737697|20391233|P12|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
5893250|NCT01737697|20391234|P11|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
5893251|NCT01737697|20391235|P10|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
5893252|NCT01737697|20391236|P9|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
5893253|NCT01737697|20391237|P8|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
5893254|NCT01737697|20391238|P7|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
5893255|NCT01737697|20391239|P6|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
5893256|NCT01737697|20391240|P5|Acute Phase-Initial 48 Hours|Lost to Follow-up|1
5893257|NCT01737697|20391241|P4|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
5893258|NCT01737697|20391242|P3|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
5893259|NCT01737697|20391243|P2|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
5893260|NCT01737697|20391244|P1|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
5893261|NCT01737697|20391230|P15|Acute Phase-Initial 48 Hours|Sponsor's decision|0
5893262|NCT01737697|20391231|P14|Acute Phase-Initial 48 Hours|Sponsor's decision|0
5893263|NCT01737697|20391232|P13|Acute Phase-Initial 48 Hours|Sponsor's decision|0
5893264|NCT01737697|20391233|P12|Acute Phase-Initial 48 Hours|Sponsor's decision|0
5893265|NCT01737697|20391234|P11|Acute Phase-Initial 48 Hours|Sponsor's decision|0
5893266|NCT01737697|20391235|P10|Acute Phase-Initial 48 Hours|Sponsor's decision|0
5893267|NCT01737697|20391236|P9|Acute Phase-Initial 48 Hours|Sponsor's decision|0
5893268|NCT01737697|20391237|P8|Acute Phase-Initial 48 Hours|Sponsor's decision|0
5893269|NCT01737697|20391238|P7|Acute Phase-Initial 48 Hours|Sponsor's decision|0
5893270|NCT01737697|20391239|P6|Acute Phase-Initial 48 Hours|Sponsor's decision|0
5893271|NCT01737697|20391240|P5|Acute Phase-Initial 48 Hours|Sponsor's decision|0
5893272|NCT01737697|20391241|P4|Acute Phase-Initial 48 Hours|Sponsor's decision|0
5893273|NCT01737697|20391242|P3|Acute Phase-Initial 48 Hours|Sponsor's decision|0
5893274|NCT01737697|20391243|P2|Acute Phase-Initial 48 Hours|Sponsor's decision|1
5893275|NCT01737697|20391244|P1|Acute Phase-Initial 48 Hours|Sponsor's decision|0
5893276|NCT01737697|20391230|P15|Acute Phase-Initial 48 Hours|Family emergency|0
5893277|NCT01737697|20391231|P14|Acute Phase-Initial 48 Hours|Family emergency|0
5893278|NCT01737697|20391232|P13|Acute Phase-Initial 48 Hours|Family emergency|0
5893279|NCT01737697|20391233|P12|Acute Phase-Initial 48 Hours|Family emergency|0
5893280|NCT01737697|20391234|P11|Acute Phase-Initial 48 Hours|Family emergency|0
5893281|NCT01737697|20391235|P10|Acute Phase-Initial 48 Hours|Family emergency|0
5893282|NCT01737697|20391236|P9|Acute Phase-Initial 48 Hours|Family emergency|0
5893283|NCT01737697|20391237|P8|Acute Phase-Initial 48 Hours|Family emergency|0
5893284|NCT01737697|20391238|P7|Acute Phase-Initial 48 Hours|Family emergency|0
5893285|NCT01737697|20391239|P6|Acute Phase-Initial 48 Hours|Family emergency|0
5893286|NCT01737697|20391240|P5|Acute Phase-Initial 48 Hours|Family emergency|0
5893287|NCT01737697|20391241|P4|Acute Phase-Initial 48 Hours|Family emergency|1
5893288|NCT01737697|20391242|P3|Acute Phase-Initial 48 Hours|Family emergency|0
5893289|NCT01737697|20391243|P2|Acute Phase-Initial 48 Hours|Family emergency|0
5893290|NCT01737697|20391244|P1|Acute Phase-Initial 48 Hours|Family emergency|0
5893291|NCT01737697|20391230|P15|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
5893292|NCT01737697|20391231|P14|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
5893293|NCT01737697|20391232|P13|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
5893294|NCT01737697|20391233|P12|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
5893295|NCT01737697|20391234|P11|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
5893296|NCT01737697|20391235|P10|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
5893297|NCT01737697|20391236|P9|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
5893298|NCT01737697|20391237|P8|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
5893299|NCT01737697|20391238|P7|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
5893300|NCT01737697|20391239|P6|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
5893301|NCT01737697|20391240|P5|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
5893302|NCT01737697|20391241|P4|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
5893303|NCT01737697|20391242|P3|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|3
5893304|NCT01737697|20391243|P2|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1
5893305|NCT01737697|20391244|P1|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1
5893306|NCT01737697|20391230|P15|Acute Phase-Initial 48 Hours|Adverse Event|0
5893307|NCT01737697|20391231|P14|Acute Phase-Initial 48 Hours|Adverse Event|0
5893308|NCT01737697|20391232|P13|Acute Phase-Initial 48 Hours|Adverse Event|0
5893309|NCT01737697|20391233|P12|Acute Phase-Initial 48 Hours|Adverse Event|0
5893310|NCT01737697|20391234|P11|Acute Phase-Initial 48 Hours|Adverse Event|0
5893311|NCT01737697|20391235|P10|Acute Phase-Initial 48 Hours|Adverse Event|0
5893312|NCT01737697|20391236|P9|Acute Phase-Initial 48 Hours|Adverse Event|0
5893313|NCT01737697|20391237|P8|Acute Phase-Initial 48 Hours|Adverse Event|0
5893314|NCT01737697|20391238|P7|Acute Phase-Initial 48 Hours|Adverse Event|0
5893315|NCT01737697|20391239|P6|Acute Phase-Initial 48 Hours|Adverse Event|0
5893316|NCT01737697|20391240|P5|Acute Phase-Initial 48 Hours|Adverse Event|1
5893317|NCT01737697|20391241|P4|Acute Phase-Initial 48 Hours|Adverse Event|1
5893318|NCT01737697|20391242|P3|Acute Phase-Initial 48 Hours|Adverse Event|0
5893319|NCT01737697|20391243|P2|Acute Phase-Initial 48 Hours|Adverse Event|1
5893320|NCT01737697|20391244|P1|Acute Phase-Initial 48 Hours|Adverse Event|0
5893321|NCT01737398|20391387|P2|Overall Study|Sponsor's decision|0
5893322|NCT01737398|20391388|P1|Overall Study|Sponsor's decision|2
5893323|NCT01737398|20391387|P2|Overall Study|Disease progression|3
5893324|NCT01737398|20391388|P1|Overall Study|Disease progression|2
5893325|NCT01737398|20391387|P2|Overall Study|Liver transplant|0
5893326|NCT01737398|20391388|P1|Overall Study|Liver transplant|1
5893327|NCT01737398|20391387|P2|Overall Study|Ineligibility|0
5893328|NCT01737398|20391388|P1|Overall Study|Ineligibility|1
5893329|NCT01737398|20391387|P2|Overall Study|Voluntary withdrawal|3
5893330|NCT01737398|20391388|P1|Overall Study|Voluntary withdrawal|2
5893331|NCT01737398|20391387|P2|Overall Study|Stopping rule met|1
5893332|NCT01737398|20391388|P1|Overall Study|Stopping rule met|2
5893333|NCT01737398|20391387|P2|Overall Study|Adverse event or SAE|1
5893334|NCT01737398|20391388|P1|Overall Study|Adverse event or SAE|16
5893335|NCT01737268|20391441|P1|Overall Study|In consideration of the patient's safety|1
5893336|NCT01737268|20391441|P1|Overall Study|Worsening of Target Disease|2
5893337|NCT01737268|20391441|P1|Overall Study|Adverse Event|6
5893338|NCT01737021|20391455|P2|Overall Study|Lost to Follow-up|3
5893339|NCT01737021|20391456|P1|Overall Study|Lost to Follow-up|5
5893340|NCT01736917|20391502|P1|Overall Study|Protocol Violation|10
5893341|NCT01736917|20391502|P1|Overall Study|Adverse Event|1
5893342|NCT01736696|20391542|P7|Overall Study|Withdrawal by Subject|0
5893343|NCT01736696|20391543|P6|Overall Study|Withdrawal by Subject|0
5893344|NCT01736696|20391544|P5|Overall Study|Withdrawal by Subject|0
5893345|NCT01736696|20391545|P4|Overall Study|Withdrawal by Subject|0
5893346|NCT01736696|20391546|P3|Overall Study|Withdrawal by Subject|1
5893347|NCT01736696|20391547|P2|Overall Study|Withdrawal by Subject|0
5893348|NCT01736696|20391548|P1|Overall Study|Withdrawal by Subject|0
5893349|NCT01736683|20391870|P5|Overall Study|Other|1
5893350|NCT01736683|20391871|P4|Overall Study|Other|9
5893351|NCT01736683|20391872|P3|Overall Study|Other|1
5893352|NCT01736683|20391873|P2|Overall Study|Other|0
5893353|NCT01736683|20391874|P1|Overall Study|Other|0
5893354|NCT01736683|20391870|P5|Overall Study|Progressive Disease|0
5893355|NCT01736683|20391871|P4|Overall Study|Progressive Disease|1
5893356|NCT01736683|20391872|P3|Overall Study|Progressive Disease|0
5893357|NCT01736683|20391873|P2|Overall Study|Progressive Disease|0
5893358|NCT01736683|20391874|P1|Overall Study|Progressive Disease|0
5893359|NCT01736683|20391870|P5|Overall Study|Lack of Therapeutic Effect|1
5893360|NCT01736683|20391871|P4|Overall Study|Lack of Therapeutic Effect|20
5893361|NCT01736683|20391872|P3|Overall Study|Lack of Therapeutic Effect|13
5893362|NCT01736683|20391873|P2|Overall Study|Lack of Therapeutic Effect|4
5893363|NCT01736683|20391874|P1|Overall Study|Lack of Therapeutic Effect|7
5893364|NCT01736683|20391870|P5|Overall Study|Withdrawal by Subject|1
5893365|NCT01736683|20391871|P4|Overall Study|Withdrawal by Subject|1
5893366|NCT01736683|20391872|P3|Overall Study|Withdrawal by Subject|3
5893367|NCT01736683|20391873|P2|Overall Study|Withdrawal by Subject|0
5893368|NCT01736683|20391874|P1|Overall Study|Withdrawal by Subject|0
5893369|NCT01736683|20391870|P5|Overall Study|Adverse Event|2
5893370|NCT01736683|20391871|P4|Overall Study|Adverse Event|3
5893371|NCT01736683|20391872|P3|Overall Study|Adverse Event|2
5893372|NCT01736683|20391873|P2|Overall Study|Adverse Event|2
5893373|NCT01736683|20391874|P1|Overall Study|Adverse Event|0
5893374|NCT01736683|20391870|P5|Overall Study|Disease Relapse|0
5893375|NCT01736683|20391871|P4|Overall Study|Disease Relapse|1
5893376|NCT01736683|20391872|P3|Overall Study|Disease Relapse|2
5893377|NCT01736683|20391873|P2|Overall Study|Disease Relapse|0
5893378|NCT01736683|20391874|P1|Overall Study|Disease Relapse|0
5893379|NCT01736657|20391936|P1|Overall Study|insufficient vascular access|1
5893380|NCT01736579|20391945|P2|Overall Study|Termination of Study by Sponsor|2
5893381|NCT01736579|20391946|P1|Overall Study|Termination of Study by Sponsor|2
5893382|NCT01736566|20391985|P5|Long Term Follow-up|Still collecting data|1
5893383|NCT01736566|20391986|P4|Long Term Follow-up|Still collecting data|0
5893384|NCT01736566|20391987|P3|Long Term Follow-up|Still collecting data|49
5893385|NCT01736566|20391988|P2|Long Term Follow-up|Still collecting data|0
5893386|NCT01736566|20391989|P1|Long Term Follow-up|Still collecting data|42
5893387|NCT01736553|20392074|P2|Overall Study|Lost to Follow-up|2
5893388|NCT01736553|20392075|P1|Overall Study|Lost to Follow-up|2
5893389|NCT01736553|20392074|P2|Overall Study|Withdrawal by Subject|2
5893390|NCT01736553|20392075|P1|Overall Study|Withdrawal by Subject|5
5893391|NCT01736553|20392074|P2|Overall Study|Death|0
5893392|NCT01736553|20392075|P1|Overall Study|Death|12
5893393|NCT01736540|20392126|P1|Overall Study|Unable to make MRI appointment|3
5893394|NCT01736540|20392126|P1|Overall Study|No show for MRI appointment|1
5893395|NCT01736540|20392126|P1|Overall Study|Unable to tolerate MRI; claustrophobic|1
5893396|NCT01736540|20392126|P1|Overall Study|Protocol Violation|1
5893397|NCT01736540|20392126|P1|Overall Study|Withdrawal by Subject|5
5893398|NCT01736540|20392126|P1|Overall Study|Abnormal test procedure|1
5893399|NCT01736540|20392126|P1|Overall Study|Death|1
5893400|NCT01736540|20392126|P1|Overall Study|Did not complete scan within 45 days|2
5893401|NCT01736475|20392192|P2|Overall Study|Other - Surgical procedure|0
5893402|NCT01736475|20392193|P1|Overall Study|Other - Surgical procedure|1
5893403|NCT01736475|20392192|P2|Overall Study|Other - Screen failure|0
5893404|NCT01736475|20392193|P1|Overall Study|Other - Screen failure|1
5893405|NCT01736475|20392192|P2|Overall Study|Protocol Violation|0
5893406|NCT01736475|20392193|P1|Overall Study|Protocol Violation|4
5893407|NCT01736475|20392192|P2|Overall Study|Withdrawal by Subject|0
5893408|NCT01736475|20392193|P1|Overall Study|Withdrawal by Subject|2
5893409|NCT01736475|20392192|P2|Overall Study|Adverse Event|0
5893410|NCT01736475|20392193|P1|Overall Study|Adverse Event|4
5893411|NCT01736397|20392248|P2|Overall Study|Not stated|4
5893412|NCT01736397|20392249|P1|Overall Study|Not stated|1
5893413|NCT01736397|20392248|P2|Overall Study|Adverse Event|3
5893414|NCT01736397|20392249|P1|Overall Study|Adverse Event|6
5893415|NCT01736397|20392248|P2|Overall Study|Lost to Follow-up|1
5893416|NCT01736397|20392249|P1|Overall Study|Lost to Follow-up|0
5893417|NCT01736397|20392248|P2|Overall Study|Withdrawal by Subject|5
5893418|NCT01736397|20392249|P1|Overall Study|Withdrawal by Subject|6
5893419|NCT01736397|20392248|P2|Overall Study|Lack of Efficacy|11
5893420|NCT01736397|20392249|P1|Overall Study|Lack of Efficacy|1
5893421|NCT01736254|20392282|P1|Period 3 (Days 13 to 23)|Adverse Event|1
5893422|NCT01736254|20392282|P1|Period 2 (Days 2 to 12)|Adverse Event|3
5893423|NCT01736215|20392347|P1|Overall Study|Insufficient data to perform analysis|8
5893424|NCT01736215|20392347|P1|Overall Study|Progressive disease stop chemotherapy|1
5893425|NCT01736215|20392347|P1|Overall Study|Adverse Event|4
5893426|NCT01736215|20392347|P1|Overall Study|Early termination of erythropoietin use|1
5893427|NCT01736189|20392359|P1|Overall Study|Criteria and protocol violations|1
5893428|NCT01736189|20392359|P1|Overall Study|Protocol Violation|4
5893429|NCT01736189|20392359|P1|Overall Study|Violation of registration criteria|41
5893430|NCT01736176|20392368|P1|Overall Study|Unable to Complete PEG Placement|1
5893431|NCT01736176|20392368|P1|Overall Study|Lack of Efficacy|3
5893432|NCT01736176|20392368|P1|Overall Study|Withdrawal by Subject|4
5893433|NCT01736176|20392368|P1|Overall Study|Adverse Event|3
5893434|NCT01735994|20392439|P2|Overall Study|Lost to Follow-up|62
5893435|NCT01735994|20392440|P1|Overall Study|Lost to Follow-up|50
5893436|NCT01735994|20392439|P2|Overall Study|Kicked off team|0
5893437|NCT01735994|20392440|P1|Overall Study|Kicked off team|5
5893438|NCT01735994|20392439|P2|Overall Study|Injury|0
5893439|NCT01735994|20392440|P1|Overall Study|Injury|2
5893440|NCT01735994|20392439|P2|Overall Study|Withdrawal by Subject|4
5893441|NCT01735994|20392440|P1|Overall Study|Withdrawal by Subject|6
5893442|NCT01735916|20392455|P3|Overall Study|Withdrawal by Subject|0
5893443|NCT01735916|20392456|P2|Overall Study|Withdrawal by Subject|0
5893444|NCT01735916|20392457|P1|Overall Study|Withdrawal by Subject|3
5893445|NCT01735916|20392455|P3|Overall Study|Early termination of study by sponsor|7
5893446|NCT01735916|20392456|P2|Overall Study|Early termination of study by sponsor|19
5893447|NCT01735916|20392457|P1|Overall Study|Early termination of study by sponsor|4
5893448|NCT01735916|20392455|P3|Overall Study|Subject not eligible to be randomized|0
5893449|NCT01735916|20392456|P2|Overall Study|Subject not eligible to be randomized|0
5893450|NCT01735916|20392457|P1|Overall Study|Subject not eligible to be randomized|11
5893451|NCT01735630|20392495|P2|Overall Study|Withdrawal by Subject|9
5893452|NCT01735630|20392496|P1|Overall Study|Withdrawal by Subject|7
5893453|NCT01735630|20392495|P2|Overall Study|Sponsor Decision|1
5893454|NCT01735630|20392496|P1|Overall Study|Sponsor Decision|2
5893455|NCT01735630|20392495|P2|Overall Study|Physician Decision|1
5893456|NCT01735630|20392496|P1|Overall Study|Physician Decision|0
5893457|NCT01735630|20392495|P2|Overall Study|Lost to Follow-up|0
5893458|NCT01735630|20392496|P1|Overall Study|Lost to Follow-up|1
5893459|NCT01735630|20392495|P2|Overall Study|Adverse Event|7
5893460|NCT01735630|20392496|P1|Overall Study|Adverse Event|8
5893461|NCT01735396|20392523|P1|Overall Study|not evaluable|1
5893462|NCT01735279|20392534|P2|Overall Study|Lost to Follow-up|8
5893463|NCT01735279|20392535|P1|Overall Study|Lost to Follow-up|11
5893464|NCT01735201|20392567|P8|Overall Study|Other Miscellaneous Reasons|1
5893465|NCT01735201|20392568|P7|Overall Study|Other Miscellaneous Reasons|1
5893466|NCT01735201|20392569|P6|Overall Study|Other Miscellaneous Reasons|2
5893467|NCT01735201|20392570|P5|Overall Study|Other Miscellaneous Reasons|0
5893468|NCT01735201|20392571|P4|Overall Study|Other Miscellaneous Reasons|1
5893469|NCT01735201|20392572|P3|Overall Study|Other Miscellaneous Reasons|0
5893470|NCT01735201|20392573|P2|Overall Study|Other Miscellaneous Reasons|0
5893471|NCT01735201|20392574|P1|Overall Study|Other Miscellaneous Reasons|0
5893472|NCT01735201|20392567|P8|Overall Study|Protocol Violation|0
5893473|NCT01735201|20392568|P7|Overall Study|Protocol Violation|0
5893474|NCT01735201|20392569|P6|Overall Study|Protocol Violation|0
5893475|NCT01735201|20392570|P5|Overall Study|Protocol Violation|0
5893476|NCT01735201|20392571|P4|Overall Study|Protocol Violation|0
5893477|NCT01735201|20392572|P3|Overall Study|Protocol Violation|0
5893478|NCT01735201|20392573|P2|Overall Study|Protocol Violation|0
5893479|NCT01735201|20392574|P1|Overall Study|Protocol Violation|1
5893480|NCT01735201|20392567|P8|Overall Study|Personal Reasons|0
5893481|NCT01735201|20392568|P7|Overall Study|Personal Reasons|0
5893482|NCT01735201|20392569|P6|Overall Study|Personal Reasons|0
5893483|NCT01735201|20392570|P5|Overall Study|Personal Reasons|0
5893484|NCT01735201|20392571|P4|Overall Study|Personal Reasons|0
5893485|NCT01735201|20392572|P3|Overall Study|Personal Reasons|0
5893486|NCT01735201|20392573|P2|Overall Study|Personal Reasons|0
5893487|NCT01735201|20392574|P1|Overall Study|Personal Reasons|1
5893488|NCT01735201|20392567|P8|Overall Study|Adverse Event|1
5893489|NCT01735201|20392568|P7|Overall Study|Adverse Event|2
5893490|NCT01735201|20392569|P6|Overall Study|Adverse Event|3
5893491|NCT01735201|20392570|P5|Overall Study|Adverse Event|1
5893492|NCT01735201|20392571|P4|Overall Study|Adverse Event|1
5893493|NCT01735201|20392572|P3|Overall Study|Adverse Event|0
5893494|NCT01735201|20392573|P2|Overall Study|Adverse Event|1
5893495|NCT01735201|20392574|P1|Overall Study|Adverse Event|1
5893496|NCT01735175|20392610|P2|Overall Study|Other (mostly EOS/EOT visit missing)|7
5893497|NCT01735175|20392611|P1|Overall Study|Other (mostly EOS/EOT visit missing)|13
5893498|NCT01735175|20392610|P2|Overall Study|Death|2
5893499|NCT01735175|20392611|P1|Overall Study|Death|3
5893500|NCT01735175|20392610|P2|Overall Study|Lost to Follow-up|2
5893501|NCT01735175|20392611|P1|Overall Study|Lost to Follow-up|4
5893502|NCT01735175|20392610|P2|Overall Study|Withdrawal by Subject|2
5893503|NCT01735175|20392611|P1|Overall Study|Withdrawal by Subject|9
5893504|NCT01734993|20392631|P1|Overall Study|Lack of Efficacy|1
5893505|NCT01734993|20392631|P1|Overall Study|Adverse Event|1
5893506|NCT01734902|20392659|P2|Overall Study|Other than listed|2
5893507|NCT01734902|20392660|P1|Overall Study|Other than listed|0
5893508|NCT01734850|20392681|P3|Overall Study|Not infused due to manufacturing failure|1
5893509|NCT01734850|20392682|P2|Overall Study|Not infused due to manufacturing failure|0
5893510|NCT01734850|20392683|P1|Overall Study|Not infused due to manufacturing failure|0
5893511|NCT01734850|20392681|P3|Overall Study|Continued to Week 48 but recommenced ART|3
5893512|NCT01734850|20392682|P2|Overall Study|Continued to Week 48 but recommenced ART|2
5893513|NCT01734850|20392683|P1|Overall Study|Continued to Week 48 but recommenced ART|3
5893514|NCT01734811|20392740|P2|Overall Study|Withdrawal by Subject|0
5893515|NCT01734811|20392741|P1|Overall Study|Withdrawal by Subject|2
5893516|NCT01734811|20392740|P2|Overall Study|Lost to Follow-up|3
5893517|NCT01734811|20392741|P1|Overall Study|Lost to Follow-up|2
5893518|NCT01734785|20392768|P4|Double-Blind Period|Not treated|0
5893519|NCT01734785|20392769|P3|Double-Blind Period|Not treated|0
5893520|NCT01734785|20392770|P2|Double-Blind Period|Not treated|0
5893521|NCT01734785|20392771|P1|Double-Blind Period|Not treated|1
5893522|NCT01734785|20392768|P4|Double-Blind Period|Withdrawal by Subject|0
5893523|NCT01734785|20392769|P3|Double-Blind Period|Withdrawal by Subject|0
5893524|NCT01734785|20392770|P2|Double-Blind Period|Withdrawal by Subject|0
5893525|NCT01734785|20392771|P1|Double-Blind Period|Withdrawal by Subject|2
5893526|NCT01734785|20392768|P4|Double-Blind Period|Lost to Follow-up|0
5893527|NCT01734785|20392769|P3|Double-Blind Period|Lost to Follow-up|2
5893528|NCT01734785|20392770|P2|Double-Blind Period|Lost to Follow-up|4
5893529|NCT01734785|20392771|P1|Double-Blind Period|Lost to Follow-up|2
5893530|NCT01734785|20392768|P4|Double-Blind Period|Protocol Violation|0
5893531|NCT01734785|20392769|P3|Double-Blind Period|Protocol Violation|1
5893532|NCT01734785|20392770|P2|Double-Blind Period|Protocol Violation|1
5893533|NCT01734785|20392771|P1|Double-Blind Period|Protocol Violation|0
5893534|NCT01734785|20392768|P4|Double-Blind Period|Lack of Efficacy|0
5893535|NCT01734785|20392769|P3|Double-Blind Period|Lack of Efficacy|0
5893536|NCT01734785|20392770|P2|Double-Blind Period|Lack of Efficacy|1
5893537|NCT01734785|20392771|P1|Double-Blind Period|Lack of Efficacy|0
5893538|NCT01734785|20392768|P4|Double-Blind Period|Adverse Event|0
5893539|NCT01734785|20392769|P3|Double-Blind Period|Adverse Event|2
5893540|NCT01734785|20392770|P2|Double-Blind Period|Adverse Event|3
5893541|NCT01734785|20392771|P1|Double-Blind Period|Adverse Event|0
5893542|NCT01734785|20392768|P4|Open-Label Period|Other Reasons|224
5893543|NCT01734785|20392769|P3|Open-Label Period|Other Reasons|0
5893544|NCT01734785|20392770|P2|Open-Label Period|Other Reasons|0
5893545|NCT01734785|20392771|P1|Open-Label Period|Other Reasons|0
5893546|NCT01734785|20392768|P4|Open-Label Period|Withdrawal by Subject|12
5893547|NCT01734785|20392769|P3|Open-Label Period|Withdrawal by Subject|0
5893548|NCT01734785|20392770|P2|Open-Label Period|Withdrawal by Subject|0
5893549|NCT01734785|20392771|P1|Open-Label Period|Withdrawal by Subject|0
5893550|NCT01734785|20392768|P4|Open-Label Period|Lost to Follow-up|14
5893551|NCT01734785|20392769|P3|Open-Label Period|Lost to Follow-up|0
5893552|NCT01734785|20392770|P2|Open-Label Period|Lost to Follow-up|0
5893553|NCT01734785|20392771|P1|Open-Label Period|Lost to Follow-up|0
5893554|NCT01734785|20392768|P4|Open-Label Period|Protocol Violation|13
5893555|NCT01734785|20392769|P3|Open-Label Period|Protocol Violation|0
5893556|NCT01734785|20392770|P2|Open-Label Period|Protocol Violation|0
5893557|NCT01734785|20392771|P1|Open-Label Period|Protocol Violation|0
5893558|NCT01734785|20392768|P4|Open-Label Period|Lack of Efficacy|1
5893559|NCT01734785|20392769|P3|Open-Label Period|Lack of Efficacy|0
5893560|NCT01734785|20392770|P2|Open-Label Period|Lack of Efficacy|0
5893561|NCT01734785|20392771|P1|Open-Label Period|Lack of Efficacy|0
5893562|NCT01734785|20392768|P4|Open-Label Period|Adverse Event|9
5893563|NCT01734785|20392769|P3|Open-Label Period|Adverse Event|0
5893564|NCT01734785|20392770|P2|Open-Label Period|Adverse Event|0
5893565|NCT01734785|20392771|P1|Open-Label Period|Adverse Event|0
5893566|NCT01734772|20392788|P2|Overall Study|Withdrawal by Subject|1
5893567|NCT01734772|20392789|P1|Overall Study|Withdrawal by Subject|0
5893568|NCT01734772|20392788|P2|Overall Study|Adverse Event|2
5893569|NCT01734772|20392789|P1|Overall Study|Adverse Event|1
5893570|NCT01734434|20392844|P4|Overall Study|17 Yr Old Subject Signed Consent form|0
5893571|NCT01734434|20392845|P3|Overall Study|17 Yr Old Subject Signed Consent form|1
5893572|NCT01734434|20392846|P2|Overall Study|17 Yr Old Subject Signed Consent form|0
5893573|NCT01734434|20392847|P1|Overall Study|17 Yr Old Subject Signed Consent form|0
5893574|NCT01734434|20392844|P4|Overall Study|Wrong Version of Consent Form Signed|0
5893575|NCT01734434|20392845|P3|Overall Study|Wrong Version of Consent Form Signed|1
5893576|NCT01734434|20392846|P2|Overall Study|Wrong Version of Consent Form Signed|0
5893667|NCT01733329|20393159|P2|Overall Study|Uterine artery injury|0
5893577|NCT01734434|20392847|P1|Overall Study|Wrong Version of Consent Form Signed|0
5893578|NCT01734434|20392844|P4|Overall Study|Treatment Defaulter|0
5893579|NCT01734434|20392845|P3|Overall Study|Treatment Defaulter|1
5893580|NCT01734434|20392846|P2|Overall Study|Treatment Defaulter|0
5893581|NCT01734434|20392847|P1|Overall Study|Treatment Defaulter|0
5893582|NCT01734434|20392844|P4|Overall Study|Subject Not Reachable|0
5893583|NCT01734434|20392845|P3|Overall Study|Subject Not Reachable|1
5893584|NCT01734434|20392846|P2|Overall Study|Subject Not Reachable|0
5893585|NCT01734434|20392847|P1|Overall Study|Subject Not Reachable|0
5893586|NCT01734434|20392844|P4|Overall Study|Signed Adult Version of Consent Form|0
5893587|NCT01734434|20392845|P3|Overall Study|Signed Adult Version of Consent Form|1
5893588|NCT01734434|20392846|P2|Overall Study|Signed Adult Version of Consent Form|0
5893589|NCT01734434|20392847|P1|Overall Study|Signed Adult Version of Consent Form|0
5893590|NCT01734434|20392844|P4|Overall Study|Withdrawal by Subject|1
5893591|NCT01734434|20392845|P3|Overall Study|Withdrawal by Subject|8
5893592|NCT01734434|20392846|P2|Overall Study|Withdrawal by Subject|0
5893593|NCT01734434|20392847|P1|Overall Study|Withdrawal by Subject|4
5893594|NCT01734434|20392844|P4|Overall Study|No Live Birth|6
5893595|NCT01734434|20392845|P3|Overall Study|No Live Birth|32
5893596|NCT01734434|20392846|P2|Overall Study|No Live Birth|2
5893597|NCT01734434|20392847|P1|Overall Study|No Live Birth|1
5893598|NCT01734434|20392844|P4|Overall Study|Lost to Follow-up|11
5893599|NCT01734434|20392845|P3|Overall Study|Lost to Follow-up|67
5893600|NCT01734434|20392846|P2|Overall Study|Lost to Follow-up|9
5893601|NCT01734434|20392847|P1|Overall Study|Lost to Follow-up|2
5893602|NCT01734434|20392844|P4|Overall Study|Death Infant|5
5893603|NCT01734434|20392845|P3|Overall Study|Death Infant|17
5893604|NCT01734434|20392846|P2|Overall Study|Death Infant|1
5893605|NCT01734434|20392847|P1|Overall Study|Death Infant|3
5893606|NCT01734395|20392869|P1|Overall Study|Missing the reasons for not completed|3
5893607|NCT01734395|20392869|P1|Overall Study|Withdrawal by Subject|10
5893608|NCT01734395|20392869|P1|Overall Study|Adverse Event|40
5893609|NCT01734395|20392869|P1|Overall Study|Lack of Efficacy|5
5893610|NCT01734395|20392869|P1|Overall Study|Lost to Follow-up|287
5893611|NCT01734395|20392869|P1|Overall Study|Other|65
5893612|NCT01734382|20392878|P3|Part 2|Withdrawal by Subject|1
5893613|NCT01734382|20392879|P2|Part 2|Withdrawal by Subject|0
5893614|NCT01734382|20392880|P1|Part 2|Withdrawal by Subject|0
5893615|NCT01734382|20392878|P3|Part 2|Protocol Violation|0
5893616|NCT01734382|20392879|P2|Part 2|Protocol Violation|1
5893617|NCT01734382|20392880|P1|Part 2|Protocol Violation|0
5893618|NCT01734382|20392878|P3|Part 2|Physician Decision|3
5893619|NCT01734382|20392879|P2|Part 2|Physician Decision|0
5893620|NCT01734382|20392880|P1|Part 2|Physician Decision|0
5893621|NCT01734382|20392878|P3|Part 2|Other|1
5893622|NCT01734382|20392879|P2|Part 2|Other|0
5893623|NCT01734382|20392880|P1|Part 2|Other|0
5893624|NCT01734382|20392878|P3|Part 2|Lack of Efficacy|1
5893625|NCT01734382|20392879|P2|Part 2|Lack of Efficacy|1
5893626|NCT01734382|20392880|P1|Part 2|Lack of Efficacy|0
5893627|NCT01734382|20392878|P3|Part 2|Adverse Event|1
5893628|NCT01734382|20392879|P2|Part 2|Adverse Event|0
5893629|NCT01734382|20392880|P1|Part 2|Adverse Event|0
5893630|NCT01734382|20392878|P3|Part 1|Adverse Event|0
5893631|NCT01734382|20392879|P2|Part 1|Adverse Event|0
5893632|NCT01734382|20392880|P1|Part 1|Adverse Event|2
5893633|NCT01733758|20392993|P4|Overall Study|Inv Decision, HbA1c not controlled|1
5893634|NCT01733758|20392994|P3|Overall Study|Inv Decision, HbA1c not controlled|0
5893635|NCT01733758|20392995|P2|Overall Study|Inv Decision, HbA1c not controlled|1
5893636|NCT01733758|20392996|P1|Overall Study|Inv Decision, HbA1c not controlled|1
5893637|NCT01733758|20392993|P4|Overall Study|Intro of New Anti-Diabetic Medication|1
5893638|NCT01733758|20392994|P3|Overall Study|Intro of New Anti-Diabetic Medication|0
5893639|NCT01733758|20392995|P2|Overall Study|Intro of New Anti-Diabetic Medication|0
5893640|NCT01733758|20392996|P1|Overall Study|Intro of New Anti-Diabetic Medication|4
5893641|NCT01733758|20392993|P4|Overall Study|Non-compliance|0
5893642|NCT01733758|20392994|P3|Overall Study|Non-compliance|0
5893643|NCT01733758|20392995|P2|Overall Study|Non-compliance|0
5893644|NCT01733758|20392996|P1|Overall Study|Non-compliance|1
5893645|NCT01733758|20392993|P4|Overall Study|Protocol Violation|2
5893646|NCT01733758|20392994|P3|Overall Study|Protocol Violation|2
5893647|NCT01733758|20392995|P2|Overall Study|Protocol Violation|1
5893648|NCT01733758|20392996|P1|Overall Study|Protocol Violation|0
5893649|NCT01733758|20392993|P4|Overall Study|Persistent Hyperglycemia|0
5893650|NCT01733758|20392994|P3|Overall Study|Persistent Hyperglycemia|0
5893651|NCT01733758|20392995|P2|Overall Study|Persistent Hyperglycemia|2
5893652|NCT01733758|20392996|P1|Overall Study|Persistent Hyperglycemia|3
5893653|NCT01733758|20392993|P4|Overall Study|Withdrawal by Subject|3
5893654|NCT01733758|20392994|P3|Overall Study|Withdrawal by Subject|5
5893655|NCT01733758|20392995|P2|Overall Study|Withdrawal by Subject|1
5893656|NCT01733758|20392996|P1|Overall Study|Withdrawal by Subject|1
5893657|NCT01733758|20392993|P4|Overall Study|Adverse Event|1
5893658|NCT01733758|20392994|P3|Overall Study|Adverse Event|8
5893659|NCT01733758|20392995|P2|Overall Study|Adverse Event|7
5893660|NCT01733758|20392996|P1|Overall Study|Adverse Event|5
5893661|NCT01733732|20393062|P2|Overall Study|Did not attend all study visits|0
5893662|NCT01733732|20393063|P1|Overall Study|Did not attend all study visits|1
5893663|NCT01733732|20393062|P2|Overall Study|Adverse Event|0
5893664|NCT01733732|20393063|P1|Overall Study|Adverse Event|1
5893665|NCT01733680|20393099|P2|Overall Study|Withdrawal by Subject|1
5893666|NCT01733680|20393100|P1|Overall Study|Withdrawal by Subject|0
5893668|NCT01733329|20393160|P1|Overall Study|Uterine artery injury|1
5893669|NCT01733329|20393159|P2|Overall Study|Protocol Violation|1
5893670|NCT01733329|20393160|P1|Overall Study|Protocol Violation|1
5893671|NCT01733316|20393172|P1|Long Term Extension Phase|Sponsor Decision|2
5893672|NCT01733316|20393172|P1|Long Term Extension Phase|Consent Withdrawn by Subject|2
5893673|NCT01733316|20393172|P1|Long Term Extension Phase|Adverse Event|1
5893674|NCT01733316|20393172|P1|RP103 Phase|Non-compliance|1
5893675|NCT01733121|20393215|P2|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0
5893676|NCT01733121|20393216|P1|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1
5893677|NCT01733121|20393215|P2|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|3
5893678|NCT01733121|20393216|P1|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1
5893679|NCT01733121|20393215|P2|Double-Blind Period (Week 0 to 6)|Non-compliance|2
5893680|NCT01733121|20393216|P1|Double-Blind Period (Week 0 to 6)|Non-compliance|3
5893681|NCT01733121|20393215|P2|Double-Blind Period (Week 0 to 6)|Adverse Event|0
5893682|NCT01733121|20393216|P1|Double-Blind Period (Week 0 to 6)|Adverse Event|2
5893683|NCT01732926|20393258|P2|Overall Study|Blind Broken by Subject or Study Site|1
5893684|NCT01732926|20393259|P1|Overall Study|Blind Broken by Subject or Study Site|1
5893685|NCT01732926|20393258|P2|Overall Study|Initiation of Other Anti-Cancer Therapy|6
5893686|NCT01732926|20393259|P1|Overall Study|Initiation of Other Anti-Cancer Therapy|7
5893687|NCT01732926|20393258|P2|Overall Study|Other Reason|4
5893688|NCT01732926|20393259|P1|Overall Study|Other Reason|21
5893689|NCT01732926|20393258|P2|Overall Study|Physician Decision|11
5893690|NCT01732926|20393259|P1|Overall Study|Physician Decision|24
5893691|NCT01732926|20393258|P2|Overall Study|Withdrawal by Subject|8
5893692|NCT01732926|20393259|P1|Overall Study|Withdrawal by Subject|46
5893693|NCT01732926|20393258|P2|Overall Study|Study Terminated by Sponsor|80
5893694|NCT01732926|20393259|P1|Overall Study|Study Terminated by Sponsor|168
5893695|NCT01732913|20393275|P2|Overall Study|Initiation of Other Anti-Cancer Therapy|2
5893696|NCT01732913|20393276|P1|Overall Study|Initiation of Other Anti-Cancer Therapy|3
5893697|NCT01732913|20393275|P2|Overall Study|Other|1
5893698|NCT01732913|20393276|P1|Overall Study|Other|7
5893699|NCT01732913|20393275|P2|Overall Study|Physician Decision|7
5893700|NCT01732913|20393276|P1|Overall Study|Physician Decision|14
5893701|NCT01732913|20393275|P2|Overall Study|Withdrawal by Subject|4
5893702|NCT01732913|20393276|P1|Overall Study|Withdrawal by Subject|27
5893703|NCT01732913|20393275|P2|Overall Study|Study Terminated by Sponsor|55
5893704|NCT01732913|20393276|P1|Overall Study|Study Terminated by Sponsor|105
5893705|NCT01732874|20393292|P2|Overall Study|Death of Infant|2
5893706|NCT01732874|20393293|P1|Overall Study|Death of Infant|3
5893707|NCT01732874|20393292|P2|Overall Study|Withdrawal by Subject|1
5893708|NCT01732874|20393293|P1|Overall Study|Withdrawal by Subject|5
5893709|NCT01732835|20393299|P1|2-year Extended Follow-up|Death|1
5893710|NCT01732835|20393299|P1|2-year Extended Follow-up|Adverse Event|3
5893711|NCT01732835|20393299|P1|2-year Extended Follow-up|Withdrawal by Subject|1
5893712|NCT01732835|20393299|P1|6-month Primary Endpoint|Adverse Event|3
5893713|NCT01732835|20393299|P1|6-month Primary Endpoint|Withdrawal by Subject|2
5893714|NCT01732835|20393299|P1|6-month Primary Endpoint|Did not receive device|19
5893715|NCT01732822|20393332|P2|Overall Study|Withdrawal by Subject|113
5893716|NCT01732822|20393333|P1|Overall Study|Withdrawal by Subject|123
5893717|NCT01732796|20393425|P3|Overall Study|Other reason not defined above|2
5893718|NCT01732796|20393426|P2|Overall Study|Other reason not defined above|0
5893719|NCT01732796|20393427|P1|Overall Study|Other reason not defined above|1
5893720|NCT01732796|20393425|P3|Overall Study|Withdrawal by Subject|2
5893721|NCT01732796|20393426|P2|Overall Study|Withdrawal by Subject|8
5893722|NCT01732796|20393427|P1|Overall Study|Withdrawal by Subject|6
5893723|NCT01732796|20393425|P3|Overall Study|Lost to Follow-up|0
5893724|NCT01732796|20393426|P2|Overall Study|Lost to Follow-up|0
5893725|NCT01732796|20393427|P1|Overall Study|Lost to Follow-up|2
5893726|NCT01732796|20393425|P3|Overall Study|Lack of Efficacy|5
5893727|NCT01732796|20393426|P2|Overall Study|Lack of Efficacy|18
5893728|NCT01732796|20393427|P1|Overall Study|Lack of Efficacy|21
5893729|NCT01732796|20393425|P3|Overall Study|Adverse Event|4
5893730|NCT01732796|20393426|P2|Overall Study|Adverse Event|16
5893731|NCT01732796|20393427|P1|Overall Study|Adverse Event|16
5893732|NCT01732783|20393446|P3|Overall Study|Withdrawal by Subject|0
5893733|NCT01732783|20393447|P2|Overall Study|Withdrawal by Subject|0
5893734|NCT01732783|20393448|P1|Overall Study|Withdrawal by Subject|1
5893735|NCT01732783|20393446|P3|Overall Study|Administrative Decision|1
5893736|NCT01732783|20393447|P2|Overall Study|Administrative Decision|2
5893737|NCT01732783|20393448|P1|Overall Study|Administrative Decision|8
5893738|NCT01732783|20393446|P3|Overall Study|Lost to Follow-up|1
5893739|NCT01732783|20393447|P2|Overall Study|Lost to Follow-up|1
5893740|NCT01732783|20393448|P1|Overall Study|Lost to Follow-up|7
5893741|NCT01732783|20393446|P3|Overall Study|Death|1
5893742|NCT01732783|20393447|P2|Overall Study|Death|4
5893743|NCT01732783|20393448|P1|Overall Study|Death|13
5893744|NCT01732783|20393446|P3|Overall Study|Discontinued Panitumumab Treatment|7
5893745|NCT01732783|20393447|P2|Overall Study|Discontinued Panitumumab Treatment|25
5893746|NCT01732783|20393448|P1|Overall Study|Discontinued Panitumumab Treatment|106
5893747|NCT01732770|20393512|P2|Overall Study|Death|0
5893748|NCT01732770|20393513|P1|Overall Study|Death|1
5893749|NCT01732770|20393512|P2|Overall Study|Decision by Sponsor|2
5893750|NCT01732770|20393513|P1|Overall Study|Decision by Sponsor|2
5893751|NCT01732770|20393512|P2|Overall Study|Withdrawal by Subject|3
5893752|NCT01732770|20393513|P1|Overall Study|Withdrawal by Subject|5
5893753|NCT01732770|20393512|P2|Overall Study|Lost to Follow-up|3
5893754|NCT01732770|20393513|P1|Overall Study|Lost to Follow-up|2
5893755|NCT01732757|20393528|P3|Overall Study|Lost to Follow-up|0
5893756|NCT01732757|20393529|P2|Overall Study|Lost to Follow-up|0
5893757|NCT01732757|20393530|P1|Overall Study|Lost to Follow-up|1
5893758|NCT01732692|20393607|P2|Overall Study|Adverse Event|1
5893759|NCT01732692|20393608|P1|Overall Study|Adverse Event|0
5893760|NCT01732640|20393622|P2|Overall Study|Death|1
5893761|NCT01732640|20393623|P1|Overall Study|Death|0
5893762|NCT01732640|20393622|P2|Overall Study|Adverse Event|1
5893763|NCT01732640|20393623|P1|Overall Study|Adverse Event|0
5893764|NCT01732627|20393640|P2|Overall Study|Withdrawal by Subject|0
5893765|NCT01732627|20393641|P1|Overall Study|Withdrawal by Subject|1
5893766|NCT01732588|20393674|P3|First Intervention (7 Days)|Adverse Event|0
5893767|NCT01732588|20393675|P2|First Intervention (7 Days)|Adverse Event|1
5893768|NCT01732588|20393676|P1|First Intervention (7 Days)|Adverse Event|0
5893769|NCT01732549|20393692|P2|Overall Study|Other|14
5893770|NCT01732549|20393693|P1|Overall Study|Other|8
5893771|NCT01732549|20393692|P2|Overall Study|Disease progression|50
5893772|NCT01732549|20393693|P1|Overall Study|Disease progression|37
5893773|NCT01732549|20393692|P2|Overall Study|Consent withdrawn|6
5893774|NCT01732549|20393693|P1|Overall Study|Consent withdrawn|13
5893775|NCT01732549|20393692|P2|Overall Study|Adverse Event|3
5893776|NCT01732549|20393693|P1|Overall Study|Adverse Event|13
5893777|NCT01732536|20393715|P2|Overall Study|Withdrawal by Subject|1
5893778|NCT01732536|20393716|P1|Overall Study|Withdrawal by Subject|1
5893779|NCT01732510|20393739|P7|Overall Study|Study Terminated By Sponsor|6
5893780|NCT01732510|20393740|P6|Overall Study|Study Terminated By Sponsor|12
5893781|NCT01732510|20393741|P5|Overall Study|Study Terminated By Sponsor|0
5893782|NCT01732510|20393742|P4|Overall Study|Study Terminated By Sponsor|1
5893783|NCT01732510|20393743|P3|Overall Study|Study Terminated By Sponsor|0
5893784|NCT01732510|20393744|P2|Overall Study|Study Terminated By Sponsor|0
5893785|NCT01732510|20393745|P1|Overall Study|Study Terminated By Sponsor|0
5893786|NCT01732510|20393739|P7|Overall Study|Pregnancy|0
5893787|NCT01732510|20393740|P6|Overall Study|Pregnancy|0
5893788|NCT01732510|20393741|P5|Overall Study|Pregnancy|0
5893789|NCT01732510|20393742|P4|Overall Study|Pregnancy|1
5893790|NCT01732510|20393743|P3|Overall Study|Pregnancy|0
5893791|NCT01732510|20393744|P2|Overall Study|Pregnancy|0
5893792|NCT01732510|20393745|P1|Overall Study|Pregnancy|0
5893793|NCT01732510|20393739|P7|Overall Study|Physician Decision|0
5893794|NCT01732510|20393740|P6|Overall Study|Physician Decision|0
5893795|NCT01732510|20393741|P5|Overall Study|Physician Decision|0
5893796|NCT01732510|20393742|P4|Overall Study|Physician Decision|0
5893797|NCT01732510|20393743|P3|Overall Study|Physician Decision|0
5893798|NCT01732510|20393744|P2|Overall Study|Physician Decision|1
5893799|NCT01732510|20393745|P1|Overall Study|Physician Decision|0
5893800|NCT01732510|20393739|P7|Overall Study|Lost to Follow-up|0
5893801|NCT01732510|20393740|P6|Overall Study|Lost to Follow-up|1
5893802|NCT01732510|20393741|P5|Overall Study|Lost to Follow-up|0
5893803|NCT01732510|20393742|P4|Overall Study|Lost to Follow-up|1
5893804|NCT01732510|20393743|P3|Overall Study|Lost to Follow-up|1
5893805|NCT01732510|20393744|P2|Overall Study|Lost to Follow-up|0
5893806|NCT01732510|20393745|P1|Overall Study|Lost to Follow-up|0
5893807|NCT01732510|20393739|P7|Overall Study|Withdrawal by Subject|1
5893808|NCT01732510|20393740|P6|Overall Study|Withdrawal by Subject|0
5893809|NCT01732510|20393741|P5|Overall Study|Withdrawal by Subject|5
5893810|NCT01732510|20393742|P4|Overall Study|Withdrawal by Subject|1
5893811|NCT01732510|20393743|P3|Overall Study|Withdrawal by Subject|2
5893812|NCT01732510|20393744|P2|Overall Study|Withdrawal by Subject|3
5893813|NCT01732510|20393745|P1|Overall Study|Withdrawal by Subject|1
5893814|NCT01732510|20393739|P7|Overall Study|Protocol Violation|0
5893815|NCT01732510|20393740|P6|Overall Study|Protocol Violation|0
5893816|NCT01732510|20393741|P5|Overall Study|Protocol Violation|0
5893817|NCT01732510|20393742|P4|Overall Study|Protocol Violation|1
5893818|NCT01732510|20393743|P3|Overall Study|Protocol Violation|0
5893819|NCT01732510|20393744|P2|Overall Study|Protocol Violation|0
5893820|NCT01732510|20393745|P1|Overall Study|Protocol Violation|0
5893821|NCT01732510|20393739|P7|Overall Study|Adverse Event|1
5893822|NCT01732510|20393740|P6|Overall Study|Adverse Event|0
5893823|NCT01732510|20393741|P5|Overall Study|Adverse Event|0
5893824|NCT01732510|20393742|P4|Overall Study|Adverse Event|0
5893825|NCT01732510|20393743|P3|Overall Study|Adverse Event|1
5893826|NCT01732510|20393744|P2|Overall Study|Adverse Event|1
5893827|NCT01732510|20393745|P1|Overall Study|Adverse Event|0
5893828|NCT01732484|20393824|P1|Overall Study|chronical illness|5
5893829|NCT01732484|20393824|P1|Overall Study|Lost to Follow-up|14
5893830|NCT01732484|20393824|P1|Overall Study|Death|7
5893831|NCT01732471|20393832|P1|Overall Study|Withdrawal by Subject|1
5893832|NCT01732458|20393843|P4|Overall Study|Screen Failure|0
5893833|NCT01732458|20393844|P3|Overall Study|Screen Failure|0
5893834|NCT01732458|20393845|P2|Overall Study|Screen Failure|1
5893835|NCT01732458|20393846|P1|Overall Study|Screen Failure|0
5893836|NCT01732458|20393843|P4|Overall Study|Protocol Violation|2
5893837|NCT01732458|20393844|P3|Overall Study|Protocol Violation|0
5893838|NCT01732458|20393845|P2|Overall Study|Protocol Violation|0
5893839|NCT01732458|20393846|P1|Overall Study|Protocol Violation|2
5893840|NCT01732458|20393843|P4|Overall Study|Physician Decision|0
5893841|NCT01732458|20393844|P3|Overall Study|Physician Decision|2
5893842|NCT01732458|20393845|P2|Overall Study|Physician Decision|2
5893843|NCT01732458|20393846|P1|Overall Study|Physician Decision|1
5893844|NCT01732458|20393843|P4|Overall Study|Non-Compliance With Study Drug|0
5893845|NCT01732458|20393844|P3|Overall Study|Non-Compliance With Study Drug|1
5893846|NCT01732458|20393845|P2|Overall Study|Non-Compliance With Study Drug|0
5893847|NCT01732458|20393846|P1|Overall Study|Non-Compliance With Study Drug|0
5893848|NCT01732458|20393843|P4|Overall Study|Lost to Follow-up|0
5893849|NCT01732458|20393844|P3|Overall Study|Lost to Follow-up|0
5893850|NCT01732458|20393845|P2|Overall Study|Lost to Follow-up|2
5893851|NCT01732458|20393846|P1|Overall Study|Lost to Follow-up|0
5893852|NCT01732107|20394008|P1|Overall Study|Withdrawal by Subject|2
5893853|NCT01732107|20394008|P1|Overall Study|Physician Decision|1
5893854|NCT01732107|20394008|P1|Overall Study|Disease Progression|8
5893855|NCT01732107|20394008|P1|Overall Study|Adverse Event|2
5893856|NCT01731990|20394025|P2|Overall Study|Death|0
5893857|NCT01731990|20394026|P1|Overall Study|Death|1
5893858|NCT01731990|20394025|P2|Overall Study|Protocol deviation|2
5893859|NCT01731990|20394026|P1|Overall Study|Protocol deviation|1
5893860|NCT01731990|20394025|P2|Overall Study|Withdrawal by Subject|1
5893861|NCT01731990|20394026|P1|Overall Study|Withdrawal by Subject|1
5893862|NCT01731990|20394025|P2|Overall Study|Adverse Event|5
5893863|NCT01731990|20394026|P1|Overall Study|Adverse Event|1
5893864|NCT01731938|20394042|P2|Primary Part II|Missed Week 6 visit|3
5893865|NCT01731938|20394043|P1|Primary Part II|Missed Week 6 visit|2
5893866|NCT01731938|20394042|P2|Primary Part II|Death|1
5893867|NCT01731938|20394043|P1|Primary Part II|Death|2
5893868|NCT01731938|20394042|P2|Primary Part II|Lost to Follow-up|5
5893869|NCT01731938|20394043|P1|Primary Part II|Lost to Follow-up|4
5893870|NCT01731938|20394042|P2|Primary Part II|Withdrawal by Subject|4
5893871|NCT01731938|20394043|P1|Primary Part II|Withdrawal by Subject|5
5893872|NCT01731938|20394042|P2|Preliminary Part I|Missed Week 6 visit|3
5893873|NCT01731938|20394043|P1|Preliminary Part I|Missed Week 6 visit|0
5893874|NCT01731938|20394042|P2|Preliminary Part I|Lost to Follow-up|3
5893875|NCT01731938|20394043|P1|Preliminary Part I|Lost to Follow-up|0
5893876|NCT01731938|20394042|P2|Preliminary Part I|Physician Decision|0
5893877|NCT01731938|20394043|P1|Preliminary Part I|Physician Decision|1
5893878|NCT01731938|20394042|P2|Preliminary Part I|Withdrawal by Subject|2
5893879|NCT01731938|20394043|P1|Preliminary Part I|Withdrawal by Subject|2
5893880|NCT01731912|20394055|P1|Overall Study|noncompliance|2
5893881|NCT01731886|20394062|P2|Overall Study|Non-compliant|0
5893882|NCT01731886|20394063|P1|Overall Study|Non-compliant|1
5893883|NCT01731886|20394062|P2|Overall Study|Never started treatment|1
5893884|NCT01731886|20394063|P1|Overall Study|Never started treatment|0
5893885|NCT01731886|20394062|P2|Overall Study|Death|0
5893886|NCT01731886|20394063|P1|Overall Study|Death|1
5893887|NCT01731678|20394108|P1|Overall Study|RMT too high, making TMS difficult|3
5893888|NCT01731678|20394108|P1|Overall Study|Did not meet inclusion criteria|1
5893889|NCT01731678|20394108|P1|Overall Study|Withdrawal by Subject|3
5893890|NCT01731600|20394114|P2|Overall Study|Other reasons|0
5893891|NCT01731600|20394115|P1|Overall Study|Other reasons|3
5893892|NCT01731600|20394114|P2|Overall Study|Withdrawal criteria|0
5893893|NCT01731600|20394115|P1|Overall Study|Withdrawal criteria|1
5893894|NCT01731600|20394114|P2|Overall Study|Adverse Event|0
5893895|NCT01731600|20394115|P1|Overall Study|Adverse Event|2
5893896|NCT01731470|20394169|P1|Overall Study|Did not meet study criteria|1
5893897|NCT01731470|20394169|P1|Overall Study|Withdrawal by Subject|1
5893898|NCT01731171|20394176|P2|Overall Study|Terminated for Safety Reasons|1
5893899|NCT01731171|20394177|P1|Overall Study|Terminated for Safety Reasons|0
5893900|NCT01731171|20394176|P2|Overall Study|Terminated for Lack of Adherence|1
5893901|NCT01731171|20394177|P1|Overall Study|Terminated for Lack of Adherence|0
5893902|NCT01731171|20394176|P2|Overall Study|Moved out of Area|2
5893903|NCT01731171|20394177|P1|Overall Study|Moved out of Area|0
5893904|NCT01731171|20394176|P2|Overall Study|Lost to Follow-up|2
5893905|NCT01731171|20394177|P1|Overall Study|Lost to Follow-up|3
5893906|NCT01731171|20394176|P2|Overall Study|Withdrawal by Subject|1
5893907|NCT01731171|20394177|P1|Overall Study|Withdrawal by Subject|4
5893908|NCT01731002|20394211|P3|Overall Study|Inappropriate use of study medications|1
5893909|NCT01731002|20394212|P2|Overall Study|Inappropriate use of study medications|0
5893910|NCT01731002|20394213|P1|Overall Study|Inappropriate use of study medications|0
5893911|NCT01731002|20394211|P3|Overall Study|Elevated IOP|0
5893912|NCT01731002|20394212|P2|Overall Study|Elevated IOP|0
5893913|NCT01731002|20394213|P1|Overall Study|Elevated IOP|1
5893914|NCT01731002|20394211|P3|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0
5893915|NCT01731002|20394212|P2|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0
5893916|NCT01731002|20394213|P1|Overall Study|Uncontrolled Intraocular Pressure (IOP)|2
5893917|NCT01731002|20394211|P3|Overall Study|Test Agent Discontinuation|0
5893918|NCT01731002|20394212|P2|Overall Study|Test Agent Discontinuation|1
5893919|NCT01731002|20394213|P1|Overall Study|Test Agent Discontinuation|0
5893920|NCT01731002|20394211|P3|Overall Study|Lost to Follow-up|0
5893921|NCT01731002|20394212|P2|Overall Study|Lost to Follow-up|0
5893922|NCT01731002|20394213|P1|Overall Study|Lost to Follow-up|1
5893923|NCT01731002|20394211|P3|Overall Study|Non-Compliant|0
5893924|NCT01731002|20394212|P2|Overall Study|Non-Compliant|1
5893925|NCT01731002|20394213|P1|Overall Study|Non-Compliant|0
5893926|NCT01731002|20394211|P3|Overall Study|Adverse Event|2
5893927|NCT01731002|20394212|P2|Overall Study|Adverse Event|2
5893928|NCT01731002|20394213|P1|Overall Study|Adverse Event|0
5893929|NCT01730950|20394226|P2|Overall Study|Protocol Violation|6
5893930|NCT01730950|20394227|P1|Overall Study|Protocol Violation|6
5893931|NCT01730729|20394273|P1|Overall Study|Progressive Disease|12
5893932|NCT01730729|20394273|P1|Overall Study|Death|1
5893933|NCT01730729|20394273|P1|Overall Study|Adverse Event|1
5893934|NCT01730586|20394287|P1|Overall Study|Hospice|1
5893935|NCT01730586|20394287|P1|Overall Study|Adverse Event|2
5893936|NCT01730586|20394287|P1|Overall Study|Inadequate Trial|8
5893937|NCT01730586|20394287|P1|Overall Study|Progressive Disease|2
5893938|NCT01730534|20394296|P2|Overall Study|Lost to Follow-up|18
5893939|NCT01730534|20394297|P1|Overall Study|Lost to Follow-up|12
5893940|NCT01730534|20394296|P2|Overall Study|Withdrawal by Subject|127
5893941|NCT01730534|20394297|P1|Overall Study|Withdrawal by Subject|97
5893942|NCT01730378|20394311|P2|Overall Study|Lost to Follow-up|0
5893943|NCT01730378|20394312|P1|Overall Study|Lost to Follow-up|1
5893944|NCT01730339|20394343|P2|Overall Study|Un-specified|0
5893945|NCT01730339|20394344|P1|Overall Study|Un-specified|1
5893946|NCT01730339|20394343|P2|Overall Study|Lost to Follow-up|1
5893947|NCT01730339|20394344|P1|Overall Study|Lost to Follow-up|1
5893948|NCT01730339|20394343|P2|Overall Study|Withdrawal by Subject|2
5893949|NCT01730339|20394344|P1|Overall Study|Withdrawal by Subject|3
5893950|NCT01730053|20394384|P6|Overall Study|Other than specified|9
5893951|NCT01730053|20394385|P5|Overall Study|Other than specified|7
5893952|NCT01730053|20394386|P4|Overall Study|Other than specified|4
5893953|NCT01730053|20394387|P3|Overall Study|Other than specified|5
5893954|NCT01730053|20394388|P2|Overall Study|Other than specified|6
5893955|NCT01730053|20394389|P1|Overall Study|Other than specified|2
5893956|NCT01730053|20394384|P6|Overall Study|Poor compliance to protocol|2
5893957|NCT01730053|20394385|P5|Overall Study|Poor compliance to protocol|0
5893958|NCT01730053|20394386|P4|Overall Study|Poor compliance to protocol|0
5893959|NCT01730053|20394387|P3|Overall Study|Poor compliance to protocol|2
5893960|NCT01730053|20394388|P2|Overall Study|Poor compliance to protocol|2
5893961|NCT01730053|20394389|P1|Overall Study|Poor compliance to protocol|1
5893962|NCT01730053|20394384|P6|Overall Study|Adverse Event|2
5893963|NCT01730053|20394385|P5|Overall Study|Adverse Event|2
5893964|NCT01730053|20394386|P4|Overall Study|Adverse Event|3
5893965|NCT01730053|20394387|P3|Overall Study|Adverse Event|3
5893966|NCT01730053|20394388|P2|Overall Study|Adverse Event|6
5893967|NCT01730053|20394389|P1|Overall Study|Adverse Event|2
5893968|NCT01730053|20394384|P6|Overall Study|Physician Decision|0
5893969|NCT01730053|20394385|P5|Overall Study|Physician Decision|0
5893970|NCT01730053|20394386|P4|Overall Study|Physician Decision|1
5893971|NCT01730053|20394387|P3|Overall Study|Physician Decision|0
5893972|NCT01730053|20394388|P2|Overall Study|Physician Decision|0
5893973|NCT01730053|20394389|P1|Overall Study|Physician Decision|0
5893974|NCT01730053|20394384|P6|Overall Study|Participant moved|0
5893975|NCT01730053|20394385|P5|Overall Study|Participant moved|0
5893976|NCT01730053|20394386|P4|Overall Study|Participant moved|0
5893977|NCT01730053|20394387|P3|Overall Study|Participant moved|1
5893978|NCT01730053|20394388|P2|Overall Study|Participant moved|0
5893979|NCT01730053|20394389|P1|Overall Study|Participant moved|0
5893980|NCT01730040|20394548|P7|Overall Study|Poor compliance to protocol|1
5893981|NCT01730040|20394549|P6|Overall Study|Poor compliance to protocol|0
5893982|NCT01730040|20394550|P5|Overall Study|Poor compliance to protocol|0
5893983|NCT01730040|20394551|P4|Overall Study|Poor compliance to protocol|0
5893984|NCT01730040|20394552|P3|Overall Study|Poor compliance to protocol|0
5893985|NCT01730040|20394553|P2|Overall Study|Poor compliance to protocol|4
5893986|NCT01730040|20394554|P1|Overall Study|Poor compliance to protocol|2
5893987|NCT01730040|20394548|P7|Overall Study|Adverse Event|2
5893988|NCT01730040|20394549|P6|Overall Study|Adverse Event|1
5893989|NCT01730040|20394550|P5|Overall Study|Adverse Event|1
5893990|NCT01730040|20394551|P4|Overall Study|Adverse Event|3
5893991|NCT01730040|20394552|P3|Overall Study|Adverse Event|5
5893992|NCT01730040|20394553|P2|Overall Study|Adverse Event|3
5893993|NCT01730040|20394554|P1|Overall Study|Adverse Event|4
5893994|NCT01730040|20394548|P7|Overall Study|Other than specified|4
5893995|NCT01730040|20394549|P6|Overall Study|Other than specified|4
5893996|NCT01730040|20394550|P5|Overall Study|Other than specified|5
5893997|NCT01730040|20394551|P4|Overall Study|Other than specified|5
5893998|NCT01730040|20394552|P3|Overall Study|Other than specified|5
5893999|NCT01730040|20394553|P2|Overall Study|Other than specified|8
5894000|NCT01730040|20394554|P1|Overall Study|Other than specified|7
5894001|NCT01730040|20394548|P7|Overall Study|Physician Decision|1
5894002|NCT01730040|20394549|P6|Overall Study|Physician Decision|1
5894003|NCT01730040|20394550|P5|Overall Study|Physician Decision|0
5894004|NCT01730040|20394551|P4|Overall Study|Physician Decision|0
5894005|NCT01730040|20394552|P3|Overall Study|Physician Decision|0
5894006|NCT01730040|20394553|P2|Overall Study|Physician Decision|0
5894007|NCT01730040|20394554|P1|Overall Study|Physician Decision|0
5894008|NCT01730040|20394548|P7|Overall Study|Subject moved|1
5894009|NCT01730040|20394549|P6|Overall Study|Subject moved|0
5894010|NCT01730040|20394550|P5|Overall Study|Subject moved|0
5894011|NCT01730040|20394551|P4|Overall Study|Subject moved|0
5894012|NCT01730040|20394552|P3|Overall Study|Subject moved|1
5894013|NCT01730040|20394553|P2|Overall Study|Subject moved|0
5894014|NCT01730040|20394554|P1|Overall Study|Subject moved|0
5894015|NCT01730040|20394548|P7|Overall Study|Randomized but not treated|0
5894016|NCT01730040|20394549|P6|Overall Study|Randomized but not treated|1
5894017|NCT01730040|20394550|P5|Overall Study|Randomized but not treated|0
5894018|NCT01730040|20394551|P4|Overall Study|Randomized but not treated|0
5894019|NCT01730040|20394552|P3|Overall Study|Randomized but not treated|0
5894020|NCT01730040|20394553|P2|Overall Study|Randomized but not treated|0
5894021|NCT01730040|20394554|P1|Overall Study|Randomized but not treated|0
5894022|NCT01729871|20394743|P2|Overall Study|Other|9
5894023|NCT01729871|20394744|P1|Overall Study|Other|4
5894024|NCT01729871|20394743|P2|Overall Study|Withdrawal by Subject|3
5894025|NCT01729871|20394744|P1|Overall Study|Withdrawal by Subject|0
5894026|NCT01729871|20394743|P2|Overall Study|Protocol Violation|0
5894027|NCT01729871|20394744|P1|Overall Study|Protocol Violation|1
5894028|NCT01729871|20394743|P2|Overall Study|Physician Decision|2
5894029|NCT01729871|20394744|P1|Overall Study|Physician Decision|0
5894030|NCT01729871|20394743|P2|Overall Study|Lack of Efficacy|1
5894031|NCT01729871|20394744|P1|Overall Study|Lack of Efficacy|0
5894032|NCT01729871|20394743|P2|Overall Study|Death|1
5894033|NCT01729871|20394744|P1|Overall Study|Death|0
5894034|NCT01729871|20394743|P2|Overall Study|Adverse Event|7
5894035|NCT01729871|20394744|P1|Overall Study|Adverse Event|7
5894036|NCT01729819|20394778|P2|Overall Study|Withdrawal by Subject|2
5894037|NCT01729819|20394779|P1|Overall Study|Withdrawal by Subject|0
5894038|NCT01729819|20394778|P2|Overall Study|Protocol Violation|1
5894039|NCT01729819|20394779|P1|Overall Study|Protocol Violation|0
5894040|NCT01729819|20394778|P2|Overall Study|Other reason|0
5894041|NCT01729819|20394779|P1|Overall Study|Other reason|1
5894042|NCT01729819|20394778|P2|Overall Study|Lost to Follow-up|0
5894043|NCT01729819|20394779|P1|Overall Study|Lost to Follow-up|2
5894044|NCT01729819|20394778|P2|Overall Study|Lack of Efficacy|0
5894045|NCT01729819|20394779|P1|Overall Study|Lack of Efficacy|1
5894046|NCT01729819|20394778|P2|Overall Study|Adverse Event|4
5894047|NCT01729819|20394779|P1|Overall Study|Adverse Event|2
5894048|NCT01729754|20394798|P10|Part 3|Other Protocol Specified Criteria|0
5894049|NCT01729754|20394799|P9|Part 3|Other Protocol Specified Criteria|0
5894050|NCT01729754|20394800|P8|Part 3|Other Protocol Specified Criteria|1
5894051|NCT01729754|20394801|P7|Part 3|Other Protocol Specified Criteria|0
5894052|NCT01729754|20394802|P6|Part 3|Other Protocol Specified Criteria|2
5894053|NCT01729754|20394803|P5|Part 3|Other Protocol Specified Criteria|0
5894054|NCT01729754|20394804|P4|Part 3|Other Protocol Specified Criteria|0
5894055|NCT01729754|20394805|P3|Part 3|Other Protocol Specified Criteria|0
5894056|NCT01729754|20394806|P2|Part 3|Other Protocol Specified Criteria|0
5894057|NCT01729754|20394807|P1|Part 3|Other Protocol Specified Criteria|0
5894058|NCT01729754|20394798|P10|Part 3|Withdrawal by Subject|0
5894059|NCT01729754|20394799|P9|Part 3|Withdrawal by Subject|0
5894060|NCT01729754|20394800|P8|Part 3|Withdrawal by Subject|2
5894061|NCT01729754|20394801|P7|Part 3|Withdrawal by Subject|0
5894062|NCT01729754|20394802|P6|Part 3|Withdrawal by Subject|1
5894063|NCT01729754|20394803|P5|Part 3|Withdrawal by Subject|2
5894064|NCT01729754|20394804|P4|Part 3|Withdrawal by Subject|0
5894065|NCT01729754|20394805|P3|Part 3|Withdrawal by Subject|1
5894066|NCT01729754|20394806|P2|Part 3|Withdrawal by Subject|4
5894067|NCT01729754|20394807|P1|Part 3|Withdrawal by Subject|0
5894068|NCT01729754|20394798|P10|Part 3|Physician Decision|0
5894069|NCT01729754|20394799|P9|Part 3|Physician Decision|0
5894070|NCT01729754|20394800|P8|Part 3|Physician Decision|0
5894071|NCT01729754|20394801|P7|Part 3|Physician Decision|0
5894072|NCT01729754|20394802|P6|Part 3|Physician Decision|0
5894073|NCT01729754|20394803|P5|Part 3|Physician Decision|0
5894074|NCT01729754|20394804|P4|Part 3|Physician Decision|0
5894075|NCT01729754|20394805|P3|Part 3|Physician Decision|1
5894076|NCT01729754|20394806|P2|Part 3|Physician Decision|0
5894077|NCT01729754|20394807|P1|Part 3|Physician Decision|0
5894078|NCT01729754|20394798|P10|Part 3|Lost to Follow-up|0
5894079|NCT01729754|20394799|P9|Part 3|Lost to Follow-up|1
5894080|NCT01729754|20394800|P8|Part 3|Lost to Follow-up|0
5894081|NCT01729754|20394801|P7|Part 3|Lost to Follow-up|0
5894082|NCT01729754|20394802|P6|Part 3|Lost to Follow-up|3
5894083|NCT01729754|20394803|P5|Part 3|Lost to Follow-up|0
5894084|NCT01729754|20394804|P4|Part 3|Lost to Follow-up|0
5894085|NCT01729754|20394805|P3|Part 3|Lost to Follow-up|2
5894086|NCT01729754|20394806|P2|Part 3|Lost to Follow-up|1
5894087|NCT01729754|20394807|P1|Part 3|Lost to Follow-up|0
5894088|NCT01729754|20394798|P10|Part 3|Lack of Efficacy|4
5894089|NCT01729754|20394799|P9|Part 3|Lack of Efficacy|0
5894090|NCT01729754|20394800|P8|Part 3|Lack of Efficacy|0
5894091|NCT01729754|20394801|P7|Part 3|Lack of Efficacy|0
5894092|NCT01729754|20394802|P6|Part 3|Lack of Efficacy|0
5894093|NCT01729754|20394803|P5|Part 3|Lack of Efficacy|2
5894094|NCT01729754|20394804|P4|Part 3|Lack of Efficacy|0
5894095|NCT01729754|20394805|P3|Part 3|Lack of Efficacy|0
5894096|NCT01729754|20394806|P2|Part 3|Lack of Efficacy|0
5894097|NCT01729754|20394807|P1|Part 3|Lack of Efficacy|0
5894098|NCT01729754|20394798|P10|Part 3|Death|0
5894099|NCT01729754|20394799|P9|Part 3|Death|0
5894100|NCT01729754|20394800|P8|Part 3|Death|0
5894101|NCT01729754|20394801|P7|Part 3|Death|0
5894102|NCT01729754|20394802|P6|Part 3|Death|2
5894103|NCT01729754|20394803|P5|Part 3|Death|0
5894104|NCT01729754|20394804|P4|Part 3|Death|0
5894105|NCT01729754|20394805|P3|Part 3|Death|0
5894106|NCT01729754|20394806|P2|Part 3|Death|0
5894107|NCT01729754|20394807|P1|Part 3|Death|0
5894108|NCT01729754|20394798|P10|Part 3|Adverse Event|3
5894109|NCT01729754|20394799|P9|Part 3|Adverse Event|0
5894110|NCT01729754|20394800|P8|Part 3|Adverse Event|0
5894111|NCT01729754|20394801|P7|Part 3|Adverse Event|0
5894112|NCT01729754|20394802|P6|Part 3|Adverse Event|5
5894113|NCT01729754|20394803|P5|Part 3|Adverse Event|0
5894114|NCT01729754|20394804|P4|Part 3|Adverse Event|0
5894115|NCT01729754|20394805|P3|Part 3|Adverse Event|1
5894116|NCT01729754|20394806|P2|Part 3|Adverse Event|0
5894117|NCT01729754|20394807|P1|Part 3|Adverse Event|0
5894118|NCT01729754|20394798|P10|Part 2|Other Protocol Specified Criteria|0
5894119|NCT01729754|20394799|P9|Part 2|Other Protocol Specified Criteria|0
5894120|NCT01729754|20394800|P8|Part 2|Other Protocol Specified Criteria|1
5894121|NCT01729754|20394801|P7|Part 2|Other Protocol Specified Criteria|0
5894122|NCT01729754|20394802|P6|Part 2|Other Protocol Specified Criteria|0
5894123|NCT01729754|20394803|P5|Part 2|Other Protocol Specified Criteria|0
5894124|NCT01729754|20394804|P4|Part 2|Other Protocol Specified Criteria|0
5894125|NCT01729754|20394805|P3|Part 2|Other Protocol Specified Criteria|0
5894126|NCT01729754|20394806|P2|Part 2|Other Protocol Specified Criteria|0
5894127|NCT01729754|20394807|P1|Part 2|Other Protocol Specified Criteria|1
5894128|NCT01729754|20394798|P10|Part 2|Withdrawal by Subject|4
5894129|NCT01729754|20394799|P9|Part 2|Withdrawal by Subject|1
5894130|NCT01729754|20394800|P8|Part 2|Withdrawal by Subject|1
5894131|NCT01729754|20394801|P7|Part 2|Withdrawal by Subject|0
5894132|NCT01729754|20394802|P6|Part 2|Withdrawal by Subject|0
5894133|NCT01729754|20394803|P5|Part 2|Withdrawal by Subject|0
5894134|NCT01729754|20394804|P4|Part 2|Withdrawal by Subject|2
5894135|NCT01729754|20394805|P3|Part 2|Withdrawal by Subject|0
5894136|NCT01729754|20394806|P2|Part 2|Withdrawal by Subject|0
5894137|NCT01729754|20394807|P1|Part 2|Withdrawal by Subject|3
5894138|NCT01729754|20394798|P10|Part 2|Pregnancy|1
5894139|NCT01729754|20394799|P9|Part 2|Pregnancy|0
5894140|NCT01729754|20394800|P8|Part 2|Pregnancy|0
5894141|NCT01729754|20394801|P7|Part 2|Pregnancy|0
5894142|NCT01729754|20394802|P6|Part 2|Pregnancy|0
5894143|NCT01729754|20394803|P5|Part 2|Pregnancy|0
5894144|NCT01729754|20394804|P4|Part 2|Pregnancy|1
5894145|NCT01729754|20394805|P3|Part 2|Pregnancy|0
5894146|NCT01729754|20394806|P2|Part 2|Pregnancy|0
5894147|NCT01729754|20394807|P1|Part 2|Pregnancy|0
5894148|NCT01729754|20394798|P10|Part 2|Non-Compliance with Study Drug|1
5894149|NCT01729754|20394799|P9|Part 2|Non-Compliance with Study Drug|0
5894150|NCT01729754|20394800|P8|Part 2|Non-Compliance with Study Drug|0
5894151|NCT01729754|20394801|P7|Part 2|Non-Compliance with Study Drug|0
5894152|NCT01729754|20394802|P6|Part 2|Non-Compliance with Study Drug|0
5894153|NCT01729754|20394803|P5|Part 2|Non-Compliance with Study Drug|0
5894154|NCT01729754|20394804|P4|Part 2|Non-Compliance with Study Drug|0
5894155|NCT01729754|20394805|P3|Part 2|Non-Compliance with Study Drug|0
5894156|NCT01729754|20394806|P2|Part 2|Non-Compliance with Study Drug|0
5894157|NCT01729754|20394807|P1|Part 2|Non-Compliance with Study Drug|0
5894158|NCT01729754|20394798|P10|Part 2|Lost to Follow-up|2
5894159|NCT01729754|20394799|P9|Part 2|Lost to Follow-up|0
5894160|NCT01729754|20394800|P8|Part 2|Lost to Follow-up|1
5894161|NCT01729754|20394801|P7|Part 2|Lost to Follow-up|0
5894162|NCT01729754|20394802|P6|Part 2|Lost to Follow-up|0
5894163|NCT01729754|20394803|P5|Part 2|Lost to Follow-up|0
5894164|NCT01729754|20394804|P4|Part 2|Lost to Follow-up|2
5894165|NCT01729754|20394805|P3|Part 2|Lost to Follow-up|0
5894166|NCT01729754|20394806|P2|Part 2|Lost to Follow-up|0
5894167|NCT01729754|20394807|P1|Part 2|Lost to Follow-up|0
5894168|NCT01729754|20394798|P10|Part 2|Lack of Efficacy|2
5894169|NCT01729754|20394799|P9|Part 2|Lack of Efficacy|2
5894170|NCT01729754|20394800|P8|Part 2|Lack of Efficacy|0
5894171|NCT01729754|20394801|P7|Part 2|Lack of Efficacy|0
5894172|NCT01729754|20394802|P6|Part 2|Lack of Efficacy|0
5894173|NCT01729754|20394803|P5|Part 2|Lack of Efficacy|0
5894174|NCT01729754|20394804|P4|Part 2|Lack of Efficacy|0
5894175|NCT01729754|20394805|P3|Part 2|Lack of Efficacy|0
5894176|NCT01729754|20394806|P2|Part 2|Lack of Efficacy|0
5894177|NCT01729754|20394807|P1|Part 2|Lack of Efficacy|0
5894178|NCT01729754|20394798|P10|Part 2|Adverse Event|2
5894179|NCT01729754|20394799|P9|Part 2|Adverse Event|1
5894180|NCT01729754|20394800|P8|Part 2|Adverse Event|0
5894181|NCT01729754|20394801|P7|Part 2|Adverse Event|0
5894182|NCT01729754|20394802|P6|Part 2|Adverse Event|0
5894183|NCT01729754|20394803|P5|Part 2|Adverse Event|0
5894184|NCT01729754|20394804|P4|Part 2|Adverse Event|0
5894185|NCT01729754|20394805|P3|Part 2|Adverse Event|0
5894186|NCT01729754|20394806|P2|Part 2|Adverse Event|0
5894187|NCT01729754|20394807|P1|Part 2|Adverse Event|2
5894188|NCT01729754|20394798|P10|Part 1|Other Protocol Specified Criteria|4
5894189|NCT01729754|20394799|P9|Part 1|Other Protocol Specified Criteria|0
5894190|NCT01729754|20394800|P8|Part 1|Other Protocol Specified Criteria|0
5894191|NCT01729754|20394801|P7|Part 1|Other Protocol Specified Criteria|1
5894192|NCT01729754|20394802|P6|Part 1|Other Protocol Specified Criteria|0
5894193|NCT01729754|20394803|P5|Part 1|Other Protocol Specified Criteria|0
5894194|NCT01729754|20394804|P4|Part 1|Other Protocol Specified Criteria|0
5894195|NCT01729754|20394805|P3|Part 1|Other Protocol Specified Criteria|0
5894196|NCT01729754|20394806|P2|Part 1|Other Protocol Specified Criteria|0
5894197|NCT01729754|20394807|P1|Part 1|Other Protocol Specified Criteria|2
5894198|NCT01729754|20394798|P10|Part 1|Withdrawal by Subject|6
5894199|NCT01729754|20394799|P9|Part 1|Withdrawal by Subject|0
5894200|NCT01729754|20394800|P8|Part 1|Withdrawal by Subject|0
5894201|NCT01729754|20394801|P7|Part 1|Withdrawal by Subject|5
5894202|NCT01729754|20394802|P6|Part 1|Withdrawal by Subject|0
5894203|NCT01729754|20394803|P5|Part 1|Withdrawal by Subject|0
5894204|NCT01729754|20394804|P4|Part 1|Withdrawal by Subject|7
5894205|NCT01729754|20394805|P3|Part 1|Withdrawal by Subject|0
5894206|NCT01729754|20394806|P2|Part 1|Withdrawal by Subject|0
5894207|NCT01729754|20394807|P1|Part 1|Withdrawal by Subject|5
5894208|NCT01729754|20394798|P10|Part 1|Protocol Violation|0
5894209|NCT01729754|20394799|P9|Part 1|Protocol Violation|0
5894210|NCT01729754|20394800|P8|Part 1|Protocol Violation|0
5894211|NCT01729754|20394801|P7|Part 1|Protocol Violation|1
5894212|NCT01729754|20394802|P6|Part 1|Protocol Violation|0
5894213|NCT01729754|20394803|P5|Part 1|Protocol Violation|0
5894214|NCT01729754|20394804|P4|Part 1|Protocol Violation|1
5894215|NCT01729754|20394805|P3|Part 1|Protocol Violation|0
5894216|NCT01729754|20394806|P2|Part 1|Protocol Violation|0
5894217|NCT01729754|20394807|P1|Part 1|Protocol Violation|2
5894218|NCT01729754|20394798|P10|Part 1|Progressive Disease|1
5894219|NCT01729754|20394799|P9|Part 1|Progressive Disease|0
5894220|NCT01729754|20394800|P8|Part 1|Progressive Disease|0
5894221|NCT01729754|20394801|P7|Part 1|Progressive Disease|0
5894222|NCT01729754|20394802|P6|Part 1|Progressive Disease|0
5894223|NCT01729754|20394803|P5|Part 1|Progressive Disease|0
5894224|NCT01729754|20394804|P4|Part 1|Progressive Disease|0
5894225|NCT01729754|20394805|P3|Part 1|Progressive Disease|0
5894226|NCT01729754|20394806|P2|Part 1|Progressive Disease|0
5894227|NCT01729754|20394807|P1|Part 1|Progressive Disease|0
5894228|NCT01729754|20394798|P10|Part 1|Pregnancy|1
5894229|NCT01729754|20394799|P9|Part 1|Pregnancy|0
5894230|NCT01729754|20394800|P8|Part 1|Pregnancy|0
5894231|NCT01729754|20394801|P7|Part 1|Pregnancy|0
5894232|NCT01729754|20394802|P6|Part 1|Pregnancy|0
5894233|NCT01729754|20394803|P5|Part 1|Pregnancy|0
5894234|NCT01729754|20394804|P4|Part 1|Pregnancy|1
5894235|NCT01729754|20394805|P3|Part 1|Pregnancy|0
5894236|NCT01729754|20394806|P2|Part 1|Pregnancy|0
5894237|NCT01729754|20394807|P1|Part 1|Pregnancy|0
5894238|NCT01729754|20394798|P10|Part 1|Physician Decision|4
5894239|NCT01729754|20394799|P9|Part 1|Physician Decision|0
5894240|NCT01729754|20394800|P8|Part 1|Physician Decision|0
5894241|NCT01729754|20394801|P7|Part 1|Physician Decision|0
5894242|NCT01729754|20394802|P6|Part 1|Physician Decision|0
5894243|NCT01729754|20394803|P5|Part 1|Physician Decision|0
5894244|NCT01729754|20394804|P4|Part 1|Physician Decision|0
5894245|NCT01729754|20394805|P3|Part 1|Physician Decision|0
5894246|NCT01729754|20394806|P2|Part 1|Physician Decision|0
5894247|NCT01729754|20394807|P1|Part 1|Physician Decision|0
5894248|NCT01729754|20394798|P10|Part 1|Non-compliance with Study Drug|0
5894249|NCT01729754|20394799|P9|Part 1|Non-compliance with Study Drug|0
5894250|NCT01729754|20394800|P8|Part 1|Non-compliance with Study Drug|0
5894251|NCT01729754|20394801|P7|Part 1|Non-compliance with Study Drug|0
5894252|NCT01729754|20394802|P6|Part 1|Non-compliance with Study Drug|0
5894253|NCT01729754|20394803|P5|Part 1|Non-compliance with Study Drug|0
5894254|NCT01729754|20394804|P4|Part 1|Non-compliance with Study Drug|0
5894255|NCT01729754|20394805|P3|Part 1|Non-compliance with Study Drug|0
5894256|NCT01729754|20394806|P2|Part 1|Non-compliance with Study Drug|0
5894257|NCT01729754|20394807|P1|Part 1|Non-compliance with Study Drug|1
5894258|NCT01729754|20394798|P10|Part 1|Lost to Follow-up|3
5894259|NCT01729754|20394799|P9|Part 1|Lost to Follow-up|0
5894260|NCT01729754|20394800|P8|Part 1|Lost to Follow-up|0
5894261|NCT01729754|20394801|P7|Part 1|Lost to Follow-up|3
5894262|NCT01729754|20394802|P6|Part 1|Lost to Follow-up|0
5894263|NCT01729754|20394803|P5|Part 1|Lost to Follow-up|0
5894264|NCT01729754|20394804|P4|Part 1|Lost to Follow-up|2
5894265|NCT01729754|20394805|P3|Part 1|Lost to Follow-up|0
5894266|NCT01729754|20394806|P2|Part 1|Lost to Follow-up|0
5894267|NCT01729754|20394807|P1|Part 1|Lost to Follow-up|1
5894268|NCT01729754|20394798|P10|Part 1|Lack of Efficacy|0
5894269|NCT01729754|20394799|P9|Part 1|Lack of Efficacy|0
5894270|NCT01729754|20394800|P8|Part 1|Lack of Efficacy|0
5894271|NCT01729754|20394801|P7|Part 1|Lack of Efficacy|2
5894272|NCT01729754|20394802|P6|Part 1|Lack of Efficacy|0
5894273|NCT01729754|20394803|P5|Part 1|Lack of Efficacy|0
5894274|NCT01729754|20394804|P4|Part 1|Lack of Efficacy|0
5894275|NCT01729754|20394805|P3|Part 1|Lack of Efficacy|0
5894276|NCT01729754|20394806|P2|Part 1|Lack of Efficacy|0
5894277|NCT01729754|20394807|P1|Part 1|Lack of Efficacy|1
5894278|NCT01729754|20394798|P10|Part 1|Adverse Event|5
5894279|NCT01729754|20394799|P9|Part 1|Adverse Event|0
5894280|NCT01729754|20394800|P8|Part 1|Adverse Event|0
5894281|NCT01729754|20394801|P7|Part 1|Adverse Event|2
5894282|NCT01729754|20394802|P6|Part 1|Adverse Event|0
5894283|NCT01729754|20394803|P5|Part 1|Adverse Event|0
5894284|NCT01729754|20394804|P4|Part 1|Adverse Event|1
5894285|NCT01729754|20394805|P3|Part 1|Adverse Event|0
5894286|NCT01729754|20394806|P2|Part 1|Adverse Event|0
5894287|NCT01729754|20394807|P1|Part 1|Adverse Event|2
5894288|NCT01729728|20395014|P3|Overall Study|Protocol Violation|1
5894289|NCT01729728|20395015|P2|Overall Study|Protocol Violation|0
5894290|NCT01729728|20395016|P1|Overall Study|Protocol Violation|1
5894291|NCT01729728|20395014|P3|Overall Study|Adverse Event|0
5894292|NCT01729728|20395015|P2|Overall Study|Adverse Event|6
5894293|NCT01729728|20395016|P1|Overall Study|Adverse Event|0
5894294|NCT01729559|20395166|P2|Overall Study|Protocol Violation|28
5894295|NCT01729559|20395167|P1|Overall Study|Protocol Violation|31
5894296|NCT01729208|20395210|P2|36 Months Follow-up|Withdrawal by Subject|4
5894297|NCT01729208|20395211|P1|36 Months Follow-up|Withdrawal by Subject|2
5894298|NCT01729208|20395210|P2|36 Months Follow-up|Physician Decision|0
5894299|NCT01729208|20395211|P1|36 Months Follow-up|Physician Decision|1
5894300|NCT01729208|20395210|P2|24 Months Follow-up|Lost to Follow-up|0
5894301|NCT01729208|20395211|P1|24 Months Follow-up|Lost to Follow-up|3
5894302|NCT01729208|20395210|P2|12 Months Follow-up|Lost to Follow-up|3
5894303|NCT01729208|20395211|P1|12 Months Follow-up|Lost to Follow-up|3
5894304|NCT01729208|20395210|P2|12 Months Follow-up|Withdrawal by Subject|7
5894305|NCT01729208|20395211|P1|12 Months Follow-up|Withdrawal by Subject|4
5894306|NCT01729208|20395210|P2|Baseline|Physician Decision|4
5894307|NCT01729208|20395211|P1|Baseline|Physician Decision|5
5894308|NCT01729156|20395244|P3|Overall Study|Withdrawal by Subject|0
5894309|NCT01729156|20395245|P2|Overall Study|Withdrawal by Subject|0
5894310|NCT01729156|20395246|P1|Overall Study|Withdrawal by Subject|1
5894311|NCT01729039|20395274|P2|Overall Study|Withdrawal by Subject|7
5894312|NCT01729039|20395275|P1|Overall Study|Withdrawal by Subject|8
5894313|NCT01729039|20395274|P2|Overall Study|disqualified|5
5894314|NCT01729039|20395275|P1|Overall Study|disqualified|2
5894315|NCT01729026|20395291|P2|3-month to 6-month (Final) Follow-up|Lost to Follow-up|2
5894316|NCT01729026|20395292|P1|3-month to 6-month (Final) Follow-up|Lost to Follow-up|1
5894317|NCT01729026|20395291|P2|Randomization to 3-month Follow-up|Lost to Follow-up|2
5894318|NCT01729026|20395292|P1|Randomization to 3-month Follow-up|Lost to Follow-up|2
5894319|NCT01728792|20395395|P5|Overall Study|Lost to Follow-up|0
5894320|NCT01728792|20395396|P4|Overall Study|Lost to Follow-up|2
5894321|NCT01728792|20395397|P3|Overall Study|Lost to Follow-up|4
5894322|NCT01728792|20395398|P2|Overall Study|Lost to Follow-up|1
5894323|NCT01728792|20395399|P1|Overall Study|Lost to Follow-up|2
5894324|NCT01728792|20395395|P5|Overall Study|Withdrawal of Consent|0
5894325|NCT01728792|20395396|P4|Overall Study|Withdrawal of Consent|1
5894326|NCT01728792|20395397|P3|Overall Study|Withdrawal of Consent|0
5894327|NCT01728792|20395398|P2|Overall Study|Withdrawal of Consent|1
5894328|NCT01728792|20395399|P1|Overall Study|Withdrawal of Consent|1
5894329|NCT01728623|20395468|P1|Overall Study|Withdrawal by Subject|1
5894330|NCT01728623|20395468|P1|Overall Study|Adverse Event|1
5894331|NCT01728623|20395468|P1|Overall Study|Disease progression|26
5894332|NCT01728584|20395494|P4|Overall Study|Other reason (not specified)|1
5894333|NCT01728584|20395495|P3|Overall Study|Other reason (not specified)|0
5894334|NCT01728584|20395496|P2|Overall Study|Other reason (not specified)|0
5894335|NCT01728584|20395497|P1|Overall Study|Other reason (not specified)|1
5894336|NCT01728584|20395494|P4|Overall Study|Screen failure|0
5894337|NCT01728584|20395495|P3|Overall Study|Screen failure|0
5894338|NCT01728584|20395496|P2|Overall Study|Screen failure|0
5894339|NCT01728584|20395497|P1|Overall Study|Screen failure|1
5894340|NCT01728584|20395494|P4|Overall Study|Withdrawal by Subject|0
5894341|NCT01728584|20395495|P3|Overall Study|Withdrawal by Subject|0
5894342|NCT01728584|20395496|P2|Overall Study|Withdrawal by Subject|0
5894343|NCT01728584|20395497|P1|Overall Study|Withdrawal by Subject|1
5894344|NCT01728584|20395494|P4|Overall Study|Physician Decision|0
5894345|NCT01728584|20395495|P3|Overall Study|Physician Decision|1
5894346|NCT01728584|20395496|P2|Overall Study|Physician Decision|0
5894347|NCT01728584|20395497|P1|Overall Study|Physician Decision|4
5894348|NCT01728584|20395494|P4|Overall Study|Adverse Event|0
5894349|NCT01728584|20395495|P3|Overall Study|Adverse Event|0
5894350|NCT01728584|20395496|P2|Overall Study|Adverse Event|0
5894351|NCT01728584|20395497|P1|Overall Study|Adverse Event|1
5894352|NCT01728454|20395552|P3|Stage 3|Withdrew due to Adverse Events/Toxicity|0
5894353|NCT01728454|20395553|P2|Stage 3|Withdrew due to Adverse Events/Toxicity|0
5894354|NCT01728454|20395554|P1|Stage 3|Withdrew due to Adverse Events/Toxicity|1
5894355|NCT01728454|20395552|P3|Stage 3|Lost to Follow-up|1
5894356|NCT01728454|20395553|P2|Stage 3|Lost to Follow-up|3
5894357|NCT01728454|20395554|P1|Stage 3|Lost to Follow-up|0
5894358|NCT01728454|20395552|P3|Stage 3|Non-compliance with Protocol|1
5894359|NCT01728454|20395553|P2|Stage 3|Non-compliance with Protocol|0
5894360|NCT01728454|20395554|P1|Stage 3|Non-compliance with Protocol|0
5894361|NCT01728454|20395552|P3|Stage 3|Withdrew Consent|1
5894362|NCT01728454|20395553|P2|Stage 3|Withdrew Consent|0
5894363|NCT01728454|20395554|P1|Stage 3|Withdrew Consent|1
5894364|NCT01728454|20395552|P3|Stage 3|Pregnancy|0
5894365|NCT01728454|20395553|P2|Stage 3|Pregnancy|0
5894366|NCT01728454|20395554|P1|Stage 3|Pregnancy|1
5894367|NCT01728454|20395552|P3|Stage 3|Subject Required Other Treatment|0
5894368|NCT01728454|20395553|P2|Stage 3|Subject Required Other Treatment|1
5894369|NCT01728454|20395554|P1|Stage 3|Subject Required Other Treatment|0
5894370|NCT01728454|20395552|P3|Stage 3|Reason Missing|1
5894371|NCT01728454|20395553|P2|Stage 3|Reason Missing|0
5894372|NCT01728454|20395554|P1|Stage 3|Reason Missing|0
5894373|NCT01728454|20395552|P3|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3
5894374|NCT01728454|20395553|P2|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3
5894375|NCT01728454|20395554|P1|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|2
5894376|NCT01728454|20395552|P3|Stage 1 and 2|Lost to Follow-up|0
5894377|NCT01728454|20395553|P2|Stage 1 and 2|Lost to Follow-up|1
5894378|NCT01728454|20395554|P1|Stage 1 and 2|Lost to Follow-up|1
5894379|NCT01728454|20395552|P3|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0
5894380|NCT01728454|20395553|P2|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0
5894381|NCT01728454|20395554|P1|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|1
5894382|NCT01728454|20395552|P3|Stage 1 and 2|Non-compliance with Protocol|1
5894383|NCT01728454|20395553|P2|Stage 1 and 2|Non-compliance with Protocol|0
5894384|NCT01728454|20395554|P1|Stage 1 and 2|Non-compliance with Protocol|0
5894385|NCT01728454|20395552|P3|Stage 1 and 2|Pregnancy|0
5894386|NCT01728454|20395553|P2|Stage 1 and 2|Pregnancy|0
5894387|NCT01728454|20395554|P1|Stage 1 and 2|Pregnancy|1
5894388|NCT01728376|20395604|P6|Overall Study|Subject/Parent/Legal Guardian Decision|1
5894389|NCT01728376|20395605|P5|Overall Study|Subject/Parent/Legal Guardian Decision|0
5894390|NCT01728376|20395606|P4|Overall Study|Subject/Parent/Legal Guardian Decision|1
5894391|NCT01728376|20395607|P3|Overall Study|Subject/Parent/Legal Guardian Decision|0
5894392|NCT01728376|20395608|P2|Overall Study|Subject/Parent/Legal Guardian Decision|0
5894393|NCT01728376|20395609|P1|Overall Study|Subject/Parent/Legal Guardian Decision|0
5894394|NCT01728376|20395604|P6|Overall Study|Did not receive treatment|0
5894395|NCT01728376|20395605|P5|Overall Study|Did not receive treatment|0
5894396|NCT01728376|20395606|P4|Overall Study|Did not receive treatment|0
5894397|NCT01728376|20395607|P3|Overall Study|Did not receive treatment|0
5894398|NCT01728376|20395608|P2|Overall Study|Did not receive treatment|1
5894399|NCT01728376|20395609|P1|Overall Study|Did not receive treatment|0
5894400|NCT01728376|20395604|P6|Overall Study|No relevant bacteria|1
5894401|NCT01728376|20395605|P5|Overall Study|No relevant bacteria|1
5894402|NCT01728376|20395606|P4|Overall Study|No relevant bacteria|0
5894403|NCT01728376|20395607|P3|Overall Study|No relevant bacteria|0
5894404|NCT01728376|20395608|P2|Overall Study|No relevant bacteria|0
5894405|NCT01728376|20395609|P1|Overall Study|No relevant bacteria|2
5894406|NCT01728376|20395604|P6|Overall Study|Persistent Positive Blood Cultures|0
5894407|NCT01728376|20395605|P5|Overall Study|Persistent Positive Blood Cultures|0
5894408|NCT01728376|20395606|P4|Overall Study|Persistent Positive Blood Cultures|0
5894409|NCT01728376|20395607|P3|Overall Study|Persistent Positive Blood Cultures|1
5894410|NCT01728376|20395608|P2|Overall Study|Persistent Positive Blood Cultures|0
5894411|NCT01728376|20395609|P1|Overall Study|Persistent Positive Blood Cultures|1
5894412|NCT01728376|20395604|P6|Overall Study|Adverse Event|0
5894413|NCT01728376|20395605|P5|Overall Study|Adverse Event|1
5894414|NCT01728376|20395606|P4|Overall Study|Adverse Event|1
5894415|NCT01728376|20395607|P3|Overall Study|Adverse Event|1
5894416|NCT01728376|20395608|P2|Overall Study|Adverse Event|1
5894417|NCT01728376|20395609|P1|Overall Study|Adverse Event|1
5894418|NCT01728324|20395682|P3|Termination of RBV|Protocol Violation (Placebo Period)|0
5894419|NCT01728324|20395683|P2|Termination of RBV|Protocol Violation (Placebo Period)|1
5894420|NCT01728324|20395684|P1|Termination of RBV|Protocol Violation (Placebo Period)|0
5894421|NCT01728324|20395682|P3|Termination of RBV|Adverse Event (Placebo Period)|0
5894422|NCT01728324|20395683|P2|Termination of RBV|Adverse Event (Placebo Period)|1
5894423|NCT01728324|20395684|P1|Termination of RBV|Adverse Event (Placebo Period)|0
5894424|NCT01728324|20395682|P3|Termination of RBV|Other than stated|1
5894425|NCT01728324|20395683|P2|Termination of RBV|Other than stated|3
5894426|NCT01728324|20395684|P1|Termination of RBV|Other than stated|1
5894427|NCT01728324|20395682|P3|Termination of RBV|Withdrawal by Subject|2
5894428|NCT01728324|20395683|P2|Termination of RBV|Withdrawal by Subject|5
5894429|NCT01728324|20395684|P1|Termination of RBV|Withdrawal by Subject|9
5894430|NCT01728324|20395682|P3|Termination of RBV|Lack of Efficacy|7
5894431|NCT01728324|20395683|P2|Termination of RBV|Lack of Efficacy|11
5894432|NCT01728324|20395684|P1|Termination of RBV|Lack of Efficacy|14
5894433|NCT01728324|20395682|P3|Termination of RBV|Adverse Event|5
5894434|NCT01728324|20395683|P2|Termination of RBV|Adverse Event|16
5894435|NCT01728324|20395684|P1|Termination of RBV|Adverse Event|15
5894436|NCT01728324|20395682|P3|Termination of FDV|Protocol Violation (Placebo Period)|0
5894437|NCT01728324|20395683|P2|Termination of FDV|Protocol Violation (Placebo Period)|1
5894438|NCT01728324|20395684|P1|Termination of FDV|Protocol Violation (Placebo Period)|0
5894439|NCT01728324|20395682|P3|Termination of FDV|Adverse Event (Placebo Period)|0
5894440|NCT01728324|20395683|P2|Termination of FDV|Adverse Event (Placebo Period)|1
5894441|NCT01728324|20395684|P1|Termination of FDV|Adverse Event (Placebo Period)|0
5894442|NCT01728324|20395682|P3|Termination of FDV|Other than stated|0
5894443|NCT01728324|20395683|P2|Termination of FDV|Other than stated|3
5894444|NCT01728324|20395684|P1|Termination of FDV|Other than stated|1
5894445|NCT01728324|20395682|P3|Termination of FDV|Withdrawal by Subject|2
5894446|NCT01728324|20395683|P2|Termination of FDV|Withdrawal by Subject|6
5894447|NCT01728324|20395684|P1|Termination of FDV|Withdrawal by Subject|9
5894448|NCT01728324|20395682|P3|Termination of FDV|Lack of Efficacy|8
5894449|NCT01728324|20395683|P2|Termination of FDV|Lack of Efficacy|12
5894450|NCT01728324|20395684|P1|Termination of FDV|Lack of Efficacy|14
5894451|NCT01728324|20395682|P3|Termination of FDV|Adverse Event|4
5894452|NCT01728324|20395683|P2|Termination of FDV|Adverse Event|13
5894453|NCT01728324|20395684|P1|Termination of FDV|Adverse Event|14
5894454|NCT01728324|20395682|P3|Termination of DBV|Protocol Violation (Placebo Period)|0
5894455|NCT01728324|20395683|P2|Termination of DBV|Protocol Violation (Placebo Period)|1
5894456|NCT01728324|20395684|P1|Termination of DBV|Protocol Violation (Placebo Period)|0
5894457|NCT01728324|20395682|P3|Termination of DBV|Adverse Event (Placebo Period)|0
5894458|NCT01728324|20395683|P2|Termination of DBV|Adverse Event (Placebo Period)|1
5894459|NCT01728324|20395684|P1|Termination of DBV|Adverse Event (Placebo Period)|0
5894460|NCT01728324|20395682|P3|Termination of DBV|Other than stated|0
5894461|NCT01728324|20395683|P2|Termination of DBV|Other than stated|3
5894462|NCT01728324|20395684|P1|Termination of DBV|Other than stated|1
5894463|NCT01728324|20395682|P3|Termination of DBV|Withdrawal by Subject|2
5894464|NCT01728324|20395683|P2|Termination of DBV|Withdrawal by Subject|6
5894465|NCT01728324|20395684|P1|Termination of DBV|Withdrawal by Subject|9
5894466|NCT01728324|20395682|P3|Termination of DBV|Lack of Efficacy|8
5894467|NCT01728324|20395683|P2|Termination of DBV|Lack of Efficacy|12
5894468|NCT01728324|20395684|P1|Termination of DBV|Lack of Efficacy|14
5894469|NCT01728324|20395682|P3|Termination of DBV|Adverse Event|4
5894470|NCT01728324|20395683|P2|Termination of DBV|Adverse Event|13
5894471|NCT01728324|20395684|P1|Termination of DBV|Adverse Event|14
5894472|NCT01728246|20395705|P2|Overall Study|Adverse Event|5
5894473|NCT01728246|20395706|P1|Overall Study|Adverse Event|8
5894474|NCT01728246|20395705|P2|Overall Study|Lack of Efficacy|1
5894475|NCT01728246|20395706|P1|Overall Study|Lack of Efficacy|1
5894476|NCT01728246|20395705|P2|Overall Study|Lost to Follow-up|22
5894477|NCT01728246|20395706|P1|Overall Study|Lost to Follow-up|23
5894478|NCT01728246|20395705|P2|Overall Study|Withdrawal by Subject|3
5894479|NCT01728246|20395706|P1|Overall Study|Withdrawal by Subject|2
5894480|NCT01728246|20395705|P2|Overall Study|Protocol Violation|0
5894481|NCT01728246|20395706|P1|Overall Study|Protocol Violation|1
5894482|NCT01728246|20395705|P2|Overall Study|Participant needed rescue medication|5
5894483|NCT01728246|20395706|P1|Overall Study|Participant needed rescue medication|1
5894484|NCT01728194|20395724|P2|Overall Study|Family Member Request|0
5894485|NCT01728194|20395725|P1|Overall Study|Family Member Request|1
5894486|NCT01728194|20395724|P2|Overall Study|Perceived Medication Side Effects|0
5894487|NCT01728194|20395725|P1|Overall Study|Perceived Medication Side Effects|4
5894488|NCT01728194|20395724|P2|Overall Study|Withdrawal by Subject|3
5894489|NCT01728194|20395725|P1|Overall Study|Withdrawal by Subject|7
5894490|NCT01728194|20395724|P2|Overall Study|Physician Decision|0
5894491|NCT01728194|20395725|P1|Overall Study|Physician Decision|4
5894492|NCT01728194|20395724|P2|Overall Study|Lost to Follow-up|3
5894493|NCT01728194|20395725|P1|Overall Study|Lost to Follow-up|4
5894494|NCT01728116|20395735|P2|Overall Study|various not noted previously|0
5894495|NCT01728116|20395736|P1|Overall Study|various not noted previously|5
5894496|NCT01728116|20395735|P2|Overall Study|Incorrectly enrolled in Study|1
5894497|NCT01728116|20395736|P1|Overall Study|Incorrectly enrolled in Study|0
5894498|NCT01728116|20395735|P2|Overall Study|Inter-current finding at procedure|0
5894499|NCT01728116|20395736|P1|Overall Study|Inter-current finding at procedure|1
5894500|NCT01728116|20395735|P2|Overall Study|Subject Non-Compliance|0
5894501|NCT01728116|20395736|P1|Overall Study|Subject Non-Compliance|2
5894502|NCT01728116|20395735|P2|Overall Study|Physician Decision|0
5894503|NCT01728116|20395736|P1|Overall Study|Physician Decision|2
5894504|NCT01728116|20395735|P2|Overall Study|Lost to Follow-up|2
5894505|NCT01728116|20395736|P1|Overall Study|Lost to Follow-up|9
5894506|NCT01728116|20395735|P2|Overall Study|Procedure/device failure|0
5894507|NCT01728116|20395736|P1|Overall Study|Procedure/device failure|7
5894508|NCT01728116|20395735|P2|Overall Study|Adverse Event|0
5894509|NCT01728116|20395736|P1|Overall Study|Adverse Event|13
5894510|NCT01728116|20395735|P2|Overall Study|Withdrawal by Subject|9
5894511|NCT01728116|20395736|P1|Overall Study|Withdrawal by Subject|16
5894512|NCT01728116|20395735|P2|Overall Study|Sponsor Terminated Study|35
5894513|NCT01728116|20395736|P1|Overall Study|Sponsor Terminated Study|106
5894514|NCT01728077|20395761|P2|Overall Study|Non compliance|0
5894515|NCT01728077|20395762|P1|Overall Study|Non compliance|1
5894516|NCT01728077|20395761|P2|Overall Study|Patient moving|0
5894517|NCT01728077|20395762|P1|Overall Study|Patient moving|1
5894518|NCT01728077|20395761|P2|Overall Study|Death|1
5894519|NCT01728077|20395762|P1|Overall Study|Death|0
5894520|NCT01728077|20395761|P2|Overall Study|Subject choice|3
5894521|NCT01728077|20395762|P1|Overall Study|Subject choice|2
5894522|NCT01728077|20395761|P2|Overall Study|Lost to Follow-up|0
5894523|NCT01728077|20395762|P1|Overall Study|Lost to Follow-up|1
5894524|NCT01728077|20395761|P2|Overall Study|Lack of Efficacy|1
5894525|NCT01728077|20395762|P1|Overall Study|Lack of Efficacy|3
5894526|NCT01727713|20395830|P1|Overall Study|Protocol Deviation|2
5894527|NCT01727713|20395830|P1|Overall Study|Withdrawal by Subject|13
5894528|NCT01727713|20395830|P1|Overall Study|Participant Met Withdrawal Criteria|5
5894529|NCT01727713|20395830|P1|Overall Study|Adverse Event|10
5894530|NCT01727713|20395830|P1|Overall Study|Lost to Follow-up|5
5894531|NCT01727700|20395857|P3|Overall Study|Protocol Violation|0
5894532|NCT01727700|20395858|P2|Overall Study|Protocol Violation|0
5894533|NCT01727700|20395859|P1|Overall Study|Protocol Violation|2
5894534|NCT01727700|20395857|P3|Overall Study|Particpant withdrew consent|1
5894535|NCT01727700|20395858|P2|Overall Study|Particpant withdrew consent|3
5894536|NCT01727700|20395859|P1|Overall Study|Particpant withdrew consent|0
5894537|NCT01727700|20395857|P3|Overall Study|Adverse Event|1
5894538|NCT01727700|20395858|P2|Overall Study|Adverse Event|7
5894539|NCT01727700|20395859|P1|Overall Study|Adverse Event|0
5894540|NCT01727505|20395882|P2|Second 24 Hours|Missing data|1
5894541|NCT01727505|20395883|P1|Second 24 Hours|Missing data|0
5894542|NCT01727505|20395882|P2|First 24 Hours|Adverse Event|1
5894543|NCT01727505|20395883|P1|First 24 Hours|Adverse Event|0
5894544|NCT01727297|20395908|P2|Overall Study|Other (e.g. AF detection pre-implant)|8
5894545|NCT01727297|20395909|P1|Overall Study|Other (e.g. AF detection pre-implant)|29
5894546|NCT01727297|20395908|P2|Overall Study|Physician Decision|5
5894547|NCT01727297|20395909|P1|Overall Study|Physician Decision|19
5894548|NCT01727297|20395908|P2|Overall Study|Withdrawal by Subject|27
5894549|NCT01727297|20395909|P1|Overall Study|Withdrawal by Subject|26
5894550|NCT01727297|20395908|P2|Overall Study|Lost to Follow-up|0
5894551|NCT01727297|20395909|P1|Overall Study|Lost to Follow-up|11
5894552|NCT01727297|20395908|P2|Overall Study|Adverse Event|1
5894553|NCT01727297|20395909|P1|Overall Study|Adverse Event|3
5894554|NCT01727297|20395908|P2|Overall Study|Protocol Violation|10
5894555|NCT01727297|20395909|P1|Overall Study|Protocol Violation|1
5894556|NCT01727297|20395908|P2|Overall Study|Death|0
5894557|NCT01727297|20395909|P1|Overall Study|Death|13
5894558|NCT01727258|20395925|P3|Overall Study|Lost to Follow-up|0
5894559|NCT01727258|20395926|P2|Overall Study|Lost to Follow-up|0
5894560|NCT01727258|20395927|P1|Overall Study|Lost to Follow-up|1
5894561|NCT01727258|20395925|P3|Overall Study|Withdrawal by Subject|0
5894562|NCT01727258|20395926|P2|Overall Study|Withdrawal by Subject|1
5894563|NCT01727258|20395927|P1|Overall Study|Withdrawal by Subject|1
5894564|NCT01727258|20395925|P3|Overall Study|Noncompliance with Study Drug|1
5894565|NCT01727258|20395926|P2|Overall Study|Noncompliance with Study Drug|0
5894566|NCT01727258|20395927|P1|Overall Study|Noncompliance with Study Drug|0
5894567|NCT01727258|20395925|P3|Overall Study|Adverse Event|0
5894568|NCT01727258|20395926|P2|Overall Study|Adverse Event|2
5894569|NCT01727258|20395927|P1|Overall Study|Adverse Event|0
5894570|NCT01727154|20395965|P1|Overall Study|No Discontinuation Documentation|4
5894571|NCT01727154|20395965|P1|Overall Study|Study Terminated|6
5894572|NCT01727154|20395965|P1|Overall Study|Subject Withdrew Consent|18
5894573|NCT01727154|20395965|P1|Overall Study|Withdrawal by Subject|14
5894574|NCT01727154|20395965|P1|Overall Study|Death|17
5894575|NCT01727141|20395973|P4|Overall Study|Withdrawal by Subject|11
5894576|NCT01727141|20395974|P3|Overall Study|Withdrawal by Subject|2
5894577|NCT01727141|20395975|P2|Overall Study|Withdrawal by Subject|4
5894578|NCT01727141|20395976|P1|Overall Study|Withdrawal by Subject|4
5894579|NCT01727141|20395973|P4|Overall Study|Protocol deviation|1
5894580|NCT01727141|20395974|P3|Overall Study|Protocol deviation|0
5894581|NCT01727141|20395975|P2|Overall Study|Protocol deviation|1
5894582|NCT01727141|20395976|P1|Overall Study|Protocol deviation|1
5894583|NCT01727141|20395973|P4|Overall Study|Death|1
5894584|NCT01727141|20395974|P3|Overall Study|Death|1
5894585|NCT01727141|20395975|P2|Overall Study|Death|1
5894586|NCT01727141|20395976|P1|Overall Study|Death|0
5894587|NCT01727141|20395973|P4|Overall Study|Lost to Follow-up|0
5894588|NCT01727141|20395974|P3|Overall Study|Lost to Follow-up|0
5894589|NCT01727141|20395975|P2|Overall Study|Lost to Follow-up|2
5894590|NCT01727141|20395976|P1|Overall Study|Lost to Follow-up|0
5894591|NCT01727141|20395973|P4|Overall Study|Physician Decision|2
5894592|NCT01727141|20395974|P3|Overall Study|Physician Decision|0
5894593|NCT01727141|20395975|P2|Overall Study|Physician Decision|1
5894594|NCT01727141|20395976|P1|Overall Study|Physician Decision|0
5894595|NCT01727024|20396041|P2|Period 1|Withdrawal by Subject|3
5894596|NCT01727024|20396042|P1|Period 1|Withdrawal by Subject|2
5894597|NCT01727024|20396041|P2|Period 1|Lost to Follow-up|1
5894598|NCT01727024|20396042|P1|Period 1|Lost to Follow-up|1
5894599|NCT01726803|20396057|P2|Overall Study|Withdrawal by Subject|0
5894600|NCT01726803|20396058|P1|Overall Study|Withdrawal by Subject|1
5894601|NCT01726803|20396057|P2|Overall Study|Lost to Follow-up|1
5894602|NCT01726803|20396058|P1|Overall Study|Lost to Follow-up|6
5894603|NCT01726517|20396110|P5|Overall Study|Withdrawal by Subject|0
5894604|NCT01726517|20396111|P4|Overall Study|Withdrawal by Subject|0
5894605|NCT01726517|20396112|P3|Overall Study|Withdrawal by Subject|1
5894606|NCT01726517|20396113|P2|Overall Study|Withdrawal by Subject|0
5894607|NCT01726517|20396114|P1|Overall Study|Withdrawal by Subject|0
5894608|NCT01726335|20396170|P1|Overall Study|Exacerbation of psychotic symptoms|1
5894609|NCT01726335|20396170|P1|Overall Study|Lost to Follow-up|2
5894610|NCT01726335|20396170|P1|Overall Study|Adverse Event|4
5894611|NCT01726335|20396170|P1|Overall Study|Withdrawal by Subject|15
5894612|NCT01726335|20396170|P1|Overall Study|Lost to Follow-up|2
5894613|NCT01726270|20396186|P1|Part 2, Actual-Use Phase|Other than reason specified above|7
5894614|NCT01726270|20396186|P1|Part 2, Actual-Use Phase|Lost to Follow-up|5
5894615|NCT01726270|20396186|P1|Part 2, Actual-Use Phase|Adverse Event|6
5894616|NCT01726270|20396186|P1|Part 2, Actual-Use Phase|Withdrawal by Subject|21
5894617|NCT01726270|20396186|P1|Eligibility for Part 2|Eligible but did not enter Part 2|20
5894618|NCT01726270|20396186|P1|Part 1, Self-Selection Phase|Withdrawal by Subject|10
5894619|NCT01726049|20396199|P2|Overall Study|refused second HC|2
5894620|NCT01726049|20396200|P1|Overall Study|refused second HC|0
5894621|NCT01726049|20396199|P2|Overall Study|Adverse Event|1
5894622|NCT01726049|20396200|P1|Overall Study|Adverse Event|4
5894623|NCT01726049|20396199|P2|Overall Study|Death|1
5894624|NCT01726049|20396200|P1|Overall Study|Death|1
5894625|NCT01726023|20396225|P2|Overall Study|Withdrawal by Subject|8
5894626|NCT01726023|20396226|P1|Overall Study|Withdrawal by Subject|16
5894627|NCT01726023|20396225|P2|Overall Study|Other Eligibility criteria|7
5894628|NCT01726023|20396226|P1|Overall Study|Other Eligibility criteria|7
5894629|NCT01726023|20396225|P2|Overall Study|Lost to Follow-up|10
5894630|NCT01726023|20396226|P1|Overall Study|Lost to Follow-up|5
5894631|NCT01726023|20396225|P2|Overall Study|Death|1
5894632|NCT01726023|20396226|P1|Overall Study|Death|1
5894633|NCT01725750|20396360|P2|Overall Study|Withdrawal by Subject|9
5894634|NCT01725750|20396361|P1|Overall Study|Withdrawal by Subject|0
5894635|NCT01725750|20396360|P2|Overall Study|Lost to Follow-up|1
5894636|NCT01725750|20396361|P1|Overall Study|Lost to Follow-up|1
5894637|NCT01725750|20396360|P2|Overall Study|Adverse Event|0
5894638|NCT01725750|20396361|P1|Overall Study|Adverse Event|1
5894639|NCT01725529|20396394|P3|Overall Study|Withdrawal by Subject|8
5894640|NCT01725529|20396395|P2|Overall Study|Withdrawal by Subject|14
5894641|NCT01725529|20396396|P1|Overall Study|Withdrawal by Subject|12
5894642|NCT01725529|20396394|P3|Overall Study|Protocol Violation|1
5894643|NCT01725529|20396395|P2|Overall Study|Protocol Violation|1
5894644|NCT01725529|20396396|P1|Overall Study|Protocol Violation|0
5894645|NCT01725529|20396394|P3|Overall Study|Lost to Follow-up|1
5894646|NCT01725529|20396395|P2|Overall Study|Lost to Follow-up|1
5894647|NCT01725529|20396396|P1|Overall Study|Lost to Follow-up|2
5894648|NCT01725529|20396394|P3|Overall Study|Adverse Event|0
5894649|NCT01725529|20396395|P2|Overall Study|Adverse Event|0
5894650|NCT01725529|20396396|P1|Overall Study|Adverse Event|1
5894651|NCT01725451|20396422|P4|Period 4|Adverse Event|0
5894652|NCT01725451|20396423|P3|Period 4|Adverse Event|1
5894653|NCT01725451|20396424|P2|Period 4|Adverse Event|0
5894654|NCT01725451|20396425|P1|Period 4|Adverse Event|0
5894655|NCT01725451|20396422|P4|Washout From Period 3|Adverse Event|0
5894656|NCT01725451|20396423|P3|Washout From Period 3|Adverse Event|0
5894657|NCT01725451|20396424|P2|Washout From Period 3|Adverse Event|1
5894658|NCT01725451|20396425|P1|Washout From Period 3|Adverse Event|0
5894659|NCT01725451|20396422|P4|Washout From Period 3|Protocol Violation|0
5894660|NCT01725451|20396423|P3|Washout From Period 3|Protocol Violation|1
5894661|NCT01725451|20396424|P2|Washout From Period 3|Protocol Violation|0
5894662|NCT01725451|20396425|P1|Washout From Period 3|Protocol Violation|0
5894663|NCT01725451|20396422|P4|Period 1|Withdrawal by Subject|0
5894664|NCT01725451|20396423|P3|Period 1|Withdrawal by Subject|0
5894665|NCT01725451|20396424|P2|Period 1|Withdrawal by Subject|0
5894666|NCT01725451|20396425|P1|Period 1|Withdrawal by Subject|1
5894667|NCT01725386|20396447|P2|Overall Study|Withdrawal by Subject|0
5894668|NCT01725386|20396448|P1|Overall Study|Withdrawal by Subject|10
5894669|NCT01725386|20396447|P2|Overall Study|Lost to Follow-up|6
5894670|NCT01725386|20396448|P1|Overall Study|Lost to Follow-up|81
5894671|NCT01725386|20396447|P2|Overall Study|Death|40
5894672|NCT01725386|20396448|P1|Overall Study|Death|84
5894673|NCT01725308|20396467|P3|Treatment Period II|Miscellaneous|7
5894674|NCT01725308|20396468|P2|Treatment Period II|Miscellaneous|3
5894675|NCT01725308|20396469|P1|Treatment Period II|Miscellaneous|5
5894676|NCT01725308|20396467|P3|Treatment Period II|Protocol Deviations|1
5894677|NCT01725308|20396468|P2|Treatment Period II|Protocol Deviations|0
5894678|NCT01725308|20396469|P1|Treatment Period II|Protocol Deviations|0
5894679|NCT01725308|20396467|P3|Treatment Period II|Lost to Follow-up|3
5894680|NCT01725308|20396468|P2|Treatment Period II|Lost to Follow-up|5
5894681|NCT01725308|20396469|P1|Treatment Period II|Lost to Follow-up|1
5894682|NCT01725308|20396467|P3|Treatment Period II|Withdrawal of Consent|16
5894683|NCT01725308|20396468|P2|Treatment Period II|Withdrawal of Consent|2
5894684|NCT01725308|20396469|P1|Treatment Period II|Withdrawal of Consent|28
5894685|NCT01725308|20396467|P3|Treatment Period II|Changes in the Episodes|5
5894686|NCT01725308|20396468|P2|Treatment Period II|Changes in the Episodes|0
5894687|NCT01725308|20396469|P1|Treatment Period II|Changes in the Episodes|1
5894688|NCT01725308|20396467|P3|Treatment Period II|Worsening of the Target Disease|2
5894689|NCT01725308|20396468|P2|Treatment Period II|Worsening of the Target Disease|4
5894690|NCT01725308|20396469|P1|Treatment Period II|Worsening of the Target Disease|1
5894691|NCT01725308|20396467|P3|Treatment Period II|Insufficient Response|6
5894692|NCT01725308|20396468|P2|Treatment Period II|Insufficient Response|4
5894693|NCT01725308|20396469|P1|Treatment Period II|Insufficient Response|2
5894694|NCT01725308|20396467|P3|Treatment Period II|Adverse Event|20
5894695|NCT01725308|20396468|P2|Treatment Period II|Adverse Event|8
5894696|NCT01725308|20396469|P1|Treatment Period II|Adverse Event|13
5894697|NCT01725308|20396467|P3|Treatment Period II|Did Not Receive Drug|0
5894698|NCT01725308|20396468|P2|Treatment Period II|Did Not Receive Drug|0
5894699|NCT01725308|20396469|P1|Treatment Period II|Did Not Receive Drug|4
5894700|NCT01725308|20396467|P3|Treatment Period II|Did Not Meet Transition Criteria|4
5894701|NCT01725308|20396468|P2|Treatment Period II|Did Not Meet Transition Criteria|3
5894702|NCT01725308|20396469|P1|Treatment Period II|Did Not Meet Transition Criteria|0
5894703|NCT01725308|20396467|P3|Treatment Period I|Miscellaneous|3
5894704|NCT01725308|20396468|P2|Treatment Period I|Miscellaneous|0
5894705|NCT01725308|20396469|P1|Treatment Period I|Miscellaneous|2
5894706|NCT01725308|20396467|P3|Treatment Period I|Protocol Deviations|1
5894707|NCT01725308|20396468|P2|Treatment Period I|Protocol Deviations|1
5894708|NCT01725308|20396469|P1|Treatment Period I|Protocol Deviations|3
5894709|NCT01725308|20396467|P3|Treatment Period I|Lost to Follow-up|2
5894710|NCT01725308|20396468|P2|Treatment Period I|Lost to Follow-up|2
5894711|NCT01725308|20396469|P1|Treatment Period I|Lost to Follow-up|3
5894712|NCT01725308|20396467|P3|Treatment Period I|Withdrawal of Consent|5
5894713|NCT01725308|20396468|P2|Treatment Period I|Withdrawal of Consent|7
5894714|NCT01725308|20396469|P1|Treatment Period I|Withdrawal of Consent|12
5894715|NCT01725308|20396467|P3|Treatment Period I|Changes in the Episodes|2
5894716|NCT01725308|20396468|P2|Treatment Period I|Changes in the Episodes|0
5894717|NCT01725308|20396469|P1|Treatment Period I|Changes in the Episodes|3
5894718|NCT01725308|20396467|P3|Treatment Period I|Worsening of the Target Disease|2
5894719|NCT01725308|20396468|P2|Treatment Period I|Worsening of the Target Disease|0
5894720|NCT01725308|20396469|P1|Treatment Period I|Worsening of the Target Disease|8
5894721|NCT01725308|20396467|P3|Treatment Period I|Insufficient Response|5
5894722|NCT01725308|20396468|P2|Treatment Period I|Insufficient Response|0
5894723|NCT01725308|20396469|P1|Treatment Period I|Insufficient Response|7
5894724|NCT01725308|20396467|P3|Treatment Period I|Adverse Event|21
5894725|NCT01725308|20396468|P2|Treatment Period I|Adverse Event|4
5894726|NCT01725308|20396469|P1|Treatment Period I|Adverse Event|5
5894727|NCT01725308|20396467|P3|Treatment Period I|Did Not Receive Drug|0
5894728|NCT01725308|20396468|P2|Treatment Period I|Did Not Receive Drug|0
5894729|NCT01725308|20396469|P1|Treatment Period I|Did Not Receive Drug|1
5894730|NCT01725282|20396616|P4|Overall Study|Lack of Efficacy|1
5894731|NCT01725282|20396617|P3|Overall Study|Lack of Efficacy|0
5894732|NCT01725282|20396618|P2|Overall Study|Lack of Efficacy|1
5894733|NCT01725282|20396619|P1|Overall Study|Lack of Efficacy|0
5894734|NCT01725282|20396616|P4|Overall Study|Withdrawal by Subject|1
5894735|NCT01725282|20396617|P3|Overall Study|Withdrawal by Subject|1
5894736|NCT01725282|20396618|P2|Overall Study|Withdrawal by Subject|0
5894737|NCT01725282|20396619|P1|Overall Study|Withdrawal by Subject|0
5894738|NCT01725282|20396616|P4|Overall Study|Study Site Withdrawal|0
5894739|NCT01725282|20396617|P3|Overall Study|Study Site Withdrawal|0
5894740|NCT01725282|20396618|P2|Overall Study|Study Site Withdrawal|1
5894741|NCT01725282|20396619|P1|Overall Study|Study Site Withdrawal|0
5894742|NCT01725282|20396616|P4|Overall Study|Met Exclusion Criteria|0
5894743|NCT01725282|20396617|P3|Overall Study|Met Exclusion Criteria|1
5894744|NCT01725282|20396618|P2|Overall Study|Met Exclusion Criteria|0
5894745|NCT01725282|20396619|P1|Overall Study|Met Exclusion Criteria|0
5894746|NCT01725282|20396616|P4|Overall Study|Exacerbation of Target Disease|1
5894747|NCT01725282|20396617|P3|Overall Study|Exacerbation of Target Disease|0
5894748|NCT01725282|20396618|P2|Overall Study|Exacerbation of Target Disease|0
5894749|NCT01725282|20396619|P1|Overall Study|Exacerbation of Target Disease|1
5894750|NCT01725282|20396616|P4|Overall Study|Adverse Event|4
5894751|NCT01725282|20396617|P3|Overall Study|Adverse Event|6
5894752|NCT01725282|20396618|P2|Overall Study|Adverse Event|3
5894753|NCT01725282|20396619|P1|Overall Study|Adverse Event|1
5894754|NCT01725217|20396652|P3|Overall Study|Withdrawal by Subject|0
5894755|NCT01725217|20396653|P2|Overall Study|Withdrawal by Subject|0
5894756|NCT01725217|20396654|P1|Overall Study|Withdrawal by Subject|1
5894757|NCT01725126|20396688|P6|Overall Study|Withdrawal by Subject|0
5894758|NCT01725126|20396689|P5|Overall Study|Withdrawal by Subject|0
5894759|NCT01725126|20396690|P4|Overall Study|Withdrawal by Subject|1
5894760|NCT01725126|20396691|P3|Overall Study|Withdrawal by Subject|0
5894761|NCT01725126|20396692|P2|Overall Study|Withdrawal by Subject|0
5894762|NCT01725126|20396693|P1|Overall Study|Withdrawal by Subject|0
5894763|NCT01725126|20396688|P6|Overall Study|Protocol Violation|0
5894764|NCT01725126|20396689|P5|Overall Study|Protocol Violation|0
5894765|NCT01725126|20396690|P4|Overall Study|Protocol Violation|0
5894766|NCT01725126|20396691|P3|Overall Study|Protocol Violation|0
5894767|NCT01725126|20396692|P2|Overall Study|Protocol Violation|1
5894768|NCT01725126|20396693|P1|Overall Study|Protocol Violation|0
5894769|NCT01724528|20396891|P2|Overall Study|Patient refused to attend last visit|0
5894770|NCT01724528|20396892|P1|Overall Study|Patient refused to attend last visit|1
5894771|NCT01724528|20396891|P2|Overall Study|Protocol Violation|1
5894772|NCT01724528|20396892|P1|Overall Study|Protocol Violation|0
5894773|NCT01724528|20396891|P2|Overall Study|Withdrawal by Subject|2
5894774|NCT01724528|20396892|P1|Overall Study|Withdrawal by Subject|0
5894775|NCT01724528|20396891|P2|Overall Study|Death|0
5894776|NCT01724528|20396892|P1|Overall Study|Death|3
5894777|NCT01724489|20396908|P2|Overall Study|Withdrawal by Subject|6
5894778|NCT01724489|20396909|P1|Overall Study|Withdrawal by Subject|6
5894779|NCT01724489|20396908|P2|Overall Study|Lost to Follow-up|2
5894780|NCT01724489|20396909|P1|Overall Study|Lost to Follow-up|1
5894781|NCT01724489|20396908|P2|Overall Study|Surgery, medication|1
5894782|NCT01724489|20396909|P1|Overall Study|Surgery, medication|1
5894783|NCT01724489|20396908|P2|Overall Study|Adverse Event|3
5894784|NCT01724489|20396909|P1|Overall Study|Adverse Event|8
5894785|NCT01724359|20396915|P1|Overall Study|Other|20
5894786|NCT01724359|20396915|P1|Overall Study|Death|1
5894787|NCT01724359|20396915|P1|Overall Study|Adverse Event|10
5894788|NCT01724216|20396928|P1|Overall Study|Scan was not completed|1
5894789|NCT01724177|20396932|P1|Overall Study|Serious Adverse Event Related|1
5894790|NCT01724177|20396932|P1|Overall Study|Nervous participant|1
5894791|NCT01724177|20396932|P1|Overall Study|Progressive disease or Relapsed Disease|16
5894792|NCT01724177|20396932|P1|Overall Study|Adverse Event|8
5894793|NCT01724021|20396978|P2|Overall Study|Missing|1
5894794|NCT01724021|20396979|P1|Overall Study|Missing|1
5894795|NCT01724021|20396978|P2|Overall Study|Reason Not Specified|39
5894796|NCT01724021|20396979|P1|Overall Study|Reason Not Specified|36
5894797|NCT01724021|20396978|P2|Overall Study|Lost to Follow-up|15
5894798|NCT01724021|20396979|P1|Overall Study|Lost to Follow-up|15
5894799|NCT01724021|20396978|P2|Overall Study|Participant request/ Withdrew consent|14
5894800|NCT01724021|20396979|P1|Overall Study|Participant request/ Withdrew consent|18
5894801|NCT01724021|20396978|P2|Overall Study|Death|58
5894802|NCT01724021|20396979|P1|Overall Study|Death|46
5894803|NCT01724021|20396978|P2|Overall Study|Adverse Event|6
5894804|NCT01724021|20396979|P1|Overall Study|Adverse Event|11
5894805|NCT01723904|20397011|P1|Overall Study|Unable to follow protocol/ judged by inv|3
5894806|NCT01723904|20397011|P1|Overall Study|Adverse Event|5
5894807|NCT01723904|20397011|P1|Overall Study|Noncompliant|3
5894808|NCT01723826|20397025|P4|Overall Study|Withdrawal by Subject|48
5894809|NCT01723826|20397026|P3|Overall Study|Withdrawal by Subject|27
5894810|NCT01723826|20397027|P2|Overall Study|Withdrawal by Subject|17
5894811|NCT01723826|20397028|P1|Overall Study|Withdrawal by Subject|10
5894812|NCT01723826|20397025|P4|Overall Study|Protocol Violation|1
5894813|NCT01723826|20397026|P3|Overall Study|Protocol Violation|3
5894814|NCT01723826|20397027|P2|Overall Study|Protocol Violation|1
5894815|NCT01723826|20397028|P1|Overall Study|Protocol Violation|1
5894816|NCT01723826|20397025|P4|Overall Study|Physician Decision|11
5894817|NCT01723826|20397026|P3|Overall Study|Physician Decision|4
5894818|NCT01723826|20397027|P2|Overall Study|Physician Decision|3
5894819|NCT01723826|20397028|P1|Overall Study|Physician Decision|1
5894820|NCT01723826|20397025|P4|Overall Study|Other Reason|14
5894821|NCT01723826|20397026|P3|Overall Study|Other Reason|12
5894822|NCT01723826|20397027|P2|Overall Study|Other Reason|6
5894823|NCT01723826|20397028|P1|Overall Study|Other Reason|8
5894824|NCT01723826|20397025|P4|Overall Study|Non-compliance With Study Drug|0
5894825|NCT01723826|20397026|P3|Overall Study|Non-compliance With Study Drug|0
5894826|NCT01723826|20397027|P2|Overall Study|Non-compliance With Study Drug|1
5894827|NCT01723826|20397028|P1|Overall Study|Non-compliance With Study Drug|0
5894828|NCT01723826|20397025|P4|Overall Study|Non-compliance|3
5894829|NCT01723826|20397026|P3|Overall Study|Non-compliance|3
5894830|NCT01723826|20397027|P2|Overall Study|Non-compliance|1
5894831|NCT01723826|20397028|P1|Overall Study|Non-compliance|0
5894832|NCT01723826|20397025|P4|Overall Study|Lost to Follow-up|1
5894833|NCT01723826|20397026|P3|Overall Study|Lost to Follow-up|1
5894834|NCT01723826|20397027|P2|Overall Study|Lost to Follow-up|3
5894835|NCT01723826|20397028|P1|Overall Study|Lost to Follow-up|1
5894836|NCT01723826|20397025|P4|Overall Study|Death according to AE eCRF|7
5894837|NCT01723826|20397026|P3|Overall Study|Death according to AE eCRF|3
5894838|NCT01723826|20397027|P2|Overall Study|Death according to AE eCRF|3
5894839|NCT01723826|20397028|P1|Overall Study|Death according to AE eCRF|2
5894840|NCT01723826|20397025|P4|Overall Study|Adverse Event|5
5894841|NCT01723826|20397026|P3|Overall Study|Adverse Event|4
5894842|NCT01723826|20397027|P2|Overall Study|Adverse Event|1
5894843|NCT01723826|20397028|P1|Overall Study|Adverse Event|4
5894844|NCT01723397|20397173|P2|Study Period 2|Protocol Violation|1
5894845|NCT01723397|20397174|P1|Study Period 2|Protocol Violation|0
5894846|NCT01723397|20397173|P2|Study Period 1|Protocol Violation|1
5894847|NCT01723397|20397174|P1|Study Period 1|Protocol Violation|0
5894848|NCT01723254|20397201|P8|Overall Study|Withdrawal by Subject|2
5894849|NCT01723254|20397202|P7|Overall Study|Withdrawal by Subject|1
5894850|NCT01723254|20397203|P6|Overall Study|Withdrawal by Subject|1
5894851|NCT01723254|20397204|P5|Overall Study|Withdrawal by Subject|1
5894852|NCT01723254|20397205|P4|Overall Study|Withdrawal by Subject|0
5894853|NCT01723254|20397206|P3|Overall Study|Withdrawal by Subject|1
5894854|NCT01723254|20397207|P2|Overall Study|Withdrawal by Subject|2
5894855|NCT01723254|20397208|P1|Overall Study|Withdrawal by Subject|1
5894856|NCT01723254|20397201|P8|Overall Study|Protocol Violation|0
5894857|NCT01723254|20397202|P7|Overall Study|Protocol Violation|0
5894858|NCT01723254|20397203|P6|Overall Study|Protocol Violation|0
5894859|NCT01723254|20397204|P5|Overall Study|Protocol Violation|0
5894860|NCT01723254|20397205|P4|Overall Study|Protocol Violation|0
5894861|NCT01723254|20397206|P3|Overall Study|Protocol Violation|0
5894862|NCT01723254|20397207|P2|Overall Study|Protocol Violation|1
5894863|NCT01723254|20397208|P1|Overall Study|Protocol Violation|0
5894864|NCT01723254|20397201|P8|Overall Study|Move/Left to another country/city|0
5894865|NCT01723254|20397202|P7|Overall Study|Move/Left to another country/city|0
5894866|NCT01723254|20397203|P6|Overall Study|Move/Left to another country/city|0
5894867|NCT01723254|20397204|P5|Overall Study|Move/Left to another country/city|1
5894868|NCT01723254|20397205|P4|Overall Study|Move/Left to another country/city|1
5894869|NCT01723254|20397206|P3|Overall Study|Move/Left to another country/city|2
5894870|NCT01723254|20397207|P2|Overall Study|Move/Left to another country/city|0
5894871|NCT01723254|20397208|P1|Overall Study|Move/Left to another country/city|0
5894872|NCT01723254|20397201|P8|Overall Study|No longer have time to participate|0
5894873|NCT01723254|20397202|P7|Overall Study|No longer have time to participate|0
5894874|NCT01723254|20397203|P6|Overall Study|No longer have time to participate|0
5894875|NCT01723254|20397204|P5|Overall Study|No longer have time to participate|0
5894876|NCT01723254|20397205|P4|Overall Study|No longer have time to participate|1
5894877|NCT01723254|20397206|P3|Overall Study|No longer have time to participate|0
5894878|NCT01723254|20397207|P2|Overall Study|No longer have time to participate|0
5894879|NCT01723254|20397208|P1|Overall Study|No longer have time to participate|0
5894880|NCT01723254|20397201|P8|Overall Study|Personal issues|0
5894881|NCT01723254|20397202|P7|Overall Study|Personal issues|0
5894882|NCT01723254|20397203|P6|Overall Study|Personal issues|1
5894883|NCT01723254|20397204|P5|Overall Study|Personal issues|0
5894884|NCT01723254|20397205|P4|Overall Study|Personal issues|0
5894885|NCT01723254|20397206|P3|Overall Study|Personal issues|0
5894886|NCT01723254|20397207|P2|Overall Study|Personal issues|0
5894887|NCT01723254|20397208|P1|Overall Study|Personal issues|0
5894888|NCT01723254|20397201|P8|Overall Study|Conflict with work schedule|1
5894889|NCT01723254|20397202|P7|Overall Study|Conflict with work schedule|0
5894890|NCT01723254|20397203|P6|Overall Study|Conflict with work schedule|0
5894891|NCT01723254|20397204|P5|Overall Study|Conflict with work schedule|0
5894892|NCT01723254|20397205|P4|Overall Study|Conflict with work schedule|0
5894893|NCT01723254|20397206|P3|Overall Study|Conflict with work schedule|0
5894894|NCT01723254|20397207|P2|Overall Study|Conflict with work schedule|0
5894895|NCT01723254|20397208|P1|Overall Study|Conflict with work schedule|0
5894896|NCT01723228|20397260|P2|Overall Study|Other|1
5894897|NCT01723228|20397261|P1|Overall Study|Other|2
5894898|NCT01723228|20397260|P2|Overall Study|Lost to Follow-up|1
5894899|NCT01723228|20397261|P1|Overall Study|Lost to Follow-up|2
5894900|NCT01723228|20397260|P2|Overall Study|Protocol Violation|2
5894901|NCT01723228|20397261|P1|Overall Study|Protocol Violation|0
5894902|NCT01723228|20397260|P2|Overall Study|Withdrawal by Subject|1
5894903|NCT01723228|20397261|P1|Overall Study|Withdrawal by Subject|2
5894904|NCT01723228|20397260|P2|Overall Study|Adverse Event|6
5894905|NCT01723228|20397261|P1|Overall Study|Adverse Event|2
5894906|NCT01723163|20397279|P2|12-Month Follow-up|Unable to Contact|28
5894907|NCT01723163|20397280|P1|12-Month Follow-up|Unable to Contact|23
5894908|NCT01723163|20397279|P2|12-Month Follow-up|Death|0
5894909|NCT01723163|20397280|P1|12-Month Follow-up|Death|1
5894910|NCT01723163|20397279|P2|6-Month Follow-up|Unable to Contact|15
5894911|NCT01723163|20397280|P1|6-Month Follow-up|Unable to Contact|17
5894912|NCT01723163|20397279|P2|6-Month Follow-up|Death|0
5894913|NCT01723163|20397280|P1|6-Month Follow-up|Death|1
5894914|NCT01723163|20397279|P2|3-Month Follow-up|Unable to Contact|19
5894915|NCT01723163|20397280|P1|3-Month Follow-up|Unable to Contact|12
5894916|NCT01723163|20397279|P2|3-Month Follow-up|Withdrawal by Subject|0
5894917|NCT01723163|20397280|P1|3-Month Follow-up|Withdrawal by Subject|1
5894918|NCT01723163|20397279|P2|Treatment Phase|Withdrawal by PI|1
5894919|NCT01723163|20397280|P1|Treatment Phase|Withdrawal by PI|5
5894920|NCT01723163|20397279|P2|Treatment Phase|Withdrawal by Subject|6
5894921|NCT01723163|20397280|P1|Treatment Phase|Withdrawal by Subject|14
5894922|NCT01723072|20397288|P2|Overall Study|Other|3
5894923|NCT01723072|20397289|P1|Overall Study|Other|4
5894924|NCT01723072|20397288|P2|Overall Study|Discon for rescue medication after wk 24|5
5894925|NCT01723072|20397289|P1|Overall Study|Discon for rescue medication after wk 24|0
5894926|NCT01723072|20397288|P2|Overall Study|Withdrawal by Subject|13
5894927|NCT01723072|20397289|P1|Overall Study|Withdrawal by Subject|7
5894928|NCT01722994|20397327|P2|Overall Study|Missing data|17
5894929|NCT01722994|20397328|P1|Overall Study|Missing data|25
5894930|NCT01722877|20397347|P1|Overall Study|Lost to Follow-up|1
5894931|NCT01722877|20397347|P1|Overall Study|Death|1
5894932|NCT01722669|20397373|P6|Overall Study|Withdrawal by Subject|2
5894933|NCT01722669|20397374|P5|Overall Study|Withdrawal by Subject|0
5894934|NCT01722669|20397375|P4|Overall Study|Withdrawal by Subject|0
5894935|NCT01722669|20397376|P3|Overall Study|Withdrawal by Subject|0
5894936|NCT01722669|20397377|P2|Overall Study|Withdrawal by Subject|0
5894937|NCT01722669|20397378|P1|Overall Study|Withdrawal by Subject|0
5894938|NCT01722331|20397449|P7|Part 3|Other Protocol Specified Criteria|0
5894939|NCT01722331|20397450|P6|Part 3|Other Protocol Specified Criteria|0
5894940|NCT01722331|20397451|P5|Part 3|Other Protocol Specified Criteria|0
5894941|NCT01722331|20397452|P4|Part 3|Other Protocol Specified Criteria|0
5894942|NCT01722331|20397453|P3|Part 3|Other Protocol Specified Criteria|0
5894943|NCT01722331|20397454|P2|Part 3|Other Protocol Specified Criteria|1
5894944|NCT01722331|20397455|P1|Part 3|Other Protocol Specified Criteria|1
5894945|NCT01722331|20397449|P7|Part 3|Withdrawal by Subject|1
5894946|NCT01722331|20397450|P6|Part 3|Withdrawal by Subject|2
5894947|NCT01722331|20397451|P5|Part 3|Withdrawal by Subject|0
5894948|NCT01722331|20397452|P4|Part 3|Withdrawal by Subject|0
5894949|NCT01722331|20397453|P3|Part 3|Withdrawal by Subject|0
5894950|NCT01722331|20397454|P2|Part 3|Withdrawal by Subject|7
5894951|NCT01722331|20397455|P1|Part 3|Withdrawal by Subject|4
5894952|NCT01722331|20397449|P7|Part 3|Protocol Violation|0
5894953|NCT01722331|20397450|P6|Part 3|Protocol Violation|0
5894954|NCT01722331|20397451|P5|Part 3|Protocol Violation|0
5894955|NCT01722331|20397452|P4|Part 3|Protocol Violation|0
5894956|NCT01722331|20397453|P3|Part 3|Protocol Violation|0
5894957|NCT01722331|20397454|P2|Part 3|Protocol Violation|1
5894958|NCT01722331|20397455|P1|Part 3|Protocol Violation|2
5894959|NCT01722331|20397449|P7|Part 3|Physician Decision|1
5894960|NCT01722331|20397450|P6|Part 3|Physician Decision|0
5894961|NCT01722331|20397451|P5|Part 3|Physician Decision|0
5894962|NCT01722331|20397452|P4|Part 3|Physician Decision|0
5894963|NCT01722331|20397453|P3|Part 3|Physician Decision|0
5894964|NCT01722331|20397454|P2|Part 3|Physician Decision|1
5894965|NCT01722331|20397455|P1|Part 3|Physician Decision|1
5894966|NCT01722331|20397449|P7|Part 3|Non-Compliance with Study Drug|0
5894967|NCT01722331|20397450|P6|Part 3|Non-Compliance with Study Drug|0
5894968|NCT01722331|20397451|P5|Part 3|Non-Compliance with Study Drug|0
5894969|NCT01722331|20397452|P4|Part 3|Non-Compliance with Study Drug|0
5894970|NCT01722331|20397453|P3|Part 3|Non-Compliance with Study Drug|0
5894971|NCT01722331|20397454|P2|Part 3|Non-Compliance with Study Drug|1
5894972|NCT01722331|20397455|P1|Part 3|Non-Compliance with Study Drug|0
5894973|NCT01722331|20397449|P7|Part 3|Lost to Follow-up|0
5894974|NCT01722331|20397450|P6|Part 3|Lost to Follow-up|1
5894975|NCT01722331|20397451|P5|Part 3|Lost to Follow-up|0
5894976|NCT01722331|20397452|P4|Part 3|Lost to Follow-up|0
5894977|NCT01722331|20397453|P3|Part 3|Lost to Follow-up|0
5894978|NCT01722331|20397454|P2|Part 3|Lost to Follow-up|4
5894979|NCT01722331|20397455|P1|Part 3|Lost to Follow-up|3
5894980|NCT01722331|20397449|P7|Part 3|Lack of Efficacy|0
5894981|NCT01722331|20397450|P6|Part 3|Lack of Efficacy|0
5894982|NCT01722331|20397451|P5|Part 3|Lack of Efficacy|0
5894983|NCT01722331|20397452|P4|Part 3|Lack of Efficacy|0
5894984|NCT01722331|20397453|P3|Part 3|Lack of Efficacy|0
5894985|NCT01722331|20397454|P2|Part 3|Lack of Efficacy|0
5894986|NCT01722331|20397455|P1|Part 3|Lack of Efficacy|1
5894987|NCT01722331|20397449|P7|Part 3|Death|0
5894988|NCT01722331|20397450|P6|Part 3|Death|0
5894989|NCT01722331|20397451|P5|Part 3|Death|0
5894990|NCT01722331|20397452|P4|Part 3|Death|0
5894991|NCT01722331|20397453|P3|Part 3|Death|0
5894992|NCT01722331|20397454|P2|Part 3|Death|0
5894993|NCT01722331|20397455|P1|Part 3|Death|1
5894994|NCT01722331|20397449|P7|Part 3|Adverse Event|0
5894995|NCT01722331|20397450|P6|Part 3|Adverse Event|0
5894996|NCT01722331|20397451|P5|Part 3|Adverse Event|0
5894997|NCT01722331|20397452|P4|Part 3|Adverse Event|1
5894998|NCT01722331|20397453|P3|Part 3|Adverse Event|0
5894999|NCT01722331|20397454|P2|Part 3|Adverse Event|2
5895000|NCT01722331|20397455|P1|Part 3|Adverse Event|2
5895001|NCT01722331|20397449|P7|Part 2|Other Protocol Specified Criteria|1
5895002|NCT01722331|20397450|P6|Part 2|Other Protocol Specified Criteria|2
5895003|NCT01722331|20397451|P5|Part 2|Other Protocol Specified Criteria|0
5895004|NCT01722331|20397452|P4|Part 2|Other Protocol Specified Criteria|0
5895005|NCT01722331|20397453|P3|Part 2|Other Protocol Specified Criteria|10
5895006|NCT01722331|20397454|P2|Part 2|Other Protocol Specified Criteria|0
5895007|NCT01722331|20397455|P1|Part 2|Other Protocol Specified Criteria|6
5895008|NCT01722331|20397449|P7|Part 2|Withdrawal by Subject|2
5895009|NCT01722331|20397450|P6|Part 2|Withdrawal by Subject|2
5895010|NCT01722331|20397451|P5|Part 2|Withdrawal by Subject|0
5895011|NCT01722331|20397452|P4|Part 2|Withdrawal by Subject|0
5895012|NCT01722331|20397453|P3|Part 2|Withdrawal by Subject|3
5895013|NCT01722331|20397454|P2|Part 2|Withdrawal by Subject|0
5895014|NCT01722331|20397455|P1|Part 2|Withdrawal by Subject|5
5895015|NCT01722331|20397449|P7|Part 2|Protocol Violation|0
5895016|NCT01722331|20397450|P6|Part 2|Protocol Violation|0
5895017|NCT01722331|20397451|P5|Part 2|Protocol Violation|0
5895018|NCT01722331|20397452|P4|Part 2|Protocol Violation|0
5895019|NCT01722331|20397453|P3|Part 2|Protocol Violation|0
5895020|NCT01722331|20397454|P2|Part 2|Protocol Violation|0
5895021|NCT01722331|20397455|P1|Part 2|Protocol Violation|1
5895022|NCT01722331|20397449|P7|Part 2|Progressive Disease|0
5895023|NCT01722331|20397450|P6|Part 2|Progressive Disease|0
5895024|NCT01722331|20397451|P5|Part 2|Progressive Disease|0
5895025|NCT01722331|20397452|P4|Part 2|Progressive Disease|0
5895026|NCT01722331|20397453|P3|Part 2|Progressive Disease|1
5895027|NCT01722331|20397454|P2|Part 2|Progressive Disease|0
5895028|NCT01722331|20397455|P1|Part 2|Progressive Disease|0
5895029|NCT01722331|20397449|P7|Part 2|Pregnancy|0
5895030|NCT01722331|20397450|P6|Part 2|Pregnancy|1
5895031|NCT01722331|20397451|P5|Part 2|Pregnancy|0
5895032|NCT01722331|20397452|P4|Part 2|Pregnancy|0
5895033|NCT01722331|20397453|P3|Part 2|Pregnancy|0
5895034|NCT01722331|20397454|P2|Part 2|Pregnancy|0
5895035|NCT01722331|20397455|P1|Part 2|Pregnancy|0
5895036|NCT01722331|20397449|P7|Part 2|Physician Decision|0
5895037|NCT01722331|20397450|P6|Part 2|Physician Decision|0
5895038|NCT01722331|20397451|P5|Part 2|Physician Decision|0
5895039|NCT01722331|20397452|P4|Part 2|Physician Decision|0
5895040|NCT01722331|20397453|P3|Part 2|Physician Decision|2
5895041|NCT01722331|20397454|P2|Part 2|Physician Decision|0
5895042|NCT01722331|20397455|P1|Part 2|Physician Decision|0
5895043|NCT01722331|20397449|P7|Part 2|Non-Compliance with Study Drug|0
5895044|NCT01722331|20397450|P6|Part 2|Non-Compliance with Study Drug|0
5895045|NCT01722331|20397451|P5|Part 2|Non-Compliance with Study Drug|0
5895046|NCT01722331|20397452|P4|Part 2|Non-Compliance with Study Drug|0
5895047|NCT01722331|20397453|P3|Part 2|Non-Compliance with Study Drug|1
5895048|NCT01722331|20397454|P2|Part 2|Non-Compliance with Study Drug|0
5895049|NCT01722331|20397455|P1|Part 2|Non-Compliance with Study Drug|1
5895050|NCT01722331|20397449|P7|Part 2|Lost to Follow-up|1
5895051|NCT01722331|20397450|P6|Part 2|Lost to Follow-up|1
5895052|NCT01722331|20397451|P5|Part 2|Lost to Follow-up|0
5895053|NCT01722331|20397452|P4|Part 2|Lost to Follow-up|0
5895054|NCT01722331|20397453|P3|Part 2|Lost to Follow-up|3
5895055|NCT01722331|20397454|P2|Part 2|Lost to Follow-up|0
5895056|NCT01722331|20397455|P1|Part 2|Lost to Follow-up|0
5895057|NCT01722331|20397449|P7|Part 2|Lack of Efficacy|3
5895058|NCT01722331|20397450|P6|Part 2|Lack of Efficacy|3
5895059|NCT01722331|20397451|P5|Part 2|Lack of Efficacy|0
5895060|NCT01722331|20397452|P4|Part 2|Lack of Efficacy|0
5895061|NCT01722331|20397453|P3|Part 2|Lack of Efficacy|11
5895062|NCT01722331|20397454|P2|Part 2|Lack of Efficacy|0
5895063|NCT01722331|20397455|P1|Part 2|Lack of Efficacy|3
5895064|NCT01722331|20397449|P7|Part 2|Adverse Event|0
5895065|NCT01722331|20397450|P6|Part 2|Adverse Event|1
5895066|NCT01722331|20397451|P5|Part 2|Adverse Event|0
5895067|NCT01722331|20397452|P4|Part 2|Adverse Event|0
5895068|NCT01722331|20397453|P3|Part 2|Adverse Event|0
5895069|NCT01722331|20397454|P2|Part 2|Adverse Event|0
5895070|NCT01722331|20397455|P1|Part 2|Adverse Event|3
5895071|NCT01722331|20397449|P7|Part 1|Withdrawal by Subject|0
5895072|NCT01722331|20397450|P6|Part 1|Withdrawal by Subject|0
5895073|NCT01722331|20397451|P5|Part 1|Withdrawal by Subject|3
5895074|NCT01722331|20397452|P4|Part 1|Withdrawal by Subject|0
5895075|NCT01722331|20397453|P3|Part 1|Withdrawal by Subject|3
5895076|NCT01722331|20397454|P2|Part 1|Withdrawal by Subject|0
5895077|NCT01722331|20397455|P1|Part 1|Withdrawal by Subject|2
5895078|NCT01722331|20397449|P7|Part 1|Protocol Violation|0
5895079|NCT01722331|20397450|P6|Part 1|Protocol Violation|0
5895080|NCT01722331|20397451|P5|Part 1|Protocol Violation|1
5895081|NCT01722331|20397452|P4|Part 1|Protocol Violation|0
5895082|NCT01722331|20397453|P3|Part 1|Protocol Violation|0
5895083|NCT01722331|20397454|P2|Part 1|Protocol Violation|0
5895084|NCT01722331|20397455|P1|Part 1|Protocol Violation|1
5895085|NCT01722331|20397449|P7|Part 1|Progressive Disease|0
5895086|NCT01722331|20397450|P6|Part 1|Progressive Disease|0
5895087|NCT01722331|20397451|P5|Part 1|Progressive Disease|1
5895088|NCT01722331|20397452|P4|Part 1|Progressive Disease|0
5895089|NCT01722331|20397453|P3|Part 1|Progressive Disease|0
5895090|NCT01722331|20397454|P2|Part 1|Progressive Disease|0
5895091|NCT01722331|20397455|P1|Part 1|Progressive Disease|0
5895092|NCT01722331|20397449|P7|Part 1|Pregnancy|0
5895093|NCT01722331|20397450|P6|Part 1|Pregnancy|0
5895094|NCT01722331|20397451|P5|Part 1|Pregnancy|0
5895095|NCT01722331|20397452|P4|Part 1|Pregnancy|0
5895096|NCT01722331|20397453|P3|Part 1|Pregnancy|0
5895097|NCT01722331|20397454|P2|Part 1|Pregnancy|0
5895098|NCT01722331|20397455|P1|Part 1|Pregnancy|1
5895099|NCT01722331|20397449|P7|Part 1|Physician Decision|0
5895100|NCT01722331|20397450|P6|Part 1|Physician Decision|0
5895101|NCT01722331|20397451|P5|Part 1|Physician Decision|1
5895102|NCT01722331|20397452|P4|Part 1|Physician Decision|0
5895103|NCT01722331|20397453|P3|Part 1|Physician Decision|3
5895104|NCT01722331|20397454|P2|Part 1|Physician Decision|0
5895105|NCT01722331|20397455|P1|Part 1|Physician Decision|0
5895106|NCT01722331|20397449|P7|Part 1|Lost to Follow-up|0
5895107|NCT01722331|20397450|P6|Part 1|Lost to Follow-up|0
5895108|NCT01722331|20397451|P5|Part 1|Lost to Follow-up|1
5895109|NCT01722331|20397452|P4|Part 1|Lost to Follow-up|0
5895110|NCT01722331|20397453|P3|Part 1|Lost to Follow-up|2
5895111|NCT01722331|20397454|P2|Part 1|Lost to Follow-up|0
5895112|NCT01722331|20397455|P1|Part 1|Lost to Follow-up|1
5895113|NCT01722331|20397449|P7|Part 1|Lack of Efficacy|0
5895114|NCT01722331|20397450|P6|Part 1|Lack of Efficacy|0
5895115|NCT01722331|20397451|P5|Part 1|Lack of Efficacy|2
5895116|NCT01722331|20397452|P4|Part 1|Lack of Efficacy|0
5895117|NCT01722331|20397453|P3|Part 1|Lack of Efficacy|1
5895118|NCT01722331|20397454|P2|Part 1|Lack of Efficacy|0
5895119|NCT01722331|20397455|P1|Part 1|Lack of Efficacy|0
5895120|NCT01722331|20397449|P7|Part 1|Adverse Event|0
5895121|NCT01722331|20397450|P6|Part 1|Adverse Event|0
5895122|NCT01722331|20397451|P5|Part 1|Adverse Event|0
5895123|NCT01722331|20397452|P4|Part 1|Adverse Event|0
5895124|NCT01722331|20397453|P3|Part 1|Adverse Event|0
5895125|NCT01722331|20397454|P2|Part 1|Adverse Event|0
5895126|NCT01722331|20397455|P1|Part 1|Adverse Event|5
5895127|NCT01722266|20397571|P4|Overall Study|Dropped out due to Nausea|0
5895128|NCT01722266|20397572|P3|Overall Study|Dropped out due to Nausea|2
5895129|NCT01722266|20397573|P2|Overall Study|Dropped out due to Nausea|0
5895130|NCT01722266|20397574|P1|Overall Study|Dropped out due to Nausea|0
5895131|NCT01722266|20397571|P4|Overall Study|Tolerated only 0.6 mg liraglutide|0
5895132|NCT01722266|20397572|P3|Overall Study|Tolerated only 0.6 mg liraglutide|3
5895133|NCT01722266|20397573|P2|Overall Study|Tolerated only 0.6 mg liraglutide|1
5895134|NCT01722266|20397574|P1|Overall Study|Tolerated only 0.6 mg liraglutide|0
5895135|NCT01722266|20397571|P4|Overall Study|Withdrawal by Subject|0
5895136|NCT01722266|20397572|P3|Overall Study|Withdrawal by Subject|0
5895137|NCT01722266|20397573|P2|Overall Study|Withdrawal by Subject|2
5895138|NCT01722266|20397574|P1|Overall Study|Withdrawal by Subject|1
5895139|NCT01722162|20397602|P2|Overall Study|Noncompliance|1
5895140|NCT01722162|20397603|P1|Overall Study|Noncompliance|0
5895141|NCT01722162|20397602|P2|Overall Study|Insurance denial post enrollment|1
5895142|NCT01722162|20397603|P1|Overall Study|Insurance denial post enrollment|0
5895143|NCT01722162|20397602|P2|Overall Study|Adverse Event|1
5895144|NCT01722162|20397603|P1|Overall Study|Adverse Event|1
5895145|NCT01722162|20397602|P2|Overall Study|Unrelated to study adverse event|2
5895146|NCT01722162|20397603|P1|Overall Study|Unrelated to study adverse event|2
5895147|NCT01722162|20397602|P2|Overall Study|Found ineligible|0
5895148|NCT01722162|20397603|P1|Overall Study|Found ineligible|1
5895149|NCT01722162|20397602|P2|Overall Study|Withdrawal by Subject|1
5895150|NCT01722162|20397603|P1|Overall Study|Withdrawal by Subject|1
5895151|NCT01722097|20397613|P2|Overall Study|Patient sheets not returned|5
5895152|NCT01722097|20397614|P1|Overall Study|Patient sheets not returned|6
5895153|NCT01722071|20397622|P2|Overall Study|Protocol Violation|0
5895154|NCT01722071|20397623|P1|Overall Study|Protocol Violation|1
5895155|NCT01722045|20397629|P1|Overall Study|Relocation (did not wish to transfer)|1
5895156|NCT01722045|20397629|P1|Overall Study|Physician Decision|3
5895157|NCT01722045|20397629|P1|Overall Study|Protocol Deviation|1
5895158|NCT01722045|20397629|P1|Overall Study|Lost to Follow-up|4
5895159|NCT01722045|20397629|P1|Overall Study|Withdrawal by Subject|8
5895160|NCT01722045|20397629|P1|Overall Study|Death|3
5895161|NCT01722045|20397629|P1|Overall Study|Adverse Event|8
5895162|NCT01721954|20397650|P2|Overall Study|Lost to Follow-up|1
5895163|NCT01721954|20397651|P1|Overall Study|Lost to Follow-up|2
5895164|NCT01721954|20397650|P2|Overall Study|Adverse Event|0
5895165|NCT01721954|20397651|P1|Overall Study|Adverse Event|2
5895166|NCT01721954|20397650|P2|Overall Study|Withdrawal by Subject|4
5895167|NCT01721954|20397651|P1|Overall Study|Withdrawal by Subject|8
5895168|NCT01721954|20397650|P2|Overall Study|Death|64
5895169|NCT01721954|20397651|P1|Overall Study|Death|58
5895170|NCT01721772|20397665|P2|Overall Study|Other|1
5895171|NCT01721772|20397666|P1|Overall Study|Other|0
5895172|NCT01721772|20397665|P2|Overall Study|Maximum clinical benefit|1
5895173|NCT01721772|20397666|P1|Overall Study|Maximum clinical benefit|1
5895174|NCT01721772|20397665|P2|Overall Study|Withdrawal by Subject|5
5895175|NCT01721772|20397666|P1|Overall Study|Withdrawal by Subject|7
5895176|NCT01721772|20397665|P2|Overall Study|Unrelated adverse event|3
5895177|NCT01721772|20397666|P1|Overall Study|Unrelated adverse event|2
5895178|NCT01721772|20397665|P2|Overall Study|Study drug toxicity|7
5895179|NCT01721772|20397666|P1|Overall Study|Study drug toxicity|5
5895180|NCT01721772|20397665|P2|Overall Study|Disease progression|175
5895181|NCT01721772|20397666|P1|Overall Study|Disease progression|96
5895182|NCT01721759|20397686|P1|Overall Study|Withdrawal by Subject|1
5895183|NCT01721759|20397686|P1|Overall Study|Adverse event unrelated to study drug|9
5895184|NCT01721759|20397686|P1|Overall Study|Study drug toxicity|14
5895185|NCT01721759|20397686|P1|Overall Study|Disease progression|78
5895186|NCT01721746|20397694|P3|Treatment Period|Other|1
5895187|NCT01721746|20397695|P2|Treatment Period|Other|1
5895188|NCT01721746|20397696|P1|Treatment Period|Other|2
5895189|NCT01721746|20397694|P3|Treatment Period|Subject No Longer Met Study Criteria|0
5895190|NCT01721746|20397695|P2|Treatment Period|Subject No Longer Met Study Criteria|0
5895191|NCT01721746|20397696|P1|Treatment Period|Subject No Longer Met Study Criteria|4
5895192|NCT01721746|20397694|P3|Treatment Period|Poor/Non-compliance|0
5895193|NCT01721746|20397695|P2|Treatment Period|Poor/Non-compliance|0
5895194|NCT01721746|20397696|P1|Treatment Period|Poor/Non-compliance|1
5895195|NCT01721746|20397694|P3|Treatment Period|Maximum Clinical Benefit|3
5895196|NCT01721746|20397695|P2|Treatment Period|Maximum Clinical Benefit|0
5895197|NCT01721746|20397696|P1|Treatment Period|Maximum Clinical Benefit|1
5895198|NCT01721746|20397694|P3|Treatment Period|Subject Withdrew Consent|2
5895199|NCT01721746|20397695|P2|Treatment Period|Subject Withdrew Consent|0
5895200|NCT01721746|20397696|P1|Treatment Period|Subject Withdrew Consent|3
5895201|NCT01721746|20397694|P3|Treatment Period|Subject Request to Discontinue Treatment|6
5895202|NCT01721746|20397695|P2|Treatment Period|Subject Request to Discontinue Treatment|1
5895203|NCT01721746|20397696|P1|Treatment Period|Subject Request to Discontinue Treatment|19
5895204|NCT01721746|20397694|P3|Treatment Period|Adverse Event Unrelated to Study Drug|2
5895205|NCT01721746|20397695|P2|Treatment Period|Adverse Event Unrelated to Study Drug|1
5895206|NCT01721746|20397696|P1|Treatment Period|Adverse Event Unrelated to Study Drug|6
5895207|NCT01721746|20397694|P3|Treatment Period|Study Drug Toxicity|9
5895208|NCT01721746|20397695|P2|Treatment Period|Study Drug Toxicity|2
5895209|NCT01721746|20397696|P1|Treatment Period|Study Drug Toxicity|15
5895210|NCT01721746|20397694|P3|Treatment Period|Disease Progression|34
5895211|NCT01721746|20397695|P2|Treatment Period|Disease Progression|40
5895212|NCT01721746|20397696|P1|Treatment Period|Disease Progression|182
5895213|NCT01721486|20397736|P2|Overall Study|Physician Decision|1
5895214|NCT01721486|20397737|P1|Overall Study|Physician Decision|0
5895215|NCT01721486|20397736|P2|Overall Study|Protocol Violation|0
5895216|NCT01721486|20397737|P1|Overall Study|Protocol Violation|1
5895217|NCT01721408|20397785|P2|Overall Study|Does not meet entrance criteria|0
5895218|NCT01721408|20397786|P1|Overall Study|Does not meet entrance criteria|1
5895219|NCT01721408|20397785|P2|Overall Study|Lost to Follow-up|2
5895220|NCT01721408|20397786|P1|Overall Study|Lost to Follow-up|1
5895221|NCT01721408|20397785|P2|Overall Study|Other|3
5895222|NCT01721408|20397786|P1|Overall Study|Other|3
5895223|NCT01721408|20397785|P2|Overall Study|Protocol Violation|2
5895224|NCT01721408|20397786|P1|Overall Study|Protocol Violation|0
5895225|NCT01721408|20397785|P2|Overall Study|No longer willing to participate study|10
5895226|NCT01721408|20397786|P1|Overall Study|No longer willing to participate study|9
5895227|NCT01721408|20397785|P2|Overall Study|Insufficient clinical response|6
5895228|NCT01721408|20397786|P1|Overall Study|Insufficient clinical response|15
5895229|NCT01721408|20397785|P2|Overall Study|Death|0
5895230|NCT01721408|20397786|P1|Overall Study|Death|1
5895231|NCT01721408|20397785|P2|Overall Study|Adverse Event|1
5895232|NCT01721408|20397786|P1|Overall Study|Adverse Event|6
5895233|NCT01721369|20397800|P1|Overall Study|Not initial etiological diagnosis|12
5895234|NCT01721330|20397806|P2|Overall Study|Withdrawal by Subject|1
5895235|NCT01721330|20397807|P1|Overall Study|Withdrawal by Subject|0
5895236|NCT01721317|20397815|P2|Overall Study|Withdrawal by Subject|1
5895237|NCT01721317|20397816|P1|Overall Study|Withdrawal by Subject|0
5895238|NCT01721317|20397815|P2|Overall Study|Physician Decision|1
5895239|NCT01721317|20397816|P1|Overall Study|Physician Decision|0
5895240|NCT01721317|20397815|P2|Overall Study|Study Closed / Terminated|2
5895241|NCT01721317|20397816|P1|Overall Study|Study Closed / Terminated|2
5895242|NCT01721200|20397895|P2|Overall Study|Lost to Follow-up|5
5895243|NCT01721200|20397896|P1|Overall Study|Lost to Follow-up|3
5895244|NCT01721161|20397921|P2|Overall Study|Other|1
5895245|NCT01721161|20397922|P1|Overall Study|Other|0
5895246|NCT01721161|20397921|P2|Overall Study|Withdrawal by Subject|1
5895247|NCT01721161|20397922|P1|Overall Study|Withdrawal by Subject|1
5895248|NCT01721161|20397921|P2|Overall Study|Lost to Follow-up|2
5895249|NCT01721161|20397922|P1|Overall Study|Lost to Follow-up|1
5895250|NCT01721161|20397921|P2|Overall Study|Adverse Event|3
5895251|NCT01721161|20397922|P1|Overall Study|Adverse Event|2
5895252|NCT01721109|20397945|P1|Overall Study|Lost to Follow-up|2
5895253|NCT01721109|20397945|P1|Overall Study|Withdrew Consent|1
5895254|NCT01721109|20397945|P1|Overall Study|Non- Compliance with Study Drug|3
5895255|NCT01721109|20397945|P1|Overall Study|Lack of Efficacy|1
5895256|NCT01721070|20398140|P1|Ketoconazole 400 mg and SUF NT 15 mcg|Withdrawal by Subject|1
5895257|NCT01721057|20398151|P7|Rescue Period|Lack of Efficacy|0
5895258|NCT01721057|20398152|P6|Rescue Period|Lack of Efficacy|0
5895259|NCT01721057|20398153|P5|Rescue Period|Lack of Efficacy|0
5895260|NCT01721057|20398154|P4|Rescue Period|Lack of Efficacy|2
5895261|NCT01721057|20398155|P3|Rescue Period|Lack of Efficacy|0
5895262|NCT01721057|20398156|P2|Rescue Period|Lack of Efficacy|0
5895263|NCT01721057|20398157|P1|Rescue Period|Lack of Efficacy|0
5895264|NCT01721057|20398151|P7|Rescue Period|Adverse Event|0
5895265|NCT01721057|20398152|P6|Rescue Period|Adverse Event|0
5895266|NCT01721057|20398153|P5|Rescue Period|Adverse Event|0
5895267|NCT01721057|20398154|P4|Rescue Period|Adverse Event|1
5895268|NCT01721057|20398155|P3|Rescue Period|Adverse Event|0
5895269|NCT01721057|20398156|P2|Rescue Period|Adverse Event|0
5895270|NCT01721057|20398157|P1|Rescue Period|Adverse Event|0
5895271|NCT01721057|20398151|P7|Treatment Period|Death|0
5895272|NCT01721057|20398152|P6|Treatment Period|Death|0
5895273|NCT01721057|20398153|P5|Treatment Period|Death|0
5895274|NCT01721057|20398154|P4|Treatment Period|Death|0
5895275|NCT01721057|20398155|P3|Treatment Period|Death|0
5895276|NCT01721057|20398156|P2|Treatment Period|Death|0
5895277|NCT01721057|20398157|P1|Treatment Period|Death|2
5895278|NCT01721057|20398151|P7|Treatment Period|Physician Decision|0
5895279|NCT01721057|20398152|P6|Treatment Period|Physician Decision|0
5895280|NCT01721057|20398153|P5|Treatment Period|Physician Decision|0
5895281|NCT01721057|20398154|P4|Treatment Period|Physician Decision|0
5895282|NCT01721057|20398155|P3|Treatment Period|Physician Decision|3
5895283|NCT01721057|20398156|P2|Treatment Period|Physician Decision|1
5895284|NCT01721057|20398157|P1|Treatment Period|Physician Decision|0
5895285|NCT01721057|20398151|P7|Treatment Period|Lost to Follow-up|0
5895286|NCT01721057|20398152|P6|Treatment Period|Lost to Follow-up|0
5895287|NCT01721057|20398153|P5|Treatment Period|Lost to Follow-up|0
5895288|NCT01721057|20398154|P4|Treatment Period|Lost to Follow-up|0
5895289|NCT01721057|20398155|P3|Treatment Period|Lost to Follow-up|0
5895290|NCT01721057|20398156|P2|Treatment Period|Lost to Follow-up|0
5895291|NCT01721057|20398157|P1|Treatment Period|Lost to Follow-up|1
5895292|NCT01721057|20398151|P7|Treatment Period|Lack of Efficacy|0
5895293|NCT01721057|20398152|P6|Treatment Period|Lack of Efficacy|0
5895294|NCT01721057|20398153|P5|Treatment Period|Lack of Efficacy|0
5895295|NCT01721057|20398154|P4|Treatment Period|Lack of Efficacy|0
5895296|NCT01721057|20398155|P3|Treatment Period|Lack of Efficacy|0
5895297|NCT01721057|20398156|P2|Treatment Period|Lack of Efficacy|3
5895298|NCT01721057|20398157|P1|Treatment Period|Lack of Efficacy|7
5895299|NCT01721057|20398151|P7|Treatment Period|Adverse Event|0
5895300|NCT01721057|20398152|P6|Treatment Period|Adverse Event|0
5895301|NCT01721057|20398153|P5|Treatment Period|Adverse Event|0
5895302|NCT01721057|20398154|P4|Treatment Period|Adverse Event|0
5895303|NCT01721057|20398155|P3|Treatment Period|Adverse Event|12
5895304|NCT01721057|20398156|P2|Treatment Period|Adverse Event|10
5895305|NCT01721057|20398157|P1|Treatment Period|Adverse Event|7
5895306|NCT01721057|20398151|P7|Treatment Period|Withdrawal by Subject|0
5895307|NCT01721057|20398152|P6|Treatment Period|Withdrawal by Subject|0
5895308|NCT01721057|20398153|P5|Treatment Period|Withdrawal by Subject|0
5895309|NCT01721057|20398154|P4|Treatment Period|Withdrawal by Subject|0
5895310|NCT01721057|20398155|P3|Treatment Period|Withdrawal by Subject|8
5895311|NCT01721057|20398156|P2|Treatment Period|Withdrawal by Subject|5
5895312|NCT01721057|20398157|P1|Treatment Period|Withdrawal by Subject|11
5895313|NCT01721044|20398230|P3|Treatment Period|Withdrawal by Subject|1
5895314|NCT01721044|20398231|P2|Treatment Period|Withdrawal by Subject|6
5895315|NCT01721044|20398232|P1|Treatment Period|Withdrawal by Subject|7
5895316|NCT01721044|20398230|P3|Treatment Period|Protocol Violation|0
5895317|NCT01721044|20398231|P2|Treatment Period|Protocol Violation|0
5895318|NCT01721044|20398232|P1|Treatment Period|Protocol Violation|1
5895319|NCT01721044|20398230|P3|Treatment Period|Physician Decision|2
5895320|NCT01721044|20398231|P2|Treatment Period|Physician Decision|0
5895321|NCT01721044|20398232|P1|Treatment Period|Physician Decision|1
5895322|NCT01721044|20398230|P3|Treatment Period|Lost to Follow-up|1
5895323|NCT01721044|20398231|P2|Treatment Period|Lost to Follow-up|0
5895324|NCT01721044|20398232|P1|Treatment Period|Lost to Follow-up|0
5895325|NCT01721044|20398230|P3|Treatment Period|Lack of Efficacy|4
5895326|NCT01721044|20398231|P2|Treatment Period|Lack of Efficacy|4
5895327|NCT01721044|20398232|P1|Treatment Period|Lack of Efficacy|16
5895328|NCT01721044|20398230|P3|Treatment Period|Death|1
5895329|NCT01721044|20398231|P2|Treatment Period|Death|0
5895330|NCT01721044|20398232|P1|Treatment Period|Death|0
5895331|NCT01721044|20398230|P3|Treatment Period|Adverse Event|10
5895332|NCT01721044|20398231|P2|Treatment Period|Adverse Event|7
5895333|NCT01721044|20398232|P1|Treatment Period|Adverse Event|7
5895334|NCT01720797|20398305|P2|Overall Study|Withdrawal by Subject|0
5895335|NCT01720797|20398306|P1|Overall Study|Withdrawal by Subject|3
5895336|NCT01720667|20398314|P2|Overall Study|Withdrawal by Subject|0
5895337|NCT01720667|20398315|P1|Overall Study|Withdrawal by Subject|3
5895338|NCT01720667|20398314|P2|Overall Study|Adverse Event|1
5895339|NCT01720667|20398315|P1|Overall Study|Adverse Event|1
5895340|NCT01720602|20398329|P1|Overall Study|Progressive disease on therapy|2
5895341|NCT01720602|20398329|P1|Overall Study|Adverse Event|3
5895342|NCT01720524|20398339|P2|Part B|Death|2
5895343|NCT01720524|20398340|P1|Part B|Death|0
5895344|NCT01720524|20398339|P2|Part B|Lost to Follow-up|3
5895345|NCT01720524|20398340|P1|Part B|Lost to Follow-up|1
5895346|NCT01720524|20398339|P2|Part B|Other|0
5895347|NCT01720524|20398340|P1|Part B|Other|2
5895348|NCT01720524|20398339|P2|Part B|Withdrawal by Subject|4
5895349|NCT01720524|20398340|P1|Part B|Withdrawal by Subject|1
5895350|NCT01720524|20398339|P2|Part B|Ongoing|5
5895351|NCT01720524|20398340|P1|Part B|Ongoing|3
5895352|NCT01720524|20398339|P2|Part A|Lost to Follow-up|1
5895353|NCT01720524|20398340|P1|Part A|Lost to Follow-up|0
5895354|NCT01720524|20398339|P2|Part A|Other|1
5895355|NCT01720524|20398340|P1|Part A|Other|0
5895356|NCT01720524|20398339|P2|Part A|Withdrawal by Subject|1
5895357|NCT01720524|20398340|P1|Part A|Withdrawal by Subject|0
5895358|NCT01720524|20398339|P2|Part A|Missed 28 day follow-up visit|1
5895359|NCT01720524|20398340|P1|Part A|Missed 28 day follow-up visit|1
5895360|NCT01720524|20398339|P2|Part A|Lost to Follow-up|1
5895361|NCT01720524|20398340|P1|Part A|Lost to Follow-up|0
5895362|NCT01720524|20398339|P2|Part A|Death|1
5895363|NCT01720524|20398340|P1|Part A|Death|2
5895364|NCT01720524|20398339|P2|Part A|Adverse Event|2
5895365|NCT01720524|20398340|P1|Part A|Adverse Event|2
5895366|NCT01720524|20398339|P2|Part A|Insufficient Clinical Response|4
5895367|NCT01720524|20398340|P1|Part A|Insufficient Clinical Response|2
5895368|NCT01720446|20398373|P4|Overall Study|Withdrawal by Subject|4
5895369|NCT01720446|20398374|P3|Overall Study|Withdrawal by Subject|4
5895370|NCT01720446|20398375|P2|Overall Study|Withdrawal by Subject|5
5895371|NCT01720446|20398376|P1|Overall Study|Withdrawal by Subject|2
5895372|NCT01720446|20398373|P4|Overall Study|Lost to Follow-up|16
5895373|NCT01720446|20398374|P3|Overall Study|Lost to Follow-up|16
5895374|NCT01720446|20398375|P2|Overall Study|Lost to Follow-up|6
5895375|NCT01720446|20398376|P1|Overall Study|Lost to Follow-up|12
5895376|NCT01720264|20398497|P1|Post-transplant (Day 16) to 1 Year|Disease Progression|4
5895377|NCT01720264|20398497|P1|Post-transplant (Day 16) to 1 Year|Death|8
5895378|NCT01720264|20398497|P1|Transplant With Sitagliptin for 15 Days|Adverse Event|1
5895379|NCT01720225|20398519|P2|Overall Study|Did not complete 2 cycles of therapy|0
5895380|NCT01720225|20398520|P1|Overall Study|Did not complete 2 cycles of therapy|3
5895381|NCT01720225|20398519|P2|Overall Study|Withdrawal by Subject|1
5895382|NCT01720225|20398520|P1|Overall Study|Withdrawal by Subject|0
5895383|NCT01720069|20398539|P3|Overall Study|Lost to Follow-up|1
5895384|NCT01720069|20398540|P2|Overall Study|Lost to Follow-up|0
5895385|NCT01720069|20398541|P1|Overall Study|Lost to Follow-up|0
5895386|NCT01720069|20398539|P3|Overall Study|Non-compliance on using e-diary|1
5895387|NCT01720069|20398540|P2|Overall Study|Non-compliance on using e-diary|0
5895388|NCT01720069|20398541|P1|Overall Study|Non-compliance on using e-diary|0
5895389|NCT01720069|20398539|P3|Overall Study|OCS bursts occured, discontinued in line|0
5895390|NCT01720069|20398540|P2|Overall Study|OCS bursts occured, discontinued in line|0
5895391|NCT01720069|20398541|P1|Overall Study|OCS bursts occured, discontinued in line|1
5895392|NCT01720069|20398539|P3|Overall Study|Withdrawal by Subject|1
5895393|NCT01720069|20398540|P2|Overall Study|Withdrawal by Subject|2
5895394|NCT01720069|20398541|P1|Overall Study|Withdrawal by Subject|0
5895395|NCT01720069|20398539|P3|Overall Study|Treatment period withdrawal criteria met|9
5895396|NCT01720069|20398540|P2|Overall Study|Treatment period withdrawal criteria met|8
5895397|NCT01720069|20398541|P1|Overall Study|Treatment period withdrawal criteria met|4
5895398|NCT01720069|20398539|P3|Overall Study|Lack of Efficacy|0
5895399|NCT01720069|20398540|P2|Overall Study|Lack of Efficacy|4
5895400|NCT01720069|20398541|P1|Overall Study|Lack of Efficacy|0
5895401|NCT01720069|20398539|P3|Overall Study|Adverse Event|1
5895402|NCT01720069|20398540|P2|Overall Study|Adverse Event|0
5895403|NCT01720069|20398541|P1|Overall Study|Adverse Event|0
5895404|NCT01720069|20398539|P3|Overall Study|Randomised without baseline values|1
5895405|NCT01720069|20398540|P2|Overall Study|Randomised without baseline values|0
5895406|NCT01720069|20398541|P1|Overall Study|Randomised without baseline values|0
5895407|NCT01720069|20398539|P3|Overall Study|Could not use e-diary correctly|1
5895408|NCT01720069|20398540|P2|Overall Study|Could not use e-diary correctly|1
5895409|NCT01720069|20398541|P1|Overall Study|Could not use e-diary correctly|0
5895410|NCT01720043|20398567|P1|Overall Study|Withdrawal by Subject|1
5895411|NCT01719861|20398596|P1|Cycle 2|Death|1
5895412|NCT01719861|20398596|P1|Cycle 1|Death|4
5895413|NCT01719783|20398606|P2|Dose 2|Physician Decision|0
5895414|NCT01719783|20398607|P1|Dose 2|Physician Decision|1
5895415|NCT01719757|20398693|P1|Overall Study|well controlled pain|27
5895416|NCT01719757|20398693|P1|Overall Study|Protocol Violation|1
5895417|NCT01719757|20398693|P1|Overall Study|Lost to Follow-up|20
5895418|NCT01719757|20398693|P1|Overall Study|Withdrawal by Subject|15
5895419|NCT01719757|20398693|P1|Overall Study|Adverse Event|38
5895420|NCT01719224|20398747|P2|Intervention 1: Sleeping Position 1|Withdrawal by Subject|2
5895421|NCT01719224|20398748|P1|Intervention 1: Sleeping Position 1|Withdrawal by Subject|4
5895422|NCT01719172|20398757|P1|Overall Study|Death|1
5895423|NCT01719172|20398757|P1|Overall Study|Lost to Follow-up|1
5895424|NCT01719003|20398771|P9|Overall Study|Lack of Efficacy|0
5895425|NCT01719003|20398772|P8|Overall Study|Lack of Efficacy|0
5895426|NCT01719003|20398773|P7|Overall Study|Lack of Efficacy|1
5895427|NCT01719003|20398774|P6|Overall Study|Lack of Efficacy|0
5895428|NCT01719003|20398775|P5|Overall Study|Lack of Efficacy|0
5895429|NCT01719003|20398776|P4|Overall Study|Lack of Efficacy|0
5895430|NCT01719003|20398777|P3|Overall Study|Lack of Efficacy|0
5895431|NCT01719003|20398778|P2|Overall Study|Lack of Efficacy|0
5895432|NCT01719003|20398779|P1|Overall Study|Lack of Efficacy|0
5895433|NCT01719003|20398771|P9|Overall Study|Reason other than those specified|1
5895434|NCT01719003|20398772|P8|Overall Study|Reason other than those specified|3
5895435|NCT01719003|20398773|P7|Overall Study|Reason other than those specified|0
5895436|NCT01719003|20398774|P6|Overall Study|Reason other than those specified|1
5895437|NCT01719003|20398775|P5|Overall Study|Reason other than those specified|4
5895438|NCT01719003|20398776|P4|Overall Study|Reason other than those specified|3
5895439|NCT01719003|20398777|P3|Overall Study|Reason other than those specified|2
5895440|NCT01719003|20398778|P2|Overall Study|Reason other than those specified|0
5895441|NCT01719003|20398779|P1|Overall Study|Reason other than those specified|0
5895442|NCT01719003|20398771|P9|Overall Study|Refusal to continue, not due to AE|1
5895443|NCT01719003|20398772|P8|Overall Study|Refusal to continue, not due to AE|7
5895444|NCT01719003|20398773|P7|Overall Study|Refusal to continue, not due to AE|8
5895445|NCT01719003|20398774|P6|Overall Study|Refusal to continue, not due to AE|3
5895446|NCT01719003|20398775|P5|Overall Study|Refusal to continue, not due to AE|4
5895447|NCT01719003|20398776|P4|Overall Study|Refusal to continue, not due to AE|4
5895448|NCT01719003|20398777|P3|Overall Study|Refusal to continue, not due to AE|4
5895449|NCT01719003|20398778|P2|Overall Study|Refusal to continue, not due to AE|5
5895450|NCT01719003|20398779|P1|Overall Study|Refusal to continue, not due to AE|2
5895451|NCT01719003|20398771|P9|Overall Study|Lost to Follow-up|2
5895452|NCT01719003|20398772|P8|Overall Study|Lost to Follow-up|2
5895453|NCT01719003|20398773|P7|Overall Study|Lost to Follow-up|3
5895454|NCT01719003|20398774|P6|Overall Study|Lost to Follow-up|4
5895455|NCT01719003|20398775|P5|Overall Study|Lost to Follow-up|3
5895456|NCT01719003|20398776|P4|Overall Study|Lost to Follow-up|2
5895457|NCT01719003|20398777|P3|Overall Study|Lost to Follow-up|7
5895458|NCT01719003|20398778|P2|Overall Study|Lost to Follow-up|6
5895459|NCT01719003|20398779|P1|Overall Study|Lost to Follow-up|0
5895460|NCT01719003|20398771|P9|Overall Study|Adverse Event|0
5895461|NCT01719003|20398772|P8|Overall Study|Adverse Event|5
5895462|NCT01719003|20398773|P7|Overall Study|Adverse Event|6
5895463|NCT01719003|20398774|P6|Overall Study|Adverse Event|3
5895464|NCT01719003|20398775|P5|Overall Study|Adverse Event|4
5895465|NCT01719003|20398776|P4|Overall Study|Adverse Event|3
5895466|NCT01719003|20398777|P3|Overall Study|Adverse Event|4
5895467|NCT01719003|20398778|P2|Overall Study|Adverse Event|5
5895468|NCT01719003|20398779|P1|Overall Study|Adverse Event|6
5895469|NCT01719003|20398771|P9|Overall Study|Non compliant with protocol|0
5895470|NCT01719003|20398772|P8|Overall Study|Non compliant with protocol|3
5895471|NCT01719003|20398773|P7|Overall Study|Non compliant with protocol|2
5895472|NCT01719003|20398774|P6|Overall Study|Non compliant with protocol|1
5895473|NCT01719003|20398775|P5|Overall Study|Non compliant with protocol|2
5895474|NCT01719003|20398776|P4|Overall Study|Non compliant with protocol|1
5895475|NCT01719003|20398777|P3|Overall Study|Non compliant with protocol|0
5895476|NCT01719003|20398778|P2|Overall Study|Non compliant with protocol|1
5895477|NCT01719003|20398779|P1|Overall Study|Non compliant with protocol|1
5895478|NCT01718535|20398860|P10|Overall Study|Bidirectional Sequencing not possible|0
5895479|NCT01718535|20398861|P9|Overall Study|Bidirectional Sequencing not possible|0
5895480|NCT01718535|20398862|P8|Overall Study|Bidirectional Sequencing not possible|0
5895481|NCT01718535|20398863|P7|Overall Study|Bidirectional Sequencing not possible|0
5895482|NCT01718535|20398864|P6|Overall Study|Bidirectional Sequencing not possible|0
5895483|NCT01718535|20398865|P5|Overall Study|Bidirectional Sequencing not possible|0
5895484|NCT01718535|20398866|P4|Overall Study|Bidirectional Sequencing not possible|1
5895485|NCT01718535|20398867|P3|Overall Study|Bidirectional Sequencing not possible|0
5895486|NCT01718535|20398868|P2|Overall Study|Bidirectional Sequencing not possible|0
5895487|NCT01718535|20398869|P1|Overall Study|Bidirectional Sequencing not possible|1
5895488|NCT01718509|20398907|P2|Overall Study|Lack of Efficacy|0
5895489|NCT01718509|20398908|P1|Overall Study|Lack of Efficacy|1
5895490|NCT01718509|20398907|P2|Overall Study|Protocol Violation|2
5895491|NCT01718509|20398908|P1|Overall Study|Protocol Violation|4
5895492|NCT01718509|20398907|P2|Overall Study|Other|11
5895493|NCT01718509|20398908|P1|Overall Study|Other|13
5895494|NCT01718509|20398907|P2|Overall Study|Adverse Event|7
5895495|NCT01718509|20398908|P1|Overall Study|Adverse Event|5
5895496|NCT01718509|20398907|P2|Overall Study|Withdrawal by Subject|13
5895497|NCT01718509|20398908|P1|Overall Study|Withdrawal by Subject|7
5895498|NCT01718509|20398907|P2|Overall Study|Lost to Follow-up|15
5895499|NCT01718509|20398908|P1|Overall Study|Lost to Follow-up|18
5895500|NCT01718483|20398954|P2|Overall Study|Lack of Efficacy|0
5895501|NCT01718483|20398955|P1|Overall Study|Lack of Efficacy|1
5895502|NCT01718483|20398954|P2|Overall Study|Pregnancy|1
5895503|NCT01718483|20398955|P1|Overall Study|Pregnancy|1
5895504|NCT01718483|20398954|P2|Overall Study|Other|4
5895505|NCT01718483|20398955|P1|Overall Study|Other|1
5895506|NCT01718483|20398954|P2|Overall Study|Protocol Violation|2
5895507|NCT01718483|20398955|P1|Overall Study|Protocol Violation|4
5895508|NCT01718483|20398954|P2|Overall Study|Lost to Follow-up|3
5895509|NCT01718483|20398955|P1|Overall Study|Lost to Follow-up|8
5895510|NCT01718483|20398954|P2|Overall Study|Adverse Event|12
5895511|NCT01718483|20398955|P1|Overall Study|Adverse Event|5
5895512|NCT01718483|20398954|P2|Overall Study|Withdrawal by Subject|12
5895513|NCT01718483|20398955|P1|Overall Study|Withdrawal by Subject|14
5895514|NCT01718353|20399010|P2|Overall Study|Randomized but not treated|0
5895515|NCT01718353|20399011|P1|Overall Study|Randomized but not treated|2
5895516|NCT01718353|20399010|P2|Overall Study|Principal Investigator's Decision|4
5895517|NCT01718353|20399011|P1|Overall Study|Principal Investigator's Decision|10
5895518|NCT01718353|20399010|P2|Overall Study|Lost to Follow-up|1
5895519|NCT01718353|20399011|P1|Overall Study|Lost to Follow-up|0
5895520|NCT01717989|20399042|P1|Overall Study|Other|40
5895521|NCT01717989|20399042|P1|Overall Study|Protocol-specified criteria|551
5895522|NCT01717989|20399042|P1|Overall Study|Death|439
5895523|NCT01717989|20399042|P1|Overall Study|Lost to Follow-up|11
5895524|NCT01717989|20399042|P1|Overall Study|Physician Decision|2
5895525|NCT01717989|20399042|P1|Overall Study|Withdrawal by Subject|11
5895526|NCT01717989|20399042|P1|Overall Study|Protocol deviation|6
5895527|NCT01717989|20399042|P1|Overall Study|Ineligibility determined|6
5895528|NCT01717976|20399110|P2|Overall Study|Protocol Violation|1
5895529|NCT01717976|20399111|P1|Overall Study|Protocol Violation|0
5895530|NCT01717859|20399166|P1|Overall Study|Withdrawal by Subject|2
5895531|NCT01717859|20399166|P1|Overall Study|Lost to Follow-up|1
5895532|NCT01717859|20399166|P1|Overall Study|Patient concerned about mental health|1
5895533|NCT01717859|20399166|P1|Overall Study|Moved out of state|1
5895534|NCT01717859|20399166|P1|Overall Study|Adverse Event|5
5895535|NCT01717768|20399187|P12|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
5895536|NCT01717768|20399188|P11|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
5895537|NCT01717768|20399189|P10|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|1
5895538|NCT01717768|20399190|P9|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
5895539|NCT01717768|20399191|P8|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
5895540|NCT01717768|20399192|P7|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
5895541|NCT01717768|20399193|P6|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
5895542|NCT01717768|20399194|P5|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
5895543|NCT01717768|20399195|P4|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
5895544|NCT01717768|20399196|P3|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
5895545|NCT01717768|20399197|P2|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
5895546|NCT01717768|20399198|P1|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
5895547|NCT01717768|20399187|P12|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
5895548|NCT01717768|20399188|P11|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
5895549|NCT01717768|20399189|P10|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
5895550|NCT01717768|20399190|P9|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
5895551|NCT01717768|20399191|P8|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|2
5895552|NCT01717768|20399192|P7|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
5895553|NCT01717768|20399193|P6|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
5895554|NCT01717768|20399194|P5|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
5895555|NCT01717768|20399195|P4|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
5895556|NCT01717768|20399196|P3|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
5895557|NCT01717768|20399197|P2|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
5895558|NCT01717768|20399198|P1|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
5895559|NCT01717768|20399187|P12|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|1
5895560|NCT01717768|20399188|P11|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
5895561|NCT01717768|20399189|P10|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
5895562|NCT01717768|20399190|P9|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
5895563|NCT01717768|20399191|P8|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
5895564|NCT01717768|20399192|P7|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
5895565|NCT01717768|20399193|P6|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
5895566|NCT01717768|20399194|P5|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
5895567|NCT01717768|20399195|P4|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
5895568|NCT01717768|20399196|P3|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
5895569|NCT01717768|20399197|P2|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
5895570|NCT01717768|20399198|P1|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
5895571|NCT01717768|20399187|P12|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
5895572|NCT01717768|20399188|P11|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
5895573|NCT01717768|20399189|P10|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
5895574|NCT01717768|20399190|P9|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
5895575|NCT01717768|20399191|P8|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
5895576|NCT01717768|20399192|P7|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
5895577|NCT01717768|20399193|P6|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
5895578|NCT01717768|20399194|P5|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
5895579|NCT01717768|20399195|P4|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
5895580|NCT01717768|20399196|P3|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
5895581|NCT01717768|20399197|P2|Part 1 (Duration of 15 Days)|Lost to Follow-up|1
5895582|NCT01717768|20399198|P1|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
5895583|NCT01717638|20399278|P13|Overall Study|Withdrawal by Subject|18
5895584|NCT01717638|20399279|P12|Overall Study|Withdrawal by Subject|0
5895585|NCT01717638|20399280|P11|Overall Study|Withdrawal by Subject|0
5895586|NCT01717638|20399281|P10|Overall Study|Withdrawal by Subject|1
5895587|NCT01717638|20399282|P9|Overall Study|Withdrawal by Subject|2
5895588|NCT01717638|20399283|P8|Overall Study|Withdrawal by Subject|1
5895589|NCT01717638|20399284|P7|Overall Study|Withdrawal by Subject|2
5895590|NCT01717638|20399285|P6|Overall Study|Withdrawal by Subject|0
5895591|NCT01717638|20399286|P5|Overall Study|Withdrawal by Subject|1
5895592|NCT01717638|20399287|P4|Overall Study|Withdrawal by Subject|0
5895593|NCT01717638|20399288|P3|Overall Study|Withdrawal by Subject|1
5895594|NCT01717638|20399289|P2|Overall Study|Withdrawal by Subject|1
5895595|NCT01717638|20399290|P1|Overall Study|Withdrawal by Subject|0
5895596|NCT01717638|20399278|P13|Overall Study|Father in hospital|1
5895597|NCT01717638|20399279|P12|Overall Study|Father in hospital|0
5895598|NCT01717638|20399280|P11|Overall Study|Father in hospital|0
5895599|NCT01717638|20399281|P10|Overall Study|Father in hospital|0
5895600|NCT01717638|20399282|P9|Overall Study|Father in hospital|0
5895601|NCT01717638|20399283|P8|Overall Study|Father in hospital|0
5895602|NCT01717638|20399284|P7|Overall Study|Father in hospital|0
5895603|NCT01717638|20399285|P6|Overall Study|Father in hospital|0
5895604|NCT01717638|20399286|P5|Overall Study|Father in hospital|0
5895605|NCT01717638|20399287|P4|Overall Study|Father in hospital|0
5895606|NCT01717638|20399288|P3|Overall Study|Father in hospital|0
5895607|NCT01717638|20399289|P2|Overall Study|Father in hospital|0
5895608|NCT01717638|20399290|P1|Overall Study|Father in hospital|0
5895609|NCT01717638|20399278|P13|Overall Study|Lost to Follow-up|0
5895610|NCT01717638|20399279|P12|Overall Study|Lost to Follow-up|0
5895611|NCT01717638|20399280|P11|Overall Study|Lost to Follow-up|0
5895612|NCT01717638|20399281|P10|Overall Study|Lost to Follow-up|0
5895613|NCT01717638|20399282|P9|Overall Study|Lost to Follow-up|0
5895614|NCT01717638|20399283|P8|Overall Study|Lost to Follow-up|0
5895615|NCT01717638|20399284|P7|Overall Study|Lost to Follow-up|0
5895616|NCT01717638|20399285|P6|Overall Study|Lost to Follow-up|1
5895617|NCT01717638|20399286|P5|Overall Study|Lost to Follow-up|0
5895618|NCT01717638|20399287|P4|Overall Study|Lost to Follow-up|0
5895619|NCT01717638|20399288|P3|Overall Study|Lost to Follow-up|0
5895620|NCT01717638|20399289|P2|Overall Study|Lost to Follow-up|0
5895621|NCT01717638|20399290|P1|Overall Study|Lost to Follow-up|0
5895622|NCT01717456|20399466|P2|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4
5895623|NCT01717456|20399467|P1|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4
5895624|NCT01717456|20399466|P2|End of Treatment|Lost to Follow-up|1
5895625|NCT01717456|20399467|P1|End of Treatment|Lost to Follow-up|0
5895626|NCT01717456|20399466|P2|End of Treatment|Physician Decision|1
5895627|NCT01717456|20399467|P1|End of Treatment|Physician Decision|0
5895628|NCT01717391|20399535|P1|Overall Study|FLT technical failure|3
5895629|NCT01717391|20399535|P1|Overall Study|Physician Decision|1
5895630|NCT01717391|20399535|P1|Overall Study|Withdrawal by Subject|5
5895731|NCT01717313|20399847|P2|Phase B (Weeks 24 to 54)|Lost to Follow-up|3
5895732|NCT01717313|20399848|P1|Phase B (Weeks 24 to 54)|Lost to Follow-up|1
5895733|NCT01717313|20399847|P2|Phase B (Weeks 24 to 54)|Withdrawal by Subject|9
5895734|NCT01717313|20399848|P1|Phase B (Weeks 24 to 54)|Withdrawal by Subject|7
5895735|NCT01717313|20399847|P2|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4
5895736|NCT01717313|20399848|P1|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4
5895737|NCT01717313|20399847|P2|Interphase|Completed Phase A Did Not Enter Phase B|0
5895738|NCT01717313|20399848|P1|Interphase|Completed Phase A Did Not Enter Phase B|1
5895739|NCT01717313|20399847|P2|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1
5895740|NCT01717313|20399848|P1|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1
5895741|NCT01717313|20399847|P2|Phase A (Weeks 0 to 24)|Adverse Event|2
5895742|NCT01717313|20399848|P1|Phase A (Weeks 0 to 24)|Adverse Event|4
5895743|NCT01717313|20399847|P2|Phase A (Weeks 0 to 24)|Withdrawal by Subject|6
5895744|NCT01717313|20399848|P1|Phase A (Weeks 0 to 24)|Withdrawal by Subject|12
5895745|NCT01717313|20399847|P2|Phase A (Weeks 0 to 24)|Lost to Follow-up|3
5895746|NCT01717313|20399848|P1|Phase A (Weeks 0 to 24)|Lost to Follow-up|1
5895747|NCT01717313|20399847|P2|Phase A (Weeks 0 to 24)|Death|1
5895748|NCT01717313|20399848|P1|Phase A (Weeks 0 to 24)|Death|0
5895749|NCT01717287|20399886|P2|Overall Study|Protocol Violation|1
5895750|NCT01717287|20399887|P1|Overall Study|Protocol Violation|0
5895751|NCT01717287|20399886|P2|Overall Study|Lost to Follow-up|2
5895752|NCT01717287|20399887|P1|Overall Study|Lost to Follow-up|0
5895753|NCT01717040|20399927|P2|Overall Study|New Substance Use Disorder|0
5895754|NCT01717040|20399928|P1|Overall Study|New Substance Use Disorder|1
5895755|NCT01717040|20399927|P2|Overall Study|Required Medication Change|1
5895756|NCT01717040|20399928|P1|Overall Study|Required Medication Change|0
5895757|NCT01717040|20399927|P2|Overall Study|Adverse Event|0
5895758|NCT01717040|20399928|P1|Overall Study|Adverse Event|1
5895759|NCT01717040|20399927|P2|Overall Study|Lack of Efficacy|1
5895760|NCT01717040|20399928|P1|Overall Study|Lack of Efficacy|1
5895761|NCT01717040|20399927|P2|Overall Study|Lost to Follow-up|3
5895762|NCT01717040|20399928|P1|Overall Study|Lost to Follow-up|2
5895763|NCT01716754|20399955|P4|Overall Study|Withdrawal by Subject|3
5895764|NCT01716754|20399956|P3|Overall Study|Withdrawal by Subject|4
5895765|NCT01716754|20399957|P2|Overall Study|Withdrawal by Subject|0
5895766|NCT01716754|20399958|P1|Overall Study|Withdrawal by Subject|5
5895767|NCT01716754|20399955|P4|Overall Study|Adverse Event|1
5895768|NCT01716754|20399956|P3|Overall Study|Adverse Event|2
5895769|NCT01716754|20399957|P2|Overall Study|Adverse Event|2
5895770|NCT01716754|20399958|P1|Overall Study|Adverse Event|4
5895771|NCT01716754|20399955|P4|Overall Study|Lost to Follow-up|1
5895772|NCT01716754|20399956|P3|Overall Study|Lost to Follow-up|0
5895773|NCT01716754|20399957|P2|Overall Study|Lost to Follow-up|0
5895774|NCT01716754|20399958|P1|Overall Study|Lost to Follow-up|1
5895775|NCT01716754|20399955|P4|Overall Study|Physician Decision|0
5895776|NCT01716754|20399956|P3|Overall Study|Physician Decision|0
5895777|NCT01716754|20399957|P2|Overall Study|Physician Decision|0
5895778|NCT01716754|20399958|P1|Overall Study|Physician Decision|1
5895779|NCT01716754|20399955|P4|Overall Study|Non-compliance with study treatment|0
5895780|NCT01716754|20399956|P3|Overall Study|Non-compliance with study treatment|1
5895781|NCT01716754|20399957|P2|Overall Study|Non-compliance with study treatment|0
5895782|NCT01716754|20399958|P1|Overall Study|Non-compliance with study treatment|0
5895783|NCT01716754|20399955|P4|Overall Study|Protocol deviation|2
5895784|NCT01716754|20399956|P3|Overall Study|Protocol deviation|7
5895785|NCT01716754|20399957|P2|Overall Study|Protocol deviation|2
5895786|NCT01716754|20399958|P1|Overall Study|Protocol deviation|0
5895787|NCT01716754|20399955|P4|Overall Study|Death|1
5895788|NCT01716754|20399956|P3|Overall Study|Death|0
5895789|NCT01716754|20399957|P2|Overall Study|Death|0
5895790|NCT01716754|20399958|P1|Overall Study|Death|0
5895791|NCT01716715|20399981|P2|Overall Study|Never Treated|4
5895792|NCT01716715|20399982|P1|Overall Study|Never Treated|2
5895793|NCT01716663|20399998|P1|Overall Study|Treated with non-study catheter|2
5895794|NCT01716663|20399998|P1|Overall Study|Withdrawn prior to procedure|4
5895795|NCT01716585|20400008|P2|Open-label Treatment|Withdrawal by Subject|3
5895796|NCT01716585|20400009|P1|Open-label Treatment|Withdrawal by Subject|0
5895797|NCT01716585|20400008|P2|Open-label Treatment|Virologic Failure|2
5895798|NCT01716585|20400009|P1|Open-label Treatment|Virologic Failure|0
5895799|NCT01716585|20400008|P2|Open-label Treatment|Adverse Event|2
5895800|NCT01716585|20400009|P1|Open-label Treatment|Adverse Event|0
5895801|NCT01716585|20400008|P2|Double-blind Treatment|Other|0
5895802|NCT01716585|20400009|P1|Double-blind Treatment|Other|1
5895803|NCT01716585|20400008|P2|Double-blind Treatment|Subject Noncompliant|0
5895804|NCT01716585|20400009|P1|Double-blind Treatment|Subject Noncompliant|1
5895805|NCT01716585|20400008|P2|Double-blind Treatment|Lost to Follow-up|0
5895806|NCT01716585|20400009|P1|Double-blind Treatment|Lost to Follow-up|2
5895807|NCT01716585|20400008|P2|Double-blind Treatment|Withdrawal by Subject|0
5895808|NCT01716585|20400009|P1|Double-blind Treatment|Withdrawal by Subject|3
5895809|NCT01716585|20400008|P2|Double-blind Treatment|Adverse Event|1
5895810|NCT01716585|20400009|P1|Double-blind Treatment|Adverse Event|2
5895811|NCT01716585|20400008|P2|Double-blind Treatment|Did Not Receive Study Drug|1
5895812|NCT01716585|20400009|P1|Double-blind Treatment|Did Not Receive Study Drug|4
5895813|NCT01716559|20400021|P1|Overall Study|Other withdrawal reason|75
5895814|NCT01716559|20400021|P1|Overall Study|Withdrawal by Subject|4
5895815|NCT01716559|20400021|P1|Overall Study|Death|21
5895816|NCT01716559|20400021|P1|Overall Study|Adverse Event|11
5895817|NCT01716533|20400033|P4|Overall Study|Immunosuppressants>14days past 6months|1
5895818|NCT01716533|20400034|P3|Overall Study|Immunosuppressants>14days past 6months|0
5895819|NCT01716533|20400035|P2|Overall Study|Immunosuppressants>14days past 6months|0
5895820|NCT01716533|20400036|P1|Overall Study|Immunosuppressants>14days past 6months|0
5895821|NCT01716533|20400033|P4|Overall Study|Death|2
5895822|NCT01716533|20400034|P3|Overall Study|Death|0
5895823|NCT01716533|20400035|P2|Overall Study|Death|0
5895824|NCT01716533|20400036|P1|Overall Study|Death|0
5895825|NCT01716533|20400033|P4|Overall Study|Withdrawal by Subject|5
5895826|NCT01716533|20400034|P3|Overall Study|Withdrawal by Subject|0
5895827|NCT01716533|20400035|P2|Overall Study|Withdrawal by Subject|0
5895828|NCT01716533|20400036|P1|Overall Study|Withdrawal by Subject|0
5895829|NCT01716533|20400033|P4|Overall Study|Failure of antibiotic treatment to treat|0
5895830|NCT01716533|20400034|P3|Overall Study|Failure of antibiotic treatment to treat|5
5895831|NCT01716533|20400035|P2|Overall Study|Failure of antibiotic treatment to treat|0
5895832|NCT01716533|20400036|P1|Overall Study|Failure of antibiotic treatment to treat|0
5895833|NCT01716520|20400090|P6|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
5895834|NCT01716520|20400091|P5|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
5895835|NCT01716520|20400092|P4|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
5895836|NCT01716520|20400093|P3|Treatment Period 3 (14 Days)|Withdrawal by Subject|1
5895837|NCT01716520|20400094|P2|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
5895838|NCT01716520|20400095|P1|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
5895839|NCT01716520|20400090|P6|Treatment Period 3 (14 Days)|Lack of Efficacy|2
5895840|NCT01716520|20400091|P5|Treatment Period 3 (14 Days)|Lack of Efficacy|0
5895841|NCT01716520|20400092|P4|Treatment Period 3 (14 Days)|Lack of Efficacy|0
5895842|NCT01716520|20400093|P3|Treatment Period 3 (14 Days)|Lack of Efficacy|0
5895843|NCT01716520|20400094|P2|Treatment Period 3 (14 Days)|Lack of Efficacy|0
5895844|NCT01716520|20400095|P1|Treatment Period 3 (14 Days)|Lack of Efficacy|0
5895845|NCT01716520|20400090|P6|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0
5895846|NCT01716520|20400091|P5|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0
5895847|NCT01716520|20400092|P4|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0
5895848|NCT01716520|20400093|P3|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0
5895849|NCT01716520|20400094|P2|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|1
5895850|NCT01716520|20400095|P1|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0
5895851|NCT01716520|20400090|P6|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|1
5895852|NCT01716520|20400091|P5|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0
5895853|NCT01716520|20400092|P4|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0
5895854|NCT01716520|20400093|P3|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0
5895855|NCT01716520|20400094|P2|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0
5895856|NCT01716520|20400095|P1|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0
5895857|NCT01716520|20400090|P6|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0
5895858|NCT01716520|20400091|P5|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0
5895859|NCT01716520|20400092|P4|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0
5895860|NCT01716520|20400093|P3|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0
5895861|NCT01716520|20400094|P2|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0
5895862|NCT01716520|20400095|P1|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|1
5895863|NCT01716520|20400090|P6|Washout Period 2 (10 to 14 Days)|Adverse Event|1
5895864|NCT01716520|20400091|P5|Washout Period 2 (10 to 14 Days)|Adverse Event|0
5895865|NCT01716520|20400092|P4|Washout Period 2 (10 to 14 Days)|Adverse Event|0
5895866|NCT01716520|20400093|P3|Washout Period 2 (10 to 14 Days)|Adverse Event|1
5895867|NCT01716520|20400094|P2|Washout Period 2 (10 to 14 Days)|Adverse Event|0
5895868|NCT01716520|20400095|P1|Washout Period 2 (10 to 14 Days)|Adverse Event|1
5895869|NCT01716520|20400090|P6|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0
5895870|NCT01716520|20400091|P5|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0
5895871|NCT01716520|20400092|P4|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|1
5895872|NCT01716520|20400093|P3|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0
5895873|NCT01716520|20400094|P2|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0
5895874|NCT01716520|20400095|P1|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0
5895875|NCT01716520|20400090|P6|Treatment Period 2 (14 Days)|Protocol Violation|0
5895876|NCT01716520|20400091|P5|Treatment Period 2 (14 Days)|Protocol Violation|1
5895877|NCT01716520|20400092|P4|Treatment Period 2 (14 Days)|Protocol Violation|0
5895878|NCT01716520|20400093|P3|Treatment Period 2 (14 Days)|Protocol Violation|0
5895879|NCT01716520|20400094|P2|Treatment Period 2 (14 Days)|Protocol Violation|0
5895880|NCT01716520|20400095|P1|Treatment Period 2 (14 Days)|Protocol Violation|0
5895881|NCT01716520|20400090|P6|Treatment Period 2 (14 Days)|Adverse Event|0
5895882|NCT01716520|20400091|P5|Treatment Period 2 (14 Days)|Adverse Event|1
5895883|NCT01716520|20400092|P4|Treatment Period 2 (14 Days)|Adverse Event|0
5895884|NCT01716520|20400093|P3|Treatment Period 2 (14 Days)|Adverse Event|0
5895885|NCT01716520|20400094|P2|Treatment Period 2 (14 Days)|Adverse Event|0
5895886|NCT01716520|20400095|P1|Treatment Period 2 (14 Days)|Adverse Event|0
5895887|NCT01716520|20400090|P6|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1
5895888|NCT01716520|20400091|P5|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0
5895889|NCT01716520|20400092|P4|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0
5895890|NCT01716520|20400093|P3|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1
5895891|NCT01716520|20400094|P2|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0
5895892|NCT01716520|20400095|P1|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0
5895893|NCT01716520|20400090|P6|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1
5895894|NCT01716520|20400091|P5|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
5895895|NCT01716520|20400092|P4|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
5895896|NCT01716520|20400093|P3|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
5895897|NCT01716520|20400094|P2|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
5895898|NCT01716520|20400095|P1|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
5895899|NCT01716520|20400090|P6|Washout Period 1 (10 to 14 Days)|Adverse Event|0
5895900|NCT01716520|20400091|P5|Washout Period 1 (10 to 14 Days)|Adverse Event|0
5895901|NCT01716520|20400092|P4|Washout Period 1 (10 to 14 Days)|Adverse Event|0
5895902|NCT01716520|20400093|P3|Washout Period 1 (10 to 14 Days)|Adverse Event|0
5895903|NCT01716520|20400094|P2|Washout Period 1 (10 to 14 Days)|Adverse Event|1
5895904|NCT01716520|20400095|P1|Washout Period 1 (10 to 14 Days)|Adverse Event|0
5895905|NCT01716520|20400090|P6|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
5895906|NCT01716520|20400091|P5|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
5895907|NCT01716520|20400092|P4|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
5895908|NCT01716520|20400093|P3|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
5895909|NCT01716520|20400094|P2|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
5895910|NCT01716520|20400095|P1|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
5895911|NCT01716520|20400090|P6|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1
5895912|NCT01716520|20400091|P5|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0
5895913|NCT01716520|20400092|P4|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1
5895914|NCT01716520|20400093|P3|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|2
5895915|NCT01716520|20400094|P2|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0
5895916|NCT01716520|20400095|P1|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1
5895917|NCT01716520|20400090|P6|Treatment Period 1 (14 Days)|Adverse Event|0
5895918|NCT01716520|20400091|P5|Treatment Period 1 (14 Days)|Adverse Event|0
5895919|NCT01716520|20400092|P4|Treatment Period 1 (14 Days)|Adverse Event|0
5895920|NCT01716520|20400093|P3|Treatment Period 1 (14 Days)|Adverse Event|0
5895921|NCT01716520|20400094|P2|Treatment Period 1 (14 Days)|Adverse Event|0
5895922|NCT01716520|20400095|P1|Treatment Period 1 (14 Days)|Adverse Event|1
5895923|NCT01716234|20400150|P7|Overall Study|Withdrawal by Subject|0
5895924|NCT01716234|20400151|P6|Overall Study|Withdrawal by Subject|3
5895925|NCT01716234|20400152|P5|Overall Study|Withdrawal by Subject|1
5895926|NCT01716234|20400153|P4|Overall Study|Withdrawal by Subject|2
5895927|NCT01716234|20400154|P3|Overall Study|Withdrawal by Subject|2
5895928|NCT01716234|20400155|P2|Overall Study|Withdrawal by Subject|0
5895929|NCT01716234|20400156|P1|Overall Study|Withdrawal by Subject|3
5895930|NCT01716234|20400150|P7|Overall Study|Adverse Event|0
5895931|NCT01716234|20400151|P6|Overall Study|Adverse Event|6
5895932|NCT01716234|20400152|P5|Overall Study|Adverse Event|3
5895933|NCT01716234|20400153|P4|Overall Study|Adverse Event|8
5895934|NCT01716234|20400154|P3|Overall Study|Adverse Event|2
5895935|NCT01716234|20400155|P2|Overall Study|Adverse Event|10
5895936|NCT01716234|20400156|P1|Overall Study|Adverse Event|7
5895937|NCT01716234|20400150|P7|Overall Study|Did not meet protocol eligibility|0
5895938|NCT01716234|20400151|P6|Overall Study|Did not meet protocol eligibility|4
5895939|NCT01716234|20400152|P5|Overall Study|Did not meet protocol eligibility|0
5895940|NCT01716234|20400153|P4|Overall Study|Did not meet protocol eligibility|0
5895941|NCT01716234|20400154|P3|Overall Study|Did not meet protocol eligibility|1
5895942|NCT01716234|20400155|P2|Overall Study|Did not meet protocol eligibility|0
5895943|NCT01716234|20400156|P1|Overall Study|Did not meet protocol eligibility|0
5895944|NCT01716234|20400150|P7|Overall Study|Lack of Efficacy|0
5895945|NCT01716234|20400151|P6|Overall Study|Lack of Efficacy|0
5895946|NCT01716234|20400152|P5|Overall Study|Lack of Efficacy|0
5895947|NCT01716234|20400153|P4|Overall Study|Lack of Efficacy|1
5895948|NCT01716234|20400154|P3|Overall Study|Lack of Efficacy|0
5895949|NCT01716234|20400155|P2|Overall Study|Lack of Efficacy|0
5895950|NCT01716234|20400156|P1|Overall Study|Lack of Efficacy|0
5895951|NCT01716234|20400150|P7|Overall Study|Protocol Violation|0
5895952|NCT01716234|20400151|P6|Overall Study|Protocol Violation|1
5895953|NCT01716234|20400152|P5|Overall Study|Protocol Violation|1
5895954|NCT01716234|20400153|P4|Overall Study|Protocol Violation|1
5895955|NCT01716234|20400154|P3|Overall Study|Protocol Violation|0
5895956|NCT01716234|20400155|P2|Overall Study|Protocol Violation|0
5895957|NCT01716234|20400156|P1|Overall Study|Protocol Violation|0
5895958|NCT01716169|20400219|P1|Overall Study|inconsistent dressing application|1
5895959|NCT01716169|20400219|P1|Overall Study|Withdrawal by Subject|1
5895960|NCT01716169|20400219|P1|Overall Study|Lost to Follow-up|1
5895961|NCT01716169|20400219|P1|Overall Study|Adverse Event|1
5895962|NCT01716156|20400228|P3|Overall Study|Lost to Follow-up|0
5895963|NCT01716156|20400229|P2|Overall Study|Lost to Follow-up|0
5895964|NCT01716156|20400230|P1|Overall Study|Lost to Follow-up|1
5895965|NCT01716156|20400228|P3|Overall Study|Withdrawal by Subject|2
5895966|NCT01716156|20400229|P2|Overall Study|Withdrawal by Subject|1
5895967|NCT01716156|20400230|P1|Overall Study|Withdrawal by Subject|0
5895968|NCT01716156|20400228|P3|Overall Study|Protocol Violation|0
5895969|NCT01716156|20400229|P2|Overall Study|Protocol Violation|0
5895970|NCT01716156|20400230|P1|Overall Study|Protocol Violation|1
5895971|NCT01716117|20400256|P2|Overall Study|Withdrawal by Subject|0
5895972|NCT01716117|20400257|P1|Overall Study|Withdrawal by Subject|2
5895973|NCT01716117|20400256|P2|Overall Study|Death|2
5895974|NCT01716117|20400257|P1|Overall Study|Death|5
5895975|NCT01716104|20400276|P2|Overall Study|Do not meet inclusion criteria|7
5895976|NCT01716104|20400277|P1|Overall Study|Do not meet inclusion criteria|6
5895977|NCT01716052|20400303|P2|Overall Study|Withdrawal of funding|1
5895978|NCT01716052|20400304|P1|Overall Study|Withdrawal of funding|1
5895979|NCT01715896|20400346|P2|Overall Study|Other|5
5895980|NCT01715896|20400347|P1|Overall Study|Other|2
5895981|NCT01715896|20400346|P2|Overall Study|Withdrawal by Subject|4
5895982|NCT01715896|20400347|P1|Overall Study|Withdrawal by Subject|1
5895983|NCT01715896|20400346|P2|Overall Study|Lost to Follow-up|2
5895984|NCT01715896|20400347|P1|Overall Study|Lost to Follow-up|0
5895985|NCT01715857|20400420|P1|Overall Study|Did Not Meet Eligibility Criteria|96
5895986|NCT01715831|20400430|P1|Overall Study|Adverse Event|1
5895987|NCT01715805|20400446|P4|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0
5895988|NCT01715805|20400447|P3|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0
5895989|NCT01715805|20400448|P2|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|3
5895990|NCT01715805|20400449|P1|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0
5895991|NCT01715805|20400446|P4|Double-Blind or Continued Treatment|Other Reason Not Specified|3
5895992|NCT01715805|20400447|P3|Double-Blind or Continued Treatment|Other Reason Not Specified|0
5895993|NCT01715805|20400448|P2|Double-Blind or Continued Treatment|Other Reason Not Specified|1
5895994|NCT01715805|20400449|P1|Double-Blind or Continued Treatment|Other Reason Not Specified|0
5895995|NCT01715805|20400446|P4|Double-Blind or Continued Treatment|Lost to Follow-up|10
5895996|NCT01715805|20400447|P3|Double-Blind or Continued Treatment|Lost to Follow-up|10
5895997|NCT01715805|20400448|P2|Double-Blind or Continued Treatment|Lost to Follow-up|7
5895998|NCT01715805|20400449|P1|Double-Blind or Continued Treatment|Lost to Follow-up|0
5895999|NCT01715805|20400446|P4|Double-Blind or Continued Treatment|Withdrawal of consent|13
5896000|NCT01715805|20400447|P3|Double-Blind or Continued Treatment|Withdrawal of consent|11
5896001|NCT01715805|20400448|P2|Double-Blind or Continued Treatment|Withdrawal of consent|11
5896002|NCT01715805|20400449|P1|Double-Blind or Continued Treatment|Withdrawal of consent|0
5896003|NCT01715805|20400446|P4|Double-Blind or Continued Treatment|Protocol Violation|19
5896004|NCT01715805|20400447|P3|Double-Blind or Continued Treatment|Protocol Violation|12
5896005|NCT01715805|20400448|P2|Double-Blind or Continued Treatment|Protocol Violation|14
5896006|NCT01715805|20400449|P1|Double-Blind or Continued Treatment|Protocol Violation|0
5896007|NCT01715805|20400446|P4|Double-Blind or Continued Treatment|Adverse Event|2
5896008|NCT01715805|20400447|P3|Double-Blind or Continued Treatment|Adverse Event|23
5896009|NCT01715805|20400448|P2|Double-Blind or Continued Treatment|Adverse Event|3
5896010|NCT01715805|20400449|P1|Double-Blind or Continued Treatment|Adverse Event|0
5896011|NCT01715805|20400446|P4|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|1
5896012|NCT01715805|20400447|P3|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0
5896013|NCT01715805|20400448|P2|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0
5896014|NCT01715805|20400449|P1|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0
5896015|NCT01715805|20400446|P4|Placebo + ADT Lead-in Period|Other Reason Not Specified|0
5896016|NCT01715805|20400447|P3|Placebo + ADT Lead-in Period|Other Reason Not Specified|0
5896017|NCT01715805|20400448|P2|Placebo + ADT Lead-in Period|Other Reason Not Specified|0
5896018|NCT01715805|20400449|P1|Placebo + ADT Lead-in Period|Other Reason Not Specified|10
5896019|NCT01715805|20400446|P4|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0
5896020|NCT01715805|20400447|P3|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0
5896021|NCT01715805|20400448|P2|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0
5896022|NCT01715805|20400449|P1|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|1
5896023|NCT01715805|20400446|P4|Placebo + ADT Lead-in Period|Lost to Follow-up|0
5896024|NCT01715805|20400447|P3|Placebo + ADT Lead-in Period|Lost to Follow-up|0
5896025|NCT01715805|20400448|P2|Placebo + ADT Lead-in Period|Lost to Follow-up|0
5896026|NCT01715805|20400449|P1|Placebo + ADT Lead-in Period|Lost to Follow-up|34
5896027|NCT01715805|20400446|P4|Placebo + ADT Lead-in Period|Withdrawal of Consent|0
5896028|NCT01715805|20400447|P3|Placebo + ADT Lead-in Period|Withdrawal of Consent|0
5896029|NCT01715805|20400448|P2|Placebo + ADT Lead-in Period|Withdrawal of Consent|0
5896030|NCT01715805|20400449|P1|Placebo + ADT Lead-in Period|Withdrawal of Consent|49
5896031|NCT01715805|20400446|P4|Placebo + ADT Lead-in Period|Protocol Violation|0
5896032|NCT01715805|20400447|P3|Placebo + ADT Lead-in Period|Protocol Violation|0
5896033|NCT01715805|20400448|P2|Placebo + ADT Lead-in Period|Protocol Violation|0
5896034|NCT01715805|20400449|P1|Placebo + ADT Lead-in Period|Protocol Violation|74
5896035|NCT01715805|20400446|P4|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0
5896036|NCT01715805|20400447|P3|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0
5896037|NCT01715805|20400448|P2|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0
5896038|NCT01715805|20400449|P1|Placebo + ADT Lead-in Period|Insufficient therapeutic response|6
5896039|NCT01715805|20400446|P4|Placebo + ADT Lead-in Period|Adverse Event|0
5896040|NCT01715805|20400447|P3|Placebo + ADT Lead-in Period|Adverse Event|0
5896041|NCT01715805|20400448|P2|Placebo + ADT Lead-in Period|Adverse Event|0
5896042|NCT01715805|20400449|P1|Placebo + ADT Lead-in Period|Adverse Event|41
5896043|NCT01715415|20400463|P2|Open-label Treatment|Subject Noncompliant|1
5896044|NCT01715415|20400464|P1|Open-label Treatment|Subject Noncompliant|0
5896045|NCT01715415|20400463|P2|Open-label Treatment|Adverse Event|1
5896046|NCT01715415|20400464|P1|Open-label Treatment|Adverse Event|0
5896047|NCT01715415|20400463|P2|Double-blind Treatment|Other|0
5896048|NCT01715415|20400464|P1|Double-blind Treatment|Other|1
5896049|NCT01715415|20400463|P2|Double-blind Treatment|Withdrawal by Subject|1
5896050|NCT01715415|20400464|P1|Double-blind Treatment|Withdrawal by Subject|1
5896051|NCT01715415|20400463|P2|Double-blind Treatment|Adverse Event|0
5896052|NCT01715415|20400464|P1|Double-blind Treatment|Adverse Event|3
5896053|NCT01715415|20400463|P2|Double-blind Treatment|Did Not Receive Study Drug|1
5896054|NCT01715415|20400464|P1|Double-blind Treatment|Did Not Receive Study Drug|0
5896055|NCT01715298|20400478|P2|Overall Study|Patient/guardian decision|9
5896056|NCT01715298|20400479|P1|Overall Study|Patient/guardian decision|7
5896057|NCT01715298|20400478|P2|Overall Study|Lost to Follow-up|2
5896058|NCT01715298|20400479|P1|Overall Study|Lost to Follow-up|0
5896059|NCT01715285|20400517|P3|Open-label (OL) Extension Phase|Ongoing|72
5896060|NCT01715285|20400518|P2|Open-label (OL) Extension Phase|Ongoing|0
5896061|NCT01715285|20400519|P1|Open-label (OL) Extension Phase|Ongoing|157
5896062|NCT01715285|20400517|P3|Treatment Period|Placebo Cross-over|0
5896063|NCT01715285|20400518|P2|Treatment Period|Placebo Cross-over|72
5896064|NCT01715285|20400519|P1|Treatment Period|Placebo Cross-over|0
5896065|NCT01715285|20400517|P3|Treatment Period|Other|0
5896066|NCT01715285|20400518|P2|Treatment Period|Other|12
5896067|NCT01715285|20400519|P1|Treatment Period|Other|10
5896068|NCT01715285|20400517|P3|Treatment Period|Ongoing|0
5896069|NCT01715285|20400518|P2|Treatment Period|Ongoing|0
5896070|NCT01715285|20400519|P1|Treatment Period|Ongoing|157
5896071|NCT01715285|20400517|P3|Treatment Period|Physician Decision|0
5896072|NCT01715285|20400518|P2|Treatment Period|Physician Decision|23
5896073|NCT01715285|20400519|P1|Treatment Period|Physician Decision|21
5896074|NCT01715285|20400517|P3|Treatment Period|Withdrawal Of Consent|0
5896075|NCT01715285|20400518|P2|Treatment Period|Withdrawal Of Consent|47
5896076|NCT01715285|20400519|P1|Treatment Period|Withdrawal Of Consent|52
5896077|NCT01715285|20400517|P3|Treatment Period|Progressive Disease|0
5896078|NCT01715285|20400518|P2|Treatment Period|Progressive Disease|388
5896079|NCT01715285|20400519|P1|Treatment Period|Progressive Disease|254
5896080|NCT01715285|20400517|P3|Treatment Period|Noncompliance With Study Drug|0
5896081|NCT01715285|20400518|P2|Treatment Period|Noncompliance With Study Drug|2
5896082|NCT01715285|20400519|P1|Treatment Period|Noncompliance With Study Drug|4
5896083|NCT01715285|20400517|P3|Treatment Period|Death|0
5896084|NCT01715285|20400518|P2|Treatment Period|Death|23
5896085|NCT01715285|20400519|P1|Treatment Period|Death|36
5896086|NCT01715285|20400517|P3|Treatment Period|Lost to Follow-up|0
5896087|NCT01715285|20400518|P2|Treatment Period|Lost to Follow-up|2
5896088|NCT01715285|20400519|P1|Treatment Period|Lost to Follow-up|3
5896089|NCT01715285|20400517|P3|Treatment Period|Adverse Event|0
5896090|NCT01715285|20400518|P2|Treatment Period|Adverse Event|33
5896091|NCT01715285|20400519|P1|Treatment Period|Adverse Event|60
5896092|NCT01715129|20400555|P1|Overall Study|Other|1
5896093|NCT01715129|20400555|P1|Overall Study|Lost to Follow-up|1
5896094|NCT01715129|20400555|P1|Overall Study|Consent Withdrawn|2
5896095|NCT01715129|20400555|P1|Overall Study|Protocol Violation|1
5896096|NCT01715129|20400555|P1|Overall Study|Lack of Efficacy|3
5896097|NCT01715129|20400555|P1|Overall Study|Adverse Event, fatal|1
5896098|NCT01714947|20400581|P1|Part B|Progressive Disease|3
5896175|NCT01714726|20400730|P4|Open-Label Period|Lost to Follow-up|4
5896176|NCT01714726|20400731|P3|Open-Label Period|Lost to Follow-up|3
5896177|NCT01714726|20400732|P2|Open-Label Period|Lost to Follow-up|0
5896178|NCT01714726|20400733|P1|Open-Label Period|Lost to Follow-up|0
5896179|NCT01714726|20400730|P4|Open-Label Period|Developed specific withdrawal criteria|2
5896260|NCT01713946|20401049|P3|Overall Study|Protocol Violation|1
5896180|NCT01714726|20400731|P3|Open-Label Period|Developed specific withdrawal criteria|5
5896181|NCT01714726|20400732|P2|Open-Label Period|Developed specific withdrawal criteria|0
5896182|NCT01714726|20400733|P1|Open-Label Period|Developed specific withdrawal criteria|0
5896183|NCT01714726|20400730|P4|Open-Label Period|Withdrawal by Subject|19
5896184|NCT01714726|20400731|P3|Open-Label Period|Withdrawal by Subject|9
5896185|NCT01714726|20400732|P2|Open-Label Period|Withdrawal by Subject|0
5896186|NCT01714726|20400733|P1|Open-Label Period|Withdrawal by Subject|0
5896187|NCT01714726|20400730|P4|Open-Label Period|Adverse Event|0
5896188|NCT01714726|20400731|P3|Open-Label Period|Adverse Event|1
5896189|NCT01714726|20400732|P2|Open-Label Period|Adverse Event|0
5896190|NCT01714726|20400733|P1|Open-Label Period|Adverse Event|0
5896191|NCT01714726|20400730|P4|Open-Label Period|Other|3
5896192|NCT01714726|20400731|P3|Open-Label Period|Other|1
5896193|NCT01714726|20400732|P2|Open-Label Period|Other|0
5896194|NCT01714726|20400733|P1|Open-Label Period|Other|0
5896195|NCT01714726|20400730|P4|Double-Blinded Induction Period|Lost to Follow-up|0
5896196|NCT01714726|20400731|P3|Double-Blinded Induction Period|Lost to Follow-up|0
5896197|NCT01714726|20400732|P2|Double-Blinded Induction Period|Lost to Follow-up|2
5896198|NCT01714726|20400733|P1|Double-Blinded Induction Period|Lost to Follow-up|0
5896199|NCT01714726|20400730|P4|Double-Blinded Induction Period|Withdrawal by Subject|0
5896200|NCT01714726|20400731|P3|Double-Blinded Induction Period|Withdrawal by Subject|0
5896201|NCT01714726|20400732|P2|Double-Blinded Induction Period|Withdrawal by Subject|3
5896202|NCT01714726|20400733|P1|Double-Blinded Induction Period|Withdrawal by Subject|5
5896203|NCT01714726|20400730|P4|Double-Blinded Induction Period|Adverse Event|0
5896204|NCT01714726|20400731|P3|Double-Blinded Induction Period|Adverse Event|0
5896205|NCT01714726|20400732|P2|Double-Blinded Induction Period|Adverse Event|1
5896206|NCT01714726|20400733|P1|Double-Blinded Induction Period|Adverse Event|0
5896207|NCT01714726|20400730|P4|Double-Blinded Induction Period|Subject not in open label period|0
5896208|NCT01714726|20400731|P3|Double-Blinded Induction Period|Subject not in open label period|0
5896209|NCT01714726|20400732|P2|Double-Blinded Induction Period|Subject not in open label period|1
5896210|NCT01714726|20400733|P1|Double-Blinded Induction Period|Subject not in open label period|3
5896211|NCT01714687|20400813|P2|Overall Study|Lost to Follow-up|4
5896212|NCT01714687|20400814|P1|Overall Study|Lost to Follow-up|2
5896213|NCT01714687|20400813|P2|Overall Study|Withdrawal by Subject|0
5896214|NCT01714687|20400814|P1|Overall Study|Withdrawal by Subject|1
5896215|NCT01714635|20400838|P3|Overall Study|Missed 6-month exam|0
5896216|NCT01714635|20400839|P2|Overall Study|Missed 6-month exam|0
5896217|NCT01714635|20400840|P1|Overall Study|Missed 6-month exam|1
5896218|NCT01714635|20400838|P3|Overall Study|Discontinued|2
5896219|NCT01714635|20400839|P2|Overall Study|Discontinued|0
5896220|NCT01714635|20400840|P1|Overall Study|Discontinued|1
5896221|NCT01714609|20400856|P2|Overall Study|Protocol Violation|0
5896222|NCT01714609|20400857|P1|Overall Study|Protocol Violation|1
5896223|NCT01714544|20400863|P1|Overall Study|Withdrawal by Subject|1
5896224|NCT01714544|20400863|P1|Overall Study|Physician Decision|1
5896225|NCT01714544|20400863|P1|Overall Study|Lost to Follow-up|1
5896226|NCT01714310|20400934|P3|Double Blind Adjunctive Treatment|Protocol Violation|0
5896227|NCT01714310|20400935|P2|Double Blind Adjunctive Treatment|Protocol Violation|2
5896228|NCT01714310|20400936|P1|Double Blind Adjunctive Treatment|Protocol Violation|1
5896229|NCT01714310|20400934|P3|Double Blind Adjunctive Treatment|Adverse Event|0
5896230|NCT01714310|20400935|P2|Double Blind Adjunctive Treatment|Adverse Event|1
5896231|NCT01714310|20400936|P1|Double Blind Adjunctive Treatment|Adverse Event|1
5896232|NCT01714310|20400934|P3|Open Lisdexamfetamine Titration|Adverse Event|3
5896233|NCT01714310|20400935|P2|Open Lisdexamfetamine Titration|Adverse Event|0
5896234|NCT01714310|20400936|P1|Open Lisdexamfetamine Titration|Adverse Event|0
5896235|NCT01714310|20400934|P3|Open Lisdexamfetamine Titration|Protocol Violation|1
5896236|NCT01714310|20400935|P2|Open Lisdexamfetamine Titration|Protocol Violation|0
5896237|NCT01714310|20400936|P1|Open Lisdexamfetamine Titration|Protocol Violation|0
5896238|NCT01714063|20400989|P1|Overall Study|Equipment malfunction|2
5896239|NCT01713998|20401026|P3|Overall Study|Withdrawal by Subject|0
5896240|NCT01713998|20401027|P2|Overall Study|Withdrawal by Subject|0
5896241|NCT01713998|20401028|P1|Overall Study|Withdrawal by Subject|1
5896242|NCT01713998|20401026|P3|Overall Study|Lost to Follow-up|2
5896243|NCT01713998|20401027|P2|Overall Study|Lost to Follow-up|0
5896244|NCT01713998|20401028|P1|Overall Study|Lost to Follow-up|2
5896245|NCT01713946|20401049|P3|Overall Study|Patients never switched to everolimus|5
5896246|NCT01713946|20401050|P2|Overall Study|Patients never switched to everolimus|0
5896247|NCT01713946|20401051|P1|Overall Study|Patients never switched to everolimus|0
5896248|NCT01713946|20401049|P3|Overall Study|Did not continue in Post-Ext. Phase|0
5896249|NCT01713946|20401050|P2|Overall Study|Did not continue in Post-Ext. Phase|2
5896250|NCT01713946|20401051|P1|Overall Study|Did not continue in Post-Ext. Phase|1
5896251|NCT01713946|20401049|P3|Overall Study|Did not continue in Ext|0
5896252|NCT01713946|20401050|P2|Overall Study|Did not continue in Ext|3
5896253|NCT01713946|20401051|P1|Overall Study|Did not continue in Ext|0
5896254|NCT01713946|20401049|P3|Overall Study|Administrative problems|0
5896255|NCT01713946|20401050|P2|Overall Study|Administrative problems|0
5896256|NCT01713946|20401051|P1|Overall Study|Administrative problems|1
5896257|NCT01713946|20401049|P3|Overall Study|Lost to Follow-up|1
5896258|NCT01713946|20401050|P2|Overall Study|Lost to Follow-up|0
5896259|NCT01713946|20401051|P1|Overall Study|Lost to Follow-up|0
5896261|NCT01713946|20401050|P2|Overall Study|Protocol Violation|4
5896262|NCT01713946|20401051|P1|Overall Study|Protocol Violation|2
5896263|NCT01713946|20401049|P3|Overall Study|Lack of Efficacy|14
5896264|NCT01713946|20401050|P2|Overall Study|Lack of Efficacy|8
5896265|NCT01713946|20401051|P1|Overall Study|Lack of Efficacy|8
5896266|NCT01713946|20401049|P3|Overall Study|Withdrawal by Subject|8
5896267|NCT01713946|20401050|P2|Overall Study|Withdrawal by Subject|12
5896268|NCT01713946|20401051|P1|Overall Study|Withdrawal by Subject|12
5896269|NCT01713946|20401049|P3|Overall Study|Adverse Event|13
5896270|NCT01713946|20401050|P2|Overall Study|Adverse Event|14
5896271|NCT01713946|20401051|P1|Overall Study|Adverse Event|19
5896272|NCT01713946|20401049|P3|Overall Study|Death|2
5896273|NCT01713946|20401050|P2|Overall Study|Death|2
5896274|NCT01713946|20401051|P1|Overall Study|Death|0
5896275|NCT01713933|20401142|P1|Overall Study|Excluded from analysis as a BMI outlier|1
5896276|NCT01713933|20401142|P1|Overall Study|Withdrawal by Subject|3
5896277|NCT01713933|20401142|P1|Overall Study|Lost to Follow-up|2
5896278|NCT01713686|20401191|P1|Overall Study|Withdrawal by Subject|6
5896279|NCT01713686|20401191|P1|Overall Study|Lost to Follow-up|9
5896280|NCT01713582|20401261|P21|Overall Study|Disease progression and adverse event|0
5896281|NCT01713582|20401262|P20|Overall Study|Disease progression and adverse event|0
5896282|NCT01713582|20401263|P19|Overall Study|Disease progression and adverse event|0
5896283|NCT01713582|20401264|P18|Overall Study|Disease progression and adverse event|0
5896284|NCT01713582|20401265|P17|Overall Study|Disease progression and adverse event|1
5896285|NCT01713582|20401266|P16|Overall Study|Disease progression and adverse event|0
5896286|NCT01713582|20401267|P15|Overall Study|Disease progression and adverse event|0
5896287|NCT01713582|20401268|P14|Overall Study|Disease progression and adverse event|0
5896288|NCT01713582|20401269|P13|Overall Study|Disease progression and adverse event|0
5896289|NCT01713582|20401270|P12|Overall Study|Disease progression and adverse event|0
5896290|NCT01713582|20401271|P11|Overall Study|Disease progression and adverse event|0
5896291|NCT01713582|20401272|P10|Overall Study|Disease progression and adverse event|0
5896292|NCT01713582|20401273|P9|Overall Study|Disease progression and adverse event|0
5896293|NCT01713582|20401274|P8|Overall Study|Disease progression and adverse event|0
5896294|NCT01713582|20401275|P7|Overall Study|Disease progression and adverse event|0
5896295|NCT01713582|20401276|P6|Overall Study|Disease progression and adverse event|0
5896296|NCT01713582|20401277|P5|Overall Study|Disease progression and adverse event|0
5896297|NCT01713582|20401278|P4|Overall Study|Disease progression and adverse event|0
5896298|NCT01713582|20401279|P3|Overall Study|Disease progression and adverse event|0
5896299|NCT01713582|20401280|P2|Overall Study|Disease progression and adverse event|0
5896300|NCT01713582|20401281|P1|Overall Study|Disease progression and adverse event|0
5896301|NCT01713582|20401261|P21|Overall Study|Stopped to receive bone marrow graft|0
5896302|NCT01713582|20401262|P20|Overall Study|Stopped to receive bone marrow graft|0
5896303|NCT01713582|20401263|P19|Overall Study|Stopped to receive bone marrow graft|0
5896304|NCT01713582|20401264|P18|Overall Study|Stopped to receive bone marrow graft|0
5896305|NCT01713582|20401265|P17|Overall Study|Stopped to receive bone marrow graft|1
5896306|NCT01713582|20401266|P16|Overall Study|Stopped to receive bone marrow graft|0
5896307|NCT01713582|20401267|P15|Overall Study|Stopped to receive bone marrow graft|0
5896308|NCT01713582|20401268|P14|Overall Study|Stopped to receive bone marrow graft|0
5896309|NCT01713582|20401269|P13|Overall Study|Stopped to receive bone marrow graft|0
5896310|NCT01713582|20401270|P12|Overall Study|Stopped to receive bone marrow graft|0
5896311|NCT01713582|20401271|P11|Overall Study|Stopped to receive bone marrow graft|0
5896312|NCT01713582|20401272|P10|Overall Study|Stopped to receive bone marrow graft|0
5896313|NCT01713582|20401273|P9|Overall Study|Stopped to receive bone marrow graft|0
5896314|NCT01713582|20401274|P8|Overall Study|Stopped to receive bone marrow graft|0
5896315|NCT01713582|20401275|P7|Overall Study|Stopped to receive bone marrow graft|0
5896316|NCT01713582|20401276|P6|Overall Study|Stopped to receive bone marrow graft|0
5896317|NCT01713582|20401277|P5|Overall Study|Stopped to receive bone marrow graft|0
5896318|NCT01713582|20401278|P4|Overall Study|Stopped to receive bone marrow graft|0
5896319|NCT01713582|20401279|P3|Overall Study|Stopped to receive bone marrow graft|0
5896320|NCT01713582|20401280|P2|Overall Study|Stopped to receive bone marrow graft|0
5896321|NCT01713582|20401281|P1|Overall Study|Stopped to receive bone marrow graft|0
5896322|NCT01713582|20401261|P21|Overall Study|Withdrawal by Subject|0
5896323|NCT01713582|20401262|P20|Overall Study|Withdrawal by Subject|0
5896324|NCT01713582|20401263|P19|Overall Study|Withdrawal by Subject|0
5896325|NCT01713582|20401264|P18|Overall Study|Withdrawal by Subject|1
5896326|NCT01713582|20401265|P17|Overall Study|Withdrawal by Subject|0
5896327|NCT01713582|20401266|P16|Overall Study|Withdrawal by Subject|0
5896328|NCT01713582|20401267|P15|Overall Study|Withdrawal by Subject|0
5896329|NCT01713582|20401268|P14|Overall Study|Withdrawal by Subject|0
5896330|NCT01713582|20401269|P13|Overall Study|Withdrawal by Subject|0
5896331|NCT01713582|20401270|P12|Overall Study|Withdrawal by Subject|0
5896332|NCT01713582|20401271|P11|Overall Study|Withdrawal by Subject|0
5896333|NCT01713582|20401272|P10|Overall Study|Withdrawal by Subject|0
5896334|NCT01713582|20401273|P9|Overall Study|Withdrawal by Subject|0
5896335|NCT01713582|20401274|P8|Overall Study|Withdrawal by Subject|0
5896336|NCT01713582|20401275|P7|Overall Study|Withdrawal by Subject|0
5896337|NCT01713582|20401276|P6|Overall Study|Withdrawal by Subject|0
5896338|NCT01713582|20401277|P5|Overall Study|Withdrawal by Subject|0
5896339|NCT01713582|20401278|P4|Overall Study|Withdrawal by Subject|0
5896340|NCT01713582|20401279|P3|Overall Study|Withdrawal by Subject|0
5896341|NCT01713582|20401280|P2|Overall Study|Withdrawal by Subject|0
5896342|NCT01713582|20401281|P1|Overall Study|Withdrawal by Subject|0
5896343|NCT01713582|20401261|P21|Overall Study|Lack of Efficacy|0
5896344|NCT01713582|20401262|P20|Overall Study|Lack of Efficacy|0
5896345|NCT01713582|20401263|P19|Overall Study|Lack of Efficacy|0
5896346|NCT01713582|20401264|P18|Overall Study|Lack of Efficacy|0
5896347|NCT01713582|20401265|P17|Overall Study|Lack of Efficacy|0
5896348|NCT01713582|20401266|P16|Overall Study|Lack of Efficacy|0
5896349|NCT01713582|20401267|P15|Overall Study|Lack of Efficacy|0
5896350|NCT01713582|20401268|P14|Overall Study|Lack of Efficacy|0
5896351|NCT01713582|20401269|P13|Overall Study|Lack of Efficacy|0
5896352|NCT01713582|20401270|P12|Overall Study|Lack of Efficacy|0
5896353|NCT01713582|20401271|P11|Overall Study|Lack of Efficacy|2
5896354|NCT01713582|20401272|P10|Overall Study|Lack of Efficacy|1
5896355|NCT01713582|20401273|P9|Overall Study|Lack of Efficacy|0
5896356|NCT01713582|20401274|P8|Overall Study|Lack of Efficacy|0
5896357|NCT01713582|20401275|P7|Overall Study|Lack of Efficacy|0
5896358|NCT01713582|20401276|P6|Overall Study|Lack of Efficacy|0
5896359|NCT01713582|20401277|P5|Overall Study|Lack of Efficacy|0
5896360|NCT01713582|20401278|P4|Overall Study|Lack of Efficacy|0
5896361|NCT01713582|20401279|P3|Overall Study|Lack of Efficacy|0
5896362|NCT01713582|20401280|P2|Overall Study|Lack of Efficacy|0
5896363|NCT01713582|20401281|P1|Overall Study|Lack of Efficacy|0
5896364|NCT01713582|20401261|P21|Overall Study|Withdrawal of consent|0
5896365|NCT01713582|20401262|P20|Overall Study|Withdrawal of consent|0
5896366|NCT01713582|20401263|P19|Overall Study|Withdrawal of consent|1
5896367|NCT01713582|20401264|P18|Overall Study|Withdrawal of consent|0
5896368|NCT01713582|20401265|P17|Overall Study|Withdrawal of consent|0
5896369|NCT01713582|20401266|P16|Overall Study|Withdrawal of consent|0
5896370|NCT01713582|20401267|P15|Overall Study|Withdrawal of consent|0
5896371|NCT01713582|20401268|P14|Overall Study|Withdrawal of consent|0
5896372|NCT01713582|20401269|P13|Overall Study|Withdrawal of consent|0
5896373|NCT01713582|20401270|P12|Overall Study|Withdrawal of consent|0
5896374|NCT01713582|20401271|P11|Overall Study|Withdrawal of consent|0
5896375|NCT01713582|20401272|P10|Overall Study|Withdrawal of consent|1
5896376|NCT01713582|20401273|P9|Overall Study|Withdrawal of consent|0
5896377|NCT01713582|20401274|P8|Overall Study|Withdrawal of consent|0
5896378|NCT01713582|20401275|P7|Overall Study|Withdrawal of consent|0
5896379|NCT01713582|20401276|P6|Overall Study|Withdrawal of consent|1
5896380|NCT01713582|20401277|P5|Overall Study|Withdrawal of consent|0
5896381|NCT01713582|20401278|P4|Overall Study|Withdrawal of consent|0
5896382|NCT01713582|20401279|P3|Overall Study|Withdrawal of consent|1
5896383|NCT01713582|20401280|P2|Overall Study|Withdrawal of consent|0
5896384|NCT01713582|20401281|P1|Overall Study|Withdrawal of consent|0
5896385|NCT01713582|20401261|P21|Overall Study|Adverse event-unrelated|0
5896386|NCT01713582|20401262|P20|Overall Study|Adverse event-unrelated|0
5896387|NCT01713582|20401263|P19|Overall Study|Adverse event-unrelated|0
5896388|NCT01713582|20401264|P18|Overall Study|Adverse event-unrelated|0
5896389|NCT01713582|20401265|P17|Overall Study|Adverse event-unrelated|0
5896390|NCT01713582|20401266|P16|Overall Study|Adverse event-unrelated|0
5896391|NCT01713582|20401267|P15|Overall Study|Adverse event-unrelated|1
5896392|NCT01713582|20401268|P14|Overall Study|Adverse event-unrelated|1
5896393|NCT01713582|20401269|P13|Overall Study|Adverse event-unrelated|0
5896394|NCT01713582|20401270|P12|Overall Study|Adverse event-unrelated|0
5896395|NCT01713582|20401271|P11|Overall Study|Adverse event-unrelated|0
5896396|NCT01713582|20401272|P10|Overall Study|Adverse event-unrelated|0
5896397|NCT01713582|20401273|P9|Overall Study|Adverse event-unrelated|0
5896398|NCT01713582|20401274|P8|Overall Study|Adverse event-unrelated|1
5896399|NCT01713582|20401275|P7|Overall Study|Adverse event-unrelated|1
5896400|NCT01713582|20401276|P6|Overall Study|Adverse event-unrelated|1
5896401|NCT01713582|20401277|P5|Overall Study|Adverse event-unrelated|0
5896402|NCT01713582|20401278|P4|Overall Study|Adverse event-unrelated|0
5896403|NCT01713582|20401279|P3|Overall Study|Adverse event-unrelated|0
5896404|NCT01713582|20401280|P2|Overall Study|Adverse event-unrelated|0
5896405|NCT01713582|20401281|P1|Overall Study|Adverse event-unrelated|0
5896406|NCT01713582|20401261|P21|Overall Study|Adverse event-related|0
5896407|NCT01713582|20401262|P20|Overall Study|Adverse event-related|0
5896408|NCT01713582|20401263|P19|Overall Study|Adverse event-related|1
5896409|NCT01713582|20401264|P18|Overall Study|Adverse event-related|0
5896410|NCT01713582|20401265|P17|Overall Study|Adverse event-related|0
5896411|NCT01713582|20401266|P16|Overall Study|Adverse event-related|0
5896412|NCT01713582|20401267|P15|Overall Study|Adverse event-related|0
5896413|NCT01713582|20401268|P14|Overall Study|Adverse event-related|0
5896414|NCT01713582|20401269|P13|Overall Study|Adverse event-related|0
5896415|NCT01713582|20401270|P12|Overall Study|Adverse event-related|0
5896416|NCT01713582|20401271|P11|Overall Study|Adverse event-related|1
5896417|NCT01713582|20401272|P10|Overall Study|Adverse event-related|1
5896418|NCT01713582|20401273|P9|Overall Study|Adverse event-related|0
5896419|NCT01713582|20401274|P8|Overall Study|Adverse event-related|0
5896420|NCT01713582|20401275|P7|Overall Study|Adverse event-related|0
5896421|NCT01713582|20401276|P6|Overall Study|Adverse event-related|0
5896422|NCT01713582|20401277|P5|Overall Study|Adverse event-related|0
5896423|NCT01713582|20401278|P4|Overall Study|Adverse event-related|0
5896424|NCT01713582|20401279|P3|Overall Study|Adverse event-related|0
5896425|NCT01713582|20401280|P2|Overall Study|Adverse event-related|0
5896426|NCT01713582|20401281|P1|Overall Study|Adverse event-related|0
5896427|NCT01713582|20401261|P21|Overall Study|Death|0
5896428|NCT01713582|20401262|P20|Overall Study|Death|0
5896429|NCT01713582|20401263|P19|Overall Study|Death|0
5896430|NCT01713582|20401264|P18|Overall Study|Death|0
5896431|NCT01713582|20401265|P17|Overall Study|Death|0
5896432|NCT01713582|20401266|P16|Overall Study|Death|0
5896433|NCT01713582|20401267|P15|Overall Study|Death|0
5896434|NCT01713582|20401268|P14|Overall Study|Death|0
5896435|NCT01713582|20401269|P13|Overall Study|Death|0
5896436|NCT01713582|20401270|P12|Overall Study|Death|0
5896437|NCT01713582|20401271|P11|Overall Study|Death|3
5896438|NCT01713582|20401272|P10|Overall Study|Death|4
5896439|NCT01713582|20401273|P9|Overall Study|Death|3
5896440|NCT01713582|20401274|P8|Overall Study|Death|2
5896441|NCT01713582|20401275|P7|Overall Study|Death|3
5896442|NCT01713582|20401276|P6|Overall Study|Death|3
5896443|NCT01713582|20401277|P5|Overall Study|Death|1
5896444|NCT01713582|20401278|P4|Overall Study|Death|1
5896445|NCT01713582|20401279|P3|Overall Study|Death|0
5896446|NCT01713582|20401280|P2|Overall Study|Death|0
5896447|NCT01713582|20401281|P1|Overall Study|Death|0
5896448|NCT01713582|20401261|P21|Overall Study|Disease progression|15
5896449|NCT01713582|20401262|P20|Overall Study|Disease progression|5
5896450|NCT01713582|20401263|P19|Overall Study|Disease progression|3
5896451|NCT01713582|20401264|P18|Overall Study|Disease progression|2
5896452|NCT01713582|20401265|P17|Overall Study|Disease progression|5
5896453|NCT01713582|20401266|P16|Overall Study|Disease progression|6
5896454|NCT01713582|20401267|P15|Overall Study|Disease progression|6
5896455|NCT01713582|20401268|P14|Overall Study|Disease progression|3
5896456|NCT01713582|20401269|P13|Overall Study|Disease progression|3
5896457|NCT01713582|20401270|P12|Overall Study|Disease progression|5
5896458|NCT01713582|20401271|P11|Overall Study|Disease progression|10
5896459|NCT01713582|20401272|P10|Overall Study|Disease progression|11
5896460|NCT01713582|20401273|P9|Overall Study|Disease progression|3
5896461|NCT01713582|20401274|P8|Overall Study|Disease progression|3
5896462|NCT01713582|20401275|P7|Overall Study|Disease progression|3
5896463|NCT01713582|20401276|P6|Overall Study|Disease progression|3
5896464|NCT01713582|20401277|P5|Overall Study|Disease progression|3
5896465|NCT01713582|20401278|P4|Overall Study|Disease progression|2
5896466|NCT01713582|20401279|P3|Overall Study|Disease progression|3
5896467|NCT01713582|20401280|P2|Overall Study|Disease progression|3
5896468|NCT01713582|20401281|P1|Overall Study|Disease progression|3
5896469|NCT01713530|20401444|P2|Overall Study|Unclassified|2
5896470|NCT01713530|20401445|P1|Overall Study|Unclassified|4
5896471|NCT01713530|20401444|P2|Overall Study|Withdrawal criteria|12
5896472|NCT01713530|20401445|P1|Overall Study|Withdrawal criteria|21
5896473|NCT01713530|20401444|P2|Overall Study|Adverse Event|5
5896474|NCT01713530|20401445|P1|Overall Study|Adverse Event|0
5896475|NCT01713348|20401476|P4|Overall Study|Lost to Follow-up|0
5896476|NCT01713348|20401477|P3|Overall Study|Lost to Follow-up|0
5896477|NCT01713348|20401478|P2|Overall Study|Lost to Follow-up|0
5896478|NCT01713348|20401479|P1|Overall Study|Lost to Follow-up|1
5896479|NCT01713348|20401476|P4|Overall Study|Withdrawal by Subject|0
5896480|NCT01713348|20401477|P3|Overall Study|Withdrawal by Subject|2
5896481|NCT01713348|20401478|P2|Overall Study|Withdrawal by Subject|2
5896482|NCT01713348|20401479|P1|Overall Study|Withdrawal by Subject|3
5896483|NCT01713283|20401509|P2|Overall Study|Lost to Follow-up|1
5896484|NCT01713283|20401510|P1|Overall Study|Lost to Follow-up|1
5896485|NCT01713283|20401509|P2|Overall Study|Lack of Efficacy|2
5896486|NCT01713283|20401510|P1|Overall Study|Lack of Efficacy|10
5896487|NCT01713036|20401532|P1|Overall Study|Death|1
5896488|NCT01712984|20401572|P3|Overall Study|Withdrawal by Subject|7
5896489|NCT01712984|20401573|P2|Overall Study|Withdrawal by Subject|6
5896490|NCT01712984|20401574|P1|Overall Study|Withdrawal by Subject|6
5896491|NCT01712984|20401572|P3|Overall Study|Lost to Follow-up|1
5896492|NCT01712984|20401573|P2|Overall Study|Lost to Follow-up|10
5896493|NCT01712984|20401574|P1|Overall Study|Lost to Follow-up|8
5896494|NCT01712984|20401572|P3|Overall Study|Protocol Violation|1
5896495|NCT01712984|20401573|P2|Overall Study|Protocol Violation|0
5896496|NCT01712984|20401574|P1|Overall Study|Protocol Violation|2
5896497|NCT01712984|20401572|P3|Overall Study|Adverse Event|1
5896498|NCT01712984|20401573|P2|Overall Study|Adverse Event|0
5896499|NCT01712984|20401574|P1|Overall Study|Adverse Event|0
5896500|NCT01712854|20401594|P1|Overall Study|Physician Decision|1
5896501|NCT01712685|20401617|P1|Overall Study|pt declined to participate before trmt|1
5896502|NCT01712516|20401633|P4|Overall Study|Withdrawal by Subject|9
5896503|NCT01712516|20401634|P3|Overall Study|Withdrawal by Subject|3
5896504|NCT01712516|20401635|P2|Overall Study|Withdrawal by Subject|9
5896505|NCT01712516|20401636|P1|Overall Study|Withdrawal by Subject|3
5896506|NCT01712516|20401633|P4|Overall Study|Physician Decision|1
5896507|NCT01712516|20401634|P3|Overall Study|Physician Decision|0
5896508|NCT01712516|20401635|P2|Overall Study|Physician Decision|0
5896509|NCT01712516|20401636|P1|Overall Study|Physician Decision|2
5896510|NCT01712516|20401633|P4|Overall Study|Protocol deviation|0
5896511|NCT01712516|20401634|P3|Overall Study|Protocol deviation|1
5896512|NCT01712516|20401635|P2|Overall Study|Protocol deviation|0
5896513|NCT01712516|20401636|P1|Overall Study|Protocol deviation|1
5896514|NCT01712516|20401633|P4|Overall Study|Death|0
5896515|NCT01712516|20401634|P3|Overall Study|Death|0
5896516|NCT01712516|20401635|P2|Overall Study|Death|1
5896517|NCT01712516|20401636|P1|Overall Study|Death|0
5896518|NCT01712516|20401633|P4|Overall Study|Lost to Follow-up|1
5896519|NCT01712516|20401634|P3|Overall Study|Lost to Follow-up|2
5896520|NCT01712516|20401635|P2|Overall Study|Lost to Follow-up|0
5896521|NCT01712516|20401636|P1|Overall Study|Lost to Follow-up|0
5896522|NCT01712516|20401633|P4|Overall Study|Technical problems|2
5896523|NCT01712516|20401634|P3|Overall Study|Technical problems|0
5896524|NCT01712516|20401635|P2|Overall Study|Technical problems|0
5896525|NCT01712516|20401636|P1|Overall Study|Technical problems|0
5896526|NCT01712490|20401688|P2|Overall Study|Lost to Follow-up|29
5896527|NCT01712490|20401689|P1|Overall Study|Lost to Follow-up|16
5896528|NCT01712490|20401688|P2|Overall Study|Withdrawal by Subject|44
5896529|NCT01712490|20401689|P1|Overall Study|Withdrawal by Subject|36
5896530|NCT01712490|20401688|P2|Overall Study|Other|11
5896531|NCT01712490|20401689|P1|Overall Study|Other|11
5896532|NCT01712490|20401688|P2|Overall Study|Ongoing|586
5896533|NCT01712490|20401689|P1|Overall Study|Ongoing|601
5896534|NCT01712438|20401726|P1|Overall Study|Prematurely Discontinued|25
5896535|NCT01712438|20401726|P1|Overall Study|Violated inclusion & exclusion criteria|4
5896536|NCT01712438|20401726|P1|Overall Study|Ongoing ITI treatment|6
5896537|NCT01712438|20401726|P1|Overall Study|Not treated with Human-cl rhFVIII|2
5896538|NCT01712399|20401736|P1|Overall Study|Study closure|345
5896539|NCT01712399|20401736|P1|Overall Study|Adverse Event|11
5896540|NCT01712399|20401736|P1|Overall Study|Death|1
5896541|NCT01712399|20401736|P1|Overall Study|Withdrawal by Subject|39
5896542|NCT01712399|20401736|P1|Overall Study|Lost to Follow-up|1
5896543|NCT01712334|20401782|P2|Treatment Period 1|Randomized in Error|2
5896544|NCT01712334|20401783|P1|Treatment Period 1|Randomized in Error|0
5896545|NCT01712256|20401791|P1|Overall Study|Lost to Follow-up|1
5896546|NCT01712204|20401821|P2|Overall Study|Protocol Violation|1
5896547|NCT01712204|20401822|P1|Overall Study|Protocol Violation|1
5896548|NCT01712204|20401821|P2|Overall Study|Lost to Follow-up|0
5896549|NCT01712204|20401822|P1|Overall Study|Lost to Follow-up|1
5896550|NCT01712204|20401821|P2|Overall Study|Withdrawal by Subject|3
5896551|NCT01712204|20401822|P1|Overall Study|Withdrawal by Subject|3
5896552|NCT01712204|20401821|P2|Overall Study|Adverse Event|1
5896553|NCT01712204|20401822|P1|Overall Study|Adverse Event|3
5896554|NCT01712178|20401830|P2|Overall Study|Lost to Follow-up|1
5896555|NCT01712178|20401831|P1|Overall Study|Lost to Follow-up|0
5896556|NCT01712178|20401830|P2|Overall Study|Serious adverse event/withdrew consent|1
5896557|NCT01712178|20401831|P1|Overall Study|Serious adverse event/withdrew consent|0
5896558|NCT01712178|20401830|P2|Overall Study|Withdrew consent due to an adverse event|1
5896559|NCT01712178|20401831|P1|Overall Study|Withdrew consent due to an adverse event|1
5896560|NCT01712074|20401856|P3|Double Blind Period|No longer met eligibility criteria|0
5896561|NCT01712074|20401857|P2|Double Blind Period|No longer met eligibility criteria|3
5896562|NCT01712074|20401858|P1|Double Blind Period|No longer met eligibility criteria|0
5896563|NCT01712074|20401856|P3|Double Blind Period|Protocol Violation|1
5896564|NCT01712074|20401857|P2|Double Blind Period|Protocol Violation|0
5896565|NCT01712074|20401858|P1|Double Blind Period|Protocol Violation|0
5896566|NCT01712074|20401856|P3|Double Blind Period|Other|1
5896567|NCT01712074|20401857|P2|Double Blind Period|Other|4
5896568|NCT01712074|20401858|P1|Double Blind Period|Other|0
5896569|NCT01712074|20401856|P3|Double Blind Period|Lost to Follow-up|1
5896570|NCT01712074|20401857|P2|Double Blind Period|Lost to Follow-up|2
5896571|NCT01712074|20401858|P1|Double Blind Period|Lost to Follow-up|0
5896572|NCT01712074|20401856|P3|Double Blind Period|Death|0
5896573|NCT01712074|20401857|P2|Double Blind Period|Death|1
5896574|NCT01712074|20401858|P1|Double Blind Period|Death|0
5896575|NCT01712074|20401856|P3|Double Blind Period|No longer willing to participate|4
5896576|NCT01712074|20401857|P2|Double Blind Period|No longer willing to participate|2
5896577|NCT01712074|20401858|P1|Double Blind Period|No longer willing to participate|0
5896578|NCT01712074|20401856|P3|Double Blind Period|Adverse Event|1
5896579|NCT01712074|20401857|P2|Double Blind Period|Adverse Event|2
5896580|NCT01712074|20401858|P1|Double Blind Period|Adverse Event|0
5896581|NCT01712074|20401856|P3|Placebo Run-in Period|No longer willing to participate|0
5896582|NCT01712074|20401857|P2|Placebo Run-in Period|No longer willing to participate|0
5896583|NCT01712074|20401858|P1|Placebo Run-in Period|No longer willing to participate|1
5896584|NCT01712074|20401856|P3|Placebo Run-in Period|Other|0
5896585|NCT01712074|20401857|P2|Placebo Run-in Period|Other|0
5896586|NCT01712074|20401858|P1|Placebo Run-in Period|Other|1
5896587|NCT01712074|20401856|P3|Placebo Run-in Period|No longer meets eligibility criteria|0
5896588|NCT01712074|20401857|P2|Placebo Run-in Period|No longer meets eligibility criteria|0
5896589|NCT01712074|20401858|P1|Placebo Run-in Period|No longer meets eligibility criteria|5
5896590|NCT01712074|20401856|P3|Placebo Run-in Period|Lost to Follow-up|0
5896591|NCT01712074|20401857|P2|Placebo Run-in Period|Lost to Follow-up|0
5896592|NCT01712074|20401858|P1|Placebo Run-in Period|Lost to Follow-up|1
5896593|NCT01712074|20401856|P3|Placebo Run-in Period|Adverse Event|0
5896594|NCT01712074|20401857|P2|Placebo Run-in Period|Adverse Event|0
5896595|NCT01712074|20401858|P1|Placebo Run-in Period|Adverse Event|2
5896596|NCT01712061|20401914|P3|Overall Study|Other|0
5896597|NCT01712061|20401915|P2|Overall Study|Other|3
5896598|NCT01712061|20401916|P1|Overall Study|Other|0
5896599|NCT01712061|20401914|P3|Overall Study|Withdrawal by Subject|1
5896600|NCT01712061|20401915|P2|Overall Study|Withdrawal by Subject|7
5896601|NCT01712061|20401916|P1|Overall Study|Withdrawal by Subject|1
5896602|NCT01712061|20401914|P3|Overall Study|Medication Error Without Associated AE|0
5896603|NCT01712061|20401915|P2|Overall Study|Medication Error Without Associated AE|1
5896604|NCT01712061|20401916|P1|Overall Study|Medication Error Without Associated AE|0
5896605|NCT01712061|20401914|P3|Overall Study|Did Not Meet Entrance Criteria|3
5896606|NCT01712061|20401915|P2|Overall Study|Did Not Meet Entrance Criteria|6
5896607|NCT01712061|20401916|P1|Overall Study|Did Not Meet Entrance Criteria|4
5896608|NCT01712061|20401914|P3|Overall Study|Lost to Follow-up|1
5896609|NCT01712061|20401915|P2|Overall Study|Lost to Follow-up|0
5896610|NCT01712061|20401916|P1|Overall Study|Lost to Follow-up|1
5896611|NCT01712061|20401914|P3|Overall Study|Death|1
5896612|NCT01712061|20401915|P2|Overall Study|Death|0
5896613|NCT01712061|20401916|P1|Overall Study|Death|0
5896614|NCT01712061|20401914|P3|Overall Study|Adverse Event|5
5896615|NCT01712061|20401915|P2|Overall Study|Adverse Event|9
5896616|NCT01712061|20401916|P1|Overall Study|Adverse Event|4
5896617|NCT01712009|20401956|P3|Overall Study|Decision by Sponsor|12
5896618|NCT01712009|20401957|P2|Overall Study|Decision by Sponsor|14
5896619|NCT01712009|20401958|P1|Overall Study|Decision by Sponsor|12
5896620|NCT01712009|20401956|P3|Overall Study|Lost to Follow-up|1
5896621|NCT01712009|20401957|P2|Overall Study|Lost to Follow-up|0
5896622|NCT01712009|20401958|P1|Overall Study|Lost to Follow-up|2
5896623|NCT01712009|20401956|P3|Overall Study|Withdrawal by Subject|8
5896624|NCT01712009|20401957|P2|Overall Study|Withdrawal by Subject|15
5896625|NCT01712009|20401958|P1|Overall Study|Withdrawal by Subject|24
5896626|NCT01711983|20401984|P1|36-Month Closure Evaluation|Missed Echocardiograph|62
5896627|NCT01711983|20401984|P1|36-Month Closure Evaluation|Test Device Removal|2
5896628|NCT01711983|20401984|P1|6-Month Closure Evaluation|Technical Failure (No Test Device)|26
5896629|NCT01711983|20401984|P1|6-Month Clinical Success Evaluation|Missed Echocardiograph|32
5896630|NCT01711879|20402004|P2|Overall Study|Death|0
5896631|NCT01711879|20402005|P1|Overall Study|Death|1
5896632|NCT01711866|20402039|P1|Overall Study|Adverse Event|2
5896633|NCT01711866|20402039|P1|Overall Study|Withdrawal by Subject|3
5896634|NCT01711866|20402039|P1|Overall Study|Noncompliant|3
5896635|NCT01711853|20402044|P1|Overall Study|Not treated|3
5896636|NCT01711736|20402051|P2|Overall Study|Migrated/moved from study area|1
5896637|NCT01711736|20402052|P1|Overall Study|Migrated/moved from study area|2
5896638|NCT01711736|20402051|P2|Overall Study|Withdrawal by Subject|6
5896639|NCT01711736|20402052|P1|Overall Study|Withdrawal by Subject|6
5896640|NCT01711736|20402051|P2|Overall Study|Lost to Follow-up|1
5896641|NCT01711736|20402052|P1|Overall Study|Lost to Follow-up|4
5896642|NCT01711645|20402080|P1|Overall Study|Physician Decision|5
5896643|NCT01711645|20402080|P1|Overall Study|Lost to Follow-up|6
5896644|NCT01711645|20402080|P1|Overall Study|Withdrawal by Subject|8
5896645|NCT01711619|20402117|P2|Overall Study|Lost to Follow-up|0
5896646|NCT01711619|20402118|P1|Overall Study|Lost to Follow-up|1
5896647|NCT01711619|20402117|P2|Overall Study|Adverse Event|0
5896648|NCT01711619|20402118|P1|Overall Study|Adverse Event|2
5896649|NCT01711619|20402117|P2|Overall Study|Protocol Violation|3
5896650|NCT01711619|20402118|P1|Overall Study|Protocol Violation|2
5896651|NCT01711619|20402117|P2|Overall Study|Withdrawal by Subject|7
5896652|NCT01711619|20402118|P1|Overall Study|Withdrawal by Subject|3
5896653|NCT01711619|20402117|P2|Overall Study|Early study termination|14
5896654|NCT01711619|20402118|P1|Overall Study|Early study termination|10
5896655|NCT01711541|20402135|P5|Overall Study|Ineligible|0
5896656|NCT01711541|20402136|P4|Overall Study|Ineligible|0
5896657|NCT01711541|20402137|P3|Overall Study|Ineligible|0
5896658|NCT01711541|20402138|P2|Overall Study|Ineligible|1
5896659|NCT01711541|20402139|P1|Overall Study|Ineligible|0
5896660|NCT01711541|20402135|P5|Overall Study|Cancel prior to treatment|0
5896661|NCT01711541|20402136|P4|Overall Study|Cancel prior to treatment|1
5896662|NCT01711541|20402137|P3|Overall Study|Cancel prior to treatment|0
5896663|NCT01711541|20402138|P2|Overall Study|Cancel prior to treatment|0
5896664|NCT01711541|20402139|P1|Overall Study|Cancel prior to treatment|0
5896665|NCT01711359|20402188|P3|Treatment Period|Randomized, Not Treated|0
5896666|NCT01711359|20402189|P2|Treatment Period|Randomized, Not Treated|1
5896667|NCT01711359|20402190|P1|Treatment Period|Randomized, Not Treated|3
5896668|NCT01711359|20402188|P3|Treatment Period|Lost to Follow-up|1
5896669|NCT01711359|20402189|P2|Treatment Period|Lost to Follow-up|1
5896670|NCT01711359|20402190|P1|Treatment Period|Lost to Follow-up|1
5896671|NCT01711359|20402188|P3|Treatment Period|Sponsor Decision|0
5896672|NCT01711359|20402189|P2|Treatment Period|Sponsor Decision|0
5896673|NCT01711359|20402190|P1|Treatment Period|Sponsor Decision|1
5896674|NCT01711359|20402188|P3|Treatment Period|Entry Criteria Not Met|0
5896675|NCT01711359|20402189|P2|Treatment Period|Entry Criteria Not Met|0
5896676|NCT01711359|20402190|P1|Treatment Period|Entry Criteria Not Met|1
5896677|NCT01711359|20402188|P3|Treatment Period|Death|0
5896678|NCT01711359|20402189|P2|Treatment Period|Death|0
5896679|NCT01711359|20402190|P1|Treatment Period|Death|3
5896680|NCT01711359|20402188|P3|Treatment Period|Physician Decision|2
5896681|NCT01711359|20402189|P2|Treatment Period|Physician Decision|3
5896682|NCT01711359|20402190|P1|Treatment Period|Physician Decision|4
5896683|NCT01711359|20402188|P3|Treatment Period|Adverse Event|24
5896684|NCT01711359|20402189|P2|Treatment Period|Adverse Event|10
5896685|NCT01711359|20402190|P1|Treatment Period|Adverse Event|8
5896686|NCT01711359|20402188|P3|Treatment Period|Lack of Efficacy|2
5896687|NCT01711359|20402189|P2|Treatment Period|Lack of Efficacy|2
5896688|NCT01711359|20402190|P1|Treatment Period|Lack of Efficacy|13
5896689|NCT01711359|20402188|P3|Treatment Period|Withdrawal by Subject|13
5896690|NCT01711359|20402189|P2|Treatment Period|Withdrawal by Subject|7
5896691|NCT01711359|20402190|P1|Treatment Period|Withdrawal by Subject|18
5896692|NCT01711216|20402319|P1|Overall Study|no reason specified|22
5896693|NCT01711216|20402319|P1|Overall Study|variety of other minor reasons|83
5896694|NCT01711216|20402319|P1|Overall Study|Lost to Follow-up|46
5896695|NCT01711216|20402319|P1|Overall Study|Withdrawal by Subject|6
5896696|NCT01711216|20402319|P1|Overall Study|Pregnancy|56
5896697|NCT01711216|20402319|P1|Overall Study|Adverse Event|4
5896698|NCT01710800|20402397|P1|Overall Study|Protocol Violation|1
5896699|NCT01710800|20402397|P1|Overall Study|Withdrawal by Subject|21
5896700|NCT01710709|20402461|P1|Overall Study|Lack of Efficacy|3
5896701|NCT01710709|20402461|P1|Overall Study|Protocol Violation|5
5896702|NCT01710709|20402461|P1|Overall Study|Withdrawal by Subject|53
5896703|NCT01710709|20402461|P1|Overall Study|Participant withdrawn by investigator|2
5896704|NCT01710709|20402461|P1|Overall Study|Participant met withdrawal criteria|33
5896705|NCT01710709|20402461|P1|Overall Study|Adverse Event|48
5896706|NCT01710709|20402461|P1|Overall Study|Lost to Follow-up|29
5896707|NCT01710657|20402476|P3|Overall Study|Lack of Efficacy|1
5896708|NCT01710657|20402477|P2|Overall Study|Lack of Efficacy|1
5896709|NCT01710657|20402478|P1|Overall Study|Lack of Efficacy|0
5896710|NCT01710657|20402476|P3|Overall Study|Withdrawal by Subject|2
5896711|NCT01710657|20402477|P2|Overall Study|Withdrawal by Subject|1
5896712|NCT01710657|20402478|P1|Overall Study|Withdrawal by Subject|0
5896713|NCT01710657|20402476|P3|Overall Study|Adverse Event|28
5896714|NCT01710657|20402477|P2|Overall Study|Adverse Event|8
5896715|NCT01710657|20402478|P1|Overall Study|Adverse Event|14
5896716|NCT01710657|20402476|P3|Overall Study|Protocol Violation|0
5896717|NCT01710657|20402477|P2|Overall Study|Protocol Violation|2
5896718|NCT01710657|20402478|P1|Overall Study|Protocol Violation|2
5896719|NCT01710657|20402476|P3|Overall Study|Lost to Follow-up|1
5896720|NCT01710657|20402477|P2|Overall Study|Lost to Follow-up|0
5896721|NCT01710657|20402478|P1|Overall Study|Lost to Follow-up|2
5896722|NCT01710527|20402495|P2|Period 2: Washout Period (7 Days)|Personal reasons|1
5896723|NCT01710527|20402496|P1|Period 2: Washout Period (7 Days)|Personal reasons|0
5896724|NCT01710514|20402522|P2|Overall Study|Withdrawal by Subject|0
5896725|NCT01710514|20402523|P1|Overall Study|Withdrawal by Subject|1
5896726|NCT01710514|20402522|P2|Overall Study|Adverse Event|7
5896727|NCT01710514|20402523|P1|Overall Study|Adverse Event|6
5896731|NCT01710358|20402578|P3|Rescue Period|Withdrawal by Subject|0
5896732|NCT01710358|20402579|P2|Rescue Period|Withdrawal by Subject|8
5896733|NCT01710358|20402580|P1|Rescue Period|Withdrawal by Subject|0
5896734|NCT01710358|20402578|P3|Rescue Period|Lack of Efficacy|0
5896735|NCT01710358|20402579|P2|Rescue Period|Lack of Efficacy|7
5896736|NCT01710358|20402580|P1|Rescue Period|Lack of Efficacy|0
5896737|NCT01710358|20402578|P3|Rescue Period|Death|0
5896738|NCT01710358|20402579|P2|Rescue Period|Death|1
5896739|NCT01710358|20402580|P1|Rescue Period|Death|0
5896740|NCT01710358|20402578|P3|Rescue Period|Adverse Event|0
5896741|NCT01710358|20402579|P2|Rescue Period|Adverse Event|15
5896742|NCT01710358|20402580|P1|Rescue Period|Adverse Event|0
5896743|NCT01710358|20402578|P3|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|7
5896744|NCT01710358|20402579|P2|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|3
5896745|NCT01710358|20402580|P1|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|4
5896746|NCT01710358|20402578|P3|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|0
5896747|NCT01710358|20402579|P2|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|2
5896748|NCT01710358|20402580|P1|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|1
5896749|NCT01710358|20402578|P3|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0
5896750|NCT01710358|20402579|P2|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|1
5896751|NCT01710358|20402580|P1|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0
5896752|NCT01710358|20402578|P3|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|1
5896753|NCT01710358|20402579|P2|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0
5896754|NCT01710358|20402580|P1|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0
5896755|NCT01710358|20402578|P3|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|1
5896756|NCT01710358|20402579|P2|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0
5896757|NCT01710358|20402580|P1|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0
5896758|NCT01710358|20402578|P3|Treatment Period Part B (Weeks 24 to 52)|Death|1
5896759|NCT01710358|20402579|P2|Treatment Period Part B (Weeks 24 to 52)|Death|0
5896760|NCT01710358|20402580|P1|Treatment Period Part B (Weeks 24 to 52)|Death|1
5896761|NCT01710358|20402578|P3|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|5
5896762|NCT01710358|20402579|P2|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|16
5896763|NCT01710358|20402580|P1|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|10
5896764|NCT01710358|20402578|P3|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|0
5896765|NCT01710358|20402579|P2|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1
5896766|NCT01710358|20402580|P1|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1
5896767|NCT01710358|20402578|P3|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|12
5896768|NCT01710358|20402579|P2|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|5
5896769|NCT01710358|20402580|P1|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|15
5896770|NCT01710358|20402578|P3|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0
5896771|NCT01710358|20402579|P2|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0
5896772|NCT01710358|20402580|P1|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|4
5896773|NCT01710358|20402578|P3|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0
5896774|NCT01710358|20402579|P2|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0
5896775|NCT01710358|20402580|P1|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|1
5896776|NCT01710358|20402578|P3|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0
5896777|NCT01710358|20402579|P2|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|1
5896778|NCT01710358|20402580|P1|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0
5896779|NCT01710358|20402578|P3|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|3
5896780|NCT01710358|20402579|P2|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|1
5896781|NCT01710358|20402580|P1|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|15
5896782|NCT01710358|20402578|P3|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1
5896783|NCT01710358|20402579|P2|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1
5896784|NCT01710358|20402580|P1|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|0
5896785|NCT01710358|20402578|P3|Treatment Period Part A (Weeks 0 to 24)|Death|0
5896786|NCT01710358|20402579|P2|Treatment Period Part A (Weeks 0 to 24)|Death|2
5896787|NCT01710358|20402580|P1|Treatment Period Part A (Weeks 0 to 24)|Death|0
5896788|NCT01710358|20402578|P3|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|7
5896789|NCT01710358|20402579|P2|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|18
5896790|NCT01710358|20402580|P1|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|15
5896791|NCT01710345|20402651|P3|Overall Study|Drug Dosing Error|0
5896792|NCT01710345|20402652|P2|Overall Study|Drug Dosing Error|0
5896793|NCT01710345|20402653|P1|Overall Study|Drug Dosing Error|1
5896794|NCT01710345|20402651|P3|Overall Study|Lack of Efficacy|1
5896795|NCT01710345|20402652|P2|Overall Study|Lack of Efficacy|3
5896796|NCT01710345|20402653|P1|Overall Study|Lack of Efficacy|2
5896797|NCT01710345|20402651|P3|Overall Study|Adverse Event|0
5896798|NCT01710345|20402652|P2|Overall Study|Adverse Event|2
5896799|NCT01710345|20402653|P1|Overall Study|Adverse Event|0
5896800|NCT01710046|20402712|P2|Overall Study|Lost to Follow-up|0
5896801|NCT01710046|20402713|P1|Overall Study|Lost to Follow-up|1
5896802|NCT01710033|20402753|P5|Stage 2|Adverse Event|1
5896803|NCT01710033|20402754|P4|Stage 2|Adverse Event|0
5896804|NCT01710033|20402755|P3|Stage 2|Adverse Event|0
5896805|NCT01710033|20402756|P2|Stage 2|Adverse Event|0
5896806|NCT01710033|20402757|P1|Stage 2|Adverse Event|0
5896807|NCT01710020|20402838|P1|Period 1|Protocol Violation|1
5896808|NCT01709903|20402874|P2|Overall Study|Adverse Event|18
5896809|NCT01709903|20402875|P1|Overall Study|Adverse Event|11
5896810|NCT01709903|20402874|P2|Overall Study|Withdrawal by Subject|6
5896811|NCT01709903|20402875|P1|Overall Study|Withdrawal by Subject|6
5896812|NCT01709903|20402874|P2|Overall Study|Lack of Efficacy|3
5896813|NCT01709903|20402875|P1|Overall Study|Lack of Efficacy|3
5896814|NCT01709903|20402874|P2|Overall Study|Protocol Violation|2
5896815|NCT01709903|20402875|P1|Overall Study|Protocol Violation|3
5896816|NCT01709903|20402874|P2|Overall Study|Death|0
5896817|NCT01709903|20402875|P1|Overall Study|Death|2
5896818|NCT01709903|20402874|P2|Overall Study|Lost to Follow-up|2
5896819|NCT01709903|20402875|P1|Overall Study|Lost to Follow-up|0
5896820|NCT01709903|20402874|P2|Overall Study|no longer needed study drug|1
5896821|NCT01709903|20402875|P1|Overall Study|no longer needed study drug|0
5896822|NCT01709903|20402874|P2|Overall Study|In ability to use device|1
5896823|NCT01709903|20402875|P1|Overall Study|In ability to use device|1
5896824|NCT01709903|20402874|P2|Overall Study|Abnormal test procedure results|0
5896825|NCT01709903|20402875|P1|Overall Study|Abnormal test procedure results|1
5896826|NCT01709903|20402874|P2|Overall Study|administrative problems|6
5896827|NCT01709903|20402875|P1|Overall Study|administrative problems|2
5896828|NCT01709864|20402899|P2|Overall Study|Death|1
5896829|NCT01709864|20402900|P1|Overall Study|Death|0
5896830|NCT01709864|20402899|P2|Overall Study|Adverse Event|2
5896831|NCT01709864|20402900|P1|Overall Study|Adverse Event|0
5896832|NCT01709864|20402899|P2|Overall Study|non-compliance with study treatment|1
5896833|NCT01709864|20402900|P1|Overall Study|non-compliance with study treatment|1
5896834|NCT01709864|20402899|P2|Overall Study|Lost to Follow-up|0
5896835|NCT01709864|20402900|P1|Overall Study|Lost to Follow-up|1
5896836|NCT01709864|20402899|P2|Overall Study|subject/guardian decision|6
5896837|NCT01709864|20402900|P1|Overall Study|subject/guardian decision|5
5896838|NCT01709864|20402899|P2|Overall Study|Physician Decision|1
5896839|NCT01709864|20402900|P1|Overall Study|Physician Decision|0
5896840|NCT01709838|20402934|P1|Overall Study|Protocol Violation|1
5896841|NCT01709838|20402934|P1|Overall Study|Death|3
5896842|NCT01709838|20402934|P1|Overall Study|Physician Decision|4
5896843|NCT01709838|20402934|P1|Overall Study|Adverse Event|4
5896844|NCT01709838|20402934|P1|Overall Study|Subject/guardian decision|8
5896845|NCT01709838|20402934|P1|Overall Study|Pregnancy|10
5896846|NCT01709838|20402934|P1|Overall Study|Lost to Follow-up|16
5896847|NCT01709838|20402934|P1|Overall Study|Withdrawal by Subject|21
5896848|NCT01709708|20402991|P2|Overall Study|Protocol Violation|2
5896849|NCT01709708|20402992|P1|Overall Study|Protocol Violation|1
5896850|NCT01709695|20403016|P2|Overall Study|Withdrawal by Subject|1
5896851|NCT01709695|20403017|P1|Overall Study|Withdrawal by Subject|1
5896852|NCT01709578|20403042|P3|Overall Study|Other, not related to safety or efficacy|5
5896853|NCT01709578|20403043|P2|Overall Study|Other, not related to safety or efficacy|7
5896854|NCT01709578|20403044|P1|Overall Study|Other, not related to safety or efficacy|2
5896855|NCT01709578|20403042|P3|Overall Study|Poor compliance to protocol|1
5896856|NCT01709578|20403043|P2|Overall Study|Poor compliance to protocol|2
5896857|NCT01709578|20403044|P1|Overall Study|Poor compliance to protocol|1
5896858|NCT01709578|20403042|P3|Overall Study|Lack of Efficacy|2
5896859|NCT01709578|20403043|P2|Overall Study|Lack of Efficacy|4
5896860|NCT01709578|20403044|P1|Overall Study|Lack of Efficacy|5
5896861|NCT01709578|20403042|P3|Overall Study|Adverse Event|17
5896862|NCT01709578|20403043|P2|Overall Study|Adverse Event|18
5896863|NCT01709578|20403044|P1|Overall Study|Adverse Event|9
5896864|NCT01709578|20403042|P3|Overall Study|Rescued and entered in long term safety|26
5896865|NCT01709578|20403043|P2|Overall Study|Rescued and entered in long term safety|25
5896866|NCT01709578|20403044|P1|Overall Study|Rescued and entered in long term safety|63
5896867|NCT01709513|20403175|P3|Overall Study|Other|7
5896868|NCT01709513|20403176|P2|Overall Study|Other|11
5896869|NCT01709513|20403177|P1|Overall Study|Other|3
5896870|NCT01709513|20403175|P3|Overall Study|Poor compliance to protocol|0
5896871|NCT01709513|20403176|P2|Overall Study|Poor compliance to protocol|0
5896872|NCT01709513|20403177|P1|Overall Study|Poor compliance to protocol|2
5896873|NCT01709513|20403175|P3|Overall Study|Adverse Event|23
5896874|NCT01709513|20403176|P2|Overall Study|Adverse Event|31
5896875|NCT01709513|20403177|P1|Overall Study|Adverse Event|16
5896876|NCT01709513|20403175|P3|Overall Study|Randomized but not treated|0
5896877|NCT01709513|20403176|P2|Overall Study|Randomized but not treated|1
5896878|NCT01709513|20403177|P1|Overall Study|Randomized but not treated|0
5896879|NCT01709500|20403238|P2|Overall Study|Treatment ongoing|78
5896880|NCT01709500|20403239|P1|Overall Study|Treatment ongoing|156
5896881|NCT01709500|20403238|P2|Overall Study|Related to IMP administration|0
5896882|NCT01709500|20403239|P1|Overall Study|Related to IMP administration|1
5896883|NCT01709500|20403238|P2|Overall Study|Other|1
5896884|NCT01709500|20403239|P1|Overall Study|Other|3
5896885|NCT01709500|20403238|P2|Overall Study|Poor compliance to protocol|1
5896886|NCT01709500|20403239|P1|Overall Study|Poor compliance to protocol|2
5896887|NCT01709500|20403238|P2|Overall Study|Adverse Event|1
5896888|NCT01709500|20403239|P1|Overall Study|Adverse Event|5
5896889|NCT01709500|20403238|P2|Overall Study|Randomized but not treated|1
5896890|NCT01709500|20403239|P1|Overall Study|Randomized but not treated|0
5896891|NCT01709409|20403317|P2|Overall Study|Protocol Violation|0
5896892|NCT01709409|20403318|P1|Overall Study|Protocol Violation|1
5896893|NCT01709383|20403326|P2|Overall Study|Lost to Follow-up|0
5896894|NCT01709383|20403327|P1|Overall Study|Lost to Follow-up|1
5896895|NCT01709331|20403345|P1|Overall Study|Adverse Event|1
5896896|NCT01709318|20403358|P7|Overall Study|Other Protocol Specified Criteria|0
5896897|NCT01709318|20403359|P6|Overall Study|Other Protocol Specified Criteria|0
5896898|NCT01709318|20403360|P5|Overall Study|Other Protocol Specified Criteria|0
5896899|NCT01709318|20403361|P4|Overall Study|Other Protocol Specified Criteria|0
5896900|NCT01709318|20403362|P3|Overall Study|Other Protocol Specified Criteria|0
5896901|NCT01709318|20403363|P2|Overall Study|Other Protocol Specified Criteria|1
5896902|NCT01709318|20403364|P1|Overall Study|Other Protocol Specified Criteria|0
5896903|NCT01709318|20403358|P7|Overall Study|Withdrawal by Subject|4
5896904|NCT01709318|20403359|P6|Overall Study|Withdrawal by Subject|2
5896905|NCT01709318|20403360|P5|Overall Study|Withdrawal by Subject|0
5896906|NCT01709318|20403361|P4|Overall Study|Withdrawal by Subject|3
5896907|NCT01709318|20403362|P3|Overall Study|Withdrawal by Subject|3
5896908|NCT01709318|20403363|P2|Overall Study|Withdrawal by Subject|0
5896909|NCT01709318|20403364|P1|Overall Study|Withdrawal by Subject|3
5896910|NCT01709318|20403358|P7|Overall Study|Technical Problems|0
5896911|NCT01709318|20403359|P6|Overall Study|Technical Problems|0
5896912|NCT01709318|20403360|P5|Overall Study|Technical Problems|0
5896913|NCT01709318|20403361|P4|Overall Study|Technical Problems|0
5896914|NCT01709318|20403362|P3|Overall Study|Technical Problems|0
5896915|NCT01709318|20403363|P2|Overall Study|Technical Problems|0
5896916|NCT01709318|20403364|P1|Overall Study|Technical Problems|1
5896917|NCT01709318|20403358|P7|Overall Study|Protocol Violation|1
5896918|NCT01709318|20403359|P6|Overall Study|Protocol Violation|0
5896919|NCT01709318|20403360|P5|Overall Study|Protocol Violation|2
5896920|NCT01709318|20403361|P4|Overall Study|Protocol Violation|0
5896921|NCT01709318|20403362|P3|Overall Study|Protocol Violation|0
5896922|NCT01709318|20403363|P2|Overall Study|Protocol Violation|0
5896923|NCT01709318|20403364|P1|Overall Study|Protocol Violation|0
5896924|NCT01709318|20403358|P7|Overall Study|Pregnancy|0
5896925|NCT01709318|20403359|P6|Overall Study|Pregnancy|0
5896926|NCT01709318|20403360|P5|Overall Study|Pregnancy|1
5896927|NCT01709318|20403361|P4|Overall Study|Pregnancy|0
5896928|NCT01709318|20403362|P3|Overall Study|Pregnancy|0
5896929|NCT01709318|20403363|P2|Overall Study|Pregnancy|0
5896930|NCT01709318|20403364|P1|Overall Study|Pregnancy|0
5896931|NCT01709318|20403358|P7|Overall Study|Physician Decision|1
5896932|NCT01709318|20403359|P6|Overall Study|Physician Decision|0
5896933|NCT01709318|20403360|P5|Overall Study|Physician Decision|0
5896934|NCT01709318|20403361|P4|Overall Study|Physician Decision|0
5896935|NCT01709318|20403362|P3|Overall Study|Physician Decision|0
5896936|NCT01709318|20403363|P2|Overall Study|Physician Decision|0
5896937|NCT01709318|20403364|P1|Overall Study|Physician Decision|0
5896938|NCT01709318|20403358|P7|Overall Study|Non-compliance with Study Drug|2
5896939|NCT01709318|20403359|P6|Overall Study|Non-compliance with Study Drug|0
5896940|NCT01709318|20403360|P5|Overall Study|Non-compliance with Study Drug|0
5896941|NCT01709318|20403361|P4|Overall Study|Non-compliance with Study Drug|1
5896942|NCT01709318|20403362|P3|Overall Study|Non-compliance with Study Drug|1
5896943|NCT01709318|20403363|P2|Overall Study|Non-compliance with Study Drug|2
5896944|NCT01709318|20403364|P1|Overall Study|Non-compliance with Study Drug|0
5896945|NCT01709318|20403358|P7|Overall Study|Lost to Follow-up|1
5896946|NCT01709318|20403359|P6|Overall Study|Lost to Follow-up|1
5896947|NCT01709318|20403360|P5|Overall Study|Lost to Follow-up|1
5896948|NCT01709318|20403361|P4|Overall Study|Lost to Follow-up|0
5896949|NCT01709318|20403362|P3|Overall Study|Lost to Follow-up|0
5896950|NCT01709318|20403363|P2|Overall Study|Lost to Follow-up|0
5896951|NCT01709318|20403364|P1|Overall Study|Lost to Follow-up|2
5896952|NCT01709318|20403358|P7|Overall Study|Adverse Event|2
5896953|NCT01709318|20403359|P6|Overall Study|Adverse Event|1
5896954|NCT01709318|20403360|P5|Overall Study|Adverse Event|0
5896955|NCT01709318|20403361|P4|Overall Study|Adverse Event|2
5896956|NCT01709318|20403362|P3|Overall Study|Adverse Event|2
5896957|NCT01709318|20403363|P2|Overall Study|Adverse Event|4
5896958|NCT01709318|20403364|P1|Overall Study|Adverse Event|3
5896959|NCT01709305|20403457|P5|Phase 2|Withdrawal by Subject|12
5896960|NCT01709305|20403458|P4|Phase 2|Withdrawal by Subject|15
5896961|NCT01709305|20403459|P3|Phase 2|Withdrawal by Subject|6
5896962|NCT01709305|20403460|P2|Phase 2|Withdrawal by Subject|8
5896963|NCT01709305|20403461|P1|Phase 2|Withdrawal by Subject|0
5896964|NCT01709305|20403457|P5|Phase 2|Protocol Violation|9
5896965|NCT01709305|20403458|P4|Phase 2|Protocol Violation|13
5896966|NCT01709305|20403459|P3|Phase 2|Protocol Violation|19
5896967|NCT01709305|20403460|P2|Phase 2|Protocol Violation|19
5896968|NCT01709305|20403461|P1|Phase 2|Protocol Violation|0
5896969|NCT01709305|20403457|P5|Phase 2|Physician Decision|2
5896970|NCT01709305|20403458|P4|Phase 2|Physician Decision|1
5896971|NCT01709305|20403459|P3|Phase 2|Physician Decision|0
5896972|NCT01709305|20403460|P2|Phase 2|Physician Decision|2
5896973|NCT01709305|20403461|P1|Phase 2|Physician Decision|0
5896974|NCT01709305|20403457|P5|Phase 2|Travel, moving, etc.|5
5896975|NCT01709305|20403458|P4|Phase 2|Travel, moving, etc.|3
5896976|NCT01709305|20403459|P3|Phase 2|Travel, moving, etc.|3
5896977|NCT01709305|20403460|P2|Phase 2|Travel, moving, etc.|2
5896978|NCT01709305|20403461|P1|Phase 2|Travel, moving, etc.|0
5896979|NCT01709305|20403457|P5|Phase 2|Lost to Follow-up|5
5896980|NCT01709305|20403458|P4|Phase 2|Lost to Follow-up|9
5896981|NCT01709305|20403459|P3|Phase 2|Lost to Follow-up|6
5896982|NCT01709305|20403460|P2|Phase 2|Lost to Follow-up|10
5896983|NCT01709305|20403461|P1|Phase 2|Lost to Follow-up|0
5896984|NCT01709305|20403457|P5|Phase 2|Laboratory Adverse Event|1
5896985|NCT01709305|20403458|P4|Phase 2|Laboratory Adverse Event|1
5896986|NCT01709305|20403459|P3|Phase 2|Laboratory Adverse Event|0
5896987|NCT01709305|20403460|P2|Phase 2|Laboratory Adverse Event|1
5896988|NCT01709305|20403461|P1|Phase 2|Laboratory Adverse Event|0
5896989|NCT01709305|20403457|P5|Phase 2|Hyperglycemia (lack of efficacy)|2
5896990|NCT01709305|20403458|P4|Phase 2|Hyperglycemia (lack of efficacy)|0
5896991|NCT01709305|20403459|P3|Phase 2|Hyperglycemia (lack of efficacy)|0
5896992|NCT01709305|20403460|P2|Phase 2|Hyperglycemia (lack of efficacy)|0
5896993|NCT01709305|20403461|P1|Phase 2|Hyperglycemia (lack of efficacy)|0
5896994|NCT01709305|20403457|P5|Phase 2|Death|0
5896995|NCT01709305|20403458|P4|Phase 2|Death|0
5896996|NCT01709305|20403459|P3|Phase 2|Death|1
5896997|NCT01709305|20403460|P2|Phase 2|Death|0
5896998|NCT01709305|20403461|P1|Phase 2|Death|0
5896999|NCT01709305|20403457|P5|Phase 2|Clinical Adverse Event|11
5897000|NCT01709305|20403458|P4|Phase 2|Clinical Adverse Event|6
5897001|NCT01709305|20403459|P3|Phase 2|Clinical Adverse Event|10
5897002|NCT01709305|20403460|P2|Phase 2|Clinical Adverse Event|10
5897003|NCT01709305|20403461|P1|Phase 2|Clinical Adverse Event|0
5897004|NCT01709305|20403457|P5|Phase 1|Withdrawal by Subject|0
5897005|NCT01709305|20403458|P4|Phase 1|Withdrawal by Subject|0
5897006|NCT01709305|20403459|P3|Phase 1|Withdrawal by Subject|0
5897007|NCT01709305|20403460|P2|Phase 1|Withdrawal by Subject|0
5897008|NCT01709305|20403461|P1|Phase 1|Withdrawal by Subject|218
5897009|NCT01709305|20403457|P5|Phase 1|Protocol Violation|0
5897010|NCT01709305|20403458|P4|Phase 1|Protocol Violation|0
5897011|NCT01709305|20403459|P3|Phase 1|Protocol Violation|0
5897012|NCT01709305|20403460|P2|Phase 1|Protocol Violation|0
5897013|NCT01709305|20403461|P1|Phase 1|Protocol Violation|118
5897014|NCT01709305|20403457|P5|Phase 1|Physician Decision|0
5897015|NCT01709305|20403458|P4|Phase 1|Physician Decision|0
5897016|NCT01709305|20403459|P3|Phase 1|Physician Decision|0
5897017|NCT01709305|20403460|P2|Phase 1|Physician Decision|0
5897018|NCT01709305|20403461|P1|Phase 1|Physician Decision|13
5897019|NCT01709305|20403457|P5|Phase 1|Travel, moving, etc.|0
5897020|NCT01709305|20403458|P4|Phase 1|Travel, moving, etc.|0
5897021|NCT01709305|20403459|P3|Phase 1|Travel, moving, etc.|0
5897022|NCT01709305|20403460|P2|Phase 1|Travel, moving, etc.|0
5897023|NCT01709305|20403461|P1|Phase 1|Travel, moving, etc.|30
5897024|NCT01709305|20403457|P5|Phase 1|Lost to Follow-up|0
5897025|NCT01709305|20403458|P4|Phase 1|Lost to Follow-up|0
5897026|NCT01709305|20403459|P3|Phase 1|Lost to Follow-up|0
5897027|NCT01709305|20403460|P2|Phase 1|Lost to Follow-up|0
5897028|NCT01709305|20403461|P1|Phase 1|Lost to Follow-up|147
5897029|NCT01709305|20403457|P5|Phase 1|Laboratory Adverse Event|0
5897030|NCT01709305|20403458|P4|Phase 1|Laboratory Adverse Event|0
5897031|NCT01709305|20403459|P3|Phase 1|Laboratory Adverse Event|0
5897032|NCT01709305|20403460|P2|Phase 1|Laboratory Adverse Event|0
5897033|NCT01709305|20403461|P1|Phase 1|Laboratory Adverse Event|16
5897034|NCT01709305|20403457|P5|Phase 1|Hyperglycemia (lack of efficacy)|0
5897035|NCT01709305|20403458|P4|Phase 1|Hyperglycemia (lack of efficacy)|0
5897036|NCT01709305|20403459|P3|Phase 1|Hyperglycemia (lack of efficacy)|0
5897037|NCT01709305|20403460|P2|Phase 1|Hyperglycemia (lack of efficacy)|0
5897038|NCT01709305|20403461|P1|Phase 1|Hyperglycemia (lack of efficacy)|13
5897039|NCT01709305|20403457|P5|Phase 1|Death|0
5897040|NCT01709305|20403458|P4|Phase 1|Death|0
5897041|NCT01709305|20403459|P3|Phase 1|Death|0
5897042|NCT01709305|20403460|P2|Phase 1|Death|0
5897043|NCT01709305|20403461|P1|Phase 1|Death|2
5897044|NCT01709305|20403457|P5|Phase 1|Clinical Adverse Event|0
5897045|NCT01709305|20403458|P4|Phase 1|Clinical Adverse Event|0
5897046|NCT01709305|20403459|P3|Phase 1|Clinical Adverse Event|0
5897047|NCT01709305|20403460|P2|Phase 1|Clinical Adverse Event|0
5897048|NCT01709305|20403461|P1|Phase 1|Clinical Adverse Event|80
5897049|NCT01709227|20403498|P2|Overall Study|Pleural Peritoneal communication|9
5897050|NCT01709227|20403499|P1|Overall Study|Pleural Peritoneal communication|0
5897051|NCT01709227|20403498|P2|Overall Study|Physician Decision|0
5897052|NCT01709227|20403499|P1|Overall Study|Physician Decision|1
5897053|NCT01709162|20403525|P2|Overall Study|Withdrawal by Subject|1
5897054|NCT01709162|20403526|P1|Overall Study|Withdrawal by Subject|0
5897055|NCT01709162|20403525|P2|Overall Study|Other|0
5897056|NCT01709162|20403526|P1|Overall Study|Other|1
5897057|NCT01709162|20403525|P2|Overall Study|Administrative reason by sponsor|1
5897058|NCT01709162|20403526|P1|Overall Study|Administrative reason by sponsor|0
5897059|NCT01709162|20403525|P2|Overall Study|Study drug toxicity|0
5897060|NCT01709162|20403526|P1|Overall Study|Study drug toxicity|2
5897061|NCT01709162|20403525|P2|Overall Study|Disease progression|3
5897062|NCT01709162|20403526|P1|Overall Study|Disease progression|3
5897063|NCT01709149|20403541|P3|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
5897064|NCT01709149|20403542|P2|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2
5897065|NCT01709149|20403543|P1|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
5897066|NCT01709149|20403541|P3|Double-blind, Placebo-controlled Phase|not defined|2
5897067|NCT01709149|20403542|P2|Double-blind, Placebo-controlled Phase|not defined|1
5897068|NCT01709149|20403543|P1|Double-blind, Placebo-controlled Phase|not defined|0
5897069|NCT01709149|20403541|P3|Double-blind, Placebo-controlled Phase|Death|0
5897070|NCT01709149|20403542|P2|Double-blind, Placebo-controlled Phase|Death|2
5897071|NCT01709149|20403543|P1|Double-blind, Placebo-controlled Phase|Death|0
5897072|NCT01709149|20403541|P3|Double-blind, Placebo-controlled Phase|Physician Decision|5
5897073|NCT01709149|20403542|P2|Double-blind, Placebo-controlled Phase|Physician Decision|2
5897074|NCT01709149|20403543|P1|Double-blind, Placebo-controlled Phase|Physician Decision|0
5897075|NCT01709149|20403541|P3|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|12
5897076|NCT01709149|20403542|P2|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|7
5897077|NCT01709149|20403543|P1|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0
5897078|NCT01709149|20403541|P3|Double-blind, Placebo-controlled Phase|Adverse Event|78
5897079|NCT01709149|20403542|P2|Double-blind, Placebo-controlled Phase|Adverse Event|12
5897080|NCT01709149|20403543|P1|Double-blind, Placebo-controlled Phase|Adverse Event|0
5897081|NCT01709149|20403541|P3|Open-label Lead-in Phase|Protocol Violation|0
5897082|NCT01709149|20403542|P2|Open-label Lead-in Phase|Protocol Violation|0
5897083|NCT01709149|20403543|P1|Open-label Lead-in Phase|Protocol Violation|3
5897084|NCT01709149|20403541|P3|Open-label Lead-in Phase|Death|0
5897085|NCT01709149|20403542|P2|Open-label Lead-in Phase|Death|0
5897086|NCT01709149|20403543|P1|Open-label Lead-in Phase|Death|1
5897087|NCT01709149|20403541|P3|Open-label Lead-in Phase|Withdrawal by Subject|0
5897088|NCT01709149|20403542|P2|Open-label Lead-in Phase|Withdrawal by Subject|0
5897089|NCT01709149|20403543|P1|Open-label Lead-in Phase|Withdrawal by Subject|2
5897090|NCT01709149|20403541|P3|Open-label Lead-in Phase|Adverse Event|0
5897091|NCT01709149|20403542|P2|Open-label Lead-in Phase|Adverse Event|0
5897092|NCT01709149|20403543|P1|Open-label Lead-in Phase|Adverse Event|109
5897093|NCT01709110|20403571|P2|Overall Study|Caregiver Decision|1
5897094|NCT01709110|20403572|P1|Overall Study|Caregiver Decision|1
5897095|NCT01709110|20403571|P2|Overall Study|Lack of Efficacy|1
5897096|NCT01709110|20403572|P1|Overall Study|Lack of Efficacy|1
5897097|NCT01709110|20403571|P2|Overall Study|Sponsor Decision|2
5897098|NCT01709110|20403572|P1|Overall Study|Sponsor Decision|2
5897099|NCT01709110|20403571|P2|Overall Study|Physician Decision|10
5897100|NCT01709110|20403572|P1|Overall Study|Physician Decision|4
5897101|NCT01709110|20403571|P2|Overall Study|Withdrawal by Subject|89
5897102|NCT01709110|20403572|P1|Overall Study|Withdrawal by Subject|96
5897103|NCT01709110|20403571|P2|Overall Study|Protocol Violation|6
5897104|NCT01709110|20403572|P1|Overall Study|Protocol Violation|4
5897105|NCT01709110|20403571|P2|Overall Study|Lost to Follow-up|5
5897106|NCT01709110|20403572|P1|Overall Study|Lost to Follow-up|7
5897107|NCT01709110|20403571|P2|Overall Study|Death|6
5897108|NCT01709110|20403572|P1|Overall Study|Death|14
5897109|NCT01709110|20403571|P2|Overall Study|Adverse Event|48
5897110|NCT01709110|20403572|P1|Overall Study|Adverse Event|56
5897191|NCT01708915|20403684|P4|Overall Study|Other reasons than stated above|2
5897192|NCT01708915|20403685|P3|Overall Study|Other reasons than stated above|0
5897193|NCT01708915|20403686|P2|Overall Study|Other reasons than stated above|1
5897194|NCT01708915|20403687|P1|Overall Study|Other reasons than stated above|1
5897195|NCT01708915|20403684|P4|Overall Study|Withdrawal by Subject|2
5897196|NCT01708915|20403685|P3|Overall Study|Withdrawal by Subject|2
5897197|NCT01708915|20403686|P2|Overall Study|Withdrawal by Subject|1
5897198|NCT01708915|20403687|P1|Overall Study|Withdrawal by Subject|0
5897199|NCT01708915|20403684|P4|Overall Study|Protocol Violation|1
5897200|NCT01708915|20403685|P3|Overall Study|Protocol Violation|0
5897201|NCT01708915|20403686|P2|Overall Study|Protocol Violation|0
5897202|NCT01708915|20403687|P1|Overall Study|Protocol Violation|0
5897203|NCT01708915|20403684|P4|Overall Study|Lack of Efficacy|15
5897204|NCT01708915|20403685|P3|Overall Study|Lack of Efficacy|35
5897205|NCT01708915|20403686|P2|Overall Study|Lack of Efficacy|60
5897206|NCT01708915|20403687|P1|Overall Study|Lack of Efficacy|84
5897207|NCT01708915|20403684|P4|Overall Study|Adverse Event|13
5897208|NCT01708915|20403685|P3|Overall Study|Adverse Event|9
5897209|NCT01708915|20403686|P2|Overall Study|Adverse Event|0
5897210|NCT01708915|20403687|P1|Overall Study|Adverse Event|1
5897211|NCT01708902|20403716|P7|Overall Study|Other Reason|0
5897212|NCT01708902|20403717|P6|Overall Study|Other Reason|2
5897213|NCT01708902|20403718|P5|Overall Study|Other Reason|1
5897214|NCT01708902|20403719|P4|Overall Study|Other Reason|1
5897215|NCT01708902|20403720|P3|Overall Study|Other Reason|1
5897216|NCT01708902|20403721|P2|Overall Study|Other Reason|0
5897217|NCT01708902|20403722|P1|Overall Study|Other Reason|1
5897218|NCT01708902|20403716|P7|Overall Study|Refused to continue trial medication|1
5897219|NCT01708902|20403717|P6|Overall Study|Refused to continue trial medication|1
5897220|NCT01708902|20403718|P5|Overall Study|Refused to continue trial medication|8
5897221|NCT01708902|20403719|P4|Overall Study|Refused to continue trial medication|2
5897222|NCT01708902|20403720|P3|Overall Study|Refused to continue trial medication|4
5897223|NCT01708902|20403721|P2|Overall Study|Refused to continue trial medication|0
5897224|NCT01708902|20403722|P1|Overall Study|Refused to continue trial medication|8
5897225|NCT01708902|20403716|P7|Overall Study|Lost to Follow-up|1
5897226|NCT01708902|20403717|P6|Overall Study|Lost to Follow-up|0
5897227|NCT01708902|20403718|P5|Overall Study|Lost to Follow-up|0
5897228|NCT01708902|20403719|P4|Overall Study|Lost to Follow-up|2
5897229|NCT01708902|20403720|P3|Overall Study|Lost to Follow-up|2
5897230|NCT01708902|20403721|P2|Overall Study|Lost to Follow-up|1
5897231|NCT01708902|20403722|P1|Overall Study|Lost to Follow-up|2
5897232|NCT01708902|20403716|P7|Overall Study|Non compliance with protocol|0
5897233|NCT01708902|20403717|P6|Overall Study|Non compliance with protocol|0
5897234|NCT01708902|20403718|P5|Overall Study|Non compliance with protocol|0
5897235|NCT01708902|20403719|P4|Overall Study|Non compliance with protocol|3
5897236|NCT01708902|20403720|P3|Overall Study|Non compliance with protocol|1
5897237|NCT01708902|20403721|P2|Overall Study|Non compliance with protocol|2
5897238|NCT01708902|20403722|P1|Overall Study|Non compliance with protocol|0
5897239|NCT01708902|20403716|P7|Overall Study|Lack of Efficacy|0
5897240|NCT01708902|20403717|P6|Overall Study|Lack of Efficacy|1
5897241|NCT01708902|20403718|P5|Overall Study|Lack of Efficacy|0
5897242|NCT01708902|20403719|P4|Overall Study|Lack of Efficacy|0
5897243|NCT01708902|20403720|P3|Overall Study|Lack of Efficacy|0
5897244|NCT01708902|20403721|P2|Overall Study|Lack of Efficacy|1
5897245|NCT01708902|20403722|P1|Overall Study|Lack of Efficacy|3
5897246|NCT01708902|20403716|P7|Overall Study|Adverse Event|5
5897247|NCT01708902|20403717|P6|Overall Study|Adverse Event|3
5897248|NCT01708902|20403718|P5|Overall Study|Adverse Event|7
5897249|NCT01708902|20403719|P4|Overall Study|Adverse Event|2
5897250|NCT01708902|20403720|P3|Overall Study|Adverse Event|9
5897251|NCT01708902|20403721|P2|Overall Study|Adverse Event|4
5897252|NCT01708902|20403722|P1|Overall Study|Adverse Event|3
5897253|NCT01708291|20403864|P2|Overall Study|fighting|1
5897254|NCT01708291|20403865|P1|Overall Study|fighting|2
5897255|NCT01708187|20403904|P2|Overall Study|Lost to Follow-up|1
5897256|NCT01708187|20403905|P1|Overall Study|Lost to Follow-up|0
5897257|NCT01708174|20403914|P3|Treatment Period|Adverse Event|0
5897258|NCT01708174|20403915|P2|Treatment Period|Adverse Event|1
5897259|NCT01708174|20403916|P1|Treatment Period|Adverse Event|0
5897260|NCT01708174|20403914|P3|Treatment Period|Death|1
5897261|NCT01708174|20403915|P2|Treatment Period|Death|0
5897262|NCT01708174|20403916|P1|Treatment Period|Death|0
5897263|NCT01708174|20403914|P3|Treatment Period|Progressive disease|0
5897264|NCT01708174|20403915|P2|Treatment Period|Progressive disease|1
5897265|NCT01708174|20403916|P1|Treatment Period|Progressive disease|0
5897266|NCT01708174|20403914|P3|Treatment Period|Withdrawal by Subject|0
5897267|NCT01708174|20403915|P2|Treatment Period|Withdrawal by Subject|0
5897268|NCT01708174|20403916|P1|Treatment Period|Withdrawal by Subject|1
5897269|NCT01708161|20403948|P6|Overall Study|Disease progression|0
5897270|NCT01708161|20403949|P5|Overall Study|Disease progression|3
5897271|NCT01708161|20403950|P4|Overall Study|Disease progression|13
5897272|NCT01708161|20403951|P3|Overall Study|Disease progression|5
5897273|NCT01708161|20403952|P2|Overall Study|Disease progression|5
5897274|NCT01708161|20403953|P1|Overall Study|Disease progression|3
5897275|NCT01708161|20403948|P6|Overall Study|Administrative problems|0
5897276|NCT01708161|20403949|P5|Overall Study|Administrative problems|0
5897277|NCT01708161|20403950|P4|Overall Study|Administrative problems|0
5897278|NCT01708161|20403951|P3|Overall Study|Administrative problems|0
5897279|NCT01708161|20403952|P2|Overall Study|Administrative problems|1
5897280|NCT01708161|20403953|P1|Overall Study|Administrative problems|0
5897281|NCT01708161|20403948|P6|Overall Study|Withdrawal by Subject|0
5897282|NCT01708161|20403949|P5|Overall Study|Withdrawal by Subject|0
5897283|NCT01708161|20403950|P4|Overall Study|Withdrawal by Subject|0
5897284|NCT01708161|20403951|P3|Overall Study|Withdrawal by Subject|1
5897285|NCT01708161|20403952|P2|Overall Study|Withdrawal by Subject|1
5897286|NCT01708161|20403953|P1|Overall Study|Withdrawal by Subject|0
5897287|NCT01708161|20403948|P6|Overall Study|Death|1
5897288|NCT01708161|20403949|P5|Overall Study|Death|0
5897289|NCT01708161|20403950|P4|Overall Study|Death|1
5897290|NCT01708161|20403951|P3|Overall Study|Death|0
5897291|NCT01708161|20403952|P2|Overall Study|Death|0
5897292|NCT01708161|20403953|P1|Overall Study|Death|0
5897293|NCT01708161|20403948|P6|Overall Study|Adverse Event|0
5897294|NCT01708161|20403949|P5|Overall Study|Adverse Event|3
5897295|NCT01708161|20403950|P4|Overall Study|Adverse Event|2
5897296|NCT01708161|20403951|P3|Overall Study|Adverse Event|4
5897297|NCT01708161|20403952|P2|Overall Study|Adverse Event|3
5897298|NCT01708161|20403953|P1|Overall Study|Adverse Event|1
5897299|NCT01708057|20404004|P3|Overall Study|Withdrawal due to study termination.|1
5897300|NCT01708057|20404005|P2|Overall Study|Withdrawal due to study termination.|1
5897301|NCT01708057|20404006|P1|Overall Study|Withdrawal due to study termination.|1
5897302|NCT01707992|20404065|P6|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0
5897303|NCT01707992|20404066|P5|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|4
5897304|NCT01707992|20404067|P4|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0
5897305|NCT01707992|20404068|P3|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0
5897306|NCT01707992|20404069|P2|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0
5897307|NCT01707992|20404070|P1|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0
5897308|NCT01707992|20404065|P6|Active Treatment Phase (24 Months)|Study terminated by sponsor|174
5897309|NCT01707992|20404066|P5|Active Treatment Phase (24 Months)|Study terminated by sponsor|243
5897310|NCT01707992|20404067|P4|Active Treatment Phase (24 Months)|Study terminated by sponsor|809
5897311|NCT01707992|20404068|P3|Active Treatment Phase (24 Months)|Study terminated by sponsor|0
5897312|NCT01707992|20404069|P2|Active Treatment Phase (24 Months)|Study terminated by sponsor|0
5897313|NCT01707992|20404070|P1|Active Treatment Phase (24 Months)|Study terminated by sponsor|0
5897314|NCT01707992|20404065|P6|Active Treatment Phase (24 Months)|Noncompliance|2
5897315|NCT01707992|20404066|P5|Active Treatment Phase (24 Months)|Noncompliance|4
5897316|NCT01707992|20404067|P4|Active Treatment Phase (24 Months)|Noncompliance|0
5897317|NCT01707992|20404068|P3|Active Treatment Phase (24 Months)|Noncompliance|0
5897318|NCT01707992|20404069|P2|Active Treatment Phase (24 Months)|Noncompliance|0
5897319|NCT01707992|20404070|P1|Active Treatment Phase (24 Months)|Noncompliance|0
5897320|NCT01707992|20404065|P6|Active Treatment Phase (24 Months)|Other than specified|2
5897321|NCT01707992|20404066|P5|Active Treatment Phase (24 Months)|Other than specified|5
5897322|NCT01707992|20404067|P4|Active Treatment Phase (24 Months)|Other than specified|1
5897323|NCT01707992|20404068|P3|Active Treatment Phase (24 Months)|Other than specified|0
5897324|NCT01707992|20404069|P2|Active Treatment Phase (24 Months)|Other than specified|0
5897325|NCT01707992|20404070|P1|Active Treatment Phase (24 Months)|Other than specified|0
5897326|NCT01707992|20404065|P6|Active Treatment Phase (24 Months)|Death|0
5897327|NCT01707992|20404066|P5|Active Treatment Phase (24 Months)|Death|0
5897328|NCT01707992|20404067|P4|Active Treatment Phase (24 Months)|Death|2
5897329|NCT01707992|20404068|P3|Active Treatment Phase (24 Months)|Death|0
5897330|NCT01707992|20404069|P2|Active Treatment Phase (24 Months)|Death|0
5897331|NCT01707992|20404070|P1|Active Treatment Phase (24 Months)|Death|0
5897332|NCT01707992|20404065|P6|Active Treatment Phase (24 Months)|Lost to Follow-up|1
5897333|NCT01707992|20404066|P5|Active Treatment Phase (24 Months)|Lost to Follow-up|11
5897334|NCT01707992|20404067|P4|Active Treatment Phase (24 Months)|Lost to Follow-up|5
5897335|NCT01707992|20404068|P3|Active Treatment Phase (24 Months)|Lost to Follow-up|0
5897336|NCT01707992|20404069|P2|Active Treatment Phase (24 Months)|Lost to Follow-up|0
5897337|NCT01707992|20404070|P1|Active Treatment Phase (24 Months)|Lost to Follow-up|0
5897338|NCT01707992|20404065|P6|Active Treatment Phase (24 Months)|Pregnancy|2
5897339|NCT01707992|20404066|P5|Active Treatment Phase (24 Months)|Pregnancy|5
5897340|NCT01707992|20404067|P4|Active Treatment Phase (24 Months)|Pregnancy|2
5897341|NCT01707992|20404068|P3|Active Treatment Phase (24 Months)|Pregnancy|0
5897342|NCT01707992|20404069|P2|Active Treatment Phase (24 Months)|Pregnancy|0
5897343|NCT01707992|20404070|P1|Active Treatment Phase (24 Months)|Pregnancy|0
5897344|NCT01707992|20404065|P6|Active Treatment Phase (24 Months)|Withdrawal by Subject|32
5897345|NCT01707992|20404066|P5|Active Treatment Phase (24 Months)|Withdrawal by Subject|220
5897346|NCT01707992|20404067|P4|Active Treatment Phase (24 Months)|Withdrawal by Subject|58
5897347|NCT01707992|20404068|P3|Active Treatment Phase (24 Months)|Withdrawal by Subject|0
5897348|NCT01707992|20404069|P2|Active Treatment Phase (24 Months)|Withdrawal by Subject|0
5897349|NCT01707992|20404070|P1|Active Treatment Phase (24 Months)|Withdrawal by Subject|0
5897350|NCT01707992|20404065|P6|Active Treatment Phase (24 Months)|Lack of Efficacy|2
5897351|NCT01707992|20404066|P5|Active Treatment Phase (24 Months)|Lack of Efficacy|1
5897352|NCT01707992|20404067|P4|Active Treatment Phase (24 Months)|Lack of Efficacy|3
5897353|NCT01707992|20404068|P3|Active Treatment Phase (24 Months)|Lack of Efficacy|0
5897354|NCT01707992|20404069|P2|Active Treatment Phase (24 Months)|Lack of Efficacy|0
5897355|NCT01707992|20404070|P1|Active Treatment Phase (24 Months)|Lack of Efficacy|0
5897356|NCT01707992|20404065|P6|Active Treatment Phase (24 Months)|Adverse Event|0
5897357|NCT01707992|20404066|P5|Active Treatment Phase (24 Months)|Adverse Event|1
5897358|NCT01707992|20404067|P4|Active Treatment Phase (24 Months)|Adverse Event|4
5897359|NCT01707992|20404068|P3|Active Treatment Phase (24 Months)|Adverse Event|0
5897360|NCT01707992|20404069|P2|Active Treatment Phase (24 Months)|Adverse Event|0
5897361|NCT01707992|20404070|P1|Active Treatment Phase (24 Months)|Adverse Event|0
5897362|NCT01707992|20404065|P6|Placebo-Controlled Phase (24 Months)|Other than specified|0
5897363|NCT01707992|20404066|P5|Placebo-Controlled Phase (24 Months)|Other than specified|0
5897364|NCT01707992|20404067|P4|Placebo-Controlled Phase (24 Months)|Other than specified|0
5897365|NCT01707992|20404068|P3|Placebo-Controlled Phase (24 Months)|Other than specified|10
5897366|NCT01707992|20404069|P2|Placebo-Controlled Phase (24 Months)|Other than specified|9
5897367|NCT01707992|20404070|P1|Placebo-Controlled Phase (24 Months)|Other than specified|11
5897368|NCT01707992|20404065|P6|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0
5897369|NCT01707992|20404066|P5|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0
5897370|NCT01707992|20404067|P4|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0
5897371|NCT01707992|20404068|P3|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|6
5897372|NCT01707992|20404069|P2|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|1
5897373|NCT01707992|20404070|P1|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|2
5897374|NCT01707992|20404065|P6|Placebo-Controlled Phase (24 Months)|Death|0
5897375|NCT01707992|20404066|P5|Placebo-Controlled Phase (24 Months)|Death|0
5897376|NCT01707992|20404067|P4|Placebo-Controlled Phase (24 Months)|Death|0
5897377|NCT01707992|20404068|P3|Placebo-Controlled Phase (24 Months)|Death|1
5897378|NCT01707992|20404069|P2|Placebo-Controlled Phase (24 Months)|Death|1
5897379|NCT01707992|20404070|P1|Placebo-Controlled Phase (24 Months)|Death|2
5897380|NCT01707992|20404065|P6|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0
5897381|NCT01707992|20404066|P5|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0
5897382|NCT01707992|20404067|P4|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0
5897383|NCT01707992|20404068|P3|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|9
5897384|NCT01707992|20404069|P2|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|4
5897385|NCT01707992|20404070|P1|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|10
5897386|NCT01707992|20404065|P6|Placebo-Controlled Phase (24 Months)|Pregnancy|0
5897387|NCT01707992|20404066|P5|Placebo-Controlled Phase (24 Months)|Pregnancy|0
5897388|NCT01707992|20404067|P4|Placebo-Controlled Phase (24 Months)|Pregnancy|0
5897389|NCT01707992|20404068|P3|Placebo-Controlled Phase (24 Months)|Pregnancy|9
5897390|NCT01707992|20404069|P2|Placebo-Controlled Phase (24 Months)|Pregnancy|5
5897391|NCT01707992|20404070|P1|Placebo-Controlled Phase (24 Months)|Pregnancy|12
5897392|NCT01707992|20404065|P6|Placebo-Controlled Phase (24 Months)|Protocol Violation|0
5897393|NCT01707992|20404066|P5|Placebo-Controlled Phase (24 Months)|Protocol Violation|0
5897394|NCT01707992|20404067|P4|Placebo-Controlled Phase (24 Months)|Protocol Violation|0
5897395|NCT01707992|20404068|P3|Placebo-Controlled Phase (24 Months)|Protocol Violation|0
5897396|NCT01707992|20404069|P2|Placebo-Controlled Phase (24 Months)|Protocol Violation|0
5897397|NCT01707992|20404070|P1|Placebo-Controlled Phase (24 Months)|Protocol Violation|1
5897398|NCT01707992|20404065|P6|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0
5897399|NCT01707992|20404066|P5|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0
5897400|NCT01707992|20404067|P4|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0
5897401|NCT01707992|20404068|P3|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|154
5897402|NCT01707992|20404069|P2|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|68
5897403|NCT01707992|20404070|P1|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|88
5897404|NCT01707992|20404065|P6|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0
5897405|NCT01707992|20404066|P5|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0
5897406|NCT01707992|20404067|P4|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0
5897407|NCT01707992|20404068|P3|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|2
5897408|NCT01707992|20404069|P2|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|3
5897409|NCT01707992|20404070|P1|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|10
5897410|NCT01707992|20404065|P6|Placebo-Controlled Phase (24 Months)|Adverse Event|0
5897411|NCT01707992|20404066|P5|Placebo-Controlled Phase (24 Months)|Adverse Event|0
5897412|NCT01707992|20404067|P4|Placebo-Controlled Phase (24 Months)|Adverse Event|0
5897413|NCT01707992|20404068|P3|Placebo-Controlled Phase (24 Months)|Adverse Event|9
5897414|NCT01707992|20404069|P2|Placebo-Controlled Phase (24 Months)|Adverse Event|13
5897415|NCT01707992|20404070|P1|Placebo-Controlled Phase (24 Months)|Adverse Event|8
5897416|NCT01707693|20404122|P2|Time 3 Measures @ 6 Mth|Withdrawal by Subject|2
5897417|NCT01707693|20404123|P1|Time 3 Measures @ 6 Mth|Withdrawal by Subject|0
5897418|NCT01707693|20404122|P2|Time 3 Measures @ 6 Mth|Lost to Follow-up|3
5897419|NCT01707693|20404123|P1|Time 3 Measures @ 6 Mth|Lost to Follow-up|0
5897420|NCT01707693|20404122|P2|Overall Study Allocation|Protocol Violation|3
5897421|NCT01707693|20404123|P1|Overall Study Allocation|Protocol Violation|4
5897422|NCT01707693|20404122|P2|Overall Study Allocation|Withdrawal by Subject|5
5897423|NCT01707693|20404123|P1|Overall Study Allocation|Withdrawal by Subject|9
5897424|NCT01707667|20404137|P2|Period 1|expulsion of colonic sensor catheter|0
5897425|NCT01707667|20404138|P1|Period 1|expulsion of colonic sensor catheter|1
5897426|NCT01707290|20404221|P2|Overall Study|Other unspecified|0
5897427|NCT01707290|20404222|P1|Overall Study|Other unspecified|17
5897428|NCT01707290|20404221|P2|Overall Study|Commercial drug available|1
5897429|NCT01707290|20404222|P1|Overall Study|Commercial drug available|60
5897430|NCT01707290|20404221|P2|Overall Study|Withdrawal of Consent (Not Due to AE)|0
5897431|NCT01707290|20404222|P1|Overall Study|Withdrawal of Consent (Not Due to AE)|4
5897432|NCT01707290|20404221|P2|Overall Study|Lost to Follow-up|0
5897433|NCT01707290|20404222|P1|Overall Study|Lost to Follow-up|3
5897434|NCT01707290|20404221|P2|Overall Study|Physician Decision|0
5897435|NCT01707290|20404222|P1|Overall Study|Physician Decision|1
5897436|NCT01707290|20404221|P2|Overall Study|Adverse event (AE)|0
5897437|NCT01707290|20404222|P1|Overall Study|Adverse event (AE)|1
5897438|NCT01707147|20404267|P1|Overall Study|Violated inclusion/exclusion criteria|77
5897439|NCT01707147|20404267|P1|Overall Study|Follow-up failure|17
5897440|NCT01707147|20404267|P1|Overall Study|Patients who have not taken Trajenta|1
5897441|NCT01707147|20404267|P1|Overall Study|Administered Trajenta prior to contract|5
5897442|NCT01707030|20404299|P2|Overall Study|Lost to Follow-up|13
5897443|NCT01707030|20404300|P1|Overall Study|Lost to Follow-up|8
5897444|NCT01707030|20404299|P2|Overall Study|Withdrawal by Subject|3
5897445|NCT01707030|20404300|P1|Overall Study|Withdrawal by Subject|2
5897446|NCT01707030|20404299|P2|Overall Study|Death|1
5897447|NCT01707030|20404300|P1|Overall Study|Death|1
5897448|NCT01707004|20404318|P1|Overall Study|Physician Decision|3
5897449|NCT01706926|20404372|P4|Overall Study|Other|3
5897450|NCT01706926|20404373|P3|Overall Study|Other|4
5897451|NCT01706926|20404374|P2|Overall Study|Other|4
5897452|NCT01706926|20404375|P1|Overall Study|Other|4
5897453|NCT01706926|20404372|P4|Overall Study|Withdrawal by Subject|2
5897454|NCT01706926|20404373|P3|Overall Study|Withdrawal by Subject|1
5897455|NCT01706926|20404374|P2|Overall Study|Withdrawal by Subject|0
5897456|NCT01706926|20404375|P1|Overall Study|Withdrawal by Subject|2
5897457|NCT01706926|20404372|P4|Overall Study|Lost to Follow-up|0
5897458|NCT01706926|20404373|P3|Overall Study|Lost to Follow-up|1
5897459|NCT01706926|20404374|P2|Overall Study|Lost to Follow-up|0
5897460|NCT01706926|20404375|P1|Overall Study|Lost to Follow-up|0
5897461|NCT01706770|20404494|P2|Overall Study|Physician Decision|0
5897462|NCT01706770|20404495|P1|Overall Study|Physician Decision|1
5897463|NCT01706770|20404494|P2|Overall Study|Lost to Follow-up|0
5897464|NCT01706770|20404495|P1|Overall Study|Lost to Follow-up|1
5897465|NCT01706575|20404543|P1|Overall Study|Started but not Treated|6
5897466|NCT01706575|20404543|P1|Overall Study|Lost to Follow-up|2
5897467|NCT01706575|20404543|P1|Overall Study|Participant Withdrew Consent|4
5897468|NCT01706536|20404564|P5|Overall Study|non compliance|0
5897469|NCT01706536|20404565|P4|Overall Study|non compliance|0
5897470|NCT01706536|20404566|P3|Overall Study|non compliance|0
5897471|NCT01706536|20404567|P2|Overall Study|non compliance|1
5897472|NCT01706536|20404568|P1|Overall Study|non compliance|0
5897473|NCT01706536|20404564|P5|Overall Study|Lack of Efficacy|0
5897474|NCT01706536|20404565|P4|Overall Study|Lack of Efficacy|1
5897475|NCT01706536|20404566|P3|Overall Study|Lack of Efficacy|0
5897476|NCT01706536|20404567|P2|Overall Study|Lack of Efficacy|0
5897477|NCT01706536|20404568|P1|Overall Study|Lack of Efficacy|1
5897478|NCT01706536|20404564|P5|Overall Study|Adverse Event|2
5897479|NCT01706536|20404565|P4|Overall Study|Adverse Event|3
5897480|NCT01706536|20404566|P3|Overall Study|Adverse Event|4
5897481|NCT01706536|20404567|P2|Overall Study|Adverse Event|3
5897482|NCT01706536|20404568|P1|Overall Study|Adverse Event|2
5897483|NCT01706536|20404564|P5|Overall Study|Withdrawal by Subject|0
5897484|NCT01706536|20404565|P4|Overall Study|Withdrawal by Subject|0
5897485|NCT01706536|20404566|P3|Overall Study|Withdrawal by Subject|1
5897486|NCT01706536|20404567|P2|Overall Study|Withdrawal by Subject|0
5897487|NCT01706536|20404568|P1|Overall Study|Withdrawal by Subject|1
5897488|NCT01706458|20404635|P2|Overall Study|Physician Decision|4
5897489|NCT01706458|20404636|P1|Overall Study|Physician Decision|3
5897490|NCT01706328|20404660|P3|12-week Double-blind Treatment Period|Withdrawal by Subject|11
5897491|NCT01706328|20404661|P2|12-week Double-blind Treatment Period|Withdrawal by Subject|8
5897492|NCT01706328|20404662|P1|12-week Double-blind Treatment Period|Withdrawal by Subject|0
5897493|NCT01706328|20404660|P3|12-week Double-blind Treatment Period|Physician Decision|2
5897494|NCT01706328|20404661|P2|12-week Double-blind Treatment Period|Physician Decision|2
5897495|NCT01706328|20404662|P1|12-week Double-blind Treatment Period|Physician Decision|0
5897496|NCT01706328|20404660|P3|12-week Double-blind Treatment Period|Lost to Follow-up|1
5897497|NCT01706328|20404661|P2|12-week Double-blind Treatment Period|Lost to Follow-up|3
5897498|NCT01706328|20404662|P1|12-week Double-blind Treatment Period|Lost to Follow-up|0
5897499|NCT01706328|20404660|P3|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|9
5897500|NCT01706328|20404661|P2|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|11
5897501|NCT01706328|20404662|P1|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|0
5897502|NCT01706328|20404660|P3|12-week Double-blind Treatment Period|Protocol Violation|2
5897503|NCT01706328|20404661|P2|12-week Double-blind Treatment Period|Protocol Violation|4
5897504|NCT01706328|20404662|P1|12-week Double-blind Treatment Period|Protocol Violation|0
5897505|NCT01706328|20404660|P3|12-week Double-blind Treatment Period|Lack of Efficacy|4
5897506|NCT01706328|20404661|P2|12-week Double-blind Treatment Period|Lack of Efficacy|4
5897507|NCT01706328|20404662|P1|12-week Double-blind Treatment Period|Lack of Efficacy|0
5897508|NCT01706328|20404660|P3|12-week Double-blind Treatment Period|Adverse Event|16
5897509|NCT01706328|20404661|P2|12-week Double-blind Treatment Period|Adverse Event|14
5897510|NCT01706328|20404662|P1|12-week Double-blind Treatment Period|Adverse Event|0
5897511|NCT01706328|20404660|P3|2-week Run-in Period|Lost to Follow-up|0
5897512|NCT01706328|20404661|P2|2-week Run-in Period|Lost to Follow-up|0
5897513|NCT01706328|20404662|P1|2-week Run-in Period|Lost to Follow-up|2
5897514|NCT01706328|20404660|P3|2-week Run-in Period|Adverse Event|0
5897515|NCT01706328|20404661|P2|2-week Run-in Period|Adverse Event|0
5897516|NCT01706328|20404662|P1|2-week Run-in Period|Adverse Event|4
5897517|NCT01706328|20404660|P3|2-week Run-in Period|Physician Decision|0
5897518|NCT01706328|20404661|P2|2-week Run-in Period|Physician Decision|0
5897519|NCT01706328|20404662|P1|2-week Run-in Period|Physician Decision|4
5897520|NCT01706328|20404660|P3|2-week Run-in Period|Withdrawal by Subject|0
5897521|NCT01706328|20404661|P2|2-week Run-in Period|Withdrawal by Subject|0
5897522|NCT01706328|20404662|P1|2-week Run-in Period|Withdrawal by Subject|15
5897523|NCT01706328|20404660|P3|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0
5897524|NCT01706328|20404661|P2|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0
5897525|NCT01706328|20404662|P1|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|140
5897526|NCT01706250|20404681|P1|Overall Study|Lost to Follow-up|2
5897527|NCT01706198|20404712|P2|Overall Study|Withdrawal by Subject|31
5897528|NCT01706198|20404713|P1|Overall Study|Withdrawal by Subject|23
5897529|NCT01706198|20404712|P2|Overall Study|Physician Decision|37
5897530|NCT01706198|20404713|P1|Overall Study|Physician Decision|23
5897531|NCT01706198|20404712|P2|Overall Study|Lost to Follow-up|93
5897532|NCT01706198|20404713|P1|Overall Study|Lost to Follow-up|97
5897533|NCT01706198|20404712|P2|Overall Study|Other: Subject reached stopping criteria|13
5897534|NCT01706198|20404713|P1|Overall Study|Other: Subject reached stopping criteria|11
5897535|NCT01706198|20404712|P2|Overall Study|Protocol Violation|5
5897536|NCT01706198|20404713|P1|Overall Study|Protocol Violation|7
5897537|NCT01706198|20404712|P2|Overall Study|Adverse Event|15
5897538|NCT01706198|20404713|P1|Overall Study|Adverse Event|12
5897539|NCT01706159|20404765|P2|Overall Study|Unclassified|1
5897540|NCT01706159|20404766|P1|Overall Study|Unclassified|6
5897541|NCT01706159|20404765|P2|Overall Study|Withdrawal Criteria|1
5897542|NCT01706159|20404766|P1|Overall Study|Withdrawal Criteria|2
5897543|NCT01706146|20404780|P1|Overall Study|Developed AF and need for antiplatelets|2
5897544|NCT01706146|20404780|P1|Overall Study|Adverse Event|3
5897545|NCT01706146|20404780|P1|Overall Study|Withdrawal by Subject|1
5897546|NCT01706003|20404800|P2|Overall Study|Lost to Follow-up|4
5897547|NCT01706003|20404801|P1|Overall Study|Lost to Follow-up|6
5897548|NCT01706003|20404800|P2|Overall Study|Not scheduled|0
5897549|NCT01706003|20404801|P1|Overall Study|Not scheduled|3
5897550|NCT01706003|20404800|P2|Overall Study|Withdrawal by Subject|0
5897551|NCT01706003|20404801|P1|Overall Study|Withdrawal by Subject|2
5897552|NCT01705977|20404809|P2|Overall Study|Missing study conclusion form|2
5897553|NCT01705977|20404810|P1|Overall Study|Missing study conclusion form|2
5897554|NCT01705977|20404809|P2|Overall Study|Physician Decision|38
5897555|NCT01705977|20404810|P1|Overall Study|Physician Decision|48
5897556|NCT01705977|20404809|P2|Overall Study|Lost to Follow-up|37
5897557|NCT01705977|20404810|P1|Overall Study|Lost to Follow-up|33
5897558|NCT01705977|20404809|P2|Overall Study|Site closure|2
5897559|NCT01705977|20404810|P1|Overall Study|Site closure|3
5897560|NCT01705977|20404809|P2|Overall Study|Protocol Violation|4
5897561|NCT01705977|20404810|P1|Overall Study|Protocol Violation|2
5897562|NCT01705977|20404809|P2|Overall Study|Adverse Event|49
5897563|NCT01705977|20404810|P1|Overall Study|Adverse Event|57
5897564|NCT01705977|20404809|P2|Overall Study|Withdrawal by Subject|128
5897565|NCT01705977|20404810|P1|Overall Study|Withdrawal by Subject|128
5897566|NCT01705730|20404828|P1|Overall Study|Reason not Specified|4
5897567|NCT01705730|20404828|P1|Overall Study|Lost to Follow-up|1
5897568|NCT01705730|20404828|P1|Overall Study|Adverse Event|3
5897569|NCT01705730|20404828|P1|Overall Study|Lack of Efficacy|1
5897570|NCT01705717|20404868|P2|Overall Study|Other|2
5897571|NCT01705717|20404869|P1|Overall Study|Other|0
5897572|NCT01705717|20404868|P2|Overall Study|Lack of Efficacy|1
5897573|NCT01705717|20404869|P1|Overall Study|Lack of Efficacy|0
5897574|NCT01705717|20404868|P2|Overall Study|Adverse Event|2
5897575|NCT01705717|20404869|P1|Overall Study|Adverse Event|2
5897576|NCT01705691|20404886|P2|Overall Study|Other|1
5897577|NCT01705691|20404887|P1|Overall Study|Other|0
5897578|NCT01705691|20404886|P2|Overall Study|Lost to Follow-up|1
5897579|NCT01705691|20404887|P1|Overall Study|Lost to Follow-up|1
5897580|NCT01705691|20404886|P2|Overall Study|Withdrawal by Subject|2
5897581|NCT01705691|20404887|P1|Overall Study|Withdrawal by Subject|1
5897582|NCT01705691|20404886|P2|Overall Study|Death|2
5897583|NCT01705691|20404887|P1|Overall Study|Death|1
5897584|NCT01705652|20404907|P2|Overall Study|non-compliance|1
5897585|NCT01705652|20404908|P1|Overall Study|non-compliance|1
5897586|NCT01705652|20404907|P2|Overall Study|Withdrawal by Subject|2
5897587|NCT01705652|20404908|P1|Overall Study|Withdrawal by Subject|1
5897588|NCT01705652|20404907|P2|Overall Study|Adverse Event|0
5897589|NCT01705652|20404908|P1|Overall Study|Adverse Event|1
5897590|NCT01705587|20404916|P2|Overall Study|Withdrawal by Subject|1
5897591|NCT01705587|20404917|P1|Overall Study|Withdrawal by Subject|0
5897592|NCT01705574|20404935|P4|Open-Label Extension Phase|Pregnancy|1
5897593|NCT01705574|20404936|P3|Open-Label Extension Phase|Pregnancy|1
5897594|NCT01705574|20404937|P2|Open-Label Extension Phase|Pregnancy|0
5897595|NCT01705574|20404938|P1|Open-Label Extension Phase|Pregnancy|0
5897596|NCT01705574|20404935|P4|Open-Label Extension Phase|Physician Decision|0
5897597|NCT01705574|20404936|P3|Open-Label Extension Phase|Physician Decision|2
5897598|NCT01705574|20404937|P2|Open-Label Extension Phase|Physician Decision|0
5897599|NCT01705574|20404938|P1|Open-Label Extension Phase|Physician Decision|0
5897600|NCT01705574|20404935|P4|Open-Label Extension Phase|Non-Compliance with Study Drug|0
5897601|NCT01705574|20404936|P3|Open-Label Extension Phase|Non-Compliance with Study Drug|1
5897602|NCT01705574|20404937|P2|Open-Label Extension Phase|Non-Compliance with Study Drug|0
5897603|NCT01705574|20404938|P1|Open-Label Extension Phase|Non-Compliance with Study Drug|0
5897604|NCT01705574|20404935|P4|Open-Label Extension Phase|Death|0
5897605|NCT01705574|20404936|P3|Open-Label Extension Phase|Death|1
5897606|NCT01705574|20404937|P2|Open-Label Extension Phase|Death|0
5897607|NCT01705574|20404938|P1|Open-Label Extension Phase|Death|2
5897608|NCT01705574|20404935|P4|Open-Label Extension Phase|Adverse Event|1
5897609|NCT01705574|20404936|P3|Open-Label Extension Phase|Adverse Event|0
5897610|NCT01705574|20404937|P2|Open-Label Extension Phase|Adverse Event|0
5897611|NCT01705574|20404938|P1|Open-Label Extension Phase|Adverse Event|3
5897612|NCT01705574|20404935|P4|Open-Label Extension Phase|Withdrew Consent|1
5897613|NCT01705574|20404936|P3|Open-Label Extension Phase|Withdrew Consent|4
5897614|NCT01705574|20404937|P2|Open-Label Extension Phase|Withdrew Consent|0
5897615|NCT01705574|20404938|P1|Open-Label Extension Phase|Withdrew Consent|4
5897616|NCT01705574|20404935|P4|Open-Label Extension Phase|Lost to Follow-up|2
5897617|NCT01705574|20404936|P3|Open-Label Extension Phase|Lost to Follow-up|2
5897618|NCT01705574|20404937|P2|Open-Label Extension Phase|Lost to Follow-up|0
5897619|NCT01705574|20404938|P1|Open-Label Extension Phase|Lost to Follow-up|6
5897620|NCT01705574|20404935|P4|Double-Blind Phase|Randomized but Not Treated|0
5897621|NCT01705574|20404936|P3|Double-Blind Phase|Randomized but Not Treated|0
5897622|NCT01705574|20404937|P2|Double-Blind Phase|Randomized but Not Treated|4
5897623|NCT01705574|20404938|P1|Double-Blind Phase|Randomized but Not Treated|4
5897624|NCT01705574|20404935|P4|Double-Blind Phase|Protocol Violation|0
5897625|NCT01705574|20404936|P3|Double-Blind Phase|Protocol Violation|0
5897626|NCT01705574|20404937|P2|Double-Blind Phase|Protocol Violation|0
5897627|NCT01705574|20404938|P1|Double-Blind Phase|Protocol Violation|1
5897628|NCT01705574|20404935|P4|Double-Blind Phase|Pregnancy|0
5897629|NCT01705574|20404936|P3|Double-Blind Phase|Pregnancy|0
5897630|NCT01705574|20404937|P2|Double-Blind Phase|Pregnancy|1
5897631|NCT01705574|20404938|P1|Double-Blind Phase|Pregnancy|1
5897632|NCT01705574|20404935|P4|Double-Blind Phase|Non-Compliance with Study Drug|0
5897633|NCT01705574|20404936|P3|Double-Blind Phase|Non-Compliance with Study Drug|0
5897634|NCT01705574|20404937|P2|Double-Blind Phase|Non-Compliance with Study Drug|5
5897635|NCT01705574|20404938|P1|Double-Blind Phase|Non-Compliance with Study Drug|4
5897636|NCT01705574|20404935|P4|Double-Blind Phase|Withdrew Consent|0
5897637|NCT01705574|20404936|P3|Double-Blind Phase|Withdrew Consent|0
5897638|NCT01705574|20404937|P2|Double-Blind Phase|Withdrew Consent|5
5897639|NCT01705574|20404938|P1|Double-Blind Phase|Withdrew Consent|8
5897640|NCT01705574|20404935|P4|Double-Blind Phase|Adverse Event|0
5897641|NCT01705574|20404936|P3|Double-Blind Phase|Adverse Event|0
5897642|NCT01705574|20404937|P2|Double-Blind Phase|Adverse Event|10
5897643|NCT01705574|20404938|P1|Double-Blind Phase|Adverse Event|3
5897644|NCT01705574|20404935|P4|Double-Blind Phase|Lost to Follow-up|0
5897645|NCT01705574|20404936|P3|Double-Blind Phase|Lost to Follow-up|0
5897646|NCT01705574|20404937|P2|Double-Blind Phase|Lost to Follow-up|16
5897647|NCT01705574|20404938|P1|Double-Blind Phase|Lost to Follow-up|12
5897648|NCT01705509|20404955|P1|CPET w/ Ranexa|Screen Failure|2
5897649|NCT01705509|20404955|P1|Inclusion CPET|Withdrawal by Subject|2
5897650|NCT01705509|20404955|P1|Inclusion CPET|Screen Failure|5
5897651|NCT01705236|20404982|P1|Overall Study|Adverse Event|5
5897652|NCT01705236|20404982|P1|Overall Study|Withdrawal by Subject|5
5897653|NCT01705236|20404982|P1|Overall Study|Abnormal laboratory value(s)|4
5897654|NCT01705236|20404982|P1|Overall Study|Abnormal test procedure result(s)|4
5897655|NCT01705236|20404982|P1|Overall Study|Protocol Violation|3
5897656|NCT01705236|20404982|P1|Overall Study|Unsatisfactory therapeutic effect|3
5897657|NCT01705236|20404982|P1|Overall Study|Administrative problems|2
5897658|NCT01705236|20404982|P1|Overall Study|Lost to Follow-up|1
5897659|NCT01705145|20404991|P1|Part B|Adverse Event|1
5897660|NCT01705080|20405031|P4|Overall Study|Missed 6 Month Visit|0
5897661|NCT01705080|20405032|P3|Overall Study|Missed 6 Month Visit|1
5897662|NCT01705080|20405033|P2|Overall Study|Missed 6 Month Visit|1
5897663|NCT01705080|20405034|P1|Overall Study|Missed 6 Month Visit|3
5897664|NCT01705080|20405031|P4|Overall Study|Protocol Violation|0
5897665|NCT01705080|20405032|P3|Overall Study|Protocol Violation|0
5897666|NCT01705080|20405033|P2|Overall Study|Protocol Violation|0
5897667|NCT01705080|20405034|P1|Overall Study|Protocol Violation|2
5897668|NCT01705080|20405031|P4|Overall Study|Lost to Follow-up|2
5897669|NCT01705080|20405032|P3|Overall Study|Lost to Follow-up|0
5897670|NCT01705080|20405033|P2|Overall Study|Lost to Follow-up|0
5897671|NCT01705080|20405034|P1|Overall Study|Lost to Follow-up|0
5897672|NCT01705080|20405031|P4|Overall Study|Physician Decision|8
5897673|NCT01705080|20405032|P3|Overall Study|Physician Decision|1
5897674|NCT01705080|20405033|P2|Overall Study|Physician Decision|2
5897675|NCT01705080|20405034|P1|Overall Study|Physician Decision|1
5897676|NCT01705080|20405031|P4|Overall Study|Withdrawal by Subject|12
5897677|NCT01705080|20405032|P3|Overall Study|Withdrawal by Subject|0
5897678|NCT01705080|20405033|P2|Overall Study|Withdrawal by Subject|1
5897679|NCT01705080|20405034|P1|Overall Study|Withdrawal by Subject|1
5897680|NCT01705080|20405031|P4|Overall Study|Death|0
5897681|NCT01705080|20405032|P3|Overall Study|Death|0
5897682|NCT01705080|20405033|P2|Overall Study|Death|1
5897683|NCT01705080|20405034|P1|Overall Study|Death|0
5897684|NCT01705080|20405031|P4|Overall Study|Failed Procedure|0
5897685|NCT01705080|20405032|P3|Overall Study|Failed Procedure|0
5897686|NCT01705080|20405033|P2|Overall Study|Failed Procedure|2
5897687|NCT01705080|20405034|P1|Overall Study|Failed Procedure|0
5897688|NCT01705080|20405031|P4|Overall Study|Screen Failure Post Consent|20
5897689|NCT01705080|20405032|P3|Overall Study|Screen Failure Post Consent|3
5897690|NCT01705080|20405033|P2|Overall Study|Screen Failure Post Consent|9
5897691|NCT01705080|20405034|P1|Overall Study|Screen Failure Post Consent|8
5897692|NCT01704846|20405163|P2|Treatment Period 2|Withdrawal by Subject|1
5897693|NCT01704846|20405164|P1|Treatment Period 2|Withdrawal by Subject|0
5897694|NCT01704755|20405219|P2|Overall Study|Withdrew consent and personal issues|0
5897695|NCT01704755|20405220|P1|Overall Study|Withdrew consent and personal issues|1
5897696|NCT01704755|20405219|P2|Overall Study|Other (not specified)|1
5897697|NCT01704755|20405220|P1|Overall Study|Other (not specified)|3
5897698|NCT01704755|20405219|P2|Overall Study|Withdrew consent|1
5897699|NCT01704755|20405220|P1|Overall Study|Withdrew consent|1
5897700|NCT01704755|20405219|P2|Overall Study|Lost to Follow-up|4
5897701|NCT01704755|20405220|P1|Overall Study|Lost to Follow-up|3
5897702|NCT01704755|20405219|P2|Overall Study|Adverse Event|1
5897703|NCT01704755|20405220|P1|Overall Study|Adverse Event|4
5897704|NCT01704651|20405234|P2|Overall Study|Post-op did not have laparotomy|1
5897705|NCT01704651|20405235|P1|Overall Study|Post-op did not have laparotomy|2
5897706|NCT01704651|20405234|P2|Overall Study|Nasogastric tube placement in surgery|1
5897707|NCT01704651|20405235|P1|Overall Study|Nasogastric tube placement in surgery|1
5897708|NCT01704651|20405234|P2|Overall Study|Pre-op change in treatment plan|4
5897709|NCT01704651|20405235|P1|Overall Study|Pre-op change in treatment plan|1
5897710|NCT01704651|20405234|P2|Overall Study|Pre-op withdrawal by subject|1
5897711|NCT01704651|20405235|P1|Overall Study|Pre-op withdrawal by subject|1
5897712|NCT01704599|20405243|P1|Overall Study|Adverse Event|1
5897713|NCT01704495|20405283|P4|Optional Safety Extension|Withdrawal by Subject|2
5897714|NCT01704495|20405284|P3|Optional Safety Extension|Withdrawal by Subject|1
5897715|NCT01704495|20405285|P2|Optional Safety Extension|Withdrawal by Subject|0
5897716|NCT01704495|20405286|P1|Optional Safety Extension|Withdrawal by Subject|2
5897717|NCT01704495|20405283|P4|Optional Safety Extension|Other reason|28
5897718|NCT01704495|20405284|P3|Optional Safety Extension|Other reason|30
5897719|NCT01704495|20405285|P2|Optional Safety Extension|Other reason|29
5897720|NCT01704495|20405286|P1|Optional Safety Extension|Other reason|27
5897721|NCT01704495|20405283|P4|Optional Safety Extension|Adverse Event|1
5897722|NCT01704495|20405284|P3|Optional Safety Extension|Adverse Event|0
5897723|NCT01704495|20405285|P2|Optional Safety Extension|Adverse Event|4
5897724|NCT01704495|20405286|P1|Optional Safety Extension|Adverse Event|0
5897725|NCT01704495|20405283|P4|Subjects Randomized|Eligibility criteria not fulfilled|3
5897726|NCT01704495|20405284|P3|Subjects Randomized|Eligibility criteria not fulfilled|4
5897727|NCT01704495|20405285|P2|Subjects Randomized|Eligibility criteria not fulfilled|3
5897728|NCT01704495|20405286|P1|Subjects Randomized|Eligibility criteria not fulfilled|1
5897729|NCT01704495|20405283|P4|Subjects Randomized|Protocol Violation|0
5897730|NCT01704495|20405284|P3|Subjects Randomized|Protocol Violation|2
5897731|NCT01704495|20405285|P2|Subjects Randomized|Protocol Violation|1
5897732|NCT01704495|20405286|P1|Subjects Randomized|Protocol Violation|1
5897733|NCT01704495|20405283|P4|Subjects Randomized|Withdrawal by Subject|5
5897734|NCT01704495|20405284|P3|Subjects Randomized|Withdrawal by Subject|5
5897735|NCT01704495|20405285|P2|Subjects Randomized|Withdrawal by Subject|5
5897736|NCT01704495|20405286|P1|Subjects Randomized|Withdrawal by Subject|5
5897737|NCT01704495|20405283|P4|Subjects Randomized|Adverse Event|7
5897738|NCT01704495|20405284|P3|Subjects Randomized|Adverse Event|0
5897739|NCT01704495|20405285|P2|Subjects Randomized|Adverse Event|2
5897740|NCT01704495|20405286|P1|Subjects Randomized|Adverse Event|8
5897741|NCT01704495|20405283|P4|Subjects Randomized|Discontinuation criteria met|0
5897742|NCT01704495|20405284|P3|Subjects Randomized|Discontinuation criteria met|2
5897743|NCT01704495|20405285|P2|Subjects Randomized|Discontinuation criteria met|2
5897744|NCT01704495|20405286|P1|Subjects Randomized|Discontinuation criteria met|4
5897745|NCT01704495|20405283|P4|Subjects Randomized|Other Reason|2
5897746|NCT01704495|20405284|P3|Subjects Randomized|Other Reason|3
5897747|NCT01704495|20405285|P2|Subjects Randomized|Other Reason|2
5897748|NCT01704495|20405286|P1|Subjects Randomized|Other Reason|3
5897749|NCT01704456|20405462|P2|Overall Study|Lost to Follow-up|14
5897750|NCT01704456|20405463|P1|Overall Study|Lost to Follow-up|8
5897751|NCT01704287|20405525|P5|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0
5897752|NCT01704287|20405526|P4|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|1
5897753|NCT01704287|20405527|P3|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0
5897754|NCT01704287|20405528|P2|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0
5897755|NCT01704287|20405529|P1|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0
5897756|NCT01704287|20405525|P5|Switch to Pembrolizumab Treatment Period|Death|37
5897757|NCT01704287|20405526|P4|Switch to Pembrolizumab Treatment Period|Death|35
5897758|NCT01704287|20405527|P3|Switch to Pembrolizumab Treatment Period|Death|0
5897759|NCT01704287|20405528|P2|Switch to Pembrolizumab Treatment Period|Death|0
5897760|NCT01704287|20405529|P1|Switch to Pembrolizumab Treatment Period|Death|0
5897761|NCT01704287|20405525|P5|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|1
5897762|NCT01704287|20405526|P4|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|2
5897763|NCT01704287|20405527|P3|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0
5897764|NCT01704287|20405528|P2|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0
5897765|NCT01704287|20405529|P1|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0
5897766|NCT01704287|20405525|P5|Initial Treatment Period|Switched to Pembrolizumab|0
5897767|NCT01704287|20405526|P4|Initial Treatment Period|Switched to Pembrolizumab|0
5897768|NCT01704287|20405527|P3|Initial Treatment Period|Switched to Pembrolizumab|98
5897769|NCT01704287|20405528|P2|Initial Treatment Period|Switched to Pembrolizumab|0
5897770|NCT01704287|20405529|P1|Initial Treatment Period|Switched to Pembrolizumab|0
5897771|NCT01704287|20405525|P5|Initial Treatment Period|Lost to Follow-up|0
5897772|NCT01704287|20405526|P4|Initial Treatment Period|Lost to Follow-up|0
5897773|NCT01704287|20405527|P3|Initial Treatment Period|Lost to Follow-up|0
5897774|NCT01704287|20405528|P2|Initial Treatment Period|Lost to Follow-up|3
5897775|NCT01704287|20405529|P1|Initial Treatment Period|Lost to Follow-up|5
5897776|NCT01704287|20405525|P5|Initial Treatment Period|Withdrawal by Subject|0
5897777|NCT01704287|20405526|P4|Initial Treatment Period|Withdrawal by Subject|0
5897778|NCT01704287|20405527|P3|Initial Treatment Period|Withdrawal by Subject|4
5897779|NCT01704287|20405528|P2|Initial Treatment Period|Withdrawal by Subject|2
5897780|NCT01704287|20405529|P1|Initial Treatment Period|Withdrawal by Subject|3
5897781|NCT01704287|20405525|P5|Initial Treatment Period|Death|0
5897782|NCT01704287|20405526|P4|Initial Treatment Period|Death|0
5897783|NCT01704287|20405527|P3|Initial Treatment Period|Death|71
5897784|NCT01704287|20405528|P2|Initial Treatment Period|Death|129
5897785|NCT01704287|20405529|P1|Initial Treatment Period|Death|139
5897786|NCT01704261|20405577|P2|Overall Study|Lost to Follow-up|0
5897787|NCT01704261|20405578|P1|Overall Study|Lost to Follow-up|1
5897788|NCT01704261|20405577|P2|Overall Study|Withdrawal by Subject|15
5897789|NCT01704261|20405578|P1|Overall Study|Withdrawal by Subject|12
5897790|NCT01704079|20405605|P2|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|1
5897791|NCT01704079|20405606|P1|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|0
5897792|NCT01704079|20405605|P2|Overall Study|Subject noncompliance|3
5897793|NCT01704079|20405606|P1|Overall Study|Subject noncompliance|2
5897794|NCT01704079|20405605|P2|Overall Study|Protocol Violation|0
5897795|NCT01704079|20405606|P1|Overall Study|Protocol Violation|1
5897796|NCT01704079|20405605|P2|Overall Study|Adverse Event|7
5897797|NCT01704079|20405606|P1|Overall Study|Adverse Event|4
5897798|NCT01704079|20405605|P2|Overall Study|Lost to Follow-up|5
5897799|NCT01704079|20405606|P1|Overall Study|Lost to Follow-up|2
5897800|NCT01704079|20405605|P2|Overall Study|Withdrawal by Subject|7
5897801|NCT01704079|20405606|P1|Overall Study|Withdrawal by Subject|5
5897802|NCT01703988|20405622|P4|Overall Study|Investigator Judgment|1
5897803|NCT01703988|20405623|P3|Overall Study|Investigator Judgment|0
5897804|NCT01703988|20405624|P2|Overall Study|Investigator Judgment|0
5897805|NCT01703988|20405625|P1|Overall Study|Investigator Judgment|0
5897806|NCT01703858|20405655|P3|Overall Study|Withdrawal by Subject|0
5897807|NCT01703858|20405656|P2|Overall Study|Withdrawal by Subject|1
5897808|NCT01703858|20405657|P1|Overall Study|Withdrawal by Subject|0
5897809|NCT01703845|20405682|P2|Overall Study|other than stated above|0
5897810|NCT01703845|20405683|P1|Overall Study|other than stated above|1
5897811|NCT01703845|20405682|P2|Overall Study|Protocol Violation|0
5897812|NCT01703845|20405683|P1|Overall Study|Protocol Violation|1
5897813|NCT01703845|20405682|P2|Overall Study|Adverse Event|0
5897814|NCT01703845|20405683|P1|Overall Study|Adverse Event|1
5897815|NCT01703832|20405720|P2|Overall Study|Withdrawal by Subject|0
5897816|NCT01703832|20405721|P1|Overall Study|Withdrawal by Subject|1
5897817|NCT01703819|20405753|P2|Overall Study|Withdrawal by Subject|1
5897818|NCT01703819|20405754|P1|Overall Study|Withdrawal by Subject|0
5897819|NCT01703819|20405753|P2|Overall Study|Adverse Event|1
5897820|NCT01703819|20405754|P1|Overall Study|Adverse Event|0
5897821|NCT01703741|20405784|P1|Overall Study|Subject started testosterone injections|1
5897822|NCT01703741|20405784|P1|Overall Study|Subject cannot comply with study visits|1
5897823|NCT01703741|20405784|P1|Overall Study|Subject did not want to continue|2
5897824|NCT01703741|20405784|P1|Overall Study|Lost to Follow-up|3
5897825|NCT01703741|20405784|P1|Overall Study|Protocol Violation|1
5897826|NCT01703741|20405784|P1|Overall Study|Physician Decision|2
5897827|NCT01703741|20405784|P1|Overall Study|Adverse Event|2
5897828|NCT01703741|20405784|P1|Overall Study|Withdrawal by Subject|6
5897829|NCT01703286|20405850|P6|Period 2 Including Washout|Adverse Event|0
5897830|NCT01703286|20405851|P5|Period 2 Including Washout|Adverse Event|0
5897831|NCT01703286|20405852|P4|Period 2 Including Washout|Adverse Event|1
5897832|NCT01703286|20405853|P3|Period 2 Including Washout|Adverse Event|0
5897833|NCT01703286|20405854|P2|Period 2 Including Washout|Adverse Event|0
5897834|NCT01703286|20405855|P1|Period 2 Including Washout|Adverse Event|0
5897835|NCT01703286|20405850|P6|Period 1 Including Washout|Withdrawal by Subject|1
5897836|NCT01703286|20405851|P5|Period 1 Including Washout|Withdrawal by Subject|0
5897837|NCT01703286|20405852|P4|Period 1 Including Washout|Withdrawal by Subject|1
5897838|NCT01703286|20405853|P3|Period 1 Including Washout|Withdrawal by Subject|0
5897839|NCT01703286|20405854|P2|Period 1 Including Washout|Withdrawal by Subject|0
5897840|NCT01703286|20405855|P1|Period 1 Including Washout|Withdrawal by Subject|0
5897841|NCT01703260|20405878|P3|Overall Study|Study Termination|0
5897842|NCT01703260|20405879|P2|Overall Study|Study Termination|2
5897843|NCT01703260|20405880|P1|Overall Study|Study Termination|1
5897844|NCT01703260|20405878|P3|Overall Study|Withdrawal by Subject|1
5897845|NCT01703260|20405879|P2|Overall Study|Withdrawal by Subject|0
5897846|NCT01703260|20405880|P1|Overall Study|Withdrawal by Subject|0
5897847|NCT01703260|20405878|P3|Overall Study|Lost to Follow-up|0
5897848|NCT01703260|20405879|P2|Overall Study|Lost to Follow-up|0
5897849|NCT01703260|20405880|P1|Overall Study|Lost to Follow-up|1
5897850|NCT01703260|20405878|P3|Overall Study|Adverse Event|2
5897851|NCT01703260|20405879|P2|Overall Study|Adverse Event|2
5897852|NCT01703260|20405880|P1|Overall Study|Adverse Event|1
5897853|NCT01703221|20405906|P3|Phase B - (Week 25 to 52)|Lack of Efficacy|3
5897854|NCT01703221|20405907|P2|Phase B - (Week 25 to 52)|Lack of Efficacy|10
5897855|NCT01703221|20405908|P1|Phase B - (Week 25 to 52)|Lack of Efficacy|12
5897856|NCT01703221|20405906|P3|Phase B - (Week 25 to 52)|Adverse Event|2
5897857|NCT01703221|20405907|P2|Phase B - (Week 25 to 52)|Adverse Event|3
5897858|NCT01703221|20405908|P1|Phase B - (Week 25 to 52)|Adverse Event|2
5897859|NCT01703221|20405906|P3|Phase B - (Week 25 to 52)|Withdrawal by Subject|0
5897860|NCT01703221|20405907|P2|Phase B - (Week 25 to 52)|Withdrawal by Subject|1
5897861|NCT01703221|20405908|P1|Phase B - (Week 25 to 52)|Withdrawal by Subject|2
5897862|NCT01703221|20405906|P3|Phase A (Up to 24 Weeks)|Protocol Violation|1
5897863|NCT01703221|20405907|P2|Phase A (Up to 24 Weeks)|Protocol Violation|0
5897864|NCT01703221|20405908|P1|Phase A (Up to 24 Weeks)|Protocol Violation|0
5897865|NCT01703221|20405906|P3|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1
5897866|NCT01703221|20405907|P2|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
5897867|NCT01703221|20405908|P1|Phase A (Up to 24 Weeks)|Withdrawal by Subject|2
5897868|NCT01703221|20405906|P3|Phase A (Up to 24 Weeks)|Physician Decision|0
5897869|NCT01703221|20405907|P2|Phase A (Up to 24 Weeks)|Physician Decision|0
5897870|NCT01703221|20405908|P1|Phase A (Up to 24 Weeks)|Physician Decision|1
5897871|NCT01703221|20405906|P3|Phase A (Up to 24 Weeks)|Lack of Efficacy|1
5897872|NCT01703221|20405907|P2|Phase A (Up to 24 Weeks)|Lack of Efficacy|0
5897873|NCT01703221|20405908|P1|Phase A (Up to 24 Weeks)|Lack of Efficacy|2
5897874|NCT01703221|20405906|P3|Phase A (Up to 24 Weeks)|Adverse Event|0
5897875|NCT01703221|20405907|P2|Phase A (Up to 24 Weeks)|Adverse Event|4
5897876|NCT01703221|20405908|P1|Phase A (Up to 24 Weeks)|Adverse Event|2
5897877|NCT01703208|20405939|P2|Overall Study|Protocol Deviation|0
5897878|NCT01703208|20405940|P1|Overall Study|Protocol Deviation|2
5897879|NCT01703208|20405939|P2|Overall Study|Technical Problems|1
5897880|NCT01703208|20405940|P1|Overall Study|Technical Problems|0
5897881|NCT01703208|20405939|P2|Overall Study|Adverse Event|19
5897882|NCT01703208|20405940|P1|Overall Study|Adverse Event|14
5897883|NCT01703208|20405939|P2|Overall Study|Withdrawal by Subject|209
5897884|NCT01703208|20405940|P1|Overall Study|Withdrawal by Subject|205
5897885|NCT01703208|20405939|P2|Overall Study|Study Terminated by Sponsor|1716
5897886|NCT01703208|20405940|P1|Overall Study|Study Terminated by Sponsor|1710
5897887|NCT01703208|20405939|P2|Overall Study|Protocol Violation|1
5897888|NCT01703208|20405940|P1|Overall Study|Protocol Violation|1
5897889|NCT01703208|20405939|P2|Overall Study|Progressive disease|2
5897890|NCT01703208|20405940|P1|Overall Study|Progressive disease|2
5897891|NCT01703208|20405939|P2|Overall Study|Physician Decision|13
5897892|NCT01703208|20405940|P1|Overall Study|Physician Decision|11
5897893|NCT01703208|20405939|P2|Overall Study|Site Discontinued Study Participation|27
5897894|NCT01703208|20405940|P1|Overall Study|Site Discontinued Study Participation|23
5897895|NCT01703208|20405939|P2|Overall Study|Excluded Medication|2
5897896|NCT01703208|20405940|P1|Overall Study|Excluded Medication|1
5897897|NCT01703208|20405939|P2|Overall Study|Non-Compliance with Study Drug|0
5897898|NCT01703208|20405940|P1|Overall Study|Non-Compliance with Study Drug|1
5897899|NCT01703208|20405939|P2|Overall Study|Lost to Follow-up|62
5897900|NCT01703208|20405940|P1|Overall Study|Lost to Follow-up|68
5897901|NCT01703208|20405939|P2|Overall Study|Lack of Efficacy|2
5897902|NCT01703208|20405940|P1|Overall Study|Lack of Efficacy|1
5897903|NCT01703208|20405939|P2|Overall Study|Death|48
5897904|NCT01703208|20405940|P1|Overall Study|Death|61
5897905|NCT01703091|20406004|P2|Overall Study|Sponsor Decision|0
5897906|NCT01703091|20406005|P1|Overall Study|Sponsor Decision|1
5897907|NCT01703091|20406004|P2|Overall Study|Withdrawal by Subject|0
5897908|NCT01703091|20406005|P1|Overall Study|Withdrawal by Subject|1
5897909|NCT01703091|20406004|P2|Overall Study|Physician Decision|1
5897910|NCT01703091|20406005|P1|Overall Study|Physician Decision|2
5897911|NCT01703091|20406004|P2|Overall Study|Adverse Event|3
5897912|NCT01703091|20406005|P1|Overall Study|Adverse Event|5
5897913|NCT01703065|20406023|P2|Overall Study|Lack of Efficacy|0
5897914|NCT01703065|20406024|P1|Overall Study|Lack of Efficacy|1
5897915|NCT01703000|20406054|P1|Overall Study|Death|1
5897916|NCT01702987|20406087|P2|Overall Study|Withdrawal by Subject|0
5897917|NCT01702987|20406088|P1|Overall Study|Withdrawal by Subject|1
5897918|NCT01702961|20406094|P1|Overall Study|Ongoing|11
5897919|NCT01702961|20406094|P1|Overall Study|Lost to Follow-up|2
5897920|NCT01702961|20406094|P1|Overall Study|Death|6
5897921|NCT01702961|20406094|P1|Overall Study|Relapse|20
5897922|NCT01702961|20406094|P1|Overall Study|Progressive disease|5
5897923|NCT01702961|20406094|P1|Overall Study|Additional treatment|3
5897924|NCT01702844|20406112|P1|Overall Study|Physician Decision|6
5897925|NCT01702844|20406112|P1|Overall Study|Withdrawal by Subject|3
5897926|NCT01702844|20406112|P1|Overall Study|Death|1
5897927|NCT01702844|20406112|P1|Overall Study|Adverse Event|9
5897928|NCT01702558|20406124|P5|Overall Study|Other|17
5897929|NCT01702558|20406125|P4|Overall Study|Other|16
5897930|NCT01702558|20406126|P3|Overall Study|Other|0
5897931|NCT01702558|20406127|P2|Overall Study|Other|0
5897932|NCT01702558|20406128|P1|Overall Study|Other|0
5897933|NCT01702558|20406124|P5|Overall Study|Study Terminated by Sponsor|1
5897934|NCT01702558|20406125|P4|Overall Study|Study Terminated by Sponsor|0
5897935|NCT01702558|20406126|P3|Overall Study|Study Terminated by Sponsor|0
5897936|NCT01702558|20406127|P2|Overall Study|Study Terminated by Sponsor|1
5897937|NCT01702558|20406128|P1|Overall Study|Study Terminated by Sponsor|0
5897938|NCT01702558|20406124|P5|Overall Study|Safety Follow-Up less than 3 Months|0
5897939|NCT01702558|20406125|P4|Overall Study|Safety Follow-Up less than 3 Months|0
5897940|NCT01702558|20406126|P3|Overall Study|Safety Follow-Up less than 3 Months|2
5897941|NCT01702558|20406127|P2|Overall Study|Safety Follow-Up less than 3 Months|0
5897942|NCT01702558|20406128|P1|Overall Study|Safety Follow-Up less than 3 Months|0
5897943|NCT01702558|20406124|P5|Overall Study|Death|20
5897944|NCT01702558|20406125|P4|Overall Study|Death|16
5897945|NCT01702558|20406126|P3|Overall Study|Death|3
5897946|NCT01702558|20406127|P2|Overall Study|Death|3
5897947|NCT01702558|20406128|P1|Overall Study|Death|4
5897948|NCT01702558|20406124|P5|Overall Study|Lost to Follow-up|0
5897949|NCT01702558|20406125|P4|Overall Study|Lost to Follow-up|3
5897950|NCT01702558|20406126|P3|Overall Study|Lost to Follow-up|0
5897951|NCT01702558|20406127|P2|Overall Study|Lost to Follow-up|0
5897952|NCT01702558|20406128|P1|Overall Study|Lost to Follow-up|0
5897953|NCT01702558|20406124|P5|Overall Study|Withdrawal by Subject|4
5897954|NCT01702558|20406125|P4|Overall Study|Withdrawal by Subject|12
5897955|NCT01702558|20406126|P3|Overall Study|Withdrawal by Subject|0
5897956|NCT01702558|20406127|P2|Overall Study|Withdrawal by Subject|0
5897957|NCT01702558|20406128|P1|Overall Study|Withdrawal by Subject|0
5897958|NCT01702532|20406193|P2|Overall Study|Adverse Event|1
5897959|NCT01702532|20406194|P1|Overall Study|Adverse Event|0
5897960|NCT01702519|20406204|P2|Washout Period|Withdrawal by Subject|2
5897961|NCT01702519|20406205|P1|Washout Period|Withdrawal by Subject|0
5897962|NCT01702519|20406204|P2|Washout Period|Lost to Follow-up|0
5897963|NCT01702519|20406205|P1|Washout Period|Lost to Follow-up|1
5897964|NCT01702454|20406223|P2|Overall Study|Lost to Follow-up|6
5897965|NCT01702454|20406224|P1|Overall Study|Lost to Follow-up|3
5897966|NCT01702454|20406223|P2|Overall Study|Migrated/moved from study area|1
5897967|NCT01702454|20406224|P1|Overall Study|Migrated/moved from study area|0
5897968|NCT01702454|20406223|P2|Overall Study|Consent withdrawal|1
5897969|NCT01702454|20406224|P1|Overall Study|Consent withdrawal|0
5897970|NCT01702428|20406306|P4|Overall Study|Withdrawal by Subject|10
5897971|NCT01702428|20406307|P3|Overall Study|Withdrawal by Subject|14
5897972|NCT01702428|20406308|P2|Overall Study|Withdrawal by Subject|23
5897973|NCT01702428|20406309|P1|Overall Study|Withdrawal by Subject|21
5897974|NCT01702428|20406306|P4|Overall Study|Protocol Violation|0
5897975|NCT01702428|20406307|P3|Overall Study|Protocol Violation|1
5897976|NCT01702428|20406308|P2|Overall Study|Protocol Violation|0
5897977|NCT01702428|20406309|P1|Overall Study|Protocol Violation|3
5897978|NCT01702428|20406306|P4|Overall Study|Parents too busy|0
5897979|NCT01702428|20406307|P3|Overall Study|Parents too busy|0
5897980|NCT01702428|20406308|P2|Overall Study|Parents too busy|0
5897981|NCT01702428|20406309|P1|Overall Study|Parents too busy|1
5897982|NCT01702428|20406306|P4|Overall Study|Mother transferred care|0
5897983|NCT01702428|20406307|P3|Overall Study|Mother transferred care|0
5897984|NCT01702428|20406308|P2|Overall Study|Mother transferred care|1
5897985|NCT01702428|20406309|P1|Overall Study|Mother transferred care|0
5897986|NCT01702428|20406306|P4|Overall Study|Lost Health Plan|2
5897987|NCT01702428|20406307|P3|Overall Study|Lost Health Plan|0
5897988|NCT01702428|20406308|P2|Overall Study|Lost Health Plan|5
5897989|NCT01702428|20406309|P1|Overall Study|Lost Health Plan|3
5897990|NCT01702428|20406306|P4|Overall Study|Lost Coverage|1
5897991|NCT01702428|20406307|P3|Overall Study|Lost Coverage|0
5897992|NCT01702428|20406308|P2|Overall Study|Lost Coverage|0
5897993|NCT01702428|20406309|P1|Overall Study|Lost Coverage|0
5897994|NCT01702428|20406306|P4|Overall Study|Parents cannot assist to site|0
5897995|NCT01702428|20406307|P3|Overall Study|Parents cannot assist to site|1
5897996|NCT01702428|20406308|P2|Overall Study|Parents cannot assist to site|0
5897997|NCT01702428|20406309|P1|Overall Study|Parents cannot assist to site|1
5897998|NCT01702428|20406306|P4|Overall Study|Lost to Follow-up|44
5897999|NCT01702428|20406307|P3|Overall Study|Lost to Follow-up|37
5898000|NCT01702428|20406308|P2|Overall Study|Lost to Follow-up|41
5898001|NCT01702428|20406309|P1|Overall Study|Lost to Follow-up|33
5898002|NCT01702428|20406306|P4|Overall Study|Adverse Event|0
5898003|NCT01702428|20406307|P3|Overall Study|Adverse Event|0
5898004|NCT01702428|20406308|P2|Overall Study|Adverse Event|0
5898005|NCT01702428|20406309|P1|Overall Study|Adverse Event|2
5898006|NCT01702363|20406396|P1|Overall Study|Withdrawal by Subject|2
5898007|NCT01702363|20406396|P1|Overall Study|Lack of Efficacy|4
5898008|NCT01702363|20406396|P1|Overall Study|Adverse Event|14
5898009|NCT01702311|20406413|P2|Overall Study|Physician Decision|4
5898010|NCT01702311|20406414|P1|Overall Study|Physician Decision|3
5898011|NCT01702311|20406413|P2|Overall Study|Discharge less than 24 hours|7
5898012|NCT01702311|20406414|P1|Overall Study|Discharge less than 24 hours|10
5898013|NCT01702311|20406413|P2|Overall Study|Withdrawal by Subject|2
5898014|NCT01702311|20406414|P1|Overall Study|Withdrawal by Subject|3
5898015|NCT01702298|20406444|P1|Overall Study|Withdrawal by Subject|1
5898016|NCT01702246|20406472|P1|Overall Study|Physician Decision|1
5898017|NCT01702246|20406472|P1|Overall Study|Withdrawal by Subject|2
5898018|NCT01702246|20406472|P1|Overall Study|Lost to Follow-up|2
5898019|NCT01702025|20406526|P4|Overall Study|Adverse Event|0
5898020|NCT01702025|20406527|P3|Overall Study|Adverse Event|1
5898021|NCT01702025|20406528|P2|Overall Study|Adverse Event|1
5898022|NCT01702025|20406529|P1|Overall Study|Adverse Event|1
5898023|NCT01702025|20406526|P4|Overall Study|Equipment failure|0
5898024|NCT01702025|20406527|P3|Overall Study|Equipment failure|0
5898025|NCT01702025|20406528|P2|Overall Study|Equipment failure|0
5898026|NCT01702025|20406529|P1|Overall Study|Equipment failure|1
5898027|NCT01701973|20406558|P8|Aim 1: First Intervention (1 Day)|Adverse Event|0
5898028|NCT01701973|20406559|P7|Aim 1: First Intervention (1 Day)|Adverse Event|0
5898029|NCT01701973|20406560|P6|Aim 1: First Intervention (1 Day)|Adverse Event|0
5898030|NCT01701973|20406561|P5|Aim 1: First Intervention (1 Day)|Adverse Event|0
5898031|NCT01701973|20406562|P4|Aim 1: First Intervention (1 Day)|Adverse Event|0
5898032|NCT01701973|20406563|P3|Aim 1: First Intervention (1 Day)|Adverse Event|0
5898033|NCT01701973|20406564|P2|Aim 1: First Intervention (1 Day)|Adverse Event|1
5898034|NCT01701973|20406565|P1|Aim 1: First Intervention (1 Day)|Adverse Event|0
5898036|NCT01701583|20406626|P2|Overall Study|Withdrawal by Subject|0
5898037|NCT01701583|20406627|P1|Overall Study|Withdrawal by Subject|2
5898038|NCT01701401|20406710|P4|Overall Study|Protocol Violation|0
5898039|NCT01701401|20406711|P3|Overall Study|Protocol Violation|1
5898040|NCT01701401|20406712|P2|Overall Study|Protocol Violation|0
5898041|NCT01701401|20406713|P1|Overall Study|Protocol Violation|0
5898042|NCT01701401|20406710|P4|Overall Study|Adverse Event|0
5898043|NCT01701401|20406711|P3|Overall Study|Adverse Event|0
5898044|NCT01701401|20406712|P2|Overall Study|Adverse Event|0
5898045|NCT01701401|20406713|P1|Overall Study|Adverse Event|1
5898046|NCT01701401|20406710|P4|Overall Study|Lack of Efficacy|0
5898047|NCT01701401|20406711|P3|Overall Study|Lack of Efficacy|2
5898048|NCT01701401|20406712|P2|Overall Study|Lack of Efficacy|0
5898049|NCT01701401|20406713|P1|Overall Study|Lack of Efficacy|1
5898050|NCT01701401|20406710|P4|Overall Study|Withdrew Consent|2
5898051|NCT01701401|20406711|P3|Overall Study|Withdrew Consent|1
5898052|NCT01701401|20406712|P2|Overall Study|Withdrew Consent|3
5898053|NCT01701401|20406713|P1|Overall Study|Withdrew Consent|0
5898054|NCT01701401|20406710|P4|Overall Study|Lost to Follow-up|3
5898055|NCT01701401|20406711|P3|Overall Study|Lost to Follow-up|1
5898056|NCT01701401|20406712|P2|Overall Study|Lost to Follow-up|5
5898057|NCT01701401|20406713|P1|Overall Study|Lost to Follow-up|5
5898058|NCT01701401|20406710|P4|Overall Study|Randomized But Not Treated|1
5898059|NCT01701401|20406711|P3|Overall Study|Randomized But Not Treated|0
5898060|NCT01701401|20406712|P2|Overall Study|Randomized But Not Treated|1
5898061|NCT01701401|20406713|P1|Overall Study|Randomized But Not Treated|3
5898062|NCT01701258|20406773|P13|Assessment and Scheduling|Investigator Terminated|0
5898063|NCT01701258|20406774|P12|Assessment and Scheduling|Investigator Terminated|0
5898064|NCT01701258|20406775|P11|Assessment and Scheduling|Investigator Terminated|0
5898065|NCT01701258|20406776|P10|Assessment and Scheduling|Investigator Terminated|0
5898066|NCT01701258|20406777|P9|Assessment and Scheduling|Investigator Terminated|0
5898067|NCT01701258|20406778|P8|Assessment and Scheduling|Investigator Terminated|0
5898068|NCT01701258|20406779|P7|Assessment and Scheduling|Investigator Terminated|0
5898069|NCT01701258|20406780|P6|Assessment and Scheduling|Investigator Terminated|0
5898070|NCT01701258|20406781|P5|Assessment and Scheduling|Investigator Terminated|0
5898071|NCT01701258|20406782|P4|Assessment and Scheduling|Investigator Terminated|0
5898072|NCT01701258|20406783|P3|Assessment and Scheduling|Investigator Terminated|0
5898073|NCT01701258|20406784|P2|Assessment and Scheduling|Investigator Terminated|0
5898074|NCT01701258|20406785|P1|Assessment and Scheduling|Investigator Terminated|2
5898075|NCT01701258|20406773|P13|Assessment and Scheduling|Withdrawal by Subject|0
5898076|NCT01701258|20406774|P12|Assessment and Scheduling|Withdrawal by Subject|0
5898077|NCT01701258|20406775|P11|Assessment and Scheduling|Withdrawal by Subject|0
5898078|NCT01701258|20406776|P10|Assessment and Scheduling|Withdrawal by Subject|0
5898079|NCT01701258|20406777|P9|Assessment and Scheduling|Withdrawal by Subject|0
5898080|NCT01701258|20406778|P8|Assessment and Scheduling|Withdrawal by Subject|0
5898081|NCT01701258|20406779|P7|Assessment and Scheduling|Withdrawal by Subject|0
5898082|NCT01701258|20406780|P6|Assessment and Scheduling|Withdrawal by Subject|0
5898083|NCT01701258|20406781|P5|Assessment and Scheduling|Withdrawal by Subject|0
5898084|NCT01701258|20406782|P4|Assessment and Scheduling|Withdrawal by Subject|0
5898085|NCT01701258|20406783|P3|Assessment and Scheduling|Withdrawal by Subject|0
5898086|NCT01701258|20406784|P2|Assessment and Scheduling|Withdrawal by Subject|0
5898087|NCT01701258|20406785|P1|Assessment and Scheduling|Withdrawal by Subject|14
5898088|NCT01701258|20406773|P13|Assessment and Scheduling|Lost to Follow-up|0
5898089|NCT01701258|20406774|P12|Assessment and Scheduling|Lost to Follow-up|0
5898090|NCT01701258|20406775|P11|Assessment and Scheduling|Lost to Follow-up|0
5898091|NCT01701258|20406776|P10|Assessment and Scheduling|Lost to Follow-up|0
5898092|NCT01701258|20406777|P9|Assessment and Scheduling|Lost to Follow-up|0
5898093|NCT01701258|20406778|P8|Assessment and Scheduling|Lost to Follow-up|0
5898094|NCT01701258|20406779|P7|Assessment and Scheduling|Lost to Follow-up|0
5898095|NCT01701258|20406780|P6|Assessment and Scheduling|Lost to Follow-up|0
5898096|NCT01701258|20406781|P5|Assessment and Scheduling|Lost to Follow-up|0
5898097|NCT01701258|20406782|P4|Assessment and Scheduling|Lost to Follow-up|0
5898098|NCT01701258|20406783|P3|Assessment and Scheduling|Lost to Follow-up|0
5898099|NCT01701258|20406784|P2|Assessment and Scheduling|Lost to Follow-up|0
5898100|NCT01701258|20406785|P1|Assessment and Scheduling|Lost to Follow-up|10
5898101|NCT01701258|20406773|P13|Assessment and Scheduling|Found to be Ineligible|0
5898102|NCT01701258|20406774|P12|Assessment and Scheduling|Found to be Ineligible|0
5898103|NCT01701258|20406775|P11|Assessment and Scheduling|Found to be Ineligible|0
5898104|NCT01701258|20406776|P10|Assessment and Scheduling|Found to be Ineligible|0
5898105|NCT01701258|20406777|P9|Assessment and Scheduling|Found to be Ineligible|0
5898106|NCT01701258|20406778|P8|Assessment and Scheduling|Found to be Ineligible|0
5898107|NCT01701258|20406779|P7|Assessment and Scheduling|Found to be Ineligible|0
5898108|NCT01701258|20406780|P6|Assessment and Scheduling|Found to be Ineligible|0
5898109|NCT01701258|20406781|P5|Assessment and Scheduling|Found to be Ineligible|0
5898110|NCT01701258|20406782|P4|Assessment and Scheduling|Found to be Ineligible|0
5898111|NCT01701258|20406783|P3|Assessment and Scheduling|Found to be Ineligible|0
5898112|NCT01701258|20406784|P2|Assessment and Scheduling|Found to be Ineligible|0
5898113|NCT01701258|20406785|P1|Assessment and Scheduling|Found to be Ineligible|57
5898114|NCT01701245|20406839|P2|Overall Study|Did not complete the open label period|12
5898115|NCT01701245|20406840|P1|Overall Study|Did not complete the open label period|11
5898116|NCT01701245|20406839|P2|Overall Study|Protocol Violation|3
5898117|NCT01701245|20406840|P1|Overall Study|Protocol Violation|1
5898118|NCT01701063|20406887|P3|Overall Study|Other|1
5898119|NCT01701063|20406888|P2|Overall Study|Other|0
5898120|NCT01701063|20406889|P1|Overall Study|Other|0
5898121|NCT01701063|20406887|P3|Overall Study|Withdrawal by Subject|1
5898122|NCT01701063|20406888|P2|Overall Study|Withdrawal by Subject|0
5898123|NCT01701063|20406889|P1|Overall Study|Withdrawal by Subject|0
5898124|NCT01701063|20406887|P3|Overall Study|Lost to Follow-up|0
5898125|NCT01701063|20406888|P2|Overall Study|Lost to Follow-up|1
5898126|NCT01701063|20406889|P1|Overall Study|Lost to Follow-up|0
5898127|NCT01700985|20406973|P2|Overall Study|Incarcerated|1
5898128|NCT01700985|20406974|P1|Overall Study|Incarcerated|0
5898129|NCT01700959|20406996|P6|Overall Study|Side effects|1
5898130|NCT01700959|20406997|P5|Overall Study|Side effects|4
5898131|NCT01700959|20406998|P4|Overall Study|Side effects|4
5898132|NCT01700959|20406999|P3|Overall Study|Side effects|8
5898133|NCT01700959|20407000|P2|Overall Study|Side effects|4
5898134|NCT01700959|20407001|P1|Overall Study|Side effects|1
5898135|NCT01700959|20406996|P6|Overall Study|Noncompliant|9
5898136|NCT01700959|20406997|P5|Overall Study|Noncompliant|15
5898137|NCT01700959|20406998|P4|Overall Study|Noncompliant|18
5898138|NCT01700959|20406999|P3|Overall Study|Noncompliant|17
5898139|NCT01700959|20407000|P2|Overall Study|Noncompliant|9
5898140|NCT01700959|20407001|P1|Overall Study|Noncompliant|9
5898141|NCT01700959|20406996|P6|Overall Study|Ineligible|1
5898142|NCT01700959|20406997|P5|Overall Study|Ineligible|0
5898143|NCT01700959|20406998|P4|Overall Study|Ineligible|0
5898144|NCT01700959|20406999|P3|Overall Study|Ineligible|2
5898145|NCT01700959|20407000|P2|Overall Study|Ineligible|1
5898146|NCT01700959|20407001|P1|Overall Study|Ineligible|2
5898147|NCT01700959|20406996|P6|Overall Study|Withdrawal by Subject|12
5898148|NCT01700959|20406997|P5|Overall Study|Withdrawal by Subject|8
5898149|NCT01700959|20406998|P4|Overall Study|Withdrawal by Subject|11
5898150|NCT01700959|20406999|P3|Overall Study|Withdrawal by Subject|12
5898151|NCT01700959|20407000|P2|Overall Study|Withdrawal by Subject|9
5898152|NCT01700959|20407001|P1|Overall Study|Withdrawal by Subject|15
5898153|NCT01700959|20406996|P6|Overall Study|Adverse Event|2
5898154|NCT01700959|20406997|P5|Overall Study|Adverse Event|0
5898155|NCT01700959|20406998|P4|Overall Study|Adverse Event|2
5898156|NCT01700959|20406999|P3|Overall Study|Adverse Event|1
5898157|NCT01700959|20407000|P2|Overall Study|Adverse Event|1
5898158|NCT01700959|20407001|P1|Overall Study|Adverse Event|0
5898159|NCT01700829|20407042|P2|Overall Study|Withdrawal by Subject|1
5898160|NCT01700829|20407043|P1|Overall Study|Withdrawal by Subject|1
5898161|NCT01700621|20407103|P2|Analyzed for Immunogenicity|Baseline measles measure high|2
5898162|NCT01700621|20407104|P1|Analyzed for Immunogenicity|Baseline measles measure high|1
5898163|NCT01700621|20407103|P2|Analyzed for Immunogenicity|Protocol Violation|1
5898164|NCT01700621|20407104|P1|Analyzed for Immunogenicity|Protocol Violation|5
5898165|NCT01700621|20407103|P2|Analyzed for Immunogenicity|Lost to Follow-up|4
5898166|NCT01700621|20407104|P1|Analyzed for Immunogenicity|Lost to Follow-up|7
5898167|NCT01700530|20407142|P3|Overall Study|Withdrawal by Subject|1
5898168|NCT01700530|20407143|P2|Overall Study|Withdrawal by Subject|3
5898169|NCT01700530|20407144|P1|Overall Study|Withdrawal by Subject|0
5898170|NCT01700387|20407193|P2|Overall Study|Lost to Follow-up|1
5898171|NCT01700387|20407194|P1|Overall Study|Lost to Follow-up|2
5898172|NCT01700387|20407193|P2|Overall Study|Adverse Event|1
5898173|NCT01700387|20407194|P1|Overall Study|Adverse Event|1
5898174|NCT01700387|20407193|P2|Overall Study|Withdrawal by Subject|2
5898175|NCT01700387|20407194|P1|Overall Study|Withdrawal by Subject|1
5898176|NCT01700348|20407224|P1|Overall Study|Lost to Follow-up|1
5898177|NCT01700348|20407224|P1|Overall Study|Withdrawal by Subject|22
5898178|NCT01700205|20407247|P2|Overall Study|Protocol Violation|2
5898179|NCT01700205|20407248|P1|Overall Study|Protocol Violation|2
5898180|NCT01700205|20407247|P2|Overall Study|Withdrawal by Subject|13
5898181|NCT01700205|20407248|P1|Overall Study|Withdrawal by Subject|13
5898182|NCT01700192|20407270|P2|Overall Study|Never received study drug|0
5898183|NCT01700192|20407271|P1|Overall Study|Never received study drug|1
5898184|NCT01700192|20407270|P2|Overall Study|Withdrawal by Subject|64
5898185|NCT01700192|20407271|P1|Overall Study|Withdrawal by Subject|56
5898186|NCT01700192|20407270|P2|Overall Study|Technical problems|1
5898187|NCT01700192|20407271|P1|Overall Study|Technical problems|0
5898188|NCT01700192|20407270|P2|Overall Study|Protocol Violation|4
5898189|NCT01700192|20407271|P1|Overall Study|Protocol Violation|3
5898190|NCT01700192|20407270|P2|Overall Study|Progressive disease|0
5898191|NCT01700192|20407271|P1|Overall Study|Progressive disease|1
5898192|NCT01700192|20407270|P2|Overall Study|Pregnancy|4
5898193|NCT01700192|20407271|P1|Overall Study|Pregnancy|1
5898194|NCT01700192|20407270|P2|Overall Study|Physician Decision|3
5898195|NCT01700192|20407271|P1|Overall Study|Physician Decision|2
5898196|NCT01700192|20407270|P2|Overall Study|Noncompliance with study drug|5
5898197|NCT01700192|20407271|P1|Overall Study|Noncompliance with study drug|0
5898198|NCT01700192|20407270|P2|Overall Study|Lost to Follow-up|29
5898199|NCT01700192|20407271|P1|Overall Study|Lost to Follow-up|42
5898200|NCT01700192|20407270|P2|Overall Study|Lack of Efficacy|0
5898201|NCT01700192|20407271|P1|Overall Study|Lack of Efficacy|1
5898202|NCT01700192|20407270|P2|Overall Study|Adverse Event|18
5898203|NCT01700192|20407271|P1|Overall Study|Adverse Event|73
5898204|NCT01700179|20407289|P1|Overall Study|Physician Decision|2
5898205|NCT01700140|20407296|P3|Overall Study|Inclusion/exclusion criteria deviation|0
5898206|NCT01700140|20407297|P2|Overall Study|Inclusion/exclusion criteria deviation|4
5898207|NCT01700140|20407298|P1|Overall Study|Inclusion/exclusion criteria deviation|1
5898208|NCT01700140|20407296|P3|Overall Study|Adverse Event|0
5898209|NCT01700140|20407297|P2|Overall Study|Adverse Event|1
5898210|NCT01700140|20407298|P1|Overall Study|Adverse Event|0
5898211|NCT01700140|20407296|P3|Overall Study|Aggravation of symptoms|0
5898212|NCT01700140|20407297|P2|Overall Study|Aggravation of symptoms|0
5898213|NCT01700140|20407298|P1|Overall Study|Aggravation of symptoms|1
5898214|NCT01700140|20407296|P3|Overall Study|Use of chemotherapy or surgical therapy|0
5898215|NCT01700140|20407297|P2|Overall Study|Use of chemotherapy or surgical therapy|1
5898216|NCT01700140|20407298|P1|Overall Study|Use of chemotherapy or surgical therapy|0
5898217|NCT01700140|20407296|P3|Overall Study|Discontinuation of radiotherapy|0
5898218|NCT01700140|20407297|P2|Overall Study|Discontinuation of radiotherapy|0
5898219|NCT01700140|20407298|P1|Overall Study|Discontinuation of radiotherapy|1
5898220|NCT01700140|20407296|P3|Overall Study|Use of rescue drugs|1
5898221|NCT01700140|20407297|P2|Overall Study|Use of rescue drugs|3
5898222|NCT01700140|20407298|P1|Overall Study|Use of rescue drugs|3
5898223|NCT01700049|20407330|P1|Overall Study|Withdrawal by Subject|1
5898224|NCT01699867|20407345|P1|Overall Study|Screening Failure|3
5898225|NCT01699815|20407352|P2|Overall Study|Adverse Event|1
5898226|NCT01699815|20407353|P1|Overall Study|Adverse Event|0
5898227|NCT01699815|20407352|P2|Overall Study|record could not be located|0
5898228|NCT01699815|20407353|P1|Overall Study|record could not be located|1
5898229|NCT01699815|20407352|P2|Overall Study|Protocol Violation|7
5898230|NCT01699815|20407353|P1|Overall Study|Protocol Violation|4
5898231|NCT01699789|20407365|P2|Overall Study|Lost to Follow-up|101
5898232|NCT01699789|20407366|P1|Overall Study|Lost to Follow-up|83
5898233|NCT01699789|20407365|P2|Overall Study|Death|2
5898234|NCT01699789|20407366|P1|Overall Study|Death|1
5898235|NCT01699789|20407365|P2|Overall Study|Withdrawal by Subject|23
5898236|NCT01699789|20407366|P1|Overall Study|Withdrawal by Subject|18
5898237|NCT01699750|20407436|P2|Overall Study|Other|2
5898238|NCT01699750|20407437|P1|Overall Study|Other|0
5898239|NCT01699750|20407436|P2|Overall Study|Withdrew Consent|1
5898240|NCT01699750|20407437|P1|Overall Study|Withdrew Consent|0
5898241|NCT01699685|20407472|P2|Period 2|Lost to Follow-up|0
5898242|NCT01699685|20407473|P1|Period 2|Lost to Follow-up|1
5898243|NCT01699685|20407472|P2|Period 1|Patient request|1
5898244|NCT01699685|20407473|P1|Period 1|Patient request|0
5898245|NCT01699685|20407472|P2|Period 1|Other|1
5898246|NCT01699685|20407473|P1|Period 1|Other|0
5898247|NCT01699685|20407472|P2|Period 1|Medical or ethical, noncompliance|0
5898248|NCT01699685|20407473|P1|Period 1|Medical or ethical, noncompliance|2
5898249|NCT01699685|20407472|P2|Period 1|Adverse Event|1
5898250|NCT01699685|20407473|P1|Period 1|Adverse Event|1
5898251|NCT01699503|20407499|P2|Overall Study|Excluded due to quality|791
5898252|NCT01699503|20407500|P1|Overall Study|Excluded due to quality|783
5898253|NCT01699503|20407499|P2|Overall Study|Lost to Follow-up|117
5898254|NCT01699503|20407500|P1|Overall Study|Lost to Follow-up|121
5898255|NCT01699503|20407499|P2|Overall Study|Withdrawal by Subject|57
5898256|NCT01699503|20407500|P1|Overall Study|Withdrawal by Subject|65
5898257|NCT01699503|20407499|P2|Overall Study|Death|40
5898258|NCT01699503|20407500|P1|Overall Study|Death|31
5898259|NCT01699178|20407525|P2|Overall Study|ineligible/noncompliant/ subject reason|4
5898260|NCT01699178|20407526|P1|Overall Study|ineligible/noncompliant/ subject reason|4
5898261|NCT01699178|20407525|P2|Overall Study|PSA increase of >1.4 ng/mL|3
5898262|NCT01699178|20407526|P1|Overall Study|PSA increase of >1.4 ng/mL|4
5898263|NCT01699178|20407525|P2|Overall Study|Hematocrit >54%|1
5898264|NCT01699178|20407526|P1|Overall Study|Hematocrit >54%|1
5898265|NCT01699178|20407525|P2|Overall Study|Withdrawal by Subject|12
5898266|NCT01699178|20407526|P1|Overall Study|Withdrawal by Subject|4
5898267|NCT01699178|20407525|P2|Overall Study|Physician Decision|0
5898268|NCT01699178|20407526|P1|Overall Study|Physician Decision|1
5898269|NCT01699178|20407525|P2|Overall Study|Non-compliance with Study Drug|1
5898270|NCT01699178|20407526|P1|Overall Study|Non-compliance with Study Drug|3
5898271|NCT01699178|20407525|P2|Overall Study|Lost to Follow-up|6
5898272|NCT01699178|20407526|P1|Overall Study|Lost to Follow-up|1
5898273|NCT01699178|20407525|P2|Overall Study|Adverse Event|5
5898274|NCT01699178|20407526|P1|Overall Study|Adverse Event|1
5898275|NCT01699087|20407542|P1|Overall Study|Unable to make future visits|2
5898276|NCT01699087|20407542|P1|Overall Study|Screen failure (prior to treatment)|15
5898277|NCT01699087|20407542|P1|Overall Study|Lost to Follow-up|7
5898278|NCT01699022|20407556|P1|Overall Study|Early discontinuation from the study|3
5898285|NCT01698879|20407583|P3|Overall Study|Withdrawal by Subject|0
5898286|NCT01698879|20407584|P2|Overall Study|Withdrawal by Subject|0
5898287|NCT01698879|20407585|P1|Overall Study|Withdrawal by Subject|1
5898288|NCT01698814|20407608|P2|Overall Study|Randomized in error|0
5898289|NCT01698814|20407609|P1|Overall Study|Randomized in error|1
5898290|NCT01698814|20407608|P2|Overall Study|Pregnancy|0
5898291|NCT01698814|20407609|P1|Overall Study|Pregnancy|1
5898292|NCT01698814|20407608|P2|Overall Study|Lost to Follow-up|1
5898293|NCT01698814|20407609|P1|Overall Study|Lost to Follow-up|0
5898294|NCT01698814|20407608|P2|Overall Study|Adverse Event|2
5898295|NCT01698814|20407609|P1|Overall Study|Adverse Event|0
5898296|NCT01698801|20407615|P1|Follow Up Phase|Death|4
5898297|NCT01698801|20407615|P1|Follow Up Phase|Withdrawal by Subject|1
5898298|NCT01698801|20407615|P1|Treatment Phase|Disease progression|1
5898299|NCT01698801|20407615|P1|Treatment Phase|Withdrawal by Subject|1
5898300|NCT01698801|20407615|P1|Treatment Phase|Other|4
5898301|NCT01698801|20407615|P1|Treatment Phase|Protocol Violation|1
5898302|NCT01698801|20407615|P1|Treatment Phase|Adverse Event|4
5898303|NCT01698775|20407626|P2|Phase B|Withdrawal by Subject|2
5898304|NCT01698775|20407627|P1|Phase B|Withdrawal by Subject|6
5898305|NCT01698775|20407626|P2|Phase B|Protocol Violation|1
5898306|NCT01698775|20407627|P1|Phase B|Protocol Violation|1
5898307|NCT01698775|20407626|P2|Phase B|Physician Decision|1
5898308|NCT01698775|20407627|P1|Phase B|Physician Decision|1
5898309|NCT01698775|20407626|P2|Phase B|Lost to Follow-up|1
5898310|NCT01698775|20407627|P1|Phase B|Lost to Follow-up|0
5898311|NCT01698775|20407626|P2|Phase B|Lack of Efficacy|1
5898312|NCT01698775|20407627|P1|Phase B|Lack of Efficacy|0
5898313|NCT01698775|20407626|P2|Phase B|Death|1
5898314|NCT01698775|20407627|P1|Phase B|Death|0
5898315|NCT01698775|20407626|P2|Phase B|Adverse Event|3
5898316|NCT01698775|20407627|P1|Phase B|Adverse Event|6
5898317|NCT01698775|20407626|P2|Phase B|Hyperglycemia Discontinuation Criteria|1
5898318|NCT01698775|20407627|P1|Phase B|Hyperglycemia Discontinuation Criteria|0
5898319|NCT01698775|20407626|P2|Phase A|Kidney [transplant]|1
5898320|NCT01698775|20407627|P1|Phase A|Kidney [transplant]|0
5898321|NCT01698775|20407626|P2|Phase A|Withdrawal by Subject|4
5898322|NCT01698775|20407627|P1|Phase A|Withdrawal by Subject|3
5898323|NCT01698775|20407626|P2|Phase A|Protocol Violation|0
5898324|NCT01698775|20407627|P1|Phase A|Protocol Violation|1
5898325|NCT01698775|20407626|P2|Phase A|Lost to Follow-up|2
5898326|NCT01698775|20407627|P1|Phase A|Lost to Follow-up|1
5898327|NCT01698775|20407626|P2|Phase A|Lack of Efficacy|0
5898328|NCT01698775|20407627|P1|Phase A|Lack of Efficacy|1
5898329|NCT01698775|20407626|P2|Phase A|Death|1
5898330|NCT01698775|20407627|P1|Phase A|Death|1
5898331|NCT01698775|20407626|P2|Phase A|Adverse Event|1
5898332|NCT01698775|20407627|P1|Phase A|Adverse Event|2
5898333|NCT01698554|20407676|P4|Overall Study|Other Miscellaneous Reasons|0
5898334|NCT01698554|20407677|P3|Overall Study|Other Miscellaneous Reasons|0
5898335|NCT01698554|20407678|P2|Overall Study|Other Miscellaneous Reasons|0
5898336|NCT01698554|20407679|P1|Overall Study|Other Miscellaneous Reasons|1
5898337|NCT01698554|20407676|P4|Overall Study|Protocol Violation|0
5898338|NCT01698554|20407677|P3|Overall Study|Protocol Violation|1
5898339|NCT01698554|20407678|P2|Overall Study|Protocol Violation|0
5898340|NCT01698554|20407679|P1|Overall Study|Protocol Violation|2
5898341|NCT01698554|20407676|P4|Overall Study|Personal Reasons|1
5898342|NCT01698554|20407677|P3|Overall Study|Personal Reasons|1
5898343|NCT01698554|20407678|P2|Overall Study|Personal Reasons|5
5898344|NCT01698554|20407679|P1|Overall Study|Personal Reasons|0
5898345|NCT01698554|20407676|P4|Overall Study|Lost to Follow-up|0
5898346|NCT01698554|20407677|P3|Overall Study|Lost to Follow-up|0
5898347|NCT01698554|20407678|P2|Overall Study|Lost to Follow-up|0
5898348|NCT01698554|20407679|P1|Overall Study|Lost to Follow-up|1
5898349|NCT01698554|20407676|P4|Overall Study|Adverse Event|1
5898350|NCT01698554|20407677|P3|Overall Study|Adverse Event|0
5898351|NCT01698554|20407678|P2|Overall Study|Adverse Event|5
5898352|NCT01698554|20407679|P1|Overall Study|Adverse Event|2
5898353|NCT01698320|20407749|P3|40-Week Open-Label Period|Lost to Follow-up|0
5898354|NCT01698320|20407750|P2|40-Week Open-Label Period|Lost to Follow-up|2
5898355|NCT01698320|20407751|P1|40-Week Open-Label Period|Lost to Follow-up|0
5898356|NCT01698320|20407749|P3|40-Week Open-Label Period|Sponsor requested subject withdrawal|0
5898357|NCT01698320|20407750|P2|40-Week Open-Label Period|Sponsor requested subject withdrawal|1
5898358|NCT01698320|20407751|P1|40-Week Open-Label Period|Sponsor requested subject withdrawal|0
5898359|NCT01698320|20407749|P3|40-Week Open-Label Period|Pregnancy|1
5898360|NCT01698320|20407750|P2|40-Week Open-Label Period|Pregnancy|2
5898361|NCT01698320|20407751|P1|40-Week Open-Label Period|Pregnancy|0
5898362|NCT01698320|20407749|P3|40-Week Open-Label Period|Withdrawal by Subject|7
5898363|NCT01698320|20407750|P2|40-Week Open-Label Period|Withdrawal by Subject|11
5898364|NCT01698320|20407751|P1|40-Week Open-Label Period|Withdrawal by Subject|0
5898365|NCT01698320|20407749|P3|40-Week Open-Label Period|Adverse Event|2
5898366|NCT01698320|20407750|P2|40-Week Open-Label Period|Adverse Event|3
5898367|NCT01698320|20407751|P1|40-Week Open-Label Period|Adverse Event|0
5898368|NCT01698320|20407749|P3|12-Week Double-Blind Period|Lost to Follow-up|4
5898369|NCT01698320|20407750|P2|12-Week Double-Blind Period|Lost to Follow-up|0
5898370|NCT01698320|20407751|P1|12-Week Double-Blind Period|Lost to Follow-up|0
5898371|NCT01698320|20407749|P3|12-Week Double-Blind Period|Sponsor requested subject withdrawal|2
5898372|NCT01698320|20407750|P2|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0
5898373|NCT01698320|20407751|P1|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0
5898374|NCT01698320|20407749|P3|12-Week Double-Blind Period|Pregnancy|1
5898375|NCT01698320|20407750|P2|12-Week Double-Blind Period|Pregnancy|1
5898376|NCT01698320|20407751|P1|12-Week Double-Blind Period|Pregnancy|0
5898377|NCT01698320|20407749|P3|12-Week Double-Blind Period|Protocol Violation|2
5898378|NCT01698320|20407750|P2|12-Week Double-Blind Period|Protocol Violation|0
5898379|NCT01698320|20407751|P1|12-Week Double-Blind Period|Protocol Violation|0
5898380|NCT01698320|20407749|P3|12-Week Double-Blind Period|Withdrawal by Subject|2
5898381|NCT01698320|20407750|P2|12-Week Double-Blind Period|Withdrawal by Subject|2
5898382|NCT01698320|20407751|P1|12-Week Double-Blind Period|Withdrawal by Subject|0
5898383|NCT01698320|20407749|P3|12-Week Double-Blind Period|Adverse Event|1
5898384|NCT01698320|20407750|P2|12-Week Double-Blind Period|Adverse Event|1
5898385|NCT01698320|20407751|P1|12-Week Double-Blind Period|Adverse Event|0
5898386|NCT01698320|20407749|P3|Run-In Period (Week -1 to Day 0)|Other|0
5898387|NCT01698320|20407750|P2|Run-In Period (Week -1 to Day 0)|Other|0
5898388|NCT01698320|20407751|P1|Run-In Period (Week -1 to Day 0)|Other|1
5898389|NCT01698320|20407749|P3|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0
5898390|NCT01698320|20407750|P2|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0
5898391|NCT01698320|20407751|P1|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|1
5898392|NCT01698320|20407749|P3|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0
5898393|NCT01698320|20407750|P2|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0
5898394|NCT01698320|20407751|P1|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|1
5898395|NCT01698320|20407749|P3|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0
5898396|NCT01698320|20407750|P2|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0
5898397|NCT01698320|20407751|P1|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|24
5898398|NCT01698268|20407771|P2|Overall Study|Physician Decision|1
5898399|NCT01698268|20407772|P1|Overall Study|Physician Decision|2
5898400|NCT01698008|20407780|P2|Overall Study|Withdrawal by Subject|2
5898401|NCT01698008|20407781|P1|Overall Study|Withdrawal by Subject|1
5898402|NCT01697969|20407787|P1|Overall Study|Did not meet inc/exc criteria|3
5898403|NCT01697956|20407794|P2|Overall Study|Protocol Violation|1
5898404|NCT01697956|20407795|P1|Overall Study|Protocol Violation|1
5898405|NCT01697800|20407825|P2|Overall Study|Death|1
5898406|NCT01697800|20407826|P1|Overall Study|Death|0
5898407|NCT01697748|20407834|P2|Overall Study|Lost to Follow-up|65
5898408|NCT01697748|20407835|P1|Overall Study|Lost to Follow-up|53
5898409|NCT01697748|20407834|P2|Overall Study|ineligible uterine incision|1
5898410|NCT01697748|20407835|P1|Overall Study|ineligible uterine incision|4
5898411|NCT01697748|20407834|P2|Overall Study|ineligible skin incision|2
5898412|NCT01697748|20407835|P1|Overall Study|ineligible skin incision|1
5898413|NCT01697696|20407864|P2|Overall Study|Subject/guardian decision|35
5898414|NCT01697696|20407865|P1|Overall Study|Subject/guardian decision|31
5898415|NCT01697696|20407864|P2|Overall Study|Lost to Follow-up|7
5898416|NCT01697696|20407865|P1|Overall Study|Lost to Follow-up|10
5898417|NCT01697696|20407864|P2|Overall Study|Death|2
5898418|NCT01697696|20407865|P1|Overall Study|Death|4
5898419|NCT01697696|20407864|P2|Overall Study|Physician Decision|0
5898420|NCT01697696|20407865|P1|Overall Study|Physician Decision|1
5898421|NCT01697696|20407864|P2|Overall Study|Protocol deviation|0
5898422|NCT01697696|20407865|P1|Overall Study|Protocol deviation|1
5898423|NCT01697696|20407864|P2|Overall Study|Study terminated by sponsor|3
5898424|NCT01697696|20407865|P1|Overall Study|Study terminated by sponsor|0
5898425|NCT01697592|20407897|P10|Phase B (Week 25 to Week 52)|Adverse Event|0
5898426|NCT01697592|20407898|P9|Phase B (Week 25 to Week 52)|Adverse Event|2
5898427|NCT01697592|20407899|P8|Phase B (Week 25 to Week 52)|Adverse Event|0
5898428|NCT01697592|20407900|P7|Phase B (Week 25 to Week 52)|Adverse Event|1
5898429|NCT01697592|20407901|P6|Phase B (Week 25 to Week 52)|Adverse Event|1
5898430|NCT01697592|20407902|P5|Phase B (Week 25 to Week 52)|Adverse Event|0
5898431|NCT01697592|20407903|P4|Phase B (Week 25 to Week 52)|Adverse Event|2
5898432|NCT01697592|20407904|P3|Phase B (Week 25 to Week 52)|Adverse Event|1
5898433|NCT01697592|20407905|P2|Phase B (Week 25 to Week 52)|Adverse Event|1
5898434|NCT01697592|20407906|P1|Phase B (Week 25 to Week 52)|Adverse Event|2
5898435|NCT01697592|20407897|P10|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
5898436|NCT01697592|20407898|P9|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
5898437|NCT01697592|20407899|P8|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1
5898438|NCT01697592|20407900|P7|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
5898439|NCT01697592|20407901|P6|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1
5898440|NCT01697592|20407902|P5|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
5898441|NCT01697592|20407903|P4|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
5898442|NCT01697592|20407904|P3|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
5898443|NCT01697592|20407905|P2|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
5898444|NCT01697592|20407906|P1|Phase B (Week 25 to Week 52)|Withdrawal by Subject|2
5898445|NCT01697592|20407897|P10|Phase B (Week 25 to Week 52)|Physician Decision|0
5898446|NCT01697592|20407898|P9|Phase B (Week 25 to Week 52)|Physician Decision|0
5898447|NCT01697592|20407899|P8|Phase B (Week 25 to Week 52)|Physician Decision|0
5898448|NCT01697592|20407900|P7|Phase B (Week 25 to Week 52)|Physician Decision|0
5898449|NCT01697592|20407901|P6|Phase B (Week 25 to Week 52)|Physician Decision|0
5898450|NCT01697592|20407902|P5|Phase B (Week 25 to Week 52)|Physician Decision|0
5898451|NCT01697592|20407903|P4|Phase B (Week 25 to Week 52)|Physician Decision|1
5898452|NCT01697592|20407904|P3|Phase B (Week 25 to Week 52)|Physician Decision|0
5898453|NCT01697592|20407905|P2|Phase B (Week 25 to Week 52)|Physician Decision|0
5898454|NCT01697592|20407906|P1|Phase B (Week 25 to Week 52)|Physician Decision|1
5898455|NCT01697592|20407897|P10|Phase A (Up to 24 Weeks)|Adverse Event|1
5898456|NCT01697592|20407898|P9|Phase A (Up to 24 Weeks)|Adverse Event|0
5898457|NCT01697592|20407899|P8|Phase A (Up to 24 Weeks)|Adverse Event|0
5898458|NCT01697592|20407900|P7|Phase A (Up to 24 Weeks)|Adverse Event|1
5898459|NCT01697592|20407901|P6|Phase A (Up to 24 Weeks)|Adverse Event|0
5898460|NCT01697592|20407902|P5|Phase A (Up to 24 Weeks)|Adverse Event|0
5898461|NCT01697592|20407903|P4|Phase A (Up to 24 Weeks)|Adverse Event|2
5898462|NCT01697592|20407904|P3|Phase A (Up to 24 Weeks)|Adverse Event|1
5898463|NCT01697592|20407905|P2|Phase A (Up to 24 Weeks)|Adverse Event|2
5898464|NCT01697592|20407906|P1|Phase A (Up to 24 Weeks)|Adverse Event|0
5898465|NCT01697592|20407897|P10|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1
5898466|NCT01697592|20407898|P9|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
5898467|NCT01697592|20407899|P8|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
5898468|NCT01697592|20407900|P7|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1
5898469|NCT01697592|20407901|P6|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
5898470|NCT01697592|20407902|P5|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
5898471|NCT01697592|20407903|P4|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
5898472|NCT01697592|20407904|P3|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
5898473|NCT01697592|20407905|P2|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1
5898474|NCT01697592|20407906|P1|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1
5898475|NCT01697592|20407897|P10|Phase A (Up to 24 Weeks)|Protocol Violation|0
5898476|NCT01697592|20407898|P9|Phase A (Up to 24 Weeks)|Protocol Violation|0
5898477|NCT01697592|20407899|P8|Phase A (Up to 24 Weeks)|Protocol Violation|0
5898478|NCT01697592|20407900|P7|Phase A (Up to 24 Weeks)|Protocol Violation|0
5898479|NCT01697592|20407901|P6|Phase A (Up to 24 Weeks)|Protocol Violation|0
5898480|NCT01697592|20407902|P5|Phase A (Up to 24 Weeks)|Protocol Violation|0
5898481|NCT01697592|20407903|P4|Phase A (Up to 24 Weeks)|Protocol Violation|0
5898482|NCT01697592|20407904|P3|Phase A (Up to 24 Weeks)|Protocol Violation|0
5898483|NCT01697592|20407905|P2|Phase A (Up to 24 Weeks)|Protocol Violation|0
5898484|NCT01697592|20407906|P1|Phase A (Up to 24 Weeks)|Protocol Violation|1
5898485|NCT01697592|20407897|P10|Phase A (Up to 24 Weeks)|Physician Decision|0
5898486|NCT01697592|20407898|P9|Phase A (Up to 24 Weeks)|Physician Decision|0
5898487|NCT01697592|20407899|P8|Phase A (Up to 24 Weeks)|Physician Decision|0
5898488|NCT01697592|20407900|P7|Phase A (Up to 24 Weeks)|Physician Decision|0
5898489|NCT01697592|20407901|P6|Phase A (Up to 24 Weeks)|Physician Decision|1
5898490|NCT01697592|20407902|P5|Phase A (Up to 24 Weeks)|Physician Decision|0
5898491|NCT01697592|20407903|P4|Phase A (Up to 24 Weeks)|Physician Decision|0
5898492|NCT01697592|20407904|P3|Phase A (Up to 24 Weeks)|Physician Decision|0
5898493|NCT01697592|20407905|P2|Phase A (Up to 24 Weeks)|Physician Decision|0
5898494|NCT01697592|20407906|P1|Phase A (Up to 24 Weeks)|Physician Decision|0
5898495|NCT01697592|20407897|P10|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
5898496|NCT01697592|20407898|P9|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
5898497|NCT01697592|20407899|P8|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
5898498|NCT01697592|20407900|P7|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
5898499|NCT01697592|20407901|P6|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
5898500|NCT01697592|20407902|P5|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
5898501|NCT01697592|20407903|P4|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
5898502|NCT01697592|20407904|P3|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
5898503|NCT01697592|20407905|P2|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
5898504|NCT01697592|20407906|P1|Phase A (Up to 24 Weeks)|Lost to Follow-up|1
5898505|NCT01697579|20407975|P7|Optional Extension-Cycles 2-6|Lost to Follow-up|1
5898506|NCT01697579|20407976|P6|Optional Extension-Cycles 2-6|Lost to Follow-up|0
5898507|NCT01697579|20407977|P5|Optional Extension-Cycles 2-6|Lost to Follow-up|0
5898508|NCT01697579|20407978|P4|Optional Extension-Cycles 2-6|Lost to Follow-up|0
5898509|NCT01697579|20407979|P3|Optional Extension-Cycles 2-6|Lost to Follow-up|0
5898510|NCT01697579|20407980|P2|Optional Extension-Cycles 2-6|Lost to Follow-up|0
5898511|NCT01697579|20407981|P1|Optional Extension-Cycles 2-6|Lost to Follow-up|0
5898512|NCT01697579|20407975|P7|Optional Extension-Cycles 2-6|Non-compliance With Protocol|4
5898513|NCT01697579|20407976|P6|Optional Extension-Cycles 2-6|Non-compliance With Protocol|6
5898514|NCT01697579|20407977|P5|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0
5898515|NCT01697579|20407978|P4|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0
5898516|NCT01697579|20407979|P3|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0
5898517|NCT01697579|20407980|P2|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0
5898518|NCT01697579|20407981|P1|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0
5898519|NCT01697579|20407975|P7|Optional Extension-Cycles 2-6|Participant Moved|2
5898520|NCT01697579|20407976|P6|Optional Extension-Cycles 2-6|Participant Moved|0
5898521|NCT01697579|20407977|P5|Optional Extension-Cycles 2-6|Participant Moved|0
5898522|NCT01697579|20407978|P4|Optional Extension-Cycles 2-6|Participant Moved|0
5898523|NCT01697579|20407979|P3|Optional Extension-Cycles 2-6|Participant Moved|0
5898524|NCT01697579|20407980|P2|Optional Extension-Cycles 2-6|Participant Moved|0
5898525|NCT01697579|20407981|P1|Optional Extension-Cycles 2-6|Participant Moved|0
5898526|NCT01697579|20407975|P7|Optional Extension-Cycles 2-6|Technical Problems|1
5898527|NCT01697579|20407976|P6|Optional Extension-Cycles 2-6|Technical Problems|0
5898528|NCT01697579|20407977|P5|Optional Extension-Cycles 2-6|Technical Problems|0
5898529|NCT01697579|20407978|P4|Optional Extension-Cycles 2-6|Technical Problems|0
5898530|NCT01697579|20407979|P3|Optional Extension-Cycles 2-6|Technical Problems|0
5898531|NCT01697579|20407980|P2|Optional Extension-Cycles 2-6|Technical Problems|0
5898532|NCT01697579|20407981|P1|Optional Extension-Cycles 2-6|Technical Problems|0
5898533|NCT01697579|20407975|P7|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|2
5898534|NCT01697579|20407976|P6|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0
5898535|NCT01697579|20407977|P5|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0
5898536|NCT01697579|20407978|P4|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0
5898537|NCT01697579|20407979|P3|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0
5898538|NCT01697579|20407980|P2|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0
5898539|NCT01697579|20407981|P1|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0
5898540|NCT01697579|20407975|P7|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|11
5898541|NCT01697579|20407976|P6|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|4
5898542|NCT01697579|20407977|P5|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0
5898543|NCT01697579|20407978|P4|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0
5898544|NCT01697579|20407979|P3|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0
5898545|NCT01697579|20407980|P2|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0
5898546|NCT01697579|20407981|P1|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0
5898547|NCT01697579|20407975|P7|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|24
5898548|NCT01697579|20407976|P6|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|15
5898549|NCT01697579|20407977|P5|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0
5898550|NCT01697579|20407978|P4|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0
5898551|NCT01697579|20407979|P3|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0
5898552|NCT01697579|20407980|P2|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0
5898553|NCT01697579|20407981|P1|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0
5898554|NCT01697579|20407975|P7|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0
5898555|NCT01697579|20407976|P6|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|1
5898556|NCT01697579|20407977|P5|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0
5898557|NCT01697579|20407978|P4|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0
5898558|NCT01697579|20407979|P3|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0
5898559|NCT01697579|20407980|P2|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0
5898560|NCT01697579|20407981|P1|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0
5898561|NCT01697579|20407975|P7|Optional Extension-Cycles 2-6|Excluded Medication|2
5898562|NCT01697579|20407976|P6|Optional Extension-Cycles 2-6|Excluded Medication|1
5898563|NCT01697579|20407977|P5|Optional Extension-Cycles 2-6|Excluded Medication|0
5898564|NCT01697579|20407978|P4|Optional Extension-Cycles 2-6|Excluded Medication|0
5898565|NCT01697579|20407979|P3|Optional Extension-Cycles 2-6|Excluded Medication|0
5898566|NCT01697579|20407980|P2|Optional Extension-Cycles 2-6|Excluded Medication|0
5898567|NCT01697579|20407981|P1|Optional Extension-Cycles 2-6|Excluded Medication|0
5898568|NCT01697579|20407975|P7|Optional Extension-Cycles 2-6|Protocol Violation|4
5898569|NCT01697579|20407976|P6|Optional Extension-Cycles 2-6|Protocol Violation|0
5898570|NCT01697579|20407977|P5|Optional Extension-Cycles 2-6|Protocol Violation|0
5898571|NCT01697579|20407978|P4|Optional Extension-Cycles 2-6|Protocol Violation|0
5898572|NCT01697579|20407979|P3|Optional Extension-Cycles 2-6|Protocol Violation|0
5898573|NCT01697579|20407980|P2|Optional Extension-Cycles 2-6|Protocol Violation|0
5898574|NCT01697579|20407981|P1|Optional Extension-Cycles 2-6|Protocol Violation|0
5898575|NCT01697579|20407975|P7|Optional Extension-Cycles 2-6|Physician Decision|11
5898576|NCT01697579|20407976|P6|Optional Extension-Cycles 2-6|Physician Decision|7
5898577|NCT01697579|20407977|P5|Optional Extension-Cycles 2-6|Physician Decision|0
5898578|NCT01697579|20407978|P4|Optional Extension-Cycles 2-6|Physician Decision|0
5898579|NCT01697579|20407979|P3|Optional Extension-Cycles 2-6|Physician Decision|0
5898580|NCT01697579|20407980|P2|Optional Extension-Cycles 2-6|Physician Decision|0
5898581|NCT01697579|20407981|P1|Optional Extension-Cycles 2-6|Physician Decision|0
5898582|NCT01697579|20407975|P7|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|5
5898583|NCT01697579|20407976|P6|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|1
5898584|NCT01697579|20407977|P5|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0
5898585|NCT01697579|20407978|P4|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0
5898586|NCT01697579|20407979|P3|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0
5898587|NCT01697579|20407980|P2|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0
5898588|NCT01697579|20407981|P1|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0
5898589|NCT01697579|20407975|P7|Optional Extension-Cycles 2-6|Death|2
5898590|NCT01697579|20407976|P6|Optional Extension-Cycles 2-6|Death|0
5898591|NCT01697579|20407977|P5|Optional Extension-Cycles 2-6|Death|0
5898592|NCT01697579|20407978|P4|Optional Extension-Cycles 2-6|Death|0
5898593|NCT01697579|20407979|P3|Optional Extension-Cycles 2-6|Death|0
5898594|NCT01697579|20407980|P2|Optional Extension-Cycles 2-6|Death|0
5898595|NCT01697579|20407981|P1|Optional Extension-Cycles 2-6|Death|0
5898596|NCT01697579|20407975|P7|Base Study-Cycle 1|Technical Problems|0
5898597|NCT01697579|20407976|P6|Base Study-Cycle 1|Technical Problems|0
5898598|NCT01697579|20407977|P5|Base Study-Cycle 1|Technical Problems|0
5898599|NCT01697579|20407978|P4|Base Study-Cycle 1|Technical Problems|1
5898600|NCT01697579|20407979|P3|Base Study-Cycle 1|Technical Problems|1
5898601|NCT01697579|20407980|P2|Base Study-Cycle 1|Technical Problems|0
5898602|NCT01697579|20407981|P1|Base Study-Cycle 1|Technical Problems|0
5898603|NCT01697579|20407975|P7|Base Study-Cycle 1|Consent Withdrawn by Participant|0
5898604|NCT01697579|20407976|P6|Base Study-Cycle 1|Consent Withdrawn by Participant|0
5898605|NCT01697579|20407977|P5|Base Study-Cycle 1|Consent Withdrawn by Participant|0
5898606|NCT01697579|20407978|P4|Base Study-Cycle 1|Consent Withdrawn by Participant|0
5898607|NCT01697579|20407979|P3|Base Study-Cycle 1|Consent Withdrawn by Participant|0
5898608|NCT01697579|20407980|P2|Base Study-Cycle 1|Consent Withdrawn by Participant|1
5898609|NCT01697579|20407981|P1|Base Study-Cycle 1|Consent Withdrawn by Participant|0
5898610|NCT01697579|20407975|P7|Base Study-Cycle 1|Protocol Violation|0
5898611|NCT01697579|20407976|P6|Base Study-Cycle 1|Protocol Violation|0
5898612|NCT01697579|20407977|P5|Base Study-Cycle 1|Protocol Violation|3
5898613|NCT01697579|20407978|P4|Base Study-Cycle 1|Protocol Violation|0
5898614|NCT01697579|20407979|P3|Base Study-Cycle 1|Protocol Violation|0
5898615|NCT01697579|20407980|P2|Base Study-Cycle 1|Protocol Violation|0
5898616|NCT01697579|20407981|P1|Base Study-Cycle 1|Protocol Violation|0
5898617|NCT01697579|20407975|P7|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0
5898618|NCT01697579|20407976|P6|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0
5898619|NCT01697579|20407977|P5|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0
5898620|NCT01697579|20407978|P4|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0
5898621|NCT01697579|20407979|P3|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0
5898622|NCT01697579|20407980|P2|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0
5898623|NCT01697579|20407981|P1|Base Study-Cycle 1|Withdrawal by Parent/Guardian|1
5898624|NCT01697579|20407975|P7|Base Study-Cycle 1|Adverse Event|0
5898625|NCT01697579|20407976|P6|Base Study-Cycle 1|Adverse Event|0
5898626|NCT01697579|20407977|P5|Base Study-Cycle 1|Adverse Event|0
5898627|NCT01697579|20407978|P4|Base Study-Cycle 1|Adverse Event|0
5898628|NCT01697579|20407979|P3|Base Study-Cycle 1|Adverse Event|0
5898629|NCT01697579|20407980|P2|Base Study-Cycle 1|Adverse Event|0
5898630|NCT01697579|20407981|P1|Base Study-Cycle 1|Adverse Event|1
5898631|NCT01697501|20408093|P1|Overall Study|Protocol Violation|2
5898632|NCT01697462|20408136|P1|Overall Study|Missing|5
5898633|NCT01697462|20408136|P1|Overall Study|Other|10
5898634|NCT01697462|20408136|P1|Overall Study|Death|1
5898635|NCT01697462|20408136|P1|Overall Study|Investigator Decision|21
5898636|NCT01697462|20408136|P1|Overall Study|Withdrawal by Subject|12
5898637|NCT01697462|20408136|P1|Overall Study|Lost to Follow-up|21
5898638|NCT01697462|20408136|P1|Overall Study|Adverse Event|6
5898639|NCT01697462|20408136|P1|Overall Study|Disease Progression|1
5898640|NCT01697449|20408143|P1|Overall Study|Missing|25
5898641|NCT01697449|20408143|P1|Overall Study|Other|1
5898642|NCT01697449|20408143|P1|Overall Study|Death|2
5898643|NCT01697449|20408143|P1|Overall Study|Physician Decision|1
5898644|NCT01697449|20408143|P1|Overall Study|Withdrawal by Subject|2
5898645|NCT01697449|20408143|P1|Overall Study|Lost to Follow-up|5
5898646|NCT01697449|20408143|P1|Overall Study|Adverse Event|7
5898647|NCT01697449|20408143|P1|Overall Study|Disease progression|47
5898648|NCT01697358|20408154|P2|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|26
5898649|NCT01697358|20408155|P1|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|34
5898650|NCT01697358|20408154|P2|Period II: 6-24M Long-term Follow-up|Adverse Event|3
5898651|NCT01697358|20408155|P1|Period II: 6-24M Long-term Follow-up|Adverse Event|0
5898652|NCT01697358|20408154|P2|Period II: 6-24M Long-term Follow-up|Death|1
5898653|NCT01697358|20408155|P1|Period II: 6-24M Long-term Follow-up|Death|1
5898654|NCT01697358|20408154|P2|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3
5898655|NCT01697358|20408155|P1|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3
5898656|NCT01697358|20408154|P2|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|10
5898657|NCT01697358|20408155|P1|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|8
5898658|NCT01697358|20408154|P2|Period II: 6-24M Long-term Follow-up|Physician Decision|12
5898659|NCT01697358|20408155|P1|Period II: 6-24M Long-term Follow-up|Physician Decision|3
5898660|NCT01697358|20408154|P2|Period I: Randomization to 6 Months|Lost to Follow-up|0
5898661|NCT01697358|20408155|P1|Period I: Randomization to 6 Months|Lost to Follow-up|2
5898662|NCT01697358|20408154|P2|Period I: Randomization to 6 Months|Adverse Event|1
5898663|NCT01697358|20408155|P1|Period I: Randomization to 6 Months|Adverse Event|1
5898664|NCT01697358|20408154|P2|Period I: Randomization to 6 Months|Physician Decision|0
5898665|NCT01697358|20408155|P1|Period I: Randomization to 6 Months|Physician Decision|4
5898666|NCT01697358|20408154|P2|Period I: Randomization to 6 Months|Withdrawal by Subject|0
5898667|NCT01697358|20408155|P1|Period I: Randomization to 6 Months|Withdrawal by Subject|6
5898668|NCT01697345|20408171|P1|Overall Study|Withdrawal by Subject|1
5898669|NCT01697319|20408196|P1|Extension Phase|Terminated by Sponsor|15
5898670|NCT01697319|20408196|P1|Primary Phase|Withdrawal by Subject|1
5898671|NCT01696994|20408205|P2|Overall Study|Refused Screen (Ovarian Screening)|3582
5898672|NCT01696994|20408206|P1|Overall Study|Refused Screen (Ovarian Screening)|0
5898673|NCT01696994|20408205|P2|Overall Study|Refused ASU (Control)|0
5898674|NCT01696994|20408206|P1|Overall Study|Refused ASU (Control)|311
5898675|NCT01696994|20408205|P2|Overall Study|No Ovaries at Baseline|4851
5898676|NCT01696994|20408206|P1|Overall Study|No Ovaries at Baseline|4807
5898677|NCT01696994|20408205|P2|Overall Study|Died Before ASU (Control)|0
5898678|NCT01696994|20408206|P1|Overall Study|Died Before ASU (Control)|73
5898679|NCT01696994|20408205|P2|Overall Study|Died Before Randomization|2
5898680|NCT01696994|20408206|P1|Overall Study|Died Before Randomization|1
5898681|NCT01696994|20408205|P2|Overall Study|Cancer Before Rand. (Ovarian Screening)|2
5898682|NCT01696994|20408206|P1|Overall Study|Cancer Before Rand. (Ovarian Screening)|0
5898683|NCT01696981|20408234|P2|Overall Study|Refused Screen (Colorectal Screening)|10346
5898684|NCT01696981|20408235|P1|Overall Study|Refused Screen (Colorectal Screening)|0
5898685|NCT01696981|20408234|P2|Overall Study|Refused ASU (Control)|0
5898686|NCT01696981|20408235|P1|Overall Study|Refused ASU (Control)|920
5898687|NCT01696981|20408234|P2|Overall Study|Died Before ASU (Control)|0
5898688|NCT01696981|20408235|P1|Overall Study|Died Before ASU (Control)|278
5898689|NCT01696981|20408234|P2|Overall Study|Died Before Randomization|8
5898690|NCT01696981|20408235|P1|Overall Study|Died Before Randomization|3
5898691|NCT01696981|20408234|P2|Overall Study|Cancer Before Rand. (Colo. Screening)|20
5898692|NCT01696981|20408235|P1|Overall Study|Cancer Before Rand. (Colo. Screening)|0
5898693|NCT01696968|20408255|P2|Overall Study|Refused Screen (Lung Screening)|6796
5898694|NCT01696968|20408256|P1|Overall Study|Refused Screen (Lung Screening)|0
5898695|NCT01696968|20408255|P2|Overall Study|Refused ASU (Control)|0
5898696|NCT01696968|20408256|P1|Overall Study|Refused ASU (Control)|920
5898697|NCT01696968|20408255|P2|Overall Study|Died Before ASU (Control)|0
5898698|NCT01696968|20408256|P1|Overall Study|Died Before ASU (Control)|278
5898699|NCT01696968|20408255|P2|Overall Study|Died Before Randomization|8
5898700|NCT01696968|20408256|P1|Overall Study|Died Before Randomization|3
5898701|NCT01696968|20408255|P2|Overall Study|Cancer Before Rand. (Lung Screening)|8
5898702|NCT01696968|20408256|P1|Overall Study|Cancer Before Rand. (Lung Screening)|0
5898703|NCT01696955|20408278|P2|Main Study|Withdrawal by Subject|1
5898704|NCT01696955|20408279|P1|Main Study|Withdrawal by Subject|1
5898705|NCT01696955|20408278|P2|Main Study|Protocol Violation|0
5898706|NCT01696955|20408279|P1|Main Study|Protocol Violation|1
5898707|NCT01696942|20408304|P2|Overall Study|screen failure|1
5898708|NCT01696942|20408305|P1|Overall Study|screen failure|0
5898709|NCT01696942|20408304|P2|Overall Study|Protocol Violation|2
5898710|NCT01696942|20408305|P1|Overall Study|Protocol Violation|1
5898711|NCT01696942|20408304|P2|Overall Study|Withdrawal by Subject|0
5898712|NCT01696942|20408305|P1|Overall Study|Withdrawal by Subject|1
5898713|NCT01696929|20408313|P1|Overall Study|Physician Decision|1
5898714|NCT01696877|20408320|P2|Overall Study|Adverse Event|1
5898715|NCT01696877|20408321|P1|Overall Study|Adverse Event|0
5898716|NCT01696773|20408343|P2|Days 15-27, Washout|Adverse Event|0
5898717|NCT01696773|20408344|P1|Days 15-27, Washout|Adverse Event|1
5898718|NCT01696695|20408371|P1|Overall Study|Major Protocol Violation|192
5898719|NCT01696695|20408371|P1|Overall Study|Other|74
5898720|NCT01696695|20408371|P1|Overall Study|Lost to Follow-up|48
5898721|NCT01696695|20408371|P1|Overall Study|Withdrawal by Subject|92
5898722|NCT01696695|20408371|P1|Overall Study|Adverse Event|74
5898723|NCT01696695|20408371|P1|Overall Study|Death|29
5898724|NCT01696695|20408371|P1|Overall Study|Disease progression|373
5898725|NCT01696643|20408383|P2|Overall Study|Participant Did Not Receive Study Drug|2
5898726|NCT01696643|20408384|P1|Overall Study|Participant Did Not Receive Study Drug|2
5898727|NCT01696643|20408383|P2|Overall Study|Medical Monitor Decision|2
5898728|NCT01696643|20408384|P1|Overall Study|Medical Monitor Decision|0
5898729|NCT01696643|20408383|P2|Overall Study|Participant Incarcerated|1
5898730|NCT01696643|20408384|P1|Overall Study|Participant Incarcerated|0
5898731|NCT01696643|20408383|P2|Overall Study|Site Error|1
5898732|NCT01696643|20408384|P1|Overall Study|Site Error|2
5898733|NCT01696643|20408383|P2|Overall Study|Participant on Restricted Bed Rest|0
5898734|NCT01696643|20408384|P1|Overall Study|Participant on Restricted Bed Rest|1
5898735|NCT01696643|20408383|P2|Overall Study|Withdrawal by Subject|149
5898736|NCT01696643|20408384|P1|Overall Study|Withdrawal by Subject|142
5898737|NCT01696643|20408383|P2|Overall Study|Study Terminated by Sponsor|294
5898738|NCT01696643|20408384|P1|Overall Study|Study Terminated by Sponsor|286
5898739|NCT01696643|20408383|P2|Overall Study|Protocol Violation|7
5898740|NCT01696643|20408384|P1|Overall Study|Protocol Violation|7
5898741|NCT01696643|20408383|P2|Overall Study|Pregnancy|1
5898742|NCT01696643|20408384|P1|Overall Study|Pregnancy|0
5898743|NCT01696643|20408383|P2|Overall Study|Physician Decision|2
5898744|NCT01696643|20408384|P1|Overall Study|Physician Decision|3
5898745|NCT01696643|20408383|P2|Overall Study|Lost to Follow-up|67
5898746|NCT01696643|20408384|P1|Overall Study|Lost to Follow-up|67
5898747|NCT01696643|20408383|P2|Overall Study|Lack of Efficacy|0
5898748|NCT01696643|20408384|P1|Overall Study|Lack of Efficacy|3
5898749|NCT01696643|20408383|P2|Overall Study|Death|2
5898750|NCT01696643|20408384|P1|Overall Study|Death|1
5898751|NCT01696643|20408383|P2|Overall Study|Adverse Event|7
5898752|NCT01696643|20408384|P1|Overall Study|Adverse Event|15
5898753|NCT01696396|20408403|P4|Overall Study|Death|0
5898754|NCT01696396|20408404|P3|Overall Study|Death|1
5898755|NCT01696396|20408405|P2|Overall Study|Death|0
5898756|NCT01696396|20408406|P1|Overall Study|Death|0
5898757|NCT01696396|20408403|P4|Overall Study|Lost to Follow-up|1
5898758|NCT01696396|20408404|P3|Overall Study|Lost to Follow-up|4
5898759|NCT01696396|20408405|P2|Overall Study|Lost to Follow-up|1
5898760|NCT01696396|20408406|P1|Overall Study|Lost to Follow-up|9
5898761|NCT01696396|20408403|P4|Overall Study|Decision by Sponsor|2
5898762|NCT01696396|20408404|P3|Overall Study|Decision by Sponsor|2
5898763|NCT01696396|20408405|P2|Overall Study|Decision by Sponsor|1
5898764|NCT01696396|20408406|P1|Overall Study|Decision by Sponsor|3
5898765|NCT01696396|20408403|P4|Overall Study|Withdrawal by Subject|11
5898766|NCT01696396|20408404|P3|Overall Study|Withdrawal by Subject|19
5898767|NCT01696396|20408405|P2|Overall Study|Withdrawal by Subject|5
5898768|NCT01696396|20408406|P1|Overall Study|Withdrawal by Subject|19
5898769|NCT01696279|20408457|P4|Part 3: Lanthanum Carbonate (6 Months)|Missing|1
5898770|NCT01696279|20408458|P3|Part 3: Lanthanum Carbonate (6 Months)|Missing|0
5898771|NCT01696279|20408459|P2|Part 3: Lanthanum Carbonate (6 Months)|Missing|0
5898772|NCT01696279|20408460|P1|Part 3: Lanthanum Carbonate (6 Months)|Missing|0
5898773|NCT01696279|20408457|P4|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|1
5898774|NCT01696279|20408458|P3|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0
5898775|NCT01696279|20408459|P2|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0
5898776|NCT01696279|20408460|P1|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0
5898777|NCT01696279|20408457|P4|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|6
5898778|NCT01696279|20408458|P3|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0
5898779|NCT01696279|20408459|P2|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0
5898780|NCT01696279|20408460|P1|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0
5898781|NCT01696279|20408457|P4|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0
5898782|NCT01696279|20408458|P3|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|1
5898783|NCT01696279|20408459|P2|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0
5898784|NCT01696279|20408460|P1|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0
5898785|NCT01696279|20408457|P4|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0
5898786|NCT01696279|20408458|P3|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0
5898787|NCT01696279|20408459|P2|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|2
5898788|NCT01696279|20408460|P1|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0
5898789|NCT01696279|20408457|P4|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0
5898790|NCT01696279|20408458|P3|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0
5898791|NCT01696279|20408459|P2|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|7
5898792|NCT01696279|20408460|P1|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0
5898793|NCT01696279|20408457|P4|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0
5898794|NCT01696279|20408458|P3|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0
5898795|NCT01696279|20408459|P2|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|3
5898796|NCT01696279|20408460|P1|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0
5898797|NCT01696279|20408457|P4|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0
5898798|NCT01696279|20408458|P3|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0
5898799|NCT01696279|20408459|P2|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|1
5898800|NCT01696279|20408460|P1|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0
5898801|NCT01696279|20408457|P4|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0
5898802|NCT01696279|20408458|P3|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0
5898803|NCT01696279|20408459|P2|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|1
5898804|NCT01696279|20408460|P1|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0
5898805|NCT01696279|20408457|P4|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0
5898806|NCT01696279|20408458|P3|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0
5898807|NCT01696279|20408459|P2|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|5
5898808|NCT01696279|20408460|P1|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0
5898809|NCT01696279|20408457|P4|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0
5898810|NCT01696279|20408458|P3|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0
5898811|NCT01696279|20408459|P2|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0
5898812|NCT01696279|20408460|P1|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|1
5898813|NCT01696214|20408498|P4|Overall Study|Lost to Follow-up|0
5898814|NCT01696214|20408499|P3|Overall Study|Lost to Follow-up|0
5898815|NCT01696214|20408500|P2|Overall Study|Lost to Follow-up|0
5898816|NCT01696214|20408501|P1|Overall Study|Lost to Follow-up|1
5898817|NCT01696188|20408521|P2|Overall Study|Protocol Violation|1
5898818|NCT01696188|20408522|P1|Overall Study|Protocol Violation|1
5898819|NCT01696071|20408553|P2|Treatment Period 2: 4 Weeks|Adverse Event|0
5898820|NCT01696071|20408554|P1|Treatment Period 2: 4 Weeks|Adverse Event|1
5898821|NCT01696058|20408582|P2|Overall Study|Other reason prematurely discontinued|3
5898822|NCT01696058|20408583|P1|Overall Study|Other reason prematurely discontinued|5
5898823|NCT01696058|20408582|P2|Overall Study|Withdrawal by Subject|6
5898824|NCT01696058|20408583|P1|Overall Study|Withdrawal by Subject|4
5898825|NCT01696058|20408582|P2|Overall Study|Lost to Follow-up|5
5898826|NCT01696058|20408583|P1|Overall Study|Lost to Follow-up|2
5898827|NCT01696058|20408582|P2|Overall Study|Protocol Violation|3
5898828|NCT01696058|20408583|P1|Overall Study|Protocol Violation|9
5898829|NCT01696058|20408582|P2|Overall Study|Lack of Efficacy|3
5898830|NCT01696058|20408583|P1|Overall Study|Lack of Efficacy|2
5898831|NCT01696058|20408582|P2|Overall Study|Adverse Event|11
5898832|NCT01696058|20408583|P1|Overall Study|Adverse Event|21
5898833|NCT01696045|20408611|P2|Overall Study|Disease progression|2
5898834|NCT01696045|20408612|P1|Overall Study|Disease progression|2
5898835|NCT01696045|20408611|P2|Overall Study|Study drug toxicity|5
5898836|NCT01696045|20408612|P1|Overall Study|Study drug toxicity|1
5898837|NCT01695993|20408631|P3|Overall Study|Changed Medical Facility|1
5898838|NCT01695993|20408632|P2|Overall Study|Changed Medical Facility|0
5898839|NCT01695993|20408633|P1|Overall Study|Changed Medical Facility|0
5898840|NCT01695993|20408631|P3|Overall Study|To ill to continue|0
5898841|NCT01695993|20408632|P2|Overall Study|To ill to continue|2
5898842|NCT01695993|20408633|P1|Overall Study|To ill to continue|1
5898843|NCT01695993|20408631|P3|Overall Study|Withdrawal by Subject|2
5898844|NCT01695993|20408632|P2|Overall Study|Withdrawal by Subject|2
5898845|NCT01695993|20408633|P1|Overall Study|Withdrawal by Subject|2
5898846|NCT01695993|20408631|P3|Overall Study|Lost to Follow-up|3
5898847|NCT01695993|20408632|P2|Overall Study|Lost to Follow-up|1
5898848|NCT01695993|20408633|P1|Overall Study|Lost to Follow-up|2
5898849|NCT01695954|20408643|P2|Overall Study|Adverse Event|2
5898850|NCT01695954|20408644|P1|Overall Study|Adverse Event|0
5898851|NCT01695954|20408643|P2|Overall Study|Withdrawal by Subject|0
5898852|NCT01695954|20408644|P1|Overall Study|Withdrawal by Subject|4
5898853|NCT01695772|20408654|P1|Overall Study|Unspecified Reason|1
5898854|NCT01695772|20408654|P1|Overall Study|Protocol Violation|2
5898855|NCT01695772|20408654|P1|Overall Study|Lost to Follow-up|4
5898856|NCT01695772|20408654|P1|Overall Study|Investigator Decision|5
5898857|NCT01695772|20408654|P1|Overall Study|Progressive Disease|8
5898858|NCT01695772|20408654|P1|Overall Study|Withdrawal by Subject|18
5898859|NCT01695746|20408666|P1|Overall Study|Participant not willing to participate|3
5898860|NCT01695746|20408666|P1|Overall Study|Protocol Violation|5
5898861|NCT01695746|20408666|P1|Overall Study|Non-compliance by the participant|3
5898862|NCT01695746|20408666|P1|Overall Study|Adverse Event|1
5898863|NCT01695239|20408733|P14|Post-Treatment Follow-Up Period|Protocol Violation|1
5898864|NCT01695239|20408734|P13|Post-Treatment Follow-Up Period|Protocol Violation|0
5898865|NCT01695239|20408735|P12|Post-Treatment Follow-Up Period|Protocol Violation|0
5898866|NCT01695239|20408736|P11|Post-Treatment Follow-Up Period|Protocol Violation|0
5898867|NCT01695239|20408737|P10|Post-Treatment Follow-Up Period|Protocol Violation|0
5898868|NCT01695239|20408738|P9|Post-Treatment Follow-Up Period|Protocol Violation|0
5898869|NCT01695239|20408739|P8|Post-Treatment Follow-Up Period|Protocol Violation|0
5898870|NCT01695239|20408740|P7|Post-Treatment Follow-Up Period|Protocol Violation|0
5898871|NCT01695239|20408741|P6|Post-Treatment Follow-Up Period|Protocol Violation|0
5898872|NCT01695239|20408742|P5|Post-Treatment Follow-Up Period|Protocol Violation|0
5898873|NCT01695239|20408743|P4|Post-Treatment Follow-Up Period|Protocol Violation|0
5898874|NCT01695239|20408744|P3|Post-Treatment Follow-Up Period|Protocol Violation|0
5898875|NCT01695239|20408745|P2|Post-Treatment Follow-Up Period|Protocol Violation|0
5898876|NCT01695239|20408746|P1|Post-Treatment Follow-Up Period|Protocol Violation|0
5898877|NCT01695239|20408733|P14|Post-Treatment Follow-Up Period|Physician Decision|0
5898878|NCT01695239|20408734|P13|Post-Treatment Follow-Up Period|Physician Decision|2
5898879|NCT01695239|20408735|P12|Post-Treatment Follow-Up Period|Physician Decision|0
5898880|NCT01695239|20408736|P11|Post-Treatment Follow-Up Period|Physician Decision|0
5898881|NCT01695239|20408737|P10|Post-Treatment Follow-Up Period|Physician Decision|0
5898882|NCT01695239|20408738|P9|Post-Treatment Follow-Up Period|Physician Decision|0
5898883|NCT01695239|20408739|P8|Post-Treatment Follow-Up Period|Physician Decision|0
5898884|NCT01695239|20408740|P7|Post-Treatment Follow-Up Period|Physician Decision|0
5898885|NCT01695239|20408741|P6|Post-Treatment Follow-Up Period|Physician Decision|0
5898886|NCT01695239|20408742|P5|Post-Treatment Follow-Up Period|Physician Decision|0
5898887|NCT01695239|20408743|P4|Post-Treatment Follow-Up Period|Physician Decision|0
5898888|NCT01695239|20408744|P3|Post-Treatment Follow-Up Period|Physician Decision|0
5898889|NCT01695239|20408745|P2|Post-Treatment Follow-Up Period|Physician Decision|0
5898890|NCT01695239|20408746|P1|Post-Treatment Follow-Up Period|Physician Decision|0
5898891|NCT01695239|20408733|P14|Post-Treatment Follow-Up Period|Lost to Follow-up|1
5898892|NCT01695239|20408734|P13|Post-Treatment Follow-Up Period|Lost to Follow-up|1
5898893|NCT01695239|20408735|P12|Post-Treatment Follow-Up Period|Lost to Follow-up|0
5898894|NCT01695239|20408736|P11|Post-Treatment Follow-Up Period|Lost to Follow-up|0
5898895|NCT01695239|20408737|P10|Post-Treatment Follow-Up Period|Lost to Follow-up|0
5898896|NCT01695239|20408738|P9|Post-Treatment Follow-Up Period|Lost to Follow-up|0
5898897|NCT01695239|20408739|P8|Post-Treatment Follow-Up Period|Lost to Follow-up|0
5898898|NCT01695239|20408740|P7|Post-Treatment Follow-Up Period|Lost to Follow-up|0
5898899|NCT01695239|20408741|P6|Post-Treatment Follow-Up Period|Lost to Follow-up|0
5898900|NCT01695239|20408742|P5|Post-Treatment Follow-Up Period|Lost to Follow-up|0
5898901|NCT01695239|20408743|P4|Post-Treatment Follow-Up Period|Lost to Follow-up|0
5898902|NCT01695239|20408744|P3|Post-Treatment Follow-Up Period|Lost to Follow-up|0
5898903|NCT01695239|20408745|P2|Post-Treatment Follow-Up Period|Lost to Follow-up|0
5898904|NCT01695239|20408746|P1|Post-Treatment Follow-Up Period|Lost to Follow-up|0
5898905|NCT01695239|20408733|P14|Post-Treatment Follow-Up Period|Withdrawal by Subject|3
5898906|NCT01695239|20408734|P13|Post-Treatment Follow-Up Period|Withdrawal by Subject|6
5898907|NCT01695239|20408735|P12|Post-Treatment Follow-Up Period|Withdrawal by Subject|1
5898908|NCT01695239|20408736|P11|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
5898909|NCT01695239|20408737|P10|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
5898910|NCT01695239|20408738|P9|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
5898911|NCT01695239|20408739|P8|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
5898912|NCT01695239|20408740|P7|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
5898913|NCT01695239|20408741|P6|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
5898914|NCT01695239|20408742|P5|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
5898915|NCT01695239|20408743|P4|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
5898916|NCT01695239|20408744|P3|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
5898917|NCT01695239|20408745|P2|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
5898918|NCT01695239|20408746|P1|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
5898919|NCT01695239|20408733|P14|Extension Long-Term Extension Periods|Death|0
5898920|NCT01695239|20408734|P13|Extension Long-Term Extension Periods|Death|0
5898921|NCT01695239|20408735|P12|Extension Long-Term Extension Periods|Death|0
5898922|NCT01695239|20408736|P11|Extension Long-Term Extension Periods|Death|0
5898923|NCT01695239|20408737|P10|Extension Long-Term Extension Periods|Death|0
5898924|NCT01695239|20408738|P9|Extension Long-Term Extension Periods|Death|1
5898925|NCT01695239|20408739|P8|Extension Long-Term Extension Periods|Death|0
5898926|NCT01695239|20408740|P7|Extension Long-Term Extension Periods|Death|0
5898927|NCT01695239|20408741|P6|Extension Long-Term Extension Periods|Death|0
5898928|NCT01695239|20408742|P5|Extension Long-Term Extension Periods|Death|0
5898929|NCT01695239|20408743|P4|Extension Long-Term Extension Periods|Death|0
5898930|NCT01695239|20408744|P3|Extension Long-Term Extension Periods|Death|0
5898931|NCT01695239|20408745|P2|Extension Long-Term Extension Periods|Death|0
5898932|NCT01695239|20408746|P1|Extension Long-Term Extension Periods|Death|0
5898933|NCT01695239|20408733|P14|Extension Long-Term Extension Periods|Sponsor Decision|0
5898934|NCT01695239|20408734|P13|Extension Long-Term Extension Periods|Sponsor Decision|0
5898935|NCT01695239|20408735|P12|Extension Long-Term Extension Periods|Sponsor Decision|0
5898936|NCT01695239|20408736|P11|Extension Long-Term Extension Periods|Sponsor Decision|0
5898937|NCT01695239|20408737|P10|Extension Long-Term Extension Periods|Sponsor Decision|1
5898938|NCT01695239|20408738|P9|Extension Long-Term Extension Periods|Sponsor Decision|2
5898939|NCT01695239|20408739|P8|Extension Long-Term Extension Periods|Sponsor Decision|0
5898940|NCT01695239|20408740|P7|Extension Long-Term Extension Periods|Sponsor Decision|0
5898941|NCT01695239|20408741|P6|Extension Long-Term Extension Periods|Sponsor Decision|0
5898942|NCT01695239|20408742|P5|Extension Long-Term Extension Periods|Sponsor Decision|0
5898943|NCT01695239|20408743|P4|Extension Long-Term Extension Periods|Sponsor Decision|0
5898944|NCT01695239|20408744|P3|Extension Long-Term Extension Periods|Sponsor Decision|0
5898945|NCT01695239|20408745|P2|Extension Long-Term Extension Periods|Sponsor Decision|0
5898946|NCT01695239|20408746|P1|Extension Long-Term Extension Periods|Sponsor Decision|0
5898947|NCT01695239|20408733|P14|Extension Long-Term Extension Periods|Lost to Follow-up|0
5898948|NCT01695239|20408734|P13|Extension Long-Term Extension Periods|Lost to Follow-up|0
5898949|NCT01695239|20408735|P12|Extension Long-Term Extension Periods|Lost to Follow-up|0
5898950|NCT01695239|20408736|P11|Extension Long-Term Extension Periods|Lost to Follow-up|0
5898951|NCT01695239|20408737|P10|Extension Long-Term Extension Periods|Lost to Follow-up|1
5898952|NCT01695239|20408738|P9|Extension Long-Term Extension Periods|Lost to Follow-up|2
5898953|NCT01695239|20408739|P8|Extension Long-Term Extension Periods|Lost to Follow-up|0
5898954|NCT01695239|20408740|P7|Extension Long-Term Extension Periods|Lost to Follow-up|0
5898955|NCT01695239|20408741|P6|Extension Long-Term Extension Periods|Lost to Follow-up|0
5898956|NCT01695239|20408742|P5|Extension Long-Term Extension Periods|Lost to Follow-up|0
5898957|NCT01695239|20408743|P4|Extension Long-Term Extension Periods|Lost to Follow-up|0
5898958|NCT01695239|20408744|P3|Extension Long-Term Extension Periods|Lost to Follow-up|0
5898959|NCT01695239|20408745|P2|Extension Long-Term Extension Periods|Lost to Follow-up|0
5898960|NCT01695239|20408746|P1|Extension Long-Term Extension Periods|Lost to Follow-up|0
5898961|NCT01695239|20408733|P14|Extension Long-Term Extension Periods|Physician Decision|0
5898962|NCT01695239|20408734|P13|Extension Long-Term Extension Periods|Physician Decision|0
5898963|NCT01695239|20408735|P12|Extension Long-Term Extension Periods|Physician Decision|0
5898964|NCT01695239|20408736|P11|Extension Long-Term Extension Periods|Physician Decision|0
5898965|NCT01695239|20408737|P10|Extension Long-Term Extension Periods|Physician Decision|0
5898966|NCT01695239|20408738|P9|Extension Long-Term Extension Periods|Physician Decision|3
5898967|NCT01695239|20408739|P8|Extension Long-Term Extension Periods|Physician Decision|0
5898968|NCT01695239|20408740|P7|Extension Long-Term Extension Periods|Physician Decision|0
5898969|NCT01695239|20408741|P6|Extension Long-Term Extension Periods|Physician Decision|0
5898970|NCT01695239|20408742|P5|Extension Long-Term Extension Periods|Physician Decision|0
5898971|NCT01695239|20408743|P4|Extension Long-Term Extension Periods|Physician Decision|0
5898972|NCT01695239|20408744|P3|Extension Long-Term Extension Periods|Physician Decision|0
5898973|NCT01695239|20408745|P2|Extension Long-Term Extension Periods|Physician Decision|0
5898974|NCT01695239|20408746|P1|Extension Long-Term Extension Periods|Physician Decision|0
5898975|NCT01695239|20408733|P14|Extension Long-Term Extension Periods|Withdrawal by Subject|0
5898976|NCT01695239|20408734|P13|Extension Long-Term Extension Periods|Withdrawal by Subject|0
5898977|NCT01695239|20408735|P12|Extension Long-Term Extension Periods|Withdrawal by Subject|0
5898978|NCT01695239|20408736|P11|Extension Long-Term Extension Periods|Withdrawal by Subject|0
5898979|NCT01695239|20408737|P10|Extension Long-Term Extension Periods|Withdrawal by Subject|7
5898980|NCT01695239|20408738|P9|Extension Long-Term Extension Periods|Withdrawal by Subject|6
5898981|NCT01695239|20408739|P8|Extension Long-Term Extension Periods|Withdrawal by Subject|0
5898982|NCT01695239|20408740|P7|Extension Long-Term Extension Periods|Withdrawal by Subject|0
5898983|NCT01695239|20408741|P6|Extension Long-Term Extension Periods|Withdrawal by Subject|0
5898984|NCT01695239|20408742|P5|Extension Long-Term Extension Periods|Withdrawal by Subject|0
5898985|NCT01695239|20408743|P4|Extension Long-Term Extension Periods|Withdrawal by Subject|0
5898986|NCT01695239|20408744|P3|Extension Long-Term Extension Periods|Withdrawal by Subject|0
5898987|NCT01695239|20408745|P2|Extension Long-Term Extension Periods|Withdrawal by Subject|0
5898988|NCT01695239|20408746|P1|Extension Long-Term Extension Periods|Withdrawal by Subject|0
5898989|NCT01695239|20408733|P14|Extension Long-Term Extension Periods|Adverse Event|0
5898990|NCT01695239|20408734|P13|Extension Long-Term Extension Periods|Adverse Event|0
5898991|NCT01695239|20408735|P12|Extension Long-Term Extension Periods|Adverse Event|0
5898992|NCT01695239|20408736|P11|Extension Long-Term Extension Periods|Adverse Event|0
5898993|NCT01695239|20408737|P10|Extension Long-Term Extension Periods|Adverse Event|21
5898994|NCT01695239|20408738|P9|Extension Long-Term Extension Periods|Adverse Event|15
5898995|NCT01695239|20408739|P8|Extension Long-Term Extension Periods|Adverse Event|0
5898996|NCT01695239|20408740|P7|Extension Long-Term Extension Periods|Adverse Event|0
5898997|NCT01695239|20408741|P6|Extension Long-Term Extension Periods|Adverse Event|0
5898998|NCT01695239|20408742|P5|Extension Long-Term Extension Periods|Adverse Event|0
5898999|NCT01695239|20408743|P4|Extension Long-Term Extension Periods|Adverse Event|0
5899000|NCT01695239|20408744|P3|Extension Long-Term Extension Periods|Adverse Event|0
5899001|NCT01695239|20408745|P2|Extension Long-Term Extension Periods|Adverse Event|0
5899002|NCT01695239|20408746|P1|Extension Long-Term Extension Periods|Adverse Event|0
5899003|NCT01695239|20408733|P14|Extension Long-Term Extension Periods|Lack of Efficacy|0
5899004|NCT01695239|20408734|P13|Extension Long-Term Extension Periods|Lack of Efficacy|0
5899005|NCT01695239|20408735|P12|Extension Long-Term Extension Periods|Lack of Efficacy|0
5899006|NCT01695239|20408736|P11|Extension Long-Term Extension Periods|Lack of Efficacy|0
5899007|NCT01695239|20408737|P10|Extension Long-Term Extension Periods|Lack of Efficacy|31
5899008|NCT01695239|20408738|P9|Extension Long-Term Extension Periods|Lack of Efficacy|37
5899009|NCT01695239|20408739|P8|Extension Long-Term Extension Periods|Lack of Efficacy|0
5899010|NCT01695239|20408740|P7|Extension Long-Term Extension Periods|Lack of Efficacy|0
5899011|NCT01695239|20408741|P6|Extension Long-Term Extension Periods|Lack of Efficacy|0
5899012|NCT01695239|20408742|P5|Extension Long-Term Extension Periods|Lack of Efficacy|0
5899013|NCT01695239|20408743|P4|Extension Long-Term Extension Periods|Lack of Efficacy|0
5899014|NCT01695239|20408744|P3|Extension Long-Term Extension Periods|Lack of Efficacy|0
5899015|NCT01695239|20408745|P2|Extension Long-Term Extension Periods|Lack of Efficacy|0
5899016|NCT01695239|20408746|P1|Extension Long-Term Extension Periods|Lack of Efficacy|0
5899017|NCT01695239|20408733|P14|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
5899018|NCT01695239|20408734|P13|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
5899019|NCT01695239|20408735|P12|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
5899020|NCT01695239|20408736|P11|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
5899021|NCT01695239|20408737|P10|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
5899022|NCT01695239|20408738|P9|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
5899023|NCT01695239|20408739|P8|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|1
5899024|NCT01695239|20408740|P7|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
5899025|NCT01695239|20408741|P6|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
5899026|NCT01695239|20408742|P5|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
5899027|NCT01695239|20408743|P4|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
5899028|NCT01695239|20408744|P3|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
5899029|NCT01695239|20408745|P2|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
5899030|NCT01695239|20408746|P1|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
5899031|NCT01695239|20408733|P14|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
5899032|NCT01695239|20408734|P13|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
5899033|NCT01695239|20408735|P12|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
5899034|NCT01695239|20408736|P11|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
5899035|NCT01695239|20408737|P10|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
5899036|NCT01695239|20408738|P9|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
5899037|NCT01695239|20408739|P8|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|1
5899038|NCT01695239|20408740|P7|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
5899039|NCT01695239|20408741|P6|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
5899040|NCT01695239|20408742|P5|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
5899041|NCT01695239|20408743|P4|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
5899042|NCT01695239|20408744|P3|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
5899043|NCT01695239|20408745|P2|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
5899044|NCT01695239|20408746|P1|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
5899045|NCT01695239|20408733|P14|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
5899046|NCT01695239|20408734|P13|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
5899047|NCT01695239|20408735|P12|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
5899048|NCT01695239|20408736|P11|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
5899049|NCT01695239|20408737|P10|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
5899050|NCT01695239|20408738|P9|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
5899051|NCT01695239|20408739|P8|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|9
5899052|NCT01695239|20408740|P7|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
5899053|NCT01695239|20408741|P6|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
5899054|NCT01695239|20408742|P5|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
5899055|NCT01695239|20408743|P4|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
5899056|NCT01695239|20408744|P3|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
5899057|NCT01695239|20408745|P2|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
5899058|NCT01695239|20408746|P1|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
5899059|NCT01695239|20408733|P14|Double-Blind (DB) Treatment Period|Protocol Violation|0
5899060|NCT01695239|20408734|P13|Double-Blind (DB) Treatment Period|Protocol Violation|0
5899061|NCT01695239|20408735|P12|Double-Blind (DB) Treatment Period|Protocol Violation|0
5899062|NCT01695239|20408736|P11|Double-Blind (DB) Treatment Period|Protocol Violation|0
5899063|NCT01695239|20408737|P10|Double-Blind (DB) Treatment Period|Protocol Violation|0
5899064|NCT01695239|20408738|P9|Double-Blind (DB) Treatment Period|Protocol Violation|0
5899065|NCT01695239|20408739|P8|Double-Blind (DB) Treatment Period|Protocol Violation|0
5899066|NCT01695239|20408740|P7|Double-Blind (DB) Treatment Period|Protocol Violation|0
5899067|NCT01695239|20408741|P6|Double-Blind (DB) Treatment Period|Protocol Violation|0
5899068|NCT01695239|20408742|P5|Double-Blind (DB) Treatment Period|Protocol Violation|0
5899069|NCT01695239|20408743|P4|Double-Blind (DB) Treatment Period|Protocol Violation|0
5899070|NCT01695239|20408744|P3|Double-Blind (DB) Treatment Period|Protocol Violation|0
5899071|NCT01695239|20408745|P2|Double-Blind (DB) Treatment Period|Protocol Violation|0
5899072|NCT01695239|20408746|P1|Double-Blind (DB) Treatment Period|Protocol Violation|1
5899073|NCT01695239|20408733|P14|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
5899074|NCT01695239|20408734|P13|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
5899075|NCT01695239|20408735|P12|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
5899076|NCT01695239|20408736|P11|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
5899077|NCT01695239|20408737|P10|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
5899078|NCT01695239|20408738|P9|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
5899079|NCT01695239|20408739|P8|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
5899080|NCT01695239|20408740|P7|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
5899081|NCT01695239|20408741|P6|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
5899082|NCT01695239|20408742|P5|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
5899083|NCT01695239|20408743|P4|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
5899084|NCT01695239|20408744|P3|Double-Blind (DB) Treatment Period|Lost to Follow-up|1
5899085|NCT01695239|20408745|P2|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
5899086|NCT01695239|20408746|P1|Double-Blind (DB) Treatment Period|Lost to Follow-up|1
5899087|NCT01695239|20408733|P14|Double-Blind (DB) Treatment Period|Sponsor Decision|0
5899088|NCT01695239|20408734|P13|Double-Blind (DB) Treatment Period|Sponsor Decision|0
5899089|NCT01695239|20408735|P12|Double-Blind (DB) Treatment Period|Sponsor Decision|0
5899090|NCT01695239|20408736|P11|Double-Blind (DB) Treatment Period|Sponsor Decision|0
5899091|NCT01695239|20408737|P10|Double-Blind (DB) Treatment Period|Sponsor Decision|0
5899092|NCT01695239|20408738|P9|Double-Blind (DB) Treatment Period|Sponsor Decision|0
5899093|NCT01695239|20408739|P8|Double-Blind (DB) Treatment Period|Sponsor Decision|0
5899094|NCT01695239|20408740|P7|Double-Blind (DB) Treatment Period|Sponsor Decision|0
5899095|NCT01695239|20408741|P6|Double-Blind (DB) Treatment Period|Sponsor Decision|0
5899096|NCT01695239|20408742|P5|Double-Blind (DB) Treatment Period|Sponsor Decision|0
5899097|NCT01695239|20408743|P4|Double-Blind (DB) Treatment Period|Sponsor Decision|0
5899098|NCT01695239|20408744|P3|Double-Blind (DB) Treatment Period|Sponsor Decision|1
5899099|NCT01695239|20408745|P2|Double-Blind (DB) Treatment Period|Sponsor Decision|0
5899100|NCT01695239|20408746|P1|Double-Blind (DB) Treatment Period|Sponsor Decision|3
5899101|NCT01695239|20408733|P14|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
5899102|NCT01695239|20408734|P13|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
5899103|NCT01695239|20408735|P12|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
5899104|NCT01695239|20408736|P11|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
5899105|NCT01695239|20408737|P10|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
5899106|NCT01695239|20408738|P9|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
5899107|NCT01695239|20408739|P8|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
5899108|NCT01695239|20408740|P7|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
5899109|NCT01695239|20408741|P6|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
5899110|NCT01695239|20408742|P5|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
5899111|NCT01695239|20408743|P4|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
5899112|NCT01695239|20408744|P3|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1
5899113|NCT01695239|20408745|P2|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1
5899114|NCT01695239|20408746|P1|Double-Blind (DB) Treatment Period|Withdrawal by Subject|3
5899115|NCT01695239|20408733|P14|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
5899116|NCT01695239|20408734|P13|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
5899117|NCT01695239|20408735|P12|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
5899118|NCT01695239|20408736|P11|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
5899119|NCT01695239|20408737|P10|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
5899120|NCT01695239|20408738|P9|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
5899121|NCT01695239|20408739|P8|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
5899122|NCT01695239|20408740|P7|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
5899123|NCT01695239|20408741|P6|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
5899124|NCT01695239|20408742|P5|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
5899125|NCT01695239|20408743|P4|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
5899126|NCT01695239|20408744|P3|Double-Blind (DB) Treatment Period|Lack of Efficacy|2
5899127|NCT01695239|20408745|P2|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
5899128|NCT01695239|20408746|P1|Double-Blind (DB) Treatment Period|Lack of Efficacy|4
5899129|NCT01695239|20408733|P14|Double-Blind (DB) Treatment Period|Adverse Event|0
5899130|NCT01695239|20408734|P13|Double-Blind (DB) Treatment Period|Adverse Event|0
5899131|NCT01695239|20408735|P12|Double-Blind (DB) Treatment Period|Adverse Event|0
5899132|NCT01695239|20408736|P11|Double-Blind (DB) Treatment Period|Adverse Event|0
5899133|NCT01695239|20408737|P10|Double-Blind (DB) Treatment Period|Adverse Event|0
5899134|NCT01695239|20408738|P9|Double-Blind (DB) Treatment Period|Adverse Event|0
5899135|NCT01695239|20408739|P8|Double-Blind (DB) Treatment Period|Adverse Event|0
5899136|NCT01695239|20408740|P7|Double-Blind (DB) Treatment Period|Adverse Event|0
5899137|NCT01695239|20408741|P6|Double-Blind (DB) Treatment Period|Adverse Event|0
5899138|NCT01695239|20408742|P5|Double-Blind (DB) Treatment Period|Adverse Event|0
5899139|NCT01695239|20408743|P4|Double-Blind (DB) Treatment Period|Adverse Event|3
5899140|NCT01695239|20408744|P3|Double-Blind (DB) Treatment Period|Adverse Event|2
5899141|NCT01695239|20408745|P2|Double-Blind (DB) Treatment Period|Adverse Event|2
5899142|NCT01695239|20408746|P1|Double-Blind (DB) Treatment Period|Adverse Event|2
5899143|NCT01695239|20408733|P14|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
5899144|NCT01695239|20408734|P13|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
5899145|NCT01695239|20408735|P12|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
5899146|NCT01695239|20408736|P11|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
5899147|NCT01695239|20408737|P10|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
5899225|NCT01694706|20408964|P3|Overall Study|other reason not defined above|0
5899148|NCT01695239|20408738|P9|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
5899149|NCT01695239|20408739|P8|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
5899150|NCT01695239|20408740|P7|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
5899151|NCT01695239|20408741|P6|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
5899152|NCT01695239|20408742|P5|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
5899153|NCT01695239|20408743|P4|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|4
5899154|NCT01695239|20408744|P3|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|3
5899155|NCT01695239|20408745|P2|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1
5899156|NCT01695239|20408746|P1|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1
5899157|NCT01695135|20408887|P4|Open Label Extension Treatment Phase|Noncompliance with study drug|1
5899158|NCT01695135|20408888|P3|Open Label Extension Treatment Phase|Noncompliance with study drug|0
5899159|NCT01695135|20408889|P2|Open Label Extension Treatment Phase|Noncompliance with study drug|0
5899160|NCT01695135|20408890|P1|Open Label Extension Treatment Phase|Noncompliance with study drug|0
5899161|NCT01695135|20408887|P4|Open Label Extension Treatment Phase|Death|7
5899162|NCT01695135|20408888|P3|Open Label Extension Treatment Phase|Death|2
5899163|NCT01695135|20408889|P2|Open Label Extension Treatment Phase|Death|0
5899164|NCT01695135|20408890|P1|Open Label Extension Treatment Phase|Death|0
5899165|NCT01695135|20408887|P4|Open Label Extension Treatment Phase|Physician Decision|1
5899166|NCT01695135|20408888|P3|Open Label Extension Treatment Phase|Physician Decision|4
5899167|NCT01695135|20408889|P2|Open Label Extension Treatment Phase|Physician Decision|0
5899168|NCT01695135|20408890|P1|Open Label Extension Treatment Phase|Physician Decision|0
5899169|NCT01695135|20408887|P4|Open Label Extension Treatment Phase|Other|7
5899170|NCT01695135|20408888|P3|Open Label Extension Treatment Phase|Other|4
5899171|NCT01695135|20408889|P2|Open Label Extension Treatment Phase|Other|0
5899172|NCT01695135|20408890|P1|Open Label Extension Treatment Phase|Other|0
5899173|NCT01695135|20408887|P4|Open Label Extension Treatment Phase|Adverse Event|16
5899174|NCT01695135|20408888|P3|Open Label Extension Treatment Phase|Adverse Event|11
5899175|NCT01695135|20408889|P2|Open Label Extension Treatment Phase|Adverse Event|0
5899176|NCT01695135|20408890|P1|Open Label Extension Treatment Phase|Adverse Event|0
5899177|NCT01695135|20408887|P4|Open Label Extension Treatment Phase|Withdrawal by Subject|16
5899178|NCT01695135|20408888|P3|Open Label Extension Treatment Phase|Withdrawal by Subject|6
5899179|NCT01695135|20408889|P2|Open Label Extension Treatment Phase|Withdrawal by Subject|0
5899180|NCT01695135|20408890|P1|Open Label Extension Treatment Phase|Withdrawal by Subject|0
5899181|NCT01695135|20408887|P4|Open Label Extension Treatment Phase|Progressive disease|22
5899182|NCT01695135|20408888|P3|Open Label Extension Treatment Phase|Progressive disease|13
5899183|NCT01695135|20408889|P2|Open Label Extension Treatment Phase|Progressive disease|0
5899184|NCT01695135|20408890|P1|Open Label Extension Treatment Phase|Progressive disease|0
5899185|NCT01695135|20408887|P4|Double-blind Treatment Phase|Noncompliance with study drug|0
5899186|NCT01695135|20408888|P3|Double-blind Treatment Phase|Noncompliance with study drug|0
5899187|NCT01695135|20408889|P2|Double-blind Treatment Phase|Noncompliance with study drug|1
5899188|NCT01695135|20408890|P1|Double-blind Treatment Phase|Noncompliance with study drug|0
5899189|NCT01695135|20408887|P4|Double-blind Treatment Phase|Death|0
5899190|NCT01695135|20408888|P3|Double-blind Treatment Phase|Death|0
5899191|NCT01695135|20408889|P2|Double-blind Treatment Phase|Death|1
5899192|NCT01695135|20408890|P1|Double-blind Treatment Phase|Death|1
5899193|NCT01695135|20408887|P4|Double-blind Treatment Phase|Physician Decision|0
5899194|NCT01695135|20408888|P3|Double-blind Treatment Phase|Physician Decision|0
5899195|NCT01695135|20408889|P2|Double-blind Treatment Phase|Physician Decision|3
5899196|NCT01695135|20408890|P1|Double-blind Treatment Phase|Physician Decision|6
5899197|NCT01695135|20408887|P4|Double-blind Treatment Phase|Other|0
5899198|NCT01695135|20408888|P3|Double-blind Treatment Phase|Other|0
5899199|NCT01695135|20408889|P2|Double-blind Treatment Phase|Other|3
5899200|NCT01695135|20408890|P1|Double-blind Treatment Phase|Other|1
5899201|NCT01695135|20408887|P4|Double-blind Treatment Phase|Adverse Event|0
5899202|NCT01695135|20408888|P3|Double-blind Treatment Phase|Adverse Event|0
5899203|NCT01695135|20408889|P2|Double-blind Treatment Phase|Adverse Event|7
5899204|NCT01695135|20408890|P1|Double-blind Treatment Phase|Adverse Event|7
5899205|NCT01695135|20408887|P4|Double-blind Treatment Phase|Withdrawal by Subject|0
5899206|NCT01695135|20408888|P3|Double-blind Treatment Phase|Withdrawal by Subject|0
5899207|NCT01695135|20408889|P2|Double-blind Treatment Phase|Withdrawal by Subject|14
5899208|NCT01695135|20408890|P1|Double-blind Treatment Phase|Withdrawal by Subject|6
5899209|NCT01695135|20408887|P4|Double-blind Treatment Phase|Progressive disease|0
5899210|NCT01695135|20408888|P3|Double-blind Treatment Phase|Progressive disease|0
5899211|NCT01695135|20408889|P2|Double-blind Treatment Phase|Progressive disease|110
5899212|NCT01695135|20408890|P1|Double-blind Treatment Phase|Progressive disease|50
5899213|NCT01694771|20408939|P2|Overall Study|Other reasons|6
5899214|NCT01694771|20408940|P1|Overall Study|Other reasons|5
5899215|NCT01694771|20408939|P2|Overall Study|Consent withdrawn|9
5899216|NCT01694771|20408940|P1|Overall Study|Consent withdrawn|7
5899217|NCT01694771|20408939|P2|Overall Study|Lost to Follow-up|3
5899218|NCT01694771|20408940|P1|Overall Study|Lost to Follow-up|2
5899219|NCT01694771|20408939|P2|Overall Study|Non compliance protocol|6
5899220|NCT01694771|20408940|P1|Overall Study|Non compliance protocol|7
5899221|NCT01694771|20408939|P2|Overall Study|Lack of Efficacy|0
5899222|NCT01694771|20408940|P1|Overall Study|Lack of Efficacy|1
5899223|NCT01694771|20408939|P2|Overall Study|Adverse Event|16
5899224|NCT01694771|20408940|P1|Overall Study|Adverse Event|18
5899226|NCT01694706|20408965|P2|Overall Study|other reason not defined above|0
5899227|NCT01694706|20408966|P1|Overall Study|other reason not defined above|1
5899228|NCT01694706|20408964|P3|Overall Study|Adverse Event|0
5899229|NCT01694706|20408965|P2|Overall Study|Adverse Event|1
5899230|NCT01694706|20408966|P1|Overall Study|Adverse Event|0
5899231|NCT01694485|20409025|P5|Overall Study|Death|0
5899232|NCT01694485|20409026|P4|Overall Study|Death|1
5899233|NCT01694485|20409027|P3|Overall Study|Death|0
5899234|NCT01694485|20409028|P2|Overall Study|Death|0
5899235|NCT01694485|20409029|P1|Overall Study|Death|1
5899236|NCT01694485|20409025|P5|Overall Study|Lost to Follow-up|7
5899237|NCT01694485|20409026|P4|Overall Study|Lost to Follow-up|10
5899238|NCT01694485|20409027|P3|Overall Study|Lost to Follow-up|6
5899239|NCT01694485|20409028|P2|Overall Study|Lost to Follow-up|1
5899240|NCT01694485|20409029|P1|Overall Study|Lost to Follow-up|9
5899241|NCT01694485|20409025|P5|Overall Study|Sponsor Decision|0
5899242|NCT01694485|20409026|P4|Overall Study|Sponsor Decision|2
5899243|NCT01694485|20409027|P3|Overall Study|Sponsor Decision|0
5899244|NCT01694485|20409028|P2|Overall Study|Sponsor Decision|0
5899245|NCT01694485|20409029|P1|Overall Study|Sponsor Decision|3
5899246|NCT01694485|20409025|P5|Overall Study|Withdrawal by Subject|18
5899247|NCT01694485|20409026|P4|Overall Study|Withdrawal by Subject|25
5899248|NCT01694485|20409027|P3|Overall Study|Withdrawal by Subject|7
5899249|NCT01694485|20409028|P2|Overall Study|Withdrawal by Subject|6
5899250|NCT01694485|20409029|P1|Overall Study|Withdrawal by Subject|20
5899251|NCT01694433|20409063|P2|Overall Study|Withdrawal by Subject|4
5899252|NCT01694433|20409064|P1|Overall Study|Withdrawal by Subject|3
5899253|NCT01694433|20409063|P2|Overall Study|Physician Decision|0
5899254|NCT01694433|20409064|P1|Overall Study|Physician Decision|1
5899255|NCT01694433|20409063|P2|Overall Study|Adverse Event|0
5899256|NCT01694433|20409064|P1|Overall Study|Adverse Event|7
5899257|NCT01694420|20409072|P1|Overall Study|Lost to Follow-up|3
5899258|NCT01694121|20409109|P2|Overall Study|Participant used false ID, was withdrawn|0
5899259|NCT01694121|20409110|P1|Overall Study|Participant used false ID, was withdrawn|1
5899260|NCT01693614|20409224|P3|Overall Study|Withdrawal by Subject|5
5899261|NCT01693614|20409225|P2|Overall Study|Withdrawal by Subject|0
5899262|NCT01693614|20409226|P1|Overall Study|Withdrawal by Subject|1
5899263|NCT01693614|20409224|P3|Overall Study|Withdrawal by subject/guardian|2
5899264|NCT01693614|20409225|P2|Overall Study|Withdrawal by subject/guardian|0
5899265|NCT01693614|20409226|P1|Overall Study|Withdrawal by subject/guardian|0
5899266|NCT01693614|20409224|P3|Overall Study|Physician Decision|4
5899267|NCT01693614|20409225|P2|Overall Study|Physician Decision|1
5899268|NCT01693614|20409226|P1|Overall Study|Physician Decision|1
5899269|NCT01693614|20409224|P3|Overall Study|Death|0
5899270|NCT01693614|20409225|P2|Overall Study|Death|0
5899271|NCT01693614|20409226|P1|Overall Study|Death|1
5899272|NCT01693614|20409224|P3|Overall Study|Protocol Violation|1
5899273|NCT01693614|20409225|P2|Overall Study|Protocol Violation|2
5899274|NCT01693614|20409226|P1|Overall Study|Protocol Violation|5
5899275|NCT01693614|20409224|P3|Overall Study|Disease progression|7
5899276|NCT01693614|20409225|P2|Overall Study|Disease progression|8
5899277|NCT01693614|20409226|P1|Overall Study|Disease progression|11
5899278|NCT01693614|20409224|P3|Overall Study|Adverse Event|5
5899279|NCT01693614|20409225|P2|Overall Study|Adverse Event|11
5899280|NCT01693614|20409226|P1|Overall Study|Adverse Event|7
5899281|NCT01693523|20409251|P3|Overall Study|Chemotherapy was held|0
5899282|NCT01693523|20409252|P2|Overall Study|Chemotherapy was held|2
5899283|NCT01693523|20409253|P1|Overall Study|Chemotherapy was held|1
5899284|NCT01693523|20409251|P3|Overall Study|Lack of compliance study medication|0
5899285|NCT01693523|20409252|P2|Overall Study|Lack of compliance study medication|2
5899286|NCT01693523|20409253|P1|Overall Study|Lack of compliance study medication|1
5899287|NCT01693523|20409251|P3|Overall Study|Withdrawal by Subject|2
5899288|NCT01693523|20409252|P2|Overall Study|Withdrawal by Subject|2
5899289|NCT01693523|20409253|P1|Overall Study|Withdrawal by Subject|1
5899290|NCT01693523|20409251|P3|Overall Study|Physician Decision|1
5899291|NCT01693523|20409252|P2|Overall Study|Physician Decision|0
5899292|NCT01693523|20409253|P1|Overall Study|Physician Decision|0
5899293|NCT01693523|20409251|P3|Overall Study|Lost to Follow-up|4
5899294|NCT01693523|20409252|P2|Overall Study|Lost to Follow-up|0
5899295|NCT01693523|20409253|P1|Overall Study|Lost to Follow-up|0
5899296|NCT01693523|20409251|P3|Overall Study|Death|1
5899297|NCT01693523|20409252|P2|Overall Study|Death|1
5899298|NCT01693523|20409253|P1|Overall Study|Death|0
5899299|NCT01693523|20409251|P3|Overall Study|Adverse Event|0
5899300|NCT01693523|20409252|P2|Overall Study|Adverse Event|1
5899301|NCT01693523|20409253|P1|Overall Study|Adverse Event|2
5899302|NCT01693367|20409269|P2|Overall Study|Physician Decision|1
5899303|NCT01693367|20409270|P1|Overall Study|Physician Decision|0
5899304|NCT01693367|20409269|P2|Overall Study|Withdrawal by Subject|1
5899305|NCT01693367|20409270|P1|Overall Study|Withdrawal by Subject|1
5899306|NCT01693250|20409288|P2|Overall Study|Lost to Follow-up|2
5899307|NCT01693250|20409289|P1|Overall Study|Lost to Follow-up|2
5899308|NCT01693185|20409299|P2|Overall Study|diagnostic procedure after colonoscopy|6
5899309|NCT01693185|20409300|P1|Overall Study|diagnostic procedure after colonoscopy|0
5899310|NCT01693120|20409316|P1|Phased RF Study Procedure and Follow-up|Other reasons|7
5899311|NCT01693120|20409316|P1|Phased RF Study Procedure and Follow-up|Protocol Violation|1
5899312|NCT01693120|20409316|P1|Phased RF Study Procedure and Follow-up|Physician Decision|3
5899313|NCT01693120|20409316|P1|Phased RF Study Procedure and Follow-up|Withdrawal by Subject|5
5899314|NCT01693120|20409316|P1|Phased RF Study Procedure and Follow-up|Lost to Follow-up|1
5899315|NCT01693120|20409316|P1|Enrollment|Other|1
5899316|NCT01693120|20409316|P1|Enrollment|Study closed|8
5899317|NCT01693120|20409316|P1|Enrollment|Adverse Event|1
5899318|NCT01693120|20409316|P1|Enrollment|Physician Decision|3
5899319|NCT01693120|20409316|P1|Enrollment|Protocol Violation|46
5899320|NCT01693120|20409316|P1|Enrollment|Withdrawal by Subject|10
5899321|NCT01693120|20409316|P1|Enrollment|Lost to Follow-up|1
5899322|NCT01693068|20409325|P3|Cross-over (Dacarbazine To Pimasertib)|On-study|1
5899323|NCT01693068|20409326|P2|Cross-over (Dacarbazine To Pimasertib)|On-study|0
5899324|NCT01693068|20409327|P1|Cross-over (Dacarbazine To Pimasertib)|On-study|0
5899325|NCT01693068|20409325|P3|Randomization Period|On-study|0
5899326|NCT01693068|20409326|P2|Randomization Period|On-study|5
5899327|NCT01693068|20409327|P1|Randomization Period|On-study|2
5899328|NCT01693029|20409359|P2|Overall Study|Non-compliance|1
5899329|NCT01693029|20409360|P1|Overall Study|Non-compliance|2
5899330|NCT01693029|20409359|P2|Overall Study|Death|8
5899331|NCT01693029|20409360|P1|Overall Study|Death|5
5899332|NCT01693029|20409359|P2|Overall Study|Adverse Event|6
5899333|NCT01693029|20409360|P1|Overall Study|Adverse Event|1
5899334|NCT01693029|20409359|P2|Overall Study|Lost to Follow-up|1
5899335|NCT01693029|20409360|P1|Overall Study|Lost to Follow-up|0
5899336|NCT01693029|20409359|P2|Overall Study|Physician Decision|2
5899337|NCT01693029|20409360|P1|Overall Study|Physician Decision|0
5899338|NCT01693029|20409359|P2|Overall Study|Change in dialysis modality|1
5899339|NCT01693029|20409360|P1|Overall Study|Change in dialysis modality|2
5899340|NCT01693029|20409359|P2|Overall Study|Protocol Violation|7
5899341|NCT01693029|20409360|P1|Overall Study|Protocol Violation|6
5899342|NCT01693029|20409359|P2|Overall Study|Bindinging anti-EPO antibodies|2
5899343|NCT01693029|20409360|P1|Overall Study|Bindinging anti-EPO antibodies|6
5899344|NCT01693029|20409359|P2|Overall Study|Kidney transplantation|7
5899345|NCT01693029|20409360|P1|Overall Study|Kidney transplantation|7
5899346|NCT01693029|20409359|P2|Overall Study|Withdrawal by Subject|22
5899347|NCT01693029|20409360|P1|Overall Study|Withdrawal by Subject|15
5899348|NCT01692938|20409396|P2|Overall Study|Study completed prior to site completion|3
5899349|NCT01692938|20409397|P1|Overall Study|Study completed prior to site completion|3
5899350|NCT01692938|20409396|P2|Overall Study|Protocol Deviation|1
5899351|NCT01692938|20409397|P1|Overall Study|Protocol Deviation|1
5899352|NCT01692782|20409408|P3|Overall Study|Withdrawal by Subject|3
5899353|NCT01692782|20409409|P2|Overall Study|Withdrawal by Subject|10
5899354|NCT01692782|20409410|P1|Overall Study|Withdrawal by Subject|3
5899355|NCT01692782|20409408|P3|Overall Study|SAE not related to study drug|0
5899356|NCT01692782|20409409|P2|Overall Study|SAE not related to study drug|1
5899357|NCT01692782|20409410|P1|Overall Study|SAE not related to study drug|0
5899358|NCT01692782|20409408|P3|Overall Study|Non-compliant with study visits|1
5899359|NCT01692782|20409409|P2|Overall Study|Non-compliant with study visits|0
5899360|NCT01692782|20409410|P1|Overall Study|Non-compliant with study visits|0
5899361|NCT01692782|20409408|P3|Overall Study|Non-complance with study drug|1
5899362|NCT01692782|20409409|P2|Overall Study|Non-complance with study drug|4
5899363|NCT01692782|20409410|P1|Overall Study|Non-complance with study drug|0
5899364|NCT01692782|20409408|P3|Overall Study|Protocol Violation|2
5899365|NCT01692782|20409409|P2|Overall Study|Protocol Violation|0
5899366|NCT01692782|20409410|P1|Overall Study|Protocol Violation|1
5899367|NCT01692782|20409408|P3|Overall Study|Pregnancy|0
5899368|NCT01692782|20409409|P2|Overall Study|Pregnancy|0
5899369|NCT01692782|20409410|P1|Overall Study|Pregnancy|1
5899370|NCT01692782|20409408|P3|Overall Study|Lost to Follow-up|1
5899371|NCT01692782|20409409|P2|Overall Study|Lost to Follow-up|7
5899372|NCT01692782|20409410|P1|Overall Study|Lost to Follow-up|2
5899373|NCT01692782|20409408|P3|Overall Study|Lack of Efficacy|0
5899374|NCT01692782|20409409|P2|Overall Study|Lack of Efficacy|2
5899375|NCT01692782|20409410|P1|Overall Study|Lack of Efficacy|1
5899376|NCT01692782|20409408|P3|Overall Study|Adverse Event|2
5899377|NCT01692782|20409409|P2|Overall Study|Adverse Event|32
5899378|NCT01692782|20409410|P1|Overall Study|Adverse Event|12
5899379|NCT01692730|20409519|P2|Overall Study|Lost to Follow-up|227
5899380|NCT01692730|20409520|P1|Overall Study|Lost to Follow-up|225
5899381|NCT01692626|20409534|P2|Overall Study|Withdrawal by Subject|0
5899382|NCT01692626|20409535|P1|Overall Study|Withdrawal by Subject|1
5899383|NCT01692626|20409534|P2|Overall Study|Protocol Violation|2
5899384|NCT01692626|20409535|P1|Overall Study|Protocol Violation|1
5899385|NCT01692626|20409534|P2|Overall Study|Adverse Event|3
5899386|NCT01692626|20409535|P1|Overall Study|Adverse Event|2
5899387|NCT01692626|20409534|P2|Overall Study|Death|1
5899388|NCT01692626|20409535|P1|Overall Study|Death|0
5899389|NCT01692301|20409570|P2|Overall Study|Lost to Follow-up|1
5899390|NCT01692301|20409571|P1|Overall Study|Lost to Follow-up|1
5899391|NCT01692301|20409570|P2|Overall Study|Physician Decision|2
5899392|NCT01692301|20409571|P1|Overall Study|Physician Decision|2
5899393|NCT01692301|20409570|P2|Overall Study|Technical problems|1
5899394|NCT01692301|20409571|P1|Overall Study|Technical problems|0
5899395|NCT01692301|20409570|P2|Overall Study|Patient/guardian decision|15
5899396|NCT01692301|20409571|P1|Overall Study|Patient/guardian decision|16
5899397|NCT01692301|20409570|P2|Overall Study|Protocol deviation|2
5899398|NCT01692301|20409571|P1|Overall Study|Protocol deviation|9
5899399|NCT01692301|20409570|P2|Overall Study|Non-compliance with study treatment|2
5899400|NCT01692301|20409571|P1|Overall Study|Non-compliance with study treatment|1
5899401|NCT01692301|20409570|P2|Overall Study|Lack of Efficacy|5
5899402|NCT01692301|20409571|P1|Overall Study|Lack of Efficacy|0
5899403|NCT01692301|20409570|P2|Overall Study|Death|2
5899404|NCT01692301|20409571|P1|Overall Study|Death|1
5899405|NCT01692301|20409570|P2|Overall Study|Adverse Event|12
5899406|NCT01692301|20409571|P1|Overall Study|Adverse Event|15
5899407|NCT01692275|20409603|P2|Overall Study|Withdrawal by Subject|11
5899408|NCT01692275|20409604|P1|Overall Study|Withdrawal by Subject|9
5899409|NCT01692275|20409603|P2|Overall Study|Lost to Follow-up|48
5899410|NCT01692275|20409604|P1|Overall Study|Lost to Follow-up|57
5899411|NCT01692197|20409664|P1|Overall Study|Failed Screening|3
5899412|NCT01691898|20409686|P6|Overall Study|Non-Compliance|0
5899413|NCT01691898|20409687|P5|Overall Study|Non-Compliance|1
5899414|NCT01691898|20409688|P4|Overall Study|Non-Compliance|0
5899415|NCT01691898|20409689|P3|Overall Study|Non-Compliance|0
5899416|NCT01691898|20409690|P2|Overall Study|Non-Compliance|0
5899417|NCT01691898|20409691|P1|Overall Study|Non-Compliance|0
5899418|NCT01691898|20409686|P6|Overall Study|Withdrawal by Subject|3
5899419|NCT01691898|20409687|P5|Overall Study|Withdrawal by Subject|3
5899420|NCT01691898|20409688|P4|Overall Study|Withdrawal by Subject|1
5899421|NCT01691898|20409689|P3|Overall Study|Withdrawal by Subject|2
5899422|NCT01691898|20409690|P2|Overall Study|Withdrawal by Subject|8
5899423|NCT01691898|20409691|P1|Overall Study|Withdrawal by Subject|9
5899424|NCT01691898|20409686|P6|Overall Study|Lost to Follow-up|0
5899425|NCT01691898|20409687|P5|Overall Study|Lost to Follow-up|1
5899426|NCT01691898|20409688|P4|Overall Study|Lost to Follow-up|0
5899427|NCT01691898|20409689|P3|Overall Study|Lost to Follow-up|0
5899428|NCT01691898|20409690|P2|Overall Study|Lost to Follow-up|1
5899429|NCT01691898|20409691|P1|Overall Study|Lost to Follow-up|3
5899430|NCT01691898|20409686|P6|Overall Study|Progression of Disease|1
5899431|NCT01691898|20409687|P5|Overall Study|Progression of Disease|0
5899432|NCT01691898|20409688|P4|Overall Study|Progression of Disease|0
5899433|NCT01691898|20409689|P3|Overall Study|Progression of Disease|1
5899434|NCT01691898|20409690|P2|Overall Study|Progression of Disease|2
5899435|NCT01691898|20409691|P1|Overall Study|Progression of Disease|1
5899436|NCT01691898|20409686|P6|Overall Study|Adverse Event|0
5899437|NCT01691898|20409687|P5|Overall Study|Adverse Event|1
5899438|NCT01691898|20409688|P4|Overall Study|Adverse Event|1
5899439|NCT01691898|20409689|P3|Overall Study|Adverse Event|0
5899440|NCT01691898|20409690|P2|Overall Study|Adverse Event|1
5899441|NCT01691898|20409691|P1|Overall Study|Adverse Event|0
5899442|NCT01691898|20409686|P6|Overall Study|Death|31
5899443|NCT01691898|20409687|P5|Overall Study|Death|8
5899444|NCT01691898|20409688|P4|Overall Study|Death|3
5899445|NCT01691898|20409689|P3|Overall Study|Death|6
5899446|NCT01691898|20409690|P2|Overall Study|Death|32
5899447|NCT01691898|20409691|P1|Overall Study|Death|34
5899448|NCT01691885|20409845|P2|Washout Period (7-9 Days)|Adverse Event|1
5899449|NCT01691885|20409846|P1|Washout Period (7-9 Days)|Adverse Event|0
5899450|NCT01691885|20409845|P2|Treatment Period 1(7-14 Days)|Adverse Event|1
5899451|NCT01691885|20409846|P1|Treatment Period 1(7-14 Days)|Adverse Event|1
5899452|NCT01691859|20409852|P1|Overall Study|Withdrawal by Subject|31
5899453|NCT01691859|20409852|P1|Overall Study|Physician Decision|6
5899454|NCT01691859|20409852|P1|Overall Study|Lost to Follow-up|5
5899455|NCT01691859|20409852|P1|Overall Study|Study closed/terminated|50
5899456|NCT01691859|20409852|P1|Overall Study|Product commercially available|221
5899457|NCT01691859|20409852|P1|Overall Study|Protocol Violation|4
5899458|NCT01691859|20409852|P1|Overall Study|Lack of Efficacy|11
5899459|NCT01691859|20409852|P1|Overall Study|Adverse Event|19
5899460|NCT01691820|20409899|P3|Overall Study|Other (unspecified)|1
5899461|NCT01691820|20409900|P2|Overall Study|Other (unspecified)|0
5899462|NCT01691820|20409901|P1|Overall Study|Other (unspecified)|5
5899463|NCT01691820|20409899|P3|Overall Study|Lost to Follow-up|0
5899464|NCT01691820|20409900|P2|Overall Study|Lost to Follow-up|15
5899465|NCT01691820|20409901|P1|Overall Study|Lost to Follow-up|8
5899466|NCT01691820|20409899|P3|Overall Study|Migrated/moved from study area|0
5899467|NCT01691820|20409900|P2|Overall Study|Migrated/moved from study area|4
5899468|NCT01691820|20409901|P1|Overall Study|Migrated/moved from study area|7
5899469|NCT01691820|20409899|P3|Overall Study|Consent withdrawal (not due to an AE)|0
5899470|NCT01691820|20409900|P2|Overall Study|Consent withdrawal (not due to an AE)|15
5899471|NCT01691820|20409901|P1|Overall Study|Consent withdrawal (not due to an AE)|9
5899472|NCT01691794|20409939|P3|Overall Study|Did not complete first 24 weeks of study|3
5899473|NCT01691794|20409940|P2|Overall Study|Did not complete first 24 weeks of study|3
5899474|NCT01691794|20409941|P1|Overall Study|Did not complete first 24 weeks of study|0
5899475|NCT01691794|20409939|P3|Overall Study|Completed Only first 24 weeks of study|3
5899476|NCT01691794|20409940|P2|Overall Study|Completed Only first 24 weeks of study|2
5899477|NCT01691794|20409941|P1|Overall Study|Completed Only first 24 weeks of study|0
5899478|NCT01691794|20409939|P3|Overall Study|Adverse Event|1
5899479|NCT01691794|20409940|P2|Overall Study|Adverse Event|1
5899480|NCT01691794|20409941|P1|Overall Study|Adverse Event|0
5899481|NCT01691794|20409939|P3|Overall Study|Participant request to discontinue|0
5899482|NCT01691794|20409940|P2|Overall Study|Participant request to discontinue|1
5899483|NCT01691794|20409941|P1|Overall Study|Participant request to discontinue|0
5899484|NCT01691794|20409939|P3|Overall Study|Lack of Efficacy|1
5899485|NCT01691794|20409940|P2|Overall Study|Lack of Efficacy|7
5899486|NCT01691794|20409941|P1|Overall Study|Lack of Efficacy|0
5899487|NCT01691794|20409939|P3|Overall Study|Death|1
5899488|NCT01691794|20409940|P2|Overall Study|Death|0
5899489|NCT01691794|20409941|P1|Overall Study|Death|0
5899490|NCT01691794|20409939|P3|Overall Study|Poor/Non-Compliance|1
5899491|NCT01691794|20409940|P2|Overall Study|Poor/Non-Compliance|4
5899492|NCT01691794|20409941|P1|Overall Study|Poor/Non-Compliance|1
5899493|NCT01691781|20409957|P2|Overall Study|Adverse Event|1
5899494|NCT01691781|20409958|P1|Overall Study|Adverse Event|0
5899495|NCT01691781|20409957|P2|Overall Study|Protocol Violation|2
5899496|NCT01691781|20409958|P1|Overall Study|Protocol Violation|2
5899497|NCT01691781|20409957|P2|Overall Study|Physician Decision|1
5899498|NCT01691781|20409958|P1|Overall Study|Physician Decision|1
5899499|NCT01691781|20409957|P2|Overall Study|Withdrawal by Subject|3
5899500|NCT01691781|20409958|P1|Overall Study|Withdrawal by Subject|4
5899501|NCT01691768|20409970|P2|Overall Study|Investigator decision|1
5899502|NCT01691768|20409971|P1|Overall Study|Investigator decision|1
5899503|NCT01691768|20409970|P2|Overall Study|Relocated|1
5899504|NCT01691768|20409971|P1|Overall Study|Relocated|0
5899505|NCT01691768|20409970|P2|Overall Study|Withdrawal by Subject|9
5899506|NCT01691768|20409971|P1|Overall Study|Withdrawal by Subject|10
5899507|NCT01691768|20409970|P2|Overall Study|Lost to Follow-up|3
5899508|NCT01691768|20409971|P1|Overall Study|Lost to Follow-up|4
5899509|NCT01691768|20409970|P2|Overall Study|Death|2
5899510|NCT01691768|20409971|P1|Overall Study|Death|0
5899511|NCT01691612|20410006|P1|Overall Study|Adverse Event|1
5899512|NCT01691612|20410006|P1|Overall Study|deemed ineligible after 1st visit|6
5899513|NCT01691521|20410117|P3|Overall Study|Withdrawal by Subject|4
5899514|NCT01691521|20410118|P2|Overall Study|Withdrawal by Subject|9
5899515|NCT01691521|20410119|P1|Overall Study|Withdrawal by Subject|5
5899516|NCT01691521|20410117|P3|Overall Study|Physician Decision|0
5899517|NCT01691521|20410118|P2|Overall Study|Physician Decision|1
5899518|NCT01691521|20410119|P1|Overall Study|Physician Decision|2
5899519|NCT01691521|20410117|P3|Overall Study|Lost to Follow-up|2
5899520|NCT01691521|20410118|P2|Overall Study|Lost to Follow-up|2
5899521|NCT01691521|20410119|P1|Overall Study|Lost to Follow-up|0
5899522|NCT01691521|20410117|P3|Overall Study|Protocol Violation|0
5899523|NCT01691521|20410118|P2|Overall Study|Protocol Violation|3
5899524|NCT01691521|20410119|P1|Overall Study|Protocol Violation|0
5899525|NCT01691521|20410117|P3|Overall Study|Lack of Efficacy|2
5899526|NCT01691521|20410118|P2|Overall Study|Lack of Efficacy|1
5899527|NCT01691521|20410119|P1|Overall Study|Lack of Efficacy|1
5899528|NCT01691521|20410117|P3|Overall Study|Adverse Event|1
5899529|NCT01691521|20410118|P2|Overall Study|Adverse Event|0
5899530|NCT01691521|20410119|P1|Overall Study|Adverse Event|4
5899531|NCT01691508|20410141|P2|Overall Study|Withdrawal by Subject|0
5899532|NCT01691508|20410142|P1|Overall Study|Withdrawal by Subject|1
5899533|NCT01691508|20410141|P2|Overall Study|Adverse Event|3
5899534|NCT01691508|20410142|P1|Overall Study|Adverse Event|3
5899535|NCT01691482|20410156|P2|Treatment Period 2|Protocol Violation|1
5899536|NCT01691482|20410157|P1|Treatment Period 2|Protocol Violation|1
5899537|NCT01691482|20410156|P2|Treatment Period 2|Adverse Event|1
5899538|NCT01691482|20410157|P1|Treatment Period 2|Adverse Event|0
5899539|NCT01691430|20410175|P2|Overall Study|Lost to Follow-up|3
5899540|NCT01691430|20410176|P1|Overall Study|Lost to Follow-up|0
5899541|NCT01691430|20410175|P2|Overall Study|Withdrawal by Subject|1
5899542|NCT01691430|20410176|P1|Overall Study|Withdrawal by Subject|5
5899543|NCT01691430|20410175|P2|Overall Study|Death|16
5899544|NCT01691430|20410176|P1|Overall Study|Death|17
5899545|NCT01691378|20410202|P2|Overall Study|Lost to Follow-up|2
5899546|NCT01691378|20410203|P1|Overall Study|Lost to Follow-up|5
5899547|NCT01691378|20410202|P2|Overall Study|Withdrawal by Subject|0
5899548|NCT01691378|20410203|P1|Overall Study|Withdrawal by Subject|2
5899549|NCT01691248|20410286|P2|Overall Study|Not Treated|7
5899550|NCT01691248|20410287|P1|Overall Study|Not Treated|4
5899551|NCT01691248|20410286|P2|Overall Study|Reason not provided|4
5899552|NCT01691248|20410287|P1|Overall Study|Reason not provided|4
5899553|NCT01691248|20410286|P2|Overall Study|Lost to Follow-up|5
5899554|NCT01691248|20410287|P1|Overall Study|Lost to Follow-up|2
5899555|NCT01691248|20410286|P2|Overall Study|Confirmed CDAD|31
5899556|NCT01691248|20410287|P1|Overall Study|Confirmed CDAD|14
5899557|NCT01691248|20410286|P2|Overall Study|Withdrawal by Subject|18
5899558|NCT01691248|20410287|P1|Overall Study|Withdrawal by Subject|20
5899559|NCT01691248|20410286|P2|Overall Study|Adverse Event|22
5899560|NCT01691248|20410287|P1|Overall Study|Adverse Event|24
5899561|NCT01691248|20410286|P2|Overall Study|Protocol Violation|27
5899562|NCT01691248|20410287|P1|Overall Study|Protocol Violation|43
5899563|NCT01691105|20410299|P2|12 Month Biochemical Verification|subject did not self-report abstinence|401
5899564|NCT01691105|20410300|P1|12 Month Biochemical Verification|subject did not self-report abstinence|352
5899565|NCT01691105|20410299|P2|12 Month Biochemical Verification|Lost to Follow-up|71
5899566|NCT01691105|20410300|P1|12 Month Biochemical Verification|Lost to Follow-up|50
5899567|NCT01691105|20410299|P2|12 Month Biochemical Verification|Death|30
5899568|NCT01691105|20410300|P1|12 Month Biochemical Verification|Death|22
5899569|NCT01691105|20410299|P2|12 Month Follow-up|Death|30
5899570|NCT01691105|20410300|P1|12 Month Follow-up|Death|22
5899571|NCT01691105|20410299|P2|12 Month Follow-up|Lost to Follow-up|71
5899572|NCT01691105|20410300|P1|12 Month Follow-up|Lost to Follow-up|50
5899573|NCT01691105|20410299|P2|6 Month Follow-up|Death|13
5899574|NCT01691105|20410300|P1|6 Month Follow-up|Death|13
5899575|NCT01691105|20410299|P2|6 Month Follow-up|Lost to Follow-up|58
5899576|NCT01691105|20410300|P1|6 Month Follow-up|Lost to Follow-up|39
5899577|NCT01691105|20410299|P2|1 Month Follow-up|Death|3
5899578|NCT01691105|20410300|P1|1 Month Follow-up|Death|2
5899579|NCT01691105|20410299|P2|1 Month Follow-up|Lost to Follow-up|38
5899580|NCT01691105|20410300|P1|1 Month Follow-up|Lost to Follow-up|41
5899581|NCT01691092|20410320|P1|Overall Study|screen fail|19
5899582|NCT01691092|20410320|P1|Overall Study|used for different study|2
5899583|NCT01691092|20410320|P1|Overall Study|non-compliance|3
5899584|NCT01691092|20410320|P1|Overall Study|Withdrawal by Subject|3
5899585|NCT01691092|20410320|P1|Overall Study|Physician Decision|4
5899586|NCT01691092|20410320|P1|Overall Study|Lost to Follow-up|10
5899587|NCT01691014|20410344|P4|Overall Study|Lack of Efficacy|0
5899588|NCT01691014|20410345|P3|Overall Study|Lack of Efficacy|7
5899589|NCT01691014|20410346|P2|Overall Study|Lack of Efficacy|3
5899590|NCT01691014|20410347|P1|Overall Study|Lack of Efficacy|2
5899591|NCT01691014|20410344|P4|Overall Study|Adverse Event|1
5899592|NCT01691014|20410345|P3|Overall Study|Adverse Event|1
5899593|NCT01691014|20410346|P2|Overall Study|Adverse Event|5
5899594|NCT01691014|20410347|P1|Overall Study|Adverse Event|0
5899595|NCT01691014|20410344|P4|Overall Study|Withdrawal by Subject|1
5899596|NCT01691014|20410345|P3|Overall Study|Withdrawal by Subject|1
5899597|NCT01691014|20410346|P2|Overall Study|Withdrawal by Subject|1
5899598|NCT01691014|20410347|P1|Overall Study|Withdrawal by Subject|0
5899599|NCT01691014|20410344|P4|Overall Study|Other|0
5899600|NCT01691014|20410345|P3|Overall Study|Other|2
5899601|NCT01691014|20410346|P2|Overall Study|Other|0
5899602|NCT01691014|20410347|P1|Overall Study|Other|0
5899603|NCT01691014|20410344|P4|Overall Study|Premature Termination|3
5899604|NCT01691014|20410345|P3|Overall Study|Premature Termination|0
5899605|NCT01691014|20410346|P2|Overall Study|Premature Termination|6
5899606|NCT01691014|20410347|P1|Overall Study|Premature Termination|1
5899607|NCT01690988|20410392|P3|Overall Study|Sedated|2
5899608|NCT01690988|20410393|P2|Overall Study|Sedated|1
5899609|NCT01690988|20410394|P1|Overall Study|Sedated|1
5899610|NCT01690988|20410392|P3|Overall Study|Death|1
5899611|NCT01690988|20410393|P2|Overall Study|Death|1
5899612|NCT01690988|20410394|P1|Overall Study|Death|1
5899613|NCT01690988|20410392|P3|Overall Study|Determined ineligible|0
5899614|NCT01690988|20410393|P2|Overall Study|Determined ineligible|0
5899615|NCT01690988|20410394|P1|Overall Study|Determined ineligible|1
5899616|NCT01690988|20410392|P3|Overall Study|Operation Cancelled|0
5899617|NCT01690988|20410393|P2|Overall Study|Operation Cancelled|1
5899618|NCT01690988|20410394|P1|Overall Study|Operation Cancelled|1
5899619|NCT01690988|20410392|P3|Overall Study|Physician Decision|1
5899620|NCT01690988|20410393|P2|Overall Study|Physician Decision|0
5899621|NCT01690988|20410394|P1|Overall Study|Physician Decision|0
5899622|NCT01690988|20410392|P3|Overall Study|Withdrawal by Subject|3
5899623|NCT01690988|20410393|P2|Overall Study|Withdrawal by Subject|2
5899624|NCT01690988|20410394|P1|Overall Study|Withdrawal by Subject|2
5899625|NCT01690299|20410462|P6|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|1
5899626|NCT01690299|20410463|P5|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0
5899627|NCT01690299|20410464|P4|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0
5899628|NCT01690299|20410465|P3|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0
5899629|NCT01690299|20410466|P2|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0
5899630|NCT01690299|20410467|P1|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0
5899631|NCT01690299|20410462|P6|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6
5899632|NCT01690299|20410463|P5|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|13
5899633|NCT01690299|20410464|P4|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6
5899634|NCT01690299|20410465|P3|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0
5899635|NCT01690299|20410466|P2|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0
5899636|NCT01690299|20410467|P1|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0
5899637|NCT01690299|20410462|P6|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|11
5899638|NCT01690299|20410463|P5|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|5
5899639|NCT01690299|20410464|P4|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|8
5899640|NCT01690299|20410465|P3|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0
5899641|NCT01690299|20410466|P2|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0
5899642|NCT01690299|20410467|P1|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0
5899643|NCT01690299|20410462|P6|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1
5899644|NCT01690299|20410463|P5|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1
5899645|NCT01690299|20410464|P4|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0
5899646|NCT01690299|20410465|P3|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0
5899647|NCT01690299|20410466|P2|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0
5899648|NCT01690299|20410467|P1|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0
5899649|NCT01690299|20410462|P6|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|8
5899650|NCT01690299|20410463|P5|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|10
5899651|NCT01690299|20410464|P4|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|9
5899652|NCT01690299|20410465|P3|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0
5899653|NCT01690299|20410466|P2|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0
5899654|NCT01690299|20410467|P1|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0
5899655|NCT01690299|20410462|P6|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3
5899656|NCT01690299|20410463|P5|Apremilast Extension Phase (Weeks16-104)|Adverse Event|4
5899657|NCT01690299|20410464|P4|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3
5899658|NCT01690299|20410465|P3|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0
5899659|NCT01690299|20410466|P2|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0
5899660|NCT01690299|20410467|P1|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0
5899661|NCT01690299|20410462|P6|Placebo-controlled Phase (Weeks 0-16)|Other|0
5899662|NCT01690299|20410463|P5|Placebo-controlled Phase (Weeks 0-16)|Other|0
5899663|NCT01690299|20410464|P4|Placebo-controlled Phase (Weeks 0-16)|Other|0
5899664|NCT01690299|20410465|P3|Placebo-controlled Phase (Weeks 0-16)|Other|1
5899665|NCT01690299|20410466|P2|Placebo-controlled Phase (Weeks 0-16)|Other|1
5899666|NCT01690299|20410467|P1|Placebo-controlled Phase (Weeks 0-16)|Other|2
5899667|NCT01690299|20410462|P6|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
5899668|NCT01690299|20410463|P5|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
5899669|NCT01690299|20410464|P4|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
5899670|NCT01690299|20410465|P3|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
5899671|NCT01690299|20410466|P2|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|3
5899672|NCT01690299|20410467|P1|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|1
5899673|NCT01690299|20410462|P6|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0
5899674|NCT01690299|20410463|P5|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0
5899675|NCT01690299|20410464|P4|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0
5899676|NCT01690299|20410465|P3|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0
5899677|NCT01690299|20410466|P2|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0
5899678|NCT01690299|20410467|P1|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|4
5899679|NCT01690299|20410462|P6|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0
5899680|NCT01690299|20410463|P5|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0
5899681|NCT01690299|20410464|P4|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0
5899682|NCT01690299|20410465|P3|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|1
5899683|NCT01690299|20410466|P2|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2
5899684|NCT01690299|20410467|P1|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2
5899685|NCT01690143|20410564|P1|Overall Study|Withdrawal by Subject|1
5899686|NCT01690130|20410574|P2|Overall Study|Subject have cancelled visit.|0
5899687|NCT01690130|20410575|P1|Overall Study|Subject have cancelled visit.|1
5899688|NCT01690052|20410622|P2|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|2
5899689|NCT01690052|20410623|P1|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|1
5899690|NCT01689974|20410640|P2|Overall Study|Termination of Study|5
5899691|NCT01689974|20410641|P1|Overall Study|Termination of Study|5
5899692|NCT01689857|20410672|P2|Overall Study|Lost to Follow-up|2
5899693|NCT01689857|20410673|P1|Overall Study|Lost to Follow-up|5
5899694|NCT01689649|20410766|P1|Overall Study|Lost to Follow-up|5
5899695|NCT01689649|20410766|P1|Overall Study|Protocol Violation|3
5899696|NCT01689649|20410766|P1|Overall Study|Non-compliance|11
5899697|NCT01689649|20410766|P1|Overall Study|Lack of Efficacy|3
5899698|NCT01689532|20410778|P2|Overall Study|Physician Decision|0
5899699|NCT01689532|20410779|P1|Overall Study|Physician Decision|2
5899700|NCT01689532|20410778|P2|Overall Study|Withdrawal by Subject|2
5899701|NCT01689532|20410779|P1|Overall Study|Withdrawal by Subject|1
5899702|NCT01689532|20410778|P2|Overall Study|Lack of Efficacy|2
5899703|NCT01689532|20410779|P1|Overall Study|Lack of Efficacy|2
5899704|NCT01689532|20410778|P2|Overall Study|Adverse Event|5
5899705|NCT01689532|20410779|P1|Overall Study|Adverse Event|9
5899706|NCT01689519|20410843|P2|Safety Population|Withdrawal by Subject|20
5899707|NCT01689519|20410844|P1|Safety Population|Withdrawal by Subject|20
5899708|NCT01689519|20410843|P2|Safety Population|Study Terminated By Sponsor|47
5899709|NCT01689519|20410844|P1|Safety Population|Study Terminated By Sponsor|60
5899710|NCT01689519|20410843|P2|Safety Population|Physician Decision|1
5899711|NCT01689519|20410844|P1|Safety Population|Physician Decision|4
5899712|NCT01689519|20410843|P2|Safety Population|Other|4
5899713|NCT01689519|20410844|P1|Safety Population|Other|2
5899714|NCT01689519|20410843|P2|Safety Population|Lost to Follow-up|8
5899715|NCT01689519|20410844|P1|Safety Population|Lost to Follow-up|4
5899716|NCT01689519|20410843|P2|Safety Population|Death|165
5899717|NCT01689519|20410844|P1|Safety Population|Death|158
5899718|NCT01689519|20410843|P2|Intent to Treat|Withdrawal by Subject|20
5899719|NCT01689519|20410844|P1|Intent to Treat|Withdrawal by Subject|21
5899720|NCT01689519|20410843|P2|Intent to Treat|Study terminated by Spon6sor|48
5899721|NCT01689519|20410844|P1|Intent to Treat|Study terminated by Spon6sor|59
5899722|NCT01689519|20410843|P2|Intent to Treat|Physician Decision|1
5899723|NCT01689519|20410844|P1|Intent to Treat|Physician Decision|4
5899724|NCT01689519|20410843|P2|Intent to Treat|Other|4
5899725|NCT01689519|20410844|P1|Intent to Treat|Other|2
5899726|NCT01689519|20410843|P2|Intent to Treat|Lost to Follow-up|8
5899727|NCT01689519|20410844|P1|Intent to Treat|Lost to Follow-up|4
5899728|NCT01689519|20410843|P2|Intent to Treat|Death|167
5899729|NCT01689519|20410844|P1|Intent to Treat|Death|157
5899730|NCT01689363|20410869|P8|Overall Study|Protocol Violation|0
5899731|NCT01689363|20410870|P7|Overall Study|Protocol Violation|0
5899732|NCT01689363|20410871|P6|Overall Study|Protocol Violation|0
5899733|NCT01689363|20410872|P5|Overall Study|Protocol Violation|0
5899734|NCT01689363|20410873|P4|Overall Study|Protocol Violation|0
5899735|NCT01689363|20410874|P3|Overall Study|Protocol Violation|0
5899736|NCT01689363|20410875|P2|Overall Study|Protocol Violation|1
5899737|NCT01689363|20410876|P1|Overall Study|Protocol Violation|0
5899738|NCT01689337|20410931|P1|Overall Study|Study Discontinuation|1
5899739|NCT01689207|20410970|P11|Overall Study|Adverse Event|0
5899740|NCT01689207|20410971|P10|Overall Study|Adverse Event|0
5899741|NCT01689207|20410972|P9|Overall Study|Adverse Event|1
5899742|NCT01689207|20410973|P8|Overall Study|Adverse Event|0
5899743|NCT01689207|20410974|P7|Overall Study|Adverse Event|0
5899744|NCT01689207|20410975|P6|Overall Study|Adverse Event|1
5899745|NCT01689207|20410976|P5|Overall Study|Adverse Event|2
5899746|NCT01689207|20410977|P4|Overall Study|Adverse Event|0
5899747|NCT01689207|20410978|P3|Overall Study|Adverse Event|0
5899748|NCT01689207|20410979|P2|Overall Study|Adverse Event|1
5899749|NCT01689207|20410980|P1|Overall Study|Adverse Event|0
5899750|NCT01688999|20411088|P3|Overall Study|Ineligible/Not treated|0
5899751|NCT01688999|20411089|P2|Overall Study|Ineligible/Not treated|0
5899752|NCT01688999|20411090|P1|Overall Study|Ineligible/Not treated|1
5899753|NCT01688999|20411088|P3|Overall Study|Adverse Event|2
5899754|NCT01688999|20411089|P2|Overall Study|Adverse Event|0
5899755|NCT01688999|20411090|P1|Overall Study|Adverse Event|2
5899756|NCT01688999|20411088|P3|Overall Study|Withdrawal by Subject|1
5899757|NCT01688999|20411089|P2|Overall Study|Withdrawal by Subject|1
5899758|NCT01688999|20411090|P1|Overall Study|Withdrawal by Subject|5
5899759|NCT01688973|20411106|P2|Overall Study|Ineligible|3
5899760|NCT01688973|20411107|P1|Overall Study|Ineligible|2
5899761|NCT01688921|20411121|P2|Overall Study|informed consent|0
5899762|NCT01688921|20411122|P1|Overall Study|informed consent|3
5899763|NCT01688921|20411121|P2|Overall Study|Protocol Violation|1
5899764|NCT01688921|20411122|P1|Overall Study|Protocol Violation|0
5899765|NCT01688921|20411121|P2|Overall Study|Physician Decision|1
5899766|NCT01688921|20411122|P1|Overall Study|Physician Decision|6
5899767|NCT01688921|20411121|P2|Overall Study|Lost to Follow-up|13
5899768|NCT01688921|20411122|P1|Overall Study|Lost to Follow-up|7
5899769|NCT01688882|20411154|P2|Overall Study|Administrative problems|0
5899770|NCT01688882|20411155|P1|Overall Study|Administrative problems|1
5899771|NCT01688882|20411154|P2|Overall Study|Unsatisfactory therapeutic effect|1
5899772|NCT01688882|20411155|P1|Overall Study|Unsatisfactory therapeutic effect|1
5899773|NCT01688882|20411154|P2|Overall Study|Adverse Event|0
5899774|NCT01688882|20411155|P1|Overall Study|Adverse Event|1
5899775|NCT01688830|20411226|P21|Overall Study|Lost to Follow-up|0
5899776|NCT01688830|20411227|P20|Overall Study|Lost to Follow-up|0
5899777|NCT01688830|20411228|P19|Overall Study|Lost to Follow-up|0
5899778|NCT01688830|20411229|P18|Overall Study|Lost to Follow-up|0
5899779|NCT01688830|20411230|P17|Overall Study|Lost to Follow-up|0
5899780|NCT01688830|20411231|P16|Overall Study|Lost to Follow-up|0
5899781|NCT01688830|20411232|P15|Overall Study|Lost to Follow-up|0
5899782|NCT01688830|20411233|P14|Overall Study|Lost to Follow-up|0
5899783|NCT01688830|20411234|P13|Overall Study|Lost to Follow-up|0
5899784|NCT01688830|20411235|P12|Overall Study|Lost to Follow-up|0
5899785|NCT01688830|20411236|P11|Overall Study|Lost to Follow-up|1
5899786|NCT01688830|20411237|P10|Overall Study|Lost to Follow-up|0
5899787|NCT01688830|20411238|P9|Overall Study|Lost to Follow-up|0
5899788|NCT01688830|20411239|P8|Overall Study|Lost to Follow-up|0
5899789|NCT01688830|20411240|P7|Overall Study|Lost to Follow-up|0
5899790|NCT01688830|20411241|P6|Overall Study|Lost to Follow-up|0
5899791|NCT01688830|20411242|P5|Overall Study|Lost to Follow-up|0
5899792|NCT01688830|20411243|P4|Overall Study|Lost to Follow-up|0
5899793|NCT01688830|20411244|P3|Overall Study|Lost to Follow-up|0
5899794|NCT01688830|20411245|P2|Overall Study|Lost to Follow-up|0
5899795|NCT01688830|20411246|P1|Overall Study|Lost to Follow-up|0
5899796|NCT01688739|20411400|P10|Overall Study|Administrative Decision|0
5899797|NCT01688739|20411401|P9|Overall Study|Administrative Decision|0
5899798|NCT01688739|20411402|P8|Overall Study|Administrative Decision|0
5899799|NCT01688739|20411403|P7|Overall Study|Administrative Decision|0
5899800|NCT01688739|20411404|P6|Overall Study|Administrative Decision|0
5899801|NCT01688739|20411405|P5|Overall Study|Administrative Decision|0
5899802|NCT01688739|20411406|P4|Overall Study|Administrative Decision|0
5899803|NCT01688739|20411407|P3|Overall Study|Administrative Decision|0
5899804|NCT01688739|20411408|P2|Overall Study|Administrative Decision|0
5899805|NCT01688739|20411409|P1|Overall Study|Administrative Decision|1
5899806|NCT01688726|20411485|P2|Overall Study|Relocated abroad|1
5899807|NCT01688726|20411486|P1|Overall Study|Relocated abroad|0
5899808|NCT01688726|20411485|P2|Overall Study|Adverse Event|0
5899809|NCT01688726|20411486|P1|Overall Study|Adverse Event|1
5899810|NCT01688635|20411498|P2|Washout 3|Withdrawal by Subject|0
5899811|NCT01688635|20411499|P1|Washout 3|Withdrawal by Subject|1
5899812|NCT01688635|20411498|P2|Washout 2|Sponsor Decision|2
5899813|NCT01688635|20411499|P1|Washout 2|Sponsor Decision|1
5899814|NCT01688635|20411498|P2|Washout 2|Withdrawal by Subject|0
5899815|NCT01688635|20411499|P1|Washout 2|Withdrawal by Subject|1
5899816|NCT01688635|20411498|P2|Washout 2|Physician Decision|0
5899817|NCT01688635|20411499|P1|Washout 2|Physician Decision|1
5899818|NCT01688635|20411498|P2|Washout 1|Physician Decision|1
5899819|NCT01688635|20411499|P1|Washout 1|Physician Decision|0
5899820|NCT01688635|20411498|P2|Washout 1|Adverse Event|1
5899821|NCT01688635|20411499|P1|Washout 1|Adverse Event|0
5899822|NCT01688635|20411498|P2|Washout 1|Withdrawal by Subject|0
5899823|NCT01688635|20411499|P1|Washout 1|Withdrawal by Subject|1
5899824|NCT01688466|20411546|P2|Overall Study|Not evaluable|1
5899825|NCT01688466|20411547|P1|Overall Study|Not evaluable|0
5899826|NCT01688466|20411546|P2|Overall Study|Adverse Event|4
5899827|NCT01688466|20411547|P1|Overall Study|Adverse Event|0
5899828|NCT01688466|20411546|P2|Overall Study|Death|1
5899829|NCT01688466|20411547|P1|Overall Study|Death|0
5899830|NCT01688466|20411546|P2|Overall Study|Withdrawal by Subject|1
5899831|NCT01688466|20411547|P1|Overall Study|Withdrawal by Subject|2
5899832|NCT01688050|20411638|P1|Overall Study|Withdrawal by Subject|10
5899833|NCT01688050|20411638|P1|Overall Study|Lost to Follow-up|13
5899834|NCT01688050|20411638|P1|Overall Study|Conversion to open repair|1
5899835|NCT01688050|20411638|P1|Overall Study|Death|7
5899836|NCT01688037|20411647|P3|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0
5899837|NCT01688037|20411648|P2|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|1
5899838|NCT01688037|20411649|P1|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0
5899839|NCT01688037|20411647|P3|Open-Label Period (Week 6 to 12)|Lost to Follow-up|1
5899840|NCT01688037|20411648|P2|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0
5899841|NCT01688037|20411649|P1|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0
5899842|NCT01688037|20411647|P3|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|0
5899843|NCT01688037|20411648|P2|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|2
5899844|NCT01688037|20411649|P1|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|1
5899845|NCT01688037|20411647|P3|Open-Label Period (Week 6 to 12)|Non-compliance|2
5899846|NCT01688037|20411648|P2|Open-Label Period (Week 6 to 12)|Non-compliance|0
5899847|NCT01688037|20411649|P1|Open-Label Period (Week 6 to 12)|Non-compliance|0
5899848|NCT01688037|20411647|P3|Open-Label Period (Week 6 to 12)|Adverse Event|1
5899849|NCT01688037|20411648|P2|Open-Label Period (Week 6 to 12)|Adverse Event|1
5899850|NCT01688037|20411649|P1|Open-Label Period (Week 6 to 12)|Adverse Event|4
5899851|NCT01688037|20411647|P3|Double-Blind Period (Week 0 to 6)|Physician Decision|0
5899852|NCT01688037|20411648|P2|Double-Blind Period (Week 0 to 6)|Physician Decision|1
5899853|NCT01688037|20411649|P1|Double-Blind Period (Week 0 to 6)|Physician Decision|0
5899854|NCT01688037|20411647|P3|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1
5899855|NCT01688037|20411648|P2|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0
5899856|NCT01688037|20411649|P1|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1
5899857|NCT01688037|20411647|P3|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1
5899858|NCT01688037|20411648|P2|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|0
5899859|NCT01688037|20411649|P1|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|4
5899860|NCT01688037|20411647|P3|Double-Blind Period (Week 0 to 6)|Non-compliance|3
5899861|NCT01688037|20411648|P2|Double-Blind Period (Week 0 to 6)|Non-compliance|2
5899862|NCT01688037|20411649|P1|Double-Blind Period (Week 0 to 6)|Non-compliance|1
5899863|NCT01688037|20411647|P3|Double-Blind Period (Week 0 to 6)|Adverse Event|1
5899864|NCT01688037|20411648|P2|Double-Blind Period (Week 0 to 6)|Adverse Event|0
5899865|NCT01688037|20411649|P1|Double-Blind Period (Week 0 to 6)|Adverse Event|1
5899866|NCT01687998|20411665|P2|Overall Study|Lost to Follow-up|7
5899867|NCT01687998|20411666|P1|Overall Study|Lost to Follow-up|9
5899868|NCT01687998|20411665|P2|Overall Study|Known to be Alive at Study End|62
5899869|NCT01687998|20411666|P1|Overall Study|Known to be Alive at Study End|54
5899870|NCT01687998|20411665|P2|Overall Study|Withdrawal by Subject|51
5899871|NCT01687998|20411666|P1|Overall Study|Withdrawal by Subject|49
5899872|NCT01687712|20411702|P2|Cycle 3|Miscarriage/Spontaneous Abortion|0
5899873|NCT01687712|20411703|P1|Cycle 3|Miscarriage/Spontaneous Abortion|1
5899874|NCT01687712|20411702|P2|Cycle 3|Ectopic Pregnancy|0
5899875|NCT01687712|20411703|P1|Cycle 3|Ectopic Pregnancy|1
5899876|NCT01687712|20411702|P2|Cycle 3|Early Pregnancy Loss|2
5899877|NCT01687712|20411703|P1|Cycle 3|Early Pregnancy Loss|1
5899878|NCT01687712|20411702|P2|Cycle 3|Not Biochemically Pregnant|22
5899879|NCT01687712|20411703|P1|Cycle 3|Not Biochemically Pregnant|21
5899880|NCT01687712|20411702|P2|Cycle 2|Miscarriage/Spontaneous Abortion|1
5899881|NCT01687712|20411703|P1|Cycle 2|Miscarriage/Spontaneous Abortion|0
5899882|NCT01687712|20411702|P2|Cycle 2|Still Birth|0
5899883|NCT01687712|20411703|P1|Cycle 2|Still Birth|1
5899884|NCT01687712|20411702|P2|Cycle 2|Ectopic Pregnancy|1
5899885|NCT01687712|20411703|P1|Cycle 2|Ectopic Pregnancy|0
5899886|NCT01687712|20411702|P2|Cycle 2|Early Pregnancy Loss|16
5899887|NCT01687712|20411703|P1|Cycle 2|Early Pregnancy Loss|18
5899888|NCT01687712|20411702|P2|Cycle 2|Not Biochemically Pregnant|77
5899889|NCT01687712|20411703|P1|Cycle 2|Not Biochemically Pregnant|74
5899890|NCT01687712|20411702|P2|Cycle 1|Lost to Follow-up|1
5899891|NCT01687712|20411703|P1|Cycle 1|Lost to Follow-up|1
5899892|NCT01687712|20411702|P2|Cycle 1|Intrauterine Fetal Death|1
5899893|NCT01687712|20411703|P1|Cycle 1|Intrauterine Fetal Death|0
5899894|NCT01687712|20411702|P2|Cycle 1|Abortion|0
5899895|NCT01687712|20411703|P1|Cycle 1|Abortion|3
5899896|NCT01687712|20411702|P2|Cycle 1|Miscarriage/Spontaneous Abortion|14
5899897|NCT01687712|20411703|P1|Cycle 1|Miscarriage/Spontaneous Abortion|9
5899898|NCT01687712|20411702|P2|Cycle 1|Heterotropic Pregnancy|0
5899899|NCT01687712|20411703|P1|Cycle 1|Heterotropic Pregnancy|1
5899900|NCT01687712|20411702|P2|Cycle 1|Ectopic Pregnancy|5
5899901|NCT01687712|20411703|P1|Cycle 1|Ectopic Pregnancy|5
5899902|NCT01687712|20411702|P2|Cycle 1|Early Pregnancy Loss|60
5899903|NCT01687712|20411703|P1|Cycle 1|Early Pregnancy Loss|43
5899904|NCT01687712|20411702|P2|Cycle 1|Not Biochemically Pregnant|348
5899905|NCT01687712|20411703|P1|Cycle 1|Not Biochemically Pregnant|386
5899906|NCT01687673|20411741|P1|Overall Study|Physician Decision|1
5899907|NCT01687478|20411755|P2|Overall Study|Entry Criteria Not Met|2
5899908|NCT01687478|20411756|P1|Overall Study|Entry Criteria Not Met|6
5899909|NCT01687478|20411755|P2|Overall Study|Physician Decision|3
5899910|NCT01687478|20411756|P1|Overall Study|Physician Decision|1
5899911|NCT01687478|20411755|P2|Overall Study|Withdrawal by Subject|19
5899912|NCT01687478|20411756|P1|Overall Study|Withdrawal by Subject|21
5899913|NCT01687478|20411755|P2|Overall Study|Protocol Violation|2
5899914|NCT01687478|20411756|P1|Overall Study|Protocol Violation|0
5899915|NCT01687478|20411755|P2|Overall Study|Lost to Follow-up|3
5899916|NCT01687478|20411756|P1|Overall Study|Lost to Follow-up|1
5899917|NCT01687478|20411755|P2|Overall Study|Adverse Event|10
5899918|NCT01687478|20411756|P1|Overall Study|Adverse Event|3
5899919|NCT01687413|20411780|P2|Overall Study|Patient withdrew before completing all radiotherapy|0
5899920|NCT01687413|20411781|P1|Overall Study|Patient withdrew before completing all radiotherapy|1
5899921|NCT01687413|20411780|P2|Overall Study|Not eligible|2
5899922|NCT01687413|20411781|P1|Overall Study|Not eligible|0
5899923|NCT01687413|20411780|P2|Overall Study|Withdrawal by Subject|2
5899924|NCT01687413|20411781|P1|Overall Study|Withdrawal by Subject|0
5899925|NCT01687296|20411886|P2|Overall Study|Withdrawal by Subject|3
5899926|NCT01687296|20411887|P1|Overall Study|Withdrawal by Subject|6
5899927|NCT01687296|20411886|P2|Overall Study|Protocol Violation|1
5899928|NCT01687296|20411887|P1|Overall Study|Protocol Violation|0
5899929|NCT01687296|20411886|P2|Overall Study|Lack of Efficacy|1
5899930|NCT01687296|20411887|P1|Overall Study|Lack of Efficacy|1
5899931|NCT01687283|20411909|P2|Overall Study|Withdrawal by Subject|8
5899932|NCT01687283|20411910|P1|Overall Study|Withdrawal by Subject|9
5899933|NCT01687283|20411909|P2|Overall Study|Investigator discretion|0
5899934|NCT01687283|20411910|P1|Overall Study|Investigator discretion|2
5899935|NCT01687283|20411909|P2|Overall Study|Lost to Follow-up|1
5899936|NCT01687283|20411910|P1|Overall Study|Lost to Follow-up|1
5899937|NCT01687283|20411909|P2|Overall Study|protocol defined stopping criteria|10
5899938|NCT01687283|20411910|P1|Overall Study|protocol defined stopping criteria|8
5899939|NCT01687283|20411909|P2|Overall Study|Protocol Violation|3
5899940|NCT01687283|20411910|P1|Overall Study|Protocol Violation|1
5899941|NCT01687283|20411909|P2|Overall Study|Lack of Efficacy|1
5899942|NCT01687283|20411910|P1|Overall Study|Lack of Efficacy|3
5899943|NCT01687283|20411909|P2|Overall Study|Adverse Event|4
5899944|NCT01687283|20411910|P1|Overall Study|Adverse Event|11
5899945|NCT01687270|20411933|P1|Overall Study|Lost to Follow-up|1
5899946|NCT01687270|20411933|P1|Overall Study|Lack of Efficacy|11
5899947|NCT01687257|20411944|P3|Overall Study|Investigator's Discretion|0
5899948|NCT01687257|20411945|P2|Overall Study|Investigator's Discretion|3
5899949|NCT01687257|20411946|P1|Overall Study|Investigator's Discretion|0
5899950|NCT01687257|20411944|P3|Overall Study|Adverse Event|0
5899951|NCT01687257|20411945|P2|Overall Study|Adverse Event|0
5899952|NCT01687257|20411946|P1|Overall Study|Adverse Event|1
5899953|NCT01687257|20411944|P3|Overall Study|Subject Withdrew Consent|1
5899954|NCT01687257|20411945|P2|Overall Study|Subject Withdrew Consent|1
5899955|NCT01687257|20411946|P1|Overall Study|Subject Withdrew Consent|1
5899956|NCT01687257|20411944|P3|Overall Study|Efficacy Failure|5
5899957|NCT01687257|20411945|P2|Overall Study|Efficacy Failure|0
5899958|NCT01687257|20411946|P1|Overall Study|Efficacy Failure|6
5899959|NCT01687218|20412011|P6|Overall Study|Relocated, no follow-up planned|0
5899960|NCT01687218|20412012|P5|Overall Study|Relocated, no follow-up planned|0
5899961|NCT01687218|20412013|P4|Overall Study|Relocated, no follow-up planned|1
5899962|NCT01687218|20412014|P3|Overall Study|Relocated, no follow-up planned|1
5899963|NCT01687218|20412015|P2|Overall Study|Relocated, no follow-up planned|0
5899964|NCT01687218|20412016|P1|Overall Study|Relocated, no follow-up planned|1
5899965|NCT01687218|20412011|P6|Overall Study|Withdrawal by Subject|0
5899966|NCT01687218|20412012|P5|Overall Study|Withdrawal by Subject|1
5899967|NCT01687218|20412013|P4|Overall Study|Withdrawal by Subject|1
5899968|NCT01687218|20412014|P3|Overall Study|Withdrawal by Subject|0
5899969|NCT01687218|20412015|P2|Overall Study|Withdrawal by Subject|3
5899970|NCT01687218|20412016|P1|Overall Study|Withdrawal by Subject|2
5899971|NCT01687166|20412068|P4|Overall Study|Insurance|1
5899972|NCT01687166|20412069|P3|Overall Study|Insurance|1
5899973|NCT01687166|20412070|P2|Overall Study|Insurance|0
5899974|NCT01687166|20412071|P1|Overall Study|Insurance|0
5899975|NCT01687166|20412068|P4|Overall Study|Physician choice to use different device|0
5899976|NCT01687166|20412069|P3|Overall Study|Physician choice to use different device|4
5899977|NCT01687166|20412070|P2|Overall Study|Physician choice to use different device|2
5899978|NCT01687166|20412071|P1|Overall Study|Physician choice to use different device|1
5899979|NCT01687166|20412068|P4|Overall Study|Patient unable to be compliant|0
5899980|NCT01687166|20412069|P3|Overall Study|Patient unable to be compliant|0
5899981|NCT01687166|20412070|P2|Overall Study|Patient unable to be compliant|0
5899982|NCT01687166|20412071|P1|Overall Study|Patient unable to be compliant|1
5899983|NCT01687166|20412068|P4|Overall Study|Subject moved out of state|0
5899984|NCT01687166|20412069|P3|Overall Study|Subject moved out of state|0
5899985|NCT01687166|20412070|P2|Overall Study|Subject moved out of state|1
5899986|NCT01687166|20412071|P1|Overall Study|Subject moved out of state|0
5899987|NCT01687166|20412068|P4|Overall Study|Protocol Violation|0
5899988|NCT01687166|20412069|P3|Overall Study|Protocol Violation|1
5899989|NCT01687166|20412070|P2|Overall Study|Protocol Violation|1
5899990|NCT01687166|20412071|P1|Overall Study|Protocol Violation|1
5899991|NCT01687166|20412068|P4|Overall Study|Death|0
5899992|NCT01687166|20412069|P3|Overall Study|Death|0
5899993|NCT01687166|20412070|P2|Overall Study|Death|1
5899994|NCT01687166|20412071|P1|Overall Study|Death|1
5899995|NCT01687166|20412068|P4|Overall Study|Equipment/Device Availability|0
5899996|NCT01687166|20412069|P3|Overall Study|Equipment/Device Availability|0
5899997|NCT01687166|20412070|P2|Overall Study|Equipment/Device Availability|1
5899998|NCT01687166|20412071|P1|Overall Study|Equipment/Device Availability|0
5899999|NCT01687166|20412068|P4|Overall Study|Lost to Follow-up|0
5900000|NCT01687166|20412069|P3|Overall Study|Lost to Follow-up|1
5900001|NCT01687166|20412070|P2|Overall Study|Lost to Follow-up|5
5900002|NCT01687166|20412071|P1|Overall Study|Lost to Follow-up|2
5900003|NCT01687166|20412068|P4|Overall Study|Withdrawal by Subject|0
5900004|NCT01687166|20412069|P3|Overall Study|Withdrawal by Subject|3
5900005|NCT01687166|20412070|P2|Overall Study|Withdrawal by Subject|4
5900006|NCT01687166|20412071|P1|Overall Study|Withdrawal by Subject|11
5900007|NCT01687166|20412068|P4|Overall Study|Physician Decision|0
5900008|NCT01687166|20412069|P3|Overall Study|Physician Decision|1
5900009|NCT01687166|20412070|P2|Overall Study|Physician Decision|2
5900010|NCT01687166|20412071|P1|Overall Study|Physician Decision|3
5900011|NCT01687166|20412068|P4|Overall Study|Adverse Event|0
5900012|NCT01687166|20412069|P3|Overall Study|Adverse Event|0
5900013|NCT01687166|20412070|P2|Overall Study|Adverse Event|1
5900014|NCT01687166|20412071|P1|Overall Study|Adverse Event|2
5900015|NCT01687166|20412068|P4|Overall Study|Did not meet eligibility criteria|1
5900016|NCT01687166|20412069|P3|Overall Study|Did not meet eligibility criteria|1
5900017|NCT01687166|20412070|P2|Overall Study|Did not meet eligibility criteria|6
5900018|NCT01687166|20412071|P1|Overall Study|Did not meet eligibility criteria|4
5900019|NCT01687166|20412068|P4|Overall Study|Attempt subject|0
5900020|NCT01687166|20412069|P3|Overall Study|Attempt subject|2
5900021|NCT01687166|20412070|P2|Overall Study|Attempt subject|3
5900022|NCT01687166|20412071|P1|Overall Study|Attempt subject|2
5900023|NCT01687101|20412087|P1|Overall Study|Lost to Follow-up|7
5900024|NCT01686958|20412112|P1|Overall Study|Withdrawal by Subject|1
5900025|NCT01686932|20412125|P2|Period 1|Adverse Event|1
5900026|NCT01686932|20412126|P1|Period 1|Adverse Event|1
5900027|NCT01686828|20412156|P4|Overall Study|Weight Loss|0
5900028|NCT01686828|20412157|P3|Overall Study|Weight Loss|1
5900029|NCT01686828|20412158|P2|Overall Study|Weight Loss|0
5900030|NCT01686828|20412159|P1|Overall Study|Weight Loss|0
5900031|NCT01686828|20412156|P4|Overall Study|New Job|0
5900032|NCT01686828|20412157|P3|Overall Study|New Job|0
5900033|NCT01686828|20412158|P2|Overall Study|New Job|1
5900034|NCT01686828|20412159|P1|Overall Study|New Job|0
5900035|NCT01686828|20412156|P4|Overall Study|Physician Decision|0
5900036|NCT01686828|20412157|P3|Overall Study|Physician Decision|0
5900037|NCT01686828|20412158|P2|Overall Study|Physician Decision|0
5900038|NCT01686828|20412159|P1|Overall Study|Physician Decision|1
5900039|NCT01686633|20412272|P3|Overall Study|Lost to Follow-up|1
5900040|NCT01686633|20412273|P2|Overall Study|Lost to Follow-up|1
5900041|NCT01686633|20412274|P1|Overall Study|Lost to Follow-up|0
5900042|NCT01686633|20412272|P3|Overall Study|Protocol-defined Stopping Criteria|1
5900043|NCT01686633|20412273|P2|Overall Study|Protocol-defined Stopping Criteria|0
5900044|NCT01686633|20412274|P1|Overall Study|Protocol-defined Stopping Criteria|1
5900045|NCT01686633|20412272|P3|Overall Study|Protocol Violation|0
5900046|NCT01686633|20412273|P2|Overall Study|Protocol Violation|3
5900047|NCT01686633|20412274|P1|Overall Study|Protocol Violation|2
5900048|NCT01686633|20412272|P3|Overall Study|Adverse Event|3
5900049|NCT01686633|20412273|P2|Overall Study|Adverse Event|3
5900050|NCT01686633|20412274|P1|Overall Study|Adverse Event|4
5900051|NCT01686633|20412272|P3|Overall Study|Physician Decision|4
5900052|NCT01686633|20412273|P2|Overall Study|Physician Decision|4
5900053|NCT01686633|20412274|P1|Overall Study|Physician Decision|3
5900054|NCT01686633|20412272|P3|Overall Study|Withdrawal by Subject|5
5900055|NCT01686633|20412273|P2|Overall Study|Withdrawal by Subject|8
5900056|NCT01686633|20412274|P1|Overall Study|Withdrawal by Subject|8
5900057|NCT01686633|20412272|P3|Overall Study|Lack of Efficacy|11
5900058|NCT01686633|20412273|P2|Overall Study|Lack of Efficacy|13
5900059|NCT01686633|20412274|P1|Overall Study|Lack of Efficacy|33
5900060|NCT01686581|20412297|P1|Overall Study|Reason Missing|1
5900061|NCT01686581|20412297|P1|Overall Study|Other Miscellaneous Reasons|36
5900062|NCT01686581|20412297|P1|Overall Study|Thinks it is Inconvenient|17
5900063|NCT01686581|20412297|P1|Overall Study|Trying to get Pregnant or Nursing|2
5900064|NCT01686581|20412297|P1|Overall Study|Thinks Injections Take Too Much Time|2
5900065|NCT01686581|20412297|P1|Overall Study|Thinks Injections Too Painful|8
5900066|NCT01686581|20412297|P1|Overall Study|Participant Concerned about Risks|6
5900067|NCT01686581|20412297|P1|Overall Study|Lack of Efficacy|90
5900068|NCT01686581|20412297|P1|Overall Study|Side-effects or Health Problems|15
5900069|NCT01686568|20412310|P2|Sub-Study|Not consented for sub-study|2
5900070|NCT01686568|20412311|P1|Sub-Study|Not consented for sub-study|2
5900071|NCT01686568|20412310|P2|Main Study|Liver enzymes above range of exclusion|0
5900072|NCT01686568|20412311|P1|Main Study|Liver enzymes above range of exclusion|1
5900073|NCT01686568|20412310|P2|Main Study|Noncompliance with protocol|1
5900074|NCT01686568|20412311|P1|Main Study|Noncompliance with protocol|0
5900075|NCT01686568|20412310|P2|Main Study|Withdrawal by Subject|3
5900076|NCT01686568|20412311|P1|Main Study|Withdrawal by Subject|1
5900077|NCT01686438|20412388|P3|Overall Study|Withdrawal by Subject|1
5900078|NCT01686438|20412389|P2|Overall Study|Withdrawal by Subject|0
5900079|NCT01686438|20412390|P1|Overall Study|Withdrawal by Subject|0
5900080|NCT01686438|20412388|P3|Overall Study|Protocol Violation|1
5900081|NCT01686438|20412389|P2|Overall Study|Protocol Violation|0
5900082|NCT01686438|20412390|P1|Overall Study|Protocol Violation|0
5900083|NCT01686438|20412388|P3|Overall Study|Adverse Event|1
5900084|NCT01686438|20412389|P2|Overall Study|Adverse Event|0
5900085|NCT01686438|20412390|P1|Overall Study|Adverse Event|0
5900086|NCT01686438|20412388|P3|Overall Study|Lost to Follow-up|10
5900087|NCT01686438|20412389|P2|Overall Study|Lost to Follow-up|9
5900088|NCT01686438|20412390|P1|Overall Study|Lost to Follow-up|8
5900089|NCT01686373|20412438|P2|Overall Study|Adverse Event|1
5900090|NCT01686373|20412439|P1|Overall Study|Adverse Event|0
5900091|NCT01686373|20412438|P2|Overall Study|Withdrawal by Subject|1
5900092|NCT01686373|20412439|P1|Overall Study|Withdrawal by Subject|0
5900093|NCT01686373|20412438|P2|Overall Study|Lost to Follow-up|0
5900094|NCT01686373|20412439|P1|Overall Study|Lost to Follow-up|3
5900095|NCT01686152|20412455|P3|Overall Study|Lost to Follow-up|5
5900096|NCT01686152|20412456|P2|Overall Study|Lost to Follow-up|6
5900097|NCT01686152|20412457|P1|Overall Study|Lost to Follow-up|7
5900098|NCT01686152|20412455|P3|Overall Study|IP Non-compliance|0
5900099|NCT01686152|20412456|P2|Overall Study|IP Non-compliance|5
5900100|NCT01686152|20412457|P1|Overall Study|IP Non-compliance|5
5900101|NCT01686152|20412455|P3|Overall Study|Lack of Efficacy|1
5900102|NCT01686152|20412456|P2|Overall Study|Lack of Efficacy|0
5900103|NCT01686152|20412457|P1|Overall Study|Lack of Efficacy|0
5900104|NCT01686152|20412455|P3|Overall Study|Adverse Event|0
5900105|NCT01686152|20412456|P2|Overall Study|Adverse Event|11
5900106|NCT01686152|20412457|P1|Overall Study|Adverse Event|12
5900107|NCT01686152|20412455|P3|Overall Study|Protocol Violation|0
5900108|NCT01686152|20412456|P2|Overall Study|Protocol Violation|1
5900109|NCT01686152|20412457|P1|Overall Study|Protocol Violation|6
5900110|NCT01686152|20412455|P3|Overall Study|Drug Code Unblinded|0
5900111|NCT01686152|20412456|P2|Overall Study|Drug Code Unblinded|1
5900112|NCT01686152|20412457|P1|Overall Study|Drug Code Unblinded|0
5900113|NCT01686152|20412455|P3|Overall Study|Withdrawal by Subject|3
5900114|NCT01686152|20412456|P2|Overall Study|Withdrawal by Subject|11
5900115|NCT01686152|20412457|P1|Overall Study|Withdrawal by Subject|11
5900116|NCT01685983|20412476|P1|Overall Study|Noncompliance with Study Drug|1
5900117|NCT01685983|20412476|P1|Overall Study|Progressive Disease|32
5900118|NCT01685983|20412476|P1|Overall Study|Other|7
5900119|NCT01685983|20412476|P1|Overall Study|Physician Decision|13
5900120|NCT01685983|20412476|P1|Overall Study|Protocol Violation|2
5900121|NCT01685983|20412476|P1|Overall Study|Withdrawal by Subject|19
5900122|NCT01685983|20412476|P1|Overall Study|Death|1
5900123|NCT01685983|20412476|P1|Overall Study|Adverse Event|7
5900124|NCT01685840|20412488|P2|Overall Study|Had VAD, Dialysis or Transplant|17
5900125|NCT01685840|20412489|P1|Overall Study|Had VAD, Dialysis or Transplant|11
5900126|NCT01685840|20412488|P2|Overall Study|Futility|200
5900127|NCT01685840|20412489|P1|Overall Study|Futility|197
5900128|NCT01685840|20412488|P2|Overall Study|Withdrawal by Subject|17
5900129|NCT01685840|20412489|P1|Overall Study|Withdrawal by Subject|14
5900130|NCT01685840|20412488|P2|Overall Study|Physician Decision|7
5900131|NCT01685840|20412489|P1|Overall Study|Physician Decision|3
5900132|NCT01685840|20412488|P2|Overall Study|Lost to Follow-up|25
5900133|NCT01685840|20412489|P1|Overall Study|Lost to Follow-up|27
5900134|NCT01685840|20412488|P2|Overall Study|Death|66
5900135|NCT01685840|20412489|P1|Overall Study|Death|77
5900136|NCT01685801|20412533|P4|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1
5900137|NCT01685801|20412534|P3|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0
5900138|NCT01685801|20412535|P2|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1
5900139|NCT01685801|20412536|P1|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0
5900140|NCT01685801|20412533|P4|Cycle 1 Period 2 (2 Weeks)|Adverse Event|1
5900141|NCT01685801|20412534|P3|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0
5900142|NCT01685801|20412535|P2|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0
5900143|NCT01685801|20412536|P1|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0
5900144|NCT01685697|20412558|P2|Overall Study|Protocol Violation|3
5900145|NCT01685697|20412559|P1|Overall Study|Protocol Violation|3
5900146|NCT01685606|20412593|P1|Overall Study|Withdrawal by Subject|1
5900147|NCT01685437|20412621|P1|Overall Study|Unable to make visits due to work|1
5900148|NCT01685437|20412621|P1|Overall Study|Protocol Violation|4
5900149|NCT01685437|20412621|P1|Overall Study|Adverse Event|1
5900150|NCT01685437|20412621|P1|Overall Study|Lost to Follow-up|3
5900151|NCT01685437|20412621|P1|Overall Study|Withdrawal by Subject|22
5900152|NCT01685372|20412635|P2|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|4
5900153|NCT01685372|20412636|P1|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|3
5900154|NCT01685229|20412726|P2|Overall Study|Death|0
5900155|NCT01685229|20412727|P1|Overall Study|Death|1
5900156|NCT01685229|20412726|P2|Overall Study|Withdrawal by Subject|5
5900157|NCT01685229|20412727|P1|Overall Study|Withdrawal by Subject|6
5900158|NCT01685229|20412726|P2|Overall Study|Lost to Follow-up|10
5900159|NCT01685229|20412727|P1|Overall Study|Lost to Follow-up|16
5900160|NCT01685229|20412726|P2|Overall Study|Subjects missing Study Exit form|1
5900161|NCT01685229|20412727|P1|Overall Study|Subjects missing Study Exit form|3
5900162|NCT01685216|20412753|P1|Overall Study|Did not receive study drug|1
5900163|NCT01685203|20412770|P7|Overall Study|Patient's decision|0
5900164|NCT01685203|20412771|P6|Overall Study|Patient's decision|1
5900165|NCT01685203|20412772|P5|Overall Study|Patient's decision|0
5900166|NCT01685203|20412773|P4|Overall Study|Patient's decision|0
5900167|NCT01685203|20412774|P3|Overall Study|Patient's decision|0
5900168|NCT01685203|20412775|P2|Overall Study|Patient's decision|0
5900169|NCT01685203|20412776|P1|Overall Study|Patient's decision|0
5900170|NCT01685203|20412770|P7|Overall Study|Adverse event and withdrew consent|0
5900171|NCT01685203|20412771|P6|Overall Study|Adverse event and withdrew consent|0
5900172|NCT01685203|20412772|P5|Overall Study|Adverse event and withdrew consent|0
5900173|NCT01685203|20412773|P4|Overall Study|Adverse event and withdrew consent|0
5900259|NCT01684878|20412957|P2|Part 1: Safety Run in Phase|Death|20
5900174|NCT01685203|20412774|P3|Overall Study|Adverse event and withdrew consent|0
5900175|NCT01685203|20412775|P2|Overall Study|Adverse event and withdrew consent|0
5900176|NCT01685203|20412776|P1|Overall Study|Adverse event and withdrew consent|1
5900177|NCT01685203|20412770|P7|Overall Study|Adverse Event|0
5900178|NCT01685203|20412771|P6|Overall Study|Adverse Event|2
5900179|NCT01685203|20412772|P5|Overall Study|Adverse Event|0
5900180|NCT01685203|20412773|P4|Overall Study|Adverse Event|0
5900181|NCT01685203|20412774|P3|Overall Study|Adverse Event|0
5900182|NCT01685203|20412775|P2|Overall Study|Adverse Event|0
5900183|NCT01685203|20412776|P1|Overall Study|Adverse Event|0
5900184|NCT01685203|20412770|P7|Overall Study|Lost to Follow-up|0
5900185|NCT01685203|20412771|P6|Overall Study|Lost to Follow-up|0
5900186|NCT01685203|20412772|P5|Overall Study|Lost to Follow-up|0
5900187|NCT01685203|20412773|P4|Overall Study|Lost to Follow-up|1
5900188|NCT01685203|20412774|P3|Overall Study|Lost to Follow-up|0
5900189|NCT01685203|20412775|P2|Overall Study|Lost to Follow-up|3
5900190|NCT01685203|20412776|P1|Overall Study|Lost to Follow-up|3
5900191|NCT01685138|20412820|P1|Overall Study|Progressive disease|53
5900192|NCT01685138|20412820|P1|Overall Study|Adverse Event|18
5900193|NCT01685138|20412820|P1|Overall Study|Death|10
5900194|NCT01685138|20412820|P1|Overall Study|Physician Decision|6
5900195|NCT01685138|20412820|P1|Overall Study|Subject/guardian decision|2
5900196|NCT01685138|20412820|P1|Overall Study|No longer requires treatment|1
5900197|NCT01685138|20412820|P1|Overall Study|Protocol Violation|1
5900198|NCT01685138|20412820|P1|Overall Study|Lost to Follow-up|1
5900199|NCT01685073|20412836|P2|Overall Study|Withdrawal by Subject|24
5900200|NCT01685073|20412837|P1|Overall Study|Withdrawal by Subject|24
5900201|NCT01685073|20412836|P2|Overall Study|Lost to Follow-up|8
5900202|NCT01685073|20412837|P1|Overall Study|Lost to Follow-up|6
5900203|NCT01685060|20412845|P1|Overall Study|Death|8
5900204|NCT01685060|20412845|P1|Overall Study|Lost to Follow-up|1
5900205|NCT01685060|20412845|P1|Overall Study|Subject/guardian decision|20
5900206|NCT01685060|20412845|P1|Overall Study|Physician Decision|14
5900207|NCT01685060|20412845|P1|Overall Study|Progressive disease|69
5900208|NCT01685060|20412845|P1|Overall Study|Adverse Event|12
5900209|NCT01685060|20412845|P1|Overall Study|Rollover patients|16
5900210|NCT01685047|20412860|P1|Overall Study|patient withdrawn by sponsor|1
5900211|NCT01685047|20412860|P1|Overall Study|Adverse Event|5
5900212|NCT01685047|20412860|P1|Overall Study|Physician Decision|25
5900213|NCT01685047|20412860|P1|Overall Study|Lost to Follow-up|8
5900214|NCT01685047|20412860|P1|Overall Study|Death|26
5900215|NCT01685047|20412860|P1|Overall Study|Withdrawal by Subject|20
5900216|NCT01684943|20412876|P3|Overall Study|Planning Pregnancy|0
5900217|NCT01684943|20412877|P2|Overall Study|Planning Pregnancy|0
5900218|NCT01684943|20412878|P1|Overall Study|Planning Pregnancy|1
5900219|NCT01684943|20412876|P3|Overall Study|Lost to Follow-up|0
5900220|NCT01684943|20412877|P2|Overall Study|Lost to Follow-up|0
5900221|NCT01684943|20412878|P1|Overall Study|Lost to Follow-up|3
5900222|NCT01684943|20412876|P3|Overall Study|Excluded from Analysis|1
5900223|NCT01684943|20412877|P2|Overall Study|Excluded from Analysis|1
5900224|NCT01684943|20412878|P1|Overall Study|Excluded from Analysis|1
5900225|NCT01684943|20412876|P3|Overall Study|Principal Investigator Determination|0
5900226|NCT01684943|20412877|P2|Overall Study|Principal Investigator Determination|0
5900227|NCT01684943|20412878|P1|Overall Study|Principal Investigator Determination|1
5900228|NCT01684943|20412876|P3|Overall Study|Inadequate Venous Access|0
5900229|NCT01684943|20412877|P2|Overall Study|Inadequate Venous Access|0
5900230|NCT01684943|20412878|P1|Overall Study|Inadequate Venous Access|3
5900231|NCT01684930|20412897|P2|Overall Study|Withdrawal by Subject|1
5900232|NCT01684930|20412898|P1|Overall Study|Withdrawal by Subject|3
5900233|NCT01684878|20412955|P4|Part 2: Randomized Phase|Participant noncompliance|1
5900234|NCT01684878|20412956|P3|Part 2: Randomized Phase|Participant noncompliance|0
5900235|NCT01684878|20412957|P2|Part 2: Randomized Phase|Participant noncompliance|0
5900236|NCT01684878|20412958|P1|Part 2: Randomized Phase|Participant noncompliance|0
5900237|NCT01684878|20412955|P4|Part 2: Randomized Phase|Alive at data-cut|7
5900238|NCT01684878|20412956|P3|Part 2: Randomized Phase|Alive at data-cut|13
5900239|NCT01684878|20412957|P2|Part 2: Randomized Phase|Alive at data-cut|0
5900240|NCT01684878|20412958|P1|Part 2: Randomized Phase|Alive at data-cut|0
5900241|NCT01684878|20412955|P4|Part 2: Randomized Phase|Death|68
5900242|NCT01684878|20412956|P3|Part 2: Randomized Phase|Death|62
5900243|NCT01684878|20412957|P2|Part 2: Randomized Phase|Death|0
5900244|NCT01684878|20412958|P1|Part 2: Randomized Phase|Death|0
5900245|NCT01684878|20412955|P4|Part 2: Randomized Phase|Lost to Follow-up|0
5900246|NCT01684878|20412956|P3|Part 2: Randomized Phase|Lost to Follow-up|2
5900247|NCT01684878|20412957|P2|Part 2: Randomized Phase|Lost to Follow-up|0
5900248|NCT01684878|20412958|P1|Part 2: Randomized Phase|Lost to Follow-up|0
5900249|NCT01684878|20412955|P4|Part 2: Randomized Phase|Participant withdrew consent|2
5900250|NCT01684878|20412956|P3|Part 2: Randomized Phase|Participant withdrew consent|1
5900251|NCT01684878|20412957|P2|Part 2: Randomized Phase|Participant withdrew consent|0
5900252|NCT01684878|20412958|P1|Part 2: Randomized Phase|Participant withdrew consent|0
5900253|NCT01684878|20412955|P4|Part 1: Safety Run in Phase|Lost to Follow-up|0
5900254|NCT01684878|20412956|P3|Part 1: Safety Run in Phase|Lost to Follow-up|0
5900255|NCT01684878|20412957|P2|Part 1: Safety Run in Phase|Lost to Follow-up|2
5900256|NCT01684878|20412958|P1|Part 1: Safety Run in Phase|Lost to Follow-up|0
5900257|NCT01684878|20412955|P4|Part 1: Safety Run in Phase|Death|0
5900258|NCT01684878|20412956|P3|Part 1: Safety Run in Phase|Death|0
5900260|NCT01684878|20412958|P1|Part 1: Safety Run in Phase|Death|15
5900261|NCT01684878|20412955|P4|Part 1: Safety Run in Phase|Participants withdrawn consent|0
5900262|NCT01684878|20412956|P3|Part 1: Safety Run in Phase|Participants withdrawn consent|0
5900263|NCT01684878|20412957|P2|Part 1: Safety Run in Phase|Participants withdrawn consent|1
5900264|NCT01684878|20412958|P1|Part 1: Safety Run in Phase|Participants withdrawn consent|1
5900265|NCT01684722|20413006|P4|Overall Study|Death|21
5900266|NCT01684722|20413007|P3|Overall Study|Death|19
5900267|NCT01684722|20413008|P2|Overall Study|Death|21
5900268|NCT01684722|20413009|P1|Overall Study|Death|19
5900269|NCT01684722|20413006|P4|Overall Study|Lost to Follow-up|89
5900270|NCT01684722|20413007|P3|Overall Study|Lost to Follow-up|75
5900271|NCT01684722|20413008|P2|Overall Study|Lost to Follow-up|56
5900272|NCT01684722|20413009|P1|Overall Study|Lost to Follow-up|78
5900273|NCT01684423|20413083|P5|Overall Study|Withdrawal by Subject|0
5900274|NCT01684423|20413084|P4|Overall Study|Withdrawal by Subject|0
5900275|NCT01684423|20413085|P3|Overall Study|Withdrawal by Subject|1
5900276|NCT01684423|20413086|P2|Overall Study|Withdrawal by Subject|0
5900277|NCT01684423|20413087|P1|Overall Study|Withdrawal by Subject|0
5900278|NCT01684215|20413144|P4|Phase 2|Lost to Follow-up|4
5900279|NCT01684215|20413145|P3|Phase 2|Lost to Follow-up|0
5900280|NCT01684215|20413146|P2|Phase 2|Lost to Follow-up|0
5900281|NCT01684215|20413147|P1|Phase 2|Lost to Follow-up|0
5900282|NCT01684215|20413144|P4|Phase 2|Enrolled but not treated|1
5900283|NCT01684215|20413145|P3|Phase 2|Enrolled but not treated|0
5900284|NCT01684215|20413146|P2|Phase 2|Enrolled but not treated|0
5900285|NCT01684215|20413147|P1|Phase 2|Enrolled but not treated|0
5900286|NCT01684215|20413144|P4|Phase 2|Study terminated by sponsor|30
5900287|NCT01684215|20413145|P3|Phase 2|Study terminated by sponsor|0
5900288|NCT01684215|20413146|P2|Phase 2|Study terminated by sponsor|0
5900289|NCT01684215|20413147|P1|Phase 2|Study terminated by sponsor|0
5900290|NCT01684215|20413144|P4|Phase 2|Death|8
5900291|NCT01684215|20413145|P3|Phase 2|Death|0
5900292|NCT01684215|20413146|P2|Phase 2|Death|0
5900293|NCT01684215|20413147|P1|Phase 2|Death|0
5900294|NCT01684215|20413144|P4|Phase 1, Part 2|Withdrawal by Subject|0
5900295|NCT01684215|20413145|P3|Phase 1, Part 2|Withdrawal by Subject|1
5900296|NCT01684215|20413146|P2|Phase 1, Part 2|Withdrawal by Subject|0
5900297|NCT01684215|20413147|P1|Phase 1, Part 2|Withdrawal by Subject|0
5900298|NCT01684215|20413144|P4|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0
5900299|NCT01684215|20413145|P3|Phase 1, Part 2|Commercial avaliabity of Palbociclib|4
5900300|NCT01684215|20413146|P2|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0
5900301|NCT01684215|20413147|P1|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0
5900302|NCT01684215|20413144|P4|Phase 1, Part 2|Adverse Event|0
5900303|NCT01684215|20413145|P3|Phase 1, Part 2|Adverse Event|1
5900304|NCT01684215|20413146|P2|Phase 1, Part 2|Adverse Event|0
5900305|NCT01684215|20413147|P1|Phase 1, Part 2|Adverse Event|0
5900306|NCT01684215|20413144|P4|Phase 1, Part 1|Objective progression or relapse|0
5900307|NCT01684215|20413145|P3|Phase 1, Part 1|Objective progression or relapse|0
5900308|NCT01684215|20413146|P2|Phase 1, Part 1|Objective progression or relapse|6
5900309|NCT01684215|20413147|P1|Phase 1, Part 1|Objective progression or relapse|5
5900310|NCT01684215|20413144|P4|Phase 1, Part 1|Adverse Event|0
5900311|NCT01684215|20413145|P3|Phase 1, Part 1|Adverse Event|0
5900312|NCT01684215|20413146|P2|Phase 1, Part 1|Adverse Event|0
5900313|NCT01684215|20413147|P1|Phase 1, Part 1|Adverse Event|1
5900314|NCT01684046|20413221|P2|Period 1, First 30 Days|Adverse Event|2
5900315|NCT01684046|20413222|P1|Period 1, First 30 Days|Adverse Event|0
5900316|NCT01684033|20413228|P2|Period 2, Second 30 Days|Adverse Event|0
5900317|NCT01684033|20413229|P1|Period 2, Second 30 Days|Adverse Event|1
5900318|NCT01684033|20413228|P2|Period 1, First 30 Days|Lost to Follow-up|0
5900319|NCT01684033|20413229|P1|Period 1, First 30 Days|Lost to Follow-up|1
5900320|NCT01684033|20413228|P2|Period 1, First 30 Days|Withdrawal by Subject|0
5900321|NCT01684033|20413229|P1|Period 1, First 30 Days|Withdrawal by Subject|1
5900322|NCT01684033|20413228|P2|Period 1, First 30 Days|Noncompliance|0
5900323|NCT01684033|20413229|P1|Period 1, First 30 Days|Noncompliance|1
5900324|NCT01684033|20413228|P2|Period 1, First 30 Days|Adverse Event|1
5900325|NCT01684033|20413229|P1|Period 1, First 30 Days|Adverse Event|1
5900326|NCT01683994|20413278|P5|Overall Study|Intercurrent illness|1
5900327|NCT01683994|20413279|P4|Overall Study|Intercurrent illness|2
5900328|NCT01683994|20413280|P3|Overall Study|Intercurrent illness|0
5900329|NCT01683994|20413281|P2|Overall Study|Intercurrent illness|0
5900330|NCT01683994|20413282|P1|Overall Study|Intercurrent illness|0
5900331|NCT01683994|20413278|P5|Overall Study|Withdrawal by Subject|0
5900332|NCT01683994|20413279|P4|Overall Study|Withdrawal by Subject|1
5900333|NCT01683994|20413280|P3|Overall Study|Withdrawal by Subject|0
5900334|NCT01683994|20413281|P2|Overall Study|Withdrawal by Subject|0
5900335|NCT01683994|20413282|P1|Overall Study|Withdrawal by Subject|1
5900336|NCT01683838|20413323|P2|Overall Study|Other|3
5900337|NCT01683838|20413324|P1|Overall Study|Other|4
5900338|NCT01683838|20413323|P2|Overall Study|Lost to Follow-up|1
5900339|NCT01683838|20413324|P1|Overall Study|Lost to Follow-up|1
5900340|NCT01683838|20413323|P2|Overall Study|Withdrawal by Subject|5
5900341|NCT01683838|20413324|P1|Overall Study|Withdrawal by Subject|6
5900342|NCT01683838|20413323|P2|Overall Study|Protocol Violation|1
5900343|NCT01683838|20413324|P1|Overall Study|Protocol Violation|3
5900344|NCT01683838|20413323|P2|Overall Study|Adverse Event|2
5900345|NCT01683838|20413324|P1|Overall Study|Adverse Event|12
5900346|NCT01683604|20413364|P1|Overall Study|Other|2
5900347|NCT01683604|20413364|P1|Overall Study|Lack of Efficacy|1
5900348|NCT01683604|20413364|P1|Overall Study|Adverse Event|2
5900349|NCT01683565|20413529|P2|Overall Study|Discontinued Intervention|1
5900350|NCT01683565|20413530|P1|Overall Study|Discontinued Intervention|1
5900351|NCT01683565|20413529|P2|Overall Study|Lost to Follow-up|0
5900352|NCT01683565|20413530|P1|Overall Study|Lost to Follow-up|2
5900353|NCT01683409|20413564|P5|Washout Period 2 (Weeks 29-32)|Physician Decision|0
5900354|NCT01683409|20413565|P4|Washout Period 2 (Weeks 29-32)|Physician Decision|0
5900355|NCT01683409|20413566|P3|Washout Period 2 (Weeks 29-32)|Physician Decision|1
5900356|NCT01683409|20413567|P2|Washout Period 2 (Weeks 29-32)|Physician Decision|0
5900357|NCT01683409|20413568|P1|Washout Period 2 (Weeks 29-32)|Physician Decision|0
5900358|NCT01683409|20413564|P5|Washout Period 2 (Weeks 29-32)|Adverse Event|3
5900359|NCT01683409|20413565|P4|Washout Period 2 (Weeks 29-32)|Adverse Event|0
5900360|NCT01683409|20413566|P3|Washout Period 2 (Weeks 29-32)|Adverse Event|0
5900361|NCT01683409|20413567|P2|Washout Period 2 (Weeks 29-32)|Adverse Event|0
5900362|NCT01683409|20413568|P1|Washout Period 2 (Weeks 29-32)|Adverse Event|0
5900363|NCT01683409|20413564|P5|Washout Period 1 (Weeks 25-28)|Adverse Event|2
5900364|NCT01683409|20413565|P4|Washout Period 1 (Weeks 25-28)|Adverse Event|1
5900365|NCT01683409|20413566|P3|Washout Period 1 (Weeks 25-28)|Adverse Event|0
5900366|NCT01683409|20413567|P2|Washout Period 1 (Weeks 25-28)|Adverse Event|4
5900367|NCT01683409|20413568|P1|Washout Period 1 (Weeks 25-28)|Adverse Event|0
5900368|NCT01683409|20413564|P5|Washout Period 1 (Weeks 25-28)|Physician Decision|0
5900369|NCT01683409|20413565|P4|Washout Period 1 (Weeks 25-28)|Physician Decision|0
5900370|NCT01683409|20413566|P3|Washout Period 1 (Weeks 25-28)|Physician Decision|0
5900371|NCT01683409|20413567|P2|Washout Period 1 (Weeks 25-28)|Physician Decision|0
5900372|NCT01683409|20413568|P1|Washout Period 1 (Weeks 25-28)|Physician Decision|1
5900373|NCT01683409|20413564|P5|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1
5900374|NCT01683409|20413565|P4|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0
5900375|NCT01683409|20413566|P3|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0
5900376|NCT01683409|20413567|P2|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0
5900377|NCT01683409|20413568|P1|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1
5900378|NCT01683409|20413564|P5|Washout Period 1 (Weeks 25-28)|Protocol Violation|0
5900379|NCT01683409|20413565|P4|Washout Period 1 (Weeks 25-28)|Protocol Violation|1
5900380|NCT01683409|20413566|P3|Washout Period 1 (Weeks 25-28)|Protocol Violation|0
5900381|NCT01683409|20413567|P2|Washout Period 1 (Weeks 25-28)|Protocol Violation|0
5900382|NCT01683409|20413568|P1|Washout Period 1 (Weeks 25-28)|Protocol Violation|1
5900383|NCT01683409|20413564|P5|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0
5900384|NCT01683409|20413565|P4|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0
5900385|NCT01683409|20413566|P3|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|1
5900386|NCT01683409|20413567|P2|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0
5900387|NCT01683409|20413568|P1|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0
5900388|NCT01683409|20413564|P5|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1
5900389|NCT01683409|20413565|P4|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1
5900390|NCT01683409|20413566|P3|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0
5900391|NCT01683409|20413567|P2|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0
5900392|NCT01683409|20413568|P1|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0
5900393|NCT01683409|20413564|P5|Treatment Period (Weeks 1-24)|Lost to Follow-up|0
5900394|NCT01683409|20413565|P4|Treatment Period (Weeks 1-24)|Lost to Follow-up|0
5900395|NCT01683409|20413566|P3|Treatment Period (Weeks 1-24)|Lost to Follow-up|0
5900396|NCT01683409|20413567|P2|Treatment Period (Weeks 1-24)|Lost to Follow-up|1
5900397|NCT01683409|20413568|P1|Treatment Period (Weeks 1-24)|Lost to Follow-up|0
5900398|NCT01683409|20413564|P5|Treatment Period (Weeks 1-24)|Adverse Event|1
5900399|NCT01683409|20413565|P4|Treatment Period (Weeks 1-24)|Adverse Event|1
5900400|NCT01683409|20413566|P3|Treatment Period (Weeks 1-24)|Adverse Event|0
5900401|NCT01683409|20413567|P2|Treatment Period (Weeks 1-24)|Adverse Event|3
5900402|NCT01683409|20413568|P1|Treatment Period (Weeks 1-24)|Adverse Event|0
5900403|NCT01683409|20413564|P5|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0
5900404|NCT01683409|20413565|P4|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0
5900405|NCT01683409|20413566|P3|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|1
5900406|NCT01683409|20413567|P2|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0
5900407|NCT01683409|20413568|P1|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0
5900408|NCT01683383|20413611|P2|Overall Study|Infant was not transported|0
5900409|NCT01683383|20413612|P1|Overall Study|Infant was not transported|1
5900410|NCT01683266|20413639|P2|Overall Study|Serious Adverse Event of Hypoglycemia|1
5900411|NCT01683266|20413640|P1|Overall Study|Serious Adverse Event of Hypoglycemia|0
5900412|NCT01683266|20413639|P2|Overall Study|Possibly Hypoglycemia|0
5900413|NCT01683266|20413640|P1|Overall Study|Possibly Hypoglycemia|1
5900414|NCT01683266|20413639|P2|Overall Study|Perceived Lack of Efficacy|1
5900415|NCT01683266|20413640|P1|Overall Study|Perceived Lack of Efficacy|1
5900416|NCT01683266|20413639|P2|Overall Study|Nonserious Hypoglycemia|3
5900417|NCT01683266|20413640|P1|Overall Study|Nonserious Hypoglycemia|0
5900418|NCT01683266|20413639|P2|Overall Study|Site Closure / Site Withdrawal|3
5900419|NCT01683266|20413640|P1|Overall Study|Site Closure / Site Withdrawal|1
5900420|NCT01683266|20413639|P2|Overall Study|Lost to Follow-up|0
5900421|NCT01683266|20413640|P1|Overall Study|Lost to Follow-up|5
5900422|NCT01683266|20413639|P2|Overall Study|Selection Criterion / Protocol Violation|5
5900423|NCT01683266|20413640|P1|Overall Study|Selection Criterion / Protocol Violation|7
5900424|NCT01683266|20413639|P2|Overall Study|Personal Reason|25
5900425|NCT01683266|20413640|P1|Overall Study|Personal Reason|17
5900426|NCT01683266|20413639|P2|Overall Study|Protocol Violation|6
5900427|NCT01683266|20413640|P1|Overall Study|Protocol Violation|13
5900428|NCT01683266|20413639|P2|Overall Study|Lack of Efficacy|2
5900429|NCT01683266|20413640|P1|Overall Study|Lack of Efficacy|5
5900430|NCT01683266|20413639|P2|Overall Study|Adverse Event|4
5900431|NCT01683266|20413640|P1|Overall Study|Adverse Event|5
5900432|NCT01683071|20413674|P6|Part 2|Withdrawal by investigator decision|2
5900433|NCT01683071|20413675|P5|Part 2|Withdrawal by investigator decision|1
5900434|NCT01683071|20413676|P4|Part 2|Withdrawal by investigator decision|0
5900435|NCT01683071|20413677|P3|Part 2|Withdrawal by investigator decision|0
5900436|NCT01683071|20413678|P2|Part 2|Withdrawal by investigator decision|0
5900437|NCT01683071|20413679|P1|Part 2|Withdrawal by investigator decision|0
5900438|NCT01683071|20413674|P6|Part 2|Protocol deviation|2
5900439|NCT01683071|20413675|P5|Part 2|Protocol deviation|1
5900440|NCT01683071|20413676|P4|Part 2|Protocol deviation|0
5900441|NCT01683071|20413677|P3|Part 2|Protocol deviation|0
5900442|NCT01683071|20413678|P2|Part 2|Protocol deviation|0
5900443|NCT01683071|20413679|P1|Part 2|Protocol deviation|0
5900444|NCT01683071|20413674|P6|Part 2|Met exclusion criterion|1
5900445|NCT01683071|20413675|P5|Part 2|Met exclusion criterion|1
5900446|NCT01683071|20413676|P4|Part 2|Met exclusion criterion|0
5900447|NCT01683071|20413677|P3|Part 2|Met exclusion criterion|0
5900448|NCT01683071|20413678|P2|Part 2|Met exclusion criterion|0
5900449|NCT01683071|20413679|P1|Part 2|Met exclusion criterion|0
5900450|NCT01683071|20413674|P6|Part 2|Did not receive study drug|1
5900451|NCT01683071|20413675|P5|Part 2|Did not receive study drug|2
5900452|NCT01683071|20413676|P4|Part 2|Did not receive study drug|0
5900453|NCT01683071|20413677|P3|Part 2|Did not receive study drug|0
5900454|NCT01683071|20413678|P2|Part 2|Did not receive study drug|0
5900455|NCT01683071|20413679|P1|Part 2|Did not receive study drug|0
5900456|NCT01683071|20413674|P6|Part 2|Surgery cancelled|2
5900457|NCT01683071|20413675|P5|Part 2|Surgery cancelled|4
5900458|NCT01683071|20413676|P4|Part 2|Surgery cancelled|0
5900459|NCT01683071|20413677|P3|Part 2|Surgery cancelled|0
5900460|NCT01683071|20413678|P2|Part 2|Surgery cancelled|0
5900461|NCT01683071|20413679|P1|Part 2|Surgery cancelled|0
5900462|NCT01683071|20413674|P6|Part 2|Withdrawal by Subject|3
5900463|NCT01683071|20413675|P5|Part 2|Withdrawal by Subject|3
5900464|NCT01683071|20413676|P4|Part 2|Withdrawal by Subject|0
5900465|NCT01683071|20413677|P3|Part 2|Withdrawal by Subject|0
5900466|NCT01683071|20413678|P2|Part 2|Withdrawal by Subject|0
5900467|NCT01683071|20413679|P1|Part 2|Withdrawal by Subject|0
5900468|NCT01683071|20413674|P6|Part 2|Lost to Follow-up|0
5900469|NCT01683071|20413675|P5|Part 2|Lost to Follow-up|2
5900470|NCT01683071|20413676|P4|Part 2|Lost to Follow-up|0
5900471|NCT01683071|20413677|P3|Part 2|Lost to Follow-up|0
5900472|NCT01683071|20413678|P2|Part 2|Lost to Follow-up|0
5900473|NCT01683071|20413679|P1|Part 2|Lost to Follow-up|0
5900474|NCT01683071|20413674|P6|Part 2|Lack of Efficacy|4
5900475|NCT01683071|20413675|P5|Part 2|Lack of Efficacy|3
5900476|NCT01683071|20413676|P4|Part 2|Lack of Efficacy|0
5900477|NCT01683071|20413677|P3|Part 2|Lack of Efficacy|0
5900478|NCT01683071|20413678|P2|Part 2|Lack of Efficacy|0
5900479|NCT01683071|20413679|P1|Part 2|Lack of Efficacy|0
5900480|NCT01683071|20413674|P6|Part 1|Early termination; met exclusion criteria|0
5900481|NCT01683071|20413675|P5|Part 1|Early termination; met exclusion criteria|0
5900482|NCT01683071|20413676|P4|Part 1|Early termination; met exclusion criteria|0
5900483|NCT01683071|20413677|P3|Part 1|Early termination; met exclusion criteria|1
5900484|NCT01683071|20413678|P2|Part 1|Early termination; met exclusion criteria|2
5900485|NCT01683071|20413679|P1|Part 1|Early termination; met exclusion criteria|0
5900486|NCT01683071|20413674|P6|Part 1|Did not receive study drug|0
5900487|NCT01683071|20413675|P5|Part 1|Did not receive study drug|0
5900488|NCT01683071|20413676|P4|Part 1|Did not receive study drug|1
5900489|NCT01683071|20413677|P3|Part 1|Did not receive study drug|0
5900490|NCT01683071|20413678|P2|Part 1|Did not receive study drug|0
5900491|NCT01683071|20413679|P1|Part 1|Did not receive study drug|1
5900492|NCT01683071|20413674|P6|Part 1|Surgery Cancelled|0
5900493|NCT01683071|20413675|P5|Part 1|Surgery Cancelled|0
5900494|NCT01683071|20413676|P4|Part 1|Surgery Cancelled|0
5900495|NCT01683071|20413677|P3|Part 1|Surgery Cancelled|0
5900496|NCT01683071|20413678|P2|Part 1|Surgery Cancelled|0
5900497|NCT01683071|20413679|P1|Part 1|Surgery Cancelled|1
5900498|NCT01683071|20413674|P6|Part 1|Withdrawal by Subject|0
5900499|NCT01683071|20413675|P5|Part 1|Withdrawal by Subject|0
5900500|NCT01683071|20413676|P4|Part 1|Withdrawal by Subject|1
5900501|NCT01683071|20413677|P3|Part 1|Withdrawal by Subject|2
5900502|NCT01683071|20413678|P2|Part 1|Withdrawal by Subject|2
5900503|NCT01683071|20413679|P1|Part 1|Withdrawal by Subject|1
5900504|NCT01683071|20413674|P6|Part 1|Lack of Efficacy|0
5900505|NCT01683071|20413675|P5|Part 1|Lack of Efficacy|0
5900506|NCT01683071|20413676|P4|Part 1|Lack of Efficacy|3
5900507|NCT01683071|20413677|P3|Part 1|Lack of Efficacy|0
5900508|NCT01683071|20413678|P2|Part 1|Lack of Efficacy|0
5900509|NCT01683071|20413679|P1|Part 1|Lack of Efficacy|1
5900510|NCT01683058|20413705|P1|Overall Study|Lack of Efficacy|2
5900511|NCT01683058|20413705|P1|Overall Study|Withdrawal by Subject|7
5900512|NCT01683058|20413705|P1|Overall Study|Subject Met Withdrawal Criteria|5
5900513|NCT01683058|20413705|P1|Overall Study|Adverse Event|6
5900514|NCT01683058|20413705|P1|Overall Study|Lost to Follow-up|9
5900515|NCT01683019|20413736|P3|Overall Study|Withdrawal by Subject|4
5900516|NCT01683019|20413737|P2|Overall Study|Withdrawal by Subject|1
5900517|NCT01683019|20413738|P1|Overall Study|Withdrawal by Subject|2
5900518|NCT01682876|20413772|P4|Overall Study|Other|1
5900519|NCT01682876|20413773|P3|Overall Study|Other|1
5900520|NCT01682876|20413774|P2|Overall Study|Other|0
5900521|NCT01682876|20413775|P1|Overall Study|Other|1
5900522|NCT01682876|20413772|P4|Overall Study|Withdrawal by Subject|2
5900523|NCT01682876|20413773|P3|Overall Study|Withdrawal by Subject|0
5900524|NCT01682876|20413774|P2|Overall Study|Withdrawal by Subject|0
5900525|NCT01682876|20413775|P1|Overall Study|Withdrawal by Subject|4
5900526|NCT01682876|20413772|P4|Overall Study|Protocol Violation|1
5900527|NCT01682876|20413773|P3|Overall Study|Protocol Violation|1
5900528|NCT01682876|20413774|P2|Overall Study|Protocol Violation|1
5900529|NCT01682876|20413775|P1|Overall Study|Protocol Violation|1
5900530|NCT01682876|20413772|P4|Overall Study|Lost to Follow-up|11
5900531|NCT01682876|20413773|P3|Overall Study|Lost to Follow-up|9
5900532|NCT01682876|20413774|P2|Overall Study|Lost to Follow-up|15
5900533|NCT01682876|20413775|P1|Overall Study|Lost to Follow-up|11
5900534|NCT01682876|20413772|P4|Overall Study|Adverse Event|1
5900535|NCT01682876|20413773|P3|Overall Study|Adverse Event|0
5900536|NCT01682876|20413774|P2|Overall Study|Adverse Event|0
5900537|NCT01682876|20413775|P1|Overall Study|Adverse Event|0
5900538|NCT01682876|20413772|P4|Overall Study|Administrative reason|3
5900539|NCT01682876|20413773|P3|Overall Study|Administrative reason|0
5900540|NCT01682876|20413774|P2|Overall Study|Administrative reason|4
5900541|NCT01682876|20413775|P1|Overall Study|Administrative reason|4
5900542|NCT01682863|20413821|P3|Overall Study|Physician Decision|1
5900543|NCT01682863|20413822|P2|Overall Study|Physician Decision|0
5900544|NCT01682863|20413823|P1|Overall Study|Physician Decision|0
5900545|NCT01682863|20413821|P3|Overall Study|Adverse Event|2
5900546|NCT01682863|20413822|P2|Overall Study|Adverse Event|1
5900547|NCT01682863|20413823|P1|Overall Study|Adverse Event|0
5900548|NCT01682863|20413821|P3|Overall Study|Technical problems|0
5900549|NCT01682863|20413822|P2|Overall Study|Technical problems|0
5900550|NCT01682863|20413823|P1|Overall Study|Technical problems|1
5900551|NCT01682863|20413821|P3|Overall Study|Protocol deviation|1
5900552|NCT01682863|20413822|P2|Overall Study|Protocol deviation|0
5900553|NCT01682863|20413823|P1|Overall Study|Protocol deviation|1
5900554|NCT01682863|20413821|P3|Overall Study|Death|4
5900555|NCT01682863|20413822|P2|Overall Study|Death|3
5900556|NCT01682863|20413823|P1|Overall Study|Death|1
5900557|NCT01682863|20413821|P3|Overall Study|Lost to Follow-up|6
5900558|NCT01682863|20413822|P2|Overall Study|Lost to Follow-up|1
5900559|NCT01682863|20413823|P1|Overall Study|Lost to Follow-up|5
5900560|NCT01682863|20413821|P3|Overall Study|Subject/guardian decision|10
5900561|NCT01682863|20413822|P2|Overall Study|Subject/guardian decision|12
5900562|NCT01682863|20413823|P1|Overall Study|Subject/guardian decision|19
5900563|NCT01682837|20413852|P1|Baseline|Withdrawal by Subject|5
5900564|NCT01682759|20413896|P2|Overall Study|Withdrawal by Subject|55
5900565|NCT01682759|20413897|P1|Overall Study|Withdrawal by Subject|56
5900566|NCT01682759|20413896|P2|Overall Study|Physician Decision|1
5900567|NCT01682759|20413897|P1|Overall Study|Physician Decision|1
5900568|NCT01682759|20413896|P2|Overall Study|Lost to Follow-up|13
5900569|NCT01682759|20413897|P1|Overall Study|Lost to Follow-up|10
5900570|NCT01682759|20413896|P2|Overall Study|Death|1
5900571|NCT01682759|20413897|P1|Overall Study|Death|2
5900572|NCT01682720|20413921|P4|Overall Study|Adverse Event|1
5900573|NCT01682720|20413922|P3|Overall Study|Adverse Event|1
5900574|NCT01682720|20413923|P2|Overall Study|Adverse Event|0
5900575|NCT01682720|20413924|P1|Overall Study|Adverse Event|1
5900576|NCT01682720|20413921|P4|Overall Study|Subject Withdrew Consent|2
5900577|NCT01682720|20413922|P3|Overall Study|Subject Withdrew Consent|2
5900578|NCT01682720|20413923|P2|Overall Study|Subject Withdrew Consent|0
5900579|NCT01682720|20413924|P1|Overall Study|Subject Withdrew Consent|0
5900580|NCT01682720|20413921|P4|Overall Study|Lost to Follow-up|6
5900581|NCT01682720|20413922|P3|Overall Study|Lost to Follow-up|0
5900582|NCT01682720|20413923|P2|Overall Study|Lost to Follow-up|1
5900583|NCT01682720|20413924|P1|Overall Study|Lost to Follow-up|1
5900584|NCT01682720|20413921|P4|Overall Study|Efficacy Failure|30
5900585|NCT01682720|20413922|P3|Overall Study|Efficacy Failure|3
5900586|NCT01682720|20413923|P2|Overall Study|Efficacy Failure|3
5900587|NCT01682720|20413924|P1|Overall Study|Efficacy Failure|0
5900588|NCT01682720|20413921|P4|Overall Study|Terminated by Sponsor|0
5900589|NCT01682720|20413922|P3|Overall Study|Terminated by Sponsor|0
5900590|NCT01682720|20413923|P2|Overall Study|Terminated by Sponsor|0
5900591|NCT01682720|20413924|P1|Overall Study|Terminated by Sponsor|83
5900592|NCT01682720|20413921|P4|Overall Study|Randomized but Not Treated|0
5900593|NCT01682720|20413922|P3|Overall Study|Randomized but Not Treated|1
5900594|NCT01682720|20413923|P2|Overall Study|Randomized but Not Treated|1
5900595|NCT01682720|20413924|P1|Overall Study|Randomized but Not Treated|0
5900596|NCT01682681|20413941|P1|Overall Study|Low compliance|13
5900597|NCT01682681|20413941|P1|Overall Study|Other|21
5900598|NCT01682681|20413941|P1|Overall Study|tapering of topiramate|5
5900599|NCT01682681|20413941|P1|Overall Study|Adverse Event|46
5900600|NCT01682681|20413941|P1|Overall Study|Lost to Follow-up|174
5900601|NCT01682681|20413941|P1|Overall Study|Moved to other hospital|10
5900602|NCT01682681|20413941|P1|Overall Study|Withdrawal by Subject|1
5900603|NCT01682681|20413941|P1|Overall Study|Lack of Efficacy|62
5900604|NCT01682603|20413970|P1|Overall Study|Lost to Follow-up|3
5900605|NCT01682512|20414015|P3|Overall Study|Other than stated above|2
5900606|NCT01682512|20414016|P2|Overall Study|Other than stated above|4
5900607|NCT01682512|20414017|P1|Overall Study|Other than stated above|2
5900608|NCT01682512|20414015|P3|Overall Study|Secondary lack of efficacy|0
5900609|NCT01682512|20414016|P2|Overall Study|Secondary lack of efficacy|1
5900610|NCT01682512|20414017|P1|Overall Study|Secondary lack of efficacy|1
5900611|NCT01682512|20414015|P3|Overall Study|Primary lack of efficacy|7
5900612|NCT01682512|20414016|P2|Overall Study|Primary lack of efficacy|7
5900613|NCT01682512|20414017|P1|Overall Study|Primary lack of efficacy|10
5900614|NCT01682512|20414015|P3|Overall Study|Protocol Violation|2
5900615|NCT01682512|20414016|P2|Overall Study|Protocol Violation|3
5900616|NCT01682512|20414017|P1|Overall Study|Protocol Violation|2
5900617|NCT01682512|20414015|P3|Overall Study|Lost to Follow-up|2
5900618|NCT01682512|20414016|P2|Overall Study|Lost to Follow-up|0
5900619|NCT01682512|20414017|P1|Overall Study|Lost to Follow-up|3
5900620|NCT01682512|20414015|P3|Overall Study|Study terminated by sponsor|0
5900621|NCT01682512|20414016|P2|Overall Study|Study terminated by sponsor|43
5900622|NCT01682512|20414017|P1|Overall Study|Study terminated by sponsor|46
5900623|NCT01682512|20414015|P3|Overall Study|Physician Decision|0
5900624|NCT01682512|20414016|P2|Overall Study|Physician Decision|2
5900625|NCT01682512|20414017|P1|Overall Study|Physician Decision|0
5900626|NCT01682512|20414015|P3|Overall Study|Withdrawal by Subject|3
5900627|NCT01682512|20414016|P2|Overall Study|Withdrawal by Subject|6
5900628|NCT01682512|20414017|P1|Overall Study|Withdrawal by Subject|2
5900629|NCT01682512|20414015|P3|Overall Study|Adverse Event|2
5900630|NCT01682512|20414016|P2|Overall Study|Adverse Event|5
5900631|NCT01682512|20414017|P1|Overall Study|Adverse Event|6
5900632|NCT01682460|20414042|P1|Overall Study|Did not meet inclusion criteria|2
5900633|NCT01682460|20414042|P1|Overall Study|Withdrawal by Subject|2
5900634|NCT01682213|20414057|P1|Overall Study|Withdrawal by Subject|2
5900635|NCT01682148|20414065|P2|Overall Study|Protocol Violation|1
5900636|NCT01682148|20414066|P1|Overall Study|Protocol Violation|1
5900637|NCT01682148|20414065|P2|Overall Study|Lost to Follow-up|2
5900638|NCT01682148|20414066|P1|Overall Study|Lost to Follow-up|1
5900639|NCT01682148|20414065|P2|Overall Study|Withdrawal by Subject|0
5900640|NCT01682148|20414066|P1|Overall Study|Withdrawal by Subject|2
5900641|NCT01682083|20414126|P2|Overall Study|Physician Decision|4
5900642|NCT01682083|20414127|P1|Overall Study|Physician Decision|5
5900643|NCT01682083|20414126|P2|Overall Study|Death|93
5900644|NCT01682083|20414127|P1|Overall Study|Death|60
5900645|NCT01682083|20414126|P2|Overall Study|Withdrawal by Subject|40
5900646|NCT01682083|20414127|P1|Overall Study|Withdrawal by Subject|31
5900647|NCT01682083|20414126|P2|Overall Study|Lost to Follow-up|18
5900648|NCT01682083|20414127|P1|Overall Study|Lost to Follow-up|11
5900649|NCT01682044|20414139|P1|Overall Study|Progression|3
5900650|NCT01682044|20414139|P1|Overall Study|Death|1
5900651|NCT01682031|20414151|P2|Overall Study|Patient stopped selenium on his own|1
5900652|NCT01682031|20414152|P1|Overall Study|Patient stopped selenium on his own|0
5900653|NCT01682031|20414151|P2|Overall Study|Patient could not swallow tablets|0
5900654|NCT01682031|20414152|P1|Overall Study|Patient could not swallow tablets|1
5900655|NCT01682031|20414151|P2|Overall Study|MRI results indicate increased nodul|1
5900656|NCT01682031|20414152|P1|Overall Study|MRI results indicate increased nodul|0
5900657|NCT01682031|20414151|P2|Overall Study|Adverse Event|2
5900658|NCT01682031|20414152|P1|Overall Study|Adverse Event|0
5900659|NCT01682031|20414151|P2|Overall Study|Withdrawal by Subject|1
5900660|NCT01682031|20414152|P1|Overall Study|Withdrawal by Subject|0
5900661|NCT01681992|20414175|P3|Overall Study|Withdrawal by Subject|25
5900662|NCT01681992|20414176|P2|Overall Study|Withdrawal by Subject|30
5900663|NCT01681992|20414177|P1|Overall Study|Withdrawal by Subject|27
5900664|NCT01681992|20414175|P3|Overall Study|Protocol Violation|1
5900665|NCT01681992|20414176|P2|Overall Study|Protocol Violation|0
5900666|NCT01681992|20414177|P1|Overall Study|Protocol Violation|0
5900667|NCT01681992|20414175|P3|Overall Study|As Per Sponsor Decision|1
5900668|NCT01681992|20414176|P2|Overall Study|As Per Sponsor Decision|0
5900669|NCT01681992|20414177|P1|Overall Study|As Per Sponsor Decision|0
5900670|NCT01681992|20414175|P3|Overall Study|Lost to Follow-up|53
5900671|NCT01681992|20414176|P2|Overall Study|Lost to Follow-up|38
5900672|NCT01681992|20414177|P1|Overall Study|Lost to Follow-up|36
5900673|NCT01681992|20414175|P3|Overall Study|Adverse Event|3
5900674|NCT01681992|20414176|P2|Overall Study|Adverse Event|2
5900675|NCT01681992|20414177|P1|Overall Study|Adverse Event|3
5900676|NCT01681849|20414266|P3|Overall Study|Lost to Follow-up|6
5900677|NCT01681849|20414267|P2|Overall Study|Lost to Follow-up|2
5900678|NCT01681849|20414268|P1|Overall Study|Lost to Follow-up|3
5900679|NCT01681849|20414266|P3|Overall Study|Withdrawal by Subject|33
5900680|NCT01681849|20414267|P2|Overall Study|Withdrawal by Subject|5
5900681|NCT01681849|20414268|P1|Overall Study|Withdrawal by Subject|3
5900682|NCT01681849|20414266|P3|Overall Study|Protocol Violation|0
5900683|NCT01681849|20414267|P2|Overall Study|Protocol Violation|0
5900684|NCT01681849|20414268|P1|Overall Study|Protocol Violation|2
5900685|NCT01681836|20414277|P2|Second Intervention|Withdrawal by Subject|1
5900686|NCT01681836|20414278|P1|Second Intervention|Withdrawal by Subject|0
5900687|NCT01681771|20414312|P2|Overall Study|Lost to Follow-up|2
5900688|NCT01681771|20414313|P1|Overall Study|Lost to Follow-up|4
5900689|NCT01681628|20414321|P2|19 Months Follow-up|Lost to Follow-up|43
5900690|NCT01681628|20414322|P1|19 Months Follow-up|Lost to Follow-up|61
5900691|NCT01681628|20414321|P2|19 Months Follow-up|Death|0
5900692|NCT01681628|20414322|P1|19 Months Follow-up|Death|1
5900693|NCT01681628|20414321|P2|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|15
5900694|NCT01681628|20414322|P1|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|0
5900695|NCT01681628|20414321|P2|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|6
5900696|NCT01681628|20414322|P1|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|14
5900697|NCT01681576|20414351|P2|Period 2|Non-compliance with study treatment|0
5900698|NCT01681576|20414352|P1|Period 2|Non-compliance with study treatment|1
5900699|NCT01681576|20414351|P2|Period 2|subject/guardian decision|1
5900700|NCT01681576|20414352|P1|Period 2|subject/guardian decision|3
5900701|NCT01681576|20414351|P2|Period 1|Protocol Deviation|0
5900702|NCT01681576|20414352|P1|Period 1|Protocol Deviation|1
5900703|NCT01681576|20414351|P2|Period 1|Adverse Event|0
5900704|NCT01681576|20414352|P1|Period 1|Adverse Event|1
5900705|NCT01681511|20414368|P2|Overall Study|No post-catheter sample collected|4
5900706|NCT01681511|20414369|P1|Overall Study|No post-catheter sample collected|11
5900707|NCT01681511|20414368|P2|Overall Study|No Daily Urine Sample Collected|1
5900708|NCT01681511|20414369|P1|Overall Study|No Daily Urine Sample Collected|0
5900709|NCT01681511|20414368|P2|Overall Study|No Baseline Dips Stick & Urine Culture|6
5900710|NCT01681511|20414369|P1|Overall Study|No Baseline Dips Stick & Urine Culture|3
5900711|NCT01681511|20414368|P2|Overall Study|Failed Inclusion/Exclusion|0
5900712|NCT01681511|20414369|P1|Overall Study|Failed Inclusion/Exclusion|3
5900713|NCT01681511|20414368|P2|Overall Study|No Treatment Received|3
5900714|NCT01681511|20414369|P1|Overall Study|No Treatment Received|1
5900715|NCT01681472|20414387|P4|Overall Study|Adverse Event|0
5900716|NCT01681472|20414388|P3|Overall Study|Adverse Event|0
5900717|NCT01681472|20414389|P2|Overall Study|Adverse Event|1
5900718|NCT01681472|20414390|P1|Overall Study|Adverse Event|0
5900719|NCT01681433|20414570|P2|Overall Study|Lost to Follow-up|1
5900720|NCT01681433|20414571|P1|Overall Study|Lost to Follow-up|0
5900721|NCT01681433|20414570|P2|Overall Study|Adverse Event|4
5900722|NCT01681433|20414571|P1|Overall Study|Adverse Event|2
5900723|NCT01681433|20414570|P2|Overall Study|Protocol Violation|0
5900724|NCT01681433|20414571|P1|Overall Study|Protocol Violation|2
5900725|NCT01681433|20414570|P2|Overall Study|Withdrawal by Subject|5
5900726|NCT01681433|20414571|P1|Overall Study|Withdrawal by Subject|5
5900727|NCT01681433|20414570|P2|Overall Study|Lack of Efficacy|23
5900728|NCT01681433|20414571|P1|Overall Study|Lack of Efficacy|23
5900729|NCT01681368|20414589|P1|Overall Study|Refused further follow up|1
5900730|NCT01681368|20414589|P1|Overall Study|Refused further treatment|1
5900731|NCT01681277|20414606|P5|Overall Study|Adverse Event|0
5900732|NCT01681277|20414607|P4|Overall Study|Adverse Event|0
5900733|NCT01681277|20414608|P3|Overall Study|Adverse Event|0
5900734|NCT01681277|20414609|P2|Overall Study|Adverse Event|0
5900735|NCT01681277|20414610|P1|Overall Study|Adverse Event|1
5900736|NCT01681212|20414651|P1|Overall Study|Administrative reason by sponsor|1
5900737|NCT01681212|20414651|P1|Overall Study|No longer met study criteria|5
5900738|NCT01681186|20414665|P8|Fourth Intervention|Protocol Violation|1
5900739|NCT01681186|20414666|P7|Fourth Intervention|Protocol Violation|0
5900740|NCT01681186|20414667|P6|Fourth Intervention|Protocol Violation|0
5900741|NCT01681186|20414668|P5|Fourth Intervention|Protocol Violation|0
5900742|NCT01681186|20414669|P4|Fourth Intervention|Protocol Violation|0
5900743|NCT01681186|20414670|P3|Fourth Intervention|Protocol Violation|0
5900744|NCT01681186|20414671|P2|Fourth Intervention|Protocol Violation|0
5900745|NCT01681186|20414672|P1|Fourth Intervention|Protocol Violation|0
5900746|NCT01681186|20414665|P8|Washout Period From Third Intervention|Lost to Follow-up|0
5900747|NCT01681186|20414666|P7|Washout Period From Third Intervention|Lost to Follow-up|1
5900748|NCT01681186|20414667|P6|Washout Period From Third Intervention|Lost to Follow-up|0
5900749|NCT01681186|20414668|P5|Washout Period From Third Intervention|Lost to Follow-up|0
5900750|NCT01681186|20414669|P4|Washout Period From Third Intervention|Lost to Follow-up|0
5900751|NCT01681186|20414670|P3|Washout Period From Third Intervention|Lost to Follow-up|0
5900752|NCT01681186|20414671|P2|Washout Period From Third Intervention|Lost to Follow-up|0
5900753|NCT01681186|20414672|P1|Washout Period From Third Intervention|Lost to Follow-up|0
5900754|NCT01681186|20414665|P8|Washout Period From Second Intervention|Protocol Violation|1
5900755|NCT01681186|20414666|P7|Washout Period From Second Intervention|Protocol Violation|0
5900756|NCT01681186|20414667|P6|Washout Period From Second Intervention|Protocol Violation|0
5900757|NCT01681186|20414668|P5|Washout Period From Second Intervention|Protocol Violation|0
5900758|NCT01681186|20414669|P4|Washout Period From Second Intervention|Protocol Violation|0
5900759|NCT01681186|20414670|P3|Washout Period From Second Intervention|Protocol Violation|0
5900760|NCT01681186|20414671|P2|Washout Period From Second Intervention|Protocol Violation|0
5900761|NCT01681186|20414672|P1|Washout Period From Second Intervention|Protocol Violation|0
5900762|NCT01681186|20414665|P8|Washout Period From Second Intervention|Adverse Event|0
5900763|NCT01681186|20414666|P7|Washout Period From Second Intervention|Adverse Event|1
5900764|NCT01681186|20414667|P6|Washout Period From Second Intervention|Adverse Event|0
5900765|NCT01681186|20414668|P5|Washout Period From Second Intervention|Adverse Event|0
5900766|NCT01681186|20414669|P4|Washout Period From Second Intervention|Adverse Event|0
5900767|NCT01681186|20414670|P3|Washout Period From Second Intervention|Adverse Event|0
5900768|NCT01681186|20414671|P2|Washout Period From Second Intervention|Adverse Event|0
5900769|NCT01681186|20414672|P1|Washout Period From Second Intervention|Adverse Event|0
5900770|NCT01681069|20414775|P2|Overall Study|Adverse Event|1
5900771|NCT01681069|20414776|P1|Overall Study|Adverse Event|0
5900772|NCT01681069|20414775|P2|Overall Study|Protocol Violation|1
5900773|NCT01681069|20414776|P1|Overall Study|Protocol Violation|1
5900774|NCT01681069|20414775|P2|Overall Study|Withdrawal by Subject|5
5900775|NCT01681069|20414776|P1|Overall Study|Withdrawal by Subject|4
5900776|NCT01681004|20414813|P2|Study Completion|Death|1
5900777|NCT01681004|20414814|P1|Study Completion|Death|1
5900778|NCT01681004|20414813|P2|Study Completion|Site Termination|1
5900779|NCT01681004|20414814|P1|Study Completion|Site Termination|2
5900780|NCT01681004|20414813|P2|Study Completion|Physician Decision|3
5900781|NCT01681004|20414814|P1|Study Completion|Physician Decision|1
5900782|NCT01681004|20414813|P2|Study Completion|Lost to Follow-up|3
5900783|NCT01681004|20414814|P1|Study Completion|Lost to Follow-up|8
5900784|NCT01681004|20414813|P2|Primary Endpoint: 6 Months|Withdrawal by Subject|2
5900785|NCT01681004|20414814|P1|Primary Endpoint: 6 Months|Withdrawal by Subject|1
5900786|NCT01680991|20414871|P3|Overall Study|PD confirmed in other hospital|0
5900787|NCT01680991|20414872|P2|Overall Study|PD confirmed in other hospital|0
5900788|NCT01680991|20414873|P1|Overall Study|PD confirmed in other hospital|1
5900789|NCT01680991|20414871|P3|Overall Study|Bad physical condition|1
5900790|NCT01680991|20414872|P2|Overall Study|Bad physical condition|0
5900791|NCT01680991|20414873|P1|Overall Study|Bad physical condition|0
5900792|NCT01680991|20414871|P3|Overall Study|Physician Decision|2
5900793|NCT01680991|20414872|P2|Overall Study|Physician Decision|7
5900794|NCT01680991|20414873|P1|Overall Study|Physician Decision|0
5900795|NCT01680991|20414871|P3|Overall Study|Progressive disease (PD)|0
5900796|NCT01680991|20414872|P2|Overall Study|Progressive disease (PD)|10
5900797|NCT01680991|20414873|P1|Overall Study|Progressive disease (PD)|0
5900798|NCT01680991|20414871|P3|Overall Study|Withdrawal by Subject|0
5900799|NCT01680991|20414872|P2|Overall Study|Withdrawal by Subject|1
5900800|NCT01680991|20414873|P1|Overall Study|Withdrawal by Subject|5
5900801|NCT01680991|20414871|P3|Overall Study|Protocol Violation|0
5900802|NCT01680991|20414872|P2|Overall Study|Protocol Violation|1
5900803|NCT01680991|20414873|P1|Overall Study|Protocol Violation|0
5900804|NCT01680991|20414871|P3|Overall Study|Death|1
5900805|NCT01680991|20414872|P2|Overall Study|Death|0
5900806|NCT01680991|20414873|P1|Overall Study|Death|1
5900807|NCT01680991|20414871|P3|Overall Study|Adverse Event|0
5900808|NCT01680991|20414872|P2|Overall Study|Adverse Event|0
5900809|NCT01680991|20414873|P1|Overall Study|Adverse Event|1
5900810|NCT01680965|20414936|P4|Overall Study|Death|6
5900811|NCT01680965|20414937|P3|Overall Study|Death|0
5900812|NCT01680965|20414938|P2|Overall Study|Death|0
5900813|NCT01680965|20414939|P1|Overall Study|Death|0
5900814|NCT01680861|20414980|P2|Early Post-transplant Period|Protocol Violation|1
5900815|NCT01680861|20414981|P1|Early Post-transplant Period|Protocol Violation|1
5900816|NCT01680497|20415078|P1|Overall Study|Lost to Follow-up|2
5900817|NCT01680341|20415090|P2|Overall Study|Unclassified|15
5900818|NCT01680341|20415091|P1|Overall Study|Unclassified|18
5900819|NCT01680341|20415090|P2|Overall Study|Adverse Event|2
5900820|NCT01680341|20415091|P1|Overall Study|Adverse Event|3
5900821|NCT01680159|20415162|P1|Increased Dose Period|Withdrawal by Subject|2
5900822|NCT01680159|20415162|P1|Increased Dose Period|Adverse Event|6
5900823|NCT01680159|20415162|P1|Screening Period|Not meet criteria for dose-up period|7
5900824|NCT01680016|20415189|P4|Overall Study|Withdrawal by Subject|1
5900825|NCT01680016|20415190|P3|Overall Study|Withdrawal by Subject|1
5900826|NCT01680016|20415191|P2|Overall Study|Withdrawal by Subject|7
5900827|NCT01680016|20415192|P1|Overall Study|Withdrawal by Subject|5
5900828|NCT01680016|20415189|P4|Overall Study|Protocol Violation|0
5900829|NCT01680016|20415190|P3|Overall Study|Protocol Violation|0
5900830|NCT01680016|20415191|P2|Overall Study|Protocol Violation|1
5900831|NCT01680016|20415192|P1|Overall Study|Protocol Violation|0
5900832|NCT01680016|20415189|P4|Overall Study|The Subject went out of The Trial|0
5900833|NCT01680016|20415190|P3|Overall Study|The Subject went out of The Trial|3
5900834|NCT01680016|20415191|P2|Overall Study|The Subject went out of The Trial|0
5900835|NCT01680016|20415192|P1|Overall Study|The Subject went out of The Trial|1
5900836|NCT01680016|20415189|P4|Overall Study|Adverse Event|4
5900837|NCT01680016|20415190|P3|Overall Study|Adverse Event|1
5900838|NCT01680016|20415191|P2|Overall Study|Adverse Event|0
5900839|NCT01680016|20415192|P1|Overall Study|Adverse Event|0
5900840|NCT01679613|20415254|P4|Overall Study|other than stated above|2
5900841|NCT01679613|20415255|P3|Overall Study|other than stated above|2
5900842|NCT01679613|20415256|P2|Overall Study|other than stated above|1
5900843|NCT01679613|20415257|P1|Overall Study|other than stated above|0
5900844|NCT01679405|20415279|P2|Overall Study|Death|5
5900845|NCT01679405|20415280|P1|Overall Study|Death|2
5900846|NCT01679301|20415315|P3|Screening Period|screen failure|0
5900847|NCT01679301|20415316|P2|Screening Period|screen failure|0
5900848|NCT01679301|20415317|P1|Screening Period|screen failure|3
5900849|NCT01679236|20415325|P2|Overall Study|Lost to Follow-up|15
5900850|NCT01679236|20415326|P1|Overall Study|Lost to Follow-up|15
5900851|NCT01679002|20415373|P3|Overall Study|Adverse Event|0
5900852|NCT01679002|20415374|P2|Overall Study|Adverse Event|1
5900853|NCT01679002|20415375|P1|Overall Study|Adverse Event|1
5900854|NCT01678924|20415406|P4|Overall Study|Unable to attend scheduled visits|1
5900855|NCT01678924|20415407|P3|Overall Study|Unable to attend scheduled visits|0
5900856|NCT01678924|20415408|P2|Overall Study|Unable to attend scheduled visits|0
5900857|NCT01678924|20415409|P1|Overall Study|Unable to attend scheduled visits|0
5900858|NCT01678924|20415406|P4|Overall Study|Withdrawal by Subject|2
5900859|NCT01678924|20415407|P3|Overall Study|Withdrawal by Subject|0
5900860|NCT01678924|20415408|P2|Overall Study|Withdrawal by Subject|3
5900861|NCT01678924|20415409|P1|Overall Study|Withdrawal by Subject|0
5900862|NCT01678924|20415406|P4|Overall Study|Personal Reasons|7
5900863|NCT01678924|20415407|P3|Overall Study|Personal Reasons|2
5900864|NCT01678924|20415408|P2|Overall Study|Personal Reasons|2
5900865|NCT01678924|20415409|P1|Overall Study|Personal Reasons|2
5900866|NCT01678924|20415406|P4|Overall Study|Lost to Follow-up|2
5900867|NCT01678924|20415407|P3|Overall Study|Lost to Follow-up|0
5900868|NCT01678924|20415408|P2|Overall Study|Lost to Follow-up|4
5900869|NCT01678924|20415409|P1|Overall Study|Lost to Follow-up|0
5900870|NCT01678924|20415406|P4|Overall Study|Lack of Efficacy|5
5900871|NCT01678924|20415407|P3|Overall Study|Lack of Efficacy|0
5900872|NCT01678924|20415408|P2|Overall Study|Lack of Efficacy|2
5900873|NCT01678924|20415409|P1|Overall Study|Lack of Efficacy|7
5900874|NCT01678924|20415406|P4|Overall Study|Adverse Event|1
5900875|NCT01678924|20415407|P3|Overall Study|Adverse Event|0
5900876|NCT01678924|20415408|P2|Overall Study|Adverse Event|1
5900877|NCT01678924|20415409|P1|Overall Study|Adverse Event|1
5900878|NCT01678911|20415540|P2|Second Intervention|Lost to Follow-up|0
5900879|NCT01678911|20415541|P1|Second Intervention|Lost to Follow-up|2
5900880|NCT01678898|20415558|P3|PB-102-F01|Physician Decision|0
5900881|NCT01678898|20415559|P2|PB-102-F01|Physician Decision|1
5900882|NCT01678898|20415560|P1|PB-102-F01|Physician Decision|0
5900883|NCT01678898|20415558|P3|PB-102-F01|Adverse Event|0
5900884|NCT01678898|20415559|P2|PB-102-F01|Adverse Event|1
5900885|NCT01678898|20415560|P1|PB-102-F01|Adverse Event|0
5900886|NCT01678820|20415670|P3|Overall Study|Not treated with double-blind study drug|2
5900887|NCT01678820|20415671|P2|Overall Study|Not treated with double-blind study drug|2
5900888|NCT01678820|20415672|P1|Overall Study|Not treated with double-blind study drug|0
5900889|NCT01678820|20415670|P3|Overall Study|Protocol Violation|4
5900890|NCT01678820|20415671|P2|Overall Study|Protocol Violation|5
5900891|NCT01678820|20415672|P1|Overall Study|Protocol Violation|4
5900892|NCT01678820|20415670|P3|Overall Study|Physician Decision|1
5900893|NCT01678820|20415671|P2|Overall Study|Physician Decision|0
5900894|NCT01678820|20415672|P1|Overall Study|Physician Decision|0
5900895|NCT01678820|20415670|P3|Overall Study|Non-compliance with study drug|0
5900896|NCT01678820|20415671|P2|Overall Study|Non-compliance with study drug|1
5900897|NCT01678820|20415672|P1|Overall Study|Non-compliance with study drug|0
5900898|NCT01678820|20415670|P3|Overall Study|Lost to Follow-up|2
5900899|NCT01678820|20415671|P2|Overall Study|Lost to Follow-up|2
5900900|NCT01678820|20415672|P1|Overall Study|Lost to Follow-up|7
5900901|NCT01678820|20415670|P3|Overall Study|Adverse Event|2
5900902|NCT01678820|20415671|P2|Overall Study|Adverse Event|2
5900903|NCT01678820|20415672|P1|Overall Study|Adverse Event|2
5900904|NCT01678820|20415670|P3|Overall Study|Protocol Specified Criteria|1
5900905|NCT01678820|20415671|P2|Overall Study|Protocol Specified Criteria|3
5900906|NCT01678820|20415672|P1|Overall Study|Protocol Specified Criteria|2
5900907|NCT01678820|20415670|P3|Overall Study|Withdrawal by Subject|2
5900908|NCT01678820|20415671|P2|Overall Study|Withdrawal by Subject|5
5900909|NCT01678820|20415672|P1|Overall Study|Withdrawal by Subject|2
5900910|NCT01678820|20415670|P3|Overall Study|Study Terminated by Sponsor|43
5900911|NCT01678820|20415671|P2|Overall Study|Study Terminated by Sponsor|43
5900912|NCT01678820|20415672|P1|Overall Study|Study Terminated by Sponsor|45
5900913|NCT01678807|20415717|P3|Overall Study|Withdrawn by Parent/Guardian|0
5900914|NCT01678807|20415718|P2|Overall Study|Withdrawn by Parent/Guardian|1
5900915|NCT01678807|20415719|P1|Overall Study|Withdrawn by Parent/Guardian|0
5900916|NCT01678807|20415717|P3|Overall Study|Adverse Event|0
5900917|NCT01678807|20415718|P2|Overall Study|Adverse Event|4
5900918|NCT01678807|20415719|P1|Overall Study|Adverse Event|4
5900919|NCT01678560|20415732|P2|Overall Study|Withdrawal by Subject|1
5900920|NCT01678560|20415733|P1|Overall Study|Withdrawal by Subject|0
5900921|NCT01678560|20415732|P2|Overall Study|Death|1
5900922|NCT01678560|20415733|P1|Overall Study|Death|0
5900923|NCT01678560|20415732|P2|Overall Study|Physician Decision|4
5900924|NCT01678560|20415733|P1|Overall Study|Physician Decision|4
5900925|NCT01678313|20415754|P2|Prostate Biopsy at 3 Months|Not received prostate biopsy|12
5900926|NCT01678313|20415755|P1|Prostate Biopsy at 3 Months|Not received prostate biopsy|11
5900927|NCT01678313|20415754|P2|PSA >4 ng/dL at 3 Months|PSA≦4|9
5900928|NCT01678313|20415755|P1|PSA >4 ng/dL at 3 Months|PSA≦4|8
5900929|NCT01678313|20415754|P2|Completed the 3-month Therapy|Physician Decision|4
5900930|NCT01678313|20415755|P1|Completed the 3-month Therapy|Physician Decision|3
5900931|NCT01678313|20415754|P2|Completed the 3-month Therapy|Lost to Follow-up|8
5900932|NCT01678313|20415755|P1|Completed the 3-month Therapy|Lost to Follow-up|3
5900933|NCT01678209|20415774|P3|Overall Study|screen fail|16
5900934|NCT01678209|20415775|P2|Overall Study|screen fail|17
5900935|NCT01678209|20415776|P1|Overall Study|screen fail|16
5900936|NCT01678209|20415774|P3|Overall Study|scheduling conflicts|1
5900937|NCT01678209|20415775|P2|Overall Study|scheduling conflicts|0
5900938|NCT01678209|20415776|P1|Overall Study|scheduling conflicts|0
5900939|NCT01678209|20415774|P3|Overall Study|could not scan twice|1
5900940|NCT01678209|20415775|P2|Overall Study|could not scan twice|1
5900941|NCT01678209|20415776|P1|Overall Study|could not scan twice|1
5900942|NCT01678144|20415817|P1|Stage 1: MAR Classic|Adverse Event|1
5900943|NCT01678131|20415836|P3|Overall Study|Withdrawal by Subject|2
5900944|NCT01678131|20415837|P2|Overall Study|Withdrawal by Subject|0
5900945|NCT01678131|20415838|P1|Overall Study|Withdrawal by Subject|0
5900946|NCT01678131|20415836|P3|Overall Study|Adverse Event|0
5900947|NCT01678131|20415837|P2|Overall Study|Adverse Event|1
5900948|NCT01678131|20415838|P1|Overall Study|Adverse Event|0
5900949|NCT01677988|20415846|P1|Overall Study|Lack of Efficacy|2
5900950|NCT01677936|20415859|P2|Overall Study|Protocol Violation|4
5900951|NCT01677936|20415860|P1|Overall Study|Protocol Violation|0
5900952|NCT01677936|20415859|P2|Overall Study|Lost to Follow-up|0
5900953|NCT01677936|20415860|P1|Overall Study|Lost to Follow-up|1
5900954|NCT01677936|20415859|P2|Overall Study|Adverse Event|0
5900955|NCT01677936|20415860|P1|Overall Study|Adverse Event|1
5900956|NCT01677936|20415859|P2|Overall Study|Protocol Violation|0
5900957|NCT01677936|20415860|P1|Overall Study|Protocol Violation|3
5900958|NCT01677936|20415859|P2|Overall Study|Lost to Follow-up|1
5900959|NCT01677936|20415860|P1|Overall Study|Lost to Follow-up|4
5900960|NCT01677910|20415871|P4|Open-Label Extension Period (OLE)|Lost to Follow-up|1
5900961|NCT01677910|20415872|P3|Open-Label Extension Period (OLE)|Lost to Follow-up|0
5900962|NCT01677910|20415873|P2|Open-Label Extension Period (OLE)|Lost to Follow-up|0
5900963|NCT01677910|20415874|P1|Open-Label Extension Period (OLE)|Lost to Follow-up|0
5900964|NCT01677910|20415871|P4|Open-Label Extension Period (OLE)|Adverse Event|15
5900965|NCT01677910|20415872|P3|Open-Label Extension Period (OLE)|Adverse Event|0
5900966|NCT01677910|20415873|P2|Open-Label Extension Period (OLE)|Adverse Event|0
5900967|NCT01677910|20415874|P1|Open-Label Extension Period (OLE)|Adverse Event|0
5900968|NCT01677910|20415871|P4|Open-Label Extension Period (OLE)|Lack of Efficacy|5
5900969|NCT01677910|20415872|P3|Open-Label Extension Period (OLE)|Lack of Efficacy|0
5900970|NCT01677910|20415873|P2|Open-Label Extension Period (OLE)|Lack of Efficacy|0
5900971|NCT01677910|20415874|P1|Open-Label Extension Period (OLE)|Lack of Efficacy|0
5900972|NCT01677910|20415871|P4|Open-Label Extension Period (OLE)|Withdrawal of Consent|9
5900973|NCT01677910|20415872|P3|Open-Label Extension Period (OLE)|Withdrawal of Consent|0
5900974|NCT01677910|20415873|P2|Open-Label Extension Period (OLE)|Withdrawal of Consent|0
5900975|NCT01677910|20415874|P1|Open-Label Extension Period (OLE)|Withdrawal of Consent|0
5900976|NCT01677910|20415871|P4|Open-Label Extension Period (OLE)|Reason not Specified|2
5900977|NCT01677910|20415872|P3|Open-Label Extension Period (OLE)|Reason not Specified|0
5900978|NCT01677910|20415873|P2|Open-Label Extension Period (OLE)|Reason not Specified|0
5900979|NCT01677910|20415874|P1|Open-Label Extension Period (OLE)|Reason not Specified|0
5900980|NCT01677910|20415871|P4|Open-Label Extension Period (OLE)|Physician Decision|4
5900981|NCT01677910|20415872|P3|Open-Label Extension Period (OLE)|Physician Decision|0
5900982|NCT01677910|20415873|P2|Open-Label Extension Period (OLE)|Physician Decision|0
5900983|NCT01677910|20415874|P1|Open-Label Extension Period (OLE)|Physician Decision|0
5900984|NCT01677910|20415871|P4|Double-Blind Treatment Period|Reason Not Specified|0
5900985|NCT01677910|20415872|P3|Double-Blind Treatment Period|Reason Not Specified|0
5900986|NCT01677910|20415873|P2|Double-Blind Treatment Period|Reason Not Specified|1
5900987|NCT01677910|20415874|P1|Double-Blind Treatment Period|Reason Not Specified|0
5900988|NCT01677910|20415871|P4|Double-Blind Treatment Period|Withdrawal of consent|0
5900989|NCT01677910|20415872|P3|Double-Blind Treatment Period|Withdrawal of consent|3
5900990|NCT01677910|20415873|P2|Double-Blind Treatment Period|Withdrawal of consent|0
5900991|NCT01677910|20415874|P1|Double-Blind Treatment Period|Withdrawal of consent|1
5900992|NCT01677910|20415871|P4|Double-Blind Treatment Period|Physician Decision|0
5900993|NCT01677910|20415872|P3|Double-Blind Treatment Period|Physician Decision|1
5900994|NCT01677910|20415873|P2|Double-Blind Treatment Period|Physician Decision|0
5900995|NCT01677910|20415874|P1|Double-Blind Treatment Period|Physician Decision|0
5900996|NCT01677910|20415871|P4|Double-Blind Treatment Period|Adverse Event|0
5900997|NCT01677910|20415872|P3|Double-Blind Treatment Period|Adverse Event|3
5900998|NCT01677910|20415873|P2|Double-Blind Treatment Period|Adverse Event|2
5900999|NCT01677910|20415874|P1|Double-Blind Treatment Period|Adverse Event|6
5901000|NCT01677858|20415901|P5|Overall Study|Lost to Follow-up|1
5901001|NCT01677858|20415902|P4|Overall Study|Lost to Follow-up|0
5901002|NCT01677858|20415903|P3|Overall Study|Lost to Follow-up|0
5901003|NCT01677858|20415904|P2|Overall Study|Lost to Follow-up|0
5901004|NCT01677858|20415905|P1|Overall Study|Lost to Follow-up|0
5901005|NCT01677858|20415901|P5|Overall Study|Withdrawal by Subject|15
5901006|NCT01677858|20415902|P4|Overall Study|Withdrawal by Subject|0
5901007|NCT01677858|20415903|P3|Overall Study|Withdrawal by Subject|1
5901008|NCT01677858|20415904|P2|Overall Study|Withdrawal by Subject|1
5901009|NCT01677858|20415905|P1|Overall Study|Withdrawal by Subject|0
5901010|NCT01677858|20415901|P5|Overall Study|Progressive Disease|43
5901011|NCT01677858|20415902|P4|Overall Study|Progressive Disease|3
5901012|NCT01677858|20415903|P3|Overall Study|Progressive Disease|9
5901013|NCT01677858|20415904|P2|Overall Study|Progressive Disease|1
5901014|NCT01677858|20415905|P1|Overall Study|Progressive Disease|2
5901015|NCT01677858|20415901|P5|Overall Study|Physician Decision|12
5901016|NCT01677858|20415902|P4|Overall Study|Physician Decision|0
5901017|NCT01677858|20415903|P3|Overall Study|Physician Decision|2
5901018|NCT01677858|20415904|P2|Overall Study|Physician Decision|0
5901019|NCT01677858|20415905|P1|Overall Study|Physician Decision|1
5901020|NCT01677858|20415901|P5|Overall Study|Death|1
5901021|NCT01677858|20415902|P4|Overall Study|Death|0
5901022|NCT01677858|20415903|P3|Overall Study|Death|0
5901023|NCT01677858|20415904|P2|Overall Study|Death|0
5901024|NCT01677858|20415905|P1|Overall Study|Death|0
5901025|NCT01677858|20415901|P5|Overall Study|Adverse Event|13
5901026|NCT01677858|20415902|P4|Overall Study|Adverse Event|3
5901027|NCT01677858|20415903|P3|Overall Study|Adverse Event|2
5901028|NCT01677858|20415904|P2|Overall Study|Adverse Event|0
5901029|NCT01677858|20415905|P1|Overall Study|Adverse Event|0
5901030|NCT01677767|20415978|P1|Overall Study|Non-compliance by the participants|3
5901031|NCT01677767|20415978|P1|Overall Study|Withdrawal by Subject|10
5901032|NCT01677767|20415978|P1|Overall Study|Protocol Violation|4
5901033|NCT01677767|20415978|P1|Overall Study|Death|4
5901034|NCT01677767|20415978|P1|Overall Study|Adverse Event|1
5901035|NCT01677624|20415992|P1|Overall Study|Insuf Resp: intra-articular hemorrhage|1
5901036|NCT01677507|20415997|P2|Second Assigment|Adverse Event|3
5901037|NCT01677507|20415998|P1|Second Assigment|Adverse Event|1
5901038|NCT01677507|20415997|P2|Second Assigment|Withdrawal by Subject|2
5901039|NCT01677507|20415998|P1|Second Assigment|Withdrawal by Subject|2
5901040|NCT01677507|20415997|P2|Initial Assignment|Protocol Violation|1
5901041|NCT01677507|20415998|P1|Initial Assignment|Protocol Violation|0
5901042|NCT01677507|20415997|P2|Initial Assignment|Adverse Event|1
5901043|NCT01677507|20415998|P1|Initial Assignment|Adverse Event|0
5901044|NCT01677377|20416011|P3|Overall Study|Pregnancy|1
5901045|NCT01677377|20416012|P2|Overall Study|Pregnancy|0
5901046|NCT01677377|20416013|P1|Overall Study|Pregnancy|0
5901047|NCT01677377|20416011|P3|Overall Study|Lack of Efficacy|1
5901048|NCT01677377|20416012|P2|Overall Study|Lack of Efficacy|0
5901049|NCT01677377|20416013|P1|Overall Study|Lack of Efficacy|0
5901050|NCT01677377|20416011|P3|Overall Study|Withdrawal by Subject|3
5901051|NCT01677377|20416012|P2|Overall Study|Withdrawal by Subject|0
5901052|NCT01677377|20416013|P1|Overall Study|Withdrawal by Subject|0
5901053|NCT01677377|20416011|P3|Overall Study|Lost to Follow-up|1
5901054|NCT01677377|20416012|P2|Overall Study|Lost to Follow-up|1
5901055|NCT01677377|20416013|P1|Overall Study|Lost to Follow-up|0
5901056|NCT01677377|20416011|P3|Overall Study|Protocol Violation|0
5901057|NCT01677377|20416012|P2|Overall Study|Protocol Violation|0
5901058|NCT01677377|20416013|P1|Overall Study|Protocol Violation|1
5901059|NCT01677299|20416229|P4|Overall Study|Withdrawal by Subject|1
5901060|NCT01677299|20416230|P3|Overall Study|Withdrawal by Subject|0
5901061|NCT01677299|20416231|P2|Overall Study|Withdrawal by Subject|1
5901062|NCT01677299|20416232|P1|Overall Study|Withdrawal by Subject|0
5901063|NCT01677299|20416229|P4|Overall Study|Adverse Event|0
5901064|NCT01677299|20416230|P3|Overall Study|Adverse Event|1
5901065|NCT01677299|20416231|P2|Overall Study|Adverse Event|2
5901066|NCT01677299|20416232|P1|Overall Study|Adverse Event|0
5901067|NCT01677195|20416264|P3|Overall Study|Protocol Violation|4
5901068|NCT01677195|20416265|P2|Overall Study|Protocol Violation|3
5901069|NCT01677195|20416266|P1|Overall Study|Protocol Violation|7
5901070|NCT01677195|20416264|P3|Overall Study|Pregnancy|0
5901071|NCT01677195|20416265|P2|Overall Study|Pregnancy|1
5901072|NCT01677195|20416266|P1|Overall Study|Pregnancy|0
5901073|NCT01677195|20416264|P3|Overall Study|Physician Decision|2
5901074|NCT01677195|20416265|P2|Overall Study|Physician Decision|2
5901075|NCT01677195|20416266|P1|Overall Study|Physician Decision|1
5901076|NCT01677195|20416264|P3|Overall Study|Adverse Event|1
5901077|NCT01677195|20416265|P2|Overall Study|Adverse Event|4
5901078|NCT01677195|20416266|P1|Overall Study|Adverse Event|6
5901079|NCT01677195|20416264|P3|Overall Study|Withdrawal by Subject|1
5901080|NCT01677195|20416265|P2|Overall Study|Withdrawal by Subject|0
5901081|NCT01677195|20416266|P1|Overall Study|Withdrawal by Subject|1
5901082|NCT01677195|20416264|P3|Overall Study|Lost to Follow-up|22
5901083|NCT01677195|20416265|P2|Overall Study|Lost to Follow-up|22
5901084|NCT01677195|20416266|P1|Overall Study|Lost to Follow-up|14
5901085|NCT01677182|20416277|P3|Overall Study|Other reasons|2
5901086|NCT01677182|20416278|P2|Overall Study|Other reasons|5
5901087|NCT01677182|20416279|P1|Overall Study|Other reasons|1
5901088|NCT01677182|20416277|P3|Overall Study|Lack of Efficacy|1
5901089|NCT01677182|20416278|P2|Overall Study|Lack of Efficacy|0
5901090|NCT01677182|20416279|P1|Overall Study|Lack of Efficacy|3
5901091|NCT01677182|20416277|P3|Overall Study|Study termination|11
5901092|NCT01677182|20416278|P2|Overall Study|Study termination|9
5901093|NCT01677182|20416279|P1|Overall Study|Study termination|12
5901094|NCT01677182|20416277|P3|Overall Study|Withdrawal by Subject|10
5901095|NCT01677182|20416278|P2|Overall Study|Withdrawal by Subject|12
5901096|NCT01677182|20416279|P1|Overall Study|Withdrawal by Subject|7
5901097|NCT01677182|20416277|P3|Overall Study|Lost to Follow-up|3
5901098|NCT01677182|20416278|P2|Overall Study|Lost to Follow-up|0
5901099|NCT01677182|20416279|P1|Overall Study|Lost to Follow-up|4
5901100|NCT01677182|20416277|P3|Overall Study|Protocol Violation|4
5901101|NCT01677182|20416278|P2|Overall Study|Protocol Violation|1
5901102|NCT01677182|20416279|P1|Overall Study|Protocol Violation|5
5901103|NCT01677182|20416277|P3|Overall Study|Adverse Event|8
5901104|NCT01677182|20416278|P2|Overall Study|Adverse Event|1
5901105|NCT01677182|20416279|P1|Overall Study|Adverse Event|2
5901106|NCT01676961|20416311|P1|Overall Study|Withdrawal by Subject|1
5901107|NCT01676961|20416311|P1|Overall Study|Lost to Follow-up|1
5901108|NCT01676961|20416311|P1|Overall Study|Death|3
5901109|NCT01676909|20416318|P2|Overall Study|Lost to Follow-up|9
5901110|NCT01676909|20416319|P1|Overall Study|Lost to Follow-up|15
5901111|NCT01676909|20416318|P2|Overall Study|Withdrawal by Subject|5
5901112|NCT01676909|20416319|P1|Overall Study|Withdrawal by Subject|3
5901113|NCT01676896|20416384|P3|Overall Study|Withdrawal by Subject|19
5901114|NCT01676896|20416385|P2|Overall Study|Withdrawal by Subject|7
5901115|NCT01676896|20416386|P1|Overall Study|Withdrawal by Subject|12
5901116|NCT01676727|20416494|P1|Overall Study|Valve explanted|1
5901117|NCT01676727|20416494|P1|Overall Study|Not willing to attend 1-year visit|2
5901118|NCT01676727|20416494|P1|Overall Study|Screening failure|5
5901119|NCT01676727|20416494|P1|Overall Study|Withdrawal by Subject|6
5901120|NCT01676727|20416494|P1|Overall Study|Death|18
5901121|NCT01676701|20416508|P2|Overall Study|Sponsor Decision|4
5901122|NCT01676701|20416509|P1|Overall Study|Sponsor Decision|3
5901123|NCT01676701|20416508|P2|Overall Study|Protocol Violation|0
5901124|NCT01676701|20416509|P1|Overall Study|Protocol Violation|1
5901125|NCT01676220|20416611|P2|Overall Study|No More Need of Insulin|0
5901126|NCT01676220|20416612|P1|Overall Study|No More Need of Insulin|1
5901127|NCT01676220|20416611|P2|Overall Study|Non Serious Hypoglycemia|0
5901128|NCT01676220|20416612|P1|Overall Study|Non Serious Hypoglycemia|2
5901129|NCT01676220|20416611|P2|Overall Study|Perceived Lack of Efficacy|1
5901130|NCT01676220|20416612|P1|Overall Study|Perceived Lack of Efficacy|3
5901131|NCT01676220|20416611|P2|Overall Study|Site Closure/Site Withdrawal|4
5901132|NCT01676220|20416612|P1|Overall Study|Site Closure/Site Withdrawal|1
5901133|NCT01676220|20416611|P2|Overall Study|Selection Criterion/Protocol Violation|9
5901134|NCT01676220|20416612|P1|Overall Study|Selection Criterion/Protocol Violation|9
5901135|NCT01676220|20416611|P2|Overall Study|Lost to Follow-up|18
5901136|NCT01676220|20416612|P1|Overall Study|Lost to Follow-up|11
5901137|NCT01676220|20416611|P2|Overall Study|Personal Reason|45
5901138|NCT01676220|20416612|P1|Overall Study|Personal Reason|34
5901139|NCT01676220|20416611|P2|Overall Study|Received Rescue Therapy|22
5901140|NCT01676220|20416612|P1|Overall Study|Received Rescue Therapy|14
5901141|NCT01676220|20416611|P2|Overall Study|Protocol Violation|12
5901142|NCT01676220|20416612|P1|Overall Study|Protocol Violation|11
5901143|NCT01676220|20416611|P2|Overall Study|Lack of Efficacy|5
5901144|NCT01676220|20416612|P1|Overall Study|Lack of Efficacy|2
5901145|NCT01676220|20416611|P2|Overall Study|Adverse Event|8
5901146|NCT01676220|20416612|P1|Overall Study|Adverse Event|10
5901147|NCT01676220|20416611|P2|Overall Study|Randomized But Not Treated|1
5901148|NCT01676220|20416612|P1|Overall Study|Randomized But Not Treated|4
5901149|NCT01676116|20416644|P2|Overall Study|Protocol Violation|3
5901150|NCT01676116|20416645|P1|Overall Study|Protocol Violation|9
5901151|NCT01676116|20416644|P2|Overall Study|Unclassified|10
5901152|NCT01676116|20416645|P1|Overall Study|Unclassified|4
5901153|NCT01676116|20416644|P2|Overall Study|Adverse Event|2
5901154|NCT01676116|20416645|P1|Overall Study|Adverse Event|1
5901155|NCT01676116|20416644|P2|Overall Study|Withdrawal criteria|14
5901156|NCT01676116|20416645|P1|Overall Study|Withdrawal criteria|2
5901157|NCT01676012|20416667|P1|Overall Study|incomplete set of videos|1
5901158|NCT01676012|20416667|P1|Overall Study|Adverse Event|2
5901159|NCT01675765|20416711|P2|Overall Study|Clinical progression|2
5901160|NCT01675765|20416712|P1|Overall Study|Clinical progression|3
5901161|NCT01675765|20416711|P2|Overall Study|Death|0
5901162|NCT01675765|20416712|P1|Overall Study|Death|1
5901163|NCT01675765|20416711|P2|Overall Study|Withdrawal by Subject|0
5901164|NCT01675765|20416712|P1|Overall Study|Withdrawal by Subject|2
5901165|NCT01675765|20416711|P2|Overall Study|Adverse Event|2
5901166|NCT01675765|20416712|P1|Overall Study|Adverse Event|1
5901167|NCT01675765|20416711|P2|Overall Study|Progressive disease|4
5901168|NCT01675765|20416712|P1|Overall Study|Progressive disease|4
5901169|NCT01675661|20416728|P2|Overall Study|Other reason|2
5901170|NCT01675661|20416729|P1|Overall Study|Other reason|1
5901171|NCT01675661|20416728|P2|Overall Study|Death|1
5901172|NCT01675661|20416729|P1|Overall Study|Death|0
5901173|NCT01675661|20416728|P2|Overall Study|Physician Decision|2
5901174|NCT01675661|20416729|P1|Overall Study|Physician Decision|0
5901175|NCT01675661|20416728|P2|Overall Study|Withdrawal by Subject|7
5901176|NCT01675661|20416729|P1|Overall Study|Withdrawal by Subject|3
5901177|NCT01675661|20416728|P2|Overall Study|Moved away|6
5901178|NCT01675661|20416729|P1|Overall Study|Moved away|5
5901179|NCT01675661|20416728|P2|Overall Study|Practical problems|5
5901180|NCT01675661|20416729|P1|Overall Study|Practical problems|9
5901181|NCT01675661|20416728|P2|Overall Study|Lost to Follow-up|23
5901182|NCT01675661|20416729|P1|Overall Study|Lost to Follow-up|22
5901183|NCT01675622|20416758|P2|Overall Study|Other|4
5901184|NCT01675622|20416759|P1|Overall Study|Other|5
5901185|NCT01675622|20416758|P2|Overall Study|Lost to Follow-up|3
5901186|NCT01675622|20416759|P1|Overall Study|Lost to Follow-up|1
5901187|NCT01675622|20416758|P2|Overall Study|Lack of Efficacy|4
5901188|NCT01675622|20416759|P1|Overall Study|Lack of Efficacy|2
5901189|NCT01675622|20416758|P2|Overall Study|Protocol Violation|1
5901190|NCT01675622|20416759|P1|Overall Study|Protocol Violation|4
5901191|NCT01675622|20416758|P2|Overall Study|Adverse Event|10
5901192|NCT01675622|20416759|P1|Overall Study|Adverse Event|12
5901193|NCT01675622|20416758|P2|Overall Study|Withdrawal by Subject|2
5901194|NCT01675622|20416759|P1|Overall Study|Withdrawal by Subject|2
5901195|NCT01675596|20416783|P1|Overall Study|Missed Visit|1
5901196|NCT01675596|20416783|P1|Overall Study|Exit with other reason|1
5901197|NCT01675596|20416783|P1|Overall Study|Death|6
5901198|NCT01675544|20416789|P1|Overall Study|Withdrawal by Subject|2
5901199|NCT01675531|20416794|P1|Overall Study|Protocol Violation|8
5901200|NCT01675531|20416794|P1|Overall Study|Lack of Efficacy|1
5901201|NCT01675531|20416794|P1|Overall Study|Withdrawal by Subject|7
5901202|NCT01675531|20416794|P1|Overall Study|Adverse Event|9
5901203|NCT01675492|20416801|P1|Overall Study|study completed early - product approval|42
5901204|NCT01675479|20416806|P1|Overall Study|Lost to Follow-up|11
5901205|NCT01675427|20416820|P1|Overall Study|Other|2
5901206|NCT01675427|20416820|P1|Overall Study|Lost to Follow-up|5
5901207|NCT01675427|20416820|P1|Overall Study|Sample not Collected by Mistake|2
5901208|NCT01675427|20416820|P1|Overall Study|Participant Refused Sample Collection|18
5901209|NCT01675427|20416820|P1|Overall Study|Withdrawal by Subject|7
5901210|NCT01675167|20417120|P3|Double-blind Treatment Phase|Other|5
5901211|NCT01675167|20417121|P2|Double-blind Treatment Phase|Other|7
5901212|NCT01675167|20417122|P1|Double-blind Treatment Phase|Other|0
5901213|NCT01675167|20417120|P3|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|9
5901214|NCT01675167|20417121|P2|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1
5901215|NCT01675167|20417122|P1|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0
5901216|NCT01675167|20417120|P3|Double-blind Treatment Phase|Lost to Follow-up|5
5901217|NCT01675167|20417121|P2|Double-blind Treatment Phase|Lost to Follow-up|1
5901218|NCT01675167|20417122|P1|Double-blind Treatment Phase|Lost to Follow-up|0
5901219|NCT01675167|20417120|P3|Double-blind Treatment Phase|Protocol Violation|11
5901220|NCT01675167|20417121|P2|Double-blind Treatment Phase|Protocol Violation|4
5901221|NCT01675167|20417122|P1|Double-blind Treatment Phase|Protocol Violation|0
5901222|NCT01675167|20417120|P3|Double-blind Treatment Phase|Adverse Event|13
5901223|NCT01675167|20417121|P2|Double-blind Treatment Phase|Adverse Event|5
5901224|NCT01675167|20417122|P1|Double-blind Treatment Phase|Adverse Event|0
5901225|NCT01675167|20417120|P3|Double-blind Treatment Phase|Withdrawal by Subject|6
5901226|NCT01675167|20417121|P2|Double-blind Treatment Phase|Withdrawal by Subject|11
5901227|NCT01675167|20417122|P1|Double-blind Treatment Phase|Withdrawal by Subject|0
5901228|NCT01675167|20417120|P3|Double-blind Treatment Phase|Lack of Efficacy|61
5901229|NCT01675167|20417121|P2|Double-blind Treatment Phase|Lack of Efficacy|19
5901230|NCT01675167|20417122|P1|Double-blind Treatment Phase|Lack of Efficacy|0
5901231|NCT01675167|20417120|P3|Open-label Titration Phase|Other|0
5901232|NCT01675167|20417121|P2|Open-label Titration Phase|Other|0
5901233|NCT01675167|20417122|P1|Open-label Titration Phase|Other|55
5901234|NCT01675167|20417120|P3|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0
5901235|NCT01675167|20417121|P2|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0
5901236|NCT01675167|20417122|P1|Open-label Titration Phase|Withdrawal due to opioid withdrawal|1
5901237|NCT01675167|20417120|P3|Open-label Titration Phase|Lost to Follow-up|0
5901238|NCT01675167|20417121|P2|Open-label Titration Phase|Lost to Follow-up|0
5901239|NCT01675167|20417122|P1|Open-label Titration Phase|Lost to Follow-up|15
5901240|NCT01675167|20417120|P3|Open-label Titration Phase|Protocol Violation|0
5901241|NCT01675167|20417121|P2|Open-label Titration Phase|Protocol Violation|0
5901242|NCT01675167|20417122|P1|Open-label Titration Phase|Protocol Violation|43
5901243|NCT01675167|20417120|P3|Open-label Titration Phase|Withdrawal by Subject|0
5901244|NCT01675167|20417121|P2|Open-label Titration Phase|Withdrawal by Subject|0
5901245|NCT01675167|20417122|P1|Open-label Titration Phase|Withdrawal by Subject|46
5901246|NCT01675167|20417120|P3|Open-label Titration Phase|Lack of Efficacy|0
5901247|NCT01675167|20417121|P2|Open-label Titration Phase|Lack of Efficacy|0
5901248|NCT01675167|20417122|P1|Open-label Titration Phase|Lack of Efficacy|63
5901249|NCT01675167|20417120|P3|Open-label Titration Phase|Adverse Event|0
5901250|NCT01675167|20417121|P2|Open-label Titration Phase|Adverse Event|0
5901251|NCT01675167|20417122|P1|Open-label Titration Phase|Adverse Event|81
5901252|NCT01675141|20417144|P1|Overall Study|No treatment, per protocol|1
5901253|NCT01675141|20417144|P1|Overall Study|Physician Decision|4
5901254|NCT01675141|20417144|P1|Overall Study|Withdrawal by Subject|3
5901255|NCT01675141|20417144|P1|Overall Study|Lenalidomide outside NIH|3
5901256|NCT01675128|20417157|P3|Overall Study|Pulmonary complication; off study|0
5901257|NCT01675128|20417158|P2|Overall Study|Pulmonary complication; off study|1
5901258|NCT01675128|20417159|P1|Overall Study|Pulmonary complication; off study|0
5901259|NCT01675128|20417157|P3|Overall Study|Refused further treatment|0
5901260|NCT01675128|20417158|P2|Overall Study|Refused further treatment|0
5901261|NCT01675128|20417159|P1|Overall Study|Refused further treatment|1
5901262|NCT01675128|20417157|P3|Overall Study|Disease progression on study|1
5901263|NCT01675128|20417158|P2|Overall Study|Disease progression on study|1
5901264|NCT01675128|20417159|P1|Overall Study|Disease progression on study|1
5901265|NCT01675050|20417187|P2|Period One Treatment|Withdrawal by Subject|0
5901266|NCT01675050|20417188|P1|Period One Treatment|Withdrawal by Subject|1
5901267|NCT01675011|20417198|P2|Overall Study|Trial terminated by Sponsor|1
5901268|NCT01675011|20417199|P1|Overall Study|Trial terminated by Sponsor|3
5901269|NCT01674725|20417207|P2|Overall Study|Lost to Follow-up|1
5901270|NCT01674725|20417208|P1|Overall Study|Lost to Follow-up|0
5901271|NCT01674725|20417207|P2|Overall Study|Withdrawal by Subject|0
5901272|NCT01674725|20417208|P1|Overall Study|Withdrawal by Subject|1
5901273|NCT01674725|20417207|P2|Overall Study|Did not receive study drug|0
5901274|NCT01674725|20417208|P1|Overall Study|Did not receive study drug|1
5901275|NCT01674725|20417207|P2|Overall Study|Adverse Event|0
5901276|NCT01674725|20417208|P1|Overall Study|Adverse Event|1
5901277|NCT01674712|20417227|P5|Overall Study|Lack of Efficacy|1
5901278|NCT01674712|20417228|P4|Overall Study|Lack of Efficacy|0
5901279|NCT01674712|20417229|P3|Overall Study|Lack of Efficacy|1
5901280|NCT01674712|20417230|P2|Overall Study|Lack of Efficacy|0
5901281|NCT01674712|20417231|P1|Overall Study|Lack of Efficacy|0
5901282|NCT01674712|20417227|P5|Overall Study|Administrative|1
5901283|NCT01674712|20417228|P4|Overall Study|Administrative|0
5901284|NCT01674712|20417229|P3|Overall Study|Administrative|0
5901285|NCT01674712|20417230|P2|Overall Study|Administrative|1
5901286|NCT01674712|20417231|P1|Overall Study|Administrative|0
5901287|NCT01674712|20417227|P5|Overall Study|Withdrawal by Subject|3
5901288|NCT01674712|20417228|P4|Overall Study|Withdrawal by Subject|4
5901289|NCT01674712|20417229|P3|Overall Study|Withdrawal by Subject|5
5901290|NCT01674712|20417230|P2|Overall Study|Withdrawal by Subject|2
5901291|NCT01674712|20417231|P1|Overall Study|Withdrawal by Subject|2
5901292|NCT01674712|20417227|P5|Overall Study|Protocol Violation|0
5901293|NCT01674712|20417228|P4|Overall Study|Protocol Violation|0
5901294|NCT01674712|20417229|P3|Overall Study|Protocol Violation|0
5901295|NCT01674712|20417230|P2|Overall Study|Protocol Violation|0
5901296|NCT01674712|20417231|P1|Overall Study|Protocol Violation|2
5901297|NCT01674712|20417227|P5|Overall Study|Lost to Follow-up|0
5901298|NCT01674712|20417228|P4|Overall Study|Lost to Follow-up|0
5901299|NCT01674712|20417229|P3|Overall Study|Lost to Follow-up|0
5901300|NCT01674712|20417230|P2|Overall Study|Lost to Follow-up|0
5901301|NCT01674712|20417231|P1|Overall Study|Lost to Follow-up|1
5901302|NCT01674712|20417227|P5|Overall Study|Adverse Event|6
5901303|NCT01674712|20417228|P4|Overall Study|Adverse Event|4
5901304|NCT01674712|20417229|P3|Overall Study|Adverse Event|3
5901305|NCT01674712|20417230|P2|Overall Study|Adverse Event|6
5901306|NCT01674712|20417231|P1|Overall Study|Adverse Event|5
5901307|NCT01674647|20417255|P2|30-day Safety Follow-up Period|Lost to Follow-up|5
5901308|NCT01674647|20417256|P1|30-day Safety Follow-up Period|Lost to Follow-up|8
5901309|NCT01674647|20417255|P2|30-day Safety Follow-up Period|Withdrawal by Subject|8
5901310|NCT01674647|20417256|P1|30-day Safety Follow-up Period|Withdrawal by Subject|7
5901311|NCT01674647|20417255|P2|30-day Safety Follow-up Period|Logistical difficulties|3
5901312|NCT01674647|20417256|P1|30-day Safety Follow-up Period|Logistical difficulties|1
5901313|NCT01674647|20417255|P2|30-day Safety Follow-up Period|Protocol Violation|22
5901314|NCT01674647|20417256|P1|30-day Safety Follow-up Period|Protocol Violation|39
5901315|NCT01674647|20417255|P2|30-day Safety Follow-up Period|Non-compliance with study drug|1
5901316|NCT01674647|20417256|P1|30-day Safety Follow-up Period|Non-compliance with study drug|0
5901317|NCT01674647|20417255|P2|30-day Safety Follow-up Period|Death|2
5901318|NCT01674647|20417256|P1|30-day Safety Follow-up Period|Death|3
5901319|NCT01674647|20417255|P2|Treatment Period|Protocol Violation|36
5901320|NCT01674647|20417256|P1|Treatment Period|Protocol Violation|56
5901321|NCT01674647|20417255|P2|Treatment Period|Treatment failure|14
5901322|NCT01674647|20417256|P1|Treatment Period|Treatment failure|0
5901323|NCT01674647|20417255|P2|Treatment Period|Logistical difficulties|8
5901324|NCT01674647|20417256|P1|Treatment Period|Logistical difficulties|5
5901325|NCT01674647|20417255|P2|Treatment Period|Switching to other therapy|2
5901326|NCT01674647|20417256|P1|Treatment Period|Switching to other therapy|5
5901327|NCT01674647|20417255|P2|Treatment Period|Withdrawal by Subject|16
5901328|NCT01674647|20417256|P1|Treatment Period|Withdrawal by Subject|19
5901329|NCT01674647|20417255|P2|Treatment Period|Lost to Follow-up|1
5901330|NCT01674647|20417256|P1|Treatment Period|Lost to Follow-up|1
5901331|NCT01674647|20417255|P2|Treatment Period|Non-compliance with study drug|0
5901332|NCT01674647|20417256|P1|Treatment Period|Non-compliance with study drug|3
5901333|NCT01674647|20417255|P2|Treatment Period|Adverse Event|22
5901334|NCT01674647|20417256|P1|Treatment Period|Adverse Event|60
5901335|NCT01674647|20417255|P2|Treatment Period|Physician Decision|1
5901336|NCT01674647|20417256|P1|Treatment Period|Physician Decision|3
5901337|NCT01674647|20417255|P2|Treatment Period|Efficacy outcome reached|1
5901338|NCT01674647|20417256|P1|Treatment Period|Efficacy outcome reached|0
5901339|NCT01674647|20417255|P2|Treatment Period|Death|1
5901340|NCT01674647|20417256|P1|Treatment Period|Death|4
5901341|NCT01674634|20417282|P1|Overall Study|Lost to Follow-up|3
5901342|NCT01674634|20417282|P1|Overall Study|Withdrawal by Subject|3
5901343|NCT01674621|20417302|P5|Overall Study|Other than specified|2
5901344|NCT01674621|20417303|P4|Overall Study|Other than specified|0
5901345|NCT01674621|20417304|P3|Overall Study|Other than specified|0
5901346|NCT01674621|20417305|P2|Overall Study|Other than specified|1
5901347|NCT01674621|20417306|P1|Overall Study|Other than specified|0
5901348|NCT01674621|20417302|P5|Overall Study|Withdrawal by Subject|1
5901349|NCT01674621|20417303|P4|Overall Study|Withdrawal by Subject|0
5901350|NCT01674621|20417304|P3|Overall Study|Withdrawal by Subject|2
5901351|NCT01674621|20417305|P2|Overall Study|Withdrawal by Subject|5
5901352|NCT01674621|20417306|P1|Overall Study|Withdrawal by Subject|2
5901353|NCT01674621|20417302|P5|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0
5901354|NCT01674621|20417303|P4|Overall Study|Severe Abaloparatide-SC Hypersensitivity|1
5901355|NCT01674621|20417304|P3|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0
5901356|NCT01674621|20417305|P2|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0
5901357|NCT01674621|20417306|P1|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0
5901358|NCT01674621|20417302|P5|Overall Study|Inability to Complete Study Procedures|2
5901359|NCT01674621|20417303|P4|Overall Study|Inability to Complete Study Procedures|0
5901360|NCT01674621|20417304|P3|Overall Study|Inability to Complete Study Procedures|0
5901361|NCT01674621|20417305|P2|Overall Study|Inability to Complete Study Procedures|0
5901362|NCT01674621|20417306|P1|Overall Study|Inability to Complete Study Procedures|0
5901363|NCT01674621|20417302|P5|Overall Study|Adverse Event|1
5901364|NCT01674621|20417303|P4|Overall Study|Adverse Event|5
5901365|NCT01674621|20417304|P3|Overall Study|Adverse Event|5
5901366|NCT01674621|20417305|P2|Overall Study|Adverse Event|2
5901367|NCT01674621|20417306|P1|Overall Study|Adverse Event|3
5901368|NCT01674569|20417383|P6|Overall Study|Withdrawal by Subject|0
5901369|NCT01674569|20417384|P5|Overall Study|Withdrawal by Subject|0
5901370|NCT01674569|20417385|P4|Overall Study|Withdrawal by Subject|0
5901371|NCT01674569|20417386|P3|Overall Study|Withdrawal by Subject|1
5901372|NCT01674569|20417387|P2|Overall Study|Withdrawal by Subject|0
5901373|NCT01674569|20417388|P1|Overall Study|Withdrawal by Subject|0
5901374|NCT01674569|20417383|P6|Overall Study|Protocol Violation|0
5901375|NCT01674569|20417384|P5|Overall Study|Protocol Violation|0
5901376|NCT01674569|20417385|P4|Overall Study|Protocol Violation|0
5901377|NCT01674569|20417386|P3|Overall Study|Protocol Violation|1
5901378|NCT01674569|20417387|P2|Overall Study|Protocol Violation|1
5901379|NCT01674569|20417388|P1|Overall Study|Protocol Violation|0
5901380|NCT01674569|20417383|P6|Overall Study|Adverse Event|2
5901381|NCT01674569|20417384|P5|Overall Study|Adverse Event|2
5901382|NCT01674569|20417385|P4|Overall Study|Adverse Event|1
5901383|NCT01674569|20417386|P3|Overall Study|Adverse Event|0
5901384|NCT01674569|20417387|P2|Overall Study|Adverse Event|2
5901385|NCT01674569|20417388|P1|Overall Study|Adverse Event|0
5901386|NCT01674062|20417409|P2|Overall Study|Programming Error|0
5901387|NCT01674062|20417410|P1|Overall Study|Programming Error|1
5901388|NCT01674062|20417409|P2|Overall Study|Death|1
5901389|NCT01674062|20417410|P1|Overall Study|Death|0
5901390|NCT01674062|20417409|P2|Overall Study|Adverse Event|1
5901391|NCT01674062|20417410|P1|Overall Study|Adverse Event|1
5901392|NCT01674062|20417409|P2|Overall Study|Other|1
5901393|NCT01674062|20417410|P1|Overall Study|Other|8
5901394|NCT01674062|20417409|P2|Overall Study|Insufficient Therapeutic Response|26
5901395|NCT01674062|20417410|P1|Overall Study|Insufficient Therapeutic Response|56
5901396|NCT01674010|20417425|P3|Randomization Phase 2|Withdrawal by Subject|7
5901397|NCT01674010|20417426|P2|Randomization Phase 2|Withdrawal by Subject|8
5901398|NCT01674010|20417427|P1|Randomization Phase 2|Withdrawal by Subject|0
5901399|NCT01674010|20417425|P3|Randomization Phase 2|Sponsor Decision|45
5901400|NCT01674010|20417426|P2|Randomization Phase 2|Sponsor Decision|42
5901401|NCT01674010|20417427|P1|Randomization Phase 2|Sponsor Decision|0
5901402|NCT01674010|20417425|P3|Randomization Phase 2|Protocol Violation|1
5901403|NCT01674010|20417426|P2|Randomization Phase 2|Protocol Violation|1
5901404|NCT01674010|20417427|P1|Randomization Phase 2|Protocol Violation|0
5901405|NCT01674010|20417425|P3|Randomization Phase 2|Pregnancy|1
5901406|NCT01674010|20417426|P2|Randomization Phase 2|Pregnancy|1
5901407|NCT01674010|20417427|P1|Randomization Phase 2|Pregnancy|0
5901408|NCT01674010|20417425|P3|Randomization Phase 2|Physician Decision|2
5901409|NCT01674010|20417426|P2|Randomization Phase 2|Physician Decision|0
5901410|NCT01674010|20417427|P1|Randomization Phase 2|Physician Decision|0
5901411|NCT01674010|20417425|P3|Randomization Phase 2|Mood episode recurrence|2
5901412|NCT01674010|20417426|P2|Randomization Phase 2|Mood episode recurrence|8
5901413|NCT01674010|20417427|P1|Randomization Phase 2|Mood episode recurrence|0
5901414|NCT01674010|20417425|P3|Randomization Phase 2|Lost to Follow-up|2
5901415|NCT01674010|20417426|P2|Randomization Phase 2|Lost to Follow-up|1
5901416|NCT01674010|20417427|P1|Randomization Phase 2|Lost to Follow-up|0
5901417|NCT01674010|20417425|P3|Randomization Phase 2|Adverse Event|1
5901418|NCT01674010|20417426|P2|Randomization Phase 2|Adverse Event|1
5901419|NCT01674010|20417427|P1|Randomization Phase 2|Adverse Event|0
5901420|NCT01674010|20417425|P3|Open Treatment Phase 1|Withdrawal by Subject|0
5901421|NCT01674010|20417426|P2|Open Treatment Phase 1|Withdrawal by Subject|0
5901422|NCT01674010|20417427|P1|Open Treatment Phase 1|Withdrawal by Subject|25
5901423|NCT01674010|20417425|P3|Open Treatment Phase 1|Did not remain in a stable remission|0
5901424|NCT01674010|20417426|P2|Open Treatment Phase 1|Did not remain in a stable remission|0
5901425|NCT01674010|20417427|P1|Open Treatment Phase 1|Did not remain in a stable remission|30
5901426|NCT01674010|20417425|P3|Open Treatment Phase 1|Sponsor Decision|0
5901427|NCT01674010|20417426|P2|Open Treatment Phase 1|Sponsor Decision|0
5901428|NCT01674010|20417427|P1|Open Treatment Phase 1|Sponsor Decision|79
5901429|NCT01674010|20417425|P3|Open Treatment Phase 1|Protocol Violation|0
5901430|NCT01674010|20417426|P2|Open Treatment Phase 1|Protocol Violation|0
5901431|NCT01674010|20417427|P1|Open Treatment Phase 1|Protocol Violation|7
5901432|NCT01674010|20417425|P3|Open Treatment Phase 1|Physician Decision|0
5901433|NCT01674010|20417426|P2|Open Treatment Phase 1|Physician Decision|0
5901434|NCT01674010|20417427|P1|Open Treatment Phase 1|Physician Decision|9
5901435|NCT01674010|20417425|P3|Open Treatment Phase 1|Lost to Follow-up|0
5901436|NCT01674010|20417426|P2|Open Treatment Phase 1|Lost to Follow-up|0
5901437|NCT01674010|20417427|P1|Open Treatment Phase 1|Lost to Follow-up|19
5901438|NCT01674010|20417425|P3|Open Treatment Phase 1|Death|0
5901439|NCT01674010|20417426|P2|Open Treatment Phase 1|Death|0
5901440|NCT01674010|20417427|P1|Open Treatment Phase 1|Death|1
5901441|NCT01674010|20417425|P3|Open Treatment Phase 1|Adverse Event|0
5901442|NCT01674010|20417426|P2|Open Treatment Phase 1|Adverse Event|0
5901443|NCT01674010|20417427|P1|Open Treatment Phase 1|Adverse Event|10
5901444|NCT01673984|20417446|P2|Overall Study|Study termination|6
5901445|NCT01673984|20417447|P1|Overall Study|Study termination|9
5901446|NCT01673984|20417446|P2|Overall Study|Adverse Event|0
5901447|NCT01673984|20417447|P1|Overall Study|Adverse Event|1
5901448|NCT01673867|20417497|P2|Treatment|Physician Decision|1
5901449|NCT01673867|20417498|P1|Treatment|Physician Decision|0
5901450|NCT01673867|20417497|P2|Treatment|Symptomatic deterioration|1
5901451|NCT01673867|20417498|P1|Treatment|Symptomatic deterioration|0
5901452|NCT01673867|20417497|P2|Treatment|Required prolonged hospitalization|1
5901453|NCT01673867|20417498|P1|Treatment|Required prolonged hospitalization|0
5901454|NCT01673867|20417497|P2|Treatment|Health status not improved|0
5901455|NCT01673867|20417498|P1|Treatment|Health status not improved|1
5901456|NCT01673867|20417497|P2|Treatment|Required steroid therapy|0
5901457|NCT01673867|20417498|P1|Treatment|Required steroid therapy|1
5901458|NCT01673867|20417497|P2|Treatment|No longer meets criteria|0
5901459|NCT01673867|20417498|P1|Treatment|No longer meets criteria|2
5901460|NCT01673867|20417497|P2|Treatment|Maximum clinical benefit|10
5901461|NCT01673867|20417498|P1|Treatment|Maximum clinical benefit|0
5901462|NCT01673867|20417497|P2|Treatment|Withdrawal by Subject|6
5901463|NCT01673867|20417498|P1|Treatment|Withdrawal by Subject|4
5901464|NCT01673867|20417497|P2|Treatment|Requested treatment discontinuation|16
5901465|NCT01673867|20417498|P1|Treatment|Requested treatment discontinuation|5
5901466|NCT01673867|20417497|P2|Treatment|AE unrelated to study drug|11
5901467|NCT01673867|20417498|P1|Treatment|AE unrelated to study drug|19
5901468|NCT01673867|20417497|P2|Treatment|Death|1
5901469|NCT01673867|20417498|P1|Treatment|Death|1
5901470|NCT01673867|20417497|P2|Treatment|Study Drug Toxicity|42
5901471|NCT01673867|20417498|P1|Treatment|Study Drug Toxicity|17
5901472|NCT01673867|20417497|P2|Treatment|Disease Progression|179
5901473|NCT01673867|20417498|P1|Treatment|Disease Progression|194
5901474|NCT01673867|20417497|P2|Randomization|No longer meets criteria|5
5901475|NCT01673867|20417498|P1|Randomization|No longer meets criteria|4
5901476|NCT01673867|20417497|P2|Randomization|Lost to Follow-up|1
5901477|NCT01673867|20417498|P1|Randomization|Lost to Follow-up|0
5901478|NCT01673867|20417497|P2|Randomization|Withdrawal by Subject|12
5901479|NCT01673867|20417498|P1|Randomization|Withdrawal by Subject|0
5901480|NCT01673867|20417497|P2|Randomization|Requested treatment discontinuation|4
5901481|NCT01673867|20417498|P1|Randomization|Requested treatment discontinuation|0
5901482|NCT01673867|20417497|P2|Randomization|AE unrelated to study drug|0
5901483|NCT01673867|20417498|P1|Randomization|AE unrelated to study drug|1
5901484|NCT01673854|20417524|P1|Vem 2 Phase (Vemurafenib Retreatment)|Death|1
5901485|NCT01673854|20417524|P1|Vem 2 Phase (Vemurafenib Retreatment)|Adverse event unrelated to study drug|1
5901486|NCT01673854|20417524|P1|Vem 2 Phase (Vemurafenib Retreatment)|Study drug toxicity|5
5901487|NCT01673854|20417524|P1|Vem 2 Phase (Vemurafenib Retreatment)|Disease progression|12
5901488|NCT01673854|20417524|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not reported|7
5901489|NCT01673854|20417524|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not identified|2
5901490|NCT01673854|20417524|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Death|1
5901491|NCT01673854|20417524|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Maximum clinical benefit|1
5901492|NCT01673854|20417524|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Adverse event unrelated to study drug|1
5901493|NCT01673854|20417524|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Administrative Reason by Sponsor|2
5901494|NCT01673854|20417524|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Study drug toxicity|6
5901495|NCT01673854|20417524|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Disease progression|7
5901496|NCT01673698|20417547|P2|Overall Study|Lost to Follow-up|13
5901497|NCT01673698|20417548|P1|Overall Study|Lost to Follow-up|51
5901498|NCT01673646|20417559|P3|Overall Study|Completed Core/did not enter Ext.|1
5901499|NCT01673646|20417560|P2|Overall Study|Completed Core/did not enter Ext.|1
5901500|NCT01673646|20417561|P1|Overall Study|Completed Core/did not enter Ext.|2
5901501|NCT01673646|20417559|P3|Overall Study|Withdrawal by Subject|2
5901502|NCT01673646|20417560|P2|Overall Study|Withdrawal by Subject|2
5901503|NCT01673646|20417561|P1|Overall Study|Withdrawal by Subject|0
5901504|NCT01673646|20417559|P3|Overall Study|Condition no longer requires study drug|0
5901505|NCT01673646|20417560|P2|Overall Study|Condition no longer requires study drug|1
5901506|NCT01673646|20417561|P1|Overall Study|Condition no longer requires study drug|0
5901507|NCT01673646|20417559|P3|Overall Study|Unsatisfactory therapeutic effect|0
5901508|NCT01673646|20417560|P2|Overall Study|Unsatisfactory therapeutic effect|2
5901509|NCT01673646|20417561|P1|Overall Study|Unsatisfactory therapeutic effect|0
5901510|NCT01673646|20417559|P3|Overall Study|Adverse Event|1
5901511|NCT01673646|20417560|P2|Overall Study|Adverse Event|1
5901512|NCT01673646|20417561|P1|Overall Study|Adverse Event|2
5901513|NCT01673620|20417600|P2|Overall Study|Adverse Event|0
5901514|NCT01673620|20417601|P1|Overall Study|Adverse Event|1
5901515|NCT01673594|20417611|P2|Overall Study|Withdrawal by Subject|1
5901516|NCT01673594|20417612|P1|Overall Study|Withdrawal by Subject|0
5901517|NCT01673594|20417611|P2|Overall Study|Physician Decision|4
5901518|NCT01673594|20417612|P1|Overall Study|Physician Decision|2
5901519|NCT01673594|20417611|P2|Overall Study|Lost to Follow-up|0
5901520|NCT01673594|20417612|P1|Overall Study|Lost to Follow-up|1
5901521|NCT01673594|20417611|P2|Overall Study|Adverse Event|1
5901522|NCT01673594|20417612|P1|Overall Study|Adverse Event|3
5901523|NCT01673490|20417631|P1|Overall Study|Withdrawal by Subject|3
5901524|NCT01673490|20417631|P1|Overall Study|Adverse Event|3
5901525|NCT01673490|20417631|P1|Overall Study|Lost to Follow-up|1
5901526|NCT01673386|20417648|P2|Overall Study|Withdrawal by Subject|2
5901527|NCT01673386|20417649|P1|Overall Study|Withdrawal by Subject|0
5901528|NCT01673386|20417648|P2|Overall Study|Progressive disease|1
5901529|NCT01673386|20417649|P1|Overall Study|Progressive disease|4
5901530|NCT01673386|20417648|P2|Overall Study|Adverse Event|2
5901531|NCT01673386|20417649|P1|Overall Study|Adverse Event|5
5901532|NCT01673386|20417648|P2|Overall Study|Study terminated by sponsor|22
5901533|NCT01673386|20417649|P1|Overall Study|Study terminated by sponsor|16
5901534|NCT01673373|20417679|P1|Overall Study|Death|2
5901535|NCT01673347|20417695|P1|Overall Study|failure of allograft|7
5901536|NCT01673282|20417704|P2|Overall Study|Other|6
5901537|NCT01673282|20417705|P1|Overall Study|Other|1
5901538|NCT01673282|20417704|P2|Overall Study|Withdrawal by Subject|3
5901539|NCT01673282|20417705|P1|Overall Study|Withdrawal by Subject|3
5901540|NCT01673282|20417704|P2|Overall Study|Lost to Follow-up|10
5901541|NCT01673282|20417705|P1|Overall Study|Lost to Follow-up|11
5901542|NCT01673282|20417704|P2|Overall Study|Lack of Efficacy|2
5901543|NCT01673282|20417705|P1|Overall Study|Lack of Efficacy|9
5901544|NCT01673282|20417704|P2|Overall Study|Adverse Drug Reaction - Vimpat|5
5901545|NCT01673282|20417705|P1|Overall Study|Adverse Drug Reaction - Vimpat|9
5901546|NCT01673178|20417741|P5|Overall Study|Other|0
5901547|NCT01673178|20417742|P4|Overall Study|Other|1
5901548|NCT01673178|20417743|P3|Overall Study|Other|2
5901549|NCT01673178|20417744|P2|Overall Study|Other|0
5901550|NCT01673178|20417745|P1|Overall Study|Other|1
5901551|NCT01673178|20417741|P5|Overall Study|Adverse Event|0
5901552|NCT01673178|20417742|P4|Overall Study|Adverse Event|2
5901553|NCT01673178|20417743|P3|Overall Study|Adverse Event|0
5901554|NCT01673178|20417744|P2|Overall Study|Adverse Event|0
5901555|NCT01673178|20417745|P1|Overall Study|Adverse Event|1
5901556|NCT01673178|20417741|P5|Overall Study|Protocol Violation|0
5901557|NCT01673178|20417742|P4|Overall Study|Protocol Violation|1
5901558|NCT01673178|20417743|P3|Overall Study|Protocol Violation|0
5901559|NCT01673178|20417744|P2|Overall Study|Protocol Violation|1
5901560|NCT01673178|20417745|P1|Overall Study|Protocol Violation|1
5901561|NCT01673178|20417741|P5|Overall Study|Withdrawal by Subject|2
5901562|NCT01673178|20417742|P4|Overall Study|Withdrawal by Subject|4
5901563|NCT01673178|20417743|P3|Overall Study|Withdrawal by Subject|1
5901564|NCT01673178|20417744|P2|Overall Study|Withdrawal by Subject|0
5901565|NCT01673178|20417745|P1|Overall Study|Withdrawal by Subject|0
5901566|NCT01673178|20417741|P5|Overall Study|Lost to Follow-up|0
5901567|NCT01673178|20417742|P4|Overall Study|Lost to Follow-up|0
5901568|NCT01673178|20417743|P3|Overall Study|Lost to Follow-up|0
5901569|NCT01673178|20417744|P2|Overall Study|Lost to Follow-up|1
5901570|NCT01673178|20417745|P1|Overall Study|Lost to Follow-up|0
5901571|NCT01673126|20417984|P2|Overall Study|change of diagnosis|3
5901572|NCT01673126|20417985|P1|Overall Study|change of diagnosis|4
5901573|NCT01673009|20418024|P1|Overall Study|Withdrawal by Subject|8
5901574|NCT01673009|20418024|P1|Overall Study|Physician Decision|5
5901575|NCT01672970|20418109|P1|Overall Study|Enrolled but not treated|1
5901576|NCT01672970|20418109|P1|Overall Study|Other|9
5901577|NCT01672970|20418109|P1|Overall Study|Lost to Follow-up|5
5901578|NCT01672970|20418109|P1|Overall Study|Withdrawal by Subject|2
5901579|NCT01672970|20418109|P1|Overall Study|Adverse Event|18
5901580|NCT01672970|20418109|P1|Overall Study|Lack of Efficacy|12
5901581|NCT01672957|20418145|P1|Overall Study|ICF Signed After Transplantation|5
5901582|NCT01672957|20418145|P1|Overall Study|Death|2
5901583|NCT01672957|20418145|P1|Overall Study|Protocol Violation|48
5901584|NCT01672892|20418160|P2|Overall Study|Protocol Violation|3
5901585|NCT01672892|20418161|P1|Overall Study|Protocol Violation|7
5901586|NCT01672879|20418190|P3|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0
5901587|NCT01672879|20418191|P2|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0
5901588|NCT01672879|20418192|P1|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|1
5901589|NCT01672879|20418190|P3|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1
5901590|NCT01672879|20418191|P2|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|0
5901591|NCT01672879|20418192|P1|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1
5901592|NCT01672879|20418190|P3|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1
5901593|NCT01672879|20418191|P2|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1
5901594|NCT01672879|20418192|P1|Open-Label Phase (Up to 240 Weeks)|Adverse Event|5
5901595|NCT01672879|20418190|P3|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|6
5901596|NCT01672879|20418191|P2|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|16
5901597|NCT01672879|20418192|P1|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|8
5901598|NCT01672879|20418190|P3|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|8
5901599|NCT01672879|20418191|P2|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|17
5901600|NCT01672879|20418192|P1|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|15
5901601|NCT01672879|20418190|P3|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|1
5901602|NCT01672879|20418191|P2|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0
5901603|NCT01672879|20418192|P1|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0
5901604|NCT01672879|20418190|P3|Blinded Phase (Up to 240 Weeks)|Missing|0
5901605|NCT01672879|20418191|P2|Blinded Phase (Up to 240 Weeks)|Missing|0
5901606|NCT01672879|20418192|P1|Blinded Phase (Up to 240 Weeks)|Missing|1
5901607|NCT01672879|20418190|P3|Blinded Phase (Up to 240 Weeks)|Death|0
5901608|NCT01672879|20418191|P2|Blinded Phase (Up to 240 Weeks)|Death|2
5901609|NCT01672879|20418192|P1|Blinded Phase (Up to 240 Weeks)|Death|0
5901610|NCT01672879|20418190|P3|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|2
5901611|NCT01672879|20418191|P2|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|0
5901612|NCT01672879|20418192|P1|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|5
5901613|NCT01672879|20418190|P3|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|1
5901614|NCT01672879|20418191|P2|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|3
5901615|NCT01672879|20418192|P1|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|4
5901616|NCT01672879|20418190|P3|Blinded Phase (Up to 240 Weeks)|Adverse Event|7
5901617|NCT01672879|20418191|P2|Blinded Phase (Up to 240 Weeks)|Adverse Event|2
5901618|NCT01672879|20418192|P1|Blinded Phase (Up to 240 Weeks)|Adverse Event|5
5901619|NCT01672879|20418190|P3|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|6
5901620|NCT01672879|20418191|P2|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|7
5901621|NCT01672879|20418192|P1|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|14
5901622|NCT01672879|20418190|P3|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|61
5901623|NCT01672879|20418191|P2|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|55
5901624|NCT01672879|20418192|P1|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|43
5901625|NCT01672866|20418207|P3|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0
5901626|NCT01672866|20418208|P2|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0
5901627|NCT01672866|20418209|P1|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|1
5901628|NCT01672866|20418207|P3|Open-Label Phase (up to 240 Weeks)|Death|0
5901629|NCT01672866|20418208|P2|Open-Label Phase (up to 240 Weeks)|Death|0
5901630|NCT01672866|20418209|P1|Open-Label Phase (up to 240 Weeks)|Death|1
5901631|NCT01672866|20418207|P3|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1
5901632|NCT01672866|20418208|P2|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|0
5901633|NCT01672866|20418209|P1|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1
5901634|NCT01672866|20418207|P3|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15
5901635|NCT01672866|20418208|P2|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15
5901636|NCT01672866|20418209|P1|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|8
5901637|NCT01672866|20418207|P3|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|16
5901638|NCT01672866|20418208|P2|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|15
5901639|NCT01672866|20418209|P1|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|11
5901640|NCT01672866|20418207|P3|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0
5901641|NCT01672866|20418208|P2|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0
5901642|NCT01672866|20418209|P1|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|3
5901643|NCT01672866|20418207|P3|Blinded Phase (up to 240 Weeks)|Death|1
5901644|NCT01672866|20418208|P2|Blinded Phase (up to 240 Weeks)|Death|0
5901645|NCT01672866|20418209|P1|Blinded Phase (up to 240 Weeks)|Death|0
5901646|NCT01672866|20418207|P3|Blinded Phase (up to 240 Weeks)|Protocol Violation|0
5901647|NCT01672866|20418208|P2|Blinded Phase (up to 240 Weeks)|Protocol Violation|0
5901648|NCT01672866|20418209|P1|Blinded Phase (up to 240 Weeks)|Protocol Violation|2
5901649|NCT01672866|20418207|P3|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|2
5901650|NCT01672866|20418208|P2|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3
5901651|NCT01672866|20418209|P1|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3
5901652|NCT01672866|20418207|P3|Blinded Phase (up to 240 Weeks)|Adverse Event|3
5901653|NCT01672866|20418208|P2|Blinded Phase (up to 240 Weeks)|Adverse Event|3
5901654|NCT01672866|20418209|P1|Blinded Phase (up to 240 Weeks)|Adverse Event|3
5901655|NCT01672866|20418207|P3|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|5
5901656|NCT01672866|20418208|P2|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3
5901657|NCT01672866|20418209|P1|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3
5901658|NCT01672866|20418207|P3|Blinded Phase (up to 240 Weeks)|Withdrew Consent|12
5901659|NCT01672866|20418208|P2|Blinded Phase (up to 240 Weeks)|Withdrew Consent|8
5901660|NCT01672866|20418209|P1|Blinded Phase (up to 240 Weeks)|Withdrew Consent|9
5901661|NCT01672866|20418207|P3|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|35
5901662|NCT01672866|20418208|P2|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|42
5901663|NCT01672866|20418209|P1|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|40
5901664|NCT01672853|20418224|P3|Overall Study|Randomized but Never Treated|1
5901665|NCT01672853|20418225|P2|Overall Study|Randomized but Never Treated|0
5901666|NCT01672853|20418226|P1|Overall Study|Randomized but Never Treated|0
5901667|NCT01672853|20418224|P3|Overall Study|Lost to Follow-up|0
5901668|NCT01672853|20418225|P2|Overall Study|Lost to Follow-up|1
5901669|NCT01672853|20418226|P1|Overall Study|Lost to Follow-up|0
5901670|NCT01672853|20418224|P3|Overall Study|Adverse Event|8
5901671|NCT01672853|20418225|P2|Overall Study|Adverse Event|6
5901672|NCT01672853|20418226|P1|Overall Study|Adverse Event|4
5901673|NCT01672853|20418224|P3|Overall Study|Withdrew Consent|5
5901674|NCT01672853|20418225|P2|Overall Study|Withdrew Consent|5
5901675|NCT01672853|20418226|P1|Overall Study|Withdrew Consent|5
5901676|NCT01672853|20418224|P3|Overall Study|Investigator's Discretion|0
5901677|NCT01672853|20418225|P2|Overall Study|Investigator's Discretion|0
5901678|NCT01672853|20418226|P1|Overall Study|Investigator's Discretion|1
5901679|NCT01672853|20418224|P3|Overall Study|Pregnancy|0
5901680|NCT01672853|20418225|P2|Overall Study|Pregnancy|1
5901681|NCT01672853|20418226|P1|Overall Study|Pregnancy|0
5901682|NCT01672853|20418224|P3|Overall Study|Protocol Specified Criteria for Withdraw|0
5901683|NCT01672853|20418225|P2|Overall Study|Protocol Specified Criteria for Withdraw|4
5901684|NCT01672853|20418226|P1|Overall Study|Protocol Specified Criteria for Withdraw|0
5901685|NCT01672801|20418251|P2|Overall Study|Screen Failure|1
5901686|NCT01672801|20418252|P1|Overall Study|Screen Failure|0
5901687|NCT01672788|20418260|P4|Washout Period 2 (7 Days)|Adverse Event|1
5901688|NCT01672788|20418261|P3|Washout Period 2 (7 Days)|Adverse Event|0
5901689|NCT01672788|20418262|P2|Washout Period 2 (7 Days)|Adverse Event|0
5901690|NCT01672788|20418263|P1|Washout Period 2 (7 Days)|Adverse Event|0
5901691|NCT01672736|20418293|P1|Overall Study|Available drug expired on 31 May 16|3
5901692|NCT01672723|20418297|P2|First Intervention|Adverse Event|0
5901693|NCT01672723|20418298|P1|First Intervention|Adverse Event|3
5901694|NCT01672710|20418310|P2|3 Month Follow up|follow up due after termination date|1
5901695|NCT01672710|20418311|P1|3 Month Follow up|follow up due after termination date|4
5901696|NCT01672710|20418310|P2|3 Month Follow up|Lost to Follow-up|3
5901697|NCT01672710|20418311|P1|3 Month Follow up|Lost to Follow-up|2
5901698|NCT01672710|20418310|P2|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|1
5901699|NCT01672710|20418311|P1|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|0
5901700|NCT01672294|20418346|P4|Overall Study|Lost to Follow-up|9
5901701|NCT01672294|20418347|P3|Overall Study|Lost to Follow-up|7
5901702|NCT01672294|20418348|P2|Overall Study|Lost to Follow-up|16
5901703|NCT01672294|20418349|P1|Overall Study|Lost to Follow-up|1
5901704|NCT01672294|20418346|P4|Overall Study|Excluded by study|0
5901705|NCT01672294|20418347|P3|Overall Study|Excluded by study|0
5901706|NCT01672294|20418348|P2|Overall Study|Excluded by study|1
5901707|NCT01672294|20418349|P1|Overall Study|Excluded by study|1
5901708|NCT01672294|20418346|P4|Overall Study|Withdrawal by Subject|4
5901709|NCT01672294|20418347|P3|Overall Study|Withdrawal by Subject|4
5901710|NCT01672294|20418348|P2|Overall Study|Withdrawal by Subject|4
5901711|NCT01672294|20418349|P1|Overall Study|Withdrawal by Subject|4
5901712|NCT01671748|20418394|P2|4 Week run-in Phase|Not eligible|0
5901713|NCT01671748|20418395|P1|4 Week run-in Phase|Not eligible|9
5901714|NCT01671748|20418394|P2|4 Week run-in Phase|Adverse Event|0
5901715|NCT01671748|20418395|P1|4 Week run-in Phase|Adverse Event|1
5901716|NCT01671748|20418394|P2|4 Week run-in Phase|Withdrawal by Subject|0
5901717|NCT01671748|20418395|P1|4 Week run-in Phase|Withdrawal by Subject|1
5901718|NCT01671488|20418422|P1|Overall Study|Withdrawal by Subject|1
5901719|NCT01671345|20418430|P2|Overall Study|visit with non-participating physician|3
5901720|NCT01671345|20418431|P1|Overall Study|visit with non-participating physician|3
5901721|NCT01671345|20418430|P2|Overall Study|Lost to Follow-up|6
5901722|NCT01671345|20418431|P1|Overall Study|Lost to Follow-up|10
5901723|NCT01671332|20418445|P2|Overall Study|Withdrawal by Subject|1
5901724|NCT01671332|20418446|P1|Overall Study|Withdrawal by Subject|1
5901725|NCT01671319|20418460|P1|Overall Study|Withdrawal by Subject|1
5901726|NCT01671280|20418475|P1|Overall Study|Withdrawal by Subject|2
5901727|NCT01671111|20418486|P1|Overall Study|Other|24
5901728|NCT01671111|20418486|P1|Overall Study|Physician Decision|1
5901729|NCT01671111|20418486|P1|Overall Study|Withdrawal by Subject|2
5901730|NCT01671111|20418486|P1|Overall Study|Lack of Efficacy|1
5901731|NCT01671111|20418486|P1|Overall Study|Adverse Event|2
5901732|NCT01671085|20418498|P2|Overall Study|Withdrawal by Subject|0
5901733|NCT01671085|20418499|P1|Overall Study|Withdrawal by Subject|1
5901734|NCT01671059|20418510|P1|Overall Study|Lack of Efficacy|1
5901735|NCT01671059|20418510|P1|Overall Study|Adverse Event|4
5901736|NCT01671007|20418542|P9|Overall Study|Not eligible|0
5901737|NCT01671007|20418543|P8|Overall Study|Not eligible|19
5901738|NCT01671007|20418544|P7|Overall Study|Not eligible|1
5901739|NCT01671007|20418545|P6|Overall Study|Not eligible|6
5901740|NCT01671007|20418546|P5|Overall Study|Not eligible|0
5901741|NCT01671007|20418547|P4|Overall Study|Not eligible|17
5901742|NCT01671007|20418548|P3|Overall Study|Not eligible|25
5901743|NCT01671007|20418549|P2|Overall Study|Not eligible|76
5901744|NCT01671007|20418550|P1|Overall Study|Not eligible|23
5901745|NCT01671007|20418542|P9|Overall Study|No end of study case report form|0
5901746|NCT01671007|20418543|P8|Overall Study|No end of study case report form|0
5901747|NCT01671007|20418544|P7|Overall Study|No end of study case report form|0
5901748|NCT01671007|20418545|P6|Overall Study|No end of study case report form|0
5901749|NCT01671007|20418546|P5|Overall Study|No end of study case report form|0
5901750|NCT01671007|20418547|P4|Overall Study|No end of study case report form|2
5901751|NCT01671007|20418548|P3|Overall Study|No end of study case report form|0
5901752|NCT01671007|20418549|P2|Overall Study|No end of study case report form|1
5901753|NCT01671007|20418550|P1|Overall Study|No end of study case report form|3
5901754|NCT01671007|20418542|P9|Overall Study|Lost to Follow-up|0
5901755|NCT01671007|20418543|P8|Overall Study|Lost to Follow-up|28
5901756|NCT01671007|20418544|P7|Overall Study|Lost to Follow-up|2
5901757|NCT01671007|20418545|P6|Overall Study|Lost to Follow-up|20
5901758|NCT01671007|20418546|P5|Overall Study|Lost to Follow-up|7
5901759|NCT01671007|20418547|P4|Overall Study|Lost to Follow-up|63
5901760|NCT01671007|20418548|P3|Overall Study|Lost to Follow-up|91
5901761|NCT01671007|20418549|P2|Overall Study|Lost to Follow-up|142
5901762|NCT01671007|20418550|P1|Overall Study|Lost to Follow-up|93
5901763|NCT01671007|20418542|P9|Overall Study|Withdrawal by Subject|0
5901764|NCT01671007|20418543|P8|Overall Study|Withdrawal by Subject|19
5901765|NCT01671007|20418544|P7|Overall Study|Withdrawal by Subject|1
5901766|NCT01671007|20418545|P6|Overall Study|Withdrawal by Subject|15
5901767|NCT01671007|20418546|P5|Overall Study|Withdrawal by Subject|4
5901768|NCT01671007|20418547|P4|Overall Study|Withdrawal by Subject|58
5901769|NCT01671007|20418548|P3|Overall Study|Withdrawal by Subject|53
5901770|NCT01671007|20418549|P2|Overall Study|Withdrawal by Subject|59
5901771|NCT01671007|20418550|P1|Overall Study|Withdrawal by Subject|36
5901772|NCT01671007|20418542|P9|Overall Study|Other reasons than listed|0
5901773|NCT01671007|20418543|P8|Overall Study|Other reasons than listed|66
5901774|NCT01671007|20418544|P7|Overall Study|Other reasons than listed|17
5901775|NCT01671007|20418545|P6|Overall Study|Other reasons than listed|71
5901776|NCT01671007|20418546|P5|Overall Study|Other reasons than listed|14
5901777|NCT01671007|20418547|P4|Overall Study|Other reasons than listed|228
5901778|NCT01671007|20418548|P3|Overall Study|Other reasons than listed|197
5901779|NCT01671007|20418549|P2|Overall Study|Other reasons than listed|373
5901780|NCT01671007|20418550|P1|Overall Study|Other reasons than listed|166
5901781|NCT01670721|20418656|P1|Overall Study|Other than specified above|38
5901782|NCT01670721|20418656|P1|Overall Study|Participant's decision|15
5901783|NCT01670656|20418668|P5|Overall Study|Subject moved|0
5901784|NCT01670656|20418669|P4|Overall Study|Subject moved|1
5901785|NCT01670656|20418670|P3|Overall Study|Subject moved|0
5901786|NCT01670656|20418671|P2|Overall Study|Subject moved|0
5901787|NCT01670656|20418672|P1|Overall Study|Subject moved|0
5901788|NCT01670656|20418668|P5|Overall Study|Lost to Follow-up|3
5901789|NCT01670656|20418669|P4|Overall Study|Lost to Follow-up|0
5901790|NCT01670656|20418670|P3|Overall Study|Lost to Follow-up|0
5901791|NCT01670656|20418671|P2|Overall Study|Lost to Follow-up|0
5901792|NCT01670656|20418672|P1|Overall Study|Lost to Follow-up|0
5901793|NCT01670656|20418668|P5|Overall Study|Subject withdrew consent|1
5901794|NCT01670656|20418669|P4|Overall Study|Subject withdrew consent|1
5901795|NCT01670656|20418670|P3|Overall Study|Subject withdrew consent|2
5901796|NCT01670656|20418671|P2|Overall Study|Subject withdrew consent|1
5901797|NCT01670656|20418672|P1|Overall Study|Subject withdrew consent|0
5901798|NCT01670656|20418668|P5|Overall Study|Adverse Event|3
5901799|NCT01670656|20418669|P4|Overall Study|Adverse Event|3
5901800|NCT01670656|20418670|P3|Overall Study|Adverse Event|2
5901801|NCT01670656|20418671|P2|Overall Study|Adverse Event|2
5901802|NCT01670656|20418672|P1|Overall Study|Adverse Event|2
5901803|NCT01670656|20418668|P5|Overall Study|Non-compliance with protocol|2
5901804|NCT01670656|20418669|P4|Overall Study|Non-compliance with protocol|1
5901805|NCT01670656|20418670|P3|Overall Study|Non-compliance with protocol|1
5901806|NCT01670656|20418671|P2|Overall Study|Non-compliance with protocol|3
5901807|NCT01670656|20418672|P1|Overall Study|Non-compliance with protocol|0
5901808|NCT01670656|20418668|P5|Overall Study|Withdrawal by Subject|0
5901809|NCT01670656|20418669|P4|Overall Study|Withdrawal by Subject|0
5901810|NCT01670656|20418670|P3|Overall Study|Withdrawal by Subject|0
5901811|NCT01670656|20418671|P2|Overall Study|Withdrawal by Subject|1
5901812|NCT01670656|20418672|P1|Overall Study|Withdrawal by Subject|1
5901813|NCT01670656|20418668|P5|Overall Study|Pregnancy|1
5901814|NCT01670656|20418669|P4|Overall Study|Pregnancy|0
5901815|NCT01670656|20418670|P3|Overall Study|Pregnancy|0
5901816|NCT01670656|20418671|P2|Overall Study|Pregnancy|0
5901817|NCT01670656|20418672|P1|Overall Study|Pregnancy|0
5901818|NCT01670656|20418668|P5|Overall Study|Non-compliance with study drug|1
5901819|NCT01670656|20418669|P4|Overall Study|Non-compliance with study drug|0
5901820|NCT01670656|20418670|P3|Overall Study|Non-compliance with study drug|3
5901821|NCT01670656|20418671|P2|Overall Study|Non-compliance with study drug|0
5901822|NCT01670656|20418672|P1|Overall Study|Non-compliance with study drug|0
5901823|NCT01670526|20418701|P2|Overall Study|Lost to Follow-up|5
5901824|NCT01670526|20418702|P1|Overall Study|Lost to Follow-up|9
5901825|NCT01670526|20418701|P2|Overall Study|Withdrawal by Subject|1
5901826|NCT01670526|20418702|P1|Overall Study|Withdrawal by Subject|3
5901827|NCT01670500|20418716|P2|Overall Study|Withdrawal by Subject|0
5901828|NCT01670500|20418717|P1|Overall Study|Withdrawal by Subject|1
5901829|NCT01670292|20418740|P1|Overall Study|Lost to Follow-up|14
5901830|NCT01670279|20418781|P4|Overall Study|Participant met withdrawal criteria|1
5901831|NCT01670279|20418782|P3|Overall Study|Participant met withdrawal criteria|0
5901832|NCT01670279|20418783|P2|Overall Study|Participant met withdrawal criteria|0
5901833|NCT01670279|20418784|P1|Overall Study|Participant met withdrawal criteria|0
5901834|NCT01670279|20418781|P4|Overall Study|Physician Decision|0
5901835|NCT01670279|20418782|P3|Overall Study|Physician Decision|0
5901836|NCT01670279|20418783|P2|Overall Study|Physician Decision|1
5901837|NCT01670279|20418784|P1|Overall Study|Physician Decision|0
5901838|NCT01670279|20418781|P4|Overall Study|Adverse Event|0
5901839|NCT01670279|20418782|P3|Overall Study|Adverse Event|0
5901840|NCT01670279|20418783|P2|Overall Study|Adverse Event|1
5901841|NCT01670279|20418784|P1|Overall Study|Adverse Event|0
5901842|NCT01670188|20418826|P2|Overall Study|Death|1
5901843|NCT01670188|20418827|P1|Overall Study|Death|0
5901844|NCT01670045|20418856|P1|Overall Study|Lost to Follow-up|11
5901845|NCT01670045|20418856|P1|Overall Study|Death|1
5901846|NCT01670045|20418856|P1|Overall Study|Adverse Event|1
5901847|NCT01670045|20418856|P1|Overall Study|Withdrawal by Subject|3
5901848|NCT01670019|20418874|P2|Overall Study|Withdrawal by Subject|0
5901849|NCT01670019|20418875|P1|Overall Study|Withdrawal by Subject|6
5901850|NCT01670019|20418874|P2|Overall Study|Adverse Event|0
5901851|NCT01670019|20418875|P1|Overall Study|Adverse Event|3
5901852|NCT01669902|20418889|P1|Overall Study|Other|8
5901853|NCT01669902|20418889|P1|Overall Study|Lack of Efficacy|10
5901854|NCT01669902|20418889|P1|Overall Study|Adverse Event|11
5901855|NCT01669811|20418924|P2|Overall Study|Eligibility Criteria Not Fulfilled|2
5901856|NCT01669811|20418925|P1|Overall Study|Eligibility Criteria Not Fulfilled|0
5901857|NCT01669811|20418924|P2|Overall Study|Adverse Event|6
5901858|NCT01669811|20418925|P1|Overall Study|Adverse Event|2
5901859|NCT01669811|20418924|P2|Overall Study|Withdrawal by Subject|2
5901860|NCT01669811|20418925|P1|Overall Study|Withdrawal by Subject|1
5901861|NCT01669811|20418924|P2|Overall Study|Investigator decision|1
5901862|NCT01669811|20418925|P1|Overall Study|Investigator decision|0
5901863|NCT01669798|20418943|P1|Overall Study|Physician Decision|5
5901864|NCT01669629|20419049|P2|Period 1|protocol deviation|2
5901865|NCT01669629|20419050|P1|Period 1|protocol deviation|1
5901866|NCT01669577|20419073|P1|Overall Study|Physician Decision|34
5901867|NCT01669577|20419073|P1|Overall Study|Lost to Follow-up|78
5901868|NCT01669577|20419073|P1|Overall Study|Death|22
5901869|NCT01669421|20419111|P1|Phase 1: Standard Dose Therapy|Physician Decision|1
5901870|NCT01669421|20419111|P1|Phase 1: Standard Dose Therapy|Withdrawal by Subject|1
5901871|NCT01669174|20419130|P2|Overall Study|Administrative problems|2
5901872|NCT01669174|20419131|P1|Overall Study|Administrative problems|1
5901873|NCT01669174|20419130|P2|Overall Study|Adverse Event|2
5901874|NCT01669174|20419131|P1|Overall Study|Adverse Event|2
5901875|NCT01669174|20419130|P2|Overall Study|Lost to Follow-up|0
5901876|NCT01669174|20419131|P1|Overall Study|Lost to Follow-up|1
5901877|NCT01669174|20419130|P2|Overall Study|Subject withdrew consent|2
5901878|NCT01669174|20419131|P1|Overall Study|Subject withdrew consent|2
5901879|NCT01669122|20419147|P1|Washout Period II|Protocol Violation|2
5901880|NCT01669122|20419147|P1|Period I|Lost to Follow-up|1
5901881|NCT01668966|20419214|P1|Overall Study|Not treated|2
5901882|NCT01668966|20419214|P1|Overall Study|Death|1
5901883|NCT01668966|20419214|P1|Overall Study|Withdrawal by Subject|1
5901884|NCT01668797|20419310|P4|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|38
5901885|NCT01668797|20419311|P3|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|49
5901886|NCT01668797|20419312|P2|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0
5901887|NCT01668797|20419313|P1|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0
5901888|NCT01668797|20419310|P4|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|2
5901889|NCT01668797|20419311|P3|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|4
5901890|NCT01668797|20419312|P2|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0
5901891|NCT01668797|20419313|P1|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0
5901892|NCT01668797|20419310|P4|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|30
5901893|NCT01668797|20419311|P3|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|11
5901894|NCT01668797|20419312|P2|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0
5901895|NCT01668797|20419313|P1|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0
5901896|NCT01668797|20419310|P4|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|10
5901897|NCT01668797|20419311|P3|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|2
5901898|NCT01668797|20419312|P2|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0
5901899|NCT01668797|20419313|P1|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0
5901900|NCT01668797|20419310|P4|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0
5901901|NCT01668797|20419311|P3|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|2
5901902|NCT01668797|20419312|P2|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0
5901903|NCT01668797|20419313|P1|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0
5901904|NCT01668797|20419310|P4|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|5
5901905|NCT01668797|20419311|P3|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|3
5901906|NCT01668797|20419312|P2|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0
5901907|NCT01668797|20419313|P1|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0
5901908|NCT01668797|20419310|P4|Phase C (Double-Blind Maintenance Phase)|Physician Decision|2
5901909|NCT01668797|20419311|P3|Phase C (Double-Blind Maintenance Phase)|Physician Decision|5
5901910|NCT01668797|20419312|P2|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0
5901911|NCT01668797|20419313|P1|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0
5901912|NCT01668797|20419310|P4|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3
5901913|NCT01668797|20419311|P3|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3
5901914|NCT01668797|20419312|P2|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0
5901915|NCT01668797|20419313|P1|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0
5901916|NCT01668797|20419310|P4|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|6
5901917|NCT01668797|20419311|P3|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|4
5901918|NCT01668797|20419312|P2|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0
5901919|NCT01668797|20419313|P1|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0
5901920|NCT01668797|20419310|P4|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0
5901921|NCT01668797|20419311|P3|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0
5901922|NCT01668797|20419312|P2|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|86
5901923|NCT01668797|20419313|P1|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0
5901924|NCT01668797|20419310|P4|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0
5901925|NCT01668797|20419311|P3|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0
5901926|NCT01668797|20419312|P2|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|43
5901927|NCT01668797|20419313|P1|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0
5901928|NCT01668797|20419310|P4|Phase B (Stabilization Phase)|Lack of Efficacy|0
5901929|NCT01668797|20419311|P3|Phase B (Stabilization Phase)|Lack of Efficacy|0
5901930|NCT01668797|20419312|P2|Phase B (Stabilization Phase)|Lack of Efficacy|21
5901931|NCT01668797|20419313|P1|Phase B (Stabilization Phase)|Lack of Efficacy|0
5901932|NCT01668797|20419310|P4|Phase B (Stabilization Phase)|Protocol Violation|0
5901933|NCT01668797|20419311|P3|Phase B (Stabilization Phase)|Protocol Violation|0
5901934|NCT01668797|20419312|P2|Phase B (Stabilization Phase)|Protocol Violation|3
5901935|NCT01668797|20419313|P1|Phase B (Stabilization Phase)|Protocol Violation|0
5901936|NCT01668797|20419310|P4|Phase B (Stabilization Phase)|Withdrawal by Subject|0
5901937|NCT01668797|20419311|P3|Phase B (Stabilization Phase)|Withdrawal by Subject|0
5901938|NCT01668797|20419312|P2|Phase B (Stabilization Phase)|Withdrawal by Subject|60
5901939|NCT01668797|20419313|P1|Phase B (Stabilization Phase)|Withdrawal by Subject|0
5901940|NCT01668797|20419310|P4|Phase B (Stabilization Phase)|Physician Decision|0
5901941|NCT01668797|20419311|P3|Phase B (Stabilization Phase)|Physician Decision|0
5901942|NCT01668797|20419312|P2|Phase B (Stabilization Phase)|Physician Decision|11
5901943|NCT01668797|20419313|P1|Phase B (Stabilization Phase)|Physician Decision|0
5901944|NCT01668797|20419310|P4|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0
5901945|NCT01668797|20419311|P3|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0
5901946|NCT01668797|20419312|P2|Phase B (Stabilization Phase)|Met Withdrawal Criteria|22
5901947|NCT01668797|20419313|P1|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0
5901948|NCT01668797|20419310|P4|Phase B (Stabilization Phase)|Lost to Follow-up|0
5901949|NCT01668797|20419311|P3|Phase B (Stabilization Phase)|Lost to Follow-up|0
5901950|NCT01668797|20419312|P2|Phase B (Stabilization Phase)|Lost to Follow-up|16
5901951|NCT01668797|20419313|P1|Phase B (Stabilization Phase)|Lost to Follow-up|0
5901952|NCT01668797|20419310|P4|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0
5901953|NCT01668797|20419311|P3|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0
5901954|NCT01668797|20419312|P2|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0
5901955|NCT01668797|20419313|P1|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|19
5901956|NCT01668797|20419310|P4|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0
5901957|NCT01668797|20419311|P3|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0
5901958|NCT01668797|20419312|P2|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0
5901959|NCT01668797|20419313|P1|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|8
5901960|NCT01668797|20419310|P4|Phase A (Conversion Phase)|Lack of Efficacy|0
5901961|NCT01668797|20419311|P3|Phase A (Conversion Phase)|Lack of Efficacy|0
5901962|NCT01668797|20419312|P2|Phase A (Conversion Phase)|Lack of Efficacy|0
5901963|NCT01668797|20419313|P1|Phase A (Conversion Phase)|Lack of Efficacy|7
5901964|NCT01668797|20419310|P4|Phase A (Conversion Phase)|Protocol Violation|0
5901965|NCT01668797|20419311|P3|Phase A (Conversion Phase)|Protocol Violation|0
5901966|NCT01668797|20419312|P2|Phase A (Conversion Phase)|Protocol Violation|0
5901967|NCT01668797|20419313|P1|Phase A (Conversion Phase)|Protocol Violation|2
5901968|NCT01668797|20419310|P4|Phase A (Conversion Phase)|Withdrawal by Subject|0
5901969|NCT01668797|20419311|P3|Phase A (Conversion Phase)|Withdrawal by Subject|0
5901970|NCT01668797|20419312|P2|Phase A (Conversion Phase)|Withdrawal by Subject|0
5901971|NCT01668797|20419313|P1|Phase A (Conversion Phase)|Withdrawal by Subject|16
5901972|NCT01668797|20419310|P4|Phase A (Conversion Phase)|Physician Decision|0
5901973|NCT01668797|20419311|P3|Phase A (Conversion Phase)|Physician Decision|0
5901974|NCT01668797|20419312|P2|Phase A (Conversion Phase)|Physician Decision|0
5901975|NCT01668797|20419313|P1|Phase A (Conversion Phase)|Physician Decision|2
5901976|NCT01668797|20419310|P4|Phase A (Conversion Phase)|Met Withdrawal Criteria|0
5901977|NCT01668797|20419311|P3|Phase A (Conversion Phase)|Met Withdrawal Criteria|0
5901978|NCT01668797|20419312|P2|Phase A (Conversion Phase)|Met Withdrawal Criteria|0
5901979|NCT01668797|20419313|P1|Phase A (Conversion Phase)|Met Withdrawal Criteria|3
5901980|NCT01668797|20419310|P4|Phase A (Conversion Phase)|Lost to Follow-up|0
5901981|NCT01668797|20419311|P3|Phase A (Conversion Phase)|Lost to Follow-up|0
5901982|NCT01668797|20419312|P2|Phase A (Conversion Phase)|Lost to Follow-up|0
5901983|NCT01668797|20419313|P1|Phase A (Conversion Phase)|Lost to Follow-up|3
5901984|NCT01668784|20419378|P2|Treated (Overall)|Other|4
5901985|NCT01668784|20419379|P1|Treated (Overall)|Other|0
5901986|NCT01668784|20419378|P2|Treated (Overall)|Maximal Clinical Benefit|3
5901987|NCT01668784|20419379|P1|Treated (Overall)|Maximal Clinical Benefit|2
5901988|NCT01668784|20419378|P2|Treated (Overall)|Withdrawal by Subject|3
5901989|NCT01668784|20419379|P1|Treated (Overall)|Withdrawal by Subject|2
5901990|NCT01668784|20419378|P2|Treated (Overall)|Request to Discontinue Study Treatment|18
5901991|NCT01668784|20419379|P1|Treated (Overall)|Request to Discontinue Study Treatment|5
5901992|NCT01668784|20419378|P2|Treated (Overall)|Adverse Event Unrelated to Study Drug|14
5901993|NCT01668784|20419379|P1|Treated (Overall)|Adverse Event Unrelated to Study Drug|9
5901994|NCT01668784|20419378|P2|Treated (Overall)|Death|1
5901995|NCT01668784|20419379|P1|Treated (Overall)|Death|1
5901996|NCT01668784|20419378|P2|Treated (Overall)|Study Drug Toxicity|53
5901997|NCT01668784|20419379|P1|Treated (Overall)|Study Drug Toxicity|35
5901998|NCT01668784|20419378|P2|Treated (Overall)|Disease Progression|273
5901999|NCT01668784|20419379|P1|Treated (Overall)|Disease Progression|285
5902000|NCT01668784|20419378|P2|Randomized (Pre-treatment)|Other|1
5902001|NCT01668784|20419379|P1|Randomized (Pre-treatment)|Other|0
5902002|NCT01668784|20419378|P2|Randomized (Pre-treatment)|No Longer Meets Study Criteria|1
5902003|NCT01668784|20419379|P1|Randomized (Pre-treatment)|No Longer Meets Study Criteria|2
5902004|NCT01668784|20419378|P2|Randomized (Pre-treatment)|Poor/Non-Compliance|0
5902005|NCT01668784|20419379|P1|Randomized (Pre-treatment)|Poor/Non-Compliance|1
5902006|NCT01668784|20419378|P2|Randomized (Pre-treatment)|Withdrawal by Subject|8
5902007|NCT01668784|20419379|P1|Randomized (Pre-treatment)|Withdrawal by Subject|1
5902008|NCT01668784|20419378|P2|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|3
5902009|NCT01668784|20419379|P1|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|0
5902010|NCT01668784|20419378|P2|Randomized (Pre-treatment)|Disease Progression|1
5902011|NCT01668784|20419379|P1|Randomized (Pre-treatment)|Disease Progression|0
5902012|NCT01668667|20419407|P4|Overall Study|Withdrawal by Subject|5
5902013|NCT01668667|20419408|P3|Overall Study|Withdrawal by Subject|5
5902014|NCT01668667|20419409|P2|Overall Study|Withdrawal by Subject|4
5902015|NCT01668667|20419410|P1|Overall Study|Withdrawal by Subject|7
5902016|NCT01668667|20419407|P4|Overall Study|Physician Decision|0
5902017|NCT01668667|20419408|P3|Overall Study|Physician Decision|1
5902018|NCT01668667|20419409|P2|Overall Study|Physician Decision|0
5902019|NCT01668667|20419410|P1|Overall Study|Physician Decision|3
5902020|NCT01668667|20419407|P4|Overall Study|Lost to Follow-up|6
5902021|NCT01668667|20419408|P3|Overall Study|Lost to Follow-up|7
5902022|NCT01668667|20419409|P2|Overall Study|Lost to Follow-up|4
5902023|NCT01668667|20419410|P1|Overall Study|Lost to Follow-up|9
5902024|NCT01668667|20419407|P4|Overall Study|Protocol Violation|5
5902025|NCT01668667|20419408|P3|Overall Study|Protocol Violation|12
5902026|NCT01668667|20419409|P2|Overall Study|Protocol Violation|10
5902027|NCT01668667|20419410|P1|Overall Study|Protocol Violation|6
5902028|NCT01668667|20419407|P4|Overall Study|Lack of Efficacy|3
5902029|NCT01668667|20419408|P3|Overall Study|Lack of Efficacy|2
5902030|NCT01668667|20419409|P2|Overall Study|Lack of Efficacy|2
5902031|NCT01668667|20419410|P1|Overall Study|Lack of Efficacy|3
5902032|NCT01668667|20419407|P4|Overall Study|Adverse Event|4
5902033|NCT01668667|20419408|P3|Overall Study|Adverse Event|4
5902034|NCT01668667|20419409|P2|Overall Study|Adverse Event|6
5902035|NCT01668667|20419410|P1|Overall Study|Adverse Event|3
5902036|NCT01668654|20419432|P1|Overall Study|Withdrawal by Subject|1
5902037|NCT01668654|20419432|P1|Overall Study|Study Closed/Terminated|3
5902038|NCT01668589|20419493|P4|Overall Study|Other|15
5902039|NCT01668589|20419494|P3|Overall Study|Other|7
5902040|NCT01668589|20419495|P2|Overall Study|Other|10
5902041|NCT01668589|20419496|P1|Overall Study|Other|44
5902042|NCT01668589|20419493|P4|Overall Study|Death|11
5902043|NCT01668589|20419494|P3|Overall Study|Death|2
5902044|NCT01668589|20419495|P2|Overall Study|Death|3
5902045|NCT01668589|20419496|P1|Overall Study|Death|12
5902046|NCT01668589|20419493|P4|Overall Study|Full Consent/Agreement Withdrawn|4
5902047|NCT01668589|20419494|P3|Overall Study|Full Consent/Agreement Withdrawn|11
5902048|NCT01668589|20419495|P2|Overall Study|Full Consent/Agreement Withdrawn|8
5902049|NCT01668589|20419496|P1|Overall Study|Full Consent/Agreement Withdrawn|54
5902050|NCT01668589|20419493|P4|Overall Study|Lost to Follow-up|5
5902051|NCT01668589|20419494|P3|Overall Study|Lost to Follow-up|15
5902052|NCT01668589|20419495|P2|Overall Study|Lost to Follow-up|37
5902053|NCT01668589|20419496|P1|Overall Study|Lost to Follow-up|29
5902054|NCT01668537|20419536|P2|Overall Study|Other|3
5902055|NCT01668537|20419537|P1|Overall Study|Other|2
5902056|NCT01668537|20419536|P2|Overall Study|Lost to Follow-up|6
5902057|NCT01668537|20419537|P1|Overall Study|Lost to Follow-up|13
5902058|NCT01668537|20419536|P2|Overall Study|Reason Precludes Participation|0
5902059|NCT01668537|20419537|P1|Overall Study|Reason Precludes Participation|1
5902060|NCT01668537|20419536|P2|Overall Study|Subject unwilling/unable to comply|0
5902061|NCT01668537|20419537|P1|Overall Study|Subject unwilling/unable to comply|5
5902062|NCT01668537|20419536|P2|Overall Study|Request to Discontinue Prematurely|1
5902063|NCT01668537|20419537|P1|Overall Study|Request to Discontinue Prematurely|1
5902064|NCT01668355|20419579|P2|Overall Study|Withdrawal by Subject|1
5902065|NCT01668355|20419580|P1|Overall Study|Withdrawal by Subject|6
5902066|NCT01668355|20419579|P2|Overall Study|Death|1
5902067|NCT01668355|20419580|P1|Overall Study|Death|3
5902068|NCT01668173|20419600|P1|Overall Study|Trial suspension|4
5902069|NCT01668173|20419600|P1|Overall Study|Adverse Event|3
5902070|NCT01668147|20419604|P1|Overall Study|Withdrawal by Subject|6
5902071|NCT01668004|20419734|P1|Overall Study|Non-compliance with treatment|2
5902072|NCT01668004|20419734|P1|Overall Study|Lack of Efficacy|9
5902073|NCT01668004|20419734|P1|Overall Study|Lost to Follow-up|5
5902074|NCT01668004|20419734|P1|Overall Study|Withdrawal by Subject|2
5902075|NCT01668004|20419734|P1|Overall Study|Adverse Event|7
5902076|NCT01667926|20419756|P3|Overall Study|Side effects|0
5902077|NCT01667926|20419757|P2|Overall Study|Side effects|0
5902078|NCT01667926|20419758|P1|Overall Study|Side effects|3
5902079|NCT01667926|20419756|P3|Overall Study|Lost to Follow-up|1
5902080|NCT01667926|20419757|P2|Overall Study|Lost to Follow-up|2
5902081|NCT01667926|20419758|P1|Overall Study|Lost to Follow-up|1
5902082|NCT01667926|20419756|P3|Overall Study|Inclusion/Exclusion Criteria|5
5902083|NCT01667926|20419757|P2|Overall Study|Inclusion/Exclusion Criteria|0
5902084|NCT01667926|20419758|P1|Overall Study|Inclusion/Exclusion Criteria|0
5902085|NCT01667926|20419756|P3|Overall Study|Time committment|2
5902086|NCT01667926|20419757|P2|Overall Study|Time committment|0
5902087|NCT01667926|20419758|P1|Overall Study|Time committment|0
5902088|NCT01667926|20419756|P3|Overall Study|Physician Decision|1
5902089|NCT01667926|20419757|P2|Overall Study|Physician Decision|0
5902090|NCT01667926|20419758|P1|Overall Study|Physician Decision|0
5902091|NCT01667926|20419756|P3|Overall Study|Withdrawal by Subject|2
5902092|NCT01667926|20419757|P2|Overall Study|Withdrawal by Subject|2
5902093|NCT01667926|20419758|P1|Overall Study|Withdrawal by Subject|1
5902094|NCT01667900|20419771|P20|Part B|Death|0
5902095|NCT01667900|20419772|P19|Part B|Death|0
5902096|NCT01667900|20419773|P18|Part B|Death|0
5902097|NCT01667900|20419774|P17|Part B|Death|1
5902098|NCT01667900|20419775|P16|Part B|Death|0
5902099|NCT01667900|20419776|P15|Part B|Death|0
5902100|NCT01667900|20419777|P14|Part B|Death|0
5902101|NCT01667900|20419778|P13|Part B|Death|0
5902102|NCT01667900|20419779|P12|Part B|Death|0
5902103|NCT01667900|20419780|P11|Part B|Death|0
5902104|NCT01667900|20419781|P10|Part B|Death|0
5902105|NCT01667900|20419782|P9|Part B|Death|0
5902106|NCT01667900|20419783|P8|Part B|Death|0
5902107|NCT01667900|20419784|P7|Part B|Death|0
5902108|NCT01667900|20419785|P6|Part B|Death|0
5902109|NCT01667900|20419786|P5|Part B|Death|0
5902110|NCT01667900|20419787|P4|Part B|Death|0
5902111|NCT01667900|20419788|P3|Part B|Death|0
5902112|NCT01667900|20419789|P2|Part B|Death|0
5902113|NCT01667900|20419790|P1|Part B|Death|0
5902114|NCT01667731|20419860|P5|Overall Study|Death|0
5902115|NCT01667731|20419861|P4|Overall Study|Death|0
5902116|NCT01667731|20419862|P3|Overall Study|Death|0
5902117|NCT01667731|20419863|P2|Overall Study|Death|1
5902118|NCT01667731|20419864|P1|Overall Study|Death|0
5902119|NCT01667731|20419860|P5|Overall Study|Subject Withdrew Consent|1
5902120|NCT01667731|20419861|P4|Overall Study|Subject Withdrew Consent|0
5902121|NCT01667731|20419862|P3|Overall Study|Subject Withdrew Consent|1
5902122|NCT01667731|20419863|P2|Overall Study|Subject Withdrew Consent|0
5902123|NCT01667731|20419864|P1|Overall Study|Subject Withdrew Consent|2
5902124|NCT01667731|20419860|P5|Overall Study|Lost to Follow-up|2
5902125|NCT01667731|20419861|P4|Overall Study|Lost to Follow-up|1
5902126|NCT01667731|20419862|P3|Overall Study|Lost to Follow-up|1
5902127|NCT01667731|20419863|P2|Overall Study|Lost to Follow-up|3
5902128|NCT01667731|20419864|P1|Overall Study|Lost to Follow-up|2
5902129|NCT01667731|20419860|P5|Overall Study|Efficacy Failure|24
5902130|NCT01667731|20419861|P4|Overall Study|Efficacy Failure|1
5902131|NCT01667731|20419862|P3|Overall Study|Efficacy Failure|0
5902132|NCT01667731|20419863|P2|Overall Study|Efficacy Failure|12
5902133|NCT01667731|20419864|P1|Overall Study|Efficacy Failure|1
5902134|NCT01667731|20419860|P5|Overall Study|Enrolled but not treated|1
5902135|NCT01667731|20419861|P4|Overall Study|Enrolled but not treated|0
5902136|NCT01667731|20419862|P3|Overall Study|Enrolled but not treated|0
5902137|NCT01667731|20419863|P2|Overall Study|Enrolled but not treated|0
5902138|NCT01667731|20419864|P1|Overall Study|Enrolled but not treated|0
5902139|NCT01667679|20419919|P2|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|1
5902140|NCT01667679|20419920|P1|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|0
5902141|NCT01667679|20419919|P2|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|1
5902142|NCT01667679|20419920|P1|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|0
5902143|NCT01667679|20419919|P2|Treatment Period 2 (<=12 Weeks)|Partially Dosed|1
5902144|NCT01667679|20419920|P1|Treatment Period 2 (<=12 Weeks)|Partially Dosed|0
5902145|NCT01667679|20419919|P2|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|1
5902146|NCT01667679|20419920|P1|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|0
5902147|NCT01667679|20419919|P2|Treatment Period 2 (<=12 Weeks)|Adverse Event|0
5902148|NCT01667679|20419920|P1|Treatment Period 2 (<=12 Weeks)|Adverse Event|1
5902149|NCT01667679|20419919|P2|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|0
5902150|NCT01667679|20419920|P1|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|1
5902151|NCT01667679|20419919|P2|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|0
5902152|NCT01667679|20419920|P1|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|1
5902153|NCT01667679|20419919|P2|Treatment Period 2 (<=12 Weeks)|Non-compliance|4
5902154|NCT01667679|20419920|P1|Treatment Period 2 (<=12 Weeks)|Non-compliance|3
5902155|NCT01667679|20419919|P2|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|10
5902156|NCT01667679|20419920|P1|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|8
5902157|NCT01667679|20419919|P2|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|0
5902158|NCT01667679|20419920|P1|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|2
5902159|NCT01667679|20419919|P2|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|4
5902160|NCT01667679|20419920|P1|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|6
5902161|NCT01667679|20419919|P2|Treatment Period 1 (<=12 Weeks)|Moved Out of State|1
5902162|NCT01667679|20419920|P1|Treatment Period 1 (<=12 Weeks)|Moved Out of State|0
5902163|NCT01667679|20419919|P2|Treatment Period 1 (<=12 Weeks)|Non-compliance|3
5902164|NCT01667679|20419920|P1|Treatment Period 1 (<=12 Weeks)|Non-compliance|0
5902165|NCT01667679|20419919|P2|Treatment Period 1 (<=12 Weeks)|Protocol Violation|2
5902166|NCT01667679|20419920|P1|Treatment Period 1 (<=12 Weeks)|Protocol Violation|0
5902167|NCT01667679|20419919|P2|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|2
5902168|NCT01667679|20419920|P1|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|0
5902169|NCT01667679|20419919|P2|Treatment Period 1 (<=12 Weeks)|Adverse Event|3
5902170|NCT01667679|20419920|P1|Treatment Period 1 (<=12 Weeks)|Adverse Event|3
5902171|NCT01667679|20419919|P2|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|13
5902172|NCT01667679|20419920|P1|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|6
5902173|NCT01667679|20419919|P2|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|0
5902174|NCT01667679|20419920|P1|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|1
5902175|NCT01667679|20419919|P2|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|0
5902176|NCT01667679|20419920|P1|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|2
5902177|NCT01667679|20419919|P2|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|0
5902178|NCT01667679|20419920|P1|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|2
5902179|NCT01667679|20419919|P2|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|6
5902180|NCT01667679|20419920|P1|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|2
5902181|NCT01667562|20419978|P2|Erlotinib Phase|Switch to Commercial Drug|1
5902182|NCT01667562|20419979|P1|Erlotinib Phase|Switch to Commercial Drug|0
5902183|NCT01667562|20419978|P2|Erlotinib Phase|Adverse Event|1
5902184|NCT01667562|20419979|P1|Erlotinib Phase|Adverse Event|0
5902185|NCT01667562|20419978|P2|Erlotinib Phase|Lost to Follow-up|1
5902186|NCT01667562|20419979|P1|Erlotinib Phase|Lost to Follow-up|0
5902187|NCT01667562|20419978|P2|Diagnostic Phase|Started Erlotinib in Treatment Period|0
5902188|NCT01667562|20419979|P1|Diagnostic Phase|Started Erlotinib in Treatment Period|30
5902189|NCT01667549|20419993|P5|Overall Study|Withdrawal by Subject|1
5902190|NCT01667549|20419994|P4|Overall Study|Withdrawal by Subject|6
5902191|NCT01667549|20419995|P3|Overall Study|Withdrawal by Subject|7
5902192|NCT01667549|20419996|P2|Overall Study|Withdrawal by Subject|5
5902193|NCT01667549|20419997|P1|Overall Study|Withdrawal by Subject|3
5902194|NCT01667432|20420056|P1|Overall Study|Missing Information|4
5902195|NCT01667432|20420056|P1|Overall Study|Reason Not Specified|2
5902196|NCT01667432|20420056|P1|Overall Study|Principal Investigator Decision|1
5902197|NCT01667432|20420056|P1|Overall Study|Protocol Deviation|2
5902198|NCT01667432|20420056|P1|Overall Study|Adverse Event|1
5902199|NCT01667432|20420056|P1|Overall Study|Insufficient Therapeutic Response|4
5902200|NCT01667432|20420056|P1|Overall Study|Refused Treatment/Withdrew Consent|1
5902201|NCT01667432|20420056|P1|Overall Study|Lost to Follow-up|3
5902202|NCT01667432|20420056|P1|Overall Study|Moved to Another Center|3
5902203|NCT01667432|20420056|P1|Overall Study|Failure to Return|10
5902204|NCT01667432|20420056|P1|Overall Study|Premature Study Termination|26
5902205|NCT01667419|20420065|P4|Overall Study|Death|26
5902206|NCT01667419|20420066|P3|Overall Study|Death|25
5902207|NCT01667419|20420067|P2|Overall Study|Death|33
5902208|NCT01667419|20420068|P1|Overall Study|Death|18
5902209|NCT01667419|20420065|P4|Overall Study|Lost to Follow-up|4
5902210|NCT01667419|20420066|P3|Overall Study|Lost to Follow-up|2
5902211|NCT01667419|20420067|P2|Overall Study|Lost to Follow-up|6
5902212|NCT01667419|20420068|P1|Overall Study|Lost to Follow-up|7
5902213|NCT01667419|20420065|P4|Overall Study|Protocol Violation|0
5902214|NCT01667419|20420066|P3|Overall Study|Protocol Violation|0
5902215|NCT01667419|20420067|P2|Overall Study|Protocol Violation|0
5902216|NCT01667419|20420068|P1|Overall Study|Protocol Violation|1
5902217|NCT01667419|20420065|P4|Overall Study|Non-compliance|1
5902218|NCT01667419|20420066|P3|Overall Study|Non-compliance|0
5902219|NCT01667419|20420067|P2|Overall Study|Non-compliance|0
5902220|NCT01667419|20420068|P1|Overall Study|Non-compliance|0
5902221|NCT01667419|20420065|P4|Overall Study|Withdrawal by Subject|8
5902222|NCT01667419|20420066|P3|Overall Study|Withdrawal by Subject|9
5902223|NCT01667419|20420067|P2|Overall Study|Withdrawal by Subject|8
5902224|NCT01667419|20420068|P1|Overall Study|Withdrawal by Subject|16
5902225|NCT01667419|20420065|P4|Overall Study|Reason Not Specified|0
5902226|NCT01667419|20420066|P3|Overall Study|Reason Not Specified|0
5902227|NCT01667419|20420067|P2|Overall Study|Reason Not Specified|0
5902228|NCT01667419|20420068|P1|Overall Study|Reason Not Specified|1
5902229|NCT01667224|20420116|P2|Overall Study|Protocol Violation|1
5902230|NCT01667224|20420117|P1|Overall Study|Protocol Violation|1
5902231|NCT01667224|20420116|P2|Overall Study|Withdrawal by Subject|1
5902232|NCT01667224|20420117|P1|Overall Study|Withdrawal by Subject|3
5902233|NCT01667107|20420131|P2|Overall Study|Lack of Efficacy|1
5902234|NCT01667107|20420132|P1|Overall Study|Lack of Efficacy|0
5902235|NCT01667107|20420131|P2|Overall Study|Protocol Violation|1
5902236|NCT01667107|20420132|P1|Overall Study|Protocol Violation|0
5902237|NCT01667107|20420131|P2|Overall Study|Tolerability issues|2
5902238|NCT01667107|20420132|P1|Overall Study|Tolerability issues|0
5902239|NCT01667107|20420131|P2|Overall Study|Adverse Event|3
5902240|NCT01667107|20420132|P1|Overall Study|Adverse Event|4
5902241|NCT01666951|20420191|P2|Overall Study|Not dosed|1
5902242|NCT01666951|20420192|P1|Overall Study|Not dosed|1
5902243|NCT01666782|20420243|P2|Overall Study|Enrolled both years; year 1 data used|0
5902244|NCT01666782|20420244|P1|Overall Study|Enrolled both years; year 1 data used|4
5902245|NCT01666782|20420243|P2|Overall Study|Received 2 doses of vaccine|1
5902246|NCT01666782|20420244|P1|Overall Study|Received 2 doses of vaccine|0
5902247|NCT01666652|20420265|P5|Overall Study|Lost to Follow-up|0
5902248|NCT01666652|20420266|P4|Overall Study|Lost to Follow-up|1
5902249|NCT01666652|20420267|P3|Overall Study|Lost to Follow-up|1
5902250|NCT01666652|20420268|P2|Overall Study|Lost to Follow-up|1
5902251|NCT01666652|20420269|P1|Overall Study|Lost to Follow-up|1
5902252|NCT01666652|20420265|P5|Overall Study|Moved from study area|0
5902253|NCT01666652|20420266|P4|Overall Study|Moved from study area|2
5902254|NCT01666652|20420267|P3|Overall Study|Moved from study area|0
5902255|NCT01666652|20420268|P2|Overall Study|Moved from study area|0
5902256|NCT01666652|20420269|P1|Overall Study|Moved from study area|1
5902257|NCT01666652|20420265|P5|Overall Study|Withdrawal by Subject|1
5902258|NCT01666652|20420266|P4|Overall Study|Withdrawal by Subject|0
5902259|NCT01666652|20420267|P3|Overall Study|Withdrawal by Subject|0
5902260|NCT01666652|20420268|P2|Overall Study|Withdrawal by Subject|0
5902261|NCT01666652|20420269|P1|Overall Study|Withdrawal by Subject|0
5902262|NCT01666652|20420265|P5|Overall Study|Serious Adverse Event|0
5902263|NCT01666652|20420266|P4|Overall Study|Serious Adverse Event|1
5902264|NCT01666652|20420267|P3|Overall Study|Serious Adverse Event|0
5902265|NCT01666652|20420268|P2|Overall Study|Serious Adverse Event|0
5902266|NCT01666652|20420269|P1|Overall Study|Serious Adverse Event|0
5902267|NCT01666444|20420318|P2|Overall Study|Did not initiate treatment|1
5902268|NCT01666444|20420319|P1|Overall Study|Did not initiate treatment|2
5902269|NCT01666314|20420337|P4|Overall Study|Reason not Specified|5
5902270|NCT01666314|20420338|P3|Overall Study|Reason not Specified|5
5902271|NCT01666314|20420339|P2|Overall Study|Reason not Specified|7
5902272|NCT01666314|20420340|P1|Overall Study|Reason not Specified|10
5902273|NCT01666314|20420337|P4|Overall Study|Withdrawal by Subject|3
5902274|NCT01666314|20420338|P3|Overall Study|Withdrawal by Subject|2
5902275|NCT01666314|20420339|P2|Overall Study|Withdrawal by Subject|1
5902276|NCT01666314|20420340|P1|Overall Study|Withdrawal by Subject|1
5902277|NCT01666314|20420337|P4|Overall Study|Unsatisfactory Therapeutic Response|1
5902278|NCT01666314|20420338|P3|Overall Study|Unsatisfactory Therapeutic Response|1
5902279|NCT01666314|20420339|P2|Overall Study|Unsatisfactory Therapeutic Response|2
5902280|NCT01666314|20420340|P1|Overall Study|Unsatisfactory Therapeutic Response|7
5902281|NCT01666314|20420337|P4|Overall Study|Symptomatic Deterioration|0
5902282|NCT01666314|20420338|P3|Overall Study|Symptomatic Deterioration|2
5902283|NCT01666314|20420339|P2|Overall Study|Symptomatic Deterioration|0
5902284|NCT01666314|20420340|P1|Overall Study|Symptomatic Deterioration|1
5902285|NCT01666314|20420337|P4|Overall Study|Progressive Disease|20
5902286|NCT01666314|20420338|P3|Overall Study|Progressive Disease|19
5902287|NCT01666314|20420339|P2|Overall Study|Progressive Disease|9
5902288|NCT01666314|20420340|P1|Overall Study|Progressive Disease|11
5902289|NCT01666314|20420337|P4|Overall Study|Adverse Event|7
5902290|NCT01666314|20420338|P3|Overall Study|Adverse Event|7
5902291|NCT01666314|20420339|P2|Overall Study|Adverse Event|13
5902292|NCT01666314|20420340|P1|Overall Study|Adverse Event|3
5902293|NCT01666119|20420476|P1|Overall Study|Subject experiencing withdrawal symptoms|5
5902294|NCT01666119|20420476|P1|Overall Study|non compliance with study medication, pa|18
5902295|NCT01666119|20420476|P1|Overall Study|Lost to Follow-up|7
5902296|NCT01666119|20420476|P1|Overall Study|Withdrawal by Subject|16
5902297|NCT01666119|20420476|P1|Overall Study|Adverse Event|6
5902298|NCT01666002|20420483|P2|Overall Study|Lost to Follow-up|0
5902299|NCT01666002|20420484|P1|Overall Study|Lost to Follow-up|5
5902300|NCT01665911|20420505|P1|Overall Study|Adverse Event|1
5902301|NCT01665911|20420505|P1|Overall Study|Withdrawal by Subject|1
5902302|NCT01665911|20420505|P1|Overall Study|Protocol Violation|4
5902303|NCT01665807|20420531|P3|Overall Study|Withdrawal by Subject|1
5902304|NCT01665807|20420532|P2|Overall Study|Withdrawal by Subject|0
5902305|NCT01665807|20420533|P1|Overall Study|Withdrawal by Subject|2
5902306|NCT01665768|20420544|P1|Overall Study|Withdrawal by Subject|1
5902307|NCT01665768|20420544|P1|Overall Study|Lack of Efficacy|19
5902308|NCT01665768|20420544|P1|Overall Study|Adverse Event|3
5902309|NCT01665599|20420549|P1|Overall Study|Could Not Continue Due to Time Constrain|1
5902310|NCT01665599|20420549|P1|Overall Study|Participant Left for More Than 3 Months|1
5902311|NCT01665599|20420549|P1|Overall Study|Lost to Follow-up|2
5902312|NCT01665599|20420549|P1|Overall Study|Death|1
5902313|NCT01665599|20420549|P1|Overall Study|Investigator/Sponsor decision|1
5902314|NCT01665599|20420549|P1|Overall Study|Consent Withdrawn|1
5902315|NCT01665599|20420549|P1|Overall Study|Adverse Event|1
5902316|NCT01665430|20420585|P1|Overall Study|Other Unspecified|2
5902317|NCT01665430|20420585|P1|Overall Study|Withdrawal by Subject|6
5902318|NCT01665430|20420585|P1|Overall Study|Adverse Event|1
5902319|NCT01665144|20420683|P2|Overall Study|Withdrawal by Subject|77
5902320|NCT01665144|20420684|P1|Overall Study|Withdrawal by Subject|96
5902321|NCT01665144|20420683|P2|Overall Study|Adverse Event|18
5902322|NCT01665144|20420684|P1|Overall Study|Adverse Event|45
5902323|NCT01665144|20420683|P2|Overall Study|Lack of Efficacy|11
5902324|NCT01665144|20420684|P1|Overall Study|Lack of Efficacy|16
5902325|NCT01665144|20420683|P2|Overall Study|Physician Decision|1
5902326|NCT01665144|20420684|P1|Overall Study|Physician Decision|13
5902327|NCT01665144|20420683|P2|Overall Study|Lost to Follow-up|8
5902328|NCT01665144|20420684|P1|Overall Study|Lost to Follow-up|9
5902329|NCT01665144|20420683|P2|Overall Study|Progressive disease|4
5902330|NCT01665144|20420684|P1|Overall Study|Progressive disease|8
5902331|NCT01665144|20420683|P2|Overall Study|Non-compliance w/study treatment|0
5902332|NCT01665144|20420684|P1|Overall Study|Non-compliance w/study treatment|5
5902333|NCT01665144|20420683|P2|Overall Study|Protocol deviation|1
5902334|NCT01665144|20420684|P1|Overall Study|Protocol deviation|3
5902335|NCT01665144|20420683|P2|Overall Study|Death|1
5902336|NCT01665144|20420684|P1|Overall Study|Death|3
5902337|NCT01665144|20420683|P2|Overall Study|Technical problems|0
5902338|NCT01665144|20420684|P1|Overall Study|Technical problems|2
5902339|NCT01665144|20420683|P2|Overall Study|New therapy for study indication|1
5902340|NCT01665144|20420684|P1|Overall Study|New therapy for study indication|2
5902341|NCT01664949|20420764|P2|Overall Study|Other Miscellaneous Reasons|1
5902342|NCT01664949|20420765|P1|Overall Study|Other Miscellaneous Reasons|3
5902343|NCT01664949|20420764|P2|Overall Study|Protocol Violation|5
5902344|NCT01664949|20420765|P1|Overall Study|Protocol Violation|5
5902345|NCT01664949|20420764|P2|Overall Study|Personal Reasons|4
5902346|NCT01664949|20420765|P1|Overall Study|Personal Reasons|3
5902347|NCT01664949|20420764|P2|Overall Study|Lost to Follow-up|2
5902348|NCT01664949|20420765|P1|Overall Study|Lost to Follow-up|1
5902349|NCT01664949|20420764|P2|Overall Study|Lack of Efficacy|1
5902350|NCT01664949|20420765|P1|Overall Study|Lack of Efficacy|1
5902351|NCT01664949|20420764|P2|Overall Study|Adverse Event|12
5902352|NCT01664949|20420765|P1|Overall Study|Adverse Event|11
5902353|NCT01664923|20420781|P2|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|4
5902354|NCT01664923|20420782|P1|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|2
5902355|NCT01664923|20420781|P2|Period 2: Open-label Phase-36 Months|Adverse Event|7
5902356|NCT01664923|20420782|P1|Period 2: Open-label Phase-36 Months|Adverse Event|4
5902357|NCT01664923|20420781|P2|Period 2: Open-label Phase-36 Months|Other|1
5902358|NCT01664923|20420782|P1|Period 2: Open-label Phase-36 Months|Other|3
5902359|NCT01664923|20420781|P2|Period 2: Open-label Phase-36 Months|Disease progression|9
5902360|NCT01664923|20420782|P1|Period 2: Open-label Phase-36 Months|Disease progression|28
5902361|NCT01664923|20420781|P2|Period 2: Open-label Phase-36 Months|On Treatment|1
5902362|NCT01664923|20420782|P1|Period 2: Open-label Phase-36 Months|On Treatment|1
5902363|NCT01664923|20420781|P2|Period 2: Open-label Phase-36 Months|Death|1
5902364|NCT01664923|20420782|P1|Period 2: Open-label Phase-36 Months|Death|3
5902365|NCT01664923|20420781|P2|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|0
5902366|NCT01664923|20420782|P1|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|1
5902367|NCT01664923|20420781|P2|Period1:Double Blind Phase-29 Months|Other|4
5902368|NCT01664923|20420782|P1|Period1:Double Blind Phase-29 Months|Other|3
5902369|NCT01664923|20420781|P2|Period1:Double Blind Phase-29 Months|Adverse Event|9
5902370|NCT01664923|20420782|P1|Period1:Double Blind Phase-29 Months|Adverse Event|14
5902371|NCT01664923|20420781|P2|Period1:Double Blind Phase-29 Months|Disease Progression|132
5902372|NCT01664923|20420782|P1|Period1:Double Blind Phase-29 Months|Disease Progression|65
5902373|NCT01664923|20420781|P2|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|8
5902374|NCT01664923|20420782|P1|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|12
5902375|NCT01664923|20420781|P2|Period1:Double Blind Phase-29 Months|Protocol Violation|0
5902376|NCT01664923|20420782|P1|Period1:Double Blind Phase-29 Months|Protocol Violation|2
5902377|NCT01664923|20420781|P2|Period1:Double Blind Phase-29 Months|Lost to Follow-up|1
5902378|NCT01664923|20420782|P1|Period1:Double Blind Phase-29 Months|Lost to Follow-up|0
5902379|NCT01664923|20420781|P2|Period1:Double Blind Phase-29 Months|Death|6
5902380|NCT01664923|20420782|P1|Period1:Double Blind Phase-29 Months|Death|8
5902381|NCT01664624|20420873|P4|Overall Study|Adverse Event|0
5902382|NCT01664624|20420874|P3|Overall Study|Adverse Event|0
5902383|NCT01664624|20420875|P2|Overall Study|Adverse Event|1
5902384|NCT01664624|20420876|P1|Overall Study|Adverse Event|0
5902385|NCT01664533|20420923|P1|Overall Study|Protocol Violation|3
5902386|NCT01664533|20420923|P1|Overall Study|Study termination|9
5902387|NCT01664533|20420923|P1|Overall Study|Lost to Follow-up|3
5902388|NCT01664533|20420923|P1|Overall Study|Death|42
5902389|NCT01664494|20420931|P1|Overall Study|Lost to Follow-up|99
5902390|NCT01664494|20420931|P1|Overall Study|Other|49
5902391|NCT01664494|20420931|P1|Overall Study|Death|18
5902392|NCT01664494|20420931|P1|Overall Study|Withdrawal by Subject|27
5902393|NCT01664247|20420938|P2|Overall Study|Unclassified|29
5902394|NCT01664247|20420939|P1|Overall Study|Unclassified|5
5902395|NCT01664247|20420938|P2|Overall Study|Withdrawal Criteria|4
5902396|NCT01664247|20420939|P1|Overall Study|Withdrawal Criteria|1
5902397|NCT01664247|20420938|P2|Overall Study|Protocol Violation|5
5902398|NCT01664247|20420939|P1|Overall Study|Protocol Violation|3
5902399|NCT01664247|20420938|P2|Overall Study|Adverse Event|3
5902400|NCT01664247|20420939|P1|Overall Study|Adverse Event|5
5902401|NCT01664130|20420961|P1|Overall Study|competing secondary disease|2
5902402|NCT01664104|20421039|P1|Overall Study|Unknown: Reason Unrelated to TCZ|2
5902403|NCT01664104|20421039|P1|Overall Study|Other|1
5902404|NCT01664104|20421039|P1|Overall Study|Lost to Follow-up|4
5902405|NCT01664104|20421039|P1|Overall Study|Withdrawal by Subject|1
5902406|NCT01664104|20421039|P1|Overall Study|Lack of Efficacy|2
5902407|NCT01664104|20421039|P1|Overall Study|Adverse Event|6
5902408|NCT01664091|20421106|P1|Overall Study|Withdrawal by Subject|1
5902409|NCT01664091|20421106|P1|Overall Study|Lost to Follow-up|2
5902410|NCT01664091|20421106|P1|Overall Study|Disease Progression|2
5902411|NCT01664091|20421106|P1|Overall Study|Death|1
5902412|NCT01664078|20421114|P1|Overall Study|Other|53
5902413|NCT01664078|20421114|P1|Overall Study|missed 5 year visit|1
5902414|NCT01664078|20421114|P1|Overall Study|Lost to Follow-up|2
5902415|NCT01664078|20421114|P1|Overall Study|Withdrawal by Subject|4
5902416|NCT01664078|20421114|P1|Overall Study|Death|9
5902417|NCT01664052|20421167|P2|Phase 2|No device placement|4
5902418|NCT01664052|20421168|P1|Phase 2|No device placement|0
5902419|NCT01664052|20421167|P2|Phase 1|No HSG 1 hr post placement|0
5902420|NCT01664052|20421168|P1|Phase 1|No HSG 1 hr post placement|1
5902421|NCT01664052|20421167|P2|Phase 1|No device placement|0
5902422|NCT01664052|20421168|P1|Phase 1|No device placement|6
5902423|NCT01664039|20421186|P2|Overall Study|Noncompliance|1
5902424|NCT01664039|20421187|P1|Overall Study|Noncompliance|1
5902425|NCT01664039|20421186|P2|Overall Study|Withdrawal by Subject|3
5902426|NCT01664039|20421187|P1|Overall Study|Withdrawal by Subject|1
5902427|NCT01664039|20421186|P2|Overall Study|Lost to Follow-up|1
5902428|NCT01664039|20421187|P1|Overall Study|Lost to Follow-up|1
5902429|NCT01664039|20421186|P2|Overall Study|Adverse Event|4
5902430|NCT01664039|20421187|P1|Overall Study|Adverse Event|3
5902431|NCT01663987|20421209|P2|Overall Study|Other reason not defined above|0
5902432|NCT01663987|20421210|P1|Overall Study|Other reason not defined above|3
5902433|NCT01663987|20421209|P2|Overall Study|Withdrawal by Subject|3
5902434|NCT01663987|20421210|P1|Overall Study|Withdrawal by Subject|2
5902435|NCT01663987|20421209|P2|Overall Study|Lost to Follow-up|1
5902436|NCT01663987|20421210|P1|Overall Study|Lost to Follow-up|1
5902437|NCT01663987|20421209|P2|Overall Study|Adverse Event|2
5902438|NCT01663987|20421210|P1|Overall Study|Adverse Event|7
5902439|NCT01663896|20421249|P1|Overall Study|Various reasons|43
5902440|NCT01663857|20421260|P4|Overall Study|Lost to Follow-up|1
5902441|NCT01663857|20421261|P3|Overall Study|Lost to Follow-up|3
5902442|NCT01663857|20421262|P2|Overall Study|Lost to Follow-up|0
5902443|NCT01663857|20421263|P1|Overall Study|Lost to Follow-up|0
5902444|NCT01663857|20421260|P4|Overall Study|Withdrew Consent to Study Participation|3
5902445|NCT01663857|20421261|P3|Overall Study|Withdrew Consent to Study Participation|7
5902446|NCT01663857|20421262|P2|Overall Study|Withdrew Consent to Study Participation|1
5902447|NCT01663857|20421263|P1|Overall Study|Withdrew Consent to Study Participation|0
5902448|NCT01663740|20421291|P2|Overall Study|No end of study status|0
5902449|NCT01663740|20421292|P1|Overall Study|No end of study status|3
5902450|NCT01663740|20421291|P2|Overall Study|Withdrawal by Subject|1
5902451|NCT01663740|20421292|P1|Overall Study|Withdrawal by Subject|2
5902452|NCT01663740|20421291|P2|Overall Study|Death|1
5902453|NCT01663740|20421292|P1|Overall Study|Death|0
5902454|NCT01663740|20421291|P2|Overall Study|Inclusion/Exclusion not met|0
5902455|NCT01663740|20421292|P1|Overall Study|Inclusion/Exclusion not met|1
5902456|NCT01663740|20421291|P2|Overall Study|Other|2
5902457|NCT01663740|20421292|P1|Overall Study|Other|9
5902458|NCT01663740|20421291|P2|Overall Study|Lost to Follow-up|4
5902459|NCT01663740|20421292|P1|Overall Study|Lost to Follow-up|1
5902460|NCT01663727|20421352|P2|Overall Study|Withdrawal prior to dosing.|0
5902461|NCT01663727|20421353|P1|Overall Study|Withdrawal prior to dosing.|1
5902462|NCT01663727|20421352|P2|Overall Study|Withdrawal by subject and Adverse Event.|0
5902463|NCT01663727|20421353|P1|Overall Study|Withdrawal by subject and Adverse Event.|1
5902464|NCT01663727|20421352|P2|Overall Study|Study Terminated|50
5902465|NCT01663727|20421353|P1|Overall Study|Study Terminated|51
5902466|NCT01663727|20421352|P2|Overall Study|Withdrawal by Subject|25
5902467|NCT01663727|20421353|P1|Overall Study|Withdrawal by Subject|18
5902468|NCT01663727|20421352|P2|Overall Study|Lost to Follow-up|8
5902469|NCT01663727|20421353|P1|Overall Study|Lost to Follow-up|10
5902470|NCT01663727|20421352|P2|Overall Study|Death|155
5902471|NCT01663727|20421353|P1|Overall Study|Death|161
5902472|NCT01663714|20421385|P1|Long-Term Follow-Up|Non-compliance|1
5902473|NCT01663714|20421385|P1|Long-Term Follow-Up|Death|4
5902474|NCT01663714|20421385|P1|Long-Term Follow-Up|Lost to Follow-up|1
5902475|NCT01663714|20421385|P1|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|16
5902476|NCT01663714|20421385|P1|Dosimetric and Therapeutic Treatment|Progressive Disease|11
5902477|NCT01663714|20421385|P1|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3
5902478|NCT01663636|20421414|P2|Infant SMS Reminder Feasibility Study|Lost to Follow-up|31
5902479|NCT01663636|20421415|P1|Infant SMS Reminder Feasibility Study|Lost to Follow-up|25
5902480|NCT01663623|20421423|P2|Overall Study|Withdrawal by Subject|1
5902481|NCT01663623|20421424|P1|Overall Study|Withdrawal by Subject|2
5902482|NCT01663623|20421423|P2|Overall Study|Physician Decision|4
5902483|NCT01663623|20421424|P1|Overall Study|Physician Decision|1
5902484|NCT01663623|20421423|P2|Overall Study|Other-Study closed/terminated|1
5902485|NCT01663623|20421424|P1|Overall Study|Other-Study closed/terminated|1
5902486|NCT01663623|20421423|P2|Overall Study|Protocol Violation|1
5902487|NCT01663623|20421424|P1|Overall Study|Protocol Violation|0
5902488|NCT01663623|20421423|P2|Overall Study|Lack of Efficacy|6
5902489|NCT01663623|20421424|P1|Overall Study|Lack of Efficacy|5
5902490|NCT01663623|20421423|P2|Overall Study|Adverse Event|7
5902491|NCT01663623|20421424|P1|Overall Study|Adverse Event|3
5902492|NCT01663532|20421434|P2|Overall Study|Lack of Efficacy|60
5902493|NCT01663532|20421435|P1|Overall Study|Lack of Efficacy|15
5902494|NCT01663532|20421434|P2|Overall Study|Withdrawal by Subject|17
5902495|NCT01663532|20421435|P1|Overall Study|Withdrawal by Subject|35
5902496|NCT01663532|20421434|P2|Overall Study|Physician Decision|1
5902497|NCT01663532|20421435|P1|Overall Study|Physician Decision|1
5902498|NCT01663532|20421434|P2|Overall Study|Met Withdrawal Criteria|6
5902499|NCT01663532|20421435|P1|Overall Study|Met Withdrawal Criteria|7
5902500|NCT01663532|20421434|P2|Overall Study|Adverse Event|13
5902501|NCT01663532|20421435|P1|Overall Study|Adverse Event|7
5902502|NCT01663532|20421434|P2|Overall Study|Lost to Follow-up|10
5902503|NCT01663532|20421435|P1|Overall Study|Lost to Follow-up|9
5902504|NCT01663506|20421453|P1|Overall Study|Switched to Subcutaneous Tocilizumab|2
5902505|NCT01663506|20421453|P1|Overall Study|Adverse Event|1
5902506|NCT01663506|20421453|P1|Overall Study|Lost to Follow-up|1
5902507|NCT01663506|20421453|P1|Overall Study|Consent Withdrawal by Subject|1
5902508|NCT01663506|20421453|P1|Overall Study|Lack of Efficacy|3
5902509|NCT01663402|20421484|P2|Overall Study|Other than specified above|147
5902510|NCT01663402|20421485|P1|Overall Study|Other than specified above|172
5902511|NCT01663402|20421484|P2|Overall Study|Lost to Follow-up|15
5902512|NCT01663402|20421485|P1|Overall Study|Lost to Follow-up|17
5902513|NCT01663402|20421484|P2|Overall Study|Related to study drug administration|105
5902514|NCT01663402|20421485|P1|Overall Study|Related to study drug administration|96
5902515|NCT01663402|20421484|P2|Overall Study|Withdrawal by Subject|91
5902516|NCT01663402|20421485|P1|Overall Study|Withdrawal by Subject|118
5902517|NCT01663402|20421484|P2|Overall Study|Participant moved|104
5902518|NCT01663402|20421485|P1|Overall Study|Participant moved|139
5902519|NCT01663402|20421484|P2|Overall Study|Site terminated by sponsor|3
5902520|NCT01663402|20421485|P1|Overall Study|Site terminated by sponsor|1
5902521|NCT01663402|20421484|P2|Overall Study|Physician Decision|62
5902522|NCT01663402|20421485|P1|Overall Study|Physician Decision|77
5902523|NCT01663402|20421484|P2|Overall Study|Poor compliance to protocol|454
5902524|NCT01663402|20421485|P1|Overall Study|Poor compliance to protocol|529
5902525|NCT01663402|20421484|P2|Overall Study|Two consecutive LDL-C <15 mg/dL|730
5902526|NCT01663402|20421485|P1|Overall Study|Two consecutive LDL-C <15 mg/dL|0
5902527|NCT01663402|20421484|P2|Overall Study|Adverse Event|362
5902528|NCT01663402|20421485|P1|Overall Study|Adverse Event|347
5902529|NCT01663402|20421484|P2|Overall Study|Randomized but not treated|11
5902530|NCT01663402|20421485|P1|Overall Study|Randomized but not treated|19
5902531|NCT01663233|20421551|P2|Overall Study|Lost to Follow-up|1
5902532|NCT01663233|20421552|P1|Overall Study|Lost to Follow-up|0
5902533|NCT01663233|20421551|P2|Overall Study|Protocol Deviation|4
5902534|NCT01663233|20421552|P1|Overall Study|Protocol Deviation|1
5902535|NCT01663233|20421551|P2|Overall Study|Withdrawal by Subject|2
5902536|NCT01663233|20421552|P1|Overall Study|Withdrawal by Subject|3
5902537|NCT01663103|20421576|P2|Overall Study|dog bite|0
5902538|NCT01663103|20421577|P1|Overall Study|dog bite|1
5902539|NCT01663103|20421576|P2|Overall Study|Adverse Event|0
5902540|NCT01663103|20421577|P1|Overall Study|Adverse Event|1
5902541|NCT01663103|20421576|P2|Overall Study|Withdrawal by Subject|2
5902542|NCT01663103|20421577|P1|Overall Study|Withdrawal by Subject|1
5902543|NCT01662999|20421605|P6|Period 3|Withdrawal by Subject|0
5902544|NCT01662999|20421606|P5|Period 3|Withdrawal by Subject|0
5902545|NCT01662999|20421607|P4|Period 3|Withdrawal by Subject|0
5902546|NCT01662999|20421608|P3|Period 3|Withdrawal by Subject|0
5902547|NCT01662999|20421609|P2|Period 3|Withdrawal by Subject|1
5902548|NCT01662999|20421610|P1|Period 3|Withdrawal by Subject|0
5902549|NCT01662986|20421681|P2|Overall Study|Other than stated above|0
5902550|NCT01662986|20421682|P1|Overall Study|Other than stated above|3
5902551|NCT01662986|20421681|P2|Overall Study|Not Treated|0
5902552|NCT01662986|20421682|P1|Overall Study|Not Treated|1
5902553|NCT01662986|20421681|P2|Overall Study|Withdrawal by Subject|2
5902554|NCT01662986|20421682|P1|Overall Study|Withdrawal by Subject|2
5902555|NCT01662986|20421681|P2|Overall Study|Lost to Follow-up|4
5902556|NCT01662986|20421682|P1|Overall Study|Lost to Follow-up|5
5902557|NCT01662986|20421681|P2|Overall Study|Protocol Violation|3
5902558|NCT01662986|20421682|P1|Overall Study|Protocol Violation|2
5902559|NCT01662986|20421681|P2|Overall Study|Adverse Event|4
5902560|NCT01662986|20421682|P1|Overall Study|Adverse Event|5
5902561|NCT01662895|20421770|P2|Overall Study|Lost to Follow-up|1
5902562|NCT01662895|20421771|P1|Overall Study|Lost to Follow-up|0
5902563|NCT01662648|20421895|P2|Overall Study|LOE and Participant non-compliant|1
5902564|NCT01662648|20421896|P1|Overall Study|LOE and Participant non-compliant|0
5902565|NCT01662648|20421895|P2|Overall Study|LOE and other reason unspecified|0
5902566|NCT01662648|20421896|P1|Overall Study|LOE and other reason unspecified|1
5902567|NCT01662648|20421895|P2|Overall Study|Adverse event and lack of efficacy (LOE)|0
5902568|NCT01662648|20421896|P1|Overall Study|Adverse event and lack of efficacy (LOE)|3
5902569|NCT01662648|20421895|P2|Overall Study|Other|11
5902570|NCT01662648|20421896|P1|Overall Study|Other|8
5902571|NCT01662648|20421895|P2|Overall Study|Participant non-compliant|20
5902572|NCT01662648|20421896|P1|Overall Study|Participant non-compliant|16
5902573|NCT01662648|20421895|P2|Overall Study|Withdrawal by Subject|53
5902574|NCT01662648|20421896|P1|Overall Study|Withdrawal by Subject|36
5902575|NCT01662648|20421895|P2|Overall Study|Lost to Follow-up|36
5902576|NCT01662648|20421896|P1|Overall Study|Lost to Follow-up|24
5902577|NCT01662648|20421895|P2|Overall Study|Participant ineligible to continue trial|1
5902578|NCT01662648|20421896|P1|Overall Study|Participant ineligible to continue trial|1
5902579|NCT01662648|20421895|P2|Overall Study|Lack of Efficacy|16
5902580|NCT01662648|20421896|P1|Overall Study|Lack of Efficacy|17
5902581|NCT01662648|20421895|P2|Overall Study|Adverse Event|37
5902582|NCT01662648|20421896|P1|Overall Study|Adverse Event|40
5902583|NCT01662648|20421895|P2|Overall Study|Death|3
5902584|NCT01662648|20421896|P1|Overall Study|Death|1
5902585|NCT01662635|20421918|P1|Overall Study|scarce samples for evaluation|30
5902586|NCT01662505|20421969|P3|Overall Study|Not specified above|2
5902587|NCT01662505|20421970|P2|Overall Study|Not specified above|3
5902588|NCT01662505|20421971|P1|Overall Study|Not specified above|1
5902589|NCT01662505|20421969|P3|Overall Study|Refused cont. medication|1
5902590|NCT01662505|20421970|P2|Overall Study|Refused cont. medication|0
5902591|NCT01662505|20421971|P1|Overall Study|Refused cont. medication|0
5902592|NCT01662505|20421969|P3|Overall Study|Progressive disease|5
5902593|NCT01662505|20421970|P2|Overall Study|Progressive disease|1
5902594|NCT01662505|20421971|P1|Overall Study|Progressive disease|6
5902595|NCT01662492|20421995|P3|Overall Study|Lack of Efficacy|2
5902596|NCT01662492|20421996|P2|Overall Study|Lack of Efficacy|1
5902597|NCT01662492|20421997|P1|Overall Study|Lack of Efficacy|1
5902598|NCT01662492|20421995|P3|Overall Study|Lost to Follow-up|2
5902599|NCT01662492|20421996|P2|Overall Study|Lost to Follow-up|0
5902600|NCT01662492|20421997|P1|Overall Study|Lost to Follow-up|0
5902601|NCT01662492|20421995|P3|Overall Study|Protocol Violation|0
5902602|NCT01662492|20421996|P2|Overall Study|Protocol Violation|0
5902603|NCT01662492|20421997|P1|Overall Study|Protocol Violation|1
5902604|NCT01662492|20421995|P3|Overall Study|Withdrawal by Subject|1
5902605|NCT01662492|20421996|P2|Overall Study|Withdrawal by Subject|0
5902606|NCT01662492|20421997|P1|Overall Study|Withdrawal by Subject|0
5902607|NCT01662492|20421995|P3|Overall Study|Other miscellaneous reasons.|1
5902608|NCT01662492|20421996|P2|Overall Study|Other miscellaneous reasons.|0
5902609|NCT01662492|20421997|P1|Overall Study|Other miscellaneous reasons.|1
5902610|NCT01662440|20422021|P4|Overall Study|Withdrawal by Subject|2
5902611|NCT01662440|20422022|P3|Overall Study|Withdrawal by Subject|2
5902612|NCT01662440|20422023|P2|Overall Study|Withdrawal by Subject|2
5902613|NCT01662440|20422024|P1|Overall Study|Withdrawal by Subject|5
5902614|NCT01662440|20422021|P4|Overall Study|Protocol Violation|0
5902615|NCT01662440|20422022|P3|Overall Study|Protocol Violation|0
5902616|NCT01662440|20422023|P2|Overall Study|Protocol Violation|0
5902617|NCT01662440|20422024|P1|Overall Study|Protocol Violation|1
5902618|NCT01662440|20422021|P4|Overall Study|Subject moved to another country.|0
5902619|NCT01662440|20422022|P3|Overall Study|Subject moved to another country.|0
5902620|NCT01662440|20422023|P2|Overall Study|Subject moved to another country.|1
5902621|NCT01662440|20422024|P1|Overall Study|Subject moved to another country.|0
5902622|NCT01662440|20422021|P4|Overall Study|Lost to Follow-up|1
5902623|NCT01662440|20422022|P3|Overall Study|Lost to Follow-up|4
5902624|NCT01662440|20422023|P2|Overall Study|Lost to Follow-up|2
5902625|NCT01662440|20422024|P1|Overall Study|Lost to Follow-up|2
5902626|NCT01662440|20422021|P4|Overall Study|Death|0
5902627|NCT01662440|20422022|P3|Overall Study|Death|0
5902628|NCT01662440|20422023|P2|Overall Study|Death|1
5902629|NCT01662440|20422024|P1|Overall Study|Death|0
5902630|NCT01662440|20422021|P4|Overall Study|Adverse Event|1
5902631|NCT01662440|20422022|P3|Overall Study|Adverse Event|0
5902632|NCT01662440|20422023|P2|Overall Study|Adverse Event|0
5902633|NCT01662440|20422024|P1|Overall Study|Adverse Event|1
5902634|NCT01662362|20422072|P1|Overall Study|Lost to Follow-up|38
5902635|NCT01662336|20422077|P1|Overall Study|Withdrawal by Subject|6
5902636|NCT01662336|20422077|P1|Overall Study|Other|29
5902637|NCT01662336|20422077|P1|Overall Study|No longer on LPV/r|30
5902638|NCT01662336|20422077|P1|Overall Study|Adverse Event|1
5902639|NCT01662310|20422103|P5|Open-Label Extension Phase|Withdrawal by Subject|7
5902640|NCT01662310|20422104|P4|Open-Label Extension Phase|Withdrawal by Subject|2
5902641|NCT01662310|20422105|P3|Open-Label Extension Phase|Withdrawal by Subject|0
5902642|NCT01662310|20422106|P2|Open-Label Extension Phase|Withdrawal by Subject|0
5902643|NCT01662310|20422107|P1|Open-Label Extension Phase|Withdrawal by Subject|0
5902644|NCT01662310|20422103|P5|Open-Label Extension Phase|Pregnancy|0
5902645|NCT01662310|20422104|P4|Open-Label Extension Phase|Pregnancy|1
5902646|NCT01662310|20422105|P3|Open-Label Extension Phase|Pregnancy|0
5902647|NCT01662310|20422106|P2|Open-Label Extension Phase|Pregnancy|0
5902648|NCT01662310|20422107|P1|Open-Label Extension Phase|Pregnancy|0
5902649|NCT01662310|20422103|P5|Open-Label Extension Phase|Lost to Follow-up|1
5902650|NCT01662310|20422104|P4|Open-Label Extension Phase|Lost to Follow-up|2
5902651|NCT01662310|20422105|P3|Open-Label Extension Phase|Lost to Follow-up|0
5902652|NCT01662310|20422106|P2|Open-Label Extension Phase|Lost to Follow-up|0
5902653|NCT01662310|20422107|P1|Open-Label Extension Phase|Lost to Follow-up|0
5902654|NCT01662310|20422103|P5|Open-Label Extension Phase|Lack of Efficacy|2
5902655|NCT01662310|20422104|P4|Open-Label Extension Phase|Lack of Efficacy|2
5902656|NCT01662310|20422105|P3|Open-Label Extension Phase|Lack of Efficacy|0
5902657|NCT01662310|20422106|P2|Open-Label Extension Phase|Lack of Efficacy|0
5902658|NCT01662310|20422107|P1|Open-Label Extension Phase|Lack of Efficacy|0
5902659|NCT01662310|20422103|P5|Open-Label Extension Phase|Death|0
5902660|NCT01662310|20422104|P4|Open-Label Extension Phase|Death|1
5902661|NCT01662310|20422105|P3|Open-Label Extension Phase|Death|0
5902662|NCT01662310|20422106|P2|Open-Label Extension Phase|Death|0
5902663|NCT01662310|20422107|P1|Open-Label Extension Phase|Death|0
5902664|NCT01662310|20422103|P5|Open-Label Extension Phase|Adverse Event|0
5902665|NCT01662310|20422104|P4|Open-Label Extension Phase|Adverse Event|3
5902666|NCT01662310|20422105|P3|Open-Label Extension Phase|Adverse Event|0
5902667|NCT01662310|20422106|P2|Open-Label Extension Phase|Adverse Event|0
5902668|NCT01662310|20422107|P1|Open-Label Extension Phase|Adverse Event|0
5902669|NCT01662310|20422103|P5|Double-Blind Phase|Randomized but not treated|0
5902670|NCT01662310|20422104|P4|Double-Blind Phase|Randomized but not treated|0
5902671|NCT01662310|20422105|P3|Double-Blind Phase|Randomized but not treated|0
5902672|NCT01662310|20422106|P2|Double-Blind Phase|Randomized but not treated|1
5902673|NCT01662310|20422107|P1|Double-Blind Phase|Randomized but not treated|0
5902674|NCT01662310|20422103|P5|Double-Blind Phase|Other|0
5902675|NCT01662310|20422104|P4|Double-Blind Phase|Other|0
5902676|NCT01662310|20422105|P3|Double-Blind Phase|Other|1
5902677|NCT01662310|20422106|P2|Double-Blind Phase|Other|0
5902678|NCT01662310|20422107|P1|Double-Blind Phase|Other|0
5902679|NCT01662310|20422103|P5|Double-Blind Phase|Withdrawal by Subject|0
5902680|NCT01662310|20422104|P4|Double-Blind Phase|Withdrawal by Subject|0
5902681|NCT01662310|20422105|P3|Double-Blind Phase|Withdrawal by Subject|3
5902682|NCT01662310|20422106|P2|Double-Blind Phase|Withdrawal by Subject|9
5902683|NCT01662310|20422107|P1|Double-Blind Phase|Withdrawal by Subject|0
5902684|NCT01662310|20422103|P5|Double-Blind Phase|Pregnancy|0
5902685|NCT01662310|20422104|P4|Double-Blind Phase|Pregnancy|0
5902686|NCT01662310|20422105|P3|Double-Blind Phase|Pregnancy|0
5902687|NCT01662310|20422106|P2|Double-Blind Phase|Pregnancy|2
5902688|NCT01662310|20422107|P1|Double-Blind Phase|Pregnancy|0
5902689|NCT01662310|20422103|P5|Double-Blind Phase|Lost to Follow-up|0
5902690|NCT01662310|20422104|P4|Double-Blind Phase|Lost to Follow-up|0
5902691|NCT01662310|20422105|P3|Double-Blind Phase|Lost to Follow-up|0
5902692|NCT01662310|20422106|P2|Double-Blind Phase|Lost to Follow-up|3
5902693|NCT01662310|20422107|P1|Double-Blind Phase|Lost to Follow-up|0
5902694|NCT01662310|20422103|P5|Double-Blind Phase|Adverse Event|0
5902695|NCT01662310|20422104|P4|Double-Blind Phase|Adverse Event|0
5902696|NCT01662310|20422105|P3|Double-Blind Phase|Adverse Event|1
5902697|NCT01662310|20422106|P2|Double-Blind Phase|Adverse Event|0
5902698|NCT01662310|20422107|P1|Double-Blind Phase|Adverse Event|0
5902699|NCT01662310|20422103|P5|Run-In or Stabilization Phase|Other|0
5902700|NCT01662310|20422104|P4|Run-In or Stabilization Phase|Other|0
5902701|NCT01662310|20422105|P3|Run-In or Stabilization Phase|Other|0
5902702|NCT01662310|20422106|P2|Run-In or Stabilization Phase|Other|0
5902703|NCT01662310|20422107|P1|Run-In or Stabilization Phase|Other|1
5902704|NCT01662310|20422103|P5|Run-In or Stabilization Phase|Withdrawal by Subject|0
5902705|NCT01662310|20422104|P4|Run-In or Stabilization Phase|Withdrawal by Subject|0
5902706|NCT01662310|20422105|P3|Run-In or Stabilization Phase|Withdrawal by Subject|0
5902707|NCT01662310|20422106|P2|Run-In or Stabilization Phase|Withdrawal by Subject|0
5902708|NCT01662310|20422107|P1|Run-In or Stabilization Phase|Withdrawal by Subject|25
5902709|NCT01662310|20422103|P5|Run-In or Stabilization Phase|Protocol Violation|0
5902710|NCT01662310|20422104|P4|Run-In or Stabilization Phase|Protocol Violation|0
5902711|NCT01662310|20422105|P3|Run-In or Stabilization Phase|Protocol Violation|0
5902712|NCT01662310|20422106|P2|Run-In or Stabilization Phase|Protocol Violation|0
5902713|NCT01662310|20422107|P1|Run-In or Stabilization Phase|Protocol Violation|15
5902714|NCT01662310|20422103|P5|Run-In or Stabilization Phase|Lost to Follow-up|0
5902715|NCT01662310|20422104|P4|Run-In or Stabilization Phase|Lost to Follow-up|0
5902716|NCT01662310|20422105|P3|Run-In or Stabilization Phase|Lost to Follow-up|0
5902717|NCT01662310|20422106|P2|Run-In or Stabilization Phase|Lost to Follow-up|0
5902718|NCT01662310|20422107|P1|Run-In or Stabilization Phase|Lost to Follow-up|4
5902719|NCT01662310|20422103|P5|Run-In or Stabilization Phase|Lack of Efficacy|0
5902720|NCT01662310|20422104|P4|Run-In or Stabilization Phase|Lack of Efficacy|0
5902721|NCT01662310|20422105|P3|Run-In or Stabilization Phase|Lack of Efficacy|0
5902722|NCT01662310|20422106|P2|Run-In or Stabilization Phase|Lack of Efficacy|0
5902723|NCT01662310|20422107|P1|Run-In or Stabilization Phase|Lack of Efficacy|9
5902724|NCT01662310|20422103|P5|Run-In or Stabilization Phase|Adverse Event|0
5902725|NCT01662310|20422104|P4|Run-In or Stabilization Phase|Adverse Event|0
5902726|NCT01662310|20422105|P3|Run-In or Stabilization Phase|Adverse Event|0
5902727|NCT01662310|20422106|P2|Run-In or Stabilization Phase|Adverse Event|0
5902728|NCT01662310|20422107|P1|Run-In or Stabilization Phase|Adverse Event|11
5902729|NCT01662102|20422188|P2|Overall Study|Sponsor's decision|0
5902730|NCT01662102|20422189|P1|Overall Study|Sponsor's decision|1
5902731|NCT01662063|20422197|P3|Overall Study|Other|0
5902732|NCT01662063|20422198|P2|Overall Study|Other|1
5902733|NCT01662063|20422199|P1|Overall Study|Other|0
5902734|NCT01662063|20422197|P3|Overall Study|Physician Decision|0
5902735|NCT01662063|20422198|P2|Overall Study|Physician Decision|2
5902736|NCT01662063|20422199|P1|Overall Study|Physician Decision|0
5902737|NCT01662063|20422197|P3|Overall Study|Withdrawal by Subject|1
5902738|NCT01662063|20422198|P2|Overall Study|Withdrawal by Subject|4
5902739|NCT01662063|20422199|P1|Overall Study|Withdrawal by Subject|2
5902740|NCT01662063|20422197|P3|Overall Study|Protocol Violation|0
5902741|NCT01662063|20422198|P2|Overall Study|Protocol Violation|0
5902742|NCT01662063|20422199|P1|Overall Study|Protocol Violation|1
5902743|NCT01662063|20422197|P3|Overall Study|Lost to Follow-up|0
5902744|NCT01662063|20422198|P2|Overall Study|Lost to Follow-up|4
5902745|NCT01662063|20422199|P1|Overall Study|Lost to Follow-up|0
5902746|NCT01662063|20422197|P3|Overall Study|Lack of Efficacy|0
5902747|NCT01662063|20422198|P2|Overall Study|Lack of Efficacy|6
5902748|NCT01662063|20422199|P1|Overall Study|Lack of Efficacy|1
5902749|NCT01662063|20422197|P3|Overall Study|Adverse Event or Intercurrent Illness|0
5902750|NCT01662063|20422198|P2|Overall Study|Adverse Event or Intercurrent Illness|12
5902751|NCT01662063|20422199|P1|Overall Study|Adverse Event or Intercurrent Illness|1
5902752|NCT01662024|20422278|P1|Overall Study|Withdrawal by Subject|3
5902753|NCT01662024|20422278|P1|Overall Study|Pregnancy|2
5902754|NCT01661972|20422290|P2|Overall Study|Withdrawal by Subject|1
5902755|NCT01661972|20422291|P1|Overall Study|Withdrawal by Subject|0
5902756|NCT01661972|20422290|P2|Overall Study|Death during Treatment period|1
5902757|NCT01661972|20422291|P1|Overall Study|Death during Treatment period|1
5902758|NCT01661972|20422290|P2|Overall Study|Adverse Event|2
5902759|NCT01661972|20422291|P1|Overall Study|Adverse Event|1
5902760|NCT01661933|20422310|P1|High-dose Gluten Challenge|Withdrawal by Subject|2
5902761|NCT01661933|20422310|P1|Low-dose Gluten Challenge|Physician Decision|2
5902762|NCT01661881|20422317|P1|Overall Study|Disease Progression|1
5902763|NCT01661790|20422325|P2|Overall Study|Lost to Follow-up|2
5902764|NCT01661790|20422326|P1|Overall Study|Lost to Follow-up|0
5902765|NCT01661686|20422426|P2|Overall Study|did not receive allocated intervention|1
5902766|NCT01661686|20422427|P1|Overall Study|did not receive allocated intervention|0
5902767|NCT01661686|20422426|P2|Overall Study|Lost to Follow-up|1
5902768|NCT01661686|20422427|P1|Overall Study|Lost to Follow-up|2
5902769|NCT01661595|20422468|P4|Phase 2: Week 5-8.|Protocol Violation|0
5902770|NCT01661595|20422469|P3|Phase 2: Week 5-8.|Protocol Violation|1
5902771|NCT01661595|20422470|P2|Phase 2: Week 5-8.|Protocol Violation|0
5902772|NCT01661595|20422471|P1|Phase 2: Week 5-8.|Protocol Violation|0
5902773|NCT01661595|20422468|P4|Phase 1: Week 0-4|Adverse Event|0
5902774|NCT01661595|20422469|P3|Phase 1: Week 0-4|Adverse Event|0
5902775|NCT01661595|20422470|P2|Phase 1: Week 0-4|Adverse Event|0
5902776|NCT01661595|20422471|P1|Phase 1: Week 0-4|Adverse Event|1
5902777|NCT01661205|20422599|P1|Overall Study|Physician Decision|2
5902778|NCT01661179|20422610|P1|Overall Study|Other Eligibility criteria|4
5902779|NCT01661179|20422610|P1|Overall Study|Withdrawal by Subject|1
5902780|NCT01661179|20422610|P1|Overall Study|Death|1
5902781|NCT01661140|20422614|P3|Double-Blind Period|Administrative/Other|6
5902782|NCT01661140|20422615|P2|Double-Blind Period|Administrative/Other|7
5902783|NCT01661140|20422616|P1|Double-Blind Period|Administrative/Other|0
5902784|NCT01661140|20422614|P3|Double-Blind Period|Sponsor Termination|17
5902785|NCT01661140|20422615|P2|Double-Blind Period|Sponsor Termination|14
5902786|NCT01661140|20422616|P1|Double-Blind Period|Sponsor Termination|0
5902787|NCT01661140|20422614|P3|Double-Blind Period|Investigator's Decision|2
5902788|NCT01661140|20422615|P2|Double-Blind Period|Investigator's Decision|1
5902789|NCT01661140|20422616|P1|Double-Blind Period|Investigator's Decision|0
5902790|NCT01661140|20422614|P3|Double-Blind Period|Withdrawal by Subject|3
5902791|NCT01661140|20422615|P2|Double-Blind Period|Withdrawal by Subject|1
5902792|NCT01661140|20422616|P1|Double-Blind Period|Withdrawal by Subject|0
5902793|NCT01661140|20422614|P3|Double-Blind Period|Protocol Violation|3
5902794|NCT01661140|20422615|P2|Double-Blind Period|Protocol Violation|2
5902795|NCT01661140|20422616|P1|Double-Blind Period|Protocol Violation|0
5902796|NCT01661140|20422614|P3|Double-Blind Period|Adverse Event|18
5902797|NCT01661140|20422615|P2|Double-Blind Period|Adverse Event|16
5902798|NCT01661140|20422616|P1|Double-Blind Period|Adverse Event|0
5902799|NCT01661140|20422614|P3|Double-Blind Period|Refused Treatment|1
5902800|NCT01661140|20422615|P2|Double-Blind Period|Refused Treatment|0
5902801|NCT01661140|20422616|P1|Double-Blind Period|Refused Treatment|0
5902802|NCT01661140|20422614|P3|Open-Label Period|Lost to Follow-up|0
5902803|NCT01661140|20422615|P2|Open-Label Period|Lost to Follow-up|0
5902804|NCT01661140|20422616|P1|Open-Label Period|Lost to Follow-up|2
5902805|NCT01661140|20422614|P3|Open-Label Period|Did not meet EULAR criteria|0
5902806|NCT01661140|20422615|P2|Open-Label Period|Did not meet EULAR criteria|0
5902807|NCT01661140|20422616|P1|Open-Label Period|Did not meet EULAR criteria|1
5902808|NCT01661140|20422614|P3|Open-Label Period|Sponsor termination|0
5902809|NCT01661140|20422615|P2|Open-Label Period|Sponsor termination|0
5902810|NCT01661140|20422616|P1|Open-Label Period|Sponsor termination|16
5902811|NCT01661140|20422614|P3|Open-Label Period|Administrative/Other|0
5902812|NCT01661140|20422615|P2|Open-Label Period|Administrative/Other|0
5902813|NCT01661140|20422616|P1|Open-Label Period|Administrative/Other|1
5902814|NCT01661140|20422614|P3|Open-Label Period|Death|0
5902815|NCT01661140|20422615|P2|Open-Label Period|Death|0
5902816|NCT01661140|20422616|P1|Open-Label Period|Death|1
5902817|NCT01661140|20422614|P3|Open-Label Period|Investigator Decision|0
5902818|NCT01661140|20422615|P2|Open-Label Period|Investigator Decision|0
5902819|NCT01661140|20422616|P1|Open-Label Period|Investigator Decision|3
5902820|NCT01661140|20422614|P3|Open-Label Period|Withdrawal by Subject|0
5902821|NCT01661140|20422615|P2|Open-Label Period|Withdrawal by Subject|0
5902822|NCT01661140|20422616|P1|Open-Label Period|Withdrawal by Subject|5
5902823|NCT01661140|20422614|P3|Open-Label Period|Protocol Violation|0
5902824|NCT01661140|20422615|P2|Open-Label Period|Protocol Violation|0
5902825|NCT01661140|20422616|P1|Open-Label Period|Protocol Violation|3
5902826|NCT01661140|20422614|P3|Open-Label Period|Adverse Event|0
5902827|NCT01661140|20422615|P2|Open-Label Period|Adverse Event|0
5902828|NCT01661140|20422616|P1|Open-Label Period|Adverse Event|44
5902829|NCT01661062|20422668|P1|Overall Study|Withdrawal by Subject|2
5902830|NCT01661062|20422668|P1|Overall Study|Completed Treatment Off Study|3
5902831|NCT01660906|20422673|P1|Overall Study|Discontinued due to study drug toxicity|3
5902832|NCT01660763|20422756|P2|Overall Study|Patient ready for early discharge|4
5902833|NCT01660763|20422757|P1|Overall Study|Patient ready for early discharge|28
5902834|NCT01660763|20422756|P2|Overall Study|Withdrawal by Subject|0
5902835|NCT01660763|20422757|P1|Overall Study|Withdrawal by Subject|4
5902836|NCT01660763|20422756|P2|Overall Study|Protocol Violation|0
5902837|NCT01660763|20422757|P1|Overall Study|Protocol Violation|1
5902838|NCT01660763|20422756|P2|Overall Study|Adverse Event|7
5902839|NCT01660763|20422757|P1|Overall Study|Adverse Event|22
5902840|NCT01660763|20422756|P2|Overall Study|Lack of Efficacy|50
5902841|NCT01660763|20422757|P1|Overall Study|Lack of Efficacy|45
5902866|NCT01660412|20422835|P2|Overall Study|Protocol Violation|3
5902867|NCT01660412|20422836|P1|Overall Study|Protocol Violation|0
5902868|NCT01660334|20422842|P1|Overall Study|Lost to Follow-up|1
5902869|NCT01660022|20423085|P6|First Sequence (7 Days)|Protocol Violation|1
5902870|NCT01660022|20423086|P5|First Sequence (7 Days)|Protocol Violation|0
5902871|NCT01660022|20423087|P4|First Sequence (7 Days)|Protocol Violation|0
5902872|NCT01660022|20423088|P3|First Sequence (7 Days)|Protocol Violation|0
5902873|NCT01660022|20423089|P2|First Sequence (7 Days)|Protocol Violation|0
5902874|NCT01660022|20423090|P1|First Sequence (7 Days)|Protocol Violation|0
5902875|NCT01660022|20423085|P6|First Sequence (7 Days)|Adverse Event|3
5902876|NCT01660022|20423086|P5|First Sequence (7 Days)|Adverse Event|1
5902877|NCT01660022|20423087|P4|First Sequence (7 Days)|Adverse Event|0
5902878|NCT01660022|20423088|P3|First Sequence (7 Days)|Adverse Event|0
5902879|NCT01660022|20423089|P2|First Sequence (7 Days)|Adverse Event|0
5902880|NCT01660022|20423090|P1|First Sequence (7 Days)|Adverse Event|0
5902881|NCT01660022|20423085|P6|First Sequence (7 Days)|Withdrawal by Subject|0
5902882|NCT01660022|20423086|P5|First Sequence (7 Days)|Withdrawal by Subject|0
5902883|NCT01660022|20423087|P4|First Sequence (7 Days)|Withdrawal by Subject|1
5902884|NCT01660022|20423088|P3|First Sequence (7 Days)|Withdrawal by Subject|0
5902885|NCT01660022|20423089|P2|First Sequence (7 Days)|Withdrawal by Subject|1
5902886|NCT01660022|20423090|P1|First Sequence (7 Days)|Withdrawal by Subject|0
5902887|NCT01659996|20423149|P3|Overall Study|Withdrawal by Subject|5
5902888|NCT01659996|20423150|P2|Overall Study|Withdrawal by Subject|1
5902889|NCT01659996|20423151|P1|Overall Study|Withdrawal by Subject|4
5902890|NCT01659996|20423149|P3|Overall Study|Adverse Event|1
5902891|NCT01659996|20423150|P2|Overall Study|Adverse Event|0
5902892|NCT01659996|20423151|P1|Overall Study|Adverse Event|0
5902893|NCT01659996|20423149|P3|Overall Study|Lost to Follow-up|2
5902894|NCT01659996|20423150|P2|Overall Study|Lost to Follow-up|3
5902895|NCT01659996|20423151|P1|Overall Study|Lost to Follow-up|1
5902896|NCT01659996|20423149|P3|Overall Study|Protocol Violation|3
5902897|NCT01659996|20423150|P2|Overall Study|Protocol Violation|3
5902898|NCT01659996|20423151|P1|Overall Study|Protocol Violation|3
5902899|NCT01659853|20423192|P2|Washout , 3 to 7 Days|Protocol Violation|0
5902900|NCT01659853|20423193|P1|Washout , 3 to 7 Days|Protocol Violation|1
5902901|NCT01659853|20423192|P2|Washout , 3 to 7 Days|Adverse Event|0
5902902|NCT01659853|20423193|P1|Washout , 3 to 7 Days|Adverse Event|1
5902903|NCT01659736|20423203|P2|3-month Follow-up|Lost to Follow-up|1
5902904|NCT01659736|20423204|P1|3-month Follow-up|Lost to Follow-up|0
5902905|NCT01659736|20423203|P2|Treatment Period|Withdrawal by Subject|0
5902906|NCT01659736|20423204|P1|Treatment Period|Withdrawal by Subject|1
5902907|NCT01659736|20423203|P2|Treatment Period|Protocol Violation|1
5902908|NCT01659736|20423204|P1|Treatment Period|Protocol Violation|3
5902909|NCT01659736|20423203|P2|Treatment Period|Adverse Event|1
5902910|NCT01659736|20423204|P1|Treatment Period|Adverse Event|1
5902911|NCT01659567|20423218|P1|Overall Study|Other|13
5902912|NCT01659567|20423218|P1|Overall Study|Progression of the main disease|1
5902913|NCT01659567|20423218|P1|Overall Study|Withdrawal by Subject|64
5902914|NCT01659567|20423218|P1|Overall Study|Good result at early stage of treatment|5
5902915|NCT01659567|20423218|P1|Overall Study|Adverse Event|12
5902916|NCT01659567|20423218|P1|Overall Study|Switched to Pegferon|6
5902917|NCT01659567|20423218|P1|Overall Study|Lack of Efficacy|22
5902918|NCT01659554|20423235|P1|Overall Study|Study Termination|4
5902919|NCT01659320|20423242|P1|Overall Study|Physician Decision|1
5902920|NCT01659320|20423242|P1|Overall Study|Withdrawal by Subject|2
5902921|NCT01659125|20423261|P1|Overall Study|Failed to Start Treatment|2
5902922|NCT01659125|20423261|P1|Overall Study|Time Constraints|2
5902923|NCT01659125|20423261|P1|Overall Study|Technical Problem|1
5902924|NCT01659125|20423261|P1|Overall Study|Lost to Follow-up|7
5902925|NCT01659125|20423261|P1|Overall Study|Withdrawal by Subject|2
5902926|NCT01659021|20423268|P2|Long-Term Follow Up|Withdrawal by Subject|1
5902927|NCT01659021|20423269|P1|Long-Term Follow Up|Withdrawal by Subject|2
5902928|NCT01659021|20423268|P2|Long-Term Follow Up|Lost to Follow-up|3
5902929|NCT01659021|20423269|P1|Long-Term Follow Up|Lost to Follow-up|3
5902930|NCT01659021|20423268|P2|Main Study|Study Terminated by Sponsor|1
5902931|NCT01659021|20423269|P1|Main Study|Study Terminated by Sponsor|16
5902932|NCT01659021|20423268|P2|Main Study|Withdrawal by Subject|16
5902933|NCT01659021|20423269|P1|Main Study|Withdrawal by Subject|19
5902934|NCT01659021|20423268|P2|Main Study|Physician Decision|16
5902935|NCT01659021|20423269|P1|Main Study|Physician Decision|34
5902936|NCT01659021|20423268|P2|Main Study|Unknown Reasons|1
5902937|NCT01659021|20423269|P1|Main Study|Unknown Reasons|2
5902938|NCT01659021|20423268|P2|Main Study|Lost to Follow-up|0
5902939|NCT01659021|20423269|P1|Main Study|Lost to Follow-up|1
5902940|NCT01659021|20423268|P2|Main Study|Adverse Event|3
5902941|NCT01659021|20423269|P1|Main Study|Adverse Event|2
5902942|NCT01658943|20423300|P2|Overall Study|Withdrew prior to beginning protocol Tx|0
5902943|NCT01658943|20423301|P1|Overall Study|Withdrew prior to beginning protocol Tx|1
5902944|NCT01658943|20423300|P2|Overall Study|Not eligible|9
5902945|NCT01658943|20423301|P1|Overall Study|Not eligible|7
5902946|NCT01658943|20423300|P2|Overall Study|not protocol specified|1
5902947|NCT01658943|20423301|P1|Overall Study|not protocol specified|4
5902948|NCT01658943|20423300|P2|Overall Study|Death|2
5902949|NCT01658943|20423301|P1|Overall Study|Death|4
5902950|NCT01658943|20423300|P2|Overall Study|Progression/Relapse|40
5902951|NCT01658943|20423301|P1|Overall Study|Progression/Relapse|39
5902952|NCT01658943|20423300|P2|Overall Study|Withdrawal by Subject|2
5902953|NCT01658943|20423301|P1|Overall Study|Withdrawal by Subject|9
5902954|NCT01658943|20423300|P2|Overall Study|Adverse Event|13
5902955|NCT01658943|20423301|P1|Overall Study|Adverse Event|6
5902956|NCT01658904|20423316|P3|Overall Study|Principal Investigator discretion|0
5902957|NCT01658904|20423317|P2|Overall Study|Principal Investigator discretion|0
5902958|NCT01658904|20423318|P1|Overall Study|Principal Investigator discretion|2
5902959|NCT01658813|20423344|P1|Overall Study|Disease progression|3
5902960|NCT01658735|20423355|P3|Overall Study|Withdrawal by Subject|3
5902961|NCT01658735|20423356|P2|Overall Study|Withdrawal by Subject|5
5902962|NCT01658735|20423357|P1|Overall Study|Withdrawal by Subject|3
5902963|NCT01658735|20423355|P3|Overall Study|Protocol Violation|0
5902964|NCT01658735|20423356|P2|Overall Study|Protocol Violation|1
5902965|NCT01658735|20423357|P1|Overall Study|Protocol Violation|0
5902966|NCT01658735|20423355|P3|Overall Study|Lost to Follow-up|0
5902967|NCT01658735|20423356|P2|Overall Study|Lost to Follow-up|1
5902968|NCT01658735|20423357|P1|Overall Study|Lost to Follow-up|1
5902969|NCT01658735|20423355|P3|Overall Study|Lack of Efficacy|1
5902970|NCT01658735|20423356|P2|Overall Study|Lack of Efficacy|0
5902971|NCT01658735|20423357|P1|Overall Study|Lack of Efficacy|1
5902972|NCT01658579|20423399|P4|Treatment Period B|Other|1
5902973|NCT01658579|20423400|P3|Treatment Period B|Other|0
5902974|NCT01658579|20423401|P2|Treatment Period B|Other|0
5902975|NCT01658579|20423402|P1|Treatment Period B|Other|0
5902976|NCT01658579|20423399|P4|Treatment Period A|Adverse Event|0
5902977|NCT01658579|20423400|P3|Treatment Period A|Adverse Event|0
5902978|NCT01658579|20423401|P2|Treatment Period A|Adverse Event|0
5902979|NCT01658579|20423402|P1|Treatment Period A|Adverse Event|1
5902980|NCT01658579|20423399|P4|Treatment Period A|Other|1
5902981|NCT01658579|20423400|P3|Treatment Period A|Other|1
5902982|NCT01658579|20423401|P2|Treatment Period A|Other|0
5902983|NCT01658579|20423402|P1|Treatment Period A|Other|0
5902984|NCT01658514|20423430|P3|Overall Study|Protocol Violation|2
5902985|NCT01658514|20423431|P2|Overall Study|Protocol Violation|0
5902986|NCT01658514|20423432|P1|Overall Study|Protocol Violation|1
5902987|NCT01658436|20423443|P2|Overall Study|Death|0
5902988|NCT01658436|20423444|P1|Overall Study|Death|1
5902989|NCT01658436|20423443|P2|Overall Study|Subject/guardian decision|1
5902990|NCT01658436|20423444|P1|Overall Study|Subject/guardian decision|0
5902991|NCT01658436|20423443|P2|Overall Study|Study terminated by sponsor|1
5902992|NCT01658436|20423444|P1|Overall Study|Study terminated by sponsor|0
5902993|NCT01658436|20423443|P2|Overall Study|Progressive disease|4
5902994|NCT01658436|20423444|P1|Overall Study|Progressive disease|12
5902995|NCT01658436|20423443|P2|Overall Study|Physician Decision|0
5902996|NCT01658436|20423444|P1|Overall Study|Physician Decision|1
5902997|NCT01658436|20423443|P2|Overall Study|Adverse Event|5
5902998|NCT01658436|20423444|P1|Overall Study|Adverse Event|6
5902999|NCT01658150|20423464|P1|Overall Study|Withdrawal by Subject|1
5903000|NCT01658072|20423486|P2|Overall Study|Protocol Violation|2
5903001|NCT01658072|20423487|P1|Overall Study|Protocol Violation|4
5903002|NCT01658020|20423502|P2|Overall Study|Protocol Violation|1
5903003|NCT01658020|20423503|P1|Overall Study|Protocol Violation|0
5903004|NCT01658020|20423502|P2|Overall Study|Withdrawal by Subject|5
5903005|NCT01658020|20423503|P1|Overall Study|Withdrawal by Subject|4
5903006|NCT01658020|20423502|P2|Overall Study|Lost to Follow-up|0
5903007|NCT01658020|20423503|P1|Overall Study|Lost to Follow-up|1
5903008|NCT01658020|20423502|P2|Overall Study|Adverse Event|3
5903009|NCT01658020|20423503|P1|Overall Study|Adverse Event|3
5903010|NCT01657903|20423519|P1|Overall Study|Withdrawal by Subject|1
5903011|NCT01657903|20423519|P1|Overall Study|Lost to Follow-up|1
5903012|NCT01657877|20423541|P1|Overall Study|Other Reason|2
5903013|NCT01657877|20423541|P1|Overall Study|Adverse Event|2
5903014|NCT01657877|20423541|P1|Overall Study|Protocol Violation|6
5903015|NCT01657877|20423541|P1|Overall Study|Withdrawal by Subject|4
5903016|NCT01657799|20423561|P3|Overall Study|Other|49
5903017|NCT01657799|20423562|P2|Overall Study|Other|62
5903018|NCT01657799|20423563|P1|Overall Study|Other|52
5903019|NCT01657799|20423561|P3|Overall Study|Radiographic & Clinical Progression|15
5903020|NCT01657799|20423562|P2|Overall Study|Radiographic & Clinical Progression|11
5903021|NCT01657799|20423563|P1|Overall Study|Radiographic & Clinical Progression|16
5903022|NCT01657799|20423561|P3|Overall Study|Progressive Disease Clinical|7
5903023|NCT01657799|20423562|P2|Overall Study|Progressive Disease Clinical|4
5903024|NCT01657799|20423563|P1|Overall Study|Progressive Disease Clinical|7
5903025|NCT01657799|20423561|P3|Overall Study|Disease Progression|4
5903026|NCT01657799|20423562|P2|Overall Study|Disease Progression|4
5903027|NCT01657799|20423563|P1|Overall Study|Disease Progression|2
5903028|NCT01657799|20423561|P3|Overall Study|Lost to Follow-up|1
5903029|NCT01657799|20423562|P2|Overall Study|Lost to Follow-up|0
5903030|NCT01657799|20423563|P1|Overall Study|Lost to Follow-up|1
5903031|NCT01657799|20423561|P3|Overall Study|Withdrawal by Subject|10
5903032|NCT01657799|20423562|P2|Overall Study|Withdrawal by Subject|10
5903033|NCT01657799|20423563|P1|Overall Study|Withdrawal by Subject|13
5903034|NCT01657799|20423561|P3|Overall Study|Adverse Event Not Related to Progression|4
5903035|NCT01657799|20423562|P2|Overall Study|Adverse Event Not Related to Progression|4
5903036|NCT01657799|20423563|P1|Overall Study|Adverse Event Not Related to Progression|5
5903037|NCT01657799|20423561|P3|Overall Study|Adverse Event Related to progression|12
5903038|NCT01657799|20423562|P2|Overall Study|Adverse Event Related to progression|8
5903039|NCT01657799|20423563|P1|Overall Study|Adverse Event Related to progression|6
5903040|NCT01657760|20423582|P4|Overall Study|Physician Decision|2
5903041|NCT01657760|20423583|P3|Overall Study|Physician Decision|1
5903042|NCT01657760|20423584|P2|Overall Study|Physician Decision|1
5903043|NCT01657760|20423585|P1|Overall Study|Physician Decision|1
5903044|NCT01657760|20423582|P4|Overall Study|Withdrawal by Subject|1
5903045|NCT01657760|20423583|P3|Overall Study|Withdrawal by Subject|0
5903046|NCT01657760|20423584|P2|Overall Study|Withdrawal by Subject|0
5903047|NCT01657760|20423585|P1|Overall Study|Withdrawal by Subject|0
5903048|NCT01657461|20423604|P2|Overall Study|Withdrawal by Subject|3
5903049|NCT01657461|20423605|P1|Overall Study|Withdrawal by Subject|1
5903050|NCT01657461|20423604|P2|Overall Study|Physician Decision|2
5903051|NCT01657461|20423605|P1|Overall Study|Physician Decision|0
5903052|NCT01657461|20423604|P2|Overall Study|Lost to Follow-up|3
5903053|NCT01657461|20423605|P1|Overall Study|Lost to Follow-up|0
5903054|NCT01657461|20423604|P2|Overall Study|Death|12
5903055|NCT01657461|20423605|P1|Overall Study|Death|9
5903056|NCT01657370|20423635|P6|Overall Study|Lost to Follow-up|1
5903057|NCT01657370|20423636|P5|Overall Study|Lost to Follow-up|0
5903058|NCT01657370|20423637|P4|Overall Study|Lost to Follow-up|0
5903059|NCT01657370|20423638|P3|Overall Study|Lost to Follow-up|1
5903060|NCT01657370|20423639|P2|Overall Study|Lost to Follow-up|0
5903061|NCT01657370|20423640|P1|Overall Study|Lost to Follow-up|2
5903062|NCT01657370|20423635|P6|Overall Study|Protocol Violation|0
5903063|NCT01657370|20423636|P5|Overall Study|Protocol Violation|0
5903064|NCT01657370|20423637|P4|Overall Study|Protocol Violation|1
5903065|NCT01657370|20423638|P3|Overall Study|Protocol Violation|1
5903066|NCT01657370|20423639|P2|Overall Study|Protocol Violation|1
5903067|NCT01657370|20423640|P1|Overall Study|Protocol Violation|1
5903068|NCT01657370|20423635|P6|Overall Study|Adverse Event|0
5903069|NCT01657370|20423636|P5|Overall Study|Adverse Event|1
5903070|NCT01657370|20423637|P4|Overall Study|Adverse Event|0
5903071|NCT01657370|20423638|P3|Overall Study|Adverse Event|0
5903072|NCT01657370|20423639|P2|Overall Study|Adverse Event|0
5903073|NCT01657370|20423640|P1|Overall Study|Adverse Event|0
5903074|NCT01657370|20423635|P6|Overall Study|Lack of Qualifying Event|2
5903075|NCT01657370|20423636|P5|Overall Study|Lack of Qualifying Event|1
5903076|NCT01657370|20423637|P4|Overall Study|Lack of Qualifying Event|2
5903077|NCT01657370|20423638|P3|Overall Study|Lack of Qualifying Event|3
5903078|NCT01657370|20423639|P2|Overall Study|Lack of Qualifying Event|0
5903079|NCT01657370|20423640|P1|Overall Study|Lack of Qualifying Event|1
5903080|NCT01657370|20423635|P6|Overall Study|Physician Decision|0
5903081|NCT01657370|20423636|P5|Overall Study|Physician Decision|5
5903082|NCT01657370|20423637|P4|Overall Study|Physician Decision|2
5903083|NCT01657370|20423638|P3|Overall Study|Physician Decision|1
5903084|NCT01657370|20423639|P2|Overall Study|Physician Decision|3
5903085|NCT01657370|20423640|P1|Overall Study|Physician Decision|2
5903086|NCT01657370|20423635|P6|Overall Study|Withdrawal by Subject|1
5903087|NCT01657370|20423636|P5|Overall Study|Withdrawal by Subject|0
5903088|NCT01657370|20423637|P4|Overall Study|Withdrawal by Subject|0
5903089|NCT01657370|20423638|P3|Overall Study|Withdrawal by Subject|1
5903090|NCT01657370|20423639|P2|Overall Study|Withdrawal by Subject|0
5903091|NCT01657370|20423640|P1|Overall Study|Withdrawal by Subject|0
5903092|NCT01657305|20423738|P1|Overall Study|Did not Adhere to Protocol/Procedures|4
5903093|NCT01657305|20423738|P1|Overall Study|Lost to Follow-up|1
5903094|NCT01657305|20423738|P1|Overall Study|Adverse Event|1
5903095|NCT01657305|20423738|P1|Overall Study|Withdrawal by Subject|4
5903096|NCT01657305|20423738|P1|Overall Study|Lack of Wound Closure at Day 28|15
5903097|NCT01657292|20423788|P1|Overall Study|Change of therapy|1
5903098|NCT01657292|20423788|P1|Overall Study|Violation of eligibility criteria|1
5903099|NCT01657292|20423788|P1|Overall Study|Withdrawal by Subject|2
5903100|NCT01657292|20423788|P1|Overall Study|Adverse Event|6
5903101|NCT01657266|20423797|P2|Overall Study|Adverse Event|3
5903102|NCT01657266|20423798|P1|Overall Study|Adverse Event|2
5903103|NCT01657266|20423797|P2|Overall Study|Lost to Follow-up|2
5903104|NCT01657266|20423798|P1|Overall Study|Lost to Follow-up|2
5903105|NCT01657253|20423820|P2|Overall Study|Adverse Event|1
5903106|NCT01657253|20423821|P1|Overall Study|Adverse Event|0
5903107|NCT01657253|20423820|P2|Overall Study|Withdrawal by Subject|12
5903108|NCT01657253|20423821|P1|Overall Study|Withdrawal by Subject|11
5903109|NCT01657253|20423820|P2|Overall Study|Lost to Follow-up|5
5903110|NCT01657253|20423821|P1|Overall Study|Lost to Follow-up|6
5903111|NCT01657162|20423833|P2|Overall Study|Other than Specified|2
5903112|NCT01657162|20423834|P1|Overall Study|Other than Specified|0
5903113|NCT01657162|20423833|P2|Overall Study|Hypersensitivity to Alendronate|1
5903114|NCT01657162|20423834|P1|Overall Study|Hypersensitivity to Alendronate|0
5903115|NCT01657162|20423833|P2|Overall Study|Protocol Violation|0
5903116|NCT01657162|20423834|P1|Overall Study|Protocol Violation|1
5903117|NCT01657162|20423833|P2|Overall Study|Inability to Complete Study Procedures|7
5903118|NCT01657162|20423834|P1|Overall Study|Inability to Complete Study Procedures|1
5903119|NCT01657162|20423833|P2|Overall Study|Death|3
5903120|NCT01657162|20423834|P1|Overall Study|Death|2
5903121|NCT01657162|20423833|P2|Overall Study|Lost to Follow-up|4
5903122|NCT01657162|20423834|P1|Overall Study|Lost to Follow-up|3
5903123|NCT01657162|20423833|P2|Overall Study|Refusal of Treatment|6
5903124|NCT01657162|20423834|P1|Overall Study|Refusal of Treatment|4
5903125|NCT01657162|20423833|P2|Overall Study|Continuing Significant Deterioration|3
5903126|NCT01657162|20423834|P1|Overall Study|Continuing Significant Deterioration|9
5903127|NCT01657162|20423833|P2|Overall Study|Withdrawal by Subject|13
5903128|NCT01657162|20423834|P1|Overall Study|Withdrawal by Subject|13
5903129|NCT01657162|20423833|P2|Overall Study|Adverse Event|36
5903130|NCT01657162|20423834|P1|Overall Study|Adverse Event|26
5903131|NCT01657032|20423862|P2|Overall Study|Lost to Follow-up|7
5903132|NCT01657032|20423863|P1|Overall Study|Lost to Follow-up|0
5903133|NCT01657019|20423889|P1|Overall Study|Other|58
5903134|NCT01657019|20423889|P1|Overall Study|Lack of Efficacy|3
5903135|NCT01657019|20423889|P1|Overall Study|Protocol Violation|6
5903136|NCT01657019|20423889|P1|Overall Study|Lost to Follow-up|48
5903137|NCT01657019|20423889|P1|Overall Study|Adverse Event|55
5903138|NCT01657019|20423889|P1|Overall Study|Withdrawal by Subject|65
5903139|NCT01656967|20423903|P2|Overall Study|unsuccessful ETT insertion|2
5903140|NCT01656967|20423904|P1|Overall Study|unsuccessful ETT insertion|3
5903141|NCT01656967|20423903|P2|Overall Study|faulty monitor|0
5903142|NCT01656967|20423904|P1|Overall Study|faulty monitor|1
5903143|NCT01656889|20423930|P2|Post Treatment Follow-Up, 3 Months|Site Closure|1
5903144|NCT01656889|20423931|P1|Post Treatment Follow-Up, 3 Months|Site Closure|0
5903145|NCT01656889|20423930|P2|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|1
5903146|NCT01656889|20423931|P1|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|2
5903147|NCT01656889|20423930|P2|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|2
5903148|NCT01656889|20423931|P1|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|1
5903149|NCT01656889|20423930|P2|Post Treatment Follow-Up, 3 Months|Death|5
5903150|NCT01656889|20423931|P1|Post Treatment Follow-Up, 3 Months|Death|1
5903151|NCT01656889|20423930|P2|Treatment Period, 12 Weeks|Moved out of the area|2
5903152|NCT01656889|20423931|P1|Treatment Period, 12 Weeks|Moved out of the area|0
5903153|NCT01656889|20423930|P2|Treatment Period, 12 Weeks|Protocol Violation|1
5903154|NCT01656889|20423931|P1|Treatment Period, 12 Weeks|Protocol Violation|0
5903155|NCT01656889|20423930|P2|Treatment Period, 12 Weeks|Withdrawal by Subject|2
5903156|NCT01656889|20423931|P1|Treatment Period, 12 Weeks|Withdrawal by Subject|1
5903157|NCT01656889|20423930|P2|Treatment Period, 12 Weeks|Lost to Follow-up|1
5903158|NCT01656889|20423931|P1|Treatment Period, 12 Weeks|Lost to Follow-up|1
5903159|NCT01656889|20423930|P2|Treatment Period, 12 Weeks|Death|1
5903160|NCT01656889|20423931|P1|Treatment Period, 12 Weeks|Death|0
5903161|NCT01656889|20423930|P2|Treatment Period, 12 Weeks|Adverse Event|4
5903162|NCT01656889|20423931|P1|Treatment Period, 12 Weeks|Adverse Event|10
5903163|NCT01656850|20423951|P2|First Intervention (3 Months)|Withdrawal by Subject|4
5903164|NCT01656850|20423952|P1|First Intervention (3 Months)|Withdrawal by Subject|3
5903165|NCT01656759|20424043|P2|Overall Study|Protocol Violation|3
5903166|NCT01656759|20424044|P1|Overall Study|Protocol Violation|2
5903167|NCT01656733|20424058|P2|Overall Study|Spontaneous abortion|1
5903168|NCT01656733|20424059|P1|Overall Study|Spontaneous abortion|0
5903169|NCT01656733|20424058|P2|Overall Study|Delivery at another hospital|2
5903170|NCT01656733|20424059|P1|Overall Study|Delivery at another hospital|0
5903171|NCT01656733|20424058|P2|Overall Study|No permission to collect birth outcomes|1
5903172|NCT01656733|20424059|P1|Overall Study|No permission to collect birth outcomes|0
5903173|NCT01656434|20424109|P2|Overall Study|Withdrawal by Subject|7
5903174|NCT01656434|20424110|P1|Overall Study|Withdrawal by Subject|64
5903175|NCT01656434|20424109|P2|Overall Study|Participant withdrew consent|9
5903176|NCT01656434|20424110|P1|Overall Study|Participant withdrew consent|28
5903177|NCT01656434|20424109|P2|Overall Study|Participant moved|12
5903178|NCT01656434|20424110|P1|Overall Study|Participant moved|40
5903179|NCT01656434|20424109|P2|Overall Study|Non-compliance with protocol|15
5903180|NCT01656434|20424110|P1|Overall Study|Non-compliance with protocol|39
5903181|NCT01656434|20424109|P2|Overall Study|Part. discontinued; unrelated to drug|10
5903182|NCT01656434|20424110|P1|Overall Study|Part. discontinued; unrelated to drug|55
5903183|NCT01656434|20424109|P2|Overall Study|Participant discontinued; drug related|4
5903184|NCT01656434|20424110|P1|Overall Study|Participant discontinued; drug related|13
5903185|NCT01656434|20424109|P2|Overall Study|Study terminated by sponsor|348
5903186|NCT01656434|20424110|P1|Overall Study|Study terminated by sponsor|1501
5903187|NCT01656434|20424109|P2|Overall Study|Non-compliance with study drug|9
5903188|NCT01656434|20424110|P1|Overall Study|Non-compliance with study drug|48
5903189|NCT01656434|20424109|P2|Overall Study|Physician Decision|2
5903190|NCT01656434|20424110|P1|Overall Study|Physician Decision|7
5903191|NCT01656434|20424109|P2|Overall Study|Pregnancy|10
5903192|NCT01656434|20424110|P1|Overall Study|Pregnancy|45
5903193|NCT01656434|20424109|P2|Overall Study|Pregnancy wish|6
5903194|NCT01656434|20424110|P1|Overall Study|Pregnancy wish|18
5903195|NCT01656434|20424109|P2|Overall Study|Protocol Violation|0
5903196|NCT01656434|20424110|P1|Overall Study|Protocol Violation|7
5903197|NCT01656434|20424109|P2|Overall Study|Screen failure|0
5903198|NCT01656434|20424110|P1|Overall Study|Screen failure|2
5903199|NCT01656434|20424109|P2|Overall Study|Site discontinued study participation|9
5903200|NCT01656434|20424110|P1|Overall Study|Site discontinued study participation|24
5903201|NCT01656434|20424109|P2|Overall Study|Lost to Follow-up|76
5903202|NCT01656434|20424110|P1|Overall Study|Lost to Follow-up|309
5903203|NCT01656434|20424109|P2|Overall Study|Enrollment terminated at trial site|0
5903204|NCT01656434|20424110|P1|Overall Study|Enrollment terminated at trial site|2
5903205|NCT01656434|20424109|P2|Overall Study|Adverse Event|63
5903206|NCT01656434|20424110|P1|Overall Study|Adverse Event|199
5903207|NCT01656408|20424136|P10|Overall Study|Physician Decision|3
5903208|NCT01656408|20424137|P9|Overall Study|Physician Decision|1
5903209|NCT01656408|20424138|P8|Overall Study|Physician Decision|1
5903210|NCT01656408|20424139|P7|Overall Study|Physician Decision|0
5903211|NCT01656408|20424140|P6|Overall Study|Physician Decision|1
5903212|NCT01656408|20424141|P5|Overall Study|Physician Decision|1
5903213|NCT01656408|20424142|P4|Overall Study|Physician Decision|0
5903214|NCT01656408|20424143|P3|Overall Study|Physician Decision|1
5903215|NCT01656408|20424144|P2|Overall Study|Physician Decision|0
5903216|NCT01656408|20424145|P1|Overall Study|Physician Decision|1
5903217|NCT01656408|20424136|P10|Overall Study|Adverse Event|0
5903218|NCT01656408|20424137|P9|Overall Study|Adverse Event|1
5903219|NCT01656408|20424138|P8|Overall Study|Adverse Event|0
5903220|NCT01656408|20424139|P7|Overall Study|Adverse Event|1
5903221|NCT01656408|20424140|P6|Overall Study|Adverse Event|1
5903222|NCT01656408|20424141|P5|Overall Study|Adverse Event|0
5903223|NCT01656408|20424142|P4|Overall Study|Adverse Event|0
5903224|NCT01656408|20424143|P3|Overall Study|Adverse Event|1
5903225|NCT01656408|20424144|P2|Overall Study|Adverse Event|0
5903226|NCT01656408|20424145|P1|Overall Study|Adverse Event|0
5903227|NCT01656395|20424340|P8|Overall Study|Withdrawal by Subject|0
5903228|NCT01656395|20424341|P7|Overall Study|Withdrawal by Subject|0
5903229|NCT01656395|20424342|P6|Overall Study|Withdrawal by Subject|3
5903230|NCT01656395|20424343|P5|Overall Study|Withdrawal by Subject|0
5903231|NCT01656395|20424344|P4|Overall Study|Withdrawal by Subject|2
5903232|NCT01656395|20424345|P3|Overall Study|Withdrawal by Subject|4
5903233|NCT01656395|20424346|P2|Overall Study|Withdrawal by Subject|1
5903234|NCT01656395|20424347|P1|Overall Study|Withdrawal by Subject|3
5903235|NCT01656395|20424340|P8|Overall Study|Screen Failure|0
5903236|NCT01656395|20424341|P7|Overall Study|Screen Failure|0
5903237|NCT01656395|20424342|P6|Overall Study|Screen Failure|8
5903238|NCT01656395|20424343|P5|Overall Study|Screen Failure|0
5903239|NCT01656395|20424344|P4|Overall Study|Screen Failure|1
5903240|NCT01656395|20424345|P3|Overall Study|Screen Failure|7
5903241|NCT01656395|20424346|P2|Overall Study|Screen Failure|1
5903242|NCT01656395|20424347|P1|Overall Study|Screen Failure|2
5903243|NCT01656395|20424340|P8|Overall Study|Protocol Violation|0
5903244|NCT01656395|20424341|P7|Overall Study|Protocol Violation|0
5903245|NCT01656395|20424342|P6|Overall Study|Protocol Violation|10
5903246|NCT01656395|20424343|P5|Overall Study|Protocol Violation|4
5903247|NCT01656395|20424344|P4|Overall Study|Protocol Violation|2
5903248|NCT01656395|20424345|P3|Overall Study|Protocol Violation|9
5903249|NCT01656395|20424346|P2|Overall Study|Protocol Violation|6
5903250|NCT01656395|20424347|P1|Overall Study|Protocol Violation|6
5903251|NCT01656395|20424340|P8|Overall Study|Progressive Disease|0
5903252|NCT01656395|20424341|P7|Overall Study|Progressive Disease|0
5903253|NCT01656395|20424342|P6|Overall Study|Progressive Disease|1
5903254|NCT01656395|20424343|P5|Overall Study|Progressive Disease|0
5903255|NCT01656395|20424344|P4|Overall Study|Progressive Disease|0
5903256|NCT01656395|20424345|P3|Overall Study|Progressive Disease|0
5903257|NCT01656395|20424346|P2|Overall Study|Progressive Disease|0
5903258|NCT01656395|20424347|P1|Overall Study|Progressive Disease|0
5903259|NCT01656395|20424340|P8|Overall Study|Pregnancy|0
5903260|NCT01656395|20424341|P7|Overall Study|Pregnancy|0
5903261|NCT01656395|20424342|P6|Overall Study|Pregnancy|0
5903262|NCT01656395|20424343|P5|Overall Study|Pregnancy|0
5903263|NCT01656395|20424344|P4|Overall Study|Pregnancy|0
5903264|NCT01656395|20424345|P3|Overall Study|Pregnancy|1
5903265|NCT01656395|20424346|P2|Overall Study|Pregnancy|0
5903266|NCT01656395|20424347|P1|Overall Study|Pregnancy|0
5903267|NCT01656395|20424340|P8|Overall Study|Physician Decision|0
5903268|NCT01656395|20424341|P7|Overall Study|Physician Decision|0
5903269|NCT01656395|20424342|P6|Overall Study|Physician Decision|3
5903270|NCT01656395|20424343|P5|Overall Study|Physician Decision|3
5903271|NCT01656395|20424344|P4|Overall Study|Physician Decision|2
5903272|NCT01656395|20424345|P3|Overall Study|Physician Decision|3
5903273|NCT01656395|20424346|P2|Overall Study|Physician Decision|3
5903274|NCT01656395|20424347|P1|Overall Study|Physician Decision|2
5903275|NCT01656395|20424340|P8|Overall Study|Other|0
5903276|NCT01656395|20424341|P7|Overall Study|Other|0
5903277|NCT01656395|20424342|P6|Overall Study|Other|1
5903278|NCT01656395|20424343|P5|Overall Study|Other|0
5903279|NCT01656395|20424344|P4|Overall Study|Other|0
5903280|NCT01656395|20424345|P3|Overall Study|Other|1
5903281|NCT01656395|20424346|P2|Overall Study|Other|0
5903282|NCT01656395|20424347|P1|Overall Study|Other|0
5903283|NCT01656395|20424340|P8|Overall Study|Non-Compliance with Study Drug|0
5903284|NCT01656395|20424341|P7|Overall Study|Non-Compliance with Study Drug|0
5903285|NCT01656395|20424342|P6|Overall Study|Non-Compliance with Study Drug|1
5903286|NCT01656395|20424343|P5|Overall Study|Non-Compliance with Study Drug|1
5903287|NCT01656395|20424344|P4|Overall Study|Non-Compliance with Study Drug|0
5903288|NCT01656395|20424345|P3|Overall Study|Non-Compliance with Study Drug|0
5903289|NCT01656395|20424346|P2|Overall Study|Non-Compliance with Study Drug|1
5903290|NCT01656395|20424347|P1|Overall Study|Non-Compliance with Study Drug|1
5903291|NCT01656395|20424340|P8|Overall Study|Lost to Follow-up|0
5903292|NCT01656395|20424341|P7|Overall Study|Lost to Follow-up|0
5903293|NCT01656395|20424342|P6|Overall Study|Lost to Follow-up|0
5903294|NCT01656395|20424343|P5|Overall Study|Lost to Follow-up|0
5903295|NCT01656395|20424344|P4|Overall Study|Lost to Follow-up|0
5903296|NCT01656395|20424345|P3|Overall Study|Lost to Follow-up|0
5903297|NCT01656395|20424346|P2|Overall Study|Lost to Follow-up|0
5903298|NCT01656395|20424347|P1|Overall Study|Lost to Follow-up|1
5903299|NCT01656395|20424340|P8|Overall Study|Lack of Efficacy|0
5903300|NCT01656395|20424341|P7|Overall Study|Lack of Efficacy|0
5903301|NCT01656395|20424342|P6|Overall Study|Lack of Efficacy|6
5903302|NCT01656395|20424343|P5|Overall Study|Lack of Efficacy|1
5903303|NCT01656395|20424344|P4|Overall Study|Lack of Efficacy|1
5903304|NCT01656395|20424345|P3|Overall Study|Lack of Efficacy|6
5903305|NCT01656395|20424346|P2|Overall Study|Lack of Efficacy|8
5903306|NCT01656395|20424347|P1|Overall Study|Lack of Efficacy|1
5903307|NCT01656395|20424340|P8|Overall Study|Adverse Event|0
5903308|NCT01656395|20424341|P7|Overall Study|Adverse Event|0
5903309|NCT01656395|20424342|P6|Overall Study|Adverse Event|7
5903310|NCT01656395|20424343|P5|Overall Study|Adverse Event|5
5903311|NCT01656395|20424344|P4|Overall Study|Adverse Event|4
5903312|NCT01656395|20424345|P3|Overall Study|Adverse Event|5
5903313|NCT01656395|20424346|P2|Overall Study|Adverse Event|14
5903314|NCT01656395|20424347|P1|Overall Study|Adverse Event|1
5903315|NCT01656304|20424433|P1|Overall Study|Ineligible, uncontrolled hypertension|1
5903316|NCT01656200|20424474|P1|Overall Study|Withdrawal by Subject|1
5903317|NCT01656161|20424489|P1|Overall Study|Withdrawal by Subject|1
5903318|NCT01656161|20424489|P1|Overall Study|Protocol Violation|1
5903319|NCT01656161|20424489|P1|Overall Study|Adverse Event|2
5903320|NCT01656161|20424489|P1|Overall Study|Death|3
5903321|NCT01655901|20424507|P6|Third Intervention (Hour 3)|Lost to Follow-up|0
5903322|NCT01655901|20424508|P5|Third Intervention (Hour 3)|Lost to Follow-up|1
5903323|NCT01655901|20424509|P4|Third Intervention (Hour 3)|Lost to Follow-up|0
5903324|NCT01655901|20424510|P3|Third Intervention (Hour 3)|Lost to Follow-up|1
5903325|NCT01655901|20424511|P2|Third Intervention (Hour 3)|Lost to Follow-up|1
5903326|NCT01655901|20424512|P1|Third Intervention (Hour 3)|Lost to Follow-up|1
5903327|NCT01655823|20424526|P5|Overall Study|Withdrawal by Subject|0
5903328|NCT01655823|20424527|P4|Overall Study|Withdrawal by Subject|1
5903329|NCT01655823|20424528|P3|Overall Study|Withdrawal by Subject|0
5903330|NCT01655823|20424529|P2|Overall Study|Withdrawal by Subject|1
5903331|NCT01655823|20424530|P1|Overall Study|Withdrawal by Subject|0
5903332|NCT01655823|20424526|P5|Overall Study|Lost to Follow-up|1
5903333|NCT01655823|20424527|P4|Overall Study|Lost to Follow-up|0
5903334|NCT01655823|20424528|P3|Overall Study|Lost to Follow-up|0
5903335|NCT01655823|20424529|P2|Overall Study|Lost to Follow-up|1
5903336|NCT01655823|20424530|P1|Overall Study|Lost to Follow-up|0
5903337|NCT01655498|20424561|P1|Overall Study|Withdrawal by Subject|1
5903338|NCT01655498|20424561|P1|Overall Study|Protocol Violation|2
5903339|NCT01655498|20424561|P1|Overall Study|Unrelated health issue|2
5903340|NCT01655381|20424568|P1|Overall Study|Insufficient Treatment Response|1
5903341|NCT01655381|20424568|P1|Overall Study|Moved to Another City|1
5903342|NCT01655381|20424568|P1|Overall Study|Investigator Decision|1
5903343|NCT01655069|20424608|P4|Overall Study|Withdrawal by Subject|0
5903344|NCT01655069|20424609|P3|Overall Study|Withdrawal by Subject|0
5903345|NCT01655069|20424610|P2|Overall Study|Withdrawal by Subject|3
5903346|NCT01655069|20424611|P1|Overall Study|Withdrawal by Subject|2
5903347|NCT01655069|20424608|P4|Overall Study|No Treatment Needed|0
5903348|NCT01655069|20424609|P3|Overall Study|No Treatment Needed|0
5903349|NCT01655069|20424610|P2|Overall Study|No Treatment Needed|1
5903350|NCT01655069|20424611|P1|Overall Study|No Treatment Needed|0
5903351|NCT01655069|20424608|P4|Overall Study|Lack of Efficacy|0
5903352|NCT01655069|20424609|P3|Overall Study|Lack of Efficacy|0
5903353|NCT01655069|20424610|P2|Overall Study|Lack of Efficacy|1
5903354|NCT01655069|20424611|P1|Overall Study|Lack of Efficacy|0
5903355|NCT01655069|20424608|P4|Overall Study|Adverse Event|3
5903356|NCT01655069|20424609|P3|Overall Study|Adverse Event|2
5903357|NCT01655069|20424610|P2|Overall Study|Adverse Event|7
5903358|NCT01655069|20424611|P1|Overall Study|Adverse Event|6
5903359|NCT01655069|20424608|P4|Overall Study|Physician Decision|1
5903360|NCT01655069|20424609|P3|Overall Study|Physician Decision|0
5903361|NCT01655069|20424610|P2|Overall Study|Physician Decision|0
5903362|NCT01655069|20424611|P1|Overall Study|Physician Decision|0
5903363|NCT01654666|20424671|P3|Overall Study|Withdrawal by Subject|1
5903364|NCT01654666|20424672|P2|Overall Study|Withdrawal by Subject|4
5903365|NCT01654666|20424673|P1|Overall Study|Withdrawal by Subject|4
5903366|NCT01654666|20424671|P3|Overall Study|Lost to Follow-up|5
5903367|NCT01654666|20424672|P2|Overall Study|Lost to Follow-up|5
5903368|NCT01654666|20424673|P1|Overall Study|Lost to Follow-up|4
5903369|NCT01654666|20424671|P3|Overall Study|Protocol Violation|8
5903370|NCT01654666|20424672|P2|Overall Study|Protocol Violation|4
5903371|NCT01654666|20424673|P1|Overall Study|Protocol Violation|7
5903372|NCT01654601|20424698|P2|2nd Administration|Protocol Violation|1
5903373|NCT01654601|20424699|P1|2nd Administration|Protocol Violation|0
5903374|NCT01654601|20424698|P2|2nd Administration|Adverse Event|0
5903375|NCT01654601|20424699|P1|2nd Administration|Adverse Event|1
5903376|NCT01654601|20424698|P2|1st Administration|Protocol Violation|2
5903377|NCT01654601|20424699|P1|1st Administration|Protocol Violation|0
5903378|NCT01654601|20424698|P2|1st Administration|Withdrawal by Subject|0
5903379|NCT01654601|20424699|P1|1st Administration|Withdrawal by Subject|2
5903380|NCT01654549|20424713|P2|Overall Study|H.pylori eradication not successful|1
5903381|NCT01654549|20424714|P1|Overall Study|H.pylori eradication not successful|0
5903382|NCT01654536|20424726|P2|Overall Study|Withdrawal by Subject|25
5903383|NCT01654536|20424727|P1|Overall Study|Withdrawal by Subject|27
5903384|NCT01654536|20424726|P2|Overall Study|Physician Decision|8
5903385|NCT01654536|20424727|P1|Overall Study|Physician Decision|12
5903386|NCT01654536|20424726|P2|Overall Study|Lost to Follow-up|5
5903387|NCT01654536|20424727|P1|Overall Study|Lost to Follow-up|5
5903388|NCT01654523|20424763|P1|Overall Study|Withdrawal by Subject|1
5903389|NCT01654380|20424782|P4|Part B, Period 1|Physician Decision|0
5903390|NCT01654380|20424783|P3|Part B, Period 1|Physician Decision|1
5903391|NCT01654380|20424784|P2|Part B, Period 1|Physician Decision|0
5903392|NCT01654380|20424785|P1|Part B, Period 1|Physician Decision|0
5903393|NCT01654302|20424828|P2|Second Intervention (Day 7)|Lost to Follow-up|1
5903394|NCT01654302|20424829|P1|Second Intervention (Day 7)|Lost to Follow-up|1
5903395|NCT01654289|20424838|P3|Overall Study|Withdrew from intervention only|0
5903396|NCT01654289|20424839|P2|Overall Study|Withdrew from intervention only|20
5903397|NCT01654289|20424840|P1|Overall Study|Withdrew from intervention only|17
5903398|NCT01654289|20424838|P3|Overall Study|Withdrawal by Subject|5
5903399|NCT01654289|20424839|P2|Overall Study|Withdrawal by Subject|8
5903400|NCT01654289|20424840|P1|Overall Study|Withdrawal by Subject|10
5903401|NCT01654276|20424878|P1|Overall Study|Withdrawal by Subject|1
5903402|NCT01654276|20424878|P1|Overall Study|Lost to Follow-up|4
5903403|NCT01654276|20424878|P1|Overall Study|Lack of Efficacy|1
5903404|NCT01654250|20424932|P2|Overall Study|Lost to Follow-up|0
5903405|NCT01654250|20424933|P1|Overall Study|Lost to Follow-up|1
5903406|NCT01654224|20424950|P2|Overall Study|Insufficient blood sample|2
5903407|NCT01654224|20424951|P1|Overall Study|Insufficient blood sample|3
5903408|NCT01654224|20424950|P2|Overall Study|Did not receive allocation|8
5903409|NCT01654224|20424951|P1|Overall Study|Did not receive allocation|1
5903410|NCT01654224|20424950|P2|Overall Study|Lost to Follow-up|2
5903411|NCT01654224|20424951|P1|Overall Study|Lost to Follow-up|2
5903412|NCT01653912|20424982|P6|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|1
5903413|NCT01653912|20424983|P5|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0
5903414|NCT01653912|20424984|P4|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0
5903415|NCT01653912|20424985|P3|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0
5903416|NCT01653912|20424986|P2|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0
5903417|NCT01653912|20424987|P1|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0
5903418|NCT01653912|20424982|P6|Phase 2: GSK2110183 125 mg|Clinical Progression|6
5903419|NCT01653912|20424983|P5|Phase 2: GSK2110183 125 mg|Clinical Progression|0
5903420|NCT01653912|20424984|P4|Phase 2: GSK2110183 125 mg|Clinical Progression|0
5903421|NCT01653912|20424985|P3|Phase 2: GSK2110183 125 mg|Clinical Progression|0
5903422|NCT01653912|20424986|P2|Phase 2: GSK2110183 125 mg|Clinical Progression|0
5903423|NCT01653912|20424987|P1|Phase 2: GSK2110183 125 mg|Clinical Progression|0
5903424|NCT01653912|20424982|P6|Phase 2: GSK2110183 125 mg|Adverse Event|1
5903425|NCT01653912|20424983|P5|Phase 2: GSK2110183 125 mg|Adverse Event|0
5903426|NCT01653912|20424984|P4|Phase 2: GSK2110183 125 mg|Adverse Event|0
5903427|NCT01653912|20424985|P3|Phase 2: GSK2110183 125 mg|Adverse Event|0
5903428|NCT01653912|20424986|P2|Phase 2: GSK2110183 125 mg|Adverse Event|0
5903429|NCT01653912|20424987|P1|Phase 2: GSK2110183 125 mg|Adverse Event|0
5903430|NCT01653912|20424982|P6|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0
5903431|NCT01653912|20424983|P5|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0
5903432|NCT01653912|20424984|P4|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|1
5903433|NCT01653912|20424985|P3|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0
5903434|NCT01653912|20424986|P2|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0
5903435|NCT01653912|20424987|P1|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0
5903436|NCT01653912|20424982|P6|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0
5903437|NCT01653912|20424983|P5|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0
5903438|NCT01653912|20424984|P4|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|1
5903439|NCT01653912|20424985|P3|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0
5903440|NCT01653912|20424986|P2|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0
5903441|NCT01653912|20424987|P1|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0
5903442|NCT01653912|20424982|P6|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0
5903443|NCT01653912|20424983|P5|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0
5903444|NCT01653912|20424984|P4|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0
5903445|NCT01653912|20424985|P3|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|2
5903446|NCT01653912|20424986|P2|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0
5903447|NCT01653912|20424987|P1|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0
5903448|NCT01653912|20424982|P6|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0
5903449|NCT01653912|20424983|P5|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0
5903450|NCT01653912|20424984|P4|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0
5903451|NCT01653912|20424985|P3|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0
5903452|NCT01653912|20424986|P2|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|1
5903453|NCT01653912|20424987|P1|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0
5903454|NCT01653782|20425005|P3|Overall Study|Lost to Follow-up|2
5903455|NCT01653782|20425006|P2|Overall Study|Lost to Follow-up|3
5903456|NCT01653782|20425007|P1|Overall Study|Lost to Follow-up|7
5903457|NCT01653782|20425005|P3|Overall Study|Withdrawal by Subject|4
5903458|NCT01653782|20425006|P2|Overall Study|Withdrawal by Subject|15
5903459|NCT01653782|20425007|P1|Overall Study|Withdrawal by Subject|9
5903460|NCT01653743|20425017|P2|Overall Study|Investigator discretion|0
5903461|NCT01653743|20425018|P1|Overall Study|Investigator discretion|3
5903462|NCT01653743|20425017|P2|Overall Study|Withdrawal by Subject|0
5903463|NCT01653743|20425018|P1|Overall Study|Withdrawal by Subject|1
5903464|NCT01653704|20425034|P2|Overall Study|Performance not reflective of training|0
5903465|NCT01653704|20425035|P1|Overall Study|Performance not reflective of training|1
5903466|NCT01653704|20425034|P2|Overall Study|Technical failure during recording|1
5903467|NCT01653704|20425035|P1|Overall Study|Technical failure during recording|1
5903468|NCT01653327|20425104|P1|Overall Study|Withdrawal by Subject|1
5903469|NCT01653262|20425129|P1|Overall Study|AE, non-serious non-fatal|1
5903470|NCT01653262|20425129|P1|Overall Study|SAE, non-fatal|1
5903471|NCT01653262|20425129|P1|Overall Study|Lack of Efficacy|1
5903472|NCT01653158|20425147|P8|Overall Study|Withdrawal by Subject|0
5903473|NCT01653158|20425148|P7|Overall Study|Withdrawal by Subject|0
5903474|NCT01653158|20425149|P6|Overall Study|Withdrawal by Subject|0
5903475|NCT01653158|20425150|P5|Overall Study|Withdrawal by Subject|0
5903476|NCT01653158|20425151|P4|Overall Study|Withdrawal by Subject|0
5903477|NCT01653158|20425152|P3|Overall Study|Withdrawal by Subject|0
5903478|NCT01653158|20425153|P2|Overall Study|Withdrawal by Subject|0
5903479|NCT01653158|20425154|P1|Overall Study|Withdrawal by Subject|1
5903480|NCT01653158|20425147|P8|Overall Study|Progressive disease|9
5903481|NCT01653158|20425148|P7|Overall Study|Progressive disease|2
5903482|NCT01653158|20425149|P6|Overall Study|Progressive disease|1
5903483|NCT01653158|20425150|P5|Overall Study|Progressive disease|1
5903484|NCT01653158|20425151|P4|Overall Study|Progressive disease|0
5903485|NCT01653158|20425152|P3|Overall Study|Progressive disease|0
5903486|NCT01653158|20425153|P2|Overall Study|Progressive disease|0
5903487|NCT01653158|20425154|P1|Overall Study|Progressive disease|0
5903488|NCT01653158|20425147|P8|Overall Study|Other|1
5903489|NCT01653158|20425148|P7|Overall Study|Other|0
5903490|NCT01653158|20425149|P6|Overall Study|Other|0
5903491|NCT01653158|20425150|P5|Overall Study|Other|0
5903492|NCT01653158|20425151|P4|Overall Study|Other|0
5903493|NCT01653158|20425152|P3|Overall Study|Other|0
5903494|NCT01653158|20425153|P2|Overall Study|Other|0
5903495|NCT01653158|20425154|P1|Overall Study|Other|0
5903496|NCT01653158|20425147|P8|Overall Study|Adverse Event|3
5903497|NCT01653158|20425148|P7|Overall Study|Adverse Event|0
5903498|NCT01653158|20425149|P6|Overall Study|Adverse Event|0
5903499|NCT01653158|20425150|P5|Overall Study|Adverse Event|0
5903500|NCT01653158|20425151|P4|Overall Study|Adverse Event|1
5903501|NCT01653158|20425152|P3|Overall Study|Adverse Event|0
5903502|NCT01653158|20425153|P2|Overall Study|Adverse Event|0
5903503|NCT01653158|20425154|P1|Overall Study|Adverse Event|0
5903504|NCT01653158|20425147|P8|Overall Study|Death|2
5903505|NCT01653158|20425148|P7|Overall Study|Death|0
5903506|NCT01653158|20425149|P6|Overall Study|Death|0
5903507|NCT01653158|20425150|P5|Overall Study|Death|0
5903508|NCT01653158|20425151|P4|Overall Study|Death|1
5903509|NCT01653158|20425152|P3|Overall Study|Death|0
5903510|NCT01653158|20425153|P2|Overall Study|Death|0
5903511|NCT01653158|20425154|P1|Overall Study|Death|0
5903512|NCT01653132|20425426|P2|First Intervention|Protocol Violation|0
5903513|NCT01653132|20425427|P1|First Intervention|Protocol Violation|1
5903514|NCT01652885|20425491|P1|Overall Study|Adverse Event|1
5903515|NCT01652872|20425518|P2|Overall Study|Withdrawal by Subject|84
5903516|NCT01652872|20425519|P1|Overall Study|Withdrawal by Subject|76
5903517|NCT01652872|20425518|P2|Overall Study|Decision by sponsor|7
5903518|NCT01652872|20425519|P1|Overall Study|Decision by sponsor|5
5903519|NCT01652872|20425518|P2|Overall Study|Lost to Follow-up|23
5903520|NCT01652872|20425519|P1|Overall Study|Lost to Follow-up|28
5903521|NCT01652872|20425518|P2|Overall Study|Death|39
5903522|NCT01652872|20425519|P1|Overall Study|Death|36
5903523|NCT01652729|20425536|P3|Overall Study|Administrative|0
5903524|NCT01652729|20425537|P2|Overall Study|Administrative|0
5903525|NCT01652729|20425538|P1|Overall Study|Administrative|1
5903526|NCT01652729|20425536|P3|Overall Study|Lost to Follow-up|3
5903527|NCT01652729|20425537|P2|Overall Study|Lost to Follow-up|6
5903528|NCT01652729|20425538|P1|Overall Study|Lost to Follow-up|6
5903529|NCT01652729|20425536|P3|Overall Study|Protocol Violation|0
5903530|NCT01652729|20425537|P2|Overall Study|Protocol Violation|0
5903531|NCT01652729|20425538|P1|Overall Study|Protocol Violation|1
5903532|NCT01652729|20425536|P3|Overall Study|Physician Decision|1
5903533|NCT01652729|20425537|P2|Overall Study|Physician Decision|0
5903534|NCT01652729|20425538|P1|Overall Study|Physician Decision|1
5903535|NCT01652729|20425536|P3|Overall Study|Adverse Event|3
5903536|NCT01652729|20425537|P2|Overall Study|Adverse Event|0
5903537|NCT01652729|20425538|P1|Overall Study|Adverse Event|4
5903538|NCT01652729|20425536|P3|Overall Study|Withdrawal by Subject|7
5903539|NCT01652729|20425537|P2|Overall Study|Withdrawal by Subject|7
5903540|NCT01652729|20425538|P1|Overall Study|Withdrawal by Subject|14
5903541|NCT01652716|20425560|P2|Overall Study|Withdrawal by Subject|18
5903542|NCT01652716|20425561|P1|Overall Study|Withdrawal by Subject|33
5903543|NCT01652716|20425560|P2|Overall Study|Adverse Event|10
5903544|NCT01652716|20425561|P1|Overall Study|Adverse Event|7
5903545|NCT01652716|20425560|P2|Overall Study|Protocol Violation|1
5903546|NCT01652716|20425561|P1|Overall Study|Protocol Violation|2
5903547|NCT01652716|20425560|P2|Overall Study|Lost to Follow-up|11
5903548|NCT01652716|20425561|P1|Overall Study|Lost to Follow-up|12
5903549|NCT01652716|20425560|P2|Overall Study|Investigator decision|4
5903550|NCT01652716|20425561|P1|Overall Study|Investigator decision|1
5903551|NCT01652716|20425560|P2|Overall Study|Administrative|2
5903552|NCT01652716|20425561|P1|Overall Study|Administrative|0
5903553|NCT01652716|20425560|P2|Overall Study|Loss of glucose control|0
5903554|NCT01652716|20425561|P1|Overall Study|Loss of glucose control|1
5903555|NCT01652703|20425581|P6|Overall Study|Other|1
5903556|NCT01652703|20425582|P5|Overall Study|Other|1
5903557|NCT01652703|20425583|P4|Overall Study|Other|1
5903558|NCT01652703|20425584|P3|Overall Study|Other|0
5903559|NCT01652703|20425585|P2|Overall Study|Other|0
5903560|NCT01652703|20425586|P1|Overall Study|Other|0
5903561|NCT01652703|20425581|P6|Overall Study|Withdrawal by Subject|1
5903562|NCT01652703|20425582|P5|Overall Study|Withdrawal by Subject|0
5903563|NCT01652703|20425583|P4|Overall Study|Withdrawal by Subject|1
5903564|NCT01652703|20425584|P3|Overall Study|Withdrawal by Subject|3
5903565|NCT01652703|20425585|P2|Overall Study|Withdrawal by Subject|1
5903566|NCT01652703|20425586|P1|Overall Study|Withdrawal by Subject|0
5903567|NCT01652690|20425644|P2|Overall Study|Death|2
5903568|NCT01652690|20425645|P1|Overall Study|Death|5
5903569|NCT01652690|20425644|P2|Overall Study|Lost to Follow-up|6
5903570|NCT01652690|20425645|P1|Overall Study|Lost to Follow-up|6
5903571|NCT01652690|20425644|P2|Overall Study|Other|9
5903572|NCT01652690|20425645|P1|Overall Study|Other|8
5903573|NCT01652690|20425644|P2|Overall Study|Withdrawal by Subject|4
5903574|NCT01652690|20425645|P1|Overall Study|Withdrawal by Subject|16
5903575|NCT01652664|20425679|P2|Overall Study|Inadequate IOP control|0
5903576|NCT01652664|20425680|P1|Overall Study|Inadequate IOP control|1
5903577|NCT01652664|20425679|P2|Overall Study|Treatment Failure|1
5903578|NCT01652664|20425680|P1|Overall Study|Treatment Failure|5
5903579|NCT01652573|20425689|P2|Overall Study|Adverse Event|1
5903580|NCT01652573|20425690|P1|Overall Study|Adverse Event|0
5903581|NCT01652534|20425732|P2|Overall Study|Lack of Efficacy|0
5903582|NCT01652534|20425733|P1|Overall Study|Lack of Efficacy|1
5903583|NCT01652469|20425774|P2|Overall Study|Lost to Follow-up|2
5903584|NCT01652469|20425775|P1|Overall Study|Lost to Follow-up|0
5903585|NCT01652469|20425774|P2|Overall Study|Withdrawal by Subject|4
5903586|NCT01652469|20425775|P1|Overall Study|Withdrawal by Subject|1
5903587|NCT01652287|20425791|P2|Overall Study|Withdrawal by Subject|0
5903588|NCT01652287|20425792|P1|Overall Study|Withdrawal by Subject|2
5903589|NCT01651949|20425823|P3|Overall Study|Withdrawal by Subject|9
5903590|NCT01651949|20425824|P2|Overall Study|Withdrawal by Subject|18
5903591|NCT01651949|20425825|P1|Overall Study|Withdrawal by Subject|17
5903592|NCT01651949|20425823|P3|Overall Study|Screen failure|0
5903593|NCT01651949|20425824|P2|Overall Study|Screen failure|2
5903594|NCT01651949|20425825|P1|Overall Study|Screen failure|2
5903595|NCT01651949|20425823|P3|Overall Study|Adverse Event|1
5903596|NCT01651949|20425824|P2|Overall Study|Adverse Event|2
5903597|NCT01651949|20425825|P1|Overall Study|Adverse Event|0
5903598|NCT01651949|20425823|P3|Overall Study|Physician Decision|0
5903599|NCT01651949|20425824|P2|Overall Study|Physician Decision|2
5903600|NCT01651949|20425825|P1|Overall Study|Physician Decision|0
5903601|NCT01651949|20425823|P3|Overall Study|Protocol Violation|1
5903602|NCT01651949|20425824|P2|Overall Study|Protocol Violation|2
5903603|NCT01651949|20425825|P1|Overall Study|Protocol Violation|0
5903604|NCT01651949|20425823|P3|Overall Study|Lost to Follow-up|20
5903605|NCT01651949|20425824|P2|Overall Study|Lost to Follow-up|56
5903606|NCT01651949|20425825|P1|Overall Study|Lost to Follow-up|30
5903607|NCT01651949|20425823|P3|Overall Study|Unknown status|0
5903608|NCT01651949|20425824|P2|Overall Study|Unknown status|4
5903609|NCT01651949|20425825|P1|Overall Study|Unknown status|4
5903610|NCT01651936|20425845|P3|Extension Study|Study terminated by sponsor|13
5903611|NCT01651936|20425846|P2|Extension Study|Study terminated by sponsor|0
5903612|NCT01651936|20425847|P1|Extension Study|Study terminated by sponsor|0
5903613|NCT01651936|20425845|P3|Extension Study|Lack of Efficacy|1
5903614|NCT01651936|20425846|P2|Extension Study|Lack of Efficacy|0
5903615|NCT01651936|20425847|P1|Extension Study|Lack of Efficacy|0
5903616|NCT01651936|20425845|P3|Base Study|Study terminated by sponsor|0
5903617|NCT01651936|20425846|P2|Base Study|Study terminated by sponsor|16
5903618|NCT01651936|20425847|P1|Base Study|Study terminated by sponsor|21
5903619|NCT01651936|20425845|P3|Base Study|Early Escape|0
5903620|NCT01651936|20425846|P2|Base Study|Early Escape|8
5903621|NCT01651936|20425847|P1|Base Study|Early Escape|2
5903622|NCT01651936|20425845|P3|Base Study|Withdrawal by Subject|0
5903623|NCT01651936|20425846|P2|Base Study|Withdrawal by Subject|1
5903624|NCT01651936|20425847|P1|Base Study|Withdrawal by Subject|1
5903625|NCT01651936|20425845|P3|Base Study|Adverse Event|0
5903626|NCT01651936|20425846|P2|Base Study|Adverse Event|0
5903627|NCT01651936|20425847|P1|Base Study|Adverse Event|3
5903628|NCT01651780|20425917|P2|Overall Study|Physician decision: Day 30 visit <23 day|5
5903629|NCT01651780|20425918|P1|Overall Study|Physician decision: Day 30 visit <23 day|1
5903630|NCT01651780|20425917|P2|Overall Study|Lost to Follow-up|2
5903631|NCT01651780|20425918|P1|Overall Study|Lost to Follow-up|1
5903632|NCT01651780|20425917|P2|Overall Study|Inclusion/Exclusion Criteria Not Met|0
5903633|NCT01651780|20425918|P1|Overall Study|Inclusion/Exclusion Criteria Not Met|3
5903634|NCT01651780|20425917|P2|Overall Study|Withdrawal by Subject|0
5903635|NCT01651780|20425918|P1|Overall Study|Withdrawal by Subject|2
5903636|NCT01651780|20425917|P2|Overall Study|Reason Not Specified: No 30-day visit|2
5903637|NCT01651780|20425918|P1|Overall Study|Reason Not Specified: No 30-day visit|2
5903638|NCT01651780|20425917|P2|Overall Study|Physician decision: No 30-day visit|1
5903639|NCT01651780|20425918|P1|Overall Study|Physician decision: No 30-day visit|2
5903640|NCT01651403|20425969|P2|Open-Label Phase (Weeks 49/73-120/144)|Withdrew consent/assent|2
5903641|NCT01651403|20425970|P1|Open-Label Phase (Weeks 49/73-120/144)|Withdrew consent/assent|1
5903642|NCT01651403|20425969|P2|Open-Label Phase (Weeks 49/73-120/144)|Investigator decision|1
5903643|NCT01651403|20425970|P1|Open-Label Phase (Weeks 49/73-120/144)|Investigator decision|1
5903644|NCT01651403|20425969|P2|Open-Label Phase (Weeks 49/73-120/144)|Continuing Study|13
5903645|NCT01651403|20425970|P1|Open-Label Phase (Weeks 49/73-120/144)|Continuing Study|25
5903646|NCT01651403|20425969|P2|Double-Blind Period (Through Week 48/72)|Enrolled but not Treated|1
5903647|NCT01651403|20425970|P1|Double-Blind Period (Through Week 48/72)|Enrolled but not Treated|0
5903648|NCT01651403|20425969|P2|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3
5903649|NCT01651403|20425970|P1|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3
5903650|NCT01651403|20425969|P2|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|0
5903651|NCT01651403|20425970|P1|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|1
5903652|NCT01651260|20426020|P1|Overall Study|unable to apply product|3
5903653|NCT01651208|20426027|P2|Overall Study|Lost to Follow-up|16
5903654|NCT01651208|20426028|P1|Overall Study|Lost to Follow-up|14
5903655|NCT01651117|20426040|P4|Overall Study|Death|2
5903656|NCT01651117|20426041|P3|Overall Study|Death|2
5903657|NCT01651117|20426042|P2|Overall Study|Death|3
5903658|NCT01651117|20426043|P1|Overall Study|Death|2
5903659|NCT01651052|20426123|P1|Overall Study|Lost to Follow-up|3
5903660|NCT01651052|20426123|P1|Overall Study|Withdrawal by Subject|1
5903661|NCT01651052|20426123|P1|Overall Study|Explant|1
5903662|NCT01651052|20426123|P1|Overall Study|Death|21
5903663|NCT01651039|20426143|P1|Overall Study|Progressive Disease|22
5903664|NCT01651039|20426143|P1|Overall Study|Withdrawal by Subject|1
5903665|NCT01651039|20426143|P1|Overall Study|Physician Decision|2
5903666|NCT01651039|20426143|P1|Overall Study|Non-evaluables|5
5903667|NCT01651000|20426156|P2|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|1
5903668|NCT01651000|20426157|P1|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|0
5903669|NCT01651000|20426156|P2|Overall Study|Administrative reason|0
5903670|NCT01651000|20426157|P1|Overall Study|Administrative reason|1
5903671|NCT01651000|20426156|P2|Overall Study|Physician Decision|0
5903672|NCT01651000|20426157|P1|Overall Study|Physician Decision|1
5903673|NCT01651000|20426156|P2|Overall Study|Lack of Efficacy|1
5903674|NCT01651000|20426157|P1|Overall Study|Lack of Efficacy|1
5903675|NCT01651000|20426156|P2|Overall Study|Subject noncompliance|3
5903676|NCT01651000|20426157|P1|Overall Study|Subject noncompliance|0
5903677|NCT01651000|20426156|P2|Overall Study|Withdrawal by Subject|10
5903678|NCT01651000|20426157|P1|Overall Study|Withdrawal by Subject|2
5903679|NCT01651000|20426156|P2|Overall Study|Protocol Violation|3
5903680|NCT01651000|20426157|P1|Overall Study|Protocol Violation|0
5903681|NCT01651000|20426156|P2|Overall Study|Lost to Follow-up|2
5903682|NCT01651000|20426157|P1|Overall Study|Lost to Follow-up|3
5903683|NCT01651000|20426156|P2|Overall Study|Adverse Event|8
5903684|NCT01651000|20426157|P1|Overall Study|Adverse Event|2
5903685|NCT01650831|20426178|P1|Overall Study|Screen failure|1
5903686|NCT01650805|20426188|P2|Overall Study|Withdrawal by Subject|0
5903687|NCT01650805|20426189|P1|Overall Study|Withdrawal by Subject|1
5903688|NCT01650779|20426199|P1|Overall Study|Withdrawal by Subject|1
5903689|NCT01650636|20426208|P2|Washout up to 9 Months|Lost to Follow-up|1
5903690|NCT01650636|20426209|P1|Washout up to 9 Months|Lost to Follow-up|2
5903691|NCT01650636|20426208|P2|Washout up to 9 Months|Withdrawal by Subject|2
5903692|NCT01650636|20426209|P1|Washout up to 9 Months|Withdrawal by Subject|4
5903693|NCT01650636|20426208|P2|Washout up to 5 Months|Lost to Follow-up|8
5903694|NCT01650636|20426209|P1|Washout up to 5 Months|Lost to Follow-up|2
5903695|NCT01650636|20426208|P2|Washout up to 5 Months|Death|0
5903696|NCT01650636|20426209|P1|Washout up to 5 Months|Death|1
5903697|NCT01650636|20426208|P2|Washout up to 5 Months|Physician Decision|2
5903698|NCT01650636|20426209|P1|Washout up to 5 Months|Physician Decision|2
5903699|NCT01650636|20426208|P2|Washout up to 5 Months|Withdrawal by Subject|8
5903700|NCT01650636|20426209|P1|Washout up to 5 Months|Withdrawal by Subject|4
5903701|NCT01650519|20426249|P2|Overall Study|Withdrawal by Subject|0
5903702|NCT01650519|20426250|P1|Overall Study|Withdrawal by Subject|1
5903703|NCT01650285|20426332|P1|Overall Study|Adverse Event|1
5903704|NCT01650259|20426339|P2|Overall Study|Other than listed|146
5903705|NCT01650259|20426340|P1|Overall Study|Other than listed|64
5903706|NCT01650259|20426339|P2|Overall Study|Not treated|7
5903707|NCT01650259|20426340|P1|Overall Study|Not treated|1
5903708|NCT01650259|20426339|P2|Overall Study|CRF not collected|82
5903709|NCT01650259|20426340|P1|Overall Study|CRF not collected|98
5903710|NCT01650259|20426339|P2|Overall Study|Patients had no visit after entry|0
5903711|NCT01650259|20426340|P1|Overall Study|Patients had no visit after entry|70
5903712|NCT01650259|20426339|P2|Overall Study|Lost to Follow-up|0
5903713|NCT01650259|20426340|P1|Overall Study|Lost to Follow-up|435
5903714|NCT01650259|20426339|P2|Overall Study|Lack of Efficacy|0
5903715|NCT01650259|20426340|P1|Overall Study|Lack of Efficacy|143
5903716|NCT01650259|20426339|P2|Overall Study|Adverse Event|0
5903717|NCT01650259|20426340|P1|Overall Study|Adverse Event|127
5903718|NCT01650259|20426339|P2|Overall Study|Improvement|0
5903719|NCT01650259|20426340|P1|Overall Study|Improvement|105
5903720|NCT01650246|20426345|P1|Overall Study|Lack of Efficacy|30
5903721|NCT01650246|20426345|P1|Overall Study|Death|1
5903722|NCT01650246|20426345|P1|Overall Study|Withdrawal by Subject|26
5903723|NCT01650246|20426345|P1|Overall Study|Lost to Follow-up|5
5903724|NCT01650246|20426345|P1|Overall Study|Sponsor terminated study|53
5903725|NCT01650246|20426345|P1|Overall Study|Protocol Violation|5
5903726|NCT01650246|20426345|P1|Overall Study|Adverse Event|23
5903727|NCT01650194|20426350|P1|Overall Study|Miscellaneous|10
5903728|NCT01650194|20426350|P1|Overall Study|Withdrawal by Subject|2
5903729|NCT01650194|20426350|P1|Overall Study|Progressive Disease (PD)|35
5903730|NCT01649856|20426386|P2|Overall Study|Other|5
5903731|NCT01649856|20426387|P1|Overall Study|Other|20
5903732|NCT01649856|20426386|P2|Overall Study|Lack of Compliance|1
5903733|NCT01649856|20426387|P1|Overall Study|Lack of Compliance|6
5903734|NCT01649856|20426386|P2|Overall Study|Lost to Follow-up|16
5903735|NCT01649856|20426387|P1|Overall Study|Lost to Follow-up|20
5903736|NCT01649856|20426386|P2|Overall Study|Stable or Progressed Disease|3
5903737|NCT01649856|20426387|P1|Overall Study|Stable or Progressed Disease|5
5903738|NCT01649856|20426386|P2|Overall Study|Death|34
5903739|NCT01649856|20426387|P1|Overall Study|Death|69
5903740|NCT01649856|20426386|P2|Overall Study|Treatment Failure|1
5903741|NCT01649856|20426387|P1|Overall Study|Treatment Failure|1
5903742|NCT01649856|20426386|P2|Overall Study|Protocol Violation|4
5903743|NCT01649856|20426387|P1|Overall Study|Protocol Violation|4
5903744|NCT01649856|20426386|P2|Overall Study|Withdrawal by Subject|14
5903745|NCT01649856|20426387|P1|Overall Study|Withdrawal by Subject|14
5903746|NCT01649804|20426419|P1|Overall Study|Administrative/Other|8
5903747|NCT01649791|20426431|P1|Overall Study|Adverse Event|1
5903748|NCT01649791|20426431|P1|Overall Study|Disease Progression|2
5903749|NCT01649765|20426440|P2|Overall Study|Withdrawal by Subject|1
5903750|NCT01649765|20426441|P1|Overall Study|Withdrawal by Subject|2
5903751|NCT01649765|20426440|P2|Overall Study|Protocol Violation|0
5903752|NCT01649765|20426441|P1|Overall Study|Protocol Violation|1
5903753|NCT01649765|20426440|P2|Overall Study|Physician Decision|3
5903754|NCT01649765|20426441|P1|Overall Study|Physician Decision|0
5903755|NCT01649765|20426440|P2|Overall Study|Lack of Efficacy|1
5903756|NCT01649765|20426441|P1|Overall Study|Lack of Efficacy|1
5903757|NCT01649765|20426440|P2|Overall Study|Adverse Event|3
5903758|NCT01649765|20426441|P1|Overall Study|Adverse Event|5
5903759|NCT01649557|20426492|P3|Overall Study|Lack of Efficacy|0
5903760|NCT01649557|20426493|P2|Overall Study|Lack of Efficacy|0
5903761|NCT01649557|20426494|P1|Overall Study|Lack of Efficacy|5
5903762|NCT01649557|20426492|P3|Overall Study|Protocol deviation|0
5903763|NCT01649557|20426493|P2|Overall Study|Protocol deviation|2
5903764|NCT01649557|20426494|P1|Overall Study|Protocol deviation|0
5903765|NCT01649557|20426492|P3|Overall Study|Withdrawal by Subject|4
5903766|NCT01649557|20426493|P2|Overall Study|Withdrawal by Subject|5
5903767|NCT01649557|20426494|P1|Overall Study|Withdrawal by Subject|15
5903768|NCT01649557|20426492|P3|Overall Study|Physician Decision|1
5903769|NCT01649557|20426493|P2|Overall Study|Physician Decision|2
5903770|NCT01649557|20426494|P1|Overall Study|Physician Decision|8
5903771|NCT01649557|20426492|P3|Overall Study|Met withdrawal criteria|0
5903772|NCT01649557|20426493|P2|Overall Study|Met withdrawal criteria|0
5903773|NCT01649557|20426494|P1|Overall Study|Met withdrawal criteria|4
5903774|NCT01649557|20426492|P3|Overall Study|Adverse Event|1
5903775|NCT01649557|20426493|P2|Overall Study|Adverse Event|5
5903776|NCT01649557|20426494|P1|Overall Study|Adverse Event|7
5903777|NCT01649557|20426492|P3|Overall Study|Lost to Follow-up|3
5903778|NCT01649557|20426493|P2|Overall Study|Lost to Follow-up|0
5903779|NCT01649557|20426494|P1|Overall Study|Lost to Follow-up|5
5903780|NCT01649427|20426540|P2|Overall Study|Surgical problems during nephrectomy|2
5903781|NCT01649427|20426541|P1|Overall Study|Surgical problems during nephrectomy|2
5903782|NCT01649427|20426540|P2|Overall Study|Graft loss|1
5903783|NCT01649427|20426541|P1|Overall Study|Graft loss|0
5903784|NCT01649427|20426540|P2|Overall Study|Lost to Follow-up|1
5903785|NCT01649427|20426541|P1|Overall Study|Lost to Follow-up|0
5903786|NCT01649427|20426540|P2|Overall Study|Withdrawal by Subject|7
5903787|NCT01649427|20426541|P1|Overall Study|Withdrawal by Subject|8
5903788|NCT01649427|20426540|P2|Overall Study|Adverse Event|1
5903789|NCT01649427|20426541|P1|Overall Study|Adverse Event|1
5903790|NCT01649375|20426560|P5|Week 16 up to Week 260|Adverse Event|2
5903791|NCT01649375|20426561|P4|Week 16 up to Week 260|Adverse Event|3
5903792|NCT01649375|20426562|P3|Week 16 up to Week 260|Adverse Event|0
5903793|NCT01649375|20426563|P2|Week 16 up to Week 260|Adverse Event|2
5903794|NCT01649375|20426564|P1|Week 16 up to Week 260|Adverse Event|5
5903795|NCT01649375|20426560|P5|Week 16 up to Week 260|Death|0
5903796|NCT01649375|20426561|P4|Week 16 up to Week 260|Death|0
5903797|NCT01649375|20426562|P3|Week 16 up to Week 260|Death|0
5903798|NCT01649375|20426563|P2|Week 16 up to Week 260|Death|1
5903799|NCT01649375|20426564|P1|Week 16 up to Week 260|Death|1
5903800|NCT01649375|20426560|P5|Week 16 up to Week 260|Withdrawal by Subject|1
5903801|NCT01649375|20426561|P4|Week 16 up to Week 260|Withdrawal by Subject|3
5903802|NCT01649375|20426562|P3|Week 16 up to Week 260|Withdrawal by Subject|0
5903803|NCT01649375|20426563|P2|Week 16 up to Week 260|Withdrawal by Subject|2
5903804|NCT01649375|20426564|P1|Week 16 up to Week 260|Withdrawal by Subject|7
5903805|NCT01649375|20426560|P5|Week 16 up to Week 260|Technical issues|0
5903806|NCT01649375|20426561|P4|Week 16 up to Week 260|Technical issues|1
5903807|NCT01649375|20426562|P3|Week 16 up to Week 260|Technical issues|0
5903808|NCT01649375|20426563|P2|Week 16 up to Week 260|Technical issues|1
5903809|NCT01649375|20426564|P1|Week 16 up to Week 260|Technical issues|0
5903810|NCT01649375|20426560|P5|Week 16 up to Week 260|Physician Decision|0
5903811|NCT01649375|20426561|P4|Week 16 up to Week 260|Physician Decision|0
5903812|NCT01649375|20426562|P3|Week 16 up to Week 260|Physician Decision|0
5903813|NCT01649375|20426563|P2|Week 16 up to Week 260|Physician Decision|2
5903814|NCT01649375|20426564|P1|Week 16 up to Week 260|Physician Decision|0
5903815|NCT01649375|20426560|P5|Week 16 up to Week 260|Non-compliance|0
5903816|NCT01649375|20426561|P4|Week 16 up to Week 260|Non-compliance|1
5903817|NCT01649375|20426562|P3|Week 16 up to Week 260|Non-compliance|0
5903818|NCT01649375|20426563|P2|Week 16 up to Week 260|Non-compliance|1
5903819|NCT01649375|20426564|P1|Week 16 up to Week 260|Non-compliance|0
5903820|NCT01649375|20426560|P5|Week 16 up to Week 260|Lack of Efficacy|2
5903821|NCT01649375|20426561|P4|Week 16 up to Week 260|Lack of Efficacy|4
5903822|NCT01649375|20426562|P3|Week 16 up to Week 260|Lack of Efficacy|0
5903823|NCT01649375|20426563|P2|Week 16 up to Week 260|Lack of Efficacy|4
5903824|NCT01649375|20426564|P1|Week 16 up to Week 260|Lack of Efficacy|7
5903825|NCT01649375|20426560|P5|Up to Week 16|Death|0
5903826|NCT01649375|20426561|P4|Up to Week 16|Death|0
5903827|NCT01649375|20426562|P3|Up to Week 16|Death|0
5903828|NCT01649375|20426563|P2|Up to Week 16|Death|0
5903829|NCT01649375|20426564|P1|Up to Week 16|Death|1
5903830|NCT01649375|20426560|P5|Up to Week 16|Withdrawal by Subject|0
5903831|NCT01649375|20426561|P4|Up to Week 16|Withdrawal by Subject|0
5903832|NCT01649375|20426562|P3|Up to Week 16|Withdrawal by Subject|2
5903833|NCT01649375|20426563|P2|Up to Week 16|Withdrawal by Subject|1
5903834|NCT01649375|20426564|P1|Up to Week 16|Withdrawal by Subject|2
5903835|NCT01649375|20426560|P5|Up to Week 16|Physician Decision|0
5903836|NCT01649375|20426561|P4|Up to Week 16|Physician Decision|0
5903837|NCT01649375|20426562|P3|Up to Week 16|Physician Decision|1
5903838|NCT01649375|20426563|P2|Up to Week 16|Physician Decision|0
5903839|NCT01649375|20426564|P1|Up to Week 16|Physician Decision|0
5903840|NCT01649375|20426560|P5|Up to Week 16|Lack of Efficacy|0
5903841|NCT01649375|20426561|P4|Up to Week 16|Lack of Efficacy|0
5903842|NCT01649375|20426562|P3|Up to Week 16|Lack of Efficacy|1
5903843|NCT01649375|20426563|P2|Up to Week 16|Lack of Efficacy|0
5903844|NCT01649375|20426564|P1|Up to Week 16|Lack of Efficacy|0
5903845|NCT01649375|20426560|P5|Up to Week 16|Adverse Event|0
5903846|NCT01649375|20426561|P4|Up to Week 16|Adverse Event|0
5903847|NCT01649375|20426562|P3|Up to Week 16|Adverse Event|4
5903848|NCT01649375|20426563|P2|Up to Week 16|Adverse Event|5
5903849|NCT01649375|20426564|P1|Up to Week 16|Adverse Event|2
5903850|NCT01649297|20426611|P5|Overall Study|For other reason|0
5903851|NCT01649297|20426612|P4|Overall Study|For other reason|0
5903852|NCT01649297|20426613|P3|Overall Study|For other reason|2
5903853|NCT01649297|20426614|P2|Overall Study|For other reason|1
5903854|NCT01649297|20426615|P1|Overall Study|For other reason|4
5903855|NCT01649297|20426611|P5|Overall Study|Patient withdrawal (not due to AE)|1
5903856|NCT01649297|20426612|P4|Overall Study|Patient withdrawal (not due to AE)|1
5903857|NCT01649297|20426613|P3|Overall Study|Patient withdrawal (not due to AE)|4
5903858|NCT01649297|20426614|P2|Overall Study|Patient withdrawal (not due to AE)|6
5903859|NCT01649297|20426615|P1|Overall Study|Patient withdrawal (not due to AE)|3
5903860|NCT01649297|20426611|P5|Overall Study|Lost to Follow-up|0
5903861|NCT01649297|20426612|P4|Overall Study|Lost to Follow-up|3
5903862|NCT01649297|20426613|P3|Overall Study|Lost to Follow-up|4
5903863|NCT01649297|20426614|P2|Overall Study|Lost to Follow-up|1
5903864|NCT01649297|20426615|P1|Overall Study|Lost to Follow-up|1
5903865|NCT01649297|20426611|P5|Overall Study|Non compliant with Protocol|1
5903866|NCT01649297|20426612|P4|Overall Study|Non compliant with Protocol|2
5903867|NCT01649297|20426613|P3|Overall Study|Non compliant with Protocol|3
5903868|NCT01649297|20426614|P2|Overall Study|Non compliant with Protocol|0
5903869|NCT01649297|20426615|P1|Overall Study|Non compliant with Protocol|1
5903870|NCT01649297|20426611|P5|Overall Study|Lack of Efficacy|1
5903871|NCT01649297|20426612|P4|Overall Study|Lack of Efficacy|0
5903872|NCT01649297|20426613|P3|Overall Study|Lack of Efficacy|0
5903873|NCT01649297|20426614|P2|Overall Study|Lack of Efficacy|0
5903874|NCT01649297|20426615|P1|Overall Study|Lack of Efficacy|0
5903875|NCT01649297|20426611|P5|Overall Study|Adverse Event|1
5903876|NCT01649297|20426612|P4|Overall Study|Adverse Event|13
5903877|NCT01649297|20426613|P3|Overall Study|Adverse Event|4
5903878|NCT01649297|20426614|P2|Overall Study|Adverse Event|5
5903879|NCT01649297|20426615|P1|Overall Study|Adverse Event|5
5903880|NCT01649271|20426634|P2|Overall Study|Other than stated above|0
5903881|NCT01649271|20426635|P1|Overall Study|Other than stated above|1
5903882|NCT01649271|20426634|P2|Overall Study|Withdrawal by Subject|0
5903883|NCT01649271|20426635|P1|Overall Study|Withdrawal by Subject|1
5903884|NCT01649271|20426634|P2|Overall Study|Other Adverse Event|2
5903885|NCT01649271|20426635|P1|Overall Study|Other Adverse Event|0
5903886|NCT01649271|20426634|P2|Overall Study|Progressive disease|5
5903887|NCT01649271|20426635|P1|Overall Study|Progressive disease|4
5903888|NCT01649232|20426650|P2|Overall Study|Physician Decision|0
5903889|NCT01649232|20426651|P1|Overall Study|Physician Decision|2
5903890|NCT01648790|20426707|P5|Treatment 3|Withdrawal by Subject|0
5903891|NCT01648790|20426708|P4|Treatment 3|Withdrawal by Subject|1
5903892|NCT01648790|20426709|P3|Treatment 3|Withdrawal by Subject|0
5903893|NCT01648790|20426710|P2|Treatment 3|Withdrawal by Subject|0
5903894|NCT01648790|20426711|P1|Treatment 3|Withdrawal by Subject|0
5903895|NCT01648764|20426746|P14|Overall Study|Investigator Decision|0
5903896|NCT01648764|20426747|P13|Overall Study|Investigator Decision|0
5903897|NCT01648764|20426748|P12|Overall Study|Investigator Decision|1
5903898|NCT01648764|20426749|P11|Overall Study|Investigator Decision|0
5903899|NCT01648764|20426750|P10|Overall Study|Investigator Decision|0
5903900|NCT01648764|20426751|P9|Overall Study|Investigator Decision|0
5903901|NCT01648764|20426752|P8|Overall Study|Investigator Decision|0
5903902|NCT01648764|20426753|P7|Overall Study|Investigator Decision|1
5903903|NCT01648764|20426754|P6|Overall Study|Investigator Decision|0
5903904|NCT01648764|20426755|P5|Overall Study|Investigator Decision|0
5903905|NCT01648764|20426756|P4|Overall Study|Investigator Decision|0
5903906|NCT01648764|20426757|P3|Overall Study|Investigator Decision|0
5903907|NCT01648764|20426758|P2|Overall Study|Investigator Decision|0
5903908|NCT01648764|20426759|P1|Overall Study|Investigator Decision|0
5903909|NCT01648764|20426746|P14|Overall Study|Withdrawal by Subject|0
5903910|NCT01648764|20426747|P13|Overall Study|Withdrawal by Subject|1
5903911|NCT01648764|20426748|P12|Overall Study|Withdrawal by Subject|0
5903912|NCT01648764|20426749|P11|Overall Study|Withdrawal by Subject|0
5903913|NCT01648764|20426750|P10|Overall Study|Withdrawal by Subject|0
5903914|NCT01648764|20426751|P9|Overall Study|Withdrawal by Subject|0
5903915|NCT01648764|20426752|P8|Overall Study|Withdrawal by Subject|0
5903916|NCT01648764|20426753|P7|Overall Study|Withdrawal by Subject|2
5903917|NCT01648764|20426754|P6|Overall Study|Withdrawal by Subject|0
5903918|NCT01648764|20426755|P5|Overall Study|Withdrawal by Subject|0
5903919|NCT01648764|20426756|P4|Overall Study|Withdrawal by Subject|0
5903920|NCT01648764|20426757|P3|Overall Study|Withdrawal by Subject|0
5903921|NCT01648764|20426758|P2|Overall Study|Withdrawal by Subject|0
5903922|NCT01648764|20426759|P1|Overall Study|Withdrawal by Subject|0
5903923|NCT01648764|20426746|P14|Overall Study|Death|1
5903924|NCT01648764|20426747|P13|Overall Study|Death|0
5903925|NCT01648764|20426748|P12|Overall Study|Death|0
5903926|NCT01648764|20426749|P11|Overall Study|Death|0
5903927|NCT01648764|20426750|P10|Overall Study|Death|0
5903928|NCT01648764|20426751|P9|Overall Study|Death|0
5903929|NCT01648764|20426752|P8|Overall Study|Death|0
5903930|NCT01648764|20426753|P7|Overall Study|Death|1
5903931|NCT01648764|20426754|P6|Overall Study|Death|0
5903932|NCT01648764|20426755|P5|Overall Study|Death|0
5903933|NCT01648764|20426756|P4|Overall Study|Death|0
5903934|NCT01648764|20426757|P3|Overall Study|Death|0
5903935|NCT01648764|20426758|P2|Overall Study|Death|0
5903936|NCT01648764|20426759|P1|Overall Study|Death|0
5903937|NCT01648764|20426746|P14|Overall Study|Adverse Event|1
5903938|NCT01648764|20426747|P13|Overall Study|Adverse Event|1
5903939|NCT01648764|20426748|P12|Overall Study|Adverse Event|3
5903940|NCT01648764|20426749|P11|Overall Study|Adverse Event|0
5903941|NCT01648764|20426750|P10|Overall Study|Adverse Event|1
5903942|NCT01648764|20426751|P9|Overall Study|Adverse Event|0
5903943|NCT01648764|20426752|P8|Overall Study|Adverse Event|0
5903944|NCT01648764|20426753|P7|Overall Study|Adverse Event|0
5903945|NCT01648764|20426754|P6|Overall Study|Adverse Event|1
5903946|NCT01648764|20426755|P5|Overall Study|Adverse Event|0
5903947|NCT01648764|20426756|P4|Overall Study|Adverse Event|0
5903948|NCT01648764|20426757|P3|Overall Study|Adverse Event|0
5903949|NCT01648764|20426758|P2|Overall Study|Adverse Event|0
5903950|NCT01648764|20426759|P1|Overall Study|Adverse Event|0
5903951|NCT01648764|20426746|P14|Overall Study|Progressive Disease|1
5903952|NCT01648764|20426747|P13|Overall Study|Progressive Disease|2
5903953|NCT01648764|20426748|P12|Overall Study|Progressive Disease|1
5903954|NCT01648764|20426749|P11|Overall Study|Progressive Disease|0
5903955|NCT01648764|20426750|P10|Overall Study|Progressive Disease|2
5903956|NCT01648764|20426751|P9|Overall Study|Progressive Disease|0
5903957|NCT01648764|20426752|P8|Overall Study|Progressive Disease|0
5903958|NCT01648764|20426753|P7|Overall Study|Progressive Disease|1
5903959|NCT01648764|20426754|P6|Overall Study|Progressive Disease|1
5903960|NCT01648764|20426755|P5|Overall Study|Progressive Disease|0
5903961|NCT01648764|20426756|P4|Overall Study|Progressive Disease|0
5903962|NCT01648764|20426757|P3|Overall Study|Progressive Disease|0
5903963|NCT01648764|20426758|P2|Overall Study|Progressive Disease|1
5903964|NCT01648764|20426759|P1|Overall Study|Progressive Disease|0
5903965|NCT01648699|20426911|P1|Overall Study|Unspecified/unable to complete 4 visits|2
5903966|NCT01648699|20426911|P1|Overall Study|Lost to Follow-up|2
5903967|NCT01648699|20426911|P1|Overall Study|Death|1
5903968|NCT01648582|20426940|P3|Overall Study|Sponsor Decision|1
5903969|NCT01648582|20426941|P2|Overall Study|Sponsor Decision|1
5903970|NCT01648582|20426942|P1|Overall Study|Sponsor Decision|0
5903971|NCT01648582|20426940|P3|Overall Study|Death|0
5903972|NCT01648582|20426941|P2|Overall Study|Death|0
5903973|NCT01648582|20426942|P1|Overall Study|Death|1
5903974|NCT01648582|20426940|P3|Overall Study|Physician Decision|3
5903975|NCT01648582|20426941|P2|Overall Study|Physician Decision|1
5903976|NCT01648582|20426942|P1|Overall Study|Physician Decision|0
5903977|NCT01648582|20426940|P3|Overall Study|Withdrawal by Subject|17
5903978|NCT01648582|20426941|P2|Overall Study|Withdrawal by Subject|17
5903979|NCT01648582|20426942|P1|Overall Study|Withdrawal by Subject|15
5903980|NCT01648582|20426940|P3|Overall Study|Protocol Violation|1
5903981|NCT01648582|20426941|P2|Overall Study|Protocol Violation|2
5903982|NCT01648582|20426942|P1|Overall Study|Protocol Violation|1
5903983|NCT01648582|20426940|P3|Overall Study|Lost to Follow-up|8
5903984|NCT01648582|20426941|P2|Overall Study|Lost to Follow-up|6
5903985|NCT01648582|20426942|P1|Overall Study|Lost to Follow-up|9
5903986|NCT01648582|20426940|P3|Overall Study|Adverse Event|2
5903987|NCT01648582|20426941|P2|Overall Study|Adverse Event|11
5903988|NCT01648582|20426942|P1|Overall Study|Adverse Event|6
5903989|NCT01648348|20427045|P6|Overall Study|Replaced for MTD analysis|0
5903990|NCT01648348|20427046|P5|Overall Study|Replaced for MTD analysis|0
5903991|NCT01648348|20427047|P4|Overall Study|Replaced for MTD analysis|0
5903992|NCT01648348|20427048|P3|Overall Study|Replaced for MTD analysis|1
5903993|NCT01648348|20427049|P2|Overall Study|Replaced for MTD analysis|0
5903994|NCT01648348|20427050|P1|Overall Study|Replaced for MTD analysis|1
5903995|NCT01648348|20427045|P6|Overall Study|Cancel|6
5903996|NCT01648348|20427046|P5|Overall Study|Cancel|3
5903997|NCT01648348|20427047|P4|Overall Study|Cancel|0
5903998|NCT01648348|20427048|P3|Overall Study|Cancel|0
5903999|NCT01648348|20427049|P2|Overall Study|Cancel|0
5904000|NCT01648348|20427050|P1|Overall Study|Cancel|1
5904001|NCT01648283|20427137|P1|Overall Study|Withdrawal by Subject|14
5904002|NCT01648270|20427143|P1|Intravenous Buprenorphine|Withdrawal by Subject|12
5904003|NCT01648166|20427155|P2|Overall Study|inadequate toenail samples|100
5904004|NCT01648166|20427156|P1|Overall Study|inadequate toenail samples|53
5904005|NCT01648140|20427166|P4|Overall Study|Lost to Follow-up|0
5904006|NCT01648140|20427167|P3|Overall Study|Lost to Follow-up|2
5904007|NCT01648140|20427168|P2|Overall Study|Lost to Follow-up|1
5904008|NCT01648140|20427169|P1|Overall Study|Lost to Follow-up|2
5904009|NCT01648140|20427166|P4|Overall Study|Withdrawal by Subject|2
5904010|NCT01648140|20427167|P3|Overall Study|Withdrawal by Subject|3
5904011|NCT01648140|20427168|P2|Overall Study|Withdrawal by Subject|3
5904012|NCT01648140|20427169|P1|Overall Study|Withdrawal by Subject|2
5904013|NCT01648140|20427166|P4|Overall Study|Adverse Event|0
5904014|NCT01648140|20427167|P3|Overall Study|Adverse Event|2
5904015|NCT01648140|20427168|P2|Overall Study|Adverse Event|1
5904016|NCT01648140|20427169|P1|Overall Study|Adverse Event|3
5904017|NCT01648140|20427166|P4|Overall Study|Lack of Efficacy|0
5904018|NCT01648140|20427167|P3|Overall Study|Lack of Efficacy|1
5904019|NCT01648140|20427168|P2|Overall Study|Lack of Efficacy|7
5904020|NCT01648140|20427169|P1|Overall Study|Lack of Efficacy|4
5904021|NCT01648140|20427166|P4|Overall Study|Physician Decision|0
5904022|NCT01648140|20427167|P3|Overall Study|Physician Decision|0
5904023|NCT01648140|20427168|P2|Overall Study|Physician Decision|0
5904024|NCT01648140|20427169|P1|Overall Study|Physician Decision|1
5904025|NCT01648101|20427334|P3|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0
5904026|NCT01648101|20427335|P2|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|1
5904027|NCT01648101|20427336|P1|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0
5904028|NCT01648101|20427334|P3|Transition Phase (4 Weeks)|Study Terminated|0
5904029|NCT01648101|20427335|P2|Transition Phase (4 Weeks)|Study Terminated|0
5904030|NCT01648101|20427336|P1|Transition Phase (4 Weeks)|Study Terminated|1
5904031|NCT01648101|20427334|P3|Transition Phase (4 Weeks)|Withdrawal by Subject|2
5904032|NCT01648101|20427335|P2|Transition Phase (4 Weeks)|Withdrawal by Subject|0
5904033|NCT01648101|20427336|P1|Transition Phase (4 Weeks)|Withdrawal by Subject|0
5904034|NCT01648101|20427334|P3|Transition Phase (4 Weeks)|Lack of Efficacy|0
5904035|NCT01648101|20427335|P2|Transition Phase (4 Weeks)|Lack of Efficacy|2
5904036|NCT01648101|20427336|P1|Transition Phase (4 Weeks)|Lack of Efficacy|0
5904037|NCT01648101|20427334|P3|Transition Phase (4 Weeks)|Adverse Event|2
5904038|NCT01648101|20427335|P2|Transition Phase (4 Weeks)|Adverse Event|3
5904039|NCT01648101|20427336|P1|Transition Phase (4 Weeks)|Adverse Event|4
5904040|NCT01648101|20427334|P3|Maintenance Phase (12 Weeks)|Adverse Event|4
5904041|NCT01648101|20427335|P2|Maintenance Phase (12 Weeks)|Adverse Event|3
5904042|NCT01648101|20427336|P1|Maintenance Phase (12 Weeks)|Adverse Event|1
5904043|NCT01648101|20427334|P3|Maintenance Phase (12 Weeks)|Lack of Efficacy|1
5904044|NCT01648101|20427335|P2|Maintenance Phase (12 Weeks)|Lack of Efficacy|0
5904045|NCT01648101|20427336|P1|Maintenance Phase (12 Weeks)|Lack of Efficacy|1
5904046|NCT01648101|20427334|P3|Maintenance Phase (12 Weeks)|Withdrew Consent|1
5904047|NCT01648101|20427335|P2|Maintenance Phase (12 Weeks)|Withdrew Consent|0
5904048|NCT01648101|20427336|P1|Maintenance Phase (12 Weeks)|Withdrew Consent|1
5904049|NCT01648101|20427334|P3|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|1
5904050|NCT01648101|20427335|P2|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0
5904051|NCT01648101|20427336|P1|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0
5904052|NCT01648101|20427334|P3|Titration Phase (4 Weeks)|Adverse Event|3
5904053|NCT01648101|20427335|P2|Titration Phase (4 Weeks)|Adverse Event|2
5904054|NCT01648101|20427336|P1|Titration Phase (4 Weeks)|Adverse Event|0
5904055|NCT01648101|20427334|P3|Titration Phase (4 Weeks)|Protocol Violation|2
5904056|NCT01648101|20427335|P2|Titration Phase (4 Weeks)|Protocol Violation|1
5904057|NCT01648101|20427336|P1|Titration Phase (4 Weeks)|Protocol Violation|2
5904058|NCT01647958|20427386|P2|Extended Follow-up Phase|Lost to Follow-up|0
5904059|NCT01647958|20427387|P1|Extended Follow-up Phase|Lost to Follow-up|8
5904060|NCT01647958|20427386|P2|Continuation Phase|treatment received during Overall Study|0
5904061|NCT01647958|20427387|P1|Continuation Phase|treatment received during Overall Study|39
5904062|NCT01647958|20427386|P2|Initial Study|Lost to Follow-up|3
5904063|NCT01647958|20427387|P1|Initial Study|Lost to Follow-up|2
5904064|NCT01647711|20427474|P5|Overall Study|Other reason not defined|0
5904065|NCT01647711|20427475|P4|Overall Study|Other reason not defined|1
5904066|NCT01647711|20427476|P3|Overall Study|Other reason not defined|1
5904067|NCT01647711|20427477|P2|Overall Study|Other reason not defined|1
5904068|NCT01647711|20427478|P1|Overall Study|Other reason not defined|0
5904069|NCT01647711|20427474|P5|Overall Study|Refused to continue taking medication|1
5904070|NCT01647711|20427475|P4|Overall Study|Refused to continue taking medication|2
5904071|NCT01647711|20427476|P3|Overall Study|Refused to continue taking medication|0
5904072|NCT01647711|20427477|P2|Overall Study|Refused to continue taking medication|0
5904073|NCT01647711|20427478|P1|Overall Study|Refused to continue taking medication|0
5904074|NCT01647711|20427474|P5|Overall Study|Protocol Violation|1
5904075|NCT01647711|20427475|P4|Overall Study|Protocol Violation|0
5904076|NCT01647711|20427476|P3|Overall Study|Protocol Violation|0
5904077|NCT01647711|20427477|P2|Overall Study|Protocol Violation|0
5904078|NCT01647711|20427478|P1|Overall Study|Protocol Violation|0
5904079|NCT01647711|20427474|P5|Overall Study|Other adverse event|2
5904080|NCT01647711|20427475|P4|Overall Study|Other adverse event|0
5904081|NCT01647711|20427476|P3|Overall Study|Other adverse event|2
5904082|NCT01647711|20427477|P2|Overall Study|Other adverse event|0
5904083|NCT01647711|20427478|P1|Overall Study|Other adverse event|0
5904084|NCT01647711|20427474|P5|Overall Study|Progressive disease|2
5904085|NCT01647711|20427475|P4|Overall Study|Progressive disease|8
5904086|NCT01647711|20427476|P3|Overall Study|Progressive disease|6
5904087|NCT01647711|20427477|P2|Overall Study|Progressive disease|2
5904088|NCT01647711|20427478|P1|Overall Study|Progressive disease|6
5904089|NCT01647542|20427515|P3|Overall Study|Death|1
5904090|NCT01647542|20427516|P2|Overall Study|Death|0
5904091|NCT01647542|20427517|P1|Overall Study|Death|0
5904092|NCT01647542|20427515|P3|Overall Study|Lack of Efficacy|0
5904093|NCT01647542|20427516|P2|Overall Study|Lack of Efficacy|1
5904094|NCT01647542|20427517|P1|Overall Study|Lack of Efficacy|1
5904095|NCT01647542|20427515|P3|Overall Study|Study Termination|65
5904096|NCT01647542|20427516|P2|Overall Study|Study Termination|61
5904097|NCT01647542|20427517|P1|Overall Study|Study Termination|64
5904098|NCT01647542|20427515|P3|Overall Study|Withdrawal by Subject|0
5904099|NCT01647542|20427516|P2|Overall Study|Withdrawal by Subject|4
5904100|NCT01647542|20427517|P1|Overall Study|Withdrawal by Subject|6
5904101|NCT01647542|20427515|P3|Overall Study|Lost to Follow-up|2
5904102|NCT01647542|20427516|P2|Overall Study|Lost to Follow-up|2
5904103|NCT01647542|20427517|P1|Overall Study|Lost to Follow-up|0
5904104|NCT01647542|20427515|P3|Overall Study|Adverse Event|4
5904105|NCT01647542|20427516|P2|Overall Study|Adverse Event|5
5904106|NCT01647542|20427517|P1|Overall Study|Adverse Event|4
5904107|NCT01647542|20427515|P3|Overall Study|Major Protocol Deviation|0
5904108|NCT01647542|20427516|P2|Overall Study|Major Protocol Deviation|0
5904109|NCT01647542|20427517|P1|Overall Study|Major Protocol Deviation|1
5904110|NCT01647516|20427537|P6|Open-Label Period|No completion / discontinuation visit|1
5904111|NCT01647516|20427538|P5|Open-Label Period|No completion / discontinuation visit|2
5904112|NCT01647516|20427539|P4|Open-Label Period|No completion / discontinuation visit|0
5904113|NCT01647516|20427540|P3|Open-Label Period|No completion / discontinuation visit|0
5904114|NCT01647516|20427541|P2|Open-Label Period|No completion / discontinuation visit|0
5904115|NCT01647516|20427542|P1|Open-Label Period|No completion / discontinuation visit|0
5904116|NCT01647516|20427537|P6|Open-Label Period|Participant Choice to Stop Study Drug|10
5904117|NCT01647516|20427538|P5|Open-Label Period|Participant Choice to Stop Study Drug|9
5904118|NCT01647516|20427539|P4|Open-Label Period|Participant Choice to Stop Study Drug|7
5904119|NCT01647516|20427540|P3|Open-Label Period|Participant Choice to Stop Study Drug|0
5904120|NCT01647516|20427541|P2|Open-Label Period|Participant Choice to Stop Study Drug|0
5904121|NCT01647516|20427542|P1|Open-Label Period|Participant Choice to Stop Study Drug|0
5904122|NCT01647516|20427537|P6|Open-Label Period|Lack of Efficacy|10
5904123|NCT01647516|20427538|P5|Open-Label Period|Lack of Efficacy|9
5904124|NCT01647516|20427539|P4|Open-Label Period|Lack of Efficacy|7
5904125|NCT01647516|20427540|P3|Open-Label Period|Lack of Efficacy|0
5904126|NCT01647516|20427541|P2|Open-Label Period|Lack of Efficacy|0
5904127|NCT01647516|20427542|P1|Open-Label Period|Lack of Efficacy|0
5904128|NCT01647516|20427537|P6|Open-Label Period|Sponsor Termination; moved to 3102 study|23
5904129|NCT01647516|20427538|P5|Open-Label Period|Sponsor Termination; moved to 3102 study|13
5904130|NCT01647516|20427539|P4|Open-Label Period|Sponsor Termination; moved to 3102 study|18
5904131|NCT01647516|20427540|P3|Open-Label Period|Sponsor Termination; moved to 3102 study|0
5904132|NCT01647516|20427541|P2|Open-Label Period|Sponsor Termination; moved to 3102 study|0
5904133|NCT01647516|20427542|P1|Open-Label Period|Sponsor Termination; moved to 3102 study|0
5904134|NCT01647516|20427537|P6|Open-Label Period|Lost to Follow-up|1
5904135|NCT01647516|20427538|P5|Open-Label Period|Lost to Follow-up|0
5904136|NCT01647516|20427539|P4|Open-Label Period|Lost to Follow-up|1
5904137|NCT01647516|20427540|P3|Open-Label Period|Lost to Follow-up|0
5904138|NCT01647516|20427541|P2|Open-Label Period|Lost to Follow-up|0
5904139|NCT01647516|20427542|P1|Open-Label Period|Lost to Follow-up|0
5904140|NCT01647516|20427537|P6|Open-Label Period|Withdrawal by Subject|6
5904141|NCT01647516|20427538|P5|Open-Label Period|Withdrawal by Subject|11
5904142|NCT01647516|20427539|P4|Open-Label Period|Withdrawal by Subject|9
5904143|NCT01647516|20427540|P3|Open-Label Period|Withdrawal by Subject|0
5904144|NCT01647516|20427541|P2|Open-Label Period|Withdrawal by Subject|0
5904145|NCT01647516|20427542|P1|Open-Label Period|Withdrawal by Subject|0
5904146|NCT01647516|20427537|P6|Open-Label Period|Physician Decision|0
5904147|NCT01647516|20427538|P5|Open-Label Period|Physician Decision|1
5904148|NCT01647516|20427539|P4|Open-Label Period|Physician Decision|1
5904149|NCT01647516|20427540|P3|Open-Label Period|Physician Decision|0
5904150|NCT01647516|20427541|P2|Open-Label Period|Physician Decision|0
5904151|NCT01647516|20427542|P1|Open-Label Period|Physician Decision|0
5904152|NCT01647516|20427537|P6|Open-Label Period|Non-compliance|1
5904153|NCT01647516|20427538|P5|Open-Label Period|Non-compliance|0
5904154|NCT01647516|20427539|P4|Open-Label Period|Non-compliance|1
5904155|NCT01647516|20427540|P3|Open-Label Period|Non-compliance|0
5904156|NCT01647516|20427541|P2|Open-Label Period|Non-compliance|0
5904157|NCT01647516|20427542|P1|Open-Label Period|Non-compliance|0
5904158|NCT01647516|20427537|P6|Open-Label Period|Pregnancy|1
5904159|NCT01647516|20427538|P5|Open-Label Period|Pregnancy|0
5904160|NCT01647516|20427539|P4|Open-Label Period|Pregnancy|0
5904161|NCT01647516|20427540|P3|Open-Label Period|Pregnancy|0
5904162|NCT01647516|20427541|P2|Open-Label Period|Pregnancy|0
5904163|NCT01647516|20427542|P1|Open-Label Period|Pregnancy|0
5904164|NCT01647516|20427537|P6|Open-Label Period|Adverse Event|3
5904165|NCT01647516|20427538|P5|Open-Label Period|Adverse Event|6
5904166|NCT01647516|20427539|P4|Open-Label Period|Adverse Event|5
5904167|NCT01647516|20427540|P3|Open-Label Period|Adverse Event|0
5904168|NCT01647516|20427541|P2|Open-Label Period|Adverse Event|0
5904169|NCT01647516|20427542|P1|Open-Label Period|Adverse Event|0
5904170|NCT01647516|20427537|P6|Maintenance Period (MP)|Lack of Efficacy|0
5904171|NCT01647516|20427538|P5|Maintenance Period (MP)|Lack of Efficacy|0
5904172|NCT01647516|20427539|P4|Maintenance Period (MP)|Lack of Efficacy|0
5904173|NCT01647516|20427540|P3|Maintenance Period (MP)|Lack of Efficacy|1
5904174|NCT01647516|20427541|P2|Maintenance Period (MP)|Lack of Efficacy|4
5904175|NCT01647516|20427542|P1|Maintenance Period (MP)|Lack of Efficacy|1
5904176|NCT01647516|20427537|P6|Maintenance Period (MP)|Withdrawal by Subject|0
5904177|NCT01647516|20427538|P5|Maintenance Period (MP)|Withdrawal by Subject|0
5904178|NCT01647516|20427539|P4|Maintenance Period (MP)|Withdrawal by Subject|0
5904179|NCT01647516|20427540|P3|Maintenance Period (MP)|Withdrawal by Subject|1
5904180|NCT01647516|20427541|P2|Maintenance Period (MP)|Withdrawal by Subject|1
5904181|NCT01647516|20427542|P1|Maintenance Period (MP)|Withdrawal by Subject|0
5904182|NCT01647516|20427537|P6|Maintenance Period (MP)|Non-compliance|0
5904183|NCT01647516|20427538|P5|Maintenance Period (MP)|Non-compliance|0
5904184|NCT01647516|20427539|P4|Maintenance Period (MP)|Non-compliance|0
5904185|NCT01647516|20427540|P3|Maintenance Period (MP)|Non-compliance|0
5904186|NCT01647516|20427541|P2|Maintenance Period (MP)|Non-compliance|0
5904187|NCT01647516|20427542|P1|Maintenance Period (MP)|Non-compliance|1
5904188|NCT01647516|20427537|P6|Maintenance Period (MP)|Adverse Event|0
5904189|NCT01647516|20427538|P5|Maintenance Period (MP)|Adverse Event|0
5904190|NCT01647516|20427539|P4|Maintenance Period (MP)|Adverse Event|0
5904191|NCT01647516|20427540|P3|Maintenance Period (MP)|Adverse Event|0
5904192|NCT01647516|20427541|P2|Maintenance Period (MP)|Adverse Event|1
5904193|NCT01647516|20427542|P1|Maintenance Period (MP)|Adverse Event|2
5904194|NCT01647516|20427537|P6|Induction Period (IP)|No study drug received|0
5904195|NCT01647516|20427538|P5|Induction Period (IP)|No study drug received|0
5904196|NCT01647516|20427539|P4|Induction Period (IP)|No study drug received|0
5904197|NCT01647516|20427540|P3|Induction Period (IP)|No study drug received|0
5904198|NCT01647516|20427541|P2|Induction Period (IP)|No study drug received|1
5904199|NCT01647516|20427542|P1|Induction Period (IP)|No study drug received|1
5904200|NCT01647516|20427537|P6|Induction Period (IP)|Lack of Efficacy|0
5904201|NCT01647516|20427538|P5|Induction Period (IP)|Lack of Efficacy|0
5904202|NCT01647516|20427539|P4|Induction Period (IP)|Lack of Efficacy|0
5904203|NCT01647516|20427540|P3|Induction Period (IP)|Lack of Efficacy|0
5904204|NCT01647516|20427541|P2|Induction Period (IP)|Lack of Efficacy|0
5904205|NCT01647516|20427542|P1|Induction Period (IP)|Lack of Efficacy|1
5904206|NCT01647516|20427537|P6|Induction Period (IP)|Participant Choice|0
5904207|NCT01647516|20427538|P5|Induction Period (IP)|Participant Choice|0
5904208|NCT01647516|20427539|P4|Induction Period (IP)|Participant Choice|0
5904209|NCT01647516|20427540|P3|Induction Period (IP)|Participant Choice|1
5904210|NCT01647516|20427541|P2|Induction Period (IP)|Participant Choice|0
5904211|NCT01647516|20427542|P1|Induction Period (IP)|Participant Choice|0
5904212|NCT01647516|20427537|P6|Induction Period (IP)|Withdrawal by Subject|0
5904213|NCT01647516|20427538|P5|Induction Period (IP)|Withdrawal by Subject|0
5904214|NCT01647516|20427539|P4|Induction Period (IP)|Withdrawal by Subject|0
5904215|NCT01647516|20427540|P3|Induction Period (IP)|Withdrawal by Subject|3
5904216|NCT01647516|20427541|P2|Induction Period (IP)|Withdrawal by Subject|0
5904217|NCT01647516|20427542|P1|Induction Period (IP)|Withdrawal by Subject|1
5904218|NCT01647516|20427537|P6|Induction Period (IP)|Adverse Event|0
5904219|NCT01647516|20427538|P5|Induction Period (IP)|Adverse Event|0
5904220|NCT01647516|20427539|P4|Induction Period (IP)|Adverse Event|0
5904221|NCT01647516|20427540|P3|Induction Period (IP)|Adverse Event|0
5904222|NCT01647516|20427541|P2|Induction Period (IP)|Adverse Event|2
5904223|NCT01647516|20427542|P1|Induction Period (IP)|Adverse Event|1
5904224|NCT01647516|20427537|P6|Induction Period (IP)|Physician Decision|0
5904225|NCT01647516|20427538|P5|Induction Period (IP)|Physician Decision|0
5904226|NCT01647516|20427539|P4|Induction Period (IP)|Physician Decision|0
5904227|NCT01647516|20427540|P3|Induction Period (IP)|Physician Decision|0
5904228|NCT01647516|20427541|P2|Induction Period (IP)|Physician Decision|0
5904229|NCT01647516|20427542|P1|Induction Period (IP)|Physician Decision|2
5904230|NCT01647282|20427598|P2|Overall Study|Physician Decision|5
5904231|NCT01647282|20427599|P1|Overall Study|Physician Decision|7
5904232|NCT01646827|20427620|P2|Overall Study|Withdrawal by Subject|0
5904233|NCT01646827|20427621|P1|Overall Study|Withdrawal by Subject|1
5904234|NCT01646827|20427620|P2|Overall Study|Physician Decision|2
5904235|NCT01646827|20427621|P1|Overall Study|Physician Decision|1
5904236|NCT01646827|20427620|P2|Overall Study|Lost to Follow-up|3
5904237|NCT01646827|20427621|P1|Overall Study|Lost to Follow-up|0
5904238|NCT01646645|20427706|P1|Overall Study|Inevaluable Donor|29
5904239|NCT01646645|20427706|P1|Overall Study|No Treated|1
5904240|NCT01646398|20427713|P2|Overall Study|Withdrawal by Subject|0
5904241|NCT01646398|20427714|P1|Overall Study|Withdrawal by Subject|1
5904242|NCT01646385|20427730|P2|Overall Study|Switched to alternate biologic|649
5904243|NCT01646385|20427731|P1|Overall Study|Switched to alternate biologic|636
5904244|NCT01646385|20427730|P2|Overall Study|Death|222
5904245|NCT01646385|20427731|P1|Overall Study|Death|202
5904246|NCT01646320|20427774|P2|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|2
5904247|NCT01646320|20427775|P1|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|0
5904248|NCT01646320|20427774|P2|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|1
5904249|NCT01646320|20427775|P1|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|0
5904250|NCT01646320|20427774|P2|Long-term Period (Weeks 24 to 52)|Adverse Event|2
5904251|NCT01646320|20427775|P1|Long-term Period (Weeks 24 to 52)|Adverse Event|4
5904252|NCT01646320|20427774|P2|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|2
5904253|NCT01646320|20427775|P1|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|0
5904254|NCT01646320|20427774|P2|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|0
5904255|NCT01646320|20427775|P1|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|2
5904256|NCT01646320|20427774|P2|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|0
5904257|NCT01646320|20427775|P1|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|2
5904258|NCT01646320|20427774|P2|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4
5904259|NCT01646320|20427775|P1|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4
5904260|NCT01646320|20427774|P2|Short-term Period (Day 1 to Week 24)|Other|0
5904261|NCT01646320|20427775|P1|Short-term Period (Day 1 to Week 24)|Other|1
5904262|NCT01646320|20427774|P2|Short-term Period (Day 1 to Week 24)|Not reported|2
5904263|NCT01646320|20427775|P1|Short-term Period (Day 1 to Week 24)|Not reported|2
5904264|NCT01646320|20427774|P2|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|1
5904265|NCT01646320|20427775|P1|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0
5904266|NCT01646320|20427774|P2|Short-term Period (Day 1 to Week 24)|Adverse Event|0
5904267|NCT01646320|20427775|P1|Short-term Period (Day 1 to Week 24)|Adverse Event|3
5904268|NCT01646268|20427791|P2|Overall Study|Other|0
5904269|NCT01646268|20427792|P1|Overall Study|Other|2
5904270|NCT01646268|20427791|P2|Overall Study|Withdrawal by Subject|5
5904271|NCT01646268|20427792|P1|Overall Study|Withdrawal by Subject|2
5904272|NCT01646268|20427791|P2|Overall Study|Protocol Violation|1
5904273|NCT01646268|20427792|P1|Overall Study|Protocol Violation|0
5904274|NCT01646268|20427791|P2|Overall Study|Lack of Efficacy|3
5904275|NCT01646268|20427792|P1|Overall Study|Lack of Efficacy|1
5904276|NCT01646268|20427791|P2|Overall Study|Adverse Event|7
5904277|NCT01646268|20427792|P1|Overall Study|Adverse Event|6
5904278|NCT01646255|20427806|P2|Overall Study|Inclusion Criteria Deviation|0
5904279|NCT01646255|20427807|P1|Overall Study|Inclusion Criteria Deviation|1
5904280|NCT01646255|20427806|P2|Overall Study|Compliance is not well|0
5904281|NCT01646255|20427807|P1|Overall Study|Compliance is not well|1
5904282|NCT01646255|20427806|P2|Overall Study|Withdrawal by Subject|6
5904283|NCT01646255|20427807|P1|Overall Study|Withdrawal by Subject|10
5904284|NCT01646255|20427806|P2|Overall Study|Lack of Efficacy|0
5904285|NCT01646255|20427807|P1|Overall Study|Lack of Efficacy|2
5904286|NCT01646255|20427806|P2|Overall Study|Adverse Event|8
5904287|NCT01646255|20427807|P1|Overall Study|Adverse Event|7
5904288|NCT01646216|20427839|P2|Overall Study|Investigator decision|1
5904289|NCT01646216|20427840|P1|Overall Study|Investigator decision|1
5904290|NCT01646216|20427839|P2|Overall Study|Did not complete training|2
5904291|NCT01646216|20427840|P1|Overall Study|Did not complete training|0
5904292|NCT01646216|20427839|P2|Overall Study|Baseline step length difference (<5cm)|10
5904293|NCT01646216|20427840|P1|Overall Study|Baseline step length difference (<5cm)|10
5904294|NCT01646203|20427862|P3|Overall Study|Physician's Decision|0
5904295|NCT01646203|20427863|P2|Overall Study|Physician's Decision|1
5904296|NCT01646203|20427864|P1|Overall Study|Physician's Decision|0
5904297|NCT01646203|20427862|P3|Overall Study|Withdrawal by Subject|0
5904298|NCT01646203|20427863|P2|Overall Study|Withdrawal by Subject|1
5904299|NCT01646203|20427864|P1|Overall Study|Withdrawal by Subject|0
5904300|NCT01646203|20427862|P3|Overall Study|Adverse Event|1
5904301|NCT01646203|20427863|P2|Overall Study|Adverse Event|0
5904302|NCT01646203|20427864|P1|Overall Study|Adverse Event|2
5904303|NCT01646177|20427893|P12|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|1
5904304|NCT01646177|20427894|P11|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|1
5904305|NCT01646177|20427895|P10|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0
5904306|NCT01646177|20427896|P9|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0
5904307|NCT01646177|20427897|P8|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0
5904308|NCT01646177|20427898|P7|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0
5904309|NCT01646177|20427899|P6|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0
5904310|NCT01646177|20427900|P5|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0
5904311|NCT01646177|20427901|P4|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0
5904312|NCT01646177|20427902|P3|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0
5904313|NCT01646177|20427903|P2|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0
5904314|NCT01646177|20427904|P1|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0
5904315|NCT01646177|20427893|P12|Follow-Up Period (Minimum of 12 Weeks)|Death|1
5904316|NCT01646177|20427894|P11|Follow-Up Period (Minimum of 12 Weeks)|Death|1
5904317|NCT01646177|20427895|P10|Follow-Up Period (Minimum of 12 Weeks)|Death|0
5904318|NCT01646177|20427896|P9|Follow-Up Period (Minimum of 12 Weeks)|Death|1
5904319|NCT01646177|20427897|P8|Follow-Up Period (Minimum of 12 Weeks)|Death|0
5904320|NCT01646177|20427898|P7|Follow-Up Period (Minimum of 12 Weeks)|Death|0
5904321|NCT01646177|20427899|P6|Follow-Up Period (Minimum of 12 Weeks)|Death|0
5904322|NCT01646177|20427900|P5|Follow-Up Period (Minimum of 12 Weeks)|Death|0
5904323|NCT01646177|20427901|P4|Follow-Up Period (Minimum of 12 Weeks)|Death|0
5904324|NCT01646177|20427902|P3|Follow-Up Period (Minimum of 12 Weeks)|Death|0
5904325|NCT01646177|20427903|P2|Follow-Up Period (Minimum of 12 Weeks)|Death|0
5904326|NCT01646177|20427904|P1|Follow-Up Period (Minimum of 12 Weeks)|Death|0
5904327|NCT01646177|20427893|P12|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1
5904328|NCT01646177|20427894|P11|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1
5904329|NCT01646177|20427895|P10|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1
5904330|NCT01646177|20427896|P9|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0
5904331|NCT01646177|20427897|P8|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0
5904332|NCT01646177|20427898|P7|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0
5904333|NCT01646177|20427899|P6|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0
5904334|NCT01646177|20427900|P5|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0
5904335|NCT01646177|20427901|P4|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0
5904336|NCT01646177|20427902|P3|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0
5904337|NCT01646177|20427903|P2|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0
5904338|NCT01646177|20427904|P1|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0
5904339|NCT01646177|20427893|P12|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|3
5904340|NCT01646177|20427894|P11|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|1
5904341|NCT01646177|20427895|P10|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|1
5904342|NCT01646177|20427896|P9|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0
5904343|NCT01646177|20427897|P8|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0
5904344|NCT01646177|20427898|P7|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0
5904345|NCT01646177|20427899|P6|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0
5904346|NCT01646177|20427900|P5|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0
5904347|NCT01646177|20427901|P4|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0
5904348|NCT01646177|20427902|P3|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0
5904349|NCT01646177|20427903|P2|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0
5904350|NCT01646177|20427904|P1|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0
5904351|NCT01646177|20427893|P12|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|3
5904352|NCT01646177|20427894|P11|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|2
5904353|NCT01646177|20427895|P10|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|2
5904354|NCT01646177|20427896|P9|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|1
5904355|NCT01646177|20427897|P8|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0
5904356|NCT01646177|20427898|P7|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0
5904357|NCT01646177|20427899|P6|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0
5904358|NCT01646177|20427900|P5|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0
5904359|NCT01646177|20427901|P4|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0
5904360|NCT01646177|20427902|P3|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0
5904361|NCT01646177|20427903|P2|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0
5904362|NCT01646177|20427904|P1|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0
5904363|NCT01646177|20427893|P12|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|7
5904364|NCT01646177|20427894|P11|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|4
5904365|NCT01646177|20427895|P10|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|6
5904366|NCT01646177|20427896|P9|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|1
5904367|NCT01646177|20427897|P8|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0
5904368|NCT01646177|20427898|P7|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0
5904369|NCT01646177|20427899|P6|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0
5904370|NCT01646177|20427900|P5|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0
5904371|NCT01646177|20427901|P4|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0
5904372|NCT01646177|20427902|P3|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0
5904373|NCT01646177|20427903|P2|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0
5904374|NCT01646177|20427904|P1|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0
5904375|NCT01646177|20427893|P12|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|9
5904376|NCT01646177|20427894|P11|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|8
5904377|NCT01646177|20427895|P10|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|9
5904378|NCT01646177|20427896|P9|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|4
5904379|NCT01646177|20427897|P8|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0
5904380|NCT01646177|20427898|P7|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0
5904381|NCT01646177|20427899|P6|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0
5904382|NCT01646177|20427900|P5|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0
5904383|NCT01646177|20427901|P4|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0
5904384|NCT01646177|20427902|P3|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0
5904385|NCT01646177|20427903|P2|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0
5904386|NCT01646177|20427904|P1|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0
5904387|NCT01646177|20427893|P12|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|9
5904388|NCT01646177|20427894|P11|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|9
5904389|NCT01646177|20427895|P10|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|8
5904390|NCT01646177|20427896|P9|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|4
5904391|NCT01646177|20427897|P8|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0
5904392|NCT01646177|20427898|P7|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0
5904393|NCT01646177|20427899|P6|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0
5904394|NCT01646177|20427900|P5|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0
5904395|NCT01646177|20427901|P4|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0
5904396|NCT01646177|20427902|P3|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0
5904397|NCT01646177|20427903|P2|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0
5904398|NCT01646177|20427904|P1|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0
5904399|NCT01646177|20427893|P12|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|19
5904400|NCT01646177|20427894|P11|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|19
5904401|NCT01646177|20427895|P10|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|21
5904402|NCT01646177|20427896|P9|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|7
5904403|NCT01646177|20427897|P8|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0
5904404|NCT01646177|20427898|P7|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0
5904405|NCT01646177|20427899|P6|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0
5904406|NCT01646177|20427900|P5|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0
5904407|NCT01646177|20427901|P4|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0
5904408|NCT01646177|20427902|P3|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0
5904409|NCT01646177|20427903|P2|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0
5904410|NCT01646177|20427904|P1|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0
5904411|NCT01646177|20427893|P12|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|30
5904412|NCT01646177|20427894|P11|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|34
5904413|NCT01646177|20427895|P10|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|28
5904414|NCT01646177|20427896|P9|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|13
5904415|NCT01646177|20427897|P8|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0
5904416|NCT01646177|20427898|P7|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0
5904417|NCT01646177|20427899|P6|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0
5904418|NCT01646177|20427900|P5|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0
5904419|NCT01646177|20427901|P4|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0
5904420|NCT01646177|20427902|P3|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0
5904421|NCT01646177|20427903|P2|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0
5904422|NCT01646177|20427904|P1|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0
5904423|NCT01646177|20427893|P12|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0
5904424|NCT01646177|20427894|P11|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0
5904425|NCT01646177|20427895|P10|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0
5904426|NCT01646177|20427896|P9|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0
5904427|NCT01646177|20427897|P8|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|1
5904428|NCT01646177|20427898|P7|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|2
5904429|NCT01646177|20427899|P6|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|3
5904430|NCT01646177|20427900|P5|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0
5904431|NCT01646177|20427901|P4|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0
5904432|NCT01646177|20427902|P3|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0
5904433|NCT01646177|20427903|P2|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0
5904434|NCT01646177|20427904|P1|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0
5904435|NCT01646177|20427893|P12|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0
5904436|NCT01646177|20427894|P11|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0
5904437|NCT01646177|20427895|P10|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0
5904438|NCT01646177|20427896|P9|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0
5904439|NCT01646177|20427897|P8|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|1
5904440|NCT01646177|20427898|P7|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0
5904441|NCT01646177|20427899|P6|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0
5904442|NCT01646177|20427900|P5|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0
5904443|NCT01646177|20427901|P4|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0
5904444|NCT01646177|20427902|P3|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0
5904445|NCT01646177|20427903|P2|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0
5904446|NCT01646177|20427904|P1|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0
5904447|NCT01646177|20427893|P12|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0
5904448|NCT01646177|20427894|P11|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0
5904449|NCT01646177|20427895|P10|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0
5904450|NCT01646177|20427896|P9|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0
5904451|NCT01646177|20427897|P8|Long-Term Extension Period (Week 12-264)|Clinical Relapse|4
5904452|NCT01646177|20427898|P7|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1
5904453|NCT01646177|20427899|P6|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1
5904454|NCT01646177|20427900|P5|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1
5904455|NCT01646177|20427901|P4|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0
5904456|NCT01646177|20427902|P3|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0
5904457|NCT01646177|20427903|P2|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0
5904458|NCT01646177|20427904|P1|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0
5904459|NCT01646177|20427893|P12|Long-Term Extension Period (Week 12-264)|Death|0
5904460|NCT01646177|20427894|P11|Long-Term Extension Period (Week 12-264)|Death|0
5904461|NCT01646177|20427895|P10|Long-Term Extension Period (Week 12-264)|Death|0
5904462|NCT01646177|20427896|P9|Long-Term Extension Period (Week 12-264)|Death|0
5904463|NCT01646177|20427897|P8|Long-Term Extension Period (Week 12-264)|Death|3
5904464|NCT01646177|20427898|P7|Long-Term Extension Period (Week 12-264)|Death|1
5904465|NCT01646177|20427899|P6|Long-Term Extension Period (Week 12-264)|Death|3
5904466|NCT01646177|20427900|P5|Long-Term Extension Period (Week 12-264)|Death|1
5904467|NCT01646177|20427901|P4|Long-Term Extension Period (Week 12-264)|Death|0
5904468|NCT01646177|20427902|P3|Long-Term Extension Period (Week 12-264)|Death|0
5904469|NCT01646177|20427903|P2|Long-Term Extension Period (Week 12-264)|Death|0
5904470|NCT01646177|20427904|P1|Long-Term Extension Period (Week 12-264)|Death|0
5904471|NCT01646177|20427893|P12|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0
5904472|NCT01646177|20427894|P11|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0
5904473|NCT01646177|20427895|P10|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0
5904474|NCT01646177|20427896|P9|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0
5904475|NCT01646177|20427897|P8|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2
5904476|NCT01646177|20427898|P7|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2
5904477|NCT01646177|20427899|P6|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2
5904478|NCT01646177|20427900|P5|Long-Term Extension Period (Week 12-264)|Sponsor Decision|3
5904479|NCT01646177|20427901|P4|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0
5904480|NCT01646177|20427902|P3|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0
5904481|NCT01646177|20427903|P2|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0
5904482|NCT01646177|20427904|P1|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0
5904483|NCT01646177|20427893|P12|Long-Term Extension Period (Week 12-264)|Protocol Violation|0
5904484|NCT01646177|20427894|P11|Long-Term Extension Period (Week 12-264)|Protocol Violation|0
5904485|NCT01646177|20427895|P10|Long-Term Extension Period (Week 12-264)|Protocol Violation|0
5904486|NCT01646177|20427896|P9|Long-Term Extension Period (Week 12-264)|Protocol Violation|0
5904487|NCT01646177|20427897|P8|Long-Term Extension Period (Week 12-264)|Protocol Violation|5
5904488|NCT01646177|20427898|P7|Long-Term Extension Period (Week 12-264)|Protocol Violation|0
5904489|NCT01646177|20427899|P6|Long-Term Extension Period (Week 12-264)|Protocol Violation|4
5904490|NCT01646177|20427900|P5|Long-Term Extension Period (Week 12-264)|Protocol Violation|1
5904491|NCT01646177|20427901|P4|Long-Term Extension Period (Week 12-264)|Protocol Violation|0
5904492|NCT01646177|20427902|P3|Long-Term Extension Period (Week 12-264)|Protocol Violation|0
5904493|NCT01646177|20427903|P2|Long-Term Extension Period (Week 12-264)|Protocol Violation|0
5904494|NCT01646177|20427904|P1|Long-Term Extension Period (Week 12-264)|Protocol Violation|0
5904495|NCT01646177|20427893|P12|Long-Term Extension Period (Week 12-264)|Physician Decision|0
5904496|NCT01646177|20427894|P11|Long-Term Extension Period (Week 12-264)|Physician Decision|0
5904497|NCT01646177|20427895|P10|Long-Term Extension Period (Week 12-264)|Physician Decision|0
5904498|NCT01646177|20427896|P9|Long-Term Extension Period (Week 12-264)|Physician Decision|0
5904499|NCT01646177|20427897|P8|Long-Term Extension Period (Week 12-264)|Physician Decision|5
5904500|NCT01646177|20427898|P7|Long-Term Extension Period (Week 12-264)|Physician Decision|5
5904501|NCT01646177|20427899|P6|Long-Term Extension Period (Week 12-264)|Physician Decision|5
5904502|NCT01646177|20427900|P5|Long-Term Extension Period (Week 12-264)|Physician Decision|3
5904503|NCT01646177|20427901|P4|Long-Term Extension Period (Week 12-264)|Physician Decision|0
5904504|NCT01646177|20427902|P3|Long-Term Extension Period (Week 12-264)|Physician Decision|0
5904505|NCT01646177|20427903|P2|Long-Term Extension Period (Week 12-264)|Physician Decision|0
5904506|NCT01646177|20427904|P1|Long-Term Extension Period (Week 12-264)|Physician Decision|0
5904507|NCT01646177|20427893|P12|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0
5904508|NCT01646177|20427894|P11|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0
5904509|NCT01646177|20427895|P10|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0
5904510|NCT01646177|20427896|P9|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0
5904511|NCT01646177|20427897|P8|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|11
5904512|NCT01646177|20427898|P7|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|10
5904513|NCT01646177|20427899|P6|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|14
5904514|NCT01646177|20427900|P5|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|6
5904515|NCT01646177|20427901|P4|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0
5904516|NCT01646177|20427902|P3|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0
5904517|NCT01646177|20427903|P2|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0
5904518|NCT01646177|20427904|P1|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0
5904519|NCT01646177|20427893|P12|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0
5904520|NCT01646177|20427894|P11|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0
5904521|NCT01646177|20427895|P10|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0
5904522|NCT01646177|20427896|P9|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0
5904523|NCT01646177|20427897|P8|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|18
5904524|NCT01646177|20427898|P7|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|23
5904525|NCT01646177|20427899|P6|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|17
5904526|NCT01646177|20427900|P5|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|6
5904527|NCT01646177|20427901|P4|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0
5904528|NCT01646177|20427902|P3|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0
5904529|NCT01646177|20427903|P2|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0
5904530|NCT01646177|20427904|P1|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0
5904531|NCT01646177|20427893|P12|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0
5904532|NCT01646177|20427894|P11|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0
5904533|NCT01646177|20427895|P10|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0
5904534|NCT01646177|20427896|P9|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0
5904535|NCT01646177|20427897|P8|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|27
5904536|NCT01646177|20427898|P7|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|29
5904537|NCT01646177|20427899|P6|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|30
5904538|NCT01646177|20427900|P5|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|11
5904539|NCT01646177|20427901|P4|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0
5904540|NCT01646177|20427902|P3|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0
5904541|NCT01646177|20427903|P2|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0
5904542|NCT01646177|20427904|P1|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0
5904543|NCT01646177|20427893|P12|Long-Term Extension Period (Week 12-264)|Adverse Event|0
5904544|NCT01646177|20427894|P11|Long-Term Extension Period (Week 12-264)|Adverse Event|0
5904545|NCT01646177|20427895|P10|Long-Term Extension Period (Week 12-264)|Adverse Event|0
5904546|NCT01646177|20427896|P9|Long-Term Extension Period (Week 12-264)|Adverse Event|0
5904547|NCT01646177|20427897|P8|Long-Term Extension Period (Week 12-264)|Adverse Event|30
5904548|NCT01646177|20427898|P7|Long-Term Extension Period (Week 12-264)|Adverse Event|43
5904549|NCT01646177|20427899|P6|Long-Term Extension Period (Week 12-264)|Adverse Event|34
5904550|NCT01646177|20427900|P5|Long-Term Extension Period (Week 12-264)|Adverse Event|16
5904551|NCT01646177|20427901|P4|Long-Term Extension Period (Week 12-264)|Adverse Event|0
5904552|NCT01646177|20427902|P3|Long-Term Extension Period (Week 12-264)|Adverse Event|0
5904553|NCT01646177|20427903|P2|Long-Term Extension Period (Week 12-264)|Adverse Event|0
5904554|NCT01646177|20427904|P1|Long-Term Extension Period (Week 12-264)|Adverse Event|0
5904555|NCT01646177|20427893|P12|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0
5904556|NCT01646177|20427894|P11|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0
5904557|NCT01646177|20427895|P10|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0
5904558|NCT01646177|20427896|P9|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0
5904559|NCT01646177|20427897|P8|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0
5904560|NCT01646177|20427898|P7|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0
5904561|NCT01646177|20427899|P6|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0
5904562|NCT01646177|20427900|P5|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0
5904563|NCT01646177|20427901|P4|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0
5904564|NCT01646177|20427902|P3|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2
5904565|NCT01646177|20427903|P2|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2
5904566|NCT01646177|20427904|P1|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|3
5904567|NCT01646177|20427893|P12|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
5904568|NCT01646177|20427894|P11|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
5904569|NCT01646177|20427895|P10|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
5904570|NCT01646177|20427896|P9|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
5904571|NCT01646177|20427897|P8|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
5904572|NCT01646177|20427898|P7|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
5904573|NCT01646177|20427899|P6|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
5904574|NCT01646177|20427900|P5|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
5904575|NCT01646177|20427901|P4|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|1
5904576|NCT01646177|20427902|P3|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|2
5904577|NCT01646177|20427903|P2|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
5904578|NCT01646177|20427904|P1|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
5904579|NCT01646177|20427893|P12|Blinded Induction Dosing (Week 0-12)|Physician Decision|0
5904580|NCT01646177|20427894|P11|Blinded Induction Dosing (Week 0-12)|Physician Decision|0
5904581|NCT01646177|20427895|P10|Blinded Induction Dosing (Week 0-12)|Physician Decision|0
5904582|NCT01646177|20427896|P9|Blinded Induction Dosing (Week 0-12)|Physician Decision|0
5904583|NCT01646177|20427897|P8|Blinded Induction Dosing (Week 0-12)|Physician Decision|0
5904584|NCT01646177|20427898|P7|Blinded Induction Dosing (Week 0-12)|Physician Decision|0
5904585|NCT01646177|20427899|P6|Blinded Induction Dosing (Week 0-12)|Physician Decision|0
5904586|NCT01646177|20427900|P5|Blinded Induction Dosing (Week 0-12)|Physician Decision|0
5904587|NCT01646177|20427901|P4|Blinded Induction Dosing (Week 0-12)|Physician Decision|2
5904588|NCT01646177|20427902|P3|Blinded Induction Dosing (Week 0-12)|Physician Decision|1
5904589|NCT01646177|20427903|P2|Blinded Induction Dosing (Week 0-12)|Physician Decision|2
5904590|NCT01646177|20427904|P1|Blinded Induction Dosing (Week 0-12)|Physician Decision|1
5904591|NCT01646177|20427893|P12|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0
5904592|NCT01646177|20427894|P11|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0
5904593|NCT01646177|20427895|P10|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0
5904594|NCT01646177|20427896|P9|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0
5904595|NCT01646177|20427897|P8|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0
5904596|NCT01646177|20427898|P7|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0
5904597|NCT01646177|20427899|P6|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0
5904598|NCT01646177|20427900|P5|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0
5904599|NCT01646177|20427901|P4|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4
5904600|NCT01646177|20427902|P3|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4
5904601|NCT01646177|20427903|P2|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|2
5904602|NCT01646177|20427904|P1|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|3
5904603|NCT01646177|20427893|P12|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0
5904604|NCT01646177|20427894|P11|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0
5904605|NCT01646177|20427895|P10|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0
5904606|NCT01646177|20427896|P9|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0
5904607|NCT01646177|20427897|P8|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0
5904608|NCT01646177|20427898|P7|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0
5904609|NCT01646177|20427899|P6|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0
5904610|NCT01646177|20427900|P5|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0
5904611|NCT01646177|20427901|P4|Blinded Induction Dosing (Week 0-12)|Protocol Violation|7
5904612|NCT01646177|20427902|P3|Blinded Induction Dosing (Week 0-12)|Protocol Violation|8
5904613|NCT01646177|20427903|P2|Blinded Induction Dosing (Week 0-12)|Protocol Violation|3
5904614|NCT01646177|20427904|P1|Blinded Induction Dosing (Week 0-12)|Protocol Violation|1
5904615|NCT01646177|20427893|P12|Blinded Induction Dosing (Week 0-12)|Adverse Event|0
5904616|NCT01646177|20427894|P11|Blinded Induction Dosing (Week 0-12)|Adverse Event|0
5904617|NCT01646177|20427895|P10|Blinded Induction Dosing (Week 0-12)|Adverse Event|0
5904618|NCT01646177|20427896|P9|Blinded Induction Dosing (Week 0-12)|Adverse Event|0
5904619|NCT01646177|20427897|P8|Blinded Induction Dosing (Week 0-12)|Adverse Event|0
5904620|NCT01646177|20427898|P7|Blinded Induction Dosing (Week 0-12)|Adverse Event|0
5904621|NCT01646177|20427899|P6|Blinded Induction Dosing (Week 0-12)|Adverse Event|0
5904710|NCT01645176|20428222|P1|Overall Study|Lack of Efficacy|4
5904622|NCT01646177|20427900|P5|Blinded Induction Dosing (Week 0-12)|Adverse Event|0
5904623|NCT01646177|20427901|P4|Blinded Induction Dosing (Week 0-12)|Adverse Event|8
5904624|NCT01646177|20427902|P3|Blinded Induction Dosing (Week 0-12)|Adverse Event|9
5904625|NCT01646177|20427903|P2|Blinded Induction Dosing (Week 0-12)|Adverse Event|4
5904626|NCT01646177|20427904|P1|Blinded Induction Dosing (Week 0-12)|Adverse Event|2
5904627|NCT01646138|20428006|P5|Overall Study|Lost to Follow-up|2
5904628|NCT01646138|20428007|P4|Overall Study|Lost to Follow-up|0
5904629|NCT01646138|20428008|P3|Overall Study|Lost to Follow-up|0
5904630|NCT01646138|20428009|P2|Overall Study|Lost to Follow-up|0
5904631|NCT01646138|20428010|P1|Overall Study|Lost to Follow-up|0
5904632|NCT01646125|20428024|P2|Overall Study|Subject/Guardian decision|1
5904633|NCT01646125|20428025|P1|Overall Study|Subject/Guardian decision|1
5904634|NCT01646125|20428024|P2|Overall Study|Study terminated by sponsor|1
5904635|NCT01646125|20428025|P1|Overall Study|Study terminated by sponsor|2
5904636|NCT01646125|20428024|P2|Overall Study|Progressive disease|16
5904637|NCT01646125|20428025|P1|Overall Study|Progressive disease|22
5904638|NCT01646125|20428024|P2|Overall Study|Physician Decision|3
5904639|NCT01646125|20428025|P1|Overall Study|Physician Decision|1
5904640|NCT01646125|20428024|P2|Overall Study|Death|1
5904641|NCT01646125|20428025|P1|Overall Study|Death|1
5904642|NCT01646125|20428024|P2|Overall Study|Adverse Event|1
5904643|NCT01646125|20428025|P1|Overall Study|Adverse Event|2
5904644|NCT01646125|20428024|P2|Overall Study|Untreated|5
5904645|NCT01646125|20428025|P1|Overall Study|Untreated|2
5904646|NCT01646073|20428050|P2|Period B (12 Weeks)|Lost to Follow-up|1
5904647|NCT01646073|20428051|P1|Period B (12 Weeks)|Lost to Follow-up|0
5904648|NCT01646073|20428050|P2|Period B (12 Weeks)|Withdrawal by Subject|5
5904649|NCT01646073|20428051|P1|Period B (12 Weeks)|Withdrawal by Subject|1
5904650|NCT01646073|20428050|P2|Period B (12 Weeks)|Adverse Event|7
5904651|NCT01646073|20428051|P1|Period B (12 Weeks)|Adverse Event|0
5904652|NCT01646073|20428050|P2|Period A (12 Weeks)|Other|1
5904653|NCT01646073|20428051|P1|Period A (12 Weeks)|Other|0
5904654|NCT01646073|20428050|P2|Period A (12 Weeks)|Protocol Violation|1
5904655|NCT01646073|20428051|P1|Period A (12 Weeks)|Protocol Violation|0
5904656|NCT01646073|20428050|P2|Period A (12 Weeks)|Lack of Efficacy|0
5904657|NCT01646073|20428051|P1|Period A (12 Weeks)|Lack of Efficacy|1
5904658|NCT01646073|20428050|P2|Period A (12 Weeks)|Withdrawal by Subject|1
5904659|NCT01646073|20428051|P1|Period A (12 Weeks)|Withdrawal by Subject|1
5904660|NCT01646073|20428050|P2|Period A (12 Weeks)|Adverse Event|2
5904661|NCT01646073|20428051|P1|Period A (12 Weeks)|Adverse Event|0
5904662|NCT01646021|20428092|P2|Overall Study|Withdrawal by Subject|15
5904663|NCT01646021|20428093|P1|Overall Study|Withdrawal by Subject|10
5904664|NCT01646021|20428092|P2|Overall Study|Lost to Follow-up|2
5904665|NCT01646021|20428093|P1|Overall Study|Lost to Follow-up|2
5904666|NCT01646021|20428092|P2|Overall Study|Study Terminated by Sponsor|41
5904667|NCT01646021|20428093|P1|Overall Study|Study Terminated by Sponsor|50
5904668|NCT01646021|20428092|P2|Overall Study|Death|83
5904669|NCT01646021|20428093|P1|Overall Study|Death|77
5904670|NCT01645930|20428130|P1|Overall Study|Reason not Defined|1
5904671|NCT01645930|20428130|P1|Overall Study|Withdrawal by Participant|2
5904672|NCT01645930|20428130|P1|Overall Study|Unsatisfactory Therapeutic Response|2
5904673|NCT01645930|20428130|P1|Overall Study|Adverse Event|4
5904674|NCT01645930|20428130|P1|Overall Study|Progressive Disease|12
5904675|NCT01645930|20428130|P1|Overall Study|Participants Ongoing on Study Treatment|22
5904676|NCT01645735|20428147|P2|Overall Study|Adverse Event|1
5904677|NCT01645735|20428148|P1|Overall Study|Adverse Event|0
5904678|NCT01645735|20428147|P2|Overall Study|Protocol Violation|0
5904679|NCT01645735|20428148|P1|Overall Study|Protocol Violation|1
5904680|NCT01645735|20428147|P2|Overall Study|Withdrawal by Subject|0
5904681|NCT01645735|20428148|P1|Overall Study|Withdrawal by Subject|1
5904682|NCT01645735|20428147|P2|Overall Study|Physician Decision|0
5904683|NCT01645735|20428148|P1|Overall Study|Physician Decision|2
5904684|NCT01645280|20428190|P5|Overall Study|Treatment not completed/Completed f/u|2
5904685|NCT01645280|20428191|P4|Overall Study|Treatment not completed/Completed f/u|0
5904686|NCT01645280|20428192|P3|Overall Study|Treatment not completed/Completed f/u|2
5904687|NCT01645280|20428193|P2|Overall Study|Treatment not completed/Completed f/u|1
5904688|NCT01645280|20428194|P1|Overall Study|Treatment not completed/Completed f/u|1
5904689|NCT01645280|20428190|P5|Overall Study|Other|0
5904690|NCT01645280|20428191|P4|Overall Study|Other|0
5904691|NCT01645280|20428192|P3|Overall Study|Other|2
5904692|NCT01645280|20428193|P2|Overall Study|Other|1
5904693|NCT01645280|20428194|P1|Overall Study|Other|1
5904694|NCT01645280|20428190|P5|Overall Study|Lost to Follow-up|1
5904695|NCT01645280|20428191|P4|Overall Study|Lost to Follow-up|2
5904696|NCT01645280|20428192|P3|Overall Study|Lost to Follow-up|0
5904697|NCT01645280|20428193|P2|Overall Study|Lost to Follow-up|0
5904698|NCT01645280|20428194|P1|Overall Study|Lost to Follow-up|0
5904699|NCT01645280|20428190|P5|Overall Study|Withdrawal by Subject|5
5904700|NCT01645280|20428191|P4|Overall Study|Withdrawal by Subject|4
5904701|NCT01645280|20428192|P3|Overall Study|Withdrawal by Subject|2
5904702|NCT01645280|20428193|P2|Overall Study|Withdrawal by Subject|0
5904703|NCT01645280|20428194|P1|Overall Study|Withdrawal by Subject|4
5904704|NCT01645280|20428190|P5|Overall Study|Death|0
5904705|NCT01645280|20428191|P4|Overall Study|Death|0
5904706|NCT01645280|20428192|P3|Overall Study|Death|0
5904707|NCT01645280|20428193|P2|Overall Study|Death|1
5904708|NCT01645280|20428194|P1|Overall Study|Death|0
5904709|NCT01645176|20428222|P1|Overall Study|did not complete final MRI|1
5904711|NCT01645111|20428226|P1|Overall Study|Did not require Clevidipine|15
5904712|NCT01644890|20428267|P2|Overall Study|Other|9
5904713|NCT01644890|20428268|P1|Overall Study|Other|8
5904714|NCT01644890|20428267|P2|Overall Study|> 28 days since last dose of study drug|3
5904715|NCT01644890|20428268|P1|Overall Study|> 28 days since last dose of study drug|6
5904716|NCT01644890|20428267|P2|Overall Study|Clinical Progression|6
5904717|NCT01644890|20428268|P1|Overall Study|Clinical Progression|6
5904718|NCT01644890|20428267|P2|Overall Study|Progression Disease|131
5904719|NCT01644890|20428268|P1|Overall Study|Progression Disease|160
5904720|NCT01644890|20428267|P2|Overall Study|Withdrawal by Subject|27
5904721|NCT01644890|20428268|P1|Overall Study|Withdrawal by Subject|19
5904722|NCT01644890|20428267|P2|Overall Study|Protocol Violation|7
5904723|NCT01644890|20428268|P1|Overall Study|Protocol Violation|6
5904724|NCT01644890|20428267|P2|Overall Study|Physician Decision|9
5904725|NCT01644890|20428268|P1|Overall Study|Physician Decision|3
5904726|NCT01644890|20428267|P2|Overall Study|Death|3
5904727|NCT01644890|20428268|P1|Overall Study|Death|1
5904728|NCT01644890|20428267|P2|Overall Study|Adverse Event|20
5904729|NCT01644890|20428268|P1|Overall Study|Adverse Event|7
5904730|NCT01644734|20428278|P1|Overall Study|Missing documentation|238
5904731|NCT01644734|20428278|P1|Overall Study|Reasons other than stated above|7
5904732|NCT01644734|20428278|P1|Overall Study|Lost to Follow-up|17
5904733|NCT01644734|20428278|P1|Overall Study|Adverse Event|4
5904734|NCT01644643|20428292|P4|Overall Study|Other Eligibility criteria|2
5904735|NCT01644643|20428293|P3|Overall Study|Other Eligibility criteria|0
5904736|NCT01644643|20428294|P2|Overall Study|Other Eligibility criteria|0
5904737|NCT01644643|20428295|P1|Overall Study|Other Eligibility criteria|0
5904738|NCT01644643|20428292|P4|Overall Study|Withdrawal by Subject|1
5904739|NCT01644643|20428293|P3|Overall Study|Withdrawal by Subject|2
5904740|NCT01644643|20428294|P2|Overall Study|Withdrawal by Subject|0
5904741|NCT01644643|20428295|P1|Overall Study|Withdrawal by Subject|1
5904742|NCT01644643|20428292|P4|Overall Study|Lost to Follow-up|4
5904743|NCT01644643|20428293|P3|Overall Study|Lost to Follow-up|0
5904744|NCT01644643|20428294|P2|Overall Study|Lost to Follow-up|0
5904745|NCT01644643|20428295|P1|Overall Study|Lost to Follow-up|0
5904746|NCT01644643|20428292|P4|Overall Study|Death|3
5904747|NCT01644643|20428293|P3|Overall Study|Death|3
5904748|NCT01644643|20428294|P2|Overall Study|Death|0
5904749|NCT01644643|20428295|P1|Overall Study|Death|1
5904750|NCT01644617|20428460|P3|Overall Study|Adverse Event|6
5904751|NCT01644617|20428461|P2|Overall Study|Adverse Event|0
5904752|NCT01644617|20428462|P1|Overall Study|Adverse Event|3
5904753|NCT01644617|20428460|P3|Overall Study|Lost to Follow-up|0
5904754|NCT01644617|20428461|P2|Overall Study|Lost to Follow-up|1
5904755|NCT01644617|20428462|P1|Overall Study|Lost to Follow-up|0
5904756|NCT01644617|20428460|P3|Overall Study|Withdrawal by Subject|1
5904757|NCT01644617|20428461|P2|Overall Study|Withdrawal by Subject|4
5904758|NCT01644617|20428462|P1|Overall Study|Withdrawal by Subject|3
5904795|NCT01644500|20428561|P3|Overall Study|Physician Decision|1
5904796|NCT01644500|20428562|P2|Overall Study|Physician Decision|1
5904797|NCT01644500|20428563|P1|Overall Study|Physician Decision|1
5904798|NCT01644500|20428561|P3|Overall Study|Withdrawal by Subject|12
5904799|NCT01644500|20428562|P2|Overall Study|Withdrawal by Subject|12
5904800|NCT01644500|20428563|P1|Overall Study|Withdrawal by Subject|11
5904801|NCT01644500|20428561|P3|Overall Study|Protocol Violation|0
5904802|NCT01644500|20428562|P2|Overall Study|Protocol Violation|1
5904803|NCT01644500|20428563|P1|Overall Study|Protocol Violation|1
5904804|NCT01644500|20428561|P3|Overall Study|Lost to Follow-up|0
5904805|NCT01644500|20428562|P2|Overall Study|Lost to Follow-up|8
5904806|NCT01644500|20428563|P1|Overall Study|Lost to Follow-up|3
5904807|NCT01644500|20428561|P3|Overall Study|Death|0
5904808|NCT01644500|20428562|P2|Overall Study|Death|1
5904809|NCT01644500|20428563|P1|Overall Study|Death|0
5904810|NCT01644500|20428561|P3|Overall Study|Adverse Event|2
5904811|NCT01644500|20428562|P2|Overall Study|Adverse Event|1
5904812|NCT01644500|20428563|P1|Overall Study|Adverse Event|6
5904813|NCT01644474|20428633|P2|Overall Study|Protocol Violation|0
5904814|NCT01644474|20428634|P1|Overall Study|Protocol Violation|1
5904815|NCT01644474|20428633|P2|Overall Study|Site scheduling error|1
5904816|NCT01644474|20428634|P1|Overall Study|Site scheduling error|1
5904817|NCT01644474|20428633|P2|Overall Study|Adverse Event|5
5904818|NCT01644474|20428634|P1|Overall Study|Adverse Event|4
5904819|NCT01644474|20428633|P2|Overall Study|Participant moved|1
5904820|NCT01644474|20428634|P1|Overall Study|Participant moved|0
5904821|NCT01644474|20428633|P2|Overall Study|Consent withdrawn by participant|1
5904822|NCT01644474|20428634|P1|Overall Study|Consent withdrawn by participant|0
5904823|NCT01644474|20428633|P2|Overall Study|Poor compliance to protocol|0
5904824|NCT01644474|20428634|P1|Overall Study|Poor compliance to protocol|1
5904825|NCT01644188|20428818|P2|Overall Study|Other than specified above|7
5904826|NCT01644188|20428819|P1|Overall Study|Other than specified above|6
5904827|NCT01644188|20428818|P2|Overall Study|Site closure|1
5904828|NCT01644188|20428819|P1|Overall Study|Site closure|1
5904829|NCT01644188|20428818|P2|Overall Study|Last visit outside protocol visit window|16
5904830|NCT01644188|20428819|P1|Overall Study|Last visit outside protocol visit window|14
5904831|NCT01644188|20428818|P2|Overall Study|Death|3
5904832|NCT01644188|20428819|P1|Overall Study|Death|4
5904833|NCT01644188|20428818|P2|Overall Study|Lost to Follow-up|0
5904834|NCT01644188|20428819|P1|Overall Study|Lost to Follow-up|1
5904835|NCT01644188|20428818|P2|Overall Study|Selection criteria finally not met|0
5904836|NCT01644188|20428819|P1|Overall Study|Selection criteria finally not met|2
5904837|NCT01644188|20428818|P2|Overall Study|Consent withdrawn by participant|7
5904838|NCT01644188|20428819|P1|Overall Study|Consent withdrawn by participant|14
5904839|NCT01644188|20428818|P2|Overall Study|Related to auto-injector administration|2
5904840|NCT01644188|20428819|P1|Overall Study|Related to auto-injector administration|2
5904841|NCT01644188|20428818|P2|Overall Study|Participant moved|2
5904842|NCT01644188|20428819|P1|Overall Study|Participant moved|7
5904843|NCT01644188|20428818|P2|Overall Study|Physician Decision|3
5904844|NCT01644188|20428819|P1|Overall Study|Physician Decision|1
5904845|NCT01644188|20428818|P2|Overall Study|Poor compliance to protocol|14
5904846|NCT01644188|20428819|P1|Overall Study|Poor compliance to protocol|26
5904847|NCT01644188|20428818|P2|Overall Study|Adverse Event|20
5904848|NCT01644188|20428819|P1|Overall Study|Adverse Event|44
5904849|NCT01644175|20428877|P2|Overall Study|Other than specified above|3
5904850|NCT01644175|20428878|P1|Overall Study|Other than specified above|0
5904851|NCT01644175|20428877|P2|Overall Study|Lost to Follow-up|0
5904852|NCT01644175|20428878|P1|Overall Study|Lost to Follow-up|1
5904853|NCT01644175|20428877|P2|Overall Study|Site closure|2
5904854|NCT01644175|20428878|P1|Overall Study|Site closure|2
5904855|NCT01644175|20428877|P2|Overall Study|Selection criteria finally not met|1
5904856|NCT01644175|20428878|P1|Overall Study|Selection criteria finally not met|0
5904857|NCT01644175|20428877|P2|Overall Study|Last visit outside protocol visit window|11
5904858|NCT01644175|20428878|P1|Overall Study|Last visit outside protocol visit window|4
5904859|NCT01644175|20428877|P2|Overall Study|Related to Autoinjector Administration|1
5904860|NCT01644175|20428878|P1|Overall Study|Related to Autoinjector Administration|2
5904861|NCT01644175|20428877|P2|Overall Study|Consent withdrawn by participant|4
5904862|NCT01644175|20428878|P1|Overall Study|Consent withdrawn by participant|3
5904863|NCT01644175|20428877|P2|Overall Study|Participant Moved|2
5904864|NCT01644175|20428878|P1|Overall Study|Participant Moved|1
5904865|NCT01644175|20428877|P2|Overall Study|Physician Decision|2
5904866|NCT01644175|20428878|P1|Overall Study|Physician Decision|1
5904867|NCT01644175|20428877|P2|Overall Study|Poor compliance to protocol|10
5904868|NCT01644175|20428878|P1|Overall Study|Poor compliance to protocol|9
5904869|NCT01644175|20428877|P2|Overall Study|Death|2
5904870|NCT01644175|20428878|P1|Overall Study|Death|1
5904871|NCT01644175|20428877|P2|Overall Study|Adverse Event|13
5904872|NCT01644175|20428878|P1|Overall Study|Adverse Event|8
5904873|NCT01644175|20428877|P2|Overall Study|Randomized But Not Treated|2
5904874|NCT01644175|20428878|P1|Overall Study|Randomized But Not Treated|0
5904875|NCT01644149|20428930|P2|Overall Study|Lost to Follow-up|1
5904876|NCT01644149|20428931|P1|Overall Study|Lost to Follow-up|3
5904877|NCT01644149|20428930|P2|Overall Study|Withdrawal by Subject|0
5904878|NCT01644149|20428931|P1|Overall Study|Withdrawal by Subject|1
5904879|NCT01643928|20428951|P5|Overall Study|Adverse Event|2
5904880|NCT01643928|20428952|P4|Overall Study|Adverse Event|1
5904881|NCT01643928|20428953|P3|Overall Study|Adverse Event|0
5904882|NCT01643928|20428954|P2|Overall Study|Adverse Event|1
5904883|NCT01643928|20428955|P1|Overall Study|Adverse Event|2
5904884|NCT01643928|20428951|P5|Overall Study|Other|0
5904885|NCT01643928|20428952|P4|Overall Study|Other|0
5904886|NCT01643928|20428953|P3|Overall Study|Other|1
5904887|NCT01643928|20428954|P2|Overall Study|Other|1
5904888|NCT01643928|20428955|P1|Overall Study|Other|5
5904889|NCT01643928|20428951|P5|Overall Study|Pregnancy|0
5904890|NCT01643928|20428952|P4|Overall Study|Pregnancy|1
5904891|NCT01643928|20428953|P3|Overall Study|Pregnancy|0
5904892|NCT01643928|20428954|P2|Overall Study|Pregnancy|0
5904893|NCT01643928|20428955|P1|Overall Study|Pregnancy|0
5904894|NCT01643928|20428951|P5|Overall Study|Withdrawal by Subject|0
5904895|NCT01643928|20428952|P4|Overall Study|Withdrawal by Subject|1
5904896|NCT01643928|20428953|P3|Overall Study|Withdrawal by Subject|0
5904897|NCT01643928|20428954|P2|Overall Study|Withdrawal by Subject|0
5904898|NCT01643928|20428955|P1|Overall Study|Withdrawal by Subject|2
5904899|NCT01643928|20428951|P5|Overall Study|Lost to Follow-up|0
5904900|NCT01643928|20428952|P4|Overall Study|Lost to Follow-up|0
5904901|NCT01643928|20428953|P3|Overall Study|Lost to Follow-up|2
5904902|NCT01643928|20428954|P2|Overall Study|Lost to Follow-up|0
5904903|NCT01643928|20428955|P1|Overall Study|Lost to Follow-up|1
5904904|NCT01643850|20429259|P9|Overall Study|Administrative Problems|0
5904905|NCT01643850|20429260|P8|Overall Study|Administrative Problems|0
5904906|NCT01643850|20429261|P7|Overall Study|Administrative Problems|0
5904907|NCT01643850|20429262|P6|Overall Study|Administrative Problems|0
5904908|NCT01643850|20429263|P5|Overall Study|Administrative Problems|1
5904909|NCT01643850|20429264|P4|Overall Study|Administrative Problems|0
5904910|NCT01643850|20429265|P3|Overall Study|Administrative Problems|1
5904911|NCT01643850|20429266|P2|Overall Study|Administrative Problems|0
5904912|NCT01643850|20429267|P1|Overall Study|Administrative Problems|0
5904913|NCT01643850|20429259|P9|Overall Study|Adverse Event|0
5904914|NCT01643850|20429260|P8|Overall Study|Adverse Event|0
5904915|NCT01643850|20429261|P7|Overall Study|Adverse Event|0
5904916|NCT01643850|20429262|P6|Overall Study|Adverse Event|0
5904917|NCT01643850|20429263|P5|Overall Study|Adverse Event|1
5904918|NCT01643850|20429264|P4|Overall Study|Adverse Event|0
5904919|NCT01643850|20429265|P3|Overall Study|Adverse Event|0
5904920|NCT01643850|20429266|P2|Overall Study|Adverse Event|0
5904921|NCT01643850|20429267|P1|Overall Study|Adverse Event|0
5904922|NCT01643850|20429259|P9|Overall Study|Lost to Follow-up|1
5904923|NCT01643850|20429260|P8|Overall Study|Lost to Follow-up|0
5904924|NCT01643850|20429261|P7|Overall Study|Lost to Follow-up|1
5904925|NCT01643850|20429262|P6|Overall Study|Lost to Follow-up|0
5904926|NCT01643850|20429263|P5|Overall Study|Lost to Follow-up|0
5904927|NCT01643850|20429264|P4|Overall Study|Lost to Follow-up|0
5904928|NCT01643850|20429265|P3|Overall Study|Lost to Follow-up|0
5904929|NCT01643850|20429266|P2|Overall Study|Lost to Follow-up|0
5904930|NCT01643850|20429267|P1|Overall Study|Lost to Follow-up|0
5904931|NCT01643850|20429259|P9|Overall Study|Withdrawal by Subject|0
5904932|NCT01643850|20429260|P8|Overall Study|Withdrawal by Subject|0
5904933|NCT01643850|20429261|P7|Overall Study|Withdrawal by Subject|0
5904934|NCT01643850|20429262|P6|Overall Study|Withdrawal by Subject|0
5904935|NCT01643850|20429263|P5|Overall Study|Withdrawal by Subject|1
5904936|NCT01643850|20429264|P4|Overall Study|Withdrawal by Subject|0
5904937|NCT01643850|20429265|P3|Overall Study|Withdrawal by Subject|0
5904938|NCT01643850|20429266|P2|Overall Study|Withdrawal by Subject|0
5904939|NCT01643850|20429267|P1|Overall Study|Withdrawal by Subject|0
5904940|NCT01643798|20429406|P2|Pretreatment 1 and Stimulation|Withdrawal by Subject|0
5904941|NCT01643798|20429407|P1|Pretreatment 1 and Stimulation|Withdrawal by Subject|1
5904942|NCT01643772|20429422|P4|Overall Study|Adverse Event|1
5904943|NCT01643772|20429423|P3|Overall Study|Adverse Event|0
5904944|NCT01643772|20429424|P2|Overall Study|Adverse Event|0
5904945|NCT01643772|20429425|P1|Overall Study|Adverse Event|0
5904946|NCT01643772|20429422|P4|Overall Study|Protocol Violation|1
5904947|NCT01643772|20429423|P3|Overall Study|Protocol Violation|0
5904948|NCT01643772|20429424|P2|Overall Study|Protocol Violation|0
5904949|NCT01643772|20429425|P1|Overall Study|Protocol Violation|0
5904950|NCT01643668|20429465|P1|Overall Study|Death|1
5904951|NCT01643473|20429496|P2|Overall Study|Lost to Follow-up|0
5904952|NCT01643473|20429497|P1|Overall Study|Lost to Follow-up|1
5904953|NCT01643044|20429529|P2|Overall Study|Delivered outside of hospital|2
5904954|NCT01643044|20429530|P1|Overall Study|Delivered outside of hospital|1
5904955|NCT01643044|20429529|P2|Overall Study|Miscarried baby|2
5904956|NCT01643044|20429530|P1|Overall Study|Miscarried baby|2
5904957|NCT01643044|20429529|P2|Overall Study|Lost to Follow-up|1
5904958|NCT01643044|20429530|P1|Overall Study|Lost to Follow-up|1
5904959|NCT01642914|20429539|P3|Overall Study|Other Reason|0
5904960|NCT01642914|20429540|P2|Overall Study|Other Reason|0
5904961|NCT01642914|20429541|P1|Overall Study|Other Reason|1
5904962|NCT01642914|20429539|P3|Overall Study|Lost to Follow-up|7
5904963|NCT01642914|20429540|P2|Overall Study|Lost to Follow-up|3
5904964|NCT01642914|20429541|P1|Overall Study|Lost to Follow-up|5
5904965|NCT01642914|20429539|P3|Overall Study|Withdrawal by Subject|10
5904966|NCT01642914|20429540|P2|Overall Study|Withdrawal by Subject|5
5904967|NCT01642914|20429541|P1|Overall Study|Withdrawal by Subject|5
5904968|NCT01642914|20429539|P3|Overall Study|Protocol Violation|6
5904969|NCT01642914|20429540|P2|Overall Study|Protocol Violation|13
5904970|NCT01642914|20429541|P1|Overall Study|Protocol Violation|15
5904971|NCT01642914|20429539|P3|Overall Study|Lack of Efficacy|2
5904972|NCT01642914|20429540|P2|Overall Study|Lack of Efficacy|4
5904973|NCT01642914|20429541|P1|Overall Study|Lack of Efficacy|9
5904974|NCT01642914|20429539|P3|Overall Study|Adverse Event|15
5904975|NCT01642914|20429540|P2|Overall Study|Adverse Event|7
5904976|NCT01642914|20429541|P1|Overall Study|Adverse Event|11
5904977|NCT01642732|20429616|P1|Overall Study|Withdrawal by Subject|1
5904978|NCT01642615|20429621|P3|Double Blind Maintenance Phase|Requires Treatment with Another Drug|1
5904979|NCT01642615|20429622|P2|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0
5904980|NCT01642615|20429623|P1|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0
5904981|NCT01642615|20429621|P3|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0
5904982|NCT01642615|20429622|P2|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|1
5904983|NCT01642615|20429623|P1|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0
5904984|NCT01642615|20429621|P3|Double Blind Maintenance Phase|Voluntary Withdrawal|2
5904985|NCT01642615|20429622|P2|Double Blind Maintenance Phase|Voluntary Withdrawal|5
5904986|NCT01642615|20429623|P1|Double Blind Maintenance Phase|Voluntary Withdrawal|0
5904987|NCT01642615|20429621|P3|Double Blind Maintenance Phase|Lack of Efficacy|3
5904988|NCT01642615|20429622|P2|Double Blind Maintenance Phase|Lack of Efficacy|1
5904989|NCT01642615|20429623|P1|Double Blind Maintenance Phase|Lack of Efficacy|0
5904990|NCT01642615|20429621|P3|Open Label Maintenance Phase|Did not receive treatment|0
5904991|NCT01642615|20429622|P2|Open Label Maintenance Phase|Did not receive treatment|0
5904992|NCT01642615|20429623|P1|Open Label Maintenance Phase|Did not receive treatment|1
5904993|NCT01642615|20429621|P3|Open Label Maintenance Phase|Voluntary Withdrawal|0
5904994|NCT01642615|20429622|P2|Open Label Maintenance Phase|Voluntary Withdrawal|0
5904995|NCT01642615|20429623|P1|Open Label Maintenance Phase|Voluntary Withdrawal|1
5904996|NCT01642615|20429621|P3|Open Label Maintenance Phase|Lost to Follow-up|0
5904997|NCT01642615|20429622|P2|Open Label Maintenance Phase|Lost to Follow-up|0
5904998|NCT01642615|20429623|P1|Open Label Maintenance Phase|Lost to Follow-up|1
5904999|NCT01642615|20429621|P3|Open Label Maintenance Phase|Major Protocol Deviation|0
5905000|NCT01642615|20429622|P2|Open Label Maintenance Phase|Major Protocol Deviation|0
5905001|NCT01642615|20429623|P1|Open Label Maintenance Phase|Major Protocol Deviation|1
5905002|NCT01642615|20429621|P3|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0
5905003|NCT01642615|20429622|P2|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0
5905004|NCT01642615|20429623|P1|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|1
5905005|NCT01642602|20429637|P1|Overall Study|Adverse Event|2
5905006|NCT01642589|20429644|P2|Overall Study|Withdrawal by Subject|1
5905007|NCT01642589|20429645|P1|Overall Study|Withdrawal by Subject|1
5905011|NCT01642277|20429731|P2|Overall Study|Withdrawal by Subject|0
5905012|NCT01642277|20429732|P1|Overall Study|Withdrawal by Subject|11
5905013|NCT01642277|20429731|P2|Overall Study|Protocol Violation|0
5905014|NCT01642277|20429732|P1|Overall Study|Protocol Violation|1
5905015|NCT01642277|20429731|P2|Overall Study|Physician Decision|0
5905016|NCT01642277|20429732|P1|Overall Study|Physician Decision|2
5905017|NCT01642277|20429731|P2|Overall Study|Adverse Event|0
5905018|NCT01642277|20429732|P1|Overall Study|Adverse Event|10
5905019|NCT01642251|20429744|P4|Overall Study|Ineligible/never start protocol therapy|8
5905020|NCT01642251|20429745|P3|Overall Study|Ineligible/never start protocol therapy|11
5905021|NCT01642251|20429746|P2|Overall Study|Ineligible/never start protocol therapy|0
5905022|NCT01642251|20429747|P1|Overall Study|Ineligible/never start protocol therapy|0
5905023|NCT01642251|20429744|P4|Overall Study|Other complicating disease|0
5905024|NCT01642251|20429745|P3|Overall Study|Other complicating disease|1
5905025|NCT01642251|20429746|P2|Overall Study|Other complicating disease|0
5905026|NCT01642251|20429747|P1|Overall Study|Other complicating disease|0
5905027|NCT01642251|20429744|P4|Overall Study|Alternative therapy|2
5905028|NCT01642251|20429745|P3|Overall Study|Alternative therapy|0
5905029|NCT01642251|20429746|P2|Overall Study|Alternative therapy|0
5905030|NCT01642251|20429747|P1|Overall Study|Alternative therapy|0
5905031|NCT01642251|20429744|P4|Overall Study|Withdrawal by Subject|3
5905032|NCT01642251|20429745|P3|Overall Study|Withdrawal by Subject|1
5905033|NCT01642251|20429746|P2|Overall Study|Withdrawal by Subject|0
5905034|NCT01642251|20429747|P1|Overall Study|Withdrawal by Subject|0
5905035|NCT01642251|20429744|P4|Overall Study|Death|3
5905036|NCT01642251|20429745|P3|Overall Study|Death|1
5905037|NCT01642251|20429746|P2|Overall Study|Death|0
5905038|NCT01642251|20429747|P1|Overall Study|Death|0
5905039|NCT01642251|20429744|P4|Overall Study|Adverse Event|4
5905040|NCT01642251|20429745|P3|Overall Study|Adverse Event|5
5905041|NCT01642251|20429746|P2|Overall Study|Adverse Event|0
5905042|NCT01642251|20429747|P1|Overall Study|Adverse Event|0
5905043|NCT01642251|20429744|P4|Overall Study|Progressive disease|3
5905044|NCT01642251|20429745|P3|Overall Study|Progressive disease|3
5905045|NCT01642251|20429746|P2|Overall Study|Progressive disease|0
5905046|NCT01642251|20429747|P1|Overall Study|Progressive disease|0
5905047|NCT01642212|20429785|P5|Open-label Extension|Other|1
5905048|NCT01642212|20429786|P4|Open-label Extension|Other|0
5905049|NCT01642212|20429787|P3|Open-label Extension|Other|0
5905050|NCT01642212|20429788|P2|Open-label Extension|Other|0
5905051|NCT01642212|20429789|P1|Open-label Extension|Other|0
5905052|NCT01642212|20429785|P5|Open-label Extension|Lost to Follow-up|1
5905053|NCT01642212|20429786|P4|Open-label Extension|Lost to Follow-up|0
5905054|NCT01642212|20429787|P3|Open-label Extension|Lost to Follow-up|0
5905055|NCT01642212|20429788|P2|Open-label Extension|Lost to Follow-up|0
5905056|NCT01642212|20429789|P1|Open-label Extension|Lost to Follow-up|0
5905057|NCT01642212|20429785|P5|Open-label Extension|Consent Withdrawn|2
5905058|NCT01642212|20429786|P4|Open-label Extension|Consent Withdrawn|0
5905059|NCT01642212|20429787|P3|Open-label Extension|Consent Withdrawn|0
5905060|NCT01642212|20429788|P2|Open-label Extension|Consent Withdrawn|0
5905061|NCT01642212|20429789|P1|Open-label Extension|Consent Withdrawn|0
5905062|NCT01642212|20429785|P5|Open-label Extension|Sponsor Decision|4
5905063|NCT01642212|20429786|P4|Open-label Extension|Sponsor Decision|7
5905064|NCT01642212|20429787|P3|Open-label Extension|Sponsor Decision|0
5905065|NCT01642212|20429788|P2|Open-label Extension|Sponsor Decision|0
5905066|NCT01642212|20429789|P1|Open-label Extension|Sponsor Decision|0
5905067|NCT01642212|20429785|P5|Open-label Extension|Adverse Event|0
5905068|NCT01642212|20429786|P4|Open-label Extension|Adverse Event|3
5905069|NCT01642212|20429787|P3|Open-label Extension|Adverse Event|0
5905070|NCT01642212|20429788|P2|Open-label Extension|Adverse Event|0
5905071|NCT01642212|20429789|P1|Open-label Extension|Adverse Event|0
5905072|NCT01642212|20429785|P5|Double-blind Treatment|Adverse Event|0
5905073|NCT01642212|20429786|P4|Double-blind Treatment|Adverse Event|0
5905074|NCT01642212|20429787|P3|Double-blind Treatment|Adverse Event|1
5905075|NCT01642212|20429788|P2|Double-blind Treatment|Adverse Event|0
5905076|NCT01642212|20429789|P1|Double-blind Treatment|Adverse Event|0
5905077|NCT01642212|20429785|P5|Double-blind Treatment|Non-compliance|0
5905078|NCT01642212|20429786|P4|Double-blind Treatment|Non-compliance|0
5905079|NCT01642212|20429787|P3|Double-blind Treatment|Non-compliance|0
5905080|NCT01642212|20429788|P2|Double-blind Treatment|Non-compliance|1
5905081|NCT01642212|20429789|P1|Double-blind Treatment|Non-compliance|0
5905082|NCT01642212|20429785|P5|Double-blind Treatment|Other|0
5905083|NCT01642212|20429786|P4|Double-blind Treatment|Other|0
5905084|NCT01642212|20429787|P3|Double-blind Treatment|Other|1
5905085|NCT01642212|20429788|P2|Double-blind Treatment|Other|2
5905086|NCT01642212|20429789|P1|Double-blind Treatment|Other|0
5905087|NCT01642212|20429785|P5|Single-blind Baseline|Did Not Meet Eligibility Criteria|0
5905088|NCT01642212|20429786|P4|Single-blind Baseline|Did Not Meet Eligibility Criteria|0
5905089|NCT01642212|20429787|P3|Single-blind Baseline|Did Not Meet Eligibility Criteria|0
5905090|NCT01642212|20429788|P2|Single-blind Baseline|Did Not Meet Eligibility Criteria|0
5905091|NCT01642212|20429789|P1|Single-blind Baseline|Did Not Meet Eligibility Criteria|26
5905092|NCT01642004|20429884|P2|Treatment|Missing from data|1
5905093|NCT01642004|20429885|P1|Treatment|Missing from data|0
5905094|NCT01642004|20429884|P2|Treatment|Other|2
5905095|NCT01642004|20429885|P1|Treatment|Other|1
5905096|NCT01642004|20429884|P2|Treatment|No longer meets study criteria|2
5905097|NCT01642004|20429885|P1|Treatment|No longer meets study criteria|1
5905098|NCT01642004|20429884|P2|Treatment|Poor/non-compliance|0
5905099|NCT01642004|20429885|P1|Treatment|Poor/non-compliance|1
5905100|NCT01642004|20429884|P2|Treatment|Maximum clinical benefit|7
5905101|NCT01642004|20429885|P1|Treatment|Maximum clinical benefit|2
5905102|NCT01642004|20429884|P2|Treatment|Withdrawal by Subject|9
5905103|NCT01642004|20429885|P1|Treatment|Withdrawal by Subject|5
5905104|NCT01642004|20429884|P2|Treatment|Adverse event unrelated to study drug|13
5905105|NCT01642004|20429885|P1|Treatment|Adverse event unrelated to study drug|6
5905106|NCT01642004|20429884|P2|Treatment|Death|0
5905107|NCT01642004|20429885|P1|Treatment|Death|1
5905108|NCT01642004|20429884|P2|Treatment|Study drug toxicity|13
5905109|NCT01642004|20429885|P1|Treatment|Study drug toxicity|5
5905110|NCT01642004|20429884|P2|Treatment|Disease progression|80
5905111|NCT01642004|20429885|P1|Treatment|Disease progression|88
5905112|NCT01642004|20429884|P2|Randomization|No longer meets study criteria|2
5905113|NCT01642004|20429885|P1|Randomization|No longer meets study criteria|2
5905114|NCT01642004|20429884|P2|Randomization|Withdrawal by Subject|6
5905115|NCT01642004|20429885|P1|Randomization|Withdrawal by Subject|1
5905116|NCT01642004|20429884|P2|Randomization|Adverse Event unrelated to study drug|0
5905117|NCT01642004|20429885|P1|Randomization|Adverse Event unrelated to study drug|1
5905118|NCT01641991|20429919|P4|Overall Study|no longer eligible|4
5905119|NCT01641991|20429920|P3|Overall Study|no longer eligible|0
5905120|NCT01641991|20429921|P2|Overall Study|no longer eligible|1
5905121|NCT01641991|20429922|P1|Overall Study|no longer eligible|2
5905122|NCT01641991|20429919|P4|Overall Study|Pregnancy|0
5905123|NCT01641991|20429920|P3|Overall Study|Pregnancy|1
5905124|NCT01641991|20429921|P2|Overall Study|Pregnancy|0
5905125|NCT01641991|20429922|P1|Overall Study|Pregnancy|0
5905126|NCT01641991|20429919|P4|Overall Study|Protocol Violation|0
5905127|NCT01641991|20429920|P3|Overall Study|Protocol Violation|3
5905128|NCT01641991|20429921|P2|Overall Study|Protocol Violation|1
5905129|NCT01641991|20429922|P1|Overall Study|Protocol Violation|1
5905130|NCT01641991|20429919|P4|Overall Study|Lost to Follow-up|1
5905131|NCT01641991|20429920|P3|Overall Study|Lost to Follow-up|3
5905132|NCT01641991|20429921|P2|Overall Study|Lost to Follow-up|2
5905133|NCT01641991|20429922|P1|Overall Study|Lost to Follow-up|0
5905134|NCT01641991|20429919|P4|Overall Study|Adverse Event|1
5905135|NCT01641991|20429920|P3|Overall Study|Adverse Event|2
5905136|NCT01641991|20429921|P2|Overall Study|Adverse Event|1
5905137|NCT01641991|20429922|P1|Overall Study|Adverse Event|2
5905138|NCT01641991|20429919|P4|Overall Study|Withdrawal by Subject|5
5905139|NCT01641991|20429920|P3|Overall Study|Withdrawal by Subject|1
5905140|NCT01641991|20429921|P2|Overall Study|Withdrawal by Subject|2
5905141|NCT01641991|20429922|P1|Overall Study|Withdrawal by Subject|4
5905142|NCT01641991|20429919|P4|Overall Study|Physician Decision|5
5905143|NCT01641991|20429920|P3|Overall Study|Physician Decision|7
5905144|NCT01641991|20429921|P2|Overall Study|Physician Decision|1
5905145|NCT01641991|20429922|P1|Overall Study|Physician Decision|0
5905146|NCT01641952|20430006|P1|Overall Study|Adverse Event|6
5905147|NCT01641952|20430006|P1|Overall Study|Lost to Follow-up|28
5905148|NCT01641939|20430022|P3|Overall Study|Study Terminated by Sponsor|3
5905149|NCT01641939|20430023|P2|Overall Study|Study Terminated by Sponsor|28
5905150|NCT01641939|20430024|P1|Overall Study|Study Terminated by Sponsor|10
5905151|NCT01641939|20430022|P3|Overall Study|Withdrawal by Subject|5
5905152|NCT01641939|20430023|P2|Overall Study|Withdrawal by Subject|11
5905153|NCT01641939|20430024|P1|Overall Study|Withdrawal by Subject|14
5905154|NCT01641939|20430022|P3|Overall Study|Lost to Follow-up|1
5905155|NCT01641939|20430023|P2|Overall Study|Lost to Follow-up|2
5905156|NCT01641939|20430024|P1|Overall Study|Lost to Follow-up|3
5905157|NCT01641939|20430022|P3|Overall Study|Death|61
5905158|NCT01641939|20430023|P2|Overall Study|Death|187
5905159|NCT01641939|20430024|P1|Overall Study|Death|90
5905160|NCT01641926|20430067|P4|Overall Study|Not Treated|0
5905161|NCT01641926|20430068|P3|Overall Study|Not Treated|1
5905162|NCT01641926|20430069|P2|Overall Study|Not Treated|1
5905163|NCT01641926|20430070|P1|Overall Study|Not Treated|1
5905164|NCT01641926|20430067|P4|Overall Study|Withdrawal by Subject|1
5905165|NCT01641926|20430068|P3|Overall Study|Withdrawal by Subject|6
5905166|NCT01641926|20430069|P2|Overall Study|Withdrawal by Subject|5
5905167|NCT01641926|20430070|P1|Overall Study|Withdrawal by Subject|13
5905168|NCT01641926|20430067|P4|Overall Study|Protocol Violation|1
5905169|NCT01641926|20430068|P3|Overall Study|Protocol Violation|0
5905170|NCT01641926|20430069|P2|Overall Study|Protocol Violation|0
5905171|NCT01641926|20430070|P1|Overall Study|Protocol Violation|1
5905172|NCT01641926|20430067|P4|Overall Study|Physician Decision|1
5905173|NCT01641926|20430068|P3|Overall Study|Physician Decision|0
5905174|NCT01641926|20430069|P2|Overall Study|Physician Decision|5
5905175|NCT01641926|20430070|P1|Overall Study|Physician Decision|6
5905176|NCT01641926|20430067|P4|Overall Study|Lost to Follow-up|0
5905177|NCT01641926|20430068|P3|Overall Study|Lost to Follow-up|1
5905178|NCT01641926|20430069|P2|Overall Study|Lost to Follow-up|2
5905179|NCT01641926|20430070|P1|Overall Study|Lost to Follow-up|2
5905180|NCT01641926|20430067|P4|Overall Study|Adverse Event|1
5905181|NCT01641926|20430068|P3|Overall Study|Adverse Event|3
5905182|NCT01641926|20430069|P2|Overall Study|Adverse Event|2
5905183|NCT01641926|20430070|P1|Overall Study|Adverse Event|5
5905184|NCT01641900|20430098|P2|Overall Study|Withdrawal by Subject|2
5905185|NCT01641900|20430099|P1|Overall Study|Withdrawal by Subject|2
5905186|NCT01641861|20430111|P2|Overall Study|Died due to drowning|1
5905187|NCT01641861|20430112|P1|Overall Study|Died due to drowning|0
5905188|NCT01641861|20430111|P2|Overall Study|Lost the tooth due to normal exfoliation|8
5905189|NCT01641861|20430112|P1|Overall Study|Lost the tooth due to normal exfoliation|14
5905190|NCT01641861|20430111|P2|Overall Study|Lost to Follow-up|16
5905191|NCT01641861|20430112|P1|Overall Study|Lost to Follow-up|21
5905192|NCT01641822|20430133|P3|Comparative Phase|Protocol-specified criteria for withdraw|1
5905193|NCT01641822|20430134|P2|Comparative Phase|Protocol-specified criteria for withdraw|1
5905194|NCT01641822|20430135|P1|Comparative Phase|Protocol-specified criteria for withdraw|0
5905195|NCT01641822|20430133|P3|Comparative Phase|Withdrew consent|7
5905196|NCT01641822|20430134|P2|Comparative Phase|Withdrew consent|3
5905197|NCT01641822|20430135|P1|Comparative Phase|Withdrew consent|0
5905198|NCT01641822|20430133|P3|Comparative Phase|Adverse event, serious fatal|0
5905199|NCT01641822|20430134|P2|Comparative Phase|Adverse event, serious fatal|1
5905200|NCT01641822|20430135|P1|Comparative Phase|Adverse event, serious fatal|0
5905201|NCT01641822|20430133|P3|Comparative Phase|Pregnancy|1
5905202|NCT01641822|20430134|P2|Comparative Phase|Pregnancy|0
5905203|NCT01641822|20430135|P1|Comparative Phase|Pregnancy|0
5905204|NCT01641822|20430133|P3|Comparative Phase|Investigator's discretion|1
5905205|NCT01641822|20430134|P2|Comparative Phase|Investigator's discretion|0
5905206|NCT01641822|20430135|P1|Comparative Phase|Investigator's discretion|0
5905207|NCT01641822|20430133|P3|Comparative Phase|Noncompliance with study drug|0
5905208|NCT01641822|20430134|P2|Comparative Phase|Noncompliance with study drug|1
5905209|NCT01641822|20430135|P1|Comparative Phase|Noncompliance with study drug|0
5905210|NCT01641822|20430133|P3|Run-in Phase|Protocol-specified criteria for withdraw|0
5905211|NCT01641822|20430134|P2|Run-in Phase|Protocol-specified criteria for withdraw|0
5905212|NCT01641822|20430135|P1|Run-in Phase|Protocol-specified criteria for withdraw|9
5905213|NCT01641822|20430133|P3|Run-in Phase|Withdrew consent|0
5905214|NCT01641822|20430134|P2|Run-in Phase|Withdrew consent|0
5905215|NCT01641822|20430135|P1|Run-in Phase|Withdrew consent|1
5905216|NCT01641822|20430133|P3|Run-in Phase|Adverse Event|0
5905217|NCT01641822|20430134|P2|Run-in Phase|Adverse Event|0
5905218|NCT01641822|20430135|P1|Run-in Phase|Adverse Event|3
5905219|NCT01641822|20430133|P3|Run-in Phase|Noncompliance with study drug|0
5905220|NCT01641822|20430134|P2|Run-in Phase|Noncompliance with study drug|0
5905221|NCT01641822|20430135|P1|Run-in Phase|Noncompliance with study drug|1
5905222|NCT01641809|20430156|P4|Open-label (Week 96 to Week 324)|Adverse Event|0
5905223|NCT01641809|20430157|P3|Open-label (Week 96 to Week 324)|Adverse Event|1
5905224|NCT01641809|20430158|P2|Open-label (Week 96 to Week 324)|Adverse Event|2
5905225|NCT01641809|20430159|P1|Open-label (Week 96 to Week 324)|Adverse Event|3
5905226|NCT01641809|20430156|P4|Open-label (Week 96 to Week 324)|Lack of Efficacy|0
5905227|NCT01641809|20430157|P3|Open-label (Week 96 to Week 324)|Lack of Efficacy|0
5905228|NCT01641809|20430158|P2|Open-label (Week 96 to Week 324)|Lack of Efficacy|1
5905229|NCT01641809|20430159|P1|Open-label (Week 96 to Week 324)|Lack of Efficacy|4
5905230|NCT01641809|20430156|P4|Open-label (Week 96 to Week 324)|Protocol Violation|0
5905231|NCT01641809|20430157|P3|Open-label (Week 96 to Week 324)|Protocol Violation|0
5905232|NCT01641809|20430158|P2|Open-label (Week 96 to Week 324)|Protocol Violation|1
5905233|NCT01641809|20430159|P1|Open-label (Week 96 to Week 324)|Protocol Violation|1
5905234|NCT01641809|20430156|P4|Open-label (Week 96 to Week 324)|Site closed|0
5905235|NCT01641809|20430157|P3|Open-label (Week 96 to Week 324)|Site closed|0
5905236|NCT01641809|20430158|P2|Open-label (Week 96 to Week 324)|Site closed|0
5905237|NCT01641809|20430159|P1|Open-label (Week 96 to Week 324)|Site closed|1
5905238|NCT01641809|20430156|P4|Open-label (Week 96 to Week 324)|Lost to Follow-up|0
5905239|NCT01641809|20430157|P3|Open-label (Week 96 to Week 324)|Lost to Follow-up|5
5905240|NCT01641809|20430158|P2|Open-label (Week 96 to Week 324)|Lost to Follow-up|4
5905241|NCT01641809|20430159|P1|Open-label (Week 96 to Week 324)|Lost to Follow-up|5
5905242|NCT01641809|20430156|P4|Open-label (Week 96 to Week 324)|Physician Decision|0
5905243|NCT01641809|20430157|P3|Open-label (Week 96 to Week 324)|Physician Decision|1
5905244|NCT01641809|20430158|P2|Open-label (Week 96 to Week 324)|Physician Decision|1
5905245|NCT01641809|20430159|P1|Open-label (Week 96 to Week 324)|Physician Decision|0
5905246|NCT01641809|20430156|P4|Open-label (Week 96 to Week 324)|Withdrawal by Subject|0
5905247|NCT01641809|20430157|P3|Open-label (Week 96 to Week 324)|Withdrawal by Subject|1
5905248|NCT01641809|20430158|P2|Open-label (Week 96 to Week 324)|Withdrawal by Subject|3
5905249|NCT01641809|20430159|P1|Open-label (Week 96 to Week 324)|Withdrawal by Subject|2
5905250|NCT01641809|20430156|P4|Maintenance Phase (Week 24 to Week 96)|Adverse Event|2
5905251|NCT01641809|20430157|P3|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1
5905252|NCT01641809|20430158|P2|Maintenance Phase (Week 24 to Week 96)|Adverse Event|0
5905253|NCT01641809|20430159|P1|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1
5905254|NCT01641809|20430156|P4|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|2
5905255|NCT01641809|20430157|P3|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|0
5905256|NCT01641809|20430158|P2|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1
5905257|NCT01641809|20430159|P1|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1
5905258|NCT01641809|20430156|P4|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2
5905259|NCT01641809|20430157|P3|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|1
5905260|NCT01641809|20430158|P2|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|0
5905261|NCT01641809|20430159|P1|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2
5905262|NCT01641809|20430156|P4|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0
5905263|NCT01641809|20430157|P3|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0
5905264|NCT01641809|20430158|P2|Maintenance Phase (Week 24 to Week 96)|Physician Decision|1
5905265|NCT01641809|20430159|P1|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0
5905266|NCT01641809|20430156|P4|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|0
5905267|NCT01641809|20430157|P3|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|1
5905268|NCT01641809|20430158|P2|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|3
5905269|NCT01641809|20430159|P1|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|2
5905270|NCT01641809|20430156|P4|Induction Phase (Day 1 to Week 24)|Adverse Event|7
5905271|NCT01641809|20430157|P3|Induction Phase (Day 1 to Week 24)|Adverse Event|3
5905272|NCT01641809|20430158|P2|Induction Phase (Day 1 to Week 24)|Adverse Event|1
5905273|NCT01641809|20430159|P1|Induction Phase (Day 1 to Week 24)|Adverse Event|0
5905274|NCT01641809|20430156|P4|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|3
5905275|NCT01641809|20430157|P3|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|2
5905276|NCT01641809|20430158|P2|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|1
5905277|NCT01641809|20430159|P1|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|4
5905278|NCT01641809|20430156|P4|Induction Phase (Day 1 to Week 24)|Protocol Violation|0
5905279|NCT01641809|20430157|P3|Induction Phase (Day 1 to Week 24)|Protocol Violation|1
5905280|NCT01641809|20430158|P2|Induction Phase (Day 1 to Week 24)|Protocol Violation|1
5905281|NCT01641809|20430159|P1|Induction Phase (Day 1 to Week 24)|Protocol Violation|2
5905282|NCT01641809|20430156|P4|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|3
5905283|NCT01641809|20430157|P3|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|0
5905284|NCT01641809|20430158|P2|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|2
5905285|NCT01641809|20430159|P1|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|1
5905286|NCT01641809|20430156|P4|Induction Phase (Day 1 to Week 24)|Physician Decision|1
5905287|NCT01641809|20430157|P3|Induction Phase (Day 1 to Week 24)|Physician Decision|0
5905288|NCT01641809|20430158|P2|Induction Phase (Day 1 to Week 24)|Physician Decision|1
5905289|NCT01641809|20430159|P1|Induction Phase (Day 1 to Week 24)|Physician Decision|0
5905290|NCT01641809|20430156|P4|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1
5905291|NCT01641809|20430157|P3|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|0
5905292|NCT01641809|20430158|P2|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1
5905293|NCT01641809|20430159|P1|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1
5905294|NCT01641692|20430343|P8|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0
5905295|NCT01641692|20430344|P7|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1
5905296|NCT01641692|20430345|P6|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1
5905297|NCT01641692|20430346|P5|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0
5905298|NCT01641692|20430347|P4|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1
5905299|NCT01641692|20430348|P3|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1
5905300|NCT01641692|20430349|P2|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0
5905301|NCT01641692|20430350|P1|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1
5905302|NCT01641692|20430343|P8|Washout Period 3 or Follow-up|Protocol Violation|0
5905303|NCT01641692|20430344|P7|Washout Period 3 or Follow-up|Protocol Violation|0
5905304|NCT01641692|20430345|P6|Washout Period 3 or Follow-up|Protocol Violation|1
5905305|NCT01641692|20430346|P5|Washout Period 3 or Follow-up|Protocol Violation|0
5905306|NCT01641692|20430347|P4|Washout Period 3 or Follow-up|Protocol Violation|0
5905307|NCT01641692|20430348|P3|Washout Period 3 or Follow-up|Protocol Violation|0
5905308|NCT01641692|20430349|P2|Washout Period 3 or Follow-up|Protocol Violation|0
5905309|NCT01641692|20430350|P1|Washout Period 3 or Follow-up|Protocol Violation|0
5905310|NCT01641692|20430343|P8|Treatment Period 3|Lost to Follow-up|0
5905311|NCT01641692|20430344|P7|Treatment Period 3|Lost to Follow-up|0
5905312|NCT01641692|20430345|P6|Treatment Period 3|Lost to Follow-up|0
5905313|NCT01641692|20430346|P5|Treatment Period 3|Lost to Follow-up|0
5905314|NCT01641692|20430347|P4|Treatment Period 3|Lost to Follow-up|0
5905315|NCT01641692|20430348|P3|Treatment Period 3|Lost to Follow-up|0
5905316|NCT01641692|20430349|P2|Treatment Period 3|Lost to Follow-up|1
5905317|NCT01641692|20430350|P1|Treatment Period 3|Lost to Follow-up|0
5905318|NCT01641692|20430343|P8|Treatment Period 3|Protocol-defined Stopping Criteria|0
5905319|NCT01641692|20430344|P7|Treatment Period 3|Protocol-defined Stopping Criteria|1
5905320|NCT01641692|20430345|P6|Treatment Period 3|Protocol-defined Stopping Criteria|0
5905321|NCT01641692|20430346|P5|Treatment Period 3|Protocol-defined Stopping Criteria|0
5905322|NCT01641692|20430347|P4|Treatment Period 3|Protocol-defined Stopping Criteria|0
5905323|NCT01641692|20430348|P3|Treatment Period 3|Protocol-defined Stopping Criteria|0
5905324|NCT01641692|20430349|P2|Treatment Period 3|Protocol-defined Stopping Criteria|0
5905325|NCT01641692|20430350|P1|Treatment Period 3|Protocol-defined Stopping Criteria|0
5905326|NCT01641692|20430343|P8|Treatment Period 3|Protocol Violation|0
5905327|NCT01641692|20430344|P7|Treatment Period 3|Protocol Violation|0
5905328|NCT01641692|20430345|P6|Treatment Period 3|Protocol Violation|0
5905329|NCT01641692|20430346|P5|Treatment Period 3|Protocol Violation|0
5905330|NCT01641692|20430347|P4|Treatment Period 3|Protocol Violation|0
5905331|NCT01641692|20430348|P3|Treatment Period 3|Protocol Violation|1
5905332|NCT01641692|20430349|P2|Treatment Period 3|Protocol Violation|0
5905333|NCT01641692|20430350|P1|Treatment Period 3|Protocol Violation|0
5905334|NCT01641692|20430343|P8|Treatment Period 3|Adverse Event|0
5905335|NCT01641692|20430344|P7|Treatment Period 3|Adverse Event|1
5905336|NCT01641692|20430345|P6|Treatment Period 3|Adverse Event|0
5905337|NCT01641692|20430346|P5|Treatment Period 3|Adverse Event|0
5905338|NCT01641692|20430347|P4|Treatment Period 3|Adverse Event|0
5905339|NCT01641692|20430348|P3|Treatment Period 3|Adverse Event|0
5905340|NCT01641692|20430349|P2|Treatment Period 3|Adverse Event|0
5905341|NCT01641692|20430350|P1|Treatment Period 3|Adverse Event|0
5905342|NCT01641692|20430343|P8|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1
5905343|NCT01641692|20430344|P7|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
5905344|NCT01641692|20430345|P6|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1
5905345|NCT01641692|20430346|P5|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
5905346|NCT01641692|20430347|P4|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
5905347|NCT01641692|20430348|P3|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1
5905348|NCT01641692|20430349|P2|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
5905349|NCT01641692|20430350|P1|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
5905350|NCT01641692|20430343|P8|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
5905351|NCT01641692|20430344|P7|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|1
5905352|NCT01641692|20430345|P6|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
5905353|NCT01641692|20430346|P5|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|3
5905354|NCT01641692|20430347|P4|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
5905355|NCT01641692|20430348|P3|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
5905356|NCT01641692|20430349|P2|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
5905357|NCT01641692|20430350|P1|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
5905358|NCT01641692|20430343|P8|Treatment Period 2|Withdrawal by Subject|1
5905359|NCT01641692|20430344|P7|Treatment Period 2|Withdrawal by Subject|0
5905360|NCT01641692|20430345|P6|Treatment Period 2|Withdrawal by Subject|1
5905361|NCT01641692|20430346|P5|Treatment Period 2|Withdrawal by Subject|0
5905362|NCT01641692|20430347|P4|Treatment Period 2|Withdrawal by Subject|0
5905363|NCT01641692|20430348|P3|Treatment Period 2|Withdrawal by Subject|0
5905364|NCT01641692|20430349|P2|Treatment Period 2|Withdrawal by Subject|0
5905365|NCT01641692|20430350|P1|Treatment Period 2|Withdrawal by Subject|1
5905366|NCT01641692|20430343|P8|Treatment Period 2|Lost to Follow-up|0
5905367|NCT01641692|20430344|P7|Treatment Period 2|Lost to Follow-up|0
5905368|NCT01641692|20430345|P6|Treatment Period 2|Lost to Follow-up|1
5905369|NCT01641692|20430346|P5|Treatment Period 2|Lost to Follow-up|0
5905370|NCT01641692|20430347|P4|Treatment Period 2|Lost to Follow-up|0
5905371|NCT01641692|20430348|P3|Treatment Period 2|Lost to Follow-up|0
5905372|NCT01641692|20430349|P2|Treatment Period 2|Lost to Follow-up|0
5905373|NCT01641692|20430350|P1|Treatment Period 2|Lost to Follow-up|0
5905374|NCT01641692|20430343|P8|Treatment Period 2|Protocol-defined Stopping Criteria|0
5905375|NCT01641692|20430344|P7|Treatment Period 2|Protocol-defined Stopping Criteria|0
5905376|NCT01641692|20430345|P6|Treatment Period 2|Protocol-defined Stopping Criteria|0
5905377|NCT01641692|20430346|P5|Treatment Period 2|Protocol-defined Stopping Criteria|0
5905378|NCT01641692|20430347|P4|Treatment Period 2|Protocol-defined Stopping Criteria|0
5905379|NCT01641692|20430348|P3|Treatment Period 2|Protocol-defined Stopping Criteria|0
5905380|NCT01641692|20430349|P2|Treatment Period 2|Protocol-defined Stopping Criteria|0
5905381|NCT01641692|20430350|P1|Treatment Period 2|Protocol-defined Stopping Criteria|1
5905382|NCT01641692|20430343|P8|Treatment Period 2|Lack of Efficacy|0
5905383|NCT01641692|20430344|P7|Treatment Period 2|Lack of Efficacy|0
5905384|NCT01641692|20430345|P6|Treatment Period 2|Lack of Efficacy|0
5905385|NCT01641692|20430346|P5|Treatment Period 2|Lack of Efficacy|0
5905386|NCT01641692|20430347|P4|Treatment Period 2|Lack of Efficacy|0
5905387|NCT01641692|20430348|P3|Treatment Period 2|Lack of Efficacy|0
5905388|NCT01641692|20430349|P2|Treatment Period 2|Lack of Efficacy|0
5905389|NCT01641692|20430350|P1|Treatment Period 2|Lack of Efficacy|1
5905390|NCT01641692|20430343|P8|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
5905391|NCT01641692|20430344|P7|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
5905392|NCT01641692|20430345|P6|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
5905393|NCT01641692|20430346|P5|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
5905394|NCT01641692|20430347|P4|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
5905395|NCT01641692|20430348|P3|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
5905396|NCT01641692|20430349|P2|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
5905397|NCT01641692|20430350|P1|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
5905398|NCT01641692|20430343|P8|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1
5905399|NCT01641692|20430344|P7|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0
5905400|NCT01641692|20430345|P6|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0
5905401|NCT01641692|20430346|P5|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3
5905402|NCT01641692|20430347|P4|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1
5905403|NCT01641692|20430348|P3|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3
5905404|NCT01641692|20430349|P2|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0
5905405|NCT01641692|20430350|P1|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1
5905406|NCT01641692|20430343|P8|Washout Period 1 (12-14 Days)|Protocol Violation|0
5905407|NCT01641692|20430344|P7|Washout Period 1 (12-14 Days)|Protocol Violation|1
5905408|NCT01641692|20430345|P6|Washout Period 1 (12-14 Days)|Protocol Violation|0
5905409|NCT01641692|20430346|P5|Washout Period 1 (12-14 Days)|Protocol Violation|0
5905410|NCT01641692|20430347|P4|Washout Period 1 (12-14 Days)|Protocol Violation|0
5905411|NCT01641692|20430348|P3|Washout Period 1 (12-14 Days)|Protocol Violation|0
5905412|NCT01641692|20430349|P2|Washout Period 1 (12-14 Days)|Protocol Violation|0
5905413|NCT01641692|20430350|P1|Washout Period 1 (12-14 Days)|Protocol Violation|0
5905414|NCT01641692|20430343|P8|Washout Period 1 (12-14 Days)|Adverse Event|0
5905415|NCT01641692|20430344|P7|Washout Period 1 (12-14 Days)|Adverse Event|0
5905416|NCT01641692|20430345|P6|Washout Period 1 (12-14 Days)|Adverse Event|0
5905417|NCT01641692|20430346|P5|Washout Period 1 (12-14 Days)|Adverse Event|0
5905418|NCT01641692|20430347|P4|Washout Period 1 (12-14 Days)|Adverse Event|0
5905419|NCT01641692|20430348|P3|Washout Period 1 (12-14 Days)|Adverse Event|0
5905420|NCT01641692|20430349|P2|Washout Period 1 (12-14 Days)|Adverse Event|0
5905421|NCT01641692|20430350|P1|Washout Period 1 (12-14 Days)|Adverse Event|2
5905422|NCT01641692|20430343|P8|Treatment Period 1|Withdrawal by Subject|1
5905423|NCT01641692|20430344|P7|Treatment Period 1|Withdrawal by Subject|0
5905424|NCT01641692|20430345|P6|Treatment Period 1|Withdrawal by Subject|2
5905425|NCT01641692|20430346|P5|Treatment Period 1|Withdrawal by Subject|0
5905426|NCT01641692|20430347|P4|Treatment Period 1|Withdrawal by Subject|0
5905427|NCT01641692|20430348|P3|Treatment Period 1|Withdrawal by Subject|0
5905428|NCT01641692|20430349|P2|Treatment Period 1|Withdrawal by Subject|0
5905429|NCT01641692|20430350|P1|Treatment Period 1|Withdrawal by Subject|0
5905430|NCT01641692|20430343|P8|Treatment Period 1|Physician Decision|0
5905431|NCT01641692|20430344|P7|Treatment Period 1|Physician Decision|0
5905432|NCT01641692|20430345|P6|Treatment Period 1|Physician Decision|0
5905433|NCT01641692|20430346|P5|Treatment Period 1|Physician Decision|1
5905434|NCT01641692|20430347|P4|Treatment Period 1|Physician Decision|0
5905435|NCT01641692|20430348|P3|Treatment Period 1|Physician Decision|0
5905436|NCT01641692|20430349|P2|Treatment Period 1|Physician Decision|0
5905437|NCT01641692|20430350|P1|Treatment Period 1|Physician Decision|0
5905438|NCT01641692|20430343|P8|Treatment Period 1|Lost to Follow-up|0
5905439|NCT01641692|20430344|P7|Treatment Period 1|Lost to Follow-up|0
5905440|NCT01641692|20430345|P6|Treatment Period 1|Lost to Follow-up|0
5905441|NCT01641692|20430346|P5|Treatment Period 1|Lost to Follow-up|0
5905442|NCT01641692|20430347|P4|Treatment Period 1|Lost to Follow-up|0
5905443|NCT01641692|20430348|P3|Treatment Period 1|Lost to Follow-up|1
5905444|NCT01641692|20430349|P2|Treatment Period 1|Lost to Follow-up|0
5905445|NCT01641692|20430350|P1|Treatment Period 1|Lost to Follow-up|0
5905446|NCT01641692|20430343|P8|Treatment Period 1|Protocol-defined Stopping Criteria|1
5905447|NCT01641692|20430344|P7|Treatment Period 1|Protocol-defined Stopping Criteria|0
5905448|NCT01641692|20430345|P6|Treatment Period 1|Protocol-defined Stopping Criteria|0
5905449|NCT01641692|20430346|P5|Treatment Period 1|Protocol-defined Stopping Criteria|1
5905450|NCT01641692|20430347|P4|Treatment Period 1|Protocol-defined Stopping Criteria|0
5905451|NCT01641692|20430348|P3|Treatment Period 1|Protocol-defined Stopping Criteria|0
5905452|NCT01641692|20430349|P2|Treatment Period 1|Protocol-defined Stopping Criteria|0
5905453|NCT01641692|20430350|P1|Treatment Period 1|Protocol-defined Stopping Criteria|0
5905454|NCT01641692|20430343|P8|Treatment Period 1|Protocol Violation|0
5905455|NCT01641692|20430344|P7|Treatment Period 1|Protocol Violation|0
5905456|NCT01641692|20430345|P6|Treatment Period 1|Protocol Violation|0
5905457|NCT01641692|20430346|P5|Treatment Period 1|Protocol Violation|2
5905458|NCT01641692|20430347|P4|Treatment Period 1|Protocol Violation|0
5905459|NCT01641692|20430348|P3|Treatment Period 1|Protocol Violation|0
5905460|NCT01641692|20430349|P2|Treatment Period 1|Protocol Violation|0
5905461|NCT01641692|20430350|P1|Treatment Period 1|Protocol Violation|1
5905462|NCT01641692|20430343|P8|Treatment Period 1|Lack of Efficacy|1
5905463|NCT01641692|20430344|P7|Treatment Period 1|Lack of Efficacy|0
5905464|NCT01641692|20430345|P6|Treatment Period 1|Lack of Efficacy|0
5905465|NCT01641692|20430346|P5|Treatment Period 1|Lack of Efficacy|0
5905466|NCT01641692|20430347|P4|Treatment Period 1|Lack of Efficacy|0
5905467|NCT01641692|20430348|P3|Treatment Period 1|Lack of Efficacy|0
5905468|NCT01641692|20430349|P2|Treatment Period 1|Lack of Efficacy|0
5905469|NCT01641692|20430350|P1|Treatment Period 1|Lack of Efficacy|0
5905470|NCT01641692|20430343|P8|Treatment Period 1|Adverse Event|0
5905471|NCT01641692|20430344|P7|Treatment Period 1|Adverse Event|0
5905472|NCT01641692|20430345|P6|Treatment Period 1|Adverse Event|0
5905473|NCT01641692|20430346|P5|Treatment Period 1|Adverse Event|0
5905474|NCT01641692|20430347|P4|Treatment Period 1|Adverse Event|0
5905475|NCT01641692|20430348|P3|Treatment Period 1|Adverse Event|0
5905476|NCT01641692|20430349|P2|Treatment Period 1|Adverse Event|0
5905477|NCT01641692|20430350|P1|Treatment Period 1|Adverse Event|1
5905478|NCT01641640|20430550|P1|Overall Study|Adverse Event|1
5905479|NCT01641640|20430550|P1|Overall Study|Withdrawal by Subject|2
5905480|NCT01641640|20430550|P1|Overall Study|Lost to Follow-up|3
5905481|NCT01641640|20430550|P1|Overall Study|Efficacy failure|29
5905482|NCT01641640|20430550|P1|Overall Study|Enrolled but not treated|1
5905483|NCT01641601|20430561|P2|Overall Study|Study discontinued.|5
5905484|NCT01641601|20430562|P1|Overall Study|Study discontinued.|3
5905485|NCT01641471|20430572|P2|Overall Study|Protocol Violation|4
5905486|NCT01641471|20430573|P1|Overall Study|Protocol Violation|2
5905487|NCT01641471|20430572|P2|Overall Study|Lost to Follow-up|4
5905488|NCT01641471|20430573|P1|Overall Study|Lost to Follow-up|2
5905489|NCT01641471|20430572|P2|Overall Study|Withdrawal by Subject|19
5905490|NCT01641471|20430573|P1|Overall Study|Withdrawal by Subject|19
5905491|NCT01641367|20430620|P8|Randomized Adherence Intervention|Lost to Follow-up|12
5905492|NCT01641367|20430621|P7|Randomized Adherence Intervention|Lost to Follow-up|8
5905493|NCT01641367|20430622|P6|Randomized Adherence Intervention|Lost to Follow-up|0
5905494|NCT01641367|20430623|P5|Randomized Adherence Intervention|Lost to Follow-up|0
5905495|NCT01641367|20430624|P4|Randomized Adherence Intervention|Lost to Follow-up|0
5905496|NCT01641367|20430625|P3|Randomized Adherence Intervention|Lost to Follow-up|0
5905497|NCT01641367|20430626|P2|Randomized Adherence Intervention|Lost to Follow-up|0
5905498|NCT01641367|20430627|P1|Randomized Adherence Intervention|Lost to Follow-up|0
5905499|NCT01641367|20430620|P8|Randomized Adherence Intervention|Death|12
5905500|NCT01641367|20430621|P7|Randomized Adherence Intervention|Death|11
5905501|NCT01641367|20430622|P6|Randomized Adherence Intervention|Death|0
5905502|NCT01641367|20430623|P5|Randomized Adherence Intervention|Death|0
5905503|NCT01641367|20430624|P4|Randomized Adherence Intervention|Death|0
5905504|NCT01641367|20430625|P3|Randomized Adherence Intervention|Death|0
5905505|NCT01641367|20430626|P2|Randomized Adherence Intervention|Death|0
5905506|NCT01641367|20430627|P1|Randomized Adherence Intervention|Death|0
5905507|NCT01641367|20430620|P8|Cohorts|Lost to Follow-up|0
5905508|NCT01641367|20430621|P7|Cohorts|Lost to Follow-up|0
5905509|NCT01641367|20430622|P6|Cohorts|Lost to Follow-up|0
5905510|NCT01641367|20430623|P5|Cohorts|Lost to Follow-up|2
5905511|NCT01641367|20430624|P4|Cohorts|Lost to Follow-up|0
5905512|NCT01641367|20430625|P3|Cohorts|Lost to Follow-up|2
5905513|NCT01641367|20430626|P2|Cohorts|Lost to Follow-up|0
5905514|NCT01641367|20430627|P1|Cohorts|Lost to Follow-up|16
5905515|NCT01641367|20430620|P8|Cohorts|Death|0
5905516|NCT01641367|20430621|P7|Cohorts|Death|0
5905517|NCT01641367|20430622|P6|Cohorts|Death|1
5905518|NCT01641367|20430623|P5|Cohorts|Death|1
5905519|NCT01641367|20430624|P4|Cohorts|Death|0
5905520|NCT01641367|20430625|P3|Cohorts|Death|2
5905521|NCT01641367|20430626|P2|Cohorts|Death|1
5905522|NCT01641367|20430627|P1|Cohorts|Death|18
5905523|NCT01641237|20430878|P4|Period III|Lost to Follow-up|0
5905524|NCT01641237|20430879|P3|Period III|Lost to Follow-up|0
5905525|NCT01641237|20430880|P2|Period III|Lost to Follow-up|0
5905526|NCT01641237|20430881|P1|Period III|Lost to Follow-up|1
5905527|NCT01641237|20430878|P4|Period II|Withdrawal by Subject|0
5905528|NCT01641237|20430879|P3|Period II|Withdrawal by Subject|0
5905529|NCT01641237|20430880|P2|Period II|Withdrawal by Subject|0
5905530|NCT01641237|20430881|P1|Period II|Withdrawal by Subject|1
5905531|NCT01641198|20430906|P3|At 15-20 Years of Function|Death|1
5905532|NCT01641198|20430907|P2|At 15-20 Years of Function|Death|0
5905533|NCT01641198|20430908|P1|At 15-20 Years of Function|Death|1
5905534|NCT01641198|20430906|P3|At 15-20 Years of Function|Lost to Follow-up|1
5905535|NCT01641198|20430907|P2|At 15-20 Years of Function|Lost to Follow-up|1
5905536|NCT01641198|20430908|P1|At 15-20 Years of Function|Lost to Follow-up|5
5905537|NCT01641198|20430906|P3|After 24 Months of Function|Lost to Follow-up|6
5905538|NCT01641198|20430907|P2|After 24 Months of Function|Lost to Follow-up|9
5905539|NCT01641198|20430908|P1|After 24 Months of Function|Lost to Follow-up|4
5905540|NCT01641198|20430906|P3|After 12 Months of Function|Adverse Event|0
5905541|NCT01641198|20430907|P2|After 12 Months of Function|Adverse Event|1
5905542|NCT01641198|20430908|P1|After 12 Months of Function|Adverse Event|0
5905543|NCT01641198|20430906|P3|After 12 Months of Function|Protocol Violation|0
5905544|NCT01641198|20430907|P2|After 12 Months of Function|Protocol Violation|0
5905545|NCT01641198|20430908|P1|After 12 Months of Function|Protocol Violation|1
5905546|NCT01641198|20430906|P3|After 12 Months of Function|Lost to Follow-up|2
5905547|NCT01641198|20430907|P2|After 12 Months of Function|Lost to Follow-up|2
5905548|NCT01641198|20430908|P1|After 12 Months of Function|Lost to Follow-up|3
5905549|NCT01641159|20430924|P2|Overall Study|Withdrawal by Subject|1
5905550|NCT01641159|20430925|P1|Overall Study|Withdrawal by Subject|0
5905551|NCT01641159|20430924|P2|Overall Study|Lost to Follow-up|1
5905552|NCT01641159|20430925|P1|Overall Study|Lost to Follow-up|2
5905553|NCT01641133|20430936|P3|Overall Study|Lost to Follow-up|2
5905554|NCT01641133|20430937|P2|Overall Study|Lost to Follow-up|2
5905555|NCT01641133|20430938|P1|Overall Study|Lost to Follow-up|0
5905556|NCT01641133|20430936|P3|Overall Study|Withdrawal by Subject|3
5905557|NCT01641133|20430937|P2|Overall Study|Withdrawal by Subject|3
5905558|NCT01641133|20430938|P1|Overall Study|Withdrawal by Subject|5
5905559|NCT01641133|20430936|P3|Overall Study|Adverse Event|1
5905560|NCT01641133|20430937|P2|Overall Study|Adverse Event|0
5905561|NCT01641133|20430938|P1|Overall Study|Adverse Event|0
5905562|NCT01641133|20430936|P3|Overall Study|Migrated/moved from study area|1
5905563|NCT01641133|20430937|P2|Overall Study|Migrated/moved from study area|3
5905564|NCT01641133|20430938|P1|Overall Study|Migrated/moved from study area|5
5905565|NCT01641133|20430936|P3|Overall Study|Protocol Violation|1
5905566|NCT01641133|20430937|P2|Overall Study|Protocol Violation|1
5905567|NCT01641133|20430938|P1|Overall Study|Protocol Violation|0
5905568|NCT01641081|20430991|P10|Period 5|Adverse Event|0
5905569|NCT01641081|20430992|P9|Period 5|Adverse Event|0
5905570|NCT01641081|20430993|P8|Period 5|Adverse Event|0
5905571|NCT01641081|20430994|P7|Period 5|Adverse Event|0
5905572|NCT01641081|20430995|P6|Period 5|Adverse Event|0
5905573|NCT01641081|20430996|P5|Period 5|Adverse Event|0
5905574|NCT01641081|20430997|P4|Period 5|Adverse Event|0
5905575|NCT01641081|20430998|P3|Period 5|Adverse Event|2
5905576|NCT01641081|20430999|P2|Period 5|Adverse Event|0
5905577|NCT01641081|20431000|P1|Period 5|Adverse Event|0
5905578|NCT01641081|20430991|P10|Period 4|Adverse Event|0
5905579|NCT01641081|20430992|P9|Period 4|Adverse Event|0
5905580|NCT01641081|20430993|P8|Period 4|Adverse Event|0
5905581|NCT01641081|20430994|P7|Period 4|Adverse Event|0
5905582|NCT01641081|20430995|P6|Period 4|Adverse Event|0
5905583|NCT01641081|20430996|P5|Period 4|Adverse Event|0
5905584|NCT01641081|20430997|P4|Period 4|Adverse Event|1
5905585|NCT01641081|20430998|P3|Period 4|Adverse Event|0
5905586|NCT01641081|20430999|P2|Period 4|Adverse Event|1
5905587|NCT01641081|20431000|P1|Period 4|Adverse Event|0
5905588|NCT01641081|20430991|P10|Period 3|Withdrawal by Subject|0
5905589|NCT01641081|20430992|P9|Period 3|Withdrawal by Subject|1
5905590|NCT01641081|20430993|P8|Period 3|Withdrawal by Subject|0
5905591|NCT01641081|20430994|P7|Period 3|Withdrawal by Subject|0
5905592|NCT01641081|20430995|P6|Period 3|Withdrawal by Subject|0
5905593|NCT01641081|20430996|P5|Period 3|Withdrawal by Subject|0
5905594|NCT01641081|20430997|P4|Period 3|Withdrawal by Subject|0
5905595|NCT01641081|20430998|P3|Period 3|Withdrawal by Subject|0
5905596|NCT01641081|20430999|P2|Period 3|Withdrawal by Subject|0
5905597|NCT01641081|20431000|P1|Period 3|Withdrawal by Subject|0
5905598|NCT01641081|20430991|P10|Period 3|Adverse Event|0
5905599|NCT01641081|20430992|P9|Period 3|Adverse Event|0
5905600|NCT01641081|20430993|P8|Period 3|Adverse Event|0
5905601|NCT01641081|20430994|P7|Period 3|Adverse Event|0
5905602|NCT01641081|20430995|P6|Period 3|Adverse Event|0
5905603|NCT01641081|20430996|P5|Period 3|Adverse Event|0
5905604|NCT01641081|20430997|P4|Period 3|Adverse Event|0
5905605|NCT01641081|20430998|P3|Period 3|Adverse Event|1
5905606|NCT01641081|20430999|P2|Period 3|Adverse Event|0
5905607|NCT01641081|20431000|P1|Period 3|Adverse Event|0
5905608|NCT01641081|20430991|P10|Period 2|Protocol Violation|0
5905609|NCT01641081|20430992|P9|Period 2|Protocol Violation|0
5905610|NCT01641081|20430993|P8|Period 2|Protocol Violation|0
5905611|NCT01641081|20430994|P7|Period 2|Protocol Violation|0
5905612|NCT01641081|20430995|P6|Period 2|Protocol Violation|0
5905613|NCT01641081|20430996|P5|Period 2|Protocol Violation|0
5905614|NCT01641081|20430997|P4|Period 2|Protocol Violation|0
5905615|NCT01641081|20430998|P3|Period 2|Protocol Violation|0
5905616|NCT01641081|20430999|P2|Period 2|Protocol Violation|0
5905617|NCT01641081|20431000|P1|Period 2|Protocol Violation|1
5905618|NCT01641081|20430991|P10|Period 2|Withdrawal by Subject|0
5905619|NCT01641081|20430992|P9|Period 2|Withdrawal by Subject|0
5905620|NCT01641081|20430993|P8|Period 2|Withdrawal by Subject|0
5905621|NCT01641081|20430994|P7|Period 2|Withdrawal by Subject|2
5905622|NCT01641081|20430995|P6|Period 2|Withdrawal by Subject|0
5905623|NCT01641081|20430996|P5|Period 2|Withdrawal by Subject|0
5905624|NCT01641081|20430997|P4|Period 2|Withdrawal by Subject|1
5905625|NCT01641081|20430998|P3|Period 2|Withdrawal by Subject|0
5905626|NCT01641081|20430999|P2|Period 2|Withdrawal by Subject|0
5905627|NCT01641081|20431000|P1|Period 2|Withdrawal by Subject|0
5905628|NCT01641081|20430991|P10|Period 2|Adverse Event|0
5905629|NCT01641081|20430992|P9|Period 2|Adverse Event|0
5905630|NCT01641081|20430993|P8|Period 2|Adverse Event|0
5905631|NCT01641081|20430994|P7|Period 2|Adverse Event|0
5905632|NCT01641081|20430995|P6|Period 2|Adverse Event|1
5905633|NCT01641081|20430996|P5|Period 2|Adverse Event|0
5905634|NCT01641081|20430997|P4|Period 2|Adverse Event|0
5905635|NCT01641081|20430998|P3|Period 2|Adverse Event|0
5905636|NCT01641081|20430999|P2|Period 2|Adverse Event|0
5905637|NCT01641081|20431000|P1|Period 2|Adverse Event|0
5905638|NCT01641081|20430991|P10|Period 1|Adverse Event|0
5905639|NCT01641081|20430992|P9|Period 1|Adverse Event|0
5905640|NCT01641081|20430993|P8|Period 1|Adverse Event|2
5905641|NCT01641081|20430994|P7|Period 1|Adverse Event|0
5905642|NCT01641081|20430995|P6|Period 1|Adverse Event|0
5905643|NCT01641081|20430996|P5|Period 1|Adverse Event|0
5905644|NCT01641081|20430997|P4|Period 1|Adverse Event|0
5905645|NCT01641081|20430998|P3|Period 1|Adverse Event|0
5905646|NCT01641081|20430999|P2|Period 1|Adverse Event|0
5905647|NCT01641081|20431000|P1|Period 1|Adverse Event|1
5905648|NCT01641081|20430991|P10|Period 1|Protocol Violation|0
5905649|NCT01641081|20430992|P9|Period 1|Protocol Violation|0
5905650|NCT01641081|20430993|P8|Period 1|Protocol Violation|1
5905651|NCT01641081|20430994|P7|Period 1|Protocol Violation|0
5905652|NCT01641081|20430995|P6|Period 1|Protocol Violation|0
5905653|NCT01641081|20430996|P5|Period 1|Protocol Violation|1
5905654|NCT01641081|20430997|P4|Period 1|Protocol Violation|0
5905655|NCT01641081|20430998|P3|Period 1|Protocol Violation|0
5905656|NCT01641081|20430999|P2|Period 1|Protocol Violation|0
5905657|NCT01641081|20431000|P1|Period 1|Protocol Violation|0
5905658|NCT01641081|20430991|P10|Period 1|Sponsor request (potential unblinding)|0
5905659|NCT01641081|20430992|P9|Period 1|Sponsor request (potential unblinding)|0
5905660|NCT01641081|20430993|P8|Period 1|Sponsor request (potential unblinding)|0
5905661|NCT01641081|20430994|P7|Period 1|Sponsor request (potential unblinding)|1
5905662|NCT01641081|20430995|P6|Period 1|Sponsor request (potential unblinding)|0
5905663|NCT01641081|20430996|P5|Period 1|Sponsor request (potential unblinding)|0
5905664|NCT01641081|20430997|P4|Period 1|Sponsor request (potential unblinding)|0
5905665|NCT01641081|20430998|P3|Period 1|Sponsor request (potential unblinding)|0
5905666|NCT01641081|20430999|P2|Period 1|Sponsor request (potential unblinding)|0
5905667|NCT01641081|20431000|P1|Period 1|Sponsor request (potential unblinding)|0
5905668|NCT01640964|20431069|P3|Overall Study|Protocol Deviation|2
5905669|NCT01640964|20431070|P2|Overall Study|Protocol Deviation|1
5905670|NCT01640964|20431071|P1|Overall Study|Protocol Deviation|1
5905671|NCT01640964|20431069|P3|Overall Study|Lost to Follow-up|1
5905672|NCT01640964|20431070|P2|Overall Study|Lost to Follow-up|0
5905673|NCT01640964|20431071|P1|Overall Study|Lost to Follow-up|0
5905674|NCT01640951|20431094|P8|Overall Study|Death|2
5905675|NCT01640951|20431095|P7|Overall Study|Death|0
5905676|NCT01640951|20431096|P6|Overall Study|Death|0
5905677|NCT01640951|20431097|P5|Overall Study|Death|0
5905678|NCT01640951|20431098|P4|Overall Study|Death|0
5905679|NCT01640951|20431099|P3|Overall Study|Death|1
5905680|NCT01640951|20431100|P2|Overall Study|Death|1
5905681|NCT01640951|20431101|P1|Overall Study|Death|0
5905682|NCT01640951|20431094|P8|Overall Study|Subject/Guardian decision|4
5905683|NCT01640951|20431095|P7|Overall Study|Subject/Guardian decision|5
5905684|NCT01640951|20431096|P6|Overall Study|Subject/Guardian decision|19
5905685|NCT01640951|20431097|P5|Overall Study|Subject/Guardian decision|7
5905686|NCT01640951|20431098|P4|Overall Study|Subject/Guardian decision|15
5905687|NCT01640951|20431099|P3|Overall Study|Subject/Guardian decision|13
5905688|NCT01640951|20431100|P2|Overall Study|Subject/Guardian decision|4
5905689|NCT01640951|20431101|P1|Overall Study|Subject/Guardian decision|12
5905690|NCT01640951|20431094|P8|Overall Study|Protocol Deviation|0
5905691|NCT01640951|20431095|P7|Overall Study|Protocol Deviation|0
5905692|NCT01640951|20431096|P6|Overall Study|Protocol Deviation|1
5905693|NCT01640951|20431097|P5|Overall Study|Protocol Deviation|0
5905694|NCT01640951|20431098|P4|Overall Study|Protocol Deviation|1
5905695|NCT01640951|20431099|P3|Overall Study|Protocol Deviation|2
5905696|NCT01640951|20431100|P2|Overall Study|Protocol Deviation|1
5905697|NCT01640951|20431101|P1|Overall Study|Protocol Deviation|0
5905698|NCT01640951|20431094|P8|Overall Study|Pregnancy|0
5905699|NCT01640951|20431095|P7|Overall Study|Pregnancy|2
5905700|NCT01640951|20431096|P6|Overall Study|Pregnancy|0
5905701|NCT01640951|20431097|P5|Overall Study|Pregnancy|0
5905702|NCT01640951|20431098|P4|Overall Study|Pregnancy|4
5905703|NCT01640951|20431099|P3|Overall Study|Pregnancy|0
5905704|NCT01640951|20431100|P2|Overall Study|Pregnancy|0
5905705|NCT01640951|20431101|P1|Overall Study|Pregnancy|3
5905706|NCT01640951|20431094|P8|Overall Study|Physician Decision|0
5905707|NCT01640951|20431095|P7|Overall Study|Physician Decision|3
5905708|NCT01640951|20431096|P6|Overall Study|Physician Decision|3
5905709|NCT01640951|20431097|P5|Overall Study|Physician Decision|2
5905710|NCT01640951|20431098|P4|Overall Study|Physician Decision|2
5905711|NCT01640951|20431099|P3|Overall Study|Physician Decision|2
5905712|NCT01640951|20431100|P2|Overall Study|Physician Decision|5
5905713|NCT01640951|20431101|P1|Overall Study|Physician Decision|2
5905714|NCT01640951|20431094|P8|Overall Study|Non-compliance with study treatment|0
5905715|NCT01640951|20431095|P7|Overall Study|Non-compliance with study treatment|1
5905716|NCT01640951|20431096|P6|Overall Study|Non-compliance with study treatment|4
5905717|NCT01640951|20431097|P5|Overall Study|Non-compliance with study treatment|1
5905718|NCT01640951|20431098|P4|Overall Study|Non-compliance with study treatment|1
5905719|NCT01640951|20431099|P3|Overall Study|Non-compliance with study treatment|1
5905720|NCT01640951|20431100|P2|Overall Study|Non-compliance with study treatment|0
5905721|NCT01640951|20431101|P1|Overall Study|Non-compliance with study treatment|0
5905722|NCT01640951|20431094|P8|Overall Study|Lost to Follow-up|1
5905723|NCT01640951|20431095|P7|Overall Study|Lost to Follow-up|1
5905724|NCT01640951|20431096|P6|Overall Study|Lost to Follow-up|3
5905725|NCT01640951|20431097|P5|Overall Study|Lost to Follow-up|2
5905726|NCT01640951|20431098|P4|Overall Study|Lost to Follow-up|2
5905727|NCT01640951|20431099|P3|Overall Study|Lost to Follow-up|6
5905728|NCT01640951|20431100|P2|Overall Study|Lost to Follow-up|0
5905729|NCT01640951|20431101|P1|Overall Study|Lost to Follow-up|1
5905730|NCT01640951|20431094|P8|Overall Study|Lack of Efficacy|6
5905731|NCT01640951|20431095|P7|Overall Study|Lack of Efficacy|5
5905732|NCT01640951|20431096|P6|Overall Study|Lack of Efficacy|6
5905733|NCT01640951|20431097|P5|Overall Study|Lack of Efficacy|0
5905734|NCT01640951|20431098|P4|Overall Study|Lack of Efficacy|14
5905735|NCT01640951|20431099|P3|Overall Study|Lack of Efficacy|7
5905736|NCT01640951|20431100|P2|Overall Study|Lack of Efficacy|1
5905737|NCT01640951|20431101|P1|Overall Study|Lack of Efficacy|20
5905738|NCT01640951|20431094|P8|Overall Study|Adverse Event|3
5905739|NCT01640951|20431095|P7|Overall Study|Adverse Event|1
5905740|NCT01640951|20431096|P6|Overall Study|Adverse Event|11
5905741|NCT01640951|20431097|P5|Overall Study|Adverse Event|1
5905742|NCT01640951|20431098|P4|Overall Study|Adverse Event|6
5905743|NCT01640951|20431099|P3|Overall Study|Adverse Event|10
5905744|NCT01640951|20431100|P2|Overall Study|Adverse Event|3
5905745|NCT01640951|20431101|P1|Overall Study|Adverse Event|8
5905746|NCT01640925|20431203|P2|Overall Study|Previously enrolled in this trial|11
5905747|NCT01640925|20431204|P1|Overall Study|Previously enrolled in this trial|13
5905748|NCT01640925|20431203|P2|Overall Study|Withdrawal by Subject|0
5905749|NCT01640925|20431204|P1|Overall Study|Withdrawal by Subject|1
5905750|NCT01640873|20431218|P2|Overall Study|Protocol Violation|1
5905751|NCT01640873|20431219|P1|Overall Study|Protocol Violation|2
5905752|NCT01640808|20431269|P2|Overall Study|Randomized but not treated|2
5905753|NCT01640808|20431270|P1|Overall Study|Randomized but not treated|4
5905754|NCT01640808|20431269|P2|Overall Study|Physician Decision|5
5905755|NCT01640808|20431270|P1|Overall Study|Physician Decision|19
5905756|NCT01640808|20431269|P2|Overall Study|Administration of anticancer drugs|1
5905757|NCT01640808|20431270|P1|Overall Study|Administration of anticancer drugs|2
5905758|NCT01640808|20431269|P2|Overall Study|Start an antiviral therapy using IFN|0
5905759|NCT01640808|20431270|P1|Overall Study|Start an antiviral therapy using IFN|3
5905760|NCT01640808|20431269|P2|Overall Study|Lost to Follow-up|0
5905761|NCT01640808|20431270|P1|Overall Study|Lost to Follow-up|4
5905762|NCT01640808|20431269|P2|Overall Study|Withdrawal by Subject|4
5905763|NCT01640808|20431270|P1|Overall Study|Withdrawal by Subject|12
5905764|NCT01640808|20431269|P2|Overall Study|Unable to continue dynamic CT|4
5905765|NCT01640808|20431270|P1|Overall Study|Unable to continue dynamic CT|14
5905766|NCT01640366|20431305|P1|Overall Study|Lost to Follow-up|5
5905767|NCT01640366|20431305|P1|Overall Study|Protocol Violation|16
5905768|NCT01640366|20431305|P1|Overall Study|Withdrawal by Subject|1
5905769|NCT01640353|20431318|P1|Overall Study|Physician Decision|1
5905770|NCT01640353|20431318|P1|Overall Study|Lost to Follow-up|12
5905771|NCT01640353|20431318|P1|Overall Study|Early site termination|3
5905772|NCT01640353|20431318|P1|Overall Study|Death|2
5905773|NCT01640353|20431318|P1|Overall Study|Withdrawal by Subject|5
5905774|NCT01640353|20431318|P1|Overall Study|Withdrawn from analysis at term site|12
5905775|NCT01640353|20431318|P1|Overall Study|Withdrew prior to treatment|10
5905776|NCT01640314|20431366|P2|Overall Study|Protocol Violation|1
5905777|NCT01640314|20431367|P1|Overall Study|Protocol Violation|0
5905778|NCT01640288|20431383|P2|Overall Study|Withdrawal by Subject|0
5905779|NCT01640288|20431384|P1|Overall Study|Withdrawal by Subject|1
5905780|NCT01640288|20431383|P2|Overall Study|Withdrawn by PI|0
5905781|NCT01640288|20431384|P1|Overall Study|Withdrawn by PI|5
5905782|NCT01640288|20431383|P2|Overall Study|Screen Failure|18
5905783|NCT01640288|20431384|P1|Overall Study|Screen Failure|20
5905784|NCT01640288|20431383|P2|Overall Study|Equipment Failure or Poor Image Quality|5
5905785|NCT01640288|20431384|P1|Overall Study|Equipment Failure or Poor Image Quality|4
5905786|NCT01640249|20431401|P7|Period 1|Withdrawal by Subject|0
5905787|NCT01640249|20431402|P6|Period 1|Withdrawal by Subject|1
5905788|NCT01640249|20431403|P5|Period 1|Withdrawal by Subject|0
5905789|NCT01640249|20431404|P4|Period 1|Withdrawal by Subject|0
5905790|NCT01640249|20431405|P3|Period 1|Withdrawal by Subject|0
5905791|NCT01640249|20431406|P2|Period 1|Withdrawal by Subject|0
5905792|NCT01640249|20431407|P1|Period 1|Withdrawal by Subject|1
5905793|NCT01640184|20431455|P3|Overall Study|Protocol Violation|1
5905794|NCT01640184|20431456|P2|Overall Study|Protocol Violation|0
5905795|NCT01640184|20431457|P1|Overall Study|Protocol Violation|0
5905796|NCT01640184|20431455|P3|Overall Study|Withdrawal by Subject|1
5905797|NCT01640184|20431456|P2|Overall Study|Withdrawal by Subject|1
5905798|NCT01640184|20431457|P1|Overall Study|Withdrawal by Subject|0
5905799|NCT01640184|20431455|P3|Overall Study|Physician Decision|0
5905800|NCT01640184|20431456|P2|Overall Study|Physician Decision|0
5905801|NCT01640184|20431457|P1|Overall Study|Physician Decision|3
5905802|NCT01640184|20431455|P3|Overall Study|Lost to Follow-up|0
5905803|NCT01640184|20431456|P2|Overall Study|Lost to Follow-up|1
5905804|NCT01640184|20431457|P1|Overall Study|Lost to Follow-up|4
5905805|NCT01640184|20431455|P3|Overall Study|Death|0
5905806|NCT01640184|20431456|P2|Overall Study|Death|0
5905807|NCT01640184|20431457|P1|Overall Study|Death|1
5905808|NCT01640054|20431486|P1|Overall Study|Adverse Event|2
5905809|NCT01640054|20431486|P1|Overall Study|Lack of Efficacy|3
5905810|NCT01640054|20431486|P1|Overall Study|Study-specific disc criteria|1
5905811|NCT01639833|20431507|P2|Overall Study|Withdrawal by Subject|2
5905812|NCT01639833|20431508|P1|Overall Study|Withdrawal by Subject|2
5905813|NCT01639833|20431507|P2|Overall Study|Death|2
5905814|NCT01639833|20431508|P1|Overall Study|Death|4
5905815|NCT01639755|20431516|P1|Overall Study|Patient had device explantation|4
5905816|NCT01639755|20431516|P1|Overall Study|Study Ongoing|15
5905817|NCT01639742|20431524|P1|Overall Study|Lost to Follow-up|1
5905818|NCT01639742|20431524|P1|Overall Study|Study Ongoing|17
5905819|NCT01639729|20431532|P6|Overall Study|Withdrawal by Subject|0
5905820|NCT01639729|20431533|P5|Overall Study|Withdrawal by Subject|0
5905821|NCT01639729|20431534|P4|Overall Study|Withdrawal by Subject|1
5905822|NCT01639729|20431535|P3|Overall Study|Withdrawal by Subject|1
5905823|NCT01639729|20431536|P2|Overall Study|Withdrawal by Subject|0
5905824|NCT01639729|20431537|P1|Overall Study|Withdrawal by Subject|1
5905825|NCT01639703|20431559|P1|Overall Study|Other reason|7
5905826|NCT01639703|20431559|P1|Overall Study|Withdrawal by Subject|5
5905827|NCT01639560|20431624|P2|Overall Study|Adverse Event|2
5905828|NCT01639560|20431625|P1|Overall Study|Adverse Event|0
5905829|NCT01639560|20431624|P2|Overall Study|Lost to Follow-up|11
5905830|NCT01639560|20431625|P1|Overall Study|Lost to Follow-up|9
5905831|NCT01639560|20431624|P2|Overall Study|Lack of Efficacy|2
5905832|NCT01639560|20431625|P1|Overall Study|Lack of Efficacy|1
5905833|NCT01639560|20431624|P2|Overall Study|Withdrawal by Subject|14
5905834|NCT01639560|20431625|P1|Overall Study|Withdrawal by Subject|9
5905835|NCT01639495|20431637|P1|Overall Study|No radiofrequency energy applied|2
5905836|NCT01639495|20431637|P1|Overall Study|Not meeting inclusion/exclusion criteria|4
5905837|NCT01639495|20431637|P1|Overall Study|Consented but didn't have study catheter|4
5905838|NCT01639495|20431637|P1|Overall Study|Lost to Follow-up|6
5905839|NCT01639469|20431647|P2|Overall Study|Lost to Follow-up|1
5905840|NCT01639469|20431648|P1|Overall Study|Lost to Follow-up|1
5905841|NCT01639469|20431647|P2|Overall Study|Death|2
5905842|NCT01639469|20431648|P1|Overall Study|Death|4
5905843|NCT01639339|20431684|P2|Overall Study|Adverse Event|7
5905844|NCT01639339|20431685|P1|Overall Study|Adverse Event|10
5905845|NCT01639339|20431684|P2|Overall Study|Lack of Efficacy|1
5905846|NCT01639339|20431685|P1|Overall Study|Lack of Efficacy|2
5905847|NCT01639339|20431684|P2|Overall Study|Protocol Violation|2
5905848|NCT01639339|20431685|P1|Overall Study|Protocol Violation|0
5905849|NCT01639339|20431684|P2|Overall Study|Lost to Follow-up|4
5905850|NCT01639339|20431685|P1|Overall Study|Lost to Follow-up|5
5905851|NCT01639339|20431684|P2|Overall Study|Physician Decision|5
5905852|NCT01639339|20431685|P1|Overall Study|Physician Decision|11
5905853|NCT01639339|20431684|P2|Overall Study|Withdrawal by Subject|19
5905854|NCT01639339|20431685|P1|Overall Study|Withdrawal by Subject|26
5905855|NCT01639144|20431774|P2|Overall Study|Met postoperative exclusion criteria|3
5905856|NCT01639144|20431775|P1|Overall Study|Met postoperative exclusion criteria|4
5905857|NCT01639144|20431774|P2|Overall Study|Physician Decision|0
5905858|NCT01639144|20431775|P1|Overall Study|Physician Decision|2
5905859|NCT01639144|20431774|P2|Overall Study|Withdrawal by Subject|2
5905860|NCT01639144|20431775|P1|Overall Study|Withdrawal by Subject|4
5905861|NCT01639040|20431783|P2|Overall Study|Adverse Event|0
5905862|NCT01639040|20431784|P1|Overall Study|Adverse Event|1
5905863|NCT01639001|20431802|P2|Overall Study|Long-term follow-up participants who did not respond to the contact from their study sites.|2
5905864|NCT01639001|20431803|P1|Overall Study|Long-term follow-up participants who did not respond to the contact from their study sites.|1
5905865|NCT01639001|20431802|P2|Overall Study|Randomized but not treated|2
5905866|NCT01639001|20431803|P1|Overall Study|Randomized but not treated|0
5905867|NCT01639001|20431802|P2|Overall Study|Death|61
5905868|NCT01639001|20431803|P1|Overall Study|Death|62
5905869|NCT01639001|20431802|P2|Overall Study|Lost to Follow-up|0
5905870|NCT01639001|20431803|P1|Overall Study|Lost to Follow-up|3
5905871|NCT01639001|20431802|P2|Overall Study|Refused further follow-up|12
5905872|NCT01639001|20431803|P1|Overall Study|Refused further follow-up|9
5905873|NCT01638819|20431849|P2|Overall Study|Lost to Follow-up|0
5905874|NCT01638819|20431850|P1|Overall Study|Lost to Follow-up|1
5905875|NCT01638559|20431859|P1|Overall Study|Subject declined to travel for biopsy|1
5905876|NCT01638559|20431859|P1|Overall Study|Withdrawal by Subject|1
5905877|NCT01638559|20431859|P1|Overall Study|Lost to Follow-up|1
5905878|NCT01638546|20431877|P2|Overall Study|Adverse Event|3
5905879|NCT01638546|20431878|P1|Overall Study|Adverse Event|1
5905880|NCT01638429|20431917|P1|Overall Study|Withdrawal by Subject|1
5905881|NCT01638390|20431968|P1|Overall Study|screening failures|21
5905882|NCT01638013|20431992|P3|Overall Study|Not met inclusion or exclusion criteria|1
5905883|NCT01638013|20431993|P2|Overall Study|Not met inclusion or exclusion criteria|0
5905884|NCT01638013|20431994|P1|Overall Study|Not met inclusion or exclusion criteria|0
5905885|NCT01638013|20431992|P3|Overall Study|Withdrawal of Consent|16
5905886|NCT01638013|20431993|P2|Overall Study|Withdrawal of Consent|12
5905887|NCT01638013|20431994|P1|Overall Study|Withdrawal of Consent|16
5905888|NCT01638013|20431992|P3|Overall Study|Miscellaneous|23
5905889|NCT01638013|20431993|P2|Overall Study|Miscellaneous|19
5905890|NCT01638013|20431994|P1|Overall Study|Miscellaneous|25
5905891|NCT01638013|20431992|P3|Overall Study|Subject Lost to Follow up|1
5905892|NCT01638013|20431993|P2|Overall Study|Subject Lost to Follow up|0
5905893|NCT01638013|20431994|P1|Overall Study|Subject Lost to Follow up|1
5905894|NCT01638013|20431992|P3|Overall Study|Met discontinuation criteria|7
5905895|NCT01638013|20431993|P2|Overall Study|Met discontinuation criteria|0
5905896|NCT01638013|20431994|P1|Overall Study|Met discontinuation criteria|4
5905897|NCT01638013|20431992|P3|Overall Study|Protocol Violation|11
5905898|NCT01638013|20431993|P2|Overall Study|Protocol Violation|7
5905899|NCT01638013|20431994|P1|Overall Study|Protocol Violation|10
5905900|NCT01638013|20431992|P3|Overall Study|Lack of Efficacy|14
5905901|NCT01638013|20431993|P2|Overall Study|Lack of Efficacy|11
5905902|NCT01638013|20431994|P1|Overall Study|Lack of Efficacy|39
5905903|NCT01638013|20431992|P3|Overall Study|Adverse Event|48
5905904|NCT01638013|20431993|P2|Overall Study|Adverse Event|29
5905905|NCT01638013|20431994|P1|Overall Study|Adverse Event|36
5905906|NCT01638000|20432127|P2|Overall Study|Miscellaneous|2
5905907|NCT01638000|20432128|P1|Overall Study|Miscellaneous|2
5905908|NCT01638000|20432127|P2|Overall Study|Withdrawal by Subject|24
5905909|NCT01638000|20432128|P1|Overall Study|Withdrawal by Subject|21
5905910|NCT01638000|20432127|P2|Overall Study|Protocol Violation|13
5905911|NCT01638000|20432128|P1|Overall Study|Protocol Violation|11
5905912|NCT01638000|20432127|P2|Overall Study|Lack of Efficacy|6
5905913|NCT01638000|20432128|P1|Overall Study|Lack of Efficacy|5
5905914|NCT01638000|20432127|P2|Overall Study|Adverse Event|16
5905915|NCT01638000|20432128|P1|Overall Study|Adverse Event|14
5905916|NCT01638000|20432127|P2|Overall Study|Randomized but Never Received Drug|10
5905917|NCT01638000|20432128|P1|Overall Study|Randomized but Never Received Drug|7
5905918|NCT01637961|20432226|P1|Overall Study|Ineligible: inadequate pathology|1
5905919|NCT01637961|20432226|P1|Overall Study|Ineligible: wrong primary|1
5905920|NCT01637922|20432258|P2|Overall Study|Lost to Follow-up|0
5905921|NCT01637922|20432259|P1|Overall Study|Lost to Follow-up|2
5905922|NCT01637922|20432258|P2|Overall Study|Withdrawal by Subject|3
5905923|NCT01637922|20432259|P1|Overall Study|Withdrawal by Subject|0
5905924|NCT01637922|20432258|P2|Overall Study|Protocol Violation|1
5905925|NCT01637922|20432259|P1|Overall Study|Protocol Violation|0
5905926|NCT01637922|20432258|P2|Overall Study|Adverse Event|1
5905927|NCT01637922|20432259|P1|Overall Study|Adverse Event|0
5905928|NCT01637623|20432289|P3|Overall Study|Physician Decision|1
5905929|NCT01637623|20432290|P2|Overall Study|Physician Decision|0
5905930|NCT01637623|20432291|P1|Overall Study|Physician Decision|1
5905931|NCT01637623|20432289|P3|Overall Study|Lost to Follow-up|2
5905932|NCT01637623|20432290|P2|Overall Study|Lost to Follow-up|0
5905933|NCT01637623|20432291|P1|Overall Study|Lost to Follow-up|0
5905934|NCT01637584|20432331|P2|Overall Study|Withdrawal by Subject|3
5905935|NCT01637584|20432332|P1|Overall Study|Withdrawal by Subject|1
5905936|NCT01637402|20432339|P2|Treatment Regiments Post Week 12|Progression after escalation arm closed|0
5905937|NCT01637402|20432340|P1|Treatment Regiments Post Week 12|Progression after escalation arm closed|5
5905938|NCT01637402|20432339|P2|Treatment Regiments Post Week 12|Withdrawal by Subject|0
5905939|NCT01637402|20432340|P1|Treatment Regiments Post Week 12|Withdrawal by Subject|4
5905940|NCT01637402|20432339|P2|Treatment Regiments Post Week 12|Not evaluable for response after 12wks|4
5905941|NCT01637402|20432340|P1|Treatment Regiments Post Week 12|Not evaluable for response after 12wks|0
5905942|NCT01637402|20432339|P2|Week 12 Evaluation|Lack of Efficacy|0
5905943|NCT01637402|20432340|P1|Week 12 Evaluation|Lack of Efficacy|6
5905944|NCT01637402|20432339|P2|Standard Dose Regimen|Adverse Event|0
5905945|NCT01637402|20432340|P1|Standard Dose Regimen|Adverse Event|1
5905946|NCT01637402|20432339|P2|Standard Dose Regimen|Lack of Efficacy|0
5905947|NCT01637402|20432340|P1|Standard Dose Regimen|Lack of Efficacy|2
5905948|NCT01637272|20432371|P1|Overall Study|Protocol Violation|2
5905949|NCT01637272|20432371|P1|Overall Study|Administrative problems|1
5905950|NCT01637272|20432371|P1|Overall Study|completed core, did not enter ext. phase|4
5905951|NCT01637272|20432371|P1|Overall Study|Lost to Follow-up|2
5905952|NCT01637272|20432371|P1|Overall Study|Withdrawal by Subject|3
5905953|NCT01637272|20432371|P1|Overall Study|Unsatisfactory therapeutic effect|2
5905954|NCT01637272|20432371|P1|Overall Study|Adverse Event|6
5905955|NCT01637077|20432451|P2|Overall Study|No cycle 1 questionnaire data|0
5905956|NCT01637077|20432452|P1|Overall Study|No cycle 1 questionnaire data|2
5905957|NCT01637077|20432451|P2|Overall Study|Withdrawal by Subject|0
5905958|NCT01637077|20432452|P1|Overall Study|Withdrawal by Subject|1
5905959|NCT01637077|20432451|P2|Overall Study|Cancel|1
5905960|NCT01637077|20432452|P1|Overall Study|Cancel|1
5905961|NCT01636986|20432480|P2|Overall Study|Corneal Staining|1
5905962|NCT01636986|20432481|P1|Overall Study|Corneal Staining|0
5905963|NCT01636986|20432480|P2|Overall Study|Withdrawal by Subject|1
5905964|NCT01636986|20432481|P1|Overall Study|Withdrawal by Subject|0
5905965|NCT01636960|20432487|P1|Maintenance Phase|Progressive disease|1
5905966|NCT01636960|20432487|P1|Maintenance Phase|Adverse Event|3
5905967|NCT01636960|20432487|P1|Maintenance Phase|Continued drug after regulatory approval|3
5905968|NCT01636960|20432487|P1|Induction Phase|Adverse Event|2
5905969|NCT01636947|20432495|P2|Overall Study|Did Not Meet Eligibility Criteria|4
5905970|NCT01636947|20432496|P1|Overall Study|Did Not Meet Eligibility Criteria|1
5905971|NCT01636947|20432495|P2|Overall Study|Adverse Event|1
5905972|NCT01636947|20432496|P1|Overall Study|Adverse Event|1
5905973|NCT01636947|20432495|P2|Overall Study|Withdrawal by Subject|3
5905974|NCT01636947|20432496|P1|Overall Study|Withdrawal by Subject|3
5905975|NCT01636947|20432495|P2|Overall Study|Protocol Violation|1
5905976|NCT01636947|20432496|P1|Overall Study|Protocol Violation|1
5905977|NCT01636947|20432495|P2|Overall Study|Lost to Follow-up|0
5905978|NCT01636947|20432496|P1|Overall Study|Lost to Follow-up|4
5905979|NCT01636947|20432495|P2|Overall Study|Not Treated|2
5905980|NCT01636947|20432496|P1|Overall Study|Not Treated|2
5905981|NCT01636934|20432518|P2|Overall Study|Never started study medication|1
5905982|NCT01636934|20432519|P1|Overall Study|Never started study medication|1
5905983|NCT01636934|20432518|P2|Overall Study|Too ill to continue|0
5905984|NCT01636934|20432519|P1|Overall Study|Too ill to continue|1
5905985|NCT01636934|20432518|P2|Overall Study|Chemo cancel|0
5905986|NCT01636934|20432519|P1|Overall Study|Chemo cancel|1
5905987|NCT01636934|20432518|P2|Overall Study|Withdrawal by Subject|2
5905988|NCT01636934|20432519|P1|Overall Study|Withdrawal by Subject|3
5905989|NCT01636778|20432531|P3|Follow-up Period After Part 2|Withdrawal by Subject|2
5905990|NCT01636778|20432532|P2|Follow-up Period After Part 2|Withdrawal by Subject|0
5905991|NCT01636778|20432533|P1|Follow-up Period After Part 2|Withdrawal by Subject|0
5905992|NCT01636778|20432531|P3|Follow-up Period After Part 2|Not entered FU period after withdrawal|1
5905993|NCT01636778|20432532|P2|Follow-up Period After Part 2|Not entered FU period after withdrawal|0
5905994|NCT01636778|20432533|P1|Follow-up Period After Part 2|Not entered FU period after withdrawal|0
5905995|NCT01636778|20432531|P3|Follow-up Period After Part 2|Other|1
5905996|NCT01636778|20432532|P2|Follow-up Period After Part 2|Other|0
5905997|NCT01636778|20432533|P1|Follow-up Period After Part 2|Other|0
5905998|NCT01636778|20432531|P3|Antiviral Treatment Period (Part 2)|Physician Decision|0
5905999|NCT01636778|20432532|P2|Antiviral Treatment Period (Part 2)|Physician Decision|2
5906000|NCT01636778|20432533|P1|Antiviral Treatment Period (Part 2)|Physician Decision|0
5906001|NCT01636778|20432531|P3|Antiviral Treatment Period (Part 2)|Protocol Violation|0
5906002|NCT01636778|20432532|P2|Antiviral Treatment Period (Part 2)|Protocol Violation|1
5906003|NCT01636778|20432533|P1|Antiviral Treatment Period (Part 2)|Protocol Violation|0
5906004|NCT01636778|20432531|P3|Antiviral Treatment Period (Part 2)|Adverse Event|0
5906005|NCT01636778|20432532|P2|Antiviral Treatment Period (Part 2)|Adverse Event|7
5906006|NCT01636778|20432533|P1|Antiviral Treatment Period (Part 2)|Adverse Event|0
5906007|NCT01636778|20432531|P3|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0
5906008|NCT01636778|20432532|P2|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0
5906009|NCT01636778|20432533|P1|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|1
5906010|NCT01636778|20432531|P3|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0
5906011|NCT01636778|20432532|P2|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0
5906012|NCT01636778|20432533|P1|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|3
5906013|NCT01636713|20432604|P3|Overall Study|Met Protocol-defined Stopping Criteria|4
5906014|NCT01636713|20432605|P2|Overall Study|Met Protocol-defined Stopping Criteria|2
5906015|NCT01636713|20432606|P1|Overall Study|Met Protocol-defined Stopping Criteria|2
5906016|NCT01636713|20432604|P3|Overall Study|Withdrawal by Subject|8
5906017|NCT01636713|20432605|P2|Overall Study|Withdrawal by Subject|4
5906018|NCT01636713|20432606|P1|Overall Study|Withdrawal by Subject|5
5906019|NCT01636713|20432604|P3|Overall Study|Lost to Follow-up|1
5906020|NCT01636713|20432605|P2|Overall Study|Lost to Follow-up|0
5906021|NCT01636713|20432606|P1|Overall Study|Lost to Follow-up|0
5906022|NCT01636713|20432604|P3|Overall Study|Protocol Violation|1
5906023|NCT01636713|20432605|P2|Overall Study|Protocol Violation|0
5906024|NCT01636713|20432606|P1|Overall Study|Protocol Violation|3
5906025|NCT01636713|20432604|P3|Overall Study|Lack of Efficacy|2
5906026|NCT01636713|20432605|P2|Overall Study|Lack of Efficacy|6
5906027|NCT01636713|20432606|P1|Overall Study|Lack of Efficacy|6
5906028|NCT01636713|20432604|P3|Overall Study|Adverse Event|7
5906029|NCT01636713|20432605|P2|Overall Study|Adverse Event|16
5906030|NCT01636713|20432606|P1|Overall Study|Adverse Event|16
5906031|NCT01636687|20432623|P5|Follow-up Period|Withdrawal by Subject|1
5906032|NCT01636687|20432624|P4|Follow-up Period|Withdrawal by Subject|0
5906033|NCT01636687|20432625|P3|Follow-up Period|Withdrawal by Subject|0
5906034|NCT01636687|20432626|P2|Follow-up Period|Withdrawal by Subject|0
5906035|NCT01636687|20432627|P1|Follow-up Period|Withdrawal by Subject|1
5906036|NCT01636687|20432623|P5|Extension Period|Withdrawal by Subject|0
5906037|NCT01636687|20432624|P4|Extension Period|Withdrawal by Subject|1
5906038|NCT01636687|20432625|P3|Extension Period|Withdrawal by Subject|1
5906039|NCT01636687|20432626|P2|Extension Period|Withdrawal by Subject|0
5906040|NCT01636687|20432627|P1|Extension Period|Withdrawal by Subject|1
5906041|NCT01636687|20432623|P5|Extension Period|study terminated by sponsor|0
5906042|NCT01636687|20432624|P4|Extension Period|study terminated by sponsor|23
5906043|NCT01636687|20432625|P3|Extension Period|study terminated by sponsor|17
5906044|NCT01636687|20432626|P2|Extension Period|study terminated by sponsor|50
5906045|NCT01636687|20432627|P1|Extension Period|study terminated by sponsor|33
5906046|NCT01636687|20432623|P5|Extension Period|Physician Decision|0
5906047|NCT01636687|20432624|P4|Extension Period|Physician Decision|1
5906048|NCT01636687|20432625|P3|Extension Period|Physician Decision|0
5906049|NCT01636687|20432626|P2|Extension Period|Physician Decision|0
5906050|NCT01636687|20432627|P1|Extension Period|Physician Decision|1
5906051|NCT01636687|20432623|P5|Extension Period|Lost to Follow-up|0
5906052|NCT01636687|20432624|P4|Extension Period|Lost to Follow-up|0
5906053|NCT01636687|20432625|P3|Extension Period|Lost to Follow-up|1
5906054|NCT01636687|20432626|P2|Extension Period|Lost to Follow-up|0
5906055|NCT01636687|20432627|P1|Extension Period|Lost to Follow-up|1
5906056|NCT01636687|20432623|P5|Extension Period|Lack of Efficacy|0
5906057|NCT01636687|20432624|P4|Extension Period|Lack of Efficacy|1
5906058|NCT01636687|20432625|P3|Extension Period|Lack of Efficacy|2
5906059|NCT01636687|20432626|P2|Extension Period|Lack of Efficacy|0
5906060|NCT01636687|20432627|P1|Extension Period|Lack of Efficacy|7
5906061|NCT01636687|20432623|P5|Extension Period|Adverse Event|0
5906062|NCT01636687|20432624|P4|Extension Period|Adverse Event|1
5906063|NCT01636687|20432625|P3|Extension Period|Adverse Event|2
5906064|NCT01636687|20432626|P2|Extension Period|Adverse Event|3
5906065|NCT01636687|20432627|P1|Extension Period|Adverse Event|4
5906066|NCT01636687|20432623|P5|Extension Period|technical problems|0
5906067|NCT01636687|20432624|P4|Extension Period|technical problems|1
5906068|NCT01636687|20432625|P3|Extension Period|technical problems|2
5906069|NCT01636687|20432626|P2|Extension Period|technical problems|1
5906070|NCT01636687|20432627|P1|Extension Period|technical problems|0
5906071|NCT01636687|20432623|P5|Maintenance Period|Physician Decision|1
5906072|NCT01636687|20432624|P4|Maintenance Period|Physician Decision|0
5906073|NCT01636687|20432625|P3|Maintenance Period|Physician Decision|0
5906074|NCT01636687|20432626|P2|Maintenance Period|Physician Decision|0
5906075|NCT01636687|20432627|P1|Maintenance Period|Physician Decision|0
5906076|NCT01636687|20432623|P5|Maintenance Period|Lost to Follow-up|1
5906077|NCT01636687|20432624|P4|Maintenance Period|Lost to Follow-up|0
5906078|NCT01636687|20432625|P3|Maintenance Period|Lost to Follow-up|0
5906079|NCT01636687|20432626|P2|Maintenance Period|Lost to Follow-up|1
5906080|NCT01636687|20432627|P1|Maintenance Period|Lost to Follow-up|1
5906081|NCT01636687|20432623|P5|Maintenance Period|Lack of Efficacy|0
5906082|NCT01636687|20432624|P4|Maintenance Period|Lack of Efficacy|0
5906083|NCT01636687|20432625|P3|Maintenance Period|Lack of Efficacy|0
5906084|NCT01636687|20432626|P2|Maintenance Period|Lack of Efficacy|1
5906085|NCT01636687|20432627|P1|Maintenance Period|Lack of Efficacy|4
5906086|NCT01636687|20432623|P5|Maintenance Period|Adverse Event|0
5906087|NCT01636687|20432624|P4|Maintenance Period|Adverse Event|0
5906088|NCT01636687|20432625|P3|Maintenance Period|Adverse Event|0
5906089|NCT01636687|20432626|P2|Maintenance Period|Adverse Event|0
5906090|NCT01636687|20432627|P1|Maintenance Period|Adverse Event|1
5906091|NCT01636687|20432623|P5|Maintenance Period|Withdrawal by Subject|0
5906092|NCT01636687|20432624|P4|Maintenance Period|Withdrawal by Subject|0
5906093|NCT01636687|20432625|P3|Maintenance Period|Withdrawal by Subject|2
5906094|NCT01636687|20432626|P2|Maintenance Period|Withdrawal by Subject|0
5906095|NCT01636687|20432627|P1|Maintenance Period|Withdrawal by Subject|2
5906096|NCT01636687|20432623|P5|Induction Period|Physician Decision|0
5906097|NCT01636687|20432624|P4|Induction Period|Physician Decision|0
5906098|NCT01636687|20432625|P3|Induction Period|Physician Decision|0
5906099|NCT01636687|20432626|P2|Induction Period|Physician Decision|0
5906100|NCT01636687|20432627|P1|Induction Period|Physician Decision|1
5906101|NCT01636687|20432623|P5|Induction Period|Lack of Efficacy|1
5906102|NCT01636687|20432624|P4|Induction Period|Lack of Efficacy|0
5906103|NCT01636687|20432625|P3|Induction Period|Lack of Efficacy|0
5906104|NCT01636687|20432626|P2|Induction Period|Lack of Efficacy|0
5906105|NCT01636687|20432627|P1|Induction Period|Lack of Efficacy|0
5906106|NCT01636687|20432623|P5|Induction Period|Adverse Event|1
5906107|NCT01636687|20432624|P4|Induction Period|Adverse Event|0
5906108|NCT01636687|20432625|P3|Induction Period|Adverse Event|0
5906109|NCT01636687|20432626|P2|Induction Period|Adverse Event|0
5906110|NCT01636687|20432627|P1|Induction Period|Adverse Event|1
5906111|NCT01636687|20432623|P5|Induction Period|Withdrawal by Subject|0
5906112|NCT01636687|20432624|P4|Induction Period|Withdrawal by Subject|0
5906113|NCT01636687|20432625|P3|Induction Period|Withdrawal by Subject|0
5906114|NCT01636687|20432626|P2|Induction Period|Withdrawal by Subject|0
5906115|NCT01636687|20432627|P1|Induction Period|Withdrawal by Subject|1
5906116|NCT01636362|20432768|P1|Overall Study|Withdrawal by Subject|1
5906117|NCT01636362|20432768|P1|Overall Study|Subject healed, not returning|1
5906118|NCT01636362|20432768|P1|Overall Study|Physician Decision|6
5906119|NCT01636258|20432801|P2|Overall Study|Lost to Follow-up|0
5906120|NCT01636258|20432802|P1|Overall Study|Lost to Follow-up|1
5906121|NCT01636076|20432842|P2|Overall Study|Withdrawal by Subject|10
5906122|NCT01636076|20432843|P1|Overall Study|Withdrawal by Subject|7
5906123|NCT01636076|20432842|P2|Overall Study|Adverse Event|11
5906124|NCT01636076|20432843|P1|Overall Study|Adverse Event|6
5906125|NCT01636076|20432842|P2|Overall Study|Non-compliance with study treatment|1
5906126|NCT01636076|20432843|P1|Overall Study|Non-compliance with study treatment|1
5906127|NCT01636076|20432842|P2|Overall Study|Physician Decision|1
5906128|NCT01636076|20432843|P1|Overall Study|Physician Decision|1
5906129|NCT01636076|20432842|P2|Overall Study|Lost to Follow-up|0
5906130|NCT01636076|20432843|P1|Overall Study|Lost to Follow-up|1
5906131|NCT01636076|20432842|P2|Overall Study|Lack of Efficacy|1
5906132|NCT01636076|20432843|P1|Overall Study|Lack of Efficacy|0
5906133|NCT01636076|20432842|P2|Overall Study|Terminated by sponsor|1
5906134|NCT01636076|20432843|P1|Overall Study|Terminated by sponsor|1
5906135|NCT01635998|20432914|P2|Overall Study|Withdrawal by Subject|5
5906136|NCT01635998|20432915|P1|Overall Study|Withdrawal by Subject|1
5906137|NCT01635998|20432914|P2|Overall Study|Lost to Follow-up|1
5906138|NCT01635998|20432915|P1|Overall Study|Lost to Follow-up|2
5906139|NCT01635998|20432914|P2|Overall Study|Death|1
5906140|NCT01635998|20432915|P1|Overall Study|Death|1
5906141|NCT01635933|20432943|P2|Overall Study|No longer had transportation|1
5906142|NCT01635933|20432944|P1|Overall Study|No longer had transportation|0
5906143|NCT01635933|20432943|P2|Overall Study|Noncompliance|1
5906144|NCT01635933|20432944|P1|Overall Study|Noncompliance|0
5906145|NCT01635933|20432943|P2|Overall Study|Subject decision|1
5906146|NCT01635933|20432944|P1|Overall Study|Subject decision|1
5906147|NCT01635933|20432943|P2|Overall Study|Lost to Follow-up|5
5906148|NCT01635933|20432944|P1|Overall Study|Lost to Follow-up|0
5906149|NCT01635933|20432943|P2|Overall Study|Adverse Event|0
5906150|NCT01635933|20432944|P1|Overall Study|Adverse Event|1
5906151|NCT01635920|20432956|P2|Overall Study|Subject decision|0
5906152|NCT01635920|20432957|P1|Overall Study|Subject decision|2
5906153|NCT01635920|20432956|P2|Overall Study|Lost to Follow-up|1
5906154|NCT01635920|20432957|P1|Overall Study|Lost to Follow-up|0
5906155|NCT01635920|20432956|P2|Overall Study|Adverse Event|0
5906156|NCT01635920|20432957|P1|Overall Study|Adverse Event|1
5906157|NCT01635855|20432970|P1|Overall Study|Withdrawal by Subject|4
5906158|NCT01635764|20432979|P1|Overall Study|Other|28
5906159|NCT01635764|20432979|P1|Overall Study|Lost to Follow-up|53
5906160|NCT01635764|20432979|P1|Overall Study|Withdrew Consent|67
5906161|NCT01635764|20432979|P1|Overall Study|Protocol Deviation|1
5906162|NCT01635764|20432979|P1|Overall Study|Exceed Protocol-specified Interventions|2
5906163|NCT01635764|20432979|P1|Overall Study|Lack of Efficacy|76
5906164|NCT01635764|20432979|P1|Overall Study|Adverse Event|46
5906165|NCT01635283|20433029|P1|Overall Study|Lost to Follow-up|1
5906166|NCT01635283|20433029|P1|Overall Study|Tumor Progression|3
5906167|NCT01635218|20433053|P3|Overall Study|Lost to Follow-up|6
5906168|NCT01635218|20433054|P2|Overall Study|Lost to Follow-up|7
5906169|NCT01635218|20433055|P1|Overall Study|Lost to Follow-up|3
5906170|NCT01635153|20433077|P2|Overall Study|Lost to Follow-up|43
5906171|NCT01635153|20433078|P1|Overall Study|Lost to Follow-up|40
5906172|NCT01634854|20433131|P2|Overall Study|Cesarean delivery|7
5906173|NCT01634854|20433132|P1|Overall Study|Cesarean delivery|2
5906174|NCT01634659|20433152|P2|Period 2 - Second 8 Days of Wear|Physician Decision|0
5906175|NCT01634659|20433153|P1|Period 2 - Second 8 Days of Wear|Physician Decision|1
5906176|NCT01634659|20433152|P2|Period 2 - Second 8 Days of Wear|Adverse Event|0
5906177|NCT01634659|20433153|P1|Period 2 - Second 8 Days of Wear|Adverse Event|2
5906178|NCT01634555|20433183|P1|Overall Study|Physician Decision|1
5906179|NCT01634555|20433183|P1|Overall Study|Adverse Event|3
5906180|NCT01634360|20433194|P2|Overall Study|Study termination by sponsor|44
5906181|NCT01634360|20433195|P1|Overall Study|Study termination by sponsor|18
5906182|NCT01634360|20433194|P2|Overall Study|Other|20
5906183|NCT01634360|20433195|P1|Overall Study|Other|3
5906184|NCT01634360|20433194|P2|Overall Study|Lack of Efficacy|14
5906185|NCT01634360|20433195|P1|Overall Study|Lack of Efficacy|4
5906186|NCT01634360|20433194|P2|Overall Study|Protocol Violation|1
5906187|NCT01634360|20433195|P1|Overall Study|Protocol Violation|1
5906188|NCT01634360|20433194|P2|Overall Study|subject withdrew consent|23
5906189|NCT01634360|20433195|P1|Overall Study|subject withdrew consent|13
5906190|NCT01634360|20433194|P2|Overall Study|Adverse Event|34
5906191|NCT01634360|20433195|P1|Overall Study|Adverse Event|10
5906192|NCT01634243|20433269|P2|Overall Study|Lack of Efficacy|0
5906193|NCT01634243|20433270|P1|Overall Study|Lack of Efficacy|1
5906194|NCT01634243|20433269|P2|Overall Study|Adverse Event|5
5906195|NCT01634243|20433270|P1|Overall Study|Adverse Event|5
5906196|NCT01634165|20433296|P4|Period 2|Adverse Event|0
5906197|NCT01634165|20433297|P3|Period 2|Adverse Event|0
5906198|NCT01634165|20433298|P2|Period 2|Adverse Event|1
5906199|NCT01634165|20433299|P1|Period 2|Adverse Event|0
5906200|NCT01634152|20433332|P3|Overall Study|Other reason not defined above|1
5906201|NCT01634152|20433333|P2|Overall Study|Other reason not defined above|0
5906202|NCT01634152|20433334|P1|Overall Study|Other reason not defined above|1
5906203|NCT01634152|20433332|P3|Overall Study|Not treated|0
5906204|NCT01634152|20433333|P2|Overall Study|Not treated|1
5906205|NCT01634152|20433334|P1|Overall Study|Not treated|0
5906206|NCT01634152|20433332|P3|Overall Study|Consent withdrawn not due to AE|1
5906207|NCT01634152|20433333|P2|Overall Study|Consent withdrawn not due to AE|0
5906208|NCT01634152|20433334|P1|Overall Study|Consent withdrawn not due to AE|1
5906209|NCT01634152|20433332|P3|Overall Study|Adverse Event|2
5906210|NCT01634152|20433333|P2|Overall Study|Adverse Event|0
5906211|NCT01634152|20433334|P1|Overall Study|Adverse Event|2
5906212|NCT01634139|20433417|P3|Overall Study|Not treated|0
5906213|NCT01634139|20433418|P2|Overall Study|Not treated|1
5906214|NCT01634139|20433419|P1|Overall Study|Not treated|1
5906215|NCT01634139|20433417|P3|Overall Study|Lost to Follow-up|0
5906216|NCT01634139|20433418|P2|Overall Study|Lost to Follow-up|2
5906217|NCT01634139|20433419|P1|Overall Study|Lost to Follow-up|0
5906218|NCT01634139|20433417|P3|Overall Study|Other|3
5906219|NCT01634139|20433418|P2|Overall Study|Other|0
5906220|NCT01634139|20433419|P1|Overall Study|Other|4
5906221|NCT01634139|20433417|P3|Overall Study|Consent withdrawn not due to AE|2
5906222|NCT01634139|20433418|P2|Overall Study|Consent withdrawn not due to AE|3
5906223|NCT01634139|20433419|P1|Overall Study|Consent withdrawn not due to AE|4
5906224|NCT01634139|20433417|P3|Overall Study|Non compliant with protocol|0
5906225|NCT01634139|20433418|P2|Overall Study|Non compliant with protocol|0
5906226|NCT01634139|20433419|P1|Overall Study|Non compliant with protocol|1
5906227|NCT01634113|20433520|P3|Overall Study|Not treated|1
5906228|NCT01634113|20433521|P2|Overall Study|Not treated|0
5906229|NCT01634113|20433522|P1|Overall Study|Not treated|0
5906230|NCT01634100|20433566|P6|Overall Study|Withdrawal by Subject|0
5906231|NCT01634100|20433567|P5|Overall Study|Withdrawal by Subject|0
5906232|NCT01634100|20433568|P4|Overall Study|Withdrawal by Subject|0
5906233|NCT01634100|20433569|P3|Overall Study|Withdrawal by Subject|1
5906234|NCT01634100|20433570|P2|Overall Study|Withdrawal by Subject|0
5906235|NCT01634100|20433571|P1|Overall Study|Withdrawal by Subject|1
5906236|NCT01633944|20433587|P3|Double-blind Treatment Phase|Other|0
5906237|NCT01633944|20433588|P2|Double-blind Treatment Phase|Other|7
5906238|NCT01633944|20433589|P1|Double-blind Treatment Phase|Other|0
5906239|NCT01633944|20433587|P3|Double-blind Treatment Phase|Not exposed to DB study medication|0
5906240|NCT01633944|20433588|P2|Double-blind Treatment Phase|Not exposed to DB study medication|1
5906241|NCT01633944|20433589|P1|Double-blind Treatment Phase|Not exposed to DB study medication|0
5906242|NCT01633944|20433587|P3|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1
5906243|NCT01633944|20433588|P2|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|3
5906244|NCT01633944|20433589|P1|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0
5906245|NCT01633944|20433587|P3|Double-blind Treatment Phase|Lost to Follow-up|9
5906246|NCT01633944|20433588|P2|Double-blind Treatment Phase|Lost to Follow-up|4
5906247|NCT01633944|20433589|P1|Double-blind Treatment Phase|Lost to Follow-up|0
5906248|NCT01633944|20433587|P3|Double-blind Treatment Phase|Protocol Violation|10
5906249|NCT01633944|20433588|P2|Double-blind Treatment Phase|Protocol Violation|7
5906250|NCT01633944|20433589|P1|Double-blind Treatment Phase|Protocol Violation|0
5906251|NCT01633944|20433587|P3|Double-blind Treatment Phase|Withdrawal by Subject|8
5906252|NCT01633944|20433588|P2|Double-blind Treatment Phase|Withdrawal by Subject|11
5906253|NCT01633944|20433589|P1|Double-blind Treatment Phase|Withdrawal by Subject|0
5906254|NCT01633944|20433587|P3|Double-blind Treatment Phase|Lack of Efficacy|23
5906255|NCT01633944|20433588|P2|Double-blind Treatment Phase|Lack of Efficacy|8
5906256|NCT01633944|20433589|P1|Double-blind Treatment Phase|Lack of Efficacy|0
5906257|NCT01633944|20433587|P3|Double-blind Treatment Phase|Adverse Event|7
5906258|NCT01633944|20433588|P2|Double-blind Treatment Phase|Adverse Event|13
5906259|NCT01633944|20433589|P1|Double-blind Treatment Phase|Adverse Event|0
5906260|NCT01633944|20433587|P3|Open-label Titration Phase|Other|0
5906261|NCT01633944|20433588|P2|Open-label Titration Phase|Other|0
5906262|NCT01633944|20433589|P1|Open-label Titration Phase|Other|68
5906263|NCT01633944|20433587|P3|Open-label Titration Phase|Lost to Follow-up|0
5906264|NCT01633944|20433588|P2|Open-label Titration Phase|Lost to Follow-up|0
5906265|NCT01633944|20433589|P1|Open-label Titration Phase|Lost to Follow-up|22
5906266|NCT01633944|20433587|P3|Open-label Titration Phase|Protocol Violation|0
5906267|NCT01633944|20433588|P2|Open-label Titration Phase|Protocol Violation|0
5906268|NCT01633944|20433589|P1|Open-label Titration Phase|Protocol Violation|24
5906269|NCT01633944|20433587|P3|Open-label Titration Phase|Withdrawal by Subject|0
5906270|NCT01633944|20433588|P2|Open-label Titration Phase|Withdrawal by Subject|0
5906271|NCT01633944|20433589|P1|Open-label Titration Phase|Withdrawal by Subject|34
5906272|NCT01633944|20433587|P3|Open-label Titration Phase|Lack of Efficacy|0
5906273|NCT01633944|20433588|P2|Open-label Titration Phase|Lack of Efficacy|0
5906274|NCT01633944|20433589|P1|Open-label Titration Phase|Lack of Efficacy|33
5906275|NCT01633944|20433587|P3|Open-label Titration Phase|Adverse Event|0
5906276|NCT01633944|20433588|P2|Open-label Titration Phase|Adverse Event|0
5906277|NCT01633944|20433589|P1|Open-label Titration Phase|Adverse Event|109
5906278|NCT01633788|20433657|P4|Overall Study|Other Reasons|7
5906279|NCT01633788|20433658|P3|Overall Study|Other Reasons|3
5906280|NCT01633788|20433659|P2|Overall Study|Other Reasons|2
5906281|NCT01633788|20433660|P1|Overall Study|Other Reasons|0
5906282|NCT01633788|20433657|P4|Overall Study|Protocol Violation|0
5906283|NCT01633788|20433658|P3|Overall Study|Protocol Violation|1
5906284|NCT01633788|20433659|P2|Overall Study|Protocol Violation|0
5906285|NCT01633788|20433660|P1|Overall Study|Protocol Violation|1
5906286|NCT01633788|20433657|P4|Overall Study|Personal Reasons|3
5906287|NCT01633788|20433658|P3|Overall Study|Personal Reasons|1
5906288|NCT01633788|20433659|P2|Overall Study|Personal Reasons|1
5906289|NCT01633788|20433660|P1|Overall Study|Personal Reasons|3
5906290|NCT01633788|20433657|P4|Overall Study|Lost to Follow-up|0
5906291|NCT01633788|20433658|P3|Overall Study|Lost to Follow-up|2
5906292|NCT01633788|20433659|P2|Overall Study|Lost to Follow-up|2
5906293|NCT01633788|20433660|P1|Overall Study|Lost to Follow-up|2
5906294|NCT01633788|20433657|P4|Overall Study|Adverse Event|3
5906295|NCT01633788|20433658|P3|Overall Study|Adverse Event|3
5906296|NCT01633788|20433659|P2|Overall Study|Adverse Event|3
5906297|NCT01633788|20433660|P1|Overall Study|Adverse Event|1
5906298|NCT01633112|20433692|P3|Overall Study|missing Study Completion CRF|4
5906299|NCT01633112|20433693|P2|Overall Study|missing Study Completion CRF|1
5906300|NCT01633112|20433694|P1|Overall Study|missing Study Completion CRF|1
5906301|NCT01633112|20433692|P3|Overall Study|Withdrawal by Subject|41
5906302|NCT01633112|20433693|P2|Overall Study|Withdrawal by Subject|12
5906303|NCT01633112|20433694|P1|Overall Study|Withdrawal by Subject|20
5906304|NCT01633112|20433692|P3|Overall Study|Subject no longer requires study drug|1
5906305|NCT01633112|20433693|P2|Overall Study|Subject no longer requires study drug|0
5906306|NCT01633112|20433694|P1|Overall Study|Subject no longer requires study drug|0
5906307|NCT01633112|20433692|P3|Overall Study|Protocol Violation|2
5906308|NCT01633112|20433693|P2|Overall Study|Protocol Violation|0
5906309|NCT01633112|20433694|P1|Overall Study|Protocol Violation|4
5906310|NCT01633112|20433692|P3|Overall Study|Lost to Follow-up|6
5906311|NCT01633112|20433693|P2|Overall Study|Lost to Follow-up|19
5906312|NCT01633112|20433694|P1|Overall Study|Lost to Follow-up|7
5906313|NCT01633112|20433692|P3|Overall Study|Adverse Event|20
5906314|NCT01633112|20433693|P2|Overall Study|Adverse Event|18
5906315|NCT01633112|20433694|P1|Overall Study|Adverse Event|16
5906316|NCT01633112|20433692|P3|Overall Study|Administrative problems|5
5906317|NCT01633112|20433693|P2|Overall Study|Administrative problems|2
5906318|NCT01633112|20433694|P1|Overall Study|Administrative problems|1
5906319|NCT01633112|20433692|P3|Overall Study|Abnormal test procedure result(s)|0
5906320|NCT01633112|20433693|P2|Overall Study|Abnormal test procedure result(s)|1
5906321|NCT01633112|20433694|P1|Overall Study|Abnormal test procedure result(s)|0
5906322|NCT01633112|20433692|P3|Overall Study|Abnormal laboratory value(s)|0
5906323|NCT01633112|20433693|P2|Overall Study|Abnormal laboratory value(s)|1
5906324|NCT01633112|20433694|P1|Overall Study|Abnormal laboratory value(s)|3
5906325|NCT01633112|20433692|P3|Overall Study|Lack of Efficacy|13
5906326|NCT01633112|20433693|P2|Overall Study|Lack of Efficacy|6
5906327|NCT01633112|20433694|P1|Overall Study|Lack of Efficacy|1
5906328|NCT01633060|20433729|P2|Post-Treatment Efficacy Follow-Up Phase|Death|0
5906329|NCT01633060|20433730|P1|Post-Treatment Efficacy Follow-Up Phase|Death|1
5906330|NCT01633060|20433729|P2|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1
5906331|NCT01633060|20433730|P1|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1
5906332|NCT01633060|20433729|P2|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|0
5906333|NCT01633060|20433730|P1|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|1
5906334|NCT01633060|20433729|P2|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|1
5906335|NCT01633060|20433730|P1|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|10
5906336|NCT01633060|20433729|P2|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|0
5906337|NCT01633060|20433730|P1|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|1
5906338|NCT01633060|20433729|P2|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0
5906339|NCT01633060|20433730|P1|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2
5906340|NCT01633060|20433729|P2|Treatment Phase|Death|3
5906341|NCT01633060|20433730|P1|Treatment Phase|Death|4
5906342|NCT01633060|20433729|P2|Treatment Phase|Subject/guardian decision|4
5906343|NCT01633060|20433730|P1|Treatment Phase|Subject/guardian decision|25
5906344|NCT01633060|20433729|P2|Treatment Phase|Study Terminated by sponsor|3
5906345|NCT01633060|20433730|P1|Treatment Phase|Study Terminated by sponsor|7
5906346|NCT01633060|20433729|P2|Treatment Phase|Protocol Deviation|0
5906347|NCT01633060|20433730|P1|Treatment Phase|Protocol Deviation|1
5906348|NCT01633060|20433729|P2|Treatment Phase|Progressive Disease|120
5906349|NCT01633060|20433730|P1|Treatment Phase|Progressive Disease|210
5906350|NCT01633060|20433729|P2|Treatment Phase|Physician Decision|7
5906351|NCT01633060|20433730|P1|Treatment Phase|Physician Decision|16
5906352|NCT01633060|20433729|P2|Treatment Phase|Lost to Follow-up|0
5906353|NCT01633060|20433730|P1|Treatment Phase|Lost to Follow-up|1
5906354|NCT01633060|20433729|P2|Treatment Phase|Adverse Event|3
5906355|NCT01633060|20433730|P1|Treatment Phase|Adverse Event|24
5906356|NCT01633060|20433729|P2|Randomization Phase|Technical problem|1
5906357|NCT01633060|20433730|P1|Randomization Phase|Technical problem|0
5906358|NCT01633060|20433729|P2|Randomization Phase|Protocol deviation|2
5906359|NCT01633060|20433730|P1|Randomization Phase|Protocol deviation|1
5906360|NCT01632904|20433770|P2|Overall Study|Reason for discontinuation not available|1
5906361|NCT01632904|20433771|P1|Overall Study|Reason for discontinuation not available|0
5906362|NCT01632904|20433770|P2|Overall Study|Disease Progression|1
5906363|NCT01632904|20433771|P1|Overall Study|Disease Progression|0
5906364|NCT01632904|20433770|P2|Overall Study|Subject decision|2
5906365|NCT01632904|20433771|P1|Overall Study|Subject decision|3
5906366|NCT01632904|20433770|P2|Overall Study|Physician Decision|1
5906367|NCT01632904|20433771|P1|Overall Study|Physician Decision|0
5906368|NCT01632904|20433770|P2|Overall Study|Adverse Event|1
5906369|NCT01632904|20433771|P1|Overall Study|Adverse Event|4
5906370|NCT01632891|20433782|P2|Overall Study|Withdrawal by Subject|0
5906371|NCT01632891|20433783|P1|Overall Study|Withdrawal by Subject|1
5906372|NCT01632891|20433782|P2|Overall Study|Lost to Follow-up|1
5906373|NCT01632891|20433783|P1|Overall Study|Lost to Follow-up|0
5906374|NCT01632878|20433807|P1|Treatment|no information on study completion|43
5906375|NCT01632878|20433807|P1|Treatment|missing information|4
5906376|NCT01632878|20433807|P1|Treatment|Physician Decision|34
5906377|NCT01632878|20433807|P1|Treatment|Withdrawal by Subject|36
5906378|NCT01632878|20433807|P1|Treatment|Lost to Follow-up|41
5906379|NCT01632878|20433807|P1|Screening|Physician Decision|268
5906380|NCT01632800|20433811|P1|Overall Study|Subject did not fit in apparatus|1
5906381|NCT01632579|20433878|P9|Period 2 (Second Intervention)|Adverse Event|0
5906382|NCT01632579|20433879|P8|Period 2 (Second Intervention)|Adverse Event|0
5906383|NCT01632579|20433880|P7|Period 2 (Second Intervention)|Adverse Event|0
5906384|NCT01632579|20433881|P6|Period 2 (Second Intervention)|Adverse Event|0
5906385|NCT01632579|20433882|P5|Period 2 (Second Intervention)|Adverse Event|0
5906386|NCT01632579|20433883|P4|Period 2 (Second Intervention)|Adverse Event|0
5906387|NCT01632579|20433884|P3|Period 2 (Second Intervention)|Adverse Event|0
5906388|NCT01632579|20433885|P2|Period 2 (Second Intervention)|Adverse Event|0
5906389|NCT01632579|20433886|P1|Period 2 (Second Intervention)|Adverse Event|1
5906390|NCT01632579|20433878|P9|Washout Period|Adverse Event|0
5906391|NCT01632579|20433879|P8|Washout Period|Adverse Event|0
5906392|NCT01632579|20433880|P7|Washout Period|Adverse Event|0
5906393|NCT01632579|20433881|P6|Washout Period|Adverse Event|0
5906394|NCT01632579|20433882|P5|Washout Period|Adverse Event|0
5906395|NCT01632579|20433883|P4|Washout Period|Adverse Event|0
5906396|NCT01632579|20433884|P3|Washout Period|Adverse Event|0
5906397|NCT01632579|20433885|P2|Washout Period|Adverse Event|0
5906398|NCT01632579|20433886|P1|Washout Period|Adverse Event|1
5906399|NCT01632566|20433953|P5|Overall Study|Sponsor Decision|2
5906400|NCT01632566|20433954|P4|Overall Study|Sponsor Decision|2
5906401|NCT01632566|20433955|P3|Overall Study|Sponsor Decision|9
5906402|NCT01632566|20433956|P2|Overall Study|Sponsor Decision|2
5906403|NCT01632566|20433957|P1|Overall Study|Sponsor Decision|0
5906404|NCT01632566|20433953|P5|Overall Study|Withdrawal by Subject|0
5906405|NCT01632566|20433954|P4|Overall Study|Withdrawal by Subject|0
5906406|NCT01632566|20433955|P3|Overall Study|Withdrawal by Subject|0
5906407|NCT01632566|20433956|P2|Overall Study|Withdrawal by Subject|1
5906408|NCT01632566|20433957|P1|Overall Study|Withdrawal by Subject|0
5906409|NCT01632345|20434008|P7|Treatment: Part II|Withdrawal by Subject|2
5906410|NCT01632345|20434009|P6|Treatment: Part II|Withdrawal by Subject|2
5906411|NCT01632345|20434010|P5|Treatment: Part II|Withdrawal by Subject|0
5906412|NCT01632345|20434011|P4|Treatment: Part II|Withdrawal by Subject|0
5906413|NCT01632345|20434012|P3|Treatment: Part II|Withdrawal by Subject|0
5906414|NCT01632345|20434013|P2|Treatment: Part II|Withdrawal by Subject|0
5906415|NCT01632345|20434014|P1|Treatment: Part II|Withdrawal by Subject|0
5906416|NCT01632345|20434008|P7|Treatment: Part II|Non-Compliance with Study Drug|0
5906417|NCT01632345|20434009|P6|Treatment: Part II|Non-Compliance with Study Drug|3
5906418|NCT01632345|20434010|P5|Treatment: Part II|Non-Compliance with Study Drug|0
5906419|NCT01632345|20434011|P4|Treatment: Part II|Non-Compliance with Study Drug|0
5906420|NCT01632345|20434012|P3|Treatment: Part II|Non-Compliance with Study Drug|0
5906421|NCT01632345|20434013|P2|Treatment: Part II|Non-Compliance with Study Drug|0
5906422|NCT01632345|20434014|P1|Treatment: Part II|Non-Compliance with Study Drug|0
5906423|NCT01632345|20434008|P7|Treatment: Part II|Lost to Follow-up|1
5906424|NCT01632345|20434009|P6|Treatment: Part II|Lost to Follow-up|3
5906425|NCT01632345|20434010|P5|Treatment: Part II|Lost to Follow-up|0
5906426|NCT01632345|20434011|P4|Treatment: Part II|Lost to Follow-up|0
5906427|NCT01632345|20434012|P3|Treatment: Part II|Lost to Follow-up|0
5906428|NCT01632345|20434013|P2|Treatment: Part II|Lost to Follow-up|0
5906429|NCT01632345|20434014|P1|Treatment: Part II|Lost to Follow-up|0
5906430|NCT01632345|20434008|P7|Treatment: Part II|Adverse Event|8
5906431|NCT01632345|20434009|P6|Treatment: Part II|Adverse Event|3
5906432|NCT01632345|20434010|P5|Treatment: Part II|Adverse Event|0
5906433|NCT01632345|20434011|P4|Treatment: Part II|Adverse Event|0
5906434|NCT01632345|20434012|P3|Treatment: Part II|Adverse Event|0
5906435|NCT01632345|20434013|P2|Treatment: Part II|Adverse Event|0
5906436|NCT01632345|20434014|P1|Treatment: Part II|Adverse Event|0
5906437|NCT01632345|20434008|P7|Treatment: Part I|Withdrawal by Subject|0
5906438|NCT01632345|20434009|P6|Treatment: Part I|Withdrawal by Subject|0
5906439|NCT01632345|20434010|P5|Treatment: Part I|Withdrawal by Subject|4
5906440|NCT01632345|20434011|P4|Treatment: Part I|Withdrawal by Subject|1
5906441|NCT01632345|20434012|P3|Treatment: Part I|Withdrawal by Subject|4
5906442|NCT01632345|20434013|P2|Treatment: Part I|Withdrawal by Subject|4
5906443|NCT01632345|20434014|P1|Treatment: Part I|Withdrawal by Subject|3
5906444|NCT01632345|20434008|P7|Treatment: Part I|Protocol Deviation|0
5906445|NCT01632345|20434009|P6|Treatment: Part I|Protocol Deviation|0
5906446|NCT01632345|20434010|P5|Treatment: Part I|Protocol Deviation|0
5906447|NCT01632345|20434011|P4|Treatment: Part I|Protocol Deviation|1
5906448|NCT01632345|20434012|P3|Treatment: Part I|Protocol Deviation|1
5906449|NCT01632345|20434013|P2|Treatment: Part I|Protocol Deviation|0
5906450|NCT01632345|20434014|P1|Treatment: Part I|Protocol Deviation|0
5906451|NCT01632345|20434008|P7|Treatment: Part I|Pregnancy|0
5906452|NCT01632345|20434009|P6|Treatment: Part I|Pregnancy|0
5906453|NCT01632345|20434010|P5|Treatment: Part I|Pregnancy|0
5906454|NCT01632345|20434011|P4|Treatment: Part I|Pregnancy|0
5906455|NCT01632345|20434012|P3|Treatment: Part I|Pregnancy|0
5906456|NCT01632345|20434013|P2|Treatment: Part I|Pregnancy|1
5906457|NCT01632345|20434014|P1|Treatment: Part I|Pregnancy|0
5906458|NCT01632345|20434008|P7|Treatment: Part I|Physician Decision|0
5906459|NCT01632345|20434009|P6|Treatment: Part I|Physician Decision|0
5906460|NCT01632345|20434010|P5|Treatment: Part I|Physician Decision|1
5906461|NCT01632345|20434011|P4|Treatment: Part I|Physician Decision|0
5906462|NCT01632345|20434012|P3|Treatment: Part I|Physician Decision|0
5906463|NCT01632345|20434013|P2|Treatment: Part I|Physician Decision|1
5906464|NCT01632345|20434014|P1|Treatment: Part I|Physician Decision|2
5906465|NCT01632345|20434008|P7|Treatment: Part I|Non-Compliance with Study Drug|0
5906466|NCT01632345|20434009|P6|Treatment: Part I|Non-Compliance with Study Drug|0
5906467|NCT01632345|20434010|P5|Treatment: Part I|Non-Compliance with Study Drug|0
5906468|NCT01632345|20434011|P4|Treatment: Part I|Non-Compliance with Study Drug|1
5906469|NCT01632345|20434012|P3|Treatment: Part I|Non-Compliance with Study Drug|2
5906470|NCT01632345|20434013|P2|Treatment: Part I|Non-Compliance with Study Drug|2
5906471|NCT01632345|20434014|P1|Treatment: Part I|Non-Compliance with Study Drug|3
5906472|NCT01632345|20434008|P7|Treatment: Part I|Lost to Follow-up|0
5906473|NCT01632345|20434009|P6|Treatment: Part I|Lost to Follow-up|0
5906474|NCT01632345|20434010|P5|Treatment: Part I|Lost to Follow-up|4
5906475|NCT01632345|20434011|P4|Treatment: Part I|Lost to Follow-up|3
5906476|NCT01632345|20434012|P3|Treatment: Part I|Lost to Follow-up|1
5906477|NCT01632345|20434013|P2|Treatment: Part I|Lost to Follow-up|2
5906478|NCT01632345|20434014|P1|Treatment: Part I|Lost to Follow-up|3
5906479|NCT01632345|20434008|P7|Treatment: Part I|Lack of Efficacy|0
5906480|NCT01632345|20434009|P6|Treatment: Part I|Lack of Efficacy|0
5906481|NCT01632345|20434010|P5|Treatment: Part I|Lack of Efficacy|1
5906482|NCT01632345|20434011|P4|Treatment: Part I|Lack of Efficacy|1
5906483|NCT01632345|20434012|P3|Treatment: Part I|Lack of Efficacy|0
5906484|NCT01632345|20434013|P2|Treatment: Part I|Lack of Efficacy|1
5906485|NCT01632345|20434014|P1|Treatment: Part I|Lack of Efficacy|0
5906486|NCT01632345|20434008|P7|Treatment: Part I|Adverse Event|0
5906487|NCT01632345|20434009|P6|Treatment: Part I|Adverse Event|0
5906488|NCT01632345|20434010|P5|Treatment: Part I|Adverse Event|3
5906489|NCT01632345|20434011|P4|Treatment: Part I|Adverse Event|1
5906490|NCT01632345|20434012|P3|Treatment: Part I|Adverse Event|2
5906491|NCT01632345|20434013|P2|Treatment: Part I|Adverse Event|4
5906492|NCT01632345|20434014|P1|Treatment: Part I|Adverse Event|1
5906493|NCT01632306|20434076|P3|Overall Study|Protocol Violation|0
5906494|NCT01632306|20434077|P2|Overall Study|Protocol Violation|0
5906495|NCT01632306|20434078|P1|Overall Study|Protocol Violation|1
5906496|NCT01632280|20434094|P2|Overall Study|Withdrawal by Subject|0
5906497|NCT01632280|20434095|P1|Overall Study|Withdrawal by Subject|1
5906498|NCT01632241|20434111|P2|Open-label (Week 52 to Week 76)|Adverse Event|0
5906499|NCT01632241|20434112|P1|Open-label (Week 52 to Week 76)|Adverse Event|1
5906500|NCT01632241|20434111|P2|Open-label (Week 52 to Week 76)|Lack of Efficacy|2
5906501|NCT01632241|20434112|P1|Open-label (Week 52 to Week 76)|Lack of Efficacy|0
5906502|NCT01632241|20434111|P2|Open-label (Week 52 to Week 76)|Protocol Violation|2
5906503|NCT01632241|20434112|P1|Open-label (Week 52 to Week 76)|Protocol Violation|0
5906504|NCT01632241|20434111|P2|Open-label (Week 52 to Week 76)|Site Closed|8
5906505|NCT01632241|20434112|P1|Open-label (Week 52 to Week 76)|Site Closed|2
5906506|NCT01632241|20434111|P2|Open-label (Week 52 to Week 76)|Lost to Follow-up|4
5906507|NCT01632241|20434112|P1|Open-label (Week 52 to Week 76)|Lost to Follow-up|1
5906508|NCT01632241|20434111|P2|Open-label (Week 52 to Week 76)|Physician Decision|4
5906509|NCT01632241|20434112|P1|Open-label (Week 52 to Week 76)|Physician Decision|1
5906510|NCT01632241|20434111|P2|Open-label (Week 52 to Week 76)|Withdrawal by Subject|2
5906511|NCT01632241|20434112|P1|Open-label (Week 52 to Week 76)|Withdrawal by Subject|5
5906512|NCT01632241|20434111|P2|Double-blinded (Up to Week 52)|Adverse Event|19
5906513|NCT01632241|20434112|P1|Double-blinded (Up to Week 52)|Adverse Event|10
5906514|NCT01632241|20434111|P2|Double-blinded (Up to Week 52)|Withdrawal by Subject|14
5906515|NCT01632241|20434112|P1|Double-blinded (Up to Week 52)|Withdrawal by Subject|10
5906516|NCT01632241|20434111|P2|Double-blinded (Up to Week 52)|Lack of Efficacy|15
5906517|NCT01632241|20434112|P1|Double-blinded (Up to Week 52)|Lack of Efficacy|9
5906518|NCT01632241|20434111|P2|Double-blinded (Up to Week 52)|Physician Decision|12
5906519|NCT01632241|20434112|P1|Double-blinded (Up to Week 52)|Physician Decision|9
5906520|NCT01632241|20434111|P2|Double-blinded (Up to Week 52)|Lost to Follow-up|8
5906521|NCT01632241|20434112|P1|Double-blinded (Up to Week 52)|Lost to Follow-up|1
5906522|NCT01632241|20434111|P2|Double-blinded (Up to Week 52)|Protocol Violation|6
5906523|NCT01632241|20434112|P1|Double-blinded (Up to Week 52)|Protocol Violation|2
5906524|NCT01632241|20434111|P2|Double-blinded (Up to Week 52)|Site Closed|5
5906525|NCT01632241|20434112|P1|Double-blinded (Up to Week 52)|Site Closed|3
5906526|NCT01632150|20434182|P1|Overall Study|Moved to compassionate program|2
5906527|NCT01632150|20434182|P1|Overall Study|Patient underwent autologous transplant|1
5906528|NCT01632150|20434182|P1|Overall Study|Withdrawal by Subject|2
5906529|NCT01632150|20434182|P1|Overall Study|Unrelated adverse event|7
5906530|NCT01632150|20434182|P1|Overall Study|Study drug toxicity|1
5906531|NCT01632150|20434182|P1|Overall Study|Disease progression|27
5906532|NCT01632020|20434191|P2|Overall Study|Adverse Event|0
5906533|NCT01632020|20434192|P1|Overall Study|Adverse Event|1
5906534|NCT01632020|20434191|P2|Overall Study|Withdrawal by Subject|0
5906535|NCT01632020|20434192|P1|Overall Study|Withdrawal by Subject|1
5906536|NCT01631864|20434211|P2|Overall Study|Adverse Event|3
5906537|NCT01631864|20434212|P1|Overall Study|Adverse Event|2
5906538|NCT01631864|20434211|P2|Overall Study|Withdrawal by Subject|1
5906539|NCT01631864|20434212|P1|Overall Study|Withdrawal by Subject|0
5906540|NCT01631825|20434224|P1|Overall Study|Physician Decision|2
5906541|NCT01631825|20434224|P1|Overall Study|Discontinuation criteria|1
5906542|NCT01631825|20434224|P1|Overall Study|Protocol Violation|4
5906543|NCT01631825|20434224|P1|Overall Study|Withdrawal by Subject|9
5906544|NCT01631825|20434224|P1|Overall Study|Lack of Efficacy|7
5906545|NCT01631825|20434224|P1|Overall Study|Adverse Event|42
5906546|NCT01631812|20434244|P1|Overall Study|Physician Decision|3
5906547|NCT01631812|20434244|P1|Overall Study|Withdrawal by Subject|4
5906548|NCT01631812|20434244|P1|Overall Study|Lack of Efficacy|5
5906549|NCT01631812|20434244|P1|Overall Study|Adverse Event|25
5906550|NCT01631747|20434254|P2|One Year Infant Outcomes|Patient Refused|9
5906551|NCT01631747|20434255|P1|One Year Infant Outcomes|Patient Refused|13
5906552|NCT01631747|20434254|P2|Live Birth|Stillbirth|1
5906553|NCT01631747|20434255|P1|Live Birth|Stillbirth|1
5906554|NCT01631747|20434254|P2|Live Birth|MIscarriage|0
5906555|NCT01631747|20434255|P1|Live Birth|MIscarriage|2
5906556|NCT01631747|20434254|P2|Live Birth|Pregnancy Termination|0
5906557|NCT01631747|20434255|P1|Live Birth|Pregnancy Termination|1
5906558|NCT01631747|20434254|P2|Randomization Through End of Pregnancy|Lost to Follow-up|0
5906559|NCT01631747|20434255|P1|Randomization Through End of Pregnancy|Lost to Follow-up|1
5906560|NCT01631474|20434437|P5|Overall Study|Adverse Event|0
5906561|NCT01631474|20434438|P4|Overall Study|Adverse Event|0
5906562|NCT01631474|20434439|P3|Overall Study|Adverse Event|0
5906563|NCT01631474|20434440|P2|Overall Study|Adverse Event|1
5906564|NCT01631474|20434441|P1|Overall Study|Adverse Event|0
5906565|NCT01631474|20434437|P5|Overall Study|Noncompliance with Study Drug|1
5906566|NCT01631474|20434438|P4|Overall Study|Noncompliance with Study Drug|0
5906567|NCT01631474|20434439|P3|Overall Study|Noncompliance with Study Drug|0
5906568|NCT01631474|20434440|P2|Overall Study|Noncompliance with Study Drug|0
5906569|NCT01631474|20434441|P1|Overall Study|Noncompliance with Study Drug|0
5906570|NCT01631474|20434437|P5|Overall Study|Lack of Efficacy|2
5906571|NCT01631474|20434438|P4|Overall Study|Lack of Efficacy|0
5906572|NCT01631474|20434439|P3|Overall Study|Lack of Efficacy|0
5906573|NCT01631474|20434440|P2|Overall Study|Lack of Efficacy|2
5906574|NCT01631474|20434441|P1|Overall Study|Lack of Efficacy|2
5906575|NCT01631474|20434437|P5|Overall Study|Withdrawal by Subject|5
5906576|NCT01631474|20434438|P4|Overall Study|Withdrawal by Subject|6
5906577|NCT01631474|20434439|P3|Overall Study|Withdrawal by Subject|2
5906578|NCT01631474|20434440|P2|Overall Study|Withdrawal by Subject|4
5906579|NCT01631474|20434441|P1|Overall Study|Withdrawal by Subject|4
5906580|NCT01631474|20434437|P5|Overall Study|Lost to Follow-up|5
5906581|NCT01631474|20434438|P4|Overall Study|Lost to Follow-up|5
5906582|NCT01631474|20434439|P3|Overall Study|Lost to Follow-up|7
5906583|NCT01631474|20434440|P2|Overall Study|Lost to Follow-up|5
5906584|NCT01631474|20434441|P1|Overall Study|Lost to Follow-up|8
5906585|NCT01631435|20434478|P1|Overall Study|incomplete study procedure|5
5906586|NCT01631435|20434478|P1|Overall Study|Withdrawal by Subject|2
5906587|NCT01631435|20434478|P1|Overall Study|Adverse Event|2
5906588|NCT01631227|20434492|P2|Overall Study|administrative|1
5906589|NCT01631227|20434493|P1|Overall Study|administrative|2
5906590|NCT01631227|20434492|P2|Overall Study|Adverse Event|0
5906591|NCT01631227|20434493|P1|Overall Study|Adverse Event|1
5906592|NCT01631227|20434492|P2|Overall Study|withdrawn consent|21
5906593|NCT01631227|20434493|P1|Overall Study|withdrawn consent|27
5906594|NCT01631214|20434501|P2|Overall Study|Administrative Decision|0
5906595|NCT01631214|20434502|P1|Overall Study|Administrative Decision|1
5906596|NCT01631214|20434501|P2|Overall Study|Ineligibility determined|2
5906597|NCT01631214|20434502|P1|Overall Study|Ineligibility determined|5
5906598|NCT01631214|20434501|P2|Overall Study|Protocol Deviation|3
5906599|NCT01631214|20434502|P1|Overall Study|Protocol Deviation|4
5906600|NCT01631214|20434501|P2|Overall Study|Requirement for Alternative Therapy|3
5906601|NCT01631214|20434502|P1|Overall Study|Requirement for Alternative Therapy|8
5906602|NCT01631214|20434501|P2|Overall Study|Noncompliance|15
5906603|NCT01631214|20434502|P1|Overall Study|Noncompliance|16
5906604|NCT01631214|20434501|P2|Overall Study|Other|19
5906605|NCT01631214|20434502|P1|Overall Study|Other|22
5906606|NCT01631214|20434501|P2|Overall Study|Adverse Event|45
5906607|NCT01631214|20434502|P1|Overall Study|Adverse Event|45
5906608|NCT01631214|20434501|P2|Overall Study|Lost to Follow-up|40
5906609|NCT01631214|20434502|P1|Overall Study|Lost to Follow-up|54
5906610|NCT01631214|20434501|P2|Overall Study|Death|106
5906611|NCT01631214|20434502|P1|Overall Study|Death|113
5906612|NCT01631214|20434501|P2|Overall Study|Withdrawal by Subject|290
5906613|NCT01631214|20434502|P1|Overall Study|Withdrawal by Subject|276
5906614|NCT01630811|20434611|P2|Second Intervention (8 Weeks)|Withdrawal by Subject|0
5906615|NCT01630811|20434612|P1|Second Intervention (8 Weeks)|Withdrawal by Subject|1
5906616|NCT01630616|20434639|P6|Overall Study|Withdrawal by Subject|0
5906617|NCT01630616|20434640|P5|Overall Study|Withdrawal by Subject|0
5906618|NCT01630616|20434641|P4|Overall Study|Withdrawal by Subject|2
5906619|NCT01630616|20434642|P3|Overall Study|Withdrawal by Subject|0
5906620|NCT01630616|20434643|P2|Overall Study|Withdrawal by Subject|0
5906621|NCT01630616|20434644|P1|Overall Study|Withdrawal by Subject|0
5906622|NCT01630616|20434639|P6|Overall Study|Adverse Event|0
5906623|NCT01630616|20434640|P5|Overall Study|Adverse Event|0
5906624|NCT01630616|20434641|P4|Overall Study|Adverse Event|1
5906625|NCT01630616|20434642|P3|Overall Study|Adverse Event|0
5906626|NCT01630616|20434643|P2|Overall Study|Adverse Event|0
5906627|NCT01630616|20434644|P1|Overall Study|Adverse Event|0
5906628|NCT01630135|20434744|P2|Overall Study|Protocol-defined Stopping Criteria Met|2
5906629|NCT01630135|20434745|P1|Overall Study|Protocol-defined Stopping Criteria Met|0
5906630|NCT01629966|20434809|P3|Overall Study|Adverse Event|30
5906631|NCT01629966|20434810|P2|Overall Study|Adverse Event|18
5906632|NCT01629966|20434811|P1|Overall Study|Adverse Event|11
5906633|NCT01629966|20434809|P3|Overall Study|Lack of Efficacy|4
5906634|NCT01629966|20434810|P2|Overall Study|Lack of Efficacy|2
5906635|NCT01629966|20434811|P1|Overall Study|Lack of Efficacy|5
5906636|NCT01629966|20434809|P3|Overall Study|Protocol Violation|7
5906637|NCT01629966|20434810|P2|Overall Study|Protocol Violation|9
5906638|NCT01629966|20434811|P1|Overall Study|Protocol Violation|7
5906639|NCT01629966|20434809|P3|Overall Study|Withdrawal by Subject|16
5906640|NCT01629966|20434810|P2|Overall Study|Withdrawal by Subject|9
5906641|NCT01629966|20434811|P1|Overall Study|Withdrawal by Subject|8
5906642|NCT01629966|20434809|P3|Overall Study|Lost to Follow-up|9
5906643|NCT01629966|20434810|P2|Overall Study|Lost to Follow-up|13
5906644|NCT01629966|20434811|P1|Overall Study|Lost to Follow-up|10
5906645|NCT01629966|20434809|P3|Overall Study|Pregnancy|0
5906646|NCT01629966|20434810|P2|Overall Study|Pregnancy|1
5906647|NCT01629966|20434811|P1|Overall Study|Pregnancy|0
5906648|NCT01629953|20434824|P2|Overall Study|Lost to Follow-up|14
5906649|NCT01629953|20434825|P1|Overall Study|Lost to Follow-up|10
5906650|NCT01629953|20434824|P2|Overall Study|Death|1
5906651|NCT01629953|20434825|P1|Overall Study|Death|3
5906652|NCT01629823|20434845|P3|Washout Period|Protocol Violation|0
5906653|NCT01629823|20434846|P2|Washout Period|Protocol Violation|1
5906654|NCT01629823|20434847|P1|Washout Period|Protocol Violation|0
5906655|NCT01629823|20434845|P3|Washout Period|Pregnancy|0
5906656|NCT01629823|20434846|P2|Washout Period|Pregnancy|0
5906657|NCT01629823|20434847|P1|Washout Period|Pregnancy|1
5906658|NCT01629823|20434845|P3|Washout Period|Safety|0
5906659|NCT01629823|20434846|P2|Washout Period|Safety|5
5906660|NCT01629823|20434847|P1|Washout Period|Safety|2
5906661|NCT01629823|20434845|P3|Trial Period|Failed to hold medication|1
5906662|NCT01629823|20434846|P2|Trial Period|Failed to hold medication|0
5906663|NCT01629823|20434847|P1|Trial Period|Failed to hold medication|0
5906664|NCT01629823|20434845|P3|Trial Period|Out-of-window visit|0
5906665|NCT01629823|20434846|P2|Trial Period|Out-of-window visit|2
5906666|NCT01629823|20434847|P1|Trial Period|Out-of-window visit|0
5906667|NCT01629823|20434845|P3|Trial Period|Adverse Event|0
5906668|NCT01629823|20434846|P2|Trial Period|Adverse Event|1
5906669|NCT01629823|20434847|P1|Trial Period|Adverse Event|0
5906670|NCT01629823|20434845|P3|Trial Period|Pregnancy|0
5906671|NCT01629823|20434846|P2|Trial Period|Pregnancy|0
5906672|NCT01629823|20434847|P1|Trial Period|Pregnancy|1
5906673|NCT01629823|20434845|P3|Trial Period|Pre-diluent FEV₁ predicted <70%|1
5906674|NCT01629823|20434846|P2|Trial Period|Pre-diluent FEV₁ predicted <70%|1
5906675|NCT01629823|20434847|P1|Trial Period|Pre-diluent FEV₁ predicted <70%|1
5906676|NCT01629823|20434845|P3|Trial Period|Missed visit|8
5906677|NCT01629823|20434846|P2|Trial Period|Missed visit|9
5906678|NCT01629823|20434847|P1|Trial Period|Missed visit|11
5906679|NCT01629706|20434882|P1|Phase 2 Habitual|Lost to Follow Up after Dispense|1
5906680|NCT01629706|20434882|P1|Phase 2 Habitual|Lost to Follow Up prior to Dispense|1
5906681|NCT01629706|20434882|P1|Phase 2 Habitual|Relocation prior to Dispense|1
5906682|NCT01629706|20434882|P1|Phase 2 Habitual|Slit Lamp Finding prior to Dispense|1
5906683|NCT01629706|20434882|P1|Phase 2 Habitual|Screen Failure|6
5906684|NCT01629706|20434882|P1|Phase 1 PureVision|No Solution-Induced Corneal Staining|3
5906685|NCT01629706|20434882|P1|Phase 1 PureVision|Inconvenience prior to Dispense|1
5906686|NCT01629706|20434882|P1|Phase 1 PureVision|Slit Lamp Finding prior to Dispense|1
5906687|NCT01629706|20434882|P1|Phase 1 PureVision|Screen Failure|4
5906688|NCT01629693|20434910|P2|Overall Study|Subject decision unrelated to AE|1
5906689|NCT01629693|20434911|P1|Overall Study|Subject decision unrelated to AE|0
5906690|NCT01629693|20434910|P2|Overall Study|Poor comfort of study lenses|2
5906691|NCT01629693|20434911|P1|Overall Study|Poor comfort of study lenses|0
5906692|NCT01629693|20434910|P2|Overall Study|Investigator decision|1
5906693|NCT01629693|20434911|P1|Overall Study|Investigator decision|0
5906694|NCT01629693|20434910|P2|Overall Study|Adverse Event|0
5906695|NCT01629693|20434911|P1|Overall Study|Adverse Event|1
5906696|NCT01629693|20434910|P2|Overall Study|Withdrawal by Subject|2
5906697|NCT01629693|20434911|P1|Overall Study|Withdrawal by Subject|2
5906698|NCT01629693|20434910|P2|Overall Study|Lost to Follow-up|4
5906699|NCT01629693|20434911|P1|Overall Study|Lost to Follow-up|2
5906700|NCT01629667|20434920|P3|Overall Study|Code break|0
5906701|NCT01629667|20434921|P2|Overall Study|Code break|0
5906702|NCT01629667|20434922|P1|Overall Study|Code break|1
5906703|NCT01629667|20434920|P3|Overall Study|Enrolled in another clinical study|0
5906704|NCT01629667|20434921|P2|Overall Study|Enrolled in another clinical study|1
5906705|NCT01629667|20434922|P1|Overall Study|Enrolled in another clinical study|0
5906706|NCT01629667|20434920|P3|Overall Study|Site error in safety follow-up|1
5906707|NCT01629667|20434921|P2|Overall Study|Site error in safety follow-up|0
5906708|NCT01629667|20434922|P1|Overall Study|Site error in safety follow-up|0
5906709|NCT01629667|20434920|P3|Overall Study|Started other medicine|1
5906710|NCT01629667|20434921|P2|Overall Study|Started other medicine|0
5906711|NCT01629667|20434922|P1|Overall Study|Started other medicine|1
5906712|NCT01629667|20434920|P3|Overall Study|Early tretmt termntd, cmpltd safety f-up|8
5906713|NCT01629667|20434921|P2|Overall Study|Early tretmt termntd, cmpltd safety f-up|11
5906714|NCT01629667|20434922|P1|Overall Study|Early tretmt termntd, cmpltd safety f-up|9
5906715|NCT01629667|20434920|P3|Overall Study|Requiring lung transplant|3
5906716|NCT01629667|20434921|P2|Overall Study|Requiring lung transplant|1
5906717|NCT01629667|20434922|P1|Overall Study|Requiring lung transplant|2
5906718|NCT01629667|20434920|P3|Overall Study|Ongoing AE worsening right heart failure|0
5906719|NCT01629667|20434921|P2|Overall Study|Ongoing AE worsening right heart failure|1
5906720|NCT01629667|20434922|P1|Overall Study|Ongoing AE worsening right heart failure|0
5906721|NCT01629667|20434920|P3|Overall Study|Randomized, not treated|0
5906722|NCT01629667|20434921|P2|Overall Study|Randomized, not treated|1
5906723|NCT01629667|20434922|P1|Overall Study|Randomized, not treated|2
5906724|NCT01629667|20434920|P3|Overall Study|Death|3
5906725|NCT01629667|20434921|P2|Overall Study|Death|5
5906726|NCT01629667|20434922|P1|Overall Study|Death|1
5906727|NCT01629667|20434920|P3|Overall Study|Withdrawal by Subject|28
5906728|NCT01629667|20434921|P2|Overall Study|Withdrawal by Subject|20
5906729|NCT01629667|20434922|P1|Overall Study|Withdrawal by Subject|31
5906730|NCT01629667|20434920|P3|Overall Study|Lost to Follow-up|1
5906731|NCT01629667|20434921|P2|Overall Study|Lost to Follow-up|1
5906732|NCT01629667|20434922|P1|Overall Study|Lost to Follow-up|0
5906733|NCT01629589|20435013|P2|Overall Study|Did not receive study vaccine|1
5906734|NCT01629589|20435014|P1|Overall Study|Did not receive study vaccine|0
5906735|NCT01629589|20435013|P2|Overall Study|Withdrawal by Subject|3
5906736|NCT01629589|20435014|P1|Overall Study|Withdrawal by Subject|2
5906737|NCT01629589|20435013|P2|Overall Study|Lost to Follow-up|1
5906738|NCT01629589|20435014|P1|Overall Study|Lost to Follow-up|2
5906739|NCT01629589|20435013|P2|Overall Study|Protocol Violation|2
5906740|NCT01629589|20435014|P1|Overall Study|Protocol Violation|4
5906741|NCT01629563|20435032|P2|Overall Study|Protocol Violation|1
5906742|NCT01629563|20435033|P1|Overall Study|Protocol Violation|0
5906743|NCT01629563|20435032|P2|Overall Study|Lack of return of menses|7
5906744|NCT01629563|20435033|P1|Overall Study|Lack of return of menses|12
5906745|NCT01629563|20435032|P2|Overall Study|surgery|3
5906746|NCT01629563|20435033|P1|Overall Study|surgery|0
5906747|NCT01629563|20435032|P2|Overall Study|Withdrawal by Subject|20
5906748|NCT01629563|20435033|P1|Overall Study|Withdrawal by Subject|27
5906749|NCT01629563|20435032|P2|Overall Study|Protocol Violation|1
5906750|NCT01629563|20435033|P1|Overall Study|Protocol Violation|0
5906751|NCT01629563|20435032|P2|Overall Study|Pregnancy|2
5906752|NCT01629563|20435033|P1|Overall Study|Pregnancy|1
5906753|NCT01629563|20435032|P2|Overall Study|Lost to Follow-up|0
5906754|NCT01629563|20435033|P1|Overall Study|Lost to Follow-up|1
5906755|NCT01629563|20435032|P2|Overall Study|Lack of Efficacy|3
5906756|NCT01629563|20435033|P1|Overall Study|Lack of Efficacy|2
5906757|NCT01629563|20435032|P2|Overall Study|Death|0
5906758|NCT01629563|20435033|P1|Overall Study|Death|2
5906759|NCT01629563|20435032|P2|Overall Study|Adverse Event|16
5906760|NCT01629563|20435033|P1|Overall Study|Adverse Event|16
5906761|NCT01628965|20435122|P1|Overall Study|Discontinuation criteria|8
5906762|NCT01628965|20435122|P1|Overall Study|Lost to Follow-up|1
5906763|NCT01628965|20435122|P1|Overall Study|Withdrawal by Subject|3
5906764|NCT01628965|20435122|P1|Overall Study|Lack of Efficacy|7
5906765|NCT01628965|20435122|P1|Overall Study|Adverse Event|30
5906766|NCT01628926|20435131|P3|Overall Study|Physician Decision|1
5906767|NCT01628926|20435132|P2|Overall Study|Physician Decision|2
5906768|NCT01628926|20435133|P1|Overall Study|Physician Decision|2
5906769|NCT01628926|20435131|P3|Overall Study|Discontinuation criteria|0
5906770|NCT01628926|20435132|P2|Overall Study|Discontinuation criteria|4
5906771|NCT01628926|20435133|P1|Overall Study|Discontinuation criteria|3
5906772|NCT01628926|20435131|P3|Overall Study|Protocol Violation|0
5906773|NCT01628926|20435132|P2|Overall Study|Protocol Violation|1
5906774|NCT01628926|20435133|P1|Overall Study|Protocol Violation|0
5906775|NCT01628926|20435131|P3|Overall Study|Withdrawal by Subject|2
5906776|NCT01628926|20435132|P2|Overall Study|Withdrawal by Subject|4
5906777|NCT01628926|20435133|P1|Overall Study|Withdrawal by Subject|6
5906778|NCT01628926|20435131|P3|Overall Study|Lack of Efficacy|5
5906779|NCT01628926|20435132|P2|Overall Study|Lack of Efficacy|1
5906780|NCT01628926|20435133|P1|Overall Study|Lack of Efficacy|2
5906781|NCT01628926|20435131|P3|Overall Study|Adverse Event|9
5906782|NCT01628926|20435132|P2|Overall Study|Adverse Event|11
5906783|NCT01628926|20435133|P1|Overall Study|Adverse Event|13
5906784|NCT01628913|20435182|P2|Overall Study|Physician Decision|3
5906785|NCT01628913|20435183|P1|Overall Study|Physician Decision|1
5906786|NCT01628913|20435182|P2|Overall Study|Withdrawal by Subject|0
5906787|NCT01628913|20435183|P1|Overall Study|Withdrawal by Subject|1
5906788|NCT01628913|20435182|P2|Overall Study|study terminated by Sponsor|9
5906789|NCT01628913|20435183|P1|Overall Study|study terminated by Sponsor|4
5906790|NCT01628913|20435182|P2|Overall Study|Death|0
5906791|NCT01628913|20435183|P1|Overall Study|Death|1
5906792|NCT01628913|20435182|P2|Overall Study|Protocol Violation|0
5906793|NCT01628913|20435183|P1|Overall Study|Protocol Violation|1
5906794|NCT01628913|20435182|P2|Overall Study|Disease Progression|14
5906795|NCT01628913|20435183|P1|Overall Study|Disease Progression|11
5906796|NCT01628913|20435182|P2|Overall Study|Adverse Event|5
5906797|NCT01628913|20435183|P1|Overall Study|Adverse Event|12
5906798|NCT01628874|20435197|P2|Overall Study|Age >4 months|2
5906799|NCT01628874|20435198|P1|Overall Study|Age >4 months|4
5906800|NCT01628874|20435197|P2|Overall Study|Physician Decision|1
5906801|NCT01628874|20435198|P1|Overall Study|Physician Decision|1
5906802|NCT01628848|20435214|P2|Overall Study|Physician Decision|1
5906803|NCT01628848|20435215|P1|Overall Study|Physician Decision|3
5906804|NCT01628848|20435214|P2|Overall Study|Withdrawal by Subject|2
5906805|NCT01628848|20435215|P1|Overall Study|Withdrawal by Subject|0
5906806|NCT01628848|20435214|P2|Overall Study|Lack of Efficacy|4
5906807|NCT01628848|20435215|P1|Overall Study|Lack of Efficacy|0
5906808|NCT01628848|20435214|P2|Overall Study|Adverse Event|7
5906809|NCT01628848|20435215|P1|Overall Study|Adverse Event|9
5906810|NCT01628692|20435258|P6|Overall Study|Completed 12 Week only|1
5906811|NCT01628692|20435259|P5|Overall Study|Completed 12 Week only|0
5906812|NCT01628692|20435260|P4|Overall Study|Completed 12 Week only|0
5906813|NCT01628692|20435261|P3|Overall Study|Completed 12 Week only|0
5906814|NCT01628692|20435262|P2|Overall Study|Completed 12 Week only|0
5906815|NCT01628692|20435263|P1|Overall Study|Completed 12 Week only|0
5906816|NCT01628692|20435258|P6|Overall Study|Administrative reason by sponsor|1
5906817|NCT01628692|20435259|P5|Overall Study|Administrative reason by sponsor|0
5906818|NCT01628692|20435260|P4|Overall Study|Administrative reason by sponsor|0
5906819|NCT01628692|20435261|P3|Overall Study|Administrative reason by sponsor|0
5906820|NCT01628692|20435262|P2|Overall Study|Administrative reason by sponsor|0
5906821|NCT01628692|20435263|P1|Overall Study|Administrative reason by sponsor|0
5906822|NCT01628692|20435258|P6|Overall Study|Poor compliance/noncompliance|0
5906823|NCT01628692|20435259|P5|Overall Study|Poor compliance/noncompliance|0
5906824|NCT01628692|20435260|P4|Overall Study|Poor compliance/noncompliance|0
5906825|NCT01628692|20435261|P3|Overall Study|Poor compliance/noncompliance|0
5906826|NCT01628692|20435262|P2|Overall Study|Poor compliance/noncompliance|0
5906827|NCT01628692|20435263|P1|Overall Study|Poor compliance/noncompliance|1
5906828|NCT01628692|20435258|P6|Overall Study|Death|0
5906829|NCT01628692|20435259|P5|Overall Study|Death|0
5906830|NCT01628692|20435260|P4|Overall Study|Death|0
5906831|NCT01628692|20435261|P3|Overall Study|Death|0
5906832|NCT01628692|20435262|P2|Overall Study|Death|1
5906833|NCT01628692|20435263|P1|Overall Study|Death|0
5906834|NCT01628692|20435258|P6|Overall Study|Withdrawal by Subject|0
5906835|NCT01628692|20435259|P5|Overall Study|Withdrawal by Subject|0
5906836|NCT01628692|20435260|P4|Overall Study|Withdrawal by Subject|0
5906837|NCT01628692|20435261|P3|Overall Study|Withdrawal by Subject|1
5906838|NCT01628692|20435262|P2|Overall Study|Withdrawal by Subject|1
5906839|NCT01628692|20435263|P1|Overall Study|Withdrawal by Subject|0
5906840|NCT01628692|20435258|P6|Overall Study|Adverse Event|0
5906841|NCT01628692|20435259|P5|Overall Study|Adverse Event|0
5906842|NCT01628692|20435260|P4|Overall Study|Adverse Event|0
5906843|NCT01628692|20435261|P3|Overall Study|Adverse Event|2
5906844|NCT01628692|20435262|P2|Overall Study|Adverse Event|0
5906845|NCT01628692|20435263|P1|Overall Study|Adverse Event|2
5906846|NCT01628692|20435258|P6|Overall Study|Lack of Efficacy|7
5906847|NCT01628692|20435259|P5|Overall Study|Lack of Efficacy|4
5906848|NCT01628692|20435260|P4|Overall Study|Lack of Efficacy|1
5906849|NCT01628692|20435261|P3|Overall Study|Lack of Efficacy|5
5906850|NCT01628692|20435262|P2|Overall Study|Lack of Efficacy|4
5906851|NCT01628692|20435263|P1|Overall Study|Lack of Efficacy|4
5906852|NCT01628549|20435333|P4|Overall Study|positive pregnancy test|1
5906853|NCT01628549|20435334|P3|Overall Study|positive pregnancy test|0
5906854|NCT01628549|20435335|P2|Overall Study|positive pregnancy test|0
5906855|NCT01628549|20435336|P1|Overall Study|positive pregnancy test|0
5906856|NCT01628549|20435333|P4|Overall Study|abnormal laboratory test results|0
5906857|NCT01628549|20435334|P3|Overall Study|abnormal laboratory test results|1
5906858|NCT01628549|20435335|P2|Overall Study|abnormal laboratory test results|0
5906859|NCT01628549|20435336|P1|Overall Study|abnormal laboratory test results|0
5906860|NCT01628549|20435333|P4|Overall Study|withdrawn for noncompliance|0
5906861|NCT01628549|20435334|P3|Overall Study|withdrawn for noncompliance|1
5906862|NCT01628549|20435335|P2|Overall Study|withdrawn for noncompliance|2
5906863|NCT01628549|20435336|P1|Overall Study|withdrawn for noncompliance|0
5906864|NCT01628549|20435333|P4|Overall Study|Protocol Violation|0
5906865|NCT01628549|20435334|P3|Overall Study|Protocol Violation|1
5906866|NCT01628549|20435335|P2|Overall Study|Protocol Violation|1
5906867|NCT01628549|20435336|P1|Overall Study|Protocol Violation|2
5906868|NCT01628549|20435333|P4|Overall Study|Withdrawal by Subject|1
5906869|NCT01628549|20435334|P3|Overall Study|Withdrawal by Subject|4
5906870|NCT01628549|20435335|P2|Overall Study|Withdrawal by Subject|4
5906871|NCT01628549|20435336|P1|Overall Study|Withdrawal by Subject|3
5906872|NCT01628549|20435333|P4|Overall Study|Lost to Follow-up|3
5906873|NCT01628549|20435334|P3|Overall Study|Lost to Follow-up|3
5906874|NCT01628549|20435335|P2|Overall Study|Lost to Follow-up|4
5906875|NCT01628549|20435336|P1|Overall Study|Lost to Follow-up|3
5906876|NCT01628549|20435333|P4|Overall Study|Adverse Event|4
5906877|NCT01628549|20435334|P3|Overall Study|Adverse Event|0
5906878|NCT01628549|20435335|P2|Overall Study|Adverse Event|1
5906879|NCT01628549|20435336|P1|Overall Study|Adverse Event|1
5906880|NCT01628510|20435377|P2|Overall Study|Death|1
5906881|NCT01628510|20435378|P1|Overall Study|Death|3
5906882|NCT01628510|20435377|P2|Overall Study|Withdrawal by Subject|4
5906883|NCT01628510|20435378|P1|Overall Study|Withdrawal by Subject|0
5906884|NCT01628367|20435388|P2|Overall Study|Adverse Event|0
5906885|NCT01628367|20435389|P1|Overall Study|Adverse Event|1
5906886|NCT01628198|20435408|P1|Overall Study|Screen failure|1
5906887|NCT01628198|20435408|P1|Overall Study|Withdrawal by Subject|10
5906888|NCT01628198|20435408|P1|Overall Study|Lost to Follow-up|7
5906889|NCT01628120|20435435|P1|Overall Study|Use of Standard of Care|1
5906890|NCT01628120|20435435|P1|Overall Study|Kidney Transplant|2
5906891|NCT01628120|20435435|P1|Overall Study|Moved or Relocated|5
5906892|NCT01628120|20435435|P1|Overall Study|Missed Study Drug More than 2 Weeks|3
5906893|NCT01628120|20435435|P1|Overall Study|Switched Dialysis Method|2
5906894|NCT01628120|20435435|P1|Overall Study|Sponsor Decision|5
5906895|NCT01628120|20435435|P1|Overall Study|Not Treated|3
5906896|NCT01628120|20435435|P1|Overall Study|Non-compliant with Study Procedures|1
5906897|NCT01628120|20435435|P1|Overall Study|Not met Inclusion/Exclusion Criteria|2
5906898|NCT01628120|20435435|P1|Overall Study|Lost to Follow-up|1
5906899|NCT01628120|20435435|P1|Overall Study|Adverse Event|12
5906900|NCT01628120|20435435|P1|Overall Study|Withdrawal by Subject|7
5906901|NCT01628107|20435460|P1|Overall Study|Use of Standard of Care|9
5906902|NCT01628107|20435460|P1|Overall Study|Kidney Transplant|9
5906903|NCT01628107|20435460|P1|Overall Study|Relocated|8
5906904|NCT01628107|20435460|P1|Overall Study|Missed Study Drug More than 2 Weeks|7
5906905|NCT01628107|20435460|P1|Overall Study|Sponsor Decision|11
5906906|NCT01628107|20435460|P1|Overall Study|Not Treated|8
5906907|NCT01628107|20435460|P1|Overall Study|Non-compliant with Study Procedures|10
5906908|NCT01628107|20435460|P1|Overall Study|Not met Inclusion/Exclusion Criteria|1
5906909|NCT01628107|20435460|P1|Overall Study|Physician Decision|2
5906910|NCT01628107|20435460|P1|Overall Study|Adverse Event|33
5906911|NCT01628107|20435460|P1|Overall Study|Lost to Follow-up|4
5906912|NCT01628107|20435460|P1|Overall Study|Withdrawal by Subject|17
5906913|NCT01627899|20435526|P1|Overall Study|Study terminated early by sponsor.|5
5906914|NCT01627860|20435536|P2|Overall Study|Protocol Violation|0
5906915|NCT01627860|20435537|P1|Overall Study|Protocol Violation|1
5906916|NCT01627860|20435536|P2|Overall Study|Seizure frequency doubled|1
5906917|NCT01627860|20435537|P1|Overall Study|Seizure frequency doubled|0
5906918|NCT01627860|20435536|P2|Overall Study|Withdrawal by Subject|1
5906919|NCT01627860|20435537|P1|Overall Study|Withdrawal by Subject|2
5906920|NCT01627860|20435536|P2|Overall Study|Adverse Event|4
5906921|NCT01627860|20435537|P1|Overall Study|Adverse Event|9
5906922|NCT01627782|20435551|P4|Overall Study|Randomized But Not Treated|0
5906923|NCT01627782|20435552|P3|Overall Study|Randomized But Not Treated|0
5906924|NCT01627782|20435553|P2|Overall Study|Randomized But Not Treated|0
5906925|NCT01627782|20435554|P1|Overall Study|Randomized But Not Treated|1
5906926|NCT01627782|20435551|P4|Overall Study|Other|3
5906927|NCT01627782|20435552|P3|Overall Study|Other|0
5906928|NCT01627782|20435553|P2|Overall Study|Other|2
5906929|NCT01627782|20435554|P1|Overall Study|Other|0
5906930|NCT01627782|20435551|P4|Overall Study|Withdrawal by Subject|0
5906931|NCT01627782|20435552|P3|Overall Study|Withdrawal by Subject|0
5906932|NCT01627782|20435553|P2|Overall Study|Withdrawal by Subject|1
5906933|NCT01627782|20435554|P1|Overall Study|Withdrawal by Subject|2
5906934|NCT01627782|20435551|P4|Overall Study|Protocol Violation|0
5906935|NCT01627782|20435552|P3|Overall Study|Protocol Violation|0
5906936|NCT01627782|20435553|P2|Overall Study|Protocol Violation|0
5906937|NCT01627782|20435554|P1|Overall Study|Protocol Violation|1
5906938|NCT01627782|20435551|P4|Overall Study|Lack of Efficacy|2
5906939|NCT01627782|20435552|P3|Overall Study|Lack of Efficacy|15
5906940|NCT01627782|20435553|P2|Overall Study|Lack of Efficacy|1
5906941|NCT01627782|20435554|P1|Overall Study|Lack of Efficacy|11
5906942|NCT01627782|20435551|P4|Overall Study|Adverse Event|1
5906943|NCT01627782|20435552|P3|Overall Study|Adverse Event|0
5906944|NCT01627782|20435553|P2|Overall Study|Adverse Event|2
5906945|NCT01627782|20435554|P1|Overall Study|Adverse Event|1
5906946|NCT01627691|20435610|P1|Overall Study|Missed the visit|3
5906947|NCT01627691|20435610|P1|Overall Study|Withdrawal by Subject|1
5906948|NCT01627691|20435610|P1|Overall Study|Lost to Follow-up|3
5906949|NCT01627691|20435610|P1|Overall Study|Death|11
5906950|NCT01627574|20435623|P2|Overall Study|Lost to Follow-up|13
5906951|NCT01627574|20435624|P1|Overall Study|Lost to Follow-up|13
5906952|NCT01627574|20435623|P2|Overall Study|Withdrawal by Subject|5
5906953|NCT01627574|20435624|P1|Overall Study|Withdrawal by Subject|8
5906954|NCT01627561|20435638|P2|Overall Study|Migrated/moved from study area|2
5906955|NCT01627561|20435639|P1|Overall Study|Migrated/moved from study area|0
5906956|NCT01627561|20435638|P2|Overall Study|Withdrawal by Subject|1
5906957|NCT01627561|20435639|P1|Overall Study|Withdrawal by Subject|0
5906958|NCT01627561|20435638|P2|Overall Study|Lost to Follow-up|0
5906959|NCT01627561|20435639|P1|Overall Study|Lost to Follow-up|1
5906960|NCT01627340|20435705|P2|Overall Study|Withdrawal by Subject|0
5906961|NCT01627340|20435706|P1|Overall Study|Withdrawal by Subject|2
5906962|NCT01627340|20435705|P2|Overall Study|Pregnancy|0
5906963|NCT01627340|20435706|P1|Overall Study|Pregnancy|1
5906964|NCT01627340|20435705|P2|Overall Study|Lost to Follow-up|4
5906965|NCT01627340|20435706|P1|Overall Study|Lost to Follow-up|8
5906966|NCT01627340|20435705|P2|Overall Study|Adverse Event|0
5906967|NCT01627340|20435706|P1|Overall Study|Adverse Event|1
5906968|NCT01627327|20435724|P2|Overall Study|Withdrawal by Subject|3
5906969|NCT01627327|20435725|P1|Overall Study|Withdrawal by Subject|3
5906970|NCT01627327|20435724|P2|Overall Study|Physician Decision|0
5906971|NCT01627327|20435725|P1|Overall Study|Physician Decision|1
5906972|NCT01627327|20435724|P2|Overall Study|Lost to Follow-up|3
5906973|NCT01627327|20435725|P1|Overall Study|Lost to Follow-up|1
5906974|NCT01627327|20435724|P2|Overall Study|Protocol Violation|10
5906975|NCT01627327|20435725|P1|Overall Study|Protocol Violation|4
5906976|NCT01627327|20435724|P2|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|9
5906977|NCT01627327|20435725|P1|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|4
5906978|NCT01627327|20435724|P2|Overall Study|Lack of Efficacy-No Sub-Reason|2
5906979|NCT01627327|20435725|P1|Overall Study|Lack of Efficacy-No Sub-Reason|0
5906980|NCT01627327|20435724|P2|Overall Study|Adverse Event|12
5906981|NCT01627327|20435725|P1|Overall Study|Adverse Event|6
5906982|NCT01627249|20435775|P3|Overall Study|Missed Visit|0
5906983|NCT01627249|20435776|P2|Overall Study|Missed Visit|1
5906984|NCT01627249|20435777|P1|Overall Study|Missed Visit|1
5906985|NCT01627249|20435775|P3|Overall Study|Withdrawal by Subject|9
5906986|NCT01627249|20435776|P2|Overall Study|Withdrawal by Subject|6
5906987|NCT01627249|20435777|P1|Overall Study|Withdrawal by Subject|12
5906988|NCT01627249|20435775|P3|Overall Study|Death|3
5906989|NCT01627249|20435776|P2|Overall Study|Death|5
5906990|NCT01627249|20435777|P1|Overall Study|Death|3
5906991|NCT01627067|20435812|P1|Overall Study|Screen Failure|1
5906992|NCT01626989|20435881|P3|Screening Period|Withdrawal by Subject|0
5906993|NCT01626989|20435882|P2|Screening Period|Withdrawal by Subject|0
5906994|NCT01626989|20435883|P1|Screening Period|Withdrawal by Subject|2
5906995|NCT01626989|20435881|P3|Screening Period|Screen Failure|0
5906996|NCT01626989|20435882|P2|Screening Period|Screen Failure|0
5906997|NCT01626989|20435883|P1|Screening Period|Screen Failure|15
5906998|NCT01626690|20435955|P2|Overall Study|Adverse Event|0
5906999|NCT01626690|20435956|P1|Overall Study|Adverse Event|1
5907000|NCT01626690|20435955|P2|Overall Study|Protocol Violation|0
5907001|NCT01626690|20435956|P1|Overall Study|Protocol Violation|1
5907002|NCT01626495|20435993|P1|Overall Study|Manufacturing failure|1
5907003|NCT01626495|20435993|P1|Overall Study|New cancer therapy|16
5907004|NCT01626495|20435993|P1|Overall Study|Physician Decision|1
5907005|NCT01626495|20435993|P1|Overall Study|Death|2
5907006|NCT01626495|20435993|P1|Overall Study|Administrative problem|1
5907007|NCT01626495|20435993|P1|Overall Study|Withdrawal by Subject|1
5907008|NCT01626495|20435993|P1|Overall Study|Disease progression|27
5907009|NCT01626495|20435993|P1|Overall Study|Adverse Event|3
5907010|NCT01626456|20436002|P2|Overall Study|Incarceration|2
5907011|NCT01626456|20436003|P1|Overall Study|Incarceration|0
5907012|NCT01626456|20436002|P2|Overall Study|Site Closure|3
5907013|NCT01626456|20436003|P1|Overall Study|Site Closure|2
5907014|NCT01626456|20436002|P2|Overall Study|Protocol Violation|1
5907015|NCT01626456|20436003|P1|Overall Study|Protocol Violation|1
5907016|NCT01626456|20436002|P2|Overall Study|Physician Decision|4
5907017|NCT01626456|20436003|P1|Overall Study|Physician Decision|1
5907018|NCT01626456|20436002|P2|Overall Study|Lack of Efficacy|7
5907019|NCT01626456|20436003|P1|Overall Study|Lack of Efficacy|6
5907020|NCT01626456|20436002|P2|Overall Study|Lost to Follow-up|27
5907021|NCT01626456|20436003|P1|Overall Study|Lost to Follow-up|2
5907022|NCT01626456|20436002|P2|Overall Study|Adverse Event|27
5907023|NCT01626456|20436003|P1|Overall Study|Adverse Event|2
5907024|NCT01626456|20436002|P2|Overall Study|Withdrawal by Subject|46
5907025|NCT01626456|20436003|P1|Overall Study|Withdrawal by Subject|21
5907026|NCT01626391|20436033|P2|Overall Study|Withdrawal by Subject|0
5907027|NCT01626391|20436034|P1|Overall Study|Withdrawal by Subject|1
5907028|NCT01626391|20436033|P2|Overall Study|Physician Decision|0
5907029|NCT01626391|20436034|P1|Overall Study|Physician Decision|1
5907030|NCT01626352|20436040|P1|Overall Study|Never Treated|1
5907031|NCT01626352|20436040|P1|Overall Study|Non-Compliance|1
5907032|NCT01626352|20436040|P1|Overall Study|Withdrawal by Subject|1
5907033|NCT01626352|20436040|P1|Overall Study|Death|2
5907034|NCT01626352|20436040|P1|Overall Study|Intercurrent Illness|2
5907035|NCT01626352|20436040|P1|Overall Study|Disease Progression|3
5907036|NCT01626118|20436054|P4|Overall Study|Investigator Decision|0
5907037|NCT01626118|20436055|P3|Overall Study|Investigator Decision|0
5907038|NCT01626118|20436056|P2|Overall Study|Investigator Decision|1
5907039|NCT01626118|20436057|P1|Overall Study|Investigator Decision|0
5907040|NCT01626118|20436054|P4|Overall Study|Adverse Event|0
5907041|NCT01626118|20436055|P3|Overall Study|Adverse Event|1
5907042|NCT01626118|20436056|P2|Overall Study|Adverse Event|1
5907043|NCT01626118|20436057|P1|Overall Study|Adverse Event|0
5907044|NCT01626118|20436054|P4|Overall Study|Lost to Follow-up|0
5907045|NCT01626118|20436055|P3|Overall Study|Lost to Follow-up|0
5907046|NCT01626118|20436056|P2|Overall Study|Lost to Follow-up|0
5907047|NCT01626118|20436057|P1|Overall Study|Lost to Follow-up|1
5907048|NCT01626118|20436054|P4|Overall Study|Lack of Efficacy|3
5907049|NCT01626118|20436055|P3|Overall Study|Lack of Efficacy|1
5907050|NCT01626118|20436056|P2|Overall Study|Lack of Efficacy|0
5907051|NCT01626118|20436057|P1|Overall Study|Lack of Efficacy|1
5907052|NCT01626079|20436103|P2|Overall Study|Visits Expected or Not Due|69
5907053|NCT01626079|20436104|P1|Overall Study|Visits Expected or Not Due|74
5907054|NCT01626079|20436103|P2|Overall Study|Lost to Follow-up|3
5907055|NCT01626079|20436104|P1|Overall Study|Lost to Follow-up|3
5907056|NCT01626079|20436103|P2|Overall Study|Withdrawal by Subject|29
5907057|NCT01626079|20436104|P1|Overall Study|Withdrawal by Subject|12
5907058|NCT01626079|20436103|P2|Overall Study|Death|115
5907059|NCT01626079|20436104|P1|Overall Study|Death|78
5907060|NCT01625988|20436477|P2|Overall Study|Protocol Violation|2
5907061|NCT01625988|20436478|P1|Overall Study|Protocol Violation|0
5907062|NCT01625988|20436477|P2|Overall Study|Randomized Inappropriately|0
5907063|NCT01625988|20436478|P1|Overall Study|Randomized Inappropriately|1
5907064|NCT01625988|20436477|P2|Overall Study|Lack of Efficacy|1
5907065|NCT01625988|20436478|P1|Overall Study|Lack of Efficacy|0
5907066|NCT01625988|20436477|P2|Overall Study|Adverse Event|1
5907067|NCT01625988|20436478|P1|Overall Study|Adverse Event|0
5907068|NCT01625988|20436477|P2|Overall Study|Withdrawal by Subject|3
5907069|NCT01625988|20436478|P1|Overall Study|Withdrawal by Subject|8
5907070|NCT01625988|20436477|P2|Overall Study|Lost to Follow-up|6
5907071|NCT01625988|20436478|P1|Overall Study|Lost to Follow-up|5
5907072|NCT01625910|20436502|P2|Overall Study|Lost to Follow-up|4
5907073|NCT01625910|20436503|P1|Overall Study|Lost to Follow-up|3
5907074|NCT01625845|20436513|P2|Overall Study|Withdrawal by Subject|0
5907075|NCT01625845|20436514|P1|Overall Study|Withdrawal by Subject|2
5907076|NCT01625845|20436513|P2|Overall Study|Lost to Follow-up|1
5907077|NCT01625845|20436514|P1|Overall Study|Lost to Follow-up|2
5907078|NCT01625845|20436513|P2|Overall Study|Adverse Event|2
5907079|NCT01625845|20436514|P1|Overall Study|Adverse Event|1
5907080|NCT01625689|20436534|P2|Overall Study|Migration|1
5907081|NCT01625689|20436535|P1|Overall Study|Migration|2
5907082|NCT01625377|20436590|P2|Overall Study|Abnormal laboratory values|0
5907083|NCT01625377|20436591|P1|Overall Study|Abnormal laboratory values|1
5907084|NCT01625377|20436590|P2|Overall Study|Unsatisfactory therapeutic effect|1
5907085|NCT01625377|20436591|P1|Overall Study|Unsatisfactory therapeutic effect|0
5907086|NCT01625377|20436590|P2|Overall Study|Graft loss|0
5907087|NCT01625377|20436591|P1|Overall Study|Graft loss|1
5907088|NCT01625377|20436590|P2|Overall Study|Adverse Event|16
5907089|NCT01625377|20436591|P1|Overall Study|Adverse Event|3
5907090|NCT01625377|20436590|P2|Overall Study|Protocol Violation|3
5907091|NCT01625377|20436591|P1|Overall Study|Protocol Violation|0
5907092|NCT01625377|20436590|P2|Overall Study|Administrative Problem|1
5907093|NCT01625377|20436591|P1|Overall Study|Administrative Problem|1
5907094|NCT01625377|20436590|P2|Overall Study|Death|1
5907095|NCT01625377|20436591|P1|Overall Study|Death|1
5907096|NCT01625338|20436624|P3|Overall Study|Study Discontinued by Sponsor|1
5907097|NCT01625338|20436625|P2|Overall Study|Study Discontinued by Sponsor|0
5907098|NCT01625338|20436626|P1|Overall Study|Study Discontinued by Sponsor|0
5907099|NCT01625338|20436624|P3|Overall Study|Adverse Event|1
5907100|NCT01625338|20436625|P2|Overall Study|Adverse Event|0
5907101|NCT01625338|20436626|P1|Overall Study|Adverse Event|1
5907102|NCT01625338|20436624|P3|Overall Study|Subject Withdrew Consent|2
5907103|NCT01625338|20436625|P2|Overall Study|Subject Withdrew Consent|0
5907104|NCT01625338|20436626|P1|Overall Study|Subject Withdrew Consent|1
5907105|NCT01625338|20436624|P3|Overall Study|Investigator Decision|1
5907106|NCT01625338|20436625|P2|Overall Study|Investigator Decision|2
5907107|NCT01625338|20436626|P1|Overall Study|Investigator Decision|0
5907108|NCT01625338|20436624|P3|Overall Study|Lost to Follow-up|2
5907109|NCT01625338|20436625|P2|Overall Study|Lost to Follow-up|3
5907110|NCT01625338|20436626|P1|Overall Study|Lost to Follow-up|3
5907111|NCT01625338|20436624|P3|Overall Study|Efficacy Failure|31
5907112|NCT01625338|20436625|P2|Overall Study|Efficacy Failure|39
5907113|NCT01625338|20436626|P1|Overall Study|Efficacy Failure|27
5907114|NCT01625338|20436624|P3|Overall Study|Enrolled but not Treated|1
5907115|NCT01625338|20436625|P2|Overall Study|Enrolled but not Treated|0
5907116|NCT01625338|20436626|P1|Overall Study|Enrolled but not Treated|0
5907117|NCT01625286|20436653|P7|Overall Study|Ongoing on-treatment at DCO|6
5907118|NCT01625286|20436654|P6|Overall Study|Ongoing on-treatment at DCO|8
5907119|NCT01625286|20436655|P5|Overall Study|Ongoing on-treatment at DCO|0
5907120|NCT01625286|20436656|P4|Overall Study|Ongoing on-treatment at DCO|0
5907121|NCT01625286|20436657|P3|Overall Study|Ongoing on-treatment at DCO|0
5907122|NCT01625286|20436658|P2|Overall Study|Ongoing on-treatment at DCO|4
5907123|NCT01625286|20436659|P1|Overall Study|Ongoing on-treatment at DCO|6
5907124|NCT01625286|20436653|P7|Overall Study|Ongoing off-treatment at DCO|31
5907125|NCT01625286|20436654|P6|Overall Study|Ongoing off-treatment at DCO|32
5907126|NCT01625286|20436655|P5|Overall Study|Ongoing off-treatment at DCO|0
5907127|NCT01625286|20436656|P4|Overall Study|Ongoing off-treatment at DCO|0
5907128|NCT01625286|20436657|P3|Overall Study|Ongoing off-treatment at DCO|0
5907129|NCT01625286|20436658|P2|Overall Study|Ongoing off-treatment at DCO|0
5907130|NCT01625286|20436659|P1|Overall Study|Ongoing off-treatment at DCO|0
5907131|NCT01625286|20436653|P7|Overall Study|Lost to Follow-up|1
5907132|NCT01625286|20436654|P6|Overall Study|Lost to Follow-up|0
5907133|NCT01625286|20436655|P5|Overall Study|Lost to Follow-up|0
5907134|NCT01625286|20436656|P4|Overall Study|Lost to Follow-up|0
5907135|NCT01625286|20436657|P3|Overall Study|Lost to Follow-up|0
5907136|NCT01625286|20436658|P2|Overall Study|Lost to Follow-up|0
5907137|NCT01625286|20436659|P1|Overall Study|Lost to Follow-up|0
5907138|NCT01625286|20436653|P7|Overall Study|Progressive disease|0
5907139|NCT01625286|20436654|P6|Overall Study|Progressive disease|0
5907140|NCT01625286|20436655|P5|Overall Study|Progressive disease|5
5907141|NCT01625286|20436656|P4|Overall Study|Progressive disease|5
5907142|NCT01625286|20436657|P3|Overall Study|Progressive disease|4
5907143|NCT01625286|20436658|P2|Overall Study|Progressive disease|3
5907144|NCT01625286|20436659|P1|Overall Study|Progressive disease|6
5907145|NCT01625286|20436653|P7|Overall Study|Any reason not specifically recorded|0
5907146|NCT01625286|20436654|P6|Overall Study|Any reason not specifically recorded|1
5907147|NCT01625286|20436655|P5|Overall Study|Any reason not specifically recorded|0
5907148|NCT01625286|20436656|P4|Overall Study|Any reason not specifically recorded|0
5907149|NCT01625286|20436657|P3|Overall Study|Any reason not specifically recorded|0
5907150|NCT01625286|20436658|P2|Overall Study|Any reason not specifically recorded|0
5907151|NCT01625286|20436659|P1|Overall Study|Any reason not specifically recorded|0
5907152|NCT01625286|20436653|P7|Overall Study|Withdrawal by Subject|1
5907153|NCT01625286|20436654|P6|Overall Study|Withdrawal by Subject|0
5907154|NCT01625286|20436655|P5|Overall Study|Withdrawal by Subject|0
5907155|NCT01625286|20436656|P4|Overall Study|Withdrawal by Subject|1
5907156|NCT01625286|20436657|P3|Overall Study|Withdrawal by Subject|0
5907157|NCT01625286|20436658|P2|Overall Study|Withdrawal by Subject|1
5907158|NCT01625286|20436659|P1|Overall Study|Withdrawal by Subject|0
5907159|NCT01625286|20436653|P7|Overall Study|Death|16
5907160|NCT01625286|20436654|P6|Overall Study|Death|11
5907161|NCT01625286|20436655|P5|Overall Study|Death|0
5907162|NCT01625286|20436656|P4|Overall Study|Death|1
5907163|NCT01625286|20436657|P3|Overall Study|Death|1
5907164|NCT01625286|20436658|P2|Overall Study|Death|0
5907165|NCT01625286|20436659|P1|Overall Study|Death|0
5907166|NCT01625286|20436653|P7|Overall Study|Adverse Event|1
5907167|NCT01625286|20436654|P6|Overall Study|Adverse Event|2
5907168|NCT01625286|20436655|P5|Overall Study|Adverse Event|1
5907169|NCT01625286|20436656|P4|Overall Study|Adverse Event|0
5907170|NCT01625286|20436657|P3|Overall Study|Adverse Event|0
5907171|NCT01625286|20436658|P2|Overall Study|Adverse Event|0
5907172|NCT01625286|20436659|P1|Overall Study|Adverse Event|0
5907173|NCT01625182|20436745|P2|Overall Study|Lack of Efficacy|8
5907174|NCT01625182|20436746|P1|Overall Study|Lack of Efficacy|12
5907175|NCT01625182|20436745|P2|Overall Study|Withdrawal by Subject|1
5907176|NCT01625182|20436746|P1|Overall Study|Withdrawal by Subject|5
5907177|NCT01625182|20436745|P2|Overall Study|Adverse Event|0
5907178|NCT01625182|20436746|P1|Overall Study|Adverse Event|2
5907179|NCT01625182|20436745|P2|Overall Study|Protocol deviation|2
5907180|NCT01625182|20436746|P1|Overall Study|Protocol deviation|0
5907181|NCT01625182|20436745|P2|Overall Study|Administrative problems|0
5907182|NCT01625182|20436746|P1|Overall Study|Administrative problems|1
5907183|NCT01625091|20436783|P2|Post-intervention|Study termination|1
5907184|NCT01625091|20436784|P1|Post-intervention|Study termination|2
5907185|NCT01625091|20436783|P2|Post-intervention|Lost to Follow-up|0
5907186|NCT01625091|20436784|P1|Post-intervention|Lost to Follow-up|2
5907187|NCT01625091|20436783|P2|Post-intervention|Death|1
5907188|NCT01625091|20436784|P1|Post-intervention|Death|0
5907189|NCT01625091|20436783|P2|Intervention|Study termination|3
5907190|NCT01625091|20436784|P1|Intervention|Study termination|2
5907191|NCT01625091|20436783|P2|Intervention|Lost to Follow-up|4
5907192|NCT01625091|20436784|P1|Intervention|Lost to Follow-up|4
5907193|NCT01625091|20436783|P2|Intervention|Adverse Event|2
5907194|NCT01625091|20436784|P1|Intervention|Adverse Event|0
5907195|NCT01625091|20436783|P2|Intervention|Withdrawal by Subject|1
5907196|NCT01625091|20436784|P1|Intervention|Withdrawal by Subject|4
5907197|NCT01625091|20436783|P2|Intervention|Death|1
5907198|NCT01625091|20436784|P1|Intervention|Death|1
5907199|NCT01624974|20436802|P2|Period V of Treatment (4 Weeks)|Adverse Event|0
5907200|NCT01624974|20436803|P1|Period V of Treatment (4 Weeks)|Adverse Event|1
5907201|NCT01624974|20436802|P2|Period V of Treatment (4 Weeks)|Physician Decision|0
5907202|NCT01624974|20436803|P1|Period V of Treatment (4 Weeks)|Physician Decision|3
5907203|NCT01624974|20436802|P2|Period V of Treatment (4 Weeks)|Lack of Efficacy|0
5907204|NCT01624974|20436803|P1|Period V of Treatment (4 Weeks)|Lack of Efficacy|1
5907205|NCT01624974|20436802|P2|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|1
5907206|NCT01624974|20436803|P1|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|0
5907207|NCT01624974|20436802|P2|Period IV Washout (4 Weeks)|Adverse Event|0
5907208|NCT01624974|20436803|P1|Period IV Washout (4 Weeks)|Adverse Event|2
5907209|NCT01624974|20436802|P2|Period IV Washout (4 Weeks)|Withdrawal by Subject|1
5907210|NCT01624974|20436803|P1|Period IV Washout (4 Weeks)|Withdrawal by Subject|0
5907211|NCT01624974|20436802|P2|Period IV Washout (4 Weeks)|Lack of Efficacy|1
5907212|NCT01624974|20436803|P1|Period IV Washout (4 Weeks)|Lack of Efficacy|1
5907213|NCT01624974|20436802|P2|Period III of Treatment (4 Weeks)|Adverse Event|1
5907214|NCT01624974|20436803|P1|Period III of Treatment (4 Weeks)|Adverse Event|0
5907215|NCT01624974|20436802|P2|Period III of Treatment (4 Weeks)|Protocol Violation|0
5907216|NCT01624974|20436803|P1|Period III of Treatment (4 Weeks)|Protocol Violation|1
5907217|NCT01624974|20436802|P2|Period III of Treatment (4 Weeks)|Physician Decision|3
5907218|NCT01624974|20436803|P1|Period III of Treatment (4 Weeks)|Physician Decision|5
5907219|NCT01624974|20436802|P2|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|2
5907220|NCT01624974|20436803|P1|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|1
5907221|NCT01624974|20436802|P2|Period III of Treatment (4 Weeks)|Lack of Efficacy|2
5907222|NCT01624974|20436803|P1|Period III of Treatment (4 Weeks)|Lack of Efficacy|0
5907223|NCT01624870|20436844|P1|Overall Study|Lost to follow up|1
5907224|NCT01624870|20436844|P1|Overall Study|CoreValve not implanted|6
5907225|NCT01624870|20436844|P1|Overall Study|Withdrawal by Subject|1
5907226|NCT01624870|20436844|P1|Overall Study|Death|19
5907227|NCT01624662|20436864|P4|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0
5907228|NCT01624662|20436865|P3|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1
5907229|NCT01624662|20436866|P2|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0
5907230|NCT01624662|20436867|P1|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0
5907231|NCT01624662|20436864|P4|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0
5907232|NCT01624662|20436865|P3|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0
5907233|NCT01624662|20436866|P2|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1
5907234|NCT01624662|20436867|P1|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0
5907235|NCT01624662|20436864|P4|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1
5907236|NCT01624662|20436865|P3|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0
5907237|NCT01624662|20436866|P2|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1
5907238|NCT01624662|20436867|P1|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1
5907239|NCT01624662|20436864|P4|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0
5907240|NCT01624662|20436865|P3|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3
5907241|NCT01624662|20436866|P2|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0
5907242|NCT01624662|20436867|P1|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3
5907243|NCT01624662|20436864|P4|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0
5907244|NCT01624662|20436865|P3|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0
5907245|NCT01624662|20436866|P2|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1
5907246|NCT01624662|20436867|P1|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0
5907247|NCT01624662|20436864|P4|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0
5907248|NCT01624662|20436865|P3|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0
5907249|NCT01624662|20436866|P2|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|1
5907250|NCT01624662|20436867|P1|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|5
5907251|NCT01624662|20436864|P4|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|0
5907252|NCT01624662|20436865|P3|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1
5907253|NCT01624662|20436866|P2|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1
5907254|NCT01624662|20436867|P1|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2
5907255|NCT01624467|20436938|P1|Overall Study|Subject Withdrew from Treatment|1
5907256|NCT01624467|20436938|P1|Overall Study|Per Sponsor Requirement|1
5907257|NCT01624467|20436938|P1|Overall Study|Progressive Disease|19
5907258|NCT01624467|20436938|P1|Overall Study|Adverse Event|7
5907259|NCT01624467|20436938|P1|Overall Study|Lost to Follow-up|1
5907260|NCT01624467|20436938|P1|Overall Study|Withdrawal by Subject|2
5907261|NCT01624259|20436977|P2|Overall Study|Abnormal laboratory measure|0
5907262|NCT01624259|20436978|P1|Overall Study|Abnormal laboratory measure|3
5907263|NCT01624259|20436977|P2|Overall Study|Lost to Follow-up|3
5907264|NCT01624259|20436978|P1|Overall Study|Lost to Follow-up|2
5907265|NCT01624259|20436977|P2|Overall Study|Physician Decision|1
5907266|NCT01624259|20436978|P1|Overall Study|Physician Decision|1
5907267|NCT01624259|20436977|P2|Overall Study|Withdrawal by Subject|7
5907268|NCT01624259|20436978|P1|Overall Study|Withdrawal by Subject|5
5907269|NCT01624259|20436977|P2|Overall Study|Protocol Violation|2
5907270|NCT01624259|20436978|P1|Overall Study|Protocol Violation|1
5907271|NCT01624259|20436977|P2|Overall Study|Adverse Event|18
5907272|NCT01624259|20436978|P1|Overall Study|Adverse Event|18
5907273|NCT01624233|20437027|P1|Period 6: Follow-up|Withdrawal by Subject|3
5907274|NCT01624233|20437027|P1|Period 6: Follow-up|Physician Decision|1
5907275|NCT01624233|20437027|P1|Period 6: Follow-up|Lack of Efficacy|2
5907276|NCT01624233|20437027|P1|Period 6: Follow-up|Adverse Event|3
5907277|NCT01624233|20437027|P1|Period 5 - Retreatment Period|Withdrawal by Subject|3
5907278|NCT01624233|20437027|P1|Period 5 - Retreatment Period|Physician Decision|1
5907279|NCT01624233|20437027|P1|Period 5 - Retreatment Period|Lack of Efficacy|1
5907280|NCT01624233|20437027|P1|Period 5 - Retreatment Period|Adverse Event|5
5907281|NCT01624233|20437027|P1|Period 4 - Drug Free Period|Relapsed|61
5907282|NCT01624233|20437027|P1|Period 3 - Maintenance|Withdrawal by Subject|2
5907283|NCT01624233|20437027|P1|Period 3 - Maintenance|Physician Decision|2
5907284|NCT01624233|20437027|P1|Period 3 - Maintenance|Lack of Efficacy|1
5907285|NCT01624233|20437027|P1|Period 3 - Maintenance|Adverse Event|2
5907286|NCT01624233|20437027|P1|Period 2 - Induction|Adverse Event|1
5907287|NCT01624194|20437059|P2|Overall Study|Withdrawal by Subject|0
5907288|NCT01624194|20437060|P1|Overall Study|Withdrawal by Subject|1
5907289|NCT01624194|20437059|P2|Overall Study|Lost to Follow-up|0
5907290|NCT01624194|20437060|P1|Overall Study|Lost to Follow-up|1
5907291|NCT01624142|20437128|P2|Overall Study|Other|0
5907292|NCT01624142|20437129|P1|Overall Study|Other|1
5907293|NCT01624142|20437128|P2|Overall Study|Lost to Follow-up|0
5907294|NCT01624142|20437129|P1|Overall Study|Lost to Follow-up|2
5907295|NCT01624142|20437128|P2|Overall Study|Study Closure|6
5907296|NCT01624142|20437129|P1|Overall Study|Study Closure|12
5907297|NCT01624142|20437128|P2|Overall Study|Death|6
5907298|NCT01624142|20437129|P1|Overall Study|Death|3
5907299|NCT01624142|20437128|P2|Overall Study|Withdrawal by Subject|4
5907300|NCT01624142|20437129|P1|Overall Study|Withdrawal by Subject|14
5907301|NCT01624090|20437154|P4|Overall Study|Dose escalated|0
5907302|NCT01624090|20437155|P3|Overall Study|Dose escalated|3
5907303|NCT01624090|20437156|P2|Overall Study|Dose escalated|0
5907304|NCT01624090|20437157|P1|Overall Study|Dose escalated|0
5907305|NCT01624090|20437154|P4|Overall Study|Did not complete 1 crse of therapy|0
5907306|NCT01624090|20437155|P3|Overall Study|Did not complete 1 crse of therapy|2
5907307|NCT01624090|20437156|P2|Overall Study|Did not complete 1 crse of therapy|0
5907308|NCT01624090|20437157|P1|Overall Study|Did not complete 1 crse of therapy|0
5907309|NCT01624090|20437154|P4|Overall Study|Died on study|0
5907310|NCT01624090|20437155|P3|Overall Study|Died on study|2
5907311|NCT01624090|20437156|P2|Overall Study|Died on study|0
5907312|NCT01624090|20437157|P1|Overall Study|Died on study|0
5907313|NCT01624090|20437154|P4|Overall Study|Withdrew prior to treatment|0
5907314|NCT01624090|20437155|P3|Overall Study|Withdrew prior to treatment|0
5907315|NCT01624090|20437156|P2|Overall Study|Withdrew prior to treatment|1
5907316|NCT01624090|20437157|P1|Overall Study|Withdrew prior to treatment|0
5907317|NCT01624090|20437154|P4|Overall Study|DLT, taken off therapy|0
5907318|NCT01624090|20437155|P3|Overall Study|DLT, taken off therapy|0
5907319|NCT01624090|20437156|P2|Overall Study|DLT, taken off therapy|1
5907320|NCT01624090|20437157|P1|Overall Study|DLT, taken off therapy|0
5907321|NCT01623830|20437179|P2|Overall Study|Exclusion from Study|2
5907322|NCT01623830|20437180|P1|Overall Study|Exclusion from Study|1
5907323|NCT01623830|20437179|P2|Overall Study|Withdrawal by Subject|7
5907324|NCT01623830|20437180|P1|Overall Study|Withdrawal by Subject|6
5907325|NCT01623752|20437197|P3|Phase 2 (78 Weeks)|Adverse Event|0
5907326|NCT01623752|20437198|P2|Phase 2 (78 Weeks)|Adverse Event|4
5907327|NCT01623752|20437199|P1|Phase 2 (78 Weeks)|Adverse Event|4
5907328|NCT01623752|20437197|P3|Phase 2 (78 Weeks)|No Data|0
5907329|NCT01623752|20437198|P2|Phase 2 (78 Weeks)|No Data|11
5907330|NCT01623752|20437199|P1|Phase 2 (78 Weeks)|No Data|43
5907331|NCT01623752|20437197|P3|Phase 2 (78 Weeks)|Other|0
5907332|NCT01623752|20437198|P2|Phase 2 (78 Weeks)|Other|1
5907333|NCT01623752|20437199|P1|Phase 2 (78 Weeks)|Other|5
5907334|NCT01623752|20437197|P3|Phase 2 (78 Weeks)|Lack of Efficacy|0
5907335|NCT01623752|20437198|P2|Phase 2 (78 Weeks)|Lack of Efficacy|2
5907336|NCT01623752|20437199|P1|Phase 2 (78 Weeks)|Lack of Efficacy|14
5907337|NCT01623752|20437197|P3|Phase 1 (78 Weeks)|Lack of Efficacy|0
5907338|NCT01623752|20437198|P2|Phase 1 (78 Weeks)|Lack of Efficacy|82
5907339|NCT01623752|20437199|P1|Phase 1 (78 Weeks)|Lack of Efficacy|227
5907340|NCT01623752|20437197|P3|Phase 1 (78 Weeks)|Adverse Event|0
5907341|NCT01623752|20437198|P2|Phase 1 (78 Weeks)|Adverse Event|39
5907342|NCT01623752|20437199|P1|Phase 1 (78 Weeks)|Adverse Event|122
5907343|NCT01623752|20437197|P3|Phase 1 (78 Weeks)|Other|0
5907344|NCT01623752|20437198|P2|Phase 1 (78 Weeks)|Other|20
5907345|NCT01623752|20437199|P1|Phase 1 (78 Weeks)|Other|33
5907346|NCT01623752|20437197|P3|Phase 1 (78 Weeks)|No Data|2
5907347|NCT01623752|20437198|P2|Phase 1 (78 Weeks)|No Data|66
5907348|NCT01623752|20437199|P1|Phase 1 (78 Weeks)|No Data|249
5907349|NCT01623596|20437302|P2|Overall Study|Lack of Efficacy|3
5907350|NCT01623596|20437303|P1|Overall Study|Lack of Efficacy|5
5907351|NCT01623596|20437302|P2|Overall Study|Protocol Violation|6
5907352|NCT01623596|20437303|P1|Overall Study|Protocol Violation|0
5907353|NCT01623596|20437302|P2|Overall Study|Patient no longer requires study drug|0
5907354|NCT01623596|20437303|P1|Overall Study|Patient no longer requires study drug|1
5907355|NCT01623596|20437302|P2|Overall Study|Withdrawal by Subject|31
5907356|NCT01623596|20437303|P1|Overall Study|Withdrawal by Subject|13
5907357|NCT01623596|20437302|P2|Overall Study|Lost to Follow-up|16
5907358|NCT01623596|20437303|P1|Overall Study|Lost to Follow-up|12
5907359|NCT01623596|20437302|P2|Overall Study|Death|2
5907360|NCT01623596|20437303|P1|Overall Study|Death|0
5907361|NCT01623596|20437302|P2|Overall Study|Adverse Event|29
5907362|NCT01623596|20437303|P1|Overall Study|Adverse Event|20
5907363|NCT01623596|20437302|P2|Overall Study|Administrative problems|13
5907364|NCT01623596|20437303|P1|Overall Study|Administrative problems|9
5907365|NCT01623596|20437302|P2|Overall Study|Abnormal laboratory values|0
5907366|NCT01623596|20437303|P1|Overall Study|Abnormal laboratory values|2
5907367|NCT01623531|20437321|P2|Overall Study|Missing data at primary outcome time poi|1
5907368|NCT01623531|20437322|P1|Overall Study|Missing data at primary outcome time poi|1
5907369|NCT01623531|20437321|P2|Overall Study|Protocol Violation|1
5907370|NCT01623531|20437322|P1|Overall Study|Protocol Violation|2
5907371|NCT01623531|20437321|P2|Overall Study|Death|0
5907372|NCT01623531|20437322|P1|Overall Study|Death|1
5907373|NCT01623310|20437389|P1|Overall Study|Investigators Discretion-Noncompliant|1
5907374|NCT01623310|20437389|P1|Overall Study|Diagnoses of bilateral cateracts|1
5907375|NCT01623310|20437389|P1|Overall Study|Became potentially child-bearing|1
5907376|NCT01623310|20437389|P1|Overall Study|Withdrawal by Subject|25
5907377|NCT01623310|20437389|P1|Overall Study|Protocol Violation|6
5907378|NCT01623310|20437389|P1|Overall Study|Lack of Efficacy|6
5907379|NCT01623310|20437389|P1|Overall Study|Lost to Follow-up|18
5907380|NCT01623310|20437389|P1|Overall Study|Adverse Event|21
5907381|NCT01623271|20437398|P1|Overall Study|Withdrawal by Subject|2
5907382|NCT01623154|20437415|P1|Overall Study|Did not drink Pranactin Citric|4
5907383|NCT01623115|20437423|P2|Overall Study|Other than specified above|3
5907384|NCT01623115|20437424|P1|Overall Study|Other than specified above|0
5907385|NCT01623115|20437423|P2|Overall Study|Death|4
5907386|NCT01623115|20437424|P1|Overall Study|Death|0
5907387|NCT01623115|20437423|P2|Overall Study|Site closure|7
5907388|NCT01623115|20437424|P1|Overall Study|Site closure|1
5907389|NCT01623115|20437423|P2|Overall Study|Last visit outside protocol visit window|26
5907390|NCT01623115|20437424|P1|Overall Study|Last visit outside protocol visit window|14
5907391|NCT01623115|20437423|P2|Overall Study|Related to study drug administration|2
5907392|NCT01623115|20437424|P1|Overall Study|Related to study drug administration|0
5907393|NCT01623115|20437423|P2|Overall Study|Consent withdrawn by participant|6
5907394|NCT01623115|20437424|P1|Overall Study|Consent withdrawn by participant|2
5907395|NCT01623115|20437423|P2|Overall Study|Poor compliance to protocol|10
5907396|NCT01623115|20437424|P1|Overall Study|Poor compliance to protocol|4
5907397|NCT01623115|20437423|P2|Overall Study|Adverse Event|13
5907398|NCT01623115|20437424|P1|Overall Study|Adverse Event|10
5907399|NCT01623115|20437423|P2|Overall Study|Participants moved|5
5907400|NCT01623115|20437424|P1|Overall Study|Participants moved|1
5907401|NCT01623115|20437423|P2|Overall Study|Physician Decision|0
5907402|NCT01623115|20437424|P1|Overall Study|Physician Decision|1
5907403|NCT01623115|20437423|P2|Overall Study|Randomized but not treated|1
5907404|NCT01623115|20437424|P1|Overall Study|Randomized but not treated|0
5907405|NCT01623050|20437484|P1|Overall Study|Lost to Follow-up|9
5907406|NCT01622673|20437522|P6|Treatment Period 3|Protocol Violation|0
5907407|NCT01622673|20437523|P5|Treatment Period 3|Protocol Violation|0
5907408|NCT01622673|20437524|P4|Treatment Period 3|Protocol Violation|0
5907409|NCT01622673|20437525|P3|Treatment Period 3|Protocol Violation|0
5907410|NCT01622673|20437526|P2|Treatment Period 3|Protocol Violation|1
5907411|NCT01622673|20437527|P1|Treatment Period 3|Protocol Violation|0
5907412|NCT01622673|20437522|P6|Treatment Period 2|Withdrawal by Subject|0
5907413|NCT01622673|20437523|P5|Treatment Period 2|Withdrawal by Subject|0
5907414|NCT01622673|20437524|P4|Treatment Period 2|Withdrawal by Subject|1
5907415|NCT01622673|20437525|P3|Treatment Period 2|Withdrawal by Subject|0
5907416|NCT01622673|20437526|P2|Treatment Period 2|Withdrawal by Subject|0
5907417|NCT01622673|20437527|P1|Treatment Period 2|Withdrawal by Subject|0
5907418|NCT01622673|20437522|P6|Treatment Period 1|Protocol Violation|0
5907419|NCT01622673|20437523|P5|Treatment Period 1|Protocol Violation|0
5907420|NCT01622673|20437524|P4|Treatment Period 1|Protocol Violation|0
5907421|NCT01622673|20437525|P3|Treatment Period 1|Protocol Violation|0
5907422|NCT01622673|20437526|P2|Treatment Period 1|Protocol Violation|1
5907423|NCT01622673|20437527|P1|Treatment Period 1|Protocol Violation|0
5907424|NCT01622673|20437522|P6|Treatment Period 1|Withdrawal by Subject|0
5907425|NCT01622673|20437523|P5|Treatment Period 1|Withdrawal by Subject|0
5907426|NCT01622673|20437524|P4|Treatment Period 1|Withdrawal by Subject|1
5907427|NCT01622673|20437525|P3|Treatment Period 1|Withdrawal by Subject|0
5907428|NCT01622673|20437526|P2|Treatment Period 1|Withdrawal by Subject|0
5907429|NCT01622673|20437527|P1|Treatment Period 1|Withdrawal by Subject|0
5907430|NCT01622660|20437562|P1|Overall Study|Adverse Event|1
5907431|NCT01622569|20437570|P4|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1
5907432|NCT01622569|20437571|P3|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0
5907433|NCT01622569|20437572|P2|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0
5907434|NCT01622569|20437573|P1|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0
5907435|NCT01622569|20437570|P4|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1
5907436|NCT01622569|20437571|P3|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|2
5907437|NCT01622569|20437572|P2|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0
5907438|NCT01622569|20437573|P1|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1
5907439|NCT01622569|20437570|P4|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0
5907440|NCT01622569|20437571|P3|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1
5907441|NCT01622569|20437572|P2|Open-Label Extension Phase (Wks 17-24)|Adverse Event|2
5907442|NCT01622569|20437573|P1|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0
5907443|NCT01622569|20437570|P4|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0
5907444|NCT01622569|20437571|P3|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2
5907445|NCT01622569|20437572|P2|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2
5907446|NCT01622569|20437573|P1|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2
5907447|NCT01622569|20437570|P4|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1
5907448|NCT01622569|20437571|P3|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0
5907449|NCT01622569|20437572|P2|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|2
5907450|NCT01622569|20437573|P1|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0
5907451|NCT01622569|20437570|P4|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|2
5907452|NCT01622569|20437571|P3|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|3
5907453|NCT01622569|20437572|P2|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0
5907454|NCT01622569|20437573|P1|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|6
5907455|NCT01622569|20437570|P4|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0
5907456|NCT01622569|20437571|P3|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|1
5907457|NCT01622569|20437572|P2|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0
5907458|NCT01622569|20437573|P1|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0
5907459|NCT01622569|20437570|P4|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1
5907460|NCT01622569|20437571|P3|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|3
5907461|NCT01622569|20437572|P2|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2
5907462|NCT01622569|20437573|P1|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|4
5907463|NCT01622348|20437658|P3|Overall Study|Withdrawal by Subject|1
5907464|NCT01622348|20437659|P2|Overall Study|Withdrawal by Subject|0
5907465|NCT01622348|20437660|P1|Overall Study|Withdrawal by Subject|1
5907466|NCT01622231|20437699|P1|Overall Study|Withdrawal by Subject|1
5907467|NCT01622231|20437699|P1|Overall Study|Physician Decision|1
5907468|NCT01621880|20437729|P2|Overall Study|Withdrawal by Subject|4
5907469|NCT01621880|20437730|P1|Overall Study|Withdrawal by Subject|5
5907470|NCT01621880|20437729|P2|Overall Study|Adverse Event|1
5907471|NCT01621880|20437730|P1|Overall Study|Adverse Event|5
5907472|NCT01621802|20437744|P6|Overall Study|Lost to Follow-up|11
5907473|NCT01621802|20437745|P5|Overall Study|Lost to Follow-up|31
5907474|NCT01621802|20437746|P4|Overall Study|Lost to Follow-up|7
5907475|NCT01621802|20437747|P3|Overall Study|Lost to Follow-up|24
5907476|NCT01621802|20437748|P2|Overall Study|Lost to Follow-up|16
5907477|NCT01621802|20437749|P1|Overall Study|Lost to Follow-up|36
5907478|NCT01621802|20437744|P6|Overall Study|Others|0
5907479|NCT01621802|20437745|P5|Overall Study|Others|1
5907480|NCT01621802|20437746|P4|Overall Study|Others|2
5907481|NCT01621802|20437747|P3|Overall Study|Others|3
5907482|NCT01621802|20437748|P2|Overall Study|Others|3
5907483|NCT01621802|20437749|P1|Overall Study|Others|3
5907484|NCT01621802|20437744|P6|Overall Study|Migrated/moved from study area|0
5907485|NCT01621802|20437745|P5|Overall Study|Migrated/moved from study area|1
5907486|NCT01621802|20437746|P4|Overall Study|Migrated/moved from study area|0
5907487|NCT01621802|20437747|P3|Overall Study|Migrated/moved from study area|2
5907488|NCT01621802|20437748|P2|Overall Study|Migrated/moved from study area|0
5907489|NCT01621802|20437749|P1|Overall Study|Migrated/moved from study area|0
5907490|NCT01621802|20437744|P6|Overall Study|Withdrawal by Subject|0
5907491|NCT01621802|20437745|P5|Overall Study|Withdrawal by Subject|2
5907492|NCT01621802|20437746|P4|Overall Study|Withdrawal by Subject|2
5907493|NCT01621802|20437747|P3|Overall Study|Withdrawal by Subject|4
5907494|NCT01621802|20437748|P2|Overall Study|Withdrawal by Subject|4
5907495|NCT01621802|20437749|P1|Overall Study|Withdrawal by Subject|8
5907496|NCT01621802|20437744|P6|Overall Study|Protocol Violation|1
5907497|NCT01621802|20437745|P5|Overall Study|Protocol Violation|0
5907498|NCT01621802|20437746|P4|Overall Study|Protocol Violation|0
5907499|NCT01621802|20437747|P3|Overall Study|Protocol Violation|0
5907500|NCT01621802|20437748|P2|Overall Study|Protocol Violation|0
5907501|NCT01621802|20437749|P1|Overall Study|Protocol Violation|0
5907502|NCT01621542|20437934|P6|Overall Study|study stopped by sponsor|0
5907503|NCT01621542|20437935|P5|Overall Study|study stopped by sponsor|0
5907504|NCT01621542|20437936|P4|Overall Study|study stopped by sponsor|1
5907505|NCT01621542|20437937|P3|Overall Study|study stopped by sponsor|0
5907506|NCT01621542|20437938|P2|Overall Study|study stopped by sponsor|0
5907507|NCT01621542|20437939|P1|Overall Study|study stopped by sponsor|0
5907508|NCT01621542|20437934|P6|Overall Study|Protocol Violation|0
5907509|NCT01621542|20437935|P5|Overall Study|Protocol Violation|0
5907510|NCT01621542|20437936|P4|Overall Study|Protocol Violation|1
5907511|NCT01621542|20437937|P3|Overall Study|Protocol Violation|0
5907512|NCT01621542|20437938|P2|Overall Study|Protocol Violation|0
5907513|NCT01621542|20437939|P1|Overall Study|Protocol Violation|0
5907514|NCT01621542|20437934|P6|Overall Study|progression/treatment failure|5
5907515|NCT01621542|20437935|P5|Overall Study|progression/treatment failure|3
5907516|NCT01621542|20437936|P4|Overall Study|progression/treatment failure|7
5907517|NCT01621542|20437937|P3|Overall Study|progression/treatment failure|3
5907518|NCT01621542|20437938|P2|Overall Study|progression/treatment failure|4
5907519|NCT01621542|20437939|P1|Overall Study|progression/treatment failure|2
5907520|NCT01621542|20437934|P6|Overall Study|Withdrawal by Subject|3
5907521|NCT01621542|20437935|P5|Overall Study|Withdrawal by Subject|3
5907522|NCT01621542|20437936|P4|Overall Study|Withdrawal by Subject|3
5907523|NCT01621542|20437937|P3|Overall Study|Withdrawal by Subject|1
5907524|NCT01621542|20437938|P2|Overall Study|Withdrawal by Subject|0
5907525|NCT01621542|20437939|P1|Overall Study|Withdrawal by Subject|2
5907526|NCT01621542|20437934|P6|Overall Study|Physician Decision|1
5907527|NCT01621542|20437935|P5|Overall Study|Physician Decision|3
5907528|NCT01621542|20437936|P4|Overall Study|Physician Decision|13
5907529|NCT01621542|20437937|P3|Overall Study|Physician Decision|1
5907530|NCT01621542|20437938|P2|Overall Study|Physician Decision|0
5907531|NCT01621542|20437939|P1|Overall Study|Physician Decision|1
5907532|NCT01621542|20437934|P6|Overall Study|Death|0
5907533|NCT01621542|20437935|P5|Overall Study|Death|0
5907534|NCT01621542|20437936|P4|Overall Study|Death|0
5907535|NCT01621542|20437937|P3|Overall Study|Death|0
5907536|NCT01621542|20437938|P2|Overall Study|Death|1
5907537|NCT01621542|20437939|P1|Overall Study|Death|0
5907538|NCT01621542|20437934|P6|Overall Study|Adverse Event|0
5907539|NCT01621542|20437935|P5|Overall Study|Adverse Event|0
5907540|NCT01621542|20437936|P4|Overall Study|Adverse Event|3
5907541|NCT01621542|20437937|P3|Overall Study|Adverse Event|1
5907542|NCT01621542|20437938|P2|Overall Study|Adverse Event|0
5907543|NCT01621542|20437939|P1|Overall Study|Adverse Event|0
5907544|NCT01621490|20437980|P9|Overall Study|Patient delayed due to toxicity|0
5907545|NCT01621490|20437981|P8|Overall Study|Patient delayed due to toxicity|0
5907546|NCT01621490|20437982|P7|Overall Study|Patient delayed due to toxicity|0
5907547|NCT01621490|20437983|P6|Overall Study|Patient delayed due to toxicity|1
5907548|NCT01621490|20437984|P5|Overall Study|Patient delayed due to toxicity|0
5907549|NCT01621490|20437985|P4|Overall Study|Patient delayed due to toxicity|0
5907550|NCT01621490|20437986|P3|Overall Study|Patient delayed due to toxicity|0
5907551|NCT01621490|20437987|P2|Overall Study|Patient delayed due to toxicity|0
5907552|NCT01621490|20437988|P1|Overall Study|Patient delayed due to toxicity|0
5907553|NCT01621490|20437980|P9|Overall Study|Complete response|1
5907554|NCT01621490|20437981|P8|Overall Study|Complete response|0
5907555|NCT01621490|20437982|P7|Overall Study|Complete response|0
5907556|NCT01621490|20437983|P6|Overall Study|Complete response|0
5907557|NCT01621490|20437984|P5|Overall Study|Complete response|0
5907558|NCT01621490|20437985|P4|Overall Study|Complete response|0
5907559|NCT01621490|20437986|P3|Overall Study|Complete response|0
5907560|NCT01621490|20437987|P2|Overall Study|Complete response|0
5907561|NCT01621490|20437988|P1|Overall Study|Complete response|0
5907562|NCT01621490|20437980|P9|Overall Study|Clinical deterioration|0
5907563|NCT01621490|20437981|P8|Overall Study|Clinical deterioration|0
5907564|NCT01621490|20437982|P7|Overall Study|Clinical deterioration|0
5907565|NCT01621490|20437983|P6|Overall Study|Clinical deterioration|0
5907566|NCT01621490|20437984|P5|Overall Study|Clinical deterioration|0
5907567|NCT01621490|20437985|P4|Overall Study|Clinical deterioration|0
5907568|NCT01621490|20437986|P3|Overall Study|Clinical deterioration|0
5907569|NCT01621490|20437987|P2|Overall Study|Clinical deterioration|1
5907570|NCT01621490|20437988|P1|Overall Study|Clinical deterioration|0
5907571|NCT01621490|20437980|P9|Overall Study|Patient reached treatment 2 yr limit|0
5907572|NCT01621490|20437981|P8|Overall Study|Patient reached treatment 2 yr limit|0
5907573|NCT01621490|20437982|P7|Overall Study|Patient reached treatment 2 yr limit|0
5907574|NCT01621490|20437983|P6|Overall Study|Patient reached treatment 2 yr limit|0
5907575|NCT01621490|20437984|P5|Overall Study|Patient reached treatment 2 yr limit|0
5907576|NCT01621490|20437985|P4|Overall Study|Patient reached treatment 2 yr limit|0
5907577|NCT01621490|20437986|P3|Overall Study|Patient reached treatment 2 yr limit|0
5907578|NCT01621490|20437987|P2|Overall Study|Patient reached treatment 2 yr limit|1
5907579|NCT01621490|20437988|P1|Overall Study|Patient reached treatment 2 yr limit|0
5907580|NCT01621490|20437980|P9|Overall Study|Documented disease progression|0
5907581|NCT01621490|20437981|P8|Overall Study|Documented disease progression|0
5907582|NCT01621490|20437982|P7|Overall Study|Documented disease progression|0
5907583|NCT01621490|20437983|P6|Overall Study|Documented disease progression|0
5907584|NCT01621490|20437984|P5|Overall Study|Documented disease progression|0
5907585|NCT01621490|20437985|P4|Overall Study|Documented disease progression|0
5907586|NCT01621490|20437986|P3|Overall Study|Documented disease progression|1
5907587|NCT01621490|20437987|P2|Overall Study|Documented disease progression|0
5907588|NCT01621490|20437988|P1|Overall Study|Documented disease progression|0
5907589|NCT01621490|20437980|P9|Overall Study|Investigator decision|0
5907590|NCT01621490|20437981|P8|Overall Study|Investigator decision|0
5907591|NCT01621490|20437982|P7|Overall Study|Investigator decision|1
5907592|NCT01621490|20437983|P6|Overall Study|Investigator decision|0
5907593|NCT01621490|20437984|P5|Overall Study|Investigator decision|1
5907594|NCT01621490|20437985|P4|Overall Study|Investigator decision|0
5907595|NCT01621490|20437986|P3|Overall Study|Investigator decision|1
5907596|NCT01621490|20437987|P2|Overall Study|Investigator decision|0
5907597|NCT01621490|20437988|P1|Overall Study|Investigator decision|0
5907598|NCT01621490|20437980|P9|Overall Study|BMS informed of patient status|0
5907599|NCT01621490|20437981|P8|Overall Study|BMS informed of patient status|0
5907600|NCT01621490|20437982|P7|Overall Study|BMS informed of patient status|0
5907601|NCT01621490|20437983|P6|Overall Study|BMS informed of patient status|0
5907602|NCT01621490|20437984|P5|Overall Study|BMS informed of patient status|0
5907603|NCT01621490|20437985|P4|Overall Study|BMS informed of patient status|0
5907604|NCT01621490|20437986|P3|Overall Study|BMS informed of patient status|1
5907605|NCT01621490|20437987|P2|Overall Study|BMS informed of patient status|0
5907606|NCT01621490|20437988|P1|Overall Study|BMS informed of patient status|0
5907607|NCT01621490|20437980|P9|Overall Study|Grade 4 Lipase elevation|0
5907608|NCT01621490|20437981|P8|Overall Study|Grade 4 Lipase elevation|0
5907609|NCT01621490|20437982|P7|Overall Study|Grade 4 Lipase elevation|0
5907610|NCT01621490|20437983|P6|Overall Study|Grade 4 Lipase elevation|0
5907611|NCT01621490|20437984|P5|Overall Study|Grade 4 Lipase elevation|0
5907612|NCT01621490|20437985|P4|Overall Study|Grade 4 Lipase elevation|0
5907613|NCT01621490|20437986|P3|Overall Study|Grade 4 Lipase elevation|0
5907614|NCT01621490|20437987|P2|Overall Study|Grade 4 Lipase elevation|0
5907615|NCT01621490|20437988|P1|Overall Study|Grade 4 Lipase elevation|1
5907616|NCT01621490|20437980|P9|Overall Study|Death|0
5907617|NCT01621490|20437981|P8|Overall Study|Death|1
5907618|NCT01621490|20437982|P7|Overall Study|Death|0
5907619|NCT01621490|20437983|P6|Overall Study|Death|0
5907620|NCT01621490|20437984|P5|Overall Study|Death|0
5907621|NCT01621490|20437985|P4|Overall Study|Death|0
5907622|NCT01621490|20437986|P3|Overall Study|Death|0
5907623|NCT01621490|20437987|P2|Overall Study|Death|0
5907624|NCT01621490|20437988|P1|Overall Study|Death|0
5907625|NCT01621490|20437980|P9|Overall Study|Study drug toxicity|1
5907626|NCT01621490|20437981|P8|Overall Study|Study drug toxicity|4
5907627|NCT01621490|20437982|P7|Overall Study|Study drug toxicity|1
5907628|NCT01621490|20437983|P6|Overall Study|Study drug toxicity|10
5907629|NCT01621490|20437984|P5|Overall Study|Study drug toxicity|1
5907630|NCT01621490|20437985|P4|Overall Study|Study drug toxicity|3
5907631|NCT01621490|20437986|P3|Overall Study|Study drug toxicity|5
5907632|NCT01621490|20437987|P2|Overall Study|Study drug toxicity|4
5907633|NCT01621490|20437988|P1|Overall Study|Study drug toxicity|1
5907634|NCT01621490|20437980|P9|Overall Study|Disease progression|4
5907635|NCT01621490|20437981|P8|Overall Study|Disease progression|0
5907636|NCT01621490|20437982|P7|Overall Study|Disease progression|7
5907637|NCT01621490|20437983|P6|Overall Study|Disease progression|8
5907638|NCT01621490|20437984|P5|Overall Study|Disease progression|3
5907639|NCT01621490|20437985|P4|Overall Study|Disease progression|5
5907640|NCT01621490|20437986|P3|Overall Study|Disease progression|1
5907641|NCT01621490|20437987|P2|Overall Study|Disease progression|28
5907642|NCT01621490|20437988|P1|Overall Study|Disease progression|27
5907643|NCT01621490|20437980|P9|Overall Study|Adverse event unrelated to study drug|1
5907644|NCT01621490|20437981|P8|Overall Study|Adverse event unrelated to study drug|2
5907645|NCT01621490|20437982|P7|Overall Study|Adverse event unrelated to study drug|0
5907646|NCT01621490|20437983|P6|Overall Study|Adverse event unrelated to study drug|0
5907647|NCT01621490|20437984|P5|Overall Study|Adverse event unrelated to study drug|0
5907648|NCT01621490|20437985|P4|Overall Study|Adverse event unrelated to study drug|0
5907649|NCT01621490|20437986|P3|Overall Study|Adverse event unrelated to study drug|0
5907650|NCT01621490|20437987|P2|Overall Study|Adverse event unrelated to study drug|1
5907651|NCT01621490|20437988|P1|Overall Study|Adverse event unrelated to study drug|2
5907652|NCT01621490|20437980|P9|Overall Study|Subject request to discontinue study|1
5907653|NCT01621490|20437981|P8|Overall Study|Subject request to discontinue study|0
5907654|NCT01621490|20437982|P7|Overall Study|Subject request to discontinue study|1
5907655|NCT01621490|20437983|P6|Overall Study|Subject request to discontinue study|2
5907656|NCT01621490|20437984|P5|Overall Study|Subject request to discontinue study|0
5907657|NCT01621490|20437985|P4|Overall Study|Subject request to discontinue study|1
5907658|NCT01621490|20437986|P3|Overall Study|Subject request to discontinue study|1
5907659|NCT01621490|20437987|P2|Overall Study|Subject request to discontinue study|3
5907660|NCT01621490|20437988|P1|Overall Study|Subject request to discontinue study|1
5907661|NCT01621490|20437980|P9|Overall Study|Withdrawal by Subject|0
5907662|NCT01621490|20437981|P8|Overall Study|Withdrawal by Subject|0
5907663|NCT01621490|20437982|P7|Overall Study|Withdrawal by Subject|0
5907664|NCT01621490|20437983|P6|Overall Study|Withdrawal by Subject|3
5907665|NCT01621490|20437984|P5|Overall Study|Withdrawal by Subject|0
5907666|NCT01621490|20437985|P4|Overall Study|Withdrawal by Subject|0
5907667|NCT01621490|20437986|P3|Overall Study|Withdrawal by Subject|0
5907668|NCT01621490|20437987|P2|Overall Study|Withdrawal by Subject|0
5907669|NCT01621490|20437988|P1|Overall Study|Withdrawal by Subject|1
5907670|NCT01621490|20437980|P9|Overall Study|Maximum clinical benefit|0
5907671|NCT01621490|20437981|P8|Overall Study|Maximum clinical benefit|2
5907672|NCT01621490|20437982|P7|Overall Study|Maximum clinical benefit|1
5907673|NCT01621490|20437983|P6|Overall Study|Maximum clinical benefit|0
5907674|NCT01621490|20437984|P5|Overall Study|Maximum clinical benefit|0
5907675|NCT01621490|20437985|P4|Overall Study|Maximum clinical benefit|0
5907676|NCT01621490|20437986|P3|Overall Study|Maximum clinical benefit|0
5907677|NCT01621490|20437987|P2|Overall Study|Maximum clinical benefit|2
5907678|NCT01621490|20437988|P1|Overall Study|Maximum clinical benefit|3
5907679|NCT01621490|20437980|P9|Overall Study|Subject no longer meets study criteria|0
5907680|NCT01621490|20437981|P8|Overall Study|Subject no longer meets study criteria|0
5907681|NCT01621490|20437982|P7|Overall Study|Subject no longer meets study criteria|0
5907682|NCT01621490|20437983|P6|Overall Study|Subject no longer meets study criteria|0
5907683|NCT01621490|20437984|P5|Overall Study|Subject no longer meets study criteria|1
5907684|NCT01621490|20437985|P4|Overall Study|Subject no longer meets study criteria|0
5907685|NCT01621490|20437986|P3|Overall Study|Subject no longer meets study criteria|0
5907686|NCT01621490|20437987|P2|Overall Study|Subject no longer meets study criteria|0
5907687|NCT01621490|20437988|P1|Overall Study|Subject no longer meets study criteria|0
5907688|NCT01621490|20437980|P9|Overall Study|Patient could not travel|0
5907689|NCT01621490|20437981|P8|Overall Study|Patient could not travel|0
5907690|NCT01621490|20437982|P7|Overall Study|Patient could not travel|0
5907691|NCT01621490|20437983|P6|Overall Study|Patient could not travel|0
5907692|NCT01621490|20437984|P5|Overall Study|Patient could not travel|0
5907693|NCT01621490|20437985|P4|Overall Study|Patient could not travel|0
5907694|NCT01621490|20437986|P3|Overall Study|Patient could not travel|0
5907695|NCT01621490|20437987|P2|Overall Study|Patient could not travel|0
5907696|NCT01621490|20437988|P1|Overall Study|Patient could not travel|1
5907697|NCT01621490|20437980|P9|Overall Study|Participant completed treatment|0
5907698|NCT01621490|20437981|P8|Overall Study|Participant completed treatment|1
5907699|NCT01621490|20437982|P7|Overall Study|Participant completed treatment|0
5907700|NCT01621490|20437983|P6|Overall Study|Participant completed treatment|0
5907701|NCT01621490|20437984|P5|Overall Study|Participant completed treatment|0
5907702|NCT01621490|20437985|P4|Overall Study|Participant completed treatment|0
5907703|NCT01621490|20437986|P3|Overall Study|Participant completed treatment|1
5907704|NCT01621490|20437987|P2|Overall Study|Participant completed treatment|4
5907705|NCT01621490|20437988|P1|Overall Study|Participant completed treatment|4
5907706|NCT01621191|20438240|P1|Overall Study|Site Removed From Study|1
5907707|NCT01621191|20438240|P1|Overall Study|Lost to Follow-up|1
5907708|NCT01621191|20438240|P1|Overall Study|Lack of Efficacy|6
5907709|NCT01621191|20438240|P1|Overall Study|Withdrawal by Subject|8
5907710|NCT01621191|20438240|P1|Overall Study|Adverse Event|9
5907711|NCT01621178|20438254|P3|Overall Study|Physician Decision|7
5907712|NCT01621178|20438255|P2|Overall Study|Physician Decision|2
5907713|NCT01621178|20438256|P1|Overall Study|Physician Decision|5
5907714|NCT01621178|20438254|P3|Overall Study|Withdrawal by Subject|18
5907715|NCT01621178|20438255|P2|Overall Study|Withdrawal by Subject|17
5907716|NCT01621178|20438256|P1|Overall Study|Withdrawal by Subject|14
5907717|NCT01621178|20438254|P3|Overall Study|Lost to Follow-up|1
5907718|NCT01621178|20438255|P2|Overall Study|Lost to Follow-up|2
5907719|NCT01621178|20438256|P1|Overall Study|Lost to Follow-up|1
5907720|NCT01621178|20438254|P3|Overall Study|Death|2
5907721|NCT01621178|20438255|P2|Overall Study|Death|7
5907722|NCT01621178|20438256|P1|Overall Study|Death|6
5907723|NCT01621178|20438254|P3|Overall Study|Adverse Event|8
5907724|NCT01621178|20438255|P2|Overall Study|Adverse Event|2
5907725|NCT01621178|20438256|P1|Overall Study|Adverse Event|5
5907726|NCT01621126|20438348|P1|Overall Study|Physician Decision|6
5907727|NCT01620983|20438370|P3|Overall Study|Physician Decision|5
5907728|NCT01620983|20438371|P2|Overall Study|Physician Decision|10
5907729|NCT01620983|20438372|P1|Overall Study|Physician Decision|3
5907730|NCT01620983|20438370|P3|Overall Study|Death|0
5907731|NCT01620983|20438371|P2|Overall Study|Death|0
5907732|NCT01620983|20438372|P1|Overall Study|Death|2
5907733|NCT01620983|20438370|P3|Overall Study|Withdrawal by Subject|1
5907734|NCT01620983|20438371|P2|Overall Study|Withdrawal by Subject|8
5907735|NCT01620983|20438372|P1|Overall Study|Withdrawal by Subject|6
5907736|NCT01620983|20438370|P3|Overall Study|Lost to Follow-up|9
5907737|NCT01620983|20438371|P2|Overall Study|Lost to Follow-up|4
5907738|NCT01620983|20438372|P1|Overall Study|Lost to Follow-up|8
5907739|NCT01620762|20438401|P3|Overall Study|Use of prohibted therapies|1
5907740|NCT01620762|20438402|P2|Overall Study|Use of prohibted therapies|1
5907741|NCT01620762|20438403|P1|Overall Study|Use of prohibted therapies|0
5907742|NCT01620762|20438401|P3|Overall Study|Non-specified|5
5907743|NCT01620762|20438402|P2|Overall Study|Non-specified|6
5907744|NCT01620762|20438403|P1|Overall Study|Non-specified|3
5907745|NCT01620762|20438401|P3|Overall Study|Subject deterioration|1
5907746|NCT01620762|20438402|P2|Overall Study|Subject deterioration|1
5907747|NCT01620762|20438403|P1|Overall Study|Subject deterioration|0
5907748|NCT01620762|20438401|P3|Overall Study|Protocol deviation|6
5907749|NCT01620762|20438402|P2|Overall Study|Protocol deviation|1
5907750|NCT01620762|20438403|P1|Overall Study|Protocol deviation|1
5907751|NCT01620762|20438401|P3|Overall Study|Lost to Follow-up|10
5907752|NCT01620762|20438402|P2|Overall Study|Lost to Follow-up|17
5907753|NCT01620762|20438403|P1|Overall Study|Lost to Follow-up|11
5907754|NCT01620762|20438401|P3|Overall Study|Withdrawal by Subject|27
5907755|NCT01620762|20438402|P2|Overall Study|Withdrawal by Subject|26
5907756|NCT01620762|20438403|P1|Overall Study|Withdrawal by Subject|23
5907757|NCT01620762|20438401|P3|Overall Study|Adverse Event|2
5907758|NCT01620762|20438402|P2|Overall Study|Adverse Event|5
5907759|NCT01620762|20438403|P1|Overall Study|Adverse Event|9
5907760|NCT01620762|20438401|P3|Overall Study|Protocol Violation|1
5907761|NCT01620762|20438402|P2|Overall Study|Protocol Violation|1
5907762|NCT01620762|20438403|P1|Overall Study|Protocol Violation|1
5907763|NCT01620528|20438464|P3|Post-Treatment Follow-Up Period|Other|2
5907764|NCT01620528|20438465|P2|Post-Treatment Follow-Up Period|Other|4
5907765|NCT01620528|20438466|P1|Post-Treatment Follow-Up Period|Other|6
5907766|NCT01620528|20438464|P3|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|4
5907767|NCT01620528|20438465|P2|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|3
5907768|NCT01620528|20438466|P1|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|8
5907769|NCT01620528|20438464|P3|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1
5907770|NCT01620528|20438465|P2|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1
5907771|NCT01620528|20438466|P1|Post-Treatment Follow-Up Period|Exclusionary Medication Received|0
5907772|NCT01620528|20438464|P3|Post-Treatment Follow-Up Period|Lost to Follow-up|4
5907773|NCT01620528|20438465|P2|Post-Treatment Follow-Up Period|Lost to Follow-up|2
5907774|NCT01620528|20438466|P1|Post-Treatment Follow-Up Period|Lost to Follow-up|3
5907775|NCT01620528|20438464|P3|Post-Treatment Follow-Up Period|Withdrawal by Subject|3
5907776|NCT01620528|20438465|P2|Post-Treatment Follow-Up Period|Withdrawal by Subject|7
5907777|NCT01620528|20438466|P1|Post-Treatment Follow-Up Period|Withdrawal by Subject|3
5907778|NCT01620528|20438464|P3|Treatment Period|Exclusionary Medication Received|0
5907779|NCT01620528|20438465|P2|Treatment Period|Exclusionary Medication Received|1
5907780|NCT01620528|20438466|P1|Treatment Period|Exclusionary Medication Received|0
5907781|NCT01620528|20438464|P3|Treatment Period|Surgery/Invasive Intervention|3
5907782|NCT01620528|20438465|P2|Treatment Period|Surgery/Invasive Intervention|1
5907783|NCT01620528|20438466|P1|Treatment Period|Surgery/Invasive Intervention|5
5907784|NCT01620528|20438464|P3|Treatment Period|Pregnancy|2
5907785|NCT01620528|20438465|P2|Treatment Period|Pregnancy|2
5907786|NCT01620528|20438466|P1|Treatment Period|Pregnancy|7
5907787|NCT01620528|20438464|P3|Treatment Period|Subject Noncompliant|2
5907788|NCT01620528|20438465|P2|Treatment Period|Subject Noncompliant|2
5907789|NCT01620528|20438466|P1|Treatment Period|Subject Noncompliant|11
5907790|NCT01620528|20438464|P3|Treatment Period|Other|7
5907791|NCT01620528|20438465|P2|Treatment Period|Other|5
5907792|NCT01620528|20438466|P1|Treatment Period|Other|9
5907793|NCT01620528|20438464|P3|Treatment Period|Lost to Follow-up|14
5907794|NCT01620528|20438465|P2|Treatment Period|Lost to Follow-up|8
5907795|NCT01620528|20438466|P1|Treatment Period|Lost to Follow-up|16
5907796|NCT01620528|20438464|P3|Treatment Period|Adverse Event|21
5907797|NCT01620528|20438465|P2|Treatment Period|Adverse Event|13
5907798|NCT01620528|20438466|P1|Treatment Period|Adverse Event|17
5907799|NCT01620528|20438464|P3|Treatment Period|Withdrawal by Subject|16
5907800|NCT01620528|20438465|P2|Treatment Period|Withdrawal by Subject|21
5907801|NCT01620528|20438466|P1|Treatment Period|Withdrawal by Subject|35
5907802|NCT01620528|20438464|P3|Treatment Period|Did Not Receive Study Drug|1
5907803|NCT01620528|20438465|P2|Treatment Period|Did Not Receive Study Drug|0
5907804|NCT01620528|20438466|P1|Treatment Period|Did Not Receive Study Drug|0
5907805|NCT01620489|20438806|P2|Overall Study|Unclassified|2
5907806|NCT01620489|20438807|P1|Overall Study|Unclassified|1
5907807|NCT01620489|20438806|P2|Overall Study|Withdrawal Criteria|25
5907808|NCT01620489|20438807|P1|Overall Study|Withdrawal Criteria|17
5907809|NCT01620489|20438806|P2|Overall Study|Protocol Violation|3
5907810|NCT01620489|20438807|P1|Overall Study|Protocol Violation|0
5907811|NCT01620489|20438806|P2|Overall Study|Adverse Event|4
5907812|NCT01620489|20438807|P1|Overall Study|Adverse Event|17
5907813|NCT01620255|20438828|P5|Overall Study|Withdrawn at discretion of investigator|1
5907814|NCT01620255|20438829|P4|Overall Study|Withdrawn at discretion of investigator|0
5907815|NCT01620255|20438830|P3|Overall Study|Withdrawn at discretion of investigator|0
5907816|NCT01620255|20438831|P2|Overall Study|Withdrawn at discretion of investigator|0
5907817|NCT01620255|20438832|P1|Overall Study|Withdrawn at discretion of investigator|0
5907818|NCT01620255|20438828|P5|Overall Study|Adverse Event|1
5907819|NCT01620255|20438829|P4|Overall Study|Adverse Event|1
5907820|NCT01620255|20438830|P3|Overall Study|Adverse Event|0
5907821|NCT01620255|20438831|P2|Overall Study|Adverse Event|4
5907822|NCT01620255|20438832|P1|Overall Study|Adverse Event|0
5907823|NCT01620255|20438828|P5|Overall Study|Non-compliance|0
5907824|NCT01620255|20438829|P4|Overall Study|Non-compliance|0
5907825|NCT01620255|20438830|P3|Overall Study|Non-compliance|0
5907826|NCT01620255|20438831|P2|Overall Study|Non-compliance|1
5907827|NCT01620255|20438832|P1|Overall Study|Non-compliance|0
5907828|NCT01620255|20438828|P5|Overall Study|Participant underwent fecal transplant|0
5907829|NCT01620255|20438829|P4|Overall Study|Participant underwent fecal transplant|0
5907830|NCT01620255|20438830|P3|Overall Study|Participant underwent fecal transplant|1
5907831|NCT01620255|20438831|P2|Overall Study|Participant underwent fecal transplant|0
5907832|NCT01620255|20438832|P1|Overall Study|Participant underwent fecal transplant|0
5907833|NCT01620255|20438828|P5|Overall Study|Withdrawal by Subject|4
5907834|NCT01620255|20438829|P4|Overall Study|Withdrawal by Subject|2
5907835|NCT01620255|20438830|P3|Overall Study|Withdrawal by Subject|1
5907836|NCT01620255|20438831|P2|Overall Study|Withdrawal by Subject|1
5907837|NCT01620255|20438832|P1|Overall Study|Withdrawal by Subject|4
5907838|NCT01620177|20438909|P1|Overall Study|Randomized, Not Active due to Scheduling|1
5907839|NCT01620177|20438909|P1|Overall Study|Physician Decision|2
5907840|NCT01620177|20438909|P1|Overall Study|Lost to Follow-up|7
5907841|NCT01620177|20438909|P1|Overall Study|Withdrawal by Subject|26
5907842|NCT01620177|20438909|P1|Overall Study|Failure at Screening Visit|43
5907843|NCT01620138|20438934|P2|Overall Study|Adverse Event|0
5907844|NCT01620138|20438935|P1|Overall Study|Adverse Event|2
5907845|NCT01620138|20438934|P2|Overall Study|Lack of Efficacy|0
5907846|NCT01620138|20438935|P1|Overall Study|Lack of Efficacy|1
5907847|NCT01620138|20438934|P2|Overall Study|Withdrawal by Subject|0
5907848|NCT01620138|20438935|P1|Overall Study|Withdrawal by Subject|3
5907849|NCT01620086|20438943|P3|Overall Study|Physician Decision|0
5907850|NCT01620086|20438944|P2|Overall Study|Physician Decision|0
5907851|NCT01620086|20438945|P1|Overall Study|Physician Decision|1
5907852|NCT01620086|20438943|P3|Overall Study|failed study criteria|0
5907853|NCT01620086|20438944|P2|Overall Study|failed study criteria|4
5907854|NCT01620086|20438945|P1|Overall Study|failed study criteria|1
5907855|NCT01620086|20438943|P3|Overall Study|Withdrawal by Subject|0
5907856|NCT01620086|20438944|P2|Overall Study|Withdrawal by Subject|3
5907857|NCT01620086|20438945|P1|Overall Study|Withdrawal by Subject|3
5907858|NCT01620060|20438964|P1|Overall Study|Per Sponsor Decision|2
5907859|NCT01620060|20438964|P1|Overall Study|Family emergency|1
5907860|NCT01620060|20438964|P1|Overall Study|Did not comply with Study Produre|1
5907861|NCT01620060|20438964|P1|Overall Study|Withdrawal by Subject|1
5907862|NCT01620060|20438964|P1|Overall Study|Protocol Violation|1
5907863|NCT01620060|20438964|P1|Overall Study|Adverse Event|9
5907864|NCT01619878|20439002|P1|Follow-up at 12 Months of Age|Death|2
5907865|NCT01619878|20439002|P1|Follow-up at 12 Months of Age|Lost to Follow-up|1
5907866|NCT01619878|20439002|P1|6 Week Follow-up Phase|Adverse Event|1
5907867|NCT01619852|20439016|P2|3 Month Follow up|Lost to Follow-up|34
5907868|NCT01619852|20439017|P1|3 Month Follow up|Lost to Follow-up|31
5907869|NCT01619852|20439016|P2|24 Hour Assessment|Withdrawal by Subject|1
5907870|NCT01619852|20439017|P1|24 Hour Assessment|Withdrawal by Subject|1
5907871|NCT01619800|20439033|P2|Overall Study|study terminated|0
5907872|NCT01619800|20439034|P1|Overall Study|study terminated|2
5907873|NCT01619787|20439042|P1|Overall Study|Lost to Follow-up|5
5907874|NCT01619579|20439059|P2|Overall Study|Withdrawal by Subject|3
5907875|NCT01619579|20439060|P1|Overall Study|Withdrawal by Subject|0
5907876|NCT01619423|20439074|P4|Part 1 (Dose Escalation)|High basal Mn|0
5907877|NCT01619423|20439075|P3|Part 1 (Dose Escalation)|High basal Mn|0
5907878|NCT01619423|20439076|P2|Part 1 (Dose Escalation)|High basal Mn|2
5907879|NCT01619423|20439077|P1|Part 1 (Dose Escalation)|High basal Mn|0
5907880|NCT01619410|20439090|P2|Overall Study|Lost to Follow-up|4
5907881|NCT01619410|20439091|P1|Overall Study|Lost to Follow-up|7
5907889|NCT01619059|20439109|P2|Long-Term (LT) Treatment Period|Not Met Study Criteria|1
5907890|NCT01619059|20439110|P1|Long-Term (LT) Treatment Period|Not Met Study Criteria|0
5907891|NCT01619059|20439109|P2|Long-Term (LT) Treatment Period|Lost to Follow-up|2
5907892|NCT01619059|20439110|P1|Long-Term (LT) Treatment Period|Lost to Follow-up|2
5907893|NCT01619059|20439109|P2|Long-Term (LT) Treatment Period|Death|0
5907894|NCT01619059|20439110|P1|Long-Term (LT) Treatment Period|Death|1
5907895|NCT01619059|20439109|P2|Long-Term (LT) Treatment Period|Withdrawal by Subject|2
5907896|NCT01619059|20439110|P1|Long-Term (LT) Treatment Period|Withdrawal by Subject|3
5907897|NCT01619059|20439109|P2|Long-Term (LT) Treatment Period|Adverse Event|3
5907898|NCT01619059|20439110|P1|Long-Term (LT) Treatment Period|Adverse Event|2
5907899|NCT01619059|20439109|P2|Long-Term (LT) Treatment Period|Lack of Efficacy|1
5907900|NCT01619059|20439110|P1|Long-Term (LT) Treatment Period|Lack of Efficacy|0
5907901|NCT01619059|20439109|P2|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|2
5907902|NCT01619059|20439110|P1|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|1
5907903|NCT01619059|20439109|P2|Short-Term (ST) Treatment Period|Lost to Follow-up|4
5907904|NCT01619059|20439110|P1|Short-Term (ST) Treatment Period|Lost to Follow-up|2
5907905|NCT01619059|20439109|P2|Short-Term (ST) Treatment Period|Withdrawal by Subject|5
5907906|NCT01619059|20439110|P1|Short-Term (ST) Treatment Period|Withdrawal by Subject|2
5907907|NCT01619059|20439109|P2|Short-Term (ST) Treatment Period|Adverse Event|0
5907908|NCT01619059|20439110|P1|Short-Term (ST) Treatment Period|Adverse Event|1
5907909|NCT01618968|20439126|P4|Overall Study|Death|1
5907910|NCT01618968|20439127|P3|Overall Study|Death|0
5907911|NCT01618968|20439128|P2|Overall Study|Death|0
5907912|NCT01618968|20439129|P1|Overall Study|Death|0
5907913|NCT01618968|20439126|P4|Overall Study|Adverse Event|0
5907914|NCT01618968|20439127|P3|Overall Study|Adverse Event|0
5907915|NCT01618968|20439128|P2|Overall Study|Adverse Event|0
5907916|NCT01618968|20439129|P1|Overall Study|Adverse Event|1
5907917|NCT01618916|20439202|P6|Overall Study|Lost to Follow-up|0
5907918|NCT01618916|20439203|P5|Overall Study|Lost to Follow-up|0
5907919|NCT01618916|20439204|P4|Overall Study|Lost to Follow-up|2
5907920|NCT01618916|20439205|P3|Overall Study|Lost to Follow-up|0
5907921|NCT01618916|20439206|P2|Overall Study|Lost to Follow-up|0
5907922|NCT01618916|20439207|P1|Overall Study|Lost to Follow-up|1
5907923|NCT01618916|20439202|P6|Overall Study|Withdrawal by Subject|0
5907924|NCT01618916|20439203|P5|Overall Study|Withdrawal by Subject|1
5907925|NCT01618916|20439204|P4|Overall Study|Withdrawal by Subject|0
5907926|NCT01618916|20439205|P3|Overall Study|Withdrawal by Subject|1
5907927|NCT01618916|20439206|P2|Overall Study|Withdrawal by Subject|1
5907928|NCT01618916|20439207|P1|Overall Study|Withdrawal by Subject|0
5907929|NCT01618916|20439202|P6|Overall Study|Adverse Event|0
5907930|NCT01618916|20439203|P5|Overall Study|Adverse Event|0
5907931|NCT01618916|20439204|P4|Overall Study|Adverse Event|0
5907932|NCT01618916|20439205|P3|Overall Study|Adverse Event|0
5907933|NCT01618916|20439206|P2|Overall Study|Adverse Event|0
5907934|NCT01618916|20439207|P1|Overall Study|Adverse Event|1
5907935|NCT01618864|20439237|P1|Overall Study|Lost to Follow-up|2
5907936|NCT01618864|20439237|P1|Overall Study|Withdrawal by Subject|2
5907937|NCT01618838|20439246|P1|Overall Study|slow accrual, trial closed prematurely.|4
5907938|NCT01618708|20439254|P2|Overall Study|Randomized but not treated|2
5907939|NCT01618708|20439255|P1|Overall Study|Randomized but not treated|3
5907940|NCT01618708|20439254|P2|Overall Study|Other than specified above|1
5907941|NCT01618708|20439255|P1|Overall Study|Other than specified above|1
5907942|NCT01618708|20439254|P2|Overall Study|Technical problems|0
5907943|NCT01618708|20439255|P1|Overall Study|Technical problems|2
5907944|NCT01618708|20439254|P2|Overall Study|Lack of Efficacy|8
5907945|NCT01618708|20439255|P1|Overall Study|Lack of Efficacy|8
5907946|NCT01618708|20439254|P2|Overall Study|Withdrawal by Subject|22
5907947|NCT01618708|20439255|P1|Overall Study|Withdrawal by Subject|17
5907948|NCT01618708|20439254|P2|Overall Study|Lost to Follow-up|3
5907949|NCT01618708|20439255|P1|Overall Study|Lost to Follow-up|3
5907950|NCT01618708|20439254|P2|Overall Study|Adverse Event|10
5907951|NCT01618708|20439255|P1|Overall Study|Adverse Event|10
5907952|NCT01618695|20439271|P4|Overall Study|Not treated|0
5907953|NCT01618695|20439272|P3|Overall Study|Not treated|2
5907954|NCT01618695|20439273|P2|Overall Study|Not treated|0
5907955|NCT01618695|20439274|P1|Overall Study|Not treated|1
5907956|NCT01618695|20439271|P4|Overall Study|Other than specified|2
5907957|NCT01618695|20439272|P3|Overall Study|Other than specified|2
5907958|NCT01618695|20439273|P2|Overall Study|Other than specified|2
5907959|NCT01618695|20439274|P1|Overall Study|Other than specified|1
5907960|NCT01618695|20439271|P4|Overall Study|Lack of Efficacy|1
5907961|NCT01618695|20439272|P3|Overall Study|Lack of Efficacy|1
5907962|NCT01618695|20439273|P2|Overall Study|Lack of Efficacy|2
5907963|NCT01618695|20439274|P1|Overall Study|Lack of Efficacy|1
5907964|NCT01618695|20439271|P4|Overall Study|Pregnancy|0
5907965|NCT01618695|20439272|P3|Overall Study|Pregnancy|0
5907966|NCT01618695|20439273|P2|Overall Study|Pregnancy|0
5907967|NCT01618695|20439274|P1|Overall Study|Pregnancy|2
5907968|NCT01618695|20439271|P4|Overall Study|Withdrawal by Subject|13
5907969|NCT01618695|20439272|P3|Overall Study|Withdrawal by Subject|9
5907970|NCT01618695|20439273|P2|Overall Study|Withdrawal by Subject|11
5907971|NCT01618695|20439274|P1|Overall Study|Withdrawal by Subject|16
5907972|NCT01618695|20439271|P4|Overall Study|Lost to Follow-up|0
5907973|NCT01618695|20439272|P3|Overall Study|Lost to Follow-up|1
5907974|NCT01618695|20439273|P2|Overall Study|Lost to Follow-up|0
5907975|NCT01618695|20439274|P1|Overall Study|Lost to Follow-up|0
5907976|NCT01618695|20439271|P4|Overall Study|Adverse Event|20
5907977|NCT01618695|20439272|P3|Overall Study|Adverse Event|15
5907978|NCT01618695|20439273|P2|Overall Study|Adverse Event|5
5907979|NCT01618695|20439274|P1|Overall Study|Adverse Event|4
5907980|NCT01618669|20439298|P2|Overall Study|Miscellaneous Reason|1
5907981|NCT01618669|20439299|P1|Overall Study|Miscellaneous Reason|0
5907982|NCT01618669|20439298|P2|Overall Study|Withdrawal by Subject|9
5907983|NCT01618669|20439299|P1|Overall Study|Withdrawal by Subject|9
5907984|NCT01618669|20439298|P2|Overall Study|Protocol Violation|3
5907985|NCT01618669|20439299|P1|Overall Study|Protocol Violation|5
5907986|NCT01618669|20439298|P2|Overall Study|Adverse Event|7
5907987|NCT01618669|20439299|P1|Overall Study|Adverse Event|16
5907988|NCT01618669|20439298|P2|Overall Study|Randomized but Never Received Study Drug|2
5907989|NCT01618669|20439299|P1|Overall Study|Randomized but Never Received Study Drug|3
5907990|NCT01618669|20439298|P2|Overall Study|Lost to Follow-up|1
5907991|NCT01618669|20439299|P1|Overall Study|Lost to Follow-up|1
5907992|NCT01618305|20439358|P2|Overall Study|Withdrawal by Subject|2
5907993|NCT01618305|20439359|P1|Overall Study|Withdrawal by Subject|3
5907994|NCT01618305|20439358|P2|Overall Study|Protocol Violation|0
5907995|NCT01618305|20439359|P1|Overall Study|Protocol Violation|1
5907996|NCT01618305|20439358|P2|Overall Study|Lost to Follow-up|7
5907997|NCT01618305|20439359|P1|Overall Study|Lost to Follow-up|11
5907998|NCT01618305|20439358|P2|Overall Study|Death|1
5907999|NCT01618305|20439359|P1|Overall Study|Death|0
5908000|NCT01618266|20439401|P1|Overall Study|Protocol Violation|43
5908001|NCT01618266|20439401|P1|Overall Study|Lack of Efficacy|23
5908002|NCT01618266|20439401|P1|Overall Study|Other reasons|11
5908003|NCT01618266|20439401|P1|Overall Study|Treatment satisfaction|10
5908004|NCT01618266|20439401|P1|Overall Study|Lost to Follow-up|9
5908005|NCT01618214|20439438|P2|Overall Study|Unclassified|5
5908006|NCT01618214|20439439|P1|Overall Study|Unclassified|4
5908007|NCT01618214|20439438|P2|Overall Study|Withdrawal Criteria|2
5908008|NCT01618214|20439439|P1|Overall Study|Withdrawal Criteria|1
5908009|NCT01618214|20439438|P2|Overall Study|Protocol Violation|4
5908010|NCT01618214|20439439|P1|Overall Study|Protocol Violation|1
5908011|NCT01618214|20439438|P2|Overall Study|Lack of Efficacy|1
5908012|NCT01618214|20439439|P1|Overall Study|Lack of Efficacy|1
5908013|NCT01618214|20439438|P2|Overall Study|Adverse Event|1
5908014|NCT01618214|20439439|P1|Overall Study|Adverse Event|3
5908015|NCT01618162|20439455|P2|Overall Study|Unclassified|13
5908016|NCT01618162|20439456|P1|Overall Study|Unclassified|14
5908017|NCT01618162|20439455|P2|Overall Study|Withdrawal Criteria|10
5908018|NCT01618162|20439456|P1|Overall Study|Withdrawal Criteria|2
5908019|NCT01618162|20439455|P2|Overall Study|Adverse Event|2
5908020|NCT01618162|20439456|P1|Overall Study|Adverse Event|9
5908021|NCT01618162|20439455|P2|Overall Study|Protocol Violation|10
5908022|NCT01618162|20439456|P1|Overall Study|Protocol Violation|13
5908023|NCT01618019|20439476|P2|Overall Study|Withdrawal by Subject|14
5908024|NCT01618019|20439477|P1|Overall Study|Withdrawal by Subject|14
5908025|NCT01617967|20439503|P6|Overall Study|Dosing Suspended by Sponsor|0
5908026|NCT01617967|20439504|P5|Overall Study|Dosing Suspended by Sponsor|0
5908027|NCT01617967|20439505|P4|Overall Study|Dosing Suspended by Sponsor|0
5908028|NCT01617967|20439506|P3|Overall Study|Dosing Suspended by Sponsor|0
5908029|NCT01617967|20439507|P2|Overall Study|Dosing Suspended by Sponsor|0
5908030|NCT01617967|20439508|P1|Overall Study|Dosing Suspended by Sponsor|1
5908031|NCT01617967|20439503|P6|Overall Study|Withdrawal by Subject|1
5908032|NCT01617967|20439504|P5|Overall Study|Withdrawal by Subject|0
5908033|NCT01617967|20439505|P4|Overall Study|Withdrawal by Subject|0
5908034|NCT01617967|20439506|P3|Overall Study|Withdrawal by Subject|0
5908035|NCT01617967|20439507|P2|Overall Study|Withdrawal by Subject|0
5908036|NCT01617967|20439508|P1|Overall Study|Withdrawal by Subject|0
5908037|NCT01617967|20439503|P6|Overall Study|Protocol Violation|0
5908038|NCT01617967|20439504|P5|Overall Study|Protocol Violation|0
5908039|NCT01617967|20439505|P4|Overall Study|Protocol Violation|1
5908040|NCT01617967|20439506|P3|Overall Study|Protocol Violation|0
5908041|NCT01617967|20439507|P2|Overall Study|Protocol Violation|0
5908042|NCT01617967|20439508|P1|Overall Study|Protocol Violation|0
5908043|NCT01617681|20439562|P5|Period 2 Open Label|Withdrawal by Subject|3
5908044|NCT01617681|20439563|P4|Period 2 Open Label|Withdrawal by Subject|0
5908045|NCT01617681|20439564|P3|Period 2 Open Label|Withdrawal by Subject|0
5908046|NCT01617681|20439565|P2|Period 2 Open Label|Withdrawal by Subject|0
5908047|NCT01617681|20439566|P1|Period 2 Open Label|Withdrawal by Subject|0
5908048|NCT01617681|20439562|P5|Period 2 Open Label|Adverse Event|3
5908049|NCT01617681|20439563|P4|Period 2 Open Label|Adverse Event|0
5908050|NCT01617681|20439564|P3|Period 2 Open Label|Adverse Event|0
5908051|NCT01617681|20439565|P2|Period 2 Open Label|Adverse Event|0
5908052|NCT01617681|20439566|P1|Period 2 Open Label|Adverse Event|0
5908053|NCT01617681|20439562|P5|Period 1 Double Blind|Withdrawal by Subject|0
5908054|NCT01617681|20439563|P4|Period 1 Double Blind|Withdrawal by Subject|0
5908055|NCT01617681|20439564|P3|Period 1 Double Blind|Withdrawal by Subject|1
5908056|NCT01617681|20439565|P2|Period 1 Double Blind|Withdrawal by Subject|1
5908057|NCT01617681|20439566|P1|Period 1 Double Blind|Withdrawal by Subject|1
5908058|NCT01617681|20439562|P5|Period 1 Double Blind|Adverse Event|0
5908059|NCT01617681|20439563|P4|Period 1 Double Blind|Adverse Event|2
5908060|NCT01617681|20439564|P3|Period 1 Double Blind|Adverse Event|0
5908061|NCT01617681|20439565|P2|Period 1 Double Blind|Adverse Event|0
5908062|NCT01617681|20439566|P1|Period 1 Double Blind|Adverse Event|2
5908063|NCT01617668|20439587|P4|Overall Study|Subject/guardian decision|1
5908064|NCT01617668|20439588|P3|Overall Study|Subject/guardian decision|2
5908065|NCT01617668|20439589|P2|Overall Study|Subject/guardian decision|3
5908066|NCT01617668|20439590|P1|Overall Study|Subject/guardian decision|1
5908067|NCT01617668|20439587|P4|Overall Study|Progressive Disease|9
5908068|NCT01617668|20439588|P3|Overall Study|Progressive Disease|6
5908069|NCT01617668|20439589|P2|Overall Study|Progressive Disease|4
5908070|NCT01617668|20439590|P1|Overall Study|Progressive Disease|4
5908071|NCT01617668|20439587|P4|Overall Study|Physician Decision|0
5908072|NCT01617668|20439588|P3|Overall Study|Physician Decision|3
5908073|NCT01617668|20439589|P2|Overall Study|Physician Decision|2
5908074|NCT01617668|20439590|P1|Overall Study|Physician Decision|1
5908075|NCT01617668|20439587|P4|Overall Study|Adverse Event|5
5908076|NCT01617668|20439588|P3|Overall Study|Adverse Event|12
5908077|NCT01617668|20439589|P2|Overall Study|Adverse Event|0
5908078|NCT01617668|20439590|P1|Overall Study|Adverse Event|7
5908079|NCT01617655|20439631|P2|Overall Study|Other than specified above|2
5908080|NCT01617655|20439632|P1|Overall Study|Other than specified above|1
5908081|NCT01617655|20439631|P2|Overall Study|Site closure|5
5908082|NCT01617655|20439632|P1|Overall Study|Site closure|3
5908083|NCT01617655|20439631|P2|Overall Study|Last visit outside protocol visit window|10
5908084|NCT01617655|20439632|P1|Overall Study|Last visit outside protocol visit window|1
5908085|NCT01617655|20439631|P2|Overall Study|Consent withdrawn by participant|1
5908086|NCT01617655|20439632|P1|Overall Study|Consent withdrawn by participant|1
5908087|NCT01617655|20439631|P2|Overall Study|Participants moved|4
5908088|NCT01617655|20439632|P1|Overall Study|Participants moved|0
5908089|NCT01617655|20439631|P2|Overall Study|Poor compliance to protocol|4
5908090|NCT01617655|20439632|P1|Overall Study|Poor compliance to protocol|1
5908091|NCT01617655|20439631|P2|Overall Study|Adverse Event|3
5908092|NCT01617655|20439632|P1|Overall Study|Adverse Event|2
5908093|NCT01617629|20439692|P1|Overall Study|Participant Withdrew Consent|2
5908094|NCT01617629|20439692|P1|Overall Study|Reason Not Specified|1
5908095|NCT01617629|20439692|P1|Overall Study|Investigator's Clinical Judgement|1
5908096|NCT01617629|20439692|P1|Overall Study|Death|2
5908097|NCT01617460|20439720|P1|Overall Study|Withdrawal by Subject|9
5908098|NCT01617460|20439720|P1|Overall Study|Protocol Violation|5
5908099|NCT01617460|20439720|P1|Overall Study|Physician Decision|16
5908100|NCT01617460|20439720|P1|Overall Study|Adverse Event|10
5908101|NCT01617447|20439726|P2|Overall Study|Physician Decision|2
5908102|NCT01617447|20439727|P1|Overall Study|Physician Decision|0
5908103|NCT01617447|20439726|P2|Overall Study|Adverse Event|1
5908104|NCT01617447|20439727|P1|Overall Study|Adverse Event|0
5908105|NCT01617434|20439735|P2|Overall Study|Unclassified|4
5908106|NCT01617434|20439736|P1|Overall Study|Unclassified|3
5908107|NCT01617434|20439735|P2|Overall Study|Withdrawal Criteria|37
5908108|NCT01617434|20439736|P1|Overall Study|Withdrawal Criteria|12
5908109|NCT01617434|20439735|P2|Overall Study|Protocol Violation|7
5908110|NCT01617434|20439736|P1|Overall Study|Protocol Violation|8
5908111|NCT01617434|20439735|P2|Overall Study|Adverse Event|3
5908112|NCT01617434|20439736|P1|Overall Study|Adverse Event|12
5908113|NCT01617187|20439775|P4|Treatment Through Study Completion|Protocol Violation|1
5908114|NCT01617187|20439776|P3|Treatment Through Study Completion|Protocol Violation|0
5908115|NCT01617187|20439777|P2|Treatment Through Study Completion|Protocol Violation|0
5908116|NCT01617187|20439778|P1|Treatment Through Study Completion|Protocol Violation|1
5908117|NCT01617187|20439775|P4|Treatment Through Study Completion|Withdrawal by Subject|6
5908118|NCT01617187|20439776|P3|Treatment Through Study Completion|Withdrawal by Subject|3
5908119|NCT01617187|20439777|P2|Treatment Through Study Completion|Withdrawal by Subject|8
5908120|NCT01617187|20439778|P1|Treatment Through Study Completion|Withdrawal by Subject|5
5908121|NCT01617187|20439775|P4|Treatment Through Study Completion|Lost to Follow-up|2
5908122|NCT01617187|20439776|P3|Treatment Through Study Completion|Lost to Follow-up|2
5908123|NCT01617187|20439777|P2|Treatment Through Study Completion|Lost to Follow-up|2
5908124|NCT01617187|20439778|P1|Treatment Through Study Completion|Lost to Follow-up|4
5908125|NCT01617187|20439775|P4|Treatment Through Study Completion|Adverse Event|1
5908126|NCT01617187|20439776|P3|Treatment Through Study Completion|Adverse Event|0
5908127|NCT01617187|20439777|P2|Treatment Through Study Completion|Adverse Event|1
5908128|NCT01617187|20439778|P1|Treatment Through Study Completion|Adverse Event|1
5908129|NCT01617187|20439775|P4|Randomization Through Start Treatment|Not Treated: Completed study in database|0
5908130|NCT01617187|20439776|P3|Randomization Through Start Treatment|Not Treated: Completed study in database|0
5908131|NCT01617187|20439777|P2|Randomization Through Start Treatment|Not Treated: Completed study in database|0
5908132|NCT01617187|20439778|P1|Randomization Through Start Treatment|Not Treated: Completed study in database|1
5908133|NCT01617187|20439775|P4|Randomization Through Start Treatment|Not Treated: Adverse Event|1
5908134|NCT01617187|20439776|P3|Randomization Through Start Treatment|Not Treated: Adverse Event|0
5908135|NCT01617187|20439777|P2|Randomization Through Start Treatment|Not Treated: Adverse Event|0
5908136|NCT01617187|20439778|P1|Randomization Through Start Treatment|Not Treated: Adverse Event|0
5908137|NCT01617187|20439775|P4|Randomization Through Start Treatment|Not Treated: Administrative Reason|1
5908138|NCT01617187|20439776|P3|Randomization Through Start Treatment|Not Treated: Administrative Reason|0
5908139|NCT01617187|20439777|P2|Randomization Through Start Treatment|Not Treated: Administrative Reason|0
5908140|NCT01617187|20439778|P1|Randomization Through Start Treatment|Not Treated: Administrative Reason|0
5908141|NCT01617070|20439875|P1|BH4 and LNAA (4 Weeks)|started medication interfere with study|1
5908142|NCT01617005|20439893|P1|Overall Study|Lack of motivation for treatment|1
5908143|NCT01617005|20439893|P1|Overall Study|Pregnancy|1
5908144|NCT01616953|20439902|P2|Overall Study|lack of bone and soft tissue|0
5908145|NCT01616953|20439903|P1|Overall Study|lack of bone and soft tissue|1
5908146|NCT01616953|20439902|P2|Overall Study|Lost to Follow-up|0
5908147|NCT01616953|20439903|P1|Overall Study|Lost to Follow-up|1
5908148|NCT01616771|20439911|P1|Smaller Sized GVL for 5 Sec|lack of GVL size|4
5908149|NCT01616693|20439924|P4|Blood Analyzed for Immunogenicity|Protocol Violation|1
5908150|NCT01616693|20439925|P3|Blood Analyzed for Immunogenicity|Protocol Violation|6
5908151|NCT01616693|20439926|P2|Blood Analyzed for Immunogenicity|Protocol Violation|2
5908152|NCT01616693|20439927|P1|Blood Analyzed for Immunogenicity|Protocol Violation|4
5908153|NCT01616693|20439924|P4|Received Both Vaccines|Lost to Follow-up|4
5908154|NCT01616693|20439925|P3|Received Both Vaccines|Lost to Follow-up|4
5908155|NCT01616693|20439926|P2|Received Both Vaccines|Lost to Follow-up|3
5908156|NCT01616693|20439927|P1|Received Both Vaccines|Lost to Follow-up|4
5908157|NCT01616693|20439924|P4|Received Both Vaccines|Withdrawal by Subject|15
5908158|NCT01616693|20439925|P3|Received Both Vaccines|Withdrawal by Subject|8
5908159|NCT01616693|20439926|P2|Received Both Vaccines|Withdrawal by Subject|7
5908160|NCT01616693|20439927|P1|Received Both Vaccines|Withdrawal by Subject|7
5908161|NCT01616693|20439924|P4|Received Both Vaccines|Adverse Event|0
5908162|NCT01616693|20439925|P3|Received Both Vaccines|Adverse Event|0
5908163|NCT01616693|20439926|P2|Received Both Vaccines|Adverse Event|0
5908164|NCT01616693|20439927|P1|Received Both Vaccines|Adverse Event|2
5908165|NCT01616693|20439924|P4|Evaluated for Safety|Physician Decision|0
5908166|NCT01616693|20439925|P3|Evaluated for Safety|Physician Decision|1
5908167|NCT01616693|20439926|P2|Evaluated for Safety|Physician Decision|0
5908168|NCT01616693|20439927|P1|Evaluated for Safety|Physician Decision|1
5908169|NCT01616459|20439993|P4|Overall Study|Other reason|0
5908170|NCT01616459|20439994|P3|Overall Study|Other reason|1
5908171|NCT01616459|20439995|P2|Overall Study|Other reason|1
5908172|NCT01616459|20439996|P1|Overall Study|Other reason|0
5908173|NCT01616459|20439993|P4|Overall Study|Withdrawal by Subject|4
5908174|NCT01616459|20439994|P3|Overall Study|Withdrawal by Subject|4
5908175|NCT01616459|20439995|P2|Overall Study|Withdrawal by Subject|4
5908176|NCT01616459|20439996|P1|Overall Study|Withdrawal by Subject|2
5908177|NCT01616459|20439993|P4|Overall Study|Protocol Violation|2
5908178|NCT01616459|20439994|P3|Overall Study|Protocol Violation|0
5908179|NCT01616459|20439995|P2|Overall Study|Protocol Violation|0
5908180|NCT01616459|20439996|P1|Overall Study|Protocol Violation|0
5908181|NCT01616459|20439993|P4|Overall Study|Lost to Follow-up|2
5908182|NCT01616459|20439994|P3|Overall Study|Lost to Follow-up|3
5908183|NCT01616459|20439995|P2|Overall Study|Lost to Follow-up|11
5908184|NCT01616459|20439996|P1|Overall Study|Lost to Follow-up|1
5908185|NCT01616459|20439993|P4|Overall Study|Adverse Event|0
5908186|NCT01616459|20439994|P3|Overall Study|Adverse Event|2
5908187|NCT01616459|20439995|P2|Overall Study|Adverse Event|1
5908188|NCT01616459|20439996|P1|Overall Study|Adverse Event|1
5908189|NCT01616173|20440097|P3|Overall Study|Lost to Follow-up|0
5908190|NCT01616173|20440098|P2|Overall Study|Lost to Follow-up|2
5908191|NCT01616173|20440099|P1|Overall Study|Lost to Follow-up|0
5908192|NCT01615939|20440145|P2|Overall Study|Lost to Follow-up|0
5908193|NCT01615939|20440146|P1|Overall Study|Lost to Follow-up|5
5908194|NCT01615822|20440159|P3|Period 2|Lost to Follow-up|2
5908195|NCT01615822|20440160|P2|Period 2|Lost to Follow-up|1
5908196|NCT01615822|20440161|P1|Period 2|Lost to Follow-up|0
5908197|NCT01615822|20440159|P3|Period 1|Adverse Event|0
5908198|NCT01615822|20440160|P2|Period 1|Adverse Event|1
5908199|NCT01615822|20440161|P1|Period 1|Adverse Event|1
5908200|NCT01615822|20440159|P3|Period 1|Withdrawal by Subject|0
5908201|NCT01615822|20440160|P2|Period 1|Withdrawal by Subject|1
5908202|NCT01615822|20440161|P1|Period 1|Withdrawal by Subject|0
5908203|NCT01615328|20440249|P2|Overall Study|Lost to Follow-up|5
5908204|NCT01615328|20440250|P1|Overall Study|Lost to Follow-up|3
5908205|NCT01615263|20440262|P2|Overall Study|Post-randomization exclusion|2
5908206|NCT01615263|20440263|P1|Overall Study|Post-randomization exclusion|0
5908207|NCT01615198|20440277|P2|Overall Study|Adverse Event|5
5908208|NCT01615198|20440278|P1|Overall Study|Adverse Event|11
5908209|NCT01615198|20440277|P2|Overall Study|Lack of Efficacy|6
5908210|NCT01615198|20440278|P1|Overall Study|Lack of Efficacy|1
5908211|NCT01615198|20440277|P2|Overall Study|Lost to Follow-up|1
5908212|NCT01615198|20440278|P1|Overall Study|Lost to Follow-up|1
5908213|NCT01615198|20440277|P2|Overall Study|Physician Decision|1
5908214|NCT01615198|20440278|P1|Overall Study|Physician Decision|5
5908215|NCT01615198|20440277|P2|Overall Study|Protocol deviation|1
5908216|NCT01615198|20440278|P1|Overall Study|Protocol deviation|1
5908217|NCT01615198|20440277|P2|Overall Study|Withdrawal by Subject|5
5908218|NCT01615198|20440278|P1|Overall Study|Withdrawal by Subject|5
5908219|NCT01615029|20440311|P5|Overall Study|Ongoing|23
5908220|NCT01615029|20440312|P4|Overall Study|Ongoing|2
5908221|NCT01615029|20440313|P3|Overall Study|Ongoing|3
5908222|NCT01615029|20440314|P2|Overall Study|Ongoing|2
5908223|NCT01615029|20440315|P1|Overall Study|Ongoing|1
5908224|NCT01615029|20440311|P5|Overall Study|Physician Decision|1
5908225|NCT01615029|20440312|P4|Overall Study|Physician Decision|0
5908226|NCT01615029|20440313|P3|Overall Study|Physician Decision|0
5908227|NCT01615029|20440314|P2|Overall Study|Physician Decision|0
5908228|NCT01615029|20440315|P1|Overall Study|Physician Decision|0
5908229|NCT01615029|20440311|P5|Overall Study|Progressive disease|5
5908230|NCT01615029|20440312|P4|Overall Study|Progressive disease|1
5908231|NCT01615029|20440313|P3|Overall Study|Progressive disease|1
5908232|NCT01615029|20440314|P2|Overall Study|Progressive disease|1
5908233|NCT01615029|20440315|P1|Overall Study|Progressive disease|2
5908234|NCT01615029|20440311|P5|Overall Study|Lost to Follow-up|1
5908235|NCT01615029|20440312|P4|Overall Study|Lost to Follow-up|0
5908236|NCT01615029|20440313|P3|Overall Study|Lost to Follow-up|0
5908237|NCT01615029|20440314|P2|Overall Study|Lost to Follow-up|0
5908238|NCT01615029|20440315|P1|Overall Study|Lost to Follow-up|0
5908239|NCT01615029|20440311|P5|Overall Study|Death|1
5908240|NCT01615029|20440312|P4|Overall Study|Death|0
5908241|NCT01615029|20440313|P3|Overall Study|Death|0
5908242|NCT01615029|20440314|P2|Overall Study|Death|0
5908243|NCT01615029|20440315|P1|Overall Study|Death|0
5908244|NCT01615029|20440311|P5|Overall Study|Adverse Event|1
5908245|NCT01615029|20440312|P4|Overall Study|Adverse Event|0
5908246|NCT01615029|20440313|P3|Overall Study|Adverse Event|0
5908247|NCT01615029|20440314|P2|Overall Study|Adverse Event|0
5908248|NCT01615029|20440315|P1|Overall Study|Adverse Event|0
5908249|NCT01614886|20440383|P2|Overall Study|Protocol deviation|2
5908250|NCT01614886|20440384|P1|Overall Study|Protocol deviation|0
5908251|NCT01614886|20440383|P2|Overall Study|Death|0
5908252|NCT01614886|20440384|P1|Overall Study|Death|1
5908253|NCT01614886|20440383|P2|Overall Study|Withdrawal by Subject|4
5908254|NCT01614886|20440384|P1|Overall Study|Withdrawal by Subject|4
5908255|NCT01614886|20440383|P2|Overall Study|Adverse Event|20
5908256|NCT01614886|20440384|P1|Overall Study|Adverse Event|15
5908257|NCT01614795|20440425|P4|Overall Study|Ineligible|0
5908258|NCT01614795|20440426|P3|Overall Study|Ineligible|0
5908259|NCT01614795|20440427|P2|Overall Study|Ineligible|1
5908260|NCT01614795|20440428|P1|Overall Study|Ineligible|0
5908261|NCT01614795|20440425|P4|Overall Study|Withdrawal by Subject|2
5908262|NCT01614795|20440426|P3|Overall Study|Withdrawal by Subject|0
5908263|NCT01614795|20440427|P2|Overall Study|Withdrawal by Subject|1
5908264|NCT01614795|20440428|P1|Overall Study|Withdrawal by Subject|0
5908265|NCT01614795|20440425|P4|Overall Study|Physician Decision|1
5908266|NCT01614795|20440426|P3|Overall Study|Physician Decision|1
5908267|NCT01614795|20440427|P2|Overall Study|Physician Decision|0
5908268|NCT01614795|20440428|P1|Overall Study|Physician Decision|1
5908269|NCT01614795|20440425|P4|Overall Study|Lack of Efficacy|8
5908270|NCT01614795|20440426|P3|Overall Study|Lack of Efficacy|9
5908271|NCT01614795|20440427|P2|Overall Study|Lack of Efficacy|10
5908272|NCT01614795|20440428|P1|Overall Study|Lack of Efficacy|10
5908273|NCT01614795|20440425|P4|Overall Study|Adverse Event|1
5908274|NCT01614795|20440426|P3|Overall Study|Adverse Event|1
5908275|NCT01614795|20440427|P2|Overall Study|Adverse Event|0
5908276|NCT01614795|20440428|P1|Overall Study|Adverse Event|0
5908277|NCT01614769|20440448|P6|Period 3|Withdrawal by Subject|0
5908278|NCT01614769|20440449|P5|Period 3|Withdrawal by Subject|0
5908279|NCT01614769|20440450|P4|Period 3|Withdrawal by Subject|0
5908280|NCT01614769|20440451|P3|Period 3|Withdrawal by Subject|1
5908281|NCT01614769|20440452|P2|Period 3|Withdrawal by Subject|0
5908282|NCT01614769|20440453|P1|Period 3|Withdrawal by Subject|0
5908283|NCT01614769|20440448|P6|Period 1|Withdrawal by Subject|0
5908284|NCT01614769|20440449|P5|Period 1|Withdrawal by Subject|0
5908285|NCT01614769|20440450|P4|Period 1|Withdrawal by Subject|0
5908286|NCT01614769|20440451|P3|Period 1|Withdrawal by Subject|0
5908287|NCT01614769|20440452|P2|Period 1|Withdrawal by Subject|0
5908288|NCT01614769|20440453|P1|Period 1|Withdrawal by Subject|1
5908289|NCT01614769|20440448|P6|Period 1|Protocol Violation|0
5908290|NCT01614769|20440449|P5|Period 1|Protocol Violation|0
5908291|NCT01614769|20440450|P4|Period 1|Protocol Violation|1
5908292|NCT01614769|20440451|P3|Period 1|Protocol Violation|0
5908293|NCT01614769|20440452|P2|Period 1|Protocol Violation|0
5908294|NCT01614769|20440453|P1|Period 1|Protocol Violation|0
5908295|NCT01614769|20440448|P6|Period 1|Discontinued due to Hypoglycemia|1
5908296|NCT01614769|20440449|P5|Period 1|Discontinued due to Hypoglycemia|0
5908297|NCT01614769|20440450|P4|Period 1|Discontinued due to Hypoglycemia|1
5908298|NCT01614769|20440451|P3|Period 1|Discontinued due to Hypoglycemia|0
5908299|NCT01614769|20440452|P2|Period 1|Discontinued due to Hypoglycemia|0
5908300|NCT01614769|20440453|P1|Period 1|Discontinued due to Hypoglycemia|0
5908301|NCT01614600|20440490|P1|Overall Study|Protocol deviation|1
5908302|NCT01614600|20440490|P1|Overall Study|Unable to remove lens at the end of day|1
5908303|NCT01614600|20440490|P1|Overall Study|Discomfort|1
5908304|NCT01614600|20440490|P1|Overall Study|Unacceptable fit|1
5908305|NCT01614470|20440521|P3|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|0
5908306|NCT01614470|20440522|P2|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1
5908307|NCT01614470|20440523|P1|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1
5908308|NCT01614470|20440521|P3|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
5908309|NCT01614470|20440522|P2|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
5908310|NCT01614470|20440523|P1|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|1
5908311|NCT01614457|20440545|P2|Overall Study|Pregnancy (Self or Partner)|0
5908312|NCT01614457|20440546|P1|Overall Study|Pregnancy (Self or Partner)|1
5908313|NCT01614457|20440545|P2|Overall Study|Non-Compliance|0
5908314|NCT01614457|20440546|P1|Overall Study|Non-Compliance|1
5908315|NCT01614249|20440573|P2|Overall Study|Lost to Follow-up|23
5908316|NCT01614249|20440574|P1|Overall Study|Lost to Follow-up|11
5908317|NCT01614093|20440588|P1|Overall Study|Withdrawal by Subject|1
5908318|NCT01613716|20440601|P1|Overall Study|Lost to Follow-up|4
5908319|NCT01613716|20440601|P1|Overall Study|screen failures|3
5908320|NCT01613599|20440606|P1|Overall Study|Reason not specified|3
5908321|NCT01613599|20440606|P1|Overall Study|Withdrawal by Subject|8
5908322|NCT01613599|20440606|P1|Overall Study|Lost to Follow-up|5
5908323|NCT01613599|20440606|P1|Overall Study|Death|9
5908324|NCT01613417|20440621|P2|Washout (no Second Injection/MRI)|Withdrawal by Subject|7
5908325|NCT01613417|20440622|P1|Washout (no Second Injection/MRI)|Withdrawal by Subject|13
5908326|NCT01613378|20440659|P1|Overall Study|Other Reason|4
5908327|NCT01613378|20440659|P1|Overall Study|Lost to Follow-up|1
5908328|NCT01613378|20440659|P1|Overall Study|Death|2
5908329|NCT01613378|20440659|P1|Overall Study|Withdrawal by Subject|8
5908330|NCT01613378|20440659|P1|Overall Study|Adverse Event|11
5908331|NCT01613378|20440659|P1|Overall Study|Lack of Efficacy|13
5908332|NCT01613326|20440689|P2|Overall Study|Protocol Violation|1
5908333|NCT01613326|20440690|P1|Overall Study|Protocol Violation|0
5908334|NCT01613326|20440689|P2|Overall Study|Administrative|2
5908335|NCT01613326|20440690|P1|Overall Study|Administrative|0
5908336|NCT01613326|20440689|P2|Overall Study|Lost to Follow-up|1
5908337|NCT01613326|20440690|P1|Overall Study|Lost to Follow-up|0
5908338|NCT01613326|20440689|P2|Overall Study|Lack of Efficacy|1
5908339|NCT01613326|20440690|P1|Overall Study|Lack of Efficacy|0
5908340|NCT01613326|20440689|P2|Overall Study|inability to use device|0
5908341|NCT01613326|20440690|P1|Overall Study|inability to use device|1
5908342|NCT01613326|20440689|P2|Overall Study|Abnormal test procedure result(s)|0
5908343|NCT01613326|20440690|P1|Overall Study|Abnormal test procedure result(s)|2
5908344|NCT01613326|20440689|P2|Overall Study|Withdrawal by Subject|4
5908345|NCT01613326|20440690|P1|Overall Study|Withdrawal by Subject|3
5908346|NCT01613326|20440689|P2|Overall Study|Adverse Event|5
5908347|NCT01613326|20440690|P1|Overall Study|Adverse Event|7
5908348|NCT01613248|20440747|P6|Overall Study|Pregnancy|0
5908349|NCT01613248|20440748|P5|Overall Study|Pregnancy|0
5908350|NCT01613248|20440749|P4|Overall Study|Pregnancy|1
5908351|NCT01613248|20440750|P3|Overall Study|Pregnancy|0
5908352|NCT01613248|20440751|P2|Overall Study|Pregnancy|0
5908353|NCT01613248|20440752|P1|Overall Study|Pregnancy|0
5908354|NCT01613248|20440747|P6|Overall Study|Lack of Qualifying Event|18
5908355|NCT01613248|20440748|P5|Overall Study|Lack of Qualifying Event|15
5908356|NCT01613248|20440749|P4|Overall Study|Lack of Qualifying Event|11
5908357|NCT01613248|20440750|P3|Overall Study|Lack of Qualifying Event|10
5908358|NCT01613248|20440751|P2|Overall Study|Lack of Qualifying Event|11
5908359|NCT01613248|20440752|P1|Overall Study|Lack of Qualifying Event|9
5908360|NCT01613248|20440747|P6|Overall Study|Physician Decision|6
5908361|NCT01613248|20440748|P5|Overall Study|Physician Decision|7
5908362|NCT01613248|20440749|P4|Overall Study|Physician Decision|4
5908363|NCT01613248|20440750|P3|Overall Study|Physician Decision|9
5908364|NCT01613248|20440751|P2|Overall Study|Physician Decision|8
5908365|NCT01613248|20440752|P1|Overall Study|Physician Decision|8
5908366|NCT01613248|20440747|P6|Overall Study|Study Terminated by Sponsor|11
5908367|NCT01613248|20440748|P5|Overall Study|Study Terminated by Sponsor|9
5908368|NCT01613248|20440749|P4|Overall Study|Study Terminated by Sponsor|8
5908369|NCT01613248|20440750|P3|Overall Study|Study Terminated by Sponsor|8
5908370|NCT01613248|20440751|P2|Overall Study|Study Terminated by Sponsor|6
5908371|NCT01613248|20440752|P1|Overall Study|Study Terminated by Sponsor|4
5908372|NCT01613248|20440747|P6|Overall Study|Lost to Follow-up|2
5908373|NCT01613248|20440748|P5|Overall Study|Lost to Follow-up|4
5908374|NCT01613248|20440749|P4|Overall Study|Lost to Follow-up|8
5908375|NCT01613248|20440750|P3|Overall Study|Lost to Follow-up|4
5908376|NCT01613248|20440751|P2|Overall Study|Lost to Follow-up|7
5908377|NCT01613248|20440752|P1|Overall Study|Lost to Follow-up|5
5908378|NCT01613248|20440747|P6|Overall Study|Withdrawal by Subject|1
5908379|NCT01613248|20440748|P5|Overall Study|Withdrawal by Subject|0
5908380|NCT01613248|20440749|P4|Overall Study|Withdrawal by Subject|5
5908381|NCT01613248|20440750|P3|Overall Study|Withdrawal by Subject|2
5908382|NCT01613248|20440751|P2|Overall Study|Withdrawal by Subject|2
5908383|NCT01613248|20440752|P1|Overall Study|Withdrawal by Subject|3
5908384|NCT01613248|20440747|P6|Overall Study|Adverse Event|0
5908385|NCT01613248|20440748|P5|Overall Study|Adverse Event|0
5908386|NCT01613248|20440749|P4|Overall Study|Adverse Event|1
5908387|NCT01613248|20440750|P3|Overall Study|Adverse Event|0
5908388|NCT01613248|20440751|P2|Overall Study|Adverse Event|0
5908389|NCT01613248|20440752|P1|Overall Study|Adverse Event|0
5908390|NCT01613222|20440850|P1|Overall Study|Reused disposable sensors|10
5908391|NCT01613222|20440850|P1|Overall Study|Unable to place arterial line|1
5908392|NCT01613222|20440850|P1|Overall Study|Physician Decision|1
5908393|NCT01613131|20440865|P2|Overall Study|Withdrawal by Subject|5
5908394|NCT01613131|20440866|P1|Overall Study|Withdrawal by Subject|3
5908395|NCT01613027|20440894|P1|Overall Study|Patient's Decision Due to Adverse Event|1
5908396|NCT01613027|20440894|P1|Overall Study|Lack of Efficacy|1
5908397|NCT01613027|20440894|P1|Overall Study|Switched Physician|1
5908398|NCT01613027|20440894|P1|Overall Study|Lost to Follow-up|5
5908399|NCT01612858|20440937|P2|Overall Study|Withdrawal by Subject|1
5908400|NCT01612858|20440938|P1|Overall Study|Withdrawal by Subject|5
5908401|NCT01612780|20440955|P1|Overall Study|Withdrawal by Subject|5
5908402|NCT01612780|20440955|P1|Overall Study|Treatment not completed|1
5908403|NCT01612702|20441017|P2|Overall Study|Protocol Violation|11
5908404|NCT01612702|20441018|P1|Overall Study|Protocol Violation|11
5908405|NCT01612676|20441032|P4|Overall Study|Protocol Violation|0
5908406|NCT01612676|20441033|P3|Overall Study|Protocol Violation|0
5908407|NCT01612676|20441034|P2|Overall Study|Protocol Violation|1
5908408|NCT01612676|20441035|P1|Overall Study|Protocol Violation|0
5908409|NCT01612676|20441032|P4|Overall Study|Adverse Event|3
5908410|NCT01612676|20441033|P3|Overall Study|Adverse Event|1
5908411|NCT01612676|20441034|P2|Overall Study|Adverse Event|3
5908412|NCT01612676|20441035|P1|Overall Study|Adverse Event|2
5908413|NCT01612156|20441133|P2|Overall Study|Protocol Violation|0
5908414|NCT01612156|20441134|P1|Overall Study|Protocol Violation|2
5908415|NCT01612000|20441146|P4|Overall Study|Withdrawal by Subject|2
5908416|NCT01612000|20441147|P3|Overall Study|Withdrawal by Subject|2
5908417|NCT01612000|20441148|P2|Overall Study|Withdrawal by Subject|1
5908418|NCT01612000|20441149|P1|Overall Study|Withdrawal by Subject|3
5908419|NCT01612000|20441146|P4|Overall Study|Physician Decision|0
5908420|NCT01612000|20441147|P3|Overall Study|Physician Decision|1
5908421|NCT01612000|20441148|P2|Overall Study|Physician Decision|0
5908422|NCT01612000|20441149|P1|Overall Study|Physician Decision|0
5908423|NCT01612000|20441146|P4|Overall Study|Lost to Follow-up|8
5908424|NCT01612000|20441147|P3|Overall Study|Lost to Follow-up|4
5908425|NCT01612000|20441148|P2|Overall Study|Lost to Follow-up|4
5908426|NCT01612000|20441149|P1|Overall Study|Lost to Follow-up|6
5908427|NCT01611974|20441174|P3|Overall Study|Withdrawal by Subject|4
5908428|NCT01611974|20441175|P2|Overall Study|Withdrawal by Subject|1
5908429|NCT01611974|20441176|P1|Overall Study|Withdrawal by Subject|0
5908430|NCT01611974|20441174|P3|Overall Study|Physician Decision|2
5908431|NCT01611974|20441175|P2|Overall Study|Physician Decision|1
5908432|NCT01611974|20441176|P1|Overall Study|Physician Decision|5
5908433|NCT01611974|20441174|P3|Overall Study|Lost to Follow-up|0
5908434|NCT01611974|20441175|P2|Overall Study|Lost to Follow-up|1
5908435|NCT01611974|20441176|P1|Overall Study|Lost to Follow-up|0
5908436|NCT01611974|20441174|P3|Overall Study|Death|10
5908437|NCT01611974|20441175|P2|Overall Study|Death|12
5908438|NCT01611974|20441176|P1|Overall Study|Death|10
5908439|NCT01611935|20441222|P2|Overall Study|Family Declined Participation|0
5908440|NCT01611935|20441223|P1|Overall Study|Family Declined Participation|1
5908441|NCT01611883|20441235|P2|Overall Study|Adverse Event|1
5908442|NCT01611883|20441236|P1|Overall Study|Adverse Event|1
5908443|NCT01611857|20441262|P2|Overall Study|Withdrawal by Subject|2
5908444|NCT01611857|20441263|P1|Overall Study|Withdrawal by Subject|0
5908445|NCT01611792|20441275|P2|Followup: at 6 Months|Lost to Follow-up|13
5908446|NCT01611792|20441276|P1|Followup: at 6 Months|Lost to Follow-up|6
5908447|NCT01611792|20441275|P2|Initial Period: Time 0|unable to schedule 10 consecutive appts|9
5908448|NCT01611792|20441276|P1|Initial Period: Time 0|unable to schedule 10 consecutive appts|12
5908449|NCT01611558|20441330|P1|Maintenance Phase|Elevated Uric acid|1
5908450|NCT01611558|20441330|P1|Maintenance Phase|Withdrawal by Subject|1
5908451|NCT01611558|20441330|P1|Induction Phase|Death|1
5908452|NCT01611558|20441330|P1|Induction Phase|Adverse event unrelated to study drug|3
5908453|NCT01611558|20441330|P1|Induction Phase|Heart arrest,urosepsis,respiratory fail|1
5908454|NCT01611558|20441330|P1|Induction Phase|Disease progression|18
5908455|NCT01611558|20441330|P1|Induction Phase|Study drug toxicity|15
5908456|NCT01611298|20441336|P1|Overall Study|Relapsed|2
5908457|NCT01611259|20441341|P1|Overall Study|Withdrawal by Subject|7
5908458|NCT01611259|20441341|P1|Overall Study|Adverse Event|4
5908459|NCT01611259|20441341|P1|Overall Study|Lack of Efficacy|2
5908460|NCT01611259|20441341|P1|Overall Study|Physician Decision|1
5908461|NCT01611194|20441347|P2|Overall Study|drug use|1
5908462|NCT01611194|20441348|P1|Overall Study|drug use|0
5908463|NCT01611194|20441347|P2|Overall Study|Withdrawal by Subject|1
5908464|NCT01611194|20441348|P1|Overall Study|Withdrawal by Subject|0
5908465|NCT01611194|20441347|P2|Overall Study|Lost to Follow-up|1
5908466|NCT01611194|20441348|P1|Overall Study|Lost to Follow-up|0
5908467|NCT01611155|20441386|P2|Overall Study|Ineligible patient|1
5908468|NCT01611155|20441387|P1|Overall Study|Ineligible patient|0
5908469|NCT01611155|20441386|P2|Overall Study|Alternative treatment|1
5908470|NCT01611155|20441387|P1|Overall Study|Alternative treatment|0
5908471|NCT01611155|20441386|P2|Overall Study|Withdrawal by Subject|0
5908472|NCT01611155|20441387|P1|Overall Study|Withdrawal by Subject|1
5908473|NCT01611155|20441386|P2|Overall Study|Disease progression|0
5908474|NCT01611155|20441387|P1|Overall Study|Disease progression|1
5908475|NCT01611155|20441386|P2|Overall Study|Refused further treatment|4
5908476|NCT01611155|20441387|P1|Overall Study|Refused further treatment|6
5908477|NCT01611155|20441386|P2|Overall Study|Adverse Event|1
5908478|NCT01611155|20441387|P1|Overall Study|Adverse Event|1
5908479|NCT01611090|20441397|P3|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|1
5908480|NCT01611090|20441398|P2|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0
5908481|NCT01611090|20441399|P1|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0
5908482|NCT01611090|20441397|P3|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|4
5908483|NCT01611090|20441398|P2|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0
5908484|NCT01611090|20441399|P1|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0
5908485|NCT01611090|20441397|P3|Randomized Period|Withdrawal by Subject|0
5908486|NCT01611090|20441398|P2|Randomized Period|Withdrawal by Subject|26
5908487|NCT01611090|20441399|P1|Randomized Period|Withdrawal by Subject|22
5908488|NCT01611090|20441397|P3|Randomized Period|Lost to Follow-up|0
5908489|NCT01611090|20441398|P2|Randomized Period|Lost to Follow-up|3
5908490|NCT01611090|20441399|P1|Randomized Period|Lost to Follow-up|8
5908491|NCT01610791|20441432|P1|Overall Study|Not determined|5
5908492|NCT01610791|20441432|P1|Overall Study|Death|1
5908493|NCT01610791|20441432|P1|Overall Study|Adverse event and Investigator decision|1
5908494|NCT01610791|20441432|P1|Overall Study|Physician Decision|1
5908495|NCT01610791|20441432|P1|Overall Study|Adverse Event|6
5908496|NCT01610791|20441432|P1|Overall Study|Lost to Follow-up|7
5908497|NCT01610752|20441456|P3|Overall Study|Miscarriage/Pregnancy loss|4
5908498|NCT01610752|20441457|P2|Overall Study|Miscarriage/Pregnancy loss|0
5908499|NCT01610752|20441458|P1|Overall Study|Miscarriage/Pregnancy loss|0
5908500|NCT01610713|20441480|P2|Overall Study|Lost to Follow-up|1
5908501|NCT01610713|20441481|P1|Overall Study|Lost to Follow-up|0
5908502|NCT01610713|20441480|P2|Overall Study|adv. to use original dose/amitriptyline|0
5908503|NCT01610713|20441481|P1|Overall Study|adv. to use original dose/amitriptyline|1
5908504|NCT01610713|20441480|P2|Overall Study|low mood and poor motivation|0
5908505|NCT01610713|20441481|P1|Overall Study|low mood and poor motivation|1
5908506|NCT01610713|20441480|P2|Overall Study|Lack of Efficacy|0
5908507|NCT01610713|20441481|P1|Overall Study|Lack of Efficacy|1
5908508|NCT01610713|20441480|P2|Overall Study|Adverse Event|0
5908509|NCT01610713|20441481|P1|Overall Study|Adverse Event|3
5908510|NCT01610700|20441539|P2|Overall Study|subject took one dose of street cannabis|1
5908511|NCT01610700|20441540|P1|Overall Study|subject took one dose of street cannabis|0
5908512|NCT01610700|20441539|P2|Overall Study|Withdrawal by Subject|1
5908513|NCT01610700|20441540|P1|Overall Study|Withdrawal by Subject|0
5908514|NCT01610700|20441539|P2|Overall Study|Adverse Event|1
5908515|NCT01610700|20441540|P1|Overall Study|Adverse Event|3
5908516|NCT01610687|20441594|P1|Overall Study|Felt more alter without study medication|1
5908517|NCT01610687|20441594|P1|Overall Study|Cannabis affecting job|1
5908518|NCT01610687|20441594|P1|Overall Study|Death|1
5908519|NCT01610687|20441594|P1|Overall Study|Unable to make journey|1
5908520|NCT01610687|20441594|P1|Overall Study|Symptom control without study medication|2
5908521|NCT01610687|20441594|P1|Overall Study|Lost to Follow-up|4
5908522|NCT01610687|20441594|P1|Overall Study|Withdrawal by Subject|7
5908523|NCT01610687|20441594|P1|Overall Study|Moved out of area|6
5908524|NCT01610687|20441594|P1|Overall Study|Adverse Event|18
5908525|NCT01610687|20441594|P1|Overall Study|Lack of Efficacy|26
5908526|NCT01610596|20441607|P2|Overall Study|Lost to Follow-up|1
5908527|NCT01610596|20441608|P1|Overall Study|Lost to Follow-up|0
5908528|NCT01610557|20441666|P5|Post-36-Week Extension Phase|Withdrawal by Subject|3
5908529|NCT01610557|20441667|P4|Post-36-Week Extension Phase|Withdrawal by Subject|0
5908530|NCT01610557|20441668|P3|Post-36-Week Extension Phase|Withdrawal by Subject|0
5908531|NCT01610557|20441669|P2|Post-36-Week Extension Phase|Withdrawal by Subject|0
5908532|NCT01610557|20441670|P1|Post-36-Week Extension Phase|Withdrawal by Subject|0
5908533|NCT01610557|20441666|P5|36-Week Randomized Crossover Phase|Withdrawal by Subject|0
5908534|NCT01610557|20441667|P4|36-Week Randomized Crossover Phase|Withdrawal by Subject|0
5908535|NCT01610557|20441668|P3|36-Week Randomized Crossover Phase|Withdrawal by Subject|0
5908536|NCT01610557|20441669|P2|36-Week Randomized Crossover Phase|Withdrawal by Subject|1
5908537|NCT01610557|20441670|P1|36-Week Randomized Crossover Phase|Withdrawal by Subject|0
5908538|NCT01610492|20441683|P1|Overall Study|Other:Treatment stopped due to remission|1
5908539|NCT01610492|20441683|P1|Overall Study|Other: Reached stopping criteria|1
5908540|NCT01610492|20441683|P1|Overall Study|Lack of Efficacy|3
5908541|NCT01610492|20441683|P1|Overall Study|Adverse Event|1
5908542|NCT01610414|20441749|P2|After Month 25|Study end not reached|53
5908543|NCT01610414|20441750|P1|After Month 25|Study end not reached|48
5908544|NCT01610414|20441749|P2|Month 13 - Month 25|Other reasons for withdrawal|7
5908545|NCT01610414|20441750|P1|Month 13 - Month 25|Other reasons for withdrawal|6
5908546|NCT01610414|20441749|P2|Month 13 - Month 25|Lost to Follow-up|9
5908547|NCT01610414|20441750|P1|Month 13 - Month 25|Lost to Follow-up|5
5908548|NCT01610414|20441749|P2|Month 13 - Month 25|Protocol Violation|2
5908549|NCT01610414|20441750|P1|Month 13 - Month 25|Protocol Violation|0
5908550|NCT01610414|20441749|P2|Month 13 - Month 25|Migrated/moved from study area|2
5908551|NCT01610414|20441750|P1|Month 13 - Month 25|Migrated/moved from study area|4
5908552|NCT01610414|20441749|P2|Month 13 - Month 25|Withdrawal by Subject|8
5908553|NCT01610414|20441750|P1|Month 13 - Month 25|Withdrawal by Subject|7
5908554|NCT01610414|20441749|P2|Month 13 - Month 25|Adverse Event|4
5908555|NCT01610414|20441750|P1|Month 13 - Month 25|Adverse Event|8
5908556|NCT01610414|20441749|P2|Month 13 - Month 25|Serious Adverse Event|38
5908557|NCT01610414|20441750|P1|Month 13 - Month 25|Serious Adverse Event|35
5908558|NCT01610414|20441749|P2|Study Start - Month 13|Other reasons for withdrawal|4
5908559|NCT01610414|20441750|P1|Study Start - Month 13|Other reasons for withdrawal|3
5908560|NCT01610414|20441749|P2|Study Start - Month 13|Suspected HZ episode|3
5908561|NCT01610414|20441750|P1|Study Start - Month 13|Suspected HZ episode|1
5908562|NCT01610414|20441749|P2|Study Start - Month 13|Lost to Follow-up|6
5908563|NCT01610414|20441750|P1|Study Start - Month 13|Lost to Follow-up|4
5908564|NCT01610414|20441749|P2|Study Start - Month 13|Migrated/moved from study area|4
5908565|NCT01610414|20441750|P1|Study Start - Month 13|Migrated/moved from study area|2
5908566|NCT01610414|20441749|P2|Study Start - Month 13|Withdrawal by Subject|30
5908567|NCT01610414|20441750|P1|Study Start - Month 13|Withdrawal by Subject|23
5908568|NCT01610414|20441749|P2|Study Start - Month 13|Protocol Violation|1
5908569|NCT01610414|20441750|P1|Study Start - Month 13|Protocol Violation|3
5908570|NCT01610414|20441749|P2|Study Start - Month 13|Adverse Event|14
5908571|NCT01610414|20441750|P1|Study Start - Month 13|Adverse Event|14
5908572|NCT01610414|20441749|P2|Study Start - Month 13|Serious Adverse Event|67
5908573|NCT01610414|20441750|P1|Study Start - Month 13|Serious Adverse Event|65
5908574|NCT01610297|20441779|P1|Overall Study|Lost to Follow-up|1
5908575|NCT01610284|20441789|P2|Post-Treatment Efficacy Follow-Up Phase|New therapy for study indication|13
5908576|NCT01610284|20441790|P1|Post-Treatment Efficacy Follow-Up Phase|New therapy for study indication|38
5908577|NCT01610284|20441789|P2|Post-Treatment Efficacy Follow-Up Phase|Death|4
5908578|NCT01610284|20441790|P1|Post-Treatment Efficacy Follow-Up Phase|Death|4
5908579|NCT01610284|20441789|P2|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1
5908580|NCT01610284|20441790|P1|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|11
5908581|NCT01610284|20441789|P2|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|8
5908582|NCT01610284|20441790|P1|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|24
5908583|NCT01610284|20441789|P2|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|3
5908584|NCT01610284|20441790|P1|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|10
5908585|NCT01610284|20441789|P2|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0
5908586|NCT01610284|20441790|P1|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2
5908587|NCT01610284|20441789|P2|Treatment Phase|Death|5
5908588|NCT01610284|20441790|P1|Treatment Phase|Death|6
5908589|NCT01610284|20441789|P2|Treatment Phase|Subject/Guardian Decision|23
5908590|NCT01610284|20441790|P1|Treatment Phase|Subject/Guardian Decision|55
5908591|NCT01610284|20441789|P2|Treatment Phase|Study terminated by Sponsor|15
5908592|NCT01610284|20441790|P1|Treatment Phase|Study terminated by Sponsor|18
5908593|NCT01610284|20441789|P2|Treatment Phase|Protocol Deviation|3
5908594|NCT01610284|20441790|P1|Treatment Phase|Protocol Deviation|2
5908595|NCT01610284|20441789|P2|Treatment Phase|Progressive Disease|486
5908596|NCT01610284|20441790|P1|Treatment Phase|Progressive Disease|377
5908597|NCT01610284|20441789|P2|Treatment Phase|Physician Decision|24
5908598|NCT01610284|20441790|P1|Treatment Phase|Physician Decision|27
5908599|NCT01610284|20441789|P2|Treatment Phase|Non-compliance with Study Treatment|1
5908600|NCT01610284|20441790|P1|Treatment Phase|Non-compliance with Study Treatment|8
5908601|NCT01610284|20441789|P2|Treatment Phase|Lost to Follow-up|0
5908602|NCT01610284|20441790|P1|Treatment Phase|Lost to Follow-up|1
5908603|NCT01610284|20441789|P2|Treatment Phase|Adverse Event|12
5908604|NCT01610284|20441790|P1|Treatment Phase|Adverse Event|80
5908605|NCT01610284|20441789|P2|Randomization Phase|Death|1
5908606|NCT01610284|20441790|P1|Randomization Phase|Death|0
5908607|NCT01610284|20441789|P2|Randomization Phase|Physician Decision|1
5908608|NCT01610284|20441790|P1|Randomization Phase|Physician Decision|1
5908609|NCT01610284|20441789|P2|Randomization Phase|Adverse Event|0
5908610|NCT01610284|20441790|P1|Randomization Phase|Adverse Event|1
5908611|NCT01610271|20441812|P2|Overall Study|Prosthesis not implanted|3
5908612|NCT01610271|20441813|P1|Overall Study|Prosthesis not implanted|2
5908613|NCT01610271|20441812|P2|Overall Study|Surgery not complete|1
5908614|NCT01610271|20441813|P1|Overall Study|Surgery not complete|0
5908615|NCT01610167|20441828|P3|Overall Study|Scheduling conflict.|2
5908616|NCT01610167|20441829|P2|Overall Study|Scheduling conflict.|0
5908617|NCT01610167|20441830|P1|Overall Study|Scheduling conflict.|0
5908618|NCT01610076|20441867|P2|Overall Study|Lost to Follow-up|4
5908619|NCT01610076|20441868|P1|Overall Study|Lost to Follow-up|3
5908620|NCT01610076|20441867|P2|Overall Study|Technical issue with video|1
5908621|NCT01610076|20441868|P1|Overall Study|Technical issue with video|0
5908622|NCT01610063|20441879|P2|Overall Study|Lost to Follow-up|20
5908623|NCT01610063|20441880|P1|Overall Study|Lost to Follow-up|42
5908624|NCT01610037|20441903|P3|Treatment and Follow up Period|Lost to Follow-up|4
5908625|NCT01610037|20441904|P2|Treatment and Follow up Period|Lost to Follow-up|6
5908626|NCT01610037|20441905|P1|Treatment and Follow up Period|Lost to Follow-up|1
5908627|NCT01610037|20441903|P3|Treatment and Follow up Period|Administrative problems|2
5908628|NCT01610037|20441904|P2|Treatment and Follow up Period|Administrative problems|3
5908629|NCT01610037|20441905|P1|Treatment and Follow up Period|Administrative problems|1
5908630|NCT01610037|20441903|P3|Treatment and Follow up Period|Death|4
5908631|NCT01610037|20441904|P2|Treatment and Follow up Period|Death|5
5908632|NCT01610037|20441905|P1|Treatment and Follow up Period|Death|10
5908633|NCT01610037|20441903|P3|Treatment and Follow up Period|Subject withdrew consent|16
5908634|NCT01610037|20441904|P2|Treatment and Follow up Period|Subject withdrew consent|14
5908635|NCT01610037|20441905|P1|Treatment and Follow up Period|Subject withdrew consent|13
5908636|NCT01610037|20441903|P3|All Patients|Abnormal test procedure result(s)|3
5908637|NCT01610037|20441904|P2|All Patients|Abnormal test procedure result(s)|1
5908638|NCT01610037|20441905|P1|All Patients|Abnormal test procedure result(s)|0
5908639|NCT01610037|20441903|P3|All Patients|Lost to Follow-up|0
5908640|NCT01610037|20441904|P2|All Patients|Lost to Follow-up|0
5908641|NCT01610037|20441905|P1|All Patients|Lost to Follow-up|1
5908642|NCT01610037|20441903|P3|All Patients|Administrative problems|4
5908643|NCT01610037|20441904|P2|All Patients|Administrative problems|4
5908644|NCT01610037|20441905|P1|All Patients|Administrative problems|1
5908645|NCT01610037|20441903|P3|All Patients|Abnormal laboratory value|0
5908646|NCT01610037|20441904|P2|All Patients|Abnormal laboratory value|1
5908647|NCT01610037|20441905|P1|All Patients|Abnormal laboratory value|1
5908648|NCT01610037|20441903|P3|All Patients|Protocol deviation|3
5908649|NCT01610037|20441904|P2|All Patients|Protocol deviation|3
5908650|NCT01610037|20441905|P1|All Patients|Protocol deviation|4
5908651|NCT01610037|20441903|P3|All Patients|Death|1
5908652|NCT01610037|20441904|P2|All Patients|Death|2
5908653|NCT01610037|20441905|P1|All Patients|Death|4
5908654|NCT01610037|20441903|P3|All Patients|Unsatisfactory therapeutic effect|27
5908655|NCT01610037|20441904|P2|All Patients|Unsatisfactory therapeutic effect|8
5908656|NCT01610037|20441905|P1|All Patients|Unsatisfactory therapeutic effect|9
5908657|NCT01610037|20441903|P3|All Patients|Withdrawal by Subject|20
5908658|NCT01610037|20441904|P2|All Patients|Withdrawal by Subject|10
5908659|NCT01610037|20441905|P1|All Patients|Withdrawal by Subject|12
5908660|NCT01610037|20441903|P3|All Patients|Adverse Event|26
5908661|NCT01610037|20441904|P2|All Patients|Adverse Event|22
5908662|NCT01610037|20441905|P1|All Patients|Adverse Event|27
5908663|NCT01609933|20441955|P1|Overall Study|Withdrawal by Subject|3
5908664|NCT01609933|20441955|P1|Overall Study|Adverse Event|1
5908670|NCT01609582|20442015|P2|Overall Study|Randomized, but not treated|3
5908671|NCT01609582|20442016|P1|Overall Study|Randomized, but not treated|0
5908672|NCT01609582|20442015|P2|Overall Study|Other|10
5908673|NCT01609582|20442016|P1|Overall Study|Other|9
5908674|NCT01609582|20442015|P2|Overall Study|Study Terminated by Sponsor|1548
5908675|NCT01609582|20442016|P1|Overall Study|Study Terminated by Sponsor|1543
5908676|NCT01609582|20442015|P2|Overall Study|Withdrawal by Subject|15
5908677|NCT01609582|20442016|P1|Overall Study|Withdrawal by Subject|21
5908678|NCT01609582|20442015|P2|Overall Study|Lost to Follow-up|10
5908679|NCT01609582|20442016|P1|Overall Study|Lost to Follow-up|10
5908680|NCT01609582|20442015|P2|Overall Study|Adverse Event|18
5908681|NCT01609582|20442016|P1|Overall Study|Adverse Event|20
5908682|NCT01609543|20442024|P1|Overall Study|Death|7
5908683|NCT01609543|20442024|P1|Overall Study|Protocol Violation|1
5908684|NCT01609543|20442024|P1|Overall Study|Withdrawal by Subject|1
5908685|NCT01609543|20442024|P1|Overall Study|Adverse Event|5
5908686|NCT01609543|20442024|P1|Overall Study|Disease Progression|28
5908687|NCT01609478|20442033|P3|Overall Study|Withdrawal by Subject|2
5908688|NCT01609478|20442034|P2|Overall Study|Withdrawal by Subject|0
5908689|NCT01609478|20442035|P1|Overall Study|Withdrawal by Subject|2
5908690|NCT01609478|20442033|P3|Overall Study|Physician Decision|1
5908691|NCT01609478|20442034|P2|Overall Study|Physician Decision|0
5908692|NCT01609478|20442035|P1|Overall Study|Physician Decision|1
5908693|NCT01609478|20442033|P3|Overall Study|Non-Compliance with study treatment|0
5908694|NCT01609478|20442034|P2|Overall Study|Non-Compliance with study treatment|0
5908695|NCT01609478|20442035|P1|Overall Study|Non-Compliance with study treatment|1
5908696|NCT01609478|20442033|P3|Overall Study|Protocol Deviation|1
5908697|NCT01609478|20442034|P2|Overall Study|Protocol Deviation|1
5908698|NCT01609478|20442035|P1|Overall Study|Protocol Deviation|0
5908699|NCT01609478|20442033|P3|Overall Study|Adverse Event|5
5908700|NCT01609478|20442034|P2|Overall Study|Adverse Event|1
5908701|NCT01609478|20442035|P1|Overall Study|Adverse Event|3
5908704|NCT01609257|20442121|P2|Overall Study|Non-compliance/Protocol deviation|6
5908705|NCT01609257|20442122|P1|Overall Study|Non-compliance/Protocol deviation|4
5908706|NCT01609257|20442121|P2|Overall Study|Voluntary Withdrawal by Subject|1
5908707|NCT01609257|20442122|P1|Overall Study|Voluntary Withdrawal by Subject|0
5908708|NCT01609257|20442121|P2|Overall Study|Lost to Follow-up|1
5908709|NCT01609257|20442122|P1|Overall Study|Lost to Follow-up|2
5908710|NCT01609231|20442194|P2|Overall Study|Withdrawal by Subject|0
5908711|NCT01609231|20442195|P1|Overall Study|Withdrawal by Subject|1
5908712|NCT01609231|20442194|P2|Overall Study|Physician Decision|0
5908713|NCT01609231|20442195|P1|Overall Study|Physician Decision|1
5908714|NCT01609231|20442194|P2|Overall Study|Adverse Event|3
5908715|NCT01609231|20442195|P1|Overall Study|Adverse Event|1
5908716|NCT01609062|20442205|P2|Extension Phase|Anticipated surgery & transition to EAP|1
5908717|NCT01609062|20442206|P1|Extension Phase|Anticipated surgery & transition to EAP|0
5908718|NCT01609062|20442205|P2|Extension Phase|Discontinued drug and then was pregnant|0
5908719|NCT01609062|20442206|P1|Extension Phase|Discontinued drug and then was pregnant|1
5908720|NCT01609062|20442205|P2|Extension Phase|Terminated by Sponsor|9
5908721|NCT01609062|20442206|P1|Extension Phase|Terminated by Sponsor|14
5908722|NCT01609023|20442249|P1|Overall Study|Personal reasons|1
5908723|NCT01609023|20442249|P1|Overall Study|Death|2
5908724|NCT01609023|20442249|P1|Overall Study|Physician Decision|2
5908725|NCT01609023|20442249|P1|Overall Study|Disease progression|10
5908726|NCT01609023|20442249|P1|Overall Study|Toxicity|3
5908727|NCT01609023|20442249|P1|Overall Study|Lost to Follow-up|8
5908728|NCT01609023|20442249|P1|Overall Study|Withdrawal by Subject|4
5908729|NCT01609023|20442249|P1|Overall Study|Lack of Efficacy|3
5908730|NCT01609010|20442261|P2|Overall Study|Lost to Follow-up|1
5908731|NCT01609010|20442262|P1|Overall Study|Lost to Follow-up|1
5908732|NCT01609010|20442261|P2|Overall Study|New cancer|0
5908733|NCT01609010|20442262|P1|Overall Study|New cancer|1
5908734|NCT01609010|20442261|P2|Overall Study|Protocol Violation|1
5908735|NCT01609010|20442262|P1|Overall Study|Protocol Violation|1
5908736|NCT01609010|20442261|P2|Overall Study|Pathology review|1
5908737|NCT01609010|20442262|P1|Overall Study|Pathology review|2
5908738|NCT01609010|20442261|P2|Overall Study|Other malignancy|0
5908739|NCT01609010|20442262|P1|Overall Study|Other malignancy|1
5908740|NCT01609010|20442261|P2|Overall Study|Other|0
5908741|NCT01609010|20442262|P1|Overall Study|Other|2
5908742|NCT01609010|20442261|P2|Overall Study|Withdrawal by Subject|2
5908743|NCT01609010|20442262|P1|Overall Study|Withdrawal by Subject|2
5908744|NCT01609010|20442261|P2|Overall Study|Adverse Event|6
5908745|NCT01609010|20442262|P1|Overall Study|Adverse Event|3
5908746|NCT01609010|20442261|P2|Overall Study|Progressive disease (PD)|10
5908747|NCT01609010|20442262|P1|Overall Study|Progressive disease (PD)|8
5908748|NCT01609010|20442261|P2|Overall Study|Stable disease (SD)|16
5908749|NCT01609010|20442262|P1|Overall Study|Stable disease (SD)|22
5908750|NCT01608724|20442323|P1|Overall Study|Safety reasons|1
5908751|NCT01608724|20442323|P1|Overall Study|bood sugar too high, etc.|3
5908752|NCT01608724|20442323|P1|Overall Study|Protocol Violation|6
5908753|NCT01608724|20442323|P1|Overall Study|Adverse Event|29
5908754|NCT01608724|20442323|P1|Overall Study|Study-specific discontinuation criteria|32
5908755|NCT01608724|20442323|P1|Overall Study|Lost to Follow-up|41
5908756|NCT01608724|20442323|P1|Overall Study|Withdrawal by Subject|131
5908757|NCT01608321|20442365|P2|Overall Study|Withdrawal by Subject|0
5908758|NCT01608321|20442366|P1|Overall Study|Withdrawal by Subject|1
5908759|NCT01608308|20442374|P2|Overall Study|pretreatment medical and billing reasons|2
5908760|NCT01608308|20442375|P1|Overall Study|pretreatment medical and billing reasons|0
5908761|NCT01608087|20442438|P3|Overall Study|Other Reason|0
5908762|NCT01608087|20442439|P2|Overall Study|Other Reason|1
5908763|NCT01608087|20442440|P1|Overall Study|Other Reason|0
5908764|NCT01608087|20442438|P3|Overall Study|Lost to Follow-up|0
5908765|NCT01608087|20442439|P2|Overall Study|Lost to Follow-up|1
5908766|NCT01608087|20442440|P1|Overall Study|Lost to Follow-up|0
5908767|NCT01607957|20442470|P2|Overall Study|Participant refusal|0
5908768|NCT01607957|20442471|P1|Overall Study|Participant refusal|1
5908769|NCT01607957|20442470|P2|Overall Study|Lost to Follow-up|3
5908770|NCT01607957|20442471|P1|Overall Study|Lost to Follow-up|3
5908771|NCT01607957|20442470|P2|Overall Study|Death|211
5908772|NCT01607957|20442471|P1|Overall Study|Death|367
5908773|NCT01607957|20442470|P2|Overall Study|Not treated|1
5908774|NCT01607957|20442471|P1|Overall Study|Not treated|1
5908775|NCT01607593|20442650|P1|Overall Study|Other|4
5908776|NCT01607593|20442650|P1|Overall Study|Continuation|33
5908777|NCT01607593|20442650|P1|Overall Study|Lost to Follow-up|25
5908778|NCT01607593|20442650|P1|Overall Study|Lack of Efficacy|16
5908779|NCT01607593|20442650|P1|Overall Study|Adverse Event|15
5908780|NCT01607554|20442656|P1|Overall Study|Disease progression|2
5908781|NCT01607476|20442669|P3|Overall Study|Lost to Follow-up|2
5908782|NCT01607476|20442670|P2|Overall Study|Lost to Follow-up|0
5908783|NCT01607476|20442671|P1|Overall Study|Lost to Follow-up|0
5908784|NCT01607476|20442669|P3|Overall Study|Withdrawal by Subject|1
5908785|NCT01607476|20442670|P2|Overall Study|Withdrawal by Subject|0
5908786|NCT01607476|20442671|P1|Overall Study|Withdrawal by Subject|1
5908787|NCT01607398|20442765|P2|Overall Study|Severe COPD|0
5908788|NCT01607398|20442766|P1|Overall Study|Severe COPD|2
5908789|NCT01607398|20442765|P2|Overall Study|Adverse Event|2
5908790|NCT01607398|20442766|P1|Overall Study|Adverse Event|0
5908791|NCT01607346|20442810|P1|Overall Study|Adverse Event|3
5908792|NCT01606800|20442908|P2|Overall Study|Missing completion status|0
5908793|NCT01606800|20442909|P1|Overall Study|Missing completion status|2
5908794|NCT01606800|20442908|P2|Overall Study|Participant withdrew consent|1
5908795|NCT01606800|20442909|P1|Overall Study|Participant withdrew consent|0
5908796|NCT01606800|20442908|P2|Overall Study|Adverse Event|1
5908797|NCT01606800|20442909|P1|Overall Study|Adverse Event|3
5908798|NCT01606787|20442917|P2|Overall Study|Surgery canceled|2
5908799|NCT01606787|20442918|P1|Overall Study|Surgery canceled|0
5908800|NCT01606787|20442917|P2|Overall Study|Withdrawal by Subject|5
5908801|NCT01606787|20442918|P1|Overall Study|Withdrawal by Subject|4
5908802|NCT01606761|20442929|P5|Safety Follow-up Period (Week 52-68)|Other|3
5908803|NCT01606761|20442930|P4|Safety Follow-up Period (Week 52-68)|Other|1
5908804|NCT01606761|20442931|P3|Safety Follow-up Period (Week 52-68)|Other|9
5908805|NCT01606761|20442932|P2|Safety Follow-up Period (Week 52-68)|Other|3
5908806|NCT01606761|20442933|P1|Safety Follow-up Period (Week 52-68)|Other|0
5908807|NCT01606761|20442929|P5|Safety Follow-up Period (Week 52-68)|Death|1
5908808|NCT01606761|20442930|P4|Safety Follow-up Period (Week 52-68)|Death|0
5908809|NCT01606761|20442931|P3|Safety Follow-up Period (Week 52-68)|Death|0
5908810|NCT01606761|20442932|P2|Safety Follow-up Period (Week 52-68)|Death|0
5908811|NCT01606761|20442933|P1|Safety Follow-up Period (Week 52-68)|Death|0
5908812|NCT01606761|20442929|P5|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|3
5908813|NCT01606761|20442930|P4|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|1
5908814|NCT01606761|20442931|P3|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6
5908815|NCT01606761|20442932|P2|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6
5908816|NCT01606761|20442933|P1|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|4
5908817|NCT01606761|20442929|P5|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1
5908818|NCT01606761|20442930|P4|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0
5908819|NCT01606761|20442931|P3|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|2
5908820|NCT01606761|20442932|P2|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1
5908821|NCT01606761|20442933|P1|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0
5908822|NCT01606761|20442929|P5|Week 24 to Week 52|Other|2
5908823|NCT01606761|20442930|P4|Week 24 to Week 52|Other|2
5908824|NCT01606761|20442931|P3|Week 24 to Week 52|Other|5
5908825|NCT01606761|20442932|P2|Week 24 to Week 52|Other|1
5908826|NCT01606761|20442933|P1|Week 24 to Week 52|Other|0
5908827|NCT01606761|20442929|P5|Week 24 to Week 52|Physician Decision|0
5908828|NCT01606761|20442930|P4|Week 24 to Week 52|Physician Decision|0
5908829|NCT01606761|20442931|P3|Week 24 to Week 52|Physician Decision|1
5908830|NCT01606761|20442932|P2|Week 24 to Week 52|Physician Decision|1
5908831|NCT01606761|20442933|P1|Week 24 to Week 52|Physician Decision|0
5908832|NCT01606761|20442929|P5|Week 24 to Week 52|Lack of Efficacy|3
5908833|NCT01606761|20442930|P4|Week 24 to Week 52|Lack of Efficacy|10
5908834|NCT01606761|20442931|P3|Week 24 to Week 52|Lack of Efficacy|7
5908835|NCT01606761|20442932|P2|Week 24 to Week 52|Lack of Efficacy|13
5908836|NCT01606761|20442933|P1|Week 24 to Week 52|Lack of Efficacy|0
5908837|NCT01606761|20442929|P5|Week 24 to Week 52|Death|0
5908838|NCT01606761|20442930|P4|Week 24 to Week 52|Death|1
5908839|NCT01606761|20442931|P3|Week 24 to Week 52|Death|2
5908840|NCT01606761|20442932|P2|Week 24 to Week 52|Death|0
5908841|NCT01606761|20442933|P1|Week 24 to Week 52|Death|0
5908842|NCT01606761|20442929|P5|Week 24 to Week 52|Adverse Event|15
5908843|NCT01606761|20442930|P4|Week 24 to Week 52|Adverse Event|3
5908844|NCT01606761|20442931|P3|Week 24 to Week 52|Adverse Event|14
5908845|NCT01606761|20442932|P2|Week 24 to Week 52|Adverse Event|11
5908846|NCT01606761|20442933|P1|Week 24 to Week 52|Adverse Event|0
5908847|NCT01606761|20442929|P5|Week 24 to Week 52|Withdrawal by Subject|0
5908848|NCT01606761|20442930|P4|Week 24 to Week 52|Withdrawal by Subject|0
5908849|NCT01606761|20442931|P3|Week 24 to Week 52|Withdrawal by Subject|3
5908850|NCT01606761|20442932|P2|Week 24 to Week 52|Withdrawal by Subject|6
5908851|NCT01606761|20442933|P1|Week 24 to Week 52|Withdrawal by Subject|0
5908852|NCT01606761|20442929|P5|Week 24 to Week 52|Lost to Follow-up|0
5908853|NCT01606761|20442930|P4|Week 24 to Week 52|Lost to Follow-up|1
5908854|NCT01606761|20442931|P3|Week 24 to Week 52|Lost to Follow-up|1
5908855|NCT01606761|20442932|P2|Week 24 to Week 52|Lost to Follow-up|1
5908856|NCT01606761|20442933|P1|Week 24 to Week 52|Lost to Follow-up|0
5908857|NCT01606761|20442929|P5|Prior to Week 24|Other|0
5908858|NCT01606761|20442930|P4|Prior to Week 24|Other|0
5908859|NCT01606761|20442931|P3|Prior to Week 24|Other|5
5908860|NCT01606761|20442932|P2|Prior to Week 24|Other|7
5908861|NCT01606761|20442933|P1|Prior to Week 24|Other|4
5908862|NCT01606761|20442929|P5|Prior to Week 24|Physician Decision|0
5908863|NCT01606761|20442930|P4|Prior to Week 24|Physician Decision|0
5908864|NCT01606761|20442931|P3|Prior to Week 24|Physician Decision|1
5908865|NCT01606761|20442932|P2|Prior to Week 24|Physician Decision|3
5908866|NCT01606761|20442933|P1|Prior to Week 24|Physician Decision|0
5908867|NCT01606761|20442929|P5|Prior to Week 24|Lack of Efficacy|0
5908868|NCT01606761|20442930|P4|Prior to Week 24|Lack of Efficacy|0
5908869|NCT01606761|20442931|P3|Prior to Week 24|Lack of Efficacy|8
5908870|NCT01606761|20442932|P2|Prior to Week 24|Lack of Efficacy|14
5908871|NCT01606761|20442933|P1|Prior to Week 24|Lack of Efficacy|15
5908872|NCT01606761|20442929|P5|Prior to Week 24|Adverse Event|0
5908873|NCT01606761|20442930|P4|Prior to Week 24|Adverse Event|0
5908874|NCT01606761|20442931|P3|Prior to Week 24|Adverse Event|22
5908875|NCT01606761|20442932|P2|Prior to Week 24|Adverse Event|18
5908876|NCT01606761|20442933|P1|Prior to Week 24|Adverse Event|11
5908877|NCT01606761|20442929|P5|Prior to Week 24|Withdrawal by Subject|0
5908878|NCT01606761|20442930|P4|Prior to Week 24|Withdrawal by Subject|0
5908879|NCT01606761|20442931|P3|Prior to Week 24|Withdrawal by Subject|9
5908880|NCT01606761|20442932|P2|Prior to Week 24|Withdrawal by Subject|10
5908881|NCT01606761|20442933|P1|Prior to Week 24|Withdrawal by Subject|12
5908882|NCT01606761|20442929|P5|Prior to Week 24|Lost to Follow-up|0
5908883|NCT01606761|20442930|P4|Prior to Week 24|Lost to Follow-up|0
5908884|NCT01606761|20442931|P3|Prior to Week 24|Lost to Follow-up|2
5908885|NCT01606761|20442932|P2|Prior to Week 24|Lost to Follow-up|3
5908886|NCT01606761|20442933|P1|Prior to Week 24|Lost to Follow-up|0
5908887|NCT01606748|20442959|P2|Overall Study|Withdrawal by Subject|0
5908888|NCT01606748|20442960|P1|Overall Study|Withdrawal by Subject|1
5908889|NCT01606748|20442959|P2|Overall Study|Progressive Disease|0
5908890|NCT01606748|20442960|P1|Overall Study|Progressive Disease|1
5908891|NCT01606748|20442959|P2|Overall Study|Adverse Event|0
5908892|NCT01606748|20442960|P1|Overall Study|Adverse Event|1
5908893|NCT01606670|20443012|P1|Overall Study|Other Reason|2
5908894|NCT01606670|20443012|P1|Overall Study|Withdrawal by Subject|3
5908895|NCT01606670|20443012|P1|Overall Study|Lost to Follow-up|3
5908896|NCT01606670|20443012|P1|Overall Study|Lack of Efficacy|2
5908897|NCT01606670|20443012|P1|Overall Study|Adverse Event|6
5908898|NCT01606319|20443022|P2|Overall Study|Adverse Event|4
5908899|NCT01606319|20443023|P1|Overall Study|Adverse Event|1
5908900|NCT01606319|20443022|P2|Overall Study|Lack of Efficacy|8
5908901|NCT01606319|20443023|P1|Overall Study|Lack of Efficacy|6
5908902|NCT01606319|20443022|P2|Overall Study|Physician Decision|2
5908903|NCT01606319|20443023|P1|Overall Study|Physician Decision|1
5908904|NCT01606319|20443022|P2|Overall Study|Withdrawal by Subject|12
5908905|NCT01606319|20443023|P1|Overall Study|Withdrawal by Subject|9
5908906|NCT01606319|20443022|P2|Overall Study|Lost to Follow-up|14
5908907|NCT01606319|20443023|P1|Overall Study|Lost to Follow-up|17
5908908|NCT01606306|20443041|P6|Overall Study|Physician Decision|0
5908909|NCT01606306|20443042|P5|Overall Study|Physician Decision|0
5908910|NCT01606306|20443043|P4|Overall Study|Physician Decision|0
5908911|NCT01606306|20443044|P3|Overall Study|Physician Decision|0
5908912|NCT01606306|20443045|P2|Overall Study|Physician Decision|2
5908913|NCT01606306|20443046|P1|Overall Study|Physician Decision|1
5908914|NCT01606306|20443041|P6|Overall Study|Withdrawal by Subject|4
5908915|NCT01606306|20443042|P5|Overall Study|Withdrawal by Subject|5
5908916|NCT01606306|20443043|P4|Overall Study|Withdrawal by Subject|4
5908917|NCT01606306|20443044|P3|Overall Study|Withdrawal by Subject|4
5908918|NCT01606306|20443045|P2|Overall Study|Withdrawal by Subject|3
5908919|NCT01606306|20443046|P1|Overall Study|Withdrawal by Subject|4
5908920|NCT01606306|20443041|P6|Overall Study|Lost to Follow-up|5
5908921|NCT01606306|20443042|P5|Overall Study|Lost to Follow-up|3
5908922|NCT01606306|20443043|P4|Overall Study|Lost to Follow-up|4
5908923|NCT01606306|20443044|P3|Overall Study|Lost to Follow-up|5
5908924|NCT01606306|20443045|P2|Overall Study|Lost to Follow-up|4
5908925|NCT01606306|20443046|P1|Overall Study|Lost to Follow-up|7
5908926|NCT01606306|20443041|P6|Overall Study|Adverse Event|0
5908927|NCT01606306|20443042|P5|Overall Study|Adverse Event|2
5908928|NCT01606306|20443043|P4|Overall Study|Adverse Event|1
5908929|NCT01606306|20443044|P3|Overall Study|Adverse Event|1
5908930|NCT01606306|20443045|P2|Overall Study|Adverse Event|0
5908931|NCT01606306|20443046|P1|Overall Study|Adverse Event|1
5908932|NCT01606306|20443041|P6|Overall Study|Lack of Efficacy|2
5908933|NCT01606306|20443042|P5|Overall Study|Lack of Efficacy|1
5908934|NCT01606306|20443043|P4|Overall Study|Lack of Efficacy|4
5908935|NCT01606306|20443044|P3|Overall Study|Lack of Efficacy|4
5908936|NCT01606306|20443045|P2|Overall Study|Lack of Efficacy|1
5908937|NCT01606306|20443046|P1|Overall Study|Lack of Efficacy|2
5908938|NCT01606254|20443056|P4|Overall Study|Adverse Event|1
5908939|NCT01606254|20443057|P3|Overall Study|Adverse Event|0
5908940|NCT01606254|20443058|P2|Overall Study|Adverse Event|1
5908941|NCT01606254|20443059|P1|Overall Study|Adverse Event|1
5908942|NCT01606254|20443056|P4|Overall Study|Withdrawal by Subject|2
5908943|NCT01606254|20443057|P3|Overall Study|Withdrawal by Subject|0
5908944|NCT01606254|20443058|P2|Overall Study|Withdrawal by Subject|3
5908945|NCT01606254|20443059|P1|Overall Study|Withdrawal by Subject|1
5908946|NCT01606228|20443141|P1|Overall Study|Adverse Event|1
5908947|NCT01606228|20443141|P1|Overall Study|Lack of Efficacy|2
5908948|NCT01606228|20443141|P1|Overall Study|Non-compliant|3
5908949|NCT01606228|20443141|P1|Overall Study|Withdrawal by Subject|3
5908950|NCT01606228|20443141|P1|Overall Study|Lost to Follow-up|20
5908951|NCT01606202|20443158|P2|Overall Study|Problems with administration|1
5908952|NCT01606202|20443159|P1|Overall Study|Problems with administration|0
5908953|NCT01606202|20443158|P2|Overall Study|Personal problems|1
5908954|NCT01606202|20443159|P1|Overall Study|Personal problems|0
5908955|NCT01606202|20443158|P2|Overall Study|Withdrawal by Subject|1
5908956|NCT01606202|20443159|P1|Overall Study|Withdrawal by Subject|2
5908957|NCT01606202|20443158|P2|Overall Study|Adverse Event|0
5908958|NCT01606202|20443159|P1|Overall Study|Adverse Event|5
5908959|NCT01606189|20443191|P6|Third Intenvention (14-20 Days)|Withdrawal by Subject|1
5908960|NCT01606189|20443192|P5|Third Intenvention (14-20 Days)|Withdrawal by Subject|0
5908961|NCT01606189|20443193|P4|Third Intenvention (14-20 Days)|Withdrawal by Subject|0
5908962|NCT01606189|20443194|P3|Third Intenvention (14-20 Days)|Withdrawal by Subject|0
5908963|NCT01606189|20443195|P2|Third Intenvention (14-20 Days)|Withdrawal by Subject|0
5908964|NCT01606189|20443196|P1|Third Intenvention (14-20 Days)|Withdrawal by Subject|0
5908965|NCT01606189|20443191|P6|Second Intenvention (14-20 Days)|Adverse Event|1
5908966|NCT01606189|20443192|P5|Second Intenvention (14-20 Days)|Adverse Event|0
5908967|NCT01606189|20443193|P4|Second Intenvention (14-20 Days)|Adverse Event|0
5908968|NCT01606189|20443194|P3|Second Intenvention (14-20 Days)|Adverse Event|0
5908969|NCT01606189|20443195|P2|Second Intenvention (14-20 Days)|Adverse Event|0
5908970|NCT01606189|20443196|P1|Second Intenvention (14-20 Days)|Adverse Event|0
5908971|NCT01606176|20443230|P2|Overall Study|Withdrawal by Subject|0
5908972|NCT01606176|20443231|P1|Overall Study|Withdrawal by Subject|1
5908973|NCT01606176|20443230|P2|Overall Study|Disease progression|0
5908974|NCT01606176|20443231|P1|Overall Study|Disease progression|1
5908975|NCT01606176|20443230|P2|Overall Study|Adverse Event|3
5908976|NCT01606176|20443231|P1|Overall Study|Adverse Event|2
5908977|NCT01606137|20443276|P1|Overall Study|Unable to collect consistent data|1
5908978|NCT01606137|20443276|P1|Overall Study|Patient moving|1
5908979|NCT01606137|20443276|P1|Overall Study|Unable to tolerate study med. taste|1
5908980|NCT01606137|20443276|P1|Overall Study|Personal reasons|1
5908981|NCT01606137|20443276|P1|Overall Study|Patient leaving country|1
5908982|NCT01606137|20443276|P1|Overall Study|Wanted to try another treatment|1
5908983|NCT01606137|20443276|P1|Overall Study|Not enough improvement|4
5908984|NCT01606137|20443276|P1|Overall Study|Spray causes nausea|1
5908985|NCT01606137|20443276|P1|Overall Study|Increased bilirubin|1
5908986|NCT01606137|20443276|P1|Overall Study|multiple sclerosis less stable|1
5908987|NCT01606137|20443276|P1|Overall Study|Issues with driving|4
5908988|NCT01606137|20443276|P1|Overall Study|Decreased/no pain|4
5908989|NCT01606137|20443276|P1|Overall Study|Death|1
5908990|NCT01606137|20443276|P1|Overall Study|Patient non-compliance|9
5908991|NCT01606137|20443276|P1|Overall Study|Protocol Violation|1
5908992|NCT01606137|20443276|P1|Overall Study|Lost to Follow-up|15
5908993|NCT01606137|20443276|P1|Overall Study|Lack of Efficacy|56
5908994|NCT01606137|20443276|P1|Overall Study|Withdrawal by Subject|74
5908995|NCT01606137|20443276|P1|Overall Study|Adverse Event|85
5908996|NCT01606007|20443310|P3|Overall Study|Poor/Non-compliance|0
5908997|NCT01606007|20443311|P2|Overall Study|Poor/Non-compliance|0
5908998|NCT01606007|20443312|P1|Overall Study|Poor/Non-compliance|1
5908999|NCT01606007|20443310|P3|Overall Study|Lost to Follow-up|5
5909000|NCT01606007|20443311|P2|Overall Study|Lost to Follow-up|8
5909001|NCT01606007|20443312|P1|Overall Study|Lost to Follow-up|6
5909002|NCT01606007|20443310|P3|Overall Study|discontinue study treatment|1
5909003|NCT01606007|20443311|P2|Overall Study|discontinue study treatment|2
5909004|NCT01606007|20443312|P1|Overall Study|discontinue study treatment|0
5909005|NCT01606007|20443310|P3|Overall Study|Adverse Event|1
5909006|NCT01606007|20443311|P2|Overall Study|Adverse Event|1
5909007|NCT01606007|20443312|P1|Overall Study|Adverse Event|0
5909008|NCT01606007|20443310|P3|Overall Study|Withdrawal by Subject|1
5909009|NCT01606007|20443311|P2|Overall Study|Withdrawal by Subject|6
5909010|NCT01606007|20443312|P1|Overall Study|Withdrawal by Subject|8
5909011|NCT01606007|20443310|P3|Overall Study|Pregnancy|1
5909012|NCT01606007|20443311|P2|Overall Study|Pregnancy|1
5909013|NCT01606007|20443312|P1|Overall Study|Pregnancy|0
5909014|NCT01606007|20443310|P3|Overall Study|Reason 'Other' in the protocol|1
5909015|NCT01606007|20443311|P2|Overall Study|Reason 'Other' in the protocol|1
5909016|NCT01606007|20443312|P1|Overall Study|Reason 'Other' in the protocol|0
5909017|NCT01605916|20443347|P5|Overall Study|Withdrawal by Subject|2
5909018|NCT01605916|20443348|P4|Overall Study|Withdrawal by Subject|0
5909019|NCT01605916|20443349|P3|Overall Study|Withdrawal by Subject|0
5909020|NCT01605916|20443350|P2|Overall Study|Withdrawal by Subject|1
5909021|NCT01605916|20443351|P1|Overall Study|Withdrawal by Subject|1
5909022|NCT01605916|20443347|P5|Overall Study|Lack of Efficacy|4
5909023|NCT01605916|20443348|P4|Overall Study|Lack of Efficacy|5
5909024|NCT01605916|20443349|P3|Overall Study|Lack of Efficacy|3
5909025|NCT01605916|20443350|P2|Overall Study|Lack of Efficacy|3
5909026|NCT01605916|20443351|P1|Overall Study|Lack of Efficacy|2
5909027|NCT01605916|20443347|P5|Overall Study|Adverse Event|0
5909028|NCT01605916|20443348|P4|Overall Study|Adverse Event|1
5909029|NCT01605916|20443349|P3|Overall Study|Adverse Event|0
5909030|NCT01605916|20443350|P2|Overall Study|Adverse Event|0
5909031|NCT01605916|20443351|P1|Overall Study|Adverse Event|1
5909032|NCT01605877|20443448|P1|Overall Study|Withdrawal by Subject|1
5909033|NCT01605825|20443512|P2|Overall Study|Non-Compliance with Protocol|0
5909034|NCT01605825|20443513|P1|Overall Study|Non-Compliance with Protocol|3
5909035|NCT01605825|20443512|P2|Overall Study|Non-Compliance -Investigational Drug|0
5909036|NCT01605825|20443513|P1|Overall Study|Non-Compliance -Investigational Drug|3
5909037|NCT01605825|20443512|P2|Overall Study|Withdrawal by Subject|1
5909038|NCT01605825|20443513|P1|Overall Study|Withdrawal by Subject|0
5909039|NCT01605825|20443512|P2|Overall Study|Adverse Event|2
5909040|NCT01605825|20443513|P1|Overall Study|Adverse Event|4
5909041|NCT01605799|20443521|P2|Overall Study|Withdrawal by Subject|1
5909042|NCT01605799|20443522|P1|Overall Study|Withdrawal by Subject|2
5909043|NCT01605617|20443537|P2|Washout Period of 4 Weeks|Study Terminated|1
5909044|NCT01605617|20443538|P1|Washout Period of 4 Weeks|Study Terminated|2
5909045|NCT01605617|20443537|P2|First Intervention|Adverse Event|1
5909046|NCT01605617|20443538|P1|First Intervention|Adverse Event|0
5909047|NCT01605461|20443597|P1|Overall Study|Withdrawal by Subject|1
5909048|NCT01605461|20443597|P1|Overall Study|Lost to Follow-up|3
5909049|NCT01605396|20443656|P2|Overall Study|Transfer Off Study|5
5909050|NCT01605396|20443657|P1|Overall Study|Transfer Off Study|4
5909051|NCT01605396|20443656|P2|Overall Study|Withdrawal by Subject|2
5909052|NCT01605396|20443657|P1|Overall Study|Withdrawal by Subject|4
5909053|NCT01605396|20443656|P2|Overall Study|Progressive Disease|27
5909054|NCT01605396|20443657|P1|Overall Study|Progressive Disease|23
5909055|NCT01605396|20443656|P2|Overall Study|Physician Decision|2
5909056|NCT01605396|20443657|P1|Overall Study|Physician Decision|2
5909057|NCT01605396|20443656|P2|Overall Study|Non-Compliance With Study Drug|1
5909058|NCT01605396|20443657|P1|Overall Study|Non-Compliance With Study Drug|1
5909059|NCT01605396|20443656|P2|Overall Study|Lost to Follow-up|0
5909060|NCT01605396|20443657|P1|Overall Study|Lost to Follow-up|1
5909061|NCT01605396|20443656|P2|Overall Study|Adverse Event|3
5909062|NCT01605396|20443657|P1|Overall Study|Adverse Event|5
5909063|NCT01605370|20443671|P2|Overall Study|Adverse Event|0
5909064|NCT01605370|20443672|P1|Overall Study|Adverse Event|1
5909065|NCT01605227|20443707|P2|Overall Study|Dose Held >6 weeks|1
5909066|NCT01605227|20443708|P1|Overall Study|Dose Held >6 weeks|0
5909067|NCT01605227|20443707|P2|Overall Study|Subject Decision|1
5909068|NCT01605227|20443708|P1|Overall Study|Subject Decision|0
5909069|NCT01605227|20443707|P2|Overall Study|Started New Therapy|0
5909070|NCT01605227|20443708|P1|Overall Study|Started New Therapy|1
5909071|NCT01605227|20443707|P2|Overall Study|Sponsor Decision|0
5909072|NCT01605227|20443708|P1|Overall Study|Sponsor Decision|2
5909073|NCT01605227|20443707|P2|Overall Study|Withdrawal by Subject|14
5909074|NCT01605227|20443708|P1|Overall Study|Withdrawal by Subject|18
5909075|NCT01605227|20443707|P2|Overall Study|Physician Decision|7
5909076|NCT01605227|20443708|P1|Overall Study|Physician Decision|9
5909077|NCT01605227|20443707|P2|Overall Study|Protocol Violation|0
5909078|NCT01605227|20443708|P1|Overall Study|Protocol Violation|1
5909079|NCT01605227|20443707|P2|Overall Study|Lost to Follow-up|0
5909080|NCT01605227|20443708|P1|Overall Study|Lost to Follow-up|1
5909081|NCT01605227|20443707|P2|Overall Study|Clinical Deterioration|133
5909082|NCT01605227|20443708|P1|Overall Study|Clinical Deterioration|227
5909083|NCT01605227|20443707|P2|Overall Study|Progressive Disease|128
5909084|NCT01605227|20443708|P1|Overall Study|Progressive Disease|132
5909085|NCT01605227|20443707|P2|Overall Study|Adverse Event|42
5909086|NCT01605227|20443708|P1|Overall Study|Adverse Event|228
5909087|NCT01605227|20443707|P2|Overall Study|Did not receive study treatment|3
5909088|NCT01605227|20443708|P1|Overall Study|Did not receive study treatment|2
5909089|NCT01605136|20443720|P2|Safety Follow-Up Period|Withdrawal by Subject|2
5909090|NCT01605136|20443721|P1|Safety Follow-Up Period|Withdrawal by Subject|1
5909091|NCT01605136|20443720|P2|Study Period|Lost to Follow-up|2
5909092|NCT01605136|20443721|P1|Study Period|Lost to Follow-up|0
5909093|NCT01605136|20443720|P2|Study Period|Physician Decision|1
5909094|NCT01605136|20443721|P1|Study Period|Physician Decision|1
5909095|NCT01605136|20443720|P2|Study Period|Withdrawal by Subject|0
5909096|NCT01605136|20443721|P1|Study Period|Withdrawal by Subject|2
5909097|NCT01605019|20443750|P2|Overall Study|pt did not meet transplant endpoint|0
5909098|NCT01605019|20443751|P1|Overall Study|pt did not meet transplant endpoint|3
5909099|NCT01604941|20443761|P6|Overall Study|Early Study Termination|0
5909100|NCT01604941|20443762|P5|Overall Study|Early Study Termination|0
5909101|NCT01604941|20443763|P4|Overall Study|Early Study Termination|3
5909102|NCT01604941|20443764|P3|Overall Study|Early Study Termination|3
5909103|NCT01604941|20443765|P2|Overall Study|Early Study Termination|2
5909104|NCT01604941|20443766|P1|Overall Study|Early Study Termination|9
5909105|NCT01604941|20443761|P6|Overall Study|Participant Decision|2
5909106|NCT01604941|20443762|P5|Overall Study|Participant Decision|0
5909107|NCT01604941|20443763|P4|Overall Study|Participant Decision|0
5909108|NCT01604941|20443764|P3|Overall Study|Participant Decision|0
5909109|NCT01604941|20443765|P2|Overall Study|Participant Decision|0
5909110|NCT01604941|20443766|P1|Overall Study|Participant Decision|0
5909111|NCT01604941|20443761|P6|Overall Study|Non-compliance|0
5909112|NCT01604941|20443762|P5|Overall Study|Non-compliance|0
5909113|NCT01604941|20443763|P4|Overall Study|Non-compliance|0
5909114|NCT01604941|20443764|P3|Overall Study|Non-compliance|0
5909115|NCT01604941|20443765|P2|Overall Study|Non-compliance|0
5909116|NCT01604941|20443766|P1|Overall Study|Non-compliance|1
5909117|NCT01604941|20443761|P6|Overall Study|Adverse Event|5
5909118|NCT01604941|20443762|P5|Overall Study|Adverse Event|1
5909119|NCT01604941|20443763|P4|Overall Study|Adverse Event|0
5909120|NCT01604941|20443764|P3|Overall Study|Adverse Event|0
5909121|NCT01604941|20443765|P2|Overall Study|Adverse Event|2
5909122|NCT01604941|20443766|P1|Overall Study|Adverse Event|1
5909123|NCT01604850|20443794|P2|Overall Study|Subject withdrew consent|0
5909124|NCT01604850|20443795|P1|Overall Study|Subject withdrew consent|1
5909125|NCT01604850|20443794|P2|Overall Study|Lost to Follow-up|0
5909126|NCT01604850|20443795|P1|Overall Study|Lost to Follow-up|1
5909127|NCT01604850|20443794|P2|Overall Study|Efficacy Failure|29
5909128|NCT01604850|20443795|P1|Overall Study|Efficacy Failure|50
5909129|NCT01604850|20443794|P2|Overall Study|Enrolled but never treated|1
5909130|NCT01604850|20443795|P1|Overall Study|Enrolled but never treated|0
5909131|NCT01604824|20443815|P6|Open-label Extension (OLE) Period|Refused to come into office|0
5909132|NCT01604824|20443816|P5|Open-label Extension (OLE) Period|Refused to come into office|1
5909133|NCT01604824|20443817|P4|Open-label Extension (OLE) Period|Refused to come into office|0
5909134|NCT01604824|20443818|P3|Open-label Extension (OLE) Period|Refused to come into office|0
5909135|NCT01604824|20443819|P2|Open-label Extension (OLE) Period|Refused to come into office|0
5909136|NCT01604824|20443820|P1|Open-label Extension (OLE) Period|Refused to come into office|0
5909137|NCT01604824|20443815|P6|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0
5909138|NCT01604824|20443816|P5|Open-label Extension (OLE) Period|Chose not to enter OLE Period|2
5909139|NCT01604824|20443817|P4|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0
5909140|NCT01604824|20443818|P3|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0
5909141|NCT01604824|20443819|P2|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0
5909142|NCT01604824|20443820|P1|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0
5909143|NCT01604785|20443850|P2|Overall Study|Repeat Visits Not Included in Analysis|1
5909228|NCT01604343|20443890|P1|Week 52 to Week 104|Withdrawal by Subject|0
5909144|NCT01604785|20443851|P1|Overall Study|Repeat Visits Not Included in Analysis|7
5909145|NCT01604408|20443870|P2|Observation Period|Withdrawal by Subject|2
5909146|NCT01604408|20443871|P1|Observation Period|Withdrawal by Subject|0
5909147|NCT01604408|20443870|P2|Observation Period|Adverse Event|1
5909148|NCT01604408|20443871|P1|Observation Period|Adverse Event|1
5909149|NCT01604408|20443870|P2|Treatment Period 6|Sponsor decision|1
5909150|NCT01604408|20443871|P1|Treatment Period 6|Sponsor decision|0
5909151|NCT01604408|20443870|P2|Treatment Period 6|Adverse Event|0
5909152|NCT01604408|20443871|P1|Treatment Period 6|Adverse Event|2
5909153|NCT01604408|20443870|P2|Treatment Period 6|Lost to Follow-up|1
5909154|NCT01604408|20443871|P1|Treatment Period 6|Lost to Follow-up|0
5909155|NCT01604408|20443870|P2|Treatment Period 5|Adverse Event|0
5909156|NCT01604408|20443871|P1|Treatment Period 5|Adverse Event|4
5909157|NCT01604408|20443870|P2|Treatment Period 4|Adverse Event|1
5909158|NCT01604408|20443871|P1|Treatment Period 4|Adverse Event|0
5909159|NCT01604408|20443870|P2|Treatment Period 4|Withdrawal by Subject|1
5909160|NCT01604408|20443871|P1|Treatment Period 4|Withdrawal by Subject|2
5909161|NCT01604408|20443870|P2|Treatment Period 4|Death|0
5909162|NCT01604408|20443871|P1|Treatment Period 4|Death|1
5909163|NCT01604408|20443870|P2|Treatment Period 3|Sponsor Decision|0
5909164|NCT01604408|20443871|P1|Treatment Period 3|Sponsor Decision|1
5909165|NCT01604408|20443870|P2|Treatment Period 3|Withdrawal by Subject|1
5909166|NCT01604408|20443871|P1|Treatment Period 3|Withdrawal by Subject|3
5909167|NCT01604408|20443870|P2|Treatment Period 3|Adverse Event|3
5909168|NCT01604408|20443871|P1|Treatment Period 3|Adverse Event|0
5909169|NCT01604408|20443870|P2|Treatment Period 3|Protocol Violation|1
5909170|NCT01604408|20443871|P1|Treatment Period 3|Protocol Violation|1
5909171|NCT01604408|20443870|P2|Treatment Period 2|Adverse Event|1
5909172|NCT01604408|20443871|P1|Treatment Period 2|Adverse Event|0
5909173|NCT01604408|20443870|P2|Treatment Period 2|Protocol Violation|0
5909174|NCT01604408|20443871|P1|Treatment Period 2|Protocol Violation|1
5909175|NCT01604408|20443870|P2|Treatment Period 2|Withdrawal by Subject|1
5909176|NCT01604408|20443871|P1|Treatment Period 2|Withdrawal by Subject|1
5909177|NCT01604408|20443870|P2|Treatment Period 1|Protocol Violation|1
5909178|NCT01604408|20443871|P1|Treatment Period 1|Protocol Violation|0
5909179|NCT01604343|20443886|P5|Safety Follow-up Period (Week 104-120)|Other|14
5909180|NCT01604343|20443887|P4|Safety Follow-up Period (Week 104-120)|Other|6
5909181|NCT01604343|20443888|P3|Safety Follow-up Period (Week 104-120)|Other|20
5909182|NCT01604343|20443889|P2|Safety Follow-up Period (Week 104-120)|Other|2
5909183|NCT01604343|20443890|P1|Safety Follow-up Period (Week 104-120)|Other|15
5909184|NCT01604343|20443886|P5|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|14
5909185|NCT01604343|20443887|P4|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|3
5909186|NCT01604343|20443888|P3|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|11
5909187|NCT01604343|20443889|P2|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|4
5909188|NCT01604343|20443890|P1|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|12
5909189|NCT01604343|20443886|P5|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1
5909190|NCT01604343|20443887|P4|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1
5909191|NCT01604343|20443888|P3|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|2
5909192|NCT01604343|20443889|P2|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1
5909193|NCT01604343|20443890|P1|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|3
5909194|NCT01604343|20443886|P5|Week 52 to Week 104|Other|3
5909195|NCT01604343|20443887|P4|Week 52 to Week 104|Other|6
5909196|NCT01604343|20443888|P3|Week 52 to Week 104|Other|11
5909197|NCT01604343|20443889|P2|Week 52 to Week 104|Other|11
5909198|NCT01604343|20443890|P1|Week 52 to Week 104|Other|0
5909199|NCT01604343|20443886|P5|Week 52 to Week 104|Pregnancy|1
5909200|NCT01604343|20443887|P4|Week 52 to Week 104|Pregnancy|2
5909201|NCT01604343|20443888|P3|Week 52 to Week 104|Pregnancy|1
5909202|NCT01604343|20443889|P2|Week 52 to Week 104|Pregnancy|0
5909203|NCT01604343|20443890|P1|Week 52 to Week 104|Pregnancy|0
5909204|NCT01604343|20443886|P5|Week 52 to Week 104|Physician Decision|2
5909205|NCT01604343|20443887|P4|Week 52 to Week 104|Physician Decision|0
5909206|NCT01604343|20443888|P3|Week 52 to Week 104|Physician Decision|0
5909207|NCT01604343|20443889|P2|Week 52 to Week 104|Physician Decision|1
5909208|NCT01604343|20443890|P1|Week 52 to Week 104|Physician Decision|0
5909209|NCT01604343|20443886|P5|Week 52 to Week 104|Lack of Efficacy|3
5909210|NCT01604343|20443887|P4|Week 52 to Week 104|Lack of Efficacy|2
5909211|NCT01604343|20443888|P3|Week 52 to Week 104|Lack of Efficacy|11
5909212|NCT01604343|20443889|P2|Week 52 to Week 104|Lack of Efficacy|6
5909213|NCT01604343|20443890|P1|Week 52 to Week 104|Lack of Efficacy|0
5909214|NCT01604343|20443886|P5|Week 52 to Week 104|Death|0
5909215|NCT01604343|20443887|P4|Week 52 to Week 104|Death|5
5909216|NCT01604343|20443888|P3|Week 52 to Week 104|Death|2
5909217|NCT01604343|20443889|P2|Week 52 to Week 104|Death|4
5909218|NCT01604343|20443890|P1|Week 52 to Week 104|Death|0
5909219|NCT01604343|20443886|P5|Week 52 to Week 104|Adverse Event|27
5909220|NCT01604343|20443887|P4|Week 52 to Week 104|Adverse Event|21
5909221|NCT01604343|20443888|P3|Week 52 to Week 104|Adverse Event|26
5909222|NCT01604343|20443889|P2|Week 52 to Week 104|Adverse Event|12
5909223|NCT01604343|20443890|P1|Week 52 to Week 104|Adverse Event|0
5909224|NCT01604343|20443886|P5|Week 52 to Week 104|Withdrawal by Subject|4
5909225|NCT01604343|20443887|P4|Week 52 to Week 104|Withdrawal by Subject|8
5909226|NCT01604343|20443888|P3|Week 52 to Week 104|Withdrawal by Subject|12
5909227|NCT01604343|20443889|P2|Week 52 to Week 104|Withdrawal by Subject|7
5909229|NCT01604343|20443886|P5|Week 52 to Week 104|Lost to Follow-up|1
5909230|NCT01604343|20443887|P4|Week 52 to Week 104|Lost to Follow-up|2
5909231|NCT01604343|20443888|P3|Week 52 to Week 104|Lost to Follow-up|4
5909232|NCT01604343|20443889|P2|Week 52 to Week 104|Lost to Follow-up|2
5909233|NCT01604343|20443890|P1|Week 52 to Week 104|Lost to Follow-up|0
5909234|NCT01604343|20443886|P5|Prior to W52 Administration(Through W52)|Other|6
5909235|NCT01604343|20443887|P4|Prior to W52 Administration(Through W52)|Other|0
5909236|NCT01604343|20443888|P3|Prior to W52 Administration(Through W52)|Other|10
5909237|NCT01604343|20443889|P2|Prior to W52 Administration(Through W52)|Other|0
5909238|NCT01604343|20443890|P1|Prior to W52 Administration(Through W52)|Other|15
5909239|NCT01604343|20443886|P5|Prior to W52 Administration(Through W52)|Pregnancy|0
5909240|NCT01604343|20443887|P4|Prior to W52 Administration(Through W52)|Pregnancy|0
5909241|NCT01604343|20443888|P3|Prior to W52 Administration(Through W52)|Pregnancy|1
5909242|NCT01604343|20443889|P2|Prior to W52 Administration(Through W52)|Pregnancy|0
5909243|NCT01604343|20443890|P1|Prior to W52 Administration(Through W52)|Pregnancy|1
5909244|NCT01604343|20443886|P5|Prior to W52 Administration(Through W52)|Physician Decision|2
5909245|NCT01604343|20443887|P4|Prior to W52 Administration(Through W52)|Physician Decision|0
5909246|NCT01604343|20443888|P3|Prior to W52 Administration(Through W52)|Physician Decision|1
5909247|NCT01604343|20443889|P2|Prior to W52 Administration(Through W52)|Physician Decision|0
5909248|NCT01604343|20443890|P1|Prior to W52 Administration(Through W52)|Physician Decision|4
5909249|NCT01604343|20443886|P5|Prior to W52 Administration(Through W52)|Lack of Efficacy|14
5909250|NCT01604343|20443887|P4|Prior to W52 Administration(Through W52)|Lack of Efficacy|0
5909251|NCT01604343|20443888|P3|Prior to W52 Administration(Through W52)|Lack of Efficacy|5
5909252|NCT01604343|20443889|P2|Prior to W52 Administration(Through W52)|Lack of Efficacy|0
5909253|NCT01604343|20443890|P1|Prior to W52 Administration(Through W52)|Lack of Efficacy|24
5909254|NCT01604343|20443886|P5|Prior to W52 Administration(Through W52)|Death|4
5909255|NCT01604343|20443887|P4|Prior to W52 Administration(Through W52)|Death|0
5909256|NCT01604343|20443888|P3|Prior to W52 Administration(Through W52)|Death|2
5909257|NCT01604343|20443889|P2|Prior to W52 Administration(Through W52)|Death|0
5909258|NCT01604343|20443890|P1|Prior to W52 Administration(Through W52)|Death|5
5909259|NCT01604343|20443886|P5|Prior to W52 Administration(Through W52)|Adverse Event|42
5909260|NCT01604343|20443887|P4|Prior to W52 Administration(Through W52)|Adverse Event|0
5909261|NCT01604343|20443888|P3|Prior to W52 Administration(Through W52)|Adverse Event|41
5909262|NCT01604343|20443889|P2|Prior to W52 Administration(Through W52)|Adverse Event|0
5909263|NCT01604343|20443890|P1|Prior to W52 Administration(Through W52)|Adverse Event|25
5909264|NCT01604343|20443886|P5|Prior to W52 Administration(Through W52)|Withdrawal by Subject|16
5909265|NCT01604343|20443887|P4|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0
5909266|NCT01604343|20443888|P3|Prior to W52 Administration(Through W52)|Withdrawal by Subject|12
5909267|NCT01604343|20443889|P2|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0
5909268|NCT01604343|20443890|P1|Prior to W52 Administration(Through W52)|Withdrawal by Subject|19
5909269|NCT01604343|20443886|P5|Prior to W52 Administration(Through W52)|Lost to Follow-up|3
5909270|NCT01604343|20443887|P4|Prior to W52 Administration(Through W52)|Lost to Follow-up|0
5909271|NCT01604343|20443888|P3|Prior to W52 Administration(Through W52)|Lost to Follow-up|4
5909272|NCT01604343|20443889|P2|Prior to W52 Administration(Through W52)|Lost to Follow-up|0
5909273|NCT01604343|20443890|P1|Prior to W52 Administration(Through W52)|Lost to Follow-up|5
5909274|NCT01604278|20444055|P2|Overall Study|Protocol Deviation|3
5909275|NCT01604278|20444056|P1|Overall Study|Protocol Deviation|5
5909276|NCT01604278|20444055|P2|Overall Study|Adverse Event|5
5909277|NCT01604278|20444056|P1|Overall Study|Adverse Event|3
5909278|NCT01604278|20444055|P2|Overall Study|Withdrawal by Subject|3
5909279|NCT01604278|20444056|P1|Overall Study|Withdrawal by Subject|3
5909280|NCT01604278|20444055|P2|Overall Study|Administrative problems|1
5909281|NCT01604278|20444056|P1|Overall Study|Administrative problems|2
5909282|NCT01604278|20444055|P2|Overall Study|Lost to Follow-up|0
5909283|NCT01604278|20444056|P1|Overall Study|Lost to Follow-up|1
5909284|NCT01604278|20444055|P2|Overall Study|Lack of Efficacy|1
5909285|NCT01604278|20444056|P1|Overall Study|Lack of Efficacy|0
5909286|NCT01604265|20444082|P2|Overall Study|Withdrawal by Subject|0
5909287|NCT01604265|20444083|P1|Overall Study|Withdrawal by Subject|1
5909288|NCT01604265|20444082|P2|Overall Study|Adverse Event|0
5909289|NCT01604265|20444083|P1|Overall Study|Adverse Event|1
5909290|NCT01603875|20444194|P3|Overall Study|Protocol Violation|0
5909291|NCT01603875|20444195|P2|Overall Study|Protocol Violation|1
5909292|NCT01603875|20444196|P1|Overall Study|Protocol Violation|0
5909293|NCT01603875|20444194|P3|Overall Study|Lost to Follow-up|6
5909294|NCT01603875|20444195|P2|Overall Study|Lost to Follow-up|3
5909295|NCT01603875|20444196|P1|Overall Study|Lost to Follow-up|4
5909296|NCT01603875|20444194|P3|Overall Study|Preexisting rabies antibody|3
5909297|NCT01603875|20444195|P2|Overall Study|Preexisting rabies antibody|4
5909298|NCT01603875|20444196|P1|Overall Study|Preexisting rabies antibody|3
5909299|NCT01603641|20444216|P1|Overall Study|Other Miscellaneous Reasons|6
5909300|NCT01603641|20444216|P1|Overall Study|Personal Reasons|18
5909301|NCT01603641|20444216|P1|Overall Study|Lost to Follow-up|6
5909302|NCT01603641|20444216|P1|Overall Study|Lack of Efficacy|1
5909303|NCT01603641|20444216|P1|Overall Study|Adverse Event|1
5909304|NCT01603641|20444216|P1|Overall Study|Did not Receive Treatment|3
5909305|NCT01603628|20444223|P3|Overall Study|Other Miscellaneous Reason|0
5909306|NCT01603628|20444224|P2|Overall Study|Other Miscellaneous Reason|0
5909307|NCT01603628|20444225|P1|Overall Study|Other Miscellaneous Reason|1
5909308|NCT01603628|20444223|P3|Overall Study|Lost to Follow-up|0
5909309|NCT01603628|20444224|P2|Overall Study|Lost to Follow-up|1
5909310|NCT01603628|20444225|P1|Overall Study|Lost to Follow-up|0
5909311|NCT01603628|20444223|P3|Overall Study|Protocol Violation|0
5909312|NCT01603628|20444224|P2|Overall Study|Protocol Violation|1
5909313|NCT01603628|20444225|P1|Overall Study|Protocol Violation|1
5909314|NCT01603628|20444223|P3|Overall Study|Personal Reasons|2
5909315|NCT01603628|20444224|P2|Overall Study|Personal Reasons|1
5909316|NCT01603628|20444225|P1|Overall Study|Personal Reasons|1
5909317|NCT01603615|20444242|P1|Overall Study|Other Miscellaneous|1
5909318|NCT01603615|20444242|P1|Overall Study|Personal Reasons|17
5909319|NCT01603615|20444242|P1|Overall Study|Lost to Follow-up|9
5909320|NCT01603615|20444242|P1|Overall Study|Did not Receive Treatment|7
5909321|NCT01603602|20444249|P3|Overall Study|Personal Reasons|1
5909322|NCT01603602|20444250|P2|Overall Study|Personal Reasons|0
5909323|NCT01603602|20444251|P1|Overall Study|Personal Reasons|1
5909324|NCT01603602|20444249|P3|Overall Study|Adverse Event|0
5909325|NCT01603602|20444250|P2|Overall Study|Adverse Event|0
5909326|NCT01603602|20444251|P1|Overall Study|Adverse Event|1
5909327|NCT01603459|20444271|P1|Overall Study|Administrative reason|1
5909328|NCT01603459|20444271|P1|Overall Study|Non-compliance|1
5909329|NCT01603459|20444271|P1|Overall Study|Predefined discontinuation criteria|3
5909330|NCT01603459|20444271|P1|Overall Study|Lost to Follow-up|3
5909331|NCT01603459|20444271|P1|Overall Study|Withdrawal by Subject|5
5909332|NCT01603459|20444271|P1|Overall Study|Adverse Event|5
5909333|NCT01603394|20444422|P1|Overall Study|Adverse Event|1
5909334|NCT01603355|20444476|P1|Overall Study|Lack of Efficacy|2
5909335|NCT01603277|20444482|P2|Overall Study|Non-Compliance|1
5909336|NCT01603277|20444483|P1|Overall Study|Non-Compliance|2
5909337|NCT01603277|20444482|P2|Overall Study|Withdrawal by Subject|4
5909338|NCT01603277|20444483|P1|Overall Study|Withdrawal by Subject|5
5909339|NCT01603277|20444482|P2|Overall Study|Protocol Violation|10
5909340|NCT01603277|20444483|P1|Overall Study|Protocol Violation|6
5909341|NCT01603277|20444482|P2|Overall Study|Physician Decision|1
5909342|NCT01603277|20444483|P1|Overall Study|Physician Decision|0
5909343|NCT01603277|20444482|P2|Overall Study|Adverse Event|2
5909344|NCT01603277|20444483|P1|Overall Study|Adverse Event|1
5909345|NCT01603121|20444489|P2|Second Intervention, 10 Hours|Adverse Event|0
5909346|NCT01603121|20444490|P1|Second Intervention, 10 Hours|Adverse Event|1
5909347|NCT01603082|20444502|P2|Overall Study|Failed inclusion criterion after dosed|0
5909348|NCT01603082|20444503|P1|Overall Study|Failed inclusion criterion after dosed|1
5909349|NCT01603082|20444502|P2|Overall Study|Withdrawal by Subject|0
5909350|NCT01603082|20444503|P1|Overall Study|Withdrawal by Subject|1
5909351|NCT01603082|20444502|P2|Overall Study|Adverse Event|1
5909352|NCT01603082|20444503|P1|Overall Study|Adverse Event|0
5909353|NCT01603043|20444544|P2|Overall Study|Study Futility|3
5909354|NCT01603043|20444545|P1|Overall Study|Study Futility|7
5909355|NCT01602965|20444557|P2|Overall Study|Lost to Follow-up|2
5909356|NCT01602965|20444558|P1|Overall Study|Lost to Follow-up|4
5909357|NCT01602744|20444566|P2|Overall Study|Lost to Follow-up|8
5909358|NCT01602744|20444567|P1|Overall Study|Lost to Follow-up|13
5909359|NCT01602744|20444566|P2|Overall Study|Death|15
5909360|NCT01602744|20444567|P1|Overall Study|Death|17
5909361|NCT01602666|20444625|P2|Radiation Therapy on Protocol|In-evaluable for RT dose (24Gy)|9
5909362|NCT01602666|20444626|P1|Radiation Therapy on Protocol|In-evaluable for RT dose (24Gy)|0
5909363|NCT01602666|20444625|P2|Radiation Therapy on Protocol|In-evaluable for reduced dose(18 Gy)|14
5909364|NCT01602666|20444626|P1|Radiation Therapy on Protocol|In-evaluable for reduced dose(18 Gy)|0
5909365|NCT01602666|20444625|P2|Radiation Therapy on Protocol|In-evaluable for reduced dose(30.6 Gy)|0
5909366|NCT01602666|20444626|P1|Radiation Therapy on Protocol|In-evaluable for reduced dose(30.6 Gy)|4
5909367|NCT01602666|20444625|P2|Radiation Therapy on Protocol|Withdrawal by Subject|3
5909368|NCT01602666|20444626|P1|Radiation Therapy on Protocol|Withdrawal by Subject|2
5909369|NCT01602666|20444625|P2|Radiation Therapy on Protocol|Lost to Follow-up|5
5909370|NCT01602666|20444626|P1|Radiation Therapy on Protocol|Lost to Follow-up|4
5909371|NCT01602666|20444625|P2|Induction Chemotherapy|Radiotherapy can't be initiated in 6 wks|3
5909372|NCT01602666|20444626|P1|Induction Chemotherapy|Radiotherapy can't be initiated in 6 wks|2
5909373|NCT01602666|20444625|P2|Induction Chemotherapy|Refusal of further protocol therapy|6
5909374|NCT01602666|20444626|P1|Induction Chemotherapy|Refusal of further protocol therapy|5
5909375|NCT01602666|20444625|P2|Induction Chemotherapy|Withdrawal by Subject|2
5909376|NCT01602666|20444626|P1|Induction Chemotherapy|Withdrawal by Subject|0
5909377|NCT01602666|20444625|P2|Induction Chemotherapy|Physician Decision|5
5909378|NCT01602666|20444626|P1|Induction Chemotherapy|Physician Decision|12
5909379|NCT01602666|20444625|P2|Induction Chemotherapy|Lack of Efficacy|7
5909380|NCT01602666|20444626|P1|Induction Chemotherapy|Lack of Efficacy|16
5909381|NCT01602666|20444625|P2|Induction Chemotherapy|Death|1
5909382|NCT01602666|20444626|P1|Induction Chemotherapy|Death|2
5909383|NCT01602562|20444713|P2|Overall Study|Withdrawal by Subject|1
5909384|NCT01602562|20444714|P1|Overall Study|Withdrawal by Subject|1
5909385|NCT01602562|20444713|P2|Overall Study|Physician Decision|1
5909386|NCT01602562|20444714|P1|Overall Study|Physician Decision|1
5909387|NCT01602562|20444713|P2|Overall Study|Adverse Event|1
5909388|NCT01602562|20444714|P1|Overall Study|Adverse Event|3
5909389|NCT01602549|20444750|P2|Overall Study|Withdrawal by Subject|0
5909390|NCT01602549|20444751|P1|Overall Study|Withdrawal by Subject|1
5909391|NCT01602549|20444750|P2|Overall Study|Protocol Violation|1
5909392|NCT01602549|20444751|P1|Overall Study|Protocol Violation|0
5909393|NCT01602510|20444830|P3|Randomized Phase|Withdrawal by Subject|7
5909394|NCT01602510|20444831|P2|Randomized Phase|Withdrawal by Subject|6
5909395|NCT01602510|20444832|P1|Randomized Phase|Withdrawal by Subject|0
5909396|NCT01602510|20444830|P3|Randomized Phase|Physician Decision|2
5909397|NCT01602510|20444831|P2|Randomized Phase|Physician Decision|0
5909398|NCT01602510|20444832|P1|Randomized Phase|Physician Decision|0
5909399|NCT01602510|20444830|P3|Randomized Phase|Lost to Follow-up|3
5909400|NCT01602510|20444831|P2|Randomized Phase|Lost to Follow-up|1
5909401|NCT01602510|20444832|P1|Randomized Phase|Lost to Follow-up|0
5909402|NCT01602510|20444830|P3|Randomized Phase|Met protocol-defined stopping criteria|48
5909403|NCT01602510|20444831|P2|Randomized Phase|Met protocol-defined stopping criteria|58
5909404|NCT01602510|20444832|P1|Randomized Phase|Met protocol-defined stopping criteria|0
5909405|NCT01602510|20444830|P3|Randomized Phase|Protocol Violation|3
5909406|NCT01602510|20444831|P2|Randomized Phase|Protocol Violation|3
5909407|NCT01602510|20444832|P1|Randomized Phase|Protocol Violation|0
5909408|NCT01602510|20444830|P3|Randomized Phase|Lack of Efficacy|4
5909409|NCT01602510|20444831|P2|Randomized Phase|Lack of Efficacy|4
5909410|NCT01602510|20444832|P1|Randomized Phase|Lack of Efficacy|0
5909411|NCT01602510|20444830|P3|Randomized Phase|Adverse Event|6
5909412|NCT01602510|20444831|P2|Randomized Phase|Adverse Event|2
5909413|NCT01602510|20444832|P1|Randomized Phase|Adverse Event|0
5909414|NCT01602510|20444830|P3|Open Label Phase|Withdrawal by Subject|0
5909415|NCT01602510|20444831|P2|Open Label Phase|Withdrawal by Subject|0
5909416|NCT01602510|20444832|P1|Open Label Phase|Withdrawal by Subject|57
5909417|NCT01602510|20444830|P3|Open Label Phase|Physician Decision|0
5909418|NCT01602510|20444831|P2|Open Label Phase|Physician Decision|0
5909419|NCT01602510|20444832|P1|Open Label Phase|Physician Decision|19
5909420|NCT01602510|20444830|P3|Open Label Phase|Lost to Follow-up|0
5909421|NCT01602510|20444831|P2|Open Label Phase|Lost to Follow-up|0
5909422|NCT01602510|20444832|P1|Open Label Phase|Lost to Follow-up|22
5909423|NCT01602510|20444830|P3|Open Label Phase|Met protocol-defined stopping criteria|0
5909424|NCT01602510|20444831|P2|Open Label Phase|Met protocol-defined stopping criteria|0
5909425|NCT01602510|20444832|P1|Open Label Phase|Met protocol-defined stopping criteria|122
5909426|NCT01602510|20444830|P3|Open Label Phase|Protocol Violation|0
5909427|NCT01602510|20444831|P2|Open Label Phase|Protocol Violation|0
5909428|NCT01602510|20444832|P1|Open Label Phase|Protocol Violation|15
5909429|NCT01602510|20444830|P3|Open Label Phase|Lack of Efficacy|0
5909430|NCT01602510|20444831|P2|Open Label Phase|Lack of Efficacy|0
5909431|NCT01602510|20444832|P1|Open Label Phase|Lack of Efficacy|22
5909432|NCT01602510|20444830|P3|Open Label Phase|Adverse Event|0
5909433|NCT01602510|20444831|P2|Open Label Phase|Adverse Event|0
5909434|NCT01602510|20444832|P1|Open Label Phase|Adverse Event|46
5909435|NCT01602484|20444858|P2|Overall Study|Airway issues unrelated to study|1
5909436|NCT01602484|20444859|P1|Overall Study|Airway issues unrelated to study|0
5909437|NCT01602419|20444875|P1|Overall Study|Lost to Follow-up|6
5909438|NCT01602419|20444875|P1|Overall Study|Withdrawal by Subject|5
5909439|NCT01602419|20444875|P1|Overall Study|Treatment centre closed|1
5909440|NCT01602419|20444875|P1|Overall Study|Changed treatment centre|1
5909441|NCT01602419|20444875|P1|Overall Study|Insurance issues|3
5909442|NCT01602419|20444875|P1|Overall Study|Adverse Drug Reaction|4
5909443|NCT01602419|20444875|P1|Overall Study|Not treated with Wilate|9
5909452|NCT01602341|20444955|P2|Overall Study|Adverse Event|1
5909453|NCT01602341|20444956|P1|Overall Study|Adverse Event|0
5909454|NCT01602315|20444997|P7|Overall Study|Cross-over patients to combo treatment|0
5909455|NCT01602315|20444998|P6|Overall Study|Cross-over patients to combo treatment|16
5909456|NCT01602315|20444999|P5|Overall Study|Cross-over patients to combo treatment|0
5909457|NCT01602315|20445000|P4|Overall Study|Cross-over patients to combo treatment|0
5909458|NCT01602315|20445001|P3|Overall Study|Cross-over patients to combo treatment|0
5909459|NCT01602315|20445002|P2|Overall Study|Cross-over patients to combo treatment|0
5909460|NCT01602315|20445003|P1|Overall Study|Cross-over patients to combo treatment|0
5909461|NCT01602315|20444997|P7|Overall Study|Subject/guardian decision|1
5909462|NCT01602315|20444998|P6|Overall Study|Subject/guardian decision|0
5909463|NCT01602315|20444999|P5|Overall Study|Subject/guardian decision|0
5909464|NCT01602315|20445000|P4|Overall Study|Subject/guardian decision|0
5909465|NCT01602315|20445001|P3|Overall Study|Subject/guardian decision|0
5909466|NCT01602315|20445002|P2|Overall Study|Subject/guardian decision|0
5909467|NCT01602315|20445003|P1|Overall Study|Subject/guardian decision|0
5909468|NCT01602315|20444997|P7|Overall Study|Adverse Event|9
5909469|NCT01602315|20444998|P6|Overall Study|Adverse Event|3
5909470|NCT01602315|20444999|P5|Overall Study|Adverse Event|15
5909471|NCT01602315|20445000|P4|Overall Study|Adverse Event|4
5909472|NCT01602315|20445001|P3|Overall Study|Adverse Event|5
5909473|NCT01602315|20445002|P2|Overall Study|Adverse Event|1
5909474|NCT01602315|20445003|P1|Overall Study|Adverse Event|5
5909475|NCT01602315|20444997|P7|Overall Study|Withdrawal by Subject|1
5909476|NCT01602315|20444998|P6|Overall Study|Withdrawal by Subject|0
5909477|NCT01602315|20444999|P5|Overall Study|Withdrawal by Subject|6
5909478|NCT01602315|20445000|P4|Overall Study|Withdrawal by Subject|0
5909479|NCT01602315|20445001|P3|Overall Study|Withdrawal by Subject|2
5909480|NCT01602315|20445002|P2|Overall Study|Withdrawal by Subject|0
5909481|NCT01602315|20445003|P1|Overall Study|Withdrawal by Subject|2
5909482|NCT01602315|20444997|P7|Overall Study|Death|2
5909483|NCT01602315|20444998|P6|Overall Study|Death|2
5909484|NCT01602315|20444999|P5|Overall Study|Death|7
5909485|NCT01602315|20445000|P4|Overall Study|Death|1
5909486|NCT01602315|20445001|P3|Overall Study|Death|1
5909487|NCT01602315|20445002|P2|Overall Study|Death|1
5909488|NCT01602315|20445003|P1|Overall Study|Death|1
5909489|NCT01602315|20444997|P7|Overall Study|Disease progression|15
5909490|NCT01602315|20444998|P6|Overall Study|Disease progression|12
5909491|NCT01602315|20444999|P5|Overall Study|Disease progression|41
5909492|NCT01602315|20445000|P4|Overall Study|Disease progression|1
5909493|NCT01602315|20445001|P3|Overall Study|Disease progression|10
5909494|NCT01602315|20445002|P2|Overall Study|Disease progression|3
5909495|NCT01602315|20445003|P1|Overall Study|Disease progression|6
5909496|NCT01602315|20444997|P7|Overall Study|Physician Decision|1
5909497|NCT01602315|20444998|P6|Overall Study|Physician Decision|1
5909498|NCT01602315|20444999|P5|Overall Study|Physician Decision|2
5909499|NCT01602315|20445000|P4|Overall Study|Physician Decision|0
5909500|NCT01602315|20445001|P3|Overall Study|Physician Decision|0
5909501|NCT01602315|20445002|P2|Overall Study|Physician Decision|0
5909502|NCT01602315|20445003|P1|Overall Study|Physician Decision|2
5909503|NCT01602315|20444997|P7|Overall Study|Protocol Violation|0
5909504|NCT01602315|20444998|P6|Overall Study|Protocol Violation|1
5909505|NCT01602315|20444999|P5|Overall Study|Protocol Violation|0
5909506|NCT01602315|20445000|P4|Overall Study|Protocol Violation|0
5909507|NCT01602315|20445001|P3|Overall Study|Protocol Violation|0
5909508|NCT01602315|20445002|P2|Overall Study|Protocol Violation|0
5909509|NCT01602315|20445003|P1|Overall Study|Protocol Violation|0
5909510|NCT01602224|20445092|P3|Overall Study|Withdrawal by Subject|3
5909511|NCT01602224|20445093|P2|Overall Study|Withdrawal by Subject|3
5909512|NCT01602224|20445094|P1|Overall Study|Withdrawal by Subject|5
5909513|NCT01602224|20445092|P3|Overall Study|Sponsor Decision|2
5909514|NCT01602224|20445093|P2|Overall Study|Sponsor Decision|3
5909515|NCT01602224|20445094|P1|Overall Study|Sponsor Decision|2
5909516|NCT01602224|20445092|P3|Overall Study|Protocol Violation|0
5909517|NCT01602224|20445093|P2|Overall Study|Protocol Violation|1
5909518|NCT01602224|20445094|P1|Overall Study|Protocol Violation|0
5909519|NCT01602224|20445092|P3|Overall Study|Lost to Follow-up|1
5909520|NCT01602224|20445093|P2|Overall Study|Lost to Follow-up|0
5909521|NCT01602224|20445094|P1|Overall Study|Lost to Follow-up|0
5909522|NCT01602224|20445092|P3|Overall Study|Investigator Decison|0
5909523|NCT01602224|20445093|P2|Overall Study|Investigator Decison|0
5909524|NCT01602224|20445094|P1|Overall Study|Investigator Decison|1
5909525|NCT01602224|20445092|P3|Overall Study|Adverse Event|0
5909526|NCT01602224|20445093|P2|Overall Study|Adverse Event|1
5909527|NCT01602224|20445094|P1|Overall Study|Adverse Event|0
5909528|NCT01602120|20445179|P4|Overall Study|Unspecified Reason|2
5909529|NCT01602120|20445180|P3|Overall Study|Unspecified Reason|0
5909530|NCT01602120|20445181|P2|Overall Study|Unspecified Reason|1
5909531|NCT01602120|20445182|P1|Overall Study|Unspecified Reason|3
5909532|NCT01602120|20445179|P4|Overall Study|Physician Decision|0
5909533|NCT01602120|20445180|P3|Overall Study|Physician Decision|0
5909534|NCT01602120|20445181|P2|Overall Study|Physician Decision|3
5909535|NCT01602120|20445182|P1|Overall Study|Physician Decision|2
5909536|NCT01602120|20445179|P4|Overall Study|Study Terminated by Sponsor|44
5909537|NCT01602120|20445180|P3|Overall Study|Study Terminated by Sponsor|17
5909538|NCT01602120|20445181|P2|Overall Study|Study Terminated by Sponsor|24
5909539|NCT01602120|20445182|P1|Overall Study|Study Terminated by Sponsor|12
5909540|NCT01602120|20445179|P4|Overall Study|Withdrawal by Subject|3
5909541|NCT01602120|20445180|P3|Overall Study|Withdrawal by Subject|0
5909542|NCT01602120|20445181|P2|Overall Study|Withdrawal by Subject|17
5909543|NCT01602120|20445182|P1|Overall Study|Withdrawal by Subject|8
5909544|NCT01602120|20445179|P4|Overall Study|Non-compliance|1
5909545|NCT01602120|20445180|P3|Overall Study|Non-compliance|0
5909546|NCT01602120|20445181|P2|Overall Study|Non-compliance|3
5909547|NCT01602120|20445182|P1|Overall Study|Non-compliance|0
5909548|NCT01602120|20445179|P4|Overall Study|Protocol Violation|0
5909549|NCT01602120|20445180|P3|Overall Study|Protocol Violation|0
5909550|NCT01602120|20445181|P2|Overall Study|Protocol Violation|1
5909551|NCT01602120|20445182|P1|Overall Study|Protocol Violation|1
5909552|NCT01602120|20445179|P4|Overall Study|Lost to Follow-up|1
5909553|NCT01602120|20445180|P3|Overall Study|Lost to Follow-up|0
5909554|NCT01602120|20445181|P2|Overall Study|Lost to Follow-up|1
5909555|NCT01602120|20445182|P1|Overall Study|Lost to Follow-up|0
5909556|NCT01602120|20445179|P4|Overall Study|Death|0
5909557|NCT01602120|20445180|P3|Overall Study|Death|0
5909558|NCT01602120|20445181|P2|Overall Study|Death|4
5909559|NCT01602120|20445182|P1|Overall Study|Death|0
5909560|NCT01602120|20445179|P4|Overall Study|Adverse Event|2
5909561|NCT01602120|20445180|P3|Overall Study|Adverse Event|0
5909562|NCT01602120|20445181|P2|Overall Study|Adverse Event|6
5909563|NCT01602120|20445182|P1|Overall Study|Adverse Event|3
5909564|NCT01601873|20445230|P2|Overall Study|Lost to Follow-up|3
5909565|NCT01601873|20445231|P1|Overall Study|Lost to Follow-up|2
5909566|NCT01601847|20445257|P2|Overall Study|Lost to Follow-up|3
5909567|NCT01601847|20445258|P1|Overall Study|Lost to Follow-up|1
5909568|NCT01601847|20445257|P2|Overall Study|Withdrawal by Subject|7
5909569|NCT01601847|20445258|P1|Overall Study|Withdrawal by Subject|11
5909570|NCT01601847|20445257|P2|Overall Study|Death|0
5909571|NCT01601847|20445258|P1|Overall Study|Death|1
5909572|NCT01601821|20445270|P2|Overall Study|Other|1
5909573|NCT01601821|20445271|P1|Overall Study|Other|5
5909574|NCT01601821|20445270|P2|Overall Study|Study Events|1
5909575|NCT01601821|20445271|P1|Overall Study|Study Events|7
5909576|NCT01601821|20445270|P2|Overall Study|Graft Loss|6
5909577|NCT01601821|20445271|P1|Overall Study|Graft Loss|6
5909578|NCT01601821|20445270|P2|Overall Study|Withdrawal by Subject|0
5909579|NCT01601821|20445271|P1|Overall Study|Withdrawal by Subject|1
5909580|NCT01601821|20445270|P2|Overall Study|Lost to Follow-up|14
5909581|NCT01601821|20445271|P1|Overall Study|Lost to Follow-up|6
5909582|NCT01601821|20445270|P2|Overall Study|Protocol Violation|2
5909583|NCT01601821|20445271|P1|Overall Study|Protocol Violation|2
5909584|NCT01601821|20445270|P2|Overall Study|Death|5
5909585|NCT01601821|20445271|P1|Overall Study|Death|2
5909586|NCT01601704|20445307|P2|Overall Study|Randomized but not dispensed study med|4
5909587|NCT01601704|20445308|P1|Overall Study|Randomized but not dispensed study med|1
5909588|NCT01601652|20445326|P1|Overall Study|Death|1
5909589|NCT01601626|20445334|P3|Overall Study|Not Willing to Adhere to Requirements|0
5909590|NCT01601626|20445335|P2|Overall Study|Not Willing to Adhere to Requirements|0
5909591|NCT01601626|20445336|P1|Overall Study|Not Willing to Adhere to Requirements|1
5909592|NCT01601626|20445334|P3|Overall Study|Withdrawal by Subject|1
5909593|NCT01601626|20445335|P2|Overall Study|Withdrawal by Subject|1
5909594|NCT01601626|20445336|P1|Overall Study|Withdrawal by Subject|0
5909595|NCT01601626|20445334|P3|Overall Study|Unable to Get to Clinic|0
5909596|NCT01601626|20445335|P2|Overall Study|Unable to Get to Clinic|1
5909597|NCT01601626|20445336|P1|Overall Study|Unable to Get to Clinic|0
5909598|NCT01601626|20445334|P3|Overall Study|Lost to Follow-up|0
5909599|NCT01601626|20445335|P2|Overall Study|Lost to Follow-up|2
5909600|NCT01601626|20445336|P1|Overall Study|Lost to Follow-up|1
5909601|NCT01601626|20445334|P3|Overall Study|Death|1
5909602|NCT01601626|20445335|P2|Overall Study|Death|1
5909603|NCT01601626|20445336|P1|Overall Study|Death|1
5909604|NCT01601535|20445425|P6|Phase 2|Started Another Treatment|2
5909605|NCT01601535|20445426|P5|Phase 2|Started Another Treatment|1
5909606|NCT01601535|20445427|P4|Phase 2|Started Another Treatment|0
5909607|NCT01601535|20445428|P3|Phase 2|Started Another Treatment|0
5909608|NCT01601535|20445429|P2|Phase 2|Started Another Treatment|0
5909609|NCT01601535|20445430|P1|Phase 2|Started Another Treatment|0
5909610|NCT01601535|20445425|P6|Phase 2|Progressive Disease|7
5909611|NCT01601535|20445426|P5|Phase 2|Progressive Disease|5
5909612|NCT01601535|20445427|P4|Phase 2|Progressive Disease|0
5909613|NCT01601535|20445428|P3|Phase 2|Progressive Disease|0
5909614|NCT01601535|20445429|P2|Phase 2|Progressive Disease|0
5909615|NCT01601535|20445430|P1|Phase 2|Progressive Disease|0
5909616|NCT01601535|20445425|P6|Phase 2|Withdrawal by Subject|2
5909617|NCT01601535|20445426|P5|Phase 2|Withdrawal by Subject|8
5909618|NCT01601535|20445427|P4|Phase 2|Withdrawal by Subject|0
5909619|NCT01601535|20445428|P3|Phase 2|Withdrawal by Subject|0
5909620|NCT01601535|20445429|P2|Phase 2|Withdrawal by Subject|0
5909621|NCT01601535|20445430|P1|Phase 2|Withdrawal by Subject|0
5909622|NCT01601535|20445425|P6|Phase 2|Adverse Event|1
5909623|NCT01601535|20445426|P5|Phase 2|Adverse Event|5
5909624|NCT01601535|20445427|P4|Phase 2|Adverse Event|0
5909625|NCT01601535|20445428|P3|Phase 2|Adverse Event|0
5909626|NCT01601535|20445429|P2|Phase 2|Adverse Event|0
5909627|NCT01601535|20445430|P1|Phase 2|Adverse Event|0
5909628|NCT01601535|20445425|P6|Phase 1|Started Another Treatment|0
5909629|NCT01601535|20445426|P5|Phase 1|Started Another Treatment|0
5909630|NCT01601535|20445427|P4|Phase 1|Started Another Treatment|0
5909631|NCT01601535|20445428|P3|Phase 1|Started Another Treatment|0
5909632|NCT01601535|20445429|P2|Phase 1|Started Another Treatment|2
5909633|NCT01601535|20445430|P1|Phase 1|Started Another Treatment|1
5909634|NCT01601535|20445425|P6|Phase 1|Progressive Disease|0
5909635|NCT01601535|20445426|P5|Phase 1|Progressive Disease|0
5909636|NCT01601535|20445427|P4|Phase 1|Progressive Disease|1
5909637|NCT01601535|20445428|P3|Phase 1|Progressive Disease|2
5909638|NCT01601535|20445429|P2|Phase 1|Progressive Disease|3
5909639|NCT01601535|20445430|P1|Phase 1|Progressive Disease|2
5909640|NCT01601535|20445425|P6|Phase 1|Withdrawal by Subject|0
5909641|NCT01601535|20445426|P5|Phase 1|Withdrawal by Subject|0
5909642|NCT01601535|20445427|P4|Phase 1|Withdrawal by Subject|2
5909643|NCT01601535|20445428|P3|Phase 1|Withdrawal by Subject|1
5909644|NCT01601535|20445429|P2|Phase 1|Withdrawal by Subject|1
5909645|NCT01601535|20445430|P1|Phase 1|Withdrawal by Subject|2
5909646|NCT01601535|20445425|P6|Phase 1|Adverse Event|0
5909647|NCT01601535|20445426|P5|Phase 1|Adverse Event|0
5909648|NCT01601535|20445427|P4|Phase 1|Adverse Event|1
5909649|NCT01601535|20445428|P3|Phase 1|Adverse Event|2
5909650|NCT01601535|20445429|P2|Phase 1|Adverse Event|0
5909651|NCT01601535|20445430|P1|Phase 1|Adverse Event|1
5909652|NCT01601496|20445486|P1|Overall Study|Other: patient refusal to continue|3
5909653|NCT01601496|20445486|P1|Overall Study|Death|4
5909654|NCT01601496|20445486|P1|Overall Study|Lost to Follow-up|6
5909655|NCT01601496|20445486|P1|Overall Study|Withdrawal by Subject|1
5909656|NCT01601496|20445486|P1|Overall Study|Physician Decision|1
5909657|NCT01601470|20445494|P1|Period 2 - LCZ696|Physician Decision|1
5909658|NCT01601132|20445565|P1|Overall Study|Protocol deviation|1
5909659|NCT01601132|20445565|P1|Overall Study|Patient withdrew consent|1
5909660|NCT01600885|20445610|P2|First Period|moved out of area|0
5909661|NCT01600885|20445611|P1|First Period|moved out of area|1
5909662|NCT01600885|20445610|P2|First Period|Adverse Event|1
5909663|NCT01600885|20445611|P1|First Period|Adverse Event|1
5909664|NCT01600716|20445628|P2|Overall Study|Adverse Event|1
5909665|NCT01600716|20445629|P1|Overall Study|Adverse Event|1
5909666|NCT01600716|20445628|P2|Overall Study|Lack of Efficacy|1
5909667|NCT01600716|20445629|P1|Overall Study|Lack of Efficacy|2
5909668|NCT01600716|20445628|P2|Overall Study|Pregnancy|0
5909669|NCT01600716|20445629|P1|Overall Study|Pregnancy|1
5909670|NCT01600716|20445628|P2|Overall Study|Lost to Follow-up|2
5909671|NCT01600716|20445629|P1|Overall Study|Lost to Follow-up|0
5909672|NCT01600716|20445628|P2|Overall Study|Personal Reasons|2
5909673|NCT01600716|20445629|P1|Overall Study|Personal Reasons|0
5909674|NCT01600716|20445628|P2|Overall Study|Other Reasons|1
5909675|NCT01600716|20445629|P1|Overall Study|Other Reasons|3
5909676|NCT01600586|20445677|P2|Overall Study|Physician Decision|3
5909677|NCT01600586|20445678|P1|Overall Study|Physician Decision|3
5909678|NCT01600326|20445730|P2|Overall Study|Lost to Follow-up|1
5909679|NCT01600326|20445731|P1|Overall Study|Lost to Follow-up|1
5909680|NCT01600105|20445832|P2|Sub Study V|Poor Image Quality|0
5909681|NCT01600105|20445833|P1|Sub Study V|Poor Image Quality|2
5909682|NCT01600105|20445832|P2|Sub Study III|Insufficient image quality|0
5909683|NCT01600105|20445833|P1|Sub Study III|Insufficient image quality|5
5909684|NCT01600105|20445832|P2|Sub Study II|Insufficient image quality|0
5909685|NCT01600105|20445833|P1|Sub Study II|Insufficient image quality|3
5909686|NCT01600105|20445832|P2|Sub Study II|No images in PACS|0
5909687|NCT01600105|20445833|P1|Sub Study II|No images in PACS|1
5909688|NCT01600105|20445832|P2|Sub Study II|Withdrawal by Subject|0
5909689|NCT01600105|20445833|P1|Sub Study II|Withdrawal by Subject|1
5909690|NCT01600105|20445832|P2|Sub Study I|Insufficient image quality|10
5909691|NCT01600105|20445833|P1|Sub Study I|Insufficient image quality|0
5909692|NCT01600105|20445832|P2|Total Participants|Insufficient image quality|10
5909693|NCT01600105|20445833|P1|Total Participants|Insufficient image quality|30
5909694|NCT01600105|20445832|P2|Total Participants|No images in PACS|0
5909695|NCT01600105|20445833|P1|Total Participants|No images in PACS|10
5909696|NCT01600105|20445832|P2|Total Participants|Withdrawal by Subject|0
5909697|NCT01600105|20445833|P1|Total Participants|Withdrawal by Subject|1
5909698|NCT01600092|20445861|P2|Overall Study|Randomized but not vaccinated|3
5909699|NCT01600092|20445862|P1|Overall Study|Randomized but not vaccinated|3
5909700|NCT01600092|20445861|P2|Overall Study|Physician Decision|1
5909701|NCT01600092|20445862|P1|Overall Study|Physician Decision|1
5909702|NCT01600092|20445861|P2|Overall Study|Withdrawal by parent/guardian|6
5909703|NCT01600092|20445862|P1|Overall Study|Withdrawal by parent/guardian|8
5909704|NCT01600092|20445861|P2|Overall Study|Lost to Follow-up|6
5909705|NCT01600092|20445862|P1|Overall Study|Lost to Follow-up|4
5909706|NCT01600092|20445861|P2|Overall Study|Adverse Event|0
5909707|NCT01600092|20445862|P1|Overall Study|Adverse Event|2
5909708|NCT01600053|20445876|P1|Overall Study|trial will not meet the interim endpoint|9
5909709|NCT01600053|20445876|P1|Overall Study|Adverse Event|2
5909710|NCT01600014|20445881|P2|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|0
5909711|NCT01600014|20445882|P1|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|1
5909712|NCT01600014|20445881|P2|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|0
5909713|NCT01600014|20445882|P1|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|1
5909714|NCT01600014|20445881|P2|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|0
5909715|NCT01600014|20445882|P1|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|1
5909716|NCT01600014|20445881|P2|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|3
5909717|NCT01600014|20445882|P1|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|1
5909718|NCT01600014|20445881|P2|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1
5909719|NCT01600014|20445882|P1|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1
5909720|NCT01600014|20445881|P2|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|0
5909721|NCT01600014|20445882|P1|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|5
5909722|NCT01600014|20445881|P2|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|0
5909723|NCT01600014|20445882|P1|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|1
5909724|NCT01600014|20445881|P2|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|1
5909725|NCT01600014|20445882|P1|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|2
5909726|NCT01600014|20445881|P2|2. Cycle Recalcitrant Subgroup W8 to W52|Other|3
5909727|NCT01600014|20445882|P1|2. Cycle Recalcitrant Subgroup W8 to W52|Other|1
5909728|NCT01600014|20445881|P2|2. Cycle Recalcitrant Subgroup W8 to W52|Death|2
5909729|NCT01600014|20445882|P1|2. Cycle Recalcitrant Subgroup W8 to W52|Death|1
5909730|NCT01600014|20445881|P2|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|0
5909731|NCT01600014|20445882|P1|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|8
5909732|NCT01600014|20445881|P2|1. Cycle & Observation Period D1 to W52|Protocol Violation|0
5909733|NCT01600014|20445882|P1|1. Cycle & Observation Period D1 to W52|Protocol Violation|6
5909734|NCT01600014|20445881|P2|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|0
5909735|NCT01600014|20445882|P1|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|14
5909736|NCT01600014|20445881|P2|1. Cycle & Observation Period D1 to W52|Other|0
5909737|NCT01600014|20445882|P1|1. Cycle & Observation Period D1 to W52|Other|27
5909738|NCT01600014|20445881|P2|1. Cycle & Observation Period D1 to W52|Adverse Event|0
5909739|NCT01600014|20445882|P1|1. Cycle & Observation Period D1 to W52|Adverse Event|6
5909740|NCT01600014|20445881|P2|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|0
5909741|NCT01600014|20445882|P1|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|203
5909742|NCT01600014|20445881|P2|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|0
5909743|NCT01600014|20445882|P1|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|24
5909744|NCT01599806|20445910|P2|Overall Study|Other Eligibility criteria|9
5909745|NCT01599806|20445911|P1|Overall Study|Other Eligibility criteria|11
5909746|NCT01599806|20445910|P2|Overall Study|Withdrawal by Subject|12
5909747|NCT01599806|20445911|P1|Overall Study|Withdrawal by Subject|12
5909748|NCT01599806|20445910|P2|Overall Study|Lost to Follow-up|20
5909749|NCT01599806|20445911|P1|Overall Study|Lost to Follow-up|20
5909750|NCT01599793|20446035|P1|Overall Study|Adverse Event|2
5909751|NCT01599754|20446047|P2|Overall Study|Study terminated by sponsor|285
5909752|NCT01599754|20446048|P1|Overall Study|Study terminated by sponsor|282
5909753|NCT01599754|20446047|P2|Overall Study|Withdrawal by Subject|25
5909754|NCT01599754|20446048|P1|Overall Study|Withdrawal by Subject|24
5909755|NCT01599754|20446047|P2|Overall Study|Investigator decision|3
5909756|NCT01599754|20446048|P1|Overall Study|Investigator decision|1
5909757|NCT01599754|20446047|P2|Overall Study|Adverse Event|2
5909758|NCT01599754|20446048|P1|Overall Study|Adverse Event|3
5909759|NCT01599754|20446047|P2|Overall Study|Death|33
5909760|NCT01599754|20446048|P1|Overall Study|Death|31
5909761|NCT01599754|20446047|P2|Overall Study|Lost to Follow-up|6
5909762|NCT01599754|20446048|P1|Overall Study|Lost to Follow-up|13
5909763|NCT01599754|20446047|P2|Overall Study|Participant noncompliance|4
5909764|NCT01599754|20446048|P1|Overall Study|Participant noncompliance|4
5909765|NCT01599754|20446047|P2|Overall Study|Anticancer therapy need not in protocol|2
5909766|NCT01599754|20446048|P1|Overall Study|Anticancer therapy need not in protocol|5
5909767|NCT01599650|20446079|P3|Overall Study|Adverse Event|4
5909768|NCT01599650|20446080|P2|Overall Study|Adverse Event|8
5909769|NCT01599650|20446081|P1|Overall Study|Adverse Event|3
5909770|NCT01599650|20446079|P3|Overall Study|Withdrawal by Subject|10
5909771|NCT01599650|20446080|P2|Overall Study|Withdrawal by Subject|11
5909772|NCT01599650|20446081|P1|Overall Study|Withdrawal by Subject|11
5909773|NCT01599650|20446079|P3|Overall Study|Lost to Follow-up|3
5909774|NCT01599650|20446080|P2|Overall Study|Lost to Follow-up|3
5909775|NCT01599650|20446081|P1|Overall Study|Lost to Follow-up|3
5909776|NCT01599650|20446079|P3|Overall Study|Death|2
5909777|NCT01599650|20446080|P2|Overall Study|Death|1
5909778|NCT01599650|20446081|P1|Overall Study|Death|2
5909779|NCT01599650|20446079|P3|Overall Study|Protocol Violation|0
5909780|NCT01599650|20446080|P2|Overall Study|Protocol Violation|3
5909781|NCT01599650|20446081|P1|Overall Study|Protocol Violation|0
5909782|NCT01599650|20446079|P3|Overall Study|Physician Decision|7
5909783|NCT01599650|20446080|P2|Overall Study|Physician Decision|0
5909784|NCT01599650|20446081|P1|Overall Study|Physician Decision|2
5909785|NCT01599650|20446079|P3|Overall Study|Administrative issue|1
5909786|NCT01599650|20446080|P2|Overall Study|Administrative issue|0
5909787|NCT01599650|20446081|P1|Overall Study|Administrative issue|1
5909788|NCT01599637|20446120|P3|Overall Study|Adverse Event|0
5909789|NCT01599637|20446121|P2|Overall Study|Adverse Event|0
5909790|NCT01599637|20446122|P1|Overall Study|Adverse Event|1
5909791|NCT01599637|20446120|P3|Overall Study|administrative problems|0
5909792|NCT01599637|20446121|P2|Overall Study|administrative problems|2
5909793|NCT01599637|20446122|P1|Overall Study|administrative problems|0
5909794|NCT01599585|20446169|P2|Overall Study|randomized did not start treatment|3
5909795|NCT01599585|20446170|P1|Overall Study|randomized did not start treatment|3
5909796|NCT01599585|20446169|P2|Overall Study|Lost to Follow-up|5
5909797|NCT01599585|20446170|P1|Overall Study|Lost to Follow-up|3
5909798|NCT01599585|20446169|P2|Overall Study|Withdrawal by Subject|9
5909799|NCT01599585|20446170|P1|Overall Study|Withdrawal by Subject|16
5909800|NCT01599325|20446208|P1|Extension Phase|Withdrawal by Subject|8
5909801|NCT01599325|20446208|P1|Extension Phase|Disease Progression|1
5909802|NCT01599325|20446208|P1|Extension Phase|Lack of Therapeutic Effect|4
5909803|NCT01599325|20446208|P1|Extension Phase|Stopped to Receive Stem Cell Transplant|1
5909804|NCT01599325|20446208|P1|Extension Phase|Study Closure|1
5909805|NCT01599325|20446208|P1|Primary Parent Phase|Other|2
5909806|NCT01599325|20446208|P1|Primary Parent Phase|Lack of Therapeutic Effect|9
5909807|NCT01599325|20446208|P1|Primary Parent Phase|Protocol Violation|1
5909808|NCT01599325|20446208|P1|Primary Parent Phase|Death|13
5909809|NCT01599325|20446208|P1|Primary Parent Phase|Withdrawal by Subject|20
5909810|NCT01599325|20446208|P1|Primary Parent Phase|Disease Progression|7
5909811|NCT01599325|20446208|P1|Primary Parent Phase|Adverse Event|5
5909812|NCT01599234|20446232|P2|Overall Study|Pregnancy|1
5909813|NCT01599234|20446233|P1|Overall Study|Pregnancy|0
5909814|NCT01599234|20446232|P2|Overall Study|Contra-indication discovered|1
5909815|NCT01599234|20446233|P1|Overall Study|Contra-indication discovered|0
5909816|NCT01599234|20446232|P2|Overall Study|Patient would not stop driving|0
5909817|NCT01599234|20446233|P1|Overall Study|Patient would not stop driving|1
5909818|NCT01599234|20446232|P2|Overall Study|Death|0
5909819|NCT01599234|20446233|P1|Overall Study|Death|1
5909820|NCT01599234|20446232|P2|Overall Study|Sponsor request as creatinine levels <50|1
5909821|NCT01599234|20446233|P1|Overall Study|Sponsor request as creatinine levels <50|0
5909822|NCT01599234|20446232|P2|Overall Study|Unable to operate spray|0
5909823|NCT01599234|20446233|P1|Overall Study|Unable to operate spray|1
5909824|NCT01599234|20446232|P2|Overall Study|Lack of Efficacy|4
5909825|NCT01599234|20446233|P1|Overall Study|Lack of Efficacy|2
5909826|NCT01599234|20446232|P2|Overall Study|Lost to Follow-up|2
5909827|NCT01599234|20446233|P1|Overall Study|Lost to Follow-up|1
5909828|NCT01599234|20446232|P2|Overall Study|Withdrawal by Subject|1
5909829|NCT01599234|20446233|P1|Overall Study|Withdrawal by Subject|2
5909830|NCT01599234|20446232|P2|Overall Study|Adverse Event|5
5909831|NCT01599234|20446233|P1|Overall Study|Adverse Event|9
5909832|NCT01599104|20446258|P3|Overall Study|Adverse Event|12
5909833|NCT01599104|20446259|P2|Overall Study|Adverse Event|6
5909834|NCT01599104|20446260|P1|Overall Study|Adverse Event|7
5909835|NCT01599104|20446258|P3|Overall Study|Lack of Efficacy|10
5909836|NCT01599104|20446259|P2|Overall Study|Lack of Efficacy|4
5909837|NCT01599104|20446260|P1|Overall Study|Lack of Efficacy|4
5909838|NCT01599104|20446258|P3|Overall Study|Non-compliance with study treatment|0
5909839|NCT01599104|20446259|P2|Overall Study|Non-compliance with study treatment|1
5909840|NCT01599104|20446260|P1|Overall Study|Non-compliance with study treatment|0
5909841|NCT01599104|20446258|P3|Overall Study|Physician Decision|2
5909842|NCT01599104|20446259|P2|Overall Study|Physician Decision|2
5909843|NCT01599104|20446260|P1|Overall Study|Physician Decision|3
5909844|NCT01599104|20446258|P3|Overall Study|Technical Problems|0
5909845|NCT01599104|20446259|P2|Overall Study|Technical Problems|0
5909846|NCT01599104|20446260|P1|Overall Study|Technical Problems|1
5909847|NCT01599104|20446258|P3|Overall Study|Withdrawal by Subject|2
5909848|NCT01599104|20446259|P2|Overall Study|Withdrawal by Subject|1
5909849|NCT01599104|20446260|P1|Overall Study|Withdrawal by Subject|1
5909850|NCT01598987|20446298|P1|Baseline to 24 Month|Lost to Follow-up|1
5909851|NCT01598987|20446298|P1|Baseline to 24 Month|Administrative problems|2
5909852|NCT01598987|20446298|P1|Baseline to 24 Month|Withdrawal by Subject|5
5909853|NCT01598987|20446298|P1|Baseline to Month 12|Withdrawal by Subject|4
5909854|NCT01598987|20446298|P1|Baseline to Month 12|Administrative problems|2
5909855|NCT01598896|20446357|P2|Overall Study|Lack of Efficacy|1
5909856|NCT01598896|20446358|P1|Overall Study|Lack of Efficacy|0
5909857|NCT01598896|20446357|P2|Overall Study|Withdrawal by Subject|1
5909858|NCT01598896|20446358|P1|Overall Study|Withdrawal by Subject|0
5909859|NCT01598753|20446397|P4|Overall Study|Withdrawal by Subject|1
5909860|NCT01598753|20446398|P3|Overall Study|Withdrawal by Subject|0
5909861|NCT01598753|20446399|P2|Overall Study|Withdrawal by Subject|2
5909862|NCT01598753|20446400|P1|Overall Study|Withdrawal by Subject|7
5909863|NCT01598753|20446397|P4|Overall Study|Physician Decision|2
5909864|NCT01598753|20446398|P3|Overall Study|Physician Decision|0
5909865|NCT01598753|20446399|P2|Overall Study|Physician Decision|1
5909866|NCT01598753|20446400|P1|Overall Study|Physician Decision|0
5909867|NCT01598753|20446397|P4|Overall Study|Lost to Follow-up|5
5909868|NCT01598753|20446398|P3|Overall Study|Lost to Follow-up|7
5909869|NCT01598753|20446399|P2|Overall Study|Lost to Follow-up|3
5909870|NCT01598753|20446400|P1|Overall Study|Lost to Follow-up|4
5909871|NCT01598753|20446397|P4|Overall Study|Adverse Event|7
5909872|NCT01598753|20446398|P3|Overall Study|Adverse Event|1
5909873|NCT01598753|20446399|P2|Overall Study|Adverse Event|9
5909874|NCT01598753|20446400|P1|Overall Study|Adverse Event|1
5909875|NCT01598662|20446440|P2|Overall Study|IUD expelled before month 6|2
5909876|NCT01598662|20446441|P1|Overall Study|IUD expelled before month 6|0
5909877|NCT01598662|20446440|P2|Overall Study|Physician Decision|2
5909878|NCT01598662|20446441|P1|Overall Study|Physician Decision|1
5909879|NCT01598662|20446440|P2|Overall Study|Lost to Follow-up|17
5909880|NCT01598662|20446441|P1|Overall Study|Lost to Follow-up|10
5909881|NCT01598610|20446447|P1|Overall Study|Adverse Event|1
5909882|NCT01598532|20446464|P1|Overall Study|Did not meet inclusion criteria|8
5909883|NCT01598532|20446464|P1|Overall Study|Lost to Follow-up|3
5909884|NCT01598506|20446473|P1|Overall Study|Withdrawal by Subject|2
5909885|NCT01598311|20446493|P2|Overall Study|Assigned to CB but received vancomycin|0
5909886|NCT01598311|20446494|P1|Overall Study|Assigned to CB but received vancomycin|1
5909887|NCT01598311|20446493|P2|Overall Study|Treated but no confirmed CDAD|8
5909888|NCT01598311|20446494|P1|Overall Study|Treated but no confirmed CDAD|9
5909889|NCT01598311|20446493|P2|Overall Study|Randomized but never treated|5
5909890|NCT01598311|20446494|P1|Overall Study|Randomized but never treated|8
5909891|NCT01598311|20446493|P2|Overall Study|No reason provided.|5
5909892|NCT01598311|20446494|P1|Overall Study|No reason provided.|0
5909893|NCT01598311|20446493|P2|Overall Study|Withdrawal by Subject|13
5909894|NCT01598311|20446494|P1|Overall Study|Withdrawal by Subject|9
5909895|NCT01598311|20446493|P2|Overall Study|Lost to Follow-up|12
5909896|NCT01598311|20446494|P1|Overall Study|Lost to Follow-up|7
5909897|NCT01598311|20446493|P2|Overall Study|Adverse Event|13
5909898|NCT01598311|20446494|P1|Overall Study|Adverse Event|9
5909899|NCT01598311|20446493|P2|Overall Study|Physician Decision|5
5909900|NCT01598311|20446494|P1|Overall Study|Physician Decision|4
5909901|NCT01598298|20446510|P2|Overall Study|Other reason (not protocol specified)|0
5909902|NCT01598298|20446511|P1|Overall Study|Other reason (not protocol specified)|4
5909903|NCT01598298|20446510|P2|Overall Study|Withdrawal by Subject|15
5909904|NCT01598298|20446511|P1|Overall Study|Withdrawal by Subject|10
5909905|NCT01598298|20446510|P2|Overall Study|Progression/relapse|2
5909906|NCT01598298|20446511|P1|Overall Study|Progression/relapse|0
5909907|NCT01598298|20446510|P2|Overall Study|Adverse Event|19
5909908|NCT01598298|20446511|P1|Overall Study|Adverse Event|21
5909909|NCT01598298|20446510|P2|Overall Study|Not eligible|5
5909910|NCT01598298|20446511|P1|Overall Study|Not eligible|5
5909911|NCT01598129|20446555|P1|Overall Study|Withdrawal by Subject|1
5909912|NCT01598129|20446555|P1|Overall Study|Deterioration of WHO status to WHO 4|2
5909913|NCT01598129|20446555|P1|Overall Study|Disease progression|6
5909914|NCT01598090|20446567|P3|Follow-up Period|Lost to Follow-up|12
5909915|NCT01598090|20446568|P2|Follow-up Period|Lost to Follow-up|10
5909916|NCT01598090|20446569|P1|Follow-up Period|Lost to Follow-up|2
5909917|NCT01598090|20446567|P3|Follow-up Period|Other reasons|8
5909918|NCT01598090|20446568|P2|Follow-up Period|Other reasons|8
5909919|NCT01598090|20446569|P1|Follow-up Period|Other reasons|2
5909920|NCT01598090|20446567|P3|Follow-up Period|Withdrawal by Subject|2
5909921|NCT01598090|20446568|P2|Follow-up Period|Withdrawal by Subject|3
5909922|NCT01598090|20446569|P1|Follow-up Period|Withdrawal by Subject|0
5909923|NCT01598090|20446567|P3|Follow-up Period|Not reported|4
5909924|NCT01598090|20446568|P2|Follow-up Period|Not reported|10
5909925|NCT01598090|20446569|P1|Follow-up Period|Not reported|0
5909926|NCT01598090|20446567|P3|Follow-up Period|No longer required per protocol|2
5909927|NCT01598090|20446568|P2|Follow-up Period|No longer required per protocol|3
5909928|NCT01598090|20446569|P1|Follow-up Period|No longer required per protocol|1
5909929|NCT01598090|20446567|P3|Follow-up Period|Death|0
5909930|NCT01598090|20446568|P2|Follow-up Period|Death|1
5909931|NCT01598090|20446569|P1|Follow-up Period|Death|0
5909932|NCT01598090|20446567|P3|Treatment Period|Lost to Follow-up|1
5909933|NCT01598090|20446568|P2|Treatment Period|Lost to Follow-up|5
5909934|NCT01598090|20446569|P1|Treatment Period|Lost to Follow-up|1
5909935|NCT01598090|20446567|P3|Treatment Period|Withdrawal by Subject|10
5909936|NCT01598090|20446568|P2|Treatment Period|Withdrawal by Subject|13
5909937|NCT01598090|20446569|P1|Treatment Period|Withdrawal by Subject|3
5909938|NCT01598090|20446567|P3|Treatment Period|Other reasons|1
5909939|NCT01598090|20446568|P2|Treatment Period|Other reasons|4
5909940|NCT01598090|20446569|P1|Treatment Period|Other reasons|0
5909941|NCT01598090|20446567|P3|Treatment Period|Adverse Event|17
5909942|NCT01598090|20446568|P2|Treatment Period|Adverse Event|33
5909943|NCT01598090|20446569|P1|Treatment Period|Adverse Event|2
5909944|NCT01598090|20446567|P3|Treatment Period|Lack of Efficacy|6
5909945|NCT01598090|20446568|P2|Treatment Period|Lack of Efficacy|14
5909946|NCT01598090|20446569|P1|Treatment Period|Lack of Efficacy|5
5909947|NCT01598090|20446567|P3|Treatment Period|No longer meet study criteria|0
5909948|NCT01598090|20446568|P2|Treatment Period|No longer meet study criteria|1
5909949|NCT01598090|20446569|P1|Treatment Period|No longer meet study criteria|0
5909950|NCT01598090|20446567|P3|Treatment Period|Poor/non-compliance|0
5909951|NCT01598090|20446568|P2|Treatment Period|Poor/non-compliance|2
5909952|NCT01598090|20446569|P1|Treatment Period|Poor/non-compliance|0
5909963|NCT01597791|20446663|P2|Overall Study|Protocol Violation|1
5909964|NCT01597791|20446664|P1|Overall Study|Protocol Violation|0
5909965|NCT01597791|20446663|P2|Overall Study|Subject withdrawal|1
5909966|NCT01597791|20446664|P1|Overall Study|Subject withdrawal|0
5909967|NCT01597791|20446663|P2|Overall Study|Cesarean Section|7
5909968|NCT01597791|20446664|P1|Overall Study|Cesarean Section|6
5909969|NCT01597791|20446663|P2|Overall Study|Physician Decision|1
5909970|NCT01597791|20446664|P1|Overall Study|Physician Decision|2
5909971|NCT01597635|20446751|P3|Part B|Withdrawal by Subject|0
5909972|NCT01597635|20446752|P2|Part B|Withdrawal by Subject|1
5909973|NCT01597635|20446753|P1|Part B|Withdrawal by Subject|0
5909974|NCT01597635|20446751|P3|Part B|Protocol-defined stopping criteria|3
5909975|NCT01597635|20446752|P2|Part B|Protocol-defined stopping criteria|4
5909976|NCT01597635|20446753|P1|Part B|Protocol-defined stopping criteria|0
5909977|NCT01597635|20446751|P3|Part B|Protocol Violation|0
5909978|NCT01597635|20446752|P2|Part B|Protocol Violation|1
5909979|NCT01597635|20446753|P1|Part B|Protocol Violation|0
5909980|NCT01597635|20446751|P3|Part B|Adverse Event|1
5909981|NCT01597635|20446752|P2|Part B|Adverse Event|0
5909982|NCT01597635|20446753|P1|Part B|Adverse Event|0
5909983|NCT01597635|20446751|P3|Part A|Adverse Event|0
5909984|NCT01597635|20446752|P2|Part A|Adverse Event|0
5909985|NCT01597635|20446753|P1|Part A|Adverse Event|3
5909986|NCT01597622|20446816|P1|Overall Study|Death|1
5909987|NCT01597622|20446816|P1|Overall Study|Withdrawal by Subject|20
5909988|NCT01597622|20446816|P1|Overall Study|Investigator Discretion|5
5909989|NCT01597622|20446816|P1|Overall Study|Lost to Follow-up|1
5909990|NCT01597622|20446816|P1|Overall Study|Protocol Violation|1
5909991|NCT01597622|20446816|P1|Overall Study|Lack of Efficacy|3
5909992|NCT01597622|20446816|P1|Overall Study|Adverse Event|7
5909993|NCT01597596|20446823|P2|Overall Study|Physician Decision|1
5909994|NCT01597596|20446824|P1|Overall Study|Physician Decision|0
5909995|NCT01597596|20446823|P2|Overall Study|Study terminated by sponsor|0
5909996|NCT01597596|20446824|P1|Overall Study|Study terminated by sponsor|1
5909997|NCT01597557|20446838|P2|Overall Study|Did not undergo cardioversion procedure|3
5909998|NCT01597557|20446839|P1|Overall Study|Did not undergo cardioversion procedure|4
5909999|NCT01597505|20446851|P2|Overall Study|Missing|0
5910000|NCT01597505|20446852|P1|Overall Study|Missing|1
5910001|NCT01597505|20446851|P2|Overall Study|Other|6
5910002|NCT01597505|20446852|P1|Overall Study|Other|5
5910003|NCT01597505|20446851|P2|Overall Study|Withdrawal by Subject|18
5910004|NCT01597505|20446852|P1|Overall Study|Withdrawal by Subject|10
5910005|NCT01597505|20446851|P2|Overall Study|Lost to Follow-up|2
5910006|NCT01597505|20446852|P1|Overall Study|Lost to Follow-up|4
5910007|NCT01597505|20446851|P2|Overall Study|Adverse Event|7
5910008|NCT01597505|20446852|P1|Overall Study|Adverse Event|19
5910009|NCT01597505|20446851|P2|Overall Study|Physician Decision|0
5910010|NCT01597505|20446852|P1|Overall Study|Physician Decision|5
5910011|NCT01597492|20446886|P2|Overall Study|Other Reason|0
5910012|NCT01597492|20446887|P1|Overall Study|Other Reason|2
5910013|NCT01597492|20446886|P2|Overall Study|Lost to Follow-up|2
5910014|NCT01597492|20446887|P1|Overall Study|Lost to Follow-up|0
5910015|NCT01597492|20446886|P2|Overall Study|Adverse Event|0
5910016|NCT01597492|20446887|P1|Overall Study|Adverse Event|3
5910017|NCT01597492|20446886|P2|Overall Study|Withdrawal by Subject|2
5910018|NCT01597492|20446887|P1|Overall Study|Withdrawal by Subject|1
5910019|NCT01597479|20446895|P2|Overall Study|Lost to Follow-up|0
5910020|NCT01597479|20446896|P1|Overall Study|Lost to Follow-up|1
5910021|NCT01597479|20446895|P2|Overall Study|Protocol Violation|0
5910022|NCT01597479|20446896|P1|Overall Study|Protocol Violation|1
5910023|NCT01597375|20447182|P2|Second Intervention|Failed to react at both Aspirin|1
5910024|NCT01597375|20447183|P1|Second Intervention|Failed to react at both Aspirin|1
5910025|NCT01597375|20447182|P2|Washout (2 Weeks)|Adverse Event|0
5910026|NCT01597375|20447183|P1|Washout (2 Weeks)|Adverse Event|1
5910027|NCT01597375|20447182|P2|First Intervention (4 Weeks)|Lost to Follow-up|1
5910028|NCT01597375|20447183|P1|First Intervention (4 Weeks)|Lost to Follow-up|0
5910029|NCT01597375|20447182|P2|First Intervention (4 Weeks)|Needed surgery|0
5910030|NCT01597375|20447183|P1|First Intervention (4 Weeks)|Needed surgery|1
5910031|NCT01597375|20447182|P2|First Intervention (4 Weeks)|Uncontrolled Asthma|0
5910032|NCT01597375|20447183|P1|First Intervention (4 Weeks)|Uncontrolled Asthma|1
5910033|NCT01597258|20447200|P1|Overall Study|No Drug Administration|1
5910034|NCT01597245|20447209|P21|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
5910035|NCT01597245|20447210|P20|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|1
5910036|NCT01597245|20447211|P19|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
5910037|NCT01597245|20447212|P18|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
5910038|NCT01597245|20447213|P17|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
5910039|NCT01597245|20447214|P16|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
5910040|NCT01597245|20447215|P15|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
5910041|NCT01597245|20447216|P14|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
5910042|NCT01597245|20447217|P13|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
5910043|NCT01597245|20447218|P12|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
5910044|NCT01597245|20447219|P11|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
5910045|NCT01597245|20447220|P10|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
5910046|NCT01597245|20447221|P9|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
5910047|NCT01597245|20447222|P8|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
5910048|NCT01597245|20447223|P7|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
5910049|NCT01597245|20447224|P6|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
5910050|NCT01597245|20447225|P5|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
5910051|NCT01597245|20447226|P4|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
5910052|NCT01597245|20447227|P3|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
5910053|NCT01597245|20447228|P2|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
5910054|NCT01597245|20447229|P1|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
5910055|NCT01597245|20447209|P21|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
5910056|NCT01597245|20447210|P20|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|1
5910057|NCT01597245|20447211|P19|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
5910058|NCT01597245|20447212|P18|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
5910059|NCT01597245|20447213|P17|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|1
5910060|NCT01597245|20447214|P16|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
5910061|NCT01597245|20447215|P15|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
5910062|NCT01597245|20447216|P14|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
5910063|NCT01597245|20447217|P13|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
5910064|NCT01597245|20447218|P12|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
5910065|NCT01597245|20447219|P11|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
5910066|NCT01597245|20447220|P10|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
5910067|NCT01597245|20447221|P9|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
5910068|NCT01597245|20447222|P8|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
5910069|NCT01597245|20447223|P7|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
5910070|NCT01597245|20447224|P6|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
5910071|NCT01597245|20447225|P5|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
5910072|NCT01597245|20447226|P4|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
5910073|NCT01597245|20447227|P3|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
5910074|NCT01597245|20447228|P2|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
5910075|NCT01597245|20447229|P1|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
5910076|NCT01597245|20447209|P21|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
5910077|NCT01597245|20447210|P20|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|3
5910078|NCT01597245|20447211|P19|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
5910079|NCT01597245|20447212|P18|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
5910080|NCT01597245|20447213|P17|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|2
5910081|NCT01597245|20447214|P16|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
5910082|NCT01597245|20447215|P15|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
5910083|NCT01597245|20447216|P14|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
5910084|NCT01597245|20447217|P13|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
5910085|NCT01597245|20447218|P12|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
5910086|NCT01597245|20447219|P11|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
5910087|NCT01597245|20447220|P10|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
5910088|NCT01597245|20447221|P9|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
5910089|NCT01597245|20447222|P8|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
5910090|NCT01597245|20447223|P7|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
5910091|NCT01597245|20447224|P6|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
5910092|NCT01597245|20447225|P5|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
5910093|NCT01597245|20447226|P4|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
5910094|NCT01597245|20447227|P3|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
5910095|NCT01597245|20447228|P2|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
5910096|NCT01597245|20447229|P1|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
5910097|NCT01597245|20447209|P21|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|2
5910098|NCT01597245|20447210|P20|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|6
5910099|NCT01597245|20447211|P19|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
5910100|NCT01597245|20447212|P18|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
5910101|NCT01597245|20447213|P17|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|1
5910102|NCT01597245|20447214|P16|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
5910103|NCT01597245|20447215|P15|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
5910104|NCT01597245|20447216|P14|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
5910105|NCT01597245|20447217|P13|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
5910106|NCT01597245|20447218|P12|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
5910107|NCT01597245|20447219|P11|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
5910108|NCT01597245|20447220|P10|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
5910109|NCT01597245|20447221|P9|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
5910110|NCT01597245|20447222|P8|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
5910111|NCT01597245|20447223|P7|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
5910112|NCT01597245|20447224|P6|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
5910113|NCT01597245|20447225|P5|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
5910114|NCT01597245|20447226|P4|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
5910115|NCT01597245|20447227|P3|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
5910116|NCT01597245|20447228|P2|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
5910117|NCT01597245|20447229|P1|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
5910118|NCT01597245|20447209|P21|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|1
5910119|NCT01597245|20447210|P20|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|9
5910120|NCT01597245|20447211|P19|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
5910121|NCT01597245|20447212|P18|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
5910122|NCT01597245|20447213|P17|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|1
5910123|NCT01597245|20447214|P16|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
5910124|NCT01597245|20447215|P15|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
5910125|NCT01597245|20447216|P14|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
5910126|NCT01597245|20447217|P13|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
5910127|NCT01597245|20447218|P12|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
5910128|NCT01597245|20447219|P11|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
5910129|NCT01597245|20447220|P10|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
5910130|NCT01597245|20447221|P9|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
5910131|NCT01597245|20447222|P8|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
5910132|NCT01597245|20447223|P7|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
5910133|NCT01597245|20447224|P6|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
5910134|NCT01597245|20447225|P5|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
5910135|NCT01597245|20447226|P4|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
5910136|NCT01597245|20447227|P3|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
5910137|NCT01597245|20447228|P2|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
5910138|NCT01597245|20447229|P1|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
5910139|NCT01597245|20447209|P21|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|4
5910140|NCT01597245|20447210|P20|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|14
5910141|NCT01597245|20447211|P19|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|1
5910142|NCT01597245|20447212|P18|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
5910854|NCT01595009|20447994|P4|Core|Administrative problems|0
5910143|NCT01597245|20447213|P17|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
5910144|NCT01597245|20447214|P16|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
5910145|NCT01597245|20447215|P15|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
5910146|NCT01597245|20447216|P14|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
5910147|NCT01597245|20447217|P13|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
5910148|NCT01597245|20447218|P12|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
5910149|NCT01597245|20447219|P11|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
5910150|NCT01597245|20447220|P10|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
5910151|NCT01597245|20447221|P9|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
5910152|NCT01597245|20447222|P8|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
5910153|NCT01597245|20447223|P7|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
5910154|NCT01597245|20447224|P6|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
5910155|NCT01597245|20447225|P5|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
5910156|NCT01597245|20447226|P4|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
5910157|NCT01597245|20447227|P3|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
5910158|NCT01597245|20447228|P2|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
5910159|NCT01597245|20447229|P1|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
5910160|NCT01597245|20447209|P21|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|3
5910161|NCT01597245|20447210|P20|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|29
5910162|NCT01597245|20447211|P19|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
5910163|NCT01597245|20447212|P18|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
5910164|NCT01597245|20447213|P17|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|2
5910165|NCT01597245|20447214|P16|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
5910166|NCT01597245|20447215|P15|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
5910167|NCT01597245|20447216|P14|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
5910168|NCT01597245|20447217|P13|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
5910169|NCT01597245|20447218|P12|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
5910170|NCT01597245|20447219|P11|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
5910171|NCT01597245|20447220|P10|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
5910172|NCT01597245|20447221|P9|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
5910173|NCT01597245|20447222|P8|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
5910174|NCT01597245|20447223|P7|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
5910175|NCT01597245|20447224|P6|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
5910176|NCT01597245|20447225|P5|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
5910177|NCT01597245|20447226|P4|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
5910178|NCT01597245|20447227|P3|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
5910179|NCT01597245|20447228|P2|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
5910180|NCT01597245|20447229|P1|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
5910181|NCT01597245|20447209|P21|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|13
5910182|NCT01597245|20447210|P20|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|41
5910183|NCT01597245|20447211|P19|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|1
5910184|NCT01597245|20447212|P18|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|1
5910185|NCT01597245|20447213|P17|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
5910186|NCT01597245|20447214|P16|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
5910187|NCT01597245|20447215|P15|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
5910188|NCT01597245|20447216|P14|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
5910189|NCT01597245|20447217|P13|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
5910190|NCT01597245|20447218|P12|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
5910191|NCT01597245|20447219|P11|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
5910192|NCT01597245|20447220|P10|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
5910193|NCT01597245|20447221|P9|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
5910194|NCT01597245|20447222|P8|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
5910195|NCT01597245|20447223|P7|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
5910196|NCT01597245|20447224|P6|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
5910197|NCT01597245|20447225|P5|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
5910198|NCT01597245|20447226|P4|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
5910199|NCT01597245|20447227|P3|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
5910200|NCT01597245|20447228|P2|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
5910201|NCT01597245|20447229|P1|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
5910202|NCT01597245|20447209|P21|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|13
5910203|NCT01597245|20447210|P20|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|63
5910204|NCT01597245|20447211|P19|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|8
5910205|NCT01597245|20447212|P18|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|5
5910206|NCT01597245|20447213|P17|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|9
5910207|NCT01597245|20447214|P16|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
5910208|NCT01597245|20447215|P15|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
5910209|NCT01597245|20447216|P14|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
5910210|NCT01597245|20447217|P13|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
5910855|NCT01595009|20447995|P3|Core|Administrative problems|0
5910211|NCT01597245|20447218|P12|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
5910212|NCT01597245|20447219|P11|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
5910213|NCT01597245|20447220|P10|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
5910214|NCT01597245|20447221|P9|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
5910215|NCT01597245|20447222|P8|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
5910216|NCT01597245|20447223|P7|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
5910217|NCT01597245|20447224|P6|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
5910218|NCT01597245|20447225|P5|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
5910219|NCT01597245|20447226|P4|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
5910220|NCT01597245|20447227|P3|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
5910221|NCT01597245|20447228|P2|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
5910222|NCT01597245|20447229|P1|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
5910223|NCT01597245|20447209|P21|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
5910224|NCT01597245|20447210|P20|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
5910225|NCT01597245|20447211|P19|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
5910226|NCT01597245|20447212|P18|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
5910227|NCT01597245|20447213|P17|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
5910228|NCT01597245|20447214|P16|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
5910229|NCT01597245|20447215|P15|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
5910230|NCT01597245|20447216|P14|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|23
5910231|NCT01597245|20447217|P13|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
5910232|NCT01597245|20447218|P12|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
5910233|NCT01597245|20447219|P11|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
5910234|NCT01597245|20447220|P10|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
5910235|NCT01597245|20447221|P9|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
5910236|NCT01597245|20447222|P8|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
5910237|NCT01597245|20447223|P7|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
5910238|NCT01597245|20447224|P6|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
5910239|NCT01597245|20447225|P5|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
5910240|NCT01597245|20447226|P4|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
5910241|NCT01597245|20447227|P3|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
5910242|NCT01597245|20447228|P2|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
5910243|NCT01597245|20447229|P1|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
5910244|NCT01597245|20447209|P21|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
5910245|NCT01597245|20447210|P20|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
5910246|NCT01597245|20447211|P19|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
5910247|NCT01597245|20447212|P18|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
5910248|NCT01597245|20447213|P17|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
5910249|NCT01597245|20447214|P16|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|1
5910250|NCT01597245|20447215|P15|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|1
5910251|NCT01597245|20447216|P14|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
5910252|NCT01597245|20447217|P13|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
5910253|NCT01597245|20447218|P12|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
5910254|NCT01597245|20447219|P11|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
5910255|NCT01597245|20447220|P10|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
5910256|NCT01597245|20447221|P9|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
5910257|NCT01597245|20447222|P8|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
5910258|NCT01597245|20447223|P7|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
5910259|NCT01597245|20447224|P6|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
5910260|NCT01597245|20447225|P5|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
5910261|NCT01597245|20447226|P4|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
5910262|NCT01597245|20447227|P3|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
5910263|NCT01597245|20447228|P2|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
5910264|NCT01597245|20447229|P1|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
5910265|NCT01597245|20447209|P21|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
5910266|NCT01597245|20447210|P20|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
5910267|NCT01597245|20447211|P19|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
5910268|NCT01597245|20447212|P18|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
5910269|NCT01597245|20447213|P17|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
5910270|NCT01597245|20447214|P16|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|4
5910271|NCT01597245|20447215|P15|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|4
5910272|NCT01597245|20447216|P14|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
5910273|NCT01597245|20447217|P13|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
5910274|NCT01597245|20447218|P12|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
5910275|NCT01597245|20447219|P11|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
5910276|NCT01597245|20447220|P10|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
5910277|NCT01597245|20447221|P9|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
5910278|NCT01597245|20447222|P8|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
5910856|NCT01595009|20447996|P2|Core|Administrative problems|1
5910279|NCT01597245|20447223|P7|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
5910280|NCT01597245|20447224|P6|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
5910281|NCT01597245|20447225|P5|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
5910282|NCT01597245|20447226|P4|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
5910283|NCT01597245|20447227|P3|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
5910284|NCT01597245|20447228|P2|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
5910285|NCT01597245|20447229|P1|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
5910286|NCT01597245|20447209|P21|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
5910287|NCT01597245|20447210|P20|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
5910288|NCT01597245|20447211|P19|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
5910289|NCT01597245|20447212|P18|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
5910290|NCT01597245|20447213|P17|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
5910291|NCT01597245|20447214|P16|Long Term Extension (Week 60 - Week 264)|Protocol Violation|6
5910292|NCT01597245|20447215|P15|Long Term Extension (Week 60 - Week 264)|Protocol Violation|6
5910293|NCT01597245|20447216|P14|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
5910294|NCT01597245|20447217|P13|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
5910295|NCT01597245|20447218|P12|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
5910296|NCT01597245|20447219|P11|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
5910297|NCT01597245|20447220|P10|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
5910298|NCT01597245|20447221|P9|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
5910299|NCT01597245|20447222|P8|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
5910300|NCT01597245|20447223|P7|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
5910301|NCT01597245|20447224|P6|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
5910302|NCT01597245|20447225|P5|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
5910303|NCT01597245|20447226|P4|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
5910304|NCT01597245|20447227|P3|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
5910305|NCT01597245|20447228|P2|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
5910306|NCT01597245|20447229|P1|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
5910307|NCT01597245|20447209|P21|Long Term Extension (Week 60 - Week 264)|Death|0
5910308|NCT01597245|20447210|P20|Long Term Extension (Week 60 - Week 264)|Death|0
5910309|NCT01597245|20447211|P19|Long Term Extension (Week 60 - Week 264)|Death|0
5910310|NCT01597245|20447212|P18|Long Term Extension (Week 60 - Week 264)|Death|0
5910311|NCT01597245|20447213|P17|Long Term Extension (Week 60 - Week 264)|Death|0
5910312|NCT01597245|20447214|P16|Long Term Extension (Week 60 - Week 264)|Death|8
5910313|NCT01597245|20447215|P15|Long Term Extension (Week 60 - Week 264)|Death|8
5910314|NCT01597245|20447216|P14|Long Term Extension (Week 60 - Week 264)|Death|0
5910315|NCT01597245|20447217|P13|Long Term Extension (Week 60 - Week 264)|Death|0
5910316|NCT01597245|20447218|P12|Long Term Extension (Week 60 - Week 264)|Death|0
5910317|NCT01597245|20447219|P11|Long Term Extension (Week 60 - Week 264)|Death|0
5910318|NCT01597245|20447220|P10|Long Term Extension (Week 60 - Week 264)|Death|0
5910319|NCT01597245|20447221|P9|Long Term Extension (Week 60 - Week 264)|Death|0
5910320|NCT01597245|20447222|P8|Long Term Extension (Week 60 - Week 264)|Death|0
5910321|NCT01597245|20447223|P7|Long Term Extension (Week 60 - Week 264)|Death|0
5910322|NCT01597245|20447224|P6|Long Term Extension (Week 60 - Week 264)|Death|0
5910323|NCT01597245|20447225|P5|Long Term Extension (Week 60 - Week 264)|Death|0
5910324|NCT01597245|20447226|P4|Long Term Extension (Week 60 - Week 264)|Death|0
5910325|NCT01597245|20447227|P3|Long Term Extension (Week 60 - Week 264)|Death|0
5910326|NCT01597245|20447228|P2|Long Term Extension (Week 60 - Week 264)|Death|0
5910327|NCT01597245|20447229|P1|Long Term Extension (Week 60 - Week 264)|Death|0
5910328|NCT01597245|20447209|P21|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
5910329|NCT01597245|20447210|P20|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
5910330|NCT01597245|20447211|P19|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
5910331|NCT01597245|20447212|P18|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
5910332|NCT01597245|20447213|P17|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
5910333|NCT01597245|20447214|P16|Long Term Extension (Week 60 - Week 264)|Physician Decision|12
5910334|NCT01597245|20447215|P15|Long Term Extension (Week 60 - Week 264)|Physician Decision|11
5910335|NCT01597245|20447216|P14|Long Term Extension (Week 60 - Week 264)|Physician Decision|1
5910336|NCT01597245|20447217|P13|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
5910337|NCT01597245|20447218|P12|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
5910338|NCT01597245|20447219|P11|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
5910339|NCT01597245|20447220|P10|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
5910340|NCT01597245|20447221|P9|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
5910341|NCT01597245|20447222|P8|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
5910342|NCT01597245|20447223|P7|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
5910343|NCT01597245|20447224|P6|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
5910344|NCT01597245|20447225|P5|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
5910345|NCT01597245|20447226|P4|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
5910346|NCT01597245|20447227|P3|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
5910347|NCT01597245|20447228|P2|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
5910348|NCT01597245|20447229|P1|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
5910349|NCT01597245|20447209|P21|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
5910857|NCT01595009|20447997|P1|Core|Administrative problems|0
5910350|NCT01597245|20447210|P20|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
5910351|NCT01597245|20447211|P19|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
5910352|NCT01597245|20447212|P18|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
5910353|NCT01597245|20447213|P17|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
5910354|NCT01597245|20447214|P16|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|26
5910355|NCT01597245|20447215|P15|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|26
5910356|NCT01597245|20447216|P14|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
5910357|NCT01597245|20447217|P13|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
5910358|NCT01597245|20447218|P12|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
5910359|NCT01597245|20447219|P11|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
5910360|NCT01597245|20447220|P10|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
5910361|NCT01597245|20447221|P9|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
5910362|NCT01597245|20447222|P8|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
5910363|NCT01597245|20447223|P7|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
5910364|NCT01597245|20447224|P6|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
5910365|NCT01597245|20447225|P5|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
5910366|NCT01597245|20447226|P4|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
5910367|NCT01597245|20447227|P3|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
5910368|NCT01597245|20447228|P2|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
5910369|NCT01597245|20447229|P1|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
5910370|NCT01597245|20447209|P21|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
5910371|NCT01597245|20447210|P20|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
5910372|NCT01597245|20447211|P19|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
5910373|NCT01597245|20447212|P18|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
5910374|NCT01597245|20447213|P17|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
5910375|NCT01597245|20447214|P16|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|38
5910376|NCT01597245|20447215|P15|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|38
5910377|NCT01597245|20447216|P14|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
5910378|NCT01597245|20447217|P13|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
5910379|NCT01597245|20447218|P12|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
5910380|NCT01597245|20447219|P11|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
5910381|NCT01597245|20447220|P10|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
5910382|NCT01597245|20447221|P9|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
5910383|NCT01597245|20447222|P8|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
5910384|NCT01597245|20447223|P7|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
5910385|NCT01597245|20447224|P6|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
5910386|NCT01597245|20447225|P5|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
5910387|NCT01597245|20447226|P4|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
5910388|NCT01597245|20447227|P3|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
5910389|NCT01597245|20447228|P2|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
5910390|NCT01597245|20447229|P1|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
5910391|NCT01597245|20447209|P21|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
5910392|NCT01597245|20447210|P20|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
5910393|NCT01597245|20447211|P19|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
5910394|NCT01597245|20447212|P18|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
5910395|NCT01597245|20447213|P17|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
5910396|NCT01597245|20447214|P16|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|63
5910397|NCT01597245|20447215|P15|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|62
5910398|NCT01597245|20447216|P14|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|1
5910399|NCT01597245|20447217|P13|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
5910400|NCT01597245|20447218|P12|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
5910401|NCT01597245|20447219|P11|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
5910402|NCT01597245|20447220|P10|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
5910403|NCT01597245|20447221|P9|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
5910404|NCT01597245|20447222|P8|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
5910405|NCT01597245|20447223|P7|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
5910406|NCT01597245|20447224|P6|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
5910407|NCT01597245|20447225|P5|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
5910408|NCT01597245|20447226|P4|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
5910409|NCT01597245|20447227|P3|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
5910410|NCT01597245|20447228|P2|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
5910411|NCT01597245|20447229|P1|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
5910412|NCT01597245|20447209|P21|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
5910413|NCT01597245|20447210|P20|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
5910414|NCT01597245|20447211|P19|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
5910415|NCT01597245|20447212|P18|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
5910416|NCT01597245|20447213|P17|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
5910417|NCT01597245|20447214|P16|Long Term Extension (Week 60 - Week 264)|Adverse Event|70
5910858|NCT01595009|20447994|P4|Core|Protocol deviation|0
5910418|NCT01597245|20447215|P15|Long Term Extension (Week 60 - Week 264)|Adverse Event|69
5910419|NCT01597245|20447216|P14|Long Term Extension (Week 60 - Week 264)|Adverse Event|1
5910420|NCT01597245|20447217|P13|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
5910421|NCT01597245|20447218|P12|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
5910422|NCT01597245|20447219|P11|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
5910423|NCT01597245|20447220|P10|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
5910424|NCT01597245|20447221|P9|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
5910425|NCT01597245|20447222|P8|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
5910426|NCT01597245|20447223|P7|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
5910427|NCT01597245|20447224|P6|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
5910428|NCT01597245|20447225|P5|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
5910429|NCT01597245|20447226|P4|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
5910430|NCT01597245|20447227|P3|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
5910431|NCT01597245|20447228|P2|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
5910432|NCT01597245|20447229|P1|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
5910433|NCT01597245|20447209|P21|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
5910434|NCT01597245|20447210|P20|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
5910435|NCT01597245|20447211|P19|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
5910436|NCT01597245|20447212|P18|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
5910437|NCT01597245|20447213|P17|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
5910438|NCT01597245|20447214|P16|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
5910439|NCT01597245|20447215|P15|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
5910440|NCT01597245|20447216|P14|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
5910441|NCT01597245|20447217|P13|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
5910442|NCT01597245|20447218|P12|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
5910443|NCT01597245|20447219|P11|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|1
5910444|NCT01597245|20447220|P10|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
5910445|NCT01597245|20447221|P9|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
5910446|NCT01597245|20447222|P8|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
5910447|NCT01597245|20447223|P7|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
5910448|NCT01597245|20447224|P6|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
5910449|NCT01597245|20447225|P5|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
5910450|NCT01597245|20447226|P4|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
5910451|NCT01597245|20447227|P3|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
5910452|NCT01597245|20447228|P2|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
5910453|NCT01597245|20447229|P1|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
5910454|NCT01597245|20447209|P21|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
5910455|NCT01597245|20447210|P20|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
5910456|NCT01597245|20447211|P19|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
5910457|NCT01597245|20447212|P18|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
5910458|NCT01597245|20447213|P17|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
5910459|NCT01597245|20447214|P16|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
5910460|NCT01597245|20447215|P15|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
5910461|NCT01597245|20447216|P14|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
5910462|NCT01597245|20447217|P13|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
5910463|NCT01597245|20447218|P12|Maintenance Period (Week 12 to Week 60)|Physician Decision|1
5910464|NCT01597245|20447219|P11|Maintenance Period (Week 12 to Week 60)|Physician Decision|1
5910465|NCT01597245|20447220|P10|Maintenance Period (Week 12 to Week 60)|Physician Decision|1
5910466|NCT01597245|20447221|P9|Maintenance Period (Week 12 to Week 60)|Physician Decision|1
5910467|NCT01597245|20447222|P8|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
5910468|NCT01597245|20447223|P7|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
5910469|NCT01597245|20447224|P6|Maintenance Period (Week 12 to Week 60)|Physician Decision|1
5910470|NCT01597245|20447225|P5|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
5910471|NCT01597245|20447226|P4|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
5910472|NCT01597245|20447227|P3|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
5910473|NCT01597245|20447228|P2|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
5910474|NCT01597245|20447229|P1|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
5910475|NCT01597245|20447209|P21|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
5910476|NCT01597245|20447210|P20|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
5910477|NCT01597245|20447211|P19|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
5910478|NCT01597245|20447212|P18|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
5910479|NCT01597245|20447213|P17|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
5910480|NCT01597245|20447214|P16|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
5910481|NCT01597245|20447215|P15|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
5910482|NCT01597245|20447216|P14|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
5910483|NCT01597245|20447217|P13|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1
5910484|NCT01597245|20447218|P12|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2
5910485|NCT01597245|20447219|P11|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2
5910486|NCT01597245|20447220|P10|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2
5910487|NCT01597245|20447221|P9|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1
5910488|NCT01597245|20447222|P8|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
5910489|NCT01597245|20447223|P7|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1
5910490|NCT01597245|20447224|P6|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|4
5910491|NCT01597245|20447225|P5|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|3
5910492|NCT01597245|20447226|P4|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
5910493|NCT01597245|20447227|P3|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
5910494|NCT01597245|20447228|P2|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
5910495|NCT01597245|20447229|P1|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
5910496|NCT01597245|20447209|P21|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
5910497|NCT01597245|20447210|P20|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
5910498|NCT01597245|20447211|P19|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
5910499|NCT01597245|20447212|P18|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
5910500|NCT01597245|20447213|P17|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
5910501|NCT01597245|20447214|P16|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
5910502|NCT01597245|20447215|P15|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
5910503|NCT01597245|20447216|P14|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
5910504|NCT01597245|20447217|P13|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1
5910505|NCT01597245|20447218|P12|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
5910506|NCT01597245|20447219|P11|Maintenance Period (Week 12 to Week 60)|Protocol Violation|2
5910507|NCT01597245|20447220|P10|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1
5910508|NCT01597245|20447221|P9|Maintenance Period (Week 12 to Week 60)|Protocol Violation|3
5910509|NCT01597245|20447222|P8|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
5910510|NCT01597245|20447223|P7|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
5910511|NCT01597245|20447224|P6|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
5910512|NCT01597245|20447225|P5|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1
5910513|NCT01597245|20447226|P4|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
5910514|NCT01597245|20447227|P3|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
5910515|NCT01597245|20447228|P2|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
5910516|NCT01597245|20447229|P1|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
5910517|NCT01597245|20447209|P21|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
5910518|NCT01597245|20447210|P20|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
5910519|NCT01597245|20447211|P19|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
5910520|NCT01597245|20447212|P18|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
5910521|NCT01597245|20447213|P17|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
5910522|NCT01597245|20447214|P16|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
5910523|NCT01597245|20447215|P15|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
5910524|NCT01597245|20447216|P14|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
5910525|NCT01597245|20447217|P13|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4
5910526|NCT01597245|20447218|P12|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|5
5910527|NCT01597245|20447219|P11|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|6
5910528|NCT01597245|20447220|P10|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1
5910529|NCT01597245|20447221|P9|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4
5910530|NCT01597245|20447222|P8|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
5910531|NCT01597245|20447223|P7|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1
5910532|NCT01597245|20447224|P6|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3
5910533|NCT01597245|20447225|P5|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3
5910534|NCT01597245|20447226|P4|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
5910535|NCT01597245|20447227|P3|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
5910536|NCT01597245|20447228|P2|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
5910537|NCT01597245|20447229|P1|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
5910538|NCT01597245|20447209|P21|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
5910539|NCT01597245|20447210|P20|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
5910540|NCT01597245|20447211|P19|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
5910541|NCT01597245|20447212|P18|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
5910542|NCT01597245|20447213|P17|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
5910543|NCT01597245|20447214|P16|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
5910544|NCT01597245|20447215|P15|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
5910545|NCT01597245|20447216|P14|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
5910546|NCT01597245|20447217|P13|Maintenance Period (Week 12 to Week 60)|Adverse Event|2
5910547|NCT01597245|20447218|P12|Maintenance Period (Week 12 to Week 60)|Adverse Event|1
5910548|NCT01597245|20447219|P11|Maintenance Period (Week 12 to Week 60)|Adverse Event|8
5910549|NCT01597245|20447220|P10|Maintenance Period (Week 12 to Week 60)|Adverse Event|2
5910550|NCT01597245|20447221|P9|Maintenance Period (Week 12 to Week 60)|Adverse Event|8
5910551|NCT01597245|20447222|P8|Maintenance Period (Week 12 to Week 60)|Adverse Event|1
5910552|NCT01597245|20447223|P7|Maintenance Period (Week 12 to Week 60)|Adverse Event|6
5910553|NCT01597245|20447224|P6|Maintenance Period (Week 12 to Week 60)|Adverse Event|6
5910554|NCT01597245|20447225|P5|Maintenance Period (Week 12 to Week 60)|Adverse Event|4
5910555|NCT01597245|20447226|P4|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
5910859|NCT01595009|20447995|P3|Core|Protocol deviation|0
5910556|NCT01597245|20447227|P3|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
5910557|NCT01597245|20447228|P2|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
5910558|NCT01597245|20447229|P1|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
5910559|NCT01597245|20447209|P21|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
5910560|NCT01597245|20447210|P20|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
5910561|NCT01597245|20447211|P19|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
5910562|NCT01597245|20447212|P18|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
5910563|NCT01597245|20447213|P17|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
5910564|NCT01597245|20447214|P16|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
5910565|NCT01597245|20447215|P15|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
5910566|NCT01597245|20447216|P14|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
5910567|NCT01597245|20447217|P13|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|4
5910568|NCT01597245|20447218|P12|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|10
5910569|NCT01597245|20447219|P11|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|2
5910570|NCT01597245|20447220|P10|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
5910571|NCT01597245|20447221|P9|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|3
5910572|NCT01597245|20447222|P8|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
5910573|NCT01597245|20447223|P7|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
5910574|NCT01597245|20447224|P6|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|1
5910575|NCT01597245|20447225|P5|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
5910576|NCT01597245|20447226|P4|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
5910577|NCT01597245|20447227|P3|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
5910578|NCT01597245|20447228|P2|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
5910579|NCT01597245|20447229|P1|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
5910580|NCT01597245|20447209|P21|Maintenance Period (Week 12 to Week 60)|Relapsed|0
5910581|NCT01597245|20447210|P20|Maintenance Period (Week 12 to Week 60)|Relapsed|0
5910582|NCT01597245|20447211|P19|Maintenance Period (Week 12 to Week 60)|Relapsed|0
5910583|NCT01597245|20447212|P18|Maintenance Period (Week 12 to Week 60)|Relapsed|0
5910584|NCT01597245|20447213|P17|Maintenance Period (Week 12 to Week 60)|Relapsed|0
5910585|NCT01597245|20447214|P16|Maintenance Period (Week 12 to Week 60)|Relapsed|0
5910586|NCT01597245|20447215|P15|Maintenance Period (Week 12 to Week 60)|Relapsed|0
5910587|NCT01597245|20447216|P14|Maintenance Period (Week 12 to Week 60)|Relapsed|0
5910588|NCT01597245|20447217|P13|Maintenance Period (Week 12 to Week 60)|Relapsed|0
5910589|NCT01597245|20447218|P12|Maintenance Period (Week 12 to Week 60)|Relapsed|0
5910590|NCT01597245|20447219|P11|Maintenance Period (Week 12 to Week 60)|Relapsed|0
5910591|NCT01597245|20447220|P10|Maintenance Period (Week 12 to Week 60)|Relapsed|114
5910592|NCT01597245|20447221|P9|Maintenance Period (Week 12 to Week 60)|Relapsed|0
5910593|NCT01597245|20447222|P8|Maintenance Period (Week 12 to Week 60)|Relapsed|2
5910594|NCT01597245|20447223|P7|Maintenance Period (Week 12 to Week 60)|Relapsed|80
5910595|NCT01597245|20447224|P6|Maintenance Period (Week 12 to Week 60)|Relapsed|22
5910596|NCT01597245|20447225|P5|Maintenance Period (Week 12 to Week 60)|Relapsed|150
5910597|NCT01597245|20447226|P4|Maintenance Period (Week 12 to Week 60)|Relapsed|0
5910598|NCT01597245|20447227|P3|Maintenance Period (Week 12 to Week 60)|Relapsed|0
5910599|NCT01597245|20447228|P2|Maintenance Period (Week 12 to Week 60)|Relapsed|0
5910600|NCT01597245|20447229|P1|Maintenance Period (Week 12 to Week 60)|Relapsed|0
5910601|NCT01597245|20447209|P21|Maintenance Period (Week 12 to Week 60)|On study treatment|0
5910602|NCT01597245|20447210|P20|Maintenance Period (Week 12 to Week 60)|On study treatment|0
5910603|NCT01597245|20447211|P19|Maintenance Period (Week 12 to Week 60)|On study treatment|0
5910604|NCT01597245|20447212|P18|Maintenance Period (Week 12 to Week 60)|On study treatment|0
5910605|NCT01597245|20447213|P17|Maintenance Period (Week 12 to Week 60)|On study treatment|0
5910606|NCT01597245|20447214|P16|Maintenance Period (Week 12 to Week 60)|On study treatment|0
5910607|NCT01597245|20447215|P15|Maintenance Period (Week 12 to Week 60)|On study treatment|0
5910608|NCT01597245|20447216|P14|Maintenance Period (Week 12 to Week 60)|On study treatment|0
5910609|NCT01597245|20447217|P13|Maintenance Period (Week 12 to Week 60)|On study treatment|0
5910610|NCT01597245|20447218|P12|Maintenance Period (Week 12 to Week 60)|On study treatment|0
5910611|NCT01597245|20447219|P11|Maintenance Period (Week 12 to Week 60)|On study treatment|0
5910612|NCT01597245|20447220|P10|Maintenance Period (Week 12 to Week 60)|On study treatment|0
5910613|NCT01597245|20447221|P9|Maintenance Period (Week 12 to Week 60)|On study treatment|0
5910614|NCT01597245|20447222|P8|Maintenance Period (Week 12 to Week 60)|On study treatment|0
5910615|NCT01597245|20447223|P7|Maintenance Period (Week 12 to Week 60)|On study treatment|1
5910616|NCT01597245|20447224|P6|Maintenance Period (Week 12 to Week 60)|On study treatment|1
5910617|NCT01597245|20447225|P5|Maintenance Period (Week 12 to Week 60)|On study treatment|0
5910618|NCT01597245|20447226|P4|Maintenance Period (Week 12 to Week 60)|On study treatment|0
5910619|NCT01597245|20447227|P3|Maintenance Period (Week 12 to Week 60)|On study treatment|0
5910620|NCT01597245|20447228|P2|Maintenance Period (Week 12 to Week 60)|On study treatment|0
5910621|NCT01597245|20447229|P1|Maintenance Period (Week 12 to Week 60)|On study treatment|0
5910622|NCT01597245|20447209|P21|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
5910623|NCT01597245|20447210|P20|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
5910624|NCT01597245|20447211|P19|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
5910625|NCT01597245|20447212|P18|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
5910626|NCT01597245|20447213|P17|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
5910860|NCT01595009|20447996|P2|Core|Protocol deviation|1
5910627|NCT01597245|20447214|P16|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
5910628|NCT01597245|20447215|P15|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
5910629|NCT01597245|20447216|P14|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
5910630|NCT01597245|20447217|P13|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
5910631|NCT01597245|20447218|P12|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
5910632|NCT01597245|20447219|P11|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
5910633|NCT01597245|20447220|P10|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
5910634|NCT01597245|20447221|P9|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
5910635|NCT01597245|20447222|P8|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
5910636|NCT01597245|20447223|P7|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
5910637|NCT01597245|20447224|P6|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
5910638|NCT01597245|20447225|P5|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
5910639|NCT01597245|20447226|P4|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
5910640|NCT01597245|20447227|P3|Induction Period (Week 0 - Week 12)|Lack of Efficacy|1
5910641|NCT01597245|20447228|P2|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3
5910642|NCT01597245|20447229|P1|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3
5910643|NCT01597245|20447209|P21|Induction Period (Week 0 - Week 12)|Physician Decision|0
5910644|NCT01597245|20447210|P20|Induction Period (Week 0 - Week 12)|Physician Decision|0
5910645|NCT01597245|20447211|P19|Induction Period (Week 0 - Week 12)|Physician Decision|0
5910646|NCT01597245|20447212|P18|Induction Period (Week 0 - Week 12)|Physician Decision|0
5910647|NCT01597245|20447213|P17|Induction Period (Week 0 - Week 12)|Physician Decision|0
5910648|NCT01597245|20447214|P16|Induction Period (Week 0 - Week 12)|Physician Decision|0
5910649|NCT01597245|20447215|P15|Induction Period (Week 0 - Week 12)|Physician Decision|0
5910650|NCT01597245|20447216|P14|Induction Period (Week 0 - Week 12)|Physician Decision|0
5910651|NCT01597245|20447217|P13|Induction Period (Week 0 - Week 12)|Physician Decision|0
5910652|NCT01597245|20447218|P12|Induction Period (Week 0 - Week 12)|Physician Decision|0
5910653|NCT01597245|20447219|P11|Induction Period (Week 0 - Week 12)|Physician Decision|0
5910654|NCT01597245|20447220|P10|Induction Period (Week 0 - Week 12)|Physician Decision|0
5910655|NCT01597245|20447221|P9|Induction Period (Week 0 - Week 12)|Physician Decision|0
5910656|NCT01597245|20447222|P8|Induction Period (Week 0 - Week 12)|Physician Decision|0
5910657|NCT01597245|20447223|P7|Induction Period (Week 0 - Week 12)|Physician Decision|0
5910658|NCT01597245|20447224|P6|Induction Period (Week 0 - Week 12)|Physician Decision|0
5910659|NCT01597245|20447225|P5|Induction Period (Week 0 - Week 12)|Physician Decision|0
5910660|NCT01597245|20447226|P4|Induction Period (Week 0 - Week 12)|Physician Decision|1
5910661|NCT01597245|20447227|P3|Induction Period (Week 0 - Week 12)|Physician Decision|0
5910662|NCT01597245|20447228|P2|Induction Period (Week 0 - Week 12)|Physician Decision|0
5910663|NCT01597245|20447229|P1|Induction Period (Week 0 - Week 12)|Physician Decision|1
5910664|NCT01597245|20447209|P21|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
5910665|NCT01597245|20447210|P20|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
5910666|NCT01597245|20447211|P19|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
5910667|NCT01597245|20447212|P18|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
5910668|NCT01597245|20447213|P17|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
5910669|NCT01597245|20447214|P16|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
5910670|NCT01597245|20447215|P15|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
5910671|NCT01597245|20447216|P14|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
5910672|NCT01597245|20447217|P13|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
5910673|NCT01597245|20447218|P12|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
5910674|NCT01597245|20447219|P11|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
5910675|NCT01597245|20447220|P10|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
5910676|NCT01597245|20447221|P9|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
5910677|NCT01597245|20447222|P8|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
5910678|NCT01597245|20447223|P7|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
5910679|NCT01597245|20447224|P6|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
5910680|NCT01597245|20447225|P5|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
5910681|NCT01597245|20447226|P4|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
5910682|NCT01597245|20447227|P3|Induction Period (Week 0 - Week 12)|Lost to Follow-up|2
5910683|NCT01597245|20447228|P2|Induction Period (Week 0 - Week 12)|Lost to Follow-up|5
5910684|NCT01597245|20447229|P1|Induction Period (Week 0 - Week 12)|Lost to Follow-up|1
5910685|NCT01597245|20447209|P21|Induction Period (Week 0 - Week 12)|Protocol Violation|0
5910686|NCT01597245|20447210|P20|Induction Period (Week 0 - Week 12)|Protocol Violation|0
5910687|NCT01597245|20447211|P19|Induction Period (Week 0 - Week 12)|Protocol Violation|0
5910688|NCT01597245|20447212|P18|Induction Period (Week 0 - Week 12)|Protocol Violation|0
5910689|NCT01597245|20447213|P17|Induction Period (Week 0 - Week 12)|Protocol Violation|0
5910690|NCT01597245|20447214|P16|Induction Period (Week 0 - Week 12)|Protocol Violation|0
5910691|NCT01597245|20447215|P15|Induction Period (Week 0 - Week 12)|Protocol Violation|0
5910692|NCT01597245|20447216|P14|Induction Period (Week 0 - Week 12)|Protocol Violation|0
5910693|NCT01597245|20447217|P13|Induction Period (Week 0 - Week 12)|Protocol Violation|0
5910694|NCT01597245|20447218|P12|Induction Period (Week 0 - Week 12)|Protocol Violation|0
5910695|NCT01597245|20447219|P11|Induction Period (Week 0 - Week 12)|Protocol Violation|0
5910696|NCT01597245|20447220|P10|Induction Period (Week 0 - Week 12)|Protocol Violation|0
5910697|NCT01597245|20447221|P9|Induction Period (Week 0 - Week 12)|Protocol Violation|0
5910698|NCT01597245|20447222|P8|Induction Period (Week 0 - Week 12)|Protocol Violation|0
5910699|NCT01597245|20447223|P7|Induction Period (Week 0 - Week 12)|Protocol Violation|0
5910700|NCT01597245|20447224|P6|Induction Period (Week 0 - Week 12)|Protocol Violation|0
5910701|NCT01597245|20447225|P5|Induction Period (Week 0 - Week 12)|Protocol Violation|0
5910702|NCT01597245|20447226|P4|Induction Period (Week 0 - Week 12)|Protocol Violation|2
5910703|NCT01597245|20447227|P3|Induction Period (Week 0 - Week 12)|Protocol Violation|5
5910704|NCT01597245|20447228|P2|Induction Period (Week 0 - Week 12)|Protocol Violation|4
5910705|NCT01597245|20447229|P1|Induction Period (Week 0 - Week 12)|Protocol Violation|2
5910706|NCT01597245|20447209|P21|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
5910707|NCT01597245|20447210|P20|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
5910708|NCT01597245|20447211|P19|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
5910709|NCT01597245|20447212|P18|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
5910710|NCT01597245|20447213|P17|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
5910711|NCT01597245|20447214|P16|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
5910712|NCT01597245|20447215|P15|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
5910713|NCT01597245|20447216|P14|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
5910714|NCT01597245|20447217|P13|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
5910715|NCT01597245|20447218|P12|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
5910716|NCT01597245|20447219|P11|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
5910717|NCT01597245|20447220|P10|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
5910718|NCT01597245|20447221|P9|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
5910719|NCT01597245|20447222|P8|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
5910720|NCT01597245|20447223|P7|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
5910721|NCT01597245|20447224|P6|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
5910722|NCT01597245|20447225|P5|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
5910723|NCT01597245|20447226|P4|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2
5910724|NCT01597245|20447227|P3|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|6
5910725|NCT01597245|20447228|P2|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|8
5910726|NCT01597245|20447229|P1|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2
5910727|NCT01597245|20447209|P21|Induction Period (Week 0 - Week 12)|Adverse Event|0
5910728|NCT01597245|20447210|P20|Induction Period (Week 0 - Week 12)|Adverse Event|0
5910729|NCT01597245|20447211|P19|Induction Period (Week 0 - Week 12)|Adverse Event|0
5910730|NCT01597245|20447212|P18|Induction Period (Week 0 - Week 12)|Adverse Event|0
5910731|NCT01597245|20447213|P17|Induction Period (Week 0 - Week 12)|Adverse Event|0
5910732|NCT01597245|20447214|P16|Induction Period (Week 0 - Week 12)|Adverse Event|0
5910733|NCT01597245|20447215|P15|Induction Period (Week 0 - Week 12)|Adverse Event|0
5910734|NCT01597245|20447216|P14|Induction Period (Week 0 - Week 12)|Adverse Event|0
5910735|NCT01597245|20447217|P13|Induction Period (Week 0 - Week 12)|Adverse Event|0
5910736|NCT01597245|20447218|P12|Induction Period (Week 0 - Week 12)|Adverse Event|0
5910737|NCT01597245|20447219|P11|Induction Period (Week 0 - Week 12)|Adverse Event|0
5910738|NCT01597245|20447220|P10|Induction Period (Week 0 - Week 12)|Adverse Event|0
5910739|NCT01597245|20447221|P9|Induction Period (Week 0 - Week 12)|Adverse Event|0
5910740|NCT01597245|20447222|P8|Induction Period (Week 0 - Week 12)|Adverse Event|0
5910741|NCT01597245|20447223|P7|Induction Period (Week 0 - Week 12)|Adverse Event|0
5910742|NCT01597245|20447224|P6|Induction Period (Week 0 - Week 12)|Adverse Event|0
5910743|NCT01597245|20447225|P5|Induction Period (Week 0 - Week 12)|Adverse Event|0
5910744|NCT01597245|20447226|P4|Induction Period (Week 0 - Week 12)|Adverse Event|4
5910745|NCT01597245|20447227|P3|Induction Period (Week 0 - Week 12)|Adverse Event|5
5910746|NCT01597245|20447228|P2|Induction Period (Week 0 - Week 12)|Adverse Event|5
5910747|NCT01597245|20447229|P1|Induction Period (Week 0 - Week 12)|Adverse Event|1
5910748|NCT01597193|20447327|P7|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0
5910749|NCT01597193|20447328|P6|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1
5910750|NCT01597193|20447329|P5|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0
5910751|NCT01597193|20447330|P4|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1
5910752|NCT01597193|20447331|P3|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0
5910753|NCT01597193|20447332|P2|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0
5910754|NCT01597193|20447333|P1|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0
5910755|NCT01597193|20447327|P7|Stage 2: Dose Expansion (1067 Days)|Other|0
5910756|NCT01597193|20447328|P6|Stage 2: Dose Expansion (1067 Days)|Other|1
5910757|NCT01597193|20447329|P5|Stage 2: Dose Expansion (1067 Days)|Other|0
5910758|NCT01597193|20447330|P4|Stage 2: Dose Expansion (1067 Days)|Other|0
5910759|NCT01597193|20447331|P3|Stage 2: Dose Expansion (1067 Days)|Other|0
5910760|NCT01597193|20447332|P2|Stage 2: Dose Expansion (1067 Days)|Other|0
5910761|NCT01597193|20447333|P1|Stage 2: Dose Expansion (1067 Days)|Other|0
5910762|NCT01597193|20447327|P7|Stage 2: Dose Expansion (1067 Days)|Disease progression|11
5910763|NCT01597193|20447328|P6|Stage 2: Dose Expansion (1067 Days)|Disease progression|18
5910764|NCT01597193|20447329|P5|Stage 2: Dose Expansion (1067 Days)|Disease progression|14
5910765|NCT01597193|20447330|P4|Stage 2: Dose Expansion (1067 Days)|Disease progression|18
5910766|NCT01597193|20447331|P3|Stage 2: Dose Expansion (1067 Days)|Disease progression|14
5910767|NCT01597193|20447332|P2|Stage 2: Dose Expansion (1067 Days)|Disease progression|0
5910768|NCT01597193|20447333|P1|Stage 2: Dose Expansion (1067 Days)|Disease progression|0
5910769|NCT01597193|20447327|P7|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0
5910861|NCT01595009|20447997|P1|Core|Protocol deviation|0
5910770|NCT01597193|20447328|P6|Stage 2: Dose Expansion (1067 Days)|Adverse Event|3
5910771|NCT01597193|20447329|P5|Stage 2: Dose Expansion (1067 Days)|Adverse Event|2
5910772|NCT01597193|20447330|P4|Stage 2: Dose Expansion (1067 Days)|Adverse Event|1
5910773|NCT01597193|20447331|P3|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0
5910774|NCT01597193|20447332|P2|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0
5910775|NCT01597193|20447333|P1|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0
5910776|NCT01597193|20447327|P7|Stage 1: Dose Escalation (141 Days)|Disease progression|0
5910777|NCT01597193|20447328|P6|Stage 1: Dose Escalation (141 Days)|Disease progression|0
5910778|NCT01597193|20447329|P5|Stage 1: Dose Escalation (141 Days)|Disease progression|0
5910779|NCT01597193|20447330|P4|Stage 1: Dose Escalation (141 Days)|Disease progression|0
5910780|NCT01597193|20447331|P3|Stage 1: Dose Escalation (141 Days)|Disease progression|0
5910781|NCT01597193|20447332|P2|Stage 1: Dose Escalation (141 Days)|Disease progression|8
5910782|NCT01597193|20447333|P1|Stage 1: Dose Escalation (141 Days)|Disease progression|7
5910783|NCT01597050|20447452|P2|Overall Study|Withdrawal by Subject|0
5910784|NCT01597050|20447453|P1|Overall Study|Withdrawal by Subject|1
5910785|NCT01596972|20447461|P2|Overall Study|Withdrawal by Subject|1
5910786|NCT01596972|20447462|P1|Overall Study|Withdrawal by Subject|0
5910787|NCT01596972|20447461|P2|Overall Study|Lost to Follow-up|4
5910788|NCT01596972|20447462|P1|Overall Study|Lost to Follow-up|0
5910789|NCT01596972|20447461|P2|Overall Study|Physician Decision|9
5910790|NCT01596972|20447462|P1|Overall Study|Physician Decision|1
5910791|NCT01596582|20447534|P2|Overall Study|Missing all outcome data|1
5910792|NCT01596582|20447535|P1|Overall Study|Missing all outcome data|1
5910793|NCT01596582|20447534|P2|Overall Study|Deemed ineligible after study visit|6
5910794|NCT01596582|20447535|P1|Overall Study|Deemed ineligible after study visit|3
5910795|NCT01596504|20447562|P3|Overall Study|Withdrawal by Subject|0
5910796|NCT01596504|20447563|P2|Overall Study|Withdrawal by Subject|0
5910797|NCT01596504|20447564|P1|Overall Study|Withdrawal by Subject|1
5910798|NCT01596504|20447562|P3|Overall Study|Adverse Event|1
5910799|NCT01596504|20447563|P2|Overall Study|Adverse Event|2
5910800|NCT01596504|20447564|P1|Overall Study|Adverse Event|1
5910801|NCT01596504|20447562|P3|Overall Study|Participant's Private Reason|0
5910802|NCT01596504|20447563|P2|Overall Study|Participant's Private Reason|1
5910803|NCT01596504|20447564|P1|Overall Study|Participant's Private Reason|0
5910804|NCT01596335|20447622|P2|Overall Study|exacerbation of primary disease|9
5910805|NCT01596335|20447623|P1|Overall Study|exacerbation of primary disease|5
5910806|NCT01596127|20447659|P1|Overall Study|Patient Ineligible|1
5910807|NCT01596062|20447671|P3|Overall Study|Lack of Efficacy|1
5910808|NCT01596062|20447672|P2|Overall Study|Lack of Efficacy|0
5910809|NCT01596062|20447673|P1|Overall Study|Lack of Efficacy|0
5910810|NCT01596062|20447671|P3|Overall Study|Adverse Event|2
5910811|NCT01596062|20447672|P2|Overall Study|Adverse Event|0
5910812|NCT01596062|20447673|P1|Overall Study|Adverse Event|1
5910813|NCT01595646|20447737|P3|Overall Study|Withdrawal by Subject|0
5910814|NCT01595646|20447738|P2|Overall Study|Withdrawal by Subject|0
5910815|NCT01595646|20447739|P1|Overall Study|Withdrawal by Subject|1
5910816|NCT01595529|20447761|P2|Overall Study|Entry Failure/Screening Failure|1
5910817|NCT01595529|20447762|P1|Overall Study|Entry Failure/Screening Failure|6
5910818|NCT01595529|20447761|P2|Overall Study|Administrative Decision|0
5910819|NCT01595529|20447762|P1|Overall Study|Administrative Decision|1
5910820|NCT01595529|20447761|P2|Overall Study|Consent Withdrawn/Voluntary Withdrawal|3
5910821|NCT01595529|20447762|P1|Overall Study|Consent Withdrawn/Voluntary Withdrawal|3
5910822|NCT01595529|20447761|P2|Overall Study|Physician Decision|0
5910823|NCT01595529|20447762|P1|Overall Study|Physician Decision|1
5910824|NCT01595529|20447761|P2|Overall Study|Protocol Violation|2
5910825|NCT01595529|20447762|P1|Overall Study|Protocol Violation|1
5910826|NCT01595529|20447761|P2|Overall Study|Lost to Follow-up|14
5910827|NCT01595529|20447762|P1|Overall Study|Lost to Follow-up|8
5910828|NCT01595529|20447761|P2|Overall Study|Subject Non-Compliant|0
5910829|NCT01595529|20447762|P1|Overall Study|Subject Non-Compliant|2
5910830|NCT01595529|20447761|P2|Overall Study|Adverse Event|0
5910831|NCT01595529|20447762|P1|Overall Study|Adverse Event|2
5910832|NCT01595438|20447825|P2|Overall Study|Other Eligibility criteria|9
5910833|NCT01595438|20447826|P1|Overall Study|Other Eligibility criteria|11
5910834|NCT01595438|20447825|P2|Overall Study|Withdrawal by Subject|12
5910835|NCT01595438|20447826|P1|Overall Study|Withdrawal by Subject|12
5910836|NCT01595438|20447825|P2|Overall Study|Lost to Follow-up|20
5910837|NCT01595438|20447826|P1|Overall Study|Lost to Follow-up|20
5910838|NCT01595009|20447994|P4|Extension|Adverse Event|1
5910839|NCT01595009|20447995|P3|Extension|Adverse Event|0
5910840|NCT01595009|20447996|P2|Extension|Adverse Event|0
5910841|NCT01595009|20447997|P1|Extension|Adverse Event|0
5910842|NCT01595009|20447994|P4|Extension|Disease progression|7
5910843|NCT01595009|20447995|P3|Extension|Disease progression|4
5910844|NCT01595009|20447996|P2|Extension|Disease progression|0
5910845|NCT01595009|20447997|P1|Extension|Disease progression|0
5910846|NCT01595009|20447994|P4|Extension|Patients completed per protocol|2
5910847|NCT01595009|20447995|P3|Extension|Patients completed per protocol|0
5910848|NCT01595009|20447996|P2|Extension|Patients completed per protocol|0
5910849|NCT01595009|20447997|P1|Extension|Patients completed per protocol|0
5910850|NCT01595009|20447994|P4|Extension|Administrative problems|1
5910851|NCT01595009|20447995|P3|Extension|Administrative problems|0
5910852|NCT01595009|20447996|P2|Extension|Administrative problems|0
5910853|NCT01595009|20447997|P1|Extension|Administrative problems|0
5910862|NCT01595009|20447994|P4|Core|Lost to Follow-up|0
5910863|NCT01595009|20447995|P3|Core|Lost to Follow-up|0
5910864|NCT01595009|20447996|P2|Core|Lost to Follow-up|2
5910865|NCT01595009|20447997|P1|Core|Lost to Follow-up|1
5910866|NCT01595009|20447994|P4|Core|Death|0
5910867|NCT01595009|20447995|P3|Core|Death|0
5910868|NCT01595009|20447996|P2|Core|Death|6
5910869|NCT01595009|20447997|P1|Core|Death|3
5910870|NCT01595009|20447994|P4|Core|Withdrawal by Subject|0
5910871|NCT01595009|20447995|P3|Core|Withdrawal by Subject|0
5910872|NCT01595009|20447996|P2|Core|Withdrawal by Subject|17
5910873|NCT01595009|20447997|P1|Core|Withdrawal by Subject|4
5910874|NCT01595009|20447994|P4|Core|Disease progression|0
5910875|NCT01595009|20447995|P3|Core|Disease progression|0
5910876|NCT01595009|20447996|P2|Core|Disease progression|26
5910877|NCT01595009|20447997|P1|Core|Disease progression|14
5910878|NCT01595009|20447994|P4|Core|Adverse Event|0
5910879|NCT01595009|20447995|P3|Core|Adverse Event|0
5910880|NCT01595009|20447996|P2|Core|Adverse Event|23
5910881|NCT01595009|20447997|P1|Core|Adverse Event|19
5910882|NCT01595009|20447994|P4|Core|Patients completed per protocol|0
5910883|NCT01595009|20447995|P3|Core|Patients completed per protocol|0
5910884|NCT01595009|20447996|P2|Core|Patients completed per protocol|44
5910885|NCT01595009|20447997|P1|Core|Patients completed per protocol|85
5910886|NCT01594970|20448032|P3|Overall Study|Lost to Follow-up|37
5910887|NCT01594970|20448033|P2|Overall Study|Lost to Follow-up|54
5910888|NCT01594970|20448034|P1|Overall Study|Lost to Follow-up|54
5910889|NCT01594970|20448032|P3|Overall Study|Adverse Event|23
5910890|NCT01594970|20448033|P2|Overall Study|Adverse Event|23
5910891|NCT01594970|20448034|P1|Overall Study|Adverse Event|17
5910892|NCT01594970|20448032|P3|Overall Study|Non-Adverse Event Related|6
5910893|NCT01594970|20448033|P2|Overall Study|Non-Adverse Event Related|5
5910894|NCT01594970|20448034|P1|Overall Study|Non-Adverse Event Related|4
5910895|NCT01594853|20448053|P2|Overall Study|noncompliance with exercise|1
5910896|NCT01594853|20448054|P1|Overall Study|noncompliance with exercise|0
5910897|NCT01594853|20448053|P2|Overall Study|Lost to Follow-up|1
5910898|NCT01594853|20448054|P1|Overall Study|Lost to Follow-up|1
5910899|NCT01594853|20448053|P2|Overall Study|Withdrawal by Subject|1
5910900|NCT01594853|20448054|P1|Overall Study|Withdrawal by Subject|1
5910901|NCT01594827|20448062|P2|Overall Study|Physician Decision|0
5910902|NCT01594827|20448063|P1|Overall Study|Physician Decision|3
5910903|NCT01594827|20448062|P2|Overall Study|Adverse Event|0
5910904|NCT01594827|20448063|P1|Overall Study|Adverse Event|1
5910905|NCT01594762|20448087|P2|Overall Study|Lost to Follow-up|10
5910906|NCT01594762|20448088|P1|Overall Study|Lost to Follow-up|10
5910907|NCT01594762|20448087|P2|Overall Study|Withdrawal by Subject|0
5910908|NCT01594762|20448088|P1|Overall Study|Withdrawal by Subject|1
5910909|NCT01594749|20448100|P2|Overall Study|Lost Source Documentation|0
5910910|NCT01594749|20448101|P1|Overall Study|Lost Source Documentation|1
5910911|NCT01594749|20448100|P2|Overall Study|Not Treated|10
5910912|NCT01594749|20448101|P1|Overall Study|Not Treated|4
5910913|NCT01594749|20448100|P2|Overall Study|Death|3
5910914|NCT01594749|20448101|P1|Overall Study|Death|9
5910915|NCT01594749|20448100|P2|Overall Study|Lost to Follow-up|0
5910916|NCT01594749|20448101|P1|Overall Study|Lost to Follow-up|1
5910917|NCT01594749|20448100|P2|Overall Study|Non-compliance with Protocol|1
5910918|NCT01594749|20448101|P1|Overall Study|Non-compliance with Protocol|0
5910919|NCT01594749|20448100|P2|Overall Study|Physician Decision|1
5910920|NCT01594749|20448101|P1|Overall Study|Physician Decision|1
5910921|NCT01594749|20448100|P2|Overall Study|Protocol Violation|0
5910922|NCT01594749|20448101|P1|Overall Study|Protocol Violation|2
5910923|NCT01594749|20448100|P2|Overall Study|Withdrawal by Subject|2
5910924|NCT01594749|20448101|P1|Overall Study|Withdrawal by Subject|2
5910925|NCT01594749|20448100|P2|Overall Study|Adverse Event|1
5910926|NCT01594749|20448101|P1|Overall Study|Adverse Event|2
5910927|NCT01594476|20448239|P2|Overall Study|Protocol Violation|3
5910928|NCT01594476|20448240|P1|Overall Study|Protocol Violation|1
5910929|NCT01594411|20448262|P1|Overall Study|Lost to Follow-up|2
5910930|NCT01594333|20448296|P2|Overall Study|Withdrawal by Subject|63
5910931|NCT01594333|20448297|P1|Overall Study|Withdrawal by Subject|60
5910932|NCT01594333|20448296|P2|Overall Study|Lost to Follow-up|5
5910933|NCT01594333|20448297|P1|Overall Study|Lost to Follow-up|5
5910934|NCT01594333|20448296|P2|Overall Study|Death|83
5910935|NCT01594333|20448297|P1|Overall Study|Death|96
5910936|NCT01594281|20448343|P3|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1
5910937|NCT01594281|20448344|P2|Non-Interventional Follow Up Phase|Subject Withdrew Consent|0
5910938|NCT01594281|20448345|P1|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1
5910939|NCT01594281|20448343|P3|Non-Interventional Follow Up Phase|Administrative Problems|1
5910940|NCT01594281|20448344|P2|Non-Interventional Follow Up Phase|Administrative Problems|0
5910941|NCT01594281|20448345|P1|Non-Interventional Follow Up Phase|Administrative Problems|0
5910942|NCT01594281|20448343|P3|Non-Interventional Follow Up Phase|Lost to Follow-up|0
5910943|NCT01594281|20448344|P2|Non-Interventional Follow Up Phase|Lost to Follow-up|2
5910944|NCT01594281|20448345|P1|Non-Interventional Follow Up Phase|Lost to Follow-up|2
5910945|NCT01594281|20448343|P3|Interventional Core Phase|Adverse Event|4
5910946|NCT01594281|20448344|P2|Interventional Core Phase|Adverse Event|4
5910947|NCT01594281|20448345|P1|Interventional Core Phase|Adverse Event|4
5910948|NCT01594281|20448343|P3|Interventional Core Phase|Lost to Follow-up|1
5910949|NCT01594281|20448344|P2|Interventional Core Phase|Lost to Follow-up|4
5910950|NCT01594281|20448345|P1|Interventional Core Phase|Lost to Follow-up|1
5910951|NCT01594281|20448343|P3|Interventional Core Phase|Death|2
5910952|NCT01594281|20448344|P2|Interventional Core Phase|Death|1
5910953|NCT01594281|20448345|P1|Interventional Core Phase|Death|1
5910954|NCT01594281|20448343|P3|Interventional Core Phase|Subject Withdrew Consent|1
5910955|NCT01594281|20448344|P2|Interventional Core Phase|Subject Withdrew Consent|1
5910956|NCT01594281|20448345|P1|Interventional Core Phase|Subject Withdrew Consent|0
5910957|NCT01594281|20448343|P3|Interventional Core Phase|Protocol Deviation|0
5910958|NCT01594281|20448344|P2|Interventional Core Phase|Protocol Deviation|0
5910959|NCT01594281|20448345|P1|Interventional Core Phase|Protocol Deviation|1
5910960|NCT01594125|20448385|P5|Overall Study|Progressive Disease|7
5910961|NCT01594125|20448386|P4|Overall Study|Progressive Disease|3
5910962|NCT01594125|20448387|P3|Overall Study|Progressive Disease|3
5910963|NCT01594125|20448388|P2|Overall Study|Progressive Disease|12
5910964|NCT01594125|20448389|P1|Overall Study|Progressive Disease|3
5910965|NCT01594125|20448385|P5|Overall Study|Withdrawal by Subject|0
5910966|NCT01594125|20448386|P4|Overall Study|Withdrawal by Subject|1
5910967|NCT01594125|20448387|P3|Overall Study|Withdrawal by Subject|0
5910968|NCT01594125|20448388|P2|Overall Study|Withdrawal by Subject|0
5910969|NCT01594125|20448389|P1|Overall Study|Withdrawal by Subject|1
5910970|NCT01593787|20448449|P3|Overall Study|Adverse Event|0
5910971|NCT01593787|20448450|P2|Overall Study|Adverse Event|0
5910972|NCT01593787|20448451|P1|Overall Study|Adverse Event|1
5910973|NCT01593696|20448527|P4|Dose Expansion|Fungal infection|0
5910974|NCT01593696|20448528|P3|Dose Expansion|Fungal infection|1
5910975|NCT01593696|20448529|P2|Dose Expansion|Fungal infection|0
5910976|NCT01593696|20448530|P1|Dose Expansion|Fungal infection|0
5910977|NCT01593696|20448527|P4|Dose Escalation|Progressive Disease|0
5910978|NCT01593696|20448528|P3|Dose Escalation|Progressive Disease|0
5910979|NCT01593696|20448529|P2|Dose Escalation|Progressive Disease|0
5910980|NCT01593696|20448530|P1|Dose Escalation|Progressive Disease|2
5910981|NCT01593254|20448587|P2|Follow-Up Period|Study Drug Side Effects|1
5910982|NCT01593254|20448588|P1|Follow-Up Period|Study Drug Side Effects|0
5910983|NCT01593254|20448587|P2|Follow-Up Period|Disease Progression|1
5910984|NCT01593254|20448588|P1|Follow-Up Period|Disease Progression|0
5910985|NCT01593254|20448587|P2|Follow-Up Period|Fundus Hemorrhage|1
5910986|NCT01593254|20448588|P1|Follow-Up Period|Fundus Hemorrhage|0
5910987|NCT01593254|20448587|P2|Follow-Up Period|Patient refused to return|1
5910988|NCT01593254|20448588|P1|Follow-Up Period|Patient refused to return|0
5910989|NCT01593254|20448587|P2|Follow-Up Period|Study Drug Toxicity|1
5910990|NCT01593254|20448588|P1|Follow-Up Period|Study Drug Toxicity|0
5910991|NCT01593254|20448587|P2|Follow-Up Period|Pregnancy|1
5910992|NCT01593254|20448588|P1|Follow-Up Period|Pregnancy|0
5910993|NCT01593254|20448587|P2|Follow-Up Period|Subject request to Discontinue|1
5910994|NCT01593254|20448588|P1|Follow-Up Period|Subject request to Discontinue|0
5910995|NCT01593254|20448587|P2|Follow-Up Period|Death|2
5910996|NCT01593254|20448588|P1|Follow-Up Period|Death|2
5910997|NCT01593254|20448587|P2|Follow-Up Period|Non-Compliance|0
5910998|NCT01593254|20448588|P1|Follow-Up Period|Non-Compliance|1
5910999|NCT01593254|20448587|P2|Follow-Up Period|Withdrawal by Subject|2
5911000|NCT01593254|20448588|P1|Follow-Up Period|Withdrawal by Subject|0
5911001|NCT01593254|20448587|P2|Treatment Period|Investigator Decision|1
5911002|NCT01593254|20448588|P1|Treatment Period|Investigator Decision|2
5911003|NCT01593254|20448587|P2|Treatment Period|T315I MUTATION|1
5911004|NCT01593254|20448588|P1|Treatment Period|T315I MUTATION|0
5911005|NCT01593254|20448587|P2|Treatment Period|No Response|0
5911006|NCT01593254|20448588|P1|Treatment Period|No Response|1
5911007|NCT01593254|20448587|P2|Treatment Period|Patient Refused to Return|1
5911008|NCT01593254|20448588|P1|Treatment Period|Patient Refused to Return|0
5911009|NCT01593254|20448587|P2|Treatment Period|Did Not Achieve RCC|1
5911010|NCT01593254|20448588|P1|Treatment Period|Did Not Achieve RCC|0
5911011|NCT01593254|20448587|P2|Treatment Period|Disease Progression|6
5911012|NCT01593254|20448588|P1|Treatment Period|Disease Progression|1
5911013|NCT01593254|20448587|P2|Treatment Period|Study Drug Toxicity|9
5911014|NCT01593254|20448588|P1|Treatment Period|Study Drug Toxicity|3
5911015|NCT01593254|20448587|P2|Treatment Period|Death|1
5911016|NCT01593254|20448588|P1|Treatment Period|Death|2
5911017|NCT01593254|20448587|P2|Treatment Period|AE unrelated to Study Drug|1
5911018|NCT01593254|20448588|P1|Treatment Period|AE unrelated to Study Drug|0
5911019|NCT01593254|20448587|P2|Treatment Period|Subject Request to Discontinue|1
5911020|NCT01593254|20448588|P1|Treatment Period|Subject Request to Discontinue|1
5911021|NCT01593254|20448587|P2|Treatment Period|Subject withdrew consent|5
5911022|NCT01593254|20448588|P1|Treatment Period|Subject withdrew consent|0
5911023|NCT01593254|20448587|P2|Treatment Period|Maximum clinical benefit|0
5911024|NCT01593254|20448588|P1|Treatment Period|Maximum clinical benefit|1
5911025|NCT01593254|20448587|P2|Treatment Period|Poor/Non-Compliance|1
5911026|NCT01593254|20448588|P1|Treatment Period|Poor/Non-Compliance|2
5911027|NCT01593254|20448587|P2|Treatment Period|Pregnancy|1
5911028|NCT01593254|20448588|P1|Treatment Period|Pregnancy|0
5911029|NCT01593254|20448587|P2|Treatment Period|Treatment Failure|2
5911030|NCT01593254|20448588|P1|Treatment Period|Treatment Failure|1
5911031|NCT01592864|20448606|P2|Overall Study|Withdrawal by Subject|1
5911032|NCT01592864|20448607|P1|Overall Study|Withdrawal by Subject|0
5911033|NCT01592786|20448668|P1|Overall Study|Other|3
5911034|NCT01592786|20448668|P1|Overall Study|Lost to Follow-up|19
5911035|NCT01592786|20448668|P1|Overall Study|Withdrawal by Subject|23
5911036|NCT01592786|20448668|P1|Overall Study|Protocol Violation|14
5911037|NCT01592786|20448668|P1|Overall Study|Lack of Efficacy|19
5911038|NCT01592786|20448668|P1|Overall Study|Adverse Event|60
5911039|NCT01592773|20448672|P1|Overall Study|Other Reason|1
5911040|NCT01592773|20448672|P1|Overall Study|Inclusion/exclusion not meet|1
5911041|NCT01592773|20448672|P1|Overall Study|Protocol Violation|2
5911042|NCT01592773|20448672|P1|Overall Study|Lack of Efficacy|9
5911043|NCT01592773|20448672|P1|Overall Study|Adverse Event|17
5911044|NCT01592773|20448672|P1|Overall Study|Lost to Follow-up|19
5911045|NCT01592773|20448672|P1|Overall Study|Withdrawal by Subject|35
5911046|NCT01592773|20448672|P1|Overall Study|Study Terminated by Sponsor|582
5911047|NCT01592760|20448679|P3|24-hour Follow-Up|Lost to Follow-up|2
5911048|NCT01592760|20448680|P2|24-hour Follow-Up|Lost to Follow-up|3
5911049|NCT01592760|20448681|P1|24-hour Follow-Up|Lost to Follow-up|4
5911050|NCT01592747|20448725|P3|Overall Study|Other Reasons|0
5911051|NCT01592747|20448726|P2|Overall Study|Other Reasons|1
5911052|NCT01592747|20448727|P1|Overall Study|Other Reasons|1
5911053|NCT01592747|20448725|P3|Overall Study|Lost to Follow-up|1
5911054|NCT01592747|20448726|P2|Overall Study|Lost to Follow-up|0
5911055|NCT01592747|20448727|P1|Overall Study|Lost to Follow-up|1
5911056|NCT01592747|20448725|P3|Overall Study|Withdrawal by Subject|2
5911057|NCT01592747|20448726|P2|Overall Study|Withdrawal by Subject|0
5911058|NCT01592747|20448727|P1|Overall Study|Withdrawal by Subject|2
5911059|NCT01592747|20448725|P3|Overall Study|Lack of Efficacy|0
5911060|NCT01592747|20448726|P2|Overall Study|Lack of Efficacy|1
5911061|NCT01592747|20448727|P1|Overall Study|Lack of Efficacy|0
5911062|NCT01592747|20448725|P3|Overall Study|Protocol Violation|4
5911063|NCT01592747|20448726|P2|Overall Study|Protocol Violation|0
5911064|NCT01592747|20448727|P1|Overall Study|Protocol Violation|4
5911065|NCT01592747|20448725|P3|Overall Study|Adverse Event|0
5911066|NCT01592747|20448726|P2|Overall Study|Adverse Event|0
5911067|NCT01592747|20448727|P1|Overall Study|Adverse Event|1
5911068|NCT01592747|20448725|P3|Overall Study|Inclusion/Exclusion criteria not met|1
5911069|NCT01592747|20448726|P2|Overall Study|Inclusion/Exclusion criteria not met|1
5911070|NCT01592747|20448727|P1|Overall Study|Inclusion/Exclusion criteria not met|0
5911071|NCT01592747|20448725|P3|Overall Study|Loss of Therapeutic Response|100
5911072|NCT01592747|20448726|P2|Overall Study|Loss of Therapeutic Response|108
5911073|NCT01592747|20448727|P1|Overall Study|Loss of Therapeutic Response|107
5911074|NCT01592708|20448770|P2|Overall Study|Protocol Violation|0
5911075|NCT01592708|20448771|P1|Overall Study|Protocol Violation|3
5911076|NCT01592695|20448787|P2|Overall Study|Lost to Follow-up|4
5911077|NCT01592695|20448788|P1|Overall Study|Lost to Follow-up|8
5911078|NCT01592409|20448843|P2|Overall Study|Withdrawal by Subject|1
5911079|NCT01592409|20448844|P1|Overall Study|Withdrawal by Subject|0
5911080|NCT01592383|20448868|P1|Overall Study|Adverse Event|1
5911081|NCT01592344|20448879|P2|Overall Study|not available at primary outcome visit|4
5911082|NCT01592344|20448880|P1|Overall Study|not available at primary outcome visit|2
5911083|NCT01592344|20448879|P2|Overall Study|Lack of Efficacy|0
5911084|NCT01592344|20448880|P1|Overall Study|Lack of Efficacy|1
5911085|NCT01592344|20448879|P2|Overall Study|Adverse Event|1
5911086|NCT01592344|20448880|P1|Overall Study|Adverse Event|1
5911087|NCT01592292|20448894|P4|Overall Study|Other|1
5911088|NCT01592292|20448895|P3|Overall Study|Other|2
5911089|NCT01592292|20448896|P2|Overall Study|Other|1
5911090|NCT01592292|20448897|P1|Overall Study|Other|1
5911091|NCT01592292|20448894|P4|Overall Study|Withdrew consent|0
5911092|NCT01592292|20448895|P3|Overall Study|Withdrew consent|0
5911093|NCT01592292|20448896|P2|Overall Study|Withdrew consent|1
5911094|NCT01592292|20448897|P1|Overall Study|Withdrew consent|2
5911095|NCT01592292|20448894|P4|Overall Study|Follow-up loss|0
5911096|NCT01592292|20448895|P3|Overall Study|Follow-up loss|1
5911097|NCT01592292|20448896|P2|Overall Study|Follow-up loss|3
5911098|NCT01592292|20448897|P1|Overall Study|Follow-up loss|3
5911099|NCT01592240|20448936|P7|Overall Study|Did Not Meet Entrance Criteria|0
5911100|NCT01592240|20448937|P6|Overall Study|Did Not Meet Entrance Criteria|0
5911101|NCT01592240|20448938|P5|Overall Study|Did Not Meet Entrance Criteria|0
5911102|NCT01592240|20448939|P4|Overall Study|Did Not Meet Entrance Criteria|0
5911103|NCT01592240|20448940|P3|Overall Study|Did Not Meet Entrance Criteria|1
5911104|NCT01592240|20448941|P2|Overall Study|Did Not Meet Entrance Criteria|0
5911105|NCT01592240|20448942|P1|Overall Study|Did Not Meet Entrance Criteria|1
5911106|NCT01592240|20448936|P7|Overall Study|Other|1
5911107|NCT01592240|20448937|P6|Overall Study|Other|0
5911108|NCT01592240|20448938|P5|Overall Study|Other|0
5911109|NCT01592240|20448939|P4|Overall Study|Other|1
5911110|NCT01592240|20448940|P3|Overall Study|Other|1
5911111|NCT01592240|20448941|P2|Overall Study|Other|3
5911112|NCT01592240|20448942|P1|Overall Study|Other|0
5911113|NCT01592240|20448936|P7|Overall Study|Withdrawal by Subject|2
5911114|NCT01592240|20448937|P6|Overall Study|Withdrawal by Subject|0
5911115|NCT01592240|20448938|P5|Overall Study|Withdrawal by Subject|3
5911116|NCT01592240|20448939|P4|Overall Study|Withdrawal by Subject|1
5911117|NCT01592240|20448940|P3|Overall Study|Withdrawal by Subject|4
5911118|NCT01592240|20448941|P2|Overall Study|Withdrawal by Subject|4
5911119|NCT01592240|20448942|P1|Overall Study|Withdrawal by Subject|0
5911120|NCT01592240|20448936|P7|Overall Study|Protocol Violation|0
5911121|NCT01592240|20448937|P6|Overall Study|Protocol Violation|1
5911122|NCT01592240|20448938|P5|Overall Study|Protocol Violation|0
5911123|NCT01592240|20448939|P4|Overall Study|Protocol Violation|0
5911124|NCT01592240|20448940|P3|Overall Study|Protocol Violation|0
5911125|NCT01592240|20448941|P2|Overall Study|Protocol Violation|0
5911126|NCT01592240|20448942|P1|Overall Study|Protocol Violation|0
5911127|NCT01592240|20448936|P7|Overall Study|Lost to Follow-up|0
5911128|NCT01592240|20448937|P6|Overall Study|Lost to Follow-up|2
5911129|NCT01592240|20448938|P5|Overall Study|Lost to Follow-up|3
5911130|NCT01592240|20448939|P4|Overall Study|Lost to Follow-up|0
5911131|NCT01592240|20448940|P3|Overall Study|Lost to Follow-up|1
5911132|NCT01592240|20448941|P2|Overall Study|Lost to Follow-up|3
5911133|NCT01592240|20448942|P1|Overall Study|Lost to Follow-up|1
5911134|NCT01592240|20448936|P7|Overall Study|Death|0
5911135|NCT01592240|20448937|P6|Overall Study|Death|0
5911136|NCT01592240|20448938|P5|Overall Study|Death|0
5911137|NCT01592240|20448939|P4|Overall Study|Death|0
5911138|NCT01592240|20448940|P3|Overall Study|Death|0
5911139|NCT01592240|20448941|P2|Overall Study|Death|1
5911140|NCT01592240|20448942|P1|Overall Study|Death|0
5911141|NCT01592240|20448936|P7|Overall Study|Adverse Event|0
5911142|NCT01592240|20448937|P6|Overall Study|Adverse Event|0
5911143|NCT01592240|20448938|P5|Overall Study|Adverse Event|1
5911144|NCT01592240|20448939|P4|Overall Study|Adverse Event|1
5911145|NCT01592240|20448940|P3|Overall Study|Adverse Event|0
5911146|NCT01592240|20448941|P2|Overall Study|Adverse Event|0
5911147|NCT01592240|20448942|P1|Overall Study|Adverse Event|1
5911148|NCT01592045|20449135|P2|Overall Study|Moved out of country|0
5911149|NCT01592045|20449136|P1|Overall Study|Moved out of country|2
5911150|NCT01592045|20449135|P2|Overall Study|Withdrawal by Subject|0
5911151|NCT01592045|20449136|P1|Overall Study|Withdrawal by Subject|1
5911152|NCT01592045|20449135|P2|Overall Study|Adverse Event|1
5911153|NCT01592045|20449136|P1|Overall Study|Adverse Event|1
5911154|NCT01592045|20449135|P2|Overall Study|Disease Progression|1
5911155|NCT01592045|20449136|P1|Overall Study|Disease Progression|1
5911156|NCT01591863|20449154|P1|Overall Study|Lack of Efficacy|1
5911157|NCT01591863|20449154|P1|Overall Study|recurrence|9
5911158|NCT01591863|20449154|P1|Overall Study|Withdrawal by Subject|1
5911159|NCT01591863|20449154|P1|Overall Study|Adverse Event|3
5911160|NCT01591785|20449183|P2|Overall Study|Lost to Follow-up|0
5911161|NCT01591785|20449184|P1|Overall Study|Lost to Follow-up|1
5911162|NCT01591785|20449183|P2|Overall Study|Protocol Violation|0
5911163|NCT01591785|20449184|P1|Overall Study|Protocol Violation|2
5911164|NCT01591785|20449183|P2|Overall Study|worsening condition|2
5911165|NCT01591785|20449184|P1|Overall Study|worsening condition|1
5911166|NCT01591681|20449226|P1|Overall Study|Failed to use system during run-in|1
5911167|NCT01591681|20449226|P1|Overall Study|Didn't meet min hypoglycemia requirement|3
5911168|NCT01591616|20449273|P1|Overall Study|Withdrawal by Subject|1
5911169|NCT01591499|20449414|P4|Second Intervention (up to 24 Days)|Lost to Follow-up|3
5911170|NCT01591499|20449415|P3|Second Intervention (up to 24 Days)|Lost to Follow-up|1
5911171|NCT01591499|20449416|P2|Second Intervention (up to 24 Days)|Lost to Follow-up|3
5911172|NCT01591499|20449417|P1|Second Intervention (up to 24 Days)|Lost to Follow-up|4
5911173|NCT01591499|20449414|P4|Second Intervention (up to 24 Days)|Withdrawal by Subject|0
5911174|NCT01591499|20449415|P3|Second Intervention (up to 24 Days)|Withdrawal by Subject|2
5911175|NCT01591499|20449416|P2|Second Intervention (up to 24 Days)|Withdrawal by Subject|0
5911176|NCT01591499|20449417|P1|Second Intervention (up to 24 Days)|Withdrawal by Subject|2
5911177|NCT01591499|20449414|P4|Baseline Visit|Withdrawal by Subject|2
5911178|NCT01591499|20449415|P3|Baseline Visit|Withdrawal by Subject|0
5911179|NCT01591499|20449416|P2|Baseline Visit|Withdrawal by Subject|2
5911180|NCT01591499|20449417|P1|Baseline Visit|Withdrawal by Subject|0
5911181|NCT01591460|20449483|P1|Overall Study|Protocol Violation|1
5911182|NCT01591460|20449483|P1|Overall Study|Withdrawal by Subject|1
5911183|NCT01591460|20449483|P1|Overall Study|Participant Refusal|3
5911184|NCT01591460|20449483|P1|Overall Study|Noncompliance|1
5911185|NCT01591460|20449483|P1|Overall Study|Lost to Follow-up|1
5911186|NCT01591460|20449483|P1|Overall Study|Treatment Discontinued by Error|1
5911187|NCT01591460|20449483|P1|Overall Study|Rebound or Breakthrough|3
5911188|NCT01591460|20449483|P1|Overall Study|Futility Rule (Week 24)|3
5911189|NCT01591460|20449483|P1|Overall Study|Futility Rule (Week 12)|7
5911190|NCT01591460|20449483|P1|Overall Study|Adverse Event or Intercurrent Illness|5
5911191|NCT01591382|20449574|P2|Overall Study|Participant Opted for Morphine PCA|1
5911192|NCT01591382|20449575|P1|Overall Study|Participant Opted for Morphine PCA|1
5911193|NCT01591382|20449574|P2|Overall Study|Discharged Prior to Study Completion|1
5911194|NCT01591382|20449575|P1|Overall Study|Discharged Prior to Study Completion|2
5911195|NCT01591096|20449643|P1|Overall Study|Adverse Event|1
5911196|NCT01590888|20449728|P3|Overall Study|Lost to Follow-up|0
5911197|NCT01590888|20449729|P2|Overall Study|Lost to Follow-up|0
5911198|NCT01590888|20449730|P1|Overall Study|Lost to Follow-up|1
5911199|NCT01590888|20449728|P3|Overall Study|Adverse Event|1
5911200|NCT01590888|20449729|P2|Overall Study|Adverse Event|0
5911201|NCT01590888|20449730|P1|Overall Study|Adverse Event|3
5911202|NCT01590810|20449790|P5|Overall Study|Physician Decision|0
5911203|NCT01590810|20449791|P4|Overall Study|Physician Decision|0
5911204|NCT01590810|20449792|P3|Overall Study|Physician Decision|1
5911205|NCT01590810|20449793|P2|Overall Study|Physician Decision|1
5911206|NCT01590810|20449794|P1|Overall Study|Physician Decision|0
5911207|NCT01590797|20449939|P2|Overall Study|Other Protocol Specified Criteria|4
5911208|NCT01590797|20449940|P1|Overall Study|Other Protocol Specified Criteria|2
5911209|NCT01590797|20449939|P2|Overall Study|Withdrawal by Subject|5
5911210|NCT01590797|20449940|P1|Overall Study|Withdrawal by Subject|7
5911211|NCT01590797|20449939|P2|Overall Study|Protocol Violation|1
5911212|NCT01590797|20449940|P1|Overall Study|Protocol Violation|4
5911213|NCT01590797|20449939|P2|Overall Study|Lost to Follow-up|1
5911214|NCT01590797|20449940|P1|Overall Study|Lost to Follow-up|0
5911215|NCT01590797|20449939|P2|Overall Study|Lack of Efficacy|2
5911216|NCT01590797|20449940|P1|Overall Study|Lack of Efficacy|0
5911217|NCT01590797|20449939|P2|Overall Study|Adverse Event|3
5911218|NCT01590797|20449940|P1|Overall Study|Adverse Event|4
5911219|NCT01590771|20449956|P2|Overall Study|Adverse Event|7
5911220|NCT01590771|20449957|P1|Overall Study|Adverse Event|3
5911221|NCT01590771|20449956|P2|Overall Study|Lack of Efficacy|0
5911222|NCT01590771|20449957|P1|Overall Study|Lack of Efficacy|1
5911223|NCT01590771|20449956|P2|Overall Study|Lost to Follow-up|1
5911224|NCT01590771|20449957|P1|Overall Study|Lost to Follow-up|1
5911225|NCT01590771|20449956|P2|Overall Study|Protocol Violation|2
5911226|NCT01590771|20449957|P1|Overall Study|Protocol Violation|1
5911227|NCT01590771|20449956|P2|Overall Study|Withdrawal by Subject|15
5911228|NCT01590771|20449957|P1|Overall Study|Withdrawal by Subject|8
5911229|NCT01590771|20449956|P2|Overall Study|Other Protocol Specified Criteria|14
5911230|NCT01590771|20449957|P1|Overall Study|Other Protocol Specified Criteria|5
5911231|NCT01590758|20449985|P2|Overall Study|Lost to Follow-up|2
5911232|NCT01590758|20449986|P1|Overall Study|Lost to Follow-up|4
5911233|NCT01590758|20449985|P2|Overall Study|Physician Decision|2
5911234|NCT01590758|20449986|P1|Overall Study|Physician Decision|1
5911235|NCT01590758|20449985|P2|Overall Study|Withdrawal by Subject|3
5911236|NCT01590758|20449986|P1|Overall Study|Withdrawal by Subject|0
5911237|NCT01590563|20449996|P1|Overall Study|simple uterine hyperplasia - not related|1
5911238|NCT01590433|20450010|P2|Overall Study|Adverse Event|3
5911239|NCT01590433|20450011|P1|Overall Study|Adverse Event|11
5911240|NCT01590433|20450010|P2|Overall Study|Withdrawal by Subject|11
5911241|NCT01590433|20450011|P1|Overall Study|Withdrawal by Subject|21
5911242|NCT01590433|20450010|P2|Overall Study|Lost to Follow-up|8
5911243|NCT01590433|20450011|P1|Overall Study|Lost to Follow-up|20
5911244|NCT01590212|20450033|P3|Overall Study|Lost to Follow-up|3
5911245|NCT01590212|20450034|P2|Overall Study|Lost to Follow-up|2
5911246|NCT01590212|20450035|P1|Overall Study|Lost to Follow-up|1
5911247|NCT01590212|20450033|P3|Overall Study|Withdrawal by Subject|2
5911248|NCT01590212|20450034|P2|Overall Study|Withdrawal by Subject|2
5911249|NCT01590212|20450035|P1|Overall Study|Withdrawal by Subject|2
5911250|NCT01590082|20450054|P2|Overall Study|Ineligible|0
5911251|NCT01590082|20450055|P1|Overall Study|Ineligible|1
5911252|NCT01590082|20450054|P2|Overall Study|Withdrawal by Subject|0
5911253|NCT01590082|20450055|P1|Overall Study|Withdrawal by Subject|1
5911254|NCT01590017|20450061|P1|Overall Study|Physician Decision|1
5911255|NCT01590017|20450061|P1|Overall Study|Lack of Efficacy|1
5911256|NCT01590017|20450061|P1|Overall Study|Withdrawal by Subject|1
5911257|NCT01590017|20450061|P1|Overall Study|Adverse Event|1
5911258|NCT01589822|20450114|P3|Overall Study|Missed 90 day visit|1
5911259|NCT01589822|20450115|P2|Overall Study|Missed 90 day visit|1
5911260|NCT01589822|20450116|P1|Overall Study|Missed 90 day visit|2
5911261|NCT01589822|20450114|P3|Overall Study|Death|0
5911262|NCT01589822|20450115|P2|Overall Study|Death|0
5911263|NCT01589822|20450116|P1|Overall Study|Death|1
5911264|NCT01589822|20450114|P3|Overall Study|Withdrawal by Subject|0
5911265|NCT01589822|20450115|P2|Overall Study|Withdrawal by Subject|2
5911266|NCT01589822|20450116|P1|Overall Study|Withdrawal by Subject|1
5911267|NCT01589770|20450135|P2|Overall Study|claustrophobic when entering cardiac MRI|1
5911268|NCT01589770|20450136|P1|Overall Study|claustrophobic when entering cardiac MRI|2
5911269|NCT01589770|20450135|P2|Overall Study|EGFR <60ml/min|4
5911270|NCT01589770|20450136|P1|Overall Study|EGFR <60ml/min|6
5911271|NCT01589653|20450146|P2|Overall Study|Unclassified|3
5911272|NCT01589653|20450147|P1|Overall Study|Unclassified|0
5911273|NCT01589653|20450146|P2|Overall Study|Withdrawal criteria|7
5911274|NCT01589653|20450147|P1|Overall Study|Withdrawal criteria|4
5911275|NCT01589653|20450146|P2|Overall Study|Protocol Violation|1
5911276|NCT01589653|20450147|P1|Overall Study|Protocol Violation|3
5911277|NCT01589497|20450197|P4|Overall Study|Pre-entry overnight sputum< 10ML|0
5911278|NCT01589497|20450198|P3|Overall Study|Pre-entry overnight sputum< 10ML|1
5911279|NCT01589497|20450199|P2|Overall Study|Pre-entry overnight sputum< 10ML|0
5911280|NCT01589497|20450200|P1|Overall Study|Pre-entry overnight sputum< 10ML|0
5911281|NCT01589497|20450197|P4|Overall Study|Death|0
5911282|NCT01589497|20450198|P3|Overall Study|Death|0
5911283|NCT01589497|20450199|P2|Overall Study|Death|0
5911284|NCT01589497|20450200|P1|Overall Study|Death|1
5911285|NCT01589497|20450197|P4|Overall Study|Withdrawal by Subject|1
5911286|NCT01589497|20450198|P3|Overall Study|Withdrawal by Subject|0
5911287|NCT01589497|20450199|P2|Overall Study|Withdrawal by Subject|1
5911288|NCT01589497|20450200|P1|Overall Study|Withdrawal by Subject|0
5911289|NCT01589445|20450306|P1|002 (Metformin)-3 Months|Husbands of female patients refrained|2
5911290|NCT01589445|20450306|P1|002 (Metformin)-3 Months|Adverse Event|2
5911291|NCT01589445|20450306|P1|002 (Metformin)-3 Months|Protocol Violation|2
5911292|NCT01589445|20450306|P1|002 (Metformin)-3 Months|Lost to Follow-up|2
5911293|NCT01589445|20450306|P1|002 (Metformin)-3 Months|Lack of Efficacy|1
5911294|NCT01589445|20450306|P1|001 (Pioglitazone) -3 Months|biasedness about the double blind method|2
5911295|NCT01589445|20450306|P1|001 (Pioglitazone) -3 Months|Lack of Efficacy|1
5911296|NCT01589445|20450306|P1|001 (Pioglitazone) -3 Months|Lost to Follow-up|2
5911297|NCT01589445|20450306|P1|001 (Pioglitazone) -3 Months|Withdrawal by Subject|1
5911298|NCT01589445|20450306|P1|001 (Pioglitazone) -3 Months|Protocol Violation|1
5911299|NCT01589237|20450349|P4|Part B (Planned for 78 Week-terminated)|Physician Decision|1
5911300|NCT01589237|20450350|P3|Part B (Planned for 78 Week-terminated)|Physician Decision|0
5911301|NCT01589237|20450351|P2|Part B (Planned for 78 Week-terminated)|Physician Decision|0
5911302|NCT01589237|20450352|P1|Part B (Planned for 78 Week-terminated)|Physician Decision|0
5911303|NCT01589237|20450349|P4|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|3
5911304|NCT01589237|20450350|P3|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|4
5911305|NCT01589237|20450351|P2|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5
5911306|NCT01589237|20450352|P1|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5
5911307|NCT01589237|20450349|P4|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0
5911308|NCT01589237|20450350|P3|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0
5911309|NCT01589237|20450351|P2|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|1
5911310|NCT01589237|20450352|P1|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0
5911311|NCT01589237|20450349|P4|Part A (52 Weeks)|Subject/guardian decision|0
5911312|NCT01589237|20450350|P3|Part A (52 Weeks)|Subject/guardian decision|2
5911313|NCT01589237|20450351|P2|Part A (52 Weeks)|Subject/guardian decision|3
5911314|NCT01589237|20450352|P1|Part A (52 Weeks)|Subject/guardian decision|2
5911315|NCT01589185|20450403|P5|Overall Study|Lost to Follow-up|0
5911316|NCT01589185|20450404|P4|Overall Study|Lost to Follow-up|3
5911317|NCT01589185|20450405|P3|Overall Study|Lost to Follow-up|2
5911318|NCT01589185|20450406|P2|Overall Study|Lost to Follow-up|0
5911319|NCT01589185|20450407|P1|Overall Study|Lost to Follow-up|1
5911320|NCT01589185|20450403|P5|Overall Study|Death|1
5911321|NCT01589185|20450404|P4|Overall Study|Death|0
5911322|NCT01589185|20450405|P3|Overall Study|Death|2
5911323|NCT01589185|20450406|P2|Overall Study|Death|2
5911324|NCT01589185|20450407|P1|Overall Study|Death|1
5911325|NCT01589094|20450440|P1|Overall Study|Did not receive treatment|2
5911326|NCT01588990|20450447|P1|Phase B|Other|2
5911327|NCT01588990|20450447|P1|Phase B|Physician Decision|4
5911328|NCT01588990|20450447|P1|Phase B|Withdrawal by Subject|3
5911329|NCT01588990|20450447|P1|Phase B|Still on therapy at end of study|5
5911330|NCT01588990|20450447|P1|Phase B|Adverse Event|2
5911331|NCT01588990|20450447|P1|Phase A|Still on therapy at end of study|6
5911332|NCT01588990|20450447|P1|Phase A|Adverse Event|28
5911333|NCT01588990|20450447|P1|Phase A|Death|5
5911334|NCT01588990|20450447|P1|Phase A|Lost to Follow-up|1
5911335|NCT01588990|20450447|P1|Phase A|Other|14
5911336|NCT01588990|20450447|P1|Phase A|Physician Decision|11
5911337|NCT01588990|20450447|P1|Phase A|Withdrawal by Subject|5
5911338|NCT01588951|20450475|P3|Overall Study|Ineligible in retrospect|1
5911339|NCT01588951|20450476|P2|Overall Study|Ineligible in retrospect|0
5911340|NCT01588951|20450477|P1|Overall Study|Ineligible in retrospect|0
5911341|NCT01588548|20450513|P6|Overall Study|Condition Under Investigation Worsened|3
5911342|NCT01588548|20450514|P5|Overall Study|Condition Under Investigation Worsened|3
5911343|NCT01588548|20450515|P4|Overall Study|Condition Under Investigation Worsened|4
5911344|NCT01588548|20450516|P3|Overall Study|Condition Under Investigation Worsened|4
5911345|NCT01588548|20450517|P2|Overall Study|Condition Under Investigation Worsened|6
5911346|NCT01588548|20450518|P1|Overall Study|Condition Under Investigation Worsened|3
5911347|NCT01588548|20450513|P6|Overall Study|Adverse Event|0
5911348|NCT01588548|20450514|P5|Overall Study|Adverse Event|1
5911349|NCT01588548|20450515|P4|Overall Study|Adverse Event|2
5911350|NCT01588548|20450516|P3|Overall Study|Adverse Event|1
5911351|NCT01588548|20450517|P2|Overall Study|Adverse Event|0
5911352|NCT01588548|20450518|P1|Overall Study|Adverse Event|0
5911353|NCT01588548|20450513|P6|Overall Study|Withdrawal by Subject|3
5911354|NCT01588548|20450514|P5|Overall Study|Withdrawal by Subject|2
5911355|NCT01588548|20450515|P4|Overall Study|Withdrawal by Subject|1
5911356|NCT01588548|20450516|P3|Overall Study|Withdrawal by Subject|1
5911357|NCT01588548|20450517|P2|Overall Study|Withdrawal by Subject|1
5911358|NCT01588548|20450518|P1|Overall Study|Withdrawal by Subject|0
5911359|NCT01588509|20450534|P2|Overall Study|Lost to Follow-up|0
5911360|NCT01588509|20450535|P1|Overall Study|Lost to Follow-up|1
5911361|NCT01588496|20450558|P3|Overall Study|Withdrawal by Subject|0
5911362|NCT01588496|20450559|P2|Overall Study|Withdrawal by Subject|1
5911363|NCT01588496|20450560|P1|Overall Study|Withdrawal by Subject|0
5911364|NCT01588405|20450635|P1|Overall Study|Clinical Worsening|1
5911365|NCT01588405|20450635|P1|Overall Study|Adverse Event|1
5911366|NCT01588366|20450664|P6|Overall Study|Adverse Event|2
5911367|NCT01588366|20450665|P5|Overall Study|Adverse Event|0
5911368|NCT01588366|20450666|P4|Overall Study|Adverse Event|1
5911369|NCT01588366|20450667|P3|Overall Study|Adverse Event|0
5911370|NCT01588366|20450668|P2|Overall Study|Adverse Event|1
5911371|NCT01588366|20450669|P1|Overall Study|Adverse Event|0
5911372|NCT01588353|20450697|P3|Step3|Adverse Event|2
5911373|NCT01588353|20450698|P2|Step3|Adverse Event|0
5911374|NCT01588353|20450699|P1|Step3|Adverse Event|0
5911375|NCT01588353|20450697|P3|Step2|Withdrawal by Subject|0
5911376|NCT01588353|20450698|P2|Step2|Withdrawal by Subject|1
5911377|NCT01588353|20450699|P1|Step2|Withdrawal by Subject|0
5911378|NCT01588197|20450748|P2|Overall Study|No MRI|0
5911379|NCT01588197|20450749|P1|Overall Study|No MRI|1
5911380|NCT01588197|20450748|P2|Overall Study|Lack of Efficacy|1
5911381|NCT01588197|20450749|P1|Overall Study|Lack of Efficacy|0
5911382|NCT01588184|20450765|P6|Overall Study|multiple reasons|0
5911383|NCT01588184|20450766|P5|Overall Study|multiple reasons|0
5911384|NCT01588184|20450767|P4|Overall Study|multiple reasons|1
5911385|NCT01588184|20450768|P3|Overall Study|multiple reasons|0
5911386|NCT01588184|20450769|P2|Overall Study|multiple reasons|3
5911387|NCT01588184|20450770|P1|Overall Study|multiple reasons|0
5911388|NCT01588184|20450765|P6|Overall Study|Bevacizumab treatment provision changed|3
5911389|NCT01588184|20450766|P5|Overall Study|Bevacizumab treatment provision changed|1
5911390|NCT01588184|20450767|P4|Overall Study|Bevacizumab treatment provision changed|0
5911391|NCT01588184|20450768|P3|Overall Study|Bevacizumab treatment provision changed|2
5911392|NCT01588184|20450769|P2|Overall Study|Bevacizumab treatment provision changed|6
5911393|NCT01588184|20450770|P1|Overall Study|Bevacizumab treatment provision changed|0
5911394|NCT01588184|20450765|P6|Overall Study|Withdrawal by Subject|0
5911395|NCT01588184|20450766|P5|Overall Study|Withdrawal by Subject|0
5911396|NCT01588184|20450767|P4|Overall Study|Withdrawal by Subject|1
5911397|NCT01588184|20450768|P3|Overall Study|Withdrawal by Subject|0
5911398|NCT01588184|20450769|P2|Overall Study|Withdrawal by Subject|4
5911399|NCT01588184|20450770|P1|Overall Study|Withdrawal by Subject|2
5911400|NCT01588184|20450765|P6|Overall Study|Death|1
5911401|NCT01588184|20450766|P5|Overall Study|Death|1
5911402|NCT01588184|20450767|P4|Overall Study|Death|1
5911403|NCT01588184|20450768|P3|Overall Study|Death|0
5911404|NCT01588184|20450769|P2|Overall Study|Death|0
5911405|NCT01588184|20450770|P1|Overall Study|Death|1
5911406|NCT01588106|20450823|P2|Overall Study|Withdrawal by Subject|4
5911407|NCT01588106|20450824|P1|Overall Study|Withdrawal by Subject|5
5911408|NCT01587989|20450832|P3|Randomized Study Treatment|Physician Decision|1
5911409|NCT01587989|20450833|P2|Randomized Study Treatment|Physician Decision|0
5911410|NCT01587989|20450834|P1|Randomized Study Treatment|Physician Decision|0
5911411|NCT01587989|20450832|P3|Randomized Study Treatment|Screening failure|0
5911412|NCT01587989|20450833|P2|Randomized Study Treatment|Screening failure|1
5911413|NCT01587989|20450834|P1|Randomized Study Treatment|Screening failure|0
5911414|NCT01587989|20450832|P3|Randomized Study Treatment|Withdrawal by Subject|0
5911415|NCT01587989|20450833|P2|Randomized Study Treatment|Withdrawal by Subject|1
5911416|NCT01587989|20450834|P1|Randomized Study Treatment|Withdrawal by Subject|0
5911417|NCT01587989|20450832|P3|12-Week Open-Label Run-In Period|No EULAR Response|0
5911418|NCT01587989|20450833|P2|12-Week Open-Label Run-In Period|No EULAR Response|0
5911419|NCT01587989|20450834|P1|12-Week Open-Label Run-In Period|No EULAR Response|4
5911420|NCT01587989|20450832|P3|12-Week Open-Label Run-In Period|Withdrawal by Subject|0
5911421|NCT01587989|20450833|P2|12-Week Open-Label Run-In Period|Withdrawal by Subject|0
5911422|NCT01587989|20450834|P1|12-Week Open-Label Run-In Period|Withdrawal by Subject|1
5911423|NCT01587989|20450832|P3|12-Week Open-Label Run-In Period|Physician Decision|0
5911424|NCT01587989|20450833|P2|12-Week Open-Label Run-In Period|Physician Decision|0
5911425|NCT01587989|20450834|P1|12-Week Open-Label Run-In Period|Physician Decision|7
5911426|NCT01587924|20450899|P4|Overall Study|Withdrawal by Subject|0
5911427|NCT01587924|20450900|P3|Overall Study|Withdrawal by Subject|1
5911428|NCT01587924|20450901|P2|Overall Study|Withdrawal by Subject|1
5911429|NCT01587924|20450902|P1|Overall Study|Withdrawal by Subject|0
5911430|NCT01587924|20450899|P4|Overall Study|Met Hemoglobin stopping criteria|0
5911431|NCT01587924|20450900|P3|Overall Study|Met Hemoglobin stopping criteria|1
5911432|NCT01587924|20450901|P2|Overall Study|Met Hemoglobin stopping criteria|0
5911433|NCT01587924|20450902|P1|Overall Study|Met Hemoglobin stopping criteria|2
5911434|NCT01587924|20450899|P4|Overall Study|Protocol Violation|1
5911435|NCT01587924|20450900|P3|Overall Study|Protocol Violation|2
5911436|NCT01587924|20450901|P2|Overall Study|Protocol Violation|1
5911437|NCT01587924|20450902|P1|Overall Study|Protocol Violation|2
5911438|NCT01587924|20450899|P4|Overall Study|Adverse Event|0
5911439|NCT01587924|20450900|P3|Overall Study|Adverse Event|0
5911440|NCT01587924|20450901|P2|Overall Study|Adverse Event|2
5911441|NCT01587924|20450902|P1|Overall Study|Adverse Event|0
5911442|NCT01587898|20451003|P4|Overall Study|Met haemoglobin stopping criteria|0
5911443|NCT01587898|20451004|P3|Overall Study|Met haemoglobin stopping criteria|1
5911444|NCT01587898|20451005|P2|Overall Study|Met haemoglobin stopping criteria|1
5911445|NCT01587898|20451006|P1|Overall Study|Met haemoglobin stopping criteria|1
5911446|NCT01587898|20451003|P4|Overall Study|Withdrawal by Subject|0
5911447|NCT01587898|20451004|P3|Overall Study|Withdrawal by Subject|0
5911448|NCT01587898|20451005|P2|Overall Study|Withdrawal by Subject|1
5911449|NCT01587898|20451006|P1|Overall Study|Withdrawal by Subject|2
5911450|NCT01587898|20451003|P4|Overall Study|Lost to Follow-up|1
5911451|NCT01587898|20451004|P3|Overall Study|Lost to Follow-up|0
5911452|NCT01587898|20451005|P2|Overall Study|Lost to Follow-up|0
5911453|NCT01587898|20451006|P1|Overall Study|Lost to Follow-up|0
5911454|NCT01587898|20451003|P4|Overall Study|Protocol Violation|1
5911455|NCT01587898|20451004|P3|Overall Study|Protocol Violation|1
5911456|NCT01587898|20451005|P2|Overall Study|Protocol Violation|2
5911457|NCT01587898|20451006|P1|Overall Study|Protocol Violation|0
5911458|NCT01587898|20451003|P4|Overall Study|Adverse Event|0
5911459|NCT01587898|20451004|P3|Overall Study|Adverse Event|0
5911460|NCT01587898|20451005|P2|Overall Study|Adverse Event|1
5911461|NCT01587898|20451006|P1|Overall Study|Adverse Event|1
5911462|NCT01587885|20451182|P2|Treatment Period 1|Protocol Violation|2
5911463|NCT01587885|20451183|P1|Treatment Period 1|Protocol Violation|0
5911464|NCT01587885|20451182|P2|Treatment Period 1|Failure to Return|1
5911465|NCT01587885|20451183|P1|Treatment Period 1|Failure to Return|0
5911466|NCT01587703|20451214|P19|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
5911467|NCT01587703|20451215|P18|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
5911468|NCT01587703|20451216|P17|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
5911469|NCT01587703|20451217|P16|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
5911759|NCT01587651|20451641|P1|Overall Study|Adverse Event|0
5911470|NCT01587703|20451218|P15|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
5911471|NCT01587703|20451219|P14|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
5911472|NCT01587703|20451220|P13|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
5911473|NCT01587703|20451221|P12|Part2(Median Exposure of 1.41 Months)|Physician Decision|1
5911474|NCT01587703|20451222|P11|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
5911475|NCT01587703|20451223|P10|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
5911476|NCT01587703|20451224|P9|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
5911477|NCT01587703|20451225|P8|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
5911478|NCT01587703|20451226|P7|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
5911479|NCT01587703|20451227|P6|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
5911480|NCT01587703|20451228|P5|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
5911481|NCT01587703|20451229|P4|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
5911482|NCT01587703|20451230|P3|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
5911483|NCT01587703|20451231|P2|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
5911484|NCT01587703|20451232|P1|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
5911485|NCT01587703|20451214|P19|Part2(Median Exposure of 1.41 Months)|Death|0
5911486|NCT01587703|20451215|P18|Part2(Median Exposure of 1.41 Months)|Death|0
5911487|NCT01587703|20451216|P17|Part2(Median Exposure of 1.41 Months)|Death|5
5911488|NCT01587703|20451217|P16|Part2(Median Exposure of 1.41 Months)|Death|17
5911489|NCT01587703|20451218|P15|Part2(Median Exposure of 1.41 Months)|Death|16
5911490|NCT01587703|20451219|P14|Part2(Median Exposure of 1.41 Months)|Death|21
5911491|NCT01587703|20451220|P13|Part2(Median Exposure of 1.41 Months)|Death|12
5911492|NCT01587703|20451221|P12|Part2(Median Exposure of 1.41 Months)|Death|8
5911493|NCT01587703|20451222|P11|Part2(Median Exposure of 1.41 Months)|Death|0
5911494|NCT01587703|20451223|P10|Part2(Median Exposure of 1.41 Months)|Death|0
5911495|NCT01587703|20451224|P9|Part2(Median Exposure of 1.41 Months)|Death|0
5911496|NCT01587703|20451225|P8|Part2(Median Exposure of 1.41 Months)|Death|0
5911497|NCT01587703|20451226|P7|Part2(Median Exposure of 1.41 Months)|Death|0
5911498|NCT01587703|20451227|P6|Part2(Median Exposure of 1.41 Months)|Death|0
5911499|NCT01587703|20451228|P5|Part2(Median Exposure of 1.41 Months)|Death|0
5911500|NCT01587703|20451229|P4|Part2(Median Exposure of 1.41 Months)|Death|0
5911501|NCT01587703|20451230|P3|Part2(Median Exposure of 1.41 Months)|Death|0
5911502|NCT01587703|20451231|P2|Part2(Median Exposure of 1.41 Months)|Death|0
5911503|NCT01587703|20451232|P1|Part2(Median Exposure of 1.41 Months)|Death|0
5911504|NCT01587703|20451214|P19|Part2(Median Exposure of 1.41 Months)|Site closed|0
5911505|NCT01587703|20451215|P18|Part2(Median Exposure of 1.41 Months)|Site closed|0
5911506|NCT01587703|20451216|P17|Part2(Median Exposure of 1.41 Months)|Site closed|8
5911507|NCT01587703|20451217|P16|Part2(Median Exposure of 1.41 Months)|Site closed|3
5911508|NCT01587703|20451218|P15|Part2(Median Exposure of 1.41 Months)|Site closed|1
5911509|NCT01587703|20451219|P14|Part2(Median Exposure of 1.41 Months)|Site closed|1
5911510|NCT01587703|20451220|P13|Part2(Median Exposure of 1.41 Months)|Site closed|2
5911511|NCT01587703|20451221|P12|Part2(Median Exposure of 1.41 Months)|Site closed|2
5911512|NCT01587703|20451222|P11|Part2(Median Exposure of 1.41 Months)|Site closed|0
5911513|NCT01587703|20451223|P10|Part2(Median Exposure of 1.41 Months)|Site closed|0
5911514|NCT01587703|20451224|P9|Part2(Median Exposure of 1.41 Months)|Site closed|0
5911515|NCT01587703|20451225|P8|Part2(Median Exposure of 1.41 Months)|Site closed|0
5911516|NCT01587703|20451226|P7|Part2(Median Exposure of 1.41 Months)|Site closed|0
5911517|NCT01587703|20451227|P6|Part2(Median Exposure of 1.41 Months)|Site closed|0
5911518|NCT01587703|20451228|P5|Part2(Median Exposure of 1.41 Months)|Site closed|0
5911519|NCT01587703|20451229|P4|Part2(Median Exposure of 1.41 Months)|Site closed|0
5911520|NCT01587703|20451230|P3|Part2(Median Exposure of 1.41 Months)|Site closed|0
5911521|NCT01587703|20451231|P2|Part2(Median Exposure of 1.41 Months)|Site closed|0
5911522|NCT01587703|20451232|P1|Part2(Median Exposure of 1.41 Months)|Site closed|0
5911523|NCT01587703|20451214|P19|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
5911524|NCT01587703|20451215|P18|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
5911525|NCT01587703|20451216|P17|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
5911526|NCT01587703|20451217|P16|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
5911527|NCT01587703|20451218|P15|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|2
5911528|NCT01587703|20451219|P14|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
5911529|NCT01587703|20451220|P13|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
5911530|NCT01587703|20451221|P12|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|1
5911531|NCT01587703|20451222|P11|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
5911532|NCT01587703|20451223|P10|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
5911533|NCT01587703|20451224|P9|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
5911534|NCT01587703|20451225|P8|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
5911535|NCT01587703|20451226|P7|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
5911536|NCT01587703|20451227|P6|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
5911537|NCT01587703|20451228|P5|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
5911538|NCT01587703|20451229|P4|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
5911539|NCT01587703|20451230|P3|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
5911540|NCT01587703|20451231|P2|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
5911541|NCT01587703|20451232|P1|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
5911542|NCT01587703|20451214|P19|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
5911543|NCT01587703|20451215|P18|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
5911544|NCT01587703|20451216|P17|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
5911545|NCT01587703|20451217|P16|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|1
5911546|NCT01587703|20451218|P15|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
5911547|NCT01587703|20451219|P14|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
5911548|NCT01587703|20451220|P13|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
5911549|NCT01587703|20451221|P12|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
5911550|NCT01587703|20451222|P11|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
5911551|NCT01587703|20451223|P10|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
5911552|NCT01587703|20451224|P9|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
5911553|NCT01587703|20451225|P8|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
5911554|NCT01587703|20451226|P7|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
5911555|NCT01587703|20451227|P6|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
5911556|NCT01587703|20451228|P5|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
5911557|NCT01587703|20451229|P4|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
5911558|NCT01587703|20451230|P3|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
5911559|NCT01587703|20451231|P2|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
5911560|NCT01587703|20451232|P1|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
5911561|NCT01587703|20451214|P19|Substudy-P4,Maximum Exposure of 5.5month|Death|4
5911562|NCT01587703|20451215|P18|Substudy-P4,Maximum Exposure of 5.5month|Death|5
5911563|NCT01587703|20451216|P17|Substudy-P4,Maximum Exposure of 5.5month|Death|0
5911564|NCT01587703|20451217|P16|Substudy-P4,Maximum Exposure of 5.5month|Death|0
5911565|NCT01587703|20451218|P15|Substudy-P4,Maximum Exposure of 5.5month|Death|0
5911566|NCT01587703|20451219|P14|Substudy-P4,Maximum Exposure of 5.5month|Death|0
5911567|NCT01587703|20451220|P13|Substudy-P4,Maximum Exposure of 5.5month|Death|0
5911568|NCT01587703|20451221|P12|Substudy-P4,Maximum Exposure of 5.5month|Death|0
5911569|NCT01587703|20451222|P11|Substudy-P4,Maximum Exposure of 5.5month|Death|0
5911570|NCT01587703|20451223|P10|Substudy-P4,Maximum Exposure of 5.5month|Death|0
5911571|NCT01587703|20451224|P9|Substudy-P4,Maximum Exposure of 5.5month|Death|0
5911572|NCT01587703|20451225|P8|Substudy-P4,Maximum Exposure of 5.5month|Death|0
5911573|NCT01587703|20451226|P7|Substudy-P4,Maximum Exposure of 5.5month|Death|0
5911574|NCT01587703|20451227|P6|Substudy-P4,Maximum Exposure of 5.5month|Death|0
5911575|NCT01587703|20451228|P5|Substudy-P4,Maximum Exposure of 5.5month|Death|0
5911576|NCT01587703|20451229|P4|Substudy-P4,Maximum Exposure of 5.5month|Death|0
5911577|NCT01587703|20451230|P3|Substudy-P4,Maximum Exposure of 5.5month|Death|0
5911578|NCT01587703|20451231|P2|Substudy-P4,Maximum Exposure of 5.5month|Death|0
5911579|NCT01587703|20451232|P1|Substudy-P4,Maximum Exposure of 5.5month|Death|0
5911580|NCT01587703|20451214|P19|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|1
5911581|NCT01587703|20451215|P18|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
5911582|NCT01587703|20451216|P17|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
5911583|NCT01587703|20451217|P16|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
5911584|NCT01587703|20451218|P15|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
5911585|NCT01587703|20451219|P14|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
5911586|NCT01587703|20451220|P13|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
5911587|NCT01587703|20451221|P12|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
5911588|NCT01587703|20451222|P11|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
5911589|NCT01587703|20451223|P10|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
5911590|NCT01587703|20451224|P9|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
5911591|NCT01587703|20451225|P8|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
5911592|NCT01587703|20451226|P7|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
5911593|NCT01587703|20451227|P6|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
5911594|NCT01587703|20451228|P5|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
5911595|NCT01587703|20451229|P4|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
5911596|NCT01587703|20451230|P3|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
5911597|NCT01587703|20451231|P2|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
5911598|NCT01587703|20451232|P1|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
5911599|NCT01587703|20451214|P19|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
5911600|NCT01587703|20451215|P18|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
5911601|NCT01587703|20451216|P17|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
5911602|NCT01587703|20451217|P16|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
5911603|NCT01587703|20451218|P15|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
5911604|NCT01587703|20451219|P14|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
5911605|NCT01587703|20451220|P13|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
5911606|NCT01587703|20451221|P12|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
5911607|NCT01587703|20451222|P11|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
5911608|NCT01587703|20451223|P10|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
5911609|NCT01587703|20451224|P9|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|1
5911610|NCT01587703|20451225|P8|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
5911611|NCT01587703|20451226|P7|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
5911612|NCT01587703|20451227|P6|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
5911613|NCT01587703|20451228|P5|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
5911614|NCT01587703|20451229|P4|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
5911615|NCT01587703|20451230|P3|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
5911616|NCT01587703|20451231|P2|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
5911617|NCT01587703|20451232|P1|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
5911618|NCT01587703|20451214|P19|Part1 BID(Median Exposure of 1.41months)|Site closed|0
5911619|NCT01587703|20451215|P18|Part1 BID(Median Exposure of 1.41months)|Site closed|0
5911620|NCT01587703|20451216|P17|Part1 BID(Median Exposure of 1.41months)|Site closed|0
5911621|NCT01587703|20451217|P16|Part1 BID(Median Exposure of 1.41months)|Site closed|0
5911622|NCT01587703|20451218|P15|Part1 BID(Median Exposure of 1.41months)|Site closed|0
5911623|NCT01587703|20451219|P14|Part1 BID(Median Exposure of 1.41months)|Site closed|0
5911624|NCT01587703|20451220|P13|Part1 BID(Median Exposure of 1.41months)|Site closed|0
5911625|NCT01587703|20451221|P12|Part1 BID(Median Exposure of 1.41months)|Site closed|0
5911626|NCT01587703|20451222|P11|Part1 BID(Median Exposure of 1.41months)|Site closed|1
5911627|NCT01587703|20451223|P10|Part1 BID(Median Exposure of 1.41months)|Site closed|1
5911628|NCT01587703|20451224|P9|Part1 BID(Median Exposure of 1.41months)|Site closed|0
5911629|NCT01587703|20451225|P8|Part1 BID(Median Exposure of 1.41months)|Site closed|0
5911630|NCT01587703|20451226|P7|Part1 BID(Median Exposure of 1.41months)|Site closed|0
5911631|NCT01587703|20451227|P6|Part1 BID(Median Exposure of 1.41months)|Site closed|0
5911632|NCT01587703|20451228|P5|Part1 BID(Median Exposure of 1.41months)|Site closed|0
5911633|NCT01587703|20451229|P4|Part1 BID(Median Exposure of 1.41months)|Site closed|0
5911634|NCT01587703|20451230|P3|Part1 BID(Median Exposure of 1.41months)|Site closed|0
5911635|NCT01587703|20451231|P2|Part1 BID(Median Exposure of 1.41months)|Site closed|0
5911636|NCT01587703|20451232|P1|Part1 BID(Median Exposure of 1.41months)|Site closed|0
5911637|NCT01587703|20451214|P19|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
5911638|NCT01587703|20451215|P18|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
5911639|NCT01587703|20451216|P17|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
5911640|NCT01587703|20451217|P16|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
5911641|NCT01587703|20451218|P15|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
5911642|NCT01587703|20451219|P14|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
5911643|NCT01587703|20451220|P13|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
5911644|NCT01587703|20451221|P12|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
5911645|NCT01587703|20451222|P11|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1
5911646|NCT01587703|20451223|P10|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
5911647|NCT01587703|20451224|P9|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1
5911648|NCT01587703|20451225|P8|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
5911649|NCT01587703|20451226|P7|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
5911650|NCT01587703|20451227|P6|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
5911651|NCT01587703|20451228|P5|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
5911652|NCT01587703|20451229|P4|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
5911653|NCT01587703|20451230|P3|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
5911654|NCT01587703|20451231|P2|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
5911655|NCT01587703|20451232|P1|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
5911656|NCT01587703|20451214|P19|Part1 BID(Median Exposure of 1.41months)|Death|0
5911657|NCT01587703|20451215|P18|Part1 BID(Median Exposure of 1.41months)|Death|0
5911658|NCT01587703|20451216|P17|Part1 BID(Median Exposure of 1.41months)|Death|0
5911659|NCT01587703|20451217|P16|Part1 BID(Median Exposure of 1.41months)|Death|0
5911660|NCT01587703|20451218|P15|Part1 BID(Median Exposure of 1.41months)|Death|0
5911661|NCT01587703|20451219|P14|Part1 BID(Median Exposure of 1.41months)|Death|0
5911662|NCT01587703|20451220|P13|Part1 BID(Median Exposure of 1.41months)|Death|0
5911663|NCT01587703|20451221|P12|Part1 BID(Median Exposure of 1.41months)|Death|0
5911664|NCT01587703|20451222|P11|Part1 BID(Median Exposure of 1.41months)|Death|3
5911665|NCT01587703|20451223|P10|Part1 BID(Median Exposure of 1.41months)|Death|9
5911666|NCT01587703|20451224|P9|Part1 BID(Median Exposure of 1.41months)|Death|1
5911667|NCT01587703|20451225|P8|Part1 BID(Median Exposure of 1.41months)|Death|0
5911668|NCT01587703|20451226|P7|Part1 BID(Median Exposure of 1.41months)|Death|0
5911669|NCT01587703|20451227|P6|Part1 BID(Median Exposure of 1.41months)|Death|0
5911670|NCT01587703|20451228|P5|Part1 BID(Median Exposure of 1.41months)|Death|0
5911671|NCT01587703|20451229|P4|Part1 BID(Median Exposure of 1.41months)|Death|0
5911672|NCT01587703|20451230|P3|Part1 BID(Median Exposure of 1.41months)|Death|0
5911673|NCT01587703|20451231|P2|Part1 BID(Median Exposure of 1.41months)|Death|0
5911674|NCT01587703|20451232|P1|Part1 BID(Median Exposure of 1.41months)|Death|0
5911675|NCT01587703|20451214|P19|Part1 QD(Median Exposure of 1.38months)|Death|0
5911676|NCT01587703|20451215|P18|Part1 QD(Median Exposure of 1.38months)|Death|0
5911677|NCT01587703|20451216|P17|Part1 QD(Median Exposure of 1.38months)|Death|0
5911678|NCT01587703|20451217|P16|Part1 QD(Median Exposure of 1.38months)|Death|0
5911679|NCT01587703|20451218|P15|Part1 QD(Median Exposure of 1.38months)|Death|0
5911680|NCT01587703|20451219|P14|Part1 QD(Median Exposure of 1.38months)|Death|0
5911681|NCT01587703|20451220|P13|Part1 QD(Median Exposure of 1.38months)|Death|0
5911682|NCT01587703|20451221|P12|Part1 QD(Median Exposure of 1.38months)|Death|0
5911683|NCT01587703|20451222|P11|Part1 QD(Median Exposure of 1.38months)|Death|0
5911684|NCT01587703|20451223|P10|Part1 QD(Median Exposure of 1.38months)|Death|0
5911685|NCT01587703|20451224|P9|Part1 QD(Median Exposure of 1.38months)|Death|0
5911686|NCT01587703|20451225|P8|Part1 QD(Median Exposure of 1.38months)|Death|7
5911687|NCT01587703|20451226|P7|Part1 QD(Median Exposure of 1.38months)|Death|30
5911688|NCT01587703|20451227|P6|Part1 QD(Median Exposure of 1.38months)|Death|7
5911689|NCT01587703|20451228|P5|Part1 QD(Median Exposure of 1.38months)|Death|4
5911690|NCT01587703|20451229|P4|Part1 QD(Median Exposure of 1.38months)|Death|3
5911691|NCT01587703|20451230|P3|Part1 QD(Median Exposure of 1.38months)|Death|1
5911692|NCT01587703|20451231|P2|Part1 QD(Median Exposure of 1.38months)|Death|4
5911693|NCT01587703|20451232|P1|Part1 QD(Median Exposure of 1.38months)|Death|2
5911694|NCT01587703|20451214|P19|Part1 QD(Median Exposure of 1.38months)|Site closed|0
5911695|NCT01587703|20451215|P18|Part1 QD(Median Exposure of 1.38months)|Site closed|0
5911696|NCT01587703|20451216|P17|Part1 QD(Median Exposure of 1.38months)|Site closed|0
5911697|NCT01587703|20451217|P16|Part1 QD(Median Exposure of 1.38months)|Site closed|0
5911698|NCT01587703|20451218|P15|Part1 QD(Median Exposure of 1.38months)|Site closed|0
5911699|NCT01587703|20451219|P14|Part1 QD(Median Exposure of 1.38months)|Site closed|0
5911700|NCT01587703|20451220|P13|Part1 QD(Median Exposure of 1.38months)|Site closed|0
5911701|NCT01587703|20451221|P12|Part1 QD(Median Exposure of 1.38months)|Site closed|0
5911702|NCT01587703|20451222|P11|Part1 QD(Median Exposure of 1.38months)|Site closed|0
5911703|NCT01587703|20451223|P10|Part1 QD(Median Exposure of 1.38months)|Site closed|0
5911704|NCT01587703|20451224|P9|Part1 QD(Median Exposure of 1.38months)|Site closed|0
5911705|NCT01587703|20451225|P8|Part1 QD(Median Exposure of 1.38months)|Site closed|0
5911706|NCT01587703|20451226|P7|Part1 QD(Median Exposure of 1.38months)|Site closed|2
5911707|NCT01587703|20451227|P6|Part1 QD(Median Exposure of 1.38months)|Site closed|0
5911708|NCT01587703|20451228|P5|Part1 QD(Median Exposure of 1.38months)|Site closed|0
5911709|NCT01587703|20451229|P4|Part1 QD(Median Exposure of 1.38months)|Site closed|0
5911710|NCT01587703|20451230|P3|Part1 QD(Median Exposure of 1.38months)|Site closed|0
5911711|NCT01587703|20451231|P2|Part1 QD(Median Exposure of 1.38months)|Site closed|0
5911712|NCT01587703|20451232|P1|Part1 QD(Median Exposure of 1.38months)|Site closed|0
5911713|NCT01587703|20451214|P19|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
5911714|NCT01587703|20451215|P18|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
5911715|NCT01587703|20451216|P17|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
5911716|NCT01587703|20451217|P16|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
5911717|NCT01587703|20451218|P15|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
5911718|NCT01587703|20451219|P14|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
5911719|NCT01587703|20451220|P13|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
5911720|NCT01587703|20451221|P12|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
5911721|NCT01587703|20451222|P11|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
5911722|NCT01587703|20451223|P10|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
5911723|NCT01587703|20451224|P9|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
5911724|NCT01587703|20451225|P8|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|2
5911725|NCT01587703|20451226|P7|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
5911726|NCT01587703|20451227|P6|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|1
5911727|NCT01587703|20451228|P5|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
5911728|NCT01587703|20451229|P4|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
5911729|NCT01587703|20451230|P3|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
5911730|NCT01587703|20451231|P2|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
5911731|NCT01587703|20451232|P1|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
5911732|NCT01587703|20451214|P19|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
5911733|NCT01587703|20451215|P18|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
5911734|NCT01587703|20451216|P17|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
5911735|NCT01587703|20451217|P16|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
5911736|NCT01587703|20451218|P15|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
5911737|NCT01587703|20451219|P14|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
5911738|NCT01587703|20451220|P13|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
5911739|NCT01587703|20451221|P12|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
5911740|NCT01587703|20451222|P11|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
5911741|NCT01587703|20451223|P10|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
5911742|NCT01587703|20451224|P9|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
5911743|NCT01587703|20451225|P8|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
5911744|NCT01587703|20451226|P7|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
5911745|NCT01587703|20451227|P6|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
5911746|NCT01587703|20451228|P5|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
5911747|NCT01587703|20451229|P4|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
5911748|NCT01587703|20451230|P3|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
5911749|NCT01587703|20451231|P2|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
5911750|NCT01587703|20451232|P1|Part1 QD(Median Exposure of 1.38months)|Physician Decision|1
5911751|NCT01587651|20451639|P3|Overall Study|Withdrawal by Subject|0
5911752|NCT01587651|20451640|P2|Overall Study|Withdrawal by Subject|1
5911753|NCT01587651|20451641|P1|Overall Study|Withdrawal by Subject|0
5911754|NCT01587651|20451639|P3|Overall Study|Protocol Violation|1
5911755|NCT01587651|20451640|P2|Overall Study|Protocol Violation|1
5911756|NCT01587651|20451641|P1|Overall Study|Protocol Violation|0
5911757|NCT01587651|20451639|P3|Overall Study|Adverse Event|0
5911758|NCT01587651|20451640|P2|Overall Study|Adverse Event|1
5911760|NCT01587274|20451671|P3|Overall Study|Lost to Follow-up|3
5911761|NCT01587274|20451672|P2|Overall Study|Lost to Follow-up|5
5911762|NCT01587274|20451673|P1|Overall Study|Lost to Follow-up|4
5911763|NCT01587118|20451681|P1|Overall Study|nonresponse|1
5911764|NCT01587118|20451681|P1|Overall Study|Relocation|1
5911765|NCT01587118|20451681|P1|Overall Study|Lost to Follow-up|2
5911766|NCT01587118|20451681|P1|Overall Study|Adverse Event|3
5911767|NCT01587079|20451705|P1|Overall Study|Adverse Event|14
5911768|NCT01587079|20451705|P1|Overall Study|Withdrawal by Subject|7
5911769|NCT01587079|20451705|P1|Overall Study|Physician Decision|2
5911770|NCT01587079|20451705|P1|Overall Study|Lost to Follow-up|2
5911771|NCT01587079|20451705|P1|Overall Study|Protocol Violation|5
5911772|NCT01587079|20451705|P1|Overall Study|Protocol-specified criteria|9
5911773|NCT01587040|20451831|P4|Overall Study|Other than specified|1
5911774|NCT01587040|20451832|P3|Overall Study|Other than specified|11
5911775|NCT01587040|20451833|P2|Overall Study|Other than specified|1
5911776|NCT01587040|20451834|P1|Overall Study|Other than specified|5
5911777|NCT01587040|20451831|P4|Overall Study|Disease progression|3
5911778|NCT01587040|20451832|P3|Overall Study|Disease progression|15
5911779|NCT01587040|20451833|P2|Overall Study|Disease progression|1
5911780|NCT01587040|20451834|P1|Overall Study|Disease progression|12
5911781|NCT01587040|20451831|P4|Overall Study|Adverse Event|0
5911782|NCT01587040|20451832|P3|Overall Study|Adverse Event|10
5911783|NCT01587040|20451833|P2|Overall Study|Adverse Event|1
5911784|NCT01587040|20451834|P1|Overall Study|Adverse Event|0
5911785|NCT01587040|20451831|P4|Overall Study|Protocol Violation|0
5911786|NCT01587040|20451832|P3|Overall Study|Protocol Violation|1
5911787|NCT01587040|20451833|P2|Overall Study|Protocol Violation|0
5911788|NCT01587040|20451834|P1|Overall Study|Protocol Violation|0
5911789|NCT01587014|20451861|P1|Overall Study|Death|2
5911790|NCT01587001|20451868|P2|Overall Study|Insufficient samples to complete testing|1
5911791|NCT01587001|20451869|P1|Overall Study|Insufficient samples to complete testing|4
5911792|NCT01587001|20451868|P2|Overall Study|Lost to Follow-up|0
5911793|NCT01587001|20451869|P1|Overall Study|Lost to Follow-up|2
5911794|NCT01586910|20451898|P2|Overall Study|Physician withdrew Subject|24
5911795|NCT01586910|20451899|P1|Overall Study|Physician withdrew Subject|5
5911796|NCT01586910|20451898|P2|Overall Study|Withdrawal by Subject|43
5911797|NCT01586910|20451899|P1|Overall Study|Withdrawal by Subject|6
5911798|NCT01586910|20451898|P2|Overall Study|Death|4
5911799|NCT01586910|20451899|P1|Overall Study|Death|4
5911800|NCT01586819|20451973|P2|Overall Study|Withdrawal by Subject|0
5911801|NCT01586819|20451974|P1|Overall Study|Withdrawal by Subject|1
5911802|NCT01586806|20451985|P3|Overall Study|Lost to Follow-up|2
5911803|NCT01586806|20451986|P2|Overall Study|Lost to Follow-up|3
5911804|NCT01586806|20451987|P1|Overall Study|Lost to Follow-up|2
5911805|NCT01586806|20451985|P3|Overall Study|Withdrawal by Subject|0
5911806|NCT01586806|20451986|P2|Overall Study|Withdrawal by Subject|0
5911807|NCT01586806|20451987|P1|Overall Study|Withdrawal by Subject|1
5911808|NCT01586806|20451985|P3|Overall Study|Protocol Violation|0
5911809|NCT01586806|20451986|P2|Overall Study|Protocol Violation|1
5911810|NCT01586806|20451987|P1|Overall Study|Protocol Violation|0
5911811|NCT01586364|20452020|P1|Overall Study|Other-Not specified|1
5911812|NCT01586364|20452020|P1|Overall Study|Other-PI discretion, site closing|2
5911813|NCT01586364|20452020|P1|Overall Study|Other-Site closure due to PI illness|1
5911814|NCT01586364|20452020|P1|Overall Study|Other-Subject wasn't getting much relief|1
5911815|NCT01586364|20452020|P1|Overall Study|Other-Did not feel better post-treatment|1
5911816|NCT01586364|20452020|P1|Overall Study|Lack of Efficacy|1
5911817|NCT01586364|20452020|P1|Overall Study|Protocol Violation|16
5911818|NCT01586364|20452020|P1|Overall Study|Lost to Follow-up|17
5911819|NCT01586364|20452020|P1|Overall Study|Adverse Event|37
5911820|NCT01586364|20452020|P1|Overall Study|Withdrawal by Subject|40
5911821|NCT01586338|20452073|P1|Overall Study|Other|1
5911822|NCT01586338|20452073|P1|Overall Study|Withdrawal by participant|3
5911823|NCT01586338|20452073|P1|Overall Study|Lost to Follow-up|1
5911824|NCT01586338|20452073|P1|Overall Study|Adverse Event|3
5911825|NCT01586195|20452096|P1|Overall Study|Reason not specified|9
5911826|NCT01586195|20452096|P1|Overall Study|Started new anti-melanoma therapy|1
5911827|NCT01586195|20452096|P1|Overall Study|Withdrawal of Consent|5
5911828|NCT01586195|20452096|P1|Overall Study|Death|11
5911829|NCT01586156|20452110|P3|Overall Study|Pregnancy|0
5911830|NCT01586156|20452111|P2|Overall Study|Pregnancy|1
5911831|NCT01586156|20452112|P1|Overall Study|Pregnancy|0
5911832|NCT01585987|20452169|P2|Treated|Poor/Non-Compliance|1
5911833|NCT01585987|20452170|P1|Treated|Poor/Non-Compliance|0
5911834|NCT01585987|20452169|P2|Treated|Subject Request|1
5911835|NCT01585987|20452170|P1|Treated|Subject Request|0
5911836|NCT01585987|20452169|P2|Treated|Non-Specified|2
5911837|NCT01585987|20452170|P1|Treated|Non-Specified|1
5911838|NCT01585987|20452169|P2|Treated|Maximum Clinical Benefit|1
5911839|NCT01585987|20452170|P1|Treated|Maximum Clinical Benefit|0
5911840|NCT01585987|20452169|P2|Treated|Lost to Follow-up|1
5911841|NCT01585987|20452170|P1|Treated|Lost to Follow-up|0
5911842|NCT01585987|20452169|P2|Treated|Death|0
5911843|NCT01585987|20452170|P1|Treated|Death|1
5911844|NCT01585987|20452169|P2|Treated|Withdrawal by Subject|2
5911845|NCT01585987|20452170|P1|Treated|Withdrawal by Subject|1
5911846|NCT01585987|20452169|P2|Treated|Adverse Event|0
5911847|NCT01585987|20452170|P1|Treated|Adverse Event|3
5911848|NCT01585987|20452169|P2|Treated|Study Drug Toxicity|5
5911849|NCT01585987|20452170|P1|Treated|Study Drug Toxicity|9
5911850|NCT01585987|20452169|P2|Treated|Disease Progression|36
5911851|NCT01585987|20452170|P1|Treated|Disease Progression|39
5911852|NCT01585987|20452169|P2|Randomized|No longer met criteria|2
5911853|NCT01585987|20452170|P1|Randomized|No longer met criteria|0
5911854|NCT01585987|20452169|P2|Randomized|Withdrawal by Subject|4
5911855|NCT01585987|20452170|P1|Randomized|Withdrawal by Subject|0
5911856|NCT01585961|20452185|P1|Overall Study|Ablation cancelled for slow-heal wound|1
5911857|NCT01585961|20452185|P1|Overall Study|Lost to Follow-up|23
5911858|NCT01585961|20452185|P1|Overall Study|Withdrawal by Subject|1
5911859|NCT01585961|20452185|P1|Overall Study|Decision to use non-study catheter|1
5911860|NCT01585961|20452185|P1|Overall Study|Physician Decision|1
5911861|NCT01585961|20452185|P1|Overall Study|Death|6
5911862|NCT01585766|20452263|P6|Overall Study|Physician Decision|0
5911863|NCT01585766|20452264|P5|Overall Study|Physician Decision|0
5911864|NCT01585766|20452265|P4|Overall Study|Physician Decision|0
5911865|NCT01585766|20452266|P3|Overall Study|Physician Decision|1
5911866|NCT01585766|20452267|P2|Overall Study|Physician Decision|0
5911867|NCT01585766|20452268|P1|Overall Study|Physician Decision|0
5911868|NCT01585766|20452263|P6|Overall Study|Death|0
5911869|NCT01585766|20452264|P5|Overall Study|Death|0
5911870|NCT01585766|20452265|P4|Overall Study|Death|0
5911871|NCT01585766|20452266|P3|Overall Study|Death|0
5911872|NCT01585766|20452267|P2|Overall Study|Death|1
5911873|NCT01585766|20452268|P1|Overall Study|Death|0
5911874|NCT01585766|20452263|P6|Overall Study|Withdrawal by Subject|0
5911875|NCT01585766|20452264|P5|Overall Study|Withdrawal by Subject|0
5911876|NCT01585766|20452265|P4|Overall Study|Withdrawal by Subject|0
5911877|NCT01585766|20452266|P3|Overall Study|Withdrawal by Subject|1
5911878|NCT01585766|20452267|P2|Overall Study|Withdrawal by Subject|1
5911879|NCT01585766|20452268|P1|Overall Study|Withdrawal by Subject|0
5911880|NCT01585584|20452372|P1|Overall Study|Physician Decision|2
5911881|NCT01585584|20452372|P1|Overall Study|Withdrawal by Subject|1
5911882|NCT01585584|20452372|P1|Overall Study|Lack of Efficacy|1
5911883|NCT01585558|20452379|P3|Overall Study|Lack of Efficacy|1
5911884|NCT01585558|20452380|P2|Overall Study|Lack of Efficacy|0
5911885|NCT01585558|20452381|P1|Overall Study|Lack of Efficacy|0
5911886|NCT01585558|20452379|P3|Overall Study|Protocol Violation|2
5911887|NCT01585558|20452380|P2|Overall Study|Protocol Violation|3
5911888|NCT01585558|20452381|P1|Overall Study|Protocol Violation|4
5911889|NCT01585558|20452379|P3|Overall Study|Adverse Event|1
5911890|NCT01585558|20452380|P2|Overall Study|Adverse Event|4
5911891|NCT01585558|20452381|P1|Overall Study|Adverse Event|3
5911892|NCT01585558|20452379|P3|Overall Study|Lost to Follow-up|3
5911893|NCT01585558|20452380|P2|Overall Study|Lost to Follow-up|0
5911894|NCT01585558|20452381|P1|Overall Study|Lost to Follow-up|2
5911895|NCT01585558|20452379|P3|Overall Study|Withdrawal by Subject|8
5911896|NCT01585558|20452380|P2|Overall Study|Withdrawal by Subject|5
5911897|NCT01585558|20452381|P1|Overall Study|Withdrawal by Subject|4
5911898|NCT01585428|20452615|P2|Overall Study|Death during treatment|0
5911899|NCT01585428|20452616|P1|Overall Study|Death during treatment|1
5911900|NCT01585298|20452640|P1|Overall Study|Adverse Event|24
5911901|NCT01585298|20452640|P1|Overall Study|Abnormal test procedure results|1
5911902|NCT01585298|20452640|P1|Overall Study|Withdrawal by Subject|4
5911903|NCT01585298|20452640|P1|Overall Study|Lost to Follow-up|2
5911904|NCT01585298|20452640|P1|Overall Study|Administrative problems|4
5911905|NCT01585298|20452640|P1|Overall Study|Protocol deviation|1
5911906|NCT01585298|20452640|P1|Overall Study|Study completion was not documented.|1
5911907|NCT01585272|20452648|P1|Overall Study|Withdrawal by Subject|10
5911908|NCT01585272|20452648|P1|Overall Study|Protocol Violation|7
5911909|NCT01585272|20452648|P1|Overall Study|Adverse Event|22
5911910|NCT01585246|20452661|P5|Overall Study|Other|0
5911911|NCT01585246|20452662|P4|Overall Study|Other|1
5911912|NCT01585246|20452663|P3|Overall Study|Other|1
5911913|NCT01585246|20452664|P2|Overall Study|Other|1
5911914|NCT01585246|20452665|P1|Overall Study|Other|0
5911915|NCT01585246|20452661|P5|Overall Study|Withdrawal by Subject|1
5911916|NCT01585246|20452662|P4|Overall Study|Withdrawal by Subject|2
5911917|NCT01585246|20452663|P3|Overall Study|Withdrawal by Subject|1
5911918|NCT01585246|20452664|P2|Overall Study|Withdrawal by Subject|0
5911919|NCT01585246|20452665|P1|Overall Study|Withdrawal by Subject|0
5911920|NCT01585246|20452661|P5|Overall Study|Protocol Violation|1
5911921|NCT01585246|20452662|P4|Overall Study|Protocol Violation|0
5911922|NCT01585246|20452663|P3|Overall Study|Protocol Violation|0
5911923|NCT01585246|20452664|P2|Overall Study|Protocol Violation|0
5911924|NCT01585246|20452665|P1|Overall Study|Protocol Violation|0
5911925|NCT01585246|20452661|P5|Overall Study|Lost to Follow-up|0
5911926|NCT01585246|20452662|P4|Overall Study|Lost to Follow-up|1
5911927|NCT01585246|20452663|P3|Overall Study|Lost to Follow-up|2
5911928|NCT01585246|20452664|P2|Overall Study|Lost to Follow-up|0
5911929|NCT01585246|20452665|P1|Overall Study|Lost to Follow-up|0
5911930|NCT01585194|20452684|P1|Overall Study|Lack of insurance|1
5911931|NCT01585194|20452684|P1|Overall Study|Physician Decision|2
5911932|NCT01585194|20452684|P1|Overall Study|Withdrawal by Subject|1
5911933|NCT01585168|20452693|P4|Overall Study|Lost to Follow-up|1
5911934|NCT01585168|20452694|P3|Overall Study|Lost to Follow-up|1
5911935|NCT01585168|20452695|P2|Overall Study|Lost to Follow-up|1
5911936|NCT01585168|20452696|P1|Overall Study|Lost to Follow-up|3
5911937|NCT01585155|20452716|P1|Overall Study|Worsening ulcerative colitis|2
5911938|NCT01585155|20452716|P1|Overall Study|Lack of Efficacy|2
5911939|NCT01585155|20452716|P1|Overall Study|Adverse Event|1
5911940|NCT01585038|20452738|P2|Overall Study|Adverse Event|2
5911941|NCT01585038|20452739|P1|Overall Study|Adverse Event|2
5911942|NCT01585025|20452754|P3|Overall Study|Withdrawal by Subject|4
5911943|NCT01585025|20452755|P2|Overall Study|Withdrawal by Subject|3
5911944|NCT01585025|20452756|P1|Overall Study|Withdrawal by Subject|0
5911945|NCT01584843|20452786|P6|Second Treatment Period|Withdrawal by Subject|1
5911946|NCT01584843|20452787|P5|Second Treatment Period|Withdrawal by Subject|0
5911947|NCT01584843|20452788|P4|Second Treatment Period|Withdrawal by Subject|0
5911948|NCT01584843|20452789|P3|Second Treatment Period|Withdrawal by Subject|0
5911949|NCT01584843|20452790|P2|Second Treatment Period|Withdrawal by Subject|0
5911950|NCT01584843|20452791|P1|Second Treatment Period|Withdrawal by Subject|0
5911951|NCT01584843|20452786|P6|First Treatment Period|Met Protocol-defined Stopping Criteria|1
5911952|NCT01584843|20452787|P5|First Treatment Period|Met Protocol-defined Stopping Criteria|0
5911953|NCT01584843|20452788|P4|First Treatment Period|Met Protocol-defined Stopping Criteria|0
5911954|NCT01584843|20452789|P3|First Treatment Period|Met Protocol-defined Stopping Criteria|0
5911955|NCT01584843|20452790|P2|First Treatment Period|Met Protocol-defined Stopping Criteria|0
5911956|NCT01584843|20452791|P1|First Treatment Period|Met Protocol-defined Stopping Criteria|0
5911957|NCT01584843|20452786|P6|First Treatment Period|Protocol Violation|1
5911958|NCT01584843|20452787|P5|First Treatment Period|Protocol Violation|0
5911959|NCT01584843|20452788|P4|First Treatment Period|Protocol Violation|0
5911960|NCT01584843|20452789|P3|First Treatment Period|Protocol Violation|0
5911961|NCT01584843|20452790|P2|First Treatment Period|Protocol Violation|0
5911962|NCT01584843|20452791|P1|First Treatment Period|Protocol Violation|0
5911963|NCT01584843|20452786|P6|First Treatment Period|Adverse Event|0
5911964|NCT01584843|20452787|P5|First Treatment Period|Adverse Event|0
5911965|NCT01584843|20452788|P4|First Treatment Period|Adverse Event|0
5911966|NCT01584843|20452789|P3|First Treatment Period|Adverse Event|1
5911967|NCT01584843|20452790|P2|First Treatment Period|Adverse Event|0
5911968|NCT01584843|20452791|P1|First Treatment Period|Adverse Event|0
5911979|NCT01584232|20453031|P2|Overall Study|Lost to Follow-up|0
5911980|NCT01584232|20453032|P1|Overall Study|Lost to Follow-up|1
5911981|NCT01584232|20453031|P2|Overall Study|Physician Decision|1
5911982|NCT01584232|20453032|P1|Overall Study|Physician Decision|2
5911983|NCT01584232|20453031|P2|Overall Study|Withdrawal by Subject|1
5911984|NCT01584232|20453032|P1|Overall Study|Withdrawal by Subject|2
5911985|NCT01584232|20453031|P2|Overall Study|Adverse Event|1
5911986|NCT01584232|20453032|P1|Overall Study|Adverse Event|3
5911987|NCT01584024|20453048|P1|Overall Study|Withdrawal by Subject|3
5911988|NCT01584024|20453048|P1|Overall Study|Lost to Follow-up|10
5911989|NCT01583530|20453145|P6|Overall Study|Lack of compliance|0
5911990|NCT01583530|20453146|P5|Overall Study|Lack of compliance|1
5911991|NCT01583530|20453147|P4|Overall Study|Lack of compliance|0
5911992|NCT01583530|20453148|P3|Overall Study|Lack of compliance|0
5911993|NCT01583530|20453149|P2|Overall Study|Lack of compliance|0
5911994|NCT01583530|20453150|P1|Overall Study|Lack of compliance|0
5911995|NCT01583530|20453145|P6|Overall Study|Lost to Follow-up|0
5911996|NCT01583530|20453146|P5|Overall Study|Lost to Follow-up|3
5911997|NCT01583530|20453147|P4|Overall Study|Lost to Follow-up|0
5911998|NCT01583530|20453148|P3|Overall Study|Lost to Follow-up|0
5911999|NCT01583530|20453149|P2|Overall Study|Lost to Follow-up|0
5912000|NCT01583530|20453150|P1|Overall Study|Lost to Follow-up|0
5912001|NCT01583530|20453145|P6|Overall Study|Withdrawal by Subject|2
5912002|NCT01583530|20453146|P5|Overall Study|Withdrawal by Subject|1
5912003|NCT01583530|20453147|P4|Overall Study|Withdrawal by Subject|1
5912004|NCT01583530|20453148|P3|Overall Study|Withdrawal by Subject|0
5912005|NCT01583530|20453149|P2|Overall Study|Withdrawal by Subject|3
5912006|NCT01583530|20453150|P1|Overall Study|Withdrawal by Subject|0
5912007|NCT01583530|20453145|P6|Overall Study|Adverse Event|1
5912008|NCT01583530|20453146|P5|Overall Study|Adverse Event|0
5912009|NCT01583530|20453147|P4|Overall Study|Adverse Event|0
5912010|NCT01583530|20453148|P3|Overall Study|Adverse Event|0
5912011|NCT01583530|20453149|P2|Overall Study|Adverse Event|0
5912012|NCT01583530|20453150|P1|Overall Study|Adverse Event|0
5912013|NCT01583374|20453212|P9|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1
5912014|NCT01583374|20453213|P8|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0
5912015|NCT01583374|20453214|P7|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5
5912016|NCT01583374|20453215|P6|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1
5912017|NCT01583374|20453216|P5|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0
5912018|NCT01583374|20453217|P4|Long-Term Extension Phase Weeks 52-260|Miscellaneous|2
5912019|NCT01583374|20453218|P3|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1
5912020|NCT01583374|20453219|P2|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5
5912021|NCT01583374|20453220|P1|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0
5912022|NCT01583374|20453212|P9|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0
5912023|NCT01583374|20453213|P8|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0
5912024|NCT01583374|20453214|P7|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1
5912025|NCT01583374|20453215|P6|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0
5912026|NCT01583374|20453216|P5|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1
5912027|NCT01583374|20453217|P4|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1
5912028|NCT01583374|20453218|P3|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0
5912029|NCT01583374|20453219|P2|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1
5912030|NCT01583374|20453220|P1|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0
5912031|NCT01583374|20453212|P9|Long-Term Extension Phase Weeks 52-260|Death|0
5912032|NCT01583374|20453213|P8|Long-Term Extension Phase Weeks 52-260|Death|0
5912033|NCT01583374|20453214|P7|Long-Term Extension Phase Weeks 52-260|Death|1
5912034|NCT01583374|20453215|P6|Long-Term Extension Phase Weeks 52-260|Death|0
5912035|NCT01583374|20453216|P5|Long-Term Extension Phase Weeks 52-260|Death|1
5912036|NCT01583374|20453217|P4|Long-Term Extension Phase Weeks 52-260|Death|0
5912037|NCT01583374|20453218|P3|Long-Term Extension Phase Weeks 52-260|Death|0
5912038|NCT01583374|20453219|P2|Long-Term Extension Phase Weeks 52-260|Death|0
5912039|NCT01583374|20453220|P1|Long-Term Extension Phase Weeks 52-260|Death|0
5912040|NCT01583374|20453212|P9|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3
5912041|NCT01583374|20453213|P8|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3
5912042|NCT01583374|20453214|P7|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|5
5912043|NCT01583374|20453215|P6|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|7
5912044|NCT01583374|20453216|P5|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|12
5912045|NCT01583374|20453217|P4|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|1
5912046|NCT01583374|20453218|P3|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11
5912047|NCT01583374|20453219|P2|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11
5912048|NCT01583374|20453220|P1|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|0
5912049|NCT01583374|20453212|P9|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1
5912050|NCT01583374|20453213|P8|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1
5912051|NCT01583374|20453214|P7|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0
5912052|NCT01583374|20453215|P6|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0
5912053|NCT01583374|20453216|P5|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1
5912054|NCT01583374|20453217|P4|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0
5912055|NCT01583374|20453218|P3|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0
5912056|NCT01583374|20453219|P2|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0
5912057|NCT01583374|20453220|P1|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0
5912058|NCT01583374|20453212|P9|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4
5912059|NCT01583374|20453213|P8|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|2
5912060|NCT01583374|20453214|P7|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4
5912061|NCT01583374|20453215|P6|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7
5912062|NCT01583374|20453216|P5|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|10
5912063|NCT01583374|20453217|P4|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7
5912064|NCT01583374|20453218|P3|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|6
5912065|NCT01583374|20453219|P2|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4
5912066|NCT01583374|20453220|P1|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|0
5912067|NCT01583374|20453212|P9|Long-Term Extension Phase Weeks 52-260|Adverse Event|1
5912068|NCT01583374|20453213|P8|Long-Term Extension Phase Weeks 52-260|Adverse Event|3
5912069|NCT01583374|20453214|P7|Long-Term Extension Phase Weeks 52-260|Adverse Event|2
5912070|NCT01583374|20453215|P6|Long-Term Extension Phase Weeks 52-260|Adverse Event|2
5912071|NCT01583374|20453216|P5|Long-Term Extension Phase Weeks 52-260|Adverse Event|6
5912072|NCT01583374|20453217|P4|Long-Term Extension Phase Weeks 52-260|Adverse Event|2
5912073|NCT01583374|20453218|P3|Long-Term Extension Phase Weeks 52-260|Adverse Event|2
5912074|NCT01583374|20453219|P2|Long-Term Extension Phase Weeks 52-260|Adverse Event|5
5912075|NCT01583374|20453220|P1|Long-Term Extension Phase Weeks 52-260|Adverse Event|0
5912076|NCT01583374|20453212|P9|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0
5912077|NCT01583374|20453213|P8|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0
5912078|NCT01583374|20453214|P7|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0
5912079|NCT01583374|20453215|P6|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|2
5912080|NCT01583374|20453216|P5|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1
5912081|NCT01583374|20453217|P4|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0
5912082|NCT01583374|20453218|P3|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1
5912083|NCT01583374|20453219|P2|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0
5912084|NCT01583374|20453220|P1|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0
5912085|NCT01583374|20453212|P9|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0
5912086|NCT01583374|20453213|P8|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0
5912087|NCT01583374|20453214|P7|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0
5912088|NCT01583374|20453215|P6|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0
5912089|NCT01583374|20453216|P5|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1
5912090|NCT01583374|20453217|P4|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0
5912091|NCT01583374|20453218|P3|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1
5912092|NCT01583374|20453219|P2|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|2
5912093|NCT01583374|20453220|P1|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0
5912094|NCT01583374|20453212|P9|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2
5912095|NCT01583374|20453213|P8|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1
5912096|NCT01583374|20453214|P7|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|5
5912097|NCT01583374|20453215|P6|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2
5912098|NCT01583374|20453216|P5|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|3
5912099|NCT01583374|20453217|P4|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|6
5912100|NCT01583374|20453218|P3|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0
5912101|NCT01583374|20453219|P2|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2
5912102|NCT01583374|20453220|P1|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0
5912103|NCT01583374|20453212|P9|Extension Phase (Weeks 24 to 52)|Adverse Event|0
5912104|NCT01583374|20453213|P8|Extension Phase (Weeks 24 to 52)|Adverse Event|1
5912105|NCT01583374|20453214|P7|Extension Phase (Weeks 24 to 52)|Adverse Event|0
5912106|NCT01583374|20453215|P6|Extension Phase (Weeks 24 to 52)|Adverse Event|1
5912107|NCT01583374|20453216|P5|Extension Phase (Weeks 24 to 52)|Adverse Event|1
5912108|NCT01583374|20453217|P4|Extension Phase (Weeks 24 to 52)|Adverse Event|0
5912109|NCT01583374|20453218|P3|Extension Phase (Weeks 24 to 52)|Adverse Event|2
5912110|NCT01583374|20453219|P2|Extension Phase (Weeks 24 to 52)|Adverse Event|1
5912111|NCT01583374|20453220|P1|Extension Phase (Weeks 24 to 52)|Adverse Event|0
5912112|NCT01583374|20453212|P9|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
5912113|NCT01583374|20453213|P8|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1
5912114|NCT01583374|20453214|P7|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
5912115|NCT01583374|20453215|P6|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
5912116|NCT01583374|20453216|P5|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
5912117|NCT01583374|20453217|P4|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
5912118|NCT01583374|20453218|P3|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
5912119|NCT01583374|20453219|P2|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
5912120|NCT01583374|20453220|P1|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
5912121|NCT01583374|20453212|P9|Placebo-controlled Phase (Week 0-24)|Other|0
5912122|NCT01583374|20453213|P8|Placebo-controlled Phase (Week 0-24)|Other|0
5912123|NCT01583374|20453214|P7|Placebo-controlled Phase (Week 0-24)|Other|0
5912124|NCT01583374|20453215|P6|Placebo-controlled Phase (Week 0-24)|Other|0
5912125|NCT01583374|20453216|P5|Placebo-controlled Phase (Week 0-24)|Other|0
5912126|NCT01583374|20453217|P4|Placebo-controlled Phase (Week 0-24)|Other|0
5912127|NCT01583374|20453218|P3|Placebo-controlled Phase (Week 0-24)|Other|0
5912128|NCT01583374|20453219|P2|Placebo-controlled Phase (Week 0-24)|Other|1
5912129|NCT01583374|20453220|P1|Placebo-controlled Phase (Week 0-24)|Other|0
5912130|NCT01583374|20453212|P9|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
5912131|NCT01583374|20453213|P8|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
5912132|NCT01583374|20453214|P7|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
5912133|NCT01583374|20453215|P6|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
5912134|NCT01583374|20453216|P5|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
5912135|NCT01583374|20453217|P4|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
5912136|NCT01583374|20453218|P3|Placebo-controlled Phase (Week 0-24)|Protocol Violation|3
5912137|NCT01583374|20453219|P2|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
5912138|NCT01583374|20453220|P1|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
5912139|NCT01583374|20453212|P9|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0
5912140|NCT01583374|20453213|P8|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0
5912141|NCT01583374|20453214|P7|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0
5912142|NCT01583374|20453215|P6|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0
5912143|NCT01583374|20453216|P5|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0
5912144|NCT01583374|20453217|P4|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0
5912145|NCT01583374|20453218|P3|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0
5912146|NCT01583374|20453219|P2|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|2
5912147|NCT01583374|20453220|P1|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|1
5912148|NCT01583374|20453212|P9|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
5912149|NCT01583374|20453213|P8|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
5912150|NCT01583374|20453214|P7|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
5912151|NCT01583374|20453215|P6|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
5912152|NCT01583374|20453216|P5|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
5912153|NCT01583374|20453217|P4|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
5912154|NCT01583374|20453218|P3|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5
5912155|NCT01583374|20453219|P2|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3
5912156|NCT01583374|20453220|P1|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|8
5912157|NCT01583374|20453212|P9|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
5912158|NCT01583374|20453213|P8|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
5912159|NCT01583374|20453214|P7|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
5912160|NCT01583374|20453215|P6|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
5912161|NCT01583374|20453216|P5|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
5912162|NCT01583374|20453217|P4|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
5912163|NCT01583374|20453218|P3|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
5912164|NCT01583374|20453219|P2|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1
5912165|NCT01583374|20453220|P1|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1
5912166|NCT01583374|20453212|P9|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
5912167|NCT01583374|20453213|P8|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
5912168|NCT01583374|20453214|P7|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
5912169|NCT01583374|20453215|P6|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
5912170|NCT01583374|20453216|P5|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
5912171|NCT01583374|20453217|P4|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
5912172|NCT01583374|20453218|P3|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5
5912173|NCT01583374|20453219|P2|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|2
5912174|NCT01583374|20453220|P1|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|3
5912175|NCT01583374|20453212|P9|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
5912176|NCT01583374|20453213|P8|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
5912177|NCT01583374|20453214|P7|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
5912178|NCT01583374|20453215|P6|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
5912179|NCT01583374|20453216|P5|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
5912180|NCT01583374|20453217|P4|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
5912181|NCT01583374|20453218|P3|Placebo-controlled Phase (Week 0-24)|Adverse Event|12
5912182|NCT01583374|20453219|P2|Placebo-controlled Phase (Week 0-24)|Adverse Event|7
5912183|NCT01583374|20453220|P1|Placebo-controlled Phase (Week 0-24)|Adverse Event|6
5912184|NCT01583218|20453262|P2|Overall Study|Withdraw of consent on day of random|0
5912185|NCT01583218|20453263|P1|Overall Study|Withdraw of consent on day of random|1
5912186|NCT01583218|20453262|P2|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|1
5912187|NCT01583218|20453263|P1|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|0
5912188|NCT01583218|20453262|P2|Overall Study|Patient was randomized due to mistake|0
5912189|NCT01583218|20453263|P1|Overall Study|Patient was randomized due to mistake|1
5912190|NCT01583218|20453262|P2|Overall Study|Patient was early terminated from study|1
5912191|NCT01583218|20453263|P1|Overall Study|Patient was early terminated from study|0
5912192|NCT01583218|20453262|P2|Overall Study|Patient deemed ineligible after random|0
5912193|NCT01583218|20453263|P1|Overall Study|Patient deemed ineligible after random|2
5912194|NCT01583218|20453262|P2|Overall Study|Patient was assessed via phone in person|0
5912195|NCT01583218|20453263|P1|Overall Study|Patient was assessed via phone in person|1
5912196|NCT01583218|20453262|P2|Overall Study|Patient randomized but not dosed|16
5912197|NCT01583218|20453263|P1|Overall Study|Patient randomized but not dosed|17
5912198|NCT01583218|20453262|P2|Overall Study|Patient did not wish to attend visits|1
5912199|NCT01583218|20453263|P1|Overall Study|Patient did not wish to attend visits|0
5912200|NCT01583218|20453262|P2|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|2
5912201|NCT01583218|20453263|P1|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|0
5912202|NCT01583218|20453262|P2|Overall Study|Cannot contact patient directly|2
5912203|NCT01583218|20453263|P1|Overall Study|Cannot contact patient directly|1
5912204|NCT01583218|20453262|P2|Overall Study|Patient /Family decision|0
5912205|NCT01583218|20453263|P1|Overall Study|Patient /Family decision|3
5912206|NCT01583218|20453262|P2|Overall Study|Adverse event or serious adverse event|3
5912207|NCT01583218|20453263|P1|Overall Study|Adverse event or serious adverse event|3
5912208|NCT01583218|20453262|P2|Overall Study|Lost to Follow-up|17
5912209|NCT01583218|20453263|P1|Overall Study|Lost to Follow-up|11
5912210|NCT01583218|20453262|P2|Overall Study|Death|211
5912211|NCT01583218|20453263|P1|Overall Study|Death|206
5912212|NCT01583218|20453262|P2|Overall Study|Withdrawal by Subject|29
5912213|NCT01583218|20453263|P1|Overall Study|Withdrawal by Subject|43
5912214|NCT01583179|20453283|P2|Overall Study|Screen failure|2
5912215|NCT01583179|20453284|P1|Overall Study|Screen failure|1
5912216|NCT01583166|20453294|P2|Overall Study|Withdrawal by Subject|6
5912217|NCT01583166|20453295|P1|Overall Study|Withdrawal by Subject|4
5912218|NCT01582971|20453318|P2|Overall Study|Other|13
5912219|NCT01582971|20453319|P1|Overall Study|Other|15
5912220|NCT01582971|20453318|P2|Overall Study|Withdrawal by Subject|2
5912221|NCT01582971|20453319|P1|Overall Study|Withdrawal by Subject|4
5912222|NCT01582971|20453318|P2|Overall Study|Lost to Follow-up|21
5912223|NCT01582971|20453319|P1|Overall Study|Lost to Follow-up|18
5912224|NCT01582971|20453318|P2|Overall Study|Death|1
5912225|NCT01582971|20453319|P1|Overall Study|Death|2
5912226|NCT01582945|20453337|P1|Overall Study|Scheduling conflicts|1
5912227|NCT01582945|20453337|P1|Overall Study|Intolerable side-effects|1
5912228|NCT01582854|20453351|P2|Overall Study|Other Miscellaneous Reason|0
5912229|NCT01582854|20453352|P1|Overall Study|Other Miscellaneous Reason|1
5912230|NCT01582854|20453351|P2|Overall Study|General Anaesthesia|1
5912231|NCT01582854|20453352|P1|Overall Study|General Anaesthesia|0
5912232|NCT01582854|20453351|P2|Overall Study|Carotid or Neurosurgery|1
5912233|NCT01582854|20453352|P1|Overall Study|Carotid or Neurosurgery|0
5912234|NCT01582854|20453351|P2|Overall Study|Disallowed Concomitant Medication|2
5912235|NCT01582854|20453352|P1|Overall Study|Disallowed Concomitant Medication|3
5912236|NCT01582854|20453351|P2|Overall Study|Recurrent Stroke|8
5912237|NCT01582854|20453352|P1|Overall Study|Recurrent Stroke|13
5912238|NCT01582854|20453351|P2|Overall Study|Physician Decision|1
5912239|NCT01582854|20453352|P1|Overall Study|Physician Decision|0
5912240|NCT01582854|20453351|P2|Overall Study|Lost to Follow-up|2
5912241|NCT01582854|20453352|P1|Overall Study|Lost to Follow-up|1
5912242|NCT01582854|20453351|P2|Overall Study|Withdrawal by Participant|11
5912243|NCT01582854|20453352|P1|Overall Study|Withdrawal by Participant|8
5912244|NCT01582854|20453351|P2|Overall Study|Adverse Event|3
5912245|NCT01582854|20453352|P1|Overall Study|Adverse Event|2
5912246|NCT01582854|20453351|P2|Overall Study|Death|5
5912247|NCT01582854|20453352|P1|Overall Study|Death|8
5912248|NCT01582789|20453380|P2|Second Intervention (14 Days)|Withdrawal by Subject|0
5912249|NCT01582789|20453381|P1|Second Intervention (14 Days)|Withdrawal by Subject|1
5912250|NCT01582451|20453441|P2|Overall Study|Sponsor Decision|0
5912251|NCT01582451|20453442|P1|Overall Study|Sponsor Decision|1
5912252|NCT01582451|20453441|P2|Overall Study|Physician Decision|0
5912253|NCT01582451|20453442|P1|Overall Study|Physician Decision|3
5912254|NCT01582451|20453441|P2|Overall Study|Withdrawal by Subject|9
5912255|NCT01582451|20453442|P1|Overall Study|Withdrawal by Subject|13
5912256|NCT01582451|20453441|P2|Overall Study|Protocol Violation|3
5912257|NCT01582451|20453442|P1|Overall Study|Protocol Violation|11
5912258|NCT01582451|20453441|P2|Overall Study|Lost to Follow-up|2
5912259|NCT01582451|20453442|P1|Overall Study|Lost to Follow-up|0
5912260|NCT01582451|20453441|P2|Overall Study|Death|3
5912261|NCT01582451|20453442|P1|Overall Study|Death|3
5912262|NCT01582451|20453441|P2|Overall Study|Adverse Event|3
5912263|NCT01582451|20453442|P1|Overall Study|Adverse Event|1
5912264|NCT01582308|20453484|P10|Period 4|Physician Decision|1
5912265|NCT01582308|20453485|P9|Period 4|Physician Decision|0
5912266|NCT01582308|20453486|P8|Period 4|Physician Decision|0
5912267|NCT01582308|20453487|P7|Period 4|Physician Decision|0
5912268|NCT01582308|20453488|P6|Period 4|Physician Decision|1
5912269|NCT01582308|20453489|P5|Period 4|Physician Decision|0
5912270|NCT01582308|20453490|P4|Period 4|Physician Decision|0
5912271|NCT01582308|20453491|P3|Period 4|Physician Decision|0
5912272|NCT01582308|20453492|P2|Period 4|Physician Decision|0
5912273|NCT01582308|20453493|P1|Period 4|Physician Decision|1
5912274|NCT01582308|20453484|P10|10-day Washout Following Period 1|Physician Decision|0
5912275|NCT01582308|20453485|P9|10-day Washout Following Period 1|Physician Decision|0
5912276|NCT01582308|20453486|P8|10-day Washout Following Period 1|Physician Decision|0
5912277|NCT01582308|20453487|P7|10-day Washout Following Period 1|Physician Decision|0
5912278|NCT01582308|20453488|P6|10-day Washout Following Period 1|Physician Decision|0
5912279|NCT01582308|20453489|P5|10-day Washout Following Period 1|Physician Decision|1
5912280|NCT01582308|20453490|P4|10-day Washout Following Period 1|Physician Decision|0
5912281|NCT01582308|20453491|P3|10-day Washout Following Period 1|Physician Decision|0
5912282|NCT01582308|20453492|P2|10-day Washout Following Period 1|Physician Decision|0
5912283|NCT01582308|20453493|P1|10-day Washout Following Period 1|Physician Decision|0
5912284|NCT01582308|20453484|P10|Period 1|Withdrawal by Subject|0
5912285|NCT01582308|20453485|P9|Period 1|Withdrawal by Subject|0
5912286|NCT01582308|20453486|P8|Period 1|Withdrawal by Subject|0
5912287|NCT01582308|20453487|P7|Period 1|Withdrawal by Subject|1
5912288|NCT01582308|20453488|P6|Period 1|Withdrawal by Subject|0
5912289|NCT01582308|20453489|P5|Period 1|Withdrawal by Subject|0
5912290|NCT01582308|20453490|P4|Period 1|Withdrawal by Subject|0
5912291|NCT01582308|20453491|P3|Period 1|Withdrawal by Subject|0
5912292|NCT01582308|20453492|P2|Period 1|Withdrawal by Subject|0
5912293|NCT01582308|20453493|P1|Period 1|Withdrawal by Subject|0
5912294|NCT01582282|20453521|P3|Overall Study|fasting blood glucose outside Protocol|0
5912295|NCT01582282|20453522|P2|Overall Study|fasting blood glucose outside Protocol|1
5912296|NCT01582282|20453523|P1|Overall Study|fasting blood glucose outside Protocol|0
5912297|NCT01582282|20453521|P3|Overall Study|Lost to Follow-up|0
5912298|NCT01582282|20453522|P2|Overall Study|Lost to Follow-up|0
5912299|NCT01582282|20453523|P1|Overall Study|Lost to Follow-up|1
5912300|NCT01582282|20453521|P3|Overall Study|Adverse Event|0
5912301|NCT01582282|20453522|P2|Overall Study|Adverse Event|1
5912302|NCT01582282|20453523|P1|Overall Study|Adverse Event|1
5912303|NCT01582243|20453546|P1|Overall Study|Lost to Follow-up|1
5912304|NCT01582243|20453546|P1|Overall Study|Adverse Event|1
5912305|NCT01582243|20453546|P1|Overall Study|Withdrawal by Subject|1
5912306|NCT01582178|20453557|P2|Overall Study|Physician Decision|5
5912307|NCT01582178|20453558|P1|Overall Study|Physician Decision|6
5912308|NCT01582152|20453566|P2|Overall Study|Adverse Event|1
5912309|NCT01582152|20453567|P1|Overall Study|Adverse Event|2
5912310|NCT01582152|20453566|P2|Overall Study|Disease Progression|5
5912311|NCT01582152|20453567|P1|Overall Study|Disease Progression|4
5912312|NCT01582100|20453590|P1|Overall Study|Withdrawal by Subject|1
5912313|NCT01582100|20453590|P1|Overall Study|Adverse Event|1
5912314|NCT01582061|20453596|P2|Overall Study|Lost to Follow-up|0
5912315|NCT01582061|20453597|P1|Overall Study|Lost to Follow-up|1
5912316|NCT01582061|20453596|P2|Overall Study|condition no longer requires study drug|0
5912317|NCT01582061|20453597|P1|Overall Study|condition no longer requires study drug|1
5912318|NCT01582061|20453596|P2|Overall Study|Death|1
5912319|NCT01582061|20453597|P1|Overall Study|Death|0
5912320|NCT01582061|20453596|P2|Overall Study|Abnormal laboratory value(s)|0
5912321|NCT01582061|20453597|P1|Overall Study|Abnormal laboratory value(s)|1
5912322|NCT01582061|20453596|P2|Overall Study|Withdrawal by Subject|4
5912323|NCT01582061|20453597|P1|Overall Study|Withdrawal by Subject|10
5912324|NCT01582061|20453596|P2|Overall Study|Adverse Event|8
5912325|NCT01582061|20453597|P1|Overall Study|Adverse Event|12
5912326|NCT01582061|20453596|P2|Overall Study|Lack of Efficacy|23
5912327|NCT01582061|20453597|P1|Overall Study|Lack of Efficacy|3
5912328|NCT01582009|20453647|P1|Overall Study|Physician Decision|1
5912329|NCT01582009|20453647|P1|Overall Study|Withdrawal by Subject|1
5912330|NCT01581931|20453664|P2|Washout|Adverse Event|1
5912331|NCT01581931|20453665|P1|Washout|Adverse Event|0
5912332|NCT01581684|20453718|P10|Overall Study|Other reason not defined|0
5912333|NCT01581684|20453719|P9|Overall Study|Other reason not defined|1
5912334|NCT01581684|20453720|P8|Overall Study|Other reason not defined|0
5912335|NCT01581684|20453721|P7|Overall Study|Other reason not defined|0
5912336|NCT01581684|20453722|P6|Overall Study|Other reason not defined|0
5912337|NCT01581684|20453723|P5|Overall Study|Other reason not defined|0
5912338|NCT01581684|20453724|P4|Overall Study|Other reason not defined|0
5912339|NCT01581684|20453725|P3|Overall Study|Other reason not defined|0
5912340|NCT01581684|20453726|P2|Overall Study|Other reason not defined|0
5912341|NCT01581684|20453727|P1|Overall Study|Other reason not defined|0
5912342|NCT01581619|20453823|P1|Overall Study|Lost to Follow-up|1
5912343|NCT01581619|20453823|P1|Overall Study|Withdrawal by Subject|1
5912344|NCT01581307|20453976|P1|Overall Study|Withdrawal by Subject|1
5912345|NCT01581281|20453985|P3|Overall Study|Early Study Closure|12
5912346|NCT01581281|20453986|P2|Overall Study|Early Study Closure|6
5912347|NCT01581281|20453987|P1|Overall Study|Early Study Closure|15
5912348|NCT01581021|20454009|P2|Overall Study|Lack of Efficacy|1
5912349|NCT01581021|20454010|P1|Overall Study|Lack of Efficacy|0
5912350|NCT01581021|20454009|P2|Overall Study|Lenke 6 Classification|1
5912351|NCT01581021|20454010|P1|Overall Study|Lenke 6 Classification|0
5912352|NCT01581021|20454009|P2|Overall Study|Not Randomized|2
5912353|NCT01581021|20454010|P1|Overall Study|Not Randomized|1
5912354|NCT01581021|20454009|P2|Overall Study|Neuromuscular|1
5912355|NCT01581021|20454010|P1|Overall Study|Neuromuscular|2
5912356|NCT01581021|20454009|P2|Overall Study|More than 2 hooks in thoracic|0
5912357|NCT01581021|20454010|P1|Overall Study|More than 2 hooks in thoracic|3
5912358|NCT01581021|20454009|P2|Overall Study|Lost to Follow-up|6
5912359|NCT01581021|20454010|P1|Overall Study|Lost to Follow-up|4
5912360|NCT01580995|20454037|P2|Overall Study|Lost to Follow-up|2
5912361|NCT01580995|20454038|P1|Overall Study|Lost to Follow-up|2
5912362|NCT01580969|20454047|P3|Overall Study|Physician Decision|0
5912363|NCT01580969|20454048|P2|Overall Study|Physician Decision|0
5912364|NCT01580969|20454049|P1|Overall Study|Physician Decision|3
5912365|NCT01580670|20454096|P1|Maintenance Period (Week 14 to 54)|Lack of Efficacy|1
5912366|NCT01580670|20454096|P1|Maintenance Period (Week 14 to 54)|Adverse Event|1
5912367|NCT01580488|20454137|P1|Overall Study|Withdrawal by Subject|1
5912368|NCT01580293|20454243|P3|Part B|Other reason|1
5912369|NCT01580293|20454244|P2|Part B|Other reason|0
5912370|NCT01580293|20454245|P1|Part B|Other reason|0
5912371|NCT01580293|20454243|P3|Part B|Withdrawal by Subject|1
5912372|NCT01580293|20454244|P2|Part B|Withdrawal by Subject|0
5912373|NCT01580293|20454245|P1|Part B|Withdrawal by Subject|0
5912374|NCT01580293|20454243|P3|Part A_Extension|Completed Japan only|0
5912375|NCT01580293|20454244|P2|Part A_Extension|Completed Japan only|5
5912376|NCT01580293|20454245|P1|Part A_Extension|Completed Japan only|0
5912377|NCT01580293|20454243|P3|Part A_Extension|Other Reason|0
5912378|NCT01580293|20454244|P2|Part A_Extension|Other Reason|1
5912379|NCT01580293|20454245|P1|Part A_Extension|Other Reason|0
5912380|NCT01580293|20454243|P3|Part A_Extension|Lost to Follow-up|0
5912381|NCT01580293|20454244|P2|Part A_Extension|Lost to Follow-up|1
5912382|NCT01580293|20454245|P1|Part A_Extension|Lost to Follow-up|0
5912383|NCT01580293|20454243|P3|Part A_Extension|Withdrawal by Subject|0
5912384|NCT01580293|20454244|P2|Part A_Extension|Withdrawal by Subject|3
5912385|NCT01580293|20454245|P1|Part A_Extension|Withdrawal by Subject|0
5912386|NCT01580293|20454243|P3|Part A_Extension|Adverse Event|0
5912387|NCT01580293|20454244|P2|Part A_Extension|Adverse Event|2
5912388|NCT01580293|20454245|P1|Part A_Extension|Adverse Event|0
5912389|NCT01580293|20454243|P3|Part A_Main Trial|Non-adherence to the protocol|0
5912390|NCT01580293|20454244|P2|Part A_Main Trial|Non-adherence to the protocol|0
5912391|NCT01580293|20454245|P1|Part A_Main Trial|Non-adherence to the protocol|1
5912392|NCT01580293|20454243|P3|Part A_Main Trial|Withdrawal by Subject|0
5912393|NCT01580293|20454244|P2|Part A_Main Trial|Withdrawal by Subject|4
5912394|NCT01580293|20454245|P1|Part A_Main Trial|Withdrawal by Subject|1
5912395|NCT01580293|20454243|P3|Part A_Main Trial|Adverse Event|0
5912396|NCT01580293|20454244|P2|Part A_Main Trial|Adverse Event|2
5912397|NCT01580293|20454245|P1|Part A_Main Trial|Adverse Event|0
5912398|NCT01580020|20454385|P4|Overall Study|Lost to Follow-up|0
5912399|NCT01580020|20454386|P3|Overall Study|Lost to Follow-up|1
5912400|NCT01580020|20454387|P2|Overall Study|Lost to Follow-up|0
5912401|NCT01580020|20454388|P1|Overall Study|Lost to Follow-up|0
5912402|NCT01580020|20454385|P4|Overall Study|Administrative Problems|0
5912403|NCT01580020|20454386|P3|Overall Study|Administrative Problems|1
5912404|NCT01580020|20454387|P2|Overall Study|Administrative Problems|0
5912405|NCT01580020|20454388|P1|Overall Study|Administrative Problems|0
5912406|NCT01580020|20454385|P4|Overall Study|Adverse Event|1
5912407|NCT01580020|20454386|P3|Overall Study|Adverse Event|1
5912408|NCT01580020|20454387|P2|Overall Study|Adverse Event|1
5912409|NCT01580020|20454388|P1|Overall Study|Adverse Event|1
5912410|NCT01580020|20454385|P4|Overall Study|Withdrawal by Subject|0
5912411|NCT01580020|20454386|P3|Overall Study|Withdrawal by Subject|1
5912412|NCT01580020|20454387|P2|Overall Study|Withdrawal by Subject|1
5912413|NCT01580020|20454388|P1|Overall Study|Withdrawal by Subject|0
5912414|NCT01580020|20454385|P4|Overall Study|Lack of Efficacy|1
5912415|NCT01580020|20454386|P3|Overall Study|Lack of Efficacy|0
5912416|NCT01580020|20454387|P2|Overall Study|Lack of Efficacy|5
5912417|NCT01580020|20454388|P1|Overall Study|Lack of Efficacy|0
5912418|NCT01579916|20454432|P2|Overall Study|Death|0
5912419|NCT01579916|20454433|P1|Overall Study|Death|1
5912420|NCT01579916|20454432|P2|Overall Study|Withdrawal by Subject|1
5912421|NCT01579916|20454433|P1|Overall Study|Withdrawal by Subject|1
5912422|NCT01579916|20454432|P2|Overall Study|Lost to Follow-up|1
5912423|NCT01579916|20454433|P1|Overall Study|Lost to Follow-up|6
5912424|NCT01579812|20454459|P1|Overall Study|Withdrawal by Subject|6
5912425|NCT01579812|20454459|P1|Overall Study|Noncompliance|3
5912426|NCT01579812|20454459|P1|Overall Study|Patient choice|3
5912427|NCT01579812|20454459|P1|Overall Study|Ineligible after treatment start|40
5912428|NCT01579578|20454493|P2|Overall Study|Ongoing|0
5912429|NCT01579578|20454494|P1|Overall Study|Ongoing|3
5912430|NCT01579578|20454493|P2|Overall Study|Eligibility criteria|9
5912431|NCT01579578|20454494|P1|Overall Study|Eligibility criteria|3
5912432|NCT01579578|20454493|P2|Overall Study|Withdrawal by Subject|1
5912433|NCT01579578|20454494|P1|Overall Study|Withdrawal by Subject|2
5912434|NCT01579578|20454493|P2|Overall Study|Lost to Follow-up|1
5912435|NCT01579578|20454494|P1|Overall Study|Lost to Follow-up|1
5912436|NCT01579578|20454493|P2|Overall Study|Death|1
5912437|NCT01579578|20454494|P1|Overall Study|Death|4
5912438|NCT01579565|20454506|P2|Treated|declined to return for final visit|1
5912439|NCT01579565|20454507|P1|Treated|declined to return for final visit|0
5912440|NCT01579565|20454506|P2|Treated|Lost to Follow-up|1
5912441|NCT01579565|20454507|P1|Treated|Lost to Follow-up|2
5912442|NCT01579565|20454506|P2|Treated|Physician Decision|1
5912443|NCT01579565|20454507|P1|Treated|Physician Decision|0
5912444|NCT01579565|20454506|P2|Randomized|prohibited preoperative medication|1
5912445|NCT01579565|20454507|P1|Randomized|prohibited preoperative medication|0
5912446|NCT01579565|20454506|P2|Randomized|prohibited preoperative eating|0
5912447|NCT01579565|20454507|P1|Randomized|prohibited preoperative eating|1
5912448|NCT01579565|20454506|P2|Randomized|inadequate preoperative pupil dilation|1
5912449|NCT01579565|20454507|P1|Randomized|inadequate preoperative pupil dilation|0
5912450|NCT01579565|20454506|P2|Randomized|Withdrawal by Subject|0
5912451|NCT01579565|20454507|P1|Randomized|Withdrawal by Subject|3
5912452|NCT01579565|20454506|P2|Randomized|Adverse Event|3
5912453|NCT01579565|20454507|P1|Randomized|Adverse Event|1
5912454|NCT01579474|20454558|P6|Overall Study|Withdrawal by Subject|0
5912455|NCT01579474|20454559|P5|Overall Study|Withdrawal by Subject|0
5912456|NCT01579474|20454560|P4|Overall Study|Withdrawal by Subject|0
5912457|NCT01579474|20454561|P3|Overall Study|Withdrawal by Subject|0
5912458|NCT01579474|20454562|P2|Overall Study|Withdrawal by Subject|0
5912459|NCT01579474|20454563|P1|Overall Study|Withdrawal by Subject|1
5912460|NCT01579474|20454558|P6|Overall Study|Lack of Efficacy|0
5912461|NCT01579474|20454559|P5|Overall Study|Lack of Efficacy|1
5912462|NCT01579474|20454560|P4|Overall Study|Lack of Efficacy|0
5912463|NCT01579474|20454561|P3|Overall Study|Lack of Efficacy|0
5912464|NCT01579474|20454562|P2|Overall Study|Lack of Efficacy|0
5912465|NCT01579474|20454563|P1|Overall Study|Lack of Efficacy|1
5912466|NCT01579474|20454558|P6|Overall Study|Adverse Event|1
5912467|NCT01579474|20454559|P5|Overall Study|Adverse Event|0
5912468|NCT01579474|20454560|P4|Overall Study|Adverse Event|0
5912469|NCT01579474|20454561|P3|Overall Study|Adverse Event|2
5912470|NCT01579474|20454562|P2|Overall Study|Adverse Event|13
5912471|NCT01579474|20454563|P1|Overall Study|Adverse Event|1
5912472|NCT01579318|20454637|P1|Overall Study|Disease Progression|1
5912473|NCT01579006|20454732|P1|Overall Study|Scheduled surgery|1
5912474|NCT01579006|20454732|P1|Overall Study|Due to participant's health fund|1
5912475|NCT01579006|20454732|P1|Overall Study|Non-compliance|3
5912476|NCT01579006|20454732|P1|Overall Study|Withdrawal by Subject|5
5912477|NCT01579006|20454732|P1|Overall Study|Adverse Event|13
5912478|NCT01579006|20454732|P1|Overall Study|Lack of Efficacy|10
5912479|NCT01578850|20454800|P3|Period 2|Unspecified Reasons|0
5912480|NCT01578850|20454801|P2|Period 2|Unspecified Reasons|1
5912481|NCT01578850|20454802|P1|Period 2|Unspecified Reasons|0
5912482|NCT01578850|20454800|P3|Period 2|Study Terminated by Sponsor|4
5912483|NCT01578850|20454801|P2|Period 2|Study Terminated by Sponsor|5
5912484|NCT01578850|20454802|P1|Period 2|Study Terminated by Sponsor|0
5912485|NCT01578850|20454800|P3|Period 2|Withdrawal by Subject|2
5912486|NCT01578850|20454801|P2|Period 2|Withdrawal by Subject|2
5912487|NCT01578850|20454802|P1|Period 2|Withdrawal by Subject|0
5912488|NCT01578850|20454800|P3|Period 2|Lost to Follow-up|2
5912489|NCT01578850|20454801|P2|Period 2|Lost to Follow-up|1
5912490|NCT01578850|20454802|P1|Period 2|Lost to Follow-up|0
5912491|NCT01578850|20454800|P3|Period 2|Adverse Event|6
5912492|NCT01578850|20454801|P2|Period 2|Adverse Event|3
5912493|NCT01578850|20454802|P1|Period 2|Adverse Event|0
5912494|NCT01578850|20454800|P3|Period 2|Insufficient Clinical Response|0
5912495|NCT01578850|20454801|P2|Period 2|Insufficient Clinical Response|1
5912496|NCT01578850|20454802|P1|Period 2|Insufficient Clinical Response|0
5912497|NCT01578850|20454800|P3|Period 1|Study Terminated by Sponsor|0
5912498|NCT01578850|20454801|P2|Period 1|Study Terminated by Sponsor|0
5912499|NCT01578850|20454802|P1|Period 1|Study Terminated by Sponsor|3
5912500|NCT01578850|20454800|P3|Period 1|Withdrawal by Subject|0
5912501|NCT01578850|20454801|P2|Period 1|Withdrawal by Subject|0
5912502|NCT01578850|20454802|P1|Period 1|Withdrawal by Subject|9
5912503|NCT01578850|20454800|P3|Period 1|Does Not Meet Entrance Criteria|0
5912504|NCT01578850|20454801|P2|Period 1|Does Not Meet Entrance Criteria|0
5912505|NCT01578850|20454802|P1|Period 1|Does Not Meet Entrance Criteria|12
5912506|NCT01578850|20454800|P3|Period 1|Death|0
5912507|NCT01578850|20454801|P2|Period 1|Death|0
5912508|NCT01578850|20454802|P1|Period 1|Death|1
5912509|NCT01578850|20454800|P3|Period 1|Adverse Event|0
5912510|NCT01578850|20454801|P2|Period 1|Adverse Event|0
5912511|NCT01578850|20454802|P1|Period 1|Adverse Event|11
5912512|NCT01578850|20454800|P3|Period 1|Insufficient Clinical Response|0
5912513|NCT01578850|20454801|P2|Period 1|Insufficient Clinical Response|0
5912514|NCT01578850|20454802|P1|Period 1|Insufficient Clinical Response|1
5912515|NCT01578785|20454854|P2|Overall Study|Study terminated by sponsor|118
5912516|NCT01578785|20454855|P1|Overall Study|Study terminated by sponsor|59
5912517|NCT01578785|20454854|P2|Overall Study|Withdrawal by Subject|1
5912518|NCT01578785|20454855|P1|Overall Study|Withdrawal by Subject|0
5912519|NCT01578551|20454920|P2|Overall Study|Adverse Event|0
5912520|NCT01578551|20454921|P1|Overall Study|Adverse Event|1
5912521|NCT01578499|20454933|P2|Overall Study|Died and End of Study Page not Completed|0
5912522|NCT01578499|20454934|P1|Overall Study|Died and End of Study Page not Completed|2
5912523|NCT01578499|20454933|P2|Overall Study|Death|25
5912524|NCT01578499|20454934|P1|Overall Study|Death|20
5912525|NCT01578499|20454933|P2|Overall Study|Withdrawal by Subject|16
5912526|NCT01578499|20454934|P1|Overall Study|Withdrawal by Subject|10
5912527|NCT01578499|20454933|P2|Overall Study|Lost to Follow-up|1
5912528|NCT01578499|20454934|P1|Overall Study|Lost to Follow-up|2
5912529|NCT01578499|20454933|P2|Overall Study|Reason not Specified|1
5912530|NCT01578499|20454934|P1|Overall Study|Reason not Specified|0
5912531|NCT01578486|20454968|P1|Overall Study|Withdrawal by Subject|2
5912532|NCT01578486|20454968|P1|Overall Study|Physician Decision|3
5912533|NCT01578330|20454979|P1|Overall Study|Protocol Violation|5
5912534|NCT01578330|20454979|P1|Overall Study|Adverse Event|2
5912535|NCT01578187|20455021|P1|Usability Phase|Withdrawal by Subject|1
5912536|NCT01577758|20455063|P8|mCRC Expansion Phase|Progression Disease|19
5912537|NCT01577758|20455064|P7|mCRC Expansion Phase|Progression Disease|0
5912538|NCT01577758|20455065|P6|mCRC Expansion Phase|Progression Disease|0
5912539|NCT01577758|20455066|P5|mCRC Expansion Phase|Progression Disease|0
5912540|NCT01577758|20455067|P4|mCRC Expansion Phase|Progression Disease|0
5912541|NCT01577758|20455068|P3|mCRC Expansion Phase|Progression Disease|0
5912542|NCT01577758|20455069|P2|mCRC Expansion Phase|Progression Disease|0
5912543|NCT01577758|20455070|P1|mCRC Expansion Phase|Progression Disease|0
5912544|NCT01577758|20455063|P8|mCRC Expansion Phase|Withdrawal by Subject|2
5912545|NCT01577758|20455064|P7|mCRC Expansion Phase|Withdrawal by Subject|0
5912546|NCT01577758|20455065|P6|mCRC Expansion Phase|Withdrawal by Subject|0
5912547|NCT01577758|20455066|P5|mCRC Expansion Phase|Withdrawal by Subject|0
5912548|NCT01577758|20455067|P4|mCRC Expansion Phase|Withdrawal by Subject|0
5912549|NCT01577758|20455068|P3|mCRC Expansion Phase|Withdrawal by Subject|0
5912550|NCT01577758|20455069|P2|mCRC Expansion Phase|Withdrawal by Subject|0
5912551|NCT01577758|20455070|P1|mCRC Expansion Phase|Withdrawal by Subject|0
5912552|NCT01577758|20455063|P8|mCRC Expansion Phase|Symptomatic Deterioration|4
5912553|NCT01577758|20455064|P7|mCRC Expansion Phase|Symptomatic Deterioration|0
5912554|NCT01577758|20455065|P6|mCRC Expansion Phase|Symptomatic Deterioration|0
5912555|NCT01577758|20455066|P5|mCRC Expansion Phase|Symptomatic Deterioration|0
5912556|NCT01577758|20455067|P4|mCRC Expansion Phase|Symptomatic Deterioration|0
5912557|NCT01577758|20455068|P3|mCRC Expansion Phase|Symptomatic Deterioration|0
5912558|NCT01577758|20455069|P2|mCRC Expansion Phase|Symptomatic Deterioration|0
5912559|NCT01577758|20455070|P1|mCRC Expansion Phase|Symptomatic Deterioration|0
5912560|NCT01577758|20455063|P8|Dose Escalation Phase|Progression Disease|0
5912561|NCT01577758|20455064|P7|Dose Escalation Phase|Progression Disease|0
5912562|NCT01577758|20455065|P6|Dose Escalation Phase|Progression Disease|0
5912563|NCT01577758|20455066|P5|Dose Escalation Phase|Progression Disease|5
5912564|NCT01577758|20455067|P4|Dose Escalation Phase|Progression Disease|2
5912565|NCT01577758|20455068|P3|Dose Escalation Phase|Progression Disease|1
5912566|NCT01577758|20455069|P2|Dose Escalation Phase|Progression Disease|2
5912567|NCT01577758|20455070|P1|Dose Escalation Phase|Progression Disease|2
5912568|NCT01577758|20455063|P8|Dose Escalation Phase|Withdrawal by Subject|0
5912569|NCT01577758|20455064|P7|Dose Escalation Phase|Withdrawal by Subject|0
5912570|NCT01577758|20455065|P6|Dose Escalation Phase|Withdrawal by Subject|1
5912571|NCT01577758|20455066|P5|Dose Escalation Phase|Withdrawal by Subject|0
5912572|NCT01577758|20455067|P4|Dose Escalation Phase|Withdrawal by Subject|0
5912573|NCT01577758|20455068|P3|Dose Escalation Phase|Withdrawal by Subject|0
5912574|NCT01577758|20455069|P2|Dose Escalation Phase|Withdrawal by Subject|0
5912575|NCT01577758|20455070|P1|Dose Escalation Phase|Withdrawal by Subject|0
5912576|NCT01577758|20455063|P8|Dose Escalation Phase|Symptomatic Deterioration|0
5912577|NCT01577758|20455064|P7|Dose Escalation Phase|Symptomatic Deterioration|0
5912578|NCT01577758|20455065|P6|Dose Escalation Phase|Symptomatic Deterioration|1
5912579|NCT01577758|20455066|P5|Dose Escalation Phase|Symptomatic Deterioration|1
5912580|NCT01577758|20455067|P4|Dose Escalation Phase|Symptomatic Deterioration|0
5912581|NCT01577758|20455068|P3|Dose Escalation Phase|Symptomatic Deterioration|1
5912582|NCT01577758|20455069|P2|Dose Escalation Phase|Symptomatic Deterioration|0
5912583|NCT01577758|20455070|P1|Dose Escalation Phase|Symptomatic Deterioration|0
5912584|NCT01577758|20455063|P8|Dose Escalation Phase|Adverse Event|0
5912585|NCT01577758|20455064|P7|Dose Escalation Phase|Adverse Event|1
5912586|NCT01577758|20455065|P6|Dose Escalation Phase|Adverse Event|2
5912587|NCT01577758|20455066|P5|Dose Escalation Phase|Adverse Event|0
5912588|NCT01577758|20455067|P4|Dose Escalation Phase|Adverse Event|0
5912589|NCT01577758|20455068|P3|Dose Escalation Phase|Adverse Event|0
5912590|NCT01577758|20455069|P2|Dose Escalation Phase|Adverse Event|0
5912591|NCT01577758|20455070|P1|Dose Escalation Phase|Adverse Event|0
5912592|NCT01577745|20455109|P6|Overall Study|Alternative Therapy|0
5912593|NCT01577745|20455110|P5|Overall Study|Alternative Therapy|1
5912594|NCT01577745|20455111|P4|Overall Study|Alternative Therapy|1
5912595|NCT01577745|20455112|P3|Overall Study|Alternative Therapy|0
5912596|NCT01577745|20455113|P2|Overall Study|Alternative Therapy|0
5912597|NCT01577745|20455114|P1|Overall Study|Alternative Therapy|0
5912598|NCT01577745|20455109|P6|Overall Study|Lost to Follow-up|1
5912599|NCT01577745|20455110|P5|Overall Study|Lost to Follow-up|0
5912600|NCT01577745|20455111|P4|Overall Study|Lost to Follow-up|0
5912601|NCT01577745|20455112|P3|Overall Study|Lost to Follow-up|0
5912602|NCT01577745|20455113|P2|Overall Study|Lost to Follow-up|0
5912603|NCT01577745|20455114|P1|Overall Study|Lost to Follow-up|0
5912604|NCT01577745|20455109|P6|Overall Study|Physician Decision|0
5912605|NCT01577745|20455110|P5|Overall Study|Physician Decision|1
5912606|NCT01577745|20455111|P4|Overall Study|Physician Decision|1
5912607|NCT01577745|20455112|P3|Overall Study|Physician Decision|0
5912608|NCT01577745|20455113|P2|Overall Study|Physician Decision|0
5912609|NCT01577745|20455114|P1|Overall Study|Physician Decision|0
5912610|NCT01577745|20455109|P6|Overall Study|Death|3
5912611|NCT01577745|20455110|P5|Overall Study|Death|1
5912612|NCT01577745|20455111|P4|Overall Study|Death|1
5912613|NCT01577745|20455112|P3|Overall Study|Death|2
5912614|NCT01577745|20455113|P2|Overall Study|Death|2
5912615|NCT01577745|20455114|P1|Overall Study|Death|3
5912616|NCT01577745|20455109|P6|Overall Study|Withdrawal by Subject|0
5912617|NCT01577745|20455110|P5|Overall Study|Withdrawal by Subject|2
5912618|NCT01577745|20455111|P4|Overall Study|Withdrawal by Subject|3
5912619|NCT01577745|20455112|P3|Overall Study|Withdrawal by Subject|0
5912620|NCT01577745|20455113|P2|Overall Study|Withdrawal by Subject|1
5912621|NCT01577745|20455114|P1|Overall Study|Withdrawal by Subject|0
5912622|NCT01577381|20455315|P4|Overall Study|Ongoing at Date of Cut-Off|0
5912623|NCT01577381|20455316|P3|Overall Study|Ongoing at Date of Cut-Off|1
5912624|NCT01577381|20455317|P2|Overall Study|Ongoing at Date of Cut-Off|2
5912625|NCT01577381|20455318|P1|Overall Study|Ongoing at Date of Cut-Off|0
5912626|NCT01577381|20455315|P4|Overall Study|Discontinued|2
5912627|NCT01577381|20455316|P3|Overall Study|Discontinued|2
5912628|NCT01577381|20455317|P2|Overall Study|Discontinued|1
5912629|NCT01577381|20455318|P1|Overall Study|Discontinued|2
5912630|NCT01577186|20455473|P1|Overall Study|Other|2
5912631|NCT01577186|20455473|P1|Overall Study|Non-Compliant|8
5912632|NCT01577186|20455473|P1|Overall Study|Ineligible to Continue|15
5912633|NCT01577186|20455473|P1|Overall Study|Insufficient Response|18
5912634|NCT01577186|20455473|P1|Overall Study|Withdrawal by Subject|35
5912635|NCT01577186|20455473|P1|Overall Study|Lost to Follow-up|28
5912636|NCT01577186|20455473|P1|Overall Study|Death|1
5912637|NCT01577186|20455473|P1|Overall Study|Adverse Event|23
5912638|NCT01577160|20455481|P1|Overall Study|Other|9
5912639|NCT01577160|20455481|P1|Overall Study|Subject Uncooperative|7
5912640|NCT01577160|20455481|P1|Overall Study|Withdrawal by Subject|18
5912641|NCT01577160|20455481|P1|Overall Study|Lost to Follow-up|40
5912642|NCT01577160|20455481|P1|Overall Study|Lack of Efficacy|15
5912643|NCT01577160|20455481|P1|Overall Study|Adverse Event|9
5912650|NCT01576718|20455563|P7|Treatment Period|Noncompliance to study medication|1
5912651|NCT01576718|20455564|P6|Treatment Period|Noncompliance to study medication|1
5912652|NCT01576718|20455565|P5|Treatment Period|Noncompliance to study medication|0
5912653|NCT01576718|20455566|P4|Treatment Period|Noncompliance to study medication|0
5912654|NCT01576718|20455567|P3|Treatment Period|Noncompliance to study medication|0
5912655|NCT01576718|20455568|P2|Treatment Period|Noncompliance to study medication|0
5912656|NCT01576718|20455569|P1|Treatment Period|Noncompliance to study medication|0
5912657|NCT01576718|20455563|P7|Treatment Period|Lost to Follow-up|0
5912658|NCT01576718|20455564|P6|Treatment Period|Lost to Follow-up|0
5912659|NCT01576718|20455565|P5|Treatment Period|Lost to Follow-up|1
5912660|NCT01576718|20455566|P4|Treatment Period|Lost to Follow-up|0
5912661|NCT01576718|20455567|P3|Treatment Period|Lost to Follow-up|0
5912662|NCT01576718|20455568|P2|Treatment Period|Lost to Follow-up|0
5912663|NCT01576718|20455569|P1|Treatment Period|Lost to Follow-up|0
5912664|NCT01576718|20455563|P7|Treatment Period|Met stopping criteria|15
5912665|NCT01576718|20455564|P6|Treatment Period|Met stopping criteria|33
5912666|NCT01576718|20455565|P5|Treatment Period|Met stopping criteria|16
5912667|NCT01576718|20455566|P4|Treatment Period|Met stopping criteria|19
5912668|NCT01576718|20455567|P3|Treatment Period|Met stopping criteria|13
5912669|NCT01576718|20455568|P2|Treatment Period|Met stopping criteria|16
5912670|NCT01576718|20455569|P1|Treatment Period|Met stopping criteria|0
5912671|NCT01576718|20455563|P7|Treatment Period|Sponsor request|0
5912672|NCT01576718|20455564|P6|Treatment Period|Sponsor request|1
5912673|NCT01576718|20455565|P5|Treatment Period|Sponsor request|0
5912674|NCT01576718|20455566|P4|Treatment Period|Sponsor request|0
5912675|NCT01576718|20455567|P3|Treatment Period|Sponsor request|0
5912676|NCT01576718|20455568|P2|Treatment Period|Sponsor request|1
5912677|NCT01576718|20455569|P1|Treatment Period|Sponsor request|0
5912678|NCT01576718|20455563|P7|Treatment Period|Protocol Violation|12
5912679|NCT01576718|20455564|P6|Treatment Period|Protocol Violation|8
5912680|NCT01576718|20455565|P5|Treatment Period|Protocol Violation|6
5912681|NCT01576718|20455566|P4|Treatment Period|Protocol Violation|10
5912682|NCT01576718|20455567|P3|Treatment Period|Protocol Violation|4
5912683|NCT01576718|20455568|P2|Treatment Period|Protocol Violation|5
5912684|NCT01576718|20455569|P1|Treatment Period|Protocol Violation|0
5912685|NCT01576718|20455563|P7|Treatment Period|Physician Decision|0
5912686|NCT01576718|20455564|P6|Treatment Period|Physician Decision|0
5912687|NCT01576718|20455565|P5|Treatment Period|Physician Decision|1
5912688|NCT01576718|20455566|P4|Treatment Period|Physician Decision|1
5912689|NCT01576718|20455567|P3|Treatment Period|Physician Decision|1
5912690|NCT01576718|20455568|P2|Treatment Period|Physician Decision|1
5912691|NCT01576718|20455569|P1|Treatment Period|Physician Decision|0
5912692|NCT01576718|20455563|P7|Treatment Period|Withdrawal by Subject|2
5912693|NCT01576718|20455564|P6|Treatment Period|Withdrawal by Subject|4
5912694|NCT01576718|20455565|P5|Treatment Period|Withdrawal by Subject|2
5912695|NCT01576718|20455566|P4|Treatment Period|Withdrawal by Subject|0
5912696|NCT01576718|20455567|P3|Treatment Period|Withdrawal by Subject|1
5912697|NCT01576718|20455568|P2|Treatment Period|Withdrawal by Subject|1
5912698|NCT01576718|20455569|P1|Treatment Period|Withdrawal by Subject|0
5912699|NCT01576718|20455563|P7|Treatment Period|Adverse Event|0
5912700|NCT01576718|20455564|P6|Treatment Period|Adverse Event|1
5912701|NCT01576718|20455565|P5|Treatment Period|Adverse Event|1
5912702|NCT01576718|20455566|P4|Treatment Period|Adverse Event|1
5912703|NCT01576718|20455567|P3|Treatment Period|Adverse Event|1
5912704|NCT01576718|20455568|P2|Treatment Period|Adverse Event|1
5912705|NCT01576718|20455569|P1|Treatment Period|Adverse Event|0
5912706|NCT01576718|20455563|P7|Pre-Assignment Period (Run-In Placebo)|Other|0
5912707|NCT01576718|20455564|P6|Pre-Assignment Period (Run-In Placebo)|Other|0
5912708|NCT01576718|20455565|P5|Pre-Assignment Period (Run-In Placebo)|Other|0
5912709|NCT01576718|20455566|P4|Pre-Assignment Period (Run-In Placebo)|Other|0
5912710|NCT01576718|20455567|P3|Pre-Assignment Period (Run-In Placebo)|Other|0
5912711|NCT01576718|20455568|P2|Pre-Assignment Period (Run-In Placebo)|Other|0
5912712|NCT01576718|20455569|P1|Pre-Assignment Period (Run-In Placebo)|Other|15
5912713|NCT01576718|20455563|P7|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
5912714|NCT01576718|20455564|P6|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
5912715|NCT01576718|20455565|P5|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
5912716|NCT01576718|20455566|P4|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
5912717|NCT01576718|20455567|P3|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
5912718|NCT01576718|20455568|P2|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
5912719|NCT01576718|20455569|P1|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|2
5912720|NCT01576718|20455563|P7|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
5912721|NCT01576718|20455564|P6|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
5912722|NCT01576718|20455565|P5|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
5912723|NCT01576718|20455566|P4|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
5912724|NCT01576718|20455567|P3|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
5912725|NCT01576718|20455568|P2|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
5912726|NCT01576718|20455569|P1|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|166
5912727|NCT01576718|20455563|P7|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
5912728|NCT01576718|20455564|P6|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
5912729|NCT01576718|20455565|P5|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
5912730|NCT01576718|20455566|P4|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
5912731|NCT01576718|20455567|P3|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
5912732|NCT01576718|20455568|P2|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
5912733|NCT01576718|20455569|P1|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|17
5912734|NCT01576718|20455563|P7|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
5912735|NCT01576718|20455564|P6|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
5912736|NCT01576718|20455565|P5|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
5912737|NCT01576718|20455566|P4|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
5912738|NCT01576718|20455567|P3|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
5912739|NCT01576718|20455568|P2|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
5912740|NCT01576718|20455569|P1|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|49
5912741|NCT01576705|20455665|P4|Overall Study|invalid ICF|0
5912742|NCT01576705|20455666|P3|Overall Study|invalid ICF|0
5912743|NCT01576705|20455667|P2|Overall Study|invalid ICF|1
5912744|NCT01576705|20455668|P1|Overall Study|invalid ICF|0
5912745|NCT01576705|20455665|P4|Overall Study|TSH > 7 mIU/L at baseline|3
5912746|NCT01576705|20455666|P3|Overall Study|TSH > 7 mIU/L at baseline|5
5912747|NCT01576705|20455667|P2|Overall Study|TSH > 7 mIU/L at baseline|7
5912748|NCT01576705|20455668|P1|Overall Study|TSH > 7 mIU/L at baseline|3
5912749|NCT01576575|20455689|P1|Buprenorphine + Grapefruit|Withdrawal by Subject|1
5912750|NCT01576575|20455689|P1|Buprenorphine + Rifampin|Withdrawal by Subject|3
5912751|NCT01576575|20455689|P1|Buprenorphine Control|Withdrawal by Subject|3
5912752|NCT01576549|20455699|P1|Overall Study|Sponsor Decision|2
5912753|NCT01576484|20455715|P2|Overall Study|Other|5
5912754|NCT01576484|20455716|P1|Overall Study|Other|2
5912755|NCT01576484|20455715|P2|Overall Study|Withdrawal by Subject|3
5912756|NCT01576484|20455716|P1|Overall Study|Withdrawal by Subject|0
5912757|NCT01576484|20455715|P2|Overall Study|Sponsor Decision|8
5912758|NCT01576484|20455716|P1|Overall Study|Sponsor Decision|2
5912759|NCT01576484|20455715|P2|Overall Study|Protocol Violation|2
5912760|NCT01576484|20455716|P1|Overall Study|Protocol Violation|0
5912761|NCT01576484|20455715|P2|Overall Study|Adverse Event|1
5912762|NCT01576484|20455716|P1|Overall Study|Adverse Event|1
5912763|NCT01576406|20455795|P6|Overall Study|Other|0
5912764|NCT01576406|20455796|P5|Overall Study|Other|0
5912765|NCT01576406|20455797|P4|Overall Study|Other|2
5912766|NCT01576406|20455798|P3|Overall Study|Other|2
5912767|NCT01576406|20455799|P2|Overall Study|Other|0
5912768|NCT01576406|20455800|P1|Overall Study|Other|0
5912769|NCT01576406|20455795|P6|Overall Study|Withdrawal the consent|3
5912770|NCT01576406|20455796|P5|Overall Study|Withdrawal the consent|1
5912771|NCT01576406|20455797|P4|Overall Study|Withdrawal the consent|1
5912772|NCT01576406|20455798|P3|Overall Study|Withdrawal the consent|5
5912773|NCT01576406|20455799|P2|Overall Study|Withdrawal the consent|2
5912774|NCT01576406|20455800|P1|Overall Study|Withdrawal the consent|2
5912775|NCT01576406|20455795|P6|Overall Study|Non-clinical trial supply of Crizotinib|0
5912776|NCT01576406|20455796|P5|Overall Study|Non-clinical trial supply of Crizotinib|0
5912777|NCT01576406|20455797|P4|Overall Study|Non-clinical trial supply of Crizotinib|1
5912778|NCT01576406|20455798|P3|Overall Study|Non-clinical trial supply of Crizotinib|1
5912779|NCT01576406|20455799|P2|Overall Study|Non-clinical trial supply of Crizotinib|0
5912780|NCT01576406|20455800|P1|Overall Study|Non-clinical trial supply of Crizotinib|0
5912781|NCT01576406|20455795|P6|Overall Study|Death|9
5912782|NCT01576406|20455796|P5|Overall Study|Death|7
5912783|NCT01576406|20455797|P4|Overall Study|Death|5
5912784|NCT01576406|20455798|P3|Overall Study|Death|8
5912785|NCT01576406|20455799|P2|Overall Study|Death|4
5912786|NCT01576406|20455800|P1|Overall Study|Death|3
5912787|NCT01576406|20455795|P6|Overall Study|Lost to Follow-up|0
5912788|NCT01576406|20455796|P5|Overall Study|Lost to Follow-up|0
5912789|NCT01576406|20455797|P4|Overall Study|Lost to Follow-up|0
5912790|NCT01576406|20455798|P3|Overall Study|Lost to Follow-up|0
5912791|NCT01576406|20455799|P2|Overall Study|Lost to Follow-up|2
5912792|NCT01576406|20455800|P1|Overall Study|Lost to Follow-up|1
5912793|NCT01576367|20456048|P1|Overall Study|Moved to commercial use after 6 months|1
5912794|NCT01576367|20456048|P1|Overall Study|Unsatisfactory therapeutic effect|2
5912795|NCT01576341|20456056|P1|Overall Study|Other|12
5912796|NCT01576341|20456056|P1|Overall Study|Protocol Violation|12
5912797|NCT01576341|20456056|P1|Overall Study|Kidney transplantation|10
5912798|NCT01576341|20456056|P1|Overall Study|Lost to Follow-up|2
5912799|NCT01576341|20456056|P1|Overall Study|Physician Decision|2
5912800|NCT01576341|20456056|P1|Overall Study|Death|21
5912801|NCT01576341|20456056|P1|Overall Study|Adverse Event|10
5912802|NCT01576341|20456056|P1|Overall Study|Withdrawal by Subject|24
5912803|NCT01576172|20456075|P2|Overall Study|Insurance issue|0
5912804|NCT01576172|20456076|P1|Overall Study|Insurance issue|1
5912805|NCT01576172|20456075|P2|Overall Study|Withdrawal by Subject|0
5912806|NCT01576172|20456076|P1|Overall Study|Withdrawal by Subject|2
5912807|NCT01576172|20456075|P2|Overall Study|Ineligible|1
5912808|NCT01576172|20456076|P1|Overall Study|Ineligible|2
5912809|NCT01576159|20456094|P4|Overall Study|Protocol Violation|0
5912810|NCT01576159|20456095|P3|Overall Study|Protocol Violation|0
5912811|NCT01576159|20456096|P2|Overall Study|Protocol Violation|0
5912812|NCT01576159|20456097|P1|Overall Study|Protocol Violation|1
5912813|NCT01576159|20456094|P4|Overall Study|Lost to Follow-up|1
5912814|NCT01576159|20456095|P3|Overall Study|Lost to Follow-up|0
5912815|NCT01576159|20456096|P2|Overall Study|Lost to Follow-up|0
5912816|NCT01576159|20456097|P1|Overall Study|Lost to Follow-up|0
5912817|NCT01576159|20456094|P4|Overall Study|Physician Decision|0
5912818|NCT01576159|20456095|P3|Overall Study|Physician Decision|1
5912819|NCT01576159|20456096|P2|Overall Study|Physician Decision|0
5912820|NCT01576159|20456097|P1|Overall Study|Physician Decision|0
5912821|NCT01576159|20456094|P4|Overall Study|Withdrawal by Subject|0
5912822|NCT01576159|20456095|P3|Overall Study|Withdrawal by Subject|0
5912823|NCT01576159|20456096|P2|Overall Study|Withdrawal by Subject|1
5912824|NCT01576159|20456097|P1|Overall Study|Withdrawal by Subject|0
5912825|NCT01576146|20456115|P1|Extension Period 2|Treatment Not Resumed Within 8 Weeks|1
5912826|NCT01576146|20456115|P1|Extension Period 2|Renal Transplant|1
5912827|NCT01576146|20456115|P1|Extension Period 2|Adverse Event|1
5912828|NCT01576146|20456115|P1|Extension Period 2|Death|1
5912829|NCT01576146|20456115|P1|Extension Period 2|Sponsor Decision|13
5912830|NCT01576146|20456115|P1|Extension Period 1|Renal Transplant|1
5912831|NCT01576146|20456115|P1|Extension Period 1|Parathyroidectomy|1
5912832|NCT01576146|20456115|P1|Extension Period 1|Lost to Follow-up|1
5912833|NCT01576146|20456115|P1|Extension Period 1|Withdrawal by Subject|1
5912834|NCT01576146|20456115|P1|Extension Period 1|Physician Decision|2
5912835|NCT01576146|20456115|P1|Extension Period 1|Death|2
5912836|NCT01576146|20456115|P1|Extension Period 1|Adverse Event|2
5912837|NCT01576042|20456148|P2|Overall Study|Physician Decision|0
5912838|NCT01576042|20456149|P1|Overall Study|Physician Decision|2
5912839|NCT01576016|20456171|P2|MRI Safety|MRI scan not performed at MRI visit|3
5912840|NCT01576016|20456172|P1|MRI Safety|MRI scan not performed at MRI visit|0
5912841|NCT01576016|20456171|P2|MRI Safety|Has not yet completed MRI scan|56
5912842|NCT01576016|20456172|P1|MRI Safety|Has not yet completed MRI scan|0
5912843|NCT01576016|20456171|P2|MRI Safety|Non-MRI Compatible Device or Material|5
5912844|NCT01576016|20456172|P1|MRI Safety|Non-MRI Compatible Device or Material|0
5912845|NCT01576016|20456171|P2|MRI Safety|Withdrawal by Subject|10
5912846|NCT01576016|20456172|P1|MRI Safety|Withdrawal by Subject|0
5912847|NCT01576016|20456171|P2|Lead Safety|Patient no longer followed by study PI|0
5912848|NCT01576016|20456172|P1|Lead Safety|Patient no longer followed by study PI|1
5912849|NCT01576016|20456171|P2|Lead Safety|System deactivated|0
5912850|NCT01576016|20456172|P1|Lead Safety|System deactivated|1
5912851|NCT01576016|20456171|P2|Lead Safety|Too far from study site|0
5912852|NCT01576016|20456172|P1|Lead Safety|Too far from study site|1
5912853|NCT01576016|20456171|P2|Lead Safety|Patient noncompliance|0
5912854|NCT01576016|20456172|P1|Lead Safety|Patient noncompliance|1
5912855|NCT01576016|20456171|P2|Lead Safety|Patient on Palliative Care|0
5912856|NCT01576016|20456172|P1|Lead Safety|Patient on Palliative Care|1
5912857|NCT01576016|20456171|P2|Lead Safety|Device replaced with CRT-D|0
5912858|NCT01576016|20456172|P1|Lead Safety|Device replaced with CRT-D|1
5912859|NCT01576016|20456171|P2|Lead Safety|Sponsor request|0
5912860|NCT01576016|20456172|P1|Lead Safety|Sponsor request|1
5912861|NCT01576016|20456171|P2|Lead Safety|Unsuccessful implant|0
5912862|NCT01576016|20456172|P1|Lead Safety|Unsuccessful implant|2
5912863|NCT01576016|20456171|P2|Lead Safety|Lost to Follow-up|0
5912864|NCT01576016|20456172|P1|Lead Safety|Lost to Follow-up|13
5912865|NCT01576016|20456171|P2|Lead Safety|Physician Decision|0
5912866|NCT01576016|20456172|P1|Lead Safety|Physician Decision|14
5912867|NCT01576016|20456171|P2|Lead Safety|System Explanted without Replacement|0
5912868|NCT01576016|20456172|P1|Lead Safety|System Explanted without Replacement|24
5912869|NCT01576016|20456171|P2|Lead Safety|Withdrawal by Subject|0
5912870|NCT01576016|20456172|P1|Lead Safety|Withdrawal by Subject|81
5912871|NCT01576016|20456171|P2|Lead Safety|Death|0
5912872|NCT01576016|20456172|P1|Lead Safety|Death|132
5912873|NCT01575899|20456224|P3|Overall Study|Protocol Violation|0
5912874|NCT01575899|20456225|P2|Overall Study|Protocol Violation|1
5912875|NCT01575899|20456226|P1|Overall Study|Protocol Violation|2
5912876|NCT01575899|20456224|P3|Overall Study|Lost to Follow-up|2
5912877|NCT01575899|20456225|P2|Overall Study|Lost to Follow-up|4
5912878|NCT01575899|20456226|P1|Overall Study|Lost to Follow-up|3
5912879|NCT01575873|20456240|P4|Overall Study|Other|2
5912880|NCT01575873|20456241|P3|Overall Study|Other|4
5912881|NCT01575873|20456242|P2|Overall Study|Other|0
5912882|NCT01575873|20456243|P1|Overall Study|Other|0
5912883|NCT01575873|20456240|P4|Overall Study|Requirement for Alternative Therapy|1
5912884|NCT01575873|20456241|P3|Overall Study|Requirement for Alternative Therapy|1
5912885|NCT01575873|20456242|P2|Overall Study|Requirement for Alternative Therapy|0
5912886|NCT01575873|20456243|P1|Overall Study|Requirement for Alternative Therapy|0
5912887|NCT01575873|20456240|P4|Overall Study|Protocol deviation|1
5912888|NCT01575873|20456241|P3|Overall Study|Protocol deviation|0
5912889|NCT01575873|20456242|P2|Overall Study|Protocol deviation|1
5912890|NCT01575873|20456243|P1|Overall Study|Protocol deviation|0
5912891|NCT01575873|20456240|P4|Overall Study|Administrative decision|0
5912892|NCT01575873|20456241|P3|Overall Study|Administrative decision|1
5912893|NCT01575873|20456242|P2|Overall Study|Administrative decision|1
5912894|NCT01575873|20456243|P1|Overall Study|Administrative decision|1
5912895|NCT01575873|20456240|P4|Overall Study|Noncompliance|3
5912896|NCT01575873|20456241|P3|Overall Study|Noncompliance|4
5912897|NCT01575873|20456242|P2|Overall Study|Noncompliance|2
5912898|NCT01575873|20456243|P1|Overall Study|Noncompliance|1
5912899|NCT01575873|20456240|P4|Overall Study|Death|9
5912900|NCT01575873|20456241|P3|Overall Study|Death|8
5912901|NCT01575873|20456242|P2|Overall Study|Death|2
5912902|NCT01575873|20456243|P1|Overall Study|Death|3
5912903|NCT01575873|20456240|P4|Overall Study|Lost to Follow-up|5
5912904|NCT01575873|20456241|P3|Overall Study|Lost to Follow-up|13
5912905|NCT01575873|20456242|P2|Overall Study|Lost to Follow-up|3
5912906|NCT01575873|20456243|P1|Overall Study|Lost to Follow-up|1
5912907|NCT01575873|20456240|P4|Overall Study|Adverse Event|12
5912908|NCT01575873|20456241|P3|Overall Study|Adverse Event|9
5912909|NCT01575873|20456242|P2|Overall Study|Adverse Event|7
5912910|NCT01575873|20456243|P1|Overall Study|Adverse Event|7
5912911|NCT01575873|20456240|P4|Overall Study|Withdrawal by Subject|34
5912912|NCT01575873|20456241|P3|Overall Study|Withdrawal by Subject|34
5912913|NCT01575873|20456242|P2|Overall Study|Withdrawal by Subject|20
5912914|NCT01575873|20456243|P1|Overall Study|Withdrawal by Subject|15
5912915|NCT01575860|20456267|P1|Overall Study|Progression Prior to Lenalidomide Maint.|1
5912916|NCT01575860|20456267|P1|Overall Study|Withdrawal by Subject|1
5912917|NCT01575834|20456275|P2|Overall Study|Requirement for Alternative Therapy|4
5912918|NCT01575834|20456276|P1|Overall Study|Requirement for Alternative Therapy|2
5912919|NCT01575834|20456275|P2|Overall Study|Protocol Deviation|3
5912920|NCT01575834|20456276|P1|Overall Study|Protocol Deviation|4
5912921|NCT01575834|20456275|P2|Overall Study|Ineligibility Determined|8
5912922|NCT01575834|20456276|P1|Overall Study|Ineligibility Determined|5
5912923|NCT01575834|20456275|P2|Overall Study|Administrative decision|33
5912924|NCT01575834|20456276|P1|Overall Study|Administrative decision|15
5912925|NCT01575834|20456275|P2|Overall Study|Noncompliance|27
5912926|NCT01575834|20456276|P1|Overall Study|Noncompliance|52
5912927|NCT01575834|20456275|P2|Overall Study|Lost to Follow-up|68
5912928|NCT01575834|20456276|P1|Overall Study|Lost to Follow-up|55
5912929|NCT01575834|20456275|P2|Overall Study|Adverse Event|61
5912930|NCT01575834|20456276|P1|Overall Study|Adverse Event|63
5912931|NCT01575834|20456275|P2|Overall Study|Other|70
5912932|NCT01575834|20456276|P1|Overall Study|Other|70
5912933|NCT01575834|20456275|P2|Overall Study|Death|74
5912934|NCT01575834|20456276|P1|Overall Study|Death|81
5912935|NCT01575834|20456275|P2|Overall Study|Withdrawal by Subject|390
5912936|NCT01575834|20456276|P1|Overall Study|Withdrawal by Subject|352
5912937|NCT01575808|20456328|P2|Overall Study|Withdrawal by Subject|0
5912938|NCT01575808|20456329|P1|Overall Study|Withdrawal by Subject|1
5912939|NCT01575808|20456328|P2|Overall Study|Death|0
5912940|NCT01575808|20456329|P1|Overall Study|Death|2
5912941|NCT01575769|20456376|P1|Overall Study|Study terminated by sponsor|40
5912942|NCT01575769|20456376|P1|Overall Study|Adverse Event|1
5912943|NCT01575561|20456434|P1|Overall Study|administration|1
5912944|NCT01575561|20456434|P1|Overall Study|Withdrawal by Subject|11
5912945|NCT01575561|20456434|P1|Overall Study|Protocol Violation|4
5912946|NCT01575561|20456434|P1|Overall Study|Lost to Follow-up|6
5912947|NCT01575561|20456434|P1|Overall Study|Lack of Efficacy|8
5912948|NCT01575561|20456434|P1|Overall Study|Adverse Event|9
5912949|NCT01575197|20456464|P3|Overall Study|Protocol Violation|1
5912950|NCT01575197|20456465|P2|Overall Study|Protocol Violation|1
5912951|NCT01575197|20456466|P1|Overall Study|Protocol Violation|2
5912952|NCT01575197|20456464|P3|Overall Study|Withdrawal by Subject|1
5912953|NCT01575197|20456465|P2|Overall Study|Withdrawal by Subject|1
5912954|NCT01575197|20456466|P1|Overall Study|Withdrawal by Subject|0
5912955|NCT01575197|20456464|P3|Overall Study|Lost to Follow-up|0
5912956|NCT01575197|20456465|P2|Overall Study|Lost to Follow-up|1
5912957|NCT01575197|20456466|P1|Overall Study|Lost to Follow-up|0
5912958|NCT01575197|20456464|P3|Overall Study|SAE|0
5912959|NCT01575197|20456465|P2|Overall Study|SAE|1
5912960|NCT01575197|20456466|P1|Overall Study|SAE|0
5912961|NCT01575197|20456464|P3|Overall Study|Migration out of study area|4
5912962|NCT01575197|20456465|P2|Overall Study|Migration out of study area|5
5912963|NCT01575197|20456466|P1|Overall Study|Migration out of study area|1
5912964|NCT01575054|20456494|P2|Overall Study|Adverse Event|8
5912965|NCT01575054|20456495|P1|Overall Study|Adverse Event|9
5912966|NCT01575054|20456494|P2|Overall Study|Lost to Follow-up|3
5912967|NCT01575054|20456495|P1|Overall Study|Lost to Follow-up|3
5912968|NCT01575054|20456494|P2|Overall Study|Personal Reasons|11
5912969|NCT01575054|20456495|P1|Overall Study|Personal Reasons|10
5912970|NCT01575054|20456494|P2|Overall Study|Protocol Violation|1
5912971|NCT01575054|20456495|P1|Overall Study|Protocol Violation|2
5912972|NCT01575054|20456494|P2|Overall Study|Other Reasons|3
5912973|NCT01575054|20456495|P1|Overall Study|Other Reasons|5
5912974|NCT01575028|20456511|P2|Overall Study|Physician Decision|1
5912975|NCT01575028|20456512|P1|Overall Study|Physician Decision|0
5912976|NCT01574716|20456529|P5|Part 2|Lost to Follow-up|0
5912977|NCT01574716|20456530|P4|Part 2|Lost to Follow-up|3
5912978|NCT01574716|20456531|P3|Part 2|Lost to Follow-up|0
5912979|NCT01574716|20456532|P2|Part 2|Lost to Follow-up|0
5912980|NCT01574716|20456533|P1|Part 2|Lost to Follow-up|0
5912981|NCT01574716|20456529|P5|Part 2|Brain metastases|0
5912982|NCT01574716|20456530|P4|Part 2|Brain metastases|1
5912983|NCT01574716|20456531|P3|Part 2|Brain metastases|0
5912984|NCT01574716|20456532|P2|Part 2|Brain metastases|0
5912985|NCT01574716|20456533|P1|Part 2|Brain metastases|0
5912986|NCT01574716|20456529|P5|Part 2|Withdrawal by Subject|4
5912987|NCT01574716|20456530|P4|Part 2|Withdrawal by Subject|5
5912988|NCT01574716|20456531|P3|Part 2|Withdrawal by Subject|0
5912989|NCT01574716|20456532|P2|Part 2|Withdrawal by Subject|0
5912990|NCT01574716|20456533|P1|Part 2|Withdrawal by Subject|0
5912991|NCT01574716|20456529|P5|Part 2|Discontinuation of study by sponsor|31
5912992|NCT01574716|20456530|P4|Part 2|Discontinuation of study by sponsor|51
5912993|NCT01574716|20456531|P3|Part 2|Discontinuation of study by sponsor|0
5912994|NCT01574716|20456532|P2|Part 2|Discontinuation of study by sponsor|0
5912995|NCT01574716|20456533|P1|Part 2|Discontinuation of study by sponsor|0
5912996|NCT01574716|20456529|P5|Part 2|Death|35
5912997|NCT01574716|20456530|P4|Part 2|Death|76
5912998|NCT01574716|20456531|P3|Part 2|Death|0
5912999|NCT01574716|20456532|P2|Part 2|Death|0
5913000|NCT01574716|20456533|P1|Part 2|Death|0
5913001|NCT01574716|20456529|P5|Part 2|Progressive disease|0
5913002|NCT01574716|20456530|P4|Part 2|Progressive disease|1
5913003|NCT01574716|20456531|P3|Part 2|Progressive disease|0
5913004|NCT01574716|20456532|P2|Part 2|Progressive disease|0
5913005|NCT01574716|20456533|P1|Part 2|Progressive disease|0
5913006|NCT01574716|20456529|P5|Part 1|Lost to Follow-up|0
5913007|NCT01574716|20456530|P4|Part 1|Lost to Follow-up|0
5913008|NCT01574716|20456531|P3|Part 1|Lost to Follow-up|0
5913009|NCT01574716|20456532|P2|Part 1|Lost to Follow-up|1
5913010|NCT01574716|20456533|P1|Part 1|Lost to Follow-up|0
5913011|NCT01574716|20456529|P5|Part 1|Withdrawal by Subject|0
5913012|NCT01574716|20456530|P4|Part 1|Withdrawal by Subject|0
5913013|NCT01574716|20456531|P3|Part 1|Withdrawal by Subject|0
5913014|NCT01574716|20456532|P2|Part 1|Withdrawal by Subject|2
5913015|NCT01574716|20456533|P1|Part 1|Withdrawal by Subject|0
5913016|NCT01574716|20456529|P5|Part 1|Discontinuation of study by sponsor|0
5913017|NCT01574716|20456530|P4|Part 1|Discontinuation of study by sponsor|0
5913018|NCT01574716|20456531|P3|Part 1|Discontinuation of study by sponsor|1
5913019|NCT01574716|20456532|P2|Part 1|Discontinuation of study by sponsor|0
5913020|NCT01574716|20456533|P1|Part 1|Discontinuation of study by sponsor|0
5913021|NCT01574716|20456529|P5|Part 1|Death|0
5913022|NCT01574716|20456530|P4|Part 1|Death|0
5913023|NCT01574716|20456531|P3|Part 1|Death|8
5913024|NCT01574716|20456532|P2|Part 1|Death|1
5913025|NCT01574716|20456533|P1|Part 1|Death|3
5913026|NCT01574703|20456556|P4|Overall Study|Death|0
5913027|NCT01574703|20456557|P3|Overall Study|Death|1
5913028|NCT01574703|20456558|P2|Overall Study|Death|1
5913029|NCT01574703|20456559|P1|Overall Study|Death|2
5913030|NCT01574703|20456556|P4|Overall Study|Lost to Follow-up|35
5913031|NCT01574703|20456557|P3|Overall Study|Lost to Follow-up|46
5913032|NCT01574703|20456558|P2|Overall Study|Lost to Follow-up|41
5913033|NCT01574703|20456559|P1|Overall Study|Lost to Follow-up|43
5913034|NCT01574703|20456556|P4|Overall Study|Met Withdrawal Criteria|0
5913035|NCT01574703|20456557|P3|Overall Study|Met Withdrawal Criteria|1
5913036|NCT01574703|20456558|P2|Overall Study|Met Withdrawal Criteria|1
5913037|NCT01574703|20456559|P1|Overall Study|Met Withdrawal Criteria|0
5913038|NCT01574703|20456556|P4|Overall Study|Withdrawal by Subject|61
5913039|NCT01574703|20456557|P3|Overall Study|Withdrawal by Subject|36
5913040|NCT01574703|20456558|P2|Overall Study|Withdrawal by Subject|52
5913041|NCT01574703|20456559|P1|Overall Study|Withdrawal by Subject|53
5913042|NCT01574703|20456556|P4|Overall Study|Unspecified Reason|16
5913043|NCT01574703|20456557|P3|Overall Study|Unspecified Reason|20
5913044|NCT01574703|20456558|P2|Overall Study|Unspecified Reason|15
5913045|NCT01574703|20456559|P1|Overall Study|Unspecified Reason|27
5913046|NCT01574703|20456556|P4|Overall Study|Protocol Violation|1
5913047|NCT01574703|20456557|P3|Overall Study|Protocol Violation|0
5913048|NCT01574703|20456558|P2|Overall Study|Protocol Violation|0
5913049|NCT01574703|20456559|P1|Overall Study|Protocol Violation|0
5913050|NCT01574703|20456556|P4|Overall Study|Adverse Event|1
5913051|NCT01574703|20456557|P3|Overall Study|Adverse Event|1
5913052|NCT01574703|20456558|P2|Overall Study|Adverse Event|2
5913053|NCT01574703|20456559|P1|Overall Study|Adverse Event|0
5913054|NCT01574651|20456603|P2|Overall Study|Withdrawal by Subject|10
5913055|NCT01574651|20456604|P1|Overall Study|Withdrawal by Subject|9
5913056|NCT01574651|20456603|P2|Overall Study|Protocol Violation|5
5913057|NCT01574651|20456604|P1|Overall Study|Protocol Violation|3
5913058|NCT01574651|20456603|P2|Overall Study|Unsatisfactory therapeutic effect|0
5913059|NCT01574651|20456604|P1|Overall Study|Unsatisfactory therapeutic effect|6
5913060|NCT01574651|20456603|P2|Overall Study|Abnormal test procedure result(s)|1
5913061|NCT01574651|20456604|P1|Overall Study|Abnormal test procedure result(s)|1
5913062|NCT01574651|20456603|P2|Overall Study|Abnormal laboratory value(s)|0
5913063|NCT01574651|20456604|P1|Overall Study|Abnormal laboratory value(s)|1
5913064|NCT01574651|20456603|P2|Overall Study|Adverse Event|27
5913065|NCT01574651|20456604|P1|Overall Study|Adverse Event|36
5913066|NCT01574651|20456603|P2|Overall Study|Patient's inability to use the device|1
5913067|NCT01574651|20456604|P1|Overall Study|Patient's inability to use the device|0
5913068|NCT01574651|20456603|P2|Overall Study|Death|3
5913069|NCT01574651|20456604|P1|Overall Study|Death|3
5913070|NCT01574651|20456603|P2|Overall Study|Administrative problems|1
5913071|NCT01574651|20456604|P1|Overall Study|Administrative problems|0
5913072|NCT01574651|20456603|P2|Overall Study|Lost to Follow-up|4
5913073|NCT01574651|20456604|P1|Overall Study|Lost to Follow-up|2
5913074|NCT01574612|20456626|P1|Overall Study|Lost to Follow-up|2
5913075|NCT01574612|20456626|P1|Overall Study|Withdrawal by Subject|1
5913076|NCT01574612|20456626|P1|Overall Study|non compliant with drug|2
5913077|NCT01574612|20456626|P1|Overall Study|Adverse Event|3
5913078|NCT01574352|20456632|P2|Overall Study|Injury in non-camp related sport|0
5913079|NCT01574352|20456633|P1|Overall Study|Injury in non-camp related sport|1
5913080|NCT01574352|20456632|P2|Overall Study|Withdrawal by Subject|13
5913081|NCT01574352|20456633|P1|Overall Study|Withdrawal by Subject|6
5913082|NCT01574326|20456645|P2|Overall Study|Other: Mainly kidney transplant|8
5913083|NCT01574326|20456646|P1|Overall Study|Other: Mainly kidney transplant|8
5913084|NCT01574326|20456645|P2|Overall Study|Adverse Event|3
5913085|NCT01574326|20456646|P1|Overall Study|Adverse Event|1
5913086|NCT01574326|20456645|P2|Overall Study|Physician Decision|3
5913087|NCT01574326|20456646|P1|Overall Study|Physician Decision|5
5913088|NCT01574326|20456645|P2|Overall Study|Withdrawal by Participant|4
5913089|NCT01574326|20456646|P1|Overall Study|Withdrawal by Participant|2
5913090|NCT01574326|20456645|P2|Overall Study|Randomized but not treated|1
5913091|NCT01574326|20456646|P1|Overall Study|Randomized but not treated|0
5913092|NCT01574248|20456664|P2|Overall Study|Missing primary endpoint data|0
5913093|NCT01574248|20456665|P1|Overall Study|Missing primary endpoint data|1
5913094|NCT01574248|20456664|P2|Overall Study|Withdrawal by Subject|0
5913095|NCT01574248|20456665|P1|Overall Study|Withdrawal by Subject|2
5913096|NCT01574157|20456698|P2|Overall Study|Lost to Follow-up|3
5913097|NCT01574157|20456699|P1|Overall Study|Lost to Follow-up|0
5913098|NCT01574157|20456698|P2|Overall Study|Withdrawal by Subject|5
5913099|NCT01574157|20456699|P1|Overall Study|Withdrawal by Subject|4
5913100|NCT01574079|20456733|P2|Overall Study|Lost to Follow-up|0
5913101|NCT01574079|20456734|P1|Overall Study|Lost to Follow-up|1
5913102|NCT01574079|20456733|P2|Overall Study|Physician Decision|2
5913103|NCT01574079|20456734|P1|Overall Study|Physician Decision|0
5913104|NCT01573910|20456753|P2|Overall Study|Patient decision unrelated to Advs Event|11
5913105|NCT01573910|20456754|P1|Overall Study|Patient decision unrelated to Advs Event|11
5913106|NCT01573910|20456753|P2|Overall Study|Protocol Violation|0
5913107|NCT01573910|20456754|P1|Overall Study|Protocol Violation|3
5913108|NCT01573910|20456753|P2|Overall Study|Withdrawal by Subject|1
5913109|NCT01573910|20456754|P1|Overall Study|Withdrawal by Subject|0
5913110|NCT01573910|20456753|P2|Overall Study|Lost to Follow-up|1
5913111|NCT01573910|20456754|P1|Overall Study|Lost to Follow-up|2
5913112|NCT01573910|20456753|P2|Overall Study|Adverse Event|4
5913113|NCT01573910|20456754|P1|Overall Study|Adverse Event|4
5913114|NCT01573767|20456766|P4|Overall Study|Withdrawal by Subject|0
5913115|NCT01573767|20456767|P3|Overall Study|Withdrawal by Subject|0
5913116|NCT01573767|20456768|P2|Overall Study|Withdrawal by Subject|1
5913117|NCT01573767|20456769|P1|Overall Study|Withdrawal by Subject|0
5913118|NCT01573767|20456766|P4|Overall Study|Physician Decision|2
5913119|NCT01573767|20456767|P3|Overall Study|Physician Decision|0
5913120|NCT01573767|20456768|P2|Overall Study|Physician Decision|2
5913121|NCT01573767|20456769|P1|Overall Study|Physician Decision|1
5913122|NCT01573767|20456766|P4|Overall Study|Lost to Follow-up|1
5913123|NCT01573767|20456767|P3|Overall Study|Lost to Follow-up|1
5913124|NCT01573767|20456768|P2|Overall Study|Lost to Follow-up|1
5913125|NCT01573767|20456769|P1|Overall Study|Lost to Follow-up|0
5913126|NCT01573767|20456766|P4|Overall Study|Protocol Violation|3
5913127|NCT01573767|20456767|P3|Overall Study|Protocol Violation|1
5913128|NCT01573767|20456768|P2|Overall Study|Protocol Violation|1
5913129|NCT01573767|20456769|P1|Overall Study|Protocol Violation|3
5913130|NCT01573767|20456766|P4|Overall Study|Lack of Efficacy|17
5913131|NCT01573767|20456767|P3|Overall Study|Lack of Efficacy|12
5913132|NCT01573767|20456768|P2|Overall Study|Lack of Efficacy|15
5913133|NCT01573767|20456769|P1|Overall Study|Lack of Efficacy|18
5913134|NCT01573767|20456766|P4|Overall Study|Adverse Event|1
5913135|NCT01573767|20456767|P3|Overall Study|Adverse Event|0
5913136|NCT01573767|20456768|P2|Overall Study|Adverse Event|1
5913137|NCT01573767|20456769|P1|Overall Study|Adverse Event|0
5913138|NCT01573624|20456811|P7|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0
5913139|NCT01573624|20456812|P6|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0
5913140|NCT01573624|20456813|P5|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0
5913141|NCT01573624|20456814|P4|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0
5913142|NCT01573624|20456815|P3|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0
5913143|NCT01573624|20456816|P2|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0
5913144|NCT01573624|20456817|P1|Period 6 : Follow-up Period (7 Days)|Protocol Violation|1
5913145|NCT01573624|20456811|P7|Period 6 : Follow-up Period (7 Days)|Adverse Event|0
5913146|NCT01573624|20456812|P6|Period 6 : Follow-up Period (7 Days)|Adverse Event|1
5913147|NCT01573624|20456813|P5|Period 6 : Follow-up Period (7 Days)|Adverse Event|2
5913148|NCT01573624|20456814|P4|Period 6 : Follow-up Period (7 Days)|Adverse Event|0
5913149|NCT01573624|20456815|P3|Period 6 : Follow-up Period (7 Days)|Adverse Event|0
5913150|NCT01573624|20456816|P2|Period 6 : Follow-up Period (7 Days)|Adverse Event|0
5913151|NCT01573624|20456817|P1|Period 6 : Follow-up Period (7 Days)|Adverse Event|0
5913152|NCT01573624|20456811|P7|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0
5913153|NCT01573624|20456812|P6|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0
5913154|NCT01573624|20456813|P5|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0
5913155|NCT01573624|20456814|P4|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0
5913156|NCT01573624|20456815|P3|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0
5913157|NCT01573624|20456816|P2|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0
5913158|NCT01573624|20456817|P1|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|1
5913159|NCT01573624|20456811|P7|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0
5913160|NCT01573624|20456812|P6|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1
5913161|NCT01573624|20456813|P5|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0
5913162|NCT01573624|20456814|P4|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0
5913163|NCT01573624|20456815|P3|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0
5913164|NCT01573624|20456816|P2|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1
5913165|NCT01573624|20456817|P1|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0
5913166|NCT01573624|20456811|P7|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|4
5913167|NCT01573624|20456812|P6|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1
5913168|NCT01573624|20456813|P5|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1
5913169|NCT01573624|20456814|P4|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0
5913170|NCT01573624|20456815|P3|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0
5913171|NCT01573624|20456816|P2|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0
5913172|NCT01573624|20456817|P1|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|2
5913173|NCT01573624|20456811|P7|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0
5913174|NCT01573624|20456812|P6|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1
5913175|NCT01573624|20456813|P5|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0
5913176|NCT01573624|20456814|P4|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1
5913177|NCT01573624|20456815|P3|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1
5913178|NCT01573624|20456816|P2|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1
5913179|NCT01573624|20456817|P1|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0
5913180|NCT01573624|20456811|P7|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1
5913181|NCT01573624|20456812|P6|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1
5913182|NCT01573624|20456813|P5|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
5913183|NCT01573624|20456814|P4|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
5913184|NCT01573624|20456815|P3|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
5913185|NCT01573624|20456816|P2|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
5913186|NCT01573624|20456817|P1|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
5913187|NCT01573624|20456811|P7|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0
5913188|NCT01573624|20456812|P6|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0
5913189|NCT01573624|20456813|P5|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0
5913190|NCT01573624|20456814|P4|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0
5913191|NCT01573624|20456815|P3|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0
5913192|NCT01573624|20456816|P2|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|1
5913193|NCT01573624|20456817|P1|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0
5913194|NCT01573624|20456811|P7|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0
5913195|NCT01573624|20456812|P6|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0
5913196|NCT01573624|20456813|P5|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0
5913197|NCT01573624|20456814|P4|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0
5913198|NCT01573624|20456815|P3|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0
5913199|NCT01573624|20456816|P2|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|1
5913200|NCT01573624|20456817|P1|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0
5913201|NCT01573624|20456811|P7|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1
5913202|NCT01573624|20456812|P6|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0
5913203|NCT01573624|20456813|P5|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1
5913204|NCT01573624|20456814|P4|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1
5913205|NCT01573624|20456815|P3|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1
5913206|NCT01573624|20456816|P2|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1
5913207|NCT01573624|20456817|P1|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0
5913208|NCT01573624|20456811|P7|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1
5913209|NCT01573624|20456812|P6|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0
5913210|NCT01573624|20456813|P5|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0
5913211|NCT01573624|20456814|P4|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0
5913212|NCT01573624|20456815|P3|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0
5913213|NCT01573624|20456816|P2|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0
5913214|NCT01573624|20456817|P1|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1
5913215|NCT01573624|20456811|P7|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0
5913216|NCT01573624|20456812|P6|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0
5913217|NCT01573624|20456813|P5|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0
5913218|NCT01573624|20456814|P4|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0
5913219|NCT01573624|20456815|P3|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0
5913220|NCT01573624|20456816|P2|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0
5913221|NCT01573624|20456817|P1|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|1
5913222|NCT01573624|20456811|P7|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0
5913223|NCT01573624|20456812|P6|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1
5913224|NCT01573624|20456813|P5|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0
5913225|NCT01573624|20456814|P4|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0
5913226|NCT01573624|20456815|P3|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1
5913227|NCT01573624|20456816|P2|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1
5913228|NCT01573624|20456817|P1|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0
5913229|NCT01573624|20456811|P7|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0
5913230|NCT01573624|20456812|P6|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0
5913231|NCT01573624|20456813|P5|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0
5913232|NCT01573624|20456814|P4|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0
5913233|NCT01573624|20456815|P3|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0
5913234|NCT01573624|20456816|P2|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0
5913235|NCT01573624|20456817|P1|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|1
5913236|NCT01573624|20456811|P7|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0
5913237|NCT01573624|20456812|P6|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|2
5913238|NCT01573624|20456813|P5|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0
5913239|NCT01573624|20456814|P4|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0
5913240|NCT01573624|20456815|P3|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0
5913241|NCT01573624|20456816|P2|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|1
5913242|NCT01573624|20456817|P1|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0
5913243|NCT01573624|20456811|P7|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|0
5913244|NCT01573624|20456812|P6|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2
5913245|NCT01573624|20456813|P5|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|3
5913246|NCT01573624|20456814|P4|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|1
5913247|NCT01573624|20456815|P3|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2
5913248|NCT01573624|20456816|P2|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|4
5913249|NCT01573624|20456817|P1|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|5
5913250|NCT01573624|20456811|P7|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0
5913251|NCT01573624|20456812|P6|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1
5913252|NCT01573624|20456813|P5|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0
5913253|NCT01573624|20456814|P4|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1
5913254|NCT01573624|20456815|P3|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1
5913255|NCT01573624|20456816|P2|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0
5913256|NCT01573624|20456817|P1|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0
5913257|NCT01573624|20456811|P7|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
5913409|NCT01572792|20457214|P3|Lead-in Study|Adverse Event|22
5913258|NCT01573624|20456812|P6|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
5913259|NCT01573624|20456813|P5|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
5913260|NCT01573624|20456814|P4|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|2
5913261|NCT01573624|20456815|P3|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
5913262|NCT01573624|20456816|P2|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
5913263|NCT01573624|20456817|P1|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
5913264|NCT01573624|20456811|P7|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0
5913265|NCT01573624|20456812|P6|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|1
5913266|NCT01573624|20456813|P5|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0
5913267|NCT01573624|20456814|P4|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0
5913268|NCT01573624|20456815|P3|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0
5913269|NCT01573624|20456816|P2|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0
5913270|NCT01573624|20456817|P1|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0
5913271|NCT01573624|20456811|P7|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0
5913272|NCT01573624|20456812|P6|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0
5913273|NCT01573624|20456813|P5|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0
5913274|NCT01573624|20456814|P4|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1
5913275|NCT01573624|20456815|P3|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|2
5913276|NCT01573624|20456816|P2|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0
5913277|NCT01573624|20456817|P1|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1
5913278|NCT01573624|20456811|P7|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1
5913279|NCT01573624|20456812|P6|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0
5913280|NCT01573624|20456813|P5|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0
5913281|NCT01573624|20456814|P4|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1
5913282|NCT01573624|20456815|P3|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0
5913283|NCT01573624|20456816|P2|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1
5913284|NCT01573624|20456817|P1|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0
5913285|NCT01573624|20456811|P7|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0
5913286|NCT01573624|20456812|P6|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|1
5913287|NCT01573624|20456813|P5|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0
5913288|NCT01573624|20456814|P4|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0
5913289|NCT01573624|20456815|P3|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0
5913290|NCT01573624|20456816|P2|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0
5913291|NCT01573624|20456817|P1|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0
5913292|NCT01573624|20456811|P7|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1
5913293|NCT01573624|20456812|P6|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1
5913294|NCT01573624|20456813|P5|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0
5913295|NCT01573624|20456814|P4|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1
5913296|NCT01573624|20456815|P3|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1
5913297|NCT01573624|20456816|P2|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0
5913298|NCT01573624|20456817|P1|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0
5913299|NCT01573624|20456811|P7|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0
5913300|NCT01573624|20456812|P6|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|2
5913301|NCT01573624|20456813|P5|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0
5913302|NCT01573624|20456814|P4|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0
5913303|NCT01573624|20456815|P3|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1
5913304|NCT01573624|20456816|P2|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0
5913305|NCT01573624|20456817|P1|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1
5913306|NCT01573624|20456811|P7|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0
5913307|NCT01573624|20456812|P6|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0
5913308|NCT01573624|20456813|P5|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0
5913309|NCT01573624|20456814|P4|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0
5913310|NCT01573624|20456815|P3|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0
5913311|NCT01573624|20456816|P2|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0
5913312|NCT01573624|20456817|P1|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|1
5913313|NCT01573624|20456811|P7|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1
5913314|NCT01573624|20456812|P6|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|0
5913315|NCT01573624|20456813|P5|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|2
5913316|NCT01573624|20456814|P4|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1
5913317|NCT01573624|20456815|P3|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|6
5913318|NCT01573624|20456816|P2|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|3
5913319|NCT01573624|20456817|P1|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|4
5913320|NCT01573624|20456811|P7|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0
5913321|NCT01573624|20456812|P6|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1
5913322|NCT01573624|20456813|P5|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0
5913323|NCT01573624|20456814|P4|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0
5913324|NCT01573624|20456815|P3|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1
5913325|NCT01573624|20456816|P2|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0
5913326|NCT01573624|20456817|P1|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0
5913327|NCT01573442|20456877|P2|Overall Study|Cancels|10
5913328|NCT01573442|20456878|P1|Overall Study|Cancels|9
5913329|NCT01573000|20457022|P2|Long-Term Follow-Up|Lost to Follow-up|1
5913330|NCT01573000|20457023|P1|Long-Term Follow-Up|Lost to Follow-up|0
5913331|NCT01573000|20457022|P2|Long-Term Follow-Up|Death|0
5913332|NCT01573000|20457023|P1|Long-Term Follow-Up|Death|3
5913333|NCT01573000|20457022|P2|Crossover Phase|Death|3
5913334|NCT01573000|20457023|P1|Crossover Phase|Death|0
5913335|NCT01573000|20457022|P2|Crossover Phase|Lost to Follow-up|2
5913336|NCT01573000|20457023|P1|Crossover Phase|Lost to Follow-up|0
5913337|NCT01573000|20457022|P2|Crossover Phase|Lack of Efficacy|13
5913338|NCT01573000|20457023|P1|Crossover Phase|Lack of Efficacy|0
5913339|NCT01573000|20457022|P2|Dosimetric and Therapeutic Treatment|Received Other Treatment|0
5913340|NCT01573000|20457023|P1|Dosimetric and Therapeutic Treatment|Received Other Treatment|2
5913341|NCT01573000|20457022|P2|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|0
5913342|NCT01573000|20457023|P1|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|2
5913343|NCT01573000|20457022|P2|Dosimetric and Therapeutic Treatment|Death|1
5913344|NCT01573000|20457023|P1|Dosimetric and Therapeutic Treatment|Death|0
5913345|NCT01573000|20457022|P2|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2
5913346|NCT01573000|20457023|P1|Dosimetric and Therapeutic Treatment|Lost to Follow-up|4
5913347|NCT01573000|20457022|P2|Dosimetric and Therapeutic Treatment|Lack of Efficacy|32
5913348|NCT01573000|20457023|P1|Dosimetric and Therapeutic Treatment|Lack of Efficacy|27
5913349|NCT01572948|20457119|P2|Overall Study|unable to contact|1
5913350|NCT01572948|20457120|P1|Overall Study|unable to contact|0
5913351|NCT01572948|20457119|P2|Overall Study|Lost to Follow-up|0
5913352|NCT01572948|20457120|P1|Overall Study|Lost to Follow-up|1
5913353|NCT01572922|20457136|P1|Overall Study|Death|1
5913354|NCT01572922|20457136|P1|Overall Study|Protocol Violation|1
5913355|NCT01572922|20457136|P1|Overall Study|Adverse Event|1
5913356|NCT01572909|20457148|P2|Overall Study|Infarct, comorbidity, Pt refusal of exam|3
5913357|NCT01572909|20457149|P1|Overall Study|Infarct, comorbidity, Pt refusal of exam|0
5913358|NCT01572909|20457148|P2|Overall Study|Withdrawal by Subject|11
5913359|NCT01572909|20457149|P1|Overall Study|Withdrawal by Subject|12
5913360|NCT01572909|20457148|P2|Overall Study|Technical Issues|0
5913361|NCT01572909|20457149|P1|Overall Study|Technical Issues|1
5913362|NCT01572909|20457148|P2|Overall Study|Physician Decision|1
5913363|NCT01572909|20457149|P1|Overall Study|Physician Decision|1
5913364|NCT01572909|20457148|P2|Overall Study|Lost to Follow-up|7
5913365|NCT01572909|20457149|P1|Overall Study|Lost to Follow-up|8
5913366|NCT01572909|20457148|P2|Overall Study|Death|1
5913367|NCT01572909|20457149|P1|Overall Study|Death|3
5913368|NCT01572909|20457148|P2|Overall Study|Adverse Event|2
5913369|NCT01572909|20457149|P1|Overall Study|Adverse Event|7
5913370|NCT01572844|20457193|P2|Overall Study|Physician Decision|1
5913371|NCT01572844|20457194|P1|Overall Study|Physician Decision|1
5913372|NCT01572792|20457212|P5|Extension Study|Site termination/COPD exacerbation/other|6
5913373|NCT01572792|20457213|P4|Extension Study|Site termination/COPD exacerbation/other|6
5913374|NCT01572792|20457214|P3|Extension Study|Site termination/COPD exacerbation/other|4
5913375|NCT01572792|20457215|P2|Extension Study|Site termination/COPD exacerbation/other|8
5913376|NCT01572792|20457216|P1|Extension Study|Site termination/COPD exacerbation/other|3
5913377|NCT01572792|20457212|P5|Extension Study|Adverse Event|4
5913378|NCT01572792|20457213|P4|Extension Study|Adverse Event|6
5913379|NCT01572792|20457214|P3|Extension Study|Adverse Event|5
5913380|NCT01572792|20457215|P2|Extension Study|Adverse Event|6
5913381|NCT01572792|20457216|P1|Extension Study|Adverse Event|7
5913382|NCT01572792|20457212|P5|Extension Study|Lack of Efficacy|2
5913383|NCT01572792|20457213|P4|Extension Study|Lack of Efficacy|2
5913384|NCT01572792|20457214|P3|Extension Study|Lack of Efficacy|3
5913385|NCT01572792|20457215|P2|Extension Study|Lack of Efficacy|3
5913386|NCT01572792|20457216|P1|Extension Study|Lack of Efficacy|2
5913387|NCT01572792|20457212|P5|Extension Study|Protocol Violation|3
5913388|NCT01572792|20457213|P4|Extension Study|Protocol Violation|4
5913389|NCT01572792|20457214|P3|Extension Study|Protocol Violation|3
5913390|NCT01572792|20457215|P2|Extension Study|Protocol Violation|4
5913391|NCT01572792|20457216|P1|Extension Study|Protocol Violation|0
5913392|NCT01572792|20457212|P5|Extension Study|Withdrawal by Subject|14
5913393|NCT01572792|20457213|P4|Extension Study|Withdrawal by Subject|8
5913394|NCT01572792|20457214|P3|Extension Study|Withdrawal by Subject|11
5913395|NCT01572792|20457215|P2|Extension Study|Withdrawal by Subject|6
5913396|NCT01572792|20457216|P1|Extension Study|Withdrawal by Subject|7
5913397|NCT01572792|20457212|P5|Extension Study|Lost to Follow-up|3
5913398|NCT01572792|20457213|P4|Extension Study|Lost to Follow-up|3
5913399|NCT01572792|20457214|P3|Extension Study|Lost to Follow-up|0
5913400|NCT01572792|20457215|P2|Extension Study|Lost to Follow-up|2
5913401|NCT01572792|20457216|P1|Extension Study|Lost to Follow-up|6
5913402|NCT01572792|20457212|P5|Lead-in Study|Site termination/COPD exacerbation/other|9
5913403|NCT01572792|20457213|P4|Lead-in Study|Site termination/COPD exacerbation/other|9
5913404|NCT01572792|20457214|P3|Lead-in Study|Site termination/COPD exacerbation/other|8
5913405|NCT01572792|20457215|P2|Lead-in Study|Site termination/COPD exacerbation/other|10
5913406|NCT01572792|20457216|P1|Lead-in Study|Site termination/COPD exacerbation/other|14
5913407|NCT01572792|20457212|P5|Lead-in Study|Adverse Event|14
5913408|NCT01572792|20457213|P4|Lead-in Study|Adverse Event|16
5913410|NCT01572792|20457215|P2|Lead-in Study|Adverse Event|21
5913411|NCT01572792|20457216|P1|Lead-in Study|Adverse Event|21
5913412|NCT01572792|20457212|P5|Lead-in Study|Lack of Efficacy|10
5913413|NCT01572792|20457213|P4|Lead-in Study|Lack of Efficacy|8
5913414|NCT01572792|20457214|P3|Lead-in Study|Lack of Efficacy|4
5913415|NCT01572792|20457215|P2|Lead-in Study|Lack of Efficacy|5
5913416|NCT01572792|20457216|P1|Lead-in Study|Lack of Efficacy|20
5913417|NCT01572792|20457212|P5|Lead-in Study|Protocol Violation|21
5913418|NCT01572792|20457213|P4|Lead-in Study|Protocol Violation|13
5913419|NCT01572792|20457214|P3|Lead-in Study|Protocol Violation|12
5913420|NCT01572792|20457215|P2|Lead-in Study|Protocol Violation|10
5913421|NCT01572792|20457216|P1|Lead-in Study|Protocol Violation|19
5913422|NCT01572792|20457212|P5|Lead-in Study|Withdrawal by Subject|11
5913423|NCT01572792|20457213|P4|Lead-in Study|Withdrawal by Subject|24
5913424|NCT01572792|20457214|P3|Lead-in Study|Withdrawal by Subject|12
5913425|NCT01572792|20457215|P2|Lead-in Study|Withdrawal by Subject|11
5913426|NCT01572792|20457216|P1|Lead-in Study|Withdrawal by Subject|22
5913427|NCT01572792|20457212|P5|Lead-in Study|Lost to Follow-up|4
5913428|NCT01572792|20457213|P4|Lead-in Study|Lost to Follow-up|2
5913429|NCT01572792|20457214|P3|Lead-in Study|Lost to Follow-up|4
5913430|NCT01572792|20457215|P2|Lead-in Study|Lost to Follow-up|9
5913431|NCT01572792|20457216|P1|Lead-in Study|Lost to Follow-up|5
5913432|NCT01572740|20457265|P2|Overall Study|unclassified|3
5913433|NCT01572740|20457266|P1|Overall Study|unclassified|4
5913434|NCT01572740|20457265|P2|Overall Study|Withdrawal by Subject|1
5913435|NCT01572740|20457266|P1|Overall Study|Withdrawal by Subject|1
5913436|NCT01572740|20457265|P2|Overall Study|Adverse Event|1
5913437|NCT01572740|20457266|P1|Overall Study|Adverse Event|1
5913438|NCT01572727|20457296|P2|Overall Study|Untreated|7
5913439|NCT01572727|20457297|P1|Overall Study|Untreated|4
5913440|NCT01572727|20457296|P2|Overall Study|Death|2
5913441|NCT01572727|20457297|P1|Overall Study|Death|2
5913442|NCT01572727|20457296|P2|Overall Study|Parent/guardian decision|9
5913443|NCT01572727|20457297|P1|Overall Study|Parent/guardian decision|14
5913444|NCT01572727|20457296|P2|Overall Study|Study terminated by sponsor|83
5913445|NCT01572727|20457297|P1|Overall Study|Study terminated by sponsor|61
5913446|NCT01572727|20457296|P2|Overall Study|Protocol Violation|1
5913447|NCT01572727|20457297|P1|Overall Study|Protocol Violation|0
5913448|NCT01572727|20457296|P2|Overall Study|Progressive disease|82
5913449|NCT01572727|20457297|P1|Overall Study|Progressive disease|59
5913450|NCT01572727|20457296|P2|Overall Study|Physician Decision|9
5913451|NCT01572727|20457297|P1|Overall Study|Physician Decision|23
5913452|NCT01572727|20457296|P2|Overall Study|Lost to Follow-up|1
5913453|NCT01572727|20457297|P1|Overall Study|Lost to Follow-up|1
5913454|NCT01572727|20457296|P2|Overall Study|Adverse Event|15
5913455|NCT01572727|20457297|P1|Overall Study|Adverse Event|43
5913456|NCT01572675|20457319|P2|Overall Study|Lost to Follow-up|27
5913457|NCT01572675|20457320|P1|Overall Study|Lost to Follow-up|22
5913458|NCT01572675|20457319|P2|Overall Study|Missing data|4
5913459|NCT01572675|20457320|P1|Overall Study|Missing data|1
5913460|NCT01572675|20457319|P2|Overall Study|Rheumatologist new evaluation|1
5913461|NCT01572675|20457320|P1|Overall Study|Rheumatologist new evaluation|0
5913462|NCT01572675|20457319|P2|Overall Study|Unknown reason|1
5913463|NCT01572675|20457320|P1|Overall Study|Unknown reason|1
5913464|NCT01572675|20457319|P2|Overall Study|Other disease detected|1
5913465|NCT01572675|20457320|P1|Overall Study|Other disease detected|1
5913466|NCT01572675|20457319|P2|Overall Study|Death unrelated to coxibs|1
5913467|NCT01572675|20457320|P1|Overall Study|Death unrelated to coxibs|1
5913468|NCT01572675|20457319|P2|Overall Study|Physician Decision|2
5913469|NCT01572675|20457320|P1|Overall Study|Physician Decision|2
5913470|NCT01572675|20457319|P2|Overall Study|Withdrawal by Subject|1
5913471|NCT01572675|20457320|P1|Overall Study|Withdrawal by Subject|5
5913472|NCT01572675|20457319|P2|Overall Study|Surgical intervention|6
5913473|NCT01572675|20457320|P1|Overall Study|Surgical intervention|3
5913474|NCT01572675|20457319|P2|Overall Study|Improved symptoms|2
5913475|NCT01572675|20457320|P1|Overall Study|Improved symptoms|8
5913476|NCT01572675|20457319|P2|Overall Study|Intolerance|5
5913477|NCT01572675|20457320|P1|Overall Study|Intolerance|6
5913478|NCT01572675|20457319|P2|Overall Study|Lack of Efficacy|31
5913479|NCT01572675|20457320|P1|Overall Study|Lack of Efficacy|31
5913480|NCT01572675|20457319|P2|Overall Study|Recovery|23
5913481|NCT01572675|20457320|P1|Overall Study|Recovery|16
5913482|NCT01572675|20457319|P2|Overall Study|End of prescribed treatment|118
5913483|NCT01572675|20457320|P1|Overall Study|End of prescribed treatment|140
5913484|NCT01572389|20457438|P2|Overall Study|Only A1C or Assessment was Collected|2
5913485|NCT01572389|20457439|P1|Overall Study|Only A1C or Assessment was Collected|6
5913486|NCT01572389|20457438|P2|Overall Study|Lost to Follow-up|14
5913487|NCT01572389|20457439|P1|Overall Study|Lost to Follow-up|25
5913488|NCT01572389|20457438|P2|Overall Study|Withdrawal by Subject|2
5913489|NCT01572389|20457439|P1|Overall Study|Withdrawal by Subject|14
5913490|NCT01572389|20457438|P2|Overall Study|Death|3
5913491|NCT01572389|20457439|P1|Overall Study|Death|1
5913492|NCT01572038|20457471|P1|Overall Study|Sponsor Decision|1
5913493|NCT01572038|20457471|P1|Overall Study|Patient Deterioration|1
5913494|NCT01572038|20457471|P1|Overall Study|Termination by Sponsor|2
5913495|NCT01572038|20457471|P1|Overall Study|Participated in Another Trial|3
5913496|NCT01572038|20457471|P1|Overall Study|Enrolled into Another Trial|3
5913497|NCT01572038|20457471|P1|Overall Study|Site Closed Before Completing Form|6
5913498|NCT01572038|20457471|P1|Overall Study|Progressive Disease|8
5913499|NCT01572038|20457471|P1|Overall Study|Patient Decision|14
5913500|NCT01572038|20457471|P1|Overall Study|Physician Decision|20
5913501|NCT01572038|20457471|P1|Overall Study|Lost to Follow-up|81
5913502|NCT01572038|20457471|P1|Overall Study|Withdrawal by Subject|204
5913503|NCT01572038|20457471|P1|Overall Study|Death|648
5913504|NCT01571453|20457586|P2|Overall Study|Administrative or other reason(s)|3
5913505|NCT01571453|20457587|P1|Overall Study|Administrative or other reason(s)|4
5913506|NCT01571453|20457586|P2|Overall Study|Lost to Follow-up|2
5913507|NCT01571453|20457587|P1|Overall Study|Lost to Follow-up|4
5913508|NCT01571453|20457586|P2|Overall Study|Withdrawal of consent|13
5913509|NCT01571453|20457587|P1|Overall Study|Withdrawal of consent|5
5913510|NCT01571453|20457586|P2|Overall Study|Protocol Violation|5
5913511|NCT01571453|20457587|P1|Overall Study|Protocol Violation|1
5913512|NCT01571453|20457586|P2|Overall Study|Non-compliance|4
5913513|NCT01571453|20457587|P1|Overall Study|Non-compliance|2
5913514|NCT01571453|20457586|P2|Overall Study|Lack of Efficacy|3
5913515|NCT01571453|20457587|P1|Overall Study|Lack of Efficacy|8
5913516|NCT01571453|20457586|P2|Overall Study|Adverse Event|32
5913517|NCT01571453|20457587|P1|Overall Study|Adverse Event|14
5913518|NCT01571362|20457634|P3|Double-Blind Treatment Period|Other - unspecified|1
5913519|NCT01571362|20457635|P2|Double-Blind Treatment Period|Other - unspecified|6
5913520|NCT01571362|20457636|P1|Double-Blind Treatment Period|Other - unspecified|0
5913521|NCT01571362|20457634|P3|Double-Blind Treatment Period|Insufficient clinical response|4
5913522|NCT01571362|20457635|P2|Double-Blind Treatment Period|Insufficient clinical response|16
5913523|NCT01571362|20457636|P1|Double-Blind Treatment Period|Insufficient clinical response|0
5913524|NCT01571362|20457634|P3|Double-Blind Treatment Period|Lost to Follow-up|6
5913525|NCT01571362|20457635|P2|Double-Blind Treatment Period|Lost to Follow-up|3
5913526|NCT01571362|20457636|P1|Double-Blind Treatment Period|Lost to Follow-up|0
5913527|NCT01571362|20457634|P3|Double-Blind Treatment Period|Adverse Event|14
5913528|NCT01571362|20457635|P2|Double-Blind Treatment Period|Adverse Event|9
5913529|NCT01571362|20457636|P1|Double-Blind Treatment Period|Adverse Event|0
5913530|NCT01571362|20457634|P3|Double-Blind Treatment Period|Protocol Violation|9
5913531|NCT01571362|20457635|P2|Double-Blind Treatment Period|Protocol Violation|8
5913532|NCT01571362|20457636|P1|Double-Blind Treatment Period|Protocol Violation|0
5913533|NCT01571362|20457634|P3|Double-Blind Treatment Period|Withdrawal by Subject|5
5913534|NCT01571362|20457635|P2|Double-Blind Treatment Period|Withdrawal by Subject|11
5913535|NCT01571362|20457636|P1|Double-Blind Treatment Period|Withdrawal by Subject|0
5913536|NCT01571362|20457634|P3|Open-Label Conversion + Titration Period|Other - unspecified|0
5913537|NCT01571362|20457635|P2|Open-Label Conversion + Titration Period|Other - unspecified|0
5913538|NCT01571362|20457636|P1|Open-Label Conversion + Titration Period|Other - unspecified|3
5913539|NCT01571362|20457634|P3|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0
5913540|NCT01571362|20457635|P2|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0
5913541|NCT01571362|20457636|P1|Open-Label Conversion + Titration Period|Does not meet entrance criteria|41
5913542|NCT01571362|20457634|P3|Open-Label Conversion + Titration Period|Lost to Follow-up|0
5913543|NCT01571362|20457635|P2|Open-Label Conversion + Titration Period|Lost to Follow-up|0
5913544|NCT01571362|20457636|P1|Open-Label Conversion + Titration Period|Lost to Follow-up|10
5913545|NCT01571362|20457634|P3|Open-Label Conversion + Titration Period|Adverse Event|0
5913546|NCT01571362|20457635|P2|Open-Label Conversion + Titration Period|Adverse Event|0
5913547|NCT01571362|20457636|P1|Open-Label Conversion + Titration Period|Adverse Event|57
5913548|NCT01571362|20457634|P3|Open-Label Conversion + Titration Period|Protocol Violation|0
5913549|NCT01571362|20457635|P2|Open-Label Conversion + Titration Period|Protocol Violation|0
5913550|NCT01571362|20457636|P1|Open-Label Conversion + Titration Period|Protocol Violation|7
5913551|NCT01571362|20457634|P3|Open-Label Conversion + Titration Period|Withdrawal by Subject|0
5913552|NCT01571362|20457635|P2|Open-Label Conversion + Titration Period|Withdrawal by Subject|0
5913553|NCT01571362|20457636|P1|Open-Label Conversion + Titration Period|Withdrawal by Subject|11
5913554|NCT01571284|20457806|P1|Overall Study|Other than specified above|80
5913555|NCT01571284|20457806|P1|Overall Study|Enrolled but not treated|2
5913556|NCT01571284|20457806|P1|Overall Study|Lost to Follow-up|3
5913557|NCT01571284|20457806|P1|Overall Study|Participant's decision|84
5913558|NCT01571232|20457829|P2|Overall Study|Withdrawal by Subject|0
5913559|NCT01571232|20457830|P1|Overall Study|Withdrawal by Subject|1
5913560|NCT01571232|20457829|P2|Overall Study|Lost to Follow-up|1
5913561|NCT01571232|20457830|P1|Overall Study|Lost to Follow-up|0
5913562|NCT01570868|20457842|P2|Overall Study|Withdrawal by Subject|0
5913563|NCT01570868|20457843|P1|Overall Study|Withdrawal by Subject|1
5913564|NCT01570868|20457842|P2|Overall Study|Lost to Follow-up|0
5913565|NCT01570868|20457843|P1|Overall Study|Lost to Follow-up|1
5913566|NCT01570868|20457842|P2|Overall Study|Physician Decision|4
5913567|NCT01570868|20457843|P1|Overall Study|Physician Decision|10
5913568|NCT01570868|20457842|P2|Overall Study|FDA Recommendation|3
5913569|NCT01570868|20457843|P1|Overall Study|FDA Recommendation|23
5913570|NCT01570868|20457842|P2|Overall Study|Adverse Event|1
5913571|NCT01570868|20457843|P1|Overall Study|Adverse Event|8
5913572|NCT01570751|20457855|P2|Period B (16 Weeks)|Protocol Violation|1
5913573|NCT01570751|20457856|P1|Period B (16 Weeks)|Protocol Violation|0
5913574|NCT01570751|20457855|P2|Period B (16 Weeks)|Adverse Event|0
5913575|NCT01570751|20457856|P1|Period B (16 Weeks)|Adverse Event|1
5913576|NCT01570751|20457855|P2|Period A (16 Weeks)|Unclassified|3
5913577|NCT01570751|20457856|P1|Period A (16 Weeks)|Unclassified|2
5913578|NCT01570751|20457855|P2|Period A (16 Weeks)|Withdrawal criteria|1
5913579|NCT01570751|20457856|P1|Period A (16 Weeks)|Withdrawal criteria|0
5913580|NCT01570751|20457855|P2|Period A (16 Weeks)|Protocol Violation|1
5913581|NCT01570751|20457856|P1|Period A (16 Weeks)|Protocol Violation|1
5913582|NCT01570686|20457874|P2|Overall Study|Unsatisfactory therapeutic effect|1
5913583|NCT01570686|20457875|P1|Overall Study|Unsatisfactory therapeutic effect|2
5913584|NCT01570686|20457874|P2|Overall Study|Withdrawal by Subject|4
5913585|NCT01570686|20457875|P1|Overall Study|Withdrawal by Subject|4
5913586|NCT01570686|20457874|P2|Overall Study|Protocol Deviation|0
5913587|NCT01570686|20457875|P1|Overall Study|Protocol Deviation|3
5913588|NCT01570686|20457874|P2|Overall Study|Lost to Follow-up|3
5913589|NCT01570686|20457875|P1|Overall Study|Lost to Follow-up|4
5913590|NCT01570686|20457874|P2|Overall Study|Adverse Event|6
5913591|NCT01570686|20457875|P1|Overall Study|Adverse Event|8
5913592|NCT01570686|20457874|P2|Overall Study|Administrative problems|1
5913593|NCT01570686|20457875|P1|Overall Study|Administrative problems|0
5913594|NCT01570686|20457874|P2|Overall Study|Abnormal test procedure result(s)|1
5913595|NCT01570686|20457875|P1|Overall Study|Abnormal test procedure result(s)|1
5913596|NCT01570491|20457911|P2|Overall Study|treatment: not given or discontinued|0
5913597|NCT01570491|20457912|P1|Overall Study|treatment: not given or discontinued|2
5913598|NCT01570491|20457911|P2|Overall Study|Lost to Follow-up|1
5913599|NCT01570491|20457912|P1|Overall Study|Lost to Follow-up|3
5913600|NCT01570387|20457928|P4|Overall Study|Withdrawal by Subject|1
5913601|NCT01570387|20457929|P3|Overall Study|Withdrawal by Subject|0
5913602|NCT01570387|20457930|P2|Overall Study|Withdrawal by Subject|0
5913603|NCT01570387|20457931|P1|Overall Study|Withdrawal by Subject|0
5913604|NCT01570387|20457928|P4|Overall Study|Death|1
5913605|NCT01570387|20457929|P3|Overall Study|Death|0
5913606|NCT01570387|20457930|P2|Overall Study|Death|0
5913607|NCT01570387|20457931|P1|Overall Study|Death|0
5913608|NCT01570387|20457928|P4|Overall Study|Adverse Event|0
5913609|NCT01570387|20457929|P3|Overall Study|Adverse Event|0
5913610|NCT01570387|20457930|P2|Overall Study|Adverse Event|0
5913611|NCT01570387|20457931|P1|Overall Study|Adverse Event|1
5913612|NCT01570361|20457943|P2|Overall Study|Other|2
5913613|NCT01570361|20457944|P1|Overall Study|Other|0
5913614|NCT01570361|20457943|P2|Overall Study|Death|4
5913615|NCT01570361|20457944|P1|Overall Study|Death|5
5913616|NCT01570361|20457943|P2|Overall Study|Lost to Follow-up|4
5913617|NCT01570361|20457944|P1|Overall Study|Lost to Follow-up|4
5913618|NCT01570361|20457943|P2|Overall Study|Adverse Event|1
5913619|NCT01570361|20457944|P1|Overall Study|Adverse Event|2
5913620|NCT01570361|20457943|P2|Overall Study|Subject withdrew consent|9
5913621|NCT01570361|20457944|P1|Overall Study|Subject withdrew consent|14
5913622|NCT01570361|20457943|P2|Overall Study|Subject excluded|3
5913623|NCT01570361|20457944|P1|Overall Study|Subject excluded|5
5913624|NCT01570361|20457943|P2|Overall Study|Sponsor closing the study|50
5913625|NCT01570361|20457944|P1|Overall Study|Sponsor closing the study|51
5913626|NCT01570361|20457943|P2|Overall Study|Subject discontinued|2
5913627|NCT01570361|20457944|P1|Overall Study|Subject discontinued|1
5913628|NCT01570309|20457987|P2|Overall Study|Withdrawal by Subject|3
5913629|NCT01570309|20457988|P1|Overall Study|Withdrawal by Subject|3
5913630|NCT01570283|20458005|P6|Cohort 3: Dose Level 3|Received other hematopoietic cells|1
5913631|NCT01570283|20458006|P5|Cohort 3: Dose Level 3|Received other hematopoietic cells|0
5913632|NCT01570283|20458007|P4|Cohort 3: Dose Level 3|Received other hematopoietic cells|0
5913633|NCT01570283|20458008|P3|Cohort 3: Dose Level 3|Received other hematopoietic cells|0
5913634|NCT01570283|20458009|P2|Cohort 3: Dose Level 3|Received other hematopoietic cells|0
5913635|NCT01570283|20458010|P1|Cohort 3: Dose Level 3|Received other hematopoietic cells|0
5913636|NCT01570283|20458005|P6|Cohort 3: Dose Level 3|Death|1
5913637|NCT01570283|20458006|P5|Cohort 3: Dose Level 3|Death|0
5913638|NCT01570283|20458007|P4|Cohort 3: Dose Level 3|Death|0
5913639|NCT01570283|20458008|P3|Cohort 3: Dose Level 3|Death|0
5913640|NCT01570283|20458009|P2|Cohort 3: Dose Level 3|Death|0
5913641|NCT01570283|20458010|P1|Cohort 3: Dose Level 3|Death|0
5913642|NCT01570283|20458005|P6|Cohort 2: Dose Level 2|Received other hematopoietic cells|0
5913643|NCT01570283|20458006|P5|Cohort 2: Dose Level 2|Received other hematopoietic cells|0
5913644|NCT01570283|20458007|P4|Cohort 2: Dose Level 2|Received other hematopoietic cells|1
5913645|NCT01570283|20458008|P3|Cohort 2: Dose Level 2|Received other hematopoietic cells|0
5913646|NCT01570283|20458009|P2|Cohort 2: Dose Level 2|Received other hematopoietic cells|0
5913647|NCT01570283|20458010|P1|Cohort 2: Dose Level 2|Received other hematopoietic cells|0
5913648|NCT01570283|20458005|P6|Cohort 2: Dose Level 2|Death|0
5913649|NCT01570283|20458006|P5|Cohort 2: Dose Level 2|Death|0
5913650|NCT01570283|20458007|P4|Cohort 2: Dose Level 2|Death|0
5913651|NCT01570283|20458008|P3|Cohort 2: Dose Level 2|Death|1
5913652|NCT01570283|20458009|P2|Cohort 2: Dose Level 2|Death|0
5913653|NCT01570283|20458010|P1|Cohort 2: Dose Level 2|Death|0
5913654|NCT01570283|20458005|P6|Cohort 1: Dose Level 1|Received other hematopoietic cells|0
5913655|NCT01570283|20458006|P5|Cohort 1: Dose Level 1|Received other hematopoietic cells|0
5913656|NCT01570283|20458007|P4|Cohort 1: Dose Level 1|Received other hematopoietic cells|0
5913657|NCT01570283|20458008|P3|Cohort 1: Dose Level 1|Received other hematopoietic cells|0
5913658|NCT01570283|20458009|P2|Cohort 1: Dose Level 1|Received other hematopoietic cells|1
5913659|NCT01570283|20458010|P1|Cohort 1: Dose Level 1|Received other hematopoietic cells|0
5913660|NCT01570283|20458005|P6|Cohort 1: Dose Level 1|Death|0
5913661|NCT01570283|20458006|P5|Cohort 1: Dose Level 1|Death|0
5913662|NCT01570283|20458007|P4|Cohort 1: Dose Level 1|Death|0
5913663|NCT01570283|20458008|P3|Cohort 1: Dose Level 1|Death|0
5913664|NCT01570283|20458009|P2|Cohort 1: Dose Level 1|Death|1
5913665|NCT01570283|20458010|P1|Cohort 1: Dose Level 1|Death|0
5913666|NCT01570244|20458027|P1|Microgynon+Faldaprevir|Adverse Event|1
5913667|NCT01570192|20458049|P2|Overall Study|Physician Decision|1
5913668|NCT01570192|20458050|P1|Overall Study|Physician Decision|0
5913669|NCT01570192|20458049|P2|Overall Study|changed to palliative care|0
5913670|NCT01570192|20458050|P1|Overall Study|changed to palliative care|1
5913671|NCT01570192|20458049|P2|Overall Study|no qualifying organism|12
5913672|NCT01570192|20458050|P1|Overall Study|no qualifying organism|6
5913673|NCT01569841|20458103|P2|Period A (6 Weeks)|Withdrawal by Subject|1
5913674|NCT01569841|20458104|P1|Period A (6 Weeks)|Withdrawal by Subject|0
5913675|NCT01569763|20458193|P2|Overall Study|Adverse Event|0
5913676|NCT01569763|20458194|P1|Overall Study|Adverse Event|1
5913677|NCT01569763|20458193|P2|Overall Study|Lack of Efficacy|7
5913678|NCT01569763|20458194|P1|Overall Study|Lack of Efficacy|2
5913679|NCT01569594|20458233|P1|Overall Study|No ECM used|9
5913680|NCT01569594|20458233|P1|Overall Study|Other|4
5913681|NCT01569594|20458233|P1|Overall Study|Withdrawal by Subject|13
5913682|NCT01569594|20458233|P1|Overall Study|Adverse Event|2
5913683|NCT01569594|20458233|P1|Overall Study|Lost to Follow-up|22
5913684|NCT01569594|20458233|P1|Overall Study|Death|13
5913685|NCT01569594|20458233|P1|Overall Study|Physician Decision|4
5913686|NCT01569568|20458239|P2|Overall Study|Physician Decision|2
5913687|NCT01569568|20458240|P1|Overall Study|Physician Decision|0
5913688|NCT01569464|20458263|P2|Overall Study|Other|1
5913689|NCT01569464|20458264|P1|Overall Study|Other|1
5913690|NCT01569464|20458263|P2|Overall Study|Withdrawal by Subject|1
5913691|NCT01569464|20458264|P1|Overall Study|Withdrawal by Subject|1
5913692|NCT01569464|20458263|P2|Overall Study|Lost to Follow-up|3
5913693|NCT01569464|20458264|P1|Overall Study|Lost to Follow-up|2
5913694|NCT01569464|20458263|P2|Overall Study|Protocol Violation|0
5913695|NCT01569464|20458264|P1|Overall Study|Protocol Violation|1
5913696|NCT01569464|20458263|P2|Overall Study|Lack of Efficacy|0
5913697|NCT01569464|20458264|P1|Overall Study|Lack of Efficacy|1
5913698|NCT01569464|20458263|P2|Overall Study|Adverse Event|0
5913699|NCT01569464|20458264|P1|Overall Study|Adverse Event|4
5913700|NCT01569438|20458331|P2|Overall Study|Unable to adhere to study schedule|1
5913701|NCT01569438|20458332|P1|Overall Study|Unable to adhere to study schedule|0
5913702|NCT01569438|20458331|P2|Overall Study|Sponsor/Physician decision|1
5913703|NCT01569438|20458332|P1|Overall Study|Sponsor/Physician decision|1
5913704|NCT01569438|20458331|P2|Overall Study|Decrease of GFR greater than 30 ml/min|0
5913705|NCT01569438|20458332|P1|Overall Study|Decrease of GFR greater than 30 ml/min|1
5913706|NCT01569438|20458331|P2|Overall Study|Protocol Violation|0
5913707|NCT01569438|20458332|P1|Overall Study|Protocol Violation|2
5913708|NCT01569438|20458331|P2|Overall Study|Adverse Event|15
5913709|NCT01569438|20458332|P1|Overall Study|Adverse Event|2
5913710|NCT01569438|20458331|P2|Overall Study|Withdrawal by Subject|3
5913711|NCT01569438|20458332|P1|Overall Study|Withdrawal by Subject|0
5913712|NCT01569438|20458331|P2|Overall Study|Lack of Efficacy|2
5913713|NCT01569438|20458332|P1|Overall Study|Lack of Efficacy|1
5913714|NCT01569295|20458346|P2|Overall Study|Lost to Follow-up|1
5913715|NCT01569295|20458347|P1|Overall Study|Lost to Follow-up|1
5913716|NCT01569295|20458346|P2|Overall Study|Other Anticancer/Experimental Therapy|2
5913717|NCT01569295|20458347|P1|Overall Study|Other Anticancer/Experimental Therapy|2
5913718|NCT01569295|20458346|P2|Overall Study|Non-Compliance with Study Drug|1
5913719|NCT01569295|20458347|P1|Overall Study|Non-Compliance with Study Drug|6
5913720|NCT01569295|20458346|P2|Overall Study|Other Reason not Specified|5
5913721|NCT01569295|20458347|P1|Overall Study|Other Reason not Specified|3
5913722|NCT01569295|20458346|P2|Overall Study|Study Terminated by Sponsor|2
5913723|NCT01569295|20458347|P1|Overall Study|Study Terminated by Sponsor|24
5913724|NCT01569295|20458346|P2|Overall Study|Physician Decision|18
5913725|NCT01569295|20458347|P1|Overall Study|Physician Decision|13
5913726|NCT01569295|20458346|P2|Overall Study|Death|15
5913727|NCT01569295|20458347|P1|Overall Study|Death|19
5913728|NCT01569295|20458346|P2|Overall Study|Withdrawal by Subject|12
5913729|NCT01569295|20458347|P1|Overall Study|Withdrawal by Subject|25
5913730|NCT01569295|20458346|P2|Overall Study|Adverse Event|14
5913731|NCT01569295|20458347|P1|Overall Study|Adverse Event|39
5913732|NCT01569295|20458346|P2|Overall Study|Progressive Disease|139
5913733|NCT01569295|20458347|P1|Overall Study|Progressive Disease|75
5913734|NCT01569152|20458384|P3|Safety Extension, Period 3|Study terminated by Sponsor|47
5913735|NCT01569152|20458385|P2|Safety Extension, Period 3|Study terminated by Sponsor|0
5913736|NCT01569152|20458386|P1|Safety Extension, Period 3|Study terminated by Sponsor|0
5913737|NCT01569152|20458384|P3|Safety Extension, Period 3|Physician Decision|2
5913738|NCT01569152|20458385|P2|Safety Extension, Period 3|Physician Decision|0
5913739|NCT01569152|20458386|P1|Safety Extension, Period 3|Physician Decision|0
5913740|NCT01569152|20458384|P3|Safety Extension, Period 3|Withdrawal by Subject|2
5913741|NCT01569152|20458385|P2|Safety Extension, Period 3|Withdrawal by Subject|0
5913742|NCT01569152|20458386|P1|Safety Extension, Period 3|Withdrawal by Subject|0
5913743|NCT01569152|20458384|P3|Safety Extension, Period 3|Adverse Event|4
5913744|NCT01569152|20458385|P2|Safety Extension, Period 3|Adverse Event|0
5913745|NCT01569152|20458386|P1|Safety Extension, Period 3|Adverse Event|0
5913746|NCT01569152|20458384|P3|Phase IIa, Period 1|Withdrawal by Subject|0
5913747|NCT01569152|20458385|P2|Phase IIa, Period 1|Withdrawal by Subject|1
5913748|NCT01569152|20458386|P1|Phase IIa, Period 1|Withdrawal by Subject|2
5913749|NCT01569152|20458384|P3|Phase IIa, Period 1|Protocol Violation|0
5913750|NCT01569152|20458385|P2|Phase IIa, Period 1|Protocol Violation|1
5913751|NCT01569152|20458386|P1|Phase IIa, Period 1|Protocol Violation|0
5913752|NCT01569152|20458384|P3|Phase IIa, Period 1|Study Terminated by Sponsor|0
5913753|NCT01569152|20458385|P2|Phase IIa, Period 1|Study Terminated by Sponsor|8
5913754|NCT01569152|20458386|P1|Phase IIa, Period 1|Study Terminated by Sponsor|9
5913755|NCT01569152|20458384|P3|Phase IIa, Period 1|Lost to Follow-up|0
5913756|NCT01569152|20458385|P2|Phase IIa, Period 1|Lost to Follow-up|0
5913757|NCT01569152|20458386|P1|Phase IIa, Period 1|Lost to Follow-up|1
5913758|NCT01569152|20458384|P3|Phase IIa, Period 1|Adverse Event|0
5913759|NCT01569152|20458385|P2|Phase IIa, Period 1|Adverse Event|0
5913760|NCT01569152|20458386|P1|Phase IIa, Period 1|Adverse Event|4
5913761|NCT01569152|20458384|P3|Phase IIa, Period 1|Early Escape|0
5913762|NCT01569152|20458385|P2|Phase IIa, Period 1|Early Escape|22
5913763|NCT01569152|20458386|P1|Phase IIa, Period 1|Early Escape|5
5913764|NCT01569074|20458522|P5|Overall Study|Adverse Event|0
5913765|NCT01569074|20458523|P4|Overall Study|Adverse Event|0
5913766|NCT01569074|20458524|P3|Overall Study|Adverse Event|3
5913767|NCT01569074|20458525|P2|Overall Study|Adverse Event|0
5913768|NCT01569074|20458526|P1|Overall Study|Adverse Event|1
5913769|NCT01569074|20458522|P5|Overall Study|eg change in circumstances|1
5913770|NCT01569074|20458523|P4|Overall Study|eg change in circumstances|1
5913771|NCT01569074|20458524|P3|Overall Study|eg change in circumstances|0
5913772|NCT01569074|20458525|P2|Overall Study|eg change in circumstances|2
5913773|NCT01569074|20458526|P1|Overall Study|eg change in circumstances|0
5913774|NCT01569074|20458522|P5|Overall Study|Severe non-compliance to protocol|0
5913775|NCT01569074|20458523|P4|Overall Study|Severe non-compliance to protocol|0
5913776|NCT01569074|20458524|P3|Overall Study|Severe non-compliance to protocol|1
5913777|NCT01569074|20458525|P2|Overall Study|Severe non-compliance to protocol|0
5913778|NCT01569074|20458526|P1|Overall Study|Severe non-compliance to protocol|0
5913779|NCT01569074|20458522|P5|Overall Study|Study-specific discontinuation criteria|0
5913780|NCT01569074|20458523|P4|Overall Study|Study-specific discontinuation criteria|0
5913781|NCT01569074|20458524|P3|Overall Study|Study-specific discontinuation criteria|0
5913782|NCT01569074|20458525|P2|Overall Study|Study-specific discontinuation criteria|1
5913783|NCT01569074|20458526|P1|Overall Study|Study-specific discontinuation criteria|0
5913784|NCT01569074|20458522|P5|Overall Study|Study stopped|7
5913785|NCT01569074|20458523|P4|Overall Study|Study stopped|7
5913786|NCT01569074|20458524|P3|Overall Study|Study stopped|8
5913787|NCT01569074|20458525|P2|Overall Study|Study stopped|6
5913788|NCT01569074|20458526|P1|Overall Study|Study stopped|6
5913789|NCT01569022|20458582|P2|Second Intervention|Lost to Follow-up|2
5913790|NCT01569022|20458583|P1|Second Intervention|Lost to Follow-up|2
5913791|NCT01569022|20458582|P2|First Intervention|Lost to Follow-up|1
5913792|NCT01569022|20458583|P1|First Intervention|Lost to Follow-up|2
5913793|NCT01568892|20458638|P2|Open-label Phase|Lost to Follow-up|1
5913794|NCT01568892|20458639|P1|Open-label Phase|Lost to Follow-up|0
5913795|NCT01568892|20458638|P2|Open-label Phase|Lack of Efficacy|2
5913796|NCT01568892|20458639|P1|Open-label Phase|Lack of Efficacy|4
5913797|NCT01568892|20458638|P2|Open-label Phase|Adverse Event|0
5913798|NCT01568892|20458639|P1|Open-label Phase|Adverse Event|2
5913799|NCT01568866|20458709|P2|Overall Study|Randomized but Not Dosed|1
5913800|NCT01568866|20458710|P1|Overall Study|Randomized but Not Dosed|9
5913801|NCT01568866|20458709|P2|Overall Study|Lost to Follow-up|0
5913802|NCT01568866|20458710|P1|Overall Study|Lost to Follow-up|1
5913803|NCT01568866|20458709|P2|Overall Study|Protocol Non-compliance|4
5913804|NCT01568866|20458710|P1|Overall Study|Protocol Non-compliance|2
5913805|NCT01568866|20458709|P2|Overall Study|Death|18
5913806|NCT01568866|20458710|P1|Overall Study|Death|10
5913807|NCT01568866|20458709|P2|Overall Study|Withdrawal by Subject|11
5913808|NCT01568866|20458710|P1|Overall Study|Withdrawal by Subject|19
5913809|NCT01568866|20458709|P2|Overall Study|Physician Decision|32
5913810|NCT01568866|20458710|P1|Overall Study|Physician Decision|40
5913811|NCT01568866|20458709|P2|Overall Study|Patient Request|71
5913812|NCT01568866|20458710|P1|Overall Study|Patient Request|55
5913813|NCT01568866|20458709|P2|Overall Study|Adverse Event|96
5913814|NCT01568866|20458710|P1|Overall Study|Adverse Event|94
5913815|NCT01568866|20458709|P2|Overall Study|Disease Progression|183
5913816|NCT01568866|20458710|P1|Overall Study|Disease Progression|208
5913817|NCT01568593|20458745|P2|Overall Study|Adverse Event|2
5913818|NCT01568593|20458746|P1|Overall Study|Adverse Event|3
5913819|NCT01568593|20458745|P2|Overall Study|Lack of Efficacy|1
5913820|NCT01568593|20458746|P1|Overall Study|Lack of Efficacy|4
5913821|NCT01568112|20458791|P4|Overall Study|Withdrawal by Physician|1
5913822|NCT01568112|20458792|P3|Overall Study|Withdrawal by Physician|1
5913823|NCT01568112|20458793|P2|Overall Study|Withdrawal by Physician|0
5913824|NCT01568112|20458794|P1|Overall Study|Withdrawal by Physician|1
5913825|NCT01568112|20458791|P4|Overall Study|Withdrawal by Subject|7
5913826|NCT01568112|20458792|P3|Overall Study|Withdrawal by Subject|0
5913827|NCT01568112|20458793|P2|Overall Study|Withdrawal by Subject|3
5913828|NCT01568112|20458794|P1|Overall Study|Withdrawal by Subject|2
5913829|NCT01568112|20458791|P4|Overall Study|Lost to Follow-up|1
5913830|NCT01568112|20458792|P3|Overall Study|Lost to Follow-up|0
5913831|NCT01568112|20458793|P2|Overall Study|Lost to Follow-up|0
5913832|NCT01568112|20458794|P1|Overall Study|Lost to Follow-up|0
5913833|NCT01568112|20458791|P4|Overall Study|Withdrew due to Adverse Event|3
5913834|NCT01568112|20458792|P3|Overall Study|Withdrew due to Adverse Event|6
5913835|NCT01568112|20458793|P2|Overall Study|Withdrew due to Adverse Event|4
5913836|NCT01568112|20458794|P1|Overall Study|Withdrew due to Adverse Event|2
5913837|NCT01568112|20458791|P4|Overall Study|Randomized But Not Treated|0
5913838|NCT01568112|20458792|P3|Overall Study|Randomized But Not Treated|0
5913839|NCT01568112|20458793|P2|Overall Study|Randomized But Not Treated|1
5913840|NCT01568112|20458794|P1|Overall Study|Randomized But Not Treated|0
5913841|NCT01568047|20458952|P4|Overall Study|Adverse Event|1
5913842|NCT01568047|20458953|P3|Overall Study|Adverse Event|1
5913843|NCT01568047|20458954|P2|Overall Study|Adverse Event|0
5913844|NCT01568047|20458955|P1|Overall Study|Adverse Event|0
5913845|NCT01568047|20458952|P4|Overall Study|Withdrawal by Subject|0
5913846|NCT01568047|20458953|P3|Overall Study|Withdrawal by Subject|0
5913847|NCT01568047|20458954|P2|Overall Study|Withdrawal by Subject|1
5913848|NCT01568047|20458955|P1|Overall Study|Withdrawal by Subject|0
5913849|NCT01568047|20458952|P4|Overall Study|Ineligibility|0
5913850|NCT01568047|20458953|P3|Overall Study|Ineligibility|0
5913851|NCT01568047|20458954|P2|Overall Study|Ineligibility|0
5913852|NCT01568047|20458955|P1|Overall Study|Ineligibility|1
5913853|NCT01568034|20458973|P4|Overall Study|Withdrawal by Subject|0
5913854|NCT01568034|20458974|P3|Overall Study|Withdrawal by Subject|0
5913855|NCT01568034|20458975|P2|Overall Study|Withdrawal by Subject|0
5913856|NCT01568034|20458976|P1|Overall Study|Withdrawal by Subject|1
5913857|NCT01567865|20459039|P4|Evaluated for Immunogenicity|Missing blood sample|28
5913858|NCT01567865|20459040|P3|Evaluated for Immunogenicity|Missing blood sample|16
5913859|NCT01567865|20459041|P2|Evaluated for Immunogenicity|Missing blood sample|24
5913860|NCT01567865|20459042|P1|Evaluated for Immunogenicity|Missing blood sample|17
5913861|NCT01567865|20459039|P4|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|2
5913862|NCT01567865|20459040|P3|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|3
5913863|NCT01567865|20459041|P2|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|1
5913864|NCT01567865|20459042|P1|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|0
5913865|NCT01567852|20459072|P2|Overall Study|ECT discontinued|1
5913866|NCT01567852|20459073|P1|Overall Study|ECT discontinued|1
5913867|NCT01567852|20459072|P2|Overall Study|Withdrawal by Subject|6
5913868|NCT01567852|20459073|P1|Overall Study|Withdrawal by Subject|3
5913869|NCT01567826|20459091|P2|Overall Study|Lost to Follow-up|2
5913870|NCT01567826|20459092|P1|Overall Study|Lost to Follow-up|3
5913871|NCT01567527|20459118|P5|Double-blind, Placebo-controlled Phase|Lost to Follow-up|5
5913872|NCT01567527|20459119|P4|Double-blind, Placebo-controlled Phase|Lost to Follow-up|8
5913873|NCT01567527|20459120|P3|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
5913874|NCT01567527|20459121|P2|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
5913875|NCT01567527|20459122|P1|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
5913876|NCT01567527|20459118|P5|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|35
5913877|NCT01567527|20459119|P4|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|19
5913878|NCT01567527|20459120|P3|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0
5913879|NCT01567527|20459121|P2|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0
5913880|NCT01567527|20459122|P1|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0
5913881|NCT01567527|20459118|P5|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|3
5913882|NCT01567527|20459119|P4|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|1
5913883|NCT01567527|20459120|P3|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0
5913884|NCT01567527|20459121|P2|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0
5913885|NCT01567527|20459122|P1|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0
5913886|NCT01567527|20459118|P5|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|10
5913887|NCT01567527|20459119|P4|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|13
5913888|NCT01567527|20459120|P3|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0
5913889|NCT01567527|20459121|P2|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0
5913890|NCT01567527|20459122|P1|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0
5913891|NCT01567527|20459118|P5|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|1
5913892|NCT01567527|20459119|P4|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|7
5913893|NCT01567527|20459120|P3|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0
5913894|NCT01567527|20459121|P2|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0
5913895|NCT01567527|20459122|P1|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0
5913896|NCT01567527|20459118|P5|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|7
5913897|NCT01567527|20459119|P4|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|4
5913898|NCT01567527|20459120|P3|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0
5913899|NCT01567527|20459121|P2|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0
5913900|NCT01567527|20459122|P1|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0
5913901|NCT01567527|20459118|P5|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|33
5913902|NCT01567527|20459119|P4|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|16
5913903|NCT01567527|20459120|P3|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0
5913904|NCT01567527|20459121|P2|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0
5913905|NCT01567527|20459122|P1|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0
5913906|NCT01567527|20459118|P5|Double-blind, Placebo-controlled Phase|Protocol deviation|1
5913907|NCT01567527|20459119|P4|Double-blind, Placebo-controlled Phase|Protocol deviation|1
5913908|NCT01567527|20459120|P3|Double-blind, Placebo-controlled Phase|Protocol deviation|0
5913909|NCT01567527|20459121|P2|Double-blind, Placebo-controlled Phase|Protocol deviation|0
5913910|NCT01567527|20459122|P1|Double-blind, Placebo-controlled Phase|Protocol deviation|0
5913911|NCT01567527|20459118|P5|IM Depot Stabilization.|Withdrawn by the investigator|0
5913912|NCT01567527|20459119|P4|IM Depot Stabilization.|Withdrawn by the investigator|0
5913913|NCT01567527|20459120|P3|IM Depot Stabilization.|Withdrawn by the investigator|6
5913914|NCT01567527|20459121|P2|IM Depot Stabilization.|Withdrawn by the investigator|0
5913915|NCT01567527|20459122|P1|IM Depot Stabilization.|Withdrawn by the investigator|0
5913916|NCT01567527|20459118|P5|IM Depot Stabilization.|Adverse Event|0
5913917|NCT01567527|20459119|P4|IM Depot Stabilization.|Adverse Event|0
5913918|NCT01567527|20459120|P3|IM Depot Stabilization.|Adverse Event|37
5913919|NCT01567527|20459121|P2|IM Depot Stabilization.|Adverse Event|0
5913920|NCT01567527|20459122|P1|IM Depot Stabilization.|Adverse Event|0
5913921|NCT01567527|20459118|P5|IM Depot Stabilization.|Lack of Efficacy|0
5913922|NCT01567527|20459119|P4|IM Depot Stabilization.|Lack of Efficacy|0
5913923|NCT01567527|20459120|P3|IM Depot Stabilization.|Lack of Efficacy|7
5913924|NCT01567527|20459121|P2|IM Depot Stabilization.|Lack of Efficacy|0
5913925|NCT01567527|20459122|P1|IM Depot Stabilization.|Lack of Efficacy|0
5913926|NCT01567527|20459118|P5|IM Depot Stabilization.|Lost to Follow-up|0
5913927|NCT01567527|20459119|P4|IM Depot Stabilization.|Lost to Follow-up|0
5913928|NCT01567527|20459120|P3|IM Depot Stabilization.|Lost to Follow-up|21
5913929|NCT01567527|20459121|P2|IM Depot Stabilization.|Lost to Follow-up|0
5913930|NCT01567527|20459122|P1|IM Depot Stabilization.|Lost to Follow-up|0
5913931|NCT01567527|20459118|P5|IM Depot Stabilization.|Sponsor discontinued study|0
5913932|NCT01567527|20459119|P4|IM Depot Stabilization.|Sponsor discontinued study|0
5913933|NCT01567527|20459120|P3|IM Depot Stabilization.|Sponsor discontinued study|1
5913934|NCT01567527|20459121|P2|IM Depot Stabilization.|Sponsor discontinued study|0
5913935|NCT01567527|20459122|P1|IM Depot Stabilization.|Sponsor discontinued study|0
5913936|NCT01567527|20459118|P5|IM Depot Stabilization.|Withdrawal by Subject|0
5913937|NCT01567527|20459119|P4|IM Depot Stabilization.|Withdrawal by Subject|0
5913938|NCT01567527|20459120|P3|IM Depot Stabilization.|Withdrawal by Subject|56
5913939|NCT01567527|20459121|P2|IM Depot Stabilization.|Withdrawal by Subject|0
5913940|NCT01567527|20459122|P1|IM Depot Stabilization.|Withdrawal by Subject|0
5913941|NCT01567527|20459118|P5|IM Depot Stabilization.|Met withdrawal criteria|0
5913942|NCT01567527|20459119|P4|IM Depot Stabilization.|Met withdrawal criteria|0
5913943|NCT01567527|20459120|P3|IM Depot Stabilization.|Met withdrawal criteria|26
5913944|NCT01567527|20459121|P2|IM Depot Stabilization.|Met withdrawal criteria|0
5913945|NCT01567527|20459122|P1|IM Depot Stabilization.|Met withdrawal criteria|0
5913946|NCT01567527|20459118|P5|IM Depot Stabilization.|Protocol deviation|0
5913947|NCT01567527|20459119|P4|IM Depot Stabilization.|Protocol deviation|0
5913948|NCT01567527|20459120|P3|IM Depot Stabilization.|Protocol deviation|5
5913949|NCT01567527|20459121|P2|IM Depot Stabilization.|Protocol deviation|0
5913950|NCT01567527|20459122|P1|IM Depot Stabilization.|Protocol deviation|0
5913951|NCT01567527|20459118|P5|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0
5913952|NCT01567527|20459119|P4|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0
5913953|NCT01567527|20459120|P3|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0
5913954|NCT01567527|20459121|P2|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|2
5913955|NCT01567527|20459122|P1|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0
5913956|NCT01567527|20459118|P5|Oral Aripiprazole Stabilization Phase.|Adverse Event|0
5913957|NCT01567527|20459119|P4|Oral Aripiprazole Stabilization Phase.|Adverse Event|0
5913958|NCT01567527|20459120|P3|Oral Aripiprazole Stabilization Phase.|Adverse Event|0
5913959|NCT01567527|20459121|P2|Oral Aripiprazole Stabilization Phase.|Adverse Event|63
5913960|NCT01567527|20459122|P1|Oral Aripiprazole Stabilization Phase.|Adverse Event|0
5913961|NCT01567527|20459118|P5|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0
5913962|NCT01567527|20459119|P4|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0
5913963|NCT01567527|20459120|P3|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0
5913964|NCT01567527|20459121|P2|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|12
5913965|NCT01567527|20459122|P1|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0
5913966|NCT01567527|20459118|P5|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0
5913967|NCT01567527|20459119|P4|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0
5913968|NCT01567527|20459120|P3|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0
5913969|NCT01567527|20459121|P2|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|44
5913970|NCT01567527|20459122|P1|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0
5913971|NCT01567527|20459118|P5|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0
5913972|NCT01567527|20459119|P4|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0
5913973|NCT01567527|20459120|P3|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0
5913974|NCT01567527|20459121|P2|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|45
5913975|NCT01567527|20459122|P1|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0
5913976|NCT01567527|20459118|P5|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0
5913977|NCT01567527|20459119|P4|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0
5913978|NCT01567527|20459120|P3|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0
5913979|NCT01567527|20459121|P2|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|41
5914067|NCT01566721|20459479|P2|Overall Study|Other|4
5913980|NCT01567527|20459122|P1|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0
5913981|NCT01567527|20459118|P5|Conversion Phase.|Withdrawn by the investigator|0
5913982|NCT01567527|20459119|P4|Conversion Phase.|Withdrawn by the investigator|0
5913983|NCT01567527|20459120|P3|Conversion Phase.|Withdrawn by the investigator|0
5913984|NCT01567527|20459121|P2|Conversion Phase.|Withdrawn by the investigator|0
5913985|NCT01567527|20459122|P1|Conversion Phase.|Withdrawn by the investigator|3
5913986|NCT01567527|20459118|P5|Conversion Phase.|Adverse Event|0
5913987|NCT01567527|20459119|P4|Conversion Phase.|Adverse Event|0
5913988|NCT01567527|20459120|P3|Conversion Phase.|Adverse Event|0
5913989|NCT01567527|20459121|P2|Conversion Phase.|Adverse Event|0
5913990|NCT01567527|20459122|P1|Conversion Phase.|Adverse Event|33
5913991|NCT01567527|20459118|P5|Conversion Phase.|Lack of Efficacy|0
5913992|NCT01567527|20459119|P4|Conversion Phase.|Lack of Efficacy|0
5913993|NCT01567527|20459120|P3|Conversion Phase.|Lack of Efficacy|0
5913994|NCT01567527|20459121|P2|Conversion Phase.|Lack of Efficacy|0
5913995|NCT01567527|20459122|P1|Conversion Phase.|Lack of Efficacy|2
5913996|NCT01567527|20459118|P5|Conversion Phase.|Lost to Follow-up|0
5913997|NCT01567527|20459119|P4|Conversion Phase.|Lost to Follow-up|0
5913998|NCT01567527|20459120|P3|Conversion Phase.|Lost to Follow-up|0
5913999|NCT01567527|20459121|P2|Conversion Phase.|Lost to Follow-up|0
5914000|NCT01567527|20459122|P1|Conversion Phase.|Lost to Follow-up|16
5914001|NCT01567527|20459118|P5|Conversion Phase.|Withdrawal by Subject|0
5914002|NCT01567527|20459119|P4|Conversion Phase.|Withdrawal by Subject|0
5914003|NCT01567527|20459120|P3|Conversion Phase.|Withdrawal by Subject|0
5914004|NCT01567527|20459121|P2|Conversion Phase.|Withdrawal by Subject|0
5914005|NCT01567527|20459122|P1|Conversion Phase.|Withdrawal by Subject|32
5914006|NCT01567527|20459118|P5|Conversion Phase.|Met withdrawal criteria|0
5914007|NCT01567527|20459119|P4|Conversion Phase.|Met withdrawal criteria|0
5914008|NCT01567527|20459120|P3|Conversion Phase.|Met withdrawal criteria|0
5914009|NCT01567527|20459121|P2|Conversion Phase.|Met withdrawal criteria|0
5914010|NCT01567527|20459122|P1|Conversion Phase.|Met withdrawal criteria|10
5914011|NCT01567527|20459118|P5|Conversion Phase.|Protocol deviation|0
5914012|NCT01567527|20459119|P4|Conversion Phase.|Protocol deviation|0
5914013|NCT01567527|20459120|P3|Conversion Phase.|Protocol deviation|0
5914014|NCT01567527|20459121|P2|Conversion Phase.|Protocol deviation|0
5914015|NCT01567527|20459122|P1|Conversion Phase.|Protocol deviation|3
5914016|NCT01567462|20459139|P2|Overall Study|Withdrawal by Subject|7
5914017|NCT01567462|20459140|P1|Overall Study|Withdrawal by Subject|4
5914018|NCT01567306|20459163|P6|Overall Study|Withdrawal by Subject|1
5914019|NCT01567306|20459164|P5|Overall Study|Withdrawal by Subject|0
5914020|NCT01567306|20459165|P4|Overall Study|Withdrawal by Subject|0
5914021|NCT01567306|20459166|P3|Overall Study|Withdrawal by Subject|0
5914022|NCT01567306|20459167|P2|Overall Study|Withdrawal by Subject|0
5914023|NCT01567306|20459168|P1|Overall Study|Withdrawal by Subject|0
5914024|NCT01567306|20459163|P6|Overall Study|Lost to Follow-up|0
5914025|NCT01567306|20459164|P5|Overall Study|Lost to Follow-up|2
5914026|NCT01567306|20459165|P4|Overall Study|Lost to Follow-up|0
5914027|NCT01567306|20459166|P3|Overall Study|Lost to Follow-up|0
5914028|NCT01567306|20459167|P2|Overall Study|Lost to Follow-up|0
5914029|NCT01567306|20459168|P1|Overall Study|Lost to Follow-up|0
5914030|NCT01567306|20459163|P6|Overall Study|Adverse Event|1
5914031|NCT01567306|20459164|P5|Overall Study|Adverse Event|4
5914032|NCT01567306|20459165|P4|Overall Study|Adverse Event|2
5914033|NCT01567306|20459166|P3|Overall Study|Adverse Event|0
5914034|NCT01567306|20459167|P2|Overall Study|Adverse Event|0
5914035|NCT01567306|20459168|P1|Overall Study|Adverse Event|0
5914036|NCT01567306|20459163|P6|Overall Study|Change site living|0
5914037|NCT01567306|20459164|P5|Overall Study|Change site living|0
5914038|NCT01567306|20459165|P4|Overall Study|Change site living|0
5914039|NCT01567306|20459166|P3|Overall Study|Change site living|0
5914040|NCT01567306|20459167|P2|Overall Study|Change site living|0
5914041|NCT01567306|20459168|P1|Overall Study|Change site living|1
5914042|NCT01567306|20459163|P6|Overall Study|Protocol Violation|1
5914043|NCT01567306|20459164|P5|Overall Study|Protocol Violation|1
5914044|NCT01567306|20459165|P4|Overall Study|Protocol Violation|3
5914045|NCT01567306|20459166|P3|Overall Study|Protocol Violation|0
5914046|NCT01567306|20459167|P2|Overall Study|Protocol Violation|2
5914047|NCT01567306|20459168|P1|Overall Study|Protocol Violation|2
5914048|NCT01567163|20459182|P1|Overall Study|Lost to Follow-up|2
5914049|NCT01567163|20459182|P1|Overall Study|Progressive Disease|2
5914050|NCT01567085|20459203|P1|Overall Study|Terminal chronic kidney dysfunction|1
5914051|NCT01567085|20459203|P1|Overall Study|Returned to chronic dialysis|1
5914052|NCT01567085|20459203|P1|Overall Study|Renal transplantectomy|1
5914053|NCT01567085|20459203|P1|Overall Study|Graft loss|2
5914054|NCT01567085|20459203|P1|Overall Study|Lost to Follow-up|3
5914055|NCT01567085|20459203|P1|Overall Study|Adverse Event|6
5914056|NCT01567085|20459203|P1|Overall Study|Death|6
5914057|NCT01566981|20459240|P2|Overall Study|Lost to Follow-up|8
5914058|NCT01566981|20459241|P1|Overall Study|Lost to Follow-up|5
5914059|NCT01566773|20459270|P1|Overall Study|Physician Decision|2
5914060|NCT01566773|20459270|P1|Overall Study|Adverse Event|10
5914061|NCT01566773|20459270|P1|Overall Study|Administrative reason|1
5914062|NCT01566773|20459270|P1|Overall Study|Withdrawal by Subject|9
5914063|NCT01566773|20459270|P1|Overall Study|Protocol Violation|4
5914064|NCT01566773|20459270|P1|Overall Study|Protocol specified criteria|4
5914065|NCT01566721|20459479|P2|Overall Study|Withdrew Prior to Treatment|1
5914066|NCT01566721|20459480|P1|Overall Study|Withdrew Prior to Treatment|3
5914068|NCT01566721|20459480|P1|Overall Study|Other|10
5914069|NCT01566721|20459479|P2|Overall Study|Death|3
5914070|NCT01566721|20459480|P1|Overall Study|Death|6
5914071|NCT01566721|20459479|P2|Overall Study|Lost to Follow-up|0
5914072|NCT01566721|20459480|P1|Overall Study|Lost to Follow-up|18
5914073|NCT01566721|20459479|P2|Overall Study|Disease Progression/Recurrence|28
5914074|NCT01566721|20459480|P1|Overall Study|Disease Progression/Recurrence|123
5914075|NCT01566721|20459479|P2|Overall Study|Withdrawal by Subject|15
5914076|NCT01566721|20459480|P1|Overall Study|Withdrawal by Subject|58
5914077|NCT01566721|20459479|P2|Overall Study|Ongoing Study|659
5914078|NCT01566721|20459480|P1|Overall Study|Ongoing Study|1649
5914079|NCT01566695|20459505|P2|Overall Study|Miscellaneous|6
5914080|NCT01566695|20459506|P1|Overall Study|Miscellaneous|4
5914081|NCT01566695|20459505|P2|Overall Study|Progressive Disease|6
5914082|NCT01566695|20459506|P1|Overall Study|Progressive Disease|11
5914083|NCT01566695|20459505|P2|Overall Study|Withdrawal by Subject|7
5914084|NCT01566695|20459506|P1|Overall Study|Withdrawal by Subject|14
5914085|NCT01566695|20459505|P2|Overall Study|Death|8
5914086|NCT01566695|20459506|P1|Overall Study|Death|20
5914087|NCT01566695|20459505|P2|Overall Study|Adverse Event|27
5914088|NCT01566695|20459506|P1|Overall Study|Adverse Event|28
5914089|NCT01566695|20459505|P2|Overall Study|Lack of Efficacy|45
5914090|NCT01566695|20459506|P1|Overall Study|Lack of Efficacy|18
5914091|NCT01566604|20459671|P2|Overall Study|Withdrawal by Subject|6
5914092|NCT01566604|20459672|P1|Overall Study|Withdrawal by Subject|9
5914093|NCT01566604|20459671|P2|Overall Study|Adverse Event|2
5914094|NCT01566604|20459672|P1|Overall Study|Adverse Event|4
5914095|NCT01566604|20459671|P2|Overall Study|Death|1
5914096|NCT01566604|20459672|P1|Overall Study|Death|4
5914097|NCT01566604|20459671|P2|Overall Study|Abnormal laboratory value|0
5914098|NCT01566604|20459672|P1|Overall Study|Abnormal laboratory value|2
5914099|NCT01566604|20459671|P2|Overall Study|Protocol deviation|0
5914100|NCT01566604|20459672|P1|Overall Study|Protocol deviation|2
5914101|NCT01566604|20459671|P2|Overall Study|Lack of Efficacy|2
5914102|NCT01566604|20459672|P1|Overall Study|Lack of Efficacy|1
5914103|NCT01566604|20459671|P2|Overall Study|Administrative problems|0
5914104|NCT01566604|20459672|P1|Overall Study|Administrative problems|1
5914105|NCT01566604|20459671|P2|Overall Study|Patient's inability to use the device|0
5914106|NCT01566604|20459672|P1|Overall Study|Patient's inability to use the device|1
5914107|NCT01566435|20459837|P1|ACF Definitive Chemoradiation-cisplatin|Withdrawal by Subject|1
5914108|NCT01566214|20459903|P2|Overall Study|Lost to Follow-up|0
5914109|NCT01566214|20459904|P1|Overall Study|Lost to Follow-up|3
5914110|NCT01566149|20459948|P2|Overall Study|Withdrawal by Subject|0
5914111|NCT01566149|20459949|P1|Overall Study|Withdrawal by Subject|1
5914112|NCT01566149|20459948|P2|Overall Study|Protocol Violation|1
5914113|NCT01566149|20459949|P1|Overall Study|Protocol Violation|0
5914114|NCT01566149|20459948|P2|Overall Study|Non-compliance with study medication|0
5914115|NCT01566149|20459949|P1|Overall Study|Non-compliance with study medication|2
5914116|NCT01566149|20459948|P2|Overall Study|Adverse Event|1
5914117|NCT01566149|20459949|P1|Overall Study|Adverse Event|0
5914118|NCT01565993|20459982|P2|Overall Study|Physician Decision|3
5914119|NCT01565993|20459983|P1|Overall Study|Physician Decision|0
5914120|NCT01565980|20459991|P2|Overall Study|Withdrawal by Subject|3
5914121|NCT01565980|20459992|P1|Overall Study|Withdrawal by Subject|0
5914122|NCT01565980|20459991|P2|Overall Study|stopped medical treatment|0
5914123|NCT01565980|20459992|P1|Overall Study|stopped medical treatment|1
5914124|NCT01565980|20459991|P2|Overall Study|health complications|1
5914125|NCT01565980|20459992|P1|Overall Study|health complications|1
5914126|NCT01565980|20459991|P2|Overall Study|Lost to Follow-up|0
5914127|NCT01565980|20459992|P1|Overall Study|Lost to Follow-up|1
5914128|NCT01565980|20459991|P2|Overall Study|Death|0
5914129|NCT01565980|20459992|P1|Overall Study|Death|1
5914134|NCT01565928|20460055|P1|Overall Study|Death|2
5914135|NCT01565928|20460055|P1|Overall Study|Withdrawal by Subject|1
5914136|NCT01565928|20460055|P1|Overall Study|Progressive Disease|13
5914137|NCT01565928|20460055|P1|Overall Study|Other|3
5914138|NCT01565928|20460055|P1|Overall Study|Adverse Event|3
5914139|NCT01565889|20460109|P6|Part B|Lost to Follow-up|1
5914140|NCT01565889|20460110|P5|Part B|Lost to Follow-up|0
5914141|NCT01565889|20460111|P4|Part B|Lost to Follow-up|0
5914142|NCT01565889|20460112|P3|Part B|Lost to Follow-up|0
5914143|NCT01565889|20460113|P2|Part B|Lost to Follow-up|0
5914144|NCT01565889|20460114|P1|Part B|Lost to Follow-up|0
5914145|NCT01565889|20460109|P6|Part B|Lack of Efficacy|2
5914146|NCT01565889|20460110|P5|Part B|Lack of Efficacy|0
5914147|NCT01565889|20460111|P4|Part B|Lack of Efficacy|0
5914148|NCT01565889|20460112|P3|Part B|Lack of Efficacy|0
5914149|NCT01565889|20460113|P2|Part B|Lack of Efficacy|0
5914150|NCT01565889|20460114|P1|Part B|Lack of Efficacy|0
5914151|NCT01565889|20460109|P6|Part B|Withdrawal by Subject|1
5914152|NCT01565889|20460110|P5|Part B|Withdrawal by Subject|0
5914153|NCT01565889|20460111|P4|Part B|Withdrawal by Subject|0
5914154|NCT01565889|20460112|P3|Part B|Withdrawal by Subject|0
5914155|NCT01565889|20460113|P2|Part B|Withdrawal by Subject|0
5914156|NCT01565889|20460114|P1|Part B|Withdrawal by Subject|0
5914157|NCT01565889|20460109|P6|Part A|Withdrawal by Subject|0
5914158|NCT01565889|20460110|P5|Part A|Withdrawal by Subject|0
5914159|NCT01565889|20460111|P4|Part A|Withdrawal by Subject|0
5914160|NCT01565889|20460112|P3|Part A|Withdrawal by Subject|0
5914161|NCT01565889|20460113|P2|Part A|Withdrawal by Subject|0
5914162|NCT01565889|20460114|P1|Part A|Withdrawal by Subject|1
5914163|NCT01565850|20460145|P2|Overall Study|Withdrew Consent|2
5914164|NCT01565850|20460146|P1|Overall Study|Withdrew Consent|4
5914165|NCT01565850|20460145|P2|Overall Study|Participant noncompliance|0
5914166|NCT01565850|20460146|P1|Overall Study|Participant noncompliance|2
5914167|NCT01565850|20460145|P2|Overall Study|Investigator's Discretion|1
5914168|NCT01565850|20460146|P1|Overall Study|Investigator's Discretion|2
5914169|NCT01565850|20460145|P2|Overall Study|Lost to Follow-up|4
5914170|NCT01565850|20460146|P1|Overall Study|Lost to Follow-up|12
5914171|NCT01565850|20460145|P2|Overall Study|Adverse Event|1
5914172|NCT01565850|20460146|P1|Overall Study|Adverse Event|0
5914173|NCT01565707|20460166|P4|Overall Study|Miscellaneous|2
5914174|NCT01565707|20460167|P3|Overall Study|Miscellaneous|0
5914175|NCT01565707|20460168|P2|Overall Study|Miscellaneous|1
5914176|NCT01565707|20460169|P1|Overall Study|Miscellaneous|1
5914177|NCT01565707|20460166|P4|Overall Study|Randomized but not evaluable|0
5914178|NCT01565707|20460167|P3|Overall Study|Randomized but not evaluable|0
5914179|NCT01565707|20460168|P2|Overall Study|Randomized but not evaluable|0
5914180|NCT01565707|20460169|P1|Overall Study|Randomized but not evaluable|2
5914181|NCT01565707|20460166|P4|Overall Study|Withdrawal by Subject|1
5914182|NCT01565707|20460167|P3|Overall Study|Withdrawal by Subject|1
5914183|NCT01565707|20460168|P2|Overall Study|Withdrawal by Subject|1
5914184|NCT01565707|20460169|P1|Overall Study|Withdrawal by Subject|3
5914185|NCT01565707|20460166|P4|Overall Study|Protocol Violation|1
5914186|NCT01565707|20460167|P3|Overall Study|Protocol Violation|0
5914187|NCT01565707|20460168|P2|Overall Study|Protocol Violation|0
5914188|NCT01565707|20460169|P1|Overall Study|Protocol Violation|1
5914189|NCT01565707|20460166|P4|Overall Study|Lost to Follow-up|0
5914190|NCT01565707|20460167|P3|Overall Study|Lost to Follow-up|0
5914191|NCT01565707|20460168|P2|Overall Study|Lost to Follow-up|0
5914192|NCT01565707|20460169|P1|Overall Study|Lost to Follow-up|1
5914193|NCT01565707|20460166|P4|Overall Study|Adverse Event|1
5914194|NCT01565707|20460167|P3|Overall Study|Adverse Event|2
5914195|NCT01565707|20460168|P2|Overall Study|Adverse Event|6
5914196|NCT01565707|20460169|P1|Overall Study|Adverse Event|1
5914197|NCT01565694|20460260|P1|Fixed-Dose Assessment Period|Withdrawal by Subject|4
5914198|NCT01565694|20460260|P1|Dose-Titration Period|Protocol Violation|10
5914199|NCT01565694|20460260|P1|Dose-Titration Period|Adverse Event|4
5914200|NCT01565668|20460281|P2|Overall Study|HSCT Transplant|15
5914201|NCT01565668|20460282|P1|Overall Study|HSCT Transplant|11
5914202|NCT01565668|20460281|P2|Overall Study|Withdrawal by Subject|3
5914203|NCT01565668|20460282|P1|Overall Study|Withdrawal by Subject|1
5914204|NCT01565668|20460281|P2|Overall Study|Progressive disease|14
5914205|NCT01565668|20460282|P1|Overall Study|Progressive disease|13
5914206|NCT01565668|20460281|P2|Overall Study|Randomized, but never received drug|2
5914207|NCT01565668|20460282|P1|Overall Study|Randomized, but never received drug|0
5914208|NCT01565668|20460281|P2|Overall Study|Adverse Event|1
5914209|NCT01565668|20460282|P1|Overall Study|Adverse Event|6
5914210|NCT01565668|20460281|P2|Overall Study|Participant went on Hospice Care|0
5914211|NCT01565668|20460282|P1|Overall Study|Participant went on Hospice Care|1
5914212|NCT01565668|20460281|P2|Overall Study|Lack of Efficacy|2
5914213|NCT01565668|20460282|P1|Overall Study|Lack of Efficacy|4
5914214|NCT01565668|20460281|P2|Overall Study|Death|1
5914215|NCT01565668|20460282|P1|Overall Study|Death|2
5914216|NCT01565642|20460306|P2|Overall Study|Withdrawal by Subject|1
5914217|NCT01565642|20460307|P1|Overall Study|Withdrawal by Subject|2
5914218|NCT01565564|20460342|P2|Overall Study|Lost to Follow-up|1
5914219|NCT01565564|20460343|P1|Overall Study|Lost to Follow-up|5
5914220|NCT01565499|20460373|P1|Overall Study|Withdrawal by Subject|2
5914221|NCT01565499|20460373|P1|Overall Study|Adverse Event|5
5914222|NCT01565499|20460373|P1|Overall Study|Physician Decision|1
5914223|NCT01565343|20460407|P3|Overall Study|Administrative decision/technical issues|0
5914224|NCT01565343|20460408|P2|Overall Study|Administrative decision/technical issues|0
5914225|NCT01565343|20460409|P1|Overall Study|Administrative decision/technical issues|1
5914226|NCT01565291|20460439|P2|Overall Study|Withdrawal by Subject|0
5914227|NCT01565291|20460440|P1|Overall Study|Withdrawal by Subject|1
5914228|NCT01565148|20460452|P4|Overall Study|Physician Decision|0
5914229|NCT01565148|20460453|P3|Overall Study|Physician Decision|0
5914230|NCT01565148|20460454|P2|Overall Study|Physician Decision|5
5914231|NCT01565148|20460455|P1|Overall Study|Physician Decision|2
5914232|NCT01565148|20460452|P4|Overall Study|Death|0
5914233|NCT01565148|20460453|P3|Overall Study|Death|1
5914234|NCT01565148|20460454|P2|Overall Study|Death|0
5914235|NCT01565148|20460455|P1|Overall Study|Death|0
5914236|NCT01565148|20460452|P4|Overall Study|Rescue Therapy|8
5914237|NCT01565148|20460453|P3|Overall Study|Rescue Therapy|5
5914238|NCT01565148|20460454|P2|Overall Study|Rescue Therapy|5
5914239|NCT01565148|20460455|P1|Overall Study|Rescue Therapy|8
5914240|NCT01565148|20460452|P4|Overall Study|Lost to Follow-up|3
5914241|NCT01565148|20460453|P3|Overall Study|Lost to Follow-up|0
5914242|NCT01565148|20460454|P2|Overall Study|Lost to Follow-up|4
5914243|NCT01565148|20460455|P1|Overall Study|Lost to Follow-up|4
5914244|NCT01565148|20460452|P4|Overall Study|Withdrawal by Subject|2
5914245|NCT01565148|20460453|P3|Overall Study|Withdrawal by Subject|1
5914246|NCT01565148|20460454|P2|Overall Study|Withdrawal by Subject|1
5914247|NCT01565148|20460455|P1|Overall Study|Withdrawal by Subject|1
5914248|NCT01565083|20460491|P2|Overall Study|Other|5
5914249|NCT01565083|20460492|P1|Overall Study|Other|3
5914250|NCT01565083|20460491|P2|Overall Study|Death|23
5914251|NCT01565083|20460492|P1|Overall Study|Death|22
5914252|NCT01565083|20460491|P2|Overall Study|Lost to Follow-up|7
5914253|NCT01565083|20460492|P1|Overall Study|Lost to Follow-up|2
5914254|NCT01565083|20460491|P2|Overall Study|Withdrawal by Subject|4
5914255|NCT01565083|20460492|P1|Overall Study|Withdrawal by Subject|6
5914256|NCT01564862|20460543|P3|Overall Study|Other reason(s)|0
5914257|NCT01564862|20460544|P2|Overall Study|Other reason(s)|0
5914258|NCT01564862|20460545|P1|Overall Study|Other reason(s)|1
5914259|NCT01564862|20460543|P3|Overall Study|Lack of Efficacy|6
5914260|NCT01564862|20460544|P2|Overall Study|Lack of Efficacy|5
5914261|NCT01564862|20460545|P1|Overall Study|Lack of Efficacy|1
5914262|NCT01564862|20460543|P3|Overall Study|Voluntary Withdrawal|8
5914263|NCT01564862|20460544|P2|Overall Study|Voluntary Withdrawal|6
5914264|NCT01564862|20460545|P1|Overall Study|Voluntary Withdrawal|9
5914265|NCT01564862|20460543|P3|Overall Study|Lost to Follow-up|6
5914266|NCT01564862|20460544|P2|Overall Study|Lost to Follow-up|8
5914267|NCT01564862|20460545|P1|Overall Study|Lost to Follow-up|10
5914268|NCT01564862|20460543|P3|Overall Study|Major Protocol Deviation|4
5914269|NCT01564862|20460544|P2|Overall Study|Major Protocol Deviation|3
5914270|NCT01564862|20460545|P1|Overall Study|Major Protocol Deviation|3
5914271|NCT01564862|20460543|P3|Overall Study|Pretreatment Event or Adverse Event|6
5914272|NCT01564862|20460544|P2|Overall Study|Pretreatment Event or Adverse Event|12
5914273|NCT01564862|20460545|P1|Overall Study|Pretreatment Event or Adverse Event|6
5914274|NCT01564784|20460596|P2|Overall Study|Death|126
5914275|NCT01564784|20460597|P1|Overall Study|Death|131
5914276|NCT01564784|20460596|P2|Overall Study|Lost to Follow-up|1
5914277|NCT01564784|20460597|P1|Overall Study|Lost to Follow-up|1
5914278|NCT01564784|20460596|P2|Overall Study|Subject refused further follow-up|6
5914279|NCT01564784|20460597|P1|Overall Study|Subject refused further follow-up|1
5914280|NCT01564784|20460596|P2|Overall Study|Other|0
5914281|NCT01564784|20460597|P1|Overall Study|Other|1
5914282|NCT01564758|20460624|P1|Overall Study|Other|3
5914283|NCT01564758|20460624|P1|Overall Study|Adverse Event|3
5914284|NCT01564758|20460624|P1|Overall Study|Death|8
5914285|NCT01564732|20460631|P2|Overall Study|Early termination by the study sponsor|5
5914286|NCT01564732|20460632|P1|Overall Study|Early termination by the study sponsor|6
5914287|NCT01564537|20460680|P2|Overall Study|Other Miscellaneous Reasons|2
5914288|NCT01564537|20460681|P1|Overall Study|Other Miscellaneous Reasons|1
5914289|NCT01564537|20460680|P2|Overall Study|Lost to Follow-up|0
5914290|NCT01564537|20460681|P1|Overall Study|Lost to Follow-up|1
5914291|NCT01564537|20460680|P2|Overall Study|Withdrawal by Participant|4
5914292|NCT01564537|20460681|P1|Overall Study|Withdrawal by Participant|4
5914293|NCT01564459|20460704|P3|Double-blind Treatment|Adverse Event|1
5914294|NCT01564459|20460705|P2|Double-blind Treatment|Adverse Event|0
5914295|NCT01564459|20460706|P1|Double-blind Treatment|Adverse Event|0
5914296|NCT01564459|20460704|P3|Run-In|Withdrawal by Subject|0
5914297|NCT01564459|20460705|P2|Run-In|Withdrawal by Subject|0
5914298|NCT01564459|20460706|P1|Run-In|Withdrawal by Subject|1
5914299|NCT01564459|20460704|P3|Run-In|Protocol Violation|0
5914300|NCT01564459|20460705|P2|Run-In|Protocol Violation|0
5914301|NCT01564459|20460706|P1|Run-In|Protocol Violation|1
5914302|NCT01564459|20460704|P3|Run-In|Non-compliance with study drug|0
5914303|NCT01564459|20460705|P2|Run-In|Non-compliance with study drug|0
5914304|NCT01564459|20460706|P1|Run-In|Non-compliance with study drug|2
5914305|NCT01564459|20460704|P3|Run-In|Lost to Follow-up|0
5914306|NCT01564459|20460705|P2|Run-In|Lost to Follow-up|0
5914307|NCT01564459|20460706|P1|Run-In|Lost to Follow-up|1
5914308|NCT01564459|20460704|P3|Run-In|Adverse Event|0
5914309|NCT01564459|20460705|P2|Run-In|Adverse Event|0
5914310|NCT01564459|20460706|P1|Run-In|Adverse Event|7
5914311|NCT01564407|20460730|P5|Overall Study|funding lost, study ended|0
5914312|NCT01564407|20460731|P4|Overall Study|funding lost, study ended|1
5914313|NCT01564407|20460732|P3|Overall Study|funding lost, study ended|0
5914314|NCT01564407|20460733|P2|Overall Study|funding lost, study ended|0
5914315|NCT01564407|20460734|P1|Overall Study|funding lost, study ended|0
5914316|NCT01564407|20460730|P5|Overall Study|Withdrawal by Subject|0
5914317|NCT01564407|20460731|P4|Overall Study|Withdrawal by Subject|0
5914318|NCT01564407|20460732|P3|Overall Study|Withdrawal by Subject|0
5914319|NCT01564407|20460733|P2|Overall Study|Withdrawal by Subject|1
5914320|NCT01564407|20460734|P1|Overall Study|Withdrawal by Subject|0
5914321|NCT01564407|20460730|P5|Overall Study|Lost to Follow-up|0
5914322|NCT01564407|20460731|P4|Overall Study|Lost to Follow-up|0
5914323|NCT01564407|20460732|P3|Overall Study|Lost to Follow-up|0
5914324|NCT01564407|20460733|P2|Overall Study|Lost to Follow-up|1
5914325|NCT01564407|20460734|P1|Overall Study|Lost to Follow-up|0
5914326|NCT01564394|20460775|P2|Overall Study|Withdrawal by Subject|10
5914327|NCT01564394|20460776|P1|Overall Study|Withdrawal by Subject|6
5914328|NCT01564277|20460790|P2|Overall Study|Physician Decision|0
5914329|NCT01564277|20460791|P1|Overall Study|Physician Decision|1
5914330|NCT01564277|20460790|P2|Overall Study|Protocol Violation|1
5914331|NCT01564277|20460791|P1|Overall Study|Protocol Violation|0
5914332|NCT01563978|20460809|P2|Overall Study|Adverse Event|2
5914333|NCT01563978|20460810|P1|Overall Study|Adverse Event|1
5914334|NCT01563978|20460809|P2|Overall Study|Dev. of study specific discont. criteria|0
5914335|NCT01563978|20460810|P1|Overall Study|Dev. of study specific discont. criteria|1
5914336|NCT01563978|20460809|P2|Overall Study|Lost to Follow-up|0
5914337|NCT01563978|20460810|P1|Overall Study|Lost to Follow-up|1
5914338|NCT01563978|20460809|P2|Overall Study|Physician Decision|0
5914339|NCT01563978|20460810|P1|Overall Study|Physician Decision|1
5914340|NCT01563913|20460836|P2|Overall Study|Spouse Passed Away|0
5914341|NCT01563913|20460837|P1|Overall Study|Spouse Passed Away|1
5914342|NCT01563913|20460836|P2|Overall Study|Physician Decision|0
5914343|NCT01563913|20460837|P1|Overall Study|Physician Decision|1
5914344|NCT01563536|20460849|P2|Overall Study|Lost to Follow-up|0
5914345|NCT01563536|20460850|P1|Overall Study|Lost to Follow-up|1
5914346|NCT01563536|20460849|P2|Overall Study|Withdrawal by Subject|2
5914347|NCT01563536|20460850|P1|Overall Study|Withdrawal by Subject|0
5914348|NCT01563185|20460909|P1|Overall Study|Non-Compliance with study drug|1
5914349|NCT01563185|20460909|P1|Overall Study|Withdrawal by Subject|1
5914350|NCT01563172|20460923|P1|Overall Study|Other (Not specified)|1
5914351|NCT01563172|20460923|P1|Overall Study|Other (Protocol deviation)|5
5914352|NCT01563172|20460923|P1|Overall Study|Lost to Follow-up|2
5914353|NCT01563172|20460923|P1|Overall Study|Adverse Event|5
5914354|NCT01563029|20461029|P5|Overall Study|Withdrawal by Subject|3
5914355|NCT01563029|20461030|P4|Overall Study|Withdrawal by Subject|4
5914356|NCT01563029|20461031|P3|Overall Study|Withdrawal by Subject|3
5914357|NCT01563029|20461032|P2|Overall Study|Withdrawal by Subject|1
5914358|NCT01563029|20461033|P1|Overall Study|Withdrawal by Subject|4
5914359|NCT01563029|20461029|P5|Overall Study|Physician Decision|2
5914360|NCT01563029|20461030|P4|Overall Study|Physician Decision|4
5914361|NCT01563029|20461031|P3|Overall Study|Physician Decision|2
5914362|NCT01563029|20461032|P2|Overall Study|Physician Decision|5
5914363|NCT01563029|20461033|P1|Overall Study|Physician Decision|3
5914364|NCT01563029|20461029|P5|Overall Study|Lost to Follow-up|1
5914365|NCT01563029|20461030|P4|Overall Study|Lost to Follow-up|1
5914366|NCT01563029|20461031|P3|Overall Study|Lost to Follow-up|1
5914367|NCT01563029|20461032|P2|Overall Study|Lost to Follow-up|0
5914368|NCT01563029|20461033|P1|Overall Study|Lost to Follow-up|1
5914369|NCT01563029|20461029|P5|Overall Study|Protocol defined stopping criteria|0
5914370|NCT01563029|20461030|P4|Overall Study|Protocol defined stopping criteria|0
5914371|NCT01563029|20461031|P3|Overall Study|Protocol defined stopping criteria|0
5914372|NCT01563029|20461032|P2|Overall Study|Protocol defined stopping criteria|0
5914373|NCT01563029|20461033|P1|Overall Study|Protocol defined stopping criteria|1
5914374|NCT01563029|20461029|P5|Overall Study|Protocol Violation|3
5914375|NCT01563029|20461030|P4|Overall Study|Protocol Violation|1
5914376|NCT01563029|20461031|P3|Overall Study|Protocol Violation|3
5914377|NCT01563029|20461032|P2|Overall Study|Protocol Violation|2
5914378|NCT01563029|20461033|P1|Overall Study|Protocol Violation|1
5914379|NCT01563029|20461029|P5|Overall Study|Lack of Efficacy|19
5914380|NCT01563029|20461030|P4|Overall Study|Lack of Efficacy|21
5914381|NCT01563029|20461031|P3|Overall Study|Lack of Efficacy|23
5914382|NCT01563029|20461032|P2|Overall Study|Lack of Efficacy|16
5914383|NCT01563029|20461033|P1|Overall Study|Lack of Efficacy|42
5914384|NCT01563029|20461029|P5|Overall Study|Adverse Event|1
5914385|NCT01563029|20461030|P4|Overall Study|Adverse Event|2
5914386|NCT01563029|20461031|P3|Overall Study|Adverse Event|1
5914387|NCT01563029|20461032|P2|Overall Study|Adverse Event|0
5914388|NCT01563029|20461033|P1|Overall Study|Adverse Event|1
5914389|NCT01562873|20461099|P2|Overall Study|Clinical PD and adverse event|0
5914390|NCT01562873|20461100|P1|Overall Study|Clinical PD and adverse event|1
5914391|NCT01562873|20461099|P2|Overall Study|Clinical Disease Progression|0
5914392|NCT01562873|20461100|P1|Overall Study|Clinical Disease Progression|9
5914393|NCT01562873|20461099|P2|Overall Study|Adverse Event|0
5914394|NCT01562873|20461100|P1|Overall Study|Adverse Event|1
5914395|NCT01562873|20461099|P2|Overall Study|Disease Progression per RECIST|0
5914396|NCT01562873|20461100|P1|Overall Study|Disease Progression per RECIST|10
5914397|NCT01562782|20461109|P2|Overall Study|screen failure|2
5914398|NCT01562782|20461110|P1|Overall Study|screen failure|1
5914399|NCT01562782|20461109|P2|Overall Study|Withdrawal by Subject|3
5914400|NCT01562782|20461110|P1|Overall Study|Withdrawal by Subject|3
5914401|NCT01562743|20461139|P1|Overall Study|Physician Decision|2
5914402|NCT01562743|20461139|P1|Overall Study|Lost to Follow-up|2
5914403|NCT01562743|20461139|P1|Overall Study|Discontinuation criteria|2
5914404|NCT01562743|20461139|P1|Overall Study|Protocol Violation|1
5914405|NCT01562743|20461139|P1|Overall Study|Withdrawal by Subject|13
5914406|NCT01562743|20461139|P1|Overall Study|Lack of Efficacy|3
5914407|NCT01562743|20461139|P1|Overall Study|Adverse Event|29
5914408|NCT01562613|20461158|P1|Overall Study|Withdrawal by Subject|2
5914409|NCT01562613|20461158|P1|Overall Study|Lost to Follow-up|2
5914410|NCT01562548|20461168|P4|Overall Study|Lost to Follow-up|0
5914411|NCT01562548|20461169|P3|Overall Study|Lost to Follow-up|1
5914412|NCT01562548|20461170|P2|Overall Study|Lost to Follow-up|0
5914413|NCT01562548|20461171|P1|Overall Study|Lost to Follow-up|0
5914414|NCT01562444|20461224|P3|Overall Study|Protocol forbidden medication|0
5914415|NCT01562444|20461225|P2|Overall Study|Protocol forbidden medication|0
5914416|NCT01562444|20461226|P1|Overall Study|Protocol forbidden medication|1
5914417|NCT01562444|20461224|P3|Overall Study|Protocol forbidden concomitant vaccine|1
5914418|NCT01562444|20461225|P2|Overall Study|Protocol forbidden concomitant vaccine|0
5914419|NCT01562444|20461226|P1|Overall Study|Protocol forbidden concomitant vaccine|1
5914420|NCT01562444|20461224|P3|Overall Study|Unavailable serological results|2
5914421|NCT01562444|20461225|P2|Overall Study|Unavailable serological results|2
5914422|NCT01562444|20461226|P1|Overall Study|Unavailable serological results|0
5914423|NCT01562444|20461224|P3|Overall Study|Did not comply with blood draw schedule|1
5914424|NCT01562444|20461225|P2|Overall Study|Did not comply with blood draw schedule|0
5914425|NCT01562444|20461226|P1|Overall Study|Did not comply with blood draw schedule|1
5914426|NCT01562444|20461224|P3|Overall Study|Did not meet entry criteria|3
5914427|NCT01562444|20461225|P2|Overall Study|Did not meet entry criteria|0
5914428|NCT01562444|20461226|P1|Overall Study|Did not meet entry criteria|2
5914429|NCT01562327|20461492|P1|Overall Study|Infusion not received at 6 month window|4
5914430|NCT01562327|20461492|P1|Overall Study|Participant drop-out|1
5914431|NCT01562327|20461492|P1|Overall Study|Lack of Efficacy|1
5914432|NCT01562327|20461492|P1|Overall Study|Adverse Event|2
5914433|NCT01562314|20461522|P2|Overall Study|Withdrawal by Subject|1
5914434|NCT01562314|20461523|P1|Overall Study|Withdrawal by Subject|0
5914435|NCT01562314|20461522|P2|Overall Study|Met Withdrawal Criteria|2
5914436|NCT01562314|20461523|P1|Overall Study|Met Withdrawal Criteria|3
5914437|NCT01562314|20461522|P2|Overall Study|Adverse Event|5
5914438|NCT01562314|20461523|P1|Overall Study|Adverse Event|10
5914439|NCT01562275|20461580|P13|Stage 2|Progression of Disease|4
5914440|NCT01562275|20461581|P12|Stage 2|Progression of Disease|12
5914441|NCT01562275|20461582|P11|Stage 2|Progression of Disease|0
5914442|NCT01562275|20461583|P10|Stage 2|Progression of Disease|0
5914443|NCT01562275|20461584|P9|Stage 2|Progression of Disease|0
5914444|NCT01562275|20461585|P8|Stage 2|Progression of Disease|0
5914445|NCT01562275|20461586|P7|Stage 2|Progression of Disease|0
5914446|NCT01562275|20461587|P6|Stage 2|Progression of Disease|0
5914447|NCT01562275|20461588|P5|Stage 2|Progression of Disease|0
5914448|NCT01562275|20461589|P4|Stage 2|Progression of Disease|0
5914449|NCT01562275|20461590|P3|Stage 2|Progression of Disease|0
5914450|NCT01562275|20461591|P2|Stage 2|Progression of Disease|0
5914451|NCT01562275|20461592|P1|Stage 2|Progression of Disease|0
5914452|NCT01562275|20461580|P13|Stage 2|Death|1
5914453|NCT01562275|20461581|P12|Stage 2|Death|2
5914454|NCT01562275|20461582|P11|Stage 2|Death|0
5914455|NCT01562275|20461583|P10|Stage 2|Death|0
5914456|NCT01562275|20461584|P9|Stage 2|Death|0
5914457|NCT01562275|20461585|P8|Stage 2|Death|0
5914458|NCT01562275|20461586|P7|Stage 2|Death|0
5914459|NCT01562275|20461587|P6|Stage 2|Death|0
5914460|NCT01562275|20461588|P5|Stage 2|Death|0
5914461|NCT01562275|20461589|P4|Stage 2|Death|0
5914462|NCT01562275|20461590|P3|Stage 2|Death|0
5914463|NCT01562275|20461591|P2|Stage 2|Death|0
5914464|NCT01562275|20461592|P1|Stage 2|Death|0
5914465|NCT01562275|20461580|P13|Stage 1|Withdrawal by Subject|0
5914466|NCT01562275|20461581|P12|Stage 1|Withdrawal by Subject|0
5914467|NCT01562275|20461582|P11|Stage 1|Withdrawal by Subject|0
5914468|NCT01562275|20461583|P10|Stage 1|Withdrawal by Subject|1
5914469|NCT01562275|20461584|P9|Stage 1|Withdrawal by Subject|0
5914470|NCT01562275|20461585|P8|Stage 1|Withdrawal by Subject|0
5914471|NCT01562275|20461586|P7|Stage 1|Withdrawal by Subject|1
5914472|NCT01562275|20461587|P6|Stage 1|Withdrawal by Subject|0
5914473|NCT01562275|20461588|P5|Stage 1|Withdrawal by Subject|0
5914474|NCT01562275|20461589|P4|Stage 1|Withdrawal by Subject|2
5914475|NCT01562275|20461590|P3|Stage 1|Withdrawal by Subject|0
5914476|NCT01562275|20461591|P2|Stage 1|Withdrawal by Subject|1
5914477|NCT01562275|20461592|P1|Stage 1|Withdrawal by Subject|0
5914478|NCT01562275|20461580|P13|Stage 1|Progression of Disease|0
5914479|NCT01562275|20461581|P12|Stage 1|Progression of Disease|0
5914480|NCT01562275|20461582|P11|Stage 1|Progression of Disease|3
5914481|NCT01562275|20461583|P10|Stage 1|Progression of Disease|5
5914482|NCT01562275|20461584|P9|Stage 1|Progression of Disease|2
5914483|NCT01562275|20461585|P8|Stage 1|Progression of Disease|7
5914484|NCT01562275|20461586|P7|Stage 1|Progression of Disease|1
5914485|NCT01562275|20461587|P6|Stage 1|Progression of Disease|4
5914486|NCT01562275|20461588|P5|Stage 1|Progression of Disease|2
5914487|NCT01562275|20461589|P4|Stage 1|Progression of Disease|1
5914488|NCT01562275|20461590|P3|Stage 1|Progression of Disease|2
5914489|NCT01562275|20461591|P2|Stage 1|Progression of Disease|6
5914490|NCT01562275|20461592|P1|Stage 1|Progression of Disease|2
5914491|NCT01562275|20461580|P13|Stage 1|Physician Decision|0
5914492|NCT01562275|20461581|P12|Stage 1|Physician Decision|0
5914493|NCT01562275|20461582|P11|Stage 1|Physician Decision|0
5914494|NCT01562275|20461583|P10|Stage 1|Physician Decision|0
5914495|NCT01562275|20461584|P9|Stage 1|Physician Decision|1
5914496|NCT01562275|20461585|P8|Stage 1|Physician Decision|0
5914497|NCT01562275|20461586|P7|Stage 1|Physician Decision|1
5914498|NCT01562275|20461587|P6|Stage 1|Physician Decision|0
5914499|NCT01562275|20461588|P5|Stage 1|Physician Decision|1
5914500|NCT01562275|20461589|P4|Stage 1|Physician Decision|0
5914501|NCT01562275|20461590|P3|Stage 1|Physician Decision|0
5914502|NCT01562275|20461591|P2|Stage 1|Physician Decision|0
5914503|NCT01562275|20461592|P1|Stage 1|Physician Decision|0
5914504|NCT01562275|20461580|P13|Stage 1|Non Compliance|0
5914505|NCT01562275|20461581|P12|Stage 1|Non Compliance|0
5914506|NCT01562275|20461582|P11|Stage 1|Non Compliance|0
5914507|NCT01562275|20461583|P10|Stage 1|Non Compliance|0
5914508|NCT01562275|20461584|P9|Stage 1|Non Compliance|0
5914509|NCT01562275|20461585|P8|Stage 1|Non Compliance|0
5914510|NCT01562275|20461586|P7|Stage 1|Non Compliance|0
5914511|NCT01562275|20461587|P6|Stage 1|Non Compliance|0
5914512|NCT01562275|20461588|P5|Stage 1|Non Compliance|0
5914513|NCT01562275|20461589|P4|Stage 1|Non Compliance|0
5914514|NCT01562275|20461590|P3|Stage 1|Non Compliance|1
5914515|NCT01562275|20461591|P2|Stage 1|Non Compliance|0
5914516|NCT01562275|20461592|P1|Stage 1|Non Compliance|0
5914517|NCT01562275|20461580|P13|Stage 1|Death|0
5914518|NCT01562275|20461581|P12|Stage 1|Death|0
5914519|NCT01562275|20461582|P11|Stage 1|Death|0
5914520|NCT01562275|20461583|P10|Stage 1|Death|0
5914521|NCT01562275|20461584|P9|Stage 1|Death|0
5914522|NCT01562275|20461585|P8|Stage 1|Death|0
5914523|NCT01562275|20461586|P7|Stage 1|Death|0
5914524|NCT01562275|20461587|P6|Stage 1|Death|0
5914525|NCT01562275|20461588|P5|Stage 1|Death|0
5914526|NCT01562275|20461589|P4|Stage 1|Death|0
5914527|NCT01562275|20461590|P3|Stage 1|Death|0
5914528|NCT01562275|20461591|P2|Stage 1|Death|0
5914529|NCT01562275|20461592|P1|Stage 1|Death|1
5914530|NCT01562275|20461580|P13|Stage 1|Adverse Event|0
5914531|NCT01562275|20461581|P12|Stage 1|Adverse Event|0
5914532|NCT01562275|20461582|P11|Stage 1|Adverse Event|0
5914533|NCT01562275|20461583|P10|Stage 1|Adverse Event|1
5914534|NCT01562275|20461584|P9|Stage 1|Adverse Event|0
5914535|NCT01562275|20461585|P8|Stage 1|Adverse Event|0
5914536|NCT01562275|20461586|P7|Stage 1|Adverse Event|0
5914537|NCT01562275|20461587|P6|Stage 1|Adverse Event|0
5914538|NCT01562275|20461588|P5|Stage 1|Adverse Event|1
5914539|NCT01562275|20461589|P4|Stage 1|Adverse Event|1
5914540|NCT01562275|20461590|P3|Stage 1|Adverse Event|0
5914541|NCT01562275|20461591|P2|Stage 1|Adverse Event|0
5914542|NCT01562275|20461592|P1|Stage 1|Adverse Event|0
5914543|NCT01562028|20461733|P2|Overall Study|Lost to Follow-up|1
5914544|NCT01562028|20461734|P1|Overall Study|Lost to Follow-up|2
5914545|NCT01562028|20461733|P2|Overall Study|Withdrawal by Subject|1
5914546|NCT01562028|20461734|P1|Overall Study|Withdrawal by Subject|1
5914547|NCT01561989|20461754|P2|Overall Study|accural target not met.|6
5914548|NCT01561989|20461755|P1|Overall Study|accural target not met.|5
5914549|NCT01561976|20461777|P6|Washout Period 2 (7 Days)|Non-compliance|0
5914550|NCT01561976|20461778|P5|Washout Period 2 (7 Days)|Non-compliance|0
5914551|NCT01561976|20461779|P4|Washout Period 2 (7 Days)|Non-compliance|0
5914552|NCT01561976|20461780|P3|Washout Period 2 (7 Days)|Non-compliance|1
5914553|NCT01561976|20461781|P2|Washout Period 2 (7 Days)|Non-compliance|0
5914554|NCT01561976|20461782|P1|Washout Period 2 (7 Days)|Non-compliance|1
5914555|NCT01561976|20461777|P6|Washout Period 1 (7 Days)|Withdrawal by Subject|1
5914556|NCT01561976|20461778|P5|Washout Period 1 (7 Days)|Withdrawal by Subject|0
5914557|NCT01561976|20461779|P4|Washout Period 1 (7 Days)|Withdrawal by Subject|0
5914558|NCT01561976|20461780|P3|Washout Period 1 (7 Days)|Withdrawal by Subject|0
5914559|NCT01561976|20461781|P2|Washout Period 1 (7 Days)|Withdrawal by Subject|0
5914560|NCT01561976|20461782|P1|Washout Period 1 (7 Days)|Withdrawal by Subject|0
5914561|NCT01561976|20461777|P6|Washout Period 1 (7 Days)|Adverse Event|0
5914562|NCT01561976|20461778|P5|Washout Period 1 (7 Days)|Adverse Event|0
5914563|NCT01561976|20461779|P4|Washout Period 1 (7 Days)|Adverse Event|1
5914564|NCT01561976|20461780|P3|Washout Period 1 (7 Days)|Adverse Event|0
5914565|NCT01561976|20461781|P2|Washout Period 1 (7 Days)|Adverse Event|0
5914566|NCT01561976|20461782|P1|Washout Period 1 (7 Days)|Adverse Event|0
5914567|NCT01561976|20461777|P6|Period 1|Adverse Event|0
5914568|NCT01561976|20461778|P5|Period 1|Adverse Event|0
5914569|NCT01561976|20461779|P4|Period 1|Adverse Event|0
5914570|NCT01561976|20461780|P3|Period 1|Adverse Event|1
5914571|NCT01561976|20461781|P2|Period 1|Adverse Event|0
5914572|NCT01561976|20461782|P1|Period 1|Adverse Event|0
5914573|NCT01561898|20461815|P4|Overall Study|Physician Decision|1
5914574|NCT01561898|20461816|P3|Overall Study|Physician Decision|7
5914575|NCT01561898|20461817|P2|Overall Study|Physician Decision|5
5914576|NCT01561898|20461818|P1|Overall Study|Physician Decision|1
5914577|NCT01561898|20461815|P4|Overall Study|Adverse Event|9
5914578|NCT01561898|20461816|P3|Overall Study|Adverse Event|14
5914579|NCT01561898|20461817|P2|Overall Study|Adverse Event|19
5914580|NCT01561898|20461818|P1|Overall Study|Adverse Event|1
5914581|NCT01561898|20461815|P4|Overall Study|Lost to Follow-up|0
5914582|NCT01561898|20461816|P3|Overall Study|Lost to Follow-up|1
5914583|NCT01561898|20461817|P2|Overall Study|Lost to Follow-up|0
5914584|NCT01561898|20461818|P1|Overall Study|Lost to Follow-up|0
5914585|NCT01561898|20461815|P4|Overall Study|Worsening of complications|0
5914586|NCT01561898|20461816|P3|Overall Study|Worsening of complications|0
5914587|NCT01561898|20461817|P2|Overall Study|Worsening of complications|1
5914588|NCT01561898|20461818|P1|Overall Study|Worsening of complications|0
5914589|NCT01561898|20461815|P4|Overall Study|Lack of Efficacy|5
5914590|NCT01561898|20461816|P3|Overall Study|Lack of Efficacy|10
5914591|NCT01561898|20461817|P2|Overall Study|Lack of Efficacy|8
5914592|NCT01561898|20461818|P1|Overall Study|Lack of Efficacy|0
5914593|NCT01561898|20461815|P4|Overall Study|Withdrawal by Subject|5
5914594|NCT01561898|20461816|P3|Overall Study|Withdrawal by Subject|12
5914595|NCT01561898|20461817|P2|Overall Study|Withdrawal by Subject|8
5914596|NCT01561898|20461818|P1|Overall Study|Withdrawal by Subject|0
5914597|NCT01561755|20461836|P2|Overall Study|Lost to Follow-up|1
5914598|NCT01561755|20461837|P1|Overall Study|Lost to Follow-up|0
5914599|NCT01561560|20461889|P2|Second Two Weeks of Wear|Adverse Event|1
5914600|NCT01561560|20461890|P1|Second Two Weeks of Wear|Adverse Event|0
5914601|NCT01561560|20461889|P2|First Two Weeks of Wear|Adverse Event|1
5914602|NCT01561560|20461890|P1|First Two Weeks of Wear|Adverse Event|0
5914603|NCT01561560|20461889|P2|First Two Weeks of Wear|Time/job conflict|1
5914604|NCT01561560|20461890|P1|First Two Weeks of Wear|Time/job conflict|0
5914605|NCT01561430|20461925|P4|Overall Study|Sponsor Decision|12
5914606|NCT01561430|20461926|P3|Overall Study|Sponsor Decision|13
5914607|NCT01561430|20461927|P2|Overall Study|Sponsor Decision|14
5914608|NCT01561430|20461928|P1|Overall Study|Sponsor Decision|1
5914609|NCT01561430|20461925|P4|Overall Study|Physician Decision|0
5914610|NCT01561430|20461926|P3|Overall Study|Physician Decision|0
5914611|NCT01561430|20461927|P2|Overall Study|Physician Decision|1
5914612|NCT01561430|20461928|P1|Overall Study|Physician Decision|0
5914613|NCT01561430|20461925|P4|Overall Study|Withdrawal by Subject|0
5914614|NCT01561430|20461926|P3|Overall Study|Withdrawal by Subject|1
5914615|NCT01561430|20461927|P2|Overall Study|Withdrawal by Subject|0
5914616|NCT01561430|20461928|P1|Overall Study|Withdrawal by Subject|0
5914617|NCT01561430|20461925|P4|Overall Study|Adverse Event|1
5914618|NCT01561430|20461926|P3|Overall Study|Adverse Event|3
5914619|NCT01561430|20461927|P2|Overall Study|Adverse Event|0
5914620|NCT01561430|20461928|P1|Overall Study|Adverse Event|0
5914621|NCT01561313|20461991|P2|Overall Study|Adverse event and withdrawal by subject|0
5914622|NCT01561313|20461992|P1|Overall Study|Adverse event and withdrawal by subject|1
5914623|NCT01561313|20461991|P2|Overall Study|Withdrawal by Subject|0
5914624|NCT01561313|20461992|P1|Overall Study|Withdrawal by Subject|1
5914625|NCT01561300|20462010|P2|Run in on Placebo|Adverse Event|0
5914626|NCT01561300|20462011|P1|Run in on Placebo|Adverse Event|1
5914627|NCT01561079|20462022|P1|Overall Study|Protocol Violation|2
5914628|NCT01561079|20462022|P1|Overall Study|Withdrawal by Subject|59
5914629|NCT01561079|20462022|P1|Overall Study|Physician Decision|17
5914630|NCT01560988|20462108|P2|Washout (Six Weeks)|Lost to Follow-up|2
5914631|NCT01560988|20462109|P1|Washout (Six Weeks)|Lost to Follow-up|2
5914632|NCT01560988|20462108|P2|First Intervention (Six Weeks)|Withdrawal by Subject|0
5914633|NCT01560988|20462109|P1|First Intervention (Six Weeks)|Withdrawal by Subject|3
5914634|NCT01560988|20462108|P2|First Intervention (Six Weeks)|Lost to Follow-up|4
5914635|NCT01560988|20462109|P1|First Intervention (Six Weeks)|Lost to Follow-up|7
5914636|NCT01560949|20462145|P1|Surgery Phase|Physician Decision|3
5914637|NCT01560949|20462145|P1|Systemic Phase: mFOLFIRINOX|Adverse Event|6
5914638|NCT01560871|20462179|P2|Overall Study|Lost to Follow-up|0
5914639|NCT01560871|20462180|P1|Overall Study|Lost to Follow-up|1
5914640|NCT01560871|20462179|P2|Overall Study|readmission to a hospital|1
5914641|NCT01560871|20462180|P1|Overall Study|readmission to a hospital|2
5914642|NCT01560871|20462179|P2|Overall Study|relocation|0
5914643|NCT01560871|20462180|P1|Overall Study|relocation|1
5914644|NCT01560871|20462179|P2|Overall Study|transportation issues|1
5914645|NCT01560871|20462180|P1|Overall Study|transportation issues|2
5914646|NCT01560819|20462196|P2|Overall Study|Physician Decision|0
5914647|NCT01560819|20462197|P1|Overall Study|Physician Decision|1
5914648|NCT01560780|20462203|P2|Overall Study|Patient Preference|11
5914649|NCT01560780|20462204|P1|Overall Study|Patient Preference|11
5914650|NCT01560780|20462203|P2|Overall Study|Death|1
5914651|NCT01560780|20462204|P1|Overall Study|Death|2
5914652|NCT01560507|20462240|P3|Overall Study|Withdrawal by Subject|0
5914653|NCT01560507|20462241|P2|Overall Study|Withdrawal by Subject|1
5914654|NCT01560507|20462242|P1|Overall Study|Withdrawal by Subject|1
5914655|NCT01560507|20462240|P3|Overall Study|Lost to Follow-up|2
5914656|NCT01560507|20462241|P2|Overall Study|Lost to Follow-up|1
5914657|NCT01560507|20462242|P1|Overall Study|Lost to Follow-up|3
5914658|NCT01560429|20462255|P2|Overall Study|Protocol Violation|6
5914659|NCT01560429|20462256|P1|Overall Study|Protocol Violation|3
5914660|NCT01560416|20462266|P2|Randomized Phase|Crossover Participants|0
5914661|NCT01560416|20462267|P1|Randomized Phase|Crossover Participants|7
5914662|NCT01560403|20462285|P2|Overall Study|Lost to Follow-up|1
5914663|NCT01560403|20462286|P1|Overall Study|Lost to Follow-up|0
5914664|NCT01560234|20462334|P8|Overall Study|Lost to Follow-up|2
5914665|NCT01560234|20462335|P7|Overall Study|Lost to Follow-up|0
5914666|NCT01560234|20462336|P6|Overall Study|Lost to Follow-up|2
5914667|NCT01560234|20462337|P5|Overall Study|Lost to Follow-up|0
5914668|NCT01560234|20462338|P4|Overall Study|Lost to Follow-up|0
5914669|NCT01560234|20462339|P3|Overall Study|Lost to Follow-up|1
5914670|NCT01560234|20462340|P2|Overall Study|Lost to Follow-up|0
5914671|NCT01560234|20462341|P1|Overall Study|Lost to Follow-up|3
5914672|NCT01559935|20462436|P1|Maintenance Phase|Non-compliance|2
5914673|NCT01559935|20462436|P1|Maintenance Phase|Withdrawal by Subject|5
5914674|NCT01559935|20462436|P1|Maintenance Phase|Lack of Efficacy|18
5914675|NCT01559935|20462436|P1|Maintenance Phase|Toxicity|1
5914676|NCT01559935|20462436|P1|Maintenance Phase|Remains on study|28
5914677|NCT01559935|20462436|P1|BiRD Phase|Withdrawal by Subject|2
5914678|NCT01559935|20462436|P1|BiRD Phase|Lack of Efficacy|1
5914679|NCT01559935|20462436|P1|BiRD Phase|Toxicity|1
5914680|NCT01559935|20462436|P1|Car Phase|non-compliance|1
5914681|NCT01559935|20462436|P1|Car Phase|Insurance|1
5914682|NCT01559935|20462436|P1|Car Phase|Per protocol|1
5914683|NCT01559935|20462436|P1|Car Phase|Withdrawal by Subject|2
5914684|NCT01559935|20462436|P1|Car Phase|Physician Decision|1
5914685|NCT01559935|20462436|P1|Car Phase|Lost to Follow-up|1
5914686|NCT01559935|20462436|P1|Car Phase|Lack of Efficacy|2
5914687|NCT01559935|20462436|P1|Car Phase|Death|1
5914688|NCT01559935|20462436|P1|Car Phase|Toxicity|4
5914689|NCT01559844|20462472|P1|Overall Study|No Longer A Transplant Candidate|3
5914690|NCT01559844|20462472|P1|Overall Study|Efficacy Failure|10
5914691|NCT01559844|20462472|P1|Overall Study|Death|5
5914692|NCT01559844|20462472|P1|Overall Study|Consent Withdrawn|7
5914693|NCT01559675|20462485|P2|Overall Study|2nd operation on same patient excluded|12
5914694|NCT01559675|20462486|P1|Overall Study|2nd operation on same patient excluded|14
5914695|NCT01559675|20462485|P2|Overall Study|Protocol Violation|2
5914696|NCT01559675|20462486|P1|Overall Study|Protocol Violation|1
5914697|NCT01559454|20462517|P2|Overall Study|Lack of Efficacy|1
5914698|NCT01559454|20462518|P1|Overall Study|Lack of Efficacy|0
5914699|NCT01559454|20462517|P2|Overall Study|Protocol Violation|1
5914700|NCT01559454|20462518|P1|Overall Study|Protocol Violation|0
5914701|NCT01559454|20462517|P2|Overall Study|Physician Decision|1
5914702|NCT01559454|20462518|P1|Overall Study|Physician Decision|0
5914703|NCT01559454|20462517|P2|Overall Study|Withdrawal by Subject|1
5914704|NCT01559454|20462518|P1|Overall Study|Withdrawal by Subject|0
5914705|NCT01559454|20462517|P2|Overall Study|Lost to Follow-up|2
5914706|NCT01559454|20462518|P1|Overall Study|Lost to Follow-up|3
5914707|NCT01559389|20462536|P2|Overall Study|Withdrawal by Subject|20
5914708|NCT01559389|20462537|P1|Overall Study|Withdrawal by Subject|20
5914709|NCT01559311|20462550|P3|Overall Study|Adverse Event|1
5914710|NCT01559311|20462551|P2|Overall Study|Adverse Event|0
5914711|NCT01559311|20462552|P1|Overall Study|Adverse Event|0
5914712|NCT01559311|20462550|P3|Overall Study|Lost to Follow-up|2
5914713|NCT01559311|20462551|P2|Overall Study|Lost to Follow-up|3
5914714|NCT01559311|20462552|P1|Overall Study|Lost to Follow-up|0
5914715|NCT01559311|20462550|P3|Overall Study|Death|3
5914716|NCT01559311|20462551|P2|Overall Study|Death|2
5914717|NCT01559311|20462552|P1|Overall Study|Death|0
5914718|NCT01559311|20462550|P3|Overall Study|Withdrawal by Subject|0
5914719|NCT01559311|20462551|P2|Overall Study|Withdrawal by Subject|1
5914720|NCT01559311|20462552|P1|Overall Study|Withdrawal by Subject|2
5914721|NCT01559311|20462550|P3|Overall Study|Difficulty in cannulating the lateral ve|0
5914722|NCT01559311|20462551|P2|Overall Study|Difficulty in cannulating the lateral ve|0
5914723|NCT01559311|20462552|P1|Overall Study|Difficulty in cannulating the lateral ve|1
5914724|NCT01559311|20462550|P3|Overall Study|Protocol Violation|2
5914725|NCT01559311|20462551|P2|Overall Study|Protocol Violation|0
5914726|NCT01559311|20462552|P1|Overall Study|Protocol Violation|0
5914727|NCT01559259|20462568|P5|Overall Study|Adverse Event|0
5914728|NCT01559259|20462569|P4|Overall Study|Adverse Event|0
5914729|NCT01559259|20462570|P3|Overall Study|Adverse Event|1
5914730|NCT01559259|20462571|P2|Overall Study|Adverse Event|1
5914731|NCT01559259|20462572|P1|Overall Study|Adverse Event|0
5914732|NCT01559259|20462568|P5|Overall Study|Withdrawal by Subject|0
5914733|NCT01559259|20462569|P4|Overall Study|Withdrawal by Subject|1
5914734|NCT01559259|20462570|P3|Overall Study|Withdrawal by Subject|0
5914735|NCT01559259|20462571|P2|Overall Study|Withdrawal by Subject|0
5914736|NCT01559259|20462572|P1|Overall Study|Withdrawal by Subject|0
5914737|NCT01559129|20462661|P2|Open-label Extension Period|Study Terminated by Sponsor|2
5914738|NCT01559129|20462662|P1|Open-label Extension Period|Study Terminated by Sponsor|5
5914739|NCT01559129|20462661|P2|Open-label Extension Period|Adverse Event|0
5914740|NCT01559129|20462662|P1|Open-label Extension Period|Adverse Event|1
5914741|NCT01559129|20462661|P2|Treatment Phase|Did Not Receive Study Drug|1
5914742|NCT01559129|20462662|P1|Treatment Phase|Did Not Receive Study Drug|0
5914743|NCT01559129|20462661|P2|Treatment Phase|Protocol Exclusion Criteria|0
5914744|NCT01559129|20462662|P1|Treatment Phase|Protocol Exclusion Criteria|1
5914745|NCT01559129|20462661|P2|Treatment Phase|Study Terminated by Sponsor|2
5914746|NCT01559129|20462662|P1|Treatment Phase|Study Terminated by Sponsor|3
5914747|NCT01559129|20462661|P2|Treatment Phase|Lack of Efficacy|1
5914748|NCT01559129|20462662|P1|Treatment Phase|Lack of Efficacy|0
5914749|NCT01559129|20462661|P2|Treatment Phase|Progressive Disease|1
5914750|NCT01559129|20462662|P1|Treatment Phase|Progressive Disease|1
5914751|NCT01559129|20462661|P2|Treatment Phase|Adverse Event|2
5914752|NCT01559129|20462662|P1|Treatment Phase|Adverse Event|0
5914753|NCT01559116|20462738|P1|Overall Study|other than stated above|9
5914754|NCT01559116|20462738|P1|Overall Study|Withdrawal by Subject|4
5914755|NCT01559116|20462738|P1|Overall Study|Protocol Violation|1
5914756|NCT01559116|20462738|P1|Overall Study|Lost to Follow-up|1
5914757|NCT01559116|20462738|P1|Overall Study|Lack of Efficacy|1
5914758|NCT01559116|20462738|P1|Overall Study|Adverse Event|10
5914759|NCT01559090|20462809|P3|Stage II|Withdrawal by Subject|0
5914760|NCT01559090|20462810|P2|Stage II|Withdrawal by Subject|0
5914761|NCT01559090|20462811|P1|Stage II|Withdrawal by Subject|1
5914762|NCT01559090|20462809|P3|Stage I|Withdrawal by Subject|3
5914763|NCT01559090|20462810|P2|Stage I|Withdrawal by Subject|2
5914764|NCT01559090|20462811|P1|Stage I|Withdrawal by Subject|2
5914765|NCT01559012|20462843|P2|Overall Study|Withdrawal by Subject|1
5914766|NCT01559012|20462844|P1|Overall Study|Withdrawal by Subject|0
5914767|NCT01558752|20462884|P2|Overall Study|Physician Decision|0
5914768|NCT01558752|20462885|P1|Overall Study|Physician Decision|2
5914769|NCT01558739|20462891|P1|Overall Study|Protocol Violation|1
5914770|NCT01558739|20462891|P1|Overall Study|Disease Progression|4
5914771|NCT01558739|20462891|P1|Overall Study|Death|3
5914772|NCT01558739|20462891|P1|Overall Study|Withdrawal by Subject|2
5914773|NCT01558739|20462891|P1|Overall Study|Adverse Event|7
5914774|NCT01558674|20462916|P2|Part 1|Withdrawal by Subject|0
5914775|NCT01558674|20462917|P1|Part 1|Withdrawal by Subject|1
5914776|NCT01558674|20462916|P2|Part 1|Study Terminated by Sponsor|0
5914777|NCT01558674|20462917|P1|Part 1|Study Terminated by Sponsor|10
5914778|NCT01558635|20462968|P1|Overall Study|Reveal XT was explanted|1
5914779|NCT01558635|20462968|P1|Overall Study|Subject received other treatment|1
5914780|NCT01558635|20462968|P1|Overall Study|Physician Decision|1
5914781|NCT01558635|20462968|P1|Overall Study|Withdrawal by Subject|2
5914782|NCT01558635|20462968|P1|Overall Study|Death|1
5914783|NCT01558596|20462985|P2|Overall Study|Protocol Violation|0
5914784|NCT01558596|20462986|P1|Overall Study|Protocol Violation|1
5914785|NCT01558596|20462985|P2|Overall Study|surgery elsewhere or cancelled|1
5914786|NCT01558596|20462986|P1|Overall Study|surgery elsewhere or cancelled|1
5914787|NCT01558596|20462985|P2|Overall Study|Withdrawal by Subject|0
5914788|NCT01558596|20462986|P1|Overall Study|Withdrawal by Subject|1
5914789|NCT01558297|20463001|P3|Overall Study|Withdrawal by Subject|1
5914790|NCT01558297|20463002|P2|Overall Study|Withdrawal by Subject|2
5914791|NCT01558297|20463003|P1|Overall Study|Withdrawal by Subject|2
5914792|NCT01558271|20463020|P3|Overall Study|Physician Decision|1
5914793|NCT01558271|20463021|P2|Overall Study|Physician Decision|2
5914794|NCT01558271|20463022|P1|Overall Study|Physician Decision|0
5914795|NCT01558271|20463020|P3|Overall Study|Withdrawal by Subject|12
5914796|NCT01558271|20463021|P2|Overall Study|Withdrawal by Subject|6
5914797|NCT01558271|20463022|P1|Overall Study|Withdrawal by Subject|10
5914798|NCT01558271|20463020|P3|Overall Study|Protocol Violation|0
5914799|NCT01558271|20463021|P2|Overall Study|Protocol Violation|0
5914800|NCT01558271|20463022|P1|Overall Study|Protocol Violation|1
5914801|NCT01558271|20463020|P3|Overall Study|Lost to Follow-up|0
5914802|NCT01558271|20463021|P2|Overall Study|Lost to Follow-up|0
5914803|NCT01558271|20463022|P1|Overall Study|Lost to Follow-up|1
5914804|NCT01558271|20463020|P3|Overall Study|Adverse Event|4
5914805|NCT01558271|20463021|P2|Overall Study|Adverse Event|3
5914806|NCT01558271|20463022|P1|Overall Study|Adverse Event|6
5914807|NCT01558089|20463088|P1|Overall Study|Withdrawal by Subject|6
5914808|NCT01558089|20463088|P1|Overall Study|Lost to Follow-up|5
5914809|NCT01558089|20463088|P1|Overall Study|Lack of Efficacy|1
5914810|NCT01558089|20463088|P1|Overall Study|Adverse Event|1
5914811|NCT01557946|20463141|P2|Overall Study|Adverse Event|0
5914812|NCT01557946|20463142|P1|Overall Study|Adverse Event|3
5914813|NCT01557920|20463148|P2|Overall Study|Lack of Efficacy|0
5914814|NCT01557920|20463149|P1|Overall Study|Lack of Efficacy|1
5914815|NCT01557920|20463148|P2|Overall Study|Withdrawal by Subject|3
5914816|NCT01557920|20463149|P1|Overall Study|Withdrawal by Subject|2
5914817|NCT01557842|20463218|P2|Overall Study|Not Ablated|0
5914818|NCT01557842|20463219|P1|Overall Study|Not Ablated|2
5914819|NCT01557842|20463218|P2|Overall Study|Study Terminated by Sponsor|4
5914820|NCT01557842|20463219|P1|Overall Study|Study Terminated by Sponsor|3
5914821|NCT01557842|20463218|P2|Overall Study|Not Meet Inclusion/Exclusion Criteria|0
5914822|NCT01557842|20463219|P1|Overall Study|Not Meet Inclusion/Exclusion Criteria|3
5914823|NCT01557842|20463218|P2|Overall Study|Lack of Efficacy|1
5914824|NCT01557842|20463219|P1|Overall Study|Lack of Efficacy|0
5914825|NCT01557842|20463218|P2|Overall Study|Death|0
5914826|NCT01557842|20463219|P1|Overall Study|Death|1
5914827|NCT01557842|20463218|P2|Overall Study|Lost to Follow-up|1
5914828|NCT01557842|20463219|P1|Overall Study|Lost to Follow-up|0
5914830|NCT01557582|20463276|P1|Overall Study|Operator error|2
5914831|NCT01557582|20463276|P1|Overall Study|Protocol Violation|4
5914832|NCT01557569|20463284|P2|Overall Study|noncompliance with rules of residential|1
5914833|NCT01557569|20463285|P1|Overall Study|noncompliance with rules of residential|0
5914834|NCT01557569|20463284|P2|Overall Study|Withdrawal by Subject|5
5914835|NCT01557569|20463285|P1|Overall Study|Withdrawal by Subject|3
5914836|NCT01557569|20463284|P2|Overall Study|high blood pressure|1
5914837|NCT01557569|20463285|P1|Overall Study|high blood pressure|0
5914838|NCT01557569|20463284|P2|Overall Study|Adverse Event|0
5914839|NCT01557569|20463285|P1|Overall Study|Adverse Event|2
5914840|NCT01557517|20463293|P2|Overall Study|Pt declined before treatment started|0
5914841|NCT01557517|20463294|P1|Overall Study|Pt declined before treatment started|1
5914842|NCT01557517|20463293|P2|Overall Study|Adverse Event|2
5914843|NCT01557517|20463294|P1|Overall Study|Adverse Event|0
5914844|NCT01557517|20463293|P2|Overall Study|Refused further treatment|2
5914845|NCT01557517|20463294|P1|Overall Study|Refused further treatment|0
5914846|NCT01557517|20463293|P2|Overall Study|Death|0
5914847|NCT01557517|20463294|P1|Overall Study|Death|1
5914848|NCT01557504|20463320|P2|Overall Study|Physician Decision|0
5914849|NCT01557504|20463321|P1|Overall Study|Physician Decision|1
5914850|NCT01557400|20463344|P1|Overall Study|Withdrawal by Subject|9
5914851|NCT01557400|20463344|P1|Overall Study|Lost to Follow-up|5
5914852|NCT01557400|20463344|P1|Overall Study|Adverse Event|3
5914853|NCT01557400|20463344|P1|Overall Study|Transitioned to Commercial Drug Product|40
5914854|NCT01557348|20463356|P2|Overall Study|Administrative|11
5914855|NCT01557348|20463357|P1|Overall Study|Administrative|18
5914856|NCT01557348|20463356|P2|Overall Study|Lost to Follow-up|22
5914857|NCT01557348|20463357|P1|Overall Study|Lost to Follow-up|26
5914858|NCT01557348|20463356|P2|Overall Study|Withdrawal by Subject|4
5914859|NCT01557348|20463357|P1|Overall Study|Withdrawal by Subject|5
5914860|NCT01557348|20463356|P2|Overall Study|Insufficient Therapeutic Response|28
5914861|NCT01557348|20463357|P1|Overall Study|Insufficient Therapeutic Response|13
5914862|NCT01557348|20463356|P2|Overall Study|Death|4
5914863|NCT01557348|20463357|P1|Overall Study|Death|7
5914864|NCT01557348|20463356|P2|Overall Study|Infusion reaction event|5
5914865|NCT01557348|20463357|P1|Overall Study|Infusion reaction event|5
5914866|NCT01557348|20463356|P2|Overall Study|Adverse Event|16
5914867|NCT01557348|20463357|P1|Overall Study|Adverse Event|6
5914868|NCT01557283|20463474|P1|Overall Study|Other|6
5914869|NCT01557283|20463474|P1|Overall Study|Worsening of psoriasis|1
5914870|NCT01557283|20463474|P1|Overall Study|Participant's weight too high for dose|1
5914871|NCT01557283|20463474|P1|Overall Study|Withdrawal by Subject|1
5914872|NCT01557283|20463474|P1|Overall Study|Non-compliance|1
5914873|NCT01557283|20463474|P1|Overall Study|Lack of Efficacy|1
5914874|NCT01557283|20463474|P1|Overall Study|Adverse Event|7
5914875|NCT01557283|20463474|P1|Overall Study|Non-responder|19
5914876|NCT01557283|20463474|P1|Overall Study|Lost to Follow-up|7
5914877|NCT01557166|20463486|P2|Overall Study|Unclassified|5
5914878|NCT01557166|20463487|P1|Overall Study|Unclassified|2
5914879|NCT01557166|20463486|P2|Overall Study|Psychiatric disorder|0
5914880|NCT01557166|20463487|P1|Overall Study|Psychiatric disorder|1
5914881|NCT01557166|20463486|P2|Overall Study|Target dose not tolerated|0
5914882|NCT01557166|20463487|P1|Overall Study|Target dose not tolerated|1
5914883|NCT01557166|20463486|P2|Overall Study|Withdrawn consent|20
5914884|NCT01557166|20463487|P1|Overall Study|Withdrawn consent|12
5914885|NCT01557166|20463486|P2|Overall Study|Protocol Violation|5
5914886|NCT01557166|20463487|P1|Overall Study|Protocol Violation|8
5914887|NCT01557166|20463486|P2|Overall Study|Lack of Efficacy|1
5914888|NCT01557166|20463487|P1|Overall Study|Lack of Efficacy|2
5914889|NCT01557166|20463486|P2|Overall Study|Adverse Event|6
5914890|NCT01557166|20463487|P1|Overall Study|Adverse Event|20
5914891|NCT01556997|20463502|P3|Overall Study|Other|7
5914892|NCT01556997|20463503|P2|Overall Study|Other|3
5914893|NCT01556997|20463504|P1|Overall Study|Other|2
5914894|NCT01556997|20463502|P3|Overall Study|Withdrawal by Subject|8
5914895|NCT01556997|20463503|P2|Overall Study|Withdrawal by Subject|6
5914896|NCT01556997|20463504|P1|Overall Study|Withdrawal by Subject|7
5914897|NCT01556997|20463502|P3|Overall Study|Physician Decision|1
5914898|NCT01556997|20463503|P2|Overall Study|Physician Decision|1
5914899|NCT01556997|20463504|P1|Overall Study|Physician Decision|1
5914900|NCT01556997|20463502|P3|Overall Study|Lost to Follow-up|4
5914901|NCT01556997|20463503|P2|Overall Study|Lost to Follow-up|6
5914902|NCT01556997|20463504|P1|Overall Study|Lost to Follow-up|6
5914903|NCT01556997|20463502|P3|Overall Study|Adverse Event|12
5914904|NCT01556997|20463503|P2|Overall Study|Adverse Event|12
5914905|NCT01556997|20463504|P1|Overall Study|Adverse Event|10
5914906|NCT01556932|20463515|P2|Time Point 60 Minutes|Withdrawal by Subject|1
5914907|NCT01556932|20463516|P1|Time Point 60 Minutes|Withdrawal by Subject|1
5914908|NCT01556763|20463542|P3|Overall Study|Withdrawal by Subject|0
5914909|NCT01556763|20463543|P2|Overall Study|Withdrawal by Subject|1
5914910|NCT01556763|20463544|P1|Overall Study|Withdrawal by Subject|0
5914911|NCT01556438|20463683|P2|Overall Study|Death|1
5914912|NCT01556438|20463684|P1|Overall Study|Death|0
5914913|NCT01556438|20463683|P2|Overall Study|Progressive Disease|6
5914914|NCT01556438|20463684|P1|Overall Study|Progressive Disease|0
5914915|NCT01556438|20463683|P2|Overall Study|Sponsor Decision|2
5914916|NCT01556438|20463684|P1|Overall Study|Sponsor Decision|0
5914917|NCT01556438|20463683|P2|Overall Study|Adverse Event|2
5914918|NCT01556438|20463684|P1|Overall Study|Adverse Event|4
5914919|NCT01556165|20463771|P2|Overall Study|Withdrawal of Consent|1
5914920|NCT01556165|20463772|P1|Overall Study|Withdrawal of Consent|7
5914921|NCT01556165|20463771|P2|Overall Study|Protocol Violation|3
5914922|NCT01556165|20463772|P1|Overall Study|Protocol Violation|0
5914923|NCT01556165|20463771|P2|Overall Study|Adverse Event|3
5914924|NCT01556165|20463772|P1|Overall Study|Adverse Event|5
5914925|NCT01555983|20463813|P6|Overall Study|Withdrawal by Subject|1
5914926|NCT01555983|20463814|P5|Overall Study|Withdrawal by Subject|1
5914927|NCT01555983|20463815|P4|Overall Study|Withdrawal by Subject|0
5914928|NCT01555983|20463816|P3|Overall Study|Withdrawal by Subject|0
5914929|NCT01555983|20463817|P2|Overall Study|Withdrawal by Subject|0
5914930|NCT01555983|20463818|P1|Overall Study|Withdrawal by Subject|1
5914931|NCT01555931|20463839|P2|Overall Study|Lost to Follow-up|5
5914932|NCT01555931|20463840|P1|Overall Study|Lost to Follow-up|2
5914933|NCT01555762|20463848|P1|Overall Study|Death linked to an adverse event|14
5914934|NCT01555762|20463848|P1|Overall Study|Missing data|1
5914935|NCT01555762|20463848|P1|Overall Study|Participant not wishing to continue|5
5914936|NCT01555762|20463848|P1|Overall Study|Investigator's decision|10
5914937|NCT01555762|20463848|P1|Overall Study|Lost follow-up/moved house/changed team|35
5914938|NCT01555762|20463848|P1|Overall Study|Death linked to progression of disease|165
5914939|NCT01555762|20463848|P1|Overall Study|Treatment with Bevacizumab ticked No|24
5914940|NCT01555762|20463848|P1|Overall Study|75 years old or more ticked No|1
5914941|NCT01555762|20463848|P1|Overall Study|Missing start date of infusion|8
5914942|NCT01555762|20463848|P1|Overall Study|No information on Bevacizumab intake|11
5914943|NCT01555463|20463928|P2|Follow up|Other reason|3
5914944|NCT01555463|20463929|P1|Follow up|Other reason|3
5914945|NCT01555463|20463928|P2|Follow up|Protocol Violation|4
5914946|NCT01555463|20463929|P1|Follow up|Protocol Violation|2
5914947|NCT01555463|20463928|P2|Follow up|Lost to Follow-up|10
5914948|NCT01555463|20463929|P1|Follow up|Lost to Follow-up|9
5914949|NCT01555463|20463928|P2|Follow up|Withdrawal by Subject|22
5914950|NCT01555463|20463929|P1|Follow up|Withdrawal by Subject|22
5914951|NCT01555463|20463928|P2|Follow up|Death|1
5914952|NCT01555463|20463929|P1|Follow up|Death|0
5914953|NCT01555463|20463928|P2|Follow up|Adverse Event|5
5914954|NCT01555463|20463929|P1|Follow up|Adverse Event|2
5914955|NCT01555463|20463928|P2|Treatment|Other reason|3
5914956|NCT01555463|20463929|P1|Treatment|Other reason|2
5914957|NCT01555463|20463928|P2|Treatment|Protocol Violation|5
5914958|NCT01555463|20463929|P1|Treatment|Protocol Violation|4
5914959|NCT01555463|20463928|P2|Treatment|Lost to Follow-up|23
5914960|NCT01555463|20463929|P1|Treatment|Lost to Follow-up|28
5914961|NCT01555463|20463928|P2|Treatment|Withdrawal by Subject|36
5914962|NCT01555463|20463929|P1|Treatment|Withdrawal by Subject|24
5914963|NCT01555463|20463928|P2|Treatment|Adverse Event|12
5914964|NCT01555463|20463929|P1|Treatment|Adverse Event|6
5914965|NCT01555164|20463971|P2|Overall Study|Subject Withdrew Consent|11
5914966|NCT01555164|20463972|P1|Overall Study|Subject Withdrew Consent|6
5914967|NCT01555164|20463971|P2|Overall Study|Subject Non-compliance|6
5914968|NCT01555164|20463972|P1|Overall Study|Subject Non-compliance|14
5914969|NCT01555164|20463971|P2|Overall Study|Protocol Violation|5
5914970|NCT01555164|20463972|P1|Overall Study|Protocol Violation|9
5914971|NCT01555164|20463971|P2|Overall Study|Lost to Follow-up|3
5914972|NCT01555164|20463972|P1|Overall Study|Lost to Follow-up|4
5914973|NCT01555164|20463971|P2|Overall Study|Investigator's Discretion|2
5914974|NCT01555164|20463972|P1|Overall Study|Investigator's Discretion|2
5914975|NCT01555164|20463971|P2|Overall Study|Hyperglycemia|1
5914976|NCT01555164|20463972|P1|Overall Study|Hyperglycemia|0
5914977|NCT01555164|20463971|P2|Overall Study|Adverse Event|7
5914978|NCT01555164|20463972|P1|Overall Study|Adverse Event|5
5914979|NCT01555151|20463986|P4|Overall Study|Lost to Follow-up|1
5914980|NCT01555151|20463987|P3|Overall Study|Lost to Follow-up|0
5914981|NCT01555151|20463988|P2|Overall Study|Lost to Follow-up|0
5914982|NCT01555151|20463989|P1|Overall Study|Lost to Follow-up|0
5914983|NCT01555151|20463986|P4|Overall Study|Adverse Event|2
5914984|NCT01555151|20463987|P3|Overall Study|Adverse Event|1
5914985|NCT01555151|20463988|P2|Overall Study|Adverse Event|2
5914986|NCT01555151|20463989|P1|Overall Study|Adverse Event|1
5914987|NCT01555151|20463986|P4|Overall Study|Protocol Violation|5
5914988|NCT01555151|20463987|P3|Overall Study|Protocol Violation|3
5914989|NCT01555151|20463988|P2|Overall Study|Protocol Violation|3
5914990|NCT01555151|20463989|P1|Overall Study|Protocol Violation|3
5914991|NCT01555151|20463986|P4|Overall Study|Administrative|0
5914992|NCT01555151|20463987|P3|Overall Study|Administrative|2
5914993|NCT01555151|20463988|P2|Overall Study|Administrative|1
5914994|NCT01555151|20463989|P1|Overall Study|Administrative|3
5914995|NCT01555151|20463986|P4|Overall Study|Withdrawal by Subject|2
5914996|NCT01555151|20463987|P3|Overall Study|Withdrawal by Subject|0
5914997|NCT01555151|20463988|P2|Overall Study|Withdrawal by Subject|2
5914998|NCT01555151|20463989|P1|Overall Study|Withdrawal by Subject|6
5914999|NCT01555138|20464042|P2|Overall Study|Adverse Event|14
5915000|NCT01555138|20464043|P1|Overall Study|Adverse Event|14
5915001|NCT01555138|20464042|P2|Overall Study|Withdrawal by Subject|15
5915002|NCT01555138|20464043|P1|Overall Study|Withdrawal by Subject|16
5915003|NCT01555138|20464042|P2|Overall Study|Administrative problems|0
5915004|NCT01555138|20464043|P1|Overall Study|Administrative problems|8
5915005|NCT01555138|20464042|P2|Overall Study|Protocol Violation|3
5915006|NCT01555138|20464043|P1|Overall Study|Protocol Violation|5
5915007|NCT01555138|20464042|P2|Overall Study|Lack of Efficacy|2
5915008|NCT01555138|20464043|P1|Overall Study|Lack of Efficacy|2
5915009|NCT01555138|20464042|P2|Overall Study|Abnormal Lab reults|3
5915010|NCT01555138|20464043|P1|Overall Study|Abnormal Lab reults|1
5915011|NCT01555138|20464042|P2|Overall Study|Lost to Follow-up|0
5915012|NCT01555138|20464043|P1|Overall Study|Lost to Follow-up|1
5915013|NCT01555138|20464042|P2|Overall Study|Death|1
5915014|NCT01555138|20464043|P1|Overall Study|Death|0
5915015|NCT01555125|20464072|P5|Follow-Up Period|Subject / guardian decision|0
5915016|NCT01555125|20464073|P4|Follow-Up Period|Subject / guardian decision|1
5915017|NCT01555125|20464074|P3|Follow-Up Period|Subject / guardian decision|1
5915018|NCT01555125|20464075|P2|Follow-Up Period|Subject / guardian decision|1
5915019|NCT01555125|20464076|P1|Follow-Up Period|Subject / guardian decision|3
5915020|NCT01555125|20464072|P5|Follow-Up Period|Lost to Follow-up|0
5915021|NCT01555125|20464073|P4|Follow-Up Period|Lost to Follow-up|0
5915022|NCT01555125|20464074|P3|Follow-Up Period|Lost to Follow-up|0
5915023|NCT01555125|20464075|P2|Follow-Up Period|Lost to Follow-up|0
5915024|NCT01555125|20464076|P1|Follow-Up Period|Lost to Follow-up|1
5915025|NCT01555125|20464072|P5|Extension|Technical Problems|0
5915026|NCT01555125|20464073|P4|Extension|Technical Problems|1
5915027|NCT01555125|20464074|P3|Extension|Technical Problems|0
5915028|NCT01555125|20464075|P2|Extension|Technical Problems|0
5915029|NCT01555125|20464076|P1|Extension|Technical Problems|1
5915030|NCT01555125|20464072|P5|Extension|Subject/guardian decision|0
5915031|NCT01555125|20464073|P4|Extension|Subject/guardian decision|0
5915032|NCT01555125|20464074|P3|Extension|Subject/guardian decision|1
5915033|NCT01555125|20464075|P2|Extension|Subject/guardian decision|9
5915034|NCT01555125|20464076|P1|Extension|Subject/guardian decision|1
5915035|NCT01555125|20464072|P5|Extension|Study terminated by sponsor|0
5915036|NCT01555125|20464073|P4|Extension|Study terminated by sponsor|20
5915037|NCT01555125|20464074|P3|Extension|Study terminated by sponsor|16
5915038|NCT01555125|20464075|P2|Extension|Study terminated by sponsor|33
5915039|NCT01555125|20464076|P1|Extension|Study terminated by sponsor|32
5915040|NCT01555125|20464072|P5|Extension|Lost to Follow-up|0
5915041|NCT01555125|20464073|P4|Extension|Lost to Follow-up|0
5915042|NCT01555125|20464074|P3|Extension|Lost to Follow-up|2
5915043|NCT01555125|20464075|P2|Extension|Lost to Follow-up|1
5915044|NCT01555125|20464076|P1|Extension|Lost to Follow-up|2
5915045|NCT01555125|20464072|P5|Extension|Lack of Efficacy|0
5915046|NCT01555125|20464073|P4|Extension|Lack of Efficacy|0
5915047|NCT01555125|20464074|P3|Extension|Lack of Efficacy|3
5915048|NCT01555125|20464075|P2|Extension|Lack of Efficacy|6
5915049|NCT01555125|20464076|P1|Extension|Lack of Efficacy|7
5915050|NCT01555125|20464072|P5|Extension|Protocol deviation|0
5915051|NCT01555125|20464073|P4|Extension|Protocol deviation|0
5915052|NCT01555125|20464074|P3|Extension|Protocol deviation|0
5915053|NCT01555125|20464075|P2|Extension|Protocol deviation|0
5915054|NCT01555125|20464076|P1|Extension|Protocol deviation|1
5915055|NCT01555125|20464072|P5|Extension|Adverse Event|0
5915056|NCT01555125|20464073|P4|Extension|Adverse Event|1
5915057|NCT01555125|20464074|P3|Extension|Adverse Event|1
5915058|NCT01555125|20464075|P2|Extension|Adverse Event|2
5915059|NCT01555125|20464076|P1|Extension|Adverse Event|1
5915060|NCT01555125|20464072|P5|Maintenance Period|Death|0
5915061|NCT01555125|20464073|P4|Maintenance Period|Death|1
5915062|NCT01555125|20464074|P3|Maintenance Period|Death|0
5915063|NCT01555125|20464075|P2|Maintenance Period|Death|0
5915064|NCT01555125|20464076|P1|Maintenance Period|Death|0
5915065|NCT01555125|20464072|P5|Maintenance Period|Physician Decision|0
5915066|NCT01555125|20464073|P4|Maintenance Period|Physician Decision|0
5915067|NCT01555125|20464074|P3|Maintenance Period|Physician Decision|1
5915068|NCT01555125|20464075|P2|Maintenance Period|Physician Decision|0
5915069|NCT01555125|20464076|P1|Maintenance Period|Physician Decision|0
5915070|NCT01555125|20464072|P5|Maintenance Period|Lack of Efficacy|0
5915071|NCT01555125|20464073|P4|Maintenance Period|Lack of Efficacy|0
5915072|NCT01555125|20464074|P3|Maintenance Period|Lack of Efficacy|3
5915073|NCT01555125|20464075|P2|Maintenance Period|Lack of Efficacy|1
5915074|NCT01555125|20464076|P1|Maintenance Period|Lack of Efficacy|6
5915075|NCT01555125|20464072|P5|Maintenance Period|Lost to Follow-up|0
5915076|NCT01555125|20464073|P4|Maintenance Period|Lost to Follow-up|1
5915077|NCT01555125|20464074|P3|Maintenance Period|Lost to Follow-up|0
5915078|NCT01555125|20464075|P2|Maintenance Period|Lost to Follow-up|0
5915079|NCT01555125|20464076|P1|Maintenance Period|Lost to Follow-up|2
5915080|NCT01555125|20464072|P5|Maintenance Period|Subject / guardian decision|0
5915081|NCT01555125|20464073|P4|Maintenance Period|Subject / guardian decision|0
5915082|NCT01555125|20464074|P3|Maintenance Period|Subject / guardian decision|0
5915083|NCT01555125|20464075|P2|Maintenance Period|Subject / guardian decision|2
5915084|NCT01555125|20464076|P1|Maintenance Period|Subject / guardian decision|1
5915085|NCT01555125|20464072|P5|Maintenance Period|Adverse Event|0
5915086|NCT01555125|20464073|P4|Maintenance Period|Adverse Event|0
5915087|NCT01555125|20464074|P3|Maintenance Period|Adverse Event|0
5915088|NCT01555125|20464075|P2|Maintenance Period|Adverse Event|1
5915089|NCT01555125|20464076|P1|Maintenance Period|Adverse Event|1
5915090|NCT01555125|20464072|P5|Induction Period|Death|0
5915091|NCT01555125|20464073|P4|Induction Period|Death|0
5915092|NCT01555125|20464074|P3|Induction Period|Death|0
5915093|NCT01555125|20464075|P2|Induction Period|Death|0
5915094|NCT01555125|20464076|P1|Induction Period|Death|1
5915095|NCT01555125|20464072|P5|Induction Period|Subject / guardian decision|2
5915096|NCT01555125|20464073|P4|Induction Period|Subject / guardian decision|0
5915097|NCT01555125|20464074|P3|Induction Period|Subject / guardian decision|0
5915098|NCT01555125|20464075|P2|Induction Period|Subject / guardian decision|0
5915099|NCT01555125|20464076|P1|Induction Period|Subject / guardian decision|0
5915100|NCT01555125|20464072|P5|Induction Period|Adverse Event|1
5915101|NCT01555125|20464073|P4|Induction Period|Adverse Event|0
5915102|NCT01555125|20464074|P3|Induction Period|Adverse Event|0
5915103|NCT01555125|20464075|P2|Induction Period|Adverse Event|1
5915104|NCT01555125|20464076|P1|Induction Period|Adverse Event|0
5915105|NCT01555125|20464072|P5|Induction Period|Lost to Follow-up|0
5915106|NCT01555125|20464073|P4|Induction Period|Lost to Follow-up|0
5915107|NCT01555125|20464074|P3|Induction Period|Lost to Follow-up|0
5915108|NCT01555125|20464075|P2|Induction Period|Lost to Follow-up|2
5915109|NCT01555125|20464076|P1|Induction Period|Lost to Follow-up|0
5915110|NCT01555073|20464169|P4|Overall Study|Lost to Follow-up|5
5915111|NCT01555073|20464170|P3|Overall Study|Lost to Follow-up|0
5915112|NCT01555073|20464171|P2|Overall Study|Lost to Follow-up|2
5915113|NCT01555073|20464172|P1|Overall Study|Lost to Follow-up|1
5915114|NCT01555021|20464188|P2|Overall Study|Lost to Follow-up|2
5915115|NCT01555021|20464189|P1|Overall Study|Lost to Follow-up|1
5915116|NCT01554904|20464214|P1|Overall Study|Had sleep apnea on Home Study 1|1
5915117|NCT01554904|20464214|P1|Overall Study|Withdrawal by Subject|3
5915118|NCT01554618|20464259|P2|Open-Label Extension Period|Lost to Follow-up|1
5915119|NCT01554618|20464260|P1|Open-Label Extension Period|Lost to Follow-up|1
5915120|NCT01554618|20464259|P2|Open-Label Extension Period|Physician Decision|1
5915121|NCT01554618|20464260|P1|Open-Label Extension Period|Physician Decision|0
5915122|NCT01554618|20464259|P2|Open-Label Extension Period|Withdrawal by Subject|3
5915123|NCT01554618|20464260|P1|Open-Label Extension Period|Withdrawal by Subject|2
5915124|NCT01554618|20464259|P2|Controlled Assessment Period|Withdrawal by Subject|0
5915125|NCT01554618|20464260|P1|Controlled Assessment Period|Withdrawal by Subject|6
5915126|NCT01554618|20464259|P2|Controlled Assessment Period|Lost to Follow-up|1
5915127|NCT01554618|20464260|P1|Controlled Assessment Period|Lost to Follow-up|2
5915128|NCT01554618|20464259|P2|Randomized Through Start of Treatment|Adverse Event|0
5915129|NCT01554618|20464260|P1|Randomized Through Start of Treatment|Adverse Event|1
5915130|NCT01554579|20464312|P2|Overall Study|Withdrawal by Subject|1
5915131|NCT01554579|20464313|P1|Overall Study|Withdrawal by Subject|2
5915132|NCT01554579|20464312|P2|Overall Study|Lack of Efficacy|1
5915133|NCT01554579|20464313|P1|Overall Study|Lack of Efficacy|2
5915134|NCT01554579|20464312|P2|Overall Study|Adverse Event|25
5915135|NCT01554579|20464313|P1|Overall Study|Adverse Event|6
5915136|NCT01554527|20464326|P3|Overall Study|Physician Decision|1
5915137|NCT01554527|20464327|P2|Overall Study|Physician Decision|0
5915138|NCT01554527|20464328|P1|Overall Study|Physician Decision|0
5915139|NCT01554527|20464326|P3|Overall Study|Lost to Follow-up|4
5915140|NCT01554527|20464327|P2|Overall Study|Lost to Follow-up|0
5915141|NCT01554527|20464328|P1|Overall Study|Lost to Follow-up|0
5915142|NCT01554527|20464326|P3|Overall Study|Withdrawal by Subject|3
5915143|NCT01554527|20464327|P2|Overall Study|Withdrawal by Subject|0
5915144|NCT01554527|20464328|P1|Overall Study|Withdrawal by Subject|1
5915145|NCT01554241|20464384|P4|Overall Study|Withdrawal by Subject|0
5915146|NCT01554241|20464385|P3|Overall Study|Withdrawal by Subject|2
5915147|NCT01554241|20464386|P2|Overall Study|Withdrawal by Subject|0
5915148|NCT01554241|20464387|P1|Overall Study|Withdrawal by Subject|0
5915149|NCT01554241|20464384|P4|Overall Study|protocol specified change in eGFR|0
5915150|NCT01554241|20464385|P3|Overall Study|protocol specified change in eGFR|1
5915151|NCT01554241|20464386|P2|Overall Study|protocol specified change in eGFR|0
5915152|NCT01554241|20464387|P1|Overall Study|protocol specified change in eGFR|0
5915153|NCT01554241|20464384|P4|Overall Study|protocol specified renal stone|1
5915154|NCT01554241|20464385|P3|Overall Study|protocol specified renal stone|0
5915155|NCT01554241|20464386|P2|Overall Study|protocol specified renal stone|0
5915156|NCT01554241|20464387|P1|Overall Study|protocol specified renal stone|0
5915157|NCT01554241|20464384|P4|Overall Study|Death|0
5915158|NCT01554241|20464385|P3|Overall Study|Death|1
5915159|NCT01554241|20464386|P2|Overall Study|Death|1
5915160|NCT01554241|20464387|P1|Overall Study|Death|3
5915161|NCT01554176|20464403|P5|Run-out Phase|Protocol Violation|0
5915162|NCT01554176|20464404|P4|Run-out Phase|Protocol Violation|1
5915163|NCT01554176|20464405|P3|Run-out Phase|Protocol Violation|0
5915164|NCT01554176|20464406|P2|Run-out Phase|Protocol Violation|0
5915165|NCT01554176|20464407|P1|Run-out Phase|Protocol Violation|0
5915166|NCT01554176|20464403|P5|Treatment Phase|Lost to Follow-up|0
5915167|NCT01554176|20464404|P4|Treatment Phase|Lost to Follow-up|0
5915168|NCT01554176|20464405|P3|Treatment Phase|Lost to Follow-up|0
5915169|NCT01554176|20464406|P2|Treatment Phase|Lost to Follow-up|0
5915170|NCT01554176|20464407|P1|Treatment Phase|Lost to Follow-up|3
5915171|NCT01554176|20464403|P5|Treatment Phase|Withdrawal by Subject|0
5915172|NCT01554176|20464404|P4|Treatment Phase|Withdrawal by Subject|0
5915173|NCT01554176|20464405|P3|Treatment Phase|Withdrawal by Subject|0
5915174|NCT01554176|20464406|P2|Treatment Phase|Withdrawal by Subject|0
5915175|NCT01554176|20464407|P1|Treatment Phase|Withdrawal by Subject|1
5915176|NCT01554176|20464403|P5|Treatment Phase|Non-compliance with study drug|0
5915177|NCT01554176|20464404|P4|Treatment Phase|Non-compliance with study drug|0
5915178|NCT01554176|20464405|P3|Treatment Phase|Non-compliance with study drug|0
5915179|NCT01554176|20464406|P2|Treatment Phase|Non-compliance with study drug|0
5915180|NCT01554176|20464407|P1|Treatment Phase|Non-compliance with study drug|1
5915181|NCT01554176|20464403|P5|Treatment Phase|Adverse event, non-fatal|0
5915182|NCT01554176|20464404|P4|Treatment Phase|Adverse event, non-fatal|0
5915183|NCT01554176|20464405|P3|Treatment Phase|Adverse event, non-fatal|0
5915184|NCT01554176|20464406|P2|Treatment Phase|Adverse event, non-fatal|1
5915185|NCT01554176|20464407|P1|Treatment Phase|Adverse event, non-fatal|1
5915186|NCT01554176|20464403|P5|Treatment Phase|Lack of Efficacy|0
5915187|NCT01554176|20464404|P4|Treatment Phase|Lack of Efficacy|0
5915188|NCT01554176|20464405|P3|Treatment Phase|Lack of Efficacy|0
5915189|NCT01554176|20464406|P2|Treatment Phase|Lack of Efficacy|1
5915190|NCT01554176|20464407|P1|Treatment Phase|Lack of Efficacy|0
5915191|NCT01554176|20464403|P5|Treatment Phase|Physician Decision|0
5915192|NCT01554176|20464404|P4|Treatment Phase|Physician Decision|0
5915193|NCT01554176|20464405|P3|Treatment Phase|Physician Decision|0
5915194|NCT01554176|20464406|P2|Treatment Phase|Physician Decision|1
5915195|NCT01554176|20464407|P1|Treatment Phase|Physician Decision|1
5915196|NCT01554176|20464403|P5|Treatment Phase|Protocol Violation|0
5915197|NCT01554176|20464404|P4|Treatment Phase|Protocol Violation|0
5915198|NCT01554176|20464405|P3|Treatment Phase|Protocol Violation|0
5915199|NCT01554176|20464406|P2|Treatment Phase|Protocol Violation|2
5915200|NCT01554176|20464407|P1|Treatment Phase|Protocol Violation|1
5915201|NCT01554163|20464434|P2|Overall Study|Not Treated|0
5915202|NCT01554163|20464435|P1|Overall Study|Not Treated|1
5915203|NCT01554163|20464434|P2|Overall Study|Withdrawal by Subject|5
5915204|NCT01554163|20464435|P1|Overall Study|Withdrawal by Subject|1
5915205|NCT01554163|20464434|P2|Overall Study|Protocol Violation|4
5915206|NCT01554163|20464435|P1|Overall Study|Protocol Violation|0
5915207|NCT01554163|20464434|P2|Overall Study|Non-Compliance With Study Drug|1
5915208|NCT01554163|20464435|P1|Overall Study|Non-Compliance With Study Drug|1
5915209|NCT01554163|20464434|P2|Overall Study|Lost to Follow-up|0
5915210|NCT01554163|20464435|P1|Overall Study|Lost to Follow-up|1
5915211|NCT01554163|20464434|P2|Overall Study|Lack of Efficacy|0
5915212|NCT01554163|20464435|P1|Overall Study|Lack of Efficacy|1
5915213|NCT01554163|20464434|P2|Overall Study|Adverse Event|0
5915214|NCT01554163|20464435|P1|Overall Study|Adverse Event|3
5915215|NCT01553916|20464453|P1|Overall Study|Pre-treatment MRI metastatic disease|1
5915216|NCT01553916|20464453|P1|Overall Study|Withdrawal by Subject|2
5915217|NCT01553851|20464470|P1|Overall Study|constipation|1
5915218|NCT01553851|20464470|P1|Overall Study|Adverse Event|2
5915219|NCT01553747|20464485|P3|Overall Study|Physician decision: lack of efficacy|3
5915220|NCT01553747|20464486|P2|Overall Study|Physician decision: lack of efficacy|5
5915221|NCT01553747|20464487|P1|Overall Study|Physician decision: lack of efficacy|1
5915222|NCT01553747|20464485|P3|Overall Study|Sponsor decision, specify|0
5915223|NCT01553747|20464486|P2|Overall Study|Sponsor decision, specify|5
5915224|NCT01553747|20464487|P1|Overall Study|Sponsor decision, specify|7
5915225|NCT01553747|20464485|P3|Overall Study|Lost to Follow-up|6
5915226|NCT01553747|20464486|P2|Overall Study|Lost to Follow-up|5
5915227|NCT01553747|20464487|P1|Overall Study|Lost to Follow-up|11
5915228|NCT01553747|20464485|P3|Overall Study|Physician decision: other|7
5915229|NCT01553747|20464486|P2|Overall Study|Physician decision: other|8
5915230|NCT01553747|20464487|P1|Overall Study|Physician decision: other|10
5915231|NCT01553747|20464485|P3|Overall Study|Adverse event or SAE|19
5915232|NCT01553747|20464486|P2|Overall Study|Adverse event or SAE|28
5915233|NCT01553747|20464487|P1|Overall Study|Adverse event or SAE|32
5915234|NCT01553747|20464485|P3|Overall Study|Voluntarily withdrew|74
5915235|NCT01553747|20464486|P2|Overall Study|Voluntarily withdrew|66
5915236|NCT01553747|20464487|P1|Overall Study|Voluntarily withdrew|70
5915237|NCT01553747|20464485|P3|Overall Study|Protocol Violation|0
5915238|NCT01553747|20464486|P2|Overall Study|Protocol Violation|2
5915239|NCT01553747|20464487|P1|Overall Study|Protocol Violation|0
5915240|NCT01553591|20464549|P3|Overall Study|Randomized and never dispensed drug|0
5915241|NCT01553591|20464550|P2|Overall Study|Randomized and never dispensed drug|1
5915242|NCT01553591|20464551|P1|Overall Study|Randomized and never dispensed drug|0
5915243|NCT01553591|20464549|P3|Overall Study|Sponsor decision|3
5915244|NCT01553591|20464550|P2|Overall Study|Sponsor decision|0
5915245|NCT01553591|20464551|P1|Overall Study|Sponsor decision|1
5915246|NCT01553591|20464549|P3|Overall Study|Protocol Violation|4
5915247|NCT01553591|20464550|P2|Overall Study|Protocol Violation|4
5915248|NCT01553591|20464551|P1|Overall Study|Protocol Violation|3
5915249|NCT01553591|20464549|P3|Overall Study|Physician decision: lack of efficacy|7
5915250|NCT01553591|20464550|P2|Overall Study|Physician decision: lack of efficacy|3
5915251|NCT01553591|20464551|P1|Overall Study|Physician decision: lack of efficacy|2
5915252|NCT01553591|20464549|P3|Overall Study|Physician decision: other|16
5915253|NCT01553591|20464550|P2|Overall Study|Physician decision: other|14
5915254|NCT01553591|20464551|P1|Overall Study|Physician decision: other|11
5915255|NCT01553591|20464549|P3|Overall Study|Lost to Follow-up|16
5915256|NCT01553591|20464550|P2|Overall Study|Lost to Follow-up|23
5915257|NCT01553591|20464551|P1|Overall Study|Lost to Follow-up|25
5915258|NCT01553591|20464549|P3|Overall Study|Adverse Event|16
5915259|NCT01553591|20464550|P2|Overall Study|Adverse Event|45
5915260|NCT01553591|20464551|P1|Overall Study|Adverse Event|36
5915261|NCT01553591|20464549|P3|Overall Study|Voluntarily withdrew|96
5915262|NCT01553591|20464550|P2|Overall Study|Voluntarily withdrew|79
5915263|NCT01553591|20464551|P1|Overall Study|Voluntarily withdrew|94
5915264|NCT01553318|20464611|P2|Overall Study|Protocol Violation|2
5915265|NCT01553318|20464612|P1|Overall Study|Protocol Violation|3
5915266|NCT01553279|20464642|P2|Period 2: Toddler Vaccinations|Lost to Follow-up|2
5915267|NCT01553279|20464643|P1|Period 2: Toddler Vaccinations|Lost to Follow-up|3
5915268|NCT01553279|20464642|P2|Period 2: Toddler Vaccinations|Withdrawal by Subject|5
5915269|NCT01553279|20464643|P1|Period 2: Toddler Vaccinations|Withdrawal by Subject|0
5915270|NCT01553279|20464642|P2|Interim Period|Lost to Follow-up|0
5915271|NCT01553279|20464643|P1|Interim Period|Lost to Follow-up|1
5915272|NCT01553279|20464642|P2|Interim Period|Withdrawal by Subject|2
5915273|NCT01553279|20464643|P1|Interim Period|Withdrawal by Subject|2
5915274|NCT01553279|20464642|P2|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1
5915275|NCT01553279|20464643|P1|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1
5915276|NCT01553279|20464642|P2|Part 1 (Infant Vaccinations)|Lost to Follow-up|0
5915277|NCT01553279|20464643|P1|Part 1 (Infant Vaccinations)|Lost to Follow-up|1
5915278|NCT01553188|20464718|P4|Overall Study|Intercurrent illness and adverse event|0
5915279|NCT01553188|20464719|P3|Overall Study|Intercurrent illness and adverse event|2
5915280|NCT01553188|20464720|P2|Overall Study|Intercurrent illness and adverse event|1
5915281|NCT01553188|20464721|P1|Overall Study|Intercurrent illness and adverse event|0
5915282|NCT01553188|20464718|P4|Overall Study|Patient choice|0
5915283|NCT01553188|20464719|P3|Overall Study|Patient choice|0
5915284|NCT01553188|20464720|P2|Overall Study|Patient choice|0
5915285|NCT01553188|20464721|P1|Overall Study|Patient choice|1
5915286|NCT01553136|20464748|P2|Overall Study|Scheduling Difficulties|4
5915287|NCT01553136|20464749|P1|Overall Study|Scheduling Difficulties|5
5915288|NCT01553136|20464748|P2|Overall Study|Physician Decision|3
5915289|NCT01553136|20464749|P1|Overall Study|Physician Decision|2
5915290|NCT01553136|20464748|P2|Overall Study|Lost to Follow-up|10
5915291|NCT01553136|20464749|P1|Overall Study|Lost to Follow-up|4
5915292|NCT01553136|20464748|P2|Overall Study|Withdrawal by Subject|3
5915293|NCT01553136|20464749|P1|Overall Study|Withdrawal by Subject|2
5915294|NCT01553136|20464748|P2|Overall Study|Adverse Event|2
5915295|NCT01553136|20464749|P1|Overall Study|Adverse Event|3
5915296|NCT01553084|20464766|P3|Overall Study|Withdrawal by Subject|35
5915297|NCT01553084|20464767|P2|Overall Study|Withdrawal by Subject|13
5915298|NCT01553084|20464768|P1|Overall Study|Withdrawal by Subject|15
5915299|NCT01552954|20464850|P2|Overall Study|diagnosed DM|0
5915300|NCT01552954|20464851|P1|Overall Study|diagnosed DM|1
5915301|NCT01552954|20464850|P2|Overall Study|Protocol Violation|2
5915302|NCT01552954|20464851|P1|Overall Study|Protocol Violation|1
5915303|NCT01552954|20464850|P2|Overall Study|Withdrawal by Subject|1
5915304|NCT01552954|20464851|P1|Overall Study|Withdrawal by Subject|1
5915305|NCT01552954|20464850|P2|Overall Study|Lost to Follow-up|1
5915306|NCT01552954|20464851|P1|Overall Study|Lost to Follow-up|1
5915307|NCT01552954|20464850|P2|Overall Study|Adverse Event|2
5915308|NCT01552954|20464851|P1|Overall Study|Adverse Event|1
5915309|NCT01552928|20464867|P4|Period 3|Adverse Event|0
5915310|NCT01552928|20464868|P3|Period 3|Adverse Event|1
5915311|NCT01552928|20464869|P2|Period 3|Adverse Event|0
5915312|NCT01552928|20464870|P1|Period 3|Adverse Event|0
5915313|NCT01552915|20464917|P3|Overall Study|Other|6
5915314|NCT01552915|20464918|P2|Overall Study|Other|0
5915315|NCT01552915|20464919|P1|Overall Study|Other|2
5915316|NCT01552915|20464917|P3|Overall Study|Lack of Efficacy|4
5915317|NCT01552915|20464918|P2|Overall Study|Lack of Efficacy|1
5915318|NCT01552915|20464919|P1|Overall Study|Lack of Efficacy|8
5915319|NCT01552915|20464917|P3|Overall Study|Protocol Violation|4
5915320|NCT01552915|20464918|P2|Overall Study|Protocol Violation|4
5915321|NCT01552915|20464919|P1|Overall Study|Protocol Violation|0
5915322|NCT01552915|20464917|P3|Overall Study|Withdrawal by Subject|5
5915323|NCT01552915|20464918|P2|Overall Study|Withdrawal by Subject|4
5915324|NCT01552915|20464919|P1|Overall Study|Withdrawal by Subject|6
5915325|NCT01552915|20464917|P3|Overall Study|Lost to Follow-up|5
5915326|NCT01552915|20464918|P2|Overall Study|Lost to Follow-up|6
5915327|NCT01552915|20464919|P1|Overall Study|Lost to Follow-up|4
5915328|NCT01552915|20464917|P3|Overall Study|Adverse Event|3
5915329|NCT01552915|20464918|P2|Overall Study|Adverse Event|14
5915330|NCT01552915|20464919|P1|Overall Study|Adverse Event|3
5915331|NCT01552902|20464942|P3|Overall Study|Other|3
5915332|NCT01552902|20464943|P2|Overall Study|Other|4
5915333|NCT01552902|20464944|P1|Overall Study|Other|3
5915334|NCT01552902|20464942|P3|Overall Study|Lost to Follow-up|6
5915335|NCT01552902|20464943|P2|Overall Study|Lost to Follow-up|3
5915336|NCT01552902|20464944|P1|Overall Study|Lost to Follow-up|1
5915337|NCT01552902|20464942|P3|Overall Study|Withdrawal by Subject|6
5915338|NCT01552902|20464943|P2|Overall Study|Withdrawal by Subject|9
5915339|NCT01552902|20464944|P1|Overall Study|Withdrawal by Subject|1
5915340|NCT01552902|20464942|P3|Overall Study|Lack of Efficacy|1
5915341|NCT01552902|20464943|P2|Overall Study|Lack of Efficacy|3
5915342|NCT01552902|20464944|P1|Overall Study|Lack of Efficacy|4
5915343|NCT01552902|20464942|P3|Overall Study|Protocol Violation|3
5915344|NCT01552902|20464943|P2|Overall Study|Protocol Violation|3
5915345|NCT01552902|20464944|P1|Overall Study|Protocol Violation|3
5915346|NCT01552902|20464942|P3|Overall Study|Adverse Event|14
5915347|NCT01552902|20464943|P2|Overall Study|Adverse Event|15
5915348|NCT01552902|20464944|P1|Overall Study|Adverse Event|1
5915349|NCT01552772|20464994|P1|Overall Study|Protocol Deviation|1
5915350|NCT01552772|20464994|P1|Overall Study|Adverse Event|1
5915351|NCT01552772|20464994|P1|Overall Study|Lost to Follow-up|2
5915352|NCT01552694|20465010|P2|Overall Study|Protocol Violation|1
5915353|NCT01552694|20465011|P1|Overall Study|Protocol Violation|0
5915354|NCT01552694|20465010|P2|Overall Study|Lost to Follow-up|1
5915355|NCT01552694|20465011|P1|Overall Study|Lost to Follow-up|0
5915356|NCT01552681|20465027|P2|Overall Study|Subject moved away|1
5915357|NCT01552681|20465028|P1|Overall Study|Subject moved away|0
5915358|NCT01552681|20465027|P2|Overall Study|Physician Decision|0
5915359|NCT01552681|20465028|P1|Overall Study|Physician Decision|1
5915360|NCT01552681|20465027|P2|Overall Study|Withdrawal by Subject|0
5915361|NCT01552681|20465028|P1|Overall Study|Withdrawal by Subject|4
5915362|NCT01552603|20465076|P1|Overall Study|Physician Decision|1
5915363|NCT01552408|20465083|P2|Overall Study|Withdrawal by Subject|1
5915364|NCT01552408|20465084|P1|Overall Study|Withdrawal by Subject|2
5915365|NCT01552408|20465083|P2|Overall Study|Relocation|1
5915366|NCT01552408|20465084|P1|Overall Study|Relocation|0
5915367|NCT01552408|20465083|P2|Overall Study|Lost to Follow-up|0
5915368|NCT01552408|20465084|P1|Overall Study|Lost to Follow-up|2
5915369|NCT01552369|20465106|P2|Overall Study|Did not consent to extended follow up|9
5915370|NCT01552369|20465107|P1|Overall Study|Did not consent to extended follow up|8
5915371|NCT01552057|20465196|P2|Overall Study|Physician Decision|0
5915372|NCT01552057|20465197|P1|Overall Study|Physician Decision|1
5915373|NCT01552057|20465196|P2|Overall Study|Entry Criteria Not Met|2
5915374|NCT01552057|20465197|P1|Overall Study|Entry Criteria Not Met|2
5915375|NCT01552057|20465196|P2|Overall Study|Withdrawal by Subject|8
5915376|NCT01552057|20465197|P1|Overall Study|Withdrawal by Subject|5
5915377|NCT01552057|20465196|P2|Overall Study|Lack of Efficacy|23
5915378|NCT01552057|20465197|P1|Overall Study|Lack of Efficacy|8
5915379|NCT01552057|20465196|P2|Overall Study|Adverse Event|15
5915380|NCT01552057|20465197|P1|Overall Study|Adverse Event|14
5915381|NCT01551758|20465263|P2|Overall Study|Withdrawal by Subject|17
5915382|NCT01551758|20465264|P1|Overall Study|Withdrawal by Subject|14
5915383|NCT01551758|20465263|P2|Overall Study|Physician Decision|3
5915384|NCT01551758|20465264|P1|Overall Study|Physician Decision|9
5915385|NCT01551758|20465263|P2|Overall Study|Lost to Follow-up|25
5915386|NCT01551758|20465264|P1|Overall Study|Lost to Follow-up|29
5915387|NCT01551758|20465263|P2|Overall Study|Met Protocol-defined stopping criteria|10
5915388|NCT01551758|20465264|P1|Overall Study|Met Protocol-defined stopping criteria|8
5915389|NCT01551758|20465263|P2|Overall Study|Protocol Violation|6
5915390|NCT01551758|20465264|P1|Overall Study|Protocol Violation|5
5915391|NCT01551758|20465263|P2|Overall Study|Lack of Efficacy|1
5915392|NCT01551758|20465264|P1|Overall Study|Lack of Efficacy|0
5915393|NCT01551758|20465263|P2|Overall Study|Adverse Event|43
5915394|NCT01551758|20465264|P1|Overall Study|Adverse Event|29
5915397|NCT01551693|20465311|P2|Overall Study|Withdrawal by Subject|1
5915398|NCT01551693|20465312|P1|Overall Study|Withdrawal by Subject|0
5915399|NCT01551693|20465311|P2|Overall Study|Adverse Event|1
5915400|NCT01551693|20465312|P1|Overall Study|Adverse Event|0
5915401|NCT01551693|20465311|P2|Overall Study|Disease Progression|0
5915402|NCT01551693|20465312|P1|Overall Study|Disease Progression|1
5915403|NCT01551420|20465333|P2|Home Use (Part B)|Withdrawal by staff|1
5915404|NCT01551420|20465334|P1|Home Use (Part B)|Withdrawal by staff|0
5915405|NCT01551420|20465333|P2|Home Use (Part B)|Withdrawal by Subject|0
5915406|NCT01551420|20465334|P1|Home Use (Part B)|Withdrawal by Subject|6
5915407|NCT01551420|20465333|P2|Screened for Part B Eligibility|Deemed ineligible by staff|2
5915408|NCT01551420|20465334|P1|Screened for Part B Eligibility|Deemed ineligible by staff|1
5915409|NCT01551420|20465333|P2|Screened for Part B Eligibility|Declined participation|1
5915410|NCT01551420|20465334|P1|Screened for Part B Eligibility|Declined participation|8
5915411|NCT01551420|20465333|P2|In-laboratory (Part A)|Scheduling conflict|1
5915412|NCT01551420|20465334|P1|In-laboratory (Part A)|Scheduling conflict|2
5915413|NCT01551420|20465333|P2|In-laboratory (Part A)|Withdrawal by Subject|0
5915414|NCT01551420|20465334|P1|In-laboratory (Part A)|Withdrawal by Subject|2
5915415|NCT01551420|20465333|P2|In-laboratory (Part A)|Lost to Follow-up|1
5915416|NCT01551420|20465334|P1|In-laboratory (Part A)|Lost to Follow-up|2
5915417|NCT01551355|20465364|P6|Overall Study|Lost to Follow-up|6
5915418|NCT01551355|20465365|P5|Overall Study|Lost to Follow-up|9
5915419|NCT01551355|20465366|P4|Overall Study|Lost to Follow-up|24
5915420|NCT01551355|20465367|P3|Overall Study|Lost to Follow-up|34
5915421|NCT01551355|20465368|P2|Overall Study|Lost to Follow-up|49
5915422|NCT01551355|20465369|P1|Overall Study|Lost to Follow-up|51
5915423|NCT01551303|20465383|P2|Overall Study|failed awareness check on vision test|7
5915424|NCT01551303|20465384|P1|Overall Study|failed awareness check on vision test|4
5915425|NCT01551212|20465392|P2|Overall Study|Never Received Study Treatment|4
5915426|NCT01551212|20465393|P1|Overall Study|Never Received Study Treatment|2
5915427|NCT01551212|20465392|P2|Overall Study|Death|4
5915428|NCT01551212|20465393|P1|Overall Study|Death|2
5915429|NCT01551212|20465392|P2|Overall Study|Withdrawal by Subject|7
5915430|NCT01551212|20465393|P1|Overall Study|Withdrawal by Subject|0
5915431|NCT01551212|20465392|P2|Overall Study|Protocol Violation|1
5915432|NCT01551212|20465393|P1|Overall Study|Protocol Violation|0
5915433|NCT01551212|20465392|P2|Overall Study|Lost to Follow-up|1
5915434|NCT01551212|20465393|P1|Overall Study|Lost to Follow-up|0
5915435|NCT01551212|20465392|P2|Overall Study|Administrative problems|2
5915436|NCT01551212|20465393|P1|Overall Study|Administrative problems|1
5915437|NCT01551212|20465392|P2|Overall Study|Graft loss/Retransplantation|1
5915438|NCT01551212|20465393|P1|Overall Study|Graft loss/Retransplantation|0
5915439|NCT01551173|20465428|P2|Overall Study|Other|3
5915440|NCT01551173|20465429|P1|Overall Study|Other|5
5915441|NCT01551173|20465428|P2|Overall Study|Lost to Follow-up|7
5915442|NCT01551173|20465429|P1|Overall Study|Lost to Follow-up|5
5915443|NCT01551173|20465428|P2|Overall Study|Adverse Event|6
5915444|NCT01551173|20465429|P1|Overall Study|Adverse Event|7
5915445|NCT01551173|20465428|P2|Overall Study|Withdrawal by Subject|16
5915446|NCT01551173|20465429|P1|Overall Study|Withdrawal by Subject|11
5915447|NCT01550965|20465506|P1|Overall Study|Other|13
5915448|NCT01550965|20465506|P1|Overall Study|Lack of Efficacy|59
5915449|NCT01550965|20465506|P1|Overall Study|Lost to Follow-up|2
5915450|NCT01550965|20465506|P1|Overall Study|Withdrawal by Subject|10
5915451|NCT01550965|20465506|P1|Overall Study|Adverse Event|26
5915452|NCT01550757|20465550|P4|Overall Study|Withdrawal by Subject|1
5915453|NCT01550757|20465551|P3|Overall Study|Withdrawal by Subject|3
5915454|NCT01550757|20465552|P2|Overall Study|Withdrawal by Subject|0
5915455|NCT01550757|20465553|P1|Overall Study|Withdrawal by Subject|2
5915456|NCT01550757|20465550|P4|Overall Study|Lost to Follow-up|53
5915457|NCT01550757|20465551|P3|Overall Study|Lost to Follow-up|42
5915458|NCT01550757|20465552|P2|Overall Study|Lost to Follow-up|14
5915459|NCT01550757|20465553|P1|Overall Study|Lost to Follow-up|21
5915460|NCT01550744|20465563|P3|Double-Blind|Other|10
5915461|NCT01550744|20465564|P2|Double-Blind|Other|2
5915462|NCT01550744|20465565|P1|Double-Blind|Other|0
5915463|NCT01550744|20465563|P3|Double-Blind|Pregnancy|3
5915464|NCT01550744|20465564|P2|Double-Blind|Pregnancy|0
5915465|NCT01550744|20465565|P1|Double-Blind|Pregnancy|0
5915466|NCT01550744|20465563|P3|Double-Blind|Protocol Violation|4
5915467|NCT01550744|20465564|P2|Double-Blind|Protocol Violation|0
5915468|NCT01550744|20465565|P1|Double-Blind|Protocol Violation|0
5915469|NCT01550744|20465563|P3|Double-Blind|Lack of Efficacy|8
5915470|NCT01550744|20465564|P2|Double-Blind|Lack of Efficacy|2
5915471|NCT01550744|20465565|P1|Double-Blind|Lack of Efficacy|0
5915472|NCT01550744|20465563|P3|Double-Blind|Death|0
5915473|NCT01550744|20465564|P2|Double-Blind|Death|1
5915474|NCT01550744|20465565|P1|Double-Blind|Death|0
5915475|NCT01550744|20465563|P3|Double-Blind|Adverse Event|15
5915476|NCT01550744|20465564|P2|Double-Blind|Adverse Event|4
5915477|NCT01550744|20465565|P1|Double-Blind|Adverse Event|0
5915478|NCT01550744|20465563|P3|Double-Blind|Withdrawal by Subject|15
5915479|NCT01550744|20465564|P2|Double-Blind|Withdrawal by Subject|2
5915480|NCT01550744|20465565|P1|Double-Blind|Withdrawal by Subject|0
5915481|NCT01550744|20465563|P3|Double-Blind|Lost to Follow-up|12
5915482|NCT01550744|20465564|P2|Double-Blind|Lost to Follow-up|6
5915483|NCT01550744|20465565|P1|Double-Blind|Lost to Follow-up|0
5915484|NCT01550744|20465563|P3|Open-Label|Other|0
5915485|NCT01550744|20465564|P2|Open-Label|Other|0
5915486|NCT01550744|20465565|P1|Open-Label|Other|1
5915487|NCT01550744|20465563|P3|Open-Label|Static PGA-cleared/minimal not achieved|0
5915488|NCT01550744|20465564|P2|Open-Label|Static PGA-cleared/minimal not achieved|0
5915489|NCT01550744|20465565|P1|Open-Label|Static PGA-cleared/minimal not achieved|58
5915490|NCT01550744|20465563|P3|Open-Label|Not all 3 study drug injections received|0
5915491|NCT01550744|20465564|P2|Open-Label|Not all 3 study drug injections received|0
5915492|NCT01550744|20465565|P1|Open-Label|Not all 3 study drug injections received|2
5915493|NCT01550744|20465563|P3|Open-Label|Protocol Violation|0
5915494|NCT01550744|20465564|P2|Open-Label|Protocol Violation|0
5915495|NCT01550744|20465565|P1|Open-Label|Protocol Violation|4
5915496|NCT01550744|20465563|P3|Open-Label|Lack of Efficacy|0
5915497|NCT01550744|20465564|P2|Open-Label|Lack of Efficacy|0
5915498|NCT01550744|20465565|P1|Open-Label|Lack of Efficacy|4
5915499|NCT01550744|20465563|P3|Open-Label|Adverse Event|0
5915500|NCT01550744|20465564|P2|Open-Label|Adverse Event|0
5915501|NCT01550744|20465565|P1|Open-Label|Adverse Event|11
5915502|NCT01550744|20465563|P3|Open-Label|Withdrawal by Subject|0
5915503|NCT01550744|20465564|P2|Open-Label|Withdrawal by Subject|0
5915504|NCT01550744|20465565|P1|Open-Label|Withdrawal by Subject|13
5915505|NCT01550744|20465563|P3|Open-Label|Lost to Follow-up|0
5915506|NCT01550744|20465564|P2|Open-Label|Lost to Follow-up|0
5915507|NCT01550744|20465565|P1|Open-Label|Lost to Follow-up|7
5915508|NCT01550289|20465714|P2|Overall Study|Withdrawal by Subject|3
5915509|NCT01550289|20465715|P1|Overall Study|Withdrawal by Subject|11
5915510|NCT01550289|20465714|P2|Overall Study|Lost to Follow-up|1
5915511|NCT01550289|20465715|P1|Overall Study|Lost to Follow-up|1
5915512|NCT01550289|20465714|P2|Overall Study|Protocol Violation|0
5915513|NCT01550289|20465715|P1|Overall Study|Protocol Violation|1
5915514|NCT01549964|20465791|P4|80-Week Extension Period|Pretreatment Event/Adverse Event|2
5915515|NCT01549964|20465792|P3|80-Week Extension Period|Pretreatment Event/Adverse Event|1
5915516|NCT01549964|20465793|P2|80-Week Extension Period|Pretreatment Event/Adverse Event|0
5915517|NCT01549964|20465794|P1|80-Week Extension Period|Pretreatment Event/Adverse Event|0
5915518|NCT01549964|20465791|P4|80-Week Extension Period|Lost to Follow-up|1
5915519|NCT01549964|20465792|P3|80-Week Extension Period|Lost to Follow-up|2
5915520|NCT01549964|20465793|P2|80-Week Extension Period|Lost to Follow-up|0
5915521|NCT01549964|20465794|P1|80-Week Extension Period|Lost to Follow-up|1
5915522|NCT01549964|20465791|P4|80-Week Extension Period|Voluntary Withdrawal|2
5915523|NCT01549964|20465792|P3|80-Week Extension Period|Voluntary Withdrawal|4
5915524|NCT01549964|20465793|P2|80-Week Extension Period|Voluntary Withdrawal|1
5915525|NCT01549964|20465794|P1|80-Week Extension Period|Voluntary Withdrawal|0
5915526|NCT01549964|20465791|P4|80-Week Extension Period|Study Terminated by Sponsor|132
5915527|NCT01549964|20465792|P3|80-Week Extension Period|Study Terminated by Sponsor|132
5915528|NCT01549964|20465793|P2|80-Week Extension Period|Study Terminated by Sponsor|137
5915529|NCT01549964|20465794|P1|80-Week Extension Period|Study Terminated by Sponsor|65
5915530|NCT01549964|20465791|P4|80-Week Extension Period|Pregnancy|0
5915531|NCT01549964|20465792|P3|80-Week Extension Period|Pregnancy|1
5915532|NCT01549964|20465793|P2|80-Week Extension Period|Pregnancy|0
5915533|NCT01549964|20465794|P1|80-Week Extension Period|Pregnancy|0
5915534|NCT01549964|20465791|P4|24-Week Treatment Period|Completion Status Unknown|0
5915535|NCT01549964|20465792|P3|24-Week Treatment Period|Completion Status Unknown|1
5915536|NCT01549964|20465793|P2|24-Week Treatment Period|Completion Status Unknown|0
5915537|NCT01549964|20465794|P1|24-Week Treatment Period|Completion Status Unknown|1
5915538|NCT01549964|20465791|P4|24-Week Treatment Period|Randomized but Not Treated|1
5915539|NCT01549964|20465792|P3|24-Week Treatment Period|Randomized but Not Treated|0
5915540|NCT01549964|20465793|P2|24-Week Treatment Period|Randomized but Not Treated|0
5915541|NCT01549964|20465794|P1|24-Week Treatment Period|Randomized but Not Treated|0
5915542|NCT01549964|20465791|P4|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0
5915543|NCT01549964|20465792|P3|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|1
5915544|NCT01549964|20465793|P2|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0
5915545|NCT01549964|20465794|P1|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0
5915546|NCT01549964|20465791|P4|24-Week Treatment Period|Other|0
5915547|NCT01549964|20465792|P3|24-Week Treatment Period|Other|1
5915548|NCT01549964|20465793|P2|24-Week Treatment Period|Other|0
5915549|NCT01549964|20465794|P1|24-Week Treatment Period|Other|1
5915550|NCT01549964|20465791|P4|24-Week Treatment Period|Lack of Efficacy|1
5915551|NCT01549964|20465792|P3|24-Week Treatment Period|Lack of Efficacy|1
5915552|NCT01549964|20465793|P2|24-Week Treatment Period|Lack of Efficacy|0
5915553|NCT01549964|20465794|P1|24-Week Treatment Period|Lack of Efficacy|1
5915554|NCT01549964|20465791|P4|24-Week Treatment Period|Lost to Follow-up|2
5915555|NCT01549964|20465792|P3|24-Week Treatment Period|Lost to Follow-up|1
5915556|NCT01549964|20465793|P2|24-Week Treatment Period|Lost to Follow-up|0
5915557|NCT01549964|20465794|P1|24-Week Treatment Period|Lost to Follow-up|1
5915558|NCT01549964|20465791|P4|24-Week Treatment Period|Pretreatment Event/Adverse Event|4
5915559|NCT01549964|20465792|P3|24-Week Treatment Period|Pretreatment Event/Adverse Event|4
5915560|NCT01549964|20465793|P2|24-Week Treatment Period|Pretreatment Event/Adverse Event|4
5915561|NCT01549964|20465794|P1|24-Week Treatment Period|Pretreatment Event/Adverse Event|1
5915562|NCT01549964|20465791|P4|24-Week Treatment Period|Voluntary Withdrawal|8
5915563|NCT01549964|20465792|P3|24-Week Treatment Period|Voluntary Withdrawal|3
5915564|NCT01549964|20465793|P2|24-Week Treatment Period|Voluntary Withdrawal|3
5915565|NCT01549964|20465794|P1|24-Week Treatment Period|Voluntary Withdrawal|6
5915566|NCT01549964|20465791|P4|24-Week Treatment Period|Study Terminated by Sponsor|105
5915567|NCT01549964|20465792|P3|24-Week Treatment Period|Study Terminated by Sponsor|104
5915568|NCT01549964|20465793|P2|24-Week Treatment Period|Study Terminated by Sponsor|104
5915569|NCT01549964|20465794|P1|24-Week Treatment Period|Study Terminated by Sponsor|50
5915570|NCT01549951|20465812|P1|Overall Study|Other|2
5915571|NCT01549951|20465812|P1|Overall Study|Symptomatic deterioration|1
5915572|NCT01549951|20465812|P1|Overall Study|Progressive disease|29
5915573|NCT01549951|20465812|P1|Overall Study|Unsatisfactory therapeutic response|1
5915574|NCT01549951|20465812|P1|Overall Study|Withdrawal by Subject|2
5915575|NCT01549951|20465812|P1|Overall Study|Adverse Event|15
5915576|NCT01549873|20465839|P2|Overall Study|Physician Decision|1
5915577|NCT01549873|20465840|P1|Overall Study|Physician Decision|0
5915578|NCT01549860|20465852|P2|Overall Study|Physician Decision|1
5915579|NCT01549860|20465853|P1|Overall Study|Physician Decision|1
5915580|NCT01549860|20465852|P2|Overall Study|Withdrawal by Subject|0
5915581|NCT01549860|20465853|P1|Overall Study|Withdrawal by Subject|1
5915582|NCT01549652|20465866|P4|Overall Study|Withdrawal by Subject|3
5915583|NCT01549652|20465867|P3|Overall Study|Withdrawal by Subject|5
5915584|NCT01549652|20465868|P2|Overall Study|Withdrawal by Subject|0
5915585|NCT01549652|20465869|P1|Overall Study|Withdrawal by Subject|0
5915586|NCT01549652|20465866|P4|Overall Study|Titration Side Effects|3
5915587|NCT01549652|20465867|P3|Overall Study|Titration Side Effects|6
5915588|NCT01549652|20465868|P2|Overall Study|Titration Side Effects|0
5915589|NCT01549652|20465869|P1|Overall Study|Titration Side Effects|0
5915590|NCT01549652|20465866|P4|Overall Study|Titration Non-Compliance|5
5915591|NCT01549652|20465867|P3|Overall Study|Titration Non-Compliance|4
5915592|NCT01549652|20465868|P2|Overall Study|Titration Non-Compliance|3
5915593|NCT01549652|20465869|P1|Overall Study|Titration Non-Compliance|1
5915594|NCT01549652|20465866|P4|Overall Study|Problem with Infusion|0
5915595|NCT01549652|20465867|P3|Overall Study|Problem with Infusion|0
5915596|NCT01549652|20465868|P2|Overall Study|Problem with Infusion|0
5915597|NCT01549652|20465869|P1|Overall Study|Problem with Infusion|1
5915598|NCT01549652|20465866|P4|Overall Study|Did Not Return Due to Withdrawal Effect|0
5915599|NCT01549652|20465867|P3|Overall Study|Did Not Return Due to Withdrawal Effect|0
5915600|NCT01549652|20465868|P2|Overall Study|Did Not Return Due to Withdrawal Effect|1
5915601|NCT01549652|20465869|P1|Overall Study|Did Not Return Due to Withdrawal Effect|5
5915602|NCT01549652|20465866|P4|Overall Study|Withdrawal Effect|0
5915603|NCT01549652|20465867|P3|Overall Study|Withdrawal Effect|0
5915604|NCT01549652|20465868|P2|Overall Study|Withdrawal Effect|2
5915605|NCT01549652|20465869|P1|Overall Study|Withdrawal Effect|0
5915606|NCT01549652|20465866|P4|Overall Study|Study Drug Titration Failure|0
5915607|NCT01549652|20465867|P3|Overall Study|Study Drug Titration Failure|0
5915608|NCT01549652|20465868|P2|Overall Study|Study Drug Titration Failure|6
5915609|NCT01549652|20465869|P1|Overall Study|Study Drug Titration Failure|5
5915610|NCT01549652|20465866|P4|Overall Study|Did Not Receive Allocated Intervention|0
5915611|NCT01549652|20465867|P3|Overall Study|Did Not Receive Allocated Intervention|2
5915612|NCT01549652|20465868|P2|Overall Study|Did Not Receive Allocated Intervention|0
5915613|NCT01549652|20465869|P1|Overall Study|Did Not Receive Allocated Intervention|0
5915614|NCT01549613|20465887|P2|Overall Study|Lost to Follow-up|11
5915615|NCT01549613|20465888|P1|Overall Study|Lost to Follow-up|11
5915616|NCT01549392|20465926|P2|Overall Study|Withdrawal by Subject|0
5915617|NCT01549392|20465927|P1|Overall Study|Withdrawal by Subject|1
5915618|NCT01549275|20465965|P2|Overall Study|Lost to Follow-up|0
5915619|NCT01549275|20465966|P1|Overall Study|Lost to Follow-up|1
5915620|NCT01549041|20465989|P2|Overall Study|Adverse Event|4
5915621|NCT01549041|20465990|P1|Overall Study|Adverse Event|0
5915622|NCT01549041|20465989|P2|Overall Study|Lack of Efficacy|4
5915623|NCT01549041|20465990|P1|Overall Study|Lack of Efficacy|2
5915624|NCT01549002|20466000|P2|Overall Study|Moderate sedation required|2
5915625|NCT01549002|20466001|P1|Overall Study|Moderate sedation required|0
5915626|NCT01549002|20466000|P2|Overall Study|Excessive pain|2
5915627|NCT01549002|20466001|P1|Overall Study|Excessive pain|0
5915628|NCT01548768|20466028|P4|Overall Study|Non-Compliance|3
5915629|NCT01548768|20466029|P3|Overall Study|Non-Compliance|0
5915630|NCT01548768|20466030|P2|Overall Study|Non-Compliance|0
5915631|NCT01548768|20466031|P1|Overall Study|Non-Compliance|0
5915632|NCT01548768|20466028|P4|Overall Study|Adverse Event|1
5915633|NCT01548768|20466029|P3|Overall Study|Adverse Event|0
5915634|NCT01548768|20466030|P2|Overall Study|Adverse Event|0
5915635|NCT01548768|20466031|P1|Overall Study|Adverse Event|0
5915636|NCT01548768|20466028|P4|Overall Study|Physician Decision|0
5915637|NCT01548768|20466029|P3|Overall Study|Physician Decision|0
5915638|NCT01548768|20466030|P2|Overall Study|Physician Decision|0
5915639|NCT01548768|20466031|P1|Overall Study|Physician Decision|1
5915640|NCT01548768|20466028|P4|Overall Study|Withdrawal by Subject|0
5915641|NCT01548768|20466029|P3|Overall Study|Withdrawal by Subject|1
5915642|NCT01548768|20466030|P2|Overall Study|Withdrawal by Subject|2
5915643|NCT01548768|20466031|P1|Overall Study|Withdrawal by Subject|0
5915644|NCT01548638|20466109|P1|Overall Study|Withdrawal by Subject|1
5915645|NCT01548638|20466109|P1|Overall Study|Protocol Violation|3
5915646|NCT01548599|20466121|P2|Overall Study|Death|1
5915647|NCT01548599|20466122|P1|Overall Study|Death|2
5915648|NCT01548599|20466121|P2|Overall Study|Withdrawal by Subject|0
5915649|NCT01548599|20466122|P1|Overall Study|Withdrawal by Subject|4
5915650|NCT01548599|20466121|P2|Overall Study|Lost to Follow-up|1
5915651|NCT01548599|20466122|P1|Overall Study|Lost to Follow-up|0
5915652|NCT01548573|20466138|P1|Overall Study|Withdrawal by Subject|2
5915653|NCT01548573|20466138|P1|Overall Study|Death|3
5915654|NCT01548417|20466147|P2|Overall Study|Withdrawal by Subject|2
5915655|NCT01548417|20466148|P1|Overall Study|Withdrawal by Subject|0
5915656|NCT01548404|20466158|P2|Overall Study|Other than specified above|2
5915657|NCT01548404|20466159|P1|Overall Study|Other than specified above|0
5915658|NCT01548404|20466158|P2|Overall Study|Withdrawal by Subject|3
5915659|NCT01548404|20466159|P1|Overall Study|Withdrawal by Subject|0
5915660|NCT01548404|20466158|P2|Overall Study|Lost to Follow-up|0
5915661|NCT01548404|20466159|P1|Overall Study|Lost to Follow-up|2
5915662|NCT01548404|20466158|P2|Overall Study|Inadequate response to study treatment|7
5915663|NCT01548404|20466159|P1|Overall Study|Inadequate response to study treatment|23
5915664|NCT01548404|20466158|P2|Overall Study|Physician Decision|1
5915665|NCT01548404|20466159|P1|Overall Study|Physician Decision|2
5915666|NCT01548404|20466158|P2|Overall Study|Adverse Event|1
5915667|NCT01548404|20466159|P1|Overall Study|Adverse Event|3
5915668|NCT01548287|20466198|P5|Randomized Period|Adverse Event|0
5915669|NCT01548287|20466199|P4|Randomized Period|Adverse Event|0
5915670|NCT01548287|20466200|P3|Randomized Period|Adverse Event|5
5915671|NCT01548287|20466201|P2|Randomized Period|Adverse Event|2
5915672|NCT01548287|20466202|P1|Randomized Period|Adverse Event|0
5915673|NCT01548287|20466198|P5|Randomized Period|Did not meet inclusion criteria|0
5915674|NCT01548287|20466199|P4|Randomized Period|Did not meet inclusion criteria|0
5915675|NCT01548287|20466200|P3|Randomized Period|Did not meet inclusion criteria|2
5915676|NCT01548287|20466201|P2|Randomized Period|Did not meet inclusion criteria|0
5915677|NCT01548287|20466202|P1|Randomized Period|Did not meet inclusion criteria|0
5915678|NCT01548287|20466198|P5|Screening|Did not meet eligibility criteria|74
5915679|NCT01548287|20466199|P4|Screening|Did not meet eligibility criteria|0
5915680|NCT01548287|20466200|P3|Screening|Did not meet eligibility criteria|0
5915681|NCT01548287|20466201|P2|Screening|Did not meet eligibility criteria|0
5915682|NCT01548287|20466202|P1|Screening|Did not meet eligibility criteria|0
5915683|NCT01548287|20466198|P5|Screening|No reason provided|9
5915684|NCT01548287|20466199|P4|Screening|No reason provided|0
5915685|NCT01548287|20466200|P3|Screening|No reason provided|0
5915686|NCT01548287|20466201|P2|Screening|No reason provided|0
5915687|NCT01548287|20466202|P1|Screening|No reason provided|0
5915688|NCT01547728|20466259|P1|Overall Study|Screen failure|39
5915689|NCT01547728|20466259|P1|Overall Study|Drug not ready for subject|1
5915690|NCT01547728|20466259|P1|Overall Study|Change in procedure and equipment|1
5915691|NCT01547598|20466368|P2|Overall Study|Other Miscellaneous Reasons|1
5915692|NCT01547598|20466369|P1|Overall Study|Other Miscellaneous Reasons|2
5915693|NCT01547598|20466368|P2|Overall Study|Protocol Violation|1
5915694|NCT01547598|20466369|P1|Overall Study|Protocol Violation|1
5915695|NCT01547598|20466368|P2|Overall Study|Adverse Event|1
5915696|NCT01547598|20466369|P1|Overall Study|Adverse Event|1
5915697|NCT01547598|20466368|P2|Overall Study|Lost to Follow-up|1
5915698|NCT01547598|20466369|P1|Overall Study|Lost to Follow-up|1
5915699|NCT01547598|20466368|P2|Overall Study|Withdrew consent|1
5915700|NCT01547598|20466369|P1|Overall Study|Withdrew consent|1
5915701|NCT01547390|20466386|P2|Overall Study|Adverse Event|0
5915702|NCT01547390|20466387|P1|Overall Study|Adverse Event|3
5915703|NCT01547390|20466386|P2|Overall Study|Lost to Follow-up|2
5915704|NCT01547390|20466387|P1|Overall Study|Lost to Follow-up|0
5915705|NCT01547390|20466386|P2|Overall Study|termination of pregnancy|1
5915706|NCT01547390|20466387|P1|Overall Study|termination of pregnancy|0
5915707|NCT01547390|20466386|P2|Overall Study|Withdrawal by Subject|7
5915708|NCT01547390|20466387|P1|Overall Study|Withdrawal by Subject|10
5915709|NCT01547299|20466397|P2|Overall Study|Withdrawal by Subject|2
5915710|NCT01547299|20466398|P1|Overall Study|Withdrawal by Subject|2
5915711|NCT01547286|20466464|P1|Overall Study|Physician Decision|1
5915712|NCT01547286|20466464|P1|Overall Study|Did not meet all eligibility criteria|1
5915713|NCT01547130|20466484|P2|Overall Study|Lost to Follow-up|5
5915714|NCT01547130|20466485|P1|Overall Study|Lost to Follow-up|9
5915715|NCT01546922|20466508|P2|Second Period of 10 Weeks|Withdrawal by Subject|2
5915716|NCT01546922|20466509|P1|Second Period of 10 Weeks|Withdrawal by Subject|0
5915717|NCT01546922|20466508|P2|Second Period of 10 Weeks|Protocol Violation|1
5915718|NCT01546922|20466509|P1|Second Period of 10 Weeks|Protocol Violation|3
5915719|NCT01546922|20466508|P2|First Period of 10 Weeks|Investigator's judgment|0
5915720|NCT01546922|20466509|P1|First Period of 10 Weeks|Investigator's judgment|1
5915721|NCT01546922|20466508|P2|First Period of 10 Weeks|Withdrawal by Subject|1
5915722|NCT01546922|20466509|P1|First Period of 10 Weeks|Withdrawal by Subject|1
5915723|NCT01546922|20466508|P2|First Period of 10 Weeks|Protocol Violation|1
5915724|NCT01546922|20466509|P1|First Period of 10 Weeks|Protocol Violation|3
5915725|NCT01546883|20466515|P1|Overall Study|other unrelated illness|1
5915726|NCT01546883|20466515|P1|Overall Study|early closure of study|2
5915727|NCT01546883|20466515|P1|Overall Study|Lost to Follow-up|2
5915728|NCT01546883|20466515|P1|Overall Study|Adverse Event|4
5915729|NCT01546883|20466515|P1|Overall Study|Withdrawal by Subject|3
5915730|NCT01546857|20466521|P2|Overall Study|Withdrawal by Subject|3
5915731|NCT01546857|20466522|P1|Overall Study|Withdrawal by Subject|2
5915732|NCT01546688|20466536|P2|Overall Study|Lack of Efficacy|0
5915733|NCT01546688|20466537|P1|Overall Study|Lack of Efficacy|1
5915734|NCT01546688|20466536|P2|Overall Study|Withdrawal by Subject|1
5915735|NCT01546688|20466537|P1|Overall Study|Withdrawal by Subject|2
5915736|NCT01546688|20466536|P2|Overall Study|Adverse Event|4
5915737|NCT01546688|20466537|P1|Overall Study|Adverse Event|0
5915738|NCT01546649|20466569|P2|Overall Study|Withdrawal by Subject|2
5915739|NCT01546649|20466570|P1|Overall Study|Withdrawal by Subject|1
5915740|NCT01546649|20466569|P2|Overall Study|Discovery of secondary cancer|1
5915741|NCT01546649|20466570|P1|Overall Study|Discovery of secondary cancer|0
5915742|NCT01546649|20466569|P2|Overall Study|Recurrence|1
5915743|NCT01546649|20466570|P1|Overall Study|Recurrence|1
5915744|NCT01546649|20466569|P2|Overall Study|Lack of Efficacy|0
5915745|NCT01546649|20466570|P1|Overall Study|Lack of Efficacy|1
5915746|NCT01546649|20466569|P2|Overall Study|Protocol Violation|0
5915747|NCT01546649|20466570|P1|Overall Study|Protocol Violation|1
5915748|NCT01546649|20466569|P2|Overall Study|Adverse Event|5
5915749|NCT01546649|20466570|P1|Overall Study|Adverse Event|4
5915750|NCT01546623|20466605|P2|Overall Study|Did Not Receive Study Drug|1
5915751|NCT01546623|20466606|P1|Overall Study|Did Not Receive Study Drug|1
5915752|NCT01546623|20466605|P2|Overall Study|High Prostate specific antigen|1
5915753|NCT01546623|20466606|P1|Overall Study|High Prostate specific antigen|2
5915754|NCT01546623|20466605|P2|Overall Study|Major Protocol Deviation|1
5915755|NCT01546623|20466606|P1|Overall Study|Major Protocol Deviation|1
5915756|NCT01546623|20466605|P2|Overall Study|Adverse Event|3
5915757|NCT01546623|20466606|P1|Overall Study|Adverse Event|2
5915758|NCT01546519|20466636|P4|Overall Study|Withdrawal by Subject|0
5915759|NCT01546519|20466637|P3|Overall Study|Withdrawal by Subject|0
5915760|NCT01546519|20466638|P2|Overall Study|Withdrawal by Subject|0
5915761|NCT01546519|20466639|P1|Overall Study|Withdrawal by Subject|1
5915762|NCT01546519|20466636|P4|Overall Study|Physician Decision|3
5915763|NCT01546519|20466637|P3|Overall Study|Physician Decision|2
5915764|NCT01546519|20466638|P2|Overall Study|Physician Decision|5
5915765|NCT01546519|20466639|P1|Overall Study|Physician Decision|6
5915766|NCT01546519|20466636|P4|Overall Study|related to disease progression|1
5915767|NCT01546519|20466637|P3|Overall Study|related to disease progression|2
5915768|NCT01546519|20466638|P2|Overall Study|related to disease progression|2
5915769|NCT01546519|20466639|P1|Overall Study|related to disease progression|2
5915770|NCT01546519|20466636|P4|Overall Study|Death|1
5915771|NCT01546519|20466637|P3|Overall Study|Death|3
5915772|NCT01546519|20466638|P2|Overall Study|Death|1
5915773|NCT01546519|20466639|P1|Overall Study|Death|0
5915774|NCT01546519|20466636|P4|Overall Study|Adverse Event|1
5915775|NCT01546519|20466637|P3|Overall Study|Adverse Event|1
5915776|NCT01546519|20466638|P2|Overall Study|Adverse Event|0
5915777|NCT01546519|20466639|P1|Overall Study|Adverse Event|0
5915778|NCT01546207|20466704|P1|Overall Study|Death|1
5915779|NCT01546168|20466719|P2|Overall Study|ineligible after signing consent|0
5915780|NCT01546168|20466720|P1|Overall Study|ineligible after signing consent|2
5915781|NCT01546168|20466719|P2|Overall Study|Withdrawal by Subject|0
5915782|NCT01546168|20466720|P1|Overall Study|Withdrawal by Subject|1
5915783|NCT01546168|20466719|P2|Overall Study|Lost to Follow-up|0
5915784|NCT01546168|20466720|P1|Overall Study|Lost to Follow-up|1
5915785|NCT01546155|20466732|P1|Overall Study|could not tolerate long scan duration|3
5915786|NCT01546142|20466738|P2|Overall Study|Subject Randomized but Not Treated|0
5915787|NCT01546142|20466739|P1|Overall Study|Subject Randomized but Not Treated|1
5915788|NCT01546142|20466738|P2|Overall Study|Consent Withdrawn (Subject Discomfort)|0
5915789|NCT01546142|20466739|P1|Overall Study|Consent Withdrawn (Subject Discomfort)|1
5915790|NCT01546142|20466738|P2|Overall Study|Lost to Follow-up|15
5915791|NCT01546142|20466739|P1|Overall Study|Lost to Follow-up|20
5915792|NCT01546142|20466738|P2|Overall Study|Adverse Event|3
5915793|NCT01546142|20466739|P1|Overall Study|Adverse Event|6
5915794|NCT01546142|20466738|P2|Overall Study|Subject Noncompliance|1
5915795|NCT01546142|20466739|P1|Overall Study|Subject Noncompliance|1
5915796|NCT01546142|20466738|P2|Overall Study|Consent Withdrawn (Subject Convenience)|15
5915797|NCT01546142|20466739|P1|Overall Study|Consent Withdrawn (Subject Convenience)|15
5915798|NCT01546038|20466757|P9|Overall Study|: Randomized, not treated|3
5915799|NCT01546038|20466758|P8|Overall Study|: Randomized, not treated|4
5915800|NCT01546038|20466759|P7|Overall Study|: Randomized, not treated|2
5915801|NCT01546038|20466760|P6|Overall Study|: Randomized, not treated|0
5915802|NCT01546038|20466761|P5|Overall Study|: Randomized, not treated|0
5915803|NCT01546038|20466762|P4|Overall Study|: Randomized, not treated|0
5915804|NCT01546038|20466763|P3|Overall Study|: Randomized, not treated|0
5915805|NCT01546038|20466764|P2|Overall Study|: Randomized, not treated|0
5915806|NCT01546038|20466765|P1|Overall Study|: Randomized, not treated|0
5915807|NCT01546038|20466757|P9|Overall Study|Withdrawal by Subject|1
5915808|NCT01546038|20466758|P8|Overall Study|Withdrawal by Subject|3
5915809|NCT01546038|20466759|P7|Overall Study|Withdrawal by Subject|3
5915810|NCT01546038|20466760|P6|Overall Study|Withdrawal by Subject|1
5915811|NCT01546038|20466761|P5|Overall Study|Withdrawal by Subject|0
5915812|NCT01546038|20466762|P4|Overall Study|Withdrawal by Subject|1
5915813|NCT01546038|20466763|P3|Overall Study|Withdrawal by Subject|0
5915814|NCT01546038|20466764|P2|Overall Study|Withdrawal by Subject|0
5915815|NCT01546038|20466765|P1|Overall Study|Withdrawal by Subject|1
5915816|NCT01546038|20466757|P9|Overall Study|Lost to Follow-up|0
5915817|NCT01546038|20466758|P8|Overall Study|Lost to Follow-up|1
5915818|NCT01546038|20466759|P7|Overall Study|Lost to Follow-up|2
5915819|NCT01546038|20466760|P6|Overall Study|Lost to Follow-up|0
5915820|NCT01546038|20466761|P5|Overall Study|Lost to Follow-up|1
5915821|NCT01546038|20466762|P4|Overall Study|Lost to Follow-up|0
5915822|NCT01546038|20466763|P3|Overall Study|Lost to Follow-up|0
5915823|NCT01546038|20466764|P2|Overall Study|Lost to Follow-up|0
5915824|NCT01546038|20466765|P1|Overall Study|Lost to Follow-up|0
5915825|NCT01546038|20466757|P9|Overall Study|Death|39
5915826|NCT01546038|20466758|P8|Overall Study|Death|76
5915827|NCT01546038|20466759|P7|Overall Study|Death|46
5915828|NCT01546038|20466760|P6|Overall Study|Death|3
5915829|NCT01546038|20466761|P5|Overall Study|Death|9
5915830|NCT01546038|20466762|P4|Overall Study|Death|2
5915831|NCT01546038|20466763|P3|Overall Study|Death|4
5915832|NCT01546038|20466764|P2|Overall Study|Death|6
5915833|NCT01546038|20466765|P1|Overall Study|Death|15
5915834|NCT01545817|20466959|P2|Everolimus|Adverse Event|6
5915835|NCT01545817|20466960|P1|Everolimus|Adverse Event|0
5915836|NCT01545817|20466959|P2|Everolimus|Disease progression|25
5915837|NCT01545817|20466960|P1|Everolimus|Disease progression|0
5915838|NCT01545817|20466959|P2|Everolimus|Other reason|7
5915839|NCT01545817|20466960|P1|Everolimus|Other reason|0
5915840|NCT01545817|20466959|P2|Pazopanib|Other reason|0
5915841|NCT01545817|20466960|P1|Pazopanib|Other reason|4
5915842|NCT01545817|20466959|P2|Pazopanib|Adverse Event|0
5915843|NCT01545817|20466960|P1|Pazopanib|Adverse Event|19
5915844|NCT01545817|20466959|P2|Pazopanib|Disease progression|0
5915845|NCT01545817|20466960|P1|Pazopanib|Disease progression|51
5915846|NCT01545388|20467109|P3|Overall Study|Other|0
5915847|NCT01545388|20467110|P2|Overall Study|Other|1
5915848|NCT01545388|20467111|P1|Overall Study|Other|1
5915849|NCT01545388|20467109|P3|Overall Study|Withdrawal by Subject|2
5915850|NCT01545388|20467110|P2|Overall Study|Withdrawal by Subject|4
5915851|NCT01545388|20467111|P1|Overall Study|Withdrawal by Subject|1
5915852|NCT01545388|20467109|P3|Overall Study|Participant moved or relocated|0
5915853|NCT01545388|20467110|P2|Overall Study|Participant moved or relocated|0
5915854|NCT01545388|20467111|P1|Overall Study|Participant moved or relocated|1
5915855|NCT01545388|20467109|P3|Overall Study|Lack of Efficacy|5
5915856|NCT01545388|20467110|P2|Overall Study|Lack of Efficacy|2
5915857|NCT01545388|20467111|P1|Overall Study|Lack of Efficacy|3
5915858|NCT01545388|20467109|P3|Overall Study|Adverse Event|1
5915859|NCT01545388|20467110|P2|Overall Study|Adverse Event|4
5915860|NCT01545388|20467111|P1|Overall Study|Adverse Event|2
5915861|NCT01545375|20467130|P2|Overall Study|Withdrawal by Subject|55
5915862|NCT01545375|20467131|P1|Overall Study|Withdrawal by Subject|58
5915863|NCT01545375|20467130|P2|Overall Study|Protocol Violation|3
5915864|NCT01545375|20467131|P1|Overall Study|Protocol Violation|3
5915865|NCT01545375|20467130|P2|Overall Study|Lost to Follow-up|31
5915866|NCT01545375|20467131|P1|Overall Study|Lost to Follow-up|34
5915867|NCT01545375|20467130|P2|Overall Study|Adverse Event|1
5915868|NCT01545375|20467131|P1|Overall Study|Adverse Event|2
5915869|NCT01545076|20467263|P5|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0
5915870|NCT01545076|20467264|P4|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|3
5915871|NCT01545076|20467265|P3|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|2
5915872|NCT01545076|20467266|P2|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|8
5915873|NCT01545076|20467267|P1|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0
5915874|NCT01545076|20467263|P5|IgPro20 Subcutaneous Treatment Period|Adverse Event|0
5915875|NCT01545076|20467264|P4|IgPro20 Subcutaneous Treatment Period|Adverse Event|0
5915876|NCT01545076|20467265|P3|IgPro20 Subcutaneous Treatment Period|Adverse Event|1
5915877|NCT01545076|20467266|P2|IgPro20 Subcutaneous Treatment Period|Adverse Event|1
5915878|NCT01545076|20467267|P1|IgPro20 Subcutaneous Treatment Period|Adverse Event|0
5915879|NCT01545076|20467263|P5|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0
5915880|NCT01545076|20467264|P4|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|32
5915881|NCT01545076|20467265|P3|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|18
5915882|NCT01545076|20467266|P2|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|10
5915883|NCT01545076|20467267|P1|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0
5915884|NCT01545076|20467263|P5|IgPro20 Subcutaneous Treatment Period|Physician Decision|0
5915885|NCT01545076|20467264|P4|IgPro20 Subcutaneous Treatment Period|Physician Decision|1
5915886|NCT01545076|20467265|P3|IgPro20 Subcutaneous Treatment Period|Physician Decision|0
5915887|NCT01545076|20467266|P2|IgPro20 Subcutaneous Treatment Period|Physician Decision|0
5915888|NCT01545076|20467267|P1|IgPro20 Subcutaneous Treatment Period|Physician Decision|0
5915889|NCT01545076|20467263|P5|IgPro10 Restabilization Period|Withdrawal by Subject|0
5915890|NCT01545076|20467264|P4|IgPro10 Restabilization Period|Withdrawal by Subject|0
5915891|NCT01545076|20467265|P3|IgPro10 Restabilization Period|Withdrawal by Subject|0
5915892|NCT01545076|20467266|P2|IgPro10 Restabilization Period|Withdrawal by Subject|0
5915893|NCT01545076|20467267|P1|IgPro10 Restabilization Period|Withdrawal by Subject|7
5915894|NCT01545076|20467263|P5|IgPro10 Restabilization Period|Failure to meet randomization criteria|0
5915895|NCT01545076|20467264|P4|IgPro10 Restabilization Period|Failure to meet randomization criteria|0
5915896|NCT01545076|20467265|P3|IgPro10 Restabilization Period|Failure to meet randomization criteria|0
5915897|NCT01545076|20467266|P2|IgPro10 Restabilization Period|Failure to meet randomization criteria|0
5915898|NCT01545076|20467267|P1|IgPro10 Restabilization Period|Failure to meet randomization criteria|22
5915899|NCT01545076|20467263|P5|IgPro10 Restabilization Period|Protocol Violation|0
5915900|NCT01545076|20467264|P4|IgPro10 Restabilization Period|Protocol Violation|0
5915901|NCT01545076|20467265|P3|IgPro10 Restabilization Period|Protocol Violation|0
5915902|NCT01545076|20467266|P2|IgPro10 Restabilization Period|Protocol Violation|0
5915903|NCT01545076|20467267|P1|IgPro10 Restabilization Period|Protocol Violation|1
5915904|NCT01545076|20467263|P5|IgPro10 Restabilization Period|Physician Decision|0
5915905|NCT01545076|20467264|P4|IgPro10 Restabilization Period|Physician Decision|0
5915906|NCT01545076|20467265|P3|IgPro10 Restabilization Period|Physician Decision|0
5915907|NCT01545076|20467266|P2|IgPro10 Restabilization Period|Physician Decision|0
5915908|NCT01545076|20467267|P1|IgPro10 Restabilization Period|Physician Decision|2
5915909|NCT01545076|20467263|P5|IgPro10 Restabilization Period|Adverse Event|0
5915910|NCT01545076|20467264|P4|IgPro10 Restabilization Period|Adverse Event|0
5915911|NCT01545076|20467265|P3|IgPro10 Restabilization Period|Adverse Event|0
5915912|NCT01545076|20467266|P2|IgPro10 Restabilization Period|Adverse Event|0
5915913|NCT01545076|20467267|P1|IgPro10 Restabilization Period|Adverse Event|4
5915914|NCT01544920|20467338|P2|Overall Study|Withdrawal by Subject|4
5915915|NCT01544920|20467339|P1|Overall Study|Withdrawal by Subject|4
5915916|NCT01544920|20467338|P2|Overall Study|Physician Decision|1
5915917|NCT01544920|20467339|P1|Overall Study|Physician Decision|4
5915918|NCT01544920|20467338|P2|Overall Study|Protocol Violation|2
5915919|NCT01544920|20467339|P1|Overall Study|Protocol Violation|0
5915920|NCT01544920|20467338|P2|Overall Study|Lost to Follow-up|12
5915921|NCT01544920|20467339|P1|Overall Study|Lost to Follow-up|11
5915922|NCT01544920|20467338|P2|Overall Study|Death|1
5915923|NCT01544920|20467339|P1|Overall Study|Death|0
5915924|NCT01544920|20467338|P2|Overall Study|Adverse Event|3
5915925|NCT01544920|20467339|P1|Overall Study|Adverse Event|0
5915926|NCT01544595|20467353|P6|Status at Week 156|Lack of Efficacy|5
5915927|NCT01544595|20467354|P5|Status at Week 156|Lack of Efficacy|10
5915928|NCT01544595|20467355|P4|Status at Week 156|Lack of Efficacy|4
5915929|NCT01544595|20467356|P3|Status at Week 156|Lack of Efficacy|1
5915930|NCT01544595|20467357|P2|Status at Week 156|Lack of Efficacy|0
5915931|NCT01544595|20467358|P1|Status at Week 156|Lack of Efficacy|1
5915932|NCT01544595|20467353|P6|Status at Week 156|Moved to treatment period ≤ wk 156|0
5915933|NCT01544595|20467354|P5|Status at Week 156|Moved to treatment period ≤ wk 156|0
5915934|NCT01544595|20467355|P4|Status at Week 156|Moved to treatment period ≤ wk 156|145
5915935|NCT01544595|20467356|P3|Status at Week 156|Moved to treatment period ≤ wk 156|131
5915936|NCT01544595|20467357|P2|Status at Week 156|Moved to treatment period ≤ wk 156|44
5915937|NCT01544595|20467358|P1|Status at Week 156|Moved to treatment period ≤ wk 156|86
5915938|NCT01544595|20467353|P6|Status at Week 156|Technical problems|0
5915939|NCT01544595|20467354|P5|Status at Week 156|Technical problems|0
5915940|NCT01544595|20467355|P4|Status at Week 156|Technical problems|1
5915941|NCT01544595|20467356|P3|Status at Week 156|Technical problems|0
5915942|NCT01544595|20467357|P2|Status at Week 156|Technical problems|1
5915943|NCT01544595|20467358|P1|Status at Week 156|Technical problems|3
5915944|NCT01544595|20467353|P6|Status at Week 156|Protocol Violation|0
5915945|NCT01544595|20467354|P5|Status at Week 156|Protocol Violation|0
5915946|NCT01544595|20467355|P4|Status at Week 156|Protocol Violation|2
5915947|NCT01544595|20467356|P3|Status at Week 156|Protocol Violation|2
5915948|NCT01544595|20467357|P2|Status at Week 156|Protocol Violation|1
5915949|NCT01544595|20467358|P1|Status at Week 156|Protocol Violation|3
5915950|NCT01544595|20467353|P6|Status at Week 156|Pregnancy|0
5915951|NCT01544595|20467354|P5|Status at Week 156|Pregnancy|0
5915952|NCT01544595|20467355|P4|Status at Week 156|Pregnancy|0
5915953|NCT01544595|20467356|P3|Status at Week 156|Pregnancy|0
5915954|NCT01544595|20467357|P2|Status at Week 156|Pregnancy|3
5915955|NCT01544595|20467358|P1|Status at Week 156|Pregnancy|2
5915956|NCT01544595|20467353|P6|Status at Week 156|Physician Decision|0
5915957|NCT01544595|20467354|P5|Status at Week 156|Physician Decision|0
5915958|NCT01544595|20467355|P4|Status at Week 156|Physician Decision|0
5915959|NCT01544595|20467356|P3|Status at Week 156|Physician Decision|1
5915960|NCT01544595|20467357|P2|Status at Week 156|Physician Decision|3
5915961|NCT01544595|20467358|P1|Status at Week 156|Physician Decision|0
5915962|NCT01544595|20467353|P6|Status at Week 156|Non-compliance with study treatement|1
5915963|NCT01544595|20467354|P5|Status at Week 156|Non-compliance with study treatement|0
5915964|NCT01544595|20467355|P4|Status at Week 156|Non-compliance with study treatement|1
5915965|NCT01544595|20467356|P3|Status at Week 156|Non-compliance with study treatement|0
5915966|NCT01544595|20467357|P2|Status at Week 156|Non-compliance with study treatement|1
5915967|NCT01544595|20467358|P1|Status at Week 156|Non-compliance with study treatement|0
5915968|NCT01544595|20467353|P6|Status at Week 156|Lost to Follow-up|1
5915969|NCT01544595|20467354|P5|Status at Week 156|Lost to Follow-up|4
5915970|NCT01544595|20467355|P4|Status at Week 156|Lost to Follow-up|1
5915971|NCT01544595|20467356|P3|Status at Week 156|Lost to Follow-up|0
5915972|NCT01544595|20467357|P2|Status at Week 156|Lost to Follow-up|4
5915973|NCT01544595|20467358|P1|Status at Week 156|Lost to Follow-up|4
5915974|NCT01544595|20467353|P6|Status at Week 156|Adverse Event|2
5915975|NCT01544595|20467354|P5|Status at Week 156|Adverse Event|4
5915976|NCT01544595|20467355|P4|Status at Week 156|Adverse Event|3
5915977|NCT01544595|20467356|P3|Status at Week 156|Adverse Event|1
5915978|NCT01544595|20467357|P2|Status at Week 156|Adverse Event|11
5915979|NCT01544595|20467358|P1|Status at Week 156|Adverse Event|9
5915980|NCT01544595|20467353|P6|Status at Week 156|Withdrawal by Subject|6
5915981|NCT01544595|20467354|P5|Status at Week 156|Withdrawal by Subject|20
5915982|NCT01544595|20467355|P4|Status at Week 156|Withdrawal by Subject|9
5915983|NCT01544595|20467356|P3|Status at Week 156|Withdrawal by Subject|4
5915984|NCT01544595|20467357|P2|Status at Week 156|Withdrawal by Subject|10
5915985|NCT01544595|20467358|P1|Status at Week 156|Withdrawal by Subject|9
5915986|NCT01544595|20467353|P6|Status at Week 68|Moved to treatment period ≤ wk 68|0
5915987|NCT01544595|20467354|P5|Status at Week 68|Moved to treatment period ≤ wk 68|0
5915988|NCT01544595|20467355|P4|Status at Week 68|Moved to treatment period ≤ wk 68|46
5915989|NCT01544595|20467356|P3|Status at Week 68|Moved to treatment period ≤ wk 68|60
5915990|NCT01544595|20467357|P2|Status at Week 68|Moved to treatment period ≤ wk 68|13
5915991|NCT01544595|20467358|P1|Status at Week 68|Moved to treatment period ≤ wk 68|30
5915992|NCT01544595|20467353|P6|Status at Week 68|Withdrawal by Subject|0
5915993|NCT01544595|20467354|P5|Status at Week 68|Withdrawal by Subject|0
5915994|NCT01544595|20467355|P4|Status at Week 68|Withdrawal by Subject|2
5915995|NCT01544595|20467356|P3|Status at Week 68|Withdrawal by Subject|1
5915996|NCT01544595|20467357|P2|Status at Week 68|Withdrawal by Subject|1
5915997|NCT01544595|20467358|P1|Status at Week 68|Withdrawal by Subject|0
5915998|NCT01544595|20467353|P6|Status at Week 68|Technical problems|0
5915999|NCT01544595|20467354|P5|Status at Week 68|Technical problems|0
5916000|NCT01544595|20467355|P4|Status at Week 68|Technical problems|1
5916001|NCT01544595|20467356|P3|Status at Week 68|Technical problems|0
5916002|NCT01544595|20467357|P2|Status at Week 68|Technical problems|0
5916003|NCT01544595|20467358|P1|Status at Week 68|Technical problems|1
5916004|NCT01544595|20467353|P6|Status at Week 68|Protocol Violation|0
5916005|NCT01544595|20467354|P5|Status at Week 68|Protocol Violation|0
5916006|NCT01544595|20467355|P4|Status at Week 68|Protocol Violation|1
5916007|NCT01544595|20467356|P3|Status at Week 68|Protocol Violation|1
5916008|NCT01544595|20467357|P2|Status at Week 68|Protocol Violation|0
5916009|NCT01544595|20467358|P1|Status at Week 68|Protocol Violation|2
5916010|NCT01544595|20467353|P6|Status at Week 68|Non-compliance with study treatment|0
5916011|NCT01544595|20467354|P5|Status at Week 68|Non-compliance with study treatment|0
5916012|NCT01544595|20467355|P4|Status at Week 68|Non-compliance with study treatment|1
5916013|NCT01544595|20467356|P3|Status at Week 68|Non-compliance with study treatment|0
5916014|NCT01544595|20467357|P2|Status at Week 68|Non-compliance with study treatment|0
5916015|NCT01544595|20467358|P1|Status at Week 68|Non-compliance with study treatment|1
5916016|NCT01544595|20467353|P6|Status at Week 68|Lost to Follow-up|0
5916017|NCT01544595|20467354|P5|Status at Week 68|Lost to Follow-up|0
5916018|NCT01544595|20467355|P4|Status at Week 68|Lost to Follow-up|0
5916019|NCT01544595|20467356|P3|Status at Week 68|Lost to Follow-up|0
5916020|NCT01544595|20467357|P2|Status at Week 68|Lost to Follow-up|1
5916021|NCT01544595|20467358|P1|Status at Week 68|Lost to Follow-up|1
5916022|NCT01544595|20467353|P6|Status at Week 68|Lack of Efficacy|0
5916023|NCT01544595|20467354|P5|Status at Week 68|Lack of Efficacy|0
5916024|NCT01544595|20467355|P4|Status at Week 68|Lack of Efficacy|0
5916025|NCT01544595|20467356|P3|Status at Week 68|Lack of Efficacy|0
5916026|NCT01544595|20467357|P2|Status at Week 68|Lack of Efficacy|0
5916027|NCT01544595|20467358|P1|Status at Week 68|Lack of Efficacy|1
5916028|NCT01544595|20467353|P6|Status at Week 68|Adverse Event|0
5916029|NCT01544595|20467354|P5|Status at Week 68|Adverse Event|0
5916030|NCT01544595|20467355|P4|Status at Week 68|Adverse Event|0
5916031|NCT01544595|20467356|P3|Status at Week 68|Adverse Event|1
5916032|NCT01544595|20467357|P2|Status at Week 68|Adverse Event|2
5916033|NCT01544595|20467358|P1|Status at Week 68|Adverse Event|3
5916034|NCT01544582|20467434|P4|Analysis Population|Participant in Jail|0
5916035|NCT01544582|20467435|P3|Analysis Population|Participant in Jail|1
5916036|NCT01544582|20467436|P2|Analysis Population|Participant in Jail|0
5916037|NCT01544582|20467437|P1|Analysis Population|Participant in Jail|0
5916038|NCT01544582|20467434|P4|Analysis Population|Programmed Surgery|0
5916039|NCT01544582|20467435|P3|Analysis Population|Programmed Surgery|0
5916040|NCT01544582|20467436|P2|Analysis Population|Programmed Surgery|1
5916041|NCT01544582|20467437|P1|Analysis Population|Programmed Surgery|0
5916042|NCT01544582|20467434|P4|Analysis Population|Poor Participant Compliance|0
5916043|NCT01544582|20467435|P3|Analysis Population|Poor Participant Compliance|0
5916044|NCT01544582|20467436|P2|Analysis Population|Poor Participant Compliance|1
5916045|NCT01544582|20467437|P1|Analysis Population|Poor Participant Compliance|0
5916046|NCT01544582|20467434|P4|Analysis Population|Poor Adherence|0
5916047|NCT01544582|20467435|P3|Analysis Population|Poor Adherence|1
5916048|NCT01544582|20467436|P2|Analysis Population|Poor Adherence|0
5916049|NCT01544582|20467437|P1|Analysis Population|Poor Adherence|0
5916050|NCT01544582|20467434|P4|Analysis Population|No Social Insurance|0
5916051|NCT01544582|20467435|P3|Analysis Population|No Social Insurance|1
5916052|NCT01544582|20467436|P2|Analysis Population|No Social Insurance|0
5916053|NCT01544582|20467437|P1|Analysis Population|No Social Insurance|0
5916054|NCT01544582|20467434|P4|Analysis Population|Liver Transplantation|0
5916055|NCT01544582|20467435|P3|Analysis Population|Liver Transplantation|1
5916056|NCT01544582|20467436|P2|Analysis Population|Liver Transplantation|0
5916057|NCT01544582|20467437|P1|Analysis Population|Liver Transplantation|0
5916058|NCT01544582|20467434|P4|Analysis Population|Intolerance|0
5916059|NCT01544582|20467435|P3|Analysis Population|Intolerance|0
5916060|NCT01544582|20467436|P2|Analysis Population|Intolerance|1
5916061|NCT01544582|20467437|P1|Analysis Population|Intolerance|0
5916062|NCT01544582|20467434|P4|Analysis Population|Did Not Meet Inclusion Criteria|0
5916063|NCT01544582|20467435|P3|Analysis Population|Did Not Meet Inclusion Criteria|3
5916064|NCT01544582|20467436|P2|Analysis Population|Did Not Meet Inclusion Criteria|0
5916065|NCT01544582|20467437|P1|Analysis Population|Did Not Meet Inclusion Criteria|0
5916066|NCT01544582|20467434|P4|Analysis Population|Bad Tolerance to Treatment|0
5916067|NCT01544582|20467435|P3|Analysis Population|Bad Tolerance to Treatment|2
5916068|NCT01544582|20467436|P2|Analysis Population|Bad Tolerance to Treatment|0
5916069|NCT01544582|20467437|P1|Analysis Population|Bad Tolerance to Treatment|0
5916070|NCT01544582|20467434|P4|Analysis Population|Lost to Follow-up|5
5916071|NCT01544582|20467435|P3|Analysis Population|Lost to Follow-up|6
5916072|NCT01544582|20467436|P2|Analysis Population|Lost to Follow-up|6
5916073|NCT01544582|20467437|P1|Analysis Population|Lost to Follow-up|0
5916074|NCT01544582|20467434|P4|Analysis Population|New Contraindication-Alcohol Abuse|1
5916075|NCT01544582|20467435|P3|Analysis Population|New Contraindication-Alcohol Abuse|0
5916076|NCT01544582|20467436|P2|Analysis Population|New Contraindication-Alcohol Abuse|0
5916077|NCT01544582|20467437|P1|Analysis Population|New Contraindication-Alcohol Abuse|0
5916078|NCT01544582|20467434|P4|Analysis Population|Effectiveness Reason|12
5916079|NCT01544582|20467435|P3|Analysis Population|Effectiveness Reason|29
5916080|NCT01544582|20467436|P2|Analysis Population|Effectiveness Reason|48
5916081|NCT01544582|20467437|P1|Analysis Population|Effectiveness Reason|0
5916082|NCT01544582|20467434|P4|Analysis Population|Safety Reason|8
5916083|NCT01544582|20467435|P3|Analysis Population|Safety Reason|31
5916084|NCT01544582|20467436|P2|Analysis Population|Safety Reason|33
5916085|NCT01544582|20467437|P1|Analysis Population|Safety Reason|0
5916086|NCT01544582|20467434|P4|Analysis Population|Physician Decision|9
5916087|NCT01544582|20467435|P3|Analysis Population|Physician Decision|10
5916088|NCT01544582|20467436|P2|Analysis Population|Physician Decision|13
5916089|NCT01544582|20467437|P1|Analysis Population|Physician Decision|0
5916090|NCT01544582|20467434|P4|Analysis Population|Participant Refuses to Continue Study|4
5916091|NCT01544582|20467435|P3|Analysis Population|Participant Refuses to Continue Study|17
5916092|NCT01544582|20467436|P2|Analysis Population|Participant Refuses to Continue Study|15
5916093|NCT01544582|20467437|P1|Analysis Population|Participant Refuses to Continue Study|0
5916094|NCT01544582|20467434|P4|Screening/Eligibility|Eligibility Criteria Not Met|0
5916095|NCT01544582|20467435|P3|Screening/Eligibility|Eligibility Criteria Not Met|0
5916096|NCT01544582|20467436|P2|Screening/Eligibility|Eligibility Criteria Not Met|0
5916097|NCT01544582|20467437|P1|Screening/Eligibility|Eligibility Criteria Not Met|33
5916098|NCT01544582|20467434|P4|Screening/Eligibility|Initiated Different CHC Treatment|0
5916099|NCT01544582|20467435|P3|Screening/Eligibility|Initiated Different CHC Treatment|0
5916100|NCT01544582|20467436|P2|Screening/Eligibility|Initiated Different CHC Treatment|0
5916101|NCT01544582|20467437|P1|Screening/Eligibility|Initiated Different CHC Treatment|1
5916102|NCT01544491|20467497|P2|Overall Study|administrative problems|0
5916103|NCT01544491|20467498|P1|Overall Study|administrative problems|2
5916104|NCT01544491|20467497|P2|Overall Study|Lost to Follow-up|1
5916105|NCT01544491|20467498|P1|Overall Study|Lost to Follow-up|0
5916106|NCT01544491|20467497|P2|Overall Study|Withdrawal by Subject|2
5916107|NCT01544491|20467498|P1|Overall Study|Withdrawal by Subject|3
5916108|NCT01544478|20467524|P1|Overall Study|Withdrawal by Subject|52
5916109|NCT01544478|20467524|P1|Overall Study|Pregnancy|1
5916110|NCT01544478|20467524|P1|Overall Study|Physician Decision|15
5916111|NCT01544478|20467524|P1|Overall Study|Lost to Follow-up|48
5916112|NCT01544478|20467524|P1|Overall Study|Death|1
5916113|NCT01544478|20467524|P1|Overall Study|Adverse Event|1
5916114|NCT01544348|20467567|P8|Overall Study|Physician Decision|0
5916115|NCT01544348|20467568|P7|Overall Study|Physician Decision|0
5916116|NCT01544348|20467569|P6|Overall Study|Physician Decision|1
5916117|NCT01544348|20467570|P5|Overall Study|Physician Decision|0
5916118|NCT01544348|20467571|P4|Overall Study|Physician Decision|0
5916119|NCT01544348|20467572|P3|Overall Study|Physician Decision|0
5916120|NCT01544348|20467573|P2|Overall Study|Physician Decision|0
5916121|NCT01544348|20467574|P1|Overall Study|Physician Decision|0
5916122|NCT01544348|20467567|P8|Overall Study|Withdrawal by Subject|0
5916123|NCT01544348|20467568|P7|Overall Study|Withdrawal by Subject|1
5916124|NCT01544348|20467569|P6|Overall Study|Withdrawal by Subject|2
5916125|NCT01544348|20467570|P5|Overall Study|Withdrawal by Subject|1
5916126|NCT01544348|20467571|P4|Overall Study|Withdrawal by Subject|0
5916127|NCT01544348|20467572|P3|Overall Study|Withdrawal by Subject|0
5916128|NCT01544348|20467573|P2|Overall Study|Withdrawal by Subject|0
5916129|NCT01544348|20467574|P1|Overall Study|Withdrawal by Subject|1
5916130|NCT01544348|20467567|P8|Overall Study|Lost to Follow-up|0
5916131|NCT01544348|20467568|P7|Overall Study|Lost to Follow-up|1
5916132|NCT01544348|20467569|P6|Overall Study|Lost to Follow-up|0
5916133|NCT01544348|20467570|P5|Overall Study|Lost to Follow-up|0
5916134|NCT01544348|20467571|P4|Overall Study|Lost to Follow-up|0
5916135|NCT01544348|20467572|P3|Overall Study|Lost to Follow-up|0
5916136|NCT01544348|20467573|P2|Overall Study|Lost to Follow-up|0
5916137|NCT01544348|20467574|P1|Overall Study|Lost to Follow-up|1
5916138|NCT01544309|20467616|P2|Overall Study|Administered prohibit prior medication|0
5916139|NCT01544309|20467617|P1|Overall Study|Administered prohibit prior medication|1
5916140|NCT01544309|20467616|P2|Overall Study|Not performed pre-dose examination|2
5916141|NCT01544309|20467617|P1|Overall Study|Not performed pre-dose examination|1
5916142|NCT01544309|20467616|P2|Overall Study|Physician Decision|1
5916143|NCT01544309|20467617|P1|Overall Study|Physician Decision|4
5916144|NCT01544309|20467616|P2|Overall Study|Protocol Violation|1
5916145|NCT01544309|20467617|P1|Overall Study|Protocol Violation|2
5916146|NCT01544309|20467616|P2|Overall Study|Withdrawal by Subject|7
5916147|NCT01544309|20467617|P1|Overall Study|Withdrawal by Subject|12
5916148|NCT01544179|20467655|P2|Overall Study|Eligibility criteria not fulfilled|0
5916149|NCT01544179|20467656|P1|Overall Study|Eligibility criteria not fulfilled|1
5916150|NCT01544179|20467655|P2|Overall Study|Withdrawal by Subject|7
5916151|NCT01544179|20467656|P1|Overall Study|Withdrawal by Subject|12
5916152|NCT01544179|20467655|P2|Overall Study|Adverse Event|1
5916153|NCT01544179|20467656|P1|Overall Study|Adverse Event|0
5916154|NCT01544179|20467655|P2|Overall Study|Lost to Follow-up|1
5916155|NCT01544179|20467656|P1|Overall Study|Lost to Follow-up|0
5916156|NCT01544179|20467655|P2|Overall Study|Death|37
5916157|NCT01544179|20467656|P1|Overall Study|Death|50
5916158|NCT01544153|20467749|P4|Overall Study|Non-smoker|0
5916159|NCT01544153|20467750|P3|Overall Study|Non-smoker|1
5916160|NCT01544153|20467751|P2|Overall Study|Non-smoker|0
5916161|NCT01544153|20467752|P1|Overall Study|Non-smoker|0
5916162|NCT01544153|20467749|P4|Overall Study|Under 18|0
5916163|NCT01544153|20467750|P3|Overall Study|Under 18|0
5916164|NCT01544153|20467751|P2|Overall Study|Under 18|1
5916165|NCT01544153|20467752|P1|Overall Study|Under 18|0
5916166|NCT01544127|20467769|P3|Overall Study|Went active duty|1
5916167|NCT01544127|20467770|P2|Overall Study|Went active duty|0
5916168|NCT01544127|20467771|P1|Overall Study|Went active duty|0
5916169|NCT01544127|20467769|P3|Overall Study|Researcher withdrew|0
5916170|NCT01544127|20467770|P2|Overall Study|Researcher withdrew|0
5916171|NCT01544127|20467771|P1|Overall Study|Researcher withdrew|1
5916172|NCT01544127|20467769|P3|Overall Study|Became Psychotic|0
5916173|NCT01544127|20467770|P2|Overall Study|Became Psychotic|0
5916174|NCT01544127|20467771|P1|Overall Study|Became Psychotic|1
5916175|NCT01544127|20467769|P3|Overall Study|Jail or Prison|2
5916176|NCT01544127|20467770|P2|Overall Study|Jail or Prison|1
5916177|NCT01544127|20467771|P1|Overall Study|Jail or Prison|1
5916178|NCT01544127|20467769|P3|Overall Study|Death|0
5916179|NCT01544127|20467770|P2|Overall Study|Death|0
5916180|NCT01544127|20467771|P1|Overall Study|Death|1
5916181|NCT01544127|20467769|P3|Overall Study|Discharged out of catchment area|1
5916182|NCT01544127|20467770|P2|Overall Study|Discharged out of catchment area|1
5916183|NCT01544127|20467771|P1|Overall Study|Discharged out of catchment area|1
5916184|NCT01544127|20467769|P3|Overall Study|Withdrawal by Subject|1
5916185|NCT01544127|20467770|P2|Overall Study|Withdrawal by Subject|2
5916186|NCT01544127|20467771|P1|Overall Study|Withdrawal by Subject|2
5916187|NCT01544127|20467769|P3|Overall Study|Lost to Follow-up|9
5916188|NCT01544127|20467770|P2|Overall Study|Lost to Follow-up|2
5916189|NCT01544127|20467771|P1|Overall Study|Lost to Follow-up|4
5916190|NCT01544114|20467791|P3|Overall Study|Protocol Violation|0
5916191|NCT01544114|20467792|P2|Overall Study|Protocol Violation|1
5916192|NCT01544114|20467793|P1|Overall Study|Protocol Violation|0
5916193|NCT01544114|20467791|P3|Overall Study|Adverse Event|2
5916194|NCT01544114|20467792|P2|Overall Study|Adverse Event|1
5916195|NCT01544114|20467793|P1|Overall Study|Adverse Event|1
5916196|NCT01544114|20467791|P3|Overall Study|Lost to Follow-up|0
5916197|NCT01544114|20467792|P2|Overall Study|Lost to Follow-up|2
5916198|NCT01544114|20467793|P1|Overall Study|Lost to Follow-up|0
5916199|NCT01544114|20467791|P3|Overall Study|Withdrawal by Subject|3
5916200|NCT01544114|20467792|P2|Overall Study|Withdrawal by Subject|0
5916201|NCT01544114|20467793|P1|Overall Study|Withdrawal by Subject|0
5916202|NCT01543958|20467891|P1|Overall Study|ART initiation|1
5916203|NCT01543958|20467891|P1|Overall Study|Loss to follow-up|3
5916204|NCT01543828|20467946|P2|Treatment 2|Lost to Follow-up|0
5916205|NCT01543828|20467947|P1|Treatment 2|Lost to Follow-up|1
5916206|NCT01543776|20467957|P2|Overall Study|Withdrawal by Subject|2
5916207|NCT01543776|20467958|P1|Overall Study|Withdrawal by Subject|2
5916208|NCT01543685|20467977|P5|Overall Study|Adverse Event|2
5916209|NCT01543685|20467978|P4|Overall Study|Adverse Event|0
5916210|NCT01543685|20467979|P3|Overall Study|Adverse Event|0
5916211|NCT01543685|20467980|P2|Overall Study|Adverse Event|1
5916212|NCT01543685|20467981|P1|Overall Study|Adverse Event|2
5916213|NCT01543685|20467977|P5|Overall Study|Lack of Efficacy|2
5916214|NCT01543685|20467978|P4|Overall Study|Lack of Efficacy|0
5916215|NCT01543685|20467979|P3|Overall Study|Lack of Efficacy|2
5916216|NCT01543685|20467980|P2|Overall Study|Lack of Efficacy|2
5916217|NCT01543685|20467981|P1|Overall Study|Lack of Efficacy|1
5916218|NCT01543503|20468053|P2|Overall Study|Screen failure|0
5916219|NCT01543503|20468054|P1|Overall Study|Screen failure|1
5916220|NCT01543503|20468053|P2|Overall Study|Participant went to United States|0
5916221|NCT01543503|20468054|P1|Overall Study|Participant went to United States|1
5916222|NCT01543503|20468053|P2|Overall Study|Participant consented to another study|2
5916223|NCT01543503|20468054|P1|Overall Study|Participant consented to another study|0
5916224|NCT01543503|20468053|P2|Overall Study|Moved to other rheumatologic site|1
5916225|NCT01543503|20468054|P1|Overall Study|Moved to other rheumatologic site|0
5916226|NCT01543503|20468053|P2|Overall Study|Participant did not attend a visit|0
5916227|NCT01543503|20468054|P1|Overall Study|Participant did not attend a visit|1
5916228|NCT01543503|20468053|P2|Overall Study|Site stopped participation|1
5916229|NCT01543503|20468054|P1|Overall Study|Site stopped participation|5
5916230|NCT01543503|20468053|P2|Overall Study|Participant recruited after closing date|1
5916231|NCT01543503|20468054|P1|Overall Study|Participant recruited after closing date|0
5916232|NCT01543503|20468053|P2|Overall Study|Investigator did not wish to participate|1
5916233|NCT01543503|20468054|P1|Overall Study|Investigator did not wish to participate|1
5916234|NCT01543503|20468053|P2|Overall Study|Participant decision to stop treatment|0
5916235|NCT01543503|20468054|P1|Overall Study|Participant decision to stop treatment|1
5916236|NCT01543503|20468053|P2|Overall Study|Participant moved to Scotland|0
5916237|NCT01543503|20468054|P1|Overall Study|Participant moved to Scotland|1
5916317|NCT01542788|20468342|P2|Overall Study|Death|0
5916238|NCT01543503|20468053|P2|Overall Study|Participant transferred to another city|0
5916239|NCT01543503|20468054|P1|Overall Study|Participant transferred to another city|1
5916240|NCT01543503|20468053|P2|Overall Study|Participant will not return for visits|2
5916241|NCT01543503|20468054|P1|Overall Study|Participant will not return for visits|0
5916242|NCT01543503|20468053|P2|Overall Study|Participant moved to another city|0
5916243|NCT01543503|20468054|P1|Overall Study|Participant moved to another city|2
5916244|NCT01543503|20468053|P2|Overall Study|Incorrect medication received|0
5916245|NCT01543503|20468054|P1|Overall Study|Incorrect medication received|1
5916246|NCT01543503|20468053|P2|Overall Study|Refused to continue treatment|0
5916247|NCT01543503|20468054|P1|Overall Study|Refused to continue treatment|7
5916248|NCT01543503|20468053|P2|Overall Study|Participant did not complete last visit|2
5916249|NCT01543503|20468054|P1|Overall Study|Participant did not complete last visit|0
5916250|NCT01543503|20468053|P2|Overall Study|Probable overlap of RA with fibromyalgia|0
5916251|NCT01543503|20468054|P1|Overall Study|Probable overlap of RA with fibromyalgia|1
5916252|NCT01543503|20468053|P2|Overall Study|Intolerance to the biologic treatment|1
5916253|NCT01543503|20468054|P1|Overall Study|Intolerance to the biologic treatment|0
5916254|NCT01543503|20468053|P2|Overall Study|Change of jobs|1
5916255|NCT01543503|20468054|P1|Overall Study|Change of jobs|0
5916256|NCT01543503|20468053|P2|Overall Study|Participant withdrew informed consent|10
5916257|NCT01543503|20468054|P1|Overall Study|Participant withdrew informed consent|8
5916258|NCT01543503|20468053|P2|Overall Study|Lack of Efficacy|16
5916259|NCT01543503|20468054|P1|Overall Study|Lack of Efficacy|4
5916260|NCT01543503|20468053|P2|Overall Study|Adverse Event|13
5916261|NCT01543503|20468054|P1|Overall Study|Adverse Event|9
5916262|NCT01543503|20468053|P2|Overall Study|Lost to Follow-up|36
5916263|NCT01543503|20468054|P1|Overall Study|Lost to Follow-up|32
5916264|NCT01543204|20468098|P1|Overall Study|Lost to Follow-up|1
5916265|NCT01543204|20468098|P1|Overall Study|Requirement for Alternative Therapy|1
5916266|NCT01543204|20468098|P1|Overall Study|Withdrawal by Subject|4
5916267|NCT01543204|20468098|P1|Overall Study|Adverse Event|1
5916268|NCT01543204|20468098|P1|Overall Study|Non-compliance|1
5916269|NCT01543087|20468160|P6|Booster Stage (26 Months)|Lost to Follow-up|0
5916270|NCT01543087|20468161|P5|Booster Stage (26 Months)|Lost to Follow-up|0
5916271|NCT01543087|20468162|P4|Booster Stage (26 Months)|Lost to Follow-up|0
5916272|NCT01543087|20468163|P3|Booster Stage (26 Months)|Lost to Follow-up|1
5916273|NCT01543087|20468164|P2|Booster Stage (26 Months)|Lost to Follow-up|0
5916274|NCT01543087|20468165|P1|Booster Stage (26 Months)|Lost to Follow-up|0
5916275|NCT01543087|20468160|P6|Booster Stage (26 Months)|Withdrawal before booster vaccination|0
5916276|NCT01543087|20468161|P5|Booster Stage (26 Months)|Withdrawal before booster vaccination|2
5916277|NCT01543087|20468162|P4|Booster Stage (26 Months)|Withdrawal before booster vaccination|0
5916278|NCT01543087|20468163|P3|Booster Stage (26 Months)|Withdrawal before booster vaccination|0
5916279|NCT01543087|20468164|P2|Booster Stage (26 Months)|Withdrawal before booster vaccination|1
5916280|NCT01543087|20468165|P1|Booster Stage (26 Months)|Withdrawal before booster vaccination|0
5916281|NCT01543087|20468160|P6|Stage 1 (48 Months)|Protocol Violation|0
5916282|NCT01543087|20468161|P5|Stage 1 (48 Months)|Protocol Violation|0
5916283|NCT01543087|20468162|P4|Stage 1 (48 Months)|Protocol Violation|0
5916284|NCT01543087|20468163|P3|Stage 1 (48 Months)|Protocol Violation|0
5916285|NCT01543087|20468164|P2|Stage 1 (48 Months)|Protocol Violation|3
5916286|NCT01543087|20468165|P1|Stage 1 (48 Months)|Protocol Violation|0
5916287|NCT01543087|20468160|P6|Stage 1 (48 Months)|Other than specified|0
5916288|NCT01543087|20468161|P5|Stage 1 (48 Months)|Other than specified|0
5916289|NCT01543087|20468162|P4|Stage 1 (48 Months)|Other than specified|0
5916290|NCT01543087|20468163|P3|Stage 1 (48 Months)|Other than specified|9
5916291|NCT01543087|20468164|P2|Stage 1 (48 Months)|Other than specified|0
5916292|NCT01543087|20468165|P1|Stage 1 (48 Months)|Other than specified|5
5916293|NCT01543087|20468160|P6|Stage 1 (48 Months)|No longer willing to participate|0
5916294|NCT01543087|20468161|P5|Stage 1 (48 Months)|No longer willing to participate|3
5916295|NCT01543087|20468162|P4|Stage 1 (48 Months)|No longer willing to participate|6
5916296|NCT01543087|20468163|P3|Stage 1 (48 Months)|No longer willing to participate|18
5916297|NCT01543087|20468164|P2|Stage 1 (48 Months)|No longer willing to participate|3
5916298|NCT01543087|20468165|P1|Stage 1 (48 Months)|No longer willing to participate|5
5916299|NCT01543087|20468160|P6|Stage 1 (48 Months)|No longer met eligibility criteria|0
5916300|NCT01543087|20468161|P5|Stage 1 (48 Months)|No longer met eligibility criteria|0
5916301|NCT01543087|20468162|P4|Stage 1 (48 Months)|No longer met eligibility criteria|2
5916302|NCT01543087|20468163|P3|Stage 1 (48 Months)|No longer met eligibility criteria|1
5916303|NCT01543087|20468164|P2|Stage 1 (48 Months)|No longer met eligibility criteria|0
5916304|NCT01543087|20468165|P1|Stage 1 (48 Months)|No longer met eligibility criteria|1
5916305|NCT01543087|20468160|P6|Stage 1 (48 Months)|Lost to Follow-up|0
5916306|NCT01543087|20468161|P5|Stage 1 (48 Months)|Lost to Follow-up|0
5916307|NCT01543087|20468162|P4|Stage 1 (48 Months)|Lost to Follow-up|0
5916308|NCT01543087|20468163|P3|Stage 1 (48 Months)|Lost to Follow-up|12
5916309|NCT01543087|20468164|P2|Stage 1 (48 Months)|Lost to Follow-up|4
5916310|NCT01543087|20468165|P1|Stage 1 (48 Months)|Lost to Follow-up|3
5916311|NCT01542788|20468342|P2|Overall Study|Withdrawal by Subject|0
5916312|NCT01542788|20468343|P1|Overall Study|Withdrawal by Subject|1
5916313|NCT01542788|20468342|P2|Overall Study|Physician Decision|0
5916314|NCT01542788|20468343|P1|Overall Study|Physician Decision|1
5916315|NCT01542788|20468342|P2|Overall Study|Protocol Violation|0
5916316|NCT01542788|20468343|P1|Overall Study|Protocol Violation|2
5916318|NCT01542788|20468343|P1|Overall Study|Death|3
5916319|NCT01542788|20468342|P2|Overall Study|Lost to Follow-up|0
5916320|NCT01542788|20468343|P1|Overall Study|Lost to Follow-up|5
5916321|NCT01542788|20468342|P2|Overall Study|Lack of Efficacy|71
5916322|NCT01542788|20468343|P1|Overall Study|Lack of Efficacy|41
5916323|NCT01542788|20468342|P2|Overall Study|Randomized but Not Treated|0
5916324|NCT01542788|20468343|P1|Overall Study|Randomized but Not Treated|2
5916325|NCT01542632|20468390|P6|Overall Study|Sponsor/Investigator Decision|0
5916326|NCT01542632|20468391|P5|Overall Study|Sponsor/Investigator Decision|1
5916327|NCT01542632|20468392|P4|Overall Study|Sponsor/Investigator Decision|0
5916328|NCT01542632|20468393|P3|Overall Study|Sponsor/Investigator Decision|0
5916329|NCT01542632|20468394|P2|Overall Study|Sponsor/Investigator Decision|0
5916330|NCT01542632|20468395|P1|Overall Study|Sponsor/Investigator Decision|0
5916331|NCT01542632|20468390|P6|Overall Study|Lost to Follow-up|0
5916332|NCT01542632|20468391|P5|Overall Study|Lost to Follow-up|0
5916333|NCT01542632|20468392|P4|Overall Study|Lost to Follow-up|0
5916334|NCT01542632|20468393|P3|Overall Study|Lost to Follow-up|0
5916335|NCT01542632|20468394|P2|Overall Study|Lost to Follow-up|1
5916336|NCT01542632|20468395|P1|Overall Study|Lost to Follow-up|0
5916337|NCT01542632|20468390|P6|Overall Study|Adverse Event|0
5916338|NCT01542632|20468391|P5|Overall Study|Adverse Event|0
5916339|NCT01542632|20468392|P4|Overall Study|Adverse Event|0
5916340|NCT01542632|20468393|P3|Overall Study|Adverse Event|1
5916341|NCT01542632|20468394|P2|Overall Study|Adverse Event|0
5916342|NCT01542632|20468395|P1|Overall Study|Adverse Event|0
5916343|NCT01542632|20468390|P6|Overall Study|Withdrawal of Consent|0
5916344|NCT01542632|20468391|P5|Overall Study|Withdrawal of Consent|3
5916345|NCT01542632|20468392|P4|Overall Study|Withdrawal of Consent|2
5916346|NCT01542632|20468393|P3|Overall Study|Withdrawal of Consent|0
5916347|NCT01542632|20468394|P2|Overall Study|Withdrawal of Consent|0
5916348|NCT01542632|20468395|P1|Overall Study|Withdrawal of Consent|0
5916349|NCT01542528|20468452|P2|Overall Study|Withdrawal by Subject|6
5916350|NCT01542528|20468453|P1|Overall Study|Withdrawal by Subject|9
5916351|NCT01542528|20468452|P2|Overall Study|Physician Decision|0
5916352|NCT01542528|20468453|P1|Overall Study|Physician Decision|1
5916353|NCT01542528|20468452|P2|Overall Study|Lost to Follow-up|1
5916354|NCT01542528|20468453|P1|Overall Study|Lost to Follow-up|2
5916355|NCT01542034|20468561|P2|Overall Study|Lost to Follow-up|6
5916356|NCT01542034|20468562|P1|Overall Study|Lost to Follow-up|7
5916357|NCT01542034|20468561|P2|Overall Study|Adverse Event|2
5916358|NCT01542034|20468562|P1|Overall Study|Adverse Event|2
5916359|NCT01542034|20468561|P2|Overall Study|Subject Noncompliance|0
5916360|NCT01542034|20468562|P1|Overall Study|Subject Noncompliance|1
5916361|NCT01542034|20468561|P2|Overall Study|Administrative decision|3
5916362|NCT01542034|20468562|P1|Overall Study|Administrative decision|0
5916363|NCT01542034|20468561|P2|Overall Study|Consent Withdrawn (Subject Convenience)|12
5916364|NCT01542034|20468562|P1|Overall Study|Consent Withdrawn (Subject Convenience)|20
5916365|NCT01541969|20468576|P2|Open Label Extension (12-36 Weeks)|Adverse Event|3
5916366|NCT01541969|20468577|P1|Open Label Extension (12-36 Weeks)|Adverse Event|2
5916367|NCT01541969|20468576|P2|Open Label Extension (12-36 Weeks)|Lost to Follow-up|8
5916368|NCT01541969|20468577|P1|Open Label Extension (12-36 Weeks)|Lost to Follow-up|6
5916369|NCT01541969|20468576|P2|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1
5916370|NCT01541969|20468577|P1|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1
5916371|NCT01541969|20468576|P2|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|0
5916372|NCT01541969|20468577|P1|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|1
5916373|NCT01541969|20468576|P2|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1
5916374|NCT01541969|20468577|P1|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1
5916375|NCT01541969|20468576|P2|Double-blind (0-12 Weeks)|Adverse Event|0
5916376|NCT01541969|20468577|P1|Double-blind (0-12 Weeks)|Adverse Event|2
5916377|NCT01541969|20468576|P2|Double-blind (0-12 Weeks)|Lost to Follow-up|0
5916378|NCT01541969|20468577|P1|Double-blind (0-12 Weeks)|Lost to Follow-up|1
5916379|NCT01541969|20468576|P2|Double-blind (0-12 Weeks)|Withdrawal by Subject|0
5916380|NCT01541969|20468577|P1|Double-blind (0-12 Weeks)|Withdrawal by Subject|2
5916381|NCT01541969|20468576|P2|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1
5916382|NCT01541969|20468577|P1|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1
5916383|NCT01541969|20468576|P2|Double-blind (0-12 Weeks)|Dominant pitch match not possible|1
5916384|NCT01541969|20468577|P1|Double-blind (0-12 Weeks)|Dominant pitch match not possible|0
5916385|NCT01541930|20468593|P1|Overall Study|Withdrawal by Subject|1
5916386|NCT01541917|20468615|P2|Overall Study|Withdrawal by Subject|7
5916387|NCT01541917|20468616|P1|Overall Study|Withdrawal by Subject|13
5916388|NCT01541917|20468615|P2|Overall Study|Lost to Follow-up|2
5916389|NCT01541917|20468616|P1|Overall Study|Lost to Follow-up|2
5916390|NCT01541865|20468645|P1|Overall Study|Protocol Violation|1
5916391|NCT01541865|20468645|P1|Overall Study|Adverse Event|1
5916392|NCT01541865|20468645|P1|Overall Study|Withdrawal by Subject|9
5916393|NCT01541865|20468645|P1|Overall Study|Lost to Follow-up|11
5916394|NCT01541826|20468663|P3|Overall Study|Withdrawal by Subject|0
5916395|NCT01541826|20468664|P2|Overall Study|Withdrawal by Subject|0
5916396|NCT01541826|20468665|P1|Overall Study|Withdrawal by Subject|2
5916397|NCT01541826|20468663|P3|Overall Study|Lost to Follow-up|0
5916398|NCT01541826|20468664|P2|Overall Study|Lost to Follow-up|3
5916399|NCT01541826|20468665|P1|Overall Study|Lost to Follow-up|2
5916400|NCT01541748|20468732|P1|Overall Study|Did not receive study device|1
5916401|NCT01541748|20468732|P1|Overall Study|Screen failure|5
5916402|NCT01541748|20468732|P1|Overall Study|Withdrawal by Subject|7
5916403|NCT01541748|20468732|P1|Overall Study|Moved out of state|1
5916404|NCT01541748|20468732|P1|Overall Study|Lost to Follow-up|17
5916405|NCT01541644|20468768|P1|Overall Study|Withdrawal by Subject|3
5916406|NCT01541397|20468787|P2|Overall Study|Study ended prior to data collection|2
5916407|NCT01541397|20468788|P1|Overall Study|Study ended prior to data collection|4
5916408|NCT01541371|20468813|P1|Overall Study|Other|6
5916409|NCT01541371|20468813|P1|Overall Study|Study medication non-compliance|3
5916410|NCT01541371|20468813|P1|Overall Study|Protocol Violation|6
5916411|NCT01541371|20468813|P1|Overall Study|Lack of Efficacy|12
5916412|NCT01541371|20468813|P1|Overall Study|Adverse Event|15
5916413|NCT01541371|20468813|P1|Overall Study|Lost to Follow-up|21
5916414|NCT01541371|20468813|P1|Overall Study|Withdrawal by Subject|14
5916415|NCT01541254|20468842|P1|Overall Study|alternate stent used|1
5916416|NCT01541254|20468842|P1|Overall Study|stent not required|1
5916417|NCT01541254|20468842|P1|Overall Study|GI bleed prior to procedure|1
5916418|NCT01541254|20468842|P1|Overall Study|enrolled after study closed|1
5916419|NCT01541254|20468842|P1|Overall Study|excluded - metal allergy|1
5916420|NCT01541254|20468842|P1|Overall Study|Withdrawal by Subject|1
5916421|NCT01541215|20468849|P2|Follow up 1 (Weeks 53-104)|Withdrawal by Subject|0
5916422|NCT01541215|20468850|P1|Follow up 1 (Weeks 53-104)|Withdrawal by Subject|1
5916423|NCT01541215|20468849|P2|Follow up 1 (Weeks 53-104)|Lost to Follow-up|0
5916424|NCT01541215|20468850|P1|Follow up 1 (Weeks 53-104)|Lost to Follow-up|1
5916425|NCT01541215|20468849|P2|Treatment Period (52 Weeks)|Unclassified|3
5916426|NCT01541215|20468850|P1|Treatment Period (52 Weeks)|Unclassified|0
5916427|NCT01541215|20468849|P2|Treatment Period (52 Weeks)|Adverse Event|1
5916428|NCT01541215|20468850|P1|Treatment Period (52 Weeks)|Adverse Event|0
5916429|NCT01541215|20468849|P2|Treatment Period (52 Weeks)|Non-compliance|4
5916430|NCT01541215|20468850|P1|Treatment Period (52 Weeks)|Non-compliance|4
5916431|NCT01541215|20468849|P2|Treatment Period (52 Weeks)|Withdrawal criteria|8
5916432|NCT01541215|20468850|P1|Treatment Period (52 Weeks)|Withdrawal criteria|6
5916433|NCT01540981|20468996|P2|Overall Study|Withdrawal by Subject|0
5916434|NCT01540981|20468997|P1|Overall Study|Withdrawal by Subject|1
5916435|NCT01540851|20469007|P2|Overall Study|Withdrawal by Subject|3
5916436|NCT01540851|20469008|P1|Overall Study|Withdrawal by Subject|7
5916437|NCT01540851|20469007|P2|Overall Study|Lost to Follow-up|15
5916438|NCT01540851|20469008|P1|Overall Study|Lost to Follow-up|14
5916439|NCT01540838|20469020|P2|Overall Study|Not BM. Other treatment|1
5916440|NCT01540838|20469021|P1|Overall Study|Not BM. Other treatment|3
5916441|NCT01540838|20469020|P2|Overall Study|Died before treatment initiation|1
5916442|NCT01540838|20469021|P1|Overall Study|Died before treatment initiation|1
5916443|NCT01540838|20469020|P2|Overall Study|Additional antibiotic treatment|2
5916444|NCT01540838|20469021|P1|Overall Study|Additional antibiotic treatment|1
5916445|NCT01540838|20469020|P2|Overall Study|Treatment doses missing|12
5916446|NCT01540838|20469021|P1|Overall Study|Treatment doses missing|8
5916447|NCT01540838|20469020|P2|Overall Study|Open nasogastric tube|7
5916448|NCT01540838|20469021|P1|Overall Study|Open nasogastric tube|9
5916449|NCT01540565|20469171|P1|Overall Study|Ineligible|2
5916450|NCT01540487|20469190|P2|Overall Study|Protocol Violation|0
5916451|NCT01540487|20469191|P1|Overall Study|Protocol Violation|1
5916452|NCT01539837|20469330|P3|Overall Study|bad compliance|1
5916453|NCT01539837|20469331|P2|Overall Study|bad compliance|0
5916454|NCT01539837|20469332|P1|Overall Study|bad compliance|0
5916455|NCT01539837|20469330|P3|Overall Study|reduce neutrophil level|1
5916456|NCT01539837|20469331|P2|Overall Study|reduce neutrophil level|1
5916457|NCT01539837|20469332|P1|Overall Study|reduce neutrophil level|0
5916458|NCT01539759|20469354|P2|Overall Study|Lost to Follow-up|8
5916459|NCT01539759|20469355|P1|Overall Study|Lost to Follow-up|6
5916460|NCT01539642|20469376|P2|Overall Study|Withdrawal by Subject|2
5916461|NCT01539642|20469377|P1|Overall Study|Withdrawal by Subject|2
5916462|NCT01539642|20469376|P2|Overall Study|Adverse Event|4
5916463|NCT01539642|20469377|P1|Overall Study|Adverse Event|6
5916464|NCT01539642|20469376|P2|Overall Study|Patient ready for early discharge|7
5916465|NCT01539642|20469377|P1|Overall Study|Patient ready for early discharge|8
5916466|NCT01539642|20469376|P2|Overall Study|Lack of Efficacy|18
5916467|NCT01539642|20469377|P1|Overall Study|Lack of Efficacy|20
5916468|NCT01539538|20469394|P2|Overall Study|PCA no longer required or PCA problem|7
5916469|NCT01539538|20469395|P1|Overall Study|PCA no longer required or PCA problem|3
5916470|NCT01539538|20469394|P2|Overall Study|Withdrawal by Subject|3
5916471|NCT01539538|20469395|P1|Overall Study|Withdrawal by Subject|2
5916472|NCT01539538|20469394|P2|Overall Study|Lack of Efficacy|16
5916473|NCT01539538|20469395|P1|Overall Study|Lack of Efficacy|13
5916474|NCT01539538|20469394|P2|Overall Study|Adverse Event|18
5916475|NCT01539538|20469395|P1|Overall Study|Adverse Event|13
5916476|NCT01539525|20469404|P3|Overall Study|Protocol Violation|4
5916477|NCT01539525|20469405|P2|Overall Study|Protocol Violation|1
5916478|NCT01539525|20469406|P1|Overall Study|Protocol Violation|1
5916479|NCT01539525|20469404|P3|Overall Study|Withdrawal by Subject|2
5916480|NCT01539525|20469405|P2|Overall Study|Withdrawal by Subject|3
5916481|NCT01539525|20469406|P1|Overall Study|Withdrawal by Subject|0
5916482|NCT01539525|20469404|P3|Overall Study|Lost to Follow-up|11
5916483|NCT01539525|20469405|P2|Overall Study|Lost to Follow-up|12
5916484|NCT01539525|20469406|P1|Overall Study|Lost to Follow-up|19
5916485|NCT01539512|20469425|P2|Overall Study|Richter's Transformation|0
5916486|NCT01539512|20469426|P1|Overall Study|Richter's Transformation|1
5916487|NCT01539512|20469425|P2|Overall Study|Withdrawal by Subject|5
5916488|NCT01539512|20469426|P1|Overall Study|Withdrawal by Subject|12
5916489|NCT01539512|20469425|P2|Overall Study|Physician Decision|1
5916490|NCT01539512|20469426|P1|Overall Study|Physician Decision|1
5916491|NCT01539512|20469425|P2|Overall Study|Adverse Event|7
5916492|NCT01539512|20469426|P1|Overall Study|Adverse Event|9
5916493|NCT01539317|20469442|P2|Overall Study|Screening Error. Deleted from analysis.|0
5916494|NCT01539317|20469443|P1|Overall Study|Screening Error. Deleted from analysis.|1
5916495|NCT01539291|20469461|P4|Study GS-US-312-0117|Other|1
5916496|NCT01539291|20469462|P3|Study GS-US-312-0117|Other|1
5916497|NCT01539291|20469463|P2|Study GS-US-312-0117|Other|1
5916498|NCT01539291|20469464|P1|Study GS-US-312-0117|Other|2
5916499|NCT01539291|20469461|P4|Study GS-US-312-0117|Study Terminated by Sponsor|5
5916500|NCT01539291|20469462|P3|Study GS-US-312-0117|Study Terminated by Sponsor|0
5916501|NCT01539291|20469463|P2|Study GS-US-312-0117|Study Terminated by Sponsor|0
5916502|NCT01539291|20469464|P1|Study GS-US-312-0117|Study Terminated by Sponsor|3
5916503|NCT01539291|20469461|P4|Study GS-US-312-0117|Withdrawal by Subject|4
5916504|NCT01539291|20469462|P3|Study GS-US-312-0117|Withdrawal by Subject|6
5916505|NCT01539291|20469463|P2|Study GS-US-312-0117|Withdrawal by Subject|0
5916506|NCT01539291|20469464|P1|Study GS-US-312-0117|Withdrawal by Subject|5
5916507|NCT01539291|20469461|P4|Study GS-US-312-0117|Physician Decision|4
5916508|NCT01539291|20469462|P3|Study GS-US-312-0117|Physician Decision|6
5916509|NCT01539291|20469463|P2|Study GS-US-312-0117|Physician Decision|0
5916510|NCT01539291|20469464|P1|Study GS-US-312-0117|Physician Decision|9
5916511|NCT01539291|20469461|P4|Study GS-US-312-0117|Adverse Event|12
5916512|NCT01539291|20469462|P3|Study GS-US-312-0117|Adverse Event|9
5916513|NCT01539291|20469463|P2|Study GS-US-312-0117|Adverse Event|1
5916514|NCT01539291|20469464|P1|Study GS-US-312-0117|Adverse Event|22
5916515|NCT01539291|20469461|P4|Study GS-US-312-0116|Other|0
5916516|NCT01539291|20469462|P3|Study GS-US-312-0116|Other|0
5916517|NCT01539291|20469463|P2|Study GS-US-312-0116|Other|0
5916518|NCT01539291|20469464|P1|Study GS-US-312-0116|Other|1
5916519|NCT01539291|20469461|P4|Study GS-US-312-0116|Study Terminated by Sponsor|0
5916520|NCT01539291|20469462|P3|Study GS-US-312-0116|Study Terminated by Sponsor|0
5916521|NCT01539291|20469463|P2|Study GS-US-312-0116|Study Terminated by Sponsor|0
5916522|NCT01539291|20469464|P1|Study GS-US-312-0116|Study Terminated by Sponsor|2
5916523|NCT01539291|20469461|P4|Study GS-US-312-0116|Withdrawal by Subject|0
5916524|NCT01539291|20469462|P3|Study GS-US-312-0116|Withdrawal by Subject|0
5916525|NCT01539291|20469463|P2|Study GS-US-312-0116|Withdrawal by Subject|0
5916526|NCT01539291|20469464|P1|Study GS-US-312-0116|Withdrawal by Subject|12
5916527|NCT01539291|20469461|P4|Study GS-US-312-0116|Physician Decision|0
5916528|NCT01539291|20469462|P3|Study GS-US-312-0116|Physician Decision|0
5916529|NCT01539291|20469463|P2|Study GS-US-312-0116|Physician Decision|0
5916530|NCT01539291|20469464|P1|Study GS-US-312-0116|Physician Decision|1
5916531|NCT01539291|20469461|P4|Study GS-US-312-0116|Adverse Event|0
5916532|NCT01539291|20469462|P3|Study GS-US-312-0116|Adverse Event|0
5916533|NCT01539291|20469463|P2|Study GS-US-312-0116|Adverse Event|0
5916534|NCT01539291|20469464|P1|Study GS-US-312-0116|Adverse Event|9
5916535|NCT01539239|20469536|P2|Overall Study|Lost to Follow-up|12
5916536|NCT01539239|20469537|P1|Overall Study|Lost to Follow-up|7
5916537|NCT01539239|20469536|P2|Overall Study|Death|5
5916538|NCT01539239|20469537|P1|Overall Study|Death|5
5916539|NCT01539083|20469560|P3|After Randomization (TP and VTP)|Death|11
5916540|NCT01539083|20469561|P2|After Randomization (TP and VTP)|Death|6
5916541|NCT01539083|20469562|P1|After Randomization (TP and VTP)|Death|0
5916542|NCT01539083|20469560|P3|After Randomization (TP and VTP)|Progressive Disease|3
5916543|NCT01539083|20469561|P2|After Randomization (TP and VTP)|Progressive Disease|6
5916544|NCT01539083|20469562|P1|After Randomization (TP and VTP)|Progressive Disease|0
5916545|NCT01539083|20469560|P3|After Randomization (TP and VTP)|Withdrawal by Subject|4
5916546|NCT01539083|20469561|P2|After Randomization (TP and VTP)|Withdrawal by Subject|5
5916547|NCT01539083|20469562|P1|After Randomization (TP and VTP)|Withdrawal by Subject|0
5916548|NCT01539083|20469560|P3|After Randomization (TP and VTP)|Lost to Follow-up|2
5916549|NCT01539083|20469561|P2|After Randomization (TP and VTP)|Lost to Follow-up|2
5916550|NCT01539083|20469562|P1|After Randomization (TP and VTP)|Lost to Follow-up|0
5916551|NCT01539083|20469560|P3|After Randomization (TP and VTP)|Adverse Event|1
5916552|NCT01539083|20469561|P2|After Randomization (TP and VTP)|Adverse Event|1
5916553|NCT01539083|20469562|P1|After Randomization (TP and VTP)|Adverse Event|0
5916554|NCT01539083|20469560|P3|After Randomization (TP and VTP)|Other|1
5916555|NCT01539083|20469561|P2|After Randomization (TP and VTP)|Other|1
5916556|NCT01539083|20469562|P1|After Randomization (TP and VTP)|Other|0
5916557|NCT01539083|20469560|P3|After Randomization (TP and VTP)|Physician Decision|1
5916558|NCT01539083|20469561|P2|After Randomization (TP and VTP)|Physician Decision|0
5916559|NCT01539083|20469562|P1|After Randomization (TP and VTP)|Physician Decision|0
5916560|NCT01539083|20469560|P3|Before Randomization (VCD Induction)|Other|0
5916561|NCT01539083|20469561|P2|Before Randomization (VCD Induction)|Other|0
5916562|NCT01539083|20469562|P1|Before Randomization (VCD Induction)|Other|5
5916563|NCT01539083|20469560|P3|Before Randomization (VCD Induction)|Progressive Disease|0
5916564|NCT01539083|20469561|P2|Before Randomization (VCD Induction)|Progressive Disease|0
5916565|NCT01539083|20469562|P1|Before Randomization (VCD Induction)|Progressive Disease|8
5916566|NCT01539083|20469560|P3|Before Randomization (VCD Induction)|Physician Decision|0
5916567|NCT01539083|20469561|P2|Before Randomization (VCD Induction)|Physician Decision|0
5916568|NCT01539083|20469562|P1|Before Randomization (VCD Induction)|Physician Decision|14
5916569|NCT01539083|20469560|P3|Before Randomization (VCD Induction)|Protocol Violation|0
5916570|NCT01539083|20469561|P2|Before Randomization (VCD Induction)|Protocol Violation|0
5916571|NCT01539083|20469562|P1|Before Randomization (VCD Induction)|Protocol Violation|2
5916572|NCT01539083|20469560|P3|Before Randomization (VCD Induction)|Death|0
5916573|NCT01539083|20469561|P2|Before Randomization (VCD Induction)|Death|0
5916574|NCT01539083|20469562|P1|Before Randomization (VCD Induction)|Death|6
5916575|NCT01539083|20469560|P3|Before Randomization (VCD Induction)|Adverse Event|0
5916576|NCT01539083|20469561|P2|Before Randomization (VCD Induction)|Adverse Event|0
5916577|NCT01539083|20469562|P1|Before Randomization (VCD Induction)|Adverse Event|14
5916578|NCT01539083|20469560|P3|Before Randomization (VCD Induction)|Withdrawal by Subject|0
5916579|NCT01539083|20469561|P2|Before Randomization (VCD Induction)|Withdrawal by Subject|0
5916580|NCT01539083|20469562|P1|Before Randomization (VCD Induction)|Withdrawal by Subject|4
5916581|NCT01538719|20469606|P2|Overall Study|Lost to Follow-up|0
5916582|NCT01538719|20469607|P1|Overall Study|Lost to Follow-up|2
5916583|NCT01538472|20469630|P1|Overall Study|Death|1
5916584|NCT01538472|20469630|P1|Overall Study|Disease Progression|3
5916585|NCT01538199|20469641|P4|Overall Study|Lack of Efficacy|0
5916586|NCT01538199|20469642|P3|Overall Study|Lack of Efficacy|0
5916587|NCT01538199|20469643|P2|Overall Study|Lack of Efficacy|1
5916588|NCT01538199|20469644|P1|Overall Study|Lack of Efficacy|0
5916589|NCT01538199|20469641|P4|Overall Study|participant did not have time|2
5916590|NCT01538199|20469642|P3|Overall Study|participant did not have time|0
5916591|NCT01538199|20469643|P2|Overall Study|participant did not have time|0
5916592|NCT01538199|20469644|P1|Overall Study|participant did not have time|1
5916593|NCT01538199|20469641|P4|Overall Study|Lost to Follow-up|0
5916594|NCT01538199|20469642|P3|Overall Study|Lost to Follow-up|1
5916595|NCT01538199|20469643|P2|Overall Study|Lost to Follow-up|2
5916596|NCT01538199|20469644|P1|Overall Study|Lost to Follow-up|1
5916597|NCT01537887|20469678|P6|Period 3|Withdrawal by Subject|0
5916598|NCT01537887|20469679|P5|Period 3|Withdrawal by Subject|0
5916599|NCT01537887|20469680|P4|Period 3|Withdrawal by Subject|0
5916600|NCT01537887|20469681|P3|Period 3|Withdrawal by Subject|0
5916601|NCT01537887|20469682|P2|Period 3|Withdrawal by Subject|1
5916602|NCT01537887|20469683|P1|Period 3|Withdrawal by Subject|0
5916603|NCT01537887|20469678|P6|Period 3|Adverse Event|0
5916604|NCT01537887|20469679|P5|Period 3|Adverse Event|0
5916605|NCT01537887|20469680|P4|Period 3|Adverse Event|0
5916606|NCT01537887|20469681|P3|Period 3|Adverse Event|1
5916607|NCT01537887|20469682|P2|Period 3|Adverse Event|0
5916608|NCT01537887|20469683|P1|Period 3|Adverse Event|0
5916609|NCT01537887|20469678|P6|Period 2|Withdrawal by Subject|0
5916610|NCT01537887|20469679|P5|Period 2|Withdrawal by Subject|0
5916611|NCT01537887|20469680|P4|Period 2|Withdrawal by Subject|0
5916612|NCT01537887|20469681|P3|Period 2|Withdrawal by Subject|0
5916613|NCT01537887|20469682|P2|Period 2|Withdrawal by Subject|1
5916614|NCT01537887|20469683|P1|Period 2|Withdrawal by Subject|0
5916615|NCT01537887|20469678|P6|Period 1|Did not receive treatment|0
5916616|NCT01537887|20469679|P5|Period 1|Did not receive treatment|0
5916617|NCT01537887|20469680|P4|Period 1|Did not receive treatment|0
5916618|NCT01537887|20469681|P3|Period 1|Did not receive treatment|1
5916619|NCT01537887|20469682|P2|Period 1|Did not receive treatment|0
5916620|NCT01537887|20469683|P1|Period 1|Did not receive treatment|0
5916621|NCT01537887|20469678|P6|Period 1|Physician Decision|1
5916622|NCT01537887|20469679|P5|Period 1|Physician Decision|1
5916623|NCT01537887|20469680|P4|Period 1|Physician Decision|0
5916624|NCT01537887|20469681|P3|Period 1|Physician Decision|0
5916625|NCT01537887|20469682|P2|Period 1|Physician Decision|0
5916626|NCT01537887|20469683|P1|Period 1|Physician Decision|0
5916627|NCT01537783|20469712|P2|Overall Study|Lost to Follow-up|2
5916628|NCT01537783|20469713|P1|Overall Study|Lost to Follow-up|11
5916629|NCT01537549|20469764|P1|Overall Study|Withdrawal by Subject|2
5916630|NCT01537549|20469764|P1|Overall Study|Lost to Follow-up|1
5916631|NCT01537432|20469772|P2|Overall Study|Unsatisfactory therapeutic effect|0
5916632|NCT01537432|20469773|P1|Overall Study|Unsatisfactory therapeutic effect|1
5916633|NCT01537432|20469772|P2|Overall Study|Adverse Event|0
5916634|NCT01537432|20469773|P1|Overall Study|Adverse Event|1
5916635|NCT01537432|20469772|P2|Overall Study|Administrative problems|0
5916636|NCT01537432|20469773|P1|Overall Study|Administrative problems|1
5916637|NCT01537432|20469772|P2|Overall Study|Withdrawal by Subject|1
5916638|NCT01537432|20469773|P1|Overall Study|Withdrawal by Subject|0
5916639|NCT01537432|20469772|P2|Overall Study|Lost to Follow-up|1
5916640|NCT01537432|20469773|P1|Overall Study|Lost to Follow-up|3
5916641|NCT01537393|20469796|P2|Overall Study|Censored (severe event unrelated to PT)|1
5916642|NCT01537393|20469797|P1|Overall Study|Censored (severe event unrelated to PT)|1
5916643|NCT01537393|20469796|P2|Overall Study|Failure - Not regrafted|6
5916644|NCT01537393|20469797|P1|Overall Study|Failure - Not regrafted|2
5916645|NCT01537393|20469796|P2|Overall Study|Failure - Regrafted|43
5916646|NCT01537393|20469797|P1|Overall Study|Failure - Regrafted|28
5916647|NCT01537393|20469796|P2|Overall Study|Lost to Follow-up|48
5916648|NCT01537393|20469797|P1|Overall Study|Lost to Follow-up|53
5916649|NCT01537393|20469796|P2|Overall Study|Withdrawal by Subject|17
5916650|NCT01537393|20469797|P1|Overall Study|Withdrawal by Subject|18
5916651|NCT01537393|20469796|P2|Overall Study|Death|32
5916652|NCT01537393|20469797|P1|Overall Study|Death|20
5916653|NCT01537393|20469796|P2|Overall Study|Exclude prior to study|44
5916654|NCT01537393|20469797|P1|Overall Study|Exclude prior to study|32
5916655|NCT01537302|20469833|P1|Overall Study|Withdrawal by Subject|1
5916656|NCT01537302|20469833|P1|Overall Study|Lost to Follow-up|1
5916657|NCT01537211|20469842|P2|Overall Study|Lost to Follow-up|1
5916658|NCT01537211|20469843|P1|Overall Study|Lost to Follow-up|0
5916659|NCT01537198|20469877|P1|Overall Study|Other|111
5916660|NCT01537198|20469877|P1|Overall Study|No Further Visits to the Clinic|37
5916661|NCT01537198|20469877|P1|Overall Study|Adverse Event|4
5916662|NCT01537198|20469877|P1|Overall Study|RSV infection|2
5916663|NCT01537133|20469906|P4|Overall Study|Lost to Follow-up|0
5916664|NCT01537133|20469907|P3|Overall Study|Lost to Follow-up|0
5916665|NCT01537133|20469908|P2|Overall Study|Lost to Follow-up|0
5916666|NCT01537133|20469909|P1|Overall Study|Lost to Follow-up|1
5916667|NCT01537133|20469906|P4|Overall Study|Withdrawal by Subject|0
5916668|NCT01537133|20469907|P3|Overall Study|Withdrawal by Subject|0
5916669|NCT01537133|20469908|P2|Overall Study|Withdrawal by Subject|0
5916670|NCT01537133|20469909|P1|Overall Study|Withdrawal by Subject|2
5916671|NCT01537120|20469925|P1|3 Weeks Placebo|Withdrawal by Subject|1
5916672|NCT01537120|20469925|P1|8 Weeks Washout|Inclusion/exclusion criteria not met|1
5916673|NCT01537081|20469938|P3|Overall Study|Assigned but never dosed|0
5916674|NCT01537081|20469939|P2|Overall Study|Assigned but never dosed|0
5916675|NCT01537081|20469940|P1|Overall Study|Assigned but never dosed|1
5916676|NCT01537081|20469938|P3|Overall Study|Sponsor decision|0
5916677|NCT01537081|20469939|P2|Overall Study|Sponsor decision|1
5916678|NCT01537081|20469940|P1|Overall Study|Sponsor decision|0
5916679|NCT01537081|20469938|P3|Overall Study|Physician Decision|0
5916680|NCT01537081|20469939|P2|Overall Study|Physician Decision|6
5916681|NCT01537081|20469940|P1|Overall Study|Physician Decision|5
5916682|NCT01537081|20469938|P3|Overall Study|Withdrawal by Subject|3
5916683|NCT01537081|20469939|P2|Overall Study|Withdrawal by Subject|11
5916684|NCT01537081|20469940|P1|Overall Study|Withdrawal by Subject|6
5916685|NCT01537081|20469938|P3|Overall Study|Protocol Violation|2
5916686|NCT01537081|20469939|P2|Overall Study|Protocol Violation|2
5916687|NCT01537081|20469940|P1|Overall Study|Protocol Violation|3
5916688|NCT01537081|20469938|P3|Overall Study|Lost to Follow-up|9
5916689|NCT01537081|20469939|P2|Overall Study|Lost to Follow-up|15
5916690|NCT01537081|20469940|P1|Overall Study|Lost to Follow-up|17
5916691|NCT01537081|20469938|P3|Overall Study|Lack of Efficacy|0
5916692|NCT01537081|20469939|P2|Overall Study|Lack of Efficacy|1
5916693|NCT01537081|20469940|P1|Overall Study|Lack of Efficacy|2
5916694|NCT01537081|20469938|P3|Overall Study|Adverse Event|2
5916695|NCT01537081|20469939|P2|Overall Study|Adverse Event|2
5916696|NCT01537081|20469940|P1|Overall Study|Adverse Event|5
5916697|NCT01537068|20469953|P2|Overall Study|Lack of Efficacy|0
5916698|NCT01537068|20469954|P1|Overall Study|Lack of Efficacy|1
5916699|NCT01537068|20469953|P2|Overall Study|Withdrawal by Subject|1
5916700|NCT01537068|20469954|P1|Overall Study|Withdrawal by Subject|1
5916701|NCT01537068|20469953|P2|Overall Study|Adverse Event|1
5916702|NCT01537068|20469954|P1|Overall Study|Adverse Event|0
5916703|NCT01537068|20469953|P2|Overall Study|Lost to Follow-up|1
5916704|NCT01537068|20469954|P1|Overall Study|Lost to Follow-up|2
5916705|NCT01537042|20469966|P2|Overall Study|Other|1
5916706|NCT01537042|20469967|P1|Overall Study|Other|0
5916707|NCT01537042|20469966|P2|Overall Study|Protocol Violation|1
5916708|NCT01537042|20469967|P1|Overall Study|Protocol Violation|0
5916709|NCT01537042|20469966|P2|Overall Study|Lack of Efficacy|1
5916710|NCT01537042|20469967|P1|Overall Study|Lack of Efficacy|0
5916711|NCT01537042|20469966|P2|Overall Study|Adverse Event|2
5916712|NCT01537042|20469967|P1|Overall Study|Adverse Event|0
5916713|NCT01536951|20470009|P9|Second Intervention and Washout Period 2|Adverse Event|0
5916714|NCT01536951|20470010|P8|Second Intervention and Washout Period 2|Adverse Event|1
5916715|NCT01536951|20470011|P7|Second Intervention and Washout Period 2|Adverse Event|0
5916716|NCT01536951|20470012|P6|Second Intervention and Washout Period 2|Adverse Event|0
5916717|NCT01536951|20470013|P5|Second Intervention and Washout Period 2|Adverse Event|0
5916718|NCT01536951|20470014|P4|Second Intervention and Washout Period 2|Adverse Event|0
5916719|NCT01536951|20470015|P3|Second Intervention and Washout Period 2|Adverse Event|0
5916720|NCT01536951|20470016|P2|Second Intervention and Washout Period 2|Adverse Event|0
5916721|NCT01536951|20470017|P1|Second Intervention and Washout Period 2|Adverse Event|0
5916722|NCT01536951|20470009|P9|First Intervention and Washout Period 1|Withdrawal by Subject|0
5916723|NCT01536951|20470010|P8|First Intervention and Washout Period 1|Withdrawal by Subject|0
5916724|NCT01536951|20470011|P7|First Intervention and Washout Period 1|Withdrawal by Subject|0
5916725|NCT01536951|20470012|P6|First Intervention and Washout Period 1|Withdrawal by Subject|0
5916726|NCT01536951|20470013|P5|First Intervention and Washout Period 1|Withdrawal by Subject|0
5916727|NCT01536951|20470014|P4|First Intervention and Washout Period 1|Withdrawal by Subject|0
5916728|NCT01536951|20470015|P3|First Intervention and Washout Period 1|Withdrawal by Subject|1
5916729|NCT01536951|20470016|P2|First Intervention and Washout Period 1|Withdrawal by Subject|0
5916730|NCT01536951|20470017|P1|First Intervention and Washout Period 1|Withdrawal by Subject|0
5916731|NCT01536860|20470074|P3|Washout Period (3 Days)|Lost to Follow-up|0
5916732|NCT01536860|20470075|P2|Washout Period (3 Days)|Lost to Follow-up|0
5916733|NCT01536860|20470076|P1|Washout Period (3 Days)|Lost to Follow-up|1
5916738|NCT01536704|20470101|P4|Washout Period 3|Adverse Event|0
5916739|NCT01536704|20470102|P3|Washout Period 3|Adverse Event|1
5916740|NCT01536704|20470103|P2|Washout Period 3|Adverse Event|0
5916741|NCT01536704|20470104|P1|Washout Period 3|Adverse Event|0
5916742|NCT01536704|20470101|P4|Period 3|Adverse Event|1
5916743|NCT01536704|20470102|P3|Period 3|Adverse Event|0
5916744|NCT01536704|20470103|P2|Period 3|Adverse Event|0
5916745|NCT01536704|20470104|P1|Period 3|Adverse Event|0
5916746|NCT01536704|20470101|P4|Washout Period 2|Withdrawal by Subject|1
5916747|NCT01536704|20470102|P3|Washout Period 2|Withdrawal by Subject|0
5916748|NCT01536704|20470103|P2|Washout Period 2|Withdrawal by Subject|0
5916749|NCT01536704|20470104|P1|Washout Period 2|Withdrawal by Subject|0
5916750|NCT01536704|20470101|P4|Washout Period 2|Adverse Event|0
5916751|NCT01536704|20470102|P3|Washout Period 2|Adverse Event|0
5916752|NCT01536704|20470103|P2|Washout Period 2|Adverse Event|0
5916753|NCT01536704|20470104|P1|Washout Period 2|Adverse Event|1
5916754|NCT01536704|20470101|P4|Washout Period 1|Withdrawal by Subject|0
5916755|NCT01536704|20470102|P3|Washout Period 1|Withdrawal by Subject|0
5916756|NCT01536704|20470103|P2|Washout Period 1|Withdrawal by Subject|2
5916757|NCT01536704|20470104|P1|Washout Period 1|Withdrawal by Subject|1
5916758|NCT01536587|20470134|P1|Overall Study|Adverse Event|2
5916759|NCT01536574|20470173|P2|Overall Study|Lack of Efficacy|0
5916760|NCT01536574|20470174|P1|Overall Study|Lack of Efficacy|1
5916761|NCT01536574|20470173|P2|Overall Study|Withdrawal by Subject|2
5916762|NCT01536574|20470174|P1|Overall Study|Withdrawal by Subject|1
5916763|NCT01536574|20470173|P2|Overall Study|Adverse Event|5
5916764|NCT01536574|20470174|P1|Overall Study|Adverse Event|4
5916765|NCT01536561|20470192|P1|Dosimetric and Therapeutic Treatment|Enrolled in Study BEX104526|13
5916766|NCT01536561|20470192|P1|Dosimetric and Therapeutic Treatment|Death|2
5916767|NCT01536561|20470192|P1|Dosimetric and Therapeutic Treatment|Lost to Follow-up|1
5916768|NCT01536561|20470192|P1|Dosimetric and Therapeutic Treatment|Adverse Event|1
5916769|NCT01536561|20470192|P1|Dosimetric and Therapeutic Treatment|Received Alternate Treatment|2
5916770|NCT01536561|20470192|P1|Dosimetric and Therapeutic Treatment|Progressive Disease|40
5916771|NCT01536535|20470232|P2|Overall Study|Participant moved|1
5916772|NCT01536535|20470233|P1|Overall Study|Participant moved|0
5916773|NCT01536535|20470232|P2|Overall Study|Physician Decision|1
5916774|NCT01536535|20470233|P1|Overall Study|Physician Decision|1
5916775|NCT01536535|20470232|P2|Overall Study|Lost to Follow-up|6
5916776|NCT01536535|20470233|P1|Overall Study|Lost to Follow-up|4
5916777|NCT01536535|20470232|P2|Overall Study|Withdrawal by Subject|5
5916778|NCT01536535|20470233|P1|Overall Study|Withdrawal by Subject|10
5916779|NCT01536418|20470282|P2|Overall Study|Withdrawal by Subject|3
5916780|NCT01536418|20470283|P1|Overall Study|Withdrawal by Subject|5
5916781|NCT01536418|20470282|P2|Overall Study|Met Liver Chemistry Stopping criteria|0
5916782|NCT01536418|20470283|P1|Overall Study|Met Liver Chemistry Stopping criteria|1
5916783|NCT01536418|20470282|P2|Overall Study|Adverse Event|4
5916784|NCT01536418|20470283|P1|Overall Study|Adverse Event|9
5916785|NCT01536418|20470282|P2|Overall Study|Lack of Efficacy|16
5916786|NCT01536418|20470283|P1|Overall Study|Lack of Efficacy|10
5916787|NCT01536418|20470282|P2|Overall Study|Study closed/terminated|37
5916788|NCT01536418|20470283|P1|Overall Study|Study closed/terminated|41
5916789|NCT01536418|20470282|P2|Overall Study|Physician Decision|3
5916790|NCT01536418|20470283|P1|Overall Study|Physician Decision|1
5916791|NCT01536418|20470282|P2|Overall Study|Protocol Violation|3
5916792|NCT01536418|20470283|P1|Overall Study|Protocol Violation|2
5916793|NCT01536405|20470303|P2|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20
5916794|NCT01536405|20470304|P1|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20
5916795|NCT01536405|20470303|P2|Visit 4 to Extended Study Follow-up|Adverse Event|1
5916796|NCT01536405|20470304|P1|Visit 4 to Extended Study Follow-up|Adverse Event|0
5916797|NCT01536405|20470303|P2|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|2
5916798|NCT01536405|20470304|P1|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|0
5916799|NCT01536405|20470303|P2|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|14
5916800|NCT01536405|20470304|P1|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|16
5916801|NCT01536405|20470303|P2|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|0
5916802|NCT01536405|20470304|P1|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|1
5916803|NCT01536405|20470303|P2|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|2
5916804|NCT01536405|20470304|P1|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|3
5916805|NCT01536405|20470303|P2|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2
5916806|NCT01536405|20470304|P1|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2
5916807|NCT01536405|20470303|P2|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|10
5916808|NCT01536405|20470304|P1|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|9
5916809|NCT01536405|20470303|P2|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3
5916810|NCT01536405|20470304|P1|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3
5916811|NCT01536405|20470303|P2|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|13
5916812|NCT01536405|20470304|P1|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|17
5916813|NCT01536405|20470303|P2|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|22
5916814|NCT01536405|20470304|P1|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|20
5916815|NCT01536405|20470303|P2|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|18
5916816|NCT01536405|20470304|P1|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|12
5916817|NCT01536405|20470303|P2|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|4
5916818|NCT01536405|20470304|P1|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|8
5916819|NCT01536379|20470342|P2|Overall Study|Withdrawal by Subject|1
5916820|NCT01536379|20470343|P1|Overall Study|Withdrawal by Subject|1
5916821|NCT01536379|20470342|P2|Overall Study|Adverse Event|2
5916822|NCT01536379|20470343|P1|Overall Study|Adverse Event|1
5916823|NCT01536262|20470435|P3|Overall Study|Other than stated above|0
5916824|NCT01536262|20470436|P2|Overall Study|Other than stated above|0
5916825|NCT01536262|20470437|P1|Overall Study|Other than stated above|1
5916826|NCT01536262|20470435|P3|Overall Study|Withdrawal by Subject|0
5916827|NCT01536262|20470436|P2|Overall Study|Withdrawal by Subject|1
5916828|NCT01536262|20470437|P1|Overall Study|Withdrawal by Subject|1
5916829|NCT01536262|20470435|P3|Overall Study|Adverse Event|2
5916830|NCT01536262|20470436|P2|Overall Study|Adverse Event|1
5916831|NCT01536262|20470437|P1|Overall Study|Adverse Event|6
5916832|NCT01536171|20470479|P1|Overall Study|Withdrawal by Subject|1
5916833|NCT01536145|20470484|P11|Overall Study|Adverse Event|3
5916834|NCT01536145|20470485|P10|Overall Study|Adverse Event|0
5916835|NCT01536145|20470486|P9|Overall Study|Adverse Event|0
5916836|NCT01536145|20470487|P8|Overall Study|Adverse Event|2
5916837|NCT01536145|20470488|P7|Overall Study|Adverse Event|0
5916838|NCT01536145|20470489|P6|Overall Study|Adverse Event|0
5916839|NCT01536145|20470490|P5|Overall Study|Adverse Event|0
5916840|NCT01536145|20470491|P4|Overall Study|Adverse Event|0
5916841|NCT01536145|20470492|P3|Overall Study|Adverse Event|0
5916842|NCT01536145|20470493|P2|Overall Study|Adverse Event|0
5916843|NCT01536145|20470494|P1|Overall Study|Adverse Event|0
5916844|NCT01536145|20470484|P11|Overall Study|Death|0
5916845|NCT01536145|20470485|P10|Overall Study|Death|0
5916846|NCT01536145|20470486|P9|Overall Study|Death|0
5916847|NCT01536145|20470487|P8|Overall Study|Death|0
5916848|NCT01536145|20470488|P7|Overall Study|Death|1
5916849|NCT01536145|20470489|P6|Overall Study|Death|0
5916850|NCT01536145|20470490|P5|Overall Study|Death|0
5916851|NCT01536145|20470491|P4|Overall Study|Death|0
5916852|NCT01536145|20470492|P3|Overall Study|Death|0
5916853|NCT01536145|20470493|P2|Overall Study|Death|0
5916854|NCT01536145|20470494|P1|Overall Study|Death|0
5916855|NCT01536145|20470484|P11|Overall Study|Other|2
5916856|NCT01536145|20470485|P10|Overall Study|Other|3
5916857|NCT01536145|20470486|P9|Overall Study|Other|0
5916858|NCT01536145|20470487|P8|Overall Study|Other|0
5916859|NCT01536145|20470488|P7|Overall Study|Other|0
5916860|NCT01536145|20470489|P6|Overall Study|Other|0
5916861|NCT01536145|20470490|P5|Overall Study|Other|1
5916862|NCT01536145|20470491|P4|Overall Study|Other|0
5916863|NCT01536145|20470492|P3|Overall Study|Other|0
5916864|NCT01536145|20470493|P2|Overall Study|Other|0
5916865|NCT01536145|20470494|P1|Overall Study|Other|0
5916866|NCT01536145|20470484|P11|Overall Study|Withdrawal by Subject|2
5916867|NCT01536145|20470485|P10|Overall Study|Withdrawal by Subject|0
5916868|NCT01536145|20470486|P9|Overall Study|Withdrawal by Subject|2
5916869|NCT01536145|20470487|P8|Overall Study|Withdrawal by Subject|0
5916870|NCT01536145|20470488|P7|Overall Study|Withdrawal by Subject|0
5916871|NCT01536145|20470489|P6|Overall Study|Withdrawal by Subject|1
5916872|NCT01536145|20470490|P5|Overall Study|Withdrawal by Subject|0
5916873|NCT01536145|20470491|P4|Overall Study|Withdrawal by Subject|0
5916874|NCT01536145|20470492|P3|Overall Study|Withdrawal by Subject|1
5916875|NCT01536145|20470493|P2|Overall Study|Withdrawal by Subject|0
5916876|NCT01536145|20470494|P1|Overall Study|Withdrawal by Subject|0
5916877|NCT01536145|20470484|P11|Overall Study|Progressive disease|3
5916878|NCT01536145|20470485|P10|Overall Study|Progressive disease|3
5916879|NCT01536145|20470486|P9|Overall Study|Progressive disease|1
5916880|NCT01536145|20470487|P8|Overall Study|Progressive disease|2
5916881|NCT01536145|20470488|P7|Overall Study|Progressive disease|1
5916882|NCT01536145|20470489|P6|Overall Study|Progressive disease|2
5916883|NCT01536145|20470490|P5|Overall Study|Progressive disease|1
5916884|NCT01536145|20470491|P4|Overall Study|Progressive disease|2
5916885|NCT01536145|20470492|P3|Overall Study|Progressive disease|1
5916886|NCT01536145|20470493|P2|Overall Study|Progressive disease|4
5916887|NCT01536145|20470494|P1|Overall Study|Progressive disease|3
5916888|NCT01536119|20470601|P2|Overall Study|Lost to Follow-up|14
5916889|NCT01536119|20470602|P1|Overall Study|Lost to Follow-up|17
5916890|NCT01536093|20470628|P2|Overall Study|Withdrawal by Subject|1
5916891|NCT01536093|20470629|P1|Overall Study|Withdrawal by Subject|0
5916892|NCT01536093|20470628|P2|Overall Study|absence of maternal colostrum|0
5916893|NCT01536093|20470629|P1|Overall Study|absence of maternal colostrum|2
5916894|NCT01536093|20470628|P2|Overall Study|Death|2
5916895|NCT01536093|20470629|P1|Overall Study|Death|1
5916896|NCT01536067|20470645|P1|Overall Study|Disease Progression|1
5916897|NCT01536015|20470658|P2|Overall Study|Study closure|5
5916898|NCT01536015|20470659|P1|Overall Study|Study closure|5
5916899|NCT01536015|20470658|P2|Overall Study|Inclusion Criterion not met|0
5916900|NCT01536015|20470659|P1|Overall Study|Inclusion Criterion not met|2
5916901|NCT01536015|20470658|P2|Overall Study|Lost to Follow-up|1
5916902|NCT01536015|20470659|P1|Overall Study|Lost to Follow-up|0
5916903|NCT01536015|20470658|P2|Overall Study|Adverse Event|4
5916904|NCT01536015|20470659|P1|Overall Study|Adverse Event|1
5916905|NCT01535807|20470697|P2|Overall Study|Data collection error|1
5916906|NCT01535807|20470698|P1|Overall Study|Data collection error|1
5916907|NCT01535807|20470697|P2|Overall Study|Withdrawal by Subject|1
5916908|NCT01535807|20470698|P1|Overall Study|Withdrawal by Subject|1
5916909|NCT01535729|20470704|P1|Overall Study|No participant record available|5
5916910|NCT01535729|20470704|P1|Overall Study|Not treated|9
5916911|NCT01535729|20470704|P1|Overall Study|Screening failure|1
5916912|NCT01535729|20470704|P1|Overall Study|Protocol Violation|11
5916913|NCT01535729|20470704|P1|Overall Study|NSCLC grade IV histology not confirmed|20
5916914|NCT01535729|20470704|P1|Overall Study|No previous chemotherapy|33
5916915|NCT01535729|20470704|P1|Overall Study|Did not sign informed consent|1
5916916|NCT01535729|20470704|P1|Overall Study|Other|19
5916917|NCT01535729|20470704|P1|Overall Study|Death|52
5916918|NCT01535729|20470704|P1|Overall Study|Lost to Follow-up|8
5916919|NCT01535729|20470704|P1|Overall Study|Discontinued treatment|25
5916920|NCT01535729|20470704|P1|Overall Study|Disease progression|230
5916921|NCT01535729|20470704|P1|Overall Study|Withdrawal by Subject|2
5916922|NCT01535638|20470745|P6|Treatment 3 (Single Dose)|Protocol Violation|0
5916923|NCT01535638|20470746|P5|Treatment 3 (Single Dose)|Protocol Violation|0
5916924|NCT01535638|20470747|P4|Treatment 3 (Single Dose)|Protocol Violation|1
5916925|NCT01535638|20470748|P3|Treatment 3 (Single Dose)|Protocol Violation|0
5916926|NCT01535638|20470749|P2|Treatment 3 (Single Dose)|Protocol Violation|0
5916927|NCT01535638|20470750|P1|Treatment 3 (Single Dose)|Protocol Violation|0
5916928|NCT01535638|20470745|P6|Treatment 1 (Single Dose)|Protocol Violation|1
5916929|NCT01535638|20470746|P5|Treatment 1 (Single Dose)|Protocol Violation|0
5916930|NCT01535638|20470747|P4|Treatment 1 (Single Dose)|Protocol Violation|0
5916931|NCT01535638|20470748|P3|Treatment 1 (Single Dose)|Protocol Violation|0
5916932|NCT01535638|20470749|P2|Treatment 1 (Single Dose)|Protocol Violation|0
5916933|NCT01535638|20470750|P1|Treatment 1 (Single Dose)|Protocol Violation|0
5916934|NCT01535599|20470764|P2|Overall Study|Noncompliance|1
5916935|NCT01535599|20470765|P1|Overall Study|Noncompliance|0
5916936|NCT01535599|20470764|P2|Overall Study|Stopped medication|1
5916937|NCT01535599|20470765|P1|Overall Study|Stopped medication|0
5916938|NCT01535599|20470764|P2|Overall Study|Other|0
5916939|NCT01535599|20470765|P1|Overall Study|Other|1
5916940|NCT01535599|20470764|P2|Overall Study|Did not use product|0
5916941|NCT01535599|20470765|P1|Overall Study|Did not use product|1
5916942|NCT01535599|20470764|P2|Overall Study|Randomized in Error|4
5916943|NCT01535599|20470765|P1|Overall Study|Randomized in Error|2
5916944|NCT01535599|20470764|P2|Overall Study|BL Culture + for Yeast//Fungi|1
5916945|NCT01535599|20470765|P1|Overall Study|BL Culture + for Yeast//Fungi|0
5916946|NCT01535599|20470764|P2|Overall Study|BL Culture + for Group A Strep|1
5916947|NCT01535599|20470765|P1|Overall Study|BL Culture + for Group A Strep|0
5916948|NCT01535599|20470764|P2|Overall Study|Treatment Failure|66
5916949|NCT01535599|20470765|P1|Overall Study|Treatment Failure|33
5916950|NCT01535599|20470764|P2|Overall Study|Subj Decision Unrelated to Adverse Event|3
5916951|NCT01535599|20470765|P1|Overall Study|Subj Decision Unrelated to Adverse Event|4
5916952|NCT01535599|20470764|P2|Overall Study|Lost to Follow-up|4
5916953|NCT01535599|20470765|P1|Overall Study|Lost to Follow-up|3
5916954|NCT01535599|20470764|P2|Overall Study|Adverse Event|15
5916955|NCT01535599|20470765|P1|Overall Study|Adverse Event|6
5916956|NCT01535560|20470799|P2|Overall Study|Randomized in Error|1
5916957|NCT01535560|20470800|P1|Overall Study|Randomized in Error|0
5916958|NCT01535560|20470799|P2|Overall Study|Other|1
5916959|NCT01535560|20470800|P1|Overall Study|Other|0
5916960|NCT01535560|20470799|P2|Overall Study|Treatment Failure|83
5916961|NCT01535560|20470800|P1|Overall Study|Treatment Failure|21
5916962|NCT01535560|20470799|P2|Overall Study|Subj Decision Unrel to an Adverse Event|1
5916963|NCT01535560|20470800|P1|Overall Study|Subj Decision Unrel to an Adverse Event|3
5916964|NCT01535560|20470799|P2|Overall Study|Lost to Follow-up|3
5916965|NCT01535560|20470800|P1|Overall Study|Lost to Follow-up|1
5916966|NCT01535560|20470799|P2|Overall Study|Adverse Event|7
5916967|NCT01535560|20470800|P1|Overall Study|Adverse Event|12
5916968|NCT01535443|20470810|P1|Overall Study|Physician Decision|3
5916969|NCT01535287|20470860|P2|Overall Study|drug not prepared in time|6
5916970|NCT01535287|20470861|P1|Overall Study|drug not prepared in time|5
5916971|NCT01535261|20470877|P1|Overall Study|Adverse Event|12
5916972|NCT01535261|20470877|P1|Overall Study|Withdrawal by Subject|14
5916973|NCT01535261|20470877|P1|Overall Study|Lost to Follow-up|8
5916974|NCT01535261|20470877|P1|Overall Study|Death|5
5916975|NCT01535261|20470877|P1|Overall Study|Protocol Violation|3
5916976|NCT01535261|20470877|P1|Overall Study|Physician Decision|8
5916977|NCT01535235|20470890|P2|Overall Study|Adverse Event|0
5916978|NCT01535235|20470891|P1|Overall Study|Adverse Event|1
5916979|NCT01535222|20470905|P6|Overall Study|Inclusion/exclusion|0
5916980|NCT01535222|20470906|P5|Overall Study|Inclusion/exclusion|0
5916981|NCT01535222|20470907|P4|Overall Study|Inclusion/exclusion|0
5916982|NCT01535222|20470908|P3|Overall Study|Inclusion/exclusion|1
5916983|NCT01535222|20470909|P2|Overall Study|Inclusion/exclusion|0
5916984|NCT01535222|20470910|P1|Overall Study|Inclusion/exclusion|0
5916985|NCT01535053|20470941|P2|Overall Study|Ineligible|2
5916986|NCT01535053|20470942|P1|Overall Study|Ineligible|1
5916987|NCT01535040|20470960|P2|Overall Study|Multiple Reasons|1
5916988|NCT01535040|20470961|P1|Overall Study|Multiple Reasons|1
5916989|NCT01535040|20470960|P2|Overall Study|Toxicity|5
5916990|NCT01535040|20470961|P1|Overall Study|Toxicity|7
5916991|NCT01535040|20470960|P2|Overall Study|Never Started|4
5916992|NCT01535040|20470961|P1|Overall Study|Never Started|9
5916993|NCT01535040|20470960|P2|Overall Study|Withdrawal by Subject|10
5916994|NCT01535040|20470961|P1|Overall Study|Withdrawal by Subject|13
5916995|NCT01535040|20470960|P2|Overall Study|Physician Decision|1
5916996|NCT01535040|20470961|P1|Overall Study|Physician Decision|0
5916997|NCT01534962|20471058|P4|Overall Study|Discontinued at AF recurrence|31
5916998|NCT01534962|20471059|P3|Overall Study|Discontinued at AF recurrence|24
5916999|NCT01534962|20471060|P2|Overall Study|Discontinued at AF recurrence|26
5917000|NCT01534962|20471061|P1|Overall Study|Discontinued at AF recurrence|35
5917001|NCT01534962|20471058|P4|Overall Study|Randomized but did not start treatment|1
5917002|NCT01534962|20471059|P3|Overall Study|Randomized but did not start treatment|0
5917003|NCT01534962|20471060|P2|Overall Study|Randomized but did not start treatment|0
5917004|NCT01534962|20471061|P1|Overall Study|Randomized but did not start treatment|2
5917005|NCT01534676|20471118|P2|Overall Study|Study closed due to poor enrollment|1
5917006|NCT01534676|20471119|P1|Overall Study|Study closed due to poor enrollment|2
5917007|NCT01534663|20471127|P2|Overall Study|Adverse Event|1
5917008|NCT01534663|20471128|P1|Overall Study|Adverse Event|2
5917009|NCT01534663|20471127|P2|Overall Study|Lost to Follow-up|2
5917010|NCT01534663|20471128|P1|Overall Study|Lost to Follow-up|0
5917011|NCT01534637|20471162|P1|Overall Study|Liver Mets before treatment|1
5917012|NCT01534637|20471162|P1|Overall Study|Adverse Event|1
5917013|NCT01534637|20471162|P1|Overall Study|Withdrawal by Subject|1
5917014|NCT01534637|20471162|P1|Overall Study|Lack of Efficacy|3
5917015|NCT01534637|20471162|P1|Overall Study|Physician Decision|3
5917016|NCT01534533|20471172|P4|Overall Study|Withdrawal by Subject|1
5917017|NCT01534533|20471173|P3|Overall Study|Withdrawal by Subject|4
5917018|NCT01534533|20471174|P2|Overall Study|Withdrawal by Subject|3
5917019|NCT01534533|20471175|P1|Overall Study|Withdrawal by Subject|5
5917020|NCT01534533|20471172|P4|Overall Study|Lost to Follow-up|3
5917021|NCT01534533|20471173|P3|Overall Study|Lost to Follow-up|4
5917022|NCT01534533|20471174|P2|Overall Study|Lost to Follow-up|0
5917023|NCT01534533|20471175|P1|Overall Study|Lost to Follow-up|3
5917024|NCT01534520|20471203|P2|Overall Study|Adverse Event|1
5917025|NCT01534520|20471204|P1|Overall Study|Adverse Event|0
5917026|NCT01534351|20471238|P3|Overall Study|Study Terminated Early|0
5917027|NCT01534351|20471239|P2|Overall Study|Study Terminated Early|0
5917028|NCT01534351|20471240|P1|Overall Study|Study Terminated Early|1
5917029|NCT01534273|20471261|P7|Period 1|Physician Decision|0
5917030|NCT01534273|20471262|P6|Period 1|Physician Decision|0
5917031|NCT01534273|20471263|P5|Period 1|Physician Decision|0
5917032|NCT01534273|20471264|P4|Period 1|Physician Decision|1
5917033|NCT01534273|20471265|P3|Period 1|Physician Decision|0
5917034|NCT01534273|20471266|P2|Period 1|Physician Decision|0
5917035|NCT01534273|20471267|P1|Period 1|Physician Decision|0
5917036|NCT01534260|20471294|P2|Overall Study|No treatment, per protocol|1
5917037|NCT01534260|20471295|P1|Overall Study|No treatment, per protocol|0
5917038|NCT01534260|20471294|P2|Overall Study|Physician Decision|1
5917039|NCT01534260|20471295|P1|Overall Study|Physician Decision|3
5917040|NCT01534260|20471294|P2|Overall Study|Disease Progression|6
5917041|NCT01534260|20471295|P1|Overall Study|Disease Progression|8
5917042|NCT01534260|20471294|P2|Overall Study|Withdrawal by Subject|3
5917043|NCT01534260|20471295|P1|Overall Study|Withdrawal by Subject|1
5917044|NCT01534260|20471294|P2|Overall Study|Lack of Efficacy|1
5917045|NCT01534260|20471295|P1|Overall Study|Lack of Efficacy|1
5917046|NCT01534260|20471294|P2|Overall Study|Death|0
5917047|NCT01534260|20471295|P1|Overall Study|Death|2
5917048|NCT01534260|20471294|P2|Overall Study|Adverse Event|8
5917049|NCT01534260|20471295|P1|Overall Study|Adverse Event|1
5917050|NCT01534208|20471305|P2|Overall Study|Needed prohibited meds|0
5917051|NCT01534208|20471306|P1|Overall Study|Needed prohibited meds|1
5917052|NCT01534208|20471305|P2|Overall Study|PCP decision|0
5917053|NCT01534208|20471306|P1|Overall Study|PCP decision|1
5917054|NCT01534208|20471305|P2|Overall Study|Eligibility error|0
5917055|NCT01534208|20471306|P1|Overall Study|Eligibility error|3
5917056|NCT01534208|20471305|P2|Overall Study|Lab assessment|1
5917057|NCT01534208|20471306|P1|Overall Study|Lab assessment|2
5917058|NCT01534208|20471305|P2|Overall Study|Subject relocation|0
5917059|NCT01534208|20471306|P1|Overall Study|Subject relocation|2
5917060|NCT01534208|20471305|P2|Overall Study|Sponsor decision|1
5917061|NCT01534208|20471306|P1|Overall Study|Sponsor decision|4
5917062|NCT01534208|20471305|P2|Overall Study|Protocol Violation|2
5917063|NCT01534208|20471306|P1|Overall Study|Protocol Violation|2
5917064|NCT01534208|20471305|P2|Overall Study|Lack of Efficacy|3
5917065|NCT01534208|20471306|P1|Overall Study|Lack of Efficacy|0
5917066|NCT01534208|20471305|P2|Overall Study|Physician Decision|0
5917067|NCT01534208|20471306|P1|Overall Study|Physician Decision|2
5917068|NCT01534208|20471305|P2|Overall Study|Adverse Event|8
5917069|NCT01534208|20471306|P1|Overall Study|Adverse Event|15
5917070|NCT01534208|20471305|P2|Overall Study|Withdrawal by Subject|20
5917071|NCT01534208|20471306|P1|Overall Study|Withdrawal by Subject|6
5917072|NCT01534208|20471305|P2|Overall Study|Lost to Follow-up|14
5917073|NCT01534208|20471306|P1|Overall Study|Lost to Follow-up|19
5917074|NCT01534195|20471324|P2|Overall Study|Withdrawal by Subject|1
5917075|NCT01534195|20471325|P1|Overall Study|Withdrawal by Subject|1
5917076|NCT01534182|20471339|P2|Overall Study|Adverse Event|3
5917077|NCT01534182|20471340|P1|Overall Study|Adverse Event|7
5917078|NCT01534182|20471339|P2|Overall Study|Withdrawal by Subject|7
5917079|NCT01534182|20471340|P1|Overall Study|Withdrawal by Subject|4
5917080|NCT01534182|20471339|P2|Overall Study|Administrative problems|0
5917081|NCT01534182|20471340|P1|Overall Study|Administrative problems|1
5917082|NCT01534078|20471371|P1|Overall Study|Withdrawal by Subject|1
5917083|NCT01534078|20471371|P1|Overall Study|Death|1
5917084|NCT01533935|20471408|P5|Overall Study|Other reason not defined above|1
5917085|NCT01533935|20471409|P4|Overall Study|Other reason not defined above|0
5917086|NCT01533935|20471410|P3|Overall Study|Other reason not defined above|1
5917087|NCT01533935|20471411|P2|Overall Study|Other reason not defined above|0
5917088|NCT01533935|20471412|P1|Overall Study|Other reason not defined above|1
5917089|NCT01533935|20471408|P5|Overall Study|Withdrawal by Subject|4
5917090|NCT01533935|20471409|P4|Overall Study|Withdrawal by Subject|2
5917091|NCT01533935|20471410|P3|Overall Study|Withdrawal by Subject|5
5917092|NCT01533935|20471411|P2|Overall Study|Withdrawal by Subject|4
5917093|NCT01533935|20471412|P1|Overall Study|Withdrawal by Subject|0
5917094|NCT01533935|20471408|P5|Overall Study|Lost to Follow-up|0
5917095|NCT01533935|20471409|P4|Overall Study|Lost to Follow-up|0
5917096|NCT01533935|20471410|P3|Overall Study|Lost to Follow-up|1
5917097|NCT01533935|20471411|P2|Overall Study|Lost to Follow-up|0
5917098|NCT01533935|20471412|P1|Overall Study|Lost to Follow-up|0
5917099|NCT01533935|20471408|P5|Overall Study|Protocol Violation|0
5917100|NCT01533935|20471409|P4|Overall Study|Protocol Violation|0
5917101|NCT01533935|20471410|P3|Overall Study|Protocol Violation|0
5917102|NCT01533935|20471411|P2|Overall Study|Protocol Violation|2
5917103|NCT01533935|20471412|P1|Overall Study|Protocol Violation|0
5917104|NCT01533935|20471408|P5|Overall Study|Adverse Event|3
5917105|NCT01533935|20471409|P4|Overall Study|Adverse Event|5
5917106|NCT01533935|20471410|P3|Overall Study|Adverse Event|1
5917107|NCT01533935|20471411|P2|Overall Study|Adverse Event|7
5917108|NCT01533935|20471412|P1|Overall Study|Adverse Event|5
5917109|NCT01533922|20471439|P5|Overall Study|Other reason not defined above|0
5917110|NCT01533922|20471440|P4|Overall Study|Other reason not defined above|0
5917111|NCT01533922|20471441|P3|Overall Study|Other reason not defined above|1
5917112|NCT01533922|20471442|P2|Overall Study|Other reason not defined above|0
5917113|NCT01533922|20471443|P1|Overall Study|Other reason not defined above|2
5917114|NCT01533922|20471439|P5|Overall Study|Withdrawal by Subject|1
5917115|NCT01533922|20471440|P4|Overall Study|Withdrawal by Subject|2
5917116|NCT01533922|20471441|P3|Overall Study|Withdrawal by Subject|2
5917117|NCT01533922|20471442|P2|Overall Study|Withdrawal by Subject|1
5917118|NCT01533922|20471443|P1|Overall Study|Withdrawal by Subject|3
5917119|NCT01533922|20471439|P5|Overall Study|Protocol Violation|1
5917120|NCT01533922|20471440|P4|Overall Study|Protocol Violation|0
5917121|NCT01533922|20471441|P3|Overall Study|Protocol Violation|0
5917122|NCT01533922|20471442|P2|Overall Study|Protocol Violation|3
5917123|NCT01533922|20471443|P1|Overall Study|Protocol Violation|0
5917124|NCT01533922|20471439|P5|Overall Study|Lack of Efficacy|0
5917125|NCT01533922|20471440|P4|Overall Study|Lack of Efficacy|0
5917126|NCT01533922|20471441|P3|Overall Study|Lack of Efficacy|1
5917127|NCT01533922|20471442|P2|Overall Study|Lack of Efficacy|0
5917128|NCT01533922|20471443|P1|Overall Study|Lack of Efficacy|0
5917129|NCT01533922|20471439|P5|Overall Study|Adverse Event|4
5917130|NCT01533922|20471440|P4|Overall Study|Adverse Event|3
5917131|NCT01533922|20471441|P3|Overall Study|Adverse Event|6
5917132|NCT01533922|20471442|P2|Overall Study|Adverse Event|8
5917133|NCT01533922|20471443|P1|Overall Study|Adverse Event|5
5917134|NCT01533688|20471488|P3|Overall Study|Had colonoscopy at outside hospital|2
5917135|NCT01533688|20471489|P2|Overall Study|Had colonoscopy at outside hospital|3
5917136|NCT01533688|20471490|P1|Overall Study|Had colonoscopy at outside hospital|2
5917137|NCT01533688|20471488|P3|Overall Study|Medically unstable|3
5917138|NCT01533688|20471489|P2|Overall Study|Medically unstable|3
5917139|NCT01533688|20471490|P1|Overall Study|Medically unstable|1
5917140|NCT01533688|20471488|P3|Overall Study|Withdrawal by Subject|3
5917141|NCT01533688|20471489|P2|Overall Study|Withdrawal by Subject|4
5917142|NCT01533688|20471490|P1|Overall Study|Withdrawal by Subject|5
5917143|NCT01533493|20471522|P2|Overall Study|Lost to Follow-up|0
5917144|NCT01533493|20471523|P1|Overall Study|Lost to Follow-up|2
5917145|NCT01533493|20471522|P2|Overall Study|Withdrawal by Subject|2
5917146|NCT01533493|20471523|P1|Overall Study|Withdrawal by Subject|1
5917147|NCT01533493|20471522|P2|Overall Study|Adverse Event|1
5917148|NCT01533493|20471523|P1|Overall Study|Adverse Event|2
5917149|NCT01533428|20471531|P2|Overall Study|Withdrawal by Subject|6
5917150|NCT01533428|20471532|P1|Overall Study|Withdrawal by Subject|7
5917151|NCT01533428|20471531|P2|Overall Study|Lost to Follow-up|1
5917152|NCT01533428|20471532|P1|Overall Study|Lost to Follow-up|2
5917153|NCT01533428|20471531|P2|Overall Study|Adverse Event|1
5917154|NCT01533428|20471532|P1|Overall Study|Adverse Event|0
5917155|NCT01533246|20471578|P1|Overall Study|Withdrawal by Subject|1
5917156|NCT01533246|20471578|P1|Overall Study|Adverse Event|1
5917157|NCT01533181|20471602|P2|Overall Study|Patient withdrawal pre-active treatment|0
5917158|NCT01533181|20471603|P1|Overall Study|Patient withdrawal pre-active treatment|1
5917159|NCT01533181|20471602|P2|Overall Study|Disease progression pre-active treatment|1
5917160|NCT01533181|20471603|P1|Overall Study|Disease progression pre-active treatment|0
5917161|NCT01532999|20471720|P2|Overall Study|New job|2
5917162|NCT01532999|20471721|P1|Overall Study|New job|0
5917163|NCT01532999|20471720|P2|Overall Study|incarcerated|1
5917164|NCT01532999|20471721|P1|Overall Study|incarcerated|0
5917165|NCT01532999|20471720|P2|Overall Study|Adverse Event|1
5917166|NCT01532999|20471721|P1|Overall Study|Adverse Event|0
5917167|NCT01532999|20471720|P2|Overall Study|no show for week 9 assessments|4
5917168|NCT01532999|20471721|P1|Overall Study|no show for week 9 assessments|6
5917169|NCT01532999|20471720|P2|Overall Study|substantial noncompliance|0
5917170|NCT01532999|20471721|P1|Overall Study|substantial noncompliance|2
5917171|NCT01532999|20471720|P2|Overall Study|should not have been randomized|0
5917172|NCT01532999|20471721|P1|Overall Study|should not have been randomized|1
5917173|NCT01532999|20471720|P2|Overall Study|Relocated|0
5917174|NCT01532999|20471721|P1|Overall Study|Relocated|2
5917175|NCT01532999|20471720|P2|Overall Study|Withdrawal by Subject|0
5917176|NCT01532999|20471721|P1|Overall Study|Withdrawal by Subject|5
5917177|NCT01532999|20471720|P2|Overall Study|Physician Decision|2
5917178|NCT01532999|20471721|P1|Overall Study|Physician Decision|1
5917179|NCT01532999|20471720|P2|Overall Study|Lost to Follow-up|8
5917180|NCT01532999|20471721|P1|Overall Study|Lost to Follow-up|14
5917181|NCT01532986|20471745|P2|Overall Study|Physician Decision|5
5917182|NCT01532986|20471746|P1|Overall Study|Physician Decision|7
5917183|NCT01532986|20471745|P2|Overall Study|Withdrawal by Subject|10
5917184|NCT01532986|20471746|P1|Overall Study|Withdrawal by Subject|7
5917185|NCT01532986|20471745|P2|Overall Study|Death|9
5917186|NCT01532986|20471746|P1|Overall Study|Death|9
5917187|NCT01532934|20471830|P2|Overall Study|In controlled environment|2
5917188|NCT01532934|20471831|P1|Overall Study|In controlled environment|3
5917189|NCT01532934|20471830|P2|Overall Study|Lost to Follow-up|11
5917190|NCT01532934|20471831|P1|Overall Study|Lost to Follow-up|11
5917191|NCT01532921|20471841|P1|Overall Study|Device was explanted during procedure|1
5917192|NCT01532921|20471841|P1|Overall Study|Physician Decision|7
5917193|NCT01532921|20471841|P1|Overall Study|Lost to Follow-up|3
5917194|NCT01532921|20471841|P1|Overall Study|Withdrawal by Subject|2
5917195|NCT01532921|20471841|P1|Overall Study|Death|3
5917196|NCT01532869|20471863|P2|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1
5917197|NCT01532869|20471864|P1|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1
5917198|NCT01532869|20471863|P2|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1
5917199|NCT01532869|20471864|P1|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1
5917200|NCT01532869|20471863|P2|Open-label Period (Week 48 to Week 96)|Non-compliance|0
5917201|NCT01532869|20471864|P1|Open-label Period (Week 48 to Week 96)|Non-compliance|1
5917202|NCT01532869|20471863|P2|Open-label Period (Week 48 to Week 96)|Adverse Event|1
5917203|NCT01532869|20471864|P1|Open-label Period (Week 48 to Week 96)|Adverse Event|4
5917204|NCT01532869|20471863|P2|Blinded-Treatment Period (Up to Week 48)|Physician Decision|0
5917205|NCT01532869|20471864|P1|Blinded-Treatment Period (Up to Week 48)|Physician Decision|1
5917206|NCT01532869|20471863|P2|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|3
5917207|NCT01532869|20471864|P1|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|5
5917208|NCT01532869|20471863|P2|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|1
5917209|NCT01532869|20471864|P1|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|0
5917210|NCT01532869|20471863|P2|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|0
5917211|NCT01532869|20471864|P1|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|1
5917212|NCT01532869|20471863|P2|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|1
5917213|NCT01532869|20471864|P1|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|0
5917214|NCT01532869|20471863|P2|Blinded-Treatment Period (Up to Week 48)|Adverse Event|5
5917215|NCT01532869|20471864|P1|Blinded-Treatment Period (Up to Week 48)|Adverse Event|4
5917216|NCT01532869|20471863|P2|Blinded-Treatment Period (Up to Week 48)|Death|3
5917217|NCT01532869|20471864|P1|Blinded-Treatment Period (Up to Week 48)|Death|0
5917218|NCT01532869|20471863|P2|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|2
5917219|NCT01532869|20471864|P1|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|4
5917220|NCT01532869|20471863|P2|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1
5917221|NCT01532869|20471864|P1|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1
5917222|NCT01532869|20471863|P2|Blinded-Treatment Period (Up to Week 24)|Non-compliance|0
5917223|NCT01532869|20471864|P1|Blinded-Treatment Period (Up to Week 24)|Non-compliance|1
5917224|NCT01532869|20471863|P2|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|1
5917225|NCT01532869|20471864|P1|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|0
5917226|NCT01532869|20471863|P2|Blinded-Treatment Period (Up to Week 24)|Adverse Event|3
5917227|NCT01532869|20471864|P1|Blinded-Treatment Period (Up to Week 24)|Adverse Event|2
5917228|NCT01532869|20471863|P2|Blinded-Treatment Period (Up to Week 24)|Death|1
5917229|NCT01532869|20471864|P1|Blinded-Treatment Period (Up to Week 24)|Death|0
5917230|NCT01532648|20471923|P2|Overall Study|Withdrawal by Subject|2
5917231|NCT01532648|20471924|P1|Overall Study|Withdrawal by Subject|16
5917232|NCT01532648|20471923|P2|Overall Study|Adverse Event|9
5917233|NCT01532648|20471924|P1|Overall Study|Adverse Event|12
5917234|NCT01532648|20471923|P2|Overall Study|Protocol Violation|1
5917235|NCT01532648|20471924|P1|Overall Study|Protocol Violation|1
5917236|NCT01532648|20471923|P2|Overall Study|Lack of Efficacy|1
5917237|NCT01532648|20471924|P1|Overall Study|Lack of Efficacy|4
5917238|NCT01532648|20471923|P2|Overall Study|Lost to Follow-up|4
5917239|NCT01532648|20471924|P1|Overall Study|Lost to Follow-up|3
5917240|NCT01532570|20471958|P4|Overall Study|Withdrawal by Subject|0
5917241|NCT01532570|20471959|P3|Overall Study|Withdrawal by Subject|0
5917242|NCT01532570|20471960|P2|Overall Study|Withdrawal by Subject|1
5917243|NCT01532570|20471961|P1|Overall Study|Withdrawal by Subject|0
5917244|NCT01532570|20471958|P4|Overall Study|Lack of Efficacy|0
5917245|NCT01532570|20471959|P3|Overall Study|Lack of Efficacy|0
5917246|NCT01532570|20471960|P2|Overall Study|Lack of Efficacy|0
5917247|NCT01532570|20471961|P1|Overall Study|Lack of Efficacy|1
5917248|NCT01532414|20472006|P3|Overall Study|Withdrawn by sponsor|0
5917249|NCT01532414|20472007|P2|Overall Study|Withdrawn by sponsor|0
5917250|NCT01532414|20472008|P1|Overall Study|Withdrawn by sponsor|1
5917251|NCT01532414|20472006|P3|Overall Study|Unable to complete 24 hour PK|1
5917252|NCT01532414|20472007|P2|Overall Study|Unable to complete 24 hour PK|0
5917253|NCT01532414|20472008|P1|Overall Study|Unable to complete 24 hour PK|0
5917254|NCT01532414|20472006|P3|Overall Study|Adverse Event|1
5917255|NCT01532414|20472007|P2|Overall Study|Adverse Event|1
5917256|NCT01532414|20472008|P1|Overall Study|Adverse Event|0
5917257|NCT01532414|20472006|P3|Overall Study|No V6 semen sample|0
5917258|NCT01532414|20472007|P2|Overall Study|No V6 semen sample|1
5917259|NCT01532414|20472008|P1|Overall Study|No V6 semen sample|0
5917260|NCT01532414|20472006|P3|Overall Study|Withdrawal by Subject|0
5917261|NCT01532414|20472007|P2|Overall Study|Withdrawal by Subject|0
5917262|NCT01532414|20472008|P1|Overall Study|Withdrawal by Subject|3
5917263|NCT01532414|20472006|P3|Overall Study|Lost to Follow-up|1
5917264|NCT01532414|20472007|P2|Overall Study|Lost to Follow-up|0
5917265|NCT01532414|20472008|P1|Overall Study|Lost to Follow-up|3
5917266|NCT01532388|20472018|P2|12-month Follow-up|Lost to Follow-up|67
5917267|NCT01532388|20472019|P1|12-month Follow-up|Lost to Follow-up|69
5917268|NCT01532388|20472018|P2|6-month Follow-up|Lost to Follow-up|66
5917269|NCT01532388|20472019|P1|6-month Follow-up|Lost to Follow-up|74
5917270|NCT01532388|20472018|P2|3-month Follow-up|Lost to Follow-up|68
5917271|NCT01532388|20472019|P1|3-month Follow-up|Lost to Follow-up|68
5917272|NCT01531998|20472124|P1|Overall Study|Withdrawal by Subject|3
5917273|NCT01531894|20472146|P1|Overall Study|Death|1
5917274|NCT01531894|20472146|P1|Overall Study|Physician Decision|8
5917275|NCT01531725|20472163|P1|Overall Study|Protocol Violation|5
5917276|NCT01531673|20472181|P13|Overall Study|Other|0
5917277|NCT01531673|20472182|P12|Overall Study|Other|0
5917278|NCT01531673|20472183|P11|Overall Study|Other|0
5917279|NCT01531673|20472184|P10|Overall Study|Other|1
5917280|NCT01531673|20472185|P9|Overall Study|Other|0
5917281|NCT01531673|20472186|P8|Overall Study|Other|0
5917282|NCT01531673|20472187|P7|Overall Study|Other|0
5917283|NCT01531673|20472188|P6|Overall Study|Other|0
5917284|NCT01531673|20472189|P5|Overall Study|Other|0
5917285|NCT01531673|20472190|P4|Overall Study|Other|1
5917286|NCT01531673|20472191|P3|Overall Study|Other|0
5917287|NCT01531673|20472192|P2|Overall Study|Other|0
5917288|NCT01531673|20472193|P1|Overall Study|Other|0
5917289|NCT01531673|20472181|P13|Overall Study|Lost to Follow-up|0
5917290|NCT01531673|20472182|P12|Overall Study|Lost to Follow-up|0
5917291|NCT01531673|20472183|P11|Overall Study|Lost to Follow-up|0
5917292|NCT01531673|20472184|P10|Overall Study|Lost to Follow-up|0
5917293|NCT01531673|20472185|P9|Overall Study|Lost to Follow-up|0
5917294|NCT01531673|20472186|P8|Overall Study|Lost to Follow-up|0
5917295|NCT01531673|20472187|P7|Overall Study|Lost to Follow-up|0
5917296|NCT01531673|20472188|P6|Overall Study|Lost to Follow-up|0
5917297|NCT01531673|20472189|P5|Overall Study|Lost to Follow-up|1
5917298|NCT01531673|20472190|P4|Overall Study|Lost to Follow-up|0
5917299|NCT01531673|20472191|P3|Overall Study|Lost to Follow-up|0
5917300|NCT01531673|20472192|P2|Overall Study|Lost to Follow-up|0
5917301|NCT01531673|20472193|P1|Overall Study|Lost to Follow-up|0
5917302|NCT01531673|20472181|P13|Overall Study|Adverse Event|0
5917303|NCT01531673|20472182|P12|Overall Study|Adverse Event|0
5917304|NCT01531673|20472183|P11|Overall Study|Adverse Event|0
5917305|NCT01531673|20472184|P10|Overall Study|Adverse Event|0
5917306|NCT01531673|20472185|P9|Overall Study|Adverse Event|0
5917307|NCT01531673|20472186|P8|Overall Study|Adverse Event|0
5917308|NCT01531673|20472187|P7|Overall Study|Adverse Event|0
5917309|NCT01531673|20472188|P6|Overall Study|Adverse Event|0
5917310|NCT01531673|20472189|P5|Overall Study|Adverse Event|0
5917311|NCT01531673|20472190|P4|Overall Study|Adverse Event|0
5917312|NCT01531673|20472191|P3|Overall Study|Adverse Event|0
5917313|NCT01531673|20472192|P2|Overall Study|Adverse Event|1
5917314|NCT01531673|20472193|P1|Overall Study|Adverse Event|0
5917315|NCT01531673|20472181|P13|Overall Study|Non-Compliance|0
5917316|NCT01531673|20472182|P12|Overall Study|Non-Compliance|0
5917317|NCT01531673|20472183|P11|Overall Study|Non-Compliance|0
5917318|NCT01531673|20472184|P10|Overall Study|Non-Compliance|0
5917319|NCT01531673|20472185|P9|Overall Study|Non-Compliance|0
5917320|NCT01531673|20472186|P8|Overall Study|Non-Compliance|0
5917321|NCT01531673|20472187|P7|Overall Study|Non-Compliance|0
5917322|NCT01531673|20472188|P6|Overall Study|Non-Compliance|1
5917323|NCT01531673|20472189|P5|Overall Study|Non-Compliance|0
5917324|NCT01531673|20472190|P4|Overall Study|Non-Compliance|0
5917325|NCT01531673|20472191|P3|Overall Study|Non-Compliance|0
5917326|NCT01531673|20472192|P2|Overall Study|Non-Compliance|0
5917327|NCT01531673|20472193|P1|Overall Study|Non-Compliance|0
5917328|NCT01531387|20472319|P2|Overall Study|Early termination of study|11
5917329|NCT01531387|20472320|P1|Overall Study|Early termination of study|11
5917330|NCT01531205|20472412|P1|Overall Study|Did not proceed to surgery|1
5917331|NCT01531153|20472424|P3|Overall Study|Withdrawal by Subject|15
5917332|NCT01531153|20472425|P2|Overall Study|Withdrawal by Subject|9
5917333|NCT01531153|20472426|P1|Overall Study|Withdrawal by Subject|10
5917334|NCT01530997|20472482|P1|Overall Study|Withdrawal by Subject|1
5917335|NCT01530997|20472482|P1|Overall Study|Physician Decision|1
5917336|NCT01530464|20472526|P2|Washout (24h)|Withdrawal by Subject|1
5917337|NCT01530464|20472527|P1|Washout (24h)|Withdrawal by Subject|0
5917338|NCT01530464|20472526|P2|Washout (24h)|Withdrawal by Subject|0
5917339|NCT01530464|20472527|P1|Washout (24h)|Withdrawal by Subject|1
5917340|NCT01530334|20472579|P1|Overall Study|Progressive disease|47
5917341|NCT01530334|20472579|P1|Overall Study|unknown reason|1
5917342|NCT01530334|20472579|P1|Overall Study|Adverse Event|3
5917343|NCT01530087|20472626|P1|Overall Study|Physician Decision|2
5917344|NCT01529749|20472642|P4|Overall Study|Protocol Violation|1
5917345|NCT01529749|20472643|P3|Overall Study|Protocol Violation|0
5917346|NCT01529749|20472644|P2|Overall Study|Protocol Violation|0
5917347|NCT01529749|20472645|P1|Overall Study|Protocol Violation|0
5917348|NCT01529749|20472642|P4|Overall Study|Withdrawal by Subject|0
5917349|NCT01529749|20472643|P3|Overall Study|Withdrawal by Subject|1
5917350|NCT01529749|20472644|P2|Overall Study|Withdrawal by Subject|1
5917351|NCT01529749|20472645|P1|Overall Study|Withdrawal by Subject|0
5917352|NCT01529749|20472642|P4|Overall Study|Physician Decision|1
5917353|NCT01529749|20472643|P3|Overall Study|Physician Decision|0
5917354|NCT01529749|20472644|P2|Overall Study|Physician Decision|0
5917355|NCT01529749|20472645|P1|Overall Study|Physician Decision|0
5917356|NCT01529749|20472642|P4|Overall Study|Lost to Follow-up|0
5917357|NCT01529749|20472643|P3|Overall Study|Lost to Follow-up|1
5917358|NCT01529749|20472644|P2|Overall Study|Lost to Follow-up|1
5917359|NCT01529749|20472645|P1|Overall Study|Lost to Follow-up|0
5917360|NCT01529645|20472729|P10|Overall Study|Withdrawal by Subject|0
5917361|NCT01529645|20472730|P9|Overall Study|Withdrawal by Subject|0
5917362|NCT01529645|20472731|P8|Overall Study|Withdrawal by Subject|0
5917363|NCT01529645|20472732|P7|Overall Study|Withdrawal by Subject|0
5917364|NCT01529645|20472733|P6|Overall Study|Withdrawal by Subject|1
5917365|NCT01529645|20472734|P5|Overall Study|Withdrawal by Subject|1
5917366|NCT01529645|20472735|P4|Overall Study|Withdrawal by Subject|1
5917367|NCT01529645|20472736|P3|Overall Study|Withdrawal by Subject|0
5917368|NCT01529645|20472737|P2|Overall Study|Withdrawal by Subject|0
5917369|NCT01529645|20472738|P1|Overall Study|Withdrawal by Subject|2
5917370|NCT01529645|20472729|P10|Overall Study|SAE - Premature contractions|0
5917371|NCT01529645|20472730|P9|Overall Study|SAE - Premature contractions|0
5917372|NCT01529645|20472731|P8|Overall Study|SAE - Premature contractions|0
5917373|NCT01529645|20472732|P7|Overall Study|SAE - Premature contractions|0
5917374|NCT01529645|20472733|P6|Overall Study|SAE - Premature contractions|0
5917375|NCT01529645|20472734|P5|Overall Study|SAE - Premature contractions|0
5917376|NCT01529645|20472735|P4|Overall Study|SAE - Premature contractions|0
5917377|NCT01529645|20472736|P3|Overall Study|SAE - Premature contractions|1
5917378|NCT01529645|20472737|P2|Overall Study|SAE - Premature contractions|0
5917379|NCT01529645|20472738|P1|Overall Study|SAE - Premature contractions|0
5917380|NCT01529645|20472729|P10|Overall Study|Lost to Follow-up|0
5917381|NCT01529645|20472730|P9|Overall Study|Lost to Follow-up|1
5917382|NCT01529645|20472731|P8|Overall Study|Lost to Follow-up|0
5917383|NCT01529645|20472732|P7|Overall Study|Lost to Follow-up|2
5917384|NCT01529645|20472733|P6|Overall Study|Lost to Follow-up|0
5917385|NCT01529645|20472734|P5|Overall Study|Lost to Follow-up|1
5917386|NCT01529645|20472735|P4|Overall Study|Lost to Follow-up|1
5917387|NCT01529645|20472736|P3|Overall Study|Lost to Follow-up|1
5917388|NCT01529645|20472737|P2|Overall Study|Lost to Follow-up|1
5917389|NCT01529645|20472738|P1|Overall Study|Lost to Follow-up|0
5917390|NCT01529632|20472836|P2|Overall Study|Adverse Event|1
5917391|NCT01529632|20472837|P1|Overall Study|Adverse Event|1
5917392|NCT01529632|20472836|P2|Overall Study|Protocol Violation|1
5917393|NCT01529632|20472837|P1|Overall Study|Protocol Violation|0
5917394|NCT01529632|20472836|P2|Overall Study|Administrative problem|1
5917395|NCT01529632|20472837|P1|Overall Study|Administrative problem|2
5917396|NCT01529606|20472857|P2|Overall Study|Lost to Follow-up|18
5917397|NCT01529606|20472858|P1|Overall Study|Lost to Follow-up|21
5917398|NCT01529515|20472870|P4|DOUBLE BLIND PHASE|Other|2
5917399|NCT01529515|20472871|P3|DOUBLE BLIND PHASE|Other|9
5917400|NCT01529515|20472872|P2|DOUBLE BLIND PHASE|Other|0
5917401|NCT01529515|20472873|P1|DOUBLE BLIND PHASE|Other|0
5917402|NCT01529515|20472870|P4|DOUBLE BLIND PHASE|Protocol Violation|0
5917403|NCT01529515|20472871|P3|DOUBLE BLIND PHASE|Protocol Violation|1
5917404|NCT01529515|20472872|P2|DOUBLE BLIND PHASE|Protocol Violation|0
5917405|NCT01529515|20472873|P1|DOUBLE BLIND PHASE|Protocol Violation|0
5917406|NCT01529515|20472870|P4|DOUBLE BLIND PHASE|Withdrawal by Subject|7
5917407|NCT01529515|20472871|P3|DOUBLE BLIND PHASE|Withdrawal by Subject|10
5917408|NCT01529515|20472872|P2|DOUBLE BLIND PHASE|Withdrawal by Subject|0
5917409|NCT01529515|20472873|P1|DOUBLE BLIND PHASE|Withdrawal by Subject|0
5917410|NCT01529515|20472870|P4|DOUBLE BLIND PHASE|Pregnancy|0
5917411|NCT01529515|20472871|P3|DOUBLE BLIND PHASE|Pregnancy|1
5917412|NCT01529515|20472872|P2|DOUBLE BLIND PHASE|Pregnancy|0
5917413|NCT01529515|20472873|P1|DOUBLE BLIND PHASE|Pregnancy|0
5917414|NCT01529515|20472870|P4|DOUBLE BLIND PHASE|Lost to Follow-up|3
5917415|NCT01529515|20472871|P3|DOUBLE BLIND PHASE|Lost to Follow-up|1
5917416|NCT01529515|20472872|P2|DOUBLE BLIND PHASE|Lost to Follow-up|0
5917417|NCT01529515|20472873|P1|DOUBLE BLIND PHASE|Lost to Follow-up|0
5917418|NCT01529515|20472870|P4|DOUBLE BLIND PHASE|Adverse Event|0
5917419|NCT01529515|20472871|P3|DOUBLE BLIND PHASE|Adverse Event|1
5917420|NCT01529515|20472872|P2|DOUBLE BLIND PHASE|Adverse Event|0
5917421|NCT01529515|20472873|P1|DOUBLE BLIND PHASE|Adverse Event|0
5917422|NCT01529515|20472870|P4|MAINTENANCE PHASE|Other|0
5917423|NCT01529515|20472871|P3|MAINTENANCE PHASE|Other|0
5917424|NCT01529515|20472872|P2|MAINTENANCE PHASE|Other|10
5917425|NCT01529515|20472873|P1|MAINTENANCE PHASE|Other|0
5917426|NCT01529515|20472870|P4|MAINTENANCE PHASE|Failed Randomization Criteria|0
5917427|NCT01529515|20472871|P3|MAINTENANCE PHASE|Failed Randomization Criteria|0
5917428|NCT01529515|20472872|P2|MAINTENANCE PHASE|Failed Randomization Criteria|13
5917429|NCT01529515|20472873|P1|MAINTENANCE PHASE|Failed Randomization Criteria|0
5917430|NCT01529515|20472870|P4|MAINTENANCE PHASE|Withdrawal by Subject|0
5917431|NCT01529515|20472871|P3|MAINTENANCE PHASE|Withdrawal by Subject|0
5917432|NCT01529515|20472872|P2|MAINTENANCE PHASE|Withdrawal by Subject|15
5917433|NCT01529515|20472873|P1|MAINTENANCE PHASE|Withdrawal by Subject|0
5917434|NCT01529515|20472870|P4|MAINTENANCE PHASE|Protocol Violation|0
5917435|NCT01529515|20472871|P3|MAINTENANCE PHASE|Protocol Violation|0
5917436|NCT01529515|20472872|P2|MAINTENANCE PHASE|Protocol Violation|12
5917437|NCT01529515|20472873|P1|MAINTENANCE PHASE|Protocol Violation|0
5917438|NCT01529515|20472870|P4|MAINTENANCE PHASE|Lost to Follow-up|0
5917439|NCT01529515|20472871|P3|MAINTENANCE PHASE|Lost to Follow-up|0
5917440|NCT01529515|20472872|P2|MAINTENANCE PHASE|Lost to Follow-up|5
5917441|NCT01529515|20472873|P1|MAINTENANCE PHASE|Lost to Follow-up|0
5917442|NCT01529515|20472870|P4|MAINTENANCE PHASE|Lack of Efficacy|0
5917443|NCT01529515|20472871|P3|MAINTENANCE PHASE|Lack of Efficacy|0
5917444|NCT01529515|20472872|P2|MAINTENANCE PHASE|Lack of Efficacy|9
5917445|NCT01529515|20472873|P1|MAINTENANCE PHASE|Lack of Efficacy|0
5917446|NCT01529515|20472870|P4|MAINTENANCE PHASE|Adverse Event|0
5917447|NCT01529515|20472871|P3|MAINTENANCE PHASE|Adverse Event|0
5917448|NCT01529515|20472872|P2|MAINTENANCE PHASE|Adverse Event|10
5917449|NCT01529515|20472873|P1|MAINTENANCE PHASE|Adverse Event|0
5917450|NCT01529515|20472870|P4|TRANSITION PHASE|Other|0
5917451|NCT01529515|20472871|P3|TRANSITION PHASE|Other|0
5917452|NCT01529515|20472872|P2|TRANSITION PHASE|Other|0
5917453|NCT01529515|20472873|P1|TRANSITION PHASE|Other|9
5917454|NCT01529515|20472870|P4|TRANSITION PHASE|Failed Maintenance Phase Criteria|0
5917455|NCT01529515|20472871|P3|TRANSITION PHASE|Failed Maintenance Phase Criteria|0
5917456|NCT01529515|20472872|P2|TRANSITION PHASE|Failed Maintenance Phase Criteria|0
5917457|NCT01529515|20472873|P1|TRANSITION PHASE|Failed Maintenance Phase Criteria|8
5917458|NCT01529515|20472870|P4|TRANSITION PHASE|Withdrawal by Subject|0
5917459|NCT01529515|20472871|P3|TRANSITION PHASE|Withdrawal by Subject|0
5917460|NCT01529515|20472872|P2|TRANSITION PHASE|Withdrawal by Subject|0
5917461|NCT01529515|20472873|P1|TRANSITION PHASE|Withdrawal by Subject|51
5917462|NCT01529515|20472870|P4|TRANSITION PHASE|Protocol Violation|0
5917463|NCT01529515|20472871|P3|TRANSITION PHASE|Protocol Violation|0
5917464|NCT01529515|20472872|P2|TRANSITION PHASE|Protocol Violation|0
5917465|NCT01529515|20472873|P1|TRANSITION PHASE|Protocol Violation|4
5917466|NCT01529515|20472870|P4|TRANSITION PHASE|Lost to Follow-up|0
5917467|NCT01529515|20472871|P3|TRANSITION PHASE|Lost to Follow-up|0
5917468|NCT01529515|20472872|P2|TRANSITION PHASE|Lost to Follow-up|0
5917469|NCT01529515|20472873|P1|TRANSITION PHASE|Lost to Follow-up|19
5917470|NCT01529515|20472870|P4|TRANSITION PHASE|Lack of Efficacy|0
5917471|NCT01529515|20472871|P3|TRANSITION PHASE|Lack of Efficacy|0
5917472|NCT01529515|20472872|P2|TRANSITION PHASE|Lack of Efficacy|0
5917473|NCT01529515|20472873|P1|TRANSITION PHASE|Lack of Efficacy|19
5917474|NCT01529515|20472870|P4|TRANSITION PHASE|Death|0
5917475|NCT01529515|20472871|P3|TRANSITION PHASE|Death|0
5917476|NCT01529515|20472872|P2|TRANSITION PHASE|Death|0
5917477|NCT01529515|20472873|P1|TRANSITION PHASE|Death|1
5917478|NCT01529515|20472870|P4|TRANSITION PHASE|Adverse Event|0
5917479|NCT01529515|20472871|P3|TRANSITION PHASE|Adverse Event|0
5917480|NCT01529515|20472872|P2|TRANSITION PHASE|Adverse Event|0
5917481|NCT01529515|20472873|P1|TRANSITION PHASE|Adverse Event|16
5917482|NCT01529385|20472920|P2|Overall Study|Lost to Follow-up|1
5917483|NCT01529385|20472921|P1|Overall Study|Lost to Follow-up|2
5917484|NCT01529346|20472950|P5|Overall Study|Other|0
5917485|NCT01529346|20472951|P4|Overall Study|Other|0
5917486|NCT01529346|20472952|P3|Overall Study|Other|1
5917487|NCT01529346|20472953|P2|Overall Study|Other|1
5917488|NCT01529346|20472954|P1|Overall Study|Other|0
5917489|NCT01529346|20472950|P5|Overall Study|Lost to Follow-up|0
5917490|NCT01529346|20472951|P4|Overall Study|Lost to Follow-up|0
5917491|NCT01529346|20472952|P3|Overall Study|Lost to Follow-up|1
5917492|NCT01529346|20472953|P2|Overall Study|Lost to Follow-up|0
5917493|NCT01529346|20472954|P1|Overall Study|Lost to Follow-up|2
5917494|NCT01529268|20473042|P2|Overall Study|Moved|0
5917495|NCT01529268|20473043|P1|Overall Study|Moved|3
5917496|NCT01529268|20473042|P2|Overall Study|Lost to Follow-up|3
5917497|NCT01529268|20473043|P1|Overall Study|Lost to Follow-up|9
5917498|NCT01529112|20473105|P2|Overall Study|Withdrawal by Subject|3
5917499|NCT01529112|20473106|P1|Overall Study|Withdrawal by Subject|7
5917500|NCT01529112|20473105|P2|Overall Study|Protocol Violation|0
5917501|NCT01529112|20473106|P1|Overall Study|Protocol Violation|1
5917502|NCT01529112|20473105|P2|Overall Study|Death|38
5917503|NCT01529112|20473106|P1|Overall Study|Death|59
5917504|NCT01529112|20473105|P2|Overall Study|Adverse Event|0
5917505|NCT01529112|20473106|P1|Overall Study|Adverse Event|2
5917506|NCT01529034|20473142|P1|Overall Study|Study drug not available|2
5917507|NCT01529034|20473142|P1|Overall Study|Investigator no longer available|2
5917508|NCT01529034|20473142|P1|Overall Study|Lack of Efficacy|4
5917509|NCT01529034|20473142|P1|Overall Study|Protocol Violation|4
5917510|NCT01529034|20473142|P1|Overall Study|Adverse Event|4
5917511|NCT01529034|20473142|P1|Overall Study|Caregiver no longer available|7
5917512|NCT01529034|20473142|P1|Overall Study|Noncompliance|8
5917513|NCT01529034|20473142|P1|Overall Study|No treated SCs within protocol window|13
5917514|NCT01529034|20473142|P1|Overall Study|Withdrawal by Subject|25
5917515|NCT01529034|20473142|P1|Overall Study|Study termination|29
5917516|NCT01529034|20473142|P1|Overall Study|Site closure|62
5917517|NCT01529034|20473142|P1|Overall Study|Discontinued prior to study treatment|14
5917518|NCT01528969|20473157|P2|Overall Study|absent from the school at baseline|0
5917519|NCT01528969|20473158|P1|Overall Study|absent from the school at baseline|2
5917520|NCT01528787|20473191|P4|Overall Study|Family Emergency|0
5917521|NCT01528787|20473192|P3|Overall Study|Family Emergency|1
5917522|NCT01528787|20473193|P2|Overall Study|Family Emergency|0
5917523|NCT01528787|20473194|P1|Overall Study|Family Emergency|0
5917524|NCT01528787|20473191|P4|Overall Study|Withdrawal by Subject|1
5917525|NCT01528787|20473192|P3|Overall Study|Withdrawal by Subject|0
5917526|NCT01528787|20473193|P2|Overall Study|Withdrawal by Subject|0
5917527|NCT01528787|20473194|P1|Overall Study|Withdrawal by Subject|0
5917528|NCT01528735|20473206|P2|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|0
5917529|NCT01528735|20473207|P1|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|1
5917530|NCT01528735|20473206|P2|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1
5917531|NCT01528735|20473207|P1|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1
5917532|NCT01528709|20473309|P2|Overall Study|allergy|0
5917533|NCT01528709|20473310|P1|Overall Study|allergy|1
5917534|NCT01528709|20473309|P2|Overall Study|Withdrawal by Subject|15
5917535|NCT01528709|20473310|P1|Overall Study|Withdrawal by Subject|10
5917536|NCT01528709|20473309|P2|Overall Study|Death|0
5917537|NCT01528709|20473310|P1|Overall Study|Death|2
5917538|NCT01528696|20473320|P2|Overall Study|See detailed description|19
5917539|NCT01528696|20473321|P1|Overall Study|See detailed description|18
5917540|NCT01528605|20473337|P6|Overall Study|Death|0
5917541|NCT01528605|20473338|P5|Overall Study|Death|0
5917542|NCT01528605|20473339|P4|Overall Study|Death|0
5917543|NCT01528605|20473340|P3|Overall Study|Death|0
5917544|NCT01528605|20473341|P2|Overall Study|Death|0
5917545|NCT01528605|20473342|P1|Overall Study|Death|1
5917546|NCT01528605|20473337|P6|Overall Study|Lost to Follow-up|0
5917547|NCT01528605|20473338|P5|Overall Study|Lost to Follow-up|0
5917548|NCT01528605|20473339|P4|Overall Study|Lost to Follow-up|1
5917549|NCT01528605|20473340|P3|Overall Study|Lost to Follow-up|1
5917550|NCT01528605|20473341|P2|Overall Study|Lost to Follow-up|0
5917551|NCT01528605|20473342|P1|Overall Study|Lost to Follow-up|1
5917552|NCT01528345|20473372|P2|Overall Study|Subject/Guardian Decision|0
5917553|NCT01528345|20473373|P1|Overall Study|Subject/Guardian Decision|5
5917554|NCT01528345|20473372|P2|Overall Study|Study Terminated by Sponsor|8
5917555|NCT01528345|20473373|P1|Overall Study|Study Terminated by Sponsor|4
5917556|NCT01528345|20473372|P2|Overall Study|Progressive Disease|40
5917557|NCT01528345|20473373|P1|Overall Study|Progressive Disease|26
5917558|NCT01528345|20473372|P2|Overall Study|Non-compliance with study treatment|0
5917559|NCT01528345|20473373|P1|Overall Study|Non-compliance with study treatment|1
5917560|NCT01528345|20473372|P2|Overall Study|Death|1
5917561|NCT01528345|20473373|P1|Overall Study|Death|1
5917562|NCT01528345|20473372|P2|Overall Study|Adverse Event|1
5917563|NCT01528345|20473373|P1|Overall Study|Adverse Event|10
5917564|NCT01528254|20473424|P2|Overall Study|No longer requires study drug|1
5917565|NCT01528254|20473425|P1|Overall Study|No longer requires study drug|1
5917566|NCT01528254|20473424|P2|Overall Study|Abnormal test procedure result(s)|0
5917567|NCT01528254|20473425|P1|Overall Study|Abnormal test procedure result(s)|1
5917568|NCT01528254|20473424|P2|Overall Study|Abnormal laboratory value(s)|7
5917569|NCT01528254|20473425|P1|Overall Study|Abnormal laboratory value(s)|3
5917570|NCT01528254|20473424|P2|Overall Study|Withdrawal by Subject|4
5917571|NCT01528254|20473425|P1|Overall Study|Withdrawal by Subject|5
5917572|NCT01528254|20473424|P2|Overall Study|Unsatisfactory therapeutic effect|8
5917573|NCT01528254|20473425|P1|Overall Study|Unsatisfactory therapeutic effect|6
5917574|NCT01528254|20473424|P2|Overall Study|New therapy for study indication|6
5917575|NCT01528254|20473425|P1|Overall Study|New therapy for study indication|8
5917576|NCT01528254|20473424|P2|Overall Study|Protocol deviation|19
5917577|NCT01528254|20473425|P1|Overall Study|Protocol deviation|9
5917578|NCT01528254|20473424|P2|Overall Study|Death|9
5917579|NCT01528254|20473425|P1|Overall Study|Death|13
5917580|NCT01528254|20473424|P2|Overall Study|Lost to Follow-up|24
5917581|NCT01528254|20473425|P1|Overall Study|Lost to Follow-up|17
5917582|NCT01528254|20473424|P2|Overall Study|Adverse Event|44
5917583|NCT01528254|20473425|P1|Overall Study|Adverse Event|28
5917584|NCT01528254|20473424|P2|Overall Study|Administrative problems|94
5917585|NCT01528254|20473425|P1|Overall Study|Administrative problems|96
5917586|NCT01528215|20473457|P2|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|0
5917587|NCT01528215|20473458|P1|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|3
5917588|NCT01528215|20473457|P2|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|13
5917589|NCT01528215|20473458|P1|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|10
5917590|NCT01528215|20473457|P2|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2
5917591|NCT01528215|20473458|P1|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2
5917592|NCT01528215|20473457|P2|Enrollment to 1 Year Follow-up|Adverse Event|1
5917593|NCT01528215|20473458|P1|Enrollment to 1 Year Follow-up|Adverse Event|4
5917594|NCT01528072|20473517|P1|Overall Study|Early Termination of Study|52
5917595|NCT01528072|20473517|P1|Overall Study|Death|2
5917596|NCT01528072|20473517|P1|Overall Study|Site Closure|4
5917597|NCT01528072|20473517|P1|Overall Study|Explanted|2
5917598|NCT01528072|20473517|P1|Overall Study|Lost to Follow-up|5
5917599|NCT01528072|20473517|P1|Overall Study|Missed Visit|2
5917600|NCT01528072|20473517|P1|Overall Study|Determined not eligible by AEAC|1
5917601|NCT01528072|20473517|P1|Overall Study|Physician Decision|1
5917602|NCT01528072|20473517|P1|Overall Study|Withdrawal by Subject|5
5917603|NCT01528033|20473523|P2|Follow Up|No data available|44
5917604|NCT01528033|20473524|P1|Follow Up|No data available|46
5917605|NCT01528033|20473523|P2|Primary Endpoint Assessment ITT|No post baseline documentation|2
5917606|NCT01528033|20473524|P1|Primary Endpoint Assessment ITT|No post baseline documentation|2
5917607|NCT01528033|20473523|P2|Primary Endpoint Assessment ITT|Physician Decision|1
5917608|NCT01528033|20473524|P1|Primary Endpoint Assessment ITT|Physician Decision|2
5917609|NCT01528033|20473523|P2|Primary Endpoint Assessment ITT|Death|2
5917610|NCT01528033|20473524|P1|Primary Endpoint Assessment ITT|Death|2
5917611|NCT01528033|20473523|P2|Primary Endpoint Assessment ITT|No or deliquent informed consent|3
5917612|NCT01528033|20473524|P1|Primary Endpoint Assessment ITT|No or deliquent informed consent|3
5917613|NCT01528033|20473523|P2|Primary Endpoint Assessment ITT|Withdrawal by Subject|7
5917614|NCT01528033|20473524|P1|Primary Endpoint Assessment ITT|Withdrawal by Subject|8
5917615|NCT01527682|20473547|P1|Overall Study|Protocol Violation|8
5917616|NCT01527500|20473570|P2|Part B|Adverse Event|0
5917617|NCT01527500|20473571|P1|Part B|Adverse Event|1
5917618|NCT01527500|20473570|P2|Part A|Withdrawal by Subject|0
5917619|NCT01527500|20473571|P1|Part A|Withdrawal by Subject|2
5917620|NCT01527500|20473570|P2|Part A|Protocol Deviation|2
5917621|NCT01527500|20473571|P1|Part A|Protocol Deviation|9
5917622|NCT01527500|20473570|P2|Part A|Lost to Follow-up|1
5917623|NCT01527500|20473571|P1|Part A|Lost to Follow-up|0
5917624|NCT01527500|20473570|P2|Part A|Death|1
5917625|NCT01527500|20473571|P1|Part A|Death|4
5917626|NCT01527500|20473570|P2|Part A|Adverse Event|2
5917627|NCT01527500|20473571|P1|Part A|Adverse Event|4
5917628|NCT01527500|20473570|P2|Part A|Administrative|7
5917629|NCT01527500|20473571|P1|Part A|Administrative|11
5917630|NCT01527487|20473601|P2|Overall Study|Death|1
5917631|NCT01527487|20473602|P1|Overall Study|Death|0
5917632|NCT01527487|20473601|P2|Overall Study|Adverse Event|1
5917633|NCT01527487|20473602|P1|Overall Study|Adverse Event|1
5917634|NCT01527487|20473601|P2|Overall Study|Disease Progression|1
5917635|NCT01527487|20473602|P1|Overall Study|Disease Progression|4
5917636|NCT01527487|20473601|P2|Overall Study|MD Discretion/Lack of Efficacy|4
5917637|NCT01527487|20473602|P1|Overall Study|MD Discretion/Lack of Efficacy|3
5917638|NCT01527383|20473616|P2|Overall Study|Withdrawal by Subject|3
5917639|NCT01527383|20473617|P1|Overall Study|Withdrawal by Subject|2
5917640|NCT01527383|20473616|P2|Overall Study|Participant moved|1
5917641|NCT01527383|20473617|P1|Overall Study|Participant moved|0
5917642|NCT01527383|20473616|P2|Overall Study|Screen failure|0
5917643|NCT01527383|20473617|P1|Overall Study|Screen failure|1
5917644|NCT01527383|20473616|P2|Overall Study|Protocol Violation|0
5917645|NCT01527383|20473617|P1|Overall Study|Protocol Violation|1
5917646|NCT01527383|20473616|P2|Overall Study|Pregnancy|0
5917647|NCT01527383|20473617|P1|Overall Study|Pregnancy|1
5917648|NCT01527383|20473616|P2|Overall Study|Physician Decision|0
5917649|NCT01527383|20473617|P1|Overall Study|Physician Decision|2
5917650|NCT01527383|20473616|P2|Overall Study|Lost to Follow-up|0
5917651|NCT01527383|20473617|P1|Overall Study|Lost to Follow-up|3
5917652|NCT01527383|20473616|P2|Overall Study|Adverse Event|0
5917653|NCT01527383|20473617|P1|Overall Study|Adverse Event|5
5917654|NCT01527370|20473631|P1|Overall Study|Death|1
5917655|NCT01527370|20473631|P1|Overall Study|Physician Decision|1
5917656|NCT01527370|20473631|P1|Overall Study|Withdrawal by Subject|4
5917657|NCT01527357|20473639|P2|Overall Study|Did Not Receive Treatment|0
5917658|NCT01527357|20473640|P1|Overall Study|Did Not Receive Treatment|2
5917659|NCT01527357|20473639|P2|Overall Study|No Day 29 Visit|1
5917660|NCT01527357|20473640|P1|Overall Study|No Day 29 Visit|0
5917661|NCT01527357|20473639|P2|Overall Study|Non-compliance|1
5917662|NCT01527357|20473640|P1|Overall Study|Non-compliance|0
5917663|NCT01527357|20473639|P2|Overall Study|Withdrew Consent|1
5917664|NCT01527357|20473640|P1|Overall Study|Withdrew Consent|1
5917665|NCT01527357|20473639|P2|Overall Study|Lost to Follow-up|4
5917666|NCT01527357|20473640|P1|Overall Study|Lost to Follow-up|6
5917667|NCT01527357|20473639|P2|Overall Study|Death|2
5917668|NCT01527357|20473640|P1|Overall Study|Death|8
5917669|NCT01527292|20473662|P2|Overall Study|Physician Decision|3
5917670|NCT01527292|20473663|P1|Overall Study|Physician Decision|0
5917671|NCT01527149|20473690|P1|Overall Study|Death|2
5917672|NCT01527110|20473705|P1|Overall Study|Adverse Event|1
5917673|NCT01527006|20473786|P2|Extension Phase|Other|3
5917674|NCT01527006|20473787|P1|Extension Phase|Other|0
5917675|NCT01527006|20473786|P2|Extension Phase|Inadequate therapeutic effect|1
5917676|NCT01527006|20473787|P1|Extension Phase|Inadequate therapeutic effect|1
5917677|NCT01527006|20473786|P2|Extension Phase|Subject Choice|1
5917678|NCT01527006|20473787|P1|Extension Phase|Subject Choice|1
5917679|NCT01527006|20473786|P2|Extension Phase|Lost to Follow-up|1
5917680|NCT01527006|20473787|P1|Extension Phase|Lost to Follow-up|0
5917681|NCT01527006|20473786|P2|Extension Phase|Adverse Event|2
5917682|NCT01527006|20473787|P1|Extension Phase|Adverse Event|4
5917683|NCT01527006|20473786|P2|Core Study|Other|2
5917684|NCT01527006|20473787|P1|Core Study|Other|0
5917685|NCT01527006|20473786|P2|Core Study|Withdrawal by Subject|1
5917686|NCT01527006|20473787|P1|Core Study|Withdrawal by Subject|0
5917687|NCT01527006|20473786|P2|Core Study|Inadequate Therapeutic Effect|0
5917688|NCT01527006|20473787|P1|Core Study|Inadequate Therapeutic Effect|1
5917689|NCT01527006|20473786|P2|Core Study|Subject Choice|0
5917690|NCT01527006|20473787|P1|Core Study|Subject Choice|1
5917691|NCT01527006|20473786|P2|Core Study|Lost to Follow-up|1
5917692|NCT01527006|20473787|P1|Core Study|Lost to Follow-up|0
5917693|NCT01527006|20473786|P2|Core Study|Adverse Event|2
5917694|NCT01527006|20473787|P1|Core Study|Adverse Event|0
5917695|NCT01526928|20473843|P6|Overall Study|Missing|0
5917696|NCT01526928|20473844|P5|Overall Study|Missing|2
5917697|NCT01526928|20473845|P4|Overall Study|Missing|0
5917698|NCT01526928|20473846|P3|Overall Study|Missing|1
5917699|NCT01526928|20473847|P2|Overall Study|Missing|0
5917700|NCT01526928|20473848|P1|Overall Study|Missing|0
5917701|NCT01526928|20473843|P6|Overall Study|Protocol Deviation|0
5917702|NCT01526928|20473844|P5|Overall Study|Protocol Deviation|0
5917703|NCT01526928|20473845|P4|Overall Study|Protocol Deviation|2
5917704|NCT01526928|20473846|P3|Overall Study|Protocol Deviation|0
5917705|NCT01526928|20473847|P2|Overall Study|Protocol Deviation|0
5917706|NCT01526928|20473848|P1|Overall Study|Protocol Deviation|0
5917707|NCT01526928|20473843|P6|Overall Study|Lost to Follow-up|0
5917708|NCT01526928|20473844|P5|Overall Study|Lost to Follow-up|0
5917709|NCT01526928|20473845|P4|Overall Study|Lost to Follow-up|1
5917710|NCT01526928|20473846|P3|Overall Study|Lost to Follow-up|0
5917711|NCT01526928|20473847|P2|Overall Study|Lost to Follow-up|0
5917712|NCT01526928|20473848|P1|Overall Study|Lost to Follow-up|0
5917713|NCT01526928|20473843|P6|Overall Study|Other Reason|0
5917714|NCT01526928|20473844|P5|Overall Study|Other Reason|1
5917715|NCT01526928|20473845|P4|Overall Study|Other Reason|4
5917716|NCT01526928|20473846|P3|Overall Study|Other Reason|11
5917717|NCT01526928|20473847|P2|Overall Study|Other Reason|1
5917718|NCT01526928|20473848|P1|Overall Study|Other Reason|0
5917719|NCT01526928|20473843|P6|Overall Study|Physician Decision|0
5917720|NCT01526928|20473844|P5|Overall Study|Physician Decision|0
5917721|NCT01526928|20473845|P4|Overall Study|Physician Decision|5
5917722|NCT01526928|20473846|P3|Overall Study|Physician Decision|2
5917723|NCT01526928|20473847|P2|Overall Study|Physician Decision|0
5917724|NCT01526928|20473848|P1|Overall Study|Physician Decision|0
5917725|NCT01526928|20473843|P6|Overall Study|Withdrawal by Subject|0
5917726|NCT01526928|20473844|P5|Overall Study|Withdrawal by Subject|3
5917727|NCT01526928|20473845|P4|Overall Study|Withdrawal by Subject|11
5917728|NCT01526928|20473846|P3|Overall Study|Withdrawal by Subject|13
5917729|NCT01526928|20473847|P2|Overall Study|Withdrawal by Subject|0
5917730|NCT01526928|20473848|P1|Overall Study|Withdrawal by Subject|1
5917731|NCT01526928|20473843|P6|Overall Study|Death|0
5917732|NCT01526928|20473844|P5|Overall Study|Death|0
5917733|NCT01526928|20473845|P4|Overall Study|Death|0
5917734|NCT01526928|20473846|P3|Overall Study|Death|3
5917735|NCT01526928|20473847|P2|Overall Study|Death|0
5917736|NCT01526928|20473848|P1|Overall Study|Death|0
5917737|NCT01526928|20473843|P6|Overall Study|Adverse Event|2
5917738|NCT01526928|20473844|P5|Overall Study|Adverse Event|13
5917739|NCT01526928|20473845|P4|Overall Study|Adverse Event|40
5917740|NCT01526928|20473846|P3|Overall Study|Adverse Event|29
5917741|NCT01526928|20473847|P2|Overall Study|Adverse Event|1
5917742|NCT01526928|20473848|P1|Overall Study|Adverse Event|2
5917743|NCT01526928|20473843|P6|Overall Study|Progressive Disease|4
5917744|NCT01526928|20473844|P5|Overall Study|Progressive Disease|76
5917745|NCT01526928|20473845|P4|Overall Study|Progressive Disease|182
5917746|NCT01526928|20473846|P3|Overall Study|Progressive Disease|150
5917747|NCT01526928|20473847|P2|Overall Study|Progressive Disease|17
5917748|NCT01526928|20473848|P1|Overall Study|Progressive Disease|35
5917749|NCT01526889|20473986|P2|Treatment Extension Period|Administrative problems|0
5917750|NCT01526889|20473987|P1|Treatment Extension Period|Administrative problems|1
5917751|NCT01526889|20473986|P2|Treatment Period|Adverse Event|0
5917752|NCT01526889|20473987|P1|Treatment Period|Adverse Event|2
5917753|NCT01526785|20474008|P1|Overall Study|Withdrawal by Subject|2
5917754|NCT01526785|20474008|P1|Overall Study|Physician Decision|1
5917755|NCT01526785|20474008|P1|Overall Study|Death|2
5917756|NCT01526785|20474008|P1|Overall Study|Study Terminated by Sponsor|8
5917757|NCT01526733|20474018|P2|Phase 1|Withdrawal by Subject|1
5917758|NCT01526733|20474019|P1|Phase 1|Withdrawal by Subject|1
5917759|NCT01526733|20474018|P2|Phase 1|Protocol Violation|0
5917760|NCT01526733|20474019|P1|Phase 1|Protocol Violation|1
5917761|NCT01526551|20474058|P1|Overall Study|Lack of returned parental consent form|424
5917762|NCT01526148|20474136|P2|Overall Study|Incarcerated|2
5917763|NCT01526148|20474137|P1|Overall Study|Incarcerated|0
5917764|NCT01526148|20474136|P2|Overall Study|Moved out of state|0
5917765|NCT01526148|20474137|P1|Overall Study|Moved out of state|1
5917766|NCT01526148|20474136|P2|Overall Study|Unable to discontinue concomitant med|0
5917767|NCT01526148|20474137|P1|Overall Study|Unable to discontinue concomitant med|1
5917768|NCT01526148|20474136|P2|Overall Study|Unstable Medical Condition|0
5917769|NCT01526148|20474137|P1|Overall Study|Unstable Medical Condition|1
5917770|NCT01526148|20474136|P2|Overall Study|Withdrawal by Subject|0
5917771|NCT01526148|20474137|P1|Overall Study|Withdrawal by Subject|2
5917772|NCT01526148|20474136|P2|Overall Study|Lost to Follow-up|6
5917773|NCT01526148|20474137|P1|Overall Study|Lost to Follow-up|3
5917774|NCT01526148|20474136|P2|Overall Study|Adverse Event|5
5917775|NCT01526148|20474137|P1|Overall Study|Adverse Event|6
5917776|NCT01526057|20474148|P3|Overall Study|Protocol Violation|1
5917777|NCT01526057|20474149|P2|Overall Study|Protocol Violation|0
5917778|NCT01526057|20474150|P1|Overall Study|Protocol Violation|0
5917779|NCT01526057|20474148|P3|Overall Study|Other|1
5917780|NCT01526057|20474149|P2|Overall Study|Other|0
5917781|NCT01526057|20474150|P1|Overall Study|Other|1
5917782|NCT01526057|20474148|P3|Overall Study|Lost to Follow-up|1
5917783|NCT01526057|20474149|P2|Overall Study|Lost to Follow-up|0
5917784|NCT01526057|20474150|P1|Overall Study|Lost to Follow-up|1
5917785|NCT01526057|20474148|P3|Overall Study|Death|0
5917786|NCT01526057|20474149|P2|Overall Study|Death|0
5917787|NCT01526057|20474150|P1|Overall Study|Death|1
5917788|NCT01526057|20474148|P3|Overall Study|Adverse Event|1
5917789|NCT01526057|20474149|P2|Overall Study|Adverse Event|1
5917790|NCT01526057|20474150|P1|Overall Study|Adverse Event|3
5917791|NCT01526057|20474148|P3|Overall Study|Withdrawal by Subject|2
5917792|NCT01526057|20474149|P2|Overall Study|Withdrawal by Subject|2
5917793|NCT01526057|20474150|P1|Overall Study|Withdrawal by Subject|3
5917794|NCT01525875|20474249|P2|Open-label Period|Lost to Follow-up|2
5917795|NCT01525875|20474250|P1|Open-label Period|Lost to Follow-up|0
5917796|NCT01525875|20474249|P2|Placebo-controlled Period|Withdrawal by Subject|2
5917797|NCT01525875|20474250|P1|Placebo-controlled Period|Withdrawal by Subject|1
5917798|NCT01525849|20474273|P2|Overall Study|Anatomic exclusion criteria identified|3
5917799|NCT01525849|20474274|P1|Overall Study|Anatomic exclusion criteria identified|0
5917800|NCT01525849|20474273|P2|Overall Study|Unrelated medical issue (not treated)|2
5917801|NCT01525849|20474274|P1|Overall Study|Unrelated medical issue (not treated)|1
5917802|NCT01525849|20474273|P2|Overall Study|Withdrawal by Subject|9
5917803|NCT01525849|20474274|P1|Overall Study|Withdrawal by Subject|1
5917804|NCT01525849|20474273|P2|Overall Study|Lost to Follow-up|2
5917805|NCT01525849|20474274|P1|Overall Study|Lost to Follow-up|3
5917806|NCT01525641|20474330|P1|Overall Study|Other than stated above|7
5917807|NCT01525641|20474330|P1|Overall Study|Lost to follow-up (Changing hospital)|19
5917808|NCT01525641|20474330|P1|Overall Study|Lost to follow-up (Unknown reason)|10
5917809|NCT01525641|20474330|P1|Overall Study|Lost to follow-up (relocation)|1
5917810|NCT01525641|20474330|P1|Overall Study|Improvement|5
5917811|NCT01525641|20474330|P1|Overall Study|Lack of Efficacy|24
5917812|NCT01525641|20474330|P1|Overall Study|Adverse Event|73
5917813|NCT01525641|20474330|P1|Overall Study|No visit since the first visit|16
5917814|NCT01525641|20474330|P1|Overall Study|Case report form not collected|25
5917815|NCT01525628|20474344|P5|Overall Study|Other reason not defined above|0
5917816|NCT01525628|20474345|P4|Overall Study|Other reason not defined above|3
5917817|NCT01525628|20474346|P3|Overall Study|Other reason not defined above|0
5917818|NCT01525628|20474347|P2|Overall Study|Other reason not defined above|0
5917819|NCT01525628|20474348|P1|Overall Study|Other reason not defined above|0
5917820|NCT01525628|20474344|P5|Overall Study|Withdrawal by Subject|0
5917821|NCT01525628|20474345|P4|Overall Study|Withdrawal by Subject|0
5917822|NCT01525628|20474346|P3|Overall Study|Withdrawal by Subject|0
5917823|NCT01525628|20474347|P2|Overall Study|Withdrawal by Subject|1
5917824|NCT01525628|20474348|P1|Overall Study|Withdrawal by Subject|0
5917825|NCT01525628|20474344|P5|Overall Study|Lost to Follow-up|0
5917826|NCT01525628|20474345|P4|Overall Study|Lost to Follow-up|0
5917827|NCT01525628|20474346|P3|Overall Study|Lost to Follow-up|0
5917828|NCT01525628|20474347|P2|Overall Study|Lost to Follow-up|1
5917829|NCT01525628|20474348|P1|Overall Study|Lost to Follow-up|1
5917830|NCT01525628|20474344|P5|Overall Study|Protocol Violation|0
5917831|NCT01525628|20474345|P4|Overall Study|Protocol Violation|0
5917832|NCT01525628|20474346|P3|Overall Study|Protocol Violation|1
5917833|NCT01525628|20474347|P2|Overall Study|Protocol Violation|0
5917834|NCT01525628|20474348|P1|Overall Study|Protocol Violation|0
5917835|NCT01525628|20474344|P5|Overall Study|Lack of Efficacy|2
5917836|NCT01525628|20474345|P4|Overall Study|Lack of Efficacy|1
5917837|NCT01525628|20474346|P3|Overall Study|Lack of Efficacy|2
5917838|NCT01525628|20474347|P2|Overall Study|Lack of Efficacy|2
5917839|NCT01525628|20474348|P1|Overall Study|Lack of Efficacy|0
5917840|NCT01525628|20474344|P5|Overall Study|Adverse Event|1
5917841|NCT01525628|20474345|P4|Overall Study|Adverse Event|0
5917842|NCT01525628|20474346|P3|Overall Study|Adverse Event|2
5917843|NCT01525628|20474347|P2|Overall Study|Adverse Event|1
5917844|NCT01525628|20474348|P1|Overall Study|Adverse Event|1
5917845|NCT01525615|20474415|P3|Overall Study|Other reason not described above|1
5917846|NCT01525615|20474416|P2|Overall Study|Other reason not described above|0
5917847|NCT01525615|20474417|P1|Overall Study|Other reason not described above|1
5917848|NCT01525615|20474415|P3|Overall Study|Withdrawal by Subject|0
5917849|NCT01525615|20474416|P2|Overall Study|Withdrawal by Subject|0
5917850|NCT01525615|20474417|P1|Overall Study|Withdrawal by Subject|1
5917851|NCT01525615|20474415|P3|Overall Study|Lost to Follow-up|0
5917852|NCT01525615|20474416|P2|Overall Study|Lost to Follow-up|0
5917853|NCT01525615|20474417|P1|Overall Study|Lost to Follow-up|1
5917854|NCT01525615|20474415|P3|Overall Study|Adverse Event|5
5917855|NCT01525615|20474416|P2|Overall Study|Adverse Event|7
5917856|NCT01525615|20474417|P1|Overall Study|Adverse Event|11
5917857|NCT01525602|20474469|P8|Overall Study|Unqualified based on biopsy; not dosed|1
5917858|NCT01525602|20474470|P7|Overall Study|Unqualified based on biopsy; not dosed|1
5917859|NCT01525602|20474471|P6|Overall Study|Unqualified based on biopsy; not dosed|0
5917860|NCT01525602|20474472|P5|Overall Study|Unqualified based on biopsy; not dosed|0
5917861|NCT01525602|20474473|P4|Overall Study|Unqualified based on biopsy; not dosed|0
5917862|NCT01525602|20474474|P3|Overall Study|Unqualified based on biopsy; not dosed|0
5917863|NCT01525602|20474475|P2|Overall Study|Unqualified based on biopsy; not dosed|0
5917864|NCT01525602|20474476|P1|Overall Study|Unqualified based on biopsy; not dosed|0
5917865|NCT01525602|20474469|P8|Overall Study|Death|0
5917866|NCT01525602|20474470|P7|Overall Study|Death|0
5917867|NCT01525602|20474471|P6|Overall Study|Death|1
5917868|NCT01525602|20474472|P5|Overall Study|Death|1
5917869|NCT01525602|20474473|P4|Overall Study|Death|0
5917870|NCT01525602|20474474|P3|Overall Study|Death|0
5917871|NCT01525602|20474475|P2|Overall Study|Death|0
5917872|NCT01525602|20474476|P1|Overall Study|Death|0
5917873|NCT01525602|20474469|P8|Overall Study|Physician Decision|0
5917874|NCT01525602|20474470|P7|Overall Study|Physician Decision|1
5917875|NCT01525602|20474471|P6|Overall Study|Physician Decision|0
5917876|NCT01525602|20474472|P5|Overall Study|Physician Decision|3
5917877|NCT01525602|20474473|P4|Overall Study|Physician Decision|0
5917878|NCT01525602|20474474|P3|Overall Study|Physician Decision|0
5917879|NCT01525602|20474475|P2|Overall Study|Physician Decision|0
5917880|NCT01525602|20474476|P1|Overall Study|Physician Decision|0
5917881|NCT01525602|20474469|P8|Overall Study|Withdrawal by Subject|1
5917882|NCT01525602|20474470|P7|Overall Study|Withdrawal by Subject|0
5917883|NCT01525602|20474471|P6|Overall Study|Withdrawal by Subject|1
5917884|NCT01525602|20474472|P5|Overall Study|Withdrawal by Subject|3
5917885|NCT01525602|20474473|P4|Overall Study|Withdrawal by Subject|0
5917886|NCT01525602|20474474|P3|Overall Study|Withdrawal by Subject|0
5917887|NCT01525602|20474475|P2|Overall Study|Withdrawal by Subject|0
5917888|NCT01525602|20474476|P1|Overall Study|Withdrawal by Subject|0
5917889|NCT01525602|20474469|P8|Overall Study|Non-compliance|0
5917890|NCT01525602|20474470|P7|Overall Study|Non-compliance|0
5917891|NCT01525602|20474471|P6|Overall Study|Non-compliance|0
5917892|NCT01525602|20474472|P5|Overall Study|Non-compliance|1
5917893|NCT01525602|20474473|P4|Overall Study|Non-compliance|0
5917894|NCT01525602|20474474|P3|Overall Study|Non-compliance|0
5917895|NCT01525602|20474475|P2|Overall Study|Non-compliance|0
5917896|NCT01525602|20474476|P1|Overall Study|Non-compliance|0
5917897|NCT01525602|20474469|P8|Overall Study|Clinical progression|1
5917898|NCT01525602|20474470|P7|Overall Study|Clinical progression|1
5917899|NCT01525602|20474471|P6|Overall Study|Clinical progression|0
5917900|NCT01525602|20474472|P5|Overall Study|Clinical progression|0
5917901|NCT01525602|20474473|P4|Overall Study|Clinical progression|0
5917902|NCT01525602|20474474|P3|Overall Study|Clinical progression|0
5917903|NCT01525602|20474475|P2|Overall Study|Clinical progression|0
5917904|NCT01525602|20474476|P1|Overall Study|Clinical progression|2
5917905|NCT01525602|20474469|P8|Overall Study|Disease progression|3
5917906|NCT01525602|20474470|P7|Overall Study|Disease progression|3
5917907|NCT01525602|20474471|P6|Overall Study|Disease progression|2
5917908|NCT01525602|20474472|P5|Overall Study|Disease progression|22
5917909|NCT01525602|20474473|P4|Overall Study|Disease progression|5
5917910|NCT01525602|20474474|P3|Overall Study|Disease progression|2
5917911|NCT01525602|20474475|P2|Overall Study|Disease progression|3
5917912|NCT01525602|20474476|P1|Overall Study|Disease progression|6
5917913|NCT01525602|20474469|P8|Overall Study|Adverse Event|1
5917914|NCT01525602|20474470|P7|Overall Study|Adverse Event|0
5917915|NCT01525602|20474471|P6|Overall Study|Adverse Event|3
5917916|NCT01525602|20474472|P5|Overall Study|Adverse Event|3
5917917|NCT01525602|20474473|P4|Overall Study|Adverse Event|1
5917918|NCT01525602|20474474|P3|Overall Study|Adverse Event|1
5917919|NCT01525602|20474475|P2|Overall Study|Adverse Event|0
5917920|NCT01525602|20474476|P1|Overall Study|Adverse Event|1
5917921|NCT01525589|20474547|P3|Overall Study|Withdrawal by Subject|0
5917922|NCT01525589|20474548|P2|Overall Study|Withdrawal by Subject|1
5917923|NCT01525589|20474549|P1|Overall Study|Withdrawal by Subject|0
5917924|NCT01525589|20474547|P3|Overall Study|Other reasons|0
5917925|NCT01525589|20474548|P2|Overall Study|Other reasons|1
5917926|NCT01525589|20474549|P1|Overall Study|Other reasons|0
5917927|NCT01525589|20474547|P3|Overall Study|Treatment-related AE|2
5917928|NCT01525589|20474548|P2|Overall Study|Treatment-related AE|1
5917929|NCT01525589|20474549|P1|Overall Study|Treatment-related AE|1
5917930|NCT01525589|20474547|P3|Overall Study|Death|2
5917931|NCT01525589|20474548|P2|Overall Study|Death|0
5917932|NCT01525589|20474549|P1|Overall Study|Death|0
5917933|NCT01525589|20474547|P3|Overall Study|Physician Decision|2
5917934|NCT01525589|20474548|P2|Overall Study|Physician Decision|2
5917935|NCT01525589|20474549|P1|Overall Study|Physician Decision|4
5917936|NCT01525589|20474547|P3|Overall Study|Never treated|0
5917937|NCT01525589|20474548|P2|Overall Study|Never treated|0
5917938|NCT01525589|20474549|P1|Overall Study|Never treated|2
5917939|NCT01525589|20474547|P3|Overall Study|Progressive disease|29
5917940|NCT01525589|20474548|P2|Overall Study|Progressive disease|15
5917941|NCT01525589|20474549|P1|Overall Study|Progressive disease|48
5917942|NCT01525589|20474547|P3|Overall Study|Non-treatment-related AE|0
5917943|NCT01525589|20474548|P2|Overall Study|Non-treatment-related AE|0
5917944|NCT01525589|20474549|P1|Overall Study|Non-treatment-related AE|1
5917945|NCT01525550|20474605|P2|Overall Study|Withdrawal by Subject|0
5917946|NCT01525550|20474606|P1|Overall Study|Withdrawal by Subject|4
5917947|NCT01525550|20474605|P2|Overall Study|Sponsor's Decision|11
5917948|NCT01525550|20474606|P1|Overall Study|Sponsor's Decision|30
5917949|NCT01525550|20474605|P2|Overall Study|Other|4
5917950|NCT01525550|20474606|P1|Overall Study|Other|0
5917951|NCT01525550|20474605|P2|Overall Study|Death|28
5917952|NCT01525550|20474606|P1|Overall Study|Death|19
5917953|NCT01525550|20474605|P2|Overall Study|Lost to Follow-up|2
5917954|NCT01525550|20474606|P1|Overall Study|Lost to Follow-up|8
5917955|NCT01525407|20474677|P2|Overall Study|Delay in Transplant|0
5917956|NCT01525407|20474678|P1|Overall Study|Delay in Transplant|1
5917957|NCT01525407|20474677|P2|Overall Study|Transplant was delayed|1
5917958|NCT01525407|20474678|P1|Overall Study|Transplant was delayed|0
5917959|NCT01525407|20474677|P2|Overall Study|Withdrawal by Subject|1
5917960|NCT01525407|20474678|P1|Overall Study|Withdrawal by Subject|0
5917961|NCT01525407|20474677|P2|Overall Study|Change in recipient treatment plan|2
5917962|NCT01525407|20474678|P1|Overall Study|Change in recipient treatment plan|2
5917963|NCT01525238|20474712|P3|Overall Study|Withdrawal by Subject|0
5917964|NCT01525238|20474713|P2|Overall Study|Withdrawal by Subject|0
5917965|NCT01525238|20474714|P1|Overall Study|Withdrawal by Subject|1
5917966|NCT01525225|20474779|P1|Enrollment|Other|1
5917967|NCT01525225|20474779|P1|Enrollment|No longer met study criteria|1
5917968|NCT01525082|20474793|P1|Overall Study|Death|1
5917969|NCT01524991|20474804|P1|Overall Study|Symptomatic Deterioration|1
5917970|NCT01524991|20474804|P1|Overall Study|Withdrawal by Subject|2
5917971|NCT01524991|20474804|P1|Overall Study|Other complicating disease|1
5917972|NCT01524991|20474804|P1|Overall Study|Disease ProgressionDu|17
5917973|NCT01524991|20474804|P1|Overall Study|Death|1
5917974|NCT01524991|20474804|P1|Overall Study|Adverse Event|12
5917975|NCT01524978|20474822|P11|Overall Study|Death|17
5917976|NCT01524978|20474823|P10|Overall Study|Death|6
5917977|NCT01524978|20474824|P9|Overall Study|Death|5
5917978|NCT01524978|20474825|P8|Overall Study|Death|9
5917979|NCT01524978|20474826|P7|Overall Study|Death|1
5917980|NCT01524978|20474827|P6|Overall Study|Death|4
5917981|NCT01524978|20474828|P5|Overall Study|Death|4
5917982|NCT01524978|20474829|P4|Overall Study|Death|24
5917983|NCT01524978|20474830|P3|Overall Study|Death|5
5917984|NCT01524978|20474831|P2|Overall Study|Death|2
5917985|NCT01524978|20474832|P1|Overall Study|Death|34
5917986|NCT01524978|20474822|P11|Overall Study|Lost to Follow-up|1
5917987|NCT01524978|20474823|P10|Overall Study|Lost to Follow-up|1
5917988|NCT01524978|20474824|P9|Overall Study|Lost to Follow-up|1
5917989|NCT01524978|20474825|P8|Overall Study|Lost to Follow-up|0
5917990|NCT01524978|20474826|P7|Overall Study|Lost to Follow-up|2
5917991|NCT01524978|20474827|P6|Overall Study|Lost to Follow-up|1
5917992|NCT01524978|20474828|P5|Overall Study|Lost to Follow-up|1
5917993|NCT01524978|20474829|P4|Overall Study|Lost to Follow-up|0
5917994|NCT01524978|20474830|P3|Overall Study|Lost to Follow-up|3
5917995|NCT01524978|20474831|P2|Overall Study|Lost to Follow-up|0
5917996|NCT01524978|20474832|P1|Overall Study|Lost to Follow-up|0
5917997|NCT01524978|20474822|P11|Overall Study|Withdrawal by Subject|5
5917998|NCT01524978|20474823|P10|Overall Study|Withdrawal by Subject|0
5917999|NCT01524978|20474824|P9|Overall Study|Withdrawal by Subject|4
5918000|NCT01524978|20474825|P8|Overall Study|Withdrawal by Subject|2
5918001|NCT01524978|20474826|P7|Overall Study|Withdrawal by Subject|6
5918002|NCT01524978|20474827|P6|Overall Study|Withdrawal by Subject|1
5918003|NCT01524978|20474828|P5|Overall Study|Withdrawal by Subject|3
5918004|NCT01524978|20474829|P4|Overall Study|Withdrawal by Subject|1
5918005|NCT01524978|20474830|P3|Overall Study|Withdrawal by Subject|1
5918006|NCT01524978|20474831|P2|Overall Study|Withdrawal by Subject|0
5918007|NCT01524978|20474832|P1|Overall Study|Withdrawal by Subject|12
5918008|NCT01524978|20474822|P11|Overall Study|Other|5
5918009|NCT01524978|20474823|P10|Overall Study|Other|2
5918010|NCT01524978|20474824|P9|Overall Study|Other|2
5918011|NCT01524978|20474825|P8|Overall Study|Other|1
5918012|NCT01524978|20474826|P7|Overall Study|Other|17
5918013|NCT01524978|20474827|P6|Overall Study|Other|3
5918014|NCT01524978|20474828|P5|Overall Study|Other|1
5918015|NCT01524978|20474829|P4|Overall Study|Other|2
5918016|NCT01524978|20474830|P3|Overall Study|Other|1
5918017|NCT01524978|20474831|P2|Overall Study|Other|2
5918018|NCT01524978|20474832|P1|Overall Study|Other|16
5918019|NCT01524913|20474960|P3|Overall Study|Lost to Follow-up|0
5918020|NCT01524913|20474961|P2|Overall Study|Lost to Follow-up|0
5918021|NCT01524913|20474962|P1|Overall Study|Lost to Follow-up|4
5918022|NCT01524900|20474984|P5|Overall Study|No reason documented|0
5918023|NCT01524900|20474985|P4|Overall Study|No reason documented|1
5918024|NCT01524900|20474986|P3|Overall Study|No reason documented|0
5918025|NCT01524900|20474987|P2|Overall Study|No reason documented|1
5918026|NCT01524900|20474988|P1|Overall Study|No reason documented|2
5918027|NCT01524900|20474984|P5|Overall Study|Other reason than stated above|0
5918028|NCT01524900|20474985|P4|Overall Study|Other reason than stated above|0
5918029|NCT01524900|20474986|P3|Overall Study|Other reason than stated above|0
5918030|NCT01524900|20474987|P2|Overall Study|Other reason than stated above|1
5918031|NCT01524900|20474988|P1|Overall Study|Other reason than stated above|1
5918032|NCT01524900|20474984|P5|Overall Study|Lost to Follow-up|0
5918033|NCT01524900|20474985|P4|Overall Study|Lost to Follow-up|0
5918034|NCT01524900|20474986|P3|Overall Study|Lost to Follow-up|1
5918035|NCT01524900|20474987|P2|Overall Study|Lost to Follow-up|12
5918036|NCT01524900|20474988|P1|Overall Study|Lost to Follow-up|3
5918037|NCT01524887|20475033|P3|Overall Study|Use of prohibited medication|0
5918038|NCT01524887|20475034|P2|Overall Study|Use of prohibited medication|0
5918039|NCT01524887|20475035|P1|Overall Study|Use of prohibited medication|1
5918040|NCT01524887|20475033|P3|Overall Study|Withdrawal by Caregiver|2
5918041|NCT01524887|20475034|P2|Overall Study|Withdrawal by Caregiver|0
5918042|NCT01524887|20475035|P1|Overall Study|Withdrawal by Caregiver|0
5918043|NCT01524887|20475033|P3|Overall Study|Study termination|79
5918044|NCT01524887|20475034|P2|Overall Study|Study termination|87
5918045|NCT01524887|20475035|P1|Overall Study|Study termination|73
5918046|NCT01524887|20475033|P3|Overall Study|Protocol Violation|1
5918047|NCT01524887|20475034|P2|Overall Study|Protocol Violation|0
5918048|NCT01524887|20475035|P1|Overall Study|Protocol Violation|0
5918049|NCT01524887|20475033|P3|Overall Study|Adverse Event|1
5918050|NCT01524887|20475034|P2|Overall Study|Adverse Event|1
5918051|NCT01524887|20475035|P1|Overall Study|Adverse Event|5
5918052|NCT01524887|20475033|P3|Overall Study|Withdrawal by Subject|3
5918053|NCT01524887|20475034|P2|Overall Study|Withdrawal by Subject|2
5918054|NCT01524887|20475035|P1|Overall Study|Withdrawal by Subject|6
5918055|NCT01524783|20475081|P2|Randomized and Treated|Death|1
5918056|NCT01524783|20475082|P1|Randomized and Treated|Death|4
5918057|NCT01524783|20475081|P2|Randomized and Treated|Protocol Violation|1
5918058|NCT01524783|20475082|P1|Randomized and Treated|Protocol Violation|1
5918059|NCT01524783|20475081|P2|Randomized and Treated|Withdrawal by Subject|5
5918060|NCT01524783|20475082|P1|Randomized and Treated|Withdrawal by Subject|15
5918061|NCT01524783|20475081|P2|Randomized and Treated|Disease Progression|70
5918062|NCT01524783|20475082|P1|Randomized and Treated|Disease Progression|76
5918063|NCT01524783|20475081|P2|Randomized and Treated|Adverse Event|7
5918064|NCT01524783|20475082|P1|Randomized and Treated|Adverse Event|59
5918065|NCT01524783|20475081|P2|Randomized But Not Treated|Randomized, did not receive drug|0
5918066|NCT01524783|20475082|P1|Randomized But Not Treated|Randomized, did not receive drug|2
5918067|NCT01524770|20475090|P2|First Intervention|Protocol Violation|0
5918068|NCT01524770|20475091|P1|First Intervention|Protocol Violation|1
5918069|NCT01524770|20475090|P2|First Intervention|Adverse Event|1
5918070|NCT01524770|20475091|P1|First Intervention|Adverse Event|1
5918071|NCT01524770|20475090|P2|First Intervention|Withdrawal by Subject|0
5918072|NCT01524770|20475091|P1|First Intervention|Withdrawal by Subject|1
5918073|NCT01524692|20475101|P1|Overall Study|Withdrawal by Subject|3
5918074|NCT01524679|20475111|P2|Overall Study|e.g.wish for children, relocation|1
5918075|NCT01524679|20475112|P1|Overall Study|e.g.wish for children, relocation|6
5918076|NCT01524679|20475111|P2|Overall Study|Lack of Efficacy|0
5918077|NCT01524679|20475112|P1|Overall Study|Lack of Efficacy|2
5918078|NCT01524679|20475111|P2|Overall Study|Protocol Violation|0
5918079|NCT01524679|20475112|P1|Overall Study|Protocol Violation|1
5918080|NCT01524679|20475111|P2|Overall Study|Adverse Event|0
5918081|NCT01524679|20475112|P1|Overall Study|Adverse Event|9
5918082|NCT01524679|20475111|P2|Overall Study|Withdrawal by Subject|4
5918083|NCT01524679|20475112|P1|Overall Study|Withdrawal by Subject|4
5918084|NCT01524679|20475111|P2|Overall Study|Lost to Follow-up|4
5918085|NCT01524679|20475112|P1|Overall Study|Lost to Follow-up|1
5918086|NCT01524627|20475124|P2|Overall Study|Lost to Follow-up|1
5918087|NCT01524627|20475125|P1|Overall Study|Lost to Follow-up|1
5918088|NCT01524627|20475124|P2|Overall Study|Physician Decision|1
5918089|NCT01524627|20475125|P1|Overall Study|Physician Decision|0
5918090|NCT01524289|20475152|P2|Overall Study|Did not take study medication|0
5918091|NCT01524289|20475153|P1|Overall Study|Did not take study medication|1
5918092|NCT01524289|20475152|P2|Overall Study|Adverse Event|5
5918093|NCT01524289|20475153|P1|Overall Study|Adverse Event|12
5918094|NCT01524289|20475152|P2|Overall Study|Withdrawal by Subject|7
5918095|NCT01524289|20475153|P1|Overall Study|Withdrawal by Subject|11
5918096|NCT01524289|20475152|P2|Overall Study|Protocol Violation|1
5918097|NCT01524289|20475153|P1|Overall Study|Protocol Violation|5
5918098|NCT01524289|20475152|P2|Overall Study|Physician Decision|0
5918099|NCT01524289|20475153|P1|Overall Study|Physician Decision|1
5918100|NCT01524289|20475152|P2|Overall Study|Lost to Follow-up|1
5918101|NCT01524289|20475153|P1|Overall Study|Lost to Follow-up|0
5918102|NCT01524224|20475211|P8|Overall Study|Sponsor Decision|0
5918103|NCT01524224|20475212|P7|Overall Study|Sponsor Decision|0
5918104|NCT01524224|20475213|P6|Overall Study|Sponsor Decision|0
5918105|NCT01524224|20475214|P5|Overall Study|Sponsor Decision|1
5918106|NCT01524224|20475215|P4|Overall Study|Sponsor Decision|0
5918107|NCT01524224|20475216|P3|Overall Study|Sponsor Decision|0
5918108|NCT01524224|20475217|P2|Overall Study|Sponsor Decision|0
5918109|NCT01524224|20475218|P1|Overall Study|Sponsor Decision|0
5918110|NCT01524224|20475211|P8|Overall Study|Physician Decision|1
5918111|NCT01524224|20475212|P7|Overall Study|Physician Decision|0
5918112|NCT01524224|20475213|P6|Overall Study|Physician Decision|0
5918113|NCT01524224|20475214|P5|Overall Study|Physician Decision|1
5918114|NCT01524224|20475215|P4|Overall Study|Physician Decision|1
5918115|NCT01524224|20475216|P3|Overall Study|Physician Decision|0
5918116|NCT01524224|20475217|P2|Overall Study|Physician Decision|0
5918117|NCT01524224|20475218|P1|Overall Study|Physician Decision|0
5918118|NCT01524224|20475211|P8|Overall Study|Adverse Event|0
5918119|NCT01524224|20475212|P7|Overall Study|Adverse Event|0
5918120|NCT01524224|20475213|P6|Overall Study|Adverse Event|1
5918121|NCT01524224|20475214|P5|Overall Study|Adverse Event|0
5918122|NCT01524224|20475215|P4|Overall Study|Adverse Event|0
5918123|NCT01524224|20475216|P3|Overall Study|Adverse Event|0
5918124|NCT01524224|20475217|P2|Overall Study|Adverse Event|1
5918125|NCT01524224|20475218|P1|Overall Study|Adverse Event|0
5918126|NCT01524224|20475211|P8|Overall Study|Withdrawal by Subject|0
5918127|NCT01524224|20475212|P7|Overall Study|Withdrawal by Subject|2
5918128|NCT01524224|20475213|P6|Overall Study|Withdrawal by Subject|0
5918129|NCT01524224|20475214|P5|Overall Study|Withdrawal by Subject|0
5918130|NCT01524224|20475215|P4|Overall Study|Withdrawal by Subject|0
5918131|NCT01524224|20475216|P3|Overall Study|Withdrawal by Subject|0
5918132|NCT01524224|20475217|P2|Overall Study|Withdrawal by Subject|0
5918133|NCT01524224|20475218|P1|Overall Study|Withdrawal by Subject|2
5918134|NCT01524224|20475211|P8|Overall Study|Progressive Disease|5
5918135|NCT01524224|20475212|P7|Overall Study|Progressive Disease|1
5918136|NCT01524224|20475213|P6|Overall Study|Progressive Disease|1
5918137|NCT01524224|20475214|P5|Overall Study|Progressive Disease|2
5918138|NCT01524224|20475215|P4|Overall Study|Progressive Disease|1
5918139|NCT01524224|20475216|P3|Overall Study|Progressive Disease|2
5918140|NCT01524224|20475217|P2|Overall Study|Progressive Disease|0
5918141|NCT01524224|20475218|P1|Overall Study|Progressive Disease|1
5918142|NCT01524198|20475254|P2|Overall Study|Withdrawal by Subject|10
5918143|NCT01524198|20475255|P1|Overall Study|Withdrawal by Subject|15
5918144|NCT01524198|20475254|P2|Overall Study|Protocol Violation|6
5918145|NCT01524198|20475255|P1|Overall Study|Protocol Violation|8
5918146|NCT01524133|20475266|P3|Overall Study 52 Weeks|Lost to Follow-up|15
5918147|NCT01524133|20475267|P2|Overall Study 52 Weeks|Lost to Follow-up|15
5918148|NCT01524133|20475268|P1|Overall Study 52 Weeks|Lost to Follow-up|16
5918149|NCT01524133|20475266|P3|Overall Study 52 Weeks|Physician Decision|2
5918150|NCT01524133|20475267|P2|Overall Study 52 Weeks|Physician Decision|0
5918151|NCT01524133|20475268|P1|Overall Study 52 Weeks|Physician Decision|1
5918152|NCT01524133|20475266|P3|Overall Study 52 Weeks|Withdrawal by Subject|10
5918153|NCT01524133|20475267|P2|Overall Study 52 Weeks|Withdrawal by Subject|5
5918154|NCT01524133|20475268|P1|Overall Study 52 Weeks|Withdrawal by Subject|4
5918155|NCT01524133|20475266|P3|Treatment Phase|Lost to Follow-up|2
5918156|NCT01524133|20475267|P2|Treatment Phase|Lost to Follow-up|1
5918157|NCT01524133|20475268|P1|Treatment Phase|Lost to Follow-up|0
5918158|NCT01524133|20475266|P3|Treatment Phase|Physician Decision|3
5918159|NCT01524133|20475267|P2|Treatment Phase|Physician Decision|3
5918160|NCT01524133|20475268|P1|Treatment Phase|Physician Decision|6
5918161|NCT01524133|20475266|P3|Treatment Phase|Withdrawal by Subject|31
5918162|NCT01524133|20475267|P2|Treatment Phase|Withdrawal by Subject|28
5918163|NCT01524133|20475268|P1|Treatment Phase|Withdrawal by Subject|13
5918164|NCT01523886|20475311|P2|Overall Study|surgery cancelled|1
5918165|NCT01523886|20475312|P1|Overall Study|surgery cancelled|0
5918166|NCT01523873|20475318|P1|Overall Study|Protocol Violation|422
5918167|NCT01523756|20475413|P2|Test Period 2|Withdrawal by Subject|1
5918168|NCT01523756|20475414|P1|Test Period 2|Withdrawal by Subject|0
5918169|NCT01523756|20475413|P2|Test Period 1|Adverse Event|0
5918170|NCT01523756|20475414|P1|Test Period 1|Adverse Event|1
5918171|NCT01523756|20475413|P2|Baseline Period|Adverse Event|1
5918172|NCT01523756|20475414|P1|Baseline Period|Adverse Event|0
5918173|NCT01523743|20475422|P2|Period 2|Adverse Event|0
5918174|NCT01523743|20475423|P1|Period 2|Adverse Event|1
5918175|NCT01523743|20475422|P2|Period 2|Withdrawal by Subject|2
5918176|NCT01523743|20475423|P1|Period 2|Withdrawal by Subject|0
5918177|NCT01523743|20475422|P2|Period 1|Felt unable to empty bladder|0
5918178|NCT01523743|20475423|P1|Period 1|Felt unable to empty bladder|1
5918179|NCT01523743|20475422|P2|Period 1|Lack of Efficacy|0
5918180|NCT01523743|20475423|P1|Period 1|Lack of Efficacy|1
5918181|NCT01523743|20475422|P2|Period 1|Lost to Follow-up|0
5918182|NCT01523743|20475423|P1|Period 1|Lost to Follow-up|1
5918183|NCT01523743|20475422|P2|Period 1|Withdrawal by Subject|2
5918184|NCT01523743|20475423|P1|Period 1|Withdrawal by Subject|6
5918185|NCT01523743|20475422|P2|Period 1|Adverse Event|0
5918186|NCT01523743|20475423|P1|Period 1|Adverse Event|1
5918187|NCT01523587|20475459|P2|Overall Study|Randomised but bot treated|2
5918188|NCT01523587|20475460|P1|Overall Study|Randomised but bot treated|6
5918189|NCT01523587|20475459|P2|Overall Study|Withdrew due to Progressive disease|279
5918190|NCT01523587|20475460|P1|Overall Study|Withdrew due to Progressive disease|265
5918191|NCT01523587|20475459|P2|Overall Study|Withdrawal by Subject|20
5918192|NCT01523587|20475460|P1|Overall Study|Withdrawal by Subject|28
5918193|NCT01523587|20475459|P2|Overall Study|Lost to Follow-up|2
5918194|NCT01523587|20475460|P1|Overall Study|Lost to Follow-up|2
5918195|NCT01523587|20475459|P2|Overall Study|Protocol Violation|3
5918196|NCT01523587|20475460|P1|Overall Study|Protocol Violation|5
5918197|NCT01523587|20475459|P2|Overall Study|Adverse Event|52
5918198|NCT01523587|20475460|P1|Overall Study|Adverse Event|68
5918199|NCT01523587|20475459|P2|Overall Study|Worsening of underlying cancer disease|34
5918200|NCT01523587|20475460|P1|Overall Study|Worsening of underlying cancer disease|19
5918201|NCT01523587|20475459|P2|Overall Study|Other than listed|5
5918202|NCT01523587|20475460|P1|Overall Study|Other than listed|5
5918203|NCT01523457|20475503|P2|Overall Study|Withdrawal by Subject|2
5918204|NCT01523457|20475504|P1|Overall Study|Withdrawal by Subject|7
5918205|NCT01523392|20475522|P2|Washout Period - 10 to 14 Days|Adverse Event|0
5918206|NCT01523392|20475523|P1|Washout Period - 10 to 14 Days|Adverse Event|1
5918207|NCT01523392|20475522|P2|Treatment Period 1|Did not complete 7-9 days of treatment.|0
5918208|NCT01523392|20475523|P1|Treatment Period 1|Did not complete 7-9 days of treatment.|1
5918209|NCT01523392|20475522|P2|Treatment Period 1|Withdrawal by Subject|0
5918210|NCT01523392|20475523|P1|Treatment Period 1|Withdrawal by Subject|2
5918211|NCT01523366|20475539|P2|Treatment Period 2|Not completed at least 7 days treatment|0
5918212|NCT01523366|20475540|P1|Treatment Period 2|Not completed at least 7 days treatment|1
5918213|NCT01523366|20475539|P2|Treatment Period 1|Withdrawal by Subject|0
5918214|NCT01523366|20475540|P1|Treatment Period 1|Withdrawal by Subject|1
5918215|NCT01523301|20475556|P2|Overall Study|Other Reason|2
5918216|NCT01523301|20475557|P1|Overall Study|Other Reason|0
5918217|NCT01523301|20475556|P2|Overall Study|Withdrawal by Subject|8
5918218|NCT01523301|20475557|P1|Overall Study|Withdrawal by Subject|6
5918219|NCT01523301|20475556|P2|Overall Study|Lost to Follow-up|0
5918220|NCT01523301|20475557|P1|Overall Study|Lost to Follow-up|1
5918221|NCT01523301|20475556|P2|Overall Study|Protocol Violation|4
5918222|NCT01523301|20475557|P1|Overall Study|Protocol Violation|3
5918223|NCT01523301|20475556|P2|Overall Study|Lack of Efficacy|2
5918224|NCT01523301|20475557|P1|Overall Study|Lack of Efficacy|0
5918225|NCT01523301|20475556|P2|Overall Study|Adverse Event|16
5918226|NCT01523301|20475557|P1|Overall Study|Adverse Event|25
5918227|NCT01523275|20475577|P2|Overall Study|Withdrawal by Subject|0
5918228|NCT01523275|20475578|P1|Overall Study|Withdrawal by Subject|1
5918229|NCT01523275|20475577|P2|Overall Study|Lost to Follow-up|2
5918230|NCT01523275|20475578|P1|Overall Study|Lost to Follow-up|1
5918231|NCT01522976|20475591|P3|Overall Study|Not protocol specified|27
5918232|NCT01522976|20475592|P2|Overall Study|Not protocol specified|27
5918233|NCT01522976|20475593|P1|Overall Study|Not protocol specified|22
5918234|NCT01522976|20475591|P3|Overall Study|Refusal unrelated to adverse event|14
5918235|NCT01522976|20475592|P2|Overall Study|Refusal unrelated to adverse event|13
5918236|NCT01522976|20475593|P1|Overall Study|Refusal unrelated to adverse event|10
5918237|NCT01522976|20475591|P3|Overall Study|Adverse Event|18
5918238|NCT01522976|20475592|P2|Overall Study|Adverse Event|7
5918239|NCT01522976|20475593|P1|Overall Study|Adverse Event|17
5918240|NCT01522976|20475591|P3|Overall Study|Disease progression|25
5918241|NCT01522976|20475592|P2|Overall Study|Disease progression|30
5918242|NCT01522976|20475593|P1|Overall Study|Disease progression|28
5918243|NCT01522976|20475591|P3|Overall Study|Still on treatment|6
5918244|NCT01522976|20475592|P2|Overall Study|Still on treatment|9
5918245|NCT01522976|20475593|P1|Overall Study|Still on treatment|9
5918246|NCT01522976|20475591|P3|Overall Study|Death|2
5918247|NCT01522976|20475592|P2|Overall Study|Death|6
5918248|NCT01522976|20475593|P1|Overall Study|Death|7
5918249|NCT01522976|20475591|P3|Overall Study|Ineligible|1
5918250|NCT01522976|20475592|P2|Overall Study|Ineligible|0
5918251|NCT01522976|20475593|P1|Overall Study|Ineligible|4
5918252|NCT01522950|20475638|P3|Overall Study|Study Medication Sensitivity|0
5918253|NCT01522950|20475639|P2|Overall Study|Study Medication Sensitivity|1
5918254|NCT01522950|20475640|P1|Overall Study|Study Medication Sensitivity|0
5918255|NCT01522950|20475638|P3|Overall Study|Death|1
5918256|NCT01522950|20475639|P2|Overall Study|Death|1
5918257|NCT01522950|20475640|P1|Overall Study|Death|0
5918258|NCT01522950|20475638|P3|Overall Study|Protocol Violation|2
5918259|NCT01522950|20475639|P2|Overall Study|Protocol Violation|0
5918260|NCT01522950|20475640|P1|Overall Study|Protocol Violation|0
5918261|NCT01522950|20475638|P3|Overall Study|Adverse Event|1
5918262|NCT01522950|20475639|P2|Overall Study|Adverse Event|1
5918263|NCT01522950|20475640|P1|Overall Study|Adverse Event|3
5918264|NCT01522950|20475638|P3|Overall Study|Withdrawal by Subject|1
5918265|NCT01522950|20475639|P2|Overall Study|Withdrawal by Subject|2
5918266|NCT01522950|20475640|P1|Overall Study|Withdrawal by Subject|3
5918267|NCT01522651|20475708|P5|Overall Study|Randomized but Never Treated|1
5918268|NCT01522651|20475709|P4|Overall Study|Randomized but Never Treated|1
5918269|NCT01522651|20475710|P3|Overall Study|Randomized but Never Treated|0
5918270|NCT01522651|20475711|P2|Overall Study|Randomized but Never Treated|1
5918271|NCT01522651|20475712|P1|Overall Study|Randomized but Never Treated|0
5918272|NCT01522651|20475708|P5|Overall Study|Withdrew Consent|1
5918273|NCT01522651|20475709|P4|Overall Study|Withdrew Consent|1
5918274|NCT01522651|20475710|P3|Overall Study|Withdrew Consent|0
5918275|NCT01522651|20475711|P2|Overall Study|Withdrew Consent|1
5918276|NCT01522651|20475712|P1|Overall Study|Withdrew Consent|1
5918277|NCT01522651|20475708|P5|Overall Study|Participant Non-Compliance|0
5918278|NCT01522651|20475709|P4|Overall Study|Participant Non-Compliance|0
5918279|NCT01522651|20475710|P3|Overall Study|Participant Non-Compliance|0
5918280|NCT01522651|20475711|P2|Overall Study|Participant Non-Compliance|0
5918281|NCT01522651|20475712|P1|Overall Study|Participant Non-Compliance|1
5918282|NCT01522651|20475708|P5|Overall Study|Reason Not Specified|0
5918283|NCT01522651|20475709|P4|Overall Study|Reason Not Specified|1
5918284|NCT01522651|20475710|P3|Overall Study|Reason Not Specified|0
5918285|NCT01522651|20475711|P2|Overall Study|Reason Not Specified|0
5918286|NCT01522651|20475712|P1|Overall Study|Reason Not Specified|0
5918287|NCT01522651|20475708|P5|Overall Study|Protocol Violation|0
5918288|NCT01522651|20475709|P4|Overall Study|Protocol Violation|0
5918289|NCT01522651|20475710|P3|Overall Study|Protocol Violation|0
5918290|NCT01522651|20475711|P2|Overall Study|Protocol Violation|0
5918291|NCT01522651|20475712|P1|Overall Study|Protocol Violation|3
5918292|NCT01522651|20475708|P5|Overall Study|Investigator's Discretion|0
5918293|NCT01522651|20475709|P4|Overall Study|Investigator's Discretion|0
5918294|NCT01522651|20475710|P3|Overall Study|Investigator's Discretion|0
5918295|NCT01522651|20475711|P2|Overall Study|Investigator's Discretion|1
5918296|NCT01522651|20475712|P1|Overall Study|Investigator's Discretion|0
5918297|NCT01522651|20475708|P5|Overall Study|Device Malfunction|0
5918298|NCT01522651|20475709|P4|Overall Study|Device Malfunction|0
5918299|NCT01522651|20475710|P3|Overall Study|Device Malfunction|0
5918300|NCT01522651|20475711|P2|Overall Study|Device Malfunction|1
5918301|NCT01522651|20475712|P1|Overall Study|Device Malfunction|0
5918302|NCT01522651|20475708|P5|Overall Study|Cardioversion|0
5918303|NCT01522651|20475709|P4|Overall Study|Cardioversion|0
5918304|NCT01522651|20475710|P3|Overall Study|Cardioversion|0
5918305|NCT01522651|20475711|P2|Overall Study|Cardioversion|0
5918306|NCT01522651|20475712|P1|Overall Study|Cardioversion|1
5918307|NCT01522651|20475708|P5|Overall Study|Adverse Event|4
5918308|NCT01522651|20475709|P4|Overall Study|Adverse Event|5
5918309|NCT01522651|20475710|P3|Overall Study|Adverse Event|4
5918310|NCT01522651|20475711|P2|Overall Study|Adverse Event|4
5918311|NCT01522651|20475712|P1|Overall Study|Adverse Event|3
5918312|NCT01522456|20475739|P1|Overall Study|Tolerability Assessment|1
5918313|NCT01522456|20475739|P1|Overall Study|Pregnancy|1
5918314|NCT01522456|20475739|P1|Overall Study|Withdrawal by Subject|2
5918315|NCT01522456|20475739|P1|Overall Study|Lost to Follow-up|2
5918316|NCT01522456|20475739|P1|Overall Study|Adverse Event|2
5918317|NCT01522443|20475802|P2|Overall Study|Other|3
5918318|NCT01522443|20475803|P1|Overall Study|Other|1
5918319|NCT01522443|20475802|P2|Overall Study|No study treatment given|1
5918320|NCT01522443|20475803|P1|Overall Study|No study treatment given|1
5918321|NCT01522443|20475802|P2|Overall Study|Withdrawal by Subject|8
5918322|NCT01522443|20475803|P1|Overall Study|Withdrawal by Subject|5
5918323|NCT01522443|20475802|P2|Overall Study|Adverse Event|15
5918324|NCT01522443|20475803|P1|Overall Study|Adverse Event|10
5918325|NCT01522443|20475802|P2|Overall Study|No longer receiving clinical benefit|28
5918326|NCT01522443|20475803|P1|Overall Study|No longer receiving clinical benefit|36
5918327|NCT01522404|20475815|P2|Second Intervention (up to Week 58)|Withdrawal by Subject|0
5918328|NCT01522404|20475816|P1|Second Intervention (up to Week 58)|Withdrawal by Subject|1
5918329|NCT01522404|20475815|P2|First Intervention (up to Week 29)|Adverse Event|0
5918330|NCT01522404|20475816|P1|First Intervention (up to Week 29)|Adverse Event|1
5918331|NCT01522404|20475815|P2|First Intervention (up to Week 29)|Withdrawal by Subject|0
5918332|NCT01522404|20475816|P1|First Intervention (up to Week 29)|Withdrawal by Subject|1
5918333|NCT01522248|20475902|P2|Overall Study|Lost to Follow-up|0
5918334|NCT01522248|20475903|P1|Overall Study|Lost to Follow-up|1
5918335|NCT01522235|20475918|P2|Overall Study|Physician Decision|1
5918336|NCT01522235|20475919|P1|Overall Study|Physician Decision|1
5918337|NCT01521923|20475955|P4|Overall Study|AE, captured in Period 1|1
5918338|NCT01521923|20475956|P3|Overall Study|AE, captured in Period 1|0
5918339|NCT01521923|20475957|P2|Overall Study|AE, captured in Period 1|1
5918340|NCT01521923|20475958|P1|Overall Study|AE, captured in Period 1|0
5918341|NCT01521923|20475955|P4|Overall Study|Other|6
5918342|NCT01521923|20475956|P3|Overall Study|Other|3
5918343|NCT01521923|20475957|P2|Overall Study|Other|1
5918344|NCT01521923|20475958|P1|Overall Study|Other|2
5918345|NCT01521923|20475955|P4|Overall Study|Withdrawal by Subject|2
5918346|NCT01521923|20475956|P3|Overall Study|Withdrawal by Subject|1
5918347|NCT01521923|20475957|P2|Overall Study|Withdrawal by Subject|1
5918348|NCT01521923|20475958|P1|Overall Study|Withdrawal by Subject|1
5918349|NCT01521923|20475955|P4|Overall Study|Lost to Follow-up|1
5918350|NCT01521923|20475956|P3|Overall Study|Lost to Follow-up|2
5918351|NCT01521923|20475957|P2|Overall Study|Lost to Follow-up|0
5918352|NCT01521923|20475958|P1|Overall Study|Lost to Follow-up|1
5918353|NCT01521923|20475955|P4|Overall Study|Protocol Violation|0
5918354|NCT01521923|20475956|P3|Overall Study|Protocol Violation|1
5918355|NCT01521923|20475957|P2|Overall Study|Protocol Violation|0
5918356|NCT01521923|20475958|P1|Overall Study|Protocol Violation|0
5918357|NCT01521923|20475955|P4|Overall Study|Lack of Efficacy|0
5918358|NCT01521923|20475956|P3|Overall Study|Lack of Efficacy|0
5918359|NCT01521923|20475957|P2|Overall Study|Lack of Efficacy|1
5918360|NCT01521923|20475958|P1|Overall Study|Lack of Efficacy|1
5918361|NCT01521923|20475955|P4|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|1
5918362|NCT01521923|20475956|P3|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0
5918363|NCT01521923|20475957|P2|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0
5918364|NCT01521923|20475958|P1|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0
5918365|NCT01521923|20475955|P4|Overall Study|AE, non-serious, non-fatal|2
5918366|NCT01521923|20475956|P3|Overall Study|AE, non-serious, non-fatal|6
5918367|NCT01521923|20475957|P2|Overall Study|AE, non-serious, non-fatal|3
5918368|NCT01521923|20475958|P1|Overall Study|AE, non-serious, non-fatal|1
5918369|NCT01521923|20475955|P4|Overall Study|SAE, non-fatal|0
5918370|NCT01521923|20475956|P3|Overall Study|SAE, non-fatal|2
5918371|NCT01521923|20475957|P2|Overall Study|SAE, non-fatal|2
5918372|NCT01521923|20475958|P1|Overall Study|SAE, non-fatal|0
5918373|NCT01521923|20475955|P4|Overall Study|AE, serious fatal|0
5918374|NCT01521923|20475956|P3|Overall Study|AE, serious fatal|0
5918375|NCT01521923|20475957|P2|Overall Study|AE, serious fatal|0
5918376|NCT01521923|20475958|P1|Overall Study|AE, serious fatal|1
5918377|NCT01521897|20476078|P1|Overall Study|Lost to Follow-up|5
5918378|NCT01521897|20476078|P1|Overall Study|Protocol Violation|18
5918379|NCT01521884|20476090|P1|Overall Study|Lost to Follow-up|4
5918380|NCT01521884|20476090|P1|Overall Study|Participant non-eligible|1
5918381|NCT01521884|20476090|P1|Overall Study|Protocol Violation|3
5918382|NCT01521884|20476090|P1|Overall Study|Physician Decision|2
5918383|NCT01521884|20476090|P1|Overall Study|Withdrawal by Subject|1
5918384|NCT01521884|20476090|P1|Overall Study|Pregnancy|1
5918385|NCT01521884|20476090|P1|Overall Study|Adverse Event|5
5918386|NCT01521884|20476090|P1|Overall Study|Non Responders|10
5918387|NCT01521559|20476187|P2|Overall Study|Other|2
5918388|NCT01521559|20476188|P1|Overall Study|Other|1
5918389|NCT01521559|20476187|P2|Overall Study|Protocol Violation|0
5918390|NCT01521559|20476188|P1|Overall Study|Protocol Violation|1
5918391|NCT01521559|20476187|P2|Overall Study|Lost to Follow-up|1
5918392|NCT01521559|20476188|P1|Overall Study|Lost to Follow-up|3
5918393|NCT01521559|20476187|P2|Overall Study|Withdrawal by Subject|11
5918394|NCT01521559|20476188|P1|Overall Study|Withdrawal by Subject|9
5918395|NCT01521559|20476187|P2|Overall Study|Death|0
5918396|NCT01521559|20476188|P1|Overall Study|Death|1
5918397|NCT01521559|20476187|P2|Overall Study|Adverse Event|4
5918398|NCT01521559|20476188|P1|Overall Study|Adverse Event|0
5918399|NCT01521507|20476211|P2|Stage 2: Observational Design|Physician Decision|0
5918400|NCT01521507|20476212|P1|Stage 2: Observational Design|Physician Decision|1
5918401|NCT01521507|20476211|P2|Stage 2: Observational Design|Withdrawal by Subject|1
5918402|NCT01521507|20476212|P1|Stage 2: Observational Design|Withdrawal by Subject|3
5918403|NCT01521507|20476211|P2|Stage 2: Observational Design|Device did not fit, No Treatment|1
5918404|NCT01521507|20476212|P1|Stage 2: Observational Design|Device did not fit, No Treatment|0
5918405|NCT01521507|20476211|P2|Stage 1: Randomized Design|Lost to Follow-up|2
5918406|NCT01521507|20476212|P1|Stage 1: Randomized Design|Lost to Follow-up|0
5918407|NCT01521507|20476211|P2|Stage 1: Randomized Design|Withdrawal by Subject|3
5918408|NCT01521507|20476212|P1|Stage 1: Randomized Design|Withdrawal by Subject|1
5918409|NCT01521507|20476211|P2|Stage 1: Randomized Design|Device did not fit, No Treatment|0
5918410|NCT01521507|20476212|P1|Stage 1: Randomized Design|Device did not fit, No Treatment|2
5918411|NCT01521494|20476234|P5|Overall Study|Physician Decision|2
5918412|NCT01521494|20476235|P4|Overall Study|Physician Decision|0
5918413|NCT01521494|20476236|P3|Overall Study|Physician Decision|0
5918414|NCT01521494|20476237|P2|Overall Study|Physician Decision|0
5918415|NCT01521494|20476238|P1|Overall Study|Physician Decision|0
5918416|NCT01521494|20476234|P5|Overall Study|Decrease in serum calcium|1
5918417|NCT01521494|20476235|P4|Overall Study|Decrease in serum calcium|1
5918418|NCT01521494|20476236|P3|Overall Study|Decrease in serum calcium|0
5918419|NCT01521494|20476237|P2|Overall Study|Decrease in serum calcium|0
5918420|NCT01521494|20476238|P1|Overall Study|Decrease in serum calcium|0
5918421|NCT01521494|20476234|P5|Overall Study|Decrease in serum phosphate|0
5918422|NCT01521494|20476235|P4|Overall Study|Decrease in serum phosphate|12
5918423|NCT01521494|20476236|P3|Overall Study|Decrease in serum phosphate|3
5918424|NCT01521494|20476237|P2|Overall Study|Decrease in serum phosphate|2
5918425|NCT01521494|20476238|P1|Overall Study|Decrease in serum phosphate|0
5918426|NCT01521494|20476234|P5|Overall Study|Withdrawal by Subject|0
5918427|NCT01521494|20476235|P4|Overall Study|Withdrawal by Subject|2
5918428|NCT01521494|20476236|P3|Overall Study|Withdrawal by Subject|0
5918429|NCT01521494|20476237|P2|Overall Study|Withdrawal by Subject|1
5918430|NCT01521494|20476238|P1|Overall Study|Withdrawal by Subject|1
5918431|NCT01521494|20476234|P5|Overall Study|Lack of Efficacy|2
5918432|NCT01521494|20476235|P4|Overall Study|Lack of Efficacy|0
5918433|NCT01521494|20476236|P3|Overall Study|Lack of Efficacy|0
5918434|NCT01521494|20476237|P2|Overall Study|Lack of Efficacy|0
5918435|NCT01521494|20476238|P1|Overall Study|Lack of Efficacy|0
5918436|NCT01521494|20476234|P5|Overall Study|Adverse Event|2
5918437|NCT01521494|20476235|P4|Overall Study|Adverse Event|6
5918438|NCT01521494|20476236|P3|Overall Study|Adverse Event|9
5918439|NCT01521494|20476237|P2|Overall Study|Adverse Event|2
5918440|NCT01521494|20476238|P1|Overall Study|Adverse Event|1
5918441|NCT01521364|20476260|P1|Linezolid + 500mg Claritromycin (wk 4&5)|Withdrawal by Subject|1
5918442|NCT01521364|20476260|P1|Linezolid + 250mg Claritromycin (wk 2&3)|Protocol Violation|1
5918443|NCT01520987|20476336|P8|Overall Study|Withdrawal by Subject|0
5918444|NCT01520987|20476337|P7|Overall Study|Withdrawal by Subject|0
5918445|NCT01520987|20476338|P6|Overall Study|Withdrawal by Subject|1
5918446|NCT01520987|20476339|P5|Overall Study|Withdrawal by Subject|0
5918447|NCT01520987|20476340|P4|Overall Study|Withdrawal by Subject|0
5918448|NCT01520987|20476341|P3|Overall Study|Withdrawal by Subject|0
5918449|NCT01520987|20476342|P2|Overall Study|Withdrawal by Subject|0
5918450|NCT01520987|20476343|P1|Overall Study|Withdrawal by Subject|1
5918451|NCT01520922|20476403|P2|Survival Follow-up|Withdrawal by Subject|0
5918452|NCT01520922|20476404|P1|Survival Follow-up|Withdrawal by Subject|1
5918453|NCT01520922|20476403|P2|Follow up|Lost to Follow-up|1
5918454|NCT01520922|20476404|P1|Follow up|Lost to Follow-up|0
5918455|NCT01520922|20476403|P2|Treatment Phase|Adverse Event|5
5918456|NCT01520922|20476404|P1|Treatment Phase|Adverse Event|3
5918457|NCT01520922|20476403|P2|Treatment Phase|Progression|2
5918458|NCT01520922|20476404|P1|Treatment Phase|Progression|0
5918459|NCT01520922|20476403|P2|Treatment Phase|Physician Decision|1
5918460|NCT01520922|20476404|P1|Treatment Phase|Physician Decision|2
5918461|NCT01520909|20476466|P3|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|1
5918462|NCT01520909|20476467|P2|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0
5918463|NCT01520909|20476468|P1|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0
5918464|NCT01520909|20476466|P3|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|2
5918465|NCT01520909|20476467|P2|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0
5918466|NCT01520909|20476468|P1|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0
5918467|NCT01520909|20476466|P3|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|4
5918468|NCT01520909|20476467|P2|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0
5918469|NCT01520909|20476468|P1|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0
5918470|NCT01520909|20476466|P3|Part 1 (Randomized Period)|Adverse Event|0
5918471|NCT01520909|20476467|P2|Part 1 (Randomized Period)|Adverse Event|2
5918472|NCT01520909|20476468|P1|Part 1 (Randomized Period)|Adverse Event|1
5918473|NCT01520714|20476585|P2|Overall Study|Lack of Efficacy|1
5918474|NCT01520714|20476586|P1|Overall Study|Lack of Efficacy|0
5918475|NCT01520714|20476585|P2|Overall Study|Adverse Event|2
5918476|NCT01520714|20476586|P1|Overall Study|Adverse Event|0
5918477|NCT01520714|20476585|P2|Overall Study|Protocol Violation|3
5918478|NCT01520714|20476586|P1|Overall Study|Protocol Violation|0
5918479|NCT01520506|20476631|P1|Overall Study|Withdrawal by Subject|1
5918480|NCT01520506|20476631|P1|Overall Study|Lost to Follow-up|1
5918481|NCT01520506|20476631|P1|Overall Study|Missed Visit|4
5918482|NCT01520402|20476686|P1|Overall Study|Physician Decision|3
5918483|NCT01520402|20476686|P1|Overall Study|Withdrawal by Subject|2
5918484|NCT01520363|20476699|P2|Overall Study|Withdrawal by Subject|0
5918485|NCT01520363|20476700|P1|Overall Study|Withdrawal by Subject|2
5918486|NCT01520324|20476774|P1|Overall Study|Subject discontinued (moderate illness)|1
5918487|NCT01519960|20476803|P3|Overall Study|Lost to Follow-up|0
5918488|NCT01519960|20476804|P2|Overall Study|Lost to Follow-up|1
5918489|NCT01519960|20476805|P1|Overall Study|Lost to Follow-up|0
5918490|NCT01519960|20476803|P3|Overall Study|Withdrawal by Subject|0
5918491|NCT01519960|20476804|P2|Overall Study|Withdrawal by Subject|4
5918492|NCT01519960|20476805|P1|Overall Study|Withdrawal by Subject|0
5918493|NCT01519960|20476803|P3|Overall Study|Adverse Event|0
5918494|NCT01519960|20476804|P2|Overall Study|Adverse Event|1
5918495|NCT01519960|20476805|P1|Overall Study|Adverse Event|0
5918496|NCT01519960|20476803|P3|Overall Study|Ongoing/Switched to PEG-IFN|0
5918497|NCT01519960|20476804|P2|Overall Study|Ongoing/Switched to PEG-IFN|33
5918498|NCT01519960|20476805|P1|Overall Study|Ongoing/Switched to PEG-IFN|0
5918499|NCT01519960|20476803|P3|Overall Study|Ongoing in Follow-Up|10
5918500|NCT01519960|20476804|P2|Overall Study|Ongoing in Follow-Up|11
5918501|NCT01519960|20476805|P1|Overall Study|Ongoing in Follow-Up|101
5918502|NCT01519947|20476915|P4|Overall Study|Adverse Event|1
5918503|NCT01519947|20476916|P3|Overall Study|Adverse Event|1
5918504|NCT01519947|20476917|P2|Overall Study|Adverse Event|0
5918505|NCT01519947|20476918|P1|Overall Study|Adverse Event|1
5918506|NCT01519947|20476915|P4|Overall Study|Poor Response|1
5918507|NCT01519947|20476916|P3|Overall Study|Poor Response|0
5918508|NCT01519947|20476917|P2|Overall Study|Poor Response|0
5918509|NCT01519947|20476918|P1|Overall Study|Poor Response|1
5918510|NCT01519947|20476915|P4|Overall Study|Lost to Follow-up|2
5918511|NCT01519947|20476916|P3|Overall Study|Lost to Follow-up|3
5918512|NCT01519947|20476917|P2|Overall Study|Lost to Follow-up|0
5918513|NCT01519947|20476918|P1|Overall Study|Lost to Follow-up|0
5918514|NCT01519947|20476915|P4|Overall Study|Withdrawal by Subject|1
5918515|NCT01519947|20476916|P3|Overall Study|Withdrawal by Subject|0
5918516|NCT01519947|20476917|P2|Overall Study|Withdrawal by Subject|1
5918517|NCT01519947|20476918|P1|Overall Study|Withdrawal by Subject|0
5918518|NCT01519947|20476915|P4|Overall Study|Blood Transfusion|0
5918519|NCT01519947|20476916|P3|Overall Study|Blood Transfusion|1
5918520|NCT01519947|20476917|P2|Overall Study|Blood Transfusion|1
5918521|NCT01519947|20476918|P1|Overall Study|Blood Transfusion|0
5918522|NCT01519947|20476915|P4|Overall Study|Development of Anemia|1
5918523|NCT01519947|20476916|P3|Overall Study|Development of Anemia|0
5918524|NCT01519947|20476917|P2|Overall Study|Development of Anemia|1
5918525|NCT01519947|20476918|P1|Overall Study|Development of Anemia|0
5918526|NCT01519947|20476915|P4|Overall Study|Peritoneal Dialysis Needed|0
5918527|NCT01519947|20476916|P3|Overall Study|Peritoneal Dialysis Needed|0
5918528|NCT01519947|20476917|P2|Overall Study|Peritoneal Dialysis Needed|1
5918529|NCT01519947|20476918|P1|Overall Study|Peritoneal Dialysis Needed|0
5918530|NCT01519947|20476915|P4|Overall Study|Protocol Violation|1
5918531|NCT01519947|20476916|P3|Overall Study|Protocol Violation|2
5918532|NCT01519947|20476917|P2|Overall Study|Protocol Violation|0
5918533|NCT01519947|20476918|P1|Overall Study|Protocol Violation|0
5918534|NCT01519947|20476915|P4|Overall Study|Death|1
5918535|NCT01519947|20476916|P3|Overall Study|Death|0
5918536|NCT01519947|20476917|P2|Overall Study|Death|0
5918537|NCT01519947|20476918|P1|Overall Study|Death|0
5918538|NCT01519934|20476948|P1|Overall Study|Lost to Follow-up|3
5918539|NCT01519921|20476957|P2|Overall Study|High alanine aminotransferase (ALT)|1
5918540|NCT01519921|20476958|P1|Overall Study|High alanine aminotransferase (ALT)|0
5918541|NCT01519921|20476957|P2|Overall Study|Treatment refusal|1
5918542|NCT01519921|20476958|P1|Overall Study|Treatment refusal|2
5918543|NCT01519921|20476957|P2|Overall Study|Lost to Follow-up|1
5918544|NCT01519921|20476958|P1|Overall Study|Lost to Follow-up|2
5918545|NCT01519921|20476957|P2|Overall Study|Withdrawal by Subject|0
5918546|NCT01519921|20476958|P1|Overall Study|Withdrawal by Subject|3
5918547|NCT01519921|20476957|P2|Overall Study|Lack of Efficacy|3
5918548|NCT01519921|20476958|P1|Overall Study|Lack of Efficacy|4
5918549|NCT01519921|20476957|P2|Overall Study|Adverse Event|9
5918550|NCT01519921|20476958|P1|Overall Study|Adverse Event|10
5918551|NCT01519869|20477007|P1|Overall Study|Lost to Follow-up|1
5918552|NCT01519817|20477011|P4|Overall Study|Off study due to infection|1
5918553|NCT01519817|20477012|P3|Overall Study|Off study due to infection|0
5918554|NCT01519817|20477013|P2|Overall Study|Off study due to infection|0
5918555|NCT01519817|20477014|P1|Overall Study|Off study due to infection|0
5918556|NCT01519817|20477011|P4|Overall Study|Withdrawal by Subject|0
5918557|NCT01519817|20477012|P3|Overall Study|Withdrawal by Subject|0
5918558|NCT01519817|20477013|P2|Overall Study|Withdrawal by Subject|0
5918559|NCT01519817|20477014|P1|Overall Study|Withdrawal by Subject|1
5918560|NCT01519791|20477054|P2|Overall Study|Lost to Follow-up|14
5918561|NCT01519791|20477055|P1|Overall Study|Lost to Follow-up|6
5918562|NCT01519791|20477054|P2|Overall Study|Withdrawal by Subject|37
5918563|NCT01519791|20477055|P1|Overall Study|Withdrawal by Subject|15
5918564|NCT01519791|20477054|P2|Overall Study|AE, non-serious non-fatal|31
5918565|NCT01519791|20477055|P1|Overall Study|AE, non-serious non-fatal|12
5918566|NCT01519791|20477054|P2|Overall Study|SAE, fatal + SAE, non-fatal|1
5918567|NCT01519791|20477055|P1|Overall Study|SAE, fatal + SAE, non-fatal|0
5918568|NCT01519791|20477054|P2|Overall Study|AE, serious fatal|1
5918569|NCT01519791|20477055|P1|Overall Study|AE, serious fatal|0
5918570|NCT01519791|20477054|P2|Overall Study|SAE, non-fatal|22
5918571|NCT01519791|20477055|P1|Overall Study|SAE, non-fatal|6
5918572|NCT01519791|20477054|P2|Overall Study|Lack of Efficacy|20
5918573|NCT01519791|20477055|P1|Overall Study|Lack of Efficacy|16
5918574|NCT01519791|20477054|P2|Overall Study|subjects randomized in error|0
5918575|NCT01519791|20477055|P1|Overall Study|subjects randomized in error|2
5918576|NCT01519791|20477054|P2|Overall Study|Other Reason|222
5918577|NCT01519791|20477055|P1|Overall Study|Other Reason|87
5918578|NCT01519791|20477054|P2|Overall Study|Protocol Violation|19
5918579|NCT01519791|20477055|P1|Overall Study|Protocol Violation|6
5918669|NCT01519089|20477500|P1|Overall Study|Adverse Event|4
5918580|NCT01519791|20477054|P2|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|1
5918581|NCT01519791|20477055|P1|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|2
5918582|NCT01519778|20477119|P1|Overall Study|Physician Decision|1
5918583|NCT01519778|20477119|P1|Overall Study|Lost to Follow-up|10
5918584|NCT01519778|20477119|P1|Overall Study|Withdrawal by Subject|3
5918585|NCT01519765|20477125|P2|Overall Study|Withdrawal by Subject|1
5918586|NCT01519765|20477126|P1|Overall Study|Withdrawal by Subject|0
5918587|NCT01519765|20477125|P2|Overall Study|Protocol Violation|0
5918588|NCT01519765|20477126|P1|Overall Study|Protocol Violation|1
5918589|NCT01519765|20477125|P2|Overall Study|Lack of Efficacy|0
5918590|NCT01519765|20477126|P1|Overall Study|Lack of Efficacy|2
5918591|NCT01519765|20477125|P2|Overall Study|Adverse Event|1
5918592|NCT01519765|20477126|P1|Overall Study|Adverse Event|0
5918593|NCT01519700|20477204|P4|Overall Study|Other Reason|4
5918594|NCT01519700|20477205|P3|Overall Study|Other Reason|0
5918595|NCT01519700|20477206|P2|Overall Study|Other Reason|2
5918596|NCT01519700|20477207|P1|Overall Study|Other Reason|2
5918597|NCT01519700|20477204|P4|Overall Study|Withdrawal by Subject|2
5918598|NCT01519700|20477205|P3|Overall Study|Withdrawal by Subject|3
5918599|NCT01519700|20477206|P2|Overall Study|Withdrawal by Subject|3
5918600|NCT01519700|20477207|P1|Overall Study|Withdrawal by Subject|5
5918601|NCT01519700|20477204|P4|Overall Study|Physician Decision|0
5918602|NCT01519700|20477205|P3|Overall Study|Physician Decision|3
5918603|NCT01519700|20477206|P2|Overall Study|Physician Decision|1
5918604|NCT01519700|20477207|P1|Overall Study|Physician Decision|1
5918605|NCT01519700|20477204|P4|Overall Study|Lost to Follow-up|1
5918606|NCT01519700|20477205|P3|Overall Study|Lost to Follow-up|1
5918607|NCT01519700|20477206|P2|Overall Study|Lost to Follow-up|0
5918608|NCT01519700|20477207|P1|Overall Study|Lost to Follow-up|0
5918609|NCT01519700|20477204|P4|Overall Study|Death|0
5918610|NCT01519700|20477205|P3|Overall Study|Death|0
5918611|NCT01519700|20477206|P2|Overall Study|Death|0
5918612|NCT01519700|20477207|P1|Overall Study|Death|1
5918613|NCT01519674|20477242|P3|Overall Study|Unsclassified|3
5918614|NCT01519674|20477243|P2|Overall Study|Unsclassified|4
5918615|NCT01519674|20477244|P1|Overall Study|Unsclassified|10
5918616|NCT01519674|20477242|P3|Overall Study|Withdrawal Criteria|7
5918617|NCT01519674|20477243|P2|Overall Study|Withdrawal Criteria|2
5918618|NCT01519674|20477244|P1|Overall Study|Withdrawal Criteria|7
5918619|NCT01519674|20477242|P3|Overall Study|Protocol Violation|1
5918620|NCT01519674|20477243|P2|Overall Study|Protocol Violation|3
5918621|NCT01519674|20477244|P1|Overall Study|Protocol Violation|0
5918622|NCT01519674|20477242|P3|Overall Study|Lack of Efficacy|1
5918623|NCT01519674|20477243|P2|Overall Study|Lack of Efficacy|1
5918624|NCT01519674|20477244|P1|Overall Study|Lack of Efficacy|1
5918625|NCT01519674|20477242|P3|Overall Study|Adverse Event|0
5918626|NCT01519674|20477243|P2|Overall Study|Adverse Event|3
5918627|NCT01519674|20477244|P1|Overall Study|Adverse Event|3
5918628|NCT01519661|20477282|P1|Overall Study|Adverse Event|29
5918629|NCT01519661|20477282|P1|Overall Study|Lack of Efficacy|6
5918630|NCT01519661|20477282|P1|Overall Study|Withdrawal by Subject|17
5918631|NCT01519661|20477282|P1|Overall Study|Lost to Follow-up|3
5918632|NCT01519661|20477282|P1|Overall Study|Protocol deviation|6
5918633|NCT01519635|20477308|P2|Overall Study|No possibility to put a catheter|2
5918634|NCT01519635|20477309|P1|Overall Study|No possibility to put a catheter|1
5918635|NCT01519635|20477308|P2|Overall Study|Withdrawal by Subject|1
5918636|NCT01519635|20477309|P1|Overall Study|Withdrawal by Subject|0
5918637|NCT01519518|20477326|P2|Overall Study|Consent not available|10
5918638|NCT01519518|20477327|P1|Overall Study|Consent not available|7
5918639|NCT01519427|20477352|P1|Overall Study|disease progression|2
5918640|NCT01519323|20477384|P2|Overall Study|Study terminated by sponsor|1
5918641|NCT01519323|20477385|P1|Overall Study|Study terminated by sponsor|0
5918642|NCT01519323|20477384|P2|Overall Study|Death|2
5918643|NCT01519323|20477385|P1|Overall Study|Death|3
5918644|NCT01519245|20477445|P2|Overall Study|Met exclusion criteria, not analysed|2
5918645|NCT01519245|20477446|P1|Overall Study|Met exclusion criteria, not analysed|1
5918646|NCT01519206|20477458|P1|Overall Study|Missed Visit|2
5918647|NCT01519206|20477458|P1|Overall Study|Lost to Follow-up|3
5918648|NCT01519167|20477472|P2|Overall Study|Physician Decision|1
5918649|NCT01519167|20477473|P1|Overall Study|Physician Decision|0
5918650|NCT01519167|20477472|P2|Overall Study|Medical condition changes&deep sedation|2
5918651|NCT01519167|20477473|P1|Overall Study|Medical condition changes&deep sedation|0
5918652|NCT01519167|20477472|P2|Overall Study|Lack of Efficacy|1
5918653|NCT01519167|20477473|P1|Overall Study|Lack of Efficacy|0
5918654|NCT01519167|20477472|P2|Overall Study|Adverse Event|1
5918655|NCT01519167|20477473|P1|Overall Study|Adverse Event|0
5918656|NCT01519167|20477472|P2|Overall Study|Diagnostic/TherapeuticProcedureCompleted|3
5918657|NCT01519167|20477473|P1|Overall Study|Diagnostic/TherapeuticProcedureCompleted|0
5918658|NCT01519089|20477499|P2|Overall Study|Not received study drug|1
5918659|NCT01519089|20477500|P1|Overall Study|Not received study drug|0
5918660|NCT01519089|20477499|P2|Overall Study|Other|6
5918661|NCT01519089|20477500|P1|Overall Study|Other|2
5918662|NCT01519089|20477499|P2|Overall Study|Withdrawal by Subject|2
5918663|NCT01519089|20477500|P1|Overall Study|Withdrawal by Subject|0
5918664|NCT01519089|20477499|P2|Overall Study|Lost to Follow-up|0
5918665|NCT01519089|20477500|P1|Overall Study|Lost to Follow-up|1
5918666|NCT01519089|20477499|P2|Overall Study|Lack of Efficacy|2
5918667|NCT01519089|20477500|P1|Overall Study|Lack of Efficacy|0
5918668|NCT01519089|20477499|P2|Overall Study|Adverse Event|4
5918670|NCT01518972|20477642|P2|Overall Study|Declined medication starting on day 12|1
5918671|NCT01518972|20477643|P1|Overall Study|Declined medication starting on day 12|0
5918672|NCT01518972|20477642|P2|Overall Study|Exclusionary medication|1
5918673|NCT01518972|20477643|P1|Overall Study|Exclusionary medication|0
5918674|NCT01518972|20477642|P2|Overall Study|Missed safety visits|1
5918675|NCT01518972|20477643|P1|Overall Study|Missed safety visits|0
5918676|NCT01518972|20477642|P2|Overall Study|Exclusionary medical condition|0
5918677|NCT01518972|20477643|P1|Overall Study|Exclusionary medical condition|1
5918678|NCT01518972|20477642|P2|Overall Study|Transportation problems|0
5918679|NCT01518972|20477643|P1|Overall Study|Transportation problems|1
5918680|NCT01518972|20477642|P2|Overall Study|Moved from area|0
5918681|NCT01518972|20477643|P1|Overall Study|Moved from area|1
5918682|NCT01518972|20477642|P2|Overall Study|Withdrawal by Subject|0
5918683|NCT01518972|20477643|P1|Overall Study|Withdrawal by Subject|1
5918684|NCT01518972|20477642|P2|Overall Study|Lost to Follow-up|1
5918685|NCT01518972|20477643|P1|Overall Study|Lost to Follow-up|2
5918686|NCT01518946|20477657|P3|Randomized Phase (First Intervention)|Other|0
5918687|NCT01518946|20477658|P2|Randomized Phase (First Intervention)|Other|1
5918688|NCT01518946|20477659|P1|Randomized Phase (First Intervention)|Other|0
5918689|NCT01518946|20477657|P3|Open-label Phase|Other|0
5918690|NCT01518946|20477658|P2|Open-label Phase|Other|0
5918691|NCT01518946|20477659|P1|Open-label Phase|Other|4
5918692|NCT01518374|20477679|P1|Overall Study|Lost to Follow-up|2
5918693|NCT01518374|20477679|P1|Overall Study|Protocol Violation|3
5918694|NCT01518374|20477679|P1|Overall Study|Withdrawal by Subject|2
5918695|NCT01518322|20477683|P1|Overall Study|FeNO measurement was missing|13
5918696|NCT01518309|20477696|P1|Overall Study|Not in Predefined Categories|9
5918697|NCT01518309|20477696|P1|Overall Study|Sponsor Decision|2
5918698|NCT01518309|20477696|P1|Overall Study|Physician Decision|3
5918699|NCT01518309|20477696|P1|Overall Study|Withdrawal by Subject|6
5918700|NCT01518309|20477696|P1|Overall Study|Lack of Efficacy|7
5918701|NCT01518309|20477696|P1|Overall Study|Death|6
5918702|NCT01518309|20477696|P1|Overall Study|Adverse Event|6
5918703|NCT01518257|20477708|P2|Overall Study|Other Miscellaneous Reason|0
5918704|NCT01518257|20477709|P1|Overall Study|Other Miscellaneous Reason|1
5918705|NCT01518257|20477708|P2|Overall Study|Lost to Follow-up|0
5918706|NCT01518257|20477709|P1|Overall Study|Lost to Follow-up|1
5918707|NCT01518244|20477731|P1|Overall Study|Adverse Event|3
5918708|NCT01518192|20477739|P3|Overall Study|Lost to Follow-up|35
5918709|NCT01518192|20477740|P2|Overall Study|Lost to Follow-up|26
5918710|NCT01518192|20477741|P1|Overall Study|Lost to Follow-up|29
5918711|NCT01518153|20477762|P3|Donor Lymphocyte Infusion|Death|1
5918712|NCT01518153|20477763|P2|Donor Lymphocyte Infusion|Death|2
5918713|NCT01518153|20477764|P1|Donor Lymphocyte Infusion|Death|0
5918714|NCT01518153|20477762|P3|Stem Cell Transplant|Adverse Event|0
5918715|NCT01518153|20477763|P2|Stem Cell Transplant|Adverse Event|0
5918716|NCT01518153|20477764|P1|Stem Cell Transplant|Adverse Event|1
5918717|NCT01518153|20477762|P3|Stem Cell Transplant|Secondary graft failure|0
5918718|NCT01518153|20477763|P2|Stem Cell Transplant|Secondary graft failure|0
5918719|NCT01518153|20477764|P1|Stem Cell Transplant|Secondary graft failure|1
5918720|NCT01518153|20477762|P3|Stem Cell Transplant|Death|0
5918721|NCT01518153|20477763|P2|Stem Cell Transplant|Death|0
5918722|NCT01518153|20477764|P1|Stem Cell Transplant|Death|2
5918723|NCT01518153|20477762|P3|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0
5918724|NCT01518153|20477763|P2|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0
5918725|NCT01518153|20477764|P1|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|5
5918726|NCT01517984|20477775|P4|Overall Study|Ineligible for randomization|0
5918727|NCT01517984|20477776|P3|Overall Study|Ineligible for randomization|0
5918728|NCT01517984|20477777|P2|Overall Study|Ineligible for randomization|14
5918729|NCT01517984|20477778|P1|Overall Study|Ineligible for randomization|0
5918730|NCT01517984|20477775|P4|Overall Study|Screen Failure|0
5918731|NCT01517984|20477776|P3|Overall Study|Screen Failure|0
5918732|NCT01517984|20477777|P2|Overall Study|Screen Failure|0
5918733|NCT01517984|20477778|P1|Overall Study|Screen Failure|4
5918734|NCT01517984|20477775|P4|Overall Study|Withdrawal by Subject|1
5918735|NCT01517984|20477776|P3|Overall Study|Withdrawal by Subject|4
5918736|NCT01517984|20477777|P2|Overall Study|Withdrawal by Subject|8
5918737|NCT01517984|20477778|P1|Overall Study|Withdrawal by Subject|1
5918738|NCT01517984|20477775|P4|Overall Study|Lost to Follow-up|0
5918739|NCT01517984|20477776|P3|Overall Study|Lost to Follow-up|0
5918740|NCT01517984|20477777|P2|Overall Study|Lost to Follow-up|1
5918741|NCT01517984|20477778|P1|Overall Study|Lost to Follow-up|0
5918742|NCT01517893|20477804|P2|Overall Study|Withdrawal by Subject|0
5918743|NCT01517893|20477805|P1|Overall Study|Withdrawal by Subject|3
5918744|NCT01517867|20477827|P2|Overall Study|Still in treatment at study end|3
5918745|NCT01517867|20477828|P1|Overall Study|Still in treatment at study end|0
5918746|NCT01517867|20477827|P2|Overall Study|Withdrawal by Subject|30
5918747|NCT01517867|20477828|P1|Overall Study|Withdrawal by Subject|34
5918748|NCT01517867|20477827|P2|Overall Study|never started treatment|32
5918749|NCT01517867|20477828|P1|Overall Study|never started treatment|29
5918750|NCT01517750|20477856|P4|Overall Study|Lost to Follow-up|1
5918751|NCT01517750|20477857|P3|Overall Study|Lost to Follow-up|4
5918752|NCT01517750|20477858|P2|Overall Study|Lost to Follow-up|2
5918753|NCT01517750|20477859|P1|Overall Study|Lost to Follow-up|1
5918754|NCT01517412|20477903|P2|Overall Study|Other than specified above|5
5918755|NCT01517412|20477904|P1|Overall Study|Other than specified above|8
5918756|NCT01517412|20477903|P2|Overall Study|Poor compliance to protocol|3
5918757|NCT01517412|20477904|P1|Overall Study|Poor compliance to protocol|8
5918758|NCT01517412|20477903|P2|Overall Study|Lack of Efficacy|5
5918759|NCT01517412|20477904|P1|Overall Study|Lack of Efficacy|10
5918760|NCT01517412|20477903|P2|Overall Study|Adverse Event|11
5918761|NCT01517412|20477904|P1|Overall Study|Adverse Event|10
5918762|NCT01517373|20477933|P6|Treatment Period|Medication error without AEs|2
5918763|NCT01517373|20477934|P5|Treatment Period|Medication error without AEs|0
5918764|NCT01517373|20477935|P4|Treatment Period|Medication error without AEs|1
5918765|NCT01517373|20477936|P3|Treatment Period|Medication error without AEs|2
5918766|NCT01517373|20477937|P2|Treatment Period|Medication error without AEs|0
5918767|NCT01517373|20477938|P1|Treatment Period|Medication error without AEs|0
5918768|NCT01517373|20477933|P6|Treatment Period|Lack of Efficacy|0
5918769|NCT01517373|20477934|P5|Treatment Period|Lack of Efficacy|2
5918770|NCT01517373|20477935|P4|Treatment Period|Lack of Efficacy|3
5918771|NCT01517373|20477936|P3|Treatment Period|Lack of Efficacy|1
5918772|NCT01517373|20477937|P2|Treatment Period|Lack of Efficacy|1
5918773|NCT01517373|20477938|P1|Treatment Period|Lack of Efficacy|0
5918774|NCT01517373|20477933|P6|Treatment Period|Protocol Violation|0
5918775|NCT01517373|20477934|P5|Treatment Period|Protocol Violation|1
5918776|NCT01517373|20477935|P4|Treatment Period|Protocol Violation|0
5918777|NCT01517373|20477936|P3|Treatment Period|Protocol Violation|0
5918778|NCT01517373|20477937|P2|Treatment Period|Protocol Violation|0
5918779|NCT01517373|20477938|P1|Treatment Period|Protocol Violation|0
5918780|NCT01517373|20477933|P6|Treatment Period|Other|0
5918781|NCT01517373|20477934|P5|Treatment Period|Other|1
5918782|NCT01517373|20477935|P4|Treatment Period|Other|0
5918783|NCT01517373|20477936|P3|Treatment Period|Other|0
5918784|NCT01517373|20477937|P2|Treatment Period|Other|0
5918785|NCT01517373|20477938|P1|Treatment Period|Other|0
5918786|NCT01517373|20477933|P6|Treatment Period|Withdrawal by Subject|3
5918787|NCT01517373|20477934|P5|Treatment Period|Withdrawal by Subject|2
5918788|NCT01517373|20477935|P4|Treatment Period|Withdrawal by Subject|2
5918789|NCT01517373|20477936|P3|Treatment Period|Withdrawal by Subject|2
5918790|NCT01517373|20477937|P2|Treatment Period|Withdrawal by Subject|3
5918791|NCT01517373|20477938|P1|Treatment Period|Withdrawal by Subject|0
5918792|NCT01517373|20477933|P6|Treatment Period|Lost to Follow-up|0
5918793|NCT01517373|20477934|P5|Treatment Period|Lost to Follow-up|0
5918794|NCT01517373|20477935|P4|Treatment Period|Lost to Follow-up|1
5918795|NCT01517373|20477936|P3|Treatment Period|Lost to Follow-up|1
5918796|NCT01517373|20477937|P2|Treatment Period|Lost to Follow-up|0
5918797|NCT01517373|20477938|P1|Treatment Period|Lost to Follow-up|0
5918798|NCT01517373|20477933|P6|Treatment Period|Adverse Event|2
5918799|NCT01517373|20477934|P5|Treatment Period|Adverse Event|0
5918800|NCT01517373|20477935|P4|Treatment Period|Adverse Event|0
5918801|NCT01517373|20477936|P3|Treatment Period|Adverse Event|0
5918802|NCT01517373|20477937|P2|Treatment Period|Adverse Event|0
5918803|NCT01517373|20477938|P1|Treatment Period|Adverse Event|0
5918804|NCT01517373|20477933|P6|Run-in Period|Other|0
5918805|NCT01517373|20477934|P5|Run-in Period|Other|0
5918806|NCT01517373|20477935|P4|Run-in Period|Other|0
5918807|NCT01517373|20477936|P3|Run-in Period|Other|0
5918808|NCT01517373|20477937|P2|Run-in Period|Other|0
5918809|NCT01517373|20477938|P1|Run-in Period|Other|1
5918810|NCT01517373|20477933|P6|Run-in Period|Sponsor Decision|0
5918811|NCT01517373|20477934|P5|Run-in Period|Sponsor Decision|0
5918812|NCT01517373|20477935|P4|Run-in Period|Sponsor Decision|0
5918813|NCT01517373|20477936|P3|Run-in Period|Sponsor Decision|0
5918814|NCT01517373|20477937|P2|Run-in Period|Sponsor Decision|0
5918815|NCT01517373|20477938|P1|Run-in Period|Sponsor Decision|3
5918816|NCT01517373|20477933|P6|Run-in Period|Withdrawal by Subject|0
5918817|NCT01517373|20477934|P5|Run-in Period|Withdrawal by Subject|0
5918818|NCT01517373|20477935|P4|Run-in Period|Withdrawal by Subject|0
5918819|NCT01517373|20477936|P3|Run-in Period|Withdrawal by Subject|0
5918820|NCT01517373|20477937|P2|Run-in Period|Withdrawal by Subject|0
5918821|NCT01517373|20477938|P1|Run-in Period|Withdrawal by Subject|12
5918822|NCT01517373|20477933|P6|Run-in Period|Lost to Follow-up|0
5918823|NCT01517373|20477934|P5|Run-in Period|Lost to Follow-up|0
5918824|NCT01517373|20477935|P4|Run-in Period|Lost to Follow-up|0
5918825|NCT01517373|20477936|P3|Run-in Period|Lost to Follow-up|0
5918826|NCT01517373|20477937|P2|Run-in Period|Lost to Follow-up|0
5918827|NCT01517373|20477938|P1|Run-in Period|Lost to Follow-up|1
5918828|NCT01517373|20477933|P6|Run-in Period|Did not meet eligibility criteria|0
5918829|NCT01517373|20477934|P5|Run-in Period|Did not meet eligibility criteria|0
5918830|NCT01517373|20477935|P4|Run-in Period|Did not meet eligibility criteria|0
5918831|NCT01517373|20477936|P3|Run-in Period|Did not meet eligibility criteria|0
5918832|NCT01517373|20477937|P2|Run-in Period|Did not meet eligibility criteria|0
5918833|NCT01517373|20477938|P1|Run-in Period|Did not meet eligibility criteria|34
5918834|NCT01517373|20477933|P6|Run-in Period|Adverse Event|0
5918835|NCT01517373|20477934|P5|Run-in Period|Adverse Event|0
5918836|NCT01517373|20477935|P4|Run-in Period|Adverse Event|0
5918837|NCT01517373|20477936|P3|Run-in Period|Adverse Event|0
5918838|NCT01517373|20477937|P2|Run-in Period|Adverse Event|0
5918839|NCT01517373|20477938|P1|Run-in Period|Adverse Event|5
5918840|NCT01517373|20477933|P6|Run-in Period|Death|0
5918841|NCT01517373|20477934|P5|Run-in Period|Death|0
5918842|NCT01517373|20477935|P4|Run-in Period|Death|0
5918843|NCT01517373|20477936|P3|Run-in Period|Death|0
5918844|NCT01517373|20477937|P2|Run-in Period|Death|0
5918845|NCT01517373|20477938|P1|Run-in Period|Death|1
5918846|NCT01517295|20478008|P2|Overall Study|Physician Decision|0
5918847|NCT01517295|20478009|P1|Overall Study|Physician Decision|1
5918848|NCT01517282|20478023|P4|Overall Study|Physician Decision|0
5918849|NCT01517282|20478024|P3|Overall Study|Physician Decision|0
5918850|NCT01517282|20478025|P2|Overall Study|Physician Decision|0
5918851|NCT01517282|20478026|P1|Overall Study|Physician Decision|1
5918852|NCT01517282|20478023|P4|Overall Study|Consent withdrawn|1
5918853|NCT01517282|20478024|P3|Overall Study|Consent withdrawn|1
5918854|NCT01517282|20478025|P2|Overall Study|Consent withdrawn|1
5918855|NCT01517282|20478026|P1|Overall Study|Consent withdrawn|0
5918856|NCT01517178|20478060|P2|Period 2|E.g. study termination|2
5918857|NCT01517178|20478061|P1|Period 2|E.g. study termination|2
5918858|NCT01517178|20478060|P2|Period 2|Withdrawal by Subject|0
5918859|NCT01517178|20478061|P1|Period 2|Withdrawal by Subject|3
5918860|NCT01517178|20478060|P2|Period 2|Adverse Event|0
5918861|NCT01517178|20478061|P1|Period 2|Adverse Event|1
5918862|NCT01517178|20478060|P2|Period 1|Withdrawal by Subject|1
5918863|NCT01517178|20478061|P1|Period 1|Withdrawal by Subject|0
5918864|NCT01517178|20478060|P2|Period 1|E.g. study termination|1
5918865|NCT01517178|20478061|P1|Period 1|E.g. study termination|3
5918866|NCT01517178|20478060|P2|Period 1|Lack of Efficacy|1
5918867|NCT01517178|20478061|P1|Period 1|Lack of Efficacy|0
5918868|NCT01517178|20478060|P2|Period 1|Adverse Event|2
5918869|NCT01517178|20478061|P1|Period 1|Adverse Event|1
5918870|NCT01516970|20478089|P2|Overall Study|Other|7
5918871|NCT01516970|20478090|P1|Overall Study|Other|9
5918872|NCT01516970|20478089|P2|Overall Study|Withdrawal by Subject|1
5918873|NCT01516970|20478090|P1|Overall Study|Withdrawal by Subject|1
5918874|NCT01516970|20478089|P2|Overall Study|Adverse Event|5
5918875|NCT01516970|20478090|P1|Overall Study|Adverse Event|1
5918876|NCT01516970|20478089|P2|Overall Study|Lost to Follow-up|8
5918877|NCT01516970|20478090|P1|Overall Study|Lost to Follow-up|7
5918878|NCT01516892|20478129|P1|Overall Study|Missing|1
5918879|NCT01516892|20478129|P1|Overall Study|Other Miscellaneous Reasons|43
5918880|NCT01516892|20478129|P1|Overall Study|Protocol Violation|60
5918881|NCT01516892|20478129|P1|Overall Study|Subject Withdrew Consent|92
5918882|NCT01516892|20478129|P1|Overall Study|Lost to Follow-up|82
5918883|NCT01516892|20478129|P1|Overall Study|Pregnancy|5
5918884|NCT01516892|20478129|P1|Overall Study|Lack of Efficacy|35
5918885|NCT01516892|20478129|P1|Overall Study|Adverse Event|25
5918886|NCT01516879|20478137|P2|Overall Study|Other|10
5918887|NCT01516879|20478138|P1|Overall Study|Other|5
5918888|NCT01516879|20478137|P2|Overall Study|Lost to Follow-up|11
5918889|NCT01516879|20478138|P1|Overall Study|Lost to Follow-up|2
5918890|NCT01516879|20478137|P2|Overall Study|Death|2
5918891|NCT01516879|20478138|P1|Overall Study|Death|0
5918892|NCT01516879|20478137|P2|Overall Study|Withdrawal by Subject|11
5918893|NCT01516879|20478138|P1|Overall Study|Withdrawal by Subject|9
5918894|NCT01516749|20478172|P1|Follow-up Off Therapy|Lost to Follow-up|1
5918895|NCT01516749|20478172|P1|Active Therapy|Lost to Follow-up|1
5918896|NCT01516736|20478181|P2|Overall Study|Other (not specified)|1
5918897|NCT01516736|20478182|P1|Overall Study|Other (not specified)|0
5918898|NCT01516736|20478181|P2|Overall Study|Protocol Violation|1
5918899|NCT01516736|20478182|P1|Overall Study|Protocol Violation|0
5918900|NCT01516736|20478181|P2|Overall Study|Lack of Efficacy|0
5918901|NCT01516736|20478182|P1|Overall Study|Lack of Efficacy|1
5918902|NCT01516736|20478181|P2|Overall Study|Physician Decision|1
5918903|NCT01516736|20478182|P1|Overall Study|Physician Decision|2
5918904|NCT01516736|20478181|P2|Overall Study|Death|1
5918905|NCT01516736|20478182|P1|Overall Study|Death|3
5918906|NCT01516736|20478181|P2|Overall Study|Adverse Event|5
5918907|NCT01516736|20478182|P1|Overall Study|Adverse Event|4
5918908|NCT01516736|20478181|P2|Overall Study|Withdrawal by Subject|4
5918909|NCT01516736|20478182|P1|Overall Study|Withdrawal by Subject|10
5918910|NCT01516437|20478236|P4|Overall Study|Reason not specified|1
5918911|NCT01516437|20478237|P3|Overall Study|Reason not specified|1
5918912|NCT01516437|20478238|P2|Overall Study|Reason not specified|0
5918913|NCT01516437|20478239|P1|Overall Study|Reason not specified|0
5918914|NCT01516034|20478311|P1|Overall Study|Lack of Efficacy|7
5918915|NCT01516034|20478311|P1|Overall Study|Physician Decision|1
5918916|NCT01516008|20478318|P3|Overall Study|Reason not specified|1
5918917|NCT01516008|20478319|P2|Overall Study|Reason not specified|0
5918918|NCT01516008|20478320|P1|Overall Study|Reason not specified|0
5918919|NCT01516008|20478318|P3|Overall Study|Protocol Violation|0
5918920|NCT01516008|20478319|P2|Overall Study|Protocol Violation|0
5918921|NCT01516008|20478320|P1|Overall Study|Protocol Violation|1
5918922|NCT01516008|20478318|P3|Overall Study|Lack of Efficacy|10
5918923|NCT01516008|20478319|P2|Overall Study|Lack of Efficacy|14
5918924|NCT01516008|20478320|P1|Overall Study|Lack of Efficacy|44
5918925|NCT01516008|20478318|P3|Overall Study|Adverse Event|7
5918926|NCT01516008|20478319|P2|Overall Study|Adverse Event|2
5918927|NCT01516008|20478320|P1|Overall Study|Adverse Event|0
5918928|NCT01515865|20478425|P3|Part B (Open-label)|Other|0
5918929|NCT01515865|20478426|P2|Part B (Open-label)|Other|0
5918930|NCT01515865|20478427|P1|Part B (Open-label)|Other|1
5918931|NCT01515865|20478425|P3|Part B (Open-label)|Withdrawal by Subject|0
5918932|NCT01515865|20478426|P2|Part B (Open-label)|Withdrawal by Subject|0
5918933|NCT01515865|20478427|P1|Part B (Open-label)|Withdrawal by Subject|1
5918934|NCT01515865|20478425|P3|Part A (Open-label)|Other|0
5918935|NCT01515865|20478426|P2|Part A (Open-label)|Other|0
5918936|NCT01515865|20478427|P1|Part A (Open-label)|Other|3
5918937|NCT01515748|20478437|P2|Overall Study|Ongoing|90
5918938|NCT01515748|20478438|P1|Overall Study|Ongoing|86
5918939|NCT01515748|20478437|P2|Overall Study|Lost to Follow-up|4
5918940|NCT01515748|20478438|P1|Overall Study|Lost to Follow-up|2
5918941|NCT01515748|20478437|P2|Overall Study|Withdrawal by Subject|41
5918942|NCT01515748|20478438|P1|Overall Study|Withdrawal by Subject|32
5918943|NCT01515475|20478521|P4|Overall Study|Lost to Follow-up|12
5918944|NCT01515475|20478522|P3|Overall Study|Lost to Follow-up|12
5918945|NCT01515475|20478523|P2|Overall Study|Lost to Follow-up|15
5918946|NCT01515475|20478524|P1|Overall Study|Lost to Follow-up|20
5918947|NCT01515423|20478598|P3|DOUBLE BLIND|Blind broken by investigator|0
5918948|NCT01515423|20478599|P2|DOUBLE BLIND|Blind broken by investigator|1
5918949|NCT01515423|20478600|P1|DOUBLE BLIND|Blind broken by investigator|0
5918950|NCT01515423|20478598|P3|DOUBLE BLIND|Other|12
5918951|NCT01515423|20478599|P2|DOUBLE BLIND|Other|6
5918952|NCT01515423|20478600|P1|DOUBLE BLIND|Other|0
5918953|NCT01515423|20478598|P3|DOUBLE BLIND|Withdrawal by Subject|53
5918954|NCT01515423|20478599|P2|DOUBLE BLIND|Withdrawal by Subject|50
5918955|NCT01515423|20478600|P1|DOUBLE BLIND|Withdrawal by Subject|0
5918956|NCT01515423|20478598|P3|DOUBLE BLIND|Pregnancy|0
5918957|NCT01515423|20478599|P2|DOUBLE BLIND|Pregnancy|2
5918958|NCT01515423|20478600|P1|DOUBLE BLIND|Pregnancy|0
5918959|NCT01515423|20478598|P3|DOUBLE BLIND|Lost to Follow-up|12
5918960|NCT01515423|20478599|P2|DOUBLE BLIND|Lost to Follow-up|7
5918961|NCT01515423|20478600|P1|DOUBLE BLIND|Lost to Follow-up|0
5918962|NCT01515423|20478598|P3|DOUBLE BLIND|Death|2
5918963|NCT01515423|20478599|P2|DOUBLE BLIND|Death|1
5918964|NCT01515423|20478600|P1|DOUBLE BLIND|Death|0
5918965|NCT01515423|20478598|P3|DOUBLE BLIND|Adverse Event|13
5918966|NCT01515423|20478599|P2|DOUBLE BLIND|Adverse Event|15
5918967|NCT01515423|20478600|P1|DOUBLE BLIND|Adverse Event|0
5918968|NCT01515423|20478598|P3|Open Label Phase|Other|0
5918969|NCT01515423|20478599|P2|Open Label Phase|Other|0
5918970|NCT01515423|20478600|P1|Open Label Phase|Other|28
5918971|NCT01515423|20478598|P3|Open Label Phase|excluded from DB Phase|0
5918972|NCT01515423|20478599|P2|Open Label Phase|excluded from DB Phase|0
5918973|NCT01515423|20478600|P1|Open Label Phase|excluded from DB Phase|70
5918974|NCT01515423|20478598|P3|Open Label Phase|Withdrawal by Subject|0
5918975|NCT01515423|20478599|P2|Open Label Phase|Withdrawal by Subject|0
5918976|NCT01515423|20478600|P1|Open Label Phase|Withdrawal by Subject|118
5918977|NCT01515423|20478598|P3|Open Label Phase|Lost to Follow-up|0
5918978|NCT01515423|20478599|P2|Open Label Phase|Lost to Follow-up|0
5918979|NCT01515423|20478600|P1|Open Label Phase|Lost to Follow-up|21
5918980|NCT01515423|20478598|P3|Open Label Phase|Lack of Efficacy|0
5918981|NCT01515423|20478599|P2|Open Label Phase|Lack of Efficacy|0
5918982|NCT01515423|20478600|P1|Open Label Phase|Lack of Efficacy|117
5918983|NCT01515423|20478598|P3|Open Label Phase|Death|0
5918984|NCT01515423|20478599|P2|Open Label Phase|Death|0
5918985|NCT01515423|20478600|P1|Open Label Phase|Death|2
5918986|NCT01515423|20478598|P3|Open Label Phase|Adverse Event|0
5918987|NCT01515423|20478599|P2|Open Label Phase|Adverse Event|0
5918988|NCT01515423|20478600|P1|Open Label Phase|Adverse Event|57
5918989|NCT01515306|20478641|P2|Overall Study|Ongoing receiving treatment|14
5918990|NCT01515306|20478642|P1|Overall Study|Ongoing receiving treatment|9
5918991|NCT01515306|20478641|P2|Overall Study|Progressive Disease|0
5918992|NCT01515306|20478642|P1|Overall Study|Progressive Disease|1
5918993|NCT01515306|20478641|P2|Overall Study|Adverse Event|0
5918994|NCT01515306|20478642|P1|Overall Study|Adverse Event|2
5918995|NCT01515189|20478655|P2|First Re-Induction Phase|Other|0
5918996|NCT01515189|20478656|P1|First Re-Induction Phase|Other|1
5918997|NCT01515189|20478655|P2|First Re-Induction Phase|No longer meets study criteria|0
5918998|NCT01515189|20478656|P1|First Re-Induction Phase|No longer meets study criteria|1
5918999|NCT01515189|20478655|P2|First Re-Induction Phase|Withdrawal by Subject|1
5919000|NCT01515189|20478656|P1|First Re-Induction Phase|Withdrawal by Subject|1
5919001|NCT01515189|20478655|P2|First Re-Induction Phase|Study drug toxicity|0
5919002|NCT01515189|20478656|P1|First Re-Induction Phase|Study drug toxicity|5
5919003|NCT01515189|20478655|P2|First Re-Induction Phase|Disease progression|14
5919004|NCT01515189|20478656|P1|First Re-Induction Phase|Disease progression|6
5919005|NCT01515189|20478655|P2|Induction|Other|4
5919006|NCT01515189|20478656|P1|Induction|Other|0
5919007|NCT01515189|20478655|P2|Induction|Lost to Follow-up|0
5919008|NCT01515189|20478656|P1|Induction|Lost to Follow-up|1
5919009|NCT01515189|20478655|P2|Induction|No longer meets study criteria|2
5919010|NCT01515189|20478656|P1|Induction|No longer meets study criteria|0
5919011|NCT01515189|20478655|P2|Induction|Withdrawal by Subject|9
5919012|NCT01515189|20478656|P1|Induction|Withdrawal by Subject|3
5919013|NCT01515189|20478655|P2|Induction|Adverse Event|9
5919014|NCT01515189|20478656|P1|Induction|Adverse Event|14
5919015|NCT01515189|20478655|P2|Induction|Death|17
5919016|NCT01515189|20478656|P1|Induction|Death|24
5919017|NCT01515189|20478655|P2|Induction|Study drug toxicity|36
5919018|NCT01515189|20478656|P1|Induction|Study drug toxicity|86
5919019|NCT01515189|20478655|P2|Induction|Disease Progression|155
5919020|NCT01515189|20478656|P1|Induction|Disease Progression|109
5919021|NCT01514864|20478744|P2|Overall Study|Study drug toxicity|0
5919022|NCT01514864|20478745|P1|Overall Study|Study drug toxicity|2
5919023|NCT01514864|20478744|P2|Overall Study|Disease progression|5
5919024|NCT01514864|20478745|P1|Overall Study|Disease progression|7
5919025|NCT01514760|20478770|P1|Overall Study|Lost to Follow-up|2
5919026|NCT01514682|20478783|P2|Overall Study|Physician Decision|3
5919027|NCT01514682|20478784|P1|Overall Study|Physician Decision|4
5919028|NCT01514682|20478783|P2|Overall Study|Withdrawal by Subject|3
5919029|NCT01514682|20478784|P1|Overall Study|Withdrawal by Subject|2
5919030|NCT01514461|20478818|P3|Overall Study|Death|0
5919031|NCT01514461|20478819|P2|Overall Study|Death|0
5919032|NCT01514461|20478820|P1|Overall Study|Death|1
5919033|NCT01514461|20478818|P3|Overall Study|Patient/guardian decision|1
5919034|NCT01514461|20478819|P2|Overall Study|Patient/guardian decision|1
5919035|NCT01514461|20478820|P1|Overall Study|Patient/guardian decision|1
5919036|NCT01514461|20478818|P3|Overall Study|Physician Decision|0
5919037|NCT01514461|20478819|P2|Overall Study|Physician Decision|1
5919038|NCT01514461|20478820|P1|Overall Study|Physician Decision|1
5919039|NCT01514461|20478818|P3|Overall Study|Adverse Event|3
5919040|NCT01514461|20478819|P2|Overall Study|Adverse Event|1
5919041|NCT01514461|20478820|P1|Overall Study|Adverse Event|2
5919042|NCT01514448|20478859|P2|Overall Study|New Cancer Therapy|0
5919043|NCT01514448|20478860|P1|Overall Study|New Cancer Therapy|1
5919044|NCT01514448|20478859|P2|Overall Study|Lost to Follow-up|0
5919045|NCT01514448|20478860|P1|Overall Study|Lost to Follow-up|2
5919046|NCT01514448|20478859|P2|Overall Study|Withdrawal by Subject|0
5919047|NCT01514448|20478860|P1|Overall Study|Withdrawal by Subject|2
5919048|NCT01514448|20478859|P2|Overall Study|Death|8
5919049|NCT01514448|20478860|P1|Overall Study|Death|7
5919050|NCT01514422|20478875|P1|Overall Study|Lost to Follow-up|1
5919051|NCT01514370|20478893|P2|Overall Study|Other|7
5919052|NCT01514370|20478894|P1|Overall Study|Other|6
5919053|NCT01514370|20478893|P2|Overall Study|Adverse Event|3
5919054|NCT01514370|20478894|P1|Overall Study|Adverse Event|1
5919055|NCT01514370|20478893|P2|Overall Study|Withdrawal by Subject|1
5919056|NCT01514370|20478894|P1|Overall Study|Withdrawal by Subject|2
5919057|NCT01514370|20478893|P2|Overall Study|Lost to Follow-up|2
5919058|NCT01514370|20478894|P1|Overall Study|Lost to Follow-up|0
5919059|NCT01514370|20478893|P2|Overall Study|Protocol Violation|3
5919060|NCT01514370|20478894|P1|Overall Study|Protocol Violation|2
5919061|NCT01514357|20478940|P2|Overall Study|Withdrawal by Subject|0
5919062|NCT01514357|20478941|P1|Overall Study|Withdrawal by Subject|2
5919063|NCT01514357|20478940|P2|Overall Study|Screen failure|0
5919064|NCT01514357|20478941|P1|Overall Study|Screen failure|2
5919065|NCT01514240|20479026|P2|Overall Study|Subject Decision|7
5919066|NCT01514240|20479027|P1|Overall Study|Subject Decision|2
5919067|NCT01514240|20479026|P2|Overall Study|Adverse Event|4
5919068|NCT01514240|20479027|P1|Overall Study|Adverse Event|4
5919069|NCT01514201|20479105|P4|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|22
5919070|NCT01514201|20479106|P3|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0
5919071|NCT01514201|20479107|P2|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0
5919072|NCT01514201|20479108|P1|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0
5919073|NCT01514201|20479105|P4|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|7
5919074|NCT01514201|20479106|P3|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0
5919075|NCT01514201|20479107|P2|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0
5919076|NCT01514201|20479108|P1|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0
5919077|NCT01514201|20479105|P4|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|4
5919078|NCT01514201|20479106|P3|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0
5919079|NCT01514201|20479107|P2|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0
5919080|NCT01514201|20479108|P1|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0
5919081|NCT01514201|20479105|P4|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|6
5919082|NCT01514201|20479106|P3|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0
5919083|NCT01514201|20479107|P2|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0
5919084|NCT01514201|20479108|P1|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0
5919085|NCT01514201|20479105|P4|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|2
5919086|NCT01514201|20479106|P3|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0
5919087|NCT01514201|20479107|P2|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0
5919088|NCT01514201|20479108|P1|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0
5919089|NCT01514201|20479105|P4|PHASE II: Veliparib + Radiation Therapy|Death|1
5919090|NCT01514201|20479106|P3|PHASE II: Veliparib + Radiation Therapy|Death|0
5919091|NCT01514201|20479107|P2|PHASE II: Veliparib + Radiation Therapy|Death|0
5919092|NCT01514201|20479108|P1|PHASE II: Veliparib + Radiation Therapy|Death|0
5919093|NCT01514201|20479105|P4|PHASE II: Veliparib + Radiation Therapy|Adverse Event|2
5919094|NCT01514201|20479106|P3|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0
5919095|NCT01514201|20479107|P2|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0
5919096|NCT01514201|20479108|P1|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0
5919097|NCT01514201|20479105|P4|PHASE II: Veliparib + Radiation Therapy|Ineligible|1
5919098|NCT01514201|20479106|P3|PHASE II: Veliparib + Radiation Therapy|Ineligible|0
5919099|NCT01514201|20479107|P2|PHASE II: Veliparib + Radiation Therapy|Ineligible|0
5919100|NCT01514201|20479108|P1|PHASE II: Veliparib + Radiation Therapy|Ineligible|0
5919101|NCT01514201|20479105|P4|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0
5919102|NCT01514201|20479106|P3|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0
5919103|NCT01514201|20479107|P2|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1
5919104|NCT01514201|20479108|P1|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1
5919105|NCT01514201|20479105|P4|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|0
5919106|NCT01514201|20479106|P3|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|5
5919107|NCT01514201|20479107|P2|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4
5919108|NCT01514201|20479108|P1|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4
5919109|NCT01514201|20479105|P4|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0
5919110|NCT01514201|20479106|P3|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1
5919111|NCT01514201|20479107|P2|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1
5919112|NCT01514201|20479108|P1|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0
5919113|NCT01514201|20479105|P4|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0
5919114|NCT01514201|20479106|P3|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0
5919115|NCT01514201|20479107|P2|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0
5919116|NCT01514201|20479108|P1|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|1
5919117|NCT01514136|20479206|P8|Test Period 2; Test C*|Protocol Violation|0
5919118|NCT01514136|20479207|P7|Test Period 2; Test C*|Protocol Violation|1
5919119|NCT01514136|20479208|P6|Test Period 2; Test C*|Protocol Violation|0
5919120|NCT01514136|20479209|P5|Test Period 2; Test C*|Protocol Violation|0
5919121|NCT01514136|20479210|P4|Test Period 2; Test C*|Protocol Violation|0
5919122|NCT01514136|20479211|P3|Test Period 2; Test C*|Protocol Violation|0
5919123|NCT01514136|20479212|P2|Test Period 2; Test C*|Protocol Violation|0
5919124|NCT01514136|20479213|P1|Test Period 2; Test C*|Protocol Violation|0
5919125|NCT01514136|20479206|P8|Test Period 2; Test C*|holiday|0
5919126|NCT01514136|20479207|P7|Test Period 2; Test C*|holiday|1
5919127|NCT01514136|20479208|P6|Test Period 2; Test C*|holiday|0
5919128|NCT01514136|20479209|P5|Test Period 2; Test C*|holiday|0
5919129|NCT01514136|20479210|P4|Test Period 2; Test C*|holiday|0
5919130|NCT01514136|20479211|P3|Test Period 2; Test C*|holiday|0
5919131|NCT01514136|20479212|P2|Test Period 2; Test C*|holiday|0
5919132|NCT01514136|20479213|P1|Test Period 2; Test C*|holiday|0
5919133|NCT01514136|20479206|P8|Test Period 2; Test C*|Withdrawal by Subject|0
5919134|NCT01514136|20479207|P7|Test Period 2; Test C*|Withdrawal by Subject|1
5919135|NCT01514136|20479208|P6|Test Period 2; Test C*|Withdrawal by Subject|0
5919136|NCT01514136|20479209|P5|Test Period 2; Test C*|Withdrawal by Subject|0
5919137|NCT01514136|20479210|P4|Test Period 2; Test C*|Withdrawal by Subject|0
5919138|NCT01514136|20479211|P3|Test Period 2; Test C*|Withdrawal by Subject|0
5919139|NCT01514136|20479212|P2|Test Period 2; Test C*|Withdrawal by Subject|0
5919140|NCT01514136|20479213|P1|Test Period 2; Test C*|Withdrawal by Subject|0
5919141|NCT01514136|20479206|P8|Test Period 2; Test B*|Withdrawal by Subject|0
5919142|NCT01514136|20479207|P7|Test Period 2; Test B*|Withdrawal by Subject|0
5919143|NCT01514136|20479208|P6|Test Period 2; Test B*|Withdrawal by Subject|2
5919144|NCT01514136|20479209|P5|Test Period 2; Test B*|Withdrawal by Subject|0
5919145|NCT01514136|20479210|P4|Test Period 2; Test B*|Withdrawal by Subject|0
5919146|NCT01514136|20479211|P3|Test Period 2; Test B*|Withdrawal by Subject|0
5919147|NCT01514136|20479212|P2|Test Period 2; Test B*|Withdrawal by Subject|0
5919148|NCT01514136|20479213|P1|Test Period 2; Test B*|Withdrawal by Subject|0
5919149|NCT01514136|20479206|P8|Test Period 2; Test A*|Holiday|0
5919150|NCT01514136|20479207|P7|Test Period 2; Test A*|Holiday|0
5919151|NCT01514136|20479208|P6|Test Period 2; Test A*|Holiday|0
5919152|NCT01514136|20479209|P5|Test Period 2; Test A*|Holiday|1
5919153|NCT01514136|20479210|P4|Test Period 2; Test A*|Holiday|0
5919154|NCT01514136|20479211|P3|Test Period 2; Test A*|Holiday|0
5919155|NCT01514136|20479212|P2|Test Period 2; Test A*|Holiday|0
5919156|NCT01514136|20479213|P1|Test Period 2; Test A*|Holiday|0
5919157|NCT01514136|20479206|P8|Test Period 2; Test A*|Adverse Event|0
5919158|NCT01514136|20479207|P7|Test Period 2; Test A*|Adverse Event|0
5919159|NCT01514136|20479208|P6|Test Period 2; Test A*|Adverse Event|0
5919160|NCT01514136|20479209|P5|Test Period 2; Test A*|Adverse Event|1
5919161|NCT01514136|20479210|P4|Test Period 2; Test A*|Adverse Event|0
5919162|NCT01514136|20479211|P3|Test Period 2; Test A*|Adverse Event|0
5919163|NCT01514136|20479212|P2|Test Period 2; Test A*|Adverse Event|0
5919164|NCT01514136|20479213|P1|Test Period 2; Test A*|Adverse Event|0
5919165|NCT01514136|20479206|P8|Test Period 1; Test D|Subject took a break due to holiday|0
5919166|NCT01514136|20479207|P7|Test Period 1; Test D|Subject took a break due to holiday|0
5919167|NCT01514136|20479208|P6|Test Period 1; Test D|Subject took a break due to holiday|0
5919168|NCT01514136|20479209|P5|Test Period 1; Test D|Subject took a break due to holiday|0
5919169|NCT01514136|20479210|P4|Test Period 1; Test D|Subject took a break due to holiday|2
5919170|NCT01514136|20479211|P3|Test Period 1; Test D|Subject took a break due to holiday|0
5919171|NCT01514136|20479212|P2|Test Period 1; Test D|Subject took a break due to holiday|0
5919172|NCT01514136|20479213|P1|Test Period 1; Test D|Subject took a break due to holiday|0
5919173|NCT01514136|20479206|P8|Test Period 1; Test B|Withdrawal by Subject|0
5919174|NCT01514136|20479207|P7|Test Period 1; Test B|Withdrawal by Subject|0
5919175|NCT01514136|20479208|P6|Test Period 1; Test B|Withdrawal by Subject|0
5919176|NCT01514136|20479209|P5|Test Period 1; Test B|Withdrawal by Subject|0
5919177|NCT01514136|20479210|P4|Test Period 1; Test B|Withdrawal by Subject|0
5919178|NCT01514136|20479211|P3|Test Period 1; Test B|Withdrawal by Subject|0
5919179|NCT01514136|20479212|P2|Test Period 1; Test B|Withdrawal by Subject|1
5919180|NCT01514136|20479213|P1|Test Period 1; Test B|Withdrawal by Subject|0
5919181|NCT01514136|20479206|P8|Test Period 1; Test A|Break from study holiday|0
5919182|NCT01514136|20479207|P7|Test Period 1; Test A|Break from study holiday|0
5919183|NCT01514136|20479208|P6|Test Period 1; Test A|Break from study holiday|0
5919184|NCT01514136|20479209|P5|Test Period 1; Test A|Break from study holiday|0
5919185|NCT01514136|20479210|P4|Test Period 1; Test A|Break from study holiday|0
5919186|NCT01514136|20479211|P3|Test Period 1; Test A|Break from study holiday|0
5919187|NCT01514136|20479212|P2|Test Period 1; Test A|Break from study holiday|0
5919188|NCT01514136|20479213|P1|Test Period 1; Test A|Break from study holiday|2
5919189|NCT01514136|20479206|P8|Test Period 1; Test A|Protocol Violation|0
5919190|NCT01514136|20479207|P7|Test Period 1; Test A|Protocol Violation|0
5919191|NCT01514136|20479208|P6|Test Period 1; Test A|Protocol Violation|0
5919192|NCT01514136|20479209|P5|Test Period 1; Test A|Protocol Violation|0
5919193|NCT01514136|20479210|P4|Test Period 1; Test A|Protocol Violation|0
5919194|NCT01514136|20479211|P3|Test Period 1; Test A|Protocol Violation|0
5919195|NCT01514136|20479212|P2|Test Period 1; Test A|Protocol Violation|0
5919196|NCT01514136|20479213|P1|Test Period 1; Test A|Protocol Violation|1
5919197|NCT01513967|20479247|P8|Overall Study|Physician Decision|0
5919198|NCT01513967|20479248|P7|Overall Study|Physician Decision|0
5919199|NCT01513967|20479249|P6|Overall Study|Physician Decision|1
5919200|NCT01513967|20479250|P5|Overall Study|Physician Decision|0
5919201|NCT01513967|20479251|P4|Overall Study|Physician Decision|0
5919202|NCT01513967|20479252|P3|Overall Study|Physician Decision|0
5919203|NCT01513967|20479253|P2|Overall Study|Physician Decision|0
5919204|NCT01513967|20479254|P1|Overall Study|Physician Decision|0
5919205|NCT01513967|20479247|P8|Overall Study|excluded due to positive drug screen|2
5919206|NCT01513967|20479248|P7|Overall Study|excluded due to positive drug screen|0
5919207|NCT01513967|20479249|P6|Overall Study|excluded due to positive drug screen|0
5919208|NCT01513967|20479250|P5|Overall Study|excluded due to positive drug screen|0
5919209|NCT01513967|20479251|P4|Overall Study|excluded due to positive drug screen|0
5919210|NCT01513967|20479252|P3|Overall Study|excluded due to positive drug screen|0
5919211|NCT01513967|20479253|P2|Overall Study|excluded due to positive drug screen|0
5919212|NCT01513967|20479254|P1|Overall Study|excluded due to positive drug screen|0
5919213|NCT01513967|20479247|P8|Overall Study|missed a study visit|0
5919214|NCT01513967|20479248|P7|Overall Study|missed a study visit|1
5919215|NCT01513967|20479249|P6|Overall Study|missed a study visit|0
5919216|NCT01513967|20479250|P5|Overall Study|missed a study visit|0
5919217|NCT01513967|20479251|P4|Overall Study|missed a study visit|0
5919218|NCT01513967|20479252|P3|Overall Study|missed a study visit|0
5919219|NCT01513967|20479253|P2|Overall Study|missed a study visit|0
5919220|NCT01513967|20479254|P1|Overall Study|missed a study visit|0
5919221|NCT01513967|20479247|P8|Overall Study|Pregnancy|0
5919222|NCT01513967|20479248|P7|Overall Study|Pregnancy|1
5919223|NCT01513967|20479249|P6|Overall Study|Pregnancy|0
5919224|NCT01513967|20479250|P5|Overall Study|Pregnancy|0
5919225|NCT01513967|20479251|P4|Overall Study|Pregnancy|0
5919226|NCT01513967|20479252|P3|Overall Study|Pregnancy|0
5919227|NCT01513967|20479253|P2|Overall Study|Pregnancy|0
5919228|NCT01513967|20479254|P1|Overall Study|Pregnancy|0
5919229|NCT01513759|20479312|P1|Overall Study|Death during catheter placement|1
5919230|NCT01513759|20479312|P1|Overall Study|Protocol Violation|4
5919231|NCT01513590|20479323|P2|Overall Study|Unclassified|10
5919232|NCT01513590|20479324|P1|Overall Study|Unclassified|5
5919233|NCT01513590|20479323|P2|Overall Study|Withdrawal Criteria|0
5919234|NCT01513590|20479324|P1|Overall Study|Withdrawal Criteria|3
5919235|NCT01513590|20479323|P2|Overall Study|Adverse Event|3
5919236|NCT01513590|20479324|P1|Overall Study|Adverse Event|2
5919237|NCT01513551|20479345|P3|Overall Study|Randomized but not vaccinated|1
5919238|NCT01513551|20479346|P2|Overall Study|Randomized but not vaccinated|0
5919239|NCT01513551|20479347|P1|Overall Study|Randomized but not vaccinated|0
5919240|NCT01513551|20479345|P3|Overall Study|Withdrawal by Subject|2
5919241|NCT01513551|20479346|P2|Overall Study|Withdrawal by Subject|0
5919242|NCT01513551|20479347|P1|Overall Study|Withdrawal by Subject|1
5919243|NCT01513551|20479345|P3|Overall Study|Lost to Follow-up|2
5919244|NCT01513551|20479346|P2|Overall Study|Lost to Follow-up|5
5919245|NCT01513551|20479347|P1|Overall Study|Lost to Follow-up|3
5919246|NCT01513551|20479345|P3|Overall Study|Death|0
5919247|NCT01513551|20479346|P2|Overall Study|Death|1
5919248|NCT01513551|20479347|P1|Overall Study|Death|0
5919249|NCT01513473|20479379|P2|Extension Trial (26 Weeks)|Withdrawal by Subject|5
5919250|NCT01513473|20479380|P1|Extension Trial (26 Weeks)|Withdrawal by Subject|1
5919251|NCT01513473|20479379|P2|Extension Trial (26 Weeks)|Adverse Event|1
5919252|NCT01513473|20479380|P1|Extension Trial (26 Weeks)|Adverse Event|0
5919253|NCT01513473|20479379|P2|Main Trial (26 Weeks)|Unclassified|2
5919254|NCT01513473|20479380|P1|Main Trial (26 Weeks)|Unclassified|0
5919255|NCT01513473|20479379|P2|Main Trial (26 Weeks)|Withdrawal by Subject|7
5919256|NCT01513473|20479380|P1|Main Trial (26 Weeks)|Withdrawal by Subject|4
5919257|NCT01513473|20479379|P2|Main Trial (26 Weeks)|Adverse Event|2
5919258|NCT01513473|20479380|P1|Main Trial (26 Weeks)|Adverse Event|0
5919259|NCT01513460|20479407|P3|Overall Study|Abnormal test procedure|0
5919260|NCT01513460|20479408|P2|Overall Study|Abnormal test procedure|0
5919261|NCT01513460|20479409|P1|Overall Study|Abnormal test procedure|1
5919262|NCT01513460|20479407|P3|Overall Study|Adverse Event|23
5919263|NCT01513460|20479408|P2|Overall Study|Adverse Event|18
5919264|NCT01513460|20479409|P1|Overall Study|Adverse Event|16
5919265|NCT01513460|20479407|P3|Overall Study|Withdrawal by Subject|21
5919266|NCT01513460|20479408|P2|Overall Study|Withdrawal by Subject|8
5919267|NCT01513460|20479409|P1|Overall Study|Withdrawal by Subject|7
5919268|NCT01513460|20479407|P3|Overall Study|Protocol deviations|3
5919269|NCT01513460|20479408|P2|Overall Study|Protocol deviations|4
5919270|NCT01513460|20479409|P1|Overall Study|Protocol deviations|3
5919271|NCT01513460|20479407|P3|Overall Study|Lack of Efficacy|5
5919272|NCT01513460|20479408|P2|Overall Study|Lack of Efficacy|2
5919273|NCT01513460|20479409|P1|Overall Study|Lack of Efficacy|1
5919274|NCT01513460|20479407|P3|Overall Study|Abnormal laboratory value|1
5919275|NCT01513460|20479408|P2|Overall Study|Abnormal laboratory value|0
5919276|NCT01513460|20479409|P1|Overall Study|Abnormal laboratory value|1
5919277|NCT01513460|20479407|P3|Overall Study|Lost to Follow-up|2
5919278|NCT01513460|20479408|P2|Overall Study|Lost to Follow-up|0
5919279|NCT01513460|20479409|P1|Overall Study|Lost to Follow-up|0
5919280|NCT01513460|20479407|P3|Overall Study|Death|1
5919281|NCT01513460|20479408|P2|Overall Study|Death|0
5919282|NCT01513460|20479409|P1|Overall Study|Death|0
5919283|NCT01513330|20479444|P2|Standard Care First,|Other|0
5919284|NCT01513330|20479445|P1|Standard Care First,|Other|1
5919285|NCT01513330|20479444|P2|Standard Care First,|Withdrawal by Subject|2
5919286|NCT01513330|20479445|P1|Standard Care First,|Withdrawal by Subject|1
5919287|NCT01513330|20479444|P2|Standard Care First,|Lack of Efficacy|2
5919288|NCT01513330|20479445|P1|Standard Care First,|Lack of Efficacy|2
5919289|NCT01513330|20479444|P2|SenSura Mio First,|Other|0
5919290|NCT01513330|20479445|P1|SenSura Mio First,|Other|1
5919291|NCT01513330|20479444|P2|SenSura Mio First,|Withdrawal by Subject|1
5919292|NCT01513330|20479445|P1|SenSura Mio First,|Withdrawal by Subject|1
5919293|NCT01513330|20479444|P2|SenSura Mio First,|Lack of Efficacy|1
5919294|NCT01513330|20479445|P1|SenSura Mio First,|Lack of Efficacy|0
5919295|NCT01513330|20479444|P2|SenSura Mio First,|Adverse Event|0
5919296|NCT01513330|20479445|P1|SenSura Mio First,|Adverse Event|2
5919297|NCT01513317|20479453|P2|Overall Study|Other|1
5919298|NCT01513317|20479454|P1|Overall Study|Other|0
5919299|NCT01513317|20479453|P2|Overall Study|Study terminated by sponsor|18
5919300|NCT01513317|20479454|P1|Overall Study|Study terminated by sponsor|18
5919301|NCT01513317|20479453|P2|Overall Study|Death|1
5919302|NCT01513317|20479454|P1|Overall Study|Death|1
5919303|NCT01513317|20479453|P2|Overall Study|Withdrawal by Subject|4
5919304|NCT01513317|20479454|P1|Overall Study|Withdrawal by Subject|15
5919305|NCT01513291|20479472|P5|Run-out Period|Withdrawal by Subject|0
5919306|NCT01513291|20479473|P4|Run-out Period|Withdrawal by Subject|1
5919307|NCT01513291|20479474|P3|Run-out Period|Withdrawal by Subject|0
5919308|NCT01513291|20479475|P2|Run-out Period|Withdrawal by Subject|0
5919309|NCT01513291|20479476|P1|Run-out Period|Withdrawal by Subject|0
5919310|NCT01513291|20479472|P5|Run-out Period|Lost to Follow-up|0
5919311|NCT01513291|20479473|P4|Run-out Period|Lost to Follow-up|1
5919312|NCT01513291|20479474|P3|Run-out Period|Lost to Follow-up|0
5919313|NCT01513291|20479475|P2|Run-out Period|Lost to Follow-up|0
5919314|NCT01513291|20479476|P1|Run-out Period|Lost to Follow-up|0
5919315|NCT01513291|20479472|P5|Treatment Period|Randomized not treated|0
5919316|NCT01513291|20479473|P4|Treatment Period|Randomized not treated|0
5919317|NCT01513291|20479474|P3|Treatment Period|Randomized not treated|0
5919318|NCT01513291|20479475|P2|Treatment Period|Randomized not treated|2
5919319|NCT01513291|20479476|P1|Treatment Period|Randomized not treated|0
5919320|NCT01513291|20479472|P5|Treatment Period|Withdrawal by Subject|0
5919321|NCT01513291|20479473|P4|Treatment Period|Withdrawal by Subject|0
5919322|NCT01513291|20479474|P3|Treatment Period|Withdrawal by Subject|0
5919323|NCT01513291|20479475|P2|Treatment Period|Withdrawal by Subject|5
5919324|NCT01513291|20479476|P1|Treatment Period|Withdrawal by Subject|8
5919325|NCT01513291|20479472|P5|Treatment Period|Protocol Violation|0
5919326|NCT01513291|20479473|P4|Treatment Period|Protocol Violation|0
5919327|NCT01513291|20479474|P3|Treatment Period|Protocol Violation|0
5919328|NCT01513291|20479475|P2|Treatment Period|Protocol Violation|2
5919329|NCT01513291|20479476|P1|Treatment Period|Protocol Violation|1
5919330|NCT01513291|20479472|P5|Treatment Period|Physician Decision|0
5919331|NCT01513291|20479473|P4|Treatment Period|Physician Decision|0
5919332|NCT01513291|20479474|P3|Treatment Period|Physician Decision|0
5919333|NCT01513291|20479475|P2|Treatment Period|Physician Decision|0
5919334|NCT01513291|20479476|P1|Treatment Period|Physician Decision|1
5919335|NCT01513291|20479472|P5|Treatment Period|Lost to Follow-up|0
5919336|NCT01513291|20479473|P4|Treatment Period|Lost to Follow-up|0
5919337|NCT01513291|20479474|P3|Treatment Period|Lost to Follow-up|0
5919338|NCT01513291|20479475|P2|Treatment Period|Lost to Follow-up|3
5919339|NCT01513291|20479476|P1|Treatment Period|Lost to Follow-up|2
5919340|NCT01513291|20479472|P5|Treatment Period|Lack of Efficacy|0
5919341|NCT01513291|20479473|P4|Treatment Period|Lack of Efficacy|0
5919342|NCT01513291|20479474|P3|Treatment Period|Lack of Efficacy|0
5919343|NCT01513291|20479475|P2|Treatment Period|Lack of Efficacy|0
5919344|NCT01513291|20479476|P1|Treatment Period|Lack of Efficacy|3
5919345|NCT01513291|20479472|P5|Treatment Period|Adverse Event|0
5919346|NCT01513291|20479473|P4|Treatment Period|Adverse Event|0
5919347|NCT01513291|20479474|P3|Treatment Period|Adverse Event|0
5919348|NCT01513291|20479475|P2|Treatment Period|Adverse Event|4
5919349|NCT01513291|20479476|P1|Treatment Period|Adverse Event|8
5919350|NCT01513239|20479504|P6|Period 2: 9 Month Extension Phase|Technical Problems|1
5919351|NCT01513239|20479505|P5|Period 2: 9 Month Extension Phase|Technical Problems|1
5919352|NCT01513239|20479506|P4|Period 2: 9 Month Extension Phase|Technical Problems|0
5919353|NCT01513239|20479507|P3|Period 2: 9 Month Extension Phase|Technical Problems|0
5919354|NCT01513239|20479508|P2|Period 2: 9 Month Extension Phase|Technical Problems|0
5919355|NCT01513239|20479509|P1|Period 2: 9 Month Extension Phase|Technical Problems|0
5919356|NCT01513239|20479504|P6|Period 2: 9 Month Extension Phase|Physician Decision|0
5919357|NCT01513239|20479505|P5|Period 2: 9 Month Extension Phase|Physician Decision|0
5919440|NCT01512745|20479731|P2|Overall Study|Withdrawal by Subject|2
5919358|NCT01513239|20479506|P4|Period 2: 9 Month Extension Phase|Physician Decision|1
5919359|NCT01513239|20479507|P3|Period 2: 9 Month Extension Phase|Physician Decision|0
5919360|NCT01513239|20479508|P2|Period 2: 9 Month Extension Phase|Physician Decision|0
5919361|NCT01513239|20479509|P1|Period 2: 9 Month Extension Phase|Physician Decision|0
5919362|NCT01513239|20479504|P6|Period 2: 9 Month Extension Phase|Lost to Follow-up|0
5919363|NCT01513239|20479505|P5|Period 2: 9 Month Extension Phase|Lost to Follow-up|1
5919364|NCT01513239|20479506|P4|Period 2: 9 Month Extension Phase|Lost to Follow-up|2
5919365|NCT01513239|20479507|P3|Period 2: 9 Month Extension Phase|Lost to Follow-up|0
5919366|NCT01513239|20479508|P2|Period 2: 9 Month Extension Phase|Lost to Follow-up|0
5919367|NCT01513239|20479509|P1|Period 2: 9 Month Extension Phase|Lost to Follow-up|0
5919368|NCT01513239|20479504|P6|Period 2: 9 Month Extension Phase|Death|2
5919369|NCT01513239|20479505|P5|Period 2: 9 Month Extension Phase|Death|5
5919370|NCT01513239|20479506|P4|Period 2: 9 Month Extension Phase|Death|2
5919371|NCT01513239|20479507|P3|Period 2: 9 Month Extension Phase|Death|0
5919372|NCT01513239|20479508|P2|Period 2: 9 Month Extension Phase|Death|0
5919373|NCT01513239|20479509|P1|Period 2: 9 Month Extension Phase|Death|0
5919374|NCT01513239|20479504|P6|Period 2: 9 Month Extension Phase|Withdrawal by Subject|2
5919375|NCT01513239|20479505|P5|Period 2: 9 Month Extension Phase|Withdrawal by Subject|3
5919376|NCT01513239|20479506|P4|Period 2: 9 Month Extension Phase|Withdrawal by Subject|5
5919377|NCT01513239|20479507|P3|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0
5919378|NCT01513239|20479508|P2|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0
5919379|NCT01513239|20479509|P1|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0
5919380|NCT01513239|20479504|P6|Period 1: Main Phase|Withdrawal by Subject|0
5919381|NCT01513239|20479505|P5|Period 1: Main Phase|Withdrawal by Subject|0
5919382|NCT01513239|20479506|P4|Period 1: Main Phase|Withdrawal by Subject|0
5919383|NCT01513239|20479507|P3|Period 1: Main Phase|Withdrawal by Subject|42
5919384|NCT01513239|20479508|P2|Period 1: Main Phase|Withdrawal by Subject|29
5919385|NCT01513239|20479509|P1|Period 1: Main Phase|Withdrawal by Subject|27
5919386|NCT01513239|20479504|P6|Period 1: Main Phase|Technical Problems|0
5919387|NCT01513239|20479505|P5|Period 1: Main Phase|Technical Problems|0
5919388|NCT01513239|20479506|P4|Period 1: Main Phase|Technical Problems|0
5919389|NCT01513239|20479507|P3|Period 1: Main Phase|Technical Problems|0
5919390|NCT01513239|20479508|P2|Period 1: Main Phase|Technical Problems|2
5919391|NCT01513239|20479509|P1|Period 1: Main Phase|Technical Problems|1
5919392|NCT01513239|20479504|P6|Period 1: Main Phase|Protocol Violation|0
5919393|NCT01513239|20479505|P5|Period 1: Main Phase|Protocol Violation|0
5919394|NCT01513239|20479506|P4|Period 1: Main Phase|Protocol Violation|0
5919395|NCT01513239|20479507|P3|Period 1: Main Phase|Protocol Violation|2
5919396|NCT01513239|20479508|P2|Period 1: Main Phase|Protocol Violation|2
5919397|NCT01513239|20479509|P1|Period 1: Main Phase|Protocol Violation|2
5919398|NCT01513239|20479504|P6|Period 1: Main Phase|Physician Decision|0
5919399|NCT01513239|20479505|P5|Period 1: Main Phase|Physician Decision|0
5919400|NCT01513239|20479506|P4|Period 1: Main Phase|Physician Decision|0
5919401|NCT01513239|20479507|P3|Period 1: Main Phase|Physician Decision|4
5919402|NCT01513239|20479508|P2|Period 1: Main Phase|Physician Decision|4
5919403|NCT01513239|20479509|P1|Period 1: Main Phase|Physician Decision|4
5919404|NCT01513239|20479504|P6|Period 1: Main Phase|Lost to Follow-up|0
5919405|NCT01513239|20479505|P5|Period 1: Main Phase|Lost to Follow-up|0
5919406|NCT01513239|20479506|P4|Period 1: Main Phase|Lost to Follow-up|0
5919407|NCT01513239|20479507|P3|Period 1: Main Phase|Lost to Follow-up|6
5919408|NCT01513239|20479508|P2|Period 1: Main Phase|Lost to Follow-up|10
5919409|NCT01513239|20479509|P1|Period 1: Main Phase|Lost to Follow-up|11
5919410|NCT01513239|20479504|P6|Period 1: Main Phase|Death|0
5919411|NCT01513239|20479505|P5|Period 1: Main Phase|Death|0
5919412|NCT01513239|20479506|P4|Period 1: Main Phase|Death|0
5919413|NCT01513239|20479507|P3|Period 1: Main Phase|Death|32
5919414|NCT01513239|20479508|P2|Period 1: Main Phase|Death|22
5919415|NCT01513239|20479509|P1|Period 1: Main Phase|Death|29
5919416|NCT01513239|20479504|P6|Period 1: Main Phase|Adverse Event|0
5919417|NCT01513239|20479505|P5|Period 1: Main Phase|Adverse Event|0
5919418|NCT01513239|20479506|P4|Period 1: Main Phase|Adverse Event|0
5919419|NCT01513239|20479507|P3|Period 1: Main Phase|Adverse Event|2
5919420|NCT01513239|20479508|P2|Period 1: Main Phase|Adverse Event|1
5919421|NCT01513239|20479509|P1|Period 1: Main Phase|Adverse Event|1
5919422|NCT01513148|20479562|P2|Overall Study|Protocol Violation|2
5919423|NCT01513148|20479563|P1|Overall Study|Protocol Violation|2
5919424|NCT01512979|20479630|P2|Overall Study|Reason other than stated above|9
5919425|NCT01512979|20479631|P1|Overall Study|Reason other than stated above|13
5919426|NCT01512979|20479630|P2|Overall Study|Withdrawal by Subject|2
5919427|NCT01512979|20479631|P1|Overall Study|Withdrawal by Subject|1
5919428|NCT01512979|20479630|P2|Overall Study|Lost to Follow-up|5
5919429|NCT01512979|20479631|P1|Overall Study|Lost to Follow-up|2
5919430|NCT01512979|20479630|P2|Overall Study|Protocol Violation|4
5919431|NCT01512979|20479631|P1|Overall Study|Protocol Violation|1
5919432|NCT01512979|20479630|P2|Overall Study|Adverse Event|2
5919433|NCT01512979|20479631|P1|Overall Study|Adverse Event|2
5919434|NCT01512745|20479731|P2|Overall Study|Protocol Violation|0
5919435|NCT01512745|20479732|P1|Overall Study|Protocol Violation|1
5919436|NCT01512745|20479731|P2|Overall Study|Lack of Efficacy|2
5919437|NCT01512745|20479732|P1|Overall Study|Lack of Efficacy|2
5919438|NCT01512745|20479731|P2|Overall Study|Lost to Follow-up|0
5919439|NCT01512745|20479732|P1|Overall Study|Lost to Follow-up|4
5919441|NCT01512745|20479732|P1|Overall Study|Withdrawal by Subject|2
5919442|NCT01512745|20479731|P2|Overall Study|Death|13
5919443|NCT01512745|20479732|P1|Overall Study|Death|9
5919444|NCT01512745|20479731|P2|Overall Study|Adverse Event|3
5919445|NCT01512745|20479732|P1|Overall Study|Adverse Event|22
5919446|NCT01512693|20479748|P2|Overall Study|Withdrawal by Subject|1
5919447|NCT01512693|20479749|P1|Overall Study|Withdrawal by Subject|0
5919448|NCT01512368|20479789|P1|Overall Study|Protocol Violation|3
5919449|NCT01512264|20479802|P4|Overall Study|Lost to Follow-up|1
5919450|NCT01512264|20479803|P3|Overall Study|Lost to Follow-up|0
5919451|NCT01512264|20479804|P2|Overall Study|Lost to Follow-up|0
5919452|NCT01512264|20479805|P1|Overall Study|Lost to Follow-up|0
5919453|NCT01512160|20479944|P4|Overall Study|Withdrawal by Subject|1
5919454|NCT01512160|20479945|P3|Overall Study|Withdrawal by Subject|0
5919455|NCT01512160|20479946|P2|Overall Study|Withdrawal by Subject|0
5919456|NCT01512160|20479947|P1|Overall Study|Withdrawal by Subject|1
5919457|NCT01512160|20479944|P4|Overall Study|Lost to Follow-up|0
5919458|NCT01512160|20479945|P3|Overall Study|Lost to Follow-up|0
5919459|NCT01512160|20479946|P2|Overall Study|Lost to Follow-up|0
5919460|NCT01512160|20479947|P1|Overall Study|Lost to Follow-up|1
5919461|NCT01512108|20480039|P2|Overall Study|Unclassified|3
5919462|NCT01512108|20480040|P1|Overall Study|Unclassified|11
5919463|NCT01512108|20480039|P2|Overall Study|Withdrawal Criteria|0
5919464|NCT01512108|20480040|P1|Overall Study|Withdrawal Criteria|1
5919465|NCT01512108|20480039|P2|Overall Study|Protocol Violation|2
5919466|NCT01512108|20480040|P1|Overall Study|Protocol Violation|1
5919467|NCT01512108|20480039|P2|Overall Study|Adverse Event|4
5919468|NCT01512108|20480040|P1|Overall Study|Adverse Event|9
5919469|NCT01511939|20480066|P3|Overall Study|Withdrawal by Subject|0
5919470|NCT01511939|20480067|P2|Overall Study|Withdrawal by Subject|1
5919471|NCT01511939|20480068|P1|Overall Study|Withdrawal by Subject|2
5919472|NCT01511536|20480097|P3|Phase 2|Other|9
5919473|NCT01511536|20480098|P2|Phase 2|Other|0
5919474|NCT01511536|20480099|P1|Phase 2|Other|0
5919475|NCT01511536|20480097|P3|Phase 1|Other|0
5919476|NCT01511536|20480098|P2|Phase 1|Other|1
5919477|NCT01511536|20480099|P1|Phase 1|Other|0
5919478|NCT01511445|20480121|P2|Overall Study|Protocol Violation|0
5919479|NCT01511445|20480122|P1|Overall Study|Protocol Violation|1
5919480|NCT01511445|20480121|P2|Overall Study|Protocol Violation|3
5919481|NCT01511445|20480122|P1|Overall Study|Protocol Violation|1
5919482|NCT01511445|20480121|P2|Overall Study|Lost to Follow-up|1
5919483|NCT01511445|20480122|P1|Overall Study|Lost to Follow-up|3
5919484|NCT01511419|20480132|P2|Dose 2|Physician Decision|0
5919485|NCT01511419|20480133|P1|Dose 2|Physician Decision|1
5919486|NCT01511250|20480245|P10|Overall Study|Protocol Violation|0
5919487|NCT01511250|20480246|P9|Overall Study|Protocol Violation|0
5919488|NCT01511250|20480247|P8|Overall Study|Protocol Violation|0
5919489|NCT01511250|20480248|P7|Overall Study|Protocol Violation|0
5919490|NCT01511250|20480249|P6|Overall Study|Protocol Violation|0
5919491|NCT01511250|20480250|P5|Overall Study|Protocol Violation|0
5919492|NCT01511250|20480251|P4|Overall Study|Protocol Violation|0
5919493|NCT01511250|20480252|P3|Overall Study|Protocol Violation|1
5919494|NCT01511250|20480253|P2|Overall Study|Protocol Violation|2
5919495|NCT01511250|20480254|P1|Overall Study|Protocol Violation|0
5919496|NCT01511250|20480245|P10|Overall Study|Lost to Follow-up|5
5919497|NCT01511250|20480246|P9|Overall Study|Lost to Follow-up|13
5919498|NCT01511250|20480247|P8|Overall Study|Lost to Follow-up|3
5919499|NCT01511250|20480248|P7|Overall Study|Lost to Follow-up|2
5919500|NCT01511250|20480249|P6|Overall Study|Lost to Follow-up|0
5919501|NCT01511250|20480250|P5|Overall Study|Lost to Follow-up|0
5919502|NCT01511250|20480251|P4|Overall Study|Lost to Follow-up|3
5919503|NCT01511250|20480252|P3|Overall Study|Lost to Follow-up|3
5919504|NCT01511250|20480253|P2|Overall Study|Lost to Follow-up|3
5919505|NCT01511250|20480254|P1|Overall Study|Lost to Follow-up|7
5919506|NCT01511250|20480245|P10|Overall Study|Sponsor/Investigator Decision|0
5919507|NCT01511250|20480246|P9|Overall Study|Sponsor/Investigator Decision|0
5919508|NCT01511250|20480247|P8|Overall Study|Sponsor/Investigator Decision|0
5919509|NCT01511250|20480248|P7|Overall Study|Sponsor/Investigator Decision|0
5919510|NCT01511250|20480249|P6|Overall Study|Sponsor/Investigator Decision|0
5919511|NCT01511250|20480250|P5|Overall Study|Sponsor/Investigator Decision|0
5919512|NCT01511250|20480251|P4|Overall Study|Sponsor/Investigator Decision|0
5919513|NCT01511250|20480252|P3|Overall Study|Sponsor/Investigator Decision|0
5919514|NCT01511250|20480253|P2|Overall Study|Sponsor/Investigator Decision|0
5919515|NCT01511250|20480254|P1|Overall Study|Sponsor/Investigator Decision|1
5919516|NCT01511250|20480245|P10|Overall Study|Withdrawal of Consent|0
5919517|NCT01511250|20480246|P9|Overall Study|Withdrawal of Consent|1
5919518|NCT01511250|20480247|P8|Overall Study|Withdrawal of Consent|1
5919519|NCT01511250|20480248|P7|Overall Study|Withdrawal of Consent|0
5919520|NCT01511250|20480249|P6|Overall Study|Withdrawal of Consent|0
5919521|NCT01511250|20480250|P5|Overall Study|Withdrawal of Consent|0
5919522|NCT01511250|20480251|P4|Overall Study|Withdrawal of Consent|0
5919523|NCT01511250|20480252|P3|Overall Study|Withdrawal of Consent|0
5919524|NCT01511250|20480253|P2|Overall Study|Withdrawal of Consent|0
5919525|NCT01511250|20480254|P1|Overall Study|Withdrawal of Consent|1
5919526|NCT01511107|20480402|P2|Overall Study|Withdrawal by Subject|20
5919527|NCT01511107|20480403|P1|Overall Study|Withdrawal by Subject|9
5919528|NCT01511107|20480402|P2|Overall Study|Lost to Follow-up|19
5919529|NCT01511107|20480403|P1|Overall Study|Lost to Follow-up|10
5919530|NCT01511107|20480402|P2|Overall Study|Ineligible|2
5919531|NCT01511107|20480403|P1|Overall Study|Ineligible|3
5919532|NCT01511055|20480475|P1|Overall Study|Withdrawal by Subject|6
5919533|NCT01510912|20480499|P1|Overall Study|Other, including joint replacement|5
5919534|NCT01510912|20480499|P1|Overall Study|Lost to Follow-up|26
5919535|NCT01510912|20480499|P1|Overall Study|Protocol Violation|27
5919536|NCT01510912|20480499|P1|Overall Study|Physician Decision|1
5919537|NCT01510912|20480499|P1|Overall Study|Withdrawal by Subject|49
5919538|NCT01510912|20480499|P1|Overall Study|Non-compliance with trial drug|23
5919539|NCT01510912|20480499|P1|Overall Study|Lack of Efficacy|12
5919540|NCT01510912|20480499|P1|Overall Study|Adverse Event|99
5919541|NCT01510769|20480515|P3|Overall Study|Death|0
5919542|NCT01510769|20480516|P2|Overall Study|Death|1
5919543|NCT01510769|20480517|P1|Overall Study|Death|1
5919544|NCT01510769|20480515|P3|Overall Study|Withdrawal by Subject|3
5919545|NCT01510769|20480516|P2|Overall Study|Withdrawal by Subject|4
5919546|NCT01510769|20480517|P1|Overall Study|Withdrawal by Subject|3
5919547|NCT01510769|20480515|P3|Overall Study|Lost to Follow-up|5
5919548|NCT01510769|20480516|P2|Overall Study|Lost to Follow-up|1
5919549|NCT01510769|20480517|P1|Overall Study|Lost to Follow-up|5
5919550|NCT01510769|20480515|P3|Overall Study|Protocol Violation|9
5919551|NCT01510769|20480516|P2|Overall Study|Protocol Violation|10
5919552|NCT01510769|20480517|P1|Overall Study|Protocol Violation|11
5919553|NCT01510769|20480515|P3|Overall Study|Gout Flare|1
5919554|NCT01510769|20480516|P2|Overall Study|Gout Flare|3
5919555|NCT01510769|20480517|P1|Overall Study|Gout Flare|0
5919556|NCT01510769|20480515|P3|Overall Study|Adverse Event|4
5919557|NCT01510769|20480516|P2|Overall Study|Adverse Event|6
5919558|NCT01510769|20480517|P1|Overall Study|Adverse Event|7
5919559|NCT01510756|20480534|P1|Overall Study|Physician Decision|1
5919560|NCT01510756|20480534|P1|Overall Study|Lack of Efficacy|2
5919561|NCT01510756|20480534|P1|Overall Study|Death|1
5919562|NCT01510717|20480542|P2|Overall Study|Withdrawal by Subject|2
5919563|NCT01510717|20480543|P1|Overall Study|Withdrawal by Subject|0
5919564|NCT01510717|20480542|P2|Overall Study|Lost to Follow-up|1
5919565|NCT01510717|20480543|P1|Overall Study|Lost to Follow-up|0
5919566|NCT01510717|20480542|P2|Overall Study|Death|0
5919567|NCT01510717|20480543|P1|Overall Study|Death|1
5919568|NCT01510717|20480542|P2|Overall Study|Adverse Event|2
5919569|NCT01510717|20480543|P1|Overall Study|Adverse Event|1
5919570|NCT01510158|20480663|P3|Overall Study|Death|0
5919571|NCT01510158|20480664|P2|Overall Study|Death|0
5919572|NCT01510158|20480665|P1|Overall Study|Death|1
5919573|NCT01510158|20480663|P3|Overall Study|Withdrawal by Subject|10
5919574|NCT01510158|20480664|P2|Overall Study|Withdrawal by Subject|13
5919575|NCT01510158|20480665|P1|Overall Study|Withdrawal by Subject|10
5919576|NCT01510158|20480663|P3|Overall Study|Lost to Follow-up|9
5919577|NCT01510158|20480664|P2|Overall Study|Lost to Follow-up|16
5919578|NCT01510158|20480665|P1|Overall Study|Lost to Follow-up|13
5919579|NCT01510158|20480663|P3|Overall Study|Sponsor terminated study.|2
5919580|NCT01510158|20480664|P2|Overall Study|Sponsor terminated study.|0
5919581|NCT01510158|20480665|P1|Overall Study|Sponsor terminated study.|2
5919582|NCT01510158|20480663|P3|Overall Study|Protocol Violation|24
5919583|NCT01510158|20480664|P2|Overall Study|Protocol Violation|16
5919584|NCT01510158|20480665|P1|Overall Study|Protocol Violation|17
5919585|NCT01510158|20480663|P3|Overall Study|Gout flare|0
5919586|NCT01510158|20480664|P2|Overall Study|Gout flare|0
5919587|NCT01510158|20480665|P1|Overall Study|Gout flare|1
5919588|NCT01510158|20480663|P3|Overall Study|Adverse Event|5
5919589|NCT01510158|20480664|P2|Overall Study|Adverse Event|8
5919590|NCT01510158|20480665|P1|Overall Study|Adverse Event|7
5919591|NCT01510145|20480679|P1|Overall Study|Relative reported subject withdrew|1
5919592|NCT01510145|20480679|P1|Overall Study|Withdrawal by Subject|6
5919593|NCT01510145|20480679|P1|Overall Study|Lost to Follow-up|5
5919594|NCT01510145|20480679|P1|Overall Study|Adverse Event|6
5919595|NCT01510028|20480688|P4|Overall Study|Lack of Efficacy|0
5919596|NCT01510028|20480689|P3|Overall Study|Lack of Efficacy|0
5919597|NCT01510028|20480690|P2|Overall Study|Lack of Efficacy|0
5919598|NCT01510028|20480691|P1|Overall Study|Lack of Efficacy|1
5919599|NCT01509664|20480952|P2|Overall Study|Lost to Follow-up|21
5919600|NCT01509664|20480953|P1|Overall Study|Lost to Follow-up|15
5919601|NCT01509547|20481029|P2|Overall Study|Physician Decision|1
5919602|NCT01509547|20481030|P1|Overall Study|Physician Decision|0
5919603|NCT01509547|20481029|P2|Overall Study|Withdrawal by Subject|24
5919604|NCT01509547|20481030|P1|Overall Study|Withdrawal by Subject|11
5919605|NCT01509547|20481029|P2|Overall Study|Lost to Follow-up|14
5919606|NCT01509547|20481030|P1|Overall Study|Lost to Follow-up|24
5919607|NCT01509079|20481097|P2|Overall Study|started an excluded medication|1
5919608|NCT01509079|20481098|P1|Overall Study|started an excluded medication|0
5919609|NCT01509079|20481097|P2|Overall Study|Lack of Efficacy|2
5919610|NCT01509079|20481098|P1|Overall Study|Lack of Efficacy|0
5919611|NCT01509053|20481118|P1|Aripiprazole IM Depot Extension Phase(C)|Sponsor discontinued study|3
5919612|NCT01509053|20481118|P1|Aripiprazole IM Depot Treatment Phase(B)|Subject withdrew consent|1
5919613|NCT01509053|20481118|P1|Aripiprazole IM Depot Treatment Phase(B)|Subject was withdrawn by investigator|1
5919614|NCT01509053|20481118|P1|Aripiprazole IM Depot Treatment Phase(B)|Sponsor discontinued study|13
5919615|NCT01509053|20481118|P1|Aripiprazole IM Depot Treatment Phase(B)|Adverse Event|1
5919616|NCT01509053|20481118|P1|Oral Aripirazole (Phase A)|Sponsor discontinued study|11
5919617|NCT01508936|20481180|P2|Overall Study|Data from 2 sites deemed invalid|11
5919618|NCT01508936|20481181|P1|Overall Study|Data from 2 sites deemed invalid|4
5919619|NCT01508936|20481180|P2|Overall Study|Other|5
5919620|NCT01508936|20481181|P1|Overall Study|Other|0
5919621|NCT01508936|20481180|P2|Overall Study|Lost to Follow-up|9
5919622|NCT01508936|20481181|P1|Overall Study|Lost to Follow-up|2
5919623|NCT01508936|20481180|P2|Overall Study|Protocol Violation|3
5919624|NCT01508936|20481181|P1|Overall Study|Protocol Violation|2
5919625|NCT01508936|20481180|P2|Overall Study|Withdrawal by Subject|18
5919626|NCT01508936|20481181|P1|Overall Study|Withdrawal by Subject|4
5919627|NCT01508936|20481180|P2|Overall Study|Lack of Efficacy|1
5919628|NCT01508936|20481181|P1|Overall Study|Lack of Efficacy|0
5919629|NCT01508936|20481180|P2|Overall Study|Adverse Event|32
5919630|NCT01508936|20481181|P1|Overall Study|Adverse Event|11
5919631|NCT01508910|20481220|P4|Treatment|Sponsor Decision|1
5919632|NCT01508910|20481221|P3|Treatment|Sponsor Decision|0
5919633|NCT01508910|20481222|P2|Treatment|Sponsor Decision|0
5919634|NCT01508910|20481223|P1|Treatment|Sponsor Decision|0
5919635|NCT01508910|20481220|P4|Treatment|Withdrawal by Subject|1
5919636|NCT01508910|20481221|P3|Treatment|Withdrawal by Subject|6
5919637|NCT01508910|20481222|P2|Treatment|Withdrawal by Subject|1
5919638|NCT01508910|20481223|P1|Treatment|Withdrawal by Subject|0
5919639|NCT01508910|20481220|P4|Treatment|Lost to Follow-up|1
5919640|NCT01508910|20481221|P3|Treatment|Lost to Follow-up|2
5919641|NCT01508910|20481222|P2|Treatment|Lost to Follow-up|0
5919642|NCT01508910|20481223|P1|Treatment|Lost to Follow-up|0
5919643|NCT01508910|20481220|P4|Treatment|Death|0
5919644|NCT01508910|20481221|P3|Treatment|Death|2
5919645|NCT01508910|20481222|P2|Treatment|Death|3
5919646|NCT01508910|20481223|P1|Treatment|Death|2
5919647|NCT01508702|20481256|P2|Overall Study|Withdrawal by Subject|7
5919648|NCT01508702|20481257|P1|Overall Study|Withdrawal by Subject|11
5919649|NCT01508702|20481256|P2|Overall Study|Lost to Follow-up|2
5919650|NCT01508702|20481257|P1|Overall Study|Lost to Follow-up|1
5919651|NCT01508702|20481256|P2|Overall Study|Protocol Violation|1
5919652|NCT01508702|20481257|P1|Overall Study|Protocol Violation|2
5919653|NCT01508702|20481256|P2|Overall Study|Gout flare|0
5919654|NCT01508702|20481257|P1|Overall Study|Gout flare|2
5919655|NCT01508702|20481256|P2|Overall Study|Adverse Event|3
5919656|NCT01508702|20481257|P1|Overall Study|Adverse Event|7
5919657|NCT01508676|20481265|P2|Phase II (2 Weeks)|Medication Exclusion|0
5919658|NCT01508676|20481266|P1|Phase II (2 Weeks)|Medication Exclusion|1
5919659|NCT01508676|20481265|P2|Phase II (2 Weeks)|Skin Sensitivity|1
5919660|NCT01508676|20481266|P1|Phase II (2 Weeks)|Skin Sensitivity|0
5919661|NCT01508676|20481265|P2|Phase I (2 Weeks)|Positive Drug Screen|2
5919662|NCT01508676|20481266|P1|Phase I (2 Weeks)|Positive Drug Screen|0
5919663|NCT01508676|20481265|P2|Phase I (2 Weeks)|Wrong Pain Type|0
5919664|NCT01508676|20481266|P1|Phase I (2 Weeks)|Wrong Pain Type|1
5919665|NCT01508676|20481265|P2|Phase I (2 Weeks)|Medication Exclusion|1
5919666|NCT01508676|20481266|P1|Phase I (2 Weeks)|Medication Exclusion|1
5919667|NCT01508650|20481278|P2|Overall Study|Lost to Follow-up|3
5919668|NCT01508650|20481279|P1|Overall Study|Lost to Follow-up|0
5919669|NCT01508325|20481298|P2|Overall Study|Other|2
5919670|NCT01508325|20481299|P1|Overall Study|Other|2
5919671|NCT01508325|20481298|P2|Overall Study|Lost to Follow-up|6
5919672|NCT01508325|20481299|P1|Overall Study|Lost to Follow-up|5
5919673|NCT01508325|20481298|P2|Overall Study|Adverse Event|0
5919674|NCT01508325|20481299|P1|Overall Study|Adverse Event|1
5919675|NCT01508325|20481298|P2|Overall Study|Physician Decision|1
5919676|NCT01508325|20481299|P1|Overall Study|Physician Decision|2
5919677|NCT01508325|20481298|P2|Overall Study|Protocol Violation|3
5919678|NCT01508325|20481299|P1|Overall Study|Protocol Violation|0
5919679|NCT01508325|20481298|P2|Overall Study|Withdrawal by Subject|9
5919680|NCT01508325|20481299|P1|Overall Study|Withdrawal by Subject|8
5919681|NCT01508169|20481329|P2|Overall Study|Lost to Follow-up|2
5919682|NCT01508169|20481330|P1|Overall Study|Lost to Follow-up|1
5919683|NCT01508169|20481329|P2|Overall Study|Withdrawal by Subject|0
5919684|NCT01508169|20481330|P1|Overall Study|Withdrawal by Subject|1
5919685|NCT01508169|20481329|P2|Overall Study|Adverse Event|0
5919686|NCT01508169|20481330|P1|Overall Study|Adverse Event|1
5919687|NCT01508130|20481344|P2|Overall Study|Administrative|3
5919688|NCT01508130|20481345|P1|Overall Study|Administrative|14
5919689|NCT01508130|20481344|P2|Overall Study|Insufficient therapeutic response|23
5919690|NCT01508130|20481345|P1|Overall Study|Insufficient therapeutic response|74
5919691|NCT01508130|20481344|P2|Overall Study|Subject's substantial non-compliance|9
5919692|NCT01508130|20481345|P1|Overall Study|Subject's substantial non-compliance|25
5919693|NCT01508130|20481344|P2|Overall Study|Withdrawal by Subject|3
5919694|NCT01508130|20481345|P1|Overall Study|Withdrawal by Subject|3
5919695|NCT01508130|20481344|P2|Overall Study|Lost to Follow-up|2
5919696|NCT01508130|20481345|P1|Overall Study|Lost to Follow-up|25
5919697|NCT01508130|20481344|P2|Overall Study|Protocol Violation|0
5919698|NCT01508130|20481345|P1|Overall Study|Protocol Violation|2
5919699|NCT01508130|20481344|P2|Overall Study|Death|1
5919700|NCT01508130|20481345|P1|Overall Study|Death|3
5919701|NCT01508130|20481344|P2|Overall Study|Adverse Event|28
5919702|NCT01508130|20481345|P1|Overall Study|Adverse Event|81
5919703|NCT01507896|20481413|P1|Overall Study|The surgery was denied by the sponsor.|1
5919704|NCT01507896|20481413|P1|Overall Study|Withdrawal by Subject|1
5919705|NCT01507831|20481456|P2|Overall Study|Other|6
5919706|NCT01507831|20481457|P1|Overall Study|Other|3
5919707|NCT01507831|20481456|P2|Overall Study|Potential lost to follow-up|0
5919708|NCT01507831|20481457|P1|Overall Study|Potential lost to follow-up|3
5919709|NCT01507831|20481456|P2|Overall Study|Site closure|3
5919710|NCT01507831|20481457|P1|Overall Study|Site closure|0
5919711|NCT01507831|20481456|P2|Overall Study|Selection criteria finally not met|1
5919712|NCT01507831|20481457|P1|Overall Study|Selection criteria finally not met|0
5919713|NCT01507831|20481456|P2|Overall Study|Last visit outside protocol visit window|143
5919714|NCT01507831|20481457|P1|Overall Study|Last visit outside protocol visit window|51
5919715|NCT01507831|20481456|P2|Overall Study|Related to study drug administration|14
5919716|NCT01507831|20481457|P1|Overall Study|Related to study drug administration|5
5919717|NCT01507831|20481456|P2|Overall Study|Consent withdrawn by participant|72
5919718|NCT01507831|20481457|P1|Overall Study|Consent withdrawn by participant|34
5919719|NCT01507831|20481456|P2|Overall Study|Participant moved|19
5919720|NCT01507831|20481457|P1|Overall Study|Participant moved|5
5919721|NCT01507831|20481456|P2|Overall Study|Physician Decision|4
5919722|NCT01507831|20481457|P1|Overall Study|Physician Decision|0
5919723|NCT01507831|20481456|P2|Overall Study|Poor compliance to protocol|60
5919724|NCT01507831|20481457|P1|Overall Study|Poor compliance to protocol|38
5919725|NCT01507831|20481456|P2|Overall Study|Death|2
5919726|NCT01507831|20481457|P1|Overall Study|Death|6
5919727|NCT01507831|20481456|P2|Overall Study|Adverse Event|113
5919728|NCT01507831|20481457|P1|Overall Study|Adverse Event|48
5919729|NCT01507831|20481456|P2|Overall Study|Randomized but not treated|3
5919730|NCT01507831|20481457|P1|Overall Study|Randomized but not treated|0
5919731|NCT01507662|20481577|P2|Overall Study|Proxy interview done|3
5919732|NCT01507662|20481578|P1|Overall Study|Proxy interview done|2
5919733|NCT01507662|20481577|P2|Overall Study|Lost to Follow-up|523
5919734|NCT01507662|20481578|P1|Overall Study|Lost to Follow-up|498
5919735|NCT01507662|20481577|P2|Overall Study|Withdrawal by Subject|287
5919736|NCT01507662|20481578|P1|Overall Study|Withdrawal by Subject|290
5919737|NCT01507662|20481577|P2|Overall Study|Death|18
5919738|NCT01507662|20481578|P1|Overall Study|Death|26
5919739|NCT01507298|20481613|P2|Overall Study|Protocol Violation|6
5919740|NCT01507298|20481614|P1|Overall Study|Protocol Violation|0
5919741|NCT01507246|20481624|P2|Overall Study|Required different surgical procedures|1
5919742|NCT01507246|20481625|P1|Overall Study|Required different surgical procedures|2
5919743|NCT01507090|20481723|P1|Overall Study|incomplete dataset|18
5919744|NCT01507051|20481762|P4|Overall Study|Adverse Event|0
5919745|NCT01507051|20481763|P3|Overall Study|Adverse Event|0
5919746|NCT01507051|20481764|P2|Overall Study|Adverse Event|0
5919747|NCT01507051|20481765|P1|Overall Study|Adverse Event|1
5919748|NCT01507051|20481762|P4|Overall Study|Physician Decision|1
5919749|NCT01507051|20481763|P3|Overall Study|Physician Decision|0
5919750|NCT01507051|20481764|P2|Overall Study|Physician Decision|0
5919751|NCT01507051|20481765|P1|Overall Study|Physician Decision|0
5919752|NCT01507051|20481762|P4|Overall Study|Withdrawal by Subject|6
5919753|NCT01507051|20481763|P3|Overall Study|Withdrawal by Subject|1
5919754|NCT01507051|20481764|P2|Overall Study|Withdrawal by Subject|3
5919755|NCT01507051|20481765|P1|Overall Study|Withdrawal by Subject|1
5919756|NCT01506960|20481883|P1|Overall Study|Did not meet angiographic criteria|47
5919757|NCT01506947|20481889|P1|Overall Study|Did Not Meet Eligibility Criteria|3
5919758|NCT01506947|20481889|P1|Overall Study|Death|1
5919759|NCT01506947|20481889|P1|Overall Study|Adverse Event|5
5919760|NCT01506947|20481889|P1|Overall Study|Lost to Follow-up|7
5919761|NCT01506908|20481907|P2|Overall Study|Adverse Event|0
5919762|NCT01506908|20481908|P1|Overall Study|Adverse Event|1
5919763|NCT01506882|20481926|P2|Overall Study|Other Reason|0
5919764|NCT01506882|20481927|P1|Overall Study|Other Reason|2
5919765|NCT01506882|20481926|P2|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
5919766|NCT01506882|20481927|P1|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1
5919767|NCT01506882|20481926|P2|Overall Study|AE, non-serious non-fatal|1
5919768|NCT01506882|20481927|P1|Overall Study|AE, non-serious non-fatal|3
5919769|NCT01506882|20481926|P2|Overall Study|SAE, non-fatal|0
5919770|NCT01506882|20481927|P1|Overall Study|SAE, non-fatal|2
5919771|NCT01506882|20481926|P2|Overall Study|Withdrawal by Subject|3
5919772|NCT01506882|20481927|P1|Overall Study|Withdrawal by Subject|9
5919773|NCT01506882|20481926|P2|Overall Study|Lost to Follow-up|0
5919774|NCT01506882|20481927|P1|Overall Study|Lost to Follow-up|1
5919775|NCT01506882|20481926|P2|Overall Study|Lack of Efficacy|3
5919776|NCT01506882|20481927|P1|Overall Study|Lack of Efficacy|4
5919777|NCT01506726|20481941|P2|Overall Study|Adverse Event|2
5919778|NCT01506726|20481942|P1|Overall Study|Adverse Event|1
5919779|NCT01506596|20481982|P1|Overall Study|ineligible pathology|1
5919780|NCT01506479|20481993|P3|Overall Study|Adverse Event|0
5919781|NCT01506479|20481994|P2|Overall Study|Adverse Event|1
5919782|NCT01506479|20481995|P1|Overall Study|Adverse Event|0
5919783|NCT01506479|20481993|P3|Overall Study|Missing assessment|0
5919784|NCT01506479|20481994|P2|Overall Study|Missing assessment|0
5919785|NCT01506479|20481995|P1|Overall Study|Missing assessment|1
5919786|NCT01506479|20481993|P3|Overall Study|Withdrawal by Subject|1
5919787|NCT01506479|20481994|P2|Overall Study|Withdrawal by Subject|2
5919788|NCT01506479|20481995|P1|Overall Study|Withdrawal by Subject|1
5919789|NCT01506479|20481993|P3|Overall Study|Lost to Follow-up|2
5919790|NCT01506479|20481994|P2|Overall Study|Lost to Follow-up|2
5919791|NCT01506479|20481995|P1|Overall Study|Lost to Follow-up|1
5919792|NCT01506453|20482009|P2|Overall Study|Withdrawal prior to treatment|2
5919793|NCT01506453|20482010|P1|Overall Study|Withdrawal prior to treatment|0
5919794|NCT01506323|20482026|P2|Overall Study|Started another treatment|0
5919795|NCT01506323|20482027|P1|Overall Study|Started another treatment|1
5919796|NCT01506323|20482026|P2|Overall Study|Schedule or Transportation conflict|0
5919797|NCT01506323|20482027|P1|Overall Study|Schedule or Transportation conflict|8
5919798|NCT01506323|20482026|P2|Overall Study|Moved out of area|2
5919799|NCT01506323|20482027|P1|Overall Study|Moved out of area|5
5919800|NCT01506323|20482026|P2|Overall Study|Lack of Efficacy|3
5919801|NCT01506323|20482027|P1|Overall Study|Lack of Efficacy|1
5919802|NCT01506323|20482026|P2|Overall Study|Withdrawal by Subject|4
5919803|NCT01506323|20482027|P1|Overall Study|Withdrawal by Subject|4
5919804|NCT01506323|20482026|P2|Overall Study|Lost to Follow-up|4
5919805|NCT01506323|20482027|P1|Overall Study|Lost to Follow-up|5
5919806|NCT01506271|20482056|P3|Overall Study|Lost to Follow-up|2
5919807|NCT01506271|20482057|P2|Overall Study|Lost to Follow-up|1
5919808|NCT01506271|20482058|P1|Overall Study|Lost to Follow-up|0
5919809|NCT01506271|20482056|P3|Overall Study|Withdrawal by Subject|1
5919810|NCT01506271|20482057|P2|Overall Study|Withdrawal by Subject|1
5919811|NCT01506271|20482058|P1|Overall Study|Withdrawal by Subject|0
5919812|NCT01506271|20482056|P3|Overall Study|Insufficient supply of study drug|0
5919813|NCT01506271|20482057|P2|Overall Study|Insufficient supply of study drug|0
5919814|NCT01506271|20482058|P1|Overall Study|Insufficient supply of study drug|1
5919815|NCT01506271|20482056|P3|Overall Study|Adverse Event|0
5919816|NCT01506271|20482057|P2|Overall Study|Adverse Event|2
5919817|NCT01506271|20482058|P1|Overall Study|Adverse Event|0
5919818|NCT01506271|20482056|P3|Overall Study|Death|0
5919819|NCT01506271|20482057|P2|Overall Study|Death|1
5919820|NCT01506271|20482058|P1|Overall Study|Death|0
5919821|NCT01506271|20482056|P3|Overall Study|Protocol Violation|0
5919822|NCT01506271|20482057|P2|Overall Study|Protocol Violation|1
5919823|NCT01506271|20482058|P1|Overall Study|Protocol Violation|3
5919824|NCT01506271|20482056|P3|Overall Study|Progressive disease|0
5919825|NCT01506271|20482057|P2|Overall Study|Progressive disease|1
5919826|NCT01506271|20482058|P1|Overall Study|Progressive disease|0
5919827|NCT01506193|20482120|P3|Overall Study|Lost to Follow-up|3
5919828|NCT01506193|20482121|P2|Overall Study|Lost to Follow-up|3
5919829|NCT01506193|20482122|P1|Overall Study|Lost to Follow-up|8
5919830|NCT01506193|20482120|P3|Overall Study|Withdrawal by Subject|8
5919831|NCT01506193|20482121|P2|Overall Study|Withdrawal by Subject|1
5919832|NCT01506193|20482122|P1|Overall Study|Withdrawal by Subject|5
5919833|NCT01506193|20482120|P3|Overall Study|Adverse event, non-fatal|1
5919834|NCT01506193|20482121|P2|Overall Study|Adverse event, non-fatal|0
5919835|NCT01506193|20482122|P1|Overall Study|Adverse event, non-fatal|0
5919836|NCT01506193|20482120|P3|Overall Study|Migrated/moved from study area|1
5919837|NCT01506193|20482121|P2|Overall Study|Migrated/moved from study area|0
5919838|NCT01506193|20482122|P1|Overall Study|Migrated/moved from study area|0
5919839|NCT01506193|20482120|P3|Overall Study|Protocol Violation|1
5919840|NCT01506193|20482121|P2|Overall Study|Protocol Violation|0
5919841|NCT01506193|20482122|P1|Overall Study|Protocol Violation|1
5919842|NCT01505881|20482168|P2|Overall Study|Withdrawal by Subject|0
5919843|NCT01505881|20482169|P1|Overall Study|Withdrawal by Subject|2
5919844|NCT01505881|20482168|P2|Overall Study|Lost to Follow-up|0
5919845|NCT01505881|20482169|P1|Overall Study|Lost to Follow-up|2
5919846|NCT01505881|20482168|P2|Overall Study|Adverse Event|1
5919847|NCT01505881|20482169|P1|Overall Study|Adverse Event|0
5919848|NCT01505647|20482275|P2|Day 43 Through Day 182 Follow-up|Lost to Follow-up|2
5919849|NCT01505647|20482276|P1|Day 43 Through Day 182 Follow-up|Lost to Follow-up|1
5919850|NCT01505647|20482275|P2|Day 43 Through Day 182 Follow-up|Death|1
5919851|NCT01505647|20482276|P1|Day 43 Through Day 182 Follow-up|Death|0
5919852|NCT01505647|20482275|P2|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|0
5919853|NCT01505647|20482276|P1|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|1
5919854|NCT01505647|20482275|P2|Day 1 Through Day 42 Follow-up|Physician Decision|0
5919855|NCT01505647|20482276|P1|Day 1 Through Day 42 Follow-up|Physician Decision|1
5919856|NCT01505647|20482275|P2|Day 1 Through Day 42 Follow-up|Lost to Follow-up|0
5919857|NCT01505647|20482276|P1|Day 1 Through Day 42 Follow-up|Lost to Follow-up|1
5919858|NCT01505634|20482293|P3|Overall Study|In a conflict zone|1
5919859|NCT01505634|20482294|P2|Overall Study|In a conflict zone|0
5919860|NCT01505634|20482295|P1|Overall Study|In a conflict zone|0
5919861|NCT01505634|20482293|P3|Overall Study|Death|0
5919862|NCT01505634|20482294|P2|Overall Study|Death|0
5919863|NCT01505634|20482295|P1|Overall Study|Death|1
5919864|NCT01505634|20482293|P3|Overall Study|Lost to Follow-up|4
5919865|NCT01505634|20482294|P2|Overall Study|Lost to Follow-up|4
5919866|NCT01505634|20482295|P1|Overall Study|Lost to Follow-up|1
5919867|NCT01505634|20482293|P3|Overall Study|Protocol Violation|0
5919868|NCT01505634|20482294|P2|Overall Study|Protocol Violation|0
5919869|NCT01505634|20482295|P1|Overall Study|Protocol Violation|2
5919870|NCT01505634|20482293|P3|Overall Study|Insufficient supply of drug at site|0
5919871|NCT01505634|20482294|P2|Overall Study|Insufficient supply of drug at site|0
5919872|NCT01505634|20482295|P1|Overall Study|Insufficient supply of drug at site|1
5919873|NCT01505634|20482293|P3|Overall Study|Adverse Event|0
5919874|NCT01505634|20482294|P2|Overall Study|Adverse Event|0
5919875|NCT01505634|20482295|P1|Overall Study|Adverse Event|1
5919876|NCT01505634|20482293|P3|Overall Study|Physician Decision|0
5919877|NCT01505634|20482294|P2|Overall Study|Physician Decision|1
5919878|NCT01505634|20482295|P1|Overall Study|Physician Decision|1
5919879|NCT01505634|20482293|P3|Overall Study|Withdrawal by Subject|1
5919880|NCT01505634|20482294|P2|Overall Study|Withdrawal by Subject|5
5919881|NCT01505634|20482295|P1|Overall Study|Withdrawal by Subject|2
5919882|NCT01505608|20482350|P2|Phase II|Protocol Violation|1
5919883|NCT01505608|20482351|P1|Phase II|Protocol Violation|0
5919884|NCT01505608|20482350|P2|Phase II|Lack of Efficacy|1
5919885|NCT01505608|20482351|P1|Phase II|Lack of Efficacy|2
5919886|NCT01505608|20482350|P2|Phase I|Withdrawal by Subject|1
5919887|NCT01505608|20482351|P1|Phase I|Withdrawal by Subject|0
5919888|NCT01505608|20482350|P2|Phase I|Adverse Event|1
5919889|NCT01505608|20482351|P1|Phase I|Adverse Event|0
5919890|NCT01505608|20482350|P2|Phase I|Lack of Efficacy|4
5919891|NCT01505608|20482351|P1|Phase I|Lack of Efficacy|0
5919892|NCT01505530|20482370|P3|Overall Study|entry criteria not met|0
5919893|NCT01505530|20482371|P2|Overall Study|entry criteria not met|1
5919894|NCT01505530|20482372|P1|Overall Study|entry criteria not met|0
5919895|NCT01505530|20482370|P3|Overall Study|Death|5
5919896|NCT01505530|20482371|P2|Overall Study|Death|6
5919897|NCT01505530|20482372|P1|Overall Study|Death|7
5919898|NCT01505530|20482370|P3|Overall Study|Sponsor Decision|7
5919899|NCT01505530|20482371|P2|Overall Study|Sponsor Decision|8
5919900|NCT01505530|20482372|P1|Overall Study|Sponsor Decision|1
5919901|NCT01505530|20482370|P3|Overall Study|Physician Decision|5
5919902|NCT01505530|20482371|P2|Overall Study|Physician Decision|2
5919903|NCT01505530|20482372|P1|Overall Study|Physician Decision|6
5919904|NCT01505530|20482370|P3|Overall Study|Withdrawal by Subject|6
5919905|NCT01505530|20482371|P2|Overall Study|Withdrawal by Subject|8
5919906|NCT01505530|20482372|P1|Overall Study|Withdrawal by Subject|7
5919907|NCT01505530|20482370|P3|Overall Study|Adverse Event|0
5919908|NCT01505530|20482371|P2|Overall Study|Adverse Event|1
5919909|NCT01505530|20482372|P1|Overall Study|Adverse Event|1
5919910|NCT01505530|20482370|P3|Overall Study|Progressive Disease|18
5919911|NCT01505530|20482371|P2|Overall Study|Progressive Disease|17
5919912|NCT01505530|20482372|P1|Overall Study|Progressive Disease|19
5919913|NCT01505491|20482416|P3|Overall Study|Lost to Follow-up|1
5919914|NCT01505491|20482417|P2|Overall Study|Lost to Follow-up|0
5919915|NCT01505491|20482418|P1|Overall Study|Lost to Follow-up|0
5919916|NCT01505491|20482416|P3|Overall Study|Withdrawal by Subject|4
5919917|NCT01505491|20482417|P2|Overall Study|Withdrawal by Subject|1
5919918|NCT01505491|20482418|P1|Overall Study|Withdrawal by Subject|1
5919919|NCT01505491|20482416|P3|Overall Study|Other reason not listed|0
5919920|NCT01505491|20482417|P2|Overall Study|Other reason not listed|0
5919921|NCT01505491|20482418|P1|Overall Study|Other reason not listed|1
5919922|NCT01505387|20482457|P2|Overall Study|Withdrawal by Subject|1
5919923|NCT01505387|20482458|P1|Overall Study|Withdrawal by Subject|1
5919924|NCT01505387|20482457|P2|Overall Study|Protocol Violation|0
5919925|NCT01505387|20482458|P1|Overall Study|Protocol Violation|1
5919926|NCT01505374|20482464|P2|Overall Study|Lost to Follow-up|0
5919927|NCT01505374|20482465|P1|Overall Study|Lost to Follow-up|1
5919928|NCT01505114|20482515|P4|Overall Study|investigator decision|0
5919929|NCT01505114|20482516|P3|Overall Study|investigator decision|1
5919930|NCT01505114|20482517|P2|Overall Study|investigator decision|0
5919931|NCT01505114|20482518|P1|Overall Study|investigator decision|1
5919932|NCT01505114|20482515|P4|Overall Study|staff safety concerns|1
5919933|NCT01505114|20482516|P3|Overall Study|staff safety concerns|0
5919934|NCT01505114|20482517|P2|Overall Study|staff safety concerns|0
5919935|NCT01505114|20482518|P1|Overall Study|staff safety concerns|0
5919936|NCT01505114|20482515|P4|Overall Study|inadvertent enrollment due to peanut all|1
5919937|NCT01505114|20482516|P3|Overall Study|inadvertent enrollment due to peanut all|0
5919938|NCT01505114|20482517|P2|Overall Study|inadvertent enrollment due to peanut all|0
5919939|NCT01505114|20482518|P1|Overall Study|inadvertent enrollment due to peanut all|0
5919940|NCT01505114|20482515|P4|Overall Study|relocated|3
5919941|NCT01505114|20482516|P3|Overall Study|relocated|2
5919942|NCT01505114|20482517|P2|Overall Study|relocated|2
5919943|NCT01505114|20482518|P1|Overall Study|relocated|4
5919944|NCT01505114|20482515|P4|Overall Study|Lost to Follow-up|7
5919945|NCT01505114|20482516|P3|Overall Study|Lost to Follow-up|8
5919946|NCT01505114|20482517|P2|Overall Study|Lost to Follow-up|5
5919947|NCT01505114|20482518|P1|Overall Study|Lost to Follow-up|11
5919948|NCT01505114|20482515|P4|Overall Study|unable to adhere to visit schedule|3
5919949|NCT01505114|20482516|P3|Overall Study|unable to adhere to visit schedule|3
5919950|NCT01505114|20482517|P2|Overall Study|unable to adhere to visit schedule|2
5919951|NCT01505114|20482518|P1|Overall Study|unable to adhere to visit schedule|3
5919952|NCT01505114|20482515|P4|Overall Study|Death|1
5919953|NCT01505114|20482516|P3|Overall Study|Death|0
5919954|NCT01505114|20482517|P2|Overall Study|Death|0
5919955|NCT01505114|20482518|P1|Overall Study|Death|1
5919956|NCT01505114|20482515|P4|Overall Study|Withdrawal by Subject|7
5919957|NCT01505114|20482516|P3|Overall Study|Withdrawal by Subject|4
5919958|NCT01505114|20482517|P2|Overall Study|Withdrawal by Subject|4
5919959|NCT01505114|20482518|P1|Overall Study|Withdrawal by Subject|5
5919960|NCT01505010|20482546|P2|Overall Study|Lost to Follow-up|1
5919961|NCT01505010|20482547|P1|Overall Study|Lost to Follow-up|0
5919962|NCT01505010|20482546|P2|Overall Study|Protocol Violation|1
5919963|NCT01505010|20482547|P1|Overall Study|Protocol Violation|0
5919964|NCT01504971|20482561|P1|Overall Study|Physician Decision|13
5919965|NCT01504867|20482590|P2|Overall Study|Consent revoked|1
5919966|NCT01504867|20482591|P1|Overall Study|Consent revoked|5
5919967|NCT01504867|20482590|P2|Overall Study|Inclusion criteria not met|2
5919968|NCT01504867|20482591|P1|Overall Study|Inclusion criteria not met|2
5919969|NCT01504841|20482629|P3|Overall Study|On study due to Long-term Follow-up|0
5919970|NCT01504841|20482630|P2|Overall Study|On study due to Long-term Follow-up|3
5919971|NCT01504841|20482631|P1|Overall Study|On study due to Long-term Follow-up|15
5919972|NCT01504841|20482629|P3|Overall Study|Withdrawal by Subject|0
5919973|NCT01504841|20482630|P2|Overall Study|Withdrawal by Subject|1
5919974|NCT01504841|20482631|P1|Overall Study|Withdrawal by Subject|1
5919975|NCT01504412|20482684|P5|Overall Study|Death|0
5919976|NCT01504412|20482685|P4|Overall Study|Death|1
5919977|NCT01504412|20482686|P3|Overall Study|Death|0
5919978|NCT01504412|20482687|P2|Overall Study|Death|0
5919979|NCT01504412|20482688|P1|Overall Study|Death|0
5919980|NCT01504412|20482684|P5|Overall Study|Lack of Efficacy|1
5919981|NCT01504412|20482685|P4|Overall Study|Lack of Efficacy|0
5919982|NCT01504412|20482686|P3|Overall Study|Lack of Efficacy|1
5919983|NCT01504412|20482687|P2|Overall Study|Lack of Efficacy|0
5919984|NCT01504412|20482688|P1|Overall Study|Lack of Efficacy|0
5919985|NCT01504412|20482684|P5|Overall Study|Lost to Follow-up|0
5919986|NCT01504412|20482685|P4|Overall Study|Lost to Follow-up|0
5919987|NCT01504412|20482686|P3|Overall Study|Lost to Follow-up|0
5919988|NCT01504412|20482687|P2|Overall Study|Lost to Follow-up|2
5919989|NCT01504412|20482688|P1|Overall Study|Lost to Follow-up|0
5919990|NCT01504412|20482684|P5|Overall Study|Other|1
5919991|NCT01504412|20482685|P4|Overall Study|Other|6
5919992|NCT01504412|20482686|P3|Overall Study|Other|1
5919993|NCT01504412|20482687|P2|Overall Study|Other|1
5919994|NCT01504412|20482688|P1|Overall Study|Other|2
5919995|NCT01504412|20482684|P5|Overall Study|Withdrawal by Subject|1
5919996|NCT01504412|20482685|P4|Overall Study|Withdrawal by Subject|5
5919997|NCT01504412|20482686|P3|Overall Study|Withdrawal by Subject|1
5919998|NCT01504412|20482687|P2|Overall Study|Withdrawal by Subject|1
5919999|NCT01504412|20482688|P1|Overall Study|Withdrawal by Subject|2
5920000|NCT01504412|20482684|P5|Overall Study|Adverse Event|10
5920001|NCT01504412|20482685|P4|Overall Study|Adverse Event|7
5920002|NCT01504412|20482686|P3|Overall Study|Adverse Event|1
5920003|NCT01504412|20482687|P2|Overall Study|Adverse Event|8
5920004|NCT01504412|20482688|P1|Overall Study|Adverse Event|1
5920005|NCT01504204|20482707|P2|Overall Study|Lost to Follow-up|1
5920006|NCT01504204|20482708|P1|Overall Study|Lost to Follow-up|1
5920007|NCT01503515|20482736|P2|Overall Study|Ineligible|1
5920008|NCT01503515|20482737|P1|Overall Study|Ineligible|1
5920009|NCT01503515|20482736|P2|Overall Study|Institutional dx of proven/probable IFI|4
5920010|NCT01503515|20482737|P1|Overall Study|Institutional dx of proven/probable IFI|2
5920011|NCT01503515|20482736|P2|Overall Study|Withdrawal by Subject|1
5920012|NCT01503515|20482737|P1|Overall Study|Withdrawal by Subject|0
5920013|NCT01503515|20482736|P2|Overall Study|Physician Decision|23
5920014|NCT01503515|20482737|P1|Overall Study|Physician Decision|14
5920015|NCT01503515|20482736|P2|Overall Study|Death|1
5920016|NCT01503515|20482737|P1|Overall Study|Death|0
5920017|NCT01503515|20482736|P2|Overall Study|Adverse Event|5
5920018|NCT01503515|20482737|P1|Overall Study|Adverse Event|4
5920019|NCT01503164|20482774|P2|Overall Study|Withdrawal by Subject|1
5920020|NCT01503164|20482775|P1|Overall Study|Withdrawal by Subject|2
5920021|NCT01503021|20482805|P2|Overall Study|Moved, received transplant, etc.|7
5920022|NCT01503021|20482806|P1|Overall Study|Moved, received transplant, etc.|5
5920023|NCT01503021|20482805|P2|Overall Study|Withdrawal by Subject|8
5920024|NCT01503021|20482806|P1|Overall Study|Withdrawal by Subject|9
5920025|NCT01503021|20482805|P2|Overall Study|Protocol Violation|3
5920026|NCT01503021|20482806|P1|Overall Study|Protocol Violation|1
5920027|NCT01503021|20482805|P2|Overall Study|Physician Decision|0
5920028|NCT01503021|20482806|P1|Overall Study|Physician Decision|3
5920029|NCT01503021|20482805|P2|Overall Study|Lost to Follow-up|0
5920030|NCT01503021|20482806|P1|Overall Study|Lost to Follow-up|2
5920031|NCT01503021|20482805|P2|Overall Study|Death|2
5920032|NCT01503021|20482806|P1|Overall Study|Death|0
5920033|NCT01503021|20482805|P2|Overall Study|Adverse Event|6
5920034|NCT01503021|20482806|P1|Overall Study|Adverse Event|7
5920035|NCT01502956|20482855|P2|Overall Study|Withdrawal by Subject|10
5920036|NCT01502956|20482856|P1|Overall Study|Withdrawal by Subject|8
5920037|NCT01502956|20482855|P2|Overall Study|Physician Decision|3
5920038|NCT01502956|20482856|P1|Overall Study|Physician Decision|2
5920039|NCT01502956|20482855|P2|Overall Study|Lost to Follow-up|11
5920040|NCT01502956|20482856|P1|Overall Study|Lost to Follow-up|14
5920041|NCT01502956|20482855|P2|Overall Study|Death|2
5920042|NCT01502956|20482856|P1|Overall Study|Death|0
5920043|NCT01502709|20482914|P2|Overall Study|Lost to Follow-up|0
5920044|NCT01502709|20482915|P1|Overall Study|Lost to Follow-up|4
5920045|NCT01502644|20482928|P4|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1
5920046|NCT01502644|20482929|P3|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1
5920047|NCT01502644|20482930|P2|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0
5920048|NCT01502644|20482931|P1|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0
5920049|NCT01502644|20482928|P4|Assigned to NA Groups|Drop Out due to Side Effects|7
5920050|NCT01502644|20482929|P3|Assigned to NA Groups|Drop Out due to Side Effects|2
5920051|NCT01502644|20482930|P2|Assigned to NA Groups|Drop Out due to Side Effects|6
5920052|NCT01502644|20482931|P1|Assigned to NA Groups|Drop Out due to Side Effects|0
5920053|NCT01502644|20482928|P4|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0
5920054|NCT01502644|20482929|P3|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0
5920055|NCT01502644|20482930|P2|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0
5920056|NCT01502644|20482931|P1|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|6
5920057|NCT01502644|20482928|P4|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0
5920058|NCT01502644|20482929|P3|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0
5920059|NCT01502644|20482930|P2|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0
5920060|NCT01502644|20482931|P1|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|2
5920061|NCT01502644|20482928|P4|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0
5920062|NCT01502644|20482929|P3|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0
5920063|NCT01502644|20482930|P2|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0
5920064|NCT01502644|20482931|P1|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|1
5920065|NCT01502631|20482941|P2|Overall Study|Other|5
5920066|NCT01502631|20482942|P1|Overall Study|Other|10
5920067|NCT01502631|20482941|P2|Overall Study|Investigator's decision|1
5920068|NCT01502631|20482942|P1|Overall Study|Investigator's decision|0
5920069|NCT01502631|20482941|P2|Overall Study|Participant non-compliant|0
5920070|NCT01502631|20482942|P1|Overall Study|Participant non-compliant|1
5920071|NCT01502631|20482941|P2|Overall Study|Participant withdrew consent|4
5920072|NCT01502631|20482942|P1|Overall Study|Participant withdrew consent|2
5920073|NCT01502631|20482941|P2|Overall Study|Lost to Follow-up|2
5920074|NCT01502631|20482942|P1|Overall Study|Lost to Follow-up|2
5920075|NCT01502631|20482941|P2|Overall Study|Adverse Event|8
5920076|NCT01502631|20482942|P1|Overall Study|Adverse Event|5
5920077|NCT01502423|20482962|P2|Overall Study|Withdrawal by Subject|1
5920078|NCT01502423|20482963|P1|Overall Study|Withdrawal by Subject|0
5920079|NCT01502410|20482985|P4|Overall Study|Withdrawal by Subject|0
5920080|NCT01502410|20482986|P3|Overall Study|Withdrawal by Subject|0
5920081|NCT01502410|20482987|P2|Overall Study|Withdrawal by Subject|0
5920082|NCT01502410|20482988|P1|Overall Study|Withdrawal by Subject|2
5920083|NCT01502410|20482985|P4|Overall Study|Physician Decision|0
5920084|NCT01502410|20482986|P3|Overall Study|Physician Decision|0
5920085|NCT01502410|20482987|P2|Overall Study|Physician Decision|1
5920086|NCT01502410|20482988|P1|Overall Study|Physician Decision|0
5920087|NCT01502410|20482985|P4|Overall Study|Lack of Efficacy|0
5920088|NCT01502410|20482986|P3|Overall Study|Lack of Efficacy|0
5920089|NCT01502410|20482987|P2|Overall Study|Lack of Efficacy|7
5920090|NCT01502410|20482988|P1|Overall Study|Lack of Efficacy|7
5920091|NCT01502410|20482985|P4|Overall Study|Adverse Event|0
5920092|NCT01502410|20482986|P3|Overall Study|Adverse Event|0
5920093|NCT01502410|20482987|P2|Overall Study|Adverse Event|2
5920094|NCT01502410|20482988|P1|Overall Study|Adverse Event|1
5920095|NCT01502371|20483006|P5|Overall Study|Excluded Medication|1
5920096|NCT01502371|20483007|P4|Overall Study|Excluded Medication|0
5920097|NCT01502371|20483008|P3|Overall Study|Excluded Medication|1
5920098|NCT01502371|20483009|P2|Overall Study|Excluded Medication|1
5920099|NCT01502371|20483010|P1|Overall Study|Excluded Medication|0
5920100|NCT01502371|20483006|P5|Overall Study|Protocol Violation|10
5920101|NCT01502371|20483007|P4|Overall Study|Protocol Violation|5
5920102|NCT01502371|20483008|P3|Overall Study|Protocol Violation|6
5920103|NCT01502371|20483009|P2|Overall Study|Protocol Violation|5
5920104|NCT01502371|20483010|P1|Overall Study|Protocol Violation|9
5920105|NCT01502371|20483006|P5|Overall Study|Technical Problems|1
5920106|NCT01502371|20483007|P4|Overall Study|Technical Problems|4
5920107|NCT01502371|20483008|P3|Overall Study|Technical Problems|2
5920108|NCT01502371|20483009|P2|Overall Study|Technical Problems|0
5920109|NCT01502371|20483010|P1|Overall Study|Technical Problems|1
5920110|NCT01502371|20483006|P5|Overall Study|Noncompliance with Study Drug|1
5920111|NCT01502371|20483007|P4|Overall Study|Noncompliance with Study Drug|2
5920112|NCT01502371|20483008|P3|Overall Study|Noncompliance with Study Drug|1
5920113|NCT01502371|20483009|P2|Overall Study|Noncompliance with Study Drug|0
5920114|NCT01502371|20483010|P1|Overall Study|Noncompliance with Study Drug|0
5920115|NCT01502371|20483006|P5|Overall Study|Physician Decision|1
5920116|NCT01502371|20483007|P4|Overall Study|Physician Decision|0
5920117|NCT01502371|20483008|P3|Overall Study|Physician Decision|0
5920118|NCT01502371|20483009|P2|Overall Study|Physician Decision|0
5920119|NCT01502371|20483010|P1|Overall Study|Physician Decision|3
5920120|NCT01502371|20483006|P5|Overall Study|Lack of Efficacy|4
5920121|NCT01502371|20483007|P4|Overall Study|Lack of Efficacy|2
5920122|NCT01502371|20483008|P3|Overall Study|Lack of Efficacy|2
5920123|NCT01502371|20483009|P2|Overall Study|Lack of Efficacy|3
5920124|NCT01502371|20483010|P1|Overall Study|Lack of Efficacy|3
5920125|NCT01502371|20483006|P5|Overall Study|Treatment Failure|30
5920126|NCT01502371|20483007|P4|Overall Study|Treatment Failure|19
5920127|NCT01502371|20483008|P3|Overall Study|Treatment Failure|12
5920128|NCT01502371|20483009|P2|Overall Study|Treatment Failure|20
5920129|NCT01502371|20483010|P1|Overall Study|Treatment Failure|22
5920130|NCT01502371|20483006|P5|Overall Study|Adverse Event|3
5920131|NCT01502371|20483007|P4|Overall Study|Adverse Event|4
5920132|NCT01502371|20483008|P3|Overall Study|Adverse Event|0
5920133|NCT01502371|20483009|P2|Overall Study|Adverse Event|1
5920134|NCT01502371|20483010|P1|Overall Study|Adverse Event|2
5920135|NCT01502371|20483006|P5|Overall Study|Withdrawal by Subject|1
5920136|NCT01502371|20483007|P4|Overall Study|Withdrawal by Subject|1
5920137|NCT01502371|20483008|P3|Overall Study|Withdrawal by Subject|1
5920138|NCT01502371|20483009|P2|Overall Study|Withdrawal by Subject|2
5920139|NCT01502371|20483010|P1|Overall Study|Withdrawal by Subject|1
5920140|NCT01502293|20483075|P3|Overall Study|Physician Decision|1
5920141|NCT01502293|20483076|P2|Overall Study|Physician Decision|0
5920142|NCT01502293|20483077|P1|Overall Study|Physician Decision|0
5920143|NCT01502293|20483075|P3|Overall Study|Reason Not Specified|0
5920144|NCT01502293|20483076|P2|Overall Study|Reason Not Specified|0
5920145|NCT01502293|20483077|P1|Overall Study|Reason Not Specified|2
5920146|NCT01502293|20483075|P3|Overall Study|Adverse Event|0
5920147|NCT01502293|20483076|P2|Overall Study|Adverse Event|2
5920148|NCT01502293|20483077|P1|Overall Study|Adverse Event|0
5920149|NCT01502293|20483075|P3|Overall Study|Withdrawal by Subject|1
5920150|NCT01502293|20483076|P2|Overall Study|Withdrawal by Subject|3
5920151|NCT01502293|20483077|P1|Overall Study|Withdrawal by Subject|3
5920152|NCT01502293|20483075|P3|Overall Study|Progressive Disease|2
5920153|NCT01502293|20483076|P2|Overall Study|Progressive Disease|12
5920154|NCT01502293|20483077|P1|Overall Study|Progressive Disease|20
5920155|NCT01502228|20483106|P1|Overall Study|Death|1
5920156|NCT01502033|20483111|P1|Overall Study|1 participant went back to school|1
5920157|NCT01502033|20483111|P1|Overall Study|1 participant had worsening depression|1
5920158|NCT01502033|20483111|P1|Overall Study|1 participant had scalp discomfort|1
5920163|NCT01501110|20483184|P2|Overall Study|Death|1
5920164|NCT01501110|20483185|P1|Overall Study|Death|0
5920165|NCT01500720|20483270|P2|Overall Study|Other|8
5920166|NCT01500720|20483271|P1|Overall Study|Other|4
5920167|NCT01500720|20483270|P2|Overall Study|Randomized But Not Treated|1
5920168|NCT01500720|20483271|P1|Overall Study|Randomized But Not Treated|1
5920169|NCT01500694|20483285|P2|Overall Study|Other|3
5920170|NCT01500694|20483286|P1|Overall Study|Other|9
5920171|NCT01500694|20483285|P2|Overall Study|Lack of Efficacy|5
5920172|NCT01500694|20483286|P1|Overall Study|Lack of Efficacy|14
5920173|NCT01500694|20483285|P2|Overall Study|Lost to Follow-up|3
5920174|NCT01500694|20483286|P1|Overall Study|Lost to Follow-up|2
5920175|NCT01500694|20483285|P2|Overall Study|Withdrawal by Subject|14
5920176|NCT01500694|20483286|P1|Overall Study|Withdrawal by Subject|23
5920177|NCT01500694|20483285|P2|Overall Study|Protocol Violation|1
5920178|NCT01500694|20483286|P1|Overall Study|Protocol Violation|0
5920179|NCT01500694|20483285|P2|Overall Study|Adverse Event|3
5920180|NCT01500694|20483286|P1|Overall Study|Adverse Event|4
5920181|NCT01500629|20483312|P2|Washout Period of 14 to 30 Days|Pregnancy|0
5920182|NCT01500629|20483313|P1|Washout Period of 14 to 30 Days|Pregnancy|1
5920183|NCT01500434|20483397|P1|Overall Study|Missed 12-month follow-up|5
5920184|NCT01500434|20483397|P1|Overall Study|Withdrawal by Subject|1
5920185|NCT01500434|20483397|P1|Overall Study|Death|1
5920186|NCT01500382|20483430|P4|Washout Period|Study site went out of business|0
5920187|NCT01500382|20483431|P3|Washout Period|Study site went out of business|1
5920188|NCT01500382|20483432|P2|Washout Period|Study site went out of business|0
5920189|NCT01500382|20483433|P1|Washout Period|Study site went out of business|0
5920190|NCT01500317|20483458|P3|Overall Study|Withdrawal by Subject|0
5920191|NCT01500317|20483459|P2|Overall Study|Withdrawal by Subject|2
5920192|NCT01500317|20483460|P1|Overall Study|Withdrawal by Subject|3
5920193|NCT01500278|20483482|P2|Week 13 - Week 104|Adverse Event|54
5920194|NCT01500278|20483483|P1|Week 13 - Week 104|Adverse Event|54
5920195|NCT01500278|20483482|P2|Week 13 - Week 104|Death|4
5920196|NCT01500278|20483483|P1|Week 13 - Week 104|Death|2
5920197|NCT01500278|20483482|P2|Week 13 - Week 104|Not completed|1
5920198|NCT01500278|20483483|P1|Week 13 - Week 104|Not completed|0
5920199|NCT01500278|20483482|P2|Week 13 - Week 104|Personal reason|1
5920200|NCT01500278|20483483|P1|Week 13 - Week 104|Personal reason|0
5920201|NCT01500278|20483482|P2|Week 13 - Week 104|Medical monitor decision|2
5920202|NCT01500278|20483483|P1|Week 13 - Week 104|Medical monitor decision|0
5920203|NCT01500278|20483482|P2|Week 13 - Week 104|Sponsor decision|2
5920204|NCT01500278|20483483|P1|Week 13 - Week 104|Sponsor decision|0
5920205|NCT01500278|20483482|P2|Week 13 - Week 104|Relocation|1
5920206|NCT01500278|20483483|P1|Week 13 - Week 104|Relocation|0
5920207|NCT01500278|20483482|P2|Week 13 - Week 104|Abnormal questionable chest X-ray|2
5920208|NCT01500278|20483483|P1|Week 13 - Week 104|Abnormal questionable chest X-ray|0
5920209|NCT01500278|20483482|P2|Week 13 - Week 104|Patient declined Safety Follow Up Visit|0
5920210|NCT01500278|20483483|P1|Week 13 - Week 104|Patient declined Safety Follow Up Visit|1
5920211|NCT01500278|20483482|P2|Week 13 - Week 104|Principal investigator retiring|0
5920212|NCT01500278|20483483|P1|Week 13 - Week 104|Principal investigator retiring|1
5920213|NCT01500278|20483482|P2|Week 13 - Week 104|Protocol deviation|0
5920214|NCT01500278|20483483|P1|Week 13 - Week 104|Protocol deviation|1
5920215|NCT01500278|20483482|P2|Week 13 - Week 104|Exclusion criteria not met|0
5920216|NCT01500278|20483483|P1|Week 13 - Week 104|Exclusion criteria not met|1
5920217|NCT01500278|20483482|P2|Week 13 - Week 104|Withdrawn in error|0
5920218|NCT01500278|20483483|P1|Week 13 - Week 104|Withdrawn in error|1
5920219|NCT01500278|20483482|P2|Week 13 - Week 104|Sponsor request|0
5920220|NCT01500278|20483483|P1|Week 13 - Week 104|Sponsor request|4
5920221|NCT01500278|20483482|P2|Week 13 - Week 104|False positive test|2
5920222|NCT01500278|20483483|P1|Week 13 - Week 104|False positive test|1
5920223|NCT01500278|20483482|P2|Week 13 - Week 104|Recurrent infections|0
5920224|NCT01500278|20483483|P1|Week 13 - Week 104|Recurrent infections|1
5920225|NCT01500278|20483482|P2|Week 13 - Week 104|Non/bad compliance|5
5920226|NCT01500278|20483483|P1|Week 13 - Week 104|Non/bad compliance|7
5920227|NCT01500278|20483482|P2|Week 13 - Week 104|Week 24 Non-Responder|16
5920228|NCT01500278|20483483|P1|Week 13 - Week 104|Week 24 Non-Responder|20
5920229|NCT01500278|20483482|P2|Week 13 - Week 104|Withdrawal by Subject|13
5920230|NCT01500278|20483483|P1|Week 13 - Week 104|Withdrawal by Subject|22
5920231|NCT01500278|20483482|P2|Week 13 - Week 104|Lost to Follow-up|5
5920232|NCT01500278|20483483|P1|Week 13 - Week 104|Lost to Follow-up|6
5920233|NCT01500278|20483482|P2|Week 13 - Week 104|Protocol Violation|6
5920234|NCT01500278|20483483|P1|Week 13 - Week 104|Protocol Violation|6
5920235|NCT01500278|20483482|P2|Week 13 - Week 104|Lack of Efficacy|12
5920236|NCT01500278|20483483|P1|Week 13 - Week 104|Lack of Efficacy|11
5920237|NCT01500278|20483482|P2|Week 0 - Week 12|Adverse event (AE), not fatal|8
5920238|NCT01500278|20483483|P1|Week 0 - Week 12|Adverse event (AE), not fatal|7
5920239|NCT01500278|20483482|P2|Week 0 - Week 12|Other serious disease|1
5920240|NCT01500278|20483483|P1|Week 0 - Week 12|Other serious disease|0
5920241|NCT01500278|20483482|P2|Week 0 - Week 12|Personal reason|1
5920242|NCT01500278|20483483|P1|Week 0 - Week 12|Personal reason|0
5920243|NCT01500278|20483482|P2|Week 0 - Week 12|Sponsor decision|0
5920244|NCT01500278|20483483|P1|Week 0 - Week 12|Sponsor decision|1
5920245|NCT01500278|20483482|P2|Week 0 - Week 12|Prior history of serious disease|0
5920246|NCT01500278|20483483|P1|Week 0 - Week 12|Prior history of serious disease|1
5920247|NCT01500278|20483482|P2|Week 0 - Week 12|Investigator decision|0
5920248|NCT01500278|20483483|P1|Week 0 - Week 12|Investigator decision|1
5920249|NCT01500278|20483482|P2|Week 0 - Week 12|Exclusion criteria not met|0
5920250|NCT01500278|20483483|P1|Week 0 - Week 12|Exclusion criteria not met|1
5920251|NCT01500278|20483482|P2|Week 0 - Week 12|Patient decision|0
5920252|NCT01500278|20483483|P1|Week 0 - Week 12|Patient decision|1
5920253|NCT01500278|20483482|P2|Week 0 - Week 12|Protocol violation on screening X-ray|0
5920254|NCT01500278|20483483|P1|Week 0 - Week 12|Protocol violation on screening X-ray|1
5920255|NCT01500278|20483482|P2|Week 0 - Week 12|Withdrawal by Subject|2
5920256|NCT01500278|20483483|P1|Week 0 - Week 12|Withdrawal by Subject|7
5920257|NCT01500278|20483482|P2|Week 0 - Week 12|Lost to Follow-up|1
5920258|NCT01500278|20483483|P1|Week 0 - Week 12|Lost to Follow-up|1
5920259|NCT01500278|20483482|P2|Week 0 - Week 12|Protocol Violation|16
5920260|NCT01500278|20483483|P1|Week 0 - Week 12|Protocol Violation|10
5920261|NCT01500278|20483482|P2|Week 0 - Week 12|Lack of Efficacy|1
5920262|NCT01500278|20483483|P1|Week 0 - Week 12|Lack of Efficacy|0
5920263|NCT01500252|20483507|P2|Overall Study|Lost to Follow-up|4
5920264|NCT01500252|20483508|P1|Overall Study|Lost to Follow-up|5
5920265|NCT01500252|20483507|P2|Overall Study|Death|2
5920266|NCT01500252|20483508|P1|Overall Study|Death|4
5920267|NCT01500226|20483534|P2|Overall Study|Other Reasons|16
5920268|NCT01500226|20483535|P1|Overall Study|Other Reasons|19
5920269|NCT01500226|20483534|P2|Overall Study|Lost to Follow-up|5
5920270|NCT01500226|20483535|P1|Overall Study|Lost to Follow-up|9
5920271|NCT01500226|20483534|P2|Overall Study|Lack of Efficacy|30
5920272|NCT01500226|20483535|P1|Overall Study|Lack of Efficacy|14
5920273|NCT01500226|20483534|P2|Overall Study|Physician Decision|15
5920274|NCT01500226|20483535|P1|Overall Study|Physician Decision|17
5920275|NCT01500226|20483534|P2|Overall Study|Protocol Violation|39
5920276|NCT01500226|20483535|P1|Overall Study|Protocol Violation|53
5920277|NCT01500226|20483534|P2|Overall Study|Disease Progression|14
5920278|NCT01500226|20483535|P1|Overall Study|Disease Progression|16
5920279|NCT01500226|20483534|P2|Overall Study|Death|4
5920280|NCT01500226|20483535|P1|Overall Study|Death|12
5920281|NCT01500226|20483534|P2|Overall Study|Withdrawal by Subject|96
5920282|NCT01500226|20483535|P1|Overall Study|Withdrawal by Subject|93
5920283|NCT01500226|20483534|P2|Overall Study|Chemo Completed or Change in Therapy|237
5920284|NCT01500226|20483535|P1|Overall Study|Chemo Completed or Change in Therapy|235
5920285|NCT01500226|20483534|P2|Overall Study|Adverse Event|38
5920286|NCT01500226|20483535|P1|Overall Study|Adverse Event|31
5920287|NCT01500213|20483547|P2|Overall Study|Other Reasons|5
5920288|NCT01500213|20483548|P1|Overall Study|Other Reasons|7
5920289|NCT01500213|20483547|P2|Overall Study|Lost to Follow-up|6
5920290|NCT01500213|20483548|P1|Overall Study|Lost to Follow-up|3
5920291|NCT01500213|20483547|P2|Overall Study|Lack of Efficacy|7
5920292|NCT01500213|20483548|P1|Overall Study|Lack of Efficacy|9
5920293|NCT01500213|20483547|P2|Overall Study|Physician Decision|10
5920294|NCT01500213|20483548|P1|Overall Study|Physician Decision|12
5920295|NCT01500213|20483547|P2|Overall Study|Protocol Violation|19
5920296|NCT01500213|20483548|P1|Overall Study|Protocol Violation|19
5920297|NCT01500213|20483547|P2|Overall Study|Disease Progression|21
5920298|NCT01500213|20483548|P1|Overall Study|Disease Progression|13
5920299|NCT01500213|20483547|P2|Overall Study|Death|3
5920300|NCT01500213|20483548|P1|Overall Study|Death|7
5920301|NCT01500213|20483547|P2|Overall Study|Withdrawal by Subject|37
5920302|NCT01500213|20483548|P1|Overall Study|Withdrawal by Subject|28
5920303|NCT01500213|20483547|P2|Overall Study|Chemo Completed or Change in Therapy|81
5920304|NCT01500213|20483548|P1|Overall Study|Chemo Completed or Change in Therapy|84
5920305|NCT01500213|20483547|P2|Overall Study|Adverse Event|35
5920306|NCT01500213|20483548|P1|Overall Study|Adverse Event|35
5920307|NCT01500200|20483561|P6|Stage 2|Adverse Event|4
5920308|NCT01500200|20483562|P5|Stage 2|Adverse Event|5
5920309|NCT01500200|20483563|P4|Stage 2|Adverse Event|0
5920310|NCT01500200|20483564|P3|Stage 2|Adverse Event|0
5920311|NCT01500200|20483565|P2|Stage 2|Adverse Event|0
5920312|NCT01500200|20483566|P1|Stage 2|Adverse Event|0
5920313|NCT01500200|20483561|P6|Stage 1|Physician Decision|0
5920314|NCT01500200|20483562|P5|Stage 1|Physician Decision|0
5920315|NCT01500200|20483563|P4|Stage 1|Physician Decision|0
5920316|NCT01500200|20483564|P3|Stage 1|Physician Decision|0
5920317|NCT01500200|20483565|P2|Stage 1|Physician Decision|0
5920318|NCT01500200|20483566|P1|Stage 1|Physician Decision|1
5920319|NCT01500200|20483561|P6|Stage 1|Noncompliance with Study Drug|0
5920320|NCT01500200|20483562|P5|Stage 1|Noncompliance with Study Drug|0
5920321|NCT01500200|20483563|P4|Stage 1|Noncompliance with Study Drug|0
5920322|NCT01500200|20483564|P3|Stage 1|Noncompliance with Study Drug|0
5920323|NCT01500200|20483565|P2|Stage 1|Noncompliance with Study Drug|0
5920324|NCT01500200|20483566|P1|Stage 1|Noncompliance with Study Drug|1
5920325|NCT01500200|20483561|P6|Stage 1|Withdrawal by Subject|0
5920326|NCT01500200|20483562|P5|Stage 1|Withdrawal by Subject|0
5920327|NCT01500200|20483563|P4|Stage 1|Withdrawal by Subject|0
5920328|NCT01500200|20483564|P3|Stage 1|Withdrawal by Subject|0
5920329|NCT01500200|20483565|P2|Stage 1|Withdrawal by Subject|0
5920330|NCT01500200|20483566|P1|Stage 1|Withdrawal by Subject|3
5920331|NCT01500200|20483561|P6|Stage 1|Lost to Follow-up|0
5920332|NCT01500200|20483562|P5|Stage 1|Lost to Follow-up|0
5920333|NCT01500200|20483563|P4|Stage 1|Lost to Follow-up|0
5920334|NCT01500200|20483564|P3|Stage 1|Lost to Follow-up|1
5920335|NCT01500200|20483565|P2|Stage 1|Lost to Follow-up|2
5920336|NCT01500200|20483566|P1|Stage 1|Lost to Follow-up|2
5920337|NCT01500200|20483561|P6|Stage 1|Adverse Event|0
5920338|NCT01500200|20483562|P5|Stage 1|Adverse Event|0
5920339|NCT01500200|20483563|P4|Stage 1|Adverse Event|0
5920340|NCT01500200|20483564|P3|Stage 1|Adverse Event|5
5920341|NCT01500200|20483565|P2|Stage 1|Adverse Event|4
5920342|NCT01500200|20483566|P1|Stage 1|Adverse Event|1
5920343|NCT01500187|20483600|P2|Overall Study|Lost to Follow-up|0
5920344|NCT01500187|20483601|P1|Overall Study|Lost to Follow-up|6
5920345|NCT01500135|20483609|P2|Overall Study|Patient Unable to Make Follow-up Visit|1
5920346|NCT01500135|20483610|P1|Overall Study|Patient Unable to Make Follow-up Visit|0
5920347|NCT01500135|20483609|P2|Overall Study|Participant was a Safety Concern|0
5920348|NCT01500135|20483610|P1|Overall Study|Participant was a Safety Concern|1
5920349|NCT01500135|20483609|P2|Overall Study|Patient Missed Scheduled Appointments|1
5920350|NCT01500135|20483610|P1|Overall Study|Patient Missed Scheduled Appointments|0
5920351|NCT01500135|20483609|P2|Overall Study|Principal Investigator (PI) Discretion|0
5920352|NCT01500135|20483610|P1|Overall Study|Principal Investigator (PI) Discretion|1
5920353|NCT01500135|20483609|P2|Overall Study|Fatal Adverse Event (AE)|5
5920354|NCT01500135|20483610|P1|Overall Study|Fatal Adverse Event (AE)|5
5920355|NCT01500135|20483609|P2|Overall Study|Lost to Follow-up|4
5920356|NCT01500135|20483610|P1|Overall Study|Lost to Follow-up|6
5920357|NCT01500135|20483609|P2|Overall Study|Withdrawal of Consent|0
5920358|NCT01500135|20483610|P1|Overall Study|Withdrawal of Consent|4
5920359|NCT01500096|20483637|P4|Overall Study|Lost to Follow-up|2
5920360|NCT01500096|20483638|P3|Overall Study|Lost to Follow-up|0
5920361|NCT01500096|20483639|P2|Overall Study|Lost to Follow-up|0
5920362|NCT01500096|20483640|P1|Overall Study|Lost to Follow-up|1
5920363|NCT01500083|20483696|P2|Overall Study|Other Reasons|5
5920364|NCT01500083|20483697|P1|Overall Study|Other Reasons|2
5920365|NCT01500083|20483696|P2|Overall Study|Investigator Discretion|8
5920366|NCT01500083|20483697|P1|Overall Study|Investigator Discretion|3
5920367|NCT01500083|20483696|P2|Overall Study|Disease Progression|10
5920368|NCT01500083|20483697|P1|Overall Study|Disease Progression|2
5920369|NCT01500083|20483696|P2|Overall Study|Withdrawal of Consent|1
5920370|NCT01500083|20483697|P1|Overall Study|Withdrawal of Consent|0
5920371|NCT01500083|20483696|P2|Overall Study|Lost to Follow-up|0
5920372|NCT01500083|20483697|P1|Overall Study|Lost to Follow-up|1
5920373|NCT01500083|20483696|P2|Overall Study|Death|2
5920374|NCT01500083|20483697|P1|Overall Study|Death|0
5920375|NCT01500083|20483696|P2|Overall Study|Adverse Event|17
5920376|NCT01500083|20483697|P1|Overall Study|Adverse Event|4
5920377|NCT01500057|20483705|P2|Overall Study|Lost to Follow-up|4
5920378|NCT01500057|20483706|P1|Overall Study|Lost to Follow-up|6
5920379|NCT01500031|20483716|P1|Overall Study|Withdrawal by Subject|4
5920380|NCT01500031|20483716|P1|Overall Study|Death|1
5920381|NCT01499849|20483751|P2|Overall Study|Other Reasons|30
5920382|NCT01499849|20483752|P1|Overall Study|Other Reasons|27
5920383|NCT01499849|20483751|P2|Overall Study|Lost to Follow-up|3
5920384|NCT01499849|20483752|P1|Overall Study|Lost to Follow-up|6
5920385|NCT01499849|20483751|P2|Overall Study|Lack of Efficacy|4
5920386|NCT01499849|20483752|P1|Overall Study|Lack of Efficacy|3
5920387|NCT01499849|20483751|P2|Overall Study|Physician Decision|19
5920388|NCT01499849|20483752|P1|Overall Study|Physician Decision|20
5920389|NCT01499849|20483751|P2|Overall Study|Protocol Violation|11
5920390|NCT01499849|20483752|P1|Overall Study|Protocol Violation|11
5920391|NCT01499849|20483751|P2|Overall Study|Disease Progression|10
5920392|NCT01499849|20483752|P1|Overall Study|Disease Progression|11
5920393|NCT01499849|20483751|P2|Overall Study|Death|7
5920394|NCT01499849|20483752|P1|Overall Study|Death|5
5920395|NCT01499849|20483751|P2|Overall Study|Withdrawal by Subject|43
5920396|NCT01499849|20483752|P1|Overall Study|Withdrawal by Subject|43
5920397|NCT01499849|20483751|P2|Overall Study|Chemo completed or Change in Therapy|67
5920398|NCT01499849|20483752|P1|Overall Study|Chemo completed or Change in Therapy|70
5920399|NCT01499849|20483751|P2|Overall Study|Adverse Event|32
5920400|NCT01499849|20483752|P1|Overall Study|Adverse Event|28
5920401|NCT01499810|20483762|P1|Overall Study|Withdrawal by Subject|1
5920402|NCT01499810|20483762|P1|Overall Study|Protocol Violation|1
5920403|NCT01499810|20483762|P1|Overall Study|Lost to Follow-up|10
5920404|NCT01499667|20483812|P3|Overall Study|Lack of Efficacy|0
5920405|NCT01499667|20483813|P2|Overall Study|Lack of Efficacy|0
5920406|NCT01499667|20483814|P1|Overall Study|Lack of Efficacy|2
5920407|NCT01499667|20483812|P3|Overall Study|Withdrawal by Subject|1
5920408|NCT01499667|20483813|P2|Overall Study|Withdrawal by Subject|1
5920409|NCT01499667|20483814|P1|Overall Study|Withdrawal by Subject|2
5920410|NCT01499667|20483812|P3|Overall Study|Adverse Event|2
5920411|NCT01499667|20483813|P2|Overall Study|Adverse Event|2
5920412|NCT01499667|20483814|P1|Overall Study|Adverse Event|0
5920413|NCT01499667|20483812|P3|Overall Study|Protocol Violation|2
5920414|NCT01499667|20483813|P2|Overall Study|Protocol Violation|3
5920415|NCT01499667|20483814|P1|Overall Study|Protocol Violation|1
5920416|NCT01499667|20483812|P3|Overall Study|administrative problems|5
5920417|NCT01499667|20483813|P2|Overall Study|administrative problems|5
5920418|NCT01499667|20483814|P1|Overall Study|administrative problems|4
5920419|NCT01499576|20483862|P1|Overall Study|Withdrawal by Subject|9
5920420|NCT01499576|20483862|P1|Overall Study|Physician Decision|12
5920421|NCT01499511|20483870|P2|Overall Study|Death|0
5920422|NCT01499511|20483871|P1|Overall Study|Death|1
5920423|NCT01499368|20483899|P3|Overall Study|Error of Prescriptions|1
5920424|NCT01499368|20483900|P2|Overall Study|Error of Prescriptions|0
5920425|NCT01499368|20483901|P1|Overall Study|Error of Prescriptions|0
5920426|NCT01499368|20483899|P3|Overall Study|Deviation from visit window|1
5920427|NCT01499368|20483900|P2|Overall Study|Deviation from visit window|0
5920428|NCT01499368|20483901|P1|Overall Study|Deviation from visit window|0
5920429|NCT01499368|20483899|P3|Overall Study|Physician Decision|0
5920430|NCT01499368|20483900|P2|Overall Study|Physician Decision|1
5920431|NCT01499368|20483901|P1|Overall Study|Physician Decision|0
5920432|NCT01499368|20483899|P3|Overall Study|Adverse Event|2
5920433|NCT01499368|20483900|P2|Overall Study|Adverse Event|0
5920434|NCT01499368|20483901|P1|Overall Study|Adverse Event|4
5920435|NCT01499368|20483899|P3|Overall Study|Lost to Follow-up|5
5920436|NCT01499368|20483900|P2|Overall Study|Lost to Follow-up|2
5920437|NCT01499368|20483901|P1|Overall Study|Lost to Follow-up|3
5920438|NCT01499368|20483899|P3|Overall Study|Withdrawal by Subject|8
5920439|NCT01499368|20483900|P2|Overall Study|Withdrawal by Subject|10
5920440|NCT01499368|20483901|P1|Overall Study|Withdrawal by Subject|11
5920441|NCT01499368|20483899|P3|Overall Study|Prohibited Concomitant medication|0
5920442|NCT01499368|20483900|P2|Overall Study|Prohibited Concomitant medication|1
5920443|NCT01499368|20483901|P1|Overall Study|Prohibited Concomitant medication|1
5920444|NCT01499368|20483899|P3|Overall Study|Did not meet I/E criteria|4
5920445|NCT01499368|20483900|P2|Overall Study|Did not meet I/E criteria|4
5920446|NCT01499368|20483901|P1|Overall Study|Did not meet I/E criteria|8
5920447|NCT01499355|20483918|P4|Double-Blind Period|Lost to Follow-up|0
5920448|NCT01499355|20483919|P3|Double-Blind Period|Lost to Follow-up|0
5920449|NCT01499355|20483920|P2|Double-Blind Period|Lost to Follow-up|1
5920450|NCT01499355|20483921|P1|Double-Blind Period|Lost to Follow-up|0
5920451|NCT01499355|20483918|P4|Double-Blind Period|Consent Withdrawn|2
5920452|NCT01499355|20483919|P3|Double-Blind Period|Consent Withdrawn|1
5920453|NCT01499355|20483920|P2|Double-Blind Period|Consent Withdrawn|0
5920454|NCT01499355|20483921|P1|Double-Blind Period|Consent Withdrawn|0
5920455|NCT01499355|20483918|P4|Double-Blind Period|Investigator Decision|3
5920456|NCT01499355|20483919|P3|Double-Blind Period|Investigator Decision|3
5920457|NCT01499355|20483920|P2|Double-Blind Period|Investigator Decision|0
5920458|NCT01499355|20483921|P1|Double-Blind Period|Investigator Decision|0
5920459|NCT01499355|20483918|P4|Double-Blind Period|Death|0
5920460|NCT01499355|20483919|P3|Double-Blind Period|Death|0
5920461|NCT01499355|20483920|P2|Double-Blind Period|Death|1
5920462|NCT01499355|20483921|P1|Double-Blind Period|Death|0
5920463|NCT01499355|20483918|P4|Double-Blind Period|Other|2
5920464|NCT01499355|20483919|P3|Double-Blind Period|Other|2
5920465|NCT01499355|20483920|P2|Double-Blind Period|Other|1
5920466|NCT01499355|20483921|P1|Double-Blind Period|Other|0
5920467|NCT01499355|20483918|P4|Double-Blind Period|Study Termination|14
5920468|NCT01499355|20483919|P3|Double-Blind Period|Study Termination|16
5920469|NCT01499355|20483920|P2|Double-Blind Period|Study Termination|18
5920470|NCT01499355|20483921|P1|Double-Blind Period|Study Termination|0
5920471|NCT01499355|20483918|P4|Double-Blind Period|Adverse Event|2
5920472|NCT01499355|20483919|P3|Double-Blind Period|Adverse Event|3
5920473|NCT01499355|20483920|P2|Double-Blind Period|Adverse Event|2
5920474|NCT01499355|20483921|P1|Double-Blind Period|Adverse Event|0
5920475|NCT01499355|20483918|P4|Run-In Period|Adverse Event|0
5920476|NCT01499355|20483919|P3|Run-In Period|Adverse Event|0
5920477|NCT01499355|20483920|P2|Run-In Period|Adverse Event|0
5920478|NCT01499355|20483921|P1|Run-In Period|Adverse Event|8
5920479|NCT01499355|20483918|P4|Run-In Period|Consent Withdrawn|0
5920480|NCT01499355|20483919|P3|Run-In Period|Consent Withdrawn|0
5920481|NCT01499355|20483920|P2|Run-In Period|Consent Withdrawn|0
5920482|NCT01499355|20483921|P1|Run-In Period|Consent Withdrawn|1
5920483|NCT01499355|20483918|P4|Run-In Period|Investigator Decision|0
5920484|NCT01499355|20483919|P3|Run-In Period|Investigator Decision|0
5920485|NCT01499355|20483920|P2|Run-In Period|Investigator Decision|0
5920486|NCT01499355|20483921|P1|Run-In Period|Investigator Decision|2
5920487|NCT01499355|20483918|P4|Run-In Period|Death|0
5920488|NCT01499355|20483919|P3|Run-In Period|Death|0
5920489|NCT01499355|20483920|P2|Run-In Period|Death|0
5920490|NCT01499355|20483921|P1|Run-In Period|Death|2
5920491|NCT01499355|20483918|P4|Run-In Period|Other|0
5920492|NCT01499355|20483919|P3|Run-In Period|Other|0
5920493|NCT01499355|20483920|P2|Run-In Period|Other|0
5920494|NCT01499355|20483921|P1|Run-In Period|Other|3
5920495|NCT01499355|20483918|P4|Run-In Period|Study Termination|0
5920496|NCT01499355|20483919|P3|Run-In Period|Study Termination|0
5920497|NCT01499355|20483920|P2|Run-In Period|Study Termination|0
5920498|NCT01499355|20483921|P1|Run-In Period|Study Termination|15
5920499|NCT01499303|20483954|P2|Overall Study|Other|1
5920500|NCT01499303|20483955|P1|Overall Study|Other|0
5920501|NCT01499303|20483954|P2|Overall Study|Adverse Event|4
5920502|NCT01499303|20483955|P1|Overall Study|Adverse Event|1
5920503|NCT01499303|20483954|P2|Overall Study|Withdrawal by Subject|1
5920504|NCT01499303|20483955|P1|Overall Study|Withdrawal by Subject|0
5920505|NCT01499303|20483954|P2|Overall Study|Ongoing|1
5920506|NCT01499303|20483955|P1|Overall Study|Ongoing|2
5920507|NCT01499290|20483963|P2|Overall Study|Adverse Event|7
5920508|NCT01499290|20483964|P1|Overall Study|Adverse Event|14
5920509|NCT01499290|20483963|P2|Overall Study|Lack of Efficacy|8
5920510|NCT01499290|20483964|P1|Overall Study|Lack of Efficacy|7
5920511|NCT01499290|20483963|P2|Overall Study|Condition improved/subject recovered|0
5920512|NCT01499290|20483964|P1|Overall Study|Condition improved/subject recovered|1
5920513|NCT01499290|20483963|P2|Overall Study|Not specified in study report|5
5920514|NCT01499290|20483964|P1|Overall Study|Not specified in study report|11
5920515|NCT01499290|20483963|P2|Overall Study|Withdrawal by Subject|15
5920516|NCT01499290|20483964|P1|Overall Study|Withdrawal by Subject|22
5920517|NCT01499277|20484014|P2|Overall Study|Lack of therapeutic response and other|7
5920518|NCT01499277|20484015|P1|Overall Study|Lack of therapeutic response and other|8
5920519|NCT01499277|20484014|P2|Overall Study|Withdrawal by Subject|6
5920520|NCT01499277|20484015|P1|Overall Study|Withdrawal by Subject|16
5920521|NCT01499277|20484014|P2|Overall Study|Protocol Violation|3
5920522|NCT01499277|20484015|P1|Overall Study|Protocol Violation|2
5920523|NCT01499277|20484014|P2|Overall Study|Lost to Follow-up|8
5920524|NCT01499277|20484015|P1|Overall Study|Lost to Follow-up|15
5920525|NCT01499277|20484014|P2|Overall Study|Death|2
5920526|NCT01499277|20484015|P1|Overall Study|Death|3
5920527|NCT01499277|20484014|P2|Overall Study|Adverse Event|6
5920528|NCT01499277|20484015|P1|Overall Study|Adverse Event|3
5920529|NCT01499199|20484037|P1|Overall Study|Lack of Efficacy|1
5920530|NCT01499199|20484037|P1|Overall Study|Adverse Event|1
5920531|NCT01499160|20484066|P1|Overall Study|Withdrawal by Subject|1
5920532|NCT01499160|20484066|P1|Overall Study|Adverse Event|1
5920533|NCT01499134|20484089|P2|Overall Study|Withdrawal by Subject|1
5920534|NCT01499134|20484090|P1|Overall Study|Withdrawal by Subject|0
5920535|NCT01499095|20484112|P2|Overall Study|Perceived Lack of Efficacy|1
5920536|NCT01499095|20484113|P1|Overall Study|Perceived Lack of Efficacy|1
5920537|NCT01499095|20484112|P2|Overall Study|Change in Injection Schedule|0
5920538|NCT01499095|20484113|P1|Overall Study|Change in Injection Schedule|2
5920539|NCT01499095|20484112|P2|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|1
5920540|NCT01499095|20484113|P1|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|2
5920541|NCT01499095|20484112|P2|Overall Study|Hypoglycemia|1
5920542|NCT01499095|20484113|P1|Overall Study|Hypoglycemia|3
5920543|NCT01499095|20484112|P2|Overall Study|Insulin Dropped Below Authorized Dose|5
5920544|NCT01499095|20484113|P1|Overall Study|Insulin Dropped Below Authorized Dose|0
5920545|NCT01499095|20484112|P2|Overall Study|Lost to Follow-up|4
5920546|NCT01499095|20484113|P1|Overall Study|Lost to Follow-up|6
5920547|NCT01499095|20484112|P2|Overall Study|Diverse Reasons|25
5920548|NCT01499095|20484113|P1|Overall Study|Diverse Reasons|22
5920549|NCT01499095|20484112|P2|Overall Study|Received Rescue Therapy|40
5920550|NCT01499095|20484113|P1|Overall Study|Received Rescue Therapy|32
5920551|NCT01499095|20484112|P2|Overall Study|Protocol Violation|7
5920552|NCT01499095|20484113|P1|Overall Study|Protocol Violation|6
5920553|NCT01499095|20484112|P2|Overall Study|Lack of Efficacy|1
5920554|NCT01499095|20484113|P1|Overall Study|Lack of Efficacy|2
5920555|NCT01499095|20484112|P2|Overall Study|Adverse Event|7
5920556|NCT01499095|20484113|P1|Overall Study|Adverse Event|12
5920557|NCT01499095|20484112|P2|Overall Study|Randomized But Not Treated|1
5920558|NCT01499095|20484113|P1|Overall Study|Randomized But Not Treated|1
5920559|NCT01499082|20484143|P2|Overall Study|Lost to Follow-up|3
5920560|NCT01499082|20484144|P1|Overall Study|Lost to Follow-up|1
5920561|NCT01499082|20484143|P2|Overall Study|Hypoglycemia|3
5920562|NCT01499082|20484144|P1|Overall Study|Hypoglycemia|2
5920563|NCT01499082|20484143|P2|Overall Study|Site Closure for Noncompliance|2
5920564|NCT01499082|20484144|P1|Overall Study|Site Closure for Noncompliance|5
5920565|NCT01499082|20484143|P2|Overall Study|Diverse Reasons|14
5920566|NCT01499082|20484144|P1|Overall Study|Diverse Reasons|18
5920567|NCT01499082|20484143|P2|Overall Study|Protocol Violation|8
5920568|NCT01499082|20484144|P1|Overall Study|Protocol Violation|6
5920569|NCT01499082|20484143|P2|Overall Study|Lack of Efficacy|1
5920570|NCT01499082|20484144|P1|Overall Study|Lack of Efficacy|1
5920571|NCT01499082|20484143|P2|Overall Study|Adverse Event|16
5920572|NCT01499082|20484144|P1|Overall Study|Adverse Event|12
5920573|NCT01499082|20484143|P2|Overall Study|Randomized but not Treated|1
5920574|NCT01499082|20484144|P1|Overall Study|Randomized but not Treated|0
5920575|NCT01499043|20484172|P1|Overall Study|Adverse Event|1
5920576|NCT01499043|20484172|P1|Overall Study|Withdrawal by Subject|2
5920577|NCT01499043|20484172|P1|Overall Study|Progressive disease (clinical)|1
5920578|NCT01499043|20484172|P1|Overall Study|Progressive disease (radiographic)|2
5920579|NCT01498952|20484215|P5|Overall Study|Death|0
5920580|NCT01498952|20484216|P4|Overall Study|Death|0
5920581|NCT01498952|20484217|P3|Overall Study|Death|0
5920582|NCT01498952|20484218|P2|Overall Study|Death|2
5920583|NCT01498952|20484219|P1|Overall Study|Death|2
5920584|NCT01498887|20484261|P2|Overall Study|Adverse Event|1
5920585|NCT01498887|20484262|P1|Overall Study|Adverse Event|4
5920586|NCT01498887|20484261|P2|Overall Study|Abnormal laboratory value|2
5920587|NCT01498887|20484262|P1|Overall Study|Abnormal laboratory value|2
5920588|NCT01498887|20484261|P2|Overall Study|Abnormal result from test procedure|1
5920589|NCT01498887|20484262|P1|Overall Study|Abnormal result from test procedure|1
5920590|NCT01498887|20484261|P2|Overall Study|Lack of Efficacy|3
5920591|NCT01498887|20484262|P1|Overall Study|Lack of Efficacy|5
5920592|NCT01498887|20484261|P2|Overall Study|Protocol Violation|3
5920593|NCT01498887|20484262|P1|Overall Study|Protocol Violation|1
5920594|NCT01498887|20484261|P2|Overall Study|Withdrawal by Subject|0
5920595|NCT01498887|20484262|P1|Overall Study|Withdrawal by Subject|1
5920596|NCT01498887|20484261|P2|Overall Study|Lost to Follow-up|1
5920597|NCT01498887|20484262|P1|Overall Study|Lost to Follow-up|1
5920598|NCT01498887|20484261|P2|Overall Study|Administrative problems|0
5920599|NCT01498887|20484262|P1|Overall Study|Administrative problems|1
5920600|NCT01498822|20484283|P2|Overall Study|Lost to Follow-up|3
5920601|NCT01498822|20484284|P1|Overall Study|Lost to Follow-up|8
5920602|NCT01498822|20484283|P2|Overall Study|Withdrawal by Subject|25
5920603|NCT01498822|20484284|P1|Overall Study|Withdrawal by Subject|15
5920604|NCT01498822|20484283|P2|Overall Study|Adverse Event, serious fatal|1
5920605|NCT01498822|20484284|P1|Overall Study|Adverse Event, serious fatal|1
5920606|NCT01498822|20484283|P2|Overall Study|SAE, non-fatal|2
5920607|NCT01498822|20484284|P1|Overall Study|SAE, non-fatal|2
5920608|NCT01498822|20484283|P2|Overall Study|AE, non-serious non-fatal|17
5920609|NCT01498822|20484284|P1|Overall Study|AE, non-serious non-fatal|8
5920610|NCT01498822|20484283|P2|Overall Study|Lack of Efficacy|2
5920611|NCT01498822|20484284|P1|Overall Study|Lack of Efficacy|7
5920612|NCT01498822|20484283|P2|Overall Study|Other Reason|2
5920613|NCT01498822|20484284|P1|Overall Study|Other Reason|5
5920614|NCT01498822|20484283|P2|Overall Study|Protocol Violation|4
5920615|NCT01498822|20484284|P1|Overall Study|Protocol Violation|8
5920616|NCT01498692|20484311|P1|Overall Study|Missed 12-month visit|3
5920617|NCT01498692|20484311|P1|Overall Study|Withdrawal by Subject|1
5920618|NCT01498692|20484311|P1|Overall Study|Death|4
5920619|NCT01498679|20484342|P2|Overall Study|Withdrawal by Subject|4
5920620|NCT01498679|20484343|P1|Overall Study|Withdrawal by Subject|12
5920621|NCT01498679|20484342|P2|Overall Study|Physician Decision|2
5920622|NCT01498679|20484343|P1|Overall Study|Physician Decision|0
5920623|NCT01498679|20484342|P2|Overall Study|Protocol Violation|0
5920624|NCT01498679|20484343|P1|Overall Study|Protocol Violation|4
5920625|NCT01498679|20484342|P2|Overall Study|Lack of Efficacy|12
5920626|NCT01498679|20484343|P1|Overall Study|Lack of Efficacy|72
5920627|NCT01498679|20484342|P2|Overall Study|Adverse Event|4
5920628|NCT01498679|20484343|P1|Overall Study|Adverse Event|1
5920629|NCT01498653|20484359|P2|Overall Study|Withdrawal by Subject|3
5920630|NCT01498653|20484360|P1|Overall Study|Withdrawal by Subject|2
5920631|NCT01498653|20484359|P2|Overall Study|Physician Decision|0
5920632|NCT01498653|20484360|P1|Overall Study|Physician Decision|2
5920633|NCT01498653|20484359|P2|Overall Study|Lost to Follow-up|0
5920634|NCT01498653|20484360|P1|Overall Study|Lost to Follow-up|1
5920635|NCT01498653|20484359|P2|Overall Study|Protocol Violation|4
5920636|NCT01498653|20484360|P1|Overall Study|Protocol Violation|0
5920637|NCT01498653|20484359|P2|Overall Study|Lack of Efficacy|26
5920638|NCT01498653|20484360|P1|Overall Study|Lack of Efficacy|12
5920639|NCT01498653|20484359|P2|Overall Study|Adverse Event|2
5920640|NCT01498653|20484360|P1|Overall Study|Adverse Event|2
5920641|NCT01498640|20484374|P1|Overall Study|Other|3
5920642|NCT01498640|20484374|P1|Overall Study|Death|1
5920643|NCT01498640|20484374|P1|Overall Study|Lost to Follow-up|1
5920644|NCT01498575|20484404|P2|On the Road Driving Assessment (ODA)|Protocol Violation|18
5920645|NCT01498575|20484405|P1|On the Road Driving Assessment (ODA)|Protocol Violation|23
5920646|NCT01498575|20484404|P2|On the Road Driving Assessment (ODA)|Withdrawal by Subject|6
5920647|NCT01498575|20484405|P1|On the Road Driving Assessment (ODA)|Withdrawal by Subject|19
5920648|NCT01498575|20484404|P2|Overall Sample|Withdrawal by Subject|14
5920649|NCT01498575|20484405|P1|Overall Sample|Withdrawal by Subject|60
5920650|NCT01498458|20484422|P1|Overall Study|Physician Decision|3
5920651|NCT01498458|20484422|P1|Overall Study|Adverse Event|4
5920652|NCT01498445|20484437|P6|Overall Study|Screen Failure|1
5920653|NCT01498445|20484438|P5|Overall Study|Screen Failure|1
5920654|NCT01498445|20484439|P4|Overall Study|Screen Failure|0
5920655|NCT01498445|20484440|P3|Overall Study|Screen Failure|0
5920656|NCT01498445|20484441|P2|Overall Study|Screen Failure|0
5920657|NCT01498445|20484442|P1|Overall Study|Screen Failure|0
5920658|NCT01498445|20484437|P6|Overall Study|Lack of Efficacy|0
5920659|NCT01498445|20484438|P5|Overall Study|Lack of Efficacy|0
5920660|NCT01498445|20484439|P4|Overall Study|Lack of Efficacy|2
5920661|NCT01498445|20484440|P3|Overall Study|Lack of Efficacy|1
5920662|NCT01498445|20484441|P2|Overall Study|Lack of Efficacy|0
5920663|NCT01498445|20484442|P1|Overall Study|Lack of Efficacy|0
5920664|NCT01498289|20484517|P2|Overall Study|Reason under review|1
5920665|NCT01498289|20484518|P1|Overall Study|Reason under review|0
5920666|NCT01498289|20484517|P2|Overall Study|Not protocol specified|2
5920667|NCT01498289|20484518|P1|Overall Study|Not protocol specified|7
5920668|NCT01498289|20484517|P2|Overall Study|Progression/relapse|59
5920669|NCT01498289|20484518|P1|Overall Study|Progression/relapse|53
5920670|NCT01498289|20484517|P2|Overall Study|Withdrawal unrelated to AE|16
5920671|NCT01498289|20484518|P1|Overall Study|Withdrawal unrelated to AE|16
5920672|NCT01498289|20484517|P2|Overall Study|Death|8
5920673|NCT01498289|20484518|P1|Overall Study|Death|6
5920674|NCT01498289|20484517|P2|Overall Study|Adverse Event|18
5920675|NCT01498289|20484518|P1|Overall Study|Adverse Event|16
5920676|NCT01498185|20484539|P5|Overall Study|No longer met criteria, etc|2
5920677|NCT01498185|20484540|P4|Overall Study|No longer met criteria, etc|0
5920678|NCT01498185|20484541|P3|Overall Study|No longer met criteria, etc|0
5920679|NCT01498185|20484542|P2|Overall Study|No longer met criteria, etc|0
5920680|NCT01498185|20484543|P1|Overall Study|No longer met criteria, etc|0
5920681|NCT01498185|20484539|P5|Overall Study|Withdrawal by Subject|1
5920682|NCT01498185|20484540|P4|Overall Study|Withdrawal by Subject|2
5920683|NCT01498185|20484541|P3|Overall Study|Withdrawal by Subject|0
5920684|NCT01498185|20484542|P2|Overall Study|Withdrawal by Subject|1
5920685|NCT01498185|20484543|P1|Overall Study|Withdrawal by Subject|1
5920686|NCT01498185|20484539|P5|Overall Study|Adverse Event|0
5920687|NCT01498185|20484540|P4|Overall Study|Adverse Event|1
5920688|NCT01498185|20484541|P3|Overall Study|Adverse Event|0
5920689|NCT01498185|20484542|P2|Overall Study|Adverse Event|0
5920690|NCT01498185|20484543|P1|Overall Study|Adverse Event|0
5920691|NCT01498120|20484583|P1|Overall Study|Other|4
5920692|NCT01498120|20484583|P1|Overall Study|AE, non-serious non-fatal|3
5920693|NCT01498120|20484583|P1|Overall Study|Withdrawal by Subject|5
5920694|NCT01498120|20484583|P1|Overall Study|Lost to Follow-up|1
5920695|NCT01498068|20484590|P2|Overall Study|Withdrawal by Subject|1
5920696|NCT01498068|20484591|P1|Overall Study|Withdrawal by Subject|1
5920697|NCT01497938|20484609|P2|Overall Study|Device Violation|0
5920698|NCT01497938|20484610|P1|Overall Study|Device Violation|1
5920699|NCT01497938|20484609|P2|Overall Study|Withdrawal by Subject|0
5920700|NCT01497938|20484610|P1|Overall Study|Withdrawal by Subject|4
5920701|NCT01497938|20484609|P2|Overall Study|Physician Decision|1
5920702|NCT01497938|20484610|P1|Overall Study|Physician Decision|0
5920703|NCT01497938|20484609|P2|Overall Study|Adverse Event|1
5920704|NCT01497938|20484610|P1|Overall Study|Adverse Event|0
5920705|NCT01497899|20484622|P4|Open-Label Extension Phase|Lost to Follow-up|5
5920706|NCT01497899|20484623|P3|Open-Label Extension Phase|Lost to Follow-up|5
5920707|NCT01497899|20484624|P2|Open-Label Extension Phase|Lost to Follow-up|3
5920708|NCT01497899|20484625|P1|Open-Label Extension Phase|Lost to Follow-up|9
5920709|NCT01497899|20484622|P4|Open-Label Extension Phase|Protocol Violation|0
5920710|NCT01497899|20484623|P3|Open-Label Extension Phase|Protocol Violation|1
5920711|NCT01497899|20484624|P2|Open-Label Extension Phase|Protocol Violation|0
5920712|NCT01497899|20484625|P1|Open-Label Extension Phase|Protocol Violation|0
5920713|NCT01497899|20484622|P4|Open-Label Extension Phase|Pregnancy|0
5920714|NCT01497899|20484623|P3|Open-Label Extension Phase|Pregnancy|1
5920715|NCT01497899|20484624|P2|Open-Label Extension Phase|Pregnancy|1
5920716|NCT01497899|20484625|P1|Open-Label Extension Phase|Pregnancy|0
5920717|NCT01497899|20484622|P4|Open-Label Extension Phase|Withdrew Consent|0
5920718|NCT01497899|20484623|P3|Open-Label Extension Phase|Withdrew Consent|2
5920719|NCT01497899|20484624|P2|Open-Label Extension Phase|Withdrew Consent|3
5920720|NCT01497899|20484625|P1|Open-Label Extension Phase|Withdrew Consent|8
5920721|NCT01497899|20484622|P4|Open-Label Extension Phase|Death|0
5920722|NCT01497899|20484623|P3|Open-Label Extension Phase|Death|0
5920723|NCT01497899|20484624|P2|Open-Label Extension Phase|Death|0
5920724|NCT01497899|20484625|P1|Open-Label Extension Phase|Death|1
5920725|NCT01497899|20484622|P4|Open-Label Extension Phase|Adverse Event|0
5920726|NCT01497899|20484623|P3|Open-Label Extension Phase|Adverse Event|0
5920727|NCT01497899|20484624|P2|Open-Label Extension Phase|Adverse Event|0
5920728|NCT01497899|20484625|P1|Open-Label Extension Phase|Adverse Event|1
5920729|NCT01497899|20484622|P4|Double-Blind Phase|Subject Non-Compliance|0
5920730|NCT01497899|20484623|P3|Double-Blind Phase|Subject Non-Compliance|0
5920731|NCT01497899|20484624|P2|Double-Blind Phase|Subject Non-Compliance|1
5920732|NCT01497899|20484625|P1|Double-Blind Phase|Subject Non-Compliance|0
5920733|NCT01497899|20484622|P4|Double-Blind Phase|Lost to Follow-up|0
5920734|NCT01497899|20484623|P3|Double-Blind Phase|Lost to Follow-up|0
5920735|NCT01497899|20484624|P2|Double-Blind Phase|Lost to Follow-up|2
5920736|NCT01497899|20484625|P1|Double-Blind Phase|Lost to Follow-up|3
5920737|NCT01497899|20484622|P4|Double-Blind Phase|Withdrew Consent|0
5920738|NCT01497899|20484623|P3|Double-Blind Phase|Withdrew Consent|0
5920739|NCT01497899|20484624|P2|Double-Blind Phase|Withdrew Consent|1
5920740|NCT01497899|20484625|P1|Double-Blind Phase|Withdrew Consent|0
5920741|NCT01497899|20484622|P4|Double-Blind Phase|Investigator's Discretion|0
5920742|NCT01497899|20484623|P3|Double-Blind Phase|Investigator's Discretion|0
5920743|NCT01497899|20484624|P2|Double-Blind Phase|Investigator's Discretion|0
5920744|NCT01497899|20484625|P1|Double-Blind Phase|Investigator's Discretion|1
5920745|NCT01497899|20484622|P4|Double-Blind Phase|Lack of Efficacy|0
5920746|NCT01497899|20484623|P3|Double-Blind Phase|Lack of Efficacy|0
5920747|NCT01497899|20484624|P2|Double-Blind Phase|Lack of Efficacy|1
5920748|NCT01497899|20484625|P1|Double-Blind Phase|Lack of Efficacy|0
5920749|NCT01497899|20484622|P4|Double-Blind Phase|Adverse Event|0
5920750|NCT01497899|20484623|P3|Double-Blind Phase|Adverse Event|0
5920751|NCT01497899|20484624|P2|Double-Blind Phase|Adverse Event|0
5920752|NCT01497899|20484625|P1|Double-Blind Phase|Adverse Event|1
5920753|NCT01497899|20484622|P4|Double-Blind Phase|Randomized but not Treated|0
5920754|NCT01497899|20484623|P3|Double-Blind Phase|Randomized but not Treated|0
5920755|NCT01497899|20484624|P2|Double-Blind Phase|Randomized but not Treated|0
5920756|NCT01497899|20484625|P1|Double-Blind Phase|Randomized but not Treated|1
5920757|NCT01497366|20484702|P2|Overall Study|Randomized but not treated|21
5920758|NCT01497366|20484703|P1|Overall Study|Randomized but not treated|7
5920759|NCT01497366|20484702|P2|Overall Study|Death|1
5920760|NCT01497366|20484703|P1|Overall Study|Death|1
5920761|NCT01497366|20484702|P2|Overall Study|Other|0
5920762|NCT01497366|20484703|P1|Overall Study|Other|5
5920763|NCT01497366|20484702|P2|Overall Study|Initiated Non-protocol HCV Treatment|0
5920764|NCT01497366|20484703|P1|Overall Study|Initiated Non-protocol HCV Treatment|7
5920765|NCT01497366|20484702|P2|Overall Study|Withdrawal by Subject|6
5920766|NCT01497366|20484703|P1|Overall Study|Withdrawal by Subject|6
5920767|NCT01497366|20484702|P2|Overall Study|Lost to Follow-up|10
5920768|NCT01497366|20484703|P1|Overall Study|Lost to Follow-up|11
5920769|NCT01497366|20484702|P2|Overall Study|Virologic failure|50
5920770|NCT01497366|20484703|P1|Overall Study|Virologic failure|2
5920771|NCT01497275|20484721|P1|Overall Study|Adverse Event|1
5920772|NCT01497275|20484721|P1|Overall Study|Death|1
5920773|NCT01497262|20484728|P1|Overall Study|Protocol Violation|1
5920774|NCT01497262|20484728|P1|Overall Study|Adverse Event|2
5920775|NCT01497262|20484728|P1|Overall Study|Withdrawal by Subject|2
5920776|NCT01497262|20484728|P1|Overall Study|Physician Decision|1
5920777|NCT01497262|20484728|P1|Overall Study|Abnormal Test Procedure Result|1
5920778|NCT01497262|20484728|P1|Overall Study|Abnormal Lab Values|4
5920779|NCT01497197|20484735|P2|Overall Study|Other|1
5920780|NCT01497197|20484736|P1|Overall Study|Other|3
5920781|NCT01497197|20484735|P2|Overall Study|All embryos discarded|3
5920782|NCT01497197|20484736|P1|Overall Study|All embryos discarded|0
5920783|NCT01497197|20484735|P2|Overall Study|Intention to freeze all embryos|1
5920784|NCT01497197|20484736|P1|Overall Study|Intention to freeze all embryos|0
5920785|NCT01497197|20484735|P2|Overall Study|No fertilisation|5
5920786|NCT01497197|20484736|P1|Overall Study|No fertilisation|6
5920787|NCT01497197|20484735|P2|Overall Study|No oocytes retrieved|2
5920788|NCT01497197|20484736|P1|Overall Study|No oocytes retrieved|3
5920789|NCT01497197|20484735|P2|Overall Study|Risk of OHSS|0
5920790|NCT01497197|20484736|P1|Overall Study|Risk of OHSS|1
5920791|NCT01497197|20484735|P2|Overall Study|Excessive/lack of response to treatment|0
5920792|NCT01497197|20484736|P1|Overall Study|Excessive/lack of response to treatment|1
5920793|NCT01497197|20484735|P2|Overall Study|Withdrawal by Subject|1
5920794|NCT01497197|20484736|P1|Overall Study|Withdrawal by Subject|2
5920795|NCT01497197|20484735|P2|Overall Study|Protocol Violation|2
5920796|NCT01497197|20484736|P1|Overall Study|Protocol Violation|0
5920797|NCT01497197|20484735|P2|Overall Study|Lost to Follow-up|0
5920798|NCT01497197|20484736|P1|Overall Study|Lost to Follow-up|1
5920799|NCT01497067|20484771|P1|Overall Study|Other|13
5920800|NCT01497067|20484771|P1|Overall Study|Patient decision unrel to Adverse Event|10
5920801|NCT01497067|20484771|P1|Overall Study|Adverse Event|3
5920802|NCT01497067|20484771|P1|Overall Study|Lost to Follow-up|56
5920803|NCT01496846|20484782|P6|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0
5920804|NCT01496846|20484783|P5|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0
5920805|NCT01496846|20484784|P4|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0
5920806|NCT01496846|20484785|P3|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0
5920807|NCT01496846|20484786|P2|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1
5920808|NCT01496846|20484787|P1|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1
5920809|NCT01496807|20484798|P1|Overall Study|Change in diagnosis|1
5920810|NCT01496807|20484798|P1|Overall Study|Participant preference/toxicity|8
5920811|NCT01496807|20484798|P1|Overall Study|Progressive Disease|21
5920812|NCT01496469|20484810|P2|Overall Study|Other|1
5920813|NCT01496469|20484811|P1|Overall Study|Other|1
5920814|NCT01496469|20484810|P2|Overall Study|BP exceeds protocol limits|2
5920815|NCT01496469|20484811|P1|Overall Study|BP exceeds protocol limits|1
5920816|NCT01496469|20484810|P2|Overall Study|Withdrawal by Subject|4
5920817|NCT01496469|20484811|P1|Overall Study|Withdrawal by Subject|4
5920818|NCT01496469|20484810|P2|Overall Study|Lost to Follow-up|1
5920819|NCT01496469|20484811|P1|Overall Study|Lost to Follow-up|1
5920820|NCT01496469|20484810|P2|Overall Study|Protocol Violation|0
5920821|NCT01496469|20484811|P1|Overall Study|Protocol Violation|2
5920822|NCT01496469|20484810|P2|Overall Study|Adverse Event|0
5920823|NCT01496469|20484811|P1|Overall Study|Adverse Event|1
5920824|NCT01496456|20484821|P1|Overall Study|Lost to Follow-up|7
5920825|NCT01496456|20484821|P1|Overall Study|Protocol Violation|1
5920826|NCT01496430|20484834|P3|Overall Study|Other|0
5920827|NCT01496430|20484835|P2|Overall Study|Other|0
5920828|NCT01496430|20484836|P1|Overall Study|Other|2
5920829|NCT01496430|20484834|P3|Overall Study|Principal Investigator Discretion|1
5920830|NCT01496430|20484835|P2|Overall Study|Principal Investigator Discretion|1
5920831|NCT01496430|20484836|P1|Overall Study|Principal Investigator Discretion|0
5920832|NCT01496430|20484834|P3|Overall Study|Voluntary Withdrawal|6
5920833|NCT01496430|20484835|P2|Overall Study|Voluntary Withdrawal|1
5920834|NCT01496430|20484836|P1|Overall Study|Voluntary Withdrawal|2
5920835|NCT01496430|20484834|P3|Overall Study|Lost to Follow-up|1
5920836|NCT01496430|20484835|P2|Overall Study|Lost to Follow-up|3
5920837|NCT01496430|20484836|P1|Overall Study|Lost to Follow-up|2
5920838|NCT01496430|20484834|P3|Overall Study|Major Protocol Deviation|1
5920839|NCT01496430|20484835|P2|Overall Study|Major Protocol Deviation|0
5920840|NCT01496430|20484836|P1|Overall Study|Major Protocol Deviation|0
5920841|NCT01496430|20484834|P3|Overall Study|Adverse Event|1
5920842|NCT01496430|20484835|P2|Overall Study|Adverse Event|0
5920843|NCT01496430|20484836|P1|Overall Study|Adverse Event|0
5920844|NCT01496365|20484917|P7|Overall Study|Other|1
5920845|NCT01496365|20484918|P6|Overall Study|Other|0
5920846|NCT01496365|20484919|P5|Overall Study|Other|3
5920847|NCT01496365|20484920|P4|Overall Study|Other|1
5920848|NCT01496365|20484921|P3|Overall Study|Other|2
5920849|NCT01496365|20484922|P2|Overall Study|Other|4
5920850|NCT01496365|20484923|P1|Overall Study|Other|4
5920851|NCT01496365|20484917|P7|Overall Study|Lost to Follow-up|0
5920852|NCT01496365|20484918|P6|Overall Study|Lost to Follow-up|0
5920853|NCT01496365|20484919|P5|Overall Study|Lost to Follow-up|2
5920854|NCT01496365|20484920|P4|Overall Study|Lost to Follow-up|0
5920855|NCT01496365|20484921|P3|Overall Study|Lost to Follow-up|0
5920856|NCT01496365|20484922|P2|Overall Study|Lost to Follow-up|1
5920857|NCT01496365|20484923|P1|Overall Study|Lost to Follow-up|0
5920858|NCT01496365|20484917|P7|Overall Study|Lack of Efficacy|0
5920859|NCT01496365|20484918|P6|Overall Study|Lack of Efficacy|1
5920860|NCT01496365|20484919|P5|Overall Study|Lack of Efficacy|0
5920861|NCT01496365|20484920|P4|Overall Study|Lack of Efficacy|0
5920862|NCT01496365|20484921|P3|Overall Study|Lack of Efficacy|0
5920863|NCT01496365|20484922|P2|Overall Study|Lack of Efficacy|0
5920864|NCT01496365|20484923|P1|Overall Study|Lack of Efficacy|1
5920865|NCT01496365|20484917|P7|Overall Study|Protocol Violation|0
5920866|NCT01496365|20484918|P6|Overall Study|Protocol Violation|1
5920867|NCT01496365|20484919|P5|Overall Study|Protocol Violation|0
5920868|NCT01496365|20484920|P4|Overall Study|Protocol Violation|0
5920869|NCT01496365|20484921|P3|Overall Study|Protocol Violation|1
5920870|NCT01496365|20484922|P2|Overall Study|Protocol Violation|1
5920871|NCT01496365|20484923|P1|Overall Study|Protocol Violation|2
5920872|NCT01496365|20484917|P7|Overall Study|Withdrawal by Subject|1
5920873|NCT01496365|20484918|P6|Overall Study|Withdrawal by Subject|2
5920874|NCT01496365|20484919|P5|Overall Study|Withdrawal by Subject|3
5920875|NCT01496365|20484920|P4|Overall Study|Withdrawal by Subject|1
5920876|NCT01496365|20484921|P3|Overall Study|Withdrawal by Subject|0
5920877|NCT01496365|20484922|P2|Overall Study|Withdrawal by Subject|6
5920878|NCT01496365|20484923|P1|Overall Study|Withdrawal by Subject|6
5920879|NCT01496365|20484917|P7|Overall Study|Adverse Event|4
5920880|NCT01496365|20484918|P6|Overall Study|Adverse Event|6
5920881|NCT01496365|20484919|P5|Overall Study|Adverse Event|5
5920882|NCT01496365|20484920|P4|Overall Study|Adverse Event|2
5920883|NCT01496365|20484921|P3|Overall Study|Adverse Event|3
5920884|NCT01496365|20484922|P2|Overall Study|Adverse Event|3
5920885|NCT01496365|20484923|P1|Overall Study|Adverse Event|2
5920886|NCT01496287|20485061|P1|Overall Study|Incomplete anesthesia|5
5920887|NCT01496287|20485061|P1|Overall Study|Lost to Follow-up|1
5920888|NCT01496274|20485071|P2|Overall Study|Lost to Follow-up|3
5920889|NCT01496274|20485072|P1|Overall Study|Lost to Follow-up|0
5920890|NCT01496274|20485071|P2|Overall Study|Withdrawal by Subject|0
5920891|NCT01496274|20485072|P1|Overall Study|Withdrawal by Subject|2
5920892|NCT01496274|20485071|P2|Overall Study|Adverse Event|1
5920893|NCT01496274|20485072|P1|Overall Study|Adverse Event|1
5920894|NCT01496274|20485071|P2|Overall Study|Protocol Violation|1
5920895|NCT01496274|20485072|P1|Overall Study|Protocol Violation|0
5920896|NCT01496183|20485117|P2|Overall Study|Withdrawal by Subject|1
5920897|NCT01496183|20485118|P1|Overall Study|Withdrawal by Subject|0
5920898|NCT01496183|20485117|P2|Overall Study|Physician Decision|1
5920899|NCT01496183|20485118|P1|Overall Study|Physician Decision|3
5920900|NCT01496066|20485170|P2|Overall Study|Death|4
5920901|NCT01496066|20485171|P1|Overall Study|Death|1
5920902|NCT01496066|20485170|P2|Overall Study|Explant|0
5920903|NCT01496066|20485171|P1|Overall Study|Explant|3
5920904|NCT01496066|20485170|P2|Overall Study|Lost to Follow-up|5
5920905|NCT01496066|20485171|P1|Overall Study|Lost to Follow-up|8
5920906|NCT01495975|20485233|P2|Overall Study|Lost to Follow-up|0
5920907|NCT01495975|20485234|P1|Overall Study|Lost to Follow-up|1
5920908|NCT01495793|20485358|P1|Overall Study|Violation of inclusion criteria|1
5920909|NCT01495793|20485358|P1|Overall Study|Lost to Follow-up|1
5920910|NCT01495702|20485371|P2|Randomized Phase|Protocol Violation|1
5920911|NCT01495702|20485372|P1|Randomized Phase|Protocol Violation|3
5920912|NCT01495702|20485371|P2|Randomized Phase|Participant Noncompliance|0
5920913|NCT01495702|20485372|P1|Randomized Phase|Participant Noncompliance|1
5920914|NCT01495702|20485371|P2|Randomized Phase|Lost to Follow-up|3
5920915|NCT01495702|20485372|P1|Randomized Phase|Lost to Follow-up|4
5920916|NCT01495702|20485371|P2|Randomized Phase|Withdrew Consent|18
5920917|NCT01495702|20485372|P1|Randomized Phase|Withdrew Consent|10
5920918|NCT01495702|20485371|P2|Randomized Phase|Investigators Discretion|0
5920919|NCT01495702|20485372|P1|Randomized Phase|Investigators Discretion|2
5920920|NCT01495702|20485371|P2|Randomized Phase|Lack of Efficacy|0
5920921|NCT01495702|20485372|P1|Randomized Phase|Lack of Efficacy|2
5920922|NCT01495702|20485371|P2|Randomized Phase|Death|0
5920923|NCT01495702|20485372|P1|Randomized Phase|Death|1
5920924|NCT01495702|20485371|P2|Randomized Phase|Adverse Event|2
5920925|NCT01495702|20485372|P1|Randomized Phase|Adverse Event|2
5920926|NCT01495702|20485371|P2|Randomized Phase|Randomized But Not Treated|4
5920927|NCT01495702|20485372|P1|Randomized Phase|Randomized But Not Treated|1
5920928|NCT01495000|20485450|P2|Overall Study|Withdrawal by Subject|10
5920929|NCT01495000|20485451|P1|Overall Study|Withdrawal by Subject|10
5920930|NCT01495000|20485450|P2|Overall Study|Protocol Violation|0
5920931|NCT01495000|20485451|P1|Overall Study|Protocol Violation|1
5920932|NCT01495000|20485450|P2|Overall Study|Lost to Follow-up|2
5920933|NCT01495000|20485451|P1|Overall Study|Lost to Follow-up|2
5920934|NCT01494987|20485493|P2|Overall Study|Subject Withdrew Consent|3
5920935|NCT01494987|20485494|P1|Overall Study|Subject Withdrew Consent|2
5920936|NCT01494987|20485493|P2|Overall Study|Subject Non-Compliance|10
5920937|NCT01494987|20485494|P1|Overall Study|Subject Non-Compliance|9
5920938|NCT01494987|20485493|P2|Overall Study|Protocol Violation|3
5920939|NCT01494987|20485494|P1|Overall Study|Protocol Violation|3
5920940|NCT01494987|20485493|P2|Overall Study|Lost to Follow-up|1
5920941|NCT01494987|20485494|P1|Overall Study|Lost to Follow-up|1
5920942|NCT01494987|20485493|P2|Overall Study|Investigator's Discretion|2
5920943|NCT01494987|20485494|P1|Overall Study|Investigator's Discretion|1
5920944|NCT01494987|20485493|P2|Overall Study|Hyperglycemia|4
5920945|NCT01494987|20485494|P1|Overall Study|Hyperglycemia|6
5920946|NCT01494987|20485493|P2|Overall Study|Adverse Event|5
5920947|NCT01494987|20485494|P1|Overall Study|Adverse Event|6
5920948|NCT01494818|20485508|P2|Overall Study|Lost to Follow-up|0
5920949|NCT01494818|20485509|P1|Overall Study|Lost to Follow-up|1
5920950|NCT01494818|20485508|P2|Overall Study|Relocation|2
5920951|NCT01494818|20485509|P1|Overall Study|Relocation|1
5920952|NCT01494649|20485540|P2|Overall Study|Lost to Follow-up|1
5920953|NCT01494649|20485541|P1|Overall Study|Lost to Follow-up|0
5920954|NCT01494610|20485557|P2|Period 4|Protocol Violation|0
5920955|NCT01494610|20485558|P1|Period 4|Protocol Violation|1
5920956|NCT01494610|20485557|P2|Period 3|Withdrawal by Subject|0
5920957|NCT01494610|20485558|P1|Period 3|Withdrawal by Subject|1
5920958|NCT01494610|20485557|P2|Period 3|Adverse Event|0
5920959|NCT01494610|20485558|P1|Period 3|Adverse Event|1
5920960|NCT01494610|20485557|P2|Period 1|Withdrawal by Subject|1
5920961|NCT01494610|20485558|P1|Period 1|Withdrawal by Subject|1
5920962|NCT01494584|20485626|P1|Overall Study|Study Closed/Terminated|1
5920963|NCT01494532|20485758|P6|Overall Study|Withdrawal by Subject|0
5920964|NCT01494532|20485759|P5|Overall Study|Withdrawal by Subject|2
5920965|NCT01494532|20485760|P4|Overall Study|Withdrawal by Subject|3
5920966|NCT01494532|20485761|P3|Overall Study|Withdrawal by Subject|4
5920967|NCT01494532|20485762|P2|Overall Study|Withdrawal by Subject|1
5920968|NCT01494532|20485763|P1|Overall Study|Withdrawal by Subject|3
5920969|NCT01494532|20485758|P6|Overall Study|Physician Decision|0
5920970|NCT01494532|20485759|P5|Overall Study|Physician Decision|0
5920971|NCT01494532|20485760|P4|Overall Study|Physician Decision|2
5920972|NCT01494532|20485761|P3|Overall Study|Physician Decision|1
5920973|NCT01494532|20485762|P2|Overall Study|Physician Decision|1
5920974|NCT01494532|20485763|P1|Overall Study|Physician Decision|0
5920975|NCT01494532|20485758|P6|Overall Study|Lost to Follow-up|0
5920976|NCT01494532|20485759|P5|Overall Study|Lost to Follow-up|0
5920977|NCT01494532|20485760|P4|Overall Study|Lost to Follow-up|2
5920978|NCT01494532|20485761|P3|Overall Study|Lost to Follow-up|0
5920979|NCT01494532|20485762|P2|Overall Study|Lost to Follow-up|0
5920980|NCT01494532|20485763|P1|Overall Study|Lost to Follow-up|1
5920981|NCT01494532|20485758|P6|Overall Study|Protocol-defined stopping criteria|0
5920982|NCT01494532|20485759|P5|Overall Study|Protocol-defined stopping criteria|0
5920983|NCT01494532|20485760|P4|Overall Study|Protocol-defined stopping criteria|0
5920984|NCT01494532|20485761|P3|Overall Study|Protocol-defined stopping criteria|1
5920985|NCT01494532|20485762|P2|Overall Study|Protocol-defined stopping criteria|0
5920986|NCT01494532|20485763|P1|Overall Study|Protocol-defined stopping criteria|0
5920987|NCT01494532|20485758|P6|Overall Study|Protocol deviation|0
5920988|NCT01494532|20485759|P5|Overall Study|Protocol deviation|3
5920989|NCT01494532|20485760|P4|Overall Study|Protocol deviation|2
5920990|NCT01494532|20485761|P3|Overall Study|Protocol deviation|3
5920991|NCT01494532|20485762|P2|Overall Study|Protocol deviation|1
5920992|NCT01494532|20485763|P1|Overall Study|Protocol deviation|2
5920993|NCT01494532|20485758|P6|Overall Study|Lack of Efficacy|0
5920994|NCT01494532|20485759|P5|Overall Study|Lack of Efficacy|2
5920995|NCT01494532|20485760|P4|Overall Study|Lack of Efficacy|0
5920996|NCT01494532|20485761|P3|Overall Study|Lack of Efficacy|0
5920997|NCT01494532|20485762|P2|Overall Study|Lack of Efficacy|0
5920998|NCT01494532|20485763|P1|Overall Study|Lack of Efficacy|0
5920999|NCT01494532|20485758|P6|Overall Study|Adverse Event|0
5921000|NCT01494532|20485759|P5|Overall Study|Adverse Event|5
5921001|NCT01494532|20485760|P4|Overall Study|Adverse Event|6
5921002|NCT01494532|20485761|P3|Overall Study|Adverse Event|8
5921003|NCT01494532|20485762|P2|Overall Study|Adverse Event|1
5921004|NCT01494532|20485763|P1|Overall Study|Adverse Event|4
5921005|NCT01494506|20485918|P3|Overall Study|Other|1
5921006|NCT01494506|20485919|P2|Overall Study|Other|3
5921007|NCT01494506|20485920|P1|Overall Study|Other|0
5921008|NCT01494506|20485918|P3|Overall Study|Sponsor Decision|1
5921009|NCT01494506|20485919|P2|Overall Study|Sponsor Decision|0
5921010|NCT01494506|20485920|P1|Overall Study|Sponsor Decision|0
5921011|NCT01494506|20485918|P3|Overall Study|Clinical Deterioration|13
5921012|NCT01494506|20485919|P2|Overall Study|Clinical Deterioration|17
5921013|NCT01494506|20485920|P1|Overall Study|Clinical Deterioration|21
5921014|NCT01494506|20485918|P3|Overall Study|Withdrawal by Subject|14
5921015|NCT01494506|20485919|P2|Overall Study|Withdrawal by Subject|20
5921016|NCT01494506|20485920|P1|Overall Study|Withdrawal by Subject|17
5921017|NCT01494506|20485918|P3|Overall Study|Physician Decision|4
5921018|NCT01494506|20485919|P2|Overall Study|Physician Decision|5
5921019|NCT01494506|20485920|P1|Overall Study|Physician Decision|7
5921020|NCT01494506|20485918|P3|Overall Study|Death|2
5921021|NCT01494506|20485919|P2|Overall Study|Death|5
5921022|NCT01494506|20485920|P1|Overall Study|Death|9
5921023|NCT01494506|20485918|P3|Overall Study|Adverse Event|11
5921024|NCT01494506|20485919|P2|Overall Study|Adverse Event|10
5921025|NCT01494506|20485920|P1|Overall Study|Adverse Event|17
5921026|NCT01494506|20485918|P3|Overall Study|Lack of Efficacy|57
5921027|NCT01494506|20485919|P2|Overall Study|Lack of Efficacy|83
5921028|NCT01494506|20485920|P1|Overall Study|Lack of Efficacy|77
5921057|NCT01494350|20485974|P1|Overall Study|Worsening of lesion|1
5921058|NCT01494298|20485984|P2|Overall Study|Protocol Violation|8
5921059|NCT01494298|20485985|P1|Overall Study|Protocol Violation|2
5921060|NCT01494038|20486008|P2|Overall Study|Death|4
5921061|NCT01494038|20486009|P1|Overall Study|Death|2
5921062|NCT01494038|20486008|P2|Overall Study|Not willing to adhere to reqs|9
5921063|NCT01494038|20486009|P1|Overall Study|Not willing to adhere to reqs|2
5921064|NCT01494038|20486008|P2|Overall Study|Not able to get to clinic|15
5921065|NCT01494038|20486009|P1|Overall Study|Not able to get to clinic|21
5921066|NCT01494038|20486008|P2|Overall Study|Withdrawal by Subject|34
5921067|NCT01494038|20486009|P1|Overall Study|Withdrawal by Subject|44
5921068|NCT01494038|20486008|P2|Overall Study|Lost to Follow-up|20
5921069|NCT01494038|20486009|P1|Overall Study|Lost to Follow-up|18
5921070|NCT01494038|20486008|P2|Overall Study|Protocol Violation|1
5921071|NCT01494038|20486009|P1|Overall Study|Protocol Violation|1
5921072|NCT01493960|20486097|P2|Overall Study|Non-specified|4
5921073|NCT01493960|20486098|P1|Overall Study|Non-specified|4
5921074|NCT01493960|20486097|P2|Overall Study|Withdrawal by Subject|4
5921075|NCT01493960|20486098|P1|Overall Study|Withdrawal by Subject|10
5921076|NCT01493960|20486097|P2|Overall Study|Protocol Violation|0
5921077|NCT01493960|20486098|P1|Overall Study|Protocol Violation|3
5921078|NCT01493960|20486097|P2|Overall Study|Lack of Efficacy|9
5921079|NCT01493960|20486098|P1|Overall Study|Lack of Efficacy|15
5921080|NCT01493960|20486097|P2|Overall Study|Adverse Event|1
5921081|NCT01493960|20486098|P1|Overall Study|Adverse Event|0
5921082|NCT01493778|20486129|P1|Overall Study|Withdrawal by Subject|8
5921113|NCT01493557|20486211|P3|Adding the Second Strategy|Withdrawal by Subject|0
5921114|NCT01493557|20486212|P2|Adding the Second Strategy|Withdrawal by Subject|1
5921115|NCT01493557|20486213|P1|Adding the Second Strategy|Withdrawal by Subject|0
5921116|NCT01493557|20486211|P3|Adding the Second Strategy|Other adverse event|0
5921117|NCT01493557|20486212|P2|Adding the Second Strategy|Other adverse event|2
5921118|NCT01493557|20486213|P1|Adding the Second Strategy|Other adverse event|1
5921119|NCT01493557|20486211|P3|Adding the Second Strategy|Worsening of events associate with GIS|0
5921120|NCT01493557|20486212|P2|Adding the Second Strategy|Worsening of events associate with GIS|1
5921121|NCT01493557|20486213|P1|Adding the Second Strategy|Worsening of events associate with GIS|1
5921122|NCT01493557|20486211|P3|Randomized to Management Strategies|Other than stated above|0
5921123|NCT01493557|20486212|P2|Randomized to Management Strategies|Other than stated above|3
5921124|NCT01493557|20486213|P1|Randomized to Management Strategies|Other than stated above|1
5921125|NCT01493557|20486211|P3|Randomized to Management Strategies|Withdrawal by Subject|0
5921126|NCT01493557|20486212|P2|Randomized to Management Strategies|Withdrawal by Subject|1
5921127|NCT01493557|20486213|P1|Randomized to Management Strategies|Withdrawal by Subject|0
5921128|NCT01493557|20486211|P3|Randomized to Management Strategies|Protocol Violation|0
5921129|NCT01493557|20486212|P2|Randomized to Management Strategies|Protocol Violation|0
5921130|NCT01493557|20486213|P1|Randomized to Management Strategies|Protocol Violation|3
5921131|NCT01493557|20486211|P3|Randomized to Management Strategies|Other adverse event|0
5921132|NCT01493557|20486212|P2|Randomized to Management Strategies|Other adverse event|5
5921133|NCT01493557|20486213|P1|Randomized to Management Strategies|Other adverse event|8
5921134|NCT01493557|20486211|P3|Randomized to Management Strategies|Worsening of events associate with GIS|0
5921135|NCT01493557|20486212|P2|Randomized to Management Strategies|Worsening of events associate with GIS|2
5921136|NCT01493557|20486213|P1|Randomized to Management Strategies|Worsening of events associate with GIS|3
5921137|NCT01493557|20486211|P3|Not Randomized to Management Strategies|Other than stated above|21
5921138|NCT01493557|20486212|P2|Not Randomized to Management Strategies|Other than stated above|0
5921139|NCT01493557|20486213|P1|Not Randomized to Management Strategies|Other than stated above|0
5921140|NCT01493557|20486211|P3|Not Randomized to Management Strategies|Early termination|34
5921141|NCT01493557|20486212|P2|Not Randomized to Management Strategies|Early termination|0
5921142|NCT01493557|20486213|P1|Not Randomized to Management Strategies|Early termination|0
5921143|NCT01493557|20486211|P3|Not Randomized to Management Strategies|Withdrawal by Subject|10
5921144|NCT01493557|20486212|P2|Not Randomized to Management Strategies|Withdrawal by Subject|0
5921145|NCT01493557|20486213|P1|Not Randomized to Management Strategies|Withdrawal by Subject|0
5921146|NCT01493557|20486211|P3|Not Randomized to Management Strategies|Lost to Follow-up|4
5921147|NCT01493557|20486212|P2|Not Randomized to Management Strategies|Lost to Follow-up|0
5921148|NCT01493557|20486213|P1|Not Randomized to Management Strategies|Lost to Follow-up|0
5921149|NCT01493557|20486211|P3|Not Randomized to Management Strategies|Protocol Violation|1
5921150|NCT01493557|20486212|P2|Not Randomized to Management Strategies|Protocol Violation|0
5921151|NCT01493557|20486213|P1|Not Randomized to Management Strategies|Protocol Violation|0
5921152|NCT01493557|20486211|P3|Not Randomized to Management Strategies|Other adverse event|54
5921153|NCT01493557|20486212|P2|Not Randomized to Management Strategies|Other adverse event|0
5921154|NCT01493557|20486213|P1|Not Randomized to Management Strategies|Other adverse event|0
5921155|NCT01493557|20486211|P3|Not Randomized to Management Strategies|Worsening of other pre-existing disease|9
5921156|NCT01493557|20486212|P2|Not Randomized to Management Strategies|Worsening of other pre-existing disease|0
5921157|NCT01493557|20486213|P1|Not Randomized to Management Strategies|Worsening of other pre-existing disease|0
5921158|NCT01493557|20486211|P3|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|1
5921159|NCT01493557|20486212|P2|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0
5921160|NCT01493557|20486213|P1|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0
5921161|NCT01493531|20486241|P3|Overall Study|Death|0
5921162|NCT01493531|20486242|P2|Overall Study|Death|1
5921163|NCT01493531|20486243|P1|Overall Study|Death|0
5921164|NCT01493531|20486241|P3|Overall Study|Withdrawal by Subject|11
5921165|NCT01493531|20486242|P2|Overall Study|Withdrawal by Subject|13
5921166|NCT01493531|20486243|P1|Overall Study|Withdrawal by Subject|16
5921167|NCT01493531|20486241|P3|Overall Study|Lost to Follow-up|11
5921168|NCT01493531|20486242|P2|Overall Study|Lost to Follow-up|7
5921169|NCT01493531|20486243|P1|Overall Study|Lost to Follow-up|5
5921170|NCT01493531|20486241|P3|Overall Study|Sponsor terminated study|3
5921171|NCT01493531|20486242|P2|Overall Study|Sponsor terminated study|2
5921172|NCT01493531|20486243|P1|Overall Study|Sponsor terminated study|5
5921173|NCT01493531|20486241|P3|Overall Study|Protocol Violation|12
5921174|NCT01493531|20486242|P2|Overall Study|Protocol Violation|15
5921175|NCT01493531|20486243|P1|Overall Study|Protocol Violation|8
5921176|NCT01493531|20486241|P3|Overall Study|Gout flare|2
5921177|NCT01493531|20486242|P2|Overall Study|Gout flare|0
5921178|NCT01493531|20486243|P1|Overall Study|Gout flare|3
5921179|NCT01493531|20486241|P3|Overall Study|Adverse Event|9
5921180|NCT01493531|20486242|P2|Overall Study|Adverse Event|12
5921181|NCT01493531|20486243|P1|Overall Study|Adverse Event|4
5921182|NCT01493427|20486257|P1|Overall Study|Other|2
5921183|NCT01493427|20486257|P1|Overall Study|Inability to Follow Instructions|2
5921184|NCT01493427|20486257|P1|Overall Study|Lost to Follow-up|2
5921185|NCT01493427|20486257|P1|Overall Study|Personal Reasons|4
5921186|NCT01493427|20486257|P1|Overall Study|Adverse Event|10
5921187|NCT01493414|20486262|P1|Overall Study|Lost to Follow-up|16
5921188|NCT01493414|20486262|P1|Overall Study|Administrative problems|25
5921189|NCT01493414|20486262|P1|Overall Study|Protocol deviation|27
5921190|NCT01493414|20486262|P1|Overall Study|Withdrawal by Subject|79
5921191|NCT01493414|20486262|P1|Overall Study|Physician Decision|93
5921192|NCT01493414|20486262|P1|Overall Study|Death|101
5921193|NCT01493414|20486262|P1|Overall Study|Disease progression|204
5921194|NCT01493414|20486262|P1|Overall Study|Adverse Event|405
5921195|NCT01493284|20486275|P1|Overall Study|Withdrawal by Subject|32
5921196|NCT01493284|20486275|P1|Overall Study|Death|29
5921197|NCT01493089|20486297|P2|Overall Study|Physician Decision|1
5921198|NCT01493089|20486298|P1|Overall Study|Physician Decision|0
5921199|NCT01493089|20486297|P2|Overall Study|Withdrawal by Subject|0
5921200|NCT01493089|20486298|P1|Overall Study|Withdrawal by Subject|1
5921201|NCT01493089|20486297|P2|Overall Study|Protocol Violation|2
5921202|NCT01493089|20486298|P1|Overall Study|Protocol Violation|2
5921203|NCT01492686|20486397|P2|Open-label Phase|Due to a discontinuation criterion|9
5921204|NCT01492686|20486398|P1|Open-label Phase|Due to a discontinuation criterion|4
5921205|NCT01492686|20486397|P2|Open-label Phase|Withdrawal by Subject|7
5921206|NCT01492686|20486398|P1|Open-label Phase|Withdrawal by Subject|6
5921207|NCT01492686|20486397|P2|Open-label Phase|Physician Decision|0
5921208|NCT01492686|20486398|P1|Open-label Phase|Physician Decision|1
5921209|NCT01492686|20486397|P2|Open-label Phase|Adverse Event|2
5921210|NCT01492686|20486398|P1|Open-label Phase|Adverse Event|1
5921211|NCT01492686|20486397|P2|Double-blind Phase|Due to a discontinuation criterion|3
5921212|NCT01492686|20486398|P1|Double-blind Phase|Due to a discontinuation criterion|2
5921213|NCT01492686|20486397|P2|Double-blind Phase|Withdrawal by Subject|2
5921214|NCT01492686|20486398|P1|Double-blind Phase|Withdrawal by Subject|0
5921215|NCT01492686|20486397|P2|Double-blind Phase|Physician Decision|1
5921216|NCT01492686|20486398|P1|Double-blind Phase|Physician Decision|0
5921217|NCT01492686|20486397|P2|Double-blind Phase|Adverse Event|2
5921218|NCT01492686|20486398|P1|Double-blind Phase|Adverse Event|0
5921219|NCT01492439|20486455|P2|Overall Study|Withdrew from RTE|9
5921220|NCT01492439|20486456|P1|Overall Study|Withdrew from RTE|4
5921221|NCT01492426|20486504|P2|Follow-Up|Lost to Follow-up|6
5921222|NCT01492426|20486505|P1|Follow-Up|Lost to Follow-up|12
5921223|NCT01492426|20486504|P2|Follow-Up|Participant Withdrew Consent|1
5921224|NCT01492426|20486505|P1|Follow-Up|Participant Withdrew Consent|6
5921225|NCT01492426|20486504|P2|Follow-Up|Other|2
5921226|NCT01492426|20486505|P1|Follow-Up|Other|4
5921227|NCT01492426|20486504|P2|Follow-Up|Death|0
5921228|NCT01492426|20486505|P1|Follow-Up|Death|1
5921229|NCT01492426|20486504|P2|Follow-Up|Protocol Requires no Follow-Up|1
5921230|NCT01492426|20486505|P1|Follow-Up|Protocol Requires no Follow-Up|2
5921231|NCT01492426|20486504|P2|Treatment|Participant does not meet study criteria|0
5921232|NCT01492426|20486505|P1|Treatment|Participant does not meet study criteria|1
5921233|NCT01492426|20486504|P2|Treatment|Lost to Follow-up|4
5921234|NCT01492426|20486505|P1|Treatment|Lost to Follow-up|9
5921235|NCT01492426|20486504|P2|Treatment|Subject requested discontinue study drug|3
5921236|NCT01492426|20486505|P1|Treatment|Subject requested discontinue study drug|7
5921237|NCT01492426|20486504|P2|Treatment|Poor compliance/noncompliance|0
5921238|NCT01492426|20486505|P1|Treatment|Poor compliance/noncompliance|1
5921239|NCT01492426|20486504|P2|Treatment|Participant withdrew consent|2
5921240|NCT01492426|20486505|P1|Treatment|Participant withdrew consent|1
5921241|NCT01492426|20486504|P2|Treatment|Lack of Efficacy|5
5921242|NCT01492426|20486505|P1|Treatment|Lack of Efficacy|38
5921243|NCT01492426|20486504|P2|Treatment|Adverse Event|25
5921244|NCT01492426|20486505|P1|Treatment|Adverse Event|25
5921245|NCT01492426|20486504|P2|Treatment|Other|0
5921246|NCT01492426|20486505|P1|Treatment|Other|1
5921247|NCT01492426|20486504|P2|Treatment|Death|1
5921248|NCT01492426|20486505|P1|Treatment|Death|0
5921249|NCT01492400|20486523|P2|Overall Study|Adverse Event|5
5921250|NCT01492400|20486524|P1|Overall Study|Adverse Event|10
5921251|NCT01492400|20486523|P2|Overall Study|Lack of Efficacy|1
5921252|NCT01492400|20486524|P1|Overall Study|Lack of Efficacy|1
5921253|NCT01492400|20486523|P2|Overall Study|Pregnancy|1
5921254|NCT01492400|20486524|P1|Overall Study|Pregnancy|0
5921255|NCT01492400|20486523|P2|Overall Study|Lost to Follow-up|1
5921256|NCT01492400|20486524|P1|Overall Study|Lost to Follow-up|3
5921257|NCT01492400|20486523|P2|Overall Study|Personal Reasons|5
5921258|NCT01492400|20486524|P1|Overall Study|Personal Reasons|0
5921259|NCT01492400|20486523|P2|Overall Study|Miscellaneous Reasons|3
5921260|NCT01492400|20486524|P1|Overall Study|Miscellaneous Reasons|2
5921261|NCT01492088|20486548|P3|Overall Study|Alive at Last Follow-up|11
5921262|NCT01492088|20486549|P2|Overall Study|Alive at Last Follow-up|6
5921263|NCT01492088|20486550|P1|Overall Study|Alive at Last Follow-up|0
5921264|NCT01492088|20486548|P3|Overall Study|Completed Post Treatment Followup (PTFU)|1
5921265|NCT01492088|20486549|P2|Overall Study|Completed Post Treatment Followup (PTFU)|0
5921266|NCT01492088|20486550|P1|Overall Study|Completed Post Treatment Followup (PTFU)|2
5921267|NCT01492088|20486548|P3|Overall Study|Death|2
5921268|NCT01492088|20486549|P2|Overall Study|Death|6
5921269|NCT01492088|20486550|P1|Overall Study|Death|1
5921270|NCT01492088|20486548|P3|Overall Study|Withdrawal by Patient|0
5921271|NCT01492088|20486549|P2|Overall Study|Withdrawal by Patient|2
5921272|NCT01492088|20486550|P1|Overall Study|Withdrawal by Patient|0
5921273|NCT01491919|20486631|P3|Overall Study|Insufficient PK sampling|1
5921274|NCT01491919|20486632|P2|Overall Study|Insufficient PK sampling|2
5921275|NCT01491919|20486633|P1|Overall Study|Insufficient PK sampling|1
5921276|NCT01491854|20486704|P1|Overall Study|Lost to Follow-up|33
5921277|NCT01491854|20486704|P1|Overall Study|Withdrawal by Subject|3
5921278|NCT01491854|20486704|P1|Overall Study|Death|1
5921279|NCT01491854|20486704|P1|Overall Study|mainly due to premature termination|93
5921280|NCT01491841|20486715|P1|Overall Study|Withdrawal by Subject|1
5921281|NCT01491841|20486715|P1|Overall Study|Screen Failure|10
5921282|NCT01491802|20486729|P2|Overall Study|Withdrawal by Subject|1
5921283|NCT01491802|20486730|P1|Overall Study|Withdrawal by Subject|0
5921284|NCT01491802|20486729|P2|Overall Study|Adverse Event|1
5921285|NCT01491802|20486730|P1|Overall Study|Adverse Event|1
5921286|NCT01491737|20486757|P2|Overall Study|Reason Not Specified|9
5921287|NCT01491737|20486758|P1|Overall Study|Reason Not Specified|8
5921288|NCT01491737|20486757|P2|Overall Study|Study Termination by Sponsor|36
5921289|NCT01491737|20486758|P1|Overall Study|Study Termination by Sponsor|36
5921290|NCT01491737|20486757|P2|Overall Study|Death|57
5921291|NCT01491737|20486758|P1|Overall Study|Death|63
5921292|NCT01491737|20486757|P2|Overall Study|Lost to Follow-up|10
5921293|NCT01491737|20486758|P1|Overall Study|Lost to Follow-up|2
5921294|NCT01491737|20486757|P2|Overall Study|Withdrawal by Subject|17
5921295|NCT01491737|20486758|P1|Overall Study|Withdrawal by Subject|20
5921296|NCT01491672|20486785|P3|Overall Study|Death|0
5921297|NCT01491672|20486786|P2|Overall Study|Death|4
5921298|NCT01491672|20486787|P1|Overall Study|Death|0
5921299|NCT01491672|20486785|P3|Overall Study|Protocol deviation|0
5921300|NCT01491672|20486786|P2|Overall Study|Protocol deviation|1
5921301|NCT01491672|20486787|P1|Overall Study|Protocol deviation|0
5921302|NCT01491672|20486785|P3|Overall Study|Disease progression|6
5921303|NCT01491672|20486786|P2|Overall Study|Disease progression|34
5921304|NCT01491672|20486787|P1|Overall Study|Disease progression|42
5921305|NCT01491672|20486785|P3|Overall Study|Adverse Event|4
5921306|NCT01491672|20486786|P2|Overall Study|Adverse Event|10
5921307|NCT01491672|20486787|P1|Overall Study|Adverse Event|8
5921308|NCT01491672|20486785|P3|Overall Study|Withdrawal by Subject|0
5921309|NCT01491672|20486786|P2|Overall Study|Withdrawal by Subject|7
5921310|NCT01491672|20486787|P1|Overall Study|Withdrawal by Subject|6
5921311|NCT01491672|20486785|P3|Overall Study|Lost to Follow-up|1
5921312|NCT01491672|20486786|P2|Overall Study|Lost to Follow-up|4
5921313|NCT01491672|20486787|P1|Overall Study|Lost to Follow-up|0
5921314|NCT01491607|20486824|P1|Overall Study|Withdrawal by Subject|3
5921315|NCT01491607|20486824|P1|Overall Study|Lost to Follow-up|7
5921316|NCT01491178|20486929|P1|Overall Study|Other than specified above|657
5921317|NCT01491178|20486929|P1|Overall Study|To take a contraindication|20
5921318|NCT01491178|20486929|P1|Overall Study|Lost to follow-up (changing hospital)|545
5921319|NCT01491178|20486929|P1|Overall Study|Lost to follow-up (unknown reason)|287
5921320|NCT01491178|20486929|P1|Overall Study|To conduct invasive treatment|59
5921321|NCT01491178|20486929|P1|Overall Study|Improvement of NVAF|210
5921322|NCT01491178|20486929|P1|Overall Study|Adverse Event|1016
5921323|NCT01491035|20487038|P8|Overall Study|Lost to Follow-up|0
5921324|NCT01491035|20487039|P7|Overall Study|Lost to Follow-up|0
5921325|NCT01491035|20487040|P6|Overall Study|Lost to Follow-up|0
5921326|NCT01491035|20487041|P5|Overall Study|Lost to Follow-up|1
5921327|NCT01491035|20487042|P4|Overall Study|Lost to Follow-up|0
5921328|NCT01491035|20487043|P3|Overall Study|Lost to Follow-up|0
5921329|NCT01491035|20487044|P2|Overall Study|Lost to Follow-up|0
5921330|NCT01491035|20487045|P1|Overall Study|Lost to Follow-up|0
5921331|NCT01490918|20487149|P3|Overall Study|other cause|8
5921332|NCT01490918|20487150|P2|Overall Study|other cause|5
5921333|NCT01490918|20487151|P1|Overall Study|other cause|4
5921334|NCT01490918|20487149|P3|Overall Study|Adverse Event|1
5921335|NCT01490918|20487150|P2|Overall Study|Adverse Event|0
5921336|NCT01490918|20487151|P1|Overall Study|Adverse Event|0
5921337|NCT01490918|20487149|P3|Overall Study|Withdrawal by Subject|3
5921338|NCT01490918|20487150|P2|Overall Study|Withdrawal by Subject|8
5921339|NCT01490918|20487151|P1|Overall Study|Withdrawal by Subject|7
5921340|NCT01490918|20487149|P3|Overall Study|Lost to Follow-up|0
5921341|NCT01490918|20487150|P2|Overall Study|Lost to Follow-up|1
5921342|NCT01490918|20487151|P1|Overall Study|Lost to Follow-up|2
5921343|NCT01490866|20487189|P1|Axitinib Maintenance Therapy|Intercurrent illness|2
5921344|NCT01490866|20487189|P1|Axitinib Maintenance Therapy|Protocol Violation|2
5921345|NCT01490866|20487189|P1|Axitinib Maintenance Therapy|Withdrawal by Subject|3
5921346|NCT01490866|20487189|P1|Axitinib Maintenance Therapy|Adverse Event|12
5921347|NCT01490866|20487189|P1|Axitinib Maintenance Therapy|Disease Progression|30
5921348|NCT01490866|20487189|P1|FOLFOX/Bevacizumab Treatment|Physician Decision|2
5921349|NCT01490866|20487189|P1|FOLFOX/Bevacizumab Treatment|Intercurrent illness|1
5921350|NCT01490866|20487189|P1|FOLFOX/Bevacizumab Treatment|Protocol Violation|1
5921351|NCT01490866|20487189|P1|FOLFOX/Bevacizumab Treatment|Withdrawal by Subject|5
5921352|NCT01490866|20487189|P1|FOLFOX/Bevacizumab Treatment|Adverse Event|6
5921353|NCT01490866|20487189|P1|FOLFOX/Bevacizumab Treatment|Disease Progression|6
5921354|NCT01490840|20487200|P2|Phase 2|Adverse Event|1
5921355|NCT01490840|20487201|P1|Phase 2|Adverse Event|1
5921356|NCT01490840|20487200|P2|Phase 2|Lost to Follow-up|1
5921357|NCT01490840|20487201|P1|Phase 2|Lost to Follow-up|1
5921358|NCT01490840|20487200|P2|Phase 2|Permanent interruption of fingolimod|1
5921359|NCT01490840|20487201|P1|Phase 2|Permanent interruption of fingolimod|0
5921360|NCT01490840|20487200|P2|Phase 2|Withdrawal by Subject|3
5921361|NCT01490840|20487201|P1|Phase 2|Withdrawal by Subject|4
5921362|NCT01490840|20487200|P2|Phase 1|Visit 6a omitted|0
5921363|NCT01490840|20487201|P1|Phase 1|Visit 6a omitted|1
5921364|NCT01490840|20487200|P2|Phase 1|Withdrawal by Subject|5
5921365|NCT01490840|20487201|P1|Phase 1|Withdrawal by Subject|6
5921366|NCT01490840|20487200|P2|Phase 1|Adverse Event|1
5921367|NCT01490840|20487201|P1|Phase 1|Adverse Event|2
5921368|NCT01490840|20487200|P2|Phase 1|Lost to Follow-up|0
5921369|NCT01490840|20487201|P1|Phase 1|Lost to Follow-up|1
5921370|NCT01490814|20487225|P2|Overall Study|Withdrawal by Subject|5
5921371|NCT01490814|20487226|P1|Overall Study|Withdrawal by Subject|0
5921372|NCT01490814|20487225|P2|Overall Study|Physician Decision|0
5921373|NCT01490814|20487226|P1|Overall Study|Physician Decision|1
5921374|NCT01490814|20487225|P2|Overall Study|Inclusion/Exclusion Criteria Violation|3
5921375|NCT01490814|20487226|P1|Overall Study|Inclusion/Exclusion Criteria Violation|3
5921376|NCT01490697|20487269|P2|Overall Study|Did Not Meet PTSD Diagnostic Criteria|2
5921377|NCT01490697|20487270|P1|Overall Study|Did Not Meet PTSD Diagnostic Criteria|1
5921378|NCT01490632|20487290|P20|Part D: Re-Treatment Period|Withdrawal by Subject|1
5921379|NCT01490632|20487291|P19|Part D: Re-Treatment Period|Withdrawal by Subject|1
5921380|NCT01490632|20487292|P18|Part D: Re-Treatment Period|Withdrawal by Subject|1
5921381|NCT01490632|20487293|P17|Part D: Re-Treatment Period|Withdrawal by Subject|0
5921382|NCT01490632|20487294|P16|Part D: Re-Treatment Period|Withdrawal by Subject|0
5921383|NCT01490632|20487295|P15|Part D: Re-Treatment Period|Withdrawal by Subject|0
5921384|NCT01490632|20487296|P14|Part D: Re-Treatment Period|Withdrawal by Subject|0
5921385|NCT01490632|20487297|P13|Part D: Re-Treatment Period|Withdrawal by Subject|0
5921386|NCT01490632|20487298|P12|Part D: Re-Treatment Period|Withdrawal by Subject|0
5921387|NCT01490632|20487299|P11|Part D: Re-Treatment Period|Withdrawal by Subject|0
5921388|NCT01490632|20487300|P10|Part D: Re-Treatment Period|Withdrawal by Subject|0
5921389|NCT01490632|20487301|P9|Part D: Re-Treatment Period|Withdrawal by Subject|0
5921390|NCT01490632|20487302|P8|Part D: Re-Treatment Period|Withdrawal by Subject|0
5921391|NCT01490632|20487303|P7|Part D: Re-Treatment Period|Withdrawal by Subject|0
5921392|NCT01490632|20487304|P6|Part D: Re-Treatment Period|Withdrawal by Subject|0
5921393|NCT01490632|20487305|P5|Part D: Re-Treatment Period|Withdrawal by Subject|0
5921394|NCT01490632|20487306|P4|Part D: Re-Treatment Period|Withdrawal by Subject|0
5921395|NCT01490632|20487307|P3|Part D: Re-Treatment Period|Withdrawal by Subject|0
5921396|NCT01490632|20487308|P2|Part D: Re-Treatment Period|Withdrawal by Subject|0
5921397|NCT01490632|20487309|P1|Part D: Re-Treatment Period|Withdrawal by Subject|0
5921398|NCT01490632|20487290|P20|Part D: Re-Treatment Period|Protocol Violation|0
5921399|NCT01490632|20487291|P19|Part D: Re-Treatment Period|Protocol Violation|1
5921400|NCT01490632|20487292|P18|Part D: Re-Treatment Period|Protocol Violation|0
5921401|NCT01490632|20487293|P17|Part D: Re-Treatment Period|Protocol Violation|0
5921402|NCT01490632|20487294|P16|Part D: Re-Treatment Period|Protocol Violation|0
5921403|NCT01490632|20487295|P15|Part D: Re-Treatment Period|Protocol Violation|0
5921404|NCT01490632|20487296|P14|Part D: Re-Treatment Period|Protocol Violation|0
5921405|NCT01490632|20487297|P13|Part D: Re-Treatment Period|Protocol Violation|0
5921406|NCT01490632|20487298|P12|Part D: Re-Treatment Period|Protocol Violation|0
5921407|NCT01490632|20487299|P11|Part D: Re-Treatment Period|Protocol Violation|0
5921408|NCT01490632|20487300|P10|Part D: Re-Treatment Period|Protocol Violation|0
5921409|NCT01490632|20487301|P9|Part D: Re-Treatment Period|Protocol Violation|0
5921410|NCT01490632|20487302|P8|Part D: Re-Treatment Period|Protocol Violation|0
5921411|NCT01490632|20487303|P7|Part D: Re-Treatment Period|Protocol Violation|0
5921412|NCT01490632|20487304|P6|Part D: Re-Treatment Period|Protocol Violation|0
5921413|NCT01490632|20487305|P5|Part D: Re-Treatment Period|Protocol Violation|0
5921414|NCT01490632|20487306|P4|Part D: Re-Treatment Period|Protocol Violation|0
5921415|NCT01490632|20487307|P3|Part D: Re-Treatment Period|Protocol Violation|0
5921416|NCT01490632|20487308|P2|Part D: Re-Treatment Period|Protocol Violation|0
5921417|NCT01490632|20487309|P1|Part D: Re-Treatment Period|Protocol Violation|0
5921418|NCT01490632|20487290|P20|Part D: Re-Treatment Period|Physician Decision|1
5921419|NCT01490632|20487291|P19|Part D: Re-Treatment Period|Physician Decision|1
5921420|NCT01490632|20487292|P18|Part D: Re-Treatment Period|Physician Decision|0
5921421|NCT01490632|20487293|P17|Part D: Re-Treatment Period|Physician Decision|0
5921422|NCT01490632|20487294|P16|Part D: Re-Treatment Period|Physician Decision|0
5921423|NCT01490632|20487295|P15|Part D: Re-Treatment Period|Physician Decision|0
5921424|NCT01490632|20487296|P14|Part D: Re-Treatment Period|Physician Decision|0
5921425|NCT01490632|20487297|P13|Part D: Re-Treatment Period|Physician Decision|0
5921426|NCT01490632|20487298|P12|Part D: Re-Treatment Period|Physician Decision|0
5921427|NCT01490632|20487299|P11|Part D: Re-Treatment Period|Physician Decision|0
5921428|NCT01490632|20487300|P10|Part D: Re-Treatment Period|Physician Decision|0
5921429|NCT01490632|20487301|P9|Part D: Re-Treatment Period|Physician Decision|0
5921430|NCT01490632|20487302|P8|Part D: Re-Treatment Period|Physician Decision|0
5921431|NCT01490632|20487303|P7|Part D: Re-Treatment Period|Physician Decision|0
5921432|NCT01490632|20487304|P6|Part D: Re-Treatment Period|Physician Decision|0
5921433|NCT01490632|20487305|P5|Part D: Re-Treatment Period|Physician Decision|0
5921434|NCT01490632|20487306|P4|Part D: Re-Treatment Period|Physician Decision|0
5921435|NCT01490632|20487307|P3|Part D: Re-Treatment Period|Physician Decision|0
5921436|NCT01490632|20487308|P2|Part D: Re-Treatment Period|Physician Decision|0
5921437|NCT01490632|20487309|P1|Part D: Re-Treatment Period|Physician Decision|0
5921438|NCT01490632|20487290|P20|Part D: Re-Treatment Period|Lost to Follow-up|0
5921439|NCT01490632|20487291|P19|Part D: Re-Treatment Period|Lost to Follow-up|1
5921440|NCT01490632|20487292|P18|Part D: Re-Treatment Period|Lost to Follow-up|0
5921441|NCT01490632|20487293|P17|Part D: Re-Treatment Period|Lost to Follow-up|0
5921442|NCT01490632|20487294|P16|Part D: Re-Treatment Period|Lost to Follow-up|0
5921443|NCT01490632|20487295|P15|Part D: Re-Treatment Period|Lost to Follow-up|0
5921444|NCT01490632|20487296|P14|Part D: Re-Treatment Period|Lost to Follow-up|0
5921445|NCT01490632|20487297|P13|Part D: Re-Treatment Period|Lost to Follow-up|0
5921446|NCT01490632|20487298|P12|Part D: Re-Treatment Period|Lost to Follow-up|0
5921447|NCT01490632|20487299|P11|Part D: Re-Treatment Period|Lost to Follow-up|0
5921448|NCT01490632|20487300|P10|Part D: Re-Treatment Period|Lost to Follow-up|0
5921449|NCT01490632|20487301|P9|Part D: Re-Treatment Period|Lost to Follow-up|0
5921450|NCT01490632|20487302|P8|Part D: Re-Treatment Period|Lost to Follow-up|0
5921451|NCT01490632|20487303|P7|Part D: Re-Treatment Period|Lost to Follow-up|0
5921452|NCT01490632|20487304|P6|Part D: Re-Treatment Period|Lost to Follow-up|0
5921453|NCT01490632|20487305|P5|Part D: Re-Treatment Period|Lost to Follow-up|0
5921454|NCT01490632|20487306|P4|Part D: Re-Treatment Period|Lost to Follow-up|0
5921455|NCT01490632|20487307|P3|Part D: Re-Treatment Period|Lost to Follow-up|0
5921456|NCT01490632|20487308|P2|Part D: Re-Treatment Period|Lost to Follow-up|0
5921457|NCT01490632|20487309|P1|Part D: Re-Treatment Period|Lost to Follow-up|0
5921458|NCT01490632|20487290|P20|Part D: Re-Treatment Period|Lack of Efficacy|2
5921459|NCT01490632|20487291|P19|Part D: Re-Treatment Period|Lack of Efficacy|1
5921460|NCT01490632|20487292|P18|Part D: Re-Treatment Period|Lack of Efficacy|3
5921461|NCT01490632|20487293|P17|Part D: Re-Treatment Period|Lack of Efficacy|0
5921462|NCT01490632|20487294|P16|Part D: Re-Treatment Period|Lack of Efficacy|0
5921463|NCT01490632|20487295|P15|Part D: Re-Treatment Period|Lack of Efficacy|0
5921464|NCT01490632|20487296|P14|Part D: Re-Treatment Period|Lack of Efficacy|0
5921465|NCT01490632|20487297|P13|Part D: Re-Treatment Period|Lack of Efficacy|0
5921466|NCT01490632|20487298|P12|Part D: Re-Treatment Period|Lack of Efficacy|0
5921467|NCT01490632|20487299|P11|Part D: Re-Treatment Period|Lack of Efficacy|0
5921468|NCT01490632|20487300|P10|Part D: Re-Treatment Period|Lack of Efficacy|0
5921469|NCT01490632|20487301|P9|Part D: Re-Treatment Period|Lack of Efficacy|0
5921470|NCT01490632|20487302|P8|Part D: Re-Treatment Period|Lack of Efficacy|0
5921471|NCT01490632|20487303|P7|Part D: Re-Treatment Period|Lack of Efficacy|0
5921472|NCT01490632|20487304|P6|Part D: Re-Treatment Period|Lack of Efficacy|0
5921473|NCT01490632|20487305|P5|Part D: Re-Treatment Period|Lack of Efficacy|0
5921474|NCT01490632|20487306|P4|Part D: Re-Treatment Period|Lack of Efficacy|0
5921475|NCT01490632|20487307|P3|Part D: Re-Treatment Period|Lack of Efficacy|0
5921476|NCT01490632|20487308|P2|Part D: Re-Treatment Period|Lack of Efficacy|0
5921477|NCT01490632|20487309|P1|Part D: Re-Treatment Period|Lack of Efficacy|0
5921478|NCT01490632|20487290|P20|Part D: Re-Treatment Period|Death|0
5921479|NCT01490632|20487291|P19|Part D: Re-Treatment Period|Death|1
5921480|NCT01490632|20487292|P18|Part D: Re-Treatment Period|Death|0
5921481|NCT01490632|20487293|P17|Part D: Re-Treatment Period|Death|0
5921482|NCT01490632|20487294|P16|Part D: Re-Treatment Period|Death|0
5921483|NCT01490632|20487295|P15|Part D: Re-Treatment Period|Death|0
5921484|NCT01490632|20487296|P14|Part D: Re-Treatment Period|Death|0
5921485|NCT01490632|20487297|P13|Part D: Re-Treatment Period|Death|0
5921486|NCT01490632|20487298|P12|Part D: Re-Treatment Period|Death|0
5921487|NCT01490632|20487299|P11|Part D: Re-Treatment Period|Death|0
5921488|NCT01490632|20487300|P10|Part D: Re-Treatment Period|Death|0
5921489|NCT01490632|20487301|P9|Part D: Re-Treatment Period|Death|0
5921490|NCT01490632|20487302|P8|Part D: Re-Treatment Period|Death|0
5921491|NCT01490632|20487303|P7|Part D: Re-Treatment Period|Death|0
5921492|NCT01490632|20487304|P6|Part D: Re-Treatment Period|Death|0
5921493|NCT01490632|20487305|P5|Part D: Re-Treatment Period|Death|0
5921494|NCT01490632|20487306|P4|Part D: Re-Treatment Period|Death|0
5921495|NCT01490632|20487307|P3|Part D: Re-Treatment Period|Death|0
5921496|NCT01490632|20487308|P2|Part D: Re-Treatment Period|Death|0
5921497|NCT01490632|20487309|P1|Part D: Re-Treatment Period|Death|0
5921498|NCT01490632|20487290|P20|Part D: Re-Treatment Period|Adverse Event|3
5921499|NCT01490632|20487291|P19|Part D: Re-Treatment Period|Adverse Event|1
5921500|NCT01490632|20487292|P18|Part D: Re-Treatment Period|Adverse Event|1
5921501|NCT01490632|20487293|P17|Part D: Re-Treatment Period|Adverse Event|0
5921502|NCT01490632|20487294|P16|Part D: Re-Treatment Period|Adverse Event|0
5921503|NCT01490632|20487295|P15|Part D: Re-Treatment Period|Adverse Event|0
5921504|NCT01490632|20487296|P14|Part D: Re-Treatment Period|Adverse Event|0
5921505|NCT01490632|20487297|P13|Part D: Re-Treatment Period|Adverse Event|0
5921506|NCT01490632|20487298|P12|Part D: Re-Treatment Period|Adverse Event|0
5921507|NCT01490632|20487299|P11|Part D: Re-Treatment Period|Adverse Event|0
5921508|NCT01490632|20487300|P10|Part D: Re-Treatment Period|Adverse Event|0
5921509|NCT01490632|20487301|P9|Part D: Re-Treatment Period|Adverse Event|0
5921510|NCT01490632|20487302|P8|Part D: Re-Treatment Period|Adverse Event|0
5921511|NCT01490632|20487303|P7|Part D: Re-Treatment Period|Adverse Event|0
5921512|NCT01490632|20487304|P6|Part D: Re-Treatment Period|Adverse Event|0
5921513|NCT01490632|20487305|P5|Part D: Re-Treatment Period|Adverse Event|0
5921514|NCT01490632|20487306|P4|Part D: Re-Treatment Period|Adverse Event|0
5921515|NCT01490632|20487307|P3|Part D: Re-Treatment Period|Adverse Event|0
5921516|NCT01490632|20487308|P2|Part D: Re-Treatment Period|Adverse Event|0
5921517|NCT01490632|20487309|P1|Part D: Re-Treatment Period|Adverse Event|0
5921518|NCT01490632|20487290|P20|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
5921519|NCT01490632|20487291|P19|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
5921520|NCT01490632|20487292|P18|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
5921521|NCT01490632|20487293|P17|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
5921522|NCT01490632|20487294|P16|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|34
5921523|NCT01490632|20487295|P15|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|14
5921524|NCT01490632|20487296|P14|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|9
5921525|NCT01490632|20487297|P13|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|5
5921526|NCT01490632|20487298|P12|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
5921527|NCT01490632|20487299|P11|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
5921528|NCT01490632|20487300|P10|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
5921529|NCT01490632|20487301|P9|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
5921530|NCT01490632|20487302|P8|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
5921531|NCT01490632|20487303|P7|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
5921532|NCT01490632|20487304|P6|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
5921533|NCT01490632|20487305|P5|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
5921534|NCT01490632|20487306|P4|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
5921535|NCT01490632|20487307|P3|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
5921536|NCT01490632|20487308|P2|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
5921537|NCT01490632|20487309|P1|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
5921538|NCT01490632|20487290|P20|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
5921539|NCT01490632|20487291|P19|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
5921540|NCT01490632|20487292|P18|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
5921541|NCT01490632|20487293|P17|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
5921542|NCT01490632|20487294|P16|Part C: Washout or Step-Down Period|Withdrawal by Subject|1
5921543|NCT01490632|20487295|P15|Part C: Washout or Step-Down Period|Withdrawal by Subject|2
5921544|NCT01490632|20487296|P14|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
5921545|NCT01490632|20487297|P13|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
5921546|NCT01490632|20487298|P12|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
5921547|NCT01490632|20487299|P11|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
5921548|NCT01490632|20487300|P10|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
5921549|NCT01490632|20487301|P9|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
5921550|NCT01490632|20487302|P8|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
5921551|NCT01490632|20487303|P7|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
5921552|NCT01490632|20487304|P6|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
5921553|NCT01490632|20487305|P5|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
5921554|NCT01490632|20487306|P4|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
5921555|NCT01490632|20487307|P3|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
5921556|NCT01490632|20487308|P2|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
5921557|NCT01490632|20487309|P1|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
5921558|NCT01490632|20487290|P20|Part C: Washout or Step-Down Period|Lost to Follow-up|0
5921559|NCT01490632|20487291|P19|Part C: Washout or Step-Down Period|Lost to Follow-up|0
5921560|NCT01490632|20487292|P18|Part C: Washout or Step-Down Period|Lost to Follow-up|0
5921561|NCT01490632|20487293|P17|Part C: Washout or Step-Down Period|Lost to Follow-up|0
5921562|NCT01490632|20487294|P16|Part C: Washout or Step-Down Period|Lost to Follow-up|0
5921563|NCT01490632|20487295|P15|Part C: Washout or Step-Down Period|Lost to Follow-up|0
5921564|NCT01490632|20487296|P14|Part C: Washout or Step-Down Period|Lost to Follow-up|1
5921565|NCT01490632|20487297|P13|Part C: Washout or Step-Down Period|Lost to Follow-up|0
5921566|NCT01490632|20487298|P12|Part C: Washout or Step-Down Period|Lost to Follow-up|0
5921567|NCT01490632|20487299|P11|Part C: Washout or Step-Down Period|Lost to Follow-up|0
5921568|NCT01490632|20487300|P10|Part C: Washout or Step-Down Period|Lost to Follow-up|0
5921569|NCT01490632|20487301|P9|Part C: Washout or Step-Down Period|Lost to Follow-up|0
5921570|NCT01490632|20487302|P8|Part C: Washout or Step-Down Period|Lost to Follow-up|0
5921571|NCT01490632|20487303|P7|Part C: Washout or Step-Down Period|Lost to Follow-up|0
5921572|NCT01490632|20487304|P6|Part C: Washout or Step-Down Period|Lost to Follow-up|0
5921573|NCT01490632|20487305|P5|Part C: Washout or Step-Down Period|Lost to Follow-up|0
5921574|NCT01490632|20487306|P4|Part C: Washout or Step-Down Period|Lost to Follow-up|0
5921575|NCT01490632|20487307|P3|Part C: Washout or Step-Down Period|Lost to Follow-up|0
5921576|NCT01490632|20487308|P2|Part C: Washout or Step-Down Period|Lost to Follow-up|0
5921577|NCT01490632|20487309|P1|Part C: Washout or Step-Down Period|Lost to Follow-up|0
5921578|NCT01490632|20487290|P20|Part C: Washout or Step-Down Period|Adverse Event|0
5921579|NCT01490632|20487291|P19|Part C: Washout or Step-Down Period|Adverse Event|0
5921580|NCT01490632|20487292|P18|Part C: Washout or Step-Down Period|Adverse Event|0
5921581|NCT01490632|20487293|P17|Part C: Washout or Step-Down Period|Adverse Event|0
5921582|NCT01490632|20487294|P16|Part C: Washout or Step-Down Period|Adverse Event|2
5921583|NCT01490632|20487295|P15|Part C: Washout or Step-Down Period|Adverse Event|2
5921584|NCT01490632|20487296|P14|Part C: Washout or Step-Down Period|Adverse Event|0
5921585|NCT01490632|20487297|P13|Part C: Washout or Step-Down Period|Adverse Event|0
5921586|NCT01490632|20487298|P12|Part C: Washout or Step-Down Period|Adverse Event|0
5921587|NCT01490632|20487299|P11|Part C: Washout or Step-Down Period|Adverse Event|0
5921588|NCT01490632|20487300|P10|Part C: Washout or Step-Down Period|Adverse Event|0
5921589|NCT01490632|20487301|P9|Part C: Washout or Step-Down Period|Adverse Event|0
5921590|NCT01490632|20487302|P8|Part C: Washout or Step-Down Period|Adverse Event|0
5921591|NCT01490632|20487303|P7|Part C: Washout or Step-Down Period|Adverse Event|0
5921592|NCT01490632|20487304|P6|Part C: Washout or Step-Down Period|Adverse Event|0
5921593|NCT01490632|20487305|P5|Part C: Washout or Step-Down Period|Adverse Event|0
5921594|NCT01490632|20487306|P4|Part C: Washout or Step-Down Period|Adverse Event|0
5921595|NCT01490632|20487307|P3|Part C: Washout or Step-Down Period|Adverse Event|0
5921596|NCT01490632|20487308|P2|Part C: Washout or Step-Down Period|Adverse Event|0
5921597|NCT01490632|20487309|P1|Part C: Washout or Step-Down Period|Adverse Event|0
5921598|NCT01490632|20487290|P20|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
5921599|NCT01490632|20487291|P19|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
5921600|NCT01490632|20487292|P18|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
5921601|NCT01490632|20487293|P17|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
5921602|NCT01490632|20487294|P16|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
5921603|NCT01490632|20487295|P15|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
5921604|NCT01490632|20487296|P14|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
5921605|NCT01490632|20487297|P13|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
5921606|NCT01490632|20487298|P12|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|5
5921607|NCT01490632|20487299|P11|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|16
5921608|NCT01490632|20487300|P10|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|19
5921609|NCT01490632|20487301|P9|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|8
5921610|NCT01490632|20487302|P8|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6
5921611|NCT01490632|20487303|P7|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6
5921612|NCT01490632|20487304|P6|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|1
5921613|NCT01490632|20487305|P5|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
5921614|NCT01490632|20487306|P4|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
5921615|NCT01490632|20487307|P3|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
5921616|NCT01490632|20487308|P2|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
5921617|NCT01490632|20487309|P1|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
5921618|NCT01490632|20487290|P20|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
5921619|NCT01490632|20487291|P19|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
5921620|NCT01490632|20487292|P18|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
5921621|NCT01490632|20487293|P17|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
5921622|NCT01490632|20487294|P16|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
5921623|NCT01490632|20487295|P15|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
5921624|NCT01490632|20487296|P14|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
5921625|NCT01490632|20487297|P13|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
5921626|NCT01490632|20487298|P12|Part B: Extension or Step-Up Period|Withdrawal by Subject|2
5921627|NCT01490632|20487299|P11|Part B: Extension or Step-Up Period|Withdrawal by Subject|1
5921628|NCT01490632|20487300|P10|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
5921629|NCT01490632|20487301|P9|Part B: Extension or Step-Up Period|Withdrawal by Subject|1
5921630|NCT01490632|20487302|P8|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
5921631|NCT01490632|20487303|P7|Part B: Extension or Step-Up Period|Withdrawal by Subject|1
5921632|NCT01490632|20487304|P6|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
5921633|NCT01490632|20487305|P5|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
5921634|NCT01490632|20487306|P4|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
5921635|NCT01490632|20487307|P3|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
5921636|NCT01490632|20487308|P2|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
5921637|NCT01490632|20487309|P1|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
5921638|NCT01490632|20487290|P20|Part B: Extension or Step-Up Period|Sponsor Decision|0
5921639|NCT01490632|20487291|P19|Part B: Extension or Step-Up Period|Sponsor Decision|0
5921640|NCT01490632|20487292|P18|Part B: Extension or Step-Up Period|Sponsor Decision|0
5921641|NCT01490632|20487293|P17|Part B: Extension or Step-Up Period|Sponsor Decision|0
5921642|NCT01490632|20487294|P16|Part B: Extension or Step-Up Period|Sponsor Decision|0
5921643|NCT01490632|20487295|P15|Part B: Extension or Step-Up Period|Sponsor Decision|0
5921644|NCT01490632|20487296|P14|Part B: Extension or Step-Up Period|Sponsor Decision|0
5921645|NCT01490632|20487297|P13|Part B: Extension or Step-Up Period|Sponsor Decision|0
5921646|NCT01490632|20487298|P12|Part B: Extension or Step-Up Period|Sponsor Decision|0
5921647|NCT01490632|20487299|P11|Part B: Extension or Step-Up Period|Sponsor Decision|0
5921648|NCT01490632|20487300|P10|Part B: Extension or Step-Up Period|Sponsor Decision|0
5921649|NCT01490632|20487301|P9|Part B: Extension or Step-Up Period|Sponsor Decision|0
5921650|NCT01490632|20487302|P8|Part B: Extension or Step-Up Period|Sponsor Decision|0
5921651|NCT01490632|20487303|P7|Part B: Extension or Step-Up Period|Sponsor Decision|0
5921652|NCT01490632|20487304|P6|Part B: Extension or Step-Up Period|Sponsor Decision|1
5921653|NCT01490632|20487305|P5|Part B: Extension or Step-Up Period|Sponsor Decision|0
5921654|NCT01490632|20487306|P4|Part B: Extension or Step-Up Period|Sponsor Decision|0
5921655|NCT01490632|20487307|P3|Part B: Extension or Step-Up Period|Sponsor Decision|0
5921656|NCT01490632|20487308|P2|Part B: Extension or Step-Up Period|Sponsor Decision|0
5921657|NCT01490632|20487309|P1|Part B: Extension or Step-Up Period|Sponsor Decision|0
5921658|NCT01490632|20487290|P20|Part B: Extension or Step-Up Period|Physician Decision|0
5921659|NCT01490632|20487291|P19|Part B: Extension or Step-Up Period|Physician Decision|0
5921660|NCT01490632|20487292|P18|Part B: Extension or Step-Up Period|Physician Decision|0
5921661|NCT01490632|20487293|P17|Part B: Extension or Step-Up Period|Physician Decision|0
5921662|NCT01490632|20487294|P16|Part B: Extension or Step-Up Period|Physician Decision|0
5921663|NCT01490632|20487295|P15|Part B: Extension or Step-Up Period|Physician Decision|0
5921664|NCT01490632|20487296|P14|Part B: Extension or Step-Up Period|Physician Decision|0
5921665|NCT01490632|20487297|P13|Part B: Extension or Step-Up Period|Physician Decision|0
5921666|NCT01490632|20487298|P12|Part B: Extension or Step-Up Period|Physician Decision|0
5921667|NCT01490632|20487299|P11|Part B: Extension or Step-Up Period|Physician Decision|0
5921668|NCT01490632|20487300|P10|Part B: Extension or Step-Up Period|Physician Decision|0
5921669|NCT01490632|20487301|P9|Part B: Extension or Step-Up Period|Physician Decision|0
5921670|NCT01490632|20487302|P8|Part B: Extension or Step-Up Period|Physician Decision|0
5921671|NCT01490632|20487303|P7|Part B: Extension or Step-Up Period|Physician Decision|1
5921672|NCT01490632|20487304|P6|Part B: Extension or Step-Up Period|Physician Decision|0
5921673|NCT01490632|20487305|P5|Part B: Extension or Step-Up Period|Physician Decision|0
5921674|NCT01490632|20487306|P4|Part B: Extension or Step-Up Period|Physician Decision|0
5921675|NCT01490632|20487307|P3|Part B: Extension or Step-Up Period|Physician Decision|0
5921676|NCT01490632|20487308|P2|Part B: Extension or Step-Up Period|Physician Decision|0
5921677|NCT01490632|20487309|P1|Part B: Extension or Step-Up Period|Physician Decision|0
5921678|NCT01490632|20487290|P20|Part B: Extension or Step-Up Period|Lost to Follow-up|0
5921679|NCT01490632|20487291|P19|Part B: Extension or Step-Up Period|Lost to Follow-up|0
5921680|NCT01490632|20487292|P18|Part B: Extension or Step-Up Period|Lost to Follow-up|0
5921681|NCT01490632|20487293|P17|Part B: Extension or Step-Up Period|Lost to Follow-up|0
5921682|NCT01490632|20487294|P16|Part B: Extension or Step-Up Period|Lost to Follow-up|0
5921683|NCT01490632|20487295|P15|Part B: Extension or Step-Up Period|Lost to Follow-up|0
5921684|NCT01490632|20487296|P14|Part B: Extension or Step-Up Period|Lost to Follow-up|0
5921685|NCT01490632|20487297|P13|Part B: Extension or Step-Up Period|Lost to Follow-up|0
5921686|NCT01490632|20487298|P12|Part B: Extension or Step-Up Period|Lost to Follow-up|0
5921687|NCT01490632|20487299|P11|Part B: Extension or Step-Up Period|Lost to Follow-up|0
5921688|NCT01490632|20487300|P10|Part B: Extension or Step-Up Period|Lost to Follow-up|1
5921689|NCT01490632|20487301|P9|Part B: Extension or Step-Up Period|Lost to Follow-up|0
5921690|NCT01490632|20487302|P8|Part B: Extension or Step-Up Period|Lost to Follow-up|0
5921691|NCT01490632|20487303|P7|Part B: Extension or Step-Up Period|Lost to Follow-up|2
5921692|NCT01490632|20487304|P6|Part B: Extension or Step-Up Period|Lost to Follow-up|0
5921693|NCT01490632|20487305|P5|Part B: Extension or Step-Up Period|Lost to Follow-up|0
5921694|NCT01490632|20487306|P4|Part B: Extension or Step-Up Period|Lost to Follow-up|0
5921695|NCT01490632|20487307|P3|Part B: Extension or Step-Up Period|Lost to Follow-up|0
5921696|NCT01490632|20487308|P2|Part B: Extension or Step-Up Period|Lost to Follow-up|0
5921697|NCT01490632|20487309|P1|Part B: Extension or Step-Up Period|Lost to Follow-up|0
5921698|NCT01490632|20487290|P20|Part B: Extension or Step-Up Period|Lack of Efficacy|0
5921699|NCT01490632|20487291|P19|Part B: Extension or Step-Up Period|Lack of Efficacy|0
5921700|NCT01490632|20487292|P18|Part B: Extension or Step-Up Period|Lack of Efficacy|0
5921701|NCT01490632|20487293|P17|Part B: Extension or Step-Up Period|Lack of Efficacy|0
5921702|NCT01490632|20487294|P16|Part B: Extension or Step-Up Period|Lack of Efficacy|0
5921703|NCT01490632|20487295|P15|Part B: Extension or Step-Up Period|Lack of Efficacy|0
5921704|NCT01490632|20487296|P14|Part B: Extension or Step-Up Period|Lack of Efficacy|0
5921705|NCT01490632|20487297|P13|Part B: Extension or Step-Up Period|Lack of Efficacy|0
5921706|NCT01490632|20487298|P12|Part B: Extension or Step-Up Period|Lack of Efficacy|0
5921707|NCT01490632|20487299|P11|Part B: Extension or Step-Up Period|Lack of Efficacy|1
5921708|NCT01490632|20487300|P10|Part B: Extension or Step-Up Period|Lack of Efficacy|3
5921709|NCT01490632|20487301|P9|Part B: Extension or Step-Up Period|Lack of Efficacy|1
5921710|NCT01490632|20487302|P8|Part B: Extension or Step-Up Period|Lack of Efficacy|0
5921711|NCT01490632|20487303|P7|Part B: Extension or Step-Up Period|Lack of Efficacy|1
5921712|NCT01490632|20487304|P6|Part B: Extension or Step-Up Period|Lack of Efficacy|0
5921713|NCT01490632|20487305|P5|Part B: Extension or Step-Up Period|Lack of Efficacy|0
5921714|NCT01490632|20487306|P4|Part B: Extension or Step-Up Period|Lack of Efficacy|0
5921715|NCT01490632|20487307|P3|Part B: Extension or Step-Up Period|Lack of Efficacy|0
5921716|NCT01490632|20487308|P2|Part B: Extension or Step-Up Period|Lack of Efficacy|0
5921717|NCT01490632|20487309|P1|Part B: Extension or Step-Up Period|Lack of Efficacy|0
5921718|NCT01490632|20487290|P20|Part B: Extension or Step-Up Period|Adverse Event|0
5921719|NCT01490632|20487291|P19|Part B: Extension or Step-Up Period|Adverse Event|0
5921720|NCT01490632|20487292|P18|Part B: Extension or Step-Up Period|Adverse Event|0
5921721|NCT01490632|20487293|P17|Part B: Extension or Step-Up Period|Adverse Event|0
5921722|NCT01490632|20487294|P16|Part B: Extension or Step-Up Period|Adverse Event|0
5921723|NCT01490632|20487295|P15|Part B: Extension or Step-Up Period|Adverse Event|0
5921724|NCT01490632|20487296|P14|Part B: Extension or Step-Up Period|Adverse Event|0
5921725|NCT01490632|20487297|P13|Part B: Extension or Step-Up Period|Adverse Event|0
5921726|NCT01490632|20487298|P12|Part B: Extension or Step-Up Period|Adverse Event|1
5921727|NCT01490632|20487299|P11|Part B: Extension or Step-Up Period|Adverse Event|3
5921728|NCT01490632|20487300|P10|Part B: Extension or Step-Up Period|Adverse Event|2
5921729|NCT01490632|20487301|P9|Part B: Extension or Step-Up Period|Adverse Event|0
5921730|NCT01490632|20487302|P8|Part B: Extension or Step-Up Period|Adverse Event|0
5921731|NCT01490632|20487303|P7|Part B: Extension or Step-Up Period|Adverse Event|2
5921732|NCT01490632|20487304|P6|Part B: Extension or Step-Up Period|Adverse Event|2
5921733|NCT01490632|20487305|P5|Part B: Extension or Step-Up Period|Adverse Event|0
5921734|NCT01490632|20487306|P4|Part B: Extension or Step-Up Period|Adverse Event|0
5921735|NCT01490632|20487307|P3|Part B: Extension or Step-Up Period|Adverse Event|0
5921736|NCT01490632|20487308|P2|Part B: Extension or Step-Up Period|Adverse Event|0
5921737|NCT01490632|20487309|P1|Part B: Extension or Step-Up Period|Adverse Event|0
5921738|NCT01490632|20487290|P20|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
5921739|NCT01490632|20487291|P19|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
5921740|NCT01490632|20487292|P18|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
5921741|NCT01490632|20487293|P17|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
5921742|NCT01490632|20487294|P16|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
5921743|NCT01490632|20487295|P15|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
5921744|NCT01490632|20487296|P14|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
5921745|NCT01490632|20487297|P13|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
5921746|NCT01490632|20487298|P12|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
5921747|NCT01490632|20487299|P11|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
5921748|NCT01490632|20487300|P10|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
5921749|NCT01490632|20487301|P9|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
5921750|NCT01490632|20487302|P8|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
5921751|NCT01490632|20487303|P7|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
5921752|NCT01490632|20487304|P6|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
5921753|NCT01490632|20487305|P5|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|9
5921754|NCT01490632|20487306|P4|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
5921755|NCT01490632|20487307|P3|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
5921756|NCT01490632|20487308|P2|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
5921757|NCT01490632|20487309|P1|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
5921758|NCT01490632|20487290|P20|Part A: Initial Treatment Period|Withdrawal by Subject|0
5921759|NCT01490632|20487291|P19|Part A: Initial Treatment Period|Withdrawal by Subject|0
5921760|NCT01490632|20487292|P18|Part A: Initial Treatment Period|Withdrawal by Subject|0
5921761|NCT01490632|20487293|P17|Part A: Initial Treatment Period|Withdrawal by Subject|0
5921762|NCT01490632|20487294|P16|Part A: Initial Treatment Period|Withdrawal by Subject|0
5921763|NCT01490632|20487295|P15|Part A: Initial Treatment Period|Withdrawal by Subject|0
5921764|NCT01490632|20487296|P14|Part A: Initial Treatment Period|Withdrawal by Subject|0
5921765|NCT01490632|20487297|P13|Part A: Initial Treatment Period|Withdrawal by Subject|0
5921766|NCT01490632|20487298|P12|Part A: Initial Treatment Period|Withdrawal by Subject|0
5921767|NCT01490632|20487299|P11|Part A: Initial Treatment Period|Withdrawal by Subject|0
5921768|NCT01490632|20487300|P10|Part A: Initial Treatment Period|Withdrawal by Subject|0
5921769|NCT01490632|20487301|P9|Part A: Initial Treatment Period|Withdrawal by Subject|0
5921770|NCT01490632|20487302|P8|Part A: Initial Treatment Period|Withdrawal by Subject|0
5921771|NCT01490632|20487303|P7|Part A: Initial Treatment Period|Withdrawal by Subject|0
5921772|NCT01490632|20487304|P6|Part A: Initial Treatment Period|Withdrawal by Subject|0
5921773|NCT01490632|20487305|P5|Part A: Initial Treatment Period|Withdrawal by Subject|2
5921774|NCT01490632|20487306|P4|Part A: Initial Treatment Period|Withdrawal by Subject|1
5921775|NCT01490632|20487307|P3|Part A: Initial Treatment Period|Withdrawal by Subject|0
5921776|NCT01490632|20487308|P2|Part A: Initial Treatment Period|Withdrawal by Subject|2
5921777|NCT01490632|20487309|P1|Part A: Initial Treatment Period|Withdrawal by Subject|2
5921778|NCT01490632|20487290|P20|Part A: Initial Treatment Period|Sponsor Decision|0
5921779|NCT01490632|20487291|P19|Part A: Initial Treatment Period|Sponsor Decision|0
5921780|NCT01490632|20487292|P18|Part A: Initial Treatment Period|Sponsor Decision|0
5921781|NCT01490632|20487293|P17|Part A: Initial Treatment Period|Sponsor Decision|0
5921782|NCT01490632|20487294|P16|Part A: Initial Treatment Period|Sponsor Decision|0
5921783|NCT01490632|20487295|P15|Part A: Initial Treatment Period|Sponsor Decision|0
5921784|NCT01490632|20487296|P14|Part A: Initial Treatment Period|Sponsor Decision|0
5921785|NCT01490632|20487297|P13|Part A: Initial Treatment Period|Sponsor Decision|0
5921786|NCT01490632|20487298|P12|Part A: Initial Treatment Period|Sponsor Decision|0
5921787|NCT01490632|20487299|P11|Part A: Initial Treatment Period|Sponsor Decision|0
5921788|NCT01490632|20487300|P10|Part A: Initial Treatment Period|Sponsor Decision|0
5921789|NCT01490632|20487301|P9|Part A: Initial Treatment Period|Sponsor Decision|0
5921790|NCT01490632|20487302|P8|Part A: Initial Treatment Period|Sponsor Decision|0
5921791|NCT01490632|20487303|P7|Part A: Initial Treatment Period|Sponsor Decision|0
5921792|NCT01490632|20487304|P6|Part A: Initial Treatment Period|Sponsor Decision|0
5921793|NCT01490632|20487305|P5|Part A: Initial Treatment Period|Sponsor Decision|0
5921794|NCT01490632|20487306|P4|Part A: Initial Treatment Period|Sponsor Decision|0
5921795|NCT01490632|20487307|P3|Part A: Initial Treatment Period|Sponsor Decision|0
5921796|NCT01490632|20487308|P2|Part A: Initial Treatment Period|Sponsor Decision|0
5921797|NCT01490632|20487309|P1|Part A: Initial Treatment Period|Sponsor Decision|2
5921798|NCT01490632|20487290|P20|Part A: Initial Treatment Period|Physician Decision|0
5921799|NCT01490632|20487291|P19|Part A: Initial Treatment Period|Physician Decision|0
5921800|NCT01490632|20487292|P18|Part A: Initial Treatment Period|Physician Decision|0
5921801|NCT01490632|20487293|P17|Part A: Initial Treatment Period|Physician Decision|0
5921802|NCT01490632|20487294|P16|Part A: Initial Treatment Period|Physician Decision|0
5921803|NCT01490632|20487295|P15|Part A: Initial Treatment Period|Physician Decision|0
5921804|NCT01490632|20487296|P14|Part A: Initial Treatment Period|Physician Decision|0
5921805|NCT01490632|20487297|P13|Part A: Initial Treatment Period|Physician Decision|0
5921806|NCT01490632|20487298|P12|Part A: Initial Treatment Period|Physician Decision|0
5921807|NCT01490632|20487299|P11|Part A: Initial Treatment Period|Physician Decision|0
5921808|NCT01490632|20487300|P10|Part A: Initial Treatment Period|Physician Decision|0
5921809|NCT01490632|20487301|P9|Part A: Initial Treatment Period|Physician Decision|0
5921810|NCT01490632|20487302|P8|Part A: Initial Treatment Period|Physician Decision|0
5921811|NCT01490632|20487303|P7|Part A: Initial Treatment Period|Physician Decision|0
5921812|NCT01490632|20487304|P6|Part A: Initial Treatment Period|Physician Decision|0
5921813|NCT01490632|20487305|P5|Part A: Initial Treatment Period|Physician Decision|0
5921814|NCT01490632|20487306|P4|Part A: Initial Treatment Period|Physician Decision|1
5921815|NCT01490632|20487307|P3|Part A: Initial Treatment Period|Physician Decision|0
5921816|NCT01490632|20487308|P2|Part A: Initial Treatment Period|Physician Decision|1
5921817|NCT01490632|20487309|P1|Part A: Initial Treatment Period|Physician Decision|0
5921818|NCT01490632|20487290|P20|Part A: Initial Treatment Period|Lost to Follow-up|0
5921819|NCT01490632|20487291|P19|Part A: Initial Treatment Period|Lost to Follow-up|0
5921820|NCT01490632|20487292|P18|Part A: Initial Treatment Period|Lost to Follow-up|0
5921821|NCT01490632|20487293|P17|Part A: Initial Treatment Period|Lost to Follow-up|0
5921822|NCT01490632|20487294|P16|Part A: Initial Treatment Period|Lost to Follow-up|0
5921823|NCT01490632|20487295|P15|Part A: Initial Treatment Period|Lost to Follow-up|0
5921824|NCT01490632|20487296|P14|Part A: Initial Treatment Period|Lost to Follow-up|0
5921825|NCT01490632|20487297|P13|Part A: Initial Treatment Period|Lost to Follow-up|0
5921826|NCT01490632|20487298|P12|Part A: Initial Treatment Period|Lost to Follow-up|0
5921827|NCT01490632|20487299|P11|Part A: Initial Treatment Period|Lost to Follow-up|0
5921828|NCT01490632|20487300|P10|Part A: Initial Treatment Period|Lost to Follow-up|0
5921829|NCT01490632|20487301|P9|Part A: Initial Treatment Period|Lost to Follow-up|0
5921830|NCT01490632|20487302|P8|Part A: Initial Treatment Period|Lost to Follow-up|0
5921831|NCT01490632|20487303|P7|Part A: Initial Treatment Period|Lost to Follow-up|0
5921832|NCT01490632|20487304|P6|Part A: Initial Treatment Period|Lost to Follow-up|0
5921833|NCT01490632|20487305|P5|Part A: Initial Treatment Period|Lost to Follow-up|2
5921834|NCT01490632|20487306|P4|Part A: Initial Treatment Period|Lost to Follow-up|1
5921835|NCT01490632|20487307|P3|Part A: Initial Treatment Period|Lost to Follow-up|1
5921836|NCT01490632|20487308|P2|Part A: Initial Treatment Period|Lost to Follow-up|0
5921837|NCT01490632|20487309|P1|Part A: Initial Treatment Period|Lost to Follow-up|0
5921838|NCT01490632|20487290|P20|Part A: Initial Treatment Period|Lack of Efficacy|0
5921839|NCT01490632|20487291|P19|Part A: Initial Treatment Period|Lack of Efficacy|0
5921840|NCT01490632|20487292|P18|Part A: Initial Treatment Period|Lack of Efficacy|0
5921841|NCT01490632|20487293|P17|Part A: Initial Treatment Period|Lack of Efficacy|0
5921842|NCT01490632|20487294|P16|Part A: Initial Treatment Period|Lack of Efficacy|0
5921843|NCT01490632|20487295|P15|Part A: Initial Treatment Period|Lack of Efficacy|0
5921844|NCT01490632|20487296|P14|Part A: Initial Treatment Period|Lack of Efficacy|0
5921845|NCT01490632|20487297|P13|Part A: Initial Treatment Period|Lack of Efficacy|0
5921846|NCT01490632|20487298|P12|Part A: Initial Treatment Period|Lack of Efficacy|0
5921847|NCT01490632|20487299|P11|Part A: Initial Treatment Period|Lack of Efficacy|0
5921848|NCT01490632|20487300|P10|Part A: Initial Treatment Period|Lack of Efficacy|0
5921849|NCT01490632|20487301|P9|Part A: Initial Treatment Period|Lack of Efficacy|0
5921850|NCT01490632|20487302|P8|Part A: Initial Treatment Period|Lack of Efficacy|0
5921851|NCT01490632|20487303|P7|Part A: Initial Treatment Period|Lack of Efficacy|0
5921852|NCT01490632|20487304|P6|Part A: Initial Treatment Period|Lack of Efficacy|0
5921853|NCT01490632|20487305|P5|Part A: Initial Treatment Period|Lack of Efficacy|0
5921854|NCT01490632|20487306|P4|Part A: Initial Treatment Period|Lack of Efficacy|2
5921855|NCT01490632|20487307|P3|Part A: Initial Treatment Period|Lack of Efficacy|2
5921856|NCT01490632|20487308|P2|Part A: Initial Treatment Period|Lack of Efficacy|1
5921857|NCT01490632|20487309|P1|Part A: Initial Treatment Period|Lack of Efficacy|3
5921858|NCT01490632|20487290|P20|Part A: Initial Treatment Period|Adverse Event|0
5921859|NCT01490632|20487291|P19|Part A: Initial Treatment Period|Adverse Event|0
5921860|NCT01490632|20487292|P18|Part A: Initial Treatment Period|Adverse Event|0
5921861|NCT01490632|20487293|P17|Part A: Initial Treatment Period|Adverse Event|0
5921862|NCT01490632|20487294|P16|Part A: Initial Treatment Period|Adverse Event|0
5921863|NCT01490632|20487295|P15|Part A: Initial Treatment Period|Adverse Event|0
5921864|NCT01490632|20487296|P14|Part A: Initial Treatment Period|Adverse Event|0
5921865|NCT01490632|20487297|P13|Part A: Initial Treatment Period|Adverse Event|0
5921866|NCT01490632|20487298|P12|Part A: Initial Treatment Period|Adverse Event|0
5921867|NCT01490632|20487299|P11|Part A: Initial Treatment Period|Adverse Event|0
5921868|NCT01490632|20487300|P10|Part A: Initial Treatment Period|Adverse Event|0
5921869|NCT01490632|20487301|P9|Part A: Initial Treatment Period|Adverse Event|0
5921870|NCT01490632|20487302|P8|Part A: Initial Treatment Period|Adverse Event|0
5921871|NCT01490632|20487303|P7|Part A: Initial Treatment Period|Adverse Event|0
5921872|NCT01490632|20487304|P6|Part A: Initial Treatment Period|Adverse Event|0
5921873|NCT01490632|20487305|P5|Part A: Initial Treatment Period|Adverse Event|4
5921874|NCT01490632|20487306|P4|Part A: Initial Treatment Period|Adverse Event|4
5921875|NCT01490632|20487307|P3|Part A: Initial Treatment Period|Adverse Event|2
5921876|NCT01490632|20487308|P2|Part A: Initial Treatment Period|Adverse Event|0
5921877|NCT01490632|20487309|P1|Part A: Initial Treatment Period|Adverse Event|0
5921878|NCT01490580|20487439|P2|Overall Study|Parents withdrew consent|2
5921879|NCT01490580|20487440|P1|Overall Study|Parents withdrew consent|0
5921880|NCT01490294|20487487|P4|Overall Study|Adverse Event|0
5921881|NCT01490294|20487488|P3|Overall Study|Adverse Event|0
5921882|NCT01490294|20487489|P2|Overall Study|Adverse Event|0
5921883|NCT01490294|20487490|P1|Overall Study|Adverse Event|1
5921884|NCT01490294|20487487|P4|Overall Study|Prematurely discontinuation|1
5921885|NCT01490294|20487488|P3|Overall Study|Prematurely discontinuation|1
5921886|NCT01490294|20487489|P2|Overall Study|Prematurely discontinuation|0
5921887|NCT01490294|20487490|P1|Overall Study|Prematurely discontinuation|4
5921888|NCT01490190|20487724|P1|Overall Study|Ring expulsion|2
5921889|NCT01490190|20487724|P1|Overall Study|Inconvenience|1
5921890|NCT01490190|20487724|P1|Overall Study|Relocation|1
5921891|NCT01490190|20487724|P1|Overall Study|Lost to Follow-up|13
5921892|NCT01490190|20487724|P1|Overall Study|Protocol Violation|5
5921893|NCT01490190|20487724|P1|Overall Study|Adverse Event|17
5921894|NCT01490190|20487724|P1|Overall Study|Withdrawal by Subject|9
5921895|NCT01490125|20487751|P6|Period III|Lack of Efficacy|0
5921896|NCT01490125|20487752|P5|Period III|Lack of Efficacy|1
5921897|NCT01490125|20487753|P4|Period III|Lack of Efficacy|0
5921898|NCT01490125|20487754|P3|Period III|Lack of Efficacy|0
5921899|NCT01490125|20487755|P2|Period III|Lack of Efficacy|0
5921900|NCT01490125|20487756|P1|Period III|Lack of Efficacy|0
5921901|NCT01490125|20487751|P6|Period III|Death|0
5921902|NCT01490125|20487752|P5|Period III|Death|0
5921903|NCT01490125|20487753|P4|Period III|Death|1
5921904|NCT01490125|20487754|P3|Period III|Death|0
5921905|NCT01490125|20487755|P2|Period III|Death|0
5921906|NCT01490125|20487756|P1|Period III|Death|0
5921907|NCT01490125|20487751|P6|Period III|Adverse Event|0
5921908|NCT01490125|20487752|P5|Period III|Adverse Event|0
5921909|NCT01490125|20487753|P4|Period III|Adverse Event|1
5921910|NCT01490125|20487754|P3|Period III|Adverse Event|0
5921911|NCT01490125|20487755|P2|Period III|Adverse Event|1
5921912|NCT01490125|20487756|P1|Period III|Adverse Event|3
5921913|NCT01490125|20487751|P6|Period II|Withdrawal by Subject|0
5921914|NCT01490125|20487752|P5|Period II|Withdrawal by Subject|0
5921915|NCT01490125|20487753|P4|Period II|Withdrawal by Subject|0
5921916|NCT01490125|20487754|P3|Period II|Withdrawal by Subject|0
5921917|NCT01490125|20487755|P2|Period II|Withdrawal by Subject|0
5921918|NCT01490125|20487756|P1|Period II|Withdrawal by Subject|1
5921919|NCT01490125|20487751|P6|Period II|Lost to Follow-up|0
5921920|NCT01490125|20487752|P5|Period II|Lost to Follow-up|0
5921921|NCT01490125|20487753|P4|Period II|Lost to Follow-up|0
5921922|NCT01490125|20487754|P3|Period II|Lost to Follow-up|0
5921923|NCT01490125|20487755|P2|Period II|Lost to Follow-up|1
5921924|NCT01490125|20487756|P1|Period II|Lost to Follow-up|0
5921925|NCT01490125|20487751|P6|Period II|Protocol Violation|0
5921926|NCT01490125|20487752|P5|Period II|Protocol Violation|0
5921927|NCT01490125|20487753|P4|Period II|Protocol Violation|1
5921928|NCT01490125|20487754|P3|Period II|Protocol Violation|1
5921929|NCT01490125|20487755|P2|Period II|Protocol Violation|0
5921930|NCT01490125|20487756|P1|Period II|Protocol Violation|0
5921931|NCT01490125|20487751|P6|Period II|Adverse Event|2
5921932|NCT01490125|20487752|P5|Period II|Adverse Event|4
5921933|NCT01490125|20487753|P4|Period II|Adverse Event|2
5921934|NCT01490125|20487754|P3|Period II|Adverse Event|2
5921935|NCT01490125|20487755|P2|Period II|Adverse Event|3
5921936|NCT01490125|20487756|P1|Period II|Adverse Event|2
5921937|NCT01490125|20487751|P6|Period I|Withdrawal by Subject|1
5921938|NCT01490125|20487752|P5|Period I|Withdrawal by Subject|2
5921939|NCT01490125|20487753|P4|Period I|Withdrawal by Subject|1
5921940|NCT01490125|20487754|P3|Period I|Withdrawal by Subject|2
5921941|NCT01490125|20487755|P2|Period I|Withdrawal by Subject|3
5921942|NCT01490125|20487756|P1|Period I|Withdrawal by Subject|1
5921943|NCT01490125|20487751|P6|Period I|Protocol Violation|0
5921944|NCT01490125|20487752|P5|Period I|Protocol Violation|0
5921945|NCT01490125|20487753|P4|Period I|Protocol Violation|1
5921946|NCT01490125|20487754|P3|Period I|Protocol Violation|1
5921947|NCT01490125|20487755|P2|Period I|Protocol Violation|1
5921948|NCT01490125|20487756|P1|Period I|Protocol Violation|1
5921949|NCT01490125|20487751|P6|Period I|Adverse Event|4
5921950|NCT01490125|20487752|P5|Period I|Adverse Event|2
5921951|NCT01490125|20487753|P4|Period I|Adverse Event|3
5921952|NCT01490125|20487754|P3|Period I|Adverse Event|1
5921953|NCT01490125|20487755|P2|Period I|Adverse Event|1
5921954|NCT01490125|20487756|P1|Period I|Adverse Event|4
5921955|NCT01490086|20487784|P5|Overall Study|Subject left hospital|0
5921956|NCT01490086|20487785|P4|Overall Study|Subject left hospital|1
5921957|NCT01490086|20487786|P3|Overall Study|Subject left hospital|0
5921958|NCT01490086|20487787|P2|Overall Study|Subject left hospital|1
5921959|NCT01490086|20487788|P1|Overall Study|Subject left hospital|0
5921960|NCT01490086|20487784|P5|Overall Study|Subject uncontrollable and abusive|0
5921961|NCT01490086|20487785|P4|Overall Study|Subject uncontrollable and abusive|0
5921962|NCT01490086|20487786|P3|Overall Study|Subject uncontrollable and abusive|0
5921963|NCT01490086|20487787|P2|Overall Study|Subject uncontrollable and abusive|1
5921964|NCT01490086|20487788|P1|Overall Study|Subject uncontrollable and abusive|0
5921965|NCT01490086|20487784|P5|Overall Study|Worsening of symptoms|0
5921966|NCT01490086|20487785|P4|Overall Study|Worsening of symptoms|1
5921967|NCT01490086|20487786|P3|Overall Study|Worsening of symptoms|0
5921968|NCT01490086|20487787|P2|Overall Study|Worsening of symptoms|1
5921969|NCT01490086|20487788|P1|Overall Study|Worsening of symptoms|0
5921970|NCT01490086|20487784|P5|Overall Study|Lack of Efficacy|8
5921971|NCT01490086|20487785|P4|Overall Study|Lack of Efficacy|0
5921972|NCT01490086|20487786|P3|Overall Study|Lack of Efficacy|1
5921973|NCT01490086|20487787|P2|Overall Study|Lack of Efficacy|3
5921974|NCT01490086|20487788|P1|Overall Study|Lack of Efficacy|0
5921975|NCT01490086|20487784|P5|Overall Study|Adverse Event|0
5921976|NCT01490086|20487785|P4|Overall Study|Adverse Event|2
5921977|NCT01490086|20487786|P3|Overall Study|Adverse Event|1
5921978|NCT01490086|20487787|P2|Overall Study|Adverse Event|0
5921979|NCT01490086|20487788|P1|Overall Study|Adverse Event|0
5921980|NCT01490086|20487784|P5|Overall Study|Physician Decision|1
5921981|NCT01490086|20487785|P4|Overall Study|Physician Decision|3
5921982|NCT01490086|20487786|P3|Overall Study|Physician Decision|2
5921983|NCT01490086|20487787|P2|Overall Study|Physician Decision|4
5921984|NCT01490086|20487788|P1|Overall Study|Physician Decision|3
5921985|NCT01490086|20487784|P5|Overall Study|Lost to Follow-up|1
5921986|NCT01490086|20487785|P4|Overall Study|Lost to Follow-up|0
5921987|NCT01490086|20487786|P3|Overall Study|Lost to Follow-up|0
5921988|NCT01490086|20487787|P2|Overall Study|Lost to Follow-up|0
5921989|NCT01490086|20487788|P1|Overall Study|Lost to Follow-up|0
5921990|NCT01490086|20487784|P5|Overall Study|Abnormal laboratory findings|0
5921991|NCT01490086|20487785|P4|Overall Study|Abnormal laboratory findings|0
5921992|NCT01490086|20487786|P3|Overall Study|Abnormal laboratory findings|0
5921993|NCT01490086|20487787|P2|Overall Study|Abnormal laboratory findings|0
5921994|NCT01490086|20487788|P1|Overall Study|Abnormal laboratory findings|1
5921995|NCT01490086|20487784|P5|Overall Study|Non-compliance|0
5921996|NCT01490086|20487785|P4|Overall Study|Non-compliance|0
5921997|NCT01490086|20487786|P3|Overall Study|Non-compliance|0
5921998|NCT01490086|20487787|P2|Overall Study|Non-compliance|1
5921999|NCT01490086|20487788|P1|Overall Study|Non-compliance|0
5922000|NCT01490086|20487784|P5|Overall Study|Consent withdrawn|1
5922001|NCT01490086|20487785|P4|Overall Study|Consent withdrawn|0
5922002|NCT01490086|20487786|P3|Overall Study|Consent withdrawn|3
5922003|NCT01490086|20487787|P2|Overall Study|Consent withdrawn|4
5922004|NCT01490086|20487788|P1|Overall Study|Consent withdrawn|4
5922005|NCT01490060|20487833|P4|Cycle 2|Adverse Event Related to Chemotherapy|0
5922006|NCT01490060|20487834|P3|Cycle 2|Adverse Event Related to Chemotherapy|0
5922007|NCT01490060|20487835|P2|Cycle 2|Adverse Event Related to Chemotherapy|0
5922008|NCT01490060|20487836|P1|Cycle 2|Adverse Event Related to Chemotherapy|1
5922009|NCT01490060|20487833|P4|Cycle 2|Non-Compliance|0
5922010|NCT01490060|20487834|P3|Cycle 2|Non-Compliance|1
5922011|NCT01490060|20487835|P2|Cycle 2|Non-Compliance|0
5922012|NCT01490060|20487836|P1|Cycle 2|Non-Compliance|0
5922013|NCT01490060|20487833|P4|Cycle 2|Change of Treatment|0
5922014|NCT01490060|20487834|P3|Cycle 2|Change of Treatment|0
5922015|NCT01490060|20487835|P2|Cycle 2|Change of Treatment|1
5922016|NCT01490060|20487836|P1|Cycle 2|Change of Treatment|1
5922017|NCT01490060|20487833|P4|Cycle 1|Treatment at Another Facility|1
5922018|NCT01490060|20487834|P3|Cycle 1|Treatment at Another Facility|0
5922019|NCT01490060|20487835|P2|Cycle 1|Treatment at Another Facility|0
5922020|NCT01490060|20487836|P1|Cycle 1|Treatment at Another Facility|0
5922021|NCT01490060|20487833|P4|Cycle 1|Withdrawal by Subject|1
5922022|NCT01490060|20487834|P3|Cycle 1|Withdrawal by Subject|0
5922023|NCT01490060|20487835|P2|Cycle 1|Withdrawal by Subject|0
5922024|NCT01490060|20487836|P1|Cycle 1|Withdrawal by Subject|0
5922025|NCT01490060|20487833|P4|Cycle 1|Insurance Denied|0
5922026|NCT01490060|20487834|P3|Cycle 1|Insurance Denied|2
5922027|NCT01490060|20487835|P2|Cycle 1|Insurance Denied|0
5922028|NCT01490060|20487836|P1|Cycle 1|Insurance Denied|0
5922029|NCT01490060|20487833|P4|Cycle 1|Change of Treatment|1
5922030|NCT01490060|20487834|P3|Cycle 1|Change of Treatment|1
5922031|NCT01490060|20487835|P2|Cycle 1|Change of Treatment|1
5922032|NCT01490060|20487836|P1|Cycle 1|Change of Treatment|0
5922033|NCT01489956|20487865|P3|Overall Study|Withdrawal by Subject|1
5922034|NCT01489956|20487866|P2|Overall Study|Withdrawal by Subject|0
5922035|NCT01489956|20487867|P1|Overall Study|Withdrawal by Subject|0
5922036|NCT01489956|20487865|P3|Overall Study|Lost to Follow-up|0
5922037|NCT01489956|20487866|P2|Overall Study|Lost to Follow-up|0
5922038|NCT01489956|20487867|P1|Overall Study|Lost to Follow-up|1
5922039|NCT01489891|20487904|P2|Overall Study|Endoscopy failure|0
5922040|NCT01489891|20487905|P1|Overall Study|Endoscopy failure|1
5922041|NCT01489527|20488060|P2|Overall Study|Not compliant|0
5922042|NCT01489527|20488061|P1|Overall Study|Not compliant|1
5922043|NCT01489527|20488060|P2|Overall Study|Procedures|0
5922044|NCT01489527|20488061|P1|Overall Study|Procedures|1
5922045|NCT01489527|20488060|P2|Overall Study|Lost to Follow-up|1
5922046|NCT01489527|20488061|P1|Overall Study|Lost to Follow-up|5
5922047|NCT01489527|20488060|P2|Overall Study|Withdrawal by Subject|4
5922048|NCT01489527|20488061|P1|Overall Study|Withdrawal by Subject|0
5922049|NCT01489527|20488060|P2|Overall Study|Participant moved|7
5922050|NCT01489527|20488061|P1|Overall Study|Participant moved|6
5922051|NCT01489527|20488060|P2|Overall Study|Pregnancy|14
5922052|NCT01489527|20488061|P1|Overall Study|Pregnancy|9
5922053|NCT01489358|20488078|P3|Overall Study|Lost to Follow-up|2
5922054|NCT01489358|20488079|P2|Overall Study|Lost to Follow-up|0
5922055|NCT01489358|20488080|P1|Overall Study|Lost to Follow-up|0
5922056|NCT01489254|20488130|P4|Open-label Extension Part|Other reasons for not completing study|5
5922057|NCT01489254|20488131|P3|Open-label Extension Part|Other reasons for not completing study|0
5922058|NCT01489254|20488132|P2|Open-label Extension Part|Other reasons for not completing study|0
5922059|NCT01489254|20488133|P1|Open-label Extension Part|Other reasons for not completing study|0
5922060|NCT01489254|20488130|P4|Open-label Extension Part|Lost to Follow-up|9
5922061|NCT01489254|20488131|P3|Open-label Extension Part|Lost to Follow-up|0
5922062|NCT01489254|20488132|P2|Open-label Extension Part|Lost to Follow-up|0
5922063|NCT01489254|20488133|P1|Open-label Extension Part|Lost to Follow-up|0
5922064|NCT01489254|20488130|P4|Open-label Extension Part|Protocol Violation|1
5922065|NCT01489254|20488131|P3|Open-label Extension Part|Protocol Violation|0
5922066|NCT01489254|20488132|P2|Open-label Extension Part|Protocol Violation|0
5922067|NCT01489254|20488133|P1|Open-label Extension Part|Protocol Violation|0
5922068|NCT01489254|20488130|P4|Open-label Extension Part|Withdrawal by Subject|30
5922069|NCT01489254|20488131|P3|Open-label Extension Part|Withdrawal by Subject|0
5922070|NCT01489254|20488132|P2|Open-label Extension Part|Withdrawal by Subject|0
5922071|NCT01489254|20488133|P1|Open-label Extension Part|Withdrawal by Subject|0
5922072|NCT01489254|20488130|P4|Open-label Extension Part|Pregnancy|3
5922073|NCT01489254|20488131|P3|Open-label Extension Part|Pregnancy|0
5922074|NCT01489254|20488132|P2|Open-label Extension Part|Pregnancy|0
5922075|NCT01489254|20488133|P1|Open-label Extension Part|Pregnancy|0
5922076|NCT01489254|20488130|P4|Open-label Extension Part|Adverse Event|10
5922077|NCT01489254|20488131|P3|Open-label Extension Part|Adverse Event|0
5922078|NCT01489254|20488132|P2|Open-label Extension Part|Adverse Event|0
5922079|NCT01489254|20488133|P1|Open-label Extension Part|Adverse Event|0
5922080|NCT01489254|20488130|P4|Double-blind Part|Other reasons for not completing study|0
5922081|NCT01489254|20488131|P3|Double-blind Part|Other reasons for not completing study|0
5922082|NCT01489254|20488132|P2|Double-blind Part|Other reasons for not completing study|6
5922083|NCT01489254|20488133|P1|Double-blind Part|Other reasons for not completing study|4
5922084|NCT01489254|20488130|P4|Double-blind Part|Lost to Follow-up|0
5922085|NCT01489254|20488131|P3|Double-blind Part|Lost to Follow-up|0
5922086|NCT01489254|20488132|P2|Double-blind Part|Lost to Follow-up|2
5922087|NCT01489254|20488133|P1|Double-blind Part|Lost to Follow-up|1
5922088|NCT01489254|20488130|P4|Double-blind Part|Withdrawal by Subject|0
5922089|NCT01489254|20488131|P3|Double-blind Part|Withdrawal by Subject|1
5922090|NCT01489254|20488132|P2|Double-blind Part|Withdrawal by Subject|20
5922091|NCT01489254|20488133|P1|Double-blind Part|Withdrawal by Subject|12
5922092|NCT01489254|20488130|P4|Double-blind Part|Pregnancy|0
5922093|NCT01489254|20488131|P3|Double-blind Part|Pregnancy|0
5922094|NCT01489254|20488132|P2|Double-blind Part|Pregnancy|3
5922095|NCT01489254|20488133|P1|Double-blind Part|Pregnancy|1
5922096|NCT01489254|20488130|P4|Double-blind Part|Adverse Event|0
5922097|NCT01489254|20488131|P3|Double-blind Part|Adverse Event|2
5922098|NCT01489254|20488132|P2|Double-blind Part|Adverse Event|2
5922099|NCT01489254|20488133|P1|Double-blind Part|Adverse Event|7
5922100|NCT01489189|20488144|P2|Overall Study|Missed Visit|4
5922101|NCT01489189|20488145|P1|Overall Study|Missed Visit|1
5922102|NCT01489189|20488144|P2|Overall Study|Death|8
5922103|NCT01489189|20488145|P1|Overall Study|Death|10
5922104|NCT01489189|20488144|P2|Overall Study|Withdrawal by Subject|23
5922105|NCT01489189|20488145|P1|Overall Study|Withdrawal by Subject|20
5922106|NCT01489111|20488170|P1|Overall Study|Withdrawal criterion|1
5922107|NCT01489020|20488191|P6|Overall Study|Concomitant disease|0
5922108|NCT01489020|20488192|P5|Overall Study|Concomitant disease|3
5922109|NCT01489020|20488193|P4|Overall Study|Concomitant disease|0
5922110|NCT01489020|20488194|P3|Overall Study|Concomitant disease|0
5922111|NCT01489020|20488195|P2|Overall Study|Concomitant disease|0
5922112|NCT01489020|20488196|P1|Overall Study|Concomitant disease|0
5922113|NCT01489020|20488191|P6|Overall Study|Adverse Event|0
5922114|NCT01489020|20488192|P5|Overall Study|Adverse Event|3
5922115|NCT01489020|20488193|P4|Overall Study|Adverse Event|0
5922116|NCT01489020|20488194|P3|Overall Study|Adverse Event|3
5922117|NCT01489020|20488195|P2|Overall Study|Adverse Event|0
5922118|NCT01489020|20488196|P1|Overall Study|Adverse Event|0
5922119|NCT01489020|20488191|P6|Overall Study|Withdrawal by Subject|0
5922120|NCT01489020|20488192|P5|Overall Study|Withdrawal by Subject|0
5922121|NCT01489020|20488193|P4|Overall Study|Withdrawal by Subject|0
5922122|NCT01489020|20488194|P3|Overall Study|Withdrawal by Subject|0
5922123|NCT01489020|20488195|P2|Overall Study|Withdrawal by Subject|0
5922124|NCT01489020|20488196|P1|Overall Study|Withdrawal by Subject|1
5922125|NCT01488994|20488230|P2|Overall Study|Withdrawal by Subject|1
5922126|NCT01488994|20488231|P1|Overall Study|Withdrawal by Subject|0
5922127|NCT01488890|20488322|P4|Overall Study|Withdrawal by Subject|2
5922128|NCT01488890|20488323|P3|Overall Study|Withdrawal by Subject|11
5922129|NCT01488890|20488324|P2|Overall Study|Withdrawal by Subject|10
5922130|NCT01488890|20488325|P1|Overall Study|Withdrawal by Subject|14
5922131|NCT01488890|20488322|P4|Overall Study|Lost to Follow-up|3
5922132|NCT01488890|20488323|P3|Overall Study|Lost to Follow-up|20
5922133|NCT01488890|20488324|P2|Overall Study|Lost to Follow-up|10
5922134|NCT01488890|20488325|P1|Overall Study|Lost to Follow-up|13
5922135|NCT01488890|20488322|P4|Overall Study|Protocol Violation|0
5922136|NCT01488890|20488323|P3|Overall Study|Protocol Violation|4
5922137|NCT01488890|20488324|P2|Overall Study|Protocol Violation|0
5922138|NCT01488890|20488325|P1|Overall Study|Protocol Violation|3
5922139|NCT01488890|20488322|P4|Overall Study|Serious adverse event|0
5922140|NCT01488890|20488323|P3|Overall Study|Serious adverse event|0
5922141|NCT01488890|20488324|P2|Overall Study|Serious adverse event|0
5922142|NCT01488890|20488325|P1|Overall Study|Serious adverse event|2
5922143|NCT01488487|20488403|P1|Overall Study|Withdrawal by Subject|2
5922144|NCT01488487|20488403|P1|Overall Study|Death|1
5922145|NCT01488487|20488403|P1|Overall Study|Adverse Event|6
5922146|NCT01488448|20488412|P2|Overall Study|Protocol Violation|3
5922147|NCT01488448|20488413|P1|Overall Study|Protocol Violation|4
5922148|NCT01488448|20488412|P2|Overall Study|Physician Decision|9
5922149|NCT01488448|20488413|P1|Overall Study|Physician Decision|4
5922150|NCT01488448|20488412|P2|Overall Study|Adverse Event|4
5922151|NCT01488448|20488413|P1|Overall Study|Adverse Event|9
5922152|NCT01488448|20488412|P2|Overall Study|Withdrawal by Subject|1
5922153|NCT01488448|20488413|P1|Overall Study|Withdrawal by Subject|3
5922154|NCT01488370|20488455|P3|Overall Study|Protocol Violation|1
5922155|NCT01488370|20488456|P2|Overall Study|Protocol Violation|1
5922156|NCT01488370|20488457|P1|Overall Study|Protocol Violation|0
5922157|NCT01488097|20488516|P1|Overall Study|Lost to Follow-up|1
5922158|NCT01488071|20488529|P2|Overall Study|Administrative or Other Reason(s)|4
5922159|NCT01488071|20488530|P1|Overall Study|Administrative or Other Reason(s)|5
5922160|NCT01488071|20488529|P2|Overall Study|Lost to Follow-up|0
5922161|NCT01488071|20488530|P1|Overall Study|Lost to Follow-up|1
5922162|NCT01488071|20488529|P2|Overall Study|Withdrawal of Consent|12
5922163|NCT01488071|20488530|P1|Overall Study|Withdrawal of Consent|14
5922164|NCT01488071|20488529|P2|Overall Study|Protocol Violation|7
5922165|NCT01488071|20488530|P1|Overall Study|Protocol Violation|5
5922166|NCT01488071|20488529|P2|Overall Study|Non-compliance with study drug|0
5922167|NCT01488071|20488530|P1|Overall Study|Non-compliance with study drug|2
5922168|NCT01488071|20488529|P2|Overall Study|Lack of Efficacy|17
5922169|NCT01488071|20488530|P1|Overall Study|Lack of Efficacy|11
5922170|NCT01488071|20488529|P2|Overall Study|Adverse Event|23
5922171|NCT01488071|20488530|P1|Overall Study|Adverse Event|15
5922172|NCT01487863|20488610|P2|Overall Study|Death|19
5922173|NCT01487863|20488611|P1|Overall Study|Death|19
5922174|NCT01487577|20488628|P1|Overall Study|Became ineligible after signing consent|1
5922175|NCT01487525|20488642|P2|Overall Study|Withdrawal by Subject|1
5922176|NCT01487525|20488643|P1|Overall Study|Withdrawal by Subject|0
5922177|NCT01487265|20488659|P1|Overall Study|Still on Treatment|1
5922178|NCT01487265|20488659|P1|Overall Study|Death|2
5922179|NCT01487265|20488659|P1|Overall Study|Disease Progression|21
5922180|NCT01487265|20488659|P1|Overall Study|Withdrawal by Subject|5
5922181|NCT01487265|20488659|P1|Overall Study|Adverse Event|8
5922182|NCT01487200|20488671|P4|Overall Study|Withdrawal by Subject|0
5922183|NCT01487200|20488672|P3|Overall Study|Withdrawal by Subject|0
5922184|NCT01487200|20488673|P2|Overall Study|Withdrawal by Subject|1
5922185|NCT01487200|20488674|P1|Overall Study|Withdrawal by Subject|0
5922186|NCT01487161|20488704|P4|Overall Study|missing data|0
5922187|NCT01487161|20488705|P3|Overall Study|missing data|0
5922188|NCT01487161|20488706|P2|Overall Study|missing data|1
5922189|NCT01487161|20488707|P1|Overall Study|missing data|0
5922190|NCT01487161|20488704|P4|Overall Study|Withdrawal by Subject|2
5922191|NCT01487161|20488705|P3|Overall Study|Withdrawal by Subject|1
5922192|NCT01487161|20488706|P2|Overall Study|Withdrawal by Subject|1
5922193|NCT01487161|20488707|P1|Overall Study|Withdrawal by Subject|1
5922194|NCT01487161|20488704|P4|Overall Study|Adverse Event|0
5922195|NCT01487161|20488705|P3|Overall Study|Adverse Event|0
5922196|NCT01487161|20488706|P2|Overall Study|Adverse Event|0
5922197|NCT01487161|20488707|P1|Overall Study|Adverse Event|1
5922198|NCT01486966|20488772|P2|Overall Study|Withdrawal by Subject|1
5922199|NCT01486966|20488773|P1|Overall Study|Withdrawal by Subject|0
5922200|NCT01486966|20488772|P2|Overall Study|Adverse Event|1
5922201|NCT01486966|20488773|P1|Overall Study|Adverse Event|0
5922202|NCT01486927|20488797|P1|Overall Study|Subject did not reach 6 mo of treatment|1
5922203|NCT01486927|20488797|P1|Overall Study|Withdrawal by Subject|8
5922204|NCT01486927|20488797|P1|Overall Study|50 Exposure days not reached|2
5922205|NCT01486927|20488797|P1|Overall Study|Physician Decision|1
5922206|NCT01486927|20488797|P1|Overall Study|Knee surgery (prior to surgery substudy)|1
5922207|NCT01486758|20488835|P2|Overall Study|Lost to Follow-up|1
5922208|NCT01486758|20488836|P1|Overall Study|Lost to Follow-up|0
5922209|NCT01486446|20488903|P2|Overall Study|Adverse Event|0
5922210|NCT01486446|20488904|P1|Overall Study|Adverse Event|1
5922211|NCT01486316|20488927|P4|Overall Study|Death|0
5922212|NCT01486316|20488928|P3|Overall Study|Death|0
5922213|NCT01486316|20488929|P2|Overall Study|Death|1
5922214|NCT01486316|20488930|P1|Overall Study|Death|0
5922215|NCT01486316|20488927|P4|Overall Study|Physician Decision|0
5922216|NCT01486316|20488928|P3|Overall Study|Physician Decision|1
5922217|NCT01486316|20488929|P2|Overall Study|Physician Decision|0
5922218|NCT01486316|20488930|P1|Overall Study|Physician Decision|0
5922219|NCT01486316|20488927|P4|Overall Study|Withdrawal by Subject|0
5922220|NCT01486316|20488928|P3|Overall Study|Withdrawal by Subject|3
5922221|NCT01486316|20488929|P2|Overall Study|Withdrawal by Subject|0
5922222|NCT01486316|20488930|P1|Overall Study|Withdrawal by Subject|1
5922223|NCT01486316|20488927|P4|Overall Study|Not meeting eligibility criteria|0
5922224|NCT01486316|20488928|P3|Overall Study|Not meeting eligibility criteria|1
5922225|NCT01486316|20488929|P2|Overall Study|Not meeting eligibility criteria|0
5922226|NCT01486316|20488930|P1|Overall Study|Not meeting eligibility criteria|0
5922227|NCT01486316|20488927|P4|Overall Study|Device explanted with/without re-implant|2
5922228|NCT01486316|20488928|P3|Overall Study|Device explanted with/without re-implant|0
5922229|NCT01486316|20488929|P2|Overall Study|Device explanted with/without re-implant|2
5922230|NCT01486316|20488930|P1|Overall Study|Device explanted with/without re-implant|3
5922231|NCT01486264|20488942|P2|Overall Study|Not treated|1
5922232|NCT01486264|20488943|P1|Overall Study|Not treated|0
5922233|NCT01486264|20488942|P2|Overall Study|Other|11
5922234|NCT01486264|20488943|P1|Overall Study|Other|5
5922235|NCT01486264|20488942|P2|Overall Study|Lost to Follow-up|2
5922236|NCT01486264|20488943|P1|Overall Study|Lost to Follow-up|3
5922237|NCT01486264|20488942|P2|Overall Study|Protocol Violation|0
5922238|NCT01486264|20488943|P1|Overall Study|Protocol Violation|3
5922239|NCT01486264|20488942|P2|Overall Study|Physician Decision|1
5922240|NCT01486264|20488943|P1|Overall Study|Physician Decision|1
5922241|NCT01486264|20488942|P2|Overall Study|Withdrawal by Subject|18
5922242|NCT01486264|20488943|P1|Overall Study|Withdrawal by Subject|7
5922243|NCT01486264|20488942|P2|Overall Study|Lack of Efficacy|10
5922244|NCT01486264|20488943|P1|Overall Study|Lack of Efficacy|6
5922245|NCT01486264|20488942|P2|Overall Study|Adverse Event|3
5922246|NCT01486264|20488943|P1|Overall Study|Adverse Event|3
5922247|NCT01486264|20488942|P2|Overall Study|Death|1
5922248|NCT01486264|20488943|P1|Overall Study|Death|1
5922249|NCT01486238|20488975|P2|Overall Study|Lost to Follow-up|3
5922250|NCT01486238|20488976|P1|Overall Study|Lost to Follow-up|0
5922251|NCT01486238|20488975|P2|Overall Study|Withdrawal by Subject|1
5922252|NCT01486238|20488976|P1|Overall Study|Withdrawal by Subject|2
5922253|NCT01486238|20488975|P2|Overall Study|Death|2
5922254|NCT01486238|20488976|P1|Overall Study|Death|0
5922255|NCT01486199|20488984|P2|Two Year Period Between Study Days|Physician Decision|0
5922256|NCT01486199|20488985|P1|Two Year Period Between Study Days|Physician Decision|1
5922257|NCT01485991|20489005|P2|Overall Study|randomized but not treated|2
5922258|NCT01485991|20489006|P1|Overall Study|randomized but not treated|6
5922259|NCT01485991|20489005|P2|Overall Study|Withdrawal by Subject|20
5922260|NCT01485991|20489006|P1|Overall Study|Withdrawal by Subject|13
5922261|NCT01485991|20489005|P2|Overall Study|Lost to Follow-up|10
5922262|NCT01485991|20489006|P1|Overall Study|Lost to Follow-up|13
5922263|NCT01485991|20489005|P2|Overall Study|Adverse Event|4
5922264|NCT01485991|20489006|P1|Overall Study|Adverse Event|0
5922265|NCT01485796|20489016|P1|Overall Trial (Incl. Safety Follow-up)|Withdrawal During Safety-Follow-up|2
5922266|NCT01485796|20489016|P1|Overall Trial (Incl. Safety Follow-up)|Adverse Event in Epoch 2|3
5922267|NCT01485796|20489016|P1|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 2|6
5922268|NCT01485796|20489016|P1|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 1|1
5922269|NCT01485796|20489016|P1|Period 2: Epoch 2|Switch to safety follow-up|26
5922270|NCT01485796|20489016|P1|Period 2: Epoch 2|Adverse Event|3
5922271|NCT01485796|20489016|P1|Period 2: Epoch 2|Withdrawal by Subject|6
5922272|NCT01485796|20489016|P1|Period 1: Epoch 1 (Ramp-up)|Withdrawal by Subject|1
5922273|NCT01485640|20489038|P1|Overall Study|Terminated by Sponsor|95
5922274|NCT01485640|20489038|P1|Overall Study|Withdrawal by Subject|14
5922275|NCT01485640|20489038|P1|Overall Study|Protocol Violation|1
5922276|NCT01485640|20489038|P1|Overall Study|Lack of Efficacy|2
5922277|NCT01485640|20489038|P1|Overall Study|Adverse Event|10
5922278|NCT01485627|20489045|P2|Overall Study|caregiver was not bereaved|35
5922279|NCT01485627|20489046|P1|Overall Study|caregiver was not bereaved|42
5922280|NCT01485627|20489045|P2|Overall Study|Caregiver died|0
5922281|NCT01485627|20489046|P1|Overall Study|Caregiver died|1
5922282|NCT01485627|20489045|P2|Overall Study|Caregiver lost to follow up|12
5922283|NCT01485627|20489046|P1|Overall Study|Caregiver lost to follow up|11
5922284|NCT01485627|20489045|P2|Overall Study|Caregiver withdrew|3
5922285|NCT01485627|20489046|P1|Overall Study|Caregiver withdrew|3
5922286|NCT01485627|20489045|P2|Overall Study|Patient lost to followup|1
5922287|NCT01485627|20489046|P1|Overall Study|Patient lost to followup|0
5922288|NCT01485627|20489045|P2|Overall Study|Patient died|1
5922289|NCT01485627|20489046|P1|Overall Study|Patient died|3
5922290|NCT01485627|20489045|P2|Overall Study|Patient withdrew|5
5922291|NCT01485627|20489046|P1|Overall Study|Patient withdrew|6
5922292|NCT01485614|20489068|P4|Weeks 20-54|Withdrawal by Subject|0
5922293|NCT01485614|20489069|P3|Weeks 20-54|Withdrawal by Subject|0
5922294|NCT01485614|20489070|P2|Weeks 20-54|Withdrawal by Subject|3
5922295|NCT01485614|20489071|P1|Weeks 20-54|Withdrawal by Subject|5
5922296|NCT01485614|20489068|P4|Weeks 20-54|Withdrawal by Parent/Guardian|0
5922297|NCT01485614|20489069|P3|Weeks 20-54|Withdrawal by Parent/Guardian|1
5922298|NCT01485614|20489070|P2|Weeks 20-54|Withdrawal by Parent/Guardian|2
5922299|NCT01485614|20489071|P1|Weeks 20-54|Withdrawal by Parent/Guardian|2
5922300|NCT01485614|20489068|P4|Weeks 20-54|Lost to Follow-up|0
5922301|NCT01485614|20489069|P3|Weeks 20-54|Lost to Follow-up|1
5922302|NCT01485614|20489070|P2|Weeks 20-54|Lost to Follow-up|3
5922303|NCT01485614|20489071|P1|Weeks 20-54|Lost to Follow-up|4
5922304|NCT01485614|20489068|P4|Weeks 0-20|Withdrawal by Subject|0
5922305|NCT01485614|20489069|P3|Weeks 0-20|Withdrawal by Subject|1
5922306|NCT01485614|20489070|P2|Weeks 0-20|Withdrawal by Subject|2
5922307|NCT01485614|20489071|P1|Weeks 0-20|Withdrawal by Subject|3
5922308|NCT01485614|20489068|P4|Weeks 0-20|Withdrawal by Parent/Guardian|0
5922309|NCT01485614|20489069|P3|Weeks 0-20|Withdrawal by Parent/Guardian|0
5922310|NCT01485614|20489070|P2|Weeks 0-20|Withdrawal by Parent/Guardian|2
5922311|NCT01485614|20489071|P1|Weeks 0-20|Withdrawal by Parent/Guardian|5
5922312|NCT01485614|20489068|P4|Weeks 0-20|Lost to Follow-up|0
5922313|NCT01485614|20489069|P3|Weeks 0-20|Lost to Follow-up|0
5922314|NCT01485614|20489070|P2|Weeks 0-20|Lost to Follow-up|0
5922315|NCT01485614|20489071|P1|Weeks 0-20|Lost to Follow-up|2
5922316|NCT01485614|20489068|P4|Randomization|Not Treated|0
5922317|NCT01485614|20489069|P3|Randomization|Not Treated|0
5922318|NCT01485614|20489070|P2|Randomization|Not Treated|0
5922319|NCT01485614|20489071|P1|Randomization|Not Treated|1
5922320|NCT01485536|20489443|P1|Overall Study|Adverse Event|1
5922321|NCT01485536|20489443|P1|Overall Study|Withdrawal by Subject|3
5922322|NCT01485354|20489461|P1|Overall Study|Withdrawal by Subject|5
5922323|NCT01485172|20489475|P6|Overall Study|Withdrawal by Subject|1
5922324|NCT01485172|20489476|P5|Overall Study|Withdrawal by Subject|1
5922325|NCT01485172|20489477|P4|Overall Study|Withdrawal by Subject|1
5922326|NCT01485172|20489478|P3|Overall Study|Withdrawal by Subject|0
5922327|NCT01485172|20489479|P2|Overall Study|Withdrawal by Subject|0
5922328|NCT01485172|20489480|P1|Overall Study|Withdrawal by Subject|2
5922329|NCT01485172|20489475|P6|Overall Study|Physician Decision|0
5922330|NCT01485172|20489476|P5|Overall Study|Physician Decision|1
5922331|NCT01485172|20489477|P4|Overall Study|Physician Decision|0
5922332|NCT01485172|20489478|P3|Overall Study|Physician Decision|0
5922333|NCT01485172|20489479|P2|Overall Study|Physician Decision|0
5922334|NCT01485172|20489480|P1|Overall Study|Physician Decision|0
5922335|NCT01485172|20489475|P6|Overall Study|Lost to Follow-up|1
5922336|NCT01485172|20489476|P5|Overall Study|Lost to Follow-up|0
5922337|NCT01485172|20489477|P4|Overall Study|Lost to Follow-up|0
5922338|NCT01485172|20489478|P3|Overall Study|Lost to Follow-up|1
5922339|NCT01485172|20489479|P2|Overall Study|Lost to Follow-up|0
5922340|NCT01485172|20489480|P1|Overall Study|Lost to Follow-up|0
5922341|NCT01485172|20489475|P6|Overall Study|Protocol defined stopping criteria|0
5922342|NCT01485172|20489476|P5|Overall Study|Protocol defined stopping criteria|1
5922343|NCT01485172|20489477|P4|Overall Study|Protocol defined stopping criteria|0
5922344|NCT01485172|20489478|P3|Overall Study|Protocol defined stopping criteria|0
5922345|NCT01485172|20489479|P2|Overall Study|Protocol defined stopping criteria|0
5922346|NCT01485172|20489480|P1|Overall Study|Protocol defined stopping criteria|1
5922347|NCT01485172|20489475|P6|Overall Study|Protocol Violation|0
5922348|NCT01485172|20489476|P5|Overall Study|Protocol Violation|1
5922349|NCT01485172|20489477|P4|Overall Study|Protocol Violation|5
5922350|NCT01485172|20489478|P3|Overall Study|Protocol Violation|4
5922351|NCT01485172|20489479|P2|Overall Study|Protocol Violation|0
5922352|NCT01485172|20489480|P1|Overall Study|Protocol Violation|0
5922353|NCT01485172|20489475|P6|Overall Study|Lack of Efficacy|0
5922354|NCT01485172|20489476|P5|Overall Study|Lack of Efficacy|0
5922355|NCT01485172|20489477|P4|Overall Study|Lack of Efficacy|0
5922356|NCT01485172|20489478|P3|Overall Study|Lack of Efficacy|0
5922357|NCT01485172|20489479|P2|Overall Study|Lack of Efficacy|0
5922358|NCT01485172|20489480|P1|Overall Study|Lack of Efficacy|2
5922359|NCT01485172|20489475|P6|Overall Study|Adverse Event|2
5922360|NCT01485172|20489476|P5|Overall Study|Adverse Event|1
5922361|NCT01485172|20489477|P4|Overall Study|Adverse Event|2
5922362|NCT01485172|20489478|P3|Overall Study|Adverse Event|2
5922363|NCT01485172|20489479|P2|Overall Study|Adverse Event|1
5922364|NCT01485172|20489480|P1|Overall Study|Adverse Event|2
5922365|NCT01485120|20489554|P1|Overall Study|Withdrawal by Subject|2
5922366|NCT01485094|20489562|P3|Overall Study|Withdrawal by Subject|0
5922367|NCT01485094|20489563|P2|Overall Study|Withdrawal by Subject|1
5922368|NCT01485094|20489564|P1|Overall Study|Withdrawal by Subject|1
5922369|NCT01485094|20489562|P3|Overall Study|Lost to Follow-up|0
5922370|NCT01485094|20489563|P2|Overall Study|Lost to Follow-up|0
5922371|NCT01485094|20489564|P1|Overall Study|Lost to Follow-up|1
5922372|NCT01485094|20489562|P3|Overall Study|Adverse Event|1
5922373|NCT01485094|20489563|P2|Overall Study|Adverse Event|1
5922374|NCT01485094|20489564|P1|Overall Study|Adverse Event|1
5922375|NCT01484977|20489609|P1|Overall Study|Lack of Compliance|1
5922376|NCT01484977|20489609|P1|Overall Study|Low White Blood Cell Count|1
5922377|NCT01484977|20489609|P1|Overall Study|Moving Overseas|1
5922378|NCT01484977|20489609|P1|Overall Study|Subject Protocol Non-compliant|1
5922379|NCT01484977|20489609|P1|Overall Study|Withdrawal by Subject|4
5922380|NCT01484977|20489609|P1|Overall Study|Lost to Follow-up|1
5922381|NCT01484977|20489609|P1|Overall Study|Protocol Violation|6
5922382|NCT01484977|20489609|P1|Overall Study|Lack of Efficacy|4
5922383|NCT01484977|20489609|P1|Overall Study|Adverse Event|8
5922384|NCT01484951|20489613|P1|Overall Study|Non-Compliance|1
5922385|NCT01484951|20489613|P1|Overall Study|Personal Reasons|1
5922386|NCT01484951|20489613|P1|Overall Study|Adverse Event|3
5922387|NCT01484938|20489618|P1|Overall Study|Noncompliance|1
5922388|NCT01484938|20489618|P1|Overall Study|Lost to Follow-up|1
5922389|NCT01484938|20489618|P1|Overall Study|Adverse Event|2
5922390|NCT01484912|20489625|P2|Overall Study|Physician Decision|1
5922391|NCT01484912|20489626|P1|Overall Study|Physician Decision|0
5922392|NCT01484912|20489625|P2|Overall Study|Withdrawal by Subject|0
5922393|NCT01484912|20489626|P1|Overall Study|Withdrawal by Subject|1
5922394|NCT01484873|20489636|P1|Overall Study|Withdrawal by Subject|2
5922395|NCT01484834|20489648|P4|Overall Study|Lost to Follow-up|4
5922396|NCT01484834|20489649|P3|Overall Study|Lost to Follow-up|1
5922397|NCT01484834|20489650|P2|Overall Study|Lost to Follow-up|8
5922398|NCT01484834|20489651|P1|Overall Study|Lost to Follow-up|5
5922399|NCT01484561|20489692|P2|Overall Study|Adverse Event|4
5922400|NCT01484561|20489693|P1|Overall Study|Adverse Event|1
5922401|NCT01484561|20489692|P2|Overall Study|Other|1
5922402|NCT01484561|20489693|P1|Overall Study|Other|1
5922403|NCT01484561|20489692|P2|Overall Study|Withdrawal by Subject|0
5922404|NCT01484561|20489693|P1|Overall Study|Withdrawal by Subject|3
5922405|NCT01484561|20489692|P2|Overall Study|Lost to Follow-up|0
5922406|NCT01484561|20489693|P1|Overall Study|Lost to Follow-up|1
5922407|NCT01484561|20489692|P2|Overall Study|Lack of Efficacy|1
5922408|NCT01484561|20489693|P1|Overall Study|Lack of Efficacy|3
5922409|NCT01484496|20489783|P4|Period 2|Other|6
5922410|NCT01484496|20489784|P3|Period 2|Other|9
5922411|NCT01484496|20489785|P2|Period 2|Other|0
5922412|NCT01484496|20489786|P1|Period 2|Other|0
5922413|NCT01484496|20489783|P4|Period 2|Adverse Event|13
5922414|NCT01484496|20489784|P3|Period 2|Adverse Event|5
5922415|NCT01484496|20489785|P2|Period 2|Adverse Event|0
5922416|NCT01484496|20489786|P1|Period 2|Adverse Event|0
5922417|NCT01484496|20489783|P4|Period 2|Lack of Efficacy|3
5922418|NCT01484496|20489784|P3|Period 2|Lack of Efficacy|1
5922419|NCT01484496|20489785|P2|Period 2|Lack of Efficacy|0
5922420|NCT01484496|20489786|P1|Period 2|Lack of Efficacy|0
5922421|NCT01484496|20489783|P4|Period 1|Unable to Visit Site|0
5922422|NCT01484496|20489784|P3|Period 1|Unable to Visit Site|0
5922423|NCT01484496|20489785|P2|Period 1|Unable to Visit Site|2
5922424|NCT01484496|20489786|P1|Period 1|Unable to Visit Site|0
5922425|NCT01484496|20489783|P4|Period 1|Lack of Compliance|0
5922426|NCT01484496|20489784|P3|Period 1|Lack of Compliance|0
5922427|NCT01484496|20489785|P2|Period 1|Lack of Compliance|1
5922428|NCT01484496|20489786|P1|Period 1|Lack of Compliance|2
5922429|NCT01484496|20489783|P4|Period 1|Treatment Failure|0
5922430|NCT01484496|20489784|P3|Period 1|Treatment Failure|0
5922431|NCT01484496|20489785|P2|Period 1|Treatment Failure|6
5922432|NCT01484496|20489786|P1|Period 1|Treatment Failure|3
5922433|NCT01484496|20489783|P4|Period 1|Positive Pregnancy|0
5922434|NCT01484496|20489784|P3|Period 1|Positive Pregnancy|0
5922435|NCT01484496|20489785|P2|Period 1|Positive Pregnancy|6
5922436|NCT01484496|20489786|P1|Period 1|Positive Pregnancy|1
5922437|NCT01484496|20489783|P4|Period 1|Lost to Follow-up|0
5922438|NCT01484496|20489784|P3|Period 1|Lost to Follow-up|0
5922439|NCT01484496|20489785|P2|Period 1|Lost to Follow-up|6
5922440|NCT01484496|20489786|P1|Period 1|Lost to Follow-up|2
5922441|NCT01484496|20489783|P4|Period 1|Withdrawal by Subject|0
5922442|NCT01484496|20489784|P3|Period 1|Withdrawal by Subject|0
5922443|NCT01484496|20489785|P2|Period 1|Withdrawal by Subject|12
5922444|NCT01484496|20489786|P1|Period 1|Withdrawal by Subject|15
5922445|NCT01484496|20489783|P4|Period 1|Adverse Event|0
5922446|NCT01484496|20489784|P3|Period 1|Adverse Event|0
5922447|NCT01484496|20489785|P2|Period 1|Adverse Event|40
5922448|NCT01484496|20489786|P1|Period 1|Adverse Event|25
5922449|NCT01484496|20489783|P4|Period 1|Lack of Efficacy|0
5922450|NCT01484496|20489784|P3|Period 1|Lack of Efficacy|0
5922451|NCT01484496|20489785|P2|Period 1|Lack of Efficacy|15
5922452|NCT01484496|20489786|P1|Period 1|Lack of Efficacy|10
5922453|NCT01484496|20489783|P4|Period 1|Physician Decision|0
5922454|NCT01484496|20489784|P3|Period 1|Physician Decision|0
5922455|NCT01484496|20489785|P2|Period 1|Physician Decision|1
5922456|NCT01484496|20489786|P1|Period 1|Physician Decision|5
5922457|NCT01484496|20489783|P4|Period 1|Protocol Violation|0
5922458|NCT01484496|20489784|P3|Period 1|Protocol Violation|0
5922459|NCT01484496|20489785|P2|Period 1|Protocol Violation|4
5922460|NCT01484496|20489786|P1|Period 1|Protocol Violation|3
5922461|NCT01484431|20489801|P3|Period 2|Non-Compliance with Study Drug|0
5922462|NCT01484431|20489802|P2|Period 2|Non-Compliance with Study Drug|0
5922463|NCT01484431|20489803|P1|Period 2|Non-Compliance with Study Drug|1
5922464|NCT01484431|20489801|P3|Period 2|Physician Decision|1
5922465|NCT01484431|20489802|P2|Period 2|Physician Decision|0
5922466|NCT01484431|20489803|P1|Period 2|Physician Decision|0
5922467|NCT01484431|20489801|P3|Period 2|Death|1
5922468|NCT01484431|20489802|P2|Period 2|Death|1
5922469|NCT01484431|20489803|P1|Period 2|Death|0
5922470|NCT01484431|20489801|P3|Period 1: High Dose|Physician Decision|0
5922471|NCT01484431|20489802|P2|Period 1: High Dose|Physician Decision|1
5922472|NCT01484431|20489803|P1|Period 1: High Dose|Physician Decision|0
5922473|NCT01484275|20489841|P2|Overall Study|Lost to Follow-up|1
5922474|NCT01484275|20489842|P1|Overall Study|Lost to Follow-up|1
5922475|NCT01484275|20489841|P2|Overall Study|Withdrawal by Subject|5
5922476|NCT01484275|20489842|P1|Overall Study|Withdrawal by Subject|1
5922477|NCT01484275|20489841|P2|Overall Study|Death|4
5922478|NCT01484275|20489842|P1|Overall Study|Death|3
5922479|NCT01484275|20489841|P2|Overall Study|Other|0
5922480|NCT01484275|20489842|P1|Overall Study|Other|10
5922481|NCT01484275|20489841|P2|Overall Study|Study terminated by sponsor|32
5922482|NCT01484275|20489842|P1|Overall Study|Study terminated by sponsor|28
5922483|NCT01484197|20489864|P4|Treatment Period 2|Subject withdrew consent|1
5922484|NCT01484197|20489865|P3|Treatment Period 2|Subject withdrew consent|0
5922485|NCT01484197|20489866|P2|Treatment Period 2|Subject withdrew consent|0
5922486|NCT01484197|20489867|P1|Treatment Period 2|Subject withdrew consent|0
5922487|NCT01484197|20489864|P4|Treatment Period 1|Adverse Event|0
5922488|NCT01484197|20489865|P3|Treatment Period 1|Adverse Event|0
5922489|NCT01484197|20489866|P2|Treatment Period 1|Adverse Event|0
5922490|NCT01484197|20489867|P1|Treatment Period 1|Adverse Event|1
5922491|NCT01484132|20489950|P1|Overall Study|No post-treatment urine sample collected|10
5922492|NCT01484132|20489950|P1|Overall Study|No pre-treatment urine sample collected|1
5922493|NCT01484132|20489950|P1|Overall Study|Ineligible|1
5922494|NCT01484132|20489950|P1|Overall Study|Difficulty with time commitment|2
5922495|NCT01484132|20489950|P1|Overall Study|Lost to Follow-up|8
5922496|NCT01484054|20489958|P2|Period 1|Withdrawal by Subject|1
5922497|NCT01484054|20489959|P1|Period 1|Withdrawal by Subject|0
5922498|NCT01484028|20489977|P4|Period 1|Lens Discomfort|0
5922499|NCT01484028|20489978|P3|Period 1|Lens Discomfort|0
5922500|NCT01484028|20489979|P2|Period 1|Lens Discomfort|1
5922501|NCT01484028|20489980|P1|Period 1|Lens Discomfort|0
5922502|NCT01484028|20489977|P4|Period 1|Non-Compliance to Protocol|1
5922503|NCT01484028|20489978|P3|Period 1|Non-Compliance to Protocol|0
5922504|NCT01484028|20489979|P2|Period 1|Non-Compliance to Protocol|1
5922505|NCT01484028|20489980|P1|Period 1|Non-Compliance to Protocol|0
5922506|NCT01484028|20489977|P4|Period 1|Lost to Follow-up|0
5922507|NCT01484028|20489978|P3|Period 1|Lost to Follow-up|0
5922508|NCT01484028|20489979|P2|Period 1|Lost to Follow-up|1
5922509|NCT01484028|20489980|P1|Period 1|Lost to Follow-up|0
5922510|NCT01483937|20490073|P2|Overall Study|Withdrawal by Subject|3
5922511|NCT01483937|20490074|P1|Overall Study|Withdrawal by Subject|4
5922512|NCT01483924|20490101|P5|Overall Study|Sponsor concern over ECG result|0
5922513|NCT01483924|20490102|P4|Overall Study|Sponsor concern over ECG result|1
5922514|NCT01483924|20490103|P3|Overall Study|Sponsor concern over ECG result|0
5922515|NCT01483924|20490104|P2|Overall Study|Sponsor concern over ECG result|0
5922516|NCT01483924|20490105|P1|Overall Study|Sponsor concern over ECG result|0
5922517|NCT01483924|20490101|P5|Overall Study|Non-compliance|1
5922518|NCT01483924|20490102|P4|Overall Study|Non-compliance|1
5922519|NCT01483924|20490103|P3|Overall Study|Non-compliance|0
5922520|NCT01483924|20490104|P2|Overall Study|Non-compliance|0
5922521|NCT01483924|20490105|P1|Overall Study|Non-compliance|0
5922522|NCT01483924|20490101|P5|Overall Study|Adverse Event|0
5922523|NCT01483924|20490102|P4|Overall Study|Adverse Event|1
5922524|NCT01483924|20490103|P3|Overall Study|Adverse Event|1
5922525|NCT01483924|20490104|P2|Overall Study|Adverse Event|0
5922526|NCT01483924|20490105|P1|Overall Study|Adverse Event|0
5922527|NCT01483924|20490101|P5|Overall Study|Withdrawal by Subject|1
5922528|NCT01483924|20490102|P4|Overall Study|Withdrawal by Subject|1
5922529|NCT01483924|20490103|P3|Overall Study|Withdrawal by Subject|0
5922530|NCT01483924|20490104|P2|Overall Study|Withdrawal by Subject|0
5922531|NCT01483924|20490105|P1|Overall Study|Withdrawal by Subject|2
5922532|NCT01483820|20490158|P1|Overall Study|Death|1
5922533|NCT01483820|20490158|P1|Overall Study|Adverse Event|1
5922534|NCT01483820|20490158|P1|Overall Study|Lack of Efficacy|6
5922535|NCT01483690|20490181|P2|Overall Study|exclusionary procedure|1
5922536|NCT01483690|20490182|P1|Overall Study|exclusionary procedure|0
5922537|NCT01483690|20490181|P2|Overall Study|Physician Decision|2
5922538|NCT01483690|20490182|P1|Overall Study|Physician Decision|0
5922539|NCT01483690|20490181|P2|Overall Study|clinical deterioration|0
5922540|NCT01483690|20490182|P1|Overall Study|clinical deterioration|1
5922541|NCT01483690|20490181|P2|Overall Study|Adverse Event|2
5922542|NCT01483690|20490182|P1|Overall Study|Adverse Event|1
5922543|NCT01483651|20490190|P6|Overall Study|Withdrawal by Subject|1
5922544|NCT01483651|20490191|P5|Overall Study|Withdrawal by Subject|0
5922545|NCT01483651|20490192|P4|Overall Study|Withdrawal by Subject|0
5922546|NCT01483651|20490193|P3|Overall Study|Withdrawal by Subject|1
5922547|NCT01483651|20490194|P2|Overall Study|Withdrawal by Subject|1
5922548|NCT01483651|20490195|P1|Overall Study|Withdrawal by Subject|0
5922549|NCT01483625|20490205|P2|Overall Study|Due to other reason|0
5922550|NCT01483625|20490206|P1|Overall Study|Due to other reason|1
5922551|NCT01483625|20490205|P2|Overall Study|Refused to continue medication|1
5922552|NCT01483625|20490206|P1|Overall Study|Refused to continue medication|2
5922553|NCT01483625|20490205|P2|Overall Study|Adverse Event|1
5922554|NCT01483625|20490206|P1|Overall Study|Adverse Event|1
5922555|NCT01483599|20490229|P14|After Controlled Period(Week 16-Week 40)|Other|0
5922556|NCT01483599|20490230|P13|After Controlled Period(Week 16-Week 40)|Other|1
5922557|NCT01483599|20490231|P12|After Controlled Period(Week 16-Week 40)|Other|0
5922558|NCT01483599|20490232|P11|After Controlled Period(Week 16-Week 40)|Other|0
5922559|NCT01483599|20490233|P10|After Controlled Period(Week 16-Week 40)|Other|4
5922560|NCT01483599|20490234|P9|After Controlled Period(Week 16-Week 40)|Other|0
5922561|NCT01483599|20490235|P8|After Controlled Period(Week 16-Week 40)|Other|1
5922562|NCT01483599|20490236|P7|After Controlled Period(Week 16-Week 40)|Other|0
5922563|NCT01483599|20490237|P6|After Controlled Period(Week 16-Week 40)|Other|0
5922564|NCT01483599|20490238|P5|After Controlled Period(Week 16-Week 40)|Other|0
5922565|NCT01483599|20490239|P4|After Controlled Period(Week 16-Week 40)|Other|0
5922566|NCT01483599|20490240|P3|After Controlled Period(Week 16-Week 40)|Other|0
5922567|NCT01483599|20490241|P2|After Controlled Period(Week 16-Week 40)|Other|0
5922568|NCT01483599|20490242|P1|After Controlled Period(Week 16-Week 40)|Other|0
5922569|NCT01483599|20490229|P14|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|4
5922570|NCT01483599|20490230|P13|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|1
5922571|NCT01483599|20490231|P12|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
5922572|NCT01483599|20490232|P11|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
5922573|NCT01483599|20490233|P10|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
5922574|NCT01483599|20490234|P9|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|5
5922575|NCT01483599|20490235|P8|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
5922576|NCT01483599|20490236|P7|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
5922577|NCT01483599|20490237|P6|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
5922578|NCT01483599|20490238|P5|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
5922579|NCT01483599|20490239|P4|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
5922580|NCT01483599|20490240|P3|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
5922581|NCT01483599|20490241|P2|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
5922582|NCT01483599|20490242|P1|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
5922583|NCT01483599|20490229|P14|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1
5922584|NCT01483599|20490230|P13|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
5922585|NCT01483599|20490231|P12|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
5922586|NCT01483599|20490232|P11|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|2
5922587|NCT01483599|20490233|P10|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
5922588|NCT01483599|20490234|P9|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1
5922589|NCT01483599|20490235|P8|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
5922590|NCT01483599|20490236|P7|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
5922591|NCT01483599|20490237|P6|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
5922592|NCT01483599|20490238|P5|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
5922593|NCT01483599|20490239|P4|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
5922594|NCT01483599|20490240|P3|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
5922595|NCT01483599|20490241|P2|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
5922596|NCT01483599|20490242|P1|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
5922597|NCT01483599|20490229|P14|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1
5922598|NCT01483599|20490230|P13|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
5922599|NCT01483599|20490231|P12|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1
5922600|NCT01483599|20490232|P11|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
5922601|NCT01483599|20490233|P10|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
5922602|NCT01483599|20490234|P9|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1
5922603|NCT01483599|20490235|P8|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
5922604|NCT01483599|20490236|P7|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
5922605|NCT01483599|20490237|P6|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
5922606|NCT01483599|20490238|P5|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
5922607|NCT01483599|20490239|P4|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
5922608|NCT01483599|20490240|P3|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
5922609|NCT01483599|20490241|P2|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
5922610|NCT01483599|20490242|P1|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
5922611|NCT01483599|20490229|P14|After Controlled Period(Week 16-Week 40)|Adverse Event|1
5922612|NCT01483599|20490230|P13|After Controlled Period(Week 16-Week 40)|Adverse Event|1
5922613|NCT01483599|20490231|P12|After Controlled Period(Week 16-Week 40)|Adverse Event|0
5922614|NCT01483599|20490232|P11|After Controlled Period(Week 16-Week 40)|Adverse Event|0
5922615|NCT01483599|20490233|P10|After Controlled Period(Week 16-Week 40)|Adverse Event|0
5922616|NCT01483599|20490234|P9|After Controlled Period(Week 16-Week 40)|Adverse Event|1
5922617|NCT01483599|20490235|P8|After Controlled Period(Week 16-Week 40)|Adverse Event|1
5922618|NCT01483599|20490236|P7|After Controlled Period(Week 16-Week 40)|Adverse Event|0
5922619|NCT01483599|20490237|P6|After Controlled Period(Week 16-Week 40)|Adverse Event|0
5922620|NCT01483599|20490238|P5|After Controlled Period(Week 16-Week 40)|Adverse Event|0
5922621|NCT01483599|20490239|P4|After Controlled Period(Week 16-Week 40)|Adverse Event|0
5922622|NCT01483599|20490240|P3|After Controlled Period(Week 16-Week 40)|Adverse Event|0
5922623|NCT01483599|20490241|P2|After Controlled Period(Week 16-Week 40)|Adverse Event|0
5922624|NCT01483599|20490242|P1|After Controlled Period(Week 16-Week 40)|Adverse Event|0
5922625|NCT01483599|20490229|P14|After Controlled Period(Week 16-Week 40)|Death|0
5922626|NCT01483599|20490230|P13|After Controlled Period(Week 16-Week 40)|Death|0
5922627|NCT01483599|20490231|P12|After Controlled Period(Week 16-Week 40)|Death|0
5922628|NCT01483599|20490232|P11|After Controlled Period(Week 16-Week 40)|Death|0
5922629|NCT01483599|20490233|P10|After Controlled Period(Week 16-Week 40)|Death|0
5922630|NCT01483599|20490234|P9|After Controlled Period(Week 16-Week 40)|Death|1
5922631|NCT01483599|20490235|P8|After Controlled Period(Week 16-Week 40)|Death|0
5922632|NCT01483599|20490236|P7|After Controlled Period(Week 16-Week 40)|Death|0
5922633|NCT01483599|20490237|P6|After Controlled Period(Week 16-Week 40)|Death|0
5922634|NCT01483599|20490238|P5|After Controlled Period(Week 16-Week 40)|Death|0
5922635|NCT01483599|20490239|P4|After Controlled Period(Week 16-Week 40)|Death|0
5922636|NCT01483599|20490240|P3|After Controlled Period(Week 16-Week 40)|Death|0
5922637|NCT01483599|20490241|P2|After Controlled Period(Week 16-Week 40)|Death|0
5922638|NCT01483599|20490242|P1|After Controlled Period(Week 16-Week 40)|Death|0
5922639|NCT01483599|20490229|P14|Controlled Period (CP) (up to Week 16)|Other|0
5922640|NCT01483599|20490230|P13|Controlled Period (CP) (up to Week 16)|Other|0
5922641|NCT01483599|20490231|P12|Controlled Period (CP) (up to Week 16)|Other|0
5922642|NCT01483599|20490232|P11|Controlled Period (CP) (up to Week 16)|Other|0
5922643|NCT01483599|20490233|P10|Controlled Period (CP) (up to Week 16)|Other|0
5922644|NCT01483599|20490234|P9|Controlled Period (CP) (up to Week 16)|Other|0
5922645|NCT01483599|20490235|P8|Controlled Period (CP) (up to Week 16)|Other|0
5922646|NCT01483599|20490236|P7|Controlled Period (CP) (up to Week 16)|Other|0
5922647|NCT01483599|20490237|P6|Controlled Period (CP) (up to Week 16)|Other|0
5922648|NCT01483599|20490238|P5|Controlled Period (CP) (up to Week 16)|Other|1
5922649|NCT01483599|20490239|P4|Controlled Period (CP) (up to Week 16)|Other|1
5922650|NCT01483599|20490240|P3|Controlled Period (CP) (up to Week 16)|Other|0
5922651|NCT01483599|20490241|P2|Controlled Period (CP) (up to Week 16)|Other|2
5922652|NCT01483599|20490242|P1|Controlled Period (CP) (up to Week 16)|Other|0
5922653|NCT01483599|20490229|P14|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
5922654|NCT01483599|20490230|P13|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
5922655|NCT01483599|20490231|P12|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
5922656|NCT01483599|20490232|P11|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
5922657|NCT01483599|20490233|P10|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
5922658|NCT01483599|20490234|P9|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
5922659|NCT01483599|20490235|P8|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
5922660|NCT01483599|20490236|P7|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
5922661|NCT01483599|20490237|P6|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
5922662|NCT01483599|20490238|P5|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
5922663|NCT01483599|20490239|P4|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
5922664|NCT01483599|20490240|P3|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
5922665|NCT01483599|20490241|P2|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
5922666|NCT01483599|20490242|P1|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|1
5922667|NCT01483599|20490229|P14|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
5922668|NCT01483599|20490230|P13|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
5922669|NCT01483599|20490231|P12|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
5922670|NCT01483599|20490232|P11|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
5922671|NCT01483599|20490233|P10|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
5922672|NCT01483599|20490234|P9|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
5922673|NCT01483599|20490235|P8|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
5922674|NCT01483599|20490236|P7|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1
5922675|NCT01483599|20490237|P6|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
5922676|NCT01483599|20490238|P5|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
5922677|NCT01483599|20490239|P4|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1
5922678|NCT01483599|20490240|P3|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
5922679|NCT01483599|20490241|P2|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1
5922680|NCT01483599|20490242|P1|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
5922681|NCT01483599|20490229|P14|Controlled Period (CP) (up to Week 16)|Adverse Event|0
5922682|NCT01483599|20490230|P13|Controlled Period (CP) (up to Week 16)|Adverse Event|0
5922683|NCT01483599|20490231|P12|Controlled Period (CP) (up to Week 16)|Adverse Event|0
5922684|NCT01483599|20490232|P11|Controlled Period (CP) (up to Week 16)|Adverse Event|0
5922685|NCT01483599|20490233|P10|Controlled Period (CP) (up to Week 16)|Adverse Event|0
5922686|NCT01483599|20490234|P9|Controlled Period (CP) (up to Week 16)|Adverse Event|0
5922687|NCT01483599|20490235|P8|Controlled Period (CP) (up to Week 16)|Adverse Event|0
5922688|NCT01483599|20490236|P7|Controlled Period (CP) (up to Week 16)|Adverse Event|3
5922689|NCT01483599|20490237|P6|Controlled Period (CP) (up to Week 16)|Adverse Event|4
5922690|NCT01483599|20490238|P5|Controlled Period (CP) (up to Week 16)|Adverse Event|1
5922691|NCT01483599|20490239|P4|Controlled Period (CP) (up to Week 16)|Adverse Event|1
5922692|NCT01483599|20490240|P3|Controlled Period (CP) (up to Week 16)|Adverse Event|0
5922693|NCT01483599|20490241|P2|Controlled Period (CP) (up to Week 16)|Adverse Event|0
5922694|NCT01483599|20490242|P1|Controlled Period (CP) (up to Week 16)|Adverse Event|2
5922695|NCT01483183|20490355|P10|Overall Study|Withdrawal by Subject|1
5922696|NCT01483183|20490356|P9|Overall Study|Withdrawal by Subject|0
5922697|NCT01483183|20490357|P8|Overall Study|Withdrawal by Subject|0
5922698|NCT01483183|20490358|P7|Overall Study|Withdrawal by Subject|0
5922699|NCT01483183|20490359|P6|Overall Study|Withdrawal by Subject|0
5922700|NCT01483183|20490360|P5|Overall Study|Withdrawal by Subject|0
5922701|NCT01483183|20490361|P4|Overall Study|Withdrawal by Subject|0
5922702|NCT01483183|20490362|P3|Overall Study|Withdrawal by Subject|0
5922703|NCT01483183|20490363|P2|Overall Study|Withdrawal by Subject|0
5922704|NCT01483183|20490364|P1|Overall Study|Withdrawal by Subject|0
5922705|NCT01483183|20490355|P10|Overall Study|Physician Decision|0
5922706|NCT01483183|20490356|P9|Overall Study|Physician Decision|0
5922707|NCT01483183|20490357|P8|Overall Study|Physician Decision|0
5922708|NCT01483183|20490358|P7|Overall Study|Physician Decision|2
5922709|NCT01483183|20490359|P6|Overall Study|Physician Decision|0
5922710|NCT01483183|20490360|P5|Overall Study|Physician Decision|0
5922711|NCT01483183|20490361|P4|Overall Study|Physician Decision|0
5922712|NCT01483183|20490362|P3|Overall Study|Physician Decision|0
5922713|NCT01483183|20490363|P2|Overall Study|Physician Decision|0
5922714|NCT01483183|20490364|P1|Overall Study|Physician Decision|0
5922715|NCT01483118|20490434|P2|Overall Study|Lost to Follow-up|16
5922716|NCT01483118|20490435|P1|Overall Study|Lost to Follow-up|12
5922717|NCT01482962|20490447|P2|Overall Study|Did not Receive Study Drug|6
5922718|NCT01482962|20490448|P1|Overall Study|Did not Receive Study Drug|1
5922719|NCT01482962|20490447|P2|Overall Study|Study Terminated by Sponsor|2
5922720|NCT01482962|20490448|P1|Overall Study|Study Terminated by Sponsor|5
5922721|NCT01482962|20490447|P2|Overall Study|Other Reason|5
5922722|NCT01482962|20490448|P1|Overall Study|Other Reason|1
5922723|NCT01482962|20490447|P2|Overall Study|Hematopoietic Stem Cell Transplant|9
5922724|NCT01482962|20490448|P1|Overall Study|Hematopoietic Stem Cell Transplant|3
5922725|NCT01482962|20490447|P2|Overall Study|Withdrawal by Participant|13
5922726|NCT01482962|20490448|P1|Overall Study|Withdrawal by Participant|8
5922727|NCT01482962|20490447|P2|Overall Study|Adverse Event|22
5922728|NCT01482962|20490448|P1|Overall Study|Adverse Event|18
5922729|NCT01482962|20490447|P2|Overall Study|Unsatisfactory Therapeutic Response|23
5922730|NCT01482962|20490448|P1|Overall Study|Unsatisfactory Therapeutic Response|37
5922731|NCT01482962|20490447|P2|Overall Study|Progressive Disease|53
5922732|NCT01482962|20490448|P1|Overall Study|Progressive Disease|65
5922733|NCT01482910|20490481|P2|Overall Study|Death|0
5922734|NCT01482910|20490482|P1|Overall Study|Death|1
5922735|NCT01482910|20490481|P2|Overall Study|Withdrawal by Subject|2
5922736|NCT01482910|20490482|P1|Overall Study|Withdrawal by Subject|7
5922737|NCT01482910|20490481|P2|Overall Study|Protocol Violation|1
5922738|NCT01482910|20490482|P1|Overall Study|Protocol Violation|1
5922739|NCT01482910|20490481|P2|Overall Study|Lost to Follow-up|1
5922740|NCT01482910|20490482|P1|Overall Study|Lost to Follow-up|0
5922741|NCT01482910|20490481|P2|Overall Study|Adverse Event|5
5922742|NCT01482910|20490482|P1|Overall Study|Adverse Event|6
5922743|NCT01482884|20490494|P2|Overall Study|Withdrawal by Subject|13
5922744|NCT01482884|20490495|P1|Overall Study|Withdrawal by Subject|8
5922745|NCT01482884|20490494|P2|Overall Study|Adverse Event|1
5922746|NCT01482884|20490495|P1|Overall Study|Adverse Event|2
5922747|NCT01482884|20490494|P2|Overall Study|Lack of Efficacy|1
5922748|NCT01482884|20490495|P1|Overall Study|Lack of Efficacy|0
5922749|NCT01482884|20490494|P2|Overall Study|Lost to Follow-up|2
5922750|NCT01482884|20490495|P1|Overall Study|Lost to Follow-up|2
5922751|NCT01482884|20490494|P2|Overall Study|Protocol Violation|0
5922752|NCT01482884|20490495|P1|Overall Study|Protocol Violation|1
5922753|NCT01482884|20490494|P2|Overall Study|Medical decision due to lack of efficacy|1
5922754|NCT01482884|20490495|P1|Overall Study|Medical decision due to lack of efficacy|0
5922755|NCT01482819|20490521|P1|Overall Study|Lost to Follow-up|2
5922756|NCT01482767|20490541|P2|Overall Study|Nurse error|0
5922757|NCT01482767|20490542|P1|Overall Study|Nurse error|1
5922758|NCT01482767|20490541|P2|Overall Study|Ineligible|5
5922759|NCT01482767|20490542|P1|Overall Study|Ineligible|0
5922760|NCT01482767|20490541|P2|Overall Study|Alternate HCV treatment|8
5922761|NCT01482767|20490542|P1|Overall Study|Alternate HCV treatment|7
5922762|NCT01482767|20490541|P2|Overall Study|Non-adherence to study requirements|7
5922763|NCT01482767|20490542|P1|Overall Study|Non-adherence to study requirements|4
5922764|NCT01482767|20490541|P2|Overall Study|Site closure|14
5922765|NCT01482767|20490542|P1|Overall Study|Site closure|22
5922766|NCT01482767|20490541|P2|Overall Study|Adverse Event|3
5922767|NCT01482767|20490542|P1|Overall Study|Adverse Event|0
5922768|NCT01482767|20490541|P2|Overall Study|Lost to Follow-up|6
5922769|NCT01482767|20490542|P1|Overall Study|Lost to Follow-up|12
5922770|NCT01482767|20490541|P2|Overall Study|Withdrawal by Subject|5
5922771|NCT01482767|20490542|P1|Overall Study|Withdrawal by Subject|7
5922772|NCT01482767|20490541|P2|Overall Study|Death|1
5922773|NCT01482767|20490542|P1|Overall Study|Death|1
5922774|NCT01482598|20490670|P2|Overall Study|Lost to Follow-up|4
5922775|NCT01482598|20490671|P1|Overall Study|Lost to Follow-up|5
5922776|NCT01482598|20490670|P2|Overall Study|Withdrawal by Subject|5
5922777|NCT01482598|20490671|P1|Overall Study|Withdrawal by Subject|4
5922778|NCT01482598|20490670|P2|Overall Study|Physician Decision|3
5922779|NCT01482598|20490671|P1|Overall Study|Physician Decision|0
5922780|NCT01482598|20490670|P2|Overall Study|Death|10
5922781|NCT01482598|20490671|P1|Overall Study|Death|7
5922782|NCT01482429|20490679|P2|Protocol|Protocol Violation|0
5922783|NCT01482429|20490680|P1|Protocol|Protocol Violation|275
5922784|NCT01482429|20490679|P2|Care Usual|Lost to Follow-up|1
5922785|NCT01482429|20490680|P1|Care Usual|Lost to Follow-up|0
5922786|NCT01482429|20490679|P2|Care Usual|Protocol Violation|172
5922787|NCT01482429|20490680|P1|Care Usual|Protocol Violation|0
5922788|NCT01482312|20490716|P3|Period 2, 90 Minutes of Wear|Other|0
5922789|NCT01482312|20490717|P2|Period 2, 90 Minutes of Wear|Other|0
5922790|NCT01482312|20490718|P1|Period 2, 90 Minutes of Wear|Other|1
5922791|NCT01482312|20490716|P3|Period 1, 90 Minutes of Wear|Other|0
5922792|NCT01482312|20490717|P2|Period 1, 90 Minutes of Wear|Other|0
5922793|NCT01482312|20490718|P1|Period 1, 90 Minutes of Wear|Other|1
5922794|NCT01482221|20490732|P3|Overall Study|Physician Decision|0
5922795|NCT01482221|20490733|P2|Overall Study|Physician Decision|1
5922796|NCT01482221|20490734|P1|Overall Study|Physician Decision|0
5922797|NCT01482221|20490732|P3|Overall Study|Incorrect randomization|0
5922798|NCT01482221|20490733|P2|Overall Study|Incorrect randomization|1
5922799|NCT01482221|20490734|P1|Overall Study|Incorrect randomization|0
5922800|NCT01482221|20490732|P3|Overall Study|Withdrawal by Subject|12
5922801|NCT01482221|20490733|P2|Overall Study|Withdrawal by Subject|7
5922802|NCT01482221|20490734|P1|Overall Study|Withdrawal by Subject|10
5922803|NCT01482221|20490732|P3|Overall Study|Adverse Event|3
5922804|NCT01482221|20490733|P2|Overall Study|Adverse Event|7
5922805|NCT01482221|20490734|P1|Overall Study|Adverse Event|1
5922806|NCT01482221|20490732|P3|Overall Study|Severe Non-Compliance to Protocol|1
5922807|NCT01482221|20490733|P2|Overall Study|Severe Non-Compliance to Protocol|0
5922808|NCT01482221|20490734|P1|Overall Study|Severe Non-Compliance to Protocol|1
5922809|NCT01482221|20490732|P3|Overall Study|Condition under Investigation Worsened|4
5922810|NCT01482221|20490733|P2|Overall Study|Condition under Investigation Worsened|2
5922811|NCT01482221|20490734|P1|Overall Study|Condition under Investigation Worsened|3
5922812|NCT01482221|20490732|P3|Overall Study|Study-Specific Withdrawal Criteria|1
5922813|NCT01482221|20490733|P2|Overall Study|Study-Specific Withdrawal Criteria|0
5922814|NCT01482221|20490734|P1|Overall Study|Study-Specific Withdrawal Criteria|2
5922815|NCT01482221|20490732|P3|Overall Study|Lost to Follow-up|1
5922816|NCT01482221|20490733|P2|Overall Study|Lost to Follow-up|2
5922817|NCT01482221|20490734|P1|Overall Study|Lost to Follow-up|3
5922818|NCT01482221|20490732|P3|Overall Study|Lack of Efficacy|1
5922819|NCT01482221|20490733|P2|Overall Study|Lack of Efficacy|0
5922820|NCT01482221|20490734|P1|Overall Study|Lack of Efficacy|1
5922821|NCT01482169|20490775|P1|Overall Study|Physician Decision|2
5922822|NCT01482065|20490817|P2|Overall Study|Withdrawal by Subject|1
5922823|NCT01482065|20490818|P1|Overall Study|Withdrawal by Subject|0
5922824|NCT01481896|20490839|P1|Overall Study|Lost to Follow-up|12
5922825|NCT01481779|20490855|P2|Overall Study|Sponsor Decision|1
5922826|NCT01481779|20490856|P1|Overall Study|Sponsor Decision|3
5922827|NCT01481779|20490855|P2|Overall Study|Physician Decision|4
5922828|NCT01481779|20490856|P1|Overall Study|Physician Decision|13
5922829|NCT01481779|20490855|P2|Overall Study|Withdrawal by Subject|13
5922830|NCT01481779|20490856|P1|Overall Study|Withdrawal by Subject|26
5922831|NCT01481779|20490855|P2|Overall Study|Protocol Violation|3
5922832|NCT01481779|20490856|P1|Overall Study|Protocol Violation|2
5922833|NCT01481779|20490855|P2|Overall Study|Lost to Follow-up|2
5922834|NCT01481779|20490856|P1|Overall Study|Lost to Follow-up|3
5922835|NCT01481779|20490855|P2|Overall Study|Adverse Event|5
5922836|NCT01481779|20490856|P1|Overall Study|Adverse Event|23
5922837|NCT01481324|20490941|P3|Overall Study|Missing Data|2
5922838|NCT01481324|20490942|P2|Overall Study|Missing Data|2
5922839|NCT01481324|20490943|P1|Overall Study|Missing Data|0
5922840|NCT01481116|20490962|P3|Overall Study|Hypoglycemic Event|0
5922841|NCT01481116|20490963|P2|Overall Study|Hypoglycemic Event|0
5922842|NCT01481116|20490964|P1|Overall Study|Hypoglycemic Event|4
5922843|NCT01481116|20490962|P3|Overall Study|Death|0
5922844|NCT01481116|20490963|P2|Overall Study|Death|1
5922845|NCT01481116|20490964|P1|Overall Study|Death|2
5922846|NCT01481116|20490962|P3|Overall Study|Investigator's Discretion|0
5922847|NCT01481116|20490963|P2|Overall Study|Investigator's Discretion|0
5922848|NCT01481116|20490964|P1|Overall Study|Investigator's Discretion|2
5922849|NCT01481116|20490962|P3|Overall Study|Non-Compliant With Study Drug|1
5922850|NCT01481116|20490963|P2|Overall Study|Non-Compliant With Study Drug|1
5922851|NCT01481116|20490964|P1|Overall Study|Non-Compliant With Study Drug|0
5922852|NCT01481116|20490962|P3|Overall Study|Sponsor Decision|3
5922853|NCT01481116|20490963|P2|Overall Study|Sponsor Decision|1
5922854|NCT01481116|20490964|P1|Overall Study|Sponsor Decision|0
5922855|NCT01481116|20490962|P3|Overall Study|Investigator Decision|1
5922856|NCT01481116|20490963|P2|Overall Study|Investigator Decision|2
5922857|NCT01481116|20490964|P1|Overall Study|Investigator Decision|3
5922858|NCT01481116|20490962|P3|Overall Study|Participant Moved Out of Country|1
5922859|NCT01481116|20490963|P2|Overall Study|Participant Moved Out of Country|0
5922860|NCT01481116|20490964|P1|Overall Study|Participant Moved Out of Country|1
5922861|NCT01481116|20490962|P3|Overall Study|Participant Moved Out of Area|1
5922862|NCT01481116|20490963|P2|Overall Study|Participant Moved Out of Area|0
5922863|NCT01481116|20490964|P1|Overall Study|Participant Moved Out of Area|2
5922864|NCT01481116|20490962|P3|Overall Study|Participant Started Taking Glipizide|0
5922865|NCT01481116|20490963|P2|Overall Study|Participant Started Taking Glipizide|0
5922866|NCT01481116|20490964|P1|Overall Study|Participant Started Taking Glipizide|1
5922867|NCT01481116|20490962|P3|Overall Study|Other|0
5922868|NCT01481116|20490963|P2|Overall Study|Other|1
5922869|NCT01481116|20490964|P1|Overall Study|Other|1
5922870|NCT01481116|20490962|P3|Overall Study|Contraindications|0
5922871|NCT01481116|20490963|P2|Overall Study|Contraindications|1
5922872|NCT01481116|20490964|P1|Overall Study|Contraindications|1
5922873|NCT01481116|20490962|P3|Overall Study|Lack of Efficacy|1
5922874|NCT01481116|20490963|P2|Overall Study|Lack of Efficacy|3
5922875|NCT01481116|20490964|P1|Overall Study|Lack of Efficacy|3
5922876|NCT01481116|20490962|P3|Overall Study|Pregnancy|1
5922877|NCT01481116|20490963|P2|Overall Study|Pregnancy|0
5922878|NCT01481116|20490964|P1|Overall Study|Pregnancy|0
5922879|NCT01481116|20490962|P3|Overall Study|Study Termination|713
5922880|NCT01481116|20490963|P2|Overall Study|Study Termination|729
5922881|NCT01481116|20490964|P1|Overall Study|Study Termination|730
5922882|NCT01481116|20490962|P3|Overall Study|Withdrawal by Subject|37
5922883|NCT01481116|20490963|P2|Overall Study|Withdrawal by Subject|33
5922884|NCT01481116|20490964|P1|Overall Study|Withdrawal by Subject|37
5922885|NCT01481116|20490962|P3|Overall Study|Lost to Follow-up|11
5922886|NCT01481116|20490963|P2|Overall Study|Lost to Follow-up|12
5922887|NCT01481116|20490964|P1|Overall Study|Lost to Follow-up|8
5922888|NCT01481116|20490962|P3|Overall Study|Major Protocol Deviation|1
5922889|NCT01481116|20490963|P2|Overall Study|Major Protocol Deviation|7
5922890|NCT01481116|20490964|P1|Overall Study|Major Protocol Deviation|3
5922891|NCT01481116|20490962|P3|Overall Study|Adverse Event|42
5922892|NCT01481116|20490963|P2|Overall Study|Adverse Event|26
5922893|NCT01481116|20490964|P1|Overall Study|Adverse Event|26
5922894|NCT01480674|20490995|P1|Overall Study|visit not done|10
5922895|NCT01480674|20490995|P1|Overall Study|Lost to Follow-up|2
5922896|NCT01480674|20490995|P1|Overall Study|Death|23
5922897|NCT01480596|20491009|P2|Overall Study|MG exacerbation or change in medication|2
5922898|NCT01480596|20491010|P1|Overall Study|MG exacerbation or change in medication|2
5922899|NCT01480596|20491009|P2|Overall Study|Adverse Event|0
5922900|NCT01480596|20491010|P1|Overall Study|Adverse Event|3
5922901|NCT01480284|20491058|P2|Overall Study|Physician Decision|0
5922902|NCT01480284|20491059|P1|Overall Study|Physician Decision|1
5922903|NCT01480284|20491058|P2|Overall Study|Lost to Follow-up|0
5922904|NCT01480284|20491059|P1|Overall Study|Lost to Follow-up|1
5922905|NCT01480284|20491058|P2|Overall Study|Study closed/terminated|0
5922906|NCT01480284|20491059|P1|Overall Study|Study closed/terminated|3
5922907|NCT01480284|20491058|P2|Overall Study|Adverse Event|0
5922908|NCT01480284|20491059|P1|Overall Study|Adverse Event|1
5922909|NCT01480284|20491058|P2|Overall Study|Withdrawal by Subject|0
5922910|NCT01480284|20491059|P1|Overall Study|Withdrawal by Subject|2
5922911|NCT01480258|20491089|P2|Interim Period|Withdrawal by Subject|6
5922912|NCT01480258|20491090|P1|Interim Period|Withdrawal by Subject|9
5922913|NCT01480258|20491089|P2|Interim Period|Protocol Violation|1
5922914|NCT01480258|20491090|P1|Interim Period|Protocol Violation|0
5922915|NCT01480258|20491089|P2|Interim Period|Physician Decision|0
5922916|NCT01480258|20491090|P1|Interim Period|Physician Decision|1
5922917|NCT01480258|20491089|P2|Interim Period|Lost to Follow-up|2
5922918|NCT01480258|20491090|P1|Interim Period|Lost to Follow-up|0
5922919|NCT01480258|20491089|P2|Infant Series|Withdrawal by Subject|6
5922920|NCT01480258|20491090|P1|Infant Series|Withdrawal by Subject|1
5922921|NCT01480258|20491089|P2|Infant Series|Adverse Event|1
5922922|NCT01480258|20491090|P1|Infant Series|Adverse Event|1
5922923|NCT01480258|20491089|P2|Infant Series|Not Vaccinated|0
5922924|NCT01480258|20491090|P1|Infant Series|Not Vaccinated|3
5922925|NCT01480258|20491089|P2|Infant Series|Physician Decision|1
5922926|NCT01480258|20491090|P1|Infant Series|Physician Decision|0
5922927|NCT01480258|20491089|P2|Infant Series|Protocol Violation|0
5922928|NCT01480258|20491090|P1|Infant Series|Protocol Violation|2
5922929|NCT01480180|20491156|P6|Extension Phase, Part 2|Unclassified|0
5922930|NCT01480180|20491157|P5|Extension Phase, Part 2|Unclassified|1
5922931|NCT01480180|20491158|P4|Extension Phase, Part 2|Unclassified|1
5922932|NCT01480180|20491159|P3|Extension Phase, Part 2|Unclassified|3
5922933|NCT01480180|20491160|P2|Extension Phase, Part 2|Unclassified|0
5922934|NCT01480180|20491161|P1|Extension Phase, Part 2|Unclassified|0
5922935|NCT01480180|20491156|P6|Extension Phase, Part 2|Lack of Efficacy|0
5922936|NCT01480180|20491157|P5|Extension Phase, Part 2|Lack of Efficacy|0
5922937|NCT01480180|20491158|P4|Extension Phase, Part 2|Lack of Efficacy|0
5922938|NCT01480180|20491159|P3|Extension Phase, Part 2|Lack of Efficacy|4
5922939|NCT01480180|20491160|P2|Extension Phase, Part 2|Lack of Efficacy|0
5922940|NCT01480180|20491161|P1|Extension Phase, Part 2|Lack of Efficacy|0
5922941|NCT01480180|20491156|P6|Extension Phase, Part 2|Withdrawal criteria|0
5922942|NCT01480180|20491157|P5|Extension Phase, Part 2|Withdrawal criteria|1
5922943|NCT01480180|20491158|P4|Extension Phase, Part 2|Withdrawal criteria|6
5922944|NCT01480180|20491159|P3|Extension Phase, Part 2|Withdrawal criteria|10
5922945|NCT01480180|20491160|P2|Extension Phase, Part 2|Withdrawal criteria|0
5922946|NCT01480180|20491161|P1|Extension Phase, Part 2|Withdrawal criteria|0
5922947|NCT01480180|20491156|P6|Extension Phase, Part 1|Change of treatment|0
5922948|NCT01480180|20491157|P5|Extension Phase, Part 1|Change of treatment|0
5922949|NCT01480180|20491158|P4|Extension Phase, Part 1|Change of treatment|9
5922950|NCT01480180|20491159|P3|Extension Phase, Part 1|Change of treatment|0
5922951|NCT01480180|20491160|P2|Extension Phase, Part 1|Change of treatment|0
5922952|NCT01480180|20491161|P1|Extension Phase, Part 1|Change of treatment|0
5922953|NCT01480180|20491156|P6|Extension Phase, Part 1|Adverse Event|0
5922954|NCT01480180|20491157|P5|Extension Phase, Part 1|Adverse Event|0
5922955|NCT01480180|20491158|P4|Extension Phase, Part 1|Adverse Event|1
5922956|NCT01480180|20491159|P3|Extension Phase, Part 1|Adverse Event|4
5922957|NCT01480180|20491160|P2|Extension Phase, Part 1|Adverse Event|0
5922958|NCT01480180|20491161|P1|Extension Phase, Part 1|Adverse Event|0
5922959|NCT01480180|20491156|P6|Extension Phase, Part 1|Unclassified|0
5922960|NCT01480180|20491157|P5|Extension Phase, Part 1|Unclassified|0
5922961|NCT01480180|20491158|P4|Extension Phase, Part 1|Unclassified|0
5922962|NCT01480180|20491159|P3|Extension Phase, Part 1|Unclassified|1
5922963|NCT01480180|20491160|P2|Extension Phase, Part 1|Unclassified|0
5922964|NCT01480180|20491161|P1|Extension Phase, Part 1|Unclassified|0
5922965|NCT01480180|20491156|P6|Extension Phase, Part 1|Withdrawal criteria|0
5922966|NCT01480180|20491157|P5|Extension Phase, Part 1|Withdrawal criteria|0
5922967|NCT01480180|20491158|P4|Extension Phase, Part 1|Withdrawal criteria|0
5922968|NCT01480180|20491159|P3|Extension Phase, Part 1|Withdrawal criteria|5
5922969|NCT01480180|20491160|P2|Extension Phase, Part 1|Withdrawal criteria|0
5922970|NCT01480180|20491161|P1|Extension Phase, Part 1|Withdrawal criteria|0
5922971|NCT01480180|20491156|P6|Main Phase|Unclassified|0
5922972|NCT01480180|20491157|P5|Main Phase|Unclassified|0
5922973|NCT01480180|20491158|P4|Main Phase|Unclassified|0
5922974|NCT01480180|20491159|P3|Main Phase|Unclassified|0
5922975|NCT01480180|20491160|P2|Main Phase|Unclassified|0
5922976|NCT01480180|20491161|P1|Main Phase|Unclassified|3
5922977|NCT01480180|20491156|P6|Main Phase|Non-compliance|0
5922978|NCT01480180|20491157|P5|Main Phase|Non-compliance|0
5922979|NCT01480180|20491158|P4|Main Phase|Non-compliance|0
5922980|NCT01480180|20491159|P3|Main Phase|Non-compliance|0
5922981|NCT01480180|20491160|P2|Main Phase|Non-compliance|0
5922982|NCT01480180|20491161|P1|Main Phase|Non-compliance|3
5922983|NCT01480180|20491156|P6|Main Phase|Lack of Efficacy|0
5922984|NCT01480180|20491157|P5|Main Phase|Lack of Efficacy|0
5922985|NCT01480180|20491158|P4|Main Phase|Lack of Efficacy|0
5922986|NCT01480180|20491159|P3|Main Phase|Lack of Efficacy|0
5922987|NCT01480180|20491160|P2|Main Phase|Lack of Efficacy|0
5922988|NCT01480180|20491161|P1|Main Phase|Lack of Efficacy|1
5922989|NCT01480180|20491156|P6|Main Phase|Withdrawal criteria|0
5922990|NCT01480180|20491157|P5|Main Phase|Withdrawal criteria|0
5922991|NCT01480180|20491158|P4|Main Phase|Withdrawal criteria|0
5922992|NCT01480180|20491159|P3|Main Phase|Withdrawal criteria|0
5922993|NCT01480180|20491160|P2|Main Phase|Withdrawal criteria|1
5922994|NCT01480180|20491161|P1|Main Phase|Withdrawal criteria|12
5922995|NCT01480076|20491329|P1|Overall Study|Other|52
5922996|NCT01480076|20491329|P1|Overall Study|Investigator Decision|13
5922997|NCT01480076|20491329|P1|Overall Study|Lost to Follow-up|7
5922998|NCT01480076|20491329|P1|Overall Study|Withdrawal by Subject|105
5922999|NCT01480076|20491329|P1|Overall Study|Non-compliance With Study Protocol|15
5923000|NCT01480076|20491329|P1|Overall Study|Disease Progression|5
5923001|NCT01480076|20491329|P1|Overall Study|Death|2
5923002|NCT01480076|20491329|P1|Overall Study|Adverse Event|39
5923003|NCT01480076|20491329|P1|Overall Study|Run-in Failure|52
5923004|NCT01479985|20491450|P2|Overall Study|No post-visit survey|3
5923005|NCT01479985|20491451|P1|Overall Study|No post-visit survey|5
5923006|NCT01479985|20491450|P2|Overall Study|No decisional conflict scale responses|2
5923007|NCT01479985|20491451|P1|Overall Study|No decisional conflict scale responses|0
5923008|NCT01479985|20491450|P2|Overall Study|Tablet malfunction, no data saved|1
5923009|NCT01479985|20491451|P1|Overall Study|Tablet malfunction, no data saved|1
5923010|NCT01479868|20491459|P1|Overall Study|Initiation of new HCV Therapy|1
5923011|NCT01479868|20491459|P1|Overall Study|Sponsor's Decision|1
5923012|NCT01479868|20491459|P1|Overall Study|Withdrawal by Subject|1
5923013|NCT01479868|20491459|P1|Overall Study|Protocol Violation|1
5923014|NCT01479868|20491459|P1|Overall Study|Lost to Follow-up|4
5923015|NCT01479868|20491459|P1|Overall Study|Adverse Event|1
5923016|NCT01479777|20491474|P1|Overall Study|Physician Decision|2
5923017|NCT01479764|20491486|P2|Treated|Lost to Follow-up|2
5923018|NCT01479764|20491487|P1|Treated|Lost to Follow-up|0
5923019|NCT01479764|20491486|P2|Randomized|Withdrawal by Subject|0
5923020|NCT01479764|20491487|P1|Randomized|Withdrawal by Subject|1
5923021|NCT01479764|20491486|P2|Randomized|Adverse Event|1
5923022|NCT01479764|20491487|P1|Randomized|Adverse Event|1
5923023|NCT01479621|20491510|P7|Treatment Period|Met stopping criteria|6
5923024|NCT01479621|20491511|P6|Treatment Period|Met stopping criteria|20
5923025|NCT01479621|20491512|P5|Treatment Period|Met stopping criteria|9
5923026|NCT01479621|20491513|P4|Treatment Period|Met stopping criteria|4
5923027|NCT01479621|20491514|P3|Treatment Period|Met stopping criteria|7
5923028|NCT01479621|20491515|P2|Treatment Period|Met stopping criteria|8
5923029|NCT01479621|20491516|P1|Treatment Period|Met stopping criteria|0
5923030|NCT01479621|20491510|P7|Treatment Period|Lost to Follow-up|1
5923031|NCT01479621|20491511|P6|Treatment Period|Lost to Follow-up|2
5923032|NCT01479621|20491512|P5|Treatment Period|Lost to Follow-up|2
5923033|NCT01479621|20491513|P4|Treatment Period|Lost to Follow-up|0
5923034|NCT01479621|20491514|P3|Treatment Period|Lost to Follow-up|1
5923035|NCT01479621|20491515|P2|Treatment Period|Lost to Follow-up|0
5923036|NCT01479621|20491516|P1|Treatment Period|Lost to Follow-up|0
5923037|NCT01479621|20491510|P7|Treatment Period|Sponsor request subject to be withdrawn|3
5923038|NCT01479621|20491511|P6|Treatment Period|Sponsor request subject to be withdrawn|1
5923039|NCT01479621|20491512|P5|Treatment Period|Sponsor request subject to be withdrawn|1
5923040|NCT01479621|20491513|P4|Treatment Period|Sponsor request subject to be withdrawn|1
5923041|NCT01479621|20491514|P3|Treatment Period|Sponsor request subject to be withdrawn|3
5923042|NCT01479621|20491515|P2|Treatment Period|Sponsor request subject to be withdrawn|2
5923043|NCT01479621|20491516|P1|Treatment Period|Sponsor request subject to be withdrawn|0
5923044|NCT01479621|20491510|P7|Treatment Period|Pregnancy|0
5923045|NCT01479621|20491511|P6|Treatment Period|Pregnancy|0
5923046|NCT01479621|20491512|P5|Treatment Period|Pregnancy|0
5923047|NCT01479621|20491513|P4|Treatment Period|Pregnancy|0
5923048|NCT01479621|20491514|P3|Treatment Period|Pregnancy|2
5923049|NCT01479621|20491515|P2|Treatment Period|Pregnancy|0
5923050|NCT01479621|20491516|P1|Treatment Period|Pregnancy|0
5923051|NCT01479621|20491510|P7|Treatment Period|Protocol Violation|6
5923052|NCT01479621|20491511|P6|Treatment Period|Protocol Violation|10
5923053|NCT01479621|20491512|P5|Treatment Period|Protocol Violation|2
5923054|NCT01479621|20491513|P4|Treatment Period|Protocol Violation|5
5923055|NCT01479621|20491514|P3|Treatment Period|Protocol Violation|6
5923056|NCT01479621|20491515|P2|Treatment Period|Protocol Violation|9
5923057|NCT01479621|20491516|P1|Treatment Period|Protocol Violation|0
5923058|NCT01479621|20491510|P7|Treatment Period|Non-compliance to study drug|1
5923059|NCT01479621|20491511|P6|Treatment Period|Non-compliance to study drug|0
5923060|NCT01479621|20491512|P5|Treatment Period|Non-compliance to study drug|0
5923061|NCT01479621|20491513|P4|Treatment Period|Non-compliance to study drug|0
5923062|NCT01479621|20491514|P3|Treatment Period|Non-compliance to study drug|0
5923063|NCT01479621|20491515|P2|Treatment Period|Non-compliance to study drug|1
5923064|NCT01479621|20491516|P1|Treatment Period|Non-compliance to study drug|0
5923065|NCT01479621|20491510|P7|Treatment Period|Physician Decision|0
5923066|NCT01479621|20491511|P6|Treatment Period|Physician Decision|1
5923067|NCT01479621|20491512|P5|Treatment Period|Physician Decision|1
5923068|NCT01479621|20491513|P4|Treatment Period|Physician Decision|0
5923069|NCT01479621|20491514|P3|Treatment Period|Physician Decision|0
5923070|NCT01479621|20491515|P2|Treatment Period|Physician Decision|0
5923071|NCT01479621|20491516|P1|Treatment Period|Physician Decision|0
5923072|NCT01479621|20491510|P7|Treatment Period|Withdrawal by Subject|1
5923073|NCT01479621|20491511|P6|Treatment Period|Withdrawal by Subject|5
5923074|NCT01479621|20491512|P5|Treatment Period|Withdrawal by Subject|5
5923075|NCT01479621|20491513|P4|Treatment Period|Withdrawal by Subject|2
5923076|NCT01479621|20491514|P3|Treatment Period|Withdrawal by Subject|2
5923077|NCT01479621|20491515|P2|Treatment Period|Withdrawal by Subject|4
5923078|NCT01479621|20491516|P1|Treatment Period|Withdrawal by Subject|0
5923079|NCT01479621|20491510|P7|Treatment Period|Adverse Event|2
5923080|NCT01479621|20491511|P6|Treatment Period|Adverse Event|2
5923081|NCT01479621|20491512|P5|Treatment Period|Adverse Event|1
5923082|NCT01479621|20491513|P4|Treatment Period|Adverse Event|0
5923083|NCT01479621|20491514|P3|Treatment Period|Adverse Event|0
5923084|NCT01479621|20491515|P2|Treatment Period|Adverse Event|0
5923085|NCT01479621|20491516|P1|Treatment Period|Adverse Event|0
5923086|NCT01479621|20491510|P7|Pre-Assignment Period (Run-In Placebo)|Other|0
5923087|NCT01479621|20491511|P6|Pre-Assignment Period (Run-In Placebo)|Other|0
5923088|NCT01479621|20491512|P5|Pre-Assignment Period (Run-In Placebo)|Other|0
5923089|NCT01479621|20491513|P4|Pre-Assignment Period (Run-In Placebo)|Other|0
5923090|NCT01479621|20491514|P3|Pre-Assignment Period (Run-In Placebo)|Other|0
5923091|NCT01479621|20491515|P2|Pre-Assignment Period (Run-In Placebo)|Other|0
5923092|NCT01479621|20491516|P1|Pre-Assignment Period (Run-In Placebo)|Other|15
5923093|NCT01479621|20491510|P7|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
5923094|NCT01479621|20491511|P6|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
5923095|NCT01479621|20491512|P5|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
5923096|NCT01479621|20491513|P4|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
5923097|NCT01479621|20491514|P3|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
5923098|NCT01479621|20491515|P2|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
5923099|NCT01479621|20491516|P1|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|7
5923100|NCT01479621|20491510|P7|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
5923101|NCT01479621|20491511|P6|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
5923102|NCT01479621|20491512|P5|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
5923103|NCT01479621|20491513|P4|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
5923104|NCT01479621|20491514|P3|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
5923105|NCT01479621|20491515|P2|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
5923106|NCT01479621|20491516|P1|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|153
5923107|NCT01479621|20491510|P7|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
5923108|NCT01479621|20491511|P6|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
5923109|NCT01479621|20491512|P5|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
5923110|NCT01479621|20491513|P4|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
5923111|NCT01479621|20491514|P3|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
5923112|NCT01479621|20491515|P2|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
5923113|NCT01479621|20491516|P1|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|19
5923114|NCT01479621|20491510|P7|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
5923115|NCT01479621|20491511|P6|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
5923116|NCT01479621|20491512|P5|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
5923117|NCT01479621|20491513|P4|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
5923118|NCT01479621|20491514|P3|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
5923119|NCT01479621|20491515|P2|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
5923120|NCT01479621|20491516|P1|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|93
5923121|NCT01479595|20491604|P2|Overall Study|Adverse Event|1
5923122|NCT01479595|20491605|P1|Overall Study|Adverse Event|2
5923123|NCT01479595|20491604|P2|Overall Study|Protocol deviation|1
5923124|NCT01479595|20491605|P1|Overall Study|Protocol deviation|0
5923125|NCT01479530|20491650|P2|Overall Study|Withdrawal of Consent|2
5923126|NCT01479530|20491651|P1|Overall Study|Withdrawal of Consent|3
5923127|NCT01479530|20491650|P2|Overall Study|Protocol Violation|3
5923128|NCT01479530|20491651|P1|Overall Study|Protocol Violation|2
5923129|NCT01479530|20491650|P2|Overall Study|Lack of Efficacy|1
5923130|NCT01479530|20491651|P1|Overall Study|Lack of Efficacy|0
5923131|NCT01479530|20491650|P2|Overall Study|Adverse Event|6
5923132|NCT01479530|20491651|P1|Overall Study|Adverse Event|5
5923133|NCT01479465|20491732|P4|Overall Study|Lost to Follow-up|0
5923134|NCT01479465|20491733|P3|Overall Study|Lost to Follow-up|1
5923135|NCT01479465|20491734|P2|Overall Study|Lost to Follow-up|0
5923136|NCT01479465|20491735|P1|Overall Study|Lost to Follow-up|0
5923137|NCT01479465|20491732|P4|Overall Study|Death|1
5923138|NCT01479465|20491733|P3|Overall Study|Death|0
5923139|NCT01479465|20491734|P2|Overall Study|Death|0
5923140|NCT01479465|20491735|P1|Overall Study|Death|0
5923141|NCT01479465|20491732|P4|Overall Study|Protocol Violation|0
5923142|NCT01479465|20491733|P3|Overall Study|Protocol Violation|1
5923143|NCT01479465|20491734|P2|Overall Study|Protocol Violation|1
5923144|NCT01479465|20491735|P1|Overall Study|Protocol Violation|0
5923145|NCT01479465|20491732|P4|Overall Study|Subject Withdrew Consent|1
5923146|NCT01479465|20491733|P3|Overall Study|Subject Withdrew Consent|2
5923147|NCT01479465|20491734|P2|Overall Study|Subject Withdrew Consent|5
5923148|NCT01479465|20491735|P1|Overall Study|Subject Withdrew Consent|0
5923149|NCT01479465|20491732|P4|Overall Study|Subject Request|2
5923150|NCT01479465|20491733|P3|Overall Study|Subject Request|4
5923151|NCT01479465|20491734|P2|Overall Study|Subject Request|3
5923152|NCT01479465|20491735|P1|Overall Study|Subject Request|1
5923153|NCT01479465|20491732|P4|Overall Study|Investigator Discretion|4
5923154|NCT01479465|20491733|P3|Overall Study|Investigator Discretion|2
5923155|NCT01479465|20491734|P2|Overall Study|Investigator Discretion|4
5923156|NCT01479465|20491735|P1|Overall Study|Investigator Discretion|1
5923157|NCT01479465|20491732|P4|Overall Study|Adverse Event|4
5923158|NCT01479465|20491733|P3|Overall Study|Adverse Event|6
5923159|NCT01479465|20491734|P2|Overall Study|Adverse Event|3
5923160|NCT01479465|20491735|P1|Overall Study|Adverse Event|0
5923161|NCT01479465|20491732|P4|Overall Study|Study Discontinued by Sponsor|3
5923162|NCT01479465|20491733|P3|Overall Study|Study Discontinued by Sponsor|5
5923163|NCT01479465|20491734|P2|Overall Study|Study Discontinued by Sponsor|7
5923164|NCT01479465|20491735|P1|Overall Study|Study Discontinued by Sponsor|0
5923165|NCT01479465|20491732|P4|Overall Study|Disease Progression|70
5923166|NCT01479465|20491733|P3|Overall Study|Disease Progression|65
5923167|NCT01479465|20491734|P2|Overall Study|Disease Progression|61
5923168|NCT01479465|20491735|P1|Overall Study|Disease Progression|9
5923169|NCT01479439|20491756|P3|Overall Study|Protocol Violation|2
5923170|NCT01479439|20491757|P2|Overall Study|Protocol Violation|0
5923171|NCT01479439|20491758|P1|Overall Study|Protocol Violation|0
5923172|NCT01479439|20491756|P3|Overall Study|Lost to Follow-up|0
5923173|NCT01479439|20491757|P2|Overall Study|Lost to Follow-up|1
5923174|NCT01479439|20491758|P1|Overall Study|Lost to Follow-up|0
5923175|NCT01479439|20491756|P3|Overall Study|Adverse Event|0
5923176|NCT01479439|20491757|P2|Overall Study|Adverse Event|0
5923177|NCT01479439|20491758|P1|Overall Study|Adverse Event|1
5923178|NCT01479374|20491790|P3|Overall Study|Other|5
5923179|NCT01479374|20491791|P2|Overall Study|Other|4
5923180|NCT01479374|20491792|P1|Overall Study|Other|0
5923181|NCT01479374|20491790|P3|Overall Study|Decision Unrelated to Adverse Event|0
5923182|NCT01479374|20491791|P2|Overall Study|Decision Unrelated to Adverse Event|1
5923183|NCT01479374|20491792|P1|Overall Study|Decision Unrelated to Adverse Event|0
5923184|NCT01479374|20491790|P3|Overall Study|Lost to Follow-up|0
5923185|NCT01479374|20491791|P2|Overall Study|Lost to Follow-up|2
5923186|NCT01479374|20491792|P1|Overall Study|Lost to Follow-up|1
5923187|NCT01479374|20491790|P3|Overall Study|Adverse Event|0
5923188|NCT01479374|20491791|P2|Overall Study|Adverse Event|1
5923189|NCT01479374|20491792|P1|Overall Study|Adverse Event|2
5923190|NCT01478971|20491886|P1|Peginesatide Treatment Period|Other|4
5923191|NCT01478971|20491886|P1|Peginesatide Treatment Period|Lost to Follow-up|4
5923192|NCT01478971|20491886|P1|Peginesatide Treatment Period|Death|4
5923193|NCT01478971|20491886|P1|Peginesatide Treatment Period|Withdrawal by Subject|1
5923194|NCT01478971|20491886|P1|Peginesatide Treatment Period|Adverse Event|1
5923195|NCT01478971|20491886|P1|Standard of Care Period|Other|4
5923196|NCT01478971|20491886|P1|Standard of Care Period|Lost to Follow-up|9
5923197|NCT01478971|20491886|P1|Standard of Care Period|Death|8
5923198|NCT01478971|20491886|P1|Standard of Care Period|Withdrawal by Subject|3
5923199|NCT01478971|20491886|P1|Standard of Care Period|Adverse Event|1
5923200|NCT01478958|20491903|P3|Overall Study|Unable to comply|2
5923201|NCT01478958|20491904|P2|Overall Study|Unable to comply|0
5923202|NCT01478958|20491905|P1|Overall Study|Unable to comply|0
5923203|NCT01478958|20491903|P3|Overall Study|Re-located|0
5923204|NCT01478958|20491904|P2|Overall Study|Re-located|1
5923205|NCT01478958|20491905|P1|Overall Study|Re-located|0
5923206|NCT01478958|20491903|P3|Overall Study|Weight loss|0
5923207|NCT01478958|20491904|P2|Overall Study|Weight loss|0
5923208|NCT01478958|20491905|P1|Overall Study|Weight loss|1
5923209|NCT01478958|20491903|P3|Overall Study|Withdrawal by Subject|1
5923210|NCT01478958|20491904|P2|Overall Study|Withdrawal by Subject|1
5923211|NCT01478958|20491905|P1|Overall Study|Withdrawal by Subject|1
5923212|NCT01478828|20491925|P1|Overall Study|Adverse Event|1
5923213|NCT01478620|20491936|P1|Overall Study|Lost to Follow-up|6
5923214|NCT01478594|20491942|P2|Overall Study|Study Closed by Sponsor|5
5923215|NCT01478594|20491943|P1|Overall Study|Study Closed by Sponsor|8
5923216|NCT01478594|20491942|P2|Overall Study|Withdrawal by Subject|3
5923217|NCT01478594|20491943|P1|Overall Study|Withdrawal by Subject|9
5923218|NCT01478594|20491942|P2|Overall Study|Lost to Follow-up|1
5923219|NCT01478594|20491943|P1|Overall Study|Lost to Follow-up|3
5923220|NCT01478594|20491942|P2|Overall Study|Death|18
5923221|NCT01478594|20491943|P1|Overall Study|Death|45
5923222|NCT01478594|20491942|P2|Overall Study|Randomized but Never Received Study Drug|1
5923223|NCT01478594|20491943|P1|Overall Study|Randomized but Never Received Study Drug|0
5923224|NCT01478373|20492072|P1|Survival Phase|Progressive Disease|27
5923225|NCT01478373|20492072|P1|Survival Phase|crossover to another study|2
5923226|NCT01478373|20492072|P1|Survival Phase|Protocol Violation|1
5923227|NCT01478373|20492072|P1|Survival Phase|Adverse Event|8
5923228|NCT01478373|20492072|P1|Treatment Phase|Protocol Violation|1
5923229|NCT01478360|20492085|P2|Overall Study|Administrative problems|2
5923230|NCT01478360|20492086|P1|Overall Study|Administrative problems|1
5923231|NCT01478360|20492085|P2|Overall Study|Adverse Event|1
5923232|NCT01478360|20492086|P1|Overall Study|Adverse Event|0
5923233|NCT01478360|20492085|P2|Overall Study|Lost to Follow-up|0
5923234|NCT01478360|20492086|P1|Overall Study|Lost to Follow-up|1
5923235|NCT01478347|20492092|P1|Visit 4-Visit 7 (Day 151-331) - Part II|Withdrawal by Subject|4
5923236|NCT01478347|20492092|P1|Visit 4-Visit 7 (Day 151-331) - Part II|Lost to Follow-up|4
5923237|NCT01478347|20492092|P1|Visit 1-Visit 3 (Day 0-91) - Part I|Lost to Follow-up|1
5923238|NCT01478321|20492097|P1|Adjuvant Therapy Until PD or Toxicity|Progressive Disease|8
5923239|NCT01478321|20492097|P1|Adjuvant Therapy Until PD or Toxicity|Withdrawal by Subject|1
5923240|NCT01478321|20492097|P1|Adjuvant Therapy Until PD or Toxicity|Death|1
5923241|NCT01478321|20492097|P1|Started Adjuvant Therapy|Withdrawal by Subject|1
5923242|NCT01478321|20492097|P1|Concurrent Therapy (5 Weeks)|Progressive Disease|5
5923243|NCT01478321|20492097|P1|Concurrent Therapy (5 Weeks)|Withdrawal by Subject|5
5923244|NCT01478321|20492097|P1|Concurrent Therapy (5 Weeks)|Death|2
5923245|NCT01478321|20492097|P1|Concurrent Therapy (5 Weeks)|Adverse Event|4
5923246|NCT01478113|20492120|P2|Overall Study|Physician Decision|0
5923247|NCT01478113|20492121|P1|Overall Study|Physician Decision|1
5923248|NCT01478113|20492120|P2|Overall Study|Withdrawal by Subject|1
5923249|NCT01478113|20492121|P1|Overall Study|Withdrawal by Subject|0
5923250|NCT01478087|20492139|P1|Overall Study|due to sponsor closing study|1
5923251|NCT01478048|20492146|P2|Overall Study|no longer meets study criteria|0
5923252|NCT01478048|20492147|P1|Overall Study|no longer meets study criteria|1
5923253|NCT01478048|20492146|P2|Overall Study|poor/non-compliance|1
5923254|NCT01478048|20492147|P1|Overall Study|poor/non-compliance|0
5923255|NCT01478048|20492146|P2|Overall Study|non-specified|4
5923256|NCT01478048|20492147|P1|Overall Study|non-specified|6
5923257|NCT01478048|20492146|P2|Overall Study|Withdrawal by Subject|5
5923258|NCT01478048|20492147|P1|Overall Study|Withdrawal by Subject|2
5923259|NCT01478048|20492146|P2|Overall Study|subject request to discontinue treatment|5
5923260|NCT01478048|20492147|P1|Overall Study|subject request to discontinue treatment|3
5923261|NCT01478048|20492146|P2|Overall Study|Adverse Event|11
5923262|NCT01478048|20492147|P1|Overall Study|Adverse Event|2
5923263|NCT01478048|20492146|P2|Overall Study|study drug toxicity|14
5923264|NCT01478048|20492147|P1|Overall Study|study drug toxicity|11
5923265|NCT01478048|20492146|P2|Overall Study|Disease Progression|35
5923266|NCT01478048|20492147|P1|Overall Study|Disease Progression|52
5923267|NCT01477892|20492176|P2|Overall Study|Withdrawal by Subject|2
5923268|NCT01477892|20492177|P1|Overall Study|Withdrawal by Subject|0
5923269|NCT01477853|20492188|P3|Phase B|Study terminated by sponsor|11
5923270|NCT01477853|20492189|P2|Phase B|Study terminated by sponsor|10
5923271|NCT01477853|20492190|P1|Phase B|Study terminated by sponsor|12
5923272|NCT01477853|20492188|P3|Phase B|Lost to Follow-up|0
5923273|NCT01477853|20492189|P2|Phase B|Lost to Follow-up|1
5923274|NCT01477853|20492190|P1|Phase B|Lost to Follow-up|0
5923275|NCT01477853|20492188|P3|Phase A|Study terminated by sponsor|39
5923276|NCT01477853|20492189|P2|Phase A|Study terminated by sponsor|40
5923277|NCT01477853|20492190|P1|Phase A|Study terminated by sponsor|37
5923278|NCT01477853|20492188|P3|Phase A|Physician Decision|1
5923279|NCT01477853|20492189|P2|Phase A|Physician Decision|0
5923280|NCT01477853|20492190|P1|Phase A|Physician Decision|1
5923281|NCT01477853|20492188|P3|Phase A|Lost to Follow-up|2
5923282|NCT01477853|20492189|P2|Phase A|Lost to Follow-up|3
5923283|NCT01477853|20492190|P1|Phase A|Lost to Follow-up|4
5923284|NCT01477853|20492188|P3|Phase A|Adverse Event|2
5923285|NCT01477853|20492189|P2|Phase A|Adverse Event|2
5923286|NCT01477853|20492190|P1|Phase A|Adverse Event|1
5923287|NCT01477749|20492257|P1|Overall Study|Physician Decision|4
5923288|NCT01477333|20492365|P1|Overall Study|Clinical Deterioration|1
5923289|NCT01477333|20492365|P1|Overall Study|Withdrawal by Subject|1
5923290|NCT01477333|20492365|P1|Overall Study|Adverse Event|1
5923291|NCT01476722|20492416|P1|Overall Study|Adverse Event|1
5923292|NCT01476696|20492423|P3|Overall Study|Withdrawal by Subject|0
5923293|NCT01476696|20492424|P2|Overall Study|Withdrawal by Subject|0
5923294|NCT01476696|20492425|P1|Overall Study|Withdrawal by Subject|1
5923295|NCT01476696|20492423|P3|Overall Study|Sponsor decision|0
5923296|NCT01476696|20492424|P2|Overall Study|Sponsor decision|1
5923297|NCT01476696|20492425|P1|Overall Study|Sponsor decision|2
5923298|NCT01476644|20492439|P1|Overall Study|Withdrawal by Subject|13
5923299|NCT01476644|20492439|P1|Overall Study|Lost to Follow-up|19
5923300|NCT01476644|20492439|P1|Overall Study|moved to another state|2
5923301|NCT01476644|20492439|P1|Overall Study|Death|5
5923302|NCT01476475|20492446|P2|Overall Study|Other reasons|2
5923303|NCT01476475|20492447|P1|Overall Study|Other reasons|4
5923304|NCT01476475|20492446|P2|Overall Study|Poor compliance to protocol|1
5923305|NCT01476475|20492447|P1|Overall Study|Poor compliance to protocol|1
5923306|NCT01476475|20492446|P2|Overall Study|Adverse Event|0
5923307|NCT01476475|20492447|P1|Overall Study|Adverse Event|6
5923308|NCT01475851|20492898|P2|Overall Study|Protocol defined stopping criteria|0
5923309|NCT01475851|20492899|P1|Overall Study|Protocol defined stopping criteria|1
5923310|NCT01475838|20492927|P2|Extension Phase|Participant Noncompliance|0
5923311|NCT01475838|20492928|P1|Extension Phase|Participant Noncompliance|1
5923312|NCT01475838|20492927|P2|Randomized Phase|Protocol Violation|4
5923313|NCT01475838|20492928|P1|Randomized Phase|Protocol Violation|9
5923314|NCT01475838|20492927|P2|Randomized Phase|Participant Noncompliance|5
5923315|NCT01475838|20492928|P1|Randomized Phase|Participant Noncompliance|1
5923316|NCT01475838|20492927|P2|Randomized Phase|Lost to Follow-up|4
5923317|NCT01475838|20492928|P1|Randomized Phase|Lost to Follow-up|3
5923318|NCT01475838|20492927|P2|Randomized Phase|Withdrew Consent|14
5923319|NCT01475838|20492928|P1|Randomized Phase|Withdrew Consent|10
5923320|NCT01475838|20492927|P2|Randomized Phase|Investigators Discretion|2
5923321|NCT01475838|20492928|P1|Randomized Phase|Investigators Discretion|1
5923322|NCT01475838|20492927|P2|Randomized Phase|Pregnancy|1
5923323|NCT01475838|20492928|P1|Randomized Phase|Pregnancy|0
5923324|NCT01475838|20492927|P2|Randomized Phase|Adverse Event|1
5923325|NCT01475838|20492928|P1|Randomized Phase|Adverse Event|6
5923326|NCT01475838|20492927|P2|Randomized Phase|Randomized but Not Treated|5
5923327|NCT01475838|20492928|P1|Randomized Phase|Randomized but Not Treated|0
5923328|NCT01475825|20492945|P4|Overall Study|Did not enter OLC|11
5923329|NCT01475825|20492946|P3|Overall Study|Did not enter OLC|15
5923330|NCT01475825|20492947|P2|Overall Study|Did not enter OLC|11
5923331|NCT01475825|20492948|P1|Overall Study|Did not enter OLC|15
5923332|NCT01475825|20492945|P4|Overall Study|Withdrawal by Subject|7
5923333|NCT01475825|20492946|P3|Overall Study|Withdrawal by Subject|11
5923334|NCT01475825|20492947|P2|Overall Study|Withdrawal by Subject|3
5923335|NCT01475825|20492948|P1|Overall Study|Withdrawal by Subject|8
5923336|NCT01475825|20492945|P4|Overall Study|Physician Decision|0
5923337|NCT01475825|20492946|P3|Overall Study|Physician Decision|0
5923338|NCT01475825|20492947|P2|Overall Study|Physician Decision|1
5923339|NCT01475825|20492948|P1|Overall Study|Physician Decision|0
5923340|NCT01475825|20492945|P4|Overall Study|Protocol Violation|0
5923341|NCT01475825|20492946|P3|Overall Study|Protocol Violation|0
5923342|NCT01475825|20492947|P2|Overall Study|Protocol Violation|0
5923343|NCT01475825|20492948|P1|Overall Study|Protocol Violation|1
5923344|NCT01475825|20492945|P4|Overall Study|Other: Not available|0
5923345|NCT01475825|20492946|P3|Overall Study|Other: Not available|2
5923346|NCT01475825|20492947|P2|Overall Study|Other: Not available|0
5923347|NCT01475825|20492948|P1|Overall Study|Other: Not available|0
5923348|NCT01475825|20492945|P4|Overall Study|Non-compliance with Study Drug|0
5923349|NCT01475825|20492946|P3|Overall Study|Non-compliance with Study Drug|4
5923350|NCT01475825|20492947|P2|Overall Study|Non-compliance with Study Drug|2
5923351|NCT01475825|20492948|P1|Overall Study|Non-compliance with Study Drug|1
5923352|NCT01475825|20492945|P4|Overall Study|Lost to Follow-up|1
5923353|NCT01475825|20492946|P3|Overall Study|Lost to Follow-up|3
5923354|NCT01475825|20492947|P2|Overall Study|Lost to Follow-up|0
5923355|NCT01475825|20492948|P1|Overall Study|Lost to Follow-up|0
5923356|NCT01475825|20492945|P4|Overall Study|Lack of Efficacy|0
5923357|NCT01475825|20492946|P3|Overall Study|Lack of Efficacy|1
5923358|NCT01475825|20492947|P2|Overall Study|Lack of Efficacy|0
5923359|NCT01475825|20492948|P1|Overall Study|Lack of Efficacy|0
5923360|NCT01475825|20492945|P4|Overall Study|Death|0
5923361|NCT01475825|20492946|P3|Overall Study|Death|1
5923362|NCT01475825|20492947|P2|Overall Study|Death|0
5923363|NCT01475825|20492948|P1|Overall Study|Death|1
5923364|NCT01475825|20492945|P4|Overall Study|Adverse Event|11
5923365|NCT01475825|20492946|P3|Overall Study|Adverse Event|27
5923366|NCT01475825|20492947|P2|Overall Study|Adverse Event|15
5923367|NCT01475825|20492948|P1|Overall Study|Adverse Event|41
5923368|NCT01475734|20492980|P2|Overall Study|Physician Decision|1
5923369|NCT01475734|20492981|P1|Overall Study|Physician Decision|0
5923370|NCT01475734|20492980|P2|Overall Study|Protocol Violation|0
5923371|NCT01475734|20492981|P1|Overall Study|Protocol Violation|1
5923372|NCT01475734|20492980|P2|Overall Study|Withdrawal by Subject|0
5923373|NCT01475734|20492981|P1|Overall Study|Withdrawal by Subject|1
5923374|NCT01475721|20493009|P2|Overall Study|Withdrawal by Subject|8
5923375|NCT01475721|20493010|P1|Overall Study|Withdrawal by Subject|8
5923376|NCT01475721|20493009|P2|Overall Study|Death|6
5923377|NCT01475721|20493010|P1|Overall Study|Death|3
5923378|NCT01475487|20493076|P2|Overall Study|had to leave early for personal reasons|1
5923379|NCT01475487|20493077|P1|Overall Study|had to leave early for personal reasons|2
5923380|NCT01475474|20493089|P1|Baseline Period - 4 Weeks|Withdrawal by Subject|2
5923381|NCT01475474|20493089|P1|Baseline Period - 4 Weeks|Did not meet eligibility for treatment|4
5923382|NCT01475461|20493100|P7|Treatment Period|Adverse Event|0
5923383|NCT01475461|20493101|P6|Treatment Period|Adverse Event|0
5923384|NCT01475461|20493102|P5|Treatment Period|Adverse Event|0
5923385|NCT01475461|20493103|P4|Treatment Period|Adverse Event|1
5923386|NCT01475461|20493104|P3|Treatment Period|Adverse Event|0
5923387|NCT01475461|20493105|P2|Treatment Period|Adverse Event|0
5923388|NCT01475461|20493106|P1|Treatment Period|Adverse Event|0
5923389|NCT01475461|20493100|P7|Treatment Period|Medication Error|0
5923390|NCT01475461|20493101|P6|Treatment Period|Medication Error|0
5923391|NCT01475461|20493102|P5|Treatment Period|Medication Error|0
5923392|NCT01475461|20493103|P4|Treatment Period|Medication Error|1
5923393|NCT01475461|20493104|P3|Treatment Period|Medication Error|0
5923394|NCT01475461|20493105|P2|Treatment Period|Medication Error|0
5923395|NCT01475461|20493106|P1|Treatment Period|Medication Error|0
5923396|NCT01475461|20493100|P7|Treatment Period|Lack of Efficacy|0
5923397|NCT01475461|20493101|P6|Treatment Period|Lack of Efficacy|1
5923398|NCT01475461|20493102|P5|Treatment Period|Lack of Efficacy|1
5923399|NCT01475461|20493103|P4|Treatment Period|Lack of Efficacy|2
5923400|NCT01475461|20493104|P3|Treatment Period|Lack of Efficacy|0
5923401|NCT01475461|20493105|P2|Treatment Period|Lack of Efficacy|2
5923402|NCT01475461|20493106|P1|Treatment Period|Lack of Efficacy|0
5923403|NCT01475461|20493100|P7|Treatment Period|Protocol Violation|1
5923404|NCT01475461|20493101|P6|Treatment Period|Protocol Violation|0
5923405|NCT01475461|20493102|P5|Treatment Period|Protocol Violation|0
5923406|NCT01475461|20493103|P4|Treatment Period|Protocol Violation|0
5923407|NCT01475461|20493104|P3|Treatment Period|Protocol Violation|0
5923408|NCT01475461|20493105|P2|Treatment Period|Protocol Violation|1
5923409|NCT01475461|20493106|P1|Treatment Period|Protocol Violation|0
5923410|NCT01475461|20493100|P7|Treatment Period|Other|0
5923411|NCT01475461|20493101|P6|Treatment Period|Other|0
5923412|NCT01475461|20493102|P5|Treatment Period|Other|0
5923413|NCT01475461|20493103|P4|Treatment Period|Other|0
5923414|NCT01475461|20493104|P3|Treatment Period|Other|0
5923415|NCT01475461|20493105|P2|Treatment Period|Other|1
5923416|NCT01475461|20493106|P1|Treatment Period|Other|0
5923417|NCT01475461|20493100|P7|Treatment Period|Withdrawal by Subject|0
5923418|NCT01475461|20493101|P6|Treatment Period|Withdrawal by Subject|2
5923419|NCT01475461|20493102|P5|Treatment Period|Withdrawal by Subject|2
5923420|NCT01475461|20493103|P4|Treatment Period|Withdrawal by Subject|0
5923421|NCT01475461|20493104|P3|Treatment Period|Withdrawal by Subject|2
5923422|NCT01475461|20493105|P2|Treatment Period|Withdrawal by Subject|2
5923423|NCT01475461|20493106|P1|Treatment Period|Withdrawal by Subject|0
5923424|NCT01475461|20493100|P7|Treatment Period|Lost to Follow-up|1
5923425|NCT01475461|20493101|P6|Treatment Period|Lost to Follow-up|2
5923426|NCT01475461|20493102|P5|Treatment Period|Lost to Follow-up|1
5923427|NCT01475461|20493103|P4|Treatment Period|Lost to Follow-up|3
5923428|NCT01475461|20493104|P3|Treatment Period|Lost to Follow-up|2
5923429|NCT01475461|20493105|P2|Treatment Period|Lost to Follow-up|3
5923430|NCT01475461|20493106|P1|Treatment Period|Lost to Follow-up|0
5923431|NCT01475461|20493100|P7|Treatment Period|Death|0
5923432|NCT01475461|20493101|P6|Treatment Period|Death|0
5923433|NCT01475461|20493102|P5|Treatment Period|Death|0
5923434|NCT01475461|20493103|P4|Treatment Period|Death|1
5923435|NCT01475461|20493104|P3|Treatment Period|Death|0
5923436|NCT01475461|20493105|P2|Treatment Period|Death|0
5923437|NCT01475461|20493106|P1|Treatment Period|Death|0
5923438|NCT01475461|20493100|P7|Run-in Period|Protocol Violation|0
5923439|NCT01475461|20493101|P6|Run-in Period|Protocol Violation|0
5923440|NCT01475461|20493102|P5|Run-in Period|Protocol Violation|0
5923441|NCT01475461|20493103|P4|Run-in Period|Protocol Violation|0
5923442|NCT01475461|20493104|P3|Run-in Period|Protocol Violation|0
5923443|NCT01475461|20493105|P2|Run-in Period|Protocol Violation|0
5923444|NCT01475461|20493106|P1|Run-in Period|Protocol Violation|4
5923445|NCT01475461|20493100|P7|Run-in Period|Other|0
5923446|NCT01475461|20493101|P6|Run-in Period|Other|0
5923447|NCT01475461|20493102|P5|Run-in Period|Other|0
5923448|NCT01475461|20493103|P4|Run-in Period|Other|0
5923449|NCT01475461|20493104|P3|Run-in Period|Other|0
5923450|NCT01475461|20493105|P2|Run-in Period|Other|0
5923451|NCT01475461|20493106|P1|Run-in Period|Other|3
5923452|NCT01475461|20493100|P7|Run-in Period|Withdrawal by Subject|0
5923453|NCT01475461|20493101|P6|Run-in Period|Withdrawal by Subject|0
5923454|NCT01475461|20493102|P5|Run-in Period|Withdrawal by Subject|0
5923455|NCT01475461|20493103|P4|Run-in Period|Withdrawal by Subject|0
5923456|NCT01475461|20493104|P3|Run-in Period|Withdrawal by Subject|0
5923457|NCT01475461|20493105|P2|Run-in Period|Withdrawal by Subject|0
5923458|NCT01475461|20493106|P1|Run-in Period|Withdrawal by Subject|11
5923459|NCT01475461|20493100|P7|Run-in Period|Lost to Follow-up|0
5923460|NCT01475461|20493101|P6|Run-in Period|Lost to Follow-up|0
5923461|NCT01475461|20493102|P5|Run-in Period|Lost to Follow-up|0
5923462|NCT01475461|20493103|P4|Run-in Period|Lost to Follow-up|0
5923463|NCT01475461|20493104|P3|Run-in Period|Lost to Follow-up|0
5923464|NCT01475461|20493105|P2|Run-in Period|Lost to Follow-up|0
5923465|NCT01475461|20493106|P1|Run-in Period|Lost to Follow-up|7
5923466|NCT01475461|20493100|P7|Run-in Period|Not meet eligibility criteria|0
5923467|NCT01475461|20493101|P6|Run-in Period|Not meet eligibility criteria|0
5923468|NCT01475461|20493102|P5|Run-in Period|Not meet eligibility criteria|0
5923469|NCT01475461|20493103|P4|Run-in Period|Not meet eligibility criteria|0
5923470|NCT01475461|20493104|P3|Run-in Period|Not meet eligibility criteria|0
5923471|NCT01475461|20493105|P2|Run-in Period|Not meet eligibility criteria|0
5923472|NCT01475461|20493106|P1|Run-in Period|Not meet eligibility criteria|16
5923473|NCT01475331|20493186|P2|Overall Study|cyst found to be prohibitively small|1
5923474|NCT01475331|20493187|P1|Overall Study|cyst found to be prohibitively small|0
5923475|NCT01475331|20493186|P2|Overall Study|Sign of malignancy during the procedure|0
5923476|NCT01475331|20493187|P1|Overall Study|Sign of malignancy during the procedure|2
5923477|NCT01475331|20493186|P2|Overall Study|Loss of needle positioning due pt. cough|0
5923478|NCT01475331|20493187|P1|Overall Study|Loss of needle positioning due pt. cough|1
5923479|NCT01475331|20493186|P2|Overall Study|excessive main duct communication|1
5923480|NCT01475331|20493187|P1|Overall Study|excessive main duct communication|1
5923481|NCT01475331|20493186|P2|Overall Study|Osteophyte obstruction of the proximal|0
5923482|NCT01475331|20493187|P1|Overall Study|Osteophyte obstruction of the proximal|1
5923483|NCT01475253|20493239|P4|Randomized, Blinded Study|Lost to Follow-up|0
5923484|NCT01475253|20493240|P3|Randomized, Blinded Study|Lost to Follow-up|0
5923485|NCT01475253|20493241|P2|Randomized, Blinded Study|Lost to Follow-up|0
5923486|NCT01475253|20493242|P1|Randomized, Blinded Study|Lost to Follow-up|1
5923487|NCT01475253|20493239|P4|Randomized, Blinded Study|Withdrawal by Subject|0
5923488|NCT01475253|20493240|P3|Randomized, Blinded Study|Withdrawal by Subject|0
5923489|NCT01475253|20493241|P2|Randomized, Blinded Study|Withdrawal by Subject|1
5923490|NCT01475253|20493242|P1|Randomized, Blinded Study|Withdrawal by Subject|1
5923491|NCT01475214|20493271|P3|Overall Study|Withdrawal by Subject|1
5923492|NCT01475214|20493272|P2|Overall Study|Withdrawal by Subject|4
5923493|NCT01475214|20493273|P1|Overall Study|Withdrawal by Subject|2
5923494|NCT01475214|20493271|P3|Overall Study|Physician Decision|0
5923495|NCT01475214|20493272|P2|Overall Study|Physician Decision|0
5923496|NCT01475214|20493273|P1|Overall Study|Physician Decision|2
5923497|NCT01475214|20493271|P3|Overall Study|Lost to Follow-up|1
5923498|NCT01475214|20493272|P2|Overall Study|Lost to Follow-up|0
5923499|NCT01475214|20493273|P1|Overall Study|Lost to Follow-up|1
5923500|NCT01475162|20493296|P1|Overall Study|Study closed for safety|3
5923501|NCT01475162|20493296|P1|Overall Study|Death|10
5923502|NCT01475162|20493296|P1|Overall Study|Physician Decision|1
5923503|NCT01475097|20493309|P2|Overall Study|Protocol Violation|1
5923504|NCT01475097|20493310|P1|Overall Study|Protocol Violation|1
5923508|NCT01474993|20493328|P2|Overall Study|Adverse Event|1
5923509|NCT01474993|20493329|P1|Overall Study|Adverse Event|0
5923510|NCT01474993|20493328|P2|Overall Study|Lost to Follow-up|2
5923511|NCT01474993|20493329|P1|Overall Study|Lost to Follow-up|1
5923512|NCT01474876|20493371|P3|Overall Study|Investigator's decision and pt request|0
5923513|NCT01474876|20493372|P2|Overall Study|Investigator's decision and pt request|0
5923514|NCT01474876|20493373|P1|Overall Study|Investigator's decision and pt request|1
5923515|NCT01474876|20493371|P3|Overall Study|Patient's request|0
5923516|NCT01474876|20493372|P2|Overall Study|Patient's request|5
5923517|NCT01474876|20493373|P1|Overall Study|Patient's request|19
5923518|NCT01474876|20493371|P3|Overall Study|Investigator's decision|0
5923519|NCT01474876|20493372|P2|Overall Study|Investigator's decision|6
5923520|NCT01474876|20493373|P1|Overall Study|Investigator's decision|28
5923521|NCT01474876|20493371|P3|Overall Study|Lost to Follow-up|0
5923522|NCT01474876|20493372|P2|Overall Study|Lost to Follow-up|4
5923523|NCT01474876|20493373|P1|Overall Study|Lost to Follow-up|5
5923524|NCT01474876|20493371|P3|Overall Study|Serious Adverse Event|0
5923525|NCT01474876|20493372|P2|Overall Study|Serious Adverse Event|3
5923526|NCT01474876|20493373|P1|Overall Study|Serious Adverse Event|2
5923527|NCT01474876|20493371|P3|Overall Study|Adverse Event|0
5923528|NCT01474876|20493372|P2|Overall Study|Adverse Event|5
5923529|NCT01474876|20493373|P1|Overall Study|Adverse Event|11
5923530|NCT01474746|20493419|P2|Overall Study|Withdrawal by Subject|1
5923531|NCT01474746|20493420|P1|Overall Study|Withdrawal by Subject|2
5923532|NCT01474746|20493419|P2|Overall Study|Lost to Follow-up|1
5923533|NCT01474746|20493420|P1|Overall Study|Lost to Follow-up|1
5923534|NCT01474681|20493484|P4|Overall Study|Death|6
5923535|NCT01474681|20493485|P3|Overall Study|Death|2
5923536|NCT01474681|20493486|P2|Overall Study|Death|3
5923537|NCT01474681|20493487|P1|Overall Study|Death|0
5923538|NCT01474551|20493538|P1|Overall Study|Death|1
5923539|NCT01474538|20493544|P2|Treatment Period 2|Protocol Violation|0
5923540|NCT01474538|20493545|P1|Treatment Period 2|Protocol Violation|1
5923541|NCT01474538|20493544|P2|Treatment Period 2|Physician Decision|1
5923542|NCT01474538|20493545|P1|Treatment Period 2|Physician Decision|0
5923543|NCT01474538|20493544|P2|Treatment Period 2|Sponsor decision|0
5923544|NCT01474538|20493545|P1|Treatment Period 2|Sponsor decision|1
5923545|NCT01474538|20493544|P2|Treatment Period 2|Withdrawal by Subject|0
5923546|NCT01474538|20493545|P1|Treatment Period 2|Withdrawal by Subject|2
5923547|NCT01474538|20493544|P2|Treatment Period 2|Adverse Event|1
5923548|NCT01474538|20493545|P1|Treatment Period 2|Adverse Event|1
5923549|NCT01474538|20493544|P2|Treatment Period 2|Death|0
5923550|NCT01474538|20493545|P1|Treatment Period 2|Death|1
5923551|NCT01474538|20493544|P2|Treatment Period 1|Protocol Violation|1
5923552|NCT01474538|20493545|P1|Treatment Period 1|Protocol Violation|0
5923553|NCT01474538|20493544|P2|Treatment Period 1|Withdrawal by Subject|3
5923554|NCT01474538|20493545|P1|Treatment Period 1|Withdrawal by Subject|1
5923555|NCT01474538|20493544|P2|Treatment Period 1|Physician Decision|0
5923556|NCT01474538|20493545|P1|Treatment Period 1|Physician Decision|1
5923557|NCT01474538|20493544|P2|Treatment Period 1|Death|0
5923558|NCT01474538|20493545|P1|Treatment Period 1|Death|1
5923559|NCT01474512|20493562|P18|Post-Treatment Follow-Up|Death|0
5923560|NCT01474512|20493563|P17|Post-Treatment Follow-Up|Death|1
5923561|NCT01474512|20493564|P16|Post-Treatment Follow-Up|Death|0
5923562|NCT01474512|20493565|P15|Post-Treatment Follow-Up|Death|0
5923563|NCT01474512|20493566|P14|Post-Treatment Follow-Up|Death|0
5923564|NCT01474512|20493567|P13|Post-Treatment Follow-Up|Death|0
5923565|NCT01474512|20493568|P12|Post-Treatment Follow-Up|Death|0
5923566|NCT01474512|20493569|P11|Post-Treatment Follow-Up|Death|0
5923567|NCT01474512|20493570|P10|Post-Treatment Follow-Up|Death|0
5923568|NCT01474512|20493571|P9|Post-Treatment Follow-Up|Death|0
5923569|NCT01474512|20493572|P8|Post-Treatment Follow-Up|Death|0
5923570|NCT01474512|20493573|P7|Post-Treatment Follow-Up|Death|0
5923571|NCT01474512|20493574|P6|Post-Treatment Follow-Up|Death|0
5923572|NCT01474512|20493575|P5|Post-Treatment Follow-Up|Death|0
5923573|NCT01474512|20493576|P4|Post-Treatment Follow-Up|Death|0
5923574|NCT01474512|20493577|P3|Post-Treatment Follow-Up|Death|0
5923575|NCT01474512|20493578|P2|Post-Treatment Follow-Up|Death|0
5923576|NCT01474512|20493579|P1|Post-Treatment Follow-Up|Death|0
5923577|NCT01474512|20493562|P18|Post-Treatment Follow-Up|Parent/Caregiver Decision|1
5923578|NCT01474512|20493563|P17|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
5923579|NCT01474512|20493564|P16|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
5923580|NCT01474512|20493565|P15|Post-Treatment Follow-Up|Parent/Caregiver Decision|1
5923581|NCT01474512|20493566|P14|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
5923582|NCT01474512|20493567|P13|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
5923583|NCT01474512|20493568|P12|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
5923584|NCT01474512|20493569|P11|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
5923585|NCT01474512|20493570|P10|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
5923586|NCT01474512|20493571|P9|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
5923587|NCT01474512|20493572|P8|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
5923588|NCT01474512|20493573|P7|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
5923589|NCT01474512|20493574|P6|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
5923590|NCT01474512|20493575|P5|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
5923591|NCT01474512|20493576|P4|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
5923592|NCT01474512|20493577|P3|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
5923593|NCT01474512|20493578|P2|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
5923594|NCT01474512|20493579|P1|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
5923595|NCT01474512|20493562|P18|Post-Treatment Follow-Up|Sponsor Decision|0
5923596|NCT01474512|20493563|P17|Post-Treatment Follow-Up|Sponsor Decision|4
5923597|NCT01474512|20493564|P16|Post-Treatment Follow-Up|Sponsor Decision|0
5923598|NCT01474512|20493565|P15|Post-Treatment Follow-Up|Sponsor Decision|1
5923599|NCT01474512|20493566|P14|Post-Treatment Follow-Up|Sponsor Decision|0
5923600|NCT01474512|20493567|P13|Post-Treatment Follow-Up|Sponsor Decision|0
5923601|NCT01474512|20493568|P12|Post-Treatment Follow-Up|Sponsor Decision|0
5923602|NCT01474512|20493569|P11|Post-Treatment Follow-Up|Sponsor Decision|0
5923603|NCT01474512|20493570|P10|Post-Treatment Follow-Up|Sponsor Decision|0
5923604|NCT01474512|20493571|P9|Post-Treatment Follow-Up|Sponsor Decision|0
5923605|NCT01474512|20493572|P8|Post-Treatment Follow-Up|Sponsor Decision|0
5923606|NCT01474512|20493573|P7|Post-Treatment Follow-Up|Sponsor Decision|0
5923607|NCT01474512|20493574|P6|Post-Treatment Follow-Up|Sponsor Decision|0
5923608|NCT01474512|20493575|P5|Post-Treatment Follow-Up|Sponsor Decision|0
5923609|NCT01474512|20493576|P4|Post-Treatment Follow-Up|Sponsor Decision|0
5923610|NCT01474512|20493577|P3|Post-Treatment Follow-Up|Sponsor Decision|0
5923611|NCT01474512|20493578|P2|Post-Treatment Follow-Up|Sponsor Decision|0
5923612|NCT01474512|20493579|P1|Post-Treatment Follow-Up|Sponsor Decision|0
5923613|NCT01474512|20493562|P18|Post-Treatment Follow-Up|Protocol Violation|0
5923614|NCT01474512|20493563|P17|Post-Treatment Follow-Up|Protocol Violation|4
5923615|NCT01474512|20493564|P16|Post-Treatment Follow-Up|Protocol Violation|2
5923616|NCT01474512|20493565|P15|Post-Treatment Follow-Up|Protocol Violation|2
5923617|NCT01474512|20493566|P14|Post-Treatment Follow-Up|Protocol Violation|0
5923618|NCT01474512|20493567|P13|Post-Treatment Follow-Up|Protocol Violation|0
5923619|NCT01474512|20493568|P12|Post-Treatment Follow-Up|Protocol Violation|0
5923620|NCT01474512|20493569|P11|Post-Treatment Follow-Up|Protocol Violation|0
5923621|NCT01474512|20493570|P10|Post-Treatment Follow-Up|Protocol Violation|0
5923622|NCT01474512|20493571|P9|Post-Treatment Follow-Up|Protocol Violation|0
5923623|NCT01474512|20493572|P8|Post-Treatment Follow-Up|Protocol Violation|0
5923624|NCT01474512|20493573|P7|Post-Treatment Follow-Up|Protocol Violation|0
5923625|NCT01474512|20493574|P6|Post-Treatment Follow-Up|Protocol Violation|0
5923626|NCT01474512|20493575|P5|Post-Treatment Follow-Up|Protocol Violation|0
5923627|NCT01474512|20493576|P4|Post-Treatment Follow-Up|Protocol Violation|0
5923628|NCT01474512|20493577|P3|Post-Treatment Follow-Up|Protocol Violation|0
5923629|NCT01474512|20493578|P2|Post-Treatment Follow-Up|Protocol Violation|0
5923630|NCT01474512|20493579|P1|Post-Treatment Follow-Up|Protocol Violation|0
5923631|NCT01474512|20493562|P18|Post-Treatment Follow-Up|Clinical Relapse|2
5923632|NCT01474512|20493563|P17|Post-Treatment Follow-Up|Clinical Relapse|6
5923633|NCT01474512|20493564|P16|Post-Treatment Follow-Up|Clinical Relapse|0
5923634|NCT01474512|20493565|P15|Post-Treatment Follow-Up|Clinical Relapse|0
5923635|NCT01474512|20493566|P14|Post-Treatment Follow-Up|Clinical Relapse|0
5923636|NCT01474512|20493567|P13|Post-Treatment Follow-Up|Clinical Relapse|0
5923637|NCT01474512|20493568|P12|Post-Treatment Follow-Up|Clinical Relapse|0
5923638|NCT01474512|20493569|P11|Post-Treatment Follow-Up|Clinical Relapse|0
5923639|NCT01474512|20493570|P10|Post-Treatment Follow-Up|Clinical Relapse|0
5923640|NCT01474512|20493571|P9|Post-Treatment Follow-Up|Clinical Relapse|0
5923641|NCT01474512|20493572|P8|Post-Treatment Follow-Up|Clinical Relapse|0
5923642|NCT01474512|20493573|P7|Post-Treatment Follow-Up|Clinical Relapse|0
5923643|NCT01474512|20493574|P6|Post-Treatment Follow-Up|Clinical Relapse|0
5923644|NCT01474512|20493575|P5|Post-Treatment Follow-Up|Clinical Relapse|0
5923645|NCT01474512|20493576|P4|Post-Treatment Follow-Up|Clinical Relapse|0
5923646|NCT01474512|20493577|P3|Post-Treatment Follow-Up|Clinical Relapse|0
5923647|NCT01474512|20493578|P2|Post-Treatment Follow-Up|Clinical Relapse|0
5923648|NCT01474512|20493579|P1|Post-Treatment Follow-Up|Clinical Relapse|0
5923649|NCT01474512|20493562|P18|Post-Treatment Follow-Up|Physician Decision|5
5923650|NCT01474512|20493563|P17|Post-Treatment Follow-Up|Physician Decision|4
5923651|NCT01474512|20493564|P16|Post-Treatment Follow-Up|Physician Decision|0
5923652|NCT01474512|20493565|P15|Post-Treatment Follow-Up|Physician Decision|0
5923653|NCT01474512|20493566|P14|Post-Treatment Follow-Up|Physician Decision|0
5923654|NCT01474512|20493567|P13|Post-Treatment Follow-Up|Physician Decision|0
5923655|NCT01474512|20493568|P12|Post-Treatment Follow-Up|Physician Decision|0
5923656|NCT01474512|20493569|P11|Post-Treatment Follow-Up|Physician Decision|0
5923657|NCT01474512|20493570|P10|Post-Treatment Follow-Up|Physician Decision|0
5923658|NCT01474512|20493571|P9|Post-Treatment Follow-Up|Physician Decision|0
5923659|NCT01474512|20493572|P8|Post-Treatment Follow-Up|Physician Decision|0
5923660|NCT01474512|20493573|P7|Post-Treatment Follow-Up|Physician Decision|0
5923661|NCT01474512|20493574|P6|Post-Treatment Follow-Up|Physician Decision|0
5923662|NCT01474512|20493575|P5|Post-Treatment Follow-Up|Physician Decision|0
5923663|NCT01474512|20493576|P4|Post-Treatment Follow-Up|Physician Decision|0
5923664|NCT01474512|20493577|P3|Post-Treatment Follow-Up|Physician Decision|0
5923665|NCT01474512|20493578|P2|Post-Treatment Follow-Up|Physician Decision|0
5923666|NCT01474512|20493579|P1|Post-Treatment Follow-Up|Physician Decision|0
5923667|NCT01474512|20493562|P18|Post-Treatment Follow-Up|Lost to Follow-up|7
5923668|NCT01474512|20493563|P17|Post-Treatment Follow-Up|Lost to Follow-up|12
5923669|NCT01474512|20493564|P16|Post-Treatment Follow-Up|Lost to Follow-up|0
5923670|NCT01474512|20493565|P15|Post-Treatment Follow-Up|Lost to Follow-up|0
5923671|NCT01474512|20493566|P14|Post-Treatment Follow-Up|Lost to Follow-up|0
5923672|NCT01474512|20493567|P13|Post-Treatment Follow-Up|Lost to Follow-up|0
5923673|NCT01474512|20493568|P12|Post-Treatment Follow-Up|Lost to Follow-up|0
5923674|NCT01474512|20493569|P11|Post-Treatment Follow-Up|Lost to Follow-up|0
5923675|NCT01474512|20493570|P10|Post-Treatment Follow-Up|Lost to Follow-up|0
5923676|NCT01474512|20493571|P9|Post-Treatment Follow-Up|Lost to Follow-up|0
5923677|NCT01474512|20493572|P8|Post-Treatment Follow-Up|Lost to Follow-up|0
5923678|NCT01474512|20493573|P7|Post-Treatment Follow-Up|Lost to Follow-up|0
5923679|NCT01474512|20493574|P6|Post-Treatment Follow-Up|Lost to Follow-up|0
5923680|NCT01474512|20493575|P5|Post-Treatment Follow-Up|Lost to Follow-up|0
5923681|NCT01474512|20493576|P4|Post-Treatment Follow-Up|Lost to Follow-up|0
5923682|NCT01474512|20493577|P3|Post-Treatment Follow-Up|Lost to Follow-up|0
5923683|NCT01474512|20493578|P2|Post-Treatment Follow-Up|Lost to Follow-up|0
5923684|NCT01474512|20493579|P1|Post-Treatment Follow-Up|Lost to Follow-up|0
5923685|NCT01474512|20493562|P18|Post-Treatment Follow-Up|Lack of Efficacy|3
5923686|NCT01474512|20493563|P17|Post-Treatment Follow-Up|Lack of Efficacy|31
5923687|NCT01474512|20493564|P16|Post-Treatment Follow-Up|Lack of Efficacy|2
5923688|NCT01474512|20493565|P15|Post-Treatment Follow-Up|Lack of Efficacy|3
5923689|NCT01474512|20493566|P14|Post-Treatment Follow-Up|Lack of Efficacy|0
5923690|NCT01474512|20493567|P13|Post-Treatment Follow-Up|Lack of Efficacy|0
5923691|NCT01474512|20493568|P12|Post-Treatment Follow-Up|Lack of Efficacy|0
5923692|NCT01474512|20493569|P11|Post-Treatment Follow-Up|Lack of Efficacy|0
5923693|NCT01474512|20493570|P10|Post-Treatment Follow-Up|Lack of Efficacy|0
5923694|NCT01474512|20493571|P9|Post-Treatment Follow-Up|Lack of Efficacy|0
5923695|NCT01474512|20493572|P8|Post-Treatment Follow-Up|Lack of Efficacy|0
5923696|NCT01474512|20493573|P7|Post-Treatment Follow-Up|Lack of Efficacy|0
5923697|NCT01474512|20493574|P6|Post-Treatment Follow-Up|Lack of Efficacy|0
5923698|NCT01474512|20493575|P5|Post-Treatment Follow-Up|Lack of Efficacy|0
5923699|NCT01474512|20493576|P4|Post-Treatment Follow-Up|Lack of Efficacy|0
5923700|NCT01474512|20493577|P3|Post-Treatment Follow-Up|Lack of Efficacy|0
5923701|NCT01474512|20493578|P2|Post-Treatment Follow-Up|Lack of Efficacy|0
5923702|NCT01474512|20493579|P1|Post-Treatment Follow-Up|Lack of Efficacy|0
5923703|NCT01474512|20493562|P18|Post-Treatment Follow-Up|Withdrawal by Subject|17
5923704|NCT01474512|20493563|P17|Post-Treatment Follow-Up|Withdrawal by Subject|36
5923705|NCT01474512|20493564|P16|Post-Treatment Follow-Up|Withdrawal by Subject|2
5923706|NCT01474512|20493565|P15|Post-Treatment Follow-Up|Withdrawal by Subject|3
5923707|NCT01474512|20493566|P14|Post-Treatment Follow-Up|Withdrawal by Subject|0
5923708|NCT01474512|20493567|P13|Post-Treatment Follow-Up|Withdrawal by Subject|0
5923709|NCT01474512|20493568|P12|Post-Treatment Follow-Up|Withdrawal by Subject|0
5923710|NCT01474512|20493569|P11|Post-Treatment Follow-Up|Withdrawal by Subject|0
5923711|NCT01474512|20493570|P10|Post-Treatment Follow-Up|Withdrawal by Subject|0
5923712|NCT01474512|20493571|P9|Post-Treatment Follow-Up|Withdrawal by Subject|0
5923713|NCT01474512|20493572|P8|Post-Treatment Follow-Up|Withdrawal by Subject|0
5923714|NCT01474512|20493573|P7|Post-Treatment Follow-Up|Withdrawal by Subject|0
5923715|NCT01474512|20493574|P6|Post-Treatment Follow-Up|Withdrawal by Subject|0
5923716|NCT01474512|20493575|P5|Post-Treatment Follow-Up|Withdrawal by Subject|0
5923717|NCT01474512|20493576|P4|Post-Treatment Follow-Up|Withdrawal by Subject|0
5923718|NCT01474512|20493577|P3|Post-Treatment Follow-Up|Withdrawal by Subject|0
5923719|NCT01474512|20493578|P2|Post-Treatment Follow-Up|Withdrawal by Subject|0
5923720|NCT01474512|20493579|P1|Post-Treatment Follow-Up|Withdrawal by Subject|0
5923721|NCT01474512|20493562|P18|Post-Treatment Follow-Up|Adverse Event|11
5923722|NCT01474512|20493563|P17|Post-Treatment Follow-Up|Adverse Event|58
5923723|NCT01474512|20493564|P16|Post-Treatment Follow-Up|Adverse Event|2
5923724|NCT01474512|20493565|P15|Post-Treatment Follow-Up|Adverse Event|8
5923725|NCT01474512|20493566|P14|Post-Treatment Follow-Up|Adverse Event|0
5923726|NCT01474512|20493567|P13|Post-Treatment Follow-Up|Adverse Event|0
5923727|NCT01474512|20493568|P12|Post-Treatment Follow-Up|Adverse Event|0
5923728|NCT01474512|20493569|P11|Post-Treatment Follow-Up|Adverse Event|0
5923729|NCT01474512|20493570|P10|Post-Treatment Follow-Up|Adverse Event|0
5923730|NCT01474512|20493571|P9|Post-Treatment Follow-Up|Adverse Event|0
5923731|NCT01474512|20493572|P8|Post-Treatment Follow-Up|Adverse Event|0
5923732|NCT01474512|20493573|P7|Post-Treatment Follow-Up|Adverse Event|0
5923733|NCT01474512|20493574|P6|Post-Treatment Follow-Up|Adverse Event|0
5923734|NCT01474512|20493575|P5|Post-Treatment Follow-Up|Adverse Event|0
5923735|NCT01474512|20493576|P4|Post-Treatment Follow-Up|Adverse Event|0
5923736|NCT01474512|20493577|P3|Post-Treatment Follow-Up|Adverse Event|0
5923737|NCT01474512|20493578|P2|Post-Treatment Follow-Up|Adverse Event|0
5923738|NCT01474512|20493579|P1|Post-Treatment Follow-Up|Adverse Event|0
5923739|NCT01474512|20493562|P18|Long-Term Extension Period|Switched From PBO to Ixe|0
5923740|NCT01474512|20493563|P17|Long-Term Extension Period|Switched From PBO to Ixe|0
5923741|NCT01474512|20493564|P16|Long-Term Extension Period|Switched From PBO to Ixe|0
5923742|NCT01474512|20493565|P15|Long-Term Extension Period|Switched From PBO to Ixe|0
5923743|NCT01474512|20493566|P14|Long-Term Extension Period|Switched From PBO to Ixe|0
5923744|NCT01474512|20493567|P13|Long-Term Extension Period|Switched From PBO to Ixe|0
5923745|NCT01474512|20493568|P12|Long-Term Extension Period|Switched From PBO to Ixe|21
5923746|NCT01474512|20493569|P11|Long-Term Extension Period|Switched From PBO to Ixe|0
5923747|NCT01474512|20493570|P10|Long-Term Extension Period|Switched From PBO to Ixe|0
5923748|NCT01474512|20493571|P9|Long-Term Extension Period|Switched From PBO to Ixe|0
5923749|NCT01474512|20493572|P8|Long-Term Extension Period|Switched From PBO to Ixe|0
5923750|NCT01474512|20493573|P7|Long-Term Extension Period|Switched From PBO to Ixe|0
5923751|NCT01474512|20493574|P6|Long-Term Extension Period|Switched From PBO to Ixe|0
5923752|NCT01474512|20493575|P5|Long-Term Extension Period|Switched From PBO to Ixe|0
5923753|NCT01474512|20493576|P4|Long-Term Extension Period|Switched From PBO to Ixe|0
5923754|NCT01474512|20493577|P3|Long-Term Extension Period|Switched From PBO to Ixe|0
5923755|NCT01474512|20493578|P2|Long-Term Extension Period|Switched From PBO to Ixe|0
5923756|NCT01474512|20493579|P1|Long-Term Extension Period|Switched From PBO to Ixe|0
5923757|NCT01474512|20493562|P18|Long-Term Extension Period|Parent/Caregiver Decision|0
5923758|NCT01474512|20493563|P17|Long-Term Extension Period|Parent/Caregiver Decision|0
5923759|NCT01474512|20493564|P16|Long-Term Extension Period|Parent/Caregiver Decision|0
5923760|NCT01474512|20493565|P15|Long-Term Extension Period|Parent/Caregiver Decision|0
5923761|NCT01474512|20493566|P14|Long-Term Extension Period|Parent/Caregiver Decision|1
5923762|NCT01474512|20493567|P13|Long-Term Extension Period|Parent/Caregiver Decision|1
5923763|NCT01474512|20493568|P12|Long-Term Extension Period|Parent/Caregiver Decision|0
5923764|NCT01474512|20493569|P11|Long-Term Extension Period|Parent/Caregiver Decision|0
5923765|NCT01474512|20493570|P10|Long-Term Extension Period|Parent/Caregiver Decision|0
5923766|NCT01474512|20493571|P9|Long-Term Extension Period|Parent/Caregiver Decision|0
5923767|NCT01474512|20493572|P8|Long-Term Extension Period|Parent/Caregiver Decision|0
5923768|NCT01474512|20493573|P7|Long-Term Extension Period|Parent/Caregiver Decision|0
5923769|NCT01474512|20493574|P6|Long-Term Extension Period|Parent/Caregiver Decision|0
5923770|NCT01474512|20493575|P5|Long-Term Extension Period|Parent/Caregiver Decision|0
5923771|NCT01474512|20493576|P4|Long-Term Extension Period|Parent/Caregiver Decision|0
5923772|NCT01474512|20493577|P3|Long-Term Extension Period|Parent/Caregiver Decision|0
5923773|NCT01474512|20493578|P2|Long-Term Extension Period|Parent/Caregiver Decision|0
5923774|NCT01474512|20493579|P1|Long-Term Extension Period|Parent/Caregiver Decision|0
5923775|NCT01474512|20493562|P18|Long-Term Extension Period|Protocol Violation|0
5923776|NCT01474512|20493563|P17|Long-Term Extension Period|Protocol Violation|0
5923777|NCT01474512|20493564|P16|Long-Term Extension Period|Protocol Violation|0
5923778|NCT01474512|20493565|P15|Long-Term Extension Period|Protocol Violation|0
5923779|NCT01474512|20493566|P14|Long-Term Extension Period|Protocol Violation|5
5923780|NCT01474512|20493567|P13|Long-Term Extension Period|Protocol Violation|5
5923781|NCT01474512|20493568|P12|Long-Term Extension Period|Protocol Violation|0
5923782|NCT01474512|20493569|P11|Long-Term Extension Period|Protocol Violation|0
5923783|NCT01474512|20493570|P10|Long-Term Extension Period|Protocol Violation|0
5923784|NCT01474512|20493571|P9|Long-Term Extension Period|Protocol Violation|0
5923785|NCT01474512|20493572|P8|Long-Term Extension Period|Protocol Violation|0
5923786|NCT01474512|20493573|P7|Long-Term Extension Period|Protocol Violation|0
5923787|NCT01474512|20493574|P6|Long-Term Extension Period|Protocol Violation|0
5923788|NCT01474512|20493575|P5|Long-Term Extension Period|Protocol Violation|0
5923789|NCT01474512|20493576|P4|Long-Term Extension Period|Protocol Violation|0
5923790|NCT01474512|20493577|P3|Long-Term Extension Period|Protocol Violation|0
5923791|NCT01474512|20493578|P2|Long-Term Extension Period|Protocol Violation|0
5923792|NCT01474512|20493579|P1|Long-Term Extension Period|Protocol Violation|0
5923793|NCT01474512|20493562|P18|Long-Term Extension Period|Sponsor Decision|0
5923794|NCT01474512|20493563|P17|Long-Term Extension Period|Sponsor Decision|0
5923795|NCT01474512|20493564|P16|Long-Term Extension Period|Sponsor Decision|0
5923796|NCT01474512|20493565|P15|Long-Term Extension Period|Sponsor Decision|0
5923797|NCT01474512|20493566|P14|Long-Term Extension Period|Sponsor Decision|6
5923798|NCT01474512|20493567|P13|Long-Term Extension Period|Sponsor Decision|6
5923799|NCT01474512|20493568|P12|Long-Term Extension Period|Sponsor Decision|0
5923800|NCT01474512|20493569|P11|Long-Term Extension Period|Sponsor Decision|0
5923801|NCT01474512|20493570|P10|Long-Term Extension Period|Sponsor Decision|0
5923802|NCT01474512|20493571|P9|Long-Term Extension Period|Sponsor Decision|0
5923803|NCT01474512|20493572|P8|Long-Term Extension Period|Sponsor Decision|0
5923804|NCT01474512|20493573|P7|Long-Term Extension Period|Sponsor Decision|0
5923805|NCT01474512|20493574|P6|Long-Term Extension Period|Sponsor Decision|0
5923806|NCT01474512|20493575|P5|Long-Term Extension Period|Sponsor Decision|0
5923807|NCT01474512|20493576|P4|Long-Term Extension Period|Sponsor Decision|0
5923808|NCT01474512|20493577|P3|Long-Term Extension Period|Sponsor Decision|0
5923809|NCT01474512|20493578|P2|Long-Term Extension Period|Sponsor Decision|0
5923810|NCT01474512|20493579|P1|Long-Term Extension Period|Sponsor Decision|0
5923811|NCT01474512|20493562|P18|Long-Term Extension Period|Death|0
5923812|NCT01474512|20493563|P17|Long-Term Extension Period|Death|0
5923813|NCT01474512|20493564|P16|Long-Term Extension Period|Death|0
5923814|NCT01474512|20493565|P15|Long-Term Extension Period|Death|0
5923815|NCT01474512|20493566|P14|Long-Term Extension Period|Death|9
5923816|NCT01474512|20493567|P13|Long-Term Extension Period|Death|9
5923817|NCT01474512|20493568|P12|Long-Term Extension Period|Death|0
5923818|NCT01474512|20493569|P11|Long-Term Extension Period|Death|0
5923819|NCT01474512|20493570|P10|Long-Term Extension Period|Death|0
5923820|NCT01474512|20493571|P9|Long-Term Extension Period|Death|0
5923821|NCT01474512|20493572|P8|Long-Term Extension Period|Death|0
5923822|NCT01474512|20493573|P7|Long-Term Extension Period|Death|0
5923823|NCT01474512|20493574|P6|Long-Term Extension Period|Death|0
5923824|NCT01474512|20493575|P5|Long-Term Extension Period|Death|0
5923825|NCT01474512|20493576|P4|Long-Term Extension Period|Death|0
5923826|NCT01474512|20493577|P3|Long-Term Extension Period|Death|0
5923827|NCT01474512|20493578|P2|Long-Term Extension Period|Death|0
5923828|NCT01474512|20493579|P1|Long-Term Extension Period|Death|0
5923829|NCT01474512|20493562|P18|Long-Term Extension Period|Clinical Relapse|0
5923830|NCT01474512|20493563|P17|Long-Term Extension Period|Clinical Relapse|0
5923831|NCT01474512|20493564|P16|Long-Term Extension Period|Clinical Relapse|0
5923832|NCT01474512|20493565|P15|Long-Term Extension Period|Clinical Relapse|0
5923833|NCT01474512|20493566|P14|Long-Term Extension Period|Clinical Relapse|9
5923834|NCT01474512|20493567|P13|Long-Term Extension Period|Clinical Relapse|9
5923835|NCT01474512|20493568|P12|Long-Term Extension Period|Clinical Relapse|0
5923836|NCT01474512|20493569|P11|Long-Term Extension Period|Clinical Relapse|0
5923837|NCT01474512|20493570|P10|Long-Term Extension Period|Clinical Relapse|0
5923838|NCT01474512|20493571|P9|Long-Term Extension Period|Clinical Relapse|0
5923839|NCT01474512|20493572|P8|Long-Term Extension Period|Clinical Relapse|0
5923840|NCT01474512|20493573|P7|Long-Term Extension Period|Clinical Relapse|0
5923841|NCT01474512|20493574|P6|Long-Term Extension Period|Clinical Relapse|0
5923842|NCT01474512|20493575|P5|Long-Term Extension Period|Clinical Relapse|0
5923843|NCT01474512|20493576|P4|Long-Term Extension Period|Clinical Relapse|0
5923844|NCT01474512|20493577|P3|Long-Term Extension Period|Clinical Relapse|0
5923845|NCT01474512|20493578|P2|Long-Term Extension Period|Clinical Relapse|0
5923846|NCT01474512|20493579|P1|Long-Term Extension Period|Clinical Relapse|0
5923847|NCT01474512|20493562|P18|Long-Term Extension Period|Physician Decision|0
5923848|NCT01474512|20493563|P17|Long-Term Extension Period|Physician Decision|0
5923849|NCT01474512|20493564|P16|Long-Term Extension Period|Physician Decision|0
5923850|NCT01474512|20493565|P15|Long-Term Extension Period|Physician Decision|0
5923851|NCT01474512|20493566|P14|Long-Term Extension Period|Physician Decision|21
5923852|NCT01474512|20493567|P13|Long-Term Extension Period|Physician Decision|21
5923853|NCT01474512|20493568|P12|Long-Term Extension Period|Physician Decision|0
5923854|NCT01474512|20493569|P11|Long-Term Extension Period|Physician Decision|0
5923855|NCT01474512|20493570|P10|Long-Term Extension Period|Physician Decision|0
5923856|NCT01474512|20493571|P9|Long-Term Extension Period|Physician Decision|0
5923857|NCT01474512|20493572|P8|Long-Term Extension Period|Physician Decision|0
5923858|NCT01474512|20493573|P7|Long-Term Extension Period|Physician Decision|0
5923859|NCT01474512|20493574|P6|Long-Term Extension Period|Physician Decision|0
5923860|NCT01474512|20493575|P5|Long-Term Extension Period|Physician Decision|0
5923861|NCT01474512|20493576|P4|Long-Term Extension Period|Physician Decision|0
5923862|NCT01474512|20493577|P3|Long-Term Extension Period|Physician Decision|0
5923863|NCT01474512|20493578|P2|Long-Term Extension Period|Physician Decision|0
5923864|NCT01474512|20493579|P1|Long-Term Extension Period|Physician Decision|0
5923865|NCT01474512|20493562|P18|Long-Term Extension Period|Lack of Efficacy|0
5923866|NCT01474512|20493563|P17|Long-Term Extension Period|Lack of Efficacy|0
5923867|NCT01474512|20493564|P16|Long-Term Extension Period|Lack of Efficacy|0
5923868|NCT01474512|20493565|P15|Long-Term Extension Period|Lack of Efficacy|0
5923869|NCT01474512|20493566|P14|Long-Term Extension Period|Lack of Efficacy|25
5923870|NCT01474512|20493567|P13|Long-Term Extension Period|Lack of Efficacy|24
5923871|NCT01474512|20493568|P12|Long-Term Extension Period|Lack of Efficacy|1
5923872|NCT01474512|20493569|P11|Long-Term Extension Period|Lack of Efficacy|0
5923873|NCT01474512|20493570|P10|Long-Term Extension Period|Lack of Efficacy|0
5923874|NCT01474512|20493571|P9|Long-Term Extension Period|Lack of Efficacy|0
5923875|NCT01474512|20493572|P8|Long-Term Extension Period|Lack of Efficacy|0
5923876|NCT01474512|20493573|P7|Long-Term Extension Period|Lack of Efficacy|0
5923877|NCT01474512|20493574|P6|Long-Term Extension Period|Lack of Efficacy|0
5923878|NCT01474512|20493575|P5|Long-Term Extension Period|Lack of Efficacy|0
5923879|NCT01474512|20493576|P4|Long-Term Extension Period|Lack of Efficacy|0
5923880|NCT01474512|20493577|P3|Long-Term Extension Period|Lack of Efficacy|0
5923881|NCT01474512|20493578|P2|Long-Term Extension Period|Lack of Efficacy|0
5923882|NCT01474512|20493579|P1|Long-Term Extension Period|Lack of Efficacy|0
5923883|NCT01474512|20493562|P18|Long-Term Extension Period|Lost to Follow-up|0
5923884|NCT01474512|20493563|P17|Long-Term Extension Period|Lost to Follow-up|0
5923885|NCT01474512|20493564|P16|Long-Term Extension Period|Lost to Follow-up|0
5923886|NCT01474512|20493565|P15|Long-Term Extension Period|Lost to Follow-up|0
5923887|NCT01474512|20493566|P14|Long-Term Extension Period|Lost to Follow-up|25
5923888|NCT01474512|20493567|P13|Long-Term Extension Period|Lost to Follow-up|25
5923889|NCT01474512|20493568|P12|Long-Term Extension Period|Lost to Follow-up|0
5923890|NCT01474512|20493569|P11|Long-Term Extension Period|Lost to Follow-up|0
5923891|NCT01474512|20493570|P10|Long-Term Extension Period|Lost to Follow-up|0
5923892|NCT01474512|20493571|P9|Long-Term Extension Period|Lost to Follow-up|0
5923893|NCT01474512|20493572|P8|Long-Term Extension Period|Lost to Follow-up|0
5923894|NCT01474512|20493573|P7|Long-Term Extension Period|Lost to Follow-up|0
5923895|NCT01474512|20493574|P6|Long-Term Extension Period|Lost to Follow-up|0
5923896|NCT01474512|20493575|P5|Long-Term Extension Period|Lost to Follow-up|0
5923897|NCT01474512|20493576|P4|Long-Term Extension Period|Lost to Follow-up|0
5923898|NCT01474512|20493577|P3|Long-Term Extension Period|Lost to Follow-up|0
5923899|NCT01474512|20493578|P2|Long-Term Extension Period|Lost to Follow-up|0
5923900|NCT01474512|20493579|P1|Long-Term Extension Period|Lost to Follow-up|0
5923901|NCT01474512|20493562|P18|Long-Term Extension Period|Adverse Event|0
5923902|NCT01474512|20493563|P17|Long-Term Extension Period|Adverse Event|0
5923903|NCT01474512|20493564|P16|Long-Term Extension Period|Adverse Event|0
5923904|NCT01474512|20493565|P15|Long-Term Extension Period|Adverse Event|0
5923905|NCT01474512|20493566|P14|Long-Term Extension Period|Adverse Event|58
5923906|NCT01474512|20493567|P13|Long-Term Extension Period|Adverse Event|57
5923907|NCT01474512|20493568|P12|Long-Term Extension Period|Adverse Event|1
5923908|NCT01474512|20493569|P11|Long-Term Extension Period|Adverse Event|0
5923909|NCT01474512|20493570|P10|Long-Term Extension Period|Adverse Event|0
5923910|NCT01474512|20493571|P9|Long-Term Extension Period|Adverse Event|0
5923911|NCT01474512|20493572|P8|Long-Term Extension Period|Adverse Event|0
5923912|NCT01474512|20493573|P7|Long-Term Extension Period|Adverse Event|0
5923913|NCT01474512|20493574|P6|Long-Term Extension Period|Adverse Event|0
5923914|NCT01474512|20493575|P5|Long-Term Extension Period|Adverse Event|0
5923915|NCT01474512|20493576|P4|Long-Term Extension Period|Adverse Event|0
5923916|NCT01474512|20493577|P3|Long-Term Extension Period|Adverse Event|0
5923917|NCT01474512|20493578|P2|Long-Term Extension Period|Adverse Event|0
5923918|NCT01474512|20493579|P1|Long-Term Extension Period|Adverse Event|0
5923919|NCT01474512|20493562|P18|Long-Term Extension Period|Withdrawal by Subject|0
5923920|NCT01474512|20493563|P17|Long-Term Extension Period|Withdrawal by Subject|0
5923921|NCT01474512|20493564|P16|Long-Term Extension Period|Withdrawal by Subject|0
5923922|NCT01474512|20493565|P15|Long-Term Extension Period|Withdrawal by Subject|0
5923923|NCT01474512|20493566|P14|Long-Term Extension Period|Withdrawal by Subject|61
5923924|NCT01474512|20493567|P13|Long-Term Extension Period|Withdrawal by Subject|61
5923925|NCT01474512|20493568|P12|Long-Term Extension Period|Withdrawal by Subject|3
5923926|NCT01474512|20493569|P11|Long-Term Extension Period|Withdrawal by Subject|0
5923927|NCT01474512|20493570|P10|Long-Term Extension Period|Withdrawal by Subject|0
5923928|NCT01474512|20493571|P9|Long-Term Extension Period|Withdrawal by Subject|0
5923929|NCT01474512|20493572|P8|Long-Term Extension Period|Withdrawal by Subject|0
5923930|NCT01474512|20493573|P7|Long-Term Extension Period|Withdrawal by Subject|0
5923931|NCT01474512|20493574|P6|Long-Term Extension Period|Withdrawal by Subject|0
5923932|NCT01474512|20493575|P5|Long-Term Extension Period|Withdrawal by Subject|0
5923933|NCT01474512|20493576|P4|Long-Term Extension Period|Withdrawal by Subject|0
5923934|NCT01474512|20493577|P3|Long-Term Extension Period|Withdrawal by Subject|0
5923935|NCT01474512|20493578|P2|Long-Term Extension Period|Withdrawal by Subject|0
5923936|NCT01474512|20493579|P1|Long-Term Extension Period|Withdrawal by Subject|0
5923937|NCT01474512|20493562|P18|Maintenance Period|Treated but Discontinued in Induction|0
5923938|NCT01474512|20493563|P17|Maintenance Period|Treated but Discontinued in Induction|0
5923939|NCT01474512|20493564|P16|Maintenance Period|Treated but Discontinued in Induction|0
5923940|NCT01474512|20493565|P15|Maintenance Period|Treated but Discontinued in Induction|0
5923941|NCT01474512|20493566|P14|Maintenance Period|Treated but Discontinued in Induction|0
5923942|NCT01474512|20493567|P13|Maintenance Period|Treated but Discontinued in Induction|0
5923943|NCT01474512|20493568|P12|Maintenance Period|Treated but Discontinued in Induction|0
5923944|NCT01474512|20493569|P11|Maintenance Period|Treated but Discontinued in Induction|0
5923945|NCT01474512|20493570|P10|Maintenance Period|Treated but Discontinued in Induction|0
5923946|NCT01474512|20493571|P9|Maintenance Period|Treated but Discontinued in Induction|0
5923947|NCT01474512|20493572|P8|Maintenance Period|Treated but Discontinued in Induction|0
5923948|NCT01474512|20493573|P7|Maintenance Period|Treated but Discontinued in Induction|0
5923949|NCT01474512|20493574|P6|Maintenance Period|Treated but Discontinued in Induction|0
5923950|NCT01474512|20493575|P5|Maintenance Period|Treated but Discontinued in Induction|1
5923951|NCT01474512|20493576|P4|Maintenance Period|Treated but Discontinued in Induction|0
5923952|NCT01474512|20493577|P3|Maintenance Period|Treated but Discontinued in Induction|0
5923953|NCT01474512|20493578|P2|Maintenance Period|Treated but Discontinued in Induction|0
5923954|NCT01474512|20493579|P1|Maintenance Period|Treated but Discontinued in Induction|0
5923955|NCT01474512|20493562|P18|Maintenance Period|Protocol Violation|0
5923956|NCT01474512|20493563|P17|Maintenance Period|Protocol Violation|0
5923957|NCT01474512|20493564|P16|Maintenance Period|Protocol Violation|0
5923958|NCT01474512|20493565|P15|Maintenance Period|Protocol Violation|0
5923959|NCT01474512|20493566|P14|Maintenance Period|Protocol Violation|0
5923960|NCT01474512|20493567|P13|Maintenance Period|Protocol Violation|0
5923961|NCT01474512|20493568|P12|Maintenance Period|Protocol Violation|0
5923962|NCT01474512|20493569|P11|Maintenance Period|Protocol Violation|0
5923963|NCT01474512|20493570|P10|Maintenance Period|Protocol Violation|1
5923964|NCT01474512|20493571|P9|Maintenance Period|Protocol Violation|0
5923965|NCT01474512|20493572|P8|Maintenance Period|Protocol Violation|1
5923966|NCT01474512|20493573|P7|Maintenance Period|Protocol Violation|0
5923967|NCT01474512|20493574|P6|Maintenance Period|Protocol Violation|0
5923968|NCT01474512|20493575|P5|Maintenance Period|Protocol Violation|0
5923969|NCT01474512|20493576|P4|Maintenance Period|Protocol Violation|1
5923970|NCT01474512|20493577|P3|Maintenance Period|Protocol Violation|0
5923971|NCT01474512|20493578|P2|Maintenance Period|Protocol Violation|0
5923972|NCT01474512|20493579|P1|Maintenance Period|Protocol Violation|0
5923973|NCT01474512|20493562|P18|Maintenance Period|Lack of Efficacy|0
5923974|NCT01474512|20493563|P17|Maintenance Period|Lack of Efficacy|0
5923975|NCT01474512|20493564|P16|Maintenance Period|Lack of Efficacy|0
5923976|NCT01474512|20493565|P15|Maintenance Period|Lack of Efficacy|0
5923977|NCT01474512|20493566|P14|Maintenance Period|Lack of Efficacy|0
5923978|NCT01474512|20493567|P13|Maintenance Period|Lack of Efficacy|0
5923979|NCT01474512|20493568|P12|Maintenance Period|Lack of Efficacy|0
5923980|NCT01474512|20493569|P11|Maintenance Period|Lack of Efficacy|0
5923981|NCT01474512|20493570|P10|Maintenance Period|Lack of Efficacy|12
5923982|NCT01474512|20493571|P9|Maintenance Period|Lack of Efficacy|11
5923983|NCT01474512|20493572|P8|Maintenance Period|Lack of Efficacy|11
5923984|NCT01474512|20493573|P7|Maintenance Period|Lack of Efficacy|0
5923985|NCT01474512|20493574|P6|Maintenance Period|Lack of Efficacy|0
5923986|NCT01474512|20493575|P5|Maintenance Period|Lack of Efficacy|0
5923987|NCT01474512|20493576|P4|Maintenance Period|Lack of Efficacy|1
5923988|NCT01474512|20493577|P3|Maintenance Period|Lack of Efficacy|0
5923989|NCT01474512|20493578|P2|Maintenance Period|Lack of Efficacy|0
5923990|NCT01474512|20493579|P1|Maintenance Period|Lack of Efficacy|0
5923991|NCT01474512|20493562|P18|Maintenance Period|Clinical Relapse|0
5923992|NCT01474512|20493563|P17|Maintenance Period|Clinical Relapse|0
5923993|NCT01474512|20493564|P16|Maintenance Period|Clinical Relapse|0
5923994|NCT01474512|20493565|P15|Maintenance Period|Clinical Relapse|0
5923995|NCT01474512|20493566|P14|Maintenance Period|Clinical Relapse|0
5923996|NCT01474512|20493567|P13|Maintenance Period|Clinical Relapse|0
5923997|NCT01474512|20493568|P12|Maintenance Period|Clinical Relapse|0
5923998|NCT01474512|20493569|P11|Maintenance Period|Clinical Relapse|0
5923999|NCT01474512|20493570|P10|Maintenance Period|Clinical Relapse|0
5924000|NCT01474512|20493571|P9|Maintenance Period|Clinical Relapse|0
5924001|NCT01474512|20493572|P8|Maintenance Period|Clinical Relapse|0
5924002|NCT01474512|20493573|P7|Maintenance Period|Clinical Relapse|0
5924003|NCT01474512|20493574|P6|Maintenance Period|Clinical Relapse|0
5924004|NCT01474512|20493575|P5|Maintenance Period|Clinical Relapse|0
5924005|NCT01474512|20493576|P4|Maintenance Period|Clinical Relapse|1
5924006|NCT01474512|20493577|P3|Maintenance Period|Clinical Relapse|0
5924007|NCT01474512|20493578|P2|Maintenance Period|Clinical Relapse|0
5924008|NCT01474512|20493579|P1|Maintenance Period|Clinical Relapse|0
5924009|NCT01474512|20493562|P18|Maintenance Period|Physician Decision|0
5924010|NCT01474512|20493563|P17|Maintenance Period|Physician Decision|0
5924011|NCT01474512|20493564|P16|Maintenance Period|Physician Decision|0
5924012|NCT01474512|20493565|P15|Maintenance Period|Physician Decision|0
5924013|NCT01474512|20493566|P14|Maintenance Period|Physician Decision|0
5924014|NCT01474512|20493567|P13|Maintenance Period|Physician Decision|0
5924015|NCT01474512|20493568|P12|Maintenance Period|Physician Decision|0
5924016|NCT01474512|20493569|P11|Maintenance Period|Physician Decision|0
5924017|NCT01474512|20493570|P10|Maintenance Period|Physician Decision|0
5924018|NCT01474512|20493571|P9|Maintenance Period|Physician Decision|0
5924019|NCT01474512|20493572|P8|Maintenance Period|Physician Decision|2
5924020|NCT01474512|20493573|P7|Maintenance Period|Physician Decision|0
5924021|NCT01474512|20493574|P6|Maintenance Period|Physician Decision|1
5924022|NCT01474512|20493575|P5|Maintenance Period|Physician Decision|0
5924023|NCT01474512|20493576|P4|Maintenance Period|Physician Decision|0
5924024|NCT01474512|20493577|P3|Maintenance Period|Physician Decision|0
5924025|NCT01474512|20493578|P2|Maintenance Period|Physician Decision|0
5924026|NCT01474512|20493579|P1|Maintenance Period|Physician Decision|0
5924027|NCT01474512|20493562|P18|Maintenance Period|Death|0
5924028|NCT01474512|20493563|P17|Maintenance Period|Death|0
5924029|NCT01474512|20493564|P16|Maintenance Period|Death|0
5924030|NCT01474512|20493565|P15|Maintenance Period|Death|0
5924031|NCT01474512|20493566|P14|Maintenance Period|Death|0
5924032|NCT01474512|20493567|P13|Maintenance Period|Death|0
5924033|NCT01474512|20493568|P12|Maintenance Period|Death|0
5924034|NCT01474512|20493569|P11|Maintenance Period|Death|0
5924035|NCT01474512|20493570|P10|Maintenance Period|Death|0
5924036|NCT01474512|20493571|P9|Maintenance Period|Death|0
5924037|NCT01474512|20493572|P8|Maintenance Period|Death|0
5924038|NCT01474512|20493573|P7|Maintenance Period|Death|0
5924039|NCT01474512|20493574|P6|Maintenance Period|Death|2
5924040|NCT01474512|20493575|P5|Maintenance Period|Death|0
5924041|NCT01474512|20493576|P4|Maintenance Period|Death|0
5924042|NCT01474512|20493577|P3|Maintenance Period|Death|0
5924043|NCT01474512|20493578|P2|Maintenance Period|Death|0
5924044|NCT01474512|20493579|P1|Maintenance Period|Death|0
5924045|NCT01474512|20493562|P18|Maintenance Period|Lost to Follow-up|0
5924046|NCT01474512|20493563|P17|Maintenance Period|Lost to Follow-up|0
5924047|NCT01474512|20493564|P16|Maintenance Period|Lost to Follow-up|0
5924048|NCT01474512|20493565|P15|Maintenance Period|Lost to Follow-up|0
5924049|NCT01474512|20493566|P14|Maintenance Period|Lost to Follow-up|0
5924050|NCT01474512|20493567|P13|Maintenance Period|Lost to Follow-up|0
5924051|NCT01474512|20493568|P12|Maintenance Period|Lost to Follow-up|0
5924052|NCT01474512|20493569|P11|Maintenance Period|Lost to Follow-up|0
5924053|NCT01474512|20493570|P10|Maintenance Period|Lost to Follow-up|1
5924054|NCT01474512|20493571|P9|Maintenance Period|Lost to Follow-up|1
5924055|NCT01474512|20493572|P8|Maintenance Period|Lost to Follow-up|2
5924056|NCT01474512|20493573|P7|Maintenance Period|Lost to Follow-up|0
5924057|NCT01474512|20493574|P6|Maintenance Period|Lost to Follow-up|0
5924058|NCT01474512|20493575|P5|Maintenance Period|Lost to Follow-up|3
5924059|NCT01474512|20493576|P4|Maintenance Period|Lost to Follow-up|3
5924060|NCT01474512|20493577|P3|Maintenance Period|Lost to Follow-up|0
5924061|NCT01474512|20493578|P2|Maintenance Period|Lost to Follow-up|0
5924062|NCT01474512|20493579|P1|Maintenance Period|Lost to Follow-up|0
5924063|NCT01474512|20493562|P18|Maintenance Period|Withdrawal by Subject|0
5924064|NCT01474512|20493563|P17|Maintenance Period|Withdrawal by Subject|0
5924065|NCT01474512|20493564|P16|Maintenance Period|Withdrawal by Subject|0
5924066|NCT01474512|20493565|P15|Maintenance Period|Withdrawal by Subject|0
5924067|NCT01474512|20493566|P14|Maintenance Period|Withdrawal by Subject|0
5924068|NCT01474512|20493567|P13|Maintenance Period|Withdrawal by Subject|0
5924069|NCT01474512|20493568|P12|Maintenance Period|Withdrawal by Subject|0
5924070|NCT01474512|20493569|P11|Maintenance Period|Withdrawal by Subject|0
5924071|NCT01474512|20493570|P10|Maintenance Period|Withdrawal by Subject|1
5924072|NCT01474512|20493571|P9|Maintenance Period|Withdrawal by Subject|3
5924073|NCT01474512|20493572|P8|Maintenance Period|Withdrawal by Subject|6
5924074|NCT01474512|20493573|P7|Maintenance Period|Withdrawal by Subject|1
5924075|NCT01474512|20493574|P6|Maintenance Period|Withdrawal by Subject|3
5924076|NCT01474512|20493575|P5|Maintenance Period|Withdrawal by Subject|2
5924077|NCT01474512|20493576|P4|Maintenance Period|Withdrawal by Subject|6
5924078|NCT01474512|20493577|P3|Maintenance Period|Withdrawal by Subject|0
5924079|NCT01474512|20493578|P2|Maintenance Period|Withdrawal by Subject|0
5924080|NCT01474512|20493579|P1|Maintenance Period|Withdrawal by Subject|0
5924081|NCT01474512|20493562|P18|Maintenance Period|Adverse Event|0
5924082|NCT01474512|20493563|P17|Maintenance Period|Adverse Event|0
5924083|NCT01474512|20493564|P16|Maintenance Period|Adverse Event|0
5924084|NCT01474512|20493565|P15|Maintenance Period|Adverse Event|0
5924085|NCT01474512|20493566|P14|Maintenance Period|Adverse Event|0
5924086|NCT01474512|20493567|P13|Maintenance Period|Adverse Event|0
5924087|NCT01474512|20493568|P12|Maintenance Period|Adverse Event|0
5924088|NCT01474512|20493569|P11|Maintenance Period|Adverse Event|0
5924089|NCT01474512|20493570|P10|Maintenance Period|Adverse Event|3
5924090|NCT01474512|20493571|P9|Maintenance Period|Adverse Event|1
5924091|NCT01474512|20493572|P8|Maintenance Period|Adverse Event|19
5924092|NCT01474512|20493573|P7|Maintenance Period|Adverse Event|0
5924093|NCT01474512|20493574|P6|Maintenance Period|Adverse Event|7
5924094|NCT01474512|20493575|P5|Maintenance Period|Adverse Event|2
5924095|NCT01474512|20493576|P4|Maintenance Period|Adverse Event|4
5924096|NCT01474512|20493577|P3|Maintenance Period|Adverse Event|0
5924097|NCT01474512|20493578|P2|Maintenance Period|Adverse Event|0
5924098|NCT01474512|20493579|P1|Maintenance Period|Adverse Event|0
5924099|NCT01474512|20493562|P18|Maintenance Period|Relapsed (sPGA ≥3)|0
5924100|NCT01474512|20493563|P17|Maintenance Period|Relapsed (sPGA ≥3)|0
5924101|NCT01474512|20493564|P16|Maintenance Period|Relapsed (sPGA ≥3)|0
5924102|NCT01474512|20493565|P15|Maintenance Period|Relapsed (sPGA ≥3)|0
5924103|NCT01474512|20493566|P14|Maintenance Period|Relapsed (sPGA ≥3)|0
5924104|NCT01474512|20493567|P13|Maintenance Period|Relapsed (sPGA ≥3)|0
5924105|NCT01474512|20493568|P12|Maintenance Period|Relapsed (sPGA ≥3)|0
5924106|NCT01474512|20493569|P11|Maintenance Period|Relapsed (sPGA ≥3)|0
5924107|NCT01474512|20493570|P10|Maintenance Period|Relapsed (sPGA ≥3)|0
5924108|NCT01474512|20493571|P9|Maintenance Period|Relapsed (sPGA ≥3)|0
5924109|NCT01474512|20493572|P8|Maintenance Period|Relapsed (sPGA ≥3)|0
5924110|NCT01474512|20493573|P7|Maintenance Period|Relapsed (sPGA ≥3)|9
5924111|NCT01474512|20493574|P6|Maintenance Period|Relapsed (sPGA ≥3)|39
5924112|NCT01474512|20493575|P5|Maintenance Period|Relapsed (sPGA ≥3)|111
5924113|NCT01474512|20493576|P4|Maintenance Period|Relapsed (sPGA ≥3)|186
5924114|NCT01474512|20493577|P3|Maintenance Period|Relapsed (sPGA ≥3)|0
5924115|NCT01474512|20493578|P2|Maintenance Period|Relapsed (sPGA ≥3)|0
5924116|NCT01474512|20493579|P1|Maintenance Period|Relapsed (sPGA ≥3)|0
5924117|NCT01474512|20493562|P18|Induction Period|Lost to Follow-up|0
5924118|NCT01474512|20493563|P17|Induction Period|Lost to Follow-up|0
5924119|NCT01474512|20493564|P16|Induction Period|Lost to Follow-up|0
5924120|NCT01474512|20493565|P15|Induction Period|Lost to Follow-up|0
5924121|NCT01474512|20493566|P14|Induction Period|Lost to Follow-up|0
5924122|NCT01474512|20493567|P13|Induction Period|Lost to Follow-up|0
5924123|NCT01474512|20493568|P12|Induction Period|Lost to Follow-up|0
5924124|NCT01474512|20493569|P11|Induction Period|Lost to Follow-up|0
5924125|NCT01474512|20493570|P10|Induction Period|Lost to Follow-up|0
5924126|NCT01474512|20493571|P9|Induction Period|Lost to Follow-up|0
5924127|NCT01474512|20493572|P8|Induction Period|Lost to Follow-up|0
5924128|NCT01474512|20493573|P7|Induction Period|Lost to Follow-up|0
5924129|NCT01474512|20493574|P6|Induction Period|Lost to Follow-up|0
5924130|NCT01474512|20493575|P5|Induction Period|Lost to Follow-up|0
5924131|NCT01474512|20493576|P4|Induction Period|Lost to Follow-up|0
5924132|NCT01474512|20493577|P3|Induction Period|Lost to Follow-up|2
5924133|NCT01474512|20493578|P2|Induction Period|Lost to Follow-up|0
5924134|NCT01474512|20493579|P1|Induction Period|Lost to Follow-up|1
5924135|NCT01474512|20493562|P18|Induction Period|Sponsor Decision|0
5924136|NCT01474512|20493563|P17|Induction Period|Sponsor Decision|0
5924137|NCT01474512|20493564|P16|Induction Period|Sponsor Decision|0
5924138|NCT01474512|20493565|P15|Induction Period|Sponsor Decision|0
5924139|NCT01474512|20493566|P14|Induction Period|Sponsor Decision|0
5924140|NCT01474512|20493567|P13|Induction Period|Sponsor Decision|0
5924141|NCT01474512|20493568|P12|Induction Period|Sponsor Decision|0
5924142|NCT01474512|20493569|P11|Induction Period|Sponsor Decision|0
5924143|NCT01474512|20493570|P10|Induction Period|Sponsor Decision|0
5924144|NCT01474512|20493571|P9|Induction Period|Sponsor Decision|0
5924145|NCT01474512|20493572|P8|Induction Period|Sponsor Decision|0
5924146|NCT01474512|20493573|P7|Induction Period|Sponsor Decision|0
5924147|NCT01474512|20493574|P6|Induction Period|Sponsor Decision|0
5924148|NCT01474512|20493575|P5|Induction Period|Sponsor Decision|0
5924149|NCT01474512|20493576|P4|Induction Period|Sponsor Decision|0
5924150|NCT01474512|20493577|P3|Induction Period|Sponsor Decision|1
5924151|NCT01474512|20493578|P2|Induction Period|Sponsor Decision|1
5924152|NCT01474512|20493579|P1|Induction Period|Sponsor Decision|1
5924153|NCT01474512|20493562|P18|Induction Period|Protocol Violation|0
5924154|NCT01474512|20493563|P17|Induction Period|Protocol Violation|0
5924155|NCT01474512|20493564|P16|Induction Period|Protocol Violation|0
5924156|NCT01474512|20493565|P15|Induction Period|Protocol Violation|0
5924157|NCT01474512|20493566|P14|Induction Period|Protocol Violation|0
5924158|NCT01474512|20493567|P13|Induction Period|Protocol Violation|0
5924159|NCT01474512|20493568|P12|Induction Period|Protocol Violation|0
5924160|NCT01474512|20493569|P11|Induction Period|Protocol Violation|0
5924161|NCT01474512|20493570|P10|Induction Period|Protocol Violation|0
5924162|NCT01474512|20493571|P9|Induction Period|Protocol Violation|0
5924163|NCT01474512|20493572|P8|Induction Period|Protocol Violation|0
5924164|NCT01474512|20493573|P7|Induction Period|Protocol Violation|0
5924165|NCT01474512|20493574|P6|Induction Period|Protocol Violation|0
5924166|NCT01474512|20493575|P5|Induction Period|Protocol Violation|0
5924167|NCT01474512|20493576|P4|Induction Period|Protocol Violation|0
5924168|NCT01474512|20493577|P3|Induction Period|Protocol Violation|0
5924169|NCT01474512|20493578|P2|Induction Period|Protocol Violation|6
5924170|NCT01474512|20493579|P1|Induction Period|Protocol Violation|3
5924171|NCT01474512|20493562|P18|Induction Period|Withdrawal by Subject|0
5924172|NCT01474512|20493563|P17|Induction Period|Withdrawal by Subject|0
5924173|NCT01474512|20493564|P16|Induction Period|Withdrawal by Subject|0
5924174|NCT01474512|20493565|P15|Induction Period|Withdrawal by Subject|0
5924175|NCT01474512|20493566|P14|Induction Period|Withdrawal by Subject|0
5924176|NCT01474512|20493567|P13|Induction Period|Withdrawal by Subject|0
5924177|NCT01474512|20493568|P12|Induction Period|Withdrawal by Subject|0
5924178|NCT01474512|20493569|P11|Induction Period|Withdrawal by Subject|0
5924179|NCT01474512|20493570|P10|Induction Period|Withdrawal by Subject|0
5924180|NCT01474512|20493571|P9|Induction Period|Withdrawal by Subject|0
5924181|NCT01474512|20493572|P8|Induction Period|Withdrawal by Subject|0
5924182|NCT01474512|20493573|P7|Induction Period|Withdrawal by Subject|0
5924183|NCT01474512|20493574|P6|Induction Period|Withdrawal by Subject|0
5924184|NCT01474512|20493575|P5|Induction Period|Withdrawal by Subject|0
5924185|NCT01474512|20493576|P4|Induction Period|Withdrawal by Subject|0
5924186|NCT01474512|20493577|P3|Induction Period|Withdrawal by Subject|5
5924187|NCT01474512|20493578|P2|Induction Period|Withdrawal by Subject|6
5924188|NCT01474512|20493579|P1|Induction Period|Withdrawal by Subject|6
5924189|NCT01474512|20493562|P18|Induction Period|Lack of Efficacy|0
5924190|NCT01474512|20493563|P17|Induction Period|Lack of Efficacy|0
5924191|NCT01474512|20493564|P16|Induction Period|Lack of Efficacy|0
5924192|NCT01474512|20493565|P15|Induction Period|Lack of Efficacy|0
5924193|NCT01474512|20493566|P14|Induction Period|Lack of Efficacy|0
5924194|NCT01474512|20493567|P13|Induction Period|Lack of Efficacy|0
5924195|NCT01474512|20493568|P12|Induction Period|Lack of Efficacy|0
5924196|NCT01474512|20493569|P11|Induction Period|Lack of Efficacy|0
5924197|NCT01474512|20493570|P10|Induction Period|Lack of Efficacy|0
5924198|NCT01474512|20493571|P9|Induction Period|Lack of Efficacy|0
5924199|NCT01474512|20493572|P8|Induction Period|Lack of Efficacy|0
5924200|NCT01474512|20493573|P7|Induction Period|Lack of Efficacy|0
5924201|NCT01474512|20493574|P6|Induction Period|Lack of Efficacy|0
5924202|NCT01474512|20493575|P5|Induction Period|Lack of Efficacy|0
5924203|NCT01474512|20493576|P4|Induction Period|Lack of Efficacy|0
5924204|NCT01474512|20493577|P3|Induction Period|Lack of Efficacy|0
5924205|NCT01474512|20493578|P2|Induction Period|Lack of Efficacy|1
5924206|NCT01474512|20493579|P1|Induction Period|Lack of Efficacy|7
5924207|NCT01474512|20493562|P18|Induction Period|Adverse Event|0
5924208|NCT01474512|20493563|P17|Induction Period|Adverse Event|0
5924209|NCT01474512|20493564|P16|Induction Period|Adverse Event|0
5924210|NCT01474512|20493565|P15|Induction Period|Adverse Event|0
5924211|NCT01474512|20493566|P14|Induction Period|Adverse Event|0
5924212|NCT01474512|20493567|P13|Induction Period|Adverse Event|0
5924213|NCT01474512|20493568|P12|Induction Period|Adverse Event|0
5924214|NCT01474512|20493569|P11|Induction Period|Adverse Event|0
5924215|NCT01474512|20493570|P10|Induction Period|Adverse Event|0
5924216|NCT01474512|20493571|P9|Induction Period|Adverse Event|0
5924217|NCT01474512|20493572|P8|Induction Period|Adverse Event|0
5924218|NCT01474512|20493573|P7|Induction Period|Adverse Event|0
5924219|NCT01474512|20493574|P6|Induction Period|Adverse Event|0
5924220|NCT01474512|20493575|P5|Induction Period|Adverse Event|0
5924221|NCT01474512|20493576|P4|Induction Period|Adverse Event|0
5924222|NCT01474512|20493577|P3|Induction Period|Adverse Event|10
5924223|NCT01474512|20493578|P2|Induction Period|Adverse Event|10
5924224|NCT01474512|20493579|P1|Induction Period|Adverse Event|6
5924225|NCT01474434|20493655|P4|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0
5924226|NCT01474434|20493656|P3|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0
5924227|NCT01474434|20493657|P2|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0
5924228|NCT01474434|20493658|P1|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|1
5924229|NCT01474434|20493655|P4|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|1
5924230|NCT01474434|20493656|P3|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0
5924231|NCT01474434|20493657|P2|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0
5924496|NCT01472939|20494620|P4|Overall Study|Withdrawal By PI|0
5924232|NCT01474434|20493658|P1|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0
5924233|NCT01474434|20493655|P4|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1
5924234|NCT01474434|20493656|P3|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1
5924235|NCT01474434|20493657|P2|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0
5924236|NCT01474434|20493658|P1|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0
5924237|NCT01474317|20493700|P1|Overall Study|Subject ineligible for study|1
5924238|NCT01474317|20493700|P1|Overall Study|Adverse Event|1
5924239|NCT01474291|20493709|P1|Overall Study|Death|2
5924240|NCT01474291|20493709|P1|Overall Study|No Reason Reported|10
5924241|NCT01474291|20493709|P1|Overall Study|Patient No Longer Wanted to Participate|12
5924242|NCT01474291|20493709|P1|Overall Study|Lost to Follow-up|29
5924243|NCT01474291|20493709|P1|Overall Study|Adverse Event|53
5924244|NCT01474291|20493709|P1|Overall Study|Lack of Treatment Efficacy|88
5924245|NCT01474291|20493709|P1|Overall Study|Not Evaluable for Efficacy|26
5924246|NCT01474239|20493753|P2|Overall Study|Withdrawal for Economic Reason|0
5924247|NCT01474239|20493754|P1|Overall Study|Withdrawal for Economic Reason|1
5924248|NCT01474239|20493753|P2|Overall Study|Clinical Disease Progression|1
5924249|NCT01474239|20493754|P1|Overall Study|Clinical Disease Progression|7
5924250|NCT01474239|20493753|P2|Overall Study|Death|1
5924251|NCT01474239|20493754|P1|Overall Study|Death|1
5924252|NCT01474239|20493753|P2|Overall Study|Withdrawal by Subject|2
5924253|NCT01474239|20493754|P1|Overall Study|Withdrawal by Subject|1
5924254|NCT01474239|20493753|P2|Overall Study|Adverse Event|3
5924255|NCT01474239|20493754|P1|Overall Study|Adverse Event|12
5924256|NCT01474239|20493753|P2|Overall Study|Disease Progression|25
5924257|NCT01474239|20493754|P1|Overall Study|Disease Progression|37
5924258|NCT01474018|20493926|P2|Overall Study|Withdrawal by Subject|2
5924259|NCT01474018|20493927|P1|Overall Study|Withdrawal by Subject|0
5924260|NCT01474018|20493926|P2|Overall Study|Lost to Follow-up|1
5924261|NCT01474018|20493927|P1|Overall Study|Lost to Follow-up|0
5924262|NCT01473953|20493959|P5|Overall Study|Other|0
5924263|NCT01473953|20493960|P4|Overall Study|Other|0
5924264|NCT01473953|20493961|P3|Overall Study|Other|0
5924265|NCT01473953|20493962|P2|Overall Study|Other|0
5924266|NCT01473953|20493963|P1|Overall Study|Other|1
5924267|NCT01473940|20494009|P4|Maintenance Therapy|Progressive Disease|4
5924268|NCT01473940|20494010|P3|Maintenance Therapy|Progressive Disease|1
5924269|NCT01473940|20494011|P2|Maintenance Therapy|Progressive Disease|2
5924270|NCT01473940|20494012|P1|Maintenance Therapy|Progressive Disease|1
5924271|NCT01473940|20494009|P4|Induction Therapy|Progressive Disease|0
5924272|NCT01473940|20494010|P3|Induction Therapy|Progressive Disease|1
5924273|NCT01473940|20494011|P2|Induction Therapy|Progressive Disease|1
5924274|NCT01473940|20494012|P1|Induction Therapy|Progressive Disease|0
5924275|NCT01473940|20494009|P4|Induction Therapy|Death|1
5924276|NCT01473940|20494010|P3|Induction Therapy|Death|1
5924277|NCT01473940|20494011|P2|Induction Therapy|Death|0
5924278|NCT01473940|20494012|P1|Induction Therapy|Death|0
5924279|NCT01473836|20494042|P1|Overall Study|Does not meet entrance criteria|1
5924280|NCT01473836|20494042|P1|Overall Study|Lack of Efficacy|1
5924281|NCT01473836|20494042|P1|Overall Study|Adverse Event|4
5924282|NCT01473758|20494053|P4|Cycle 2|Adverse Event|0
5924283|NCT01473758|20494054|P3|Cycle 2|Adverse Event|5
5924284|NCT01473758|20494055|P2|Cycle 2|Adverse Event|0
5924285|NCT01473758|20494056|P1|Cycle 2|Adverse Event|0
5924286|NCT01473758|20494053|P4|Cycle 1|Withdrawal by Subject|0
5924287|NCT01473758|20494054|P3|Cycle 1|Withdrawal by Subject|0
5924288|NCT01473758|20494055|P2|Cycle 1|Withdrawal by Subject|1
5924289|NCT01473758|20494056|P1|Cycle 1|Withdrawal by Subject|1
5924290|NCT01473758|20494053|P4|Cycle 1|Adverse Event|0
5924291|NCT01473758|20494054|P3|Cycle 1|Adverse Event|0
5924292|NCT01473758|20494055|P2|Cycle 1|Adverse Event|2
5924293|NCT01473758|20494056|P1|Cycle 1|Adverse Event|10
5924294|NCT01473732|20494193|P2|Overall Study|Death|0
5924295|NCT01473732|20494194|P1|Overall Study|Death|1
5924296|NCT01473732|20494193|P2|Overall Study|Adverse Event|0
5924297|NCT01473732|20494194|P1|Overall Study|Adverse Event|1
5924298|NCT01473602|20494202|P2|Overall Study|Physician Decision|0
5924299|NCT01473602|20494203|P1|Overall Study|Physician Decision|1
5924300|NCT01473602|20494202|P2|Overall Study|Withdrawal by Subject|4
5924301|NCT01473602|20494203|P1|Overall Study|Withdrawal by Subject|5
5924302|NCT01473602|20494202|P2|Overall Study|Lost to Follow-up|1
5924303|NCT01473602|20494203|P1|Overall Study|Lost to Follow-up|1
5924304|NCT01473602|20494202|P2|Overall Study|Death|1
5924305|NCT01473602|20494203|P1|Overall Study|Death|0
5924306|NCT01473602|20494202|P2|Overall Study|Adverse Event|2
5924307|NCT01473602|20494203|P1|Overall Study|Adverse Event|1
5924308|NCT01473589|20494239|P2|Overall Study|Entry criteria not met|1
5924309|NCT01473589|20494240|P1|Overall Study|Entry criteria not met|0
5924310|NCT01473589|20494239|P2|Overall Study|Physician Decision|1
5924311|NCT01473589|20494240|P1|Overall Study|Physician Decision|0
5924312|NCT01473589|20494239|P2|Overall Study|Withdrawal by Subject|11
5924313|NCT01473589|20494240|P1|Overall Study|Withdrawal by Subject|5
5924314|NCT01473589|20494239|P2|Overall Study|Protocol Violation|0
5924315|NCT01473589|20494240|P1|Overall Study|Protocol Violation|1
5924316|NCT01473589|20494239|P2|Overall Study|Lost to Follow-up|2
5924317|NCT01473589|20494240|P1|Overall Study|Lost to Follow-up|2
5924318|NCT01473589|20494239|P2|Overall Study|Death|0
5924319|NCT01473589|20494240|P1|Overall Study|Death|2
5924320|NCT01473589|20494239|P2|Overall Study|Adverse Event|1
5924321|NCT01473589|20494240|P1|Overall Study|Adverse Event|1
5924322|NCT01473563|20494274|P1|Overall Study|Lost to FU post tx discontinuation|1
5924323|NCT01473524|20494296|P6|LTSE Phase|Protocol Violation|1
5924324|NCT01473524|20494297|P5|LTSE Phase|Protocol Violation|0
5924325|NCT01473524|20494298|P4|LTSE Phase|Protocol Violation|0
5924326|NCT01473524|20494299|P3|LTSE Phase|Protocol Violation|0
5924327|NCT01473524|20494300|P2|LTSE Phase|Protocol Violation|0
5924328|NCT01473524|20494301|P1|LTSE Phase|Protocol Violation|0
5924329|NCT01473524|20494296|P6|LTSE Phase|Pregnancy|0
5924330|NCT01473524|20494297|P5|LTSE Phase|Pregnancy|0
5924331|NCT01473524|20494298|P4|LTSE Phase|Pregnancy|1
5924332|NCT01473524|20494299|P3|LTSE Phase|Pregnancy|0
5924333|NCT01473524|20494300|P2|LTSE Phase|Pregnancy|0
5924334|NCT01473524|20494301|P1|LTSE Phase|Pregnancy|0
5924335|NCT01473524|20494296|P6|LTSE Phase|Liver Transplantation|1
5924336|NCT01473524|20494297|P5|LTSE Phase|Liver Transplantation|0
5924337|NCT01473524|20494298|P4|LTSE Phase|Liver Transplantation|0
5924338|NCT01473524|20494299|P3|LTSE Phase|Liver Transplantation|0
5924339|NCT01473524|20494300|P2|LTSE Phase|Liver Transplantation|0
5924340|NCT01473524|20494301|P1|LTSE Phase|Liver Transplantation|0
5924341|NCT01473524|20494296|P6|LTSE Phase|Principal Investigator Decision|3
5924342|NCT01473524|20494297|P5|LTSE Phase|Principal Investigator Decision|1
5924343|NCT01473524|20494298|P4|LTSE Phase|Principal Investigator Decision|1
5924344|NCT01473524|20494299|P3|LTSE Phase|Principal Investigator Decision|0
5924345|NCT01473524|20494300|P2|LTSE Phase|Principal Investigator Decision|0
5924346|NCT01473524|20494301|P1|LTSE Phase|Principal Investigator Decision|0
5924347|NCT01473524|20494296|P6|LTSE Phase|Lost to Follow-up|2
5924348|NCT01473524|20494297|P5|LTSE Phase|Lost to Follow-up|3
5924349|NCT01473524|20494298|P4|LTSE Phase|Lost to Follow-up|1
5924350|NCT01473524|20494299|P3|LTSE Phase|Lost to Follow-up|0
5924351|NCT01473524|20494300|P2|LTSE Phase|Lost to Follow-up|0
5924352|NCT01473524|20494301|P1|LTSE Phase|Lost to Follow-up|0
5924353|NCT01473524|20494296|P6|LTSE Phase|Other Clinical/ Laboratory Adverse Event|6
5924354|NCT01473524|20494297|P5|LTSE Phase|Other Clinical/ Laboratory Adverse Event|4
5924355|NCT01473524|20494298|P4|LTSE Phase|Other Clinical/ Laboratory Adverse Event|2
5924356|NCT01473524|20494299|P3|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0
5924357|NCT01473524|20494300|P2|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0
5924358|NCT01473524|20494301|P1|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0
5924359|NCT01473524|20494296|P6|LTSE Phase|Adverse Event of Pruritus|2
5924360|NCT01473524|20494297|P5|LTSE Phase|Adverse Event of Pruritus|5
5924361|NCT01473524|20494298|P4|LTSE Phase|Adverse Event of Pruritus|1
5924362|NCT01473524|20494299|P3|LTSE Phase|Adverse Event of Pruritus|0
5924363|NCT01473524|20494300|P2|LTSE Phase|Adverse Event of Pruritus|0
5924364|NCT01473524|20494301|P1|LTSE Phase|Adverse Event of Pruritus|0
5924365|NCT01473524|20494296|P6|LTSE Phase|Death|0
5924366|NCT01473524|20494297|P5|LTSE Phase|Death|1
5924367|NCT01473524|20494298|P4|LTSE Phase|Death|0
5924368|NCT01473524|20494299|P3|LTSE Phase|Death|0
5924369|NCT01473524|20494300|P2|LTSE Phase|Death|0
5924370|NCT01473524|20494301|P1|LTSE Phase|Death|0
5924371|NCT01473524|20494296|P6|LTSE Phase|Withdrawal by Subject|6
5924372|NCT01473524|20494297|P5|LTSE Phase|Withdrawal by Subject|3
5924373|NCT01473524|20494298|P4|LTSE Phase|Withdrawal by Subject|3
5924374|NCT01473524|20494299|P3|LTSE Phase|Withdrawal by Subject|0
5924375|NCT01473524|20494300|P2|LTSE Phase|Withdrawal by Subject|0
5924376|NCT01473524|20494301|P1|LTSE Phase|Withdrawal by Subject|0
5924377|NCT01473524|20494296|P6|DB Phase|Withdrawal by Subject|0
5924378|NCT01473524|20494297|P5|DB Phase|Withdrawal by Subject|0
5924379|NCT01473524|20494298|P4|DB Phase|Withdrawal by Subject|0
5924380|NCT01473524|20494299|P3|DB Phase|Withdrawal by Subject|1
5924381|NCT01473524|20494300|P2|DB Phase|Withdrawal by Subject|1
5924382|NCT01473524|20494301|P1|DB Phase|Withdrawal by Subject|2
5924383|NCT01473524|20494296|P6|DB Phase|Death|0
5924384|NCT01473524|20494297|P5|DB Phase|Death|0
5924385|NCT01473524|20494298|P4|DB Phase|Death|0
5924386|NCT01473524|20494299|P3|DB Phase|Death|0
5924387|NCT01473524|20494300|P2|DB Phase|Death|0
5924388|NCT01473524|20494301|P1|DB Phase|Death|1
5924389|NCT01473524|20494296|P6|DB Phase|Adverse Event|0
5924390|NCT01473524|20494297|P5|DB Phase|Adverse Event|0
5924391|NCT01473524|20494298|P4|DB Phase|Adverse Event|0
5924392|NCT01473524|20494299|P3|DB Phase|Adverse Event|2
5924393|NCT01473524|20494300|P2|DB Phase|Adverse Event|8
5924394|NCT01473524|20494301|P1|DB Phase|Adverse Event|4
5924395|NCT01473420|20494350|P2|Maintenance Period (16 Weeks)|Elevated Hemoglobin|0
5924396|NCT01473420|20494351|P1|Maintenance Period (16 Weeks)|Elevated Hemoglobin|1
5924397|NCT01473420|20494350|P2|Maintenance Period (16 Weeks)|Sponsor's Decision|0
5924398|NCT01473420|20494351|P1|Maintenance Period (16 Weeks)|Sponsor's Decision|1
5924399|NCT01473420|20494350|P2|Maintenance Period (16 Weeks)|Long term hospitalization|1
5924400|NCT01473420|20494351|P1|Maintenance Period (16 Weeks)|Long term hospitalization|0
5924401|NCT01473420|20494350|P2|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|0
5924402|NCT01473420|20494351|P1|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|1
5924403|NCT01473420|20494350|P2|Maintenance Period (16 Weeks)|Site closure|1
5924404|NCT01473420|20494351|P1|Maintenance Period (16 Weeks)|Site closure|3
5924405|NCT01473420|20494350|P2|Maintenance Period (16 Weeks)|Withdrawal by Subject|6
5924406|NCT01473420|20494351|P1|Maintenance Period (16 Weeks)|Withdrawal by Subject|4
5924407|NCT01473420|20494350|P2|Maintenance Period (16 Weeks)|Lost to Follow-up|2
5924408|NCT01473420|20494351|P1|Maintenance Period (16 Weeks)|Lost to Follow-up|1
5924409|NCT01473420|20494350|P2|Maintenance Period (16 Weeks)|Kidney transplant|1
5924410|NCT01473420|20494351|P1|Maintenance Period (16 Weeks)|Kidney transplant|3
5924411|NCT01473420|20494350|P2|Maintenance Period (16 Weeks)|Did not meet criteria|2
5924412|NCT01473420|20494351|P1|Maintenance Period (16 Weeks)|Did not meet criteria|0
5924413|NCT01473420|20494350|P2|Maintenance Period (16 Weeks)|Physician Decision|2
5924414|NCT01473420|20494351|P1|Maintenance Period (16 Weeks)|Physician Decision|1
5924415|NCT01473420|20494350|P2|Maintenance Period (16 Weeks)|Adverse Event|2
5924416|NCT01473420|20494351|P1|Maintenance Period (16 Weeks)|Adverse Event|3
5924417|NCT01473420|20494350|P2|Titration Period (18 Weeks)|Did not meet criteria|32
5924418|NCT01473420|20494351|P1|Titration Period (18 Weeks)|Did not meet criteria|32
5924419|NCT01473420|20494350|P2|Titration Period (18 Weeks)|Adverse Event|6
5924420|NCT01473420|20494351|P1|Titration Period (18 Weeks)|Adverse Event|4
5924421|NCT01473407|20494435|P2|Overall Study|Site Closure|0
5924422|NCT01473407|20494436|P1|Overall Study|Site Closure|1
5924423|NCT01473407|20494435|P2|Overall Study|Sponsor's Decision|10
5924424|NCT01473407|20494436|P1|Overall Study|Sponsor's Decision|10
5924425|NCT01473407|20494435|P2|Overall Study|Transfer to Another Facility/Unit|3
5924426|NCT01473407|20494436|P1|Overall Study|Transfer to Another Facility/Unit|4
5924427|NCT01473407|20494435|P2|Overall Study|Temperature Excursion|3
5924428|NCT01473407|20494436|P1|Overall Study|Temperature Excursion|2
5924429|NCT01473407|20494435|P2|Overall Study|Patient Lost Green Card Status|0
5924430|NCT01473407|20494436|P1|Overall Study|Patient Lost Green Card Status|1
5924431|NCT01473407|20494435|P2|Overall Study|Patient Received Aranesp|0
5924432|NCT01473407|20494436|P1|Overall Study|Patient Received Aranesp|1
5924433|NCT01473407|20494435|P2|Overall Study|Elevated Hemoglobin|0
5924434|NCT01473407|20494436|P1|Overall Study|Elevated Hemoglobin|1
5924435|NCT01473407|20494435|P2|Overall Study|Vacation/Travel|1
5924436|NCT01473407|20494436|P1|Overall Study|Vacation/Travel|1
5924437|NCT01473407|20494435|P2|Overall Study|Kidney Transplant|6
5924438|NCT01473407|20494436|P1|Overall Study|Kidney Transplant|7
5924439|NCT01473407|20494435|P2|Overall Study|Withdrawal by Subject|7
5924440|NCT01473407|20494436|P1|Overall Study|Withdrawal by Subject|4
5924441|NCT01473407|20494435|P2|Overall Study|Randomization Error|1
5924442|NCT01473407|20494436|P1|Overall Study|Randomization Error|3
5924443|NCT01473407|20494435|P2|Overall Study|Adverse Event|8
5924444|NCT01473407|20494436|P1|Overall Study|Adverse Event|8
5924445|NCT01473407|20494435|P2|Overall Study|Lost to Follow-up|4
5924446|NCT01473407|20494436|P1|Overall Study|Lost to Follow-up|10
5924447|NCT01473407|20494435|P2|Overall Study|Physician Decision|4
5924448|NCT01473407|20494436|P1|Overall Study|Physician Decision|1
5924449|NCT01473394|20494490|P2|Overall Study|Lost to Follow-up|11
5924450|NCT01473394|20494491|P1|Overall Study|Lost to Follow-up|9
5924451|NCT01473394|20494490|P2|Overall Study|Withdrew Consent|10
5924452|NCT01473394|20494491|P1|Overall Study|Withdrew Consent|12
5924453|NCT01473394|20494490|P2|Overall Study|Protocol Violation|5
5924454|NCT01473394|20494491|P1|Overall Study|Protocol Violation|7
5924455|NCT01473394|20494490|P2|Overall Study|Insufficient Therapeutic Response|1
5924456|NCT01473394|20494491|P1|Overall Study|Insufficient Therapeutic Response|4
5924457|NCT01473394|20494490|P2|Overall Study|Adverse Event|16
5924458|NCT01473394|20494491|P1|Overall Study|Adverse Event|13
5924459|NCT01473381|20494505|P4|Overall Study|Other Reasons|3
5924460|NCT01473381|20494506|P3|Overall Study|Other Reasons|1
5924461|NCT01473381|20494507|P2|Overall Study|Other Reasons|0
5924462|NCT01473381|20494508|P1|Overall Study|Other Reasons|0
5924463|NCT01473381|20494505|P4|Overall Study|Lost to Follow-up|23
5924464|NCT01473381|20494506|P3|Overall Study|Lost to Follow-up|35
5924465|NCT01473381|20494507|P2|Overall Study|Lost to Follow-up|28
5924466|NCT01473381|20494508|P1|Overall Study|Lost to Follow-up|25
5924467|NCT01473381|20494505|P4|Overall Study|Withdrawal of Consent|26
5924468|NCT01473381|20494506|P3|Overall Study|Withdrawal of Consent|20
5924469|NCT01473381|20494507|P2|Overall Study|Withdrawal of Consent|21
5924470|NCT01473381|20494508|P1|Overall Study|Withdrawal of Consent|20
5924471|NCT01473381|20494505|P4|Overall Study|Protocol Violation|17
5924472|NCT01473381|20494506|P3|Overall Study|Protocol Violation|19
5924473|NCT01473381|20494507|P2|Overall Study|Protocol Violation|23
5924474|NCT01473381|20494508|P1|Overall Study|Protocol Violation|17
5924475|NCT01473381|20494505|P4|Overall Study|Insufficient Therapeutic Response|3
5924476|NCT01473381|20494506|P3|Overall Study|Insufficient Therapeutic Response|2
5924477|NCT01473381|20494507|P2|Overall Study|Insufficient Therapeutic Response|1
5924478|NCT01473381|20494508|P1|Overall Study|Insufficient Therapeutic Response|10
5924479|NCT01473381|20494505|P4|Overall Study|Adverse Event|17
5924480|NCT01473381|20494506|P3|Overall Study|Adverse Event|25
5924481|NCT01473381|20494507|P2|Overall Study|Adverse Event|20
5924482|NCT01473381|20494508|P1|Overall Study|Adverse Event|8
5924483|NCT01473355|20494570|P1|Overall Study|Lost to Follow-up|2
5924484|NCT01473355|20494570|P1|Overall Study|Adverse Event|2
5924485|NCT01473355|20494570|P1|Overall Study|Protocol Violation|2
5924486|NCT01472965|20494599|P2|Overall Study|Withdrawal by Subject|0
5924487|NCT01472965|20494600|P1|Overall Study|Withdrawal by Subject|1
5924488|NCT01472939|20494620|P4|Overall Study|Withdrawal by Subject|4
5924489|NCT01472939|20494621|P3|Overall Study|Withdrawal by Subject|1
5924490|NCT01472939|20494622|P2|Overall Study|Withdrawal by Subject|3
5924491|NCT01472939|20494623|P1|Overall Study|Withdrawal by Subject|9
5924492|NCT01472939|20494620|P4|Overall Study|Protocol Violation|1
5924493|NCT01472939|20494621|P3|Overall Study|Protocol Violation|0
5924494|NCT01472939|20494622|P2|Overall Study|Protocol Violation|3
5924495|NCT01472939|20494623|P1|Overall Study|Protocol Violation|3
5924497|NCT01472939|20494621|P3|Overall Study|Withdrawal By PI|0
5924498|NCT01472939|20494622|P2|Overall Study|Withdrawal By PI|0
5924499|NCT01472939|20494623|P1|Overall Study|Withdrawal By PI|1
5924500|NCT01472939|20494620|P4|Overall Study|Prohibited Medication|0
5924501|NCT01472939|20494621|P3|Overall Study|Prohibited Medication|0
5924502|NCT01472939|20494622|P2|Overall Study|Prohibited Medication|1
5924503|NCT01472939|20494623|P1|Overall Study|Prohibited Medication|0
5924504|NCT01472939|20494620|P4|Overall Study|Clinically Significant Pre-Dose ECG|0
5924505|NCT01472939|20494621|P3|Overall Study|Clinically Significant Pre-Dose ECG|1
5924506|NCT01472939|20494622|P2|Overall Study|Clinically Significant Pre-Dose ECG|0
5924507|NCT01472939|20494623|P1|Overall Study|Clinically Significant Pre-Dose ECG|0
5924508|NCT01472939|20494620|P4|Overall Study|Lost to Follow-up|0
5924509|NCT01472939|20494621|P3|Overall Study|Lost to Follow-up|2
5924510|NCT01472939|20494622|P2|Overall Study|Lost to Follow-up|0
5924511|NCT01472939|20494623|P1|Overall Study|Lost to Follow-up|3
5924512|NCT01472939|20494620|P4|Overall Study|Lack of Efficacy|1
5924513|NCT01472939|20494621|P3|Overall Study|Lack of Efficacy|0
5924514|NCT01472939|20494622|P2|Overall Study|Lack of Efficacy|0
5924515|NCT01472939|20494623|P1|Overall Study|Lack of Efficacy|1
5924516|NCT01472939|20494620|P4|Overall Study|Adverse Event|14
5924517|NCT01472939|20494621|P3|Overall Study|Adverse Event|7
5924518|NCT01472939|20494622|P2|Overall Study|Adverse Event|7
5924519|NCT01472939|20494623|P1|Overall Study|Adverse Event|3
5924520|NCT01472835|20494667|P2|Overall Study|Lost to Follow-up|0
5924521|NCT01472835|20494668|P1|Overall Study|Lost to Follow-up|2
5924522|NCT01472757|20494703|P4|Overall Study|Other reasons|2
5924523|NCT01472757|20494704|P3|Overall Study|Other reasons|2
5924524|NCT01472757|20494705|P2|Overall Study|Other reasons|0
5924525|NCT01472757|20494706|P1|Overall Study|Other reasons|1
5924526|NCT01472757|20494703|P4|Overall Study|Protocol Violation|4
5924527|NCT01472757|20494704|P3|Overall Study|Protocol Violation|4
5924528|NCT01472757|20494705|P2|Overall Study|Protocol Violation|2
5924529|NCT01472757|20494706|P1|Overall Study|Protocol Violation|3
5924530|NCT01472757|20494703|P4|Overall Study|Treatment period withdrawal criteria met|12
5924531|NCT01472757|20494704|P3|Overall Study|Treatment period withdrawal criteria met|9
5924532|NCT01472757|20494705|P2|Overall Study|Treatment period withdrawal criteria met|8
5924533|NCT01472757|20494706|P1|Overall Study|Treatment period withdrawal criteria met|21
5924534|NCT01472757|20494703|P4|Overall Study|Asthma exacerbation|1
5924535|NCT01472757|20494704|P3|Overall Study|Asthma exacerbation|2
5924536|NCT01472757|20494705|P2|Overall Study|Asthma exacerbation|1
5924537|NCT01472757|20494706|P1|Overall Study|Asthma exacerbation|4
5924538|NCT01472757|20494703|P4|Overall Study|Withdrawal by Subject|0
5924539|NCT01472757|20494704|P3|Overall Study|Withdrawal by Subject|2
5924540|NCT01472757|20494705|P2|Overall Study|Withdrawal by Subject|2
5924541|NCT01472757|20494706|P1|Overall Study|Withdrawal by Subject|1
5924542|NCT01472380|20494821|P1|1 Day Period Between Dosing|Protocol Violation|1
5924543|NCT01472380|20494821|P1|Efavirenz Alone|Withdrawal by Subject|1
5924544|NCT01472341|20494832|P1|Overall Study|Death|9
5924545|NCT01472341|20494832|P1|Overall Study|Laboratory parameters unavailable|25
5924546|NCT01472341|20494832|P1|Overall Study|Lost to Follow-up|52
5924547|NCT01472341|20494832|P1|Overall Study|Withdrawal by Subject|39
5924548|NCT01472341|20494832|P1|Overall Study|Started therapy with a DPP-IV/GLP-1|92
5924549|NCT01472341|20494832|P1|Overall Study|Started insulin therapy|55
5924550|NCT01472289|20494838|P1|Overall Study|Death|2
5924551|NCT01472185|20494850|P2|Overall Study|Subject Withdrew Consent|3
5924552|NCT01472185|20494851|P1|Overall Study|Subject Withdrew Consent|6
5924553|NCT01472185|20494850|P2|Overall Study|Subject Noncompliance|15
5924554|NCT01472185|20494851|P1|Overall Study|Subject Noncompliance|8
5924555|NCT01472185|20494850|P2|Overall Study|Protocol Violation|1
5924556|NCT01472185|20494851|P1|Overall Study|Protocol Violation|5
5924557|NCT01472185|20494850|P2|Overall Study|Lost to Follow-up|1
5924558|NCT01472185|20494851|P1|Overall Study|Lost to Follow-up|4
5924559|NCT01472185|20494850|P2|Overall Study|Investigator's Discretion|1
5924560|NCT01472185|20494851|P1|Overall Study|Investigator's Discretion|3
5924561|NCT01472185|20494850|P2|Overall Study|Hyperglycemia|2
5924562|NCT01472185|20494851|P1|Overall Study|Hyperglycemia|5
5924563|NCT01472185|20494850|P2|Overall Study|Adverse Event Other than Hyperglycemia|10
5924564|NCT01472185|20494851|P1|Overall Study|Adverse Event Other than Hyperglycemia|3
5924565|NCT01472185|20494850|P2|Overall Study|Randomized but Not Treated|1
5924566|NCT01472185|20494851|P1|Overall Study|Randomized but Not Treated|0
5924567|NCT01472081|20494871|P6|Overall Study|Subject request to discontinue treatment|0
5924568|NCT01472081|20494872|P5|Overall Study|Subject request to discontinue treatment|0
5924569|NCT01472081|20494873|P4|Overall Study|Subject request to discontinue treatment|1
5924570|NCT01472081|20494874|P3|Overall Study|Subject request to discontinue treatment|1
5924571|NCT01472081|20494875|P2|Overall Study|Subject request to discontinue treatment|3
5924572|NCT01472081|20494876|P1|Overall Study|Subject request to discontinue treatment|0
5924573|NCT01472081|20494871|P6|Overall Study|No longer meets study criteria|0
5924574|NCT01472081|20494872|P5|Overall Study|No longer meets study criteria|0
5924575|NCT01472081|20494873|P4|Overall Study|No longer meets study criteria|0
5924576|NCT01472081|20494874|P3|Overall Study|No longer meets study criteria|1
5924577|NCT01472081|20494875|P2|Overall Study|No longer meets study criteria|0
5924578|NCT01472081|20494876|P1|Overall Study|No longer meets study criteria|0
5924579|NCT01472081|20494871|P6|Overall Study|Poor/non-compliance|0
5924580|NCT01472081|20494872|P5|Overall Study|Poor/non-compliance|1
5924581|NCT01472081|20494873|P4|Overall Study|Poor/non-compliance|0
5924582|NCT01472081|20494874|P3|Overall Study|Poor/non-compliance|1
5924583|NCT01472081|20494875|P2|Overall Study|Poor/non-compliance|0
5924584|NCT01472081|20494876|P1|Overall Study|Poor/non-compliance|0
5924585|NCT01472081|20494871|P6|Overall Study|Withdrawal by Subject|1
5924586|NCT01472081|20494872|P5|Overall Study|Withdrawal by Subject|0
5924587|NCT01472081|20494873|P4|Overall Study|Withdrawal by Subject|0
5924588|NCT01472081|20494874|P3|Overall Study|Withdrawal by Subject|0
5924589|NCT01472081|20494875|P2|Overall Study|Withdrawal by Subject|0
5924590|NCT01472081|20494876|P1|Overall Study|Withdrawal by Subject|0
5924591|NCT01472081|20494871|P6|Overall Study|Adverse Event unrelated to study drug|0
5924592|NCT01472081|20494872|P5|Overall Study|Adverse Event unrelated to study drug|1
5924593|NCT01472081|20494873|P4|Overall Study|Adverse Event unrelated to study drug|0
5924594|NCT01472081|20494874|P3|Overall Study|Adverse Event unrelated to study drug|0
5924595|NCT01472081|20494875|P2|Overall Study|Adverse Event unrelated to study drug|0
5924596|NCT01472081|20494876|P1|Overall Study|Adverse Event unrelated to study drug|0
5924597|NCT01472081|20494871|P6|Overall Study|Death|0
5924598|NCT01472081|20494872|P5|Overall Study|Death|1
5924599|NCT01472081|20494873|P4|Overall Study|Death|0
5924600|NCT01472081|20494874|P3|Overall Study|Death|0
5924601|NCT01472081|20494875|P2|Overall Study|Death|0
5924602|NCT01472081|20494876|P1|Overall Study|Death|0
5924603|NCT01472081|20494871|P6|Overall Study|Study drug toxicity|2
5924604|NCT01472081|20494872|P5|Overall Study|Study drug toxicity|13
5924605|NCT01472081|20494873|P4|Overall Study|Study drug toxicity|6
5924606|NCT01472081|20494874|P3|Overall Study|Study drug toxicity|4
5924607|NCT01472081|20494875|P2|Overall Study|Study drug toxicity|9
5924608|NCT01472081|20494876|P1|Overall Study|Study drug toxicity|2
5924609|NCT01472081|20494871|P6|Overall Study|Disease Progression|3
5924610|NCT01472081|20494872|P5|Overall Study|Disease Progression|22
5924611|NCT01472081|20494873|P4|Overall Study|Disease Progression|31
5924612|NCT01472081|20494874|P3|Overall Study|Disease Progression|12
5924613|NCT01472081|20494875|P2|Overall Study|Disease Progression|10
5924614|NCT01472081|20494876|P1|Overall Study|Disease Progression|4
5924615|NCT01472081|20494871|P6|Overall Study|Continuing treatment at time of analysis|0
5924616|NCT01472081|20494872|P5|Overall Study|Continuing treatment at time of analysis|9
5924617|NCT01472081|20494873|P4|Overall Study|Continuing treatment at time of analysis|8
5924618|NCT01472081|20494874|P3|Overall Study|Continuing treatment at time of analysis|1
5924619|NCT01472081|20494875|P2|Overall Study|Continuing treatment at time of analysis|4
5924620|NCT01472081|20494876|P1|Overall Study|Continuing treatment at time of analysis|1
5924621|NCT01471782|20494925|P6|Overall Study|Death|1
5924622|NCT01471782|20494926|P5|Overall Study|Death|0
5924623|NCT01471782|20494927|P4|Overall Study|Death|0
5924624|NCT01471782|20494928|P3|Overall Study|Death|0
5924625|NCT01471782|20494929|P2|Overall Study|Death|0
5924626|NCT01471782|20494930|P1|Overall Study|Death|0
5924627|NCT01471782|20494925|P6|Overall Study|Withdrawal by Parent/Guardian|0
5924628|NCT01471782|20494926|P5|Overall Study|Withdrawal by Parent/Guardian|1
5924629|NCT01471782|20494927|P4|Overall Study|Withdrawal by Parent/Guardian|0
5924630|NCT01471782|20494928|P3|Overall Study|Withdrawal by Parent/Guardian|0
5924631|NCT01471782|20494929|P2|Overall Study|Withdrawal by Parent/Guardian|0
5924632|NCT01471782|20494930|P1|Overall Study|Withdrawal by Parent/Guardian|0
5924633|NCT01471782|20494925|P6|Overall Study|Physician Decision|8
5924634|NCT01471782|20494926|P5|Overall Study|Physician Decision|3
5924635|NCT01471782|20494927|P4|Overall Study|Physician Decision|0
5924636|NCT01471782|20494928|P3|Overall Study|Physician Decision|0
5924637|NCT01471782|20494929|P2|Overall Study|Physician Decision|0
5924638|NCT01471782|20494930|P1|Overall Study|Physician Decision|0
5924639|NCT01471782|20494925|P6|Overall Study|Disease Relapse|1
5924640|NCT01471782|20494926|P5|Overall Study|Disease Relapse|2
5924641|NCT01471782|20494927|P4|Overall Study|Disease Relapse|1
5924642|NCT01471782|20494928|P3|Overall Study|Disease Relapse|0
5924643|NCT01471782|20494929|P2|Overall Study|Disease Relapse|0
5924644|NCT01471782|20494930|P1|Overall Study|Disease Relapse|0
5924645|NCT01471782|20494925|P6|Overall Study|Change of Chemotherapy|4
5924646|NCT01471782|20494926|P5|Overall Study|Change of Chemotherapy|1
5924647|NCT01471782|20494927|P4|Overall Study|Change of Chemotherapy|0
5924648|NCT01471782|20494928|P3|Overall Study|Change of Chemotherapy|0
5924649|NCT01471782|20494929|P2|Overall Study|Change of Chemotherapy|1
5924650|NCT01471782|20494930|P1|Overall Study|Change of Chemotherapy|1
5924651|NCT01471782|20494925|P6|Overall Study|Other|5
5924652|NCT01471782|20494926|P5|Overall Study|Other|6
5924653|NCT01471782|20494927|P4|Overall Study|Other|1
5924654|NCT01471782|20494928|P3|Overall Study|Other|1
5924655|NCT01471782|20494929|P2|Overall Study|Other|0
5924656|NCT01471782|20494930|P1|Overall Study|Other|0
5924657|NCT01471782|20494925|P6|Overall Study|Adverse Event|1
5924658|NCT01471782|20494926|P5|Overall Study|Adverse Event|3
5924659|NCT01471782|20494927|P4|Overall Study|Adverse Event|2
5924660|NCT01471782|20494928|P3|Overall Study|Adverse Event|2
5924661|NCT01471782|20494929|P2|Overall Study|Adverse Event|1
5924662|NCT01471782|20494930|P1|Overall Study|Adverse Event|1
5924663|NCT01471782|20494925|P6|Overall Study|Lack of Efficacy|18
5924664|NCT01471782|20494926|P5|Overall Study|Lack of Efficacy|5
5924665|NCT01471782|20494927|P4|Overall Study|Lack of Efficacy|1
5924666|NCT01471782|20494928|P3|Overall Study|Lack of Efficacy|1
5924667|NCT01471782|20494929|P2|Overall Study|Lack of Efficacy|2
5924668|NCT01471782|20494930|P1|Overall Study|Lack of Efficacy|1
5924669|NCT01471782|20494925|P6|Overall Study|Hematopoietic Stem Cell Transplantation|3
5924670|NCT01471782|20494926|P5|Overall Study|Hematopoietic Stem Cell Transplantation|5
5924671|NCT01471782|20494927|P4|Overall Study|Hematopoietic Stem Cell Transplantation|0
5924672|NCT01471782|20494928|P3|Overall Study|Hematopoietic Stem Cell Transplantation|1
5924673|NCT01471782|20494929|P2|Overall Study|Hematopoietic Stem Cell Transplantation|2
5924674|NCT01471782|20494930|P1|Overall Study|Hematopoietic Stem Cell Transplantation|2
5924675|NCT01471691|20494984|P2|Overall Study|Lack of Efficacy|1
5924676|NCT01471691|20494985|P1|Overall Study|Lack of Efficacy|0
5924677|NCT01471379|20494994|P3|Overall Study|Study terminated|0
5924678|NCT01471379|20494995|P2|Overall Study|Study terminated|1
5924679|NCT01471379|20494996|P1|Overall Study|Study terminated|0
5924680|NCT01471379|20494994|P3|Overall Study|Adverse Event|0
5924681|NCT01471379|20494995|P2|Overall Study|Adverse Event|0
5924682|NCT01471379|20494996|P1|Overall Study|Adverse Event|1
5924683|NCT01471353|20495016|P1|Overall Study|remain on study|3
5924684|NCT01471340|20495027|P2|Overall Study|Invalid informed consent|0
5924685|NCT01471340|20495028|P1|Overall Study|Invalid informed consent|1
5924686|NCT01471340|20495027|P2|Overall Study|Investigational site closure|1
5924687|NCT01471340|20495028|P1|Overall Study|Investigational site closure|0
5924688|NCT01471340|20495027|P2|Overall Study|Lost to Follow-up|1
5924689|NCT01471340|20495028|P1|Overall Study|Lost to Follow-up|0
5924690|NCT01471340|20495027|P2|Overall Study|Death|4
5924691|NCT01471340|20495028|P1|Overall Study|Death|5
5924692|NCT01471574|20495051|P4|Follow-up Period|Follow-up no longer required|0
5924693|NCT01471574|20495052|P3|Follow-up Period|Follow-up no longer required|0
5924694|NCT01471574|20495053|P2|Follow-up Period|Follow-up no longer required|1
5924695|NCT01471574|20495054|P1|Follow-up Period|Follow-up no longer required|0
5924696|NCT01471574|20495051|P4|Follow-up Period|Death|0
5924697|NCT01471574|20495052|P3|Follow-up Period|Death|1
5924698|NCT01471574|20495053|P2|Follow-up Period|Death|0
5924699|NCT01471574|20495054|P1|Follow-up Period|Death|0
5924700|NCT01471574|20495051|P4|Follow-up Period|Lost to Follow-up|2
5924701|NCT01471574|20495052|P3|Follow-up Period|Lost to Follow-up|3
5924702|NCT01471574|20495053|P2|Follow-up Period|Lost to Follow-up|1
5924703|NCT01471574|20495054|P1|Follow-up Period|Lost to Follow-up|4
5924704|NCT01471574|20495051|P4|Follow-up Period|Withdrawal by Subject|1
5924705|NCT01471574|20495052|P3|Follow-up Period|Withdrawal by Subject|3
5924706|NCT01471574|20495053|P2|Follow-up Period|Withdrawal by Subject|0
5924707|NCT01471574|20495054|P1|Follow-up Period|Withdrawal by Subject|3
5924708|NCT01471574|20495051|P4|Treatment Period|Other|0
5924709|NCT01471574|20495052|P3|Treatment Period|Other|0
5924710|NCT01471574|20495053|P2|Treatment Period|Other|0
5924711|NCT01471574|20495054|P1|Treatment Period|Other|1
5924712|NCT01471574|20495051|P4|Treatment Period|Patient no Longer Meets Study Criteria|0
5924713|NCT01471574|20495052|P3|Treatment Period|Patient no Longer Meets Study Criteria|0
5924714|NCT01471574|20495053|P2|Treatment Period|Patient no Longer Meets Study Criteria|0
5924715|NCT01471574|20495054|P1|Treatment Period|Patient no Longer Meets Study Criteria|1
5924716|NCT01471574|20495051|P4|Treatment Period|Lost to Follow-up|0
5924717|NCT01471574|20495052|P3|Treatment Period|Lost to Follow-up|2
5924718|NCT01471574|20495053|P2|Treatment Period|Lost to Follow-up|2
5924719|NCT01471574|20495054|P1|Treatment Period|Lost to Follow-up|1
5924720|NCT01471574|20495051|P4|Treatment Period|Patient Requested Discontinue Study drug|1
5924721|NCT01471574|20495052|P3|Treatment Period|Patient Requested Discontinue Study drug|1
5924722|NCT01471574|20495053|P2|Treatment Period|Patient Requested Discontinue Study drug|0
5924723|NCT01471574|20495054|P1|Treatment Period|Patient Requested Discontinue Study drug|4
5924724|NCT01471574|20495051|P4|Treatment Period|Withdrawal by Subject|0
5924725|NCT01471574|20495052|P3|Treatment Period|Withdrawal by Subject|1
5924726|NCT01471574|20495053|P2|Treatment Period|Withdrawal by Subject|1
5924727|NCT01471574|20495054|P1|Treatment Period|Withdrawal by Subject|5
5924728|NCT01471574|20495051|P4|Treatment Period|Adverse Event|1
5924729|NCT01471574|20495052|P3|Treatment Period|Adverse Event|6
5924730|NCT01471574|20495053|P2|Treatment Period|Adverse Event|3
5924731|NCT01471574|20495054|P1|Treatment Period|Adverse Event|7
5924732|NCT01471574|20495051|P4|Treatment Period|Lack of Efficacy|1
5924733|NCT01471574|20495052|P3|Treatment Period|Lack of Efficacy|14
5924734|NCT01471574|20495053|P2|Treatment Period|Lack of Efficacy|4
5924735|NCT01471574|20495054|P1|Treatment Period|Lack of Efficacy|12
5924736|NCT01471522|20495085|P2|Overall Study|Lost to Follow-up|26
5924737|NCT01471522|20495086|P1|Overall Study|Lost to Follow-up|36
5924738|NCT01471522|20495085|P2|Overall Study|Withdrawal by Subject|22
5924739|NCT01471522|20495086|P1|Overall Study|Withdrawal by Subject|28
5924740|NCT01471197|20495123|P2|Overall Study|Study Drug Toxicity|0
5924741|NCT01471197|20495124|P1|Overall Study|Study Drug Toxicity|1
5924742|NCT01471197|20495123|P2|Overall Study|Death|0
5924743|NCT01471197|20495124|P1|Overall Study|Death|1
5924744|NCT01471197|20495123|P2|Overall Study|Disease Progression|2
5924745|NCT01471197|20495124|P1|Overall Study|Disease Progression|4
5924746|NCT01471171|20495134|P2|Treatment Period 2|Adverse Event|0
5924747|NCT01471171|20495135|P1|Treatment Period 2|Adverse Event|1
5924748|NCT01471171|20495134|P2|Treatment Period 1|Adverse Event|1
5924749|NCT01471171|20495135|P1|Treatment Period 1|Adverse Event|4
5924750|NCT01471054|20495147|P2|Overall Study|Study terminated prematurely|0
5924751|NCT01471054|20495148|P1|Overall Study|Study terminated prematurely|4
5924752|NCT01471028|20495171|P2|VTI-208E|Lost to Follow-up|2
5924753|NCT01471028|20495172|P1|VTI-208E|Lost to Follow-up|0
5924754|NCT01471028|20495171|P2|VTI-208E|Withdrawal by Subject|0
5924755|NCT01471028|20495172|P1|VTI-208E|Withdrawal by Subject|1
5924756|NCT01471028|20495171|P2|VTI-208E|Death|10
5924757|NCT01471028|20495172|P1|VTI-208E|Death|7
5924758|NCT01471028|20495171|P2|VTI-208|Lost to Follow-up|1
5924759|NCT01471028|20495172|P1|VTI-208|Lost to Follow-up|1
5924760|NCT01471028|20495171|P2|VTI-208|Withdrawal by Subject|2
5924761|NCT01471028|20495172|P1|VTI-208|Withdrawal by Subject|0
5924762|NCT01471028|20495171|P2|VTI-208|Adverse Event|41
5924763|NCT01471028|20495172|P1|VTI-208|Adverse Event|39
5924764|NCT01471015|20495187|P3|Overall Study|Death|1
5924765|NCT01471015|20495188|P2|Overall Study|Death|1
5924766|NCT01471015|20495189|P1|Overall Study|Death|0
5924767|NCT01470599|20495250|P2|Overall Study|Adverse event not related to study drug|5
5924768|NCT01470599|20495251|P1|Overall Study|Adverse event not related to study drug|1
5924769|NCT01470599|20495250|P2|Overall Study|Insufficient clinical response|27
5924770|NCT01470599|20495251|P1|Overall Study|Insufficient clinical response|6
5924771|NCT01470599|20495250|P2|Overall Study|Adverse event related to study drug|5
5924772|NCT01470599|20495251|P1|Overall Study|Adverse event related to study drug|2
5924773|NCT01470599|20495250|P2|Overall Study|Protocol Violation|1
5924774|NCT01470599|20495251|P1|Overall Study|Protocol Violation|3
5924775|NCT01470599|20495250|P2|Overall Study|Other|0
5924776|NCT01470599|20495251|P1|Overall Study|Other|1
5924777|NCT01470599|20495250|P2|Overall Study|Withdrawal by Subject|4
5924778|NCT01470599|20495251|P1|Overall Study|Withdrawal by Subject|3
5924779|NCT01470599|20495250|P2|Overall Study|Lost to Follow-up|1
5924780|NCT01470599|20495251|P1|Overall Study|Lost to Follow-up|2
5924781|NCT01470599|20495250|P2|Overall Study|Did not meet entrance criteria|0
5924782|NCT01470599|20495251|P1|Overall Study|Did not meet entrance criteria|1
5924783|NCT01470469|20495315|P2|Overall Study|Other|1
5924784|NCT01470469|20495316|P1|Overall Study|Other|2
5924785|NCT01470469|20495315|P2|Overall Study|Protocol Violation|1
5924786|NCT01470469|20495316|P1|Overall Study|Protocol Violation|1
5924787|NCT01470469|20495315|P2|Overall Study|Lost to Follow-up|2
5924788|NCT01470469|20495316|P1|Overall Study|Lost to Follow-up|2
5924789|NCT01470469|20495315|P2|Overall Study|Adverse Event|7
5924790|NCT01470469|20495316|P1|Overall Study|Adverse Event|0
5924791|NCT01470469|20495315|P2|Overall Study|Lack of Efficacy|7
5924792|NCT01470469|20495316|P1|Overall Study|Lack of Efficacy|1
5924793|NCT01470469|20495315|P2|Overall Study|Withdrawal by Subject|6
5924794|NCT01470469|20495316|P1|Overall Study|Withdrawal by Subject|4
5924795|NCT01470417|20495336|P2|Overall Study|Disease progression|2
5924796|NCT01470417|20495337|P1|Overall Study|Disease progression|0
5924797|NCT01470326|20495349|P1|Overall Study|No Visit After 1st Day of Treatment|119
5924798|NCT01470326|20495349|P1|Overall Study|No Drug Administration Information|2
5924799|NCT01470326|20495349|P1|Overall Study|Protocol Violation|32
5924801|NCT01470144|20495416|P1|Overall Study|Patient's and investigator's decision|1
5924802|NCT01470144|20495416|P1|Overall Study|Lung transplant|6
5924803|NCT01470144|20495416|P1|Overall Study|Death|1
5924804|NCT01470144|20495416|P1|Overall Study|Adverse Event|2
5924805|NCT01470001|20495521|P2|Overall Study|Withdrawal by Subject|1
5924806|NCT01470001|20495522|P1|Overall Study|Withdrawal by Subject|2
5924807|NCT01470001|20495521|P2|Overall Study|Physician Decision|0
5924808|NCT01470001|20495522|P1|Overall Study|Physician Decision|2
5924809|NCT01470001|20495521|P2|Overall Study|Lost to Follow-up|1
5924810|NCT01470001|20495522|P1|Overall Study|Lost to Follow-up|1
5924811|NCT01469819|20495532|P1|Overall Study|Technical malfunction of SmartPill data|3
5924812|NCT01469819|20495532|P1|Overall Study|Could not swallow SmartPill|2
5924813|NCT01469819|20495532|P1|Overall Study|Did not meet inclusionary criteria|2
5924814|NCT01469819|20495532|P1|Overall Study|Withdrawal by Subject|1
5924815|NCT01469637|20495556|P2|Second Intervention|Incarcerated|0
5924816|NCT01469637|20495557|P1|Second Intervention|Incarcerated|1
5924817|NCT01469637|20495556|P2|First Intervention|Unacceptable behavior|1
5924818|NCT01469637|20495557|P1|First Intervention|Unacceptable behavior|0
5924819|NCT01469546|20495576|P1|Received 5 mg Dose|Physician Decision|3
5924820|NCT01469546|20495576|P1|Received 5 mg Dose|Progressive Disease|3
5924821|NCT01469546|20495576|P1|Received 5 mg Dose|Protocol Violation|2
5924822|NCT01469546|20495576|P1|Received 5 mg Dose|Death|2
5924823|NCT01469546|20495576|P1|Received 5 mg Dose|Adverse Event|13
5924824|NCT01469377|20495586|P3|Overall Study|Other Miscellaneous Reasons|0
5924825|NCT01469377|20495587|P2|Overall Study|Other Miscellaneous Reasons|0
5924826|NCT01469377|20495588|P1|Overall Study|Other Miscellaneous Reasons|2
5924827|NCT01469377|20495586|P3|Overall Study|Insufficient Therapeutic Response|0
5924828|NCT01469377|20495587|P2|Overall Study|Insufficient Therapeutic Response|4
5924829|NCT01469377|20495588|P1|Overall Study|Insufficient Therapeutic Response|3
5924830|NCT01469377|20495586|P3|Overall Study|Adverse Event|36
5924831|NCT01469377|20495587|P2|Overall Study|Adverse Event|18
5924832|NCT01469377|20495588|P1|Overall Study|Adverse Event|8
5924833|NCT01469377|20495586|P3|Overall Study|Withdrawal of Consent|15
5924834|NCT01469377|20495587|P2|Overall Study|Withdrawal of Consent|14
5924835|NCT01469377|20495588|P1|Overall Study|Withdrawal of Consent|12
5924836|NCT01469377|20495586|P3|Overall Study|Lost to Follow-up|5
5924837|NCT01469377|20495587|P2|Overall Study|Lost to Follow-up|2
5924838|NCT01469377|20495588|P1|Overall Study|Lost to Follow-up|3
5924839|NCT01469377|20495586|P3|Overall Study|Protocol Deviation|10
5924840|NCT01469377|20495587|P2|Overall Study|Protocol Deviation|10
5924841|NCT01469377|20495588|P1|Overall Study|Protocol Deviation|7
5924842|NCT01469364|20495599|P1|Overall Study|Withdrawal by Subject|1
5924843|NCT01469364|20495599|P1|Overall Study|Adverse Event|1
5924844|NCT01469221|20495650|P3|Double Blind Phase|Sponsor Terminate Study|0
5924845|NCT01469221|20495651|P2|Double Blind Phase|Sponsor Terminate Study|16
5924846|NCT01469221|20495652|P1|Double Blind Phase|Sponsor Terminate Study|12
5924847|NCT01469221|20495650|P3|Double Blind Phase|Physician Decision|0
5924848|NCT01469221|20495651|P2|Double Blind Phase|Physician Decision|1
5924849|NCT01469221|20495652|P1|Double Blind Phase|Physician Decision|1
5924850|NCT01469221|20495650|P3|Double Blind Phase|Protocol Violation|0
5924851|NCT01469221|20495651|P2|Double Blind Phase|Protocol Violation|0
5924852|NCT01469221|20495652|P1|Double Blind Phase|Protocol Violation|1
5924853|NCT01469182|20495663|P2|Overall Study|Did not meet Protocol Eligibility|0
5924854|NCT01469182|20495664|P1|Overall Study|Did not meet Protocol Eligibility|3
5924855|NCT01469182|20495663|P2|Overall Study|Protocol Violation|2
5924856|NCT01469182|20495664|P1|Overall Study|Protocol Violation|4
5924857|NCT01469182|20495663|P2|Overall Study|Withdrawal by Subject|1
5924858|NCT01469182|20495664|P1|Overall Study|Withdrawal by Subject|4
5924859|NCT01469182|20495663|P2|Overall Study|Lost to Follow-up|0
5924860|NCT01469182|20495664|P1|Overall Study|Lost to Follow-up|3
5924861|NCT01469182|20495663|P2|Overall Study|Adverse Event|3
5924862|NCT01469182|20495664|P1|Overall Study|Adverse Event|21
5924863|NCT01469065|20495691|P5|Overall Study|Other|0
5924864|NCT01469065|20495692|P4|Overall Study|Other|0
5924865|NCT01469065|20495693|P3|Overall Study|Other|0
5924866|NCT01469065|20495694|P2|Overall Study|Other|1
5924867|NCT01469065|20495695|P1|Overall Study|Other|0
5924868|NCT01469065|20495691|P5|Overall Study|Lack of Efficacy|1
5924869|NCT01469065|20495692|P4|Overall Study|Lack of Efficacy|0
5924870|NCT01469065|20495693|P3|Overall Study|Lack of Efficacy|0
5924871|NCT01469065|20495694|P2|Overall Study|Lack of Efficacy|0
5924872|NCT01469065|20495695|P1|Overall Study|Lack of Efficacy|0
5924873|NCT01469052|20495791|P6|Overall Study|Other|0
5924874|NCT01469052|20495792|P5|Overall Study|Other|1
5924875|NCT01469052|20495793|P4|Overall Study|Other|0
5924876|NCT01469052|20495794|P3|Overall Study|Other|0
5924877|NCT01469052|20495795|P2|Overall Study|Other|1
5924878|NCT01469052|20495796|P1|Overall Study|Other|0
5924879|NCT01469052|20495791|P6|Overall Study|Moved to rollover protocol|1
5924880|NCT01469052|20495792|P5|Overall Study|Moved to rollover protocol|0
5924881|NCT01469052|20495793|P4|Overall Study|Moved to rollover protocol|0
5924882|NCT01469052|20495794|P3|Overall Study|Moved to rollover protocol|1
5924883|NCT01469052|20495795|P2|Overall Study|Moved to rollover protocol|0
5924884|NCT01469052|20495796|P1|Overall Study|Moved to rollover protocol|1
5924885|NCT01469052|20495791|P6|Overall Study|Lack of Efficacy|2
5924886|NCT01469052|20495792|P5|Overall Study|Lack of Efficacy|0
5924887|NCT01469052|20495793|P4|Overall Study|Lack of Efficacy|0
5924888|NCT01469052|20495794|P3|Overall Study|Lack of Efficacy|0
5924889|NCT01469052|20495795|P2|Overall Study|Lack of Efficacy|0
5924890|NCT01469052|20495796|P1|Overall Study|Lack of Efficacy|0
5924891|NCT01469052|20495791|P6|Overall Study|Progressive disease|2
5924892|NCT01469052|20495792|P5|Overall Study|Progressive disease|7
5924893|NCT01469052|20495793|P4|Overall Study|Progressive disease|3
5924894|NCT01469052|20495794|P3|Overall Study|Progressive disease|5
5924895|NCT01469052|20495795|P2|Overall Study|Progressive disease|0
5924896|NCT01469052|20495796|P1|Overall Study|Progressive disease|3
5924897|NCT01469052|20495791|P6|Overall Study|Adverse Event|1
5924898|NCT01469052|20495792|P5|Overall Study|Adverse Event|0
5924899|NCT01469052|20495793|P4|Overall Study|Adverse Event|2
5924900|NCT01469052|20495794|P3|Overall Study|Adverse Event|0
5924901|NCT01469052|20495795|P2|Overall Study|Adverse Event|3
5924902|NCT01469052|20495796|P1|Overall Study|Adverse Event|2
5924903|NCT01469013|20495861|P13|Part B (Extension Period)|Withdrawal by Subject|3
5924904|NCT01469013|20495862|P12|Part B (Extension Period)|Withdrawal by Subject|0
5924905|NCT01469013|20495863|P11|Part B (Extension Period)|Withdrawal by Subject|1
5924906|NCT01469013|20495864|P10|Part B (Extension Period)|Withdrawal by Subject|0
5924907|NCT01469013|20495865|P9|Part B (Extension Period)|Withdrawal by Subject|1
5924908|NCT01469013|20495866|P8|Part B (Extension Period)|Withdrawal by Subject|0
5924909|NCT01469013|20495867|P7|Part B (Extension Period)|Withdrawal by Subject|0
5924910|NCT01469013|20495868|P6|Part B (Extension Period)|Withdrawal by Subject|0
5924911|NCT01469013|20495869|P5|Part B (Extension Period)|Withdrawal by Subject|0
5924912|NCT01469013|20495870|P4|Part B (Extension Period)|Withdrawal by Subject|0
5924913|NCT01469013|20495871|P3|Part B (Extension Period)|Withdrawal by Subject|0
5924914|NCT01469013|20495872|P2|Part B (Extension Period)|Withdrawal by Subject|0
5924915|NCT01469013|20495873|P1|Part B (Extension Period)|Withdrawal by Subject|0
5924916|NCT01469013|20495861|P13|Part B (Extension Period)|Adverse Event|3
5924917|NCT01469013|20495862|P12|Part B (Extension Period)|Adverse Event|6
5924918|NCT01469013|20495863|P11|Part B (Extension Period)|Adverse Event|1
5924919|NCT01469013|20495864|P10|Part B (Extension Period)|Adverse Event|3
5924920|NCT01469013|20495865|P9|Part B (Extension Period)|Adverse Event|3
5924921|NCT01469013|20495866|P8|Part B (Extension Period)|Adverse Event|5
5924922|NCT01469013|20495867|P7|Part B (Extension Period)|Adverse Event|5
5924923|NCT01469013|20495868|P6|Part B (Extension Period)|Adverse Event|2
5924924|NCT01469013|20495869|P5|Part B (Extension Period)|Adverse Event|0
5924925|NCT01469013|20495870|P4|Part B (Extension Period)|Adverse Event|0
5924926|NCT01469013|20495871|P3|Part B (Extension Period)|Adverse Event|0
5924927|NCT01469013|20495872|P2|Part B (Extension Period)|Adverse Event|0
5924928|NCT01469013|20495873|P1|Part B (Extension Period)|Adverse Event|0
5924929|NCT01469013|20495861|P13|Part A (Treatment Period)|Withdrawal by Subject|0
5924930|NCT01469013|20495862|P12|Part A (Treatment Period)|Withdrawal by Subject|0
5924931|NCT01469013|20495863|P11|Part A (Treatment Period)|Withdrawal by Subject|0
5924932|NCT01469013|20495864|P10|Part A (Treatment Period)|Withdrawal by Subject|0
5924933|NCT01469013|20495865|P9|Part A (Treatment Period)|Withdrawal by Subject|0
5924934|NCT01469013|20495866|P8|Part A (Treatment Period)|Withdrawal by Subject|0
5924935|NCT01469013|20495867|P7|Part A (Treatment Period)|Withdrawal by Subject|0
5924936|NCT01469013|20495868|P6|Part A (Treatment Period)|Withdrawal by Subject|0
5924937|NCT01469013|20495869|P5|Part A (Treatment Period)|Withdrawal by Subject|0
5924938|NCT01469013|20495870|P4|Part A (Treatment Period)|Withdrawal by Subject|0
5924939|NCT01469013|20495871|P3|Part A (Treatment Period)|Withdrawal by Subject|1
5924940|NCT01469013|20495872|P2|Part A (Treatment Period)|Withdrawal by Subject|0
5924941|NCT01469013|20495873|P1|Part A (Treatment Period)|Withdrawal by Subject|0
5924942|NCT01469013|20495861|P13|Part A (Treatment Period)|Adverse Event|0
5924943|NCT01469013|20495862|P12|Part A (Treatment Period)|Adverse Event|0
5924944|NCT01469013|20495863|P11|Part A (Treatment Period)|Adverse Event|0
5924945|NCT01469013|20495864|P10|Part A (Treatment Period)|Adverse Event|0
5924946|NCT01469013|20495865|P9|Part A (Treatment Period)|Adverse Event|0
5924947|NCT01469013|20495866|P8|Part A (Treatment Period)|Adverse Event|0
5924948|NCT01469013|20495867|P7|Part A (Treatment Period)|Adverse Event|0
5924949|NCT01469013|20495868|P6|Part A (Treatment Period)|Adverse Event|0
5924950|NCT01469013|20495869|P5|Part A (Treatment Period)|Adverse Event|1
5924951|NCT01469013|20495870|P4|Part A (Treatment Period)|Adverse Event|0
5924952|NCT01469013|20495871|P3|Part A (Treatment Period)|Adverse Event|0
5924953|NCT01469013|20495872|P2|Part A (Treatment Period)|Adverse Event|0
5924954|NCT01469013|20495873|P1|Part A (Treatment Period)|Adverse Event|1
5924955|NCT01469000|20495958|P2|Overall Study|Sponsor Decision|1
5924956|NCT01469000|20495959|P1|Overall Study|Sponsor Decision|4
5924957|NCT01469000|20495958|P2|Overall Study|Withdrawal by Subject|3
5924958|NCT01469000|20495959|P1|Overall Study|Withdrawal by Subject|16
5924959|NCT01468987|20495979|P2|Overall Study|Sponsor Decision|0
5924960|NCT01468987|20495980|P1|Overall Study|Sponsor Decision|1
5924961|NCT01468987|20495979|P2|Overall Study|Physician Decision|15
5924962|NCT01468987|20495980|P1|Overall Study|Physician Decision|8
5924963|NCT01468987|20495979|P2|Overall Study|Withdrawal by Subject|28
5924964|NCT01468987|20495980|P1|Overall Study|Withdrawal by Subject|28
5924965|NCT01468987|20495979|P2|Overall Study|Protocol Violation|2
5924966|NCT01468987|20495980|P1|Overall Study|Protocol Violation|8
5924967|NCT01468987|20495979|P2|Overall Study|Lost to Follow-up|5
5924968|NCT01468987|20495980|P1|Overall Study|Lost to Follow-up|10
5924969|NCT01468987|20495979|P2|Overall Study|Death|1
5924970|NCT01468987|20495980|P1|Overall Study|Death|4
5924971|NCT01468987|20495979|P2|Overall Study|Adverse Event|9
5924972|NCT01468987|20495980|P1|Overall Study|Adverse Event|12
5924973|NCT01468909|20496157|P2|Overall Study|Never Treated|2
5924974|NCT01468909|20496158|P1|Overall Study|Never Treated|2
5924975|NCT01468818|20496191|P1|Overall Study|Death during treatment|2
5924976|NCT01468597|20496205|P1|Overall Study|no platelet function data|5
5924977|NCT01468597|20496205|P1|Overall Study|off-pump CABG|1
5924978|NCT01468597|20496205|P1|Overall Study|concomitant valves|12
5924979|NCT01468597|20496205|P1|Overall Study|Found ineligible|17
5924980|NCT01468311|20496254|P1|Overall Study|Withdrawal by Subject|1
5924981|NCT01468311|20496254|P1|Overall Study|mobilization failure|1
5924982|NCT01468233|20496266|P6|Treatment Period 2|Other|0
5924983|NCT01468233|20496267|P5|Treatment Period 2|Other|1
5924984|NCT01468233|20496268|P4|Treatment Period 2|Other|0
5924985|NCT01468233|20496269|P3|Treatment Period 2|Other|3
5924986|NCT01468233|20496270|P2|Treatment Period 2|Other|0
5924987|NCT01468233|20496271|P1|Treatment Period 2|Other|0
5924988|NCT01468233|20496266|P6|Treatment Period 2|Lost to Follow-up|0
5924989|NCT01468233|20496267|P5|Treatment Period 2|Lost to Follow-up|2
5924990|NCT01468233|20496268|P4|Treatment Period 2|Lost to Follow-up|0
5924991|NCT01468233|20496269|P3|Treatment Period 2|Lost to Follow-up|3
5924992|NCT01468233|20496270|P2|Treatment Period 2|Lost to Follow-up|0
5924993|NCT01468233|20496271|P1|Treatment Period 2|Lost to Follow-up|0
5924994|NCT01468233|20496266|P6|Treatment Period 2|Loss/absence of response (per protocol)|20
5924995|NCT01468233|20496267|P5|Treatment Period 2|Loss/absence of response (per protocol)|22
5924996|NCT01468233|20496268|P4|Treatment Period 2|Loss/absence of response (per protocol)|25
5924997|NCT01468233|20496269|P3|Treatment Period 2|Loss/absence of response (per protocol)|84
5924998|NCT01468233|20496270|P2|Treatment Period 2|Loss/absence of response (per protocol)|0
5924999|NCT01468233|20496271|P1|Treatment Period 2|Loss/absence of response (per protocol)|0
5925000|NCT01468233|20496266|P6|Treatment Period 2|Withdrawal by Subject|1
5925001|NCT01468233|20496267|P5|Treatment Period 2|Withdrawal by Subject|1
5925002|NCT01468233|20496268|P4|Treatment Period 2|Withdrawal by Subject|1
5925003|NCT01468233|20496269|P3|Treatment Period 2|Withdrawal by Subject|9
5925004|NCT01468233|20496270|P2|Treatment Period 2|Withdrawal by Subject|0
5925005|NCT01468233|20496271|P1|Treatment Period 2|Withdrawal by Subject|0
5925006|NCT01468233|20496266|P6|Treatment Period 2|Lack of Efficacy|1
5925007|NCT01468233|20496267|P5|Treatment Period 2|Lack of Efficacy|0
5925008|NCT01468233|20496268|P4|Treatment Period 2|Lack of Efficacy|2
5925009|NCT01468233|20496269|P3|Treatment Period 2|Lack of Efficacy|9
5925010|NCT01468233|20496270|P2|Treatment Period 2|Lack of Efficacy|0
5925011|NCT01468233|20496271|P1|Treatment Period 2|Lack of Efficacy|0
5925012|NCT01468233|20496266|P6|Treatment Period 2|Adverse Event|1
5925013|NCT01468233|20496267|P5|Treatment Period 2|Adverse Event|2
5925014|NCT01468233|20496268|P4|Treatment Period 2|Adverse Event|0
5925015|NCT01468233|20496269|P3|Treatment Period 2|Adverse Event|3
5925016|NCT01468233|20496270|P2|Treatment Period 2|Adverse Event|0
5925017|NCT01468233|20496271|P1|Treatment Period 2|Adverse Event|0
5925018|NCT01468233|20496266|P6|Treatment Period 1|Other|0
5925019|NCT01468233|20496267|P5|Treatment Period 1|Other|0
5925020|NCT01468233|20496268|P4|Treatment Period 1|Other|0
5925021|NCT01468233|20496269|P3|Treatment Period 1|Other|0
5925022|NCT01468233|20496270|P2|Treatment Period 1|Other|1
5925023|NCT01468233|20496271|P1|Treatment Period 1|Other|1
5925024|NCT01468233|20496266|P6|Treatment Period 1|Lost to Follow-up|0
5925025|NCT01468233|20496267|P5|Treatment Period 1|Lost to Follow-up|0
5925026|NCT01468233|20496268|P4|Treatment Period 1|Lost to Follow-up|0
5925027|NCT01468233|20496269|P3|Treatment Period 1|Lost to Follow-up|0
5925028|NCT01468233|20496270|P2|Treatment Period 1|Lost to Follow-up|0
5925029|NCT01468233|20496271|P1|Treatment Period 1|Lost to Follow-up|3
5925030|NCT01468233|20496266|P6|Treatment Period 1|Withdrawal by Subject|0
5925031|NCT01468233|20496267|P5|Treatment Period 1|Withdrawal by Subject|0
5925032|NCT01468233|20496268|P4|Treatment Period 1|Withdrawal by Subject|0
5925033|NCT01468233|20496269|P3|Treatment Period 1|Withdrawal by Subject|0
5925034|NCT01468233|20496270|P2|Treatment Period 1|Withdrawal by Subject|4
5925035|NCT01468233|20496271|P1|Treatment Period 1|Withdrawal by Subject|3
5925036|NCT01468233|20496266|P6|Treatment Period 1|Adverse Event|0
5925037|NCT01468233|20496267|P5|Treatment Period 1|Adverse Event|0
5925038|NCT01468233|20496268|P4|Treatment Period 1|Adverse Event|0
5925039|NCT01468233|20496269|P3|Treatment Period 1|Adverse Event|0
5925040|NCT01468233|20496270|P2|Treatment Period 1|Adverse Event|3
5925041|NCT01468233|20496271|P1|Treatment Period 1|Adverse Event|5
5925042|NCT01468207|20496293|P6|Treatment Period 2|Other|2
5925043|NCT01468207|20496294|P5|Treatment Period 2|Other|1
5925044|NCT01468207|20496295|P4|Treatment Period 2|Other|1
5925045|NCT01468207|20496296|P3|Treatment Period 2|Other|5
5925046|NCT01468207|20496297|P2|Treatment Period 2|Other|0
5925047|NCT01468207|20496298|P1|Treatment Period 2|Other|0
5925048|NCT01468207|20496293|P6|Treatment Period 2|Lost to Follow-up|0
5925049|NCT01468207|20496294|P5|Treatment Period 2|Lost to Follow-up|0
5925050|NCT01468207|20496295|P4|Treatment Period 2|Lost to Follow-up|1
5925051|NCT01468207|20496296|P3|Treatment Period 2|Lost to Follow-up|5
5925052|NCT01468207|20496297|P2|Treatment Period 2|Lost to Follow-up|0
5925053|NCT01468207|20496298|P1|Treatment Period 2|Lost to Follow-up|0
5925054|NCT01468207|20496293|P6|Treatment Period 2|Loss/abscence of response (per protocol)|13
5925055|NCT01468207|20496294|P5|Treatment Period 2|Loss/abscence of response (per protocol)|18
5925056|NCT01468207|20496295|P4|Treatment Period 2|Loss/abscence of response (per protocol)|23
5925057|NCT01468207|20496296|P3|Treatment Period 2|Loss/abscence of response (per protocol)|30
5925058|NCT01468207|20496297|P2|Treatment Period 2|Loss/abscence of response (per protocol)|0
5925059|NCT01468207|20496298|P1|Treatment Period 2|Loss/abscence of response (per protocol)|0
5925060|NCT01468207|20496293|P6|Treatment Period 2|Withdrawal by Subject|2
5925061|NCT01468207|20496294|P5|Treatment Period 2|Withdrawal by Subject|0
5925062|NCT01468207|20496295|P4|Treatment Period 2|Withdrawal by Subject|0
5925063|NCT01468207|20496296|P3|Treatment Period 2|Withdrawal by Subject|5
5925064|NCT01468207|20496297|P2|Treatment Period 2|Withdrawal by Subject|0
5925065|NCT01468207|20496298|P1|Treatment Period 2|Withdrawal by Subject|0
5925066|NCT01468207|20496293|P6|Treatment Period 2|Lack of Efficacy|2
5925067|NCT01468207|20496294|P5|Treatment Period 2|Lack of Efficacy|0
5925068|NCT01468207|20496295|P4|Treatment Period 2|Lack of Efficacy|1
5925069|NCT01468207|20496296|P3|Treatment Period 2|Lack of Efficacy|1
5925070|NCT01468207|20496297|P2|Treatment Period 2|Lack of Efficacy|0
5925071|NCT01468207|20496298|P1|Treatment Period 2|Lack of Efficacy|0
5925072|NCT01468207|20496293|P6|Treatment Period 2|Adverse Event|1
5925073|NCT01468207|20496294|P5|Treatment Period 2|Adverse Event|2
5925074|NCT01468207|20496295|P4|Treatment Period 2|Adverse Event|1
5925075|NCT01468207|20496296|P3|Treatment Period 2|Adverse Event|6
5925076|NCT01468207|20496297|P2|Treatment Period 2|Adverse Event|0
5925077|NCT01468207|20496298|P1|Treatment Period 2|Adverse Event|0
5925078|NCT01468207|20496293|P6|Treatment Period 1|Other|0
5925079|NCT01468207|20496294|P5|Treatment Period 1|Other|0
5925080|NCT01468207|20496295|P4|Treatment Period 1|Other|0
5925081|NCT01468207|20496296|P3|Treatment Period 1|Other|0
5925082|NCT01468207|20496297|P2|Treatment Period 1|Other|2
5925083|NCT01468207|20496298|P1|Treatment Period 1|Other|0
5925084|NCT01468207|20496293|P6|Treatment Period 1|Lost to Follow-up|0
5925085|NCT01468207|20496294|P5|Treatment Period 1|Lost to Follow-up|0
5925086|NCT01468207|20496295|P4|Treatment Period 1|Lost to Follow-up|0
5925087|NCT01468207|20496296|P3|Treatment Period 1|Lost to Follow-up|0
5925088|NCT01468207|20496297|P2|Treatment Period 1|Lost to Follow-up|1
5925089|NCT01468207|20496298|P1|Treatment Period 1|Lost to Follow-up|2
5925090|NCT01468207|20496293|P6|Treatment Period 1|Withdrawal by Subject|0
5925091|NCT01468207|20496294|P5|Treatment Period 1|Withdrawal by Subject|0
5925092|NCT01468207|20496295|P4|Treatment Period 1|Withdrawal by Subject|0
5925093|NCT01468207|20496296|P3|Treatment Period 1|Withdrawal by Subject|0
5925094|NCT01468207|20496297|P2|Treatment Period 1|Withdrawal by Subject|4
5925095|NCT01468207|20496298|P1|Treatment Period 1|Withdrawal by Subject|5
5925096|NCT01468207|20496293|P6|Treatment Period 1|Protocol Violation|0
5925097|NCT01468207|20496294|P5|Treatment Period 1|Protocol Violation|0
5925098|NCT01468207|20496295|P4|Treatment Period 1|Protocol Violation|0
5925099|NCT01468207|20496296|P3|Treatment Period 1|Protocol Violation|0
5925100|NCT01468207|20496297|P2|Treatment Period 1|Protocol Violation|1
5925101|NCT01468207|20496298|P1|Treatment Period 1|Protocol Violation|1
5925102|NCT01468207|20496293|P6|Treatment Period 1|Adverse Event|0
5925103|NCT01468207|20496294|P5|Treatment Period 1|Adverse Event|0
5925104|NCT01468207|20496295|P4|Treatment Period 1|Adverse Event|0
5925105|NCT01468207|20496296|P3|Treatment Period 1|Adverse Event|0
5925106|NCT01468207|20496297|P2|Treatment Period 1|Adverse Event|0
5925107|NCT01468207|20496298|P1|Treatment Period 1|Adverse Event|1
5925108|NCT01468181|20496323|P5|Overall Study|Withdrawal by Subject|0
5925109|NCT01468181|20496324|P4|Overall Study|Withdrawal by Subject|0
5925110|NCT01468181|20496325|P3|Overall Study|Withdrawal by Subject|0
5925111|NCT01468181|20496326|P2|Overall Study|Withdrawal by Subject|1
5925112|NCT01468181|20496327|P1|Overall Study|Withdrawal by Subject|0
5925113|NCT01468181|20496323|P5|Overall Study|Lost to Follow-up|1
5925114|NCT01468181|20496324|P4|Overall Study|Lost to Follow-up|0
5925115|NCT01468181|20496325|P3|Overall Study|Lost to Follow-up|1
5925116|NCT01468181|20496326|P2|Overall Study|Lost to Follow-up|0
5925117|NCT01468181|20496327|P1|Overall Study|Lost to Follow-up|0
5925118|NCT01468181|20496323|P5|Overall Study|Physician Decision|1
5925119|NCT01468181|20496324|P4|Overall Study|Physician Decision|1
5925120|NCT01468181|20496325|P3|Overall Study|Physician Decision|0
5925121|NCT01468181|20496326|P2|Overall Study|Physician Decision|0
5925122|NCT01468181|20496327|P1|Overall Study|Physician Decision|0
5925123|NCT01468181|20496323|P5|Overall Study|Protocol Violation|1
5925124|NCT01468181|20496324|P4|Overall Study|Protocol Violation|0
5925125|NCT01468181|20496325|P3|Overall Study|Protocol Violation|1
5925126|NCT01468181|20496326|P2|Overall Study|Protocol Violation|0
5925127|NCT01468181|20496327|P1|Overall Study|Protocol Violation|2
5925128|NCT01468181|20496323|P5|Overall Study|Adverse Event|2
5925129|NCT01468181|20496324|P4|Overall Study|Adverse Event|2
5925130|NCT01468181|20496325|P3|Overall Study|Adverse Event|6
5925131|NCT01468181|20496326|P2|Overall Study|Adverse Event|1
5925132|NCT01468181|20496327|P1|Overall Study|Adverse Event|8
5925133|NCT01468077|20496376|P2|Overall Study|Physician Decision|0
5925134|NCT01468077|20496377|P1|Overall Study|Physician Decision|1
5925135|NCT01468077|20496376|P2|Overall Study|Lack of Efficacy|1
5925136|NCT01468077|20496377|P1|Overall Study|Lack of Efficacy|1
5925137|NCT01468077|20496376|P2|Overall Study|Adverse Event|2
5925138|NCT01468077|20496377|P1|Overall Study|Adverse Event|2
5925139|NCT01467960|20496439|P6|Overall Study|Enrollment of patients (PD) in 09/2013|30
5925140|NCT01467960|20496440|P5|Overall Study|Enrollment of patients (PD) in 09/2013|30
5925141|NCT01467960|20496441|P4|Overall Study|Enrollment of patients (PD) in 09/2013|30
5925142|NCT01467960|20496442|P3|Overall Study|Enrollment of patients (PD) in 09/2013|0
5925143|NCT01467960|20496443|P2|Overall Study|Enrollment of patients (PD) in 09/2013|0
5925144|NCT01467960|20496444|P1|Overall Study|Enrollment of patients (PD) in 09/2013|0
5925145|NCT01467713|20496503|P4|Overall Study|Reason not Specified|7
5925146|NCT01467713|20496504|P3|Overall Study|Reason not Specified|8
5925147|NCT01467713|20496505|P2|Overall Study|Reason not Specified|11
5925148|NCT01467713|20496506|P1|Overall Study|Reason not Specified|6
5925149|NCT01467713|20496503|P4|Overall Study|Relapse|35
5925150|NCT01467713|20496504|P3|Overall Study|Relapse|28
5925151|NCT01467713|20496505|P2|Overall Study|Relapse|25
5925152|NCT01467713|20496506|P1|Overall Study|Relapse|35
5925153|NCT01467713|20496503|P4|Overall Study|Pregnancy|3
5925154|NCT01467713|20496504|P3|Overall Study|Pregnancy|1
5925155|NCT01467713|20496505|P2|Overall Study|Pregnancy|1
5925156|NCT01467713|20496506|P1|Overall Study|Pregnancy|0
5925157|NCT01467713|20496503|P4|Overall Study|Study Termination|29
5925158|NCT01467713|20496504|P3|Overall Study|Study Termination|28
5925159|NCT01467713|20496505|P2|Overall Study|Study Termination|33
5925160|NCT01467713|20496506|P1|Overall Study|Study Termination|23
5925161|NCT01467713|20496503|P4|Overall Study|Voluntary Withdrawal|20
5925162|NCT01467713|20496504|P3|Overall Study|Voluntary Withdrawal|21
5925163|NCT01467713|20496505|P2|Overall Study|Voluntary Withdrawal|14
5925164|NCT01467713|20496506|P1|Overall Study|Voluntary Withdrawal|18
5925165|NCT01467713|20496503|P4|Overall Study|Lost to Follow-up|9
5925166|NCT01467713|20496504|P3|Overall Study|Lost to Follow-up|6
5925167|NCT01467713|20496505|P2|Overall Study|Lost to Follow-up|12
5925168|NCT01467713|20496506|P1|Overall Study|Lost to Follow-up|9
5925169|NCT01467713|20496503|P4|Overall Study|Major Protocol Deviation|1
5925170|NCT01467713|20496504|P3|Overall Study|Major Protocol Deviation|4
5925171|NCT01467713|20496505|P2|Overall Study|Major Protocol Deviation|4
5925172|NCT01467713|20496506|P1|Overall Study|Major Protocol Deviation|2
5925173|NCT01467713|20496503|P4|Overall Study|Pretreatment Event or Adverse Event|5
5925174|NCT01467713|20496504|P3|Overall Study|Pretreatment Event or Adverse Event|6
5925175|NCT01467713|20496505|P2|Overall Study|Pretreatment Event or Adverse Event|4
5925176|NCT01467713|20496506|P1|Overall Study|Pretreatment Event or Adverse Event|9
5925177|NCT01467700|20496560|P4|Overall Study|Reason not Specified|8
5925178|NCT01467700|20496561|P3|Overall Study|Reason not Specified|2
5925179|NCT01467700|20496562|P2|Overall Study|Reason not Specified|3
5925180|NCT01467700|20496563|P1|Overall Study|Reason not Specified|1
5925181|NCT01467700|20496560|P4|Overall Study|Lack of Efficacy|1
5925182|NCT01467700|20496561|P3|Overall Study|Lack of Efficacy|2
5925183|NCT01467700|20496562|P2|Overall Study|Lack of Efficacy|0
5925184|NCT01467700|20496563|P1|Overall Study|Lack of Efficacy|2
5925185|NCT01467700|20496560|P4|Overall Study|Pregnancy|0
5925186|NCT01467700|20496561|P3|Overall Study|Pregnancy|1
5925187|NCT01467700|20496562|P2|Overall Study|Pregnancy|1
5925188|NCT01467700|20496563|P1|Overall Study|Pregnancy|0
5925189|NCT01467700|20496560|P4|Overall Study|Study Termination|7
5925190|NCT01467700|20496561|P3|Overall Study|Study Termination|10
5925191|NCT01467700|20496562|P2|Overall Study|Study Termination|5
5925192|NCT01467700|20496563|P1|Overall Study|Study Termination|6
5925193|NCT01467700|20496560|P4|Overall Study|Voluntary Withdrawal|2
5925194|NCT01467700|20496561|P3|Overall Study|Voluntary Withdrawal|6
5925195|NCT01467700|20496562|P2|Overall Study|Voluntary Withdrawal|7
5925196|NCT01467700|20496563|P1|Overall Study|Voluntary Withdrawal|5
5925197|NCT01467700|20496560|P4|Overall Study|Lost to Follow-up|3
5925198|NCT01467700|20496561|P3|Overall Study|Lost to Follow-up|2
5925199|NCT01467700|20496562|P2|Overall Study|Lost to Follow-up|5
5925200|NCT01467700|20496563|P1|Overall Study|Lost to Follow-up|6
5925201|NCT01467700|20496560|P4|Overall Study|Major Protocol Deviation|3
5925202|NCT01467700|20496561|P3|Overall Study|Major Protocol Deviation|2
5925203|NCT01467700|20496562|P2|Overall Study|Major Protocol Deviation|3
5925204|NCT01467700|20496563|P1|Overall Study|Major Protocol Deviation|3
5925205|NCT01467700|20496560|P4|Overall Study|Pretreatment Event or Adverse Event|3
5925206|NCT01467700|20496561|P3|Overall Study|Pretreatment Event or Adverse Event|2
5925207|NCT01467700|20496562|P2|Overall Study|Pretreatment Event or Adverse Event|4
5925208|NCT01467700|20496563|P1|Overall Study|Pretreatment Event or Adverse Event|6
5925209|NCT01467661|20496605|P1|Overall Study|Not enrolled to SPD422-309 (NCT01467661)|1
5925210|NCT01467661|20496605|P1|Overall Study|Lack of Efficacy|3
5925211|NCT01467661|20496605|P1|Overall Study|Withdrawal by Subject|1
5925212|NCT01467661|20496605|P1|Overall Study|Adverse Event|16
5925213|NCT01467583|20496625|P3|Overall Study|Protocol Violation|2
5925214|NCT01467583|20496626|P2|Overall Study|Protocol Violation|0
5925215|NCT01467583|20496627|P1|Overall Study|Protocol Violation|0
5925216|NCT01467583|20496625|P3|Overall Study|Withdrawal by Subject|0
5925217|NCT01467583|20496626|P2|Overall Study|Withdrawal by Subject|0
5925218|NCT01467583|20496627|P1|Overall Study|Withdrawal by Subject|1
5925219|NCT01467583|20496625|P3|Overall Study|Death|0
5925220|NCT01467583|20496626|P2|Overall Study|Death|1
5925221|NCT01467583|20496627|P1|Overall Study|Death|1
5925222|NCT01467570|20496640|P2|Overall Study|Lost to Follow-up|9
5925223|NCT01467570|20496641|P1|Overall Study|Lost to Follow-up|8
5925224|NCT01467505|20496678|P2|Overall Study|Study Terminated by Sponsor|3
5925225|NCT01467505|20496679|P1|Overall Study|Study Terminated by Sponsor|28
5925226|NCT01467505|20496678|P2|Overall Study|Withdrawal by Subject|0
5925227|NCT01467505|20496679|P1|Overall Study|Withdrawal by Subject|4
5925228|NCT01467505|20496678|P2|Overall Study|Adverse Event|0
5925229|NCT01467505|20496679|P1|Overall Study|Adverse Event|1
5925230|NCT01467492|20496711|P2|Overall Study|Enrolled But Not Treated|0
5925231|NCT01467492|20496712|P1|Overall Study|Enrolled But Not Treated|1
5925232|NCT01467492|20496711|P2|Overall Study|Undefined|0
5925233|NCT01467492|20496712|P1|Overall Study|Undefined|2
5925234|NCT01467492|20496711|P2|Overall Study|Lost to Follow-up|2
5925235|NCT01467492|20496712|P1|Overall Study|Lost to Follow-up|3
5925236|NCT01467492|20496711|P2|Overall Study|Adverse Event|3
5925237|NCT01467492|20496712|P1|Overall Study|Adverse Event|4
5925238|NCT01467492|20496711|P2|Overall Study|Study Terminated by Sponsor|4
5925239|NCT01467492|20496712|P1|Overall Study|Study Terminated by Sponsor|6
5925240|NCT01467492|20496711|P2|Overall Study|Withdrawal by Subject|4
5925241|NCT01467492|20496712|P1|Overall Study|Withdrawal by Subject|6
5925242|NCT01467479|20496736|P3|Overall Study|Other|0
5925243|NCT01467479|20496737|P2|Overall Study|Other|0
5925244|NCT01467479|20496738|P1|Overall Study|Other|1
5925245|NCT01467479|20496736|P3|Overall Study|Study Terminated by Sponsor|3
5925246|NCT01467479|20496737|P2|Overall Study|Study Terminated by Sponsor|3
5925247|NCT01467479|20496738|P1|Overall Study|Study Terminated by Sponsor|1
5925248|NCT01467479|20496736|P3|Overall Study|Withdrawal of Consent|7
5925249|NCT01467479|20496737|P2|Overall Study|Withdrawal of Consent|7
5925250|NCT01467479|20496738|P1|Overall Study|Withdrawal of Consent|3
5925251|NCT01467479|20496736|P3|Overall Study|Lost to Follow-up|3
5925252|NCT01467479|20496737|P2|Overall Study|Lost to Follow-up|5
5925253|NCT01467479|20496738|P1|Overall Study|Lost to Follow-up|2
5925254|NCT01467479|20496736|P3|Overall Study|Death|1
5925255|NCT01467479|20496737|P2|Overall Study|Death|0
5925256|NCT01467479|20496738|P1|Overall Study|Death|0
5925257|NCT01467479|20496736|P3|Overall Study|Adverse Event|0
5925258|NCT01467479|20496737|P2|Overall Study|Adverse Event|2
5925259|NCT01467479|20496738|P1|Overall Study|Adverse Event|1
5925260|NCT01467479|20496736|P3|Overall Study|No Study Medication|2
5925261|NCT01467479|20496737|P2|Overall Study|No Study Medication|0
5925262|NCT01467479|20496738|P1|Overall Study|No Study Medication|1
5925263|NCT01467466|20496769|P4|Overall Study|No Endpoint Blood Draw|43
5925264|NCT01467466|20496770|P3|Overall Study|No Endpoint Blood Draw|51
5925265|NCT01467466|20496771|P2|Overall Study|No Endpoint Blood Draw|32
5925266|NCT01467466|20496772|P1|Overall Study|No Endpoint Blood Draw|38
5925267|NCT01467466|20496769|P4|Overall Study|Procedure Cancelled|29
5925268|NCT01467466|20496770|P3|Overall Study|Procedure Cancelled|25
5925269|NCT01467466|20496771|P2|Overall Study|Procedure Cancelled|45
5925270|NCT01467466|20496772|P1|Overall Study|Procedure Cancelled|46
5925271|NCT01467466|20496769|P4|Overall Study|Revoked Consent Prior To Procedure|5
5925272|NCT01467466|20496770|P3|Overall Study|Revoked Consent Prior To Procedure|15
5925273|NCT01467466|20496771|P2|Overall Study|Revoked Consent Prior To Procedure|9
5925274|NCT01467466|20496772|P1|Overall Study|Revoked Consent Prior To Procedure|10
5925275|NCT01467466|20496769|P4|Overall Study|Withdrawal by Subject|11
5925276|NCT01467466|20496770|P3|Overall Study|Withdrawal by Subject|13
5925277|NCT01467466|20496771|P2|Overall Study|Withdrawal by Subject|18
5925278|NCT01467466|20496772|P1|Overall Study|Withdrawal by Subject|15
5925279|NCT01467427|20496784|P2|Overall Study|Not continuing in extension phase|2
5925280|NCT01467427|20496785|P1|Overall Study|Not continuing in extension phase|0
5925281|NCT01467427|20496784|P2|Overall Study|Entered extension phase|11
5925282|NCT01467427|20496785|P1|Overall Study|Entered extension phase|11
5925283|NCT01467427|20496784|P2|Overall Study|Withdrawal by Subject|0
5925284|NCT01467427|20496785|P1|Overall Study|Withdrawal by Subject|1
5925285|NCT01467271|20496803|P1|Overall Study|Other reason|14
5925286|NCT01467271|20496803|P1|Overall Study|Retraction of patient's consent|21
5925287|NCT01467271|20496803|P1|Overall Study|Lost to Follow-up|83
5925288|NCT01467271|20496803|P1|Overall Study|Death|84
5925289|NCT01467076|20496810|P3|Overall Study|Lost to Follow-up|0
5925290|NCT01467076|20496811|P2|Overall Study|Lost to Follow-up|0
5925291|NCT01467076|20496812|P1|Overall Study|Lost to Follow-up|1
5925292|NCT01466881|20496884|P1|Overall Study|Other reason not protocol specified|5
5925293|NCT01466881|20496884|P1|Overall Study|Death|4
5925294|NCT01466881|20496884|P1|Overall Study|Progression/relapse|20
5925295|NCT01466881|20496884|P1|Overall Study|Adverse Event|6
5925296|NCT01466881|20496884|P1|Overall Study|Ineligible|5
5925297|NCT01466790|20496901|P8|Overall Study|Withdrawal by Subject|1
5925298|NCT01466790|20496902|P7|Overall Study|Withdrawal by Subject|1
5925299|NCT01466790|20496903|P6|Overall Study|Withdrawal by Subject|0
5925300|NCT01466790|20496904|P5|Overall Study|Withdrawal by Subject|1
5925301|NCT01466790|20496905|P4|Overall Study|Withdrawal by Subject|0
5925302|NCT01466790|20496906|P3|Overall Study|Withdrawal by Subject|0
5925303|NCT01466790|20496907|P2|Overall Study|Withdrawal by Subject|1
5925304|NCT01466790|20496908|P1|Overall Study|Withdrawal by Subject|1
5925305|NCT01466790|20496901|P8|Overall Study|Lost to Follow-up|0
5925306|NCT01466790|20496902|P7|Overall Study|Lost to Follow-up|0
5925307|NCT01466790|20496903|P6|Overall Study|Lost to Follow-up|0
5925308|NCT01466790|20496904|P5|Overall Study|Lost to Follow-up|0
5925309|NCT01466790|20496905|P4|Overall Study|Lost to Follow-up|0
5925310|NCT01466790|20496906|P3|Overall Study|Lost to Follow-up|0
5925311|NCT01466790|20496907|P2|Overall Study|Lost to Follow-up|0
5925312|NCT01466790|20496908|P1|Overall Study|Lost to Follow-up|2
5925313|NCT01466790|20496901|P8|Overall Study|Adverse Event|0
5925314|NCT01466790|20496902|P7|Overall Study|Adverse Event|0
5925315|NCT01466790|20496903|P6|Overall Study|Adverse Event|0
5925316|NCT01466790|20496904|P5|Overall Study|Adverse Event|2
5925317|NCT01466790|20496905|P4|Overall Study|Adverse Event|0
5925318|NCT01466790|20496906|P3|Overall Study|Adverse Event|0
5925319|NCT01466790|20496907|P2|Overall Study|Adverse Event|0
5925320|NCT01466790|20496908|P1|Overall Study|Adverse Event|1
5925321|NCT01466673|20497004|P2|Overall Study|Adverse Event|1
5925322|NCT01466673|20497005|P1|Overall Study|Adverse Event|2
5925323|NCT01466673|20497004|P2|Overall Study|Lost to Follow-up|5
5925324|NCT01466673|20497005|P1|Overall Study|Lost to Follow-up|3
5925325|NCT01466673|20497004|P2|Overall Study|Non-compliance with study treatment|0
5925326|NCT01466673|20497005|P1|Overall Study|Non-compliance with study treatment|2
5925327|NCT01466660|20497031|P2|Overall Study|Other reason not defined above|8
5925328|NCT01466660|20497032|P1|Overall Study|Other reason not defined above|10
5925329|NCT01466660|20497031|P2|Overall Study|Refused continuation of trial medication|3
5925330|NCT01466660|20497032|P1|Overall Study|Refused continuation of trial medication|4
5925331|NCT01466660|20497031|P2|Overall Study|Protocol Violation|1
5925332|NCT01466660|20497032|P1|Overall Study|Protocol Violation|2
5925333|NCT01466660|20497031|P2|Overall Study|Other adverse event|18
5925334|NCT01466660|20497032|P1|Overall Study|Other adverse event|19
5925335|NCT01466660|20497031|P2|Overall Study|Worsening of underlying cancer disease|2
5925336|NCT01466660|20497032|P1|Overall Study|Worsening of underlying cancer disease|5
5925337|NCT01466660|20497031|P2|Overall Study|Progressive Disease (RECIST 1.1)|127
5925338|NCT01466660|20497032|P1|Overall Study|Progressive Disease (RECIST 1.1)|120
5925339|NCT01466595|20497058|P2|Overall Study|Withdrawal by Subject|1
5925340|NCT01466595|20497059|P1|Overall Study|Withdrawal by Subject|0
5925341|NCT01466491|20497153|P4|Overall Study|Missing Data|0
5925342|NCT01466491|20497154|P3|Overall Study|Missing Data|1
5925343|NCT01466491|20497155|P2|Overall Study|Missing Data|0
5925344|NCT01466491|20497156|P1|Overall Study|Missing Data|0
5925345|NCT01466491|20497153|P4|Overall Study|Protocol Violation|0
5925346|NCT01466491|20497154|P3|Overall Study|Protocol Violation|2
5925347|NCT01466491|20497155|P2|Overall Study|Protocol Violation|3
5925348|NCT01466491|20497156|P1|Overall Study|Protocol Violation|0
5925349|NCT01466387|20497176|P6|Overall Study|Protocol Violation|0
5925350|NCT01466387|20497177|P5|Overall Study|Protocol Violation|0
5925351|NCT01466387|20497178|P4|Overall Study|Protocol Violation|1
5925352|NCT01466387|20497179|P3|Overall Study|Protocol Violation|0
5925353|NCT01466387|20497180|P2|Overall Study|Protocol Violation|0
5925354|NCT01466387|20497181|P1|Overall Study|Protocol Violation|1
5925355|NCT01466387|20497176|P6|Overall Study|Lost to Follow-up|1
5925356|NCT01466387|20497177|P5|Overall Study|Lost to Follow-up|0
5925357|NCT01466387|20497178|P4|Overall Study|Lost to Follow-up|0
5925358|NCT01466387|20497179|P3|Overall Study|Lost to Follow-up|0
5925359|NCT01466387|20497180|P2|Overall Study|Lost to Follow-up|0
5925360|NCT01466387|20497181|P1|Overall Study|Lost to Follow-up|0
5925361|NCT01466387|20497176|P6|Overall Study|Adverse Event|0
5925362|NCT01466387|20497177|P5|Overall Study|Adverse Event|0
5925363|NCT01466387|20497178|P4|Overall Study|Adverse Event|1
5925364|NCT01466387|20497179|P3|Overall Study|Adverse Event|1
5925365|NCT01466387|20497180|P2|Overall Study|Adverse Event|0
5925366|NCT01466387|20497181|P1|Overall Study|Adverse Event|0
5925367|NCT01466348|20497242|P2|Period I - First Intervention|Withdrawal by Subject|1
5925368|NCT01466348|20497243|P1|Period I - First Intervention|Withdrawal by Subject|0
5925369|NCT01466270|20497271|P2|Overall Study|Multiple|1
5925370|NCT01466270|20497272|P1|Overall Study|Multiple|1
5925371|NCT01466270|20497271|P2|Overall Study|Toxicity|1
5925372|NCT01466270|20497272|P1|Overall Study|Toxicity|4
5925373|NCT01466270|20497271|P2|Overall Study|Progression|0
5925374|NCT01466270|20497272|P1|Overall Study|Progression|1
5925375|NCT01466270|20497271|P2|Overall Study|Lost to Follow-up|3
5925376|NCT01466270|20497272|P1|Overall Study|Lost to Follow-up|1
5925377|NCT01466270|20497271|P2|Overall Study|Physician Decision|0
5925378|NCT01466270|20497272|P1|Overall Study|Physician Decision|1
5925379|NCT01466270|20497271|P2|Overall Study|Withdrawal by Subject|1
5925380|NCT01466270|20497272|P1|Overall Study|Withdrawal by Subject|4
5925381|NCT01466192|20497284|P1|Overall Study|Withdrawal by Subject|3
5925382|NCT01466192|20497284|P1|Overall Study|Physician Decision|1
5925383|NCT01466179|20497288|P1|Overall Study|Other|3
5925384|NCT01466179|20497288|P1|Overall Study|Protocol Violation|2
5925385|NCT01466179|20497288|P1|Overall Study|Withdrawal by Subject|7
5925386|NCT01466179|20497288|P1|Overall Study|Death|7
5925387|NCT01466179|20497288|P1|Overall Study|Lack of Efficacy|14
5925388|NCT01466179|20497288|P1|Overall Study|Disease relapse|23
5925389|NCT01466179|20497288|P1|Overall Study|Adverse Event|32
5925390|NCT01466179|20497288|P1|Overall Study|Progressive disease|43
5925391|NCT01466179|20497288|P1|Overall Study|Physician Decision|46
5925392|NCT01466179|20497288|P1|Overall Study|Ongoing in core study|2
5925393|NCT01466166|20497308|P1|Overall Study|Other|20
5925394|NCT01466166|20497308|P1|Overall Study|Protocol Violation/Noncompliance|2
5925395|NCT01466166|20497308|P1|Overall Study|Sponsor Decision|4
5925396|NCT01466166|20497308|P1|Overall Study|Withdrawal by Subject|13
5925397|NCT01466166|20497308|P1|Overall Study|Elevated Serum Uric Acid|78
5925398|NCT01466166|20497308|P1|Overall Study|Adverse Event (Other than IR)|11
5925399|NCT01466166|20497308|P1|Overall Study|Infusion Reaction (IR)|27
5925400|NCT01466166|20497308|P1|Overall Study|Lost to Follow-up|7
5925401|NCT01466166|20497308|P1|Overall Study|Death|1
5925402|NCT01466153|20497322|P3|Overall Study|Other-Unspecified|2
5925403|NCT01466153|20497323|P2|Overall Study|Other-Unspecified|4
5925404|NCT01466153|20497324|P1|Overall Study|Other-Unspecified|6
5925405|NCT01466153|20497322|P3|Overall Study|Randomized-Not Treated|4
5925406|NCT01466153|20497323|P2|Overall Study|Randomized-Not Treated|3
5925407|NCT01466153|20497324|P1|Overall Study|Randomized-Not Treated|2
5925408|NCT01466153|20497322|P3|Overall Study|Investigator Discretion|2
5925409|NCT01466153|20497323|P2|Overall Study|Investigator Discretion|2
5925410|NCT01466153|20497324|P1|Overall Study|Investigator Discretion|3
5925411|NCT01466153|20497322|P3|Overall Study|Withdrawal of Consent|0
5925412|NCT01466153|20497323|P2|Overall Study|Withdrawal of Consent|0
5925413|NCT01466153|20497324|P1|Overall Study|Withdrawal of Consent|2
5925414|NCT01466153|20497322|P3|Overall Study|Adverse Event|17
5925415|NCT01466153|20497323|P2|Overall Study|Adverse Event|13
5925416|NCT01466153|20497324|P1|Overall Study|Adverse Event|14
5925417|NCT01466153|20497322|P3|Overall Study|Disease Progression|0
5925418|NCT01466153|20497323|P2|Overall Study|Disease Progression|2
5925419|NCT01466153|20497324|P1|Overall Study|Disease Progression|2
5925420|NCT01466062|20497379|P1|Overall Study|Withdrawal by Subject|1
5925421|NCT01466062|20497379|P1|Overall Study|Adverse Event|1
5925422|NCT01465997|20497402|P2|Overall Study|subject left participation SP0993|1
5925423|NCT01465997|20497403|P1|Overall Study|subject left participation SP0993|0
5925424|NCT01465997|20497402|P2|Overall Study|decision by site staff|1
5925425|NCT01465997|20497403|P1|Overall Study|decision by site staff|0
5925426|NCT01465997|20497402|P2|Overall Study|withdrew before follow-up|13
5925427|NCT01465997|20497403|P1|Overall Study|withdrew before follow-up|0
5925428|NCT01465997|20497402|P2|Overall Study|local lab unblinded site|0
5925429|NCT01465997|20497403|P1|Overall Study|local lab unblinded site|1
5925430|NCT01465997|20497402|P2|Overall Study|subject withdrew consent|0
5925431|NCT01465997|20497403|P1|Overall Study|subject withdrew consent|1
5925432|NCT01465997|20497402|P2|Overall Study|sponsor's decision|1
5925433|NCT01465997|20497403|P1|Overall Study|sponsor's decision|1
5925434|NCT01465997|20497402|P2|Overall Study|Death|1
5925435|NCT01465997|20497403|P1|Overall Study|Death|0
5925436|NCT01465997|20497402|P2|Overall Study|investigator's decision|1
5925437|NCT01465997|20497403|P1|Overall Study|investigator's decision|1
5925438|NCT01465997|20497402|P2|Overall Study|Withdrawal by Subject|35
5925439|NCT01465997|20497403|P1|Overall Study|Withdrawal by Subject|32
5925440|NCT01465997|20497402|P2|Overall Study|Lost to Follow-up|9
5925441|NCT01465997|20497403|P1|Overall Study|Lost to Follow-up|6
5925442|NCT01465997|20497402|P2|Overall Study|Protocol Violation|4
5925443|NCT01465997|20497403|P1|Overall Study|Protocol Violation|1
5925444|NCT01465997|20497402|P2|Overall Study|Lack of Efficacy|1
5925445|NCT01465997|20497403|P1|Overall Study|Lack of Efficacy|13
5925446|NCT01465997|20497402|P2|Overall Study|Adverse Event|22
5925447|NCT01465997|20497403|P1|Overall Study|Adverse Event|12
5925448|NCT01465958|20497413|P2|Subcutaneous (SC) Phase|Adverse Event|1
5925449|NCT01465958|20497414|P1|Subcutaneous (SC) Phase|Adverse Event|0
5925450|NCT01465958|20497413|P2|Run-in Phase|Protocol Violation|0
5925451|NCT01465958|20497414|P1|Run-in Phase|Protocol Violation|1
5925452|NCT01465802|20497435|P5|Overall Study|Death|2
5925453|NCT01465802|20497436|P4|Overall Study|Death|10
5925454|NCT01465802|20497437|P3|Overall Study|Death|0
5925455|NCT01465802|20497438|P2|Overall Study|Death|12
5925456|NCT01465802|20497439|P1|Overall Study|Death|15
5925457|NCT01465802|20497435|P5|Overall Study|Reason not specified|2
5925458|NCT01465802|20497436|P4|Overall Study|Reason not specified|10
5925459|NCT01465802|20497437|P3|Overall Study|Reason not specified|0
5925460|NCT01465802|20497438|P2|Overall Study|Reason not specified|4
5925461|NCT01465802|20497439|P1|Overall Study|Reason not specified|9
5925462|NCT01465802|20497435|P5|Overall Study|Lost to Follow-up|0
5925463|NCT01465802|20497436|P4|Overall Study|Lost to Follow-up|0
5925464|NCT01465802|20497437|P3|Overall Study|Lost to Follow-up|0
5925465|NCT01465802|20497438|P2|Overall Study|Lost to Follow-up|1
5925466|NCT01465802|20497439|P1|Overall Study|Lost to Follow-up|1
5925467|NCT01465802|20497435|P5|Overall Study|Withdrawal by Subject|1
5925468|NCT01465802|20497436|P4|Overall Study|Withdrawal by Subject|8
5925469|NCT01465802|20497437|P3|Overall Study|Withdrawal by Subject|0
5925470|NCT01465802|20497438|P2|Overall Study|Withdrawal by Subject|7
5925471|NCT01465802|20497439|P1|Overall Study|Withdrawal by Subject|7
5925472|NCT01465802|20497435|P5|Overall Study|Study terminated by sponsor|7
5925473|NCT01465802|20497436|P4|Overall Study|Study terminated by sponsor|1
5925474|NCT01465802|20497437|P3|Overall Study|Study terminated by sponsor|0
5925475|NCT01465802|20497438|P2|Overall Study|Study terminated by sponsor|0
5925476|NCT01465802|20497439|P1|Overall Study|Study terminated by sponsor|1
5925477|NCT01465763|20497491|P3|Overall Study|Death|0
5925478|NCT01465763|20497492|P2|Overall Study|Death|0
5925479|NCT01465763|20497493|P1|Overall Study|Death|1
5925480|NCT01465763|20497491|P3|Overall Study|Protocol Violation|1
5925481|NCT01465763|20497492|P2|Overall Study|Protocol Violation|1
5925482|NCT01465763|20497493|P1|Overall Study|Protocol Violation|4
5925483|NCT01465763|20497491|P3|Overall Study|Other|0
5925484|NCT01465763|20497492|P2|Overall Study|Other|0
5925485|NCT01465763|20497493|P1|Overall Study|Other|2
5925486|NCT01465763|20497491|P3|Overall Study|Adverse Event|1
5925487|NCT01465763|20497492|P2|Overall Study|Adverse Event|0
5925488|NCT01465763|20497493|P1|Overall Study|Adverse Event|9
5925489|NCT01465763|20497491|P3|Overall Study|Insufficient Clinical Response|1
5925490|NCT01465763|20497492|P2|Overall Study|Insufficient Clinical Response|0
5925491|NCT01465763|20497493|P1|Overall Study|Insufficient Clinical Response|11
5925492|NCT01465763|20497491|P3|Overall Study|Withdrawal by Subject|1
5925493|NCT01465763|20497492|P2|Overall Study|Withdrawal by Subject|0
5925494|NCT01465763|20497493|P1|Overall Study|Withdrawal by Subject|4
5925495|NCT01465659|20497522|P4|Completed Follow for 1 Year|Still in FU|2
5925496|NCT01465659|20497523|P3|Completed Follow for 1 Year|Still in FU|1
5925497|NCT01465659|20497524|P2|Completed Follow for 1 Year|Still in FU|0
5925498|NCT01465659|20497525|P1|Completed Follow for 1 Year|Still in FU|0
5925499|NCT01465659|20497522|P4|Completed Follow for 1 Year|Death|4
5925500|NCT01465659|20497523|P3|Completed Follow for 1 Year|Death|1
5925501|NCT01465659|20497524|P2|Completed Follow for 1 Year|Death|3
5925502|NCT01465659|20497525|P1|Completed Follow for 1 Year|Death|6
5925503|NCT01465659|20497522|P4|Completed 2 Cycles/Reached 1st Response|Adverse Event|0
5925504|NCT01465659|20497523|P3|Completed 2 Cycles/Reached 1st Response|Adverse Event|1
5925505|NCT01465659|20497524|P2|Completed 2 Cycles/Reached 1st Response|Adverse Event|0
5925506|NCT01465659|20497525|P1|Completed 2 Cycles/Reached 1st Response|Adverse Event|1
5925507|NCT01465659|20497522|P4|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1
5925508|NCT01465659|20497523|P3|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1
5925509|NCT01465659|20497524|P2|Completed 2 Cycles/Reached 1st Response|Progressive Disease|0
5925510|NCT01465659|20497525|P1|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1
5925511|NCT01465659|20497522|P4|Completed 1 Cycle of Treatment|Adverse Event|1
5925512|NCT01465659|20497523|P3|Completed 1 Cycle of Treatment|Adverse Event|0
5925513|NCT01465659|20497524|P2|Completed 1 Cycle of Treatment|Adverse Event|0
5925514|NCT01465659|20497525|P1|Completed 1 Cycle of Treatment|Adverse Event|0
5925515|NCT01465659|20497522|P4|Completed 1 Cycle of Treatment|Death|0
5925516|NCT01465659|20497523|P3|Completed 1 Cycle of Treatment|Death|0
5925517|NCT01465659|20497524|P2|Completed 1 Cycle of Treatment|Death|1
5925518|NCT01465659|20497525|P1|Completed 1 Cycle of Treatment|Death|0
5925519|NCT01465464|20497535|P2|Overall Study|Ongoing treatment at cutoff date|166
5925520|NCT01465464|20497536|P1|Overall Study|Ongoing treatment at cutoff date|140
5925521|NCT01465464|20497535|P2|Overall Study|Other|3
5925522|NCT01465464|20497536|P1|Overall Study|Other|9
5925523|NCT01465464|20497535|P2|Overall Study|Withdrawal by Subject|30
5925524|NCT01465464|20497536|P1|Overall Study|Withdrawal by Subject|46
5925525|NCT01465464|20497535|P2|Overall Study|Protocol Violation|1
5925526|NCT01465464|20497536|P1|Overall Study|Protocol Violation|1
5925527|NCT01465464|20497535|P2|Overall Study|Physician Decision|5
5925528|NCT01465464|20497536|P1|Overall Study|Physician Decision|13
5925529|NCT01465464|20497535|P2|Overall Study|Lack of Efficacy|190
5925530|NCT01465464|20497536|P1|Overall Study|Lack of Efficacy|139
5925531|NCT01465464|20497535|P2|Overall Study|Adverse Event|49
5925532|NCT01465464|20497536|P1|Overall Study|Adverse Event|96
5925533|NCT01465386|20497589|P1|Overall Study|Adverse Event|1
5925534|NCT01465386|20497589|P1|Overall Study|Lack of Efficacy|3
5925535|NCT01465347|20497593|P2|Overall Study|Admitted to hospice|1
5925536|NCT01465347|20497594|P1|Overall Study|Admitted to hospice|0
5925537|NCT01465347|20497593|P2|Overall Study|Physician Decision|1
5925538|NCT01465347|20497594|P1|Overall Study|Physician Decision|0
5925539|NCT01465347|20497593|P2|Overall Study|Withdrawal by Subject|1
5925540|NCT01465347|20497594|P1|Overall Study|Withdrawal by Subject|1
5925541|NCT01465334|20497606|P2|Overall Study|Refractory Disease|3
5925542|NCT01465334|20497607|P1|Overall Study|Refractory Disease|0
5925543|NCT01465334|20497606|P2|Overall Study|Richter's transformation|3
5925544|NCT01465334|20497607|P1|Overall Study|Richter's transformation|0
5925545|NCT01465334|20497606|P2|Overall Study|Adverse Event|0
5925546|NCT01465334|20497607|P1|Overall Study|Adverse Event|1
5925547|NCT01465334|20497606|P2|Overall Study|Disease Progression|0
5925548|NCT01465334|20497607|P1|Overall Study|Disease Progression|1
5925549|NCT01465230|20497633|P1|Overall Study|Withdrawal by Subject|2
5925550|NCT01465191|20497640|P3|Overall Study|Lost to Follow-up|4
5925551|NCT01465191|20497641|P2|Overall Study|Lost to Follow-up|6
5925552|NCT01465191|20497642|P1|Overall Study|Lost to Follow-up|3
5925553|NCT01465191|20497640|P3|Overall Study|Protocol Violation|3
5925554|NCT01465191|20497641|P2|Overall Study|Protocol Violation|3
5925555|NCT01465191|20497642|P1|Overall Study|Protocol Violation|6
5925556|NCT01465178|20497691|P2|Overall Study|Withdrawal by Subject|0
5925557|NCT01465178|20497692|P1|Overall Study|Withdrawal by Subject|1
5925558|NCT01465022|20497716|P3|Overall Study|Not Randomized|70
5925559|NCT01465022|20497717|P2|Overall Study|Not Randomized|0
5925560|NCT01465022|20497718|P1|Overall Study|Not Randomized|0
5925561|NCT01465022|20497716|P3|Overall Study|Breastfeeding discontinuation before 8 w|0
5925562|NCT01465022|20497717|P2|Overall Study|Breastfeeding discontinuation before 8 w|9
5925563|NCT01465022|20497718|P1|Overall Study|Breastfeeding discontinuation before 8 w|8
5925564|NCT01465022|20497716|P3|Overall Study|Lost to Follow-up|0
5925565|NCT01465022|20497717|P2|Overall Study|Lost to Follow-up|14
5925566|NCT01465022|20497718|P1|Overall Study|Lost to Follow-up|15
5925567|NCT01464931|20497752|P2|Overall Study|Withdrawal by Subject|0
5925568|NCT01464931|20497753|P1|Overall Study|Withdrawal by Subject|1
5925569|NCT01464879|20497790|P1|Overall Study|Non-compliance|1
5925570|NCT01464879|20497790|P1|Overall Study|Physician Decision|1
5925571|NCT01464827|20497851|P14|Overall Study|Not Treated|2
5925572|NCT01464827|20497852|P13|Overall Study|Not Treated|0
5925573|NCT01464827|20497853|P12|Overall Study|Not Treated|1
5925574|NCT01464827|20497854|P11|Overall Study|Not Treated|0
5925575|NCT01464827|20497855|P10|Overall Study|Not Treated|2
5925576|NCT01464827|20497856|P9|Overall Study|Not Treated|0
5925577|NCT01464827|20497857|P8|Overall Study|Not Treated|0
5925578|NCT01464827|20497858|P7|Overall Study|Not Treated|1
5925579|NCT01464827|20497859|P6|Overall Study|Not Treated|0
5925580|NCT01464827|20497860|P5|Overall Study|Not Treated|1
5925581|NCT01464827|20497861|P4|Overall Study|Not Treated|0
5925582|NCT01464827|20497862|P3|Overall Study|Not Treated|0
5925583|NCT01464827|20497863|P2|Overall Study|Not Treated|2
5925584|NCT01464827|20497864|P1|Overall Study|Not Treated|0
5925585|NCT01464827|20497851|P14|Overall Study|Other|0
5925586|NCT01464827|20497852|P13|Overall Study|Other|1
5925587|NCT01464827|20497853|P12|Overall Study|Other|0
5925588|NCT01464827|20497854|P11|Overall Study|Other|2
5925589|NCT01464827|20497855|P10|Overall Study|Other|1
5925590|NCT01464827|20497856|P9|Overall Study|Other|3
5925591|NCT01464827|20497857|P8|Overall Study|Other|0
5925592|NCT01464827|20497858|P7|Overall Study|Other|1
5925593|NCT01464827|20497859|P6|Overall Study|Other|0
5925594|NCT01464827|20497860|P5|Overall Study|Other|3
5925595|NCT01464827|20497861|P4|Overall Study|Other|2
5925596|NCT01464827|20497862|P3|Overall Study|Other|0
5925597|NCT01464827|20497863|P2|Overall Study|Other|3
5925598|NCT01464827|20497864|P1|Overall Study|Other|2
5925599|NCT01464827|20497851|P14|Overall Study|Lost to Follow-up|1
5925600|NCT01464827|20497852|P13|Overall Study|Lost to Follow-up|0
5925601|NCT01464827|20497853|P12|Overall Study|Lost to Follow-up|1
5925602|NCT01464827|20497854|P11|Overall Study|Lost to Follow-up|0
5925603|NCT01464827|20497855|P10|Overall Study|Lost to Follow-up|0
5925604|NCT01464827|20497856|P9|Overall Study|Lost to Follow-up|0
5925605|NCT01464827|20497857|P8|Overall Study|Lost to Follow-up|2
5925606|NCT01464827|20497858|P7|Overall Study|Lost to Follow-up|2
5925607|NCT01464827|20497859|P6|Overall Study|Lost to Follow-up|1
5925608|NCT01464827|20497860|P5|Overall Study|Lost to Follow-up|3
5925609|NCT01464827|20497861|P4|Overall Study|Lost to Follow-up|2
5925610|NCT01464827|20497862|P3|Overall Study|Lost to Follow-up|0
5925611|NCT01464827|20497863|P2|Overall Study|Lost to Follow-up|2
5925612|NCT01464827|20497864|P1|Overall Study|Lost to Follow-up|0
5925613|NCT01464827|20497851|P14|Overall Study|Withdrawal by Subject|0
5925614|NCT01464827|20497852|P13|Overall Study|Withdrawal by Subject|0
5925615|NCT01464827|20497853|P12|Overall Study|Withdrawal by Subject|0
5925616|NCT01464827|20497854|P11|Overall Study|Withdrawal by Subject|0
5925617|NCT01464827|20497855|P10|Overall Study|Withdrawal by Subject|0
5925618|NCT01464827|20497856|P9|Overall Study|Withdrawal by Subject|0
5925619|NCT01464827|20497857|P8|Overall Study|Withdrawal by Subject|1
5925620|NCT01464827|20497858|P7|Overall Study|Withdrawal by Subject|0
5925621|NCT01464827|20497859|P6|Overall Study|Withdrawal by Subject|0
5925622|NCT01464827|20497860|P5|Overall Study|Withdrawal by Subject|1
5925623|NCT01464827|20497861|P4|Overall Study|Withdrawal by Subject|0
5925624|NCT01464827|20497862|P3|Overall Study|Withdrawal by Subject|0
5925625|NCT01464827|20497863|P2|Overall Study|Withdrawal by Subject|0
5925626|NCT01464827|20497864|P1|Overall Study|Withdrawal by Subject|1
5925627|NCT01464827|20497851|P14|Overall Study|Adverse Event|0
5925628|NCT01464827|20497852|P13|Overall Study|Adverse Event|1
5925629|NCT01464827|20497853|P12|Overall Study|Adverse Event|0
5925630|NCT01464827|20497854|P11|Overall Study|Adverse Event|0
5925631|NCT01464827|20497855|P10|Overall Study|Adverse Event|0
5925632|NCT01464827|20497856|P9|Overall Study|Adverse Event|0
5925633|NCT01464827|20497857|P8|Overall Study|Adverse Event|0
5925634|NCT01464827|20497858|P7|Overall Study|Adverse Event|0
5925635|NCT01464827|20497859|P6|Overall Study|Adverse Event|0
5925636|NCT01464827|20497860|P5|Overall Study|Adverse Event|0
5925637|NCT01464827|20497861|P4|Overall Study|Adverse Event|0
5925638|NCT01464827|20497862|P3|Overall Study|Adverse Event|0
5925639|NCT01464827|20497863|P2|Overall Study|Adverse Event|0
5925640|NCT01464827|20497864|P1|Overall Study|Adverse Event|0
5925641|NCT01464788|20497911|P3|Overall Study|Patient had hemorrhage after tPA started|0
5925642|NCT01464788|20497912|P2|Overall Study|Patient had hemorrhage after tPA started|1
5925643|NCT01464788|20497913|P1|Overall Study|Patient had hemorrhage after tPA started|0
5925644|NCT01464788|20497911|P3|Overall Study|Lost to Follow-up|0
5925645|NCT01464788|20497912|P2|Overall Study|Lost to Follow-up|1
5925646|NCT01464788|20497913|P1|Overall Study|Lost to Follow-up|0
5925647|NCT01464619|20497999|P2|Overall Study|Lost to Follow-up|4
5925648|NCT01464619|20498000|P1|Overall Study|Lost to Follow-up|3
5925649|NCT01464424|20498020|P2|Period 1, First 6 Weeks|Adverse Event|1
5925650|NCT01464424|20498021|P1|Period 1, First 6 Weeks|Adverse Event|0
5925651|NCT01464346|20498041|P3|Overall Study|Withdrawal by Subject|1
5925652|NCT01464346|20498042|P2|Overall Study|Withdrawal by Subject|0
5925653|NCT01464346|20498043|P1|Overall Study|Withdrawal by Subject|0
5925654|NCT01464333|20498052|P1|Overall Study|No Hospital Visit|42
5925655|NCT01464333|20498052|P1|Overall Study|Other|4
5925656|NCT01464333|20498052|P1|Overall Study|Withdrawal by Subject|11
5925657|NCT01464333|20498052|P1|Overall Study|Lack of Efficacy|72
5925658|NCT01464333|20498052|P1|Overall Study|Adverse Event|34
5925659|NCT01464307|20498065|P2|Open-Label Extension Period|Predefined discontinuation criteria|0
5925660|NCT01464307|20498066|P1|Open-Label Extension Period|Predefined discontinuation criteria|6
5925661|NCT01464307|20498065|P2|Open-Label Extension Period|Non-compliance|0
5925662|NCT01464307|20498066|P1|Open-Label Extension Period|Non-compliance|9
5925663|NCT01464307|20498065|P2|Open-Label Extension Period|Lost to Follow-up|0
5925664|NCT01464307|20498066|P1|Open-Label Extension Period|Lost to Follow-up|1
5925665|NCT01464307|20498065|P2|Open-Label Extension Period|Death|0
5925666|NCT01464307|20498066|P1|Open-Label Extension Period|Death|1
5925667|NCT01464307|20498065|P2|Open-Label Extension Period|Lack of Efficacy|0
5925668|NCT01464307|20498066|P1|Open-Label Extension Period|Lack of Efficacy|5
5925669|NCT01464307|20498065|P2|Open-Label Extension Period|Withdrawal by Subject|0
5925670|NCT01464307|20498066|P1|Open-Label Extension Period|Withdrawal by Subject|14
5925671|NCT01464307|20498065|P2|Open-Label Extension Period|Adverse Event|0
5925672|NCT01464307|20498066|P1|Open-Label Extension Period|Adverse Event|15
5925673|NCT01464307|20498065|P2|Main Period|Predefined discontinuation criteria|1
5925674|NCT01464307|20498066|P1|Main Period|Predefined discontinuation criteria|2
5925675|NCT01464307|20498065|P2|Main Period|Withdrawal by Subject|2
5925676|NCT01464307|20498066|P1|Main Period|Withdrawal by Subject|5
5925677|NCT01464307|20498065|P2|Main Period|Lack of Efficacy|0
5925678|NCT01464307|20498066|P1|Main Period|Lack of Efficacy|2
5925679|NCT01464307|20498065|P2|Main Period|Adverse Event|1
5925680|NCT01464307|20498066|P1|Main Period|Adverse Event|6
5925681|NCT01464307|20498065|P2|Main Period|Death|1
5925682|NCT01464307|20498066|P1|Main Period|Death|0
5925683|NCT01464255|20498081|P2|Overall Study|unresolve corneal staining|1
5925684|NCT01464255|20498082|P1|Overall Study|unresolve corneal staining|0
5925685|NCT01464021|20498127|P1|Overall Study|various|11
5925686|NCT01464021|20498127|P1|Overall Study|Lack of Efficacy|1
5925687|NCT01464021|20498127|P1|Overall Study|Lost to Follow-up|1
5925688|NCT01464021|20498127|P1|Overall Study|Withdrawal by Subject|13
5925689|NCT01463982|20498143|P4|Overall Study|Treatment delay over 5 week|0
5925690|NCT01463982|20498144|P3|Overall Study|Treatment delay over 5 week|1
5925691|NCT01463982|20498145|P2|Overall Study|Treatment delay over 5 week|0
5925692|NCT01463982|20498146|P1|Overall Study|Treatment delay over 5 week|0
5925693|NCT01463982|20498143|P4|Overall Study|Withdrawal by Subject|0
5925694|NCT01463982|20498144|P3|Overall Study|Withdrawal by Subject|1
5925695|NCT01463982|20498145|P2|Overall Study|Withdrawal by Subject|1
5925696|NCT01463982|20498146|P1|Overall Study|Withdrawal by Subject|0
5925697|NCT01463878|20498162|P2|Overall Study|no longer met criteria for tube feed|2
5925698|NCT01463878|20498163|P1|Overall Study|no longer met criteria for tube feed|2
5925699|NCT01463696|20498177|P8|Overall Study|Not Treated|0
5925700|NCT01463696|20498178|P7|Overall Study|Not Treated|1
5925701|NCT01463696|20498179|P6|Overall Study|Not Treated|0
5925702|NCT01463696|20498180|P5|Overall Study|Not Treated|0
5925703|NCT01463696|20498181|P4|Overall Study|Not Treated|0
5925704|NCT01463696|20498182|P3|Overall Study|Not Treated|0
5925705|NCT01463696|20498183|P2|Overall Study|Not Treated|0
5925706|NCT01463696|20498184|P1|Overall Study|Not Treated|0
5925707|NCT01463696|20498177|P8|Overall Study|Withdrawal by Subject|0
5925708|NCT01463696|20498178|P7|Overall Study|Withdrawal by Subject|2
5925709|NCT01463696|20498179|P6|Overall Study|Withdrawal by Subject|1
5925710|NCT01463696|20498180|P5|Overall Study|Withdrawal by Subject|1
5925711|NCT01463696|20498181|P4|Overall Study|Withdrawal by Subject|1
5925712|NCT01463696|20498182|P3|Overall Study|Withdrawal by Subject|0
5925713|NCT01463696|20498183|P2|Overall Study|Withdrawal by Subject|0
5925714|NCT01463696|20498184|P1|Overall Study|Withdrawal by Subject|0
5925715|NCT01463696|20498177|P8|Overall Study|Progressive Disease|2
5925716|NCT01463696|20498178|P7|Overall Study|Progressive Disease|4
5925717|NCT01463696|20498179|P6|Overall Study|Progressive Disease|1
5925718|NCT01463696|20498180|P5|Overall Study|Progressive Disease|0
5925719|NCT01463696|20498181|P4|Overall Study|Progressive Disease|1
5925720|NCT01463696|20498182|P3|Overall Study|Progressive Disease|0
5925721|NCT01463696|20498183|P2|Overall Study|Progressive Disease|1
5925722|NCT01463696|20498184|P1|Overall Study|Progressive Disease|0
5925723|NCT01463696|20498177|P8|Overall Study|Lost to Follow-up|0
5925724|NCT01463696|20498178|P7|Overall Study|Lost to Follow-up|0
5925725|NCT01463696|20498179|P6|Overall Study|Lost to Follow-up|0
5925726|NCT01463696|20498180|P5|Overall Study|Lost to Follow-up|0
5925727|NCT01463696|20498181|P4|Overall Study|Lost to Follow-up|0
5925728|NCT01463696|20498182|P3|Overall Study|Lost to Follow-up|1
5925729|NCT01463696|20498183|P2|Overall Study|Lost to Follow-up|0
5925730|NCT01463696|20498184|P1|Overall Study|Lost to Follow-up|0
5925731|NCT01463696|20498177|P8|Overall Study|Adverse Event|2
5925732|NCT01463696|20498178|P7|Overall Study|Adverse Event|3
5925733|NCT01463696|20498179|P6|Overall Study|Adverse Event|1
5925734|NCT01463696|20498180|P5|Overall Study|Adverse Event|0
5925735|NCT01463696|20498181|P4|Overall Study|Adverse Event|2
5925736|NCT01463696|20498182|P3|Overall Study|Adverse Event|0
5925737|NCT01463696|20498183|P2|Overall Study|Adverse Event|1
5925738|NCT01463696|20498184|P1|Overall Study|Adverse Event|0
5925739|NCT01463683|20498237|P3|Overall Study|Withdrawal by Subject|2
5925740|NCT01463683|20498238|P2|Overall Study|Withdrawal by Subject|17
5925741|NCT01463683|20498239|P1|Overall Study|Withdrawal by Subject|5
5925742|NCT01463683|20498237|P3|Overall Study|Pregnancy|1
5925743|NCT01463683|20498238|P2|Overall Study|Pregnancy|2
5925744|NCT01463683|20498239|P1|Overall Study|Pregnancy|2
5925745|NCT01463683|20498237|P3|Overall Study|Physician Decision|1
5925746|NCT01463683|20498238|P2|Overall Study|Physician Decision|3
5925747|NCT01463683|20498239|P1|Overall Study|Physician Decision|0
5925748|NCT01463683|20498237|P3|Overall Study|Lost to Follow-up|7
5925749|NCT01463683|20498238|P2|Overall Study|Lost to Follow-up|9
5925750|NCT01463683|20498239|P1|Overall Study|Lost to Follow-up|10
5925751|NCT01463683|20498237|P3|Overall Study|Adverse Event|0
5925752|NCT01463683|20498238|P2|Overall Study|Adverse Event|0
5925753|NCT01463683|20498239|P1|Overall Study|Adverse Event|2
5925754|NCT01463631|20498256|P4|Overall Study|Progressive Disease|5
5925755|NCT01463631|20498257|P3|Overall Study|Progressive Disease|0
5925756|NCT01463631|20498258|P2|Overall Study|Progressive Disease|0
5925757|NCT01463631|20498259|P1|Overall Study|Progressive Disease|0
5925758|NCT01463631|20498256|P4|Overall Study|Death|0
5925759|NCT01463631|20498257|P3|Overall Study|Death|1
5925760|NCT01463631|20498258|P2|Overall Study|Death|0
5925761|NCT01463631|20498259|P1|Overall Study|Death|0
5925762|NCT01463631|20498256|P4|Overall Study|Withdrawal by Subject|1
5925763|NCT01463631|20498257|P3|Overall Study|Withdrawal by Subject|0
5925764|NCT01463631|20498258|P2|Overall Study|Withdrawal by Subject|0
5925765|NCT01463631|20498259|P1|Overall Study|Withdrawal by Subject|0
5925766|NCT01463527|20498281|P2|Overall Study|Crying >20% of sedation|6
5925767|NCT01463527|20498282|P1|Overall Study|Crying >20% of sedation|5
5925768|NCT01463527|20498281|P2|Overall Study|Protocol Violation|1
5925769|NCT01463527|20498282|P1|Overall Study|Protocol Violation|1
5925770|NCT01463306|20498305|P3|Overall Study|Approval expiry at site|0
5925771|NCT01463306|20498306|P2|Overall Study|Approval expiry at site|0
5925772|NCT01463306|20498307|P1|Overall Study|Approval expiry at site|1
5925773|NCT01463306|20498305|P3|Overall Study|Other|0
5925774|NCT01463306|20498306|P2|Overall Study|Other|13
5925775|NCT01463306|20498307|P1|Overall Study|Other|26
5925776|NCT01463306|20498305|P3|Overall Study|Withdrawal by Subject|1
5925777|NCT01463306|20498306|P2|Overall Study|Withdrawal by Subject|9
5925778|NCT01463306|20498307|P1|Overall Study|Withdrawal by Subject|19
5925779|NCT01463306|20498305|P3|Overall Study|Protocol Violation|0
5925780|NCT01463306|20498306|P2|Overall Study|Protocol Violation|0
5925781|NCT01463306|20498307|P1|Overall Study|Protocol Violation|4
5925782|NCT01463306|20498305|P3|Overall Study|Lost to Follow-up|0
5925783|NCT01463306|20498306|P2|Overall Study|Lost to Follow-up|2
5925784|NCT01463306|20498307|P1|Overall Study|Lost to Follow-up|5
5925785|NCT01463306|20498305|P3|Overall Study|Lack of Efficacy|1
5925786|NCT01463306|20498306|P2|Overall Study|Lack of Efficacy|16
5925787|NCT01463306|20498307|P1|Overall Study|Lack of Efficacy|22
5925788|NCT01463306|20498305|P3|Overall Study|Death|0
5925789|NCT01463306|20498306|P2|Overall Study|Death|3
5925790|NCT01463306|20498307|P1|Overall Study|Death|3
5925791|NCT01463306|20498305|P3|Overall Study|Adverse Event|3
5925792|NCT01463306|20498306|P2|Overall Study|Adverse Event|9
5925793|NCT01463306|20498307|P1|Overall Study|Adverse Event|6
5925794|NCT01463293|20498378|P3|Overall Study|Other|2
5925795|NCT01463293|20498379|P2|Overall Study|Other|0
5925796|NCT01463293|20498380|P1|Overall Study|Other|0
5925797|NCT01463293|20498378|P3|Overall Study|Withdrawal by Subject|5
5925798|NCT01463293|20498379|P2|Overall Study|Withdrawal by Subject|10
5925799|NCT01463293|20498380|P1|Overall Study|Withdrawal by Subject|4
5925800|NCT01463293|20498378|P3|Overall Study|Adverse Event|0
5925801|NCT01463293|20498379|P2|Overall Study|Adverse Event|2
5925802|NCT01463293|20498380|P1|Overall Study|Adverse Event|1
5925803|NCT01463293|20498378|P3|Overall Study|Lost to Follow-up|5
5925804|NCT01463293|20498379|P2|Overall Study|Lost to Follow-up|4
5925805|NCT01463293|20498380|P1|Overall Study|Lost to Follow-up|1
5925806|NCT01463111|20498424|P1|Overall Study|Physician Decision|2
5925807|NCT01463111|20498424|P1|Overall Study|Lost to Follow-up|5
5925808|NCT01463111|20498424|P1|Overall Study|Withdrawal by Subject|2
5925809|NCT01463098|20498446|P14|Part B (11 Days)|Participant Choice|0
5925810|NCT01463098|20498447|P13|Part B (11 Days)|Participant Choice|0
5925811|NCT01463098|20498448|P12|Part B (11 Days)|Participant Choice|1
5925812|NCT01463098|20498449|P11|Part B (11 Days)|Participant Choice|0
5925813|NCT01463098|20498450|P10|Part B (11 Days)|Participant Choice|0
5925814|NCT01463098|20498451|P9|Part B (11 Days)|Participant Choice|0
5925815|NCT01463098|20498452|P8|Part B (11 Days)|Participant Choice|0
5925816|NCT01463098|20498453|P7|Part B (11 Days)|Participant Choice|0
5925817|NCT01463098|20498454|P6|Part B (11 Days)|Participant Choice|0
5925818|NCT01463098|20498455|P5|Part B (11 Days)|Participant Choice|0
5925819|NCT01463098|20498456|P4|Part B (11 Days)|Participant Choice|0
5925820|NCT01463098|20498457|P3|Part B (11 Days)|Participant Choice|0
5925821|NCT01463098|20498458|P2|Part B (11 Days)|Participant Choice|0
5925822|NCT01463098|20498459|P1|Part B (11 Days)|Participant Choice|0
5925823|NCT01463098|20498446|P14|Part A (11 Days)|Lost to Follow-up|0
5925824|NCT01463098|20498447|P13|Part A (11 Days)|Lost to Follow-up|0
5925825|NCT01463098|20498448|P12|Part A (11 Days)|Lost to Follow-up|0
5925826|NCT01463098|20498449|P11|Part A (11 Days)|Lost to Follow-up|0
5925827|NCT01463098|20498450|P10|Part A (11 Days)|Lost to Follow-up|0
5925828|NCT01463098|20498451|P9|Part A (11 Days)|Lost to Follow-up|0
5925829|NCT01463098|20498452|P8|Part A (11 Days)|Lost to Follow-up|0
5925830|NCT01463098|20498453|P7|Part A (11 Days)|Lost to Follow-up|0
5925831|NCT01463098|20498454|P6|Part A (11 Days)|Lost to Follow-up|0
5925832|NCT01463098|20498455|P5|Part A (11 Days)|Lost to Follow-up|1
5925833|NCT01463098|20498456|P4|Part A (11 Days)|Lost to Follow-up|0
5925834|NCT01463098|20498457|P3|Part A (11 Days)|Lost to Follow-up|0
5925835|NCT01463098|20498458|P2|Part A (11 Days)|Lost to Follow-up|0
5925836|NCT01463098|20498459|P1|Part A (11 Days)|Lost to Follow-up|0
5925837|NCT01463098|20498446|P14|Part A (11 Days)|Participant Choice|0
5925838|NCT01463098|20498447|P13|Part A (11 Days)|Participant Choice|0
5925839|NCT01463098|20498448|P12|Part A (11 Days)|Participant Choice|0
5925840|NCT01463098|20498449|P11|Part A (11 Days)|Participant Choice|0
5925841|NCT01463098|20498450|P10|Part A (11 Days)|Participant Choice|0
5925842|NCT01463098|20498451|P9|Part A (11 Days)|Participant Choice|1
5925843|NCT01463098|20498452|P8|Part A (11 Days)|Participant Choice|0
5925844|NCT01463098|20498453|P7|Part A (11 Days)|Participant Choice|0
5925845|NCT01463098|20498454|P6|Part A (11 Days)|Participant Choice|0
5925846|NCT01463098|20498455|P5|Part A (11 Days)|Participant Choice|0
5925847|NCT01463098|20498456|P4|Part A (11 Days)|Participant Choice|0
5925848|NCT01463098|20498457|P3|Part A (11 Days)|Participant Choice|0
5925849|NCT01463098|20498458|P2|Part A (11 Days)|Participant Choice|0
5925850|NCT01463098|20498459|P1|Part A (11 Days)|Participant Choice|2
5925851|NCT01463033|20498782|P2|Overall Study|Death|2
5925852|NCT01463033|20498783|P1|Overall Study|Death|3
5925853|NCT01463033|20498782|P2|Overall Study|Lost to Follow-up|4
5925854|NCT01463033|20498783|P1|Overall Study|Lost to Follow-up|4
5925855|NCT01463007|20498790|P1|Overall Study|Physician Decision|1
5925856|NCT01462942|20498801|P5|Overall Study|Protocol Violation|6
5925857|NCT01462942|20498802|P4|Overall Study|Protocol Violation|9
5925858|NCT01462942|20498803|P3|Overall Study|Protocol Violation|9
5925859|NCT01462942|20498804|P2|Overall Study|Protocol Violation|6
5925860|NCT01462942|20498805|P1|Overall Study|Protocol Violation|4
5925861|NCT01462942|20498801|P5|Overall Study|Lost to Follow-up|1
5925862|NCT01462942|20498802|P4|Overall Study|Lost to Follow-up|1
5925863|NCT01462942|20498803|P3|Overall Study|Lost to Follow-up|1
5925864|NCT01462942|20498804|P2|Overall Study|Lost to Follow-up|1
5925865|NCT01462942|20498805|P1|Overall Study|Lost to Follow-up|0
5925866|NCT01462942|20498801|P5|Overall Study|Lack of Efficacy|3
5925867|NCT01462942|20498802|P4|Overall Study|Lack of Efficacy|5
5925868|NCT01462942|20498803|P3|Overall Study|Lack of Efficacy|4
5925869|NCT01462942|20498804|P2|Overall Study|Lack of Efficacy|0
5925870|NCT01462942|20498805|P1|Overall Study|Lack of Efficacy|6
5925871|NCT01462942|20498801|P5|Overall Study|Withdrawal by Subject|19
5925872|NCT01462942|20498802|P4|Overall Study|Withdrawal by Subject|16
5925873|NCT01462942|20498803|P3|Overall Study|Withdrawal by Subject|14
5925874|NCT01462942|20498804|P2|Overall Study|Withdrawal by Subject|10
5925875|NCT01462942|20498805|P1|Overall Study|Withdrawal by Subject|14
5925876|NCT01462942|20498801|P5|Overall Study|Other, including COPD exacerbation|5
5925877|NCT01462942|20498802|P4|Overall Study|Other, including COPD exacerbation|8
5925878|NCT01462942|20498803|P3|Overall Study|Other, including COPD exacerbation|2
5925879|NCT01462942|20498804|P2|Overall Study|Other, including COPD exacerbation|5
5925880|NCT01462942|20498805|P1|Overall Study|Other, including COPD exacerbation|3
5925881|NCT01462942|20498801|P5|Overall Study|Adverse Event|11
5925882|NCT01462942|20498802|P4|Overall Study|Adverse Event|11
5925883|NCT01462942|20498803|P3|Overall Study|Adverse Event|10
5925884|NCT01462942|20498804|P2|Overall Study|Adverse Event|12
5925885|NCT01462942|20498805|P1|Overall Study|Adverse Event|7
5925886|NCT01462929|20498835|P3|Overall Study|Lack of Efficacy|1
5925887|NCT01462929|20498836|P2|Overall Study|Lack of Efficacy|0
5925888|NCT01462929|20498837|P1|Overall Study|Lack of Efficacy|0
5925889|NCT01462929|20498835|P3|Overall Study|Withdrawal by Subject|0
5925890|NCT01462929|20498836|P2|Overall Study|Withdrawal by Subject|1
5925891|NCT01462929|20498837|P1|Overall Study|Withdrawal by Subject|2
5925892|NCT01462929|20498835|P3|Overall Study|Adverse Event|4
5925893|NCT01462929|20498836|P2|Overall Study|Adverse Event|3
5925894|NCT01462929|20498837|P1|Overall Study|Adverse Event|3
5925895|NCT01462695|20498878|P2|Overall Study|Inevaluable (did not receive study drug)|0
5925896|NCT01462695|20498879|P1|Overall Study|Inevaluable (did not receive study drug)|1
5925897|NCT01462695|20498878|P2|Overall Study|Withdrawal by Subject|0
5925898|NCT01462695|20498879|P1|Overall Study|Withdrawal by Subject|2
5925899|NCT01462695|20498878|P2|Overall Study|Physician Decision|0
5925900|NCT01462695|20498879|P1|Overall Study|Physician Decision|5
5925901|NCT01462695|20498878|P2|Overall Study|Lack of Efficacy|12
5925902|NCT01462695|20498879|P1|Overall Study|Lack of Efficacy|6
5925903|NCT01462695|20498878|P2|Overall Study|Death|0
5925904|NCT01462695|20498879|P1|Overall Study|Death|2
5925905|NCT01462695|20498878|P2|Overall Study|Adverse Event|1
5925906|NCT01462695|20498879|P1|Overall Study|Adverse Event|1
5925907|NCT01462435|20498907|P4|Overall Study|Lost to Follow-up|1
5925908|NCT01462435|20498908|P3|Overall Study|Lost to Follow-up|0
5925909|NCT01462435|20498909|P2|Overall Study|Lost to Follow-up|0
5925910|NCT01462435|20498910|P1|Overall Study|Lost to Follow-up|0
5925911|NCT01462435|20498907|P4|Overall Study|Withdrawal by Subject|1
5925912|NCT01462435|20498908|P3|Overall Study|Withdrawal by Subject|0
5925913|NCT01462435|20498909|P2|Overall Study|Withdrawal by Subject|0
5925914|NCT01462435|20498910|P1|Overall Study|Withdrawal by Subject|0
5925915|NCT01462435|20498907|P4|Overall Study|Physician Decision|0
5925916|NCT01462435|20498908|P3|Overall Study|Physician Decision|1
5925917|NCT01462435|20498909|P2|Overall Study|Physician Decision|0
5925918|NCT01462435|20498910|P1|Overall Study|Physician Decision|0
5925919|NCT01462435|20498907|P4|Overall Study|Lack of Efficacy|3
5925920|NCT01462435|20498908|P3|Overall Study|Lack of Efficacy|0
5925921|NCT01462435|20498909|P2|Overall Study|Lack of Efficacy|0
5925922|NCT01462435|20498910|P1|Overall Study|Lack of Efficacy|1
5925923|NCT01462370|20498948|P2|Overall Study|Withdrawal by Subject|3
5925924|NCT01462370|20498949|P1|Overall Study|Withdrawal by Subject|0
5925925|NCT01462370|20498948|P2|Overall Study|Physician Decision|1
5925926|NCT01462370|20498949|P1|Overall Study|Physician Decision|0
5925927|NCT01462370|20498948|P2|Overall Study|Lack of Qualifying Event|1
5925928|NCT01462370|20498949|P1|Overall Study|Lack of Qualifying Event|1
5925929|NCT01462357|20498984|P3|Overall Study|Lost to Follow-up|7
5925930|NCT01462357|20498985|P2|Overall Study|Lost to Follow-up|5
5925931|NCT01462357|20498986|P1|Overall Study|Lost to Follow-up|3
5925932|NCT01462357|20498984|P3|Overall Study|Migrated/moved from study area|1
5925933|NCT01462357|20498985|P2|Overall Study|Migrated/moved from study area|3
5925934|NCT01462357|20498986|P1|Overall Study|Migrated/moved from study area|2
5925935|NCT01462357|20498984|P3|Overall Study|Withdrawal by Subject|3
5925936|NCT01462357|20498985|P2|Overall Study|Withdrawal by Subject|11
5925937|NCT01462357|20498986|P1|Overall Study|Withdrawal by Subject|3
5925938|NCT01462357|20498984|P3|Overall Study|Death|1
5925939|NCT01462357|20498985|P2|Overall Study|Death|0
5925940|NCT01462357|20498986|P1|Overall Study|Death|0
5925941|NCT01462344|20499059|P2|Overall Study|Lost to Follow-up|7
5925942|NCT01462344|20499060|P1|Overall Study|Lost to Follow-up|7
5925943|NCT01462344|20499059|P2|Overall Study|Protocol Violation|53
5925944|NCT01462344|20499060|P1|Overall Study|Protocol Violation|68
5925945|NCT01462344|20499059|P2|Overall Study|Lack of Efficacy|6
5925946|NCT01462344|20499060|P1|Overall Study|Lack of Efficacy|5
5925947|NCT01462344|20499059|P2|Overall Study|Asthma Exacerbation|35
5925948|NCT01462344|20499060|P1|Overall Study|Asthma Exacerbation|34
5925949|NCT01462344|20499059|P2|Overall Study|Adverse Event|23
5925950|NCT01462344|20499060|P1|Overall Study|Adverse Event|24
5925951|NCT01462344|20499059|P2|Overall Study|Withdrawal by Subject|226
5925952|NCT01462344|20499060|P1|Overall Study|Withdrawal by Subject|245
5925953|NCT01462318|20499082|P3|Extension Phase|Adverse Event|22
5925954|NCT01462318|20499083|P2|Extension Phase|Adverse Event|0
5925955|NCT01462318|20499084|P1|Extension Phase|Adverse Event|0
5925956|NCT01462318|20499082|P3|Extension Phase|Investigator Decision|5
5925957|NCT01462318|20499083|P2|Extension Phase|Investigator Decision|0
5925958|NCT01462318|20499084|P1|Extension Phase|Investigator Decision|0
5925959|NCT01462318|20499082|P3|Extension Phase|Withdrawal by Subject|15
5925960|NCT01462318|20499083|P2|Extension Phase|Withdrawal by Subject|0
5925961|NCT01462318|20499084|P1|Extension Phase|Withdrawal by Subject|0
5925962|NCT01462318|20499082|P3|Extension Phase|Disease Progression|1
5925963|NCT01462318|20499083|P2|Extension Phase|Disease Progression|0
5925964|NCT01462318|20499084|P1|Extension Phase|Disease Progression|0
5925965|NCT01462318|20499082|P3|Extension Phase|Other|1
5925966|NCT01462318|20499083|P2|Extension Phase|Other|0
5925967|NCT01462318|20499084|P1|Extension Phase|Other|0
5925968|NCT01462318|20499082|P3|Extension Phase|Lost to Follow-up|1
5925969|NCT01462318|20499083|P2|Extension Phase|Lost to Follow-up|0
5925970|NCT01462318|20499084|P1|Extension Phase|Lost to Follow-up|0
5925971|NCT01462318|20499082|P3|Main Study / TP-DI Study|Adverse Event|0
5925972|NCT01462318|20499083|P2|Main Study / TP-DI Study|Adverse Event|0
5925973|NCT01462318|20499084|P1|Main Study / TP-DI Study|Adverse Event|4
5925974|NCT01462318|20499082|P3|Main Study / TP-DI Study|Withdrawal by Subject|0
5925975|NCT01462318|20499083|P2|Main Study / TP-DI Study|Withdrawal by Subject|0
5925976|NCT01462318|20499084|P1|Main Study / TP-DI Study|Withdrawal by Subject|2
5925977|NCT01462318|20499082|P3|Main Study / TP-DI Study|Other|0
5925978|NCT01462318|20499083|P2|Main Study / TP-DI Study|Other|0
5925979|NCT01462318|20499084|P1|Main Study / TP-DI Study|Other|2
5925980|NCT01462266|20499185|P2|Overall Study|Screen failure|1
5925981|NCT01462266|20499186|P1|Overall Study|Screen failure|1
5925982|NCT01462266|20499185|P2|Overall Study|Withdrawal by Subject|2
5925983|NCT01462266|20499186|P1|Overall Study|Withdrawal by Subject|7
5925984|NCT01462266|20499185|P2|Overall Study|Protocol Violation|3
5925985|NCT01462266|20499186|P1|Overall Study|Protocol Violation|1
5925986|NCT01462266|20499185|P2|Overall Study|Physician Decision|5
5925987|NCT01462266|20499186|P1|Overall Study|Physician Decision|2
5925988|NCT01462266|20499185|P2|Overall Study|Creatinine and eGFR, excluded medication|4
5925989|NCT01462266|20499186|P1|Overall Study|Creatinine and eGFR, excluded medication|8
5925990|NCT01462266|20499185|P2|Overall Study|Non-compliance with study drug|0
5925991|NCT01462266|20499186|P1|Overall Study|Non-compliance with study drug|3
5925992|NCT01462266|20499185|P2|Overall Study|Lost to Follow-up|3
5925993|NCT01462266|20499186|P1|Overall Study|Lost to Follow-up|4
5925994|NCT01462266|20499185|P2|Overall Study|Lack of Efficacy|2
5925995|NCT01462266|20499186|P1|Overall Study|Lack of Efficacy|0
5925996|NCT01462266|20499185|P2|Overall Study|Death|1
5925997|NCT01462266|20499186|P1|Overall Study|Death|2
5925998|NCT01462266|20499185|P2|Overall Study|Adverse Event|6
5925999|NCT01462266|20499186|P1|Overall Study|Adverse Event|7
5926000|NCT01462227|20499211|P4|Second Assignment|Protocol Violation|0
5926001|NCT01462227|20499212|P3|Second Assignment|Protocol Violation|1
5926002|NCT01462227|20499213|P2|Second Assignment|Protocol Violation|1
5926003|NCT01462227|20499214|P1|Second Assignment|Protocol Violation|0
5926004|NCT01462227|20499211|P4|Second Assignment|Lost to Follow-up|0
5926005|NCT01462227|20499212|P3|Second Assignment|Lost to Follow-up|0
5926006|NCT01462227|20499213|P2|Second Assignment|Lost to Follow-up|0
5926007|NCT01462227|20499214|P1|Second Assignment|Lost to Follow-up|1
5926008|NCT01462162|20499232|P1|Overall Study|Other|2
5926009|NCT01462162|20499232|P1|Overall Study|Abnormal laboratory parameters|1
5926010|NCT01462162|20499232|P1|Overall Study|Lack of Efficacy|4
5926011|NCT01462162|20499232|P1|Overall Study|Adverse Event|5
5926012|NCT01462110|20499259|P2|Overall Study|Adverse Event|0
5926013|NCT01462110|20499260|P1|Overall Study|Adverse Event|1
5926014|NCT01462084|20499280|P2|Overall Study|Protocol Violation|1
5926015|NCT01462084|20499281|P1|Overall Study|Protocol Violation|1
5926016|NCT01462084|20499280|P2|Overall Study|Withdrawal by Subject|0
5926017|NCT01462084|20499281|P1|Overall Study|Withdrawal by Subject|1
5926018|NCT01462045|20499292|P3|Overall Study|Family matter|0
5926019|NCT01462045|20499293|P2|Overall Study|Family matter|1
5926020|NCT01462045|20499294|P1|Overall Study|Family matter|0
5926021|NCT01461993|20499308|P3|Overall Study|Other|6
5926022|NCT01461993|20499309|P2|Overall Study|Other|15
5926023|NCT01461993|20499310|P1|Overall Study|Other|13
5926024|NCT01461993|20499308|P3|Overall Study|Did not meet entrance criteria|0
5926025|NCT01461993|20499309|P2|Overall Study|Did not meet entrance criteria|3
5926026|NCT01461993|20499310|P1|Overall Study|Did not meet entrance criteria|2
5926027|NCT01461993|20499308|P3|Overall Study|No longer met eligibility criteria|10
5926028|NCT01461993|20499309|P2|Overall Study|No longer met eligibility criteria|18
5926029|NCT01461993|20499310|P1|Overall Study|No longer met eligibility criteria|13
5926030|NCT01461993|20499308|P3|Overall Study|Adverse Event|3
5926031|NCT01461993|20499309|P2|Overall Study|Adverse Event|11
5926032|NCT01461993|20499310|P1|Overall Study|Adverse Event|9
5926033|NCT01461993|20499308|P3|Overall Study|Protocol Violation|7
5926034|NCT01461993|20499309|P2|Overall Study|Protocol Violation|9
5926035|NCT01461993|20499310|P1|Overall Study|Protocol Violation|10
5926036|NCT01461993|20499308|P3|Overall Study|Lost to Follow-up|22
5926037|NCT01461993|20499309|P2|Overall Study|Lost to Follow-up|48
5926038|NCT01461993|20499310|P1|Overall Study|Lost to Follow-up|44
5926039|NCT01461993|20499308|P3|Overall Study|Withdrawal by Subject|16
5926040|NCT01461993|20499309|P2|Overall Study|Withdrawal by Subject|53
5926041|NCT01461993|20499310|P1|Overall Study|Withdrawal by Subject|60
5926042|NCT01461980|20499335|P3|Overall Study|Randomized but not vaccinated|7
5926043|NCT01461980|20499336|P2|Overall Study|Randomized but not vaccinated|8
5926044|NCT01461980|20499337|P1|Overall Study|Randomized but not vaccinated|4
5926045|NCT01461980|20499335|P3|Overall Study|No longer willing to participate|54
5926046|NCT01461980|20499336|P2|Overall Study|No longer willing to participate|38
5926047|NCT01461980|20499337|P1|Overall Study|No longer willing to participate|52
5926048|NCT01461980|20499335|P3|Overall Study|Lost to Follow-up|51
5926049|NCT01461980|20499336|P2|Overall Study|Lost to Follow-up|53
5926050|NCT01461980|20499337|P1|Overall Study|Lost to Follow-up|52
5926051|NCT01461980|20499335|P3|Overall Study|No longer meets eligibility criteria|19
5926052|NCT01461980|20499336|P2|Overall Study|No longer meets eligibility criteria|9
5926053|NCT01461980|20499337|P1|Overall Study|No longer meets eligibility criteria|18
5926054|NCT01461980|20499335|P3|Overall Study|Protocol Violation|16
5926055|NCT01461980|20499336|P2|Overall Study|Protocol Violation|19
5926056|NCT01461980|20499337|P1|Overall Study|Protocol Violation|12
5926057|NCT01461980|20499335|P3|Overall Study|Adverse Event|6
5926058|NCT01461980|20499336|P2|Overall Study|Adverse Event|5
5926059|NCT01461980|20499337|P1|Overall Study|Adverse Event|12
5926060|NCT01461980|20499335|P3|Overall Study|Medication error|6
5926061|NCT01461980|20499336|P2|Overall Study|Medication error|5
5926062|NCT01461980|20499337|P1|Overall Study|Medication error|7
5926063|NCT01461980|20499335|P3|Overall Study|Other|6
5926064|NCT01461980|20499336|P2|Overall Study|Other|8
5926065|NCT01461980|20499337|P1|Overall Study|Other|9
5926066|NCT01461928|20499367|P3|Maintenance II (15 Months)|Refused to be transferred to other site|1
5926067|NCT01461928|20499368|P2|Maintenance II (15 Months)|Refused to be transferred to other site|0
5926068|NCT01461928|20499369|P1|Maintenance II (15 Months)|Refused to be transferred to other site|0
5926069|NCT01461928|20499367|P3|Maintenance II (15 Months)|Withdrew informed consent|1
5926070|NCT01461928|20499368|P2|Maintenance II (15 Months)|Withdrew informed consent|0
5926071|NCT01461928|20499369|P1|Maintenance II (15 Months)|Withdrew informed consent|0
5926072|NCT01461928|20499367|P3|Maintenance II (15 Months)|Squamous lung carcinoma|1
5926073|NCT01461928|20499368|P2|Maintenance II (15 Months)|Squamous lung carcinoma|0
5926074|NCT01461928|20499369|P1|Maintenance II (15 Months)|Squamous lung carcinoma|0
5926075|NCT01461928|20499367|P3|Maintenance II (15 Months)|Changed physician in another hospital|1
5926076|NCT01461928|20499368|P2|Maintenance II (15 Months)|Changed physician in another hospital|0
5926077|NCT01461928|20499369|P1|Maintenance II (15 Months)|Changed physician in another hospital|0
5926078|NCT01461928|20499367|P3|Maintenance II (15 Months)|Withdrawal by Subject|8
5926079|NCT01461928|20499368|P2|Maintenance II (15 Months)|Withdrawal by Subject|9
5926080|NCT01461928|20499369|P1|Maintenance II (15 Months)|Withdrawal by Subject|0
5926081|NCT01461928|20499367|P3|Maintenance II (15 Months)|Disease progression|3
5926082|NCT01461928|20499368|P2|Maintenance II (15 Months)|Disease progression|0
5926083|NCT01461928|20499369|P1|Maintenance II (15 Months)|Disease progression|0
5926084|NCT01461928|20499367|P3|Maintenance II (15 Months)|Moved to another town|0
5926085|NCT01461928|20499368|P2|Maintenance II (15 Months)|Moved to another town|1
5926086|NCT01461928|20499369|P1|Maintenance II (15 Months)|Moved to another town|0
5926087|NCT01461928|20499367|P3|Maintenance II (15 Months)|Lost to Follow-up|0
5926088|NCT01461928|20499368|P2|Maintenance II (15 Months)|Lost to Follow-up|1
5926089|NCT01461928|20499369|P1|Maintenance II (15 Months)|Lost to Follow-up|0
5926090|NCT01461928|20499367|P3|Maintenance II (15 Months)|Physician Decision|4
5926091|NCT01461928|20499368|P2|Maintenance II (15 Months)|Physician Decision|0
5926092|NCT01461928|20499369|P1|Maintenance II (15 Months)|Physician Decision|0
5926093|NCT01461928|20499367|P3|Maintenance II (15 Months)|Death|8
5926094|NCT01461928|20499368|P2|Maintenance II (15 Months)|Death|10
5926095|NCT01461928|20499369|P1|Maintenance II (15 Months)|Death|0
5926096|NCT01461928|20499367|P3|Maintenance II (15 Months)|Adverse Event|0
5926097|NCT01461928|20499368|P2|Maintenance II (15 Months)|Adverse Event|2
5926098|NCT01461928|20499369|P1|Maintenance II (15 Months)|Adverse Event|0
5926099|NCT01461928|20499367|P3|Maintenance I (24 Months)|Did not meet criteria|0
5926100|NCT01461928|20499368|P2|Maintenance I (24 Months)|Did not meet criteria|0
5926101|NCT01461928|20499369|P1|Maintenance I (24 Months)|Did not meet criteria|5
5926102|NCT01461928|20499367|P3|Maintenance I (24 Months)|Not compliant|0
5926103|NCT01461928|20499368|P2|Maintenance I (24 Months)|Not compliant|0
5926104|NCT01461928|20499369|P1|Maintenance I (24 Months)|Not compliant|1
5926105|NCT01461928|20499367|P3|Maintenance I (24 Months)|Delay in rituximab administration|0
5926106|NCT01461928|20499368|P2|Maintenance I (24 Months)|Delay in rituximab administration|0
5926107|NCT01461928|20499369|P1|Maintenance I (24 Months)|Delay in rituximab administration|1
5926108|NCT01461928|20499367|P3|Maintenance I (24 Months)|Did not perform scheduled assessment|0
5926109|NCT01461928|20499368|P2|Maintenance I (24 Months)|Did not perform scheduled assessment|0
5926110|NCT01461928|20499369|P1|Maintenance I (24 Months)|Did not perform scheduled assessment|2
5926111|NCT01461928|20499367|P3|Maintenance I (24 Months)|Did not meet randomization criteria|0
5926112|NCT01461928|20499368|P2|Maintenance I (24 Months)|Did not meet randomization criteria|0
5926113|NCT01461928|20499369|P1|Maintenance I (24 Months)|Did not meet randomization criteria|2
5926114|NCT01461928|20499367|P3|Maintenance I (24 Months)|Physician Decision|0
5926115|NCT01461928|20499368|P2|Maintenance I (24 Months)|Physician Decision|0
5926116|NCT01461928|20499369|P1|Maintenance I (24 Months)|Physician Decision|9
5926117|NCT01461928|20499367|P3|Maintenance I (24 Months)|Adverse Event|0
5926118|NCT01461928|20499368|P2|Maintenance I (24 Months)|Adverse Event|0
5926119|NCT01461928|20499369|P1|Maintenance I (24 Months)|Adverse Event|70
5926120|NCT01461928|20499367|P3|Maintenance I (24 Months)|Diseases progression|0
5926121|NCT01461928|20499368|P2|Maintenance I (24 Months)|Diseases progression|0
5926122|NCT01461928|20499369|P1|Maintenance I (24 Months)|Diseases progression|91
5926123|NCT01461928|20499367|P3|Maintenance I (24 Months)|Lost to Follow-up|0
5926124|NCT01461928|20499368|P2|Maintenance I (24 Months)|Lost to Follow-up|0
5926125|NCT01461928|20499369|P1|Maintenance I (24 Months)|Lost to Follow-up|2
5926126|NCT01461928|20499367|P3|Maintenance I (24 Months)|Withdrawal by Subject|0
5926127|NCT01461928|20499368|P2|Maintenance I (24 Months)|Withdrawal by Subject|0
5926128|NCT01461928|20499369|P1|Maintenance I (24 Months)|Withdrawal by Subject|32
5926129|NCT01461928|20499367|P3|Maintenance I (24 Months)|Death|0
5926130|NCT01461928|20499368|P2|Maintenance I (24 Months)|Death|0
5926131|NCT01461928|20499369|P1|Maintenance I (24 Months)|Death|3
5926132|NCT01461928|20499367|P3|Induction (up to 8 Months)|Medical advisor request|0
5926133|NCT01461928|20499368|P2|Induction (up to 8 Months)|Medical advisor request|0
5926134|NCT01461928|20499369|P1|Induction (up to 8 Months)|Medical advisor request|1
5926135|NCT01461928|20499367|P3|Induction (up to 8 Months)|Exceeded time limit for next cycle|0
5926136|NCT01461928|20499368|P2|Induction (up to 8 Months)|Exceeded time limit for next cycle|0
5926137|NCT01461928|20499369|P1|Induction (up to 8 Months)|Exceeded time limit for next cycle|1
5926138|NCT01461928|20499367|P3|Induction (up to 8 Months)|Promotor request|0
5926139|NCT01461928|20499368|P2|Induction (up to 8 Months)|Promotor request|0
5926140|NCT01461928|20499369|P1|Induction (up to 8 Months)|Promotor request|1
5926141|NCT01461928|20499367|P3|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0
5926142|NCT01461928|20499368|P2|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0
5926143|NCT01461928|20499369|P1|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|1
5926144|NCT01461928|20499367|P3|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0
5926145|NCT01461928|20499368|P2|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0
5926146|NCT01461928|20499369|P1|Induction (up to 8 Months)|Prednisolone given prior to enrolment|1
5926147|NCT01461928|20499367|P3|Induction (up to 8 Months)|Protocol deviation|0
5926148|NCT01461928|20499368|P2|Induction (up to 8 Months)|Protocol deviation|0
5926149|NCT01461928|20499369|P1|Induction (up to 8 Months)|Protocol deviation|2
5926150|NCT01461928|20499367|P3|Induction (up to 8 Months)|Sponsor decision|0
5926151|NCT01461928|20499368|P2|Induction (up to 8 Months)|Sponsor decision|0
5926152|NCT01461928|20499369|P1|Induction (up to 8 Months)|Sponsor decision|1
5926153|NCT01461928|20499367|P3|Induction (up to 8 Months)|Treated before eligibility was confirmed|0
5926154|NCT01461928|20499368|P2|Induction (up to 8 Months)|Treated before eligibility was confirmed|0
5926155|NCT01461928|20499369|P1|Induction (up to 8 Months)|Treated before eligibility was confirmed|1
5926156|NCT01461928|20499367|P3|Induction (up to 8 Months)|Termination of study in Switzerland|0
5926157|NCT01461928|20499368|P2|Induction (up to 8 Months)|Termination of study in Switzerland|0
5926158|NCT01461928|20499369|P1|Induction (up to 8 Months)|Termination of study in Switzerland|1
5926159|NCT01461928|20499367|P3|Induction (up to 8 Months)|Not responding to treatment|0
5926160|NCT01461928|20499368|P2|Induction (up to 8 Months)|Not responding to treatment|0
5926161|NCT01461928|20499369|P1|Induction (up to 8 Months)|Not responding to treatment|11
5926162|NCT01461928|20499367|P3|Induction (up to 8 Months)|Completed Induction, no Maint I received|0
5926163|NCT01461928|20499368|P2|Induction (up to 8 Months)|Completed Induction, no Maint I received|0
5926164|NCT01461928|20499369|P1|Induction (up to 8 Months)|Completed Induction, no Maint I received|11
5926165|NCT01461928|20499367|P3|Induction (up to 8 Months)|Eligibility criteria deviation|0
5926166|NCT01461928|20499368|P2|Induction (up to 8 Months)|Eligibility criteria deviation|0
5926167|NCT01461928|20499369|P1|Induction (up to 8 Months)|Eligibility criteria deviation|10
5926168|NCT01461928|20499367|P3|Induction (up to 8 Months)|Disease progression|0
5926169|NCT01461928|20499368|P2|Induction (up to 8 Months)|Disease progression|0
5926170|NCT01461928|20499369|P1|Induction (up to 8 Months)|Disease progression|45
5926171|NCT01461928|20499367|P3|Induction (up to 8 Months)|Withdrawal by Subject|0
5926172|NCT01461928|20499368|P2|Induction (up to 8 Months)|Withdrawal by Subject|0
5926173|NCT01461928|20499369|P1|Induction (up to 8 Months)|Withdrawal by Subject|18
5926174|NCT01461928|20499367|P3|Induction (up to 8 Months)|Physician Decision|0
5926175|NCT01461928|20499368|P2|Induction (up to 8 Months)|Physician Decision|0
5926176|NCT01461928|20499369|P1|Induction (up to 8 Months)|Physician Decision|9
5926177|NCT01461928|20499367|P3|Induction (up to 8 Months)|Lost to Follow-up|0
5926178|NCT01461928|20499368|P2|Induction (up to 8 Months)|Lost to Follow-up|0
5926179|NCT01461928|20499369|P1|Induction (up to 8 Months)|Lost to Follow-up|5
5926180|NCT01461928|20499367|P3|Induction (up to 8 Months)|Death|0
5926181|NCT01461928|20499368|P2|Induction (up to 8 Months)|Death|0
5926182|NCT01461928|20499369|P1|Induction (up to 8 Months)|Death|3
5926183|NCT01461928|20499367|P3|Induction (up to 8 Months)|Adverse Event|0
5926184|NCT01461928|20499368|P2|Induction (up to 8 Months)|Adverse Event|0
5926185|NCT01461928|20499369|P1|Induction (up to 8 Months)|Adverse Event|76
5926186|NCT01461811|20499420|P2|Overall Study|Noncompliance|1
5926187|NCT01461811|20499421|P1|Overall Study|Noncompliance|1
5926188|NCT01461811|20499420|P2|Overall Study|Subject decision unrelated to an AE|1
5926189|NCT01461811|20499421|P1|Overall Study|Subject decision unrelated to an AE|1
5926190|NCT01461811|20499420|P2|Overall Study|Adverse Event|1
5926191|NCT01461811|20499421|P1|Overall Study|Adverse Event|2
5926192|NCT01461707|20499460|P2|Overall Study|Withdrawal by Subject|0
5926193|NCT01461707|20499461|P1|Overall Study|Withdrawal by Subject|1
5926194|NCT01461551|20499498|P3|Overall Study|Physician Decision|2
5926195|NCT01461551|20499499|P2|Overall Study|Physician Decision|1
5926196|NCT01461551|20499500|P1|Overall Study|Physician Decision|2
5926197|NCT01461538|20499511|P3|Overall Study|Withdrawal by Subject|0
5926198|NCT01461538|20499512|P2|Overall Study|Withdrawal by Subject|1
5926199|NCT01461538|20499513|P1|Overall Study|Withdrawal by Subject|1
5926200|NCT01461538|20499511|P3|Overall Study|Study Stopped by Sponsor|0
5926201|NCT01461538|20499512|P2|Overall Study|Study Stopped by Sponsor|1
5926202|NCT01461538|20499513|P1|Overall Study|Study Stopped by Sponsor|2
5926203|NCT01461538|20499511|P3|Overall Study|Death|2
5926204|NCT01461538|20499512|P2|Overall Study|Death|6
5926205|NCT01461538|20499513|P1|Overall Study|Death|15
5926206|NCT01461369|20499582|P3|Overall Study|Withdrawal by Subject|2
5926207|NCT01461369|20499583|P2|Overall Study|Withdrawal by Subject|3
5926208|NCT01461369|20499584|P1|Overall Study|Withdrawal by Subject|1
5926209|NCT01461369|20499582|P3|Overall Study|Protocol Violation|2
5926210|NCT01461369|20499583|P2|Overall Study|Protocol Violation|2
5926211|NCT01461369|20499584|P1|Overall Study|Protocol Violation|1
5926212|NCT01461369|20499582|P3|Overall Study|Adverse Event|4
5926213|NCT01461369|20499583|P2|Overall Study|Adverse Event|12
5926214|NCT01461369|20499584|P1|Overall Study|Adverse Event|9
5926215|NCT01461369|20499582|P3|Overall Study|Lost to Follow-up|3
5926216|NCT01461369|20499583|P2|Overall Study|Lost to Follow-up|0
5926217|NCT01461369|20499584|P1|Overall Study|Lost to Follow-up|0
5926218|NCT01461369|20499582|P3|Overall Study|Lack of Efficacy|6
5926219|NCT01461369|20499583|P2|Overall Study|Lack of Efficacy|0
5926220|NCT01461369|20499584|P1|Overall Study|Lack of Efficacy|2
5926221|NCT01461096|20499609|P2|Overall Study|Lost to Follow-up|4
5926222|NCT01461096|20499610|P1|Overall Study|Lost to Follow-up|8
5926223|NCT01461096|20499609|P2|Overall Study|Subj not willing to adhere to reqs|4
5926224|NCT01461096|20499610|P1|Overall Study|Subj not willing to adhere to reqs|3
5926225|NCT01461096|20499609|P2|Overall Study|Withdrawal by Subject|3
5926226|NCT01461096|20499610|P1|Overall Study|Withdrawal by Subject|5
5926227|NCT01461096|20499609|P2|Overall Study|Site is closing|30
5926228|NCT01461096|20499610|P1|Overall Study|Site is closing|27
5926229|NCT01461096|20499609|P2|Overall Study|Subj not able to get to clinic|13
5926230|NCT01461096|20499610|P1|Overall Study|Subj not able to get to clinic|15
5926231|NCT01461096|20499609|P2|Overall Study|Severe debilitation, unable to continue|1
5926232|NCT01461096|20499610|P1|Overall Study|Severe debilitation, unable to continue|1
5926233|NCT01461096|20499609|P2|Overall Study|Death|6
5926234|NCT01461096|20499610|P1|Overall Study|Death|3
5926235|NCT01461057|20499626|P2|Overall Study|Study Terminated by Sponsor|0
5926236|NCT01461057|20499627|P1|Overall Study|Study Terminated by Sponsor|2
5926237|NCT01461057|20499626|P2|Overall Study|Progression of Disease|0
5926238|NCT01461057|20499627|P1|Overall Study|Progression of Disease|1
5926239|NCT01461057|20499626|P2|Overall Study|Adverse Event|1
5926240|NCT01461057|20499627|P1|Overall Study|Adverse Event|0
5926241|NCT01461057|20499626|P2|Overall Study|Physician Decision|2
5926242|NCT01461057|20499627|P1|Overall Study|Physician Decision|0
5926243|NCT01461057|20499626|P2|Overall Study|Withdrawal by Subject|3
5926244|NCT01461057|20499627|P1|Overall Study|Withdrawal by Subject|2
5926245|NCT01461057|20499626|P2|Overall Study|Death|9
5926246|NCT01461057|20499627|P1|Overall Study|Death|10
5926247|NCT01461044|20499637|P2|Overall Study|Lost to Follow-up|5
5926248|NCT01461044|20499638|P1|Overall Study|Lost to Follow-up|12
5926249|NCT01461044|20499637|P2|Overall Study|Death|35
5926250|NCT01461044|20499638|P1|Overall Study|Death|58
5926251|NCT01461005|20499711|P1|Overall Study|FDA reclassified Dynamic Stabilization D|1
5926252|NCT01460901|20499734|P1|Overall Study|Withdrawal by Subject|2
5926253|NCT01460719|20499766|P1|Overall Study|Withdrawal by Subject|1
5926254|NCT01460719|20499766|P1|Overall Study|Adverse Event|1
5926255|NCT01460628|20499776|P1|Overall Study|Withdrawal by Subject|2
5926256|NCT01460628|20499776|P1|Overall Study|Adverse Event|3
5926257|NCT01460446|20499788|P2|Overall Study|Other Reasons Incl. Lost for Follow-Up|3
5926258|NCT01460446|20499789|P1|Overall Study|Other Reasons Incl. Lost for Follow-Up|0
5926259|NCT01460446|20499788|P2|Overall Study|Pregnancy|0
5926260|NCT01460446|20499789|P1|Overall Study|Pregnancy|1
5926261|NCT01460446|20499788|P2|Overall Study|Surgery/Illness|1
5926262|NCT01460446|20499789|P1|Overall Study|Surgery/Illness|1
5926263|NCT01460446|20499788|P2|Overall Study|Non-compliance & Consent Withdrawn|3
5926264|NCT01460446|20499789|P1|Overall Study|Non-compliance & Consent Withdrawn|1
5926265|NCT01460446|20499788|P2|Overall Study|Consent Withdrawn|4
5926266|NCT01460446|20499789|P1|Overall Study|Consent Withdrawn|0
5926267|NCT01460446|20499788|P2|Overall Study|Non-compliance|9
5926268|NCT01460446|20499789|P1|Overall Study|Non-compliance|2
5926269|NCT01460407|20499816|P2|Period 2: Day 6 to Day 14|Adverse Event|1
5926270|NCT01460407|20499817|P1|Period 2: Day 6 to Day 14|Adverse Event|0
5926271|NCT01460381|20499830|P2|Period 2 (Days 8-15)|Lost to Follow-up|0
5926272|NCT01460381|20499831|P1|Period 2 (Days 8-15)|Lost to Follow-up|1
5926273|NCT01460368|20499847|P7|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0
5926274|NCT01460368|20499848|P6|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1
5926275|NCT01460368|20499849|P5|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0
5926276|NCT01460368|20499850|P4|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1
5926277|NCT01460368|20499851|P3|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1
5926278|NCT01460368|20499852|P2|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0
5926279|NCT01460368|20499853|P1|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0
5926280|NCT01460368|20499847|P7|Part B: Washout (up to 15 Days)|Protocol Violation|0
5926281|NCT01460368|20499848|P6|Part B: Washout (up to 15 Days)|Protocol Violation|0
5926282|NCT01460368|20499849|P5|Part B: Washout (up to 15 Days)|Protocol Violation|0
5926283|NCT01460368|20499850|P4|Part B: Washout (up to 15 Days)|Protocol Violation|0
5926284|NCT01460368|20499851|P3|Part B: Washout (up to 15 Days)|Protocol Violation|1
5926285|NCT01460368|20499852|P2|Part B: Washout (up to 15 Days)|Protocol Violation|0
5926286|NCT01460368|20499853|P1|Part B: Washout (up to 15 Days)|Protocol Violation|0
5926287|NCT01460368|20499847|P7|Part B: Second Intervention (Period 2)|Lost to Follow-up|0
5926288|NCT01460368|20499848|P6|Part B: Second Intervention (Period 2)|Lost to Follow-up|0
5926289|NCT01460368|20499849|P5|Part B: Second Intervention (Period 2)|Lost to Follow-up|0
5926290|NCT01460368|20499850|P4|Part B: Second Intervention (Period 2)|Lost to Follow-up|0
5926291|NCT01460368|20499851|P3|Part B: Second Intervention (Period 2)|Lost to Follow-up|0
5926292|NCT01460368|20499852|P2|Part B: Second Intervention (Period 2)|Lost to Follow-up|1
5926293|NCT01460368|20499853|P1|Part B: Second Intervention (Period 2)|Lost to Follow-up|0
5926294|NCT01460368|20499847|P7|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1
5926295|NCT01460368|20499848|P6|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0
5926296|NCT01460368|20499849|P5|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0
5926297|NCT01460368|20499850|P4|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0
5926298|NCT01460368|20499851|P3|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0
5926299|NCT01460368|20499852|P2|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1
5926300|NCT01460368|20499853|P1|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0
5926301|NCT01460368|20499847|P7|Part B: First Intervention (Period 1)|Lost to Follow-up|0
5926302|NCT01460368|20499848|P6|Part B: First Intervention (Period 1)|Lost to Follow-up|0
5926303|NCT01460368|20499849|P5|Part B: First Intervention (Period 1)|Lost to Follow-up|1
5926304|NCT01460368|20499850|P4|Part B: First Intervention (Period 1)|Lost to Follow-up|0
5926305|NCT01460368|20499851|P3|Part B: First Intervention (Period 1)|Lost to Follow-up|0
5926306|NCT01460368|20499852|P2|Part B: First Intervention (Period 1)|Lost to Follow-up|0
5926307|NCT01460368|20499853|P1|Part B: First Intervention (Period 1)|Lost to Follow-up|0
5926308|NCT01460342|20499865|P2|Overall Study|Lack of Efficacy|0
5926309|NCT01460342|20499866|P1|Overall Study|Lack of Efficacy|1
5926310|NCT01460342|20499865|P2|Overall Study|Physician Decision|3
5926311|NCT01460342|20499866|P1|Overall Study|Physician Decision|1
5926312|NCT01460342|20499865|P2|Overall Study|Withdrawal by Subject|4
5926313|NCT01460342|20499866|P1|Overall Study|Withdrawal by Subject|3
5926314|NCT01460342|20499865|P2|Overall Study|Protocol Violation|1
5926315|NCT01460342|20499866|P1|Overall Study|Protocol Violation|0
5926316|NCT01460342|20499865|P2|Overall Study|Lost to Follow-up|2
5926317|NCT01460342|20499866|P1|Overall Study|Lost to Follow-up|1
5926318|NCT01460342|20499865|P2|Overall Study|Adverse Event|4
5926319|NCT01460342|20499866|P1|Overall Study|Adverse Event|5
5926320|NCT01460290|20499897|P1|Overall Study|Elevated liver function|1
5926321|NCT01460290|20499897|P1|Overall Study|Adverse Event|3
5926322|NCT01460160|20499924|P2|Follow-up|Lost to Follow-up|0
5926323|NCT01460160|20499925|P1|Follow-up|Lost to Follow-up|1
5926324|NCT01460160|20499924|P2|Follow-up|Death|2
5926325|NCT01460160|20499925|P1|Follow-up|Death|7
5926326|NCT01460160|20499924|P2|Follow-up|Withdrawal by Subject|0
5926327|NCT01460160|20499925|P1|Follow-up|Withdrawal by Subject|3
5926328|NCT01460160|20499924|P2|Treatment|Subject refused to continue Chemo|0
5926329|NCT01460160|20499925|P1|Treatment|Subject refused to continue Chemo|1
5926330|NCT01460160|20499924|P2|Treatment|Family did not wish to restart after SCT|0
5926331|NCT01460160|20499925|P1|Treatment|Family did not wish to restart after SCT|1
5926332|NCT01460160|20499924|P2|Treatment|PI decision to pursue other options|1
5926333|NCT01460160|20499925|P1|Treatment|PI decision to pursue other options|1
5926334|NCT01460160|20499924|P2|Treatment|PI not to follow protocol therapy|0
5926335|NCT01460160|20499925|P1|Treatment|PI not to follow protocol therapy|1
5926336|NCT01460160|20499924|P2|Treatment|PI decision to not re-initiate after SCT|2
5926337|NCT01460160|20499925|P1|Treatment|PI decision to not re-initiate after SCT|2
5926338|NCT01460160|20499924|P2|Treatment|Death|2
5926339|NCT01460160|20499925|P1|Treatment|Death|0
5926340|NCT01460160|20499924|P2|Treatment|Withdrawal by Subject|0
5926341|NCT01460160|20499925|P1|Treatment|Withdrawal by Subject|4
5926342|NCT01460160|20499924|P2|Treatment|Adverse Event|0
5926343|NCT01460160|20499925|P1|Treatment|Adverse Event|8
5926344|NCT01460160|20499924|P2|Treatment|Study Drug Toxicity|0
5926345|NCT01460160|20499925|P1|Treatment|Study Drug Toxicity|2
5926346|NCT01460160|20499924|P2|Treatment|Lack of Efficacy|0
5926347|NCT01460160|20499925|P1|Treatment|Lack of Efficacy|3
5926348|NCT01459913|20499966|P4|Overall Study|Did Not Meet Inclusion Criteria|1
5926349|NCT01459913|20499967|P3|Overall Study|Did Not Meet Inclusion Criteria|0
5926350|NCT01459913|20499968|P2|Overall Study|Did Not Meet Inclusion Criteria|0
5926351|NCT01459913|20499969|P1|Overall Study|Did Not Meet Inclusion Criteria|0
5926352|NCT01459913|20499966|P4|Overall Study|Other|1
5926353|NCT01459913|20499967|P3|Overall Study|Other|3
5926354|NCT01459913|20499968|P2|Overall Study|Other|0
5926355|NCT01459913|20499969|P1|Overall Study|Other|0
5926356|NCT01459913|20499966|P4|Overall Study|Study Terminated by Sponsor|11
5926357|NCT01459913|20499967|P3|Overall Study|Study Terminated by Sponsor|9
5926358|NCT01459913|20499968|P2|Overall Study|Study Terminated by Sponsor|15
5926359|NCT01459913|20499969|P1|Overall Study|Study Terminated by Sponsor|30
5926360|NCT01459913|20499966|P4|Overall Study|Physician Decision|0
5926361|NCT01459913|20499967|P3|Overall Study|Physician Decision|0
5926362|NCT01459913|20499968|P2|Overall Study|Physician Decision|1
5926363|NCT01459913|20499969|P1|Overall Study|Physician Decision|0
5926364|NCT01459913|20499966|P4|Overall Study|Non- Compliance|3
5926365|NCT01459913|20499967|P3|Overall Study|Non- Compliance|0
5926366|NCT01459913|20499968|P2|Overall Study|Non- Compliance|0
5926367|NCT01459913|20499969|P1|Overall Study|Non- Compliance|0
5926368|NCT01459913|20499966|P4|Overall Study|Death|1
5926369|NCT01459913|20499967|P3|Overall Study|Death|0
5926370|NCT01459913|20499968|P2|Overall Study|Death|0
5926371|NCT01459913|20499969|P1|Overall Study|Death|0
5926372|NCT01459913|20499966|P4|Overall Study|Lost to Follow-up|8
5926373|NCT01459913|20499967|P3|Overall Study|Lost to Follow-up|1
5926374|NCT01459913|20499968|P2|Overall Study|Lost to Follow-up|4
5926375|NCT01459913|20499969|P1|Overall Study|Lost to Follow-up|7
5926376|NCT01459913|20499966|P4|Overall Study|Withdrawal by Subject|5
5926377|NCT01459913|20499967|P3|Overall Study|Withdrawal by Subject|0
5926378|NCT01459913|20499968|P2|Overall Study|Withdrawal by Subject|0
5926379|NCT01459913|20499969|P1|Overall Study|Withdrawal by Subject|4
5926380|NCT01459913|20499966|P4|Overall Study|Adverse Event|3
5926381|NCT01459913|20499967|P3|Overall Study|Adverse Event|0
5926382|NCT01459913|20499968|P2|Overall Study|Adverse Event|0
5926383|NCT01459913|20499969|P1|Overall Study|Adverse Event|0
5926384|NCT01459796|20500000|P2|Overall Study|Decision by the sponsor|108
5926385|NCT01459796|20500001|P1|Overall Study|Decision by the sponsor|75
5926386|NCT01459796|20500000|P2|Overall Study|Reason unspecified|2
5926387|NCT01459796|20500001|P1|Overall Study|Reason unspecified|1
5926388|NCT01459796|20500000|P2|Overall Study|Lost to Follow-up|4
5926389|NCT01459796|20500001|P1|Overall Study|Lost to Follow-up|5
5926390|NCT01459796|20500000|P2|Overall Study|Withdrawal by Subject|3
5926391|NCT01459796|20500001|P1|Overall Study|Withdrawal by Subject|6
5926392|NCT01459796|20500000|P2|Overall Study|Adverse Event|5
5926393|NCT01459796|20500001|P1|Overall Study|Adverse Event|5
5926394|NCT01459796|20500000|P2|Overall Study|Non compliance with protocol|4
5926395|NCT01459796|20500001|P1|Overall Study|Non compliance with protocol|2
5926396|NCT01459783|20500019|P2|6 Months to 12 Months|Study ended before 12-month follow-up|17
5926397|NCT01459783|20500020|P1|6 Months to 12 Months|Study ended before 12-month follow-up|11
5926398|NCT01459783|20500019|P2|6 Months to 12 Months|Lost to Follow-up|7
5926399|NCT01459783|20500020|P1|6 Months to 12 Months|Lost to Follow-up|2
5926400|NCT01459783|20500019|P2|6 Months to 12 Months|Withdrawal by Subject|5
5926401|NCT01459783|20500020|P1|6 Months to 12 Months|Withdrawal by Subject|6
5926402|NCT01459783|20500019|P2|6 Months to 12 Months|Death|1
5926403|NCT01459783|20500020|P1|6 Months to 12 Months|Death|0
5926404|NCT01459783|20500019|P2|Baseline to 6 Months|Lost to Follow-up|14
5926405|NCT01459783|20500020|P1|Baseline to 6 Months|Lost to Follow-up|19
5926406|NCT01459783|20500019|P2|Baseline to 6 Months|Withdrawal by Subject|6
5926407|NCT01459783|20500020|P1|Baseline to 6 Months|Withdrawal by Subject|12
5926408|NCT01459783|20500019|P2|Baseline to 6 Months|Death|0
5926409|NCT01459783|20500020|P1|Baseline to 6 Months|Death|1
5926410|NCT01459718|20500028|P1|Overall Study|Adverse Event|1
5926411|NCT01459718|20500028|P1|Overall Study|Lost to Follow-up|1
5926412|NCT01459718|20500028|P1|Overall Study|Physician Decision|1
5926413|NCT01459614|20500210|P2|Overall Study|Adverse Event|0
5926414|NCT01459614|20500211|P1|Overall Study|Adverse Event|1
5926415|NCT01459068|20500258|P2|Overall Study|Death|1
5926416|NCT01459068|20500259|P1|Overall Study|Death|0
5926417|NCT01459068|20500258|P2|Overall Study|Lost to Follow-up|15
5926418|NCT01459068|20500259|P1|Overall Study|Lost to Follow-up|31
5926419|NCT01459068|20500258|P2|Overall Study|Withdrawal by Subject|18
5926420|NCT01459068|20500259|P1|Overall Study|Withdrawal by Subject|8
5926421|NCT01459016|20500275|P1|Overall Study|Amendment Discontinuation Criteria|4
5926422|NCT01459016|20500275|P1|Overall Study|Withdrawal by Subject|11
5926423|NCT01458951|20500303|P3|Overall Study|Insufficient Clinical Response|11
5926424|NCT01458951|20500304|P2|Overall Study|Insufficient Clinical Response|0
5926425|NCT01458951|20500305|P1|Overall Study|Insufficient Clinical Response|17
5926426|NCT01458951|20500303|P3|Overall Study|Adverse Event|2
5926427|NCT01458951|20500304|P2|Overall Study|Adverse Event|0
5926428|NCT01458951|20500305|P1|Overall Study|Adverse Event|7
5926429|NCT01458951|20500303|P3|Overall Study|Withdrawal by Subject|2
5926430|NCT01458951|20500304|P2|Overall Study|Withdrawal by Subject|0
5926431|NCT01458951|20500305|P1|Overall Study|Withdrawal by Subject|2
5926432|NCT01458951|20500303|P3|Overall Study|Protocol Violation|0
5926433|NCT01458951|20500304|P2|Overall Study|Protocol Violation|1
5926434|NCT01458951|20500305|P1|Overall Study|Protocol Violation|5
5926435|NCT01458951|20500303|P3|Overall Study|Other|0
5926436|NCT01458951|20500304|P2|Overall Study|Other|0
5926437|NCT01458951|20500305|P1|Overall Study|Other|1
5926438|NCT01458639|20500330|P1|Overall Study|Inability to obtain subject blood sample|1
5926439|NCT01458639|20500330|P1|Overall Study|Equipment issue|1
5926440|NCT01458639|20500330|P1|Overall Study|Physician Decision|4
5926441|NCT01458587|20500342|P2|Overall Study|Withdrawal by Subject|0
5926442|NCT01458587|20500343|P1|Overall Study|Withdrawal by Subject|1
5926443|NCT01458574|20500506|P3|Overall Study|Randomized but not treated|0
5926444|NCT01458574|20500507|P2|Overall Study|Randomized but not treated|1
5926445|NCT01458574|20500508|P1|Overall Study|Randomized but not treated|0
5926446|NCT01458574|20500506|P3|Overall Study|Other|0
5926447|NCT01458574|20500507|P2|Overall Study|Other|1
5926448|NCT01458574|20500508|P1|Overall Study|Other|2
5926449|NCT01458574|20500506|P3|Overall Study|Withdrawal by Subject|5
5926450|NCT01458574|20500507|P2|Overall Study|Withdrawal by Subject|3
5926451|NCT01458574|20500508|P1|Overall Study|Withdrawal by Subject|6
5926452|NCT01458574|20500506|P3|Overall Study|Protocol Violation|0
5926453|NCT01458574|20500507|P2|Overall Study|Protocol Violation|1
5926454|NCT01458574|20500508|P1|Overall Study|Protocol Violation|0
5926455|NCT01458574|20500506|P3|Overall Study|Pregnancy|0
5926456|NCT01458574|20500507|P2|Overall Study|Pregnancy|1
5926457|NCT01458574|20500508|P1|Overall Study|Pregnancy|1
5926458|NCT01458574|20500506|P3|Overall Study|Lost to Follow-up|1
5926459|NCT01458574|20500507|P2|Overall Study|Lost to Follow-up|2
5926460|NCT01458574|20500508|P1|Overall Study|Lost to Follow-up|3
5926461|NCT01458574|20500506|P3|Overall Study|Lack of Efficacy|132
5926462|NCT01458574|20500507|P2|Overall Study|Lack of Efficacy|53
5926463|NCT01458574|20500508|P1|Overall Study|Lack of Efficacy|70
5926464|NCT01458574|20500506|P3|Overall Study|Adverse Event|7
5926465|NCT01458574|20500507|P2|Overall Study|Adverse Event|9
5926466|NCT01458574|20500508|P1|Overall Study|Adverse Event|5
5926467|NCT01458535|20500638|P6|Overall Study|Adverse Event|0
5926468|NCT01458535|20500639|P5|Overall Study|Adverse Event|0
5926469|NCT01458535|20500640|P4|Overall Study|Adverse Event|1
5926470|NCT01458535|20500641|P3|Overall Study|Adverse Event|0
5926471|NCT01458535|20500642|P2|Overall Study|Adverse Event|0
5926472|NCT01458535|20500643|P1|Overall Study|Adverse Event|0
5926473|NCT01458535|20500638|P6|Overall Study|Lost to Follow-up|2
5926474|NCT01458535|20500639|P5|Overall Study|Lost to Follow-up|2
5926475|NCT01458535|20500640|P4|Overall Study|Lost to Follow-up|3
5926476|NCT01458535|20500641|P3|Overall Study|Lost to Follow-up|0
5926477|NCT01458535|20500642|P2|Overall Study|Lost to Follow-up|2
5926478|NCT01458535|20500643|P1|Overall Study|Lost to Follow-up|0
5926479|NCT01458535|20500638|P6|Overall Study|Withdrawal by Subject|1
5926480|NCT01458535|20500639|P5|Overall Study|Withdrawal by Subject|1
5926481|NCT01458535|20500640|P4|Overall Study|Withdrawal by Subject|0
5926482|NCT01458535|20500641|P3|Overall Study|Withdrawal by Subject|2
5926483|NCT01458535|20500642|P2|Overall Study|Withdrawal by Subject|0
5926484|NCT01458535|20500643|P1|Overall Study|Withdrawal by Subject|0
5926485|NCT01458535|20500638|P6|Overall Study|Other|1
5926486|NCT01458535|20500639|P5|Overall Study|Other|1
5926487|NCT01458535|20500640|P4|Overall Study|Other|0
5926488|NCT01458535|20500641|P3|Overall Study|Other|0
5926489|NCT01458535|20500642|P2|Overall Study|Other|0
5926490|NCT01458535|20500643|P1|Overall Study|Other|0
5926491|NCT01458522|20500695|P2|Overall Study|Physician Decision|9
5926492|NCT01458522|20500696|P1|Overall Study|Physician Decision|1
5926493|NCT01458522|20500695|P2|Overall Study|Withdrawal by Subject|2
5926494|NCT01458522|20500696|P1|Overall Study|Withdrawal by Subject|2
5926495|NCT01458392|20500742|P3|Overall Study|Patient unwilling to comply with protoco|2
5926496|NCT01458392|20500743|P2|Overall Study|Patient unwilling to comply with protoco|0
5926497|NCT01458392|20500744|P1|Overall Study|Patient unwilling to comply with protoco|0
5926498|NCT01458392|20500742|P3|Overall Study|At the discretion of the sponsor|7
5926499|NCT01458392|20500743|P2|Overall Study|At the discretion of the sponsor|2
5926500|NCT01458392|20500744|P1|Overall Study|At the discretion of the sponsor|0
5926501|NCT01458392|20500742|P3|Overall Study|Death|22
5926502|NCT01458392|20500743|P2|Overall Study|Death|11
5926503|NCT01458392|20500744|P1|Overall Study|Death|2
5926504|NCT01458366|20500769|P5|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|1
5926505|NCT01458366|20500770|P4|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0
5926506|NCT01458366|20500771|P3|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0
5926507|NCT01458366|20500772|P2|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0
5926508|NCT01458366|20500773|P1|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0
5926509|NCT01458366|20500769|P5|Period 1: 70mg/m^2|Physician Decision|0
5926510|NCT01458366|20500770|P4|Period 1: 70mg/m^2|Physician Decision|0
5926511|NCT01458366|20500771|P3|Period 1: 70mg/m^2|Physician Decision|0
5926512|NCT01458366|20500772|P2|Period 1: 70mg/m^2|Physician Decision|0
5926513|NCT01458366|20500773|P1|Period 1: 70mg/m^2|Physician Decision|2
5926514|NCT01458275|20500800|P3|Overall Study|Withdrawal by Subject|1
5926515|NCT01458275|20500801|P2|Overall Study|Withdrawal by Subject|2
5926516|NCT01458275|20500802|P1|Overall Study|Withdrawal by Subject|3
5926517|NCT01458275|20500800|P3|Overall Study|Protocol Violation|2
5926518|NCT01458275|20500801|P2|Overall Study|Protocol Violation|5
5926519|NCT01458275|20500802|P1|Overall Study|Protocol Violation|5
5926520|NCT01458275|20500800|P3|Overall Study|Lost to Follow-up|5
5926521|NCT01458275|20500801|P2|Overall Study|Lost to Follow-up|2
5926522|NCT01458275|20500802|P1|Overall Study|Lost to Follow-up|3
5926523|NCT01458275|20500800|P3|Overall Study|Adverse Event|1
5926524|NCT01458275|20500801|P2|Overall Study|Adverse Event|4
5926525|NCT01458275|20500802|P1|Overall Study|Adverse Event|3
5926526|NCT01458249|20500844|P1|Overall Study|Ongoing|1
5926527|NCT01458249|20500844|P1|Overall Study|Other|2
5926528|NCT01458249|20500844|P1|Overall Study|Adverse Event|4
5926529|NCT01458249|20500844|P1|Overall Study|Not treated|1
5926530|NCT01458210|20500863|P1|Ortho-Cyclen + Dulaglutide (Period 2)|Adverse Event|1
5926531|NCT01458210|20500863|P1|Ortho-Cyclen + Dulaglutide (Period 2)|Withdrawal by Subject|2
5926532|NCT01458210|20500863|P1|Ortho-Cyclen Alone (Period 1)|Lost to Follow-up|2
5926533|NCT01458210|20500863|P1|Ortho-Cyclen Alone (Period 1)|Withdrawal by Subject|2
5926534|NCT01458171|20500880|P1|Overall Study|Adverse Event|1
5926535|NCT01458132|20500903|P2|Overall Study|Other|3
5926536|NCT01458132|20500904|P1|Overall Study|Other|15
5926537|NCT01458119|20500912|P1|Overall Study|Non-compliance With Study Drug|3
5926538|NCT01458119|20500912|P1|Overall Study|Consent Withdrawn by Participant|8
5926539|NCT01458119|20500912|P1|Overall Study|Adverse Event|1
5926540|NCT01458119|20500912|P1|Overall Study|Death|2
5926541|NCT01458119|20500912|P1|Overall Study|Pregnancy|1
5926542|NCT01458119|20500912|P1|Overall Study|Withdrawal Due to Nonamenable Mutation|1
5926543|NCT01458119|20500912|P1|Overall Study|Physician Decision|4
5926544|NCT01458106|20500919|P2|Overall Study|Withdrawn Per Protocol|1
5926545|NCT01458106|20500920|P1|Overall Study|Withdrawn Per Protocol|0
5926546|NCT01458106|20500919|P2|Overall Study|Pre-rFVIIIFc Adverse Event|0
5926547|NCT01458106|20500920|P1|Overall Study|Pre-rFVIIIFc Adverse Event|1
5926548|NCT01458106|20500919|P2|Overall Study|Withdrawal by Subject|0
5926549|NCT01458106|20500920|P1|Overall Study|Withdrawal by Subject|2
5926550|NCT01457950|20500997|P4|Open-Label Phase|Withdrawal by Subject|0
5926551|NCT01457950|20500998|P3|Open-Label Phase|Withdrawal by Subject|2
5926552|NCT01457950|20500999|P2|Open-Label Phase|Withdrawal by Subject|0
5926553|NCT01457950|20501000|P1|Open-Label Phase|Withdrawal by Subject|0
5926554|NCT01457950|20500997|P4|Open-Label Phase|Protocol Violation|1
5926555|NCT01457950|20500998|P3|Open-Label Phase|Protocol Violation|0
5926556|NCT01457950|20500999|P2|Open-Label Phase|Protocol Violation|0
5926557|NCT01457950|20501000|P1|Open-Label Phase|Protocol Violation|0
5926558|NCT01457950|20500997|P4|Open-Label Phase|Adverse Event|1
5926559|NCT01457950|20500998|P3|Open-Label Phase|Adverse Event|0
5926560|NCT01457950|20500999|P2|Open-Label Phase|Adverse Event|0
5926561|NCT01457950|20501000|P1|Open-Label Phase|Adverse Event|0
5926562|NCT01457950|20500997|P4|Double-Blind Phase|Withdrawal by Subject|0
5926563|NCT01457950|20500998|P3|Double-Blind Phase|Withdrawal by Subject|0
5926564|NCT01457950|20500999|P2|Double-Blind Phase|Withdrawal by Subject|2
5926565|NCT01457950|20501000|P1|Double-Blind Phase|Withdrawal by Subject|6
5926566|NCT01457950|20500997|P4|Double-Blind Phase|Protocol Violation|0
5926567|NCT01457950|20500998|P3|Double-Blind Phase|Protocol Violation|0
5926568|NCT01457950|20500999|P2|Double-Blind Phase|Protocol Violation|1
5926569|NCT01457950|20501000|P1|Double-Blind Phase|Protocol Violation|2
5926570|NCT01457950|20500997|P4|Double-Blind Phase|Continuation Criteria Not Met|0
5926571|NCT01457950|20500998|P3|Double-Blind Phase|Continuation Criteria Not Met|0
5926572|NCT01457950|20500999|P2|Double-Blind Phase|Continuation Criteria Not Met|0
5926573|NCT01457950|20501000|P1|Double-Blind Phase|Continuation Criteria Not Met|1
5926574|NCT01457924|20501079|P5|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1
5926575|NCT01457924|20501080|P4|Individualized FUP (Weeks 48+)|Withdrawal by Subject|2
5926576|NCT01457924|20501081|P3|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1
5926577|NCT01457924|20501082|P2|Individualized FUP (Weeks 48+)|Withdrawal by Subject|0
5926578|NCT01457924|20501083|P1|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1
5926579|NCT01457924|20501079|P5|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|5
5926580|NCT01457924|20501080|P4|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3
5926581|NCT01457924|20501081|P3|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|2
5926582|NCT01457924|20501082|P2|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|4
5926583|NCT01457924|20501083|P1|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3
5926584|NCT01457924|20501079|P5|Individualized FUP (Weeks 48+)|Lost to Follow-up|0
5926585|NCT01457924|20501080|P4|Individualized FUP (Weeks 48+)|Lost to Follow-up|0
5926586|NCT01457924|20501081|P3|Individualized FUP (Weeks 48+)|Lost to Follow-up|1
5926587|NCT01457924|20501082|P2|Individualized FUP (Weeks 48+)|Lost to Follow-up|0
5926588|NCT01457924|20501083|P1|Individualized FUP (Weeks 48+)|Lost to Follow-up|1
5926589|NCT01457924|20501079|P5|FUP (Weeks 24-48)|Withdrawal by Subject|2
5926590|NCT01457924|20501080|P4|FUP (Weeks 24-48)|Withdrawal by Subject|0
5926591|NCT01457924|20501081|P3|FUP (Weeks 24-48)|Withdrawal by Subject|0
5926592|NCT01457924|20501082|P2|FUP (Weeks 24-48)|Withdrawal by Subject|1
5926593|NCT01457924|20501083|P1|FUP (Weeks 24-48)|Withdrawal by Subject|2
5926594|NCT01457924|20501079|P5|FUP (Weeks 24-48)|Lost to Follow-up|0
5926595|NCT01457924|20501080|P4|FUP (Weeks 24-48)|Lost to Follow-up|1
5926596|NCT01457924|20501081|P3|FUP (Weeks 24-48)|Lost to Follow-up|0
5926597|NCT01457924|20501082|P2|FUP (Weeks 24-48)|Lost to Follow-up|0
5926598|NCT01457924|20501083|P1|FUP (Weeks 24-48)|Lost to Follow-up|0
5926599|NCT01457924|20501079|P5|FUP (Weeks 24-48)|Physician Decision|0
5926600|NCT01457924|20501080|P4|FUP (Weeks 24-48)|Physician Decision|0
5926601|NCT01457924|20501081|P3|FUP (Weeks 24-48)|Physician Decision|1
5926602|NCT01457924|20501082|P2|FUP (Weeks 24-48)|Physician Decision|0
5926603|NCT01457924|20501083|P1|FUP (Weeks 24-48)|Physician Decision|1
5926604|NCT01457924|20501079|P5|FUP (Weeks 24-48)|Adverse Event|0
5926605|NCT01457924|20501080|P4|FUP (Weeks 24-48)|Adverse Event|0
5926606|NCT01457924|20501081|P3|FUP (Weeks 24-48)|Adverse Event|1
5926607|NCT01457924|20501082|P2|FUP (Weeks 24-48)|Adverse Event|0
5926608|NCT01457924|20501083|P1|FUP (Weeks 24-48)|Adverse Event|0
5926609|NCT01457924|20501079|P5|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|2
5926610|NCT01457924|20501080|P4|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0
5926611|NCT01457924|20501081|P3|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0
5926612|NCT01457924|20501082|P2|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1
5926613|NCT01457924|20501083|P1|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1
5926614|NCT01457924|20501079|P5|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1
5926615|NCT01457924|20501080|P4|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1
5926616|NCT01457924|20501081|P3|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0
5926617|NCT01457924|20501082|P2|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0
5926618|NCT01457924|20501083|P1|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0
5926619|NCT01457924|20501079|P5|Treatment Phase (Weeks 0-24)|Protocol Violation|0
5926620|NCT01457924|20501080|P4|Treatment Phase (Weeks 0-24)|Protocol Violation|0
5926621|NCT01457924|20501081|P3|Treatment Phase (Weeks 0-24)|Protocol Violation|1
5926622|NCT01457924|20501082|P2|Treatment Phase (Weeks 0-24)|Protocol Violation|0
5926623|NCT01457924|20501083|P1|Treatment Phase (Weeks 0-24)|Protocol Violation|1
5926624|NCT01457924|20501079|P5|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0
5926625|NCT01457924|20501080|P4|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0
5926626|NCT01457924|20501081|P3|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0
5926627|NCT01457924|20501082|P2|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0
5926628|NCT01457924|20501083|P1|Treatment Phase (Weeks 0-24)|Lack of Efficacy|1
5926629|NCT01457924|20501079|P5|Treatment Phase (Weeks 0-24)|Physician Decision|1
5926630|NCT01457924|20501080|P4|Treatment Phase (Weeks 0-24)|Physician Decision|0
5926631|NCT01457924|20501081|P3|Treatment Phase (Weeks 0-24)|Physician Decision|0
5926632|NCT01457924|20501082|P2|Treatment Phase (Weeks 0-24)|Physician Decision|0
5926633|NCT01457924|20501083|P1|Treatment Phase (Weeks 0-24)|Physician Decision|0
5926634|NCT01457924|20501079|P5|Treatment Phase (Weeks 0-24)|Adverse Event|2
5926635|NCT01457924|20501080|P4|Treatment Phase (Weeks 0-24)|Adverse Event|0
5926636|NCT01457924|20501081|P3|Treatment Phase (Weeks 0-24)|Adverse Event|1
5926637|NCT01457924|20501082|P2|Treatment Phase (Weeks 0-24)|Adverse Event|4
5926638|NCT01457924|20501083|P1|Treatment Phase (Weeks 0-24)|Adverse Event|0
5926639|NCT01457846|20501153|P2|Overall Study|Lost to Follow-up|0
5926640|NCT01457846|20501154|P1|Overall Study|Lost to Follow-up|1
5926641|NCT01457846|20501153|P2|Overall Study|Withdrawal by Subject|1
5926642|NCT01457846|20501154|P1|Overall Study|Withdrawal by Subject|1
5926643|NCT01457846|20501153|P2|Overall Study|Unclassified reason for not completed|10
5926644|NCT01457846|20501154|P1|Overall Study|Unclassified reason for not completed|11
5926645|NCT01457846|20501153|P2|Overall Study|Death|16
5926646|NCT01457846|20501154|P1|Overall Study|Death|27
5926647|NCT01457846|20501153|P2|Overall Study|Did not receive treatment|1
5926648|NCT01457846|20501154|P1|Overall Study|Did not receive treatment|0
5926649|NCT01457846|20501153|P2|Overall Study|Death before treatment|2
5926650|NCT01457846|20501154|P1|Overall Study|Death before treatment|1
5926651|NCT01457703|20501170|P2|Overall Study|Withdrawal by Subject|4
5926652|NCT01457703|20501171|P1|Overall Study|Withdrawal by Subject|1
5926653|NCT01457703|20501170|P2|Overall Study|Screen Failure|7
5926654|NCT01457703|20501171|P1|Overall Study|Screen Failure|5
5926655|NCT01457352|20501282|P2|Period 3|Sponsor's withdrawal|1
5926656|NCT01457352|20501283|P1|Period 3|Sponsor's withdrawal|0
5926657|NCT01457352|20501282|P2|Period 3|incorrect treatment|1
5926658|NCT01457352|20501283|P1|Period 3|incorrect treatment|0
5926659|NCT01457352|20501282|P2|Period 3|Withdrawal by Subject|2
5926660|NCT01457352|20501283|P1|Period 3|Withdrawal by Subject|0
5926661|NCT01457352|20501282|P2|Period 3|Adverse Event|1
5926662|NCT01457352|20501283|P1|Period 3|Adverse Event|1
5926663|NCT01457352|20501282|P2|Period 2|Did not meet eligibility criteria|0
5926664|NCT01457352|20501283|P1|Period 2|Did not meet eligibility criteria|3
5926665|NCT01457352|20501282|P2|Period 2|Physician Decision|0
5926666|NCT01457352|20501283|P1|Period 2|Physician Decision|1
5926667|NCT01457352|20501282|P2|Period 2|dose change|0
5926668|NCT01457352|20501283|P1|Period 2|dose change|1
5926669|NCT01457352|20501282|P2|Period 2|Lost to Follow-up|0
5926670|NCT01457352|20501283|P1|Period 2|Lost to Follow-up|1
5926671|NCT01457352|20501282|P2|Period 2|Sponsor's withdrawal|0
5926672|NCT01457352|20501283|P1|Period 2|Sponsor's withdrawal|7
5926673|NCT01457352|20501282|P2|Period 2|Protocol Violation|0
5926674|NCT01457352|20501283|P1|Period 2|Protocol Violation|4
5926675|NCT01457352|20501282|P2|Period 2|Lack of Efficacy|0
5926676|NCT01457352|20501283|P1|Period 2|Lack of Efficacy|8
5926677|NCT01457352|20501282|P2|Period 2|no analysis|0
5926678|NCT01457352|20501283|P1|Period 2|no analysis|10
5926679|NCT01457352|20501282|P2|Period 2|Adverse Event|0
5926680|NCT01457352|20501283|P1|Period 2|Adverse Event|22
5926681|NCT01457352|20501282|P2|Period 2|Withdrawal by Subject|0
5926682|NCT01457352|20501283|P1|Period 2|Withdrawal by Subject|23
5926683|NCT01457352|20501282|P2|Period 1|Did not meet eligibility criteria|0
5926684|NCT01457352|20501283|P1|Period 1|Did not meet eligibility criteria|3
5926685|NCT01457352|20501282|P2|Period 1|Protocol Violation|0
5926686|NCT01457352|20501283|P1|Period 1|Protocol Violation|4
5926687|NCT01457352|20501282|P2|Period 1|withdrew per sponsor|0
5926688|NCT01457352|20501283|P1|Period 1|withdrew per sponsor|1
5926689|NCT01457352|20501282|P2|Period 1|Withdrawn|0
5926690|NCT01457352|20501283|P1|Period 1|Withdrawn|1
5926691|NCT01457352|20501282|P2|Period 1|MS related disease progression|0
5926692|NCT01457352|20501283|P1|Period 1|MS related disease progression|1
5926693|NCT01457352|20501282|P2|Period 1|Physician Decision|0
5926694|NCT01457352|20501283|P1|Period 1|Physician Decision|2
5926695|NCT01457352|20501282|P2|Period 1|Withdrawal by Subject|0
5926696|NCT01457352|20501283|P1|Period 1|Withdrawal by Subject|2
5926697|NCT01457352|20501282|P2|Period 1|Adverse Event|0
5926698|NCT01457352|20501283|P1|Period 1|Adverse Event|2
5926699|NCT01457339|20501295|P2|Period 6 (250 mg)|Personal appointment|1
5926700|NCT01457339|20501296|P1|Period 6 (250 mg)|Personal appointment|0
5926701|NCT01457339|20501295|P2|Period 6 (250 mg)|Family Emergency|0
5926702|NCT01457339|20501296|P1|Period 6 (250 mg)|Family Emergency|1
5926703|NCT01457339|20501295|P2|Period 5 (200 mg)|Met stopping criteria for PANSS score|1
5926704|NCT01457339|20501296|P1|Period 5 (200 mg)|Met stopping criteria for PANSS score|0
5926705|NCT01457339|20501295|P2|Period 3 (100 mg)|Adverse Event|1
5926706|NCT01457339|20501296|P1|Period 3 (100 mg)|Adverse Event|0
5926707|NCT01457053|20501468|P2|Overall Study|Unable to undergo selected treatment|1
5926708|NCT01457053|20501469|P1|Overall Study|Unable to undergo selected treatment|1
5926709|NCT01457014|20501475|P4|First Night|Withdrawal by Subject|0
5926710|NCT01457014|20501476|P3|First Night|Withdrawal by Subject|0
5926711|NCT01457014|20501477|P2|First Night|Withdrawal by Subject|0
5926712|NCT01457014|20501478|P1|First Night|Withdrawal by Subject|3
5926713|NCT01457014|20501475|P4|First Night|Didn't meet inclusion/exclusion criteria|0
5926714|NCT01457014|20501476|P3|First Night|Didn't meet inclusion/exclusion criteria|0
5926715|NCT01457014|20501477|P2|First Night|Didn't meet inclusion/exclusion criteria|0
5926716|NCT01457014|20501478|P1|First Night|Didn't meet inclusion/exclusion criteria|37
5926717|NCT01456962|20501495|P2|Overall Study|Lost to Follow-up|1
5926718|NCT01456962|20501496|P1|Overall Study|Lost to Follow-up|2
5926719|NCT01456949|20501502|P1|Study Cryoablation Procedure & Follow-up|Treated did not meet I/E criteria|4
5926720|NCT01456949|20501502|P1|Study Cryoablation Procedure & Follow-up|Rollover not included in completer total|6
5926721|NCT01456949|20501502|P1|Study Cryoablation Procedure & Follow-up|Failure to maintain study compliance|2
5926722|NCT01456949|20501502|P1|Study Cryoablation Procedure & Follow-up|Subject Relocation|10
5926723|NCT01456949|20501502|P1|Study Cryoablation Procedure & Follow-up|Physician Decision|1
5926724|NCT01456949|20501502|P1|Study Cryoablation Procedure & Follow-up|Lost to Follow-up|11
5926725|NCT01456949|20501502|P1|Study Cryoablation Procedure & Follow-up|Withdrawal by Subject|23
5926726|NCT01456949|20501502|P1|Study Cryoablation Procedure & Follow-up|Death|5
5926727|NCT01456949|20501502|P1|Enrollment|Withdrawal by Subject|7
5926728|NCT01456949|20501502|P1|Enrollment|Physician Decision|10
5926729|NCT01456949|20501502|P1|Enrollment|I/E criteria not met prior to procedure|13
5926730|NCT01456949|20501502|P1|Enrollment|Death|1
5926731|NCT01456949|20501502|P1|Enrollment|PI death- incomplete data|6
5926732|NCT01456936|20501513|P4|Overall Study|Randomized but not treated|21
5926733|NCT01456936|20501514|P3|Overall Study|Randomized but not treated|16
5926734|NCT01456936|20501515|P2|Overall Study|Randomized but not treated|28
5926735|NCT01456936|20501516|P1|Overall Study|Randomized but not treated|21
5926736|NCT01456936|20501513|P4|Overall Study|Death|3
5926737|NCT01456936|20501514|P3|Overall Study|Death|1
5926738|NCT01456936|20501515|P2|Overall Study|Death|3
5926739|NCT01456936|20501516|P1|Overall Study|Death|0
5926740|NCT01456936|20501513|P4|Overall Study|Adverse event (study drug unrelated)|9
5926741|NCT01456936|20501514|P3|Overall Study|Adverse event (study drug unrelated)|9
5926742|NCT01456936|20501515|P2|Overall Study|Adverse event (study drug unrelated)|7
5926743|NCT01456936|20501516|P1|Overall Study|Adverse event (study drug unrelated)|9
5926744|NCT01456936|20501513|P4|Overall Study|Adverse event (study drug)|17
5926745|NCT01456936|20501514|P3|Overall Study|Adverse event (study drug)|26
5926746|NCT01456936|20501515|P2|Overall Study|Adverse event (study drug)|21
5926747|NCT01456936|20501516|P1|Overall Study|Adverse event (study drug)|25
5926748|NCT01456936|20501513|P4|Overall Study|Medication error|1
5926749|NCT01456936|20501514|P3|Overall Study|Medication error|0
5926750|NCT01456936|20501515|P2|Overall Study|Medication error|1
5926751|NCT01456936|20501516|P1|Overall Study|Medication error|0
5926752|NCT01456936|20501513|P4|Overall Study|Lost to Follow-up|127
5926753|NCT01456936|20501514|P3|Overall Study|Lost to Follow-up|144
5926754|NCT01456936|20501515|P2|Overall Study|Lost to Follow-up|126
5926755|NCT01456936|20501516|P1|Overall Study|Lost to Follow-up|135
5926756|NCT01456936|20501513|P4|Overall Study|No longer willing to participate|248
5926757|NCT01456936|20501514|P3|Overall Study|No longer willing to participate|224
5926758|NCT01456936|20501515|P2|Overall Study|No longer willing to participate|218
5926759|NCT01456936|20501516|P1|Overall Study|No longer willing to participate|195
5926760|NCT01456936|20501513|P4|Overall Study|Insufficient clinical response|13
5926761|NCT01456936|20501514|P3|Overall Study|Insufficient clinical response|14
5926762|NCT01456936|20501515|P2|Overall Study|Insufficient clinical response|4
5926763|NCT01456936|20501516|P1|Overall Study|Insufficient clinical response|4
5926764|NCT01456936|20501513|P4|Overall Study|Pregnancy|1
5926765|NCT01456936|20501514|P3|Overall Study|Pregnancy|0
5926766|NCT01456936|20501515|P2|Overall Study|Pregnancy|0
5926767|NCT01456936|20501516|P1|Overall Study|Pregnancy|1
5926768|NCT01456936|20501513|P4|Overall Study|Protocol Violation|5
5926769|NCT01456936|20501514|P3|Overall Study|Protocol Violation|5
5926770|NCT01456936|20501515|P2|Overall Study|Protocol Violation|2
5926771|NCT01456936|20501516|P1|Overall Study|Protocol Violation|4
5926772|NCT01456936|20501513|P4|Overall Study|No longer meets eligibility criteria|5
5926773|NCT01456936|20501514|P3|Overall Study|No longer meets eligibility criteria|6
5926774|NCT01456936|20501515|P2|Overall Study|No longer meets eligibility criteria|8
5926775|NCT01456936|20501516|P1|Overall Study|No longer meets eligibility criteria|4
5926776|NCT01456936|20501513|P4|Overall Study|Other reason|33
5926777|NCT01456936|20501514|P3|Overall Study|Other reason|36
5926778|NCT01456936|20501515|P2|Overall Study|Other reason|30
5926779|NCT01456936|20501516|P1|Overall Study|Other reason|41
5926780|NCT01456897|20501624|P2|Overall Study|Lack of Efficacy|11
5926781|NCT01456897|20501625|P1|Overall Study|Lack of Efficacy|4
5926782|NCT01456897|20501624|P2|Overall Study|Withdrawal by Subject|17
5926783|NCT01456897|20501625|P1|Overall Study|Withdrawal by Subject|44
5926784|NCT01456897|20501624|P2|Overall Study|Physician Decision|3
5926785|NCT01456897|20501625|P1|Overall Study|Physician Decision|5
5926786|NCT01456897|20501624|P2|Overall Study|Protocol Violation|4
5926787|NCT01456897|20501625|P1|Overall Study|Protocol Violation|3
5926788|NCT01456897|20501624|P2|Overall Study|Adverse Event|22
5926789|NCT01456897|20501625|P1|Overall Study|Adverse Event|19
5926790|NCT01456780|20501644|P3|Overall Study|Lost to Follow-up|0
5926791|NCT01456780|20501645|P2|Overall Study|Lost to Follow-up|3
5926792|NCT01456780|20501646|P1|Overall Study|Lost to Follow-up|3
5926793|NCT01456221|20501695|P2|Overall Study|Incomplete data|2
5926794|NCT01456221|20501696|P1|Overall Study|Incomplete data|4
5926795|NCT01456221|20501695|P2|Overall Study|Received medication|2
5926796|NCT01456221|20501696|P1|Overall Study|Received medication|3
5926797|NCT01456221|20501695|P2|Overall Study|Lost to Follow-up|4
5926798|NCT01456221|20501696|P1|Overall Study|Lost to Follow-up|1
5926799|NCT01456221|20501695|P2|Overall Study|Withdrawal by Subject|49
5926800|NCT01456221|20501696|P1|Overall Study|Withdrawal by Subject|56
5926801|NCT01456195|20501711|P3|Overall Study|Other Reasons|3
5926802|NCT01456195|20501712|P2|Overall Study|Other Reasons|1
5926803|NCT01456195|20501713|P1|Overall Study|Other Reasons|2
5926804|NCT01456195|20501711|P3|Overall Study|Lack of Efficacy|0
5926805|NCT01456195|20501712|P2|Overall Study|Lack of Efficacy|1
5926806|NCT01456195|20501713|P1|Overall Study|Lack of Efficacy|0
5926807|NCT01456195|20501711|P3|Overall Study|Voluntary Withdrawal|7
5926808|NCT01456195|20501712|P2|Overall Study|Voluntary Withdrawal|3
5926809|NCT01456195|20501713|P1|Overall Study|Voluntary Withdrawal|5
5926810|NCT01456195|20501711|P3|Overall Study|Lost to Follow-up|3
5926811|NCT01456195|20501712|P2|Overall Study|Lost to Follow-up|1
5926812|NCT01456195|20501713|P1|Overall Study|Lost to Follow-up|3
5926813|NCT01456195|20501711|P3|Overall Study|Pretreatment Event/Adverse Event|1
5926814|NCT01456195|20501712|P2|Overall Study|Pretreatment Event/Adverse Event|4
5926815|NCT01456195|20501713|P1|Overall Study|Pretreatment Event/Adverse Event|1
5926816|NCT01456169|20501733|P3|Overall Study|Other|0
5926817|NCT01456169|20501734|P2|Overall Study|Other|1
5926818|NCT01456169|20501735|P1|Overall Study|Other|1
5926819|NCT01456169|20501733|P3|Overall Study|Lack of Efficacy|0
5926820|NCT01456169|20501734|P2|Overall Study|Lack of Efficacy|0
5926821|NCT01456169|20501735|P1|Overall Study|Lack of Efficacy|2
5926822|NCT01456169|20501733|P3|Overall Study|Voluntary Withdrawal|2
5926823|NCT01456169|20501734|P2|Overall Study|Voluntary Withdrawal|0
5926824|NCT01456169|20501735|P1|Overall Study|Voluntary Withdrawal|3
5926825|NCT01456169|20501733|P3|Overall Study|Major Protocol Deviation|3
5926826|NCT01456169|20501734|P2|Overall Study|Major Protocol Deviation|2
5926827|NCT01456169|20501735|P1|Overall Study|Major Protocol Deviation|3
5926828|NCT01456169|20501733|P3|Overall Study|Adverse Event|7
5926829|NCT01456169|20501734|P2|Overall Study|Adverse Event|2
5926830|NCT01456169|20501735|P1|Overall Study|Adverse Event|1
5926831|NCT01456130|20501795|P1|Overall Study|Other|1
5926832|NCT01456130|20501795|P1|Overall Study|Lack of Efficacy|4
5926833|NCT01456130|20501795|P1|Overall Study|Voluntary Withdrawal|1
5926834|NCT01456130|20501795|P1|Overall Study|Adverse Event|4
5926835|NCT01456052|20501805|P3|Overall Study|Treatment Failure|1
5926836|NCT01456052|20501806|P2|Overall Study|Treatment Failure|1
5926837|NCT01456052|20501807|P1|Overall Study|Treatment Failure|0
5926838|NCT01456052|20501805|P3|Overall Study|Physician Decision|1
5926839|NCT01456052|20501806|P2|Overall Study|Physician Decision|0
5926840|NCT01456052|20501807|P1|Overall Study|Physician Decision|1
5926841|NCT01456052|20501805|P3|Overall Study|Protocol Violation|0
5926842|NCT01456052|20501806|P2|Overall Study|Protocol Violation|1
5926843|NCT01456052|20501807|P1|Overall Study|Protocol Violation|0
5926844|NCT01456052|20501805|P3|Overall Study|Consent withdrawn|1
5926845|NCT01456052|20501806|P2|Overall Study|Consent withdrawn|2
5926846|NCT01456052|20501807|P1|Overall Study|Consent withdrawn|0
5926847|NCT01456052|20501805|P3|Overall Study|Adverse Event|2
5926848|NCT01456052|20501806|P2|Overall Study|Adverse Event|1
5926849|NCT01456052|20501807|P1|Overall Study|Adverse Event|1
5926850|NCT01456039|20501827|P3|Phase 2 (Second Step)|Other|1
5926851|NCT01456039|20501828|P2|Phase 2 (Second Step)|Other|0
5926852|NCT01456039|20501829|P1|Phase 2 (Second Step)|Other|0
5926853|NCT01456039|20501827|P3|Phase 2 (Second Step)|Protocol Violation|1
5926854|NCT01456039|20501828|P2|Phase 2 (Second Step)|Protocol Violation|0
5926855|NCT01456039|20501829|P1|Phase 2 (Second Step)|Protocol Violation|0
5926856|NCT01456039|20501827|P3|Phase 2 (Second Step)|Withdrawal by Subject|4
5926857|NCT01456039|20501828|P2|Phase 2 (Second Step)|Withdrawal by Subject|0
5926858|NCT01456039|20501829|P1|Phase 2 (Second Step)|Withdrawal by Subject|0
5926859|NCT01456039|20501827|P3|Phase 2 (Second Step)|Adverse Event|10
5926860|NCT01456039|20501828|P2|Phase 2 (Second Step)|Adverse Event|0
5926861|NCT01456039|20501829|P1|Phase 2 (Second Step)|Adverse Event|0
5926862|NCT01456039|20501827|P3|Phase 2 (Second Step)|Disease Progression|17
5926863|NCT01456039|20501828|P2|Phase 2 (Second Step)|Disease Progression|0
5926864|NCT01456039|20501829|P1|Phase 2 (Second Step)|Disease Progression|0
5926865|NCT01456039|20501827|P3|Phase 1 (First Step)|Other|0
5926866|NCT01456039|20501828|P2|Phase 1 (First Step)|Other|1
5926867|NCT01456039|20501829|P1|Phase 1 (First Step)|Other|0
5926868|NCT01456039|20501827|P3|Phase 1 (First Step)|Adverse Event|0
5926869|NCT01456039|20501828|P2|Phase 1 (First Step)|Adverse Event|3
5926870|NCT01456039|20501829|P1|Phase 1 (First Step)|Adverse Event|0
5926871|NCT01456039|20501827|P3|Phase 1 (First Step)|Withdrawal by Subject|0
5926872|NCT01456039|20501828|P2|Phase 1 (First Step)|Withdrawal by Subject|2
5926873|NCT01456039|20501829|P1|Phase 1 (First Step)|Withdrawal by Subject|1
5926874|NCT01456039|20501827|P3|Phase 1 (First Step)|Disease Progression|0
5926875|NCT01456039|20501828|P2|Phase 1 (First Step)|Disease Progression|1
5926876|NCT01456039|20501829|P1|Phase 1 (First Step)|Disease Progression|1
5926877|NCT01455220|20501970|P1|Overall Study|screen fail|30
5926878|NCT01455194|20501980|P4|Overall Study|Miscellaneous|4
5926879|NCT01455194|20501981|P3|Overall Study|Miscellaneous|1
5926880|NCT01455194|20501982|P2|Overall Study|Miscellaneous|5
5926881|NCT01455194|20501983|P1|Overall Study|Miscellaneous|4
5926882|NCT01455194|20501980|P4|Overall Study|Discontinuation criterion fulfilled|2
5926883|NCT01455194|20501981|P3|Overall Study|Discontinuation criterion fulfilled|0
5926884|NCT01455194|20501982|P2|Overall Study|Discontinuation criterion fulfilled|2
5926885|NCT01455194|20501983|P1|Overall Study|Discontinuation criterion fulfilled|3
5926886|NCT01455194|20501980|P4|Overall Study|Pregnancy|0
5926887|NCT01455194|20501981|P3|Overall Study|Pregnancy|1
5926888|NCT01455194|20501982|P2|Overall Study|Pregnancy|1
5926889|NCT01455194|20501983|P1|Overall Study|Pregnancy|0
5926890|NCT01455194|20501980|P4|Overall Study|Lost to Follow-up|1
5926891|NCT01455194|20501981|P3|Overall Study|Lost to Follow-up|1
5926892|NCT01455194|20501982|P2|Overall Study|Lost to Follow-up|0
5926893|NCT01455194|20501983|P1|Overall Study|Lost to Follow-up|2
5926894|NCT01455194|20501980|P4|Overall Study|Withdrawal by Subject|9
5926895|NCT01455194|20501981|P3|Overall Study|Withdrawal by Subject|12
5926896|NCT01455194|20501982|P2|Overall Study|Withdrawal by Subject|16
5926897|NCT01455194|20501983|P1|Overall Study|Withdrawal by Subject|21
5926898|NCT01455194|20501980|P4|Overall Study|Adverse Event|3
5926899|NCT01455194|20501981|P3|Overall Study|Adverse Event|1
5926900|NCT01455194|20501982|P2|Overall Study|Adverse Event|1
5926901|NCT01455194|20501983|P1|Overall Study|Adverse Event|1
5926902|NCT01455194|20501980|P4|Overall Study|Deterioration in asthma|9
5926903|NCT01455194|20501981|P3|Overall Study|Deterioration in asthma|14
5926904|NCT01455194|20501982|P2|Overall Study|Deterioration in asthma|6
5926905|NCT01455194|20501983|P1|Overall Study|Deterioration in asthma|12
5926906|NCT01455194|20501980|P4|Overall Study|Randomisation Failure|0
5926907|NCT01455194|20501981|P3|Overall Study|Randomisation Failure|0
5926908|NCT01455194|20501982|P2|Overall Study|Randomisation Failure|0
5926909|NCT01455194|20501983|P1|Overall Study|Randomisation Failure|90
5926910|NCT01455194|20501980|P4|Overall Study|Screen Failure|0
5926911|NCT01455194|20501981|P3|Overall Study|Screen Failure|0
5926912|NCT01455194|20501982|P2|Overall Study|Screen Failure|0
5926913|NCT01455194|20501983|P1|Overall Study|Screen Failure|20
5926914|NCT01455012|20502046|P2|Overall Study|Unknown reason|0
5926915|NCT01455012|20502047|P1|Overall Study|Unknown reason|2
5926916|NCT01455012|20502046|P2|Overall Study|Withdrawal by Subject|1
5926917|NCT01455012|20502047|P1|Overall Study|Withdrawal by Subject|3
5926918|NCT01455012|20502046|P2|Overall Study|Lack of Efficacy|1
5926919|NCT01455012|20502047|P1|Overall Study|Lack of Efficacy|6
5926920|NCT01455012|20502046|P2|Overall Study|Adverse Event|2
5926921|NCT01455012|20502047|P1|Overall Study|Adverse Event|0
5926922|NCT01454934|20502114|P2|Overall Study|Not treated|2
5926923|NCT01454934|20502115|P1|Overall Study|Not treated|1
5926924|NCT01454934|20502114|P2|Overall Study|Lost to Follow-up|1
5926925|NCT01454934|20502115|P1|Overall Study|Lost to Follow-up|0
5926926|NCT01454934|20502114|P2|Overall Study|Disease progression|181
5926927|NCT01454934|20502115|P1|Overall Study|Disease progression|194
5926928|NCT01454934|20502114|P2|Overall Study|Withdrawal by Subject|15
5926929|NCT01454934|20502115|P1|Overall Study|Withdrawal by Subject|11
5926930|NCT01454934|20502114|P2|Overall Study|Withdrawn consent|5
5926931|NCT01454934|20502115|P1|Overall Study|Withdrawn consent|2
5926932|NCT01454934|20502114|P2|Overall Study|Adverse Event|24
5926933|NCT01454934|20502115|P1|Overall Study|Adverse Event|28
5926934|NCT01454934|20502114|P2|Overall Study|Other|17
5926935|NCT01454934|20502115|P1|Overall Study|Other|6
5926936|NCT01454934|20502114|P2|Overall Study|Clinical progression|25
5926937|NCT01454934|20502115|P1|Overall Study|Clinical progression|28
5926938|NCT01454830|20502127|P2|Overall Study|Withdrawal - no polysomnography|2
5926939|NCT01454830|20502128|P1|Overall Study|Withdrawal - no polysomnography|3
5926940|NCT01454830|20502127|P2|Overall Study|Post-allocation Exclude-other treatment|7
5926941|NCT01454830|20502128|P1|Overall Study|Post-allocation Exclude-other treatment|6
5926942|NCT01454830|20502127|P2|Overall Study|Post-allocation Exclude-refused PAP|2
5926943|NCT01454830|20502128|P1|Overall Study|Post-allocation Exclude-refused PAP|0
5926944|NCT01454830|20502127|P2|Overall Study|Post-allocation Exclude- AHI<10|12
5926945|NCT01454830|20502128|P1|Overall Study|Post-allocation Exclude- AHI<10|18
5926946|NCT01454830|20502127|P2|Overall Study|Withdrawal by Subject|4
5926947|NCT01454830|20502128|P1|Overall Study|Withdrawal by Subject|4
5926948|NCT01454778|20502159|P1|Overall Study|Death|1
5926949|NCT01454778|20502159|P1|Overall Study|Lost to Follow-up|2
5926950|NCT01454739|20502170|P2|Overall Study|Adverse Event|1
5926951|NCT01454739|20502171|P1|Overall Study|Adverse Event|0
5926952|NCT01454739|20502170|P2|Overall Study|Lost to Follow-up|1
5926953|NCT01454739|20502171|P1|Overall Study|Lost to Follow-up|0
5926954|NCT01454739|20502170|P2|Overall Study|Physician Decision|5
5926955|NCT01454739|20502171|P1|Overall Study|Physician Decision|0
5926956|NCT01454739|20502170|P2|Overall Study|Other|5
5926957|NCT01454739|20502171|P1|Overall Study|Other|3
5926958|NCT01454739|20502170|P2|Overall Study|Withdrawal by Subject|6
5926959|NCT01454739|20502171|P1|Overall Study|Withdrawal by Subject|2
5926960|NCT01454739|20502170|P2|Overall Study|Protocol Violation|3
5926961|NCT01454739|20502171|P1|Overall Study|Protocol Violation|2
5926962|NCT01454726|20502200|P2|Overall Study|Withdrawal by Subject|1
5926963|NCT01454726|20502201|P1|Overall Study|Withdrawal by Subject|0
5926964|NCT01454596|20502219|P12|Overall Study|Death|0
5926965|NCT01454596|20502220|P11|Overall Study|Death|1
5926966|NCT01454596|20502221|P10|Overall Study|Death|1
5926967|NCT01454596|20502222|P9|Overall Study|Death|0
5926968|NCT01454596|20502223|P8|Overall Study|Death|0
5926969|NCT01454596|20502224|P7|Overall Study|Death|0
5926970|NCT01454596|20502225|P6|Overall Study|Death|0
5926971|NCT01454596|20502226|P5|Overall Study|Death|0
5926972|NCT01454596|20502227|P4|Overall Study|Death|0
5926973|NCT01454596|20502228|P3|Overall Study|Death|0
5926974|NCT01454596|20502229|P2|Overall Study|Death|0
5926975|NCT01454596|20502230|P1|Overall Study|Death|0
5926976|NCT01454583|20502307|P3|3rd Year|Lost to Follow-up|297
5926977|NCT01454583|20502308|P2|3rd Year|Lost to Follow-up|512
5926978|NCT01454583|20502309|P1|3rd Year|Lost to Follow-up|1959
5926979|NCT01454583|20502307|P3|2nd Year|Lost to Follow-up|737
5926980|NCT01454583|20502308|P2|2nd Year|Lost to Follow-up|1049
5926981|NCT01454583|20502309|P1|2nd Year|Lost to Follow-up|3965
5926982|NCT01454583|20502307|P3|1st Year|Lost to Follow-up|180
5926983|NCT01454583|20502308|P2|1st Year|Lost to Follow-up|318
5926984|NCT01454583|20502309|P1|1st Year|Lost to Follow-up|1057
5926985|NCT01454570|20502377|P1|Overall Study|Screen Failure|7
5926986|NCT01454570|20502377|P1|Overall Study|Withdrawal by Subject|2
5926987|NCT01454531|20502381|P1|Overall Study|Other|1
5926988|NCT01454531|20502381|P1|Overall Study|Delay in IMP administration|1
5926989|NCT01454531|20502381|P1|Overall Study|Physician Decision|1
5926990|NCT01454531|20502381|P1|Overall Study|Lost to Follow-up|1
5926991|NCT01454531|20502381|P1|Overall Study|Withdrawal by Subject|5
5926992|NCT01454531|20502381|P1|Overall Study|Adverse Event|14
5926993|NCT01454401|20502417|P1|Overall Study|non-adherence|1
5926994|NCT01454401|20502417|P1|Overall Study|osteomyelitis|2
5926995|NCT01454401|20502417|P1|Overall Study|hospitalised|1
5926996|NCT01454401|20502417|P1|Overall Study|Death|1
5926997|NCT01454284|20502441|P2|Overall Study|Sponsor Decision|2
5926998|NCT01454284|20502442|P1|Overall Study|Sponsor Decision|0
5926999|NCT01454284|20502441|P2|Overall Study|Physician Decision|11
5927000|NCT01454284|20502442|P1|Overall Study|Physician Decision|16
5927001|NCT01454284|20502441|P2|Overall Study|Withdrawal by Subject|36
5927002|NCT01454284|20502442|P1|Overall Study|Withdrawal by Subject|58
5927003|NCT01454284|20502441|P2|Overall Study|Protocol Violation|6
5927004|NCT01454284|20502442|P1|Overall Study|Protocol Violation|9
5927005|NCT01454284|20502441|P2|Overall Study|Lost to Follow-up|8
5927006|NCT01454284|20502442|P1|Overall Study|Lost to Follow-up|13
5927007|NCT01454284|20502441|P2|Overall Study|Death|3
5927008|NCT01454284|20502442|P1|Overall Study|Death|0
5927009|NCT01454284|20502441|P2|Overall Study|Adverse Event|7
5927010|NCT01454284|20502442|P1|Overall Study|Adverse Event|20
5927011|NCT01454102|20502512|P16|Overall Study|Continuing in the treatment period|1
5927012|NCT01454102|20502513|P15|Overall Study|Continuing in the treatment period|3
5927013|NCT01454102|20502514|P14|Overall Study|Continuing in the treatment period|4
5927014|NCT01454102|20502515|P13|Overall Study|Continuing in the treatment period|7
5927015|NCT01454102|20502516|P12|Overall Study|Continuing in the treatment period|4
5927016|NCT01454102|20502517|P11|Overall Study|Continuing in the treatment period|0
5927017|NCT01454102|20502518|P10|Overall Study|Continuing in the treatment period|0
5927018|NCT01454102|20502519|P9|Overall Study|Continuing in the treatment period|1
5927019|NCT01454102|20502520|P8|Overall Study|Continuing in the treatment period|0
5927020|NCT01454102|20502521|P7|Overall Study|Continuing in the treatment period|2
5927021|NCT01454102|20502522|P6|Overall Study|Continuing in the treatment period|3
5927022|NCT01454102|20502523|P5|Overall Study|Continuing in the treatment period|3
5927023|NCT01454102|20502524|P4|Overall Study|Continuing in the treatment period|0
5927024|NCT01454102|20502525|P3|Overall Study|Continuing in the treatment period|0
5927025|NCT01454102|20502526|P2|Overall Study|Continuing in the treatment period|0
5927026|NCT01454102|20502527|P1|Overall Study|Continuing in the treatment period|0
5927027|NCT01454076|20502647|P5|Overall Study|Adverse Event|2
5927028|NCT01454076|20502648|P4|Overall Study|Adverse Event|0
5927029|NCT01454076|20502649|P3|Overall Study|Adverse Event|7
5927030|NCT01454076|20502650|P2|Overall Study|Adverse Event|2
5927031|NCT01454076|20502651|P1|Overall Study|Adverse Event|8
5927032|NCT01454076|20502647|P5|Overall Study|Withdrawal by Subject|2
5927033|NCT01454076|20502648|P4|Overall Study|Withdrawal by Subject|1
5927034|NCT01454076|20502649|P3|Overall Study|Withdrawal by Subject|2
5927035|NCT01454076|20502650|P2|Overall Study|Withdrawal by Subject|4
5927036|NCT01454076|20502651|P1|Overall Study|Withdrawal by Subject|3
5927037|NCT01454076|20502647|P5|Overall Study|Other|2
5927038|NCT01454076|20502648|P4|Overall Study|Other|1
5927039|NCT01454076|20502649|P3|Overall Study|Other|0
5927040|NCT01454076|20502650|P2|Overall Study|Other|0
5927041|NCT01454076|20502651|P1|Overall Study|Other|2
5927042|NCT01454063|20502704|P2|Randomized|Protocol Violation|1
5927043|NCT01454063|20502705|P1|Randomized|Protocol Violation|0
5927044|NCT01454063|20502704|P2|Randomized|Adverse Event|1
5927045|NCT01454063|20502705|P1|Randomized|Adverse Event|1
5927046|NCT01453998|20502726|P3|After Protocol Amendment 2.|Withdrawal by Subject|0
5927047|NCT01453998|20502727|P2|After Protocol Amendment 2.|Withdrawal by Subject|0
5927048|NCT01453998|20502728|P1|After Protocol Amendment 2.|Withdrawal by Subject|1
5927049|NCT01453946|20502892|P1|Overall Study|Adverse Event|3
5927050|NCT01453946|20502892|P1|Overall Study|Lack of Efficacy|3
5927051|NCT01453946|20502892|P1|Overall Study|Protocol Violation|2
5927052|NCT01453946|20502892|P1|Overall Study|Did not receive drug for the taper phase|1
5927053|NCT01453855|20502909|P2|Overall Study|Other|1
5927054|NCT01453855|20502910|P1|Overall Study|Other|0
5927055|NCT01453855|20502909|P2|Overall Study|Inadequate Control of IOP|5
5927056|NCT01453855|20502910|P1|Overall Study|Inadequate Control of IOP|1
5927057|NCT01453855|20502909|P2|Overall Study|Noncompliance|0
5927058|NCT01453855|20502910|P1|Overall Study|Noncompliance|1
5927059|NCT01453855|20502909|P2|Overall Study|Patient Decision Unrel to Adverse Event|3
5927060|NCT01453855|20502910|P1|Overall Study|Patient Decision Unrel to Adverse Event|3
5927061|NCT01453855|20502909|P2|Overall Study|Lost to Follow-up|1
5927062|NCT01453855|20502910|P1|Overall Study|Lost to Follow-up|2
5927063|NCT01453855|20502909|P2|Overall Study|Adverse Event|4
5927064|NCT01453855|20502910|P1|Overall Study|Adverse Event|3
5927065|NCT01453725|20502918|P2|Overall Study|Physician Decision|1
5927066|NCT01453725|20502919|P1|Overall Study|Physician Decision|1
5927067|NCT01453725|20502918|P2|Overall Study|Pregnancy|0
5927068|NCT01453725|20502919|P1|Overall Study|Pregnancy|1
5927069|NCT01453725|20502918|P2|Overall Study|Pregnancy Wish|2
5927070|NCT01453725|20502919|P1|Overall Study|Pregnancy Wish|0
5927071|NCT01453725|20502918|P2|Overall Study|Withdrawal by Subject|3
5927072|NCT01453725|20502919|P1|Overall Study|Withdrawal by Subject|2
5927073|NCT01453725|20502918|P2|Overall Study|Protocol Violation|0
5927074|NCT01453725|20502919|P1|Overall Study|Protocol Violation|1
5927075|NCT01453725|20502918|P2|Overall Study|Non-compliance With Protocol|2
5927076|NCT01453725|20502919|P1|Overall Study|Non-compliance With Protocol|1
5927077|NCT01453725|20502918|P2|Overall Study|Lost to Follow-up|0
5927078|NCT01453725|20502919|P1|Overall Study|Lost to Follow-up|4
5927079|NCT01453725|20502918|P2|Overall Study|Adverse Event|3
5927080|NCT01453725|20502919|P1|Overall Study|Adverse Event|3
5927081|NCT01453595|20502942|P3|Overall Study|Dose Limiting Toxicity (DLT)|2
5927082|NCT01453595|20502943|P2|Overall Study|Dose Limiting Toxicity (DLT)|1
5927083|NCT01453595|20502944|P1|Overall Study|Dose Limiting Toxicity (DLT)|2
5927084|NCT01453439|20502974|P2|Follow-up|Lost to Follow-up|10
5927085|NCT01453439|20502975|P1|Follow-up|Lost to Follow-up|5
5927086|NCT01453439|20502974|P2|Follow-up|Withdrawal by Subject|1
5927087|NCT01453439|20502975|P1|Follow-up|Withdrawal by Subject|0
5927088|NCT01453439|20502974|P2|Treatment Phase|Therapist conflict of interest|0
5927089|NCT01453439|20502975|P1|Treatment Phase|Therapist conflict of interest|1
5927090|NCT01453439|20502974|P2|Treatment Phase|Need for higher level of care|1
5927091|NCT01453439|20502975|P1|Treatment Phase|Need for higher level of care|1
5927092|NCT01453439|20502974|P2|Treatment Phase|Suicidal Ideation|0
5927093|NCT01453439|20502975|P1|Treatment Phase|Suicidal Ideation|2
5927094|NCT01453439|20502974|P2|Treatment Phase|Withdrawal by Subject|10
5927095|NCT01453439|20502975|P1|Treatment Phase|Withdrawal by Subject|13
5927096|NCT01453374|20503086|P1|Overall Study|Incarcerated|2
5927097|NCT01453374|20503086|P1|Overall Study|Withdrawal by Subject|5
5927098|NCT01453374|20503086|P1|Overall Study|Lost to Follow-up|3
5927099|NCT01453374|20503086|P1|Overall Study|Lack of Efficacy|1
5927100|NCT01453374|20503086|P1|Overall Study|Adverse Event|7
5927101|NCT01453361|20503102|P1|Overall Study|Screen-Failures|10
5927102|NCT01453361|20503102|P1|Overall Study|Disease Progression|6
5927103|NCT01453348|20503110|P3|Overall Study|Protocol Violation|0
5927104|NCT01453348|20503111|P2|Overall Study|Protocol Violation|0
5927105|NCT01453348|20503112|P1|Overall Study|Protocol Violation|1
5927106|NCT01453348|20503110|P3|Overall Study|Withdrawal by Subject|0
5927107|NCT01453348|20503111|P2|Overall Study|Withdrawal by Subject|1
5927108|NCT01453348|20503112|P1|Overall Study|Withdrawal by Subject|0
5927109|NCT01453348|20503110|P3|Overall Study|Death|1
5927110|NCT01453348|20503111|P2|Overall Study|Death|0
5927111|NCT01453348|20503112|P1|Overall Study|Death|0
5927112|NCT01453296|20503128|P2|Treatment Period 2|Withdrawal by Subject|0
5927113|NCT01453296|20503129|P1|Treatment Period 2|Withdrawal by Subject|1
5927114|NCT01453296|20503128|P2|Treatment Period 2|Adverse Event|0
5927115|NCT01453296|20503129|P1|Treatment Period 2|Adverse Event|1
5927116|NCT01453296|20503128|P2|Treatment Period 1|Met Protocol-Defined Stopping Criteria|0
5927117|NCT01453296|20503129|P1|Treatment Period 1|Met Protocol-Defined Stopping Criteria|1
5927118|NCT01453296|20503128|P2|Treatment Period 1|Adverse Event|1
5927119|NCT01453296|20503129|P1|Treatment Period 1|Adverse Event|0
5927120|NCT01453205|20503196|P3|Overall Study|Other|35
5927121|NCT01453205|20503197|P2|Overall Study|Other|27
5927122|NCT01453205|20503198|P1|Overall Study|Other|45
5927123|NCT01453205|20503196|P3|Overall Study|Death|18
5927124|NCT01453205|20503197|P2|Overall Study|Death|22
5927125|NCT01453205|20503198|P1|Overall Study|Death|24
5927126|NCT01453205|20503196|P3|Overall Study|Withdrawal by Subject|0
5927127|NCT01453205|20503197|P2|Overall Study|Withdrawal by Subject|3
5927128|NCT01453205|20503198|P1|Overall Study|Withdrawal by Subject|8
5927129|NCT01453205|20503196|P3|Overall Study|Lost to Follow-up|1
5927130|NCT01453205|20503197|P2|Overall Study|Lost to Follow-up|0
5927131|NCT01453205|20503198|P1|Overall Study|Lost to Follow-up|3
5927132|NCT01453153|20503274|P3|Overall Study|Adverse Event|1
5927133|NCT01453153|20503275|P2|Overall Study|Adverse Event|1
5927134|NCT01453153|20503276|P1|Overall Study|Adverse Event|1
5927135|NCT01453153|20503274|P3|Overall Study|Withdrawal by Subject|2
5927136|NCT01453153|20503275|P2|Overall Study|Withdrawal by Subject|1
5927137|NCT01453153|20503276|P1|Overall Study|Withdrawal by Subject|0
5927138|NCT01453153|20503274|P3|Overall Study|Progressive Disease|16
5927139|NCT01453153|20503275|P2|Overall Study|Progressive Disease|2
5927140|NCT01453153|20503276|P1|Overall Study|Progressive Disease|3
5927141|NCT01453153|20503274|P3|Overall Study|Physician Decision|1
5927142|NCT01453153|20503275|P2|Overall Study|Physician Decision|0
5927143|NCT01453153|20503276|P1|Overall Study|Physician Decision|0
5927144|NCT01453049|20503358|P2|Overall Study|Randomized in Error|0
5927145|NCT01453049|20503359|P1|Overall Study|Randomized in Error|1
5927146|NCT01453049|20503358|P2|Overall Study|Withdrawal by Subject|0
5927147|NCT01453049|20503359|P1|Overall Study|Withdrawal by Subject|1
5927148|NCT01453049|20503358|P2|Overall Study|Withdrawn When Sponsor Terminated Study|36
5927149|NCT01453049|20503359|P1|Overall Study|Withdrawn When Sponsor Terminated Study|35
5927150|NCT01453049|20503358|P2|Overall Study|Lost to Follow-up|1
5927151|NCT01453049|20503359|P1|Overall Study|Lost to Follow-up|2
5927152|NCT01453049|20503358|P2|Overall Study|Protocol Violation|5
5927153|NCT01453049|20503359|P1|Overall Study|Protocol Violation|2
5927154|NCT01453036|20503432|P3|Overall Study|Lost to Follow-up|31
5927155|NCT01453036|20503433|P2|Overall Study|Lost to Follow-up|115
5927156|NCT01453036|20503434|P1|Overall Study|Lost to Follow-up|26
5927157|NCT01453023|20503442|P2|Treatment Period 2|Protocol Violation|1
5927158|NCT01453023|20503443|P1|Treatment Period 2|Protocol Violation|0
5927159|NCT01453023|20503442|P2|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|1
5927160|NCT01453023|20503443|P1|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|0
5927161|NCT01453023|20503442|P2|Treatment Period (TP) 1|Protocol Violation|0
5927162|NCT01453023|20503443|P1|Treatment Period (TP) 1|Protocol Violation|1
5927163|NCT01452789|20503517|P2|Overall Study|Withdrawal by Subject|2
5927164|NCT01452789|20503518|P1|Overall Study|Withdrawal by Subject|3
5927165|NCT01452529|20503532|P3|Double-blind (DB) Period|Administrative|7
5927166|NCT01452529|20503533|P2|Double-blind (DB) Period|Administrative|11
5927167|NCT01452529|20503534|P1|Double-blind (DB) Period|Administrative|0
5927168|NCT01452529|20503532|P3|Double-blind (DB) Period|Confirmed or suspected diversion|3
5927169|NCT01452529|20503533|P2|Double-blind (DB) Period|Confirmed or suspected diversion|2
5927170|NCT01452529|20503534|P1|Double-blind (DB) Period|Confirmed or suspected diversion|0
5927171|NCT01452529|20503532|P3|Double-blind (DB) Period|Lack of Efficacy|44
5927172|NCT01452529|20503533|P2|Double-blind (DB) Period|Lack of Efficacy|16
5927173|NCT01452529|20503534|P1|Double-blind (DB) Period|Lack of Efficacy|0
5927174|NCT01452529|20503532|P3|Double-blind (DB) Period|Lost to Follow-up|3
5927175|NCT01452529|20503533|P2|Double-blind (DB) Period|Lost to Follow-up|5
5927176|NCT01452529|20503534|P1|Double-blind (DB) Period|Lost to Follow-up|0
5927177|NCT01452529|20503532|P3|Double-blind (DB) Period|Withdrawal by Subject|14
5927178|NCT01452529|20503533|P2|Double-blind (DB) Period|Withdrawal by Subject|15
5927179|NCT01452529|20503534|P1|Double-blind (DB) Period|Withdrawal by Subject|0
5927180|NCT01452529|20503532|P3|Double-blind (DB) Period|Adverse Event|11
5927181|NCT01452529|20503533|P2|Double-blind (DB) Period|Adverse Event|18
5927182|NCT01452529|20503534|P1|Double-blind (DB) Period|Adverse Event|0
5927183|NCT01452529|20503532|P3|Run-in Period|Did not qualify for Double-Blind Phase|0
5927184|NCT01452529|20503533|P2|Run-in Period|Did not qualify for Double-Blind Phase|0
5927185|NCT01452529|20503534|P1|Run-in Period|Did not qualify for Double-Blind Phase|59
5927186|NCT01452529|20503532|P3|Run-in Period|Administrative|0
5927187|NCT01452529|20503533|P2|Run-in Period|Administrative|0
5927188|NCT01452529|20503534|P1|Run-in Period|Administrative|21
5927189|NCT01452529|20503532|P3|Run-in Period|Confirmed or suspected diversion|0
5927190|NCT01452529|20503533|P2|Run-in Period|Confirmed or suspected diversion|0
5927191|NCT01452529|20503534|P1|Run-in Period|Confirmed or suspected diversion|23
5927192|NCT01452529|20503532|P3|Run-in Period|Lack of Efficacy|0
5927193|NCT01452529|20503533|P2|Run-in Period|Lack of Efficacy|0
5927194|NCT01452529|20503534|P1|Run-in Period|Lack of Efficacy|46
5927195|NCT01452529|20503532|P3|Run-in Period|Lost to Follow-up|0
5927196|NCT01452529|20503533|P2|Run-in Period|Lost to Follow-up|0
5927197|NCT01452529|20503534|P1|Run-in Period|Lost to Follow-up|19
5927198|NCT01452529|20503532|P3|Run-in Period|Withdrawal by Subject|0
5927199|NCT01452529|20503533|P2|Run-in Period|Withdrawal by Subject|0
5927200|NCT01452529|20503534|P1|Run-in Period|Withdrawal by Subject|49
5927201|NCT01452529|20503532|P3|Run-in Period|Adverse Event|0
5927202|NCT01452529|20503533|P2|Run-in Period|Adverse Event|0
5927203|NCT01452529|20503534|P1|Run-in Period|Adverse Event|96
5927204|NCT01452412|20503556|P2|Overall Study|Other|0
5927205|NCT01452412|20503557|P1|Overall Study|Other|2
5927206|NCT01452412|20503556|P2|Overall Study|Initiated dialysis|0
5927207|NCT01452412|20503557|P1|Overall Study|Initiated dialysis|1
5927208|NCT01452412|20503556|P2|Overall Study|Death|0
5927209|NCT01452412|20503557|P1|Overall Study|Death|1
5927210|NCT01452412|20503556|P2|Overall Study|Lost to Follow-up|3
5927211|NCT01452412|20503557|P1|Overall Study|Lost to Follow-up|5
5927212|NCT01452412|20503556|P2|Overall Study|Adverse Event|3
5927213|NCT01452412|20503557|P1|Overall Study|Adverse Event|4
5927214|NCT01452412|20503556|P2|Overall Study|Withdrawal by Subject|11
5927215|NCT01452412|20503557|P1|Overall Study|Withdrawal by Subject|15
5927216|NCT01452347|20503573|P2|Overall Study|Other reason not defined above|0
5927217|NCT01452347|20503574|P1|Overall Study|Other reason not defined above|2
5927218|NCT01452347|20503573|P2|Overall Study|Not treated|3
5927219|NCT01452347|20503574|P1|Overall Study|Not treated|6
5927220|NCT01452347|20503573|P2|Overall Study|Withdrawal by Subject|3
5927221|NCT01452347|20503574|P1|Overall Study|Withdrawal by Subject|3
5927222|NCT01452347|20503573|P2|Overall Study|Lost to Follow-up|0
5927223|NCT01452347|20503574|P1|Overall Study|Lost to Follow-up|2
5927224|NCT01452347|20503573|P2|Overall Study|Non compliance protocol|0
5927225|NCT01452347|20503574|P1|Overall Study|Non compliance protocol|2
5927226|NCT01452347|20503573|P2|Overall Study|Adverse Event|1
5927227|NCT01452347|20503574|P1|Overall Study|Adverse Event|2
5927228|NCT01452152|20503634|P3|Overall Study|Study termination by sponsor|4
5927229|NCT01452152|20503635|P2|Overall Study|Study termination by sponsor|0
5927230|NCT01452152|20503636|P1|Overall Study|Study termination by sponsor|5
5927231|NCT01451931|20503708|P3|Overall Study|Withdrawal by Subject|22
5927232|NCT01451931|20503709|P2|Overall Study|Withdrawal by Subject|22
5927233|NCT01451931|20503710|P1|Overall Study|Withdrawal by Subject|16
5927234|NCT01451931|20503708|P3|Overall Study|Lost to Follow-up|21
5927235|NCT01451931|20503709|P2|Overall Study|Lost to Follow-up|36
5927236|NCT01451931|20503710|P1|Overall Study|Lost to Follow-up|17
5927237|NCT01451827|20503734|P4|Overall Study|Withdrawal by Subject|1
5927238|NCT01451827|20503735|P3|Overall Study|Withdrawal by Subject|1
5927239|NCT01451827|20503736|P2|Overall Study|Withdrawal by Subject|0
5927240|NCT01451827|20503737|P1|Overall Study|Withdrawal by Subject|0
5927241|NCT01451827|20503734|P4|Overall Study|Participant met withdrawal criteria|0
5927242|NCT01451827|20503735|P3|Overall Study|Participant met withdrawal criteria|0
5927243|NCT01451827|20503736|P2|Overall Study|Participant met withdrawal criteria|2
5927244|NCT01451827|20503737|P1|Overall Study|Participant met withdrawal criteria|0
5927245|NCT01451827|20503734|P4|Overall Study|Lost to Follow-up|2
5927246|NCT01451827|20503735|P3|Overall Study|Lost to Follow-up|0
5927247|NCT01451827|20503736|P2|Overall Study|Lost to Follow-up|3
5927248|NCT01451827|20503737|P1|Overall Study|Lost to Follow-up|0
5927249|NCT01451827|20503734|P4|Overall Study|Protocol deviation|0
5927250|NCT01451827|20503735|P3|Overall Study|Protocol deviation|0
5927251|NCT01451827|20503736|P2|Overall Study|Protocol deviation|0
5927252|NCT01451827|20503737|P1|Overall Study|Protocol deviation|1
5927253|NCT01451827|20503734|P4|Overall Study|Adverse Event|1
5927254|NCT01451827|20503735|P3|Overall Study|Adverse Event|1
5927255|NCT01451827|20503736|P2|Overall Study|Adverse Event|0
5927256|NCT01451827|20503737|P1|Overall Study|Adverse Event|2
5927257|NCT01451814|20503757|P2|Overall Study|Lost to Follow-up|4
5927258|NCT01451814|20503758|P1|Overall Study|Lost to Follow-up|5
5927259|NCT01451814|20503757|P2|Overall Study|Withdrawal by Subject|1
5927260|NCT01451814|20503758|P1|Overall Study|Withdrawal by Subject|1
5927261|NCT01451762|20503790|P3|Overall Study|Lost to Follow-up|6
5927262|NCT01451762|20503791|P2|Overall Study|Lost to Follow-up|6
5927263|NCT01451762|20503792|P1|Overall Study|Lost to Follow-up|3
5927264|NCT01451749|20503802|P2|Overall Study|Withdrawal by Subject|1
5927265|NCT01451749|20503803|P1|Overall Study|Withdrawal by Subject|0
5927266|NCT01451749|20503802|P2|Overall Study|Adverse Event|0
5927267|NCT01451749|20503803|P1|Overall Study|Adverse Event|2
5927268|NCT01451749|20503802|P2|Overall Study|Meet the exclusion criteria,and|1
5927269|NCT01451749|20503803|P1|Overall Study|Meet the exclusion criteria,and|1
5927270|NCT01451749|20503802|P2|Overall Study|Lost to Follow-up|5
5927271|NCT01451749|20503803|P1|Overall Study|Lost to Follow-up|15
5927272|NCT01451749|20503802|P2|Overall Study|Protocol Violation|7
5927273|NCT01451749|20503803|P1|Overall Study|Protocol Violation|14
5927274|NCT01451723|20503815|P2|Overall Study|study halted|5
5927275|NCT01451723|20503816|P1|Overall Study|study halted|6
5927276|NCT01451645|20503826|P2|Overall Study|Lost to Follow-up|3
5927277|NCT01451645|20503827|P1|Overall Study|Lost to Follow-up|4
5927278|NCT01451645|20503826|P2|Overall Study|Withdrawal by Subject|2
5927279|NCT01451645|20503827|P1|Overall Study|Withdrawal by Subject|4
5927280|NCT01451645|20503826|P2|Overall Study|Adverse Event|3
5927281|NCT01451645|20503827|P1|Overall Study|Adverse Event|0
5927282|NCT01451645|20503826|P2|Overall Study|Protocol Violation|0
5927283|NCT01451645|20503827|P1|Overall Study|Protocol Violation|1
5927284|NCT01451606|20503898|P2|Overall Study|Withdrawal by Subject|3
5927285|NCT01451606|20503899|P1|Overall Study|Withdrawal by Subject|4
5927286|NCT01451554|20503909|P2|Overall Study|Withdrawal by Subject|9
5927287|NCT01451554|20503910|P1|Overall Study|Withdrawal by Subject|14
5927288|NCT01451541|20503921|P3|Overall Study|randomization error, noncompliance|8
5927289|NCT01451541|20503922|P2|Overall Study|randomization error, noncompliance|10
5927290|NCT01451541|20503923|P1|Overall Study|randomization error, noncompliance|11
5927291|NCT01451541|20503921|P3|Overall Study|Withdrawal by Subject|6
5927292|NCT01451541|20503922|P2|Overall Study|Withdrawal by Subject|8
5927293|NCT01451541|20503923|P1|Overall Study|Withdrawal by Subject|15
5927294|NCT01451541|20503921|P3|Overall Study|Lost to Follow-up|7
5927295|NCT01451541|20503922|P2|Overall Study|Lost to Follow-up|4
5927296|NCT01451541|20503923|P1|Overall Study|Lost to Follow-up|4
5927297|NCT01451541|20503921|P3|Overall Study|Lack of Efficacy|0
5927298|NCT01451541|20503922|P2|Overall Study|Lack of Efficacy|0
5927299|NCT01451541|20503923|P1|Overall Study|Lack of Efficacy|2
5927300|NCT01451541|20503921|P3|Overall Study|Adverse Event|6
5927301|NCT01451541|20503922|P2|Overall Study|Adverse Event|3
5927302|NCT01451541|20503923|P1|Overall Study|Adverse Event|4
5927303|NCT01451437|20503981|P9|Overall Study|Withdrawal by Subject|0
5927304|NCT01451437|20503982|P8|Overall Study|Withdrawal by Subject|0
5927305|NCT01451437|20503983|P7|Overall Study|Withdrawal by Subject|1
5927306|NCT01451437|20503984|P6|Overall Study|Withdrawal by Subject|0
5927307|NCT01451437|20503985|P5|Overall Study|Withdrawal by Subject|1
5927308|NCT01451437|20503986|P4|Overall Study|Withdrawal by Subject|0
5927309|NCT01451437|20503987|P3|Overall Study|Withdrawal by Subject|0
5927310|NCT01451437|20503988|P2|Overall Study|Withdrawal by Subject|0
5927311|NCT01451437|20503989|P1|Overall Study|Withdrawal by Subject|0
5927312|NCT01451437|20503981|P9|Overall Study|Protocol Violation|0
5927313|NCT01451437|20503982|P8|Overall Study|Protocol Violation|0
5927314|NCT01451437|20503983|P7|Overall Study|Protocol Violation|1
5927315|NCT01451437|20503984|P6|Overall Study|Protocol Violation|0
5927316|NCT01451437|20503985|P5|Overall Study|Protocol Violation|0
5927317|NCT01451437|20503986|P4|Overall Study|Protocol Violation|0
5927318|NCT01451437|20503987|P3|Overall Study|Protocol Violation|0
5927319|NCT01451437|20503988|P2|Overall Study|Protocol Violation|0
5927320|NCT01451437|20503989|P1|Overall Study|Protocol Violation|0
5927321|NCT01451437|20503981|P9|Overall Study|Disease Progression|3
5927322|NCT01451437|20503982|P8|Overall Study|Disease Progression|1
5927323|NCT01451437|20503983|P7|Overall Study|Disease Progression|3
5927324|NCT01451437|20503984|P6|Overall Study|Disease Progression|2
5927325|NCT01451437|20503985|P5|Overall Study|Disease Progression|3
5927326|NCT01451437|20503986|P4|Overall Study|Disease Progression|1
5927327|NCT01451437|20503987|P3|Overall Study|Disease Progression|1
5927328|NCT01451437|20503988|P2|Overall Study|Disease Progression|0
5927329|NCT01451437|20503989|P1|Overall Study|Disease Progression|0
5927330|NCT01451437|20503981|P9|Overall Study|Physician Decision|0
5927331|NCT01451437|20503982|P8|Overall Study|Physician Decision|0
5927332|NCT01451437|20503983|P7|Overall Study|Physician Decision|0
5927333|NCT01451437|20503984|P6|Overall Study|Physician Decision|0
5927334|NCT01451437|20503985|P5|Overall Study|Physician Decision|0
5927335|NCT01451437|20503986|P4|Overall Study|Physician Decision|0
5927336|NCT01451437|20503987|P3|Overall Study|Physician Decision|2
5927337|NCT01451437|20503988|P2|Overall Study|Physician Decision|1
5927338|NCT01451437|20503989|P1|Overall Study|Physician Decision|1
5927339|NCT01451437|20503981|P9|Overall Study|Adverse Event|1
5927340|NCT01451437|20503982|P8|Overall Study|Adverse Event|2
5927341|NCT01451437|20503983|P7|Overall Study|Adverse Event|1
5927342|NCT01451437|20503984|P6|Overall Study|Adverse Event|1
5927343|NCT01451437|20503985|P5|Overall Study|Adverse Event|0
5927344|NCT01451437|20503986|P4|Overall Study|Adverse Event|0
5927345|NCT01451437|20503987|P3|Overall Study|Adverse Event|0
5927346|NCT01451437|20503988|P2|Overall Study|Adverse Event|0
5927347|NCT01451437|20503989|P1|Overall Study|Adverse Event|0
5927348|NCT01451424|20504121|P4|Overall Study|Adverse Event|1
5927349|NCT01451424|20504122|P3|Overall Study|Adverse Event|0
5927350|NCT01451424|20504123|P2|Overall Study|Adverse Event|0
5927351|NCT01451424|20504124|P1|Overall Study|Adverse Event|0
5927352|NCT01451424|20504121|P4|Overall Study|Physician Decision|1
5927353|NCT01451424|20504122|P3|Overall Study|Physician Decision|1
5927354|NCT01451424|20504123|P2|Overall Study|Physician Decision|0
5927355|NCT01451424|20504124|P1|Overall Study|Physician Decision|0
5927356|NCT01451424|20504121|P4|Overall Study|Lost to Follow-up|1
5927357|NCT01451424|20504122|P3|Overall Study|Lost to Follow-up|0
5927358|NCT01451424|20504123|P2|Overall Study|Lost to Follow-up|1
5927359|NCT01451424|20504124|P1|Overall Study|Lost to Follow-up|0
5927360|NCT01451424|20504121|P4|Overall Study|Withdrawal by Subject|2
5927361|NCT01451424|20504122|P3|Overall Study|Withdrawal by Subject|0
5927362|NCT01451424|20504123|P2|Overall Study|Withdrawal by Subject|1
5927363|NCT01451424|20504124|P1|Overall Study|Withdrawal by Subject|1
5927364|NCT01451398|20504182|P2|Overall Study|Lack of Efficacy|1
5927365|NCT01451398|20504183|P1|Overall Study|Lack of Efficacy|0
5927366|NCT01451398|20504182|P2|Overall Study|Adverse Event + Elevated Fasting Glucose|1
5927367|NCT01451398|20504183|P1|Overall Study|Adverse Event + Elevated Fasting Glucose|0
5927368|NCT01451398|20504182|P2|Overall Study|Moved out of country|1
5927369|NCT01451398|20504183|P1|Overall Study|Moved out of country|0
5927370|NCT01451398|20504182|P2|Overall Study|Non-compliance with protocol|1
5927371|NCT01451398|20504183|P1|Overall Study|Non-compliance with protocol|1
5927372|NCT01451398|20504182|P2|Overall Study|Non-compliance with study drug|3
5927373|NCT01451398|20504183|P1|Overall Study|Non-compliance with study drug|1
5927374|NCT01451398|20504182|P2|Overall Study|Lost to Follow-up|4
5927375|NCT01451398|20504183|P1|Overall Study|Lost to Follow-up|6
5927376|NCT01451398|20504182|P2|Overall Study|Withdrawal by Subject|14
5927377|NCT01451398|20504183|P1|Overall Study|Withdrawal by Subject|10
5927378|NCT01451398|20504182|P2|Overall Study|Physician Decision|1
5927379|NCT01451398|20504183|P1|Overall Study|Physician Decision|1
5927380|NCT01451398|20504182|P2|Overall Study|Protocol Violation|2
5927381|NCT01451398|20504183|P1|Overall Study|Protocol Violation|1
5927382|NCT01451398|20504182|P2|Overall Study|Adverse Event|9
5927383|NCT01451398|20504183|P1|Overall Study|Adverse Event|7
5927384|NCT01451203|20504234|P2|Post-treatment Period|Investigator decision|1
5927385|NCT01451203|20504235|P1|Post-treatment Period|Investigator decision|0
5927386|NCT01451203|20504234|P2|Post-treatment Period|Adverse Event|1
5927387|NCT01451203|20504235|P1|Post-treatment Period|Adverse Event|0
5927388|NCT01451203|20504234|P2|Post-treatment Period|Lack of Efficacy|28
5927389|NCT01451203|20504235|P1|Post-treatment Period|Lack of Efficacy|12
5927390|NCT01451203|20504234|P2|Post-treatment Period|Consent withdrawn|4
5927391|NCT01451203|20504235|P1|Post-treatment Period|Consent withdrawn|2
5927392|NCT01451203|20504234|P2|Double-blind Treatment Period|Investigator decision|0
5927393|NCT01451203|20504235|P1|Double-blind Treatment Period|Investigator decision|2
5927394|NCT01451203|20504234|P2|Double-blind Treatment Period|Violation of eligibility criteria|0
5927395|NCT01451203|20504235|P1|Double-blind Treatment Period|Violation of eligibility criteria|1
5927396|NCT01451203|20504234|P2|Double-blind Treatment Period|Missing study medication ≥6 times|0
5927397|NCT01451203|20504235|P1|Double-blind Treatment Period|Missing study medication ≥6 times|1
5927398|NCT01451203|20504234|P2|Double-blind Treatment Period|Adverse Event|9
5927399|NCT01451203|20504235|P1|Double-blind Treatment Period|Adverse Event|6
5927400|NCT01451203|20504234|P2|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|1
5927401|NCT01451203|20504235|P1|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|0
5927402|NCT01451203|20504234|P2|Double-blind Treatment Period|Lack of Efficacy|36
5927403|NCT01451203|20504235|P1|Double-blind Treatment Period|Lack of Efficacy|71
5927404|NCT01451203|20504234|P2|Double-blind Treatment Period|Consent Withdrawn|2
5927405|NCT01451203|20504235|P1|Double-blind Treatment Period|Consent Withdrawn|3
5927406|NCT01451203|20504234|P2|Double-blind Treatment Period|Did not receive treatment|2
5927407|NCT01451203|20504235|P1|Double-blind Treatment Period|Did not receive treatment|1
5927408|NCT01451164|20504253|P4|Overall Study|Lack of Efficacy|7
5927409|NCT01451164|20504254|P3|Overall Study|Lack of Efficacy|9
5927410|NCT01451164|20504255|P2|Overall Study|Lack of Efficacy|9
5927411|NCT01451164|20504256|P1|Overall Study|Lack of Efficacy|7
5927412|NCT01451164|20504253|P4|Overall Study|Protocol Violation|0
5927413|NCT01451164|20504254|P3|Overall Study|Protocol Violation|0
5927414|NCT01451164|20504255|P2|Overall Study|Protocol Violation|1
5927415|NCT01451164|20504256|P1|Overall Study|Protocol Violation|0
5927416|NCT01451164|20504253|P4|Overall Study|Withdrawal by Subject|17
5927417|NCT01451164|20504254|P3|Overall Study|Withdrawal by Subject|16
5927418|NCT01451164|20504255|P2|Overall Study|Withdrawal by Subject|11
5927419|NCT01451164|20504256|P1|Overall Study|Withdrawal by Subject|14
5927420|NCT01451164|20504253|P4|Overall Study|Physician Decision|0
5927421|NCT01451164|20504254|P3|Overall Study|Physician Decision|1
5927422|NCT01451164|20504255|P2|Overall Study|Physician Decision|0
5927423|NCT01451164|20504256|P1|Overall Study|Physician Decision|2
5927424|NCT01451164|20504253|P4|Overall Study|Withdrawal Criteria|1
5927425|NCT01451164|20504254|P3|Overall Study|Withdrawal Criteria|1
5927426|NCT01451164|20504255|P2|Overall Study|Withdrawal Criteria|1
5927427|NCT01451164|20504256|P1|Overall Study|Withdrawal Criteria|1
5927428|NCT01451164|20504253|P4|Overall Study|Adverse Event|21
5927429|NCT01451164|20504254|P3|Overall Study|Adverse Event|18
5927430|NCT01451164|20504255|P2|Overall Study|Adverse Event|12
5927431|NCT01451164|20504256|P1|Overall Study|Adverse Event|19
5927432|NCT01450943|20504285|P3|Overall Study|Screen failure, loss to follow-up|6
5927433|NCT01450943|20504286|P2|Overall Study|Screen failure, loss to follow-up|7
5927434|NCT01450943|20504287|P1|Overall Study|Screen failure, loss to follow-up|2
5927435|NCT01450813|20504320|P4|Overall Study|Physician Decision|3
5927436|NCT01450813|20504321|P3|Overall Study|Physician Decision|0
5927437|NCT01450813|20504322|P2|Overall Study|Physician Decision|1
5927438|NCT01450813|20504323|P1|Overall Study|Physician Decision|1
5927439|NCT01450800|20504337|P2|Overall Study|Protocol Violation|3
5927440|NCT01450800|20504338|P1|Overall Study|Protocol Violation|1
5927441|NCT01450761|20504373|P2|Treatment With Blinded Study Therapy|Administrative reason by sponsor|3
5927442|NCT01450761|20504374|P1|Treatment With Blinded Study Therapy|Administrative reason by sponsor|2
5927443|NCT01450761|20504373|P2|Treatment With Blinded Study Therapy|Poor/non-compliance|0
5927444|NCT01450761|20504374|P1|Treatment With Blinded Study Therapy|Poor/non-compliance|1
5927445|NCT01450761|20504373|P2|Treatment With Blinded Study Therapy|Not reported|2
5927446|NCT01450761|20504374|P1|Treatment With Blinded Study Therapy|Not reported|2
5927447|NCT01450761|20504373|P2|Treatment With Blinded Study Therapy|No longer meets study criteria|2
5927448|NCT01450761|20504374|P1|Treatment With Blinded Study Therapy|No longer meets study criteria|1
5927449|NCT01450761|20504373|P2|Treatment With Blinded Study Therapy|Maximum clinical benefit|2
5927450|NCT01450761|20504374|P1|Treatment With Blinded Study Therapy|Maximum clinical benefit|1
5927451|NCT01450761|20504373|P2|Treatment With Blinded Study Therapy|Lost to Follow-up|1
5927452|NCT01450761|20504374|P1|Treatment With Blinded Study Therapy|Lost to Follow-up|2
5927453|NCT01450761|20504373|P2|Treatment With Blinded Study Therapy|Other/Unspecified|4
5927454|NCT01450761|20504374|P1|Treatment With Blinded Study Therapy|Other/Unspecified|5
5927455|NCT01450761|20504373|P2|Treatment With Blinded Study Therapy|Death|6
5927456|NCT01450761|20504374|P1|Treatment With Blinded Study Therapy|Death|5
5927457|NCT01450761|20504373|P2|Treatment With Blinded Study Therapy|Withdrawal by Subject|5
5927458|NCT01450761|20504374|P1|Treatment With Blinded Study Therapy|Withdrawal by Subject|12
5927459|NCT01450761|20504373|P2|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|8
5927460|NCT01450761|20504374|P1|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|15
5927461|NCT01450761|20504373|P2|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|19
5927462|NCT01450761|20504374|P1|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|27
5927463|NCT01450761|20504373|P2|Treatment With Blinded Study Therapy|Study drug toxicity|9
5927464|NCT01450761|20504374|P1|Treatment With Blinded Study Therapy|Study drug toxicity|87
5927465|NCT01450761|20504373|P2|Treatment With Blinded Study Therapy|Disease progression|415
5927466|NCT01450761|20504374|P1|Treatment With Blinded Study Therapy|Disease progression|318
5927467|NCT01450761|20504373|P2|Lead-in Chemotherapy|Lost to Follow-up|0
5927468|NCT01450761|20504374|P1|Lead-in Chemotherapy|Lost to Follow-up|2
5927469|NCT01450761|20504373|P2|Lead-in Chemotherapy|Other|2
5927470|NCT01450761|20504374|P1|Lead-in Chemotherapy|Other|2
5927471|NCT01450761|20504373|P2|Lead-in Chemotherapy|Death|3
5927472|NCT01450761|20504374|P1|Lead-in Chemotherapy|Death|3
5927473|NCT01450761|20504373|P2|Lead-in Chemotherapy|No longer meets study criteria|7
5927474|NCT01450761|20504374|P1|Lead-in Chemotherapy|No longer meets study criteria|3
5927475|NCT01450761|20504373|P2|Lead-in Chemotherapy|Study drug toxicity|10
5927476|NCT01450761|20504374|P1|Lead-in Chemotherapy|Study drug toxicity|6
5927477|NCT01450761|20504373|P2|Lead-in Chemotherapy|Withdrawal by Subject|12
5927478|NCT01450761|20504374|P1|Lead-in Chemotherapy|Withdrawal by Subject|14
5927479|NCT01450761|20504373|P2|Lead-in Chemotherapy|Adverse event unrelated to study drug|19
5927480|NCT01450761|20504374|P1|Lead-in Chemotherapy|Adverse event unrelated to study drug|21
5927481|NCT01450761|20504373|P2|Lead-in Chemotherapy|Disease progression|32
5927482|NCT01450761|20504374|P1|Lead-in Chemotherapy|Disease progression|33
5927483|NCT01450761|20504373|P2|Randomization|Other|1
5927484|NCT01450761|20504374|P1|Randomization|Other|0
5927485|NCT01450761|20504373|P2|Randomization|Adverse Event unrelated to study drug|0
5927486|NCT01450761|20504374|P1|Randomization|Adverse Event unrelated to study drug|1
5927487|NCT01450761|20504373|P2|Randomization|Disease progression|2
5927488|NCT01450761|20504374|P1|Randomization|Disease progression|0
5927489|NCT01450761|20504373|P2|Randomization|Withdrawal by Subject|0
5927490|NCT01450761|20504374|P1|Randomization|Withdrawal by Subject|2
5927491|NCT01450761|20504373|P2|Randomization|Subject no longer meets study criteria|2
5927492|NCT01450761|20504374|P1|Randomization|Subject no longer meets study criteria|1
5927493|NCT01450696|20504386|P2|Overall Study|Study Terminated by Sponsor|58
5927494|NCT01450696|20504387|P1|Overall Study|Study Terminated by Sponsor|53
5927495|NCT01450696|20504386|P2|Overall Study|Withdrawal by Subject|2
5927496|NCT01450696|20504387|P1|Overall Study|Withdrawal by Subject|13
5927497|NCT01450696|20504386|P2|Overall Study|Non-Compliance|0
5927498|NCT01450696|20504387|P1|Overall Study|Non-Compliance|1
5927499|NCT01450696|20504386|P2|Overall Study|Lost to Follow-up|3
5927500|NCT01450696|20504387|P1|Overall Study|Lost to Follow-up|3
5927501|NCT01450696|20504386|P2|Overall Study|Death|84
5927502|NCT01450696|20504387|P1|Overall Study|Death|77
5927503|NCT01450696|20504386|P2|Overall Study|Never Treated|1
5927504|NCT01450696|20504387|P1|Overall Study|Never Treated|1
5927505|NCT01450683|20504409|P1|Overall Study|Adverse Event|2
5927506|NCT01450631|20504415|P2|Overall Study|Withdrawal by Subject|0
5927507|NCT01450631|20504416|P1|Overall Study|Withdrawal by Subject|1
5927508|NCT01450631|20504415|P2|Overall Study|Lost to Follow-up|4
5927509|NCT01450631|20504416|P1|Overall Study|Lost to Follow-up|2
5927510|NCT01450137|20504546|P2|Week 12 to Study End|Withdrawal by Subject|1
5927511|NCT01450137|20504547|P1|Week 12 to Study End|Withdrawal by Subject|0
5927512|NCT01450137|20504546|P2|Week 12 to Study End|Death|1
5927513|NCT01450137|20504547|P1|Week 12 to Study End|Death|0
5927514|NCT01450137|20504546|P2|Up to Week 12|Withdrawal by Subject|2
5927515|NCT01450137|20504547|P1|Up to Week 12|Withdrawal by Subject|0
5927516|NCT01450137|20504546|P2|Up to Week 12|Adverse Event|1
5927517|NCT01450137|20504547|P1|Up to Week 12|Adverse Event|2
5927518|NCT01450098|20504561|P2|Period 3|Withdrawal by Subject|2
5927519|NCT01450098|20504562|P1|Period 3|Withdrawal by Subject|0
5927520|NCT01450098|20504561|P2|Period 3|Protocol Violation|1
5927521|NCT01450098|20504562|P1|Period 3|Protocol Violation|0
5927522|NCT01450007|20504581|P3|Overall Study|Adverse Event|0
5927523|NCT01450007|20504582|P2|Overall Study|Adverse Event|1
5927524|NCT01450007|20504583|P1|Overall Study|Adverse Event|0
5927525|NCT01450007|20504581|P3|Overall Study|Protocol Violation|1
5927526|NCT01450007|20504582|P2|Overall Study|Protocol Violation|1
5927527|NCT01450007|20504583|P1|Overall Study|Protocol Violation|0
5927528|NCT01450007|20504581|P3|Overall Study|Late exclusion before treatment|2
5927529|NCT01450007|20504582|P2|Overall Study|Late exclusion before treatment|3
5927530|NCT01450007|20504583|P1|Overall Study|Late exclusion before treatment|2
5927531|NCT01449955|20504602|P2|Overall Study|Withdrawal by Subject|2
5927532|NCT01449955|20504603|P1|Overall Study|Withdrawal by Subject|1
5927533|NCT01449929|20504631|P3|Extension Phase Approximately 3 Years|Lost to Follow-up|4
5927534|NCT01449929|20504632|P2|Extension Phase Approximately 3 Years|Lost to Follow-up|0
5927535|NCT01449929|20504633|P1|Extension Phase Approximately 3 Years|Lost to Follow-up|0
5927536|NCT01449929|20504631|P3|Extension Phase Approximately 3 Years|Lack of Efficacy|2
5927537|NCT01449929|20504632|P2|Extension Phase Approximately 3 Years|Lack of Efficacy|0
5927538|NCT01449929|20504633|P1|Extension Phase Approximately 3 Years|Lack of Efficacy|0
5927539|NCT01449929|20504631|P3|Extension Phase Approximately 3 Years|Adverse Event|2
5927540|NCT01449929|20504632|P2|Extension Phase Approximately 3 Years|Adverse Event|0
5927541|NCT01449929|20504633|P1|Extension Phase Approximately 3 Years|Adverse Event|0
5927542|NCT01449929|20504631|P3|Randomization Phase 96 Week|Other: study closed/terminated|0
5927543|NCT01449929|20504632|P2|Randomization Phase 96 Week|Other: study closed/terminated|1
5927544|NCT01449929|20504633|P1|Randomization Phase 96 Week|Other: study closed/terminated|0
5927545|NCT01449929|20504631|P3|Randomization Phase 96 Week|Physician Decision|0
5927546|NCT01449929|20504632|P2|Randomization Phase 96 Week|Physician Decision|3
5927547|NCT01449929|20504633|P1|Randomization Phase 96 Week|Physician Decision|2
5927548|NCT01449929|20504631|P3|Randomization Phase 96 Week|Withdrawal by Subject|0
5927549|NCT01449929|20504632|P2|Randomization Phase 96 Week|Withdrawal by Subject|8
5927550|NCT01449929|20504633|P1|Randomization Phase 96 Week|Withdrawal by Subject|2
5927551|NCT01449929|20504631|P3|Randomization Phase 96 Week|Lost to Follow-up|0
5927552|NCT01449929|20504632|P2|Randomization Phase 96 Week|Lost to Follow-up|18
5927553|NCT01449929|20504633|P1|Randomization Phase 96 Week|Lost to Follow-up|15
5927554|NCT01449929|20504631|P3|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0
5927555|NCT01449929|20504632|P2|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0
5927556|NCT01449929|20504633|P1|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|1
5927557|NCT01449929|20504631|P3|Randomization Phase 96 Week|Protocol Violation|0
5927558|NCT01449929|20504632|P2|Randomization Phase 96 Week|Protocol Violation|6
5927559|NCT01449929|20504633|P1|Randomization Phase 96 Week|Protocol Violation|5
5927560|NCT01449929|20504631|P3|Randomization Phase 96 Week|Lack of Efficacy|0
5927561|NCT01449929|20504632|P2|Randomization Phase 96 Week|Lack of Efficacy|4
5927562|NCT01449929|20504633|P1|Randomization Phase 96 Week|Lack of Efficacy|3
5927563|NCT01449929|20504631|P3|Randomization Phase 96 Week|Adverse Event|0
5927564|NCT01449929|20504632|P2|Randomization Phase 96 Week|Adverse Event|13
5927565|NCT01449929|20504633|P1|Randomization Phase 96 Week|Adverse Event|5
5927566|NCT01449812|20504678|P3|Overall Study|Lost to Follow-up|0
5927567|NCT01449812|20504679|P2|Overall Study|Lost to Follow-up|0
5927568|NCT01449812|20504680|P1|Overall Study|Lost to Follow-up|1
5927569|NCT01449812|20504678|P3|Overall Study|Withdrawal by Subject|1
5927570|NCT01449812|20504679|P2|Overall Study|Withdrawal by Subject|0
5927571|NCT01449812|20504680|P1|Overall Study|Withdrawal by Subject|0
5927572|NCT01449812|20504678|P3|Overall Study|Migrated/moved from study area|0
5927573|NCT01449812|20504679|P2|Overall Study|Migrated/moved from study area|0
5927574|NCT01449812|20504680|P1|Overall Study|Migrated/moved from study area|1
5927575|NCT01449721|20504795|P2|Overall Study|Physician Decision|1
5927576|NCT01449721|20504796|P1|Overall Study|Physician Decision|0
5927577|NCT01449721|20504795|P2|Overall Study|Physician Decision|1
5927578|NCT01449721|20504796|P1|Overall Study|Physician Decision|0
5927579|NCT01449708|20504808|P2|Overall Study|respiratory failure|0
5927580|NCT01449708|20504809|P1|Overall Study|respiratory failure|1
5927581|NCT01449708|20504808|P2|Overall Study|surgical complication|2
5927582|NCT01449708|20504809|P1|Overall Study|surgical complication|1
5927583|NCT01449708|20504808|P2|Overall Study|Protocol Violation|1
5927584|NCT01449708|20504809|P1|Overall Study|Protocol Violation|0
5927585|NCT01449682|20504820|P2|Overall Study|Adverse Event|0
5927586|NCT01449682|20504821|P1|Overall Study|Adverse Event|1
5927587|NCT01449682|20504820|P2|Overall Study|Death|1
5927588|NCT01449682|20504821|P1|Overall Study|Death|0
5927589|NCT01449630|20504842|P9|Period 2|Sponsor Decision|0
5927590|NCT01449630|20504843|P8|Period 2|Sponsor Decision|0
5927591|NCT01449630|20504844|P7|Period 2|Sponsor Decision|1
5927592|NCT01449630|20504845|P6|Period 2|Sponsor Decision|0
5927593|NCT01449630|20504846|P5|Period 2|Sponsor Decision|0
5927594|NCT01449630|20504847|P4|Period 2|Sponsor Decision|0
5927595|NCT01449630|20504848|P3|Period 2|Sponsor Decision|0
5927596|NCT01449630|20504849|P2|Period 2|Sponsor Decision|0
5927597|NCT01449630|20504850|P1|Period 2|Sponsor Decision|0
5927598|NCT01449630|20504842|P9|Period 1|Sponsor Decision|0
5927599|NCT01449630|20504843|P8|Period 1|Sponsor Decision|0
5927600|NCT01449630|20504844|P7|Period 1|Sponsor Decision|0
5927601|NCT01449630|20504845|P6|Period 1|Sponsor Decision|1
5927602|NCT01449630|20504846|P5|Period 1|Sponsor Decision|0
5927603|NCT01449630|20504847|P4|Period 1|Sponsor Decision|0
5927604|NCT01449630|20504848|P3|Period 1|Sponsor Decision|0
5927605|NCT01449630|20504849|P2|Period 1|Sponsor Decision|0
5927606|NCT01449630|20504850|P1|Period 1|Sponsor Decision|0
5927607|NCT01449630|20504842|P9|Period 1|Physician Decision|0
5927608|NCT01449630|20504843|P8|Period 1|Physician Decision|0
5927609|NCT01449630|20504844|P7|Period 1|Physician Decision|0
5927610|NCT01449630|20504845|P6|Period 1|Physician Decision|0
5927611|NCT01449630|20504846|P5|Period 1|Physician Decision|0
5927612|NCT01449630|20504847|P4|Period 1|Physician Decision|1
5927613|NCT01449630|20504848|P3|Period 1|Physician Decision|0
5927614|NCT01449630|20504849|P2|Period 1|Physician Decision|0
5927615|NCT01449630|20504850|P1|Period 1|Physician Decision|1
5927616|NCT01449539|20504920|P1|Overall Study|Toxicity not study related|1
5927617|NCT01449539|20504920|P1|Overall Study|Withdrawal by Subject|3
5927618|NCT01449526|20504926|P2|Overall Study|Cannot maintain visits|1
5927619|NCT01449526|20504927|P1|Overall Study|Cannot maintain visits|0
5927620|NCT01449526|20504926|P2|Overall Study|Lack of Motivation|1
5927621|NCT01449526|20504927|P1|Overall Study|Lack of Motivation|0
5927622|NCT01449526|20504926|P2|Overall Study|Symptoms/complaints|1
5927623|NCT01449526|20504927|P1|Overall Study|Symptoms/complaints|0
5927624|NCT01449526|20504926|P2|Overall Study|Withdrawal by Subject|1
5927625|NCT01449526|20504927|P1|Overall Study|Withdrawal by Subject|1
5927626|NCT01449526|20504926|P2|Overall Study|Lost to Follow-up|2
5927627|NCT01449526|20504927|P1|Overall Study|Lost to Follow-up|1
5927628|NCT01449461|20504996|P6|Overall Study|Reason not specified|1
5927629|NCT01449461|20504997|P5|Overall Study|Reason not specified|0
5927630|NCT01449461|20504998|P4|Overall Study|Reason not specified|3
5927631|NCT01449461|20504999|P3|Overall Study|Reason not specified|0
5927632|NCT01449461|20505000|P2|Overall Study|Reason not specified|1
5927633|NCT01449461|20505001|P1|Overall Study|Reason not specified|0
5927634|NCT01449461|20504996|P6|Overall Study|Clinical progressive disease|3
5927635|NCT01449461|20504997|P5|Overall Study|Clinical progressive disease|3
5927636|NCT01449461|20504998|P4|Overall Study|Clinical progressive disease|0
5927637|NCT01449461|20504999|P3|Overall Study|Clinical progressive disease|0
5927638|NCT01449461|20505000|P2|Overall Study|Clinical progressive disease|1
5927639|NCT01449461|20505001|P1|Overall Study|Clinical progressive disease|2
5927640|NCT01449461|20504996|P6|Overall Study|Documented progressive disease|5
5927641|NCT01449461|20504997|P5|Overall Study|Documented progressive disease|21
5927642|NCT01449461|20504998|P4|Overall Study|Documented progressive disease|11
5927643|NCT01449461|20504999|P3|Overall Study|Documented progressive disease|14
5927644|NCT01449461|20505000|P2|Overall Study|Documented progressive disease|6
5927645|NCT01449461|20505001|P1|Overall Study|Documented progressive disease|4
5927646|NCT01449461|20504996|P6|Overall Study|Death|1
5927647|NCT01449461|20504997|P5|Overall Study|Death|4
5927648|NCT01449461|20504998|P4|Overall Study|Death|0
5927649|NCT01449461|20504999|P3|Overall Study|Death|0
5927650|NCT01449461|20505000|P2|Overall Study|Death|1
5927651|NCT01449461|20505001|P1|Overall Study|Death|0
5927652|NCT01449461|20504996|P6|Overall Study|Adverse Event|3
5927653|NCT01449461|20504997|P5|Overall Study|Adverse Event|3
5927654|NCT01449461|20504998|P4|Overall Study|Adverse Event|3
5927655|NCT01449461|20504999|P3|Overall Study|Adverse Event|2
5927656|NCT01449461|20505000|P2|Overall Study|Adverse Event|3
5927657|NCT01449461|20505001|P1|Overall Study|Adverse Event|0
5927658|NCT01449461|20504996|P6|Overall Study|Ongoing|2
5927659|NCT01449461|20504997|P5|Overall Study|Ongoing|17
5927660|NCT01449461|20504998|P4|Overall Study|Ongoing|15
5927661|NCT01449461|20504999|P3|Overall Study|Ongoing|2
5927662|NCT01449461|20505000|P2|Overall Study|Ongoing|6
5927663|NCT01449461|20505001|P1|Overall Study|Ongoing|0
5927664|NCT01449370|20505138|P25|Overall Study|Death|1
5927665|NCT01449370|20505139|P24|Overall Study|Death|0
5927666|NCT01449370|20505140|P23|Overall Study|Death|0
5927667|NCT01449370|20505141|P22|Overall Study|Death|0
5927668|NCT01449370|20505142|P21|Overall Study|Death|0
5927669|NCT01449370|20505143|P20|Overall Study|Death|0
5927670|NCT01449370|20505144|P19|Overall Study|Death|0
5927671|NCT01449370|20505145|P18|Overall Study|Death|0
5927672|NCT01449370|20505146|P17|Overall Study|Death|0
5927673|NCT01449370|20505147|P16|Overall Study|Death|0
5927674|NCT01449370|20505148|P15|Overall Study|Death|0
5927675|NCT01449370|20505149|P14|Overall Study|Death|0
5927676|NCT01449370|20505150|P13|Overall Study|Death|0
5927677|NCT01449370|20505151|P12|Overall Study|Death|0
5927678|NCT01449370|20505152|P11|Overall Study|Death|0
5927679|NCT01449370|20505153|P10|Overall Study|Death|0
5927680|NCT01449370|20505154|P9|Overall Study|Death|0
5927681|NCT01449370|20505155|P8|Overall Study|Death|0
5927682|NCT01449370|20505156|P7|Overall Study|Death|0
5927683|NCT01449370|20505157|P6|Overall Study|Death|0
5927684|NCT01449370|20505158|P5|Overall Study|Death|0
5927685|NCT01449370|20505159|P4|Overall Study|Death|0
5927686|NCT01449370|20505160|P3|Overall Study|Death|0
5927687|NCT01449370|20505161|P2|Overall Study|Death|0
5927688|NCT01449370|20505162|P1|Overall Study|Death|0
5927689|NCT01449370|20505138|P25|Overall Study|Medication Prohibited by Protocol|0
5927690|NCT01449370|20505139|P24|Overall Study|Medication Prohibited by Protocol|1
5927691|NCT01449370|20505140|P23|Overall Study|Medication Prohibited by Protocol|0
5927692|NCT01449370|20505141|P22|Overall Study|Medication Prohibited by Protocol|0
5927693|NCT01449370|20505142|P21|Overall Study|Medication Prohibited by Protocol|0
5927694|NCT01449370|20505143|P20|Overall Study|Medication Prohibited by Protocol|0
5927695|NCT01449370|20505144|P19|Overall Study|Medication Prohibited by Protocol|0
5927696|NCT01449370|20505145|P18|Overall Study|Medication Prohibited by Protocol|0
5927697|NCT01449370|20505146|P17|Overall Study|Medication Prohibited by Protocol|0
5927698|NCT01449370|20505147|P16|Overall Study|Medication Prohibited by Protocol|0
5927699|NCT01449370|20505148|P15|Overall Study|Medication Prohibited by Protocol|0
5927700|NCT01449370|20505149|P14|Overall Study|Medication Prohibited by Protocol|0
5927701|NCT01449370|20505150|P13|Overall Study|Medication Prohibited by Protocol|0
5927702|NCT01449370|20505151|P12|Overall Study|Medication Prohibited by Protocol|0
5927703|NCT01449370|20505152|P11|Overall Study|Medication Prohibited by Protocol|0
5927704|NCT01449370|20505153|P10|Overall Study|Medication Prohibited by Protocol|0
5927705|NCT01449370|20505154|P9|Overall Study|Medication Prohibited by Protocol|0
5927706|NCT01449370|20505155|P8|Overall Study|Medication Prohibited by Protocol|0
5927707|NCT01449370|20505156|P7|Overall Study|Medication Prohibited by Protocol|0
5927708|NCT01449370|20505157|P6|Overall Study|Medication Prohibited by Protocol|0
5927709|NCT01449370|20505158|P5|Overall Study|Medication Prohibited by Protocol|0
5927710|NCT01449370|20505159|P4|Overall Study|Medication Prohibited by Protocol|0
5927711|NCT01449370|20505160|P3|Overall Study|Medication Prohibited by Protocol|0
5927712|NCT01449370|20505161|P2|Overall Study|Medication Prohibited by Protocol|0
5927713|NCT01449370|20505162|P1|Overall Study|Medication Prohibited by Protocol|0
5927714|NCT01449370|20505138|P25|Overall Study|Other|0
5927715|NCT01449370|20505139|P24|Overall Study|Other|1
5927716|NCT01449370|20505140|P23|Overall Study|Other|1
5927717|NCT01449370|20505141|P22|Overall Study|Other|0
5927718|NCT01449370|20505142|P21|Overall Study|Other|0
5927719|NCT01449370|20505143|P20|Overall Study|Other|0
5927720|NCT01449370|20505144|P19|Overall Study|Other|0
5927721|NCT01449370|20505145|P18|Overall Study|Other|0
5927722|NCT01449370|20505146|P17|Overall Study|Other|0
5927723|NCT01449370|20505147|P16|Overall Study|Other|0
5927724|NCT01449370|20505148|P15|Overall Study|Other|0
5927725|NCT01449370|20505149|P14|Overall Study|Other|0
5927726|NCT01449370|20505150|P13|Overall Study|Other|0
5927727|NCT01449370|20505151|P12|Overall Study|Other|0
5927728|NCT01449370|20505152|P11|Overall Study|Other|0
5927729|NCT01449370|20505153|P10|Overall Study|Other|1
5927730|NCT01449370|20505154|P9|Overall Study|Other|1
5927731|NCT01449370|20505155|P8|Overall Study|Other|0
5927732|NCT01449370|20505156|P7|Overall Study|Other|0
5927733|NCT01449370|20505157|P6|Overall Study|Other|0
5927734|NCT01449370|20505158|P5|Overall Study|Other|0
5927735|NCT01449370|20505159|P4|Overall Study|Other|0
5927736|NCT01449370|20505160|P3|Overall Study|Other|0
5927737|NCT01449370|20505161|P2|Overall Study|Other|0
5927738|NCT01449370|20505162|P1|Overall Study|Other|0
5927739|NCT01449370|20505138|P25|Overall Study|Lost to Follow-up|0
5927740|NCT01449370|20505139|P24|Overall Study|Lost to Follow-up|0
5927741|NCT01449370|20505140|P23|Overall Study|Lost to Follow-up|0
5927742|NCT01449370|20505141|P22|Overall Study|Lost to Follow-up|0
5927743|NCT01449370|20505142|P21|Overall Study|Lost to Follow-up|1
5927744|NCT01449370|20505143|P20|Overall Study|Lost to Follow-up|0
5927745|NCT01449370|20505144|P19|Overall Study|Lost to Follow-up|0
5927746|NCT01449370|20505145|P18|Overall Study|Lost to Follow-up|0
5927747|NCT01449370|20505146|P17|Overall Study|Lost to Follow-up|0
5927748|NCT01449370|20505147|P16|Overall Study|Lost to Follow-up|0
5927749|NCT01449370|20505148|P15|Overall Study|Lost to Follow-up|0
5927750|NCT01449370|20505149|P14|Overall Study|Lost to Follow-up|0
5927751|NCT01449370|20505150|P13|Overall Study|Lost to Follow-up|0
5927752|NCT01449370|20505151|P12|Overall Study|Lost to Follow-up|0
5927753|NCT01449370|20505152|P11|Overall Study|Lost to Follow-up|0
5927754|NCT01449370|20505153|P10|Overall Study|Lost to Follow-up|0
5927755|NCT01449370|20505154|P9|Overall Study|Lost to Follow-up|0
5927756|NCT01449370|20505155|P8|Overall Study|Lost to Follow-up|0
5927757|NCT01449370|20505156|P7|Overall Study|Lost to Follow-up|0
5927758|NCT01449370|20505157|P6|Overall Study|Lost to Follow-up|0
5927759|NCT01449370|20505158|P5|Overall Study|Lost to Follow-up|0
5927760|NCT01449370|20505159|P4|Overall Study|Lost to Follow-up|0
5927761|NCT01449370|20505160|P3|Overall Study|Lost to Follow-up|0
5927762|NCT01449370|20505161|P2|Overall Study|Lost to Follow-up|0
5927763|NCT01449370|20505162|P1|Overall Study|Lost to Follow-up|0
5927764|NCT01449370|20505138|P25|Overall Study|Participant Decision|1
5927765|NCT01449370|20505139|P24|Overall Study|Participant Decision|0
5927766|NCT01449370|20505140|P23|Overall Study|Participant Decision|0
5927767|NCT01449370|20505141|P22|Overall Study|Participant Decision|1
5927768|NCT01449370|20505142|P21|Overall Study|Participant Decision|0
5927769|NCT01449370|20505143|P20|Overall Study|Participant Decision|0
5927770|NCT01449370|20505144|P19|Overall Study|Participant Decision|1
5927771|NCT01449370|20505145|P18|Overall Study|Participant Decision|0
5927772|NCT01449370|20505146|P17|Overall Study|Participant Decision|3
5927773|NCT01449370|20505147|P16|Overall Study|Participant Decision|1
5927774|NCT01449370|20505148|P15|Overall Study|Participant Decision|0
5927775|NCT01449370|20505149|P14|Overall Study|Participant Decision|1
5927776|NCT01449370|20505150|P13|Overall Study|Participant Decision|1
5927777|NCT01449370|20505151|P12|Overall Study|Participant Decision|0
5927778|NCT01449370|20505152|P11|Overall Study|Participant Decision|0
5927779|NCT01449370|20505153|P10|Overall Study|Participant Decision|0
5927780|NCT01449370|20505154|P9|Overall Study|Participant Decision|1
5927781|NCT01449370|20505155|P8|Overall Study|Participant Decision|1
5927782|NCT01449370|20505156|P7|Overall Study|Participant Decision|0
5927783|NCT01449370|20505157|P6|Overall Study|Participant Decision|0
5927784|NCT01449370|20505158|P5|Overall Study|Participant Decision|0
5927785|NCT01449370|20505159|P4|Overall Study|Participant Decision|0
5927786|NCT01449370|20505160|P3|Overall Study|Participant Decision|0
5927787|NCT01449370|20505161|P2|Overall Study|Participant Decision|0
5927788|NCT01449370|20505162|P1|Overall Study|Participant Decision|0
5927789|NCT01449370|20505138|P25|Overall Study|Adverse Event|3
5927790|NCT01449370|20505139|P24|Overall Study|Adverse Event|1
5927791|NCT01449370|20505140|P23|Overall Study|Adverse Event|0
5927792|NCT01449370|20505141|P22|Overall Study|Adverse Event|1
5927793|NCT01449370|20505142|P21|Overall Study|Adverse Event|0
5927794|NCT01449370|20505143|P20|Overall Study|Adverse Event|1
5927795|NCT01449370|20505144|P19|Overall Study|Adverse Event|1
5927796|NCT01449370|20505145|P18|Overall Study|Adverse Event|0
5927797|NCT01449370|20505146|P17|Overall Study|Adverse Event|0
5927798|NCT01449370|20505147|P16|Overall Study|Adverse Event|1
5927799|NCT01449370|20505148|P15|Overall Study|Adverse Event|0
5927800|NCT01449370|20505149|P14|Overall Study|Adverse Event|2
5927801|NCT01449370|20505150|P13|Overall Study|Adverse Event|0
5927802|NCT01449370|20505151|P12|Overall Study|Adverse Event|0
5927803|NCT01449370|20505152|P11|Overall Study|Adverse Event|0
5927804|NCT01449370|20505153|P10|Overall Study|Adverse Event|1
5927805|NCT01449370|20505154|P9|Overall Study|Adverse Event|1
5927806|NCT01449370|20505155|P8|Overall Study|Adverse Event|0
5927807|NCT01449370|20505156|P7|Overall Study|Adverse Event|0
5927808|NCT01449370|20505157|P6|Overall Study|Adverse Event|0
5927809|NCT01449370|20505158|P5|Overall Study|Adverse Event|0
5927810|NCT01449370|20505159|P4|Overall Study|Adverse Event|1
5927811|NCT01449370|20505160|P3|Overall Study|Adverse Event|0
5927812|NCT01449370|20505161|P2|Overall Study|Adverse Event|2
5927813|NCT01449370|20505162|P1|Overall Study|Adverse Event|1
5927814|NCT01449370|20505138|P25|Overall Study|Disease Progression|3
5927815|NCT01449370|20505139|P24|Overall Study|Disease Progression|7
5927816|NCT01449370|20505140|P23|Overall Study|Disease Progression|3
5927817|NCT01449370|20505141|P22|Overall Study|Disease Progression|2
5927818|NCT01449370|20505142|P21|Overall Study|Disease Progression|5
5927819|NCT01449370|20505143|P20|Overall Study|Disease Progression|2
5927820|NCT01449370|20505144|P19|Overall Study|Disease Progression|1
5927821|NCT01449370|20505145|P18|Overall Study|Disease Progression|3
5927822|NCT01449370|20505146|P17|Overall Study|Disease Progression|4
5927823|NCT01449370|20505147|P16|Overall Study|Disease Progression|1
5927824|NCT01449370|20505148|P15|Overall Study|Disease Progression|3
5927825|NCT01449370|20505149|P14|Overall Study|Disease Progression|8
5927826|NCT01449370|20505150|P13|Overall Study|Disease Progression|2
5927827|NCT01449370|20505151|P12|Overall Study|Disease Progression|3
5927828|NCT01449370|20505152|P11|Overall Study|Disease Progression|3
5927829|NCT01449370|20505153|P10|Overall Study|Disease Progression|1
5927830|NCT01449370|20505154|P9|Overall Study|Disease Progression|9
5927831|NCT01449370|20505155|P8|Overall Study|Disease Progression|2
5927832|NCT01449370|20505156|P7|Overall Study|Disease Progression|3
5927833|NCT01449370|20505157|P6|Overall Study|Disease Progression|3
5927834|NCT01449370|20505158|P5|Overall Study|Disease Progression|3
5927835|NCT01449370|20505159|P4|Overall Study|Disease Progression|3
5927836|NCT01449370|20505160|P3|Overall Study|Disease Progression|8
5927837|NCT01449370|20505161|P2|Overall Study|Disease Progression|4
5927838|NCT01449370|20505162|P1|Overall Study|Disease Progression|5
5927839|NCT01449279|20505540|P1|Overall Study|Toxicity|2
5927840|NCT01449279|20505540|P1|Overall Study|Lack of Efficacy|5
5927841|NCT01449006|20505565|P2|Overall Study|Protocol Violation|0
5927842|NCT01449006|20505566|P1|Overall Study|Protocol Violation|1
5927843|NCT01449006|20505565|P2|Overall Study|Withdrawal by Subject|0
5927844|NCT01449006|20505566|P1|Overall Study|Withdrawal by Subject|1
5927845|NCT01449006|20505565|P2|Overall Study|Lost to Follow-up|0
5927846|NCT01449006|20505566|P1|Overall Study|Lost to Follow-up|1
5927847|NCT01448850|20505580|P2|Overall Study|Other|12
5927848|NCT01448850|20505581|P1|Overall Study|Other|15
5927849|NCT01448850|20505580|P2|Overall Study|Lost to Follow-up|1
5927850|NCT01448850|20505581|P1|Overall Study|Lost to Follow-up|3
5927851|NCT01448850|20505580|P2|Overall Study|Withdrawal by Subject|21
5927852|NCT01448850|20505581|P1|Overall Study|Withdrawal by Subject|13
5927853|NCT01448850|20505580|P2|Overall Study|Death|6
5927854|NCT01448850|20505581|P1|Overall Study|Death|3
5927855|NCT01448824|20505612|P8|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|1
5927856|NCT01448824|20505613|P7|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0
5927857|NCT01448824|20505614|P6|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0
5927858|NCT01448824|20505615|P5|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0
5927859|NCT01448824|20505616|P4|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0
5927860|NCT01448824|20505617|P3|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0
5927861|NCT01448824|20505618|P2|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0
5927862|NCT01448824|20505619|P1|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0
5927863|NCT01448824|20505612|P8|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|1
5927864|NCT01448824|20505613|P7|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0
5927865|NCT01448824|20505614|P6|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0
5927866|NCT01448824|20505615|P5|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0
5927867|NCT01448824|20505616|P4|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0
5927868|NCT01448824|20505617|P3|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0
5927869|NCT01448824|20505618|P2|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0
5927870|NCT01448824|20505619|P1|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0
5927871|NCT01448824|20505612|P8|Part 2 Period 2: Drug-drug Interaction|Adverse Event|1
5927872|NCT01448824|20505613|P7|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0
5927873|NCT01448824|20505614|P6|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0
5927874|NCT01448824|20505615|P5|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0
5927875|NCT01448824|20505616|P4|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0
5927876|NCT01448824|20505617|P3|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0
5927877|NCT01448824|20505618|P2|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0
5927878|NCT01448824|20505619|P1|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0
5927879|NCT01448824|20505612|P8|Part 2 Period 1: Drug-drug Interaction|Adverse Event|1
5927880|NCT01448824|20505613|P7|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0
5927881|NCT01448824|20505614|P6|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0
5927882|NCT01448824|20505615|P5|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0
5927883|NCT01448824|20505616|P4|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0
5927884|NCT01448824|20505617|P3|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0
5927885|NCT01448824|20505618|P2|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0
5927886|NCT01448824|20505619|P1|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0
5927887|NCT01448824|20505612|P8|Part 1: Washout Period|Lost to Follow-up|0
5927888|NCT01448824|20505613|P7|Part 1: Washout Period|Lost to Follow-up|0
5927889|NCT01448824|20505614|P6|Part 1: Washout Period|Lost to Follow-up|0
5927890|NCT01448824|20505615|P5|Part 1: Washout Period|Lost to Follow-up|0
5927891|NCT01448824|20505616|P4|Part 1: Washout Period|Lost to Follow-up|0
5927892|NCT01448824|20505617|P3|Part 1: Washout Period|Lost to Follow-up|0
5927893|NCT01448824|20505618|P2|Part 1: Washout Period|Lost to Follow-up|0
5927894|NCT01448824|20505619|P1|Part 1: Washout Period|Lost to Follow-up|1
5927895|NCT01448824|20505612|P8|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0
5927896|NCT01448824|20505613|P7|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0
5927897|NCT01448824|20505614|P6|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|1
5927898|NCT01448824|20505615|P5|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0
5927899|NCT01448824|20505616|P4|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0
5927900|NCT01448824|20505617|P3|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0
5927901|NCT01448824|20505618|P2|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0
5927902|NCT01448824|20505619|P1|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0
5927903|NCT01448824|20505612|P8|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0
5927904|NCT01448824|20505613|P7|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0
5927905|NCT01448824|20505614|P6|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1
5927906|NCT01448824|20505615|P5|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|2
5927907|NCT01448824|20505616|P4|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1
5927908|NCT01448824|20505617|P3|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0
5927909|NCT01448824|20505618|P2|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0
5927910|NCT01448824|20505619|P1|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0
5927911|NCT01448824|20505612|P8|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0
5927912|NCT01448824|20505613|P7|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|1
5927913|NCT01448824|20505614|P6|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0
5927914|NCT01448824|20505615|P5|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0
5927915|NCT01448824|20505616|P4|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0
5927916|NCT01448824|20505617|P3|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0
5927917|NCT01448824|20505618|P2|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0
5927918|NCT01448824|20505619|P1|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0
5927919|NCT01448707|20505670|P2|Overall Study|Other|4
5927920|NCT01448707|20505671|P1|Overall Study|Other|7
5927921|NCT01448707|20505670|P2|Overall Study|Withdrawal by Subject|7
5927922|NCT01448707|20505671|P1|Overall Study|Withdrawal by Subject|6
5927923|NCT01448707|20505670|P2|Overall Study|Lost to Follow-up|6
5927924|NCT01448707|20505671|P1|Overall Study|Lost to Follow-up|2
5927925|NCT01448707|20505670|P2|Overall Study|Adverse Event|1
5927926|NCT01448707|20505671|P1|Overall Study|Adverse Event|3
5927927|NCT01448616|20505692|P4|Study Drug (Treatment Phase)|Withdrawal by Subject|2
5927928|NCT01448616|20505693|P3|Study Drug (Treatment Phase)|Withdrawal by Subject|2
5927929|NCT01448616|20505694|P2|Study Drug (Treatment Phase)|Withdrawal by Subject|1
5927930|NCT01448616|20505695|P1|Study Drug (Treatment Phase)|Withdrawal by Subject|0
5927931|NCT01448616|20505692|P4|Study Drug (Treatment Phase)|Never initiated study drug|2
5927932|NCT01448616|20505693|P3|Study Drug (Treatment Phase)|Never initiated study drug|1
5927933|NCT01448616|20505694|P2|Study Drug (Treatment Phase)|Never initiated study drug|0
5927934|NCT01448616|20505695|P1|Study Drug (Treatment Phase)|Never initiated study drug|0
5927935|NCT01448616|20505692|P4|Study Drug (Treatment Phase)|Adverse Event|0
5927936|NCT01448616|20505693|P3|Study Drug (Treatment Phase)|Adverse Event|1
5927937|NCT01448616|20505694|P2|Study Drug (Treatment Phase)|Adverse Event|1
5927938|NCT01448616|20505695|P1|Study Drug (Treatment Phase)|Adverse Event|0
5927939|NCT01448616|20505692|P4|Lead-In (Observational Phase)|Collected <90% of required swabs|0
5928111|NCT01446419|20506352|P1|Overall Study|Terminated per protocol|3
5927940|NCT01448616|20505693|P3|Lead-In (Observational Phase)|Collected <90% of required swabs|0
5927941|NCT01448616|20505694|P2|Lead-In (Observational Phase)|Collected <90% of required swabs|0
5927942|NCT01448616|20505695|P1|Lead-In (Observational Phase)|Collected <90% of required swabs|6
5927943|NCT01448616|20505692|P4|Lead-In (Observational Phase)|Collected no genital swabs|0
5927944|NCT01448616|20505693|P3|Lead-In (Observational Phase)|Collected no genital swabs|0
5927945|NCT01448616|20505694|P2|Lead-In (Observational Phase)|Collected no genital swabs|0
5927946|NCT01448616|20505695|P1|Lead-In (Observational Phase)|Collected no genital swabs|3
5927947|NCT01448213|20505747|P2|Overall Study|Protocol Violation|2
5927948|NCT01448213|20505748|P1|Overall Study|Protocol Violation|1
5927949|NCT01448213|20505747|P2|Overall Study|Adverse Event|10
5927950|NCT01448213|20505748|P1|Overall Study|Adverse Event|4
5927951|NCT01448213|20505747|P2|Overall Study|Lost to Follow-up|10
5927952|NCT01448213|20505748|P1|Overall Study|Lost to Follow-up|12
5927953|NCT01448057|20505758|P2|Overall Study|Withdrawal by Subject|0
5927954|NCT01448057|20505759|P1|Overall Study|Withdrawal by Subject|2
5927955|NCT01448057|20505758|P2|Overall Study|Adverse Event|2
5927956|NCT01448057|20505759|P1|Overall Study|Adverse Event|0
5927957|NCT01448057|20505758|P2|Overall Study|Lost to Follow-up|0
5927958|NCT01448057|20505759|P1|Overall Study|Lost to Follow-up|3
5927959|NCT01448057|20505758|P2|Overall Study|Protocol Violation|2
5927960|NCT01448057|20505759|P1|Overall Study|Protocol Violation|3
5927961|NCT01448044|20505769|P2|Follow Up Period|Other|11
5927962|NCT01448044|20505770|P1|Follow Up Period|Other|5
5927963|NCT01448044|20505769|P2|Follow Up Period|Lost to Follow-up|2
5927964|NCT01448044|20505770|P1|Follow Up Period|Lost to Follow-up|6
5927965|NCT01448044|20505769|P2|Follow Up Period|Withdrawal by Subject|1
5927966|NCT01448044|20505770|P1|Follow Up Period|Withdrawal by Subject|1
5927967|NCT01448044|20505769|P2|Treatment Period|Other reason|0
5927968|NCT01448044|20505770|P1|Treatment Period|Other reason|2
5927969|NCT01448044|20505769|P2|Treatment Period|Lost to Follow-up|1
5927970|NCT01448044|20505770|P1|Treatment Period|Lost to Follow-up|2
5927971|NCT01448044|20505769|P2|Treatment Period|Participant does not meet study criteria|0
5927972|NCT01448044|20505770|P1|Treatment Period|Participant does not meet study criteria|1
5927973|NCT01448044|20505769|P2|Treatment Period|Completed 24 weeks treatment period only|0
5927974|NCT01448044|20505770|P1|Treatment Period|Completed 24 weeks treatment period only|8
5927975|NCT01448044|20505769|P2|Treatment Period|Subject requested discontinue study drug|0
5927976|NCT01448044|20505770|P1|Treatment Period|Subject requested discontinue study drug|1
5927977|NCT01448044|20505769|P2|Treatment Period|Lack of Efficacy|12
5927978|NCT01448044|20505770|P1|Treatment Period|Lack of Efficacy|5
5927979|NCT01448044|20505769|P2|Treatment Period|Adverse Event|3
5927980|NCT01448044|20505770|P1|Treatment Period|Adverse Event|4
5927981|NCT01447927|20505786|P2|Overall Study|Withdrawal by Subject|0
5927982|NCT01447927|20505787|P1|Overall Study|Withdrawal by Subject|1
5927983|NCT01447927|20505786|P2|Overall Study|Adverse Event|3
5927984|NCT01447927|20505787|P1|Overall Study|Adverse Event|4
5927985|NCT01447719|20505832|P1|Overall Study|Family withdrew autopsy consent|7
5927986|NCT01447719|20505832|P1|Overall Study|Withdrawal by Subject|2
5927987|NCT01447719|20505832|P1|Overall Study|Subject still living at end of study|79
5927988|NCT01447719|20505832|P1|Overall Study|Invalid image or not imaged|3
5927989|NCT01447719|20505832|P1|Overall Study|Image acquisition failure|2
5927990|NCT01447576|20505858|P1|Overall Study|Physician Decision|6
5927991|NCT01447576|20505858|P1|Overall Study|Lack of Efficacy|68
5927992|NCT01447576|20505858|P1|Overall Study|Protocol deviation|83
5927993|NCT01447576|20505858|P1|Overall Study|Withdrawal by Subject|100
5927994|NCT01447576|20505858|P1|Overall Study|Participant met withdrawal criteria|40
5927995|NCT01447576|20505858|P1|Overall Study|Adverse Event|127
5927996|NCT01447576|20505858|P1|Overall Study|Lost to Follow-up|52
5927997|NCT01447446|20505891|P6|Overall Study|Reason not Specified|0
5927998|NCT01447446|20505892|P5|Overall Study|Reason not Specified|1
5927999|NCT01447446|20505893|P4|Overall Study|Reason not Specified|1
5928000|NCT01447446|20505894|P3|Overall Study|Reason not Specified|1
5928001|NCT01447446|20505895|P2|Overall Study|Reason not Specified|1
5928002|NCT01447446|20505896|P1|Overall Study|Reason not Specified|1
5928003|NCT01447446|20505891|P6|Overall Study|New Treatment Started|0
5928004|NCT01447446|20505892|P5|Overall Study|New Treatment Started|2
5928005|NCT01447446|20505893|P4|Overall Study|New Treatment Started|0
5928006|NCT01447446|20505894|P3|Overall Study|New Treatment Started|1
5928007|NCT01447446|20505895|P2|Overall Study|New Treatment Started|2
5928008|NCT01447446|20505896|P1|Overall Study|New Treatment Started|8
5928009|NCT01447446|20505891|P6|Overall Study|SVR12 Assessment|5
5928010|NCT01447446|20505892|P5|Overall Study|SVR12 Assessment|5
5928011|NCT01447446|20505893|P4|Overall Study|SVR12 Assessment|1
5928012|NCT01447446|20505894|P3|Overall Study|SVR12 Assessment|2
5928013|NCT01447446|20505895|P2|Overall Study|SVR12 Assessment|1
5928014|NCT01447446|20505896|P1|Overall Study|SVR12 Assessment|13
5928015|NCT01447446|20505891|P6|Overall Study|Administrative/Other|4
5928016|NCT01447446|20505892|P5|Overall Study|Administrative/Other|33
5928017|NCT01447446|20505893|P4|Overall Study|Administrative/Other|2
5928018|NCT01447446|20505894|P3|Overall Study|Administrative/Other|10
5928019|NCT01447446|20505895|P2|Overall Study|Administrative/Other|9
5928020|NCT01447446|20505896|P1|Overall Study|Administrative/Other|34
5928021|NCT01447446|20505891|P6|Overall Study|Insuff. VR/TRT too Short to Expect VR|14
5928022|NCT01447446|20505892|P5|Overall Study|Insuff. VR/TRT too Short to Expect VR|92
5928023|NCT01447446|20505893|P4|Overall Study|Insuff. VR/TRT too Short to Expect VR|21
5928024|NCT01447446|20505894|P3|Overall Study|Insuff. VR/TRT too Short to Expect VR|52
5928025|NCT01447446|20505895|P2|Overall Study|Insuff. VR/TRT too Short to Expect VR|71
5928026|NCT01447446|20505896|P1|Overall Study|Insuff. VR/TRT too Short to Expect VR|300
5928027|NCT01447446|20505891|P6|Overall Study|Failure to Return/Consent Withdrawn|9
5928028|NCT01447446|20505892|P5|Overall Study|Failure to Return/Consent Withdrawn|69
5928029|NCT01447446|20505893|P4|Overall Study|Failure to Return/Consent Withdrawn|7
5928030|NCT01447446|20505894|P3|Overall Study|Failure to Return/Consent Withdrawn|31
5928031|NCT01447446|20505895|P2|Overall Study|Failure to Return/Consent Withdrawn|78
5928032|NCT01447446|20505896|P1|Overall Study|Failure to Return/Consent Withdrawn|357
5928033|NCT01447446|20505891|P6|Overall Study|Adverse Event|0
5928034|NCT01447446|20505892|P5|Overall Study|Adverse Event|2
5928035|NCT01447446|20505893|P4|Overall Study|Adverse Event|0
5928036|NCT01447446|20505894|P3|Overall Study|Adverse Event|1
5928037|NCT01447446|20505895|P2|Overall Study|Adverse Event|0
5928038|NCT01447446|20505896|P1|Overall Study|Adverse Event|3
5928039|NCT01447446|20505891|P6|Overall Study|Death|0
5928040|NCT01447446|20505892|P5|Overall Study|Death|7
5928041|NCT01447446|20505893|P4|Overall Study|Death|1
5928042|NCT01447446|20505894|P3|Overall Study|Death|2
5928043|NCT01447446|20505895|P2|Overall Study|Death|3
5928044|NCT01447446|20505896|P1|Overall Study|Death|6
5928045|NCT01447433|20505986|P2|Overall Study|Protocol Violation|1
5928046|NCT01447433|20505987|P1|Overall Study|Protocol Violation|1
5928047|NCT01447433|20505986|P2|Overall Study|Withdrawal by Subject|3
5928048|NCT01447433|20505987|P1|Overall Study|Withdrawal by Subject|3
5928049|NCT01447433|20505986|P2|Overall Study|Lost to Follow-up|2
5928050|NCT01447433|20505987|P1|Overall Study|Lost to Follow-up|0
5928051|NCT01447420|20506014|P3|Overall Study|Lack of Efficacy|8
5928052|NCT01447420|20506015|P2|Overall Study|Lack of Efficacy|19
5928053|NCT01447420|20506016|P1|Overall Study|Lack of Efficacy|1
5928054|NCT01447420|20506014|P3|Overall Study|Withdrawal by Subject|0
5928055|NCT01447420|20506015|P2|Overall Study|Withdrawal by Subject|1
5928056|NCT01447420|20506016|P1|Overall Study|Withdrawal by Subject|4
5928057|NCT01447420|20506014|P3|Overall Study|Protocol Violation|0
5928058|NCT01447420|20506015|P2|Overall Study|Protocol Violation|3
5928059|NCT01447420|20506016|P1|Overall Study|Protocol Violation|3
5928060|NCT01447420|20506014|P3|Overall Study|Adverse Event|2
5928061|NCT01447420|20506015|P2|Overall Study|Adverse Event|4
5928062|NCT01447420|20506016|P1|Overall Study|Adverse Event|2
5928063|NCT01447407|20506036|P4|Overall Study|Physician Decision|1
5928064|NCT01447407|20506037|P3|Overall Study|Physician Decision|1
5928065|NCT01447407|20506038|P2|Overall Study|Physician Decision|0
5928066|NCT01447407|20506039|P1|Overall Study|Physician Decision|0
5928067|NCT01447407|20506036|P4|Overall Study|Withdrawal by Subject|1
5928068|NCT01447407|20506037|P3|Overall Study|Withdrawal by Subject|0
5928069|NCT01447407|20506038|P2|Overall Study|Withdrawal by Subject|0
5928070|NCT01447407|20506039|P1|Overall Study|Withdrawal by Subject|2
5928071|NCT01446965|20506172|P2|Participants Followed and Analyzed|Lost to Follow-up|12
5928072|NCT01446965|20506173|P1|Participants Followed and Analyzed|Lost to Follow-up|10
5928073|NCT01446965|20506172|P2|Randominization|One site was dismissed due to IRB irregularity|16
5928074|NCT01446965|20506173|P1|Randominization|One site was dismissed due to IRB irregularity|30
5928075|NCT01446913|20506186|P3|Overall Study|Lost to Follow-up|3
5928076|NCT01446913|20506187|P2|Overall Study|Lost to Follow-up|5
5928077|NCT01446913|20506188|P1|Overall Study|Lost to Follow-up|3
5928078|NCT01446913|20506186|P3|Overall Study|Physician Decision|2
5928079|NCT01446913|20506187|P2|Overall Study|Physician Decision|0
5928080|NCT01446913|20506188|P1|Overall Study|Physician Decision|0
5928081|NCT01446913|20506186|P3|Overall Study|Withdrawal by Subject|5
5928082|NCT01446913|20506187|P2|Overall Study|Withdrawal by Subject|3
5928083|NCT01446913|20506188|P1|Overall Study|Withdrawal by Subject|5
5928084|NCT01446913|20506186|P3|Overall Study|Significant illness|1
5928085|NCT01446913|20506187|P2|Overall Study|Significant illness|1
5928086|NCT01446913|20506188|P1|Overall Study|Significant illness|1
5928087|NCT01446874|20506249|P3|Overall Study|Withdrawal by Subject|4
5928088|NCT01446874|20506250|P2|Overall Study|Withdrawal by Subject|0
5928089|NCT01446874|20506251|P1|Overall Study|Withdrawal by Subject|0
5928090|NCT01446874|20506249|P3|Overall Study|Antibiotics for pre-op infection|2
5928091|NCT01446874|20506250|P2|Overall Study|Antibiotics for pre-op infection|0
5928092|NCT01446874|20506251|P1|Overall Study|Antibiotics for pre-op infection|0
5928093|NCT01446874|20506249|P3|Overall Study|Non-compliance|0
5928094|NCT01446874|20506250|P2|Overall Study|Non-compliance|4
5928095|NCT01446874|20506251|P1|Overall Study|Non-compliance|0
5928096|NCT01446874|20506249|P3|Overall Study|No surgery/No qualifying surgery|12
5928097|NCT01446874|20506250|P2|Overall Study|No surgery/No qualifying surgery|0
5928098|NCT01446874|20506251|P1|Overall Study|No surgery/No qualifying surgery|1
5928099|NCT01446874|20506249|P3|Overall Study|Not eligible|0
5928100|NCT01446874|20506250|P2|Overall Study|Not eligible|0
5928101|NCT01446874|20506251|P1|Overall Study|Not eligible|1
5928102|NCT01446809|20506279|P3|Overall Study|Failure to complete study procedures|1
5928103|NCT01446809|20506280|P2|Overall Study|Failure to complete study procedures|0
5928104|NCT01446809|20506281|P1|Overall Study|Failure to complete study procedures|0
5928105|NCT01446809|20506279|P3|Overall Study|Adverse Event|1
5928106|NCT01446809|20506280|P2|Overall Study|Adverse Event|0
5928107|NCT01446809|20506281|P1|Overall Study|Adverse Event|0
5928108|NCT01446796|20506304|P2|Overall Study|Withdrawal by Subject|0
5928109|NCT01446796|20506305|P1|Overall Study|Withdrawal by Subject|1
5928110|NCT01446419|20506351|P2|Overall Study|Terminated per protocol|0
5928112|NCT01446419|20506351|P2|Overall Study|Withdrawal by Subject|1
5928113|NCT01446419|20506352|P1|Overall Study|Withdrawal by Subject|1
5928114|NCT01446419|20506351|P2|Overall Study|Death|0
5928115|NCT01446419|20506352|P1|Overall Study|Death|1
5928116|NCT01446289|20506366|P4|Overall Study|Withdrawal by Subject|0
5928117|NCT01446289|20506367|P3|Overall Study|Withdrawal by Subject|1
5928118|NCT01446289|20506368|P2|Overall Study|Withdrawal by Subject|0
5928119|NCT01446289|20506369|P1|Overall Study|Withdrawal by Subject|1
5928120|NCT01446237|20506412|P1|Overall Study|Withdrawal by Subject|7
5928121|NCT01446237|20506412|P1|Overall Study|Lost to Follow-up|2
5928122|NCT01446237|20506412|P1|Overall Study|Adverse Event|1
5928123|NCT01446159|20506424|P4|Overall Study|Other|13
5928124|NCT01446159|20506425|P3|Overall Study|Other|13
5928125|NCT01446159|20506426|P2|Overall Study|Other|0
5928126|NCT01446159|20506427|P1|Overall Study|Other|0
5928127|NCT01446159|20506424|P4|Overall Study|Death|36
5928128|NCT01446159|20506425|P3|Overall Study|Death|43
5928129|NCT01446159|20506426|P2|Overall Study|Death|3
5928130|NCT01446159|20506427|P1|Overall Study|Death|2
5928131|NCT01446159|20506424|P4|Overall Study|Lost to Follow-up|2
5928132|NCT01446159|20506425|P3|Overall Study|Lost to Follow-up|1
5928133|NCT01446159|20506426|P2|Overall Study|Lost to Follow-up|0
5928134|NCT01446159|20506427|P1|Overall Study|Lost to Follow-up|0
5928135|NCT01446159|20506424|P4|Overall Study|Withdrawal by Subject|11
5928136|NCT01446159|20506425|P3|Overall Study|Withdrawal by Subject|14
5928137|NCT01446159|20506426|P2|Overall Study|Withdrawal by Subject|0
5928138|NCT01446159|20506427|P1|Overall Study|Withdrawal by Subject|1
5928139|NCT01446042|20506502|P3|Overall Study|Other reasons|1
5928140|NCT01446042|20506503|P2|Overall Study|Other reasons|1
5928141|NCT01446042|20506504|P1|Overall Study|Other reasons|2
5928142|NCT01446042|20506502|P3|Overall Study|Lost to Follow-up|0
5928143|NCT01446042|20506503|P2|Overall Study|Lost to Follow-up|0
5928144|NCT01446042|20506504|P1|Overall Study|Lost to Follow-up|5
5928145|NCT01446042|20506502|P3|Overall Study|Adverse Event|4
5928146|NCT01446042|20506503|P2|Overall Study|Adverse Event|0
5928147|NCT01446042|20506504|P1|Overall Study|Adverse Event|1
5928148|NCT01446042|20506502|P3|Overall Study|Withdrawal by Subject|4
5928149|NCT01446042|20506503|P2|Overall Study|Withdrawal by Subject|2
5928150|NCT01446042|20506504|P1|Overall Study|Withdrawal by Subject|12
5928151|NCT01446003|20506515|P2|Period 2|Adverse Event|0
5928152|NCT01446003|20506516|P1|Period 2|Adverse Event|1
5928153|NCT01446003|20506515|P2|Period 1|Protocol Violation|0
5928154|NCT01446003|20506516|P1|Period 1|Protocol Violation|2
5928155|NCT01445951|20506537|P3|Overall Study|Cough|0
5928156|NCT01445951|20506538|P2|Overall Study|Cough|1
5928157|NCT01445951|20506539|P1|Overall Study|Cough|0
5928158|NCT01445951|20506537|P3|Overall Study|Sponsor decision - subject travel|0
5928159|NCT01445951|20506538|P2|Overall Study|Sponsor decision - subject travel|1
5928160|NCT01445951|20506539|P1|Overall Study|Sponsor decision - subject travel|0
5928161|NCT01445951|20506537|P3|Overall Study|Non-compliance with protocol|0
5928162|NCT01445951|20506538|P2|Overall Study|Non-compliance with protocol|1
5928163|NCT01445951|20506539|P1|Overall Study|Non-compliance with protocol|0
5928164|NCT01445951|20506537|P3|Overall Study|Non-compliance with study drug|0
5928165|NCT01445951|20506538|P2|Overall Study|Non-compliance with study drug|2
5928166|NCT01445951|20506539|P1|Overall Study|Non-compliance with study drug|1
5928167|NCT01445951|20506537|P3|Overall Study|Death|1
5928168|NCT01445951|20506538|P2|Overall Study|Death|0
5928169|NCT01445951|20506539|P1|Overall Study|Death|0
5928170|NCT01445951|20506537|P3|Overall Study|Pregnancy|4
5928171|NCT01445951|20506538|P2|Overall Study|Pregnancy|1
5928172|NCT01445951|20506539|P1|Overall Study|Pregnancy|0
5928173|NCT01445951|20506537|P3|Overall Study|Lost to Follow-up|4
5928174|NCT01445951|20506538|P2|Overall Study|Lost to Follow-up|2
5928175|NCT01445951|20506539|P1|Overall Study|Lost to Follow-up|1
5928176|NCT01445951|20506537|P3|Overall Study|Physician Decision|0
5928177|NCT01445951|20506538|P2|Overall Study|Physician Decision|1
5928178|NCT01445951|20506539|P1|Overall Study|Physician Decision|3
5928179|NCT01445951|20506537|P3|Overall Study|Withdrawal by Subject|8
5928180|NCT01445951|20506538|P2|Overall Study|Withdrawal by Subject|16
5928181|NCT01445951|20506539|P1|Overall Study|Withdrawal by Subject|21
5928182|NCT01445951|20506537|P3|Overall Study|Protocol Violation|2
5928183|NCT01445951|20506538|P2|Overall Study|Protocol Violation|2
5928184|NCT01445951|20506539|P1|Overall Study|Protocol Violation|2
5928185|NCT01445951|20506537|P3|Overall Study|Adverse Event|0
5928186|NCT01445951|20506538|P2|Overall Study|Adverse Event|9
5928187|NCT01445951|20506539|P1|Overall Study|Adverse Event|16
5928188|NCT01445886|20506577|P1|Overall Study|Protocol Violation|3
5928189|NCT01445886|20506577|P1|Overall Study|Lost to Follow-up|2
5928190|NCT01445847|20506617|P2|Overall Study|Missed Data|0
5928191|NCT01445847|20506618|P1|Overall Study|Missed Data|1
5928192|NCT01445847|20506617|P2|Overall Study|Protocol Violation|14
5928193|NCT01445847|20506618|P1|Overall Study|Protocol Violation|13
5928194|NCT01445769|20506635|P1|Overall Study|Lost to Follow-up|5
5928195|NCT01445769|20506635|P1|Overall Study|Disease Progression|1
5928196|NCT01445769|20506635|P1|Overall Study|Consent Withdrawn|2
5928197|NCT01445678|20506655|P2|Overall Study|Withdrawal by Subject|5
5928198|NCT01445678|20506656|P1|Overall Study|Withdrawal by Subject|9
5928199|NCT01445678|20506655|P2|Overall Study|Protocol Violation|1
5928200|NCT01445678|20506656|P1|Overall Study|Protocol Violation|1
5928201|NCT01445678|20506655|P2|Overall Study|Lost to Follow-up|5
5928202|NCT01445678|20506656|P1|Overall Study|Lost to Follow-up|8
5928203|NCT01445678|20506655|P2|Overall Study|Lack of Efficacy|2
5928204|NCT01445678|20506656|P1|Overall Study|Lack of Efficacy|0
5928205|NCT01445678|20506655|P2|Overall Study|Adverse Event|8
5928206|NCT01445678|20506656|P1|Overall Study|Adverse Event|12
5928207|NCT01445652|20506674|P2|Overall Study|Adverse Event|0
5928208|NCT01445652|20506675|P1|Overall Study|Adverse Event|1
5928209|NCT01445652|20506674|P2|Overall Study|Failed teach session|0
5928210|NCT01445652|20506675|P1|Overall Study|Failed teach session|2
5928211|NCT01445652|20506674|P2|Overall Study|Failed to attend scheduled visit|3
5928212|NCT01445652|20506675|P1|Overall Study|Failed to attend scheduled visit|2
5928213|NCT01445652|20506674|P2|Overall Study|Not comfortable in lenses|0
5928214|NCT01445652|20506675|P1|Overall Study|Not comfortable in lenses|5
5928215|NCT01445613|20506693|P1|1-year Follow-up|Received a non-study stent|2
5928216|NCT01445613|20506693|P1|1-year Follow-up|Physician Decision|2
5928217|NCT01445613|20506693|P1|1-year Follow-up|Death|30
5928218|NCT01445613|20506693|P1|1-year Follow-up|Lost to Follow-up|2
5928219|NCT01445613|20506693|P1|1-year Follow-up|Missed visit|29
5928220|NCT01445613|20506693|P1|1-year Follow-up|Withdrawal by Subject|12
5928221|NCT01445613|20506693|P1|30-day Follow-up|Death|3
5928222|NCT01445613|20506693|P1|30-day Follow-up|Missed visit|23
5928223|NCT01445613|20506693|P1|30-day Follow-up|Physician Decision|3
5928224|NCT01445613|20506693|P1|30-day Follow-up|Withdrawal by Subject|6
5928225|NCT01445548|20506711|P1|Overall Study|Adverse Event|1
5928226|NCT01445535|20506737|P4|Overall Study|PI discretion|1
5928227|NCT01445535|20506738|P3|Overall Study|PI discretion|0
5928228|NCT01445535|20506739|P2|Overall Study|PI discretion|0
5928229|NCT01445535|20506740|P1|Overall Study|PI discretion|0
5928230|NCT01445535|20506737|P4|Overall Study|Disease progression|0
5928231|NCT01445535|20506738|P3|Overall Study|Disease progression|1
5928232|NCT01445535|20506739|P2|Overall Study|Disease progression|0
5928233|NCT01445535|20506740|P1|Overall Study|Disease progression|1
5928234|NCT01445535|20506737|P4|Overall Study|Enrolled/taken off study, no drug avail.|1
5928235|NCT01445535|20506738|P3|Overall Study|Enrolled/taken off study, no drug avail.|0
5928236|NCT01445535|20506739|P2|Overall Study|Enrolled/taken off study, no drug avail.|0
5928237|NCT01445535|20506740|P1|Overall Study|Enrolled/taken off study, no drug avail.|0
5928238|NCT01445301|20506764|P3|Overall Study|Withdrawal by Subject|4
5928239|NCT01445301|20506765|P2|Overall Study|Withdrawal by Subject|6
5928240|NCT01445301|20506766|P1|Overall Study|Withdrawal by Subject|5
5928241|NCT01445301|20506764|P3|Overall Study|Physician Decision|0
5928242|NCT01445301|20506765|P2|Overall Study|Physician Decision|2
5928243|NCT01445301|20506766|P1|Overall Study|Physician Decision|0
5928244|NCT01445301|20506764|P3|Overall Study|Protocol-Defined Stopping Criteria|1
5928245|NCT01445301|20506765|P2|Overall Study|Protocol-Defined Stopping Criteria|1
5928246|NCT01445301|20506766|P1|Overall Study|Protocol-Defined Stopping Criteria|0
5928247|NCT01445301|20506764|P3|Overall Study|Protocol Violation|0
5928248|NCT01445301|20506765|P2|Overall Study|Protocol Violation|0
5928249|NCT01445301|20506766|P1|Overall Study|Protocol Violation|1
5928250|NCT01445301|20506764|P3|Overall Study|Lack of Efficacy|0
5928251|NCT01445301|20506765|P2|Overall Study|Lack of Efficacy|1
5928252|NCT01445301|20506766|P1|Overall Study|Lack of Efficacy|0
5928253|NCT01445301|20506764|P3|Overall Study|Adverse Event|4
5928254|NCT01445301|20506765|P2|Overall Study|Adverse Event|25
5928255|NCT01445301|20506766|P1|Overall Study|Adverse Event|15
5928256|NCT01445171|20506801|P1|Overall Study|Consented but did not receive device|8
5928257|NCT01445171|20506801|P1|Overall Study|Subjects declined to return for followup|9
5928258|NCT01445171|20506801|P1|Overall Study|Death|51
5928259|NCT01445171|20506801|P1|Overall Study|Withdrawal by Subject|16
5928260|NCT01445171|20506801|P1|Overall Study|Lost to Follow-up|11
5928261|NCT01444898|20506857|P1|Overall Study|Withdrawal by Subject|1
5928262|NCT01444781|20506872|P3|Overall Study|Withdrawal by Subject|2
5928263|NCT01444781|20506873|P2|Overall Study|Withdrawal by Subject|1
5928264|NCT01444781|20506874|P1|Overall Study|Withdrawal by Subject|3
5928265|NCT01444781|20506872|P3|Overall Study|Lost to Follow-up|1
5928266|NCT01444781|20506873|P2|Overall Study|Lost to Follow-up|3
5928267|NCT01444781|20506874|P1|Overall Study|Lost to Follow-up|0
5928268|NCT01444742|20506912|P1|Overall Study|Death|1
5928269|NCT01444651|20506919|P2|Overall Study|Missing data|1
5928270|NCT01444651|20506920|P1|Overall Study|Missing data|1
5928271|NCT01444651|20506919|P2|Overall Study|Non-fasting|1
5928272|NCT01444651|20506920|P1|Overall Study|Non-fasting|2
5928273|NCT01444651|20506919|P2|Overall Study|Lost to Follow-up|5
5928274|NCT01444651|20506920|P1|Overall Study|Lost to Follow-up|5
5928275|NCT01444651|20506919|P2|Overall Study|Adverse Event|2
5928276|NCT01444651|20506920|P1|Overall Study|Adverse Event|3
5928277|NCT01444456|20506936|P1|Overall Study|Not treated|104
5928278|NCT01444456|20506936|P1|Overall Study|Other|18
5928279|NCT01444456|20506936|P1|Overall Study|Ineligibility determined|23
5928280|NCT01444456|20506936|P1|Overall Study|Death|73
5928281|NCT01444456|20506936|P1|Overall Study|Lost to Follow-up|37
5928282|NCT01444456|20506936|P1|Overall Study|Physician Decision|9
5928283|NCT01444456|20506936|P1|Overall Study|Withdrawal by Subject|21
5928284|NCT01444430|20506947|P2|Overall Study|CRF termination module not completed.|1
5928285|NCT01444430|20506948|P1|Overall Study|CRF termination module not completed.|0
5928286|NCT01444430|20506947|P2|Overall Study|Lost to Follow-up|0
5928287|NCT01444430|20506948|P1|Overall Study|Lost to Follow-up|2
5928288|NCT01444430|20506947|P2|Overall Study|Death|8
5928289|NCT01444430|20506948|P1|Overall Study|Death|6
5928290|NCT01444430|20506947|P2|Overall Study|Withdrawal by Subject|72
5928291|NCT01444430|20506948|P1|Overall Study|Withdrawal by Subject|53
5928292|NCT01444417|20506970|P2|Overall Study|Withdrawal by Subject|0
5928293|NCT01444417|20506971|P1|Overall Study|Withdrawal by Subject|2
5928294|NCT01444417|20506970|P2|Overall Study|Ineligibility Determined|1
5928295|NCT01444417|20506971|P1|Overall Study|Ineligibility Determined|0
5928296|NCT01444391|20506987|P1|Overall Study|Death|1
5928297|NCT01444378|20506995|P1|Overall Study|Missed Visits|10
5928298|NCT01444378|20506995|P1|Overall Study|Administrative Closure Of The Study|2
5928299|NCT01444378|20506995|P1|Overall Study|Death|3
5928300|NCT01444378|20506995|P1|Overall Study|Withdrawal by Subject|1
5928301|NCT01444378|20506995|P1|Overall Study|Lost to Follow-up|1
5928302|NCT01444300|20507107|P2|Overall Study|Adverse Event|0
5928303|NCT01444300|20507108|P1|Overall Study|Adverse Event|4
5928304|NCT01444092|20507140|P1|Overall Study|Other Eligibility criteria|7
5928305|NCT01444092|20507140|P1|Overall Study|Withdrawal by Subject|1
5928306|NCT01444092|20507140|P1|Overall Study|Protocol Violation|1
5928307|NCT01444092|20507140|P1|Overall Study|Adverse Event|8
5928308|NCT01444027|20507149|P3|Overall Study|Lost to Follow-up|14
5928309|NCT01444027|20507150|P2|Overall Study|Lost to Follow-up|20
5928310|NCT01444027|20507151|P1|Overall Study|Lost to Follow-up|26
5928311|NCT01444027|20507149|P3|Overall Study|Withdrawal by Subject|24
5928312|NCT01444027|20507150|P2|Overall Study|Withdrawal by Subject|10
5928313|NCT01444027|20507151|P1|Overall Study|Withdrawal by Subject|4
5928314|NCT01443923|20507173|P2|Overall Study|Adverse Event|0
5928315|NCT01443923|20507174|P1|Overall Study|Adverse Event|1
5928316|NCT01443858|20507191|P3|Overall Study|Lost to Follow-up|2
5928317|NCT01443858|20507192|P2|Overall Study|Lost to Follow-up|5
5928318|NCT01443858|20507193|P1|Overall Study|Lost to Follow-up|5
5928319|NCT01443858|20507191|P3|Overall Study|Lack of Efficacy|0
5928320|NCT01443858|20507192|P2|Overall Study|Lack of Efficacy|0
5928321|NCT01443858|20507193|P1|Overall Study|Lack of Efficacy|1
5928322|NCT01443858|20507191|P3|Overall Study|Withdrawal by Subject|5
5928323|NCT01443858|20507192|P2|Overall Study|Withdrawal by Subject|8
5928324|NCT01443858|20507193|P1|Overall Study|Withdrawal by Subject|9
5928325|NCT01443845|20507215|P2|Overall Study|Lost to Follow-up|13
5928326|NCT01443845|20507216|P1|Overall Study|Lost to Follow-up|9
5928327|NCT01443845|20507215|P2|Overall Study|Military Conflict - Site Terminated|21
5928328|NCT01443845|20507216|P1|Overall Study|Military Conflict - Site Terminated|20
5928329|NCT01443845|20507215|P2|Overall Study|Withdrawal by Subject|67
5928330|NCT01443845|20507216|P1|Overall Study|Withdrawal by Subject|63
5928331|NCT01443845|20507215|P2|Overall Study|Adverse Event|138
5928332|NCT01443845|20507216|P1|Overall Study|Adverse Event|64
5928333|NCT01443845|20507215|P2|Overall Study|Lack of Efficacy|5
5928334|NCT01443845|20507216|P1|Overall Study|Lack of Efficacy|10
5928335|NCT01443845|20507215|P2|Overall Study|Deterioration in pulmonary function|4
5928336|NCT01443845|20507216|P1|Overall Study|Deterioration in pulmonary function|1
5928337|NCT01443845|20507215|P2|Overall Study|Other reasons, such as COPD exacerbation|44
5928338|NCT01443845|20507216|P1|Overall Study|Other reasons, such as COPD exacerbation|44
5928339|NCT01443845|20507215|P2|Overall Study|Protocol Violation|45
5928340|NCT01443845|20507216|P1|Overall Study|Protocol Violation|43
5928341|NCT01443403|20507271|P4|Overall Study|Other - Miscellaneous|1
5928342|NCT01443403|20507272|P3|Overall Study|Other - Miscellaneous|0
5928343|NCT01443403|20507273|P2|Overall Study|Other - Miscellaneous|0
5928344|NCT01443403|20507274|P1|Overall Study|Other - Miscellaneous|1
5928345|NCT01443403|20507271|P4|Overall Study|Use of Prohibited Treatment|0
5928346|NCT01443403|20507272|P3|Overall Study|Use of Prohibited Treatment|0
5928347|NCT01443403|20507273|P2|Overall Study|Use of Prohibited Treatment|3
5928348|NCT01443403|20507274|P1|Overall Study|Use of Prohibited Treatment|2
5928349|NCT01443403|20507271|P4|Overall Study|Protocol Violation|1
5928350|NCT01443403|20507272|P3|Overall Study|Protocol Violation|1
5928351|NCT01443403|20507273|P2|Overall Study|Protocol Violation|1
5928352|NCT01443403|20507274|P1|Overall Study|Protocol Violation|2
5928353|NCT01443403|20507271|P4|Overall Study|Lost to Follow-up|1
5928354|NCT01443403|20507272|P3|Overall Study|Lost to Follow-up|0
5928355|NCT01443403|20507273|P2|Overall Study|Lost to Follow-up|0
5928356|NCT01443403|20507274|P1|Overall Study|Lost to Follow-up|0
5928357|NCT01443403|20507271|P4|Overall Study|Withdrawal by Subject|1
5928358|NCT01443403|20507272|P3|Overall Study|Withdrawal by Subject|2
5928359|NCT01443403|20507273|P2|Overall Study|Withdrawal by Subject|1
5928360|NCT01443403|20507274|P1|Overall Study|Withdrawal by Subject|0
5928361|NCT01443403|20507271|P4|Overall Study|Adverse Event|5
5928362|NCT01443403|20507272|P3|Overall Study|Adverse Event|4
5928363|NCT01443403|20507273|P2|Overall Study|Adverse Event|1
5928364|NCT01443403|20507274|P1|Overall Study|Adverse Event|1
5928365|NCT01443364|20507421|P1|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
5928366|NCT01443364|20507421|P1|Overall Study|AE, non-serious non-fatal|8
5928367|NCT01443364|20507421|P1|Overall Study|SAE, non-fatal|6
5928368|NCT01443364|20507421|P1|Overall Study|Other Reason|4
5928369|NCT01443364|20507421|P1|Overall Study|Withdrawal by Subject|5
5928370|NCT01443364|20507421|P1|Overall Study|Lost to Follow-up|3
5928371|NCT01443364|20507421|P1|Overall Study|Lack of Efficacy|14
5928372|NCT01443130|20507550|P6|Overall Study|Death of Subject's Infant|0
5928373|NCT01443130|20507551|P5|Overall Study|Death of Subject's Infant|0
5928374|NCT01443130|20507552|P4|Overall Study|Death of Subject's Infant|0
5928375|NCT01443130|20507553|P3|Overall Study|Death of Subject's Infant|11
5928376|NCT01443130|20507554|P2|Overall Study|Death of Subject's Infant|10
5928377|NCT01443130|20507555|P1|Overall Study|Death of Subject's Infant|5
5928378|NCT01443130|20507550|P6|Overall Study|Withdrawal by Subject|2
5928379|NCT01443130|20507551|P5|Overall Study|Withdrawal by Subject|7
5928380|NCT01443130|20507552|P4|Overall Study|Withdrawal by Subject|7
5928381|NCT01443130|20507553|P3|Overall Study|Withdrawal by Subject|12
5928382|NCT01443130|20507554|P2|Overall Study|Withdrawal by Subject|14
5928383|NCT01443130|20507555|P1|Overall Study|Withdrawal by Subject|15
5928384|NCT01443130|20507550|P6|Overall Study|Protocol Violation|3
5928385|NCT01443130|20507551|P5|Overall Study|Protocol Violation|2
5928386|NCT01443130|20507552|P4|Overall Study|Protocol Violation|2
5928387|NCT01443130|20507553|P3|Overall Study|Protocol Violation|3
5928388|NCT01443130|20507554|P2|Overall Study|Protocol Violation|1
5928389|NCT01443130|20507555|P1|Overall Study|Protocol Violation|2
5928390|NCT01443130|20507550|P6|Overall Study|Adverse Event|0
5928391|NCT01443130|20507551|P5|Overall Study|Adverse Event|0
5928392|NCT01443130|20507552|P4|Overall Study|Adverse Event|0
5928393|NCT01443130|20507553|P3|Overall Study|Adverse Event|1
5928394|NCT01443130|20507554|P2|Overall Study|Adverse Event|1
5928395|NCT01443130|20507555|P1|Overall Study|Adverse Event|2
5928396|NCT01443130|20507550|P6|Overall Study|Death|8
5928397|NCT01443130|20507551|P5|Overall Study|Death|10
5928398|NCT01443130|20507552|P4|Overall Study|Death|7
5928399|NCT01443130|20507553|P3|Overall Study|Death|0
5928400|NCT01443130|20507554|P2|Overall Study|Death|1
5928401|NCT01443130|20507555|P1|Overall Study|Death|0
5928402|NCT01443130|20507550|P6|Overall Study|Lost to Follow-up|21
5928403|NCT01443130|20507551|P5|Overall Study|Lost to Follow-up|25
5928404|NCT01443130|20507552|P4|Overall Study|Lost to Follow-up|23
5928405|NCT01443130|20507553|P3|Overall Study|Lost to Follow-up|50
5928406|NCT01443130|20507554|P2|Overall Study|Lost to Follow-up|42
5928407|NCT01443130|20507555|P1|Overall Study|Lost to Follow-up|44
5928408|NCT01443078|20507605|P1|Overall Study|Patient had brain mets|1
5928409|NCT01443078|20507605|P1|Overall Study|Withdrawal by Subject|1
5928410|NCT01443078|20507605|P1|Overall Study|Responded to neoadjuvant platinum txt|27
5928411|NCT01443026|20507612|P2|Overall Study|Lost to Follow-up|1
5928412|NCT01443026|20507613|P1|Overall Study|Lost to Follow-up|2
5928413|NCT01443026|20507612|P2|Overall Study|Withdrawal by Subject|3
5928414|NCT01443026|20507613|P1|Overall Study|Withdrawal by Subject|0
5928415|NCT01443026|20507612|P2|Overall Study|Death|1
5928416|NCT01443026|20507613|P1|Overall Study|Death|0
5928417|NCT01443026|20507612|P2|Overall Study|Physician Decision|0
5928418|NCT01443026|20507613|P1|Overall Study|Physician Decision|1
5928419|NCT01442779|20507628|P1|Overall Study|Non-compliance|1
5928420|NCT01442779|20507628|P1|Overall Study|Death|3
5928421|NCT01442779|20507628|P1|Overall Study|Withdrawal by Subject|3
5928422|NCT01442714|20507634|P1|Overall Study|Withdrawal by Subject|1
5928423|NCT01442714|20507634|P1|Overall Study|Death|11
5928424|NCT01442688|20507642|P2|Second Intervention|Adverse Event|0
5928425|NCT01442688|20507643|P1|Second Intervention|Adverse Event|1
5928426|NCT01442688|20507642|P2|First Intervention|subject incarcerated|0
5928427|NCT01442688|20507643|P1|First Intervention|subject incarcerated|1
5928428|NCT01442688|20507642|P2|First Intervention|Withdrawal by Subject|0
5928429|NCT01442688|20507643|P1|First Intervention|Withdrawal by Subject|1
5928430|NCT01442675|20507651|P1|Overall Study|Withdrawal by Subject|4
5928431|NCT01442675|20507651|P1|Overall Study|Lost to Follow-up|2
5928432|NCT01442675|20507651|P1|Overall Study|Protocol Violation|6
5928433|NCT01442493|20507663|P2|Overall Study|withdrawn from study|2
5928434|NCT01442493|20507664|P1|Overall Study|withdrawn from study|3
5928435|NCT01442376|20507685|P3|Overall Study|Not eligible for subsequent cycles|0
5928436|NCT01442376|20507686|P2|Overall Study|Not eligible for subsequent cycles|2
5928437|NCT01442376|20507687|P1|Overall Study|Not eligible for subsequent cycles|1
5928438|NCT01442376|20507685|P3|Overall Study|Patients not treated|1
5928439|NCT01442376|20507686|P2|Overall Study|Patients not treated|3
5928440|NCT01442376|20507687|P1|Overall Study|Patients not treated|2
5928441|NCT01442376|20507685|P3|Overall Study|Withdrawal of consent|1
5928442|NCT01442376|20507686|P2|Overall Study|Withdrawal of consent|0
5928443|NCT01442376|20507687|P1|Overall Study|Withdrawal of consent|0
5928444|NCT01442376|20507685|P3|Overall Study|Death|1
5928445|NCT01442376|20507686|P2|Overall Study|Death|1
5928446|NCT01442376|20507687|P1|Overall Study|Death|0
5928447|NCT01442376|20507685|P3|Overall Study|Adverse Event|2
5928448|NCT01442376|20507686|P2|Overall Study|Adverse Event|3
5928449|NCT01442376|20507687|P1|Overall Study|Adverse Event|0
5928450|NCT01442181|20507700|P2|Overall Study|atrial fibrillation not noted|1
5928451|NCT01442181|20507701|P1|Overall Study|atrial fibrillation not noted|0
5928452|NCT01442181|20507700|P2|Overall Study|patient in an additional study|0
5928453|NCT01442181|20507701|P1|Overall Study|patient in an additional study|1
5928454|NCT01442181|20507700|P2|Overall Study|Lost to Follow-up|1
5928455|NCT01442181|20507701|P1|Overall Study|Lost to Follow-up|1
5928456|NCT01442181|20507700|P2|Overall Study|low ejection factor|1
5928457|NCT01442181|20507701|P1|Overall Study|low ejection factor|0
5928458|NCT01442181|20507700|P2|Overall Study|no insurance for surgery|0
5928459|NCT01442181|20507701|P1|Overall Study|no insurance for surgery|1
5928460|NCT01442181|20507700|P2|Overall Study|patient refused surgery|0
5928461|NCT01442181|20507701|P1|Overall Study|patient refused surgery|1
5928462|NCT01442155|20507725|P1|Overall Study|Lost to Follow-up|2
5928463|NCT01442155|20507725|P1|Overall Study|Adverse Event|2
5928464|NCT01442155|20507725|P1|Overall Study|Recurrence|26
5928465|NCT01442155|20507725|P1|Overall Study|Complete remission|35
5928466|NCT01442103|20507741|P1|Overall Study|Lost to Follow-up|2
5928467|NCT01442064|20507751|P6|Overall Study|Condition mandated other intervention|2
5928468|NCT01442064|20507752|P5|Overall Study|Condition mandated other intervention|0
5928469|NCT01442064|20507753|P4|Overall Study|Condition mandated other intervention|0
5928470|NCT01442064|20507754|P3|Overall Study|Condition mandated other intervention|2
5928471|NCT01442064|20507755|P2|Overall Study|Condition mandated other intervention|1
5928472|NCT01442064|20507756|P1|Overall Study|Condition mandated other intervention|1
5928473|NCT01442064|20507751|P6|Overall Study|Subject non-compliance|2
5928474|NCT01442064|20507752|P5|Overall Study|Subject non-compliance|0
5928475|NCT01442064|20507753|P4|Overall Study|Subject non-compliance|0
5928476|NCT01442064|20507754|P3|Overall Study|Subject non-compliance|0
5928477|NCT01442064|20507755|P2|Overall Study|Subject non-compliance|0
5928478|NCT01442064|20507756|P1|Overall Study|Subject non-compliance|0
5928479|NCT01442064|20507751|P6|Overall Study|Sponsor decision|87
5928480|NCT01442064|20507752|P5|Overall Study|Sponsor decision|95
5928481|NCT01442064|20507753|P4|Overall Study|Sponsor decision|88
5928482|NCT01442064|20507754|P3|Overall Study|Sponsor decision|92
5928483|NCT01442064|20507755|P2|Overall Study|Sponsor decision|88
5928484|NCT01442064|20507756|P1|Overall Study|Sponsor decision|82
5928485|NCT01442064|20507751|P6|Overall Study|Withdrawal by Subject|1
5928486|NCT01442064|20507752|P5|Overall Study|Withdrawal by Subject|2
5928487|NCT01442064|20507753|P4|Overall Study|Withdrawal by Subject|2
5928488|NCT01442064|20507754|P3|Overall Study|Withdrawal by Subject|2
5928489|NCT01442064|20507755|P2|Overall Study|Withdrawal by Subject|3
5928490|NCT01442064|20507756|P1|Overall Study|Withdrawal by Subject|6
5928491|NCT01442064|20507751|P6|Overall Study|Physician Decision|1
5928492|NCT01442064|20507752|P5|Overall Study|Physician Decision|3
5928493|NCT01442064|20507753|P4|Overall Study|Physician Decision|3
5928494|NCT01442064|20507754|P3|Overall Study|Physician Decision|2
5928495|NCT01442064|20507755|P2|Overall Study|Physician Decision|1
5928496|NCT01442064|20507756|P1|Overall Study|Physician Decision|1
5928497|NCT01442064|20507751|P6|Overall Study|Lost to Follow-up|3
5928498|NCT01442064|20507752|P5|Overall Study|Lost to Follow-up|3
5928499|NCT01442064|20507753|P4|Overall Study|Lost to Follow-up|1
5928500|NCT01442064|20507754|P3|Overall Study|Lost to Follow-up|1
5928501|NCT01442064|20507755|P2|Overall Study|Lost to Follow-up|5
5928502|NCT01442064|20507756|P1|Overall Study|Lost to Follow-up|5
5928503|NCT01442064|20507751|P6|Overall Study|Death|3
5928504|NCT01442064|20507752|P5|Overall Study|Death|1
5928505|NCT01442064|20507753|P4|Overall Study|Death|3
5928506|NCT01442064|20507754|P3|Overall Study|Death|3
5928507|NCT01442064|20507755|P2|Overall Study|Death|1
5928508|NCT01442064|20507756|P1|Overall Study|Death|0
5928509|NCT01442064|20507751|P6|Overall Study|Adverse Event|0
5928510|NCT01442064|20507752|P5|Overall Study|Adverse Event|2
5928511|NCT01442064|20507753|P4|Overall Study|Adverse Event|1
5928512|NCT01442064|20507754|P3|Overall Study|Adverse Event|2
5928513|NCT01442064|20507755|P2|Overall Study|Adverse Event|2
5928514|NCT01442064|20507756|P1|Overall Study|Adverse Event|2
5928515|NCT01442038|20507793|P2|Overall Study|Study Terminated By Sponsor|3
5928516|NCT01442038|20507794|P1|Overall Study|Study Terminated By Sponsor|2
5928517|NCT01442038|20507793|P2|Overall Study|Investigator's Discretion|16
5928518|NCT01442038|20507794|P1|Overall Study|Investigator's Discretion|13
5928519|NCT01442038|20507793|P2|Overall Study|Protocol Deviation|20
5928520|NCT01442038|20507794|P1|Overall Study|Protocol Deviation|9
5928521|NCT01442038|20507793|P2|Overall Study|Adverse Event|15
5928522|NCT01442038|20507794|P1|Overall Study|Adverse Event|26
5928523|NCT01442038|20507793|P2|Overall Study|Lost to Follow-up|51
5928524|NCT01442038|20507794|P1|Overall Study|Lost to Follow-up|37
5928525|NCT01442038|20507793|P2|Overall Study|Participant Withdrew Consent|102
5928526|NCT01442038|20507794|P1|Overall Study|Participant Withdrew Consent|137
5928527|NCT01442038|20507793|P2|Overall Study|Investigator-Initiated Early Closure|43
5928528|NCT01442038|20507794|P1|Overall Study|Investigator-Initiated Early Closure|44
5928529|NCT01442038|20507793|P2|Overall Study|Death|29
5928530|NCT01442038|20507794|P1|Overall Study|Death|35
5928531|NCT01441973|20507808|P2|Overall Study|Participant withdrew consent|1
5928532|NCT01441973|20507809|P1|Overall Study|Participant withdrew consent|0
5928533|NCT01441973|20507808|P2|Overall Study|Administrative reason by sponsor|5
5928534|NCT01441973|20507809|P1|Overall Study|Administrative reason by sponsor|3
5928535|NCT01441973|20507808|P2|Overall Study|Poor compliance/noncompliance|1
5928536|NCT01441973|20507809|P1|Overall Study|Poor compliance/noncompliance|0
5928537|NCT01441973|20507808|P2|Overall Study|Participant request to discontinue|1
5928538|NCT01441973|20507809|P1|Overall Study|Participant request to discontinue|1
5928539|NCT01441973|20507808|P2|Overall Study|Adverse event unrelated to study drug|2
5928540|NCT01441973|20507809|P1|Overall Study|Adverse event unrelated to study drug|3
5928541|NCT01441973|20507808|P2|Overall Study|Disease progression|6
5928542|NCT01441973|20507809|P1|Overall Study|Disease progression|8
5928543|NCT01441960|20507831|P2|First Neuromuscular Blocking Agent:|Withdrawal by Subject|0
5928544|NCT01441960|20507832|P1|First Neuromuscular Blocking Agent:|Withdrawal by Subject|1
5928545|NCT01441960|20507831|P2|First Neuromuscular Blocking Agent:|Protocol Violation|1
5928546|NCT01441960|20507832|P1|First Neuromuscular Blocking Agent:|Protocol Violation|1
5928547|NCT01441960|20507831|P2|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|5
5928548|NCT01441960|20507832|P1|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|6
5928549|NCT01441765|20507857|P2|Overall Study|Death|0
5928550|NCT01441765|20507858|P1|Overall Study|Death|1
5928551|NCT01441635|20507882|P10|Overall Study|Other|0
5928552|NCT01441635|20507883|P9|Overall Study|Other|0
5928553|NCT01441635|20507884|P8|Overall Study|Other|1
5928554|NCT01441635|20507885|P7|Overall Study|Other|0
5928555|NCT01441635|20507886|P6|Overall Study|Other|0
5928556|NCT01441635|20507887|P5|Overall Study|Other|0
5928557|NCT01441635|20507888|P4|Overall Study|Other|0
5928558|NCT01441635|20507889|P3|Overall Study|Other|0
5928559|NCT01441635|20507890|P2|Overall Study|Other|0
5928560|NCT01441635|20507891|P1|Overall Study|Other|0
5928561|NCT01441635|20507882|P10|Overall Study|Received Exclusionary Medication|0
5928562|NCT01441635|20507883|P9|Overall Study|Received Exclusionary Medication|0
5928563|NCT01441635|20507884|P8|Overall Study|Received Exclusionary Medication|0
5928564|NCT01441635|20507885|P7|Overall Study|Received Exclusionary Medication|0
5928565|NCT01441635|20507886|P6|Overall Study|Received Exclusionary Medication|0
5928566|NCT01441635|20507887|P5|Overall Study|Received Exclusionary Medication|0
5928567|NCT01441635|20507888|P4|Overall Study|Received Exclusionary Medication|0
5928568|NCT01441635|20507889|P3|Overall Study|Received Exclusionary Medication|0
5928569|NCT01441635|20507890|P2|Overall Study|Received Exclusionary Medication|0
5928570|NCT01441635|20507891|P1|Overall Study|Received Exclusionary Medication|1
5928571|NCT01441635|20507882|P10|Overall Study|Surgery or Invasive Intervention|0
5928572|NCT01441635|20507883|P9|Overall Study|Surgery or Invasive Intervention|0
5928573|NCT01441635|20507884|P8|Overall Study|Surgery or Invasive Intervention|0
5928574|NCT01441635|20507885|P7|Overall Study|Surgery or Invasive Intervention|0
5928575|NCT01441635|20507886|P6|Overall Study|Surgery or Invasive Intervention|0
5928576|NCT01441635|20507887|P5|Overall Study|Surgery or Invasive Intervention|0
5928577|NCT01441635|20507888|P4|Overall Study|Surgery or Invasive Intervention|0
5928578|NCT01441635|20507889|P3|Overall Study|Surgery or Invasive Intervention|1
5928579|NCT01441635|20507890|P2|Overall Study|Surgery or Invasive Intervention|0
5928580|NCT01441635|20507891|P1|Overall Study|Surgery or Invasive Intervention|0
5928581|NCT01441635|20507882|P10|Overall Study|Noncompliance|0
5928582|NCT01441635|20507883|P9|Overall Study|Noncompliance|0
5928583|NCT01441635|20507884|P8|Overall Study|Noncompliance|0
5928584|NCT01441635|20507885|P7|Overall Study|Noncompliance|1
5928585|NCT01441635|20507886|P6|Overall Study|Noncompliance|0
5928586|NCT01441635|20507887|P5|Overall Study|Noncompliance|0
5928587|NCT01441635|20507888|P4|Overall Study|Noncompliance|0
5928588|NCT01441635|20507889|P3|Overall Study|Noncompliance|0
5928589|NCT01441635|20507890|P2|Overall Study|Noncompliance|1
5928590|NCT01441635|20507891|P1|Overall Study|Noncompliance|0
5928591|NCT01441635|20507882|P10|Overall Study|Lost to Follow-up|1
5928592|NCT01441635|20507883|P9|Overall Study|Lost to Follow-up|0
5928593|NCT01441635|20507884|P8|Overall Study|Lost to Follow-up|1
5928594|NCT01441635|20507885|P7|Overall Study|Lost to Follow-up|1
5928595|NCT01441635|20507886|P6|Overall Study|Lost to Follow-up|3
5928596|NCT01441635|20507887|P5|Overall Study|Lost to Follow-up|1
5928597|NCT01441635|20507888|P4|Overall Study|Lost to Follow-up|1
5928598|NCT01441635|20507889|P3|Overall Study|Lost to Follow-up|1
5928599|NCT01441635|20507890|P2|Overall Study|Lost to Follow-up|1
5928600|NCT01441635|20507891|P1|Overall Study|Lost to Follow-up|0
5928601|NCT01441635|20507882|P10|Overall Study|Withdrawal by Subject|1
5928602|NCT01441635|20507883|P9|Overall Study|Withdrawal by Subject|1
5928603|NCT01441635|20507884|P8|Overall Study|Withdrawal by Subject|0
5928604|NCT01441635|20507885|P7|Overall Study|Withdrawal by Subject|2
5928605|NCT01441635|20507886|P6|Overall Study|Withdrawal by Subject|0
5928606|NCT01441635|20507887|P5|Overall Study|Withdrawal by Subject|0
5928607|NCT01441635|20507888|P4|Overall Study|Withdrawal by Subject|1
5928608|NCT01441635|20507889|P3|Overall Study|Withdrawal by Subject|0
5928609|NCT01441635|20507890|P2|Overall Study|Withdrawal by Subject|1
5928610|NCT01441635|20507891|P1|Overall Study|Withdrawal by Subject|1
5928611|NCT01441635|20507882|P10|Overall Study|Adverse Event|0
5928612|NCT01441635|20507883|P9|Overall Study|Adverse Event|1
5928613|NCT01441635|20507884|P8|Overall Study|Adverse Event|2
5928614|NCT01441635|20507885|P7|Overall Study|Adverse Event|2
5928615|NCT01441635|20507886|P6|Overall Study|Adverse Event|2
5928616|NCT01441635|20507887|P5|Overall Study|Adverse Event|1
5928617|NCT01441635|20507888|P4|Overall Study|Adverse Event|5
5928618|NCT01441635|20507889|P3|Overall Study|Adverse Event|1
5928619|NCT01441635|20507890|P2|Overall Study|Adverse Event|3
5928620|NCT01441635|20507891|P1|Overall Study|Adverse Event|4
5928621|NCT01441596|20508106|P3|Overall Study|Not treated|1
5928622|NCT01441596|20508107|P2|Overall Study|Not treated|1
5928623|NCT01441596|20508108|P1|Overall Study|Not treated|0
5928624|NCT01441596|20508106|P3|Overall Study|Withdrawal by Subject|2
5928625|NCT01441596|20508107|P2|Overall Study|Withdrawal by Subject|0
5928626|NCT01441596|20508108|P1|Overall Study|Withdrawal by Subject|4
5928627|NCT01441596|20508106|P3|Overall Study|Other reason not defined below|1
5928628|NCT01441596|20508107|P2|Overall Study|Other reason not defined below|2
5928629|NCT01441596|20508108|P1|Overall Study|Other reason not defined below|0
5928630|NCT01441414|20508179|P1|Overall Study|Subject refused further follow-up|1
5928631|NCT01441414|20508179|P1|Overall Study|Study terminated by sponsor|2
5928632|NCT01441414|20508179|P1|Overall Study|Other reasons|3
5928633|NCT01441414|20508179|P1|Overall Study|Participant died|9
5928634|NCT01441180|20508258|P3|Overall Study|Discontinued|2
5928635|NCT01441180|20508259|P2|Overall Study|Discontinued|0
5928636|NCT01441180|20508260|P1|Overall Study|Discontinued|0
5928637|NCT01441180|20508258|P3|Overall Study|Lost to Follow-up|1
5928638|NCT01441180|20508259|P2|Overall Study|Lost to Follow-up|1
5928639|NCT01441180|20508260|P1|Overall Study|Lost to Follow-up|1
5928640|NCT01441102|20508271|P1|Overall Study|Withdrawal by Subject|2
5928641|NCT01441102|20508271|P1|Overall Study|Adverse Event|1
5928642|NCT01441063|20508309|P1|Tocilizumab + Zidovudine /Valganciclovir|Worsening KSHV-MCD symptoms|1
5928643|NCT01441063|20508309|P1|Tocilizumab Alone|Required AZT/VGC addition|3
5928644|NCT01440972|20508344|P2|Overall Study|Withdrawal by Subject|2
5928645|NCT01440972|20508345|P1|Overall Study|Withdrawal by Subject|3
5928646|NCT01440946|20508369|P2|Overall Study|Physician Decision|0
5928647|NCT01440946|20508370|P1|Overall Study|Physician Decision|1
5928648|NCT01440946|20508369|P2|Overall Study|Lost to Follow-up|1
5928649|NCT01440946|20508370|P1|Overall Study|Lost to Follow-up|1
5928650|NCT01440881|20508409|P2|Overall Study|Death|1
5928651|NCT01440881|20508410|P1|Overall Study|Death|0
5928652|NCT01440816|20508424|P2|Overall Study|To Be Seen By Local Oncologist|2
5928653|NCT01440816|20508425|P1|Overall Study|To Be Seen By Local Oncologist|1
5928654|NCT01440816|20508424|P2|Overall Study|Disease Progression|9
5928655|NCT01440816|20508425|P1|Overall Study|Disease Progression|0
5928656|NCT01440803|20508441|P2|Overall Study|Withdrawal by Subject|1
5928657|NCT01440803|20508442|P1|Overall Study|Withdrawal by Subject|0
5928658|NCT01440803|20508441|P2|Overall Study|Lost to Follow-up|2
5928659|NCT01440803|20508442|P1|Overall Study|Lost to Follow-up|0
5928660|NCT01440803|20508441|P2|Overall Study|Met study stopping rule|1
5928661|NCT01440803|20508442|P1|Overall Study|Met study stopping rule|2
5928662|NCT01440647|20508478|P2|Overall Study|Death|3
5928663|NCT01440647|20508479|P1|Overall Study|Death|2
5928664|NCT01440595|20508498|P3|Overall Study|Study terminated by sponsor.|1
5928665|NCT01440595|20508499|P2|Overall Study|Study terminated by sponsor.|2
5928666|NCT01440595|20508500|P1|Overall Study|Study terminated by sponsor.|1
5928667|NCT01440595|20508498|P3|Overall Study|Lost to Follow-up|0
5928668|NCT01440595|20508499|P2|Overall Study|Lost to Follow-up|1
5928669|NCT01440595|20508500|P1|Overall Study|Lost to Follow-up|0
5928670|NCT01440569|20508520|P2|Open-Label Rollover Phase|Subject Non-Compliance|1
5928671|NCT01440569|20508521|P1|Open-Label Rollover Phase|Subject Non-Compliance|1
5928672|NCT01440569|20508520|P2|Open-Label Rollover Phase|Lost to Follow-up|3
5928673|NCT01440569|20508521|P1|Open-Label Rollover Phase|Lost to Follow-up|26
5928674|NCT01440569|20508520|P2|Open-Label Rollover Phase|Withdrew Consent|1
5928675|NCT01440569|20508521|P1|Open-Label Rollover Phase|Withdrew Consent|11
5928676|NCT01440569|20508520|P2|Open-Label Rollover Phase|Investigator's Discretion|1
5928677|NCT01440569|20508521|P1|Open-Label Rollover Phase|Investigator's Discretion|3
5928678|NCT01440569|20508520|P2|Open-Label Rollover Phase|Lack of Efficacy|0
5928679|NCT01440569|20508521|P1|Open-Label Rollover Phase|Lack of Efficacy|2
5928680|NCT01440569|20508520|P2|Open-Label Rollover Phase|Pregnancy|0
5928681|NCT01440569|20508521|P1|Open-Label Rollover Phase|Pregnancy|1
5928682|NCT01440569|20508520|P2|Open-Label Rollover Phase|Adverse Event|0
5928683|NCT01440569|20508521|P1|Open-Label Rollover Phase|Adverse Event|3
5928684|NCT01440569|20508520|P2|Main Study|Protocol Violation|0
5928685|NCT01440569|20508521|P1|Main Study|Protocol Violation|1
5928686|NCT01440569|20508520|P2|Main Study|Subject Non-Compliance|0
5928687|NCT01440569|20508521|P1|Main Study|Subject Non-Compliance|3
5928688|NCT01440569|20508520|P2|Main Study|Lost to Follow-up|2
5928689|NCT01440569|20508521|P1|Main Study|Lost to Follow-up|13
5928690|NCT01440569|20508520|P2|Main Study|Withdrew Consent|1
5928691|NCT01440569|20508521|P1|Main Study|Withdrew Consent|7
5928692|NCT01440569|20508520|P2|Main Study|Investigator's Discretion|1
5928693|NCT01440569|20508521|P1|Main Study|Investigator's Discretion|1
5928694|NCT01440569|20508520|P2|Main Study|Pregnancy|0
5928695|NCT01440569|20508521|P1|Main Study|Pregnancy|1
5928696|NCT01440569|20508520|P2|Main Study|Adverse Event|0
5928697|NCT01440569|20508521|P1|Main Study|Adverse Event|9
5928698|NCT01440569|20508520|P2|Main Study|Enrolled but not treated|0
5928699|NCT01440569|20508521|P1|Main Study|Enrolled but not treated|1
5928700|NCT01440517|20508556|P1|Overall Study|Subject withdrawn prior to dosing|1
5928701|NCT01440374|20508632|P4|Part 3: Extension|Physician Decision|14
5928702|NCT01440374|20508633|P3|Part 3: Extension|Physician Decision|0
5928703|NCT01440374|20508634|P2|Part 3: Extension|Physician Decision|0
5928704|NCT01440374|20508635|P1|Part 3: Extension|Physician Decision|0
5928705|NCT01440374|20508632|P4|Part 3: Extension|Adverse Event|13
5928706|NCT01440374|20508633|P3|Part 3: Extension|Adverse Event|0
5928707|NCT01440374|20508634|P2|Part 3: Extension|Adverse Event|0
5928708|NCT01440374|20508635|P1|Part 3: Extension|Adverse Event|0
5928709|NCT01440374|20508632|P4|Part 3: Extension|Withdrawal by Subject|5
5928710|NCT01440374|20508633|P3|Part 3: Extension|Withdrawal by Subject|0
5928711|NCT01440374|20508634|P2|Part 3: Extension|Withdrawal by Subject|0
5928712|NCT01440374|20508635|P1|Part 3: Extension|Withdrawal by Subject|0
5928713|NCT01440374|20508632|P4|Part 2; Double-blind Phase|Not treated|0
5928714|NCT01440374|20508633|P3|Part 2; Double-blind Phase|Not treated|1
5928715|NCT01440374|20508634|P2|Part 2; Double-blind Phase|Not treated|0
5928716|NCT01440374|20508635|P1|Part 2; Double-blind Phase|Not treated|0
5928717|NCT01440374|20508632|P4|Part 2; Double-blind Phase|Adverse Event|0
5928718|NCT01440374|20508633|P3|Part 2; Double-blind Phase|Adverse Event|31
5928719|NCT01440374|20508634|P2|Part 2; Double-blind Phase|Adverse Event|7
5928720|NCT01440374|20508635|P1|Part 2; Double-blind Phase|Adverse Event|0
5928721|NCT01440374|20508632|P4|Part 2; Double-blind Phase|Lack of Efficacy|0
5928722|NCT01440374|20508633|P3|Part 2; Double-blind Phase|Lack of Efficacy|0
5928723|NCT01440374|20508634|P2|Part 2; Double-blind Phase|Lack of Efficacy|1
5928724|NCT01440374|20508635|P1|Part 2; Double-blind Phase|Lack of Efficacy|0
5928725|NCT01440374|20508632|P4|Part 2; Double-blind Phase|Protocol Violation|0
5928726|NCT01440374|20508633|P3|Part 2; Double-blind Phase|Protocol Violation|1
5928727|NCT01440374|20508634|P2|Part 2; Double-blind Phase|Protocol Violation|0
5928728|NCT01440374|20508635|P1|Part 2; Double-blind Phase|Protocol Violation|0
5928729|NCT01440374|20508632|P4|Part 2; Double-blind Phase|Withdrawal by Subject|0
5928730|NCT01440374|20508633|P3|Part 2; Double-blind Phase|Withdrawal by Subject|5
5928731|NCT01440374|20508634|P2|Part 2; Double-blind Phase|Withdrawal by Subject|4
5928732|NCT01440374|20508635|P1|Part 2; Double-blind Phase|Withdrawal by Subject|0
5928733|NCT01440374|20508632|P4|Part 2; Double-blind Phase|Physician Decision|0
5928734|NCT01440374|20508633|P3|Part 2; Double-blind Phase|Physician Decision|17
5928735|NCT01440374|20508634|P2|Part 2; Double-blind Phase|Physician Decision|8
5928736|NCT01440374|20508635|P1|Part 2; Double-blind Phase|Physician Decision|0
5928737|NCT01440374|20508632|P4|Part 1: Open-label Phase|Physician Decision|0
5928738|NCT01440374|20508633|P3|Part 1: Open-label Phase|Physician Decision|0
5928739|NCT01440374|20508634|P2|Part 1: Open-label Phase|Physician Decision|0
5928740|NCT01440374|20508635|P1|Part 1: Open-label Phase|Physician Decision|1
5928741|NCT01440374|20508632|P4|Part 1: Open-label Phase|Adverse Event|0
5928742|NCT01440374|20508633|P3|Part 1: Open-label Phase|Adverse Event|0
5928743|NCT01440374|20508634|P2|Part 1: Open-label Phase|Adverse Event|0
5928744|NCT01440374|20508635|P1|Part 1: Open-label Phase|Adverse Event|5
5928745|NCT01440322|20508670|P2|Overall Study|Other Non-Product Related|0
5928746|NCT01440322|20508671|P1|Overall Study|Other Non-Product Related|1
5928747|NCT01440322|20508670|P2|Overall Study|Unrelated Medical Problem|1
5928748|NCT01440322|20508671|P1|Overall Study|Unrelated Medical Problem|0
5928749|NCT01440322|20508670|P2|Overall Study|Other Product Related|0
5928750|NCT01440322|20508671|P1|Overall Study|Other Product Related|1
5928751|NCT01440322|20508670|P2|Overall Study|Unacceptable Subjective Vision|0
5928752|NCT01440322|20508671|P1|Overall Study|Unacceptable Subjective Vision|1
5928753|NCT01440322|20508670|P2|Overall Study|Symptoms and Problems|0
5928754|NCT01440322|20508671|P1|Overall Study|Symptoms and Problems|1
5928755|NCT01440322|20508670|P2|Overall Study|Biomicroscopy|0
5928756|NCT01440322|20508671|P1|Overall Study|Biomicroscopy|1
5928757|NCT01440322|20508670|P2|Overall Study|Discomfort|0
5928758|NCT01440322|20508671|P1|Overall Study|Discomfort|2
5928759|NCT01440283|20508693|P1|Overall Study|Physician Decision|3
5928760|NCT01440283|20508693|P1|Overall Study|Withdrawal by Subject|4
5928761|NCT01440283|20508693|P1|Overall Study|Death|3
5928762|NCT01440101|20508708|P3|Overall Study|Other|0
5928763|NCT01440101|20508709|P2|Overall Study|Other|1
5928764|NCT01440101|20508710|P1|Overall Study|Other|0
5928765|NCT01440101|20508708|P3|Overall Study|Withdrawal by Subject|1
5928766|NCT01440101|20508709|P2|Overall Study|Withdrawal by Subject|3
5928767|NCT01440101|20508710|P1|Overall Study|Withdrawal by Subject|0
5928768|NCT01440101|20508708|P3|Overall Study|Adverse Event|0
5928769|NCT01440101|20508709|P2|Overall Study|Adverse Event|0
5928770|NCT01440101|20508710|P1|Overall Study|Adverse Event|2
5928771|NCT01440049|20508743|P1|Overall Study|Adverse Event|5
5928772|NCT01439971|20508775|P5|Overall Study|Required number in cohort dosed|1
5928773|NCT01439971|20508776|P4|Overall Study|Required number in cohort dosed|0
5928774|NCT01439971|20508777|P3|Overall Study|Required number in cohort dosed|2
5928775|NCT01439971|20508778|P2|Overall Study|Required number in cohort dosed|1
5928776|NCT01439971|20508779|P1|Overall Study|Required number in cohort dosed|0
5928777|NCT01439945|20508959|P4|Double-Blind Treatment Phase|Ineligible|1
5928778|NCT01439945|20508960|P3|Double-Blind Treatment Phase|Ineligible|0
5928779|NCT01439945|20508961|P2|Double-Blind Treatment Phase|Ineligible|2
5928780|NCT01439945|20508962|P1|Double-Blind Treatment Phase|Ineligible|1
5928781|NCT01439945|20508959|P4|Double-Blind Treatment Phase|Withdrawal by Subject|1
5928782|NCT01439945|20508960|P3|Double-Blind Treatment Phase|Withdrawal by Subject|3
5928783|NCT01439945|20508961|P2|Double-Blind Treatment Phase|Withdrawal by Subject|3
5928784|NCT01439945|20508962|P1|Double-Blind Treatment Phase|Withdrawal by Subject|3
5928785|NCT01439880|20508987|P2|All-IP Period (Years 2 to 5)|Reason Missing|0
5928786|NCT01439880|20508988|P1|All-IP Period (Years 2 to 5)|Reason Missing|1
5928787|NCT01439880|20508987|P2|All-IP Period (Years 2 to 5)|Other|31
5928788|NCT01439880|20508988|P1|All-IP Period (Years 2 to 5)|Other|14
5928789|NCT01439880|20508987|P2|All-IP Period (Years 2 to 5)|Sponsor Decision|0
5928790|NCT01439880|20508988|P1|All-IP Period (Years 2 to 5)|Sponsor Decision|1
5928791|NCT01439880|20508987|P2|All-IP Period (Years 2 to 5)|Death|13
5928792|NCT01439880|20508988|P1|All-IP Period (Years 2 to 5)|Death|3
5928793|NCT01439880|20508987|P2|All-IP Period (Years 2 to 5)|Withdrawal by Subject|66
5928794|NCT01439880|20508988|P1|All-IP Period (Years 2 to 5)|Withdrawal by Subject|30
5928795|NCT01439880|20508987|P2|All-IP Period (Years 2 to 5)|Lost to Follow-up|30
5928796|NCT01439880|20508988|P1|All-IP Period (Years 2 to 5)|Lost to Follow-up|21
5928797|NCT01439880|20508987|P2|SOC-controlled Period (Year 1)|Reason Missing|2
5928798|NCT01439880|20508988|P1|SOC-controlled Period (Year 1)|Reason Missing|0
5928799|NCT01439880|20508987|P2|SOC-controlled Period (Year 1)|Other|13
5928800|NCT01439880|20508988|P1|SOC-controlled Period (Year 1)|Other|8
5928801|NCT01439880|20508987|P2|SOC-controlled Period (Year 1)|Lost to Follow-up|5
5928802|NCT01439880|20508988|P1|SOC-controlled Period (Year 1)|Lost to Follow-up|10
5928803|NCT01439880|20508987|P2|SOC-controlled Period (Year 1)|Sponsor Decision|1
5928804|NCT01439880|20508988|P1|SOC-controlled Period (Year 1)|Sponsor Decision|0
5928805|NCT01439880|20508987|P2|SOC-controlled Period (Year 1)|Death|1
5928806|NCT01439880|20508988|P1|SOC-controlled Period (Year 1)|Death|2
5928807|NCT01439880|20508987|P2|SOC-controlled Period (Year 1)|Withdrawal by Subject|38
5928808|NCT01439880|20508988|P1|SOC-controlled Period (Year 1)|Withdrawal by Subject|24
5928809|NCT01439867|20509031|P2|Overall Study|Protocol-specified Criteria|0
5928810|NCT01439867|20509032|P1|Overall Study|Protocol-specified Criteria|1
5928811|NCT01439867|20509031|P2|Overall Study|Administrative Decision|5
5928812|NCT01439867|20509032|P1|Overall Study|Administrative Decision|4
5928813|NCT01439867|20509031|P2|Overall Study|Withdrawal by Subject|2
5928814|NCT01439867|20509032|P1|Overall Study|Withdrawal by Subject|1
5928815|NCT01439867|20509031|P2|Overall Study|Non-compliance|1
5928816|NCT01439867|20509032|P1|Overall Study|Non-compliance|0
5928817|NCT01439724|20509084|P2|Overall Study|missing consultation|8
5928818|NCT01439724|20509085|P1|Overall Study|missing consultation|9
5928819|NCT01439711|20509091|P1|Overall Study|No MRI|9
5928820|NCT01439711|20509091|P1|Overall Study|Noncompliance|3
5928821|NCT01439711|20509091|P1|Overall Study|Progression During Active Tx|3
5928822|NCT01439711|20509091|P1|Overall Study|Withdrawal by Subject|3
5928823|NCT01439711|20509091|P1|Overall Study|Adverse Event|5
5928824|NCT01439711|20509091|P1|Overall Study|Progression Prior to Beginning Tx|1
5928825|NCT01439711|20509091|P1|Overall Study|Cancel|3
5928826|NCT01439711|20509091|P1|Overall Study|Ineligible|13
5928827|NCT01439568|20509129|P2|Overall Study|Withdrawal by Subject|2
5928828|NCT01439568|20509130|P1|Overall Study|Withdrawal by Subject|2
5928829|NCT01439568|20509129|P2|Overall Study|Lost to Follow-up|0
5928830|NCT01439568|20509130|P1|Overall Study|Lost to Follow-up|1
5928831|NCT01439555|20509142|P1|Overall Study|Protocol Violation|1
5928832|NCT01439373|20509154|P2|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|0
5928833|NCT01439373|20509155|P1|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|2
5928834|NCT01439373|20509154|P2|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|1
5928835|NCT01439373|20509155|P1|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|0
5928836|NCT01439360|20509198|P2|Overall Study|Withdrawal by Subject|129
5928837|NCT01439360|20509199|P1|Overall Study|Withdrawal by Subject|140
5928838|NCT01439360|20509198|P2|Overall Study|Protocol Violation|0
5928839|NCT01439360|20509199|P1|Overall Study|Protocol Violation|1
5928840|NCT01439360|20509198|P2|Overall Study|Others|5
5928841|NCT01439360|20509199|P1|Overall Study|Others|10
5928842|NCT01439360|20509198|P2|Overall Study|Lost to Follow-up|58
5928843|NCT01439360|20509199|P1|Overall Study|Lost to Follow-up|43
5928844|NCT01439360|20509198|P2|Overall Study|Adverse Event|16
5928845|NCT01439360|20509199|P1|Overall Study|Adverse Event|4
5928846|NCT01439282|20509249|P2|Overall Study|Other|1
5928847|NCT01439282|20509250|P1|Overall Study|Other|1
5928848|NCT01439282|20509249|P2|Overall Study|Withdrawal by Subject|0
5928849|NCT01439282|20509250|P1|Overall Study|Withdrawal by Subject|2
5928850|NCT01439282|20509249|P2|Overall Study|Adverse Event|0
5928851|NCT01439282|20509250|P1|Overall Study|Adverse Event|5
5928852|NCT01439204|20509262|P2|Overall Study|poor/non-compliance|0
5928853|NCT01439204|20509263|P1|Overall Study|poor/non-compliance|3
5928854|NCT01439204|20509262|P2|Overall Study|No longer meets study criteria|0
5928855|NCT01439204|20509263|P1|Overall Study|No longer meets study criteria|1
5928856|NCT01439204|20509262|P2|Overall Study|Lost to Follow-up|2
5928857|NCT01439204|20509263|P1|Overall Study|Lost to Follow-up|0
5928858|NCT01439204|20509262|P2|Overall Study|Withdrawal by Subject|1
5928859|NCT01439204|20509263|P1|Overall Study|Withdrawal by Subject|0
5928860|NCT01439165|20509297|P2|Overall Study|Withdrawal by Subject|1
5928861|NCT01439165|20509298|P1|Overall Study|Withdrawal by Subject|7
5928862|NCT01439165|20509297|P2|Overall Study|Lost to Follow-up|1
5928863|NCT01439165|20509298|P1|Overall Study|Lost to Follow-up|11
5928864|NCT01439165|20509297|P2|Overall Study|Protocol Violation|0
5928865|NCT01439165|20509298|P1|Overall Study|Protocol Violation|3
5928866|NCT01439126|20509312|P2|Overall Study|Other-Miscellaneous|12
5928867|NCT01439126|20509313|P1|Overall Study|Other-Miscellaneous|12
5928868|NCT01439126|20509312|P2|Overall Study|Other-Use of prohibited treatment|2
5928869|NCT01439126|20509313|P1|Overall Study|Other-Use of prohibited treatment|0
5928870|NCT01439126|20509312|P2|Overall Study|Lost to Follow-up|3
5928871|NCT01439126|20509313|P1|Overall Study|Lost to Follow-up|6
5928872|NCT01439126|20509312|P2|Overall Study|Protocol Violation|4
5928873|NCT01439126|20509313|P1|Overall Study|Protocol Violation|6
5928874|NCT01439126|20509312|P2|Overall Study|Withdrawal by Subject|21
5928875|NCT01439126|20509313|P1|Overall Study|Withdrawal by Subject|5
5928876|NCT01439126|20509312|P2|Overall Study|Adverse Event|0
5928877|NCT01439126|20509313|P1|Overall Study|Adverse Event|2
5928878|NCT01439074|20509339|P2|Overall Study|Other|4
5928879|NCT01439074|20509340|P1|Overall Study|Other|4
5928880|NCT01439074|20509339|P2|Overall Study|Withdrawal by Subject|5
5928881|NCT01439074|20509340|P1|Overall Study|Withdrawal by Subject|1
5928882|NCT01439074|20509339|P2|Overall Study|Subject shedding|0
5928883|NCT01439074|20509340|P1|Overall Study|Subject shedding|1
5928884|NCT01439074|20509339|P2|Overall Study|Lost to Follow-up|4
5928885|NCT01439074|20509340|P1|Overall Study|Lost to Follow-up|3
5928886|NCT01439009|20509358|P2|Overall Study|Deviation of exclusion criteria|0
5928887|NCT01439009|20509359|P1|Overall Study|Deviation of exclusion criteria|1
5928888|NCT01439009|20509358|P2|Overall Study|Protocol Violation|0
5928889|NCT01439009|20509359|P1|Overall Study|Protocol Violation|2
5928890|NCT01439009|20509358|P2|Overall Study|Physician Decision|3
5928891|NCT01439009|20509359|P1|Overall Study|Physician Decision|5
5928892|NCT01438996|20509392|P3|Overall Study|Not meeting Inclusion Criteria|0
5928893|NCT01438996|20509393|P2|Overall Study|Not meeting Inclusion Criteria|1
5928894|NCT01438996|20509394|P1|Overall Study|Not meeting Inclusion Criteria|4
5928895|NCT01438840|20509428|P3|Extension Phase|Other|1
5928896|NCT01438840|20509429|P2|Extension Phase|Other|0
5928897|NCT01438840|20509430|P1|Extension Phase|Other|0
5928898|NCT01438840|20509428|P3|Extension Phase|Lack of Efficacy|2
5928899|NCT01438840|20509429|P2|Extension Phase|Lack of Efficacy|0
5928900|NCT01438840|20509430|P1|Extension Phase|Lack of Efficacy|0
5928901|NCT01438840|20509428|P3|Extension Phase|Withdrawal by Subject|3
5928902|NCT01438840|20509429|P2|Extension Phase|Withdrawal by Subject|0
5928903|NCT01438840|20509430|P1|Extension Phase|Withdrawal by Subject|0
5928904|NCT01438840|20509428|P3|Extension Phase|Lost to Follow-up|1
5928905|NCT01438840|20509429|P2|Extension Phase|Lost to Follow-up|0
5928906|NCT01438840|20509430|P1|Extension Phase|Lost to Follow-up|0
5928907|NCT01438840|20509428|P3|Extension Phase|Adverse Event|3
5928908|NCT01438840|20509429|P2|Extension Phase|Adverse Event|0
5928909|NCT01438840|20509430|P1|Extension Phase|Adverse Event|0
5928910|NCT01438840|20509428|P3|Core Study|Withdrawal of consent|0
5928911|NCT01438840|20509429|P2|Core Study|Withdrawal of consent|0
5928912|NCT01438840|20509430|P1|Core Study|Withdrawal of consent|1
5928913|NCT01438840|20509428|P3|Core Study|Lack of Efficacy|0
5928914|NCT01438840|20509429|P2|Core Study|Lack of Efficacy|7
5928915|NCT01438840|20509430|P1|Core Study|Lack of Efficacy|15
5928916|NCT01438840|20509428|P3|Core Study|Adverse Event|0
5928917|NCT01438840|20509429|P2|Core Study|Adverse Event|3
5928918|NCT01438840|20509430|P1|Core Study|Adverse Event|0
5928919|NCT01438814|20509443|P2|Overall Study|Other|4
5928920|NCT01438814|20509444|P1|Overall Study|Other|2
5928921|NCT01438814|20509443|P2|Overall Study|Withdrawal by Subject|2
5928922|NCT01438814|20509444|P1|Overall Study|Withdrawal by Subject|4
5928923|NCT01438814|20509443|P2|Overall Study|Lost to Follow-up|3
5928924|NCT01438814|20509444|P1|Overall Study|Lost to Follow-up|4
5928925|NCT01438814|20509443|P2|Overall Study|Protocol Violation|2
5928926|NCT01438814|20509444|P1|Overall Study|Protocol Violation|1
5928927|NCT01438814|20509443|P2|Overall Study|Adverse Event|3
5928928|NCT01438814|20509444|P1|Overall Study|Adverse Event|3
5928929|NCT01438541|20509480|P1|Overall Study|discharge from the hospital|5
5928930|NCT01438541|20509480|P1|Overall Study|Withdrawal by Subject|1
5928931|NCT01438541|20509480|P1|Overall Study|Physician Decision|1
5928932|NCT01438489|20509489|P3|Overall Study|Inadequate venous access|0
5928933|NCT01438489|20509490|P2|Overall Study|Inadequate venous access|2
5928934|NCT01438489|20509491|P1|Overall Study|Inadequate venous access|0
5928935|NCT01438489|20509489|P3|Overall Study|Did not complete all 3 follow-up visits|2
5928936|NCT01438489|20509490|P2|Overall Study|Did not complete all 3 follow-up visits|5
5928937|NCT01438489|20509491|P1|Overall Study|Did not complete all 3 follow-up visits|2
5928938|NCT01438489|20509489|P3|Overall Study|Received prohibited medication|0
5928939|NCT01438489|20509490|P2|Overall Study|Received prohibited medication|0
5928940|NCT01438489|20509491|P1|Overall Study|Received prohibited medication|1
5928941|NCT01438489|20509489|P3|Overall Study|AE/SAEs|1
5928942|NCT01438489|20509490|P2|Overall Study|AE/SAEs|1
5928943|NCT01438489|20509491|P1|Overall Study|AE/SAEs|2
5928944|NCT01438489|20509489|P3|Overall Study|Investigator decision|0
5928945|NCT01438489|20509490|P2|Overall Study|Investigator decision|1
5928946|NCT01438489|20509491|P1|Overall Study|Investigator decision|0
5928947|NCT01438489|20509489|P3|Overall Study|Subject choice/Subject moved|1
5928948|NCT01438489|20509490|P2|Overall Study|Subject choice/Subject moved|1
5928949|NCT01438489|20509491|P1|Overall Study|Subject choice/Subject moved|2
5928950|NCT01438489|20509489|P3|Overall Study|Sponsor decision|4
5928951|NCT01438489|20509490|P2|Overall Study|Sponsor decision|1
5928952|NCT01438489|20509491|P1|Overall Study|Sponsor decision|4
5928953|NCT01438489|20509489|P3|Overall Study|Death|1
5928954|NCT01438489|20509490|P2|Overall Study|Death|0
5928955|NCT01438489|20509491|P1|Overall Study|Death|0
5928956|NCT01438489|20509489|P3|Overall Study|Withdrawal by Subject|8
5928957|NCT01438489|20509490|P2|Overall Study|Withdrawal by Subject|3
5928958|NCT01438489|20509491|P1|Overall Study|Withdrawal by Subject|11
5928959|NCT01438489|20509489|P3|Overall Study|Lost to Follow-up|2
5928960|NCT01438489|20509490|P2|Overall Study|Lost to Follow-up|2
5928961|NCT01438489|20509491|P1|Overall Study|Lost to Follow-up|4
5928962|NCT01438476|20509536|P2|Overall Study|Communication barrier|1
5928963|NCT01438476|20509537|P1|Overall Study|Communication barrier|0
5928964|NCT01438476|20509536|P2|Overall Study|No Surgery- Disease|10
5928965|NCT01438476|20509537|P1|Overall Study|No Surgery- Disease|8
5928966|NCT01438476|20509536|P2|Overall Study|Withdrawal by Subject|0
5928967|NCT01438476|20509537|P1|Overall Study|Withdrawal by Subject|1
5928968|NCT01438476|20509536|P2|Overall Study|Protocol Violation|0
5928969|NCT01438476|20509537|P1|Overall Study|Protocol Violation|1
5928970|NCT01438424|20509543|P1|Overall Study|Participant noncompliance|20
5928971|NCT01438424|20509543|P1|Overall Study|No longer met inclusion criteria|1
5928972|NCT01438424|20509543|P1|Overall Study|Pregnancy|7
5928973|NCT01438424|20509543|P1|Overall Study|Need for drug prohibited by protocol|14
5928974|NCT01438424|20509543|P1|Overall Study|Abnormal laboratory test result|14
5928975|NCT01438424|20509543|P1|Overall Study|Lost to Follow-up|17
5928976|NCT01438424|20509543|P1|Overall Study|Adverse Event|17
5928977|NCT01438424|20509543|P1|Overall Study|Death|22
5928978|NCT01438424|20509543|P1|Overall Study|Progression of chronic hepatitis B|22
5928979|NCT01438424|20509543|P1|Overall Study|Withdrawal by Subject|104
5928980|NCT01438424|20509543|P1|Overall Study|Not identified|55
5928981|NCT01438424|20509543|P1|Overall Study|Minimal virologic response|95
5928982|NCT01438424|20509543|P1|Overall Study|Continuing treatment|29
5928983|NCT01438411|20509579|P1|Overall Study|Withdrawal by Subject|3
5928984|NCT01438411|20509579|P1|Overall Study|Lack of Efficacy|1
5928985|NCT01438411|20509579|P1|Overall Study|Lost to Follow-up|1
5928986|NCT01438411|20509579|P1|Overall Study|Adverse Event|8
5928987|NCT01438307|20509594|P2|Overall Study|Death|1
5928988|NCT01438307|20509595|P1|Overall Study|Death|1
5928989|NCT01438294|20509609|P2|Overall Study|Lost to Follow-up|7
5928990|NCT01438294|20509610|P1|Overall Study|Lost to Follow-up|3
5928991|NCT01438177|20509653|P1|Overall Study|Initiation of new therapy|1
5928992|NCT01438177|20509653|P1|Overall Study|Withdrawal by Subject|1
5928993|NCT01438151|20509660|P1|Overall Study|study terminated|8
5928994|NCT01438060|20509666|P2|On Study Beyond Week 140|Other Reason|3
5928995|NCT01438060|20509667|P1|On Study Beyond Week 140|Other Reason|0
5928996|NCT01438060|20509666|P2|On Study Beyond Week 140|Death|1
5928997|NCT01438060|20509667|P1|On Study Beyond Week 140|Death|0
5928998|NCT01438060|20509666|P2|On Study Beyond Week 140|Withdrawal by Subject|1
5928999|NCT01438060|20509667|P1|On Study Beyond Week 140|Withdrawal by Subject|0
5929000|NCT01438060|20509666|P2|On Study Beyond Week 140|Lack of Efficacy|1
5929001|NCT01438060|20509667|P1|On Study Beyond Week 140|Lack of Efficacy|0
5929002|NCT01438060|20509666|P2|On Study Beyond Week 140|Adverse Event|2
5929003|NCT01438060|20509667|P1|On Study Beyond Week 140|Adverse Event|0
5929004|NCT01438060|20509666|P2|Extension Phase: Week 10 to Week 130|Other Reason|15
5929005|NCT01438060|20509667|P1|Extension Phase: Week 10 to Week 130|Other Reason|7
5929006|NCT01438060|20509666|P2|Extension Phase: Week 10 to Week 130|Death|12
5929007|NCT01438060|20509667|P1|Extension Phase: Week 10 to Week 130|Death|22
5929008|NCT01438060|20509666|P2|Extension Phase: Week 10 to Week 130|Lost to Follow-up|0
5929009|NCT01438060|20509667|P1|Extension Phase: Week 10 to Week 130|Lost to Follow-up|2
5929010|NCT01438060|20509666|P2|Extension Phase: Week 10 to Week 130|Participant Unreliability|0
5929011|NCT01438060|20509667|P1|Extension Phase: Week 10 to Week 130|Participant Unreliability|1
5929012|NCT01438060|20509666|P2|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|5
5929013|NCT01438060|20509667|P1|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|3
5929014|NCT01438060|20509666|P2|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8
5929015|NCT01438060|20509667|P1|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8
5929016|NCT01438060|20509666|P2|Extension Phase: Week 10 to Week 130|Adverse Event|16
5929017|NCT01438060|20509667|P1|Extension Phase: Week 10 to Week 130|Adverse Event|15
5929018|NCT01438060|20509666|P2|Acute Phase: Double-blind, 10 Weeks|Other Reason|0
5929019|NCT01438060|20509667|P1|Acute Phase: Double-blind, 10 Weeks|Other Reason|1
5929020|NCT01438060|20509666|P2|Acute Phase: Double-blind, 10 Weeks|Death|2
5929021|NCT01438060|20509667|P1|Acute Phase: Double-blind, 10 Weeks|Death|0
5929022|NCT01438060|20509666|P2|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|0
5929023|NCT01438060|20509667|P1|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|1
5929024|NCT01438060|20509666|P2|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|4
5929025|NCT01438060|20509667|P1|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|3
5929026|NCT01438060|20509666|P2|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|3
5929027|NCT01438060|20509667|P1|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|6
5929028|NCT01438060|20509666|P2|Acute Phase: Double-blind, 10 Weeks|Adverse Event|9
5929029|NCT01438060|20509667|P1|Acute Phase: Double-blind, 10 Weeks|Adverse Event|7
5929030|NCT01437995|20509759|P3|Overall Study|Lost to Follow-up|20
5929031|NCT01437995|20509760|P2|Overall Study|Lost to Follow-up|18
5929032|NCT01437995|20509761|P1|Overall Study|Lost to Follow-up|11
5929033|NCT01437943|20509783|P2|Overall Study|Adverse Event|0
5929034|NCT01437943|20509784|P1|Overall Study|Adverse Event|2
5929035|NCT01437943|20509783|P2|Overall Study|Subject expressed pregnancy plans|0
5929036|NCT01437943|20509784|P1|Overall Study|Subject expressed pregnancy plans|1
5929037|NCT01437943|20509783|P2|Overall Study|Aliskiren trials terminated by Novartis|2
5929038|NCT01437943|20509784|P1|Overall Study|Aliskiren trials terminated by Novartis|4
5929039|NCT01437878|20509792|P2|Overall Study|Withdrawal by Subject|0
5929040|NCT01437878|20509793|P1|Overall Study|Withdrawal by Subject|1
5929041|NCT01437540|20509860|P2|Overall Study|Withdrawal by Subject|15
5929042|NCT01437540|20509861|P1|Overall Study|Withdrawal by Subject|31
5929043|NCT01437540|20509860|P2|Overall Study|Adverse Event|13
5929044|NCT01437540|20509861|P1|Overall Study|Adverse Event|26
5929045|NCT01437540|20509860|P2|Overall Study|Protocol Violation|12
5929046|NCT01437540|20509861|P1|Overall Study|Protocol Violation|24
5929047|NCT01437540|20509860|P2|Overall Study|Lack of Efficacy|11
5929048|NCT01437540|20509861|P1|Overall Study|Lack of Efficacy|23
5929049|NCT01437540|20509860|P2|Overall Study|Lost to Follow-up|5
5929050|NCT01437540|20509861|P1|Overall Study|Lost to Follow-up|3
5929051|NCT01437540|20509860|P2|Overall Study|COPD exacerbation|3
5929052|NCT01437540|20509861|P1|Overall Study|COPD exacerbation|13
5929053|NCT01437540|20509860|P2|Overall Study|Not listed below|6
5929054|NCT01437540|20509861|P1|Overall Study|Not listed below|7
5929055|NCT01437423|20509898|P1|Overall Study|Off label usage|3
5929056|NCT01437423|20509898|P1|Overall Study|Lost to Follow-up|12
5929057|NCT01437397|20509910|P5|Overall Study|Site termination/COPD exacerbation/other|14
5929058|NCT01437397|20509911|P4|Overall Study|Site termination/COPD exacerbation/other|9
5929059|NCT01437397|20509912|P3|Overall Study|Site termination/COPD exacerbation/other|9
5929060|NCT01437397|20509913|P2|Overall Study|Site termination/COPD exacerbation/other|8
5929061|NCT01437397|20509914|P1|Overall Study|Site termination/COPD exacerbation/other|10
5929062|NCT01437397|20509910|P5|Overall Study|Adverse Event|21
5929063|NCT01437397|20509911|P4|Overall Study|Adverse Event|14
5929064|NCT01437397|20509912|P3|Overall Study|Adverse Event|16
5929065|NCT01437397|20509913|P2|Overall Study|Adverse Event|22
5929066|NCT01437397|20509914|P1|Overall Study|Adverse Event|21
5929067|NCT01437397|20509910|P5|Overall Study|Lack of Efficacy|20
5929068|NCT01437397|20509911|P4|Overall Study|Lack of Efficacy|10
5929069|NCT01437397|20509912|P3|Overall Study|Lack of Efficacy|8
5929070|NCT01437397|20509913|P2|Overall Study|Lack of Efficacy|4
5929071|NCT01437397|20509914|P1|Overall Study|Lack of Efficacy|5
5929072|NCT01437397|20509910|P5|Overall Study|Protocol Violation|19
5929073|NCT01437397|20509911|P4|Overall Study|Protocol Violation|21
5929074|NCT01437397|20509912|P3|Overall Study|Protocol Violation|13
5929075|NCT01437397|20509913|P2|Overall Study|Protocol Violation|12
5929076|NCT01437397|20509914|P1|Overall Study|Protocol Violation|10
5929077|NCT01437397|20509910|P5|Overall Study|Withdrawal by Subject|22
5929078|NCT01437397|20509911|P4|Overall Study|Withdrawal by Subject|11
5929079|NCT01437397|20509912|P3|Overall Study|Withdrawal by Subject|24
5929080|NCT01437397|20509913|P2|Overall Study|Withdrawal by Subject|12
5929081|NCT01437397|20509914|P1|Overall Study|Withdrawal by Subject|11
5929082|NCT01437397|20509910|P5|Overall Study|Lost to Follow-up|5
5929083|NCT01437397|20509911|P4|Overall Study|Lost to Follow-up|4
5929084|NCT01437397|20509912|P3|Overall Study|Lost to Follow-up|2
5929085|NCT01437397|20509913|P2|Overall Study|Lost to Follow-up|4
5929086|NCT01437397|20509914|P1|Overall Study|Lost to Follow-up|9
5929087|NCT01437319|20509941|P3|Phase II|Protocol Violation|0
5929088|NCT01437319|20509942|P2|Phase II|Protocol Violation|1
5929089|NCT01437319|20509943|P1|Phase II|Protocol Violation|0
5929090|NCT01437319|20509941|P3|Phase II|Study related symptoms/complaints|19
5929091|NCT01437319|20509942|P2|Phase II|Study related symptoms/complaints|28
5929092|NCT01437319|20509943|P1|Phase II|Study related symptoms/complaints|0
5929093|NCT01437319|20509941|P3|Phase II|Lost to Follow-up|2
5929094|NCT01437319|20509942|P2|Phase II|Lost to Follow-up|7
5929095|NCT01437319|20509943|P1|Phase II|Lost to Follow-up|0
5929096|NCT01437319|20509941|P3|Phase II|Withdrawal by Subject|16
5929097|NCT01437319|20509942|P2|Phase II|Withdrawal by Subject|8
5929098|NCT01437319|20509943|P1|Phase II|Withdrawal by Subject|0
5929099|NCT01437319|20509941|P3|Phase I|Withdrawal by Subject|0
5929100|NCT01437319|20509942|P2|Phase I|Withdrawal by Subject|0
5929101|NCT01437319|20509943|P1|Phase I|Withdrawal by Subject|25
5929102|NCT01437319|20509941|P3|Phase I|Study related symptoms/complaints|0
5929103|NCT01437319|20509942|P2|Phase I|Study related symptoms/complaints|0
5929104|NCT01437319|20509943|P1|Phase I|Study related symptoms/complaints|27
5929105|NCT01437319|20509941|P3|Phase I|Protocol Violation|0
5929106|NCT01437319|20509942|P2|Phase I|Protocol Violation|0
5929107|NCT01437319|20509943|P1|Phase I|Protocol Violation|1
5929108|NCT01437319|20509941|P3|Phase I|Lost to Follow-up|0
5929109|NCT01437319|20509942|P2|Phase I|Lost to Follow-up|0
5929110|NCT01437319|20509943|P1|Phase I|Lost to Follow-up|2
5929111|NCT01437267|20509958|P6|Overall Study|Protocol Violation|0
5929112|NCT01437267|20509959|P5|Overall Study|Protocol Violation|0
5929113|NCT01437267|20509960|P4|Overall Study|Protocol Violation|0
5929114|NCT01437267|20509961|P3|Overall Study|Protocol Violation|0
5929115|NCT01437267|20509962|P2|Overall Study|Protocol Violation|1
5929116|NCT01437267|20509963|P1|Overall Study|Protocol Violation|0
5929117|NCT01437267|20509958|P6|Overall Study|Withdrawal by Subject|0
5929118|NCT01437267|20509959|P5|Overall Study|Withdrawal by Subject|0
5929119|NCT01437267|20509960|P4|Overall Study|Withdrawal by Subject|1
5929120|NCT01437267|20509961|P3|Overall Study|Withdrawal by Subject|0
5929121|NCT01437267|20509962|P2|Overall Study|Withdrawal by Subject|0
5929122|NCT01437267|20509963|P1|Overall Study|Withdrawal by Subject|0
5929123|NCT01437111|20510006|P1|Overall Study|Protocol Violation|1
5929124|NCT01437111|20510006|P1|Overall Study|Lost to Follow-up|5
5929125|NCT01437111|20510006|P1|Overall Study|Physician Decision|1
5929126|NCT01437111|20510006|P1|Overall Study|Not reported|5
5929127|NCT01437111|20510006|P1|Overall Study|Withdrawal by Subject|4
5929128|NCT01437111|20510006|P1|Overall Study|Adverse Event|2
5929129|NCT01436643|20510084|P4|Core Phase (16 Weeks)|Protocol Violation|0
5929130|NCT01436643|20510085|P3|Core Phase (16 Weeks)|Protocol Violation|1
5929131|NCT01436643|20510086|P2|Core Phase (16 Weeks)|Protocol Violation|1
5929132|NCT01436643|20510087|P1|Core Phase (16 Weeks)|Protocol Violation|1
5929133|NCT01436643|20510084|P4|Core Phase (16 Weeks)|Abnormal Test result|0
5929134|NCT01436643|20510085|P3|Core Phase (16 Weeks)|Abnormal Test result|1
5929135|NCT01436643|20510086|P2|Core Phase (16 Weeks)|Abnormal Test result|0
5929136|NCT01436643|20510087|P1|Core Phase (16 Weeks)|Abnormal Test result|0
5929137|NCT01436643|20510084|P4|Core Phase (16 Weeks)|Adverse Event|0
5929138|NCT01436643|20510085|P3|Core Phase (16 Weeks)|Adverse Event|1
5929139|NCT01436643|20510086|P2|Core Phase (16 Weeks)|Adverse Event|3
5929140|NCT01436643|20510087|P1|Core Phase (16 Weeks)|Adverse Event|0
5929141|NCT01436643|20510084|P4|2-week Pre-treatment|Protocol Violation|4
5929142|NCT01436643|20510085|P3|2-week Pre-treatment|Protocol Violation|0
5929143|NCT01436643|20510086|P2|2-week Pre-treatment|Protocol Violation|0
5929144|NCT01436643|20510087|P1|2-week Pre-treatment|Protocol Violation|0
5929145|NCT01436643|20510084|P4|2-week Pre-treatment|Adverse Event|5
5929146|NCT01436643|20510085|P3|2-week Pre-treatment|Adverse Event|0
5929147|NCT01436643|20510086|P2|2-week Pre-treatment|Adverse Event|0
5929148|NCT01436643|20510087|P1|2-week Pre-treatment|Adverse Event|0
5929149|NCT01436643|20510084|P4|2-week Pre-treatment|Abnormal test result|1
5929150|NCT01436643|20510085|P3|2-week Pre-treatment|Abnormal test result|0
5929151|NCT01436643|20510086|P2|2-week Pre-treatment|Abnormal test result|0
5929152|NCT01436643|20510087|P1|2-week Pre-treatment|Abnormal test result|0
5929153|NCT01436500|20510122|P5|Overall Study|Other|0
5929154|NCT01436500|20510123|P4|Overall Study|Other|1
5929155|NCT01436500|20510124|P3|Overall Study|Other|0
5929156|NCT01436500|20510125|P2|Overall Study|Other|1
5929157|NCT01436500|20510126|P1|Overall Study|Other|0
5929158|NCT01436500|20510122|P5|Overall Study|discontinued study drug|0
5929159|NCT01436500|20510123|P4|Overall Study|discontinued study drug|0
5929160|NCT01436500|20510124|P3|Overall Study|discontinued study drug|0
5929161|NCT01436500|20510125|P2|Overall Study|discontinued study drug|0
5929162|NCT01436500|20510126|P1|Overall Study|discontinued study drug|1
5929163|NCT01436500|20510122|P5|Overall Study|initiation of dialysis|1
5929164|NCT01436500|20510123|P4|Overall Study|initiation of dialysis|0
5929165|NCT01436500|20510124|P3|Overall Study|initiation of dialysis|0
5929166|NCT01436500|20510125|P2|Overall Study|initiation of dialysis|0
5929167|NCT01436500|20510126|P1|Overall Study|initiation of dialysis|0
5929168|NCT01436500|20510122|P5|Overall Study|liver transplant|0
5929169|NCT01436500|20510123|P4|Overall Study|liver transplant|0
5929170|NCT01436500|20510124|P3|Overall Study|liver transplant|0
5929171|NCT01436500|20510125|P2|Overall Study|liver transplant|0
5929172|NCT01436500|20510126|P1|Overall Study|liver transplant|1
5929173|NCT01436500|20510122|P5|Overall Study|Physician Decision|0
5929174|NCT01436500|20510123|P4|Overall Study|Physician Decision|0
5929175|NCT01436500|20510124|P3|Overall Study|Physician Decision|1
5929176|NCT01436500|20510125|P2|Overall Study|Physician Decision|0
5929177|NCT01436500|20510126|P1|Overall Study|Physician Decision|0
5929178|NCT01436500|20510122|P5|Overall Study|Withdrawal by Subject|2
5929179|NCT01436500|20510123|P4|Overall Study|Withdrawal by Subject|0
5929180|NCT01436500|20510124|P3|Overall Study|Withdrawal by Subject|2
5929181|NCT01436500|20510125|P2|Overall Study|Withdrawal by Subject|0
5929182|NCT01436500|20510126|P1|Overall Study|Withdrawal by Subject|0
5929183|NCT01436500|20510122|P5|Overall Study|Adverse Event|1
5929184|NCT01436500|20510123|P4|Overall Study|Adverse Event|0
5929185|NCT01436500|20510124|P3|Overall Study|Adverse Event|2
5929186|NCT01436500|20510125|P2|Overall Study|Adverse Event|2
5929187|NCT01436500|20510126|P1|Overall Study|Adverse Event|0
5929188|NCT01436500|20510122|P5|Overall Study|Death|0
5929189|NCT01436500|20510123|P4|Overall Study|Death|0
5929190|NCT01436500|20510124|P3|Overall Study|Death|0
5929191|NCT01436500|20510125|P2|Overall Study|Death|0
5929192|NCT01436500|20510126|P1|Overall Study|Death|1
5929193|NCT01436396|20510170|P2|Overall Study|Lost to Follow-up|3
5929194|NCT01436396|20510171|P1|Overall Study|Lost to Follow-up|3
5929195|NCT01436396|20510170|P2|Overall Study|Serious adverse event|3
5929196|NCT01436396|20510171|P1|Overall Study|Serious adverse event|2
5929197|NCT01436396|20510170|P2|Overall Study|Withdrawal by Subject|29
5929198|NCT01436396|20510171|P1|Overall Study|Withdrawal by Subject|19
5929199|NCT01436396|20510170|P2|Overall Study|Adverse Event|2
5929200|NCT01436396|20510171|P1|Overall Study|Adverse Event|1
5929201|NCT01436396|20510170|P2|Overall Study|Protocol Violation|5
5929202|NCT01436396|20510171|P1|Overall Study|Protocol Violation|7
5929203|NCT01436370|20510211|P8|Overall Study|Lost to Follow-up|0
5929204|NCT01436370|20510212|P7|Overall Study|Lost to Follow-up|0
5929205|NCT01436370|20510213|P6|Overall Study|Lost to Follow-up|0
5929206|NCT01436370|20510214|P5|Overall Study|Lost to Follow-up|1
5929207|NCT01436370|20510215|P4|Overall Study|Lost to Follow-up|0
5929208|NCT01436370|20510216|P3|Overall Study|Lost to Follow-up|0
5929209|NCT01436370|20510217|P2|Overall Study|Lost to Follow-up|0
5929210|NCT01436370|20510218|P1|Overall Study|Lost to Follow-up|0
5929211|NCT01436357|20510298|P2|Overall Study|Subject in rehab|1
5929212|NCT01436357|20510299|P1|Overall Study|Subject in rehab|0
5929213|NCT01436357|20510298|P2|Overall Study|Moved out of area|2
5929214|NCT01436357|20510299|P1|Overall Study|Moved out of area|1
5929215|NCT01436357|20510298|P2|Overall Study|Physician Decision|4
5929216|NCT01436357|20510299|P1|Overall Study|Physician Decision|3
5929217|NCT01436357|20510298|P2|Overall Study|Withdrawal by Subject|38
5929218|NCT01436357|20510299|P1|Overall Study|Withdrawal by Subject|26
5929219|NCT01436357|20510298|P2|Overall Study|Protocol Violation|0
5929220|NCT01436357|20510299|P1|Overall Study|Protocol Violation|1
5929221|NCT01436357|20510298|P2|Overall Study|Lost to Follow-up|61
5929222|NCT01436357|20510299|P1|Overall Study|Lost to Follow-up|67
5929223|NCT01436357|20510298|P2|Overall Study|Incarceration|20
5929224|NCT01436357|20510299|P1|Overall Study|Incarceration|18
5929225|NCT01436357|20510298|P2|Overall Study|Enrolled but not vaccinated|1
5929226|NCT01436357|20510299|P1|Overall Study|Enrolled but not vaccinated|1
5929227|NCT01436357|20510298|P2|Overall Study|Death|1
5929228|NCT01436357|20510299|P1|Overall Study|Death|5
5929229|NCT01436305|20510320|P3|Overall Study|Withdrawal by Subject|0
5929230|NCT01436305|20510321|P2|Overall Study|Withdrawal by Subject|3
5929231|NCT01436305|20510322|P1|Overall Study|Withdrawal by Subject|1
5929232|NCT01436305|20510320|P3|Overall Study|Lost to Follow-up|0
5929233|NCT01436305|20510321|P2|Overall Study|Lost to Follow-up|1
5929234|NCT01436305|20510322|P1|Overall Study|Lost to Follow-up|0
5929235|NCT01436305|20510320|P3|Overall Study|Death|0
5929236|NCT01436305|20510321|P2|Overall Study|Death|0
5929237|NCT01436305|20510322|P1|Overall Study|Death|1
5929238|NCT01436253|20510449|P1|Overall Study|Not meeting all eligibility criteria|117
5929239|NCT01436253|20510449|P1|Overall Study|Lost to Follow-up|182
5929240|NCT01436201|20510454|P1|Overall Study|Protocol Violation|1
5929241|NCT01436201|20510454|P1|Overall Study|Withdrawal by Subject|1
5929242|NCT01436201|20510454|P1|Overall Study|Adverse Event|2
5929243|NCT01436175|20510464|P1|Overall Study|Other|826
5929244|NCT01436175|20510464|P1|Overall Study|Met blood pressure or pulse withdrawal|63
5929245|NCT01436175|20510464|P1|Overall Study|Lack of Efficacy|24
5929246|NCT01436175|20510464|P1|Overall Study|Lost to Follow-up|89
5929247|NCT01436175|20510464|P1|Overall Study|Withdrawal by Subject|108
5929248|NCT01436175|20510464|P1|Overall Study|Protocol Violation|49
5929249|NCT01436175|20510464|P1|Overall Study|Adverse Event|111
5929250|NCT01436162|20510491|P3|Randomized Phase|Other|4
5929251|NCT01436162|20510492|P2|Randomized Phase|Other|5
5929252|NCT01436162|20510493|P1|Randomized Phase|Other|2
5929253|NCT01436162|20510491|P3|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|0
5929254|NCT01436162|20510492|P2|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2
5929255|NCT01436162|20510493|P1|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|4
5929256|NCT01436162|20510491|P3|Randomized Phase|Lack of Efficacy|1
5929257|NCT01436162|20510492|P2|Randomized Phase|Lack of Efficacy|1
5929258|NCT01436162|20510493|P1|Randomized Phase|Lack of Efficacy|0
5929259|NCT01436162|20510491|P3|Randomized Phase|Lost to Follow-up|4
5929260|NCT01436162|20510492|P2|Randomized Phase|Lost to Follow-up|5
5929261|NCT01436162|20510493|P1|Randomized Phase|Lost to Follow-up|17
5929262|NCT01436162|20510491|P3|Randomized Phase|Withdrawal by Subject|8
5929263|NCT01436162|20510492|P2|Randomized Phase|Withdrawal by Subject|9
5929264|NCT01436162|20510493|P1|Randomized Phase|Withdrawal by Subject|16
5929265|NCT01436162|20510491|P3|Randomized Phase|Protocol Violation|2
5929266|NCT01436162|20510492|P2|Randomized Phase|Protocol Violation|4
5929267|NCT01436162|20510493|P1|Randomized Phase|Protocol Violation|4
5929268|NCT01436162|20510491|P3|Randomized Phase|Adverse Event|6
5929269|NCT01436162|20510492|P2|Randomized Phase|Adverse Event|5
5929270|NCT01436162|20510493|P1|Randomized Phase|Adverse Event|1
5929271|NCT01436162|20510491|P3|Single-blind Lead-in Phase|Other|0
5929272|NCT01436162|20510492|P2|Single-blind Lead-in Phase|Other|0
5929273|NCT01436162|20510493|P1|Single-blind Lead-in Phase|Other|107
5929274|NCT01436162|20510491|P3|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
5929275|NCT01436162|20510492|P2|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
5929276|NCT01436162|20510493|P1|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|13
5929277|NCT01436162|20510491|P3|Single-blind Lead-in Phase|Lost to Follow-up|0
5929278|NCT01436162|20510492|P2|Single-blind Lead-in Phase|Lost to Follow-up|0
5929279|NCT01436162|20510493|P1|Single-blind Lead-in Phase|Lost to Follow-up|43
5929280|NCT01436162|20510491|P3|Single-blind Lead-in Phase|Withdrawal by Subject|0
5929281|NCT01436162|20510492|P2|Single-blind Lead-in Phase|Withdrawal by Subject|0
5929282|NCT01436162|20510493|P1|Single-blind Lead-in Phase|Withdrawal by Subject|69
5929283|NCT01436162|20510491|P3|Single-blind Lead-in Phase|Protocol Violation|0
5929284|NCT01436162|20510492|P2|Single-blind Lead-in Phase|Protocol Violation|0
5929285|NCT01436162|20510493|P1|Single-blind Lead-in Phase|Protocol Violation|24
5929286|NCT01436162|20510491|P3|Single-blind Lead-in Phase|Adverse Event|0
5929287|NCT01436162|20510492|P2|Single-blind Lead-in Phase|Adverse Event|0
5929288|NCT01436162|20510493|P1|Single-blind Lead-in Phase|Adverse Event|26
5929289|NCT01436149|20510527|P3|Randomized Phase|Other|11
5929290|NCT01436149|20510528|P2|Randomized Phase|Other|5
5929291|NCT01436149|20510529|P1|Randomized Phase|Other|12
5929292|NCT01436149|20510527|P3|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3
5929293|NCT01436149|20510528|P2|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3
5929294|NCT01436149|20510529|P1|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2
5929295|NCT01436149|20510527|P3|Randomized Phase|Lack of Efficacy|1
5929296|NCT01436149|20510528|P2|Randomized Phase|Lack of Efficacy|0
5929297|NCT01436149|20510529|P1|Randomized Phase|Lack of Efficacy|0
5929298|NCT01436149|20510527|P3|Randomized Phase|Lost to Follow-up|6
5929299|NCT01436149|20510528|P2|Randomized Phase|Lost to Follow-up|5
5929300|NCT01436149|20510529|P1|Randomized Phase|Lost to Follow-up|34
5929301|NCT01436149|20510527|P3|Randomized Phase|Withdrawal by Subject|10
5929302|NCT01436149|20510528|P2|Randomized Phase|Withdrawal by Subject|10
5929303|NCT01436149|20510529|P1|Randomized Phase|Withdrawal by Subject|16
5929304|NCT01436149|20510527|P3|Randomized Phase|Protocol Violation|0
5929305|NCT01436149|20510528|P2|Randomized Phase|Protocol Violation|5
5929306|NCT01436149|20510529|P1|Randomized Phase|Protocol Violation|4
5929307|NCT01436149|20510527|P3|Randomized Phase|Adverse Event|11
5929308|NCT01436149|20510528|P2|Randomized Phase|Adverse Event|10
5929309|NCT01436149|20510529|P1|Randomized Phase|Adverse Event|9
5929310|NCT01436149|20510527|P3|Antidepressant Lead-in Phase|Other|0
5929311|NCT01436149|20510528|P2|Antidepressant Lead-in Phase|Other|0
5929312|NCT01436149|20510529|P1|Antidepressant Lead-in Phase|Other|119
5929313|NCT01436149|20510527|P3|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0
5929314|NCT01436149|20510528|P2|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0
5929315|NCT01436149|20510529|P1|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|22
5929316|NCT01436149|20510527|P3|Antidepressant Lead-in Phase|Lost to Follow-up|0
5929317|NCT01436149|20510528|P2|Antidepressant Lead-in Phase|Lost to Follow-up|0
5929318|NCT01436149|20510529|P1|Antidepressant Lead-in Phase|Lost to Follow-up|96
5929319|NCT01436149|20510527|P3|Antidepressant Lead-in Phase|Withdrawal by Subject|0
5929320|NCT01436149|20510528|P2|Antidepressant Lead-in Phase|Withdrawal by Subject|0
5929321|NCT01436149|20510529|P1|Antidepressant Lead-in Phase|Withdrawal by Subject|61
5929322|NCT01436149|20510527|P3|Antidepressant Lead-in Phase|Protocol Violation|0
5929323|NCT01436149|20510528|P2|Antidepressant Lead-in Phase|Protocol Violation|0
5929324|NCT01436149|20510529|P1|Antidepressant Lead-in Phase|Protocol Violation|29
5929325|NCT01436149|20510527|P3|Antidepressant Lead-in Phase|Adverse Event|0
5929326|NCT01436149|20510528|P2|Antidepressant Lead-in Phase|Adverse Event|0
5929327|NCT01436149|20510529|P1|Antidepressant Lead-in Phase|Adverse Event|39
5929328|NCT01436110|20510560|P3|Overall Study|Did Not Receive Trial Medication|3
5929329|NCT01436110|20510561|P2|Overall Study|Did Not Receive Trial Medication|0
5929330|NCT01436110|20510562|P1|Overall Study|Did Not Receive Trial Medication|1
5929331|NCT01436110|20510560|P3|Overall Study|Protocol Violation|1
5929332|NCT01436110|20510561|P2|Overall Study|Protocol Violation|1
5929333|NCT01436110|20510562|P1|Overall Study|Protocol Violation|3
5929334|NCT01436110|20510560|P3|Overall Study|Lost to Follow-up|3
5929335|NCT01436110|20510561|P2|Overall Study|Lost to Follow-up|1
5929336|NCT01436110|20510562|P1|Overall Study|Lost to Follow-up|1
5929337|NCT01436110|20510560|P3|Overall Study|Physician Decision|1
5929338|NCT01436110|20510561|P2|Overall Study|Physician Decision|1
5929339|NCT01436110|20510562|P1|Overall Study|Physician Decision|3
5929340|NCT01436110|20510560|P3|Overall Study|Adverse Event|2
5929341|NCT01436110|20510561|P2|Overall Study|Adverse Event|1
5929342|NCT01436110|20510562|P1|Overall Study|Adverse Event|2
5929343|NCT01436110|20510560|P3|Overall Study|Withdrawal by Subject|4
5929344|NCT01436110|20510561|P2|Overall Study|Withdrawal by Subject|8
5929345|NCT01436110|20510562|P1|Overall Study|Withdrawal by Subject|6
5929346|NCT01436110|20510560|P3|Overall Study|Lack of Efficacy|9
5929347|NCT01436110|20510561|P2|Overall Study|Lack of Efficacy|14
5929348|NCT01436110|20510562|P1|Overall Study|Lack of Efficacy|23
5929349|NCT01436084|20510585|P1|Overall Study|Early Closure of Study|1
5929350|NCT01436084|20510585|P1|Overall Study|Withdrawal by Subject|1
5929351|NCT01436084|20510585|P1|Overall Study|Disease Progression|2
5929352|NCT01436071|20510591|P2|Overall Study|Did Not Receive Trial Medication|3
5929353|NCT01436071|20510592|P1|Overall Study|Did Not Receive Trial Medication|3
5929354|NCT01436071|20510591|P2|Overall Study|Withdrawal by Subject|2
5929355|NCT01436071|20510592|P1|Overall Study|Withdrawal by Subject|2
5929356|NCT01436071|20510591|P2|Overall Study|Physician Decision|0
5929357|NCT01436071|20510592|P1|Overall Study|Physician Decision|1
5929358|NCT01436071|20510591|P2|Overall Study|Lost to Follow-up|1
5929359|NCT01436071|20510592|P1|Overall Study|Lost to Follow-up|3
5929360|NCT01436071|20510591|P2|Overall Study|Protocol Violation|1
5929361|NCT01436071|20510592|P1|Overall Study|Protocol Violation|0
5929362|NCT01436071|20510591|P2|Overall Study|Lack of Efficacy|7
5929363|NCT01436071|20510592|P1|Overall Study|Lack of Efficacy|16
5929364|NCT01436071|20510591|P2|Overall Study|Adverse Event|0
5929365|NCT01436071|20510592|P1|Overall Study|Adverse Event|1
5929366|NCT01435928|20510634|P3|Double Blind Phase - 28 Weeks|Administrative|2
5929367|NCT01435928|20510635|P2|Double Blind Phase - 28 Weeks|Administrative|5
5929368|NCT01435928|20510636|P1|Double Blind Phase - 28 Weeks|Administrative|0
5929369|NCT01435928|20510634|P3|Double Blind Phase - 28 Weeks|Relapse criteria met|58
5929370|NCT01435928|20510635|P2|Double Blind Phase - 28 Weeks|Relapse criteria met|43
5929371|NCT01435928|20510636|P1|Double Blind Phase - 28 Weeks|Relapse criteria met|0
5929372|NCT01435928|20510634|P3|Double Blind Phase - 28 Weeks|Terminated at study completion|39
5929373|NCT01435928|20510635|P2|Double Blind Phase - 28 Weeks|Terminated at study completion|47
5929374|NCT01435928|20510636|P1|Double Blind Phase - 28 Weeks|Terminated at study completion|0
5929375|NCT01435928|20510634|P3|Double Blind Phase - 28 Weeks|Withdrawal by Subject|12
5929376|NCT01435928|20510635|P2|Double Blind Phase - 28 Weeks|Withdrawal by Subject|5
5929377|NCT01435928|20510636|P1|Double Blind Phase - 28 Weeks|Withdrawal by Subject|0
5929378|NCT01435928|20510634|P3|Double Blind Phase - 28 Weeks|Protocol Violation|4
5929379|NCT01435928|20510635|P2|Double Blind Phase - 28 Weeks|Protocol Violation|11
5929380|NCT01435928|20510636|P1|Double Blind Phase - 28 Weeks|Protocol Violation|0
5929381|NCT01435928|20510634|P3|Double Blind Phase - 28 Weeks|Lost to Follow-up|5
5929382|NCT01435928|20510635|P2|Double Blind Phase - 28 Weeks|Lost to Follow-up|2
5929383|NCT01435928|20510636|P1|Double Blind Phase - 28 Weeks|Lost to Follow-up|0
5929384|NCT01435928|20510634|P3|Double Blind Phase - 28 Weeks|Adverse Event|1
5929385|NCT01435928|20510635|P2|Double Blind Phase - 28 Weeks|Adverse Event|3
5929386|NCT01435928|20510636|P1|Double Blind Phase - 28 Weeks|Adverse Event|0
5929387|NCT01435928|20510634|P3|Open Label Phase - up to 24 Weeks|Administrative|0
5929388|NCT01435928|20510635|P2|Open Label Phase - up to 24 Weeks|Administrative|0
5929389|NCT01435928|20510636|P1|Open Label Phase - up to 24 Weeks|Administrative|14
5929390|NCT01435928|20510634|P3|Open Label Phase - up to 24 Weeks|Terminated at study completion|0
5929391|NCT01435928|20510635|P2|Open Label Phase - up to 24 Weeks|Terminated at study completion|0
5929392|NCT01435928|20510636|P1|Open Label Phase - up to 24 Weeks|Terminated at study completion|6
5929393|NCT01435928|20510634|P3|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0
5929394|NCT01435928|20510635|P2|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0
5929395|NCT01435928|20510636|P1|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|44
5929396|NCT01435928|20510634|P3|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0
5929397|NCT01435928|20510635|P2|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0
5929398|NCT01435928|20510636|P1|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|96
5929399|NCT01435928|20510634|P3|Open Label Phase - up to 24 Weeks|Protocol Violation|0
5929400|NCT01435928|20510635|P2|Open Label Phase - up to 24 Weeks|Protocol Violation|0
5929401|NCT01435928|20510636|P1|Open Label Phase - up to 24 Weeks|Protocol Violation|39
5929402|NCT01435928|20510634|P3|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0
5929403|NCT01435928|20510635|P2|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0
5929404|NCT01435928|20510636|P1|Open Label Phase - up to 24 Weeks|Lost to Follow-up|60
5929405|NCT01435928|20510634|P3|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0
5929406|NCT01435928|20510635|P2|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0
5929407|NCT01435928|20510636|P1|Open Label Phase - up to 24 Weeks|Lack of Efficacy|46
5929408|NCT01435928|20510634|P3|Open Label Phase - up to 24 Weeks|Death|0
5929409|NCT01435928|20510635|P2|Open Label Phase - up to 24 Weeks|Death|0
5929410|NCT01435928|20510636|P1|Open Label Phase - up to 24 Weeks|Death|1
5929411|NCT01435928|20510634|P3|Open Label Phase - up to 24 Weeks|Adverse Event|0
5929412|NCT01435928|20510635|P2|Open Label Phase - up to 24 Weeks|Adverse Event|0
5929413|NCT01435928|20510636|P1|Open Label Phase - up to 24 Weeks|Adverse Event|83
5929414|NCT01435798|20510682|P1|Overall Study|Withdrawal by Subject|1
5929415|NCT01435772|20510699|P3|Overall Study|Other - study termination|10
5929416|NCT01435772|20510700|P2|Overall Study|Other - study termination|2
5929417|NCT01435772|20510701|P1|Overall Study|Other - study termination|2
5929418|NCT01435772|20510699|P3|Overall Study|Withdrawal by Subject|3
5929419|NCT01435772|20510700|P2|Overall Study|Withdrawal by Subject|1
5929420|NCT01435772|20510701|P1|Overall Study|Withdrawal by Subject|0
5929421|NCT01435772|20510699|P3|Overall Study|Adverse Event|2
5929422|NCT01435772|20510700|P2|Overall Study|Adverse Event|0
5929423|NCT01435772|20510701|P1|Overall Study|Adverse Event|1
5929424|NCT01435759|20510751|P6|Double-blind Phase|Other|0
5929425|NCT01435759|20510752|P5|Double-blind Phase|Other|0
5929426|NCT01435759|20510753|P4|Double-blind Phase|Other|2
5929427|NCT01435759|20510754|P3|Double-blind Phase|Other|0
5929428|NCT01435759|20510755|P2|Double-blind Phase|Other|2
5929429|NCT01435759|20510756|P1|Double-blind Phase|Other|8
5929430|NCT01435759|20510751|P6|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0
5929431|NCT01435759|20510752|P5|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|3
5929432|NCT01435759|20510753|P4|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0
5929433|NCT01435759|20510754|P3|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0
5929434|NCT01435759|20510755|P2|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0
5929435|NCT01435759|20510756|P1|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|1
5929436|NCT01435759|20510751|P6|Double-blind Phase|Lost to Follow-up|3
5929437|NCT01435759|20510752|P5|Double-blind Phase|Lost to Follow-up|3
5929438|NCT01435759|20510753|P4|Double-blind Phase|Lost to Follow-up|0
5929439|NCT01435759|20510754|P3|Double-blind Phase|Lost to Follow-up|2
5929440|NCT01435759|20510755|P2|Double-blind Phase|Lost to Follow-up|1
5929441|NCT01435759|20510756|P1|Double-blind Phase|Lost to Follow-up|31
5929442|NCT01435759|20510751|P6|Double-blind Phase|Withdrawal by Subject|2
5929443|NCT01435759|20510752|P5|Double-blind Phase|Withdrawal by Subject|2
5929444|NCT01435759|20510753|P4|Double-blind Phase|Withdrawal by Subject|4
5929445|NCT01435759|20510754|P3|Double-blind Phase|Withdrawal by Subject|3
5929446|NCT01435759|20510755|P2|Double-blind Phase|Withdrawal by Subject|4
5929447|NCT01435759|20510756|P1|Double-blind Phase|Withdrawal by Subject|17
5929448|NCT01435759|20510751|P6|Double-blind Phase|Protocol Violation|1
5929449|NCT01435759|20510752|P5|Double-blind Phase|Protocol Violation|0
5929450|NCT01435759|20510753|P4|Double-blind Phase|Protocol Violation|2
5929451|NCT01435759|20510754|P3|Double-blind Phase|Protocol Violation|1
5929452|NCT01435759|20510755|P2|Double-blind Phase|Protocol Violation|0
5929453|NCT01435759|20510756|P1|Double-blind Phase|Protocol Violation|2
5929454|NCT01435759|20510751|P6|Double-blind Phase|Adverse Event|3
5929455|NCT01435759|20510752|P5|Double-blind Phase|Adverse Event|1
5929456|NCT01435759|20510753|P4|Double-blind Phase|Adverse Event|1
5929457|NCT01435759|20510754|P3|Double-blind Phase|Adverse Event|1
5929458|NCT01435759|20510755|P2|Double-blind Phase|Adverse Event|0
5929459|NCT01435759|20510756|P1|Double-blind Phase|Adverse Event|7
5929460|NCT01435759|20510751|P6|Antidepressant Lead-in Phase|Other|0
5929461|NCT01435759|20510752|P5|Antidepressant Lead-in Phase|Other|0
5929462|NCT01435759|20510753|P4|Antidepressant Lead-in Phase|Other|0
5929463|NCT01435759|20510754|P3|Antidepressant Lead-in Phase|Other|0
5929464|NCT01435759|20510755|P2|Antidepressant Lead-in Phase|Other|0
5929465|NCT01435759|20510756|P1|Antidepressant Lead-in Phase|Other|119
5929466|NCT01435759|20510751|P6|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
5929467|NCT01435759|20510752|P5|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
5929468|NCT01435759|20510753|P4|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
5929469|NCT01435759|20510754|P3|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
5929470|NCT01435759|20510755|P2|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
5929471|NCT01435759|20510756|P1|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|10
5929472|NCT01435759|20510751|P6|Antidepressant Lead-in Phase|Lost to Follow-up|0
5929473|NCT01435759|20510752|P5|Antidepressant Lead-in Phase|Lost to Follow-up|0
5929474|NCT01435759|20510753|P4|Antidepressant Lead-in Phase|Lost to Follow-up|0
5929475|NCT01435759|20510754|P3|Antidepressant Lead-in Phase|Lost to Follow-up|0
5929476|NCT01435759|20510755|P2|Antidepressant Lead-in Phase|Lost to Follow-up|0
5929477|NCT01435759|20510756|P1|Antidepressant Lead-in Phase|Lost to Follow-up|83
5929478|NCT01435759|20510751|P6|Antidepressant Lead-in Phase|Withdrawal by Subject|0
5929479|NCT01435759|20510752|P5|Antidepressant Lead-in Phase|Withdrawal by Subject|0
5929480|NCT01435759|20510753|P4|Antidepressant Lead-in Phase|Withdrawal by Subject|0
5929481|NCT01435759|20510754|P3|Antidepressant Lead-in Phase|Withdrawal by Subject|0
5929482|NCT01435759|20510755|P2|Antidepressant Lead-in Phase|Withdrawal by Subject|0
5929483|NCT01435759|20510756|P1|Antidepressant Lead-in Phase|Withdrawal by Subject|74
5929484|NCT01435759|20510751|P6|Antidepressant Lead-in Phase|Protocol Violation|0
5929485|NCT01435759|20510752|P5|Antidepressant Lead-in Phase|Protocol Violation|0
5929486|NCT01435759|20510753|P4|Antidepressant Lead-in Phase|Protocol Violation|0
5929487|NCT01435759|20510754|P3|Antidepressant Lead-in Phase|Protocol Violation|0
5929488|NCT01435759|20510755|P2|Antidepressant Lead-in Phase|Protocol Violation|0
5929489|NCT01435759|20510756|P1|Antidepressant Lead-in Phase|Protocol Violation|16
5929490|NCT01435759|20510751|P6|Antidepressant Lead-in Phase|Adverse Event|0
5929491|NCT01435759|20510752|P5|Antidepressant Lead-in Phase|Adverse Event|0
5929492|NCT01435759|20510753|P4|Antidepressant Lead-in Phase|Adverse Event|0
5929493|NCT01435759|20510754|P3|Antidepressant Lead-in Phase|Adverse Event|0
5929494|NCT01435759|20510755|P2|Antidepressant Lead-in Phase|Adverse Event|0
5929495|NCT01435759|20510756|P1|Antidepressant Lead-in Phase|Adverse Event|40
5929496|NCT01435655|20510783|P1|Overall Study|Other|1
5929497|NCT01435655|20510783|P1|Overall Study|Death|2
5929498|NCT01435616|20510797|P2|Overall Study|Sponsor Decision|0
5929499|NCT01435616|20510798|P1|Overall Study|Sponsor Decision|1
5929500|NCT01435616|20510797|P2|Overall Study|Physician Decision|7
5929501|NCT01435616|20510798|P1|Overall Study|Physician Decision|20
5929502|NCT01435616|20510797|P2|Overall Study|Withdrawal by Subject|24
5929503|NCT01435616|20510798|P1|Overall Study|Withdrawal by Subject|66
5929504|NCT01435616|20510797|P2|Overall Study|Protocol Violation|13
5929505|NCT01435616|20510798|P1|Overall Study|Protocol Violation|16
5929506|NCT01435616|20510797|P2|Overall Study|Lost to Follow-up|13
5929507|NCT01435616|20510798|P1|Overall Study|Lost to Follow-up|22
5929508|NCT01435616|20510797|P2|Overall Study|Death|2
5929509|NCT01435616|20510798|P1|Overall Study|Death|7
5929510|NCT01435616|20510797|P2|Overall Study|Adverse Event|21
5929511|NCT01435616|20510798|P1|Overall Study|Adverse Event|39
5929512|NCT01435577|20510853|P2|Overall Study|Alternative treatment started|1
5929513|NCT01435577|20510854|P1|Overall Study|Alternative treatment started|0
5929514|NCT01435577|20510853|P2|Overall Study|Lack of Efficacy|51
5929515|NCT01435577|20510854|P1|Overall Study|Lack of Efficacy|7
5929516|NCT01435577|20510853|P2|Overall Study|Adverse Event|0
5929517|NCT01435577|20510854|P1|Overall Study|Adverse Event|10
5929518|NCT01435460|20510915|P2|Overall Study|Did not meet eligibility criteria|0
5929519|NCT01435460|20510916|P1|Overall Study|Did not meet eligibility criteria|2
5929520|NCT01435460|20510915|P2|Overall Study|Protocol Violation|1
5929521|NCT01435460|20510916|P1|Overall Study|Protocol Violation|0
5929522|NCT01435460|20510915|P2|Overall Study|Withdrawal by Subject|3
5929523|NCT01435460|20510916|P1|Overall Study|Withdrawal by Subject|1
5929524|NCT01435460|20510915|P2|Overall Study|Lost to Follow-up|1
5929525|NCT01435460|20510916|P1|Overall Study|Lost to Follow-up|6
5929526|NCT01435460|20510915|P2|Overall Study|Adverse Event|1
5929527|NCT01435460|20510916|P1|Overall Study|Adverse Event|2
5929528|NCT01435382|20510932|P4|Overall Study|Withdrawal by Subject|1
5929529|NCT01435382|20510933|P3|Overall Study|Withdrawal by Subject|0
5929530|NCT01435382|20510934|P2|Overall Study|Withdrawal by Subject|2
5929531|NCT01435382|20510935|P1|Overall Study|Withdrawal by Subject|0
5929532|NCT01435382|20510932|P4|Overall Study|Lost to Follow-up|0
5929533|NCT01435382|20510933|P3|Overall Study|Lost to Follow-up|1
5929534|NCT01435382|20510934|P2|Overall Study|Lost to Follow-up|0
5929535|NCT01435382|20510935|P1|Overall Study|Lost to Follow-up|1
5929536|NCT01435356|20511024|P2|Overall Study|Patient moved to another city|1
5929537|NCT01435356|20511025|P1|Overall Study|Patient moved to another city|1
5929538|NCT01435356|20511024|P2|Overall Study|Patient decision|0
5929539|NCT01435356|20511025|P1|Overall Study|Patient decision|3
5929540|NCT01435356|20511024|P2|Overall Study|Physician Decision|0
5929541|NCT01435356|20511025|P1|Overall Study|Physician Decision|1
5929542|NCT01435356|20511024|P2|Overall Study|IC withdrawal due to study cancellation|0
5929543|NCT01435356|20511025|P1|Overall Study|IC withdrawal due to study cancellation|1
5929544|NCT01435356|20511024|P2|Overall Study|Facial palsy|0
5929545|NCT01435356|20511025|P1|Overall Study|Facial palsy|1
5929546|NCT01435356|20511024|P2|Overall Study|Withdrawal by Subject|1
5929547|NCT01435356|20511025|P1|Overall Study|Withdrawal by Subject|1
5929548|NCT01435356|20511024|P2|Overall Study|Study Discontinuation, amendment 4|11
5929549|NCT01435356|20511025|P1|Overall Study|Study Discontinuation, amendment 4|5
5929550|NCT01435356|20511024|P2|Overall Study|Protocol Violation|1
5929551|NCT01435356|20511025|P1|Overall Study|Protocol Violation|0
5929552|NCT01435356|20511024|P2|Overall Study|Disease progression/recurrence|10
5929553|NCT01435356|20511025|P1|Overall Study|Disease progression/recurrence|17
5929554|NCT01435356|20511024|P2|Overall Study|Adverse Event|0
5929555|NCT01435356|20511025|P1|Overall Study|Adverse Event|2
5929556|NCT01435265|20511058|P2|Overall Study|Lost to Follow-up|1
5929557|NCT01435265|20511059|P1|Overall Study|Lost to Follow-up|0
5929558|NCT01435122|20511073|P1|Overall Study|Early withdrawal due to toxicity|8
5929559|NCT01435031|20511082|P1|ITT at 4 Years|Lost to Follow-up|1
5929560|NCT01435031|20511082|P1|ITT at 4 Years|Withdrawal by Subject|2
5929561|NCT01435031|20511082|P1|ITT at 4 Years|Death|4
5929562|NCT01435031|20511082|P1|ITT at 3 Years|Lost to Follow-up|4
5929563|NCT01435031|20511082|P1|ITT at 3 Years|Withdrawal by Subject|2
5929564|NCT01435031|20511082|P1|ITT at 3 Years|Death|5
5929565|NCT01435031|20511082|P1|ITT at 2 Years|Lost to Follow-up|4
5929566|NCT01435031|20511082|P1|ITT at 2 Years|Withdrawal by Subject|2
5929567|NCT01435031|20511082|P1|ITT at 2 Years|Death|7
5929568|NCT01435031|20511082|P1|ITT at 1 Year|Lost to Follow-up|6
5929569|NCT01435031|20511082|P1|ITT at 1 Year|Withdrawal by Subject|2
5929570|NCT01435031|20511082|P1|ITT at 1 Year|Death|1
5929571|NCT01435031|20511082|P1|ITT at 6 Months|Lost to Follow-up|3
5929572|NCT01435031|20511082|P1|ITT at 6 Months|Death|2
5929573|NCT01435031|20511082|P1|ITT at 1 Month|Lost to Follow-up|4
5929574|NCT01435031|20511082|P1|ITT at 1 Month|Death|1
5929575|NCT01435031|20511082|P1|ITT at 1 Month|Withdrawal by Subject|1
5929576|NCT01435018|20511183|P3|Overall Study|Never started chemotherapy|1
5929577|NCT01435018|20511184|P2|Overall Study|Never started chemotherapy|0
5929578|NCT01435018|20511185|P1|Overall Study|Never started chemotherapy|3
5929579|NCT01435018|20511183|P3|Overall Study|Enrollment Violation|0
5929580|NCT01435018|20511184|P2|Overall Study|Enrollment Violation|1
5929581|NCT01435018|20511185|P1|Overall Study|Enrollment Violation|0
5929582|NCT01435018|20511183|P3|Overall Study|Unable to contact participant/parent|1
5929583|NCT01435018|20511184|P2|Overall Study|Unable to contact participant/parent|1
5929584|NCT01435018|20511185|P1|Overall Study|Unable to contact participant/parent|1
5929585|NCT01435018|20511183|P3|Overall Study|Severe debilitation, unable to continue|1
5929586|NCT01435018|20511184|P2|Overall Study|Severe debilitation, unable to continue|0
5929587|NCT01435018|20511185|P1|Overall Study|Severe debilitation, unable to continue|0
5929588|NCT01435018|20511183|P3|Overall Study|Not able to get to clinic|2
5929589|NCT01435018|20511184|P2|Overall Study|Not able to get to clinic|0
5929590|NCT01435018|20511185|P1|Overall Study|Not able to get to clinic|2
5929591|NCT01435018|20511183|P3|Overall Study|Not willing to adhere to requirements|3
5929592|NCT01435018|20511184|P2|Overall Study|Not willing to adhere to requirements|2
5929593|NCT01435018|20511185|P1|Overall Study|Not willing to adhere to requirements|0
5929594|NCT01435018|20511183|P3|Overall Study|Withdrew consent|1
5929595|NCT01435018|20511184|P2|Overall Study|Withdrew consent|3
5929596|NCT01435018|20511185|P1|Overall Study|Withdrew consent|0
5929597|NCT01435018|20511183|P3|Overall Study|Site is closing|7
5929598|NCT01435018|20511184|P2|Overall Study|Site is closing|9
5929599|NCT01435018|20511185|P1|Overall Study|Site is closing|4
5929600|NCT01435018|20511183|P3|Overall Study|Death|25
5929601|NCT01435018|20511184|P2|Overall Study|Death|18
5929602|NCT01435018|20511185|P1|Overall Study|Death|37
5929603|NCT01434823|20511278|P2|Overall Study|Incomplete data in medical record|7
5929604|NCT01434823|20511279|P1|Overall Study|Incomplete data in medical record|4
5929605|NCT01434810|20511297|P2|Overall Study|Missing data/received <5hr phototherapy|7
5929606|NCT01434810|20511298|P1|Overall Study|Missing data/received <5hr phototherapy|12
5929607|NCT01434810|20511297|P2|Overall Study|Did not receive treatment|3
5929608|NCT01434810|20511298|P1|Overall Study|Did not receive treatment|11
5929609|NCT01434693|20511333|P4|Overall Study|Lost to Follow-up|0
5929610|NCT01434693|20511334|P3|Overall Study|Lost to Follow-up|0
5929611|NCT01434693|20511335|P2|Overall Study|Lost to Follow-up|0
5929612|NCT01434693|20511336|P1|Overall Study|Lost to Follow-up|1
5929613|NCT01434693|20511333|P4|Overall Study|Withdrawal by Subject|1
5929614|NCT01434693|20511334|P3|Overall Study|Withdrawal by Subject|1
5929615|NCT01434693|20511335|P2|Overall Study|Withdrawal by Subject|0
5929616|NCT01434693|20511336|P1|Overall Study|Withdrawal by Subject|1
5929617|NCT01434693|20511333|P4|Overall Study|Adverse Event|0
5929618|NCT01434693|20511334|P3|Overall Study|Adverse Event|0
5929619|NCT01434693|20511335|P2|Overall Study|Adverse Event|0
5929620|NCT01434693|20511336|P1|Overall Study|Adverse Event|1
5929621|NCT01434680|20511350|P4|Overall Study|Protocol Violation|0
5929622|NCT01434680|20511351|P3|Overall Study|Protocol Violation|0
5929623|NCT01434680|20511352|P2|Overall Study|Protocol Violation|1
5929624|NCT01434680|20511353|P1|Overall Study|Protocol Violation|1
5929625|NCT01434680|20511350|P4|Overall Study|Lost to Follow-up|0
5929626|NCT01434680|20511351|P3|Overall Study|Lost to Follow-up|0
5929627|NCT01434680|20511352|P2|Overall Study|Lost to Follow-up|1
5929628|NCT01434680|20511353|P1|Overall Study|Lost to Follow-up|1
5929629|NCT01434680|20511350|P4|Overall Study|Withdrawal by Subject|0
5929630|NCT01434680|20511351|P3|Overall Study|Withdrawal by Subject|2
5929631|NCT01434680|20511352|P2|Overall Study|Withdrawal by Subject|0
5929632|NCT01434680|20511353|P1|Overall Study|Withdrawal by Subject|1
5929633|NCT01434667|20511370|P2|Overall Study|Lost to Follow-up|10
5929634|NCT01434667|20511371|P1|Overall Study|Lost to Follow-up|5
5929635|NCT01434654|20511397|P2|Overall Study|Lost to Follow-up|0
5929636|NCT01434654|20511398|P1|Overall Study|Lost to Follow-up|1
5929637|NCT01434654|20511397|P2|Overall Study|Withdrawal by Subject|0
5929638|NCT01434654|20511398|P1|Overall Study|Withdrawal by Subject|1
5929639|NCT01434290|20511445|P2|Overall Study|No protocol treatment|4
5929640|NCT01434290|20511446|P1|Overall Study|No protocol treatment|2
5929641|NCT01434290|20511445|P2|Overall Study|Protocol Violation|3
5929642|NCT01434290|20511446|P1|Overall Study|Protocol Violation|6
5929643|NCT01433978|20511519|P3|Extension Phase|Study Terminated by Sponsor|4
5929644|NCT01433978|20511520|P2|Extension Phase|Study Terminated by Sponsor|0
5929645|NCT01433978|20511521|P1|Extension Phase|Study Terminated by Sponsor|0
5929646|NCT01433978|20511519|P3|Extension Phase|Lack of Efficacy|1
5929647|NCT01433978|20511520|P2|Extension Phase|Lack of Efficacy|0
5929648|NCT01433978|20511521|P1|Extension Phase|Lack of Efficacy|0
5929649|NCT01433978|20511519|P3|Extension Phase|Adverse Event, Non-Fatal|1
5929650|NCT01433978|20511520|P2|Extension Phase|Adverse Event, Non-Fatal|0
5929651|NCT01433978|20511521|P1|Extension Phase|Adverse Event, Non-Fatal|0
5929652|NCT01433978|20511519|P3|Core Study|Study Terminated by Sponsor|0
5929653|NCT01433978|20511520|P2|Core Study|Study Terminated by Sponsor|9
5929654|NCT01433978|20511521|P1|Core Study|Study Terminated by Sponsor|6
5929655|NCT01433978|20511519|P3|Core Study|Lack of Efficacy|0
5929656|NCT01433978|20511520|P2|Core Study|Lack of Efficacy|1
5929657|NCT01433978|20511521|P1|Core Study|Lack of Efficacy|5
5929658|NCT01433978|20511519|P3|Core Study|Adverse Event, Non-Fatal|0
5929659|NCT01433978|20511520|P2|Core Study|Adverse Event, Non-Fatal|1
5929660|NCT01433978|20511521|P1|Core Study|Adverse Event, Non-Fatal|0
5929661|NCT01433549|20511578|P2|Phase 2: Second Study Product|Adverse Event|1
5929662|NCT01433549|20511579|P1|Phase 2: Second Study Product|Adverse Event|0
5929663|NCT01433471|20511589|P2|Overall Study|Withdrawal by Subject|1
5929664|NCT01433471|20511590|P1|Overall Study|Withdrawal by Subject|0
5929665|NCT01433354|20511606|P1|Overall Study|Subject Withdrew Consent|3
5929666|NCT01433354|20511606|P1|Overall Study|Lack of Efficacy|17
5929667|NCT01433354|20511606|P1|Overall Study|Protocol Violation|2
5929668|NCT01433354|20511606|P1|Overall Study|Administrative problems|90
5929669|NCT01433354|20511606|P1|Overall Study|Lost to Follow-up|1
5929670|NCT01433354|20511606|P1|Overall Study|Adverse Event|6
5929671|NCT01433263|20511622|P2|Overall Study|Withdrawal by Subject|7
5929672|NCT01433263|20511623|P1|Overall Study|Withdrawal by Subject|10
5929673|NCT01433263|20511622|P2|Overall Study|Protocol Deviation|0
5929674|NCT01433263|20511623|P1|Overall Study|Protocol Deviation|1
5929675|NCT01433263|20511622|P2|Overall Study|Lost to Follow-up|1
5929676|NCT01433263|20511623|P1|Overall Study|Lost to Follow-up|0
5929677|NCT01433263|20511622|P2|Overall Study|Death|3
5929678|NCT01433263|20511623|P1|Overall Study|Death|5
5929679|NCT01433263|20511622|P2|Overall Study|Adverse Event|1
5929680|NCT01433263|20511623|P1|Overall Study|Adverse Event|3
5929681|NCT01433250|20511652|P2|Overall Study|Withdrawal by Subject|2
5929682|NCT01433250|20511653|P1|Overall Study|Withdrawal by Subject|3
5929683|NCT01433250|20511652|P2|Overall Study|Protocol Violation|1
5929684|NCT01433250|20511653|P1|Overall Study|Protocol Violation|0
5929685|NCT01433172|20511672|P3|Overall Study|Death|0
5929686|NCT01433172|20511673|P2|Overall Study|Death|2
5929687|NCT01433172|20511674|P1|Overall Study|Death|0
5929688|NCT01433172|20511672|P3|Overall Study|Disease Progression|1
5929689|NCT01433172|20511673|P2|Overall Study|Disease Progression|0
5929690|NCT01433172|20511674|P1|Overall Study|Disease Progression|0
5929691|NCT01433172|20511672|P3|Overall Study|Withdrawal by Subject|0
5929692|NCT01433172|20511673|P2|Overall Study|Withdrawal by Subject|1
5929693|NCT01433172|20511674|P1|Overall Study|Withdrawal by Subject|0
5929694|NCT01433159|20511686|P2|Overall Study|Protocol Violation|1
5929695|NCT01433159|20511687|P1|Overall Study|Protocol Violation|0
5929696|NCT01433159|20511686|P2|Overall Study|Physician Decision|0
5929697|NCT01433159|20511687|P1|Overall Study|Physician Decision|1
5929698|NCT01433159|20511686|P2|Overall Study|Adverse Event|0
5929699|NCT01433159|20511687|P1|Overall Study|Adverse Event|1
5929700|NCT01433055|20511719|P2|Overall Study|Severely elevated triglycerides at entry|0
5929701|NCT01433055|20511720|P1|Overall Study|Severely elevated triglycerides at entry|1
5929702|NCT01433055|20511719|P2|Overall Study|Diagnosed with cancer unrelated to study|0
5929703|NCT01433055|20511720|P1|Overall Study|Diagnosed with cancer unrelated to study|1
5929704|NCT01432951|20511742|P1|Treatment Phase (Day 1 to 30)|Never Treated|1
5929705|NCT01432938|20511751|P2|Second Intervention|Adverse Event|0
5929706|NCT01432938|20511752|P1|Second Intervention|Adverse Event|1
5929707|NCT01432938|20511751|P2|First Intervention|Physician Decision|0
5929708|NCT01432938|20511752|P1|First Intervention|Physician Decision|1
5929709|NCT01432938|20511751|P2|First Intervention|Protocol Violation|0
5929710|NCT01432938|20511752|P1|First Intervention|Protocol Violation|1
5929711|NCT01432756|20511782|P4|Overall Study|Lost to Follow-up|1
5929712|NCT01432756|20511783|P3|Overall Study|Lost to Follow-up|2
5929713|NCT01432756|20511784|P2|Overall Study|Lost to Follow-up|0
5929714|NCT01432756|20511785|P1|Overall Study|Lost to Follow-up|1
5929715|NCT01432730|20511793|P2|Period 2|Adverse Event|4
5929716|NCT01432730|20511794|P1|Period 2|Adverse Event|0
5929717|NCT01432730|20511793|P2|Period 1|Adverse Event|0
5929718|NCT01432730|20511794|P1|Period 1|Adverse Event|2
5929719|NCT01432626|20511830|P1|Overall Study|Imaging agent not available|1
5929720|NCT01432626|20511830|P1|Overall Study|Only 1 image competed|2
5929721|NCT01432626|20511830|P1|Overall Study|Withdrawal by Subject|2
5929722|NCT01432626|20511830|P1|Overall Study|LV function recovered|2
5929723|NCT01432600|20511837|P3|Overall Study|Rapid PD, allocated intv. not rec'd|1
5929724|NCT01432600|20511838|P2|Overall Study|Rapid PD, allocated intv. not rec'd|1
5929725|NCT01432600|20511839|P1|Overall Study|Rapid PD, allocated intv. not rec'd|0
5929726|NCT01432574|20511855|P1|Overall Study|Not interested|1
5929727|NCT01432574|20511855|P1|Overall Study|Moved|2
5929728|NCT01432457|20511901|P3|Overall Study|Did not take study drug|3
5929729|NCT01432457|20511902|P2|Overall Study|Did not take study drug|6
5929730|NCT01432457|20511903|P1|Overall Study|Did not take study drug|6
5929731|NCT01432457|20511901|P3|Overall Study|Reasons not defined|4
5929732|NCT01432457|20511902|P2|Overall Study|Reasons not defined|3
5929733|NCT01432457|20511903|P1|Overall Study|Reasons not defined|2
5929734|NCT01432457|20511901|P3|Overall Study|Withdrawal by Subject|9
5929735|NCT01432457|20511902|P2|Overall Study|Withdrawal by Subject|11
5929736|NCT01432457|20511903|P1|Overall Study|Withdrawal by Subject|6
5929737|NCT01432457|20511901|P3|Overall Study|Protocol Violation|6
5929738|NCT01432457|20511902|P2|Overall Study|Protocol Violation|2
5929739|NCT01432457|20511903|P1|Overall Study|Protocol Violation|3
5929740|NCT01432457|20511901|P3|Overall Study|Lost to Follow-up|20
5929741|NCT01432457|20511902|P2|Overall Study|Lost to Follow-up|15
5929742|NCT01432457|20511903|P1|Overall Study|Lost to Follow-up|11
5929743|NCT01432457|20511901|P3|Overall Study|Lack of Efficacy|1
5929744|NCT01432457|20511902|P2|Overall Study|Lack of Efficacy|1
5929745|NCT01432457|20511903|P1|Overall Study|Lack of Efficacy|2
5929746|NCT01432457|20511901|P3|Overall Study|Adverse Event|16
5929747|NCT01432457|20511902|P2|Overall Study|Adverse Event|10
5929748|NCT01432457|20511903|P1|Overall Study|Adverse Event|7
5929749|NCT01432444|20511932|P3|Extension Phase|Withdrawal by Subject|13
5929750|NCT01432444|20511933|P2|Extension Phase|Withdrawal by Subject|0
5929751|NCT01432444|20511934|P1|Extension Phase|Withdrawal by Subject|0
5929752|NCT01432444|20511932|P3|Extension Phase|Physician Decision|1
5929753|NCT01432444|20511933|P2|Extension Phase|Physician Decision|0
5929754|NCT01432444|20511934|P1|Extension Phase|Physician Decision|0
5929755|NCT01432444|20511932|P3|Extension Phase|Met Withdrawal Criteria|144
5929756|NCT01432444|20511933|P2|Extension Phase|Met Withdrawal Criteria|0
5929757|NCT01432444|20511934|P1|Extension Phase|Met Withdrawal Criteria|0
5929758|NCT01432444|20511932|P3|Extension Phase|Sponsor Discontinued Trial|7
5929759|NCT01432444|20511933|P2|Extension Phase|Sponsor Discontinued Trial|0
5929760|NCT01432444|20511934|P1|Extension Phase|Sponsor Discontinued Trial|0
5929761|NCT01432444|20511932|P3|Extension Phase|Adverse Event|10
5929762|NCT01432444|20511933|P2|Extension Phase|Adverse Event|0
5929763|NCT01432444|20511934|P1|Extension Phase|Adverse Event|0
5929764|NCT01432444|20511932|P3|Extension Phase|Lost to Follow-up|17
5929765|NCT01432444|20511933|P2|Extension Phase|Lost to Follow-up|0
5929766|NCT01432444|20511934|P1|Extension Phase|Lost to Follow-up|0
5929767|NCT01432444|20511932|P3|Treatment Phase|Lack of Efficacy|0
5929768|NCT01432444|20511933|P2|Treatment Phase|Lack of Efficacy|10
5929769|NCT01432444|20511934|P1|Treatment Phase|Lack of Efficacy|0
5929770|NCT01432444|20511932|P3|Treatment Phase|Protocol Deviation|0
5929771|NCT01432444|20511933|P2|Treatment Phase|Protocol Deviation|3
5929772|NCT01432444|20511934|P1|Treatment Phase|Protocol Deviation|0
5929773|NCT01432444|20511932|P3|Treatment Phase|Withdrawal by Subject|0
5929774|NCT01432444|20511933|P2|Treatment Phase|Withdrawal by Subject|41
5929775|NCT01432444|20511934|P1|Treatment Phase|Withdrawal by Subject|0
5929776|NCT01432444|20511932|P3|Treatment Phase|Physician Decision|0
5929777|NCT01432444|20511933|P2|Treatment Phase|Physician Decision|5
5929778|NCT01432444|20511934|P1|Treatment Phase|Physician Decision|0
5929779|NCT01432444|20511932|P3|Treatment Phase|Met Withdrawal Criteria|0
5929780|NCT01432444|20511933|P2|Treatment Phase|Met Withdrawal Criteria|11
5929781|NCT01432444|20511934|P1|Treatment Phase|Met Withdrawal Criteria|0
5929782|NCT01432444|20511932|P3|Treatment Phase|Adverse Event|0
5929783|NCT01432444|20511933|P2|Treatment Phase|Adverse Event|37
5929784|NCT01432444|20511934|P1|Treatment Phase|Adverse Event|0
5929785|NCT01432444|20511932|P3|Treatment Phase|Lost to Follow-up|0
5929786|NCT01432444|20511933|P2|Treatment Phase|Lost to Follow-up|33
5929787|NCT01432444|20511934|P1|Treatment Phase|Lost to Follow-up|0
5929788|NCT01432444|20511932|P3|Tolerability/Cross-titration Phase|Lack of Efficacy|0
5929789|NCT01432444|20511933|P2|Tolerability/Cross-titration Phase|Lack of Efficacy|0
5929790|NCT01432444|20511934|P1|Tolerability/Cross-titration Phase|Lack of Efficacy|5
5929791|NCT01432444|20511932|P3|Tolerability/Cross-titration Phase|Protocol Deviation|0
5929792|NCT01432444|20511933|P2|Tolerability/Cross-titration Phase|Protocol Deviation|0
5929793|NCT01432444|20511934|P1|Tolerability/Cross-titration Phase|Protocol Deviation|1
5929794|NCT01432444|20511932|P3|Tolerability/Cross-titration Phase|Withdrawal by Subject|0
5929795|NCT01432444|20511933|P2|Tolerability/Cross-titration Phase|Withdrawal by Subject|0
5929796|NCT01432444|20511934|P1|Tolerability/Cross-titration Phase|Withdrawal by Subject|15
5929797|NCT01432444|20511932|P3|Tolerability/Cross-titration Phase|Physician Decision|0
5929798|NCT01432444|20511933|P2|Tolerability/Cross-titration Phase|Physician Decision|0
5929799|NCT01432444|20511934|P1|Tolerability/Cross-titration Phase|Physician Decision|8
5929800|NCT01432444|20511932|P3|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0
5929801|NCT01432444|20511933|P2|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0
5929802|NCT01432444|20511934|P1|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|5
5929803|NCT01432444|20511932|P3|Tolerability/Cross-titration Phase|Adverse Event|0
5929804|NCT01432444|20511933|P2|Tolerability/Cross-titration Phase|Adverse Event|0
5929805|NCT01432444|20511934|P1|Tolerability/Cross-titration Phase|Adverse Event|16
5929806|NCT01432444|20511932|P3|Tolerability/Cross-titration Phase|Lost to Follow-up|0
5929807|NCT01432444|20511933|P2|Tolerability/Cross-titration Phase|Lost to Follow-up|0
5929808|NCT01432444|20511934|P1|Tolerability/Cross-titration Phase|Lost to Follow-up|10
5929809|NCT01432366|20511960|P1|Overall Study|Other|14
5929810|NCT01432366|20511960|P1|Overall Study|Investigator Forget to Complete Visits|1
5929811|NCT01432366|20511960|P1|Overall Study|Site Closed|20
5929812|NCT01432366|20511960|P1|Overall Study|Lack of Efficacy|1
5929813|NCT01432366|20511960|P1|Overall Study|Lost to Follow-up|13
5929814|NCT01432366|20511960|P1|Overall Study|Pregnancy|1
5929815|NCT01432366|20511960|P1|Overall Study|Withdrawal Due to Non-Compliance|3
5929816|NCT01432366|20511960|P1|Overall Study|Adverse Event|8
5929817|NCT01432366|20511960|P1|Overall Study|Non-Responder|7
5929818|NCT01432327|20511982|P4|Posttest 1 Year|Allergic reaction|1
5929819|NCT01432327|20511983|P3|Posttest 1 Year|Allergic reaction|1
5929820|NCT01432327|20511984|P2|Posttest 1 Year|Allergic reaction|0
5929821|NCT01432327|20511985|P1|Posttest 1 Year|Allergic reaction|0
5929822|NCT01432327|20511982|P4|Posttest 1 Year|Lost to Follow-up|2
5929823|NCT01432327|20511983|P3|Posttest 1 Year|Lost to Follow-up|4
5929824|NCT01432327|20511984|P2|Posttest 1 Year|Lost to Follow-up|0
5929825|NCT01432327|20511985|P1|Posttest 1 Year|Lost to Follow-up|0
5929826|NCT01432327|20511982|P4|Posttest 1 Year|Measurement have to take place in future|20
5929827|NCT01432327|20511983|P3|Posttest 1 Year|Measurement have to take place in future|15
5929828|NCT01432327|20511984|P2|Posttest 1 Year|Measurement have to take place in future|28
5929829|NCT01432327|20511985|P1|Posttest 1 Year|Measurement have to take place in future|24
5929830|NCT01432327|20511982|P4|Posttest 6 Months|Withdrawal by Subject|0
5929831|NCT01432327|20511983|P3|Posttest 6 Months|Withdrawal by Subject|1
5929832|NCT01432327|20511984|P2|Posttest 6 Months|Withdrawal by Subject|0
5929833|NCT01432327|20511985|P1|Posttest 6 Months|Withdrawal by Subject|0
5929834|NCT01432327|20511982|P4|Posttest 6 Months|Allergic reaction|0
5929835|NCT01432327|20511983|P3|Posttest 6 Months|Allergic reaction|1
5929836|NCT01432327|20511984|P2|Posttest 6 Months|Allergic reaction|0
5929837|NCT01432327|20511985|P1|Posttest 6 Months|Allergic reaction|0
5929838|NCT01432327|20511982|P4|Posttest 6 Months|Lost to Follow-up|2
5929839|NCT01432327|20511983|P3|Posttest 6 Months|Lost to Follow-up|3
5929840|NCT01432327|20511984|P2|Posttest 6 Months|Lost to Follow-up|0
5929841|NCT01432327|20511985|P1|Posttest 6 Months|Lost to Follow-up|0
5929842|NCT01432327|20511982|P4|Posttest 3 Months|Allergic reaction|0
5929843|NCT01432327|20511983|P3|Posttest 3 Months|Allergic reaction|0
5929844|NCT01432327|20511984|P2|Posttest 3 Months|Allergic reaction|2
5929845|NCT01432327|20511985|P1|Posttest 3 Months|Allergic reaction|0
5929846|NCT01432327|20511982|P4|Posttest 3 Months|Lost to Follow-up|1
5929847|NCT01432327|20511983|P3|Posttest 3 Months|Lost to Follow-up|2
5929848|NCT01432327|20511984|P2|Posttest 3 Months|Lost to Follow-up|0
5929849|NCT01432327|20511985|P1|Posttest 3 Months|Lost to Follow-up|1
5929850|NCT01432327|20511982|P4|Posttest 3 Months|depression|0
5929851|NCT01432327|20511983|P3|Posttest 3 Months|depression|0
5929852|NCT01432327|20511984|P2|Posttest 3 Months|depression|0
5929853|NCT01432327|20511985|P1|Posttest 3 Months|depression|3
5929854|NCT01432275|20511995|P2|ADC With Calculator (10 Days)|Protocol Violation|1
5929855|NCT01432275|20511996|P1|ADC With Calculator (10 Days)|Protocol Violation|0
5929856|NCT01432275|20511995|P2|ADC With Calculator (10 Days)|Withdrawal by Subject|0
5929857|NCT01432275|20511996|P1|ADC With Calculator (10 Days)|Withdrawal by Subject|2
5929858|NCT01432275|20511995|P2|ADC With Calculator (10 Days)|Physician Decision|1
5929859|NCT01432275|20511996|P1|ADC With Calculator (10 Days)|Physician Decision|1
5929860|NCT01432275|20511995|P2|Second BG Meter System (7 Days)|Withdrawal by Subject|1
5929861|NCT01432275|20511996|P1|Second BG Meter System (7 Days)|Withdrawal by Subject|0
5929862|NCT01432275|20511995|P2|Second BG Meter System (7 Days)|Physician Decision|1
5929863|NCT01432275|20511996|P1|Second BG Meter System (7 Days)|Physician Decision|0
5929864|NCT01432275|20511995|P2|Second BG Meter System (7 Days)|Lost to Follow-up|0
5929865|NCT01432275|20511996|P1|Second BG Meter System (7 Days)|Lost to Follow-up|1
5929866|NCT01432275|20511995|P2|Second BG Meter System (7 Days)|Adverse Event|1
5929867|NCT01432275|20511996|P1|Second BG Meter System (7 Days)|Adverse Event|1
5929868|NCT01432275|20511995|P2|First BG Meter System (7 Days)|Withdrawal by Subject|1
5929869|NCT01432275|20511996|P1|First BG Meter System (7 Days)|Withdrawal by Subject|0
5929870|NCT01432275|20511995|P2|First BG Meter System (7 Days)|Adverse Event|2
5929871|NCT01432275|20511996|P1|First BG Meter System (7 Days)|Adverse Event|0
5929872|NCT01432262|20512005|P2|Overall Study|Withdrawal by Subject|1
5929873|NCT01432262|20512006|P1|Overall Study|Withdrawal by Subject|2
5929874|NCT01432171|20512072|P2|Overall Study|Patient moved to palliative care|0
5929875|NCT01432171|20512073|P1|Overall Study|Patient moved to palliative care|1
5929876|NCT01432171|20512072|P2|Overall Study|Insurance denial trial coverage|0
5929877|NCT01432171|20512073|P1|Overall Study|Insurance denial trial coverage|1
5929878|NCT01432171|20512072|P2|Overall Study|Noncompliance|3
5929879|NCT01432171|20512073|P1|Overall Study|Noncompliance|2
5929880|NCT01432171|20512072|P2|Overall Study|Withdrawal by Subject|1
5929881|NCT01432171|20512073|P1|Overall Study|Withdrawal by Subject|3
5929882|NCT01432171|20512072|P2|Overall Study|Lost to Follow-up|5
5929883|NCT01432171|20512073|P1|Overall Study|Lost to Follow-up|6
5929884|NCT01432171|20512072|P2|Overall Study|Death|2
5929885|NCT01432171|20512073|P1|Overall Study|Death|1
5929886|NCT01431976|20512114|P1|Overall Study|Withdrawal by Subject|1
5929887|NCT01431976|20512114|P1|Overall Study|Physician Decision|1
5929888|NCT01431976|20512114|P1|Overall Study|Met Protocol-defined Stopping Criteria|4
5929889|NCT01431976|20512114|P1|Overall Study|Lack of Efficacy|2
5929890|NCT01431976|20512114|P1|Overall Study|Adverse Event|6
5929891|NCT01431963|20512125|P1|Overall Study|Withdrawal by Subject|3
5929892|NCT01431963|20512125|P1|Overall Study|Physician Decision|4
5929893|NCT01431963|20512125|P1|Overall Study|Protocol-defined Stopping Criteria|2
5929894|NCT01431963|20512125|P1|Overall Study|Protocol Violation|1
5929895|NCT01431963|20512125|P1|Overall Study|Lack of Efficacy|7
5929896|NCT01431963|20512125|P1|Overall Study|Adverse Event|18
5929897|NCT01431950|20512133|P2|Overall Study|Met Protocol-defined Stopping Criteria|1
5929898|NCT01431950|20512134|P1|Overall Study|Met Protocol-defined Stopping Criteria|0
5929899|NCT01431950|20512133|P2|Overall Study|Lost to Follow-up|1
5929900|NCT01431950|20512134|P1|Overall Study|Lost to Follow-up|0
5929901|NCT01431950|20512133|P2|Overall Study|Lack of Efficacy|1
5929902|NCT01431950|20512134|P1|Overall Study|Lack of Efficacy|2
5929903|NCT01431950|20512133|P2|Overall Study|Physician Decision|1
5929904|NCT01431950|20512134|P1|Overall Study|Physician Decision|2
5929905|NCT01431950|20512133|P2|Overall Study|Adverse Event|2
5929906|NCT01431950|20512134|P1|Overall Study|Adverse Event|2
5929907|NCT01431950|20512133|P2|Overall Study|Protocol Violation|3
5929908|NCT01431950|20512134|P1|Overall Study|Protocol Violation|2
5929909|NCT01431950|20512133|P2|Overall Study|Withdrawal by Subject|3
5929910|NCT01431950|20512134|P1|Overall Study|Withdrawal by Subject|4
5929911|NCT01431950|20512133|P2|Overall Study|Study Site Closed/Terminated|3
5929912|NCT01431950|20512134|P1|Overall Study|Study Site Closed/Terminated|7
5929913|NCT01431716|20512199|P1|Overall Study|Withdrawal of consent|1
5929914|NCT01431534|20512223|P3|Treatment Phase|Progressive Disease|10
5929915|NCT01431534|20512224|P2|Treatment Phase|Progressive Disease|3
5929916|NCT01431534|20512225|P1|Treatment Phase|Progressive Disease|4
5929917|NCT01431534|20512223|P3|Treatment Phase|Adverse Event|1
5929918|NCT01431534|20512224|P2|Treatment Phase|Adverse Event|0
5929919|NCT01431534|20512225|P1|Treatment Phase|Adverse Event|0
5929920|NCT01431521|20512240|P4|Overall Study|Withdrawal by Subject|0
5929921|NCT01431521|20512241|P3|Overall Study|Withdrawal by Subject|1
5929922|NCT01431521|20512242|P2|Overall Study|Withdrawal by Subject|0
5929923|NCT01431521|20512243|P1|Overall Study|Withdrawal by Subject|0
5929924|NCT01431508|20512264|P1|Overall Study|Unable to Follow Protocol Procedures|1
5929925|NCT01431508|20512264|P1|Overall Study|Lack of Efficacy|1
5929926|NCT01431287|20512349|P5|Overall Study|not stated above|1
5929927|NCT01431287|20512350|P4|Overall Study|not stated above|2
5929928|NCT01431287|20512351|P3|Overall Study|not stated above|2
5929929|NCT01431287|20512352|P2|Overall Study|not stated above|2
5929930|NCT01431287|20512353|P1|Overall Study|not stated above|4
5929931|NCT01431287|20512349|P5|Overall Study|Consent withdrawn not due to AE|29
5929932|NCT01431287|20512350|P4|Overall Study|Consent withdrawn not due to AE|19
5929933|NCT01431287|20512351|P3|Overall Study|Consent withdrawn not due to AE|34
5929934|NCT01431287|20512352|P2|Overall Study|Consent withdrawn not due to AE|30
5929935|NCT01431287|20512353|P1|Overall Study|Consent withdrawn not due to AE|29
5929936|NCT01431287|20512349|P5|Overall Study|Lost to Follow-up|1
5929937|NCT01431287|20512350|P4|Overall Study|Lost to Follow-up|3
5929938|NCT01431287|20512351|P3|Overall Study|Lost to Follow-up|2
5929939|NCT01431287|20512352|P2|Overall Study|Lost to Follow-up|3
5929940|NCT01431287|20512353|P1|Overall Study|Lost to Follow-up|0
5929941|NCT01431287|20512349|P5|Overall Study|Non compliant with protocol|5
5929942|NCT01431287|20512350|P4|Overall Study|Non compliant with protocol|6
5929943|NCT01431287|20512351|P3|Overall Study|Non compliant with protocol|5
5929944|NCT01431287|20512352|P2|Overall Study|Non compliant with protocol|6
5929945|NCT01431287|20512353|P1|Overall Study|Non compliant with protocol|6
5929946|NCT01431287|20512349|P5|Overall Study|Adverse Event|41
5929947|NCT01431287|20512350|P4|Overall Study|Adverse Event|33
5929948|NCT01431287|20512351|P3|Overall Study|Adverse Event|53
5929949|NCT01431287|20512352|P2|Overall Study|Adverse Event|57
5929950|NCT01431287|20512353|P1|Overall Study|Adverse Event|59
5929951|NCT01431287|20512349|P5|Overall Study|not treated|0
5929952|NCT01431287|20512350|P4|Overall Study|not treated|0
5929953|NCT01431287|20512351|P3|Overall Study|not treated|1
5929954|NCT01431287|20512352|P2|Overall Study|not treated|0
5929955|NCT01431287|20512353|P1|Overall Study|not treated|0
5929956|NCT01431274|20512515|P5|Overall Study|Other reason not stated above|4
5929957|NCT01431274|20512516|P4|Overall Study|Other reason not stated above|2
5929958|NCT01431274|20512517|P3|Overall Study|Other reason not stated above|7
5929959|NCT01431274|20512518|P2|Overall Study|Other reason not stated above|5
5929960|NCT01431274|20512519|P1|Overall Study|Other reason not stated above|6
5929961|NCT01431274|20512515|P5|Overall Study|Lost to Follow-up|0
5929962|NCT01431274|20512516|P4|Overall Study|Lost to Follow-up|4
5929963|NCT01431274|20512517|P3|Overall Study|Lost to Follow-up|1
5929964|NCT01431274|20512518|P2|Overall Study|Lost to Follow-up|7
5929965|NCT01431274|20512519|P1|Overall Study|Lost to Follow-up|6
5929966|NCT01431274|20512515|P5|Overall Study|Non compliant with protocol|4
5929967|NCT01431274|20512516|P4|Overall Study|Non compliant with protocol|4
5929968|NCT01431274|20512517|P3|Overall Study|Non compliant with protocol|4
5929969|NCT01431274|20512518|P2|Overall Study|Non compliant with protocol|8
5929970|NCT01431274|20512519|P1|Overall Study|Non compliant with protocol|5
5929971|NCT01431274|20512515|P5|Overall Study|Consent withdrawn not due to AE|11
5929972|NCT01431274|20512516|P4|Overall Study|Consent withdrawn not due to AE|20
5929973|NCT01431274|20512517|P3|Overall Study|Consent withdrawn not due to AE|17
5929974|NCT01431274|20512518|P2|Overall Study|Consent withdrawn not due to AE|20
5929975|NCT01431274|20512519|P1|Overall Study|Consent withdrawn not due to AE|29
5929976|NCT01431274|20512515|P5|Overall Study|Adverse Event|37
5929977|NCT01431274|20512516|P4|Overall Study|Adverse Event|30
5929978|NCT01431274|20512517|P3|Overall Study|Adverse Event|43
5929979|NCT01431274|20512518|P2|Overall Study|Adverse Event|37
5929980|NCT01431274|20512519|P1|Overall Study|Adverse Event|51
5929981|NCT01431144|20512697|P2|Overall Study|Implant mobility and removal|0
5929982|NCT01431144|20512698|P1|Overall Study|Implant mobility and removal|2
5929983|NCT01431079|20512721|P2|Overall Study|Lost to Follow-up|39
5929984|NCT01431079|20512722|P1|Overall Study|Lost to Follow-up|35
5929985|NCT01430754|20512801|P2|Run-In Phase|Lost to Follow-up|0
5929986|NCT01430754|20512802|P1|Run-In Phase|Lost to Follow-up|1
5929987|NCT01430754|20512801|P2|Run-In Phase|Withdrawal by Subject|0
5929988|NCT01430754|20512802|P1|Run-In Phase|Withdrawal by Subject|2
5929989|NCT01430754|20512801|P2|Run-In Phase|Other|0
5929990|NCT01430754|20512802|P1|Run-In Phase|Other|2
5929991|NCT01430754|20512801|P2|Run-In Phase|Adverse Event|0
5929992|NCT01430754|20512802|P1|Run-In Phase|Adverse Event|2
5929993|NCT01430754|20512801|P2|Run-In Phase|Protocol Violation|0
5929994|NCT01430754|20512802|P1|Run-In Phase|Protocol Violation|6
5929995|NCT01430754|20512801|P2|Run-In Phase|Circadian Period Ineligible|0
5929996|NCT01430754|20512802|P1|Run-In Phase|Circadian Period Ineligible|24
5929997|NCT01430624|20512860|P3|Overall Study|technical or eligibility|2
5929998|NCT01430624|20512861|P2|Overall Study|technical or eligibility|5
5929999|NCT01430624|20512862|P1|Overall Study|technical or eligibility|5
5930000|NCT01430624|20512860|P3|Overall Study|Lost to Follow-up|27
5930001|NCT01430624|20512861|P2|Overall Study|Lost to Follow-up|29
5930002|NCT01430624|20512862|P1|Overall Study|Lost to Follow-up|23
5930003|NCT01430611|20512893|P2|Overall Study|Withdrawal by Subject|14
5930004|NCT01430611|20512894|P1|Overall Study|Withdrawal by Subject|15
5930005|NCT01430611|20512893|P2|Overall Study|Lost to Follow-up|0
5930006|NCT01430611|20512894|P1|Overall Study|Lost to Follow-up|1
5930007|NCT01430611|20512893|P2|Overall Study|Protocol Violation|0
5930008|NCT01430611|20512894|P1|Overall Study|Protocol Violation|1
5930009|NCT01430611|20512893|P2|Overall Study|Adverse Event|1
5930010|NCT01430611|20512894|P1|Overall Study|Adverse Event|0
5930011|NCT01430585|20512912|P1|Overall Study|Other|7
5930012|NCT01430585|20512912|P1|Overall Study|Study Terminated by Sponsor|3
5930013|NCT01430585|20512912|P1|Overall Study|Objective Progression or Relapse|3
5930014|NCT01430585|20512912|P1|Overall Study|Death|1
5930015|NCT01430559|20512947|P2|Overall Study|Randomized, Not Treated|3
5930016|NCT01430559|20512948|P1|Overall Study|Randomized, Not Treated|3
5930017|NCT01430559|20512947|P2|Overall Study|Other|3
5930018|NCT01430559|20512948|P1|Overall Study|Other|3
5930019|NCT01430559|20512947|P2|Overall Study|Protocol Violation|0
5930020|NCT01430559|20512948|P1|Overall Study|Protocol Violation|1
5930021|NCT01430559|20512947|P2|Overall Study|Withdrawal by Subject|2
5930022|NCT01430559|20512948|P1|Overall Study|Withdrawal by Subject|3
5930023|NCT01430559|20512947|P2|Overall Study|Medication error|0
5930024|NCT01430559|20512948|P1|Overall Study|Medication error|1
5930025|NCT01430559|20512947|P2|Overall Study|Lost to Follow-up|0
5930026|NCT01430559|20512948|P1|Overall Study|Lost to Follow-up|1
5930027|NCT01430559|20512947|P2|Overall Study|Entry criteria not met|1
5930028|NCT01430559|20512948|P1|Overall Study|Entry criteria not met|1
5930029|NCT01430559|20512947|P2|Overall Study|Adverse Event|3
5930030|NCT01430559|20512948|P1|Overall Study|Adverse Event|7
5930031|NCT01430468|20512984|P2|Overall Study|Withdrawal by Subject|5
5930032|NCT01430468|20512985|P1|Overall Study|Withdrawal by Subject|5
5930033|NCT01430468|20512984|P2|Overall Study|Physician Decision|1
5930034|NCT01430468|20512985|P1|Overall Study|Physician Decision|2
5930035|NCT01430455|20512993|P1|Overall Study|Switched to follow-up phase|1
5930036|NCT01430455|20512993|P1|Overall Study|Withdrawal by Subject|1
5930037|NCT01430442|20513005|P8|Overall Study|Patient No Longer Meets Study Criteria|6
5930038|NCT01430442|20513006|P7|Overall Study|Patient No Longer Meets Study Criteria|9
5930039|NCT01430442|20513007|P6|Overall Study|Patient No Longer Meets Study Criteria|5
5930040|NCT01430442|20513008|P5|Overall Study|Patient No Longer Meets Study Criteria|5
5930041|NCT01430442|20513009|P4|Overall Study|Patient No Longer Meets Study Criteria|2
5930042|NCT01430442|20513010|P3|Overall Study|Patient No Longer Meets Study Criteria|3
5930043|NCT01430442|20513011|P2|Overall Study|Patient No Longer Meets Study Criteria|6
5930044|NCT01430442|20513012|P1|Overall Study|Patient No Longer Meets Study Criteria|7
5930045|NCT01430442|20513005|P8|Overall Study|Pregnancy|0
5930046|NCT01430442|20513006|P7|Overall Study|Pregnancy|0
5930047|NCT01430442|20513007|P6|Overall Study|Pregnancy|1
5930048|NCT01430442|20513008|P5|Overall Study|Pregnancy|0
5930049|NCT01430442|20513009|P4|Overall Study|Pregnancy|0
5930050|NCT01430442|20513010|P3|Overall Study|Pregnancy|0
5930051|NCT01430442|20513011|P2|Overall Study|Pregnancy|0
5930052|NCT01430442|20513012|P1|Overall Study|Pregnancy|1
5930053|NCT01430442|20513005|P8|Overall Study|Lost to Follow-up|1
5930054|NCT01430442|20513006|P7|Overall Study|Lost to Follow-up|5
5930055|NCT01430442|20513007|P6|Overall Study|Lost to Follow-up|1
5930056|NCT01430442|20513008|P5|Overall Study|Lost to Follow-up|2
5930057|NCT01430442|20513009|P4|Overall Study|Lost to Follow-up|2
5930058|NCT01430442|20513010|P3|Overall Study|Lost to Follow-up|1
5930059|NCT01430442|20513011|P2|Overall Study|Lost to Follow-up|0
5930060|NCT01430442|20513012|P1|Overall Study|Lost to Follow-up|2
5930061|NCT01430442|20513005|P8|Overall Study|Subject Withdrew Consent|2
5930062|NCT01430442|20513006|P7|Overall Study|Subject Withdrew Consent|5
5930063|NCT01430442|20513007|P6|Overall Study|Subject Withdrew Consent|1
5930064|NCT01430442|20513008|P5|Overall Study|Subject Withdrew Consent|2
5930065|NCT01430442|20513009|P4|Overall Study|Subject Withdrew Consent|0
5930066|NCT01430442|20513010|P3|Overall Study|Subject Withdrew Consent|1
5930067|NCT01430442|20513011|P2|Overall Study|Subject Withdrew Consent|0
5930068|NCT01430442|20513012|P1|Overall Study|Subject Withdrew Consent|3
5930069|NCT01430403|20513065|P3|Overall Study|Withdrawal by Subject|3
5930070|NCT01430403|20513066|P2|Overall Study|Withdrawal by Subject|1
5930071|NCT01430403|20513067|P1|Overall Study|Withdrawal by Subject|9
5930072|NCT01430403|20513065|P3|Overall Study|Protocol Violation|2
5930073|NCT01430403|20513066|P2|Overall Study|Protocol Violation|3
5930074|NCT01430403|20513067|P1|Overall Study|Protocol Violation|2
5930075|NCT01430403|20513065|P3|Overall Study|Physician Decision|0
5930076|NCT01430403|20513066|P2|Overall Study|Physician Decision|0
5930077|NCT01430403|20513067|P1|Overall Study|Physician Decision|1
5930078|NCT01430403|20513065|P3|Overall Study|Lost to Follow-up|3
5930079|NCT01430403|20513066|P2|Overall Study|Lost to Follow-up|5
5930080|NCT01430403|20513067|P1|Overall Study|Lost to Follow-up|5
5930081|NCT01430130|20513174|P1|Overall Study|Infection on Control Side of Incision|1
5930082|NCT01430130|20513174|P1|Overall Study|Lost to Follow-up|1
5930083|NCT01430104|20513180|P1|28-Day Teriparatide Treatment Period|Adverse Event|1
5930084|NCT01429792|20513247|P1|Overall Study|Lost to Follow-up|88
5930085|NCT01429792|20513247|P1|Overall Study|Withdrawal by Subject|70
5930086|NCT01429792|20513247|P1|Overall Study|Positive HCV-RNA at Week 24|50
5930087|NCT01429792|20513247|P1|Overall Study|Decrease of less than 2-log in HCV RNA|32
5930088|NCT01429792|20513247|P1|Overall Study|Negative HCV-RNA at Week 12|4
5930089|NCT01429792|20513247|P1|Overall Study|Negative HCV-RNA at Week 4|1
5930090|NCT01429792|20513247|P1|Overall Study|Unknown Disposition|94
5930091|NCT01429792|20513247|P1|Overall Study|Other Reasons|67
5930092|NCT01429623|20513261|P2|Overall Study|No post baseline data|4
5930093|NCT01429623|20513262|P1|Overall Study|No post baseline data|4
5930094|NCT01429623|20513261|P2|Overall Study|Conversion to Alzheimer's disease|21
5930095|NCT01429623|20513262|P1|Overall Study|Conversion to Alzheimer's disease|14
5930096|NCT01429623|20513261|P2|Overall Study|Assorted|2
5930097|NCT01429623|20513262|P1|Overall Study|Assorted|1
5930098|NCT01429623|20513261|P2|Overall Study|Protocol Violation|2
5930099|NCT01429623|20513262|P1|Overall Study|Protocol Violation|3
5930100|NCT01429623|20513261|P2|Overall Study|Physician Decision|3
5930101|NCT01429623|20513262|P1|Overall Study|Physician Decision|2
5930102|NCT01429623|20513261|P2|Overall Study|Withdrawal by Subject|13
5930103|NCT01429623|20513262|P1|Overall Study|Withdrawal by Subject|19
5930104|NCT01429623|20513261|P2|Overall Study|Adverse Event|14
5930105|NCT01429623|20513262|P1|Overall Study|Adverse Event|7
5930106|NCT01429623|20513261|P2|Overall Study|Death|0
5930107|NCT01429623|20513262|P1|Overall Study|Death|1
5930108|NCT01429584|20513276|P2|Overall Study|Protocol Violation|1
5930109|NCT01429584|20513277|P1|Overall Study|Protocol Violation|0
5930110|NCT01429584|20513276|P2|Overall Study|Withdrawal by Subject|0
5930111|NCT01429584|20513277|P1|Overall Study|Withdrawal by Subject|1
5930112|NCT01429441|20513319|P2|Overall Study|Withdrawal by Subject|18
5930113|NCT01429441|20513320|P1|Overall Study|Withdrawal by Subject|27
5930114|NCT01429441|20513319|P2|Overall Study|Physician Decision|0
5930115|NCT01429441|20513320|P1|Overall Study|Physician Decision|1
5930116|NCT01429441|20513319|P2|Overall Study|Lost to Follow-up|2
5930117|NCT01429441|20513320|P1|Overall Study|Lost to Follow-up|5
5930118|NCT01429441|20513319|P2|Overall Study|Death|2
5930119|NCT01429441|20513320|P1|Overall Study|Death|0
5930120|NCT01429441|20513319|P2|Overall Study|Adverse Event|1
5930121|NCT01429441|20513320|P1|Overall Study|Adverse Event|5
5930122|NCT01429298|20513345|P2|Overall Study|Protocol Violation|6
5930123|NCT01429298|20513346|P1|Overall Study|Protocol Violation|4
5930124|NCT01429285|20513362|P2|Overall Study|Erroneously Enrolled Twice|2
5930125|NCT01429285|20513363|P1|Overall Study|Erroneously Enrolled Twice|8
5930126|NCT01429285|20513362|P2|Overall Study|Missing Data|3
5930127|NCT01429285|20513363|P1|Overall Study|Missing Data|5
5930128|NCT01429285|20513362|P2|Overall Study|Protocol Violation|4
5930129|NCT01429285|20513363|P1|Overall Study|Protocol Violation|9
5930130|NCT01429077|20513409|P2|Overall Study|Lost to Follow-up|3
5930131|NCT01429077|20513410|P1|Overall Study|Lost to Follow-up|0
5930132|NCT01429051|20513433|P1|Tolerability Phase|Other|2
5930133|NCT01429051|20513433|P1|Tolerability Phase|Physician Decision|1
5930134|NCT01429051|20513433|P1|Tolerability Phase|Withdrawal by Subject|5
5930135|NCT01429051|20513433|P1|Tolerability Phase|Adverse Event|2
5930136|NCT01429051|20513433|P1|Tolerability Phase|Death|5
5930137|NCT01429051|20513433|P1|Efficacy Phase|Death|1
5930138|NCT01429051|20513433|P1|Efficacy Phase|Adverse Event|1
5930139|NCT01429051|20513433|P1|Titration Phase|Less than 3 BTP episodes per week|2
5930140|NCT01429051|20513433|P1|Titration Phase|Unsuccessful titration at any dose|1
5930141|NCT01429051|20513433|P1|Titration Phase|Physician Decision|1
5930142|NCT01429051|20513433|P1|Titration Phase|Withdrawal by Subject|7
5930143|NCT01429051|20513433|P1|Titration Phase|Death|1
5930144|NCT01428882|20513456|P2|Overall Study|Protocol Violation|3
5930145|NCT01428882|20513457|P1|Overall Study|Protocol Violation|4
5930146|NCT01428882|20513456|P2|Overall Study|Lack of Efficacy|7
5930147|NCT01428882|20513457|P1|Overall Study|Lack of Efficacy|2
5930148|NCT01428713|20513480|P2|Overall Study|Adverse Event|2
5930149|NCT01428713|20513481|P1|Overall Study|Adverse Event|0
5930150|NCT01428713|20513480|P2|Overall Study|Withdrawal by Subject|1
5930151|NCT01428713|20513481|P1|Overall Study|Withdrawal by Subject|1
5930152|NCT01428713|20513480|P2|Overall Study|Non-compliance|2
5930153|NCT01428713|20513481|P1|Overall Study|Non-compliance|2
5930154|NCT01428661|20513490|P3|Open Label Extension|**Various|185
5930155|NCT01428661|20513491|P2|Open Label Extension|**Various|0
5930156|NCT01428661|20513492|P1|Open Label Extension|**Various|0
5930157|NCT01428661|20513490|P3|Open Label Extension|Lack of Efficacy|24
5930158|NCT01428661|20513491|P2|Open Label Extension|Lack of Efficacy|0
5930159|NCT01428661|20513492|P1|Open Label Extension|Lack of Efficacy|0
5930160|NCT01428661|20513490|P3|Open Label Extension|Withdrawal by Subject|49
5930161|NCT01428661|20513491|P2|Open Label Extension|Withdrawal by Subject|0
5930162|NCT01428661|20513492|P1|Open Label Extension|Withdrawal by Subject|0
5930163|NCT01428661|20513490|P3|Open Label Extension|Lost to Follow-up|38
5930164|NCT01428661|20513491|P2|Open Label Extension|Lost to Follow-up|0
5930165|NCT01428661|20513492|P1|Open Label Extension|Lost to Follow-up|0
5930166|NCT01428661|20513490|P3|Open Label Extension|Adverse Event|15
5930167|NCT01428661|20513491|P2|Open Label Extension|Adverse Event|0
5930168|NCT01428661|20513492|P1|Open Label Extension|Adverse Event|0
5930169|NCT01428661|20513490|P3|Open Label Extension|Protocol Violation|9
5930170|NCT01428661|20513491|P2|Open Label Extension|Protocol Violation|0
5930171|NCT01428661|20513492|P1|Open Label Extension|Protocol Violation|0
5930172|NCT01428661|20513490|P3|Double-Masked Phase|*Various|0
5930173|NCT01428661|20513491|P2|Double-Masked Phase|*Various|6
5930174|NCT01428661|20513492|P1|Double-Masked Phase|*Various|1
5930175|NCT01428661|20513490|P3|Double-Masked Phase|Lack of Efficacy|0
5930176|NCT01428661|20513491|P2|Double-Masked Phase|Lack of Efficacy|1
5930177|NCT01428661|20513492|P1|Double-Masked Phase|Lack of Efficacy|2
5930178|NCT01428661|20513490|P3|Double-Masked Phase|Withdrawal by Subject|0
5930179|NCT01428661|20513491|P2|Double-Masked Phase|Withdrawal by Subject|20
5930180|NCT01428661|20513492|P1|Double-Masked Phase|Withdrawal by Subject|18
5930181|NCT01428661|20513490|P3|Double-Masked Phase|Lost to Follow-up|0
5930182|NCT01428661|20513491|P2|Double-Masked Phase|Lost to Follow-up|14
5930183|NCT01428661|20513492|P1|Double-Masked Phase|Lost to Follow-up|14
5930184|NCT01428661|20513490|P3|Double-Masked Phase|Adverse Event|0
5930185|NCT01428661|20513491|P2|Double-Masked Phase|Adverse Event|4
5930186|NCT01428661|20513492|P1|Double-Masked Phase|Adverse Event|13
5930187|NCT01428661|20513490|P3|Double-Masked Phase|Protocol Violation|0
5930188|NCT01428661|20513491|P2|Double-Masked Phase|Protocol Violation|4
5930189|NCT01428661|20513492|P1|Double-Masked Phase|Protocol Violation|9
5930190|NCT01428583|20513500|P1|Overall Study|Other|6
5930191|NCT01428583|20513500|P1|Overall Study|Sponsor's request|3
5930192|NCT01428583|20513500|P1|Overall Study|Confirmed positive urine drug test|8
5930193|NCT01428583|20513500|P1|Overall Study|Non-compliant|25
5930194|NCT01428583|20513500|P1|Overall Study|Physician Decision|12
5930195|NCT01428583|20513500|P1|Overall Study|Protocol Violation|1
5930196|NCT01428583|20513500|P1|Overall Study|Pregnancy|1
5930197|NCT01428583|20513500|P1|Overall Study|Death|1
5930198|NCT01428583|20513500|P1|Overall Study|Lost to Follow-up|17
5930199|NCT01428583|20513500|P1|Overall Study|Lack of Efficacy|37
5930200|NCT01428583|20513500|P1|Overall Study|Withdrawal by Subject|51
5930201|NCT01428583|20513500|P1|Overall Study|Adverse Event|75
5930202|NCT01428453|20513524|P2|Overall Study|Withdrawal by Subject|1
5930203|NCT01428453|20513525|P1|Overall Study|Withdrawal by Subject|3
5930204|NCT01428453|20513524|P2|Overall Study|Lost to Follow-up|1
5930205|NCT01428453|20513525|P1|Overall Study|Lost to Follow-up|0
5930206|NCT01428453|20513524|P2|Overall Study|Protocol Violation|0
5930207|NCT01428453|20513525|P1|Overall Study|Protocol Violation|1
5930208|NCT01428453|20513524|P2|Overall Study|Adverse Event|7
5930209|NCT01428453|20513525|P1|Overall Study|Adverse Event|2
5930210|NCT01428258|20513564|P2|Intervention 1|Withdrawal by Subject|0
5930211|NCT01428258|20513565|P1|Intervention 1|Withdrawal by Subject|2
5930212|NCT01428219|20513587|P1|Overall Study|25 patients enrolled, 3 were not treated|3
5930213|NCT01428193|20513598|P1|Overall Study|Elevated screening liver enzymes|1
5930214|NCT01428193|20513598|P1|Overall Study|Physician Decision|1
5930215|NCT01428128|20513602|P1|Overall Study|Adverse Event|1
5930216|NCT01428128|20513602|P1|Overall Study|Received Neulasta in one cycle|2
5930217|NCT01428128|20513602|P1|Overall Study|Screen failure by p53|10
5930218|NCT01428128|20513602|P1|Overall Study|Withdrawal by Subject|4
5930219|NCT01428115|20513607|P1|Overall Study|Withdrawal by Subject|4
5930220|NCT01428115|20513607|P1|Overall Study|Protocol Violation|3
5930221|NCT01428115|20513607|P1|Overall Study|Pregnancy|1
5930222|NCT01428115|20513607|P1|Overall Study|Lost to Follow-up|10
5930223|NCT01428115|20513607|P1|Overall Study|Lack of Efficacy|3
5930224|NCT01428076|20513622|P2|Overall Study|Adverse Event|1
5930225|NCT01428076|20513623|P1|Overall Study|Adverse Event|0
5930226|NCT01428063|20513634|P3|Overall Study|No longer meets study criteria|0
5930227|NCT01428063|20513635|P2|Overall Study|No longer meets study criteria|1
5930228|NCT01428063|20513636|P1|Overall Study|No longer meets study criteria|0
5930229|NCT01428063|20513634|P3|Overall Study|Lost to Follow-up|0
5930230|NCT01428063|20513635|P2|Overall Study|Lost to Follow-up|2
5930231|NCT01428063|20513636|P1|Overall Study|Lost to Follow-up|0
5930232|NCT01428063|20513634|P3|Overall Study|Adverse Event|0
5930233|NCT01428063|20513635|P2|Overall Study|Adverse Event|3
5930234|NCT01428063|20513636|P1|Overall Study|Adverse Event|2
5930235|NCT01428063|20513634|P3|Overall Study|Lack of Efficacy|1
5930236|NCT01428063|20513635|P2|Overall Study|Lack of Efficacy|4
5930237|NCT01428063|20513636|P1|Overall Study|Lack of Efficacy|8
5930238|NCT01427972|20513737|P12|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
5930239|NCT01427972|20513738|P11|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
5930240|NCT01427972|20513739|P10|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
5930241|NCT01427972|20513740|P9|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
5930242|NCT01427972|20513741|P8|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
5930243|NCT01427972|20513742|P7|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
5930244|NCT01427972|20513743|P6|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
5930245|NCT01427972|20513744|P5|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
5930246|NCT01427972|20513745|P4|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
5930247|NCT01427972|20513746|P3|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
5930248|NCT01427972|20513747|P2|Treatment Period 2 (21 Days)|Withdrawal by Subject|1
5930249|NCT01427972|20513748|P1|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
5930250|NCT01427972|20513737|P12|Washout (at Least 28 Days)|Withdrawal by Subject|0
5930251|NCT01427972|20513738|P11|Washout (at Least 28 Days)|Withdrawal by Subject|0
5930252|NCT01427972|20513739|P10|Washout (at Least 28 Days)|Withdrawal by Subject|0
5930253|NCT01427972|20513740|P9|Washout (at Least 28 Days)|Withdrawal by Subject|0
5930254|NCT01427972|20513741|P8|Washout (at Least 28 Days)|Withdrawal by Subject|0
5930255|NCT01427972|20513742|P7|Washout (at Least 28 Days)|Withdrawal by Subject|0
5930256|NCT01427972|20513743|P6|Washout (at Least 28 Days)|Withdrawal by Subject|2
5930257|NCT01427972|20513744|P5|Washout (at Least 28 Days)|Withdrawal by Subject|0
5930258|NCT01427972|20513745|P4|Washout (at Least 28 Days)|Withdrawal by Subject|0
5930259|NCT01427972|20513746|P3|Washout (at Least 28 Days)|Withdrawal by Subject|0
5930260|NCT01427972|20513747|P2|Washout (at Least 28 Days)|Withdrawal by Subject|0
5930261|NCT01427972|20513748|P1|Washout (at Least 28 Days)|Withdrawal by Subject|0
5930262|NCT01427972|20513737|P12|Treatment Period 1 (21 Days)|Protocol Violation|0
5930263|NCT01427972|20513738|P11|Treatment Period 1 (21 Days)|Protocol Violation|0
5930264|NCT01427972|20513739|P10|Treatment Period 1 (21 Days)|Protocol Violation|0
5930265|NCT01427972|20513740|P9|Treatment Period 1 (21 Days)|Protocol Violation|0
5930266|NCT01427972|20513741|P8|Treatment Period 1 (21 Days)|Protocol Violation|1
5930267|NCT01427972|20513742|P7|Treatment Period 1 (21 Days)|Protocol Violation|0
5930268|NCT01427972|20513743|P6|Treatment Period 1 (21 Days)|Protocol Violation|0
5930269|NCT01427972|20513744|P5|Treatment Period 1 (21 Days)|Protocol Violation|0
5930270|NCT01427972|20513745|P4|Treatment Period 1 (21 Days)|Protocol Violation|0
5930271|NCT01427972|20513746|P3|Treatment Period 1 (21 Days)|Protocol Violation|0
5930272|NCT01427972|20513747|P2|Treatment Period 1 (21 Days)|Protocol Violation|0
5930273|NCT01427972|20513748|P1|Treatment Period 1 (21 Days)|Protocol Violation|0
5930274|NCT01427933|20513774|P2|Overall Study|Investigator's Decision|0
5930275|NCT01427933|20513775|P1|Overall Study|Investigator's Decision|1
5930276|NCT01427933|20513774|P2|Overall Study|Other|0
5930277|NCT01427933|20513775|P1|Overall Study|Other|1
5930278|NCT01427933|20513774|P2|Overall Study|Lost to Follow-up|5
5930279|NCT01427933|20513775|P1|Overall Study|Lost to Follow-up|1
5930280|NCT01427933|20513774|P2|Overall Study|Withdrawal by Subject|8
5930281|NCT01427933|20513775|P1|Overall Study|Withdrawal by Subject|5
5930282|NCT01427920|20513795|P2|Overall Study|Unclassified|8
5930283|NCT01427920|20513796|P1|Overall Study|Unclassified|2
5930284|NCT01427920|20513795|P2|Overall Study|Withdrawal Criteria|4
5930285|NCT01427920|20513796|P1|Overall Study|Withdrawal Criteria|4
5930286|NCT01427920|20513795|P2|Overall Study|Protocol Violation|3
5930287|NCT01427920|20513796|P1|Overall Study|Protocol Violation|1
5930288|NCT01427920|20513795|P2|Overall Study|Lack of Efficacy|0
5930289|NCT01427920|20513796|P1|Overall Study|Lack of Efficacy|1
5930290|NCT01427920|20513795|P2|Overall Study|Adverse Event|2
5930291|NCT01427920|20513796|P1|Overall Study|Adverse Event|1
5930292|NCT01427907|20513816|P2|Overall Study|Withdrawal by Subject|4
5930293|NCT01427907|20513817|P1|Overall Study|Withdrawal by Subject|3
5930294|NCT01427803|20513838|P2|Overall Study|did not take product|0
5930295|NCT01427803|20513839|P1|Overall Study|did not take product|1
5930296|NCT01427803|20513838|P2|Overall Study|Physician Decision|0
5930297|NCT01427803|20513839|P1|Overall Study|Physician Decision|3
5930298|NCT01427803|20513838|P2|Overall Study|Protocol Violation|0
5930299|NCT01427803|20513839|P1|Overall Study|Protocol Violation|1
5930300|NCT01427803|20513838|P2|Overall Study|Unable to complete full treatment period|0
5930301|NCT01427803|20513839|P1|Overall Study|Unable to complete full treatment period|6
5930302|NCT01427803|20513838|P2|Overall Study|Withdrawal by Subject|0
5930303|NCT01427803|20513839|P1|Overall Study|Withdrawal by Subject|20
5930304|NCT01427803|20513838|P2|Overall Study|Lost to Follow-up|26
5930305|NCT01427803|20513839|P1|Overall Study|Lost to Follow-up|32
5930306|NCT01427751|20513853|P2|Overall Study|Other miscellaneous reasons|4
5930307|NCT01427751|20513854|P1|Overall Study|Other miscellaneous reasons|6
5930308|NCT01427751|20513853|P2|Overall Study|Death|0
5930309|NCT01427751|20513854|P1|Overall Study|Death|2
5930310|NCT01427751|20513853|P2|Overall Study|Protocol Violation|4
5930311|NCT01427751|20513854|P1|Overall Study|Protocol Violation|6
5930312|NCT01427751|20513853|P2|Overall Study|Withdrawal of consent|2
5930313|NCT01427751|20513854|P1|Overall Study|Withdrawal of consent|2
5930314|NCT01427751|20513853|P2|Overall Study|Lost to Follow-up|1
5930315|NCT01427751|20513854|P1|Overall Study|Lost to Follow-up|3
5930316|NCT01427751|20513853|P2|Overall Study|No further treatment benefit expected|1
5930317|NCT01427751|20513854|P1|Overall Study|No further treatment benefit expected|5
5930318|NCT01427751|20513853|P2|Overall Study|Adverse Event|2
5930319|NCT01427751|20513854|P1|Overall Study|Adverse Event|18
5930320|NCT01427738|20513874|P2|Overall Study|Lost to Follow-up|5
5930321|NCT01427738|20513875|P1|Overall Study|Lost to Follow-up|1
5930322|NCT01427738|20513874|P2|Overall Study|Subject not willing to adhere to reqs|2
5930323|NCT01427738|20513875|P1|Overall Study|Subject not willing to adhere to reqs|1
5930324|NCT01427738|20513874|P2|Overall Study|Withdrawal by Subject|2
5930325|NCT01427738|20513875|P1|Overall Study|Withdrawal by Subject|0
5930326|NCT01427738|20513874|P2|Overall Study|Subject unable to get to clinic|2
5930327|NCT01427738|20513875|P1|Overall Study|Subject unable to get to clinic|5
5930328|NCT01427738|20513874|P2|Overall Study|Severe debilitation, unable to continue|1
5930329|NCT01427738|20513875|P1|Overall Study|Severe debilitation, unable to continue|0
5930330|NCT01427738|20513874|P2|Overall Study|Death|9
5930331|NCT01427738|20513875|P1|Overall Study|Death|12
5930332|NCT01427608|20513895|P2|Overall Study|Events not attributed to study meds|1
5930333|NCT01427608|20513896|P1|Overall Study|Events not attributed to study meds|0
5930334|NCT01427608|20513895|P2|Overall Study|Relapsed-all cause|34
5930335|NCT01427608|20513896|P1|Overall Study|Relapsed-all cause|13
5930336|NCT01427608|20513895|P2|Overall Study|Withdrawal by Subject|3
5930337|NCT01427608|20513896|P1|Overall Study|Withdrawal by Subject|7
5930338|NCT01427608|20513895|P2|Overall Study|Death|0
5930339|NCT01427608|20513896|P1|Overall Study|Death|1
5930340|NCT01427309|20513957|P4|Overall Study|Withdrawal by Subject|55
5930341|NCT01427309|20513958|P3|Overall Study|Withdrawal by Subject|61
5930342|NCT01427309|20513959|P2|Overall Study|Withdrawal by Subject|148
5930343|NCT01427309|20513960|P1|Overall Study|Withdrawal by Subject|148
5930344|NCT01427309|20513957|P4|Overall Study|Serious adverse event|61
5930345|NCT01427309|20513958|P3|Overall Study|Serious adverse event|50
5930346|NCT01427309|20513959|P2|Overall Study|Serious adverse event|45
5930347|NCT01427309|20513960|P1|Overall Study|Serious adverse event|52
5930348|NCT01427309|20513957|P4|Overall Study|Adverse Event|1
5930349|NCT01427309|20513958|P3|Overall Study|Adverse Event|3
5930350|NCT01427309|20513959|P2|Overall Study|Adverse Event|0
5930351|NCT01427309|20513960|P1|Overall Study|Adverse Event|0
5930352|NCT01427309|20513957|P4|Overall Study|Protocol Violation|124
5930353|NCT01427309|20513958|P3|Overall Study|Protocol Violation|125
5930354|NCT01427309|20513959|P2|Overall Study|Protocol Violation|69
5930355|NCT01427309|20513960|P1|Overall Study|Protocol Violation|42
5930356|NCT01427309|20513957|P4|Overall Study|Lost to Follow-up|135
5930357|NCT01427309|20513958|P3|Overall Study|Lost to Follow-up|122
5930358|NCT01427309|20513959|P2|Overall Study|Lost to Follow-up|145
5930359|NCT01427309|20513960|P1|Overall Study|Lost to Follow-up|130
5930360|NCT01426958|20514007|P1|Overall Study|Adverse Event|2
5930361|NCT01426854|20514036|P2|Overall Study|Other|2
5930362|NCT01426854|20514037|P1|Overall Study|Other|3
5930363|NCT01426854|20514036|P2|Overall Study|Protocol Deviation|1
5930364|NCT01426854|20514037|P1|Overall Study|Protocol Deviation|0
5930365|NCT01426854|20514036|P2|Overall Study|Treatment Failure|16
5930366|NCT01426854|20514037|P1|Overall Study|Treatment Failure|0
5930367|NCT01426854|20514036|P2|Overall Study|Noncompliance|1
5930368|NCT01426854|20514037|P1|Overall Study|Noncompliance|0
5930369|NCT01426854|20514036|P2|Overall Study|Lost to Follow-up|0
5930370|NCT01426854|20514037|P1|Overall Study|Lost to Follow-up|3
5930371|NCT01426854|20514036|P2|Overall Study|Subject Decision Unrelated to AE|6
5930372|NCT01426854|20514037|P1|Overall Study|Subject Decision Unrelated to AE|5
5930373|NCT01426854|20514036|P2|Overall Study|Adverse Event|5
5930374|NCT01426854|20514037|P1|Overall Study|Adverse Event|1
5930375|NCT01426789|20514056|P6|Part 2|Adverse Event|0
5930376|NCT01426789|20514057|P5|Part 2|Adverse Event|1
5930377|NCT01426789|20514058|P4|Part 2|Adverse Event|0
5930378|NCT01426789|20514059|P3|Part 2|Adverse Event|2
5930379|NCT01426789|20514060|P2|Part 2|Adverse Event|0
5930380|NCT01426789|20514061|P1|Part 2|Adverse Event|0
5930381|NCT01426789|20514056|P6|Part 2|Lack of Efficacy|0
5930382|NCT01426789|20514057|P5|Part 2|Lack of Efficacy|2
5930383|NCT01426789|20514058|P4|Part 2|Lack of Efficacy|0
5930384|NCT01426789|20514059|P3|Part 2|Lack of Efficacy|5
5930385|NCT01426789|20514060|P2|Part 2|Lack of Efficacy|0
5930386|NCT01426789|20514061|P1|Part 2|Lack of Efficacy|0
5930387|NCT01426789|20514056|P6|Part 2|Withdrawal by Subject|0
5930388|NCT01426789|20514057|P5|Part 2|Withdrawal by Subject|2
5930389|NCT01426789|20514058|P4|Part 2|Withdrawal by Subject|1
5930390|NCT01426789|20514059|P3|Part 2|Withdrawal by Subject|0
5930391|NCT01426789|20514060|P2|Part 2|Withdrawal by Subject|0
5930392|NCT01426789|20514061|P1|Part 2|Withdrawal by Subject|0
5930393|NCT01426789|20514056|P6|Part 2|Lost to Follow-up|0
5930394|NCT01426789|20514057|P5|Part 2|Lost to Follow-up|1
5930395|NCT01426789|20514058|P4|Part 2|Lost to Follow-up|0
5930396|NCT01426789|20514059|P3|Part 2|Lost to Follow-up|4
5930397|NCT01426789|20514060|P2|Part 2|Lost to Follow-up|0
5930398|NCT01426789|20514061|P1|Part 2|Lost to Follow-up|0
5930399|NCT01426789|20514056|P6|Part 2|Administrative problems|0
5930400|NCT01426789|20514057|P5|Part 2|Administrative problems|1
5930401|NCT01426789|20514058|P4|Part 2|Administrative problems|0
5930402|NCT01426789|20514059|P3|Part 2|Administrative problems|2
5930403|NCT01426789|20514060|P2|Part 2|Administrative problems|0
5930404|NCT01426789|20514061|P1|Part 2|Administrative problems|0
5930405|NCT01426789|20514056|P6|Part 2|Death|0
5930406|NCT01426789|20514057|P5|Part 2|Death|1
5930407|NCT01426789|20514058|P4|Part 2|Death|0
5930408|NCT01426789|20514059|P3|Part 2|Death|1
5930409|NCT01426789|20514060|P2|Part 2|Death|0
5930410|NCT01426789|20514061|P1|Part 2|Death|0
5930411|NCT01426789|20514056|P6|Part 2|Protocol deviation|0
5930412|NCT01426789|20514057|P5|Part 2|Protocol deviation|0
5930413|NCT01426789|20514058|P4|Part 2|Protocol deviation|0
5930414|NCT01426789|20514059|P3|Part 2|Protocol deviation|1
5930415|NCT01426789|20514060|P2|Part 2|Protocol deviation|0
5930416|NCT01426789|20514061|P1|Part 2|Protocol deviation|0
5930417|NCT01426789|20514056|P6|Part 1|Adverse Event|0
5930418|NCT01426789|20514057|P5|Part 1|Adverse Event|0
5930419|NCT01426789|20514058|P4|Part 1|Adverse Event|0
5930420|NCT01426789|20514059|P3|Part 1|Adverse Event|0
5930421|NCT01426789|20514060|P2|Part 1|Adverse Event|0
5930422|NCT01426789|20514061|P1|Part 1|Adverse Event|3
5930423|NCT01426789|20514056|P6|Part 1|Lack of Efficacy|0
5930424|NCT01426789|20514057|P5|Part 1|Lack of Efficacy|0
5930425|NCT01426789|20514058|P4|Part 1|Lack of Efficacy|0
5930426|NCT01426789|20514059|P3|Part 1|Lack of Efficacy|0
5930427|NCT01426789|20514060|P2|Part 1|Lack of Efficacy|1
5930428|NCT01426789|20514061|P1|Part 1|Lack of Efficacy|2
5930429|NCT01426789|20514056|P6|Part 1|Lost to Follow-up|0
5930430|NCT01426789|20514057|P5|Part 1|Lost to Follow-up|0
5930431|NCT01426789|20514058|P4|Part 1|Lost to Follow-up|0
5930432|NCT01426789|20514059|P3|Part 1|Lost to Follow-up|0
5930433|NCT01426789|20514060|P2|Part 1|Lost to Follow-up|2
5930434|NCT01426789|20514061|P1|Part 1|Lost to Follow-up|1
5930435|NCT01426789|20514056|P6|Part 1|Protocol deviation|0
5930436|NCT01426789|20514057|P5|Part 1|Protocol deviation|0
5930437|NCT01426789|20514058|P4|Part 1|Protocol deviation|0
5930438|NCT01426789|20514059|P3|Part 1|Protocol deviation|0
5930439|NCT01426789|20514060|P2|Part 1|Protocol deviation|1
5930440|NCT01426789|20514061|P1|Part 1|Protocol deviation|0
5930441|NCT01426438|20514123|P2|Overall Study|Missed Scan|2
5930442|NCT01426438|20514124|P1|Overall Study|Missed Scan|2
5930443|NCT01426438|20514123|P2|Overall Study|Poor scan quality|2
5930444|NCT01426438|20514124|P1|Overall Study|Poor scan quality|3
5930445|NCT01426438|20514123|P2|Overall Study|Off study Treatment|3
5930446|NCT01426438|20514124|P1|Overall Study|Off study Treatment|9
5930447|NCT01426438|20514123|P2|Overall Study|Lost to Follow-up|3
5930448|NCT01426438|20514124|P1|Overall Study|Lost to Follow-up|1
5930449|NCT01426425|20514156|P1|Overall Study|Met inclusion/exclusion, not treated|2
5930450|NCT01426425|20514156|P1|Overall Study|Inclusion/exclusion criteria not met|151
5930451|NCT01426425|20514156|P1|Overall Study|Exited prior to EP study|22
5930452|NCT01426412|20514171|P9|Overall Study|Withdrawal by Subject|1
5930453|NCT01426412|20514172|P8|Overall Study|Withdrawal by Subject|3
5930454|NCT01426412|20514173|P7|Overall Study|Withdrawal by Subject|0
5930455|NCT01426412|20514174|P6|Overall Study|Withdrawal by Subject|0
5930456|NCT01426412|20514175|P5|Overall Study|Withdrawal by Subject|1
5930457|NCT01426412|20514176|P4|Overall Study|Withdrawal by Subject|0
5930458|NCT01426412|20514177|P3|Overall Study|Withdrawal by Subject|0
5930459|NCT01426412|20514178|P2|Overall Study|Withdrawal by Subject|0
5930460|NCT01426412|20514179|P1|Overall Study|Withdrawal by Subject|1
5930461|NCT01426386|20514242|P6|Overall Study|Personal reasons|0
5930462|NCT01426386|20514243|P5|Overall Study|Personal reasons|1
5930463|NCT01426386|20514244|P4|Overall Study|Personal reasons|0
5930464|NCT01426386|20514245|P3|Overall Study|Personal reasons|0
5930465|NCT01426386|20514246|P2|Overall Study|Personal reasons|0
5930466|NCT01426386|20514247|P1|Overall Study|Personal reasons|0
5930467|NCT01426386|20514242|P6|Overall Study|Poor response|0
5930468|NCT01426386|20514243|P5|Overall Study|Poor response|1
5930469|NCT01426386|20514244|P4|Overall Study|Poor response|0
5930470|NCT01426386|20514245|P3|Overall Study|Poor response|2
5930471|NCT01426386|20514246|P2|Overall Study|Poor response|1
5930472|NCT01426386|20514247|P1|Overall Study|Poor response|2
5930473|NCT01426386|20514242|P6|Overall Study|Did not attend scheduled visit|1
5930474|NCT01426386|20514243|P5|Overall Study|Did not attend scheduled visit|2
5930475|NCT01426386|20514244|P4|Overall Study|Did not attend scheduled visit|0
5930476|NCT01426386|20514245|P3|Overall Study|Did not attend scheduled visit|0
5930477|NCT01426386|20514246|P2|Overall Study|Did not attend scheduled visit|4
5930478|NCT01426386|20514247|P1|Overall Study|Did not attend scheduled visit|1
5930479|NCT01426386|20514242|P6|Overall Study|Adverse Event|0
5930480|NCT01426386|20514243|P5|Overall Study|Adverse Event|0
5930481|NCT01426386|20514244|P4|Overall Study|Adverse Event|0
5930482|NCT01426386|20514245|P3|Overall Study|Adverse Event|0
5930483|NCT01426386|20514246|P2|Overall Study|Adverse Event|1
5930484|NCT01426386|20514247|P1|Overall Study|Adverse Event|0
5930485|NCT01426373|20514303|P1|Overall Study|Miscellaneous Reasons|4
5930486|NCT01426373|20514303|P1|Overall Study|Participant Convenience|10
5930487|NCT01426373|20514303|P1|Overall Study|Lost to Follow-up|14
5930488|NCT01426373|20514303|P1|Overall Study|Adverse Event|6
5930489|NCT01426347|20514336|P2|Overall Study|Withdrawal by Subject|0
5930490|NCT01426347|20514337|P1|Overall Study|Withdrawal by Subject|5
5930491|NCT01426347|20514336|P2|Overall Study|Protocol Violation|0
5930492|NCT01426347|20514337|P1|Overall Study|Protocol Violation|2
5930493|NCT01426347|20514336|P2|Overall Study|Lost to Follow-up|3
5930494|NCT01426347|20514337|P1|Overall Study|Lost to Follow-up|0
5930495|NCT01426269|20514345|P3|Period 2: 40 Weeks|Relapsed|18
5930496|NCT01426269|20514346|P2|Period 2: 40 Weeks|Relapsed|9
5930497|NCT01426269|20514347|P1|Period 2: 40 Weeks|Relapsed|0
5930498|NCT01426269|20514345|P3|Period 2: 40 Weeks|Site closed|5
5930499|NCT01426269|20514346|P2|Period 2: 40 Weeks|Site closed|6
5930500|NCT01426269|20514347|P1|Period 2: 40 Weeks|Site closed|0
5930501|NCT01426269|20514345|P3|Period 2: 40 Weeks|Lost to Follow-up|6
5930502|NCT01426269|20514346|P2|Period 2: 40 Weeks|Lost to Follow-up|8
5930503|NCT01426269|20514347|P1|Period 2: 40 Weeks|Lost to Follow-up|0
5930504|NCT01426269|20514345|P3|Period 2: 40 Weeks|Protocol Violation|5
5930505|NCT01426269|20514346|P2|Period 2: 40 Weeks|Protocol Violation|5
5930506|NCT01426269|20514347|P1|Period 2: 40 Weeks|Protocol Violation|0
5930507|NCT01426269|20514345|P3|Period 2: 40 Weeks|Withdrawal by Subject|11
5930508|NCT01426269|20514346|P2|Period 2: 40 Weeks|Withdrawal by Subject|9
5930509|NCT01426269|20514347|P1|Period 2: 40 Weeks|Withdrawal by Subject|0
5930510|NCT01426269|20514345|P3|Period 2: 40 Weeks|Adverse Event|2
5930511|NCT01426269|20514346|P2|Period 2: 40 Weeks|Adverse Event|1
5930512|NCT01426269|20514347|P1|Period 2: 40 Weeks|Adverse Event|0
5930513|NCT01426269|20514345|P3|Eligibility for Period 2, Randomization|Qualified, opted out|0
5930514|NCT01426269|20514346|P2|Eligibility for Period 2, Randomization|Qualified, opted out|0
5930515|NCT01426269|20514347|P1|Eligibility for Period 2, Randomization|Qualified, opted out|8
5930516|NCT01426269|20514345|P3|Eligibility for Period 2, Randomization|Did not qualify|0
5930517|NCT01426269|20514346|P2|Eligibility for Period 2, Randomization|Did not qualify|0
5930518|NCT01426269|20514347|P1|Eligibility for Period 2, Randomization|Did not qualify|42
5930519|NCT01426269|20514345|P3|Period 1: 12 Weeks|Pregnancy|0
5930520|NCT01426269|20514346|P2|Period 1: 12 Weeks|Pregnancy|0
5930521|NCT01426269|20514347|P1|Period 1: 12 Weeks|Pregnancy|1
5930522|NCT01426269|20514345|P3|Period 1: 12 Weeks|Lost to Follow-up|0
5930523|NCT01426269|20514346|P2|Period 1: 12 Weeks|Lost to Follow-up|0
5930524|NCT01426269|20514347|P1|Period 1: 12 Weeks|Lost to Follow-up|22
5930525|NCT01426269|20514345|P3|Period 1: 12 Weeks|Protocol Violation|0
5930526|NCT01426269|20514346|P2|Period 1: 12 Weeks|Protocol Violation|0
5930527|NCT01426269|20514347|P1|Period 1: 12 Weeks|Protocol Violation|5
5930528|NCT01426269|20514345|P3|Period 1: 12 Weeks|Withdrawal by Subject|0
5930529|NCT01426269|20514346|P2|Period 1: 12 Weeks|Withdrawal by Subject|0
5930530|NCT01426269|20514347|P1|Period 1: 12 Weeks|Withdrawal by Subject|22
5930531|NCT01426269|20514345|P3|Period 1: 12 Weeks|Adverse Event|0
5930532|NCT01426269|20514346|P2|Period 1: 12 Weeks|Adverse Event|0
5930533|NCT01426269|20514347|P1|Period 1: 12 Weeks|Adverse Event|5
5930534|NCT01426217|20514382|P2|Overall Study|lost sample|14
5930535|NCT01426217|20514383|P1|Overall Study|lost sample|8
5930536|NCT01426113|20514396|P2|Overall Study|Adverse Event|1
5930537|NCT01426113|20514397|P1|Overall Study|Adverse Event|0
5930538|NCT01426113|20514396|P2|Overall Study|Study Discontinued|1
5930539|NCT01426113|20514397|P1|Overall Study|Study Discontinued|1
5930540|NCT01426009|20514403|P1|Washout 4|Lost to Follow-up|1
5930541|NCT01426009|20514403|P1|Period 4-Fourth Intervention (7 Days)|personal reasons|1
5930542|NCT01426009|20514403|P1|Washout 3|personal reasons|1
5930543|NCT01426009|20514403|P1|Washout 2|electrive surgery|1
5930544|NCT01426009|20514403|P1|Period 2-Second Intervention (7 Days)|personal reasons|1
5930545|NCT01426009|20514403|P1|Period 2-Second Intervention (7 Days)|Adverse Event|4
5930546|NCT01426009|20514403|P1|Washout 1|Personal Reasons|1
5930547|NCT01426009|20514403|P1|Washout 1|Withdrawal by Subject|1
5930548|NCT01426009|20514403|P1|Period 1-First Intervention (7 Days)|Personal Reasons|1
5930549|NCT01426009|20514403|P1|Period 1-First Intervention (7 Days)|Adverse Event|1
5930550|NCT01425814|20514499|P6|Period 5|Stability criteria not fulfilled|1
5930551|NCT01425814|20514500|P5|Period 5|Stability criteria not fulfilled|0
5930552|NCT01425814|20514501|P4|Period 5|Stability criteria not fulfilled|0
5930553|NCT01425814|20514502|P3|Period 5|Stability criteria not fulfilled|1
5930554|NCT01425814|20514503|P2|Period 5|Stability criteria not fulfilled|0
5930555|NCT01425814|20514504|P1|Period 5|Stability criteria not fulfilled|0
5930556|NCT01425814|20514499|P6|Period 4|Adverse Event|0
5930557|NCT01425814|20514500|P5|Period 4|Adverse Event|0
5930558|NCT01425814|20514501|P4|Period 4|Adverse Event|0
5930559|NCT01425814|20514502|P3|Period 4|Adverse Event|1
5930560|NCT01425814|20514503|P2|Period 4|Adverse Event|0
5930561|NCT01425814|20514504|P1|Period 4|Adverse Event|1
5930562|NCT01425814|20514499|P6|Period 3|Adverse Event|1
5930563|NCT01425814|20514500|P5|Period 3|Adverse Event|0
5930564|NCT01425814|20514501|P4|Period 3|Adverse Event|0
5930565|NCT01425814|20514502|P3|Period 3|Adverse Event|0
5930566|NCT01425814|20514503|P2|Period 3|Adverse Event|0
5930567|NCT01425814|20514504|P1|Period 3|Adverse Event|0
5930568|NCT01425814|20514499|P6|Period 2|Stability criteria not fulfilled|0
5930569|NCT01425814|20514500|P5|Period 2|Stability criteria not fulfilled|0
5930570|NCT01425814|20514501|P4|Period 2|Stability criteria not fulfilled|0
5930571|NCT01425814|20514502|P3|Period 2|Stability criteria not fulfilled|0
5930572|NCT01425814|20514503|P2|Period 2|Stability criteria not fulfilled|1
5930573|NCT01425814|20514504|P1|Period 2|Stability criteria not fulfilled|0
5930574|NCT01425814|20514499|P6|Period 1|Stability criteria not fulfilled|0
5930575|NCT01425814|20514500|P5|Period 1|Stability criteria not fulfilled|0
5930576|NCT01425814|20514501|P4|Period 1|Stability criteria not fulfilled|0
5930577|NCT01425814|20514502|P3|Period 1|Stability criteria not fulfilled|0
5930578|NCT01425814|20514503|P2|Period 1|Stability criteria not fulfilled|1
5930579|NCT01425814|20514504|P1|Period 1|Stability criteria not fulfilled|0
5930580|NCT01425801|20514596|P6|Period 4|Not able to maintain visit schedule|0
5930581|NCT01425801|20514597|P5|Period 4|Not able to maintain visit schedule|0
5930582|NCT01425801|20514598|P4|Period 4|Not able to maintain visit schedule|0
5930583|NCT01425801|20514599|P3|Period 4|Not able to maintain visit schedule|1
5930584|NCT01425801|20514600|P2|Period 4|Not able to maintain visit schedule|0
5930585|NCT01425801|20514601|P1|Period 4|Not able to maintain visit schedule|0
5930586|NCT01425801|20514596|P6|Period 3|Stability criteria not fullfilled|0
5930587|NCT01425801|20514597|P5|Period 3|Stability criteria not fullfilled|0
5930588|NCT01425801|20514598|P4|Period 3|Stability criteria not fullfilled|0
5930589|NCT01425801|20514599|P3|Period 3|Stability criteria not fullfilled|1
5930590|NCT01425801|20514600|P2|Period 3|Stability criteria not fullfilled|0
5930591|NCT01425801|20514601|P1|Period 3|Stability criteria not fullfilled|0
5930592|NCT01425801|20514596|P6|Period 2|Withdrawal by Subject|0
5930593|NCT01425801|20514597|P5|Period 2|Withdrawal by Subject|1
5930594|NCT01425801|20514598|P4|Period 2|Withdrawal by Subject|0
5930595|NCT01425801|20514599|P3|Period 2|Withdrawal by Subject|0
5930596|NCT01425801|20514600|P2|Period 2|Withdrawal by Subject|0
5930597|NCT01425801|20514601|P1|Period 2|Withdrawal by Subject|0
5930598|NCT01425801|20514596|P6|Period 1|Withdrawal by Subject|0
5930599|NCT01425801|20514597|P5|Period 1|Withdrawal by Subject|1
5930600|NCT01425801|20514598|P4|Period 1|Withdrawal by Subject|0
5930601|NCT01425801|20514599|P3|Period 1|Withdrawal by Subject|0
5930602|NCT01425801|20514600|P2|Period 1|Withdrawal by Subject|0
5930603|NCT01425801|20514601|P1|Period 1|Withdrawal by Subject|0
5930604|NCT01425749|20514707|P2|Overall Study|progression of melanoma|1
5930605|NCT01425749|20514708|P1|Overall Study|progression of melanoma|0
5930606|NCT01425723|20514725|P2|Overall Study|Other|10
5930607|NCT01425723|20514726|P1|Overall Study|Other|1
5930608|NCT01425723|20514725|P2|Overall Study|Physician Decision|0
5930609|NCT01425723|20514726|P1|Overall Study|Physician Decision|2
5930610|NCT01425723|20514725|P2|Overall Study|Lost to Follow-up|3
5930611|NCT01425723|20514726|P1|Overall Study|Lost to Follow-up|0
5930612|NCT01425723|20514725|P2|Overall Study|Withdrawal by Subject|4
5930613|NCT01425723|20514726|P1|Overall Study|Withdrawal by Subject|1
5930614|NCT01425723|20514725|P2|Overall Study|Lack of Efficacy|1
5930615|NCT01425723|20514726|P1|Overall Study|Lack of Efficacy|0
5930616|NCT01425632|20514756|P3|Overall Study|Withdrawal by Subject|1
5930617|NCT01425632|20514757|P2|Overall Study|Withdrawal by Subject|0
5930618|NCT01425632|20514758|P1|Overall Study|Withdrawal by Subject|0
5930619|NCT01425632|20514756|P3|Overall Study|Protocol Violation|2
5930620|NCT01425632|20514757|P2|Overall Study|Protocol Violation|0
5930621|NCT01425632|20514758|P1|Overall Study|Protocol Violation|0
5930622|NCT01425632|20514756|P3|Overall Study|Physician Decision|0
5930623|NCT01425632|20514757|P2|Overall Study|Physician Decision|0
5930624|NCT01425632|20514758|P1|Overall Study|Physician Decision|1
5930625|NCT01425632|20514756|P3|Overall Study|Adverse Event|1
5930626|NCT01425632|20514757|P2|Overall Study|Adverse Event|1
5930627|NCT01425632|20514758|P1|Overall Study|Adverse Event|0
5930628|NCT01425528|20514768|P2|Overall Study|Withdrawal by Subject|1
5930629|NCT01425528|20514769|P1|Overall Study|Withdrawal by Subject|1
5930630|NCT01425463|20514777|P2|Overall Study|Unknown Reason|7
5930631|NCT01425463|20514778|P1|Overall Study|Unknown Reason|4
5930632|NCT01425463|20514777|P2|Overall Study|Withdrawal by Subject|5
5930633|NCT01425463|20514778|P1|Overall Study|Withdrawal by Subject|7
5930634|NCT01425463|20514777|P2|Overall Study|Lost to Follow-up|2
5930635|NCT01425463|20514778|P1|Overall Study|Lost to Follow-up|5
5930636|NCT01425463|20514777|P2|Overall Study|Protocol Violation|2
5930637|NCT01425463|20514778|P1|Overall Study|Protocol Violation|2
5930638|NCT01425463|20514777|P2|Overall Study|Lack of Efficacy|1
5930639|NCT01425463|20514778|P1|Overall Study|Lack of Efficacy|1
5930640|NCT01425463|20514777|P2|Overall Study|Adverse Event|7
5930641|NCT01425463|20514778|P1|Overall Study|Adverse Event|5
5930642|NCT01425359|20514794|P2|Overall Study|Did Not Meet Qualifying Criteria|5
5930643|NCT01425359|20514795|P1|Overall Study|Did Not Meet Qualifying Criteria|3
5930644|NCT01425359|20514794|P2|Overall Study|Investigator's Discretion|0
5930645|NCT01425359|20514795|P1|Overall Study|Investigator's Discretion|2
5930646|NCT01425359|20514794|P2|Overall Study|Subject Withdrew Consent|2
5930647|NCT01425359|20514795|P1|Overall Study|Subject Withdrew Consent|1
5930648|NCT01425359|20514794|P2|Overall Study|Protocol Violation|2
5930649|NCT01425359|20514795|P1|Overall Study|Protocol Violation|1
5930650|NCT01425359|20514794|P2|Overall Study|Unsatisfactory Response|0
5930651|NCT01425359|20514795|P1|Overall Study|Unsatisfactory Response|1
5930652|NCT01425359|20514794|P2|Overall Study|Death|1
5930653|NCT01425359|20514795|P1|Overall Study|Death|0
5930654|NCT01425359|20514794|P2|Overall Study|Revascularization|1
5930655|NCT01425359|20514795|P1|Overall Study|Revascularization|0
5930656|NCT01425359|20514794|P2|Overall Study|Adverse Event|8
5930657|NCT01425359|20514795|P1|Overall Study|Adverse Event|9
5930658|NCT01425359|20514794|P2|Overall Study|Randomized but Not Treated|3
5930659|NCT01425359|20514795|P1|Overall Study|Randomized but Not Treated|2
5930660|NCT01425281|20514826|P2|At 5-year Clinical Follow-up|Refused/terminated|3
5930661|NCT01425281|20514827|P1|At 5-year Clinical Follow-up|Refused/terminated|9
5930662|NCT01425281|20514826|P2|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|7
5930663|NCT01425281|20514827|P1|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|19
5930664|NCT01425281|20514826|P2|At 5-year Clinical Follow-up|Lost to Follow-up|1
5930665|NCT01425281|20514827|P1|At 5-year Clinical Follow-up|Lost to Follow-up|2
5930666|NCT01425281|20514826|P2|At 5-year Clinical Follow-up|Death|0
5930667|NCT01425281|20514827|P1|At 5-year Clinical Follow-up|Death|2
5930668|NCT01425281|20514826|P2|At 4-year Clinical Follow-up|Lost to Follow-up|1
5930669|NCT01425281|20514827|P1|At 4-year Clinical Follow-up|Lost to Follow-up|4
5930670|NCT01425281|20514826|P2|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|5
5930671|NCT01425281|20514827|P1|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|6
5930672|NCT01425281|20514826|P2|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10
5930673|NCT01425281|20514827|P1|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10
5930674|NCT01425281|20514826|P2|At 4-year Clinical Follow-up|Withdrawal by Subject|2
5930675|NCT01425281|20514827|P1|At 4-year Clinical Follow-up|Withdrawal by Subject|3
5930676|NCT01425281|20514826|P2|At 4-year Clinical Follow-up|Death|3
5930677|NCT01425281|20514827|P1|At 4-year Clinical Follow-up|Death|7
5930678|NCT01425281|20514826|P2|At 3-year Clinical Follow-up|Death|3
5930679|NCT01425281|20514827|P1|At 3-year Clinical Follow-up|Death|2
5930680|NCT01425281|20514826|P2|At 3-year Clinical Follow-up|Withdrawal by Subject|3
5930681|NCT01425281|20514827|P1|At 3-year Clinical Follow-up|Withdrawal by Subject|3
5930682|NCT01425281|20514826|P2|At 2-year Clinical Follow-up|Patient did not want to participate in t|0
5930683|NCT01425281|20514827|P1|At 2-year Clinical Follow-up|Patient did not want to participate in t|1
5930684|NCT01425281|20514826|P2|At 2-year Clinical Follow-up|Lost to Follow-up|0
5930685|NCT01425281|20514827|P1|At 2-year Clinical Follow-up|Lost to Follow-up|1
5930686|NCT01425281|20514826|P2|At 2-year Clinical Follow-up|Death|0
5930687|NCT01425281|20514827|P1|At 2-year Clinical Follow-up|Death|2
5930688|NCT01425281|20514826|P2|At 2-year Clinical Follow-up|Withdrawal by Subject|1
5930689|NCT01425281|20514827|P1|At 2-year Clinical Follow-up|Withdrawal by Subject|2
5930690|NCT01425281|20514826|P2|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|0
5930691|NCT01425281|20514827|P1|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|1
5930692|NCT01425281|20514826|P2|At 1-year Clinical Follow-up|Withdrawal by Subject|1
5930693|NCT01425281|20514827|P1|At 1-year Clinical Follow-up|Withdrawal by Subject|1
5930694|NCT01425281|20514826|P2|At 180-day Clinical Follow-up|Death|1
5930695|NCT01425281|20514827|P1|At 180-day Clinical Follow-up|Death|0
5930696|NCT01425281|20514826|P2|At 180-day Clinical Follow-up|Withdrawal by Subject|0
5930697|NCT01425281|20514827|P1|At 180-day Clinical Follow-up|Withdrawal by Subject|3
5930698|NCT01425281|20514826|P2|At 30-day Clinical Follow-up|Withdrawal by Subject|0
5930699|NCT01425281|20514827|P1|At 30-day Clinical Follow-up|Withdrawal by Subject|1
5930700|NCT01425268|20515045|P2|Overall Study|Physician Decision|0
5930701|NCT01425268|20515046|P1|Overall Study|Physician Decision|1
5930702|NCT01425268|20515045|P2|Overall Study|Sponsor Decision|0
5930703|NCT01425268|20515046|P1|Overall Study|Sponsor Decision|5
5930704|NCT01425268|20515045|P2|Overall Study|Withdrawal by Subject|0
5930705|NCT01425268|20515046|P1|Overall Study|Withdrawal by Subject|2
5930727|NCT01425190|20515086|P3|Overall Study|Full dose not consumed.|0
5930728|NCT01425190|20515087|P2|Overall Study|Full dose not consumed.|0
5930729|NCT01425190|20515088|P1|Overall Study|Full dose not consumed.|1
5930730|NCT01425008|20515124|P19|Dose Expansion Phase|Unsatisfactory Therapeutic Response|1
5930731|NCT01425008|20515125|P18|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
5930732|NCT01425008|20515126|P17|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
5930733|NCT01425008|20515127|P16|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
5930734|NCT01425008|20515128|P15|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
5930735|NCT01425008|20515129|P14|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
5930736|NCT01425008|20515130|P13|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
5930737|NCT01425008|20515131|P12|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
5930738|NCT01425008|20515132|P11|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
5930739|NCT01425008|20515133|P10|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
5930740|NCT01425008|20515134|P9|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
5930741|NCT01425008|20515135|P8|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
5930742|NCT01425008|20515136|P7|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
5930743|NCT01425008|20515137|P6|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
5930744|NCT01425008|20515138|P5|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
5930745|NCT01425008|20515139|P4|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
5930746|NCT01425008|20515140|P3|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
5930747|NCT01425008|20515141|P2|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
5930748|NCT01425008|20515142|P1|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
5930749|NCT01425008|20515124|P19|Dose Expansion Phase|Lost to Follow-up|0
5930750|NCT01425008|20515125|P18|Dose Expansion Phase|Lost to Follow-up|0
5930751|NCT01425008|20515126|P17|Dose Expansion Phase|Lost to Follow-up|1
5930752|NCT01425008|20515127|P16|Dose Expansion Phase|Lost to Follow-up|0
5930753|NCT01425008|20515128|P15|Dose Expansion Phase|Lost to Follow-up|0
5930754|NCT01425008|20515129|P14|Dose Expansion Phase|Lost to Follow-up|0
5930755|NCT01425008|20515130|P13|Dose Expansion Phase|Lost to Follow-up|0
5930756|NCT01425008|20515131|P12|Dose Expansion Phase|Lost to Follow-up|0
5930757|NCT01425008|20515132|P11|Dose Expansion Phase|Lost to Follow-up|0
5930758|NCT01425008|20515133|P10|Dose Expansion Phase|Lost to Follow-up|0
5930759|NCT01425008|20515134|P9|Dose Expansion Phase|Lost to Follow-up|0
5930760|NCT01425008|20515135|P8|Dose Expansion Phase|Lost to Follow-up|0
5930761|NCT01425008|20515136|P7|Dose Expansion Phase|Lost to Follow-up|0
5930762|NCT01425008|20515137|P6|Dose Expansion Phase|Lost to Follow-up|0
5930763|NCT01425008|20515138|P5|Dose Expansion Phase|Lost to Follow-up|0
5930764|NCT01425008|20515139|P4|Dose Expansion Phase|Lost to Follow-up|0
5930765|NCT01425008|20515140|P3|Dose Expansion Phase|Lost to Follow-up|0
5930766|NCT01425008|20515141|P2|Dose Expansion Phase|Lost to Follow-up|0
5930767|NCT01425008|20515142|P1|Dose Expansion Phase|Lost to Follow-up|0
5930768|NCT01425008|20515124|P19|Dose Expansion Phase|Adverse Event|3
5930769|NCT01425008|20515125|P18|Dose Expansion Phase|Adverse Event|0
5930770|NCT01425008|20515126|P17|Dose Expansion Phase|Adverse Event|5
5930771|NCT01425008|20515127|P16|Dose Expansion Phase|Adverse Event|1
5930772|NCT01425008|20515128|P15|Dose Expansion Phase|Adverse Event|1
5930773|NCT01425008|20515129|P14|Dose Expansion Phase|Adverse Event|0
5930774|NCT01425008|20515130|P13|Dose Expansion Phase|Adverse Event|3
5930775|NCT01425008|20515131|P12|Dose Expansion Phase|Adverse Event|3
5930776|NCT01425008|20515132|P11|Dose Expansion Phase|Adverse Event|2
5930777|NCT01425008|20515133|P10|Dose Expansion Phase|Adverse Event|0
5930778|NCT01425008|20515134|P9|Dose Expansion Phase|Adverse Event|0
5930779|NCT01425008|20515135|P8|Dose Expansion Phase|Adverse Event|0
5930780|NCT01425008|20515136|P7|Dose Expansion Phase|Adverse Event|0
5930781|NCT01425008|20515137|P6|Dose Expansion Phase|Adverse Event|0
5930782|NCT01425008|20515138|P5|Dose Expansion Phase|Adverse Event|0
5930783|NCT01425008|20515139|P4|Dose Expansion Phase|Adverse Event|0
5930784|NCT01425008|20515140|P3|Dose Expansion Phase|Adverse Event|0
5930785|NCT01425008|20515141|P2|Dose Expansion Phase|Adverse Event|0
5930786|NCT01425008|20515142|P1|Dose Expansion Phase|Adverse Event|0
5930787|NCT01425008|20515124|P19|Dose Expansion Phase|Symptomatic Deterioration|1
5930788|NCT01425008|20515125|P18|Dose Expansion Phase|Symptomatic Deterioration|0
5930789|NCT01425008|20515126|P17|Dose Expansion Phase|Symptomatic Deterioration|2
5930790|NCT01425008|20515127|P16|Dose Expansion Phase|Symptomatic Deterioration|1
5930791|NCT01425008|20515128|P15|Dose Expansion Phase|Symptomatic Deterioration|0
5930792|NCT01425008|20515129|P14|Dose Expansion Phase|Symptomatic Deterioration|0
5930793|NCT01425008|20515130|P13|Dose Expansion Phase|Symptomatic Deterioration|0
5930794|NCT01425008|20515131|P12|Dose Expansion Phase|Symptomatic Deterioration|1
5930795|NCT01425008|20515132|P11|Dose Expansion Phase|Symptomatic Deterioration|2
5930796|NCT01425008|20515133|P10|Dose Expansion Phase|Symptomatic Deterioration|0
5930797|NCT01425008|20515134|P9|Dose Expansion Phase|Symptomatic Deterioration|0
5930798|NCT01425008|20515135|P8|Dose Expansion Phase|Symptomatic Deterioration|0
5930799|NCT01425008|20515136|P7|Dose Expansion Phase|Symptomatic Deterioration|0
5930800|NCT01425008|20515137|P6|Dose Expansion Phase|Symptomatic Deterioration|0
5930801|NCT01425008|20515138|P5|Dose Expansion Phase|Symptomatic Deterioration|0
5930802|NCT01425008|20515139|P4|Dose Expansion Phase|Symptomatic Deterioration|0
5930803|NCT01425008|20515140|P3|Dose Expansion Phase|Symptomatic Deterioration|0
5930804|NCT01425008|20515141|P2|Dose Expansion Phase|Symptomatic Deterioration|0
5930805|NCT01425008|20515142|P1|Dose Expansion Phase|Symptomatic Deterioration|0
5930806|NCT01425008|20515124|P19|Dose Expansion Phase|Other|4
5930807|NCT01425008|20515125|P18|Dose Expansion Phase|Other|0
5930808|NCT01425008|20515126|P17|Dose Expansion Phase|Other|2
5930809|NCT01425008|20515127|P16|Dose Expansion Phase|Other|0
5930810|NCT01425008|20515128|P15|Dose Expansion Phase|Other|0
5930811|NCT01425008|20515129|P14|Dose Expansion Phase|Other|0
5930812|NCT01425008|20515130|P13|Dose Expansion Phase|Other|1
5930813|NCT01425008|20515131|P12|Dose Expansion Phase|Other|0
5930814|NCT01425008|20515132|P11|Dose Expansion Phase|Other|0
5930815|NCT01425008|20515133|P10|Dose Expansion Phase|Other|0
5930816|NCT01425008|20515134|P9|Dose Expansion Phase|Other|0
5930817|NCT01425008|20515135|P8|Dose Expansion Phase|Other|0
5930818|NCT01425008|20515136|P7|Dose Expansion Phase|Other|0
5930819|NCT01425008|20515137|P6|Dose Expansion Phase|Other|0
5930820|NCT01425008|20515138|P5|Dose Expansion Phase|Other|0
5930821|NCT01425008|20515139|P4|Dose Expansion Phase|Other|0
5930822|NCT01425008|20515140|P3|Dose Expansion Phase|Other|0
5930823|NCT01425008|20515141|P2|Dose Expansion Phase|Other|0
5930824|NCT01425008|20515142|P1|Dose Expansion Phase|Other|0
5930825|NCT01425008|20515124|P19|Dose Expansion Phase|Withdrawal by Subject|0
5930826|NCT01425008|20515125|P18|Dose Expansion Phase|Withdrawal by Subject|0
5930827|NCT01425008|20515126|P17|Dose Expansion Phase|Withdrawal by Subject|1
5930828|NCT01425008|20515127|P16|Dose Expansion Phase|Withdrawal by Subject|1
5930829|NCT01425008|20515128|P15|Dose Expansion Phase|Withdrawal by Subject|0
5930830|NCT01425008|20515129|P14|Dose Expansion Phase|Withdrawal by Subject|0
5930831|NCT01425008|20515130|P13|Dose Expansion Phase|Withdrawal by Subject|0
5930832|NCT01425008|20515131|P12|Dose Expansion Phase|Withdrawal by Subject|0
5930833|NCT01425008|20515132|P11|Dose Expansion Phase|Withdrawal by Subject|1
5930834|NCT01425008|20515133|P10|Dose Expansion Phase|Withdrawal by Subject|0
5930835|NCT01425008|20515134|P9|Dose Expansion Phase|Withdrawal by Subject|0
5930836|NCT01425008|20515135|P8|Dose Expansion Phase|Withdrawal by Subject|0
5930837|NCT01425008|20515136|P7|Dose Expansion Phase|Withdrawal by Subject|0
5930838|NCT01425008|20515137|P6|Dose Expansion Phase|Withdrawal by Subject|0
5930839|NCT01425008|20515138|P5|Dose Expansion Phase|Withdrawal by Subject|0
5930840|NCT01425008|20515139|P4|Dose Expansion Phase|Withdrawal by Subject|0
5930841|NCT01425008|20515140|P3|Dose Expansion Phase|Withdrawal by Subject|0
5930842|NCT01425008|20515141|P2|Dose Expansion Phase|Withdrawal by Subject|0
5930843|NCT01425008|20515142|P1|Dose Expansion Phase|Withdrawal by Subject|0
5930844|NCT01425008|20515124|P19|Dose Expansion Phase|Progressive Disease|10
5930845|NCT01425008|20515125|P18|Dose Expansion Phase|Progressive Disease|2
5930846|NCT01425008|20515126|P17|Dose Expansion Phase|Progressive Disease|9
5930847|NCT01425008|20515127|P16|Dose Expansion Phase|Progressive Disease|8
5930848|NCT01425008|20515128|P15|Dose Expansion Phase|Progressive Disease|5
5930849|NCT01425008|20515129|P14|Dose Expansion Phase|Progressive Disease|1
5930850|NCT01425008|20515130|P13|Dose Expansion Phase|Progressive Disease|12
5930851|NCT01425008|20515131|P12|Dose Expansion Phase|Progressive Disease|4
5930852|NCT01425008|20515132|P11|Dose Expansion Phase|Progressive Disease|10
5930853|NCT01425008|20515133|P10|Dose Expansion Phase|Progressive Disease|0
5930854|NCT01425008|20515134|P9|Dose Expansion Phase|Progressive Disease|0
5930855|NCT01425008|20515135|P8|Dose Expansion Phase|Progressive Disease|0
5930856|NCT01425008|20515136|P7|Dose Expansion Phase|Progressive Disease|0
5930857|NCT01425008|20515137|P6|Dose Expansion Phase|Progressive Disease|0
5930858|NCT01425008|20515138|P5|Dose Expansion Phase|Progressive Disease|0
5930859|NCT01425008|20515139|P4|Dose Expansion Phase|Progressive Disease|0
5930860|NCT01425008|20515140|P3|Dose Expansion Phase|Progressive Disease|0
5930861|NCT01425008|20515141|P2|Dose Expansion Phase|Progressive Disease|0
5930862|NCT01425008|20515142|P1|Dose Expansion Phase|Progressive Disease|0
5930863|NCT01425008|20515124|P19|Dose Escalation Phase|Other|0
5930864|NCT01425008|20515125|P18|Dose Escalation Phase|Other|0
5930865|NCT01425008|20515126|P17|Dose Escalation Phase|Other|0
5930866|NCT01425008|20515127|P16|Dose Escalation Phase|Other|0
5930867|NCT01425008|20515128|P15|Dose Escalation Phase|Other|0
5930868|NCT01425008|20515129|P14|Dose Escalation Phase|Other|0
5930869|NCT01425008|20515130|P13|Dose Escalation Phase|Other|0
5930870|NCT01425008|20515131|P12|Dose Escalation Phase|Other|0
5930871|NCT01425008|20515132|P11|Dose Escalation Phase|Other|0
5930872|NCT01425008|20515133|P10|Dose Escalation Phase|Other|0
5930873|NCT01425008|20515134|P9|Dose Escalation Phase|Other|1
5930874|NCT01425008|20515135|P8|Dose Escalation Phase|Other|0
5930875|NCT01425008|20515136|P7|Dose Escalation Phase|Other|0
5930876|NCT01425008|20515137|P6|Dose Escalation Phase|Other|0
5930877|NCT01425008|20515138|P5|Dose Escalation Phase|Other|0
5930878|NCT01425008|20515139|P4|Dose Escalation Phase|Other|0
5930879|NCT01425008|20515140|P3|Dose Escalation Phase|Other|0
5930880|NCT01425008|20515141|P2|Dose Escalation Phase|Other|0
5930881|NCT01425008|20515142|P1|Dose Escalation Phase|Other|0
5930882|NCT01425008|20515124|P19|Dose Escalation Phase|Symptomatic Deterioration|0
5930883|NCT01425008|20515125|P18|Dose Escalation Phase|Symptomatic Deterioration|0
5930884|NCT01425008|20515126|P17|Dose Escalation Phase|Symptomatic Deterioration|0
5930885|NCT01425008|20515127|P16|Dose Escalation Phase|Symptomatic Deterioration|0
5930886|NCT01425008|20515128|P15|Dose Escalation Phase|Symptomatic Deterioration|0
5930887|NCT01425008|20515129|P14|Dose Escalation Phase|Symptomatic Deterioration|0
5930888|NCT01425008|20515130|P13|Dose Escalation Phase|Symptomatic Deterioration|0
5930889|NCT01425008|20515131|P12|Dose Escalation Phase|Symptomatic Deterioration|0
5930890|NCT01425008|20515132|P11|Dose Escalation Phase|Symptomatic Deterioration|0
5930891|NCT01425008|20515133|P10|Dose Escalation Phase|Symptomatic Deterioration|2
5930892|NCT01425008|20515134|P9|Dose Escalation Phase|Symptomatic Deterioration|2
5930893|NCT01425008|20515135|P8|Dose Escalation Phase|Symptomatic Deterioration|0
5930894|NCT01425008|20515136|P7|Dose Escalation Phase|Symptomatic Deterioration|0
5930895|NCT01425008|20515137|P6|Dose Escalation Phase|Symptomatic Deterioration|0
5930896|NCT01425008|20515138|P5|Dose Escalation Phase|Symptomatic Deterioration|0
5930897|NCT01425008|20515139|P4|Dose Escalation Phase|Symptomatic Deterioration|0
5930898|NCT01425008|20515140|P3|Dose Escalation Phase|Symptomatic Deterioration|1
5930899|NCT01425008|20515141|P2|Dose Escalation Phase|Symptomatic Deterioration|0
5930900|NCT01425008|20515142|P1|Dose Escalation Phase|Symptomatic Deterioration|0
5930901|NCT01425008|20515124|P19|Dose Escalation Phase|Withdrawal by Subject|0
5930902|NCT01425008|20515125|P18|Dose Escalation Phase|Withdrawal by Subject|0
5930903|NCT01425008|20515126|P17|Dose Escalation Phase|Withdrawal by Subject|0
5930904|NCT01425008|20515127|P16|Dose Escalation Phase|Withdrawal by Subject|0
5930905|NCT01425008|20515128|P15|Dose Escalation Phase|Withdrawal by Subject|0
5930906|NCT01425008|20515129|P14|Dose Escalation Phase|Withdrawal by Subject|0
5930907|NCT01425008|20515130|P13|Dose Escalation Phase|Withdrawal by Subject|0
5930908|NCT01425008|20515131|P12|Dose Escalation Phase|Withdrawal by Subject|0
5930909|NCT01425008|20515132|P11|Dose Escalation Phase|Withdrawal by Subject|0
5930910|NCT01425008|20515133|P10|Dose Escalation Phase|Withdrawal by Subject|0
5930911|NCT01425008|20515134|P9|Dose Escalation Phase|Withdrawal by Subject|1
5930912|NCT01425008|20515135|P8|Dose Escalation Phase|Withdrawal by Subject|0
5930913|NCT01425008|20515136|P7|Dose Escalation Phase|Withdrawal by Subject|1
5930914|NCT01425008|20515137|P6|Dose Escalation Phase|Withdrawal by Subject|1
5930915|NCT01425008|20515138|P5|Dose Escalation Phase|Withdrawal by Subject|1
5930916|NCT01425008|20515139|P4|Dose Escalation Phase|Withdrawal by Subject|0
5930917|NCT01425008|20515140|P3|Dose Escalation Phase|Withdrawal by Subject|0
5930918|NCT01425008|20515141|P2|Dose Escalation Phase|Withdrawal by Subject|0
5930919|NCT01425008|20515142|P1|Dose Escalation Phase|Withdrawal by Subject|0
5930920|NCT01425008|20515124|P19|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
5930921|NCT01425008|20515125|P18|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
5930922|NCT01425008|20515126|P17|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
5930923|NCT01425008|20515127|P16|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
5930924|NCT01425008|20515128|P15|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
5930925|NCT01425008|20515129|P14|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
5930926|NCT01425008|20515130|P13|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
5930927|NCT01425008|20515131|P12|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
5930928|NCT01425008|20515132|P11|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
5930929|NCT01425008|20515133|P10|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
5930930|NCT01425008|20515134|P9|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1
5930931|NCT01425008|20515135|P8|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1
5930932|NCT01425008|20515136|P7|Dose Escalation Phase|Unsatisfactory Therapeutic Response|2
5930933|NCT01425008|20515137|P6|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
5930934|NCT01425008|20515138|P5|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1
5930935|NCT01425008|20515139|P4|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
5930936|NCT01425008|20515140|P3|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
5930937|NCT01425008|20515141|P2|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
5930938|NCT01425008|20515142|P1|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
5930939|NCT01425008|20515124|P19|Dose Escalation Phase|Adverse Event|0
5930940|NCT01425008|20515125|P18|Dose Escalation Phase|Adverse Event|0
5930941|NCT01425008|20515126|P17|Dose Escalation Phase|Adverse Event|0
5930942|NCT01425008|20515127|P16|Dose Escalation Phase|Adverse Event|0
5930943|NCT01425008|20515128|P15|Dose Escalation Phase|Adverse Event|0
5930944|NCT01425008|20515129|P14|Dose Escalation Phase|Adverse Event|0
5930945|NCT01425008|20515130|P13|Dose Escalation Phase|Adverse Event|0
5930946|NCT01425008|20515131|P12|Dose Escalation Phase|Adverse Event|0
5930947|NCT01425008|20515132|P11|Dose Escalation Phase|Adverse Event|0
5930948|NCT01425008|20515133|P10|Dose Escalation Phase|Adverse Event|0
5930949|NCT01425008|20515134|P9|Dose Escalation Phase|Adverse Event|2
5930950|NCT01425008|20515135|P8|Dose Escalation Phase|Adverse Event|0
5930951|NCT01425008|20515136|P7|Dose Escalation Phase|Adverse Event|0
5930952|NCT01425008|20515137|P6|Dose Escalation Phase|Adverse Event|2
5930953|NCT01425008|20515138|P5|Dose Escalation Phase|Adverse Event|0
5930954|NCT01425008|20515139|P4|Dose Escalation Phase|Adverse Event|0
5930955|NCT01425008|20515140|P3|Dose Escalation Phase|Adverse Event|0
5930956|NCT01425008|20515141|P2|Dose Escalation Phase|Adverse Event|0
5930957|NCT01425008|20515142|P1|Dose Escalation Phase|Adverse Event|2
5930958|NCT01425008|20515124|P19|Dose Escalation Phase|Progressive Disease|0
5930959|NCT01425008|20515125|P18|Dose Escalation Phase|Progressive Disease|0
5930960|NCT01425008|20515126|P17|Dose Escalation Phase|Progressive Disease|0
5930961|NCT01425008|20515127|P16|Dose Escalation Phase|Progressive Disease|0
5930962|NCT01425008|20515128|P15|Dose Escalation Phase|Progressive Disease|0
5930963|NCT01425008|20515129|P14|Dose Escalation Phase|Progressive Disease|0
5930964|NCT01425008|20515130|P13|Dose Escalation Phase|Progressive Disease|0
5930965|NCT01425008|20515131|P12|Dose Escalation Phase|Progressive Disease|0
5930966|NCT01425008|20515132|P11|Dose Escalation Phase|Progressive Disease|0
5930967|NCT01425008|20515133|P10|Dose Escalation Phase|Progressive Disease|2
5930968|NCT01425008|20515134|P9|Dose Escalation Phase|Progressive Disease|6
5930969|NCT01425008|20515135|P8|Dose Escalation Phase|Progressive Disease|2
5930970|NCT01425008|20515136|P7|Dose Escalation Phase|Progressive Disease|0
5930971|NCT01425008|20515137|P6|Dose Escalation Phase|Progressive Disease|4
5930972|NCT01425008|20515138|P5|Dose Escalation Phase|Progressive Disease|5
5930973|NCT01425008|20515139|P4|Dose Escalation Phase|Progressive Disease|3
5930974|NCT01425008|20515140|P3|Dose Escalation Phase|Progressive Disease|2
5930975|NCT01425008|20515141|P2|Dose Escalation Phase|Progressive Disease|3
5930976|NCT01425008|20515142|P1|Dose Escalation Phase|Progressive Disease|2
5930977|NCT01424930|20515445|P2|Overall Study|Reason not specified|6
5930978|NCT01424930|20515446|P1|Overall Study|Reason not specified|0
5930979|NCT01424930|20515445|P2|Overall Study|Screen Failure|1
5930980|NCT01424930|20515446|P1|Overall Study|Screen Failure|0
5930981|NCT01424930|20515445|P2|Overall Study|Progressive Disease|6
5930982|NCT01424930|20515446|P1|Overall Study|Progressive Disease|3
5930983|NCT01424930|20515445|P2|Overall Study|Death|0
5930984|NCT01424930|20515446|P1|Overall Study|Death|1
5930985|NCT01424930|20515445|P2|Overall Study|Adverse Event|1
5930986|NCT01424930|20515446|P1|Overall Study|Adverse Event|0
5930987|NCT01424813|20515460|P2|Overall Study|Other|2
5930988|NCT01424813|20515461|P1|Overall Study|Other|1
5930989|NCT01424813|20515460|P2|Overall Study|Protocol Violation|0
5930990|NCT01424813|20515461|P1|Overall Study|Protocol Violation|1
5930991|NCT01424813|20515460|P2|Overall Study|Withdrawal by Subject|0
5930992|NCT01424813|20515461|P1|Overall Study|Withdrawal by Subject|3
5930993|NCT01424670|20515481|P2|Continuation Period|Withdrawal by Subject|4
5930994|NCT01424670|20515482|P1|Continuation Period|Withdrawal by Subject|13
5930995|NCT01424670|20515481|P2|Continuation Period|Physician Decision|4
5930996|NCT01424670|20515482|P1|Continuation Period|Physician Decision|5
5930997|NCT01424670|20515481|P2|Continuation Period|Met Protocol Withdrawal Criteria|1
5930998|NCT01424670|20515482|P1|Continuation Period|Met Protocol Withdrawal Criteria|1
5930999|NCT01424670|20515481|P2|Continuation Period|Lost to Follow-up|0
5931000|NCT01424670|20515482|P1|Continuation Period|Lost to Follow-up|2
5931001|NCT01424670|20515481|P2|Continuation Period|Adverse Event|5
5931002|NCT01424670|20515482|P1|Continuation Period|Adverse Event|13
5931003|NCT01424670|20515481|P2|6-Month Intensive Period (182 Days)|Withdrawal by Subject|7
5931004|NCT01424670|20515482|P1|6-Month Intensive Period (182 Days)|Withdrawal by Subject|13
5931005|NCT01424670|20515481|P2|6-Month Intensive Period (182 Days)|Physician Decision|3
5931006|NCT01424670|20515482|P1|6-Month Intensive Period (182 Days)|Physician Decision|2
5931007|NCT01424670|20515481|P2|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|1
5931008|NCT01424670|20515482|P1|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|2
5931009|NCT01424670|20515481|P2|6-Month Intensive Period (182 Days)|Lost to Follow-up|1
5931010|NCT01424670|20515482|P1|6-Month Intensive Period (182 Days)|Lost to Follow-up|0
5931011|NCT01424670|20515481|P2|6-Month Intensive Period (182 Days)|Adverse Event|2
5931012|NCT01424670|20515482|P1|6-Month Intensive Period (182 Days)|Adverse Event|2
5931013|NCT01424644|20515504|P2|Overall Study|Unable to Classify|0
5931014|NCT01424644|20515505|P1|Overall Study|Unable to Classify|1
5931015|NCT01424644|20515504|P2|Overall Study|Administrative Reason|0
5931016|NCT01424644|20515505|P1|Overall Study|Administrative Reason|1
5931017|NCT01424644|20515504|P2|Overall Study|Protocol Violation|3
5931018|NCT01424644|20515505|P1|Overall Study|Protocol Violation|4
5931019|NCT01424644|20515504|P2|Overall Study|Lost to Follow-up|12
5931020|NCT01424644|20515505|P1|Overall Study|Lost to Follow-up|16
5931021|NCT01424644|20515504|P2|Overall Study|Withdrawal by Subject|12
5931022|NCT01424644|20515505|P1|Overall Study|Withdrawal by Subject|9
5931023|NCT01424644|20515504|P2|Overall Study|Adverse Event|0
5931024|NCT01424644|20515505|P1|Overall Study|Adverse Event|2
5931025|NCT01424566|20515519|P3|Double-blind Treatment|Lack of Efficacy|1
5931026|NCT01424566|20515520|P2|Double-blind Treatment|Lack of Efficacy|1
5931027|NCT01424566|20515521|P1|Double-blind Treatment|Lack of Efficacy|0
5931028|NCT01424566|20515519|P3|Double-blind Treatment|Withdrawal by Investigator|1
5931029|NCT01424566|20515520|P2|Double-blind Treatment|Withdrawal by Investigator|1
5931030|NCT01424566|20515521|P1|Double-blind Treatment|Withdrawal by Investigator|0
5931031|NCT01424566|20515519|P3|Double-blind Treatment|Withdrawal by Subject|0
5931032|NCT01424566|20515520|P2|Double-blind Treatment|Withdrawal by Subject|2
5931033|NCT01424566|20515521|P1|Double-blind Treatment|Withdrawal by Subject|0
5931034|NCT01424566|20515519|P3|Double-blind Treatment|Adverse Event|13
5931035|NCT01424566|20515520|P2|Double-blind Treatment|Adverse Event|21
5931036|NCT01424566|20515521|P1|Double-blind Treatment|Adverse Event|0
5931037|NCT01424566|20515519|P3|Single-blind Treatment|Did Not Administer Any Study Drug|0
5931038|NCT01424566|20515520|P2|Single-blind Treatment|Did Not Administer Any Study Drug|0
5931039|NCT01424566|20515521|P1|Single-blind Treatment|Did Not Administer Any Study Drug|2
5931040|NCT01424566|20515519|P3|Single-blind Treatment|Met Exclusion Criteria|0
5931041|NCT01424566|20515520|P2|Single-blind Treatment|Met Exclusion Criteria|0
5931042|NCT01424566|20515521|P1|Single-blind Treatment|Met Exclusion Criteria|1
5931043|NCT01424566|20515519|P3|Single-blind Treatment|Did Not Meet Inclusion Criteria|0
5931044|NCT01424566|20515520|P2|Single-blind Treatment|Did Not Meet Inclusion Criteria|0
5931045|NCT01424566|20515521|P1|Single-blind Treatment|Did Not Meet Inclusion Criteria|108
5931046|NCT01424566|20515519|P3|Single-blind Treatment|Withdrawal by Investigator|0
5931047|NCT01424566|20515520|P2|Single-blind Treatment|Withdrawal by Investigator|0
5931048|NCT01424566|20515521|P1|Single-blind Treatment|Withdrawal by Investigator|2
5931049|NCT01424566|20515519|P3|Single-blind Treatment|Withdrawal by Subject|0
5931050|NCT01424566|20515520|P2|Single-blind Treatment|Withdrawal by Subject|0
5931051|NCT01424566|20515521|P1|Single-blind Treatment|Withdrawal by Subject|16
5931052|NCT01424566|20515519|P3|Single-blind Treatment|Adverse Event|0
5931053|NCT01424566|20515520|P2|Single-blind Treatment|Adverse Event|0
5931054|NCT01424566|20515521|P1|Single-blind Treatment|Adverse Event|71
5931055|NCT01424514|20515548|P2|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|0
5931056|NCT01424514|20515549|P1|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|1
5931057|NCT01424514|20515548|P2|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1
5931058|NCT01424514|20515549|P1|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1
5931059|NCT01424501|20515594|P6|Overall Study|Lost to Follow-up|0
5931060|NCT01424501|20515595|P5|Overall Study|Lost to Follow-up|0
5931061|NCT01424501|20515596|P4|Overall Study|Lost to Follow-up|0
5931062|NCT01424501|20515597|P3|Overall Study|Lost to Follow-up|1
5931063|NCT01424501|20515598|P2|Overall Study|Lost to Follow-up|1
5931064|NCT01424501|20515599|P1|Overall Study|Lost to Follow-up|0
5931065|NCT01424501|20515594|P6|Overall Study|Withdrawal by Subject|0
5931066|NCT01424501|20515595|P5|Overall Study|Withdrawal by Subject|0
5931067|NCT01424501|20515596|P4|Overall Study|Withdrawal by Subject|0
5931068|NCT01424501|20515597|P3|Overall Study|Withdrawal by Subject|1
5931069|NCT01424501|20515598|P2|Overall Study|Withdrawal by Subject|0
5931070|NCT01424501|20515599|P1|Overall Study|Withdrawal by Subject|1
5931071|NCT01424397|20515775|P12|Period-2 (8 Days)|Withdrawal by Subject|0
5931072|NCT01424397|20515776|P11|Period-2 (8 Days)|Withdrawal by Subject|0
5931073|NCT01424397|20515777|P10|Period-2 (8 Days)|Withdrawal by Subject|0
5931074|NCT01424397|20515778|P9|Period-2 (8 Days)|Withdrawal by Subject|0
5931075|NCT01424397|20515779|P8|Period-2 (8 Days)|Withdrawal by Subject|0
5931076|NCT01424397|20515780|P7|Period-2 (8 Days)|Withdrawal by Subject|0
5931077|NCT01424397|20515781|P6|Period-2 (8 Days)|Withdrawal by Subject|0
5931078|NCT01424397|20515782|P5|Period-2 (8 Days)|Withdrawal by Subject|0
5931079|NCT01424397|20515783|P4|Period-2 (8 Days)|Withdrawal by Subject|0
5931080|NCT01424397|20515784|P3|Period-2 (8 Days)|Withdrawal by Subject|1
5931081|NCT01424397|20515785|P2|Period-2 (8 Days)|Withdrawal by Subject|0
5931082|NCT01424397|20515786|P1|Period-2 (8 Days)|Withdrawal by Subject|0
5931083|NCT01424306|20515832|P6|Overall Study|Protocol Violation|0
5931084|NCT01424306|20515833|P5|Overall Study|Protocol Violation|1
5931085|NCT01424306|20515834|P4|Overall Study|Protocol Violation|0
5931086|NCT01424306|20515835|P3|Overall Study|Protocol Violation|0
5931087|NCT01424306|20515836|P2|Overall Study|Protocol Violation|0
5931088|NCT01424306|20515837|P1|Overall Study|Protocol Violation|0
5931089|NCT01424228|20515886|P2|Overall Study|Unplanned journey|1
5931090|NCT01424228|20515887|P1|Overall Study|Unplanned journey|0
5931091|NCT01424228|20515886|P2|Overall Study|Worsening of symptoms|0
5931092|NCT01424228|20515887|P1|Overall Study|Worsening of symptoms|1
5931093|NCT01424228|20515886|P2|Overall Study|Non-compliance|0
5931094|NCT01424228|20515887|P1|Overall Study|Non-compliance|2
5931095|NCT01424228|20515886|P2|Overall Study|inclusion/exclusion criteria not met|2
5931096|NCT01424228|20515887|P1|Overall Study|inclusion/exclusion criteria not met|2
5931097|NCT01424228|20515886|P2|Overall Study|Lack of Efficacy|7
5931098|NCT01424228|20515887|P1|Overall Study|Lack of Efficacy|5
5931099|NCT01424228|20515886|P2|Overall Study|Sponsor's decision|12
5931100|NCT01424228|20515887|P1|Overall Study|Sponsor's decision|9
5931101|NCT01424228|20515886|P2|Overall Study|Adverse Event|14
5931102|NCT01424228|20515887|P1|Overall Study|Adverse Event|10
5931103|NCT01424228|20515886|P2|Overall Study|Withdrawal by Subject|11
5931104|NCT01424228|20515887|P1|Overall Study|Withdrawal by Subject|27
5931105|NCT01424189|20515938|P2|Overall Study|Death|1
5931106|NCT01424189|20515939|P1|Overall Study|Death|3
5931107|NCT01424189|20515938|P2|Overall Study|Subject moved|0
5931108|NCT01424189|20515939|P1|Overall Study|Subject moved|1
5931109|NCT01424189|20515938|P2|Overall Study|Withdrawal by Subject|4
5931110|NCT01424189|20515939|P1|Overall Study|Withdrawal by Subject|4
5931111|NCT01424189|20515938|P2|Overall Study|Lost to Follow-up|1
5931112|NCT01424189|20515939|P1|Overall Study|Lost to Follow-up|4
5931113|NCT01424189|20515938|P2|Overall Study|Adverse Event|0
5931114|NCT01424189|20515939|P1|Overall Study|Adverse Event|1
5931115|NCT01423916|20515980|P3|Overall Study|Protocol Deviation|0
5931116|NCT01423916|20515981|P2|Overall Study|Protocol Deviation|0
5931117|NCT01423916|20515982|P1|Overall Study|Protocol Deviation|1
5931118|NCT01423916|20515980|P3|Overall Study|Withdrawal by Subject|3
5931119|NCT01423916|20515981|P2|Overall Study|Withdrawal by Subject|10
5931120|NCT01423916|20515982|P1|Overall Study|Withdrawal by Subject|3
5931121|NCT01423916|20515980|P3|Overall Study|Physician Decision|1
5931122|NCT01423916|20515981|P2|Overall Study|Physician Decision|0
5931123|NCT01423916|20515982|P1|Overall Study|Physician Decision|1
5931124|NCT01423916|20515980|P3|Overall Study|Met Withdrawal Criteria|1
5931125|NCT01423916|20515981|P2|Overall Study|Met Withdrawal Criteria|1
5931126|NCT01423916|20515982|P1|Overall Study|Met Withdrawal Criteria|1
5931127|NCT01423916|20515980|P3|Overall Study|Adverse Event|2
5931128|NCT01423916|20515981|P2|Overall Study|Adverse Event|9
5931129|NCT01423916|20515982|P1|Overall Study|Adverse Event|5
5931130|NCT01423812|20516038|P2|Overall Study|Withdrawal by Subject|2
5931131|NCT01423812|20516039|P1|Overall Study|Withdrawal by Subject|1
5931132|NCT01423812|20516038|P2|Overall Study|Lost to Follow-up|2
5931133|NCT01423812|20516039|P1|Overall Study|Lost to Follow-up|2
5931134|NCT01423617|20516067|P2|Overall Study|Lost to Follow-up|1
5931135|NCT01423617|20516068|P1|Overall Study|Lost to Follow-up|0
5931136|NCT01423604|20516085|P2|Randomized|Patient decision|9
5931137|NCT01423604|20516086|P1|Randomized|Patient decision|5
5931138|NCT01423604|20516085|P2|Randomized|Other - unspecified|31
5931139|NCT01423604|20516086|P1|Randomized|Other - unspecified|37
5931140|NCT01423604|20516085|P2|Randomized|Physician Decision|13
5931141|NCT01423604|20516086|P1|Randomized|Physician Decision|16
5931142|NCT01423604|20516085|P2|Randomized|Death|0
5931143|NCT01423604|20516086|P1|Randomized|Death|1
5931144|NCT01423604|20516085|P2|Randomized|Adverse Event|10
5931145|NCT01423604|20516086|P1|Randomized|Adverse Event|4
5931146|NCT01423604|20516085|P2|Safety Run-In|Patient decision|0
5931147|NCT01423604|20516086|P1|Safety Run-In|Patient decision|1
5931148|NCT01423604|20516085|P2|Safety Run-In|Disease progression|0
5931149|NCT01423604|20516086|P1|Safety Run-In|Disease progression|3
5931150|NCT01423604|20516085|P2|Safety Run-In|Physician Decision|0
5931151|NCT01423604|20516086|P1|Safety Run-In|Physician Decision|1
5931152|NCT01423604|20516085|P2|Safety Run-In|Death|0
5931153|NCT01423604|20516086|P1|Safety Run-In|Death|1
5931154|NCT01423604|20516085|P2|Safety Run-In|Adverse Event|0
5931155|NCT01423604|20516086|P1|Safety Run-In|Adverse Event|3
5931156|NCT01423253|20516101|P1|Overall Study|Withdrawal by Subject|2
5931157|NCT01423253|20516101|P1|Overall Study|Protocol Violation|2
5931158|NCT01423253|20516101|P1|Overall Study|Lost to Follow-up|1
5931159|NCT01423253|20516101|P1|Overall Study|Lack of Efficacy|2
5931160|NCT01423253|20516101|P1|Overall Study|Adverse Event|2
5931161|NCT01423084|20516123|P2|Overall Study|Withdrawal by Subject|3
5931162|NCT01423084|20516124|P1|Overall Study|Withdrawal by Subject|2
5931163|NCT01423084|20516123|P2|Overall Study|Adverse Event|1
5931164|NCT01423084|20516124|P1|Overall Study|Adverse Event|0
5931165|NCT01422915|20516154|P1|Overall Study|Adverse Event|1
5931166|NCT01422889|20516159|P1|Overall Study|No Data Entered for Study Stent|9
5931167|NCT01422876|20516174|P10|Week 52|Death|0
5931168|NCT01422876|20516175|P9|Week 52|Death|1
5931169|NCT01422876|20516176|P8|Week 52|Death|3
5931170|NCT01422876|20516177|P7|Week 52|Death|1
5931171|NCT01422876|20516178|P6|Week 52|Death|0
5931172|NCT01422876|20516179|P5|Week 52|Death|0
5931173|NCT01422876|20516180|P4|Week 52|Death|1
5931174|NCT01422876|20516181|P3|Week 52|Death|0
5931175|NCT01422876|20516182|P2|Week 52|Death|1
5931176|NCT01422876|20516183|P1|Week 52|Death|0
5931177|NCT01422876|20516174|P10|Week 52|Consent withdrawn|9
5931178|NCT01422876|20516175|P9|Week 52|Consent withdrawn|13
5931179|NCT01422876|20516176|P8|Week 52|Consent withdrawn|12
5931180|NCT01422876|20516177|P7|Week 52|Consent withdrawn|10
5931181|NCT01422876|20516178|P6|Week 52|Consent withdrawn|12
5931182|NCT01422876|20516179|P5|Week 52|Consent withdrawn|7
5931183|NCT01422876|20516180|P4|Week 52|Consent withdrawn|12
5931184|NCT01422876|20516181|P3|Week 52|Consent withdrawn|6
5931185|NCT01422876|20516182|P2|Week 52|Consent withdrawn|4
5931186|NCT01422876|20516183|P1|Week 52|Consent withdrawn|9
5931187|NCT01422876|20516174|P10|Week 52|Lost to Follow-up|8
5931188|NCT01422876|20516175|P9|Week 52|Lost to Follow-up|7
5931189|NCT01422876|20516176|P8|Week 52|Lost to Follow-up|8
5931190|NCT01422876|20516177|P7|Week 52|Lost to Follow-up|5
5931191|NCT01422876|20516178|P6|Week 52|Lost to Follow-up|5
5931192|NCT01422876|20516179|P5|Week 52|Lost to Follow-up|8
5931193|NCT01422876|20516180|P4|Week 52|Lost to Follow-up|5
5931194|NCT01422876|20516181|P3|Week 52|Lost to Follow-up|7
5931195|NCT01422876|20516182|P2|Week 52|Lost to Follow-up|5
5931196|NCT01422876|20516183|P1|Week 52|Lost to Follow-up|3
5931197|NCT01422876|20516174|P10|Week 24|Death|0
5931198|NCT01422876|20516175|P9|Week 24|Death|0
5931199|NCT01422876|20516176|P8|Week 24|Death|0
5931200|NCT01422876|20516177|P7|Week 24|Death|0
5931201|NCT01422876|20516178|P6|Week 24|Death|0
5931202|NCT01422876|20516179|P5|Week 24|Death|0
5931203|NCT01422876|20516180|P4|Week 24|Death|0
5931204|NCT01422876|20516181|P3|Week 24|Death|0
5931205|NCT01422876|20516182|P2|Week 24|Death|1
5931206|NCT01422876|20516183|P1|Week 24|Death|0
5931207|NCT01422876|20516174|P10|Week 24|Consent withdrawn|6
5931208|NCT01422876|20516175|P9|Week 24|Consent withdrawn|3
5931209|NCT01422876|20516176|P8|Week 24|Consent withdrawn|4
5931210|NCT01422876|20516177|P7|Week 24|Consent withdrawn|5
5931211|NCT01422876|20516178|P6|Week 24|Consent withdrawn|6
5931212|NCT01422876|20516179|P5|Week 24|Consent withdrawn|5
5931213|NCT01422876|20516180|P4|Week 24|Consent withdrawn|4
5931214|NCT01422876|20516181|P3|Week 24|Consent withdrawn|3
5931215|NCT01422876|20516182|P2|Week 24|Consent withdrawn|1
5931216|NCT01422876|20516183|P1|Week 24|Consent withdrawn|5
5931217|NCT01422876|20516174|P10|Week 24|Lost to Follow-up|4
5931218|NCT01422876|20516175|P9|Week 24|Lost to Follow-up|3
5931219|NCT01422876|20516176|P8|Week 24|Lost to Follow-up|3
5931220|NCT01422876|20516177|P7|Week 24|Lost to Follow-up|1
5931221|NCT01422876|20516178|P6|Week 24|Lost to Follow-up|0
5931222|NCT01422876|20516179|P5|Week 24|Lost to Follow-up|2
5931223|NCT01422876|20516180|P4|Week 24|Lost to Follow-up|4
5931224|NCT01422876|20516181|P3|Week 24|Lost to Follow-up|2
5931225|NCT01422876|20516182|P2|Week 24|Lost to Follow-up|1
5931226|NCT01422876|20516183|P1|Week 24|Lost to Follow-up|1
5931227|NCT01422850|20516230|P1|Overall Study|Physician Decision|3
5931228|NCT01422824|20516236|P1|Overall Study|Lost to Follow-up|37
5931229|NCT01422824|20516236|P1|Overall Study|Case record form not evaluated|1
5931230|NCT01422720|20516241|P1|Overall Study|Ineligibility|1
5931231|NCT01422720|20516241|P1|Overall Study|Withdrawal by Subject|4
5931232|NCT01422720|20516241|P1|Overall Study|Lack of Efficacy|1
5931233|NCT01422720|20516241|P1|Overall Study|Adverse Event|16
5931234|NCT01422538|20516252|P3|Overall Study|Missed visit|1
5931235|NCT01422538|20516253|P2|Overall Study|Missed visit|1
5931236|NCT01422538|20516254|P1|Overall Study|Missed visit|0
5931237|NCT01422538|20516252|P3|Overall Study|Lost to Follow-up|1
5931238|NCT01422538|20516253|P2|Overall Study|Lost to Follow-up|1
5931239|NCT01422538|20516254|P1|Overall Study|Lost to Follow-up|0
5931240|NCT01422408|20516298|P1|Overall Study|Withdrawal by Subject|3
5931241|NCT01422408|20516298|P1|Overall Study|Adverse Event|1
5931242|NCT01422382|20516327|P1|NK-104 4mg QD and Diltiazem 240 mg QD|personal reasons|1
5931257|NCT01422239|20516376|P2|Overall Study|Lost to Follow-up|3
5931258|NCT01422239|20516377|P1|Overall Study|Lost to Follow-up|4
5931259|NCT01422213|20516399|P3|Overall Study|Administrative or Other Reason(s)|2
5931260|NCT01422213|20516400|P2|Overall Study|Administrative or Other Reason(s)|4
5931261|NCT01422213|20516401|P1|Overall Study|Administrative or Other Reason(s)|5
5931262|NCT01422213|20516399|P3|Overall Study|Lost to Follow-up|5
5931263|NCT01422213|20516400|P2|Overall Study|Lost to Follow-up|3
5931264|NCT01422213|20516401|P1|Overall Study|Lost to Follow-up|3
5931265|NCT01422213|20516399|P3|Overall Study|Withdrawal of Consent|5
5931266|NCT01422213|20516400|P2|Overall Study|Withdrawal of Consent|3
5931267|NCT01422213|20516401|P1|Overall Study|Withdrawal of Consent|7
5931268|NCT01422213|20516399|P3|Overall Study|Protocol Violation|4
5931269|NCT01422213|20516400|P2|Overall Study|Protocol Violation|2
5931270|NCT01422213|20516401|P1|Overall Study|Protocol Violation|0
5931271|NCT01422213|20516399|P3|Overall Study|Non-compliance with study drug|0
5931272|NCT01422213|20516400|P2|Overall Study|Non-compliance with study drug|1
5931273|NCT01422213|20516401|P1|Overall Study|Non-compliance with study drug|0
5931274|NCT01422213|20516399|P3|Overall Study|Lack of Efficacy|2
5931275|NCT01422213|20516400|P2|Overall Study|Lack of Efficacy|2
5931276|NCT01422213|20516401|P1|Overall Study|Lack of Efficacy|10
5931277|NCT01422213|20516399|P3|Overall Study|Adverse Event|11
5931278|NCT01422213|20516400|P2|Overall Study|Adverse Event|7
5931279|NCT01422213|20516401|P1|Overall Study|Adverse Event|8
5931280|NCT01422187|20516473|P3|Overall Study|Lost to Follow-up|0
5931281|NCT01422187|20516474|P2|Overall Study|Lost to Follow-up|1
5931282|NCT01422187|20516475|P1|Overall Study|Lost to Follow-up|0
5931283|NCT01422187|20516473|P3|Overall Study|Personal reason|0
5931284|NCT01422187|20516474|P2|Overall Study|Personal reason|0
5931285|NCT01422187|20516475|P1|Overall Study|Personal reason|1
5931286|NCT01421719|20516539|P1|Overall Study|Withdrawal by Subject|4
5931287|NCT01421667|20516548|P4|Overall Study|Lost to Follow-up|0
5931288|NCT01421667|20516549|P3|Overall Study|Lost to Follow-up|0
5931289|NCT01421667|20516550|P2|Overall Study|Lost to Follow-up|1
5931290|NCT01421667|20516551|P1|Overall Study|Lost to Follow-up|0
5931291|NCT01421667|20516548|P4|Overall Study|Withdrawal by Subject|1
5931292|NCT01421667|20516549|P3|Overall Study|Withdrawal by Subject|2
5931293|NCT01421667|20516550|P2|Overall Study|Withdrawal by Subject|1
5931294|NCT01421667|20516551|P1|Overall Study|Withdrawal by Subject|0
5931295|NCT01421641|20516612|P2|Overall Study|Protocol Violation|2
5931296|NCT01421641|20516613|P1|Overall Study|Protocol Violation|2
5931297|NCT01421511|20516635|P2|Overall Study|Death|1
5931298|NCT01421511|20516636|P1|Overall Study|Death|1
5931299|NCT01421511|20516635|P2|Overall Study|Withdrawal by Subject|5
5931300|NCT01421511|20516636|P1|Overall Study|Withdrawal by Subject|6
5931301|NCT01421511|20516635|P2|Overall Study|Physician Decision|1
5931302|NCT01421511|20516636|P1|Overall Study|Physician Decision|0
5931303|NCT01421511|20516635|P2|Overall Study|Randomized but didn't receive study drug|7
5931304|NCT01421511|20516636|P1|Overall Study|Randomized but didn't receive study drug|1
5931305|NCT01421511|20516635|P2|Overall Study|Lost to Follow-up|14
5931306|NCT01421511|20516636|P1|Overall Study|Lost to Follow-up|11
5931307|NCT01421459|20516686|P2|Overall Study|Withdrawal by Subject|16
5931308|NCT01421459|20516687|P1|Overall Study|Withdrawal by Subject|12
5931309|NCT01421459|20516686|P2|Overall Study|Protocol Violation|5
5931310|NCT01421459|20516687|P1|Overall Study|Protocol Violation|8
5931311|NCT01421459|20516686|P2|Overall Study|Physician Decision|9
5931312|NCT01421459|20516687|P1|Overall Study|Physician Decision|9
5931313|NCT01421459|20516686|P2|Overall Study|Lost to Follow-up|9
5931314|NCT01421459|20516687|P1|Overall Study|Lost to Follow-up|8
5931315|NCT01421459|20516686|P2|Overall Study|Lack of Efficacy|2
5931316|NCT01421459|20516687|P1|Overall Study|Lack of Efficacy|1
5931317|NCT01421459|20516686|P2|Overall Study|Death|1
5931318|NCT01421459|20516687|P1|Overall Study|Death|1
5931319|NCT01421459|20516686|P2|Overall Study|Adverse Event|10
5931320|NCT01421459|20516687|P1|Overall Study|Adverse Event|6
5931321|NCT01421342|20516728|P3|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|7
5931322|NCT01421342|20516729|P2|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|0
5931323|NCT01421342|20516730|P1|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|6
5931324|NCT01421342|20516728|P3|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2
5931325|NCT01421342|20516729|P2|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2
5931326|NCT01421342|20516730|P1|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2
5931327|NCT01421342|20516728|P3|Continuation of Treatment (Week 12 - 36)|Participant moved away|3
5931328|NCT01421342|20516729|P2|Continuation of Treatment (Week 12 - 36)|Participant moved away|1
5931329|NCT01421342|20516730|P1|Continuation of Treatment (Week 12 - 36)|Participant moved away|4
5931330|NCT01421342|20516728|P3|Continuation of Treatment (Week 12 - 36)|End of Study Time|14
5931331|NCT01421342|20516729|P2|Continuation of Treatment (Week 12 - 36)|End of Study Time|20
5931332|NCT01421342|20516730|P1|Continuation of Treatment (Week 12 - 36)|End of Study Time|15
5931333|NCT01421342|20516728|P3|Continuation of Treatment (Week 12 - 36)|Non-adherence|4
5931334|NCT01421342|20516729|P2|Continuation of Treatment (Week 12 - 36)|Non-adherence|8
5931335|NCT01421342|20516730|P1|Continuation of Treatment (Week 12 - 36)|Non-adherence|3
5931336|NCT01421342|20516728|P3|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|9
5931337|NCT01421342|20516729|P2|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|11
5931338|NCT01421342|20516730|P1|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|4
5931339|NCT01421342|20516728|P3|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|4
5931340|NCT01421342|20516729|P2|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|6
5931341|NCT01421342|20516730|P1|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|7
5931342|NCT01421342|20516728|P3|Continuation of Treatment (Week 12 - 36)|Adverse Event|11
5931343|NCT01421342|20516729|P2|Continuation of Treatment (Week 12 - 36)|Adverse Event|6
5931344|NCT01421342|20516730|P1|Continuation of Treatment (Week 12 - 36)|Adverse Event|0
5931345|NCT01421342|20516728|P3|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11
5931346|NCT01421342|20516729|P2|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|5
5931347|NCT01421342|20516730|P1|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11
5931348|NCT01421342|20516728|P3|Completed to Week 12 But Then Withdrawn|End of Study Time|2
5931349|NCT01421342|20516729|P2|Completed to Week 12 But Then Withdrawn|End of Study Time|0
5931350|NCT01421342|20516730|P1|Completed to Week 12 But Then Withdrawn|End of Study Time|0
5931351|NCT01421342|20516728|P3|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|4
5931352|NCT01421342|20516729|P2|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3
5931353|NCT01421342|20516730|P1|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3
5931354|NCT01421342|20516728|P3|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5
5931355|NCT01421342|20516729|P2|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5
5931356|NCT01421342|20516730|P1|Completed to Week 12 But Then Withdrawn|Participant Moved Away|1
5931357|NCT01421342|20516728|P3|Completed to Week 12 But Then Withdrawn|Due to Other Illness|2
5931358|NCT01421342|20516729|P2|Completed to Week 12 But Then Withdrawn|Due to Other Illness|0
5931359|NCT01421342|20516730|P1|Completed to Week 12 But Then Withdrawn|Due to Other Illness|1
5931360|NCT01421342|20516728|P3|Completed to Week 12 But Then Withdrawn|Non-adherence|5
5931361|NCT01421342|20516729|P2|Completed to Week 12 But Then Withdrawn|Non-adherence|4
5931362|NCT01421342|20516730|P1|Completed to Week 12 But Then Withdrawn|Non-adherence|5
5931363|NCT01421342|20516728|P3|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3
5931364|NCT01421342|20516729|P2|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3
5931365|NCT01421342|20516730|P1|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|4
5931366|NCT01421342|20516728|P3|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|11
5931367|NCT01421342|20516729|P2|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|4
5931368|NCT01421342|20516730|P1|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|13
5931369|NCT01421342|20516728|P3|Completed to Week 12 But Then Withdrawn|Adverse Event|6
5931370|NCT01421342|20516729|P2|Completed to Week 12 But Then Withdrawn|Adverse Event|3
5931371|NCT01421342|20516730|P1|Completed to Week 12 But Then Withdrawn|Adverse Event|4
5931372|NCT01421342|20516728|P3|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|12
5931373|NCT01421342|20516729|P2|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|10
5931374|NCT01421342|20516730|P1|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|7
5931375|NCT01421342|20516728|P3|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|88
5931376|NCT01421342|20516729|P2|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|93
5931377|NCT01421342|20516730|P1|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|111
5931378|NCT01421342|20516728|P3|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|4
5931379|NCT01421342|20516729|P2|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|9
5931380|NCT01421342|20516730|P1|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|8
5931381|NCT01421342|20516728|P3|Acute Treatment Phase (12 Weeks)|Participant moved away|1
5931382|NCT01421342|20516729|P2|Acute Treatment Phase (12 Weeks)|Participant moved away|6
5931383|NCT01421342|20516730|P1|Acute Treatment Phase (12 Weeks)|Participant moved away|1
5931384|NCT01421342|20516728|P3|Acute Treatment Phase (12 Weeks)|Dure to other illness|4
5931385|NCT01421342|20516729|P2|Acute Treatment Phase (12 Weeks)|Dure to other illness|2
5931386|NCT01421342|20516730|P1|Acute Treatment Phase (12 Weeks)|Dure to other illness|3
5931387|NCT01421342|20516728|P3|Acute Treatment Phase (12 Weeks)|Non-adherence|13
5931388|NCT01421342|20516729|P2|Acute Treatment Phase (12 Weeks)|Non-adherence|7
5931389|NCT01421342|20516730|P1|Acute Treatment Phase (12 Weeks)|Non-adherence|15
5931390|NCT01421342|20516728|P3|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|21
5931391|NCT01421342|20516729|P2|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|18
5931392|NCT01421342|20516730|P1|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|6
5931393|NCT01421342|20516728|P3|Acute Treatment Phase (12 Weeks)|Death|3
5931394|NCT01421342|20516729|P2|Acute Treatment Phase (12 Weeks)|Death|0
5931395|NCT01421342|20516730|P1|Acute Treatment Phase (12 Weeks)|Death|0
5931396|NCT01421342|20516728|P3|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|13
5931397|NCT01421342|20516729|P2|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|20
5931398|NCT01421342|20516730|P1|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|23
5931399|NCT01421342|20516728|P3|Acute Treatment Phase (12 Weeks)|Adverse Event|27
5931400|NCT01421342|20516729|P2|Acute Treatment Phase (12 Weeks)|Adverse Event|38
5931401|NCT01421342|20516730|P1|Acute Treatment Phase (12 Weeks)|Adverse Event|53
5931402|NCT01421342|20516728|P3|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|13
5931403|NCT01421342|20516729|P2|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|28
5931404|NCT01421342|20516730|P1|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|49
5931405|NCT01421303|20516747|P1|Overall Study|Withdrawal by Subject|1
5931406|NCT01421303|20516747|P1|Overall Study|Other|7
5931407|NCT01421303|20516747|P1|Overall Study|Non compliance with study procedure|1
5931408|NCT01421303|20516747|P1|Overall Study|Lost to Follow-up|13
5931409|NCT01421277|20516774|P2|Overall Study|Incomplete baseline data|31
5931410|NCT01421277|20516775|P1|Overall Study|Incomplete baseline data|0
5931411|NCT01421277|20516774|P2|Overall Study|Lack of qualifying event|61
5931412|NCT01421277|20516775|P1|Overall Study|Lack of qualifying event|0
5931413|NCT01421225|20516787|P2|Overall Study|Withdrawal by Subject|1
5931414|NCT01421225|20516788|P1|Overall Study|Withdrawal by Subject|0
5931415|NCT01421147|20516802|P2|Extension Period|Withdrawal by Subject|3
5931416|NCT01421147|20516803|P1|Extension Period|Withdrawal by Subject|5
5931417|NCT01421147|20516802|P2|Extension Period|Physician Decision|0
5931418|NCT01421147|20516803|P1|Extension Period|Physician Decision|1
5931419|NCT01421147|20516802|P2|Extension Period|Lost to Follow-up|5
5931420|NCT01421147|20516803|P1|Extension Period|Lost to Follow-up|2
5931421|NCT01421147|20516802|P2|Extension Period|Death|1
5931422|NCT01421147|20516803|P1|Extension Period|Death|0
5931423|NCT01421147|20516802|P2|Extension Period|Adverse Event|2
5931424|NCT01421147|20516803|P1|Extension Period|Adverse Event|0
5931425|NCT01421147|20516802|P2|Treatment Period|Withdrawal by Subject|5
5931426|NCT01421147|20516803|P1|Treatment Period|Withdrawal by Subject|10
5931427|NCT01421147|20516802|P2|Treatment Period|Physician Decision|2
5931428|NCT01421147|20516803|P1|Treatment Period|Physician Decision|2
5931429|NCT01421147|20516802|P2|Treatment Period|Lost to Follow-up|1
5931430|NCT01421147|20516803|P1|Treatment Period|Lost to Follow-up|2
5931431|NCT01421147|20516802|P2|Treatment Period|Adverse Event|3
5931432|NCT01421147|20516803|P1|Treatment Period|Adverse Event|2
5931433|NCT01421134|20516835|P2|Overall Study|Lost to Follow-up|1
5931434|NCT01421134|20516836|P1|Overall Study|Lost to Follow-up|1
5931435|NCT01421134|20516835|P2|Overall Study|Administrative|1
5931436|NCT01421134|20516836|P1|Overall Study|Administrative|0
5931437|NCT01421134|20516835|P2|Overall Study|Withdrawal by Subject|1
5931438|NCT01421134|20516836|P1|Overall Study|Withdrawal by Subject|1
5931439|NCT01421134|20516835|P2|Overall Study|Protocol Violation|3
5931440|NCT01421134|20516836|P1|Overall Study|Protocol Violation|0
5931441|NCT01421134|20516835|P2|Overall Study|Lack of Efficacy|4
5931442|NCT01421134|20516836|P1|Overall Study|Lack of Efficacy|2
5931443|NCT01421134|20516835|P2|Overall Study|Adverse Event|5
5931444|NCT01421134|20516836|P1|Overall Study|Adverse Event|3
5931445|NCT01420965|20516857|P3|Overall Study|Adverse Event|0
5931446|NCT01420965|20516858|P2|Overall Study|Adverse Event|1
5931447|NCT01420965|20516859|P1|Overall Study|Adverse Event|0
5931448|NCT01420965|20516857|P3|Overall Study|Withdrawal by Subject|0
5931449|NCT01420965|20516858|P2|Overall Study|Withdrawal by Subject|0
5931450|NCT01420965|20516859|P1|Overall Study|Withdrawal by Subject|1
5931463|NCT01420627|20516920|P1|EZN-2279 Treatment Period|Adverse Event|1
5931464|NCT01420549|20516936|P2|Overall Study|Non-adherence to medication|1
5931465|NCT01420549|20516937|P1|Overall Study|Non-adherence to medication|4
5931466|NCT01420549|20516936|P2|Overall Study|Protocol Violation|1
5931467|NCT01420549|20516937|P1|Overall Study|Protocol Violation|0
5931468|NCT01420549|20516936|P2|Overall Study|Lost to Follow-up|2
5931469|NCT01420549|20516937|P1|Overall Study|Lost to Follow-up|2
5931470|NCT01420549|20516936|P2|Overall Study|Adverse Event|1
5931471|NCT01420549|20516937|P1|Overall Study|Adverse Event|1
5931472|NCT01420536|20516945|P2|Period 1 (30 Days)|Withdrawal by Subject|0
5931473|NCT01420536|20516946|P1|Period 1 (30 Days)|Withdrawal by Subject|3
5931474|NCT01420081|20517004|P9|Overall Study|Other Reasons|0
5931475|NCT01420081|20517005|P8|Overall Study|Other Reasons|0
5931476|NCT01420081|20517006|P7|Overall Study|Other Reasons|0
5931477|NCT01420081|20517007|P6|Overall Study|Other Reasons|0
5931478|NCT01420081|20517008|P5|Overall Study|Other Reasons|0
5931479|NCT01420081|20517009|P4|Overall Study|Other Reasons|0
5931480|NCT01420081|20517010|P3|Overall Study|Other Reasons|1
5931481|NCT01420081|20517011|P2|Overall Study|Other Reasons|0
5931482|NCT01420081|20517012|P1|Overall Study|Other Reasons|0
5931483|NCT01420081|20517004|P9|Overall Study|Subject Refused Futher Follow-up|0
5931484|NCT01420081|20517005|P8|Overall Study|Subject Refused Futher Follow-up|0
5931485|NCT01420081|20517006|P7|Overall Study|Subject Refused Futher Follow-up|0
5931486|NCT01420081|20517007|P6|Overall Study|Subject Refused Futher Follow-up|0
5931487|NCT01420081|20517008|P5|Overall Study|Subject Refused Futher Follow-up|1
5931488|NCT01420081|20517009|P4|Overall Study|Subject Refused Futher Follow-up|0
5931489|NCT01420081|20517010|P3|Overall Study|Subject Refused Futher Follow-up|1
5931490|NCT01420081|20517011|P2|Overall Study|Subject Refused Futher Follow-up|0
5931491|NCT01420081|20517012|P1|Overall Study|Subject Refused Futher Follow-up|0
5931492|NCT01420081|20517004|P9|Overall Study|Study Terminated by Sponsor|2
5931493|NCT01420081|20517005|P8|Overall Study|Study Terminated by Sponsor|2
5931494|NCT01420081|20517006|P7|Overall Study|Study Terminated by Sponsor|3
5931495|NCT01420081|20517007|P6|Overall Study|Study Terminated by Sponsor|7
5931496|NCT01420081|20517008|P5|Overall Study|Study Terminated by Sponsor|11
5931497|NCT01420081|20517009|P4|Overall Study|Study Terminated by Sponsor|3
5931498|NCT01420081|20517010|P3|Overall Study|Study Terminated by Sponsor|1
5931499|NCT01420081|20517011|P2|Overall Study|Study Terminated by Sponsor|1
5931500|NCT01420081|20517012|P1|Overall Study|Study Terminated by Sponsor|2
5931501|NCT01420081|20517004|P9|Overall Study|Lost to Follow-up|0
5931502|NCT01420081|20517005|P8|Overall Study|Lost to Follow-up|0
5931503|NCT01420081|20517006|P7|Overall Study|Lost to Follow-up|0
5931504|NCT01420081|20517007|P6|Overall Study|Lost to Follow-up|1
5931505|NCT01420081|20517008|P5|Overall Study|Lost to Follow-up|1
5931506|NCT01420081|20517009|P4|Overall Study|Lost to Follow-up|0
5931507|NCT01420081|20517010|P3|Overall Study|Lost to Follow-up|0
5931508|NCT01420081|20517011|P2|Overall Study|Lost to Follow-up|0
5931509|NCT01420081|20517012|P1|Overall Study|Lost to Follow-up|0
5931510|NCT01420081|20517004|P9|Overall Study|Death|1
5931511|NCT01420081|20517005|P8|Overall Study|Death|1
5931512|NCT01420081|20517006|P7|Overall Study|Death|0
5931513|NCT01420081|20517007|P6|Overall Study|Death|12
5931514|NCT01420081|20517008|P5|Overall Study|Death|7
5931515|NCT01420081|20517009|P4|Overall Study|Death|0
5931516|NCT01420081|20517010|P3|Overall Study|Death|8
5931517|NCT01420081|20517011|P2|Overall Study|Death|0
5931518|NCT01420081|20517012|P1|Overall Study|Death|1
5931519|NCT01420068|20517093|P2|Overall Study|Withdrawal by Subject|2
5931520|NCT01420068|20517094|P1|Overall Study|Withdrawal by Subject|1
5931521|NCT01420068|20517093|P2|Overall Study|Administrative problems|3
5931522|NCT01420068|20517094|P1|Overall Study|Administrative problems|1
5931523|NCT01419769|20517165|P1|Overall Study|Not evaluable due to pigtail stents|1
5931524|NCT01419769|20517165|P1|Overall Study|Did not receive the AXIOS stent|3
5931525|NCT01419717|20517178|P1|Overall Study|Noncompliance|1
5931526|NCT01419717|20517178|P1|Overall Study|Administrative Decision|1
5931527|NCT01419717|20517178|P1|Overall Study|Lost to Follow-up|2
5931528|NCT01419717|20517178|P1|Overall Study|Other|4
5931529|NCT01419717|20517178|P1|Overall Study|Disease Progression|9
5931530|NCT01419717|20517178|P1|Overall Study|Withdrawal by Subject|10
5931531|NCT01419717|20517178|P1|Overall Study|Death|17
5931532|NCT01419717|20517178|P1|Overall Study|Adverse Event|19
5931533|NCT01419717|20517178|P1|Overall Study|Protocol-specified Criteria|62
5931534|NCT01419626|20517192|P3|Overall Study|Lost to Follow-up|1
5931535|NCT01419626|20517193|P2|Overall Study|Lost to Follow-up|1
5931536|NCT01419626|20517194|P1|Overall Study|Lost to Follow-up|0
5931537|NCT01419626|20517192|P3|Overall Study|Withdrawal by Subject|0
5931538|NCT01419626|20517193|P2|Overall Study|Withdrawal by Subject|0
5931539|NCT01419626|20517194|P1|Overall Study|Withdrawal by Subject|1
5931540|NCT01419626|20517192|P3|Overall Study|Protocol Violation|2
5931541|NCT01419626|20517193|P2|Overall Study|Protocol Violation|2
5931542|NCT01419626|20517194|P1|Overall Study|Protocol Violation|3
5931543|NCT01419314|20517225|P2|Follow-up at Week 6 of the Trial|Lost to Follow-up|2
5931544|NCT01419314|20517226|P1|Follow-up at Week 6 of the Trial|Lost to Follow-up|1
5931545|NCT01419314|20517225|P2|Follow-up at Week 3 of the Trial|Lost to Follow-up|0
5931546|NCT01419314|20517226|P1|Follow-up at Week 3 of the Trial|Lost to Follow-up|3
5931547|NCT01419314|20517225|P2|Follow-up at Week 3 of the Trial|Withdrawal by Subject|1
5931548|NCT01419314|20517226|P1|Follow-up at Week 3 of the Trial|Withdrawal by Subject|3
5931549|NCT01419236|20517267|P2|Overall Study|Entry Criteria Not Met|0
5931550|NCT01419236|20517268|P1|Overall Study|Entry Criteria Not Met|1
5931551|NCT01419236|20517267|P2|Overall Study|Withdrawal by Subject|4
5931552|NCT01419236|20517268|P1|Overall Study|Withdrawal by Subject|1
5931553|NCT01419236|20517267|P2|Overall Study|Physician Decision|0
5931554|NCT01419236|20517268|P1|Overall Study|Physician Decision|1
5931555|NCT01419236|20517267|P2|Overall Study|Lost to Follow-up|0
5931556|NCT01419236|20517268|P1|Overall Study|Lost to Follow-up|1
5931557|NCT01419236|20517267|P2|Overall Study|Lack of Efficacy|1
5931558|NCT01419236|20517268|P1|Overall Study|Lack of Efficacy|0
5931559|NCT01419236|20517267|P2|Overall Study|Adverse Event|0
5931560|NCT01419236|20517268|P1|Overall Study|Adverse Event|1
5931561|NCT01419197|20517292|P2|Overall Study|Lost to Follow-up|4
5931562|NCT01419197|20517293|P1|Overall Study|Lost to Follow-up|14
5931563|NCT01419197|20517292|P2|Overall Study|Reason Not Specified|1
5931564|NCT01419197|20517293|P1|Overall Study|Reason Not Specified|0
5931565|NCT01419197|20517292|P2|Overall Study|Study Completed by Sponsor|34
5931566|NCT01419197|20517293|P1|Overall Study|Study Completed by Sponsor|103
5931567|NCT01419197|20517292|P2|Overall Study|Withdrawal by Subject|32
5931568|NCT01419197|20517293|P1|Overall Study|Withdrawal by Subject|33
5931569|NCT01419197|20517292|P2|Overall Study|Non-compliance|1
5931570|NCT01419197|20517293|P1|Overall Study|Non-compliance|3
5931571|NCT01419197|20517292|P2|Overall Study|Physician Decision|4
5931572|NCT01419197|20517293|P1|Overall Study|Physician Decision|4
5931573|NCT01419197|20517292|P2|Overall Study|Death|122
5931574|NCT01419197|20517293|P1|Overall Study|Death|247
5931575|NCT01419184|20517318|P2|Overall Study|Participant randomized, not treated|0
5931576|NCT01419184|20517319|P1|Overall Study|Participant randomized, not treated|1
5931577|NCT01419184|20517318|P2|Overall Study|No IRLOS-No adverse event treatment date|1
5931578|NCT01419184|20517319|P1|Overall Study|No IRLOS-No adverse event treatment date|0
5931579|NCT01419184|20517318|P2|Overall Study|No IRLOS-non trial antibiotic used|2
5931580|NCT01419184|20517319|P1|Overall Study|No IRLOS-non trial antibiotic used|1
5931581|NCT01419184|20517318|P2|Overall Study|No IRLOS-randomized, not treated|4
5931582|NCT01419184|20517319|P1|Overall Study|No IRLOS-randomized, not treated|2
5931583|NCT01419184|20517318|P2|Overall Study|No IRLOS-No in-patient end date reported|6
5931584|NCT01419184|20517319|P1|Overall Study|No IRLOS-No in-patient end date reported|3
5931585|NCT01419184|20517318|P2|Overall Study|Site data not available|2
5931586|NCT01419184|20517319|P1|Overall Study|Site data not available|3
5931587|NCT01419080|20517352|P1|Overall Study|Too Ill|3
5931588|NCT01419080|20517352|P1|Overall Study|Lost to Follow-up|23
5931589|NCT01419080|20517352|P1|Overall Study|Death|30
5931590|NCT01419080|20517352|P1|Overall Study|Withdrawal by Subject|75
5931591|NCT01419015|20517363|P1|Overall Study|Death|2
5931592|NCT01418937|20517367|P1|Overall Study|Withdrawal by Subject|1
5931593|NCT01418937|20517367|P1|Overall Study|Pregnancy|1
5931594|NCT01418937|20517367|P1|Overall Study|Protocol Violation|1
5931595|NCT01418937|20517367|P1|Overall Study|Lost to Follow-up|5
5931596|NCT01418378|20517398|P2|Overall Study|developed chronic myopathy|1
5931597|NCT01418378|20517399|P1|Overall Study|developed chronic myopathy|0
5931598|NCT01418378|20517398|P2|Overall Study|ligament imbalance|1
5931599|NCT01418378|20517399|P1|Overall Study|ligament imbalance|0
5931600|NCT01418378|20517398|P2|Overall Study|Physician Decision|1
5931601|NCT01418378|20517399|P1|Overall Study|Physician Decision|0
5931602|NCT01418378|20517398|P2|Overall Study|Death|2
5931603|NCT01418378|20517399|P1|Overall Study|Death|1
5931604|NCT01418365|20517473|P2|Second Intervention|Withdrawal by Subject|1
5931605|NCT01418365|20517474|P1|Second Intervention|Withdrawal by Subject|0
5931606|NCT01418365|20517473|P2|First Intervention|Non-compliance|0
5931607|NCT01418365|20517474|P1|First Intervention|Non-compliance|1
5931608|NCT01418365|20517473|P2|First Intervention|Withdrawal by Subject|1
5931609|NCT01418365|20517474|P1|First Intervention|Withdrawal by Subject|0
5931610|NCT01418209|20517485|P3|Overall Study|Did not provide hot flash diary data|3
5931611|NCT01418209|20517486|P2|Overall Study|Did not provide hot flash diary data|3
5931612|NCT01418209|20517487|P1|Overall Study|Did not provide hot flash diary data|1
5931613|NCT01418209|20517485|P3|Overall Study|Withdrawal by Subject|1
5931614|NCT01418209|20517486|P2|Overall Study|Withdrawal by Subject|0
5931615|NCT01418209|20517487|P1|Overall Study|Withdrawal by Subject|1
5931616|NCT01417481|20517551|P2|First Intervention (8 Weeks)|Withdrawal by Subject|2
5931617|NCT01417481|20517552|P1|First Intervention (8 Weeks)|Withdrawal by Subject|0
5931618|NCT01417377|20517617|P1|Overall Study|Enrolled, but not treated|1
5931619|NCT01417377|20517617|P1|Overall Study|Lost to Follow-up|12
5931620|NCT01417234|20517624|P1|Overall Study|Subject non-compliant|3
5931621|NCT01417195|20517633|P2|Overall Study|No transfer due to elevated progesterone|0
5931622|NCT01417195|20517634|P1|Overall Study|No transfer due to elevated progesterone|1
5931623|NCT01417195|20517633|P2|Overall Study|No transfer due to risk of OHSS|0
5931624|NCT01417195|20517634|P1|Overall Study|No transfer due to risk of OHSS|1
5931625|NCT01417195|20517633|P2|Overall Study|No embryos for transfer|1
5931626|NCT01417195|20517634|P1|Overall Study|No embryos for transfer|0
5931627|NCT01417195|20517633|P2|Overall Study|Stimulation failure|0
5931628|NCT01417195|20517634|P1|Overall Study|Stimulation failure|1
5931629|NCT01417156|20517650|P1|Overall Study|Protocol Violation|2
5931630|NCT01417156|20517650|P1|Overall Study|Adverse Event|12
5931631|NCT01417104|20517660|P2|Overall Study|Adverse Event|0
5931632|NCT01417104|20517661|P1|Overall Study|Adverse Event|1
5931633|NCT01417104|20517660|P2|Overall Study|Failure to make contact|1
5931634|NCT01417104|20517661|P1|Overall Study|Failure to make contact|0
5931635|NCT01417104|20517660|P2|Overall Study|Withdrawal by Subject|1
5931636|NCT01417104|20517661|P1|Overall Study|Withdrawal by Subject|5
5931637|NCT01417078|20517671|P1|Overall Study|Withdrawal by Subject|1
5931638|NCT01417000|20517696|P2|Overall Study|Study Terminated by Sponsor|1
5931639|NCT01417000|20517697|P1|Overall Study|Study Terminated by Sponsor|1
5931640|NCT01417000|20517696|P2|Overall Study|Lost to Follow-up|0
5931641|NCT01417000|20517697|P1|Overall Study|Lost to Follow-up|1
5931642|NCT01417000|20517696|P2|Overall Study|Death|28
5931643|NCT01417000|20517697|P1|Overall Study|Death|59
5931644|NCT01416805|20517714|P2|Overall Study|Lost to Follow-up|4
5931645|NCT01416805|20517715|P1|Overall Study|Lost to Follow-up|4
5931646|NCT01416610|20517754|P1|Overall Study|Sufficient treatment duration (PCR neg.)|7
5931647|NCT01416610|20517754|P1|Overall Study|Lost to Follow-up|7
5931648|NCT01416610|20517754|P1|Overall Study|Withdrawal by Subject|13
5931649|NCT01416610|20517754|P1|Overall Study|No reason given|5
5931650|NCT01416610|20517754|P1|Overall Study|Lack of Efficacy|4
5931651|NCT01416610|20517754|P1|Overall Study|Adverse Event -Patient decision|3
5931652|NCT01416610|20517754|P1|Overall Study|Adverse Event|4
5931653|NCT01416571|20517808|P1|Overall Study|Lost to Follow-up|2
5931654|NCT01416389|20517837|P2|Overall Study|Started New Therapy|0
5931655|NCT01416389|20517838|P1|Overall Study|Started New Therapy|2
5931656|NCT01416389|20517837|P2|Overall Study|Lost to Follow-up|0
5931657|NCT01416389|20517838|P1|Overall Study|Lost to Follow-up|1
5931658|NCT01416272|20517855|P1|Overall Study|Study related complaints|1
5931659|NCT01416272|20517855|P1|Overall Study|Lost to Follow-up|1
5931660|NCT01416272|20517855|P1|Overall Study|Unacceptable distance visual acuity|2
5931661|NCT01416181|20517912|P2|Part 2|Lost to Follow-up|2
5931662|NCT01416181|20517913|P1|Part 2|Lost to Follow-up|2
5931663|NCT01416181|20517912|P2|Part 2|Lack of Efficacy|1
5931664|NCT01416181|20517913|P1|Part 2|Lack of Efficacy|4
5931665|NCT01416181|20517912|P2|Part 2|Withdrawal by Subject|5
5931666|NCT01416181|20517913|P1|Part 2|Withdrawal by Subject|14
5931667|NCT01416181|20517912|P2|Part 2|Investigator Decision|7
5931668|NCT01416181|20517913|P1|Part 2|Investigator Decision|6
5931669|NCT01416181|20517912|P2|Part 2|Other|267
5931670|NCT01416181|20517913|P1|Part 2|Other|234
5931671|NCT01416181|20517912|P2|Part 2|Adverse Event|4
5931672|NCT01416181|20517913|P1|Part 2|Adverse Event|11
5931673|NCT01416181|20517912|P2|Part 1|Ongoing in Follow-Up|8
5931674|NCT01416181|20517913|P1|Part 1|Ongoing in Follow-Up|14
5931675|NCT01416181|20517912|P2|Part 1|Adverse Event|18
5931676|NCT01416181|20517913|P1|Part 1|Adverse Event|15
5931677|NCT01416181|20517912|P2|Part 1|Lost to Follow-up|1
5931678|NCT01416181|20517913|P1|Part 1|Lost to Follow-up|1
5931679|NCT01416181|20517912|P2|Part 1|Lack of Efficacy|8
5931680|NCT01416181|20517913|P1|Part 1|Lack of Efficacy|16
5931681|NCT01416181|20517912|P2|Part 1|Withdrawal by Subject|48
5931682|NCT01416181|20517913|P1|Part 1|Withdrawal by Subject|74
5931683|NCT01416181|20517912|P2|Part 1|Investigator Decision|6
5931684|NCT01416181|20517913|P1|Part 1|Investigator Decision|7
5931685|NCT01416181|20517912|P2|Part 1|Death|1
5931686|NCT01416181|20517913|P1|Part 1|Death|0
5931687|NCT01416181|20517912|P2|Part 1|Other|24
5931688|NCT01416181|20517913|P1|Part 1|Other|10
5931689|NCT01416155|20517975|P1|Overall Study|Other|7
5931690|NCT01416155|20517975|P1|Overall Study|Investigator decision|8
5931691|NCT01416155|20517975|P1|Overall Study|Withdrawal by Subject|33
5931692|NCT01416155|20517975|P1|Overall Study|Positive for anti-BG00002 antibodies|2
5931693|NCT01416155|20517975|P1|Overall Study|Adverse Event|8
5931694|NCT01416142|20517982|P3|PureVision2 HD|Inability to maintain lens wear|1
5931695|NCT01416142|20517983|P2|PureVision2 HD|Inability to maintain lens wear|0
5931696|NCT01416142|20517984|P1|PureVision2 HD|Inability to maintain lens wear|0
5931697|NCT01415986|20518011|P1|Overall Study|Lost to Follow-up|1
5931698|NCT01415921|20518037|P2|Overall Study|Other|0
5931699|NCT01415921|20518038|P1|Overall Study|Other|2
5931700|NCT01415921|20518037|P2|Overall Study|Withdrawal by Subject|1
5931701|NCT01415921|20518038|P1|Overall Study|Withdrawal by Subject|0
5931702|NCT01415921|20518037|P2|Overall Study|Physician Decision|1
5931703|NCT01415921|20518038|P1|Overall Study|Physician Decision|1
5931704|NCT01415921|20518037|P2|Overall Study|Adverse Event|1
5931705|NCT01415921|20518038|P1|Overall Study|Adverse Event|0
5931706|NCT01415908|20518048|P2|Overall Study|Withdrawal by Subject|0
5931707|NCT01415908|20518049|P1|Overall Study|Withdrawal by Subject|1
5931708|NCT01415531|20518086|P2|Overall Study|Other Reasons|2
5931709|NCT01415531|20518087|P1|Overall Study|Other Reasons|3
5931710|NCT01415531|20518086|P2|Overall Study|Lack of Compliance|4
5931711|NCT01415531|20518087|P1|Overall Study|Lack of Compliance|1
5931712|NCT01415531|20518086|P2|Overall Study|Lost to Follow-up|14
5931713|NCT01415531|20518087|P1|Overall Study|Lost to Follow-up|6
5931714|NCT01415531|20518086|P2|Overall Study|Withdrawal by Subject|4
5931715|NCT01415531|20518087|P1|Overall Study|Withdrawal by Subject|5
5931716|NCT01415531|20518086|P2|Overall Study|Protocol Violation|1
5931717|NCT01415531|20518087|P1|Overall Study|Protocol Violation|0
5931718|NCT01415531|20518086|P2|Overall Study|Lack of Efficacy|2
5931719|NCT01415531|20518087|P1|Overall Study|Lack of Efficacy|3
5931720|NCT01415531|20518086|P2|Overall Study|Adverse Event|10
5931721|NCT01415531|20518087|P1|Overall Study|Adverse Event|7
5931722|NCT01415518|20518097|P2|Overall Study|Condition under Investigation Worsened|1
5931723|NCT01415518|20518098|P1|Overall Study|Condition under Investigation Worsened|1
5931724|NCT01415518|20518097|P2|Overall Study|Death|1
5931725|NCT01415518|20518098|P1|Overall Study|Death|1
5931726|NCT01415518|20518097|P2|Overall Study|Adverse Event|4
5931727|NCT01415518|20518098|P1|Overall Study|Adverse Event|3
5931728|NCT01415518|20518097|P2|Overall Study|Lost to Follow-up|5
5931729|NCT01415518|20518098|P1|Overall Study|Lost to Follow-up|3
5931730|NCT01415518|20518097|P2|Overall Study|Protocol Violation|8
5931731|NCT01415518|20518098|P1|Overall Study|Protocol Violation|6
5931732|NCT01415518|20518097|P2|Overall Study|Withdrawal by Subject|12
5931733|NCT01415518|20518098|P1|Overall Study|Withdrawal by Subject|2
5931734|NCT01415440|20518157|P3|Overall Study|Withdrawal by Subject|0
5931735|NCT01415440|20518158|P2|Overall Study|Withdrawal by Subject|0
5931736|NCT01415440|20518159|P1|Overall Study|Withdrawal by Subject|1
5931737|NCT01415440|20518157|P3|Overall Study|Physician Decision|0
5931738|NCT01415440|20518158|P2|Overall Study|Physician Decision|0
5931739|NCT01415440|20518159|P1|Overall Study|Physician Decision|3
5931740|NCT01415440|20518157|P3|Overall Study|Lost to Follow-up|2
5931741|NCT01415440|20518158|P2|Overall Study|Lost to Follow-up|1
5931742|NCT01415440|20518159|P1|Overall Study|Lost to Follow-up|0
5931743|NCT01415401|20518210|P1|Overall Study|Terminated by Sponsor|1
5931744|NCT01415401|20518210|P1|Overall Study|DId not meet inclusion/exclusion criteri|1
5931745|NCT01415401|20518210|P1|Overall Study|Adverse Event|5
5931746|NCT01415349|20518215|P2|Treatment Period 1|Withdrawal by Subject|1
5931747|NCT01415349|20518216|P1|Treatment Period 1|Withdrawal by Subject|0
5931748|NCT01415349|20518215|P2|Treatment Period 1|Adverse Event|1
5931749|NCT01415349|20518216|P1|Treatment Period 1|Adverse Event|0
5931750|NCT01414855|20518228|P1|Overall Study|Withdrawal by Subject|7
5931751|NCT01414855|20518228|P1|Overall Study|Lost to Follow-up|5
5931752|NCT01414855|20518228|P1|Overall Study|Death|17
5931753|NCT01414738|20518244|P1|Overall Study|(Unknown) NOS (Not Otherwise Specified)|3
5931754|NCT01414738|20518244|P1|Overall Study|Refused, disease progression|8
5931755|NCT01414738|20518244|P1|Overall Study|Lost to Follow-up|2
5931756|NCT01414738|20518244|P1|Overall Study|Refused testing|5
5931757|NCT01414738|20518244|P1|Overall Study|Death|26
5931758|NCT01414257|20518315|P1|Overall Study|Protocol Violation|10
5931759|NCT01414257|20518315|P1|Overall Study|No Visit After First Day of Treatment|12
5931760|NCT01414205|20518343|P2|Overall Study|Randomized but not Treated|1
5931761|NCT01414205|20518344|P1|Overall Study|Randomized but not Treated|1
5931762|NCT01414205|20518343|P2|Overall Study|Physician Decision|1
5931763|NCT01414205|20518344|P1|Overall Study|Physician Decision|0
5931764|NCT01414205|20518343|P2|Overall Study|Lost to Follow-up|4
5931765|NCT01414205|20518344|P1|Overall Study|Lost to Follow-up|1
5931766|NCT01414205|20518343|P2|Overall Study|Death|1
5931767|NCT01414205|20518344|P1|Overall Study|Death|5
5931768|NCT01414166|20518413|P2|Overall Study|Withdrawal by Subject|5
5931769|NCT01414166|20518414|P1|Overall Study|Withdrawal by Subject|3
5931770|NCT01414166|20518413|P2|Overall Study|Study terminated by Sponsor|75
5931771|NCT01414166|20518414|P1|Overall Study|Study terminated by Sponsor|68
5931772|NCT01414166|20518413|P2|Overall Study|Protocol Violation|0
5931773|NCT01414166|20518414|P1|Overall Study|Protocol Violation|2
5931774|NCT01414166|20518413|P2|Overall Study|Physician Decision|0
5931775|NCT01414166|20518414|P1|Overall Study|Physician Decision|2
5931776|NCT01414166|20518413|P2|Overall Study|Non-compliance with study drug|0
5931777|NCT01414166|20518414|P1|Overall Study|Non-compliance with study drug|2
5931778|NCT01414166|20518413|P2|Overall Study|Lost to Follow-up|1
5931779|NCT01414166|20518414|P1|Overall Study|Lost to Follow-up|4
5931780|NCT01414166|20518413|P2|Overall Study|Adverse Event|2
5931781|NCT01414166|20518414|P1|Overall Study|Adverse Event|10
5931782|NCT01414114|20518477|P1|Overall Study|Other|2
5931783|NCT01414114|20518477|P1|Overall Study|Withdrawal by Subject|1
5931784|NCT01414114|20518477|P1|Overall Study|Adverse Event|2
5931785|NCT01413958|20518533|P2|Overall Study|Lost to Follow-up|1
5931786|NCT01413958|20518534|P1|Overall Study|Lost to Follow-up|0
5931787|NCT01413542|20518585|P4|Overall Study|Adverse Event|1
5931788|NCT01413542|20518586|P3|Overall Study|Adverse Event|0
5931789|NCT01413542|20518587|P2|Overall Study|Adverse Event|0
5931790|NCT01413542|20518588|P1|Overall Study|Adverse Event|0
5931791|NCT01413542|20518585|P4|Overall Study|Physician Decision|0
5931792|NCT01413542|20518586|P3|Overall Study|Physician Decision|3
5931793|NCT01413542|20518587|P2|Overall Study|Physician Decision|0
5931794|NCT01413542|20518588|P1|Overall Study|Physician Decision|1
5931795|NCT01413503|20518610|P1|Overall Study|Lost to Follow-up|1
5931796|NCT01413360|20518614|P1|Overall Study|Adverse Event|1
5931797|NCT01413360|20518614|P1|Overall Study|Lost to Follow-up|2
5931798|NCT01413204|20518622|P3|Overall Study|Fasting plasma glucose level increased|10
5931799|NCT01413204|20518623|P2|Overall Study|Fasting plasma glucose level increased|0
5931800|NCT01413204|20518624|P1|Overall Study|Fasting plasma glucose level increased|1
5931801|NCT01413204|20518622|P3|Overall Study|Clearly not eligible for the study|1
5931802|NCT01413204|20518623|P2|Overall Study|Clearly not eligible for the study|0
5931803|NCT01413204|20518624|P1|Overall Study|Clearly not eligible for the study|0
5931804|NCT01413204|20518622|P3|Overall Study|Withdrawal by Subject|4
5931805|NCT01413204|20518623|P2|Overall Study|Withdrawal by Subject|4
5931806|NCT01413204|20518624|P1|Overall Study|Withdrawal by Subject|1
5931807|NCT01413204|20518622|P3|Overall Study|Physician Decision|2
5931808|NCT01413204|20518623|P2|Overall Study|Physician Decision|0
5931809|NCT01413204|20518624|P1|Overall Study|Physician Decision|3
5931810|NCT01413204|20518622|P3|Overall Study|Adverse Event|2
5931811|NCT01413204|20518623|P2|Overall Study|Adverse Event|2
5931812|NCT01413204|20518624|P1|Overall Study|Adverse Event|1
5931813|NCT01413191|20518632|P1|Overall Study|Death|1
5931814|NCT01413191|20518632|P1|Overall Study|Disease Progression|5
5931815|NCT01413191|20518632|P1|Overall Study|Lost to Follow-up|5
5931816|NCT01413178|20518644|P2|Overall Study|Ineligible|2
5931817|NCT01413178|20518645|P1|Overall Study|Ineligible|0
5931818|NCT01413178|20518644|P2|Overall Study|Toxicity|0
5931819|NCT01413178|20518645|P1|Overall Study|Toxicity|1
5931820|NCT01412983|20518688|P2|1st Period|Inability to maintain wear|1
5931821|NCT01412983|20518689|P1|1st Period|Inability to maintain wear|0
5931822|NCT01412983|20518688|P2|1st Period|Unacceptable lens movement|1
5931823|NCT01412983|20518689|P1|1st Period|Unacceptable lens movement|0
5931824|NCT01412983|20518688|P2|1st Period|Positive slit lamp finding|1
5931825|NCT01412983|20518689|P1|1st Period|Positive slit lamp finding|0
5931826|NCT01412983|20518688|P2|1st Period|Ineligible|1
5931827|NCT01412983|20518689|P1|1st Period|Ineligible|0
5931828|NCT01412957|20518699|P2|Overall Study|Death|133
5931829|NCT01412957|20518700|P1|Overall Study|Death|136
5931830|NCT01412957|20518699|P2|Overall Study|Lost to Follow-up|2
5931831|NCT01412957|20518700|P1|Overall Study|Lost to Follow-up|7
5931832|NCT01412957|20518699|P2|Overall Study|Withdrawal by Subject|22
5931833|NCT01412957|20518700|P1|Overall Study|Withdrawal by Subject|6
5931834|NCT01412944|20518722|P6|Entire: IV + Maintenance|Adverse Event|0
5931835|NCT01412944|20518723|P5|Entire: IV + Maintenance|Adverse Event|0
5931836|NCT01412944|20518724|P4|Entire: IV + Maintenance|Adverse Event|0
5931837|NCT01412944|20518725|P3|Entire: IV + Maintenance|Adverse Event|0
5931838|NCT01412944|20518726|P2|Entire: IV + Maintenance|Adverse Event|1
5931839|NCT01412944|20518727|P1|Entire: IV + Maintenance|Adverse Event|0
5931840|NCT01412944|20518722|P6|Entire: IV + Maintenance|Lack of Efficacy|0
5931841|NCT01412944|20518723|P5|Entire: IV + Maintenance|Lack of Efficacy|0
5931842|NCT01412944|20518724|P4|Entire: IV + Maintenance|Lack of Efficacy|0
5931843|NCT01412944|20518725|P3|Entire: IV + Maintenance|Lack of Efficacy|0
5931844|NCT01412944|20518726|P2|Entire: IV + Maintenance|Lack of Efficacy|1
5931845|NCT01412944|20518727|P1|Entire: IV + Maintenance|Lack of Efficacy|0
5931846|NCT01412944|20518722|P6|Entire: IV + Maintenance|Lost to Follow-up|0
5931847|NCT01412944|20518723|P5|Entire: IV + Maintenance|Lost to Follow-up|0
5931848|NCT01412944|20518724|P4|Entire: IV + Maintenance|Lost to Follow-up|0
5931849|NCT01412944|20518725|P3|Entire: IV + Maintenance|Lost to Follow-up|0
5931850|NCT01412944|20518726|P2|Entire: IV + Maintenance|Lost to Follow-up|1
5931851|NCT01412944|20518727|P1|Entire: IV + Maintenance|Lost to Follow-up|0
5931852|NCT01412944|20518722|P6|Entire: IV + Maintenance|Protocol deviation|0
5931853|NCT01412944|20518723|P5|Entire: IV + Maintenance|Protocol deviation|0
5931854|NCT01412944|20518724|P4|Entire: IV + Maintenance|Protocol deviation|0
5931855|NCT01412944|20518725|P3|Entire: IV + Maintenance|Protocol deviation|0
5931856|NCT01412944|20518726|P2|Entire: IV + Maintenance|Protocol deviation|1
5931857|NCT01412944|20518727|P1|Entire: IV + Maintenance|Protocol deviation|0
5931858|NCT01412944|20518722|P6|Entire: IV + Maintenance|Withdrawal by Subject|0
5931859|NCT01412944|20518723|P5|Entire: IV + Maintenance|Withdrawal by Subject|0
5931860|NCT01412944|20518724|P4|Entire: IV + Maintenance|Withdrawal by Subject|0
5931861|NCT01412944|20518725|P3|Entire: IV + Maintenance|Withdrawal by Subject|0
5931862|NCT01412944|20518726|P2|Entire: IV + Maintenance|Withdrawal by Subject|1
5931863|NCT01412944|20518727|P1|Entire: IV + Maintenance|Withdrawal by Subject|2
5931864|NCT01412944|20518722|P6|Entire: IV + Maintenance|Lack of Efficacy|0
5931865|NCT01412944|20518723|P5|Entire: IV + Maintenance|Lack of Efficacy|1
5931866|NCT01412944|20518724|P4|Entire: IV + Maintenance|Lack of Efficacy|0
5931867|NCT01412944|20518725|P3|Entire: IV + Maintenance|Lack of Efficacy|0
5931868|NCT01412944|20518726|P2|Entire: IV + Maintenance|Lack of Efficacy|0
5931869|NCT01412944|20518727|P1|Entire: IV + Maintenance|Lack of Efficacy|0
5931870|NCT01412944|20518722|P6|Entire: IV + Maintenance|Lost to Follow-up|1
5931871|NCT01412944|20518723|P5|Entire: IV + Maintenance|Lost to Follow-up|0
5931872|NCT01412944|20518724|P4|Entire: IV + Maintenance|Lost to Follow-up|0
5931873|NCT01412944|20518725|P3|Entire: IV + Maintenance|Lost to Follow-up|0
5931874|NCT01412944|20518726|P2|Entire: IV + Maintenance|Lost to Follow-up|0
5931875|NCT01412944|20518727|P1|Entire: IV + Maintenance|Lost to Follow-up|0
5931876|NCT01412944|20518722|P6|Entire: IV + Maintenance|Protocol deviation|1
5931877|NCT01412944|20518723|P5|Entire: IV + Maintenance|Protocol deviation|0
5931878|NCT01412944|20518724|P4|Entire: IV + Maintenance|Protocol deviation|0
5931879|NCT01412944|20518725|P3|Entire: IV + Maintenance|Protocol deviation|0
5931880|NCT01412944|20518726|P2|Entire: IV + Maintenance|Protocol deviation|0
5931881|NCT01412944|20518727|P1|Entire: IV + Maintenance|Protocol deviation|0
5931882|NCT01412944|20518722|P6|Entire: IV + Maintenance|Adverse Event|0
5931883|NCT01412944|20518723|P5|Entire: IV + Maintenance|Adverse Event|1
5931884|NCT01412944|20518724|P4|Entire: IV + Maintenance|Adverse Event|0
5931885|NCT01412944|20518725|P3|Entire: IV + Maintenance|Adverse Event|0
5931886|NCT01412944|20518726|P2|Entire: IV + Maintenance|Adverse Event|0
5931887|NCT01412944|20518727|P1|Entire: IV + Maintenance|Adverse Event|0
5931888|NCT01412944|20518722|P6|Entire: IV + Maintenance|Withdrawal by Subject|0
5931889|NCT01412944|20518723|P5|Entire: IV + Maintenance|Withdrawal by Subject|1
5931890|NCT01412944|20518724|P4|Entire: IV + Maintenance|Withdrawal by Subject|1
5931891|NCT01412944|20518725|P3|Entire: IV + Maintenance|Withdrawal by Subject|1
5931892|NCT01412944|20518726|P2|Entire: IV + Maintenance|Withdrawal by Subject|0
5931893|NCT01412944|20518727|P1|Entire: IV + Maintenance|Withdrawal by Subject|0
5931894|NCT01412944|20518722|P6|IV: Per CAIN457A2307|Lost to Follow-up|0
5931895|NCT01412944|20518723|P5|IV: Per CAIN457A2307|Lost to Follow-up|0
5931896|NCT01412944|20518724|P4|IV: Per CAIN457A2307|Lost to Follow-up|0
5931897|NCT01412944|20518725|P3|IV: Per CAIN457A2307|Lost to Follow-up|0
5931898|NCT01412944|20518726|P2|IV: Per CAIN457A2307|Lost to Follow-up|1
5931899|NCT01412944|20518727|P1|IV: Per CAIN457A2307|Lost to Follow-up|0
5931900|NCT01412944|20518722|P6|IV: Per CAIN457A2307|Protocol deviation|0
5931901|NCT01412944|20518723|P5|IV: Per CAIN457A2307|Protocol deviation|0
5931902|NCT01412944|20518724|P4|IV: Per CAIN457A2307|Protocol deviation|0
5931903|NCT01412944|20518725|P3|IV: Per CAIN457A2307|Protocol deviation|0
5931904|NCT01412944|20518726|P2|IV: Per CAIN457A2307|Protocol deviation|1
5931905|NCT01412944|20518727|P1|IV: Per CAIN457A2307|Protocol deviation|0
5931906|NCT01412944|20518722|P6|IV: Per CAIN457A2307|Withdrawal by Subject|0
5931907|NCT01412944|20518723|P5|IV: Per CAIN457A2307|Withdrawal by Subject|0
5931908|NCT01412944|20518724|P4|IV: Per CAIN457A2307|Withdrawal by Subject|0
5931909|NCT01412944|20518725|P3|IV: Per CAIN457A2307|Withdrawal by Subject|0
5931910|NCT01412944|20518726|P2|IV: Per CAIN457A2307|Withdrawal by Subject|0
5931911|NCT01412944|20518727|P1|IV: Per CAIN457A2307|Withdrawal by Subject|1
5931912|NCT01412944|20518722|P6|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|1
5931913|NCT01412944|20518723|P5|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0
5931914|NCT01412944|20518724|P4|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0
5931915|NCT01412944|20518725|P3|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0
5931916|NCT01412944|20518726|P2|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0
5931917|NCT01412944|20518727|P1|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0
5931918|NCT01412944|20518722|P6|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|1
5931919|NCT01412944|20518723|P5|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0
5931920|NCT01412944|20518724|P4|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0
5931921|NCT01412944|20518725|P3|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0
5931922|NCT01412944|20518726|P2|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0
5931923|NCT01412944|20518727|P1|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0
5931924|NCT01412944|20518722|P6|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0
5931925|NCT01412944|20518723|P5|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0
5931926|NCT01412944|20518724|P4|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0
5931927|NCT01412944|20518725|P3|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|1
5931928|NCT01412944|20518726|P2|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0
5931929|NCT01412944|20518727|P1|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0
5931930|NCT01412879|20518773|P3|Initial Registration (Induction Therapy)|Treatment not Given|0
5931931|NCT01412879|20518774|P2|Initial Registration (Induction Therapy)|Treatment not Given|0
5931932|NCT01412879|20518775|P1|Initial Registration (Induction Therapy)|Treatment not Given|1
5931933|NCT01412879|20518773|P3|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|0
5931934|NCT01412879|20518774|P2|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|1
5931935|NCT01412879|20518775|P1|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|6
5931936|NCT01412879|20518773|P3|Initial Registration (Induction Therapy)|Progression/Relapse|0
5931937|NCT01412879|20518774|P2|Initial Registration (Induction Therapy)|Progression/Relapse|1
5931938|NCT01412879|20518775|P1|Initial Registration (Induction Therapy)|Progression/Relapse|0
5931939|NCT01412879|20518773|P3|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|0
5931940|NCT01412879|20518774|P2|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|3
5931941|NCT01412879|20518775|P1|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|1
5931942|NCT01412879|20518773|P3|Initial Registration (Induction Therapy)|Adverse Event|0
5931943|NCT01412879|20518774|P2|Initial Registration (Induction Therapy)|Adverse Event|3
5931944|NCT01412879|20518775|P1|Initial Registration (Induction Therapy)|Adverse Event|5
5931945|NCT01412801|20518804|P6|Overall Study|Relocated to another area|0
5931946|NCT01412801|20518805|P5|Overall Study|Relocated to another area|0
5931947|NCT01412801|20518806|P4|Overall Study|Relocated to another area|0
5931948|NCT01412801|20518807|P3|Overall Study|Relocated to another area|2
5931949|NCT01412801|20518808|P2|Overall Study|Relocated to another area|0
5931950|NCT01412801|20518809|P1|Overall Study|Relocated to another area|0
5931951|NCT01412801|20518804|P6|Overall Study|Withdrawal by Subject|0
5931952|NCT01412801|20518805|P5|Overall Study|Withdrawal by Subject|0
5931953|NCT01412801|20518806|P4|Overall Study|Withdrawal by Subject|0
5931954|NCT01412801|20518807|P3|Overall Study|Withdrawal by Subject|1
5931955|NCT01412801|20518808|P2|Overall Study|Withdrawal by Subject|2
5931956|NCT01412801|20518809|P1|Overall Study|Withdrawal by Subject|3
5931957|NCT01412801|20518804|P6|Overall Study|Lost to Follow-up|1
5931958|NCT01412801|20518805|P5|Overall Study|Lost to Follow-up|1
5931959|NCT01412801|20518806|P4|Overall Study|Lost to Follow-up|0
5931960|NCT01412801|20518807|P3|Overall Study|Lost to Follow-up|4
5931961|NCT01412801|20518808|P2|Overall Study|Lost to Follow-up|2
5931962|NCT01412801|20518809|P1|Overall Study|Lost to Follow-up|1
5931963|NCT01412801|20518804|P6|Overall Study|Death|2
5931964|NCT01412801|20518805|P5|Overall Study|Death|2
5931965|NCT01412801|20518806|P4|Overall Study|Death|4
5931966|NCT01412801|20518807|P3|Overall Study|Death|0
5931967|NCT01412801|20518808|P2|Overall Study|Death|1
5931968|NCT01412801|20518809|P1|Overall Study|Death|0
5931969|NCT01412424|20518904|P1|Extension Treatment Period|Patient Request|2
5931970|NCT01412424|20518904|P1|Extension Treatment Period|Treatment Failure|2
5931971|NCT01412424|20518904|P1|Extension Treatment Period|Adverse Event|2
5931972|NCT01412424|20518904|P1|Core Treatment Period|Sponsor Request|1
5931973|NCT01412424|20518904|P1|Core Treatment Period|Lost to Follow-up|2
5931974|NCT01412424|20518904|P1|Core Treatment Period|Patient Request|5
5931975|NCT01412424|20518904|P1|Core Treatment Period|Adverse Event|21
5931976|NCT01412424|20518904|P1|Core Treatment Period|Treatment Failure|24
5931977|NCT01412333|20518941|P2|Overall Study|Lost to Follow-up|6
5931978|NCT01412333|20518942|P1|Overall Study|Lost to Follow-up|10
5931979|NCT01412333|20518941|P2|Overall Study|Adverse Event|16
5931980|NCT01412333|20518942|P1|Overall Study|Adverse Event|25
5931981|NCT01412333|20518941|P2|Overall Study|Consent withdrawn by participant|12
5931982|NCT01412333|20518942|P1|Overall Study|Consent withdrawn by participant|25
5931983|NCT01412333|20518941|P2|Overall Study|Pregnancy|0
5931984|NCT01412333|20518942|P1|Overall Study|Pregnancy|3
5931985|NCT01412333|20518941|P2|Overall Study|Lack of Efficacy|6
5931986|NCT01412333|20518942|P1|Overall Study|Lack of Efficacy|15
5931987|NCT01412333|20518941|P2|Overall Study|Non-compliance|3
5931988|NCT01412333|20518942|P1|Overall Study|Non-compliance|1
5931989|NCT01412333|20518941|P2|Overall Study|Protocol Violation|1
5931990|NCT01412333|20518942|P1|Overall Study|Protocol Violation|1
5931991|NCT01412333|20518941|P2|Overall Study|Non-compliance with study drug|1
5931992|NCT01412333|20518942|P1|Overall Study|Non-compliance with study drug|1
5931993|NCT01412333|20518941|P2|Overall Study|Reason not specified|10
5931994|NCT01412333|20518942|P1|Overall Study|Reason not specified|16
5931995|NCT01412333|20518941|P2|Overall Study|Physician Decision|1
5931996|NCT01412333|20518942|P1|Overall Study|Physician Decision|0
5931997|NCT01412333|20518941|P2|Overall Study|Death|1
5931998|NCT01412333|20518942|P1|Overall Study|Death|1
5931999|NCT01412229|20519002|P1|Overall Study|Physician Decision|1
5932000|NCT01412151|20519025|P1|Week 306 - 310 - Washout Period|Withdrawal by Subject|2
5932001|NCT01412151|20519025|P1|Week 0 - 306 - Treatment Period|Withdrawal by Investigator|3
5932002|NCT01412151|20519025|P1|Week 0 - 306 - Treatment Period|Withdrawal by Subject|1
5932003|NCT01412151|20519025|P1|Week 0 - 306 - Treatment Period|Death|1
5932004|NCT01412060|20519036|P3|Double-blind Treatment Phase (DBP)|Relapse|25
5932005|NCT01412060|20519037|P2|Double-blind Treatment Phase (DBP)|Relapse|47
5932006|NCT01412060|20519038|P1|Double-blind Treatment Phase (DBP)|Relapse|0
5932007|NCT01412060|20519036|P3|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|27
5932008|NCT01412060|20519037|P2|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|11
5932009|NCT01412060|20519038|P1|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|0
5932010|NCT01412060|20519036|P3|Double-blind Treatment Phase (DBP)|Lost to Follow-up|5
5932011|NCT01412060|20519037|P2|Double-blind Treatment Phase (DBP)|Lost to Follow-up|6
5932012|NCT01412060|20519038|P1|Double-blind Treatment Phase (DBP)|Lost to Follow-up|0
5932013|NCT01412060|20519036|P3|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|15
5932014|NCT01412060|20519037|P2|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|10
5932015|NCT01412060|20519038|P1|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|0
5932016|NCT01412060|20519036|P3|Double-blind Treatment Phase (DBP)|Protocol Violation|5
5932017|NCT01412060|20519037|P2|Double-blind Treatment Phase (DBP)|Protocol Violation|4
5932018|NCT01412060|20519038|P1|Double-blind Treatment Phase (DBP)|Protocol Violation|0
5932019|NCT01412060|20519036|P3|Double-blind Treatment Phase (DBP)|Adverse Event|6
5932020|NCT01412060|20519037|P2|Double-blind Treatment Phase (DBP)|Adverse Event|5
5932021|NCT01412060|20519038|P1|Double-blind Treatment Phase (DBP)|Adverse Event|0
5932022|NCT01412060|20519036|P3|Period Between SP and DBP|Other Miscellaneous Reasons|0
5932023|NCT01412060|20519037|P2|Period Between SP and DBP|Other Miscellaneous Reasons|0
5932024|NCT01412060|20519038|P1|Period Between SP and DBP|Other Miscellaneous Reasons|55
5932025|NCT01412060|20519036|P3|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0
5932026|NCT01412060|20519037|P2|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0
5932027|NCT01412060|20519038|P1|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|4
5932028|NCT01412060|20519036|P3|Period Between SP and DBP|Lost to Follow-up|0
5932029|NCT01412060|20519037|P2|Period Between SP and DBP|Lost to Follow-up|0
5932030|NCT01412060|20519038|P1|Period Between SP and DBP|Lost to Follow-up|1
5932031|NCT01412060|20519036|P3|Period Between SP and DBP|Withdrawal of Consent|0
5932032|NCT01412060|20519037|P2|Period Between SP and DBP|Withdrawal of Consent|0
5932033|NCT01412060|20519038|P1|Period Between SP and DBP|Withdrawal of Consent|2
5932034|NCT01412060|20519036|P3|Period Between SP and DBP|Protocol Violation|0
5932035|NCT01412060|20519037|P2|Period Between SP and DBP|Protocol Violation|0
5932036|NCT01412060|20519038|P1|Period Between SP and DBP|Protocol Violation|2
5932037|NCT01412060|20519036|P3|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0
5932038|NCT01412060|20519037|P2|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0
5932039|NCT01412060|20519038|P1|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|19
5932040|NCT01412060|20519036|P3|Open-label Stabilization Period (SP)|Lost to Follow-up|0
5932041|NCT01412060|20519037|P2|Open-label Stabilization Period (SP)|Lost to Follow-up|0
5932042|NCT01412060|20519038|P1|Open-label Stabilization Period (SP)|Lost to Follow-up|9
5932043|NCT01412060|20519036|P3|Open-label Stabilization Period (SP)|Withdrawal of Consent|0
5932044|NCT01412060|20519037|P2|Open-label Stabilization Period (SP)|Withdrawal of Consent|0
5932045|NCT01412060|20519038|P1|Open-label Stabilization Period (SP)|Withdrawal of Consent|40
5932046|NCT01412060|20519036|P3|Open-label Stabilization Period (SP)|Protocol Violation|0
5932047|NCT01412060|20519037|P2|Open-label Stabilization Period (SP)|Protocol Violation|0
5932048|NCT01412060|20519038|P1|Open-label Stabilization Period (SP)|Protocol Violation|14
5932049|NCT01412060|20519036|P3|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0
5932050|NCT01412060|20519037|P2|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0
5932051|NCT01412060|20519038|P1|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|9
5932052|NCT01412060|20519036|P3|Open-label Stabilization Period (SP)|Adverse Event|0
5932053|NCT01412060|20519037|P2|Open-label Stabilization Period (SP)|Adverse Event|0
5932054|NCT01412060|20519038|P1|Open-label Stabilization Period (SP)|Adverse Event|9
5932055|NCT01412060|20519036|P3|Period Between RIP and SP|Other Miscellaneous Reasons|0
5932056|NCT01412060|20519037|P2|Period Between RIP and SP|Other Miscellaneous Reasons|0
5932057|NCT01412060|20519038|P1|Period Between RIP and SP|Other Miscellaneous Reasons|23
5932058|NCT01412060|20519036|P3|Period Between RIP and SP|Lost to Follow-up|0
5932059|NCT01412060|20519037|P2|Period Between RIP and SP|Lost to Follow-up|0
5932060|NCT01412060|20519038|P1|Period Between RIP and SP|Lost to Follow-up|5
5932061|NCT01412060|20519036|P3|Period Between RIP and SP|Withdrawal of Consent|0
5932062|NCT01412060|20519037|P2|Period Between RIP and SP|Withdrawal of Consent|0
5932063|NCT01412060|20519038|P1|Period Between RIP and SP|Withdrawal of Consent|1
5932064|NCT01412060|20519036|P3|Period Between RIP and SP|Protocol Violation|0
5932065|NCT01412060|20519037|P2|Period Between RIP and SP|Protocol Violation|0
5932066|NCT01412060|20519038|P1|Period Between RIP and SP|Protocol Violation|2
5932067|NCT01412060|20519036|P3|Period Between RIP and SP|Insufficient Therapeutic Response|0
5932068|NCT01412060|20519037|P2|Period Between RIP and SP|Insufficient Therapeutic Response|0
5932069|NCT01412060|20519038|P1|Period Between RIP and SP|Insufficient Therapeutic Response|19
5932070|NCT01412060|20519036|P3|Period Between RIP and SP|Adverse Event|0
5932071|NCT01412060|20519037|P2|Period Between RIP and SP|Adverse Event|0
5932072|NCT01412060|20519038|P1|Period Between RIP and SP|Adverse Event|4
5932073|NCT01412060|20519036|P3|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0
5932074|NCT01412060|20519037|P2|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0
5932075|NCT01412060|20519038|P1|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|19
5932076|NCT01412060|20519036|P3|Open-label Run-in Period (RIP)|Lost to Follow-up|0
5932077|NCT01412060|20519037|P2|Open-label Run-in Period (RIP)|Lost to Follow-up|0
5932078|NCT01412060|20519038|P1|Open-label Run-in Period (RIP)|Lost to Follow-up|32
5932079|NCT01412060|20519036|P3|Open-label Run-in Period (RIP)|Withdrawal of Consent|0
5932080|NCT01412060|20519037|P2|Open-label Run-in Period (RIP)|Withdrawal of Consent|0
5932081|NCT01412060|20519038|P1|Open-label Run-in Period (RIP)|Withdrawal of Consent|117
5932082|NCT01412060|20519036|P3|Open-label Run-in Period (RIP)|Protocol Violation|0
5932083|NCT01412060|20519037|P2|Open-label Run-in Period (RIP)|Protocol Violation|0
5932084|NCT01412060|20519038|P1|Open-label Run-in Period (RIP)|Protocol Violation|27
5932085|NCT01412060|20519036|P3|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0
5932086|NCT01412060|20519037|P2|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0
5932087|NCT01412060|20519038|P1|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|66
5932088|NCT01412060|20519036|P3|Open-label Run-in Period (RIP)|Adverse Event|0
5932089|NCT01412060|20519037|P2|Open-label Run-in Period (RIP)|Adverse Event|0
5932090|NCT01412060|20519038|P1|Open-label Run-in Period (RIP)|Adverse Event|86
5932091|NCT01412021|20519048|P1|Overall Study|Transferred to Other Hospital|9
5932092|NCT01412021|20519048|P1|Overall Study|Treatment Prior to Approval|3
5932093|NCT01412021|20519048|P1|Overall Study|Case Report Forms Not Retrieved|7
5932094|NCT01411995|20519085|P2|Overall Study|Failed IUD insertion|1
5932095|NCT01411995|20519086|P1|Overall Study|Failed IUD insertion|0
5932096|NCT01411917|20519094|P2|Overall Study|Patient did not undergo scheduled surger|1
5932097|NCT01411917|20519095|P1|Overall Study|Patient did not undergo scheduled surger|0
5932098|NCT01411891|20519117|P2|Overall Study|Catheter dislodgement or loss to follow-|2
5932099|NCT01411891|20519118|P1|Overall Study|Catheter dislodgement or loss to follow-|3
5932100|NCT01411852|20519128|P2|Hospital Intervention Phase|Vascular access failed|0
5932101|NCT01411852|20519129|P1|Hospital Intervention Phase|Vascular access failed|1
5932102|NCT01411852|20519128|P2|Hospital Intervention Phase|Withdrawal by Subject|0
5932103|NCT01411852|20519129|P1|Hospital Intervention Phase|Withdrawal by Subject|1
5932104|NCT01411852|20519128|P2|Hospital Intervention Phase|Spinal cord injury|0
5932105|NCT01411852|20519129|P1|Hospital Intervention Phase|Spinal cord injury|2
5932106|NCT01411852|20519128|P2|Hospital Intervention Phase|Other ineligible|2
5932107|NCT01411852|20519129|P1|Hospital Intervention Phase|Other ineligible|2
5932108|NCT01411852|20519128|P2|Hospital Intervention Phase|Physician/hospital staff noncompliance|4
5932109|NCT01411852|20519129|P1|Hospital Intervention Phase|Physician/hospital staff noncompliance|0
5932110|NCT01411852|20519128|P2|Hospital Intervention Phase|Diagnosis of dehydration|1
5932111|NCT01411852|20519129|P1|Hospital Intervention Phase|Diagnosis of dehydration|0
5932112|NCT01411852|20519128|P2|Hospital Intervention Phase|Diagnosis of sepsis|2
5932113|NCT01411852|20519129|P1|Hospital Intervention Phase|Diagnosis of sepsis|0
5932114|NCT01411852|20519128|P2|Hospital Intervention Phase|Misunderstanding of protocol|1
5932115|NCT01411852|20519129|P1|Hospital Intervention Phase|Misunderstanding of protocol|4
5932116|NCT01411852|20519128|P2|Hospital Intervention Phase|CPR administered|1
5932117|NCT01411852|20519129|P1|Hospital Intervention Phase|CPR administered|3
5932118|NCT01411852|20519128|P2|Hospital Intervention Phase|Miscommunication error|2
5932119|NCT01411852|20519129|P1|Hospital Intervention Phase|Miscommunication error|1
5932120|NCT01411852|20519128|P2|Hospital Intervention Phase|No qualifying SBP|1
5932121|NCT01411852|20519129|P1|Hospital Intervention Phase|No qualifying SBP|5
5932122|NCT01411852|20519128|P2|Hospital Intervention Phase|Severe head injury|4
5932123|NCT01411852|20519129|P1|Hospital Intervention Phase|Severe head injury|5
5932124|NCT01411852|20519128|P2|Prehospital Intervention Phase|Severe head injury with GCS≤8|0
5932125|NCT01411852|20519129|P1|Prehospital Intervention Phase|Severe head injury with GCS≤8|5
5932126|NCT01411852|20519128|P2|Prehospital Intervention Phase|Found to be under age|1
5932127|NCT01411852|20519129|P1|Prehospital Intervention Phase|Found to be under age|0
5932128|NCT01411852|20519128|P2|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2
5932129|NCT01411852|20519129|P1|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2
5932130|NCT01411852|20519128|P2|Prehospital Intervention Phase|No qualifying SBP|4
5932131|NCT01411852|20519129|P1|Prehospital Intervention Phase|No qualifying SBP|5
5932132|NCT01411839|20519174|P2|Overall Study|Lost to Follow-up|3
5932133|NCT01411839|20519175|P1|Overall Study|Lost to Follow-up|4
5932134|NCT01411774|20519187|P2|Overall Study|Withdrawal by Subject|3
5932135|NCT01411774|20519188|P1|Overall Study|Withdrawal by Subject|0
5932136|NCT01411241|20519303|P2|Overall Study|Lost to Follow-up|4
5932137|NCT01411241|20519304|P1|Overall Study|Lost to Follow-up|2
5932138|NCT01411241|20519303|P2|Overall Study|Serious Adverse Event|3
5932139|NCT01411241|20519304|P1|Overall Study|Serious Adverse Event|0
5932140|NCT01411241|20519303|P2|Overall Study|Withdrawal by Subject|10
5932141|NCT01411241|20519304|P1|Overall Study|Withdrawal by Subject|9
5932142|NCT01411241|20519303|P2|Overall Study|Protocol Violation|5
5932143|NCT01411241|20519304|P1|Overall Study|Protocol Violation|0
5932144|NCT01411228|20519329|P3|Overall Study|Withdrawal by Subject|0
5932145|NCT01411228|20519330|P2|Overall Study|Withdrawal by Subject|0
5932146|NCT01411228|20519331|P1|Overall Study|Withdrawal by Subject|1
5932147|NCT01411228|20519329|P3|Overall Study|Lost to Follow-up|1
5932148|NCT01411228|20519330|P2|Overall Study|Lost to Follow-up|0
5932149|NCT01411228|20519331|P1|Overall Study|Lost to Follow-up|0
5932150|NCT01411215|20519353|P2|Overall Study|Screen failure|1
5932151|NCT01411215|20519354|P1|Overall Study|Screen failure|0
5932152|NCT01411215|20519353|P2|Overall Study|Other|17
5932153|NCT01411215|20519354|P1|Overall Study|Other|12
5932154|NCT01411215|20519353|P2|Overall Study|Withdrawal by Subject|21
5932155|NCT01411215|20519354|P1|Overall Study|Withdrawal by Subject|34
5932156|NCT01411215|20519353|P2|Overall Study|Protocol Violation|5
5932157|NCT01411215|20519354|P1|Overall Study|Protocol Violation|3
5932158|NCT01411215|20519353|P2|Overall Study|Study terminated by sponsor|15
5932159|NCT01411215|20519354|P1|Overall Study|Study terminated by sponsor|2
5932160|NCT01411215|20519353|P2|Overall Study|Did not meet entrance criteria|1
5932161|NCT01411215|20519354|P1|Overall Study|Did not meet entrance criteria|0
5932162|NCT01411215|20519353|P2|Overall Study|Lost to Follow-up|18
5932163|NCT01411215|20519354|P1|Overall Study|Lost to Follow-up|12
5932164|NCT01411215|20519353|P2|Overall Study|Lack of Efficacy|4
5932165|NCT01411215|20519354|P1|Overall Study|Lack of Efficacy|2
5932166|NCT01411215|20519353|P2|Overall Study|Adverse Event|2
5932167|NCT01411215|20519354|P1|Overall Study|Adverse Event|1
5932168|NCT01411085|20519406|P1|Overall Study|Adverse Event|1
5932169|NCT01411085|20519406|P1|Overall Study|Protocol Violation|1
5932170|NCT01411085|20519406|P1|Overall Study|Physician Decision|1
5932171|NCT01410799|20519426|P1|Overall Study|PI decision|13
5932172|NCT01410604|20519442|P2|Overall Study|Physician Decision|1
5932173|NCT01410604|20519443|P1|Overall Study|Physician Decision|0
5932174|NCT01410604|20519442|P2|Overall Study|Lost to Follow-up|0
5932175|NCT01410604|20519443|P1|Overall Study|Lost to Follow-up|1
5932176|NCT01410604|20519442|P2|Overall Study|Adverse Event|1
5932177|NCT01410604|20519443|P1|Overall Study|Adverse Event|2
5932178|NCT01410474|20519484|P2|Overall Study|Withdrawal by Subject|1
5932179|NCT01410474|20519485|P1|Overall Study|Withdrawal by Subject|0
5932180|NCT01410448|20519508|P2|Overall Study|Death|3
5932181|NCT01410448|20519509|P1|Overall Study|Death|2
5932182|NCT01410448|20519508|P2|Overall Study|Protocol Violation|4
5932183|NCT01410448|20519509|P1|Overall Study|Protocol Violation|0
5932184|NCT01410448|20519508|P2|Overall Study|Withdrawal by Subject|2
5932185|NCT01410448|20519509|P1|Overall Study|Withdrawal by Subject|3
5932186|NCT01410448|20519508|P2|Overall Study|Lost to Follow-up|0
5932187|NCT01410448|20519509|P1|Overall Study|Lost to Follow-up|1
5932188|NCT01410448|20519508|P2|Overall Study|Administrative issues|1
5932189|NCT01410448|20519509|P1|Overall Study|Administrative issues|2
5932190|NCT01410448|20519508|P2|Overall Study|Graft loss|1
5932191|NCT01410448|20519509|P1|Overall Study|Graft loss|4
5932192|NCT01410448|20519508|P2|Overall Study|No conversion to everolimus|24
5932193|NCT01410448|20519509|P1|Overall Study|No conversion to everolimus|0
5932194|NCT01410357|20519574|P2|Overall Study|Lost to Follow-up|21
5932195|NCT01410357|20519575|P1|Overall Study|Lost to Follow-up|23
5932196|NCT01410357|20519574|P2|Overall Study|Withdrawal by Subject|2
5932197|NCT01410357|20519575|P1|Overall Study|Withdrawal by Subject|1
5932198|NCT01410357|20519574|P2|Overall Study|Death|1
5932199|NCT01410357|20519575|P1|Overall Study|Death|2
5932200|NCT01410240|20519646|P3|Overall Study|Missed week 6 assessments|1
5932201|NCT01410240|20519647|P2|Overall Study|Missed week 6 assessments|1
5932202|NCT01410240|20519648|P1|Overall Study|Missed week 6 assessments|1
5932203|NCT01410240|20519646|P3|Overall Study|Physician Decision|1
5932204|NCT01410240|20519647|P2|Overall Study|Physician Decision|0
5932205|NCT01410240|20519648|P1|Overall Study|Physician Decision|0
5932206|NCT01410227|20519719|P4|Overall Study|Met Excl. Criteria After Starting Study|0
5932207|NCT01410227|20519720|P3|Overall Study|Met Excl. Criteria After Starting Study|1
5932208|NCT01410227|20519721|P2|Overall Study|Met Excl. Criteria After Starting Study|0
5932209|NCT01410227|20519722|P1|Overall Study|Met Excl. Criteria After Starting Study|0
5932210|NCT01410227|20519719|P4|Overall Study|Pregnancy|1
5932211|NCT01410227|20519720|P3|Overall Study|Pregnancy|0
5932212|NCT01410227|20519721|P2|Overall Study|Pregnancy|0
5932213|NCT01410227|20519722|P1|Overall Study|Pregnancy|0
5932214|NCT01410227|20519719|P4|Overall Study|Withdrawal by Subject|0
5932215|NCT01410227|20519720|P3|Overall Study|Withdrawal by Subject|1
5932216|NCT01410227|20519721|P2|Overall Study|Withdrawal by Subject|0
5932217|NCT01410227|20519722|P1|Overall Study|Withdrawal by Subject|3
5932218|NCT01410227|20519719|P4|Overall Study|Adverse Event|0
5932219|NCT01410227|20519720|P3|Overall Study|Adverse Event|0
5932220|NCT01410227|20519721|P2|Overall Study|Adverse Event|0
5932221|NCT01410227|20519722|P1|Overall Study|Adverse Event|1
5932222|NCT01410110|20519794|P2|Overall Study|Withdrawal by Subject|2
5932223|NCT01410110|20519795|P1|Overall Study|Withdrawal by Subject|4
5932224|NCT01409993|20519870|P4|Overall Study|Lost to Follow-up|0
5932225|NCT01409993|20519871|P3|Overall Study|Lost to Follow-up|0
5932226|NCT01409993|20519872|P2|Overall Study|Lost to Follow-up|1
5932227|NCT01409993|20519873|P1|Overall Study|Lost to Follow-up|0
5932228|NCT01409993|20519870|P4|Overall Study|Withdrawal by Subject|4
5932229|NCT01409993|20519871|P3|Overall Study|Withdrawal by Subject|0
5932230|NCT01409993|20519872|P2|Overall Study|Withdrawal by Subject|0
5932231|NCT01409993|20519873|P1|Overall Study|Withdrawal by Subject|0
5932232|NCT01409993|20519870|P4|Overall Study|Adverse Event|1
5932233|NCT01409993|20519871|P3|Overall Study|Adverse Event|3
5932234|NCT01409993|20519872|P2|Overall Study|Adverse Event|4
5932235|NCT01409993|20519873|P1|Overall Study|Adverse Event|4
5932236|NCT01409928|20519891|P1|Overall Study|Physician Decision|12
5932237|NCT01409837|20519897|P2|Overall Study|Physician Decision|1
5932238|NCT01409837|20519898|P1|Overall Study|Physician Decision|0
5932239|NCT01409837|20519897|P2|Overall Study|Lost to Follow-up|0
5932240|NCT01409837|20519898|P1|Overall Study|Lost to Follow-up|1
5932241|NCT01409837|20519897|P2|Overall Study|Withdrawal by Subject|1
5932242|NCT01409837|20519898|P1|Overall Study|Withdrawal by Subject|2
5932243|NCT01409811|20519920|P1|Overall Study|Insurance denial|1
5932244|NCT01409707|20519927|P3|Overall Study|Withdrawal by Subject|16
5932245|NCT01409707|20519928|P2|Overall Study|Withdrawal by Subject|17
5932246|NCT01409707|20519929|P1|Overall Study|Withdrawal by Subject|5
5932247|NCT01409564|20519941|P2|Overall Study|brain abnormalities found in T1 MR|2
5932248|NCT01409564|20519942|P1|Overall Study|brain abnormalities found in T1 MR|1
5932249|NCT01409564|20519941|P2|Overall Study|low medication compliance|3
5932250|NCT01409564|20519942|P1|Overall Study|low medication compliance|4
5932251|NCT01409434|20519960|P1|Overall Study|Protocol Violation|4
5932252|NCT01409382|20519970|P2|Overall Study|Had a 2nd trimester loss after accident|0
5932253|NCT01409382|20519971|P1|Overall Study|Had a 2nd trimester loss after accident|1
5932254|NCT01409382|20519970|P2|Overall Study|Did not manage to get pregnant|70
5932255|NCT01409382|20519971|P1|Overall Study|Did not manage to get pregnant|64
5932256|NCT01409382|20519970|P2|Overall Study|Still pregnant when study ended|2
5932257|NCT01409382|20519971|P1|Overall Study|Still pregnant when study ended|13
5932258|NCT01409382|20519970|P2|Overall Study|Multiple pregnancy|4
5932259|NCT01409382|20519971|P1|Overall Study|Multiple pregnancy|2
5932260|NCT01409382|20519970|P2|Overall Study|Protocol Violation|3
5932261|NCT01409382|20519971|P1|Overall Study|Protocol Violation|0
5932262|NCT01409382|20519970|P2|Overall Study|Lost to Follow-up|1
5932263|NCT01409382|20519971|P1|Overall Study|Lost to Follow-up|1
5932264|NCT01409031|20520025|P2|Overall Study|transferred to other hosp|0
5932265|NCT01409031|20520026|P1|Overall Study|transferred to other hosp|1
5932266|NCT01408914|20520057|P3|Overall Study|Change in local TB/HIV norms|1
5932267|NCT01408914|20520058|P2|Overall Study|Change in local TB/HIV norms|1
5932268|NCT01408914|20520059|P1|Overall Study|Change in local TB/HIV norms|0
5932269|NCT01408914|20520057|P3|Overall Study|Late exclusion|3
5932270|NCT01408914|20520058|P2|Overall Study|Late exclusion|3
5932271|NCT01408914|20520059|P1|Overall Study|Late exclusion|0
5932272|NCT01408914|20520057|P3|Overall Study|Moved out of study jurisdiction|0
5932273|NCT01408914|20520058|P2|Overall Study|Moved out of study jurisdiction|1
5932274|NCT01408914|20520059|P1|Overall Study|Moved out of study jurisdiction|1
5932275|NCT01408914|20520057|P3|Overall Study|Withdrawal by Subject|1
5932276|NCT01408914|20520058|P2|Overall Study|Withdrawal by Subject|0
5932277|NCT01408914|20520059|P1|Overall Study|Withdrawal by Subject|1
5932278|NCT01408914|20520057|P3|Overall Study|Physician Decision|0
5932279|NCT01408914|20520058|P2|Overall Study|Physician Decision|1
5932280|NCT01408914|20520059|P1|Overall Study|Physician Decision|1
5932281|NCT01408914|20520057|P3|Overall Study|Lost to Follow-up|2
5932282|NCT01408914|20520058|P2|Overall Study|Lost to Follow-up|1
5932283|NCT01408914|20520059|P1|Overall Study|Lost to Follow-up|4
5932284|NCT01408914|20520057|P3|Overall Study|Could not complete tx in protocol period|6
5932285|NCT01408914|20520058|P2|Overall Study|Could not complete tx in protocol period|5
5932286|NCT01408914|20520059|P1|Overall Study|Could not complete tx in protocol period|5
5932287|NCT01408901|20520077|P4|26-Week Follow-Up|Death|0
5932288|NCT01408901|20520078|P3|26-Week Follow-Up|Death|0
5932289|NCT01408901|20520079|P2|26-Week Follow-Up|Death|1
5932290|NCT01408901|20520080|P1|26-Week Follow-Up|Death|0
5932291|NCT01408901|20520077|P4|26-Week Follow-Up|Lost to Follow-up|1
5932292|NCT01408901|20520078|P3|26-Week Follow-Up|Lost to Follow-up|0
5932293|NCT01408901|20520079|P2|26-Week Follow-Up|Lost to Follow-up|1
5932294|NCT01408901|20520080|P1|26-Week Follow-Up|Lost to Follow-up|1
5932295|NCT01408901|20520077|P4|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|1
5932296|NCT01408901|20520078|P3|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0
5932297|NCT01408901|20520079|P2|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|2
5932298|NCT01408901|20520080|P1|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0
5932299|NCT01408901|20520077|P4|12-Week Follow-Up (Primary Endpoint)|Death|0
5932300|NCT01408901|20520078|P3|12-Week Follow-Up (Primary Endpoint)|Death|0
5932301|NCT01408901|20520079|P2|12-Week Follow-Up (Primary Endpoint)|Death|0
5932302|NCT01408901|20520080|P1|12-Week Follow-Up (Primary Endpoint)|Death|1
5932303|NCT01408901|20520077|P4|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|2
5932304|NCT01408901|20520078|P3|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0
5932305|NCT01408901|20520079|P2|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0
5932306|NCT01408901|20520080|P1|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0
5932307|NCT01408901|20520077|P4|6-Week Follow-Up|Cancelled visit|2
5932308|NCT01408901|20520078|P3|6-Week Follow-Up|Cancelled visit|0
5932309|NCT01408901|20520079|P2|6-Week Follow-Up|Cancelled visit|1
5932310|NCT01408901|20520080|P1|6-Week Follow-Up|Cancelled visit|0
5932311|NCT01408901|20520077|P4|6-Week Follow-Up|Death|0
5932312|NCT01408901|20520078|P3|6-Week Follow-Up|Death|0
5932313|NCT01408901|20520079|P2|6-Week Follow-Up|Death|0
5932314|NCT01408901|20520080|P1|6-Week Follow-Up|Death|1
5932315|NCT01408901|20520077|P4|6-Week Follow-Up|Lost to Follow-up|2
5932316|NCT01408901|20520078|P3|6-Week Follow-Up|Lost to Follow-up|3
5932317|NCT01408901|20520079|P2|6-Week Follow-Up|Lost to Follow-up|1
5932318|NCT01408901|20520080|P1|6-Week Follow-Up|Lost to Follow-up|2
5932319|NCT01408888|20520106|P2|Second Intervention|Adverse Event|0
5932320|NCT01408888|20520107|P1|Second Intervention|Adverse Event|1
5932321|NCT01408888|20520106|P2|Second Intervention|Withdrawal by Subject|0
5932322|NCT01408888|20520107|P1|Second Intervention|Withdrawal by Subject|1
5932323|NCT01408888|20520106|P2|First Intervention|Withdrawal by Subject|2
5932324|NCT01408888|20520107|P1|First Intervention|Withdrawal by Subject|0
5932325|NCT01408888|20520106|P2|First Intervention|Adverse Event|1
5932326|NCT01408888|20520107|P1|First Intervention|Adverse Event|0
5932327|NCT01408732|20520135|P2|Overall Study|Withdrawal by Subject|2
5932328|NCT01408732|20520136|P1|Overall Study|Withdrawal by Subject|2
5932329|NCT01408706|20520193|P2|Overall Study|Physician Decision|0
5932330|NCT01408706|20520194|P1|Overall Study|Physician Decision|1
5932331|NCT01408641|20520206|P2|Overall Study|Physician Decision|0
5932332|NCT01408641|20520207|P1|Overall Study|Physician Decision|1
5932333|NCT01408628|20520215|P1|Completed 6 Month Follow-Up|Withdrawal by Subject|5
5932334|NCT01408628|20520215|P1|Completed 6 Month Follow-Up|Protocol Violation|6
5932335|NCT01408628|20520215|P1|Completed 6 Month Follow-Up|Lost to Follow-up|3
5932336|NCT01408628|20520215|P1|Consented|Withdrawal by Subject|12
5932337|NCT01408576|20520224|P3|Overall Study|Other|18
5932338|NCT01408576|20520225|P2|Overall Study|Other|16
5932339|NCT01408576|20520226|P1|Overall Study|Other|10
5932340|NCT01408576|20520224|P3|Overall Study|AE, unknown type|0
5932341|NCT01408576|20520225|P2|Overall Study|AE, unknown type|1
5932342|NCT01408576|20520226|P1|Overall Study|AE, unknown type|0
5932343|NCT01408576|20520224|P3|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
5932344|NCT01408576|20520225|P2|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
5932345|NCT01408576|20520226|P1|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0
5932346|NCT01408576|20520224|P3|Overall Study|AE, non-serious non-fatal|11
5932347|NCT01408576|20520225|P2|Overall Study|AE, non-serious non-fatal|19
5932348|NCT01408576|20520226|P1|Overall Study|AE, non-serious non-fatal|12
5932349|NCT01408576|20520224|P3|Overall Study|SAE, non-fatal|14
5932350|NCT01408576|20520225|P2|Overall Study|SAE, non-fatal|23
5932351|NCT01408576|20520226|P1|Overall Study|SAE, non-fatal|11
5932352|NCT01408576|20520224|P3|Overall Study|AE, serious fatal|1
5932353|NCT01408576|20520225|P2|Overall Study|AE, serious fatal|4
5932354|NCT01408576|20520226|P1|Overall Study|AE, serious fatal|4
5932355|NCT01408576|20520224|P3|Overall Study|Sponsor terminated study|330
5932356|NCT01408576|20520225|P2|Overall Study|Sponsor terminated study|333
5932357|NCT01408576|20520226|P1|Overall Study|Sponsor terminated study|89
5932358|NCT01408576|20520224|P3|Overall Study|Withdrawal by Subject|66
5932359|NCT01408576|20520225|P2|Overall Study|Withdrawal by Subject|60
5932360|NCT01408576|20520226|P1|Overall Study|Withdrawal by Subject|34
5932361|NCT01408576|20520224|P3|Overall Study|Lost to Follow-up|17
5932362|NCT01408576|20520225|P2|Overall Study|Lost to Follow-up|9
5932363|NCT01408576|20520226|P1|Overall Study|Lost to Follow-up|10
5932364|NCT01408576|20520224|P3|Overall Study|Protocol Violation|2
5932365|NCT01408576|20520225|P2|Overall Study|Protocol Violation|2
5932366|NCT01408576|20520226|P1|Overall Study|Protocol Violation|1
5932367|NCT01408576|20520224|P3|Overall Study|Lack of Efficacy|48
5932368|NCT01408576|20520225|P2|Overall Study|Lack of Efficacy|30
5932369|NCT01408576|20520226|P1|Overall Study|Lack of Efficacy|17
5932370|NCT01408563|20520273|P1|Overall Study|Ineligible after consent/ registration|2
5932371|NCT01408537|20520289|P1|Overall Study|Lost to Follow-up|3
5932372|NCT01408537|20520289|P1|Overall Study|Protocol Violation|3
5932373|NCT01408537|20520289|P1|Overall Study|Withdrawal by Subject|2
5932374|NCT01408485|20520305|P1|Overall Study|Withdrawal by Subject|21
5932375|NCT01408303|20520323|P3|Overall Study|Noncompliance|1
5932376|NCT01408303|20520324|P2|Overall Study|Noncompliance|0
5932377|NCT01408303|20520325|P1|Overall Study|Noncompliance|1
5932378|NCT01408303|20520323|P3|Overall Study|Protocol Violation|0
5932379|NCT01408303|20520324|P2|Overall Study|Protocol Violation|1
5932380|NCT01408303|20520325|P1|Overall Study|Protocol Violation|0
5932381|NCT01408303|20520323|P3|Overall Study|Withdrawal by Subject|1
5932382|NCT01408303|20520324|P2|Overall Study|Withdrawal by Subject|3
5932383|NCT01408303|20520325|P1|Overall Study|Withdrawal by Subject|2
5932384|NCT01408303|20520323|P3|Overall Study|Lost to Follow-up|2
5932385|NCT01408303|20520324|P2|Overall Study|Lost to Follow-up|1
5932386|NCT01408303|20520325|P1|Overall Study|Lost to Follow-up|0
5932387|NCT01408303|20520323|P3|Overall Study|Adverse Event|2
5932388|NCT01408303|20520324|P2|Overall Study|Adverse Event|7
5932389|NCT01408303|20520325|P1|Overall Study|Adverse Event|3
5932390|NCT01408277|20520335|P2|Overall Study|Protocol Violation|0
5932391|NCT01408277|20520336|P1|Overall Study|Protocol Violation|2
5932392|NCT01408277|20520335|P2|Overall Study|Withdrawal by Subject|0
5932393|NCT01408277|20520336|P1|Overall Study|Withdrawal by Subject|2
5932394|NCT01408277|20520335|P2|Overall Study|Lost to Follow-up|0
5932395|NCT01408277|20520336|P1|Overall Study|Lost to Follow-up|1
5932396|NCT01408277|20520335|P2|Overall Study|Adverse Event|4
5932397|NCT01408277|20520336|P1|Overall Study|Adverse Event|3
5932398|NCT01408147|20520344|P2|Overall Study|Withdrawal by Subject|1
5932399|NCT01408147|20520345|P1|Overall Study|Withdrawal by Subject|0
5932400|NCT01408043|20520353|P1|Overall Study|unable to collect cells|1
5932401|NCT01408030|20520372|P4|Observation Phase (Off Drug)|Other|1
5932402|NCT01408030|20520373|P3|Observation Phase (Off Drug)|Other|1
5932403|NCT01408030|20520374|P2|Observation Phase (Off Drug)|Other|1
5932404|NCT01408030|20520375|P1|Observation Phase (Off Drug)|Other|1
5932405|NCT01408030|20520372|P4|Observation Phase (Off Drug)|Physician Decision|0
5932406|NCT01408030|20520373|P3|Observation Phase (Off Drug)|Physician Decision|2
5932407|NCT01408030|20520374|P2|Observation Phase (Off Drug)|Physician Decision|1
5932408|NCT01408030|20520375|P1|Observation Phase (Off Drug)|Physician Decision|0
5932409|NCT01408030|20520372|P4|Observation Phase (Off Drug)|Withdrawal by Subject|3
5932410|NCT01408030|20520373|P3|Observation Phase (Off Drug)|Withdrawal by Subject|1
5932411|NCT01408030|20520374|P2|Observation Phase (Off Drug)|Withdrawal by Subject|2
5932412|NCT01408030|20520375|P1|Observation Phase (Off Drug)|Withdrawal by Subject|3
5932413|NCT01408030|20520372|P4|Observation Phase (Off Drug)|Lost to Follow-up|0
5932414|NCT01408030|20520373|P3|Observation Phase (Off Drug)|Lost to Follow-up|2
5932415|NCT01408030|20520374|P2|Observation Phase (Off Drug)|Lost to Follow-up|2
5932416|NCT01408030|20520375|P1|Observation Phase (Off Drug)|Lost to Follow-up|0
5932417|NCT01408030|20520372|P4|Treatment Phase (on Drug)|Protocol Violation|0
5932418|NCT01408030|20520373|P3|Treatment Phase (on Drug)|Protocol Violation|0
5932419|NCT01408030|20520374|P2|Treatment Phase (on Drug)|Protocol Violation|1
5932420|NCT01408030|20520375|P1|Treatment Phase (on Drug)|Protocol Violation|0
5932421|NCT01408030|20520372|P4|Treatment Phase (on Drug)|Lack of Efficacy|3
5932422|NCT01408030|20520373|P3|Treatment Phase (on Drug)|Lack of Efficacy|0
5932423|NCT01408030|20520374|P2|Treatment Phase (on Drug)|Lack of Efficacy|6
5932424|NCT01408030|20520375|P1|Treatment Phase (on Drug)|Lack of Efficacy|2
5932425|NCT01408030|20520372|P4|Treatment Phase (on Drug)|Lost to Follow-up|0
5932426|NCT01408030|20520373|P3|Treatment Phase (on Drug)|Lost to Follow-up|1
5932427|NCT01408030|20520374|P2|Treatment Phase (on Drug)|Lost to Follow-up|0
5932428|NCT01408030|20520375|P1|Treatment Phase (on Drug)|Lost to Follow-up|1
5932429|NCT01407926|20520434|P1|Overall Study|Lost to Follow-up|55
5932430|NCT01407367|20520482|P2|Overall Study|Lost to Follow-up|2
5932431|NCT01407367|20520483|P1|Overall Study|Lost to Follow-up|0
5932432|NCT01407367|20520482|P2|Overall Study|Withdrawal by Subject|15
5932433|NCT01407367|20520483|P1|Overall Study|Withdrawal by Subject|4
5932434|NCT01407367|20520482|P2|Overall Study|Renal Replacement Therapy (RRT)|29
5932435|NCT01407367|20520483|P1|Overall Study|Renal Replacement Therapy (RRT)|12
5932436|NCT01407367|20520482|P2|Overall Study|Death|32
5932437|NCT01407367|20520483|P1|Overall Study|Death|24
5932438|NCT01407354|20520497|P2|First Intervention|Physician Decision|0
5932439|NCT01407354|20520498|P1|First Intervention|Physician Decision|1
5932440|NCT01407354|20520497|P2|First Intervention|Adverse Event|0
5932441|NCT01407354|20520498|P1|First Intervention|Adverse Event|1
5932442|NCT01407354|20520497|P2|First Intervention|Withdrawal by Subject|2
5932443|NCT01407354|20520498|P1|First Intervention|Withdrawal by Subject|0
5932444|NCT01407276|20520514|P8|Overall Study|Withdrawal by Subject|1
5932445|NCT01407276|20520515|P7|Overall Study|Withdrawal by Subject|0
5932446|NCT01407276|20520516|P6|Overall Study|Withdrawal by Subject|0
5932447|NCT01407276|20520517|P5|Overall Study|Withdrawal by Subject|0
5932448|NCT01407276|20520518|P4|Overall Study|Withdrawal by Subject|0
5932449|NCT01407276|20520519|P3|Overall Study|Withdrawal by Subject|0
5932450|NCT01407276|20520520|P2|Overall Study|Withdrawal by Subject|0
5932451|NCT01407276|20520521|P1|Overall Study|Withdrawal by Subject|0
5932452|NCT01406938|20520689|P6|Follow up|Lost to Follow-up|1
5932453|NCT01406938|20520690|P5|Follow up|Lost to Follow-up|2
5932454|NCT01406938|20520691|P4|Follow up|Lost to Follow-up|1
5932455|NCT01406938|20520692|P3|Follow up|Lost to Follow-up|0
5932456|NCT01406938|20520693|P2|Follow up|Lost to Follow-up|1
5932457|NCT01406938|20520694|P1|Follow up|Lost to Follow-up|1
5932458|NCT01406938|20520689|P6|Follow up|Physician Decision|1
5932459|NCT01406938|20520690|P5|Follow up|Physician Decision|3
5932460|NCT01406938|20520691|P4|Follow up|Physician Decision|0
5932461|NCT01406938|20520692|P3|Follow up|Physician Decision|2
5932462|NCT01406938|20520693|P2|Follow up|Physician Decision|0
5932463|NCT01406938|20520694|P1|Follow up|Physician Decision|0
5932464|NCT01406938|20520689|P6|Follow up|Protocol Violation|0
5932465|NCT01406938|20520690|P5|Follow up|Protocol Violation|0
5932466|NCT01406938|20520691|P4|Follow up|Protocol Violation|0
5932467|NCT01406938|20520692|P3|Follow up|Protocol Violation|1
5932468|NCT01406938|20520693|P2|Follow up|Protocol Violation|0
5932469|NCT01406938|20520694|P1|Follow up|Protocol Violation|0
5932470|NCT01406938|20520689|P6|Follow up|Patient/guardian decision|1
5932471|NCT01406938|20520690|P5|Follow up|Patient/guardian decision|4
5932472|NCT01406938|20520691|P4|Follow up|Patient/guardian decision|2
5932473|NCT01406938|20520692|P3|Follow up|Patient/guardian decision|4
5932474|NCT01406938|20520693|P2|Follow up|Patient/guardian decision|2
5932475|NCT01406938|20520694|P1|Follow up|Patient/guardian decision|4
5932476|NCT01406938|20520689|P6|Follow up|Lack of Efficacy|0
5932477|NCT01406938|20520690|P5|Follow up|Lack of Efficacy|0
5932478|NCT01406938|20520691|P4|Follow up|Lack of Efficacy|0
5932479|NCT01406938|20520692|P3|Follow up|Lack of Efficacy|1
5932480|NCT01406938|20520693|P2|Follow up|Lack of Efficacy|2
5932481|NCT01406938|20520694|P1|Follow up|Lack of Efficacy|3
5932482|NCT01406938|20520689|P6|Maintenance Period|Lack of Efficacy|5
5932483|NCT01406938|20520690|P5|Maintenance Period|Lack of Efficacy|3
5932484|NCT01406938|20520691|P4|Maintenance Period|Lack of Efficacy|1
5932485|NCT01406938|20520692|P3|Maintenance Period|Lack of Efficacy|2
5932486|NCT01406938|20520693|P2|Maintenance Period|Lack of Efficacy|0
5932487|NCT01406938|20520694|P1|Maintenance Period|Lack of Efficacy|0
5932488|NCT01406938|20520689|P6|Maintenance Period|Lost to Follow-up|0
5932489|NCT01406938|20520690|P5|Maintenance Period|Lost to Follow-up|4
5932490|NCT01406938|20520691|P4|Maintenance Period|Lost to Follow-up|0
5932491|NCT01406938|20520692|P3|Maintenance Period|Lost to Follow-up|0
5932492|NCT01406938|20520693|P2|Maintenance Period|Lost to Follow-up|0
5932493|NCT01406938|20520694|P1|Maintenance Period|Lost to Follow-up|0
5932494|NCT01406938|20520689|P6|Maintenance Period|Pregnancy|0
5932495|NCT01406938|20520690|P5|Maintenance Period|Pregnancy|1
5932496|NCT01406938|20520691|P4|Maintenance Period|Pregnancy|0
5932497|NCT01406938|20520692|P3|Maintenance Period|Pregnancy|0
5932498|NCT01406938|20520693|P2|Maintenance Period|Pregnancy|0
5932499|NCT01406938|20520694|P1|Maintenance Period|Pregnancy|0
5932500|NCT01406938|20520689|P6|Maintenance Period|Protocol Violation|2
5932501|NCT01406938|20520690|P5|Maintenance Period|Protocol Violation|2
5932502|NCT01406938|20520691|P4|Maintenance Period|Protocol Violation|2
5932503|NCT01406938|20520692|P3|Maintenance Period|Protocol Violation|2
5932504|NCT01406938|20520693|P2|Maintenance Period|Protocol Violation|0
5932505|NCT01406938|20520694|P1|Maintenance Period|Protocol Violation|0
5932506|NCT01406938|20520689|P6|Maintenance Period|Subject/guardian decision|7
5932507|NCT01406938|20520690|P5|Maintenance Period|Subject/guardian decision|10
5932508|NCT01406938|20520691|P4|Maintenance Period|Subject/guardian decision|7
5932509|NCT01406938|20520692|P3|Maintenance Period|Subject/guardian decision|11
5932510|NCT01406938|20520693|P2|Maintenance Period|Subject/guardian decision|0
5932511|NCT01406938|20520694|P1|Maintenance Period|Subject/guardian decision|0
5932512|NCT01406938|20520689|P6|Maintenance Period|Death|0
5932513|NCT01406938|20520690|P5|Maintenance Period|Death|1
5932514|NCT01406938|20520691|P4|Maintenance Period|Death|0
5932515|NCT01406938|20520692|P3|Maintenance Period|Death|0
5932516|NCT01406938|20520693|P2|Maintenance Period|Death|0
5932517|NCT01406938|20520694|P1|Maintenance Period|Death|0
5932518|NCT01406938|20520689|P6|Maintenance Period|Adverse Event|2
5932519|NCT01406938|20520690|P5|Maintenance Period|Adverse Event|4
5932520|NCT01406938|20520691|P4|Maintenance Period|Adverse Event|8
5932521|NCT01406938|20520692|P3|Maintenance Period|Adverse Event|2
5932522|NCT01406938|20520693|P2|Maintenance Period|Adverse Event|0
5932523|NCT01406938|20520694|P1|Maintenance Period|Adverse Event|0
5932524|NCT01406938|20520689|P6|Induction Period|Lost to Follow-up|0
5932525|NCT01406938|20520690|P5|Induction Period|Lost to Follow-up|0
5932526|NCT01406938|20520691|P4|Induction Period|Lost to Follow-up|0
5932527|NCT01406938|20520692|P3|Induction Period|Lost to Follow-up|0
5932528|NCT01406938|20520693|P2|Induction Period|Lost to Follow-up|3
5932529|NCT01406938|20520694|P1|Induction Period|Lost to Follow-up|2
5932530|NCT01406938|20520689|P6|Induction Period|Lack of Efficacy|0
5932531|NCT01406938|20520690|P5|Induction Period|Lack of Efficacy|0
5932532|NCT01406938|20520691|P4|Induction Period|Lack of Efficacy|0
5932533|NCT01406938|20520692|P3|Induction Period|Lack of Efficacy|0
5932534|NCT01406938|20520693|P2|Induction Period|Lack of Efficacy|0
5932535|NCT01406938|20520694|P1|Induction Period|Lack of Efficacy|1
5932536|NCT01406938|20520689|P6|Induction Period|Adverse Event|0
5932537|NCT01406938|20520690|P5|Induction Period|Adverse Event|0
5932538|NCT01406938|20520691|P4|Induction Period|Adverse Event|0
5932539|NCT01406938|20520692|P3|Induction Period|Adverse Event|0
5932540|NCT01406938|20520693|P2|Induction Period|Adverse Event|9
5932541|NCT01406938|20520694|P1|Induction Period|Adverse Event|8
5932542|NCT01406938|20520689|P6|Induction Period|Protocol deviation|0
5932543|NCT01406938|20520690|P5|Induction Period|Protocol deviation|0
5932544|NCT01406938|20520691|P4|Induction Period|Protocol deviation|0
5932545|NCT01406938|20520692|P3|Induction Period|Protocol deviation|0
5932546|NCT01406938|20520693|P2|Induction Period|Protocol deviation|0
5932547|NCT01406938|20520694|P1|Induction Period|Protocol deviation|1
5932548|NCT01406938|20520689|P6|Induction Period|Subject/guardian decision|0
5932549|NCT01406938|20520690|P5|Induction Period|Subject/guardian decision|0
5932550|NCT01406938|20520691|P4|Induction Period|Subject/guardian decision|0
5932551|NCT01406938|20520692|P3|Induction Period|Subject/guardian decision|0
5932552|NCT01406938|20520693|P2|Induction Period|Subject/guardian decision|8
5932553|NCT01406938|20520694|P1|Induction Period|Subject/guardian decision|6
5932554|NCT01406873|20520812|P2|Overall Study|Withdrawal by Subject|1
5932555|NCT01406873|20520813|P1|Overall Study|Withdrawal by Subject|1
5932556|NCT01406795|20520844|P1|Overall Study|Withdrawal by Subject|1
5932557|NCT01406717|20520860|P2|Overall Study|Non-completion of visit activity|1
5932558|NCT01406717|20520861|P1|Overall Study|Non-completion of visit activity|0
5932559|NCT01406717|20520860|P2|Overall Study|Lack of Efficacy|1
5932560|NCT01406717|20520861|P1|Overall Study|Lack of Efficacy|0
5932561|NCT01406717|20520860|P2|Overall Study|Adverse Event|2
5932562|NCT01406717|20520861|P1|Overall Study|Adverse Event|1
5932563|NCT01406717|20520860|P2|Overall Study|Withdrawal by Subject|15
5932564|NCT01406717|20520861|P1|Overall Study|Withdrawal by Subject|19
5932565|NCT01406717|20520860|P2|Overall Study|Lost to Follow-up|8
5932566|NCT01406717|20520861|P1|Overall Study|Lost to Follow-up|14
5932567|NCT01406717|20520860|P2|Overall Study|Protocol Violation|1
5932568|NCT01406717|20520861|P1|Overall Study|Protocol Violation|5
5932569|NCT01406717|20520860|P2|Overall Study|Subject non-compliance|3
5932570|NCT01406717|20520861|P1|Overall Study|Subject non-compliance|4
5932571|NCT01406652|20520891|P2|Overall Study|Infection not sure|10
5932572|NCT01406652|20520892|P1|Overall Study|Infection not sure|10
5932573|NCT01406652|20520891|P2|Overall Study|Insufficient follow-up|4
5932574|NCT01406652|20520892|P1|Overall Study|Insufficient follow-up|5
5932575|NCT01406652|20520891|P2|Overall Study|Withdrawal by Subject|2
5932576|NCT01406652|20520892|P1|Overall Study|Withdrawal by Subject|2
5932577|NCT01406652|20520891|P2|Overall Study|Lost-to-follow-up|4
5932578|NCT01406652|20520892|P1|Overall Study|Lost-to-follow-up|3
5932579|NCT01406574|20520900|P4|Overall Study|Definite progression of primary disease|0
5932580|NCT01406574|20520901|P3|Overall Study|Definite progression of primary disease|0
5932581|NCT01406574|20520902|P2|Overall Study|Definite progression of primary disease|0
5932582|NCT01406574|20520903|P1|Overall Study|Definite progression of primary disease|1
5932583|NCT01406574|20520900|P4|Overall Study|Withdrawal by Subject|0
5932584|NCT01406574|20520901|P3|Overall Study|Withdrawal by Subject|0
5932585|NCT01406574|20520902|P2|Overall Study|Withdrawal by Subject|1
5932586|NCT01406574|20520903|P1|Overall Study|Withdrawal by Subject|0
5932587|NCT01406574|20520900|P4|Overall Study|Physician Decision|1
5932588|NCT01406574|20520901|P3|Overall Study|Physician Decision|0
5932589|NCT01406574|20520902|P2|Overall Study|Physician Decision|0
5932590|NCT01406574|20520903|P1|Overall Study|Physician Decision|0
5932591|NCT01406574|20520900|P4|Overall Study|Adverse Event|3
5932592|NCT01406574|20520901|P3|Overall Study|Adverse Event|1
5932593|NCT01406574|20520902|P2|Overall Study|Adverse Event|0
5932594|NCT01406574|20520903|P1|Overall Study|Adverse Event|0
5932595|NCT01406015|20520954|P2|Overall Study|Withdrawal by Subject|3
5932596|NCT01406015|20520955|P1|Overall Study|Withdrawal by Subject|3
5932597|NCT01405950|20520971|P4|Overall Study|Withdrawal by Subject|0
5932598|NCT01405950|20520972|P3|Overall Study|Withdrawal by Subject|0
5932599|NCT01405950|20520973|P2|Overall Study|Withdrawal by Subject|0
5932600|NCT01405950|20520974|P1|Overall Study|Withdrawal by Subject|1
5932601|NCT01405924|20521009|P1|Overall Study|Missing/Incomplete Data|2
5932602|NCT01405924|20521009|P1|Overall Study|Protocol Violation|8
5932603|NCT01405911|20521022|P3|Overall Study|Withdrawal by Subject|1
5932604|NCT01405911|20521023|P2|Overall Study|Withdrawal by Subject|1
5932605|NCT01405911|20521024|P1|Overall Study|Withdrawal by Subject|3
5932606|NCT01405911|20521022|P3|Overall Study|Protocol Violation|0
5932607|NCT01405911|20521023|P2|Overall Study|Protocol Violation|0
5932608|NCT01405911|20521024|P1|Overall Study|Protocol Violation|1
5932609|NCT01405911|20521022|P3|Overall Study|Lost to Follow-up|0
5932610|NCT01405911|20521023|P2|Overall Study|Lost to Follow-up|1
5932611|NCT01405911|20521024|P1|Overall Study|Lost to Follow-up|0
5932612|NCT01405911|20521022|P3|Overall Study|Pre-treatment lab AE|0
5932613|NCT01405911|20521023|P2|Overall Study|Pre-treatment lab AE|1
5932614|NCT01405911|20521024|P1|Overall Study|Pre-treatment lab AE|0
5932615|NCT01405898|20521043|P2|Overall Study|Withdrawal by Subject|2
5932616|NCT01405898|20521044|P1|Overall Study|Withdrawal by Subject|2
5932617|NCT01405820|20521068|P6|Open-Label Treatment Period|Adverse Event|0
5932618|NCT01405820|20521069|P5|Open-Label Treatment Period|Adverse Event|0
5932619|NCT01405820|20521070|P4|Open-Label Treatment Period|Adverse Event|1
5932620|NCT01405820|20521071|P3|Open-Label Treatment Period|Adverse Event|0
5932621|NCT01405820|20521072|P2|Open-Label Treatment Period|Adverse Event|0
5932622|NCT01405820|20521073|P1|Open-Label Treatment Period|Adverse Event|0
5932623|NCT01405820|20521068|P6|Open-Label Treatment Period|Physician Decision|0
5932624|NCT01405820|20521069|P5|Open-Label Treatment Period|Physician Decision|1
5932625|NCT01405820|20521070|P4|Open-Label Treatment Period|Physician Decision|2
5932626|NCT01405820|20521071|P3|Open-Label Treatment Period|Physician Decision|1
5932627|NCT01405820|20521072|P2|Open-Label Treatment Period|Physician Decision|0
5932628|NCT01405820|20521073|P1|Open-Label Treatment Period|Physician Decision|0
5932629|NCT01405820|20521068|P6|Open-Label Treatment Period|Other|1
5932630|NCT01405820|20521069|P5|Open-Label Treatment Period|Other|1
5932631|NCT01405820|20521070|P4|Open-Label Treatment Period|Other|1
5932632|NCT01405820|20521071|P3|Open-Label Treatment Period|Other|1
5932633|NCT01405820|20521072|P2|Open-Label Treatment Period|Other|1
5932634|NCT01405820|20521073|P1|Open-Label Treatment Period|Other|1
5932635|NCT01405820|20521068|P6|Open-Label Treatment Period|Withdrawal by Subject|1
5932636|NCT01405820|20521069|P5|Open-Label Treatment Period|Withdrawal by Subject|0
5932637|NCT01405820|20521070|P4|Open-Label Treatment Period|Withdrawal by Subject|1
5932638|NCT01405820|20521071|P3|Open-Label Treatment Period|Withdrawal by Subject|1
5932639|NCT01405820|20521072|P2|Open-Label Treatment Period|Withdrawal by Subject|1
5932640|NCT01405820|20521073|P1|Open-Label Treatment Period|Withdrawal by Subject|3
5932641|NCT01405820|20521068|P6|Randomized Treatment Period|Withdrew Prior to Dosing|0
5932642|NCT01405820|20521069|P5|Randomized Treatment Period|Withdrew Prior to Dosing|0
5932643|NCT01405820|20521070|P4|Randomized Treatment Period|Withdrew Prior to Dosing|1
5932644|NCT01405820|20521071|P3|Randomized Treatment Period|Withdrew Prior to Dosing|0
5932645|NCT01405820|20521072|P2|Randomized Treatment Period|Withdrew Prior to Dosing|0
5932646|NCT01405820|20521073|P1|Randomized Treatment Period|Withdrew Prior to Dosing|0
5932647|NCT01405820|20521068|P6|Randomized Treatment Period|Death|0
5932648|NCT01405820|20521069|P5|Randomized Treatment Period|Death|0
5932649|NCT01405820|20521070|P4|Randomized Treatment Period|Death|1
5932650|NCT01405820|20521071|P3|Randomized Treatment Period|Death|0
5932651|NCT01405820|20521072|P2|Randomized Treatment Period|Death|0
5932652|NCT01405820|20521073|P1|Randomized Treatment Period|Death|0
5932653|NCT01405820|20521068|P6|Randomized Treatment Period|Treatment Arm Closed|28
5932654|NCT01405820|20521069|P5|Randomized Treatment Period|Treatment Arm Closed|33
5932655|NCT01405820|20521070|P4|Randomized Treatment Period|Treatment Arm Closed|36
5932656|NCT01405820|20521071|P3|Randomized Treatment Period|Treatment Arm Closed|20
5932657|NCT01405820|20521072|P2|Randomized Treatment Period|Treatment Arm Closed|0
5932658|NCT01405820|20521073|P1|Randomized Treatment Period|Treatment Arm Closed|0
5932659|NCT01405820|20521068|P6|Randomized Treatment Period|Incorrect Study Treatment|0
5932660|NCT01405820|20521069|P5|Randomized Treatment Period|Incorrect Study Treatment|2
5932661|NCT01405820|20521070|P4|Randomized Treatment Period|Incorrect Study Treatment|0
5932662|NCT01405820|20521071|P3|Randomized Treatment Period|Incorrect Study Treatment|3
5932663|NCT01405820|20521072|P2|Randomized Treatment Period|Incorrect Study Treatment|0
5932664|NCT01405820|20521073|P1|Randomized Treatment Period|Incorrect Study Treatment|0
5932665|NCT01405820|20521068|P6|Randomized Treatment Period|Rescue|8
5932666|NCT01405820|20521069|P5|Randomized Treatment Period|Rescue|8
5932667|NCT01405820|20521070|P4|Randomized Treatment Period|Rescue|10
5932668|NCT01405820|20521071|P3|Randomized Treatment Period|Rescue|13
5932669|NCT01405820|20521072|P2|Randomized Treatment Period|Rescue|1
5932670|NCT01405820|20521073|P1|Randomized Treatment Period|Rescue|0
5932671|NCT01405820|20521068|P6|Randomized Treatment Period|Physician Decision|0
5932672|NCT01405820|20521069|P5|Randomized Treatment Period|Physician Decision|0
5932673|NCT01405820|20521070|P4|Randomized Treatment Period|Physician Decision|0
5932674|NCT01405820|20521071|P3|Randomized Treatment Period|Physician Decision|1
5932675|NCT01405820|20521072|P2|Randomized Treatment Period|Physician Decision|2
5932676|NCT01405820|20521073|P1|Randomized Treatment Period|Physician Decision|0
5932677|NCT01405820|20521068|P6|Randomized Treatment Period|Other|0
5932678|NCT01405820|20521069|P5|Randomized Treatment Period|Other|0
5932679|NCT01405820|20521070|P4|Randomized Treatment Period|Other|1
5932680|NCT01405820|20521071|P3|Randomized Treatment Period|Other|1
5932681|NCT01405820|20521072|P2|Randomized Treatment Period|Other|2
5932682|NCT01405820|20521073|P1|Randomized Treatment Period|Other|2
5932683|NCT01405820|20521068|P6|Randomized Treatment Period|Withdrawal by Subject|0
5932684|NCT01405820|20521069|P5|Randomized Treatment Period|Withdrawal by Subject|0
5932685|NCT01405820|20521070|P4|Randomized Treatment Period|Withdrawal by Subject|2
5932686|NCT01405820|20521071|P3|Randomized Treatment Period|Withdrawal by Subject|2
5932687|NCT01405820|20521072|P2|Randomized Treatment Period|Withdrawal by Subject|2
5932688|NCT01405820|20521073|P1|Randomized Treatment Period|Withdrawal by Subject|6
5932689|NCT01405820|20521068|P6|Randomized Treatment Period|Adverse Event|1
5932690|NCT01405820|20521069|P5|Randomized Treatment Period|Adverse Event|2
5932691|NCT01405820|20521070|P4|Randomized Treatment Period|Adverse Event|0
5932692|NCT01405820|20521071|P3|Randomized Treatment Period|Adverse Event|3
5932693|NCT01405820|20521072|P2|Randomized Treatment Period|Adverse Event|3
5932694|NCT01405820|20521073|P1|Randomized Treatment Period|Adverse Event|3
5932695|NCT01405768|20521169|P2|Overall Study|Didn't complete questionnaire correctly|0
5932696|NCT01405768|20521170|P1|Overall Study|Didn't complete questionnaire correctly|4
5932697|NCT01405742|20521182|P2|Overall Study|Lost to Follow-up|0
5932698|NCT01405742|20521183|P1|Overall Study|Lost to Follow-up|1
5932699|NCT01405560|20521193|P1|Overall Study|Physician Decision|1
5932700|NCT01405508|20521208|P4|Overall Study|AE, non-serious non-fatal|0
5932701|NCT01405508|20521209|P3|Overall Study|AE, non-serious non-fatal|0
5932702|NCT01405508|20521210|P2|Overall Study|AE, non-serious non-fatal|1
5932703|NCT01405508|20521211|P1|Overall Study|AE, non-serious non-fatal|1
5932704|NCT01405456|20521243|P2|Overall Study|Physician Decision|0
5932705|NCT01405456|20521244|P1|Overall Study|Physician Decision|1
5932706|NCT01405456|20521243|P2|Overall Study|Lost to Follow-up|1
5932707|NCT01405456|20521244|P1|Overall Study|Lost to Follow-up|2
5932708|NCT01405196|20521284|P4|Overall Study|Lost to Follow-up|1
5932709|NCT01405196|20521285|P3|Overall Study|Lost to Follow-up|3
5932710|NCT01405196|20521286|P2|Overall Study|Lost to Follow-up|2
5932711|NCT01405196|20521287|P1|Overall Study|Lost to Follow-up|2
5932712|NCT01405196|20521284|P4|Overall Study|Death|0
5932713|NCT01405196|20521285|P3|Overall Study|Death|3
5932714|NCT01405196|20521286|P2|Overall Study|Death|0
5932715|NCT01405196|20521287|P1|Overall Study|Death|1
5932716|NCT01405196|20521284|P4|Overall Study|Adverse Event|2
5932717|NCT01405196|20521285|P3|Overall Study|Adverse Event|0
5932718|NCT01405196|20521286|P2|Overall Study|Adverse Event|2
5932719|NCT01405196|20521287|P1|Overall Study|Adverse Event|2
5932720|NCT01405196|20521284|P4|Overall Study|Withdrawal by Subject|6
5932721|NCT01405196|20521285|P3|Overall Study|Withdrawal by Subject|3
5932722|NCT01405196|20521286|P2|Overall Study|Withdrawal by Subject|6
5932723|NCT01405196|20521287|P1|Overall Study|Withdrawal by Subject|4
5932724|NCT01405196|20521284|P4|Overall Study|Other|0
5932725|NCT01405196|20521285|P3|Overall Study|Other|5
5932726|NCT01405196|20521286|P2|Overall Study|Other|2
5932727|NCT01405196|20521287|P1|Overall Study|Other|2
5932728|NCT01405196|20521284|P4|Overall Study|Study Terminated by Sponsor|0
5932729|NCT01405196|20521285|P3|Overall Study|Study Terminated by Sponsor|9
5932730|NCT01405196|20521286|P2|Overall Study|Study Terminated by Sponsor|0
5932731|NCT01405196|20521287|P1|Overall Study|Study Terminated by Sponsor|0
5932732|NCT01405053|20521374|P2|Overall Study|Other|1
5932733|NCT01405053|20521375|P1|Overall Study|Other|0
5932734|NCT01405053|20521374|P2|Overall Study|Withdrawal by Subject|4
5932735|NCT01405053|20521375|P1|Overall Study|Withdrawal by Subject|3
5932736|NCT01405053|20521374|P2|Overall Study|Inadequate therapeutic effect|1
5932737|NCT01405053|20521375|P1|Overall Study|Inadequate therapeutic effect|2
5932738|NCT01405053|20521374|P2|Overall Study|Participant choice|1
5932739|NCT01405053|20521375|P1|Overall Study|Participant choice|2
5932740|NCT01405053|20521374|P2|Overall Study|Lost to Follow-up|1
5932741|NCT01405053|20521375|P1|Overall Study|Lost to Follow-up|0
5932742|NCT01405053|20521374|P2|Overall Study|Adverse Event|0
5932743|NCT01405053|20521375|P1|Overall Study|Adverse Event|3
5932744|NCT01405027|20521401|P2|Overall Study|Other or Unknown|25
5932745|NCT01405027|20521402|P1|Overall Study|Other or Unknown|12
5932746|NCT01405027|20521401|P2|Overall Study|Death|0
5932747|NCT01405027|20521402|P1|Overall Study|Death|1
5932748|NCT01405027|20521401|P2|Overall Study|Investigator judgement|2
5932749|NCT01405027|20521402|P1|Overall Study|Investigator judgement|0
5932750|NCT01405027|20521401|P2|Overall Study|Lost to Follow-up|24
5932751|NCT01405027|20521402|P1|Overall Study|Lost to Follow-up|16
5932752|NCT01405027|20521401|P2|Overall Study|Withdrawn consent|0
5932753|NCT01405027|20521402|P1|Overall Study|Withdrawn consent|3
5932754|NCT01404988|20521419|P3|Overall Study|Lost to Follow-up|1
5932755|NCT01404988|20521420|P2|Overall Study|Lost to Follow-up|2
5932756|NCT01404988|20521421|P1|Overall Study|Lost to Follow-up|1
5932757|NCT01404988|20521419|P3|Overall Study|Withdrawal by Subject|0
5932758|NCT01404988|20521420|P2|Overall Study|Withdrawal by Subject|2
5932759|NCT01404988|20521421|P1|Overall Study|Withdrawal by Subject|2
5932760|NCT01404988|20521419|P3|Overall Study|Adverse Event|0
5932761|NCT01404988|20521420|P2|Overall Study|Adverse Event|0
5932762|NCT01404988|20521421|P1|Overall Study|Adverse Event|1
5932763|NCT01404988|20521419|P3|Overall Study|Death|2
5932764|NCT01404988|20521420|P2|Overall Study|Death|0
5932765|NCT01404988|20521421|P1|Overall Study|Death|2
5932766|NCT01404325|20521542|P2|Overall Study|non-specified reason|2
5932767|NCT01404325|20521543|P1|Overall Study|non-specified reason|0
5932768|NCT01404325|20521542|P2|Overall Study|Graft loss/Retransplantation|0
5932769|NCT01404325|20521543|P1|Overall Study|Graft loss/Retransplantation|1
5932770|NCT01404325|20521542|P2|Overall Study|Death|0
5932771|NCT01404325|20521543|P1|Overall Study|Death|2
5932772|NCT01404325|20521542|P2|Overall Study|Lost to Follow-up|0
5932773|NCT01404325|20521543|P1|Overall Study|Lost to Follow-up|1
5932774|NCT01404312|20521601|P2|Overall Study|Severe debilitation, unable to continue|2
5932775|NCT01404312|20521602|P1|Overall Study|Severe debilitation, unable to continue|1
5932776|NCT01404312|20521601|P2|Overall Study|Participant not willing to adhere to req|29
5932777|NCT01404312|20521602|P1|Overall Study|Participant not willing to adhere to req|31
5932778|NCT01404312|20521601|P2|Overall Study|Site closed|21
5932779|NCT01404312|20521602|P1|Overall Study|Site closed|22
5932780|NCT01404312|20521601|P2|Overall Study|Lost to Follow-up|111
5932781|NCT01404312|20521602|P1|Overall Study|Lost to Follow-up|115
5932782|NCT01404312|20521601|P2|Overall Study|Participant Unable to get to clinic|103
5932783|NCT01404312|20521602|P1|Overall Study|Participant Unable to get to clinic|93
5932784|NCT01404312|20521601|P2|Overall Study|Withdrawal by Subject|18
5932785|NCT01404312|20521602|P1|Overall Study|Withdrawal by Subject|15
5932786|NCT01404312|20521601|P2|Overall Study|Death|27
5932787|NCT01404312|20521602|P1|Overall Study|Death|21
5932788|NCT01404234|20521632|P1|Overall Study|Withdrawal by Subject|2
5932789|NCT01404208|20521648|P2|Overall Study|Discontinued|0
5932790|NCT01404208|20521649|P1|Overall Study|Discontinued|3
5932791|NCT01403987|20521714|P3|Overall Study|Residents forgot their secret PIN|18
5932792|NCT01403987|20521715|P2|Overall Study|Residents forgot their secret PIN|17
5932793|NCT01403987|20521716|P1|Overall Study|Residents forgot their secret PIN|18
5932794|NCT01403948|20521740|P10|Overall Study|other than above|0
5932795|NCT01403948|20521741|P9|Overall Study|other than above|0
5932796|NCT01403948|20521742|P8|Overall Study|other than above|0
5932797|NCT01403948|20521743|P7|Overall Study|other than above|2
5932798|NCT01403948|20521744|P6|Overall Study|other than above|1
5932799|NCT01403948|20521745|P5|Overall Study|other than above|1
5932800|NCT01403948|20521746|P4|Overall Study|other than above|0
5932801|NCT01403948|20521747|P3|Overall Study|other than above|1
5932802|NCT01403948|20521748|P2|Overall Study|other than above|2
5932803|NCT01403948|20521749|P1|Overall Study|other than above|1
5932804|NCT01403948|20521740|P10|Overall Study|Refused cont. medication|1
5932805|NCT01403948|20521741|P9|Overall Study|Refused cont. medication|0
5932806|NCT01403948|20521742|P8|Overall Study|Refused cont. medication|0
5932807|NCT01403948|20521743|P7|Overall Study|Refused cont. medication|0
5932808|NCT01403948|20521744|P6|Overall Study|Refused cont. medication|0
5932809|NCT01403948|20521745|P5|Overall Study|Refused cont. medication|1
5932810|NCT01403948|20521746|P4|Overall Study|Refused cont. medication|0
5932811|NCT01403948|20521747|P3|Overall Study|Refused cont. medication|0
5932812|NCT01403948|20521748|P2|Overall Study|Refused cont. medication|0
5932813|NCT01403948|20521749|P1|Overall Study|Refused cont. medication|0
5932814|NCT01403948|20521740|P10|Overall Study|Lost to Follow-up|1
5932815|NCT01403948|20521741|P9|Overall Study|Lost to Follow-up|0
5932816|NCT01403948|20521742|P8|Overall Study|Lost to Follow-up|0
5932817|NCT01403948|20521743|P7|Overall Study|Lost to Follow-up|0
5932818|NCT01403948|20521744|P6|Overall Study|Lost to Follow-up|0
5932819|NCT01403948|20521745|P5|Overall Study|Lost to Follow-up|0
5932820|NCT01403948|20521746|P4|Overall Study|Lost to Follow-up|0
5932821|NCT01403948|20521747|P3|Overall Study|Lost to Follow-up|0
5932822|NCT01403948|20521748|P2|Overall Study|Lost to Follow-up|0
5932823|NCT01403948|20521749|P1|Overall Study|Lost to Follow-up|0
5932824|NCT01403948|20521740|P10|Overall Study|Other Adverse Event (Other than DLT)|0
5932825|NCT01403948|20521741|P9|Overall Study|Other Adverse Event (Other than DLT)|1
5932826|NCT01403948|20521742|P8|Overall Study|Other Adverse Event (Other than DLT)|0
5932827|NCT01403948|20521743|P7|Overall Study|Other Adverse Event (Other than DLT)|2
5932828|NCT01403948|20521744|P6|Overall Study|Other Adverse Event (Other than DLT)|0
5932829|NCT01403948|20521745|P5|Overall Study|Other Adverse Event (Other than DLT)|2
5932830|NCT01403948|20521746|P4|Overall Study|Other Adverse Event (Other than DLT)|0
5932831|NCT01403948|20521747|P3|Overall Study|Other Adverse Event (Other than DLT)|0
5932832|NCT01403948|20521748|P2|Overall Study|Other Adverse Event (Other than DLT)|0
5932833|NCT01403948|20521749|P1|Overall Study|Other Adverse Event (Other than DLT)|0
5932834|NCT01403948|20521740|P10|Overall Study|Progressive disease|5
5932835|NCT01403948|20521741|P9|Overall Study|Progressive disease|5
5932836|NCT01403948|20521742|P8|Overall Study|Progressive disease|4
5932837|NCT01403948|20521743|P7|Overall Study|Progressive disease|2
5932838|NCT01403948|20521744|P6|Overall Study|Progressive disease|6
5932839|NCT01403948|20521745|P5|Overall Study|Progressive disease|2
5932840|NCT01403948|20521746|P4|Overall Study|Progressive disease|4
5932841|NCT01403948|20521747|P3|Overall Study|Progressive disease|2
5932842|NCT01403948|20521748|P2|Overall Study|Progressive disease|2
5932843|NCT01403948|20521749|P1|Overall Study|Progressive disease|0
5932844|NCT01403805|20521822|P2|Overall Study|Death|1
5932845|NCT01403805|20521823|P1|Overall Study|Death|0
5932846|NCT01403805|20521822|P2|Overall Study|Lost to Follow-up|2
5932847|NCT01403805|20521823|P1|Overall Study|Lost to Follow-up|0
5932848|NCT01403805|20521822|P2|Overall Study|Withdrawal by Subject|4
5932849|NCT01403805|20521823|P1|Overall Study|Withdrawal by Subject|0
5932850|NCT01403610|20521839|P4|Overall Study|Didn't recover from surgery sufficiently|0
5932851|NCT01403610|20521840|P3|Overall Study|Didn't recover from surgery sufficiently|0
5932852|NCT01403610|20521841|P2|Overall Study|Didn't recover from surgery sufficiently|3
5932853|NCT01403610|20521842|P1|Overall Study|Didn't recover from surgery sufficiently|0
5932854|NCT01403610|20521839|P4|Overall Study|Withdrawal by Subject|0
5932855|NCT01403610|20521840|P3|Overall Study|Withdrawal by Subject|0
5932856|NCT01403610|20521841|P2|Overall Study|Withdrawal by Subject|0
5932857|NCT01403610|20521842|P1|Overall Study|Withdrawal by Subject|2
5932858|NCT01403194|20521888|P1|Overall Study|Lost to Follow-up|8
5932859|NCT01403194|20521888|P1|Overall Study|Screen Failure|2
5932860|NCT01403116|20521896|P2|Overall Study|unable to keep appointments|2
5932861|NCT01403116|20521897|P1|Overall Study|unable to keep appointments|0
5932862|NCT01403116|20521896|P2|Overall Study|Hct >54%|0
5932863|NCT01403116|20521897|P1|Overall Study|Hct >54%|2
5932864|NCT01403116|20521896|P2|Overall Study|undisclosed Hx of Prostate Ca|0
5932865|NCT01403116|20521897|P1|Overall Study|undisclosed Hx of Prostate Ca|1
5932866|NCT01403116|20521896|P2|Overall Study|Protocol Violation|1
5932867|NCT01403116|20521897|P1|Overall Study|Protocol Violation|0
5932868|NCT01403116|20521896|P2|Overall Study|Non-compliance of study drug|0
5932869|NCT01403116|20521897|P1|Overall Study|Non-compliance of study drug|3
5932870|NCT01403116|20521896|P2|Overall Study|Withdrawal by Subject|15
5932871|NCT01403116|20521897|P1|Overall Study|Withdrawal by Subject|12
5932872|NCT01403116|20521896|P2|Overall Study|Lost to Follow-up|5
5932873|NCT01403116|20521897|P1|Overall Study|Lost to Follow-up|7
5932874|NCT01403116|20521896|P2|Overall Study|Adverse Event|4
5932875|NCT01403116|20521897|P1|Overall Study|Adverse Event|7
5932876|NCT01403051|20521910|P2|Overall Study|Lost to Follow-up|5
5932877|NCT01403051|20521911|P1|Overall Study|Lost to Follow-up|5
5932878|NCT01403051|20521910|P2|Overall Study|Withdrawal by Subject|1
5932879|NCT01403051|20521911|P1|Overall Study|Withdrawal by Subject|2
5932880|NCT01403051|20521910|P2|Overall Study|Death|0
5932881|NCT01403051|20521911|P1|Overall Study|Death|1
5932882|NCT01403051|20521910|P2|Overall Study|Protocol Violation|0
5932883|NCT01403051|20521911|P1|Overall Study|Protocol Violation|2
5932884|NCT01402986|20521947|P4|Overall Study|Other|6
5932885|NCT01402986|20521948|P3|Overall Study|Other|1
5932886|NCT01402986|20521949|P2|Overall Study|Other|5
5932887|NCT01402986|20521950|P1|Overall Study|Other|2
5932888|NCT01402986|20521947|P4|Overall Study|Lost to Follow-up|1
5932889|NCT01402986|20521948|P3|Overall Study|Lost to Follow-up|0
5932890|NCT01402986|20521949|P2|Overall Study|Lost to Follow-up|0
5932891|NCT01402986|20521950|P1|Overall Study|Lost to Follow-up|0
5932892|NCT01402986|20521947|P4|Overall Study|Death|2
5932893|NCT01402986|20521948|P3|Overall Study|Death|0
5932894|NCT01402986|20521949|P2|Overall Study|Death|0
5932895|NCT01402986|20521950|P1|Overall Study|Death|0
5932896|NCT01402986|20521947|P4|Overall Study|Withdrawal by Subject|13
5932897|NCT01402986|20521948|P3|Overall Study|Withdrawal by Subject|7
5932898|NCT01402986|20521949|P2|Overall Study|Withdrawal by Subject|10
5932899|NCT01402986|20521950|P1|Overall Study|Withdrawal by Subject|7
5932900|NCT01402947|20522085|P2|First Intervention|Adverse Event|1
5932901|NCT01402947|20522086|P1|First Intervention|Adverse Event|0
5932902|NCT01402908|20522096|P2|Overall Study|Physician Decision|0
5932903|NCT01402908|20522097|P1|Overall Study|Physician Decision|1
5932904|NCT01402908|20522096|P2|Overall Study|Lost to Follow-up|1
5932905|NCT01402908|20522097|P1|Overall Study|Lost to Follow-up|3
5932906|NCT01402908|20522096|P2|Overall Study|Withdrawal by Subject|17
5932907|NCT01402908|20522097|P1|Overall Study|Withdrawal by Subject|30
5932908|NCT01402869|20522112|P3|Overall Study|Required Tooth Extraction|1
5932909|NCT01402869|20522113|P2|Overall Study|Required Tooth Extraction|0
5932910|NCT01402869|20522114|P1|Overall Study|Required Tooth Extraction|0
5932911|NCT01402817|20522128|P1|Overall Study|Study Suspended by FDA|8
5932912|NCT01402817|20522128|P1|Overall Study|Withdrawal by Subject|3
5932913|NCT01402700|20522133|P1|Overall Study|Missed Visit|1
5932914|NCT01402700|20522133|P1|Overall Study|Withdrawal by Subject|3
5932915|NCT01402700|20522133|P1|Overall Study|Death|3
5932916|NCT01402570|20522137|P1|Overall Study|Adverse Event|1
5932917|NCT01402544|20522144|P1|Overall Study|Withdrawal by Subject|6
5932918|NCT01402284|20522218|P1|Overall Study|Disease progression on study|10
5932919|NCT01402284|20522218|P1|Overall Study|Physician Decision|1
5932920|NCT01402284|20522218|P1|Overall Study|Follows up at Memorial Sloan Kettering|1
5932921|NCT01402284|20522218|P1|Overall Study|Withdrawal consent|2
5932922|NCT01402102|20522300|P2|Overall Study|Withdrawal by Subject|2
5932923|NCT01402102|20522301|P1|Overall Study|Withdrawal by Subject|0
5932924|NCT01402102|20522300|P2|Overall Study|Insufficiency of compliance|1
5932925|NCT01402102|20522301|P1|Overall Study|Insufficiency of compliance|1
5932926|NCT01402102|20522300|P2|Overall Study|Protocol Violation|0
5932927|NCT01402102|20522301|P1|Overall Study|Protocol Violation|1
5932928|NCT01402063|20522321|P2|Overall Study|Withdrawal by Subject|3
5932929|NCT01402063|20522322|P1|Overall Study|Withdrawal by Subject|3
5932930|NCT01402011|20522340|P3|Nine Month Follow-up|Withdrawal by Subject|0
5932931|NCT01402011|20522341|P2|Nine Month Follow-up|Withdrawal by Subject|1
5932932|NCT01402011|20522342|P1|Nine Month Follow-up|Withdrawal by Subject|0
5932933|NCT01402011|20522340|P3|Active Treatment Period|Withdrawal by Subject|0
5932934|NCT01402011|20522341|P2|Active Treatment Period|Withdrawal by Subject|3
5932935|NCT01402011|20522342|P1|Active Treatment Period|Withdrawal by Subject|1
5932936|NCT01402011|20522340|P3|Delayed Treatment Period|Withdrawal by Subject|0
5932937|NCT01402011|20522341|P2|Delayed Treatment Period|Withdrawal by Subject|0
5932938|NCT01402011|20522342|P1|Delayed Treatment Period|Withdrawal by Subject|1
5932939|NCT01401959|20522371|P3|Treated|Protocol Violation|0
5932940|NCT01401959|20522372|P2|Treated|Protocol Violation|1
5932941|NCT01401959|20522373|P1|Treated|Protocol Violation|0
5932942|NCT01401959|20522371|P3|Treated|Withdrawal by Subject|2
5932943|NCT01401959|20522372|P2|Treated|Withdrawal by Subject|2
5932944|NCT01401959|20522373|P1|Treated|Withdrawal by Subject|1
5932945|NCT01401959|20522371|P3|Treated|Adverse Event|2
5932946|NCT01401959|20522372|P2|Treated|Adverse Event|3
5932947|NCT01401959|20522373|P1|Treated|Adverse Event|4
5932948|NCT01401959|20522371|P3|Treated|Disease Progression|1
5932949|NCT01401959|20522372|P2|Treated|Disease Progression|2
5932950|NCT01401959|20522373|P1|Treated|Disease Progression|2
5932951|NCT01401959|20522371|P3|Enrolled|Withdrawal by Subject|0
5932952|NCT01401959|20522372|P2|Enrolled|Withdrawal by Subject|0
5932953|NCT01401959|20522373|P1|Enrolled|Withdrawal by Subject|1
5932954|NCT01401842|20522412|P2|Overall Study|other/unknown|17
5932955|NCT01401842|20522413|P1|Overall Study|other/unknown|28
5932956|NCT01401842|20522412|P2|Overall Study|on profile|5
5932957|NCT01401842|20522413|P1|Overall Study|on profile|9
5932958|NCT01401842|20522412|P2|Overall Study|invalid follow-up strength data|4
5932959|NCT01401842|20522413|P1|Overall Study|invalid follow-up strength data|1
5932960|NCT01401842|20522412|P2|Overall Study|discharged from US Army|4
5932961|NCT01401842|20522413|P1|Overall Study|discharged from US Army|3
5932962|NCT01401842|20522412|P2|Overall Study|changed companies|34
5932963|NCT01401842|20522413|P1|Overall Study|changed companies|20
5932964|NCT01401842|20522412|P2|Overall Study|academic reason|1
5932965|NCT01401842|20522413|P1|Overall Study|academic reason|4
5932966|NCT01401842|20522412|P2|Overall Study|Withdrawal by Subject|2
5932967|NCT01401842|20522413|P1|Overall Study|Withdrawal by Subject|3
5932968|NCT01401647|20522430|P3|Overall Study|Lost to Follow-up|1
5932969|NCT01401647|20522431|P2|Overall Study|Lost to Follow-up|3
5932970|NCT01401647|20522432|P1|Overall Study|Lost to Follow-up|3
5932971|NCT01401647|20522430|P3|Overall Study|Withdrawal by Subject|2
5932972|NCT01401647|20522431|P2|Overall Study|Withdrawal by Subject|5
5932973|NCT01401647|20522432|P1|Overall Study|Withdrawal by Subject|1
5932974|NCT01401530|20522502|P3|Overall Study|Physician Decision|0
5932975|NCT01401530|20522503|P2|Overall Study|Physician Decision|1
5932976|NCT01401530|20522504|P1|Overall Study|Physician Decision|0
5932977|NCT01401530|20522502|P3|Overall Study|Participant Choice|1
5932978|NCT01401530|20522503|P2|Overall Study|Participant Choice|2
5932979|NCT01401530|20522504|P1|Overall Study|Participant Choice|1
5932980|NCT01401530|20522502|P3|Overall Study|Adverse Event|1
5932981|NCT01401530|20522503|P2|Overall Study|Adverse Event|1
5932982|NCT01401530|20522504|P1|Overall Study|Adverse Event|1
5932983|NCT01401530|20522502|P3|Overall Study|Disease Progression|1
5932984|NCT01401530|20522503|P2|Overall Study|Disease Progression|2
5932985|NCT01401530|20522504|P1|Overall Study|Disease Progression|1
5932986|NCT01401478|20522563|P1|Overall Study|Serious adverse event|1
5932987|NCT01401478|20522563|P1|Overall Study|Low intact parathyroid hormone|1
5932988|NCT01401478|20522563|P1|Overall Study|Hyperphosphatemia and adverse event|1
5932989|NCT01401478|20522563|P1|Overall Study|Blood samples not available|1
5932990|NCT01401478|20522563|P1|Overall Study|Withdrawal by Subject|3
5932991|NCT01401478|20522563|P1|Overall Study|Kidney transplantation|3
5932992|NCT01401478|20522563|P1|Overall Study|Lost to Follow-up|5
5932993|NCT01401478|20522563|P1|Overall Study|Hyperphosphatemia|5
5932994|NCT01401478|20522563|P1|Overall Study|Adverse Event|5
5932995|NCT01401478|20522563|P1|Overall Study|Study drug not available|6
5932996|NCT01401465|20522576|P2|Treatment Period 2|Withdrawal by Subject|1
5932997|NCT01401465|20522577|P1|Treatment Period 2|Withdrawal by Subject|0
5932998|NCT01401465|20522576|P2|Treatment Period 2|Lost to Follow-up|1
5932999|NCT01401465|20522577|P1|Treatment Period 2|Lost to Follow-up|0
5933000|NCT01401465|20522576|P2|Treatment Period 1|Scheduling Difficulties|1
5933001|NCT01401465|20522577|P1|Treatment Period 1|Scheduling Difficulties|1
5933002|NCT01401465|20522576|P2|Treatment Period 1|Inability to Meet Continuation Criteria|9
5933003|NCT01401465|20522577|P1|Treatment Period 1|Inability to Meet Continuation Criteria|3
5933004|NCT01401465|20522576|P2|Treatment Period 1|Non-Compliance to Study Drug|0
5933005|NCT01401465|20522577|P1|Treatment Period 1|Non-Compliance to Study Drug|1
5933006|NCT01401465|20522576|P2|Treatment Period 1|Withdrawal by Subject|4
5933007|NCT01401465|20522577|P1|Treatment Period 1|Withdrawal by Subject|1
5933008|NCT01401465|20522576|P2|Treatment Period 1|Protocol Violation|0
5933009|NCT01401465|20522577|P1|Treatment Period 1|Protocol Violation|5
5933010|NCT01401465|20522576|P2|Treatment Period 1|Pregnancy|1
5933011|NCT01401465|20522577|P1|Treatment Period 1|Pregnancy|0
5933012|NCT01401465|20522576|P2|Treatment Period 1|Adverse Event|1
5933013|NCT01401465|20522577|P1|Treatment Period 1|Adverse Event|4
5933014|NCT01401452|20522640|P1|Overall Study|Participant withdrew consent|1
5933015|NCT01401452|20522640|P1|Overall Study|Subject chose to discontinue treatment|1
5933016|NCT01401452|20522640|P1|Overall Study|Subject withdrew because of Tx success|1
5933017|NCT01401452|20522640|P1|Overall Study|Unsatisfactory output|1
5933018|NCT01401452|20522640|P1|Overall Study|Treatment failure|1
5933019|NCT01401452|20522640|P1|Overall Study|Discontinuation for personal reasons|1
5933020|NCT01401452|20522640|P1|Overall Study|Participant stopped Tx|2
5933021|NCT01401452|20522640|P1|Overall Study|Psoriatic arthritis|1
5933022|NCT01401452|20522640|P1|Overall Study|Subject's wife wants to get pregnant|1
5933023|NCT01401452|20522640|P1|Overall Study|Subject moved to another city|1
5933024|NCT01401452|20522640|P1|Overall Study|Subject didn't return for routine visits|1
5933025|NCT01401452|20522640|P1|Overall Study|Subject did not come to follow up visits|2
5933026|NCT01401452|20522640|P1|Overall Study|No more visits within the 36 wk followup|4
5933027|NCT01401452|20522640|P1|Overall Study|Tx stopped by psychiatrist|1
5933028|NCT01401452|20522640|P1|Overall Study|Tx stopped due to financial reasons|1
5933029|NCT01401452|20522640|P1|Overall Study|Participant developed breast cancer|1
5933030|NCT01401452|20522640|P1|Overall Study|Lack of Efficacy|30
5933031|NCT01401452|20522640|P1|Overall Study|Lost to Follow-up|12
5933032|NCT01401452|20522640|P1|Overall Study|Adverse reaction|9
5933033|NCT01401361|20522652|P1|Overall Study|Subject/family decision post procedure|2
5933034|NCT01401361|20522652|P1|Overall Study|Lost to Follow-up|3
5933035|NCT01401361|20522652|P1|Overall Study|Physician Decision|1
5933036|NCT01401361|20522652|P1|Overall Study|Lack of Efficacy|6
5933037|NCT01401361|20522652|P1|Overall Study|Withdrawal by Subject|16
5933038|NCT01401322|20522658|P1|Overall Study|Physician Decision|1
5933039|NCT01401322|20522658|P1|Overall Study|Withdrawal by Subject|1
5933040|NCT01401283|20522664|P2|Overall Study|suspicion of malignant hyperthermia|1
5933041|NCT01401283|20522665|P1|Overall Study|suspicion of malignant hyperthermia|0
5933042|NCT01401283|20522664|P2|Overall Study|no central venous access|1
5933043|NCT01401283|20522665|P1|Overall Study|no central venous access|0
5933044|NCT01401283|20522664|P2|Overall Study|preoperative arrhythmia|0
5933045|NCT01401283|20522665|P1|Overall Study|preoperative arrhythmia|5
5933046|NCT01401283|20522664|P2|Overall Study|surgery cancelled|8
5933047|NCT01401283|20522665|P1|Overall Study|surgery cancelled|5
5933048|NCT01401153|20522731|P2|Second Test Day|illness|5
5933049|NCT01401153|20522732|P1|Second Test Day|illness|0
5933050|NCT01401153|20522731|P2|First Test Day|Learning disabilities; illness|10
5933051|NCT01401153|20522732|P1|First Test Day|Learning disabilities; illness|1
5933052|NCT01401062|20522779|P2|Overall Study|Withdrawal by Subject|1
5933053|NCT01401062|20522780|P1|Overall Study|Withdrawal by Subject|1
5933054|NCT01401062|20522779|P2|Overall Study|Physician Decision|0
5933055|NCT01401062|20522780|P1|Overall Study|Physician Decision|1
5933056|NCT01401062|20522779|P2|Overall Study|Death|7
5933057|NCT01401062|20522780|P1|Overall Study|Death|9
5933058|NCT01401010|20522807|P2|Overall Study|Could not interpret assay results|0
5933059|NCT01401010|20522808|P1|Overall Study|Could not interpret assay results|1
5933060|NCT01400971|20522831|P1|Overall Study|Other|422
5933061|NCT01400971|20522831|P1|Overall Study|Withdrawal by Subject|158
5933062|NCT01400971|20522831|P1|Overall Study|Physician Decision|57
5933063|NCT01400971|20522831|P1|Overall Study|Lost to follow up + Subject Decision|2
5933064|NCT01400971|20522831|P1|Overall Study|Lost to Follow-up|196
5933065|NCT01400971|20522831|P1|Overall Study|Death|82
5933066|NCT01400958|20522840|P2|Overall Study|Adverse Event|0
5933067|NCT01400958|20522841|P1|Overall Study|Adverse Event|1
5933068|NCT01400958|20522840|P2|Overall Study|Withdrawal by Subject|1
5933069|NCT01400958|20522841|P1|Overall Study|Withdrawal by Subject|0
5933070|NCT01400958|20522840|P2|Overall Study|Physician Decision|1
5933071|NCT01400958|20522841|P1|Overall Study|Physician Decision|0
5933072|NCT01400932|20522851|P2|Overall Study|Met Protocol-defined Stopping Criteria|0
5933073|NCT01400932|20522852|P1|Overall Study|Met Protocol-defined Stopping Criteria|1
5933074|NCT01400932|20522851|P2|Overall Study|Protocol Deviation|1
5933075|NCT01400932|20522852|P1|Overall Study|Protocol Deviation|0
5933076|NCT01400932|20522851|P2|Overall Study|Lost to Follow-up|0
5933077|NCT01400932|20522852|P1|Overall Study|Lost to Follow-up|1
5933078|NCT01400932|20522851|P2|Overall Study|Withdrawal by Subject|6
5933079|NCT01400932|20522852|P1|Overall Study|Withdrawal by Subject|2
5933080|NCT01400932|20522851|P2|Overall Study|Lack of Efficacy|3
5933081|NCT01400932|20522852|P1|Overall Study|Lack of Efficacy|0
5933082|NCT01400932|20522851|P2|Overall Study|Adverse Event|5
5933083|NCT01400932|20522852|P1|Overall Study|Adverse Event|10
5933084|NCT01400919|20522874|P1|Overall Study|Missed visit|2
5933085|NCT01400919|20522874|P1|Overall Study|Lost to Follow-up|2
5933086|NCT01400919|20522874|P1|Overall Study|Withdrawal by Subject|4
5933087|NCT01400893|20522917|P2|Overall Study|Lost to Follow-up|6
5933088|NCT01400893|20522918|P1|Overall Study|Lost to Follow-up|0
5933089|NCT01400893|20522917|P2|Overall Study|Death|21
5933090|NCT01400893|20522918|P1|Overall Study|Death|27
5933091|NCT01400841|20522930|P1|Extended Study Phase (2 Years)|Adverse Event|2
5933092|NCT01400841|20522930|P1|Initial Study Phase (6 Months)|Death|1
5933093|NCT01400698|20522968|P6|Overall Study|Other|0
5933094|NCT01400698|20522969|P5|Overall Study|Other|1
5933095|NCT01400698|20522970|P4|Overall Study|Other|2
5933096|NCT01400698|20522971|P3|Overall Study|Other|0
5933097|NCT01400698|20522972|P2|Overall Study|Other|2
5933098|NCT01400698|20522973|P1|Overall Study|Other|4
5933099|NCT01400698|20522968|P6|Overall Study|Adverse Event|0
5933100|NCT01400698|20522969|P5|Overall Study|Adverse Event|0
5933101|NCT01400698|20522970|P4|Overall Study|Adverse Event|0
5933102|NCT01400698|20522971|P3|Overall Study|Adverse Event|0
5933103|NCT01400698|20522972|P2|Overall Study|Adverse Event|0
5933104|NCT01400698|20522973|P1|Overall Study|Adverse Event|1
5933105|NCT01400698|20522968|P6|Overall Study|Non-compliance|0
5933106|NCT01400698|20522969|P5|Overall Study|Non-compliance|0
5933107|NCT01400698|20522970|P4|Overall Study|Non-compliance|1
5933108|NCT01400698|20522971|P3|Overall Study|Non-compliance|0
5933109|NCT01400698|20522972|P2|Overall Study|Non-compliance|1
5933110|NCT01400698|20522973|P1|Overall Study|Non-compliance|0
5933111|NCT01400698|20522968|P6|Overall Study|Protocol Violation|0
5933112|NCT01400698|20522969|P5|Overall Study|Protocol Violation|1
5933113|NCT01400698|20522970|P4|Overall Study|Protocol Violation|0
5933114|NCT01400698|20522971|P3|Overall Study|Protocol Violation|0
5933115|NCT01400698|20522972|P2|Overall Study|Protocol Violation|1
5933116|NCT01400698|20522973|P1|Overall Study|Protocol Violation|0
5933117|NCT01400698|20522968|P6|Overall Study|Withdrawal by Subject|3
5933118|NCT01400698|20522969|P5|Overall Study|Withdrawal by Subject|1
5933119|NCT01400698|20522970|P4|Overall Study|Withdrawal by Subject|4
5933120|NCT01400698|20522971|P3|Overall Study|Withdrawal by Subject|0
5933121|NCT01400698|20522972|P2|Overall Study|Withdrawal by Subject|2
5933122|NCT01400698|20522973|P1|Overall Study|Withdrawal by Subject|8
5933123|NCT01400698|20522968|P6|Overall Study|Lost to Follow-up|3
5933124|NCT01400698|20522969|P5|Overall Study|Lost to Follow-up|4
5933125|NCT01400698|20522970|P4|Overall Study|Lost to Follow-up|1
5933126|NCT01400698|20522971|P3|Overall Study|Lost to Follow-up|2
5933127|NCT01400698|20522972|P2|Overall Study|Lost to Follow-up|5
5933128|NCT01400698|20522973|P1|Overall Study|Lost to Follow-up|2
5933129|NCT01400516|20522997|P2|Primary Trial|Withdrawal by Subject|2
5933130|NCT01400516|20522998|P1|Primary Trial|Withdrawal by Subject|0
5933131|NCT01400503|20523008|P1|Overall Study|Other|1
5933132|NCT01400503|20523008|P1|Overall Study|Study Terminated by Sponsor|58
5933133|NCT01400503|20523008|P1|Overall Study|Withdrawal by Subject|1
5933134|NCT01400451|20523031|P3|Combination Treatment (or Intended)|Dose-limiting toxicity|0
5933135|NCT01400451|20523032|P2|Combination Treatment (or Intended)|Dose-limiting toxicity|1
5933136|NCT01400451|20523033|P1|Combination Treatment (or Intended)|Dose-limiting toxicity|0
5933137|NCT01400451|20523031|P3|Combination Treatment (or Intended)|Disease Progression|1
5933138|NCT01400451|20523032|P2|Combination Treatment (or Intended)|Disease Progression|1
5933139|NCT01400451|20523033|P1|Combination Treatment (or Intended)|Disease Progression|3
5933140|NCT01400451|20523031|P3|Combination Treatment (or Intended)|Adverse Event|0
5933141|NCT01400451|20523032|P2|Combination Treatment (or Intended)|Adverse Event|0
5933142|NCT01400451|20523033|P1|Combination Treatment (or Intended)|Adverse Event|1
5933143|NCT01400451|20523031|P3|Combination Treatment (or Intended)|Drug Toxicity|0
5933144|NCT01400451|20523032|P2|Combination Treatment (or Intended)|Drug Toxicity|1
5933145|NCT01400451|20523033|P1|Combination Treatment (or Intended)|Drug Toxicity|0
5933146|NCT01400451|20523031|P3|Combination Treatment (or Intended)|Withdrawal by Subject|1
5933147|NCT01400451|20523032|P2|Combination Treatment (or Intended)|Withdrawal by Subject|1
5933148|NCT01400451|20523033|P1|Combination Treatment (or Intended)|Withdrawal by Subject|2
5933149|NCT01400425|20523047|P1|Overall Study|Withdrawal by Subject|10
5933150|NCT01400412|20523060|P2|Overall Study|Never started study treatment|3
5933151|NCT01400412|20523061|P1|Overall Study|Never started study treatment|0
5933152|NCT01400412|20523060|P2|Overall Study|Unable to complete|3
5933153|NCT01400412|20523061|P1|Overall Study|Unable to complete|3
5933154|NCT01400412|20523060|P2|Overall Study|Withdrawal by Subject|4
5933155|NCT01400412|20523061|P1|Overall Study|Withdrawal by Subject|3
5933156|NCT01400412|20523060|P2|Overall Study|Lost to Follow-up|7
5933157|NCT01400412|20523061|P1|Overall Study|Lost to Follow-up|4
5933158|NCT01400243|20523107|P2|Overall Study|Protocol Violation|11
5933159|NCT01400243|20523108|P1|Overall Study|Protocol Violation|8
5933160|NCT01400139|20523130|P1|HYD Extension Period|Administrative|10
5933161|NCT01400139|20523130|P1|HYD Extension Period|Withdrawal by Subject|5
5933162|NCT01400139|20523130|P1|HYD Extension Period|Adverse Event|8
5933163|NCT01400139|20523130|P1|HYD Core Study|Did not qualify for Maintenance Period|14
5933164|NCT01400139|20523130|P1|HYD Core Study|Administrative|56
5933165|NCT01400139|20523130|P1|HYD Core Study|Confirmed or suspected diversion|20
5933166|NCT01400139|20523130|P1|HYD Core Study|Lost to Follow-up|39
5933167|NCT01400139|20523130|P1|HYD Core Study|Withdrawal by Subject|114
5933168|NCT01400139|20523130|P1|HYD Core Study|Lack of Efficacy|59
5933169|NCT01400139|20523130|P1|HYD Core Study|Adverse Event|210
5933170|NCT01400113|20523153|P2|Overall Study|Withdrawal by Subject|1
5933171|NCT01400113|20523154|P1|Overall Study|Withdrawal by Subject|1
5933172|NCT01399905|20523162|P2|Overall Study|Withdrawal by Subject|1
5933173|NCT01399905|20523163|P1|Overall Study|Withdrawal by Subject|1
5933174|NCT01399788|20523211|P2|First Intervention Period|Adverse Event|0
5933175|NCT01399788|20523212|P1|First Intervention Period|Adverse Event|1
5933176|NCT01399736|20523234|P2|Overall Study|Lost to Follow-up|2
5933177|NCT01399736|20523235|P1|Overall Study|Lost to Follow-up|0
5933178|NCT01399736|20523234|P2|Overall Study|Withdrawal by Subject|2
5933179|NCT01399736|20523235|P1|Overall Study|Withdrawal by Subject|4
5933180|NCT01399723|20523311|P2|Overall Study|Lost to Follow-up|1
5933181|NCT01399723|20523312|P1|Overall Study|Lost to Follow-up|0
5933182|NCT01399697|20523325|P3|Overall Study|Sponsor Decision|0
5933183|NCT01399697|20523326|P2|Overall Study|Sponsor Decision|0
5933184|NCT01399697|20523327|P1|Overall Study|Sponsor Decision|1
5933185|NCT01399697|20523325|P3|Overall Study|Clinical RA remission|0
5933186|NCT01399697|20523326|P2|Overall Study|Clinical RA remission|0
5933187|NCT01399697|20523327|P1|Overall Study|Clinical RA remission|1
5933188|NCT01399697|20523325|P3|Overall Study|Positive result for hepatitis B|0
5933189|NCT01399697|20523326|P2|Overall Study|Positive result for hepatitis B|0
5933190|NCT01399697|20523327|P1|Overall Study|Positive result for hepatitis B|1
5933191|NCT01399697|20523325|P3|Overall Study|Inclusion Error|0
5933192|NCT01399697|20523326|P2|Overall Study|Inclusion Error|0
5933193|NCT01399697|20523327|P1|Overall Study|Inclusion Error|2
5933194|NCT01399697|20523325|P3|Overall Study|Non-Compliant|0
5933195|NCT01399697|20523326|P2|Overall Study|Non-Compliant|0
5933196|NCT01399697|20523327|P1|Overall Study|Non-Compliant|1
5933197|NCT01399697|20523325|P3|Overall Study|Protocol Violation|0
5933198|NCT01399697|20523326|P2|Overall Study|Protocol Violation|0
5933199|NCT01399697|20523327|P1|Overall Study|Protocol Violation|2
5933200|NCT01399697|20523325|P3|Overall Study|Lack of Efficacy|1
5933201|NCT01399697|20523326|P2|Overall Study|Lack of Efficacy|0
5933202|NCT01399697|20523327|P1|Overall Study|Lack of Efficacy|9
5933203|NCT01399697|20523325|P3|Overall Study|Investigator Decisión|2
5933204|NCT01399697|20523326|P2|Overall Study|Investigator Decisión|0
5933205|NCT01399697|20523327|P1|Overall Study|Investigator Decisión|1
5933206|NCT01399697|20523325|P3|Overall Study|Withdrawal by Subject|0
5933207|NCT01399697|20523326|P2|Overall Study|Withdrawal by Subject|0
5933208|NCT01399697|20523327|P1|Overall Study|Withdrawal by Subject|8
5933209|NCT01399697|20523325|P3|Overall Study|Lost to Follow-up|0
5933210|NCT01399697|20523326|P2|Overall Study|Lost to Follow-up|0
5933211|NCT01399697|20523327|P1|Overall Study|Lost to Follow-up|2
5933212|NCT01399697|20523325|P3|Overall Study|Adverse Event|1
5933213|NCT01399697|20523326|P2|Overall Study|Adverse Event|3
5933214|NCT01399697|20523327|P1|Overall Study|Adverse Event|13
5933215|NCT01399619|20523354|P4|Overall Study|Not treated|2
5933216|NCT01399619|20523355|P3|Overall Study|Not treated|0
5933217|NCT01399619|20523356|P2|Overall Study|Not treated|0
5933218|NCT01399619|20523357|P1|Overall Study|Not treated|0
5933219|NCT01399619|20523354|P4|Overall Study|Protocol Violation|1
5933220|NCT01399619|20523355|P3|Overall Study|Protocol Violation|0
5933221|NCT01399619|20523356|P2|Overall Study|Protocol Violation|0
5933222|NCT01399619|20523357|P1|Overall Study|Protocol Violation|0
5933223|NCT01399619|20523354|P4|Overall Study|Withdrawal by Subject|4
5933224|NCT01399619|20523355|P3|Overall Study|Withdrawal by Subject|3
5933225|NCT01399619|20523356|P2|Overall Study|Withdrawal by Subject|0
5933226|NCT01399619|20523357|P1|Overall Study|Withdrawal by Subject|6
5933227|NCT01399619|20523354|P4|Overall Study|Lack of Efficacy|0
5933228|NCT01399619|20523355|P3|Overall Study|Lack of Efficacy|5
5933229|NCT01399619|20523356|P2|Overall Study|Lack of Efficacy|0
5933230|NCT01399619|20523357|P1|Overall Study|Lack of Efficacy|9
5933231|NCT01399619|20523354|P4|Overall Study|Adverse Event|10
5933232|NCT01399619|20523355|P3|Overall Study|Adverse Event|4
5933233|NCT01399619|20523356|P2|Overall Study|Adverse Event|0
5933234|NCT01399619|20523357|P1|Overall Study|Adverse Event|10
5933235|NCT01399593|20523420|P2|Overall Study|Transplantectomy|1
5933236|NCT01399593|20523421|P1|Overall Study|Transplantectomy|0
5933237|NCT01399593|20523420|P2|Overall Study|Death|1
5933238|NCT01399593|20523421|P1|Overall Study|Death|1
5933239|NCT01399593|20523420|P2|Overall Study|Adverse Event|0
5933240|NCT01399593|20523421|P1|Overall Study|Adverse Event|1
5933241|NCT01399593|20523420|P2|Overall Study|Physician Decision|0
5933242|NCT01399593|20523421|P1|Overall Study|Physician Decision|1
5933243|NCT01399190|20523454|P1|Overall Study|Physician Decision|2
5933244|NCT01399190|20523454|P1|Overall Study|Participant's Request|5
5933245|NCT01399190|20523454|P1|Overall Study|Adverse Event|8
5933246|NCT01399190|20523454|P1|Overall Study|Not Eligible for Final Analysis|5
5933247|NCT01399125|20523462|P2|Overall Study|Protocol Deviation|2
5933248|NCT01399125|20523463|P1|Overall Study|Protocol Deviation|5
5933249|NCT01399125|20523462|P2|Overall Study|Death|1
5933250|NCT01399125|20523463|P1|Overall Study|Death|0
5933251|NCT01399125|20523462|P2|Overall Study|Administrative Problems|11
5933252|NCT01399125|20523463|P1|Overall Study|Administrative Problems|7
5933253|NCT01399125|20523462|P2|Overall Study|Lost to Follow-up|3
5933254|NCT01399125|20523463|P1|Overall Study|Lost to Follow-up|2
5933255|NCT01399125|20523462|P2|Overall Study|Withdrawal by Subject|8
5933256|NCT01399125|20523463|P1|Overall Study|Withdrawal by Subject|5
5933257|NCT01399125|20523462|P2|Overall Study|Unsatisfactory Therapeutic Effect|4
5933258|NCT01399125|20523463|P1|Overall Study|Unsatisfactory Therapeutic Effect|0
5933259|NCT01399125|20523462|P2|Overall Study|Abnormal Lab values|1
5933260|NCT01399125|20523463|P1|Overall Study|Abnormal Lab values|0
5933261|NCT01399125|20523462|P2|Overall Study|Adverse Event|30
5933262|NCT01399125|20523463|P1|Overall Study|Adverse Event|32
5933263|NCT01399099|20523477|P1|Overall Study|Miscellaneous|4
5933264|NCT01399099|20523477|P1|Overall Study|Infection|1
5933265|NCT01399099|20523477|P1|Overall Study|Skin Irritation|13
5933266|NCT01399099|20523477|P1|Overall Study|Protocol Violation|1
5933267|NCT01399099|20523477|P1|Overall Study|Physician Decision|1
5933268|NCT01399099|20523477|P1|Overall Study|Lost to Follow-up|11
5933269|NCT01399047|20523484|P2|Overall Study|Withdrawal by Subject|1
5933270|NCT01399047|20523485|P1|Overall Study|Withdrawal by Subject|0
5933271|NCT01398956|20523521|P1|Overall Study|Subject moved a long distance|1
5933272|NCT01398956|20523521|P1|Overall Study|Withdrawal Criteria No.3|1
5933273|NCT01398956|20523521|P1|Overall Study|AE, non-serious non-fatal|4
5933274|NCT01398956|20523521|P1|Overall Study|Withdrawal by Subject|4
5933275|NCT01398787|20523553|P1|Overall Study|Adverse Event|1
5933276|NCT01398514|20523571|P2|Overall Study|Failure to show a conditioned response|3
5933277|NCT01398514|20523572|P1|Overall Study|Failure to show a conditioned response|4
5933278|NCT01398514|20523571|P2|Overall Study|Physiologic non-responsiveness|3
5933279|NCT01398514|20523572|P1|Overall Study|Physiologic non-responsiveness|1
5933280|NCT01398514|20523571|P2|Overall Study|Non-compliance with study procedures|0
5933281|NCT01398514|20523572|P1|Overall Study|Non-compliance with study procedures|2
5933282|NCT01398514|20523571|P2|Overall Study|Adverse Event|0
5933283|NCT01398514|20523572|P1|Overall Study|Adverse Event|1
5933284|NCT01398410|20523607|P2|Overall Study|Other|29
5933285|NCT01398410|20523608|P1|Overall Study|Other|36
5933286|NCT01398410|20523607|P2|Overall Study|Inadequate Therapeutic Effect|0
5933287|NCT01398410|20523608|P1|Overall Study|Inadequate Therapeutic Effect|2
5933288|NCT01398410|20523607|P2|Overall Study|Participants Choice|11
5933289|NCT01398410|20523608|P1|Overall Study|Participants Choice|8
5933290|NCT01398410|20523607|P2|Overall Study|Adverse Event|16
5933291|NCT01398410|20523608|P1|Overall Study|Adverse Event|12
5933292|NCT01398358|20523619|P3|Overall Study|no longer eligible|1
5933293|NCT01398358|20523620|P2|Overall Study|no longer eligible|0
5933294|NCT01398358|20523621|P1|Overall Study|no longer eligible|1
5933295|NCT01398358|20523619|P3|Overall Study|Withdrawal by Subject|2
5933296|NCT01398358|20523620|P2|Overall Study|Withdrawal by Subject|2
5933297|NCT01398358|20523621|P1|Overall Study|Withdrawal by Subject|3
5933298|NCT01398358|20523619|P3|Overall Study|Lost to Follow-up|18
5933299|NCT01398358|20523620|P2|Overall Study|Lost to Follow-up|21
5933300|NCT01398358|20523621|P1|Overall Study|Lost to Follow-up|11
5933301|NCT01398176|20523643|P2|Overall Study|Physician Decision|3
5933302|NCT01398176|20523644|P1|Overall Study|Physician Decision|2
5933303|NCT01398176|20523643|P2|Overall Study|Lost to Follow-up|3
5933304|NCT01398176|20523644|P1|Overall Study|Lost to Follow-up|1
5933305|NCT01397890|20523677|P2|Overall Study|Others|1
5933306|NCT01397890|20523678|P1|Overall Study|Others|2
5933307|NCT01397890|20523677|P2|Overall Study|Severe Non-Compliance to Protocol|1
5933308|NCT01397890|20523678|P1|Overall Study|Severe Non-Compliance to Protocol|2
5933309|NCT01397890|20523677|P2|Overall Study|Adverse Event|2
5933310|NCT01397890|20523678|P1|Overall Study|Adverse Event|1
5933311|NCT01397890|20523677|P2|Overall Study|Condition under Investigation Worsened|3
5933312|NCT01397890|20523678|P1|Overall Study|Condition under Investigation Worsened|1
5933313|NCT01397890|20523677|P2|Overall Study|Lost to Follow-up|4
5933314|NCT01397890|20523678|P1|Overall Study|Lost to Follow-up|1
5933315|NCT01397890|20523677|P2|Overall Study|Death|3
5933316|NCT01397890|20523678|P1|Overall Study|Death|2
5933317|NCT01397890|20523677|P2|Overall Study|Eligibility Criteria Not Fulfilled|6
5933318|NCT01397890|20523678|P1|Overall Study|Eligibility Criteria Not Fulfilled|7
5933319|NCT01397890|20523677|P2|Overall Study|Withdrawal by Subject|11
5933320|NCT01397890|20523678|P1|Overall Study|Withdrawal by Subject|7
5933321|NCT01397825|20523749|P5|Overall Study|Withdrawal by Subject|0
5933322|NCT01397825|20523750|P4|Overall Study|Withdrawal by Subject|1
5933323|NCT01397825|20523751|P3|Overall Study|Withdrawal by Subject|5
5933324|NCT01397825|20523752|P2|Overall Study|Withdrawal by Subject|0
5933325|NCT01397825|20523753|P1|Overall Study|Withdrawal by Subject|1
5933326|NCT01397825|20523749|P5|Overall Study|Adverse Event|0
5933327|NCT01397825|20523750|P4|Overall Study|Adverse Event|1
5933328|NCT01397825|20523751|P3|Overall Study|Adverse Event|5
5933329|NCT01397825|20523752|P2|Overall Study|Adverse Event|1
5933330|NCT01397825|20523753|P1|Overall Study|Adverse Event|0
5933331|NCT01397825|20523749|P5|Overall Study|Symptomatic Deterioration|0
5933332|NCT01397825|20523750|P4|Overall Study|Symptomatic Deterioration|0
5933333|NCT01397825|20523751|P3|Overall Study|Symptomatic Deterioration|4
5933334|NCT01397825|20523752|P2|Overall Study|Symptomatic Deterioration|0
5933335|NCT01397825|20523753|P1|Overall Study|Symptomatic Deterioration|2
5933336|NCT01397825|20523749|P5|Overall Study|Progressive Disease|0
5933337|NCT01397825|20523750|P4|Overall Study|Progressive Disease|1
5933338|NCT01397825|20523751|P3|Overall Study|Progressive Disease|11
5933339|NCT01397825|20523752|P2|Overall Study|Progressive Disease|3
5933340|NCT01397825|20523753|P1|Overall Study|Progressive Disease|10
5933341|NCT01397786|20523823|P3|Phase B|Lack of Efficacy|14
5933342|NCT01397786|20523824|P2|Phase B|Lack of Efficacy|7
5933343|NCT01397786|20523825|P1|Phase B|Lack of Efficacy|22
5933344|NCT01397786|20523823|P3|Phase B|Protocol Deviation|4
5933345|NCT01397786|20523824|P2|Phase B|Protocol Deviation|2
5933346|NCT01397786|20523825|P1|Phase B|Protocol Deviation|1
5933347|NCT01397786|20523823|P3|Phase B|Withdrawal by Subject|30
5933348|NCT01397786|20523824|P2|Phase B|Withdrawal by Subject|45
5933349|NCT01397786|20523825|P1|Phase B|Withdrawal by Subject|102
5933350|NCT01397786|20523823|P3|Phase B|Physician Decision|3
5933351|NCT01397786|20523824|P2|Phase B|Physician Decision|1
5933352|NCT01397786|20523825|P1|Phase B|Physician Decision|9
5933353|NCT01397786|20523823|P3|Phase B|Subject Met Withdrawal Criteria|38
5933354|NCT01397786|20523824|P2|Phase B|Subject Met Withdrawal Criteria|5
5933355|NCT01397786|20523825|P1|Phase B|Subject Met Withdrawal Criteria|38
5933356|NCT01397786|20523823|P3|Phase B|Adverse Event|27
5933357|NCT01397786|20523824|P2|Phase B|Adverse Event|23
5933358|NCT01397786|20523825|P1|Phase B|Adverse Event|109
5933359|NCT01397786|20523823|P3|Phase B|Lost to Follow-up|22
5933360|NCT01397786|20523824|P2|Phase B|Lost to Follow-up|12
5933361|NCT01397786|20523825|P1|Phase B|Lost to Follow-up|22
5933362|NCT01397786|20523823|P3|Phase A|Lack of Efficacy|1
5933363|NCT01397786|20523824|P2|Phase A|Lack of Efficacy|0
5933364|NCT01397786|20523825|P1|Phase A|Lack of Efficacy|0
5933365|NCT01397786|20523823|P3|Phase A|Withdrawal by Subject|5
5933366|NCT01397786|20523824|P2|Phase A|Withdrawal by Subject|0
5933367|NCT01397786|20523825|P1|Phase A|Withdrawal by Subject|0
5933368|NCT01397786|20523823|P3|Phase A|Physician Decision|1
5933369|NCT01397786|20523824|P2|Phase A|Physician Decision|0
5933370|NCT01397786|20523825|P1|Phase A|Physician Decision|0
5933371|NCT01397786|20523823|P3|Phase A|Subject Met Withdrawal Criteria|7
5933372|NCT01397786|20523824|P2|Phase A|Subject Met Withdrawal Criteria|0
5933373|NCT01397786|20523825|P1|Phase A|Subject Met Withdrawal Criteria|0
5933374|NCT01397786|20523823|P3|Phase A|Adverse Event|8
5933375|NCT01397786|20523824|P2|Phase A|Adverse Event|0
5933376|NCT01397786|20523825|P1|Phase A|Adverse Event|0
5933377|NCT01397786|20523823|P3|Phase A|Lost to Follow-up|6
5933378|NCT01397786|20523824|P2|Phase A|Lost to Follow-up|0
5933379|NCT01397786|20523825|P1|Phase A|Lost to Follow-up|0
5933380|NCT01397747|20523891|P1|Overall Study|FIT excluded|34
5933381|NCT01397747|20523891|P1|Overall Study|Colonoscopy excluded|304
5933382|NCT01397747|20523891|P1|Overall Study|Multitarget DNA test excluded|689
5933383|NCT01397552|20523941|P2|Overall Study|Withdrawal by Subject|1
5933384|NCT01397552|20523942|P1|Overall Study|Withdrawal by Subject|2
5933385|NCT01397552|20523941|P2|Overall Study|Adverse Event|0
5933386|NCT01397552|20523942|P1|Overall Study|Adverse Event|1
5933387|NCT01397461|20523951|P3|Overall Study|Not treated|1
5933388|NCT01397461|20523952|P2|Overall Study|Not treated|0
5933389|NCT01397461|20523953|P1|Overall Study|Not treated|0
5933390|NCT01397461|20523951|P3|Overall Study|Lack of Efficacy|0
5933391|NCT01397461|20523952|P2|Overall Study|Lack of Efficacy|3
5933392|NCT01397461|20523953|P1|Overall Study|Lack of Efficacy|0
5933393|NCT01397461|20523951|P3|Overall Study|Lost to Follow-up|1
5933394|NCT01397461|20523952|P2|Overall Study|Lost to Follow-up|2
5933395|NCT01397461|20523953|P1|Overall Study|Lost to Follow-up|0
5933396|NCT01397461|20523951|P3|Overall Study|Withdrawal by Subject|0
5933397|NCT01397461|20523952|P2|Overall Study|Withdrawal by Subject|1
5933398|NCT01397461|20523953|P1|Overall Study|Withdrawal by Subject|2
5933399|NCT01397448|20523964|P3|Overall Study|Other|4
5933400|NCT01397448|20523965|P2|Overall Study|Other|7
5933401|NCT01397448|20523966|P1|Overall Study|Other|8
5933402|NCT01397448|20523964|P3|Overall Study|Lack of Efficacy|5
5933403|NCT01397448|20523965|P2|Overall Study|Lack of Efficacy|0
5933404|NCT01397448|20523966|P1|Overall Study|Lack of Efficacy|2
5933405|NCT01397448|20523964|P3|Overall Study|Withdrawal by Subject|3
5933406|NCT01397448|20523965|P2|Overall Study|Withdrawal by Subject|4
5933407|NCT01397448|20523966|P1|Overall Study|Withdrawal by Subject|4
5933408|NCT01397448|20523964|P3|Overall Study|Adverse Event|6
5933409|NCT01397448|20523965|P2|Overall Study|Adverse Event|4
5933410|NCT01397448|20523966|P1|Overall Study|Adverse Event|4
5933411|NCT01397422|20523981|P4|Overall Study|Increased bradykinesia related to PD|0
5933412|NCT01397422|20523982|P3|Overall Study|Increased bradykinesia related to PD|0
5933413|NCT01397422|20523983|P2|Overall Study|Increased bradykinesia related to PD|0
5933414|NCT01397422|20523984|P1|Overall Study|Increased bradykinesia related to PD|1
5933415|NCT01397422|20523981|P4|Overall Study|Withdrawal by Subject|0
5933416|NCT01397422|20523982|P3|Overall Study|Withdrawal by Subject|0
5933417|NCT01397422|20523983|P2|Overall Study|Withdrawal by Subject|0
5933418|NCT01397422|20523984|P1|Overall Study|Withdrawal by Subject|1
5933419|NCT01397422|20523981|P4|Overall Study|Adverse Event|8
5933420|NCT01397422|20523982|P3|Overall Study|Adverse Event|3
5933421|NCT01397422|20523983|P2|Overall Study|Adverse Event|3
5933422|NCT01397422|20523984|P1|Overall Study|Adverse Event|0
5933423|NCT01397409|20524024|P10|Stage 3|Other Miscellaneous Reasons|0
5933424|NCT01397409|20524025|P9|Stage 3|Other Miscellaneous Reasons|0
5933425|NCT01397409|20524026|P8|Stage 3|Other Miscellaneous Reasons|1
5933426|NCT01397409|20524027|P7|Stage 3|Other Miscellaneous Reasons|0
5933427|NCT01397409|20524028|P6|Stage 3|Other Miscellaneous Reasons|0
5933428|NCT01397409|20524029|P5|Stage 3|Other Miscellaneous Reasons|0
5933429|NCT01397409|20524030|P4|Stage 3|Other Miscellaneous Reasons|0
5933430|NCT01397409|20524031|P3|Stage 3|Other Miscellaneous Reasons|0
5933431|NCT01397409|20524032|P2|Stage 3|Other Miscellaneous Reasons|0
5933432|NCT01397409|20524033|P1|Stage 3|Other Miscellaneous Reasons|0
5933433|NCT01397409|20524024|P10|Stage 3|Adverse Event|0
5933434|NCT01397409|20524025|P9|Stage 3|Adverse Event|0
5933435|NCT01397409|20524026|P8|Stage 3|Adverse Event|1
5933436|NCT01397409|20524027|P7|Stage 3|Adverse Event|0
5933437|NCT01397409|20524028|P6|Stage 3|Adverse Event|0
5933438|NCT01397409|20524029|P5|Stage 3|Adverse Event|0
5933439|NCT01397409|20524030|P4|Stage 3|Adverse Event|0
5933440|NCT01397409|20524031|P3|Stage 3|Adverse Event|0
5933441|NCT01397409|20524032|P2|Stage 3|Adverse Event|0
5933442|NCT01397409|20524033|P1|Stage 3|Adverse Event|0
5933443|NCT01397409|20524024|P10|Stage 2|Other Miscellaneous Reasons|0
5933444|NCT01397409|20524025|P9|Stage 2|Other Miscellaneous Reasons|0
5933445|NCT01397409|20524026|P8|Stage 2|Other Miscellaneous Reasons|0
5933446|NCT01397409|20524027|P7|Stage 2|Other Miscellaneous Reasons|0
5933447|NCT01397409|20524028|P6|Stage 2|Other Miscellaneous Reasons|1
5933448|NCT01397409|20524029|P5|Stage 2|Other Miscellaneous Reasons|1
5933449|NCT01397409|20524030|P4|Stage 2|Other Miscellaneous Reasons|0
5933450|NCT01397409|20524031|P3|Stage 2|Other Miscellaneous Reasons|0
5933451|NCT01397409|20524032|P2|Stage 2|Other Miscellaneous Reasons|0
5933452|NCT01397409|20524033|P1|Stage 2|Other Miscellaneous Reasons|0
5933453|NCT01397409|20524024|P10|Stage 2|Personal Reasons|0
5933454|NCT01397409|20524025|P9|Stage 2|Personal Reasons|0
5933455|NCT01397409|20524026|P8|Stage 2|Personal Reasons|0
5933456|NCT01397409|20524027|P7|Stage 2|Personal Reasons|0
5933457|NCT01397409|20524028|P6|Stage 2|Personal Reasons|0
5933458|NCT01397409|20524029|P5|Stage 2|Personal Reasons|1
5933459|NCT01397409|20524030|P4|Stage 2|Personal Reasons|0
5933460|NCT01397409|20524031|P3|Stage 2|Personal Reasons|0
5933461|NCT01397409|20524032|P2|Stage 2|Personal Reasons|0
5933462|NCT01397409|20524033|P1|Stage 2|Personal Reasons|0
5933463|NCT01397409|20524024|P10|Stage 2|Adverse Event|0
5933464|NCT01397409|20524025|P9|Stage 2|Adverse Event|0
5933465|NCT01397409|20524026|P8|Stage 2|Adverse Event|0
5933466|NCT01397409|20524027|P7|Stage 2|Adverse Event|0
5933467|NCT01397409|20524028|P6|Stage 2|Adverse Event|3
5933468|NCT01397409|20524029|P5|Stage 2|Adverse Event|6
5933469|NCT01397409|20524030|P4|Stage 2|Adverse Event|0
5933470|NCT01397409|20524031|P3|Stage 2|Adverse Event|0
5933471|NCT01397409|20524032|P2|Stage 2|Adverse Event|0
5933472|NCT01397409|20524033|P1|Stage 2|Adverse Event|0
5933473|NCT01397253|20524073|P2|Overall Study|Reviewed by only 1 pharmacist|149
5933474|NCT01397253|20524074|P1|Overall Study|Reviewed by only 1 pharmacist|126
5933475|NCT01397084|20524080|P1|Overall Study|Used other proton pump inhibitor|1
5933476|NCT01397084|20524080|P1|Overall Study|Lost to Follow-up|1
5933477|NCT01397084|20524080|P1|Overall Study|Withdrawal by Subject|1
5933478|NCT01397084|20524080|P1|Overall Study|Adverse Event|2
5933479|NCT01397084|20524080|P1|Overall Study|Protocol Violation|2
5933480|NCT01397084|20524080|P1|Overall Study|Severe Non-Compliance to Protocol|1
5933481|NCT01396525|20524106|P1|Overall Study|Lost to Follow-up|4
5933482|NCT01396525|20524106|P1|Overall Study|Death|14
5933483|NCT01396525|20524106|P1|Overall Study|Withdrawal by Subject|8
5933484|NCT01396512|20524206|P2|Overall Study|Withdrawal by Subject|1
5933485|NCT01396512|20524207|P1|Overall Study|Withdrawal by Subject|0
5933486|NCT01396447|20524239|P4|Overall Study|Other Miscellaneous Reasons|0
5933487|NCT01396447|20524240|P3|Overall Study|Other Miscellaneous Reasons|1
5933488|NCT01396447|20524241|P2|Overall Study|Other Miscellaneous Reasons|2
5933489|NCT01396447|20524242|P1|Overall Study|Other Miscellaneous Reasons|0
5933490|NCT01396447|20524239|P4|Overall Study|Lost to Follow-up|9
5933491|NCT01396447|20524240|P3|Overall Study|Lost to Follow-up|7
5933492|NCT01396447|20524241|P2|Overall Study|Lost to Follow-up|8
5933493|NCT01396447|20524242|P1|Overall Study|Lost to Follow-up|4
5933494|NCT01396447|20524239|P4|Overall Study|Withdrawal of Consent|15
5933495|NCT01396447|20524240|P3|Overall Study|Withdrawal of Consent|4
5933496|NCT01396447|20524241|P2|Overall Study|Withdrawal of Consent|9
5933497|NCT01396447|20524242|P1|Overall Study|Withdrawal of Consent|11
5933498|NCT01396447|20524239|P4|Overall Study|Protocol Violation|7
5933499|NCT01396447|20524240|P3|Overall Study|Protocol Violation|3
5933500|NCT01396447|20524241|P2|Overall Study|Protocol Violation|2
5933501|NCT01396447|20524242|P1|Overall Study|Protocol Violation|5
5933502|NCT01396447|20524239|P4|Overall Study|Insufficient Therapeutic Response|4
5933503|NCT01396447|20524240|P3|Overall Study|Insufficient Therapeutic Response|2
5933504|NCT01396447|20524241|P2|Overall Study|Insufficient Therapeutic Response|5
5933505|NCT01396447|20524242|P1|Overall Study|Insufficient Therapeutic Response|5
5933506|NCT01396447|20524239|P4|Overall Study|Adverse Event|17
5933507|NCT01396447|20524240|P3|Overall Study|Adverse Event|12
5933508|NCT01396447|20524241|P2|Overall Study|Adverse Event|12
5933509|NCT01396447|20524242|P1|Overall Study|Adverse Event|15
5933510|NCT01396447|20524239|P4|Overall Study|Did Not Receive Treatment|0
5933511|NCT01396447|20524240|P3|Overall Study|Did Not Receive Treatment|1
5933512|NCT01396447|20524241|P2|Overall Study|Did Not Receive Treatment|2
5933513|NCT01396447|20524242|P1|Overall Study|Did Not Receive Treatment|3
5933514|NCT01396434|20524259|P3|Overall Study|Other|0
5933515|NCT01396434|20524260|P2|Overall Study|Other|0
5933516|NCT01396434|20524261|P1|Overall Study|Other|10
5933517|NCT01396434|20524259|P3|Overall Study|Lost to Follow-up|0
5933518|NCT01396434|20524260|P2|Overall Study|Lost to Follow-up|0
5933519|NCT01396434|20524261|P1|Overall Study|Lost to Follow-up|1
5933520|NCT01396421|20524273|P4|Overall Study|Lack of Efficacy|18
5933521|NCT01396421|20524274|P3|Overall Study|Lack of Efficacy|7
5933522|NCT01396421|20524275|P2|Overall Study|Lack of Efficacy|17
5933523|NCT01396421|20524276|P1|Overall Study|Lack of Efficacy|7
5933524|NCT01396421|20524273|P4|Overall Study|Protocol Deviation|0
5933525|NCT01396421|20524274|P3|Overall Study|Protocol Deviation|1
5933526|NCT01396421|20524275|P2|Overall Study|Protocol Deviation|1
5933527|NCT01396421|20524276|P1|Overall Study|Protocol Deviation|2
5933528|NCT01396421|20524273|P4|Overall Study|Withdrawal by Subject|21
5933529|NCT01396421|20524274|P3|Overall Study|Withdrawal by Subject|13
5933530|NCT01396421|20524275|P2|Overall Study|Withdrawal by Subject|24
5933531|NCT01396421|20524276|P1|Overall Study|Withdrawal by Subject|31
5933532|NCT01396421|20524273|P4|Overall Study|Physician Decision|3
5933533|NCT01396421|20524274|P3|Overall Study|Physician Decision|0
5933534|NCT01396421|20524275|P2|Overall Study|Physician Decision|1
5933535|NCT01396421|20524276|P1|Overall Study|Physician Decision|1
5933536|NCT01396421|20524273|P4|Overall Study|Participant Met Withdrawal Criteria|0
5933537|NCT01396421|20524274|P3|Overall Study|Participant Met Withdrawal Criteria|1
5933538|NCT01396421|20524275|P2|Overall Study|Participant Met Withdrawal Criteria|0
5933539|NCT01396421|20524276|P1|Overall Study|Participant Met Withdrawal Criteria|1
5933540|NCT01396421|20524273|P4|Overall Study|Adverse Event|32
5933541|NCT01396421|20524274|P3|Overall Study|Adverse Event|12
5933542|NCT01396421|20524275|P2|Overall Study|Adverse Event|15
5933543|NCT01396421|20524276|P1|Overall Study|Adverse Event|17
5933544|NCT01396421|20524273|P4|Overall Study|Lost to Follow-up|1
5933545|NCT01396421|20524274|P3|Overall Study|Lost to Follow-up|0
5933546|NCT01396421|20524275|P2|Overall Study|Lost to Follow-up|0
5933547|NCT01396421|20524276|P1|Overall Study|Lost to Follow-up|0
5933548|NCT01396395|20524348|P2|Overall Study|Other|1
5933549|NCT01396395|20524349|P1|Overall Study|Other|0
5933550|NCT01396395|20524348|P2|Overall Study|Lost to Follow-up|11
5933551|NCT01396395|20524349|P1|Overall Study|Lost to Follow-up|17
5933552|NCT01396395|20524348|P2|Overall Study|Adverse Event|2
5933553|NCT01396395|20524349|P1|Overall Study|Adverse Event|10
5933554|NCT01396395|20524348|P2|Overall Study|Protocol Violation|1
5933555|NCT01396395|20524349|P1|Overall Study|Protocol Violation|3
5933556|NCT01396395|20524348|P2|Overall Study|Withdrawal by Subject|12
5933557|NCT01396395|20524349|P1|Overall Study|Withdrawal by Subject|10
5933558|NCT01396317|20524391|P2|Overall Study|Adverse Event|0
5933559|NCT01396317|20524392|P1|Overall Study|Adverse Event|1
5933560|NCT01396265|20524406|P1|Rifa+Afatinib|Withdrawal by Subject|1
5933561|NCT01396187|20524495|P5|Overall Study|Other|1
5933562|NCT01396187|20524496|P4|Overall Study|Other|0
5933563|NCT01396187|20524497|P3|Overall Study|Other|0
5933564|NCT01396187|20524498|P2|Overall Study|Other|1
5933565|NCT01396187|20524499|P1|Overall Study|Other|1
5933566|NCT01396187|20524495|P5|Overall Study|Withdrawal by Subject|0
5933567|NCT01396187|20524496|P4|Overall Study|Withdrawal by Subject|0
5933568|NCT01396187|20524497|P3|Overall Study|Withdrawal by Subject|1
5933569|NCT01396187|20524498|P2|Overall Study|Withdrawal by Subject|1
5933570|NCT01396187|20524499|P1|Overall Study|Withdrawal by Subject|0
5933571|NCT01396187|20524495|P5|Overall Study|Adverse Event|0
5933572|NCT01396187|20524496|P4|Overall Study|Adverse Event|0
5933573|NCT01396187|20524497|P3|Overall Study|Adverse Event|0
5933574|NCT01396187|20524498|P2|Overall Study|Adverse Event|1
5933575|NCT01396187|20524499|P1|Overall Study|Adverse Event|0
5933576|NCT01396161|20524599|P7|Overall Study|Other|1
5933577|NCT01396161|20524600|P6|Overall Study|Other|0
5933578|NCT01396161|20524601|P5|Overall Study|Other|0
5933579|NCT01396161|20524602|P4|Overall Study|Other|0
5933580|NCT01396161|20524603|P3|Overall Study|Other|0
5933581|NCT01396161|20524604|P2|Overall Study|Other|0
5933582|NCT01396161|20524605|P1|Overall Study|Other|0
5933583|NCT01396161|20524599|P7|Overall Study|Withdrawal by Subject|0
5933584|NCT01396161|20524600|P6|Overall Study|Withdrawal by Subject|0
5933585|NCT01396161|20524601|P5|Overall Study|Withdrawal by Subject|1
5933586|NCT01396161|20524602|P4|Overall Study|Withdrawal by Subject|0
5933587|NCT01396161|20524603|P3|Overall Study|Withdrawal by Subject|0
5933588|NCT01396161|20524604|P2|Overall Study|Withdrawal by Subject|0
5933589|NCT01396161|20524605|P1|Overall Study|Withdrawal by Subject|0
5933590|NCT01396148|20524658|P1|Overall Study|Patient Decision|1
5933591|NCT01396083|20524688|P2|Overall Study|Lost to Follow-up|0
5933592|NCT01396083|20524689|P1|Overall Study|Lost to Follow-up|1
5933593|NCT01396083|20524688|P2|Overall Study|Administrative problems|0
5933594|NCT01396083|20524689|P1|Overall Study|Administrative problems|1
5933595|NCT01396083|20524688|P2|Overall Study|Abnormal laboratory value(s)|0
5933596|NCT01396083|20524689|P1|Overall Study|Abnormal laboratory value(s)|1
5933597|NCT01396083|20524688|P2|Overall Study|Protocol deviation(s)|1
5933598|NCT01396083|20524689|P1|Overall Study|Protocol deviation(s)|0
5933599|NCT01396083|20524688|P2|Overall Study|Consent withdrawn|5
5933600|NCT01396083|20524689|P1|Overall Study|Consent withdrawn|4
5933601|NCT01396083|20524688|P2|Overall Study|Unsatisfactory therapeutic effect|13
5933602|NCT01396083|20524689|P1|Overall Study|Unsatisfactory therapeutic effect|2
5933603|NCT01396083|20524688|P2|Overall Study|Adverse Event|28
5933604|NCT01396083|20524689|P1|Overall Study|Adverse Event|2
5933605|NCT01396070|20524713|P1|Overall Study|Lack of Efficacy|4
5933606|NCT01396070|20524713|P1|Overall Study|Physician Decision|3
5933607|NCT01396070|20524713|P1|Overall Study|Adverse Event|8
5933608|NCT01396070|20524713|P1|Overall Study|Death|2
5933609|NCT01396070|20524713|P1|Overall Study|Withdrawal by Subject|2
5933610|NCT01396057|20524722|P2|Overall Study|Consent withdrawn|2
5933611|NCT01396057|20524723|P1|Overall Study|Consent withdrawn|3
5933612|NCT01396057|20524722|P2|Overall Study|Protocol deviation|4
5933613|NCT01396057|20524723|P1|Overall Study|Protocol deviation|4
5933614|NCT01396057|20524722|P2|Overall Study|Unsatisfactory therapeutic effect|6
5933615|NCT01396057|20524723|P1|Overall Study|Unsatisfactory therapeutic effect|2
5933616|NCT01396057|20524722|P2|Overall Study|Adverse Event|6
5933617|NCT01396057|20524723|P1|Overall Study|Adverse Event|2
5933618|NCT01396005|20524772|P2|Overall Study|Non-compliance with protocol|1
5933619|NCT01396005|20524773|P1|Overall Study|Non-compliance with protocol|0
5933620|NCT01396005|20524772|P2|Overall Study|Withdrawal by Subject|1
5933621|NCT01396005|20524773|P1|Overall Study|Withdrawal by Subject|0
5933622|NCT01395914|20524804|P2|Overall Study|Lost to Follow-up|2
5933623|NCT01395914|20524805|P1|Overall Study|Lost to Follow-up|6
5933624|NCT01395914|20524804|P2|Overall Study|Study drug-related AE|0
5933625|NCT01395914|20524805|P1|Overall Study|Study drug-related AE|1
5933626|NCT01395914|20524804|P2|Overall Study|Withdrawal by patient|14
5933627|NCT01395914|20524805|P1|Overall Study|Withdrawal by patient|27
5933628|NCT01395914|20524804|P2|Overall Study|Other|3
5933629|NCT01395914|20524805|P1|Overall Study|Other|9
5933630|NCT01395914|20524804|P2|Overall Study|Death|17
5933631|NCT01395914|20524805|P1|Overall Study|Death|23
5933632|NCT01395914|20524804|P2|Overall Study|Unrelated to study drug AE|1
5933633|NCT01395914|20524805|P1|Overall Study|Unrelated to study drug AE|6
5933634|NCT01395901|20524819|P2|Overall Study|Withdrawal of consent|0
5933635|NCT01395901|20524820|P1|Overall Study|Withdrawal of consent|1
5933636|NCT01395901|20524819|P2|Overall Study|Adverse Event|1
5933637|NCT01395901|20524820|P1|Overall Study|Adverse Event|0
5933638|NCT01395901|20524819|P2|Overall Study|Randomized but not received study drug|4
5933639|NCT01395901|20524820|P1|Overall Study|Randomized but not received study drug|5
5933640|NCT01395901|20524819|P2|Overall Study|Lost to Follow-up|0
5933641|NCT01395901|20524820|P1|Overall Study|Lost to Follow-up|4
5933642|NCT01395888|20524836|P3|Treatment Period (TP)|Withdrawal by Subject|3
5933643|NCT01395888|20524837|P2|Treatment Period (TP)|Withdrawal by Subject|2
5933644|NCT01395888|20524838|P1|Treatment Period (TP)|Withdrawal by Subject|0
5933645|NCT01395888|20524836|P3|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0
5933646|NCT01395888|20524837|P2|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|1
5933647|NCT01395888|20524838|P1|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0
5933648|NCT01395888|20524836|P3|Treatment Period (TP)|Protocol Violation|5
5933649|NCT01395888|20524837|P2|Treatment Period (TP)|Protocol Violation|1
5933650|NCT01395888|20524838|P1|Treatment Period (TP)|Protocol Violation|0
5933651|NCT01395888|20524836|P3|Treatment Period (TP)|Lack of Efficacy|3
5933652|NCT01395888|20524837|P2|Treatment Period (TP)|Lack of Efficacy|4
5933653|NCT01395888|20524838|P1|Treatment Period (TP)|Lack of Efficacy|0
5933654|NCT01395888|20524836|P3|Treatment Period (TP)|Adverse Event|6
5933655|NCT01395888|20524837|P2|Treatment Period (TP)|Adverse Event|7
5933656|NCT01395888|20524838|P1|Treatment Period (TP)|Adverse Event|0
5933657|NCT01395888|20524836|P3|2-week Run-in Period|Withdrawal by Subject|0
5933658|NCT01395888|20524837|P2|2-week Run-in Period|Withdrawal by Subject|0
5933659|NCT01395888|20524838|P1|2-week Run-in Period|Withdrawal by Subject|4
5933660|NCT01395888|20524836|P3|2-week Run-in Period|Protocol Violation|0
5933661|NCT01395888|20524837|P2|2-week Run-in Period|Protocol Violation|0
5933662|NCT01395888|20524838|P1|2-week Run-in Period|Protocol Violation|2
5933663|NCT01395888|20524836|P3|2-week Run-in Period|Lost to Follow-up|0
5933664|NCT01395888|20524837|P2|2-week Run-in Period|Lost to Follow-up|0
5933665|NCT01395888|20524838|P1|2-week Run-in Period|Lost to Follow-up|1
5933666|NCT01395888|20524836|P3|2-week Run-in Period|Continuation Criteria Not Met|0
5933667|NCT01395888|20524837|P2|2-week Run-in Period|Continuation Criteria Not Met|0
5933668|NCT01395888|20524838|P1|2-week Run-in Period|Continuation Criteria Not Met|13
5933669|NCT01395888|20524836|P3|2-week Run-in Period|Adverse Event|0
5933670|NCT01395888|20524837|P2|2-week Run-in Period|Adverse Event|0
5933671|NCT01395888|20524838|P1|2-week Run-in Period|Adverse Event|2
5933672|NCT01395823|20524846|P2|Overall Study|Withdrawal by Subject|4
5933673|NCT01395823|20524847|P1|Overall Study|Withdrawal by Subject|5
5933674|NCT01395823|20524846|P2|Overall Study|GI symptoms|0
5933675|NCT01395823|20524847|P1|Overall Study|GI symptoms|1
5933676|NCT01395823|20524846|P2|Overall Study|Transplant|0
5933677|NCT01395823|20524847|P1|Overall Study|Transplant|1
5933678|NCT01395823|20524846|P2|Overall Study|Lost to Follow-up|0
5933679|NCT01395823|20524847|P1|Overall Study|Lost to Follow-up|1
5933680|NCT01395823|20524846|P2|Overall Study|Physician Decision|1
5933681|NCT01395823|20524847|P1|Overall Study|Physician Decision|3
5933682|NCT01395823|20524846|P2|Overall Study|Death|4
5933683|NCT01395823|20524847|P1|Overall Study|Death|4
5933684|NCT01395810|20524857|P4|Overall Study|Unclassified|0
5933685|NCT01395810|20524858|P3|Overall Study|Unclassified|0
5933686|NCT01395810|20524859|P2|Overall Study|Unclassified|0
5933687|NCT01395810|20524860|P1|Overall Study|Unclassified|2
5933688|NCT01395810|20524857|P4|Overall Study|Withdrawal criteria|0
5933689|NCT01395810|20524858|P3|Overall Study|Withdrawal criteria|0
5933690|NCT01395810|20524859|P2|Overall Study|Withdrawal criteria|2
5933691|NCT01395810|20524860|P1|Overall Study|Withdrawal criteria|0
5933692|NCT01395810|20524857|P4|Overall Study|Lack of Efficacy|0
5933693|NCT01395810|20524858|P3|Overall Study|Lack of Efficacy|0
5933694|NCT01395810|20524859|P2|Overall Study|Lack of Efficacy|1
5933695|NCT01395810|20524860|P1|Overall Study|Lack of Efficacy|0
5933696|NCT01395810|20524857|P4|Overall Study|Adverse Event|0
5933697|NCT01395810|20524858|P3|Overall Study|Adverse Event|0
5933698|NCT01395810|20524859|P2|Overall Study|Adverse Event|1
5933699|NCT01395810|20524860|P1|Overall Study|Adverse Event|0
5933700|NCT01395784|20524919|P1|Overall Study|Physician Decision|5
5933701|NCT01395784|20524919|P1|Overall Study|Withdrawal by Subject|3
5933702|NCT01395784|20524919|P1|Overall Study|Lost to Follow-up|7
5933703|NCT01395758|20524926|P3|Open-label Treatment Period|Withdrawal by Subject|0
5933704|NCT01395758|20524927|P2|Open-label Treatment Period|Withdrawal by Subject|0
5933705|NCT01395758|20524928|P1|Open-label Treatment Period|Withdrawal by Subject|4
5933706|NCT01395524|20524948|P3|Overall Study|Subject had spinal surgery|1
5933707|NCT01395524|20524949|P2|Overall Study|Subject had spinal surgery|0
5933708|NCT01395524|20524950|P1|Overall Study|Subject had spinal surgery|0
5933709|NCT01395524|20524948|P3|Overall Study|Did not receive treatment|3
5933710|NCT01395524|20524949|P2|Overall Study|Did not receive treatment|1
5933711|NCT01395524|20524950|P1|Overall Study|Did not receive treatment|1
5933712|NCT01395524|20524948|P3|Overall Study|Withdrawal by Subject|8
5933713|NCT01395524|20524949|P2|Overall Study|Withdrawal by Subject|8
5933714|NCT01395524|20524950|P1|Overall Study|Withdrawal by Subject|4
5933715|NCT01395524|20524948|P3|Overall Study|Eligibility Criteria Not Fulfilled|0
5933716|NCT01395524|20524949|P2|Overall Study|Eligibility Criteria Not Fulfilled|0
5933717|NCT01395524|20524950|P1|Overall Study|Eligibility Criteria Not Fulfilled|2
5933718|NCT01395524|20524948|P3|Overall Study|Death|0
5933719|NCT01395524|20524949|P2|Overall Study|Death|0
5933720|NCT01395524|20524950|P1|Overall Study|Death|1
5933721|NCT01395524|20524948|P3|Overall Study|Adverse Event|3
5933722|NCT01395524|20524949|P2|Overall Study|Adverse Event|4
5933723|NCT01395524|20524950|P1|Overall Study|Adverse Event|4
5933724|NCT01395524|20524948|P3|Overall Study|Severe noncompliance with protocol|0
5933725|NCT01395524|20524949|P2|Overall Study|Severe noncompliance with protocol|0
5933726|NCT01395524|20524950|P1|Overall Study|Severe noncompliance with protocol|1
5933727|NCT01395524|20524948|P3|Overall Study|Study-Specific Withdrawal Criteria|0
5933728|NCT01395524|20524949|P2|Overall Study|Study-Specific Withdrawal Criteria|2
5933729|NCT01395524|20524950|P1|Overall Study|Study-Specific Withdrawal Criteria|1
5933730|NCT01395524|20524948|P3|Overall Study|Lost to Follow-up|1
5933731|NCT01395524|20524949|P2|Overall Study|Lost to Follow-up|1
5933732|NCT01395524|20524950|P1|Overall Study|Lost to Follow-up|3
5933733|NCT01395524|20524948|P3|Overall Study|Non-compliance with study schedule|1
5933734|NCT01395524|20524949|P2|Overall Study|Non-compliance with study schedule|0
5933735|NCT01395524|20524950|P1|Overall Study|Non-compliance with study schedule|1
5933736|NCT01395394|20524973|P3|Baseline Study Visit|Protocol Violation|0
5933737|NCT01395394|20524974|P2|Baseline Study Visit|Protocol Violation|0
5933738|NCT01395394|20524975|P1|Baseline Study Visit|Protocol Violation|1
5933739|NCT01395368|20524986|P1|Overall Study|Withdrawal by Subject|2
5933740|NCT01395368|20524986|P1|Overall Study|Physician Decision|14
5933741|NCT01395316|20525042|P1|Overall Study|poor MRI quality|1
5933742|NCT01395316|20525042|P1|Overall Study|Lost to Follow-up|2
5933743|NCT01395030|20525062|P1|Overall Study|Did not complete FCH PET/CT|7
5933744|NCT01395017|20525072|P2|Overall Study|Sponsor discontinued study|4
5933745|NCT01395017|20525073|P1|Overall Study|Sponsor discontinued study|1
5933746|NCT01395017|20525072|P2|Overall Study|Disease progression|58
5933747|NCT01395017|20525073|P1|Overall Study|Disease progression|42
5933748|NCT01395017|20525072|P2|Overall Study|Death|3
5933749|NCT01395017|20525073|P1|Overall Study|Death|4
5933750|NCT01395017|20525072|P2|Overall Study|Protocol deviation|2
5933751|NCT01395017|20525073|P1|Overall Study|Protocol deviation|1
5933752|NCT01395017|20525072|P2|Overall Study|Withdrawal by Subject|8
5933753|NCT01395017|20525073|P1|Overall Study|Withdrawal by Subject|14
5933754|NCT01395017|20525072|P2|Overall Study|Physician Decision|15
5933755|NCT01395017|20525073|P1|Overall Study|Physician Decision|11
5933756|NCT01395017|20525072|P2|Overall Study|Adverse Event|12
5933757|NCT01395017|20525073|P1|Overall Study|Adverse Event|26
5933758|NCT01395017|20525072|P2|Overall Study|Lost to Follow-up|0
5933759|NCT01395017|20525073|P1|Overall Study|Lost to Follow-up|1
5933760|NCT01394991|20525083|P2|Overall Study|Prematurely Termination of Trial|10
5933761|NCT01394991|20525084|P1|Overall Study|Prematurely Termination of Trial|9
5933762|NCT01394991|20525083|P2|Overall Study|Disease Progression|7
5933763|NCT01394991|20525084|P1|Overall Study|Disease Progression|7
5933764|NCT01394991|20525083|P2|Overall Study|Chemotherapy Termination|15
5933765|NCT01394991|20525084|P1|Overall Study|Chemotherapy Termination|10
5933766|NCT01394991|20525083|P2|Overall Study|Withdrawal by Subject|17
5933767|NCT01394991|20525084|P1|Overall Study|Withdrawal by Subject|20
5933768|NCT01394991|20525083|P2|Overall Study|Protocol Violation|1
5933769|NCT01394991|20525084|P1|Overall Study|Protocol Violation|1
5933770|NCT01394991|20525083|P2|Overall Study|Physician Decision|3
5933771|NCT01394991|20525084|P1|Overall Study|Physician Decision|1
5933772|NCT01394991|20525083|P2|Overall Study|Lost to Follow-up|8
5933773|NCT01394991|20525084|P1|Overall Study|Lost to Follow-up|6
5933774|NCT01394991|20525083|P2|Overall Study|Lack of Efficacy|7
5933775|NCT01394991|20525084|P1|Overall Study|Lack of Efficacy|5
5933776|NCT01394991|20525083|P2|Overall Study|Adverse Event|4
5933777|NCT01394991|20525084|P1|Overall Study|Adverse Event|0
5933778|NCT01394978|20525106|P2|Overall Study|Death|7
5933779|NCT01394978|20525107|P1|Overall Study|Death|6
5933780|NCT01394978|20525106|P2|Overall Study|Lost to Follow-up|20
5933781|NCT01394978|20525107|P1|Overall Study|Lost to Follow-up|13
5933782|NCT01394978|20525106|P2|Overall Study|Withdrawal by Subject|4
5933783|NCT01394978|20525107|P1|Overall Study|Withdrawal by Subject|2
5933784|NCT01394952|20525115|P2|Overall Study|Sponsor Decision|7
5933785|NCT01394952|20525116|P1|Overall Study|Sponsor Decision|5
5933786|NCT01394952|20525115|P2|Overall Study|Physician Decision|0
5933787|NCT01394952|20525116|P1|Overall Study|Physician Decision|2
5933788|NCT01394952|20525115|P2|Overall Study|Withdrawal by Subject|5
5933789|NCT01394952|20525116|P1|Overall Study|Withdrawal by Subject|10
5933790|NCT01394952|20525115|P2|Overall Study|Lost to Follow-up|5
5933791|NCT01394952|20525116|P1|Overall Study|Lost to Follow-up|0
5933792|NCT01394939|20525136|P4|Overall Study|Others|3
5933793|NCT01394939|20525137|P3|Overall Study|Others|0
5933794|NCT01394939|20525138|P2|Overall Study|Others|2
5933795|NCT01394939|20525139|P1|Overall Study|Others|0
5933796|NCT01394939|20525136|P4|Overall Study|Withdrawal by Subject|2
5933797|NCT01394939|20525137|P3|Overall Study|Withdrawal by Subject|0
5933798|NCT01394939|20525138|P2|Overall Study|Withdrawal by Subject|2
5933799|NCT01394939|20525139|P1|Overall Study|Withdrawal by Subject|0
5933800|NCT01394939|20525136|P4|Overall Study|Physician Decision|0
5933801|NCT01394939|20525137|P3|Overall Study|Physician Decision|0
5933802|NCT01394939|20525138|P2|Overall Study|Physician Decision|1
5933803|NCT01394939|20525139|P1|Overall Study|Physician Decision|0
5933804|NCT01394939|20525136|P4|Overall Study|Death|0
5933805|NCT01394939|20525137|P3|Overall Study|Death|0
5933806|NCT01394939|20525138|P2|Overall Study|Death|2
5933807|NCT01394939|20525139|P1|Overall Study|Death|0
5933808|NCT01394939|20525136|P4|Overall Study|Adverse Event|2
5933809|NCT01394939|20525137|P3|Overall Study|Adverse Event|0
5933810|NCT01394939|20525138|P2|Overall Study|Adverse Event|3
5933811|NCT01394939|20525139|P1|Overall Study|Adverse Event|1
5933812|NCT01394718|20525160|P2|Overall Study|Met protocol-specific stopping criteria|1
5933813|NCT01394718|20525161|P1|Overall Study|Met protocol-specific stopping criteria|2
5933814|NCT01394627|20525193|P2|Washout (1-3 Months)|concurrent enrollment in another study|0
5933815|NCT01394627|20525194|P1|Washout (1-3 Months)|concurrent enrollment in another study|1
5933816|NCT01394627|20525193|P2|First Intervention (1 Day)|poor intravenous access|1
5933817|NCT01394627|20525194|P1|First Intervention (1 Day)|poor intravenous access|0
5933818|NCT01394523|20525214|P3|Overall Study|Unable to place block|0
5933819|NCT01394523|20525215|P2|Overall Study|Unable to place block|0
5933820|NCT01394523|20525216|P1|Overall Study|Unable to place block|1
5933821|NCT01394276|20525230|P1|Overall Study|Symptoms of concurrent diseases|1
5933822|NCT01394276|20525230|P1|Overall Study|unavailability of drug at the Hospital|2
5933823|NCT01394276|20525230|P1|Overall Study|Pregnancy|1
5933824|NCT01394276|20525230|P1|Overall Study|Participant moved to another site|1
5933825|NCT01394276|20525230|P1|Overall Study|Lost to Follow-up|5
5933826|NCT01394276|20525230|P1|Overall Study|Insufficient compliance|9
5933827|NCT01394276|20525230|P1|Overall Study|Insufficient therapeutic effect|17
5933828|NCT01394276|20525230|P1|Overall Study|Remission of disease|2
5933829|NCT01394276|20525230|P1|Overall Study|Not related AEs|9
5933830|NCT01394276|20525230|P1|Overall Study|Related Adverse event (AEs)|15
5933831|NCT01394250|20525254|P2|Successful IV Placement & Follow-Up|Withdrawal by Subject|11
5933832|NCT01394250|20525255|P1|Successful IV Placement & Follow-Up|Withdrawal by Subject|6
5933833|NCT01394250|20525254|P2|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|13
5933834|NCT01394250|20525255|P1|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|14
5933835|NCT01394185|20525269|P6|Overall Study|Protocol Violation|1
5933836|NCT01394185|20525270|P5|Overall Study|Protocol Violation|0
5933837|NCT01394185|20525271|P4|Overall Study|Protocol Violation|1
5933838|NCT01394185|20525272|P3|Overall Study|Protocol Violation|0
5933839|NCT01394185|20525273|P2|Overall Study|Protocol Violation|0
5933840|NCT01394185|20525274|P1|Overall Study|Protocol Violation|1
5933841|NCT01394185|20525269|P6|Overall Study|Change in protocol|0
5933842|NCT01394185|20525270|P5|Overall Study|Change in protocol|3
5933843|NCT01394185|20525271|P4|Overall Study|Change in protocol|0
5933844|NCT01394185|20525272|P3|Overall Study|Change in protocol|0
5933845|NCT01394185|20525273|P2|Overall Study|Change in protocol|0
5933846|NCT01394185|20525274|P1|Overall Study|Change in protocol|3
5933847|NCT01394185|20525269|P6|Overall Study|Withdrawal by Subject|0
5933848|NCT01394185|20525270|P5|Overall Study|Withdrawal by Subject|1
5933849|NCT01394185|20525271|P4|Overall Study|Withdrawal by Subject|0
5933850|NCT01394185|20525272|P3|Overall Study|Withdrawal by Subject|0
5933851|NCT01394185|20525273|P2|Overall Study|Withdrawal by Subject|0
5933852|NCT01394185|20525274|P1|Overall Study|Withdrawal by Subject|2
5933853|NCT01393990|20525378|P18|Overall Study|Withdrawal by Subject|0
5933854|NCT01393990|20525379|P17|Overall Study|Withdrawal by Subject|0
5933855|NCT01393990|20525380|P16|Overall Study|Withdrawal by Subject|1
5933856|NCT01393990|20525381|P15|Overall Study|Withdrawal by Subject|1
5933857|NCT01393990|20525382|P14|Overall Study|Withdrawal by Subject|0
5933858|NCT01393990|20525383|P13|Overall Study|Withdrawal by Subject|0
5933859|NCT01393990|20525384|P12|Overall Study|Withdrawal by Subject|0
5933860|NCT01393990|20525385|P11|Overall Study|Withdrawal by Subject|0
5933861|NCT01393990|20525386|P10|Overall Study|Withdrawal by Subject|0
5933862|NCT01393990|20525387|P9|Overall Study|Withdrawal by Subject|0
5933863|NCT01393990|20525388|P8|Overall Study|Withdrawal by Subject|0
5933864|NCT01393990|20525389|P7|Overall Study|Withdrawal by Subject|0
5933865|NCT01393990|20525390|P6|Overall Study|Withdrawal by Subject|0
5933866|NCT01393990|20525391|P5|Overall Study|Withdrawal by Subject|0
5933867|NCT01393990|20525392|P4|Overall Study|Withdrawal by Subject|0
5933868|NCT01393990|20525393|P3|Overall Study|Withdrawal by Subject|0
5933869|NCT01393990|20525394|P2|Overall Study|Withdrawal by Subject|0
5933870|NCT01393990|20525395|P1|Overall Study|Withdrawal by Subject|0
5933871|NCT01393990|20525378|P18|Overall Study|Death|0
5933872|NCT01393990|20525379|P17|Overall Study|Death|0
5933873|NCT01393990|20525380|P16|Overall Study|Death|0
5933874|NCT01393990|20525381|P15|Overall Study|Death|1
5933875|NCT01393990|20525382|P14|Overall Study|Death|1
5933876|NCT01393990|20525383|P13|Overall Study|Death|0
5933877|NCT01393990|20525384|P12|Overall Study|Death|0
5933878|NCT01393990|20525385|P11|Overall Study|Death|0
5933879|NCT01393990|20525386|P10|Overall Study|Death|0
5933880|NCT01393990|20525387|P9|Overall Study|Death|0
5933881|NCT01393990|20525388|P8|Overall Study|Death|0
5933882|NCT01393990|20525389|P7|Overall Study|Death|0
5933883|NCT01393990|20525390|P6|Overall Study|Death|0
5933884|NCT01393990|20525391|P5|Overall Study|Death|1
5933885|NCT01393990|20525392|P4|Overall Study|Death|0
5933886|NCT01393990|20525393|P3|Overall Study|Death|0
5933887|NCT01393990|20525394|P2|Overall Study|Death|0
5933888|NCT01393990|20525395|P1|Overall Study|Death|0
5933889|NCT01393990|20525378|P18|Overall Study|Progressive Disease|0
5933890|NCT01393990|20525379|P17|Overall Study|Progressive Disease|0
5933891|NCT01393990|20525380|P16|Overall Study|Progressive Disease|1
5933892|NCT01393990|20525381|P15|Overall Study|Progressive Disease|6
5933893|NCT01393990|20525382|P14|Overall Study|Progressive Disease|1
5933894|NCT01393990|20525383|P13|Overall Study|Progressive Disease|0
5933895|NCT01393990|20525384|P12|Overall Study|Progressive Disease|0
5933896|NCT01393990|20525385|P11|Overall Study|Progressive Disease|0
5933897|NCT01393990|20525386|P10|Overall Study|Progressive Disease|1
5933898|NCT01393990|20525387|P9|Overall Study|Progressive Disease|3
5933899|NCT01393990|20525388|P8|Overall Study|Progressive Disease|1
5933900|NCT01393990|20525389|P7|Overall Study|Progressive Disease|1
5933901|NCT01393990|20525390|P6|Overall Study|Progressive Disease|1
5933902|NCT01393990|20525391|P5|Overall Study|Progressive Disease|1
5933903|NCT01393990|20525392|P4|Overall Study|Progressive Disease|1
5933904|NCT01393990|20525393|P3|Overall Study|Progressive Disease|0
5933905|NCT01393990|20525394|P2|Overall Study|Progressive Disease|0
5933906|NCT01393990|20525395|P1|Overall Study|Progressive Disease|1
5933907|NCT01393990|20525378|P18|Overall Study|Adverse Event|0
5933908|NCT01393990|20525379|P17|Overall Study|Adverse Event|0
5933909|NCT01393990|20525380|P16|Overall Study|Adverse Event|1
5933910|NCT01393990|20525381|P15|Overall Study|Adverse Event|1
5933911|NCT01393990|20525382|P14|Overall Study|Adverse Event|0
5933912|NCT01393990|20525383|P13|Overall Study|Adverse Event|0
5933913|NCT01393990|20525384|P12|Overall Study|Adverse Event|0
5933914|NCT01393990|20525385|P11|Overall Study|Adverse Event|0
5933915|NCT01393990|20525386|P10|Overall Study|Adverse Event|0
5933916|NCT01393990|20525387|P9|Overall Study|Adverse Event|0
5933917|NCT01393990|20525388|P8|Overall Study|Adverse Event|0
5933918|NCT01393990|20525389|P7|Overall Study|Adverse Event|0
5933919|NCT01393990|20525390|P6|Overall Study|Adverse Event|0
5933920|NCT01393990|20525391|P5|Overall Study|Adverse Event|0
5933921|NCT01393990|20525392|P4|Overall Study|Adverse Event|0
5933922|NCT01393990|20525393|P3|Overall Study|Adverse Event|0
5933923|NCT01393990|20525394|P2|Overall Study|Adverse Event|0
5933924|NCT01393990|20525395|P1|Overall Study|Adverse Event|0
5933925|NCT01393964|20525486|P3|Overall Study|Subject to receive non-protocol therapy|1
5933926|NCT01393964|20525487|P2|Overall Study|Subject to receive non-protocol therapy|0
5933927|NCT01393964|20525488|P1|Overall Study|Subject to receive non-protocol therapy|0
5933928|NCT01393964|20525486|P3|Overall Study|Subject converted to roll-over study|0
5933929|NCT01393964|20525487|P2|Overall Study|Subject converted to roll-over study|1
5933930|NCT01393964|20525488|P1|Overall Study|Subject converted to roll-over study|0
5933931|NCT01393964|20525486|P3|Overall Study|Investigator removed subject from study|0
5933932|NCT01393964|20525487|P2|Overall Study|Investigator removed subject from study|1
5933933|NCT01393964|20525488|P1|Overall Study|Investigator removed subject from study|0
5933934|NCT01393964|20525486|P3|Overall Study|Subject plateaued in terms of effect|0
5933935|NCT01393964|20525487|P2|Overall Study|Subject plateaued in terms of effect|0
5933936|NCT01393964|20525488|P1|Overall Study|Subject plateaued in terms of effect|1
5933937|NCT01393964|20525486|P3|Overall Study|Subject switched to commercial supply|2
5933938|NCT01393964|20525487|P2|Overall Study|Subject switched to commercial supply|0
5933939|NCT01393964|20525488|P1|Overall Study|Subject switched to commercial supply|1
5933940|NCT01393964|20525486|P3|Overall Study|Subject decided to move to transplant|0
5933941|NCT01393964|20525487|P2|Overall Study|Subject decided to move to transplant|0
5933942|NCT01393964|20525488|P1|Overall Study|Subject decided to move to transplant|1
5933943|NCT01393964|20525486|P3|Overall Study|Subject request stop study treatment|0
5933944|NCT01393964|20525487|P2|Overall Study|Subject request stop study treatment|1
5933945|NCT01393964|20525488|P1|Overall Study|Subject request stop study treatment|0
5933946|NCT01393964|20525486|P3|Overall Study|Adverse event unrelated to study drug|0
5933947|NCT01393964|20525487|P2|Overall Study|Adverse event unrelated to study drug|3
5933948|NCT01393964|20525488|P1|Overall Study|Adverse event unrelated to study drug|0
5933949|NCT01393964|20525486|P3|Overall Study|Withdrawal by Subject|1
5933950|NCT01393964|20525487|P2|Overall Study|Withdrawal by Subject|0
5933951|NCT01393964|20525488|P1|Overall Study|Withdrawal by Subject|0
5933952|NCT01393964|20525486|P3|Overall Study|Study drug toxicity|0
5933953|NCT01393964|20525487|P2|Overall Study|Study drug toxicity|0
5933954|NCT01393964|20525488|P1|Overall Study|Study drug toxicity|1
5933955|NCT01393964|20525486|P3|Overall Study|Disease Progression|5
5933956|NCT01393964|20525487|P2|Overall Study|Disease Progression|3
5933957|NCT01393964|20525488|P1|Overall Study|Disease Progression|4
5933958|NCT01393899|20525529|P3|Overall Study|Adverse Event|3
5933959|NCT01393899|20525530|P2|Overall Study|Adverse Event|5
5933960|NCT01393899|20525531|P1|Overall Study|Adverse Event|1
5933961|NCT01393899|20525529|P3|Overall Study|Lack of Efficacy|16
5933962|NCT01393899|20525530|P2|Overall Study|Lack of Efficacy|21
5933963|NCT01393899|20525531|P1|Overall Study|Lack of Efficacy|26
5933964|NCT01393899|20525529|P3|Overall Study|Does not meet entrance criteria|1
5933965|NCT01393899|20525530|P2|Overall Study|Does not meet entrance criteria|0
5933966|NCT01393899|20525531|P1|Overall Study|Does not meet entrance criteria|1
5933967|NCT01393899|20525529|P3|Overall Study|Lost to Follow-up|1
5933968|NCT01393899|20525530|P2|Overall Study|Lost to Follow-up|0
5933969|NCT01393899|20525531|P1|Overall Study|Lost to Follow-up|0
5933970|NCT01393899|20525529|P3|Overall Study|Withdrawal by Subject|1
5933971|NCT01393899|20525530|P2|Overall Study|Withdrawal by Subject|2
5933972|NCT01393899|20525531|P1|Overall Study|Withdrawal by Subject|2
5933973|NCT01393899|20525529|P3|Overall Study|Other|0
5933974|NCT01393899|20525530|P2|Overall Study|Other|0
5933975|NCT01393899|20525531|P1|Overall Study|Other|1
5933976|NCT01393899|20525529|P3|Overall Study|Study terminated by sponsor|1
5933977|NCT01393899|20525530|P2|Overall Study|Study terminated by sponsor|0
5933978|NCT01393899|20525531|P1|Overall Study|Study terminated by sponsor|1
5933979|NCT01393821|20525585|P2|Overall Study|not evaluable for primary endpoint|2
5933980|NCT01393821|20525586|P1|Overall Study|not evaluable for primary endpoint|4
5933981|NCT01393821|20525585|P2|Overall Study|Cancel|1
5933982|NCT01393821|20525586|P1|Overall Study|Cancel|1
5933983|NCT01393743|20525600|P3|Extension Phase|Other|14
5933984|NCT01393743|20525601|P2|Extension Phase|Other|0
5933985|NCT01393743|20525602|P1|Extension Phase|Other|0
5933986|NCT01393743|20525600|P3|Extension Phase|Pregnancy|1
5933987|NCT01393743|20525601|P2|Extension Phase|Pregnancy|0
5933988|NCT01393743|20525602|P1|Extension Phase|Pregnancy|0
5933989|NCT01393743|20525600|P3|Extension Phase|Withdrawal by Subject|8
5933990|NCT01393743|20525601|P2|Extension Phase|Withdrawal by Subject|0
5933991|NCT01393743|20525602|P1|Extension Phase|Withdrawal by Subject|0
5933992|NCT01393743|20525600|P3|Extension Phase|Inadequate therapeutic effect|7
5933993|NCT01393743|20525601|P2|Extension Phase|Inadequate therapeutic effect|0
5933994|NCT01393743|20525602|P1|Extension Phase|Inadequate therapeutic effect|0
5933995|NCT01393743|20525600|P3|Extension Phase|Participant choice|16
5933996|NCT01393743|20525601|P2|Extension Phase|Participant choice|0
5933997|NCT01393743|20525602|P1|Extension Phase|Participant choice|0
5933998|NCT01393743|20525600|P3|Extension Phase|Lost to Follow-up|2
5933999|NCT01393743|20525601|P2|Extension Phase|Lost to Follow-up|0
5934000|NCT01393743|20525602|P1|Extension Phase|Lost to Follow-up|0
5934001|NCT01393743|20525600|P3|Extension Phase|Adverse Event|12
5934002|NCT01393743|20525601|P2|Extension Phase|Adverse Event|0
5934003|NCT01393743|20525602|P1|Extension Phase|Adverse Event|0
5934004|NCT01393743|20525600|P3|Core Study|Inadequate therapeutic effect|0
5934005|NCT01393743|20525601|P2|Core Study|Inadequate therapeutic effect|0
5934006|NCT01393743|20525602|P1|Core Study|Inadequate therapeutic effect|2
5934007|NCT01393743|20525600|P3|Core Study|Participant's Choice|0
5934008|NCT01393743|20525601|P2|Core Study|Participant's Choice|3
5934009|NCT01393743|20525602|P1|Core Study|Participant's Choice|2
5934010|NCT01393743|20525600|P3|Core Study|Lost to Follow-up|0
5934011|NCT01393743|20525601|P2|Core Study|Lost to Follow-up|1
5934012|NCT01393743|20525602|P1|Core Study|Lost to Follow-up|1
5934013|NCT01393743|20525600|P3|Core Study|Adverse Event|0
5934014|NCT01393743|20525601|P2|Core Study|Adverse Event|9
5934015|NCT01393743|20525602|P1|Core Study|Adverse Event|5
5934016|NCT01393730|20525625|P1|Overall Study|Adverse Event|1
5934017|NCT01393730|20525625|P1|Overall Study|Other|2
5934018|NCT01393730|20525625|P1|Overall Study|Withdrawal by Subject|3
5934019|NCT01393626|20525671|P4|Overall Study|Protocol Violation|0
5934020|NCT01393626|20525672|P3|Overall Study|Protocol Violation|2
5934021|NCT01393626|20525673|P2|Overall Study|Protocol Violation|0
5934022|NCT01393626|20525674|P1|Overall Study|Protocol Violation|1
5934023|NCT01393626|20525671|P4|Overall Study|Other|0
5934024|NCT01393626|20525672|P3|Overall Study|Other|0
5934025|NCT01393626|20525673|P2|Overall Study|Other|0
5934026|NCT01393626|20525674|P1|Overall Study|Other|1
5934027|NCT01393626|20525671|P4|Overall Study|Withdrawal by Subject|0
5934028|NCT01393626|20525672|P3|Overall Study|Withdrawal by Subject|0
5934029|NCT01393626|20525673|P2|Overall Study|Withdrawal by Subject|4
5934030|NCT01393626|20525674|P1|Overall Study|Withdrawal by Subject|6
5934031|NCT01393626|20525671|P4|Overall Study|Lost to Follow-up|0
5934032|NCT01393626|20525672|P3|Overall Study|Lost to Follow-up|1
5934033|NCT01393626|20525673|P2|Overall Study|Lost to Follow-up|1
5934034|NCT01393626|20525674|P1|Overall Study|Lost to Follow-up|1
5934035|NCT01393626|20525671|P4|Overall Study|Lack of Efficacy|1
5934036|NCT01393626|20525672|P3|Overall Study|Lack of Efficacy|4
5934037|NCT01393626|20525673|P2|Overall Study|Lack of Efficacy|6
5934038|NCT01393626|20525674|P1|Overall Study|Lack of Efficacy|6
5934039|NCT01393626|20525671|P4|Overall Study|Did not meet entrance criteria|0
5934040|NCT01393626|20525672|P3|Overall Study|Did not meet entrance criteria|0
5934041|NCT01393626|20525673|P2|Overall Study|Did not meet entrance criteria|0
5934042|NCT01393626|20525674|P1|Overall Study|Did not meet entrance criteria|1
5934043|NCT01393626|20525671|P4|Overall Study|Adverse Event|0
5934044|NCT01393626|20525672|P3|Overall Study|Adverse Event|5
5934045|NCT01393626|20525673|P2|Overall Study|Adverse Event|1
5934046|NCT01393626|20525674|P1|Overall Study|Adverse Event|2
5934047|NCT01393613|20525754|P4|Overall Study|Lack of Efficacy|21
5934048|NCT01393613|20525755|P3|Overall Study|Lack of Efficacy|16
5934049|NCT01393613|20525756|P2|Overall Study|Lack of Efficacy|20
5934050|NCT01393613|20525757|P1|Overall Study|Lack of Efficacy|9
5934051|NCT01393613|20525754|P4|Overall Study|Protocol Deviation|0
5934052|NCT01393613|20525755|P3|Overall Study|Protocol Deviation|0
5934053|NCT01393613|20525756|P2|Overall Study|Protocol Deviation|1
5934054|NCT01393613|20525757|P1|Overall Study|Protocol Deviation|2
5934055|NCT01393613|20525754|P4|Overall Study|Withdrawal by Subject|21
5934056|NCT01393613|20525755|P3|Overall Study|Withdrawal by Subject|23
5934057|NCT01393613|20525756|P2|Overall Study|Withdrawal by Subject|25
5934058|NCT01393613|20525757|P1|Overall Study|Withdrawal by Subject|15
5934059|NCT01393613|20525754|P4|Overall Study|Physician Decision|1
5934060|NCT01393613|20525755|P3|Overall Study|Physician Decision|0
5934061|NCT01393613|20525756|P2|Overall Study|Physician Decision|0
5934062|NCT01393613|20525757|P1|Overall Study|Physician Decision|2
5934063|NCT01393613|20525754|P4|Overall Study|Participant Met Withdrawal Criteria|1
5934064|NCT01393613|20525755|P3|Overall Study|Participant Met Withdrawal Criteria|2
5934065|NCT01393613|20525756|P2|Overall Study|Participant Met Withdrawal Criteria|0
5934066|NCT01393613|20525757|P1|Overall Study|Participant Met Withdrawal Criteria|0
5934067|NCT01393613|20525754|P4|Overall Study|Adverse Event|22
5934068|NCT01393613|20525755|P3|Overall Study|Adverse Event|13
5934069|NCT01393613|20525756|P2|Overall Study|Adverse Event|11
5934070|NCT01393613|20525757|P1|Overall Study|Adverse Event|11
5934071|NCT01393600|20525819|P4|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0
5934072|NCT01393600|20525820|P3|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|1
5934073|NCT01393600|20525821|P2|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0
5934074|NCT01393600|20525822|P1|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0
5934075|NCT01393600|20525819|P4|Treatment Period 2 (Day 15 to 28)|Physician Decision|0
5934076|NCT01393600|20525820|P3|Treatment Period 2 (Day 15 to 28)|Physician Decision|1
5934077|NCT01393600|20525821|P2|Treatment Period 2 (Day 15 to 28)|Physician Decision|0
5934078|NCT01393600|20525822|P1|Treatment Period 2 (Day 15 to 28)|Physician Decision|0
5934079|NCT01393600|20525819|P4|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0
5934080|NCT01393600|20525820|P3|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|1
5934081|NCT01393600|20525821|P2|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0
5934082|NCT01393600|20525822|P1|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0
5934083|NCT01393600|20525819|P4|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|1
5934084|NCT01393600|20525820|P3|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0
5934085|NCT01393600|20525821|P2|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0
5934086|NCT01393600|20525822|P1|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0
5934087|NCT01393600|20525819|P4|Treatment Period 1 (Day 1 to 14)|Adverse Event|1
5934088|NCT01393600|20525820|P3|Treatment Period 1 (Day 1 to 14)|Adverse Event|0
5934089|NCT01393600|20525821|P2|Treatment Period 1 (Day 1 to 14)|Adverse Event|0
5934090|NCT01393600|20525822|P1|Treatment Period 1 (Day 1 to 14)|Adverse Event|0
5934091|NCT01393600|20525819|P4|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0
5934092|NCT01393600|20525820|P3|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|1
5934093|NCT01393600|20525821|P2|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0
5934094|NCT01393600|20525822|P1|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0
5934095|NCT01393600|20525819|P4|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0
5934096|NCT01393600|20525820|P3|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0
5934097|NCT01393600|20525821|P2|Treatment Period 1 (Day 1 to 14)|Protocol Violation|1
5934098|NCT01393600|20525822|P1|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0
5934099|NCT01393444|20525858|P1|Overall Study|Determined ineligible during screening.|2
5934100|NCT01393444|20525858|P1|Overall Study|Withdrawal by Subject|1
5934101|NCT01393405|20525863|P3|Maintenance Period Week|Lost to Follow-up|0
5934102|NCT01393405|20525864|P2|Maintenance Period Week|Lost to Follow-up|1
5934103|NCT01393405|20525865|P1|Maintenance Period Week|Lost to Follow-up|0
5934104|NCT01393405|20525863|P3|Maintenance Period Week|Withdrawal by Subject|0
5934105|NCT01393405|20525864|P2|Maintenance Period Week|Withdrawal by Subject|1
5934106|NCT01393405|20525865|P1|Maintenance Period Week|Withdrawal by Subject|0
5934107|NCT01393405|20525863|P3|Maintenance Period Week|Adverse Event|2
5934108|NCT01393405|20525864|P2|Maintenance Period Week|Adverse Event|5
5934109|NCT01393405|20525865|P1|Maintenance Period Week|Adverse Event|0
5934110|NCT01393405|20525863|P3|Maintenance Period Week|Lack of Efficacy|22
5934111|NCT01393405|20525864|P2|Maintenance Period Week|Lack of Efficacy|22
5934112|NCT01393405|20525865|P1|Maintenance Period Week|Lack of Efficacy|0
5934113|NCT01393405|20525863|P3|Induction Period (week1-16)|Withdrawal by Subject|0
5934114|NCT01393405|20525864|P2|Induction Period (week1-16)|Withdrawal by Subject|0
5934115|NCT01393405|20525865|P1|Induction Period (week1-16)|Withdrawal by Subject|9
5934116|NCT01393405|20525863|P3|Induction Period (week1-16)|Adverse Event|0
5934117|NCT01393405|20525864|P2|Induction Period (week1-16)|Adverse Event|0
5934118|NCT01393405|20525865|P1|Induction Period (week1-16)|Adverse Event|16
5934119|NCT01393405|20525863|P3|Induction Period (week1-16)|Lack of Efficacy|0
5934120|NCT01393405|20525864|P2|Induction Period (week1-16)|Lack of Efficacy|0
5934121|NCT01393405|20525865|P1|Induction Period (week1-16)|Lack of Efficacy|70
5934122|NCT01393301|20525903|P2|Overall Study|Completed <7 sessions (intervention)|0
5934123|NCT01393301|20525904|P1|Overall Study|Completed <7 sessions (intervention)|2
5934124|NCT01393301|20525903|P2|Overall Study|Withdrawal by Subject|0
5934125|NCT01393301|20525904|P1|Overall Study|Withdrawal by Subject|2
5934126|NCT01393301|20525903|P2|Overall Study|Lost to Follow-up|3
5934127|NCT01393301|20525904|P1|Overall Study|Lost to Follow-up|5
5934128|NCT01393158|20525917|P2|Overall Study|Adverse Event|0
5934129|NCT01393158|20525918|P1|Overall Study|Adverse Event|1
5934130|NCT01393106|20525945|P1|Overall Study|Lack of Efficacy|1
5934131|NCT01393106|20525945|P1|Overall Study|Withdrawal by Subject|1
5934132|NCT01393106|20525945|P1|Overall Study|Adverse Event|3
5934133|NCT01392963|20525972|P2|Week 24 Follow-up|Lost to Follow-up|0
5934134|NCT01392963|20525973|P1|Week 24 Follow-up|Lost to Follow-up|2
5934135|NCT01392963|20525972|P2|Week 0 (First Intervention)|Withdrawal by Subject|1
5934136|NCT01392963|20525973|P1|Week 0 (First Intervention)|Withdrawal by Subject|0
5934137|NCT01392963|20525972|P2|Week 0 (First Intervention)|Lost to Follow-up|1
5934138|NCT01392963|20525973|P1|Week 0 (First Intervention)|Lost to Follow-up|0
5934139|NCT01392742|20525981|P1|Overall Study|Missing information|13
5934140|NCT01392742|20525981|P1|Overall Study|Other|3
5934141|NCT01392742|20525981|P1|Overall Study|Protocol Violation|14
5934142|NCT01392742|20525981|P1|Overall Study|Adverse event/intercurrent illness|17
5934143|NCT01392742|20525981|P1|Overall Study|ITR and Protocol deviation|1
5934144|NCT01392742|20525981|P1|Overall Study|Insufficient therapeutic response (ITR)|30
5934145|NCT01392742|20525981|P1|Overall Study|Lost to Follow-up|34
5934146|NCT01392742|20525981|P1|Overall Study|No treatment/no cooperation/withdrew|12
5934147|NCT01392742|20525981|P1|Overall Study|Failure to return|35
5934148|NCT01392742|20525981|P1|Overall Study|Premature study termination|42
5934149|NCT01392677|20526027|P2|Overall Study|Other reason|2
5934150|NCT01392677|20526028|P1|Overall Study|Other reason|3
5934151|NCT01392677|20526027|P2|Overall Study|Incorrect enrollment|3
5934152|NCT01392677|20526028|P1|Overall Study|Incorrect enrollment|2
5934153|NCT01392677|20526027|P2|Overall Study|Withdrawal by Subject|2
5934154|NCT01392677|20526028|P1|Overall Study|Withdrawal by Subject|0
5934155|NCT01392677|20526027|P2|Overall Study|Adverse Event|1
5934156|NCT01392677|20526028|P1|Overall Study|Adverse Event|3
5934157|NCT01392573|20526063|P2|Overall Study|Unclassified|6
5934158|NCT01392573|20526064|P1|Overall Study|Unclassified|9
5934159|NCT01392573|20526063|P2|Overall Study|Site closure|7
5934160|NCT01392573|20526064|P1|Overall Study|Site closure|8
5934161|NCT01392573|20526063|P2|Overall Study|Withdrawal Criteria|15
5934162|NCT01392573|20526064|P1|Overall Study|Withdrawal Criteria|13
5934163|NCT01392573|20526063|P2|Overall Study|Protocol Violation|2
5934164|NCT01392573|20526064|P1|Overall Study|Protocol Violation|0
5934165|NCT01392573|20526063|P2|Overall Study|Lack of Efficacy|2
5934166|NCT01392573|20526064|P1|Overall Study|Lack of Efficacy|1
5934167|NCT01392573|20526063|P2|Overall Study|Adverse Event|3
5934168|NCT01392573|20526064|P1|Overall Study|Adverse Event|1
5934169|NCT01392560|20526072|P1|Overall Study|discontinued during placebo run-in|2
5934170|NCT01392560|20526072|P1|Overall Study|not entered|8
5934171|NCT01392560|20526072|P1|Overall Study|Adverse Event|2
5934172|NCT01392547|20526078|P1|Overall Study|Unclassified|1
5934173|NCT01392547|20526078|P1|Overall Study|Withdrawal criteria|3
5934174|NCT01392547|20526078|P1|Overall Study|Non-compliance|2
5934175|NCT01392547|20526078|P1|Overall Study|Adverse Event|2
5934176|NCT01392495|20526092|P1|Overall Study|Adverse Event|3
5934177|NCT01392495|20526092|P1|Overall Study|Withdrawal by Subject|2
5934178|NCT01392495|20526092|P1|Overall Study|Administrative problems|8
5934179|NCT01392495|20526092|P1|Overall Study|Death|3
5934180|NCT01392443|20526104|P1|Overall Study|Protocol Violation|1
5934181|NCT01392443|20526104|P1|Overall Study|Lost to Follow-up|1
5934182|NCT01392443|20526104|P1|Overall Study|Withdrawal by Subject|5
5934183|NCT01392443|20526104|P1|Overall Study|Death|7
5934184|NCT01392443|20526104|P1|Overall Study|Adverse Event|24
5934185|NCT01392443|20526104|P1|Overall Study|Disease progression|30
5934186|NCT01392378|20526117|P5|Toddler Dose|Withdrawal by Parent|1
5934187|NCT01392378|20526118|P4|Toddler Dose|Withdrawal by Parent|1
5934188|NCT01392378|20526119|P3|Toddler Dose|Withdrawal by Parent|0
5934189|NCT01392378|20526120|P2|Toddler Dose|Withdrawal by Parent|1
5934190|NCT01392378|20526121|P1|Toddler Dose|Withdrawal by Parent|0
5934191|NCT01392378|20526117|P5|Toddler Dose|Lost to Follow-up|0
5934192|NCT01392378|20526118|P4|Toddler Dose|Lost to Follow-up|1
5934193|NCT01392378|20526119|P3|Toddler Dose|Lost to Follow-up|0
5934194|NCT01392378|20526120|P2|Toddler Dose|Lost to Follow-up|0
5934195|NCT01392378|20526121|P1|Toddler Dose|Lost to Follow-up|0
5934196|NCT01392378|20526117|P5|After Infant Series|Withdrawal by Parent|1
5934197|NCT01392378|20526118|P4|After Infant Series|Withdrawal by Parent|0
5934198|NCT01392378|20526119|P3|After Infant Series|Withdrawal by Parent|1
5934199|NCT01392378|20526120|P2|After Infant Series|Withdrawal by Parent|1
5934200|NCT01392378|20526121|P1|After Infant Series|Withdrawal by Parent|0
5934201|NCT01392378|20526117|P5|After Infant Series|Lost to Follow-up|0
5934202|NCT01392378|20526118|P4|After Infant Series|Lost to Follow-up|0
5934203|NCT01392378|20526119|P3|After Infant Series|Lost to Follow-up|1
5934204|NCT01392378|20526120|P2|After Infant Series|Lost to Follow-up|0
5934205|NCT01392378|20526121|P1|After Infant Series|Lost to Follow-up|0
5934206|NCT01392378|20526117|P5|Infant Series|Withdrawal by Parent|0
5934207|NCT01392378|20526118|P4|Infant Series|Withdrawal by Parent|0
5934208|NCT01392378|20526119|P3|Infant Series|Withdrawal by Parent|0
5934209|NCT01392378|20526120|P2|Infant Series|Withdrawal by Parent|1
5934210|NCT01392378|20526121|P1|Infant Series|Withdrawal by Parent|4
5934211|NCT01392378|20526117|P5|Infant Series|Protocol Violation|0
5934212|NCT01392378|20526118|P4|Infant Series|Protocol Violation|0
5934213|NCT01392378|20526119|P3|Infant Series|Protocol Violation|0
5934214|NCT01392378|20526120|P2|Infant Series|Protocol Violation|1
5934215|NCT01392378|20526121|P1|Infant Series|Protocol Violation|0
5934216|NCT01392378|20526117|P5|Infant Series|Lost to Follow-up|0
5934217|NCT01392378|20526118|P4|Infant Series|Lost to Follow-up|1
5934218|NCT01392378|20526119|P3|Infant Series|Lost to Follow-up|0
5934219|NCT01392378|20526120|P2|Infant Series|Lost to Follow-up|0
5934220|NCT01392378|20526121|P1|Infant Series|Lost to Follow-up|0
5934221|NCT01392378|20526117|P5|Infant Series|Adverse Event|0
5934222|NCT01392378|20526118|P4|Infant Series|Adverse Event|1
5934223|NCT01392378|20526119|P3|Infant Series|Adverse Event|0
5934224|NCT01392378|20526120|P2|Infant Series|Adverse Event|0
5934225|NCT01392378|20526121|P1|Infant Series|Adverse Event|0
5934226|NCT01392326|20526261|P3|Overall Study|Adverse Event|11
5934227|NCT01392326|20526262|P2|Overall Study|Adverse Event|6
5934228|NCT01392326|20526263|P1|Overall Study|Adverse Event|9
5934229|NCT01392326|20526261|P3|Overall Study|Lack of Efficacy|15
5934230|NCT01392326|20526262|P2|Overall Study|Lack of Efficacy|10
5934231|NCT01392326|20526263|P1|Overall Study|Lack of Efficacy|14
5934232|NCT01392326|20526261|P3|Overall Study|Lost to Follow-up|4
5934233|NCT01392326|20526262|P2|Overall Study|Lost to Follow-up|3
5934234|NCT01392326|20526263|P1|Overall Study|Lost to Follow-up|1
5934235|NCT01392326|20526261|P3|Overall Study|Physician Decision|2
5934236|NCT01392326|20526262|P2|Overall Study|Physician Decision|5
5934237|NCT01392326|20526263|P1|Overall Study|Physician Decision|7
5934238|NCT01392326|20526261|P3|Overall Study|Pregnancy|1
5934239|NCT01392326|20526262|P2|Overall Study|Pregnancy|0
5934240|NCT01392326|20526263|P1|Overall Study|Pregnancy|0
5934241|NCT01392326|20526261|P3|Overall Study|Protocol Violation|0
5934242|NCT01392326|20526262|P2|Overall Study|Protocol Violation|0
5934243|NCT01392326|20526263|P1|Overall Study|Protocol Violation|2
5934244|NCT01392326|20526261|P3|Overall Study|Withdrawal by Subject|15
5934245|NCT01392326|20526262|P2|Overall Study|Withdrawal by Subject|11
5934246|NCT01392326|20526263|P1|Overall Study|Withdrawal by Subject|12
5934247|NCT01392326|20526261|P3|Overall Study|Death|0
5934248|NCT01392326|20526262|P2|Overall Study|Death|0
5934249|NCT01392326|20526263|P1|Overall Study|Death|2
5934250|NCT01392300|20526300|P3|Open Label Extension (OLEX) Period|Lost to Follow-up|6
5934251|NCT01392300|20526301|P2|Open Label Extension (OLEX) Period|Lost to Follow-up|0
5934252|NCT01392300|20526302|P1|Open Label Extension (OLEX) Period|Lost to Follow-up|0
5934253|NCT01392300|20526300|P3|Open Label Extension (OLEX) Period|Withdrawal by Subject|17
5934254|NCT01392300|20526301|P2|Open Label Extension (OLEX) Period|Withdrawal by Subject|0
5934255|NCT01392300|20526302|P1|Open Label Extension (OLEX) Period|Withdrawal by Subject|0
5934256|NCT01392300|20526300|P3|Open Label Extension (OLEX) Period|Adverse Event|7
5934257|NCT01392300|20526301|P2|Open Label Extension (OLEX) Period|Adverse Event|0
5934258|NCT01392300|20526302|P1|Open Label Extension (OLEX) Period|Adverse Event|0
5934259|NCT01392300|20526300|P3|Open Label Extension (OLEX) Period|Death|4
5934260|NCT01392300|20526301|P2|Open Label Extension (OLEX) Period|Death|0
5934261|NCT01392300|20526302|P1|Open Label Extension (OLEX) Period|Death|0
5934262|NCT01392300|20526300|P3|Open Label Extension (OLEX) Period|Non-compliance|1
5934263|NCT01392300|20526301|P2|Open Label Extension (OLEX) Period|Non-compliance|0
5934264|NCT01392300|20526302|P1|Open Label Extension (OLEX) Period|Non-compliance|0
5934265|NCT01392300|20526300|P3|Open Label Extension (OLEX) Period|Lack of Efficacy|3
5934266|NCT01392300|20526301|P2|Open Label Extension (OLEX) Period|Lack of Efficacy|0
5934267|NCT01392300|20526302|P1|Open Label Extension (OLEX) Period|Lack of Efficacy|0
5934268|NCT01392300|20526300|P3|Open Label Extension (OLEX) Period|Protocol Violation|13
5934269|NCT01392300|20526301|P2|Open Label Extension (OLEX) Period|Protocol Violation|0
5934270|NCT01392300|20526302|P1|Open Label Extension (OLEX) Period|Protocol Violation|0
5934271|NCT01392300|20526300|P3|Main Period (MP)|Non-compliance|0
5934272|NCT01392300|20526301|P2|Main Period (MP)|Non-compliance|0
5934273|NCT01392300|20526302|P1|Main Period (MP)|Non-compliance|1
5934274|NCT01392300|20526300|P3|Main Period (MP)|Lost to Follow-up|0
5934275|NCT01392300|20526301|P2|Main Period (MP)|Lost to Follow-up|3
5934276|NCT01392300|20526302|P1|Main Period (MP)|Lost to Follow-up|3
5934277|NCT01392300|20526300|P3|Main Period (MP)|Withdrawal by Subject|0
5934278|NCT01392300|20526301|P2|Main Period (MP)|Withdrawal by Subject|1
5934279|NCT01392300|20526302|P1|Main Period (MP)|Withdrawal by Subject|5
5934280|NCT01392300|20526300|P3|Main Period (MP)|Predefined discontinuation criteria|0
5934281|NCT01392300|20526301|P2|Main Period (MP)|Predefined discontinuation criteria|3
5934282|NCT01392300|20526302|P1|Main Period (MP)|Predefined discontinuation criteria|2
5934283|NCT01392170|20526407|P1|Overall Study|Ineligible|1
5934284|NCT01392170|20526407|P1|Overall Study|Withdrawal by Subject|1
5934285|NCT01391832|20526457|P2|Overall Study|Lost to Follow-up|1
5934286|NCT01391832|20526458|P1|Overall Study|Lost to Follow-up|0
5934287|NCT01391832|20526457|P2|Overall Study|Withdrawal by Subject|22
5934288|NCT01391832|20526458|P1|Overall Study|Withdrawal by Subject|21
5934289|NCT01391819|20526466|P1|Overall Study|Other|9
5934290|NCT01391819|20526466|P1|Overall Study|Death|3
5934291|NCT01391819|20526466|P1|Overall Study|Lost to Follow-up|252
5934292|NCT01391819|20526466|P1|Overall Study|Migrated/moved from study area|82
5934293|NCT01391819|20526466|P1|Overall Study|Withdrawal by Subject|56
5934294|NCT01391793|20526510|P2|Overall Study|No DMSA|57
5934295|NCT01391793|20526511|P1|Overall Study|No DMSA|73
5934296|NCT01391793|20526510|P2|Overall Study|Urine Culture Negative or Indeterminate|87
5934297|NCT01391793|20526511|P1|Overall Study|Urine Culture Negative or Indeterminate|71
5934298|NCT01391793|20526510|P2|Overall Study|Ineligible|0
5934299|NCT01391793|20526511|P1|Overall Study|Ineligible|3
5934300|NCT01391663|20526525|P4|Overall Study|Withdrawal by Subject|0
5934301|NCT01391663|20526526|P3|Overall Study|Withdrawal by Subject|1
5934302|NCT01391663|20526527|P2|Overall Study|Withdrawal by Subject|0
5934303|NCT01391663|20526528|P1|Overall Study|Withdrawal by Subject|0
5934304|NCT01391546|20526572|P2|Overall Study|History of Herpes Zoster (HZ)|0
5934305|NCT01391546|20526573|P1|Overall Study|History of Herpes Zoster (HZ)|1
5934306|NCT01391507|20526595|P4|Overall Study|Protocol Violation|2
5934307|NCT01391507|20526596|P3|Overall Study|Protocol Violation|1
5934308|NCT01391507|20526597|P2|Overall Study|Protocol Violation|1
5934309|NCT01391507|20526598|P1|Overall Study|Protocol Violation|2
5934310|NCT01391507|20526595|P4|Overall Study|Lack of Efficacy|1
5934311|NCT01391507|20526596|P3|Overall Study|Lack of Efficacy|0
5934312|NCT01391507|20526597|P2|Overall Study|Lack of Efficacy|0
5934313|NCT01391507|20526598|P1|Overall Study|Lack of Efficacy|0
5934314|NCT01391507|20526595|P4|Overall Study|Withdrawal by Subject|1
5934315|NCT01391507|20526596|P3|Overall Study|Withdrawal by Subject|1
5934316|NCT01391507|20526597|P2|Overall Study|Withdrawal by Subject|2
5934317|NCT01391507|20526598|P1|Overall Study|Withdrawal by Subject|1
5934318|NCT01391507|20526595|P4|Overall Study|Adverse Event|2
5934319|NCT01391507|20526596|P3|Overall Study|Adverse Event|2
5934320|NCT01391507|20526597|P2|Overall Study|Adverse Event|1
5934321|NCT01391507|20526598|P1|Overall Study|Adverse Event|1
5934322|NCT01391507|20526595|P4|Overall Study|Death|1
5934323|NCT01391507|20526596|P3|Overall Study|Death|0
5934324|NCT01391507|20526597|P2|Overall Study|Death|0
5934325|NCT01391507|20526598|P1|Overall Study|Death|0
5934326|NCT01391130|20526749|P2|Overall Study|Did not Receive Drug|1
5934327|NCT01391130|20526750|P1|Overall Study|Did not Receive Drug|1
5934328|NCT01391130|20526749|P2|Overall Study|Physician Decision|3
5934329|NCT01391130|20526750|P1|Overall Study|Physician Decision|2
5934330|NCT01391130|20526749|P2|Overall Study|Withdrawal by Subject|2
5934331|NCT01391130|20526750|P1|Overall Study|Withdrawal by Subject|3
5934332|NCT01391000|20526807|P2|Overall Study|Lost to Follow-up|0
5934333|NCT01391000|20526808|P1|Overall Study|Lost to Follow-up|2
5934334|NCT01390948|20526821|P3|Overall Study|Death during follow-up|1
5934335|NCT01390948|20526822|P2|Overall Study|Death during follow-up|11
5934336|NCT01390948|20526823|P1|Overall Study|Death during follow-up|10
5934337|NCT01390948|20526821|P3|Overall Study|Progressive Disease|0
5934338|NCT01390948|20526822|P2|Overall Study|Progressive Disease|5
5934339|NCT01390948|20526823|P1|Overall Study|Progressive Disease|2
5934340|NCT01390948|20526821|P3|Overall Study|Withdrew consent|0
5934341|NCT01390948|20526822|P2|Overall Study|Withdrew consent|2
5934342|NCT01390948|20526823|P1|Overall Study|Withdrew consent|2
5934343|NCT01390948|20526821|P3|Overall Study|End of Study|0
5934344|NCT01390948|20526822|P2|Overall Study|End of Study|0
5934345|NCT01390948|20526823|P1|Overall Study|End of Study|1
5934346|NCT01390857|20526891|P1|Overall Study|No Visit after the First Visit|7
5934347|NCT01390857|20526891|P1|Overall Study|Lost to Follow-up|1
5934348|NCT01390857|20526891|P1|Overall Study|Protocol Violation|2
5934349|NCT01390844|20526902|P4|Follow-Up Phase|Non-Medical Reasons|0
5934350|NCT01390844|20526903|P3|Follow-Up Phase|Non-Medical Reasons|1
5934351|NCT01390844|20526904|P2|Follow-Up Phase|Non-Medical Reasons|1
5934352|NCT01390844|20526905|P1|Follow-Up Phase|Non-Medical Reasons|1
5934353|NCT01390844|20526902|P4|Treatment Phase|Non-GCP Compliant|3
5934354|NCT01390844|20526903|P3|Treatment Phase|Non-GCP Compliant|10
5934355|NCT01390844|20526904|P2|Treatment Phase|Non-GCP Compliant|0
5934356|NCT01390844|20526905|P1|Treatment Phase|Non-GCP Compliant|0
5934357|NCT01390844|20526902|P4|Treatment Phase|Non-Medical Reasons|1
5934358|NCT01390844|20526903|P3|Treatment Phase|Non-Medical Reasons|8
5934359|NCT01390844|20526904|P2|Treatment Phase|Non-Medical Reasons|1
5934360|NCT01390844|20526905|P1|Treatment Phase|Non-Medical Reasons|5
5934361|NCT01390844|20526902|P4|Treatment Phase|Treatment Failure|13
5934362|NCT01390844|20526903|P3|Treatment Phase|Treatment Failure|10
5934363|NCT01390844|20526904|P2|Treatment Phase|Treatment Failure|25
5934364|NCT01390844|20526905|P1|Treatment Phase|Treatment Failure|23
5934365|NCT01390844|20526902|P4|Treatment Phase|Adverse Event|2
5934366|NCT01390844|20526903|P3|Treatment Phase|Adverse Event|3
5934367|NCT01390844|20526904|P2|Treatment Phase|Adverse Event|2
5934368|NCT01390844|20526905|P1|Treatment Phase|Adverse Event|12
5934369|NCT01390779|20527232|P1|Overall Study|Physician Decision|1
5934370|NCT01390649|20527237|P1|Overall Study|Physician Decision|1
5934371|NCT01390584|20527244|P3|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|1
5934372|NCT01390584|20527245|P2|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|0
5934373|NCT01390584|20527246|P1|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|0
5934374|NCT01390441|20527268|P5|Extension Period|Protocol Violation|0
5934375|NCT01390441|20527269|P4|Extension Period|Protocol Violation|1
5934376|NCT01390441|20527270|P3|Extension Period|Protocol Violation|0
5934377|NCT01390441|20527271|P2|Extension Period|Protocol Violation|1
5934378|NCT01390441|20527272|P1|Extension Period|Protocol Violation|3
5934379|NCT01390441|20527268|P5|Treatment Period|Lost to Follow-up|0
5934380|NCT01390441|20527269|P4|Treatment Period|Lost to Follow-up|0
5934381|NCT01390441|20527270|P3|Treatment Period|Lost to Follow-up|0
5934382|NCT01390441|20527271|P2|Treatment Period|Lost to Follow-up|0
5934383|NCT01390441|20527272|P1|Treatment Period|Lost to Follow-up|1
5934384|NCT01390441|20527268|P5|Treatment Period|Withdrawal by Subject|1
5934385|NCT01390441|20527269|P4|Treatment Period|Withdrawal by Subject|0
5934386|NCT01390441|20527270|P3|Treatment Period|Withdrawal by Subject|1
5934387|NCT01390441|20527271|P2|Treatment Period|Withdrawal by Subject|0
5934388|NCT01390441|20527272|P1|Treatment Period|Withdrawal by Subject|0
5934389|NCT01390441|20527268|P5|Treatment Period|Adverse Event|2
5934390|NCT01390441|20527269|P4|Treatment Period|Adverse Event|1
5934391|NCT01390441|20527270|P3|Treatment Period|Adverse Event|1
5934392|NCT01390441|20527271|P2|Treatment Period|Adverse Event|0
5934393|NCT01390441|20527272|P1|Treatment Period|Adverse Event|0
5934394|NCT01390441|20527268|P5|Treatment Period|Unknown due to early stopping of study|7
5934395|NCT01390441|20527269|P4|Treatment Period|Unknown due to early stopping of study|11
5934396|NCT01390441|20527270|P3|Treatment Period|Unknown due to early stopping of study|8
5934397|NCT01390441|20527271|P2|Treatment Period|Unknown due to early stopping of study|0
5934398|NCT01390441|20527272|P1|Treatment Period|Unknown due to early stopping of study|0
5934399|NCT01390441|20527268|P5|Treatment Period|Lack of Efficacy|1
5934400|NCT01390441|20527269|P4|Treatment Period|Lack of Efficacy|0
5934401|NCT01390441|20527270|P3|Treatment Period|Lack of Efficacy|0
5934402|NCT01390441|20527271|P2|Treatment Period|Lack of Efficacy|0
5934403|NCT01390441|20527272|P1|Treatment Period|Lack of Efficacy|0
5934404|NCT01390441|20527268|P5|Treatment Period|Physician Decision|0
5934405|NCT01390441|20527269|P4|Treatment Period|Physician Decision|1
5934406|NCT01390441|20527270|P3|Treatment Period|Physician Decision|0
5934407|NCT01390441|20527271|P2|Treatment Period|Physician Decision|0
5934408|NCT01390441|20527272|P1|Treatment Period|Physician Decision|0
5934409|NCT01390441|20527268|P5|Treatment Period|Protocol Violation|0
5934410|NCT01390441|20527269|P4|Treatment Period|Protocol Violation|0
5934411|NCT01390441|20527270|P3|Treatment Period|Protocol Violation|0
5934412|NCT01390441|20527271|P2|Treatment Period|Protocol Violation|1
5934413|NCT01390441|20527272|P1|Treatment Period|Protocol Violation|0
5934414|NCT01390428|20527337|P6|Overall Study|Withdrawal by Subject|0
5934415|NCT01390428|20527338|P5|Overall Study|Withdrawal by Subject|0
5934416|NCT01390428|20527339|P4|Overall Study|Withdrawal by Subject|0
5934417|NCT01390428|20527340|P3|Overall Study|Withdrawal by Subject|1
5934418|NCT01390428|20527341|P2|Overall Study|Withdrawal by Subject|0
5934419|NCT01390428|20527342|P1|Overall Study|Withdrawal by Subject|0
5934420|NCT01390428|20527337|P6|Overall Study|Elective Surgery|0
5934421|NCT01390428|20527338|P5|Overall Study|Elective Surgery|1
5934422|NCT01390428|20527339|P4|Overall Study|Elective Surgery|0
5934423|NCT01390428|20527340|P3|Overall Study|Elective Surgery|0
5934424|NCT01390428|20527341|P2|Overall Study|Elective Surgery|0
5934425|NCT01390428|20527342|P1|Overall Study|Elective Surgery|0
5934426|NCT01390402|20527405|P1|Overall Study|Disease Progression|4
5934427|NCT01390402|20527405|P1|Overall Study|Death|1
5934428|NCT01390389|20527411|P2|Overall Study|Screen Fail|1
5934429|NCT01390389|20527412|P1|Overall Study|Screen Fail|2
5934430|NCT01390389|20527411|P2|Overall Study|Withdrawal by Subject|0
5934431|NCT01390389|20527412|P1|Overall Study|Withdrawal by Subject|2
5934432|NCT01390298|20527422|P1|Overall Study|Surgery cancelled|1
5934433|NCT01390298|20527422|P1|Overall Study|Lost to Follow-up|7
5934434|NCT01390298|20527422|P1|Overall Study|Withdrawal by Subject|14
5934435|NCT01390298|20527422|P1|Overall Study|long term ICU admission|1
5934436|NCT01390298|20527422|P1|Overall Study|Death|1
5934437|NCT01390272|20527428|P2|Overall Study|Patient moved, no longer eligible|8
5934438|NCT01390272|20527429|P1|Overall Study|Patient moved, no longer eligible|5
5934439|NCT01390272|20527428|P2|Overall Study|Withdrawal by Subject|5
5934440|NCT01390272|20527429|P1|Overall Study|Withdrawal by Subject|9
5934441|NCT01390272|20527428|P2|Overall Study|Death|2
5934442|NCT01390272|20527429|P1|Overall Study|Death|3
5934443|NCT01390220|20527497|P3|Comparative Phase|Withdrawal by Subject|0
5934444|NCT01390220|20527498|P2|Comparative Phase|Withdrawal by Subject|1
5934445|NCT01390220|20527499|P1|Comparative Phase|Withdrawal by Subject|0
5934446|NCT01390220|20527497|P3|Test Dose Phase|Logistical|0
5934447|NCT01390220|20527498|P2|Test Dose Phase|Logistical|0
5934448|NCT01390220|20527499|P1|Test Dose Phase|Logistical|6
5934449|NCT01390220|20527497|P3|Test Dose Phase|Noncompliance|0
5934450|NCT01390220|20527498|P2|Test Dose Phase|Noncompliance|0
5934451|NCT01390220|20527499|P1|Test Dose Phase|Noncompliance|2
5934452|NCT01390220|20527497|P3|Test Dose Phase|Caregiver no longer available|0
5934453|NCT01390220|20527498|P2|Test Dose Phase|Caregiver no longer available|0
5934454|NCT01390220|20527499|P1|Test Dose Phase|Caregiver no longer available|5
5934455|NCT01390220|20527497|P3|Test Dose Phase|Study/Site closure|0
5934456|NCT01390220|20527498|P2|Test Dose Phase|Study/Site closure|0
5934457|NCT01390220|20527499|P1|Test Dose Phase|Study/Site closure|6
5934458|NCT01390220|20527497|P3|Test Dose Phase|No treated seizure cluster episode|0
5934459|NCT01390220|20527498|P2|Test Dose Phase|No treated seizure cluster episode|0
5934460|NCT01390220|20527499|P1|Test Dose Phase|No treated seizure cluster episode|37
5934461|NCT01390220|20527497|P3|Test Dose Phase|Protocol Violation|0
5934462|NCT01390220|20527498|P2|Test Dose Phase|Protocol Violation|0
5934463|NCT01390220|20527499|P1|Test Dose Phase|Protocol Violation|8
5934464|NCT01390220|20527497|P3|Test Dose Phase|Lost to Follow-up|0
5934465|NCT01390220|20527498|P2|Test Dose Phase|Lost to Follow-up|0
5934466|NCT01390220|20527499|P1|Test Dose Phase|Lost to Follow-up|2
5934467|NCT01390220|20527497|P3|Test Dose Phase|Withdrawal by Subject|0
5934468|NCT01390220|20527498|P2|Test Dose Phase|Withdrawal by Subject|0
5934469|NCT01390220|20527499|P1|Test Dose Phase|Withdrawal by Subject|8
5934470|NCT01390220|20527497|P3|Test Dose Phase|Adverse Event|0
5934471|NCT01390220|20527498|P2|Test Dose Phase|Adverse Event|0
5934472|NCT01390220|20527499|P1|Test Dose Phase|Adverse Event|17
5934473|NCT01390181|20527514|P1|Overall Study|Study Terminated due to Low Accrual|3
5934474|NCT01390181|20527514|P1|Overall Study|Lost to Follow-up|1
5934475|NCT01390038|20527527|P1|Overall Study|Simpliciti System Removal|2
5934476|NCT01390038|20527527|P1|Overall Study|Withdrawal by Subject|4
5934477|NCT01390038|20527527|P1|Overall Study|Lost to Follow-up|1
5934478|NCT01390038|20527527|P1|Overall Study|Death|1
5934479|NCT01389973|20527537|P1|Overall Study|Other|10
5934480|NCT01389973|20527537|P1|Overall Study|Trial Stopped by Sponsor|9
5934481|NCT01389973|20527537|P1|Overall Study|Lost to Follow-up|1
5934482|NCT01389882|20527547|P2|Overall Study|Withdrawal by Subject|1
5934483|NCT01389882|20527548|P1|Overall Study|Withdrawal by Subject|0
5934484|NCT01389882|20527547|P2|Overall Study|Respiratory rate > 80/min during study|3
5934485|NCT01389882|20527548|P1|Overall Study|Respiratory rate > 80/min during study|1
5934486|NCT01389817|20527636|P2|Overall Study|Withdrawal by Subject|0
5934487|NCT01389817|20527637|P1|Overall Study|Withdrawal by Subject|2
5934488|NCT01389817|20527636|P2|Overall Study|Lost to Follow-up|0
5934489|NCT01389817|20527637|P1|Overall Study|Lost to Follow-up|1
5934490|NCT01389817|20527636|P2|Overall Study|Physician Decision|0
5934491|NCT01389817|20527637|P1|Overall Study|Physician Decision|1
5934492|NCT01389752|20527654|P2|Study Period 2|Sponsor decision|0
5934493|NCT01389752|20527655|P1|Study Period 2|Sponsor decision|1
5934494|NCT01389752|20527654|P2|Study Period 1|Sponsor decision|2
5934495|NCT01389752|20527655|P1|Study Period 1|Sponsor decision|0
5934496|NCT01389596|20527668|P3|Overall Study|Other Unspecified|0
5934497|NCT01389596|20527669|P2|Overall Study|Other Unspecified|1
5934498|NCT01389596|20527670|P1|Overall Study|Other Unspecified|2
5934499|NCT01389596|20527668|P3|Overall Study|Death|0
5934500|NCT01389596|20527669|P2|Overall Study|Death|1
5934501|NCT01389596|20527670|P1|Overall Study|Death|0
5934502|NCT01389596|20527668|P3|Overall Study|Adverse Event|0
5934503|NCT01389596|20527669|P2|Overall Study|Adverse Event|4
5934504|NCT01389596|20527670|P1|Overall Study|Adverse Event|1
5934505|NCT01389596|20527668|P3|Overall Study|Insufficient Clinical Response|5
5934506|NCT01389596|20527669|P2|Overall Study|Insufficient Clinical Response|4
5934507|NCT01389596|20527670|P1|Overall Study|Insufficient Clinical Response|3
5934508|NCT01389596|20527668|P3|Overall Study|Withdrawal by Subject|2
5934509|NCT01389596|20527669|P2|Overall Study|Withdrawal by Subject|2
5934510|NCT01389596|20527670|P1|Overall Study|Withdrawal by Subject|1
5934511|NCT01389596|20527668|P3|Overall Study|Protocol Violation|3
5934512|NCT01389596|20527669|P2|Overall Study|Protocol Violation|4
5934513|NCT01389596|20527670|P1|Overall Study|Protocol Violation|3
5934514|NCT01389323|20527729|P1|Follow-up Period (up to 48 Weeks)|Other|3
5934515|NCT01389323|20527729|P1|Follow-up Period (up to 48 Weeks)|Follow-up no longer needed per protocol|2
5934516|NCT01389323|20527729|P1|Follow-up Period (up to 48 Weeks)|Lost to Follow-up|22
5934517|NCT01389323|20527729|P1|Follow-up Period (up to 48 Weeks)|Withdrawal by Subject|10
5934518|NCT01389323|20527729|P1|Treatment Period (up to 48 Weeks)|Did not meet study criteria|2
5934519|NCT01389323|20527729|P1|Treatment Period (up to 48 Weeks)|Poor/non-compliance|5
5934520|NCT01389323|20527729|P1|Treatment Period (up to 48 Weeks)|Lost to Follow-up|10
5934521|NCT01389323|20527729|P1|Treatment Period (up to 48 Weeks)|Withdrawal by Subject|7
5934522|NCT01389323|20527729|P1|Treatment Period (up to 48 Weeks)|Participant's request to discontinue|6
5934523|NCT01389323|20527729|P1|Treatment Period (up to 48 Weeks)|Adverse Event|24
5934524|NCT01389323|20527729|P1|Treatment Period (up to 48 Weeks)|Lack of Efficacy|41
5934525|NCT01389258|20527786|P1|Overall Study|Lost to Follow-up|5
5934526|NCT01389245|20527796|P1|Overall Study|Withdrawal by Subject|2
5934527|NCT01389245|20527796|P1|Overall Study|Lost to Follow-up|3
5934528|NCT01389245|20527796|P1|Overall Study|Protocol Violation|10
5934529|NCT01389128|20527806|P2|Overall Study|Intolerance to procedure|2
5934530|NCT01389128|20527807|P1|Overall Study|Intolerance to procedure|0
5934531|NCT01389128|20527806|P2|Overall Study|Rapid labor evolution|2
5934532|NCT01389128|20527807|P1|Overall Study|Rapid labor evolution|3
5934533|NCT01389128|20527806|P2|Overall Study|Cervix dilation stop|2
5934534|NCT01389128|20527807|P1|Overall Study|Cervix dilation stop|1
5934535|NCT01389128|20527806|P2|Overall Study|Fetal distress|0
5934536|NCT01389128|20527807|P1|Overall Study|Fetal distress|1
5934537|NCT01389102|20527831|P6|Overall Study|Investigator Judgement|0
5934538|NCT01389102|20527832|P5|Overall Study|Investigator Judgement|0
5934539|NCT01389102|20527833|P4|Overall Study|Investigator Judgement|0
5934540|NCT01389102|20527834|P3|Overall Study|Investigator Judgement|0
5934541|NCT01389102|20527835|P2|Overall Study|Investigator Judgement|1
5934542|NCT01389102|20527836|P1|Overall Study|Investigator Judgement|0
5934543|NCT01389102|20527831|P6|Overall Study|Unavailable due to husband's illness|0
5934544|NCT01389102|20527832|P5|Overall Study|Unavailable due to husband's illness|0
5934545|NCT01389102|20527833|P4|Overall Study|Unavailable due to husband's illness|0
5934546|NCT01389102|20527834|P3|Overall Study|Unavailable due to husband's illness|0
5934547|NCT01389102|20527835|P2|Overall Study|Unavailable due to husband's illness|1
5934548|NCT01389102|20527836|P1|Overall Study|Unavailable due to husband's illness|0
5934549|NCT01389102|20527831|P6|Overall Study|Subject Moved|0
5934550|NCT01389102|20527832|P5|Overall Study|Subject Moved|0
5934551|NCT01389102|20527833|P4|Overall Study|Subject Moved|0
5934552|NCT01389102|20527834|P3|Overall Study|Subject Moved|1
5934553|NCT01389102|20527835|P2|Overall Study|Subject Moved|0
5934554|NCT01389102|20527836|P1|Overall Study|Subject Moved|2
5934555|NCT01389102|20527831|P6|Overall Study|Subject Traveling Out of Country|0
5934556|NCT01389102|20527832|P5|Overall Study|Subject Traveling Out of Country|0
5934557|NCT01389102|20527833|P4|Overall Study|Subject Traveling Out of Country|1
5934558|NCT01389102|20527834|P3|Overall Study|Subject Traveling Out of Country|0
5934559|NCT01389102|20527835|P2|Overall Study|Subject Traveling Out of Country|0
5934560|NCT01389102|20527836|P1|Overall Study|Subject Traveling Out of Country|0
5934561|NCT01389102|20527831|P6|Overall Study|Withdrawal by Subject|3
5934562|NCT01389102|20527832|P5|Overall Study|Withdrawal by Subject|3
5934563|NCT01389102|20527833|P4|Overall Study|Withdrawal by Subject|2
5934564|NCT01389102|20527834|P3|Overall Study|Withdrawal by Subject|9
5934565|NCT01389102|20527835|P2|Overall Study|Withdrawal by Subject|4
5934566|NCT01389102|20527836|P1|Overall Study|Withdrawal by Subject|7
5934567|NCT01389102|20527831|P6|Overall Study|Protocol Violation|1
5934568|NCT01389102|20527832|P5|Overall Study|Protocol Violation|1
5934569|NCT01389102|20527833|P4|Overall Study|Protocol Violation|0
5934570|NCT01389102|20527834|P3|Overall Study|Protocol Violation|3
5934571|NCT01389102|20527835|P2|Overall Study|Protocol Violation|0
5934572|NCT01389102|20527836|P1|Overall Study|Protocol Violation|0
5934573|NCT01389102|20527831|P6|Overall Study|Lost to Follow-up|1
5934574|NCT01389102|20527832|P5|Overall Study|Lost to Follow-up|4
5934575|NCT01389102|20527833|P4|Overall Study|Lost to Follow-up|2
5934576|NCT01389102|20527834|P3|Overall Study|Lost to Follow-up|1
5934577|NCT01389102|20527835|P2|Overall Study|Lost to Follow-up|1
5934578|NCT01389102|20527836|P1|Overall Study|Lost to Follow-up|4
5934579|NCT01389102|20527831|P6|Overall Study|Hurricane Katrina|1
5934580|NCT01389102|20527832|P5|Overall Study|Hurricane Katrina|3
5934581|NCT01389102|20527833|P4|Overall Study|Hurricane Katrina|0
5934582|NCT01389102|20527834|P3|Overall Study|Hurricane Katrina|3
5934583|NCT01389102|20527835|P2|Overall Study|Hurricane Katrina|2
5934584|NCT01389102|20527836|P1|Overall Study|Hurricane Katrina|4
5934585|NCT01389102|20527831|P6|Overall Study|Adverse Event|2
5934586|NCT01389102|20527832|P5|Overall Study|Adverse Event|2
5934587|NCT01389102|20527833|P4|Overall Study|Adverse Event|2
5934588|NCT01389102|20527834|P3|Overall Study|Adverse Event|2
5934589|NCT01389102|20527835|P2|Overall Study|Adverse Event|3
5934590|NCT01389102|20527836|P1|Overall Study|Adverse Event|1
5934591|NCT01388985|20527866|P2|Overall Study|Error of nurse|1
5934592|NCT01388985|20527867|P1|Overall Study|Error of nurse|5
5934593|NCT01388985|20527866|P2|Overall Study|Other (no reason)|1
5934594|NCT01388985|20527867|P1|Overall Study|Other (no reason)|0
5934595|NCT01388985|20527866|P2|Overall Study|Subject unavailable|1
5934596|NCT01388985|20527867|P1|Overall Study|Subject unavailable|1
5934597|NCT01388985|20527866|P2|Overall Study|Withdrawal by Subject|4
5934598|NCT01388985|20527867|P1|Overall Study|Withdrawal by Subject|13
5934599|NCT01388985|20527866|P2|Overall Study|Lost to Follow-up|30
5934600|NCT01388985|20527867|P1|Overall Study|Lost to Follow-up|30
5934601|NCT01388985|20527866|P2|Overall Study|Death|1
5934602|NCT01388985|20527867|P1|Overall Study|Death|0
5934603|NCT01388907|20527931|P2|Overall Study|Adverse Event|0
5934604|NCT01388907|20527932|P1|Overall Study|Adverse Event|2
5934605|NCT01388816|20527948|P4|Overall Study|Protocol Violation|0
5934606|NCT01388816|20527949|P3|Overall Study|Protocol Violation|2
5934607|NCT01388816|20527950|P2|Overall Study|Protocol Violation|0
5934608|NCT01388816|20527951|P1|Overall Study|Protocol Violation|0
5934609|NCT01388816|20527948|P4|Overall Study|Withdrawal by Subject|0
5934610|NCT01388816|20527949|P3|Overall Study|Withdrawal by Subject|1
5934611|NCT01388816|20527950|P2|Overall Study|Withdrawal by Subject|1
5934612|NCT01388816|20527951|P1|Overall Study|Withdrawal by Subject|2
5934613|NCT01388816|20527948|P4|Overall Study|Lost to Follow-up|0
5934614|NCT01388816|20527949|P3|Overall Study|Lost to Follow-up|0
5934615|NCT01388816|20527950|P2|Overall Study|Lost to Follow-up|1
5934616|NCT01388816|20527951|P1|Overall Study|Lost to Follow-up|0
5934617|NCT01388816|20527948|P4|Overall Study|Adverse Event|0
5934618|NCT01388816|20527949|P3|Overall Study|Adverse Event|0
5934619|NCT01388816|20527950|P2|Overall Study|Adverse Event|2
5934620|NCT01388816|20527951|P1|Overall Study|Adverse Event|0
5934621|NCT01388790|20527980|P1|Overall Study|Ongoing at data cut-off date|8
5934622|NCT01388647|20527991|P2|Overall Study|Adverse Event|2
5934623|NCT01388647|20527992|P1|Overall Study|Adverse Event|1
5934624|NCT01388543|20528005|P2|Day 14|Adverse Event|4
5934625|NCT01388543|20528006|P1|Day 14|Adverse Event|1
5934626|NCT01388530|20528012|P1|Overall Study|Lost to Follow-up|5
5934627|NCT01388491|20528021|P2|Overall Study|Pregnancy|0
5934628|NCT01388491|20528022|P1|Overall Study|Pregnancy|1
5934629|NCT01388491|20528021|P2|Overall Study|Noncompliance|0
5934630|NCT01388491|20528022|P1|Overall Study|Noncompliance|2
5934631|NCT01388491|20528021|P2|Overall Study|Protocol Violation|0
5934632|NCT01388491|20528022|P1|Overall Study|Protocol Violation|2
5934633|NCT01388491|20528021|P2|Overall Study|Lost to Follow-up|3
5934634|NCT01388491|20528022|P1|Overall Study|Lost to Follow-up|4
5934635|NCT01388491|20528021|P2|Overall Study|Withdrawal by Subject|10
5934636|NCT01388491|20528022|P1|Overall Study|Withdrawal by Subject|6
5934637|NCT01388491|20528021|P2|Overall Study|Sponsor Request|7
5934638|NCT01388491|20528022|P1|Overall Study|Sponsor Request|9
5934639|NCT01388491|20528021|P2|Overall Study|Adverse Event|9
5934640|NCT01388491|20528022|P1|Overall Study|Adverse Event|10
5934641|NCT01388361|20528057|P3|Overall Study|Unclassified|1
5934642|NCT01388361|20528058|P2|Overall Study|Unclassified|0
5934643|NCT01388361|20528059|P1|Overall Study|Unclassified|0
5934644|NCT01388361|20528057|P3|Overall Study|Withdrawal criteria|10
5934645|NCT01388361|20528058|P2|Overall Study|Withdrawal criteria|7
5934646|NCT01388361|20528059|P1|Overall Study|Withdrawal criteria|12
5934647|NCT01388361|20528057|P3|Overall Study|Protocol Violation|2
5934648|NCT01388361|20528058|P2|Overall Study|Protocol Violation|0
5934649|NCT01388361|20528059|P1|Overall Study|Protocol Violation|0
5934650|NCT01388361|20528057|P3|Overall Study|Adverse Event|1
5934651|NCT01388361|20528058|P2|Overall Study|Adverse Event|5
5934652|NCT01388361|20528059|P1|Overall Study|Adverse Event|0
5934653|NCT01388335|20528076|P1|Safety Extension|Progressive Disease|7
5934654|NCT01388335|20528076|P1|Period 2|Sponsor Decision|1
5934655|NCT01388335|20528076|P1|Period 2|Progressive Disease|2
5934656|NCT01388335|20528076|P1|Period 1|Progressive Disease|1
5934657|NCT01388166|20528103|P1|Overall Study|Others than specified above|13
5934658|NCT01388166|20528103|P1|Overall Study|Lost to Follow-up|30
5934659|NCT01388166|20528103|P1|Overall Study|Adverse Event|16
5934660|NCT01387789|20528406|P1|Overall Study|Lost to Follow-up|1
5934661|NCT01387789|20528406|P1|Overall Study|Lack of Efficacy|2
5934662|NCT01387789|20528406|P1|Overall Study|Adverse Event|5
5934663|NCT01387737|20528420|P2|Overall Study|Clearly not eligible for the study|3
5934664|NCT01387737|20528421|P1|Overall Study|Clearly not eligible for the study|1
5934665|NCT01387737|20528420|P2|Overall Study|Withdrawal by Subject|31
5934666|NCT01387737|20528421|P1|Overall Study|Withdrawal by Subject|27
5934667|NCT01387737|20528420|P2|Overall Study|Physician Decision|10
5934668|NCT01387737|20528421|P1|Overall Study|Physician Decision|3
5934669|NCT01387737|20528420|P2|Overall Study|Lack of Efficacy|0
5934670|NCT01387737|20528421|P1|Overall Study|Lack of Efficacy|1
5934671|NCT01387737|20528420|P2|Overall Study|Adverse Event|30
5934672|NCT01387737|20528421|P1|Overall Study|Adverse Event|20
5934673|NCT01387594|20528455|P2|Overall Study|Lost to Follow-up|1
5934674|NCT01387594|20528456|P1|Overall Study|Lost to Follow-up|0
5934675|NCT01387594|20528455|P2|Overall Study|Withdrawal by Subject|2
5934676|NCT01387594|20528456|P1|Overall Study|Withdrawal by Subject|0
5934677|NCT01387542|20528484|P1|Overall Study|Lost to Follow-up|1
5934678|NCT01387542|20528484|P1|Overall Study|Non-compliant|1
5934679|NCT01387542|20528484|P1|Overall Study|Insufficient response|1
5934680|NCT01387542|20528484|P1|Overall Study|Changed diagnosis|1
5934681|NCT01387542|20528484|P1|Overall Study|Withdrawal by Subject|1
5934682|NCT01387542|20528484|P1|Overall Study|Adverse Event|3
5934683|NCT01387516|20528495|P4|Overall Study|Death|1
5934684|NCT01387516|20528496|P3|Overall Study|Death|0
5934685|NCT01387516|20528497|P2|Overall Study|Death|0
5934686|NCT01387516|20528498|P1|Overall Study|Death|0
5934687|NCT01387516|20528495|P4|Overall Study|Withdrawal by Subject|0
5934688|NCT01387516|20528496|P3|Overall Study|Withdrawal by Subject|2
5934689|NCT01387516|20528497|P2|Overall Study|Withdrawal by Subject|1
5934690|NCT01387516|20528498|P1|Overall Study|Withdrawal by Subject|1
5934691|NCT01387516|20528495|P4|Overall Study|Lost to Follow-up|3
5934692|NCT01387516|20528496|P3|Overall Study|Lost to Follow-up|2
5934693|NCT01387516|20528497|P2|Overall Study|Lost to Follow-up|4
5934694|NCT01387516|20528498|P1|Overall Study|Lost to Follow-up|4
5934695|NCT01387347|20528531|P2|Overall Study|Lost to Follow-up|1
5934696|NCT01387347|20528532|P1|Overall Study|Lost to Follow-up|2
5934697|NCT01387282|20528544|P2|Overall Study|Lost to Follow-up|1
5934698|NCT01387282|20528545|P1|Overall Study|Lost to Follow-up|4
5934699|NCT01387282|20528544|P2|Overall Study|Study drug-related AE|2
5934700|NCT01387282|20528545|P1|Overall Study|Study drug-related AE|2
5934701|NCT01387282|20528544|P2|Overall Study|Withdrawal by patient|23
5934702|NCT01387282|20528545|P1|Overall Study|Withdrawal by patient|33
5934703|NCT01387282|20528544|P2|Overall Study|Unrelated AE|4
5934704|NCT01387282|20528545|P1|Overall Study|Unrelated AE|6
5934705|NCT01387282|20528544|P2|Overall Study|Other|1
5934706|NCT01387282|20528545|P1|Overall Study|Other|5
5934707|NCT01387282|20528544|P2|Overall Study|Death|16
5934708|NCT01387282|20528545|P1|Overall Study|Death|47
5934709|NCT01387269|20528561|P2|Overall Study|Lost to Follow-up|0
5934710|NCT01387269|20528562|P1|Overall Study|Lost to Follow-up|1
5934711|NCT01387269|20528561|P2|Overall Study|Study drug-related AE|0
5934712|NCT01387269|20528562|P1|Overall Study|Study drug-related AE|1
5934713|NCT01387269|20528561|P2|Overall Study|Withdrawal by patient|10
5934714|NCT01387269|20528562|P1|Overall Study|Withdrawal by patient|32
5934715|NCT01387269|20528561|P2|Overall Study|Unrelated AE|3
5934716|NCT01387269|20528562|P1|Overall Study|Unrelated AE|12
5934717|NCT01387269|20528561|P2|Overall Study|Other|7
5934718|NCT01387269|20528562|P1|Overall Study|Other|8
5934719|NCT01387269|20528561|P2|Overall Study|Death|20
5934720|NCT01387269|20528562|P1|Overall Study|Death|38
5934721|NCT01387230|20528579|P3|Overall Study|Withdrawal by Subject|0
5934722|NCT01387230|20528580|P2|Overall Study|Withdrawal by Subject|1
5934723|NCT01387230|20528581|P1|Overall Study|Withdrawal by Subject|4
5934724|NCT01387230|20528579|P3|Overall Study|Lost to Follow-up|1
5934725|NCT01387230|20528580|P2|Overall Study|Lost to Follow-up|0
5934726|NCT01387230|20528581|P1|Overall Study|Lost to Follow-up|0
5934727|NCT01387230|20528579|P3|Overall Study|Protocol-defined Stopping Criteria|5
5934728|NCT01387230|20528580|P2|Overall Study|Protocol-defined Stopping Criteria|0
5934729|NCT01387230|20528581|P1|Overall Study|Protocol-defined Stopping Criteria|6
5934730|NCT01387230|20528579|P3|Overall Study|Lack of Efficacy|4
5934731|NCT01387230|20528580|P2|Overall Study|Lack of Efficacy|5
5934732|NCT01387230|20528581|P1|Overall Study|Lack of Efficacy|8
5934733|NCT01387230|20528579|P3|Overall Study|Adverse Event|3
5934734|NCT01387230|20528580|P2|Overall Study|Adverse Event|1
5934735|NCT01387230|20528581|P1|Overall Study|Adverse Event|0
5934736|NCT01387074|20528627|P1|Overall Study|Lack of Efficacy|1
5934737|NCT01387074|20528627|P1|Overall Study|Lost to Follow-up|7
5934738|NCT01387022|20528640|P2|Overall Study|Lost to Follow-up|3
5934739|NCT01387022|20528641|P1|Overall Study|Lost to Follow-up|0
5934740|NCT01387022|20528640|P2|Overall Study|Death|1
5934741|NCT01387022|20528641|P1|Overall Study|Death|1
5934742|NCT01386970|20528670|P2|Overall Study|Adverse Event|1
5934743|NCT01386970|20528671|P1|Overall Study|Adverse Event|4
5934744|NCT01386970|20528670|P2|Overall Study|Withdrawal by Subject|1
5934745|NCT01386970|20528671|P1|Overall Study|Withdrawal by Subject|0
5934746|NCT01386944|20528679|P1|Overall Study|Unspecified reason|8
5934747|NCT01386944|20528679|P1|Overall Study|Lost to Follow-up|8
5934748|NCT01386944|20528679|P1|Overall Study|Lack of Efficacy|14
5934749|NCT01386944|20528679|P1|Overall Study|Adverse Event|26
5934750|NCT01386788|20528689|P1|Overall Study|Lost to Follow-up|2
5934751|NCT01386684|20528694|P1|Overall Study|Missing|3
5934752|NCT01386684|20528694|P1|Overall Study|Protocol Violation|4
5934753|NCT01386684|20528694|P1|Overall Study|Noncompliance|8
5934754|NCT01386684|20528694|P1|Overall Study|Adverse Event|20
5934755|NCT01386684|20528694|P1|Overall Study|Disease Progression|28
5934756|NCT01386684|20528694|P1|Overall Study|Alternative Therapy Required|37
5934757|NCT01386684|20528694|P1|Overall Study|Withdrawal of Consent|44
5934758|NCT01386684|20528694|P1|Overall Study|Death|47
5934759|NCT01386684|20528694|P1|Overall Study|Other|51
5934760|NCT01386684|20528694|P1|Overall Study|Lost to Follow-up|51
5934761|NCT01386658|20528735|P2|Initial Icatibant Exposure|Lack of adherence and poor compliance|3
5934762|NCT01386658|20528736|P1|Initial Icatibant Exposure|Lack of adherence and poor compliance|0
5934763|NCT01386658|20528735|P2|Initial Icatibant Exposure|Withdrawal by Subject|9
5934764|NCT01386658|20528736|P1|Initial Icatibant Exposure|Withdrawal by Subject|0
5934765|NCT01386645|20528802|P3|Overall Study|Withdrawal by Subject|1
5934766|NCT01386645|20528803|P2|Overall Study|Withdrawal by Subject|1
5934767|NCT01386645|20528804|P1|Overall Study|Withdrawal by Subject|0
5934768|NCT01386645|20528802|P3|Overall Study|Physician Decision|1
5934769|NCT01386645|20528803|P2|Overall Study|Physician Decision|0
5934770|NCT01386645|20528804|P1|Overall Study|Physician Decision|0
5934771|NCT01386606|20528833|P4|Overall Study|T levels too high|0
5934772|NCT01386606|20528834|P3|Overall Study|T levels too high|1
5934773|NCT01386606|20528835|P2|Overall Study|T levels too high|1
5934774|NCT01386606|20528836|P1|Overall Study|T levels too high|0
5934775|NCT01386606|20528833|P4|Overall Study|Unable to draw PK|0
5934776|NCT01386606|20528834|P3|Overall Study|Unable to draw PK|0
5934777|NCT01386606|20528835|P2|Overall Study|Unable to draw PK|0
5934778|NCT01386606|20528836|P1|Overall Study|Unable to draw PK|1
5934779|NCT01386606|20528833|P4|Overall Study|Subject incarcerated|0
5934780|NCT01386606|20528834|P3|Overall Study|Subject incarcerated|0
5934781|NCT01386606|20528835|P2|Overall Study|Subject incarcerated|1
5934782|NCT01386606|20528836|P1|Overall Study|Subject incarcerated|0
5934783|NCT01386606|20528833|P4|Overall Study|Lost to Follow-up|0
5934784|NCT01386606|20528834|P3|Overall Study|Lost to Follow-up|0
5934785|NCT01386606|20528835|P2|Overall Study|Lost to Follow-up|0
5934786|NCT01386606|20528836|P1|Overall Study|Lost to Follow-up|2
5934787|NCT01386606|20528833|P4|Overall Study|Protocol Violation|1
5934788|NCT01386606|20528834|P3|Overall Study|Protocol Violation|1
5934789|NCT01386606|20528835|P2|Overall Study|Protocol Violation|0
5934790|NCT01386606|20528836|P1|Overall Study|Protocol Violation|1
5934791|NCT01386606|20528833|P4|Overall Study|Withdrawal by Subject|0
5934792|NCT01386606|20528834|P3|Overall Study|Withdrawal by Subject|1
5934793|NCT01386606|20528835|P2|Overall Study|Withdrawal by Subject|1
5934794|NCT01386606|20528836|P1|Overall Study|Withdrawal by Subject|0
5934795|NCT01386606|20528833|P4|Overall Study|Adverse Event|0
5934796|NCT01386606|20528834|P3|Overall Study|Adverse Event|0
5934797|NCT01386606|20528835|P2|Overall Study|Adverse Event|1
5934798|NCT01386606|20528836|P1|Overall Study|Adverse Event|0
5934799|NCT01386554|20528867|P3|Overall Study|Reason not collected|0
5934800|NCT01386554|20528868|P2|Overall Study|Reason not collected|1
5934801|NCT01386554|20528869|P1|Overall Study|Reason not collected|0
5934802|NCT01386554|20528867|P3|Overall Study|Investigator discretion|1
5934803|NCT01386554|20528868|P2|Overall Study|Investigator discretion|0
5934804|NCT01386554|20528869|P1|Overall Study|Investigator discretion|0
5934805|NCT01386554|20528867|P3|Overall Study|Administration of live vaccines|0
5934806|NCT01386554|20528868|P2|Overall Study|Administration of live vaccines|1
5934807|NCT01386554|20528869|P1|Overall Study|Administration of live vaccines|0
5934808|NCT01386554|20528867|P3|Overall Study|Progressive disease|2
5934809|NCT01386554|20528868|P2|Overall Study|Progressive disease|2
5934810|NCT01386554|20528869|P1|Overall Study|Progressive disease|1
5934811|NCT01386554|20528867|P3|Overall Study|Adverse Event|2
5934812|NCT01386554|20528868|P2|Overall Study|Adverse Event|5
5934813|NCT01386554|20528869|P1|Overall Study|Adverse Event|2
5934814|NCT01386554|20528867|P3|Overall Study|Lost to Follow-up|1
5934815|NCT01386554|20528868|P2|Overall Study|Lost to Follow-up|0
5934816|NCT01386554|20528869|P1|Overall Study|Lost to Follow-up|0
5934817|NCT01386125|20528892|P2|Overall Study|Participant Leaving Country|0
5934818|NCT01386125|20528893|P1|Overall Study|Participant Leaving Country|1
5934819|NCT01386125|20528892|P2|Overall Study|Lack of Efficacy|1
5934820|NCT01386125|20528893|P1|Overall Study|Lack of Efficacy|0
5934821|NCT01386125|20528892|P2|Overall Study|Adverse Event|5
5934822|NCT01386125|20528893|P1|Overall Study|Adverse Event|2
5934823|NCT01386125|20528892|P2|Overall Study|Withdrawal by Subject|12
5934824|NCT01386125|20528893|P1|Overall Study|Withdrawal by Subject|13
5934825|NCT01386125|20528892|P2|Overall Study|Disease Progress|2
5934826|NCT01386125|20528893|P1|Overall Study|Disease Progress|1
5934827|NCT01386125|20528892|P2|Overall Study|Protocol Violation|7
5934828|NCT01386125|20528893|P1|Overall Study|Protocol Violation|5
5934829|NCT01386125|20528892|P2|Overall Study|Physician Decision|1
5934830|NCT01386125|20528893|P1|Overall Study|Physician Decision|0
5934831|NCT01386125|20528892|P2|Overall Study|Lost to Follow-up|9
5934832|NCT01386125|20528893|P1|Overall Study|Lost to Follow-up|3
5934833|NCT01386008|20528901|P1|Overall Study|Adverse Event|3
5934834|NCT01386008|20528901|P1|Overall Study|exited w/o incident /study discontinued|17
5934835|NCT01385995|20528910|P2|Period 1, 2 Months|Physician Decision|0
5934836|NCT01385995|20528911|P1|Period 1, 2 Months|Physician Decision|1
5934837|NCT01385748|20528928|P3|Overall Study|Adverse Event|1
5934838|NCT01385748|20528929|P2|Overall Study|Adverse Event|2
5934839|NCT01385748|20528930|P1|Overall Study|Adverse Event|4
5934840|NCT01385748|20528928|P3|Overall Study|Other|1
5934841|NCT01385748|20528929|P2|Overall Study|Other|7
5934842|NCT01385748|20528930|P1|Overall Study|Other|1
5934843|NCT01385748|20528928|P3|Overall Study|Noncompliance|6
5934844|NCT01385748|20528929|P2|Overall Study|Noncompliance|1
5934845|NCT01385748|20528930|P1|Overall Study|Noncompliance|3
5934846|NCT01385748|20528928|P3|Overall Study|Withdrawal by Subject|5
5934847|NCT01385748|20528929|P2|Overall Study|Withdrawal by Subject|4
5934848|NCT01385748|20528930|P1|Overall Study|Withdrawal by Subject|7
5934849|NCT01385566|20529015|P6|Overall Study|Withdrawal by Subject|0
5934850|NCT01385566|20529016|P5|Overall Study|Withdrawal by Subject|0
5934851|NCT01385566|20529017|P4|Overall Study|Withdrawal by Subject|1
5934852|NCT01385566|20529018|P3|Overall Study|Withdrawal by Subject|0
5934853|NCT01385566|20529019|P2|Overall Study|Withdrawal by Subject|0
5934854|NCT01385566|20529020|P1|Overall Study|Withdrawal by Subject|0
5934855|NCT01385566|20529015|P6|Overall Study|Lost to Follow-up|0
5934856|NCT01385566|20529016|P5|Overall Study|Lost to Follow-up|0
5934857|NCT01385566|20529017|P4|Overall Study|Lost to Follow-up|0
5934858|NCT01385566|20529018|P3|Overall Study|Lost to Follow-up|0
5934859|NCT01385566|20529019|P2|Overall Study|Lost to Follow-up|0
5934860|NCT01385566|20529020|P1|Overall Study|Lost to Follow-up|1
5934861|NCT01385371|20529074|P2|Overall Study|Administrative|2
5934862|NCT01385371|20529075|P1|Overall Study|Administrative|2
5934863|NCT01385371|20529074|P2|Overall Study|Protocol Violation|21
5934864|NCT01385371|20529075|P1|Overall Study|Protocol Violation|25
5934865|NCT01385371|20529074|P2|Overall Study|Withdrawal by Subject|39
5934866|NCT01385371|20529075|P1|Overall Study|Withdrawal by Subject|52
5934867|NCT01385371|20529074|P2|Overall Study|Lost to Follow-up|16
5934868|NCT01385371|20529075|P1|Overall Study|Lost to Follow-up|16
5934869|NCT01385371|20529074|P2|Overall Study|Adverse Event|19
5934870|NCT01385371|20529075|P1|Overall Study|Adverse Event|54
5934871|NCT01385202|20529123|P1|Overall Study|Withdrawn|1
5934872|NCT01385202|20529123|P1|Overall Study|Not Eligible|11
5934873|NCT01385202|20529123|P1|Overall Study|Lost to Follow-up|6
5934874|NCT01385176|20529160|P2|6-18 Month All VNS Active|Heart Transplant|0
5934875|NCT01385176|20529161|P1|6-18 Month All VNS Active|Heart Transplant|1
5934876|NCT01385176|20529160|P2|6-18 Month All VNS Active|Withdrawal by Subject|0
5934877|NCT01385176|20529161|P1|6-18 Month All VNS Active|Withdrawal by Subject|2
5934878|NCT01385176|20529160|P2|6-18 Month All VNS Active|Physician Decision|1
5934879|NCT01385176|20529161|P1|6-18 Month All VNS Active|Physician Decision|0
5934880|NCT01385176|20529160|P2|6-18 Month All VNS Active|Death|2
5934881|NCT01385176|20529161|P1|6-18 Month All VNS Active|Death|1
5934882|NCT01385176|20529160|P2|Randomization Phase|Death|2
5934883|NCT01385176|20529161|P1|Randomization Phase|Death|1
5934884|NCT01385098|20529192|P1|Overall Study|Lost to Follow-up|4
5934885|NCT01385098|20529192|P1|Overall Study|Adverse Event|10
5934886|NCT01384877|20529214|P2|Treatment 2|Lost to Follow-up|2
5934887|NCT01384877|20529215|P1|Treatment 2|Lost to Follow-up|2
5934888|NCT01384760|20529241|P2|Overall Study|Protocol Violation|0
5934889|NCT01384760|20529242|P1|Overall Study|Protocol Violation|16
5934890|NCT01384760|20529241|P2|Overall Study|Lost to Follow-up|6
5934891|NCT01384760|20529242|P1|Overall Study|Lost to Follow-up|0
5934892|NCT01384734|20529255|P5|Overall Study|Physician Decision|0
5934893|NCT01384734|20529256|P4|Overall Study|Physician Decision|0
5934894|NCT01384734|20529257|P3|Overall Study|Physician Decision|0
5934895|NCT01384734|20529258|P2|Overall Study|Physician Decision|0
5934896|NCT01384734|20529259|P1|Overall Study|Physician Decision|1
5934897|NCT01384734|20529255|P5|Overall Study|Early termination|1
5934898|NCT01384734|20529256|P4|Overall Study|Early termination|0
5934899|NCT01384734|20529257|P3|Overall Study|Early termination|0
5934900|NCT01384734|20529258|P2|Overall Study|Early termination|0
5934901|NCT01384734|20529259|P1|Overall Study|Early termination|0
5934902|NCT01384734|20529255|P5|Overall Study|Adhesion problem|0
5934903|NCT01384734|20529256|P4|Overall Study|Adhesion problem|1
5934904|NCT01384734|20529257|P3|Overall Study|Adhesion problem|0
5934905|NCT01384734|20529258|P2|Overall Study|Adhesion problem|0
5934906|NCT01384734|20529259|P1|Overall Study|Adhesion problem|0
5934907|NCT01384734|20529255|P5|Overall Study|Missed End of treatment visit|0
5934908|NCT01384734|20529256|P4|Overall Study|Missed End of treatment visit|1
5934909|NCT01384734|20529257|P3|Overall Study|Missed End of treatment visit|0
5934910|NCT01384734|20529258|P2|Overall Study|Missed End of treatment visit|0
5934911|NCT01384734|20529259|P1|Overall Study|Missed End of treatment visit|0
5934912|NCT01384734|20529255|P5|Overall Study|As per Exclusion criteria|0
5934913|NCT01384734|20529256|P4|Overall Study|As per Exclusion criteria|0
5934914|NCT01384734|20529257|P3|Overall Study|As per Exclusion criteria|0
5934915|NCT01384734|20529258|P2|Overall Study|As per Exclusion criteria|1
5934916|NCT01384734|20529259|P1|Overall Study|As per Exclusion criteria|0
5934917|NCT01384734|20529255|P5|Overall Study|Prison|0
5934918|NCT01384734|20529256|P4|Overall Study|Prison|0
5934919|NCT01384734|20529257|P3|Overall Study|Prison|1
5934920|NCT01384734|20529258|P2|Overall Study|Prison|0
5934921|NCT01384734|20529259|P1|Overall Study|Prison|0
5934922|NCT01384734|20529255|P5|Overall Study|Unable to come back for visit|0
5934923|NCT01384734|20529256|P4|Overall Study|Unable to come back for visit|1
5934924|NCT01384734|20529257|P3|Overall Study|Unable to come back for visit|1
5934925|NCT01384734|20529258|P2|Overall Study|Unable to come back for visit|0
5934926|NCT01384734|20529259|P1|Overall Study|Unable to come back for visit|1
5934927|NCT01384734|20529255|P5|Overall Study|Investigator relocating|1
5934928|NCT01384734|20529256|P4|Overall Study|Investigator relocating|3
5934929|NCT01384734|20529257|P3|Overall Study|Investigator relocating|0
5934930|NCT01384734|20529258|P2|Overall Study|Investigator relocating|2
5934931|NCT01384734|20529259|P1|Overall Study|Investigator relocating|0
5934932|NCT01384734|20529255|P5|Overall Study|Withdrawal by Subject|9
5934933|NCT01384734|20529256|P4|Overall Study|Withdrawal by Subject|7
5934934|NCT01384734|20529257|P3|Overall Study|Withdrawal by Subject|6
5934935|NCT01384734|20529258|P2|Overall Study|Withdrawal by Subject|5
5934936|NCT01384734|20529259|P1|Overall Study|Withdrawal by Subject|5
5934937|NCT01384734|20529255|P5|Overall Study|Sponsor terminated|1
5934938|NCT01384734|20529256|P4|Overall Study|Sponsor terminated|0
5934939|NCT01384734|20529257|P3|Overall Study|Sponsor terminated|0
5934940|NCT01384734|20529258|P2|Overall Study|Sponsor terminated|0
5934941|NCT01384734|20529259|P1|Overall Study|Sponsor terminated|0
5934942|NCT01384734|20529255|P5|Overall Study|Pregnancy|1
5934943|NCT01384734|20529256|P4|Overall Study|Pregnancy|0
5934944|NCT01384734|20529257|P3|Overall Study|Pregnancy|0
5934945|NCT01384734|20529258|P2|Overall Study|Pregnancy|1
5934946|NCT01384734|20529259|P1|Overall Study|Pregnancy|0
5934947|NCT01384734|20529255|P5|Overall Study|Non-compliance with study drug|2
5934948|NCT01384734|20529256|P4|Overall Study|Non-compliance with study drug|0
5934949|NCT01384734|20529257|P3|Overall Study|Non-compliance with study drug|6
5934950|NCT01384734|20529258|P2|Overall Study|Non-compliance with study drug|2
5934951|NCT01384734|20529259|P1|Overall Study|Non-compliance with study drug|1
5934952|NCT01384734|20529255|P5|Overall Study|Lost to Follow-up|5
5934953|NCT01384734|20529256|P4|Overall Study|Lost to Follow-up|8
5934954|NCT01384734|20529257|P3|Overall Study|Lost to Follow-up|3
5934955|NCT01384734|20529258|P2|Overall Study|Lost to Follow-up|3
5934956|NCT01384734|20529259|P1|Overall Study|Lost to Follow-up|5
5934957|NCT01384734|20529255|P5|Overall Study|Lack of Efficacy|2
5934958|NCT01384734|20529256|P4|Overall Study|Lack of Efficacy|4
5934959|NCT01384734|20529257|P3|Overall Study|Lack of Efficacy|4
5934960|NCT01384734|20529258|P2|Overall Study|Lack of Efficacy|7
5934961|NCT01384734|20529259|P1|Overall Study|Lack of Efficacy|3
5934962|NCT01384734|20529255|P5|Overall Study|Continuation criteria not met|0
5934963|NCT01384734|20529256|P4|Overall Study|Continuation criteria not met|1
5934964|NCT01384734|20529257|P3|Overall Study|Continuation criteria not met|1
5934965|NCT01384734|20529258|P2|Overall Study|Continuation criteria not met|0
5934966|NCT01384734|20529259|P1|Overall Study|Continuation criteria not met|0
5934967|NCT01384734|20529255|P5|Overall Study|Death|0
5934968|NCT01384734|20529256|P4|Overall Study|Death|0
5934969|NCT01384734|20529257|P3|Overall Study|Death|1
5934970|NCT01384734|20529258|P2|Overall Study|Death|0
5934971|NCT01384734|20529259|P1|Overall Study|Death|1
5934972|NCT01384734|20529255|P5|Overall Study|Adverse Event|7
5934973|NCT01384734|20529256|P4|Overall Study|Adverse Event|2
5934974|NCT01384734|20529257|P3|Overall Study|Adverse Event|0
5934975|NCT01384734|20529258|P2|Overall Study|Adverse Event|3
5934976|NCT01384734|20529259|P1|Overall Study|Adverse Event|0
5934977|NCT01384292|20529488|P3|Part B|Severe non-compliance to protocol|0
5934978|NCT01384292|20529489|P2|Part B|Severe non-compliance to protocol|0
5934979|NCT01384292|20529490|P1|Part B|Severe non-compliance to protocol|1
5934980|NCT01384019|20529502|P2|Overall Study|MRI refusal|6
5934981|NCT01384019|20529503|P1|Overall Study|MRI refusal|6
5934982|NCT01384019|20529502|P2|Overall Study|Death|0
5934983|NCT01384019|20529503|P1|Overall Study|Death|1
5934984|NCT01384019|20529502|P2|Overall Study|Withdrawal by Subject|0
5934985|NCT01384019|20529503|P1|Overall Study|Withdrawal by Subject|3
5934986|NCT01383993|20529512|P3|Overall Study|Marketed voriconazole in post-therapy|0
5934987|NCT01383993|20529513|P2|Overall Study|Marketed voriconazole in post-therapy|0
5934988|NCT01383993|20529514|P1|Overall Study|Marketed voriconazole in post-therapy|2
5934989|NCT01383993|20529512|P3|Overall Study|Withdrawal by Subject|1
5934990|NCT01383993|20529513|P2|Overall Study|Withdrawal by Subject|0
5934991|NCT01383993|20529514|P1|Overall Study|Withdrawal by Subject|0
5934992|NCT01383993|20529512|P3|Overall Study|Adverse Event|0
5934993|NCT01383993|20529513|P2|Overall Study|Adverse Event|1
5934994|NCT01383993|20529514|P1|Overall Study|Adverse Event|1
5934995|NCT01383954|20529561|P1|Overall Study|Reason Not Specified|9
5934996|NCT01383954|20529561|P1|Overall Study|Adverse Event|1
5934997|NCT01383954|20529561|P1|Overall Study|Electronic Diary Too Cumbersome to Use|2
5934998|NCT01383954|20529561|P1|Overall Study|Lack of Efficacy|2
5934999|NCT01383928|20529569|P3|Overall Study|Unsatisfactory Therapeutic Response|1
5935000|NCT01383928|20529570|P2|Overall Study|Unsatisfactory Therapeutic Response|0
5935001|NCT01383928|20529571|P1|Overall Study|Unsatisfactory Therapeutic Response|0
5935002|NCT01383928|20529569|P3|Overall Study|Withdrawal by Subject|4
5935003|NCT01383928|20529570|P2|Overall Study|Withdrawal by Subject|0
5935004|NCT01383928|20529571|P1|Overall Study|Withdrawal by Subject|0
5935005|NCT01383928|20529569|P3|Overall Study|Progressive Disease|5
5935006|NCT01383928|20529570|P2|Overall Study|Progressive Disease|1
5935007|NCT01383928|20529571|P1|Overall Study|Progressive Disease|1
5935008|NCT01383928|20529569|P3|Overall Study|Other|4
5935009|NCT01383928|20529570|P2|Overall Study|Other|3
5935010|NCT01383928|20529571|P1|Overall Study|Other|1
5935011|NCT01383928|20529569|P3|Overall Study|Adverse Event|8
5935012|NCT01383928|20529570|P2|Overall Study|Adverse Event|2
5935013|NCT01383928|20529571|P1|Overall Study|Adverse Event|1
5935014|NCT01383928|20529569|P3|Overall Study|Initiation of ASCT|18
5935015|NCT01383928|20529570|P2|Overall Study|Initiation of ASCT|1
5935016|NCT01383928|20529571|P1|Overall Study|Initiation of ASCT|2
5935017|NCT01383707|20529652|P1|Overall Study|Progressive disease|23
5935018|NCT01383707|20529652|P1|Overall Study|Adverse Event|14
5935019|NCT01383707|20529652|P1|Overall Study|Sponsor's decision|2
5935020|NCT01383707|20529652|P1|Overall Study|Other|8
5935021|NCT01383707|20529652|P1|Overall Study|Death|19
5935022|NCT01383707|20529652|P1|Overall Study|Consent withdrawal|6
5935023|NCT01383499|20529692|P4|Period 1 (4 Weeks)|Withdrawal by Subject|0
5935024|NCT01383499|20529693|P3|Period 1 (4 Weeks)|Withdrawal by Subject|0
5935025|NCT01383499|20529694|P2|Period 1 (4 Weeks)|Withdrawal by Subject|0
5935026|NCT01383499|20529695|P1|Period 1 (4 Weeks)|Withdrawal by Subject|1
5935027|NCT01383486|20529745|P1|Overall Study|Did not take any product|6
5935028|NCT01383486|20529745|P1|Overall Study|Incomplete information for analysis|2
5935029|NCT01383486|20529745|P1|Overall Study|Lost to Follow-up|10
5935030|NCT01383356|20529822|P2|Period 1|Personal|2
5935031|NCT01383356|20529823|P1|Period 1|Personal|0
5935032|NCT01383356|20529822|P2|Period 1|Out of Range Mid-study-Test|1
5935033|NCT01383356|20529823|P1|Period 1|Out of Range Mid-study-Test|0
5935034|NCT01383356|20529822|P2|Period 1|Non-compliance|0
5935035|NCT01383356|20529823|P1|Period 1|Non-compliance|3
5935036|NCT01383356|20529822|P2|Period 1|Adverse Event|3
5935037|NCT01383356|20529823|P1|Period 1|Adverse Event|5
5935038|NCT01383317|20529835|P2|Overall Study|Adverse Event|1
5935039|NCT01383317|20529836|P1|Overall Study|Adverse Event|0
5935040|NCT01383317|20529835|P2|Overall Study|Death|0
5935041|NCT01383317|20529836|P1|Overall Study|Death|1
5935042|NCT01383317|20529835|P2|Overall Study|Lost to Follow-up|1
5935043|NCT01383317|20529836|P1|Overall Study|Lost to Follow-up|2
5935044|NCT01383174|20529878|P2|6 Month Assessment|Refused to complete|0
5935045|NCT01383174|20529879|P1|6 Month Assessment|Refused to complete|4
5935046|NCT01383174|20529878|P2|6 Month Assessment|Lost to Follow-up|1
5935047|NCT01383174|20529879|P1|6 Month Assessment|Lost to Follow-up|1
5935048|NCT01383174|20529878|P2|3 Month Assessment|Refused to complete|0
5935049|NCT01383174|20529879|P1|3 Month Assessment|Refused to complete|4
5935050|NCT01383174|20529878|P2|3 Month Assessment|Lost to Follow-up|0
5935051|NCT01383174|20529879|P1|3 Month Assessment|Lost to Follow-up|2
5935052|NCT01383174|20529878|P2|3 Month Assessment|Death|1
5935053|NCT01383174|20529879|P1|3 Month Assessment|Death|0
5935054|NCT01383161|20529905|P2|Overall Study|Lack of Efficacy|1
5935055|NCT01383161|20529906|P1|Overall Study|Lack of Efficacy|0
5935056|NCT01383161|20529905|P2|Overall Study|Withdrawal by Subject|2
5935057|NCT01383161|20529906|P1|Overall Study|Withdrawal by Subject|0
5935058|NCT01383161|20529905|P2|Overall Study|Adverse Event|1
5935059|NCT01383161|20529906|P1|Overall Study|Adverse Event|5
5935060|NCT01383096|20529925|P3|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0
5935061|NCT01383096|20529926|P2|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0
5935062|NCT01383096|20529927|P1|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|1
5935063|NCT01383096|20529925|P3|Fifth Intervention (8 Days)|Withdrawal by Subject|0
5935064|NCT01383096|20529926|P2|Fifth Intervention (8 Days)|Withdrawal by Subject|0
5935065|NCT01383096|20529927|P1|Fifth Intervention (8 Days)|Withdrawal by Subject|1
5935066|NCT01383096|20529925|P3|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0
5935067|NCT01383096|20529926|P2|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0
5935068|NCT01383096|20529927|P1|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|1
5935069|NCT01383096|20529925|P3|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0
5935070|NCT01383096|20529926|P2|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0
5935071|NCT01383096|20529927|P1|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1
5935072|NCT01383096|20529925|P3|Third Intervention (8 Days)|QTcF was greater than 450 msec|0
5935073|NCT01383096|20529926|P2|Third Intervention (8 Days)|QTcF was greater than 450 msec|0
5935074|NCT01383096|20529927|P1|Third Intervention (8 Days)|QTcF was greater than 450 msec|1
5935075|NCT01383096|20529925|P3|Third Intervention (8 Days)|Withdrawal by Subject|0
5935076|NCT01383096|20529926|P2|Third Intervention (8 Days)|Withdrawal by Subject|0
5935077|NCT01383096|20529927|P1|Third Intervention (8 Days)|Withdrawal by Subject|1
5935078|NCT01383096|20529925|P3|Third Intervention (8 Days)|Adverse Event|0
5935079|NCT01383096|20529926|P2|Third Intervention (8 Days)|Adverse Event|0
5935080|NCT01383096|20529927|P1|Third Intervention (8 Days)|Adverse Event|1
5935081|NCT01383096|20529925|P3|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|0
5935082|NCT01383096|20529926|P2|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|3
5935083|NCT01383096|20529927|P1|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|1
5935084|NCT01383096|20529925|P3|Third Intervention (8 Days)|Elevated AST|0
5935085|NCT01383096|20529926|P2|Third Intervention (8 Days)|Elevated AST|1
5935086|NCT01383096|20529927|P1|Third Intervention (8 Days)|Elevated AST|0
5935087|NCT01383096|20529925|P3|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1
5935088|NCT01383096|20529926|P2|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1
5935089|NCT01383096|20529927|P1|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0
5935090|NCT01383096|20529925|P3|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|1
5935091|NCT01383096|20529926|P2|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0
5935092|NCT01383096|20529927|P1|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0
5935103|NCT01382940|20530035|P1|Overall Study|Protocol Violation|20
5935104|NCT01382940|20530035|P1|Overall Study|Withdrawal by Subject|23
5935105|NCT01382940|20530035|P1|Overall Study|Physician Decision|7
5935106|NCT01382940|20530035|P1|Overall Study|Lost to Follow-up|4
5935107|NCT01382940|20530035|P1|Overall Study|Adverse Event|19
5935108|NCT01382602|20530097|P2|Overall Study|Withdrawal by Subject|1
5935109|NCT01382602|20530098|P1|Overall Study|Withdrawal by Subject|0
5935110|NCT01382602|20530097|P2|Overall Study|Protocol Violation|3
5935111|NCT01382602|20530098|P1|Overall Study|Protocol Violation|0
5935112|NCT01382446|20530106|P2|Overall Study|Removal from Mechanical Ventilation|3
5935113|NCT01382446|20530107|P1|Overall Study|Removal from Mechanical Ventilation|3
5935114|NCT01382446|20530106|P2|Overall Study|Withdrawal by Subject|1
5935115|NCT01382446|20530107|P1|Overall Study|Withdrawal by Subject|0
5935116|NCT01382251|20530134|P2|Overall Study|Contacted after study closed|1
5935117|NCT01382251|20530135|P1|Overall Study|Contacted after study closed|1
5935118|NCT01382251|20530134|P2|Overall Study|Lost to Follow-up|4
5935119|NCT01382251|20530135|P1|Overall Study|Lost to Follow-up|4
5935120|NCT01382251|20530134|P2|Overall Study|Surgeries cancelled or delayed|16
5935121|NCT01382251|20530135|P1|Overall Study|Surgeries cancelled or delayed|16
5935122|NCT01382225|20530148|P2|Overall Study|Other|2
5935123|NCT01382225|20530149|P1|Overall Study|Other|4
5935124|NCT01382225|20530148|P2|Overall Study|Subject Withdrew Consent|2
5935125|NCT01382225|20530149|P1|Overall Study|Subject Withdrew Consent|5
5935126|NCT01382225|20530148|P2|Overall Study|Protocol Violation|1
5935127|NCT01382225|20530149|P1|Overall Study|Protocol Violation|2
5935128|NCT01382225|20530148|P2|Overall Study|Adverse Event|2
5935129|NCT01382225|20530149|P1|Overall Study|Adverse Event|3
5935130|NCT01382212|20530171|P1|Overall Study|Withdrew consent|1
5935131|NCT01382212|20530171|P1|Overall Study|Kidney transplant|1
5935132|NCT01381926|20530234|P2|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|1
5935133|NCT01381926|20530235|P1|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|0
5935134|NCT01381926|20530234|P2|Low/High Dose of 1st Treatment (2months)|Adverse Event|0
5935135|NCT01381926|20530235|P1|Low/High Dose of 1st Treatment (2months)|Adverse Event|2
5935136|NCT01381900|20530248|P3|Overall Study|Early withdraw|1
5935137|NCT01381900|20530249|P2|Overall Study|Early withdraw|1
5935138|NCT01381900|20530250|P1|Overall Study|Early withdraw|3
5935139|NCT01381900|20530248|P3|Overall Study|Withdrawal by Subject|1
5935140|NCT01381900|20530249|P2|Overall Study|Withdrawal by Subject|0
5935141|NCT01381900|20530250|P1|Overall Study|Withdrawal by Subject|0
5935142|NCT01381900|20530248|P3|Overall Study|Protocol Violation|1
5935143|NCT01381900|20530249|P2|Overall Study|Protocol Violation|1
5935144|NCT01381900|20530250|P1|Overall Study|Protocol Violation|0
5935145|NCT01381900|20530248|P3|Overall Study|Physician Decision|1
5935146|NCT01381900|20530249|P2|Overall Study|Physician Decision|1
5935147|NCT01381900|20530250|P1|Overall Study|Physician Decision|0
5935148|NCT01381900|20530248|P3|Overall Study|Noncompliance with study drug|1
5935149|NCT01381900|20530249|P2|Overall Study|Noncompliance with study drug|0
5935150|NCT01381900|20530250|P1|Overall Study|Noncompliance with study drug|0
5935151|NCT01381900|20530248|P3|Overall Study|Adverse Event|7
5935152|NCT01381900|20530249|P2|Overall Study|Adverse Event|6
5935153|NCT01381900|20530250|P1|Overall Study|Adverse Event|4
5935154|NCT01381900|20530248|P3|Overall Study|Subject meets glycemic withdrawal crit.|0
5935155|NCT01381900|20530249|P2|Overall Study|Subject meets glycemic withdrawal crit.|0
5935156|NCT01381900|20530250|P1|Overall Study|Subject meets glycemic withdrawal crit.|2
5935157|NCT01381874|20530273|P3|Overall Study|Other|67
5935158|NCT01381874|20530274|P2|Overall Study|Other|52
5935159|NCT01381874|20530275|P1|Overall Study|Other|67
5935160|NCT01381874|20530273|P3|Overall Study|Withdrawal by Subject|9
5935161|NCT01381874|20530274|P2|Overall Study|Withdrawal by Subject|10
5935162|NCT01381874|20530275|P1|Overall Study|Withdrawal by Subject|9
5935163|NCT01381874|20530273|P3|Overall Study|Lost to Follow-up|0
5935164|NCT01381874|20530274|P2|Overall Study|Lost to Follow-up|1
5935165|NCT01381874|20530275|P1|Overall Study|Lost to Follow-up|1
5935166|NCT01381679|20530312|P1|Overall Study|Lost to Follow-up|885
5935167|NCT01381679|20530312|P1|Overall Study|Adverse Event|3
5935168|NCT01381575|20530327|P3|Overall Study|Lost to Follow-up|9
5935169|NCT01381575|20530328|P2|Overall Study|Lost to Follow-up|17
5935170|NCT01381575|20530329|P1|Overall Study|Lost to Follow-up|8
5935171|NCT01381575|20530327|P3|Overall Study|Migrated/moved from study area|2
5935172|NCT01381575|20530328|P2|Overall Study|Migrated/moved from study area|12
5935173|NCT01381575|20530329|P1|Overall Study|Migrated/moved from study area|2
5935174|NCT01381575|20530327|P3|Overall Study|Withdrawal by Subject|7
5935175|NCT01381575|20530328|P2|Overall Study|Withdrawal by Subject|9
5935176|NCT01381575|20530329|P1|Overall Study|Withdrawal by Subject|15
5935177|NCT01381575|20530327|P3|Overall Study|Protocol Violation|1
5935178|NCT01381575|20530328|P2|Overall Study|Protocol Violation|1
5935179|NCT01381575|20530329|P1|Overall Study|Protocol Violation|0
5935180|NCT01381575|20530327|P3|Overall Study|Non-Serious Adverse Event|1
5935181|NCT01381575|20530328|P2|Overall Study|Non-Serious Adverse Event|0
5935182|NCT01381575|20530329|P1|Overall Study|Non-Serious Adverse Event|0
5935183|NCT01381575|20530327|P3|Overall Study|Serious Adverse Event|0
5935184|NCT01381575|20530328|P2|Overall Study|Serious Adverse Event|0
5935185|NCT01381575|20530329|P1|Overall Study|Serious Adverse Event|1
5935186|NCT01381562|20530386|P3|Overall Study|Adverse Event|0
5935187|NCT01381562|20530387|P2|Overall Study|Adverse Event|1
5935188|NCT01381562|20530388|P1|Overall Study|Adverse Event|0
5935189|NCT01381549|20530456|P3|Overall Study|Ineligible: No organisms isolated|1
5935190|NCT01381549|20530457|P2|Overall Study|Ineligible: No organisms isolated|0
5935191|NCT01381549|20530458|P1|Overall Study|Ineligible: No organisms isolated|0
5935192|NCT01381068|20530584|P2|Overall Study|Death|0
5935193|NCT01381068|20530585|P1|Overall Study|Death|1
5935194|NCT01381016|20530605|P2|Overall Study|Physician Decision|2
5935195|NCT01381016|20530606|P1|Overall Study|Physician Decision|0
5935196|NCT01381016|20530605|P2|Overall Study|Withdrawal by Subject|1
5935197|NCT01381016|20530606|P1|Overall Study|Withdrawal by Subject|0
5935198|NCT01381016|20530605|P2|Overall Study|Screen Failure|2
5935199|NCT01381016|20530606|P1|Overall Study|Screen Failure|2
5935200|NCT01381016|20530605|P2|Overall Study|Lost to Follow-up|1
5935201|NCT01381016|20530606|P1|Overall Study|Lost to Follow-up|1
5935202|NCT01380834|20530616|P2|Overall Study|Physician Decision|0
5935203|NCT01380834|20530617|P1|Overall Study|Physician Decision|1
5935204|NCT01380782|20530629|P4|Overall Study|Withdrawal by Subject|1
5935205|NCT01380782|20530630|P3|Overall Study|Withdrawal by Subject|1
5935206|NCT01380782|20530631|P2|Overall Study|Withdrawal by Subject|0
5935207|NCT01380782|20530632|P1|Overall Study|Withdrawal by Subject|0
5935208|NCT01380782|20530629|P4|Overall Study|Physician Decision|0
5935209|NCT01380782|20530630|P3|Overall Study|Physician Decision|0
5935210|NCT01380782|20530631|P2|Overall Study|Physician Decision|0
5935211|NCT01380782|20530632|P1|Overall Study|Physician Decision|1
5935212|NCT01380782|20530629|P4|Overall Study|Lack of Efficacy|3
5935213|NCT01380782|20530630|P3|Overall Study|Lack of Efficacy|10
5935214|NCT01380782|20530631|P2|Overall Study|Lack of Efficacy|9
5935215|NCT01380782|20530632|P1|Overall Study|Lack of Efficacy|10
5935216|NCT01380782|20530629|P4|Overall Study|Death|0
5935217|NCT01380782|20530630|P3|Overall Study|Death|0
5935218|NCT01380782|20530631|P2|Overall Study|Death|0
5935219|NCT01380782|20530632|P1|Overall Study|Death|1
5935220|NCT01380782|20530629|P4|Overall Study|Adverse Event|0
5935221|NCT01380782|20530630|P3|Overall Study|Adverse Event|0
5935222|NCT01380782|20530631|P2|Overall Study|Adverse Event|1
5935223|NCT01380782|20530632|P1|Overall Study|Adverse Event|0
5935224|NCT01380769|20530655|P2|Overall Study|Protocol Violation|1
5935225|NCT01380769|20530656|P1|Overall Study|Protocol Violation|0
5935226|NCT01380769|20530655|P2|Overall Study|Adverse Event|1
5935227|NCT01380769|20530656|P1|Overall Study|Adverse Event|1
5935228|NCT01380769|20530655|P2|Overall Study|Physician Decision|1
5935229|NCT01380769|20530656|P1|Overall Study|Physician Decision|1
5935230|NCT01380769|20530655|P2|Overall Study|Withdrawal by Subject|11
5935231|NCT01380769|20530656|P1|Overall Study|Withdrawal by Subject|7
5935232|NCT01380730|20530717|P8|Overall Study|Death|0
5935233|NCT01380730|20530718|P7|Overall Study|Death|0
5935234|NCT01380730|20530719|P6|Overall Study|Death|0
5935235|NCT01380730|20530720|P5|Overall Study|Death|1
5935236|NCT01380730|20530721|P4|Overall Study|Death|0
5935237|NCT01380730|20530722|P3|Overall Study|Death|0
5935238|NCT01380730|20530723|P2|Overall Study|Death|0
5935239|NCT01380730|20530724|P1|Overall Study|Death|0
5935240|NCT01380691|20530782|P4|Washout (7 Days)|Withdrawal by Subject|0
5935241|NCT01380691|20530783|P3|Washout (7 Days)|Withdrawal by Subject|1
5935242|NCT01380691|20530784|P2|Washout (7 Days)|Withdrawal by Subject|0
5935243|NCT01380691|20530785|P1|Washout (7 Days)|Withdrawal by Subject|0
5935244|NCT01380691|20530782|P4|Washout (7 Days)|Protocol Violation|1
5935245|NCT01380691|20530783|P3|Washout (7 Days)|Protocol Violation|0
5935246|NCT01380691|20530784|P2|Washout (7 Days)|Protocol Violation|0
5935247|NCT01380691|20530785|P1|Washout (7 Days)|Protocol Violation|0
5935248|NCT01380535|20530846|P2|Overall Study|Lack of Efficacy|3
5935249|NCT01380535|20530847|P1|Overall Study|Lack of Efficacy|0
5935250|NCT01380535|20530846|P2|Overall Study|Protocol Violation|2
5935251|NCT01380535|20530847|P1|Overall Study|Protocol Violation|0
5935252|NCT01380535|20530846|P2|Overall Study|Withdrawal by Subject|2
5935253|NCT01380535|20530847|P1|Overall Study|Withdrawal by Subject|1
5935254|NCT01380535|20530846|P2|Overall Study|Study site closed|5
5935255|NCT01380535|20530847|P1|Overall Study|Study site closed|0
5935256|NCT01380535|20530846|P2|Overall Study|Death|0
5935257|NCT01380535|20530847|P1|Overall Study|Death|3
5935258|NCT01380535|20530846|P2|Overall Study|Adverse Event|3
5935259|NCT01380535|20530847|P1|Overall Study|Adverse Event|3
5935260|NCT01380379|20530853|P1|Overall Study|Pregnancy|1
5935261|NCT01380327|20530866|P3|Overall Study|Questionable onset of epilepsy|1
5935262|NCT01380327|20530867|P2|Overall Study|Questionable onset of epilepsy|0
5935263|NCT01380327|20530868|P1|Overall Study|Questionable onset of epilepsy|0
5935264|NCT01380327|20530866|P3|Overall Study|Housing situation precluded ability to k|1
5935265|NCT01380327|20530867|P2|Overall Study|Housing situation precluded ability to k|0
5935266|NCT01380327|20530868|P1|Overall Study|Housing situation precluded ability to k|0
5935267|NCT01380327|20530866|P3|Overall Study|Withdrawal by Subject|1
5935268|NCT01380327|20530867|P2|Overall Study|Withdrawal by Subject|0
5935269|NCT01380327|20530868|P1|Overall Study|Withdrawal by Subject|0
5935270|NCT01380327|20530866|P3|Overall Study|Protocol Violation|3
5935271|NCT01380327|20530867|P2|Overall Study|Protocol Violation|2
5935272|NCT01380327|20530868|P1|Overall Study|Protocol Violation|3
5935273|NCT01380327|20530866|P3|Overall Study|Lost to Follow-up|1
5935274|NCT01380327|20530867|P2|Overall Study|Lost to Follow-up|1
5935275|NCT01380327|20530868|P1|Overall Study|Lost to Follow-up|0
5935276|NCT01380184|20530899|P1|Part 2|Lost to Follow-up|1
5935277|NCT01380184|20530899|P1|Part 2|Disease Progression|8
5935278|NCT01380184|20530899|P1|Part 2|Adverse Event|5
5935279|NCT01380184|20530899|P1|Part 1 (19 Days)|Adverse Event|1
5935280|NCT01380145|20530910|P1|Overall Study|Progressive disease|4
5935281|NCT01380093|20530929|P9|Treatment Phase: Third Intervention|Other|1
5935282|NCT01380093|20530930|P8|Treatment Phase: Third Intervention|Other|0
5935283|NCT01380093|20530931|P7|Treatment Phase: Third Intervention|Other|0
5935284|NCT01380093|20530932|P6|Treatment Phase: Third Intervention|Other|0
5935285|NCT01380093|20530933|P5|Treatment Phase: Third Intervention|Other|0
5935286|NCT01380093|20530934|P4|Treatment Phase: Third Intervention|Other|0
5935287|NCT01380093|20530935|P3|Treatment Phase: Third Intervention|Other|0
5935288|NCT01380093|20530936|P2|Treatment Phase: Third Intervention|Other|0
5935289|NCT01380093|20530937|P1|Treatment Phase: Third Intervention|Other|0
5935290|NCT01380093|20530929|P9|Treatment Phase: Third Intervention|Non-compliance|1
5935291|NCT01380093|20530930|P8|Treatment Phase: Third Intervention|Non-compliance|0
5935292|NCT01380093|20530931|P7|Treatment Phase: Third Intervention|Non-compliance|0
5935293|NCT01380093|20530932|P6|Treatment Phase: Third Intervention|Non-compliance|0
5935294|NCT01380093|20530933|P5|Treatment Phase: Third Intervention|Non-compliance|0
5935295|NCT01380093|20530934|P4|Treatment Phase: Third Intervention|Non-compliance|0
5935296|NCT01380093|20530935|P3|Treatment Phase: Third Intervention|Non-compliance|0
5935297|NCT01380093|20530936|P2|Treatment Phase: Third Intervention|Non-compliance|0
5935298|NCT01380093|20530937|P1|Treatment Phase: Third Intervention|Non-compliance|0
5935299|NCT01380093|20530929|P9|Treatment Phase: Second Intervention|Other|0
5935300|NCT01380093|20530930|P8|Treatment Phase: Second Intervention|Other|0
5935301|NCT01380093|20530931|P7|Treatment Phase: Second Intervention|Other|0
5935302|NCT01380093|20530932|P6|Treatment Phase: Second Intervention|Other|0
5935303|NCT01380093|20530933|P5|Treatment Phase: Second Intervention|Other|0
5935304|NCT01380093|20530934|P4|Treatment Phase: Second Intervention|Other|1
5935305|NCT01380093|20530935|P3|Treatment Phase: Second Intervention|Other|0
5935306|NCT01380093|20530936|P2|Treatment Phase: Second Intervention|Other|0
5935307|NCT01380093|20530937|P1|Treatment Phase: Second Intervention|Other|0
5935308|NCT01380093|20530929|P9|Drug Discrimination Phase: Day 2|Sponsor decision|0
5935309|NCT01380093|20530930|P8|Drug Discrimination Phase: Day 2|Sponsor decision|0
5935310|NCT01380093|20530931|P7|Drug Discrimination Phase: Day 2|Sponsor decision|0
5935311|NCT01380093|20530932|P6|Drug Discrimination Phase: Day 2|Sponsor decision|0
5935312|NCT01380093|20530933|P5|Drug Discrimination Phase: Day 2|Sponsor decision|0
5935313|NCT01380093|20530934|P4|Drug Discrimination Phase: Day 2|Sponsor decision|0
5935314|NCT01380093|20530935|P3|Drug Discrimination Phase: Day 2|Sponsor decision|1
5935315|NCT01380093|20530936|P2|Drug Discrimination Phase: Day 2|Sponsor decision|0
5935316|NCT01380093|20530937|P1|Drug Discrimination Phase: Day 2|Sponsor decision|0
5935317|NCT01380093|20530929|P9|Drug Discrimination Phase: Day 2|Backup participant|0
5935318|NCT01380093|20530930|P8|Drug Discrimination Phase: Day 2|Backup participant|0
5935319|NCT01380093|20530931|P7|Drug Discrimination Phase: Day 2|Backup participant|0
5935320|NCT01380093|20530932|P6|Drug Discrimination Phase: Day 2|Backup participant|0
5935321|NCT01380093|20530933|P5|Drug Discrimination Phase: Day 2|Backup participant|0
5935322|NCT01380093|20530934|P4|Drug Discrimination Phase: Day 2|Backup participant|0
5935323|NCT01380093|20530935|P3|Drug Discrimination Phase: Day 2|Backup participant|1
5935324|NCT01380093|20530936|P2|Drug Discrimination Phase: Day 2|Backup participant|0
5935325|NCT01380093|20530937|P1|Drug Discrimination Phase: Day 2|Backup participant|0
5935326|NCT01380093|20530929|P9|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
5935327|NCT01380093|20530930|P8|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
5935328|NCT01380093|20530931|P7|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
5935329|NCT01380093|20530932|P6|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
5935330|NCT01380093|20530933|P5|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
5935331|NCT01380093|20530934|P4|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
5935332|NCT01380093|20530935|P3|Drug Discrimination Phase: Day 2|Positive urine drug screen|1
5935333|NCT01380093|20530936|P2|Drug Discrimination Phase: Day 2|Positive urine drug screen|1
5935334|NCT01380093|20530937|P1|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
5935335|NCT01380093|20530929|P9|Drug Discrimination Phase: Day 2|Discrimination failure|0
5935336|NCT01380093|20530930|P8|Drug Discrimination Phase: Day 2|Discrimination failure|0
5935337|NCT01380093|20530931|P7|Drug Discrimination Phase: Day 2|Discrimination failure|0
5935338|NCT01380093|20530932|P6|Drug Discrimination Phase: Day 2|Discrimination failure|0
5935339|NCT01380093|20530933|P5|Drug Discrimination Phase: Day 2|Discrimination failure|0
5935340|NCT01380093|20530934|P4|Drug Discrimination Phase: Day 2|Discrimination failure|0
5935341|NCT01380093|20530935|P3|Drug Discrimination Phase: Day 2|Discrimination failure|9
5935342|NCT01380093|20530936|P2|Drug Discrimination Phase: Day 2|Discrimination failure|4
5935343|NCT01380093|20530937|P1|Drug Discrimination Phase: Day 2|Discrimination failure|0
5935344|NCT01380093|20530929|P9|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
5935345|NCT01380093|20530930|P8|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
5935346|NCT01380093|20530931|P7|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
5935347|NCT01380093|20530932|P6|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
5935348|NCT01380093|20530933|P5|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
5935349|NCT01380093|20530934|P4|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
5935350|NCT01380093|20530935|P3|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
5935351|NCT01380093|20530936|P2|Drug Discrimination Phase: Day 2|Withdrawal by Subject|1
5935352|NCT01380093|20530937|P1|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
5935353|NCT01380093|20530929|P9|Drug Discrimination Phase: Day 2|Physician Decision|0
5935354|NCT01380093|20530930|P8|Drug Discrimination Phase: Day 2|Physician Decision|0
5935355|NCT01380093|20530931|P7|Drug Discrimination Phase: Day 2|Physician Decision|0
5935356|NCT01380093|20530932|P6|Drug Discrimination Phase: Day 2|Physician Decision|0
5935357|NCT01380093|20530933|P5|Drug Discrimination Phase: Day 2|Physician Decision|0
5935358|NCT01380093|20530934|P4|Drug Discrimination Phase: Day 2|Physician Decision|0
5935359|NCT01380093|20530935|P3|Drug Discrimination Phase: Day 2|Physician Decision|1
5935360|NCT01380093|20530936|P2|Drug Discrimination Phase: Day 2|Physician Decision|3
5935361|NCT01380093|20530937|P1|Drug Discrimination Phase: Day 2|Physician Decision|0
5935362|NCT01380093|20530929|P9|Drug Discrimination Phase: Day 1|Discrimination failure|0
5935363|NCT01380093|20530930|P8|Drug Discrimination Phase: Day 1|Discrimination failure|0
5935364|NCT01380093|20530931|P7|Drug Discrimination Phase: Day 1|Discrimination failure|0
5935365|NCT01380093|20530932|P6|Drug Discrimination Phase: Day 1|Discrimination failure|0
5935366|NCT01380093|20530933|P5|Drug Discrimination Phase: Day 1|Discrimination failure|0
5935367|NCT01380093|20530934|P4|Drug Discrimination Phase: Day 1|Discrimination failure|0
5935368|NCT01380093|20530935|P3|Drug Discrimination Phase: Day 1|Discrimination failure|0
5935369|NCT01380093|20530936|P2|Drug Discrimination Phase: Day 1|Discrimination failure|1
5935370|NCT01380093|20530937|P1|Drug Discrimination Phase: Day 1|Discrimination failure|0
5935371|NCT01380093|20530929|P9|Naloxone Challenge Phase|Screen failures|0
5935372|NCT01380093|20530930|P8|Naloxone Challenge Phase|Screen failures|0
5935373|NCT01380093|20530931|P7|Naloxone Challenge Phase|Screen failures|0
5935374|NCT01380093|20530932|P6|Naloxone Challenge Phase|Screen failures|0
5935375|NCT01380093|20530933|P5|Naloxone Challenge Phase|Screen failures|0
5935376|NCT01380093|20530934|P4|Naloxone Challenge Phase|Screen failures|0
5935377|NCT01380093|20530935|P3|Naloxone Challenge Phase|Screen failures|0
5935378|NCT01380093|20530936|P2|Naloxone Challenge Phase|Screen failures|0
5935379|NCT01380093|20530937|P1|Naloxone Challenge Phase|Screen failures|21
5935380|NCT01379937|20531236|P4|Overall Study|Lost to Follow-up|0
5935381|NCT01379937|20531237|P3|Overall Study|Lost to Follow-up|2
5935382|NCT01379937|20531238|P2|Overall Study|Lost to Follow-up|2
5935383|NCT01379937|20531239|P1|Overall Study|Lost to Follow-up|1
5935384|NCT01379937|20531236|P4|Overall Study|Consent withdrawal|0
5935385|NCT01379937|20531237|P3|Overall Study|Consent withdrawal|0
5935386|NCT01379937|20531238|P2|Overall Study|Consent withdrawal|1
5935387|NCT01379937|20531239|P1|Overall Study|Consent withdrawal|0
5935388|NCT01379937|20531236|P4|Overall Study|Protocol Violation|1
5935389|NCT01379937|20531237|P3|Overall Study|Protocol Violation|0
5935390|NCT01379937|20531238|P2|Overall Study|Protocol Violation|0
5935391|NCT01379937|20531239|P1|Overall Study|Protocol Violation|0
5935392|NCT01379781|20531359|P2|Overall Study|Lost to Follow-up|8
5935393|NCT01379781|20531360|P1|Overall Study|Lost to Follow-up|11
5935394|NCT01379768|20531369|P3|Overall Study|Lost to Follow-up|0
5935395|NCT01379768|20531370|P2|Overall Study|Lost to Follow-up|0
5935396|NCT01379768|20531371|P1|Overall Study|Lost to Follow-up|2
5935397|NCT01379768|20531369|P3|Overall Study|Adverse Event|0
5935398|NCT01379768|20531370|P2|Overall Study|Adverse Event|1
5935399|NCT01379768|20531371|P1|Overall Study|Adverse Event|1
5935400|NCT01379703|20531394|P3|9 Months Through 18 Months|Reason Unknown|0
5935401|NCT01379703|20531395|P2|9 Months Through 18 Months|Reason Unknown|23
5935402|NCT01379703|20531396|P1|9 Months Through 18 Months|Reason Unknown|0
5935403|NCT01379703|20531394|P3|9 Months Through 18 Months|Fatigue|0
5935404|NCT01379703|20531395|P2|9 Months Through 18 Months|Fatigue|1
5935405|NCT01379703|20531396|P1|9 Months Through 18 Months|Fatigue|0
5935406|NCT01379703|20531394|P3|9 Months Through 18 Months|Tuberculosis/TB treatment|0
5935407|NCT01379703|20531395|P2|9 Months Through 18 Months|Tuberculosis/TB treatment|2
5935408|NCT01379703|20531396|P1|9 Months Through 18 Months|Tuberculosis/TB treatment|0
5935409|NCT01379703|20531394|P3|9 Months Through 18 Months|Patient Noncompliance|0
5935410|NCT01379703|20531395|P2|9 Months Through 18 Months|Patient Noncompliance|4
5935411|NCT01379703|20531396|P1|9 Months Through 18 Months|Patient Noncompliance|0
5935412|NCT01379703|20531394|P3|9 Months Through 18 Months|Treatment failure|0
5935413|NCT01379703|20531395|P2|9 Months Through 18 Months|Treatment failure|5
5935414|NCT01379703|20531396|P1|9 Months Through 18 Months|Treatment failure|0
5935415|NCT01379703|20531394|P3|9 Months Through 18 Months|Adverse Event|0
5935416|NCT01379703|20531395|P2|9 Months Through 18 Months|Adverse Event|6
5935417|NCT01379703|20531396|P1|9 Months Through 18 Months|Adverse Event|0
5935418|NCT01379703|20531394|P3|9 Months Through 18 Months|Withdrawal by Subject|0
5935419|NCT01379703|20531395|P2|9 Months Through 18 Months|Withdrawal by Subject|11
5935420|NCT01379703|20531396|P1|9 Months Through 18 Months|Withdrawal by Subject|0
5935421|NCT01379703|20531394|P3|9 Months Through 18 Months|Lost to Follow-up|0
5935422|NCT01379703|20531395|P2|9 Months Through 18 Months|Lost to Follow-up|178
5935423|NCT01379703|20531396|P1|9 Months Through 18 Months|Lost to Follow-up|0
5935424|NCT01379703|20531394|P3|Study Start Through 9 Months|Reason unknown|24
5935425|NCT01379703|20531395|P2|Study Start Through 9 Months|Reason unknown|31
5935426|NCT01379703|20531396|P1|Study Start Through 9 Months|Reason unknown|2
5935427|NCT01379703|20531394|P3|Study Start Through 9 Months|Increased triglycerides|0
5935428|NCT01379703|20531395|P2|Study Start Through 9 Months|Increased triglycerides|1
5935429|NCT01379703|20531396|P1|Study Start Through 9 Months|Increased triglycerides|0
5935430|NCT01379703|20531394|P3|Study Start Through 9 Months|Poor general condition|0
5935431|NCT01379703|20531395|P2|Study Start Through 9 Months|Poor general condition|1
5935432|NCT01379703|20531396|P1|Study Start Through 9 Months|Poor general condition|0
5935433|NCT01379703|20531394|P3|Study Start Through 9 Months|Medication not available|1
5935434|NCT01379703|20531395|P2|Study Start Through 9 Months|Medication not available|2
5935435|NCT01379703|20531396|P1|Study Start Through 9 Months|Medication not available|0
5935436|NCT01379703|20531394|P3|Study Start Through 9 Months|Tuberculosis/TB treatment|0
5935437|NCT01379703|20531395|P2|Study Start Through 9 Months|Tuberculosis/TB treatment|4
5935438|NCT01379703|20531396|P1|Study Start Through 9 Months|Tuberculosis/TB treatment|0
5935439|NCT01379703|20531394|P3|Study Start Through 9 Months|Patient Noncompliance|1
5935440|NCT01379703|20531395|P2|Study Start Through 9 Months|Patient Noncompliance|0
5935441|NCT01379703|20531396|P1|Study Start Through 9 Months|Patient Noncompliance|0
5935442|NCT01379703|20531394|P3|Study Start Through 9 Months|Treatment Failure|2
5935443|NCT01379703|20531395|P2|Study Start Through 9 Months|Treatment Failure|2
5935444|NCT01379703|20531396|P1|Study Start Through 9 Months|Treatment Failure|0
5935445|NCT01379703|20531394|P3|Study Start Through 9 Months|Withdrawal by Subject|1
5935446|NCT01379703|20531395|P2|Study Start Through 9 Months|Withdrawal by Subject|6
5935447|NCT01379703|20531396|P1|Study Start Through 9 Months|Withdrawal by Subject|0
5935448|NCT01379703|20531394|P3|Study Start Through 9 Months|Adverse Event|10
5935449|NCT01379703|20531395|P2|Study Start Through 9 Months|Adverse Event|14
5935450|NCT01379703|20531396|P1|Study Start Through 9 Months|Adverse Event|0
5935451|NCT01379703|20531394|P3|Study Start Through 9 Months|Lost to Follow-up|104
5935452|NCT01379703|20531395|P2|Study Start Through 9 Months|Lost to Follow-up|61
5935453|NCT01379703|20531396|P1|Study Start Through 9 Months|Lost to Follow-up|2
5935456|NCT01379534|20531508|P2|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|0
5935457|NCT01379534|20531509|P1|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|1
5935458|NCT01379534|20531508|P2|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|1
5935459|NCT01379534|20531509|P1|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|0
5935460|NCT01379534|20531508|P2|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|0
5935461|NCT01379534|20531509|P1|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|3
5935462|NCT01379534|20531508|P2|Tumor Assessment Follow-up (f/u) Phase|Death|1
5935463|NCT01379534|20531509|P1|Tumor Assessment Follow-up (f/u) Phase|Death|0
5935464|NCT01379534|20531508|P2|Treatment Phase|Adverse Event|7
5935465|NCT01379534|20531509|P1|Treatment Phase|Adverse Event|7
5935466|NCT01379534|20531508|P2|Treatment Phase|Progressive disease|22
5935467|NCT01379534|20531509|P1|Treatment Phase|Progressive disease|13
5935468|NCT01379534|20531508|P2|Treatment Phase|Withdrawal by Subject|2
5935469|NCT01379534|20531509|P1|Treatment Phase|Withdrawal by Subject|2
5935470|NCT01379521|20531529|P2|Post-Treatment Evaluations|Death|0
5935471|NCT01379521|20531530|P1|Post-Treatment Evaluations|Death|1
5935472|NCT01379521|20531529|P2|Post-Treatment Evaluations|Withdrawal by Subject|1
5935473|NCT01379521|20531530|P1|Post-Treatment Evaluations|Withdrawal by Subject|2
5935474|NCT01379521|20531529|P2|Post-Treatment Evaluations|Disease Progression|20
5935475|NCT01379521|20531530|P1|Post-Treatment Evaluations|Disease Progression|22
5935476|NCT01379521|20531529|P2|Overall Study -Treatment Period|Death|1
5935477|NCT01379521|20531530|P1|Overall Study -Treatment Period|Death|2
5935478|NCT01379521|20531529|P2|Overall Study -Treatment Period|Administrative Problems|0
5935479|NCT01379521|20531530|P1|Overall Study -Treatment Period|Administrative Problems|1
5935480|NCT01379521|20531529|P2|Overall Study -Treatment Period|Withdrawal by Subject|0
5935481|NCT01379521|20531530|P1|Overall Study -Treatment Period|Withdrawal by Subject|3
5935482|NCT01379521|20531529|P2|Overall Study -Treatment Period|Protocol Deviation|2
5935483|NCT01379521|20531530|P1|Overall Study -Treatment Period|Protocol Deviation|0
5935484|NCT01379521|20531529|P2|Overall Study -Treatment Period|New Cancer Therapy|0
5935485|NCT01379521|20531530|P1|Overall Study -Treatment Period|New Cancer Therapy|1
5935486|NCT01379521|20531529|P2|Overall Study -Treatment Period|Disease Progression|22
5935487|NCT01379521|20531530|P1|Overall Study -Treatment Period|Disease Progression|23
5935488|NCT01379521|20531529|P2|Overall Study -Treatment Period|Abnormal test procedure results|1
5935489|NCT01379521|20531530|P1|Overall Study -Treatment Period|Abnormal test procedure results|0
5935490|NCT01379521|20531529|P2|Overall Study -Treatment Period|Adverse Event|0
5935491|NCT01379521|20531530|P1|Overall Study -Treatment Period|Adverse Event|3
5935492|NCT01379508|20531552|P4|Extension Period Weeks 109-156|Protocol Violation|0
5935493|NCT01379508|20531553|P3|Extension Period Weeks 109-156|Protocol Violation|0
5935494|NCT01379508|20531554|P2|Extension Period Weeks 109-156|Protocol Violation|1
5935495|NCT01379508|20531555|P1|Extension Period Weeks 109-156|Protocol Violation|2
5935496|NCT01379508|20531552|P4|Extension Period Weeks 109-156|Administrative problems|0
5935497|NCT01379508|20531553|P3|Extension Period Weeks 109-156|Administrative problems|1
5935498|NCT01379508|20531554|P2|Extension Period Weeks 109-156|Administrative problems|0
5935499|NCT01379508|20531555|P1|Extension Period Weeks 109-156|Administrative problems|3
5935500|NCT01379508|20531552|P4|Extension Period Weeks 109-156|Lost to Follow-up|0
5935501|NCT01379508|20531553|P3|Extension Period Weeks 109-156|Lost to Follow-up|5
5935502|NCT01379508|20531554|P2|Extension Period Weeks 109-156|Lost to Follow-up|1
5935503|NCT01379508|20531555|P1|Extension Period Weeks 109-156|Lost to Follow-up|6
5935504|NCT01379508|20531552|P4|Extension Period Weeks 109-156|Withdrawal by Subject|0
5935505|NCT01379508|20531553|P3|Extension Period Weeks 109-156|Withdrawal by Subject|8
5935506|NCT01379508|20531554|P2|Extension Period Weeks 109-156|Withdrawal by Subject|1
5935507|NCT01379508|20531555|P1|Extension Period Weeks 109-156|Withdrawal by Subject|8
5935508|NCT01379508|20531552|P4|Treatment to Week 104|Protocol Violation|0
5935509|NCT01379508|20531553|P3|Treatment to Week 104|Protocol Violation|1
5935510|NCT01379508|20531554|P2|Treatment to Week 104|Protocol Violation|1
5935511|NCT01379508|20531555|P1|Treatment to Week 104|Protocol Violation|1
5935512|NCT01379508|20531552|P4|Treatment to Week 104|Administrative problems|0
5935513|NCT01379508|20531553|P3|Treatment to Week 104|Administrative problems|0
5935514|NCT01379508|20531554|P2|Treatment to Week 104|Administrative problems|1
5935515|NCT01379508|20531555|P1|Treatment to Week 104|Administrative problems|3
5935516|NCT01379508|20531552|P4|Treatment to Week 104|Lost to Follow-up|0
5935517|NCT01379508|20531553|P3|Treatment to Week 104|Lost to Follow-up|3
5935518|NCT01379508|20531554|P2|Treatment to Week 104|Lost to Follow-up|0
5935519|NCT01379508|20531555|P1|Treatment to Week 104|Lost to Follow-up|5
5935520|NCT01379508|20531552|P4|Treatment to Week 104|Withdrawal by Subject|0
5935521|NCT01379508|20531553|P3|Treatment to Week 104|Withdrawal by Subject|4
5935522|NCT01379508|20531554|P2|Treatment to Week 104|Withdrawal by Subject|1
5935523|NCT01379508|20531555|P1|Treatment to Week 104|Withdrawal by Subject|6
5935524|NCT01379508|20531552|P4|Treatment to Week 104|Abnormal test procedure result(s)|0
5935525|NCT01379508|20531553|P3|Treatment to Week 104|Abnormal test procedure result(s)|0
5935526|NCT01379508|20531554|P2|Treatment to Week 104|Abnormal test procedure result(s)|0
5935527|NCT01379508|20531555|P1|Treatment to Week 104|Abnormal test procedure result(s)|1
5935528|NCT01379508|20531552|P4|Treatment to Week 104|Abnormal lab value|0
5935529|NCT01379508|20531553|P3|Treatment to Week 104|Abnormal lab value|0
5935530|NCT01379508|20531554|P2|Treatment to Week 104|Abnormal lab value|0
5935531|NCT01379508|20531555|P1|Treatment to Week 104|Abnormal lab value|1
5935532|NCT01379508|20531552|P4|Treatment to Week 104|Adverse Event|0
5935533|NCT01379508|20531553|P3|Treatment to Week 104|Adverse Event|5
5935534|NCT01379508|20531554|P2|Treatment to Week 104|Adverse Event|0
5935535|NCT01379508|20531555|P1|Treatment to Week 104|Adverse Event|2
5935536|NCT01379274|20531581|P1|Overall Study|funding withdrawn|1
5935537|NCT01378975|20531641|P2|Overall Study|Withdrew Consent|3
5935538|NCT01378975|20531642|P1|Overall Study|Withdrew Consent|4
5935539|NCT01378975|20531641|P2|Overall Study|Lost to Follow-up|1
5935540|NCT01378975|20531642|P1|Overall Study|Lost to Follow-up|4
5935541|NCT01378975|20531641|P2|Overall Study|Investigator Request|0
5935542|NCT01378975|20531642|P1|Overall Study|Investigator Request|1
5935543|NCT01378975|20531641|P2|Overall Study|Death|46
5935544|NCT01378975|20531642|P1|Overall Study|Death|77
5935545|NCT01378962|20531668|P1|Overall Study|Other|2
5935546|NCT01378962|20531668|P1|Overall Study|Lost to Follow-up|1
5935547|NCT01378962|20531668|P1|Overall Study|Death|14
5935548|NCT01378429|20531694|P2|Overall Study|Noncompliance with study drug|0
5935549|NCT01378429|20531695|P1|Overall Study|Noncompliance with study drug|1
5935550|NCT01378325|20531808|P2|Overall Study|Protocol Violation|1
5935551|NCT01378325|20531809|P1|Overall Study|Protocol Violation|0
5935552|NCT01378195|20531878|P2|Overall Study|Lost to Follow-up|18
5935553|NCT01378195|20531879|P1|Overall Study|Lost to Follow-up|29
5935554|NCT01378117|20531892|P3|Overall Study|discharged before med given|1
5935555|NCT01378117|20531893|P2|Overall Study|discharged before med given|0
5935556|NCT01378117|20531894|P1|Overall Study|discharged before med given|2
5935557|NCT01378117|20531892|P3|Overall Study|withdrawal|2
5935558|NCT01378117|20531893|P2|Overall Study|withdrawal|1
5935559|NCT01378117|20531894|P1|Overall Study|withdrawal|2
5935560|NCT01378104|20531928|P2|Overall Study|Withdrawal by Subject|13
5935561|NCT01378104|20531929|P1|Overall Study|Withdrawal by Subject|12
5935562|NCT01378104|20531928|P2|Overall Study|Lack of Efficacy|5
5935563|NCT01378104|20531929|P1|Overall Study|Lack of Efficacy|7
5935564|NCT01378104|20531928|P2|Overall Study|Adverse Event|8
5935565|NCT01378104|20531929|P1|Overall Study|Adverse Event|8
5935566|NCT01377987|20531974|P2|Washout (7 Days)|Withdrawal by Subject|1
5935567|NCT01377987|20531975|P1|Washout (7 Days)|Withdrawal by Subject|1
5935568|NCT01377922|20531993|P2|Overall Study|rescue tx after part 2, entered part 4|0
5935569|NCT01377922|20531994|P1|Overall Study|rescue tx after part 2, entered part 4|1
5935570|NCT01377480|20532079|P4|Overall Study|Other|6
5935571|NCT01377480|20532080|P3|Overall Study|Other|7
5935572|NCT01377480|20532081|P2|Overall Study|Other|0
5935573|NCT01377480|20532082|P1|Overall Study|Other|0
5935574|NCT01377480|20532079|P4|Overall Study|Serious adverse event|1
5935575|NCT01377480|20532080|P3|Overall Study|Serious adverse event|1
5935576|NCT01377480|20532081|P2|Overall Study|Serious adverse event|0
5935577|NCT01377480|20532082|P1|Overall Study|Serious adverse event|0
5935578|NCT01377480|20532079|P4|Overall Study|Withdrawal by Subject|0
5935579|NCT01377480|20532080|P3|Overall Study|Withdrawal by Subject|1
5935580|NCT01377480|20532081|P2|Overall Study|Withdrawal by Subject|0
5935581|NCT01377480|20532082|P1|Overall Study|Withdrawal by Subject|0
5935582|NCT01377480|20532079|P4|Overall Study|Evidence of drug-induced hepatotoxicity|0
5935583|NCT01377480|20532080|P3|Overall Study|Evidence of drug-induced hepatotoxicity|1
5935584|NCT01377480|20532081|P2|Overall Study|Evidence of drug-induced hepatotoxicity|1
5935585|NCT01377480|20532082|P1|Overall Study|Evidence of drug-induced hepatotoxicity|0
5935586|NCT01377480|20532079|P4|Overall Study|Protocol Violation|4
5935587|NCT01377480|20532080|P3|Overall Study|Protocol Violation|0
5935588|NCT01377480|20532081|P2|Overall Study|Protocol Violation|0
5935589|NCT01377480|20532082|P1|Overall Study|Protocol Violation|0
5935590|NCT01377389|20532158|P1|Overall Study|Screen failure|2
5935591|NCT01377389|20532158|P1|Overall Study|Withdrawal by Subject|1
5935592|NCT01377233|20532172|P5|Double-blind|Administrative or other|1
5935593|NCT01377233|20532173|P4|Double-blind|Administrative or other|1
5935594|NCT01377233|20532174|P3|Double-blind|Administrative or other|0
5935595|NCT01377233|20532175|P2|Double-blind|Administrative or other|0
5935596|NCT01377233|20532176|P1|Double-blind|Administrative or other|0
5935597|NCT01377233|20532172|P5|Double-blind|Withdrawal by Subject|0
5935598|NCT01377233|20532173|P4|Double-blind|Withdrawal by Subject|1
5935599|NCT01377233|20532174|P3|Double-blind|Withdrawal by Subject|0
5935600|NCT01377233|20532175|P2|Double-blind|Withdrawal by Subject|0
5935601|NCT01377233|20532176|P1|Double-blind|Withdrawal by Subject|0
5935602|NCT01377233|20532172|P5|Double-blind|Protocol Violation|1
5935603|NCT01377233|20532173|P4|Double-blind|Protocol Violation|0
5935604|NCT01377233|20532174|P3|Double-blind|Protocol Violation|0
5935605|NCT01377233|20532175|P2|Double-blind|Protocol Violation|0
5935606|NCT01377233|20532176|P1|Double-blind|Protocol Violation|0
5935607|NCT01377233|20532172|P5|Double-blind|Adverse Event|0
5935608|NCT01377233|20532173|P4|Double-blind|Adverse Event|2
5935609|NCT01377233|20532174|P3|Double-blind|Adverse Event|2
5935610|NCT01377233|20532175|P2|Double-blind|Adverse Event|1
5935611|NCT01377233|20532176|P1|Double-blind|Adverse Event|0
5935612|NCT01377233|20532172|P5|Open-label|Withdrawal by Subject|0
5935613|NCT01377233|20532173|P4|Open-label|Withdrawal by Subject|0
5935614|NCT01377233|20532174|P3|Open-label|Withdrawal by Subject|0
5935615|NCT01377233|20532175|P2|Open-label|Withdrawal by Subject|0
5935616|NCT01377233|20532176|P1|Open-label|Withdrawal by Subject|3
5935617|NCT01377233|20532172|P5|Open-label|Adverse Event|0
5935618|NCT01377233|20532173|P4|Open-label|Adverse Event|0
5935619|NCT01377233|20532174|P3|Open-label|Adverse Event|0
5935620|NCT01377233|20532175|P2|Open-label|Adverse Event|0
5935621|NCT01377233|20532176|P1|Open-label|Adverse Event|1
5935622|NCT01377194|20532203|P3|Overall Study|Lost to Follow-up|11
5935623|NCT01377194|20532204|P2|Overall Study|Lost to Follow-up|8
5935624|NCT01377194|20532205|P1|Overall Study|Lost to Follow-up|14
5935625|NCT01377194|20532203|P3|Overall Study|Withdrawal by Subject|7
5935626|NCT01377194|20532204|P2|Overall Study|Withdrawal by Subject|10
5935627|NCT01377194|20532205|P1|Overall Study|Withdrawal by Subject|8
5935628|NCT01377194|20532203|P3|Overall Study|Protocol Violation|6
5935629|NCT01377194|20532204|P2|Overall Study|Protocol Violation|10
5935630|NCT01377194|20532205|P1|Overall Study|Protocol Violation|4
5935631|NCT01377194|20532203|P3|Overall Study|Lack of Efficacy|3
5935632|NCT01377194|20532204|P2|Overall Study|Lack of Efficacy|3
5935633|NCT01377194|20532205|P1|Overall Study|Lack of Efficacy|3
5935634|NCT01377194|20532203|P3|Overall Study|Adverse Event|19
5935635|NCT01377194|20532204|P2|Overall Study|Adverse Event|12
5935636|NCT01377194|20532205|P1|Overall Study|Adverse Event|3
5935637|NCT01377012|20532219|P3|Extension Study, Weeks 104-260|Adverse Event|1
5935638|NCT01377012|20532220|P2|Extension Study, Weeks 104-260|Adverse Event|2
5935639|NCT01377012|20532221|P1|Extension Study, Weeks 104-260|Adverse Event|0
5935640|NCT01377012|20532219|P3|Extension Study, Weeks 104-260|Lost to Follow-up|1
5935641|NCT01377012|20532220|P2|Extension Study, Weeks 104-260|Lost to Follow-up|0
5935642|NCT01377012|20532221|P1|Extension Study, Weeks 104-260|Lost to Follow-up|0
5935643|NCT01377012|20532219|P3|Extension Study, Weeks 104-260|Physician Decision|0
5935644|NCT01377012|20532220|P2|Extension Study, Weeks 104-260|Physician Decision|0
5935645|NCT01377012|20532221|P1|Extension Study, Weeks 104-260|Physician Decision|1
5935646|NCT01377012|20532219|P3|Extension Study, Weeks 104-260|Withdrawal by Subject|3
5935647|NCT01377012|20532220|P2|Extension Study, Weeks 104-260|Withdrawal by Subject|0
5935648|NCT01377012|20532221|P1|Extension Study, Weeks 104-260|Withdrawal by Subject|1
5935649|NCT01377012|20532219|P3|Extension Study, Weeks 104-260|Study terminated by sponsor|63
5935650|NCT01377012|20532220|P2|Extension Study, Weeks 104-260|Study terminated by sponsor|69
5935651|NCT01377012|20532221|P1|Extension Study, Weeks 104-260|Study terminated by sponsor|52
5935652|NCT01377012|20532219|P3|Extension Study, Weeks 104-260|Lack of Efficacy|0
5935653|NCT01377012|20532220|P2|Extension Study, Weeks 104-260|Lack of Efficacy|0
5935654|NCT01377012|20532221|P1|Extension Study, Weeks 104-260|Lack of Efficacy|3
5935655|NCT01377012|20532219|P3|Core Study|Adverse Event|13
5935656|NCT01377012|20532220|P2|Core Study|Adverse Event|14
5935657|NCT01377012|20532221|P1|Core Study|Adverse Event|10
5935658|NCT01377012|20532219|P3|Core Study|Death|1
5935659|NCT01377012|20532220|P2|Core Study|Death|1
5935660|NCT01377012|20532221|P1|Core Study|Death|1
5935661|NCT01377012|20532219|P3|Core Study|Lack of Efficacy|37
5935662|NCT01377012|20532220|P2|Core Study|Lack of Efficacy|28
5935663|NCT01377012|20532221|P1|Core Study|Lack of Efficacy|41
5935664|NCT01377012|20532219|P3|Core Study|Lost to Follow-up|4
5935665|NCT01377012|20532220|P2|Core Study|Lost to Follow-up|5
5935666|NCT01377012|20532221|P1|Core Study|Lost to Follow-up|7
5935667|NCT01377012|20532219|P3|Core Study|No Longer require treatment|1
5935668|NCT01377012|20532220|P2|Core Study|No Longer require treatment|0
5935669|NCT01377012|20532221|P1|Core Study|No Longer require treatment|0
5935670|NCT01377012|20532219|P3|Core Study|Non-Compliant with study treatment|1
5935671|NCT01377012|20532220|P2|Core Study|Non-Compliant with study treatment|0
5935672|NCT01377012|20532221|P1|Core Study|Non-Compliant with study treatment|0
5935673|NCT01377012|20532219|P3|Core Study|Physician Decision|10
5935674|NCT01377012|20532220|P2|Core Study|Physician Decision|4
5935675|NCT01377012|20532221|P1|Core Study|Physician Decision|5
5935676|NCT01377012|20532219|P3|Core Study|Pregnancy|1
5935677|NCT01377012|20532220|P2|Core Study|Pregnancy|0
5935678|NCT01377012|20532221|P1|Core Study|Pregnancy|0
5935679|NCT01377012|20532219|P3|Core Study|Protocol Violation|2
5935680|NCT01377012|20532220|P2|Core Study|Protocol Violation|3
5935681|NCT01377012|20532221|P1|Core Study|Protocol Violation|7
5935682|NCT01377012|20532219|P3|Core Study|Withdrawal by Subject|18
5935683|NCT01377012|20532220|P2|Core Study|Withdrawal by Subject|23
5935684|NCT01377012|20532221|P1|Core Study|Withdrawal by Subject|15
5935685|NCT01377012|20532219|P3|Core Study|Technical problems|0
5935686|NCT01377012|20532220|P2|Core Study|Technical problems|0
5935687|NCT01377012|20532221|P1|Core Study|Technical problems|1
5935688|NCT01377012|20532219|P3|Core Study|Study terminated by Sponsor|46
5935689|NCT01377012|20532220|P2|Core Study|Study terminated by Sponsor|54
5935690|NCT01377012|20532221|P1|Core Study|Study terminated by Sponsor|47
5935691|NCT01376908|20532258|P2|Overall Study|Withdrawal by Subject|2
5935692|NCT01376908|20532259|P1|Overall Study|Withdrawal by Subject|1
5935693|NCT01376908|20532258|P2|Overall Study|Protocol Violation|1
5935694|NCT01376908|20532259|P1|Overall Study|Protocol Violation|1
5935695|NCT01376804|20532292|P1|Treatment Period|Patient did not receive study drug|1
5935696|NCT01376804|20532292|P1|Treatment Period|Adverse Event|6
5935697|NCT01376804|20532292|P1|Treatment Period|Withdrawal by Subject|1
5935698|NCT01376700|20532303|P1|Overall Study|Low or high titer inhibitor|8
5935699|NCT01376700|20532303|P1|Overall Study|Sponsor terminated study early|8
5935700|NCT01376388|20532365|P1|Overall Study|Withdrawal by Subject|3
5935701|NCT01376388|20532365|P1|Overall Study|Lack of Efficacy|2
5935702|NCT01376388|20532365|P1|Overall Study|Adverse Event|13
5935703|NCT01376349|20532403|P3|Raondomized Treatment|Alternative Treatment|1
5935704|NCT01376349|20532404|P2|Raondomized Treatment|Alternative Treatment|0
5935705|NCT01376349|20532405|P1|Raondomized Treatment|Alternative Treatment|0
5935706|NCT01376349|20532403|P3|Raondomized Treatment|Unkown|1
5935707|NCT01376349|20532404|P2|Raondomized Treatment|Unkown|2
5935708|NCT01376349|20532405|P1|Raondomized Treatment|Unkown|1
5935709|NCT01376349|20532403|P3|Raondomized Treatment|Adverse Event|14
5935710|NCT01376349|20532404|P2|Raondomized Treatment|Adverse Event|17
5935711|NCT01376349|20532405|P1|Raondomized Treatment|Adverse Event|13
5935712|NCT01376349|20532403|P3|Raondomized Treatment|Withdrawal by Subject|13
5935713|NCT01376349|20532404|P2|Raondomized Treatment|Withdrawal by Subject|16
5935714|NCT01376349|20532405|P1|Raondomized Treatment|Withdrawal by Subject|10
5935715|NCT01376323|20532419|P5|Overall Study|Withdrawal by Subject|0
5935716|NCT01376323|20532420|P4|Overall Study|Withdrawal by Subject|0
5935717|NCT01376323|20532421|P3|Overall Study|Withdrawal by Subject|1
5935718|NCT01376323|20532422|P2|Overall Study|Withdrawal by Subject|1
5935719|NCT01376323|20532423|P1|Overall Study|Withdrawal by Subject|0
5935720|NCT01376323|20532419|P5|Overall Study|Physician Decision|1
5935721|NCT01376323|20532420|P4|Overall Study|Physician Decision|1
5935722|NCT01376323|20532421|P3|Overall Study|Physician Decision|2
5935723|NCT01376323|20532422|P2|Overall Study|Physician Decision|0
5935724|NCT01376323|20532423|P1|Overall Study|Physician Decision|1
5935725|NCT01376323|20532419|P5|Overall Study|Lost to Follow-up|0
5935726|NCT01376323|20532420|P4|Overall Study|Lost to Follow-up|2
5935727|NCT01376323|20532421|P3|Overall Study|Lost to Follow-up|0
5935728|NCT01376323|20532422|P2|Overall Study|Lost to Follow-up|0
5935729|NCT01376323|20532423|P1|Overall Study|Lost to Follow-up|0
5935730|NCT01376323|20532419|P5|Overall Study|Adverse Event|0
5935731|NCT01376323|20532420|P4|Overall Study|Adverse Event|2
5935732|NCT01376323|20532421|P3|Overall Study|Adverse Event|0
5935733|NCT01376323|20532422|P2|Overall Study|Adverse Event|0
5935734|NCT01376323|20532423|P1|Overall Study|Adverse Event|1
5935735|NCT01376310|20532507|P2|Overall Study|Lost to Follow-up|0
5935736|NCT01376310|20532508|P1|Overall Study|Lost to Follow-up|1
5935737|NCT01376310|20532507|P2|Overall Study|Physician Decision|7
5935738|NCT01376310|20532508|P1|Overall Study|Physician Decision|26
5935739|NCT01376310|20532507|P2|Overall Study|Withdrawal by Subject|2
5935740|NCT01376310|20532508|P1|Overall Study|Withdrawal by Subject|8
5935741|NCT01376310|20532507|P2|Overall Study|Study closed/terminated|2
5935742|NCT01376310|20532508|P1|Overall Study|Study closed/terminated|1
5935743|NCT01376245|20532527|P5|24-week, Double-blind Treatment Period|Withdrawal by Subject|3
5935744|NCT01376245|20532528|P4|24-week, Double-blind Treatment Period|Withdrawal by Subject|6
5935745|NCT01376245|20532529|P3|24-week, Double-blind Treatment Period|Withdrawal by Subject|9
5935746|NCT01376245|20532530|P2|24-week, Double-blind Treatment Period|Withdrawal by Subject|6
5935747|NCT01376245|20532531|P1|24-week, Double-blind Treatment Period|Withdrawal by Subject|0
5935748|NCT01376245|20532527|P5|24-week, Double-blind Treatment Period|Physician Decision|0
5935749|NCT01376245|20532528|P4|24-week, Double-blind Treatment Period|Physician Decision|1
5935750|NCT01376245|20532529|P3|24-week, Double-blind Treatment Period|Physician Decision|1
5935751|NCT01376245|20532530|P2|24-week, Double-blind Treatment Period|Physician Decision|0
5935752|NCT01376245|20532531|P1|24-week, Double-blind Treatment Period|Physician Decision|0
5935753|NCT01376245|20532527|P5|24-week, Double-blind Treatment Period|Lost to Follow-up|1
5935754|NCT01376245|20532528|P4|24-week, Double-blind Treatment Period|Lost to Follow-up|1
5935755|NCT01376245|20532529|P3|24-week, Double-blind Treatment Period|Lost to Follow-up|0
5935756|NCT01376245|20532530|P2|24-week, Double-blind Treatment Period|Lost to Follow-up|2
5935757|NCT01376245|20532531|P1|24-week, Double-blind Treatment Period|Lost to Follow-up|0
5935758|NCT01376245|20532527|P5|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0
5935759|NCT01376245|20532528|P4|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|1
5935760|NCT01376245|20532529|P3|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|3
5935761|NCT01376245|20532530|P2|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|2
5935762|NCT01376245|20532531|P1|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0
5935763|NCT01376245|20532527|P5|24-week, Double-blind Treatment Period|Protocol Violation|1
5935764|NCT01376245|20532528|P4|24-week, Double-blind Treatment Period|Protocol Violation|2
5935765|NCT01376245|20532529|P3|24-week, Double-blind Treatment Period|Protocol Violation|0
5935766|NCT01376245|20532530|P2|24-week, Double-blind Treatment Period|Protocol Violation|2
5935767|NCT01376245|20532531|P1|24-week, Double-blind Treatment Period|Protocol Violation|0
5935768|NCT01376245|20532527|P5|24-week, Double-blind Treatment Period|Lack of Efficacy|3
5935769|NCT01376245|20532528|P4|24-week, Double-blind Treatment Period|Lack of Efficacy|4
5935770|NCT01376245|20532529|P3|24-week, Double-blind Treatment Period|Lack of Efficacy|5
5935771|NCT01376245|20532530|P2|24-week, Double-blind Treatment Period|Lack of Efficacy|4
5935772|NCT01376245|20532531|P1|24-week, Double-blind Treatment Period|Lack of Efficacy|0
5935773|NCT01376245|20532527|P5|24-week, Double-blind Treatment Period|Adverse Event|18
5935774|NCT01376245|20532528|P4|24-week, Double-blind Treatment Period|Adverse Event|8
5935775|NCT01376245|20532529|P3|24-week, Double-blind Treatment Period|Adverse Event|7
5935776|NCT01376245|20532530|P2|24-week, Double-blind Treatment Period|Adverse Event|16
5935777|NCT01376245|20532531|P1|24-week, Double-blind Treatment Period|Adverse Event|0
5935778|NCT01376245|20532527|P5|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0
5935779|NCT01376245|20532528|P4|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0
5935780|NCT01376245|20532529|P3|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0
5935781|NCT01376245|20532530|P2|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0
5935782|NCT01376245|20532531|P1|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|28
5935783|NCT01376245|20532527|P5|2-wk Single-blind Placebo Run-in Period|Physician Decision|0
5935784|NCT01376245|20532528|P4|2-wk Single-blind Placebo Run-in Period|Physician Decision|0
5935785|NCT01376245|20532529|P3|2-wk Single-blind Placebo Run-in Period|Physician Decision|0
5935786|NCT01376245|20532530|P2|2-wk Single-blind Placebo Run-in Period|Physician Decision|0
5935787|NCT01376245|20532531|P1|2-wk Single-blind Placebo Run-in Period|Physician Decision|2
5935788|NCT01376245|20532527|P5|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0
5935789|NCT01376245|20532528|P4|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0
5935790|NCT01376245|20532529|P3|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0
5935791|NCT01376245|20532530|P2|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0
5935792|NCT01376245|20532531|P1|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|1
5935793|NCT01376245|20532527|P5|2-wk Single-blind Placebo Run-in Period|Adverse Event|0
5935794|NCT01376245|20532528|P4|2-wk Single-blind Placebo Run-in Period|Adverse Event|0
5935795|NCT01376245|20532529|P3|2-wk Single-blind Placebo Run-in Period|Adverse Event|0
5935796|NCT01376245|20532530|P2|2-wk Single-blind Placebo Run-in Period|Adverse Event|0
5935797|NCT01376245|20532531|P1|2-wk Single-blind Placebo Run-in Period|Adverse Event|4
5935798|NCT01376245|20532527|P5|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0
5935799|NCT01376245|20532528|P4|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0
5935800|NCT01376245|20532529|P3|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0
5935801|NCT01376245|20532530|P2|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0
5935802|NCT01376245|20532531|P1|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|66
5935803|NCT01376167|20532548|P3|Overall Study|Withdrawal by Subject|4
5935804|NCT01376167|20532549|P2|Overall Study|Withdrawal by Subject|5
5935805|NCT01376167|20532550|P1|Overall Study|Withdrawal by Subject|1
5935806|NCT01376167|20532548|P3|Overall Study|Physician Decision|0
5935807|NCT01376167|20532549|P2|Overall Study|Physician Decision|1
5935808|NCT01376167|20532550|P1|Overall Study|Physician Decision|1
5935809|NCT01376167|20532548|P3|Overall Study|Lost to Follow-up|2
5935810|NCT01376167|20532549|P2|Overall Study|Lost to Follow-up|4
5935811|NCT01376167|20532550|P1|Overall Study|Lost to Follow-up|2
5935812|NCT01376089|20532621|P2|Overall Study|Patient received no contrast media|4
5935813|NCT01376089|20532622|P1|Overall Study|Patient received no contrast media|3
5935814|NCT01376037|20532645|P2|Overall Study|Lost to Follow-up|2
5935815|NCT01376037|20532646|P1|Overall Study|Lost to Follow-up|0
5935816|NCT01375959|20532654|P2|Second Intervention (6 Weeks)|Adverse Event|2
5935817|NCT01375959|20532655|P1|Second Intervention (6 Weeks)|Adverse Event|0
5935818|NCT01375959|20532654|P2|Second Intervention (6 Weeks)|Withdrawal by Subject|1
5935819|NCT01375959|20532655|P1|Second Intervention (6 Weeks)|Withdrawal by Subject|0
5935820|NCT01375959|20532654|P2|First Intervention (6 Weeks)|Adverse Event|3
5935821|NCT01375959|20532655|P1|First Intervention (6 Weeks)|Adverse Event|2
5935822|NCT01375777|20532683|P9|Overall Study|Other|1
5935823|NCT01375777|20532684|P8|Overall Study|Other|0
5935824|NCT01375777|20532685|P7|Overall Study|Other|0
5935825|NCT01375777|20532686|P6|Overall Study|Other|0
5935826|NCT01375777|20532687|P5|Overall Study|Other|0
5935827|NCT01375777|20532688|P4|Overall Study|Other|0
5935828|NCT01375777|20532689|P3|Overall Study|Other|0
5935829|NCT01375777|20532690|P2|Overall Study|Other|1
5935830|NCT01375777|20532691|P1|Overall Study|Other|1
5935831|NCT01375777|20532683|P9|Overall Study|Lost to Follow-up|0
5935832|NCT01375777|20532684|P8|Overall Study|Lost to Follow-up|0
5935833|NCT01375777|20532685|P7|Overall Study|Lost to Follow-up|1
5935834|NCT01375777|20532686|P6|Overall Study|Lost to Follow-up|0
5935835|NCT01375777|20532687|P5|Overall Study|Lost to Follow-up|0
5935836|NCT01375777|20532688|P4|Overall Study|Lost to Follow-up|0
5935837|NCT01375777|20532689|P3|Overall Study|Lost to Follow-up|0
5935838|NCT01375777|20532690|P2|Overall Study|Lost to Follow-up|0
5935839|NCT01375777|20532691|P1|Overall Study|Lost to Follow-up|1
5935840|NCT01375777|20532683|P9|Overall Study|Withdrawal by Subject|1
5935841|NCT01375777|20532684|P8|Overall Study|Withdrawal by Subject|2
5935842|NCT01375777|20532685|P7|Overall Study|Withdrawal by Subject|1
5935843|NCT01375777|20532686|P6|Overall Study|Withdrawal by Subject|1
5935844|NCT01375777|20532687|P5|Overall Study|Withdrawal by Subject|1
5935845|NCT01375777|20532688|P4|Overall Study|Withdrawal by Subject|0
5935846|NCT01375777|20532689|P3|Overall Study|Withdrawal by Subject|1
5935847|NCT01375777|20532690|P2|Overall Study|Withdrawal by Subject|2
5935848|NCT01375777|20532691|P1|Overall Study|Withdrawal by Subject|0
5935849|NCT01375764|20532761|P5|Overall Study|Other|0
5935850|NCT01375764|20532762|P4|Overall Study|Other|1
5935851|NCT01375764|20532763|P3|Overall Study|Other|0
5935852|NCT01375764|20532764|P2|Overall Study|Other|0
5935853|NCT01375764|20532765|P1|Overall Study|Other|0
5935854|NCT01375764|20532761|P5|Overall Study|Withdrawal by Subject|1
5935855|NCT01375764|20532762|P4|Overall Study|Withdrawal by Subject|0
5935856|NCT01375764|20532763|P3|Overall Study|Withdrawal by Subject|0
5935857|NCT01375764|20532764|P2|Overall Study|Withdrawal by Subject|0
5935858|NCT01375764|20532765|P1|Overall Study|Withdrawal by Subject|2
5935859|NCT01375764|20532761|P5|Overall Study|Lost to Follow-up|0
5935860|NCT01375764|20532762|P4|Overall Study|Lost to Follow-up|0
5935861|NCT01375764|20532763|P3|Overall Study|Lost to Follow-up|0
5935862|NCT01375764|20532764|P2|Overall Study|Lost to Follow-up|1
5935863|NCT01375764|20532765|P1|Overall Study|Lost to Follow-up|0
5935864|NCT01375751|20532811|P3|Overall Study|Other|0
5935865|NCT01375751|20532812|P2|Overall Study|Other|1
5935866|NCT01375751|20532813|P1|Overall Study|Other|0
5935867|NCT01375673|20532838|P2|Overall Study|Withdrawal by Subject|1
5935868|NCT01375673|20532839|P1|Overall Study|Withdrawal by Subject|0
5935869|NCT01375608|20532870|P1|Overall Study|Withdrawal by Subject|2
5935870|NCT01375374|20532898|P1|Overall Study|Adverse Event|1
5935871|NCT01375205|20532907|P2|Overall Study|Withdrawal by Subject|1
5935872|NCT01375205|20532908|P1|Overall Study|Withdrawal by Subject|6
5935873|NCT01375205|20532907|P2|Overall Study|Lost to Follow-up|12
5935874|NCT01375205|20532908|P1|Overall Study|Lost to Follow-up|15
5935875|NCT01375075|20532981|P6|Overall Study|Withdrawal by Subject|1
5935876|NCT01375075|20532982|P5|Overall Study|Withdrawal by Subject|0
5935877|NCT01375075|20532983|P4|Overall Study|Withdrawal by Subject|0
5935878|NCT01375075|20532984|P3|Overall Study|Withdrawal by Subject|0
5935879|NCT01375075|20532985|P2|Overall Study|Withdrawal by Subject|1
5935880|NCT01375075|20532986|P1|Overall Study|Withdrawal by Subject|0
5935881|NCT01375075|20532981|P6|Overall Study|Entry Criterion Not Met|1
5935882|NCT01375075|20532982|P5|Overall Study|Entry Criterion Not Met|0
5935883|NCT01375075|20532983|P4|Overall Study|Entry Criterion Not Met|0
5935884|NCT01375075|20532984|P3|Overall Study|Entry Criterion Not Met|0
5935885|NCT01375075|20532985|P2|Overall Study|Entry Criterion Not Met|0
5935886|NCT01375075|20532986|P1|Overall Study|Entry Criterion Not Met|1
5935887|NCT01375075|20532981|P6|Overall Study|Adverse Event|1
5935888|NCT01375075|20532982|P5|Overall Study|Adverse Event|0
5935889|NCT01375075|20532983|P4|Overall Study|Adverse Event|1
5935890|NCT01375075|20532984|P3|Overall Study|Adverse Event|3
5935891|NCT01375075|20532985|P2|Overall Study|Adverse Event|0
5935892|NCT01375075|20532986|P1|Overall Study|Adverse Event|0
5935893|NCT01375049|20533070|P1|Overall Study|Protocol-Specified Withdrawal Criteria|45
5935894|NCT01375049|20533070|P1|Overall Study|Withdrawal by Subject|2
5935895|NCT01375049|20533070|P1|Overall Study|Lost to Follow-up|1
5935896|NCT01375049|20533070|P1|Overall Study|Adverse Event|2
5935897|NCT01375010|20533087|P2|Overall Study|Withdrawal by Subject|2
5935898|NCT01375010|20533088|P1|Overall Study|Withdrawal by Subject|4
5935899|NCT01375010|20533087|P2|Overall Study|Lost to Follow-up|2
5935900|NCT01375010|20533088|P1|Overall Study|Lost to Follow-up|8
5935901|NCT01374971|20533102|P1|Overall Study|Withdrawal by Subject|1
5935902|NCT01374919|20533107|P1|Overall Study|Withdrawal by Subject|2
5935903|NCT01374906|20533114|P2|Overall Study|Unsatisfactory therapeutic effect|19
5935904|NCT01374906|20533115|P1|Overall Study|Unsatisfactory therapeutic effect|11
5935905|NCT01374906|20533114|P2|Overall Study|Withdrawal by Subject|9
5935906|NCT01374906|20533115|P1|Overall Study|Withdrawal by Subject|15
5935907|NCT01374906|20533114|P2|Overall Study|Protocol Violation|2
5935908|NCT01374906|20533115|P1|Overall Study|Protocol Violation|2
5935909|NCT01374906|20533114|P2|Overall Study|Death|2
5935910|NCT01374906|20533115|P1|Overall Study|Death|0
5935911|NCT01374906|20533114|P2|Overall Study|Adverse Event|11
5935912|NCT01374906|20533115|P1|Overall Study|Adverse Event|10
5935913|NCT01374906|20533114|P2|Overall Study|Administrative problems|2
5935914|NCT01374906|20533115|P1|Overall Study|Administrative problems|2
5935915|NCT01374906|20533114|P2|Overall Study|Abnormal laboratory value(s)|3
5935916|NCT01374906|20533115|P1|Overall Study|Abnormal laboratory value(s)|0
5935917|NCT01374568|20533196|P2|Overall Study|Lab unable to analyze BTM|2
5935918|NCT01374568|20533197|P1|Overall Study|Lab unable to analyze BTM|0
5935919|NCT01374516|20533207|P2|Surveillance Expansion Period|Serious adverse event|5
5935920|NCT01374516|20533208|P1|Surveillance Expansion Period|Serious adverse event|20
5935921|NCT01374516|20533207|P2|Surveillance Expansion Period|Lost to Follow-up|45
5935922|NCT01374516|20533208|P1|Surveillance Expansion Period|Lost to Follow-up|73
5935923|NCT01374516|20533207|P2|Surveillance Expansion Period|Withdrawal by Subject|986
5935924|NCT01374516|20533208|P1|Surveillance Expansion Period|Withdrawal by Subject|1870
5935925|NCT01374516|20533207|P2|Surveillance Expansion Period|Protocol Violation|217
5935926|NCT01374516|20533208|P1|Surveillance Expansion Period|Protocol Violation|386
5935927|NCT01374516|20533207|P2|Vaccination Phase (Up to 25 Months)|Serious adverse event|9
5935928|NCT01374516|20533208|P1|Vaccination Phase (Up to 25 Months)|Serious adverse event|7
5935929|NCT01374516|20533207|P2|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|46
5935930|NCT01374516|20533208|P1|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|106
5935931|NCT01374516|20533207|P2|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|240
5935932|NCT01374516|20533208|P1|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|480
5935933|NCT01374516|20533207|P2|Vaccination Phase (Up to 25 Months)|Adverse Event|0
5935934|NCT01374516|20533208|P1|Vaccination Phase (Up to 25 Months)|Adverse Event|3
5935935|NCT01374516|20533207|P2|Vaccination Phase (Up to 25 Months)|Protocol Violation|14
5935936|NCT01374516|20533208|P1|Vaccination Phase (Up to 25 Months)|Protocol Violation|43
5935937|NCT01374451|20533246|P2|Overall Study|Administrative problems|0
5935938|NCT01374451|20533247|P1|Overall Study|Administrative problems|1
5935939|NCT01374425|20533293|P2|Overall Study|Other|43
5935940|NCT01374425|20533294|P1|Overall Study|Other|41
5935941|NCT01374425|20533293|P2|Overall Study|Lost to Follow-up|1
5935942|NCT01374425|20533294|P1|Overall Study|Lost to Follow-up|2
5935943|NCT01374425|20533293|P2|Overall Study|Sponsor Decision|1
5935944|NCT01374425|20533294|P1|Overall Study|Sponsor Decision|0
5935945|NCT01374425|20533293|P2|Overall Study|Protocol Violation|3
5935946|NCT01374425|20533294|P1|Overall Study|Protocol Violation|2
5935947|NCT01374425|20533293|P2|Overall Study|Refused Treatment|24
5935948|NCT01374425|20533294|P1|Overall Study|Refused Treatment|10
5935949|NCT01374425|20533293|P2|Overall Study|Withdrawal by Subject|7
5935950|NCT01374425|20533294|P1|Overall Study|Withdrawal by Subject|6
5935951|NCT01374425|20533293|P2|Overall Study|Death (Adverse Event)|4
5935952|NCT01374425|20533294|P1|Overall Study|Death (Adverse Event)|2
5935953|NCT01374425|20533293|P2|Overall Study|Death (Progression of Disease)|0
5935954|NCT01374425|20533294|P1|Overall Study|Death (Progression of Disease)|1
5935955|NCT01374425|20533293|P2|Overall Study|Adverse Event|18
5935956|NCT01374425|20533294|P1|Overall Study|Adverse Event|29
5935957|NCT01374425|20533293|P2|Overall Study|Clinical Disease Progression|6
5935958|NCT01374425|20533294|P1|Overall Study|Clinical Disease Progression|9
5935959|NCT01374425|20533293|P2|Overall Study|Radiographic Disease Progression|81
5935960|NCT01374425|20533294|P1|Overall Study|Radiographic Disease Progression|86
5935961|NCT01374269|20533374|P2|Overall Study|closed research|2
5935962|NCT01374269|20533375|P1|Overall Study|closed research|1
5935963|NCT01374269|20533374|P2|Overall Study|Lost to Follow-up|3
5935964|NCT01374269|20533375|P1|Overall Study|Lost to Follow-up|1
5935965|NCT01374269|20533374|P2|Overall Study|Withdrawal by Subject|0
5935966|NCT01374269|20533375|P1|Overall Study|Withdrawal by Subject|4
5935967|NCT01374217|20533503|P1|Overall Study|Lack of Efficacy|13
5935968|NCT01374178|20533511|P2|Period 2 (up to 24 Hours After Dosing)|Adverse Event|0
5935969|NCT01374178|20533512|P1|Period 2 (up to 24 Hours After Dosing)|Adverse Event|2
5935970|NCT01374178|20533511|P2|Washout Period of at Least 7 Days|Withdrawal by Subject|0
5935971|NCT01374178|20533512|P1|Washout Period of at Least 7 Days|Withdrawal by Subject|1
5935972|NCT01374087|20533530|P2|Overall Study|Study discontinued|13
5935973|NCT01374087|20533531|P1|Overall Study|Study discontinued|13
5935974|NCT01374087|20533530|P2|Overall Study|Disease progression|2
5935975|NCT01374087|20533531|P1|Overall Study|Disease progression|2
5935976|NCT01374087|20533530|P2|Overall Study|Adverse Event|0
5935977|NCT01374087|20533531|P1|Overall Study|Adverse Event|1
5935978|NCT01373931|20533551|P2|Period 1|Withdrawal by Subject|2
5935979|NCT01373931|20533552|P1|Period 1|Withdrawal by Subject|0
5935980|NCT01373931|20533551|P2|Period 1|Adverse Event|0
5935981|NCT01373931|20533552|P1|Period 1|Adverse Event|2
5935982|NCT01373931|20533551|P2|Lead-in Period|Adverse Event|0
5935983|NCT01373931|20533552|P1|Lead-in Period|Adverse Event|2
5935984|NCT01373918|20533565|P2|Overall Study|Physician Decision|1
5935985|NCT01373918|20533566|P1|Overall Study|Physician Decision|0
5935986|NCT01373346|20533625|P1|Overall Study|Death|1
5935987|NCT01373294|20533648|P2|Overall Study|Adverse Event|0
5935988|NCT01373294|20533649|P1|Overall Study|Adverse Event|1
5935989|NCT01373281|20533658|P2|Surveillance Expansion Period|Serious adverse event|4
5935990|NCT01373281|20533659|P1|Surveillance Expansion Period|Serious adverse event|3
5935991|NCT01373281|20533658|P2|Surveillance Expansion Period|Lost to Follow-up|8
5935992|NCT01373281|20533659|P1|Surveillance Expansion Period|Lost to Follow-up|10
5935993|NCT01373281|20533658|P2|Surveillance Expansion Period|Protocol Violation|1
5935994|NCT01373281|20533659|P1|Surveillance Expansion Period|Protocol Violation|9
5935995|NCT01373281|20533658|P2|Surveillance Expansion Period|Withdrawal by Subject|105
5935996|NCT01373281|20533659|P1|Surveillance Expansion Period|Withdrawal by Subject|180
5935997|NCT01373281|20533658|P2|Vaccination Phase (Up to 25 Months)|Serious adverse event|1
5935998|NCT01373281|20533659|P1|Vaccination Phase (Up to 25 Months)|Serious adverse event|4
5935999|NCT01373281|20533658|P2|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|1
5936000|NCT01373281|20533659|P1|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|5
5936001|NCT01373281|20533658|P2|Vaccination Phase (Up to 25 Months)|Protocol Violation|2
5936002|NCT01373281|20533659|P1|Vaccination Phase (Up to 25 Months)|Protocol Violation|5
5936003|NCT01373281|20533658|P2|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|23
5936004|NCT01373281|20533659|P1|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|40
5936005|NCT01373229|20533707|P1|Overall Study|Physician Decision|3
5936006|NCT01373229|20533707|P1|Overall Study|Death|3
5936007|NCT01373164|20533721|P5|Overall Study|Withdrawal by Subject|2
5936008|NCT01373164|20533722|P4|Overall Study|Withdrawal by Subject|10
5936009|NCT01373164|20533723|P3|Overall Study|Withdrawal by Subject|0
5936010|NCT01373164|20533724|P2|Overall Study|Withdrawal by Subject|1
5936011|NCT01373164|20533725|P1|Overall Study|Withdrawal by Subject|0
5936012|NCT01373164|20533721|P5|Overall Study|Lost to Follow-up|0
5936013|NCT01373164|20533722|P4|Overall Study|Lost to Follow-up|2
5936014|NCT01373164|20533723|P3|Overall Study|Lost to Follow-up|1
5936015|NCT01373164|20533724|P2|Overall Study|Lost to Follow-up|0
5936016|NCT01373164|20533725|P1|Overall Study|Lost to Follow-up|0
5936017|NCT01372995|20533759|P3|Overall Study|Physician Decision|1
5936018|NCT01372995|20533760|P2|Overall Study|Physician Decision|0
5936019|NCT01372995|20533761|P1|Overall Study|Physician Decision|0
5936020|NCT01372995|20533759|P3|Overall Study|Spouse withdrew participant from study|0
5936021|NCT01372995|20533760|P2|Overall Study|Spouse withdrew participant from study|1
5936022|NCT01372995|20533761|P1|Overall Study|Spouse withdrew participant from study|0
5936023|NCT01372878|20533808|P1|Overall Study|incomplete study procedure|104
5936024|NCT01372878|20533808|P1|Overall Study|Protocol Violation|17
5936025|NCT01372878|20533808|P1|Overall Study|Withdrawal by Subject|63
5936026|NCT01372774|20533828|P2|Overall Study|Withdrawal prior to treatment|5
5936027|NCT01372774|20533829|P1|Overall Study|Withdrawal prior to treatment|4
5936028|NCT01372748|20533845|P2|Overall Study|Withdrawal by Subject|5
5936029|NCT01372748|20533846|P1|Overall Study|Withdrawal by Subject|7
5936030|NCT01372748|20533845|P2|Overall Study|Lost to Follow-up|34
5936031|NCT01372748|20533846|P1|Overall Study|Lost to Follow-up|16
5936032|NCT01372618|20533854|P1|Overall Study|PI Died. Study Terminated|9
5936033|NCT01372605|20533862|P2|Overall Study|Changed medical home|0
5936034|NCT01372605|20533863|P1|Overall Study|Changed medical home|2
5936035|NCT01372605|20533862|P2|Overall Study|Moved|0
5936036|NCT01372605|20533863|P1|Overall Study|Moved|3
5936037|NCT01372605|20533862|P2|Overall Study|Withdrawal by Subject|7
5936038|NCT01372605|20533863|P1|Overall Study|Withdrawal by Subject|4
5936039|NCT01372605|20533862|P2|Overall Study|Lost to Follow-up|1
5936040|NCT01372605|20533863|P1|Overall Study|Lost to Follow-up|2
5936041|NCT01372605|20533862|P2|Overall Study|Death|2
5936042|NCT01372605|20533863|P1|Overall Study|Death|1
5936043|NCT01372501|20533889|P1|Overall Study|Device migration|1
5936044|NCT01372501|20533889|P1|Overall Study|Adverse Event|4
5936045|NCT01372410|20533912|P8|Treatment Period 3 (7 Days)|Protocol Deviation|0
5936046|NCT01372410|20533913|P7|Treatment Period 3 (7 Days)|Protocol Deviation|0
5936047|NCT01372410|20533914|P6|Treatment Period 3 (7 Days)|Protocol Deviation|1
5936048|NCT01372410|20533915|P5|Treatment Period 3 (7 Days)|Protocol Deviation|0
5936049|NCT01372410|20533916|P4|Treatment Period 3 (7 Days)|Protocol Deviation|0
5936050|NCT01372410|20533917|P3|Treatment Period 3 (7 Days)|Protocol Deviation|0
5936051|NCT01372410|20533918|P2|Treatment Period 3 (7 Days)|Protocol Deviation|0
5936052|NCT01372410|20533919|P1|Treatment Period 3 (7 Days)|Protocol Deviation|0
5936053|NCT01372410|20533912|P8|Treatment Period 3 (7 Days)|Adverse Event|0
5936054|NCT01372410|20533913|P7|Treatment Period 3 (7 Days)|Adverse Event|0
5936055|NCT01372410|20533914|P6|Treatment Period 3 (7 Days)|Adverse Event|0
5936056|NCT01372410|20533915|P5|Treatment Period 3 (7 Days)|Adverse Event|0
5936057|NCT01372410|20533916|P4|Treatment Period 3 (7 Days)|Adverse Event|0
5936058|NCT01372410|20533917|P3|Treatment Period 3 (7 Days)|Adverse Event|1
5936059|NCT01372410|20533918|P2|Treatment Period 3 (7 Days)|Adverse Event|0
5936060|NCT01372410|20533919|P1|Treatment Period 3 (7 Days)|Adverse Event|0
5936061|NCT01372410|20533912|P8|Washout Period 2 (10-14 Days)|Lack of Efficacy|1
5936062|NCT01372410|20533913|P7|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
5936063|NCT01372410|20533914|P6|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
5936064|NCT01372410|20533915|P5|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
5936065|NCT01372410|20533916|P4|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
5936066|NCT01372410|20533917|P3|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
5936067|NCT01372410|20533918|P2|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
5936068|NCT01372410|20533919|P1|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
5936069|NCT01372410|20533912|P8|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1
5936070|NCT01372410|20533913|P7|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1
5936071|NCT01372410|20533914|P6|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0
5936072|NCT01372410|20533915|P5|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1
5936073|NCT01372410|20533916|P4|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0
5936074|NCT01372410|20533917|P3|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0
5936075|NCT01372410|20533918|P2|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0
5936076|NCT01372410|20533919|P1|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0
5936077|NCT01372410|20533912|P8|Washout Period 2 (10-14 Days)|Adverse Event|0
5936078|NCT01372410|20533913|P7|Washout Period 2 (10-14 Days)|Adverse Event|0
5936079|NCT01372410|20533914|P6|Washout Period 2 (10-14 Days)|Adverse Event|0
5936080|NCT01372410|20533915|P5|Washout Period 2 (10-14 Days)|Adverse Event|1
5936081|NCT01372410|20533916|P4|Washout Period 2 (10-14 Days)|Adverse Event|0
5936082|NCT01372410|20533917|P3|Washout Period 2 (10-14 Days)|Adverse Event|0
5936083|NCT01372410|20533918|P2|Washout Period 2 (10-14 Days)|Adverse Event|0
5936084|NCT01372410|20533919|P1|Washout Period 2 (10-14 Days)|Adverse Event|0
5936085|NCT01372410|20533912|P8|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1
5936086|NCT01372410|20533913|P7|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
5936087|NCT01372410|20533914|P6|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
5936088|NCT01372410|20533915|P5|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
5936089|NCT01372410|20533916|P4|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
5936090|NCT01372410|20533917|P3|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
5936091|NCT01372410|20533918|P2|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
5936092|NCT01372410|20533919|P1|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1
5936093|NCT01372410|20533912|P8|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
5936094|NCT01372410|20533913|P7|Treatment Period 1 (7 Days)|Participant Withdrew Consent|1
5936095|NCT01372410|20533914|P6|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
5936096|NCT01372410|20533915|P5|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
5936097|NCT01372410|20533916|P4|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
5936098|NCT01372410|20533917|P3|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
5936099|NCT01372410|20533918|P2|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
5936100|NCT01372410|20533919|P1|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
5936101|NCT01372410|20533912|P8|Treatment Period 1 (7 Days)|Lost to Follow-up|0
5936102|NCT01372410|20533913|P7|Treatment Period 1 (7 Days)|Lost to Follow-up|0
5936103|NCT01372410|20533914|P6|Treatment Period 1 (7 Days)|Lost to Follow-up|0
5936104|NCT01372410|20533915|P5|Treatment Period 1 (7 Days)|Lost to Follow-up|1
5936105|NCT01372410|20533916|P4|Treatment Period 1 (7 Days)|Lost to Follow-up|0
5936106|NCT01372410|20533917|P3|Treatment Period 1 (7 Days)|Lost to Follow-up|0
5936107|NCT01372410|20533918|P2|Treatment Period 1 (7 Days)|Lost to Follow-up|0
5936108|NCT01372410|20533919|P1|Treatment Period 1 (7 Days)|Lost to Follow-up|0
5936109|NCT01372410|20533912|P8|Treatment Period 1 (7 Days)|Adverse Event|0
5936110|NCT01372410|20533913|P7|Treatment Period 1 (7 Days)|Adverse Event|1
5936111|NCT01372410|20533914|P6|Treatment Period 1 (7 Days)|Adverse Event|0
5936112|NCT01372410|20533915|P5|Treatment Period 1 (7 Days)|Adverse Event|0
5936113|NCT01372410|20533916|P4|Treatment Period 1 (7 Days)|Adverse Event|0
5936114|NCT01372410|20533917|P3|Treatment Period 1 (7 Days)|Adverse Event|0
5936115|NCT01372410|20533918|P2|Treatment Period 1 (7 Days)|Adverse Event|1
5936116|NCT01372410|20533919|P1|Treatment Period 1 (7 Days)|Adverse Event|0
5936117|NCT01372410|20533912|P8|Treatment Period 1 (7 Days)|Lack of Efficacy|0
5936118|NCT01372410|20533913|P7|Treatment Period 1 (7 Days)|Lack of Efficacy|0
5936119|NCT01372410|20533914|P6|Treatment Period 1 (7 Days)|Lack of Efficacy|0
5936120|NCT01372410|20533915|P5|Treatment Period 1 (7 Days)|Lack of Efficacy|1
5936121|NCT01372410|20533916|P4|Treatment Period 1 (7 Days)|Lack of Efficacy|0
5936122|NCT01372410|20533917|P3|Treatment Period 1 (7 Days)|Lack of Efficacy|0
5936123|NCT01372410|20533918|P2|Treatment Period 1 (7 Days)|Lack of Efficacy|1
5936124|NCT01372410|20533919|P1|Treatment Period 1 (7 Days)|Lack of Efficacy|1
5936125|NCT01372384|20533956|P1|Overall Study|Progression of disease|3
5936126|NCT01372150|20533997|P3|Overall Study|Randomized but not treated|0
5936127|NCT01372150|20533998|P2|Overall Study|Randomized but not treated|1
5936128|NCT01372150|20533999|P1|Overall Study|Randomized but not treated|0
5936129|NCT01372150|20533997|P3|Overall Study|Adverse Event|2
5936130|NCT01372150|20533998|P2|Overall Study|Adverse Event|1
5936131|NCT01372150|20533999|P1|Overall Study|Adverse Event|2
5936132|NCT01372150|20533997|P3|Overall Study|Other|2
5936133|NCT01372150|20533998|P2|Overall Study|Other|0
5936134|NCT01372150|20533999|P1|Overall Study|Other|1
5936135|NCT01372150|20533997|P3|Overall Study|Withdrawal by Subject|2
5936136|NCT01372150|20533998|P2|Overall Study|Withdrawal by Subject|7
5936137|NCT01372150|20533999|P1|Overall Study|Withdrawal by Subject|2
5936138|NCT01372150|20533997|P3|Overall Study|Protocol Violation|3
5936139|NCT01372150|20533998|P2|Overall Study|Protocol Violation|0
5936140|NCT01372150|20533999|P1|Overall Study|Protocol Violation|1
5936141|NCT01372150|20533997|P3|Overall Study|Lost to Follow-up|6
5936142|NCT01372150|20533998|P2|Overall Study|Lost to Follow-up|5
5936143|NCT01372150|20533999|P1|Overall Study|Lost to Follow-up|4
5936144|NCT01372150|20533997|P3|Overall Study|Lack of Efficacy|1
5936145|NCT01372150|20533998|P2|Overall Study|Lack of Efficacy|0
5936146|NCT01372150|20533999|P1|Overall Study|Lack of Efficacy|3
5936147|NCT01372085|20534026|P10|Washout Period 3|Withdrawal by Subject|0
5936148|NCT01372085|20534027|P9|Washout Period 3|Withdrawal by Subject|0
5936149|NCT01372085|20534028|P8|Washout Period 3|Withdrawal by Subject|0
5936150|NCT01372085|20534029|P7|Washout Period 3|Withdrawal by Subject|0
5936151|NCT01372085|20534030|P6|Washout Period 3|Withdrawal by Subject|2
5936152|NCT01372085|20534031|P5|Washout Period 3|Withdrawal by Subject|0
5936153|NCT01372085|20534032|P4|Washout Period 3|Withdrawal by Subject|0
5936154|NCT01372085|20534033|P3|Washout Period 3|Withdrawal by Subject|0
5936155|NCT01372085|20534034|P2|Washout Period 3|Withdrawal by Subject|0
5936156|NCT01372085|20534035|P1|Washout Period 3|Withdrawal by Subject|0
5936157|NCT01372085|20534026|P10|Washout Period 2|Physician Decision|0
5936158|NCT01372085|20534027|P9|Washout Period 2|Physician Decision|0
5936159|NCT01372085|20534028|P8|Washout Period 2|Physician Decision|0
5936160|NCT01372085|20534029|P7|Washout Period 2|Physician Decision|0
5936161|NCT01372085|20534030|P6|Washout Period 2|Physician Decision|0
5936162|NCT01372085|20534031|P5|Washout Period 2|Physician Decision|1
5936163|NCT01372085|20534032|P4|Washout Period 2|Physician Decision|0
5936164|NCT01372085|20534033|P3|Washout Period 2|Physician Decision|0
5936165|NCT01372085|20534034|P2|Washout Period 2|Physician Decision|0
5936166|NCT01372085|20534035|P1|Washout Period 2|Physician Decision|0
5936167|NCT01371994|20534067|P2|Overall Study|Miscellaneous Reasons|4
5936168|NCT01371994|20534068|P1|Overall Study|Miscellaneous Reasons|6
5936169|NCT01371994|20534067|P2|Overall Study|Physician Decision|1
5936170|NCT01371994|20534068|P1|Overall Study|Physician Decision|1
5936171|NCT01371994|20534067|P2|Overall Study|Randomized but Never Received Study Drug|6
5936172|NCT01371994|20534068|P1|Overall Study|Randomized but Never Received Study Drug|6
5936173|NCT01371994|20534067|P2|Overall Study|Protocol Violation|17
5936174|NCT01371994|20534068|P1|Overall Study|Protocol Violation|24
5936175|NCT01371994|20534067|P2|Overall Study|Lost to Follow-up|1
5936176|NCT01371994|20534068|P1|Overall Study|Lost to Follow-up|1
5936177|NCT01371994|20534067|P2|Overall Study|Withdrawal by Subject|7
5936178|NCT01371994|20534068|P1|Overall Study|Withdrawal by Subject|13
5936179|NCT01371994|20534067|P2|Overall Study|Lack of Efficacy|0
5936180|NCT01371994|20534068|P1|Overall Study|Lack of Efficacy|3
5936181|NCT01371994|20534067|P2|Overall Study|Adverse Event|6
5936182|NCT01371994|20534068|P1|Overall Study|Adverse Event|3
5936183|NCT01371981|20534116|P6|Overall Study|Did not start treatment|2
5936184|NCT01371981|20534117|P5|Overall Study|Did not start treatment|0
5936185|NCT01371981|20534118|P4|Overall Study|Did not start treatment|0
5936186|NCT01371981|20534119|P3|Overall Study|Did not start treatment|0
5936187|NCT01371981|20534120|P2|Overall Study|Did not start treatment|3
5936188|NCT01371981|20534121|P1|Overall Study|Did not start treatment|2
5936189|NCT01371981|20534116|P6|Overall Study|Ineligible|4
5936190|NCT01371981|20534117|P5|Overall Study|Ineligible|0
5936191|NCT01371981|20534118|P4|Overall Study|Ineligible|0
5936192|NCT01371981|20534119|P3|Overall Study|Ineligible|0
5936193|NCT01371981|20534120|P2|Overall Study|Ineligible|13
5936194|NCT01371981|20534121|P1|Overall Study|Ineligible|19
5936195|NCT01371981|20534116|P6|Overall Study|Withdrawal by Subject|3
5936196|NCT01371981|20534117|P5|Overall Study|Withdrawal by Subject|10
5936197|NCT01371981|20534118|P4|Overall Study|Withdrawal by Subject|2
5936198|NCT01371981|20534119|P3|Overall Study|Withdrawal by Subject|1
5936199|NCT01371981|20534120|P2|Overall Study|Withdrawal by Subject|19
5936200|NCT01371981|20534121|P1|Overall Study|Withdrawal by Subject|12
5936201|NCT01371981|20534116|P6|Overall Study|Physician Decision|3
5936202|NCT01371981|20534117|P5|Overall Study|Physician Decision|14
5936203|NCT01371981|20534118|P4|Overall Study|Physician Decision|7
5936204|NCT01371981|20534119|P3|Overall Study|Physician Decision|1
5936205|NCT01371981|20534120|P2|Overall Study|Physician Decision|63
5936206|NCT01371981|20534121|P1|Overall Study|Physician Decision|48
5936207|NCT01371981|20534116|P6|Overall Study|Lack of Efficacy|0
5936208|NCT01371981|20534117|P5|Overall Study|Lack of Efficacy|5
5936209|NCT01371981|20534118|P4|Overall Study|Lack of Efficacy|8
5936210|NCT01371981|20534119|P3|Overall Study|Lack of Efficacy|4
5936211|NCT01371981|20534120|P2|Overall Study|Lack of Efficacy|61
5936212|NCT01371981|20534121|P1|Overall Study|Lack of Efficacy|69
5936213|NCT01371981|20534116|P6|Overall Study|Death|2
5936214|NCT01371981|20534117|P5|Overall Study|Death|2
5936215|NCT01371981|20534118|P4|Overall Study|Death|0
5936216|NCT01371981|20534119|P3|Overall Study|Death|0
5936217|NCT01371981|20534120|P2|Overall Study|Death|16
5936218|NCT01371981|20534121|P1|Overall Study|Death|22
5936219|NCT01371981|20534116|P6|Overall Study|Adverse Event|0
5936220|NCT01371981|20534117|P5|Overall Study|Adverse Event|1
5936221|NCT01371981|20534118|P4|Overall Study|Adverse Event|4
5936222|NCT01371981|20534119|P3|Overall Study|Adverse Event|0
5936223|NCT01371981|20534120|P2|Overall Study|Adverse Event|17
5936224|NCT01371981|20534121|P1|Overall Study|Adverse Event|12
5936225|NCT01371877|20534180|P2|Overall Study|3 for unknown reasons and 1 pregnant|4
5936226|NCT01371877|20534181|P1|Overall Study|3 for unknown reasons and 1 pregnant|0
5936227|NCT01371851|20534193|P2|Overall Study|Blood Pressure outside study parameters|0
5936228|NCT01371851|20534194|P1|Overall Study|Blood Pressure outside study parameters|2
5936229|NCT01371851|20534193|P2|Overall Study|non study related adverse event|0
5936230|NCT01371851|20534194|P1|Overall Study|non study related adverse event|1
5936231|NCT01371851|20534193|P2|Overall Study|was arrested and put in jail|1
5936232|NCT01371851|20534194|P1|Overall Study|was arrested and put in jail|0
5936233|NCT01371851|20534193|P2|Overall Study|Lost to Follow-up|8
5936234|NCT01371851|20534194|P1|Overall Study|Lost to Follow-up|5
5936235|NCT01371838|20534202|P2|Overall Study|Surgery|0
5936236|NCT01371838|20534203|P1|Overall Study|Surgery|1
5936237|NCT01371838|20534202|P2|Overall Study|Lack of therapeutic response|1
5936238|NCT01371838|20534203|P1|Overall Study|Lack of therapeutic response|0
5936239|NCT01371838|20534202|P2|Overall Study|Last follow-up visit not conducted|0
5936240|NCT01371838|20534203|P1|Overall Study|Last follow-up visit not conducted|2
5936241|NCT01371838|20534202|P2|Overall Study|Investigator Decision|8
5936242|NCT01371838|20534203|P1|Overall Study|Investigator Decision|3
5936243|NCT01371838|20534202|P2|Overall Study|Protocol Violation|0
5936244|NCT01371838|20534203|P1|Overall Study|Protocol Violation|3
5936245|NCT01371838|20534202|P2|Overall Study|Death|4
5936246|NCT01371838|20534203|P1|Overall Study|Death|3
5936247|NCT01371838|20534202|P2|Overall Study|Lost to Follow-up|20
5936248|NCT01371838|20534203|P1|Overall Study|Lost to Follow-up|10
5936249|NCT01371838|20534202|P2|Overall Study|Withdrawal by Subject|33
5936250|NCT01371838|20534203|P1|Overall Study|Withdrawal by Subject|27
5936251|NCT01371825|20534239|P1|Overall Study|Death|4
5936252|NCT01371747|20534273|P6|Overall Study|Other Reasons|1
5936253|NCT01371747|20534274|P5|Overall Study|Other Reasons|0
5936254|NCT01371747|20534275|P4|Overall Study|Other Reasons|0
5936255|NCT01371747|20534276|P3|Overall Study|Other Reasons|2
5936256|NCT01371747|20534277|P2|Overall Study|Other Reasons|1
5936257|NCT01371747|20534278|P1|Overall Study|Other Reasons|2
5936258|NCT01371747|20534273|P6|Overall Study|Withdrawal by Subject|4
5936259|NCT01371747|20534274|P5|Overall Study|Withdrawal by Subject|2
5936260|NCT01371747|20534275|P4|Overall Study|Withdrawal by Subject|2
5936261|NCT01371747|20534276|P3|Overall Study|Withdrawal by Subject|5
5936262|NCT01371747|20534277|P2|Overall Study|Withdrawal by Subject|12
5936263|NCT01371747|20534278|P1|Overall Study|Withdrawal by Subject|6
5936264|NCT01371747|20534273|P6|Overall Study|Physician Decision|0
5936265|NCT01371747|20534274|P5|Overall Study|Physician Decision|1
5936266|NCT01371747|20534275|P4|Overall Study|Physician Decision|0
5936267|NCT01371747|20534276|P3|Overall Study|Physician Decision|0
5936268|NCT01371747|20534277|P2|Overall Study|Physician Decision|0
5936269|NCT01371747|20534278|P1|Overall Study|Physician Decision|0
5936270|NCT01371747|20534273|P6|Overall Study|Non-Compliance|1
5936271|NCT01371747|20534274|P5|Overall Study|Non-Compliance|0
5936272|NCT01371747|20534275|P4|Overall Study|Non-Compliance|0
5936273|NCT01371747|20534276|P3|Overall Study|Non-Compliance|3
5936274|NCT01371747|20534277|P2|Overall Study|Non-Compliance|4
5936275|NCT01371747|20534278|P1|Overall Study|Non-Compliance|3
5936276|NCT01371747|20534273|P6|Overall Study|Protocol Violation|0
5936277|NCT01371747|20534274|P5|Overall Study|Protocol Violation|0
5936278|NCT01371747|20534275|P4|Overall Study|Protocol Violation|0
5936279|NCT01371747|20534276|P3|Overall Study|Protocol Violation|1
5936280|NCT01371747|20534277|P2|Overall Study|Protocol Violation|0
5936281|NCT01371747|20534278|P1|Overall Study|Protocol Violation|0
5936282|NCT01371747|20534273|P6|Overall Study|Low Serum Potassium Results|3
5936283|NCT01371747|20534274|P5|Overall Study|Low Serum Potassium Results|0
5936284|NCT01371747|20534275|P4|Overall Study|Low Serum Potassium Results|1
5936285|NCT01371747|20534276|P3|Overall Study|Low Serum Potassium Results|1
5936286|NCT01371747|20534277|P2|Overall Study|Low Serum Potassium Results|1
5936287|NCT01371747|20534278|P1|Overall Study|Low Serum Potassium Results|1
5936288|NCT01371747|20534273|P6|Overall Study|High Serum Potassium Results|2
5936289|NCT01371747|20534274|P5|Overall Study|High Serum Potassium Results|0
5936290|NCT01371747|20534275|P4|Overall Study|High Serum Potassium Results|2
5936291|NCT01371747|20534276|P3|Overall Study|High Serum Potassium Results|1
5936292|NCT01371747|20534277|P2|Overall Study|High Serum Potassium Results|1
5936293|NCT01371747|20534278|P1|Overall Study|High Serum Potassium Results|1
5936294|NCT01371747|20534273|P6|Overall Study|Abnormal Renal Function|1
5936295|NCT01371747|20534274|P5|Overall Study|Abnormal Renal Function|0
5936296|NCT01371747|20534275|P4|Overall Study|Abnormal Renal Function|1
5936297|NCT01371747|20534276|P3|Overall Study|Abnormal Renal Function|0
5936298|NCT01371747|20534277|P2|Overall Study|Abnormal Renal Function|2
5936299|NCT01371747|20534278|P1|Overall Study|Abnormal Renal Function|0
5936300|NCT01371747|20534273|P6|Overall Study|Death|0
5936301|NCT01371747|20534274|P5|Overall Study|Death|2
5936302|NCT01371747|20534275|P4|Overall Study|Death|1
5936303|NCT01371747|20534276|P3|Overall Study|Death|4
5936304|NCT01371747|20534277|P2|Overall Study|Death|0
5936305|NCT01371747|20534278|P1|Overall Study|Death|1
5936306|NCT01371747|20534273|P6|Overall Study|Adverse Event|2
5936307|NCT01371747|20534274|P5|Overall Study|Adverse Event|2
5936308|NCT01371747|20534275|P4|Overall Study|Adverse Event|2
5936309|NCT01371747|20534276|P3|Overall Study|Adverse Event|7
5936310|NCT01371747|20534277|P2|Overall Study|Adverse Event|2
5936311|NCT01371747|20534278|P1|Overall Study|Adverse Event|4
5936312|NCT01371734|20534343|P3|Overall Study|Lack of Efficacy|0
5936313|NCT01371734|20534344|P2|Overall Study|Lack of Efficacy|2
5936314|NCT01371734|20534345|P1|Overall Study|Lack of Efficacy|2
5936315|NCT01371734|20534343|P3|Overall Study|Adverse Event|3
5936316|NCT01371734|20534344|P2|Overall Study|Adverse Event|8
5936317|NCT01371734|20534345|P1|Overall Study|Adverse Event|8
5936318|NCT01371734|20534343|P3|Overall Study|Protocol Violation|2
5936319|NCT01371734|20534344|P2|Overall Study|Protocol Violation|1
5936320|NCT01371734|20534345|P1|Overall Study|Protocol Violation|3
5936321|NCT01371734|20534343|P3|Overall Study|Lost to Follow-up|1
5936322|NCT01371734|20534344|P2|Overall Study|Lost to Follow-up|3
5936323|NCT01371734|20534345|P1|Overall Study|Lost to Follow-up|5
5936324|NCT01371734|20534343|P3|Overall Study|Withdrawal by Subject|9
5936325|NCT01371734|20534344|P2|Overall Study|Withdrawal by Subject|4
5936326|NCT01371734|20534345|P1|Overall Study|Withdrawal by Subject|3
5936327|NCT01371734|20534343|P3|Overall Study|Other|2
5936328|NCT01371734|20534344|P2|Overall Study|Other|1
5936329|NCT01371734|20534345|P1|Overall Study|Other|2
5936330|NCT01371721|20534365|P3|Overall Study|Randomized but not treated|0
5936331|NCT01371721|20534366|P2|Overall Study|Randomized but not treated|0
5936332|NCT01371721|20534367|P1|Overall Study|Randomized but not treated|1
5936333|NCT01371721|20534365|P3|Overall Study|Lack of Efficacy|3
5936334|NCT01371721|20534366|P2|Overall Study|Lack of Efficacy|4
5936335|NCT01371721|20534367|P1|Overall Study|Lack of Efficacy|2
5936336|NCT01371721|20534365|P3|Overall Study|Other|0
5936337|NCT01371721|20534366|P2|Overall Study|Other|3
5936338|NCT01371721|20534367|P1|Overall Study|Other|2
5936339|NCT01371721|20534365|P3|Overall Study|Withdrawal by Subject|11
5936340|NCT01371721|20534366|P2|Overall Study|Withdrawal by Subject|7
5936341|NCT01371721|20534367|P1|Overall Study|Withdrawal by Subject|5
5936342|NCT01371721|20534365|P3|Overall Study|Lost to Follow-up|6
5936343|NCT01371721|20534366|P2|Overall Study|Lost to Follow-up|2
5936344|NCT01371721|20534367|P1|Overall Study|Lost to Follow-up|8
5936345|NCT01371721|20534365|P3|Overall Study|Protocol Violation|5
5936346|NCT01371721|20534366|P2|Overall Study|Protocol Violation|4
5936347|NCT01371721|20534367|P1|Overall Study|Protocol Violation|6
5936348|NCT01371721|20534365|P3|Overall Study|Adverse Event|5
5936349|NCT01371721|20534366|P2|Overall Study|Adverse Event|4
5936350|NCT01371721|20534367|P1|Overall Study|Adverse Event|5
5936351|NCT01371708|20534400|P3|Overall Study|Started but did not receive treatment|1
5936352|NCT01371708|20534401|P2|Overall Study|Started but did not receive treatment|0
5936353|NCT01371708|20534402|P1|Overall Study|Started but did not receive treatment|1
5936354|NCT01371708|20534400|P3|Overall Study|Adverse Event|12
5936355|NCT01371708|20534401|P2|Overall Study|Adverse Event|8
5936356|NCT01371708|20534402|P1|Overall Study|Adverse Event|5
5936357|NCT01371708|20534400|P3|Overall Study|Other|4
5936358|NCT01371708|20534401|P2|Overall Study|Other|2
5936359|NCT01371708|20534402|P1|Overall Study|Other|3
5936360|NCT01371708|20534400|P3|Overall Study|Medication error/not related to AE|0
5936361|NCT01371708|20534401|P2|Overall Study|Medication error/not related to AE|1
5936362|NCT01371708|20534402|P1|Overall Study|Medication error/not related to AE|0
5936363|NCT01371708|20534400|P3|Overall Study|No longer willing to participate|13
5936364|NCT01371708|20534401|P2|Overall Study|No longer willing to participate|7
5936365|NCT01371708|20534402|P1|Overall Study|No longer willing to participate|7
5936366|NCT01371708|20534400|P3|Overall Study|Protocol Violation|2
5936367|NCT01371708|20534401|P2|Overall Study|Protocol Violation|1
5936368|NCT01371708|20534402|P1|Overall Study|Protocol Violation|2
5936369|NCT01371708|20534400|P3|Overall Study|Lost to Follow-up|7
5936370|NCT01371708|20534401|P2|Overall Study|Lost to Follow-up|9
5936371|NCT01371708|20534402|P1|Overall Study|Lost to Follow-up|5
5936372|NCT01371708|20534400|P3|Overall Study|Insufficient clinical response|0
5936373|NCT01371708|20534401|P2|Overall Study|Insufficient clinical response|2
5936374|NCT01371708|20534402|P1|Overall Study|Insufficient clinical response|3
5936375|NCT01371656|20534434|P2|Overall Study|Ineligible|3
5936376|NCT01371656|20534435|P1|Overall Study|Ineligible|4
5936377|NCT01371656|20534434|P2|Overall Study|Withdrawal by Subject|0
5936378|NCT01371656|20534435|P1|Overall Study|Withdrawal by Subject|7
5936379|NCT01371656|20534434|P2|Overall Study|Physician Decision|7
5936380|NCT01371656|20534435|P1|Overall Study|Physician Decision|46
5936381|NCT01371656|20534434|P2|Overall Study|Death|4
5936382|NCT01371656|20534435|P1|Overall Study|Death|7
5936383|NCT01371643|20534455|P2|Overall Study|Withdrawal by Subject|0
5936384|NCT01371643|20534456|P1|Overall Study|Withdrawal by Subject|3
5936385|NCT01371565|20534466|P1|Overall Study|Resection of neuroendocrine tumor|1
5936386|NCT01371565|20534466|P1|Overall Study|Death|1
5936387|NCT01371565|20534466|P1|Overall Study|Withdrawal by Subject|1
5936388|NCT01371552|20534470|P6|Part 1, First 3 Days|Inconvenience|0
5936389|NCT01371552|20534471|P5|Part 1, First 3 Days|Inconvenience|0
5936390|NCT01371552|20534472|P4|Part 1, First 3 Days|Inconvenience|0
5936391|NCT01371552|20534473|P3|Part 1, First 3 Days|Inconvenience|1
5936392|NCT01371552|20534474|P2|Part 1, First 3 Days|Inconvenience|0
5936393|NCT01371552|20534475|P1|Part 1, First 3 Days|Inconvenience|0
5936394|NCT01371539|20534502|P2|Period Two: One Week|Time/job conflict|1
5936395|NCT01371539|20534503|P1|Period Two: One Week|Time/job conflict|0
5936396|NCT01371539|20534502|P2|Period Two: One Week|Unacceptable Objective Visual Acuity|1
5936397|NCT01371539|20534503|P1|Period Two: One Week|Unacceptable Objective Visual Acuity|0
5936398|NCT01371539|20534502|P2|Period Two: One Week|Lost to Follow-up|1
5936399|NCT01371539|20534503|P1|Period Two: One Week|Lost to Follow-up|0
5936400|NCT01371539|20534502|P2|Period One: One Week|Lost to Follow-up|1
5936401|NCT01371539|20534503|P1|Period One: One Week|Lost to Follow-up|0
5936402|NCT01371305|20534517|P6|Overall Study|Subject request|1
5936403|NCT01371305|20534518|P5|Overall Study|Subject request|0
5936404|NCT01371305|20534519|P4|Overall Study|Subject request|0
5936405|NCT01371305|20534520|P3|Overall Study|Subject request|0
5936406|NCT01371305|20534521|P2|Overall Study|Subject request|0
5936407|NCT01371305|20534522|P1|Overall Study|Subject request|0
5936408|NCT01371305|20534517|P6|Overall Study|Study terminated by sponsor|1
5936409|NCT01371305|20534518|P5|Overall Study|Study terminated by sponsor|3
5936410|NCT01371305|20534519|P4|Overall Study|Study terminated by sponsor|0
5936411|NCT01371305|20534520|P3|Overall Study|Study terminated by sponsor|0
5936412|NCT01371305|20534521|P2|Overall Study|Study terminated by sponsor|0
5936413|NCT01371305|20534522|P1|Overall Study|Study terminated by sponsor|0
5936414|NCT01371305|20534517|P6|Overall Study|Adverse Event|0
5936415|NCT01371305|20534518|P5|Overall Study|Adverse Event|1
5936416|NCT01371305|20534519|P4|Overall Study|Adverse Event|2
5936417|NCT01371305|20534520|P3|Overall Study|Adverse Event|0
5936418|NCT01371305|20534521|P2|Overall Study|Adverse Event|0
5936419|NCT01371305|20534522|P1|Overall Study|Adverse Event|0
5936420|NCT01371006|20534606|P2|Overall Study|Adverse Event|0
5936421|NCT01371006|20534607|P1|Overall Study|Adverse Event|1
5936422|NCT01370863|20534648|P2|Overall Study|Not meeting inclusion/exclusion criteria|1
5936423|NCT01370863|20534649|P1|Overall Study|Not meeting inclusion/exclusion criteria|0
5936424|NCT01370863|20534648|P2|Overall Study|Did not want second pH/MII monitoring|1
5936425|NCT01370863|20534649|P1|Overall Study|Did not want second pH/MII monitoring|1
5936426|NCT01370863|20534648|P2|Overall Study|Adverse Event|1
5936427|NCT01370863|20534649|P1|Overall Study|Adverse Event|1
5936428|NCT01370733|20534674|P2|Overall Study|Protocol Violation|3
5936429|NCT01370733|20534675|P1|Overall Study|Protocol Violation|1
5936430|NCT01370733|20534674|P2|Overall Study|Physician Decision|2
5936431|NCT01370733|20534675|P1|Overall Study|Physician Decision|0
5936432|NCT01370733|20534674|P2|Overall Study|Lack of Efficacy|5
5936433|NCT01370733|20534675|P1|Overall Study|Lack of Efficacy|3
5936434|NCT01370733|20534674|P2|Overall Study|Adverse Event|4
5936435|NCT01370733|20534675|P1|Overall Study|Adverse Event|2
5936436|NCT01370733|20534674|P2|Overall Study|Lost to Follow-up|0
5936437|NCT01370733|20534675|P1|Overall Study|Lost to Follow-up|3
5936438|NCT01370733|20534674|P2|Overall Study|Withdrawal by Subject|8
5936439|NCT01370733|20534675|P1|Overall Study|Withdrawal by Subject|8
5936440|NCT01370694|20534697|P1|Overall Study|Progressive disease|2
5936441|NCT01370694|20534697|P1|Overall Study|Switched to rituximab|4
5936442|NCT01370655|20534719|P12|Period 2|Withdrawal by Subject|0
5936443|NCT01370655|20534720|P11|Period 2|Withdrawal by Subject|0
5936444|NCT01370655|20534721|P10|Period 2|Withdrawal by Subject|0
5936445|NCT01370655|20534722|P9|Period 2|Withdrawal by Subject|1
5936446|NCT01370655|20534723|P8|Period 2|Withdrawal by Subject|0
5936447|NCT01370655|20534724|P7|Period 2|Withdrawal by Subject|0
5936448|NCT01370655|20534725|P6|Period 2|Withdrawal by Subject|0
5936449|NCT01370655|20534726|P5|Period 2|Withdrawal by Subject|0
5936450|NCT01370655|20534727|P4|Period 2|Withdrawal by Subject|0
5936451|NCT01370655|20534728|P3|Period 2|Withdrawal by Subject|0
5936452|NCT01370655|20534729|P2|Period 2|Withdrawal by Subject|0
5936453|NCT01370655|20534730|P1|Period 2|Withdrawal by Subject|0
5936454|NCT01370655|20534719|P12|Period 2|met protocol specified stopping criteria|0
5936455|NCT01370655|20534720|P11|Period 2|met protocol specified stopping criteria|1
5936456|NCT01370655|20534721|P10|Period 2|met protocol specified stopping criteria|0
5936457|NCT01370655|20534722|P9|Period 2|met protocol specified stopping criteria|1
5936458|NCT01370655|20534723|P8|Period 2|met protocol specified stopping criteria|0
5936459|NCT01370655|20534724|P7|Period 2|met protocol specified stopping criteria|1
5936460|NCT01370655|20534725|P6|Period 2|met protocol specified stopping criteria|0
5936461|NCT01370655|20534726|P5|Period 2|met protocol specified stopping criteria|0
5936462|NCT01370655|20534727|P4|Period 2|met protocol specified stopping criteria|0
5936463|NCT01370655|20534728|P3|Period 2|met protocol specified stopping criteria|1
5936464|NCT01370655|20534729|P2|Period 2|met protocol specified stopping criteria|0
5936465|NCT01370655|20534730|P1|Period 2|met protocol specified stopping criteria|0
5936466|NCT01370655|20534719|P12|Period 2|Adverse Event|0
5936467|NCT01370655|20534720|P11|Period 2|Adverse Event|0
5936468|NCT01370655|20534721|P10|Period 2|Adverse Event|0
5936469|NCT01370655|20534722|P9|Period 2|Adverse Event|0
5936470|NCT01370655|20534723|P8|Period 2|Adverse Event|1
5936471|NCT01370655|20534724|P7|Period 2|Adverse Event|0
5936472|NCT01370655|20534725|P6|Period 2|Adverse Event|0
5936473|NCT01370655|20534726|P5|Period 2|Adverse Event|1
5936474|NCT01370655|20534727|P4|Period 2|Adverse Event|0
5936475|NCT01370655|20534728|P3|Period 2|Adverse Event|1
5936476|NCT01370655|20534729|P2|Period 2|Adverse Event|0
5936477|NCT01370655|20534730|P1|Period 2|Adverse Event|0
5936478|NCT01370655|20534719|P12|Period 1|Adverse Event|0
5936479|NCT01370655|20534720|P11|Period 1|Adverse Event|0
5936480|NCT01370655|20534721|P10|Period 1|Adverse Event|0
5936481|NCT01370655|20534722|P9|Period 1|Adverse Event|0
5936482|NCT01370655|20534723|P8|Period 1|Adverse Event|0
5936483|NCT01370655|20534724|P7|Period 1|Adverse Event|1
5936484|NCT01370655|20534725|P6|Period 1|Adverse Event|0
5936485|NCT01370655|20534726|P5|Period 1|Adverse Event|0
5936486|NCT01370655|20534727|P4|Period 1|Adverse Event|0
5936487|NCT01370655|20534728|P3|Period 1|Adverse Event|0
5936488|NCT01370655|20534729|P2|Period 1|Adverse Event|0
5936489|NCT01370655|20534730|P1|Period 1|Adverse Event|2
5936490|NCT01370642|20534767|P3|Overall Study|Withdrawal by Subject|3
5936491|NCT01370642|20534768|P2|Overall Study|Withdrawal by Subject|4
5936492|NCT01370642|20534769|P1|Overall Study|Withdrawal by Subject|2
5936493|NCT01370642|20534767|P3|Overall Study|Physician Decision|2
5936494|NCT01370642|20534768|P2|Overall Study|Physician Decision|1
5936495|NCT01370642|20534769|P1|Overall Study|Physician Decision|4
5936496|NCT01370642|20534767|P3|Overall Study|Lost to Follow-up|1
5936497|NCT01370642|20534768|P2|Overall Study|Lost to Follow-up|0
5936498|NCT01370642|20534769|P1|Overall Study|Lost to Follow-up|0
5936499|NCT01370642|20534767|P3|Overall Study|Detectable HCV RNA|22
5936500|NCT01370642|20534768|P2|Overall Study|Detectable HCV RNA|0
5936501|NCT01370642|20534769|P1|Overall Study|Detectable HCV RNA|0
5936502|NCT01370642|20534767|P3|Overall Study|Adverse Event|1
5936503|NCT01370642|20534768|P2|Overall Study|Adverse Event|1
5936504|NCT01370642|20534769|P1|Overall Study|Adverse Event|2
5936505|NCT01370616|20534808|P2|Overall Study|Withdrawal by Subject|34
5936506|NCT01370616|20534809|P1|Overall Study|Withdrawal by Subject|34
5936507|NCT01370616|20534808|P2|Overall Study|Technical Problems|5
5936508|NCT01370616|20534809|P1|Overall Study|Technical Problems|3
5936509|NCT01370616|20534808|P2|Overall Study|Recovery|0
5936510|NCT01370616|20534809|P1|Overall Study|Recovery|1
5936511|NCT01370616|20534808|P2|Overall Study|Progressive Disease|1
5936512|NCT01370616|20534809|P1|Overall Study|Progressive Disease|0
5936513|NCT01370616|20534808|P2|Overall Study|Physician Decision|6
5936514|NCT01370616|20534809|P1|Overall Study|Physician Decision|6
5936515|NCT01370616|20534808|P2|Overall Study|Lost to Follow-up|3
5936516|NCT01370616|20534809|P1|Overall Study|Lost to Follow-up|0
5936517|NCT01370616|20534808|P2|Overall Study|Lack of Efficacy|2
5936518|NCT01370616|20534809|P1|Overall Study|Lack of Efficacy|6
5936519|NCT01370616|20534808|P2|Overall Study|Death|0
5936520|NCT01370616|20534809|P1|Overall Study|Death|1
5936521|NCT01370616|20534808|P2|Overall Study|Adverse Event|16
5936522|NCT01370616|20534809|P1|Overall Study|Adverse Event|11
5936523|NCT01370603|20534833|P2|Period 2|Withdrawal by Subject|0
5936524|NCT01370603|20534834|P1|Period 2|Withdrawal by Subject|1
5936525|NCT01370603|20534833|P2|Period 2|Lost to Follow-up|0
5936526|NCT01370603|20534834|P1|Period 2|Lost to Follow-up|1
5936527|NCT01370603|20534833|P2|Period 2|Adverse Event|4
5936528|NCT01370603|20534834|P1|Period 2|Adverse Event|1
5936529|NCT01370603|20534833|P2|Crossover Washout|Non-compliance with Study Drug|2
5936530|NCT01370603|20534834|P1|Crossover Washout|Non-compliance with Study Drug|0
5936531|NCT01370603|20534833|P2|Crossover Washout|Withdrawal by Subject|1
5936532|NCT01370603|20534834|P1|Crossover Washout|Withdrawal by Subject|4
5936533|NCT01370603|20534833|P2|Crossover Washout|Protocol Violation|0
5936534|NCT01370603|20534834|P1|Crossover Washout|Protocol Violation|1
5936535|NCT01370603|20534833|P2|Crossover Washout|Lost to Follow-up|0
5936536|NCT01370603|20534834|P1|Crossover Washout|Lost to Follow-up|2
5936537|NCT01370603|20534833|P2|Crossover Washout|Adverse Event|1
5936538|NCT01370603|20534834|P1|Crossover Washout|Adverse Event|2
5936539|NCT01370603|20534833|P2|Period 1|Withdrawal by Subject|5
5936540|NCT01370603|20534834|P1|Period 1|Withdrawal by Subject|5
5936541|NCT01370603|20534833|P2|Period 1|Protocol Violation|2
5936542|NCT01370603|20534834|P1|Period 1|Protocol Violation|2
5936543|NCT01370603|20534833|P2|Period 1|Lost to Follow-up|0
5936544|NCT01370603|20534834|P1|Period 1|Lost to Follow-up|2
5936545|NCT01370603|20534833|P2|Period 1|Adverse Event|3
5936546|NCT01370603|20534834|P1|Period 1|Adverse Event|5
5936547|NCT01370590|20534852|P2|Period 2|Withdrawal by Subject|1
5936548|NCT01370590|20534853|P1|Period 2|Withdrawal by Subject|1
5936549|NCT01370590|20534852|P2|Period 2|Adverse Event|1
5936550|NCT01370590|20534853|P1|Period 2|Adverse Event|0
5936551|NCT01370590|20534852|P2|Crossover Washout Period|Withdrawal by Subject|2
5936552|NCT01370590|20534853|P1|Crossover Washout Period|Withdrawal by Subject|2
5936553|NCT01370590|20534852|P2|Crossover Washout Period|Non-compliance with Study Drug|0
5936554|NCT01370590|20534853|P1|Crossover Washout Period|Non-compliance with Study Drug|1
5936555|NCT01370590|20534852|P2|Crossover Washout Period|Lost to Follow-up|0
5936556|NCT01370590|20534853|P1|Crossover Washout Period|Lost to Follow-up|2
5936557|NCT01370590|20534852|P2|Crossover Washout Period|Adverse Event|4
5936558|NCT01370590|20534853|P1|Crossover Washout Period|Adverse Event|1
5936559|NCT01370590|20534852|P2|Period 1|Could not access randomization system|1
5936560|NCT01370590|20534853|P1|Period 1|Could not access randomization system|0
5936561|NCT01370590|20534852|P2|Period 1|Withdrawal by Subject|2
5936562|NCT01370590|20534853|P1|Period 1|Withdrawal by Subject|4
5936563|NCT01370590|20534852|P2|Period 1|Protocol Violation|2
5936564|NCT01370590|20534853|P1|Period 1|Protocol Violation|2
5936565|NCT01370590|20534852|P2|Period 1|Lost to Follow-up|2
5936566|NCT01370590|20534853|P1|Period 1|Lost to Follow-up|2
5936567|NCT01370590|20534852|P2|Period 1|Adverse Event|4
5936568|NCT01370590|20534853|P1|Period 1|Adverse Event|8
5936569|NCT01370538|20534881|P2|Overall Study|Lost to follow up|10
5936570|NCT01370538|20534882|P1|Overall Study|Lost to follow up|6
5936571|NCT01370538|20534881|P2|Overall Study|Development of study specific withdrawal|1
5936572|NCT01370538|20534882|P1|Overall Study|Development of study specific withdrawal|1
5936573|NCT01370538|20534881|P2|Overall Study|Protocol Violation|5
5936574|NCT01370538|20534882|P1|Overall Study|Protocol Violation|8
5936575|NCT01370538|20534881|P2|Overall Study|Adverse Event|0
5936576|NCT01370538|20534882|P1|Overall Study|Adverse Event|1
5936577|NCT01370538|20534881|P2|Overall Study|Eligibility criteria not fulfilled|1
5936578|NCT01370538|20534882|P1|Overall Study|Eligibility criteria not fulfilled|0
5936579|NCT01370538|20534881|P2|Overall Study|Voluntary Discontinuation by Subject|2
5936580|NCT01370538|20534882|P1|Overall Study|Voluntary Discontinuation by Subject|3
5936581|NCT01370525|20534898|P2|Overall Study|Lost to follow up|6
5936582|NCT01370525|20534899|P1|Overall Study|Lost to follow up|2
5936583|NCT01370525|20534898|P2|Overall Study|Protocol Violation|1
5936584|NCT01370525|20534899|P1|Overall Study|Protocol Violation|2
5936585|NCT01370525|20534898|P2|Overall Study|Adverse Event|1
5936586|NCT01370525|20534899|P1|Overall Study|Adverse Event|0
5936587|NCT01370525|20534898|P2|Overall Study|Eligibility criteria not fulfilled|0
5936588|NCT01370525|20534899|P1|Overall Study|Eligibility criteria not fulfilled|2
5936589|NCT01370525|20534898|P2|Overall Study|Voluntary Discontinuation by Subject|3
5936590|NCT01370525|20534899|P1|Overall Study|Voluntary Discontinuation by Subject|2
5936591|NCT01370499|20534915|P2|Overall Study|Sponsor Decision|15
5936592|NCT01370499|20534916|P1|Overall Study|Sponsor Decision|41
5936593|NCT01370499|20534915|P2|Overall Study|Withdrawal by Subject|7
5936594|NCT01370499|20534916|P1|Overall Study|Withdrawal by Subject|18
5936595|NCT01370499|20534915|P2|Overall Study|Protocol Violation|4
5936596|NCT01370499|20534916|P1|Overall Study|Protocol Violation|5
5936597|NCT01370499|20534915|P2|Overall Study|Physician Decision|3
5936598|NCT01370499|20534916|P1|Overall Study|Physician Decision|3
5936599|NCT01370499|20534915|P2|Overall Study|Lost to Follow-up|1
5936600|NCT01370499|20534916|P1|Overall Study|Lost to Follow-up|2
5936601|NCT01370499|20534915|P2|Overall Study|Lack of Efficacy|2
5936602|NCT01370499|20534916|P1|Overall Study|Lack of Efficacy|4
5936603|NCT01370499|20534915|P2|Overall Study|Adverse Event|12
5936604|NCT01370499|20534916|P1|Overall Study|Adverse Event|38
5936605|NCT01370408|20534958|P1|Overall Study|treatment failure|9
5936606|NCT01370356|20535018|P2|Overall Study|AE Not Related to Study Drug|4
5936607|NCT01370356|20535019|P1|Overall Study|AE Not Related to Study Drug|1
5936608|NCT01370356|20535018|P2|Overall Study|Adverse event (AE) Related to Study Drug|9
5936609|NCT01370356|20535019|P1|Overall Study|Adverse event (AE) Related to Study Drug|12
5936610|NCT01370356|20535018|P2|Overall Study|Protocol Violation|3
5936611|NCT01370356|20535019|P1|Overall Study|Protocol Violation|3
5936612|NCT01370356|20535018|P2|Overall Study|Reason not specified|43
5936613|NCT01370356|20535019|P1|Overall Study|Reason not specified|39
5936614|NCT01370356|20535018|P2|Overall Study|Withdrawal by Subject|59
5936615|NCT01370356|20535019|P1|Overall Study|Withdrawal by Subject|54
5936616|NCT01370356|20535018|P2|Overall Study|Lost to Follow-up|81
5936617|NCT01370356|20535019|P1|Overall Study|Lost to Follow-up|76
5936618|NCT01370356|20535018|P2|Overall Study|Lack of Efficacy|28
5936619|NCT01370356|20535019|P1|Overall Study|Lack of Efficacy|6
5936620|NCT01370356|20535018|P2|Overall Study|Death|0
5936621|NCT01370356|20535019|P1|Overall Study|Death|1
5936622|NCT01370317|20535035|P2|Overall Study|Protocol deviation|1
5936623|NCT01370317|20535036|P1|Overall Study|Protocol deviation|0
5936624|NCT01370317|20535035|P2|Overall Study|Participant withdrew consent|0
5936625|NCT01370317|20535036|P1|Overall Study|Participant withdrew consent|1
5936626|NCT01370265|20535047|P2|First Intervention|Adverse Event|1
5936627|NCT01370265|20535048|P1|First Intervention|Adverse Event|1
5936628|NCT01370213|20535068|P3|Overall Study|Not evaluable|0
5936629|NCT01370213|20535069|P2|Overall Study|Not evaluable|2
5936630|NCT01370213|20535070|P1|Overall Study|Not evaluable|0
5936631|NCT01370213|20535068|P3|Overall Study|Early Death|0
5936632|NCT01370213|20535069|P2|Overall Study|Early Death|0
5936633|NCT01370213|20535070|P1|Overall Study|Early Death|1
5936634|NCT01370083|20535090|P2|Overall Study|Adverse Event|1
5936635|NCT01370083|20535091|P1|Overall Study|Adverse Event|0
5936636|NCT01370083|20535090|P2|Overall Study|Lost to Follow-up|0
5936637|NCT01370083|20535091|P1|Overall Study|Lost to Follow-up|2
5936638|NCT01370005|20535104|P3|Overall Study|Other reason not defined above|2
5936639|NCT01370005|20535105|P2|Overall Study|Other reason not defined above|0
5936640|NCT01370005|20535106|P1|Overall Study|Other reason not defined above|3
5936641|NCT01370005|20535104|P3|Overall Study|Patient refusal to continue,not due toAE|0
5936642|NCT01370005|20535105|P2|Overall Study|Patient refusal to continue,not due toAE|4
5936643|NCT01370005|20535106|P1|Overall Study|Patient refusal to continue,not due toAE|5
5936644|NCT01370005|20535104|P3|Overall Study|Lost to Follow-up|1
5936645|NCT01370005|20535105|P2|Overall Study|Lost to Follow-up|1
5936646|NCT01370005|20535106|P1|Overall Study|Lost to Follow-up|1
5936647|NCT01370005|20535104|P3|Overall Study|Non compliant with protocol|2
5936648|NCT01370005|20535105|P2|Overall Study|Non compliant with protocol|1
5936649|NCT01370005|20535106|P1|Overall Study|Non compliant with protocol|0
5936650|NCT01370005|20535104|P3|Overall Study|Lack of Efficacy|0
5936651|NCT01370005|20535105|P2|Overall Study|Lack of Efficacy|0
5936652|NCT01370005|20535106|P1|Overall Study|Lack of Efficacy|1
5936653|NCT01370005|20535104|P3|Overall Study|Adverse Event|6
5936654|NCT01370005|20535105|P2|Overall Study|Adverse Event|5
5936655|NCT01370005|20535106|P1|Overall Study|Adverse Event|5
5936656|NCT01370005|20535104|P3|Overall Study|Not treated|0
5936657|NCT01370005|20535105|P2|Overall Study|Not treated|0
5936658|NCT01370005|20535106|P1|Overall Study|Not treated|1
5936659|NCT01369849|20535188|P3|Overall Study|Ineligible after receiving treatment|0
5936660|NCT01369849|20535189|P2|Overall Study|Ineligible after receiving treatment|1
5936661|NCT01369849|20535190|P1|Overall Study|Ineligible after receiving treatment|0
5936662|NCT01369849|20535188|P3|Overall Study|Ineligible prior to treatment|1
5936663|NCT01369849|20535189|P2|Overall Study|Ineligible prior to treatment|0
5936664|NCT01369849|20535190|P1|Overall Study|Ineligible prior to treatment|0
5936665|NCT01369784|20535212|P1|Overall Study|Protocol Violation|12
5936666|NCT01369680|20535300|P4|Overall Study|Lost to Follow-up|2
5936667|NCT01369680|20535301|P3|Overall Study|Lost to Follow-up|1
5936668|NCT01369680|20535302|P2|Overall Study|Lost to Follow-up|0
5936669|NCT01369680|20535303|P1|Overall Study|Lost to Follow-up|0
5936670|NCT01369641|20535324|P1|Overall Study|Withdrawal by Subject|1
5936671|NCT01369615|20535330|P2|Overall Study|Lost to Follow-up|1
5936672|NCT01369615|20535331|P1|Overall Study|Lost to Follow-up|0
5936673|NCT01369615|20535330|P2|Overall Study|Withdrawal by Subject|1
5936674|NCT01369615|20535331|P1|Overall Study|Withdrawal by Subject|0
5936675|NCT01369511|20535341|P4|Overall Study|Withdrawal by Subject|6
5936676|NCT01369511|20535342|P3|Overall Study|Withdrawal by Subject|4
5936677|NCT01369511|20535343|P2|Overall Study|Withdrawal by Subject|6
5936678|NCT01369511|20535344|P1|Overall Study|Withdrawal by Subject|5
5936679|NCT01369511|20535341|P4|Overall Study|Sponsor decision|0
5936680|NCT01369511|20535342|P3|Overall Study|Sponsor decision|1
5936681|NCT01369511|20535343|P2|Overall Study|Sponsor decision|0
5936682|NCT01369511|20535344|P1|Overall Study|Sponsor decision|2
5936683|NCT01369511|20535341|P4|Overall Study|Physician Decision|0
5936684|NCT01369511|20535342|P3|Overall Study|Physician Decision|0
5936685|NCT01369511|20535343|P2|Overall Study|Physician Decision|4
5936686|NCT01369511|20535344|P1|Overall Study|Physician Decision|3
5936687|NCT01369511|20535341|P4|Overall Study|Protocol Violation|2
5936688|NCT01369511|20535342|P3|Overall Study|Protocol Violation|0
5936689|NCT01369511|20535343|P2|Overall Study|Protocol Violation|1
5936690|NCT01369511|20535344|P1|Overall Study|Protocol Violation|0
5936691|NCT01369511|20535341|P4|Overall Study|Lost to Follow-up|2
5936692|NCT01369511|20535342|P3|Overall Study|Lost to Follow-up|1
5936693|NCT01369511|20535343|P2|Overall Study|Lost to Follow-up|1
5936694|NCT01369511|20535344|P1|Overall Study|Lost to Follow-up|0
5936695|NCT01369511|20535341|P4|Overall Study|Entry criteria not met|1
5936696|NCT01369511|20535342|P3|Overall Study|Entry criteria not met|0
5936697|NCT01369511|20535343|P2|Overall Study|Entry criteria not met|0
5936698|NCT01369511|20535344|P1|Overall Study|Entry criteria not met|2
5936699|NCT01369511|20535341|P4|Overall Study|Adverse Event|0
5936700|NCT01369511|20535342|P3|Overall Study|Adverse Event|5
5936701|NCT01369511|20535343|P2|Overall Study|Adverse Event|1
5936702|NCT01369511|20535344|P1|Overall Study|Adverse Event|1
5936703|NCT01369498|20535362|P4|Overall Study|Disease Progression|1
5936704|NCT01369498|20535363|P3|Overall Study|Disease Progression|0
5936705|NCT01369498|20535364|P2|Overall Study|Disease Progression|0
5936706|NCT01369498|20535365|P1|Overall Study|Disease Progression|0
5936707|NCT01369498|20535362|P4|Overall Study|Unknown Reason|6
5936708|NCT01369498|20535363|P3|Overall Study|Unknown Reason|11
5936709|NCT01369498|20535364|P2|Overall Study|Unknown Reason|0
5936710|NCT01369498|20535365|P1|Overall Study|Unknown Reason|1
5936711|NCT01369498|20535362|P4|Overall Study|Investigator's Discretion|3
5936712|NCT01369498|20535363|P3|Overall Study|Investigator's Discretion|1
5936713|NCT01369498|20535364|P2|Overall Study|Investigator's Discretion|0
5936714|NCT01369498|20535365|P1|Overall Study|Investigator's Discretion|1
5936715|NCT01369498|20535362|P4|Overall Study|Death|0
5936716|NCT01369498|20535363|P3|Overall Study|Death|1
5936717|NCT01369498|20535364|P2|Overall Study|Death|0
5936718|NCT01369498|20535365|P1|Overall Study|Death|0
5936719|NCT01369498|20535362|P4|Overall Study|Withdrawal of Consent|1
5936720|NCT01369498|20535363|P3|Overall Study|Withdrawal of Consent|1
5936721|NCT01369498|20535364|P2|Overall Study|Withdrawal of Consent|1
5936722|NCT01369498|20535365|P1|Overall Study|Withdrawal of Consent|0
5936723|NCT01369498|20535362|P4|Overall Study|Adverse Event|1
5936724|NCT01369498|20535363|P3|Overall Study|Adverse Event|0
5936725|NCT01369498|20535364|P2|Overall Study|Adverse Event|2
5936726|NCT01369498|20535365|P1|Overall Study|Adverse Event|1
5936727|NCT01369498|20535362|P4|Overall Study|Lack of Efficacy|3
5936728|NCT01369498|20535363|P3|Overall Study|Lack of Efficacy|1
5936729|NCT01369498|20535364|P2|Overall Study|Lack of Efficacy|9
5936730|NCT01369498|20535365|P1|Overall Study|Lack of Efficacy|9
5936731|NCT01369485|20535397|P2|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|3
5936732|NCT01369485|20535398|P1|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|0
5936733|NCT01369485|20535397|P2|Open Label Phase (Week 12 to Month 12)|Death|1
5936734|NCT01369485|20535398|P1|Open Label Phase (Week 12 to Month 12)|Death|0
5936735|NCT01369485|20535397|P2|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|20
5936736|NCT01369485|20535398|P1|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|17
5936737|NCT01369485|20535397|P2|Open Label Phase (Week 12 to Month 12)|Physician Decision|4
5936738|NCT01369485|20535398|P1|Open Label Phase (Week 12 to Month 12)|Physician Decision|3
5936739|NCT01369485|20535397|P2|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|3
5936740|NCT01369485|20535398|P1|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|2
5936741|NCT01369485|20535397|P2|Open Label Phase (Week 12 to Month 12)|Adverse Event|9
5936742|NCT01369485|20535398|P1|Open Label Phase (Week 12 to Month 12)|Adverse Event|11
5936743|NCT01369485|20535397|P2|Randomized Phase (Day 0 to Week 12)|expired patches|0
5936744|NCT01369485|20535398|P1|Randomized Phase (Day 0 to Week 12)|expired patches|2
5936745|NCT01369485|20535397|P2|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|4
5936746|NCT01369485|20535398|P1|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|2
5936747|NCT01369485|20535397|P2|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|8
5936748|NCT01369485|20535398|P1|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|12
5936749|NCT01369485|20535397|P2|Randomized Phase (Day 0 to Week 12)|Adverse Event|5
5936750|NCT01369485|20535398|P1|Randomized Phase (Day 0 to Week 12)|Adverse Event|7
5936751|NCT01369433|20535440|P2|Overall Study|Progressive Disease|12
5936752|NCT01369433|20535441|P1|Overall Study|Progressive Disease|92
5936753|NCT01369433|20535440|P2|Overall Study|Investigator discretion|1
5936754|NCT01369433|20535441|P1|Overall Study|Investigator discretion|6
5936755|NCT01369433|20535440|P2|Overall Study|Death|0
5936756|NCT01369433|20535441|P1|Overall Study|Death|5
5936757|NCT01369433|20535440|P2|Overall Study|Lost to Follow-up|0
5936758|NCT01369433|20535441|P1|Overall Study|Lost to Follow-up|1
5936759|NCT01369433|20535440|P2|Overall Study|Study terminated by Sponsor|0
5936760|NCT01369433|20535441|P1|Overall Study|Study terminated by Sponsor|67
5936761|NCT01369433|20535440|P2|Overall Study|Withdrawal by Subject|2
5936762|NCT01369433|20535441|P1|Overall Study|Withdrawal by Subject|5
5936763|NCT01369433|20535440|P2|Overall Study|Non-compliance|0
5936764|NCT01369433|20535441|P1|Overall Study|Non-compliance|1
5936765|NCT01369433|20535440|P2|Overall Study|Required significant surgical procedure|0
5936766|NCT01369433|20535441|P1|Overall Study|Required significant surgical procedure|1
5936767|NCT01369433|20535440|P2|Overall Study|Adverse Event|1
5936768|NCT01369433|20535441|P1|Overall Study|Adverse Event|31
5936769|NCT01369355|20535453|P9|Long-term Extension (Week 44-272)|Other|17
5936770|NCT01369355|20535454|P8|Long-term Extension (Week 44-272)|Other|9
5936771|NCT01369355|20535455|P7|Long-term Extension (Week 44-272)|Other|110
5936772|NCT01369355|20535456|P6|Long-term Extension (Week 44-272)|Other|0
5936773|NCT01369355|20535457|P5|Long-term Extension (Week 44-272)|Other|0
5936774|NCT01369355|20535458|P4|Long-term Extension (Week 44-272)|Other|0
5936775|NCT01369355|20535459|P3|Long-term Extension (Week 44-272)|Other|0
5936776|NCT01369355|20535460|P2|Long-term Extension (Week 44-272)|Other|0
5936777|NCT01369355|20535461|P1|Long-term Extension (Week 44-272)|Other|0
5936778|NCT01369355|20535453|P9|Long-term Extension (Week 44-272)|Withdrawal by Subject|47
5936779|NCT01369355|20535454|P8|Long-term Extension (Week 44-272)|Withdrawal by Subject|30
5936780|NCT01369355|20535455|P7|Long-term Extension (Week 44-272)|Withdrawal by Subject|12
5936781|NCT01369355|20535456|P6|Long-term Extension (Week 44-272)|Withdrawal by Subject|0
5936782|NCT01369355|20535457|P5|Long-term Extension (Week 44-272)|Withdrawal by Subject|0
5936783|NCT01369355|20535458|P4|Long-term Extension (Week 44-272)|Withdrawal by Subject|0
5936784|NCT01369355|20535459|P3|Long-term Extension (Week 44-272)|Withdrawal by Subject|0
5936785|NCT01369355|20535460|P2|Long-term Extension (Week 44-272)|Withdrawal by Subject|0
5936786|NCT01369355|20535461|P1|Long-term Extension (Week 44-272)|Withdrawal by Subject|0
5936787|NCT01369355|20535453|P9|Long-term Extension (Week 44-272)|Lost to Follow-up|9
5936788|NCT01369355|20535454|P8|Long-term Extension (Week 44-272)|Lost to Follow-up|5
5936789|NCT01369355|20535455|P7|Long-term Extension (Week 44-272)|Lost to Follow-up|1
5936790|NCT01369355|20535456|P6|Long-term Extension (Week 44-272)|Lost to Follow-up|0
5936791|NCT01369355|20535457|P5|Long-term Extension (Week 44-272)|Lost to Follow-up|0
5936792|NCT01369355|20535458|P4|Long-term Extension (Week 44-272)|Lost to Follow-up|0
5936793|NCT01369355|20535459|P3|Long-term Extension (Week 44-272)|Lost to Follow-up|0
5936794|NCT01369355|20535460|P2|Long-term Extension (Week 44-272)|Lost to Follow-up|0
5936795|NCT01369355|20535461|P1|Long-term Extension (Week 44-272)|Lost to Follow-up|0
5936796|NCT01369355|20535453|P9|Long-term Extension (Week 44-272)|Physician Decision|11
5936797|NCT01369355|20535454|P8|Long-term Extension (Week 44-272)|Physician Decision|5
5936798|NCT01369355|20535455|P7|Long-term Extension (Week 44-272)|Physician Decision|1
5936799|NCT01369355|20535456|P6|Long-term Extension (Week 44-272)|Physician Decision|0
5936800|NCT01369355|20535457|P5|Long-term Extension (Week 44-272)|Physician Decision|0
5936801|NCT01369355|20535458|P4|Long-term Extension (Week 44-272)|Physician Decision|0
5936802|NCT01369355|20535459|P3|Long-term Extension (Week 44-272)|Physician Decision|0
5936803|NCT01369355|20535460|P2|Long-term Extension (Week 44-272)|Physician Decision|0
5936804|NCT01369355|20535461|P1|Long-term Extension (Week 44-272)|Physician Decision|0
5936805|NCT01369355|20535453|P9|Long-term Extension (Week 44-272)|Protocol Violation|2
5936806|NCT01369355|20535454|P8|Long-term Extension (Week 44-272)|Protocol Violation|1
5936807|NCT01369355|20535455|P7|Long-term Extension (Week 44-272)|Protocol Violation|0
5936808|NCT01369355|20535456|P6|Long-term Extension (Week 44-272)|Protocol Violation|0
5936809|NCT01369355|20535457|P5|Long-term Extension (Week 44-272)|Protocol Violation|0
5936810|NCT01369355|20535458|P4|Long-term Extension (Week 44-272)|Protocol Violation|0
5936811|NCT01369355|20535459|P3|Long-term Extension (Week 44-272)|Protocol Violation|0
5936812|NCT01369355|20535460|P2|Long-term Extension (Week 44-272)|Protocol Violation|0
5936813|NCT01369355|20535461|P1|Long-term Extension (Week 44-272)|Protocol Violation|0
5936814|NCT01369355|20535453|P9|Long-term Extension (Week 44-272)|Lack of Efficacy|29
5936815|NCT01369355|20535454|P8|Long-term Extension (Week 44-272)|Lack of Efficacy|26
5936816|NCT01369355|20535455|P7|Long-term Extension (Week 44-272)|Lack of Efficacy|12
5936817|NCT01369355|20535456|P6|Long-term Extension (Week 44-272)|Lack of Efficacy|0
5936818|NCT01369355|20535457|P5|Long-term Extension (Week 44-272)|Lack of Efficacy|0
5936819|NCT01369355|20535458|P4|Long-term Extension (Week 44-272)|Lack of Efficacy|0
5936820|NCT01369355|20535459|P3|Long-term Extension (Week 44-272)|Lack of Efficacy|0
5936821|NCT01369355|20535460|P2|Long-term Extension (Week 44-272)|Lack of Efficacy|0
5936822|NCT01369355|20535461|P1|Long-term Extension (Week 44-272)|Lack of Efficacy|0
5936823|NCT01369355|20535453|P9|Long-term Extension (Week 44-272)|Death|3
5936824|NCT01369355|20535454|P8|Long-term Extension (Week 44-272)|Death|1
5936825|NCT01369355|20535455|P7|Long-term Extension (Week 44-272)|Death|0
5936826|NCT01369355|20535456|P6|Long-term Extension (Week 44-272)|Death|0
5936827|NCT01369355|20535457|P5|Long-term Extension (Week 44-272)|Death|0
5936828|NCT01369355|20535458|P4|Long-term Extension (Week 44-272)|Death|0
5936829|NCT01369355|20535459|P3|Long-term Extension (Week 44-272)|Death|0
5936830|NCT01369355|20535460|P2|Long-term Extension (Week 44-272)|Death|0
5936831|NCT01369355|20535461|P1|Long-term Extension (Week 44-272)|Death|0
5936832|NCT01369355|20535453|P9|Long-term Extension (Week 44-272)|Adverse Event|53
5936833|NCT01369355|20535454|P8|Long-term Extension (Week 44-272)|Adverse Event|29
5936834|NCT01369355|20535455|P7|Long-term Extension (Week 44-272)|Adverse Event|15
5936835|NCT01369355|20535456|P6|Long-term Extension (Week 44-272)|Adverse Event|0
5936836|NCT01369355|20535457|P5|Long-term Extension (Week 44-272)|Adverse Event|0
5936837|NCT01369355|20535458|P4|Long-term Extension (Week 44-272)|Adverse Event|0
5936838|NCT01369355|20535459|P3|Long-term Extension (Week 44-272)|Adverse Event|0
5936839|NCT01369355|20535460|P2|Long-term Extension (Week 44-272)|Adverse Event|0
5936840|NCT01369355|20535461|P1|Long-term Extension (Week 44-272)|Adverse Event|0
5936841|NCT01369355|20535453|P9|Week 0 - Week 44 (Maintenance)|Other|0
5936842|NCT01369355|20535454|P8|Week 0 - Week 44 (Maintenance)|Other|0
5936843|NCT01369355|20535455|P7|Week 0 - Week 44 (Maintenance)|Other|0
5936844|NCT01369355|20535456|P6|Week 0 - Week 44 (Maintenance)|Other|0
5936845|NCT01369355|20535457|P5|Week 0 - Week 44 (Maintenance)|Other|1
5936846|NCT01369355|20535458|P4|Week 0 - Week 44 (Maintenance)|Other|0
5936847|NCT01369355|20535459|P3|Week 0 - Week 44 (Maintenance)|Other|1
5936848|NCT01369355|20535460|P2|Week 0 - Week 44 (Maintenance)|Other|0
5936849|NCT01369355|20535461|P1|Week 0 - Week 44 (Maintenance)|Other|0
5936850|NCT01369355|20535453|P9|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0
5936851|NCT01369355|20535454|P8|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0
5936852|NCT01369355|20535455|P7|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0
5936853|NCT01369355|20535456|P6|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|22
5936854|NCT01369355|20535457|P5|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|8
5936855|NCT01369355|20535458|P4|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|6
5936856|NCT01369355|20535459|P3|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|7
5936857|NCT01369355|20535460|P2|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|2
5936858|NCT01369355|20535461|P1|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|6
5936859|NCT01369355|20535453|P9|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0
5936860|NCT01369355|20535454|P8|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0
5936861|NCT01369355|20535455|P7|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0
5936862|NCT01369355|20535456|P6|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|6
5936863|NCT01369355|20535457|P5|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|5
5936864|NCT01369355|20535458|P4|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|2
5936865|NCT01369355|20535459|P3|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|1
5936866|NCT01369355|20535460|P2|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0
5936867|NCT01369355|20535461|P1|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|1
5936868|NCT01369355|20535453|P9|Week 0 - Week 44 (Maintenance)|Protocol Violation|0
5936869|NCT01369355|20535454|P8|Week 0 - Week 44 (Maintenance)|Protocol Violation|0
5936870|NCT01369355|20535455|P7|Week 0 - Week 44 (Maintenance)|Protocol Violation|0
5936871|NCT01369355|20535456|P6|Week 0 - Week 44 (Maintenance)|Protocol Violation|2
5936872|NCT01369355|20535457|P5|Week 0 - Week 44 (Maintenance)|Protocol Violation|0
5936873|NCT01369355|20535458|P4|Week 0 - Week 44 (Maintenance)|Protocol Violation|0
5936874|NCT01369355|20535459|P3|Week 0 - Week 44 (Maintenance)|Protocol Violation|1
5936875|NCT01369355|20535460|P2|Week 0 - Week 44 (Maintenance)|Protocol Violation|1
5936876|NCT01369355|20535461|P1|Week 0 - Week 44 (Maintenance)|Protocol Violation|0
5936877|NCT01369355|20535453|P9|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0
5936878|NCT01369355|20535454|P8|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0
5936879|NCT01369355|20535455|P7|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0
5936880|NCT01369355|20535456|P6|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|217
5936881|NCT01369355|20535457|P5|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|126
5936882|NCT01369355|20535458|P4|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15
5936883|NCT01369355|20535459|P3|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15
5936884|NCT01369355|20535460|P2|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|14
5936885|NCT01369355|20535461|P1|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15
5936886|NCT01369355|20535453|P9|Week 0 - Week 44 (Maintenance)|Adverse Event|0
5936887|NCT01369355|20535454|P8|Week 0 - Week 44 (Maintenance)|Adverse Event|0
5936888|NCT01369355|20535455|P7|Week 0 - Week 44 (Maintenance)|Adverse Event|0
5936889|NCT01369355|20535456|P6|Week 0 - Week 44 (Maintenance)|Adverse Event|25
5936890|NCT01369355|20535457|P5|Week 0 - Week 44 (Maintenance)|Adverse Event|14
5936891|NCT01369355|20535458|P4|Week 0 - Week 44 (Maintenance)|Adverse Event|7
5936892|NCT01369355|20535459|P3|Week 0 - Week 44 (Maintenance)|Adverse Event|6
5936893|NCT01369355|20535460|P2|Week 0 - Week 44 (Maintenance)|Adverse Event|12
5936894|NCT01369355|20535461|P1|Week 0 - Week 44 (Maintenance)|Adverse Event|9
5936895|NCT01369342|20535493|P3|Overall Study|Not Treated|0
5936896|NCT01369342|20535494|P2|Overall Study|Not Treated|0
5936897|NCT01369342|20535495|P1|Overall Study|Not Treated|1
5936898|NCT01369342|20535493|P3|Overall Study|Lost to Follow-up|1
5936899|NCT01369342|20535494|P2|Overall Study|Lost to Follow-up|2
5936900|NCT01369342|20535495|P1|Overall Study|Lost to Follow-up|5
5936901|NCT01369342|20535493|P3|Overall Study|Withdrawal by Subject|2
5936902|NCT01369342|20535494|P2|Overall Study|Withdrawal by Subject|7
5936903|NCT01369342|20535495|P1|Overall Study|Withdrawal by Subject|7
5936904|NCT01369329|20535518|P3|Overall Study|Other|2
5936905|NCT01369329|20535519|P2|Overall Study|Other|3
5936906|NCT01369329|20535520|P1|Overall Study|Other|2
5936907|NCT01369329|20535518|P3|Overall Study|Lost to Follow-up|2
5936908|NCT01369329|20535519|P2|Overall Study|Lost to Follow-up|2
5936909|NCT01369329|20535520|P1|Overall Study|Lost to Follow-up|2
5936910|NCT01369329|20535518|P3|Overall Study|Withdrawal by Subject|10
5936911|NCT01369329|20535519|P2|Overall Study|Withdrawal by Subject|6
5936912|NCT01369329|20535520|P1|Overall Study|Withdrawal by Subject|8
5936913|NCT01369225|20535546|P6|Overall Study|Adverse Event|0
5936914|NCT01369225|20535547|P5|Overall Study|Adverse Event|1
5936915|NCT01369225|20535548|P4|Overall Study|Adverse Event|1
5936916|NCT01369225|20535549|P3|Overall Study|Adverse Event|0
5936917|NCT01369225|20535550|P2|Overall Study|Adverse Event|0
5936918|NCT01369225|20535551|P1|Overall Study|Adverse Event|0
5936919|NCT01369225|20535546|P6|Overall Study|Other|0
5936920|NCT01369225|20535547|P5|Overall Study|Other|1
5936921|NCT01369225|20535548|P4|Overall Study|Other|0
5936922|NCT01369225|20535549|P3|Overall Study|Other|0
5936923|NCT01369225|20535550|P2|Overall Study|Other|0
5936924|NCT01369225|20535551|P1|Overall Study|Other|1
5936925|NCT01369225|20535546|P6|Overall Study|Does Not Meet Entrance Criteria|0
5936926|NCT01369225|20535547|P5|Overall Study|Does Not Meet Entrance Criteria|0
5936927|NCT01369225|20535548|P4|Overall Study|Does Not Meet Entrance Criteria|0
5936928|NCT01369225|20535549|P3|Overall Study|Does Not Meet Entrance Criteria|1
5936929|NCT01369225|20535550|P2|Overall Study|Does Not Meet Entrance Criteria|0
5936930|NCT01369225|20535551|P1|Overall Study|Does Not Meet Entrance Criteria|0
5936931|NCT01369225|20535546|P6|Overall Study|Withdrawal by Subject|0
5936932|NCT01369225|20535547|P5|Overall Study|Withdrawal by Subject|0
5936933|NCT01369225|20535548|P4|Overall Study|Withdrawal by Subject|1
5936934|NCT01369225|20535549|P3|Overall Study|Withdrawal by Subject|2
5936935|NCT01369225|20535550|P2|Overall Study|Withdrawal by Subject|0
5936936|NCT01369225|20535551|P1|Overall Study|Withdrawal by Subject|1
5936937|NCT01369199|20535643|P1|Overall Study|Lost to Follow-up|2
5936938|NCT01369199|20535643|P1|Overall Study|Withdrawal by Subject|1
5936939|NCT01369069|20535675|P2|Overall Study|Withdrawal by Subject|7
5936940|NCT01369069|20535676|P1|Overall Study|Withdrawal by Subject|9
5936941|NCT01369069|20535675|P2|Overall Study|Lost to Follow-up|9
5936942|NCT01369069|20535676|P1|Overall Study|Lost to Follow-up|8
5936943|NCT01368965|20535698|P1|Overall Study|Lost to Follow-up|12
5936944|NCT01368900|20535707|P1|Overall Study|Lost to Follow-up|7
5936945|NCT01368835|20535782|P1|Overall Study|Lost to Follow-up|11
5936946|NCT01368835|20535782|P1|Overall Study|Inclusion criteria/photography quality|22
5936947|NCT01368614|20535821|P4|Study Period|Lost to Follow-up|0
5936948|NCT01368614|20535822|P3|Study Period|Lost to Follow-up|1
5936949|NCT01368614|20535823|P2|Study Period|Lost to Follow-up|0
5936950|NCT01368614|20535824|P1|Study Period|Lost to Follow-up|0
5936951|NCT01368614|20535821|P4|Study Period|Withdrawal by Subject|3
5936952|NCT01368614|20535822|P3|Study Period|Withdrawal by Subject|1
5936953|NCT01368614|20535823|P2|Study Period|Withdrawal by Subject|1
5936954|NCT01368614|20535824|P1|Study Period|Withdrawal by Subject|0
5936955|NCT01368614|20535821|P4|Screening Period|Screen Failure|0
5936956|NCT01368614|20535822|P3|Screening Period|Screen Failure|0
5936957|NCT01368614|20535823|P2|Screening Period|Screen Failure|0
5936958|NCT01368614|20535824|P1|Screening Period|Screen Failure|58
5936959|NCT01368562|20535877|P1|Overall Study|Other than specified|2
5936960|NCT01368562|20535877|P1|Overall Study|Other|3
5936961|NCT01368562|20535877|P1|Overall Study|Unresponsive to treatment|5
5936962|NCT01368562|20535877|P1|Overall Study|Death|6
5936963|NCT01368562|20535877|P1|Overall Study|Lost to Follow-up|1
5936964|NCT01368562|20535877|P1|Overall Study|Disease progression|1
5936965|NCT01368562|20535877|P1|Overall Study|Adverse Event|1
5936966|NCT01368536|20535884|P3|Overall Study|Protocol deviation|1
5936967|NCT01368536|20535885|P2|Overall Study|Protocol deviation|3
5936968|NCT01368536|20535886|P1|Overall Study|Protocol deviation|0
5936969|NCT01368536|20535884|P3|Overall Study|Administrative problems|35
5936970|NCT01368536|20535885|P2|Overall Study|Administrative problems|39
5936971|NCT01368536|20535886|P1|Overall Study|Administrative problems|34
5936972|NCT01368536|20535884|P3|Overall Study|Lost to Follow-up|5
5936973|NCT01368536|20535885|P2|Overall Study|Lost to Follow-up|3
5936974|NCT01368536|20535886|P1|Overall Study|Lost to Follow-up|3
5936975|NCT01368536|20535884|P3|Overall Study|Withdrawal by Subject|4
5936976|NCT01368536|20535885|P2|Overall Study|Withdrawal by Subject|5
5936977|NCT01368536|20535886|P1|Overall Study|Withdrawal by Subject|2
5936978|NCT01368536|20535884|P3|Overall Study|No longer required study medication|1
5936979|NCT01368536|20535885|P2|Overall Study|No longer required study medication|0
5936980|NCT01368536|20535886|P1|Overall Study|No longer required study medication|0
5936981|NCT01368536|20535884|P3|Overall Study|Unsatisfactory therapeutic effect|2
5936982|NCT01368536|20535885|P2|Overall Study|Unsatisfactory therapeutic effect|2
5936983|NCT01368536|20535886|P1|Overall Study|Unsatisfactory therapeutic effect|7
5936984|NCT01368536|20535884|P3|Overall Study|Abnormal test procedure result(s)|1
5936985|NCT01368536|20535885|P2|Overall Study|Abnormal test procedure result(s)|0
5936986|NCT01368536|20535886|P1|Overall Study|Abnormal test procedure result(s)|0
5936987|NCT01368536|20535884|P3|Overall Study|Abnormal laboratory value(s)|2
5936988|NCT01368536|20535885|P2|Overall Study|Abnormal laboratory value(s)|1
5936989|NCT01368536|20535886|P1|Overall Study|Abnormal laboratory value(s)|0
5936990|NCT01368536|20535884|P3|Overall Study|Adverse Event|8
5936991|NCT01368536|20535885|P2|Overall Study|Adverse Event|6
5936992|NCT01368536|20535886|P1|Overall Study|Adverse Event|5
5936993|NCT01368497|20535907|P1|Overall Study|Lost to Follow-up|2
5936994|NCT01368432|20535936|P2|Overall Study|Lost to Follow-up|1
5936995|NCT01368432|20535937|P1|Overall Study|Lost to Follow-up|0
5936996|NCT01368406|20535971|P2|Overall Study|started working|3
5936997|NCT01368406|20535972|P1|Overall Study|started working|2
5936998|NCT01368406|20535971|P2|Overall Study|relapse of the disease|2
5936999|NCT01368406|20535972|P1|Overall Study|relapse of the disease|3
5937000|NCT01368406|20535971|P2|Overall Study|Withdrawal by Subject|4
5937001|NCT01368406|20535972|P1|Overall Study|Withdrawal by Subject|8
5937002|NCT01368406|20535971|P2|Overall Study|Lost to Follow-up|4
5937003|NCT01368406|20535972|P1|Overall Study|Lost to Follow-up|8
5937004|NCT01368276|20535980|P2|Overall Study|Death|10
5937005|NCT01368276|20535981|P1|Overall Study|Death|1
5937006|NCT01368211|20536018|P2|Second Platelets Transfusion|No need for additional transfusion|2
5937007|NCT01368211|20536019|P1|Second Platelets Transfusion|No need for additional transfusion|1
5937008|NCT01368081|20536047|P13|Overall Study|Other reason not defined above|3
5937009|NCT01368081|20536048|P12|Overall Study|Other reason not defined above|0
5937010|NCT01368081|20536049|P11|Overall Study|Other reason not defined above|0
5937011|NCT01368081|20536050|P10|Overall Study|Other reason not defined above|1
5937012|NCT01368081|20536051|P9|Overall Study|Other reason not defined above|0
5937013|NCT01368081|20536052|P8|Overall Study|Other reason not defined above|0
5937014|NCT01368081|20536053|P7|Overall Study|Other reason not defined above|2
5937015|NCT01368081|20536054|P6|Overall Study|Other reason not defined above|1
5937016|NCT01368081|20536055|P5|Overall Study|Other reason not defined above|0
5937017|NCT01368081|20536056|P4|Overall Study|Other reason not defined above|1
5937018|NCT01368081|20536057|P3|Overall Study|Other reason not defined above|0
5937019|NCT01368081|20536058|P2|Overall Study|Other reason not defined above|0
5937020|NCT01368081|20536059|P1|Overall Study|Other reason not defined above|2
5937021|NCT01368081|20536047|P13|Overall Study|Withdrawal by Subject|0
5937022|NCT01368081|20536048|P12|Overall Study|Withdrawal by Subject|2
5937023|NCT01368081|20536049|P11|Overall Study|Withdrawal by Subject|3
5937024|NCT01368081|20536050|P10|Overall Study|Withdrawal by Subject|4
5937025|NCT01368081|20536051|P9|Overall Study|Withdrawal by Subject|5
5937026|NCT01368081|20536052|P8|Overall Study|Withdrawal by Subject|2
5937027|NCT01368081|20536053|P7|Overall Study|Withdrawal by Subject|4
5937028|NCT01368081|20536054|P6|Overall Study|Withdrawal by Subject|3
5937029|NCT01368081|20536055|P5|Overall Study|Withdrawal by Subject|0
5937030|NCT01368081|20536056|P4|Overall Study|Withdrawal by Subject|1
5937031|NCT01368081|20536057|P3|Overall Study|Withdrawal by Subject|1
5937032|NCT01368081|20536058|P2|Overall Study|Withdrawal by Subject|4
5937033|NCT01368081|20536059|P1|Overall Study|Withdrawal by Subject|4
5937034|NCT01368081|20536047|P13|Overall Study|Lost to Follow-up|1
5937035|NCT01368081|20536048|P12|Overall Study|Lost to Follow-up|0
5937036|NCT01368081|20536049|P11|Overall Study|Lost to Follow-up|0
5937037|NCT01368081|20536050|P10|Overall Study|Lost to Follow-up|0
5937038|NCT01368081|20536051|P9|Overall Study|Lost to Follow-up|0
5937039|NCT01368081|20536052|P8|Overall Study|Lost to Follow-up|0
5937040|NCT01368081|20536053|P7|Overall Study|Lost to Follow-up|0
5937041|NCT01368081|20536054|P6|Overall Study|Lost to Follow-up|0
5937042|NCT01368081|20536055|P5|Overall Study|Lost to Follow-up|0
5937043|NCT01368081|20536056|P4|Overall Study|Lost to Follow-up|0
5937044|NCT01368081|20536057|P3|Overall Study|Lost to Follow-up|0
5937045|NCT01368081|20536058|P2|Overall Study|Lost to Follow-up|0
5937046|NCT01368081|20536059|P1|Overall Study|Lost to Follow-up|0
5937047|NCT01368081|20536047|P13|Overall Study|Protocol Violation|0
5937048|NCT01368081|20536048|P12|Overall Study|Protocol Violation|0
5937049|NCT01368081|20536049|P11|Overall Study|Protocol Violation|0
5937050|NCT01368081|20536050|P10|Overall Study|Protocol Violation|0
5937051|NCT01368081|20536051|P9|Overall Study|Protocol Violation|0
5937052|NCT01368081|20536052|P8|Overall Study|Protocol Violation|1
5937053|NCT01368081|20536053|P7|Overall Study|Protocol Violation|0
5937054|NCT01368081|20536054|P6|Overall Study|Protocol Violation|1
5937055|NCT01368081|20536055|P5|Overall Study|Protocol Violation|0
5937056|NCT01368081|20536056|P4|Overall Study|Protocol Violation|0
5937057|NCT01368081|20536057|P3|Overall Study|Protocol Violation|0
5937058|NCT01368081|20536058|P2|Overall Study|Protocol Violation|0
5937059|NCT01368081|20536059|P1|Overall Study|Protocol Violation|0
5937060|NCT01368081|20536047|P13|Overall Study|Lack of Efficacy|0
5937061|NCT01368081|20536048|P12|Overall Study|Lack of Efficacy|0
5937062|NCT01368081|20536049|P11|Overall Study|Lack of Efficacy|0
5937063|NCT01368081|20536050|P10|Overall Study|Lack of Efficacy|0
5937064|NCT01368081|20536051|P9|Overall Study|Lack of Efficacy|0
5937065|NCT01368081|20536052|P8|Overall Study|Lack of Efficacy|2
5937066|NCT01368081|20536053|P7|Overall Study|Lack of Efficacy|0
5937067|NCT01368081|20536054|P6|Overall Study|Lack of Efficacy|0
5937068|NCT01368081|20536055|P5|Overall Study|Lack of Efficacy|0
5937069|NCT01368081|20536056|P4|Overall Study|Lack of Efficacy|1
5937070|NCT01368081|20536057|P3|Overall Study|Lack of Efficacy|0
5937071|NCT01368081|20536058|P2|Overall Study|Lack of Efficacy|1
5937072|NCT01368081|20536059|P1|Overall Study|Lack of Efficacy|0
5937073|NCT01368081|20536047|P13|Overall Study|Adverse Event|3
5937074|NCT01368081|20536048|P12|Overall Study|Adverse Event|1
5937075|NCT01368081|20536049|P11|Overall Study|Adverse Event|6
5937076|NCT01368081|20536050|P10|Overall Study|Adverse Event|5
5937077|NCT01368081|20536051|P9|Overall Study|Adverse Event|3
5937078|NCT01368081|20536052|P8|Overall Study|Adverse Event|2
5937079|NCT01368081|20536053|P7|Overall Study|Adverse Event|6
5937080|NCT01368081|20536054|P6|Overall Study|Adverse Event|5
5937081|NCT01368081|20536055|P5|Overall Study|Adverse Event|2
5937082|NCT01368081|20536056|P4|Overall Study|Adverse Event|2
5937083|NCT01368081|20536057|P3|Overall Study|Adverse Event|3
5937084|NCT01368081|20536058|P2|Overall Study|Adverse Event|4
5937085|NCT01368081|20536059|P1|Overall Study|Adverse Event|4
5937086|NCT01368042|20536113|P1|Overall Study|Transplanted|1
5937087|NCT01368042|20536113|P1|Overall Study|Lost to Follow-up|4
5937088|NCT01368042|20536113|P1|Overall Study|Protocol Violation|11
5937089|NCT01368042|20536113|P1|Overall Study|Death|14
5937090|NCT01367886|20536133|P1|Overall Study|Death|1
5937091|NCT01367886|20536133|P1|Overall Study|Lack of Efficacy|2
5937092|NCT01367886|20536133|P1|Overall Study|Lost to Follow-up|4
5937093|NCT01367847|20536183|P2|Overall Study|Withdrawal by Subject|2
5937094|NCT01367847|20536184|P1|Overall Study|Withdrawal by Subject|2
5937095|NCT01367834|20536200|P2|Overall Study|Study was ended.|1
5937096|NCT01367834|20536201|P1|Overall Study|Study was ended.|0
5937097|NCT01367834|20536200|P2|Overall Study|Withdrawal by Subject|2
5937098|NCT01367834|20536201|P1|Overall Study|Withdrawal by Subject|2
5937099|NCT01367704|20536225|P2|Overall Study|Lost to Follow-up|161
5937100|NCT01367704|20536226|P1|Overall Study|Lost to Follow-up|47
5937101|NCT01367665|20536238|P2|Overall Study|Not Done|14
5937102|NCT01367665|20536239|P1|Overall Study|Not Done|118
5937103|NCT01367665|20536238|P2|Overall Study|Lost to Follow-up|22
5937104|NCT01367665|20536239|P1|Overall Study|Lost to Follow-up|222
5937105|NCT01367665|20536238|P2|Overall Study|Death|19
5937106|NCT01367665|20536239|P1|Overall Study|Death|102
5937107|NCT01367457|20536270|P3|Overall Study|Suspected DP/suspected active infection|0
5937108|NCT01367457|20536271|P2|Overall Study|Suspected DP/suspected active infection|0
5937109|NCT01367457|20536272|P1|Overall Study|Suspected DP/suspected active infection|1
5937110|NCT01367457|20536270|P3|Overall Study|Palliative. Overall decline|0
5937111|NCT01367457|20536271|P2|Overall Study|Palliative. Overall decline|0
5937112|NCT01367457|20536272|P1|Overall Study|Palliative. Overall decline|1
5937113|NCT01367457|20536270|P3|Overall Study|Patient's Wish|0
5937114|NCT01367457|20536271|P2|Overall Study|Patient's Wish|0
5937115|NCT01367457|20536272|P1|Overall Study|Patient's Wish|1
5937116|NCT01367457|20536270|P3|Overall Study|CD, Suspected disease progression (DP)|0
5937117|NCT01367457|20536271|P2|Overall Study|CD, Suspected disease progression (DP)|0
5937118|NCT01367457|20536272|P1|Overall Study|CD, Suspected disease progression (DP)|1
5937119|NCT01367457|20536270|P3|Overall Study|Death from septic shock|0
5937120|NCT01367457|20536271|P2|Overall Study|Death from septic shock|0
5937121|NCT01367457|20536272|P1|Overall Study|Death from septic shock|1
5937122|NCT01367457|20536270|P3|Overall Study|Lost to Follow-up|0
5937123|NCT01367457|20536271|P2|Overall Study|Lost to Follow-up|0
5937124|NCT01367457|20536272|P1|Overall Study|Lost to Follow-up|1
5937125|NCT01367457|20536270|P3|Overall Study|Rejection of treatment|0
5937126|NCT01367457|20536271|P2|Overall Study|Rejection of treatment|0
5937127|NCT01367457|20536272|P1|Overall Study|Rejection of treatment|1
5937128|NCT01367457|20536270|P3|Overall Study|Overall decline|0
5937129|NCT01367457|20536271|P2|Overall Study|Overall decline|0
5937130|NCT01367457|20536272|P1|Overall Study|Overall decline|1
5937131|NCT01367457|20536270|P3|Overall Study|Intestinal obstruction with necrosis|0
5937132|NCT01367457|20536271|P2|Overall Study|Intestinal obstruction with necrosis|0
5937133|NCT01367457|20536272|P1|Overall Study|Intestinal obstruction with necrosis|1
5937134|NCT01367457|20536270|P3|Overall Study|No clinical benefit|0
5937135|NCT01367457|20536271|P2|Overall Study|No clinical benefit|0
5937136|NCT01367457|20536272|P1|Overall Study|No clinical benefit|1
5937137|NCT01367457|20536270|P3|Overall Study|Stabilisation + frequent infections|0
5937138|NCT01367457|20536271|P2|Overall Study|Stabilisation + frequent infections|0
5937139|NCT01367457|20536272|P1|Overall Study|Stabilisation + frequent infections|1
5937140|NCT01367457|20536270|P3|Overall Study|Overall status worsens to grade 4|0
5937141|NCT01367457|20536271|P2|Overall Study|Overall status worsens to grade 4|0
5937142|NCT01367457|20536272|P1|Overall Study|Overall status worsens to grade 4|1
5937143|NCT01367457|20536270|P3|Overall Study|Uncontrolled pain|0
5937144|NCT01367457|20536271|P2|Overall Study|Uncontrolled pain|0
5937145|NCT01367457|20536272|P1|Overall Study|Uncontrolled pain|1
5937146|NCT01367457|20536270|P3|Overall Study|CD, associated leukaemia|0
5937147|NCT01367457|20536271|P2|Overall Study|CD, associated leukaemia|0
5937148|NCT01367457|20536272|P1|Overall Study|CD, associated leukaemia|1
5937149|NCT01367457|20536270|P3|Overall Study|Withdrawal by Subject|0
5937150|NCT01367457|20536271|P2|Overall Study|Withdrawal by Subject|0
5937151|NCT01367457|20536272|P1|Overall Study|Withdrawal by Subject|1
5937152|NCT01367457|20536270|P3|Overall Study|Choledocolithiasis and pancreatitis|0
5937153|NCT01367457|20536271|P2|Overall Study|Choledocolithiasis and pancreatitis|0
5937154|NCT01367457|20536272|P1|Overall Study|Choledocolithiasis and pancreatitis|1
5937155|NCT01367457|20536270|P3|Overall Study|low grade toxicities + stable disease|0
5937156|NCT01367457|20536271|P2|Overall Study|low grade toxicities + stable disease|0
5937157|NCT01367457|20536272|P1|Overall Study|low grade toxicities + stable disease|1
5937158|NCT01367457|20536270|P3|Overall Study|3 yr Temsirolimus treatment (no disease)|0
5937159|NCT01367457|20536271|P2|Overall Study|3 yr Temsirolimus treatment (no disease)|0
5937160|NCT01367457|20536272|P1|Overall Study|3 yr Temsirolimus treatment (no disease)|1
5937161|NCT01367457|20536270|P3|Overall Study|Bleeding from cavernous haemangioma|0
5937162|NCT01367457|20536271|P2|Overall Study|Bleeding from cavernous haemangioma|0
5937163|NCT01367457|20536272|P1|Overall Study|Bleeding from cavernous haemangioma|1
5937164|NCT01367457|20536270|P3|Overall Study|Investigator's opinion, stable disease|0
5937165|NCT01367457|20536271|P2|Overall Study|Investigator's opinion, stable disease|0
5937166|NCT01367457|20536272|P1|Overall Study|Investigator's opinion, stable disease|1
5937167|NCT01367457|20536270|P3|Overall Study|Patient asks for rest + slow progression|0
5937168|NCT01367457|20536271|P2|Overall Study|Patient asks for rest + slow progression|0
5937169|NCT01367457|20536272|P1|Overall Study|Patient asks for rest + slow progression|1
5937170|NCT01367457|20536270|P3|Overall Study|Progression|0
5937171|NCT01367457|20536271|P2|Overall Study|Progression|0
5937172|NCT01367457|20536272|P1|Overall Study|Progression|137
5937173|NCT01367457|20536270|P3|Overall Study|Toxicity|0
5937174|NCT01367457|20536271|P2|Overall Study|Toxicity|0
5937175|NCT01367457|20536272|P1|Overall Study|Toxicity|16
5937176|NCT01367457|20536270|P3|Overall Study|Progression and death|0
5937177|NCT01367457|20536271|P2|Overall Study|Progression and death|0
5937178|NCT01367457|20536272|P1|Overall Study|Progression and death|8
5937179|NCT01367457|20536270|P3|Overall Study|Clinical decline (CD)|0
5937180|NCT01367457|20536271|P2|Overall Study|Clinical decline (CD)|0
5937181|NCT01367457|20536272|P1|Overall Study|Clinical decline (CD)|2
5937182|NCT01367457|20536270|P3|Overall Study|Investigator's decision|0
5937183|NCT01367457|20536271|P2|Overall Study|Investigator's decision|0
5937184|NCT01367457|20536272|P1|Overall Study|Investigator's decision|2
5937185|NCT01367457|20536270|P3|Overall Study|Death|0
5937186|NCT01367457|20536271|P2|Overall Study|Death|0
5937187|NCT01367457|20536272|P1|Overall Study|Death|2
5937188|NCT01367275|20536328|P1|Overall Study|Disease Progression|2
5937189|NCT01367275|20536328|P1|Overall Study|Ineligible|1
5937190|NCT01367249|20536345|P2|Overall Study|Other|10
5937191|NCT01367249|20536346|P1|Overall Study|Other|3
5937192|NCT01367249|20536345|P2|Overall Study|Withdrawal by Subject|6
5937193|NCT01367249|20536346|P1|Overall Study|Withdrawal by Subject|6
5937194|NCT01367236|20536356|P2|Overall Study|Withdrawal by Subject|1
5937195|NCT01367236|20536357|P1|Overall Study|Withdrawal by Subject|3
5937196|NCT01367158|20536376|P11|Overall Study|Protocol Violation|0
5937197|NCT01367158|20536377|P10|Overall Study|Protocol Violation|0
5937198|NCT01367158|20536378|P9|Overall Study|Protocol Violation|0
5937199|NCT01367158|20536379|P8|Overall Study|Protocol Violation|0
5937200|NCT01367158|20536380|P7|Overall Study|Protocol Violation|0
5937201|NCT01367158|20536381|P6|Overall Study|Protocol Violation|0
5937202|NCT01367158|20536382|P5|Overall Study|Protocol Violation|0
5937203|NCT01367158|20536383|P4|Overall Study|Protocol Violation|0
5937204|NCT01367158|20536384|P3|Overall Study|Protocol Violation|0
5937205|NCT01367158|20536385|P2|Overall Study|Protocol Violation|1
5937206|NCT01367158|20536386|P1|Overall Study|Protocol Violation|0
5937207|NCT01367158|20536376|P11|Overall Study|Lost to Follow-up|1
5937208|NCT01367158|20536377|P10|Overall Study|Lost to Follow-up|0
5937209|NCT01367158|20536378|P9|Overall Study|Lost to Follow-up|0
5937210|NCT01367158|20536379|P8|Overall Study|Lost to Follow-up|1
5937211|NCT01367158|20536380|P7|Overall Study|Lost to Follow-up|0
5937212|NCT01367158|20536381|P6|Overall Study|Lost to Follow-up|2
5937213|NCT01367158|20536382|P5|Overall Study|Lost to Follow-up|0
5937214|NCT01367158|20536383|P4|Overall Study|Lost to Follow-up|1
5937215|NCT01367158|20536384|P3|Overall Study|Lost to Follow-up|0
5937216|NCT01367158|20536385|P2|Overall Study|Lost to Follow-up|0
5937217|NCT01367158|20536386|P1|Overall Study|Lost to Follow-up|0
5937218|NCT01367158|20536376|P11|Overall Study|Withdrew consent|0
5937219|NCT01367158|20536377|P10|Overall Study|Withdrew consent|0
5937220|NCT01367158|20536378|P9|Overall Study|Withdrew consent|0
5937221|NCT01367158|20536379|P8|Overall Study|Withdrew consent|1
5937222|NCT01367158|20536380|P7|Overall Study|Withdrew consent|0
5937223|NCT01367158|20536381|P6|Overall Study|Withdrew consent|0
5937224|NCT01367158|20536382|P5|Overall Study|Withdrew consent|2
5937225|NCT01367158|20536383|P4|Overall Study|Withdrew consent|0
5937226|NCT01367158|20536384|P3|Overall Study|Withdrew consent|1
5937227|NCT01367158|20536385|P2|Overall Study|Withdrew consent|2
5937228|NCT01367158|20536386|P1|Overall Study|Withdrew consent|0
5937229|NCT01367119|20536530|P2|Overall Study|Withdrawal by Subject|1
5937230|NCT01367119|20536531|P1|Overall Study|Withdrawal by Subject|1
5937231|NCT01367119|20536530|P2|Overall Study|Adverse Event|0
5937232|NCT01367119|20536531|P1|Overall Study|Adverse Event|1
5937233|NCT01366846|20536586|P4|Overall Study|Scheduling Conflicts|0
5937234|NCT01366846|20536587|P3|Overall Study|Scheduling Conflicts|1
5937235|NCT01366846|20536588|P2|Overall Study|Scheduling Conflicts|0
5937236|NCT01366846|20536589|P1|Overall Study|Scheduling Conflicts|0
5937237|NCT01366846|20536586|P4|Overall Study|Communication Difficulties|1
5937238|NCT01366846|20536587|P3|Overall Study|Communication Difficulties|0
5937239|NCT01366846|20536588|P2|Overall Study|Communication Difficulties|4
5937240|NCT01366846|20536589|P1|Overall Study|Communication Difficulties|1
5937241|NCT01366846|20536586|P4|Overall Study|Withdrawal by Subject|0
5937242|NCT01366846|20536587|P3|Overall Study|Withdrawal by Subject|0
5937243|NCT01366846|20536588|P2|Overall Study|Withdrawal by Subject|0
5937244|NCT01366846|20536589|P1|Overall Study|Withdrawal by Subject|2
5937245|NCT01366638|20536612|P3|Overall Study|Other|0
5937246|NCT01366638|20536613|P2|Overall Study|Other|0
5937247|NCT01366638|20536614|P1|Overall Study|Other|1
5937248|NCT01366638|20536612|P3|Overall Study|Withdrawal by Subject|6
5937249|NCT01366638|20536613|P2|Overall Study|Withdrawal by Subject|0
5937250|NCT01366638|20536614|P1|Overall Study|Withdrawal by Subject|0
5937251|NCT01366534|20536651|P3|Overall Study|Declined challenged|0
5937252|NCT01366534|20536652|P2|Overall Study|Declined challenged|1
5937253|NCT01366534|20536653|P1|Overall Study|Declined challenged|0
5937254|NCT01366534|20536651|P3|Overall Study|Migrated|0
5937255|NCT01366534|20536652|P2|Overall Study|Migrated|1
5937256|NCT01366534|20536653|P1|Overall Study|Migrated|1
5937257|NCT01366534|20536651|P3|Overall Study|Lost to Follow-up|0
5937258|NCT01366534|20536652|P2|Overall Study|Lost to Follow-up|0
5937259|NCT01366534|20536653|P1|Overall Study|Lost to Follow-up|1
5937260|NCT01366521|20536703|P4|Overall Study|Withdrawal by Subject|0
5937261|NCT01366521|20536704|P3|Overall Study|Withdrawal by Subject|0
5937262|NCT01366521|20536705|P2|Overall Study|Withdrawal by Subject|1
5937263|NCT01366521|20536706|P1|Overall Study|Withdrawal by Subject|0
5937264|NCT01366521|20536703|P4|Overall Study|Physician Decision|0
5937265|NCT01366521|20536704|P3|Overall Study|Physician Decision|1
5937266|NCT01366521|20536705|P2|Overall Study|Physician Decision|0
5937267|NCT01366521|20536706|P1|Overall Study|Physician Decision|0
5937268|NCT01366521|20536703|P4|Overall Study|Protocol Violation|0
5937269|NCT01366521|20536704|P3|Overall Study|Protocol Violation|1
5937270|NCT01366521|20536705|P2|Overall Study|Protocol Violation|0
5937271|NCT01366521|20536706|P1|Overall Study|Protocol Violation|0
5937272|NCT01366521|20536703|P4|Overall Study|Adverse Event|0
5937273|NCT01366521|20536704|P3|Overall Study|Adverse Event|0
5937274|NCT01366521|20536705|P2|Overall Study|Adverse Event|0
5937275|NCT01366521|20536706|P1|Overall Study|Adverse Event|1
5937276|NCT01366443|20536802|P1|Overall Study|Under 18 yo|1
5937277|NCT01366443|20536802|P1|Overall Study|Lost to Follow-up|2
5937278|NCT01366209|20536816|P2|Overall Study|Withdrew consent|3
5937279|NCT01366209|20536817|P1|Overall Study|Withdrew consent|4
5937280|NCT01366209|20536816|P2|Overall Study|Sponsors decision|1
5937281|NCT01366209|20536817|P1|Overall Study|Sponsors decision|0
5937282|NCT01366209|20536816|P2|Overall Study|Physician Decision|0
5937283|NCT01366209|20536817|P1|Overall Study|Physician Decision|1
5937284|NCT01366209|20536816|P2|Overall Study|Lost to Follow-up|1
5937285|NCT01366209|20536817|P1|Overall Study|Lost to Follow-up|2
5937286|NCT01366209|20536816|P2|Overall Study|Lung transplantation|1
5937287|NCT01366209|20536817|P1|Overall Study|Lung transplantation|6
5937288|NCT01366209|20536816|P2|Overall Study|Death|19
5937289|NCT01366209|20536817|P1|Overall Study|Death|12
5937290|NCT01366209|20536816|P2|Overall Study|Withdrawal by Subject|4
5937291|NCT01366209|20536817|P1|Overall Study|Withdrawal by Subject|4
5937292|NCT01366209|20536816|P2|Overall Study|Adverse Event|7
5937293|NCT01366209|20536817|P1|Overall Study|Adverse Event|6
5937294|NCT01365910|20536840|P1|Overall Study|pt did not get tx, nausea/vomiting|1
5937295|NCT01365910|20536840|P1|Overall Study|other complicating disease|1
5937296|NCT01365910|20536840|P1|Overall Study|Adverse Event|3
5937297|NCT01365910|20536840|P1|Overall Study|disease progression|18
5937298|NCT01365910|20536840|P1|Overall Study|Withdrawal by Subject|7
5937299|NCT01365546|20536976|P1|Overall Study|Study termination|1
5937300|NCT01365546|20536976|P1|Overall Study|Screen failure|9
5937301|NCT01365546|20536976|P1|Overall Study|Withdrawal by Subject|1
5937302|NCT01365507|20536986|P2|Overall Study|Unclassified|4
5937303|NCT01365507|20536987|P1|Overall Study|Unclassified|1
5937304|NCT01365507|20536986|P2|Overall Study|Withdrawal Criteria|5
5937305|NCT01365507|20536987|P1|Overall Study|Withdrawal Criteria|8
5937306|NCT01365494|20537003|P2|Overall Study|Lost to Follow-up|2
5937307|NCT01365494|20537004|P1|Overall Study|Lost to Follow-up|1
5937308|NCT01365494|20537003|P2|Overall Study|Withdrawal by Subject|1
5937309|NCT01365494|20537004|P1|Overall Study|Withdrawal by Subject|0
5937310|NCT01365494|20537003|P2|Overall Study|Adverse Event|0
5937311|NCT01365494|20537004|P1|Overall Study|Adverse Event|1
5937312|NCT01365481|20537020|P4|Overall Study|Unsatisfactory therapeutic effect|0
5937313|NCT01365481|20537021|P3|Overall Study|Unsatisfactory therapeutic effect|1
5937314|NCT01365481|20537022|P2|Overall Study|Unsatisfactory therapeutic effect|0
5937315|NCT01365481|20537023|P1|Overall Study|Unsatisfactory therapeutic effect|0
5937316|NCT01365481|20537020|P4|Overall Study|Protocol deviation|1
5937317|NCT01365481|20537021|P3|Overall Study|Protocol deviation|0
5937318|NCT01365481|20537022|P2|Overall Study|Protocol deviation|1
5937319|NCT01365481|20537023|P1|Overall Study|Protocol deviation|0
5937320|NCT01365481|20537020|P4|Overall Study|Administrative problems|0
5937321|NCT01365481|20537021|P3|Overall Study|Administrative problems|0
5937322|NCT01365481|20537022|P2|Overall Study|Administrative problems|1
5937323|NCT01365481|20537023|P1|Overall Study|Administrative problems|0
5937324|NCT01365481|20537020|P4|Overall Study|Abnormal laboratory value(s)|0
5937325|NCT01365481|20537021|P3|Overall Study|Abnormal laboratory value(s)|0
5937326|NCT01365481|20537022|P2|Overall Study|Abnormal laboratory value(s)|1
5937327|NCT01365481|20537023|P1|Overall Study|Abnormal laboratory value(s)|0
5937328|NCT01365481|20537020|P4|Overall Study|Lost to Follow-up|3
5937329|NCT01365481|20537021|P3|Overall Study|Lost to Follow-up|2
5937330|NCT01365481|20537022|P2|Overall Study|Lost to Follow-up|1
5937331|NCT01365481|20537023|P1|Overall Study|Lost to Follow-up|1
5937332|NCT01365481|20537020|P4|Overall Study|Withdrawal by Subject|1
5937333|NCT01365481|20537021|P3|Overall Study|Withdrawal by Subject|1
5937334|NCT01365481|20537022|P2|Overall Study|Withdrawal by Subject|2
5937335|NCT01365481|20537023|P1|Overall Study|Withdrawal by Subject|0
5937336|NCT01365481|20537020|P4|Overall Study|Adverse Event|2
5937337|NCT01365481|20537021|P3|Overall Study|Adverse Event|0
5937338|NCT01365481|20537022|P2|Overall Study|Adverse Event|9
5937339|NCT01365481|20537023|P1|Overall Study|Adverse Event|6
5937340|NCT01365468|20537043|P2|Overall Study|Lost to Follow-up|0
5937341|NCT01365468|20537044|P1|Overall Study|Lost to Follow-up|2
5937342|NCT01365468|20537043|P2|Overall Study|Disease progression|0
5937343|NCT01365468|20537044|P1|Overall Study|Disease progression|1
5937344|NCT01365468|20537043|P2|Overall Study|Physician Decision|0
5937345|NCT01365468|20537044|P1|Overall Study|Physician Decision|1
5937346|NCT01365455|20537059|P5|Maintenance Period|Subject/guardian decision|1
5937347|NCT01365455|20537060|P4|Maintenance Period|Subject/guardian decision|4
5937348|NCT01365455|20537061|P3|Maintenance Period|Subject/guardian decision|2
5937349|NCT01365455|20537062|P2|Maintenance Period|Subject/guardian decision|6
5937350|NCT01365455|20537063|P1|Maintenance Period|Subject/guardian decision|4
5937351|NCT01365455|20537059|P5|Maintenance Period|Protocol deviation|0
5937352|NCT01365455|20537060|P4|Maintenance Period|Protocol deviation|0
5937353|NCT01365455|20537061|P3|Maintenance Period|Protocol deviation|0
5937354|NCT01365455|20537062|P2|Maintenance Period|Protocol deviation|1
5937355|NCT01365455|20537063|P1|Maintenance Period|Protocol deviation|1
5937356|NCT01365455|20537059|P5|Maintenance Period|Pregnancy|2
5937357|NCT01365455|20537060|P4|Maintenance Period|Pregnancy|0
5937358|NCT01365455|20537061|P3|Maintenance Period|Pregnancy|0
5937359|NCT01365455|20537062|P2|Maintenance Period|Pregnancy|4
5937360|NCT01365455|20537063|P1|Maintenance Period|Pregnancy|0
5937361|NCT01365455|20537059|P5|Maintenance Period|Physician Decision|1
5937362|NCT01365455|20537060|P4|Maintenance Period|Physician Decision|0
5937363|NCT01365455|20537061|P3|Maintenance Period|Physician Decision|0
5937364|NCT01365455|20537062|P2|Maintenance Period|Physician Decision|1
5937365|NCT01365455|20537063|P1|Maintenance Period|Physician Decision|0
5937366|NCT01365455|20537059|P5|Maintenance Period|Non-compliance with study treatment|0
5937367|NCT01365455|20537060|P4|Maintenance Period|Non-compliance with study treatment|1
5937368|NCT01365455|20537061|P3|Maintenance Period|Non-compliance with study treatment|0
5937369|NCT01365455|20537062|P2|Maintenance Period|Non-compliance with study treatment|0
5937370|NCT01365455|20537063|P1|Maintenance Period|Non-compliance with study treatment|0
5937371|NCT01365455|20537059|P5|Maintenance Period|Lost to Follow-up|3
5937372|NCT01365455|20537060|P4|Maintenance Period|Lost to Follow-up|0
5937373|NCT01365455|20537061|P3|Maintenance Period|Lost to Follow-up|0
5937374|NCT01365455|20537062|P2|Maintenance Period|Lost to Follow-up|4
5937375|NCT01365455|20537063|P1|Maintenance Period|Lost to Follow-up|2
5937376|NCT01365455|20537059|P5|Maintenance Period|Lack of Efficacy|2
5937377|NCT01365455|20537060|P4|Maintenance Period|Lack of Efficacy|2
5937378|NCT01365455|20537061|P3|Maintenance Period|Lack of Efficacy|0
5937379|NCT01365455|20537062|P2|Maintenance Period|Lack of Efficacy|2
5937380|NCT01365455|20537063|P1|Maintenance Period|Lack of Efficacy|10
5937381|NCT01365455|20537059|P5|Maintenance Period|Adverse Event|4
5937382|NCT01365455|20537060|P4|Maintenance Period|Adverse Event|2
5937383|NCT01365455|20537061|P3|Maintenance Period|Adverse Event|1
5937384|NCT01365455|20537062|P2|Maintenance Period|Adverse Event|5
5937385|NCT01365455|20537063|P1|Maintenance Period|Adverse Event|12
5937386|NCT01365455|20537059|P5|Induction Period|Lost to Follow-up|0
5937387|NCT01365455|20537060|P4|Induction Period|Lost to Follow-up|0
5937388|NCT01365455|20537061|P3|Induction Period|Lost to Follow-up|3
5937389|NCT01365455|20537062|P2|Induction Period|Lost to Follow-up|0
5937390|NCT01365455|20537063|P1|Induction Period|Lost to Follow-up|0
5937391|NCT01365455|20537059|P5|Induction Period|Subject/guardian decision|0
5937392|NCT01365455|20537060|P4|Induction Period|Subject/guardian decision|0
5937393|NCT01365455|20537061|P3|Induction Period|Subject/guardian decision|8
5937394|NCT01365455|20537062|P2|Induction Period|Subject/guardian decision|1
5937395|NCT01365455|20537063|P1|Induction Period|Subject/guardian decision|9
5937396|NCT01365455|20537059|P5|Induction Period|Protocol deviation|0
5937397|NCT01365455|20537060|P4|Induction Period|Protocol deviation|0
5937398|NCT01365455|20537061|P3|Induction Period|Protocol deviation|1
5937399|NCT01365455|20537062|P2|Induction Period|Protocol deviation|1
5937400|NCT01365455|20537063|P1|Induction Period|Protocol deviation|0
5937401|NCT01365455|20537059|P5|Induction Period|Pregnancy|0
5937402|NCT01365455|20537060|P4|Induction Period|Pregnancy|0
5937403|NCT01365455|20537061|P3|Induction Period|Pregnancy|0
5937404|NCT01365455|20537062|P2|Induction Period|Pregnancy|1
5937405|NCT01365455|20537063|P1|Induction Period|Pregnancy|0
5937406|NCT01365455|20537059|P5|Induction Period|Lack of Efficacy|0
5937407|NCT01365455|20537060|P4|Induction Period|Lack of Efficacy|0
5937408|NCT01365455|20537061|P3|Induction Period|Lack of Efficacy|0
5937409|NCT01365455|20537062|P2|Induction Period|Lack of Efficacy|1
5937410|NCT01365455|20537063|P1|Induction Period|Lack of Efficacy|1
5937411|NCT01365455|20537059|P5|Induction Period|Adverse Event|0
5937412|NCT01365455|20537060|P4|Induction Period|Adverse Event|0
5937413|NCT01365455|20537061|P3|Induction Period|Adverse Event|4
5937414|NCT01365455|20537062|P2|Induction Period|Adverse Event|3
5937415|NCT01365455|20537063|P1|Induction Period|Adverse Event|5
5937416|NCT01365273|20537153|P2|Overall Study|Physician Decision|0
5937417|NCT01365273|20537154|P1|Overall Study|Physician Decision|1
5937418|NCT01365273|20537153|P2|Overall Study|Protocol Violation|1
5937419|NCT01365273|20537154|P1|Overall Study|Protocol Violation|0
5937420|NCT01365273|20537153|P2|Overall Study|Lost to Follow-up|0
5937421|NCT01365273|20537154|P1|Overall Study|Lost to Follow-up|1
5937422|NCT01365130|20537164|P1|Overall Study|Progression/worsening of Dx prior to txt|2
5937423|NCT01365091|20537173|P4|Period 2|Adverse Event|0
5937424|NCT01365091|20537174|P3|Period 2|Adverse Event|1
5937425|NCT01365091|20537175|P2|Period 2|Adverse Event|0
5937426|NCT01365091|20537176|P1|Period 2|Adverse Event|0
5937427|NCT01365091|20537173|P4|Period 2|Withdrawal by Subject|0
5937428|NCT01365091|20537174|P3|Period 2|Withdrawal by Subject|0
5937429|NCT01365091|20537175|P2|Period 2|Withdrawal by Subject|0
5937430|NCT01365091|20537176|P1|Period 2|Withdrawal by Subject|1
5937431|NCT01365091|20537173|P4|Period 1|Personal reasons|0
5937432|NCT01365091|20537174|P3|Period 1|Personal reasons|1
5937433|NCT01365091|20537175|P2|Period 1|Personal reasons|0
5937434|NCT01365091|20537176|P1|Period 1|Personal reasons|0
5937435|NCT01365091|20537173|P4|Period 1|Withdrawal by Subject|0
5937436|NCT01365091|20537174|P3|Period 1|Withdrawal by Subject|0
5937437|NCT01365091|20537175|P2|Period 1|Withdrawal by Subject|1
5937438|NCT01365091|20537176|P1|Period 1|Withdrawal by Subject|0
5937439|NCT01365091|20537173|P4|Period 1|No longer met study criteria|0
5937440|NCT01365091|20537174|P3|Period 1|No longer met study criteria|0
5937441|NCT01365091|20537175|P2|Period 1|No longer met study criteria|1
5937442|NCT01365091|20537176|P1|Period 1|No longer met study criteria|0
5937443|NCT01365091|20537173|P4|Period 1|Positive test result for drugs of abuse|0
5937444|NCT01365091|20537174|P3|Period 1|Positive test result for drugs of abuse|0
5937445|NCT01365091|20537175|P2|Period 1|Positive test result for drugs of abuse|0
5937446|NCT01365091|20537176|P1|Period 1|Positive test result for drugs of abuse|1
5937447|NCT01365091|20537173|P4|Period 1|Adverse Event|3
5937448|NCT01365091|20537174|P3|Period 1|Adverse Event|2
5937449|NCT01365091|20537175|P2|Period 1|Adverse Event|0
5937450|NCT01365091|20537176|P1|Period 1|Adverse Event|1
5937451|NCT01365052|20537204|P2|Overall Study|Adverse Event|4
5937452|NCT01365052|20537205|P1|Overall Study|Adverse Event|4
5937453|NCT01365039|20537221|P2|Overall Study|Study related symptoms and complaints|0
5937454|NCT01365039|20537222|P1|Overall Study|Study related symptoms and complaints|1
5937455|NCT01364922|20537233|P3|Double-Blind (DB) Period|Other, Unspecified|0
5937456|NCT01364922|20537234|P2|Double-Blind (DB) Period|Other, Unspecified|1
5937457|NCT01364922|20537235|P1|Double-Blind (DB) Period|Other, Unspecified|0
5937458|NCT01364922|20537233|P3|Double-Blind (DB) Period|Adverse Event|1
5937459|NCT01364922|20537234|P2|Double-Blind (DB) Period|Adverse Event|0
5937460|NCT01364922|20537235|P1|Double-Blind (DB) Period|Adverse Event|0
5937461|NCT01364922|20537233|P3|Double-Blind (DB) Period|Subject Noncompliant|0
5937462|NCT01364922|20537234|P2|Double-Blind (DB) Period|Subject Noncompliant|1
5937463|NCT01364922|20537235|P1|Double-Blind (DB) Period|Subject Noncompliant|0
5937464|NCT01364922|20537233|P3|Double-Blind (DB) Period|Lack of Efficacy|4
5937465|NCT01364922|20537234|P2|Double-Blind (DB) Period|Lack of Efficacy|3
5937466|NCT01364922|20537235|P1|Double-Blind (DB) Period|Lack of Efficacy|0
5937467|NCT01364922|20537233|P3|Open-label (OL) Period|Other, Unspecified|0
5937468|NCT01364922|20537234|P2|Open-label (OL) Period|Other, Unspecified|0
5937469|NCT01364922|20537235|P1|Open-label (OL) Period|Other, Unspecified|1
5937470|NCT01364922|20537233|P3|Open-label (OL) Period|Lost to Follow-up|0
5937471|NCT01364922|20537234|P2|Open-label (OL) Period|Lost to Follow-up|0
5937472|NCT01364922|20537235|P1|Open-label (OL) Period|Lost to Follow-up|1
5937473|NCT01364922|20537233|P3|Open-label (OL) Period|Lack of Efficacy|0
5937474|NCT01364922|20537234|P2|Open-label (OL) Period|Lack of Efficacy|0
5937475|NCT01364922|20537235|P1|Open-label (OL) Period|Lack of Efficacy|3
5937476|NCT01364922|20537233|P3|Open-label (OL) Period|Withdrawal by Subject|0
5937477|NCT01364922|20537234|P2|Open-label (OL) Period|Withdrawal by Subject|0
5937478|NCT01364922|20537235|P1|Open-label (OL) Period|Withdrawal by Subject|4
5937479|NCT01364922|20537233|P3|Open-label (OL) Period|Did Not Meet Randomization Criteria|0
5937480|NCT01364922|20537234|P2|Open-label (OL) Period|Did Not Meet Randomization Criteria|0
5937481|NCT01364922|20537235|P1|Open-label (OL) Period|Did Not Meet Randomization Criteria|6
5937482|NCT01364922|20537233|P3|Open-label (OL) Period|Adverse Event|0
5937483|NCT01364922|20537234|P2|Open-label (OL) Period|Adverse Event|0
5937484|NCT01364922|20537235|P1|Open-label (OL) Period|Adverse Event|7
5937485|NCT01364870|20537257|P3|Overall Study|Protocol Violation|0
5937486|NCT01364870|20537258|P2|Overall Study|Protocol Violation|0
5937487|NCT01364870|20537259|P1|Overall Study|Protocol Violation|1
5937488|NCT01364870|20537257|P3|Overall Study|Adverse Event|4
5937489|NCT01364870|20537258|P2|Overall Study|Adverse Event|6
5937490|NCT01364870|20537259|P1|Overall Study|Adverse Event|8
5937491|NCT01364870|20537257|P3|Overall Study|Withdrawal by Subject|10
5937492|NCT01364870|20537258|P2|Overall Study|Withdrawal by Subject|24
5937493|NCT01364870|20537259|P1|Overall Study|Withdrawal by Subject|13
5937494|NCT01364727|20537278|P1|Overall Study|Not Eligible|2
5937495|NCT01364649|20537286|P2|Overall Study|Other|1
5937496|NCT01364649|20537287|P1|Overall Study|Other|4
5937497|NCT01364649|20537286|P2|Overall Study|Lost to Follow-up|13
5937498|NCT01364649|20537287|P1|Overall Study|Lost to Follow-up|12
5937499|NCT01364649|20537286|P2|Overall Study|Withdrawal of Consent|7
5937500|NCT01364649|20537287|P1|Overall Study|Withdrawal of Consent|9
5937501|NCT01364649|20537286|P2|Overall Study|Protocol Deviations|8
5937502|NCT01364649|20537287|P1|Overall Study|Protocol Deviations|4
5937503|NCT01364649|20537286|P2|Overall Study|Non-compliance with Investigational Drug|0
5937504|NCT01364649|20537287|P1|Overall Study|Non-compliance with Investigational Drug|1
5937505|NCT01364649|20537286|P2|Overall Study|Lack of Efficacy|0
5937506|NCT01364649|20537287|P1|Overall Study|Lack of Efficacy|6
5937507|NCT01364649|20537286|P2|Overall Study|Pretreatment Event or Adverse Event|14
5937508|NCT01364649|20537287|P1|Overall Study|Pretreatment Event or Adverse Event|20
5937509|NCT01364467|20537375|P2|Overall Study|Lost to Follow-up|2
5937510|NCT01364467|20537376|P1|Overall Study|Lost to Follow-up|1
5937511|NCT01364428|20537388|P2|Overall Study|Other|3
5937512|NCT01364428|20537389|P1|Overall Study|Other|3
5937513|NCT01364428|20537388|P2|Overall Study|Withdrawal Criteria|10
5937514|NCT01364428|20537389|P1|Overall Study|Withdrawal Criteria|14
5937515|NCT01364428|20537388|P2|Overall Study|Protocol Violation|0
5937516|NCT01364428|20537389|P1|Overall Study|Protocol Violation|2
5937517|NCT01364428|20537388|P2|Overall Study|Adverse Event|2
5937518|NCT01364428|20537389|P1|Overall Study|Adverse Event|1
5937531|NCT01364298|20537427|P2|Overall Study|Other|3
5937532|NCT01364298|20537428|P1|Overall Study|Other|1
5937533|NCT01364298|20537427|P2|Overall Study|Withdrawal by Subject|3
5937534|NCT01364298|20537428|P1|Overall Study|Withdrawal by Subject|3
5937535|NCT01364298|20537427|P2|Overall Study|Lost to Follow-up|10
5937536|NCT01364298|20537428|P1|Overall Study|Lost to Follow-up|5
5937537|NCT01364298|20537427|P2|Overall Study|Lack of Efficacy|0
5937538|NCT01364298|20537428|P1|Overall Study|Lack of Efficacy|1
5937539|NCT01364298|20537427|P2|Overall Study|Lack of adherence to treatment|3
5937540|NCT01364298|20537428|P1|Overall Study|Lack of adherence to treatment|1
5937541|NCT01364298|20537427|P2|Overall Study|Adverse Event|4
5937542|NCT01364298|20537428|P1|Overall Study|Adverse Event|3
5937543|NCT01364233|20537461|P1|Overall Study|Lost to Follow-up|1
5937544|NCT01363986|20537506|P1|Overall Study|Disease progression|1
5937545|NCT01363908|20537516|P2|Chronic Dosing (CD) Phase|Early study termination|3
5937546|NCT01363908|20537517|P1|Chronic Dosing (CD) Phase|Early study termination|9
5937547|NCT01363908|20537516|P2|Chronic Dosing (CD) Phase|Physician Decision|1
5937548|NCT01363908|20537517|P1|Chronic Dosing (CD) Phase|Physician Decision|0
5937549|NCT01363908|20537516|P2|Chronic Dosing (CD) Phase|Patient decision|1
5937550|NCT01363908|20537517|P1|Chronic Dosing (CD) Phase|Patient decision|0
5937551|NCT01363908|20537516|P2|Chronic Dosing (CD) Phase|Adverse Event|1
5937552|NCT01363908|20537517|P1|Chronic Dosing (CD) Phase|Adverse Event|1
5937553|NCT01363765|20537554|P2|Overall Study|smear during intervention|0
5937554|NCT01363765|20537555|P1|Overall Study|smear during intervention|2170
5937555|NCT01363765|20537554|P2|Overall Study|age not recorded (used for cross-linkage|354
5937556|NCT01363765|20537555|P1|Overall Study|age not recorded (used for cross-linkage|117
5937557|NCT01363765|20537554|P2|Overall Study|non-resident|76
5937558|NCT01363765|20537555|P1|Overall Study|non-resident|156
5937559|NCT01363765|20537554|P2|Overall Study|duplicate records|3177
5937560|NCT01363765|20537555|P1|Overall Study|duplicate records|736
5937561|NCT01363765|20537554|P2|Overall Study|non-diagnostic|1124
5937562|NCT01363765|20537555|P1|Overall Study|non-diagnostic|2621
5937563|NCT01363713|20537567|P1|Overall Study|Withdrawal by Subject|2
5937564|NCT01363713|20537567|P1|Overall Study|Protocol Violation|3
5937565|NCT01363713|20537567|P1|Overall Study|Adverse Event|1
5937566|NCT01363700|20537576|P5|Epinastine vs Placebo Period1|Withdrawal by Subject|0
5937567|NCT01363700|20537577|P4|Epinastine vs Placebo Period1|Withdrawal by Subject|0
5937568|NCT01363700|20537578|P3|Epinastine vs Placebo Period1|Withdrawal by Subject|0
5937569|NCT01363700|20537579|P2|Epinastine vs Placebo Period1|Withdrawal by Subject|1
5937570|NCT01363700|20537580|P1|Epinastine vs Placebo Period1|Withdrawal by Subject|0
5937571|NCT01363661|20537599|P2|Overall Study|Lost to Follow-up|1
5937572|NCT01363661|20537600|P1|Overall Study|Lost to Follow-up|3
5937573|NCT01363661|20537599|P2|Overall Study|Protocol Violation|0
5937574|NCT01363661|20537600|P1|Overall Study|Protocol Violation|1
5937575|NCT01363661|20537599|P2|Overall Study|Withdrawal by Subject|1
5937576|NCT01363661|20537600|P1|Overall Study|Withdrawal by Subject|1
5937577|NCT01363661|20537599|P2|Overall Study|Adverse Event|2
5937578|NCT01363661|20537600|P1|Overall Study|Adverse Event|9
5937579|NCT01363440|20537641|P3|Overall Study|Other|2
5937580|NCT01363440|20537642|P2|Overall Study|Other|5
5937581|NCT01363440|20537643|P1|Overall Study|Other|4
5937582|NCT01363440|20537641|P3|Overall Study|Lost to Follow-up|5
5937583|NCT01363440|20537642|P2|Overall Study|Lost to Follow-up|4
5937584|NCT01363440|20537643|P1|Overall Study|Lost to Follow-up|2
5937585|NCT01363440|20537641|P3|Overall Study|Withdrawal by Subject|11
5937586|NCT01363440|20537642|P2|Overall Study|Withdrawal by Subject|11
5937587|NCT01363440|20537643|P1|Overall Study|Withdrawal by Subject|9
5937588|NCT01363440|20537641|P3|Overall Study|Death|5
5937589|NCT01363440|20537642|P2|Overall Study|Death|7
5937590|NCT01363440|20537643|P1|Overall Study|Death|3
5937591|NCT01363440|20537641|P3|Overall Study|Adverse Event|4
5937592|NCT01363440|20537642|P2|Overall Study|Adverse Event|4
5937593|NCT01363440|20537643|P1|Overall Study|Adverse Event|5
5937594|NCT01363349|20537702|P2|Overall Study|missing|2
5937595|NCT01363349|20537703|P1|Overall Study|missing|1
5937596|NCT01363349|20537702|P2|Overall Study|Not reported|37
5937597|NCT01363349|20537703|P1|Overall Study|Not reported|36
5937598|NCT01363349|20537702|P2|Overall Study|Lost to Follow-up|6
5937599|NCT01363349|20537703|P1|Overall Study|Lost to Follow-up|5
5937600|NCT01363349|20537702|P2|Overall Study|Withdrawal by Subject|6
5937601|NCT01363349|20537703|P1|Overall Study|Withdrawal by Subject|14
5937602|NCT01363349|20537702|P2|Overall Study|Non compliance/Protocol deviations|2
5937603|NCT01363349|20537703|P1|Overall Study|Non compliance/Protocol deviations|2
5937604|NCT01363349|20537702|P2|Overall Study|Lack of Efficacy|10
5937605|NCT01363349|20537703|P1|Overall Study|Lack of Efficacy|3
5937606|NCT01363349|20537702|P2|Overall Study|Adverse Event|7
5937607|NCT01363349|20537703|P1|Overall Study|Adverse Event|6
5937608|NCT01363297|20537714|P5|Overall Study|Death|30
5937609|NCT01363297|20537715|P4|Overall Study|Death|10
5937610|NCT01363297|20537716|P3|Overall Study|Death|6
5937611|NCT01363297|20537717|P2|Overall Study|Death|6
5937612|NCT01363297|20537718|P1|Overall Study|Death|3
5937613|NCT01363297|20537714|P5|Overall Study|Other|1
5937614|NCT01363297|20537715|P4|Overall Study|Other|0
5937615|NCT01363297|20537716|P3|Overall Study|Other|0
5937616|NCT01363297|20537717|P2|Overall Study|Other|0
5937617|NCT01363297|20537718|P1|Overall Study|Other|0
5937618|NCT01363076|20537821|P2|Overall Study|Withdrawal by Subject|1
5937619|NCT01363076|20537822|P1|Overall Study|Withdrawal by Subject|0
5937620|NCT01363011|20537854|P2|Extension Phase|Rolled Over to Another Gilead Study|1
5937621|NCT01363011|20537855|P1|Extension Phase|Rolled Over to Another Gilead Study|2
5937622|NCT01363011|20537854|P2|Extension Phase|Lost to Follow-up|2
5937623|NCT01363011|20537855|P1|Extension Phase|Lost to Follow-up|0
5937624|NCT01363011|20537854|P2|Extension Phase|Withdrew Consent|1
5937625|NCT01363011|20537855|P1|Extension Phase|Withdrew Consent|0
5937626|NCT01363011|20537854|P2|Extension Phase|Investigator's Discretion|2
5937627|NCT01363011|20537855|P1|Extension Phase|Investigator's Discretion|2
5937628|NCT01363011|20537854|P2|Extension Phase|Lack of Efficacy|1
5937629|NCT01363011|20537855|P1|Extension Phase|Lack of Efficacy|0
5937630|NCT01363011|20537854|P2|Extension Phase|Adverse Event|1
5937631|NCT01363011|20537855|P1|Extension Phase|Adverse Event|1
5937632|NCT01363011|20537854|P2|Main Study|Protocol Violation|1
5937633|NCT01363011|20537855|P1|Main Study|Protocol Violation|0
5937634|NCT01363011|20537854|P2|Main Study|Withdrew Consent|4
5937635|NCT01363011|20537855|P1|Main Study|Withdrew Consent|1
5937636|NCT01363011|20537854|P2|Main Study|Investigator's Discretion|1
5937637|NCT01363011|20537855|P1|Main Study|Investigator's Discretion|1
5937638|NCT01363011|20537854|P2|Main Study|Adverse Event|3
5937639|NCT01363011|20537855|P1|Main Study|Adverse Event|2
5937640|NCT01362790|20537982|P7|Dose De-escalation of Regimen A|Progressive disease|0
5937641|NCT01362790|20537983|P6|Dose De-escalation of Regimen A|Progressive disease|0
5937642|NCT01362790|20537984|P5|Dose De-escalation of Regimen A|Progressive disease|2
5937643|NCT01362790|20537985|P4|Dose De-escalation of Regimen A|Progressive disease|0
5937644|NCT01362790|20537986|P3|Dose De-escalation of Regimen A|Progressive disease|0
5937645|NCT01362790|20537987|P2|Dose De-escalation of Regimen A|Progressive disease|0
5937646|NCT01362790|20537988|P1|Dose De-escalation of Regimen A|Progressive disease|0
5937647|NCT01362790|20537982|P7|Dose De-escalation of Regimen A|Deveoped antibodies|0
5937648|NCT01362790|20537983|P6|Dose De-escalation of Regimen A|Deveoped antibodies|0
5937649|NCT01362790|20537984|P5|Dose De-escalation of Regimen A|Deveoped antibodies|3
5937650|NCT01362790|20537985|P4|Dose De-escalation of Regimen A|Deveoped antibodies|0
5937651|NCT01362790|20537986|P3|Dose De-escalation of Regimen A|Deveoped antibodies|0
5937652|NCT01362790|20537987|P2|Dose De-escalation of Regimen A|Deveoped antibodies|0
5937653|NCT01362790|20537988|P1|Dose De-escalation of Regimen A|Deveoped antibodies|0
5937654|NCT01362790|20537982|P7|Dose De-escalation of Regimen A|Adverse Event|0
5937655|NCT01362790|20537983|P6|Dose De-escalation of Regimen A|Adverse Event|0
5937656|NCT01362790|20537984|P5|Dose De-escalation of Regimen A|Adverse Event|1
5937657|NCT01362790|20537985|P4|Dose De-escalation of Regimen A|Adverse Event|0
5937658|NCT01362790|20537986|P3|Dose De-escalation of Regimen A|Adverse Event|0
5937659|NCT01362790|20537987|P2|Dose De-escalation of Regimen A|Adverse Event|0
5937660|NCT01362790|20537988|P1|Dose De-escalation of Regimen A|Adverse Event|0
5937661|NCT01362790|20537982|P7|Pilot Phase & Phase 2|Death on study|0
5937662|NCT01362790|20537983|P6|Pilot Phase & Phase 2|Death on study|0
5937663|NCT01362790|20537984|P5|Pilot Phase & Phase 2|Death on study|0
5937664|NCT01362790|20537985|P4|Pilot Phase & Phase 2|Death on study|1
5937665|NCT01362790|20537986|P3|Pilot Phase & Phase 2|Death on study|0
5937666|NCT01362790|20537987|P2|Pilot Phase & Phase 2|Death on study|0
5937667|NCT01362790|20537988|P1|Pilot Phase & Phase 2|Death on study|0
5937668|NCT01362790|20537982|P7|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0
5937669|NCT01362790|20537983|P6|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0
5937670|NCT01362790|20537984|P5|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0
5937671|NCT01362790|20537985|P4|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0
5937672|NCT01362790|20537986|P3|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0
5937673|NCT01362790|20537987|P2|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|2
5937674|NCT01362790|20537988|P1|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0
5937675|NCT01362790|20537982|P7|Pilot Phase & Phase 2|Treatment delay >3 weeks|0
5937676|NCT01362790|20537983|P6|Pilot Phase & Phase 2|Treatment delay >3 weeks|0
5937677|NCT01362790|20537984|P5|Pilot Phase & Phase 2|Treatment delay >3 weeks|0
5937678|NCT01362790|20537985|P4|Pilot Phase & Phase 2|Treatment delay >3 weeks|0
5937679|NCT01362790|20537986|P3|Pilot Phase & Phase 2|Treatment delay >3 weeks|0
5937680|NCT01362790|20537987|P2|Pilot Phase & Phase 2|Treatment delay >3 weeks|0
5937681|NCT01362790|20537988|P1|Pilot Phase & Phase 2|Treatment delay >3 weeks|1
5937682|NCT01362790|20537982|P7|Pilot Phase & Phase 2|Progressive disease|0
5937683|NCT01362790|20537983|P6|Pilot Phase & Phase 2|Progressive disease|2
5937684|NCT01362790|20537984|P5|Pilot Phase & Phase 2|Progressive disease|0
5937685|NCT01362790|20537985|P4|Pilot Phase & Phase 2|Progressive disease|3
5937686|NCT01362790|20537986|P3|Pilot Phase & Phase 2|Progressive disease|2
5937687|NCT01362790|20537987|P2|Pilot Phase & Phase 2|Progressive disease|2
5937688|NCT01362790|20537988|P1|Pilot Phase & Phase 2|Progressive disease|1
5937689|NCT01362790|20537982|P7|Pilot Phase & Phase 2|Refused further treatment|0
5937690|NCT01362790|20537983|P6|Pilot Phase & Phase 2|Refused further treatment|0
5937691|NCT01362790|20537984|P5|Pilot Phase & Phase 2|Refused further treatment|0
5937692|NCT01362790|20537985|P4|Pilot Phase & Phase 2|Refused further treatment|0
5937693|NCT01362790|20537986|P3|Pilot Phase & Phase 2|Refused further treatment|0
5937694|NCT01362790|20537987|P2|Pilot Phase & Phase 2|Refused further treatment|1
5937695|NCT01362790|20537988|P1|Pilot Phase & Phase 2|Refused further treatment|0
5937696|NCT01362790|20537982|P7|Pilot Phase & Phase 2|Developed antibodies|0
5937697|NCT01362790|20537983|P6|Pilot Phase & Phase 2|Developed antibodies|0
5937698|NCT01362790|20537984|P5|Pilot Phase & Phase 2|Developed antibodies|0
5937699|NCT01362790|20537985|P4|Pilot Phase & Phase 2|Developed antibodies|8
5937700|NCT01362790|20537986|P3|Pilot Phase & Phase 2|Developed antibodies|3
5937701|NCT01362790|20537987|P2|Pilot Phase & Phase 2|Developed antibodies|2
5937702|NCT01362790|20537988|P1|Pilot Phase & Phase 2|Developed antibodies|7
5937703|NCT01362790|20537982|P7|Pilot Phase & Phase 2|Physician Decision|0
5937704|NCT01362790|20537983|P6|Pilot Phase & Phase 2|Physician Decision|0
5937705|NCT01362790|20537984|P5|Pilot Phase & Phase 2|Physician Decision|0
5937706|NCT01362790|20537985|P4|Pilot Phase & Phase 2|Physician Decision|1
5937707|NCT01362790|20537986|P3|Pilot Phase & Phase 2|Physician Decision|0
5937708|NCT01362790|20537987|P2|Pilot Phase & Phase 2|Physician Decision|0
5937709|NCT01362790|20537988|P1|Pilot Phase & Phase 2|Physician Decision|0
5937710|NCT01362790|20537982|P7|Pilot Phase & Phase 2|Adverse Event|0
5937711|NCT01362790|20537983|P6|Pilot Phase & Phase 2|Adverse Event|2
5937712|NCT01362790|20537984|P5|Pilot Phase & Phase 2|Adverse Event|0
5937713|NCT01362790|20537985|P4|Pilot Phase & Phase 2|Adverse Event|1
5937714|NCT01362790|20537986|P3|Pilot Phase & Phase 2|Adverse Event|0
5937715|NCT01362790|20537987|P2|Pilot Phase & Phase 2|Adverse Event|1
5937716|NCT01362790|20537988|P1|Pilot Phase & Phase 2|Adverse Event|0
5937717|NCT01362790|20537982|P7|Pilot Phase & Phase 2|Changed treatment, too early to assess|0
5937718|NCT01362790|20537983|P6|Pilot Phase & Phase 2|Changed treatment, too early to assess|0
5937719|NCT01362790|20537984|P5|Pilot Phase & Phase 2|Changed treatment, too early to assess|0
5937720|NCT01362790|20537985|P4|Pilot Phase & Phase 2|Changed treatment, too early to assess|0
5937721|NCT01362790|20537986|P3|Pilot Phase & Phase 2|Changed treatment, too early to assess|0
5937722|NCT01362790|20537987|P2|Pilot Phase & Phase 2|Changed treatment, too early to assess|0
5937723|NCT01362790|20537988|P1|Pilot Phase & Phase 2|Changed treatment, too early to assess|1
5937724|NCT01362608|20538056|P2|Overall Study|Adverse Event|2
5937725|NCT01362608|20538057|P1|Overall Study|Adverse Event|0
5937726|NCT01362608|20538056|P2|Overall Study|Lack of Efficacy|2
5937727|NCT01362608|20538057|P1|Overall Study|Lack of Efficacy|0
5937728|NCT01362608|20538056|P2|Overall Study|Withdrawal by Subject|2
5937729|NCT01362608|20538057|P1|Overall Study|Withdrawal by Subject|1
5937730|NCT01362608|20538056|P2|Overall Study|Lost to Follow-up|1
5937731|NCT01362608|20538057|P1|Overall Study|Lost to Follow-up|3
5937732|NCT01362608|20538056|P2|Overall Study|Protocol Violation|1
5937733|NCT01362608|20538057|P1|Overall Study|Protocol Violation|0
5937734|NCT01362530|20538095|P2|Optional Extension (Cycles 2-6)|Withdrawal by Subject|0
5937735|NCT01362530|20538096|P1|Optional Extension (Cycles 2-6)|Withdrawal by Subject|18
5937736|NCT01362530|20538095|P2|Optional Extension (Cycles 2-6)|Protocol Violation|0
5937737|NCT01362530|20538096|P1|Optional Extension (Cycles 2-6)|Protocol Violation|4
5937738|NCT01362530|20538095|P2|Optional Extension (Cycles 2-6)|Physician Decision|0
5937739|NCT01362530|20538096|P1|Optional Extension (Cycles 2-6)|Physician Decision|19
5937740|NCT01362530|20538095|P2|Optional Extension (Cycles 2-6)|Lost to Follow-up|0
5937741|NCT01362530|20538096|P1|Optional Extension (Cycles 2-6)|Lost to Follow-up|1
5937742|NCT01362530|20538095|P2|Optional Extension (Cycles 2-6)|Lack of Efficacy|0
5937743|NCT01362530|20538096|P1|Optional Extension (Cycles 2-6)|Lack of Efficacy|1
5937744|NCT01362530|20538095|P2|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|0
5937745|NCT01362530|20538096|P1|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|4
5937746|NCT01362530|20538095|P2|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|0
5937747|NCT01362530|20538096|P1|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|25
5937748|NCT01362530|20538095|P2|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|0
5937749|NCT01362530|20538096|P1|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|51
5937750|NCT01362530|20538095|P2|Optional Extension (Cycles 2-6)|Adverse Event|0
5937751|NCT01362530|20538096|P1|Optional Extension (Cycles 2-6)|Adverse Event|2
5937752|NCT01362530|20538095|P2|Base Study (Cycle 1)|Withdrawal by Subject|2
5937753|NCT01362530|20538096|P1|Base Study (Cycle 1)|Withdrawal by Subject|1
5937754|NCT01362530|20538095|P2|Base Study (Cycle 1)|Protocol Violation|0
5937755|NCT01362530|20538096|P1|Base Study (Cycle 1)|Protocol Violation|2
5937756|NCT01362530|20538095|P2|Base Study (Cycle 1)|Physician Decision|1
5937757|NCT01362530|20538096|P1|Base Study (Cycle 1)|Physician Decision|0
5937758|NCT01362530|20538095|P2|Base Study (Cycle 1)|Adverse Event|0
5937759|NCT01362530|20538096|P1|Base Study (Cycle 1)|Adverse Event|2
5937760|NCT01362517|20538109|P1|Overall Study|Lost to Follow-up|1
5937761|NCT01362517|20538109|P1|Overall Study|Protocol Violation|1
5937762|NCT01362491|20538120|P3|Overall Study|Ineligible|0
5937763|NCT01362491|20538121|P2|Overall Study|Ineligible|0
5937764|NCT01362491|20538122|P1|Overall Study|Ineligible|1
5937765|NCT01362439|20538170|P1|Overall Study|Participant who withdrew consent|8
5937766|NCT01362439|20538170|P1|Overall Study|Study medication non-compliant|1
5937767|NCT01362439|20538170|P1|Overall Study|Lost to Follow-up|2
5937768|NCT01362439|20538170|P1|Overall Study|Lack of Efficacy|3
5937769|NCT01362439|20538170|P1|Overall Study|Adverse Event|1
5937770|NCT01362348|20538185|P1|Overall Study|Study closed/terminated|5
5937771|NCT01362348|20538185|P1|Overall Study|Protocol-defined stopping criteria|9
5937772|NCT01362322|20538204|P2|Overall Study|Lost to Follow-up|6
5937773|NCT01362322|20538205|P1|Overall Study|Lost to Follow-up|2
5937774|NCT01362322|20538204|P2|Overall Study|Withdrawal by Subject|1
5937775|NCT01362322|20538205|P1|Overall Study|Withdrawal by Subject|3
5937776|NCT01362296|20538237|P4|Crossover Phase|Study Closed/Terminated|0
5937777|NCT01362296|20538238|P3|Crossover Phase|Study Closed/Terminated|1
5937778|NCT01362296|20538239|P2|Crossover Phase|Study Closed/Terminated|0
5937779|NCT01362296|20538240|P1|Crossover Phase|Study Closed/Terminated|0
5937780|NCT01362296|20538237|P4|Crossover Phase|Adverse Event|0
5937781|NCT01362296|20538238|P3|Crossover Phase|Adverse Event|4
5937782|NCT01362296|20538239|P2|Crossover Phase|Adverse Event|0
5937783|NCT01362296|20538240|P1|Crossover Phase|Adverse Event|0
5937784|NCT01362296|20538237|P4|Crossover Phase|Withdrawal by Subject|1
5937785|NCT01362296|20538238|P3|Crossover Phase|Withdrawal by Subject|2
5937786|NCT01362296|20538239|P2|Crossover Phase|Withdrawal by Subject|0
5937787|NCT01362296|20538240|P1|Crossover Phase|Withdrawal by Subject|0
5937788|NCT01362296|20538237|P4|Crossover Phase|PD including Death due to PD|1
5937789|NCT01362296|20538238|P3|Crossover Phase|PD including Death due to PD|16
5937790|NCT01362296|20538239|P2|Crossover Phase|PD including Death due to PD|0
5937791|NCT01362296|20538240|P1|Crossover Phase|PD including Death due to PD|0
5937792|NCT01362296|20538237|P4|Randomized Phase (RP)|Study Closed/Terminated|0
5937793|NCT01362296|20538238|P3|Randomized Phase (RP)|Study Closed/Terminated|0
5937794|NCT01362296|20538239|P2|Randomized Phase (RP)|Study Closed/Terminated|1
5937795|NCT01362296|20538240|P1|Randomized Phase (RP)|Study Closed/Terminated|8
5937796|NCT01362296|20538237|P4|Randomized Phase (RP)|Adverse Event|0
5937797|NCT01362296|20538238|P3|Randomized Phase (RP)|Adverse Event|0
5937798|NCT01362296|20538239|P2|Randomized Phase (RP)|Adverse Event|4
5937799|NCT01362296|20538240|P1|Randomized Phase (RP)|Adverse Event|20
5937800|NCT01362296|20538237|P4|Randomized Phase (RP)|Withdrawal by Subject|0
5937801|NCT01362296|20538238|P3|Randomized Phase (RP)|Withdrawal by Subject|0
5937802|NCT01362296|20538239|P2|Randomized Phase (RP)|Withdrawal by Subject|1
5937803|NCT01362296|20538240|P1|Randomized Phase (RP)|Withdrawal by Subject|2
5937804|NCT01362296|20538237|P4|Randomized Phase (RP)|Physician Decision|0
5937805|NCT01362296|20538238|P3|Randomized Phase (RP)|Physician Decision|0
5937806|NCT01362296|20538239|P2|Randomized Phase (RP)|Physician Decision|9
5937807|NCT01362296|20538240|P1|Randomized Phase (RP)|Physician Decision|1
5937808|NCT01362296|20538237|P4|Randomized Phase (RP)|PD including Death due to PD|0
5937809|NCT01362296|20538238|P3|Randomized Phase (RP)|PD including Death due to PD|0
5937810|NCT01362296|20538239|P2|Randomized Phase (RP)|PD including Death due to PD|28
5937811|NCT01362296|20538240|P1|Randomized Phase (RP)|PD including Death due to PD|56
5937812|NCT01362270|20538288|P2|Overall Study|Met excl. criteria before 1st session|1
5937813|NCT01362270|20538289|P1|Overall Study|Met excl. criteria before 1st session|1
5937814|NCT01362270|20538288|P2|Overall Study|Met exclusion criteria after 1st session|1
5937815|NCT01362270|20538289|P1|Overall Study|Met exclusion criteria after 1st session|0
5937816|NCT01362270|20538288|P2|Overall Study|Withdrawal by Subject|0
5937817|NCT01362270|20538289|P1|Overall Study|Withdrawal by Subject|1
5937818|NCT01362244|20538301|P2|Overall Study|Protocol Defined Stopping Criteria|1
5937819|NCT01362244|20538302|P1|Overall Study|Protocol Defined Stopping Criteria|0
5937820|NCT01362244|20538301|P2|Overall Study|Did not Meet Continuation Criteria|11
5937821|NCT01362244|20538302|P1|Overall Study|Did not Meet Continuation Criteria|17
5937822|NCT01362244|20538301|P2|Overall Study|Withdrawal by Subject|1
5937823|NCT01362244|20538302|P1|Overall Study|Withdrawal by Subject|2
5937824|NCT01362244|20538301|P2|Overall Study|Protocol Violation|1
5937825|NCT01362244|20538302|P1|Overall Study|Protocol Violation|5
5937826|NCT01362244|20538301|P2|Overall Study|Lost to Follow-up|2
5937827|NCT01362244|20538302|P1|Overall Study|Lost to Follow-up|0
5937828|NCT01362244|20538301|P2|Overall Study|Lack of Efficacy|11
5937829|NCT01362244|20538302|P1|Overall Study|Lack of Efficacy|5
5937830|NCT01362244|20538301|P2|Overall Study|Adverse Event|5
5937831|NCT01362244|20538302|P1|Overall Study|Adverse Event|3
5937832|NCT01362140|20538414|P2|Overall Study|Discontinued Without Receiving Treatment|1
5937833|NCT01362140|20538415|P1|Overall Study|Discontinued Without Receiving Treatment|0
5937834|NCT01362140|20538414|P2|Overall Study|Protocol-specified Criteria|2
5937835|NCT01362140|20538415|P1|Overall Study|Protocol-specified Criteria|1
5937836|NCT01362140|20538414|P2|Overall Study|Other|1
5937837|NCT01362140|20538415|P1|Overall Study|Other|1
5937838|NCT01362140|20538414|P2|Overall Study|Death|1
5937839|NCT01362140|20538415|P1|Overall Study|Death|2
5937840|NCT01362140|20538414|P2|Overall Study|Administrative Decision|1
5937841|NCT01362140|20538415|P1|Overall Study|Administrative Decision|0
5937842|NCT01362140|20538414|P2|Overall Study|Withdrawal by Subject|3
5937843|NCT01362140|20538415|P1|Overall Study|Withdrawal by Subject|3
5937844|NCT01362140|20538414|P2|Overall Study|Adverse Event|2
5937845|NCT01362140|20538415|P1|Overall Study|Adverse Event|2
5937846|NCT01362140|20538414|P2|Overall Study|Noncompliance|0
5937847|NCT01362140|20538415|P1|Overall Study|Noncompliance|1
5937848|NCT01362062|20538452|P2|Overall Study|Had significant improvement|0
5937849|NCT01362062|20538453|P1|Overall Study|Had significant improvement|9
5937850|NCT01362062|20538452|P2|Overall Study|Detected with Spondylo-arthritis|0
5937851|NCT01362062|20538453|P1|Overall Study|Detected with Spondylo-arthritis|1
5937852|NCT01362062|20538452|P2|Overall Study|Non-compliant participant|0
5937853|NCT01362062|20538453|P1|Overall Study|Non-compliant participant|2
5937854|NCT01362062|20538452|P2|Overall Study|Withdrawal by Subject|0
5937855|NCT01362062|20538453|P1|Overall Study|Withdrawal by Subject|2
5937856|NCT01362062|20538452|P2|Overall Study|Lost to Follow-up|0
5937857|NCT01362062|20538453|P1|Overall Study|Lost to Follow-up|11
5937858|NCT01362062|20538452|P2|Overall Study|Adverse Event|0
5937859|NCT01362062|20538453|P1|Overall Study|Adverse Event|1
5937860|NCT01362049|20538474|P4|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3
5937861|NCT01362049|20538475|P3|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|2
5937862|NCT01362049|20538476|P2|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3
5937863|NCT01362049|20538477|P1|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|5
5937864|NCT01362049|20538474|P4|Follow-Up at 7 Weeks|Lost to Follow-up|1
5937865|NCT01362049|20538475|P3|Follow-Up at 7 Weeks|Lost to Follow-up|2
5937866|NCT01362049|20538476|P2|Follow-Up at 7 Weeks|Lost to Follow-up|3
5937867|NCT01362049|20538477|P1|Follow-Up at 7 Weeks|Lost to Follow-up|3
5937868|NCT01361919|20538518|P3|Overall Study|technical issues|10
5937869|NCT01361919|20538519|P2|Overall Study|technical issues|12
5937870|NCT01361919|20538520|P1|Overall Study|technical issues|10
5937871|NCT01361711|20538546|P1|10 Year Follow-up|Progressive Disease|1
5937872|NCT01361711|20538546|P1|10 Year Follow-up|Progressive Disease and New treatment started|11
5937873|NCT01361711|20538546|P1|10 Year Follow-up|New treatment started|6
5937874|NCT01361711|20538546|P1|10 Year Follow-up|Lost to Follow-up|2
5937875|NCT01361711|20538546|P1|10 Year Follow-up|Developed new cancer|1
5937876|NCT01361711|20538546|P1|10 Year Follow-up|Death|7
5937877|NCT01361711|20538546|P1|10 Year Follow-up|Still in follow-up|22
5937878|NCT01361711|20538546|P1|Completed Week 18 of Treatment|Other|9
5937879|NCT01361711|20538546|P1|Completed Week 18 of Treatment|Complete Remission|2
5937880|NCT01361711|20538546|P1|Continued Treatment After 12 Weeks|Progressive Disease at Week 11|1
5937881|NCT01361711|20538546|P1|Continued Treatment After 12 Weeks|Complete Remission in Week 12|2
5937882|NCT01361711|20538546|P1|Continued Treatment After 9 Weeks|Complete Remission in Week 9|7
5937883|NCT01361711|20538546|P1|Week 9 Bone Marrow Response Assessment|Complete Remission in Week 8|1
5937884|NCT01361711|20538546|P1|Trial Entry (Registration)|Patient did not meet Protocol criteria for trial entry|1
5937885|NCT01361607|20538565|P2|Overall Study|Met Withdrawal Criteria|1
5937886|NCT01361607|20538566|P1|Overall Study|Met Withdrawal Criteria|1
5937887|NCT01361607|20538565|P2|Overall Study|Lost to Follow-up|0
5937888|NCT01361607|20538566|P1|Overall Study|Lost to Follow-up|1
5937889|NCT01361607|20538565|P2|Overall Study|Withdrawal by Investigator|3
5937890|NCT01361607|20538566|P1|Overall Study|Withdrawal by Investigator|5
5937891|NCT01361607|20538565|P2|Overall Study|Withdrawal by Subject|8
5937892|NCT01361607|20538566|P1|Overall Study|Withdrawal by Subject|19
5937893|NCT01361607|20538565|P2|Overall Study|Adverse Event|29
5937894|NCT01361607|20538566|P1|Overall Study|Adverse Event|38
5937895|NCT01361594|20538594|P2|Overall Study|Withdrawal by Subject|2
5937896|NCT01361594|20538595|P1|Overall Study|Withdrawal by Subject|1
5937897|NCT01361568|20538609|P6|Overall Study|Withdrawal by Subject|1
5937898|NCT01361568|20538610|P5|Overall Study|Withdrawal by Subject|0
5937899|NCT01361568|20538611|P4|Overall Study|Withdrawal by Subject|0
5937900|NCT01361568|20538612|P3|Overall Study|Withdrawal by Subject|0
5937901|NCT01361568|20538613|P2|Overall Study|Withdrawal by Subject|1
5937902|NCT01361568|20538614|P1|Overall Study|Withdrawal by Subject|2
5937903|NCT01361568|20538609|P6|Overall Study|Physician Decision|1
5937904|NCT01361568|20538610|P5|Overall Study|Physician Decision|0
5937905|NCT01361568|20538611|P4|Overall Study|Physician Decision|0
5937906|NCT01361568|20538612|P3|Overall Study|Physician Decision|0
5937907|NCT01361568|20538613|P2|Overall Study|Physician Decision|0
5937908|NCT01361568|20538614|P1|Overall Study|Physician Decision|0
5937909|NCT01361568|20538609|P6|Overall Study|Adverse Event|0
5937910|NCT01361568|20538610|P5|Overall Study|Adverse Event|1
5937911|NCT01361568|20538611|P4|Overall Study|Adverse Event|0
5937912|NCT01361568|20538612|P3|Overall Study|Adverse Event|0
5937913|NCT01361568|20538613|P2|Overall Study|Adverse Event|0
5937914|NCT01361568|20538614|P1|Overall Study|Adverse Event|0
5937915|NCT01361464|20538644|P1|Overall Study|Withdrawal by Subject|2
5937916|NCT01361464|20538644|P1|Overall Study|Death|1
5937917|NCT01361308|20538653|P2|Overall Study|Other|1
5937918|NCT01361308|20538654|P1|Overall Study|Other|0
5937919|NCT01361308|20538653|P2|Overall Study|Failed C-SSRS|2
5937920|NCT01361308|20538654|P1|Overall Study|Failed C-SSRS|5
5937921|NCT01361308|20538653|P2|Overall Study|Eligibility Criteria Not Met|3
5937922|NCT01361308|20538654|P1|Overall Study|Eligibility Criteria Not Met|2
5937923|NCT01361308|20538653|P2|Overall Study|Adverse Event|4
5937924|NCT01361308|20538654|P1|Overall Study|Adverse Event|8
5937925|NCT01361308|20538653|P2|Overall Study|Lost to Follow-up|4
5937926|NCT01361308|20538654|P1|Overall Study|Lost to Follow-up|5
5937927|NCT01361308|20538653|P2|Overall Study|Protocol Violation|0
5937928|NCT01361308|20538654|P1|Overall Study|Protocol Violation|1
5937929|NCT01361308|20538653|P2|Overall Study|Lack of Efficacy|0
5937930|NCT01361308|20538654|P1|Overall Study|Lack of Efficacy|2
5937931|NCT01361308|20538653|P2|Overall Study|Physician Decision|3
5937932|NCT01361308|20538654|P1|Overall Study|Physician Decision|3
5937933|NCT01361308|20538653|P2|Overall Study|Withdrawal by Subject|13
5937934|NCT01361308|20538654|P1|Overall Study|Withdrawal by Subject|9
5937935|NCT01361178|20538702|P2|Overall Study|Death|0
5937936|NCT01361178|20538703|P1|Overall Study|Death|13
5937937|NCT01361126|20538711|P2|Overall Study|Sponsor decision|2
5937938|NCT01361126|20538712|P1|Overall Study|Sponsor decision|0
5937939|NCT01361009|20538751|P1|Overall Study|Protocol Violation|116
5937940|NCT01360996|20538761|P3|Overall Study|Noncompliant|0
5937941|NCT01360996|20538762|P2|Overall Study|Noncompliant|0
5937942|NCT01360996|20538763|P1|Overall Study|Noncompliant|2
5937943|NCT01360996|20538761|P3|Overall Study|Withdrawal by Subject|2
5937944|NCT01360996|20538762|P2|Overall Study|Withdrawal by Subject|3
5937945|NCT01360996|20538763|P1|Overall Study|Withdrawal by Subject|4
5937946|NCT01360866|20538786|P4|Overall Study|Lack of Efficacy|4
5937947|NCT01360866|20538787|P3|Overall Study|Lack of Efficacy|30
5937948|NCT01360866|20538788|P2|Overall Study|Lack of Efficacy|40
5937949|NCT01360866|20538789|P1|Overall Study|Lack of Efficacy|30
5937950|NCT01360866|20538786|P4|Overall Study|Protocol Deviation|2
5937951|NCT01360866|20538787|P3|Overall Study|Protocol Deviation|61
5937952|NCT01360866|20538788|P2|Overall Study|Protocol Deviation|33
5937953|NCT01360866|20538789|P1|Overall Study|Protocol Deviation|25
5937954|NCT01360866|20538786|P4|Overall Study|Withdrawal by participant|8
5937955|NCT01360866|20538787|P3|Overall Study|Withdrawal by participant|168
5937956|NCT01360866|20538788|P2|Overall Study|Withdrawal by participant|89
5937957|NCT01360866|20538789|P1|Overall Study|Withdrawal by participant|79
5937958|NCT01360866|20538786|P4|Overall Study|Withdrawn by Investigator|2
5937959|NCT01360866|20538787|P3|Overall Study|Withdrawn by Investigator|31
5937960|NCT01360866|20538788|P2|Overall Study|Withdrawn by Investigator|8
5937961|NCT01360866|20538789|P1|Overall Study|Withdrawn by Investigator|9
5937962|NCT01360866|20538786|P4|Overall Study|Paticipant met withdrawal criteria|0
5937963|NCT01360866|20538787|P3|Overall Study|Paticipant met withdrawal criteria|54
5937964|NCT01360866|20538788|P2|Overall Study|Paticipant met withdrawal criteria|28
5937965|NCT01360866|20538789|P1|Overall Study|Paticipant met withdrawal criteria|11
5937966|NCT01360866|20538786|P4|Overall Study|Adverse Event|6
5937967|NCT01360866|20538787|P3|Overall Study|Adverse Event|134
5937968|NCT01360866|20538788|P2|Overall Study|Adverse Event|61
5937969|NCT01360866|20538789|P1|Overall Study|Adverse Event|56
5937970|NCT01360866|20538786|P4|Overall Study|Lost to Follow-up|0
5937971|NCT01360866|20538787|P3|Overall Study|Lost to Follow-up|41
5937972|NCT01360866|20538788|P2|Overall Study|Lost to Follow-up|28
5937973|NCT01360866|20538789|P1|Overall Study|Lost to Follow-up|11
5937974|NCT01360840|20538818|P3|Overall Study|Ongoing at data cut-off|9
5937975|NCT01360840|20538819|P2|Overall Study|Ongoing at data cut-off|10
5937976|NCT01360840|20538820|P1|Overall Study|Ongoing at data cut-off|10
5937977|NCT01360762|20538870|P1|Whole Study Period|Discontinuation of study drug for safety|1
5937978|NCT01360762|20538870|P1|Whole Study Period|Patient relapsed|18
5937979|NCT01360762|20538870|P1|Whole Study Period|Death|7
5937980|NCT01360762|20538870|P1|Whole Study Period|Lost to Follow-up|10
5937981|NCT01360762|20538870|P1|Main Study Period (12-month Treatment)|Discontinuation|1
5937982|NCT01360762|20538870|P1|Main Study Period (12-month Treatment)|Patient relapsed|15
5937983|NCT01360762|20538870|P1|Main Study Period (12-month Treatment)|Discontinuation of study drug for safety|1
5937984|NCT01360762|20538870|P1|Main Study Period (12-month Treatment)|Death|5
5937985|NCT01360762|20538870|P1|Main Study Period (12-month Treatment)|Lost to Follow-up|7
5937986|NCT01360645|20538880|P4|Phase A+|Protocol Deviation|4
5937987|NCT01360645|20538881|P3|Phase A+|Protocol Deviation|0
5937988|NCT01360645|20538882|P2|Phase A+|Protocol Deviation|0
5937989|NCT01360645|20538883|P1|Phase A+|Protocol Deviation|0
5937990|NCT01360645|20538880|P4|Phase A+|Withdrawal by Subject|5
5937991|NCT01360645|20538881|P3|Phase A+|Withdrawal by Subject|0
5937992|NCT01360645|20538882|P2|Phase A+|Withdrawal by Subject|0
5937993|NCT01360645|20538883|P1|Phase A+|Withdrawal by Subject|0
5937994|NCT01360645|20538880|P4|Phase A+|Physician Decision|2
5937995|NCT01360645|20538881|P3|Phase A+|Physician Decision|0
5937996|NCT01360645|20538882|P2|Phase A+|Physician Decision|0
5937997|NCT01360645|20538883|P1|Phase A+|Physician Decision|0
5937998|NCT01360645|20538880|P4|Phase A+|Met Withdrawal Criteria|4
5937999|NCT01360645|20538881|P3|Phase A+|Met Withdrawal Criteria|0
5938000|NCT01360645|20538882|P2|Phase A+|Met Withdrawal Criteria|0
5938001|NCT01360645|20538883|P1|Phase A+|Met Withdrawal Criteria|0
5938002|NCT01360645|20538880|P4|Phase A+|Adverse Event|2
5938003|NCT01360645|20538881|P3|Phase A+|Adverse Event|0
5938004|NCT01360645|20538882|P2|Phase A+|Adverse Event|0
5938005|NCT01360645|20538883|P1|Phase A+|Adverse Event|0
5938006|NCT01360645|20538880|P4|Phase A+|Lost to Follow-up|7
5938007|NCT01360645|20538881|P3|Phase A+|Lost to Follow-up|0
5938008|NCT01360645|20538882|P2|Phase A+|Lost to Follow-up|0
5938009|NCT01360645|20538883|P1|Phase A+|Lost to Follow-up|0
5938010|NCT01360645|20538880|P4|Phase B (6 Weeks)|Protocol Deviation|0
5938011|NCT01360645|20538881|P3|Phase B (6 Weeks)|Protocol Deviation|3
5938012|NCT01360645|20538882|P2|Phase B (6 Weeks)|Protocol Deviation|1
5938013|NCT01360645|20538883|P1|Phase B (6 Weeks)|Protocol Deviation|0
5938014|NCT01360645|20538880|P4|Phase B (6 Weeks)|Withdrawal by Subject|0
5938015|NCT01360645|20538881|P3|Phase B (6 Weeks)|Withdrawal by Subject|8
5938016|NCT01360645|20538882|P2|Phase B (6 Weeks)|Withdrawal by Subject|3
5938017|NCT01360645|20538883|P1|Phase B (6 Weeks)|Withdrawal by Subject|0
5938018|NCT01360645|20538880|P4|Phase B (6 Weeks)|Met Withdrawal Criteria|0
5938019|NCT01360645|20538881|P3|Phase B (6 Weeks)|Met Withdrawal Criteria|2
5938020|NCT01360645|20538882|P2|Phase B (6 Weeks)|Met Withdrawal Criteria|3
5938021|NCT01360645|20538883|P1|Phase B (6 Weeks)|Met Withdrawal Criteria|0
5938022|NCT01360645|20538880|P4|Phase B (6 Weeks)|Adverse Event|0
5938023|NCT01360645|20538881|P3|Phase B (6 Weeks)|Adverse Event|0
5938024|NCT01360645|20538882|P2|Phase B (6 Weeks)|Adverse Event|6
5938025|NCT01360645|20538883|P1|Phase B (6 Weeks)|Adverse Event|0
5938026|NCT01360645|20538880|P4|Phase B (6 Weeks)|Lost to Follow-up|0
5938027|NCT01360645|20538881|P3|Phase B (6 Weeks)|Lost to Follow-up|0
5938028|NCT01360645|20538882|P2|Phase B (6 Weeks)|Lost to Follow-up|1
5938029|NCT01360645|20538883|P1|Phase B (6 Weeks)|Lost to Follow-up|0
5938030|NCT01360645|20538880|P4|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0
5938031|NCT01360645|20538881|P3|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0
5938032|NCT01360645|20538882|P2|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0
5938033|NCT01360645|20538883|P1|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|5
5938034|NCT01360645|20538880|P4|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0
5938035|NCT01360645|20538881|P3|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0
5938036|NCT01360645|20538882|P2|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0
5938037|NCT01360645|20538883|P1|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|24
5938038|NCT01360645|20538880|P4|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0
5938039|NCT01360645|20538881|P3|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0
5938040|NCT01360645|20538882|P2|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0
5938041|NCT01360645|20538883|P1|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|34
5938042|NCT01360645|20538880|P4|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0
5938043|NCT01360645|20538881|P3|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0
5938044|NCT01360645|20538882|P2|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0
5938045|NCT01360645|20538883|P1|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|16
5938046|NCT01360645|20538880|P4|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0
5938047|NCT01360645|20538881|P3|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0
5938048|NCT01360645|20538882|P2|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0
5938049|NCT01360645|20538883|P1|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|19
5938050|NCT01360645|20538880|P4|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0
5938051|NCT01360645|20538881|P3|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0
5938052|NCT01360645|20538882|P2|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0
5938053|NCT01360645|20538883|P1|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|16
5938054|NCT01360632|20538938|P5|Phase A+|Protocol Deviation|3
5938055|NCT01360632|20538939|P4|Phase A+|Protocol Deviation|0
5938056|NCT01360632|20538940|P3|Phase A+|Protocol Deviation|0
5938057|NCT01360632|20538941|P2|Phase A+|Protocol Deviation|0
5938058|NCT01360632|20538942|P1|Phase A+|Protocol Deviation|0
5938059|NCT01360632|20538938|P5|Phase A+|Withdrawal by Subject|8
5938060|NCT01360632|20538939|P4|Phase A+|Withdrawal by Subject|0
5938061|NCT01360632|20538940|P3|Phase A+|Withdrawal by Subject|0
5938062|NCT01360632|20538941|P2|Phase A+|Withdrawal by Subject|0
5938063|NCT01360632|20538942|P1|Phase A+|Withdrawal by Subject|0
5938064|NCT01360632|20538938|P5|Phase A+|Physician Decision|3
5938065|NCT01360632|20538939|P4|Phase A+|Physician Decision|0
5938066|NCT01360632|20538940|P3|Phase A+|Physician Decision|0
5938067|NCT01360632|20538941|P2|Phase A+|Physician Decision|0
5938068|NCT01360632|20538942|P1|Phase A+|Physician Decision|0
5938069|NCT01360632|20538938|P5|Phase A+|Met Withdrawal Criteria|7
5938070|NCT01360632|20538939|P4|Phase A+|Met Withdrawal Criteria|0
5938071|NCT01360632|20538940|P3|Phase A+|Met Withdrawal Criteria|0
5938072|NCT01360632|20538941|P2|Phase A+|Met Withdrawal Criteria|0
5938073|NCT01360632|20538942|P1|Phase A+|Met Withdrawal Criteria|0
5938074|NCT01360632|20538938|P5|Phase A+|Adverse Event|2
5938075|NCT01360632|20538939|P4|Phase A+|Adverse Event|0
5938076|NCT01360632|20538940|P3|Phase A+|Adverse Event|0
5938077|NCT01360632|20538941|P2|Phase A+|Adverse Event|0
5938078|NCT01360632|20538942|P1|Phase A+|Adverse Event|0
5938079|NCT01360632|20538938|P5|Phase A+|Lost to Follow-up|2
5938080|NCT01360632|20538939|P4|Phase A+|Lost to Follow-up|0
5938081|NCT01360632|20538940|P3|Phase A+|Lost to Follow-up|0
5938082|NCT01360632|20538941|P2|Phase A+|Lost to Follow-up|0
5938083|NCT01360632|20538942|P1|Phase A+|Lost to Follow-up|0
5938084|NCT01360632|20538938|P5|Phase B (6 Weeks)|Lack of Efficacy|0
5938085|NCT01360632|20538939|P4|Phase B (6 Weeks)|Lack of Efficacy|0
5938086|NCT01360632|20538940|P3|Phase B (6 Weeks)|Lack of Efficacy|0
5938087|NCT01360632|20538941|P2|Phase B (6 Weeks)|Lack of Efficacy|1
5938088|NCT01360632|20538942|P1|Phase B (6 Weeks)|Lack of Efficacy|0
5938089|NCT01360632|20538938|P5|Phase B (6 Weeks)|Protocol Deviation|0
5938090|NCT01360632|20538939|P4|Phase B (6 Weeks)|Protocol Deviation|1
5938091|NCT01360632|20538940|P3|Phase B (6 Weeks)|Protocol Deviation|4
5938092|NCT01360632|20538941|P2|Phase B (6 Weeks)|Protocol Deviation|1
5938093|NCT01360632|20538942|P1|Phase B (6 Weeks)|Protocol Deviation|0
5938094|NCT01360632|20538938|P5|Phase B (6 Weeks)|Withdrawal by Subject|0
5938095|NCT01360632|20538939|P4|Phase B (6 Weeks)|Withdrawal by Subject|7
5938096|NCT01360632|20538940|P3|Phase B (6 Weeks)|Withdrawal by Subject|4
5938097|NCT01360632|20538941|P2|Phase B (6 Weeks)|Withdrawal by Subject|4
5938098|NCT01360632|20538942|P1|Phase B (6 Weeks)|Withdrawal by Subject|0
5938099|NCT01360632|20538938|P5|Phase B (6 Weeks)|Physician Decision|0
5938100|NCT01360632|20538939|P4|Phase B (6 Weeks)|Physician Decision|1
5938101|NCT01360632|20538940|P3|Phase B (6 Weeks)|Physician Decision|0
5938102|NCT01360632|20538941|P2|Phase B (6 Weeks)|Physician Decision|0
5938103|NCT01360632|20538942|P1|Phase B (6 Weeks)|Physician Decision|0
5938104|NCT01360632|20538938|P5|Phase B (6 Weeks)|Met Withdrawal Criteria|0
5938105|NCT01360632|20538939|P4|Phase B (6 Weeks)|Met Withdrawal Criteria|1
5938106|NCT01360632|20538940|P3|Phase B (6 Weeks)|Met Withdrawal Criteria|2
5938107|NCT01360632|20538941|P2|Phase B (6 Weeks)|Met Withdrawal Criteria|0
5938108|NCT01360632|20538942|P1|Phase B (6 Weeks)|Met Withdrawal Criteria|0
5938109|NCT01360632|20538938|P5|Phase B (6 Weeks)|Adverse Event|0
5938110|NCT01360632|20538939|P4|Phase B (6 Weeks)|Adverse Event|3
5938111|NCT01360632|20538940|P3|Phase B (6 Weeks)|Adverse Event|9
5938112|NCT01360632|20538941|P2|Phase B (6 Weeks)|Adverse Event|3
5938113|NCT01360632|20538942|P1|Phase B (6 Weeks)|Adverse Event|0
5938114|NCT01360632|20538938|P5|Phase B (6 Weeks)|Lost to Follow-up|0
5938115|NCT01360632|20538939|P4|Phase B (6 Weeks)|Lost to Follow-up|0
5938116|NCT01360632|20538940|P3|Phase B (6 Weeks)|Lost to Follow-up|1
5938117|NCT01360632|20538941|P2|Phase B (6 Weeks)|Lost to Follow-up|1
5938118|NCT01360632|20538942|P1|Phase B (6 Weeks)|Lost to Follow-up|0
5938119|NCT01360632|20538938|P5|Phase A (8 Weeks)|Protocol Deviation|0
5938120|NCT01360632|20538939|P4|Phase A (8 Weeks)|Protocol Deviation|0
5938121|NCT01360632|20538940|P3|Phase A (8 Weeks)|Protocol Deviation|0
5938122|NCT01360632|20538941|P2|Phase A (8 Weeks)|Protocol Deviation|0
5938123|NCT01360632|20538942|P1|Phase A (8 Weeks)|Protocol Deviation|39
5938124|NCT01360632|20538938|P5|Phase A (8 Weeks)|Withdrawal by Subject|0
5938125|NCT01360632|20538939|P4|Phase A (8 Weeks)|Withdrawal by Subject|0
5938126|NCT01360632|20538940|P3|Phase A (8 Weeks)|Withdrawal by Subject|0
5938127|NCT01360632|20538941|P2|Phase A (8 Weeks)|Withdrawal by Subject|0
5938128|NCT01360632|20538942|P1|Phase A (8 Weeks)|Withdrawal by Subject|74
5938129|NCT01360632|20538938|P5|Phase A (8 Weeks)|Physician Decision|0
5938130|NCT01360632|20538939|P4|Phase A (8 Weeks)|Physician Decision|0
5938131|NCT01360632|20538940|P3|Phase A (8 Weeks)|Physician Decision|0
5938132|NCT01360632|20538941|P2|Phase A (8 Weeks)|Physician Decision|0
5938133|NCT01360632|20538942|P1|Phase A (8 Weeks)|Physician Decision|10
5938134|NCT01360632|20538938|P5|Phase A (8 Weeks)|Met Withdrawal Criteria|0
5938135|NCT01360632|20538939|P4|Phase A (8 Weeks)|Met Withdrawal Criteria|0
5938136|NCT01360632|20538940|P3|Phase A (8 Weeks)|Met Withdrawal Criteria|0
5938137|NCT01360632|20538941|P2|Phase A (8 Weeks)|Met Withdrawal Criteria|0
5938138|NCT01360632|20538942|P1|Phase A (8 Weeks)|Met Withdrawal Criteria|45
5938139|NCT01360632|20538938|P5|Phase A (8 Weeks)|Adverse Event|0
5938140|NCT01360632|20538939|P4|Phase A (8 Weeks)|Adverse Event|0
5938141|NCT01360632|20538940|P3|Phase A (8 Weeks)|Adverse Event|0
5938142|NCT01360632|20538941|P2|Phase A (8 Weeks)|Adverse Event|0
5938143|NCT01360632|20538942|P1|Phase A (8 Weeks)|Adverse Event|60
5938144|NCT01360632|20538938|P5|Phase A (8 Weeks)|Lost to Follow-up|0
5938145|NCT01360632|20538939|P4|Phase A (8 Weeks)|Lost to Follow-up|0
5938146|NCT01360632|20538940|P3|Phase A (8 Weeks)|Lost to Follow-up|0
5938147|NCT01360632|20538941|P2|Phase A (8 Weeks)|Lost to Follow-up|0
5938148|NCT01360632|20538942|P1|Phase A (8 Weeks)|Lost to Follow-up|27
5938149|NCT01360554|20539021|P2|Overall Study|Randomized but not treated.|3
5938150|NCT01360554|20539022|P1|Overall Study|Randomized but not treated.|3
5938151|NCT01360554|20539021|P2|Overall Study|Other, not specified|0
5938152|NCT01360554|20539022|P1|Overall Study|Other, not specified|1
5938153|NCT01360554|20539021|P2|Overall Study|Study terminated by sponsor|37
5938154|NCT01360554|20539022|P1|Overall Study|Study terminated by sponsor|49
5938155|NCT01360554|20539021|P2|Overall Study|Withdrawal by Subject|24
5938156|NCT01360554|20539022|P1|Overall Study|Withdrawal by Subject|23
5938157|NCT01360554|20539021|P2|Overall Study|Lost to Follow-up|4
5938158|NCT01360554|20539022|P1|Overall Study|Lost to Follow-up|4
5938159|NCT01360554|20539021|P2|Overall Study|Death|371
5938160|NCT01360554|20539022|P1|Overall Study|Death|359
5938161|NCT01360398|20539071|P1|Overall Study|Migrated/moved from study area|1
5938162|NCT01360398|20539071|P1|Overall Study|Other|7
5938163|NCT01360398|20539071|P1|Overall Study|Withdrawal by Subject|14
5938164|NCT01360021|20539105|P3|Overall Study|Adverse Event|3
5938165|NCT01360021|20539106|P2|Overall Study|Adverse Event|3
5938166|NCT01360021|20539107|P1|Overall Study|Adverse Event|2
5938167|NCT01360021|20539105|P3|Overall Study|Withdrawal by Subject|2
5938168|NCT01360021|20539106|P2|Overall Study|Withdrawal by Subject|0
5938169|NCT01360021|20539107|P1|Overall Study|Withdrawal by Subject|4
5938170|NCT01360021|20539105|P3|Overall Study|Protocol Violation|1
5938171|NCT01360021|20539106|P2|Overall Study|Protocol Violation|0
5938172|NCT01360021|20539107|P1|Overall Study|Protocol Violation|0
5938173|NCT01360021|20539105|P3|Overall Study|Eligibility criteria + other|1
5938174|NCT01360021|20539106|P2|Overall Study|Eligibility criteria + other|1
5938175|NCT01360021|20539107|P1|Overall Study|Eligibility criteria + other|2
5938176|NCT01359956|20539134|P4|Overall Study|Death|58
5938177|NCT01359956|20539135|P3|Overall Study|Death|67
5938178|NCT01359956|20539136|P2|Overall Study|Death|64
5938179|NCT01359956|20539137|P1|Overall Study|Death|61
5938180|NCT01359943|20539162|P3|Follow-up (Weeks 52 - 60)|Adverse Event|1
5938181|NCT01359943|20539163|P2|Follow-up (Weeks 52 - 60)|Adverse Event|5
5938182|NCT01359943|20539164|P1|Follow-up (Weeks 52 - 60)|Adverse Event|3
5938183|NCT01359943|20539162|P3|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0
5938184|NCT01359943|20539163|P2|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|1
5938185|NCT01359943|20539164|P1|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0
5938186|NCT01359943|20539162|P3|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3
5938187|NCT01359943|20539163|P2|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3
5938188|NCT01359943|20539164|P1|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3
5938189|NCT01359943|20539162|P3|Follow-up (Weeks 52 - 60)|Protocol deviation|0
5938190|NCT01359943|20539163|P2|Follow-up (Weeks 52 - 60)|Protocol deviation|1
5938191|NCT01359943|20539164|P1|Follow-up (Weeks 52 - 60)|Protocol deviation|0
5938192|NCT01359943|20539162|P3|Follow-up (Weeks 52 - 60)|Administrative problems|0
5938193|NCT01359943|20539163|P2|Follow-up (Weeks 52 - 60)|Administrative problems|0
5938194|NCT01359943|20539164|P1|Follow-up (Weeks 52 - 60)|Administrative problems|1
5938195|NCT01359943|20539162|P3|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|4
5938196|NCT01359943|20539163|P2|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|5
5938197|NCT01359943|20539164|P1|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|1
5938198|NCT01359943|20539162|P3|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|1
5938199|NCT01359943|20539163|P2|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|5
5938200|NCT01359943|20539164|P1|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|3
5938201|NCT01359943|20539162|P3|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0
5938202|NCT01359943|20539163|P2|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|1
5938203|NCT01359943|20539164|P1|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0
5938204|NCT01359943|20539162|P3|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3
5938205|NCT01359943|20539163|P2|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3
5938206|NCT01359943|20539164|P1|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3
5938207|NCT01359943|20539162|P3|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0
5938208|NCT01359943|20539163|P2|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|1
5938209|NCT01359943|20539164|P1|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0
5938210|NCT01359943|20539162|P3|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|4
5938211|NCT01359943|20539163|P2|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|3
5938212|NCT01359943|20539164|P1|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|1
5938213|NCT01359943|20539162|P3|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0
5938214|NCT01359943|20539163|P2|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0
5938215|NCT01359943|20539164|P1|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|1
5938216|NCT01359943|20539162|P3|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0
5938217|NCT01359943|20539163|P2|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|2
5938218|NCT01359943|20539164|P1|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0
5938219|NCT01359943|20539162|P3|Double-blind (Weeks 0 - 16)|Adverse Event|0
5938220|NCT01359943|20539163|P2|Double-blind (Weeks 0 - 16)|Adverse Event|2
5938221|NCT01359943|20539164|P1|Double-blind (Weeks 0 - 16)|Adverse Event|1
5938222|NCT01359943|20539162|P3|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0
5938223|NCT01359943|20539163|P2|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0
5938224|NCT01359943|20539164|P1|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|1
5938225|NCT01359904|20539212|P2|Overall Study|Withdrawal by Subject|0
5938226|NCT01359904|20539213|P1|Overall Study|Withdrawal by Subject|1
5938227|NCT01359644|20539267|P10|Follow-up Period|Lost to Follow-up|0
5938228|NCT01359644|20539268|P9|Follow-up Period|Lost to Follow-up|0
5938229|NCT01359644|20539269|P8|Follow-up Period|Lost to Follow-up|2
5938230|NCT01359644|20539270|P7|Follow-up Period|Lost to Follow-up|1
5938231|NCT01359644|20539271|P6|Follow-up Period|Lost to Follow-up|0
5938232|NCT01359644|20539272|P5|Follow-up Period|Lost to Follow-up|0
5938233|NCT01359644|20539273|P4|Follow-up Period|Lost to Follow-up|0
5938234|NCT01359644|20539274|P3|Follow-up Period|Lost to Follow-up|0
5938235|NCT01359644|20539275|P2|Follow-up Period|Lost to Follow-up|0
5938236|NCT01359644|20539276|P1|Follow-up Period|Lost to Follow-up|0
5938237|NCT01359644|20539267|P10|Follow-up Period|Withdrawal by Subject|0
5938238|NCT01359644|20539268|P9|Follow-up Period|Withdrawal by Subject|0
5938239|NCT01359644|20539269|P8|Follow-up Period|Withdrawal by Subject|0
5938240|NCT01359644|20539270|P7|Follow-up Period|Withdrawal by Subject|0
5938241|NCT01359644|20539271|P6|Follow-up Period|Withdrawal by Subject|1
5938242|NCT01359644|20539272|P5|Follow-up Period|Withdrawal by Subject|0
5938243|NCT01359644|20539273|P4|Follow-up Period|Withdrawal by Subject|0
5938244|NCT01359644|20539274|P3|Follow-up Period|Withdrawal by Subject|0
5938245|NCT01359644|20539275|P2|Follow-up Period|Withdrawal by Subject|0
5938246|NCT01359644|20539276|P1|Follow-up Period|Withdrawal by Subject|0
5938247|NCT01359644|20539267|P10|Treatment Period|Lost to Follow-up|0
5938248|NCT01359644|20539268|P9|Treatment Period|Lost to Follow-up|0
5938249|NCT01359644|20539269|P8|Treatment Period|Lost to Follow-up|0
5938250|NCT01359644|20539270|P7|Treatment Period|Lost to Follow-up|0
5938251|NCT01359644|20539271|P6|Treatment Period|Lost to Follow-up|1
5938252|NCT01359644|20539272|P5|Treatment Period|Lost to Follow-up|0
5938253|NCT01359644|20539273|P4|Treatment Period|Lost to Follow-up|0
5938254|NCT01359644|20539274|P3|Treatment Period|Lost to Follow-up|0
5938255|NCT01359644|20539275|P2|Treatment Period|Lost to Follow-up|0
5938256|NCT01359644|20539276|P1|Treatment Period|Lost to Follow-up|0
5938257|NCT01359644|20539267|P10|Treatment Period|Adverse Event|0
5938258|NCT01359644|20539268|P9|Treatment Period|Adverse Event|0
5938259|NCT01359644|20539269|P8|Treatment Period|Adverse Event|0
5938260|NCT01359644|20539270|P7|Treatment Period|Adverse Event|0
5938261|NCT01359644|20539271|P6|Treatment Period|Adverse Event|1
5938262|NCT01359644|20539272|P5|Treatment Period|Adverse Event|0
5938263|NCT01359644|20539273|P4|Treatment Period|Adverse Event|0
5938264|NCT01359644|20539274|P3|Treatment Period|Adverse Event|1
5938265|NCT01359644|20539275|P2|Treatment Period|Adverse Event|0
5938266|NCT01359644|20539276|P1|Treatment Period|Adverse Event|0
5938267|NCT01359644|20539267|P10|Treatment Period|Lack of Efficacy|0
5938268|NCT01359644|20539268|P9|Treatment Period|Lack of Efficacy|0
5938269|NCT01359644|20539269|P8|Treatment Period|Lack of Efficacy|0
5938270|NCT01359644|20539270|P7|Treatment Period|Lack of Efficacy|0
5938271|NCT01359644|20539271|P6|Treatment Period|Lack of Efficacy|0
5938272|NCT01359644|20539272|P5|Treatment Period|Lack of Efficacy|0
5938273|NCT01359644|20539273|P4|Treatment Period|Lack of Efficacy|0
5938274|NCT01359644|20539274|P3|Treatment Period|Lack of Efficacy|0
5938275|NCT01359644|20539275|P2|Treatment Period|Lack of Efficacy|1
5938276|NCT01359644|20539276|P1|Treatment Period|Lack of Efficacy|0
5938277|NCT01359449|20539320|P2|Overall Study|Withdrawal by Subject|2
5938278|NCT01359449|20539321|P1|Overall Study|Withdrawal by Subject|3
5938279|NCT01359449|20539320|P2|Overall Study|Protocol Violation|2
5938280|NCT01359449|20539321|P1|Overall Study|Protocol Violation|0
5938281|NCT01359449|20539320|P2|Overall Study|Lost to Follow-up|0
5938282|NCT01359449|20539321|P1|Overall Study|Lost to Follow-up|1
5938283|NCT01359254|20539371|P2|Overall Study|Death|0
5938284|NCT01359254|20539372|P1|Overall Study|Death|1
5938285|NCT01359150|20539382|P2|Overall Study|Other|0
5938286|NCT01359150|20539383|P1|Overall Study|Other|1
5938287|NCT01359150|20539382|P2|Overall Study|Adverse Event|3
5938288|NCT01359150|20539383|P1|Overall Study|Adverse Event|4
5938289|NCT01359150|20539382|P2|Overall Study|Withdrawal by Subject|1
5938290|NCT01359150|20539383|P1|Overall Study|Withdrawal by Subject|1
5938291|NCT01359150|20539382|P2|Overall Study|Lack of Efficacy|1
5938292|NCT01359150|20539383|P1|Overall Study|Lack of Efficacy|1
5938293|NCT01359046|20539414|P2|Overall Study|Physician Decision|11
5938294|NCT01359046|20539415|P1|Overall Study|Physician Decision|1
5938295|NCT01359046|20539414|P2|Overall Study|Did not receive allocated intervention|6
5938296|NCT01359046|20539415|P1|Overall Study|Did not receive allocated intervention|6
5938297|NCT01358981|20539438|P7|Period 1|Withdrawal by Subject|0
5938298|NCT01358981|20539439|P6|Period 1|Withdrawal by Subject|0
5938299|NCT01358981|20539440|P5|Period 1|Withdrawal by Subject|0
5938300|NCT01358981|20539441|P4|Period 1|Withdrawal by Subject|1
5938301|NCT01358981|20539442|P3|Period 1|Withdrawal by Subject|0
5938302|NCT01358981|20539443|P2|Period 1|Withdrawal by Subject|0
5938303|NCT01358981|20539444|P1|Period 1|Withdrawal by Subject|0
5938304|NCT01358968|20539505|P4|Continued Access Phase|Death|1
5938305|NCT01358968|20539506|P3|Continued Access Phase|Death|1
5938306|NCT01358968|20539507|P2|Continued Access Phase|Death|0
5938307|NCT01358968|20539508|P1|Continued Access Phase|Death|0
5938308|NCT01358968|20539505|P4|Continued Access Phase|Withdrawal by Subject|0
5938309|NCT01358968|20539506|P3|Continued Access Phase|Withdrawal by Subject|3
5938310|NCT01358968|20539507|P2|Continued Access Phase|Withdrawal by Subject|0
5938311|NCT01358968|20539508|P1|Continued Access Phase|Withdrawal by Subject|0
5938312|NCT01358968|20539505|P4|Continued Access Phase|Protocol Violation|2
5938313|NCT01358968|20539506|P3|Continued Access Phase|Protocol Violation|0
5938314|NCT01358968|20539507|P2|Continued Access Phase|Protocol Violation|0
5938315|NCT01358968|20539508|P1|Continued Access Phase|Protocol Violation|0
5938316|NCT01358968|20539505|P4|Continued Access Phase|Progression of Disease|4
5938317|NCT01358968|20539506|P3|Continued Access Phase|Progression of Disease|8
5938318|NCT01358968|20539507|P2|Continued Access Phase|Progression of Disease|0
5938319|NCT01358968|20539508|P1|Continued Access Phase|Progression of Disease|0
5938320|NCT01358968|20539505|P4|Period 2|Adverse Event|0
5938321|NCT01358968|20539506|P3|Period 2|Adverse Event|0
5938322|NCT01358968|20539507|P2|Period 2|Adverse Event|1
5938323|NCT01358968|20539508|P1|Period 2|Adverse Event|0
5938324|NCT01358877|20539524|P2|Overall Study|Other|129
5938325|NCT01358877|20539525|P1|Overall Study|Other|142
5938326|NCT01358877|20539524|P2|Overall Study|Ongoing follow-up for overall survival|5
5938327|NCT01358877|20539525|P1|Overall Study|Ongoing follow-up for overall survival|7
5938328|NCT01358877|20539524|P2|Overall Study|Ongoing follow-up for IDFS event|2073
5938329|NCT01358877|20539525|P1|Overall Study|Ongoing follow-up for IDFS event|2084
5938330|NCT01358877|20539524|P2|Overall Study|Ongoing follow-up for post-recurrence|108
5938331|NCT01358877|20539525|P1|Overall Study|Ongoing follow-up for post-recurrence|87
5938332|NCT01358877|20539524|P2|Overall Study|Death|89
5938333|NCT01358877|20539525|P1|Overall Study|Death|80
5938334|NCT01358864|20539595|P8|Overall Study|Not treated|0
5938335|NCT01358864|20539596|P7|Overall Study|Not treated|1
5938336|NCT01358864|20539597|P6|Overall Study|Not treated|0
5938337|NCT01358864|20539598|P5|Overall Study|Not treated|0
5938338|NCT01358864|20539599|P4|Overall Study|Not treated|0
5938339|NCT01358864|20539600|P3|Overall Study|Not treated|0
5938340|NCT01358864|20539601|P2|Overall Study|Not treated|0
5938341|NCT01358864|20539602|P1|Overall Study|Not treated|0
5938342|NCT01358864|20539595|P8|Overall Study|Other reason not defined above|0
5938343|NCT01358864|20539596|P7|Overall Study|Other reason not defined above|2
5938344|NCT01358864|20539597|P6|Overall Study|Other reason not defined above|0
5938345|NCT01358864|20539598|P5|Overall Study|Other reason not defined above|0
5938346|NCT01358864|20539599|P4|Overall Study|Other reason not defined above|0
5938347|NCT01358864|20539600|P3|Overall Study|Other reason not defined above|0
5938348|NCT01358864|20539601|P2|Overall Study|Other reason not defined above|0
5938349|NCT01358864|20539602|P1|Overall Study|Other reason not defined above|2
5938350|NCT01358864|20539595|P8|Overall Study|Withdrawal by Subject|3
5938351|NCT01358864|20539596|P7|Overall Study|Withdrawal by Subject|1
5938352|NCT01358864|20539597|P6|Overall Study|Withdrawal by Subject|1
5938353|NCT01358864|20539598|P5|Overall Study|Withdrawal by Subject|0
5938354|NCT01358864|20539599|P4|Overall Study|Withdrawal by Subject|0
5938355|NCT01358864|20539600|P3|Overall Study|Withdrawal by Subject|2
5938356|NCT01358864|20539601|P2|Overall Study|Withdrawal by Subject|4
5938357|NCT01358864|20539602|P1|Overall Study|Withdrawal by Subject|3
5938358|NCT01358864|20539595|P8|Overall Study|Lost to Follow-up|1
5938359|NCT01358864|20539596|P7|Overall Study|Lost to Follow-up|0
5938360|NCT01358864|20539597|P6|Overall Study|Lost to Follow-up|0
5938361|NCT01358864|20539598|P5|Overall Study|Lost to Follow-up|0
5938362|NCT01358864|20539599|P4|Overall Study|Lost to Follow-up|0
5938363|NCT01358864|20539600|P3|Overall Study|Lost to Follow-up|1
5938364|NCT01358864|20539601|P2|Overall Study|Lost to Follow-up|0
5938365|NCT01358864|20539602|P1|Overall Study|Lost to Follow-up|0
5938366|NCT01358864|20539595|P8|Overall Study|Lack of Efficacy|44
5938367|NCT01358864|20539596|P7|Overall Study|Lack of Efficacy|49
5938368|NCT01358864|20539597|P6|Overall Study|Lack of Efficacy|4
5938369|NCT01358864|20539598|P5|Overall Study|Lack of Efficacy|7
5938370|NCT01358864|20539599|P4|Overall Study|Lack of Efficacy|19
5938371|NCT01358864|20539600|P3|Overall Study|Lack of Efficacy|4
5938372|NCT01358864|20539601|P2|Overall Study|Lack of Efficacy|3
5938373|NCT01358864|20539602|P1|Overall Study|Lack of Efficacy|26
5938374|NCT01358864|20539595|P8|Overall Study|Adverse Event|7
5938375|NCT01358864|20539596|P7|Overall Study|Adverse Event|12
5938376|NCT01358864|20539597|P6|Overall Study|Adverse Event|8
5938377|NCT01358864|20539598|P5|Overall Study|Adverse Event|4
5938378|NCT01358864|20539599|P4|Overall Study|Adverse Event|0
5938379|NCT01358864|20539600|P3|Overall Study|Adverse Event|9
5938380|NCT01358864|20539601|P2|Overall Study|Adverse Event|6
5938381|NCT01358864|20539602|P1|Overall Study|Adverse Event|0
5938382|NCT01358825|20539693|P2|Overall Study|Blood sample not drawn|1
5938383|NCT01358825|20539694|P1|Overall Study|Blood sample not drawn|0
5938384|NCT01358760|20539718|P3|Overall Study|Entry criteria not met/Non-compliance|16
5938385|NCT01358760|20539719|P2|Overall Study|Entry criteria not met/Non-compliance|12
5938386|NCT01358760|20539720|P1|Overall Study|Entry criteria not met/Non-compliance|12
5938387|NCT01358760|20539718|P3|Overall Study|Physician Decision|1
5938388|NCT01358760|20539719|P2|Overall Study|Physician Decision|0
5938389|NCT01358760|20539720|P1|Overall Study|Physician Decision|1
5938390|NCT01358760|20539718|P3|Overall Study|Withdrawal by Subject|2
5938391|NCT01358760|20539719|P2|Overall Study|Withdrawal by Subject|3
5938392|NCT01358760|20539720|P1|Overall Study|Withdrawal by Subject|5
5938393|NCT01358760|20539718|P3|Overall Study|Lost to Follow-up|3
5938394|NCT01358760|20539719|P2|Overall Study|Lost to Follow-up|1
5938395|NCT01358760|20539720|P1|Overall Study|Lost to Follow-up|1
5938396|NCT01358760|20539718|P3|Overall Study|Adverse Event|3
5938397|NCT01358760|20539719|P2|Overall Study|Adverse Event|4
5938398|NCT01358760|20539720|P1|Overall Study|Adverse Event|3
5938399|NCT01358734|20539755|P3|Overall Study|Protocol Violation|2
5938400|NCT01358734|20539756|P2|Overall Study|Protocol Violation|0
5938401|NCT01358734|20539757|P1|Overall Study|Protocol Violation|0
5938402|NCT01358734|20539755|P3|Overall Study|Other|4
5938403|NCT01358734|20539756|P2|Overall Study|Other|5
5938404|NCT01358734|20539757|P1|Overall Study|Other|2
5938405|NCT01358734|20539755|P3|Overall Study|Non-compliance with study drug|1
5938406|NCT01358734|20539756|P2|Overall Study|Non-compliance with study drug|0
5938407|NCT01358734|20539757|P1|Overall Study|Non-compliance with study drug|0
5938408|NCT01358734|20539755|P3|Overall Study|Progressive Disease|16
5938409|NCT01358734|20539756|P2|Overall Study|Progressive Disease|13
5938410|NCT01358734|20539757|P1|Overall Study|Progressive Disease|5
5938411|NCT01358734|20539755|P3|Overall Study|Death|2
5938412|NCT01358734|20539756|P2|Overall Study|Death|7
5938413|NCT01358734|20539757|P1|Overall Study|Death|3
5938414|NCT01358734|20539755|P3|Overall Study|Withdrawal by Subject|3
5938415|NCT01358734|20539756|P2|Overall Study|Withdrawal by Subject|6
5938416|NCT01358734|20539757|P1|Overall Study|Withdrawal by Subject|1
5938417|NCT01358734|20539755|P3|Overall Study|Lack of Efficacy|3
5938418|NCT01358734|20539756|P2|Overall Study|Lack of Efficacy|1
5938419|NCT01358734|20539757|P1|Overall Study|Lack of Efficacy|0
5938420|NCT01358734|20539755|P3|Overall Study|Adverse Event|3
5938421|NCT01358734|20539756|P2|Overall Study|Adverse Event|7
5938422|NCT01358734|20539757|P1|Overall Study|Adverse Event|4
5938423|NCT01358721|20539805|P4|Overall Study|Out of State/Unmet Criteria|0
5938424|NCT01358721|20539806|P3|Overall Study|Out of State/Unmet Criteria|1
5938425|NCT01358721|20539807|P2|Overall Study|Out of State/Unmet Criteria|0
5938426|NCT01358721|20539808|P1|Overall Study|Out of State/Unmet Criteria|0
5938427|NCT01358721|20539805|P4|Overall Study|Disease Progression|15
5938428|NCT01358721|20539806|P3|Overall Study|Disease Progression|17
5938429|NCT01358721|20539807|P2|Overall Study|Disease Progression|15
5938430|NCT01358721|20539808|P1|Overall Study|Disease Progression|19
5938431|NCT01358721|20539805|P4|Overall Study|Adverse Event related to study drug|1
5938432|NCT01358721|20539806|P3|Overall Study|Adverse Event related to study drug|0
5938433|NCT01358721|20539807|P2|Overall Study|Adverse Event related to study drug|0
5938434|NCT01358721|20539808|P1|Overall Study|Adverse Event related to study drug|1
5938435|NCT01358721|20539805|P4|Overall Study|Subject No Longer Meets Study Criteria|1
5938436|NCT01358721|20539806|P3|Overall Study|Subject No Longer Meets Study Criteria|0
5938437|NCT01358721|20539807|P2|Overall Study|Subject No Longer Meets Study Criteria|2
5938438|NCT01358721|20539808|P1|Overall Study|Subject No Longer Meets Study Criteria|0
5938439|NCT01358721|20539805|P4|Overall Study|SUBJ request to discontinue study TRT|1
5938440|NCT01358721|20539806|P3|Overall Study|SUBJ request to discontinue study TRT|0
5938441|NCT01358721|20539807|P2|Overall Study|SUBJ request to discontinue study TRT|0
5938442|NCT01358721|20539808|P1|Overall Study|SUBJ request to discontinue study TRT|0
5938443|NCT01358721|20539805|P4|Overall Study|Study Drug Toxicity|5
5938444|NCT01358721|20539806|P3|Overall Study|Study Drug Toxicity|4
5938445|NCT01358721|20539807|P2|Overall Study|Study Drug Toxicity|3
5938446|NCT01358721|20539808|P1|Overall Study|Study Drug Toxicity|1
5938447|NCT01358721|20539805|P4|Overall Study|Death|0
5938448|NCT01358721|20539806|P3|Overall Study|Death|0
5938449|NCT01358721|20539807|P2|Overall Study|Death|2
5938450|NCT01358721|20539808|P1|Overall Study|Death|0
5938451|NCT01358721|20539805|P4|Overall Study|Withdrawal by Subject|1
5938452|NCT01358721|20539806|P3|Overall Study|Withdrawal by Subject|0
5938453|NCT01358721|20539807|P2|Overall Study|Withdrawal by Subject|0
5938454|NCT01358721|20539808|P1|Overall Study|Withdrawal by Subject|0
5938455|NCT01358708|20539860|P2|Double-Blind Treatment Phase|Protocol Violation|0
5938456|NCT01358708|20539861|P1|Double-Blind Treatment Phase|Protocol Violation|1
5938457|NCT01358708|20539860|P2|Double-Blind Treatment Phase|Lost to Follow-up|0
5938458|NCT01358708|20539861|P1|Double-Blind Treatment Phase|Lost to Follow-up|2
5938459|NCT01358578|20539884|P6|Follow-up Period|Physician Decision|0
5938460|NCT01358578|20539885|P5|Follow-up Period|Physician Decision|0
5938461|NCT01358578|20539886|P4|Follow-up Period|Physician Decision|2
5938462|NCT01358578|20539887|P3|Follow-up Period|Physician Decision|0
5938463|NCT01358578|20539888|P2|Follow-up Period|Physician Decision|1
5938464|NCT01358578|20539889|P1|Follow-up Period|Physician Decision|1
5938465|NCT01358578|20539884|P6|Follow-up Period|Withdrawal by Subject|0
5938466|NCT01358578|20539885|P5|Follow-up Period|Withdrawal by Subject|0
5938467|NCT01358578|20539886|P4|Follow-up Period|Withdrawal by Subject|12
5938468|NCT01358578|20539887|P3|Follow-up Period|Withdrawal by Subject|1
5938469|NCT01358578|20539888|P2|Follow-up Period|Withdrawal by Subject|3
5938470|NCT01358578|20539889|P1|Follow-up Period|Withdrawal by Subject|3
5938471|NCT01358578|20539884|P6|Follow-up Period|Pregnancy|0
5938472|NCT01358578|20539885|P5|Follow-up Period|Pregnancy|0
5938473|NCT01358578|20539886|P4|Follow-up Period|Pregnancy|0
5938474|NCT01358578|20539887|P3|Follow-up Period|Pregnancy|0
5938475|NCT01358578|20539888|P2|Follow-up Period|Pregnancy|0
5938476|NCT01358578|20539889|P1|Follow-up Period|Pregnancy|1
5938477|NCT01358578|20539884|P6|Follow-up Period|non- compliance with study treatment|0
5938478|NCT01358578|20539885|P5|Follow-up Period|non- compliance with study treatment|0
5938479|NCT01358578|20539886|P4|Follow-up Period|non- compliance with study treatment|0
5938480|NCT01358578|20539887|P3|Follow-up Period|non- compliance with study treatment|0
5938481|NCT01358578|20539888|P2|Follow-up Period|non- compliance with study treatment|0
5938482|NCT01358578|20539889|P1|Follow-up Period|non- compliance with study treatment|1
5938483|NCT01358578|20539884|P6|Follow-up Period|Lost to Follow-up|0
5938484|NCT01358578|20539885|P5|Follow-up Period|Lost to Follow-up|0
5938485|NCT01358578|20539886|P4|Follow-up Period|Lost to Follow-up|4
5938486|NCT01358578|20539887|P3|Follow-up Period|Lost to Follow-up|0
5938487|NCT01358578|20539888|P2|Follow-up Period|Lost to Follow-up|1
5938488|NCT01358578|20539889|P1|Follow-up Period|Lost to Follow-up|0
5938489|NCT01358578|20539884|P6|Follow-up Period|Lack of Efficacy|0
5938490|NCT01358578|20539885|P5|Follow-up Period|Lack of Efficacy|0
5938491|NCT01358578|20539886|P4|Follow-up Period|Lack of Efficacy|1
5938492|NCT01358578|20539887|P3|Follow-up Period|Lack of Efficacy|4
5938493|NCT01358578|20539888|P2|Follow-up Period|Lack of Efficacy|0
5938494|NCT01358578|20539889|P1|Follow-up Period|Lack of Efficacy|3
5938495|NCT01358578|20539884|P6|Follow-up Period|Adverse Event|0
5938496|NCT01358578|20539885|P5|Follow-up Period|Adverse Event|0
5938497|NCT01358578|20539886|P4|Follow-up Period|Adverse Event|0
5938498|NCT01358578|20539887|P3|Follow-up Period|Adverse Event|0
5938499|NCT01358578|20539888|P2|Follow-up Period|Adverse Event|1
5938500|NCT01358578|20539889|P1|Follow-up Period|Adverse Event|1
5938501|NCT01358578|20539884|P6|Maintenance Period|Withdrawal by Subject|3
5938502|NCT01358578|20539885|P5|Maintenance Period|Withdrawal by Subject|6
5938503|NCT01358578|20539886|P4|Maintenance Period|Withdrawal by Subject|15
5938504|NCT01358578|20539887|P3|Maintenance Period|Withdrawal by Subject|2
5938505|NCT01358578|20539888|P2|Maintenance Period|Withdrawal by Subject|7
5938506|NCT01358578|20539889|P1|Maintenance Period|Withdrawal by Subject|12
5938507|NCT01358578|20539884|P6|Maintenance Period|Protocol deviation|2
5938508|NCT01358578|20539885|P5|Maintenance Period|Protocol deviation|2
5938509|NCT01358578|20539886|P4|Maintenance Period|Protocol deviation|2
5938510|NCT01358578|20539887|P3|Maintenance Period|Protocol deviation|0
5938511|NCT01358578|20539888|P2|Maintenance Period|Protocol deviation|4
5938512|NCT01358578|20539889|P1|Maintenance Period|Protocol deviation|7
5938513|NCT01358578|20539884|P6|Maintenance Period|Pregnancy|0
5938514|NCT01358578|20539885|P5|Maintenance Period|Pregnancy|0
5938515|NCT01358578|20539886|P4|Maintenance Period|Pregnancy|0
5938516|NCT01358578|20539887|P3|Maintenance Period|Pregnancy|0
5938517|NCT01358578|20539888|P2|Maintenance Period|Pregnancy|0
5938518|NCT01358578|20539889|P1|Maintenance Period|Pregnancy|1
5938519|NCT01358578|20539884|P6|Maintenance Period|Physician Decision|0
5938520|NCT01358578|20539885|P5|Maintenance Period|Physician Decision|0
5938521|NCT01358578|20539886|P4|Maintenance Period|Physician Decision|1
5938522|NCT01358578|20539887|P3|Maintenance Period|Physician Decision|0
5938523|NCT01358578|20539888|P2|Maintenance Period|Physician Decision|1
5938524|NCT01358578|20539889|P1|Maintenance Period|Physician Decision|0
5938525|NCT01358578|20539884|P6|Maintenance Period|Non-compliance with study treatment|2
5938526|NCT01358578|20539885|P5|Maintenance Period|Non-compliance with study treatment|1
5938527|NCT01358578|20539886|P4|Maintenance Period|Non-compliance with study treatment|2
5938528|NCT01358578|20539887|P3|Maintenance Period|Non-compliance with study treatment|0
5938529|NCT01358578|20539888|P2|Maintenance Period|Non-compliance with study treatment|1
5938530|NCT01358578|20539889|P1|Maintenance Period|Non-compliance with study treatment|3
5938531|NCT01358578|20539884|P6|Maintenance Period|Lost to Follow-up|1
5938532|NCT01358578|20539885|P5|Maintenance Period|Lost to Follow-up|1
5938533|NCT01358578|20539886|P4|Maintenance Period|Lost to Follow-up|5
5938534|NCT01358578|20539887|P3|Maintenance Period|Lost to Follow-up|0
5938535|NCT01358578|20539888|P2|Maintenance Period|Lost to Follow-up|0
5938536|NCT01358578|20539889|P1|Maintenance Period|Lost to Follow-up|4
5938537|NCT01358578|20539884|P6|Maintenance Period|Lack of Efficacy|0
5938538|NCT01358578|20539885|P5|Maintenance Period|Lack of Efficacy|3
5938539|NCT01358578|20539886|P4|Maintenance Period|Lack of Efficacy|11
5938540|NCT01358578|20539887|P3|Maintenance Period|Lack of Efficacy|0
5938541|NCT01358578|20539888|P2|Maintenance Period|Lack of Efficacy|2
5938542|NCT01358578|20539889|P1|Maintenance Period|Lack of Efficacy|10
5938543|NCT01358578|20539884|P6|Maintenance Period|Adverse Event|3
5938544|NCT01358578|20539885|P5|Maintenance Period|Adverse Event|4
5938545|NCT01358578|20539886|P4|Maintenance Period|Adverse Event|6
5938546|NCT01358578|20539887|P3|Maintenance Period|Adverse Event|0
5938547|NCT01358578|20539888|P2|Maintenance Period|Adverse Event|7
5938548|NCT01358578|20539889|P1|Maintenance Period|Adverse Event|2
5938549|NCT01358578|20539884|P6|Induction Period|Withdrawal by Subject|0
5938550|NCT01358578|20539885|P5|Induction Period|Withdrawal by Subject|0
5938551|NCT01358578|20539886|P4|Induction Period|Withdrawal by Subject|6
5938552|NCT01358578|20539887|P3|Induction Period|Withdrawal by Subject|10
5938553|NCT01358578|20539888|P2|Induction Period|Withdrawal by Subject|5
5938554|NCT01358578|20539889|P1|Induction Period|Withdrawal by Subject|5
5938555|NCT01358578|20539884|P6|Induction Period|technical problems|0
5938556|NCT01358578|20539885|P5|Induction Period|technical problems|0
5938557|NCT01358578|20539886|P4|Induction Period|technical problems|1
5938558|NCT01358578|20539887|P3|Induction Period|technical problems|1
5938559|NCT01358578|20539888|P2|Induction Period|technical problems|0
5938560|NCT01358578|20539889|P1|Induction Period|technical problems|0
5938561|NCT01358578|20539884|P6|Induction Period|Protocol Deviation|0
5938562|NCT01358578|20539885|P5|Induction Period|Protocol Deviation|0
5938563|NCT01358578|20539886|P4|Induction Period|Protocol Deviation|3
5938564|NCT01358578|20539887|P3|Induction Period|Protocol Deviation|0
5938565|NCT01358578|20539888|P2|Induction Period|Protocol Deviation|5
5938566|NCT01358578|20539889|P1|Induction Period|Protocol Deviation|3
5938567|NCT01358578|20539884|P6|Induction Period|Physician Decision|0
5938568|NCT01358578|20539885|P5|Induction Period|Physician Decision|0
5938569|NCT01358578|20539886|P4|Induction Period|Physician Decision|0
5938570|NCT01358578|20539887|P3|Induction Period|Physician Decision|2
5938571|NCT01358578|20539888|P2|Induction Period|Physician Decision|1
5938572|NCT01358578|20539889|P1|Induction Period|Physician Decision|2
5938573|NCT01358578|20539884|P6|Induction Period|Lost to Follow-up|0
5938574|NCT01358578|20539885|P5|Induction Period|Lost to Follow-up|0
5938575|NCT01358578|20539886|P4|Induction Period|Lost to Follow-up|4
5938576|NCT01358578|20539887|P3|Induction Period|Lost to Follow-up|1
5938577|NCT01358578|20539888|P2|Induction Period|Lost to Follow-up|0
5938578|NCT01358578|20539889|P1|Induction Period|Lost to Follow-up|0
5938579|NCT01358578|20539884|P6|Induction Period|Lack of Efficacy|0
5938580|NCT01358578|20539885|P5|Induction Period|Lack of Efficacy|0
5938581|NCT01358578|20539886|P4|Induction Period|Lack of Efficacy|1
5938582|NCT01358578|20539887|P3|Induction Period|Lack of Efficacy|9
5938583|NCT01358578|20539888|P2|Induction Period|Lack of Efficacy|0
5938584|NCT01358578|20539889|P1|Induction Period|Lack of Efficacy|0
5938585|NCT01358578|20539884|P6|Induction Period|Adverse Event|0
5938586|NCT01358578|20539885|P5|Induction Period|Adverse Event|0
5938587|NCT01358578|20539886|P4|Induction Period|Adverse Event|6
5938588|NCT01358578|20539887|P3|Induction Period|Adverse Event|2
5938589|NCT01358578|20539888|P2|Induction Period|Adverse Event|4
5938590|NCT01358578|20539889|P1|Induction Period|Adverse Event|2
5938591|NCT01358526|20539941|P3|Double-blind Phase|Administrative|10
5938592|NCT01358526|20539942|P2|Double-blind Phase|Administrative|6
5938593|NCT01358526|20539943|P1|Double-blind Phase|Administrative|0
5938594|NCT01358526|20539941|P3|Double-blind Phase|Confirmed or suspected diversion|6
5938595|NCT01358526|20539942|P2|Double-blind Phase|Confirmed or suspected diversion|5
5938596|NCT01358526|20539943|P1|Double-blind Phase|Confirmed or suspected diversion|0
5938597|NCT01358526|20539941|P3|Double-blind Phase|Lack of Efficacy|73
5938598|NCT01358526|20539942|P2|Double-blind Phase|Lack of Efficacy|31
5938599|NCT01358526|20539943|P1|Double-blind Phase|Lack of Efficacy|0
5938600|NCT01358526|20539941|P3|Double-blind Phase|Lost to Follow-up|1
5938601|NCT01358526|20539942|P2|Double-blind Phase|Lost to Follow-up|4
5938602|NCT01358526|20539943|P1|Double-blind Phase|Lost to Follow-up|0
5938603|NCT01358526|20539941|P3|Double-blind Phase|Withdrawal by Subject|8
5938604|NCT01358526|20539942|P2|Double-blind Phase|Withdrawal by Subject|10
5938605|NCT01358526|20539943|P1|Double-blind Phase|Withdrawal by Subject|0
5938606|NCT01358526|20539941|P3|Double-blind Phase|Adverse Event|23
5938607|NCT01358526|20539942|P2|Double-blind Phase|Adverse Event|24
5938608|NCT01358526|20539943|P1|Double-blind Phase|Adverse Event|0
5938609|NCT01358526|20539941|P3|Open-label Titration Period|Did not qualify|0
5938610|NCT01358526|20539942|P2|Open-label Titration Period|Did not qualify|0
5938611|NCT01358526|20539943|P1|Open-label Titration Period|Did not qualify|178
5938612|NCT01358526|20539941|P3|Open-label Titration Period|Administrative|0
5938613|NCT01358526|20539942|P2|Open-label Titration Period|Administrative|0
5938614|NCT01358526|20539943|P1|Open-label Titration Period|Administrative|8
5938615|NCT01358526|20539941|P3|Open-label Titration Period|Confirmed or suspected diversion|0
5938616|NCT01358526|20539942|P2|Open-label Titration Period|Confirmed or suspected diversion|0
5938617|NCT01358526|20539943|P1|Open-label Titration Period|Confirmed or suspected diversion|16
5938618|NCT01358526|20539941|P3|Open-label Titration Period|Lack of Efficacy|0
5938619|NCT01358526|20539942|P2|Open-label Titration Period|Lack of Efficacy|0
5938620|NCT01358526|20539943|P1|Open-label Titration Period|Lack of Efficacy|107
5938621|NCT01358526|20539941|P3|Open-label Titration Period|Lost to Follow-up|0
5938622|NCT01358526|20539942|P2|Open-label Titration Period|Lost to Follow-up|0
5938623|NCT01358526|20539943|P1|Open-label Titration Period|Lost to Follow-up|25
5938624|NCT01358526|20539941|P3|Open-label Titration Period|Withdrawal by Subject|0
5938625|NCT01358526|20539942|P2|Open-label Titration Period|Withdrawal by Subject|0
5938626|NCT01358526|20539943|P1|Open-label Titration Period|Withdrawal by Subject|65
5938627|NCT01358526|20539941|P3|Open-label Titration Period|Adverse Event|0
5938628|NCT01358526|20539942|P2|Open-label Titration Period|Adverse Event|0
5938629|NCT01358526|20539943|P1|Open-label Titration Period|Adverse Event|95
5938630|NCT01358357|20539960|P3|Double-Blind Phase|Administrative|0
5938631|NCT01358357|20539961|P2|Double-Blind Phase|Administrative|1
5938632|NCT01358357|20539962|P1|Double-Blind Phase|Administrative|0
5938633|NCT01358357|20539960|P3|Double-Blind Phase|Recurrence of mood event|0
5938634|NCT01358357|20539961|P2|Double-Blind Phase|Recurrence of mood event|64
5938635|NCT01358357|20539962|P1|Double-Blind Phase|Recurrence of mood event|48
5938636|NCT01358357|20539960|P3|Double-Blind Phase|Terminated at study completion|0
5938637|NCT01358357|20539961|P2|Double-Blind Phase|Terminated at study completion|0
5938638|NCT01358357|20539962|P1|Double-Blind Phase|Terminated at study completion|2
5938639|NCT01358357|20539960|P3|Double-Blind Phase|Protocol Violation|0
5938640|NCT01358357|20539961|P2|Double-Blind Phase|Protocol Violation|12
5938641|NCT01358357|20539962|P1|Double-Blind Phase|Protocol Violation|16
5938642|NCT01358357|20539960|P3|Double-Blind Phase|Protocol Violation|0
5938643|NCT01358357|20539961|P2|Double-Blind Phase|Protocol Violation|11
5938644|NCT01358357|20539962|P1|Double-Blind Phase|Protocol Violation|1
5938645|NCT01358357|20539960|P3|Double-Blind Phase|Lost to Follow-up|0
5938646|NCT01358357|20539961|P2|Double-Blind Phase|Lost to Follow-up|7
5938647|NCT01358357|20539962|P1|Double-Blind Phase|Lost to Follow-up|5
5938648|NCT01358357|20539960|P3|Double-Blind Phase|Adverse Event|0
5938649|NCT01358357|20539961|P2|Double-Blind Phase|Adverse Event|5
5938650|NCT01358357|20539962|P1|Double-Blind Phase|Adverse Event|8
5938651|NCT01358357|20539960|P3|Open Label Phase|Mood episode|42
5938652|NCT01358357|20539961|P2|Open Label Phase|Mood episode|0
5938653|NCT01358357|20539962|P1|Open Label Phase|Mood episode|0
5938654|NCT01358357|20539960|P3|Open Label Phase|Terminated at study completion|5
5938655|NCT01358357|20539961|P2|Open Label Phase|Terminated at study completion|0
5938656|NCT01358357|20539962|P1|Open Label Phase|Terminated at study completion|0
5938657|NCT01358357|20539960|P3|Open Label Phase|Did not meet criteria for DB phase|16
5938658|NCT01358357|20539961|P2|Open Label Phase|Did not meet criteria for DB phase|0
5938659|NCT01358357|20539962|P1|Open Label Phase|Did not meet criteria for DB phase|0
5938660|NCT01358357|20539960|P3|Open Label Phase|Withdrawal by Subject|112
5938661|NCT01358357|20539961|P2|Open Label Phase|Withdrawal by Subject|0
5938662|NCT01358357|20539962|P1|Open Label Phase|Withdrawal by Subject|0
5938663|NCT01358357|20539960|P3|Open Label Phase|Protocol Violation|45
5938664|NCT01358357|20539961|P2|Open Label Phase|Protocol Violation|0
5938665|NCT01358357|20539962|P1|Open Label Phase|Protocol Violation|0
5938666|NCT01358357|20539960|P3|Open Label Phase|Lost to Follow-up|76
5938667|NCT01358357|20539961|P2|Open Label Phase|Lost to Follow-up|0
5938668|NCT01358357|20539962|P1|Open Label Phase|Lost to Follow-up|0
5938669|NCT01358357|20539960|P3|Open Label Phase|Lack of Efficacy|107
5938670|NCT01358357|20539961|P2|Open Label Phase|Lack of Efficacy|0
5938671|NCT01358357|20539962|P1|Open Label Phase|Lack of Efficacy|0
5938672|NCT01358357|20539960|P3|Open Label Phase|Adverse Event|59
5938673|NCT01358357|20539961|P2|Open Label Phase|Adverse Event|0
5938674|NCT01358357|20539962|P1|Open Label Phase|Adverse Event|0
5938675|NCT01358331|20540001|P6|Overall Study|Progress of disease under investigation|0
5938676|NCT01358331|20540002|P5|Overall Study|Progress of disease under investigation|3
5938677|NCT01358331|20540003|P4|Overall Study|Progress of disease under investigation|1
5938678|NCT01358331|20540004|P3|Overall Study|Progress of disease under investigation|3
5938679|NCT01358331|20540005|P2|Overall Study|Progress of disease under investigation|2
5938680|NCT01358331|20540006|P1|Overall Study|Progress of disease under investigation|1
5938681|NCT01358331|20540001|P6|Overall Study|Participants did not wish to continue|0
5938682|NCT01358331|20540002|P5|Overall Study|Participants did not wish to continue|1
5938683|NCT01358331|20540003|P4|Overall Study|Participants did not wish to continue|0
5938684|NCT01358331|20540004|P3|Overall Study|Participants did not wish to continue|0
5938685|NCT01358331|20540005|P2|Overall Study|Participants did not wish to continue|0
5938686|NCT01358331|20540006|P1|Overall Study|Participants did not wish to continue|0
5938687|NCT01358331|20540001|P6|Overall Study|Symptomatic Deterioration|0
5938688|NCT01358331|20540002|P5|Overall Study|Symptomatic Deterioration|1
5938689|NCT01358331|20540003|P4|Overall Study|Symptomatic Deterioration|0
5938690|NCT01358331|20540004|P3|Overall Study|Symptomatic Deterioration|0
5938691|NCT01358331|20540005|P2|Overall Study|Symptomatic Deterioration|0
5938692|NCT01358331|20540006|P1|Overall Study|Symptomatic Deterioration|0
5938693|NCT01358331|20540001|P6|Overall Study|Adverse Events|5
5938694|NCT01358331|20540002|P5|Overall Study|Adverse Events|1
5938695|NCT01358331|20540003|P4|Overall Study|Adverse Events|0
5938696|NCT01358331|20540004|P3|Overall Study|Adverse Events|1
5938697|NCT01358331|20540005|P2|Overall Study|Adverse Events|1
5938698|NCT01358331|20540006|P1|Overall Study|Adverse Events|1
5938699|NCT01358331|20540001|P6|Overall Study|Withdrawal by Subject|1
5938700|NCT01358331|20540002|P5|Overall Study|Withdrawal by Subject|1
5938701|NCT01358331|20540003|P4|Overall Study|Withdrawal by Subject|1
5938702|NCT01358331|20540004|P3|Overall Study|Withdrawal by Subject|0
5938703|NCT01358331|20540005|P2|Overall Study|Withdrawal by Subject|0
5938704|NCT01358331|20540006|P1|Overall Study|Withdrawal by Subject|0
5938705|NCT01358331|20540001|P6|Overall Study|Lost to Follow-up|0
5938706|NCT01358331|20540002|P5|Overall Study|Lost to Follow-up|0
5938707|NCT01358331|20540003|P4|Overall Study|Lost to Follow-up|1
5938708|NCT01358331|20540004|P3|Overall Study|Lost to Follow-up|0
5938709|NCT01358331|20540005|P2|Overall Study|Lost to Follow-up|0
5938710|NCT01358331|20540006|P1|Overall Study|Lost to Follow-up|0
5938711|NCT01358175|20540058|P3|Overall Study|Adverse Event|11
5938712|NCT01358175|20540059|P2|Overall Study|Adverse Event|11
5938713|NCT01358175|20540060|P1|Overall Study|Adverse Event|6
5938714|NCT01358175|20540058|P3|Overall Study|Lack of Efficacy|6
5938715|NCT01358175|20540059|P2|Overall Study|Lack of Efficacy|8
5938716|NCT01358175|20540060|P1|Overall Study|Lack of Efficacy|3
5938717|NCT01358175|20540058|P3|Overall Study|Lost to Follow-up|3
5938718|NCT01358175|20540059|P2|Overall Study|Lost to Follow-up|1
5938719|NCT01358175|20540060|P1|Overall Study|Lost to Follow-up|1
5938720|NCT01358175|20540058|P3|Overall Study|Non Compliance with Study Treatment|1
5938721|NCT01358175|20540059|P2|Overall Study|Non Compliance with Study Treatment|1
5938722|NCT01358175|20540060|P1|Overall Study|Non Compliance with Study Treatment|0
5938723|NCT01358175|20540058|P3|Overall Study|Physician Decision|0
5938724|NCT01358175|20540059|P2|Overall Study|Physician Decision|0
5938725|NCT01358175|20540060|P1|Overall Study|Physician Decision|1
5938726|NCT01358175|20540058|P3|Overall Study|Pregnancy|0
5938727|NCT01358175|20540059|P2|Overall Study|Pregnancy|1
5938728|NCT01358175|20540060|P1|Overall Study|Pregnancy|0
5938729|NCT01358175|20540058|P3|Overall Study|Technical issues|0
5938730|NCT01358175|20540059|P2|Overall Study|Technical issues|1
5938731|NCT01358175|20540060|P1|Overall Study|Technical issues|0
5938732|NCT01358175|20540058|P3|Overall Study|Withdrawal by Subject|10
5938733|NCT01358175|20540059|P2|Overall Study|Withdrawal by Subject|5
5938734|NCT01358175|20540060|P1|Overall Study|Withdrawal by Subject|9
5938735|NCT01358175|20540058|P3|Overall Study|Death|1
5938736|NCT01358175|20540059|P2|Overall Study|Death|0
5938737|NCT01358175|20540060|P1|Overall Study|Death|1
5938738|NCT01357980|20540097|P4|Overall Study|Consent withdrawn|0
5938739|NCT01357980|20540098|P3|Overall Study|Consent withdrawn|1
5938740|NCT01357980|20540099|P2|Overall Study|Consent withdrawn|0
5938741|NCT01357980|20540100|P1|Overall Study|Consent withdrawn|0
5938742|NCT01357980|20540097|P4|Overall Study|Lack of Efficacy|0
5938743|NCT01357980|20540098|P3|Overall Study|Lack of Efficacy|0
5938744|NCT01357980|20540099|P2|Overall Study|Lack of Efficacy|1
5938745|NCT01357980|20540100|P1|Overall Study|Lack of Efficacy|0
5938746|NCT01357915|20540144|P2|Overall Study|Lost to Follow-up|0
5938747|NCT01357915|20540145|P1|Overall Study|Lost to Follow-up|3
5938748|NCT01357889|20540163|P2|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|0
5938749|NCT01357889|20540164|P1|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|1
5938750|NCT01357889|20540163|P2|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|0
5938751|NCT01357889|20540164|P1|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|1
5938752|NCT01357889|20540163|P2|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|4
5938753|NCT01357889|20540164|P1|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|0
5938754|NCT01357889|20540163|P2|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|0
5938755|NCT01357889|20540164|P1|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|1
5938756|NCT01357889|20540163|P2|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7
5938757|NCT01357889|20540164|P1|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7
5938758|NCT01357889|20540163|P2|Multiple-dose Phase (MDP) (Overall)|Physician Decision|1
5938759|NCT01357889|20540164|P1|Multiple-dose Phase (MDP) (Overall)|Physician Decision|2
5938760|NCT01357889|20540163|P2|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|2
5938761|NCT01357889|20540164|P1|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|5
5938762|NCT01357889|20540163|P2|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|2
5938763|NCT01357889|20540164|P1|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|0
5938764|NCT01357889|20540163|P2|Multiple-dose Phase (MDP) (Overall)|Noncompliance|2
5938765|NCT01357889|20540164|P1|Multiple-dose Phase (MDP) (Overall)|Noncompliance|0
5938766|NCT01357889|20540163|P2|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2
5938767|NCT01357889|20540164|P1|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2
5938768|NCT01357889|20540163|P2|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|0
5938769|NCT01357889|20540164|P1|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|1
5938770|NCT01357889|20540163|P2|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1
5938771|NCT01357889|20540164|P1|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1
5938772|NCT01357889|20540163|P2|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|1
5938773|NCT01357889|20540164|P1|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|2
5938774|NCT01357850|20540208|P4|Overall Study|Lost to Follow-up|0
5938775|NCT01357850|20540209|P3|Overall Study|Lost to Follow-up|0
5938776|NCT01357850|20540210|P2|Overall Study|Lost to Follow-up|0
5938777|NCT01357850|20540211|P1|Overall Study|Lost to Follow-up|1
5938778|NCT01357655|20540302|P2|Overall Study|Subject Withdrew Consent|0
5938779|NCT01357655|20540303|P1|Overall Study|Subject Withdrew Consent|1
5938780|NCT01357655|20540302|P2|Overall Study|Study Drug Toxicity|0
5938781|NCT01357655|20540303|P1|Overall Study|Study Drug Toxicity|11
5938782|NCT01357655|20540302|P2|Overall Study|Reason Unspecified|0
5938783|NCT01357655|20540303|P1|Overall Study|Reason Unspecified|1
5938784|NCT01357655|20540302|P2|Overall Study|Maximum Clinical Benefit|0
5938785|NCT01357655|20540303|P1|Overall Study|Maximum Clinical Benefit|2
5938786|NCT01357655|20540302|P2|Overall Study|Lost to Follow-up|0
5938787|NCT01357655|20540303|P1|Overall Study|Lost to Follow-up|2
5938788|NCT01357655|20540302|P2|Overall Study|Disease Progression|0
5938789|NCT01357655|20540303|P1|Overall Study|Disease Progression|1
5938790|NCT01357655|20540302|P2|Overall Study|Adverse Event Unrelated to Study Drug|0
5938791|NCT01357655|20540303|P1|Overall Study|Adverse Event Unrelated to Study Drug|3
5938792|NCT01357655|20540302|P2|Overall Study|Administrative Reason by Sponsor|0
5938793|NCT01357655|20540303|P1|Overall Study|Administrative Reason by Sponsor|45
5938794|NCT01357616|20540320|P2|Overall Study|Withdrawal by Subject|0
5938795|NCT01357616|20540321|P1|Overall Study|Withdrawal by Subject|1
5938796|NCT01357616|20540320|P2|Overall Study|Decision Unrelated to Adverse Event|1
5938797|NCT01357616|20540321|P1|Overall Study|Decision Unrelated to Adverse Event|3
5938798|NCT01357616|20540320|P2|Overall Study|Inadequate Control of IOP|2
5938799|NCT01357616|20540321|P1|Overall Study|Inadequate Control of IOP|1
5938800|NCT01357616|20540320|P2|Overall Study|Protocol Violation|2
5938801|NCT01357616|20540321|P1|Overall Study|Protocol Violation|0
5938802|NCT01357616|20540320|P2|Overall Study|Lost to Follow-up|3
5938803|NCT01357616|20540321|P1|Overall Study|Lost to Follow-up|4
5938804|NCT01357616|20540320|P2|Overall Study|Adverse Event|1
5938805|NCT01357616|20540321|P1|Overall Study|Adverse Event|1
5938806|NCT01357577|20540335|P2|Overall Study|look at data in database?|2
5938807|NCT01357577|20540336|P1|Overall Study|look at data in database?|1
5938808|NCT01357577|20540335|P2|Overall Study|Withdrawal by Subject|8
5938809|NCT01357577|20540336|P1|Overall Study|Withdrawal by Subject|16
5938810|NCT01357577|20540335|P2|Overall Study|Lost to Follow-up|16
5938811|NCT01357577|20540336|P1|Overall Study|Lost to Follow-up|20
5938812|NCT01357551|20540363|P2|Overall Study|Lost to Follow-up|6
5938813|NCT01357551|20540364|P1|Overall Study|Lost to Follow-up|16
5938814|NCT01357551|20540363|P2|Overall Study|Death|1
5938815|NCT01357551|20540364|P1|Overall Study|Death|0
5938816|NCT01357551|20540363|P2|Overall Study|Withdrawal by Subject|4
5938817|NCT01357551|20540364|P1|Overall Study|Withdrawal by Subject|6
5938818|NCT01357239|20540412|P4|Stratum II: Partially-Methylated|Subject withdrew consent|1
5938819|NCT01357239|20540413|P3|Stratum II: Partially-Methylated|Subject withdrew consent|1
5938820|NCT01357239|20540414|P2|Stratum II: Partially-Methylated|Subject withdrew consent|0
5938821|NCT01357239|20540415|P1|Stratum II: Partially-Methylated|Subject withdrew consent|0
5938822|NCT01357239|20540412|P4|Stratum II: Partially-Methylated|Adverse Event|1
5938823|NCT01357239|20540413|P3|Stratum II: Partially-Methylated|Adverse Event|0
5938824|NCT01357239|20540414|P2|Stratum II: Partially-Methylated|Adverse Event|0
5938825|NCT01357239|20540415|P1|Stratum II: Partially-Methylated|Adverse Event|0
5938826|NCT01357239|20540412|P4|Stratum I: Fully-Methylated|Adverse Event|0
5938827|NCT01357239|20540413|P3|Stratum I: Fully-Methylated|Adverse Event|1
5938828|NCT01357239|20540414|P2|Stratum I: Fully-Methylated|Adverse Event|0
5938829|NCT01357239|20540415|P1|Stratum I: Fully-Methylated|Adverse Event|0
5938830|NCT01357239|20540412|P4|Stratum: All Patients|Subject withdrew consent|1
5938831|NCT01357239|20540413|P3|Stratum: All Patients|Subject withdrew consent|1
5938832|NCT01357239|20540414|P2|Stratum: All Patients|Subject withdrew consent|0
5938833|NCT01357239|20540415|P1|Stratum: All Patients|Subject withdrew consent|0
5938834|NCT01357239|20540412|P4|Stratum: All Patients|Adverse Event|1
5938835|NCT01357239|20540413|P3|Stratum: All Patients|Adverse Event|1
5938836|NCT01357239|20540414|P2|Stratum: All Patients|Adverse Event|0
5938837|NCT01357239|20540415|P1|Stratum: All Patients|Adverse Event|0
5938838|NCT01357161|20540473|P3|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|4
5938839|NCT01357161|20540474|P2|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|5
5938840|NCT01357161|20540475|P1|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|0
5938841|NCT01357161|20540473|P3|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|26
5938842|NCT01357161|20540474|P2|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|29
5938843|NCT01357161|20540475|P1|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|0
5938844|NCT01357161|20540473|P3|Part 2 (Double-Blind Comparison)|Progressive Disease|3
5938845|NCT01357161|20540474|P2|Part 2 (Double-Blind Comparison)|Progressive Disease|1
5938846|NCT01357161|20540475|P1|Part 2 (Double-Blind Comparison)|Progressive Disease|0
5938847|NCT01357161|20540473|P3|Part 2 (Double-Blind Comparison)|Physician Decision|4
5938848|NCT01357161|20540474|P2|Part 2 (Double-Blind Comparison)|Physician Decision|1
5938849|NCT01357161|20540475|P1|Part 2 (Double-Blind Comparison)|Physician Decision|0
5938850|NCT01357161|20540473|P3|Part 2 (Double-Blind Comparison)|Lost to Follow-up|6
5938851|NCT01357161|20540474|P2|Part 2 (Double-Blind Comparison)|Lost to Follow-up|1
5938852|NCT01357161|20540475|P1|Part 2 (Double-Blind Comparison)|Lost to Follow-up|0
5938853|NCT01357161|20540473|P3|Part 2 (Double-Blind Comparison)|Death|19
5938854|NCT01357161|20540474|P2|Part 2 (Double-Blind Comparison)|Death|22
5938855|NCT01357161|20540475|P1|Part 2 (Double-Blind Comparison)|Death|0
5938856|NCT01357161|20540473|P3|Part 1 (Open Label Run-in)|Withdrawal by Subject|0
5938857|NCT01357161|20540474|P2|Part 1 (Open Label Run-in)|Withdrawal by Subject|0
5938858|NCT01357161|20540475|P1|Part 1 (Open Label Run-in)|Withdrawal by Subject|1
5938859|NCT01357161|20540473|P3|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0
5938860|NCT01357161|20540474|P2|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0
5938861|NCT01357161|20540475|P1|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|5
5938862|NCT01357161|20540473|P3|Part 1 (Open Label Run-in)|Physician Decision|0
5938863|NCT01357161|20540474|P2|Part 1 (Open Label Run-in)|Physician Decision|0
5938864|NCT01357161|20540475|P1|Part 1 (Open Label Run-in)|Physician Decision|1
5938865|NCT01357161|20540473|P3|Part 1 (Open Label Run-in)|Lost to Follow-up|0
5938866|NCT01357161|20540474|P2|Part 1 (Open Label Run-in)|Lost to Follow-up|0
5938867|NCT01357161|20540475|P1|Part 1 (Open Label Run-in)|Lost to Follow-up|3
5938868|NCT01357161|20540473|P3|Part 1 (Open Label Run-in)|Death|0
5938869|NCT01357161|20540474|P2|Part 1 (Open Label Run-in)|Death|0
5938870|NCT01357161|20540475|P1|Part 1 (Open Label Run-in)|Death|5
5938871|NCT01356966|20540527|P2|Overall Study|Physician Decision|0
5938872|NCT01356966|20540528|P1|Overall Study|Physician Decision|1
5938873|NCT01356966|20540527|P2|Overall Study|Withdrawal by Subject|2
5938874|NCT01356966|20540528|P1|Overall Study|Withdrawal by Subject|1
5938875|NCT01356940|20540540|P2|Second Intervention (28 Days)|Withdrawal by Subject|0
5938876|NCT01356940|20540541|P1|Second Intervention (28 Days)|Withdrawal by Subject|1
5938877|NCT01356940|20540540|P2|First Intervention (28 Days)|Adverse Event|0
5938878|NCT01356940|20540541|P1|First Intervention (28 Days)|Adverse Event|1
5938879|NCT01356602|20540570|P3|Overall Study|Adverse Event|1
5938880|NCT01356602|20540571|P2|Overall Study|Adverse Event|1
5938881|NCT01356602|20540572|P1|Overall Study|Adverse Event|0
5938882|NCT01356602|20540570|P3|Overall Study|Lack of Efficacy|4
5938883|NCT01356602|20540571|P2|Overall Study|Lack of Efficacy|1
5938884|NCT01356602|20540572|P1|Overall Study|Lack of Efficacy|0
5938885|NCT01356602|20540570|P3|Overall Study|Withdrawal by Subject|7
5938886|NCT01356602|20540571|P2|Overall Study|Withdrawal by Subject|3
5938887|NCT01356602|20540572|P1|Overall Study|Withdrawal by Subject|4
5938888|NCT01356602|20540570|P3|Overall Study|Lost to Follow-up|6
5938889|NCT01356602|20540571|P2|Overall Study|Lost to Follow-up|5
5938890|NCT01356602|20540572|P1|Overall Study|Lost to Follow-up|4
5938891|NCT01356602|20540570|P3|Overall Study|Administrative Problems|5
5938892|NCT01356602|20540571|P2|Overall Study|Administrative Problems|4
5938893|NCT01356602|20540572|P1|Overall Study|Administrative Problems|1
5938894|NCT01356602|20540570|P3|Overall Study|Protocol Deviation|1
5938895|NCT01356602|20540571|P2|Overall Study|Protocol Deviation|1
5938896|NCT01356602|20540572|P1|Overall Study|Protocol Deviation|0
5938897|NCT01356589|20540631|P1|Overall Study|Dose data not recorded|2
5938898|NCT01356589|20540631|P1|Overall Study|Enrolled, but not treated|3
5938899|NCT01356407|20540688|P2|Overall Study|Not complete Endoscopy|2
5938900|NCT01356407|20540689|P1|Overall Study|Not complete Endoscopy|2
5938901|NCT01356407|20540688|P2|Overall Study|Could not afford IMP administration|1
5938902|NCT01356407|20540689|P1|Overall Study|Could not afford IMP administration|0
5938903|NCT01356407|20540688|P2|Overall Study|Patient Withdrew Consent|1
5938904|NCT01356407|20540689|P1|Overall Study|Patient Withdrew Consent|2
5938905|NCT01356407|20540688|P2|Overall Study|Lost to Follow-up|0
5938906|NCT01356407|20540689|P1|Overall Study|Lost to Follow-up|2
5938907|NCT01355679|20540761|P1|Overall Study|benign tumor types found at biopsy|2
5938908|NCT01355627|20540770|P2|Overall Study|Other|1
5938909|NCT01355627|20540771|P1|Overall Study|Other|1
5938910|NCT01355627|20540770|P2|Overall Study|Fatal Adverse Event|23
5938911|NCT01355627|20540771|P1|Overall Study|Fatal Adverse Event|19
5938912|NCT01355627|20540770|P2|Overall Study|Lost to Follow-up|7
5938913|NCT01355627|20540771|P1|Overall Study|Lost to Follow-up|8
5938914|NCT01355627|20540770|P2|Overall Study|Request By the Patient to Discontinue|7
5938915|NCT01355627|20540771|P1|Overall Study|Request By the Patient to Discontinue|5
5938916|NCT01355575|20540808|P1|Overall Study|Withdrawal by Subject|2
5938917|NCT01355523|20540820|P2|Overall Study|Adverse Event|2
5938918|NCT01355523|20540821|P1|Overall Study|Adverse Event|0
5938919|NCT01355523|20540820|P2|Overall Study|Protocol Violation|2
5938920|NCT01355523|20540821|P1|Overall Study|Protocol Violation|0
5938921|NCT01355523|20540820|P2|Overall Study|Lost to Follow-up|2
5938922|NCT01355523|20540821|P1|Overall Study|Lost to Follow-up|0
5938923|NCT01355523|20540820|P2|Overall Study|Withdrawal by Subject|4
5938924|NCT01355523|20540821|P1|Overall Study|Withdrawal by Subject|1
5938925|NCT01355497|20540865|P2|Overall Study|Adverse Event|10
5938926|NCT01355497|20540866|P1|Overall Study|Adverse Event|11
5938927|NCT01355497|20540865|P2|Overall Study|progressive disease|8
5938928|NCT01355497|20540866|P1|Overall Study|progressive disease|11
5938929|NCT01355497|20540865|P2|Overall Study|noncompliance|2
5938930|NCT01355497|20540866|P1|Overall Study|noncompliance|1
5938931|NCT01355497|20540865|P2|Overall Study|Withdrawal by Subject|20
5938932|NCT01355497|20540866|P1|Overall Study|Withdrawal by Subject|12
5938933|NCT01355497|20540865|P2|Overall Study|other-not provided|4
5938934|NCT01355497|20540866|P1|Overall Study|other-not provided|9
5938935|NCT01355497|20540865|P2|Overall Study|Protocol Violation|1
5938936|NCT01355497|20540866|P1|Overall Study|Protocol Violation|0
5938937|NCT01355497|20540865|P2|Overall Study|Lost to Follow-up|0
5938938|NCT01355497|20540866|P1|Overall Study|Lost to Follow-up|3
5938939|NCT01355497|20540865|P2|Overall Study|Death|18
5938940|NCT01355497|20540866|P1|Overall Study|Death|19
5938941|NCT01355302|20540908|P3|Phase 1b|Study terminated by sponsor|0
5938942|NCT01355302|20540909|P2|Phase 1b|Study terminated by sponsor|0
5938943|NCT01355302|20540910|P1|Phase 1b|Study terminated by sponsor|2
5938944|NCT01355302|20540908|P3|Phase 1b|Death|0
5938945|NCT01355302|20540909|P2|Phase 1b|Death|0
5938946|NCT01355302|20540910|P1|Phase 1b|Death|4
5938947|NCT01355289|20540925|P5|Open Label Extension|Other|3
5938948|NCT01355289|20540926|P4|Open Label Extension|Other|0
5938949|NCT01355289|20540927|P3|Open Label Extension|Other|0
5938950|NCT01355289|20540928|P2|Open Label Extension|Other|0
5938951|NCT01355289|20540929|P1|Open Label Extension|Other|0
5938952|NCT01355289|20540925|P5|Open Label Extension|Inadequate Therapeutic Effect|29
5938953|NCT01355289|20540926|P4|Open Label Extension|Inadequate Therapeutic Effect|0
5938954|NCT01355289|20540927|P3|Open Label Extension|Inadequate Therapeutic Effect|0
5938955|NCT01355289|20540928|P2|Open Label Extension|Inadequate Therapeutic Effect|0
5938956|NCT01355289|20540929|P1|Open Label Extension|Inadequate Therapeutic Effect|0
5938957|NCT01355289|20540925|P5|Open Label Extension|Lost to Follow-up|1
5938958|NCT01355289|20540926|P4|Open Label Extension|Lost to Follow-up|0
5938959|NCT01355289|20540927|P3|Open Label Extension|Lost to Follow-up|0
5938960|NCT01355289|20540928|P2|Open Label Extension|Lost to Follow-up|0
5938961|NCT01355289|20540929|P1|Open Label Extension|Lost to Follow-up|0
5938962|NCT01355289|20540925|P5|Open Label Extension|Adverse Event, Non-Fatal|1
5938963|NCT01355289|20540926|P4|Open Label Extension|Adverse Event, Non-Fatal|0
5938964|NCT01355289|20540927|P3|Open Label Extension|Adverse Event, Non-Fatal|0
5938965|NCT01355289|20540928|P2|Open Label Extension|Adverse Event, Non-Fatal|0
5938966|NCT01355289|20540929|P1|Open Label Extension|Adverse Event, Non-Fatal|0
5938967|NCT01355289|20540925|P5|Core Study|Other|0
5938968|NCT01355289|20540926|P4|Core Study|Other|1
5938969|NCT01355289|20540927|P3|Core Study|Other|0
5938970|NCT01355289|20540928|P2|Core Study|Other|0
5938971|NCT01355289|20540929|P1|Core Study|Other|0
5938972|NCT01355289|20540925|P5|Core Study|Inadequate Therapeutic Effect|0
5938973|NCT01355289|20540926|P4|Core Study|Inadequate Therapeutic Effect|1
5938974|NCT01355289|20540927|P3|Core Study|Inadequate Therapeutic Effect|0
5938975|NCT01355289|20540928|P2|Core Study|Inadequate Therapeutic Effect|0
5938976|NCT01355289|20540929|P1|Core Study|Inadequate Therapeutic Effect|0
5938977|NCT01355289|20540925|P5|Core Study|Adverse Event, Non-Fatal|0
5938978|NCT01355289|20540926|P4|Core Study|Adverse Event, Non-Fatal|0
5938979|NCT01355289|20540927|P3|Core Study|Adverse Event, Non-Fatal|0
5938980|NCT01355289|20540928|P2|Core Study|Adverse Event, Non-Fatal|0
5938981|NCT01355289|20540929|P1|Core Study|Adverse Event, Non-Fatal|1
5938982|NCT01355159|20540981|P2|Overall Study|Early intrauterine fetal death|6
5938983|NCT01355159|20540982|P1|Overall Study|Early intrauterine fetal death|6
5938984|NCT01355159|20540981|P2|Overall Study|Spontaneous abortion (<20 weeks)|15
5938985|NCT01355159|20540982|P1|Overall Study|Spontaneous abortion (<20 weeks)|22
5938986|NCT01355159|20540981|P2|Overall Study|No primary outcome data|11
5938987|NCT01355159|20540982|P1|Overall Study|No primary outcome data|17
5938988|NCT01355159|20540981|P2|Overall Study|Withdrew consent|47
5938989|NCT01355159|20540982|P1|Overall Study|Withdrew consent|39
5938990|NCT01355081|20541039|P3|Overall Study|Non Compliance with Study Medication|0
5938991|NCT01355081|20541040|P2|Overall Study|Non Compliance with Study Medication|1
5938992|NCT01355081|20541041|P1|Overall Study|Non Compliance with Study Medication|0
5938993|NCT01355081|20541039|P3|Overall Study|Lack of Efficacy|1
5938994|NCT01355081|20541040|P2|Overall Study|Lack of Efficacy|1
5938995|NCT01355081|20541041|P1|Overall Study|Lack of Efficacy|2
5938996|NCT01355081|20541039|P3|Overall Study|Withdrawal of Consent|3
5938997|NCT01355081|20541040|P2|Overall Study|Withdrawal of Consent|3
5938998|NCT01355081|20541041|P1|Overall Study|Withdrawal of Consent|2
5938999|NCT01355081|20541039|P3|Overall Study|Lost to Follow-up|1
5939000|NCT01355081|20541040|P2|Overall Study|Lost to Follow-up|0
5939001|NCT01355081|20541041|P1|Overall Study|Lost to Follow-up|0
5939002|NCT01355081|20541039|P3|Overall Study|Major Protocol Deviation|0
5939003|NCT01355081|20541040|P2|Overall Study|Major Protocol Deviation|1
5939004|NCT01355081|20541041|P1|Overall Study|Major Protocol Deviation|0
5939005|NCT01355081|20541039|P3|Overall Study|Pretreatment Event or Adverse Event|6
5939006|NCT01355081|20541040|P2|Overall Study|Pretreatment Event or Adverse Event|4
5939007|NCT01355081|20541041|P1|Overall Study|Pretreatment Event or Adverse Event|3
5939008|NCT01354964|20541073|P2|Overall Study|Physician Decision|0
5939009|NCT01354964|20541074|P1|Overall Study|Physician Decision|1
5939010|NCT01354964|20541073|P2|Overall Study|IV access issues|1
5939011|NCT01354964|20541074|P1|Overall Study|IV access issues|1
5939012|NCT01354964|20541073|P2|Overall Study|Lost to Follow-up|0
5939013|NCT01354964|20541074|P1|Overall Study|Lost to Follow-up|2
5939014|NCT01354938|20541097|P1|Overall Study|Lost to Follow-up|1
5939015|NCT01354899|20541103|P1|Overall Study|Protocol Violation|1
5939016|NCT01354899|20541103|P1|Overall Study|discharge from the hospital|2
5939017|NCT01354496|20541155|P6|Washout (at Least 14 Days)|Scheduling Conflict|0
5939018|NCT01354496|20541156|P5|Washout (at Least 14 Days)|Scheduling Conflict|0
5939019|NCT01354496|20541157|P4|Washout (at Least 14 Days)|Scheduling Conflict|1
5939020|NCT01354496|20541158|P3|Washout (at Least 14 Days)|Scheduling Conflict|0
5939021|NCT01354496|20541159|P2|Washout (at Least 14 Days)|Scheduling Conflict|1
5939022|NCT01354496|20541160|P1|Washout (at Least 14 Days)|Scheduling Conflict|0
5939023|NCT01354496|20541155|P6|Period 2|Adverse Event|0
5939024|NCT01354496|20541156|P5|Period 2|Adverse Event|0
5939025|NCT01354496|20541157|P4|Period 2|Adverse Event|1
5939026|NCT01354496|20541158|P3|Period 2|Adverse Event|0
5939027|NCT01354496|20541159|P2|Period 2|Adverse Event|0
5939028|NCT01354496|20541160|P1|Period 2|Adverse Event|0
5939029|NCT01354496|20541155|P6|Period 1|Physician Decision|0
5939030|NCT01354496|20541156|P5|Period 1|Physician Decision|0
5939031|NCT01354496|20541157|P4|Period 1|Physician Decision|0
5939032|NCT01354496|20541158|P3|Period 1|Physician Decision|1
5939033|NCT01354496|20541159|P2|Period 1|Physician Decision|0
5939034|NCT01354496|20541160|P1|Period 1|Physician Decision|0
5939035|NCT01354496|20541155|P6|Period 1|Adverse Event|0
5939036|NCT01354496|20541156|P5|Period 1|Adverse Event|0
5939037|NCT01354496|20541157|P4|Period 1|Adverse Event|0
5939038|NCT01354496|20541158|P3|Period 1|Adverse Event|1
5939039|NCT01354496|20541159|P2|Period 1|Adverse Event|0
5939040|NCT01354496|20541160|P1|Period 1|Adverse Event|0
5939041|NCT01354431|20541203|P3|Participants Treated|Withdrawal by Subject|1
5939042|NCT01354431|20541204|P2|Participants Treated|Withdrawal by Subject|2
5939043|NCT01354431|20541205|P1|Participants Treated|Withdrawal by Subject|1
5939044|NCT01354431|20541203|P3|Participants Treated|Adverse Event|4
5939045|NCT01354431|20541204|P2|Participants Treated|Adverse Event|2
5939046|NCT01354431|20541205|P1|Participants Treated|Adverse Event|1
5939047|NCT01354431|20541203|P3|Participants Treated|Death|0
5939048|NCT01354431|20541204|P2|Participants Treated|Death|1
5939049|NCT01354431|20541205|P1|Participants Treated|Death|0
5939050|NCT01354431|20541203|P3|Participants Treated|Study Drug Toxicity|4
5939051|NCT01354431|20541204|P2|Participants Treated|Study Drug Toxicity|7
5939052|NCT01354431|20541205|P1|Participants Treated|Study Drug Toxicity|2
5939053|NCT01354431|20541203|P3|Participants Treated|Disease Progression|41
5939054|NCT01354431|20541204|P2|Participants Treated|Disease Progression|40
5939055|NCT01354431|20541205|P1|Participants Treated|Disease Progression|49
5939056|NCT01354431|20541203|P3|Participants Treated|Continuing Treatment|4
5939057|NCT01354431|20541204|P2|Participants Treated|Continuing Treatment|2
5939058|NCT01354431|20541205|P1|Participants Treated|Continuing Treatment|6
5939059|NCT01354431|20541203|P3|Randomized to Enter Treatment Period|No longer met criteria|0
5939060|NCT01354431|20541204|P2|Randomized to Enter Treatment Period|No longer met criteria|0
5939061|NCT01354431|20541205|P1|Randomized to Enter Treatment Period|No longer met criteria|1
5939062|NCT01354314|20541229|P4|Overall Study|Less than 90% Adherence|4
5939063|NCT01354314|20541230|P3|Overall Study|Less than 90% Adherence|6
5939064|NCT01354314|20541231|P2|Overall Study|Less than 90% Adherence|2
5939065|NCT01354314|20541232|P1|Overall Study|Less than 90% Adherence|4
5939066|NCT01354314|20541229|P4|Overall Study|Protocol Violation|0
5939067|NCT01354314|20541230|P3|Overall Study|Protocol Violation|0
5939068|NCT01354314|20541231|P2|Overall Study|Protocol Violation|1
5939069|NCT01354314|20541232|P1|Overall Study|Protocol Violation|1
5939070|NCT01354314|20541229|P4|Overall Study|Adverse Event|1
5939071|NCT01354314|20541230|P3|Overall Study|Adverse Event|0
5939072|NCT01354314|20541231|P2|Overall Study|Adverse Event|0
5939073|NCT01354314|20541232|P1|Overall Study|Adverse Event|0
5939074|NCT01354314|20541229|P4|Overall Study|Withdrawal by Subject|0
5939075|NCT01354314|20541230|P3|Overall Study|Withdrawal by Subject|1
5939076|NCT01354314|20541231|P2|Overall Study|Withdrawal by Subject|0
5939077|NCT01354314|20541232|P1|Overall Study|Withdrawal by Subject|0
5939078|NCT01354314|20541229|P4|Overall Study|Lost to Follow-up|1
5939079|NCT01354314|20541230|P3|Overall Study|Lost to Follow-up|1
5939080|NCT01354314|20541231|P2|Overall Study|Lost to Follow-up|0
5939081|NCT01354314|20541232|P1|Overall Study|Lost to Follow-up|1
5939082|NCT01354223|20541368|P2|Overall Study|Withdrawal by Subject|1
5939083|NCT01354223|20541369|P1|Overall Study|Withdrawal by Subject|3
5939084|NCT01354132|20541428|P2|1 Month Post Study Medication|Withdrawal by Subject|3
5939085|NCT01354132|20541429|P1|1 Month Post Study Medication|Withdrawal by Subject|1
5939086|NCT01354132|20541428|P2|Double Blind (Visits 1-7)|Withdrawal by Subject|11
5939087|NCT01354132|20541429|P1|Double Blind (Visits 1-7)|Withdrawal by Subject|8
5939088|NCT01354132|20541428|P2|Double Blind (Visits 1-7)|Adverse Event|0
5939089|NCT01354132|20541429|P1|Double Blind (Visits 1-7)|Adverse Event|1
5939090|NCT01354132|20541428|P2|Randomization|Withdrawal by Subject|1
5939091|NCT01354132|20541429|P1|Randomization|Withdrawal by Subject|0
5939092|NCT01354132|20541428|P2|Randomization|Physician Decision|0
5939093|NCT01354132|20541429|P1|Randomization|Physician Decision|1
5939094|NCT01354106|20541467|P1|Overall Study|Withdrawal by Subject|2
5939095|NCT01354028|20541473|P2|Overall Study|No quiet alert state|1
5939096|NCT01354028|20541474|P1|Overall Study|No quiet alert state|0
5939097|NCT01354028|20541473|P2|Overall Study|Discharged before study start|2
5939098|NCT01354028|20541474|P1|Overall Study|Discharged before study start|2
5939099|NCT01354028|20541473|P2|Overall Study|Physician Decision|2
5939100|NCT01354028|20541474|P1|Overall Study|Physician Decision|0
5939101|NCT01353963|20541510|P1|Overall Study|Adverse Event|2
5939102|NCT01353911|20541528|P8|Overall Study|Status Not Recorded|0
5939103|NCT01353911|20541529|P7|Overall Study|Status Not Recorded|0
5939104|NCT01353911|20541530|P6|Overall Study|Status Not Recorded|0
5939105|NCT01353911|20541531|P5|Overall Study|Status Not Recorded|0
5939106|NCT01353911|20541532|P4|Overall Study|Status Not Recorded|0
5939107|NCT01353911|20541533|P3|Overall Study|Status Not Recorded|1
5939108|NCT01353911|20541534|P2|Overall Study|Status Not Recorded|0
5939109|NCT01353911|20541535|P1|Overall Study|Status Not Recorded|4
5939110|NCT01353911|20541528|P8|Overall Study|Withdrawal by Subject|9
5939111|NCT01353911|20541529|P7|Overall Study|Withdrawal by Subject|3
5939112|NCT01353911|20541530|P6|Overall Study|Withdrawal by Subject|3
5939113|NCT01353911|20541531|P5|Overall Study|Withdrawal by Subject|2
5939114|NCT01353911|20541532|P4|Overall Study|Withdrawal by Subject|2
5939115|NCT01353911|20541533|P3|Overall Study|Withdrawal by Subject|4
5939116|NCT01353911|20541534|P2|Overall Study|Withdrawal by Subject|3
5939117|NCT01353911|20541535|P1|Overall Study|Withdrawal by Subject|2
5939118|NCT01353911|20541528|P8|Overall Study|Lost to Follow-up|6
5939119|NCT01353911|20541529|P7|Overall Study|Lost to Follow-up|3
5939120|NCT01353911|20541530|P6|Overall Study|Lost to Follow-up|4
5939121|NCT01353911|20541531|P5|Overall Study|Lost to Follow-up|4
5939122|NCT01353911|20541532|P4|Overall Study|Lost to Follow-up|0
5939123|NCT01353911|20541533|P3|Overall Study|Lost to Follow-up|4
5939124|NCT01353911|20541534|P2|Overall Study|Lost to Follow-up|6
5939125|NCT01353911|20541535|P1|Overall Study|Lost to Follow-up|2
5939126|NCT01353898|20541615|P6|Overall Study|Study site terminated|1
5939127|NCT01353898|20541616|P5|Overall Study|Study site terminated|0
5939128|NCT01353898|20541617|P4|Overall Study|Study site terminated|0
5939129|NCT01353898|20541618|P3|Overall Study|Study site terminated|0
5939130|NCT01353898|20541619|P2|Overall Study|Study site terminated|0
5939131|NCT01353898|20541620|P1|Overall Study|Study site terminated|0
5939132|NCT01353859|20541646|P1|Overall Study|Lack of Efficacy|1
5939133|NCT01353859|20541646|P1|Overall Study|Adverse Event|3
5939134|NCT01353703|20541661|P2|Overall Study|Migrated/moved from study area|0
5939135|NCT01353703|20541662|P1|Overall Study|Migrated/moved from study area|1
5939136|NCT01353664|20541708|P1|Overall Study|Disease Progression|16
5939137|NCT01353664|20541708|P1|Overall Study|Other|3
5939138|NCT01353586|20541714|P2|Overall Study|Neurological exam not done|1
5939139|NCT01353586|20541715|P1|Overall Study|Neurological exam not done|0
5939140|NCT01353586|20541714|P2|Overall Study|Never had insertion of study catheter|1
5939141|NCT01353586|20541715|P1|Overall Study|Never had insertion of study catheter|4
5939142|NCT01353586|20541714|P2|Overall Study|Procedure terminated prior to ablation|0
5939143|NCT01353586|20541715|P1|Overall Study|Procedure terminated prior to ablation|3
5939144|NCT01353508|20541733|P4|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0
5939145|NCT01353508|20541734|P3|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0
5939146|NCT01353508|20541735|P2|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0
5939147|NCT01353508|20541736|P1|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|1
5939148|NCT01353508|20541733|P4|Period 1 - First Intervention (7 Days)|Adverse Event|1
5939149|NCT01353508|20541734|P3|Period 1 - First Intervention (7 Days)|Adverse Event|0
5939150|NCT01353508|20541735|P2|Period 1 - First Intervention (7 Days)|Adverse Event|0
5939151|NCT01353508|20541736|P1|Period 1 - First Intervention (7 Days)|Adverse Event|0
5939152|NCT01353274|20541814|P1|Overall Study|No case report form (CRF) collected|28
5939153|NCT01353222|20541824|P2|Overall Study|Site closed research department|0
5939154|NCT01353222|20541825|P1|Overall Study|Site closed research department|1
5939155|NCT01353222|20541824|P2|Overall Study|Study Terminated|37
5939156|NCT01353222|20541825|P1|Overall Study|Study Terminated|31
5939157|NCT01353222|20541824|P2|Overall Study|Withdrawal by Subject|5
5939158|NCT01353222|20541825|P1|Overall Study|Withdrawal by Subject|8
5939159|NCT01353222|20541824|P2|Overall Study|Death|30
5939160|NCT01353222|20541825|P1|Overall Study|Death|30
5939161|NCT01352845|20541868|P2|Overall Study|Death|0
5939162|NCT01352845|20541869|P1|Overall Study|Death|3
5939163|NCT01352845|20541868|P2|Overall Study|Protocol Violation|6
5939164|NCT01352845|20541869|P1|Overall Study|Protocol Violation|12
5939165|NCT01352845|20541868|P2|Overall Study|Other|7
5939166|NCT01352845|20541869|P1|Overall Study|Other|17
5939167|NCT01352845|20541868|P2|Overall Study|Adverse Event|6
5939168|NCT01352845|20541869|P1|Overall Study|Adverse Event|22
5939169|NCT01352845|20541868|P2|Overall Study|Pregnancy|7
5939170|NCT01352845|20541869|P1|Overall Study|Pregnancy|27
5939171|NCT01352845|20541868|P2|Overall Study|No Longer Meets Eligibility Criteria|11
5939172|NCT01352845|20541869|P1|Overall Study|No Longer Meets Eligibility Criteria|24
5939173|NCT01352845|20541868|P2|Overall Study|Withdrawal by Subject|16
5939174|NCT01352845|20541869|P1|Overall Study|Withdrawal by Subject|48
5939175|NCT01352845|20541868|P2|Overall Study|No Longer Willing to Participate|58
5939176|NCT01352845|20541869|P1|Overall Study|No Longer Willing to Participate|205
5939177|NCT01352845|20541868|P2|Overall Study|Lost to Follow-up|92
5939178|NCT01352845|20541869|P1|Overall Study|Lost to Follow-up|313
5939179|NCT01352793|20541958|P2|Overall Study|No longer meets eligibility criteria|15
5939180|NCT01352793|20541959|P1|Overall Study|No longer meets eligibility criteria|25
5939181|NCT01352793|20541958|P2|Overall Study|Randomized but not vaccinated|0
5939182|NCT01352793|20541959|P1|Overall Study|Randomized but not vaccinated|8
5939183|NCT01352793|20541958|P2|Overall Study|Death|0
5939184|NCT01352793|20541959|P1|Overall Study|Death|1
5939185|NCT01352793|20541958|P2|Overall Study|Medication error|2
5939186|NCT01352793|20541959|P1|Overall Study|Medication error|2
5939187|NCT01352793|20541958|P2|Overall Study|Other|7
5939188|NCT01352793|20541959|P1|Overall Study|Other|25
5939189|NCT01352793|20541958|P2|Overall Study|Pregnancy|8
5939190|NCT01352793|20541959|P1|Overall Study|Pregnancy|26
5939191|NCT01352793|20541958|P2|Overall Study|Physician Decision|0
5939192|NCT01352793|20541959|P1|Overall Study|Physician Decision|1
5939193|NCT01352793|20541958|P2|Overall Study|Adverse Event|10
5939194|NCT01352793|20541959|P1|Overall Study|Adverse Event|44
5939195|NCT01352793|20541958|P2|Overall Study|Protocol Violation|23
5939196|NCT01352793|20541959|P1|Overall Study|Protocol Violation|44
5939197|NCT01352793|20541958|P2|Overall Study|Withdrawal by Subject|55
5939198|NCT01352793|20541959|P1|Overall Study|Withdrawal by Subject|120
5939199|NCT01352793|20541958|P2|Overall Study|Lost to Follow-up|125
5939200|NCT01352793|20541959|P1|Overall Study|Lost to Follow-up|289
5939201|NCT01352741|20541983|P2|Open-Label Tapentadol Continuation Arm|Protocol Violation|0
5939202|NCT01352741|20541984|P1|Open-Label Tapentadol Continuation Arm|Protocol Violation|1
5939203|NCT01352741|20541983|P2|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|0
5939204|NCT01352741|20541984|P1|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|2
5939205|NCT01352741|20541983|P2|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|0
5939206|NCT01352741|20541984|P1|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|1
5939207|NCT01352741|20541983|P2|Open-Label Tapentadol Continuation Arm|Adverse Event|0
5939208|NCT01352741|20541984|P1|Open-Label Tapentadol Continuation Arm|Adverse Event|4
5939209|NCT01352741|20541983|P2|Double-blind Comparative Period|Other|2
5939210|NCT01352741|20541984|P1|Double-blind Comparative Period|Other|1
5939211|NCT01352741|20541983|P2|Double-blind Comparative Period|Withdrawal of consent|3
5939212|NCT01352741|20541984|P1|Double-blind Comparative Period|Withdrawal of consent|8
5939213|NCT01352741|20541983|P2|Double-blind Comparative Period|Death|1
5939214|NCT01352741|20541984|P1|Double-blind Comparative Period|Death|0
5939215|NCT01352741|20541983|P2|Double-blind Comparative Period|Lost to Follow-up|0
5939216|NCT01352741|20541984|P1|Double-blind Comparative Period|Lost to Follow-up|1
5939217|NCT01352741|20541983|P2|Double-blind Comparative Period|Adverse Event|17
5939218|NCT01352741|20541984|P1|Double-blind Comparative Period|Adverse Event|16
5939219|NCT01352741|20541983|P2|Double-blind Comparative Period|Lack of Efficacy|3
5939220|NCT01352741|20541984|P1|Double-blind Comparative Period|Lack of Efficacy|0
5939221|NCT01352741|20541983|P2|Double-blind Comparative Period|Protocol Violation|0
5939222|NCT01352741|20541984|P1|Double-blind Comparative Period|Protocol Violation|2
5939223|NCT01352741|20541983|P2|Open-label Tapentadol Titration Period|Other|0
5939224|NCT01352741|20541984|P1|Open-label Tapentadol Titration Period|Other|4
5939225|NCT01352741|20541983|P2|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|0
5939226|NCT01352741|20541984|P1|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|5
5939227|NCT01352741|20541983|P2|Open-label Tapentadol Titration Period|Withdrawal of consent|0
5939228|NCT01352741|20541984|P1|Open-label Tapentadol Titration Period|Withdrawal of consent|7
5939229|NCT01352741|20541983|P2|Open-label Tapentadol Titration Period|Adverse Event|0
5939230|NCT01352741|20541984|P1|Open-label Tapentadol Titration Period|Adverse Event|34
5939231|NCT01352741|20541983|P2|Open-label Tapentadol Titration Period|Lack of Efficacy|0
5939232|NCT01352741|20541984|P1|Open-label Tapentadol Titration Period|Lack of Efficacy|19
5939233|NCT01352741|20541983|P2|Open-label Tapentadol Titration Period|Protocol Violation|0
5939234|NCT01352741|20541984|P1|Open-label Tapentadol Titration Period|Protocol Violation|4
5939235|NCT01352715|20542078|P2|Overall Study|major ineligibility|1
5939236|NCT01352715|20542079|P1|Overall Study|major ineligibility|2
5939237|NCT01352715|20542078|P2|Overall Study|no final visit in closeout period|12
5939238|NCT01352715|20542079|P1|Overall Study|no final visit in closeout period|15
5939239|NCT01352715|20542078|P2|Overall Study|site closure|15
5939240|NCT01352715|20542079|P1|Overall Study|site closure|16
5939241|NCT01352715|20542078|P2|Overall Study|Withdrawal by Subject|8
5939242|NCT01352715|20542079|P1|Overall Study|Withdrawal by Subject|4
5939243|NCT01352715|20542078|P2|Overall Study|Lost to Follow-up|7
5939244|NCT01352715|20542079|P1|Overall Study|Lost to Follow-up|5
5939245|NCT01352715|20542078|P2|Overall Study|Death|3
5939246|NCT01352715|20542079|P1|Overall Study|Death|3
5939247|NCT01352585|20542123|P1|Overall Study|Other|7
5939248|NCT01352585|20542123|P1|Overall Study|Lost to Follow-up|1
5939249|NCT01352585|20542123|P1|Overall Study|Adverse Event|3
5939250|NCT01352507|20542140|P2|Treatment Period 2|Lack of Efficacy|0
5939251|NCT01352507|20542141|P1|Treatment Period 2|Lack of Efficacy|1
5939252|NCT01352507|20542140|P2|Treatment Period 2|Withdrawal by Subject|3
5939253|NCT01352507|20542141|P1|Treatment Period 2|Withdrawal by Subject|4
5939254|NCT01352507|20542140|P2|Treatment Period 2|Entry Criteria Not Met|0
5939255|NCT01352507|20542141|P1|Treatment Period 2|Entry Criteria Not Met|1
5939256|NCT01352507|20542140|P2|Washout Period|Withdrawal by Subject|1
5939257|NCT01352507|20542141|P1|Washout Period|Withdrawal by Subject|0
5939258|NCT01352507|20542140|P2|Treatment Period 1|Physician Decision|0
5939259|NCT01352507|20542141|P1|Treatment Period 1|Physician Decision|1
5939260|NCT01352507|20542140|P2|Treatment Period 1|Withdrawal by Subject|5
5939261|NCT01352507|20542141|P1|Treatment Period 1|Withdrawal by Subject|7
5939262|NCT01352507|20542140|P2|Treatment Period 1|Lost to Follow-up|4
5939263|NCT01352507|20542141|P1|Treatment Period 1|Lost to Follow-up|3
5939264|NCT01352507|20542140|P2|Treatment Period 1|Adverse Event|0
5939265|NCT01352507|20542141|P1|Treatment Period 1|Adverse Event|3
5939266|NCT01352416|20542194|P4|Overall Study|Physician Decision|1
5939267|NCT01352416|20542195|P3|Overall Study|Physician Decision|2
5939268|NCT01352416|20542196|P2|Overall Study|Physician Decision|2
5939269|NCT01352416|20542197|P1|Overall Study|Physician Decision|1
5939270|NCT01352221|20542219|P4|Open-label Phase|Worsening of IBD|0
5939271|NCT01352221|20542220|P3|Open-label Phase|Worsening of IBD|1
5939272|NCT01352221|20542221|P2|Open-label Phase|Worsening of IBD|0
5939273|NCT01352221|20542222|P1|Open-label Phase|Worsening of IBD|0
5939274|NCT01352221|20542219|P4|Open-label Phase|Withdrawal by Subject|6
5939275|NCT01352221|20542220|P3|Open-label Phase|Withdrawal by Subject|1
5939276|NCT01352221|20542221|P2|Open-label Phase|Withdrawal by Subject|0
5939277|NCT01352221|20542222|P1|Open-label Phase|Withdrawal by Subject|0
5939278|NCT01352221|20542219|P4|Open-label Phase|Adverse Event|4
5939279|NCT01352221|20542220|P3|Open-label Phase|Adverse Event|8
5939280|NCT01352221|20542221|P2|Open-label Phase|Adverse Event|0
5939281|NCT01352221|20542222|P1|Open-label Phase|Adverse Event|0
5939282|NCT01352221|20542219|P4|Open-label Phase|Pregnancy|0
5939283|NCT01352221|20542220|P3|Open-label Phase|Pregnancy|1
5939284|NCT01352221|20542221|P2|Open-label Phase|Pregnancy|0
5939285|NCT01352221|20542222|P1|Open-label Phase|Pregnancy|0
5939286|NCT01352221|20542219|P4|Open-label Phase|Physician Decision|1
5939287|NCT01352221|20542220|P3|Open-label Phase|Physician Decision|2
5939288|NCT01352221|20542221|P2|Open-label Phase|Physician Decision|0
5939289|NCT01352221|20542222|P1|Open-label Phase|Physician Decision|0
5939290|NCT01352221|20542219|P4|Double-blind Phase|Protocol Violation|0
5939291|NCT01352221|20542220|P3|Double-blind Phase|Protocol Violation|0
5939292|NCT01352221|20542221|P2|Double-blind Phase|Protocol Violation|1
5939293|NCT01352221|20542222|P1|Double-blind Phase|Protocol Violation|0
5939294|NCT01352221|20542219|P4|Double-blind Phase|Lost to Follow-up|0
5939295|NCT01352221|20542220|P3|Double-blind Phase|Lost to Follow-up|0
5939296|NCT01352221|20542221|P2|Double-blind Phase|Lost to Follow-up|1
5939297|NCT01352221|20542222|P1|Double-blind Phase|Lost to Follow-up|0
5939298|NCT01352221|20542219|P4|Double-blind Phase|Withdrawal by Subject|0
5939299|NCT01352221|20542220|P3|Double-blind Phase|Withdrawal by Subject|0
5939300|NCT01352221|20542221|P2|Double-blind Phase|Withdrawal by Subject|5
5939301|NCT01352221|20542222|P1|Double-blind Phase|Withdrawal by Subject|3
5939302|NCT01352221|20542219|P4|Double-blind Phase|Adverse Event|0
5939303|NCT01352221|20542220|P3|Double-blind Phase|Adverse Event|0
5939304|NCT01352221|20542221|P2|Double-blind Phase|Adverse Event|4
5939305|NCT01352221|20542222|P1|Double-blind Phase|Adverse Event|6
5939306|NCT01352117|20542301|P2|Overall Study|Ineligible (no KS diagnosis)|0
5939307|NCT01352117|20542302|P1|Overall Study|Ineligible (no KS diagnosis)|1
5939308|NCT01352117|20542301|P2|Overall Study|Did not initiate study treatment|0
5939309|NCT01352117|20542302|P1|Overall Study|Did not initiate study treatment|1
5939310|NCT01352117|20542301|P2|Overall Study|Non-adherent to study requirements|1
5939311|NCT01352117|20542302|P1|Overall Study|Non-adherent to study requirements|1
5939312|NCT01352117|20542301|P2|Overall Study|Lost to Follow-up|7
5939313|NCT01352117|20542302|P1|Overall Study|Lost to Follow-up|2
5939314|NCT01352117|20542301|P2|Overall Study|Withdrawal by Subject|0
5939315|NCT01352117|20542302|P1|Overall Study|Withdrawal by Subject|1
5939316|NCT01352117|20542301|P2|Overall Study|Death|16
5939317|NCT01352117|20542302|P1|Overall Study|Death|15
5939318|NCT01351623|20542398|P1|Overall Study|Death|2
5939319|NCT01351623|20542398|P1|Overall Study|Withdrawal by Subject|1
5939320|NCT01351623|20542398|P1|Overall Study|Adverse Event|4
5939321|NCT01351623|20542398|P1|Overall Study|Protocol Violation|2
5939322|NCT01351415|20542424|P2|Overall Study|Never Started|5
5939323|NCT01351415|20542425|P1|Overall Study|Never Started|5
5939324|NCT01351415|20542424|P2|Overall Study|Reason unknown|2
5939325|NCT01351415|20542425|P1|Overall Study|Reason unknown|0
5939326|NCT01351415|20542424|P2|Overall Study|Physician Decision|3
5939327|NCT01351415|20542425|P1|Overall Study|Physician Decision|2
5939328|NCT01351415|20542424|P2|Overall Study|Death|187
5939329|NCT01351415|20542425|P1|Overall Study|Death|190
5939330|NCT01351415|20542424|P2|Overall Study|Lost to Follow-up|7
5939331|NCT01351415|20542425|P1|Overall Study|Lost to Follow-up|5
5939332|NCT01351415|20542424|P2|Overall Study|Trial termination by the Sponsor|19
5939333|NCT01351415|20542425|P1|Overall Study|Trial termination by the Sponsor|28
5939334|NCT01351415|20542424|P2|Overall Study|Withdrawal by Subject|17
5939335|NCT01351415|20542425|P1|Overall Study|Withdrawal by Subject|15
5939336|NCT01351350|20542461|P5|Overall Study|Enrolled but not Treated|0
5939337|NCT01351350|20542462|P4|Overall Study|Enrolled but not Treated|0
5939338|NCT01351350|20542463|P3|Overall Study|Enrolled but not Treated|1
5939339|NCT01351350|20542464|P2|Overall Study|Enrolled but not Treated|0
5939340|NCT01351350|20542465|P1|Overall Study|Enrolled but not Treated|0
5939341|NCT01351350|20542461|P5|Overall Study|Participant Decision|2
5939342|NCT01351350|20542462|P4|Overall Study|Participant Decision|3
5939343|NCT01351350|20542463|P3|Overall Study|Participant Decision|3
5939344|NCT01351350|20542464|P2|Overall Study|Participant Decision|6
5939345|NCT01351350|20542465|P1|Overall Study|Participant Decision|2
5939346|NCT01351350|20542461|P5|Overall Study|Adverse Event|0
5939347|NCT01351350|20542462|P4|Overall Study|Adverse Event|2
5939348|NCT01351350|20542463|P3|Overall Study|Adverse Event|1
5939349|NCT01351350|20542464|P2|Overall Study|Adverse Event|10
5939350|NCT01351350|20542465|P1|Overall Study|Adverse Event|1
5939351|NCT01351350|20542461|P5|Overall Study|Disease Progression|5
5939352|NCT01351350|20542462|P4|Overall Study|Disease Progression|8
5939353|NCT01351350|20542463|P3|Overall Study|Disease Progression|6
5939354|NCT01351350|20542464|P2|Overall Study|Disease Progression|13
5939355|NCT01351350|20542465|P1|Overall Study|Disease Progression|5
5939356|NCT01351025|20542636|P2|Week 24 - 44|unable to get to clinic|1
5939357|NCT01351025|20542637|P1|Week 24 - 44|unable to get to clinic|1
5939358|NCT01351025|20542636|P2|Week 24 - 44|Site closed|1
5939359|NCT01351025|20542637|P1|Week 24 - 44|Site closed|0
5939360|NCT01351025|20542636|P2|Week 24 - 44|Lost to Follow-up|2
5939361|NCT01351025|20542637|P1|Week 24 - 44|Lost to Follow-up|0
5939362|NCT01351025|20542636|P2|Week 0 - 20|Withdrawal by Subject|0
5939363|NCT01351025|20542637|P1|Week 0 - 20|Withdrawal by Subject|1
5939364|NCT01351025|20542636|P2|Week 0 - 20|Lost to Follow-up|1
5939365|NCT01351025|20542637|P1|Week 0 - 20|Lost to Follow-up|2
5939366|NCT01350999|20542670|P3|Overall Study|Difficulty Making it to Study Visit|5
5939367|NCT01350999|20542671|P2|Overall Study|Difficulty Making it to Study Visit|1
5939368|NCT01350999|20542672|P1|Overall Study|Difficulty Making it to Study Visit|1
5939369|NCT01350999|20542670|P3|Overall Study|Voluntary withdrawal|6
5939370|NCT01350999|20542671|P2|Overall Study|Voluntary withdrawal|4
5939371|NCT01350999|20542672|P1|Overall Study|Voluntary withdrawal|3
5939372|NCT01350999|20542670|P3|Overall Study|Adverse Event|10
5939373|NCT01350999|20542671|P2|Overall Study|Adverse Event|9
5939374|NCT01350999|20542672|P1|Overall Study|Adverse Event|4
5939375|NCT01350973|20542710|P3|Overall Study|Voluntary Withdrawal|1
5939376|NCT01350973|20542711|P2|Overall Study|Voluntary Withdrawal|1
5939377|NCT01350973|20542712|P1|Overall Study|Voluntary Withdrawal|2
5939378|NCT01350973|20542710|P3|Overall Study|Adverse Event|7
5939379|NCT01350973|20542711|P2|Overall Study|Adverse Event|7
5939380|NCT01350973|20542712|P1|Overall Study|Adverse Event|4
5939381|NCT01350934|20542753|P2|Extension Study|Withdrawal by Subject|1
5939382|NCT01350934|20542754|P1|Extension Study|Withdrawal by Subject|0
5939383|NCT01350934|20542753|P2|Extension Study|Lack of Efficacy|1
5939384|NCT01350934|20542754|P1|Extension Study|Lack of Efficacy|0
5939385|NCT01350934|20542753|P2|Extension Study|Protocol Violation|1
5939386|NCT01350934|20542754|P1|Extension Study|Protocol Violation|1
5939387|NCT01350934|20542753|P2|Extension Study|Lost to Follow-up|0
5939388|NCT01350934|20542754|P1|Extension Study|Lost to Follow-up|2
5939389|NCT01350934|20542753|P2|Extension Study|Adverse Event|1
5939390|NCT01350934|20542754|P1|Extension Study|Adverse Event|2
5939391|NCT01350934|20542753|P2|Base Study|Non-Compliance With Study Drug|0
5939392|NCT01350934|20542754|P1|Base Study|Non-Compliance With Study Drug|2
5939393|NCT01350934|20542753|P2|Base Study|Withdrawal by Subject|2
5939394|NCT01350934|20542754|P1|Base Study|Withdrawal by Subject|1
5939395|NCT01350934|20542753|P2|Base Study|Protocol Violation|1
5939396|NCT01350934|20542754|P1|Base Study|Protocol Violation|1
5939397|NCT01350934|20542753|P2|Base Study|Lost to Follow-up|0
5939398|NCT01350934|20542754|P1|Base Study|Lost to Follow-up|1
5939399|NCT01350934|20542753|P2|Base Study|Adverse Event|0
5939400|NCT01350934|20542754|P1|Base Study|Adverse Event|6
5939401|NCT01350804|20542776|P4|Extension Study, Weeks 52 - 260|Adverse Event|3
5939402|NCT01350804|20542777|P3|Extension Study, Weeks 52 - 260|Adverse Event|2
5939403|NCT01350804|20542778|P2|Extension Study, Weeks 52 - 260|Adverse Event|1
5939404|NCT01350804|20542779|P1|Extension Study, Weeks 52 - 260|Adverse Event|3
5939405|NCT01350804|20542776|P4|Extension Study, Weeks 52 - 260|Lack of Efficacy|1
5939406|NCT01350804|20542777|P3|Extension Study, Weeks 52 - 260|Lack of Efficacy|0
5939407|NCT01350804|20542778|P2|Extension Study, Weeks 52 - 260|Lack of Efficacy|4
5939408|NCT01350804|20542779|P1|Extension Study, Weeks 52 - 260|Lack of Efficacy|4
5939409|NCT01350804|20542776|P4|Extension Study, Weeks 52 - 260|Lost to Follow-up|0
5939410|NCT01350804|20542777|P3|Extension Study, Weeks 52 - 260|Lost to Follow-up|0
5939411|NCT01350804|20542778|P2|Extension Study, Weeks 52 - 260|Lost to Follow-up|1
5939412|NCT01350804|20542779|P1|Extension Study, Weeks 52 - 260|Lost to Follow-up|0
5939413|NCT01350804|20542776|P4|Extension Study, Weeks 52 - 260|Physician Decision|0
5939414|NCT01350804|20542777|P3|Extension Study, Weeks 52 - 260|Physician Decision|2
5939415|NCT01350804|20542778|P2|Extension Study, Weeks 52 - 260|Physician Decision|0
5939416|NCT01350804|20542779|P1|Extension Study, Weeks 52 - 260|Physician Decision|1
5939417|NCT01350804|20542776|P4|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|16
5939418|NCT01350804|20542777|P3|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|64
5939419|NCT01350804|20542778|P2|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67
5939420|NCT01350804|20542779|P1|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67
5939421|NCT01350804|20542776|P4|Extension Study, Weeks 52 - 260|Withdrawal by Subject|3
5939422|NCT01350804|20542777|P3|Extension Study, Weeks 52 - 260|Withdrawal by Subject|4
5939423|NCT01350804|20542778|P2|Extension Study, Weeks 52 - 260|Withdrawal by Subject|6
5939424|NCT01350804|20542779|P1|Extension Study, Weeks 52 - 260|Withdrawal by Subject|5
5939425|NCT01350804|20542776|P4|Core Study|Adverse Event|8
5939426|NCT01350804|20542777|P3|Core Study|Adverse Event|8
5939427|NCT01350804|20542778|P2|Core Study|Adverse Event|10
5939428|NCT01350804|20542779|P1|Core Study|Adverse Event|8
5939429|NCT01350804|20542776|P4|Core Study|Death|0
5939430|NCT01350804|20542777|P3|Core Study|Death|1
5939431|NCT01350804|20542778|P2|Core Study|Death|1
5939432|NCT01350804|20542779|P1|Core Study|Death|1
5939433|NCT01350804|20542776|P4|Core Study|Lack of Efficacy|5
5939434|NCT01350804|20542777|P3|Core Study|Lack of Efficacy|18
5939435|NCT01350804|20542778|P2|Core Study|Lack of Efficacy|19
5939436|NCT01350804|20542779|P1|Core Study|Lack of Efficacy|16
5939437|NCT01350804|20542776|P4|Core Study|Lost to Follow-up|1
5939438|NCT01350804|20542777|P3|Core Study|Lost to Follow-up|2
5939439|NCT01350804|20542778|P2|Core Study|Lost to Follow-up|0
5939440|NCT01350804|20542779|P1|Core Study|Lost to Follow-up|3
5939441|NCT01350804|20542776|P4|Core Study|Physician Decision|3
5939442|NCT01350804|20542777|P3|Core Study|Physician Decision|1
5939443|NCT01350804|20542778|P2|Core Study|Physician Decision|0
5939444|NCT01350804|20542779|P1|Core Study|Physician Decision|1
5939445|NCT01350804|20542776|P4|Core Study|Protocol deviation|0
5939446|NCT01350804|20542777|P3|Core Study|Protocol deviation|1
5939447|NCT01350804|20542778|P2|Core Study|Protocol deviation|0
5939448|NCT01350804|20542779|P1|Core Study|Protocol deviation|1
5939449|NCT01350804|20542776|P4|Core Study|Study terminated by Sponsor|2
5939450|NCT01350804|20542777|P3|Core Study|Study terminated by Sponsor|0
5939451|NCT01350804|20542778|P2|Core Study|Study terminated by Sponsor|0
5939452|NCT01350804|20542779|P1|Core Study|Study terminated by Sponsor|0
5939453|NCT01350804|20542776|P4|Core Study|Withdrawal by Subject|7
5939454|NCT01350804|20542777|P3|Core Study|Withdrawal by Subject|16
5939455|NCT01350804|20542778|P2|Core Study|Withdrawal by Subject|17
5939456|NCT01350804|20542779|P1|Core Study|Withdrawal by Subject|11
5939457|NCT01350544|20542876|P2|Overall Study|Lost to Follow-up|15
5939458|NCT01350544|20542877|P1|Overall Study|Lost to Follow-up|18
5939459|NCT01350544|20542876|P2|Overall Study|Incarceration|0
5939460|NCT01350544|20542877|P1|Overall Study|Incarceration|1
5939461|NCT01350544|20542876|P2|Overall Study|Withdrawal by Subject|1
5939462|NCT01350544|20542877|P1|Overall Study|Withdrawal by Subject|0
5939463|NCT01350544|20542876|P2|Overall Study|Medical Issues|1
5939464|NCT01350544|20542877|P1|Overall Study|Medical Issues|1
5939465|NCT01350544|20542876|P2|Overall Study|Moved out of LA County|2
5939466|NCT01350544|20542877|P1|Overall Study|Moved out of LA County|2
5939467|NCT01350544|20542876|P2|Overall Study|Death|2
5939468|NCT01350544|20542877|P1|Overall Study|Death|1
5939469|NCT01350544|20542876|P2|Overall Study|Administrative Withdrawal|1
5939470|NCT01350544|20542877|P1|Overall Study|Administrative Withdrawal|0
5939471|NCT01350505|20542883|P1|Overall Study|Lost to Follow-up|4
5939472|NCT01350492|20542889|P2|Post Intervention Follow-Up|Withdrawal by Subject|1
5939473|NCT01350492|20542890|P1|Post Intervention Follow-Up|Withdrawal by Subject|0
5939474|NCT01350492|20542889|P2|Post Intervention Follow-Up|Lost to Follow-up|1
5939475|NCT01350492|20542890|P1|Post Intervention Follow-Up|Lost to Follow-up|6
5939476|NCT01350492|20542889|P2|Intervention|Withdrawal by Subject|1
5939477|NCT01350492|20542890|P1|Intervention|Withdrawal by Subject|3
5939478|NCT01350492|20542889|P2|Intervention|Lost to Follow-up|5
5939479|NCT01350492|20542890|P1|Intervention|Lost to Follow-up|2
5939480|NCT01350414|20542932|P1|Overall Study|Physician Decision|2
5939481|NCT01350414|20542932|P1|Overall Study|Withdrawal by Subject|4
5939482|NCT01350414|20542932|P1|Overall Study|Lost to Follow-up|13
5939483|NCT01350271|20542981|P3|Overall Study|Lost to Follow-up|26
5939484|NCT01350271|20542982|P2|Overall Study|Lost to Follow-up|17
5939485|NCT01350271|20542983|P1|Overall Study|Lost to Follow-up|21
5939486|NCT01350141|20543025|P3|Overall Study|Randomized but not treated|0
5939487|NCT01350141|20543026|P2|Overall Study|Randomized but not treated|0
5939488|NCT01350141|20543027|P1|Overall Study|Randomized but not treated|1
5939489|NCT01350141|20543025|P3|Overall Study|Withdrawal by Subject|0
5939490|NCT01350141|20543026|P2|Overall Study|Withdrawal by Subject|0
5939491|NCT01350141|20543027|P1|Overall Study|Withdrawal by Subject|1
5939492|NCT01350141|20543025|P3|Overall Study|Lost to Follow-up|1
5939493|NCT01350141|20543026|P2|Overall Study|Lost to Follow-up|0
5939494|NCT01350141|20543027|P1|Overall Study|Lost to Follow-up|1
5939495|NCT01350128|20543061|P1|Overall Study|Lost to Follow-up|2
5939496|NCT01350128|20543061|P1|Overall Study|Physician Decision|1
5939497|NCT01350128|20543061|P1|Overall Study|Protocol discontinuation criteria|8
5939498|NCT01350128|20543061|P1|Overall Study|Withdrawal by Subject|3
5939499|NCT01350115|20543125|P2|Long Term Follow-Up (All Patients)|Withdrawal by Subject|0
5939500|NCT01350115|20543126|P1|Long Term Follow-Up (All Patients)|Withdrawal by Subject|1
5939501|NCT01350115|20543125|P2|Long Term Follow-Up (All Patients)|Adverse Event|1
5939502|NCT01350115|20543126|P1|Long Term Follow-Up (All Patients)|Adverse Event|0
5939503|NCT01350115|20543125|P2|Long Term Follow-Up (All Patients)|Lost to Follow-up|1
5939504|NCT01350115|20543126|P1|Long Term Follow-Up (All Patients)|Lost to Follow-up|0
5939505|NCT01350102|20543142|P4|Overall Study|Adverse Event|0
5939506|NCT01350102|20543143|P3|Overall Study|Adverse Event|1
5939507|NCT01350102|20543144|P2|Overall Study|Adverse Event|0
5939508|NCT01350102|20543145|P1|Overall Study|Adverse Event|0
5939509|NCT01349959|20543182|P1|Overall Study|Adverse Event|7
5939522|NCT01349829|20543262|P2|Overall Study|Migrated/moved|7
5939523|NCT01349829|20543263|P1|Overall Study|Migrated/moved|2
5939524|NCT01349829|20543262|P2|Overall Study|Consent withdrawal|8
5939525|NCT01349829|20543263|P1|Overall Study|Consent withdrawal|3
5939526|NCT01349829|20543262|P2|Overall Study|Lost to Follow-up|8
5939527|NCT01349829|20543263|P1|Overall Study|Lost to Follow-up|4
5939528|NCT01349816|20543281|P1|Overall Study|Protocol-specified criteria|8
5939529|NCT01349816|20543281|P1|Overall Study|Protocol Violation|1
5939530|NCT01349816|20543281|P1|Overall Study|Lost to Follow-up|2
5939531|NCT01349816|20543281|P1|Overall Study|Adverse Event|14
5939532|NCT01349816|20543281|P1|Overall Study|Physician Decision|1
5939533|NCT01349816|20543281|P1|Overall Study|Withdrawal by Subject|4
5939534|NCT01349803|20543347|P4|Overall Study|Protocol-specified criteria|0
5939535|NCT01349803|20543348|P3|Overall Study|Protocol-specified criteria|3
5939536|NCT01349803|20543349|P2|Overall Study|Protocol-specified criteria|1
5939537|NCT01349803|20543350|P1|Overall Study|Protocol-specified criteria|0
5939538|NCT01349803|20543347|P4|Overall Study|Withdrawal by Subject|0
5939539|NCT01349803|20543348|P3|Overall Study|Withdrawal by Subject|0
5939540|NCT01349803|20543349|P2|Overall Study|Withdrawal by Subject|0
5939541|NCT01349803|20543350|P1|Overall Study|Withdrawal by Subject|1
5939542|NCT01349803|20543347|P4|Overall Study|Adverse Event|2
5939543|NCT01349803|20543348|P3|Overall Study|Adverse Event|0
5939544|NCT01349803|20543349|P2|Overall Study|Adverse Event|0
5939545|NCT01349803|20543350|P1|Overall Study|Adverse Event|0
5939546|NCT01349790|20543420|P1|Overall Study|Lost to Follow-up|1
5939547|NCT01349790|20543420|P1|Overall Study|Adverse Event|1
5939548|NCT01349790|20543420|P1|Overall Study|Withdrawal by Patient|2
5939549|NCT01349790|20543420|P1|Overall Study|Death|2
5939550|NCT01349790|20543420|P1|Overall Study|Investigator Judgement|3
5939551|NCT01349673|20543439|P1|Overall Study|Lack of Efficacy|8
5939552|NCT01349673|20543439|P1|Overall Study|Study Terminated By Sponsor|50
5939553|NCT01349673|20543439|P1|Overall Study|Adverse Event|17
5939554|NCT01349673|20543439|P1|Overall Study|Lost to Follow-up|6
5939555|NCT01349673|20543439|P1|Overall Study|Withdrawal by Subject|21
5939556|NCT01349673|20543439|P1|Overall Study|Site Closure|10
5939557|NCT01349673|20543439|P1|Overall Study|No Longer Qualified For Study|1
5939558|NCT01349673|20543439|P1|Overall Study|Progression Of Disease Past 40 cm|1
5939559|NCT01349660|20543449|P3|Overall Study|Declining Performance Status|1
5939560|NCT01349660|20543450|P2|Overall Study|Declining Performance Status|0
5939561|NCT01349660|20543451|P1|Overall Study|Declining Performance Status|0
5939562|NCT01349660|20543449|P3|Overall Study|Study Compliance|1
5939563|NCT01349660|20543450|P2|Overall Study|Study Compliance|0
5939564|NCT01349660|20543451|P1|Overall Study|Study Compliance|0
5939565|NCT01349660|20543449|P3|Overall Study|Non-Permitted Interventions|2
5939566|NCT01349660|20543450|P2|Overall Study|Non-Permitted Interventions|0
5939567|NCT01349660|20543451|P1|Overall Study|Non-Permitted Interventions|0
5939568|NCT01349660|20543449|P3|Overall Study|Death|0
5939569|NCT01349660|20543450|P2|Overall Study|Death|1
5939570|NCT01349660|20543451|P1|Overall Study|Death|1
5939571|NCT01349660|20543449|P3|Overall Study|Withdrawal by Subject|9
5939572|NCT01349660|20543450|P2|Overall Study|Withdrawal by Subject|0
5939573|NCT01349660|20543451|P1|Overall Study|Withdrawal by Subject|2
5939574|NCT01349660|20543449|P3|Overall Study|Adverse Event|12
5939575|NCT01349660|20543450|P2|Overall Study|Adverse Event|1
5939576|NCT01349660|20543451|P1|Overall Study|Adverse Event|1
5939577|NCT01349660|20543449|P3|Overall Study|Disease Progression|50
5939578|NCT01349660|20543450|P2|Overall Study|Disease Progression|4
5939579|NCT01349660|20543451|P1|Overall Study|Disease Progression|2
5939580|NCT01349660|20543449|P3|Overall Study|Still Receiving Study Treatment|1
5939581|NCT01349660|20543450|P2|Overall Study|Still Receiving Study Treatment|0
5939582|NCT01349660|20543451|P1|Overall Study|Still Receiving Study Treatment|0
5939583|NCT01349595|20543469|P2|Overall Study|Lack of funding|2
5939584|NCT01349595|20543470|P1|Overall Study|Lack of funding|2
5939585|NCT01349569|20543476|P1|Overall Study|Lack of Efficacy|4
5939586|NCT01349465|20543497|P2|Overall Study|Subject Ineligible To Continue The Trial|19
5939587|NCT01349465|20543498|P1|Overall Study|Subject Ineligible To Continue The Trial|0
5939588|NCT01349465|20543497|P2|Overall Study|Withdrawal by Subject|2
5939589|NCT01349465|20543498|P1|Overall Study|Withdrawal by Subject|4
5939590|NCT01349465|20543497|P2|Overall Study|Lost to Follow-up|1
5939591|NCT01349465|20543498|P1|Overall Study|Lost to Follow-up|10
5939592|NCT01349465|20543497|P2|Overall Study|Death|0
5939593|NCT01349465|20543498|P1|Overall Study|Death|3
5939594|NCT01349465|20543497|P2|Overall Study|Adverse Event|0
5939595|NCT01349465|20543498|P1|Overall Study|Adverse Event|1
5939596|NCT01349192|20543519|P2|Overall Study|Failure to adhere to Protocol|0
5939597|NCT01349192|20543520|P1|Overall Study|Failure to adhere to Protocol|2
5939598|NCT01349192|20543519|P2|Overall Study|Lost to Follow-up|3
5939599|NCT01349192|20543520|P1|Overall Study|Lost to Follow-up|1
5939600|NCT01349192|20543519|P2|Overall Study|Withdrawal by Subject|2
5939601|NCT01349192|20543520|P1|Overall Study|Withdrawal by Subject|0
5939602|NCT01349192|20543519|P2|Overall Study|Protocol Violation|1
5939603|NCT01349192|20543520|P1|Overall Study|Protocol Violation|0
5939604|NCT01349049|20543552|P9|Overall Study|Withdrawal by Subject|6
5939605|NCT01349049|20543553|P8|Overall Study|Withdrawal by Subject|0
5939606|NCT01349049|20543554|P7|Overall Study|Withdrawal by Subject|0
5939607|NCT01349049|20543555|P6|Overall Study|Withdrawal by Subject|0
5939608|NCT01349049|20543556|P5|Overall Study|Withdrawal by Subject|0
5939609|NCT01349049|20543557|P4|Overall Study|Withdrawal by Subject|0
5939610|NCT01349049|20543558|P3|Overall Study|Withdrawal by Subject|0
5939611|NCT01349049|20543559|P2|Overall Study|Withdrawal by Subject|0
5939612|NCT01349049|20543560|P1|Overall Study|Withdrawal by Subject|0
5939613|NCT01349049|20543552|P9|Overall Study|Non-compliance|0
5939614|NCT01349049|20543553|P8|Overall Study|Non-compliance|0
5939615|NCT01349049|20543554|P7|Overall Study|Non-compliance|0
5939616|NCT01349049|20543555|P6|Overall Study|Non-compliance|0
5939617|NCT01349049|20543556|P5|Overall Study|Non-compliance|0
5939618|NCT01349049|20543557|P4|Overall Study|Non-compliance|1
5939619|NCT01349049|20543558|P3|Overall Study|Non-compliance|0
5939620|NCT01349049|20543559|P2|Overall Study|Non-compliance|0
5939621|NCT01349049|20543560|P1|Overall Study|Non-compliance|0
5939622|NCT01349049|20543552|P9|Overall Study|Death|5
5939623|NCT01349049|20543553|P8|Overall Study|Death|1
5939624|NCT01349049|20543554|P7|Overall Study|Death|0
5939625|NCT01349049|20543555|P6|Overall Study|Death|0
5939626|NCT01349049|20543556|P5|Overall Study|Death|0
5939627|NCT01349049|20543557|P4|Overall Study|Death|0
5939628|NCT01349049|20543558|P3|Overall Study|Death|0
5939629|NCT01349049|20543559|P2|Overall Study|Death|0
5939630|NCT01349049|20543560|P1|Overall Study|Death|0
5939631|NCT01349049|20543552|P9|Overall Study|Other|4
5939632|NCT01349049|20543553|P8|Overall Study|Other|0
5939633|NCT01349049|20543554|P7|Overall Study|Other|0
5939634|NCT01349049|20543555|P6|Overall Study|Other|1
5939635|NCT01349049|20543556|P5|Overall Study|Other|0
5939636|NCT01349049|20543557|P4|Overall Study|Other|0
5939637|NCT01349049|20543558|P3|Overall Study|Other|0
5939638|NCT01349049|20543559|P2|Overall Study|Other|0
5939639|NCT01349049|20543560|P1|Overall Study|Other|0
5939640|NCT01349049|20543552|P9|Overall Study|Hematopoietic stem cell transplant|0
5939641|NCT01349049|20543553|P8|Overall Study|Hematopoietic stem cell transplant|1
5939642|NCT01349049|20543554|P7|Overall Study|Hematopoietic stem cell transplant|1
5939643|NCT01349049|20543555|P6|Overall Study|Hematopoietic stem cell transplant|0
5939644|NCT01349049|20543556|P5|Overall Study|Hematopoietic stem cell transplant|1
5939645|NCT01349049|20543557|P4|Overall Study|Hematopoietic stem cell transplant|0
5939646|NCT01349049|20543558|P3|Overall Study|Hematopoietic stem cell transplant|0
5939647|NCT01349049|20543559|P2|Overall Study|Hematopoietic stem cell transplant|0
5939648|NCT01349049|20543560|P1|Overall Study|Hematopoietic stem cell transplant|0
5939649|NCT01349049|20543552|P9|Overall Study|Protocol Violation|1
5939650|NCT01349049|20543553|P8|Overall Study|Protocol Violation|0
5939651|NCT01349049|20543554|P7|Overall Study|Protocol Violation|0
5939652|NCT01349049|20543555|P6|Overall Study|Protocol Violation|0
5939653|NCT01349049|20543556|P5|Overall Study|Protocol Violation|0
5939654|NCT01349049|20543557|P4|Overall Study|Protocol Violation|0
5939655|NCT01349049|20543558|P3|Overall Study|Protocol Violation|0
5939656|NCT01349049|20543559|P2|Overall Study|Protocol Violation|0
5939657|NCT01349049|20543560|P1|Overall Study|Protocol Violation|0
5939658|NCT01349049|20543552|P9|Overall Study|Physician Decision|2
5939659|NCT01349049|20543553|P8|Overall Study|Physician Decision|0
5939660|NCT01349049|20543554|P7|Overall Study|Physician Decision|0
5939661|NCT01349049|20543555|P6|Overall Study|Physician Decision|0
5939662|NCT01349049|20543556|P5|Overall Study|Physician Decision|0
5939663|NCT01349049|20543557|P4|Overall Study|Physician Decision|0
5939664|NCT01349049|20543558|P3|Overall Study|Physician Decision|0
5939665|NCT01349049|20543559|P2|Overall Study|Physician Decision|1
5939666|NCT01349049|20543560|P1|Overall Study|Physician Decision|0
5939667|NCT01349049|20543552|P9|Overall Study|Adverse Event|4
5939668|NCT01349049|20543553|P8|Overall Study|Adverse Event|0
5939669|NCT01349049|20543554|P7|Overall Study|Adverse Event|1
5939670|NCT01349049|20543555|P6|Overall Study|Adverse Event|3
5939671|NCT01349049|20543556|P5|Overall Study|Adverse Event|0
5939672|NCT01349049|20543557|P4|Overall Study|Adverse Event|0
5939673|NCT01349049|20543558|P3|Overall Study|Adverse Event|0
5939674|NCT01349049|20543559|P2|Overall Study|Adverse Event|1
5939675|NCT01349049|20543560|P1|Overall Study|Adverse Event|0
5939676|NCT01349049|20543552|P9|Overall Study|Disease progression|33
5939677|NCT01349049|20543553|P8|Overall Study|Disease progression|2
5939678|NCT01349049|20543554|P7|Overall Study|Disease progression|3
5939679|NCT01349049|20543555|P6|Overall Study|Disease progression|2
5939680|NCT01349049|20543556|P5|Overall Study|Disease progression|2
5939681|NCT01349049|20543557|P4|Overall Study|Disease progression|2
5939682|NCT01349049|20543558|P3|Overall Study|Disease progression|3
5939683|NCT01349049|20543559|P2|Overall Study|Disease progression|5
5939684|NCT01349049|20543560|P1|Overall Study|Disease progression|3
5939685|NCT01349036|20543614|P2|Overall Study|Withdrawal by Subject|2
5939686|NCT01349036|20543615|P1|Overall Study|Withdrawal by Subject|0
5939687|NCT01349036|20543614|P2|Overall Study|Other|0
5939688|NCT01349036|20543615|P1|Overall Study|Other|1
5939689|NCT01349036|20543614|P2|Overall Study|Disease progression|22
5939690|NCT01349036|20543615|P1|Overall Study|Disease progression|13
5939691|NCT01348854|20543633|P2|Overall Study|Withdrawal by Subject|0
5939692|NCT01348854|20543634|P1|Overall Study|Withdrawal by Subject|1
5939693|NCT01348854|20543633|P2|Overall Study|Lost to Follow-up|1
5939694|NCT01348854|20543634|P1|Overall Study|Lost to Follow-up|2
5939695|NCT01348789|20543642|P1|Overall Study|Withdrawal by Subject|2
5939696|NCT01348789|20543642|P1|Overall Study|Protocol Violation|2
5939697|NCT01348776|20543653|P1|Overall Study|Lost to Follow-up|3
5939698|NCT01348763|20543666|P1|With Tenofovir/Emtricitabine (10 Days)|Physician Decision|1
5939699|NCT01348763|20543666|P1|With Tenofovir/Emtricitabine (10 Days)|Withdrawal by Subject|1
5939700|NCT01348698|20543671|P1|Overall Study|PI decision to close study|68
5939701|NCT01348698|20543671|P1|Overall Study|Death|3
5939702|NCT01348698|20543671|P1|Overall Study|Does not meet lesion size criteria|1
5939703|NCT01348542|20543696|P2|Overall Study|Withdrawal by Subject|0
5939704|NCT01348542|20543697|P1|Overall Study|Withdrawal by Subject|3
5939705|NCT01348490|20543713|P1|Overall Study|Other Unspecified|8
5939706|NCT01348490|20543713|P1|Overall Study|Termination of clinical trial by sponsor|1
5939707|NCT01348490|20543713|P1|Overall Study|Lost to Follow-up|1
5939708|NCT01348490|20543713|P1|Overall Study|Disease progression|3
5939709|NCT01348490|20543713|P1|Overall Study|Consent withdrawn|7
5939710|NCT01348490|20543713|P1|Overall Study|Adverse Event|3
5939711|NCT01348490|20543713|P1|Overall Study|Death|1
5939712|NCT01348425|20543771|P2|Overall Study|Imaging was not taken.|1
5939713|NCT01348425|20543772|P1|Overall Study|Imaging was not taken.|1
5939714|NCT01348347|20543780|P3|Overall Study|Progressive disease|5
5939715|NCT01348347|20543781|P2|Overall Study|Progressive disease|5
5939716|NCT01348347|20543782|P1|Overall Study|Progressive disease|2
5939717|NCT01348347|20543780|P3|Overall Study|Withdrawal by Subject|1
5939718|NCT01348347|20543781|P2|Overall Study|Withdrawal by Subject|1
5939719|NCT01348347|20543782|P1|Overall Study|Withdrawal by Subject|1
5939720|NCT01348165|20543813|P7|Overall Study|Adverse Event|1
5939721|NCT01348165|20543814|P6|Overall Study|Adverse Event|0
5939722|NCT01348165|20543815|P5|Overall Study|Adverse Event|0
5939723|NCT01348165|20543816|P4|Overall Study|Adverse Event|0
5939724|NCT01348165|20543817|P3|Overall Study|Adverse Event|0
5939725|NCT01348165|20543818|P2|Overall Study|Adverse Event|0
5939726|NCT01348165|20543819|P1|Overall Study|Adverse Event|0
5939727|NCT01348139|20543948|P6|Period 1|Adverse Event|0
5939728|NCT01348139|20543949|P5|Period 1|Adverse Event|0
5939729|NCT01348139|20543950|P4|Period 1|Adverse Event|0
5939730|NCT01348139|20543951|P3|Period 1|Adverse Event|0
5939731|NCT01348139|20543952|P2|Period 1|Adverse Event|0
5939732|NCT01348139|20543953|P1|Period 1|Adverse Event|1
5939733|NCT01348100|20544034|P7|Overall Study|Administrative Problems|1
5939734|NCT01348100|20544035|P6|Overall Study|Administrative Problems|1
5939735|NCT01348100|20544036|P5|Overall Study|Administrative Problems|0
5939736|NCT01348100|20544037|P4|Overall Study|Administrative Problems|0
5939737|NCT01348100|20544038|P3|Overall Study|Administrative Problems|0
5939738|NCT01348100|20544039|P2|Overall Study|Administrative Problems|0
5939739|NCT01348100|20544040|P1|Overall Study|Administrative Problems|0
5939740|NCT01348100|20544034|P7|Overall Study|Lost to Follow-up|1
5939741|NCT01348100|20544035|P6|Overall Study|Lost to Follow-up|0
5939742|NCT01348100|20544036|P5|Overall Study|Lost to Follow-up|0
5939743|NCT01348100|20544037|P4|Overall Study|Lost to Follow-up|0
5939744|NCT01348100|20544038|P3|Overall Study|Lost to Follow-up|0
5939745|NCT01348100|20544039|P2|Overall Study|Lost to Follow-up|0
5939746|NCT01348100|20544040|P1|Overall Study|Lost to Follow-up|0
5939747|NCT01348100|20544034|P7|Overall Study|Unsatisfactory Therapeutic Effect|0
5939748|NCT01348100|20544035|P6|Overall Study|Unsatisfactory Therapeutic Effect|1
5939749|NCT01348100|20544036|P5|Overall Study|Unsatisfactory Therapeutic Effect|0
5939750|NCT01348100|20544037|P4|Overall Study|Unsatisfactory Therapeutic Effect|0
5939751|NCT01348100|20544038|P3|Overall Study|Unsatisfactory Therapeutic Effect|0
5939752|NCT01348100|20544039|P2|Overall Study|Unsatisfactory Therapeutic Effect|0
5939753|NCT01348100|20544040|P1|Overall Study|Unsatisfactory Therapeutic Effect|0
5939754|NCT01348100|20544034|P7|Overall Study|Protocol Deviation|0
5939755|NCT01348100|20544035|P6|Overall Study|Protocol Deviation|0
5939756|NCT01348100|20544036|P5|Overall Study|Protocol Deviation|0
5939757|NCT01348100|20544037|P4|Overall Study|Protocol Deviation|1
5939758|NCT01348100|20544038|P3|Overall Study|Protocol Deviation|0
5939759|NCT01348100|20544039|P2|Overall Study|Protocol Deviation|0
5939760|NCT01348100|20544040|P1|Overall Study|Protocol Deviation|0
5939761|NCT01348100|20544034|P7|Overall Study|Subject Withdrew Consent|1
5939762|NCT01348100|20544035|P6|Overall Study|Subject Withdrew Consent|0
5939763|NCT01348100|20544036|P5|Overall Study|Subject Withdrew Consent|1
5939764|NCT01348100|20544037|P4|Overall Study|Subject Withdrew Consent|0
5939765|NCT01348100|20544038|P3|Overall Study|Subject Withdrew Consent|2
5939766|NCT01348100|20544039|P2|Overall Study|Subject Withdrew Consent|0
5939767|NCT01348100|20544040|P1|Overall Study|Subject Withdrew Consent|0
5939768|NCT01348087|20544085|P1|Overall Study|Adverse Event|25
5939769|NCT01348087|20544085|P1|Overall Study|Subject withdrew consent|7
5939770|NCT01348087|20544085|P1|Overall Study|Lost to Follow-up|1
5939771|NCT01348087|20544085|P1|Overall Study|protocol deviation|1
5939772|NCT01348087|20544085|P1|Overall Study|Administrative problems|79
5939773|NCT01348087|20544085|P1|Overall Study|Unsatisfactory therapeutic effect|35
5939774|NCT01347931|20544099|P1|Standard Oxygen Therapy|Withdrawal by Subject|1
5939775|NCT01347879|20544111|P2|Overall Study|Other|3
5939776|NCT01347879|20544112|P1|Overall Study|Other|2
5939777|NCT01347879|20544111|P2|Overall Study|Withdrawal by Subject|2
5939778|NCT01347879|20544112|P1|Overall Study|Withdrawal by Subject|3
5939779|NCT01347879|20544111|P2|Overall Study|Lost to Follow-up|0
5939780|NCT01347879|20544112|P1|Overall Study|Lost to Follow-up|2
5939781|NCT01347879|20544111|P2|Overall Study|Adverse Event|12
5939782|NCT01347879|20544112|P1|Overall Study|Adverse Event|0
5939783|NCT01347866|20544161|P17|Overall Study|Subject refused further follow-up|2
5939784|NCT01347866|20544162|P16|Overall Study|Subject refused further follow-up|0
5939785|NCT01347866|20544163|P15|Overall Study|Subject refused further follow-up|1
5939786|NCT01347866|20544164|P14|Overall Study|Subject refused further follow-up|3
5939787|NCT01347866|20544165|P13|Overall Study|Subject refused further follow-up|1
5939788|NCT01347866|20544166|P12|Overall Study|Subject refused further follow-up|0
5939789|NCT01347866|20544167|P11|Overall Study|Subject refused further follow-up|0
5939790|NCT01347866|20544168|P10|Overall Study|Subject refused further follow-up|1
5939791|NCT01347866|20544169|P9|Overall Study|Subject refused further follow-up|4
5939792|NCT01347866|20544170|P8|Overall Study|Subject refused further follow-up|0
5939793|NCT01347866|20544171|P7|Overall Study|Subject refused further follow-up|0
5939794|NCT01347866|20544172|P6|Overall Study|Subject refused further follow-up|1
5939795|NCT01347866|20544173|P5|Overall Study|Subject refused further follow-up|0
5939796|NCT01347866|20544174|P4|Overall Study|Subject refused further follow-up|2
5939797|NCT01347866|20544175|P3|Overall Study|Subject refused further follow-up|0
5939798|NCT01347866|20544176|P2|Overall Study|Subject refused further follow-up|0
5939799|NCT01347866|20544177|P1|Overall Study|Subject refused further follow-up|2
5939800|NCT01347866|20544161|P17|Overall Study|Other|0
5939801|NCT01347866|20544162|P16|Overall Study|Other|3
5939802|NCT01347866|20544163|P15|Overall Study|Other|2
5939803|NCT01347866|20544164|P14|Overall Study|Other|4
5939804|NCT01347866|20544165|P13|Overall Study|Other|4
5939805|NCT01347866|20544166|P12|Overall Study|Other|3
5939806|NCT01347866|20544167|P11|Overall Study|Other|0
5939807|NCT01347866|20544168|P10|Overall Study|Other|5
5939808|NCT01347866|20544169|P9|Overall Study|Other|22
5939809|NCT01347866|20544170|P8|Overall Study|Other|3
5939810|NCT01347866|20544171|P7|Overall Study|Other|5
5939811|NCT01347866|20544172|P6|Overall Study|Other|0
5939812|NCT01347866|20544173|P5|Overall Study|Other|5
5939813|NCT01347866|20544174|P4|Overall Study|Other|4
5939814|NCT01347866|20544175|P3|Overall Study|Other|1
5939815|NCT01347866|20544176|P2|Overall Study|Other|1
5939816|NCT01347866|20544177|P1|Overall Study|Other|3
5939817|NCT01347866|20544161|P17|Overall Study|Lost to Follow-up|0
5939818|NCT01347866|20544162|P16|Overall Study|Lost to Follow-up|0
5939819|NCT01347866|20544163|P15|Overall Study|Lost to Follow-up|0
5939820|NCT01347866|20544164|P14|Overall Study|Lost to Follow-up|0
5939821|NCT01347866|20544165|P13|Overall Study|Lost to Follow-up|0
5939822|NCT01347866|20544166|P12|Overall Study|Lost to Follow-up|0
5939823|NCT01347866|20544167|P11|Overall Study|Lost to Follow-up|0
5939824|NCT01347866|20544168|P10|Overall Study|Lost to Follow-up|0
5939825|NCT01347866|20544169|P9|Overall Study|Lost to Follow-up|1
5939826|NCT01347866|20544170|P8|Overall Study|Lost to Follow-up|1
5939827|NCT01347866|20544171|P7|Overall Study|Lost to Follow-up|0
5939828|NCT01347866|20544172|P6|Overall Study|Lost to Follow-up|0
5939829|NCT01347866|20544173|P5|Overall Study|Lost to Follow-up|0
5939830|NCT01347866|20544174|P4|Overall Study|Lost to Follow-up|0
5939831|NCT01347866|20544175|P3|Overall Study|Lost to Follow-up|0
5939832|NCT01347866|20544176|P2|Overall Study|Lost to Follow-up|0
5939833|NCT01347866|20544177|P1|Overall Study|Lost to Follow-up|0
5939834|NCT01347866|20544161|P17|Overall Study|Death|0
5939835|NCT01347866|20544162|P16|Overall Study|Death|1
5939836|NCT01347866|20544163|P15|Overall Study|Death|0
5939837|NCT01347866|20544164|P14|Overall Study|Death|0
5939838|NCT01347866|20544165|P13|Overall Study|Death|2
5939839|NCT01347866|20544166|P12|Overall Study|Death|1
5939840|NCT01347866|20544167|P11|Overall Study|Death|3
5939841|NCT01347866|20544168|P10|Overall Study|Death|1
5939842|NCT01347866|20544169|P9|Overall Study|Death|4
5939843|NCT01347866|20544170|P8|Overall Study|Death|0
5939844|NCT01347866|20544171|P7|Overall Study|Death|1
5939845|NCT01347866|20544172|P6|Overall Study|Death|2
5939846|NCT01347866|20544173|P5|Overall Study|Death|2
5939847|NCT01347866|20544174|P4|Overall Study|Death|1
5939848|NCT01347866|20544175|P3|Overall Study|Death|0
5939849|NCT01347866|20544176|P2|Overall Study|Death|0
5939850|NCT01347866|20544177|P1|Overall Study|Death|0
5939851|NCT01347840|20544551|P1|Overall Study|Withdrawal by Subject|1
5939852|NCT01347762|20544578|P4|Overall Study|Withdrawal by Subject|3
5939853|NCT01347762|20544579|P3|Overall Study|Withdrawal by Subject|3
5939854|NCT01347762|20544580|P2|Overall Study|Withdrawal by Subject|1
5939855|NCT01347762|20544581|P1|Overall Study|Withdrawal by Subject|4
5939856|NCT01347762|20544578|P4|Overall Study|Lost to Follow-up|5
5939857|NCT01347762|20544579|P3|Overall Study|Lost to Follow-up|6
5939858|NCT01347762|20544580|P2|Overall Study|Lost to Follow-up|1
5939859|NCT01347762|20544581|P1|Overall Study|Lost to Follow-up|0
5939860|NCT01347710|20544607|P1|Overall Study|Other|3
5939861|NCT01347710|20544607|P1|Overall Study|Physician Decision|2
5939862|NCT01347710|20544607|P1|Overall Study|Lost to Follow-up|1
5939863|NCT01347710|20544607|P1|Overall Study|issue with vitals prior to dosing|1
5939864|NCT01347710|20544607|P1|Overall Study|Angio or SPECT not completed|18
5939865|NCT01347710|20544607|P1|Overall Study|Adverse Event|4
5939866|NCT01347710|20544607|P1|Overall Study|Withdrawal by Subject|2
5939867|NCT01347580|20544629|P2|Overall Study|Had other reason|6
5939868|NCT01347580|20544630|P1|Overall Study|Had other reason|9
5939869|NCT01347580|20544629|P2|Overall Study|Lost to Follow-up|1
5939870|NCT01347580|20544630|P1|Overall Study|Lost to Follow-up|3
5939871|NCT01347580|20544629|P2|Overall Study|Protocol Violation|7
5939872|NCT01347580|20544630|P1|Overall Study|Protocol Violation|10
5939873|NCT01347580|20544629|P2|Overall Study|Death|19
5939874|NCT01347580|20544630|P1|Overall Study|Death|30
5939875|NCT01347580|20544629|P2|Overall Study|Withdrawal by Subject|23
5939876|NCT01347580|20544630|P1|Overall Study|Withdrawal by Subject|13
5939877|NCT01347554|20544660|P2|Overall Study|Lack of Efficacy|11
5939878|NCT01347554|20544661|P1|Overall Study|Lack of Efficacy|7
5939879|NCT01347307|20544686|P2|Overall Study|Physician Decision|1
5939880|NCT01347307|20544687|P1|Overall Study|Physician Decision|0
5939881|NCT01347307|20544686|P2|Overall Study|Death|4
5939882|NCT01347307|20544687|P1|Overall Study|Death|0
5939883|NCT01347112|20544722|P2|Overall Study|Lost to Follow-up|5
5939884|NCT01347112|20544723|P1|Overall Study|Lost to Follow-up|3
5939885|NCT01347112|20544722|P2|Overall Study|Withdrawal by Subject|7
5939886|NCT01347112|20544723|P1|Overall Study|Withdrawal by Subject|1
5939887|NCT01347086|20544743|P10|Overall Study|failed screening visit|1
5939888|NCT01347086|20544744|P9|Overall Study|failed screening visit|0
5939889|NCT01347086|20544745|P8|Overall Study|failed screening visit|1
5939890|NCT01347086|20544746|P7|Overall Study|failed screening visit|1
5939891|NCT01347086|20544747|P6|Overall Study|failed screening visit|0
5939892|NCT01347086|20544748|P5|Overall Study|failed screening visit|0
5939893|NCT01347086|20544749|P4|Overall Study|failed screening visit|0
5939894|NCT01347086|20544750|P3|Overall Study|failed screening visit|1
5939895|NCT01347086|20544751|P2|Overall Study|failed screening visit|0
5939896|NCT01347086|20544752|P1|Overall Study|failed screening visit|0
5939897|NCT01347073|20544851|P1|Overall Study|Liver Transplant|1
5939898|NCT01347073|20544851|P1|Overall Study|Adverse Event|1
5939899|NCT01346774|20544930|P2|Overall Study|Adverse Event|2
5939900|NCT01346774|20544931|P1|Overall Study|Adverse Event|1
5939901|NCT01346774|20544930|P2|Overall Study|Protocol Violation|3
5939902|NCT01346774|20544931|P1|Overall Study|Protocol Violation|2
5939903|NCT01346774|20544930|P2|Overall Study|Withdrawal by Subject|4
5939904|NCT01346774|20544931|P1|Overall Study|Withdrawal by Subject|1
5939905|NCT01346774|20544930|P2|Overall Study|Lost to Follow-up|4
5939906|NCT01346774|20544931|P1|Overall Study|Lost to Follow-up|3
5939907|NCT01346774|20544930|P2|Overall Study|Did not take a single dose|4
5939908|NCT01346774|20544931|P1|Overall Study|Did not take a single dose|6
5939909|NCT01346696|20544937|P1|Overall Study|Death|1
5939910|NCT01346592|20544959|P3|Overall Study|Unable to Classify|6
5939911|NCT01346592|20544960|P2|Overall Study|Unable to Classify|3
5939912|NCT01346592|20544961|P1|Overall Study|Unable to Classify|7
5939913|NCT01346592|20544959|P3|Overall Study|Administrative reason|0
5939914|NCT01346592|20544960|P2|Overall Study|Administrative reason|0
5939915|NCT01346592|20544961|P1|Overall Study|Administrative reason|1
5939916|NCT01346592|20544959|P3|Overall Study|Inappropriate enrollment|1
5939917|NCT01346592|20544960|P2|Overall Study|Inappropriate enrollment|1
5939918|NCT01346592|20544961|P1|Overall Study|Inappropriate enrollment|3
5939919|NCT01346592|20544959|P3|Overall Study|Withdrawal by Subject|38
5939920|NCT01346592|20544960|P2|Overall Study|Withdrawal by Subject|51
5939921|NCT01346592|20544961|P1|Overall Study|Withdrawal by Subject|77
5939922|NCT01346592|20544959|P3|Overall Study|Adverse Event|0
5939923|NCT01346592|20544960|P2|Overall Study|Adverse Event|1
5939924|NCT01346592|20544961|P1|Overall Study|Adverse Event|0
5939925|NCT01346592|20544959|P3|Overall Study|Death|4
5939926|NCT01346592|20544960|P2|Overall Study|Death|3
5939927|NCT01346592|20544961|P1|Overall Study|Death|1
5939928|NCT01346592|20544959|P3|Overall Study|Protocol Violation|0
5939929|NCT01346592|20544960|P2|Overall Study|Protocol Violation|1
5939930|NCT01346592|20544961|P1|Overall Study|Protocol Violation|2
5939931|NCT01346592|20544959|P3|Overall Study|Lost to Follow-up|29
5939932|NCT01346592|20544960|P2|Overall Study|Lost to Follow-up|29
5939933|NCT01346592|20544961|P1|Overall Study|Lost to Follow-up|62
5939934|NCT01346540|20545053|P2|Overall Study|Adverse Event|4
5939935|NCT01346540|20545054|P1|Overall Study|Adverse Event|0
5939936|NCT01346540|20545053|P2|Overall Study|Progressive disease-RECIST 1.1 criteria|8
5939937|NCT01346540|20545054|P1|Overall Study|Progressive disease-RECIST 1.1 criteria|3
5939938|NCT01346514|20545065|P2|Overall Study|Death|4
5939939|NCT01346514|20545066|P1|Overall Study|Death|3
5939940|NCT01346514|20545065|P2|Overall Study|Withdrawal by Subject|3
5939941|NCT01346514|20545066|P1|Overall Study|Withdrawal by Subject|7
5939942|NCT01346514|20545065|P2|Overall Study|Lost to Follow-up|30
5939943|NCT01346514|20545066|P1|Overall Study|Lost to Follow-up|19
5939944|NCT01346501|20545086|P2|Overall Study|Other|12
5939945|NCT01346501|20545087|P1|Overall Study|Other|8
5939946|NCT01346501|20545086|P2|Overall Study|Initiated Other Biological Agents|1
5939947|NCT01346501|20545087|P1|Overall Study|Initiated Other Biological Agents|3
5939948|NCT01346475|20545120|P2|First Intervention|Lost to Follow-up|3
5939949|NCT01346475|20545121|P1|First Intervention|Lost to Follow-up|4
5939950|NCT01346410|20545133|P1|Overall Study|Death|1
5939951|NCT01346371|20545151|P2|Overall Study|Lost to Follow-up|0
5939952|NCT01346371|20545152|P1|Overall Study|Lost to Follow-up|2
5939953|NCT01346293|20545160|P2|Overall Study|Other|0
5939954|NCT01346293|20545161|P1|Overall Study|Other|1
5939955|NCT01346293|20545160|P2|Overall Study|Withdrawal by Subject|4
5939956|NCT01346293|20545161|P1|Overall Study|Withdrawal by Subject|15
5939957|NCT01346293|20545160|P2|Overall Study|Lost to Follow-up|8
5939958|NCT01346293|20545161|P1|Overall Study|Lost to Follow-up|21
5939959|NCT01346293|20545160|P2|Overall Study|Protocol Violation|9
5939960|NCT01346293|20545161|P1|Overall Study|Protocol Violation|30
5939961|NCT01346189|20545191|P4|Overall Study|Travel|3
5939962|NCT01346189|20545192|P3|Overall Study|Travel|0
5939963|NCT01346189|20545193|P2|Overall Study|Travel|0
5939964|NCT01346189|20545194|P1|Overall Study|Travel|0
5939965|NCT01346189|20545191|P4|Overall Study|Non-health system primary care physician|0
5939966|NCT01346189|20545192|P3|Overall Study|Non-health system primary care physician|0
5939967|NCT01346189|20545193|P2|Overall Study|Non-health system primary care physician|5
5939968|NCT01346189|20545194|P1|Overall Study|Non-health system primary care physician|0
5939969|NCT01346189|20545191|P4|Overall Study|Death|0
5939970|NCT01346189|20545192|P3|Overall Study|Death|0
5939971|NCT01346189|20545193|P2|Overall Study|Death|3
5939972|NCT01346189|20545194|P1|Overall Study|Death|0
5939973|NCT01346189|20545191|P4|Overall Study|Other|3
5939974|NCT01346189|20545192|P3|Overall Study|Other|7
5939975|NCT01346189|20545193|P2|Overall Study|Other|4
5939976|NCT01346189|20545194|P1|Overall Study|Other|2
5939977|NCT01346189|20545191|P4|Overall Study|Moved|0
5939978|NCT01346189|20545192|P3|Overall Study|Moved|4
5939979|NCT01346189|20545193|P2|Overall Study|Moved|0
5939980|NCT01346189|20545194|P1|Overall Study|Moved|3
5939981|NCT01346189|20545191|P4|Overall Study|Physician Decision|0
5939982|NCT01346189|20545192|P3|Overall Study|Physician Decision|0
5939983|NCT01346189|20545193|P2|Overall Study|Physician Decision|0
5939984|NCT01346189|20545194|P1|Overall Study|Physician Decision|4
5939985|NCT01346189|20545191|P4|Overall Study|Withdrawal by Subject|5
5939986|NCT01346189|20545192|P3|Overall Study|Withdrawal by Subject|3
5939987|NCT01346189|20545193|P2|Overall Study|Withdrawal by Subject|5
5939988|NCT01346189|20545194|P1|Overall Study|Withdrawal by Subject|7
5939989|NCT01346176|20545211|P3|Completed Satisfaction Survey|Lost to Follow-up|4
5939990|NCT01346176|20545212|P2|Completed Satisfaction Survey|Lost to Follow-up|4
5939991|NCT01346176|20545213|P1|Completed Satisfaction Survey|Lost to Follow-up|3
5939992|NCT01346176|20545211|P3|Completed Satisfaction Survey|Death|2
5939993|NCT01346176|20545212|P2|Completed Satisfaction Survey|Death|0
5939994|NCT01346176|20545213|P1|Completed Satisfaction Survey|Death|3
5939995|NCT01346176|20545211|P3|Completed Advance Directive|Other reason did not complete AD|7
5939996|NCT01346176|20545212|P2|Completed Advance Directive|Other reason did not complete AD|12
5939997|NCT01346176|20545213|P1|Completed Advance Directive|Other reason did not complete AD|7
5939998|NCT01346176|20545211|P3|Completed Advance Directive|Became Ineligible|1
5939999|NCT01346176|20545212|P2|Completed Advance Directive|Became Ineligible|0
5940000|NCT01346176|20545213|P1|Completed Advance Directive|Became Ineligible|3
5940001|NCT01346176|20545211|P3|Completed Advance Directive|Death|2
5940002|NCT01346176|20545212|P2|Completed Advance Directive|Death|2
5940003|NCT01346176|20545213|P1|Completed Advance Directive|Death|3
5940004|NCT01346176|20545211|P3|Recruited|Protocol Violation|0
5940005|NCT01346176|20545212|P2|Recruited|Protocol Violation|0
5940006|NCT01346176|20545213|P1|Recruited|Protocol Violation|1
5940007|NCT01346059|20545242|P2|Overall Study|Withdrawal by Subject|0
5940008|NCT01346059|20545243|P1|Overall Study|Withdrawal by Subject|1
5940009|NCT01345929|20545255|P2|Overall Study|Patient withdrawal|1
5940010|NCT01345929|20545256|P1|Overall Study|Patient withdrawal|0
5940011|NCT01345929|20545255|P2|Overall Study|40,000 CFU/ML|0
5940012|NCT01345929|20545256|P1|Overall Study|40,000 CFU/ML|1
5940013|NCT01345929|20545255|P2|Overall Study|Didn't meet eligibility criteria|0
5940014|NCT01345929|20545256|P1|Overall Study|Didn't meet eligibility criteria|2
5940015|NCT01345929|20545255|P2|Overall Study|Adverse Event|1
5940016|NCT01345929|20545256|P1|Overall Study|Adverse Event|0
5940017|NCT01345929|20545255|P2|Overall Study|Lost to Follow-up|9
5940018|NCT01345929|20545256|P1|Overall Study|Lost to Follow-up|9
5940019|NCT01345929|20545255|P2|Overall Study|Withdrawal by Subject|8
5940020|NCT01345929|20545256|P1|Overall Study|Withdrawal by Subject|9
5940021|NCT01345786|20545268|P4|Overall Study|Lost to Follow-up|2
5940022|NCT01345786|20545269|P3|Overall Study|Lost to Follow-up|0
5940023|NCT01345786|20545270|P2|Overall Study|Lost to Follow-up|0
5940024|NCT01345786|20545271|P1|Overall Study|Lost to Follow-up|0
5940025|NCT01345786|20545268|P4|Overall Study|Administrative|0
5940026|NCT01345786|20545269|P3|Overall Study|Administrative|0
5940027|NCT01345786|20545270|P2|Overall Study|Administrative|5
5940028|NCT01345786|20545271|P1|Overall Study|Administrative|3
5940029|NCT01345786|20545268|P4|Overall Study|Noncompliance with protocol|0
5940030|NCT01345786|20545269|P3|Overall Study|Noncompliance with protocol|1
5940031|NCT01345786|20545270|P2|Overall Study|Noncompliance with protocol|0
5940032|NCT01345786|20545271|P1|Overall Study|Noncompliance with protocol|1
5940033|NCT01345786|20545268|P4|Overall Study|Subject withdrew consent|0
5940034|NCT01345786|20545269|P3|Overall Study|Subject withdrew consent|1
5940035|NCT01345786|20545270|P2|Overall Study|Subject withdrew consent|2
5940036|NCT01345786|20545271|P1|Overall Study|Subject withdrew consent|2
5940037|NCT01345786|20545268|P4|Overall Study|Adverse Event|1
5940038|NCT01345786|20545269|P3|Overall Study|Adverse Event|3
5940039|NCT01345786|20545270|P2|Overall Study|Adverse Event|1
5940040|NCT01345786|20545271|P1|Overall Study|Adverse Event|0
5940041|NCT01345682|20545351|P2|Overall Study|Reason other than those specified above|3
5940042|NCT01345682|20545352|P1|Overall Study|Reason other than those specified above|4
5940043|NCT01345682|20545351|P2|Overall Study|Not treated|1
5940044|NCT01345682|20545352|P1|Overall Study|Not treated|2
5940045|NCT01345682|20545351|P2|Overall Study|Refused to continue trial medication|9
5940046|NCT01345682|20545352|P1|Overall Study|Refused to continue trial medication|16
5940047|NCT01345682|20545351|P2|Overall Study|Lost to Follow-up|1
5940048|NCT01345682|20545352|P1|Overall Study|Lost to Follow-up|0
5940049|NCT01345682|20545351|P2|Overall Study|Non-compliance with protocol|1
5940050|NCT01345682|20545352|P1|Overall Study|Non-compliance with protocol|0
5940051|NCT01345682|20545351|P2|Overall Study|Adverse Event|41
5940052|NCT01345682|20545352|P1|Overall Study|Adverse Event|51
5940053|NCT01345682|20545351|P2|Overall Study|Worsening of underlying cancer disease|12
5940054|NCT01345682|20545352|P1|Overall Study|Worsening of underlying cancer disease|23
5940055|NCT01345682|20545351|P2|Overall Study|Progressive disease per RECIST|93
5940056|NCT01345682|20545352|P1|Overall Study|Progressive disease per RECIST|226
5940057|NCT01345669|20545386|P2|Overall Study|Other Reasons|60
5940058|NCT01345669|20545387|P1|Overall Study|Other Reasons|111
5940059|NCT01345669|20545386|P2|Overall Study|Withdrawal by Subject|13
5940060|NCT01345669|20545387|P1|Overall Study|Withdrawal by Subject|52
5940061|NCT01345669|20545386|P2|Overall Study|Lost to Follow-up|1
5940062|NCT01345669|20545387|P1|Overall Study|Lost to Follow-up|1
5940063|NCT01345669|20545386|P2|Overall Study|Protocol Violation|1
5940064|NCT01345669|20545387|P1|Overall Study|Protocol Violation|3
5940065|NCT01345669|20545386|P2|Overall Study|Adverse Event|9
5940066|NCT01345669|20545387|P1|Overall Study|Adverse Event|63
5940067|NCT01345669|20545386|P2|Overall Study|Second primary tumour|3
5940068|NCT01345669|20545387|P1|Overall Study|Second primary tumour|4
5940069|NCT01345669|20545386|P2|Overall Study|Primary tumour recurrence|32
5940070|NCT01345669|20545387|P1|Overall Study|Primary tumour recurrence|53
5940071|NCT01345630|20545405|P2|Overall Study|Insufficient clinical response|11
5940072|NCT01345630|20545406|P1|Overall Study|Insufficient clinical response|48
5940073|NCT01345630|20545405|P2|Overall Study|No longer willing to participate|12
5940074|NCT01345630|20545406|P1|Overall Study|No longer willing to participate|9
5940075|NCT01345630|20545405|P2|Overall Study|Withdrawn due to pregnancy|2
5940076|NCT01345630|20545406|P1|Overall Study|Withdrawn due to pregnancy|1
5940077|NCT01345630|20545405|P2|Overall Study|Other reasons|8
5940078|NCT01345630|20545406|P1|Overall Study|Other reasons|6
5940079|NCT01345630|20545405|P2|Overall Study|Study terminated by sponsor|285
5940080|NCT01345630|20545406|P1|Overall Study|Study terminated by sponsor|254
5940081|NCT01345630|20545405|P2|Overall Study|Medication error without associated AE|1
5940082|NCT01345630|20545406|P1|Overall Study|Medication error without associated AE|0
5940083|NCT01345630|20545405|P2|Overall Study|Protocol Violation|1
5940084|NCT01345630|20545406|P1|Overall Study|Protocol Violation|4
5940085|NCT01345630|20545405|P2|Overall Study|Lost to Follow-up|16
5940086|NCT01345630|20545406|P1|Overall Study|Lost to Follow-up|17
5940087|NCT01345630|20545405|P2|Overall Study|Adverse Event|23
5940088|NCT01345630|20545406|P1|Overall Study|Adverse Event|22
5940089|NCT01345591|20545462|P1|Overall Study|Lost to Follow-up|1
5940090|NCT01345318|20545478|P1|Overall Study|Other|3
5940091|NCT01345318|20545478|P1|Overall Study|Withdrawal by Subject|41
5940092|NCT01345318|20545478|P1|Overall Study|Protocol Violation|1
5940093|NCT01345318|20545478|P1|Overall Study|Lost to Follow-up|2
5940094|NCT01345318|20545478|P1|Overall Study|Lack of Efficacy|17
5940095|NCT01345318|20545478|P1|Overall Study|Adverse Event|16
5940096|NCT01345292|20545486|P3|Overall Study|Withdrawal by Subject|1
5940097|NCT01345292|20545487|P2|Overall Study|Withdrawal by Subject|0
5940098|NCT01345292|20545488|P1|Overall Study|Withdrawal by Subject|2
5940099|NCT01345253|20545519|P2|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1
5940100|NCT01345253|20545520|P1|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1
5940101|NCT01345253|20545519|P2|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|82
5940102|NCT01345253|20545520|P1|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|37
5940103|NCT01345253|20545519|P2|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|24
5940104|NCT01345253|20545520|P1|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|11
5940105|NCT01345253|20545519|P2|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|6
5940106|NCT01345253|20545520|P1|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|4
5940107|NCT01345253|20545519|P2|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|5
5940108|NCT01345253|20545520|P1|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|2
5940109|NCT01345253|20545519|P2|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|7
5940110|NCT01345253|20545520|P1|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|3
5940111|NCT01345253|20545519|P2|Open-label Phase (Up to Year 5 Week 44)|Death|1
5940112|NCT01345253|20545520|P1|Open-label Phase (Up to Year 5 Week 44)|Death|0
5940113|NCT01345253|20545519|P2|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|18
5940114|NCT01345253|20545520|P1|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|7
5940115|NCT01345253|20545519|P2|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|19
5940116|NCT01345253|20545520|P1|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|9
5940117|NCT01345253|20545519|P2|Double-blind (DB) Phase (52 Weeks)|Physician Decision|12
5940118|NCT01345253|20545520|P1|Double-blind (DB) Phase (52 Weeks)|Physician Decision|4
5940119|NCT01345253|20545519|P2|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|8
5940120|NCT01345253|20545520|P1|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|3
5940121|NCT01345253|20545519|P2|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|1
5940122|NCT01345253|20545520|P1|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|6
5940123|NCT01345253|20545519|P2|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|5
5940124|NCT01345253|20545520|P1|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|1
5940125|NCT01345253|20545519|P2|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|7
5940126|NCT01345253|20545520|P1|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|11
5940127|NCT01345253|20545519|P2|Double-blind (DB) Phase (52 Weeks)|Adverse Event|27
5940128|NCT01345253|20545520|P1|Double-blind (DB) Phase (52 Weeks)|Adverse Event|22
5940129|NCT01345240|20545541|P5|Overall Study|Lost to Follow-up|9
5940130|NCT01345240|20545542|P4|Overall Study|Lost to Follow-up|7
5940131|NCT01345240|20545543|P3|Overall Study|Lost to Follow-up|14
5940132|NCT01345240|20545544|P2|Overall Study|Lost to Follow-up|9
5940133|NCT01345240|20545545|P1|Overall Study|Lost to Follow-up|8
5940134|NCT01345240|20545541|P5|Overall Study|Adverse Event|1
5940135|NCT01345240|20545542|P4|Overall Study|Adverse Event|2
5940136|NCT01345240|20545543|P3|Overall Study|Adverse Event|4
5940137|NCT01345240|20545544|P2|Overall Study|Adverse Event|5
5940138|NCT01345240|20545545|P1|Overall Study|Adverse Event|3
5940139|NCT01345188|20545665|P1|Crossover Ranolazine/Placebo 6 Weeks|Lost to Follow-up|1
5940140|NCT01345188|20545665|P1|Randomization Ranolazine/Placebo 6 Weeks|Withdrawal by Subject|2
5940141|NCT01345162|20545677|P2|Overall Study|Protocol Violation|4
5940142|NCT01345162|20545678|P1|Overall Study|Protocol Violation|2
5940143|NCT01345123|20545687|P3|Overall Study|participants no longer with health plan|88
5940144|NCT01345123|20545688|P2|Overall Study|participants no longer with health plan|85
5940145|NCT01345123|20545689|P1|Overall Study|participants no longer with health plan|79
5940146|NCT01345058|20545711|P2|Overall Study|Participant No-Show at Multiple Visits|0
5940147|NCT01345058|20545712|P1|Overall Study|Participant No-Show at Multiple Visits|1
5940148|NCT01345058|20545711|P2|Overall Study|Participant Stopped Taking Study Drug|0
5940149|NCT01345058|20545712|P1|Overall Study|Participant Stopped Taking Study Drug|1
5940231|NCT01344447|20545892|P1|Overall Study|The contrast was not seen|1
5940150|NCT01345058|20545711|P2|Overall Study|Side Effects of Hair Loss and Itchiness|0
5940151|NCT01345058|20545712|P1|Overall Study|Side Effects of Hair Loss and Itchiness|1
5940152|NCT01345058|20545711|P2|Overall Study|Participant Reported Increase in Events|0
5940153|NCT01345058|20545712|P1|Overall Study|Participant Reported Increase in Events|1
5940154|NCT01345058|20545711|P2|Overall Study|Withdrawal by Subject|0
5940155|NCT01345058|20545712|P1|Overall Study|Withdrawal by Subject|1
5940156|NCT01345019|20545728|P2|Open Label Treatment Phase|Protocol Violation|1
5940157|NCT01345019|20545729|P1|Open Label Treatment Phase|Protocol Violation|0
5940158|NCT01345019|20545728|P2|Open Label Treatment Phase|Other, Not Specified|7
5940159|NCT01345019|20545729|P1|Open Label Treatment Phase|Other, Not Specified|9
5940160|NCT01345019|20545728|P2|Open Label Treatment Phase|Pregnancy|0
5940161|NCT01345019|20545729|P1|Open Label Treatment Phase|Pregnancy|1
5940162|NCT01345019|20545728|P2|Open Label Treatment Phase|Lost to Follow-up|2
5940163|NCT01345019|20545729|P1|Open Label Treatment Phase|Lost to Follow-up|1
5940164|NCT01345019|20545728|P2|Open Label Treatment Phase|Noncompliance|4
5940165|NCT01345019|20545729|P1|Open Label Treatment Phase|Noncompliance|5
5940166|NCT01345019|20545728|P2|Open Label Treatment Phase|Disease Progression|18
5940167|NCT01345019|20545729|P1|Open Label Treatment Phase|Disease Progression|17
5940168|NCT01345019|20545728|P2|Open Label Treatment Phase|Administrative Decision|15
5940169|NCT01345019|20545729|P1|Open Label Treatment Phase|Administrative Decision|30
5940170|NCT01345019|20545728|P2|Open Label Treatment Phase|Adverse Event|51
5940171|NCT01345019|20545729|P1|Open Label Treatment Phase|Adverse Event|30
5940172|NCT01345019|20545728|P2|Open Label Treatment Phase|Withdrawal by Subject|47
5940173|NCT01345019|20545729|P1|Open Label Treatment Phase|Withdrawal by Subject|49
5940174|NCT01345019|20545728|P2|Open Label Treatment Phase|Death|48
5940175|NCT01345019|20545729|P1|Open Label Treatment Phase|Death|49
5940176|NCT01345019|20545728|P2|Blinded Treatment Phase|Lost to Follow-up|3
5940177|NCT01345019|20545729|P1|Blinded Treatment Phase|Lost to Follow-up|6
5940178|NCT01345019|20545728|P2|Blinded Treatment Phase|Other, Not Specified|3
5940179|NCT01345019|20545729|P1|Blinded Treatment Phase|Other, Not Specified|2
5940180|NCT01345019|20545728|P2|Blinded Treatment Phase|Protocol Deviation|0
5940181|NCT01345019|20545729|P1|Blinded Treatment Phase|Protocol Deviation|5
5940182|NCT01345019|20545728|P2|Blinded Treatment Phase|Ineligibility Determined|6
5940183|NCT01345019|20545729|P1|Blinded Treatment Phase|Ineligibility Determined|1
5940184|NCT01345019|20545728|P2|Blinded Treatment Phase|Noncompliance|3
5940185|NCT01345019|20545729|P1|Blinded Treatment Phase|Noncompliance|5
5940186|NCT01345019|20545728|P2|Blinded Treatment Phase|Administrative Decision|8
5940187|NCT01345019|20545729|P1|Blinded Treatment Phase|Administrative Decision|10
5940188|NCT01345019|20545728|P2|Blinded Treatment Phase|Adverse Event|13
5940189|NCT01345019|20545729|P1|Blinded Treatment Phase|Adverse Event|6
5940190|NCT01345019|20545728|P2|Blinded Treatment Phase|Disease Progression|10
5940191|NCT01345019|20545729|P1|Blinded Treatment Phase|Disease Progression|12
5940192|NCT01345019|20545728|P2|Blinded Treatment Phase|Completed Survival Follow-up|9
5940193|NCT01345019|20545729|P1|Blinded Treatment Phase|Completed Survival Follow-up|21
5940194|NCT01345019|20545728|P2|Blinded Treatment Phase|Withdrawal by Subject|112
5940195|NCT01345019|20545729|P1|Blinded Treatment Phase|Withdrawal by Subject|103
5940196|NCT01345019|20545728|P2|Blinded Treatment Phase|Death|137
5940197|NCT01345019|20545729|P1|Blinded Treatment Phase|Death|147
5940198|NCT01344876|20545751|P5|Overall Study|Definite progression of primary disease|0
5940199|NCT01344876|20545752|P4|Overall Study|Definite progression of primary disease|3
5940200|NCT01344876|20545753|P3|Overall Study|Definite progression of primary disease|0
5940201|NCT01344876|20545754|P2|Overall Study|Definite progression of primary disease|0
5940202|NCT01344876|20545755|P1|Overall Study|Definite progression of primary disease|1
5940203|NCT01344876|20545751|P5|Overall Study|Withdrawal by Subject|0
5940204|NCT01344876|20545752|P4|Overall Study|Withdrawal by Subject|0
5940205|NCT01344876|20545753|P3|Overall Study|Withdrawal by Subject|1
5940206|NCT01344876|20545754|P2|Overall Study|Withdrawal by Subject|0
5940207|NCT01344876|20545755|P1|Overall Study|Withdrawal by Subject|0
5940208|NCT01344876|20545751|P5|Overall Study|Adverse Event|1
5940209|NCT01344876|20545752|P4|Overall Study|Adverse Event|0
5940210|NCT01344876|20545753|P3|Overall Study|Adverse Event|0
5940211|NCT01344876|20545754|P2|Overall Study|Adverse Event|0
5940212|NCT01344876|20545755|P1|Overall Study|Adverse Event|0
5940213|NCT01344824|20545769|P1|Overall Study|Progression|15
5940214|NCT01344824|20545769|P1|Overall Study|Other complicating disease|1
5940215|NCT01344824|20545769|P1|Overall Study|Withdrawal by Subject|6
5940216|NCT01344824|20545769|P1|Overall Study|Adverse Event|15
5940217|NCT01344759|20545777|P2|Overall Study|Patients failed to reach sedation level|2
5940218|NCT01344759|20545778|P1|Overall Study|Patients failed to reach sedation level|0
5940219|NCT01344629|20545810|P2|Crossover Period 2|Withdrawal by Subject|1
5940220|NCT01344629|20545811|P1|Crossover Period 2|Withdrawal by Subject|0
5940221|NCT01344538|20545840|P2|Overall Study|Lost to Follow-up|0
5940222|NCT01344538|20545841|P1|Overall Study|Lost to Follow-up|1
5940223|NCT01344538|20545840|P2|Overall Study|Adverse Event|1
5940224|NCT01344538|20545841|P1|Overall Study|Adverse Event|1
5940225|NCT01344460|20545847|P1|Overall Study|Lost to Follow-up|2
5940226|NCT01344460|20545847|P1|Overall Study|Withdrawal by Subject|1
5940227|NCT01344447|20545892|P1|Overall Study|Error of power injector|1
5940228|NCT01344447|20545892|P1|Overall Study|Bolus tracking failed|1
5940229|NCT01344447|20545892|P1|Overall Study|MRA unsuccessful|1
5940230|NCT01344447|20545892|P1|Overall Study|Physician Decision|1
5940232|NCT01344447|20545892|P1|Overall Study|Withdrawal by Subject|1
5940233|NCT01344447|20545892|P1|Overall Study|Protocol Violation|1
5940234|NCT01344447|20545892|P1|Overall Study|Adverse Event|1
5940235|NCT01344369|20545936|P2|Second Intervention|Emesis within 2 x Tmax|1
5940236|NCT01344369|20545937|P1|Second Intervention|Emesis within 2 x Tmax|0
5940237|NCT01344369|20545936|P2|Washout of 28 Days|Physician Decision|1
5940238|NCT01344369|20545937|P1|Washout of 28 Days|Physician Decision|0
5940239|NCT01344369|20545936|P2|Washout of 28 Days|Withdrawal by Subject|0
5940240|NCT01344369|20545937|P1|Washout of 28 Days|Withdrawal by Subject|1
5940241|NCT01344356|20545955|P2|Overall Study|Lost to Follow-up|6
5940242|NCT01344356|20545956|P1|Overall Study|Lost to Follow-up|0
5940243|NCT01344356|20545955|P2|Overall Study|Physician Decision|3
5940244|NCT01344356|20545956|P1|Overall Study|Physician Decision|0
5940245|NCT01344226|20545968|P1|Overall Study|Lack of Efficacy|3
5940246|NCT01344226|20545968|P1|Overall Study|Withdrawal by Subject|3
5940247|NCT01344226|20545968|P1|Overall Study|Protocol Violation|2
5940248|NCT01344161|20545977|P2|Overall Study|Protocol Violation|1
5940249|NCT01344161|20545978|P1|Overall Study|Protocol Violation|1
5940250|NCT01344161|20545977|P2|Overall Study|Pregnancy|1
5940251|NCT01344161|20545978|P1|Overall Study|Pregnancy|0
5940252|NCT01344161|20545977|P2|Overall Study|Lost to Follow-up|1
5940253|NCT01344161|20545978|P1|Overall Study|Lost to Follow-up|4
5940254|NCT01344057|20545990|P1|Overall Study|Premature Withdrawal|1
5940255|NCT01343901|20545997|P1|Overall Study|Participant decision|1
5940256|NCT01343901|20545997|P1|Overall Study|Management by another medical team|11
5940257|NCT01343901|20545997|P1|Overall Study|Lost to Follow-up|12
5940258|NCT01343901|20545997|P1|Overall Study|Physician Decision|4
5940259|NCT01343901|20545997|P1|Overall Study|Death|85
5940260|NCT01343888|20546021|P3|Overall Study|other than stated above|1
5940261|NCT01343888|20546022|P2|Overall Study|other than stated above|0
5940262|NCT01343888|20546023|P1|Overall Study|other than stated above|0
5940263|NCT01343888|20546021|P3|Overall Study|Withdrawal by Subject|2
5940264|NCT01343888|20546022|P2|Overall Study|Withdrawal by Subject|4
5940265|NCT01343888|20546023|P1|Overall Study|Withdrawal by Subject|4
5940266|NCT01343888|20546021|P3|Overall Study|Protocol Violation|0
5940267|NCT01343888|20546022|P2|Overall Study|Protocol Violation|2
5940268|NCT01343888|20546023|P1|Overall Study|Protocol Violation|0
5940269|NCT01343888|20546021|P3|Overall Study|Lost to Follow-up|1
5940270|NCT01343888|20546022|P2|Overall Study|Lost to Follow-up|2
5940271|NCT01343888|20546023|P1|Overall Study|Lost to Follow-up|0
5940272|NCT01343888|20546021|P3|Overall Study|Lack of Efficacy|13
5940273|NCT01343888|20546022|P2|Overall Study|Lack of Efficacy|9
5940274|NCT01343888|20546023|P1|Overall Study|Lack of Efficacy|9
5940275|NCT01343888|20546021|P3|Overall Study|Adverse Event|5
5940276|NCT01343888|20546022|P2|Overall Study|Adverse Event|22
5940277|NCT01343888|20546023|P1|Overall Study|Adverse Event|12
5940278|NCT01343823|20546065|P4|Overall Study|Withdrawal by Subject|0
5940279|NCT01343823|20546066|P3|Overall Study|Withdrawal by Subject|0
5940280|NCT01343823|20546067|P2|Overall Study|Withdrawal by Subject|0
5940281|NCT01343823|20546068|P1|Overall Study|Withdrawal by Subject|1
5940282|NCT01343823|20546065|P4|Overall Study|Study Terminated|1
5940283|NCT01343823|20546066|P3|Overall Study|Study Terminated|0
5940284|NCT01343823|20546067|P2|Overall Study|Study Terminated|0
5940285|NCT01343823|20546068|P1|Overall Study|Study Terminated|1
5940286|NCT01343693|20546082|P1|Overall Study|Lost to Follow-up|9
5940287|NCT01343407|20546105|P6|Second Washout (Part 2)|Withdrawal by Subject|0
5940288|NCT01343407|20546106|P5|Second Washout (Part 2)|Withdrawal by Subject|0
5940289|NCT01343407|20546107|P4|Second Washout (Part 2)|Withdrawal by Subject|0
5940290|NCT01343407|20546108|P3|Second Washout (Part 2)|Withdrawal by Subject|1
5940291|NCT01343407|20546109|P2|Second Washout (Part 2)|Withdrawal by Subject|0
5940292|NCT01343407|20546110|P1|Second Washout (Part 2)|Withdrawal by Subject|0
5940293|NCT01343407|20546105|P6|Second Treatment Period (Part 2)|Adverse Event|0
5940294|NCT01343407|20546106|P5|Second Treatment Period (Part 2)|Adverse Event|0
5940295|NCT01343407|20546107|P4|Second Treatment Period (Part 2)|Adverse Event|0
5940296|NCT01343407|20546108|P3|Second Treatment Period (Part 2)|Adverse Event|1
5940297|NCT01343407|20546109|P2|Second Treatment Period (Part 2)|Adverse Event|0
5940298|NCT01343407|20546110|P1|Second Treatment Period (Part 2)|Adverse Event|0
5940299|NCT01343368|20546138|P2|Overall Study|Lost to Follow-up|0
5940300|NCT01343368|20546139|P1|Overall Study|Lost to Follow-up|1
5940301|NCT01343368|20546138|P2|Overall Study|Death|0
5940302|NCT01343368|20546139|P1|Overall Study|Death|1
5940303|NCT01343277|20546175|P2|Overall Study|Subsequent anticancer therapy|0
5940304|NCT01343277|20546176|P1|Overall Study|Subsequent anticancer therapy|1
5940305|NCT01343277|20546175|P2|Overall Study|Treatment ongoing|2
5940306|NCT01343277|20546176|P1|Overall Study|Treatment ongoing|8
5940307|NCT01343277|20546175|P2|Overall Study|Randomized not treated|21
5940308|NCT01343277|20546176|P1|Overall Study|Randomized not treated|6
5940309|NCT01343277|20546175|P2|Overall Study|Disease progression|138
5940310|NCT01343277|20546176|P1|Overall Study|Disease progression|270
5940311|NCT01343277|20546175|P2|Overall Study|Adverse Event|13
5940312|NCT01343277|20546176|P1|Overall Study|Adverse Event|67
5940313|NCT01343277|20546175|P2|Overall Study|Death|1
5940314|NCT01343277|20546176|P1|Overall Study|Death|10
5940315|NCT01343277|20546175|P2|Overall Study|Physician Decision|2
5940316|NCT01343277|20546176|P1|Overall Study|Physician Decision|1
5940317|NCT01343277|20546175|P2|Overall Study|Withdrawal by Subject|13
5940318|NCT01343277|20546176|P1|Overall Study|Withdrawal by Subject|18
5940319|NCT01343277|20546175|P2|Overall Study|Other|3
5940320|NCT01343277|20546176|P1|Overall Study|Other|3
5940321|NCT01343082|20546237|P3|Treatment Period , Switched to DE-111|Withdrawal by Subject|5
5940322|NCT01343082|20546238|P2|Treatment Period , Switched to DE-111|Withdrawal by Subject|2
5940323|NCT01343082|20546239|P1|Treatment Period , Switched to DE-111|Withdrawal by Subject|4
5940324|NCT01343082|20546237|P3|Treatment Period , Switched to DE-111|Physician Decision|2
5940325|NCT01343082|20546238|P2|Treatment Period , Switched to DE-111|Physician Decision|2
5940326|NCT01343082|20546239|P1|Treatment Period , Switched to DE-111|Physician Decision|0
5940327|NCT01343082|20546237|P3|Treatment Period , Switched to DE-111|Lack of Efficacy|2
5940328|NCT01343082|20546238|P2|Treatment Period , Switched to DE-111|Lack of Efficacy|1
5940329|NCT01343082|20546239|P1|Treatment Period , Switched to DE-111|Lack of Efficacy|0
5940330|NCT01343082|20546237|P3|Treatment Period , Switched to DE-111|Adverse Event|3
5940331|NCT01343082|20546238|P2|Treatment Period , Switched to DE-111|Adverse Event|4
5940332|NCT01343082|20546239|P1|Treatment Period , Switched to DE-111|Adverse Event|1
5940333|NCT01343082|20546237|P3|The run-in Period|Not meeting criteria|5
5940334|NCT01343082|20546238|P2|The run-in Period|Not meeting criteria|4
5940335|NCT01343082|20546239|P1|The run-in Period|Not meeting criteria|3
5940336|NCT01343056|20546247|P4|Overall Study|Lost to Follow-up|9
5940337|NCT01343056|20546248|P3|Overall Study|Lost to Follow-up|3
5940338|NCT01343056|20546249|P2|Overall Study|Lost to Follow-up|5
5940339|NCT01343056|20546250|P1|Overall Study|Lost to Follow-up|7
5940340|NCT01343043|20546292|P4|Overall Study|Death|1
5940341|NCT01343043|20546293|P3|Overall Study|Death|0
5940342|NCT01343043|20546294|P2|Overall Study|Death|1
5940343|NCT01343043|20546295|P1|Overall Study|Death|1
5940344|NCT01343043|20546292|P4|Overall Study|Withdrawal by Subject|0
5940345|NCT01343043|20546293|P3|Overall Study|Withdrawal by Subject|0
5940346|NCT01343043|20546294|P2|Overall Study|Withdrawal by Subject|0
5940347|NCT01343043|20546295|P1|Overall Study|Withdrawal by Subject|1
5940348|NCT01343043|20546292|P4|Overall Study|Disease progression before treatment|0
5940349|NCT01343043|20546293|P3|Overall Study|Disease progression before treatment|0
5940350|NCT01343043|20546294|P2|Overall Study|Disease progression before treatment|0
5940351|NCT01343043|20546295|P1|Overall Study|Disease progression before treatment|1
5940352|NCT01342965|20546383|P2|Overall Study|Withdrawal by Subject|9
5940353|NCT01342965|20546384|P1|Overall Study|Withdrawal by Subject|2
5940354|NCT01342965|20546383|P2|Overall Study|Other Reasons- Unspecified|38
5940355|NCT01342965|20546384|P1|Overall Study|Other Reasons- Unspecified|44
5940356|NCT01342965|20546383|P2|Overall Study|Lost to Follow-up|3
5940357|NCT01342965|20546384|P1|Overall Study|Lost to Follow-up|5
5940358|NCT01342965|20546383|P2|Overall Study|Death|57
5940359|NCT01342965|20546384|P1|Overall Study|Death|58
5940360|NCT01342926|20546402|P4|Overall Study|Withdrawal by Subject|5
5940361|NCT01342926|20546403|P3|Overall Study|Withdrawal by Subject|3
5940362|NCT01342926|20546404|P2|Overall Study|Withdrawal by Subject|4
5940363|NCT01342926|20546405|P1|Overall Study|Withdrawal by Subject|2
5940364|NCT01342926|20546402|P4|Overall Study|Investigator Discretion|0
5940365|NCT01342926|20546403|P3|Overall Study|Investigator Discretion|0
5940366|NCT01342926|20546404|P2|Overall Study|Investigator Discretion|2
5940367|NCT01342926|20546405|P1|Overall Study|Investigator Discretion|2
5940368|NCT01342926|20546402|P4|Overall Study|Lost to Follow-up|0
5940369|NCT01342926|20546403|P3|Overall Study|Lost to Follow-up|1
5940370|NCT01342926|20546404|P2|Overall Study|Lost to Follow-up|1
5940371|NCT01342926|20546405|P1|Overall Study|Lost to Follow-up|0
5940372|NCT01342926|20546402|P4|Overall Study|Adverse Event|7
5940373|NCT01342926|20546403|P3|Overall Study|Adverse Event|10
5940374|NCT01342926|20546404|P2|Overall Study|Adverse Event|8
5940375|NCT01342926|20546405|P1|Overall Study|Adverse Event|5
5940376|NCT01342913|20546485|P3|Double-Blind Treatment Period|Withdrawal by Subject|2
5940377|NCT01342913|20546486|P2|Double-Blind Treatment Period|Withdrawal by Subject|2
5940378|NCT01342913|20546487|P1|Double-Blind Treatment Period|Withdrawal by Subject|0
5940379|NCT01342913|20546485|P3|Double-Blind Treatment Period|Physician Decision|0
5940380|NCT01342913|20546486|P2|Double-Blind Treatment Period|Physician Decision|2
5940381|NCT01342913|20546487|P1|Double-Blind Treatment Period|Physician Decision|0
5940382|NCT01342913|20546485|P3|Double-Blind Treatment Period|Lost to Follow-up|3
5940383|NCT01342913|20546486|P2|Double-Blind Treatment Period|Lost to Follow-up|1
5940384|NCT01342913|20546487|P1|Double-Blind Treatment Period|Lost to Follow-up|0
5940385|NCT01342913|20546485|P3|Double-Blind Treatment Period|Protocol Violation|9
5940386|NCT01342913|20546486|P2|Double-Blind Treatment Period|Protocol Violation|6
5940387|NCT01342913|20546487|P1|Double-Blind Treatment Period|Protocol Violation|0
5940388|NCT01342913|20546485|P3|Double-Blind Treatment Period|Lack of Efficacy|3
5940389|NCT01342913|20546486|P2|Double-Blind Treatment Period|Lack of Efficacy|2
5940390|NCT01342913|20546487|P1|Double-Blind Treatment Period|Lack of Efficacy|0
5940391|NCT01342913|20546485|P3|Double-Blind Treatment Period|Adverse Event|6
5940392|NCT01342913|20546486|P2|Double-Blind Treatment Period|Adverse Event|3
5940393|NCT01342913|20546487|P1|Double-Blind Treatment Period|Adverse Event|0
5940394|NCT01342913|20546485|P3|2-week Run-in Period|Continuation Criteria Not Met|0
5940395|NCT01342913|20546486|P2|2-week Run-in Period|Continuation Criteria Not Met|0
5940396|NCT01342913|20546487|P1|2-week Run-in Period|Continuation Criteria Not Met|88
5940397|NCT01342913|20546485|P3|2-week Run-in Period|Protocol Violation|0
5940398|NCT01342913|20546486|P2|2-week Run-in Period|Protocol Violation|0
5940399|NCT01342913|20546487|P1|2-week Run-in Period|Protocol Violation|5
5940400|NCT01342913|20546485|P3|2-week Run-in Period|Adverse Event|0
5940401|NCT01342913|20546486|P2|2-week Run-in Period|Adverse Event|0
5940402|NCT01342913|20546487|P1|2-week Run-in Period|Adverse Event|2
5940403|NCT01342913|20546485|P3|2-week Run-in Period|Withdrawal by Subject|0
5940404|NCT01342913|20546486|P2|2-week Run-in Period|Withdrawal by Subject|0
5940405|NCT01342913|20546487|P1|2-week Run-in Period|Withdrawal by Subject|7
5940406|NCT01342913|20546485|P3|2-week Run-in Period|Physician Decision|0
5940407|NCT01342913|20546486|P2|2-week Run-in Period|Physician Decision|0
5940408|NCT01342913|20546487|P1|2-week Run-in Period|Physician Decision|6
5940409|NCT01342913|20546485|P3|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0
5940410|NCT01342913|20546486|P2|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0
5940411|NCT01342913|20546487|P1|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|66
5940412|NCT01342887|20546497|P1|Overall Study|Death|2
5940413|NCT01342640|20546538|P1|Overall Study|Other|1
5940414|NCT01342640|20546538|P1|Overall Study|Lost to Follow-up|21
5940415|NCT01342640|20546538|P1|Overall Study|Protocol Violation|16
5940416|NCT01342640|20546538|P1|Overall Study|Adverse Event|3
5940417|NCT01342510|20546633|P4|Overall Study|Protocol Violation|11
5940418|NCT01342510|20546634|P3|Overall Study|Protocol Violation|13
5940419|NCT01342510|20546635|P2|Overall Study|Protocol Violation|6
5940420|NCT01342510|20546636|P1|Overall Study|Protocol Violation|12
5940421|NCT01342484|20546653|P3|Overall Study|Withdrawal by Subject|0
5940422|NCT01342484|20546654|P2|Overall Study|Withdrawal by Subject|0
5940423|NCT01342484|20546655|P1|Overall Study|Withdrawal by Subject|1
5940424|NCT01342484|20546653|P3|Overall Study|Protocol Violation|1
5940425|NCT01342484|20546654|P2|Overall Study|Protocol Violation|0
5940426|NCT01342484|20546655|P1|Overall Study|Protocol Violation|0
5940427|NCT01342484|20546653|P3|Overall Study|Other Reasons|0
5940428|NCT01342484|20546654|P2|Overall Study|Other Reasons|0
5940429|NCT01342484|20546655|P1|Overall Study|Other Reasons|1
5940430|NCT01342445|20546711|P2|Overall Study|Experienced side effects|2
5940431|NCT01342445|20546712|P1|Overall Study|Experienced side effects|0
5940432|NCT01342341|20546728|P2|Overall Study|Lost to Follow-up|4
5940433|NCT01342341|20546729|P1|Overall Study|Lost to Follow-up|4
5940434|NCT01342211|20546740|P5|Overall Study|Randomized, but not Treated|1
5940435|NCT01342211|20546741|P4|Overall Study|Randomized, but not Treated|0
5940436|NCT01342211|20546742|P3|Overall Study|Randomized, but not Treated|0
5940437|NCT01342211|20546743|P2|Overall Study|Randomized, but not Treated|2
5940438|NCT01342211|20546744|P1|Overall Study|Randomized, but not Treated|0
5940439|NCT01342211|20546740|P5|Overall Study|Withdrawal by Subject|0
5940440|NCT01342211|20546741|P4|Overall Study|Withdrawal by Subject|1
5940441|NCT01342211|20546742|P3|Overall Study|Withdrawal by Subject|0
5940442|NCT01342211|20546743|P2|Overall Study|Withdrawal by Subject|0
5940443|NCT01342211|20546744|P1|Overall Study|Withdrawal by Subject|0
5940444|NCT01342211|20546740|P5|Overall Study|Adverse Event|1
5940445|NCT01342211|20546741|P4|Overall Study|Adverse Event|0
5940446|NCT01342211|20546742|P3|Overall Study|Adverse Event|0
5940447|NCT01342211|20546743|P2|Overall Study|Adverse Event|0
5940448|NCT01342211|20546744|P1|Overall Study|Adverse Event|0
5940449|NCT01342211|20546740|P5|Overall Study|Lost to Follow-up|0
5940450|NCT01342211|20546741|P4|Overall Study|Lost to Follow-up|1
5940451|NCT01342211|20546742|P3|Overall Study|Lost to Follow-up|0
5940452|NCT01342211|20546743|P2|Overall Study|Lost to Follow-up|0
5940453|NCT01342211|20546744|P1|Overall Study|Lost to Follow-up|0
5940454|NCT01342094|20546832|P2|Overall Study|Withdrawal by Subject|2
5940455|NCT01342094|20546833|P1|Overall Study|Withdrawal by Subject|0
5940456|NCT01342094|20546832|P2|Overall Study|Not meeting inclusion/exclusion criteria|1
5940457|NCT01342094|20546833|P1|Overall Study|Not meeting inclusion/exclusion criteria|0
5940458|NCT01342094|20546832|P2|Overall Study|Adverse Event|0
5940459|NCT01342094|20546833|P1|Overall Study|Adverse Event|5
5940460|NCT01342081|20546842|P3|Overall Study|Withdrawal by Subject|0
5940461|NCT01342081|20546843|P2|Overall Study|Withdrawal by Subject|1
5940462|NCT01342081|20546844|P1|Overall Study|Withdrawal by Subject|1
5940463|NCT01342081|20546842|P3|Overall Study|Physician Decision|0
5940464|NCT01342081|20546843|P2|Overall Study|Physician Decision|1
5940465|NCT01342081|20546844|P1|Overall Study|Physician Decision|0
5940466|NCT01342081|20546842|P3|Overall Study|Adverse Event|0
5940467|NCT01342081|20546843|P2|Overall Study|Adverse Event|0
5940468|NCT01342081|20546844|P1|Overall Study|Adverse Event|1
5940469|NCT01342081|20546842|P3|Overall Study|Did not receive allocated intervention|1
5940470|NCT01342081|20546843|P2|Overall Study|Did not receive allocated intervention|0
5940471|NCT01342081|20546844|P1|Overall Study|Did not receive allocated intervention|0
5940472|NCT01341990|20546863|P2|Overall Study|Withdrawal by Subject|0
5940473|NCT01341990|20546864|P1|Overall Study|Withdrawal by Subject|2
5940474|NCT01341990|20546863|P2|Overall Study|Torn Study Lens|0
5940475|NCT01341990|20546864|P1|Overall Study|Torn Study Lens|1
5940476|NCT01341990|20546863|P2|Overall Study|Adverse Event|1
5940477|NCT01341990|20546864|P1|Overall Study|Adverse Event|0
5940478|NCT01341782|20546888|P2|Overall Study|Other|0
5940479|NCT01341782|20546889|P1|Overall Study|Other|5
5940480|NCT01341782|20546888|P2|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3
5940481|NCT01341782|20546889|P1|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3
5940482|NCT01341782|20546888|P2|Overall Study|2 consecutive calcium values >11.5 mg/dL|1
5940483|NCT01341782|20546889|P1|Overall Study|2 consecutive calcium values >11.5 mg/dL|0
5940484|NCT01341782|20546888|P2|Overall Study|Missed 3 consecutive doses|4
5940485|NCT01341782|20546889|P1|Overall Study|Missed 3 consecutive doses|0
5940486|NCT01341782|20546888|P2|Overall Study|Withdrawal by Subject|5
5940487|NCT01341782|20546889|P1|Overall Study|Withdrawal by Subject|6
5940488|NCT01341782|20546888|P2|Overall Study|Adverse Event|1
5940489|NCT01341782|20546889|P1|Overall Study|Adverse Event|1
5940490|NCT01341652|20546918|P2|Overall Study|ineligible; presence metastatic disease|1
5940491|NCT01341652|20546919|P1|Overall Study|ineligible; presence metastatic disease|0
5940492|NCT01341652|20546918|P2|Overall Study|Incorrect Random Assignment|1
5940493|NCT01341652|20546919|P1|Overall Study|Incorrect Random Assignment|0
5940494|NCT01341639|20546935|P2|Post-Treatment|Adverse Event|2
5940495|NCT01341639|20546936|P1|Post-Treatment|Adverse Event|0
5940496|NCT01341639|20546935|P2|Post-Treatment|Withdrawal by Subject|1
5940497|NCT01341639|20546936|P1|Post-Treatment|Withdrawal by Subject|0
5940498|NCT01341639|20546935|P2|Interim Period|Protocol Violation|1
5940499|NCT01341639|20546936|P1|Interim Period|Protocol Violation|0
5940500|NCT01341639|20546935|P2|Interim Period|Physician Decision|1
5940501|NCT01341639|20546936|P1|Interim Period|Physician Decision|0
5940502|NCT01341639|20546935|P2|Interim Period|Lost to Follow-up|0
5940503|NCT01341639|20546936|P1|Interim Period|Lost to Follow-up|2
5940504|NCT01341639|20546935|P2|Interim Period|Withdrawal by Subject|7
5940505|NCT01341639|20546936|P1|Interim Period|Withdrawal by Subject|6
5940506|NCT01341639|20546935|P2|Infant Series|Site 0048 Participants|16
5940507|NCT01341639|20546936|P1|Infant Series|Site 0048 Participants|17
5940508|NCT01341639|20546935|P2|Infant Series|Lost to Follow-up|2
5940509|NCT01341639|20546936|P1|Infant Series|Lost to Follow-up|0
5940510|NCT01341639|20546935|P2|Infant Series|Withdrawal by Subject|8
5940511|NCT01341639|20546936|P1|Infant Series|Withdrawal by Subject|11
5940512|NCT01341639|20546935|P2|Infant Series|Adverse Event|5
5940513|NCT01341639|20546936|P1|Infant Series|Adverse Event|0
5940514|NCT01341639|20546935|P2|Infant Series|Not Vaccinated|1
5940515|NCT01341639|20546936|P1|Infant Series|Not Vaccinated|0
5940516|NCT01341639|20546935|P2|Infant Series|Protocol Violation|0
5940517|NCT01341639|20546936|P1|Infant Series|Protocol Violation|1
5940518|NCT01341587|20546981|P2|Overall Study|stopped using the meters|10
5940519|NCT01341587|20546982|P1|Overall Study|stopped using the meters|2
5940520|NCT01341587|20546981|P2|Overall Study|Lost to Follow-up|0
5940521|NCT01341587|20546982|P1|Overall Study|Lost to Follow-up|2
5940522|NCT01341470|20546994|P6|Overall Study|Sponsor decision|1
5940523|NCT01341470|20546995|P5|Overall Study|Sponsor decision|0
5940524|NCT01341470|20546996|P4|Overall Study|Sponsor decision|1
5940525|NCT01341470|20546997|P3|Overall Study|Sponsor decision|1
5940526|NCT01341470|20546998|P2|Overall Study|Sponsor decision|0
5940527|NCT01341470|20546999|P1|Overall Study|Sponsor decision|0
5940528|NCT01341457|20547033|P2|Overall Study|Adverse Event|0
5940529|NCT01341457|20547034|P1|Overall Study|Adverse Event|2
5940530|NCT01340976|20547079|P6|Overall Study|Adverse Event|0
5940531|NCT01340976|20547080|P5|Overall Study|Adverse Event|0
5940532|NCT01340976|20547081|P4|Overall Study|Adverse Event|0
5940533|NCT01340976|20547082|P3|Overall Study|Adverse Event|0
5940534|NCT01340976|20547083|P2|Overall Study|Adverse Event|1
5940535|NCT01340976|20547084|P1|Overall Study|Adverse Event|0
5940536|NCT01340976|20547079|P6|Overall Study|Other anemia treatment|1
5940537|NCT01340976|20547080|P5|Overall Study|Other anemia treatment|0
5940538|NCT01340976|20547081|P4|Overall Study|Other anemia treatment|1
5940539|NCT01340976|20547082|P3|Overall Study|Other anemia treatment|2
5940540|NCT01340976|20547083|P2|Overall Study|Other anemia treatment|0
5940541|NCT01340976|20547084|P1|Overall Study|Other anemia treatment|1
5940542|NCT01340976|20547079|P6|Overall Study|Withdrawal by Subject|0
5940543|NCT01340976|20547080|P5|Overall Study|Withdrawal by Subject|1
5940544|NCT01340976|20547081|P4|Overall Study|Withdrawal by Subject|1
5940545|NCT01340976|20547082|P3|Overall Study|Withdrawal by Subject|0
5940546|NCT01340976|20547083|P2|Overall Study|Withdrawal by Subject|0
5940547|NCT01340976|20547084|P1|Overall Study|Withdrawal by Subject|0
5940548|NCT01340976|20547079|P6|Overall Study|Dose Limiting Toxicity Stopping Rule|0
5940549|NCT01340976|20547080|P5|Overall Study|Dose Limiting Toxicity Stopping Rule|0
5940550|NCT01340976|20547081|P4|Overall Study|Dose Limiting Toxicity Stopping Rule|0
5940551|NCT01340976|20547082|P3|Overall Study|Dose Limiting Toxicity Stopping Rule|0
5940552|NCT01340976|20547083|P2|Overall Study|Dose Limiting Toxicity Stopping Rule|0
5940553|NCT01340976|20547084|P1|Overall Study|Dose Limiting Toxicity Stopping Rule|1
5940554|NCT01340976|20547079|P6|Overall Study|Death|0
5940555|NCT01340976|20547080|P5|Overall Study|Death|0
5940556|NCT01340976|20547081|P4|Overall Study|Death|0
5940557|NCT01340976|20547082|P3|Overall Study|Death|0
5940558|NCT01340976|20547083|P2|Overall Study|Death|1
5940559|NCT01340976|20547084|P1|Overall Study|Death|0
5940560|NCT01340976|20547079|P6|Overall Study|Physician Decision|0
5940561|NCT01340976|20547080|P5|Overall Study|Physician Decision|1
5940562|NCT01340976|20547081|P4|Overall Study|Physician Decision|1
5940563|NCT01340976|20547082|P3|Overall Study|Physician Decision|1
5940564|NCT01340976|20547083|P2|Overall Study|Physician Decision|0
5940565|NCT01340976|20547084|P1|Overall Study|Physician Decision|2
5940566|NCT01340937|20547122|P4|Period 3: Toddler Vaccinations|Technical problem|0
5940567|NCT01340937|20547123|P3|Period 3: Toddler Vaccinations|Technical problem|1
5940568|NCT01340937|20547124|P2|Period 3: Toddler Vaccinations|Technical problem|1
5940569|NCT01340937|20547125|P1|Period 3: Toddler Vaccinations|Technical problem|1
5940570|NCT01340937|20547122|P4|Period 3: Toddler Vaccinations|Protocol Violation|1
5940571|NCT01340937|20547123|P3|Period 3: Toddler Vaccinations|Protocol Violation|0
5940572|NCT01340937|20547124|P2|Period 3: Toddler Vaccinations|Protocol Violation|0
5940573|NCT01340937|20547125|P1|Period 3: Toddler Vaccinations|Protocol Violation|0
5940574|NCT01340937|20547122|P4|Period 3: Toddler Vaccinations|Lost to Follow-up|8
5940575|NCT01340937|20547123|P3|Period 3: Toddler Vaccinations|Lost to Follow-up|7
5940576|NCT01340937|20547124|P2|Period 3: Toddler Vaccinations|Lost to Follow-up|14
5940577|NCT01340937|20547125|P1|Period 3: Toddler Vaccinations|Lost to Follow-up|6
5940578|NCT01340937|20547122|P4|Period 3: Toddler Vaccinations|Withdrawal by Subject|1
5940579|NCT01340937|20547123|P3|Period 3: Toddler Vaccinations|Withdrawal by Subject|1
5940580|NCT01340937|20547124|P2|Period 3: Toddler Vaccinations|Withdrawal by Subject|2
5940581|NCT01340937|20547125|P1|Period 3: Toddler Vaccinations|Withdrawal by Subject|2
5940582|NCT01340937|20547122|P4|Period 2: Interim Period|Technical problems|3
5940583|NCT01340937|20547123|P3|Period 2: Interim Period|Technical problems|6
5940584|NCT01340937|20547124|P2|Period 2: Interim Period|Technical problems|4
5940585|NCT01340937|20547125|P1|Period 2: Interim Period|Technical problems|4
5940586|NCT01340937|20547122|P4|Period 2: Interim Period|Protocol Violation|3
5940587|NCT01340937|20547123|P3|Period 2: Interim Period|Protocol Violation|6
5940588|NCT01340937|20547124|P2|Period 2: Interim Period|Protocol Violation|3
5940589|NCT01340937|20547125|P1|Period 2: Interim Period|Protocol Violation|5
5940590|NCT01340937|20547122|P4|Period 2: Interim Period|Physician Decision|0
5940591|NCT01340937|20547123|P3|Period 2: Interim Period|Physician Decision|1
5940592|NCT01340937|20547124|P2|Period 2: Interim Period|Physician Decision|1
5940593|NCT01340937|20547125|P1|Period 2: Interim Period|Physician Decision|0
5940594|NCT01340937|20547122|P4|Period 2: Interim Period|Lost to Follow-up|23
5940595|NCT01340937|20547123|P3|Period 2: Interim Period|Lost to Follow-up|53
5940596|NCT01340937|20547124|P2|Period 2: Interim Period|Lost to Follow-up|48
5940597|NCT01340937|20547125|P1|Period 2: Interim Period|Lost to Follow-up|29
5940598|NCT01340937|20547122|P4|Period 2: Interim Period|Adverse Event|0
5940599|NCT01340937|20547123|P3|Period 2: Interim Period|Adverse Event|1
5940600|NCT01340937|20547124|P2|Period 2: Interim Period|Adverse Event|0
5940601|NCT01340937|20547125|P1|Period 2: Interim Period|Adverse Event|1
5940602|NCT01340937|20547122|P4|Period 2: Interim Period|Withdrawal by Subject|12
5940603|NCT01340937|20547123|P3|Period 2: Interim Period|Withdrawal by Subject|17
5940604|NCT01340937|20547124|P2|Period 2: Interim Period|Withdrawal by Subject|23
5940605|NCT01340937|20547125|P1|Period 2: Interim Period|Withdrawal by Subject|28
5940606|NCT01340937|20547122|P4|Period 1: Infant Series|Randomized but not vaccinated|1
5940607|NCT01340937|20547123|P3|Period 1: Infant Series|Randomized but not vaccinated|2
5940608|NCT01340937|20547124|P2|Period 1: Infant Series|Randomized but not vaccinated|5
5940609|NCT01340937|20547125|P1|Period 1: Infant Series|Randomized but not vaccinated|0
5940610|NCT01340937|20547122|P4|Period 1: Infant Series|Withdrawal by Subject|15
5940611|NCT01340937|20547123|P3|Period 1: Infant Series|Withdrawal by Subject|30
5940612|NCT01340937|20547124|P2|Period 1: Infant Series|Withdrawal by Subject|32
5940613|NCT01340937|20547125|P1|Period 1: Infant Series|Withdrawal by Subject|33
5940614|NCT01340937|20547122|P4|Period 1: Infant Series|Protocol Violation|3
5940615|NCT01340937|20547123|P3|Period 1: Infant Series|Protocol Violation|4
5940616|NCT01340937|20547124|P2|Period 1: Infant Series|Protocol Violation|4
5940617|NCT01340937|20547125|P1|Period 1: Infant Series|Protocol Violation|1
5940618|NCT01340937|20547122|P4|Period 1: Infant Series|Physician Decision|0
5940619|NCT01340937|20547123|P3|Period 1: Infant Series|Physician Decision|1
5940620|NCT01340937|20547124|P2|Period 1: Infant Series|Physician Decision|3
5940621|NCT01340937|20547125|P1|Period 1: Infant Series|Physician Decision|2
5940622|NCT01340937|20547122|P4|Period 1: Infant Series|Lost to Follow-up|13
5940623|NCT01340937|20547123|P3|Period 1: Infant Series|Lost to Follow-up|12
5940624|NCT01340937|20547124|P2|Period 1: Infant Series|Lost to Follow-up|14
5940625|NCT01340937|20547125|P1|Period 1: Infant Series|Lost to Follow-up|20
5940626|NCT01340937|20547122|P4|Period 1: Infant Series|Death|0
5940627|NCT01340937|20547123|P3|Period 1: Infant Series|Death|2
5940628|NCT01340937|20547124|P2|Period 1: Infant Series|Death|0
5940629|NCT01340937|20547125|P1|Period 1: Infant Series|Death|2
5940630|NCT01340937|20547122|P4|Period 1: Infant Series|Adverse Event|0
5940631|NCT01340937|20547123|P3|Period 1: Infant Series|Adverse Event|4
5940632|NCT01340937|20547124|P2|Period 1: Infant Series|Adverse Event|1
5940633|NCT01340937|20547125|P1|Period 1: Infant Series|Adverse Event|0
5940634|NCT01340937|20547122|P4|Period 1: Infant Series|Other protocol criterion not met|0
5940635|NCT01340937|20547123|P3|Period 1: Infant Series|Other protocol criterion not met|1
5940636|NCT01340937|20547124|P2|Period 1: Infant Series|Other protocol criterion not met|1
5940637|NCT01340937|20547125|P1|Period 1: Infant Series|Other protocol criterion not met|0
5940638|NCT01340898|20547285|P3|Booster Phase|Lost to Follow-up|3
5940639|NCT01340898|20547286|P2|Booster Phase|Lost to Follow-up|2
5940640|NCT01340898|20547287|P1|Booster Phase|Lost to Follow-up|4
5940641|NCT01340898|20547285|P3|Booster Phase|Migrated/moved from study area|0
5940642|NCT01340898|20547286|P2|Booster Phase|Migrated/moved from study area|0
5940643|NCT01340898|20547287|P1|Booster Phase|Migrated/moved from study area|3
5940644|NCT01340898|20547285|P3|Booster Phase|Withdrawal by Subject|4
5940645|NCT01340898|20547286|P2|Booster Phase|Withdrawal by Subject|0
5940646|NCT01340898|20547287|P1|Booster Phase|Withdrawal by Subject|3
5940647|NCT01340898|20547285|P3|Primary Phase|Lost to Follow-up|0
5940648|NCT01340898|20547286|P2|Primary Phase|Lost to Follow-up|1
5940649|NCT01340898|20547287|P1|Primary Phase|Lost to Follow-up|4
5940650|NCT01340898|20547285|P3|Primary Phase|Migrated/moved from study area|0
5940651|NCT01340898|20547286|P2|Primary Phase|Migrated/moved from study area|1
5940652|NCT01340898|20547287|P1|Primary Phase|Migrated/moved from study area|4
5940653|NCT01340898|20547285|P3|Primary Phase|Withdrawal by Subject|5
5940654|NCT01340898|20547286|P2|Primary Phase|Withdrawal by Subject|7
5940655|NCT01340898|20547287|P1|Primary Phase|Withdrawal by Subject|8
5940656|NCT01340898|20547285|P3|Primary Phase|Serious Adverse Events|1
5940657|NCT01340898|20547286|P2|Primary Phase|Serious Adverse Events|0
5940658|NCT01340898|20547287|P1|Primary Phase|Serious Adverse Events|0
5940659|NCT01340872|20547417|P4|Open-label Phase|Worsening of IBD|0
5940660|NCT01340872|20547418|P3|Open-label Phase|Worsening of IBD|1
5940661|NCT01340872|20547419|P2|Open-label Phase|Worsening of IBD|0
5940662|NCT01340872|20547420|P1|Open-label Phase|Worsening of IBD|0
5940663|NCT01340872|20547417|P4|Open-label Phase|Withdrawal by Subject|6
5940664|NCT01340872|20547418|P3|Open-label Phase|Withdrawal by Subject|1
5940665|NCT01340872|20547419|P2|Open-label Phase|Withdrawal by Subject|0
5940666|NCT01340872|20547420|P1|Open-label Phase|Withdrawal by Subject|0
5940667|NCT01340872|20547417|P4|Open-label Phase|Adverse Event|4
5940668|NCT01340872|20547418|P3|Open-label Phase|Adverse Event|8
5940669|NCT01340872|20547419|P2|Open-label Phase|Adverse Event|0
5940670|NCT01340872|20547420|P1|Open-label Phase|Adverse Event|0
5940671|NCT01340872|20547417|P4|Open-label Phase|Pregnancy|0
5940672|NCT01340872|20547418|P3|Open-label Phase|Pregnancy|1
5940673|NCT01340872|20547419|P2|Open-label Phase|Pregnancy|0
5940674|NCT01340872|20547420|P1|Open-label Phase|Pregnancy|0
5940675|NCT01340872|20547417|P4|Open-label Phase|Physician Decision|1
5940676|NCT01340872|20547418|P3|Open-label Phase|Physician Decision|2
5940677|NCT01340872|20547419|P2|Open-label Phase|Physician Decision|0
5940678|NCT01340872|20547420|P1|Open-label Phase|Physician Decision|0
5940679|NCT01340872|20547417|P4|Double-blind Phase|Protocol Violation|0
5940680|NCT01340872|20547418|P3|Double-blind Phase|Protocol Violation|0
5940681|NCT01340872|20547419|P2|Double-blind Phase|Protocol Violation|1
5940682|NCT01340872|20547420|P1|Double-blind Phase|Protocol Violation|0
5940683|NCT01340872|20547417|P4|Double-blind Phase|Lost to Follow-up|0
5940684|NCT01340872|20547418|P3|Double-blind Phase|Lost to Follow-up|0
5940685|NCT01340872|20547419|P2|Double-blind Phase|Lost to Follow-up|1
5940686|NCT01340872|20547420|P1|Double-blind Phase|Lost to Follow-up|0
5940687|NCT01340872|20547417|P4|Double-blind Phase|Withdrawal by Subject|0
5940688|NCT01340872|20547418|P3|Double-blind Phase|Withdrawal by Subject|0
5940689|NCT01340872|20547419|P2|Double-blind Phase|Withdrawal by Subject|5
5940690|NCT01340872|20547420|P1|Double-blind Phase|Withdrawal by Subject|3
5940691|NCT01340872|20547417|P4|Double-blind Phase|Adverse Event|0
5940692|NCT01340872|20547418|P3|Double-blind Phase|Adverse Event|0
5940693|NCT01340872|20547419|P2|Double-blind Phase|Adverse Event|4
5940694|NCT01340872|20547420|P1|Double-blind Phase|Adverse Event|6
5940695|NCT01340794|20547480|P2|Overall Study|Withdrawal by Subject|1
5940696|NCT01340794|20547481|P1|Overall Study|Withdrawal by Subject|0
5940697|NCT01340768|20547497|P2|Overall Study|Other|0
5940698|NCT01340768|20547498|P1|Overall Study|Other|2
5940699|NCT01340768|20547497|P2|Overall Study|Withdrawal by Subject|1
5940700|NCT01340768|20547498|P1|Overall Study|Withdrawal by Subject|5
5940701|NCT01340768|20547497|P2|Overall Study|Lost to Follow-up|4
5940702|NCT01340768|20547498|P1|Overall Study|Lost to Follow-up|10
5940703|NCT01340664|20547509|P3|Overall Study|Other|2
5940704|NCT01340664|20547510|P2|Overall Study|Other|2
5940705|NCT01340664|20547511|P1|Overall Study|Other|1
5940706|NCT01340664|20547509|P3|Overall Study|Creatinine or eGFR withdrawal criteria|2
5940707|NCT01340664|20547510|P2|Overall Study|Creatinine or eGFR withdrawal criteria|1
5940708|NCT01340664|20547511|P1|Overall Study|Creatinine or eGFR withdrawal criteria|0
5940709|NCT01340664|20547509|P3|Overall Study|Glycemic withdrawal criteria|0
5940710|NCT01340664|20547510|P2|Overall Study|Glycemic withdrawal criteria|0
5940711|NCT01340664|20547511|P1|Overall Study|Glycemic withdrawal criteria|2
5940712|NCT01340664|20547509|P3|Overall Study|Withdrawal by Subject|0
5940713|NCT01340664|20547510|P2|Overall Study|Withdrawal by Subject|4
5940714|NCT01340664|20547511|P1|Overall Study|Withdrawal by Subject|2
5940715|NCT01340664|20547509|P3|Overall Study|Lost to Follow-up|2
5940716|NCT01340664|20547510|P2|Overall Study|Lost to Follow-up|0
5940717|NCT01340664|20547511|P1|Overall Study|Lost to Follow-up|2
5940718|NCT01340664|20547509|P3|Overall Study|Adverse Event|7
5940719|NCT01340664|20547510|P2|Overall Study|Adverse Event|1
5940720|NCT01340664|20547511|P1|Overall Study|Adverse Event|0
5940721|NCT01340651|20547528|P1|Overall Study|Commercial Supply per Sponsor|12
5940722|NCT01340651|20547528|P1|Overall Study|Consent Withdrawn|2
5940723|NCT01340651|20547528|P1|Overall Study|Adverse Event|3
5940724|NCT01340625|20547544|P2|Washout Period of 28 Days|Withdrawal by Subject|0
5940725|NCT01340625|20547545|P1|Washout Period of 28 Days|Withdrawal by Subject|1
5940726|NCT01340625|20547544|P2|First Intervention|Adverse Event|0
5940727|NCT01340625|20547545|P1|First Intervention|Adverse Event|1
5940728|NCT01340495|20547650|P1|Overall Study|Withdrawal by Subject|1
5940729|NCT01340482|20547660|P3|Overall Study|Adverse Event|0
5940730|NCT01340482|20547661|P2|Overall Study|Adverse Event|0
5940731|NCT01340482|20547662|P1|Overall Study|Adverse Event|2
5940732|NCT01340300|20547677|P4|Overall Study|Unrelated sickness|1
5940733|NCT01340300|20547678|P3|Overall Study|Unrelated sickness|0
5940734|NCT01340300|20547679|P2|Overall Study|Unrelated sickness|2
5940735|NCT01340300|20547680|P1|Overall Study|Unrelated sickness|0
5940736|NCT01340300|20547677|P4|Overall Study|Physician Decision|0
5940737|NCT01340300|20547678|P3|Overall Study|Physician Decision|0
5940738|NCT01340300|20547679|P2|Overall Study|Physician Decision|1
5940739|NCT01340300|20547680|P1|Overall Study|Physician Decision|0
5940740|NCT01340300|20547677|P4|Overall Study|Adverse Event|0
5940741|NCT01340300|20547678|P3|Overall Study|Adverse Event|4
5940742|NCT01340300|20547679|P2|Overall Study|Adverse Event|0
5940743|NCT01340300|20547680|P1|Overall Study|Adverse Event|1
5940744|NCT01340300|20547677|P4|Overall Study|Withdrawal by Subject|3
5940745|NCT01340300|20547678|P3|Overall Study|Withdrawal by Subject|6
5940746|NCT01340300|20547679|P2|Overall Study|Withdrawal by Subject|6
5940747|NCT01340300|20547680|P1|Overall Study|Withdrawal by Subject|5
5940748|NCT01340300|20547677|P4|Overall Study|Lost to Follow-up|10
5940749|NCT01340300|20547678|P3|Overall Study|Lost to Follow-up|5
5940750|NCT01340300|20547679|P2|Overall Study|Lost to Follow-up|0
5940751|NCT01340300|20547680|P1|Overall Study|Lost to Follow-up|3
5940752|NCT01340209|20547713|P3|Overall Study|Other reason not defined above|4
5940753|NCT01340209|20547714|P2|Overall Study|Other reason not defined above|5
5940754|NCT01340209|20547715|P1|Overall Study|Other reason not defined above|3
5940755|NCT01340209|20547713|P3|Overall Study|Withdrawal by Subject|1
5940756|NCT01340209|20547714|P2|Overall Study|Withdrawal by Subject|0
5940757|NCT01340209|20547715|P1|Overall Study|Withdrawal by Subject|0
5940758|NCT01340209|20547713|P3|Overall Study|Protocol Violation|1
5940759|NCT01340209|20547714|P2|Overall Study|Protocol Violation|2
5940760|NCT01340209|20547715|P1|Overall Study|Protocol Violation|1
5940761|NCT01340209|20547713|P3|Overall Study|Adverse Event|2
5940762|NCT01340209|20547714|P2|Overall Study|Adverse Event|1
5940763|NCT01340209|20547715|P1|Overall Study|Adverse Event|1
5940764|NCT01340196|20547750|P1|Treat. Period 3 (Faldaprevir)|Adverse Event|2
5940765|NCT01340066|20547790|P3|5 Week Double Blind Randomization Period|Withdrawal by Subject|1
5940766|NCT01340066|20547791|P2|5 Week Double Blind Randomization Period|Withdrawal by Subject|2
5940767|NCT01340066|20547792|P1|5 Week Double Blind Randomization Period|Withdrawal by Subject|0
5940768|NCT01340066|20547790|P3|5 Week Double Blind Randomization Period|Physician Decision|0
5940769|NCT01340066|20547791|P2|5 Week Double Blind Randomization Period|Physician Decision|1
5940770|NCT01340066|20547792|P1|5 Week Double Blind Randomization Period|Physician Decision|0
5940771|NCT01340066|20547790|P3|5 Week Double Blind Randomization Period|Adverse Event|2
5940772|NCT01340066|20547791|P2|5 Week Double Blind Randomization Period|Adverse Event|2
5940773|NCT01340066|20547792|P1|5 Week Double Blind Randomization Period|Adverse Event|0
5940774|NCT01340066|20547790|P3|Placebo Run in Period|Screen Failures|0
5940775|NCT01340066|20547791|P2|Placebo Run in Period|Screen Failures|0
5940776|NCT01340066|20547792|P1|Placebo Run in Period|Screen Failures|27
5940777|NCT01340027|20547832|P12|Overall Study|Miscellaneous|0
5940778|NCT01340027|20547833|P11|Overall Study|Miscellaneous|1
5940779|NCT01340027|20547834|P10|Overall Study|Miscellaneous|0
5940780|NCT01340027|20547835|P9|Overall Study|Miscellaneous|0
5940781|NCT01340027|20547836|P8|Overall Study|Miscellaneous|0
5940782|NCT01340027|20547837|P7|Overall Study|Miscellaneous|0
5940783|NCT01340027|20547838|P6|Overall Study|Miscellaneous|0
5940784|NCT01340027|20547839|P5|Overall Study|Miscellaneous|0
5940785|NCT01340027|20547840|P4|Overall Study|Miscellaneous|1
5940786|NCT01340027|20547841|P3|Overall Study|Miscellaneous|0
5940787|NCT01340027|20547842|P2|Overall Study|Miscellaneous|0
5940788|NCT01340027|20547843|P1|Overall Study|Miscellaneous|0
5940789|NCT01340027|20547832|P12|Overall Study|Withdrawal by Subject|1
5940790|NCT01340027|20547833|P11|Overall Study|Withdrawal by Subject|0
5940791|NCT01340027|20547834|P10|Overall Study|Withdrawal by Subject|2
5940792|NCT01340027|20547835|P9|Overall Study|Withdrawal by Subject|1
5940793|NCT01340027|20547836|P8|Overall Study|Withdrawal by Subject|4
5940794|NCT01340027|20547837|P7|Overall Study|Withdrawal by Subject|3
5940795|NCT01340027|20547838|P6|Overall Study|Withdrawal by Subject|2
5940796|NCT01340027|20547839|P5|Overall Study|Withdrawal by Subject|3
5940797|NCT01340027|20547840|P4|Overall Study|Withdrawal by Subject|3
5940798|NCT01340027|20547841|P3|Overall Study|Withdrawal by Subject|1
5940799|NCT01340027|20547842|P2|Overall Study|Withdrawal by Subject|3
5940800|NCT01340027|20547843|P1|Overall Study|Withdrawal by Subject|4
5940801|NCT01340027|20547832|P12|Overall Study|Protocol Violation|0
5940802|NCT01340027|20547833|P11|Overall Study|Protocol Violation|0
5940803|NCT01340027|20547834|P10|Overall Study|Protocol Violation|2
5940804|NCT01340027|20547835|P9|Overall Study|Protocol Violation|2
5940805|NCT01340027|20547836|P8|Overall Study|Protocol Violation|1
5940806|NCT01340027|20547837|P7|Overall Study|Protocol Violation|0
5940807|NCT01340027|20547838|P6|Overall Study|Protocol Violation|0
5940808|NCT01340027|20547839|P5|Overall Study|Protocol Violation|6
5940809|NCT01340027|20547840|P4|Overall Study|Protocol Violation|0
5940810|NCT01340027|20547841|P3|Overall Study|Protocol Violation|0
5940811|NCT01340027|20547842|P2|Overall Study|Protocol Violation|2
5940812|NCT01340027|20547843|P1|Overall Study|Protocol Violation|1
5940813|NCT01340027|20547832|P12|Overall Study|Lost to Follow-up|0
5940814|NCT01340027|20547833|P11|Overall Study|Lost to Follow-up|0
5940815|NCT01340027|20547834|P10|Overall Study|Lost to Follow-up|1
5940816|NCT01340027|20547835|P9|Overall Study|Lost to Follow-up|0
5940817|NCT01340027|20547836|P8|Overall Study|Lost to Follow-up|0
5940818|NCT01340027|20547837|P7|Overall Study|Lost to Follow-up|1
5940819|NCT01340027|20547838|P6|Overall Study|Lost to Follow-up|0
5940820|NCT01340027|20547839|P5|Overall Study|Lost to Follow-up|0
5940821|NCT01340027|20547840|P4|Overall Study|Lost to Follow-up|0
5940822|NCT01340027|20547841|P3|Overall Study|Lost to Follow-up|0
5940823|NCT01340027|20547842|P2|Overall Study|Lost to Follow-up|1
5940824|NCT01340027|20547843|P1|Overall Study|Lost to Follow-up|0
5940825|NCT01340027|20547832|P12|Overall Study|Lack of Efficacy|0
5940826|NCT01340027|20547833|P11|Overall Study|Lack of Efficacy|0
5940827|NCT01340027|20547834|P10|Overall Study|Lack of Efficacy|0
5940828|NCT01340027|20547835|P9|Overall Study|Lack of Efficacy|1
5940829|NCT01340027|20547836|P8|Overall Study|Lack of Efficacy|1
5940830|NCT01340027|20547837|P7|Overall Study|Lack of Efficacy|1
5940831|NCT01340027|20547838|P6|Overall Study|Lack of Efficacy|0
5940832|NCT01340027|20547839|P5|Overall Study|Lack of Efficacy|0
5940833|NCT01340027|20547840|P4|Overall Study|Lack of Efficacy|0
5940834|NCT01340027|20547841|P3|Overall Study|Lack of Efficacy|0
5940835|NCT01340027|20547842|P2|Overall Study|Lack of Efficacy|0
5940836|NCT01340027|20547843|P1|Overall Study|Lack of Efficacy|0
5940837|NCT01340027|20547832|P12|Overall Study|Adverse Event|3
5940838|NCT01340027|20547833|P11|Overall Study|Adverse Event|1
5940839|NCT01340027|20547834|P10|Overall Study|Adverse Event|1
5940840|NCT01340027|20547835|P9|Overall Study|Adverse Event|4
5940841|NCT01340027|20547836|P8|Overall Study|Adverse Event|1
5940842|NCT01340027|20547837|P7|Overall Study|Adverse Event|2
5940843|NCT01340027|20547838|P6|Overall Study|Adverse Event|2
5940844|NCT01340027|20547839|P5|Overall Study|Adverse Event|1
5940845|NCT01340027|20547840|P4|Overall Study|Adverse Event|0
5940846|NCT01340027|20547841|P3|Overall Study|Adverse Event|2
5940847|NCT01340027|20547842|P2|Overall Study|Adverse Event|1
5940848|NCT01340027|20547843|P1|Overall Study|Adverse Event|0
5940849|NCT01340027|20547832|P12|Overall Study|Randomized but Never Received Study Drug|0
5940850|NCT01340027|20547833|P11|Overall Study|Randomized but Never Received Study Drug|0
5940851|NCT01340027|20547834|P10|Overall Study|Randomized but Never Received Study Drug|0
5940852|NCT01340027|20547835|P9|Overall Study|Randomized but Never Received Study Drug|0
5940853|NCT01340027|20547836|P8|Overall Study|Randomized but Never Received Study Drug|0
5940854|NCT01340027|20547837|P7|Overall Study|Randomized but Never Received Study Drug|0
5940855|NCT01340027|20547838|P6|Overall Study|Randomized but Never Received Study Drug|0
5940856|NCT01340027|20547839|P5|Overall Study|Randomized but Never Received Study Drug|0
5940857|NCT01340027|20547840|P4|Overall Study|Randomized but Never Received Study Drug|0
5940858|NCT01340027|20547841|P3|Overall Study|Randomized but Never Received Study Drug|1
5940859|NCT01340027|20547842|P2|Overall Study|Randomized but Never Received Study Drug|0
5940860|NCT01340027|20547843|P1|Overall Study|Randomized but Never Received Study Drug|0
5940861|NCT01340014|20548219|P2|Period 2, Second 7 Days|Adverse Event|1
5940862|NCT01340014|20548220|P1|Period 2, Second 7 Days|Adverse Event|0
5940863|NCT01340014|20548219|P2|Period 1, First 7 Days|Personal Reasons|0
5940864|NCT01340014|20548220|P1|Period 1, First 7 Days|Personal Reasons|1
5940865|NCT01340014|20548219|P2|Period 1, First 7 Days|Adverse Event|0
5940866|NCT01340014|20548220|P1|Period 1, First 7 Days|Adverse Event|1
5940867|NCT01339923|20548241|P7|Overall Study|Withdrawal by Subject|2
5940868|NCT01339923|20548242|P6|Overall Study|Withdrawal by Subject|3
5940869|NCT01339923|20548243|P5|Overall Study|Withdrawal by Subject|4
5940870|NCT01339923|20548244|P4|Overall Study|Withdrawal by Subject|1
5940871|NCT01339923|20548245|P3|Overall Study|Withdrawal by Subject|6
5940872|NCT01339923|20548246|P2|Overall Study|Withdrawal by Subject|11
5940873|NCT01339923|20548247|P1|Overall Study|Withdrawal by Subject|7
5940874|NCT01339923|20548241|P7|Overall Study|Unable to Classify|5
5940875|NCT01339923|20548242|P6|Overall Study|Unable to Classify|1
5940876|NCT01339923|20548243|P5|Overall Study|Unable to Classify|0
5940877|NCT01339923|20548244|P4|Overall Study|Unable to Classify|0
5940878|NCT01339923|20548245|P3|Overall Study|Unable to Classify|1
5940879|NCT01339923|20548246|P2|Overall Study|Unable to Classify|0
5940880|NCT01339923|20548247|P1|Overall Study|Unable to Classify|1
5940881|NCT01339923|20548241|P7|Overall Study|Protocol Violation|1
5940882|NCT01339923|20548242|P6|Overall Study|Protocol Violation|3
5940883|NCT01339923|20548243|P5|Overall Study|Protocol Violation|0
5940884|NCT01339923|20548244|P4|Overall Study|Protocol Violation|0
5940885|NCT01339923|20548245|P3|Overall Study|Protocol Violation|0
5940886|NCT01339923|20548246|P2|Overall Study|Protocol Violation|0
5940887|NCT01339923|20548247|P1|Overall Study|Protocol Violation|0
5940888|NCT01339923|20548241|P7|Overall Study|Lost to Follow-up|5
5940889|NCT01339923|20548242|P6|Overall Study|Lost to Follow-up|1
5940890|NCT01339923|20548243|P5|Overall Study|Lost to Follow-up|1
5940891|NCT01339923|20548244|P4|Overall Study|Lost to Follow-up|3
5940892|NCT01339923|20548245|P3|Overall Study|Lost to Follow-up|0
5940893|NCT01339923|20548246|P2|Overall Study|Lost to Follow-up|4
5940894|NCT01339923|20548247|P1|Overall Study|Lost to Follow-up|4
5940895|NCT01339923|20548241|P7|Overall Study|Inappropriate Enrollment|0
5940896|NCT01339923|20548242|P6|Overall Study|Inappropriate Enrollment|1
5940897|NCT01339923|20548243|P5|Overall Study|Inappropriate Enrollment|0
5940898|NCT01339923|20548244|P4|Overall Study|Inappropriate Enrollment|0
5940899|NCT01339923|20548245|P3|Overall Study|Inappropriate Enrollment|0
5940900|NCT01339923|20548246|P2|Overall Study|Inappropriate Enrollment|0
5940901|NCT01339923|20548247|P1|Overall Study|Inappropriate Enrollment|1
5940902|NCT01339923|20548241|P7|Overall Study|Adverse Event|1
5940903|NCT01339923|20548242|P6|Overall Study|Adverse Event|0
5940904|NCT01339923|20548243|P5|Overall Study|Adverse Event|0
5940905|NCT01339923|20548244|P4|Overall Study|Adverse Event|0
5940906|NCT01339923|20548245|P3|Overall Study|Adverse Event|1
5940907|NCT01339923|20548246|P2|Overall Study|Adverse Event|1
5940908|NCT01339923|20548247|P1|Overall Study|Adverse Event|1
5940909|NCT01339910|20548318|P2|Overall Study|Disease relapse|4
5940910|NCT01339910|20548319|P1|Overall Study|Disease relapse|1
5940911|NCT01339910|20548318|P2|Overall Study|Physician Decision|0
5940912|NCT01339910|20548319|P1|Overall Study|Physician Decision|1
5940913|NCT01339910|20548318|P2|Overall Study|Withdrawal by Subject|0
5940914|NCT01339910|20548319|P1|Overall Study|Withdrawal by Subject|1
5940915|NCT01339897|20548357|P4|Overall Study|Adverse Event|1
5940916|NCT01339897|20548358|P3|Overall Study|Adverse Event|0
5940917|NCT01339897|20548359|P2|Overall Study|Adverse Event|0
5940918|NCT01339897|20548360|P1|Overall Study|Adverse Event|1
5940919|NCT01339832|20548413|P1|Overall Study|Death|11
5940920|NCT01339832|20548413|P1|Overall Study|Lost to Follow-up|3
5940921|NCT01339559|20548424|P1|Overall Study|PI decision|1
5940922|NCT01339559|20548424|P1|Overall Study|Patient didn't wish to continue|1
5940923|NCT01339559|20548424|P1|Overall Study|Investigator decision|2
5940924|NCT01339559|20548424|P1|Overall Study|Left the country|1
5940925|NCT01339559|20548424|P1|Overall Study|Pregnancy planned|2
5940926|NCT01339559|20548424|P1|Overall Study|Epilepsy surgery|1
5940927|NCT01339559|20548424|P1|Overall Study|Incarcerated|2
5940928|NCT01339559|20548424|P1|Overall Study|Study closure at site|1
5940929|NCT01339559|20548424|P1|Overall Study|Protocol Violation|15
5940930|NCT01339559|20548424|P1|Overall Study|Subject choice|89
5940931|NCT01339559|20548424|P1|Overall Study|Lost to Follow-up|22
5940932|NCT01339559|20548424|P1|Overall Study|Lack of Efficacy|164
5940933|NCT01339559|20548424|P1|Overall Study|Death|5
5940934|NCT01339559|20548424|P1|Overall Study|Adverse Event|92
5940935|NCT01339429|20548433|P1|Overall Study|Physician Decision|3
5940936|NCT01339429|20548433|P1|Overall Study|Withdrawal by Subject|1
5940937|NCT01339390|20548473|P2|Overall Study|Lost to Follow-up|127
5940938|NCT01339390|20548474|P1|Overall Study|Lost to Follow-up|125
5940939|NCT01339390|20548473|P2|Overall Study|Death|29
5940940|NCT01339390|20548474|P1|Overall Study|Death|32
5940941|NCT01339273|20548491|P2|Overall Study|Lost to Follow-up|8
5940942|NCT01339273|20548492|P1|Overall Study|Lost to Follow-up|8
5940943|NCT01339052|20548567|P2|Overall Study|Physician Decision|0
5940944|NCT01339052|20548568|P1|Overall Study|Physician Decision|1
5940945|NCT01339052|20548567|P2|Overall Study|Withdrawal by Subject|3
5940946|NCT01339052|20548568|P1|Overall Study|Withdrawal by Subject|0
5940947|NCT01339052|20548567|P2|Overall Study|Adverse Event|1
5940948|NCT01339052|20548568|P1|Overall Study|Adverse Event|1
5940949|NCT01339052|20548567|P2|Overall Study|Disease progression|46
5940950|NCT01339052|20548568|P1|Overall Study|Disease progression|13
5940951|NCT01339000|20548594|P2|Overall Study|study closed due to lack of drug supply|0
5940952|NCT01339000|20548595|P1|Overall Study|study closed due to lack of drug supply|1
5940963|NCT01338870|20548639|P6|Overall Study|Adverse Event|1
5940964|NCT01338870|20548640|P5|Overall Study|Adverse Event|4
5940965|NCT01338870|20548641|P4|Overall Study|Adverse Event|5
5940966|NCT01338870|20548642|P3|Overall Study|Adverse Event|1
5940967|NCT01338870|20548643|P2|Overall Study|Adverse Event|4
5940968|NCT01338870|20548644|P1|Overall Study|Adverse Event|4
5940969|NCT01338870|20548639|P6|Overall Study|Protocol Violation|1
5940970|NCT01338870|20548640|P5|Overall Study|Protocol Violation|1
5940971|NCT01338870|20548641|P4|Overall Study|Protocol Violation|2
5940972|NCT01338870|20548642|P3|Overall Study|Protocol Violation|2
5940973|NCT01338870|20548643|P2|Overall Study|Protocol Violation|2
5940974|NCT01338870|20548644|P1|Overall Study|Protocol Violation|0
5940975|NCT01338870|20548639|P6|Overall Study|Other|2
5940976|NCT01338870|20548640|P5|Overall Study|Other|0
5940977|NCT01338870|20548641|P4|Overall Study|Other|2
5940978|NCT01338870|20548642|P3|Overall Study|Other|3
5940979|NCT01338870|20548643|P2|Overall Study|Other|3
5940980|NCT01338870|20548644|P1|Overall Study|Other|3
5940981|NCT01338870|20548639|P6|Overall Study|Withdrawal by Subject|2
5940982|NCT01338870|20548640|P5|Overall Study|Withdrawal by Subject|0
5940983|NCT01338870|20548641|P4|Overall Study|Withdrawal by Subject|0
5940984|NCT01338870|20548642|P3|Overall Study|Withdrawal by Subject|4
5940985|NCT01338870|20548643|P2|Overall Study|Withdrawal by Subject|3
5940986|NCT01338870|20548644|P1|Overall Study|Withdrawal by Subject|2
5940987|NCT01338870|20548639|P6|Overall Study|Lost to Follow-up|0
5940988|NCT01338870|20548640|P5|Overall Study|Lost to Follow-up|1
5940989|NCT01338870|20548641|P4|Overall Study|Lost to Follow-up|0
5940990|NCT01338870|20548642|P3|Overall Study|Lost to Follow-up|1
5940991|NCT01338870|20548643|P2|Overall Study|Lost to Follow-up|0
5940992|NCT01338870|20548644|P1|Overall Study|Lost to Follow-up|0
5940993|NCT01338818|20548699|P1|Overall Study|Protocol Deviation|4
5940994|NCT01338818|20548699|P1|Overall Study|Administrative problems|3
5940995|NCT01338818|20548699|P1|Overall Study|Lost to Follow-up|4
5940996|NCT01338818|20548699|P1|Overall Study|Withdrawal by Subject|11
5940997|NCT01338818|20548699|P1|Overall Study|no longer require study drug|1
5940998|NCT01338818|20548699|P1|Overall Study|Lack of Efficacy|5
5940999|NCT01338818|20548699|P1|Overall Study|Adverse Event|8
5941000|NCT01338792|20548705|P1|Overall Study|Withdrawal by Subject|1
5941001|NCT01338792|20548705|P1|Overall Study|Death|1
5941002|NCT01338792|20548705|P1|Overall Study|Adverse Event|2
5941003|NCT01338636|20548720|P1|Overall Study|Withdrawn due to lack of improvement|8
5941004|NCT01338610|20548734|P3|Overall Study|Adverse Event|0
5941005|NCT01338610|20548735|P2|Overall Study|Adverse Event|0
5941006|NCT01338610|20548736|P1|Overall Study|Adverse Event|3
5941007|NCT01338610|20548734|P3|Overall Study|Protocol Violation|1
5941008|NCT01338610|20548735|P2|Overall Study|Protocol Violation|0
5941009|NCT01338610|20548736|P1|Overall Study|Protocol Violation|1
5941010|NCT01338610|20548734|P3|Overall Study|Patient Decision Unrelated to Advs Event|0
5941011|NCT01338610|20548735|P2|Overall Study|Patient Decision Unrelated to Advs Event|1
5941012|NCT01338610|20548736|P1|Overall Study|Patient Decision Unrelated to Advs Event|1
5941013|NCT01338493|20548762|P1|12 Months Follow up|Lost to Follow-up|9
5941014|NCT01338493|20548762|P1|6 Months Follow up|Missed visit|8
5941015|NCT01338493|20548762|P1|6 Months Follow up|Lost to Follow-up|11
5941016|NCT01338493|20548762|P1|Discharge|Missed visit|1
5941017|NCT01338493|20548762|P1|Discharge|Death|1
5941018|NCT01338493|20548762|P1|Enrolled|Patient not implanted|4
5941019|NCT01338493|20548762|P1|Enrolled|Withdrawal by Subject|1
5941020|NCT01338415|20548769|P2|Overall Study|Other (administrative reason)|0
5941021|NCT01338415|20548770|P1|Overall Study|Other (administrative reason)|1
5941022|NCT01338415|20548769|P2|Overall Study|Other (PAH not the main etiology of PH)|2
5941023|NCT01338415|20548770|P1|Overall Study|Other (PAH not the main etiology of PH)|0
5941024|NCT01338415|20548769|P2|Overall Study|Withdrawal by Subject|1
5941025|NCT01338415|20548770|P1|Overall Study|Withdrawal by Subject|1
5941026|NCT01338415|20548769|P2|Overall Study|Adverse Event|6
5941027|NCT01338415|20548770|P1|Overall Study|Adverse Event|8
5941028|NCT01338298|20548792|P2|Overall Study|Non-adherence|0
5941029|NCT01338298|20548793|P1|Overall Study|Non-adherence|1
5941030|NCT01338298|20548792|P2|Overall Study|Depressive symptoms and nausea|0
5941031|NCT01338298|20548793|P1|Overall Study|Depressive symptoms and nausea|1
5941032|NCT01338298|20548792|P2|Overall Study|Positive symptom worsening|0
5941033|NCT01338298|20548793|P1|Overall Study|Positive symptom worsening|1
5941034|NCT01338298|20548792|P2|Overall Study|Administrative error|1
5941035|NCT01338298|20548793|P1|Overall Study|Administrative error|0
5941036|NCT01338298|20548792|P2|Overall Study|Abdominal Pain and scheduled surgery|1
5941037|NCT01338298|20548793|P1|Overall Study|Abdominal Pain and scheduled surgery|0
5941038|NCT01338298|20548792|P2|Overall Study|Withdrawal by Subject|1
5941039|NCT01338298|20548793|P1|Overall Study|Withdrawal by Subject|1
5941040|NCT01338025|20548803|P2|Overall Study|Found ineligible after starting|0
5941041|NCT01338025|20548804|P1|Overall Study|Found ineligible after starting|1
5941042|NCT01338025|20548803|P2|Overall Study|Withdrawal by Subject|2
5941043|NCT01338025|20548804|P1|Overall Study|Withdrawal by Subject|0
5941044|NCT01338025|20548803|P2|Overall Study|Unexpected closure of study|9
5941045|NCT01338025|20548804|P1|Overall Study|Unexpected closure of study|10
5941046|NCT01338012|20548816|P1|Overall Study|Study terminated|4
5941047|NCT01338012|20548816|P1|Overall Study|Death|4
5941048|NCT01337986|20548822|P2|Overall Study|Protocol Violation|3
5941049|NCT01337986|20548823|P1|Overall Study|Protocol Violation|0
5941050|NCT01337986|20548822|P2|Overall Study|Lost to Follow-up|0
5941051|NCT01337986|20548823|P1|Overall Study|Lost to Follow-up|1
5941052|NCT01337986|20548822|P2|Overall Study|Adverse Event|2
5941053|NCT01337986|20548823|P1|Overall Study|Adverse Event|2
5941054|NCT01337973|20548860|P3|Overall Study|missing data on primary outcome|3
5941055|NCT01337973|20548861|P2|Overall Study|missing data on primary outcome|1
5941056|NCT01337973|20548862|P1|Overall Study|missing data on primary outcome|3
5941057|NCT01337973|20548860|P3|Overall Study|Withdrawal by Subject|4
5941058|NCT01337973|20548861|P2|Overall Study|Withdrawal by Subject|8
5941059|NCT01337973|20548862|P1|Overall Study|Withdrawal by Subject|10
5941060|NCT01337973|20548860|P3|Overall Study|Death|1
5941061|NCT01337973|20548861|P2|Overall Study|Death|2
5941062|NCT01337973|20548862|P1|Overall Study|Death|1
5941063|NCT01337973|20548860|P3|Overall Study|Lost to Follow-up|3
5941064|NCT01337973|20548861|P2|Overall Study|Lost to Follow-up|4
5941065|NCT01337973|20548862|P1|Overall Study|Lost to Follow-up|2
5941066|NCT01337960|20548876|P3|Overall Study|Withdrawal by Subject|0
5941067|NCT01337960|20548877|P2|Overall Study|Withdrawal by Subject|0
5941068|NCT01337960|20548878|P1|Overall Study|Withdrawal by Subject|1
5941069|NCT01337960|20548876|P3|Overall Study|Lost to Follow-up|0
5941070|NCT01337960|20548877|P2|Overall Study|Lost to Follow-up|0
5941071|NCT01337960|20548878|P1|Overall Study|Lost to Follow-up|1
5941072|NCT01337674|20548943|P4|Treatment Period 2|Withdrawal by Subject|0
5941073|NCT01337674|20548944|P3|Treatment Period 2|Withdrawal by Subject|1
5941074|NCT01337674|20548945|P2|Treatment Period 2|Withdrawal by Subject|0
5941075|NCT01337674|20548946|P1|Treatment Period 2|Withdrawal by Subject|0
5941076|NCT01337674|20548943|P4|Treatment Period 1|Discontinued due to blood draws|1
5941077|NCT01337674|20548944|P3|Treatment Period 1|Discontinued due to blood draws|0
5941078|NCT01337674|20548945|P2|Treatment Period 1|Discontinued due to blood draws|0
5941079|NCT01337674|20548946|P1|Treatment Period 1|Discontinued due to blood draws|0
5941080|NCT01337674|20548943|P4|Treatment Period 1|Adverse Event|0
5941081|NCT01337674|20548944|P3|Treatment Period 1|Adverse Event|0
5941082|NCT01337674|20548945|P2|Treatment Period 1|Adverse Event|1
5941083|NCT01337674|20548946|P1|Treatment Period 1|Adverse Event|0
5941084|NCT01337635|20548964|P2|Overall Study|Lost to Follow-up|1
5941085|NCT01337635|20548965|P1|Overall Study|Lost to Follow-up|0
5941086|NCT01337596|20549007|P9|Overall Study|Withdrawal by Subject|0
5941087|NCT01337596|20549008|P8|Overall Study|Withdrawal by Subject|0
5941088|NCT01337596|20549009|P7|Overall Study|Withdrawal by Subject|0
5941089|NCT01337596|20549010|P6|Overall Study|Withdrawal by Subject|0
5941090|NCT01337596|20549011|P5|Overall Study|Withdrawal by Subject|2
5941091|NCT01337596|20549012|P4|Overall Study|Withdrawal by Subject|0
5941092|NCT01337596|20549013|P3|Overall Study|Withdrawal by Subject|0
5941093|NCT01337596|20549014|P2|Overall Study|Withdrawal by Subject|0
5941094|NCT01337596|20549015|P1|Overall Study|Withdrawal by Subject|0
5941095|NCT01337297|20549066|P2|Overall Study|Lost to Follow-up|3
5941096|NCT01337297|20549067|P1|Overall Study|Lost to Follow-up|1
5941097|NCT01337297|20549066|P2|Overall Study|They entered to single anodal tDCS|3
5941098|NCT01337297|20549067|P1|Overall Study|They entered to single anodal tDCS|4
5941099|NCT01337167|20549075|P2|Toddler Vaccinations|Withdrawal by Subject|0
5941100|NCT01337167|20549076|P1|Toddler Vaccinations|Withdrawal by Subject|3
5941101|NCT01337167|20549075|P2|Toddler Vaccinations|Protocol Violation|1
5941102|NCT01337167|20549076|P1|Toddler Vaccinations|Protocol Violation|0
5941103|NCT01337167|20549075|P2|Toddler Vaccinations|Lost to Follow-up|12
5941104|NCT01337167|20549076|P1|Toddler Vaccinations|Lost to Follow-up|11
5941105|NCT01337167|20549075|P2|Interim Period|Other protocol criterion not met|1
5941106|NCT01337167|20549076|P1|Interim Period|Other protocol criterion not met|0
5941107|NCT01337167|20549075|P2|Interim Period|Withdrawal by Subject|10
5941108|NCT01337167|20549076|P1|Interim Period|Withdrawal by Subject|18
5941109|NCT01337167|20549075|P2|Interim Period|Protocol Violation|3
5941110|NCT01337167|20549076|P1|Interim Period|Protocol Violation|5
5941111|NCT01337167|20549075|P2|Interim Period|Physician Decision|3
5941112|NCT01337167|20549076|P1|Interim Period|Physician Decision|6
5941113|NCT01337167|20549075|P2|Interim Period|Non-compliance with study drug|0
5941114|NCT01337167|20549076|P1|Interim Period|Non-compliance with study drug|1
5941115|NCT01337167|20549075|P2|Interim Period|Lost to Follow-up|23
5941116|NCT01337167|20549076|P1|Interim Period|Lost to Follow-up|51
5941117|NCT01337167|20549075|P2|Infant Series|Randomized but not vaccinated|3
5941118|NCT01337167|20549076|P1|Infant Series|Randomized but not vaccinated|5
5941119|NCT01337167|20549075|P2|Infant Series|Withdrawal by Subject|4
5941120|NCT01337167|20549076|P1|Infant Series|Withdrawal by Subject|15
5941121|NCT01337167|20549075|P2|Infant Series|Protocol Violation|9
5941122|NCT01337167|20549076|P1|Infant Series|Protocol Violation|22
5941123|NCT01337167|20549075|P2|Infant Series|Physician Decision|1
5941124|NCT01337167|20549076|P1|Infant Series|Physician Decision|3
5941125|NCT01337167|20549075|P2|Infant Series|Non-compliance with study drug|1
5941126|NCT01337167|20549076|P1|Infant Series|Non-compliance with study drug|2
5941127|NCT01337167|20549075|P2|Infant Series|Lost to Follow-up|7
5941128|NCT01337167|20549076|P1|Infant Series|Lost to Follow-up|13
5941129|NCT01337167|20549075|P2|Infant Series|Death|1
5941130|NCT01337167|20549076|P1|Infant Series|Death|1
5941131|NCT01337167|20549075|P2|Infant Series|Adverse Event|1
5941132|NCT01337167|20549076|P1|Infant Series|Adverse Event|1
5941133|NCT01337115|20549144|P2|Overall Study|Protocol Violation|0
5941134|NCT01337115|20549145|P1|Overall Study|Protocol Violation|2
5941135|NCT01337089|20549157|P1|Overall Study|Lost to Follow-up|2
5941136|NCT01337089|20549157|P1|Overall Study|Met Withdrawal Criteria|3
5941137|NCT01337089|20549157|P1|Overall Study|Withdrawal by Investigator|33
5941138|NCT01337089|20549157|P1|Overall Study|Withdrawal by Subject|129
5941139|NCT01337089|20549157|P1|Overall Study|Adverse Event|237
5941140|NCT01337050|20549172|P3|Overall Study|Participants refused further follow-up|7
5941141|NCT01337050|20549173|P2|Overall Study|Participants refused further follow-up|7
5941142|NCT01337050|20549174|P1|Overall Study|Participants refused further follow-up|0
5941143|NCT01337050|20549172|P3|Overall Study|Other|8
5941144|NCT01337050|20549173|P2|Overall Study|Other|6
5941145|NCT01337050|20549174|P1|Overall Study|Other|4
5941146|NCT01337050|20549172|P3|Overall Study|Death|4
5941147|NCT01337050|20549173|P2|Overall Study|Death|0
5941148|NCT01337050|20549174|P1|Overall Study|Death|0
5941149|NCT01336972|20549235|P3|Overall Study|Adverse Event|0
5941150|NCT01336972|20549236|P2|Overall Study|Adverse Event|1
5941151|NCT01336972|20549237|P1|Overall Study|Adverse Event|1
5941152|NCT01336894|20549299|P2|Follow-up|Study terminated prematurely|7
5941153|NCT01336894|20549300|P1|Follow-up|Study terminated prematurely|2
5941154|NCT01336764|20549332|P2|Overall Study|Withdrawal by Subject|5
5941155|NCT01336764|20549333|P1|Overall Study|Withdrawal by Subject|5
5941156|NCT01336738|20549344|P5|Overall Study|Other|4
5941157|NCT01336738|20549345|P4|Overall Study|Other|3
5941158|NCT01336738|20549346|P3|Overall Study|Other|2
5941159|NCT01336738|20549347|P2|Overall Study|Other|3
5941160|NCT01336738|20549348|P1|Overall Study|Other|3
5941161|NCT01336738|20549344|P5|Overall Study|Withdrawal by Subject|1
5941162|NCT01336738|20549345|P4|Overall Study|Withdrawal by Subject|1
5941163|NCT01336738|20549346|P3|Overall Study|Withdrawal by Subject|2
5941164|NCT01336738|20549347|P2|Overall Study|Withdrawal by Subject|0
5941165|NCT01336738|20549348|P1|Overall Study|Withdrawal by Subject|2
5941166|NCT01336738|20549344|P5|Overall Study|Protocol Violation|0
5941167|NCT01336738|20549345|P4|Overall Study|Protocol Violation|0
5941168|NCT01336738|20549346|P3|Overall Study|Protocol Violation|0
5941169|NCT01336738|20549347|P2|Overall Study|Protocol Violation|1
5941170|NCT01336738|20549348|P1|Overall Study|Protocol Violation|0
5941171|NCT01336738|20549344|P5|Overall Study|Did not meet entrance criteria|0
5941172|NCT01336738|20549345|P4|Overall Study|Did not meet entrance criteria|0
5941173|NCT01336738|20549346|P3|Overall Study|Did not meet entrance criteria|0
5941174|NCT01336738|20549347|P2|Overall Study|Did not meet entrance criteria|1
5941175|NCT01336738|20549348|P1|Overall Study|Did not meet entrance criteria|0
5941176|NCT01336738|20549344|P5|Overall Study|Lost to Follow-up|2
5941177|NCT01336738|20549345|P4|Overall Study|Lost to Follow-up|2
5941178|NCT01336738|20549346|P3|Overall Study|Lost to Follow-up|2
5941179|NCT01336738|20549347|P2|Overall Study|Lost to Follow-up|1
5941180|NCT01336738|20549348|P1|Overall Study|Lost to Follow-up|2
5941181|NCT01336738|20549344|P5|Overall Study|Adverse Event|3
5941182|NCT01336738|20549345|P4|Overall Study|Adverse Event|1
5941183|NCT01336738|20549346|P3|Overall Study|Adverse Event|2
5941184|NCT01336738|20549347|P2|Overall Study|Adverse Event|3
5941185|NCT01336738|20549348|P1|Overall Study|Adverse Event|0
5941186|NCT01336712|20549390|P1|Overall Study|Lack of Efficacy|1
5941187|NCT01336712|20549390|P1|Overall Study|Death|2
5941188|NCT01336647|20549403|P3|Overall Study|Lost to Follow-up|3
5941189|NCT01336647|20549404|P2|Overall Study|Lost to Follow-up|1
5941190|NCT01336647|20549405|P1|Overall Study|Lost to Follow-up|4
5941191|NCT01336621|20549416|P1|SFUCP (up to 2.6 Years)|Other: Study closed/terminated|3
5941192|NCT01336621|20549416|P1|SFUCP (up to 2.6 Years)|Physician Decision|1
5941193|NCT01336621|20549416|P1|SFUCP (up to 2.6 Years)|Withdrawal by Subject|3
5941194|NCT01336621|20549416|P1|SFUCP (up to 2.6 Years)|Adverse Event|1
5941195|NCT01336621|20549416|P1|SFUCP (up to 2.6 Years)|Other: Reached stopping criteria|1
5941196|NCT01336621|20549416|P1|Primary Reporting Phase (Upto 5.8 Years)|Other: Continued in SFUCP|9
5941197|NCT01336621|20549416|P1|Primary Reporting Phase (Upto 5.8 Years)|Other: lost to follow up|2
5941198|NCT01336621|20549416|P1|Primary Reporting Phase (Upto 5.8 Years)|Other: Reached stopping criteria|22
5941199|NCT01336621|20549416|P1|Primary Reporting Phase (Upto 5.8 Years)|Physician Decision|2
5941200|NCT01336621|20549416|P1|Primary Reporting Phase (Upto 5.8 Years)|Other: study terminated|11
5941201|NCT01336621|20549416|P1|Primary Reporting Phase (Upto 5.8 Years)|Withdrawal by Subject|27
5941202|NCT01336621|20549416|P1|Primary Reporting Phase (Upto 5.8 Years)|Protocol Violation|12
5941203|NCT01336621|20549416|P1|Primary Reporting Phase (Upto 5.8 Years)|Lack of Efficacy|2
5941204|NCT01336621|20549416|P1|Primary Reporting Phase (Upto 5.8 Years)|Adverse Event|11
5941205|NCT01336608|20549466|P4|24-week, Double-blind Treatment Period|Withdrawal by Subject|1
5941206|NCT01336608|20549467|P3|24-week, Double-blind Treatment Period|Withdrawal by Subject|4
5941207|NCT01336608|20549468|P2|24-week, Double-blind Treatment Period|Withdrawal by Subject|7
5941208|NCT01336608|20549469|P1|24-week, Double-blind Treatment Period|Withdrawal by Subject|0
5941209|NCT01336608|20549466|P4|24-week, Double-blind Treatment Period|Physician Decision|1
5941210|NCT01336608|20549467|P3|24-week, Double-blind Treatment Period|Physician Decision|1
5941211|NCT01336608|20549468|P2|24-week, Double-blind Treatment Period|Physician Decision|3
5941212|NCT01336608|20549469|P1|24-week, Double-blind Treatment Period|Physician Decision|0
5941213|NCT01336608|20549466|P4|24-week, Double-blind Treatment Period|Lost to Follow-up|0
5941214|NCT01336608|20549467|P3|24-week, Double-blind Treatment Period|Lost to Follow-up|0
5941215|NCT01336608|20549468|P2|24-week, Double-blind Treatment Period|Lost to Follow-up|3
5941216|NCT01336608|20549469|P1|24-week, Double-blind Treatment Period|Lost to Follow-up|0
5941217|NCT01336608|20549466|P4|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|6
5941218|NCT01336608|20549467|P3|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|3
5941219|NCT01336608|20549468|P2|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|4
5941220|NCT01336608|20549469|P1|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|0
5941221|NCT01336608|20549466|P4|24-week, Double-blind Treatment Period|Protocol Violation|3
5941222|NCT01336608|20549467|P3|24-week, Double-blind Treatment Period|Protocol Violation|3
5941223|NCT01336608|20549468|P2|24-week, Double-blind Treatment Period|Protocol Violation|4
5941224|NCT01336608|20549469|P1|24-week, Double-blind Treatment Period|Protocol Violation|0
5941225|NCT01336608|20549466|P4|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|6
5941226|NCT01336608|20549467|P3|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13
5941227|NCT01336608|20549468|P2|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13
5941228|NCT01336608|20549469|P1|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0
5941229|NCT01336608|20549466|P4|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
5941230|NCT01336608|20549467|P3|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
5941231|NCT01336608|20549468|P2|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2
5941232|NCT01336608|20549469|P1|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
5941233|NCT01336608|20549466|P4|24-week, Double-blind Treatment Period|Adverse Event|7
5941234|NCT01336608|20549467|P3|24-week, Double-blind Treatment Period|Adverse Event|6
5941235|NCT01336608|20549468|P2|24-week, Double-blind Treatment Period|Adverse Event|8
5941236|NCT01336608|20549469|P1|24-week, Double-blind Treatment Period|Adverse Event|0
5941237|NCT01336608|20549466|P4|2-week, Single-blind Run-In Period|Lost to Follow-up|0
5941238|NCT01336608|20549467|P3|2-week, Single-blind Run-In Period|Lost to Follow-up|0
5941239|NCT01336608|20549468|P2|2-week, Single-blind Run-In Period|Lost to Follow-up|0
5941240|NCT01336608|20549469|P1|2-week, Single-blind Run-In Period|Lost to Follow-up|2
5941241|NCT01336608|20549466|P4|2-week, Single-blind Run-In Period|Physician Decision|0
5941242|NCT01336608|20549467|P3|2-week, Single-blind Run-In Period|Physician Decision|0
5941243|NCT01336608|20549468|P2|2-week, Single-blind Run-In Period|Physician Decision|0
5941244|NCT01336608|20549469|P1|2-week, Single-blind Run-In Period|Physician Decision|1
5941245|NCT01336608|20549466|P4|2-week, Single-blind Run-In Period|Adverse Event|0
5941246|NCT01336608|20549467|P3|2-week, Single-blind Run-In Period|Adverse Event|0
5941247|NCT01336608|20549468|P2|2-week, Single-blind Run-In Period|Adverse Event|0
5941248|NCT01336608|20549469|P1|2-week, Single-blind Run-In Period|Adverse Event|1
5941249|NCT01336608|20549466|P4|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
5941250|NCT01336608|20549467|P3|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
5941251|NCT01336608|20549468|P2|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
5941252|NCT01336608|20549469|P1|2-week, Single-blind Run-In Period|Withdrawal by Subject|9
5941253|NCT01336608|20549466|P4|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
5941254|NCT01336608|20549467|P3|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
5941255|NCT01336608|20549468|P2|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
5941256|NCT01336608|20549469|P1|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|102
5941257|NCT01336569|20549483|P1|Overall Study|Lost to Follow-up|4
5941258|NCT01336205|20549531|P2|Overall Study|Did not receive treatment|0
5941259|NCT01336205|20549532|P1|Overall Study|Did not receive treatment|4
5941260|NCT01336205|20549531|P2|Overall Study|Withdrawal by Subject|38
5941261|NCT01336205|20549532|P1|Overall Study|Withdrawal by Subject|72
5941262|NCT01336205|20549531|P2|Overall Study|Eligibility Criteria Not Fulfilled|6
5941263|NCT01336205|20549532|P1|Overall Study|Eligibility Criteria Not Fulfilled|9
5941264|NCT01336205|20549531|P2|Overall Study|Death|1
5941265|NCT01336205|20549532|P1|Overall Study|Death|1
5941266|NCT01336205|20549531|P2|Overall Study|Adverse Event|6
5941267|NCT01336205|20549532|P1|Overall Study|Adverse Event|56
5941268|NCT01336205|20549531|P2|Overall Study|Severe noncompliance with protocol|2
5941269|NCT01336205|20549532|P1|Overall Study|Severe noncompliance with protocol|9
5941270|NCT01336205|20549531|P2|Overall Study|Lack of Efficacy|0
5941271|NCT01336205|20549532|P1|Overall Study|Lack of Efficacy|4
5941272|NCT01336205|20549531|P2|Overall Study|Study-Specific Withdrawal Criteria|7
5941273|NCT01336205|20549532|P1|Overall Study|Study-Specific Withdrawal Criteria|16
5941274|NCT01336205|20549531|P2|Overall Study|Lost to Follow-up|20
5941275|NCT01336205|20549532|P1|Overall Study|Lost to Follow-up|40
5941276|NCT01336205|20549531|P2|Overall Study|Other|9
5941277|NCT01336205|20549532|P1|Overall Study|Other|22
5941278|NCT01336023|20549560|P3|Week 27 to 52|Unclassified|9
5941279|NCT01336023|20549561|P2|Week 27 to 52|Unclassified|18
5941280|NCT01336023|20549562|P1|Week 27 to 52|Unclassified|13
5941281|NCT01336023|20549560|P3|Week 27 to 52|Withdrawal Criteria|16
5941282|NCT01336023|20549561|P2|Week 27 to 52|Withdrawal Criteria|19
5941283|NCT01336023|20549562|P1|Week 27 to 52|Withdrawal Criteria|14
5941284|NCT01336023|20549560|P3|Week 27 to 52|Protocol Violation|1
5941285|NCT01336023|20549561|P2|Week 27 to 52|Protocol Violation|2
5941286|NCT01336023|20549562|P1|Week 27 to 52|Protocol Violation|0
5941287|NCT01336023|20549560|P3|Week 27 to 52|Adverse Event|2
5941288|NCT01336023|20549561|P2|Week 27 to 52|Adverse Event|5
5941289|NCT01336023|20549562|P1|Week 27 to 52|Adverse Event|1
5941290|NCT01336023|20549560|P3|Week 0 to Week 26|Unclassified|9
5941291|NCT01336023|20549561|P2|Week 0 to Week 26|Unclassified|16
5941292|NCT01336023|20549562|P1|Week 0 to Week 26|Unclassified|5
5941293|NCT01336023|20549560|P3|Week 0 to Week 26|Withdrawal Criteria|40
5941294|NCT01336023|20549561|P2|Week 0 to Week 26|Withdrawal Criteria|69
5941295|NCT01336023|20549562|P1|Week 0 to Week 26|Withdrawal Criteria|34
5941296|NCT01336023|20549560|P3|Week 0 to Week 26|Protocol Violation|0
5941297|NCT01336023|20549561|P2|Week 0 to Week 26|Protocol Violation|2
5941298|NCT01336023|20549562|P1|Week 0 to Week 26|Protocol Violation|1
5941299|NCT01336023|20549560|P3|Week 0 to Week 26|Lack of Efficacy|0
5941300|NCT01336023|20549561|P2|Week 0 to Week 26|Lack of Efficacy|1
5941301|NCT01336023|20549562|P1|Week 0 to Week 26|Lack of Efficacy|0
5941302|NCT01336023|20549560|P3|Week 0 to Week 26|Adverse Event|24
5941303|NCT01336023|20549561|P2|Week 0 to Week 26|Adverse Event|10
5941304|NCT01336023|20549562|P1|Week 0 to Week 26|Adverse Event|8
5941305|NCT01335997|20549583|P2|Period III|Lost to Follow-up|0
5941306|NCT01335997|20549584|P1|Period III|Lost to Follow-up|1
5941307|NCT01335997|20549583|P2|Period III|Protocol Violation|1
5941308|NCT01335997|20549584|P1|Period III|Protocol Violation|0
5941309|NCT01335997|20549583|P2|Period III|Study Terminated by Sponsor|76
5941310|NCT01335997|20549584|P1|Period III|Study Terminated by Sponsor|77
5941311|NCT01335997|20549583|P2|Period III|Adverse Event|2
5941312|NCT01335997|20549584|P1|Period III|Adverse Event|0
5941313|NCT01335997|20549583|P2|Period I and II|Physician Decision|1
5941314|NCT01335997|20549584|P1|Period I and II|Physician Decision|2
5941315|NCT01335997|20549583|P2|Period I and II|Protocol Violation|10
5941316|NCT01335997|20549584|P1|Period I and II|Protocol Violation|9
5941317|NCT01335997|20549583|P2|Period I and II|Study Terminated by Sponsor|415
5941318|NCT01335997|20549584|P1|Period I and II|Study Terminated by Sponsor|406
5941319|NCT01335997|20549583|P2|Period I and II|Withdrawal by Subject|4
5941320|NCT01335997|20549584|P1|Period I and II|Withdrawal by Subject|9
5941321|NCT01335997|20549583|P2|Period I and II|Lost to Follow-up|5
5941322|NCT01335997|20549584|P1|Period I and II|Lost to Follow-up|3
5941323|NCT01335997|20549583|P2|Period I and II|Noncompliance with Study Drug|1
5941324|NCT01335997|20549584|P1|Period I and II|Noncompliance with Study Drug|1
5941325|NCT01335997|20549583|P2|Period I and II|Adverse Event|43
5941326|NCT01335997|20549584|P1|Period I and II|Adverse Event|63
5941327|NCT01335971|20549597|P3|Overall Study|Did not complete bronchoscopy|1
5941328|NCT01335971|20549598|P2|Overall Study|Did not complete bronchoscopy|1
5941329|NCT01335971|20549599|P1|Overall Study|Did not complete bronchoscopy|1
5941330|NCT01335971|20549597|P3|Overall Study|Withdrawal by Subject|0
5941331|NCT01335971|20549598|P2|Overall Study|Withdrawal by Subject|0
5941332|NCT01335971|20549599|P1|Overall Study|Withdrawal by Subject|1
5941333|NCT01335698|20549842|P5|Treatment Stage 2|Switched to another formulation|0
5941334|NCT01335698|20549843|P4|Treatment Stage 2|Switched to another formulation|0
5941335|NCT01335698|20549844|P3|Treatment Stage 2|Switched to another formulation|0
5941336|NCT01335698|20549845|P2|Treatment Stage 2|Switched to another formulation|1
5941337|NCT01335698|20549846|P1|Treatment Stage 2|Switched to another formulation|1
5941338|NCT01335698|20549842|P5|Treatment Stage 2|Subject no longer meets study criteria|0
5941339|NCT01335698|20549843|P4|Treatment Stage 2|Subject no longer meets study criteria|1
5941340|NCT01335698|20549844|P3|Treatment Stage 2|Subject no longer meets study criteria|0
5941341|NCT01335698|20549845|P2|Treatment Stage 2|Subject no longer meets study criteria|0
5941342|NCT01335698|20549846|P1|Treatment Stage 2|Subject no longer meets study criteria|0
5941343|NCT01335698|20549842|P5|Treatment Stage 2|Capsules received at state hospital|0
5941344|NCT01335698|20549843|P4|Treatment Stage 2|Capsules received at state hospital|0
5941345|NCT01335698|20549844|P3|Treatment Stage 2|Capsules received at state hospital|0
5941346|NCT01335698|20549845|P2|Treatment Stage 2|Capsules received at state hospital|0
5941347|NCT01335698|20549846|P1|Treatment Stage 2|Capsules received at state hospital|1
5941348|NCT01335698|20549842|P5|Treatment Stage 2|Lost to Follow-up|0
5941349|NCT01335698|20549843|P4|Treatment Stage 2|Lost to Follow-up|0
5941350|NCT01335698|20549844|P3|Treatment Stage 2|Lost to Follow-up|0
5941351|NCT01335698|20549845|P2|Treatment Stage 2|Lost to Follow-up|0
5941352|NCT01335698|20549846|P1|Treatment Stage 2|Lost to Follow-up|1
5941353|NCT01335698|20549842|P5|Treatment Stage 2|Poor compliance/noncompliance|1
5941354|NCT01335698|20549843|P4|Treatment Stage 2|Poor compliance/noncompliance|3
5941355|NCT01335698|20549844|P3|Treatment Stage 2|Poor compliance/noncompliance|1
5941356|NCT01335698|20549845|P2|Treatment Stage 2|Poor compliance/noncompliance|0
5941357|NCT01335698|20549846|P1|Treatment Stage 2|Poor compliance/noncompliance|1
5941358|NCT01335698|20549842|P5|Treatment Stage 2|Withdrawal by Subject|0
5941359|NCT01335698|20549843|P4|Treatment Stage 2|Withdrawal by Subject|0
5941360|NCT01335698|20549844|P3|Treatment Stage 2|Withdrawal by Subject|1
5941361|NCT01335698|20549845|P2|Treatment Stage 2|Withdrawal by Subject|1
5941362|NCT01335698|20549846|P1|Treatment Stage 2|Withdrawal by Subject|3
5941363|NCT01335698|20549842|P5|Treatment Stage 2|Adverse Event|0
5941364|NCT01335698|20549843|P4|Treatment Stage 2|Adverse Event|3
5941365|NCT01335698|20549844|P3|Treatment Stage 2|Adverse Event|0
5941366|NCT01335698|20549845|P2|Treatment Stage 2|Adverse Event|0
5941367|NCT01335698|20549846|P1|Treatment Stage 2|Adverse Event|2
5941368|NCT01335698|20549842|P5|Treatment Stage 2|Lack of Efficacy|0
5941369|NCT01335698|20549843|P4|Treatment Stage 2|Lack of Efficacy|1
5941370|NCT01335698|20549844|P3|Treatment Stage 2|Lack of Efficacy|3
5941371|NCT01335698|20549845|P2|Treatment Stage 2|Lack of Efficacy|1
5941372|NCT01335698|20549846|P1|Treatment Stage 2|Lack of Efficacy|2
5941373|NCT01335698|20549842|P5|Treatment Stage 1|Other|0
5941374|NCT01335698|20549843|P4|Treatment Stage 1|Other|1
5941375|NCT01335698|20549844|P3|Treatment Stage 1|Other|0
5941376|NCT01335698|20549845|P2|Treatment Stage 1|Other|0
5941377|NCT01335698|20549846|P1|Treatment Stage 1|Other|1
5941378|NCT01335698|20549842|P5|Treatment Stage 1|No longer meets study criteria|0
5941379|NCT01335698|20549843|P4|Treatment Stage 1|No longer meets study criteria|1
5941380|NCT01335698|20549844|P3|Treatment Stage 1|No longer meets study criteria|0
5941381|NCT01335698|20549845|P2|Treatment Stage 1|No longer meets study criteria|1
5941382|NCT01335698|20549846|P1|Treatment Stage 1|No longer meets study criteria|1
5941383|NCT01335698|20549842|P5|Treatment Stage 1|Poor compliance/noncompliance|0
5941384|NCT01335698|20549843|P4|Treatment Stage 1|Poor compliance/noncompliance|2
5941385|NCT01335698|20549844|P3|Treatment Stage 1|Poor compliance/noncompliance|0
5941386|NCT01335698|20549845|P2|Treatment Stage 1|Poor compliance/noncompliance|1
5941387|NCT01335698|20549846|P1|Treatment Stage 1|Poor compliance/noncompliance|0
5941388|NCT01335698|20549842|P5|Treatment Stage 1|Lost to Follow-up|0
5941389|NCT01335698|20549843|P4|Treatment Stage 1|Lost to Follow-up|0
5941390|NCT01335698|20549844|P3|Treatment Stage 1|Lost to Follow-up|0
5941391|NCT01335698|20549845|P2|Treatment Stage 1|Lost to Follow-up|1
5941392|NCT01335698|20549846|P1|Treatment Stage 1|Lost to Follow-up|1
5941393|NCT01335698|20549842|P5|Treatment Stage 1|Withdrawal by Subject|0
5941394|NCT01335698|20549843|P4|Treatment Stage 1|Withdrawal by Subject|1
5941395|NCT01335698|20549844|P3|Treatment Stage 1|Withdrawal by Subject|0
5941396|NCT01335698|20549845|P2|Treatment Stage 1|Withdrawal by Subject|2
5941397|NCT01335698|20549846|P1|Treatment Stage 1|Withdrawal by Subject|1
5941398|NCT01335698|20549842|P5|Treatment Stage 1|Adverse Event|1
5941399|NCT01335698|20549843|P4|Treatment Stage 1|Adverse Event|1
5941400|NCT01335698|20549844|P3|Treatment Stage 1|Adverse Event|2
5941401|NCT01335698|20549845|P2|Treatment Stage 1|Adverse Event|2
5941402|NCT01335698|20549846|P1|Treatment Stage 1|Adverse Event|1
5941403|NCT01335698|20549842|P5|Treatment Stage 1|Lack of Efficacy|1
5941404|NCT01335698|20549843|P4|Treatment Stage 1|Lack of Efficacy|3
5941405|NCT01335698|20549844|P3|Treatment Stage 1|Lack of Efficacy|3
5941406|NCT01335698|20549845|P2|Treatment Stage 1|Lack of Efficacy|1
5941407|NCT01335698|20549846|P1|Treatment Stage 1|Lack of Efficacy|3
5941408|NCT01335685|20549911|P8|Overall Study|Reason not Specified|0
5941409|NCT01335685|20549912|P7|Overall Study|Reason not Specified|0
5941410|NCT01335685|20549913|P6|Overall Study|Reason not Specified|1
5941411|NCT01335685|20549914|P5|Overall Study|Reason not Specified|0
5941412|NCT01335685|20549915|P4|Overall Study|Reason not Specified|0
5941413|NCT01335685|20549916|P3|Overall Study|Reason not Specified|1
5941414|NCT01335685|20549917|P2|Overall Study|Reason not Specified|0
5941415|NCT01335685|20549918|P1|Overall Study|Reason not Specified|0
5941416|NCT01335685|20549911|P8|Overall Study|Withdrawal by Subject|0
5941417|NCT01335685|20549912|P7|Overall Study|Withdrawal by Subject|0
5941418|NCT01335685|20549913|P6|Overall Study|Withdrawal by Subject|0
5941419|NCT01335685|20549914|P5|Overall Study|Withdrawal by Subject|0
5941420|NCT01335685|20549915|P4|Overall Study|Withdrawal by Subject|1
5941421|NCT01335685|20549916|P3|Overall Study|Withdrawal by Subject|0
5941422|NCT01335685|20549917|P2|Overall Study|Withdrawal by Subject|0
5941423|NCT01335685|20549918|P1|Overall Study|Withdrawal by Subject|1
5941424|NCT01335685|20549911|P8|Overall Study|Study Terminated by Sponsor|3
5941425|NCT01335685|20549912|P7|Overall Study|Study Terminated by Sponsor|2
5941426|NCT01335685|20549913|P6|Overall Study|Study Terminated by Sponsor|4
5941427|NCT01335685|20549914|P5|Overall Study|Study Terminated by Sponsor|0
5941428|NCT01335685|20549915|P4|Overall Study|Study Terminated by Sponsor|10
5941429|NCT01335685|20549916|P3|Overall Study|Study Terminated by Sponsor|1
5941430|NCT01335685|20549917|P2|Overall Study|Study Terminated by Sponsor|1
5941431|NCT01335685|20549918|P1|Overall Study|Study Terminated by Sponsor|2
5941432|NCT01335477|20550042|P2|Overall Study|Reason other than those stated above|2
5941433|NCT01335477|20550043|P1|Overall Study|Reason other than those stated above|2
5941434|NCT01335477|20550042|P2|Overall Study|Not treated|2
5941435|NCT01335477|20550043|P1|Overall Study|Not treated|1
5941436|NCT01335477|20550042|P2|Overall Study|Consent withdrawn, not due to AE|9
5941437|NCT01335477|20550043|P1|Overall Study|Consent withdrawn, not due to AE|7
5941438|NCT01335477|20550042|P2|Overall Study|Lost to Follow-up|2
5941439|NCT01335477|20550043|P1|Overall Study|Lost to Follow-up|1
5941440|NCT01335477|20550042|P2|Overall Study|Non compliant with protocol|2
5941441|NCT01335477|20550043|P1|Overall Study|Non compliant with protocol|0
5941442|NCT01335477|20550042|P2|Overall Study|Adverse Event|42
5941443|NCT01335477|20550043|P1|Overall Study|Adverse Event|30
5941444|NCT01335464|20550107|P2|Overall Study|Reason other than those stated above|1
5941445|NCT01335464|20550108|P1|Overall Study|Reason other than those stated above|1
5941446|NCT01335464|20550107|P2|Overall Study|Not treated|0
5941447|NCT01335464|20550108|P1|Overall Study|Not treated|2
5941448|NCT01335464|20550107|P2|Overall Study|Consent withdrawn, not due to AE|23
5941449|NCT01335464|20550108|P1|Overall Study|Consent withdrawn, not due to AE|12
5941450|NCT01335464|20550107|P2|Overall Study|Non compliant with protocol|0
5941451|NCT01335464|20550108|P1|Overall Study|Non compliant with protocol|2
5941452|NCT01335464|20550107|P2|Overall Study|Adverse Event|25
5941453|NCT01335464|20550108|P1|Overall Study|Adverse Event|15
5941454|NCT01335399|20550172|P2|Treatment Period|Not reported|0
5941455|NCT01335399|20550173|P1|Treatment Period|Not reported|1
5941456|NCT01335399|20550172|P2|Treatment Period|No longer meet study criteria|1
5941457|NCT01335399|20550173|P1|Treatment Period|No longer meet study criteria|0
5941458|NCT01335399|20550172|P2|Treatment Period|Maximum clinical benefit|1
5941459|NCT01335399|20550173|P1|Treatment Period|Maximum clinical benefit|1
5941460|NCT01335399|20550172|P2|Treatment Period|Lost to Follow-up|2
5941461|NCT01335399|20550173|P1|Treatment Period|Lost to Follow-up|0
5941462|NCT01335399|20550172|P2|Treatment Period|Poor/Non-compliance|4
5941463|NCT01335399|20550173|P1|Treatment Period|Poor/Non-compliance|3
5941464|NCT01335399|20550172|P2|Treatment Period|Death|8
5941465|NCT01335399|20550173|P1|Treatment Period|Death|7
5941466|NCT01335399|20550172|P2|Treatment Period|Consent withdrawal|6
5941467|NCT01335399|20550173|P1|Treatment Period|Consent withdrawal|10
5941468|NCT01335399|20550172|P2|Treatment Period|Other reasons|26
5941469|NCT01335399|20550173|P1|Treatment Period|Other reasons|14
5941470|NCT01335399|20550172|P2|Treatment Period|Participant request to discontinue|21
5941471|NCT01335399|20550173|P1|Treatment Period|Participant request to discontinue|27
5941472|NCT01335399|20550172|P2|Treatment Period|Study drug toxicity|64
5941473|NCT01335399|20550173|P1|Treatment Period|Study drug toxicity|51
5941474|NCT01335399|20550172|P2|Treatment Period|Adverse event unrelated to study drug|65
5941475|NCT01335399|20550173|P1|Treatment Period|Adverse event unrelated to study drug|105
5941476|NCT01335399|20550172|P2|Treatment Period|Disease progression|141
5941477|NCT01335399|20550173|P1|Treatment Period|Disease progression|114
5941478|NCT01335399|20550172|P2|Pre-treatment Period|Consent withdrawal|0
5941479|NCT01335399|20550173|P1|Pre-treatment Period|Consent withdrawal|3
5941480|NCT01335399|20550172|P2|Pre-treatment Period|Adverse event unrelated to study drug|1
5941481|NCT01335399|20550173|P1|Pre-treatment Period|Adverse event unrelated to study drug|0
5941482|NCT01335399|20550172|P2|Pre-treatment Period|Participant request to discontinue|1
5941483|NCT01335399|20550173|P1|Pre-treatment Period|Participant request to discontinue|0
5941484|NCT01335399|20550172|P2|Pre-treatment Period|No longer meeting study criteria|1
5941485|NCT01335399|20550173|P1|Pre-treatment Period|No longer meeting study criteria|0
5941486|NCT01334918|20550294|P2|Overall Study|Withdrawal by Subject|1
5941487|NCT01334918|20550295|P1|Overall Study|Withdrawal by Subject|0
5941488|NCT01334918|20550294|P2|Overall Study|Adverse Event|0
5941489|NCT01334918|20550295|P1|Overall Study|Adverse Event|2
5941490|NCT01334918|20550294|P2|Overall Study|Did not receive study drug|0
5941491|NCT01334918|20550295|P1|Overall Study|Did not receive study drug|6
5941492|NCT01334866|20550321|P1|Overall Study|medically necessary post-procedure|1
5941493|NCT01334866|20550321|P1|Overall Study|medically necessary prior to procedure|2
5941494|NCT01334866|20550321|P1|Overall Study|Physician Decision|3
5941495|NCT01334866|20550321|P1|Overall Study|Lost to Follow-up|3
5941496|NCT01334866|20550321|P1|Overall Study|Withdrawal by Subject|10
5941497|NCT01334710|20550366|P1|Overall Study|Trial was terminated|3
5941498|NCT01334606|20550371|P1|Overall Study|Study Terminated due to slow enrolment|18
5941499|NCT01334554|20550379|P2|Overall Study|Adverse Event|2
5941500|NCT01334554|20550380|P1|Overall Study|Adverse Event|4
5941501|NCT01334515|20550390|P2|Overall Study|Withdrawal by Subject|1
5941502|NCT01334515|20550391|P1|Overall Study|Withdrawal by Subject|1
5941503|NCT01334515|20550390|P2|Overall Study|Physician Decision|1
5941504|NCT01334515|20550391|P1|Overall Study|Physician Decision|1
5941505|NCT01334515|20550390|P2|Overall Study|Lack of Efficacy|21
5941506|NCT01334515|20550391|P1|Overall Study|Lack of Efficacy|8
5941507|NCT01334515|20550390|P2|Overall Study|Death|0
5941508|NCT01334515|20550391|P1|Overall Study|Death|1
5941509|NCT01334515|20550390|P2|Overall Study|Adverse Event|6
5941510|NCT01334515|20550391|P1|Overall Study|Adverse Event|1
5941511|NCT01334125|20550429|P2|Overall Study|Lost to Follow-up|3
5941512|NCT01334125|20550430|P1|Overall Study|Lost to Follow-up|3
5941513|NCT01333956|20550446|P4|Overall Study|Withdrawal by Subject|0
5941514|NCT01333956|20550447|P3|Overall Study|Withdrawal by Subject|1
5941515|NCT01333956|20550448|P2|Overall Study|Withdrawal by Subject|2
5941516|NCT01333956|20550449|P1|Overall Study|Withdrawal by Subject|0
5941517|NCT01333956|20550446|P4|Overall Study|Unable to complete study procedure|1
5941518|NCT01333956|20550447|P3|Overall Study|Unable to complete study procedure|0
5941519|NCT01333956|20550448|P2|Overall Study|Unable to complete study procedure|0
5941520|NCT01333956|20550449|P1|Overall Study|Unable to complete study procedure|1
5941521|NCT01333956|20550446|P4|Overall Study|Lost to Follow-up|1
5941522|NCT01333956|20550447|P3|Overall Study|Lost to Follow-up|0
5941523|NCT01333956|20550448|P2|Overall Study|Lost to Follow-up|2
5941524|NCT01333956|20550449|P1|Overall Study|Lost to Follow-up|1
5941525|NCT01333943|20550485|P2|Overall Study|Known neuropathy|0
5941526|NCT01333943|20550486|P1|Overall Study|Known neuropathy|1
5941527|NCT01333865|20550502|P1|Overall Study|Adverse Event|2
5941528|NCT01333722|20550522|P2|Overall Study|Withdrawal by Subject|1
5941529|NCT01333722|20550523|P1|Overall Study|Withdrawal by Subject|0
5941530|NCT01333722|20550522|P2|Overall Study|Lack of Efficacy|2
5941531|NCT01333722|20550523|P1|Overall Study|Lack of Efficacy|0
5941532|NCT01333501|20550548|P2|Overall Study|Withdrawn consent|12
5941533|NCT01333501|20550549|P1|Overall Study|Withdrawn consent|3
5941534|NCT01333501|20550548|P2|Overall Study|Unsatisfactory therapeutic effect|7
5941535|NCT01333501|20550549|P1|Overall Study|Unsatisfactory therapeutic effect|1
5941536|NCT01333501|20550548|P2|Overall Study|Abnormal laboratory value|1
5941537|NCT01333501|20550549|P1|Overall Study|Abnormal laboratory value|2
5941538|NCT01333501|20550548|P2|Overall Study|Adverse Event|1
5941539|NCT01333501|20550549|P1|Overall Study|Adverse Event|3
5941540|NCT01333475|20550616|P2|Overall Study|Toxicity|3
5941541|NCT01333475|20550617|P1|Overall Study|Toxicity|1
5941542|NCT01333475|20550616|P2|Overall Study|pt withdrew-need emergent radiation trmt|0
5941543|NCT01333475|20550617|P1|Overall Study|pt withdrew-need emergent radiation trmt|1
5941544|NCT01333397|20550643|P5|Overall Study|Lost to Follow-up|0
5941545|NCT01333397|20550644|P4|Overall Study|Lost to Follow-up|1
5941546|NCT01333397|20550645|P3|Overall Study|Lost to Follow-up|0
5941547|NCT01333397|20550646|P2|Overall Study|Lost to Follow-up|0
5941548|NCT01333397|20550647|P1|Overall Study|Lost to Follow-up|1
5941549|NCT01333189|20550721|P2|Overall Study|Moved from region|1
5941550|NCT01333189|20550722|P1|Overall Study|Moved from region|0
5941551|NCT01333189|20550721|P2|Overall Study|Transportation difficulties|1
5941552|NCT01333189|20550722|P1|Overall Study|Transportation difficulties|0
5941553|NCT01333189|20550721|P2|Overall Study|Adverse Event|0
5941554|NCT01333189|20550722|P1|Overall Study|Adverse Event|1
5941555|NCT01333189|20550721|P2|Overall Study|Time constraints|0
5941556|NCT01333189|20550722|P1|Overall Study|Time constraints|1
5941557|NCT01333111|20550753|P3|Overall Study|Ineffective therapy|1
5941558|NCT01333111|20550754|P2|Overall Study|Ineffective therapy|0
5941559|NCT01333111|20550755|P1|Overall Study|Ineffective therapy|0
5941560|NCT01333111|20550753|P3|Overall Study|Non-compliance|0
5941561|NCT01333111|20550754|P2|Overall Study|Non-compliance|0
5941562|NCT01333111|20550755|P1|Overall Study|Non-compliance|1
5941563|NCT01333111|20550753|P3|Overall Study|withdrawal criteria|0
5941564|NCT01333111|20550754|P2|Overall Study|withdrawal criteria|1
5941565|NCT01333111|20550755|P1|Overall Study|withdrawal criteria|0
5941566|NCT01333111|20550753|P3|Overall Study|unclassified|0
5941567|NCT01333111|20550754|P2|Overall Study|unclassified|0
5941568|NCT01333111|20550755|P1|Overall Study|unclassified|1
5941569|NCT01333111|20550753|P3|Overall Study|personal reasons|1
5941570|NCT01333111|20550754|P2|Overall Study|personal reasons|0
5941571|NCT01333111|20550755|P1|Overall Study|personal reasons|0
5941572|NCT01333111|20550753|P3|Overall Study|patient undergoing major surgery|0
5941573|NCT01333111|20550754|P2|Overall Study|patient undergoing major surgery|2
5941574|NCT01333111|20550755|P1|Overall Study|patient undergoing major surgery|0
5941575|NCT01333072|20550790|P2|Overall Study|Physician Decision|0
5941576|NCT01333072|20550791|P1|Overall Study|Physician Decision|1
5941577|NCT01333072|20550790|P2|Overall Study|Adverse Event|4
5941578|NCT01333072|20550791|P1|Overall Study|Adverse Event|2
5941579|NCT01333072|20550790|P2|Overall Study|Lost to Follow-up|0
5941580|NCT01333072|20550791|P1|Overall Study|Lost to Follow-up|3
5941581|NCT01333059|20550799|P2|Overall Study|Protocol Violation|0
5941582|NCT01333059|20550800|P1|Overall Study|Protocol Violation|3
5941583|NCT01333059|20550799|P2|Overall Study|Physician Decision|3
5941584|NCT01333059|20550800|P1|Overall Study|Physician Decision|3
5941585|NCT01332994|20550810|P1|Overall Study|Other|8
5941586|NCT01332994|20550810|P1|Overall Study|Administrative Problem|2
5941587|NCT01332994|20550810|P1|Overall Study|Withdrawal by Subject|15
5941588|NCT01332994|20550810|P1|Overall Study|Protocol Violation|6
5941589|NCT01332994|20550810|P1|Overall Study|Lost to Follow-up|4
5941590|NCT01332994|20550810|P1|Overall Study|Lack of Efficacy|1
5941591|NCT01332994|20550810|P1|Overall Study|Death|1
5941592|NCT01332994|20550810|P1|Overall Study|Adverse Event|34
5941593|NCT01332968|20550879|P8|Follow-Up Period|Lost to Follow-up|2
5941594|NCT01332968|20550880|P7|Follow-Up Period|Lost to Follow-up|1
5941595|NCT01332968|20550881|P6|Follow-Up Period|Lost to Follow-up|0
5941596|NCT01332968|20550882|P5|Follow-Up Period|Lost to Follow-up|0
5941597|NCT01332968|20550883|P4|Follow-Up Period|Lost to Follow-up|0
5941598|NCT01332968|20550884|P3|Follow-Up Period|Lost to Follow-up|0
5941599|NCT01332968|20550885|P2|Follow-Up Period|Lost to Follow-up|0
5941600|NCT01332968|20550886|P1|Follow-Up Period|Lost to Follow-up|0
5941601|NCT01332968|20550879|P8|Follow-Up Period|Withdrawal by Subject|2
5941602|NCT01332968|20550880|P7|Follow-Up Period|Withdrawal by Subject|1
5941603|NCT01332968|20550881|P6|Follow-Up Period|Withdrawal by Subject|0
5941604|NCT01332968|20550882|P5|Follow-Up Period|Withdrawal by Subject|0
5941605|NCT01332968|20550883|P4|Follow-Up Period|Withdrawal by Subject|0
5941606|NCT01332968|20550884|P3|Follow-Up Period|Withdrawal by Subject|0
5941607|NCT01332968|20550885|P2|Follow-Up Period|Withdrawal by Subject|0
5941608|NCT01332968|20550886|P1|Follow-Up Period|Withdrawal by Subject|0
5941609|NCT01332968|20550879|P8|Follow-Up Period|Follow-up ongoing|505
5941610|NCT01332968|20550880|P7|Follow-Up Period|Follow-up ongoing|502
5941611|NCT01332968|20550881|P6|Follow-Up Period|Follow-up ongoing|0
5941612|NCT01332968|20550882|P5|Follow-Up Period|Follow-up ongoing|0
5941613|NCT01332968|20550883|P4|Follow-Up Period|Follow-up ongoing|0
5941614|NCT01332968|20550884|P3|Follow-Up Period|Follow-up ongoing|0
5941615|NCT01332968|20550885|P2|Follow-Up Period|Follow-up ongoing|0
5941616|NCT01332968|20550886|P1|Follow-Up Period|Follow-up ongoing|0
5941617|NCT01332968|20550879|P8|Follow-Up Period|Death|22
5941618|NCT01332968|20550880|P7|Follow-Up Period|Death|38
5941619|NCT01332968|20550881|P6|Follow-Up Period|Death|0
5941620|NCT01332968|20550882|P5|Follow-Up Period|Death|0
5941621|NCT01332968|20550883|P4|Follow-Up Period|Death|0
5941622|NCT01332968|20550884|P3|Follow-Up Period|Death|0
5941623|NCT01332968|20550885|P2|Follow-Up Period|Death|0
5941624|NCT01332968|20550886|P1|Follow-Up Period|Death|0
5941625|NCT01332968|20550879|P8|Maintenance/Observation Period|Treatment ongoing|0
5941626|NCT01332968|20550880|P7|Maintenance/Observation Period|Treatment ongoing|0
5941627|NCT01332968|20550881|P6|Maintenance/Observation Period|Treatment ongoing|8
5941628|NCT01332968|20550882|P5|Maintenance/Observation Period|Treatment ongoing|10
5941629|NCT01332968|20550883|P4|Maintenance/Observation Period|Treatment ongoing|62
5941630|NCT01332968|20550884|P3|Maintenance/Observation Period|Treatment ongoing|54
5941631|NCT01332968|20550885|P2|Maintenance/Observation Period|Treatment ongoing|0
5941632|NCT01332968|20550886|P1|Maintenance/Observation Period|Treatment ongoing|0
5941633|NCT01332968|20550879|P8|Maintenance/Observation Period|Adverse Event|0
5941634|NCT01332968|20550880|P7|Maintenance/Observation Period|Adverse Event|0
5941635|NCT01332968|20550881|P6|Maintenance/Observation Period|Adverse Event|0
5941636|NCT01332968|20550882|P5|Maintenance/Observation Period|Adverse Event|0
5941637|NCT01332968|20550883|P4|Maintenance/Observation Period|Adverse Event|65
5941638|NCT01332968|20550884|P3|Maintenance/Observation Period|Adverse Event|50
5941639|NCT01332968|20550885|P2|Maintenance/Observation Period|Adverse Event|0
5941640|NCT01332968|20550886|P1|Maintenance/Observation Period|Adverse Event|0
5941641|NCT01332968|20550879|P8|Maintenance/Observation Period|Death|0
5941642|NCT01332968|20550880|P7|Maintenance/Observation Period|Death|0
5941643|NCT01332968|20550881|P6|Maintenance/Observation Period|Death|0
5941644|NCT01332968|20550882|P5|Maintenance/Observation Period|Death|0
5941645|NCT01332968|20550883|P4|Maintenance/Observation Period|Death|6
5941646|NCT01332968|20550884|P3|Maintenance/Observation Period|Death|5
5941647|NCT01332968|20550885|P2|Maintenance/Observation Period|Death|0
5941648|NCT01332968|20550886|P1|Maintenance/Observation Period|Death|0
5941649|NCT01332968|20550879|P8|Maintenance/Observation Period|Lost to Follow-up|0
5941650|NCT01332968|20550880|P7|Maintenance/Observation Period|Lost to Follow-up|0
5941651|NCT01332968|20550881|P6|Maintenance/Observation Period|Lost to Follow-up|0
5941652|NCT01332968|20550882|P5|Maintenance/Observation Period|Lost to Follow-up|0
5941653|NCT01332968|20550883|P4|Maintenance/Observation Period|Lost to Follow-up|2
5941654|NCT01332968|20550884|P3|Maintenance/Observation Period|Lost to Follow-up|1
5941655|NCT01332968|20550885|P2|Maintenance/Observation Period|Lost to Follow-up|0
5941656|NCT01332968|20550886|P1|Maintenance/Observation Period|Lost to Follow-up|0
5941657|NCT01332968|20550879|P8|Maintenance/Observation Period|Non-compliance|0
5941658|NCT01332968|20550880|P7|Maintenance/Observation Period|Non-compliance|0
5941659|NCT01332968|20550881|P6|Maintenance/Observation Period|Non-compliance|1
5941660|NCT01332968|20550882|P5|Maintenance/Observation Period|Non-compliance|0
5941661|NCT01332968|20550883|P4|Maintenance/Observation Period|Non-compliance|3
5941662|NCT01332968|20550884|P3|Maintenance/Observation Period|Non-compliance|2
5941663|NCT01332968|20550885|P2|Maintenance/Observation Period|Non-compliance|0
5941664|NCT01332968|20550886|P1|Maintenance/Observation Period|Non-compliance|0
5941665|NCT01332968|20550879|P8|Maintenance/Observation Period|Other|0
5941666|NCT01332968|20550880|P7|Maintenance/Observation Period|Other|0
5941667|NCT01332968|20550881|P6|Maintenance/Observation Period|Other|0
5941668|NCT01332968|20550882|P5|Maintenance/Observation Period|Other|0
5941669|NCT01332968|20550883|P4|Maintenance/Observation Period|Other|5
5941670|NCT01332968|20550884|P3|Maintenance/Observation Period|Other|4
5941671|NCT01332968|20550885|P2|Maintenance/Observation Period|Other|0
5941672|NCT01332968|20550886|P1|Maintenance/Observation Period|Other|0
5941673|NCT01332968|20550879|P8|Maintenance/Observation Period|Physician Decision|0
5941674|NCT01332968|20550880|P7|Maintenance/Observation Period|Physician Decision|0
5941675|NCT01332968|20550881|P6|Maintenance/Observation Period|Physician Decision|0
5941676|NCT01332968|20550882|P5|Maintenance/Observation Period|Physician Decision|0
5941677|NCT01332968|20550883|P4|Maintenance/Observation Period|Physician Decision|19
5941678|NCT01332968|20550884|P3|Maintenance/Observation Period|Physician Decision|14
5941679|NCT01332968|20550885|P2|Maintenance/Observation Period|Physician Decision|0
5941680|NCT01332968|20550886|P1|Maintenance/Observation Period|Physician Decision|0
5941681|NCT01332968|20550879|P8|Maintenance/Observation Period|Progressive disease|0
5941682|NCT01332968|20550880|P7|Maintenance/Observation Period|Progressive disease|0
5941683|NCT01332968|20550881|P6|Maintenance/Observation Period|Progressive disease|0
5941684|NCT01332968|20550882|P5|Maintenance/Observation Period|Progressive disease|0
5941685|NCT01332968|20550883|P4|Maintenance/Observation Period|Progressive disease|39
5941686|NCT01332968|20550884|P3|Maintenance/Observation Period|Progressive disease|72
5941687|NCT01332968|20550885|P2|Maintenance/Observation Period|Progressive disease|0
5941688|NCT01332968|20550886|P1|Maintenance/Observation Period|Progressive disease|0
5941689|NCT01332968|20550879|P8|Maintenance/Observation Period|Protocol Violation|0
5941690|NCT01332968|20550880|P7|Maintenance/Observation Period|Protocol Violation|0
5941691|NCT01332968|20550881|P6|Maintenance/Observation Period|Protocol Violation|0
5941692|NCT01332968|20550882|P5|Maintenance/Observation Period|Protocol Violation|0
5941693|NCT01332968|20550883|P4|Maintenance/Observation Period|Protocol Violation|1
5941694|NCT01332968|20550884|P3|Maintenance/Observation Period|Protocol Violation|1
5941695|NCT01332968|20550885|P2|Maintenance/Observation Period|Protocol Violation|0
5941696|NCT01332968|20550886|P1|Maintenance/Observation Period|Protocol Violation|0
5941697|NCT01332968|20550879|P8|Maintenance/Observation Period|Withdrawal by Subject|0
5941698|NCT01332968|20550880|P7|Maintenance/Observation Period|Withdrawal by Subject|0
5941699|NCT01332968|20550881|P6|Maintenance/Observation Period|Withdrawal by Subject|0
5941700|NCT01332968|20550882|P5|Maintenance/Observation Period|Withdrawal by Subject|0
5941701|NCT01332968|20550883|P4|Maintenance/Observation Period|Withdrawal by Subject|5
5941702|NCT01332968|20550884|P3|Maintenance/Observation Period|Withdrawal by Subject|10
5941703|NCT01332968|20550885|P2|Maintenance/Observation Period|Withdrawal by Subject|0
5941704|NCT01332968|20550886|P1|Maintenance/Observation Period|Withdrawal by Subject|0
5941705|NCT01332968|20550879|P8|Induction Period|Randomized, but not treated|0
5941706|NCT01332968|20550880|P7|Induction Period|Randomized, but not treated|0
5941707|NCT01332968|20550881|P6|Induction Period|Randomized, but not treated|0
5941708|NCT01332968|20550882|P5|Induction Period|Randomized, but not treated|0
5941709|NCT01332968|20550883|P4|Induction Period|Randomized, but not treated|0
5941710|NCT01332968|20550884|P3|Induction Period|Randomized, but not treated|0
5941711|NCT01332968|20550885|P2|Induction Period|Randomized, but not treated|7
5941712|NCT01332968|20550886|P1|Induction Period|Randomized, but not treated|4
5941713|NCT01332968|20550879|P8|Induction Period|Adverse Event|0
5941714|NCT01332968|20550880|P7|Induction Period|Adverse Event|0
5941715|NCT01332968|20550881|P6|Induction Period|Adverse Event|0
5941716|NCT01332968|20550882|P5|Induction Period|Adverse Event|0
5941717|NCT01332968|20550883|P4|Induction Period|Adverse Event|0
5941718|NCT01332968|20550884|P3|Induction Period|Adverse Event|0
5941719|NCT01332968|20550885|P2|Induction Period|Adverse Event|26
5941720|NCT01332968|20550886|P1|Induction Period|Adverse Event|23
5941721|NCT01332968|20550879|P8|Induction Period|Death|0
5941722|NCT01332968|20550880|P7|Induction Period|Death|0
5941723|NCT01332968|20550881|P6|Induction Period|Death|0
5941724|NCT01332968|20550882|P5|Induction Period|Death|0
5941725|NCT01332968|20550883|P4|Induction Period|Death|0
5941726|NCT01332968|20550884|P3|Induction Period|Death|0
5941727|NCT01332968|20550885|P2|Induction Period|Death|4
5941728|NCT01332968|20550886|P1|Induction Period|Death|1
5941729|NCT01332968|20550879|P8|Induction Period|Non-compliance|0
5941730|NCT01332968|20550880|P7|Induction Period|Non-compliance|0
5941731|NCT01332968|20550881|P6|Induction Period|Non-compliance|0
5941732|NCT01332968|20550882|P5|Induction Period|Non-compliance|0
5941733|NCT01332968|20550883|P4|Induction Period|Non-compliance|0
5941734|NCT01332968|20550884|P3|Induction Period|Non-compliance|0
5941735|NCT01332968|20550885|P2|Induction Period|Non-compliance|0
5941736|NCT01332968|20550886|P1|Induction Period|Non-compliance|1
5941737|NCT01332968|20550879|P8|Induction Period|Other|0
5941738|NCT01332968|20550880|P7|Induction Period|Other|0
5941739|NCT01332968|20550881|P6|Induction Period|Other|0
5941740|NCT01332968|20550882|P5|Induction Period|Other|0
5941741|NCT01332968|20550883|P4|Induction Period|Other|0
5941742|NCT01332968|20550884|P3|Induction Period|Other|0
5941743|NCT01332968|20550885|P2|Induction Period|Other|2
5941744|NCT01332968|20550886|P1|Induction Period|Other|2
5941745|NCT01332968|20550879|P8|Induction Period|Physician Decision|0
5941746|NCT01332968|20550880|P7|Induction Period|Physician Decision|0
5941747|NCT01332968|20550881|P6|Induction Period|Physician Decision|0
5941748|NCT01332968|20550882|P5|Induction Period|Physician Decision|0
5941749|NCT01332968|20550883|P4|Induction Period|Physician Decision|0
5941750|NCT01332968|20550884|P3|Induction Period|Physician Decision|0
5941751|NCT01332968|20550885|P2|Induction Period|Physician Decision|1
5941752|NCT01332968|20550886|P1|Induction Period|Physician Decision|6
5941753|NCT01332968|20550879|P8|Induction Period|Progressive disease|0
5941754|NCT01332968|20550880|P7|Induction Period|Progressive disease|0
5941755|NCT01332968|20550881|P6|Induction Period|Progressive disease|0
5941756|NCT01332968|20550882|P5|Induction Period|Progressive disease|0
5941757|NCT01332968|20550883|P4|Induction Period|Progressive disease|0
5941758|NCT01332968|20550884|P3|Induction Period|Progressive disease|0
5941759|NCT01332968|20550885|P2|Induction Period|Progressive disease|7
5941760|NCT01332968|20550886|P1|Induction Period|Progressive disease|15
5941761|NCT01332968|20550879|P8|Induction Period|Protocol Violation|0
5941762|NCT01332968|20550880|P7|Induction Period|Protocol Violation|0
5941763|NCT01332968|20550881|P6|Induction Period|Protocol Violation|0
5941764|NCT01332968|20550882|P5|Induction Period|Protocol Violation|0
5941765|NCT01332968|20550883|P4|Induction Period|Protocol Violation|0
5941766|NCT01332968|20550884|P3|Induction Period|Protocol Violation|0
5941767|NCT01332968|20550885|P2|Induction Period|Protocol Violation|4
5941768|NCT01332968|20550886|P1|Induction Period|Protocol Violation|3
5941769|NCT01332968|20550879|P8|Induction Period|Withdrawal by Subject|0
5941770|NCT01332968|20550880|P7|Induction Period|Withdrawal by Subject|0
5941771|NCT01332968|20550881|P6|Induction Period|Withdrawal by Subject|0
5941772|NCT01332968|20550882|P5|Induction Period|Withdrawal by Subject|0
5941773|NCT01332968|20550883|P4|Induction Period|Withdrawal by Subject|0
5941774|NCT01332968|20550884|P3|Induction Period|Withdrawal by Subject|0
5941775|NCT01332968|20550885|P2|Induction Period|Withdrawal by Subject|5
5941776|NCT01332968|20550886|P1|Induction Period|Withdrawal by Subject|3
5941777|NCT01332851|20550952|P2|Overall Study|Lost to Follow-up|11
5941778|NCT01332851|20550953|P1|Overall Study|Lost to Follow-up|7
5941779|NCT01332851|20550952|P2|Overall Study|Withdrawal by Subject|2
5941780|NCT01332851|20550953|P1|Overall Study|Withdrawal by Subject|4
5941781|NCT01332799|20550987|P2|Overall Study|Insufficient funding|10
5941782|NCT01332799|20550988|P1|Overall Study|Insufficient funding|10
5941783|NCT01332630|20551004|P1|Overall Study|Withdrawal by Subject|3
5941784|NCT01332331|20551120|P2|Overall Study|Physician Decision|0
5941785|NCT01332331|20551121|P1|Overall Study|Physician Decision|1
5941786|NCT01332331|20551120|P2|Overall Study|Adverse Event|1
5941787|NCT01332331|20551121|P1|Overall Study|Adverse Event|1
5941788|NCT01332331|20551120|P2|Overall Study|Lost to Follow-up|1
5941789|NCT01332331|20551121|P1|Overall Study|Lost to Follow-up|0
5941790|NCT01332318|20551173|P4|Overall Study|Protocol Violation|1
5941791|NCT01332318|20551174|P3|Overall Study|Protocol Violation|1
5941792|NCT01332318|20551175|P2|Overall Study|Protocol Violation|0
5941793|NCT01332318|20551176|P1|Overall Study|Protocol Violation|1
5941794|NCT01332318|20551173|P4|Overall Study|Withdrawal by Subject|1
5941795|NCT01332318|20551174|P3|Overall Study|Withdrawal by Subject|0
5941796|NCT01332318|20551175|P2|Overall Study|Withdrawal by Subject|1
5941797|NCT01332318|20551176|P1|Overall Study|Withdrawal by Subject|1
5941798|NCT01332318|20551173|P4|Overall Study|Adverse Event|0
5941799|NCT01332318|20551174|P3|Overall Study|Adverse Event|0
5941800|NCT01332318|20551175|P2|Overall Study|Adverse Event|3
5941801|NCT01332318|20551176|P1|Overall Study|Adverse Event|0
5941802|NCT01332305|20551287|P5|Overall Study|Physician Decision|0
5941803|NCT01332305|20551288|P4|Overall Study|Physician Decision|1
5941804|NCT01332305|20551289|P3|Overall Study|Physician Decision|0
5941805|NCT01332305|20551290|P2|Overall Study|Physician Decision|0
5941806|NCT01332305|20551291|P1|Overall Study|Physician Decision|0
5941807|NCT01332305|20551287|P5|Overall Study|Treatment Failure|0
5941808|NCT01332305|20551288|P4|Overall Study|Treatment Failure|0
5941809|NCT01332305|20551289|P3|Overall Study|Treatment Failure|0
5941810|NCT01332305|20551290|P2|Overall Study|Treatment Failure|1
5941811|NCT01332305|20551291|P1|Overall Study|Treatment Failure|1
5941812|NCT01332305|20551287|P5|Overall Study|Withdrawal by Sponsor|1
5941813|NCT01332305|20551288|P4|Overall Study|Withdrawal by Sponsor|1
5941814|NCT01332305|20551289|P3|Overall Study|Withdrawal by Sponsor|0
5941815|NCT01332305|20551290|P2|Overall Study|Withdrawal by Sponsor|0
5941816|NCT01332305|20551291|P1|Overall Study|Withdrawal by Sponsor|1
5941817|NCT01332305|20551287|P5|Overall Study|Protocol Violation|3
5941818|NCT01332305|20551288|P4|Overall Study|Protocol Violation|0
5941819|NCT01332305|20551289|P3|Overall Study|Protocol Violation|1
5941820|NCT01332305|20551290|P2|Overall Study|Protocol Violation|2
5941821|NCT01332305|20551291|P1|Overall Study|Protocol Violation|1
5941822|NCT01332305|20551287|P5|Overall Study|Lost to Follow-up|3
5941823|NCT01332305|20551288|P4|Overall Study|Lost to Follow-up|2
5941824|NCT01332305|20551289|P3|Overall Study|Lost to Follow-up|3
5941825|NCT01332305|20551290|P2|Overall Study|Lost to Follow-up|2
5941826|NCT01332305|20551291|P1|Overall Study|Lost to Follow-up|0
5941827|NCT01332305|20551287|P5|Overall Study|Withdrawal by Subject|0
5941828|NCT01332305|20551288|P4|Overall Study|Withdrawal by Subject|1
5941829|NCT01332305|20551289|P3|Overall Study|Withdrawal by Subject|4
5941830|NCT01332305|20551290|P2|Overall Study|Withdrawal by Subject|5
5941831|NCT01332305|20551291|P1|Overall Study|Withdrawal by Subject|6
5941832|NCT01332305|20551287|P5|Overall Study|Adverse Event|5
5941833|NCT01332305|20551288|P4|Overall Study|Adverse Event|3
5941834|NCT01332305|20551289|P3|Overall Study|Adverse Event|6
5941835|NCT01332305|20551290|P2|Overall Study|Adverse Event|4
5941836|NCT01332305|20551291|P1|Overall Study|Adverse Event|1
5941837|NCT01332292|20551313|P2|Treatment Period 2 (14 Days)|Physician Decision|1
5941838|NCT01332292|20551314|P1|Treatment Period 2 (14 Days)|Physician Decision|1
5941839|NCT01332292|20551313|P2|Treatment Period 1 (14 Days)|Protocol Violation|1
5941840|NCT01332292|20551314|P1|Treatment Period 1 (14 Days)|Protocol Violation|1
5941841|NCT01332292|20551313|P2|Treatment Period 1 (14 Days)|Adverse Event|0
5941842|NCT01332292|20551314|P1|Treatment Period 1 (14 Days)|Adverse Event|1
5941843|NCT01332227|20551405|P2|Overall Study|Patient began prohibited medication|1
5941844|NCT01332227|20551406|P1|Overall Study|Patient began prohibited medication|0
5941845|NCT01332227|20551405|P2|Overall Study|Patient moved from area|0
5941846|NCT01332227|20551406|P1|Overall Study|Patient moved from area|1
5941847|NCT01332227|20551405|P2|Overall Study|Poor compliance/noncompliance|1
5941848|NCT01332227|20551406|P1|Overall Study|Poor compliance/noncompliance|1
5941849|NCT01332227|20551405|P2|Overall Study|Lack of Efficacy|1
5941850|NCT01332227|20551406|P1|Overall Study|Lack of Efficacy|3
5941851|NCT01332227|20551405|P2|Overall Study|Lost to Follow-up|0
5941852|NCT01332227|20551406|P1|Overall Study|Lost to Follow-up|2
5941853|NCT01332227|20551405|P2|Overall Study|Withdrawal by Subject|1
5941854|NCT01332227|20551406|P1|Overall Study|Withdrawal by Subject|5
5941855|NCT01332227|20551405|P2|Overall Study|Adverse Event|1
5941856|NCT01332227|20551406|P1|Overall Study|Adverse Event|4
5941857|NCT01332019|20551609|P2|Overall Study|Adverse Event|22
5941858|NCT01332019|20551610|P1|Overall Study|Adverse Event|13
5941859|NCT01332019|20551609|P2|Overall Study|Lost to Follow-up|7
5941860|NCT01332019|20551610|P1|Overall Study|Lost to Follow-up|4
5941861|NCT01332019|20551609|P2|Overall Study|Withdrawal by Subject|71
5941862|NCT01332019|20551610|P1|Overall Study|Withdrawal by Subject|73
5941863|NCT01332019|20551609|P2|Overall Study|Physician Decision|3
5941864|NCT01332019|20551610|P1|Overall Study|Physician Decision|4
5941865|NCT01332019|20551609|P2|Overall Study|Death|1
5941866|NCT01332019|20551610|P1|Overall Study|Death|2
5941867|NCT01332019|20551609|P2|Overall Study|Other|18
5941868|NCT01332019|20551610|P1|Overall Study|Other|16
5941869|NCT01332019|20551609|P2|Overall Study|Was Not Dosed|0
5941870|NCT01332019|20551610|P1|Overall Study|Was Not Dosed|1
5941871|NCT01331837|20551694|P2|Overall Study|Withdrawal by Subject|16
5941872|NCT01331837|20551695|P1|Overall Study|Withdrawal by Subject|13
5941873|NCT01331837|20551694|P2|Overall Study|Info not recorded|16
5941874|NCT01331837|20551695|P1|Overall Study|Info not recorded|10
5941875|NCT01331837|20551694|P2|Overall Study|Lost to Follow-up|1
5941876|NCT01331837|20551695|P1|Overall Study|Lost to Follow-up|3
5941877|NCT01331837|20551694|P2|Overall Study|Death|34
5941878|NCT01331837|20551695|P1|Overall Study|Death|30
5941879|NCT01331824|20551735|P1|Overall Study|Withdrawal by Subject|1
5941880|NCT01331824|20551735|P1|Overall Study|Disease Progression|9
5941881|NCT01331824|20551735|P1|Overall Study|Death|1
5941882|NCT01331824|20551735|P1|Overall Study|Adverse Event|2
5941883|NCT01331681|20551770|P3|Overall Study|Not Received Study Treatment|2
5941884|NCT01331681|20551771|P2|Overall Study|Not Received Study Treatment|0
5941885|NCT01331681|20551772|P1|Overall Study|Not Received Study Treatment|0
5941886|NCT01331681|20551770|P3|Overall Study|Switching to other therapy|1
5941887|NCT01331681|20551771|P2|Overall Study|Switching to other therapy|0
5941888|NCT01331681|20551772|P1|Overall Study|Switching to other therapy|0
5941889|NCT01331681|20551770|P3|Overall Study|Sponsor decision|0
5941890|NCT01331681|20551771|P2|Overall Study|Sponsor decision|1
5941891|NCT01331681|20551772|P1|Overall Study|Sponsor decision|1
5941892|NCT01331681|20551770|P3|Overall Study|Therapeutic procedure required|0
5941893|NCT01331681|20551771|P2|Overall Study|Therapeutic procedure required|0
5941894|NCT01331681|20551772|P1|Overall Study|Therapeutic procedure required|1
5941895|NCT01331681|20551770|P3|Overall Study|Physician Decision|4
5941896|NCT01331681|20551771|P2|Overall Study|Physician Decision|0
5941897|NCT01331681|20551772|P1|Overall Study|Physician Decision|2
5941898|NCT01331681|20551770|P3|Overall Study|Lost to Follow-up|1
5941899|NCT01331681|20551771|P2|Overall Study|Lost to Follow-up|4
5941900|NCT01331681|20551772|P1|Overall Study|Lost to Follow-up|2
5941901|NCT01331681|20551770|P3|Overall Study|Protocol Violation|0
5941902|NCT01331681|20551771|P2|Overall Study|Protocol Violation|1
5941903|NCT01331681|20551772|P1|Overall Study|Protocol Violation|1
5941904|NCT01331681|20551770|P3|Overall Study|Withdrawal by Subject|15
5941905|NCT01331681|20551771|P2|Overall Study|Withdrawal by Subject|8
5941906|NCT01331681|20551772|P1|Overall Study|Withdrawal by Subject|12
5941907|NCT01331681|20551770|P3|Overall Study|Lack of Efficacy|0
5941908|NCT01331681|20551771|P2|Overall Study|Lack of Efficacy|1
5941909|NCT01331681|20551772|P1|Overall Study|Lack of Efficacy|0
5941910|NCT01331681|20551770|P3|Overall Study|Death|2
5941911|NCT01331681|20551771|P2|Overall Study|Death|6
5941912|NCT01331681|20551772|P1|Overall Study|Death|6
5941913|NCT01331681|20551770|P3|Overall Study|Adverse Event|10
5941914|NCT01331681|20551771|P2|Overall Study|Adverse Event|13
5941915|NCT01331681|20551772|P1|Overall Study|Adverse Event|10
5941916|NCT01331291|20551821|P2|Overall Study|Death|1
5941917|NCT01331291|20551822|P1|Overall Study|Death|0
5941918|NCT01331291|20551821|P2|Overall Study|Lack of Efficacy|8
5941919|NCT01331291|20551822|P1|Overall Study|Lack of Efficacy|2
5941920|NCT01331239|20551835|P3|Part II: Core Study|Administrative problems|0
5941921|NCT01331239|20551836|P2|Part II: Core Study|Administrative problems|1
5941922|NCT01331239|20551837|P1|Part II: Core Study|Administrative problems|0
5941923|NCT01331239|20551835|P3|Part II: Core Study|Withdrawal by Subject|0
5941924|NCT01331239|20551836|P2|Part II: Core Study|Withdrawal by Subject|2
5941925|NCT01331239|20551837|P1|Part II: Core Study|Withdrawal by Subject|0
5941926|NCT01331239|20551835|P3|Part II: Core Study|Subj's cond. no longer require treatment|1
5941927|NCT01331239|20551836|P2|Part II: Core Study|Subj's cond. no longer require treatment|2
5941928|NCT01331239|20551837|P1|Part II: Core Study|Subj's cond. no longer require treatment|0
5941929|NCT01331239|20551835|P3|Part II: Core Study|Adverse Event|0
5941930|NCT01331239|20551836|P2|Part II: Core Study|Adverse Event|3
5941931|NCT01331239|20551837|P1|Part II: Core Study|Adverse Event|0
5941932|NCT01331161|20551930|P2|Overall Study|Pregnancy|1
5941933|NCT01331161|20551931|P1|Overall Study|Pregnancy|0
5941934|NCT01331161|20551930|P2|Overall Study|Lost to Follow-up|1
5941935|NCT01331161|20551931|P1|Overall Study|Lost to Follow-up|0
5941936|NCT01331161|20551930|P2|Overall Study|Physician Decision|0
5941937|NCT01331161|20551931|P1|Overall Study|Physician Decision|1
5941938|NCT01331109|20551939|P1|Overall Study|Study Terminated by Sponsor|38
5941939|NCT01331109|20551939|P1|Overall Study|Lost to Follow-up|1
5941940|NCT01331109|20551939|P1|Overall Study|Withdrawal by Subject|7
5941941|NCT01331109|20551939|P1|Overall Study|Protocol Violation|3
5941942|NCT01331109|20551939|P1|Overall Study|Lack of Efficacy|2
5941943|NCT01331109|20551939|P1|Overall Study|Adverse Event|6
5941944|NCT01331005|20551966|P2|Overall Study|Withdrawal by Subject|3
5941945|NCT01331005|20551967|P1|Overall Study|Withdrawal by Subject|2
5941946|NCT01331005|20551966|P2|Overall Study|Lost to Follow-up|1
5941947|NCT01331005|20551967|P1|Overall Study|Lost to Follow-up|2
5941948|NCT01330914|20552038|P1|Overall Study|No longer eligible (sleeve gastrectomy)|3
5941949|NCT01330914|20552038|P1|Overall Study|Withdrawal by Subject|4
5941950|NCT01330628|20552046|P2|Overall Study|Didn't receive study treatment|0
5941951|NCT01330628|20552047|P1|Overall Study|Didn't receive study treatment|1
5941952|NCT01330628|20552046|P2|Overall Study|Withdrawn|6
5941953|NCT01330628|20552047|P1|Overall Study|Withdrawn|18
5941954|NCT01330628|20552046|P2|Overall Study|Adverse Event|25
5941955|NCT01330628|20552047|P1|Overall Study|Adverse Event|44
5941956|NCT01330628|20552046|P2|Overall Study|Lost to Follow-up|6
5941957|NCT01330628|20552047|P1|Overall Study|Lost to Follow-up|5
5941958|NCT01330628|20552046|P2|Overall Study|Death|3
5941959|NCT01330628|20552047|P1|Overall Study|Death|2
5941960|NCT01330459|20552057|P2|Overall Study|Physician Decision|2
5941961|NCT01330459|20552058|P1|Overall Study|Physician Decision|0
5941962|NCT01330433|20552074|P2|Overall Study|Lost to Follow-up|0
5941963|NCT01330433|20552075|P1|Overall Study|Lost to Follow-up|1
5941964|NCT01330433|20552074|P2|Overall Study|Death|3
5941965|NCT01330433|20552075|P1|Overall Study|Death|1
5941966|NCT01330381|20552114|P3|Open-label Treatment Period (16 Weeks)|Non-compliance|1
5941967|NCT01330381|20552115|P2|Open-label Treatment Period (16 Weeks)|Non-compliance|0
5941968|NCT01330381|20552116|P1|Open-label Treatment Period (16 Weeks)|Non-compliance|0
5941969|NCT01330381|20552114|P3|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1
5941970|NCT01330381|20552115|P2|Open-label Treatment Period (16 Weeks)|Sponsor's decision|0
5941971|NCT01330381|20552116|P1|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1
5941972|NCT01330381|20552114|P3|Open-label Treatment Period (16 Weeks)|Adverse Event|0
5941973|NCT01330381|20552115|P2|Open-label Treatment Period (16 Weeks)|Adverse Event|0
5941974|NCT01330381|20552116|P1|Open-label Treatment Period (16 Weeks)|Adverse Event|2
5941975|NCT01330381|20552114|P3|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|16
5941976|NCT01330381|20552115|P2|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|0
5941977|NCT01330381|20552116|P1|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|7
5941978|NCT01330381|20552114|P3|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0
5941979|NCT01330381|20552115|P2|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1
5941980|NCT01330381|20552116|P1|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1
5941981|NCT01330381|20552114|P3|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0
5941982|NCT01330381|20552115|P2|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0
5941983|NCT01330381|20552116|P1|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|1
5941984|NCT01330381|20552114|P3|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0
5941985|NCT01330381|20552115|P2|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0
5941986|NCT01330381|20552116|P1|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|1
5941987|NCT01330381|20552114|P3|Double-blind Treatment Period (8 Weeks)|Adverse Event|0
5941988|NCT01330381|20552115|P2|Double-blind Treatment Period (8 Weeks)|Adverse Event|1
5941989|NCT01330381|20552116|P1|Double-blind Treatment Period (8 Weeks)|Adverse Event|1
5941990|NCT01330381|20552114|P3|Double-blind Treatment Period (8 Weeks)|Non-compliance|0
5941991|NCT01330381|20552115|P2|Double-blind Treatment Period (8 Weeks)|Non-compliance|1
5941992|NCT01330381|20552116|P1|Double-blind Treatment Period (8 Weeks)|Non-compliance|2
5941993|NCT01330381|20552114|P3|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|0
5941994|NCT01330381|20552115|P2|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|4
5941995|NCT01330381|20552116|P1|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|5
5941996|NCT01330316|20552177|P2|Overall Study|other than above|1
5941997|NCT01330316|20552178|P1|Overall Study|other than above|0
5941998|NCT01330316|20552177|P2|Overall Study|Withdrawal by Subject|1
5941999|NCT01330316|20552178|P1|Overall Study|Withdrawal by Subject|0
5942000|NCT01330316|20552177|P2|Overall Study|Lost to Follow-up|1
5942001|NCT01330316|20552178|P1|Overall Study|Lost to Follow-up|0
5942002|NCT01330316|20552177|P2|Overall Study|Lack of Efficacy|10
5942003|NCT01330316|20552178|P1|Overall Study|Lack of Efficacy|0
5942004|NCT01330316|20552177|P2|Overall Study|Adverse Event|2
5942005|NCT01330316|20552178|P1|Overall Study|Adverse Event|2
5942006|NCT01330303|20552214|P2|Period 1|Withdrawal by Subject|1
5942007|NCT01330303|20552215|P1|Period 1|Withdrawal by Subject|0
5942008|NCT01330303|20552214|P2|Period 1|Protocol Violation|1
5942009|NCT01330303|20552215|P1|Period 1|Protocol Violation|0
5942010|NCT01330303|20552214|P2|Period 1|Adverse Event|0
5942011|NCT01330303|20552215|P1|Period 1|Adverse Event|1
5942012|NCT01330108|20552262|P1|Overall Study|Withdrawal by Subject|4
5942013|NCT01330030|20552280|P2|Overall Study|Lost to Follow-up|17
5942014|NCT01330030|20552281|P1|Overall Study|Lost to Follow-up|16
5942015|NCT01330017|20552292|P5|Overall Study|Unknown Reason|2
5942016|NCT01330017|20552293|P4|Overall Study|Unknown Reason|7
5942017|NCT01330017|20552294|P3|Overall Study|Unknown Reason|5
5942018|NCT01330017|20552295|P2|Overall Study|Unknown Reason|3
5942019|NCT01330017|20552296|P1|Overall Study|Unknown Reason|5
5942020|NCT01330017|20552292|P5|Overall Study|Protocol Violation|0
5942021|NCT01330017|20552293|P4|Overall Study|Protocol Violation|1
5942022|NCT01330017|20552294|P3|Overall Study|Protocol Violation|0
5942023|NCT01330017|20552295|P2|Overall Study|Protocol Violation|0
5942024|NCT01330017|20552296|P1|Overall Study|Protocol Violation|0
5942025|NCT01330017|20552292|P5|Overall Study|Lost to Follow-up|0
5942026|NCT01330017|20552293|P4|Overall Study|Lost to Follow-up|0
5942027|NCT01330017|20552294|P3|Overall Study|Lost to Follow-up|1
5942028|NCT01330017|20552295|P2|Overall Study|Lost to Follow-up|0
5942029|NCT01330017|20552296|P1|Overall Study|Lost to Follow-up|0
5942030|NCT01330017|20552292|P5|Overall Study|Withdrawal by Subject|1
5942031|NCT01330017|20552293|P4|Overall Study|Withdrawal by Subject|0
5942032|NCT01330017|20552294|P3|Overall Study|Withdrawal by Subject|1
5942033|NCT01330017|20552295|P2|Overall Study|Withdrawal by Subject|0
5942034|NCT01330017|20552296|P1|Overall Study|Withdrawal by Subject|0
5942035|NCT01330017|20552292|P5|Overall Study|Adverse Event|0
5942036|NCT01330017|20552293|P4|Overall Study|Adverse Event|4
5942037|NCT01330017|20552294|P3|Overall Study|Adverse Event|1
5942038|NCT01330017|20552295|P2|Overall Study|Adverse Event|1
5942039|NCT01330017|20552296|P1|Overall Study|Adverse Event|0
5942040|NCT01329978|20552345|P5|Rerandomization Treatment Period|Withdrawal by Subject|1
5942041|NCT01329978|20552346|P4|Rerandomization Treatment Period|Withdrawal by Subject|0
5942042|NCT01329978|20552347|P3|Rerandomization Treatment Period|Withdrawal by Subject|0
5942043|NCT01329978|20552348|P2|Rerandomization Treatment Period|Withdrawal by Subject|0
5942044|NCT01329978|20552349|P1|Rerandomization Treatment Period|Withdrawal by Subject|0
5942045|NCT01329978|20552345|P5|Rerandomization Treatment Period|Lost to Follow-up|3
5942046|NCT01329978|20552346|P4|Rerandomization Treatment Period|Lost to Follow-up|5
5942047|NCT01329978|20552347|P3|Rerandomization Treatment Period|Lost to Follow-up|0
5942048|NCT01329978|20552348|P2|Rerandomization Treatment Period|Lost to Follow-up|0
5942049|NCT01329978|20552349|P1|Rerandomization Treatment Period|Lost to Follow-up|0
5942050|NCT01329978|20552345|P5|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0
5942051|NCT01329978|20552346|P4|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0
5942052|NCT01329978|20552347|P3|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0
5942053|NCT01329978|20552348|P2|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|1
5942054|NCT01329978|20552349|P1|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0
5942055|NCT01329978|20552345|P5|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0
5942056|NCT01329978|20552346|P4|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0
5942057|NCT01329978|20552347|P3|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0
5942058|NCT01329978|20552348|P2|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|1
5942059|NCT01329978|20552349|P1|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0
5942060|NCT01329978|20552345|P5|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0
5942061|NCT01329978|20552346|P4|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0
5942062|NCT01329978|20552347|P3|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|3
5942063|NCT01329978|20552348|P2|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1
5942064|NCT01329978|20552349|P1|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1
5942065|NCT01329978|20552345|P5|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0
5942066|NCT01329978|20552346|P4|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0
5942067|NCT01329978|20552347|P3|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2
5942068|NCT01329978|20552348|P2|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|8
5942069|NCT01329978|20552349|P1|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2
5942070|NCT01329978|20552345|P5|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0
5942071|NCT01329978|20552346|P4|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0
5942072|NCT01329978|20552347|P3|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0
5942073|NCT01329978|20552348|P2|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|2
5942074|NCT01329978|20552349|P1|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|1
5942075|NCT01329939|20552423|P4|Overall Study|Adverse Event|3
5942076|NCT01329939|20552424|P3|Overall Study|Adverse Event|0
5942077|NCT01329939|20552425|P2|Overall Study|Adverse Event|0
5942078|NCT01329939|20552426|P1|Overall Study|Adverse Event|0
5942079|NCT01329939|20552423|P4|Overall Study|Withdrawal by Subject|0
5942080|NCT01329939|20552424|P3|Overall Study|Withdrawal by Subject|0
5942081|NCT01329939|20552425|P2|Overall Study|Withdrawal by Subject|1
5942082|NCT01329939|20552426|P1|Overall Study|Withdrawal by Subject|0
5942083|NCT01329939|20552423|P4|Overall Study|Lost to Follow-up|2
5942084|NCT01329939|20552424|P3|Overall Study|Lost to Follow-up|1
5942085|NCT01329939|20552425|P2|Overall Study|Lost to Follow-up|0
5942086|NCT01329939|20552426|P1|Overall Study|Lost to Follow-up|3
5942087|NCT01329900|20552464|P1|Overall Study|Elevated creatinine/renal function|1
5942088|NCT01329562|20552494|P2|Overall Study|Physician Decision|1
5942089|NCT01329562|20552495|P1|Overall Study|Physician Decision|0
5942090|NCT01329562|20552494|P2|Overall Study|Subject withdrew due to personal issues.|2
5942091|NCT01329562|20552495|P1|Overall Study|Subject withdrew due to personal issues.|3
5942092|NCT01329562|20552494|P2|Overall Study|Lost to Follow-up|1
5942093|NCT01329562|20552495|P1|Overall Study|Lost to Follow-up|1
5942094|NCT01329562|20552494|P2|Overall Study|Protocol Violation|3
5942095|NCT01329562|20552495|P1|Overall Study|Protocol Violation|5
5942096|NCT01329549|20552544|P1|Overall Study|Adverse Event|1
5942097|NCT01329549|20552544|P1|Overall Study|Withdrawal by Subject|1
5942098|NCT01329419|20552555|P1|Overall Study|Protocol Violation|235
5942099|NCT01329328|20552574|P3|Overall Study|Withdrawal by Subject|3
5942100|NCT01329328|20552575|P2|Overall Study|Withdrawal by Subject|4
5942101|NCT01329328|20552576|P1|Overall Study|Withdrawal by Subject|2
5942102|NCT01329263|20552589|P2|Overall Study|Withdrawal by Subject|2
5942103|NCT01329263|20552590|P1|Overall Study|Withdrawal by Subject|1
5942104|NCT01329263|20552589|P2|Overall Study|Lost to Follow-up|21
5942105|NCT01329263|20552590|P1|Overall Study|Lost to Follow-up|4
5942106|NCT01329029|20552627|P2|Overall Study|Met Pre-defined Discontinuation Criteria|1
5942107|NCT01329029|20552628|P1|Overall Study|Met Pre-defined Discontinuation Criteria|5
5942108|NCT01329029|20552627|P2|Overall Study|Lost to Follow-up|5
5942109|NCT01329029|20552628|P1|Overall Study|Lost to Follow-up|8
5942110|NCT01329029|20552627|P2|Overall Study|Physician Decision|13
5942111|NCT01329029|20552628|P1|Overall Study|Physician Decision|16
5942112|NCT01329029|20552627|P2|Overall Study|COPD Exacerbation|18
5942113|NCT01329029|20552628|P1|Overall Study|COPD Exacerbation|11
5942114|NCT01329029|20552627|P2|Overall Study|Other|20
5942115|NCT01329029|20552628|P1|Overall Study|Other|14
5942116|NCT01329029|20552627|P2|Overall Study|Death|19
5942117|NCT01329029|20552628|P1|Overall Study|Death|16
5942118|NCT01329029|20552627|P2|Overall Study|Adverse Event|29
5942119|NCT01329029|20552628|P1|Overall Study|Adverse Event|82
5942120|NCT01329029|20552627|P2|Overall Study|Withdrawal by Subject|87
5942121|NCT01329029|20552628|P1|Overall Study|Withdrawal by Subject|117
5942122|NCT01328951|20552718|P2|Overall Study|Other|6
5942123|NCT01328951|20552719|P1|Overall Study|Other|11
5942124|NCT01328951|20552718|P2|Overall Study|Study Closed by the Sponsor|31
5942125|NCT01328951|20552719|P1|Overall Study|Study Closed by the Sponsor|36
5942126|NCT01328951|20552718|P2|Overall Study|Withdrawal by Subject|6
5942127|NCT01328951|20552719|P1|Overall Study|Withdrawal by Subject|6
5942128|NCT01328951|20552718|P2|Overall Study|Lost to Follow-up|7
5942129|NCT01328951|20552719|P1|Overall Study|Lost to Follow-up|6
5942130|NCT01328951|20552718|P2|Overall Study|Death|258
5942131|NCT01328951|20552719|P1|Overall Study|Death|243
5942132|NCT01328951|20552718|P2|Overall Study|Adverse Event|0
5942133|NCT01328951|20552719|P1|Overall Study|Adverse Event|2
5942134|NCT01328951|20552718|P2|Overall Study|Disease Progression|14
5942135|NCT01328951|20552719|P1|Overall Study|Disease Progression|17
5942136|NCT01328756|20552788|P1|Overall Study|Other|29
5942137|NCT01328756|20552788|P1|Overall Study|Lost to Follow-up|5
5942138|NCT01328756|20552788|P1|Overall Study|Withdrawal by Subject|41
5942139|NCT01328756|20552788|P1|Overall Study|Lack of Efficacy|5
5942140|NCT01328756|20552788|P1|Overall Study|Adverse Event|39
5942141|NCT01328756|20552788|P1|Overall Study|Protocol Violation|4
5942142|NCT01328717|20552824|P1|Overall Study|Adverse Event|1
5942143|NCT01328574|20552833|P1|Overall Study|Refused further treatment|1
5942144|NCT01328548|20552847|P2|Overall Study|Protocol Violation|0
5942145|NCT01328548|20552848|P1|Overall Study|Protocol Violation|1
5942146|NCT01328548|20552847|P2|Overall Study|Death|0
5942147|NCT01328548|20552848|P1|Overall Study|Death|3
5942148|NCT01328535|20552866|P1|Overall Study|Ineligible|1
5942149|NCT01328496|20552877|P2|Overall Study|Significant Change in Health Status|0
5942150|NCT01328496|20552878|P1|Overall Study|Significant Change in Health Status|1
5942151|NCT01328444|20552896|P6|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
5942152|NCT01328444|20552897|P5|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
5942153|NCT01328444|20552898|P4|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
5942154|NCT01328444|20552899|P3|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
5942155|NCT01328444|20552900|P2|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
5942156|NCT01328444|20552901|P1|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
5942157|NCT01328444|20552896|P6|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2
5942158|NCT01328444|20552897|P5|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1
5942159|NCT01328444|20552898|P4|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1
5942160|NCT01328444|20552899|P3|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1
5942161|NCT01328444|20552900|P2|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
5942162|NCT01328444|20552901|P1|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
5942163|NCT01328444|20552896|P6|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0
5942164|NCT01328444|20552897|P5|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1
5942165|NCT01328444|20552898|P4|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1
5942166|NCT01328444|20552899|P3|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0
5942167|NCT01328444|20552900|P2|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0
5942168|NCT01328444|20552901|P1|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0
5942169|NCT01328444|20552896|P6|Treatment Period 2 (12 Weeks)|Protocol Violation|0
5942170|NCT01328444|20552897|P5|Treatment Period 2 (12 Weeks)|Protocol Violation|1
5942171|NCT01328444|20552898|P4|Treatment Period 2 (12 Weeks)|Protocol Violation|0
5942172|NCT01328444|20552899|P3|Treatment Period 2 (12 Weeks)|Protocol Violation|0
5942173|NCT01328444|20552900|P2|Treatment Period 2 (12 Weeks)|Protocol Violation|0
5942174|NCT01328444|20552901|P1|Treatment Period 2 (12 Weeks)|Protocol Violation|1
5942175|NCT01328444|20552896|P6|Treatment Period 2 (12 Weeks)|Lack of Efficacy|4
5942176|NCT01328444|20552897|P5|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3
5942177|NCT01328444|20552898|P4|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2
5942178|NCT01328444|20552899|P3|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1
5942179|NCT01328444|20552900|P2|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1
5942180|NCT01328444|20552901|P1|Treatment Period 2 (12 Weeks)|Lack of Efficacy|5
5942181|NCT01328444|20552896|P6|Treatment Period 2 (12 Weeks)|Adverse Event|0
5942182|NCT01328444|20552897|P5|Treatment Period 2 (12 Weeks)|Adverse Event|1
5942183|NCT01328444|20552898|P4|Treatment Period 2 (12 Weeks)|Adverse Event|1
5942184|NCT01328444|20552899|P3|Treatment Period 2 (12 Weeks)|Adverse Event|1
5942185|NCT01328444|20552900|P2|Treatment Period 2 (12 Weeks)|Adverse Event|0
5942186|NCT01328444|20552901|P1|Treatment Period 2 (12 Weeks)|Adverse Event|5
5942187|NCT01328444|20552896|P6|Washout Period (14 Days)|Withdrawal by Subject|1
5942188|NCT01328444|20552897|P5|Washout Period (14 Days)|Withdrawal by Subject|0
5942189|NCT01328444|20552898|P4|Washout Period (14 Days)|Withdrawal by Subject|0
5942190|NCT01328444|20552899|P3|Washout Period (14 Days)|Withdrawal by Subject|0
5942191|NCT01328444|20552900|P2|Washout Period (14 Days)|Withdrawal by Subject|0
5942192|NCT01328444|20552901|P1|Washout Period (14 Days)|Withdrawal by Subject|0
5942193|NCT01328444|20552896|P6|Washout Period (14 Days)|Lack of Efficacy|1
5942194|NCT01328444|20552897|P5|Washout Period (14 Days)|Lack of Efficacy|0
5942195|NCT01328444|20552898|P4|Washout Period (14 Days)|Lack of Efficacy|0
5942196|NCT01328444|20552899|P3|Washout Period (14 Days)|Lack of Efficacy|0
5942197|NCT01328444|20552900|P2|Washout Period (14 Days)|Lack of Efficacy|0
5942198|NCT01328444|20552901|P1|Washout Period (14 Days)|Lack of Efficacy|0
5942199|NCT01328444|20552896|P6|Washout Period (14 Days)|Adverse Event|2
5942200|NCT01328444|20552897|P5|Washout Period (14 Days)|Adverse Event|1
5942201|NCT01328444|20552898|P4|Washout Period (14 Days)|Adverse Event|1
5942202|NCT01328444|20552899|P3|Washout Period (14 Days)|Adverse Event|0
5942203|NCT01328444|20552900|P2|Washout Period (14 Days)|Adverse Event|1
5942204|NCT01328444|20552901|P1|Washout Period (14 Days)|Adverse Event|1
5942205|NCT01328444|20552896|P6|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
5942206|NCT01328444|20552897|P5|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1
5942207|NCT01328444|20552898|P4|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2
5942208|NCT01328444|20552899|P3|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1
5942209|NCT01328444|20552900|P2|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2
5942210|NCT01328444|20552901|P1|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
5942211|NCT01328444|20552896|P6|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
5942212|NCT01328444|20552897|P5|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
5942213|NCT01328444|20552898|P4|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
5942214|NCT01328444|20552899|P3|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
5942215|NCT01328444|20552900|P2|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
5942216|NCT01328444|20552901|P1|Treatment Period 1 (12 Weeks)|Lost to Follow-up|2
5942217|NCT01328444|20552896|P6|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0
5942218|NCT01328444|20552897|P5|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|2
5942219|NCT01328444|20552898|P4|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0
5942220|NCT01328444|20552899|P3|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0
5942221|NCT01328444|20552900|P2|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|1
5942222|NCT01328444|20552901|P1|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0
5942223|NCT01328444|20552896|P6|Treatment Period 1 (12 Weeks)|Protocol Violation|1
5942224|NCT01328444|20552897|P5|Treatment Period 1 (12 Weeks)|Protocol Violation|0
5942225|NCT01328444|20552898|P4|Treatment Period 1 (12 Weeks)|Protocol Violation|1
5942226|NCT01328444|20552899|P3|Treatment Period 1 (12 Weeks)|Protocol Violation|0
5942227|NCT01328444|20552900|P2|Treatment Period 1 (12 Weeks)|Protocol Violation|0
5942228|NCT01328444|20552901|P1|Treatment Period 1 (12 Weeks)|Protocol Violation|0
5942229|NCT01328444|20552896|P6|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2
5942230|NCT01328444|20552897|P5|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6
5942231|NCT01328444|20552898|P4|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1
5942232|NCT01328444|20552899|P3|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1
5942233|NCT01328444|20552900|P2|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1
5942234|NCT01328444|20552901|P1|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6
5942235|NCT01328444|20552896|P6|Treatment Period 1 (12 Weeks)|Adverse Event|2
5942236|NCT01328444|20552897|P5|Treatment Period 1 (12 Weeks)|Adverse Event|5
5942237|NCT01328444|20552898|P4|Treatment Period 1 (12 Weeks)|Adverse Event|3
5942238|NCT01328444|20552899|P3|Treatment Period 1 (12 Weeks)|Adverse Event|1
5942239|NCT01328444|20552900|P2|Treatment Period 1 (12 Weeks)|Adverse Event|1
5942240|NCT01328444|20552901|P1|Treatment Period 1 (12 Weeks)|Adverse Event|3
5942241|NCT01328431|20552947|P2|12 Month (12M)|Lost to Follow-up|91
5942242|NCT01328431|20552948|P1|12 Month (12M)|Lost to Follow-up|82
5942243|NCT01328431|20552947|P2|12 Month (12M)|Death|6
5942244|NCT01328431|20552948|P1|12 Month (12M)|Death|2
5942245|NCT01328431|20552947|P2|3 Month (3M)|Lost to Follow-up|70
5942246|NCT01328431|20552948|P1|3 Month (3M)|Lost to Follow-up|75
5942247|NCT01328431|20552947|P2|3 Month (3M)|Death|2
5942248|NCT01328431|20552948|P1|3 Month (3M)|Death|2
5942249|NCT01328431|20552947|P2|1 Month (1M)|Lost to Follow-up|58
5942250|NCT01328431|20552948|P1|1 Month (1M)|Lost to Follow-up|55
5942251|NCT01328431|20552947|P2|Baseline|Protocol Violation|2
5942252|NCT01328431|20552948|P1|Baseline|Protocol Violation|0
5942253|NCT01328366|20553004|P1|Overall Study|Lost to Follow-up|7
5942254|NCT01328366|20553004|P1|Overall Study|Withdrawal by Subject|2
5942255|NCT01328366|20553004|P1|Overall Study|Death|1
5942256|NCT01328249|20553024|P2|Overall Study|Protocol Violation|1
5942257|NCT01328249|20553025|P1|Overall Study|Protocol Violation|0
5942258|NCT01328249|20553024|P2|Overall Study|Subject choice|1
5942259|NCT01328249|20553025|P1|Overall Study|Subject choice|1
5942260|NCT01328249|20553024|P2|Overall Study|Moved before end of treatment visit|0
5942261|NCT01328249|20553025|P1|Overall Study|Moved before end of treatment visit|1
5942262|NCT01328249|20553024|P2|Overall Study|Withdrawal by Subject|1
5942263|NCT01328249|20553025|P1|Overall Study|Withdrawal by Subject|1
5942264|NCT01328249|20553024|P2|Overall Study|Disease progression|0
5942265|NCT01328249|20553025|P1|Overall Study|Disease progression|1
5942266|NCT01328249|20553024|P2|Overall Study|Adverse Event|0
5942267|NCT01328249|20553025|P1|Overall Study|Adverse Event|3
5942268|NCT01328080|20553111|P1|Overall Study|Lost to Follow-up|5
5942269|NCT01328054|20553115|P2|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|2
5942270|NCT01328054|20553116|P1|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|0
5942271|NCT01328054|20553115|P2|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|1
5942272|NCT01328054|20553116|P1|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|0
5942273|NCT01328054|20553115|P2|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|2
5942274|NCT01328054|20553116|P1|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|0
5942275|NCT01328041|20553141|P1|Overall Study|Withdrawal by Subject|7
5942276|NCT01328041|20553141|P1|Overall Study|Physician Decision|2
5942277|NCT01328041|20553141|P1|Overall Study|Lost to Follow-up|7
5942278|NCT01328041|20553141|P1|Overall Study|Protocol Violation|7
5942279|NCT01328041|20553141|P1|Overall Study|Lack of Efficacy|27
5942280|NCT01328041|20553141|P1|Overall Study|Adverse Event|7
5942281|NCT01328002|20553163|P2|Double-Blind Period|Lack of Efficacy|0
5942282|NCT01328002|20553164|P1|Double-Blind Period|Lack of Efficacy|1
5942283|NCT01328002|20553163|P2|Double-Blind Period|Adverse Event|0
5942284|NCT01328002|20553164|P1|Double-Blind Period|Adverse Event|1
5942285|NCT01328002|20553163|P2|Open-Label Period|Other Reason|0
5942286|NCT01328002|20553164|P1|Open-Label Period|Other Reason|2
5942287|NCT01328002|20553163|P2|Open-Label Period|Lost to Follow-up|0
5942288|NCT01328002|20553164|P1|Open-Label Period|Lost to Follow-up|6
5942289|NCT01328002|20553163|P2|Open-Label Period|Withdrawal by Subject|0
5942290|NCT01328002|20553164|P1|Open-Label Period|Withdrawal by Subject|9
5942291|NCT01328002|20553163|P2|Open-Label Period|Protocol Violation|0
5942292|NCT01328002|20553164|P1|Open-Label Period|Protocol Violation|2
5942293|NCT01328002|20553163|P2|Open-Label Period|Lack of Efficacy|0
5942294|NCT01328002|20553164|P1|Open-Label Period|Lack of Efficacy|3
5942295|NCT01328002|20553163|P2|Open-Label Period|Adverse Event|0
5942296|NCT01328002|20553164|P1|Open-Label Period|Adverse Event|8
5942297|NCT01328002|20553163|P2|Open-Label Period|Inclusion/exclusion criteria not met|0
5942298|NCT01328002|20553164|P1|Open-Label Period|Inclusion/exclusion criteria not met|66
5942299|NCT01327885|20553209|P2|Overall Study|Administrative decision|1
5942300|NCT01327885|20553210|P1|Overall Study|Administrative decision|0
5942301|NCT01327885|20553209|P2|Overall Study|Not treated|1
5942302|NCT01327885|20553210|P1|Overall Study|Not treated|1
5942303|NCT01327885|20553209|P2|Overall Study|Withdrawal of consent from study|4
5942304|NCT01327885|20553210|P1|Overall Study|Withdrawal of consent from study|3
5942305|NCT01327885|20553209|P2|Overall Study|Other|6
5942306|NCT01327885|20553210|P1|Overall Study|Other|8
5942307|NCT01327885|20553209|P2|Overall Study|Subject choice|10
5942308|NCT01327885|20553210|P1|Overall Study|Subject choice|5
5942309|NCT01327885|20553209|P2|Overall Study|Adverse Event|10
5942310|NCT01327885|20553210|P1|Overall Study|Adverse Event|14
5942311|NCT01327885|20553209|P2|Overall Study|Clinical progression|27
5942312|NCT01327885|20553210|P1|Overall Study|Clinical progression|24
5942313|NCT01327885|20553209|P2|Overall Study|Disease progression-according to RECIST|165
5942314|NCT01327885|20553210|P1|Overall Study|Disease progression-according to RECIST|173
5942315|NCT01327846|20553226|P4|Extension Phase|Technical Problems|2
5942316|NCT01327846|20553227|P3|Extension Phase|Technical Problems|2
5942317|NCT01327846|20553228|P2|Extension Phase|Technical Problems|4
5942318|NCT01327846|20553229|P1|Extension Phase|Technical Problems|2
5942319|NCT01327846|20553226|P4|Extension Phase|Lost to Follow-up|7
5942320|NCT01327846|20553227|P3|Extension Phase|Lost to Follow-up|4
5942321|NCT01327846|20553228|P2|Extension Phase|Lost to Follow-up|3
5942322|NCT01327846|20553229|P1|Extension Phase|Lost to Follow-up|4
5942323|NCT01327846|20553226|P4|Extension Phase|Withdrawal by Subject|37
5942324|NCT01327846|20553227|P3|Extension Phase|Withdrawal by Subject|19
5942325|NCT01327846|20553228|P2|Extension Phase|Withdrawal by Subject|13
5942326|NCT01327846|20553229|P1|Extension Phase|Withdrawal by Subject|20
5942327|NCT01327846|20553226|P4|Extension Phase|Study terminated by sponsor|1660
5942328|NCT01327846|20553227|P3|Extension Phase|Study terminated by sponsor|1067
5942329|NCT01327846|20553228|P2|Extension Phase|Study terminated by sponsor|1124
5942330|NCT01327846|20553229|P1|Extension Phase|Study terminated by sponsor|1073
5942331|NCT01327846|20553226|P4|Core Phase|Lost to Follow-up|5
5942332|NCT01327846|20553227|P3|Core Phase|Lost to Follow-up|4
5942333|NCT01327846|20553228|P2|Core Phase|Lost to Follow-up|3
5942334|NCT01327846|20553229|P1|Core Phase|Lost to Follow-up|3
5942335|NCT01327846|20553226|P4|Core Phase|Subject decision (vital stat: alive)|20
5942336|NCT01327846|20553227|P3|Core Phase|Subject decision (vital stat: alive)|13
5942337|NCT01327846|20553228|P2|Core Phase|Subject decision (vital stat: alive)|24
5942338|NCT01327846|20553229|P1|Core Phase|Subject decision (vital stat: alive)|23
5942339|NCT01327846|20553226|P4|Core Phase|Subject decision (vital stat: dead)|4
5942340|NCT01327846|20553227|P3|Core Phase|Subject decision (vital stat: dead)|4
5942341|NCT01327846|20553228|P2|Core Phase|Subject decision (vital stat: dead)|3
5942342|NCT01327846|20553229|P1|Core Phase|Subject decision (vital stat: dead)|1
5942343|NCT01327846|20553226|P4|Core Phase|Subject decision (vital stat: unkn)|3
5942344|NCT01327846|20553227|P3|Core Phase|Subject decision (vital stat: unkn)|3
5942345|NCT01327846|20553228|P2|Core Phase|Subject decision (vital stat: unkn)|0
5942346|NCT01327846|20553229|P1|Core Phase|Subject decision (vital stat: unkn)|0
5942347|NCT01327846|20553226|P4|Core Phase|Subject decision (vital status: missing)|1
5942348|NCT01327846|20553227|P3|Core Phase|Subject decision (vital status: missing)|2
5942349|NCT01327846|20553228|P2|Core Phase|Subject decision (vital status: missing)|2
5942350|NCT01327846|20553229|P1|Core Phase|Subject decision (vital status: missing)|1
5942351|NCT01327703|20553304|P2|Second Treatment Period|Protocol Violation|1
5942352|NCT01327703|20553305|P1|Second Treatment Period|Protocol Violation|0
5942353|NCT01327703|20553304|P2|Second Treatment Period|Adverse Event|1
5942354|NCT01327703|20553305|P1|Second Treatment Period|Adverse Event|1
5942355|NCT01327651|20553361|P9|Post Study Follow-up|Lost to Follow-up|2
5942356|NCT01327651|20553362|P8|Post Study Follow-up|Lost to Follow-up|1
5942357|NCT01327651|20553363|P7|Post Study Follow-up|Lost to Follow-up|4
5942358|NCT01327651|20553364|P6|Post Study Follow-up|Lost to Follow-up|0
5942359|NCT01327651|20553365|P5|Post Study Follow-up|Lost to Follow-up|0
5942360|NCT01327651|20553366|P4|Post Study Follow-up|Lost to Follow-up|0
5942361|NCT01327651|20553367|P3|Post Study Follow-up|Lost to Follow-up|1
5942362|NCT01327651|20553368|P2|Post Study Follow-up|Lost to Follow-up|1
5942363|NCT01327651|20553369|P1|Post Study Follow-up|Lost to Follow-up|0
5942364|NCT01327651|20553361|P9|Self-administered Dosing Period|Withdrawal by Subject|1
5942365|NCT01327651|20553362|P8|Self-administered Dosing Period|Withdrawal by Subject|1
5942366|NCT01327651|20553363|P7|Self-administered Dosing Period|Withdrawal by Subject|2
5942367|NCT01327651|20553364|P6|Self-administered Dosing Period|Withdrawal by Subject|0
5942368|NCT01327651|20553365|P5|Self-administered Dosing Period|Withdrawal by Subject|0
5942369|NCT01327651|20553366|P4|Self-administered Dosing Period|Withdrawal by Subject|1
5942370|NCT01327651|20553367|P3|Self-administered Dosing Period|Withdrawal by Subject|0
5942371|NCT01327651|20553368|P2|Self-administered Dosing Period|Withdrawal by Subject|1
5942372|NCT01327651|20553369|P1|Self-administered Dosing Period|Withdrawal by Subject|0
5942373|NCT01327651|20553361|P9|Self-administered Dosing Period|Ineligible (retrospective result)|0
5942374|NCT01327651|20553362|P8|Self-administered Dosing Period|Ineligible (retrospective result)|0
5942375|NCT01327651|20553363|P7|Self-administered Dosing Period|Ineligible (retrospective result)|0
5942376|NCT01327651|20553364|P6|Self-administered Dosing Period|Ineligible (retrospective result)|0
5942377|NCT01327651|20553365|P5|Self-administered Dosing Period|Ineligible (retrospective result)|0
5942378|NCT01327651|20553366|P4|Self-administered Dosing Period|Ineligible (retrospective result)|0
5942379|NCT01327651|20553367|P3|Self-administered Dosing Period|Ineligible (retrospective result)|0
5942380|NCT01327651|20553368|P2|Self-administered Dosing Period|Ineligible (retrospective result)|0
5942381|NCT01327651|20553369|P1|Self-administered Dosing Period|Ineligible (retrospective result)|1
5942382|NCT01327651|20553361|P9|Self-administered Dosing Period|Lost to Follow-up|10
5942383|NCT01327651|20553362|P8|Self-administered Dosing Period|Lost to Follow-up|9
5942384|NCT01327651|20553363|P7|Self-administered Dosing Period|Lost to Follow-up|8
5942385|NCT01327651|20553364|P6|Self-administered Dosing Period|Lost to Follow-up|0
5942386|NCT01327651|20553365|P5|Self-administered Dosing Period|Lost to Follow-up|3
5942387|NCT01327651|20553366|P4|Self-administered Dosing Period|Lost to Follow-up|2
5942388|NCT01327651|20553367|P3|Self-administered Dosing Period|Lost to Follow-up|4
5942389|NCT01327651|20553368|P2|Self-administered Dosing Period|Lost to Follow-up|2
5942390|NCT01327651|20553369|P1|Self-administered Dosing Period|Lost to Follow-up|3
5942391|NCT01327599|20553488|P1|Overall Study|Withdrawal of Consent|1
5942392|NCT01327599|20553488|P1|Overall Study|Could Not Attend Visit|1
5942393|NCT01327599|20553488|P1|Overall Study|Adverse Event|1
5942394|NCT01327573|20553498|P2|Overall Study|Physician Decision|1
5942395|NCT01327573|20553499|P1|Overall Study|Physician Decision|3
5942396|NCT01327547|20553510|P2|Overall Study|By investigator in subject's interest|1
5942397|NCT01327547|20553511|P1|Overall Study|By investigator in subject's interest|0
5942398|NCT01327547|20553510|P2|Overall Study|Non-compliance with study procedures|0
5942399|NCT01327547|20553511|P1|Overall Study|Non-compliance with study procedures|1
5942400|NCT01327547|20553510|P2|Overall Study|Required prohibited medication|0
5942401|NCT01327547|20553511|P1|Overall Study|Required prohibited medication|2
5942402|NCT01327547|20553510|P2|Overall Study|Non-compliance due to alcohol intake|1
5942403|NCT01327547|20553511|P1|Overall Study|Non-compliance due to alcohol intake|0
5942404|NCT01327547|20553510|P2|Overall Study|Protocol Violation|0
5942405|NCT01327547|20553511|P1|Overall Study|Protocol Violation|1
5942406|NCT01327547|20553510|P2|Overall Study|Does Not Meet Entrance Criteria|2
5942407|NCT01327547|20553511|P1|Overall Study|Does Not Meet Entrance Criteria|2
5942408|NCT01327547|20553510|P2|Overall Study|Withdrawal by Subject|7
5942409|NCT01327547|20553511|P1|Overall Study|Withdrawal by Subject|3
5942410|NCT01327547|20553510|P2|Overall Study|Non-Compliance With Study Treatment|2
5942411|NCT01327547|20553511|P1|Overall Study|Non-Compliance With Study Treatment|0
5942412|NCT01327547|20553510|P2|Overall Study|Lost to Follow-up|6
5942413|NCT01327547|20553511|P1|Overall Study|Lost to Follow-up|6
5942414|NCT01327547|20553510|P2|Overall Study|Death|2
5942415|NCT01327547|20553511|P1|Overall Study|Death|1
5942416|NCT01327547|20553510|P2|Overall Study|Adverse Event|1
5942417|NCT01327547|20553511|P1|Overall Study|Adverse Event|4
5942418|NCT01327495|20553579|P6|Overall Study|Physician Decision|0
5942419|NCT01327495|20553580|P5|Overall Study|Physician Decision|2
5942420|NCT01327495|20553581|P4|Overall Study|Physician Decision|0
5942421|NCT01327495|20553582|P3|Overall Study|Physician Decision|0
5942422|NCT01327495|20553583|P2|Overall Study|Physician Decision|0
5942423|NCT01327495|20553584|P1|Overall Study|Physician Decision|0
5942424|NCT01327495|20553579|P6|Overall Study|Withdrawal by Subject|0
5942425|NCT01327495|20553580|P5|Overall Study|Withdrawal by Subject|1
5942426|NCT01327495|20553581|P4|Overall Study|Withdrawal by Subject|0
5942427|NCT01327495|20553582|P3|Overall Study|Withdrawal by Subject|1
5942428|NCT01327495|20553583|P2|Overall Study|Withdrawal by Subject|1
5942429|NCT01327495|20553584|P1|Overall Study|Withdrawal by Subject|0
5942430|NCT01327495|20553579|P6|Overall Study|Adverse Event|2
5942431|NCT01327495|20553580|P5|Overall Study|Adverse Event|0
5942432|NCT01327495|20553581|P4|Overall Study|Adverse Event|0
5942433|NCT01327495|20553582|P3|Overall Study|Adverse Event|1
5942434|NCT01327495|20553583|P2|Overall Study|Adverse Event|1
5942435|NCT01327495|20553584|P1|Overall Study|Adverse Event|2
5942436|NCT01327482|20553676|P1|Overall Study|Adverse Event|1
5942437|NCT01327339|20553681|P1|Overall Study|Protocol Violation|8
5942438|NCT01327300|20553816|P2|Washout (3 Weeks)|Withdrawal by Subject|0
5942439|NCT01327300|20553817|P1|Washout (3 Weeks)|Withdrawal by Subject|1
5942440|NCT01327053|20553857|P2|Overall Study|Untreated|1
5942441|NCT01327053|20553858|P1|Overall Study|Untreated|0
5942442|NCT01327053|20553857|P2|Overall Study|Protocol Violation|1
5942443|NCT01327053|20553858|P1|Overall Study|Protocol Violation|0
5942444|NCT01327053|20553857|P2|Overall Study|Progressive disease|26
5942445|NCT01327053|20553858|P1|Overall Study|Progressive disease|31
5942446|NCT01327053|20553857|P2|Overall Study|Study terminated by Sponsor|3
5942447|NCT01327053|20553858|P1|Overall Study|Study terminated by Sponsor|1
5942448|NCT01327053|20553857|P2|Overall Study|Non-compliance with study treatment|5
5942449|NCT01327053|20553858|P1|Overall Study|Non-compliance with study treatment|0
5942450|NCT01327053|20553857|P2|Overall Study|Lost to Follow-up|4
5942451|NCT01327053|20553858|P1|Overall Study|Lost to Follow-up|2
5942452|NCT01327053|20553857|P2|Overall Study|Death|5
5942453|NCT01327053|20553858|P1|Overall Study|Death|1
5942454|NCT01327053|20553857|P2|Overall Study|Physician Decision|14
5942455|NCT01327053|20553858|P1|Overall Study|Physician Decision|10
5942456|NCT01327053|20553857|P2|Overall Study|Patient/guardian decision|35
5942457|NCT01327053|20553858|P1|Overall Study|Patient/guardian decision|11
5942458|NCT01327053|20553857|P2|Overall Study|Adverse Event|57
5942459|NCT01327053|20553858|P1|Overall Study|Adverse Event|23
5942460|NCT01326962|20553932|P1|Overall Study|Other|2
5942461|NCT01326962|20553932|P1|Overall Study|Lost to Follow-up|3
5942462|NCT01326962|20553932|P1|Overall Study|Withdrawal by Subject|1
5942463|NCT01326962|20553932|P1|Overall Study|Adverse Event|1
5942464|NCT01326910|20553955|P2|Overall Study|Protocol Violation|1
5942465|NCT01326910|20553956|P1|Overall Study|Protocol Violation|1
5942466|NCT01326910|20553955|P2|Overall Study|Withdrawal by Subject|2
5942467|NCT01326910|20553956|P1|Overall Study|Withdrawal by Subject|3
5942468|NCT01326845|20553970|P2|Overall Study|Misisng|3
5942469|NCT01326845|20553971|P1|Overall Study|Misisng|1
5942470|NCT01326845|20553970|P2|Overall Study|Adverse Event|0
5942471|NCT01326845|20553971|P1|Overall Study|Adverse Event|1
5942472|NCT01326845|20553970|P2|Overall Study|Administrative Problems|2
5942473|NCT01326845|20553971|P1|Overall Study|Administrative Problems|5
5942474|NCT01326728|20554032|P2|Overall Study|Early closure of study|9
5942475|NCT01326728|20554033|P1|Overall Study|Early closure of study|34
5942476|NCT01326728|20554032|P2|Overall Study|Death|0
5942477|NCT01326728|20554033|P1|Overall Study|Death|13
5942478|NCT01326702|20554057|P7|Overall Study|Not Treated|0
5942479|NCT01326702|20554058|P6|Overall Study|Not Treated|1
5942480|NCT01326702|20554059|P5|Overall Study|Not Treated|0
5942481|NCT01326702|20554060|P4|Overall Study|Not Treated|1
5942482|NCT01326702|20554061|P3|Overall Study|Not Treated|0
5942483|NCT01326702|20554062|P2|Overall Study|Not Treated|0
5942484|NCT01326702|20554063|P1|Overall Study|Not Treated|0
5942485|NCT01326702|20554057|P7|Overall Study|Withdrawal by Subject|3
5942486|NCT01326702|20554058|P6|Overall Study|Withdrawal by Subject|1
5942487|NCT01326702|20554059|P5|Overall Study|Withdrawal by Subject|1
5942488|NCT01326702|20554060|P4|Overall Study|Withdrawal by Subject|0
5942489|NCT01326702|20554061|P3|Overall Study|Withdrawal by Subject|1
5942490|NCT01326702|20554062|P2|Overall Study|Withdrawal by Subject|0
5942491|NCT01326702|20554063|P1|Overall Study|Withdrawal by Subject|0
5942492|NCT01326702|20554057|P7|Overall Study|Adverse Event|1
5942493|NCT01326702|20554058|P6|Overall Study|Adverse Event|3
5942494|NCT01326702|20554059|P5|Overall Study|Adverse Event|0
5942495|NCT01326702|20554060|P4|Overall Study|Adverse Event|1
5942496|NCT01326702|20554061|P3|Overall Study|Adverse Event|1
5942497|NCT01326702|20554062|P2|Overall Study|Adverse Event|0
5942498|NCT01326702|20554063|P1|Overall Study|Adverse Event|0
5942499|NCT01326702|20554057|P7|Overall Study|Death|0
5942500|NCT01326702|20554058|P6|Overall Study|Death|0
5942501|NCT01326702|20554059|P5|Overall Study|Death|0
5942502|NCT01326702|20554060|P4|Overall Study|Death|0
5942503|NCT01326702|20554061|P3|Overall Study|Death|0
5942504|NCT01326702|20554062|P2|Overall Study|Death|1
5942505|NCT01326702|20554063|P1|Overall Study|Death|0
5942506|NCT01326702|20554057|P7|Overall Study|progressive disease|3
5942507|NCT01326702|20554058|P6|Overall Study|progressive disease|2
5942508|NCT01326702|20554059|P5|Overall Study|progressive disease|3
5942509|NCT01326702|20554060|P4|Overall Study|progressive disease|1
5942510|NCT01326702|20554061|P3|Overall Study|progressive disease|3
5942511|NCT01326702|20554062|P2|Overall Study|progressive disease|1
5942512|NCT01326702|20554063|P1|Overall Study|progressive disease|1
5942513|NCT01326702|20554057|P7|Overall Study|Other|0
5942514|NCT01326702|20554058|P6|Overall Study|Other|1
5942515|NCT01326702|20554059|P5|Overall Study|Other|0
5942516|NCT01326702|20554060|P4|Overall Study|Other|0
5942517|NCT01326702|20554061|P3|Overall Study|Other|0
5942518|NCT01326702|20554062|P2|Overall Study|Other|0
5942519|NCT01326702|20554063|P1|Overall Study|Other|1
5942520|NCT01326546|20554119|P2|Overall Study|Withdrawal by Subject|1
5942521|NCT01326546|20554120|P1|Overall Study|Withdrawal by Subject|5
5942522|NCT01326546|20554119|P2|Overall Study|Adverse Event|0
5942523|NCT01326546|20554120|P1|Overall Study|Adverse Event|1
5942524|NCT01326546|20554119|P2|Overall Study|Pregnancy|1
5942525|NCT01326546|20554120|P1|Overall Study|Pregnancy|0
5942526|NCT01326546|20554119|P2|Overall Study|Protocol Violation|4
5942527|NCT01326546|20554120|P1|Overall Study|Protocol Violation|3
5942528|NCT01326546|20554119|P2|Overall Study|Lost to Follow-up|7
5942529|NCT01326546|20554120|P1|Overall Study|Lost to Follow-up|8
5942530|NCT01326533|20554128|P2|Overall Study|Adverse Event|0
5942531|NCT01326533|20554129|P1|Overall Study|Adverse Event|1
5942532|NCT01326533|20554128|P2|Overall Study|Withdrawal by Subject|0
5942533|NCT01326533|20554129|P1|Overall Study|Withdrawal by Subject|1
5942534|NCT01326533|20554128|P2|Overall Study|Lost to Follow-up|0
5942535|NCT01326533|20554129|P1|Overall Study|Lost to Follow-up|2
5942536|NCT01326481|20554137|P1|7.5 mg/kg TRC105, 1000 mg/m2 Cape|Adverse Event|1
5942537|NCT01326026|20554146|P2|Overall Study|Other|3
5942538|NCT01326026|20554147|P1|Overall Study|Other|3
5942539|NCT01326026|20554146|P2|Overall Study|Withdrawal Criteria|7
5942540|NCT01326026|20554147|P1|Overall Study|Withdrawal Criteria|5
5942541|NCT01326026|20554146|P2|Overall Study|Adverse Event|3
5942542|NCT01326026|20554147|P1|Overall Study|Adverse Event|4
5942543|NCT01325701|20554212|P2|Overall Study|Rollerover Extension Study|0
5942544|NCT01325701|20554213|P1|Overall Study|Rollerover Extension Study|4
5942545|NCT01325701|20554212|P2|Overall Study|Withdrawal by Subject|1
5942546|NCT01325701|20554213|P1|Overall Study|Withdrawal by Subject|2
5942547|NCT01325701|20554212|P2|Overall Study|Physician Decision|2
5942548|NCT01325701|20554213|P1|Overall Study|Physician Decision|2
5942549|NCT01325701|20554212|P2|Overall Study|Protocol Violation|0
5942550|NCT01325701|20554213|P1|Overall Study|Protocol Violation|1
5942551|NCT01325701|20554212|P2|Overall Study|Adverse Event|0
5942552|NCT01325701|20554213|P1|Overall Study|Adverse Event|12
5942553|NCT01325623|20554223|P1|Overall Study|Withdrawal by Subject|3
5942554|NCT01325584|20554265|P1|Overall Study|Death|1
5942555|NCT01325532|20554275|P2|Overall Study|Withdrawal by Subject|0
5942556|NCT01325532|20554276|P1|Overall Study|Withdrawal by Subject|2
5942557|NCT01325493|20554288|P2|Overall Study|Allergy|0
5942558|NCT01325493|20554289|P1|Overall Study|Allergy|1
5942559|NCT01325493|20554288|P2|Overall Study|loss of neuromonitoring signals|2
5942560|NCT01325493|20554289|P1|Overall Study|loss of neuromonitoring signals|0
5942561|NCT01325493|20554288|P2|Overall Study|Protocol Violation|1
5942562|NCT01325493|20554289|P1|Overall Study|Protocol Violation|0
5942563|NCT01325428|20554301|P1|Part B|Other reason not defined above|1
5942564|NCT01325428|20554301|P1|Part B|Refused continue taking trial medication|2
5942565|NCT01325428|20554301|P1|Part A|Other reason not defined above|2
5942566|NCT01325428|20554301|P1|Part A|Refused continue taking trial medication|2
5942567|NCT01325428|20554301|P1|Part A|Other adverse event|1
5942568|NCT01325428|20554301|P1|Part A|Clinical signs, symptoms of progression|2
5942569|NCT01325428|20554301|P1|Part A|Progressive disease according to RECIST|9
5942570|NCT01325350|20554321|P5|Overall Study|Did Not Receive Treatment|1
5942571|NCT01325350|20554322|P4|Overall Study|Did Not Receive Treatment|0
5942572|NCT01325350|20554323|P3|Overall Study|Did Not Receive Treatment|1
5942573|NCT01325350|20554324|P2|Overall Study|Did Not Receive Treatment|1
5942574|NCT01325350|20554325|P1|Overall Study|Did Not Receive Treatment|0
5942575|NCT01325350|20554321|P5|Overall Study|Withdrawal by Subject|0
5942576|NCT01325350|20554322|P4|Overall Study|Withdrawal by Subject|1
5942577|NCT01325350|20554323|P3|Overall Study|Withdrawal by Subject|1
5942578|NCT01325350|20554324|P2|Overall Study|Withdrawal by Subject|0
5942579|NCT01325350|20554325|P1|Overall Study|Withdrawal by Subject|0
5942580|NCT01325350|20554321|P5|Overall Study|Protocol Violation|0
5942581|NCT01325350|20554322|P4|Overall Study|Protocol Violation|1
5942582|NCT01325350|20554323|P3|Overall Study|Protocol Violation|0
5942583|NCT01325350|20554324|P2|Overall Study|Protocol Violation|0
5942584|NCT01325350|20554325|P1|Overall Study|Protocol Violation|0
5942585|NCT01325350|20554321|P5|Overall Study|Personal Reasons|3
5942586|NCT01325350|20554322|P4|Overall Study|Personal Reasons|5
5942587|NCT01325350|20554323|P3|Overall Study|Personal Reasons|6
5942588|NCT01325350|20554324|P2|Overall Study|Personal Reasons|1
5942589|NCT01325350|20554325|P1|Overall Study|Personal Reasons|2
5942590|NCT01325350|20554321|P5|Overall Study|Lost to Follow-up|5
5942591|NCT01325350|20554322|P4|Overall Study|Lost to Follow-up|1
5942592|NCT01325350|20554323|P3|Overall Study|Lost to Follow-up|5
5942593|NCT01325350|20554324|P2|Overall Study|Lost to Follow-up|0
5942594|NCT01325350|20554325|P1|Overall Study|Lost to Follow-up|1
5942595|NCT01325350|20554321|P5|Overall Study|Pregnancy|1
5942596|NCT01325350|20554322|P4|Overall Study|Pregnancy|0
5942597|NCT01325350|20554323|P3|Overall Study|Pregnancy|1
5942598|NCT01325350|20554324|P2|Overall Study|Pregnancy|0
5942599|NCT01325350|20554325|P1|Overall Study|Pregnancy|0
5942600|NCT01325350|20554321|P5|Overall Study|Adverse Event|2
5942601|NCT01325350|20554322|P4|Overall Study|Adverse Event|1
5942602|NCT01325350|20554323|P3|Overall Study|Adverse Event|3
5942603|NCT01325350|20554324|P2|Overall Study|Adverse Event|3
5942604|NCT01325350|20554325|P1|Overall Study|Adverse Event|3
5942605|NCT01325337|20554367|P5|Overall Study|Withdrawal by Subject|1
5942606|NCT01325337|20554368|P4|Overall Study|Withdrawal by Subject|0
5942607|NCT01325337|20554369|P3|Overall Study|Withdrawal by Subject|1
5942608|NCT01325337|20554370|P2|Overall Study|Withdrawal by Subject|0
5942609|NCT01325337|20554371|P1|Overall Study|Withdrawal by Subject|1
5942610|NCT01325337|20554367|P5|Overall Study|Personal Reasons|3
5942611|NCT01325337|20554368|P4|Overall Study|Personal Reasons|8
5942612|NCT01325337|20554369|P3|Overall Study|Personal Reasons|4
5942613|NCT01325337|20554370|P2|Overall Study|Personal Reasons|5
5942614|NCT01325337|20554371|P1|Overall Study|Personal Reasons|2
5942615|NCT01325337|20554367|P5|Overall Study|Lost to Follow-up|2
5942616|NCT01325337|20554368|P4|Overall Study|Lost to Follow-up|1
5942617|NCT01325337|20554369|P3|Overall Study|Lost to Follow-up|2
5942618|NCT01325337|20554370|P2|Overall Study|Lost to Follow-up|2
5942619|NCT01325337|20554371|P1|Overall Study|Lost to Follow-up|2
5942620|NCT01325337|20554367|P5|Overall Study|Adverse Event|2
5942621|NCT01325337|20554368|P4|Overall Study|Adverse Event|1
5942622|NCT01325337|20554369|P3|Overall Study|Adverse Event|2
5942623|NCT01325337|20554370|P2|Overall Study|Adverse Event|2
5942624|NCT01325337|20554371|P1|Overall Study|Adverse Event|0
5942625|NCT01325207|20554451|P6|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0
5942626|NCT01325207|20554452|P5|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|1
5942627|NCT01325207|20554453|P4|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0
5942628|NCT01325207|20554454|P3|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0
5942629|NCT01325207|20554455|P2|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0
5942630|NCT01325207|20554456|P1|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0
5942631|NCT01325207|20554451|P6|Follow-up Every 3 Months Until Death|Lost to Follow-up|1
5942632|NCT01325207|20554452|P5|Follow-up Every 3 Months Until Death|Lost to Follow-up|0
5942633|NCT01325207|20554453|P4|Follow-up Every 3 Months Until Death|Lost to Follow-up|0
5942634|NCT01325207|20554454|P3|Follow-up Every 3 Months Until Death|Lost to Follow-up|0
5942635|NCT01325207|20554455|P2|Follow-up Every 3 Months Until Death|Lost to Follow-up|0
5942636|NCT01325207|20554456|P1|Follow-up Every 3 Months Until Death|Lost to Follow-up|0
5942637|NCT01325207|20554451|P6|Started 9th Week/Cycle 3 of Treatment|Adverse Event|1
5942638|NCT01325207|20554452|P5|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0
5942639|NCT01325207|20554453|P4|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0
5942640|NCT01325207|20554454|P3|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0
5942641|NCT01325207|20554455|P2|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0
5942642|NCT01325207|20554456|P1|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0
5942643|NCT01325207|20554451|P6|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0
5942644|NCT01325207|20554452|P5|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0
5942645|NCT01325207|20554453|P4|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0
5942646|NCT01325207|20554454|P3|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0
5942647|NCT01325207|20554455|P2|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|1
5942648|NCT01325207|20554456|P1|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0
5942649|NCT01325207|20554451|P6|Started 9th Week/Cycle 3 of Treatment|Progressive disease|4
5942650|NCT01325207|20554452|P5|Started 9th Week/Cycle 3 of Treatment|Progressive disease|0
5942651|NCT01325207|20554453|P4|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1
5942652|NCT01325207|20554454|P3|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1
5942653|NCT01325207|20554455|P2|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1
5942654|NCT01325207|20554456|P1|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1
5942655|NCT01325207|20554451|P6|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|5
5942656|NCT01325207|20554452|P5|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|2
5942657|NCT01325207|20554453|P4|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0
5942658|NCT01325207|20554454|P3|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0
5942659|NCT01325207|20554455|P2|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1
5942660|NCT01325207|20554456|P1|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1
5942661|NCT01325207|20554451|P6|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0
5942662|NCT01325207|20554452|P5|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|2
5942663|NCT01325207|20554453|P4|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0
5942664|NCT01325207|20554454|P3|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0
5942665|NCT01325207|20554455|P2|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0
5942666|NCT01325207|20554456|P1|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0
5942667|NCT01324999|20554488|P1|Overall Study|Withdrawal by Subject|2
5942668|NCT01324999|20554488|P1|Overall Study|Adverse Event|3
5942669|NCT01324947|20554499|P1|Overall Study|1 discontinued before starting drug|1
5942670|NCT01324947|20554499|P1|Overall Study|Withdrawal by Subject|3
5942671|NCT01324947|20554499|P1|Overall Study|Progressive Disease|50
5942672|NCT01324947|20554499|P1|Overall Study|Other|3
5942673|NCT01324947|20554499|P1|Overall Study|Death|10
5942674|NCT01324947|20554499|P1|Overall Study|Adverse Event|7
5942675|NCT01324830|20554540|P19|Overall Study|Withdrawal by Subject|1
5942676|NCT01324830|20554541|P18|Overall Study|Withdrawal by Subject|0
5942677|NCT01324830|20554542|P17|Overall Study|Withdrawal by Subject|0
5942678|NCT01324830|20554543|P16|Overall Study|Withdrawal by Subject|0
5942679|NCT01324830|20554544|P15|Overall Study|Withdrawal by Subject|0
5942680|NCT01324830|20554545|P14|Overall Study|Withdrawal by Subject|0
5942681|NCT01324830|20554546|P13|Overall Study|Withdrawal by Subject|0
5942682|NCT01324830|20554547|P12|Overall Study|Withdrawal by Subject|0
5942683|NCT01324830|20554548|P11|Overall Study|Withdrawal by Subject|1
5942684|NCT01324830|20554549|P10|Overall Study|Withdrawal by Subject|0
5942685|NCT01324830|20554550|P9|Overall Study|Withdrawal by Subject|0
5942686|NCT01324830|20554551|P8|Overall Study|Withdrawal by Subject|0
5942687|NCT01324830|20554552|P7|Overall Study|Withdrawal by Subject|0
5942688|NCT01324830|20554553|P6|Overall Study|Withdrawal by Subject|1
5942689|NCT01324830|20554554|P5|Overall Study|Withdrawal by Subject|0
5942690|NCT01324830|20554555|P4|Overall Study|Withdrawal by Subject|0
5942691|NCT01324830|20554556|P3|Overall Study|Withdrawal by Subject|0
5942692|NCT01324830|20554557|P2|Overall Study|Withdrawal by Subject|0
5942693|NCT01324830|20554558|P1|Overall Study|Withdrawal by Subject|0
5942694|NCT01324830|20554540|P19|Overall Study|Adverse Event, non-fatal|0
5942695|NCT01324830|20554541|P18|Overall Study|Adverse Event, non-fatal|1
5942696|NCT01324830|20554542|P17|Overall Study|Adverse Event, non-fatal|0
5942697|NCT01324830|20554543|P16|Overall Study|Adverse Event, non-fatal|0
5942698|NCT01324830|20554544|P15|Overall Study|Adverse Event, non-fatal|0
5942699|NCT01324830|20554545|P14|Overall Study|Adverse Event, non-fatal|0
5942700|NCT01324830|20554546|P13|Overall Study|Adverse Event, non-fatal|0
5942701|NCT01324830|20554547|P12|Overall Study|Adverse Event, non-fatal|0
5942702|NCT01324830|20554548|P11|Overall Study|Adverse Event, non-fatal|1
5942703|NCT01324830|20554549|P10|Overall Study|Adverse Event, non-fatal|0
5942704|NCT01324830|20554550|P9|Overall Study|Adverse Event, non-fatal|2
5942705|NCT01324830|20554551|P8|Overall Study|Adverse Event, non-fatal|0
5942706|NCT01324830|20554552|P7|Overall Study|Adverse Event, non-fatal|0
5942707|NCT01324830|20554553|P6|Overall Study|Adverse Event, non-fatal|0
5942708|NCT01324830|20554554|P5|Overall Study|Adverse Event, non-fatal|0
5942709|NCT01324830|20554555|P4|Overall Study|Adverse Event, non-fatal|0
5942710|NCT01324830|20554556|P3|Overall Study|Adverse Event, non-fatal|0
5942711|NCT01324830|20554557|P2|Overall Study|Adverse Event, non-fatal|0
5942712|NCT01324830|20554558|P1|Overall Study|Adverse Event, non-fatal|0
5942713|NCT01324830|20554540|P19|Overall Study|Adverse Event, serious fatal|0
5942714|NCT01324830|20554541|P18|Overall Study|Adverse Event, serious fatal|0
5942715|NCT01324830|20554542|P17|Overall Study|Adverse Event, serious fatal|0
5942716|NCT01324830|20554543|P16|Overall Study|Adverse Event, serious fatal|0
5942717|NCT01324830|20554544|P15|Overall Study|Adverse Event, serious fatal|0
5942718|NCT01324830|20554545|P14|Overall Study|Adverse Event, serious fatal|0
5942719|NCT01324830|20554546|P13|Overall Study|Adverse Event, serious fatal|0
5942720|NCT01324830|20554547|P12|Overall Study|Adverse Event, serious fatal|0
5942721|NCT01324830|20554548|P11|Overall Study|Adverse Event, serious fatal|0
5942722|NCT01324830|20554549|P10|Overall Study|Adverse Event, serious fatal|0
5942723|NCT01324830|20554550|P9|Overall Study|Adverse Event, serious fatal|0
5942724|NCT01324830|20554551|P8|Overall Study|Adverse Event, serious fatal|0
5942725|NCT01324830|20554552|P7|Overall Study|Adverse Event, serious fatal|0
5942726|NCT01324830|20554553|P6|Overall Study|Adverse Event, serious fatal|0
5942727|NCT01324830|20554554|P5|Overall Study|Adverse Event, serious fatal|0
5942728|NCT01324830|20554555|P4|Overall Study|Adverse Event, serious fatal|0
5942729|NCT01324830|20554556|P3|Overall Study|Adverse Event, serious fatal|0
5942730|NCT01324830|20554557|P2|Overall Study|Adverse Event, serious fatal|1
5942731|NCT01324830|20554558|P1|Overall Study|Adverse Event, serious fatal|0
5942732|NCT01324830|20554540|P19|Overall Study|Reason not mentioned above|0
5942733|NCT01324830|20554541|P18|Overall Study|Reason not mentioned above|1
5942734|NCT01324830|20554542|P17|Overall Study|Reason not mentioned above|0
5942735|NCT01324830|20554543|P16|Overall Study|Reason not mentioned above|0
5942736|NCT01324830|20554544|P15|Overall Study|Reason not mentioned above|0
5942737|NCT01324830|20554545|P14|Overall Study|Reason not mentioned above|0
5942738|NCT01324830|20554546|P13|Overall Study|Reason not mentioned above|0
5942739|NCT01324830|20554547|P12|Overall Study|Reason not mentioned above|0
5942740|NCT01324830|20554548|P11|Overall Study|Reason not mentioned above|0
5942741|NCT01324830|20554549|P10|Overall Study|Reason not mentioned above|0
5942742|NCT01324830|20554550|P9|Overall Study|Reason not mentioned above|0
5942743|NCT01324830|20554551|P8|Overall Study|Reason not mentioned above|0
5942744|NCT01324830|20554552|P7|Overall Study|Reason not mentioned above|0
5942745|NCT01324830|20554553|P6|Overall Study|Reason not mentioned above|0
5942746|NCT01324830|20554554|P5|Overall Study|Reason not mentioned above|0
5942747|NCT01324830|20554555|P4|Overall Study|Reason not mentioned above|0
5942748|NCT01324830|20554556|P3|Overall Study|Reason not mentioned above|0
5942749|NCT01324830|20554557|P2|Overall Study|Reason not mentioned above|0
5942750|NCT01324830|20554558|P1|Overall Study|Reason not mentioned above|0
5942751|NCT01324830|20554540|P19|Overall Study|Dose limiting toxicity|1
5942752|NCT01324830|20554541|P18|Overall Study|Dose limiting toxicity|1
5942753|NCT01324830|20554542|P17|Overall Study|Dose limiting toxicity|1
5942754|NCT01324830|20554543|P16|Overall Study|Dose limiting toxicity|0
5942755|NCT01324830|20554544|P15|Overall Study|Dose limiting toxicity|0
5942756|NCT01324830|20554545|P14|Overall Study|Dose limiting toxicity|0
5942757|NCT01324830|20554546|P13|Overall Study|Dose limiting toxicity|0
5942758|NCT01324830|20554547|P12|Overall Study|Dose limiting toxicity|0
5942759|NCT01324830|20554548|P11|Overall Study|Dose limiting toxicity|0
5942760|NCT01324830|20554549|P10|Overall Study|Dose limiting toxicity|0
5942761|NCT01324830|20554550|P9|Overall Study|Dose limiting toxicity|0
5942762|NCT01324830|20554551|P8|Overall Study|Dose limiting toxicity|0
5942763|NCT01324830|20554552|P7|Overall Study|Dose limiting toxicity|0
5942764|NCT01324830|20554553|P6|Overall Study|Dose limiting toxicity|0
5942765|NCT01324830|20554554|P5|Overall Study|Dose limiting toxicity|1
5942766|NCT01324830|20554555|P4|Overall Study|Dose limiting toxicity|0
5942767|NCT01324830|20554556|P3|Overall Study|Dose limiting toxicity|0
5942768|NCT01324830|20554557|P2|Overall Study|Dose limiting toxicity|0
5942769|NCT01324830|20554558|P1|Overall Study|Dose limiting toxicity|0
5942770|NCT01324830|20554540|P19|Overall Study|Progressive Disease|4
5942771|NCT01324830|20554541|P18|Overall Study|Progressive Disease|3
5942772|NCT01324830|20554542|P17|Overall Study|Progressive Disease|2
5942773|NCT01324830|20554543|P16|Overall Study|Progressive Disease|3
5942774|NCT01324830|20554544|P15|Overall Study|Progressive Disease|1
5942775|NCT01324830|20554545|P14|Overall Study|Progressive Disease|1
5942776|NCT01324830|20554546|P13|Overall Study|Progressive Disease|1
5942777|NCT01324830|20554547|P12|Overall Study|Progressive Disease|1
5942778|NCT01324830|20554548|P11|Overall Study|Progressive Disease|2
5942779|NCT01324830|20554549|P10|Overall Study|Progressive Disease|6
5942780|NCT01324830|20554550|P9|Overall Study|Progressive Disease|3
5942781|NCT01324830|20554551|P8|Overall Study|Progressive Disease|3
5942782|NCT01324830|20554552|P7|Overall Study|Progressive Disease|3
5942783|NCT01324830|20554553|P6|Overall Study|Progressive Disease|6
5942784|NCT01324830|20554554|P5|Overall Study|Progressive Disease|6
5942785|NCT01324830|20554555|P4|Overall Study|Progressive Disease|3
5942786|NCT01324830|20554556|P3|Overall Study|Progressive Disease|3
5942787|NCT01324830|20554557|P2|Overall Study|Progressive Disease|2
5942788|NCT01324830|20554558|P1|Overall Study|Progressive Disease|3
5942789|NCT01324622|20554704|P2|Overall Study|Lack of Efficacy|0
5942790|NCT01324622|20554705|P1|Overall Study|Lack of Efficacy|1
5942791|NCT01324622|20554704|P2|Overall Study|Death|0
5942792|NCT01324622|20554705|P1|Overall Study|Death|1
5942793|NCT01324622|20554704|P2|Overall Study|Lost to Follow-up|7
5942794|NCT01324622|20554705|P1|Overall Study|Lost to Follow-up|7
5942795|NCT01324570|20554735|P2|Overall Study|Administrative|2
5942796|NCT01324570|20554736|P1|Overall Study|Administrative|0
5942797|NCT01324570|20554735|P2|Overall Study|Confirmed or suspected diversion|1
5942798|NCT01324570|20554736|P1|Overall Study|Confirmed or suspected diversion|0
5942799|NCT01324570|20554735|P2|Overall Study|Lack of Efficacy|1
5942800|NCT01324570|20554736|P1|Overall Study|Lack of Efficacy|0
5942801|NCT01324570|20554735|P2|Overall Study|Withdrawal by Subject|3
5942802|NCT01324570|20554736|P1|Overall Study|Withdrawal by Subject|0
5942803|NCT01324570|20554735|P2|Overall Study|Adverse Event|7
5942804|NCT01324570|20554736|P1|Overall Study|Adverse Event|4
5942805|NCT01324440|20554773|P2|Overall Study|Subject moved|1
5942806|NCT01324440|20554774|P1|Overall Study|Subject moved|0
5942807|NCT01324401|20554788|P2|Overall Study|Adverse Event|3
5942808|NCT01324401|20554789|P1|Overall Study|Adverse Event|1
5942809|NCT01324401|20554788|P2|Overall Study|Withdrawn before any treatment|3
5942810|NCT01324401|20554789|P1|Overall Study|Withdrawn before any treatment|0
5942811|NCT01324388|20554800|P4|Part 2 of Study: Second Intervention|Withdrawal by Subject|0
5942812|NCT01324388|20554801|P3|Part 2 of Study: Second Intervention|Withdrawal by Subject|1
5942813|NCT01324388|20554802|P2|Part 2 of Study: Second Intervention|Withdrawal by Subject|0
5942814|NCT01324388|20554803|P1|Part 2 of Study: Second Intervention|Withdrawal by Subject|0
5942815|NCT01324388|20554800|P4|Part 2 of Study: First Intervention|Protocol Violation|1
5942816|NCT01324388|20554801|P3|Part 2 of Study: First Intervention|Protocol Violation|0
5942817|NCT01324388|20554802|P2|Part 2 of Study: First Intervention|Protocol Violation|0
5942818|NCT01324388|20554803|P1|Part 2 of Study: First Intervention|Protocol Violation|0
5942819|NCT01324388|20554800|P4|Part 1 of Study|Physician Decision|0
5942820|NCT01324388|20554801|P3|Part 1 of Study|Physician Decision|0
5942821|NCT01324388|20554802|P2|Part 1 of Study|Physician Decision|0
5942822|NCT01324388|20554803|P1|Part 1 of Study|Physician Decision|1
5942823|NCT01324388|20554800|P4|Part 1 of Study|Protocol Violation|0
5942824|NCT01324388|20554801|P3|Part 1 of Study|Protocol Violation|0
5942825|NCT01324388|20554802|P2|Part 1 of Study|Protocol Violation|2
5942826|NCT01324388|20554803|P1|Part 1 of Study|Protocol Violation|1
5942827|NCT01324388|20554800|P4|Part 1 of Study|Adverse Event|0
5942828|NCT01324388|20554801|P3|Part 1 of Study|Adverse Event|0
5942829|NCT01324388|20554802|P2|Part 1 of Study|Adverse Event|0
5942830|NCT01324388|20554803|P1|Part 1 of Study|Adverse Event|2
5942831|NCT01324349|20554824|P2|Overall Study|Withdrawal by Subject|1
5942832|NCT01324349|20554825|P1|Overall Study|Withdrawal by Subject|0
5942833|NCT01324349|20554824|P2|Overall Study|Death|1
5942834|NCT01324349|20554825|P1|Overall Study|Death|1
5942835|NCT01324323|20554835|P1|Overall Study|Withdrawal by Subject|1
5942836|NCT01324310|20554855|P1|Overall Study|Disease Progression|1
5942837|NCT01324310|20554855|P1|Overall Study|Adverse Event|1
5942838|NCT01324271|20554875|P2|Overall Study|Physician Decision|0
5942839|NCT01324271|20554876|P1|Overall Study|Physician Decision|1
5942840|NCT01324271|20554875|P2|Overall Study|Lost to Follow-up|0
5942841|NCT01324271|20554876|P1|Overall Study|Lost to Follow-up|3
5942842|NCT01324102|20554899|P2|Overall Study|illness|6
5942843|NCT01324102|20554900|P1|Overall Study|illness|1
5942844|NCT01324024|20554907|P2|Second Intervention (4 Weeks)|Withdrawal by Subject|1
5942845|NCT01324024|20554908|P1|Second Intervention (4 Weeks)|Withdrawal by Subject|2
5942846|NCT01323972|20554946|P4|Overall Study|Lost to Follow-up|1
5942847|NCT01323972|20554947|P3|Overall Study|Lost to Follow-up|1
5942848|NCT01323972|20554948|P2|Overall Study|Lost to Follow-up|1
5942849|NCT01323972|20554949|P1|Overall Study|Lost to Follow-up|0
5942850|NCT01323972|20554946|P4|Overall Study|Migrated/moved from study area|0
5942851|NCT01323972|20554947|P3|Overall Study|Migrated/moved from study area|0
5942852|NCT01323972|20554948|P2|Overall Study|Migrated/moved from study area|2
5942853|NCT01323972|20554949|P1|Overall Study|Migrated/moved from study area|1
5942854|NCT01323972|20554946|P4|Overall Study|Withdrawal by Subject|0
5942855|NCT01323972|20554947|P3|Overall Study|Withdrawal by Subject|1
5942856|NCT01323972|20554948|P2|Overall Study|Withdrawal by Subject|0
5942857|NCT01323972|20554949|P1|Overall Study|Withdrawal by Subject|1
5942858|NCT01323946|20555045|P3|Overall Study|Withdrawal by Subject|0
5942859|NCT01323946|20555046|P2|Overall Study|Withdrawal by Subject|2
5942860|NCT01323946|20555047|P1|Overall Study|Withdrawal by Subject|2
5942861|NCT01323946|20555045|P3|Overall Study|Parents refused the last blood draw|0
5942862|NCT01323946|20555046|P2|Overall Study|Parents refused the last blood draw|0
5942863|NCT01323946|20555047|P1|Overall Study|Parents refused the last blood draw|1
5942864|NCT01323946|20555045|P3|Overall Study|Lost to Follow-up|0
5942865|NCT01323946|20555046|P2|Overall Study|Lost to Follow-up|1
5942866|NCT01323946|20555047|P1|Overall Study|Lost to Follow-up|0
5942867|NCT01323920|20555168|P1|Overall Study|Withdrawal by Subject|1
5942868|NCT01323920|20555168|P1|Overall Study|Death|5
5942869|NCT01323790|20555209|P3|Overall Study|Severe non-compliance with protocol|2
5942870|NCT01323790|20555210|P2|Overall Study|Severe non-compliance with protocol|2
5942871|NCT01323790|20555211|P1|Overall Study|Severe non-compliance with protocol|2
5942872|NCT01323790|20555209|P3|Overall Study|Did Not Receive Treatment|1
5942873|NCT01323790|20555210|P2|Overall Study|Did Not Receive Treatment|0
5942874|NCT01323790|20555211|P1|Overall Study|Did Not Receive Treatment|2
5942875|NCT01323790|20555209|P3|Overall Study|Withdrawal by Subject|13
5942876|NCT01323790|20555210|P2|Overall Study|Withdrawal by Subject|20
5942877|NCT01323790|20555211|P1|Overall Study|Withdrawal by Subject|23
5942878|NCT01323790|20555209|P3|Overall Study|Eligibility Criteria Not Fulfilled|1
5942879|NCT01323790|20555210|P2|Overall Study|Eligibility Criteria Not Fulfilled|0
5942880|NCT01323790|20555211|P1|Overall Study|Eligibility Criteria Not Fulfilled|0
5942881|NCT01323790|20555209|P3|Overall Study|Adverse Event|12
5942882|NCT01323790|20555210|P2|Overall Study|Adverse Event|24
5942883|NCT01323790|20555211|P1|Overall Study|Adverse Event|11
5942884|NCT01323790|20555209|P3|Overall Study|Lack of Efficacy|3
5942885|NCT01323790|20555210|P2|Overall Study|Lack of Efficacy|0
5942886|NCT01323790|20555211|P1|Overall Study|Lack of Efficacy|3
5942887|NCT01323790|20555209|P3|Overall Study|Study-Specific Withdrawal Criteria|3
5942888|NCT01323790|20555210|P2|Overall Study|Study-Specific Withdrawal Criteria|3
5942889|NCT01323790|20555211|P1|Overall Study|Study-Specific Withdrawal Criteria|0
5942890|NCT01323790|20555209|P3|Overall Study|Lost to Follow-up|9
5942891|NCT01323790|20555210|P2|Overall Study|Lost to Follow-up|9
5942892|NCT01323790|20555211|P1|Overall Study|Lost to Follow-up|11
5942893|NCT01323790|20555209|P3|Overall Study|Other|1
5942894|NCT01323790|20555210|P2|Overall Study|Other|2
5942895|NCT01323790|20555211|P1|Overall Study|Other|3
5942896|NCT01323673|20555262|P2|Overall Study|Withdrawal by Subject|3
5942897|NCT01323673|20555263|P1|Overall Study|Withdrawal by Subject|2
5942898|NCT01323673|20555262|P2|Overall Study|Protocol Violation|0
5942899|NCT01323673|20555263|P1|Overall Study|Protocol Violation|1
5942900|NCT01323673|20555262|P2|Overall Study|Lost to Follow-up|1
5942901|NCT01323673|20555263|P1|Overall Study|Lost to Follow-up|0
5942902|NCT01323673|20555262|P2|Overall Study|Adverse Event|1
5942903|NCT01323673|20555263|P1|Overall Study|Adverse Event|0
5942904|NCT01323660|20555283|P6|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
5942905|NCT01323660|20555284|P5|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2
5942906|NCT01323660|20555285|P4|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
5942907|NCT01323660|20555286|P3|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
5942908|NCT01323660|20555287|P2|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
5942909|NCT01323660|20555288|P1|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
5942910|NCT01323660|20555283|P6|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1
5942911|NCT01323660|20555284|P5|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
5942912|NCT01323660|20555285|P4|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
5942913|NCT01323660|20555286|P3|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
5942914|NCT01323660|20555287|P2|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
5942915|NCT01323660|20555288|P1|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1
5942916|NCT01323660|20555283|P6|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|1
5942917|NCT01323660|20555284|P5|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0
5942918|NCT01323660|20555285|P4|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0
5942919|NCT01323660|20555286|P3|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0
5942920|NCT01323660|20555287|P2|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0
5942921|NCT01323660|20555288|P1|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0
5942922|NCT01323660|20555283|P6|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3
5942923|NCT01323660|20555284|P5|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1
5942924|NCT01323660|20555285|P4|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2
5942925|NCT01323660|20555286|P3|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2
5942926|NCT01323660|20555287|P2|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0
5942927|NCT01323660|20555288|P1|Treatment Period 2 (12 Weeks)|Lack of Efficacy|9
5942928|NCT01323660|20555283|P6|Treatment Period 2 (12 Weeks)|Adverse Event|2
5942929|NCT01323660|20555284|P5|Treatment Period 2 (12 Weeks)|Adverse Event|1
5942930|NCT01323660|20555285|P4|Treatment Period 2 (12 Weeks)|Adverse Event|1
5942931|NCT01323660|20555286|P3|Treatment Period 2 (12 Weeks)|Adverse Event|0
5942932|NCT01323660|20555287|P2|Treatment Period 2 (12 Weeks)|Adverse Event|0
5942933|NCT01323660|20555288|P1|Treatment Period 2 (12 Weeks)|Adverse Event|1
5942934|NCT01323660|20555283|P6|Washout Period (14 Days)|Lack of Efficacy|2
5942935|NCT01323660|20555284|P5|Washout Period (14 Days)|Lack of Efficacy|2
5942936|NCT01323660|20555285|P4|Washout Period (14 Days)|Lack of Efficacy|3
5942937|NCT01323660|20555286|P3|Washout Period (14 Days)|Lack of Efficacy|1
5942938|NCT01323660|20555287|P2|Washout Period (14 Days)|Lack of Efficacy|0
5942939|NCT01323660|20555288|P1|Washout Period (14 Days)|Lack of Efficacy|0
5942940|NCT01323660|20555283|P6|Washout Period (14 Days)|Adverse Event|0
5942941|NCT01323660|20555284|P5|Washout Period (14 Days)|Adverse Event|1
5942942|NCT01323660|20555285|P4|Washout Period (14 Days)|Adverse Event|0
5942943|NCT01323660|20555286|P3|Washout Period (14 Days)|Adverse Event|0
5942944|NCT01323660|20555287|P2|Washout Period (14 Days)|Adverse Event|0
5942945|NCT01323660|20555288|P1|Washout Period (14 Days)|Adverse Event|0
5942946|NCT01323660|20555283|P6|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
5942947|NCT01323660|20555284|P5|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|3
5942948|NCT01323660|20555285|P4|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1
5942949|NCT01323660|20555286|P3|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1
5942950|NCT01323660|20555287|P2|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
5942951|NCT01323660|20555288|P1|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|5
5942952|NCT01323660|20555283|P6|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
5942953|NCT01323660|20555284|P5|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
5942954|NCT01323660|20555285|P4|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
5942955|NCT01323660|20555286|P3|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
5942956|NCT01323660|20555287|P2|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
5942957|NCT01323660|20555288|P1|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
5942958|NCT01323660|20555283|P6|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
5942959|NCT01323660|20555284|P5|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|1
5942960|NCT01323660|20555285|P4|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
5942961|NCT01323660|20555286|P3|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
5942962|NCT01323660|20555287|P2|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
5942963|NCT01323660|20555288|P1|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
5942964|NCT01323660|20555283|P6|Treatment Period 1 (12 Weeks)|Protocol Violation|2
5942965|NCT01323660|20555284|P5|Treatment Period 1 (12 Weeks)|Protocol Violation|1
5942966|NCT01323660|20555285|P4|Treatment Period 1 (12 Weeks)|Protocol Violation|1
5942967|NCT01323660|20555286|P3|Treatment Period 1 (12 Weeks)|Protocol Violation|1
5942968|NCT01323660|20555287|P2|Treatment Period 1 (12 Weeks)|Protocol Violation|0
5942969|NCT01323660|20555288|P1|Treatment Period 1 (12 Weeks)|Protocol Violation|2
5942970|NCT01323660|20555283|P6|Treatment Period 1 (12 Weeks)|Lack of Efficacy|3
5942971|NCT01323660|20555284|P5|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1
5942972|NCT01323660|20555285|P4|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0
5942973|NCT01323660|20555286|P3|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2
5942974|NCT01323660|20555287|P2|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0
5942975|NCT01323660|20555288|P1|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6
5942976|NCT01323660|20555283|P6|Treatment Period 1 (12 Weeks)|Adverse Event|4
5942977|NCT01323660|20555284|P5|Treatment Period 1 (12 Weeks)|Adverse Event|3
5942978|NCT01323660|20555285|P4|Treatment Period 1 (12 Weeks)|Adverse Event|3
5942979|NCT01323660|20555286|P3|Treatment Period 1 (12 Weeks)|Adverse Event|1
5942980|NCT01323660|20555287|P2|Treatment Period 1 (12 Weeks)|Adverse Event|1
5942981|NCT01323660|20555288|P1|Treatment Period 1 (12 Weeks)|Adverse Event|6
5942982|NCT01323647|20555334|P2|Overall Study|Lost to Follow-up|0
5942983|NCT01323647|20555335|P1|Overall Study|Lost to Follow-up|2
5942984|NCT01323647|20555334|P2|Overall Study|Withdrawal by Subject|0
5942985|NCT01323647|20555335|P1|Overall Study|Withdrawal by Subject|5
5942986|NCT01323647|20555334|P2|Overall Study|Migrated/moved from study area|0
5942987|NCT01323647|20555335|P1|Overall Study|Migrated/moved from study area|2
5942988|NCT01323634|20555352|P3|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1
5942989|NCT01323634|20555353|P2|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1
5942990|NCT01323634|20555354|P1|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|0
5942991|NCT01323634|20555352|P3|Double-Blind (DB) Treatment Period|Withdrawal by Subject|4
5942992|NCT01323634|20555353|P2|Double-Blind (DB) Treatment Period|Withdrawal by Subject|7
5942993|NCT01323634|20555354|P1|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
5942994|NCT01323634|20555352|P3|Double-Blind (DB) Treatment Period|Physician Decision|3
5942995|NCT01323634|20555353|P2|Double-Blind (DB) Treatment Period|Physician Decision|2
5942996|NCT01323634|20555354|P1|Double-Blind (DB) Treatment Period|Physician Decision|0
5942997|NCT01323634|20555352|P3|Double-Blind (DB) Treatment Period|Lost to Follow-up|1
5942998|NCT01323634|20555353|P2|Double-Blind (DB) Treatment Period|Lost to Follow-up|1
5942999|NCT01323634|20555354|P1|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
5943000|NCT01323634|20555352|P3|Double-Blind (DB) Treatment Period|Protocol Violation|7
5943001|NCT01323634|20555353|P2|Double-Blind (DB) Treatment Period|Protocol Violation|6
5943002|NCT01323634|20555354|P1|Double-Blind (DB) Treatment Period|Protocol Violation|0
5943003|NCT01323634|20555352|P3|Double-Blind (DB) Treatment Period|Lack of Efficacy|2
5943004|NCT01323634|20555353|P2|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
5943005|NCT01323634|20555354|P1|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
5943006|NCT01323634|20555352|P3|Double-Blind (DB) Treatment Period|Adverse Event|4
5943007|NCT01323634|20555353|P2|Double-Blind (DB) Treatment Period|Adverse Event|8
5943008|NCT01323634|20555354|P1|Double-Blind (DB) Treatment Period|Adverse Event|0
5943009|NCT01323634|20555352|P3|2-week Run-in Period|Adverse Event|0
5943010|NCT01323634|20555353|P2|2-week Run-in Period|Adverse Event|0
5943011|NCT01323634|20555354|P1|2-week Run-in Period|Adverse Event|1
5943012|NCT01323634|20555352|P3|2-week Run-in Period|Protocol Violation|0
5943013|NCT01323634|20555353|P2|2-week Run-in Period|Protocol Violation|0
5943014|NCT01323634|20555354|P1|2-week Run-in Period|Protocol Violation|1
5943015|NCT01323634|20555352|P3|2-week Run-in Period|Physician Decision|0
5943016|NCT01323634|20555353|P2|2-week Run-in Period|Physician Decision|0
5943017|NCT01323634|20555354|P1|2-week Run-in Period|Physician Decision|5
5943018|NCT01323634|20555352|P3|2-week Run-in Period|Withdrawal by Subject|0
5943019|NCT01323634|20555353|P2|2-week Run-in Period|Withdrawal by Subject|0
5943020|NCT01323634|20555354|P1|2-week Run-in Period|Withdrawal by Subject|7
5943021|NCT01323634|20555352|P3|2-week Run-in Period|Continuation Criteria not Met|0
5943022|NCT01323634|20555353|P2|2-week Run-in Period|Continuation Criteria not Met|0
5943023|NCT01323634|20555354|P1|2-week Run-in Period|Continuation Criteria not Met|73
5943024|NCT01323634|20555352|P3|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0
5943025|NCT01323634|20555353|P2|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0
5943026|NCT01323634|20555354|P1|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|125
5943027|NCT01323621|20555364|P3|12-week, Double-blind Treatment Period|Withdrawal by Subject|4
5943028|NCT01323621|20555365|P2|12-week, Double-blind Treatment Period|Withdrawal by Subject|5
5943029|NCT01323621|20555366|P1|12-week, Double-blind Treatment Period|Withdrawal by Subject|0
5943030|NCT01323621|20555364|P3|12-week, Double-blind Treatment Period|Physician Decision|1
5943031|NCT01323621|20555365|P2|12-week, Double-blind Treatment Period|Physician Decision|2
5943032|NCT01323621|20555366|P1|12-week, Double-blind Treatment Period|Physician Decision|0
5943033|NCT01323621|20555364|P3|12-week, Double-blind Treatment Period|Lost to Follow-up|0
5943034|NCT01323621|20555365|P2|12-week, Double-blind Treatment Period|Lost to Follow-up|1
5943035|NCT01323621|20555366|P1|12-week, Double-blind Treatment Period|Lost to Follow-up|0
5943036|NCT01323621|20555364|P3|12-week, Double-blind Treatment Period|Protocol Violation|4
5943037|NCT01323621|20555365|P2|12-week, Double-blind Treatment Period|Protocol Violation|4
5943038|NCT01323621|20555366|P1|12-week, Double-blind Treatment Period|Protocol Violation|0
5943039|NCT01323621|20555364|P3|12-week, Double-blind Treatment Period|Lack of Efficacy|6
5943040|NCT01323621|20555365|P2|12-week, Double-blind Treatment Period|Lack of Efficacy|2
5943041|NCT01323621|20555366|P1|12-week, Double-blind Treatment Period|Lack of Efficacy|0
5943042|NCT01323621|20555364|P3|12-week, Double-blind Treatment Period|Adverse Event|5
5943043|NCT01323621|20555365|P2|12-week, Double-blind Treatment Period|Adverse Event|1
5943044|NCT01323621|20555366|P1|12-week, Double-blind Treatment Period|Adverse Event|0
5943045|NCT01323621|20555364|P3|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0
5943046|NCT01323621|20555365|P2|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0
5943047|NCT01323621|20555366|P1|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|86
5943048|NCT01323621|20555364|P3|2-week, Single-blind Run In Period|Lost to Follow-up|0
5943049|NCT01323621|20555365|P2|2-week, Single-blind Run In Period|Lost to Follow-up|0
5943050|NCT01323621|20555366|P1|2-week, Single-blind Run In Period|Lost to Follow-up|1
5943051|NCT01323621|20555364|P3|2-week, Single-blind Run In Period|Protocol Violation|0
5943052|NCT01323621|20555365|P2|2-week, Single-blind Run In Period|Protocol Violation|0
5943053|NCT01323621|20555366|P1|2-week, Single-blind Run In Period|Protocol Violation|1
5943054|NCT01323621|20555364|P3|2-week, Single-blind Run In Period|Withdrawal by Subject|0
5943055|NCT01323621|20555365|P2|2-week, Single-blind Run In Period|Withdrawal by Subject|0
5943056|NCT01323621|20555366|P1|2-week, Single-blind Run In Period|Withdrawal by Subject|12
5943057|NCT01323621|20555364|P3|2-week, Single-blind Run In Period|Physician Decision|0
5943058|NCT01323621|20555365|P2|2-week, Single-blind Run In Period|Physician Decision|0
5943059|NCT01323621|20555366|P1|2-week, Single-blind Run In Period|Physician Decision|7
5943060|NCT01323621|20555364|P3|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0
5943061|NCT01323621|20555365|P2|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0
5943062|NCT01323621|20555366|P1|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|121
5943063|NCT01323582|20555387|P2|Weeks 8-11 (Period 2)|Withdrawal by Subject|1
5943064|NCT01323582|20555388|P1|Weeks 8-11 (Period 2)|Withdrawal by Subject|0
5943065|NCT01323582|20555387|P2|Weeks 5-7 (Washout)|Withdrawal by Subject|1
5943066|NCT01323582|20555388|P1|Weeks 5-7 (Washout)|Withdrawal by Subject|0
5943067|NCT01323582|20555387|P2|Weeks 1-4 (First Period)|Withdrawal by Subject|2
5943068|NCT01323582|20555388|P1|Weeks 1-4 (First Period)|Withdrawal by Subject|2
5943069|NCT01323530|20555411|P7|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|1
5943070|NCT01323530|20555412|P6|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0
5943071|NCT01323530|20555413|P5|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0
5943072|NCT01323530|20555414|P4|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0
5943073|NCT01323530|20555415|P3|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0
5943074|NCT01323530|20555416|P2|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0
5943075|NCT01323530|20555417|P1|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0
5943076|NCT01323530|20555411|P7|Phase 2 (Dose-confirmation Phase)|Investigators decision|3
5943077|NCT01323530|20555412|P6|Phase 2 (Dose-confirmation Phase)|Investigators decision|0
5943078|NCT01323530|20555413|P5|Phase 2 (Dose-confirmation Phase)|Investigators decision|0
5943079|NCT01323530|20555414|P4|Phase 2 (Dose-confirmation Phase)|Investigators decision|0
5943080|NCT01323530|20555415|P3|Phase 2 (Dose-confirmation Phase)|Investigators decision|0
5943081|NCT01323530|20555416|P2|Phase 2 (Dose-confirmation Phase)|Investigators decision|0
5943082|NCT01323530|20555417|P1|Phase 2 (Dose-confirmation Phase)|Investigators decision|0
5943083|NCT01323530|20555411|P7|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|8
5943084|NCT01323530|20555412|P6|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0
5943085|NCT01323530|20555413|P5|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0
5943086|NCT01323530|20555414|P4|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0
5943087|NCT01323530|20555415|P3|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0
5943088|NCT01323530|20555416|P2|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0
5943089|NCT01323530|20555417|P1|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0
5943090|NCT01323530|20555411|P7|Phase 2 (Dose-confirmation Phase)|Clinical progression|3
5943091|NCT01323530|20555412|P6|Phase 2 (Dose-confirmation Phase)|Clinical progression|0
5943092|NCT01323530|20555413|P5|Phase 2 (Dose-confirmation Phase)|Clinical progression|0
5943093|NCT01323530|20555414|P4|Phase 2 (Dose-confirmation Phase)|Clinical progression|0
5943094|NCT01323530|20555415|P3|Phase 2 (Dose-confirmation Phase)|Clinical progression|0
5943095|NCT01323530|20555416|P2|Phase 2 (Dose-confirmation Phase)|Clinical progression|0
5943096|NCT01323530|20555417|P1|Phase 2 (Dose-confirmation Phase)|Clinical progression|0
5943097|NCT01323530|20555411|P7|Phase 2 (Dose-confirmation Phase)|Adverse Event|2
5943098|NCT01323530|20555412|P6|Phase 2 (Dose-confirmation Phase)|Adverse Event|0
5943099|NCT01323530|20555413|P5|Phase 2 (Dose-confirmation Phase)|Adverse Event|0
5943100|NCT01323530|20555414|P4|Phase 2 (Dose-confirmation Phase)|Adverse Event|0
5943101|NCT01323530|20555415|P3|Phase 2 (Dose-confirmation Phase)|Adverse Event|0
5943102|NCT01323530|20555416|P2|Phase 2 (Dose-confirmation Phase)|Adverse Event|0
5943103|NCT01323530|20555417|P1|Phase 2 (Dose-confirmation Phase)|Adverse Event|0
5943104|NCT01323530|20555411|P7|Phase 1b (Dose Escalation Phase)|Clinical Progression|0
5943105|NCT01323530|20555412|P6|Phase 1b (Dose Escalation Phase)|Clinical Progression|1
5943106|NCT01323530|20555413|P5|Phase 1b (Dose Escalation Phase)|Clinical Progression|1
5943107|NCT01323530|20555414|P4|Phase 1b (Dose Escalation Phase)|Clinical Progression|0
5943108|NCT01323530|20555415|P3|Phase 1b (Dose Escalation Phase)|Clinical Progression|0
5943109|NCT01323530|20555416|P2|Phase 1b (Dose Escalation Phase)|Clinical Progression|1
5943110|NCT01323530|20555417|P1|Phase 1b (Dose Escalation Phase)|Clinical Progression|0
5943111|NCT01323530|20555411|P7|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0
5943112|NCT01323530|20555412|P6|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0
5943113|NCT01323530|20555413|P5|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|2
5943114|NCT01323530|20555414|P4|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0
5943115|NCT01323530|20555415|P3|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1
5943116|NCT01323530|20555416|P2|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1
5943117|NCT01323530|20555417|P1|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1
5943118|NCT01323530|20555411|P7|Phase 1b (Dose Escalation Phase)|Adverse Event|0
5943119|NCT01323530|20555412|P6|Phase 1b (Dose Escalation Phase)|Adverse Event|2
5943120|NCT01323530|20555413|P5|Phase 1b (Dose Escalation Phase)|Adverse Event|0
5943121|NCT01323530|20555414|P4|Phase 1b (Dose Escalation Phase)|Adverse Event|0
5943122|NCT01323530|20555415|P3|Phase 1b (Dose Escalation Phase)|Adverse Event|0
5943123|NCT01323530|20555416|P2|Phase 1b (Dose Escalation Phase)|Adverse Event|0
5943124|NCT01323530|20555417|P1|Phase 1b (Dose Escalation Phase)|Adverse Event|2
5943125|NCT01323478|20555454|P1|Overall Study|Administrative or Other Reasons|8
5943126|NCT01323478|20555454|P1|Overall Study|Withdrawal of Consent|1
5943127|NCT01323478|20555454|P1|Overall Study|Protocol Violation|1
5943128|NCT01323478|20555454|P1|Overall Study|Non-compliance With Study Product|3
5943129|NCT01323478|20555454|P1|Overall Study|Lack of Efficacy|4
5943130|NCT01323478|20555454|P1|Overall Study|Adverse Event|7
5943131|NCT01323387|20555467|P1|Overall Study|Randomized but Never Treated|16
5943132|NCT01323387|20555467|P1|Overall Study|Protocol Violation|12
5943133|NCT01323387|20555467|P1|Overall Study|Revision|14
5943134|NCT01323387|20555467|P1|Overall Study|Radiographic Data Unavailable|1
5943135|NCT01323387|20555467|P1|Overall Study|Withdrawal by Subject|41
5943136|NCT01323270|20555480|P2|Overall Study|Randomized, but not vaccinated|0
5943137|NCT01323270|20555481|P1|Overall Study|Randomized, but not vaccinated|1
5943138|NCT01323270|20555480|P2|Overall Study|Death|0
5943139|NCT01323270|20555481|P1|Overall Study|Death|1
5943140|NCT01323270|20555480|P2|Overall Study|Not eligible|1
5943141|NCT01323270|20555481|P1|Overall Study|Not eligible|1
5943142|NCT01323270|20555480|P2|Overall Study|Physician Decision|2
5943143|NCT01323270|20555481|P1|Overall Study|Physician Decision|0
5943144|NCT01323270|20555480|P2|Overall Study|Other|3
5943145|NCT01323270|20555481|P1|Overall Study|Other|0
5943146|NCT01323270|20555480|P2|Overall Study|Adverse Event|0
5943147|NCT01323270|20555481|P1|Overall Study|Adverse Event|8
5943148|NCT01323270|20555480|P2|Overall Study|Lost to Follow-up|6
5943149|NCT01323270|20555481|P1|Overall Study|Lost to Follow-up|4
5943150|NCT01323270|20555480|P2|Overall Study|Protocol Violation|7
5943151|NCT01323270|20555481|P1|Overall Study|Protocol Violation|9
5943152|NCT01323270|20555480|P2|Overall Study|Withdrawal by Subject|10
5943153|NCT01323270|20555481|P1|Overall Study|Withdrawal by Subject|19
5943154|NCT01323192|20555503|P2|Overall Study|Nonmedical reasons|1
5943155|NCT01323192|20555504|P1|Overall Study|Nonmedical reasons|0
5943156|NCT01323192|20555503|P2|Overall Study|Noncompliance with study medication|3
5943157|NCT01323192|20555504|P1|Overall Study|Noncompliance with study medication|0
5943158|NCT01323192|20555503|P2|Overall Study|Withdrawal by Subject|1
5943159|NCT01323192|20555504|P1|Overall Study|Withdrawal by Subject|3
5943160|NCT01323192|20555503|P2|Overall Study|Adverse Event|1
5943161|NCT01323192|20555504|P1|Overall Study|Adverse Event|6
5943162|NCT01322490|20555753|P3|Long Term Follow-up Period|Unknown/Missing|1
5943163|NCT01322490|20555754|P2|Long Term Follow-up Period|Unknown/Missing|1
5943164|NCT01322490|20555755|P1|Long Term Follow-up Period|Unknown/Missing|0
5943165|NCT01322490|20555753|P3|Long Term Follow-up Period|Other per report|2
5943166|NCT01322490|20555754|P2|Long Term Follow-up Period|Other per report|2
5943167|NCT01322490|20555755|P1|Long Term Follow-up Period|Other per report|3
5943168|NCT01322490|20555753|P3|Long Term Follow-up Period|Study Terminated by Sponsor|165
5943169|NCT01322490|20555754|P2|Long Term Follow-up Period|Study Terminated by Sponsor|158
5943170|NCT01322490|20555755|P1|Long Term Follow-up Period|Study Terminated by Sponsor|160
5943171|NCT01322490|20555753|P3|Long Term Follow-up Period|Withdrawal by Subject|6
5943172|NCT01322490|20555754|P2|Long Term Follow-up Period|Withdrawal by Subject|6
5943173|NCT01322490|20555755|P1|Long Term Follow-up Period|Withdrawal by Subject|9
5943174|NCT01322490|20555753|P3|Long Term Follow-up Period|Lost to Follow-up|3
5943175|NCT01322490|20555754|P2|Long Term Follow-up Period|Lost to Follow-up|2
5943176|NCT01322490|20555755|P1|Long Term Follow-up Period|Lost to Follow-up|2
5943177|NCT01322490|20555753|P3|Long Term Follow-up Period|Death|236
5943178|NCT01322490|20555754|P2|Long Term Follow-up Period|Death|239
5943179|NCT01322490|20555755|P1|Long Term Follow-up Period|Death|235
5943180|NCT01322490|20555753|P3|Treatment Period|Randomized but Not Treated|5
5943181|NCT01322490|20555754|P2|Treatment Period|Randomized but Not Treated|3
5943182|NCT01322490|20555755|P1|Treatment Period|Randomized but Not Treated|3
5943183|NCT01322490|20555753|P3|Treatment Period|Other per report|1
5943184|NCT01322490|20555754|P2|Treatment Period|Other per report|2
5943185|NCT01322490|20555755|P1|Treatment Period|Other per report|2
5943186|NCT01322490|20555753|P3|Treatment Period|Non-compliance with study drug|1
5943187|NCT01322490|20555754|P2|Treatment Period|Non-compliance with study drug|0
5943188|NCT01322490|20555755|P1|Treatment Period|Non-compliance with study drug|0
5943189|NCT01322490|20555753|P3|Treatment Period|Withdrawal by Subject|11
5943190|NCT01322490|20555754|P2|Treatment Period|Withdrawal by Subject|16
5943191|NCT01322490|20555755|P1|Treatment Period|Withdrawal by Subject|14
5943192|NCT01322490|20555753|P3|Treatment Period|Protocol Violation|4
5943193|NCT01322490|20555754|P2|Treatment Period|Protocol Violation|5
5943194|NCT01322490|20555755|P1|Treatment Period|Protocol Violation|7
5943195|NCT01322490|20555753|P3|Treatment Period|Physician Decision|1
5943196|NCT01322490|20555754|P2|Treatment Period|Physician Decision|2
5943197|NCT01322490|20555755|P1|Treatment Period|Physician Decision|0
5943198|NCT01322490|20555753|P3|Treatment Period|Lack of Efficacy|112
5943199|NCT01322490|20555754|P2|Treatment Period|Lack of Efficacy|100
5943200|NCT01322490|20555755|P1|Treatment Period|Lack of Efficacy|89
5943201|NCT01322490|20555753|P3|Treatment Period|Death|3
5943202|NCT01322490|20555754|P2|Treatment Period|Death|7
5943203|NCT01322490|20555755|P1|Treatment Period|Death|5
5943204|NCT01322490|20555753|P3|Treatment Period|Adverse Event|15
5943205|NCT01322490|20555754|P2|Treatment Period|Adverse Event|18
5943206|NCT01322490|20555755|P1|Treatment Period|Adverse Event|12
5943207|NCT01322386|20555768|P2|Overall Study|Physician Decision|1
5943208|NCT01322386|20555769|P1|Overall Study|Physician Decision|0
5943209|NCT01322386|20555768|P2|Overall Study|Protocol Violation|1
5943210|NCT01322386|20555769|P1|Overall Study|Protocol Violation|0
5943211|NCT01322347|20555784|P2|Overall Study|moved/changed dialysis|4
5943212|NCT01322347|20555785|P1|Overall Study|moved/changed dialysis|2
5943213|NCT01322347|20555784|P2|Overall Study|study drug withheld > 12 wks|1
5943214|NCT01322347|20555785|P1|Overall Study|study drug withheld > 12 wks|0
5943215|NCT01322347|20555784|P2|Overall Study|kidney transplant|1
5943216|NCT01322347|20555785|P1|Overall Study|kidney transplant|3
5943217|NCT01322347|20555784|P2|Overall Study|ineligible|3
5943218|NCT01322347|20555785|P1|Overall Study|ineligible|6
5943219|NCT01322347|20555784|P2|Overall Study|sponsor decision|3
5943220|NCT01322347|20555785|P1|Overall Study|sponsor decision|1
5943221|NCT01322347|20555784|P2|Overall Study|blood transfusion|5
5943222|NCT01322347|20555785|P1|Overall Study|blood transfusion|5
5943223|NCT01322347|20555784|P2|Overall Study|non-protocol change to ESA or IV iron|6
5943224|NCT01322347|20555785|P1|Overall Study|non-protocol change to ESA or IV iron|14
5943225|NCT01322347|20555784|P2|Overall Study|Withdrawal by Subject|4
5943226|NCT01322347|20555785|P1|Overall Study|Withdrawal by Subject|1
5943227|NCT01322347|20555784|P2|Overall Study|Protocol Violation|2
5943228|NCT01322347|20555785|P1|Overall Study|Protocol Violation|5
5943229|NCT01322347|20555784|P2|Overall Study|Physician Decision|1
5943230|NCT01322347|20555785|P1|Overall Study|Physician Decision|2
5943231|NCT01322347|20555784|P2|Overall Study|Death|3
5943232|NCT01322347|20555785|P1|Overall Study|Death|5
5943233|NCT01322347|20555784|P2|Overall Study|Adverse Event|2
5943234|NCT01322347|20555785|P1|Overall Study|Adverse Event|7
5943235|NCT01322009|20555848|P2|Overall Study|ng tube discontinued|1
5943236|NCT01322009|20555849|P1|Overall Study|ng tube discontinued|0
5943237|NCT01322009|20555848|P2|Overall Study|Adverse Event|1
5943238|NCT01322009|20555849|P1|Overall Study|Adverse Event|0
5943239|NCT01322009|20555848|P2|Overall Study|Death|1
5943240|NCT01322009|20555849|P1|Overall Study|Death|0
5943241|NCT01321879|20555857|P1|Overall Study|Withdrawal by Subject|1
5943242|NCT01321879|20555857|P1|Overall Study|Death|3
5943243|NCT01321879|20555857|P1|Overall Study|Adverse Event|5
5943244|NCT01321879|20555857|P1|Overall Study|Lack of Efficacy|5
5943245|NCT01321749|20555863|P2|Overall Study|Withdrawal by Subject|4
5943246|NCT01321749|20555864|P1|Overall Study|Withdrawal by Subject|5
5943247|NCT01321749|20555863|P2|Overall Study|Protocol Violation|7
5943248|NCT01321749|20555864|P1|Overall Study|Protocol Violation|4
5943249|NCT01321749|20555863|P2|Overall Study|Lost to Follow-up|11
5943250|NCT01321749|20555864|P1|Overall Study|Lost to Follow-up|4
5943251|NCT01321723|20555873|P3|Overall Study|Withdrawal by Subject|2
5943252|NCT01321723|20555874|P2|Overall Study|Withdrawal by Subject|0
5943253|NCT01321723|20555875|P1|Overall Study|Withdrawal by Subject|2
5943254|NCT01321723|20555873|P3|Overall Study|Adverse Event|2
5943255|NCT01321723|20555874|P2|Overall Study|Adverse Event|5
5943256|NCT01321723|20555875|P1|Overall Study|Adverse Event|3
5943257|NCT01321710|20555897|P3|Overall Study|Lost to Follow-up|0
5943258|NCT01321710|20555898|P2|Overall Study|Lost to Follow-up|5
5943259|NCT01321710|20555899|P1|Overall Study|Lost to Follow-up|4
5943260|NCT01321697|20555914|P1|Overall Study|Study Terminated|7
5943261|NCT01321606|20555920|P4|Overall Study|Lost to Follow-up|1
5943262|NCT01321606|20555921|P3|Overall Study|Lost to Follow-up|0
5943263|NCT01321606|20555922|P2|Overall Study|Lost to Follow-up|0
5943264|NCT01321606|20555923|P1|Overall Study|Lost to Follow-up|0
5943265|NCT01321073|20555967|P1|Overall Study|Death|3
5943266|NCT01321073|20555967|P1|Overall Study|Did not attempt implant|4
5943267|NCT01321008|20555971|P1|Overall Study|Early Study Termination|1
5943268|NCT01320943|20555977|P2|Overall Study|Randomized but not Treated|1
5943269|NCT01320943|20555978|P1|Overall Study|Randomized but not Treated|0
5943270|NCT01320943|20555977|P2|Overall Study|Physician Decision|1
5943271|NCT01320943|20555978|P1|Overall Study|Physician Decision|0
5943272|NCT01320943|20555977|P2|Overall Study|Lost to Follow-up|0
5943273|NCT01320943|20555978|P1|Overall Study|Lost to Follow-up|1
5943274|NCT01320735|20556012|P1|Overall Study|Investigator Unable to be Contacted|17
5943275|NCT01320735|20556012|P1|Overall Study|No Decrease of Prostate Specific Antigen|7
5943276|NCT01320735|20556012|P1|Overall Study|Other|1
5943277|NCT01320735|20556012|P1|Overall Study|Protocol Violation|1
5943278|NCT01320735|20556012|P1|Overall Study|Progression/Hormone-Refractory Pca|55
5943279|NCT01320735|20556012|P1|Overall Study|Administrative Reason|6
5943280|NCT01320735|20556012|P1|Overall Study|Lost to Follow-up|13
5943281|NCT01320735|20556012|P1|Overall Study|Withdrawal by Subject|3
5943282|NCT01320735|20556012|P1|Overall Study|Adverse Event|3
5943283|NCT01320722|20556034|P5|Overall Study|Withdrew due to Health Condition|1
5943284|NCT01320722|20556035|P4|Overall Study|Withdrew due to Health Condition|0
5943285|NCT01320722|20556036|P3|Overall Study|Withdrew due to Health Condition|0
5943286|NCT01320722|20556037|P2|Overall Study|Withdrew due to Health Condition|0
5943287|NCT01320722|20556038|P1|Overall Study|Withdrew due to Health Condition|0
5943288|NCT01320722|20556034|P5|Overall Study|Started an Exclusionary Medication|1
5943289|NCT01320722|20556035|P4|Overall Study|Started an Exclusionary Medication|0
5943290|NCT01320722|20556036|P3|Overall Study|Started an Exclusionary Medication|0
5943291|NCT01320722|20556037|P2|Overall Study|Started an Exclusionary Medication|0
5943292|NCT01320722|20556038|P1|Overall Study|Started an Exclusionary Medication|0
5943293|NCT01320722|20556034|P5|Overall Study|Pregnancy|0
5943294|NCT01320722|20556035|P4|Overall Study|Pregnancy|1
5943295|NCT01320722|20556036|P3|Overall Study|Pregnancy|0
5943296|NCT01320722|20556037|P2|Overall Study|Pregnancy|0
5943297|NCT01320722|20556038|P1|Overall Study|Pregnancy|0
5943298|NCT01320722|20556034|P5|Overall Study|Not Compliant with Study Procedures|0
5943299|NCT01320722|20556035|P4|Overall Study|Not Compliant with Study Procedures|4
5943300|NCT01320722|20556036|P3|Overall Study|Not Compliant with Study Procedures|0
5943301|NCT01320722|20556037|P2|Overall Study|Not Compliant with Study Procedures|0
5943302|NCT01320722|20556038|P1|Overall Study|Not Compliant with Study Procedures|0
5943303|NCT01320722|20556034|P5|Overall Study|Adverse Event|0
5943304|NCT01320722|20556035|P4|Overall Study|Adverse Event|6
5943305|NCT01320722|20556036|P3|Overall Study|Adverse Event|3
5943306|NCT01320722|20556037|P2|Overall Study|Adverse Event|0
5943307|NCT01320722|20556038|P1|Overall Study|Adverse Event|0
5943308|NCT01320722|20556034|P5|Overall Study|Non-compliant with Medication|0
5943309|NCT01320722|20556035|P4|Overall Study|Non-compliant with Medication|0
5943310|NCT01320722|20556036|P3|Overall Study|Non-compliant with Medication|1
5943311|NCT01320722|20556037|P2|Overall Study|Non-compliant with Medication|0
5943312|NCT01320722|20556038|P1|Overall Study|Non-compliant with Medication|0
5943313|NCT01320722|20556034|P5|Overall Study|Participant Developed a Rash|1
5943314|NCT01320722|20556035|P4|Overall Study|Participant Developed a Rash|1
5943315|NCT01320722|20556036|P3|Overall Study|Participant Developed a Rash|2
5943316|NCT01320722|20556037|P2|Overall Study|Participant Developed a Rash|0
5943317|NCT01320722|20556038|P1|Overall Study|Participant Developed a Rash|0
5943318|NCT01320722|20556034|P5|Overall Study|Not Available for the 8 Week Visit|0
5943319|NCT01320722|20556035|P4|Overall Study|Not Available for the 8 Week Visit|0
5943320|NCT01320722|20556036|P3|Overall Study|Not Available for the 8 Week Visit|0
5943321|NCT01320722|20556037|P2|Overall Study|Not Available for the 8 Week Visit|3
5943322|NCT01320722|20556038|P1|Overall Study|Not Available for the 8 Week Visit|0
5943323|NCT01320722|20556034|P5|Overall Study|Lost to Follow-up|3
5943324|NCT01320722|20556035|P4|Overall Study|Lost to Follow-up|1
5943325|NCT01320722|20556036|P3|Overall Study|Lost to Follow-up|0
5943326|NCT01320722|20556037|P2|Overall Study|Lost to Follow-up|1
5943327|NCT01320722|20556038|P1|Overall Study|Lost to Follow-up|0
5943328|NCT01320722|20556034|P5|Overall Study|Did not Receive Intervention|2
5943329|NCT01320722|20556035|P4|Overall Study|Did not Receive Intervention|1
5943330|NCT01320722|20556036|P3|Overall Study|Did not Receive Intervention|1
5943331|NCT01320722|20556037|P2|Overall Study|Did not Receive Intervention|2
5943332|NCT01320722|20556038|P1|Overall Study|Did not Receive Intervention|3
5943333|NCT01320683|20556075|P1|Overall Study|Positive antibody response|1
5943334|NCT01320293|20556101|P1|Overall Study|Adverse Event|1
5943335|NCT01320293|20556101|P1|Overall Study|Lack of Efficacy|1
5943336|NCT01320202|20556109|P2|Overall Study|regained renal function|0
5943337|NCT01320202|20556110|P1|Overall Study|regained renal function|1
5943338|NCT01320202|20556109|P2|Overall Study|ineligible|0
5943339|NCT01320202|20556110|P1|Overall Study|ineligible|3
5943340|NCT01320202|20556109|P2|Overall Study|sponsor request|0
5943341|NCT01320202|20556110|P1|Overall Study|sponsor request|2
5943342|NCT01320202|20556109|P2|Overall Study|moved/changed dialysis|2
5943343|NCT01320202|20556110|P1|Overall Study|moved/changed dialysis|5
5943344|NCT01320202|20556109|P2|Overall Study|blood transfusion|7
5943345|NCT01320202|20556110|P1|Overall Study|blood transfusion|1
5943346|NCT01320202|20556109|P2|Overall Study|kidney transplant|2
5943347|NCT01320202|20556110|P1|Overall Study|kidney transplant|1
5943348|NCT01320202|20556109|P2|Overall Study|non-protocol change to ESA or IV iron|20
5943349|NCT01320202|20556110|P1|Overall Study|non-protocol change to ESA or IV iron|17
5943350|NCT01320202|20556109|P2|Overall Study|Withdrawal by Subject|3
5943351|NCT01320202|20556110|P1|Overall Study|Withdrawal by Subject|10
5943352|NCT01320202|20556109|P2|Overall Study|Protocol Violation|1
5943353|NCT01320202|20556110|P1|Overall Study|Protocol Violation|2
5943354|NCT01320202|20556109|P2|Overall Study|Physician Decision|1
5943355|NCT01320202|20556110|P1|Overall Study|Physician Decision|3
5943356|NCT01320202|20556109|P2|Overall Study|Lost to Follow-up|0
5943357|NCT01320202|20556110|P1|Overall Study|Lost to Follow-up|1
5943358|NCT01320202|20556109|P2|Overall Study|Death|3
5943359|NCT01320202|20556110|P1|Overall Study|Death|5
5943360|NCT01320202|20556109|P2|Overall Study|Adverse Event|5
5943361|NCT01320202|20556110|P1|Overall Study|Adverse Event|5
5943362|NCT01320150|20556147|P1|Overall Study|Lost to Follow-up|44
5943363|NCT01320150|20556147|P1|Overall Study|Death|2
5943364|NCT01320150|20556147|P1|Overall Study|Withdrawal by Subject|5
5943365|NCT01320150|20556147|P1|Overall Study|Protocol Violation|15
5943366|NCT01320085|20556169|P3|Overall Study|Protocol Deviation|1
5943367|NCT01320085|20556170|P2|Overall Study|Protocol Deviation|0
5943368|NCT01320085|20556171|P1|Overall Study|Protocol Deviation|1
5943369|NCT01320085|20556169|P3|Overall Study|Withdrawal by Subject|1
5943370|NCT01320085|20556170|P2|Overall Study|Withdrawal by Subject|4
5943371|NCT01320085|20556171|P1|Overall Study|Withdrawal by Subject|2
5943372|NCT01320085|20556169|P3|Overall Study|Adverse Event|5
5943373|NCT01320085|20556170|P2|Overall Study|Adverse Event|14
5943374|NCT01320085|20556171|P1|Overall Study|Adverse Event|12
5943375|NCT01320085|20556169|P3|Overall Study|Disease Progression|16
5943376|NCT01320085|20556170|P2|Overall Study|Disease Progression|86
5943377|NCT01320085|20556171|P1|Overall Study|Disease Progression|26
5943378|NCT01320085|20556169|P3|Overall Study|Treatment Ongoing|2
5943379|NCT01320085|20556170|P2|Overall Study|Treatment Ongoing|13
5943380|NCT01320085|20556171|P1|Overall Study|Treatment Ongoing|0
5943399|NCT01319994|20556311|P2|Overall Study|Protocol Violation|6
5943400|NCT01319994|20556312|P1|Overall Study|Protocol Violation|7
5943401|NCT01319929|20556322|P2|Second Treatment Period (4 Weeks)|Sponsor Decision|1
5943402|NCT01319929|20556323|P1|Second Treatment Period (4 Weeks)|Sponsor Decision|0
5943403|NCT01319929|20556322|P2|Second Treatment Period (4 Weeks)|Adverse Event|0
5943404|NCT01319929|20556323|P1|Second Treatment Period (4 Weeks)|Adverse Event|1
5943405|NCT01319929|20556322|P2|First Treatment Period (4 Weeks)|Protocol Violation|1
5943406|NCT01319929|20556323|P1|First Treatment Period (4 Weeks)|Protocol Violation|0
5943407|NCT01319929|20556322|P2|First Treatment Period (4 Weeks)|Withdrawal by Subject|1
5943408|NCT01319929|20556323|P1|First Treatment Period (4 Weeks)|Withdrawal by Subject|1
5943409|NCT01319929|20556322|P2|First Treatment Period (4 Weeks)|Adverse Event|0
5943410|NCT01319929|20556323|P1|First Treatment Period (4 Weeks)|Adverse Event|2
5943411|NCT01319877|20556355|P2|Overall Study|Reason Not Specified|5
5943412|NCT01319877|20556356|P1|Overall Study|Reason Not Specified|4
5943413|NCT01319877|20556355|P2|Overall Study|Withdrawal by Subject|1
5943414|NCT01319877|20556356|P1|Overall Study|Withdrawal by Subject|0
5943415|NCT01319877|20556355|P2|Overall Study|Disease Progression|2
5943416|NCT01319877|20556356|P1|Overall Study|Disease Progression|2
5943417|NCT01319877|20556355|P2|Overall Study|Physician Decision|0
5943418|NCT01319877|20556356|P1|Overall Study|Physician Decision|2
5943419|NCT01319877|20556355|P2|Overall Study|Lost to Follow-up|37
5943420|NCT01319877|20556356|P1|Overall Study|Lost to Follow-up|100
5943421|NCT01319721|20556524|P2|Overall Study|Lost to Follow-up|6
5943422|NCT01319721|20556525|P1|Overall Study|Lost to Follow-up|1
5943423|NCT01319422|20556578|P2|Overall Study|Withdrawal by Subject|0
5943424|NCT01319422|20556579|P1|Overall Study|Withdrawal by Subject|1
5943425|NCT01319383|20556597|P2|Overall Study|No in vivo response to interval doses|1
5943426|NCT01319383|20556598|P1|Overall Study|No in vivo response to interval doses|0
5943427|NCT01319383|20556597|P2|Overall Study|Lack of Efficacy|9
5943428|NCT01319383|20556598|P1|Overall Study|Lack of Efficacy|5
5943429|NCT01319383|20556597|P2|Overall Study|Physician Decision|0
5943430|NCT01319383|20556598|P1|Overall Study|Physician Decision|3
5943431|NCT01319383|20556597|P2|Overall Study|No ex vivo or in vivo response|0
5943432|NCT01319383|20556598|P1|Overall Study|No ex vivo or in vivo response|4
5943433|NCT01318993|20556637|P1|Overall Study|Withdrawal by Subject|24
5943434|NCT01318993|20556637|P1|Overall Study|Physician Decision|13
5943435|NCT01318993|20556637|P1|Overall Study|Lost to Follow-up|4
5943436|NCT01318993|20556637|P1|Overall Study|Study closed or terminated|174
5943437|NCT01318993|20556637|P1|Overall Study|Protocol based stopping criteria|6
5943438|NCT01318993|20556637|P1|Overall Study|Protocol Violation|3
5943439|NCT01318993|20556637|P1|Overall Study|Lack of Efficacy|121
5943440|NCT01318993|20556637|P1|Overall Study|Adverse Event|53
5943441|NCT01318915|20556658|P1|Overall Study|Lost to Follow-up|1
5943442|NCT01318902|20556687|P4|Overall Study|Terminated by Sponsor|0
5943443|NCT01318902|20556688|P3|Overall Study|Terminated by Sponsor|1
5943444|NCT01318902|20556689|P2|Overall Study|Terminated by Sponsor|0
5943445|NCT01318902|20556690|P1|Overall Study|Terminated by Sponsor|0
5943446|NCT01318902|20556687|P4|Overall Study|Adverse Event|0
5943447|NCT01318902|20556688|P3|Overall Study|Adverse Event|0
5943448|NCT01318902|20556689|P2|Overall Study|Adverse Event|1
5943449|NCT01318902|20556690|P1|Overall Study|Adverse Event|0
5943450|NCT01318902|20556687|P4|Overall Study|Unsatisfactory Therapeutic Response|1
5943451|NCT01318902|20556688|P3|Overall Study|Unsatisfactory Therapeutic Response|0
5943452|NCT01318902|20556689|P2|Overall Study|Unsatisfactory Therapeutic Response|0
5943453|NCT01318902|20556690|P1|Overall Study|Unsatisfactory Therapeutic Response|1
5943454|NCT01318902|20556687|P4|Overall Study|Withdrawal by Patient|3
5943455|NCT01318902|20556688|P3|Overall Study|Withdrawal by Patient|0
5943456|NCT01318902|20556689|P2|Overall Study|Withdrawal by Patient|1
5943457|NCT01318902|20556690|P1|Overall Study|Withdrawal by Patient|0
5943458|NCT01318902|20556687|P4|Overall Study|Symptomatic Deterioration|2
5943459|NCT01318902|20556688|P3|Overall Study|Symptomatic Deterioration|1
5943460|NCT01318902|20556689|P2|Overall Study|Symptomatic Deterioration|1
5943461|NCT01318902|20556690|P1|Overall Study|Symptomatic Deterioration|0
5943462|NCT01318876|20556767|P1|Day 29 Survey|survey not completed-don't know why|1825
5943463|NCT01318876|20556767|P1|Day 8 Survey|survey not completed-don't know why|1724
5943464|NCT01318876|20556767|P1|Day 8 Survey|email address invalid|96
5943465|NCT01318811|20556774|P2|Overall Study|CRRT stopped for head MRI|1
5943466|NCT01318811|20556775|P1|Overall Study|CRRT stopped for head MRI|0
5943467|NCT01318811|20556774|P2|Overall Study|Death|1
5943468|NCT01318811|20556775|P1|Overall Study|Death|0
5943469|NCT01318811|20556774|P2|Overall Study|CRRT stopped for head CT|1
5943470|NCT01318811|20556775|P1|Overall Study|CRRT stopped for head CT|0
5943471|NCT01318811|20556774|P2|Overall Study|Physician Decision|1
5943472|NCT01318811|20556775|P1|Overall Study|Physician Decision|1
5943473|NCT01318512|20556885|P1|Maintenance Period (6 Months)|Protocol Violation|9
5943474|NCT01318512|20556885|P1|Maintenance Period (6 Months)|Death|2
5943475|NCT01318499|20556904|P3|Overall Study|Other|22
5943476|NCT01318499|20556905|P2|Overall Study|Other|10
5943477|NCT01318499|20556906|P1|Overall Study|Other|7
5943478|NCT01318499|20556904|P3|Overall Study|Patient Did Not Use Study Medication|14
5943479|NCT01318499|20556905|P2|Overall Study|Patient Did Not Use Study Medication|28
5943480|NCT01318499|20556906|P1|Overall Study|Patient Did Not Use Study Medication|18
5943481|NCT01318499|20556904|P3|Overall Study|Protocol Violation|2
5943482|NCT01318499|20556905|P2|Overall Study|Protocol Violation|4
5943483|NCT01318499|20556906|P1|Overall Study|Protocol Violation|2
5943484|NCT01318499|20556904|P3|Overall Study|Treatment Failure|101
5943485|NCT01318499|20556905|P2|Overall Study|Treatment Failure|19
5943486|NCT01318499|20556906|P1|Overall Study|Treatment Failure|19
5943487|NCT01318499|20556904|P3|Overall Study|Noncompliance|0
5943488|NCT01318499|20556905|P2|Overall Study|Noncompliance|3
5943489|NCT01318499|20556906|P1|Overall Study|Noncompliance|2
5943490|NCT01318499|20556904|P3|Overall Study|Pt Decision Unrelated to Adverse Event|2
5943491|NCT01318499|20556905|P2|Overall Study|Pt Decision Unrelated to Adverse Event|1
5943492|NCT01318499|20556906|P1|Overall Study|Pt Decision Unrelated to Adverse Event|1
5943493|NCT01318499|20556904|P3|Overall Study|Adverse Event|6
5943494|NCT01318499|20556905|P2|Overall Study|Adverse Event|11
5943495|NCT01318499|20556906|P1|Overall Study|Adverse Event|16
5943496|NCT01318382|20556929|P1|Overall Study|Protocol Violation|1
5943497|NCT01318382|20556929|P1|Overall Study|Device Malfunction|10
5943498|NCT01318382|20556929|P1|Overall Study|Physician Decision|2
5943499|NCT01318135|20556987|P8|Entered - Long-Term Extension Study|Use of Excluded Medications|1
5943500|NCT01318135|20556988|P7|Entered - Long-Term Extension Study|Use of Excluded Medications|0
5943501|NCT01318135|20556989|P6|Entered - Long-Term Extension Study|Use of Excluded Medications|0
5943502|NCT01318135|20556990|P5|Entered - Long-Term Extension Study|Use of Excluded Medications|0
5943503|NCT01318135|20556991|P4|Entered - Long-Term Extension Study|Use of Excluded Medications|0
5943504|NCT01318135|20556992|P3|Entered - Long-Term Extension Study|Use of Excluded Medications|0
5943505|NCT01318135|20556993|P2|Entered - Long-Term Extension Study|Use of Excluded Medications|0
5943506|NCT01318135|20556994|P1|Entered - Long-Term Extension Study|Use of Excluded Medications|0
5943507|NCT01318135|20556987|P8|Entered - Long-Term Extension Study|Lack of Efficacy|1
5943508|NCT01318135|20556988|P7|Entered - Long-Term Extension Study|Lack of Efficacy|1
5943509|NCT01318135|20556989|P6|Entered - Long-Term Extension Study|Lack of Efficacy|2
5943510|NCT01318135|20556990|P5|Entered - Long-Term Extension Study|Lack of Efficacy|2
5943511|NCT01318135|20556991|P4|Entered - Long-Term Extension Study|Lack of Efficacy|3
5943512|NCT01318135|20556992|P3|Entered - Long-Term Extension Study|Lack of Efficacy|2
5943513|NCT01318135|20556993|P2|Entered - Long-Term Extension Study|Lack of Efficacy|7
5943514|NCT01318135|20556994|P1|Entered - Long-Term Extension Study|Lack of Efficacy|5
5943515|NCT01318135|20556987|P8|Entered - Long-Term Extension Study|Withdrawal by Subject|1
5943516|NCT01318135|20556988|P7|Entered - Long-Term Extension Study|Withdrawal by Subject|0
5943517|NCT01318135|20556989|P6|Entered - Long-Term Extension Study|Withdrawal by Subject|0
5943518|NCT01318135|20556990|P5|Entered - Long-Term Extension Study|Withdrawal by Subject|2
5943519|NCT01318135|20556991|P4|Entered - Long-Term Extension Study|Withdrawal by Subject|1
5943520|NCT01318135|20556992|P3|Entered - Long-Term Extension Study|Withdrawal by Subject|2
5943521|NCT01318135|20556993|P2|Entered - Long-Term Extension Study|Withdrawal by Subject|2
5943522|NCT01318135|20556994|P1|Entered - Long-Term Extension Study|Withdrawal by Subject|2
5943523|NCT01318135|20556987|P8|Entered - Long-Term Extension Study|Protocol Violation|0
5943524|NCT01318135|20556988|P7|Entered - Long-Term Extension Study|Protocol Violation|0
5943525|NCT01318135|20556989|P6|Entered - Long-Term Extension Study|Protocol Violation|0
5943526|NCT01318135|20556990|P5|Entered - Long-Term Extension Study|Protocol Violation|1
5943527|NCT01318135|20556991|P4|Entered - Long-Term Extension Study|Protocol Violation|0
5943528|NCT01318135|20556992|P3|Entered - Long-Term Extension Study|Protocol Violation|0
5943529|NCT01318135|20556993|P2|Entered - Long-Term Extension Study|Protocol Violation|1
5943530|NCT01318135|20556994|P1|Entered - Long-Term Extension Study|Protocol Violation|1
5943531|NCT01318135|20556987|P8|Entered - Long-Term Extension Study|Adverse Event|0
5943532|NCT01318135|20556988|P7|Entered - Long-Term Extension Study|Adverse Event|0
5943533|NCT01318135|20556989|P6|Entered - Long-Term Extension Study|Adverse Event|2
5943534|NCT01318135|20556990|P5|Entered - Long-Term Extension Study|Adverse Event|4
5943535|NCT01318135|20556991|P4|Entered - Long-Term Extension Study|Adverse Event|3
5943536|NCT01318135|20556992|P3|Entered - Long-Term Extension Study|Adverse Event|4
5943537|NCT01318135|20556993|P2|Entered - Long-Term Extension Study|Adverse Event|3
5943538|NCT01318135|20556994|P1|Entered - Long-Term Extension Study|Adverse Event|9
5943539|NCT01318135|20556987|P8|Enrolled - Long-Term Extension Study|Treatment Complications|0
5943540|NCT01318135|20556988|P7|Enrolled - Long-Term Extension Study|Treatment Complications|0
5943541|NCT01318135|20556989|P6|Enrolled - Long-Term Extension Study|Treatment Complications|0
5943542|NCT01318135|20556990|P5|Enrolled - Long-Term Extension Study|Treatment Complications|0
5943543|NCT01318135|20556991|P4|Enrolled - Long-Term Extension Study|Treatment Complications|0
5943544|NCT01318135|20556992|P3|Enrolled - Long-Term Extension Study|Treatment Complications|0
5943545|NCT01318135|20556993|P2|Enrolled - Long-Term Extension Study|Treatment Complications|0
5943546|NCT01318135|20556994|P1|Enrolled - Long-Term Extension Study|Treatment Complications|1
5943547|NCT01318135|20556987|P8|Enrolled - Long-Term Extension Study|Adverse Event|0
5943548|NCT01318135|20556988|P7|Enrolled - Long-Term Extension Study|Adverse Event|0
5943549|NCT01318135|20556989|P6|Enrolled - Long-Term Extension Study|Adverse Event|0
5943550|NCT01318135|20556990|P5|Enrolled - Long-Term Extension Study|Adverse Event|0
5943551|NCT01318135|20556991|P4|Enrolled - Long-Term Extension Study|Adverse Event|0
5943552|NCT01318135|20556992|P3|Enrolled - Long-Term Extension Study|Adverse Event|0
5943553|NCT01318135|20556993|P2|Enrolled - Long-Term Extension Study|Adverse Event|0
5943554|NCT01318135|20556994|P1|Enrolled - Long-Term Extension Study|Adverse Event|1
5943555|NCT01318122|20557126|P4|Entered - Long-Term Extension Study|Lack of Efficacy|0
5943556|NCT01318122|20557127|P3|Entered - Long-Term Extension Study|Lack of Efficacy|3
5943557|NCT01318122|20557128|P2|Entered - Long-Term Extension Study|Lack of Efficacy|2
5943558|NCT01318122|20557129|P1|Entered - Long-Term Extension Study|Lack of Efficacy|0
5943559|NCT01318122|20557126|P4|Entered - Long-Term Extension Study|Withdrawal by Subject|0
5943560|NCT01318122|20557127|P3|Entered - Long-Term Extension Study|Withdrawal by Subject|1
5943561|NCT01318122|20557128|P2|Entered - Long-Term Extension Study|Withdrawal by Subject|3
5943562|NCT01318122|20557129|P1|Entered - Long-Term Extension Study|Withdrawal by Subject|2
5943563|NCT01318122|20557126|P4|Entered - Long-Term Extension Study|Lost to Follow-up|0
5943564|NCT01318122|20557127|P3|Entered - Long-Term Extension Study|Lost to Follow-up|0
5943565|NCT01318122|20557128|P2|Entered - Long-Term Extension Study|Lost to Follow-up|0
5943566|NCT01318122|20557129|P1|Entered - Long-Term Extension Study|Lost to Follow-up|1
5943567|NCT01318122|20557126|P4|Entered - Long-Term Extension Study|Adverse Event|4
5943568|NCT01318122|20557127|P3|Entered - Long-Term Extension Study|Adverse Event|2
5943569|NCT01318122|20557128|P2|Entered - Long-Term Extension Study|Adverse Event|6
5943570|NCT01318122|20557129|P1|Entered - Long-Term Extension Study|Adverse Event|6
5943571|NCT01318122|20557126|P4|Enrolled - Long-Term Extension Study|Other|0
5943572|NCT01318122|20557127|P3|Enrolled - Long-Term Extension Study|Other|0
5943573|NCT01318122|20557128|P2|Enrolled - Long-Term Extension Study|Other|0
5943574|NCT01318122|20557129|P1|Enrolled - Long-Term Extension Study|Other|1
5943575|NCT01318122|20557126|P4|Enrolled - Long-Term Extension Study|Adverse Event|1
5943576|NCT01318122|20557127|P3|Enrolled - Long-Term Extension Study|Adverse Event|2
5943577|NCT01318122|20557128|P2|Enrolled - Long-Term Extension Study|Adverse Event|0
5943578|NCT01318122|20557129|P1|Enrolled - Long-Term Extension Study|Adverse Event|0
5943579|NCT01318109|20557198|P3|Overall Study|Schedule Conflict|0
5943580|NCT01318109|20557199|P2|Overall Study|Schedule Conflict|1
5943581|NCT01318109|20557200|P1|Overall Study|Schedule Conflict|0
5943582|NCT01318109|20557198|P3|Overall Study|Withdrawal by Subject|0
5943583|NCT01318109|20557199|P2|Overall Study|Withdrawal by Subject|0
5943584|NCT01318109|20557200|P1|Overall Study|Withdrawal by Subject|1
5943585|NCT01318109|20557198|P3|Overall Study|Adverse Event|0
5943586|NCT01318109|20557199|P2|Overall Study|Adverse Event|2
5943587|NCT01318109|20557200|P1|Overall Study|Adverse Event|0
5943588|NCT01318083|20557235|P3|Overall Study|Lack of Study Medication Compliance|0
5943589|NCT01318083|20557236|P2|Overall Study|Lack of Study Medication Compliance|1
5943590|NCT01318083|20557237|P1|Overall Study|Lack of Study Medication Compliance|0
5943591|NCT01318083|20557235|P3|Overall Study|Treatment Complications|0
5943592|NCT01318083|20557236|P2|Overall Study|Treatment Complications|0
5943593|NCT01318083|20557237|P1|Overall Study|Treatment Complications|1
5943594|NCT01318083|20557235|P3|Overall Study|Lack of Efficacy|1
5943595|NCT01318083|20557236|P2|Overall Study|Lack of Efficacy|0
5943596|NCT01318083|20557237|P1|Overall Study|Lack of Efficacy|0
5943597|NCT01318083|20557235|P3|Overall Study|Withdrawal by Subject|2
5943598|NCT01318083|20557236|P2|Overall Study|Withdrawal by Subject|0
5943599|NCT01318083|20557237|P1|Overall Study|Withdrawal by Subject|1
5943600|NCT01318083|20557235|P3|Overall Study|Adverse Event|2
5943601|NCT01318083|20557236|P2|Overall Study|Adverse Event|1
5943602|NCT01318083|20557237|P1|Overall Study|Adverse Event|4
5943603|NCT01318070|20557272|P3|Overall Study|Principal Investigator Discretion|0
5943604|NCT01318070|20557273|P2|Overall Study|Principal Investigator Discretion|0
5943605|NCT01318070|20557274|P1|Overall Study|Principal Investigator Discretion|1
5943606|NCT01318070|20557272|P3|Overall Study|Lack of Efficacy|1
5943607|NCT01318070|20557273|P2|Overall Study|Lack of Efficacy|0
5943608|NCT01318070|20557274|P1|Overall Study|Lack of Efficacy|0
5943609|NCT01318070|20557272|P3|Overall Study|Withdrawal by Subject|1
5943610|NCT01318070|20557273|P2|Overall Study|Withdrawal by Subject|1
5943611|NCT01318070|20557274|P1|Overall Study|Withdrawal by Subject|0
5943612|NCT01318070|20557272|P3|Overall Study|Adverse Event|5
5943613|NCT01318070|20557273|P2|Overall Study|Adverse Event|1
5943614|NCT01318070|20557274|P1|Overall Study|Adverse Event|1
5943615|NCT01317940|20557321|P6|Overall Study|Change in therapy plan|0
5943616|NCT01317940|20557322|P5|Overall Study|Change in therapy plan|0
5943617|NCT01317940|20557323|P4|Overall Study|Change in therapy plan|0
5943618|NCT01317940|20557324|P3|Overall Study|Change in therapy plan|3
5943619|NCT01317940|20557325|P2|Overall Study|Change in therapy plan|0
5943620|NCT01317940|20557326|P1|Overall Study|Change in therapy plan|0
5943621|NCT01317940|20557321|P6|Overall Study|Lost to Follow-up|0
5943622|NCT01317940|20557322|P5|Overall Study|Lost to Follow-up|1
5943623|NCT01317940|20557323|P4|Overall Study|Lost to Follow-up|1
5943624|NCT01317940|20557324|P3|Overall Study|Lost to Follow-up|1
5943625|NCT01317940|20557325|P2|Overall Study|Lost to Follow-up|0
5943626|NCT01317940|20557326|P1|Overall Study|Lost to Follow-up|0
5943627|NCT01317940|20557321|P6|Overall Study|Death|0
5943628|NCT01317940|20557322|P5|Overall Study|Death|0
5943629|NCT01317940|20557323|P4|Overall Study|Death|0
5943630|NCT01317940|20557324|P3|Overall Study|Death|1
5943631|NCT01317940|20557325|P2|Overall Study|Death|0
5943632|NCT01317940|20557326|P1|Overall Study|Death|1
5943633|NCT01317797|20557357|P3|Overall Study|Withdrawal of Patient|1
5943634|NCT01317797|20557358|P2|Overall Study|Withdrawal of Patient|0
5943635|NCT01317797|20557359|P1|Overall Study|Withdrawal of Patient|0
5943636|NCT01317797|20557357|P3|Overall Study|Other|0
5943637|NCT01317797|20557358|P2|Overall Study|Other|1
5943638|NCT01317797|20557359|P1|Overall Study|Other|0
5943639|NCT01317641|20557436|P9|Overall Study|Withdrawal by Subject|0
5943640|NCT01317641|20557437|P8|Overall Study|Withdrawal by Subject|0
5943641|NCT01317641|20557438|P7|Overall Study|Withdrawal by Subject|1
5943642|NCT01317641|20557439|P6|Overall Study|Withdrawal by Subject|0
5943643|NCT01317641|20557440|P5|Overall Study|Withdrawal by Subject|0
5943644|NCT01317641|20557441|P4|Overall Study|Withdrawal by Subject|0
5943645|NCT01317641|20557442|P3|Overall Study|Withdrawal by Subject|0
5943646|NCT01317641|20557443|P2|Overall Study|Withdrawal by Subject|0
5943647|NCT01317641|20557444|P1|Overall Study|Withdrawal by Subject|0
5943648|NCT01317641|20557436|P9|Overall Study|Disease progression|4
5943649|NCT01317641|20557437|P8|Overall Study|Disease progression|3
5943650|NCT01317641|20557438|P7|Overall Study|Disease progression|0
5943651|NCT01317641|20557439|P6|Overall Study|Disease progression|0
5943652|NCT01317641|20557440|P5|Overall Study|Disease progression|0
5943653|NCT01317641|20557441|P4|Overall Study|Disease progression|0
5943654|NCT01317641|20557442|P3|Overall Study|Disease progression|0
5943655|NCT01317641|20557443|P2|Overall Study|Disease progression|0
5943656|NCT01317641|20557444|P1|Overall Study|Disease progression|0
5943657|NCT01317641|20557436|P9|Overall Study|Protocol Violation|0
5943658|NCT01317641|20557437|P8|Overall Study|Protocol Violation|0
5943659|NCT01317641|20557438|P7|Overall Study|Protocol Violation|0
5943660|NCT01317641|20557439|P6|Overall Study|Protocol Violation|0
5943661|NCT01317641|20557440|P5|Overall Study|Protocol Violation|0
5943662|NCT01317641|20557441|P4|Overall Study|Protocol Violation|0
5943663|NCT01317641|20557442|P3|Overall Study|Protocol Violation|0
5943664|NCT01317641|20557443|P2|Overall Study|Protocol Violation|0
5943665|NCT01317641|20557444|P1|Overall Study|Protocol Violation|1
5943666|NCT01317641|20557436|P9|Overall Study|Adverse Event|0
5943667|NCT01317641|20557437|P8|Overall Study|Adverse Event|1
5943668|NCT01317641|20557438|P7|Overall Study|Adverse Event|2
5943669|NCT01317641|20557439|P6|Overall Study|Adverse Event|0
5943670|NCT01317641|20557440|P5|Overall Study|Adverse Event|0
5943671|NCT01317641|20557441|P4|Overall Study|Adverse Event|1
5943672|NCT01317641|20557442|P3|Overall Study|Adverse Event|0
5943673|NCT01317641|20557443|P2|Overall Study|Adverse Event|1
5943674|NCT01317641|20557444|P1|Overall Study|Adverse Event|0
5943675|NCT01317641|20557436|P9|Overall Study|Not treated|1
5943676|NCT01317641|20557437|P8|Overall Study|Not treated|1
5943677|NCT01317641|20557438|P7|Overall Study|Not treated|0
5943678|NCT01317641|20557439|P6|Overall Study|Not treated|0
5943679|NCT01317641|20557440|P5|Overall Study|Not treated|0
5943680|NCT01317641|20557441|P4|Overall Study|Not treated|0
5943681|NCT01317641|20557442|P3|Overall Study|Not treated|0
5943682|NCT01317641|20557443|P2|Overall Study|Not treated|0
5943683|NCT01317641|20557444|P1|Overall Study|Not treated|0
5943684|NCT01317615|20557546|P1|Overall Study|Adverse Event|7
5943685|NCT01317615|20557546|P1|Overall Study|Abnormal laboratory value(s)|1
5943686|NCT01317615|20557546|P1|Overall Study|Withdrawal by Subject|5
5943687|NCT01317615|20557546|P1|Overall Study|Death|6
5943688|NCT01317615|20557546|P1|Overall Study|New cancer therapy|5
5943689|NCT01317615|20557546|P1|Overall Study|Disease progression|25
5943690|NCT01317550|20557559|P4|Overall Study|Lack of compliance study med|0
5943691|NCT01317550|20557560|P3|Overall Study|Lack of compliance study med|0
5943692|NCT01317550|20557561|P2|Overall Study|Lack of compliance study med|0
5943693|NCT01317550|20557562|P1|Overall Study|Lack of compliance study med|1
5943694|NCT01317550|20557559|P4|Overall Study|Withdrawal by Subject|0
5943695|NCT01317550|20557560|P3|Overall Study|Withdrawal by Subject|0
5943696|NCT01317550|20557561|P2|Overall Study|Withdrawal by Subject|0
5943697|NCT01317550|20557562|P1|Overall Study|Withdrawal by Subject|1
5943698|NCT01317472|20557574|P2|Overall Study|Unrelated hospitalization|0
5943699|NCT01317472|20557575|P1|Overall Study|Unrelated hospitalization|1
5943700|NCT01317472|20557574|P2|Overall Study|Withdrawal by Subject|0
5943701|NCT01317472|20557575|P1|Overall Study|Withdrawal by Subject|1
5943702|NCT01317199|20557585|P4|Randomized Phase 2|Patient transferred to other facility|0
5943703|NCT01317199|20557586|P3|Randomized Phase 2|Patient transferred to other facility|1
5943704|NCT01317199|20557587|P2|Randomized Phase 2|Patient transferred to other facility|0
5943705|NCT01317199|20557588|P1|Randomized Phase 2|Patient transferred to other facility|0
5943706|NCT01317199|20557585|P4|Randomized Phase 2|Patient stopped taking study drug|1
5943707|NCT01317199|20557586|P3|Randomized Phase 2|Patient stopped taking study drug|0
5943708|NCT01317199|20557587|P2|Randomized Phase 2|Patient stopped taking study drug|0
5943709|NCT01317199|20557588|P1|Randomized Phase 2|Patient stopped taking study drug|0
5943710|NCT01317199|20557585|P4|Randomized Phase 2|Disenrolled before treatment|2
5943711|NCT01317199|20557586|P3|Randomized Phase 2|Disenrolled before treatment|1
5943712|NCT01317199|20557587|P2|Randomized Phase 2|Disenrolled before treatment|1
5943713|NCT01317199|20557588|P1|Randomized Phase 2|Disenrolled before treatment|0
5943714|NCT01317199|20557585|P4|Randomized Phase 2|Rising PSA, not as defined by protocol|2
5943715|NCT01317199|20557586|P3|Randomized Phase 2|Rising PSA, not as defined by protocol|5
5943716|NCT01317199|20557587|P2|Randomized Phase 2|Rising PSA, not as defined by protocol|2
5943717|NCT01317199|20557588|P1|Randomized Phase 2|Rising PSA, not as defined by protocol|0
5943718|NCT01317199|20557585|P4|Randomized Phase 2|Comorbidities|2
5943719|NCT01317199|20557586|P3|Randomized Phase 2|Comorbidities|2
5943720|NCT01317199|20557587|P2|Randomized Phase 2|Comorbidities|2
5943721|NCT01317199|20557588|P1|Randomized Phase 2|Comorbidities|0
5943722|NCT01317199|20557585|P4|Randomized Phase 2|Adverse Event|1
5943723|NCT01317199|20557586|P3|Randomized Phase 2|Adverse Event|0
5943724|NCT01317199|20557587|P2|Randomized Phase 2|Adverse Event|0
5943725|NCT01317199|20557588|P1|Randomized Phase 2|Adverse Event|0
5943726|NCT01317199|20557585|P4|Randomized Phase 2|Withdrawal by Subject|4
5943727|NCT01317199|20557586|P3|Randomized Phase 2|Withdrawal by Subject|5
5943728|NCT01317199|20557587|P2|Randomized Phase 2|Withdrawal by Subject|3
5943729|NCT01317199|20557588|P1|Randomized Phase 2|Withdrawal by Subject|0
5943730|NCT01317199|20557585|P4|Randomized Phase 2|Disease progression|5
5943731|NCT01317199|20557586|P3|Randomized Phase 2|Disease progression|7
5943732|NCT01317199|20557587|P2|Randomized Phase 2|Disease progression|3
5943733|NCT01317199|20557588|P1|Randomized Phase 2|Disease progression|0
5943734|NCT01317199|20557585|P4|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0
5943735|NCT01317199|20557586|P3|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0
5943736|NCT01317199|20557587|P2|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0
5943737|NCT01317199|20557588|P1|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|1
5943738|NCT01317199|20557585|P4|Dose-escalation Phase 1|Disease progression|0
5943739|NCT01317199|20557586|P3|Dose-escalation Phase 1|Disease progression|0
5943740|NCT01317199|20557587|P2|Dose-escalation Phase 1|Disease progression|0
5943741|NCT01317199|20557588|P1|Dose-escalation Phase 1|Disease progression|1
5943742|NCT01317199|20557585|P4|Dose-escalation Phase 1|Physician Decision|0
5943743|NCT01317199|20557586|P3|Dose-escalation Phase 1|Physician Decision|0
5943744|NCT01317199|20557587|P2|Dose-escalation Phase 1|Physician Decision|0
5943745|NCT01317199|20557588|P1|Dose-escalation Phase 1|Physician Decision|5
5943746|NCT01317160|20557617|P2|Overall Study|Withdrawal by Subject|2
5943747|NCT01317160|20557618|P1|Overall Study|Withdrawal by Subject|0
5943748|NCT01317160|20557617|P2|Overall Study|Lost to Follow-up|3
5943749|NCT01317160|20557618|P1|Overall Study|Lost to Follow-up|3
5943750|NCT01317160|20557617|P2|Overall Study|Incorrect inclusion|1
5943751|NCT01317160|20557618|P1|Overall Study|Incorrect inclusion|1
5943752|NCT01317004|20557652|P2|Overall Study|Adverse Event|3
5943753|NCT01317004|20557653|P1|Overall Study|Adverse Event|3
5943754|NCT01317004|20557652|P2|Overall Study|Protocol Violation|2
5943755|NCT01317004|20557653|P1|Overall Study|Protocol Violation|0
5943756|NCT01317004|20557652|P2|Overall Study|Withdrawal by Subject|4
5943757|NCT01317004|20557653|P1|Overall Study|Withdrawal by Subject|1
5943758|NCT01316939|20557674|P3|Overall Study|Protocol Violation|0
5943759|NCT01316939|20557675|P2|Overall Study|Protocol Violation|1
5943760|NCT01316939|20557676|P1|Overall Study|Protocol Violation|0
5943761|NCT01316939|20557674|P3|Overall Study|Met Liver chemistry stopping criteria|1
5943762|NCT01316939|20557675|P2|Overall Study|Met Liver chemistry stopping criteria|0
5943763|NCT01316939|20557676|P1|Overall Study|Met Liver chemistry stopping criteria|1
5943764|NCT01316939|20557674|P3|Overall Study|Lost to Follow-up|2
5943765|NCT01316939|20557675|P2|Overall Study|Lost to Follow-up|0
5943766|NCT01316939|20557676|P1|Overall Study|Lost to Follow-up|0
5943767|NCT01316939|20557674|P3|Overall Study|Physician Decision|1
5943768|NCT01316939|20557675|P2|Overall Study|Physician Decision|2
5943769|NCT01316939|20557676|P1|Overall Study|Physician Decision|2
5943770|NCT01316939|20557674|P3|Overall Study|Withdrawal by Subject|6
5943771|NCT01316939|20557675|P2|Overall Study|Withdrawal by Subject|3
5943772|NCT01316939|20557676|P1|Overall Study|Withdrawal by Subject|1
5943773|NCT01316939|20557674|P3|Overall Study|Adverse Event|11
5943774|NCT01316939|20557675|P2|Overall Study|Adverse Event|12
5943775|NCT01316939|20557676|P1|Overall Study|Adverse Event|9
5943776|NCT01316939|20557674|P3|Overall Study|Lack of Efficacy|25
5943777|NCT01316939|20557675|P2|Overall Study|Lack of Efficacy|25
5943778|NCT01316939|20557676|P1|Overall Study|Lack of Efficacy|24
5943779|NCT01316939|20557674|P3|Overall Study|Study closed/terminated|23
5943780|NCT01316939|20557675|P2|Overall Study|Study closed/terminated|25
5943781|NCT01316939|20557676|P1|Overall Study|Study closed/terminated|26
5943782|NCT01316913|20557771|P4|Overall Study|Withdrawal by Subject|6
5943783|NCT01316913|20557772|P3|Overall Study|Withdrawal by Subject|10
5943784|NCT01316913|20557773|P2|Overall Study|Withdrawal by Subject|9
5943785|NCT01316913|20557774|P1|Overall Study|Withdrawal by Subject|10
5943786|NCT01316913|20557771|P4|Overall Study|Lost to Follow-up|2
5943787|NCT01316913|20557772|P3|Overall Study|Lost to Follow-up|0
5943788|NCT01316913|20557773|P2|Overall Study|Lost to Follow-up|1
5943789|NCT01316913|20557774|P1|Overall Study|Lost to Follow-up|0
5943790|NCT01316913|20557771|P4|Overall Study|Protocol-defined Stopping Criteria|6
5943791|NCT01316913|20557772|P3|Overall Study|Protocol-defined Stopping Criteria|11
5943792|NCT01316913|20557773|P2|Overall Study|Protocol-defined Stopping Criteria|8
5943793|NCT01316913|20557774|P1|Overall Study|Protocol-defined Stopping Criteria|7
5943794|NCT01316913|20557771|P4|Overall Study|Protocol Violation|1
5943795|NCT01316913|20557772|P3|Overall Study|Protocol Violation|4
5943796|NCT01316913|20557773|P2|Overall Study|Protocol Violation|4
5943797|NCT01316913|20557774|P1|Overall Study|Protocol Violation|1
5943798|NCT01316913|20557771|P4|Overall Study|Lack of Efficacy|13
5943799|NCT01316913|20557772|P3|Overall Study|Lack of Efficacy|9
5943800|NCT01316913|20557773|P2|Overall Study|Lack of Efficacy|12
5943801|NCT01316913|20557774|P1|Overall Study|Lack of Efficacy|22
5943802|NCT01316913|20557771|P4|Overall Study|Adverse Event|11
5943803|NCT01316913|20557772|P3|Overall Study|Adverse Event|15
5943804|NCT01316913|20557773|P2|Overall Study|Adverse Event|20
5943805|NCT01316913|20557774|P1|Overall Study|Adverse Event|17
5943806|NCT01316900|20557796|P4|Overall Study|Withdrawal by Subject|9
5943807|NCT01316900|20557797|P3|Overall Study|Withdrawal by Subject|6
5943808|NCT01316900|20557798|P2|Overall Study|Withdrawal by Subject|8
5943809|NCT01316900|20557799|P1|Overall Study|Withdrawal by Subject|7
5943810|NCT01316900|20557796|P4|Overall Study|Lost to Follow-up|1
5943811|NCT01316900|20557797|P3|Overall Study|Lost to Follow-up|1
5943812|NCT01316900|20557798|P2|Overall Study|Lost to Follow-up|0
5943813|NCT01316900|20557799|P1|Overall Study|Lost to Follow-up|1
5943814|NCT01316900|20557796|P4|Overall Study|Protocol-defined Stopping Criteria|5
5943815|NCT01316900|20557797|P3|Overall Study|Protocol-defined Stopping Criteria|10
5943816|NCT01316900|20557798|P2|Overall Study|Protocol-defined Stopping Criteria|3
5943817|NCT01316900|20557799|P1|Overall Study|Protocol-defined Stopping Criteria|2
5943818|NCT01316900|20557796|P4|Overall Study|Protocol Violation|0
5943819|NCT01316900|20557797|P3|Overall Study|Protocol Violation|4
5943820|NCT01316900|20557798|P2|Overall Study|Protocol Violation|1
5943821|NCT01316900|20557799|P1|Overall Study|Protocol Violation|7
5943822|NCT01316900|20557796|P4|Overall Study|Lack of Efficacy|7
5943823|NCT01316900|20557797|P3|Overall Study|Lack of Efficacy|5
5943824|NCT01316900|20557798|P2|Overall Study|Lack of Efficacy|9
5943825|NCT01316900|20557799|P1|Overall Study|Lack of Efficacy|17
5943826|NCT01316900|20557796|P4|Overall Study|Adverse Event|9
5943827|NCT01316900|20557797|P3|Overall Study|Adverse Event|15
5943828|NCT01316900|20557798|P2|Overall Study|Adverse Event|10
5943829|NCT01316900|20557799|P1|Overall Study|Adverse Event|10
5943830|NCT01316887|20557820|P3|Overall Study|Withdrawal by Subject|15
5943831|NCT01316887|20557821|P2|Overall Study|Withdrawal by Subject|16
5943832|NCT01316887|20557822|P1|Overall Study|Withdrawal by Subject|8
5943833|NCT01316887|20557820|P3|Overall Study|Lost to Follow-up|5
5943834|NCT01316887|20557821|P2|Overall Study|Lost to Follow-up|7
5943835|NCT01316887|20557822|P1|Overall Study|Lost to Follow-up|1
5943836|NCT01316887|20557820|P3|Overall Study|Study Closed/Terminated|3
5943837|NCT01316887|20557821|P2|Overall Study|Study Closed/Terminated|4
5943838|NCT01316887|20557822|P1|Overall Study|Study Closed/Terminated|2
5943839|NCT01316887|20557820|P3|Overall Study|Protocol-defined Stopping Criteria|36
5943840|NCT01316887|20557821|P2|Overall Study|Protocol-defined Stopping Criteria|37
5943841|NCT01316887|20557822|P1|Overall Study|Protocol-defined Stopping Criteria|8
5943842|NCT01316887|20557820|P3|Overall Study|Protocol Violation|6
5943843|NCT01316887|20557821|P2|Overall Study|Protocol Violation|6
5943844|NCT01316887|20557822|P1|Overall Study|Protocol Violation|2
5943845|NCT01316887|20557820|P3|Overall Study|Lack of Efficacy|1
5943846|NCT01316887|20557821|P2|Overall Study|Lack of Efficacy|3
5943847|NCT01316887|20557822|P1|Overall Study|Lack of Efficacy|9
5943848|NCT01316887|20557820|P3|Overall Study|Adverse Event|17
5943849|NCT01316887|20557821|P2|Overall Study|Adverse Event|21
5943850|NCT01316887|20557822|P1|Overall Study|Adverse Event|13
5943851|NCT01316692|20557947|P1|Overall Study|Disease Progression|7
5943852|NCT01316692|20557947|P1|Overall Study|Adverse Event|5
5943853|NCT01316614|20557956|P1|Overall Study|Medically unstable|1
5943854|NCT01316614|20557956|P1|Overall Study|Inadequate number of passes|2
5943855|NCT01316614|20557956|P1|Overall Study|Cystic lesion|5
5943856|NCT01316614|20557956|P1|Overall Study|Cytology slides not available for review|4
5943857|NCT01316614|20557956|P1|Overall Study|No solid lesion and FNA not indicated|25
5943858|NCT01316575|20557973|P2|Overall Study|Required alternate treatment|1
5943859|NCT01316575|20557974|P1|Overall Study|Required alternate treatment|0
5943860|NCT01316575|20557973|P2|Overall Study|Withdrawal by Subject|0
5943861|NCT01316575|20557974|P1|Overall Study|Withdrawal by Subject|2
5943862|NCT01316419|20557997|P1|Overall Study|Lost to Follow-up|19
5943863|NCT01316419|20557997|P1|Overall Study|Violated inclusion/exclusion criterion|143
5943864|NCT01316419|20557997|P1|Overall Study|Not treated|103
5943865|NCT01316380|20558023|P3|Overall Study|Not treated|0
5943866|NCT01316380|20558024|P2|Overall Study|Not treated|0
5943867|NCT01316380|20558025|P1|Overall Study|Not treated|1
5943868|NCT01316380|20558023|P3|Overall Study|Other|1
5943869|NCT01316380|20558024|P2|Overall Study|Other|1
5943870|NCT01316380|20558025|P1|Overall Study|Other|0
5943871|NCT01316380|20558023|P3|Overall Study|Withdrawal by Subject|0
5943872|NCT01316380|20558024|P2|Overall Study|Withdrawal by Subject|2
5943873|NCT01316380|20558025|P1|Overall Study|Withdrawal by Subject|1
5943874|NCT01316380|20558023|P3|Overall Study|Protocol Violation|1
5943875|NCT01316380|20558024|P2|Overall Study|Protocol Violation|0
5943876|NCT01316380|20558025|P1|Overall Study|Protocol Violation|0
5943877|NCT01316380|20558023|P3|Overall Study|Adverse Event|1
5943878|NCT01316380|20558024|P2|Overall Study|Adverse Event|2
5943879|NCT01316380|20558025|P1|Overall Study|Adverse Event|0
5943880|NCT01316276|20558162|P1|Overall Study|Other|22
5943881|NCT01316276|20558162|P1|Overall Study|Lost to Follow-up|1
5943882|NCT01316276|20558162|P1|Overall Study|Withdrawal of consent|24
5943883|NCT01316276|20558162|P1|Overall Study|Adverse Event|19
5943884|NCT01316276|20558162|P1|Overall Study|Death|1
5943885|NCT01316224|20558210|P1|Overall Study|Other|1
5943886|NCT01316224|20558210|P1|Overall Study|Adverse Event With Treatment Failure|1
5943887|NCT01316224|20558210|P1|Overall Study|Withdrawal by Subject|1
5943888|NCT01316224|20558210|P1|Overall Study|Lack of Efficacy|1
5943889|NCT01316224|20558210|P1|Overall Study|Adverse Event|3
5943890|NCT01316224|20558210|P1|Overall Study|Protocol Violation|3
5943891|NCT01316055|20558263|P3|Overall Study|Lost to Follow-up|0
5943892|NCT01316055|20558264|P2|Overall Study|Lost to Follow-up|0
5943893|NCT01316055|20558265|P1|Overall Study|Lost to Follow-up|1
5943894|NCT01315847|20558296|P2|Part III, Period 1|[11C]MK-4232 synthesis failure|1
5943895|NCT01315847|20558297|P1|Part III, Period 1|[11C]MK-4232 synthesis failure|0
5943896|NCT01315847|20558296|P2|Part I, Period 1|Reached maximum number of arterial lines|0
5943897|NCT01315847|20558297|P1|Part I, Period 1|Reached maximum number of arterial lines|3
5943898|NCT01315678|20558311|P2|Overall Study|similar reason to those listed above|2
5943899|NCT01315678|20558312|P1|Overall Study|similar reason to those listed above|3
5943900|NCT01315678|20558311|P2|Overall Study|Lost to Follow-up|0
5943901|NCT01315678|20558312|P1|Overall Study|Lost to Follow-up|1
5943902|NCT01315678|20558311|P2|Overall Study|Adverse Event|1
5943903|NCT01315678|20558312|P1|Overall Study|Adverse Event|3
5943904|NCT01315678|20558311|P2|Overall Study|Withdrawal by Subject|3
5943905|NCT01315678|20558312|P1|Overall Study|Withdrawal by Subject|7
5943906|NCT01315353|20558363|P3|Overall Study|Inadvertent randomization/assignment|2
5943907|NCT01315353|20558364|P2|Overall Study|Inadvertent randomization/assignment|0
5943908|NCT01315353|20558365|P1|Overall Study|Inadvertent randomization/assignment|0
5943909|NCT01315353|20558363|P3|Overall Study|Taken off study by site in error|0
5943910|NCT01315353|20558364|P2|Overall Study|Taken off study by site in error|1
5943911|NCT01315353|20558365|P1|Overall Study|Taken off study by site in error|0
5943912|NCT01315353|20558363|P3|Overall Study|Site closing|0
5943913|NCT01315353|20558364|P2|Overall Study|Site closing|4
5943914|NCT01315353|20558365|P1|Overall Study|Site closing|7
5943915|NCT01315353|20558363|P3|Overall Study|Unwilling to adhere to requirements|4
5943916|NCT01315353|20558364|P2|Overall Study|Unwilling to adhere to requirements|5
5943917|NCT01315353|20558365|P1|Overall Study|Unwilling to adhere to requirements|5
5943918|NCT01315353|20558363|P3|Overall Study|Lost to Follow-up|6
5943919|NCT01315353|20558364|P2|Overall Study|Lost to Follow-up|6
5943920|NCT01315353|20558365|P1|Overall Study|Lost to Follow-up|13
5943921|NCT01315353|20558363|P3|Overall Study|Withdrawal by Subject|1
5943922|NCT01315353|20558364|P2|Overall Study|Withdrawal by Subject|6
5943923|NCT01315353|20558365|P1|Overall Study|Withdrawal by Subject|2
5943924|NCT01315353|20558363|P3|Overall Study|Death|0
5943925|NCT01315353|20558364|P2|Overall Study|Death|1
5943926|NCT01315353|20558365|P1|Overall Study|Death|2
5943927|NCT01315249|20558392|P2|Overall Study|Death|1
5943928|NCT01315249|20558393|P1|Overall Study|Death|0
5943929|NCT01315249|20558392|P2|Overall Study|Lost to Follow-up|2
5943930|NCT01315249|20558393|P1|Overall Study|Lost to Follow-up|0
5943931|NCT01315249|20558392|P2|Overall Study|Lack of Efficacy|1
5943932|NCT01315249|20558393|P1|Overall Study|Lack of Efficacy|0
5943933|NCT01315249|20558392|P2|Overall Study|inability to use device|0
5943934|NCT01315249|20558393|P1|Overall Study|inability to use device|1
5943935|NCT01315249|20558392|P2|Overall Study|Administrative problems|0
5943936|NCT01315249|20558393|P1|Overall Study|Administrative problems|1
5943937|NCT01315249|20558392|P2|Overall Study|Abnormal test results|2
5943938|NCT01315249|20558393|P1|Overall Study|Abnormal test results|1
5943939|NCT01315249|20558392|P2|Overall Study|Protocol Violation|5
5943940|NCT01315249|20558393|P1|Overall Study|Protocol Violation|8
5943941|NCT01315249|20558392|P2|Overall Study|Withdrawal by Subject|10
5943942|NCT01315249|20558393|P1|Overall Study|Withdrawal by Subject|11
5943943|NCT01315249|20558392|P2|Overall Study|Adverse Event|26
5943944|NCT01315249|20558393|P1|Overall Study|Adverse Event|22
5943945|NCT01315236|20558421|P2|12-Month Follow-up Period|Did not return to the site for Month 12|0
5943946|NCT01315236|20558422|P1|12-Month Follow-up Period|Did not return to the site for Month 12|1
5943947|NCT01315236|20558421|P2|12-Month Follow-up Period|Death|1
5943948|NCT01315236|20558422|P1|12-Month Follow-up Period|Death|0
5943949|NCT01315236|20558421|P2|Open-label Phase|Other|1
5943950|NCT01315236|20558422|P1|Open-label Phase|Other|0
5943951|NCT01315236|20558421|P2|Open-label Phase|Adverse Event|1
5943952|NCT01315236|20558422|P1|Open-label Phase|Adverse Event|0
5943953|NCT01315236|20558421|P2|Open-label Phase|Death|0
5943954|NCT01315236|20558422|P1|Open-label Phase|Death|1
5943955|NCT01315236|20558421|P2|Double-blind Phase|Lost to Follow-up|0
5943956|NCT01315236|20558422|P1|Double-blind Phase|Lost to Follow-up|1
5943957|NCT01315236|20558421|P2|Double-blind Phase|Withdrawal of Consent|0
5943958|NCT01315236|20558422|P1|Double-blind Phase|Withdrawal of Consent|1
5943959|NCT01315236|20558421|P2|Double-blind Phase|Adverse Event|0
5943960|NCT01315236|20558422|P1|Double-blind Phase|Adverse Event|1
5943961|NCT01315236|20558421|P2|Double-blind Phase|Death|0
5943962|NCT01315236|20558422|P1|Double-blind Phase|Death|1
5943963|NCT01315132|20558478|P1|Overall Study|not treated due to disease progression|1
5943964|NCT01315028|20558485|P2|Overall Study|Death|1
5943965|NCT01315028|20558486|P1|Overall Study|Death|0
5943966|NCT01315028|20558485|P2|Overall Study|Lost to Follow-up|0
5943967|NCT01315028|20558486|P1|Overall Study|Lost to Follow-up|1
5943968|NCT01314911|20558513|P2|Overall Study|Never Started Treatment|0
5943969|NCT01314911|20558514|P1|Overall Study|Never Started Treatment|1
5943970|NCT01314911|20558513|P2|Overall Study|Received Non-randomized Study Drug|1
5943971|NCT01314911|20558514|P1|Overall Study|Received Non-randomized Study Drug|0
5943972|NCT01314911|20558513|P2|Overall Study|Withdrawal by Subject|3
5943973|NCT01314911|20558514|P1|Overall Study|Withdrawal by Subject|1
5943974|NCT01314911|20558513|P2|Overall Study|Lost to Follow-up|2
5943975|NCT01314911|20558514|P1|Overall Study|Lost to Follow-up|3
5943976|NCT01314872|20558565|P15|Period 2|Lost to Follow-up|6
5943977|NCT01314872|20558566|P14|Period 2|Lost to Follow-up|2
5943978|NCT01314872|20558567|P13|Period 2|Lost to Follow-up|7
5943979|NCT01314872|20558568|P12|Period 2|Lost to Follow-up|6
5943980|NCT01314872|20558569|P11|Period 2|Lost to Follow-up|0
5943981|NCT01314872|20558570|P10|Period 2|Lost to Follow-up|0
5943982|NCT01314872|20558571|P9|Period 2|Lost to Follow-up|0
5943983|NCT01314872|20558572|P8|Period 2|Lost to Follow-up|0
5943984|NCT01314872|20558573|P7|Period 2|Lost to Follow-up|0
5943985|NCT01314872|20558574|P6|Period 2|Lost to Follow-up|0
5943986|NCT01314872|20558575|P5|Period 2|Lost to Follow-up|0
5943987|NCT01314872|20558576|P4|Period 2|Lost to Follow-up|0
5943988|NCT01314872|20558577|P3|Period 2|Lost to Follow-up|0
5943989|NCT01314872|20558578|P2|Period 2|Lost to Follow-up|0
5943990|NCT01314872|20558579|P1|Period 2|Lost to Follow-up|0
5943991|NCT01314872|20558565|P15|Period 2|Withdrawal by Subject|4
5943992|NCT01314872|20558566|P14|Period 2|Withdrawal by Subject|12
5943993|NCT01314872|20558567|P13|Period 2|Withdrawal by Subject|17
5943994|NCT01314872|20558568|P12|Period 2|Withdrawal by Subject|14
5943995|NCT01314872|20558569|P11|Period 2|Withdrawal by Subject|0
5943996|NCT01314872|20558570|P10|Period 2|Withdrawal by Subject|0
5943997|NCT01314872|20558571|P9|Period 2|Withdrawal by Subject|0
5943998|NCT01314872|20558572|P8|Period 2|Withdrawal by Subject|0
5943999|NCT01314872|20558573|P7|Period 2|Withdrawal by Subject|0
5944000|NCT01314872|20558574|P6|Period 2|Withdrawal by Subject|0
5944001|NCT01314872|20558575|P5|Period 2|Withdrawal by Subject|0
5944002|NCT01314872|20558576|P4|Period 2|Withdrawal by Subject|0
5944003|NCT01314872|20558577|P3|Period 2|Withdrawal by Subject|0
5944004|NCT01314872|20558578|P2|Period 2|Withdrawal by Subject|0
5944005|NCT01314872|20558579|P1|Period 2|Withdrawal by Subject|0
5944006|NCT01314872|20558565|P15|Period 2|Adverse event, non-fatal|9
5944007|NCT01314872|20558566|P14|Period 2|Adverse event, non-fatal|24
5944008|NCT01314872|20558567|P13|Period 2|Adverse event, non-fatal|16
5944009|NCT01314872|20558568|P12|Period 2|Adverse event, non-fatal|13
5944010|NCT01314872|20558569|P11|Period 2|Adverse event, non-fatal|0
5944011|NCT01314872|20558570|P10|Period 2|Adverse event, non-fatal|0
5944012|NCT01314872|20558571|P9|Period 2|Adverse event, non-fatal|0
5944013|NCT01314872|20558572|P8|Period 2|Adverse event, non-fatal|0
5944014|NCT01314872|20558573|P7|Period 2|Adverse event, non-fatal|0
5944015|NCT01314872|20558574|P6|Period 2|Adverse event, non-fatal|0
5944016|NCT01314872|20558575|P5|Period 2|Adverse event, non-fatal|0
5944017|NCT01314872|20558576|P4|Period 2|Adverse event, non-fatal|0
5944018|NCT01314872|20558577|P3|Period 2|Adverse event, non-fatal|0
5944019|NCT01314872|20558578|P2|Period 2|Adverse event, non-fatal|0
5944020|NCT01314872|20558579|P1|Period 2|Adverse event, non-fatal|0
5944021|NCT01314872|20558565|P15|Period 2|Study terminated by Sponsor|0
5944022|NCT01314872|20558566|P14|Period 2|Study terminated by Sponsor|3
5944023|NCT01314872|20558567|P13|Period 2|Study terminated by Sponsor|2
5944024|NCT01314872|20558568|P12|Period 2|Study terminated by Sponsor|2
5944025|NCT01314872|20558569|P11|Period 2|Study terminated by Sponsor|0
5944026|NCT01314872|20558570|P10|Period 2|Study terminated by Sponsor|0
5944027|NCT01314872|20558571|P9|Period 2|Study terminated by Sponsor|0
5944028|NCT01314872|20558572|P8|Period 2|Study terminated by Sponsor|0
5944029|NCT01314872|20558573|P7|Period 2|Study terminated by Sponsor|0
5944030|NCT01314872|20558574|P6|Period 2|Study terminated by Sponsor|0
5944031|NCT01314872|20558575|P5|Period 2|Study terminated by Sponsor|0
5944032|NCT01314872|20558576|P4|Period 2|Study terminated by Sponsor|0
5944033|NCT01314872|20558577|P3|Period 2|Study terminated by Sponsor|0
5944034|NCT01314872|20558578|P2|Period 2|Study terminated by Sponsor|0
5944035|NCT01314872|20558579|P1|Period 2|Study terminated by Sponsor|0
5944036|NCT01314872|20558565|P15|Period 2|Pregnancy|1
5944037|NCT01314872|20558566|P14|Period 2|Pregnancy|0
5944038|NCT01314872|20558567|P13|Period 2|Pregnancy|0
5944039|NCT01314872|20558568|P12|Period 2|Pregnancy|0
5944040|NCT01314872|20558569|P11|Period 2|Pregnancy|0
5944041|NCT01314872|20558570|P10|Period 2|Pregnancy|0
5944042|NCT01314872|20558571|P9|Period 2|Pregnancy|0
5944043|NCT01314872|20558572|P8|Period 2|Pregnancy|0
5944044|NCT01314872|20558573|P7|Period 2|Pregnancy|0
5944045|NCT01314872|20558574|P6|Period 2|Pregnancy|0
5944046|NCT01314872|20558575|P5|Period 2|Pregnancy|0
5944047|NCT01314872|20558576|P4|Period 2|Pregnancy|0
5944048|NCT01314872|20558577|P3|Period 2|Pregnancy|0
5944049|NCT01314872|20558578|P2|Period 2|Pregnancy|0
5944050|NCT01314872|20558579|P1|Period 2|Pregnancy|0
5944051|NCT01314872|20558565|P15|Period 2|Lack of Efficacy|2
5944052|NCT01314872|20558566|P14|Period 2|Lack of Efficacy|9
5944053|NCT01314872|20558567|P13|Period 2|Lack of Efficacy|12
5944054|NCT01314872|20558568|P12|Period 2|Lack of Efficacy|7
5944055|NCT01314872|20558569|P11|Period 2|Lack of Efficacy|0
5944056|NCT01314872|20558570|P10|Period 2|Lack of Efficacy|0
5944057|NCT01314872|20558571|P9|Period 2|Lack of Efficacy|0
5944058|NCT01314872|20558572|P8|Period 2|Lack of Efficacy|0
5944059|NCT01314872|20558573|P7|Period 2|Lack of Efficacy|0
5944060|NCT01314872|20558574|P6|Period 2|Lack of Efficacy|0
5944061|NCT01314872|20558575|P5|Period 2|Lack of Efficacy|0
5944062|NCT01314872|20558576|P4|Period 2|Lack of Efficacy|0
5944063|NCT01314872|20558577|P3|Period 2|Lack of Efficacy|0
5944064|NCT01314872|20558578|P2|Period 2|Lack of Efficacy|0
5944065|NCT01314872|20558579|P1|Period 2|Lack of Efficacy|0
5944066|NCT01314872|20558565|P15|Period 2|Non-compliance with study drug|2
5944067|NCT01314872|20558566|P14|Period 2|Non-compliance with study drug|1
5944068|NCT01314872|20558567|P13|Period 2|Non-compliance with study drug|3
5944069|NCT01314872|20558568|P12|Period 2|Non-compliance with study drug|3
5944070|NCT01314872|20558569|P11|Period 2|Non-compliance with study drug|0
5944071|NCT01314872|20558570|P10|Period 2|Non-compliance with study drug|0
5944072|NCT01314872|20558571|P9|Period 2|Non-compliance with study drug|0
5944073|NCT01314872|20558572|P8|Period 2|Non-compliance with study drug|0
5944074|NCT01314872|20558573|P7|Period 2|Non-compliance with study drug|0
5944075|NCT01314872|20558574|P6|Period 2|Non-compliance with study drug|0
5944076|NCT01314872|20558575|P5|Period 2|Non-compliance with study drug|0
5944077|NCT01314872|20558576|P4|Period 2|Non-compliance with study drug|0
5944078|NCT01314872|20558577|P3|Period 2|Non-compliance with study drug|0
5944079|NCT01314872|20558578|P2|Period 2|Non-compliance with study drug|0
5944080|NCT01314872|20558579|P1|Period 2|Non-compliance with study drug|0
5944081|NCT01314872|20558565|P15|Period 2|Protocol Violation|0
5944082|NCT01314872|20558566|P14|Period 2|Protocol Violation|2
5944083|NCT01314872|20558567|P13|Period 2|Protocol Violation|3
5944084|NCT01314872|20558568|P12|Period 2|Protocol Violation|3
5944085|NCT01314872|20558569|P11|Period 2|Protocol Violation|0
5944086|NCT01314872|20558570|P10|Period 2|Protocol Violation|0
5944087|NCT01314872|20558571|P9|Period 2|Protocol Violation|0
5944088|NCT01314872|20558572|P8|Period 2|Protocol Violation|0
5944089|NCT01314872|20558573|P7|Period 2|Protocol Violation|0
5944090|NCT01314872|20558574|P6|Period 2|Protocol Violation|0
5944091|NCT01314872|20558575|P5|Period 2|Protocol Violation|0
5944092|NCT01314872|20558576|P4|Period 2|Protocol Violation|0
5944093|NCT01314872|20558577|P3|Period 2|Protocol Violation|0
5944094|NCT01314872|20558578|P2|Period 2|Protocol Violation|0
5944095|NCT01314872|20558579|P1|Period 2|Protocol Violation|0
5944096|NCT01314872|20558565|P15|Treatment Period 1|Lost to Follow-up|0
5944097|NCT01314872|20558566|P14|Treatment Period 1|Lost to Follow-up|0
5944098|NCT01314872|20558567|P13|Treatment Period 1|Lost to Follow-up|0
5944099|NCT01314872|20558568|P12|Treatment Period 1|Lost to Follow-up|0
5944100|NCT01314872|20558569|P11|Treatment Period 1|Lost to Follow-up|0
5944101|NCT01314872|20558570|P10|Treatment Period 1|Lost to Follow-up|0
5944102|NCT01314872|20558571|P9|Treatment Period 1|Lost to Follow-up|1
5944103|NCT01314872|20558572|P8|Treatment Period 1|Lost to Follow-up|1
5944104|NCT01314872|20558573|P7|Treatment Period 1|Lost to Follow-up|1
5944105|NCT01314872|20558574|P6|Treatment Period 1|Lost to Follow-up|1
5944106|NCT01314872|20558575|P5|Treatment Period 1|Lost to Follow-up|1
5944107|NCT01314872|20558576|P4|Treatment Period 1|Lost to Follow-up|2
5944108|NCT01314872|20558577|P3|Treatment Period 1|Lost to Follow-up|2
5944109|NCT01314872|20558578|P2|Treatment Period 1|Lost to Follow-up|1
5944110|NCT01314872|20558579|P1|Treatment Period 1|Lost to Follow-up|0
5944111|NCT01314872|20558565|P15|Treatment Period 1|Withdrawal by Subject|0
5944112|NCT01314872|20558566|P14|Treatment Period 1|Withdrawal by Subject|0
5944113|NCT01314872|20558567|P13|Treatment Period 1|Withdrawal by Subject|0
5944114|NCT01314872|20558568|P12|Treatment Period 1|Withdrawal by Subject|0
5944115|NCT01314872|20558569|P11|Treatment Period 1|Withdrawal by Subject|1
5944116|NCT01314872|20558570|P10|Treatment Period 1|Withdrawal by Subject|2
5944117|NCT01314872|20558571|P9|Treatment Period 1|Withdrawal by Subject|2
5944118|NCT01314872|20558572|P8|Treatment Period 1|Withdrawal by Subject|2
5944119|NCT01314872|20558573|P7|Treatment Period 1|Withdrawal by Subject|3
5944120|NCT01314872|20558574|P6|Treatment Period 1|Withdrawal by Subject|1
5944121|NCT01314872|20558575|P5|Treatment Period 1|Withdrawal by Subject|3
5944122|NCT01314872|20558576|P4|Treatment Period 1|Withdrawal by Subject|2
5944123|NCT01314872|20558577|P3|Treatment Period 1|Withdrawal by Subject|0
5944124|NCT01314872|20558578|P2|Treatment Period 1|Withdrawal by Subject|1
5944125|NCT01314872|20558579|P1|Treatment Period 1|Withdrawal by Subject|3
5944126|NCT01314872|20558565|P15|Treatment Period 1|Adverse event, non-fatal|0
5944127|NCT01314872|20558566|P14|Treatment Period 1|Adverse event, non-fatal|0
5944128|NCT01314872|20558567|P13|Treatment Period 1|Adverse event, non-fatal|0
5944129|NCT01314872|20558568|P12|Treatment Period 1|Adverse event, non-fatal|0
5944130|NCT01314872|20558569|P11|Treatment Period 1|Adverse event, non-fatal|1
5944131|NCT01314872|20558570|P10|Treatment Period 1|Adverse event, non-fatal|0
5944132|NCT01314872|20558571|P9|Treatment Period 1|Adverse event, non-fatal|3
5944133|NCT01314872|20558572|P8|Treatment Period 1|Adverse event, non-fatal|2
5944134|NCT01314872|20558573|P7|Treatment Period 1|Adverse event, non-fatal|4
5944135|NCT01314872|20558574|P6|Treatment Period 1|Adverse event, non-fatal|4
5944136|NCT01314872|20558575|P5|Treatment Period 1|Adverse event, non-fatal|2
5944137|NCT01314872|20558576|P4|Treatment Period 1|Adverse event, non-fatal|2
5944138|NCT01314872|20558577|P3|Treatment Period 1|Adverse event, non-fatal|3
5944139|NCT01314872|20558578|P2|Treatment Period 1|Adverse event, non-fatal|2
5944140|NCT01314872|20558579|P1|Treatment Period 1|Adverse event, non-fatal|4
5944141|NCT01314872|20558565|P15|Treatment Period 1|Lack of Efficacy|0
5944142|NCT01314872|20558566|P14|Treatment Period 1|Lack of Efficacy|0
5944143|NCT01314872|20558567|P13|Treatment Period 1|Lack of Efficacy|0
5944144|NCT01314872|20558568|P12|Treatment Period 1|Lack of Efficacy|0
5944145|NCT01314872|20558569|P11|Treatment Period 1|Lack of Efficacy|0
5944146|NCT01314872|20558570|P10|Treatment Period 1|Lack of Efficacy|0
5944147|NCT01314872|20558571|P9|Treatment Period 1|Lack of Efficacy|0
5944148|NCT01314872|20558572|P8|Treatment Period 1|Lack of Efficacy|2
5944149|NCT01314872|20558573|P7|Treatment Period 1|Lack of Efficacy|0
5944150|NCT01314872|20558574|P6|Treatment Period 1|Lack of Efficacy|1
5944151|NCT01314872|20558575|P5|Treatment Period 1|Lack of Efficacy|0
5944152|NCT01314872|20558576|P4|Treatment Period 1|Lack of Efficacy|0
5944153|NCT01314872|20558577|P3|Treatment Period 1|Lack of Efficacy|0
5944154|NCT01314872|20558578|P2|Treatment Period 1|Lack of Efficacy|0
5944155|NCT01314872|20558579|P1|Treatment Period 1|Lack of Efficacy|1
5944156|NCT01314872|20558565|P15|Treatment Period 1|Physician Decision|0
5944157|NCT01314872|20558566|P14|Treatment Period 1|Physician Decision|0
5944158|NCT01314872|20558567|P13|Treatment Period 1|Physician Decision|0
5944159|NCT01314872|20558568|P12|Treatment Period 1|Physician Decision|0
5944160|NCT01314872|20558569|P11|Treatment Period 1|Physician Decision|0
5944161|NCT01314872|20558570|P10|Treatment Period 1|Physician Decision|1
5944162|NCT01314872|20558571|P9|Treatment Period 1|Physician Decision|0
5944163|NCT01314872|20558572|P8|Treatment Period 1|Physician Decision|0
5944164|NCT01314872|20558573|P7|Treatment Period 1|Physician Decision|0
5944165|NCT01314872|20558574|P6|Treatment Period 1|Physician Decision|0
5944166|NCT01314872|20558575|P5|Treatment Period 1|Physician Decision|0
5944167|NCT01314872|20558576|P4|Treatment Period 1|Physician Decision|1
5944168|NCT01314872|20558577|P3|Treatment Period 1|Physician Decision|0
5944169|NCT01314872|20558578|P2|Treatment Period 1|Physician Decision|1
5944170|NCT01314872|20558579|P1|Treatment Period 1|Physician Decision|0
5944171|NCT01314872|20558565|P15|Treatment Period 1|Protocol Violation|0
5944172|NCT01314872|20558566|P14|Treatment Period 1|Protocol Violation|0
5944173|NCT01314872|20558567|P13|Treatment Period 1|Protocol Violation|0
5944174|NCT01314872|20558568|P12|Treatment Period 1|Protocol Violation|0
5944175|NCT01314872|20558569|P11|Treatment Period 1|Protocol Violation|1
5944176|NCT01314872|20558570|P10|Treatment Period 1|Protocol Violation|1
5944177|NCT01314872|20558571|P9|Treatment Period 1|Protocol Violation|0
5944178|NCT01314872|20558572|P8|Treatment Period 1|Protocol Violation|0
5944179|NCT01314872|20558573|P7|Treatment Period 1|Protocol Violation|0
5944180|NCT01314872|20558574|P6|Treatment Period 1|Protocol Violation|0
5944181|NCT01314872|20558575|P5|Treatment Period 1|Protocol Violation|1
5944182|NCT01314872|20558576|P4|Treatment Period 1|Protocol Violation|0
5944183|NCT01314872|20558577|P3|Treatment Period 1|Protocol Violation|1
5944184|NCT01314872|20558578|P2|Treatment Period 1|Protocol Violation|1
5944185|NCT01314872|20558579|P1|Treatment Period 1|Protocol Violation|2
5944186|NCT01314716|20558683|P2|Open-Label Phase|Physician Decision|4
5944187|NCT01314716|20558684|P1|Open-Label Phase|Physician Decision|5
5944188|NCT01314716|20558683|P2|Open-Label Phase|Withdrawal by Subject|2
5944189|NCT01314716|20558684|P1|Open-Label Phase|Withdrawal by Subject|1
5944190|NCT01314716|20558683|P2|Open-Label Phase|Adverse Event|6
5944191|NCT01314716|20558684|P1|Open-Label Phase|Adverse Event|4
5944192|NCT01314716|20558683|P2|Double-Blind Phase|Physician Decision|1
5944193|NCT01314716|20558684|P1|Double-Blind Phase|Physician Decision|0
5944194|NCT01314716|20558683|P2|Double-Blind Phase|Sponsor request|2
5944195|NCT01314716|20558684|P1|Double-Blind Phase|Sponsor request|1
5944196|NCT01314716|20558683|P2|Double-Blind Phase|Lost to Follow-up|1
5944197|NCT01314716|20558684|P1|Double-Blind Phase|Lost to Follow-up|0
5944198|NCT01314716|20558683|P2|Double-Blind Phase|Withdrawal by Subject|6
5944199|NCT01314716|20558684|P1|Double-Blind Phase|Withdrawal by Subject|5
5944200|NCT01314716|20558683|P2|Double-Blind Phase|Adverse Event|4
5944201|NCT01314716|20558684|P1|Double-Blind Phase|Adverse Event|10
5944202|NCT01314716|20558683|P2|Double-Blind Phase|Randomized but not treated|1
5944203|NCT01314716|20558684|P1|Double-Blind Phase|Randomized but not treated|1
5944204|NCT01314703|20558696|P1|Overall Study|screen failure and closed enrollment|8
5944205|NCT01314443|20558705|P4|Overall Study|Protocol Violation|1
5944206|NCT01314443|20558706|P3|Overall Study|Protocol Violation|1
5944207|NCT01314443|20558707|P2|Overall Study|Protocol Violation|2
5944208|NCT01314443|20558708|P1|Overall Study|Protocol Violation|2
5944209|NCT01314443|20558705|P4|Overall Study|Withdrawal by Subject|1
5944210|NCT01314443|20558706|P3|Overall Study|Withdrawal by Subject|1
5944211|NCT01314443|20558707|P2|Overall Study|Withdrawal by Subject|1
5944212|NCT01314443|20558708|P1|Overall Study|Withdrawal by Subject|2
5944213|NCT01314261|20558778|P4|Overall Study|Virologic Failure|1
5944214|NCT01314261|20558779|P3|Overall Study|Virologic Failure|0
5944215|NCT01314261|20558780|P2|Overall Study|Virologic Failure|1
5944216|NCT01314261|20558781|P1|Overall Study|Virologic Failure|0
5944217|NCT01314261|20558778|P4|Overall Study|Lost to Follow-up|2
5944218|NCT01314261|20558779|P3|Overall Study|Lost to Follow-up|2
5944219|NCT01314261|20558780|P2|Overall Study|Lost to Follow-up|0
5944220|NCT01314261|20558781|P1|Overall Study|Lost to Follow-up|1
5944221|NCT01314261|20558778|P4|Overall Study|Withdrawal by Subject|0
5944222|NCT01314261|20558779|P3|Overall Study|Withdrawal by Subject|1
5944223|NCT01314261|20558780|P2|Overall Study|Withdrawal by Subject|3
5944224|NCT01314261|20558781|P1|Overall Study|Withdrawal by Subject|0
5944225|NCT01314261|20558778|P4|Overall Study|Adverse Event|0
5944226|NCT01314261|20558779|P3|Overall Study|Adverse Event|0
5944227|NCT01314261|20558780|P2|Overall Study|Adverse Event|0
5944228|NCT01314261|20558781|P1|Overall Study|Adverse Event|1
5944229|NCT01314118|20558832|P1|Overall Study|Ongoing|62
5944230|NCT01314118|20558832|P1|Overall Study|Other|2
5944231|NCT01314118|20558832|P1|Overall Study|Withdrawal by Subject|11
5944232|NCT01314118|20558832|P1|Overall Study|Protocol Violation|5
5944233|NCT01314118|20558832|P1|Overall Study|Death|4
5944234|NCT01314118|20558832|P1|Overall Study|Physician Decision|11
5944235|NCT01314118|20558832|P1|Overall Study|Progressive disease|27
5944236|NCT01314118|20558832|P1|Overall Study|Adverse Event|9
5944237|NCT01314105|20558841|P2|Overall Study|Other Adverse Event|1
5944238|NCT01314105|20558842|P1|Overall Study|Other Adverse Event|1
5944239|NCT01314105|20558841|P2|Overall Study|Refused to continue taking medication|1
5944240|NCT01314105|20558842|P1|Overall Study|Refused to continue taking medication|0
5944241|NCT01314105|20558841|P2|Overall Study|Progressive Disease|10
5944242|NCT01314105|20558842|P1|Overall Study|Progressive Disease|6
5944243|NCT01313923|20558960|P1|Overall Study|Physician Decision|3
5944244|NCT01313884|20558976|P1|Overall Study|Per insurance pvdr, pt can't be on cl tr|1
5944245|NCT01313858|20558984|P3|Overall Study|Lost to Follow-up|47
5944246|NCT01313858|20558985|P2|Overall Study|Lost to Follow-up|51
5944247|NCT01313858|20558986|P1|Overall Study|Lost to Follow-up|35
5944248|NCT01313858|20558984|P3|Overall Study|Premature Treatment Termination|191
5944249|NCT01313858|20558985|P2|Overall Study|Premature Treatment Termination|219
5944250|NCT01313858|20558986|P1|Overall Study|Premature Treatment Termination|251
5944251|NCT01313780|20559009|P2|Overall Study|missing data|3
5944252|NCT01313780|20559010|P1|Overall Study|missing data|3
5944253|NCT01313780|20559009|P2|Overall Study|Protocol Violation|4
5944254|NCT01313780|20559010|P1|Overall Study|Protocol Violation|10
5944255|NCT01313780|20559009|P2|Overall Study|Withdrawal by Subject|8
5944256|NCT01313780|20559010|P1|Overall Study|Withdrawal by Subject|2
5944257|NCT01313780|20559009|P2|Overall Study|Adverse Event|11
5944258|NCT01313780|20559010|P1|Overall Study|Adverse Event|6
5944259|NCT01313780|20559009|P2|Overall Study|Lack of Efficacy|2
5944260|NCT01313780|20559010|P1|Overall Study|Lack of Efficacy|4
5944261|NCT01313767|20559020|P2|Overall Study|Protocol Violation|1
5944262|NCT01313767|20559021|P1|Overall Study|Protocol Violation|3
5944263|NCT01313767|20559020|P2|Overall Study|Withdrawal by Subject|1
5944264|NCT01313767|20559021|P1|Overall Study|Withdrawal by Subject|2
5944265|NCT01313767|20559020|P2|Overall Study|Lost to Follow-up|0
5944266|NCT01313767|20559021|P1|Overall Study|Lost to Follow-up|1
5944267|NCT01313767|20559020|P2|Overall Study|Adverse Event|0
5944268|NCT01313767|20559021|P1|Overall Study|Adverse Event|1
5944269|NCT01313728|20559063|P1|Informed Consent to Baseline|Withdrawal by Subject|1
5944270|NCT01313689|20559083|P5|24-Week Randomization 2|Physician Decision|4
5944271|NCT01313689|20559084|P4|24-Week Randomization 2|Physician Decision|0
5944272|NCT01313689|20559085|P3|24-Week Randomization 2|Physician Decision|0
5944273|NCT01313689|20559086|P2|24-Week Randomization 2|Physician Decision|0
5944274|NCT01313689|20559087|P1|24-Week Randomization 2|Physician Decision|0
5944275|NCT01313689|20559083|P5|24-Week Randomization 2|Withdrawal by Subject|3
5944276|NCT01313689|20559084|P4|24-Week Randomization 2|Withdrawal by Subject|1
5944277|NCT01313689|20559085|P3|24-Week Randomization 2|Withdrawal by Subject|1
5944278|NCT01313689|20559086|P2|24-Week Randomization 2|Withdrawal by Subject|0
5944279|NCT01313689|20559087|P1|24-Week Randomization 2|Withdrawal by Subject|0
5944280|NCT01313689|20559083|P5|24-Week Randomization 2|Adverse Event|8
5944281|NCT01313689|20559084|P4|24-Week Randomization 2|Adverse Event|0
5944282|NCT01313689|20559085|P3|24-Week Randomization 2|Adverse Event|2
5944283|NCT01313689|20559086|P2|24-Week Randomization 2|Adverse Event|0
5944284|NCT01313689|20559087|P1|24-Week Randomization 2|Adverse Event|0
5944285|NCT01313689|20559083|P5|24-Week Randomization 1|Withdrawal by Subject|0
5944286|NCT01313689|20559084|P4|24-Week Randomization 1|Withdrawal by Subject|0
5944287|NCT01313689|20559085|P3|24-Week Randomization 1|Withdrawal by Subject|0
5944288|NCT01313689|20559086|P2|24-Week Randomization 1|Withdrawal by Subject|0
5944289|NCT01313689|20559087|P1|24-Week Randomization 1|Withdrawal by Subject|5
5944290|NCT01313689|20559083|P5|24-Week Randomization 1|Physician Decision|0
5944291|NCT01313689|20559084|P4|24-Week Randomization 1|Physician Decision|0
5944292|NCT01313689|20559085|P3|24-Week Randomization 1|Physician Decision|0
5944293|NCT01313689|20559086|P2|24-Week Randomization 1|Physician Decision|5
5944294|NCT01313689|20559087|P1|24-Week Randomization 1|Physician Decision|4
5944295|NCT01313689|20559083|P5|24-Week Randomization 1|Adverse Event|0
5944296|NCT01313689|20559084|P4|24-Week Randomization 1|Adverse Event|0
5944297|NCT01313689|20559085|P3|24-Week Randomization 1|Adverse Event|0
5944298|NCT01313689|20559086|P2|24-Week Randomization 1|Adverse Event|5
5944299|NCT01313689|20559087|P1|24-Week Randomization 1|Adverse Event|10
5944300|NCT01313676|20559166|P4|Overall Study|Missing|0
5944301|NCT01313676|20559167|P3|Overall Study|Missing|1
5944302|NCT01313676|20559168|P2|Overall Study|Missing|1
5944303|NCT01313676|20559169|P1|Overall Study|Missing|1
5944304|NCT01313676|20559166|P4|Overall Study|Investigator Site Closed|10
5944305|NCT01313676|20559167|P3|Overall Study|Investigator Site Closed|15
5944306|NCT01313676|20559168|P2|Overall Study|Investigator Site Closed|11
5944307|NCT01313676|20559169|P1|Overall Study|Investigator Site Closed|12
5944308|NCT01313676|20559166|P4|Overall Study|Sponsor Terminated Study Treatment|1
5944309|NCT01313676|20559167|P3|Overall Study|Sponsor Terminated Study Treatment|0
5944310|NCT01313676|20559168|P2|Overall Study|Sponsor Terminated Study Treatment|1
5944311|NCT01313676|20559169|P1|Overall Study|Sponsor Terminated Study Treatment|1
5944312|NCT01313676|20559166|P4|Overall Study|Decision by Participant or Proxy|492
5944313|NCT01313676|20559167|P3|Overall Study|Decision by Participant or Proxy|515
5944314|NCT01313676|20559168|P2|Overall Study|Decision by Participant or Proxy|527
5944315|NCT01313676|20559169|P1|Overall Study|Decision by Participant or Proxy|643
5944316|NCT01313676|20559166|P4|Overall Study|Physician Decision|48
5944317|NCT01313676|20559167|P3|Overall Study|Physician Decision|62
5944318|NCT01313676|20559168|P2|Overall Study|Physician Decision|64
5944319|NCT01313676|20559169|P1|Overall Study|Physician Decision|53
5944320|NCT01313676|20559166|P4|Overall Study|Lost to Follow-up|0
5944321|NCT01313676|20559167|P3|Overall Study|Lost to Follow-up|1
5944322|NCT01313676|20559168|P2|Overall Study|Lost to Follow-up|0
5944323|NCT01313676|20559169|P1|Overall Study|Lost to Follow-up|0
5944324|NCT01313676|20559166|P4|Overall Study|Study Closed/terminated|9
5944325|NCT01313676|20559167|P3|Overall Study|Study Closed/terminated|9
5944326|NCT01313676|20559168|P2|Overall Study|Study Closed/terminated|6
5944327|NCT01313676|20559169|P1|Overall Study|Study Closed/terminated|7
5944328|NCT01313676|20559166|P4|Overall Study|Met Protocol-Defined Stopping Critera|11
5944329|NCT01313676|20559167|P3|Overall Study|Met Protocol-Defined Stopping Critera|2
5944330|NCT01313676|20559168|P2|Overall Study|Met Protocol-Defined Stopping Critera|4
5944331|NCT01313676|20559169|P1|Overall Study|Met Protocol-Defined Stopping Critera|3
5944332|NCT01313676|20559166|P4|Overall Study|Protocol Violation|44
5944333|NCT01313676|20559167|P3|Overall Study|Protocol Violation|46
5944334|NCT01313676|20559168|P2|Overall Study|Protocol Violation|44
5944335|NCT01313676|20559169|P1|Overall Study|Protocol Violation|37
5944336|NCT01313676|20559166|P4|Overall Study|Lack of Efficacy|46
5944337|NCT01313676|20559167|P3|Overall Study|Lack of Efficacy|65
5944338|NCT01313676|20559168|P2|Overall Study|Lack of Efficacy|90
5944339|NCT01313676|20559169|P1|Overall Study|Lack of Efficacy|98
5944340|NCT01313676|20559166|P4|Overall Study|Adverse Event|333
5944341|NCT01313676|20559167|P3|Overall Study|Adverse Event|372
5944342|NCT01313676|20559168|P2|Overall Study|Adverse Event|365
5944343|NCT01313676|20559169|P1|Overall Study|Adverse Event|395
5944344|NCT01313663|20559189|P2|Overall Study|Withdrawal by Subject|1
5944345|NCT01313663|20559190|P1|Overall Study|Withdrawal by Subject|2
5944346|NCT01313663|20559189|P2|Overall Study|Physician Decision|2
5944347|NCT01313663|20559190|P1|Overall Study|Physician Decision|0
5944348|NCT01313663|20559189|P2|Overall Study|Lost to Follow-up|1
5944349|NCT01313663|20559190|P1|Overall Study|Lost to Follow-up|0
5944350|NCT01313663|20559189|P2|Overall Study|Study Closed/Terminated|4
5944351|NCT01313663|20559190|P1|Overall Study|Study Closed/Terminated|2
5944352|NCT01313650|20559228|P4|Overall Study|Met Protocol-defined Stopping Criteria|15
5944353|NCT01313650|20559229|P3|Overall Study|Met Protocol-defined Stopping Criteria|24
5944354|NCT01313650|20559230|P2|Overall Study|Met Protocol-defined Stopping Criteria|13
5944355|NCT01313650|20559231|P1|Overall Study|Met Protocol-defined Stopping Criteria|9
5944356|NCT01313650|20559228|P4|Overall Study|Protocol Violation|6
5944357|NCT01313650|20559229|P3|Overall Study|Protocol Violation|5
5944358|NCT01313650|20559230|P2|Overall Study|Protocol Violation|7
5944359|NCT01313650|20559231|P1|Overall Study|Protocol Violation|4
5944360|NCT01313650|20559228|P4|Overall Study|Withdrawal by Subject|15
5944361|NCT01313650|20559229|P3|Overall Study|Withdrawal by Subject|15
5944362|NCT01313650|20559230|P2|Overall Study|Withdrawal by Subject|20
5944363|NCT01313650|20559231|P1|Overall Study|Withdrawal by Subject|16
5944364|NCT01313650|20559228|P4|Overall Study|Lost to Follow-up|2
5944365|NCT01313650|20559229|P3|Overall Study|Lost to Follow-up|3
5944366|NCT01313650|20559230|P2|Overall Study|Lost to Follow-up|0
5944367|NCT01313650|20559231|P1|Overall Study|Lost to Follow-up|1
5944368|NCT01313650|20559228|P4|Overall Study|Lack of Efficacy|20
5944369|NCT01313650|20559229|P3|Overall Study|Lack of Efficacy|32
5944370|NCT01313650|20559230|P2|Overall Study|Lack of Efficacy|20
5944371|NCT01313650|20559231|P1|Overall Study|Lack of Efficacy|37
5944372|NCT01313650|20559228|P4|Overall Study|Adverse Event|23
5944373|NCT01313650|20559229|P3|Overall Study|Adverse Event|24
5944374|NCT01313650|20559230|P2|Overall Study|Adverse Event|34
5944375|NCT01313650|20559231|P1|Overall Study|Adverse Event|9
5944376|NCT01313637|20559257|P4|Overall Study|Withdrawal by Subject|15
5944377|NCT01313637|20559258|P3|Overall Study|Withdrawal by Subject|18
5944378|NCT01313637|20559259|P2|Overall Study|Withdrawal by Subject|13
5944379|NCT01313637|20559260|P1|Overall Study|Withdrawal by Subject|11
5944380|NCT01313637|20559257|P4|Overall Study|Lost to Follow-up|3
5944381|NCT01313637|20559258|P3|Overall Study|Lost to Follow-up|1
5944382|NCT01313637|20559259|P2|Overall Study|Lost to Follow-up|2
5944383|NCT01313637|20559260|P1|Overall Study|Lost to Follow-up|0
5944384|NCT01313637|20559257|P4|Overall Study|Met Protocol- Defined Stopping Criteria|13
5944385|NCT01313637|20559258|P3|Overall Study|Met Protocol- Defined Stopping Criteria|14
5944386|NCT01313637|20559259|P2|Overall Study|Met Protocol- Defined Stopping Criteria|15
5944387|NCT01313637|20559260|P1|Overall Study|Met Protocol- Defined Stopping Criteria|16
5944388|NCT01313637|20559257|P4|Overall Study|Protocol Violation|5
5944389|NCT01313637|20559258|P3|Overall Study|Protocol Violation|11
5944390|NCT01313637|20559259|P2|Overall Study|Protocol Violation|3
5944391|NCT01313637|20559260|P1|Overall Study|Protocol Violation|4
5944392|NCT01313637|20559257|P4|Overall Study|Lack of Efficacy|24
5944393|NCT01313637|20559258|P3|Overall Study|Lack of Efficacy|37
5944394|NCT01313637|20559259|P2|Overall Study|Lack of Efficacy|38
5944395|NCT01313637|20559260|P1|Overall Study|Lack of Efficacy|44
5944396|NCT01313637|20559257|P4|Overall Study|Adverse Event|18
5944397|NCT01313637|20559258|P3|Overall Study|Adverse Event|25
5944398|NCT01313637|20559259|P2|Overall Study|Adverse Event|24
5944399|NCT01313637|20559260|P1|Overall Study|Adverse Event|17
5944400|NCT01313624|20559284|P2|Open-Label Phase|Lost to Follow-up|1
5944401|NCT01313624|20559285|P1|Open-Label Phase|Lost to Follow-up|1
5944402|NCT01313624|20559284|P2|Open-Label Phase|Withdrawal by Subject|2
5944403|NCT01313624|20559285|P1|Open-Label Phase|Withdrawal by Subject|2
5944404|NCT01313624|20559284|P2|Open-Label Phase|Adverse Event|10
5944405|NCT01313624|20559285|P1|Open-Label Phase|Adverse Event|1
5944406|NCT01313624|20559284|P2|Double-Blind Phase|Lack of Efficacy|0
5944407|NCT01313624|20559285|P1|Double-Blind Phase|Lack of Efficacy|1
5944408|NCT01313624|20559284|P2|Double-Blind Phase|Physician Decision|0
5944409|NCT01313624|20559285|P1|Double-Blind Phase|Physician Decision|1
5944410|NCT01313624|20559284|P2|Double-Blind Phase|Lost to Follow-up|2
5944411|NCT01313624|20559285|P1|Double-Blind Phase|Lost to Follow-up|0
5944412|NCT01313624|20559284|P2|Double-Blind Phase|Withdrawal by Subject|4
5944413|NCT01313624|20559285|P1|Double-Blind Phase|Withdrawal by Subject|9
5944414|NCT01313624|20559284|P2|Double-Blind Phase|Adverse Event|4
5944415|NCT01313624|20559285|P1|Double-Blind Phase|Adverse Event|27
5944416|NCT01313559|20559299|P2|Overall Study|Rising PSA|0
5944417|NCT01313559|20559300|P1|Overall Study|Rising PSA|2
5944418|NCT01313559|20559299|P2|Overall Study|Disease progression|0
5944419|NCT01313559|20559300|P1|Overall Study|Disease progression|1
5944420|NCT01313559|20559299|P2|Overall Study|Withdrawal by Subject|2
5944421|NCT01313559|20559300|P1|Overall Study|Withdrawal by Subject|1
5944422|NCT01313312|20559401|P1|Overall Study|Did Not Receive Treatment with Dysport®|4
5944423|NCT01313312|20559401|P1|Overall Study|Subject Withdrawn Early in Error|4
5944424|NCT01313312|20559401|P1|Overall Study|Observational Phase|1
5944425|NCT01313312|20559401|P1|Overall Study|Investigator Decision|1
5944426|NCT01313312|20559401|P1|Overall Study|Lack of Efficacy|3
5944427|NCT01313312|20559401|P1|Overall Study|Withdrawal by Subject|18
5944428|NCT01313312|20559401|P1|Overall Study|Adverse Event|5
5944429|NCT01313299|20559448|P3|Overall Study|Lack of subject compliance|1
5944430|NCT01313299|20559449|P2|Overall Study|Lack of subject compliance|0
5944431|NCT01313299|20559450|P1|Overall Study|Lack of subject compliance|0
5944432|NCT01313299|20559448|P3|Overall Study|Family reason and moved out of state|0
5944433|NCT01313299|20559449|P2|Overall Study|Family reason and moved out of state|2
5944434|NCT01313299|20559450|P1|Overall Study|Family reason and moved out of state|0
5944435|NCT01313299|20559448|P3|Overall Study|Withdrawal by Subject|2
5944436|NCT01313299|20559449|P2|Overall Study|Withdrawal by Subject|0
5944437|NCT01313299|20559450|P1|Overall Study|Withdrawal by Subject|1
5944438|NCT01313299|20559448|P3|Overall Study|Protocol Violation|0
5944439|NCT01313299|20559449|P2|Overall Study|Protocol Violation|0
5944440|NCT01313299|20559450|P1|Overall Study|Protocol Violation|2
5944441|NCT01313299|20559448|P3|Overall Study|Lost to Follow-up|0
5944442|NCT01313299|20559449|P2|Overall Study|Lost to Follow-up|0
5944443|NCT01313299|20559450|P1|Overall Study|Lost to Follow-up|1
5944444|NCT01313299|20559448|P3|Overall Study|Adverse Event|1
5944445|NCT01313299|20559449|P2|Overall Study|Adverse Event|1
5944446|NCT01313299|20559450|P1|Overall Study|Adverse Event|3
5944447|NCT01313286|20559464|P2|Period 1|Withdrawal by Subject|0
5944448|NCT01313286|20559465|P1|Period 1|Withdrawal by Subject|2
5944449|NCT01313273|20559475|P2|Overall Study|Screening Chromogranin A-in normal range|1
5944450|NCT01313273|20559476|P1|Overall Study|Screening Chromogranin A-in normal range|0
5944451|NCT01313273|20559475|P2|Overall Study|Withdrawal by Subject|0
5944452|NCT01313273|20559476|P1|Overall Study|Withdrawal by Subject|1
5944453|NCT01313273|20559475|P2|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|0
5944454|NCT01313273|20559476|P1|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|1
5944455|NCT01313221|20559491|P3|Overall Study|Pregnancy|2
5944456|NCT01313221|20559492|P2|Overall Study|Pregnancy|0
5944457|NCT01313221|20559493|P1|Overall Study|Pregnancy|0
5944458|NCT01313221|20559491|P3|Overall Study|Physician Decision|2
5944459|NCT01313221|20559492|P2|Overall Study|Physician Decision|0
5944460|NCT01313221|20559493|P1|Overall Study|Physician Decision|0
5944461|NCT01313221|20559491|P3|Overall Study|Disease progression|2
5944462|NCT01313221|20559492|P2|Overall Study|Disease progression|0
5944463|NCT01313221|20559493|P1|Overall Study|Disease progression|0
5944464|NCT01313221|20559491|P3|Overall Study|Adverse Event|7
5944465|NCT01313221|20559492|P2|Overall Study|Adverse Event|0
5944466|NCT01313221|20559493|P1|Overall Study|Adverse Event|0
5944467|NCT01313221|20559491|P3|Overall Study|Other|0
5944468|NCT01313221|20559492|P2|Overall Study|Other|0
5944469|NCT01313221|20559493|P1|Overall Study|Other|1
5944470|NCT01313221|20559491|P3|Overall Study|Lost to Follow-up|1
5944471|NCT01313221|20559492|P2|Overall Study|Lost to Follow-up|3
5944472|NCT01313221|20559493|P1|Overall Study|Lost to Follow-up|6
5944473|NCT01313221|20559491|P3|Overall Study|Requirement for alternative therapy|1
5944474|NCT01313221|20559492|P2|Overall Study|Requirement for alternative therapy|1
5944475|NCT01313221|20559493|P1|Overall Study|Requirement for alternative therapy|0
5944476|NCT01313221|20559491|P3|Overall Study|Withdrawal by Subject|5
5944477|NCT01313221|20559492|P2|Overall Study|Withdrawal by Subject|3
5944478|NCT01313221|20559493|P1|Overall Study|Withdrawal by Subject|2
5944479|NCT01313221|20559491|P3|Overall Study|Non-compliance|2
5944480|NCT01313221|20559492|P2|Overall Study|Non-compliance|0
5944481|NCT01313221|20559493|P1|Overall Study|Non-compliance|3
5944482|NCT01313221|20559491|P3|Overall Study|Protocol Violation|1
5944483|NCT01313221|20559492|P2|Overall Study|Protocol Violation|1
5944484|NCT01313221|20559493|P1|Overall Study|Protocol Violation|0
5944485|NCT01313208|20559545|P2|Open-label Phase (Weeks 13 - 24)|Other|0
5944486|NCT01313208|20559546|P1|Open-label Phase (Weeks 13 - 24)|Other|2
5944487|NCT01313208|20559545|P2|Open-label Phase (Weeks 13 - 24)|Adverse Event|0
5944488|NCT01313208|20559546|P1|Open-label Phase (Weeks 13 - 24)|Adverse Event|1
5944489|NCT01313208|20559545|P2|Open-label Phase (Weeks 13 - 24)|Noncompliance|2
5944490|NCT01313208|20559546|P1|Open-label Phase (Weeks 13 - 24)|Noncompliance|0
5944491|NCT01313208|20559545|P2|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|1
5944492|NCT01313208|20559546|P1|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|3
5944493|NCT01313208|20559545|P2|Double-blind Phase (Weeks 1 - 12)|Noncompliance|0
5944494|NCT01313208|20559546|P1|Double-blind Phase (Weeks 1 - 12)|Noncompliance|1
5944495|NCT01313208|20559545|P2|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|0
5944496|NCT01313208|20559546|P1|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|1
5944497|NCT01313208|20559545|P2|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|1
5944498|NCT01313208|20559546|P1|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|0
5944499|NCT01313208|20559545|P2|Double-blind Phase (Weeks 1 - 12)|Adverse Event|2
5944500|NCT01313208|20559546|P1|Double-blind Phase (Weeks 1 - 12)|Adverse Event|1
5944501|NCT01313208|20559545|P2|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|2
5944502|NCT01313208|20559546|P1|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|3
5944503|NCT01313182|20559636|P2|Overall Study|Protocol Violation|92
5944504|NCT01313182|20559637|P1|Overall Study|Protocol Violation|66
5944505|NCT01313117|20559649|P1|Cohort 5: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1
5944506|NCT01313117|20559649|P1|Cohort 2: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1
5944507|NCT01313078|20559656|P1|Overall Study|Withdrawal by Subject|1
5944508|NCT01313078|20559656|P1|Overall Study|Discontinued study drug|1
5944509|NCT01313078|20559656|P1|Overall Study|Death|1
5944510|NCT01313039|20559661|P1|Overall Study|Adverse Event|1
5944511|NCT01313039|20559661|P1|Overall Study|Physician Decision|1
5944512|NCT01312961|20559667|P2|Overall Study|Other than specified above|3
5944513|NCT01312961|20559668|P1|Overall Study|Other than specified above|2
5944514|NCT01312961|20559667|P2|Overall Study|Poor compliance to protocol|0
5944515|NCT01312961|20559668|P1|Overall Study|Poor compliance to protocol|1
5944516|NCT01312961|20559667|P2|Overall Study|Lack of Efficacy|1
5944517|NCT01312961|20559668|P1|Overall Study|Lack of Efficacy|11
5944518|NCT01312961|20559667|P2|Overall Study|Adverse Event|3
5944519|NCT01312961|20559668|P1|Overall Study|Adverse Event|3
5944520|NCT01312909|20559704|P3|Overall Study|Entrance criteria not met|2
5944521|NCT01312909|20559705|P2|Overall Study|Entrance criteria not met|0
5944522|NCT01312909|20559706|P1|Overall Study|Entrance criteria not met|0
5944523|NCT01312909|20559704|P3|Overall Study|Insufficient clinical response|1
5944524|NCT01312909|20559705|P2|Overall Study|Insufficient clinical response|0
5944525|NCT01312909|20559706|P1|Overall Study|Insufficient clinical response|0
5944526|NCT01312909|20559704|P3|Overall Study|Lost to Follow-up|20
5944527|NCT01312909|20559705|P2|Overall Study|Lost to Follow-up|17
5944528|NCT01312909|20559706|P1|Overall Study|Lost to Follow-up|21
5944529|NCT01312909|20559704|P3|Overall Study|Withdrawal by Subject|7
5944530|NCT01312909|20559705|P2|Overall Study|Withdrawal by Subject|10
5944531|NCT01312909|20559706|P1|Overall Study|Withdrawal by Subject|8
5944532|NCT01312909|20559704|P3|Overall Study|Other|11
5944533|NCT01312909|20559705|P2|Overall Study|Other|6
5944534|NCT01312909|20559706|P1|Overall Study|Other|9
5944535|NCT01312909|20559704|P3|Overall Study|Protocol Violation|2
5944536|NCT01312909|20559705|P2|Overall Study|Protocol Violation|0
5944537|NCT01312909|20559706|P1|Overall Study|Protocol Violation|2
5944538|NCT01312909|20559704|P3|Overall Study|Adverse Event|3
5944539|NCT01312909|20559705|P2|Overall Study|Adverse Event|0
5944540|NCT01312909|20559706|P1|Overall Study|Adverse Event|1
5944541|NCT01312909|20559704|P3|Overall Study|Randomized but not treated|1
5944542|NCT01312909|20559705|P2|Overall Study|Randomized but not treated|3
5944543|NCT01312909|20559706|P1|Overall Study|Randomized but not treated|1
5944544|NCT01312779|20559793|P1|Overall Study|Not Implanted with Device|27
5944545|NCT01312779|20559793|P1|Overall Study|Death|3
5944546|NCT01312779|20559793|P1|Overall Study|Withdrawal by Subject|2
5944547|NCT01312467|20559876|P1|Overall Study|Ineligible|4
5944548|NCT01312467|20559876|P1|Overall Study|Another medical condition|1
5944549|NCT01312467|20559876|P1|Overall Study|Deported to country of origin|1
5944550|NCT01312467|20559876|P1|Overall Study|Withdrawal by Subject|2
5944551|NCT01312467|20559876|P1|Overall Study|Lost to Follow-up|1
5944552|NCT01312467|20559876|P1|Overall Study|Adverse Event|4
5944553|NCT01312428|20559885|P2|Overall Study|Study Termination|4
5944554|NCT01312428|20559886|P1|Overall Study|Study Termination|3
5944555|NCT01312129|20559956|P2|Second Intervention (24 Hours)|Lost to Follow-up|1
5944556|NCT01312129|20559957|P1|Second Intervention (24 Hours)|Lost to Follow-up|0
5944557|NCT01311661|20560042|P1|Overall Study|Withdrawal by Subject|2
5944558|NCT01311661|20560042|P1|Overall Study|Protocol Violation|3
5944559|NCT01311661|20560042|P1|Overall Study|Adverse Event|2
5944560|NCT01311648|20560187|P3|Overall Study|Withdrawal by Subject|2
5944561|NCT01311648|20560188|P2|Overall Study|Withdrawal by Subject|0
5944562|NCT01311648|20560189|P1|Overall Study|Withdrawal by Subject|0
5944563|NCT01311648|20560187|P3|Overall Study|Inhibitor management|17
5944564|NCT01311648|20560188|P2|Overall Study|Inhibitor management|0
5944565|NCT01311648|20560189|P1|Overall Study|Inhibitor management|0
5944566|NCT01311648|20560187|P3|Overall Study|Adverse Event|1
5944567|NCT01311648|20560188|P2|Overall Study|Adverse Event|0
5944568|NCT01311648|20560189|P1|Overall Study|Adverse Event|0
5944569|NCT01311648|20560187|P3|Overall Study|Protocol Violation|1
5944570|NCT01311648|20560188|P2|Overall Study|Protocol Violation|0
5944571|NCT01311648|20560189|P1|Overall Study|Protocol Violation|0
5944572|NCT01311557|20560234|P2|Overall Study|Withdrawal by Subject|2
5944573|NCT01311557|20560235|P1|Overall Study|Withdrawal by Subject|1
5944574|NCT01311557|20560234|P2|Overall Study|Lost to Follow-up|1
5944575|NCT01311557|20560235|P1|Overall Study|Lost to Follow-up|0
5944576|NCT01311557|20560234|P2|Overall Study|Protocol Violation|2
5944577|NCT01311557|20560235|P1|Overall Study|Protocol Violation|4
5944578|NCT01311557|20560234|P2|Overall Study|Serious adverse event|1
5944579|NCT01311557|20560235|P1|Overall Study|Serious adverse event|0
5944580|NCT01311505|20560251|P2|First Intervention Period|Protocol Violation|1
5944581|NCT01311505|20560252|P1|First Intervention Period|Protocol Violation|0
5944584|NCT01310868|20560315|P1|Overall Study|Do not have histologically confirmed GBM|13
5944585|NCT01310803|20560332|P2|Overall Study|Subject terminated by Sponsor|0
5944586|NCT01310803|20560333|P1|Overall Study|Subject terminated by Sponsor|1
5944587|NCT01310777|20560344|P3|Overall Study|Other|2
5944588|NCT01310777|20560345|P2|Overall Study|Other|1
5944589|NCT01310777|20560346|P1|Overall Study|Other|4
5944590|NCT01310777|20560344|P3|Overall Study|Inadequate Control of IOP|10
5944591|NCT01310777|20560345|P2|Overall Study|Inadequate Control of IOP|7
5944592|NCT01310777|20560346|P1|Overall Study|Inadequate Control of IOP|5
5944593|NCT01310777|20560344|P3|Overall Study|Patient's Decision Unrelated to AE|2
5944594|NCT01310777|20560345|P2|Overall Study|Patient's Decision Unrelated to AE|1
5944595|NCT01310777|20560346|P1|Overall Study|Patient's Decision Unrelated to AE|1
5944596|NCT01310777|20560344|P3|Overall Study|Lost to Follow-up|1
5944597|NCT01310777|20560345|P2|Overall Study|Lost to Follow-up|4
5944598|NCT01310777|20560346|P1|Overall Study|Lost to Follow-up|0
5944599|NCT01310777|20560344|P3|Overall Study|Adverse Event|15
5944600|NCT01310777|20560345|P2|Overall Study|Adverse Event|1
5944601|NCT01310777|20560346|P1|Overall Study|Adverse Event|23
5944602|NCT01310699|20560356|P2|Overall Study|Patients did not complete tandem.|6
5944603|NCT01310699|20560357|P1|Overall Study|Patients did not complete tandem.|4
5944604|NCT01310413|20560384|P7|From Day U0 to Day U385|Lost to Follow-up|2
5944605|NCT01310413|20560385|P6|From Day U0 to Day U385|Lost to Follow-up|0
5944606|NCT01310413|20560386|P5|From Day U0 to Day U385|Lost to Follow-up|0
5944607|NCT01310413|20560387|P4|From Day U0 to Day U385|Lost to Follow-up|0
5944608|NCT01310413|20560388|P3|From Day U0 to Day U385|Lost to Follow-up|0
5944609|NCT01310413|20560389|P2|From Day U0 to Day U385|Lost to Follow-up|0
5944610|NCT01310413|20560390|P1|From Day U0 to Day U385|Lost to Follow-up|0
5944611|NCT01310413|20560384|P7|From Day U0 to Day U385|Withdrawal by Subject|1
5944612|NCT01310413|20560385|P6|From Day U0 to Day U385|Withdrawal by Subject|0
5944613|NCT01310413|20560386|P5|From Day U0 to Day U385|Withdrawal by Subject|0
5944614|NCT01310413|20560387|P4|From Day U0 to Day U385|Withdrawal by Subject|0
5944615|NCT01310413|20560388|P3|From Day U0 to Day U385|Withdrawal by Subject|0
5944616|NCT01310413|20560389|P2|From Day U0 to Day U385|Withdrawal by Subject|0
5944617|NCT01310413|20560390|P1|From Day U0 to Day U385|Withdrawal by Subject|0
5944618|NCT01310413|20560384|P7|Day 0 to Day 385|Other|0
5944619|NCT01310413|20560385|P6|Day 0 to Day 385|Other|0
5944620|NCT01310413|20560386|P5|Day 0 to Day 385|Other|0
5944621|NCT01310413|20560387|P4|Day 0 to Day 385|Other|0
5944622|NCT01310413|20560388|P3|Day 0 to Day 385|Other|3
5944623|NCT01310413|20560389|P2|Day 0 to Day 385|Other|0
5944624|NCT01310413|20560390|P1|Day 0 to Day 385|Other|1
5944625|NCT01310413|20560384|P7|Day 0 to Day 385|Migrated/moved from study area|0
5944626|NCT01310413|20560385|P6|Day 0 to Day 385|Migrated/moved from study area|0
5944627|NCT01310413|20560386|P5|Day 0 to Day 385|Migrated/moved from study area|1
5944628|NCT01310413|20560387|P4|Day 0 to Day 385|Migrated/moved from study area|1
5944629|NCT01310413|20560388|P3|Day 0 to Day 385|Migrated/moved from study area|1
5944630|NCT01310413|20560389|P2|Day 0 to Day 385|Migrated/moved from study area|3
5944631|NCT01310413|20560390|P1|Day 0 to Day 385|Migrated/moved from study area|3
5944632|NCT01310413|20560384|P7|Day 0 to Day 385|Lost to Follow-up|0
5944633|NCT01310413|20560385|P6|Day 0 to Day 385|Lost to Follow-up|2
5944634|NCT01310413|20560386|P5|Day 0 to Day 385|Lost to Follow-up|1
5944635|NCT01310413|20560387|P4|Day 0 to Day 385|Lost to Follow-up|5
5944636|NCT01310413|20560388|P3|Day 0 to Day 385|Lost to Follow-up|3
5944637|NCT01310413|20560389|P2|Day 0 to Day 385|Lost to Follow-up|3
5944638|NCT01310413|20560390|P1|Day 0 to Day 385|Lost to Follow-up|18
5944639|NCT01310413|20560384|P7|Day 0 to Day 385|Withdrawal by Subject|0
5944640|NCT01310413|20560385|P6|Day 0 to Day 385|Withdrawal by Subject|1
5944641|NCT01310413|20560386|P5|Day 0 to Day 385|Withdrawal by Subject|1
5944642|NCT01310413|20560387|P4|Day 0 to Day 385|Withdrawal by Subject|2
5944643|NCT01310413|20560388|P3|Day 0 to Day 385|Withdrawal by Subject|0
5944644|NCT01310413|20560389|P2|Day 0 to Day 385|Withdrawal by Subject|2
5944645|NCT01310413|20560390|P1|Day 0 to Day 385|Withdrawal by Subject|5
5944646|NCT01310127|20560572|P2|Overall Study|advanced psc cataract outlier|0
5944647|NCT01310127|20560573|P1|Overall Study|advanced psc cataract outlier|1
5944648|NCT01310127|20560572|P2|Overall Study|Protocol Violation|1
5944649|NCT01310127|20560573|P1|Overall Study|Protocol Violation|1
5944650|NCT01310075|20560587|P2|Overall Study|Withdrawal by Subject|1
5944651|NCT01310075|20560588|P1|Overall Study|Withdrawal by Subject|1
5944652|NCT01310075|20560587|P2|Overall Study|Protocol Violation|2
5944653|NCT01310075|20560588|P1|Overall Study|Protocol Violation|2
5944654|NCT01310075|20560587|P2|Overall Study|Physician Decision|7
5944655|NCT01310075|20560588|P1|Overall Study|Physician Decision|10
5944656|NCT01310075|20560587|P2|Overall Study|Lost to Follow-up|0
5944657|NCT01310075|20560588|P1|Overall Study|Lost to Follow-up|1
5944658|NCT01310036|20560594|P1|Overall Study|Adverse event or intercurrent illness|12
5944659|NCT01310036|20560594|P1|Overall Study|Death|1
5944660|NCT01310036|20560594|P1|Overall Study|Progression of Disease|164
5944661|NCT01310036|20560594|P1|Overall Study|Refused Treatment/Did not Cooperate|4
5944662|NCT01310036|20560594|P1|Overall Study|Withdrew Consent|11
5944663|NCT01310036|20560594|P1|Overall Study|Administrative/other|10
5944664|NCT01309997|20560607|P2|Overall Study|Withdrawal by Subject|1
5944665|NCT01309997|20560608|P1|Overall Study|Withdrawal by Subject|1
5944666|NCT01309997|20560607|P2|Overall Study|Lack of Efficacy|2
5944667|NCT01309997|20560608|P1|Overall Study|Lack of Efficacy|2
5944668|NCT01309997|20560607|P2|Overall Study|Death|3
5944669|NCT01309997|20560608|P1|Overall Study|Death|1
5944670|NCT01309997|20560607|P2|Overall Study|Adverse Event|0
5944671|NCT01309997|20560608|P1|Overall Study|Adverse Event|1
5944672|NCT01309919|20560632|P2|Overall Study|Did not receive a postpartum IUD|48
5944673|NCT01309919|20560633|P1|Overall Study|Did not receive a postpartum IUD|17
5944674|NCT01309893|20560656|P2|Week 2 - Crossover Intervention|Missed crossover visit|1
5944675|NCT01309893|20560657|P1|Week 2 - Crossover Intervention|Missed crossover visit|0
5944676|NCT01309893|20560656|P2|Week 2 - Crossover Intervention|Lost to Follow-up|0
5944677|NCT01309893|20560657|P1|Week 2 - Crossover Intervention|Lost to Follow-up|1
5944678|NCT01309841|20560694|P3|Overall Study|Severe non-compliance with protocol|2
5944679|NCT01309841|20560695|P2|Overall Study|Severe non-compliance with protocol|5
5944680|NCT01309841|20560696|P1|Overall Study|Severe non-compliance with protocol|0
5944681|NCT01309841|20560694|P3|Overall Study|Did Not Receive Treatment|1
5944682|NCT01309841|20560695|P2|Overall Study|Did Not Receive Treatment|0
5944683|NCT01309841|20560696|P1|Overall Study|Did Not Receive Treatment|2
5944684|NCT01309841|20560694|P3|Overall Study|Withdrawal by Subject|13
5944685|NCT01309841|20560695|P2|Overall Study|Withdrawal by Subject|6
5944686|NCT01309841|20560696|P1|Overall Study|Withdrawal by Subject|17
5944687|NCT01309841|20560694|P3|Overall Study|Eligibility Criteria Not Fulfilled|1
5944688|NCT01309841|20560695|P2|Overall Study|Eligibility Criteria Not Fulfilled|0
5944689|NCT01309841|20560696|P1|Overall Study|Eligibility Criteria Not Fulfilled|0
5944690|NCT01309841|20560694|P3|Overall Study|Death|0
5944691|NCT01309841|20560695|P2|Overall Study|Death|0
5944692|NCT01309841|20560696|P1|Overall Study|Death|1
5944693|NCT01309841|20560694|P3|Overall Study|Adverse Event|11
5944694|NCT01309841|20560695|P2|Overall Study|Adverse Event|22
5944695|NCT01309841|20560696|P1|Overall Study|Adverse Event|9
5944696|NCT01309841|20560694|P3|Overall Study|Lack of Efficacy|2
5944697|NCT01309841|20560695|P2|Overall Study|Lack of Efficacy|0
5944698|NCT01309841|20560696|P1|Overall Study|Lack of Efficacy|0
5944699|NCT01309841|20560694|P3|Overall Study|Study-Specific Withdrawal Criteria|2
5944700|NCT01309841|20560695|P2|Overall Study|Study-Specific Withdrawal Criteria|1
5944701|NCT01309841|20560696|P1|Overall Study|Study-Specific Withdrawal Criteria|3
5944702|NCT01309841|20560694|P3|Overall Study|Lost to Follow-up|4
5944703|NCT01309841|20560695|P2|Overall Study|Lost to Follow-up|6
5944704|NCT01309841|20560696|P1|Overall Study|Lost to Follow-up|7
5944705|NCT01309841|20560694|P3|Overall Study|Other|1
5944706|NCT01309841|20560695|P2|Overall Study|Other|1
5944707|NCT01309841|20560696|P1|Overall Study|Other|0
5944708|NCT01309828|20560736|P2|Overall Study|Other|0
5944709|NCT01309828|20560737|P1|Overall Study|Other|1
5944710|NCT01309828|20560736|P2|Overall Study|Major Protocol Deviation|1
5944711|NCT01309828|20560737|P1|Overall Study|Major Protocol Deviation|0
5944712|NCT01309828|20560736|P2|Overall Study|Voluntary Withdrawal|4
5944713|NCT01309828|20560737|P1|Overall Study|Voluntary Withdrawal|5
5944714|NCT01309828|20560736|P2|Overall Study|Adverse Event|11
5944715|NCT01309828|20560737|P1|Overall Study|Adverse Event|10
5944716|NCT01309737|20560771|P5|Week 16 to 52|Other|0
5944717|NCT01309737|20560772|P4|Week 16 to 52|Other|2
5944718|NCT01309737|20560773|P3|Week 16 to 52|Other|0
5944719|NCT01309737|20560774|P2|Week 16 to 52|Other|12
5944720|NCT01309737|20560775|P1|Week 16 to 52|Other|10
5944721|NCT01309737|20560771|P5|Week 16 to 52|Withdrawal by Subject|2
5944722|NCT01309737|20560772|P4|Week 16 to 52|Withdrawal by Subject|0
5944723|NCT01309737|20560773|P3|Week 16 to 52|Withdrawal by Subject|0
5944724|NCT01309737|20560774|P2|Week 16 to 52|Withdrawal by Subject|6
5944725|NCT01309737|20560775|P1|Week 16 to 52|Withdrawal by Subject|5
5944726|NCT01309737|20560771|P5|Week 16 to 52|Lost to Follow-up|4
5944727|NCT01309737|20560772|P4|Week 16 to 52|Lost to Follow-up|1
5944728|NCT01309737|20560773|P3|Week 16 to 52|Lost to Follow-up|0
5944729|NCT01309737|20560774|P2|Week 16 to 52|Lost to Follow-up|2
5944730|NCT01309737|20560775|P1|Week 16 to 52|Lost to Follow-up|4
5944731|NCT01309737|20560771|P5|Week 16 to 52|Lack of Efficacy|21
5944732|NCT01309737|20560772|P4|Week 16 to 52|Lack of Efficacy|25
5944733|NCT01309737|20560773|P3|Week 16 to 52|Lack of Efficacy|0
5944734|NCT01309737|20560774|P2|Week 16 to 52|Lack of Efficacy|76
5944735|NCT01309737|20560775|P1|Week 16 to 52|Lack of Efficacy|107
5944736|NCT01309737|20560771|P5|Week 16 to 52|Adverse Event|5
5944737|NCT01309737|20560772|P4|Week 16 to 52|Adverse Event|6
5944738|NCT01309737|20560773|P3|Week 16 to 52|Adverse Event|0
5944739|NCT01309737|20560774|P2|Week 16 to 52|Adverse Event|7
5944740|NCT01309737|20560775|P1|Week 16 to 52|Adverse Event|7
5944741|NCT01309737|20560771|P5|Week 16 to 52|Death|1
5944742|NCT01309737|20560772|P4|Week 16 to 52|Death|0
5944743|NCT01309737|20560773|P3|Week 16 to 52|Death|0
5944744|NCT01309737|20560774|P2|Week 16 to 52|Death|0
5944745|NCT01309737|20560775|P1|Week 16 to 52|Death|0
5944746|NCT01309737|20560771|P5|Week 0 to 16|Randomized, but not treated|0
5944747|NCT01309737|20560772|P4|Week 0 to 16|Randomized, but not treated|0
5944748|NCT01309737|20560773|P3|Week 0 to 16|Randomized, but not treated|0
5944749|NCT01309737|20560774|P2|Week 0 to 16|Randomized, but not treated|0
5944750|NCT01309737|20560775|P1|Week 0 to 16|Randomized, but not treated|1
5944751|NCT01309737|20560771|P5|Week 0 to 16|Other|0
5944752|NCT01309737|20560772|P4|Week 0 to 16|Other|0
5944753|NCT01309737|20560773|P3|Week 0 to 16|Other|4
5944754|NCT01309737|20560774|P2|Week 0 to 16|Other|14
5944755|NCT01309737|20560775|P1|Week 0 to 16|Other|10
5944756|NCT01309737|20560771|P5|Week 0 to 16|Withdrawal by Subject|0
5944757|NCT01309737|20560772|P4|Week 0 to 16|Withdrawal by Subject|0
5944758|NCT01309737|20560773|P3|Week 0 to 16|Withdrawal by Subject|7
5944759|NCT01309737|20560774|P2|Week 0 to 16|Withdrawal by Subject|6
5944760|NCT01309737|20560775|P1|Week 0 to 16|Withdrawal by Subject|7
5944761|NCT01309737|20560771|P5|Week 0 to 16|Lost to Follow-up|0
5944762|NCT01309737|20560772|P4|Week 0 to 16|Lost to Follow-up|0
5944763|NCT01309737|20560773|P3|Week 0 to 16|Lost to Follow-up|3
5944764|NCT01309737|20560774|P2|Week 0 to 16|Lost to Follow-up|8
5944765|NCT01309737|20560775|P1|Week 0 to 16|Lost to Follow-up|7
5944766|NCT01309737|20560771|P5|Week 0 to 16|Lack of Efficacy|0
5944767|NCT01309737|20560772|P4|Week 0 to 16|Lack of Efficacy|0
5944768|NCT01309737|20560773|P3|Week 0 to 16|Lack of Efficacy|24
5944769|NCT01309737|20560774|P2|Week 0 to 16|Lack of Efficacy|2
5944770|NCT01309737|20560775|P1|Week 0 to 16|Lack of Efficacy|15
5944771|NCT01309737|20560771|P5|Week 0 to 16|Adverse Event|0
5944772|NCT01309737|20560772|P4|Week 0 to 16|Adverse Event|0
5944773|NCT01309737|20560773|P3|Week 0 to 16|Adverse Event|5
5944774|NCT01309737|20560774|P2|Week 0 to 16|Adverse Event|10
5944775|NCT01309737|20560775|P1|Week 0 to 16|Adverse Event|11
5944776|NCT01309737|20560771|P5|Week 0 to 16|Death|0
5944777|NCT01309737|20560772|P4|Week 0 to 16|Death|0
5944778|NCT01309737|20560773|P3|Week 0 to 16|Death|1
5944779|NCT01309737|20560774|P2|Week 0 to 16|Death|0
5944780|NCT01309737|20560775|P1|Week 0 to 16|Death|1
5944781|NCT01309672|20560970|P1|Overall Study|Withdrawal by Subject|3
5944782|NCT01309672|20560970|P1|Overall Study|Adverse Event|5
5944783|NCT01309672|20560970|P1|Overall Study|Other|9
5944784|NCT01309672|20560970|P1|Overall Study|Lack of Efficacy|20
5944785|NCT01309659|20560980|P2|Overall Study|Protocol Violation|1
5944786|NCT01309659|20560981|P1|Overall Study|Protocol Violation|0
5944787|NCT01309386|20561086|P2|Overall Study|Adverse Event|8
5944788|NCT01309386|20561087|P1|Overall Study|Adverse Event|5
5944789|NCT01309386|20561086|P2|Overall Study|Lack of Efficacy|1
5944790|NCT01309386|20561087|P1|Overall Study|Lack of Efficacy|3
5944791|NCT01309386|20561086|P2|Overall Study|Physician Decision|1
5944792|NCT01309386|20561087|P1|Overall Study|Physician Decision|1
5944793|NCT01309386|20561086|P2|Overall Study|Progressive disease|11
5944794|NCT01309386|20561087|P1|Overall Study|Progressive disease|9
5944795|NCT01309386|20561086|P2|Overall Study|Withdrawal by Subject|0
5944796|NCT01309386|20561087|P1|Overall Study|Withdrawal by Subject|2
5944797|NCT01309386|20561086|P2|Overall Study|Other|0
5944798|NCT01309386|20561087|P1|Overall Study|Other|2
5944799|NCT01309308|20561135|P2|Overall Study|Lost to Follow-up|4
5944800|NCT01309308|20561136|P1|Overall Study|Lost to Follow-up|6
5944801|NCT01309282|20561144|P1|Overall Study|Lost to Follow-up|1
5944802|NCT01309269|20561161|P1|Overall Study|Enrolled but not Treated|107
5944803|NCT01309269|20561161|P1|Overall Study|Study Completion Data Not Recorded|95
5944804|NCT01309269|20561161|P1|Overall Study|Other|1
5944805|NCT01309269|20561161|P1|Overall Study|Other|256
5944806|NCT01309269|20561161|P1|Overall Study|Administrative Problems|141
5944807|NCT01309269|20561161|P1|Overall Study|Kidney Transplant|25
5944808|NCT01309269|20561161|P1|Overall Study|Other Erythropoiesis-stimulating Agents|119
5944809|NCT01309269|20561161|P1|Overall Study|Lack of Acceptance|15
5944810|NCT01309269|20561161|P1|Overall Study|Withdrawal by Subject|25
5944811|NCT01309269|20561161|P1|Overall Study|Adverse Event|56
5944812|NCT01309243|20561169|P2|Extension Phase|Lost to Follow-up|0
5944813|NCT01309243|20561170|P1|Extension Phase|Lost to Follow-up|6
5944814|NCT01309243|20561169|P2|Randomized Phase Through Week 96|Protocol Violation|1
5944815|NCT01309243|20561170|P1|Randomized Phase Through Week 96|Protocol Violation|1
5944816|NCT01309243|20561169|P2|Randomized Phase Through Week 96|Subject Non-Compliance|7
5944817|NCT01309243|20561170|P1|Randomized Phase Through Week 96|Subject Non-Compliance|9
5944818|NCT01309243|20561169|P2|Randomized Phase Through Week 96|Lost to Follow-up|22
5944819|NCT01309243|20561170|P1|Randomized Phase Through Week 96|Lost to Follow-up|23
5944820|NCT01309243|20561169|P2|Randomized Phase Through Week 96|Withdrew Consent|18
5944821|NCT01309243|20561170|P1|Randomized Phase Through Week 96|Withdrew Consent|12
5944822|NCT01309243|20561169|P2|Randomized Phase Through Week 96|Investigators Discretion|6
5944823|NCT01309243|20561170|P1|Randomized Phase Through Week 96|Investigators Discretion|3
5944824|NCT01309243|20561169|P2|Randomized Phase Through Week 96|Lack of Efficacy|4
5944825|NCT01309243|20561170|P1|Randomized Phase Through Week 96|Lack of Efficacy|16
5944826|NCT01309243|20561169|P2|Randomized Phase Through Week 96|Pregnancy|0
5944827|NCT01309243|20561170|P1|Randomized Phase Through Week 96|Pregnancy|2
5944828|NCT01309243|20561169|P2|Randomized Phase Through Week 96|Death|1
5944829|NCT01309243|20561170|P1|Randomized Phase Through Week 96|Death|0
5944830|NCT01309243|20561169|P2|Randomized Phase Through Week 96|Adverse Event|43
5944831|NCT01309243|20561170|P1|Randomized Phase Through Week 96|Adverse Event|12
5944832|NCT01309243|20561169|P2|Randomized Phase Through Week 96|Randomized but not treated|7
5944833|NCT01309243|20561170|P1|Randomized Phase Through Week 96|Randomized but not treated|6
5944834|NCT01309204|20561196|P2|Overall Study|Other|1
5944835|NCT01309204|20561197|P1|Overall Study|Other|4
5944836|NCT01309204|20561196|P2|Overall Study|Inadequate control of IOP|4
5944837|NCT01309204|20561197|P1|Overall Study|Inadequate control of IOP|4
5944838|NCT01309204|20561196|P2|Overall Study|Subject's decision unrelated to an AE|10
5944839|NCT01309204|20561197|P1|Overall Study|Subject's decision unrelated to an AE|9
5944840|NCT01309204|20561196|P2|Overall Study|Lost to Follow-up|2
5944841|NCT01309204|20561197|P1|Overall Study|Lost to Follow-up|2
5944842|NCT01309204|20561196|P2|Overall Study|Adverse Event|58
5944843|NCT01309204|20561197|P1|Overall Study|Adverse Event|48
5944844|NCT01309165|20561205|P2|Overall Study|Admitted to hospital for second stroke|0
5944845|NCT01309165|20561206|P1|Overall Study|Admitted to hospital for second stroke|1
5944846|NCT01309165|20561205|P2|Overall Study|No transportation|1
5944847|NCT01309165|20561206|P1|Overall Study|No transportation|0
5944848|NCT01309165|20561205|P2|Overall Study|Left country|1
5944849|NCT01309165|20561206|P1|Overall Study|Left country|0
5944850|NCT01309165|20561205|P2|Overall Study|Return to work|2
5944851|NCT01309165|20561206|P1|Overall Study|Return to work|1
5944852|NCT01309165|20561205|P2|Overall Study|Lost to Follow-up|3
5944853|NCT01309165|20561206|P1|Overall Study|Lost to Follow-up|4
5944854|NCT01309100|20561218|P1|Overall Study|Positive Slit lamp finding|1
5944855|NCT01309100|20561218|P1|Overall Study|Protocol Violation|1
5944856|NCT01308853|20561236|P1|Overall Study|Insertion of permanent implants|1
5944857|NCT01308853|20561236|P1|Overall Study|Lost to Follow-up|2
5944858|NCT01308853|20561236|P1|Overall Study|Adverse Event|1
5944859|NCT01308788|20561271|P2|2-year Treatment|medication change by treating physician|11
5944860|NCT01308788|20561272|P1|2-year Treatment|medication change by treating physician|4
5944861|NCT01308762|20561307|P3|Overall Study|Protocol Violation|0
5944862|NCT01308762|20561308|P2|Overall Study|Protocol Violation|1
5944863|NCT01308762|20561309|P1|Overall Study|Protocol Violation|0
5944864|NCT01308749|20561322|P2|Period 2: Open Label Treatment|Lost to Follow-up|1
5944865|NCT01308749|20561323|P1|Period 2: Open Label Treatment|Lost to Follow-up|0
5944866|NCT01308749|20561322|P2|Period 2: Open Label Treatment|Adverse Event|1
5944867|NCT01308749|20561323|P1|Period 2: Open Label Treatment|Adverse Event|0
5944868|NCT01308749|20561322|P2|Period 1: Double Blind Treatment|Adverse Event|0
5944869|NCT01308749|20561323|P1|Period 1: Double Blind Treatment|Adverse Event|1
5944870|NCT01308736|20561353|P2|Overall Study|Did not attend a single session|5
5944871|NCT01308736|20561354|P1|Overall Study|Did not attend a single session|6
5944872|NCT01308580|20561377|P2|Overall Study|Lost to Follow-up|7
5944873|NCT01308580|20561378|P1|Overall Study|Lost to Follow-up|12
5944874|NCT01308567|20561421|P3|Overall Study|Lost to Follow-up|4
5944875|NCT01308567|20561422|P2|Overall Study|Lost to Follow-up|4
5944876|NCT01308567|20561423|P1|Overall Study|Lost to Follow-up|2
5944877|NCT01308476|20561463|P2|Overall Study|Other|0
5944878|NCT01308476|20561464|P1|Overall Study|Other|1
5944879|NCT01308476|20561463|P2|Overall Study|Lost to Follow-up|2
5944880|NCT01308476|20561464|P1|Overall Study|Lost to Follow-up|2
5944881|NCT01308463|20561484|P1|Overall Study|Revision|2
5944882|NCT01308463|20561484|P1|Overall Study|Death|4
5944883|NCT01308463|20561484|P1|Overall Study|Study Discontinued|23
5944884|NCT01308424|20561497|P3|Randomization|Physician Decision|1
5944885|NCT01308424|20561498|P2|Randomization|Physician Decision|1
5944886|NCT01308424|20561499|P1|Randomization|Physician Decision|0
5944887|NCT01308424|20561497|P3|Randomization|Lost to Follow-up|0
5944888|NCT01308424|20561498|P2|Randomization|Lost to Follow-up|1
5944889|NCT01308424|20561499|P1|Randomization|Lost to Follow-up|0
5944890|NCT01308424|20561497|P3|Randomization|Adverse Event|1
5944891|NCT01308424|20561498|P2|Randomization|Adverse Event|1
5944892|NCT01308424|20561499|P1|Randomization|Adverse Event|0
5944893|NCT01308424|20561497|P3|Baseline Eligibility|Screen Failures|0
5944894|NCT01308424|20561498|P2|Baseline Eligibility|Screen Failures|0
5944895|NCT01308424|20561499|P1|Baseline Eligibility|Screen Failures|71
5944896|NCT01308008|20561551|P2|4 Weeks|Illness, disinterest, time|2
5944897|NCT01308008|20561552|P1|4 Weeks|Illness, disinterest, time|9
5944898|NCT01307891|20561575|P2|Overall Study|Progressive Disease|1
5944899|NCT01307891|20561576|P1|Overall Study|Progressive Disease|3
5944900|NCT01307787|20561588|P2|Overall Study|Withdrawal by Subject|0
5944901|NCT01307787|20561589|P1|Overall Study|Withdrawal by Subject|2
5944902|NCT01307579|20561658|P2|Overall Study|Ineligible|4
5944903|NCT01307579|20561659|P1|Overall Study|Ineligible|3
5944904|NCT01307579|20561658|P2|Overall Study|Refractory or relapsed AML|23
5944905|NCT01307579|20561659|P1|Overall Study|Refractory or relapsed AML|38
5944906|NCT01307579|20561658|P2|Overall Study|Begin conditioning for HSCT|44
5944907|NCT01307579|20561659|P1|Overall Study|Begin conditioning for HSCT|42
5944908|NCT01307579|20561658|P2|Overall Study|Institutional diagnosis of IFD|36
5944909|NCT01307579|20561659|P1|Overall Study|Institutional diagnosis of IFD|21
5944910|NCT01307579|20561658|P2|Overall Study|Withdrawal by Subject|3
5944911|NCT01307579|20561659|P1|Overall Study|Withdrawal by Subject|7
5944912|NCT01307579|20561658|P2|Overall Study|Physician Decision|29
5944913|NCT01307579|20561659|P1|Overall Study|Physician Decision|26
5944914|NCT01307579|20561658|P2|Overall Study|Death|6
5944915|NCT01307579|20561659|P1|Overall Study|Death|3
5944916|NCT01307501|20561671|P1|Overall Study|Starting Hospice|1
5944917|NCT01307501|20561671|P1|Overall Study|Lost to Follow-up|1
5944918|NCT01307501|20561671|P1|Overall Study|Death|20
5944919|NCT01307501|20561671|P1|Overall Study|Treatment Failure|1
5944920|NCT01307449|20561701|P4|Overall Study|Adverse Event|0
5944921|NCT01307449|20561702|P3|Overall Study|Adverse Event|0
5944922|NCT01307449|20561703|P2|Overall Study|Adverse Event|0
5944923|NCT01307449|20561704|P1|Overall Study|Adverse Event|1
5944924|NCT01307423|20561737|P9|Long-term Safety Phase (Year 5)|Miscellaneous|1
5944925|NCT01307423|20561738|P8|Long-term Safety Phase (Year 5)|Miscellaneous|1
5944926|NCT01307423|20561739|P7|Long-term Safety Phase (Year 5)|Miscellaneous|0
5944927|NCT01307423|20561740|P6|Long-term Safety Phase (Year 5)|Miscellaneous|0
5944928|NCT01307423|20561741|P5|Long-term Safety Phase (Year 5)|Miscellaneous|0
5944929|NCT01307423|20561742|P4|Long-term Safety Phase (Year 5)|Miscellaneous|0
5944930|NCT01307423|20561743|P3|Long-term Safety Phase (Year 5)|Miscellaneous|2
5944931|NCT01307423|20561744|P2|Long-term Safety Phase (Year 5)|Miscellaneous|0
5944932|NCT01307423|20561745|P1|Long-term Safety Phase (Year 5)|Miscellaneous|0
5944933|NCT01307423|20561737|P9|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
5944934|NCT01307423|20561738|P8|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
5944935|NCT01307423|20561739|P7|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
5944936|NCT01307423|20561740|P6|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
5944937|NCT01307423|20561741|P5|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
5944938|NCT01307423|20561742|P4|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
5944939|NCT01307423|20561743|P3|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
5944940|NCT01307423|20561744|P2|Long-term Safety Phase (Year 5)|Lost to Follow-up|1
5944941|NCT01307423|20561745|P1|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
5944942|NCT01307423|20561737|P9|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1
5944943|NCT01307423|20561738|P8|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
5944944|NCT01307423|20561739|P7|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
5944945|NCT01307423|20561740|P6|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
5944946|NCT01307423|20561741|P5|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
5944947|NCT01307423|20561742|P4|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
5944948|NCT01307423|20561743|P3|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2
5944949|NCT01307423|20561744|P2|Long-term Safety Phase (Year 5)|Withdrawal by Subject|6
5944950|NCT01307423|20561745|P1|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
5944951|NCT01307423|20561737|P9|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
5944952|NCT01307423|20561738|P8|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
5944953|NCT01307423|20561739|P7|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
5944954|NCT01307423|20561740|P6|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
5944955|NCT01307423|20561741|P5|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
5944956|NCT01307423|20561742|P4|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
5944957|NCT01307423|20561743|P3|Long-term Safety Phase (Year 5)|Lack of Efficacy|1
5944958|NCT01307423|20561744|P2|Long-term Safety Phase (Year 5)|Lack of Efficacy|2
5944959|NCT01307423|20561745|P1|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
5944960|NCT01307423|20561737|P9|Long-term Safety Phase (Year 5)|Adverse Event|1
5944961|NCT01307423|20561738|P8|Long-term Safety Phase (Year 5)|Adverse Event|0
5944962|NCT01307423|20561739|P7|Long-term Safety Phase (Year 5)|Adverse Event|0
5944963|NCT01307423|20561740|P6|Long-term Safety Phase (Year 5)|Adverse Event|0
5944964|NCT01307423|20561741|P5|Long-term Safety Phase (Year 5)|Adverse Event|0
5944965|NCT01307423|20561742|P4|Long-term Safety Phase (Year 5)|Adverse Event|0
5944966|NCT01307423|20561743|P3|Long-term Safety Phase (Year 5)|Adverse Event|1
5944967|NCT01307423|20561744|P2|Long-term Safety Phase (Year 5)|Adverse Event|1
5944968|NCT01307423|20561745|P1|Long-term Safety Phase (Year 5)|Adverse Event|0
5944969|NCT01307423|20561737|P9|Long-term Safety Phase (Year 4)|Miscellaneous|0
5944970|NCT01307423|20561738|P8|Long-term Safety Phase (Year 4)|Miscellaneous|1
5944971|NCT01307423|20561739|P7|Long-term Safety Phase (Year 4)|Miscellaneous|0
5944972|NCT01307423|20561740|P6|Long-term Safety Phase (Year 4)|Miscellaneous|0
5944973|NCT01307423|20561741|P5|Long-term Safety Phase (Year 4)|Miscellaneous|0
5944974|NCT01307423|20561742|P4|Long-term Safety Phase (Year 4)|Miscellaneous|0
5944975|NCT01307423|20561743|P3|Long-term Safety Phase (Year 4)|Miscellaneous|0
5944976|NCT01307423|20561744|P2|Long-term Safety Phase (Year 4)|Miscellaneous|0
5944977|NCT01307423|20561745|P1|Long-term Safety Phase (Year 4)|Miscellaneous|0
5944978|NCT01307423|20561737|P9|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
5944979|NCT01307423|20561738|P8|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
5944980|NCT01307423|20561739|P7|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
5944981|NCT01307423|20561740|P6|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
5944982|NCT01307423|20561741|P5|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
5944983|NCT01307423|20561742|P4|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
5944984|NCT01307423|20561743|P3|Long-term Safety Phase (Year 4)|Lost to Follow-up|1
5944985|NCT01307423|20561744|P2|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
5944986|NCT01307423|20561745|P1|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
5944987|NCT01307423|20561737|P9|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4
5944988|NCT01307423|20561738|P8|Long-term Safety Phase (Year 4)|Withdrawal by Subject|1
5944989|NCT01307423|20561739|P7|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
5944990|NCT01307423|20561740|P6|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
5944991|NCT01307423|20561741|P5|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
5944992|NCT01307423|20561742|P4|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
5944993|NCT01307423|20561743|P3|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4
5944994|NCT01307423|20561744|P2|Long-term Safety Phase (Year 4)|Withdrawal by Subject|5
5944995|NCT01307423|20561745|P1|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
5944996|NCT01307423|20561737|P9|Long-term Safety Phase (Year 4)|Lack of Efficacy|1
5944997|NCT01307423|20561738|P8|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
5944998|NCT01307423|20561739|P7|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
5944999|NCT01307423|20561740|P6|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
5945000|NCT01307423|20561741|P5|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
5945001|NCT01307423|20561742|P4|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
5945002|NCT01307423|20561743|P3|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
5945003|NCT01307423|20561744|P2|Long-term Safety Phase (Year 4)|Lack of Efficacy|1
5945004|NCT01307423|20561745|P1|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
5945005|NCT01307423|20561737|P9|Long-term Safety Phase (Year 4)|Adverse Event|0
5945006|NCT01307423|20561738|P8|Long-term Safety Phase (Year 4)|Adverse Event|0
5945007|NCT01307423|20561739|P7|Long-term Safety Phase (Year 4)|Adverse Event|0
5945008|NCT01307423|20561740|P6|Long-term Safety Phase (Year 4)|Adverse Event|0
5945009|NCT01307423|20561741|P5|Long-term Safety Phase (Year 4)|Adverse Event|0
5945010|NCT01307423|20561742|P4|Long-term Safety Phase (Year 4)|Adverse Event|0
5945011|NCT01307423|20561743|P3|Long-term Safety Phase (Year 4)|Adverse Event|0
5945012|NCT01307423|20561744|P2|Long-term Safety Phase (Year 4)|Adverse Event|2
5945013|NCT01307423|20561745|P1|Long-term Safety Phase (Year 4)|Adverse Event|0
5945014|NCT01307423|20561737|P9|Long-term Safety Phase (Year 3)|Miscellaneous|0
5945015|NCT01307423|20561738|P8|Long-term Safety Phase (Year 3)|Miscellaneous|1
5945016|NCT01307423|20561739|P7|Long-term Safety Phase (Year 3)|Miscellaneous|0
5945017|NCT01307423|20561740|P6|Long-term Safety Phase (Year 3)|Miscellaneous|0
5945018|NCT01307423|20561741|P5|Long-term Safety Phase (Year 3)|Miscellaneous|0
5945019|NCT01307423|20561742|P4|Long-term Safety Phase (Year 3)|Miscellaneous|0
5945020|NCT01307423|20561743|P3|Long-term Safety Phase (Year 3)|Miscellaneous|0
5945021|NCT01307423|20561744|P2|Long-term Safety Phase (Year 3)|Miscellaneous|1
5945022|NCT01307423|20561745|P1|Long-term Safety Phase (Year 3)|Miscellaneous|0
5945023|NCT01307423|20561737|P9|Long-term Safety Phase (Year 3)|Lost to Follow-up|1
5945024|NCT01307423|20561738|P8|Long-term Safety Phase (Year 3)|Lost to Follow-up|1
5945025|NCT01307423|20561739|P7|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
5945331|NCT01307267|20562009|P1|Overall Study|Lost to Follow-up|0
5945026|NCT01307423|20561740|P6|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
5945027|NCT01307423|20561741|P5|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
5945028|NCT01307423|20561742|P4|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
5945029|NCT01307423|20561743|P3|Long-term Safety Phase (Year 3)|Lost to Follow-up|3
5945030|NCT01307423|20561744|P2|Long-term Safety Phase (Year 3)|Lost to Follow-up|2
5945031|NCT01307423|20561745|P1|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
5945032|NCT01307423|20561737|P9|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4
5945033|NCT01307423|20561738|P8|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2
5945034|NCT01307423|20561739|P7|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
5945035|NCT01307423|20561740|P6|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
5945036|NCT01307423|20561741|P5|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
5945037|NCT01307423|20561742|P4|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
5945038|NCT01307423|20561743|P3|Long-term Safety Phase (Year 3)|Withdrawal by Subject|8
5945039|NCT01307423|20561744|P2|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2
5945040|NCT01307423|20561745|P1|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
5945041|NCT01307423|20561737|P9|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0
5945042|NCT01307423|20561738|P8|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0
5945043|NCT01307423|20561739|P7|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0
5945044|NCT01307423|20561740|P6|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0
5945045|NCT01307423|20561741|P5|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0
5945046|NCT01307423|20561742|P4|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0
5945047|NCT01307423|20561743|P3|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1
5945048|NCT01307423|20561744|P2|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1
5945049|NCT01307423|20561745|P1|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0
5945050|NCT01307423|20561737|P9|Long-term Safety Phase (Year 3)|Lack of Efficacy|2
5945051|NCT01307423|20561738|P8|Long-term Safety Phase (Year 3)|Lack of Efficacy|1
5945052|NCT01307423|20561739|P7|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
5945053|NCT01307423|20561740|P6|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
5945054|NCT01307423|20561741|P5|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
5945055|NCT01307423|20561742|P4|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
5945056|NCT01307423|20561743|P3|Long-term Safety Phase (Year 3)|Lack of Efficacy|4
5945057|NCT01307423|20561744|P2|Long-term Safety Phase (Year 3)|Lack of Efficacy|2
5945058|NCT01307423|20561745|P1|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
5945059|NCT01307423|20561737|P9|Long-term Safety Phase (Year 3)|Adverse Event|4
5945060|NCT01307423|20561738|P8|Long-term Safety Phase (Year 3)|Adverse Event|3
5945061|NCT01307423|20561739|P7|Long-term Safety Phase (Year 3)|Adverse Event|0
5945062|NCT01307423|20561740|P6|Long-term Safety Phase (Year 3)|Adverse Event|0
5945063|NCT01307423|20561741|P5|Long-term Safety Phase (Year 3)|Adverse Event|0
5945064|NCT01307423|20561742|P4|Long-term Safety Phase (Year 3)|Adverse Event|0
5945065|NCT01307423|20561743|P3|Long-term Safety Phase (Year 3)|Adverse Event|2
5945066|NCT01307423|20561744|P2|Long-term Safety Phase (Year 3)|Adverse Event|1
5945067|NCT01307423|20561745|P1|Long-term Safety Phase (Year 3)|Adverse Event|0
5945068|NCT01307423|20561737|P9|Long-term Safety Phase (Year 2)|Miscellaneous|1
5945069|NCT01307423|20561738|P8|Long-term Safety Phase (Year 2)|Miscellaneous|1
5945070|NCT01307423|20561739|P7|Long-term Safety Phase (Year 2)|Miscellaneous|0
5945071|NCT01307423|20561740|P6|Long-term Safety Phase (Year 2)|Miscellaneous|0
5945072|NCT01307423|20561741|P5|Long-term Safety Phase (Year 2)|Miscellaneous|0
5945073|NCT01307423|20561742|P4|Long-term Safety Phase (Year 2)|Miscellaneous|0
5945074|NCT01307423|20561743|P3|Long-term Safety Phase (Year 2)|Miscellaneous|0
5945075|NCT01307423|20561744|P2|Long-term Safety Phase (Year 2)|Miscellaneous|1
5945076|NCT01307423|20561745|P1|Long-term Safety Phase (Year 2)|Miscellaneous|0
5945077|NCT01307423|20561737|P9|Long-term Safety Phase (Year 2)|Withdrawal by Subject|2
5945078|NCT01307423|20561738|P8|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3
5945079|NCT01307423|20561739|P7|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
5945080|NCT01307423|20561740|P6|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
5945081|NCT01307423|20561741|P5|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
5945082|NCT01307423|20561742|P4|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
5945083|NCT01307423|20561743|P3|Long-term Safety Phase (Year 2)|Withdrawal by Subject|12
5945084|NCT01307423|20561744|P2|Long-term Safety Phase (Year 2)|Withdrawal by Subject|13
5945085|NCT01307423|20561745|P1|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
5945086|NCT01307423|20561737|P9|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
5945087|NCT01307423|20561738|P8|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
5945088|NCT01307423|20561739|P7|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
5945089|NCT01307423|20561740|P6|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
5945090|NCT01307423|20561741|P5|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
5945091|NCT01307423|20561742|P4|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
5945092|NCT01307423|20561743|P3|Long-term Safety Phase (Year 2)|Noncompliance with study drug|1
5945093|NCT01307423|20561744|P2|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
5945094|NCT01307423|20561745|P1|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
5945095|NCT01307423|20561737|P9|Long-term Safety Phase (Year 2)|Lack of Efficacy|3
5945096|NCT01307423|20561738|P8|Long-term Safety Phase (Year 2)|Lack of Efficacy|4
5945097|NCT01307423|20561739|P7|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
5945098|NCT01307423|20561740|P6|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
5945099|NCT01307423|20561741|P5|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
5945100|NCT01307423|20561742|P4|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
5945101|NCT01307423|20561743|P3|Long-term Safety Phase (Year 2)|Lack of Efficacy|5
5945102|NCT01307423|20561744|P2|Long-term Safety Phase (Year 2)|Lack of Efficacy|7
5945103|NCT01307423|20561745|P1|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
5945104|NCT01307423|20561737|P9|Long-term Safety Phase (Year 2)|Adverse Event|1
5945105|NCT01307423|20561738|P8|Long-term Safety Phase (Year 2)|Adverse Event|1
5945106|NCT01307423|20561739|P7|Long-term Safety Phase (Year 2)|Adverse Event|0
5945107|NCT01307423|20561740|P6|Long-term Safety Phase (Year 2)|Adverse Event|0
5945108|NCT01307423|20561741|P5|Long-term Safety Phase (Year 2)|Adverse Event|0
5945109|NCT01307423|20561742|P4|Long-term Safety Phase (Year 2)|Adverse Event|0
5945110|NCT01307423|20561743|P3|Long-term Safety Phase (Year 2)|Adverse Event|7
5945111|NCT01307423|20561744|P2|Long-term Safety Phase (Year 2)|Adverse Event|2
5945112|NCT01307423|20561745|P1|Long-term Safety Phase (Year 2)|Adverse Event|0
5945113|NCT01307423|20561737|P9|Active Treatment Phase (Week 25-52)|Protocol Violation|0
5945114|NCT01307423|20561738|P8|Active Treatment Phase (Week 25-52)|Protocol Violation|0
5945115|NCT01307423|20561739|P7|Active Treatment Phase (Week 25-52)|Protocol Violation|0
5945116|NCT01307423|20561740|P6|Active Treatment Phase (Week 25-52)|Protocol Violation|1
5945117|NCT01307423|20561741|P5|Active Treatment Phase (Week 25-52)|Protocol Violation|0
5945118|NCT01307423|20561742|P4|Active Treatment Phase (Week 25-52)|Protocol Violation|0
5945119|NCT01307423|20561743|P3|Active Treatment Phase (Week 25-52)|Protocol Violation|0
5945120|NCT01307423|20561744|P2|Active Treatment Phase (Week 25-52)|Protocol Violation|0
5945121|NCT01307423|20561745|P1|Active Treatment Phase (Week 25-52)|Protocol Violation|0
5945122|NCT01307423|20561737|P9|Active Treatment Phase (Week 25-52)|Other|0
5945123|NCT01307423|20561738|P8|Active Treatment Phase (Week 25-52)|Other|0
5945124|NCT01307423|20561739|P7|Active Treatment Phase (Week 25-52)|Other|0
5945125|NCT01307423|20561740|P6|Active Treatment Phase (Week 25-52)|Other|0
5945126|NCT01307423|20561741|P5|Active Treatment Phase (Week 25-52)|Other|0
5945127|NCT01307423|20561742|P4|Active Treatment Phase (Week 25-52)|Other|1
5945128|NCT01307423|20561743|P3|Active Treatment Phase (Week 25-52)|Other|0
5945129|NCT01307423|20561744|P2|Active Treatment Phase (Week 25-52)|Other|0
5945130|NCT01307423|20561745|P1|Active Treatment Phase (Week 25-52)|Other|0
5945131|NCT01307423|20561737|P9|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
5945132|NCT01307423|20561738|P8|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
5945133|NCT01307423|20561739|P7|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
5945134|NCT01307423|20561740|P6|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
5945135|NCT01307423|20561741|P5|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
5945136|NCT01307423|20561742|P4|Active Treatment Phase (Week 25-52)|Lost to Follow-up|2
5945137|NCT01307423|20561743|P3|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
5945138|NCT01307423|20561744|P2|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
5945139|NCT01307423|20561745|P1|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
5945140|NCT01307423|20561737|P9|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0
5945141|NCT01307423|20561738|P8|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0
5945142|NCT01307423|20561739|P7|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1
5945143|NCT01307423|20561740|P6|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1
5945144|NCT01307423|20561741|P5|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0
5945145|NCT01307423|20561742|P4|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0
5945146|NCT01307423|20561743|P3|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|2
5945147|NCT01307423|20561744|P2|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|11
5945148|NCT01307423|20561745|P1|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0
5945149|NCT01307423|20561737|P9|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
5945150|NCT01307423|20561738|P8|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
5945151|NCT01307423|20561739|P7|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
5945152|NCT01307423|20561740|P6|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|1
5945153|NCT01307423|20561741|P5|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
5945154|NCT01307423|20561742|P4|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
5945155|NCT01307423|20561743|P3|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
5945156|NCT01307423|20561744|P2|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
5945157|NCT01307423|20561745|P1|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
5945158|NCT01307423|20561737|P9|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0
5945159|NCT01307423|20561738|P8|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0
5945160|NCT01307423|20561739|P7|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0
5945161|NCT01307423|20561740|P6|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0
5945162|NCT01307423|20561741|P5|Active Treatment Phase (Week 25-52)|Lack of Efficacy|1
5945163|NCT01307423|20561742|P4|Active Treatment Phase (Week 25-52)|Lack of Efficacy|3
5945164|NCT01307423|20561743|P3|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5
5945165|NCT01307423|20561744|P2|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5
5945166|NCT01307423|20561745|P1|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0
5945167|NCT01307423|20561737|P9|Active Treatment Phase (Week 25-52)|Adverse Event|0
5945168|NCT01307423|20561738|P8|Active Treatment Phase (Week 25-52)|Adverse Event|0
5945332|NCT01307267|20561987|P23|Overall Study|Death|2
5945169|NCT01307423|20561739|P7|Active Treatment Phase (Week 25-52)|Adverse Event|0
5945170|NCT01307423|20561740|P6|Active Treatment Phase (Week 25-52)|Adverse Event|0
5945171|NCT01307423|20561741|P5|Active Treatment Phase (Week 25-52)|Adverse Event|2
5945172|NCT01307423|20561742|P4|Active Treatment Phase (Week 25-52)|Adverse Event|2
5945173|NCT01307423|20561743|P3|Active Treatment Phase (Week 25-52)|Adverse Event|2
5945174|NCT01307423|20561744|P2|Active Treatment Phase (Week 25-52)|Adverse Event|3
5945175|NCT01307423|20561745|P1|Active Treatment Phase (Week 25-52)|Adverse Event|0
5945176|NCT01307423|20561737|P9|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
5945177|NCT01307423|20561738|P8|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
5945178|NCT01307423|20561739|P7|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
5945179|NCT01307423|20561740|P6|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
5945180|NCT01307423|20561741|P5|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
5945181|NCT01307423|20561742|P4|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
5945182|NCT01307423|20561743|P3|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1
5945183|NCT01307423|20561744|P2|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1
5945184|NCT01307423|20561745|P1|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
5945185|NCT01307423|20561737|P9|Placebo-controlled Phase (Week 0 - 24)|Other|0
5945186|NCT01307423|20561738|P8|Placebo-controlled Phase (Week 0 - 24)|Other|0
5945187|NCT01307423|20561739|P7|Placebo-controlled Phase (Week 0 - 24)|Other|0
5945188|NCT01307423|20561740|P6|Placebo-controlled Phase (Week 0 - 24)|Other|0
5945189|NCT01307423|20561741|P5|Placebo-controlled Phase (Week 0 - 24)|Other|0
5945190|NCT01307423|20561742|P4|Placebo-controlled Phase (Week 0 - 24)|Other|0
5945191|NCT01307423|20561743|P3|Placebo-controlled Phase (Week 0 - 24)|Other|0
5945192|NCT01307423|20561744|P2|Placebo-controlled Phase (Week 0 - 24)|Other|2
5945193|NCT01307423|20561745|P1|Placebo-controlled Phase (Week 0 - 24)|Other|1
5945194|NCT01307423|20561737|P9|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
5945195|NCT01307423|20561738|P8|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
5945196|NCT01307423|20561739|P7|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
5945197|NCT01307423|20561740|P6|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
5945198|NCT01307423|20561741|P5|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
5945199|NCT01307423|20561742|P4|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
5945200|NCT01307423|20561743|P3|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
5945201|NCT01307423|20561744|P2|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
5945202|NCT01307423|20561745|P1|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1
5945203|NCT01307423|20561737|P9|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
5945204|NCT01307423|20561738|P8|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
5945205|NCT01307423|20561739|P7|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
5945206|NCT01307423|20561740|P6|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
5945207|NCT01307423|20561741|P5|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
5945208|NCT01307423|20561742|P4|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
5945209|NCT01307423|20561743|P3|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2
5945210|NCT01307423|20561744|P2|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1
5945211|NCT01307423|20561745|P1|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|5
5945212|NCT01307423|20561737|P9|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
5945213|NCT01307423|20561738|P8|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
5945214|NCT01307423|20561739|P7|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
5945215|NCT01307423|20561740|P6|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
5945216|NCT01307423|20561741|P5|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
5945217|NCT01307423|20561742|P4|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
5945218|NCT01307423|20561743|P3|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1
5945219|NCT01307423|20561744|P2|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
5945220|NCT01307423|20561745|P1|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
5945221|NCT01307423|20561737|P9|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
5945222|NCT01307423|20561738|P8|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
5945223|NCT01307423|20561739|P7|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
5945224|NCT01307423|20561740|P6|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
5945225|NCT01307423|20561741|P5|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
5945226|NCT01307423|20561742|P4|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
5945227|NCT01307423|20561743|P3|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|10
5945228|NCT01307423|20561744|P2|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4
5945229|NCT01307423|20561745|P1|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|8
5945230|NCT01307423|20561737|P9|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
5945231|NCT01307423|20561738|P8|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
5945232|NCT01307423|20561739|P7|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
5945233|NCT01307423|20561740|P6|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
5945234|NCT01307423|20561741|P5|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
5945235|NCT01307423|20561742|P4|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
5945236|NCT01307423|20561743|P3|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2
5945237|NCT01307423|20561744|P2|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3
5945238|NCT01307423|20561745|P1|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|1
5945333|NCT01307267|20561988|P22|Overall Study|Death|2
5945239|NCT01307423|20561737|P9|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
5945240|NCT01307423|20561738|P8|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
5945241|NCT01307423|20561739|P7|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
5945242|NCT01307423|20561740|P6|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
5945243|NCT01307423|20561741|P5|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
5945244|NCT01307423|20561742|P4|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
5945245|NCT01307423|20561743|P3|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|6
5945246|NCT01307423|20561744|P2|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4
5945247|NCT01307423|20561745|P1|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4
5945248|NCT01307319|20561951|P3|Overall Study|Other|3
5945249|NCT01307319|20561952|P2|Overall Study|Other|4
5945250|NCT01307319|20561953|P1|Overall Study|Other|0
5945251|NCT01307319|20561951|P3|Overall Study|Withdrawal by Subject|2
5945252|NCT01307319|20561952|P2|Overall Study|Withdrawal by Subject|1
5945253|NCT01307319|20561953|P1|Overall Study|Withdrawal by Subject|0
5945254|NCT01307319|20561951|P3|Overall Study|Protocol Violation|0
5945255|NCT01307319|20561952|P2|Overall Study|Protocol Violation|1
5945256|NCT01307319|20561953|P1|Overall Study|Protocol Violation|1
5945257|NCT01307319|20561951|P3|Overall Study|Lost to Follow-up|1
5945258|NCT01307319|20561952|P2|Overall Study|Lost to Follow-up|0
5945259|NCT01307319|20561953|P1|Overall Study|Lost to Follow-up|1
5945260|NCT01307319|20561951|P3|Overall Study|Adverse Event|1
5945261|NCT01307319|20561952|P2|Overall Study|Adverse Event|2
5945262|NCT01307319|20561953|P1|Overall Study|Adverse Event|2
5945263|NCT01307267|20561987|P23|Overall Study|Other|2
5945264|NCT01307267|20561988|P22|Overall Study|Other|3
5945265|NCT01307267|20561989|P21|Overall Study|Other|2
5945266|NCT01307267|20561990|P20|Overall Study|Other|19
5945267|NCT01307267|20561991|P19|Overall Study|Other|0
5945268|NCT01307267|20561992|P18|Overall Study|Other|0
5945269|NCT01307267|20561993|P17|Overall Study|Other|0
5945270|NCT01307267|20561994|P16|Overall Study|Other|1
5945271|NCT01307267|20561995|P15|Overall Study|Other|2
5945272|NCT01307267|20561996|P14|Overall Study|Other|0
5945273|NCT01307267|20561997|P13|Overall Study|Other|1
5945274|NCT01307267|20561998|P12|Overall Study|Other|1
5945275|NCT01307267|20561999|P11|Overall Study|Other|1
5945276|NCT01307267|20562000|P10|Overall Study|Other|0
5945277|NCT01307267|20562001|P9|Overall Study|Other|3
5945278|NCT01307267|20562002|P8|Overall Study|Other|1
5945279|NCT01307267|20562003|P7|Overall Study|Other|0
5945280|NCT01307267|20562004|P6|Overall Study|Other|7
5945281|NCT01307267|20562005|P5|Overall Study|Other|0
5945282|NCT01307267|20562006|P4|Overall Study|Other|0
5945283|NCT01307267|20562007|P3|Overall Study|Other|0
5945284|NCT01307267|20562008|P2|Overall Study|Other|0
5945285|NCT01307267|20562009|P1|Overall Study|Other|0
5945286|NCT01307267|20561987|P23|Overall Study|Withdrawal by Subject|0
5945287|NCT01307267|20561988|P22|Overall Study|Withdrawal by Subject|0
5945288|NCT01307267|20561989|P21|Overall Study|Withdrawal by Subject|0
5945289|NCT01307267|20561990|P20|Overall Study|Withdrawal by Subject|3
5945290|NCT01307267|20561991|P19|Overall Study|Withdrawal by Subject|0
5945291|NCT01307267|20561992|P18|Overall Study|Withdrawal by Subject|0
5945292|NCT01307267|20561993|P17|Overall Study|Withdrawal by Subject|0
5945293|NCT01307267|20561994|P16|Overall Study|Withdrawal by Subject|0
5945294|NCT01307267|20561995|P15|Overall Study|Withdrawal by Subject|0
5945295|NCT01307267|20561996|P14|Overall Study|Withdrawal by Subject|0
5945296|NCT01307267|20561997|P13|Overall Study|Withdrawal by Subject|0
5945297|NCT01307267|20561998|P12|Overall Study|Withdrawal by Subject|1
5945298|NCT01307267|20561999|P11|Overall Study|Withdrawal by Subject|1
5945299|NCT01307267|20562000|P10|Overall Study|Withdrawal by Subject|1
5945300|NCT01307267|20562001|P9|Overall Study|Withdrawal by Subject|5
5945301|NCT01307267|20562002|P8|Overall Study|Withdrawal by Subject|1
5945302|NCT01307267|20562003|P7|Overall Study|Withdrawal by Subject|0
5945303|NCT01307267|20562004|P6|Overall Study|Withdrawal by Subject|1
5945304|NCT01307267|20562005|P5|Overall Study|Withdrawal by Subject|0
5945305|NCT01307267|20562006|P4|Overall Study|Withdrawal by Subject|0
5945306|NCT01307267|20562007|P3|Overall Study|Withdrawal by Subject|0
5945307|NCT01307267|20562008|P2|Overall Study|Withdrawal by Subject|0
5945308|NCT01307267|20562009|P1|Overall Study|Withdrawal by Subject|0
5945309|NCT01307267|20561987|P23|Overall Study|Lost to Follow-up|0
5945310|NCT01307267|20561988|P22|Overall Study|Lost to Follow-up|0
5945311|NCT01307267|20561989|P21|Overall Study|Lost to Follow-up|0
5945312|NCT01307267|20561990|P20|Overall Study|Lost to Follow-up|2
5945313|NCT01307267|20561991|P19|Overall Study|Lost to Follow-up|0
5945314|NCT01307267|20561992|P18|Overall Study|Lost to Follow-up|0
5945315|NCT01307267|20561993|P17|Overall Study|Lost to Follow-up|0
5945316|NCT01307267|20561994|P16|Overall Study|Lost to Follow-up|0
5945317|NCT01307267|20561995|P15|Overall Study|Lost to Follow-up|0
5945318|NCT01307267|20561996|P14|Overall Study|Lost to Follow-up|0
5945319|NCT01307267|20561997|P13|Overall Study|Lost to Follow-up|0
5945320|NCT01307267|20561998|P12|Overall Study|Lost to Follow-up|0
5945321|NCT01307267|20561999|P11|Overall Study|Lost to Follow-up|1
5945322|NCT01307267|20562000|P10|Overall Study|Lost to Follow-up|2
5945323|NCT01307267|20562001|P9|Overall Study|Lost to Follow-up|1
5945324|NCT01307267|20562002|P8|Overall Study|Lost to Follow-up|0
5945325|NCT01307267|20562003|P7|Overall Study|Lost to Follow-up|0
5945326|NCT01307267|20562004|P6|Overall Study|Lost to Follow-up|7
5945327|NCT01307267|20562005|P5|Overall Study|Lost to Follow-up|0
5945328|NCT01307267|20562006|P4|Overall Study|Lost to Follow-up|0
5945329|NCT01307267|20562007|P3|Overall Study|Lost to Follow-up|0
5945330|NCT01307267|20562008|P2|Overall Study|Lost to Follow-up|0
5945334|NCT01307267|20561989|P21|Overall Study|Death|1
5945335|NCT01307267|20561990|P20|Overall Study|Death|8
5945336|NCT01307267|20561991|P19|Overall Study|Death|2
5945337|NCT01307267|20561992|P18|Overall Study|Death|1
5945338|NCT01307267|20561993|P17|Overall Study|Death|1
5945339|NCT01307267|20561994|P16|Overall Study|Death|0
5945340|NCT01307267|20561995|P15|Overall Study|Death|0
5945341|NCT01307267|20561996|P14|Overall Study|Death|0
5945342|NCT01307267|20561997|P13|Overall Study|Death|0
5945343|NCT01307267|20561998|P12|Overall Study|Death|9
5945344|NCT01307267|20561999|P11|Overall Study|Death|3
5945345|NCT01307267|20562000|P10|Overall Study|Death|2
5945346|NCT01307267|20562001|P9|Overall Study|Death|21
5945347|NCT01307267|20562002|P8|Overall Study|Death|2
5945348|NCT01307267|20562003|P7|Overall Study|Death|2
5945349|NCT01307267|20562004|P6|Overall Study|Death|26
5945350|NCT01307267|20562005|P5|Overall Study|Death|1
5945351|NCT01307267|20562006|P4|Overall Study|Death|3
5945352|NCT01307267|20562007|P3|Overall Study|Death|5
5945353|NCT01307267|20562008|P2|Overall Study|Death|3
5945354|NCT01307267|20562009|P1|Overall Study|Death|4
5945355|NCT01307111|20562600|P2|1-2 Week IUD Check up|IUD expulsion/removal|2
5945356|NCT01307111|20562601|P1|1-2 Week IUD Check up|IUD expulsion/removal|2
5945357|NCT01307111|20562600|P2|IUD Insertion|Lost to Follow-up|0
5945358|NCT01307111|20562601|P1|IUD Insertion|Lost to Follow-up|2
5945359|NCT01307046|20562624|P2|Overall Study|Blood Pressure Withdrawal Criteria Met|3
5945360|NCT01307046|20562625|P1|Overall Study|Blood Pressure Withdrawal Criteria Met|2
5945361|NCT01307046|20562624|P2|Overall Study|Serum Potassium Withdrawal Criteria Met|2
5945362|NCT01307046|20562625|P1|Overall Study|Serum Potassium Withdrawal Criteria Met|4
5945363|NCT01307046|20562624|P2|Overall Study|Withdrawal by Subject|1
5945364|NCT01307046|20562625|P1|Overall Study|Withdrawal by Subject|1
5945365|NCT01307046|20562624|P2|Overall Study|Physician Decision|0
5945366|NCT01307046|20562625|P1|Overall Study|Physician Decision|2
5945367|NCT01307046|20562624|P2|Overall Study|Lack of Efficacy|2
5945368|NCT01307046|20562625|P1|Overall Study|Lack of Efficacy|0
5945369|NCT01307046|20562624|P2|Overall Study|Adverse Event|3
5945370|NCT01307046|20562625|P1|Overall Study|Adverse Event|3
5945371|NCT01307033|20562637|P4|44-week Open-label Extension|Death|1
5945372|NCT01307033|20562638|P3|44-week Open-label Extension|Death|0
5945373|NCT01307033|20562639|P2|44-week Open-label Extension|Death|0
5945374|NCT01307033|20562640|P1|44-week Open-label Extension|Death|0
5945375|NCT01307033|20562637|P4|44-week Open-label Extension|Potassium Withdrawal Criteria Met|7
5945376|NCT01307033|20562638|P3|44-week Open-label Extension|Potassium Withdrawal Criteria Met|6
5945377|NCT01307033|20562639|P2|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0
5945378|NCT01307033|20562640|P1|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0
5945379|NCT01307033|20562637|P4|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|2
5945380|NCT01307033|20562638|P3|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0
5945381|NCT01307033|20562639|P2|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0
5945382|NCT01307033|20562640|P1|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0
5945383|NCT01307033|20562637|P4|44-week Open-label Extension|Physician Decision|0
5945384|NCT01307033|20562638|P3|44-week Open-label Extension|Physician Decision|1
5945385|NCT01307033|20562639|P2|44-week Open-label Extension|Physician Decision|0
5945386|NCT01307033|20562640|P1|44-week Open-label Extension|Physician Decision|0
5945387|NCT01307033|20562637|P4|44-week Open-label Extension|Withdrawal by Subject|1
5945388|NCT01307033|20562638|P3|44-week Open-label Extension|Withdrawal by Subject|2
5945389|NCT01307033|20562639|P2|44-week Open-label Extension|Withdrawal by Subject|0
5945390|NCT01307033|20562640|P1|44-week Open-label Extension|Withdrawal by Subject|0
5945391|NCT01307033|20562637|P4|44-week Open-label Extension|Adverse Event|1
5945392|NCT01307033|20562638|P3|44-week Open-label Extension|Adverse Event|2
5945393|NCT01307033|20562639|P2|44-week Open-label Extension|Adverse Event|0
5945394|NCT01307033|20562640|P1|44-week Open-label Extension|Adverse Event|0
5945395|NCT01307033|20562637|P4|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0
5945396|NCT01307033|20562638|P3|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0
5945397|NCT01307033|20562639|P2|8-week Double-blind Period|Potassium Withdrawal Criteria Met|3
5945398|NCT01307033|20562640|P1|8-week Double-blind Period|Potassium Withdrawal Criteria Met|6
5945399|NCT01307033|20562637|P4|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0
5945400|NCT01307033|20562638|P3|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0
5945401|NCT01307033|20562639|P2|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|3
5945402|NCT01307033|20562640|P1|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0
5945403|NCT01307033|20562637|P4|8-week Double-blind Period|Lack of Efficacy|0
5945404|NCT01307033|20562638|P3|8-week Double-blind Period|Lack of Efficacy|0
5945405|NCT01307033|20562639|P2|8-week Double-blind Period|Lack of Efficacy|0
5945406|NCT01307033|20562640|P1|8-week Double-blind Period|Lack of Efficacy|1
5945407|NCT01307033|20562637|P4|8-week Double-blind Period|Withdrawal by Subject|0
5945408|NCT01307033|20562638|P3|8-week Double-blind Period|Withdrawal by Subject|0
5945409|NCT01307033|20562639|P2|8-week Double-blind Period|Withdrawal by Subject|1
5945410|NCT01307033|20562640|P1|8-week Double-blind Period|Withdrawal by Subject|4
5945411|NCT01307033|20562637|P4|8-week Double-blind Period|Adverse Event|0
5945412|NCT01307033|20562638|P3|8-week Double-blind Period|Adverse Event|0
5945413|NCT01307033|20562639|P2|8-week Double-blind Period|Adverse Event|0
5945414|NCT01307033|20562640|P1|8-week Double-blind Period|Adverse Event|2
5945415|NCT01307020|20562662|P10|Overall Study|Electronic data capture failure|0
5945416|NCT01307020|20562663|P9|Overall Study|Electronic data capture failure|0
5945417|NCT01307020|20562664|P8|Overall Study|Electronic data capture failure|0
5945418|NCT01307020|20562665|P7|Overall Study|Electronic data capture failure|0
5945419|NCT01307020|20562666|P6|Overall Study|Electronic data capture failure|0
5945420|NCT01307020|20562667|P5|Overall Study|Electronic data capture failure|0
5945421|NCT01307020|20562668|P4|Overall Study|Electronic data capture failure|0
5945422|NCT01307020|20562669|P3|Overall Study|Electronic data capture failure|0
5945423|NCT01307020|20562670|P2|Overall Study|Electronic data capture failure|1
5945424|NCT01307020|20562671|P1|Overall Study|Electronic data capture failure|0
5945425|NCT01307020|20562662|P10|Overall Study|Lost to Follow-up|0
5945426|NCT01307020|20562663|P9|Overall Study|Lost to Follow-up|0
5945427|NCT01307020|20562664|P8|Overall Study|Lost to Follow-up|0
5945428|NCT01307020|20562665|P7|Overall Study|Lost to Follow-up|1
5945429|NCT01307020|20562666|P6|Overall Study|Lost to Follow-up|0
5945430|NCT01307020|20562667|P5|Overall Study|Lost to Follow-up|0
5945431|NCT01307020|20562668|P4|Overall Study|Lost to Follow-up|1
5945432|NCT01307020|20562669|P3|Overall Study|Lost to Follow-up|1
5945433|NCT01307020|20562670|P2|Overall Study|Lost to Follow-up|0
5945434|NCT01307020|20562671|P1|Overall Study|Lost to Follow-up|0
5945435|NCT01306968|20562726|P4|Overall Study|Withdrew over privacy concerns|1
5945436|NCT01306968|20562727|P3|Overall Study|Withdrew over privacy concerns|0
5945437|NCT01306968|20562728|P2|Overall Study|Withdrew over privacy concerns|0
5945438|NCT01306968|20562729|P1|Overall Study|Withdrew over privacy concerns|0
5945439|NCT01306968|20562726|P4|Overall Study|Withdrew - time commitment|2
5945440|NCT01306968|20562727|P3|Overall Study|Withdrew - time commitment|0
5945441|NCT01306968|20562728|P2|Overall Study|Withdrew - time commitment|0
5945442|NCT01306968|20562729|P1|Overall Study|Withdrew - time commitment|0
5945443|NCT01306968|20562726|P4|Overall Study|Relocated and left active duty|1
5945444|NCT01306968|20562727|P3|Overall Study|Relocated and left active duty|1
5945445|NCT01306968|20562728|P2|Overall Study|Relocated and left active duty|1
5945446|NCT01306968|20562729|P1|Overall Study|Relocated and left active duty|0
5945447|NCT01306968|20562726|P4|Overall Study|Physician Decision|0
5945448|NCT01306968|20562727|P3|Overall Study|Physician Decision|0
5945449|NCT01306968|20562728|P2|Overall Study|Physician Decision|1
5945450|NCT01306968|20562729|P1|Overall Study|Physician Decision|0
5945451|NCT01306968|20562726|P4|Overall Study|Lost to Follow-up|0
5945452|NCT01306968|20562727|P3|Overall Study|Lost to Follow-up|0
5945453|NCT01306968|20562728|P2|Overall Study|Lost to Follow-up|1
5945454|NCT01306968|20562729|P1|Overall Study|Lost to Follow-up|1
5945455|NCT01306942|20562754|P4|Phase II|Protocol Violation|1
5945456|NCT01306942|20562755|P3|Phase II|Protocol Violation|0
5945457|NCT01306942|20562756|P2|Phase II|Protocol Violation|0
5945458|NCT01306942|20562757|P1|Phase II|Protocol Violation|0
5945459|NCT01306942|20562754|P4|Phase II|Not finished treatment|1
5945460|NCT01306942|20562755|P3|Phase II|Not finished treatment|0
5945461|NCT01306942|20562756|P2|Phase II|Not finished treatment|0
5945462|NCT01306942|20562757|P1|Phase II|Not finished treatment|0
5945463|NCT01306942|20562754|P4|Phase II|Death|1
5945464|NCT01306942|20562755|P3|Phase II|Death|0
5945465|NCT01306942|20562756|P2|Phase II|Death|0
5945466|NCT01306942|20562757|P1|Phase II|Death|0
5945467|NCT01306942|20562754|P4|Phase II|Withdrawal by Subject|2
5945468|NCT01306942|20562755|P3|Phase II|Withdrawal by Subject|0
5945469|NCT01306942|20562756|P2|Phase II|Withdrawal by Subject|0
5945470|NCT01306942|20562757|P1|Phase II|Withdrawal by Subject|0
5945471|NCT01306942|20562754|P4|Phase II|Physician Decision|5
5945472|NCT01306942|20562755|P3|Phase II|Physician Decision|0
5945473|NCT01306942|20562756|P2|Phase II|Physician Decision|0
5945474|NCT01306942|20562757|P1|Phase II|Physician Decision|2
5945475|NCT01306942|20562754|P4|Phase II|Adverse Event|6
5945476|NCT01306942|20562755|P3|Phase II|Adverse Event|0
5945477|NCT01306942|20562756|P2|Phase II|Adverse Event|0
5945478|NCT01306942|20562757|P1|Phase II|Adverse Event|0
5945479|NCT01306942|20562754|P4|Phase I|Physician Decision|0
5945480|NCT01306942|20562755|P3|Phase I|Physician Decision|0
5945481|NCT01306942|20562756|P2|Phase I|Physician Decision|1
5945482|NCT01306942|20562757|P1|Phase I|Physician Decision|3
5945483|NCT01306942|20562754|P4|Phase I|Adverse Event|0
5945484|NCT01306942|20562755|P3|Phase I|Adverse Event|0
5945485|NCT01306942|20562756|P2|Phase I|Adverse Event|2
5945486|NCT01306942|20562757|P1|Phase I|Adverse Event|2
5945487|NCT01306890|20562789|P1|Overall Study|No discontinuation documentation|41
5945488|NCT01306890|20562789|P1|Overall Study|Study Termination|3
5945489|NCT01306890|20562789|P1|Overall Study|Unspecified reasons|104
5945490|NCT01306890|20562789|P1|Overall Study|Withdrawal by Subject|88
5945491|NCT01306890|20562789|P1|Overall Study|Lost to Follow-up|58
5945492|NCT01306890|20562789|P1|Overall Study|Death|1223
5945493|NCT01306890|20562789|P1|Overall Study|Adverse Event|2
5945494|NCT01306877|20562796|P2|Overall Study|Physician Decision|1
5945495|NCT01306877|20562797|P1|Overall Study|Physician Decision|0
5945496|NCT01306877|20562796|P2|Overall Study|Lost to Follow-up|3
5945497|NCT01306877|20562797|P1|Overall Study|Lost to Follow-up|3
5945498|NCT01306656|20562817|P2|Overall Study|Lost to Follow-up|0
5945499|NCT01306656|20562818|P1|Overall Study|Lost to Follow-up|1
5945500|NCT01306643|20562830|P1|Overall Study|Other: Change in Eligibility Status|1
5945501|NCT01306643|20562830|P1|Overall Study|Disease Progression|7
5945502|NCT01306643|20562830|P1|Overall Study|Adverse Event|5
5945503|NCT01306617|20562842|P3|Overall Study|Non-compliance|0
5945504|NCT01306617|20562843|P2|Overall Study|Non-compliance|1
5945505|NCT01306617|20562844|P1|Overall Study|Non-compliance|0
5945506|NCT01306617|20562842|P3|Overall Study|Virologic Failure|5
5945507|NCT01306617|20562843|P2|Overall Study|Virologic Failure|0
5945508|NCT01306617|20562844|P1|Overall Study|Virologic Failure|0
5945509|NCT01306617|20562842|P3|Overall Study|Adverse Event|0
5945510|NCT01306617|20562843|P2|Overall Study|Adverse Event|0
5945511|NCT01306617|20562844|P1|Overall Study|Adverse Event|1
5945512|NCT01306331|20562887|P2|Overall Study|Other|32
5945513|NCT01306331|20562888|P1|Overall Study|Other|34
5945514|NCT01306331|20562887|P2|Overall Study|Meth. no longer prim. meth. birth cntrl|20
5945515|NCT01306331|20562888|P1|Overall Study|Meth. no longer prim. meth. birth cntrl|10
5945516|NCT01306331|20562887|P2|Overall Study|Not sexually active|28
5945517|NCT01306331|20562888|P1|Overall Study|Not sexually active|29
5945518|NCT01306331|20562887|P2|Overall Study|Withdrawal by Subject|152
5945519|NCT01306331|20562888|P1|Overall Study|Withdrawal by Subject|163
5945520|NCT01306331|20562887|P2|Overall Study|Protocol Violation|124
5945521|NCT01306331|20562888|P1|Overall Study|Protocol Violation|154
5945522|NCT01306331|20562887|P2|Overall Study|Pregnancy|151
5945523|NCT01306331|20562888|P1|Overall Study|Pregnancy|136
5945524|NCT01306331|20562887|P2|Overall Study|Physician Decision|22
5945525|NCT01306331|20562888|P1|Overall Study|Physician Decision|26
5945526|NCT01306331|20562887|P2|Overall Study|Lost to Follow-up|323
5945527|NCT01306331|20562888|P1|Overall Study|Lost to Follow-up|321
5945528|NCT01306331|20562887|P2|Overall Study|Adverse Event|25
5945529|NCT01306331|20562888|P1|Overall Study|Adverse Event|28
5945530|NCT01306305|20562898|P2|Overall Study|Withdrew consent|0
5945531|NCT01306305|20562899|P1|Overall Study|Withdrew consent|1
5945532|NCT01306305|20562898|P2|Overall Study|Lost to Follow-up|0
5945533|NCT01306305|20562899|P1|Overall Study|Lost to Follow-up|1
5945534|NCT01306253|20562936|P2|Overall Study|Lost to Follow-up|1
5945535|NCT01306253|20562937|P1|Overall Study|Lost to Follow-up|1
5945536|NCT01306214|20562954|P3|Overall Study|Not treated|1
5945537|NCT01306214|20562955|P2|Overall Study|Not treated|1
5945538|NCT01306214|20562956|P1|Overall Study|Not treated|1
5945539|NCT01306214|20562954|P3|Overall Study|Withdrawal by Subject|16
5945540|NCT01306214|20562955|P2|Overall Study|Withdrawal by Subject|22
5945541|NCT01306214|20562956|P1|Overall Study|Withdrawal by Subject|24
5945542|NCT01306214|20562954|P3|Overall Study|Lost to Follow-up|4
5945543|NCT01306214|20562955|P2|Overall Study|Lost to Follow-up|5
5945544|NCT01306214|20562956|P1|Overall Study|Lost to Follow-up|3
5945545|NCT01306214|20562954|P3|Overall Study|Death|1
5945546|NCT01306214|20562955|P2|Overall Study|Death|0
5945547|NCT01306214|20562956|P1|Overall Study|Death|0
5945548|NCT01306201|20562973|P1|Overall Study|Files unreadable|3
5945549|NCT01306201|20562973|P1|Overall Study|Files could not be processed|3
5945550|NCT01306201|20562973|P1|Overall Study|Arrhythmia|4
5945551|NCT01306162|20562995|P4|Washout 1|Non-compliance to protocol|0
5945552|NCT01306162|20562996|P3|Washout 1|Non-compliance to protocol|0
5945553|NCT01306162|20562997|P2|Washout 1|Non-compliance to protocol|1
5945554|NCT01306162|20562998|P1|Washout 1|Non-compliance to protocol|0
5945555|NCT01306162|20562995|P4|Period 1|Adverse Event|1
5945556|NCT01306162|20562996|P3|Period 1|Adverse Event|0
5945557|NCT01306162|20562997|P2|Period 1|Adverse Event|0
5945558|NCT01306162|20562998|P1|Period 1|Adverse Event|0
5945559|NCT01306058|20563026|P1|Overall Study|Enrolled but did not get treatment|1
5945560|NCT01306058|20563026|P1|Overall Study|Death|1
5945561|NCT01306032|20563053|P6|Disease Progression/Crossover|other/symptomatic progression|0
5945562|NCT01306032|20563054|P5|Disease Progression/Crossover|other/symptomatic progression|0
5945563|NCT01306032|20563055|P4|Disease Progression/Crossover|other/symptomatic progression|2
5945564|NCT01306032|20563056|P3|Disease Progression/Crossover|other/symptomatic progression|0
5945565|NCT01306032|20563057|P2|Disease Progression/Crossover|other/symptomatic progression|2
5945566|NCT01306032|20563058|P1|Disease Progression/Crossover|other/symptomatic progression|0
5945567|NCT01306032|20563053|P6|Disease Progression/Crossover|Withdrawal by Subject|0
5945568|NCT01306032|20563054|P5|Disease Progression/Crossover|Withdrawal by Subject|0
5945569|NCT01306032|20563055|P4|Disease Progression/Crossover|Withdrawal by Subject|1
5945570|NCT01306032|20563056|P3|Disease Progression/Crossover|Withdrawal by Subject|0
5945571|NCT01306032|20563057|P2|Disease Progression/Crossover|Withdrawal by Subject|0
5945572|NCT01306032|20563058|P1|Disease Progression/Crossover|Withdrawal by Subject|0
5945573|NCT01306032|20563053|P6|First Intervention|Progressive disease|0
5945574|NCT01306032|20563054|P5|First Intervention|Progressive disease|2
5945575|NCT01306032|20563055|P4|First Intervention|Progressive disease|0
5945576|NCT01306032|20563056|P3|First Intervention|Progressive disease|0
5945577|NCT01306032|20563057|P2|First Intervention|Progressive disease|0
5945578|NCT01306032|20563058|P1|First Intervention|Progressive disease|0
5945579|NCT01306032|20563053|P6|First Intervention|Ineligible|1
5945580|NCT01306032|20563054|P5|First Intervention|Ineligible|0
5945581|NCT01306032|20563055|P4|First Intervention|Ineligible|0
5945582|NCT01306032|20563056|P3|First Intervention|Ineligible|0
5945583|NCT01306032|20563057|P2|First Intervention|Ineligible|0
5945584|NCT01306032|20563058|P1|First Intervention|Ineligible|0
5945585|NCT01306032|20563053|P6|First Intervention|Death|0
5945586|NCT01306032|20563054|P5|First Intervention|Death|0
5945587|NCT01306032|20563055|P4|First Intervention|Death|0
5945588|NCT01306032|20563056|P3|First Intervention|Death|1
5945589|NCT01306032|20563057|P2|First Intervention|Death|0
5945590|NCT01306032|20563058|P1|First Intervention|Death|0
5945591|NCT01306032|20563053|P6|First Intervention|Withdrawal by Subject|0
5945592|NCT01306032|20563054|P5|First Intervention|Withdrawal by Subject|0
5945593|NCT01306032|20563055|P4|First Intervention|Withdrawal by Subject|1
5945594|NCT01306032|20563056|P3|First Intervention|Withdrawal by Subject|0
5945595|NCT01306032|20563057|P2|First Intervention|Withdrawal by Subject|2
5945596|NCT01306032|20563058|P1|First Intervention|Withdrawal by Subject|0
5945597|NCT01306032|20563053|P6|First Intervention|Adverse Event|1
5945598|NCT01306032|20563054|P5|First Intervention|Adverse Event|0
5945599|NCT01306032|20563055|P4|First Intervention|Adverse Event|0
5945600|NCT01306032|20563056|P3|First Intervention|Adverse Event|1
5945601|NCT01306032|20563057|P2|First Intervention|Adverse Event|0
5945602|NCT01306032|20563058|P1|First Intervention|Adverse Event|1
5945603|NCT01305941|20563110|P1|Overall Study|Death|1
5945604|NCT01305941|20563110|P1|Overall Study|Withdrawal by Subject|1
5945605|NCT01305941|20563110|P1|Overall Study|Clinical decline|2
5945606|NCT01305941|20563110|P1|Overall Study|Adverse Event|6
5945607|NCT01305577|20563150|P3|Overall Study|Protocol Deviation|1
5945608|NCT01305577|20563151|P2|Overall Study|Protocol Deviation|1
5945609|NCT01305577|20563152|P1|Overall Study|Protocol Deviation|0
5945610|NCT01305577|20563150|P3|Overall Study|Lost to Follow-up|2
5945611|NCT01305577|20563151|P2|Overall Study|Lost to Follow-up|3
5945612|NCT01305577|20563152|P1|Overall Study|Lost to Follow-up|4
5945613|NCT01305577|20563150|P3|Overall Study|Withdrawal by Subject|6
5945614|NCT01305577|20563151|P2|Overall Study|Withdrawal by Subject|5
5945615|NCT01305577|20563152|P1|Overall Study|Withdrawal by Subject|7
5945616|NCT01305577|20563150|P3|Overall Study|Adverse Event|1
5945617|NCT01305577|20563151|P2|Overall Study|Adverse Event|2
5945618|NCT01305577|20563152|P1|Overall Study|Adverse Event|2
5945619|NCT01305564|20563181|P1|Overall Study|Physician Decision|3
5945620|NCT01305564|20563181|P1|Overall Study|Withdrawal by Subject|1
5945621|NCT01305564|20563181|P1|Overall Study|Lost to Follow-up|12
5945622|NCT01305564|20563181|P1|Overall Study|Death|21
5945623|NCT01305408|20563208|P2|Overall Study|Other|0
5945624|NCT01305408|20563209|P1|Overall Study|Other|1
5945625|NCT01305408|20563208|P2|Overall Study|Noncompliance with study procedures|1
5945626|NCT01305408|20563209|P1|Overall Study|Noncompliance with study procedures|0
5945627|NCT01305408|20563208|P2|Overall Study|Noncompliance with study medication|1
5945628|NCT01305408|20563209|P1|Overall Study|Noncompliance with study medication|0
5945629|NCT01305408|20563208|P2|Overall Study|Lost to Follow-up|3
5945630|NCT01305408|20563209|P1|Overall Study|Lost to Follow-up|5
5945631|NCT01305408|20563208|P2|Overall Study|Protocol Violation|6
5945632|NCT01305408|20563209|P1|Overall Study|Protocol Violation|4
5945633|NCT01305408|20563208|P2|Overall Study|Withdrawal by Subject|9
5945634|NCT01305408|20563209|P1|Overall Study|Withdrawal by Subject|9
5945635|NCT01305408|20563208|P2|Overall Study|Lack of Efficacy|4
5945636|NCT01305408|20563209|P1|Overall Study|Lack of Efficacy|3
5945637|NCT01305408|20563208|P2|Overall Study|Adverse Event|7
5945638|NCT01305408|20563209|P1|Overall Study|Adverse Event|10
5945639|NCT01305239|20563302|P1|Overall Study|Exemestane taken prior to inclusion only|1
5945640|NCT01305239|20563302|P1|Overall Study|Adverse Event|22
5945641|NCT01305200|20563332|P3|Overall Study|Death|0
5945642|NCT01305200|20563333|P2|Overall Study|Death|2
5945643|NCT01305200|20563334|P1|Overall Study|Death|0
5945644|NCT01305200|20563332|P3|Overall Study|Ineligible|1
5945645|NCT01305200|20563333|P2|Overall Study|Ineligible|2
5945646|NCT01305200|20563334|P1|Overall Study|Ineligible|1
5945647|NCT01305200|20563332|P3|Overall Study|Withdrawal by Subject|1
5945648|NCT01305200|20563333|P2|Overall Study|Withdrawal by Subject|21
5945649|NCT01305200|20563334|P1|Overall Study|Withdrawal by Subject|24
5945650|NCT01305200|20563332|P3|Overall Study|Physician Decision|1
5945651|NCT01305200|20563333|P2|Overall Study|Physician Decision|6
5945652|NCT01305200|20563334|P1|Overall Study|Physician Decision|4
5945653|NCT01305044|20563364|P2|Overall Study|Withdrawal by Subject|6
5945654|NCT01305044|20563365|P1|Overall Study|Withdrawal by Subject|3
5945655|NCT01304940|20563397|P2|Overall Study|not meet symptom severity requirement|0
5945656|NCT01304940|20563398|P1|Overall Study|not meet symptom severity requirement|3
5945657|NCT01304706|20563404|P1|Overall Study|Discontinued due to failed drug admin.|1
5945658|NCT01304706|20563404|P1|Overall Study|Lost to Follow-up|7
5945659|NCT01304706|20563404|P1|Overall Study|Withdrawal by Subject|3
5945660|NCT01304706|20563404|P1|Overall Study|Death|3
5945661|NCT01304706|20563404|P1|Overall Study|Lack of Efficacy|1
5945662|NCT01304706|20563404|P1|Overall Study|Adverse Event|2
5945663|NCT01304693|20563413|P5|Overall Study|Decision Unrelated to an Adverse Event|0
5945664|NCT01304693|20563414|P4|Overall Study|Decision Unrelated to an Adverse Event|1
5945665|NCT01304693|20563415|P3|Overall Study|Decision Unrelated to an Adverse Event|1
5945666|NCT01304693|20563416|P2|Overall Study|Decision Unrelated to an Adverse Event|0
5945667|NCT01304693|20563417|P1|Overall Study|Decision Unrelated to an Adverse Event|0
5945668|NCT01304693|20563413|P5|Overall Study|Adverse Event|1
5945669|NCT01304693|20563414|P4|Overall Study|Adverse Event|0
5945670|NCT01304693|20563415|P3|Overall Study|Adverse Event|0
5945671|NCT01304693|20563416|P2|Overall Study|Adverse Event|0
5945672|NCT01304693|20563417|P1|Overall Study|Adverse Event|0
5945673|NCT01304498|20563464|P2|Overall Study|Lost to Follow-up|1
5945674|NCT01304498|20563465|P1|Overall Study|Lost to Follow-up|2
5945675|NCT01304498|20563464|P2|Overall Study|Protocol Violation|0
5945676|NCT01304498|20563465|P1|Overall Study|Protocol Violation|1
5945677|NCT01304498|20563464|P2|Overall Study|Withdrawal by Subject|3
5945678|NCT01304498|20563465|P1|Overall Study|Withdrawal by Subject|2
5945679|NCT01304498|20563464|P2|Overall Study|Adverse Event|1
5945680|NCT01304498|20563465|P1|Overall Study|Adverse Event|1
5945681|NCT01304329|20563489|P6|Third Intervention (3 Days)|Adverse Event|0
5945682|NCT01304329|20563490|P5|Third Intervention (3 Days)|Adverse Event|0
5945683|NCT01304329|20563491|P4|Third Intervention (3 Days)|Adverse Event|0
5945684|NCT01304329|20563492|P3|Third Intervention (3 Days)|Adverse Event|0
5945685|NCT01304329|20563493|P2|Third Intervention (3 Days)|Adverse Event|1
5945686|NCT01304329|20563494|P1|Third Intervention (3 Days)|Adverse Event|0
5945687|NCT01304147|20563628|P2|Second Intervention (7days)|Withdrawal by Subject|1
5945688|NCT01304147|20563629|P1|Second Intervention (7days)|Withdrawal by Subject|1
5945689|NCT01303965|20563660|P2|Overall Study|Disease Progression|6
5945690|NCT01303965|20563661|P1|Overall Study|Disease Progression|1
5945691|NCT01303965|20563660|P2|Overall Study|Withdrawal by Subject|0
5945692|NCT01303965|20563661|P1|Overall Study|Withdrawal by Subject|1
5945693|NCT01303965|20563660|P2|Overall Study|Death|3
5945694|NCT01303965|20563661|P1|Overall Study|Death|0
5945695|NCT01303965|20563660|P2|Overall Study|Adverse Event|1
5945696|NCT01303965|20563661|P1|Overall Study|Adverse Event|1
5945697|NCT01303861|20563689|P4|Overall Study|Pregnancy|0
5945698|NCT01303861|20563690|P3|Overall Study|Pregnancy|0
5945699|NCT01303861|20563691|P2|Overall Study|Pregnancy|0
5945700|NCT01303861|20563692|P1|Overall Study|Pregnancy|1
5945701|NCT01303861|20563689|P4|Overall Study|Adverse Event|5
5945702|NCT01303861|20563690|P3|Overall Study|Adverse Event|0
5945703|NCT01303861|20563691|P2|Overall Study|Adverse Event|1
5945704|NCT01303861|20563692|P1|Overall Study|Adverse Event|4
5945705|NCT01303861|20563689|P4|Overall Study|Withdrawal by Subject|23
5945706|NCT01303861|20563690|P3|Overall Study|Withdrawal by Subject|8
5945707|NCT01303861|20563691|P2|Overall Study|Withdrawal by Subject|8
5945708|NCT01303861|20563692|P1|Overall Study|Withdrawal by Subject|16
5945709|NCT01303861|20563689|P4|Overall Study|Lack of Efficacy|0
5945710|NCT01303861|20563690|P3|Overall Study|Lack of Efficacy|1
5945711|NCT01303861|20563691|P2|Overall Study|Lack of Efficacy|2
5945712|NCT01303861|20563692|P1|Overall Study|Lack of Efficacy|3
5945713|NCT01303861|20563689|P4|Overall Study|Lost to Follow-up|31
5945714|NCT01303861|20563690|P3|Overall Study|Lost to Follow-up|27
5945715|NCT01303861|20563691|P2|Overall Study|Lost to Follow-up|14
5945716|NCT01303861|20563692|P1|Overall Study|Lost to Follow-up|34
5945717|NCT01303627|20563751|P2|Overall Study|the failure while performing URS|1
5945718|NCT01303627|20563752|P1|Overall Study|the failure while performing URS|0
5945719|NCT01303510|20563760|P2|Overall Study|Lost to Follow-up|0
5945720|NCT01303510|20563761|P1|Overall Study|Lost to Follow-up|1
5945721|NCT01303445|20563775|P2|Follow-up Period (14 Days)|Withdrawal by Subject|1
5945722|NCT01303445|20563776|P1|Follow-up Period (14 Days)|Withdrawal by Subject|0
5945723|NCT01303445|20563775|P2|Fourth Intervention (7 Days)|Withdrawal by Subject|0
5945724|NCT01303445|20563776|P1|Fourth Intervention (7 Days)|Withdrawal by Subject|1
5945725|NCT01303445|20563775|P2|Washout (14 Days)|Lost to Follow-up|2
5945726|NCT01303445|20563776|P1|Washout (14 Days)|Lost to Follow-up|0
5945727|NCT01303445|20563775|P2|Washout (14 Days)|Protocol Violation|0
5945728|NCT01303445|20563776|P1|Washout (14 Days)|Protocol Violation|1
5945729|NCT01303445|20563775|P2|Second Intervention (7 Days)|Withdrawal by Subject|0
5945730|NCT01303445|20563776|P1|Second Intervention (7 Days)|Withdrawal by Subject|1
5945731|NCT01303445|20563775|P2|Second Intervention (7 Days)|Adverse Event|2
5945732|NCT01303445|20563776|P1|Second Intervention (7 Days)|Adverse Event|0
5945733|NCT01303445|20563775|P2|First Intervention (7 Days)|Withdrawal by Subject|0
5945734|NCT01303445|20563776|P1|First Intervention (7 Days)|Withdrawal by Subject|1
5945735|NCT01303419|20563806|P1|Overall Study|Did not meet all I/E after screening|31
5945736|NCT01303419|20563806|P1|Overall Study|Did not complete both imaging methods|5
5945737|NCT01303419|20563806|P1|Overall Study|Discontinuation of study|60
5945738|NCT01303380|20563825|P1|Overall Study|Lack of compliance to study procedures|1
5945739|NCT01303159|20563884|P1|Overall Study|Study Termination|7
5945740|NCT01303159|20563884|P1|Overall Study|Death|16
5945741|NCT01302964|20563902|P2|Overall Study|Adverse Event|0
5945742|NCT01302964|20563903|P1|Overall Study|Adverse Event|1
5945743|NCT01302899|20563913|P2|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|1
5945744|NCT01302899|20563914|P1|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|0
5945745|NCT01302899|20563913|P2|Period 2 (Weeks 7 to 12)|Protocol Deviation|0
5945746|NCT01302899|20563914|P1|Period 2 (Weeks 7 to 12)|Protocol Deviation|1
5945751|NCT01302691|20564058|P2|Overall Study|Protocol Violation|0
5945752|NCT01302691|20564059|P1|Overall Study|Protocol Violation|1
5945753|NCT01302691|20564058|P2|Overall Study|Physician Decision|1
5945754|NCT01302691|20564059|P1|Overall Study|Physician Decision|0
5945755|NCT01302691|20564058|P2|Overall Study|Blood Pressure/Potassium Criteria Met|4
5945756|NCT01302691|20564059|P1|Overall Study|Blood Pressure/Potassium Criteria Met|6
5945757|NCT01302691|20564058|P2|Overall Study|Lost to Follow-up|0
5945758|NCT01302691|20564059|P1|Overall Study|Lost to Follow-up|1
5945759|NCT01302691|20564058|P2|Overall Study|Death|1
5945760|NCT01302691|20564059|P1|Overall Study|Death|0
5945761|NCT01302691|20564058|P2|Overall Study|Adverse Event|0
5945762|NCT01302691|20564059|P1|Overall Study|Adverse Event|2
5945763|NCT01302548|20564079|P2|Overall Study|Lost to Follow-up|1
5945764|NCT01302548|20564080|P1|Overall Study|Lost to Follow-up|2
5945765|NCT01302418|20564130|P1|Overall Study|Non-evaluable|9
5945766|NCT01302418|20564130|P1|Overall Study|Protocol Violation|9
5945767|NCT01302392|20564136|P2|Overall Study|Withdrawal by Subject|1
5945768|NCT01302392|20564137|P1|Overall Study|Withdrawal by Subject|6
5945769|NCT01302392|20564136|P2|Overall Study|Lost to Follow-up|0
5945770|NCT01302392|20564137|P1|Overall Study|Lost to Follow-up|1
5945771|NCT01302366|20564188|P1|Overall Study|patient choice or noncompliance|5
5945772|NCT01302119|20564196|P2|Overall Study|Non-specific|1
5945773|NCT01302119|20564197|P1|Overall Study|Non-specific|4
5945774|NCT01302119|20564196|P2|Overall Study|Non-compliance|2
5945775|NCT01302119|20564197|P1|Overall Study|Non-compliance|4
5945776|NCT01302119|20564196|P2|Overall Study|Adverse Event|1
5945777|NCT01302119|20564197|P1|Overall Study|Adverse Event|2
5945778|NCT01302119|20564196|P2|Overall Study|Lost to Follow-up|4
5945779|NCT01302119|20564197|P1|Overall Study|Lost to Follow-up|10
5945780|NCT01302119|20564196|P2|Overall Study|Withdrawal by Subject|20
5945781|NCT01302119|20564197|P1|Overall Study|Withdrawal by Subject|30
5945782|NCT01302067|20564212|P3|Overall Study|Adverse Event|45
5945783|NCT01302067|20564213|P2|Overall Study|Adverse Event|14
5945784|NCT01302067|20564214|P1|Overall Study|Adverse Event|27
5945785|NCT01302067|20564212|P3|Overall Study|Protocol Violation|8
5945786|NCT01302067|20564213|P2|Overall Study|Protocol Violation|0
5945787|NCT01302067|20564214|P1|Overall Study|Protocol Violation|11
5945788|NCT01302067|20564212|P3|Overall Study|Other|3
5945789|NCT01302067|20564213|P2|Overall Study|Other|1
5945790|NCT01302067|20564214|P1|Overall Study|Other|1
5945791|NCT01302067|20564212|P3|Overall Study|Withdrawal by Subject|10
5945792|NCT01302067|20564213|P2|Overall Study|Withdrawal by Subject|6
5945793|NCT01302067|20564214|P1|Overall Study|Withdrawal by Subject|13
5945794|NCT01302067|20564212|P3|Overall Study|Lost to Follow-up|15
5945795|NCT01302067|20564213|P2|Overall Study|Lost to Follow-up|4
5945796|NCT01302067|20564214|P1|Overall Study|Lost to Follow-up|9
5945797|NCT01302067|20564212|P3|Overall Study|Lack of Efficacy|2
5945798|NCT01302067|20564213|P2|Overall Study|Lack of Efficacy|4
5945799|NCT01302067|20564214|P1|Overall Study|Lack of Efficacy|8
5945800|NCT01302067|20564212|P3|Overall Study|Physician Decision|14
5945801|NCT01302067|20564213|P2|Overall Study|Physician Decision|5
5945802|NCT01302067|20564214|P1|Overall Study|Physician Decision|9
5945803|NCT01302067|20564212|P3|Overall Study|Death|1
5945804|NCT01302067|20564213|P2|Overall Study|Death|0
5945805|NCT01302067|20564214|P1|Overall Study|Death|0
5945806|NCT01302054|20564285|P3|Double-Blind Treatment Phase|Other|9
5945807|NCT01302054|20564286|P2|Double-Blind Treatment Phase|Other|4
5945808|NCT01302054|20564287|P1|Double-Blind Treatment Phase|Other|0
5945809|NCT01302054|20564285|P3|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|2
5945810|NCT01302054|20564286|P2|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0
5945811|NCT01302054|20564287|P1|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0
5945812|NCT01302054|20564285|P3|Double-Blind Treatment Phase|Adverse Event|10
5945813|NCT01302054|20564286|P2|Double-Blind Treatment Phase|Adverse Event|10
5945814|NCT01302054|20564287|P1|Double-Blind Treatment Phase|Adverse Event|0
5945815|NCT01302054|20564285|P3|Double-Blind Treatment Phase|Protocol Violation|6
5945816|NCT01302054|20564286|P2|Double-Blind Treatment Phase|Protocol Violation|3
5945817|NCT01302054|20564287|P1|Double-Blind Treatment Phase|Protocol Violation|0
5945818|NCT01302054|20564285|P3|Double-Blind Treatment Phase|Withdrawal by Subject|14
5945819|NCT01302054|20564286|P2|Double-Blind Treatment Phase|Withdrawal by Subject|6
5945820|NCT01302054|20564287|P1|Double-Blind Treatment Phase|Withdrawal by Subject|0
5945821|NCT01302054|20564285|P3|Double-Blind Treatment Phase|Lost to Follow-up|1
5945822|NCT01302054|20564286|P2|Double-Blind Treatment Phase|Lost to Follow-up|2
5945823|NCT01302054|20564287|P1|Double-Blind Treatment Phase|Lost to Follow-up|0
5945824|NCT01302054|20564285|P3|Double-Blind Treatment Phase|Lack of Efficacy|4
5945825|NCT01302054|20564286|P2|Double-Blind Treatment Phase|Lack of Efficacy|2
5945826|NCT01302054|20564287|P1|Double-Blind Treatment Phase|Lack of Efficacy|0
5945827|NCT01302054|20564285|P3|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0
5945828|NCT01302054|20564286|P2|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0
5945829|NCT01302054|20564287|P1|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|2
5945830|NCT01302054|20564285|P3|Tolterodine Open-Label Run-In Phase|Other|0
5945831|NCT01302054|20564286|P2|Tolterodine Open-Label Run-In Phase|Other|0
5945832|NCT01302054|20564287|P1|Tolterodine Open-Label Run-In Phase|Other|7
5945833|NCT01302054|20564285|P3|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0
5945834|NCT01302054|20564286|P2|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0
5945835|NCT01302054|20564287|P1|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|314
5945836|NCT01302054|20564285|P3|Tolterodine Open-Label Run-In Phase|Adverse Event|0
5945837|NCT01302054|20564286|P2|Tolterodine Open-Label Run-In Phase|Adverse Event|0
5945838|NCT01302054|20564287|P1|Tolterodine Open-Label Run-In Phase|Adverse Event|13
5945839|NCT01302054|20564285|P3|Tolterodine Open-Label Run-In Phase|Protocol Violation|0
5945840|NCT01302054|20564286|P2|Tolterodine Open-Label Run-In Phase|Protocol Violation|0
5945841|NCT01302054|20564287|P1|Tolterodine Open-Label Run-In Phase|Protocol Violation|8
5945842|NCT01302054|20564285|P3|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0
5945843|NCT01302054|20564286|P2|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0
5945844|NCT01302054|20564287|P1|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|16
5945845|NCT01302054|20564285|P3|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0
5945846|NCT01302054|20564286|P2|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0
5945847|NCT01302054|20564287|P1|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|17
5945848|NCT01302054|20564285|P3|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0
5945849|NCT01302054|20564286|P2|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0
5945850|NCT01302054|20564287|P1|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|4
5945851|NCT01302041|20564314|P1|Overall Study|Other-Miscellaneous Reason|2
5945852|NCT01302041|20564314|P1|Overall Study|Other-Transitioned to 9785-CL-0123|29
5945853|NCT01302041|20564314|P1|Overall Study|Withdrawal by Subject|4
5945854|NCT01302041|20564314|P1|Overall Study|Death|5
5945855|NCT01301950|20564356|P2|Overall Study|Surgery was cancelled by patient|1
5945856|NCT01301950|20564357|P1|Overall Study|Surgery was cancelled by patient|0
5945857|NCT01301833|20564375|P4|Overall Study|Personal matter|0
5945858|NCT01301833|20564376|P3|Overall Study|Personal matter|0
5945859|NCT01301833|20564377|P2|Overall Study|Personal matter|0
5945860|NCT01301833|20564378|P1|Overall Study|Personal matter|1
5945861|NCT01301833|20564375|P4|Overall Study|Withdrawal by Subject|2
5945862|NCT01301833|20564376|P3|Overall Study|Withdrawal by Subject|1
5945863|NCT01301833|20564377|P2|Overall Study|Withdrawal by Subject|1
5945864|NCT01301833|20564378|P1|Overall Study|Withdrawal by Subject|3
5945865|NCT01301833|20564375|P4|Overall Study|Physician Decision|0
5945866|NCT01301833|20564376|P3|Overall Study|Physician Decision|1
5945867|NCT01301833|20564377|P2|Overall Study|Physician Decision|1
5945868|NCT01301833|20564378|P1|Overall Study|Physician Decision|3
5945869|NCT01301833|20564375|P4|Overall Study|Lack of Efficacy|0
5945870|NCT01301833|20564376|P3|Overall Study|Lack of Efficacy|0
5945871|NCT01301833|20564377|P2|Overall Study|Lack of Efficacy|1
5945872|NCT01301833|20564378|P1|Overall Study|Lack of Efficacy|1
5945873|NCT01301833|20564375|P4|Overall Study|Adverse Event|5
5945874|NCT01301833|20564376|P3|Overall Study|Adverse Event|5
5945875|NCT01301833|20564377|P2|Overall Study|Adverse Event|5
5945876|NCT01301833|20564378|P1|Overall Study|Adverse Event|7
5945877|NCT01301729|20564416|P1|Overall Study|Violated Selection Criteria|1
5945878|NCT01301729|20564416|P1|Overall Study|Participant did not Return for Treatment|1
5945879|NCT01301729|20564416|P1|Overall Study|Withdrawal by Subject|2
5945880|NCT01301625|20564427|P1|Overall Study|Lost to Follow-up|1
5945881|NCT01301625|20564427|P1|Overall Study|Expected|8
5945882|NCT01301625|20564427|P1|Overall Study|Not Due|21
5945883|NCT01301625|20564427|P1|Overall Study|Death|5
5945884|NCT01301508|20564499|P2|Overall Study|Lost to Follow-up|1
5945885|NCT01301508|20564500|P1|Overall Study|Lost to Follow-up|0
5945886|NCT01301508|20564499|P2|Overall Study|Withdrawal by Subject|2
5945887|NCT01301508|20564500|P1|Overall Study|Withdrawal by Subject|1
5945888|NCT01301456|20564530|P12|Stage 2|Adverse Event|0
5945889|NCT01301456|20564531|P11|Stage 2|Adverse Event|1
5945890|NCT01301456|20564532|P10|Stage 2|Adverse Event|0
5945891|NCT01301456|20564533|P9|Stage 2|Adverse Event|0
5945892|NCT01301456|20564534|P8|Stage 2|Adverse Event|0
5945893|NCT01301456|20564535|P7|Stage 2|Adverse Event|0
5945894|NCT01301456|20564536|P6|Stage 2|Adverse Event|0
5945895|NCT01301456|20564537|P5|Stage 2|Adverse Event|0
5945896|NCT01301456|20564538|P4|Stage 2|Adverse Event|0
5945897|NCT01301456|20564539|P3|Stage 2|Adverse Event|0
5945898|NCT01301456|20564540|P2|Stage 2|Adverse Event|0
5945899|NCT01301456|20564541|P1|Stage 2|Adverse Event|0
5945900|NCT01301456|20564530|P12|Stage 1|Randomized but not treated|0
5945901|NCT01301456|20564531|P11|Stage 1|Randomized but not treated|0
5945902|NCT01301456|20564532|P10|Stage 1|Randomized but not treated|0
5945903|NCT01301456|20564533|P9|Stage 1|Randomized but not treated|0
5945904|NCT01301456|20564534|P8|Stage 1|Randomized but not treated|0
5945905|NCT01301456|20564535|P7|Stage 1|Randomized but not treated|1
5945906|NCT01301456|20564536|P6|Stage 1|Randomized but not treated|0
5945907|NCT01301456|20564537|P5|Stage 1|Randomized but not treated|0
5945908|NCT01301456|20564538|P4|Stage 1|Randomized but not treated|0
5945909|NCT01301456|20564539|P3|Stage 1|Randomized but not treated|0
5945910|NCT01301456|20564540|P2|Stage 1|Randomized but not treated|0
5945911|NCT01301456|20564541|P1|Stage 1|Randomized but not treated|0
5945912|NCT01301456|20564530|P12|Stage 1|Withdrawal by Subject|0
5945913|NCT01301456|20564531|P11|Stage 1|Withdrawal by Subject|0
5945914|NCT01301456|20564532|P10|Stage 1|Withdrawal by Subject|0
5945915|NCT01301456|20564533|P9|Stage 1|Withdrawal by Subject|0
5945916|NCT01301456|20564534|P8|Stage 1|Withdrawal by Subject|0
5945917|NCT01301456|20564535|P7|Stage 1|Withdrawal by Subject|0
5945918|NCT01301456|20564536|P6|Stage 1|Withdrawal by Subject|0
5945919|NCT01301456|20564537|P5|Stage 1|Withdrawal by Subject|1
5945920|NCT01301456|20564538|P4|Stage 1|Withdrawal by Subject|0
5945921|NCT01301456|20564539|P3|Stage 1|Withdrawal by Subject|1
5945922|NCT01301456|20564540|P2|Stage 1|Withdrawal by Subject|0
5945923|NCT01301456|20564541|P1|Stage 1|Withdrawal by Subject|0
5945924|NCT01301391|20564767|P1|Overall Study|Sponsor's decision|8
5945925|NCT01301391|20564767|P1|Overall Study|Physician Decision|2
5945926|NCT01301391|20564767|P1|Overall Study|Lost to Follow-up|3
5945927|NCT01301391|20564767|P1|Overall Study|Death|13
5945928|NCT01301274|20564779|P2|Overall Study|Physician Decision|1
5945929|NCT01301274|20564780|P1|Overall Study|Physician Decision|2
5945930|NCT01301092|20564795|P3|Overall Study|Lost to Follow-up|1
5945931|NCT01301092|20564796|P2|Overall Study|Lost to Follow-up|0
5945932|NCT01301092|20564797|P1|Overall Study|Lost to Follow-up|0
5945933|NCT01301079|20564814|P2|Overall Study|Lost to Follow-up|2
5945934|NCT01301079|20564815|P1|Overall Study|Lost to Follow-up|2
5945935|NCT01301066|20564893|P2|Overall Study|Other|0
5945936|NCT01301066|20564894|P1|Overall Study|Other|2
5945937|NCT01301066|20564893|P2|Overall Study|Physician Decision|1
5945938|NCT01301066|20564894|P1|Overall Study|Physician Decision|0
5945939|NCT01301066|20564893|P2|Overall Study|Sponsor Decision|1
5945940|NCT01301066|20564894|P1|Overall Study|Sponsor Decision|2
5945941|NCT01301066|20564893|P2|Overall Study|Adverse Event|6
5945942|NCT01301066|20564894|P1|Overall Study|Adverse Event|6
5945943|NCT01301066|20564893|P2|Overall Study|Withdrawal by Subject|9
5945944|NCT01301066|20564894|P1|Overall Study|Withdrawal by Subject|4
5945945|NCT01301066|20564893|P2|Overall Study|Protocol Violation|7
5945946|NCT01301066|20564894|P1|Overall Study|Protocol Violation|8
5945947|NCT01301066|20564893|P2|Overall Study|Lost to Follow-up|11
5945948|NCT01301066|20564894|P1|Overall Study|Lost to Follow-up|5
5945949|NCT01301027|20564902|P2|Overall Study|Volume Overload|0
5945950|NCT01301027|20564903|P1|Overall Study|Volume Overload|3
5945951|NCT01301027|20564902|P2|Overall Study|Transplant|2
5945952|NCT01301027|20564903|P1|Overall Study|Transplant|0
5945953|NCT01301027|20564902|P2|Overall Study|Fracture|3
5945954|NCT01301027|20564903|P1|Overall Study|Fracture|1
5945955|NCT01301027|20564902|P2|Overall Study|Adverse Event|2
5945956|NCT01301027|20564903|P1|Overall Study|Adverse Event|0
5945957|NCT01301027|20564902|P2|Overall Study|Withdrawal by Subject|3
5945958|NCT01301027|20564903|P1|Overall Study|Withdrawal by Subject|2
5945959|NCT01301027|20564902|P2|Overall Study|Physician Decision|0
5945960|NCT01301027|20564903|P1|Overall Study|Physician Decision|2
5945961|NCT01301001|20564915|P2|Second Intervention|Withdrawal by Subject|0
5945962|NCT01301001|20564916|P1|Second Intervention|Withdrawal by Subject|2
5945963|NCT01301001|20564915|P2|Second Intervention|Adverse Event|0
5945964|NCT01301001|20564916|P1|Second Intervention|Adverse Event|2
5945965|NCT01301001|20564915|P2|First Intervention|Protocol Violation|1
5945966|NCT01301001|20564916|P1|First Intervention|Protocol Violation|0
5945967|NCT01301001|20564915|P2|First Intervention|Adverse Event|0
5945968|NCT01301001|20564916|P1|First Intervention|Adverse Event|5
5945969|NCT01301001|20564915|P2|First Intervention|Withdrawal by Subject|4
5945970|NCT01301001|20564916|P1|First Intervention|Withdrawal by Subject|1
5945971|NCT01301001|20564915|P2|First Intervention|Lost to Follow-up|4
5945972|NCT01301001|20564916|P1|First Intervention|Lost to Follow-up|4
5945973|NCT01300923|20564939|P2|Overall Study|Physician Decision|2
5945974|NCT01300923|20564940|P1|Overall Study|Physician Decision|0
5945975|NCT01300819|20564953|P2|Overall Study|Follow up call was not done|0
5945976|NCT01300819|20564954|P1|Overall Study|Follow up call was not done|1
5945977|NCT01300819|20564953|P2|Overall Study|Safety follow up not done by mistake|1
5945978|NCT01300819|20564954|P1|Overall Study|Safety follow up not done by mistake|0
5945979|NCT01300819|20564953|P2|Overall Study|Administrative reason|1
5945980|NCT01300819|20564954|P1|Overall Study|Administrative reason|0
5945981|NCT01300819|20564953|P2|Overall Study|Refusal to down titrate study drug|1
5945982|NCT01300819|20564954|P1|Overall Study|Refusal to down titrate study drug|0
5945983|NCT01300819|20564953|P2|Overall Study|Patient was 1 month late for Visit 10|1
5945984|NCT01300819|20564954|P1|Overall Study|Patient was 1 month late for Visit 10|0
5945985|NCT01300819|20564953|P2|Overall Study|Withdrawal by Subject|12
5945986|NCT01300819|20564954|P1|Overall Study|Withdrawal by Subject|10
5945987|NCT01300819|20564953|P2|Overall Study|Lack of Efficacy|1
5945988|NCT01300819|20564954|P1|Overall Study|Lack of Efficacy|2
5945989|NCT01300819|20564953|P2|Overall Study|Adverse Event|27
5945990|NCT01300819|20564954|P1|Overall Study|Adverse Event|9
5945991|NCT01300767|20564982|P1|Overall Study|Unacceptable fit|1
5945992|NCT01300767|20564982|P1|Overall Study|Biomicroscopy|1
5945993|NCT01300767|20564982|P1|Overall Study|Discomfort|2
5945994|NCT01300741|20565010|P1|Overall Study|Discomfort|1
5945995|NCT01300741|20565010|P1|Overall Study|Lost to Follow-up|1
5945996|NCT01300741|20565010|P1|Overall Study|Lens deposits|1
5945997|NCT01300728|20565040|P2|Overall Study|Physician Decision|0
5945998|NCT01300728|20565041|P1|Overall Study|Physician Decision|1
5945999|NCT01300728|20565040|P2|Overall Study|Withdrawal by Subject|1
5946000|NCT01300728|20565041|P1|Overall Study|Withdrawal by Subject|1
5946001|NCT01300650|20565055|P1|Overall Study|Adverse Event|1
5946002|NCT01300572|20565071|P1|Overall Study|HAMA + post dosimetry|1
5946003|NCT01300546|20565095|P2|Overall Study|Adverse Event|1
5946004|NCT01300546|20565096|P1|Overall Study|Adverse Event|0
5946005|NCT01300546|20565095|P2|Overall Study|Lack of Efficacy|3
5946006|NCT01300546|20565096|P1|Overall Study|Lack of Efficacy|0
5946007|NCT01300546|20565095|P2|Overall Study|Lost to Follow-up|2
5946008|NCT01300546|20565096|P1|Overall Study|Lost to Follow-up|0
5946009|NCT01300546|20565095|P2|Overall Study|Withdrawal by Subject|0
5946010|NCT01300546|20565096|P1|Overall Study|Withdrawal by Subject|1
5946011|NCT01300455|20565126|P2|Washout|Withdrawal by Subject|0
5946012|NCT01300455|20565127|P1|Washout|Withdrawal by Subject|1
5946013|NCT01300351|20565147|P2|Overall Study|Withdrawal by Subject|10
5946014|NCT01300351|20565148|P1|Overall Study|Withdrawal by Subject|7
5946015|NCT01300351|20565147|P2|Overall Study|Adverse Event|4
5946016|NCT01300351|20565148|P1|Overall Study|Adverse Event|0
5946017|NCT01300351|20565147|P2|Overall Study|Lost to Follow-up|1
5946018|NCT01300351|20565148|P1|Overall Study|Lost to Follow-up|0
5946019|NCT01300351|20565147|P2|Overall Study|Ongoing treatment at data cut-off|23
5946020|NCT01300351|20565148|P1|Overall Study|Ongoing treatment at data cut-off|27
5946021|NCT01300351|20565147|P2|Overall Study|Did not receive treatment|0
5946022|NCT01300351|20565148|P1|Overall Study|Did not receive treatment|2
5946023|NCT01300338|20565164|P2|Overall Study|Lost to Follow-up|0
5946024|NCT01300338|20565165|P1|Overall Study|Lost to Follow-up|5
5946025|NCT01300286|20565173|P1|Overall Study|did not get dosed|1
5946026|NCT01300260|20565183|P2|Period 2 of Study: Second Intervention|Adverse Event|1
5946027|NCT01300260|20565184|P1|Period 2 of Study: Second Intervention|Adverse Event|0
5946028|NCT01300260|20565183|P2|Period 1 of Study: First Intervention|Withdrawal by Subject|0
5946029|NCT01300260|20565184|P1|Period 1 of Study: First Intervention|Withdrawal by Subject|1
5946030|NCT01300260|20565183|P2|Period 1 of Study: First Intervention|Adverse Event|1
5946031|NCT01300260|20565184|P1|Period 1 of Study: First Intervention|Adverse Event|0
5946032|NCT01300247|20565216|P2|Overall Study|Non-Compliance|1
5946033|NCT01300247|20565217|P1|Overall Study|Non-Compliance|0
5946034|NCT01300247|20565216|P2|Overall Study|Withdrawal by Subject|0
5946035|NCT01300247|20565217|P1|Overall Study|Withdrawal by Subject|1
5946036|NCT01300247|20565216|P2|Overall Study|Lost to Follow-up|0
5946037|NCT01300247|20565217|P1|Overall Study|Lost to Follow-up|2
5946038|NCT01300247|20565216|P2|Overall Study|Death|1
5946039|NCT01300247|20565217|P1|Overall Study|Death|1
5946040|NCT01300234|20565249|P2|Overall Study|Participant refused return to hospital|0
5946041|NCT01300234|20565250|P1|Overall Study|Participant refused return to hospital|1
5946042|NCT01300234|20565249|P2|Overall Study|Participant stopped medication|1
5946043|NCT01300234|20565250|P1|Overall Study|Participant stopped medication|1
5946044|NCT01300234|20565249|P2|Overall Study|Participant reached stopping critera|0
5946045|NCT01300234|20565250|P1|Overall Study|Participant reached stopping critera|2
5946046|NCT01300234|20565249|P2|Overall Study|Pregnancy|1
5946047|NCT01300234|20565250|P1|Overall Study|Pregnancy|2
5946048|NCT01300234|20565249|P2|Overall Study|Lost to Follow-up|12
5946049|NCT01300234|20565250|P1|Overall Study|Lost to Follow-up|14
5946050|NCT01300234|20565249|P2|Overall Study|Withdrawal by Subject|9
5946051|NCT01300234|20565250|P1|Overall Study|Withdrawal by Subject|5
5946052|NCT01300234|20565249|P2|Overall Study|Protocol Violation|3
5946053|NCT01300234|20565250|P1|Overall Study|Protocol Violation|2
5946054|NCT01300234|20565249|P2|Overall Study|Adverse Event|1
5946055|NCT01300234|20565250|P1|Overall Study|Adverse Event|1
5946056|NCT01300052|20565297|P2|Overall Study|Protocol Violation|1
5946057|NCT01300052|20565298|P1|Overall Study|Protocol Violation|1
5946058|NCT01300052|20565297|P2|Overall Study|Withdrawal by Subject|2
5946059|NCT01300052|20565298|P1|Overall Study|Withdrawal by Subject|2
5946060|NCT01300052|20565297|P2|Overall Study|Adverse Event|0
5946061|NCT01300052|20565298|P1|Overall Study|Adverse Event|3
5946062|NCT01299961|20565316|P1|Overall Study|Lost to Follow-up|1
5946063|NCT01299961|20565316|P1|Overall Study|Lack of Efficacy|2
5946064|NCT01299961|20565316|P1|Overall Study|Adverse Event|3
5946065|NCT01299909|20565325|P3|Overall Study|Lost to Follow-up|17
5946066|NCT01299909|20565326|P2|Overall Study|Lost to Follow-up|18
5946067|NCT01299909|20565327|P1|Overall Study|Lost to Follow-up|22
5946068|NCT01299896|20565342|P2|Overall Study|Lost to Follow-up|11
5946069|NCT01299896|20565343|P1|Overall Study|Lost to Follow-up|0
5946070|NCT01299896|20565342|P2|Overall Study|Withdrawal by Subject|7
5946071|NCT01299896|20565343|P1|Overall Study|Withdrawal by Subject|1
5946072|NCT01299805|20565351|P2|Overall Study|Adverse Event|0
5946073|NCT01299805|20565352|P1|Overall Study|Adverse Event|2
5946074|NCT01299766|20565382|P2|Overall Study|Withdrawal by Subject|19
5946075|NCT01299766|20565383|P1|Overall Study|Withdrawal by Subject|29
5946076|NCT01299766|20565382|P2|Overall Study|Death|4
5946077|NCT01299766|20565383|P1|Overall Study|Death|5
5946078|NCT01299727|20565394|P3|Overall Study|Completed the Treatment Period|3
5946079|NCT01299727|20565395|P2|Overall Study|Completed the Treatment Period|4
5946080|NCT01299727|20565396|P1|Overall Study|Completed the Treatment Period|3
5946081|NCT01299727|20565394|P3|Overall Study|Adverse Event|1
5946082|NCT01299727|20565395|P2|Overall Study|Adverse Event|0
5946083|NCT01299727|20565396|P1|Overall Study|Adverse Event|0
5946084|NCT01299727|20565394|P3|Overall Study|Withdrawal by Subject|0
5946085|NCT01299727|20565395|P2|Overall Study|Withdrawal by Subject|0
5946086|NCT01299727|20565396|P1|Overall Study|Withdrawal by Subject|1
5946087|NCT01299584|20565490|P1|Overall Study|Protocol Violation|9
5946088|NCT01299571|20565497|P1|Overall Study|Protocol Violation|107
5946089|NCT01299480|20565508|P5|Overall Study|Started, but not vaccinated|0
5946090|NCT01299480|20565509|P4|Overall Study|Started, but not vaccinated|1
5946091|NCT01299480|20565510|P3|Overall Study|Started, but not vaccinated|1
5946092|NCT01299480|20565511|P2|Overall Study|Started, but not vaccinated|0
5946093|NCT01299480|20565512|P1|Overall Study|Started, but not vaccinated|0
5946094|NCT01299480|20565508|P5|Overall Study|Other|3
5946095|NCT01299480|20565509|P4|Overall Study|Other|0
5946096|NCT01299480|20565510|P3|Overall Study|Other|3
5946097|NCT01299480|20565511|P2|Overall Study|Other|2
5946098|NCT01299480|20565512|P1|Overall Study|Other|3
5946099|NCT01299480|20565508|P5|Overall Study|Lost to Follow-up|2
5946100|NCT01299480|20565509|P4|Overall Study|Lost to Follow-up|1
5946101|NCT01299480|20565510|P3|Overall Study|Lost to Follow-up|2
5946102|NCT01299480|20565511|P2|Overall Study|Lost to Follow-up|1
5946103|NCT01299480|20565512|P1|Overall Study|Lost to Follow-up|3
5946104|NCT01299480|20565508|P5|Overall Study|Physician Decision|0
5946105|NCT01299480|20565509|P4|Overall Study|Physician Decision|2
5946106|NCT01299480|20565510|P3|Overall Study|Physician Decision|0
5946107|NCT01299480|20565511|P2|Overall Study|Physician Decision|1
5946108|NCT01299480|20565512|P1|Overall Study|Physician Decision|1
5946109|NCT01299480|20565508|P5|Overall Study|Withdrawal due to pregnancy|0
5946110|NCT01299480|20565509|P4|Overall Study|Withdrawal due to pregnancy|0
5946111|NCT01299480|20565510|P3|Overall Study|Withdrawal due to pregnancy|1
5946112|NCT01299480|20565511|P2|Overall Study|Withdrawal due to pregnancy|1
5946113|NCT01299480|20565512|P1|Overall Study|Withdrawal due to pregnancy|0
5946114|NCT01299480|20565508|P5|Overall Study|Adverse Event|0
5946115|NCT01299480|20565509|P4|Overall Study|Adverse Event|4
5946116|NCT01299480|20565510|P3|Overall Study|Adverse Event|5
5946117|NCT01299480|20565511|P2|Overall Study|Adverse Event|4
5946118|NCT01299480|20565512|P1|Overall Study|Adverse Event|6
5946119|NCT01299480|20565508|P5|Overall Study|Withdrawal by Subject|4
5946120|NCT01299480|20565509|P4|Overall Study|Withdrawal by Subject|3
5946121|NCT01299480|20565510|P3|Overall Study|Withdrawal by Subject|7
5946122|NCT01299480|20565511|P2|Overall Study|Withdrawal by Subject|4
5946123|NCT01299480|20565512|P1|Overall Study|Withdrawal by Subject|3
5946124|NCT01299480|20565508|P5|Overall Study|Protocol Violation|1
5946125|NCT01299480|20565509|P4|Overall Study|Protocol Violation|1
5946126|NCT01299480|20565510|P3|Overall Study|Protocol Violation|8
5946127|NCT01299480|20565511|P2|Overall Study|Protocol Violation|5
5946128|NCT01299480|20565512|P1|Overall Study|Protocol Violation|7
5946129|NCT01299480|20565508|P5|Overall Study|No longer willing to participate|10
5946130|NCT01299480|20565509|P4|Overall Study|No longer willing to participate|13
5946131|NCT01299480|20565510|P3|Overall Study|No longer willing to participate|14
5946132|NCT01299480|20565511|P2|Overall Study|No longer willing to participate|17
5946133|NCT01299480|20565512|P1|Overall Study|No longer willing to participate|19
5946134|NCT01299389|20565714|P4|Post-observational|Other|6
5946135|NCT01299389|20565715|P3|Post-observational|Other|12
5946136|NCT01299389|20565716|P2|Post-observational|Other|0
5946137|NCT01299389|20565717|P1|Post-observational|Other|0
5946138|NCT01299389|20565714|P4|Double-blind|"fail to meet study population criteria"|0
5946139|NCT01299389|20565715|P3|Double-blind|"fail to meet study population criteria"|0
5946140|NCT01299389|20565716|P2|Double-blind|"fail to meet study population criteria"|1
5946141|NCT01299389|20565717|P1|Double-blind|"fail to meet study population criteria"|0
5946142|NCT01299389|20565714|P4|Double-blind|Other|0
5946143|NCT01299389|20565715|P3|Double-blind|Other|0
5946144|NCT01299389|20565716|P2|Double-blind|Other|1
5946145|NCT01299389|20565717|P1|Double-blind|Other|1
5946146|NCT01299389|20565714|P4|Double-blind|Withdrawal by Subject|0
5946147|NCT01299389|20565715|P3|Double-blind|Withdrawal by Subject|0
5946148|NCT01299389|20565716|P2|Double-blind|Withdrawal by Subject|13
5946149|NCT01299389|20565717|P1|Double-blind|Withdrawal by Subject|16
5946150|NCT01299389|20565714|P4|Double-blind|Lost to Follow-up|0
5946151|NCT01299389|20565715|P3|Double-blind|Lost to Follow-up|0
5946152|NCT01299389|20565716|P2|Double-blind|Lost to Follow-up|1
5946153|NCT01299389|20565717|P1|Double-blind|Lost to Follow-up|2
5946154|NCT01299389|20565714|P4|Double-blind|Lack of Efficacy|0
5946155|NCT01299389|20565715|P3|Double-blind|Lack of Efficacy|0
5946156|NCT01299389|20565716|P2|Double-blind|Lack of Efficacy|21
5946157|NCT01299389|20565717|P1|Double-blind|Lack of Efficacy|45
5946158|NCT01299389|20565714|P4|Double-blind|Adverse Event|0
5946159|NCT01299389|20565715|P3|Double-blind|Adverse Event|0
5946160|NCT01299389|20565716|P2|Double-blind|Adverse Event|27
5946161|NCT01299389|20565717|P1|Double-blind|Adverse Event|45
5946162|NCT01299376|20565739|P2|Extension (Weeks 9 to 52)|Physician Decision|0
5946163|NCT01299376|20565740|P1|Extension (Weeks 9 to 52)|Physician Decision|1
5946164|NCT01299376|20565739|P2|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|9
5946165|NCT01299376|20565740|P1|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|4
5946166|NCT01299376|20565739|P2|Extension (Weeks 9 to 52)|Lost to Follow-up|2
5946167|NCT01299376|20565740|P1|Extension (Weeks 9 to 52)|Lost to Follow-up|1
5946168|NCT01299376|20565739|P2|Extension (Weeks 9 to 52)|Adverse Event|3
5946169|NCT01299376|20565740|P1|Extension (Weeks 9 to 52)|Adverse Event|2
5946170|NCT01299376|20565739|P2|Extension (Weeks 9 to 52)|Withdrawal by Subject|1
5946171|NCT01299376|20565740|P1|Extension (Weeks 9 to 52)|Withdrawal by Subject|2
5946172|NCT01299376|20565739|P2|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1
5946173|NCT01299376|20565740|P1|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1
5946174|NCT01299376|20565739|P2|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|0
5946175|NCT01299376|20565740|P1|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|1
5946176|NCT01299376|20565739|P2|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|7
5946177|NCT01299376|20565740|P1|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|4
5946178|NCT01299376|20565739|P2|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|1
5946179|NCT01299376|20565740|P1|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|0
5946180|NCT01299376|20565739|P2|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|1
5946181|NCT01299376|20565740|P1|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|0
5946182|NCT01299376|20565739|P2|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|2
5946183|NCT01299376|20565740|P1|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|1
5946184|NCT01299272|20565783|P4|Double-blind (DB) Randomized Period|Sponsor Decision|1
5946185|NCT01299272|20565784|P3|Double-blind (DB) Randomized Period|Sponsor Decision|1
5946186|NCT01299272|20565785|P2|Double-blind (DB) Randomized Period|Sponsor Decision|0
5946187|NCT01299272|20565786|P1|Double-blind (DB) Randomized Period|Sponsor Decision|0
5946188|NCT01299272|20565783|P4|Double-blind (DB) Randomized Period|Physician Decision|1
5946189|NCT01299272|20565784|P3|Double-blind (DB) Randomized Period|Physician Decision|2
5946190|NCT01299272|20565785|P2|Double-blind (DB) Randomized Period|Physician Decision|0
5946191|NCT01299272|20565786|P1|Double-blind (DB) Randomized Period|Physician Decision|0
5946192|NCT01299272|20565783|P4|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|10
5946193|NCT01299272|20565784|P3|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|4
5946194|NCT01299272|20565785|P2|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0
5946195|NCT01299272|20565786|P1|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0
5946196|NCT01299272|20565783|P4|Double-blind (DB) Randomized Period|Lost to Follow-up|5
5946197|NCT01299272|20565784|P3|Double-blind (DB) Randomized Period|Lost to Follow-up|5
5946198|NCT01299272|20565785|P2|Double-blind (DB) Randomized Period|Lost to Follow-up|0
5946199|NCT01299272|20565786|P1|Double-blind (DB) Randomized Period|Lost to Follow-up|0
5946200|NCT01299272|20565783|P4|Double-blind (DB) Randomized Period|Protocol Violation|7
5946201|NCT01299272|20565784|P3|Double-blind (DB) Randomized Period|Protocol Violation|8
5946202|NCT01299272|20565785|P2|Double-blind (DB) Randomized Period|Protocol Violation|0
5946203|NCT01299272|20565786|P1|Double-blind (DB) Randomized Period|Protocol Violation|0
5946204|NCT01299272|20565783|P4|Double-blind (DB) Randomized Period|Adverse Event|9
5946205|NCT01299272|20565784|P3|Double-blind (DB) Randomized Period|Adverse Event|8
5946206|NCT01299272|20565785|P2|Double-blind (DB) Randomized Period|Adverse Event|0
5946207|NCT01299272|20565786|P1|Double-blind (DB) Randomized Period|Adverse Event|0
5946208|NCT01299272|20565783|P4|Double-blind (DB) Randomized Period|Lack of Efficacy|10
5946209|NCT01299272|20565784|P3|Double-blind (DB) Randomized Period|Lack of Efficacy|20
5946210|NCT01299272|20565785|P2|Double-blind (DB) Randomized Period|Lack of Efficacy|0
5946211|NCT01299272|20565786|P1|Double-blind (DB) Randomized Period|Lack of Efficacy|0
5946212|NCT01299272|20565783|P4|Double-blind (DB) Randomized Period|Withdrawal by Subject|15
5946213|NCT01299272|20565784|P3|Double-blind (DB) Randomized Period|Withdrawal by Subject|22
5946214|NCT01299272|20565785|P2|Double-blind (DB) Randomized Period|Withdrawal by Subject|0
5946215|NCT01299272|20565786|P1|Double-blind (DB) Randomized Period|Withdrawal by Subject|0
5946216|NCT01299272|20565783|P4|Stabilization Open-label (OL) Period|Physician Decision|0
5946217|NCT01299272|20565784|P3|Stabilization Open-label (OL) Period|Physician Decision|0
5946218|NCT01299272|20565785|P2|Stabilization Open-label (OL) Period|Physician Decision|3
5946219|NCT01299272|20565786|P1|Stabilization Open-label (OL) Period|Physician Decision|0
5946220|NCT01299272|20565783|P4|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0
5946221|NCT01299272|20565784|P3|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0
5946222|NCT01299272|20565785|P2|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|6
5946223|NCT01299272|20565786|P1|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0
5946224|NCT01299272|20565783|P4|Stabilization Open-label (OL) Period|Lost to Follow-up|0
5946225|NCT01299272|20565784|P3|Stabilization Open-label (OL) Period|Lost to Follow-up|0
5946226|NCT01299272|20565785|P2|Stabilization Open-label (OL) Period|Lost to Follow-up|9
5946227|NCT01299272|20565786|P1|Stabilization Open-label (OL) Period|Lost to Follow-up|0
5946228|NCT01299272|20565783|P4|Stabilization Open-label (OL) Period|Lack of Efficacy|0
5946229|NCT01299272|20565784|P3|Stabilization Open-label (OL) Period|Lack of Efficacy|0
5946230|NCT01299272|20565785|P2|Stabilization Open-label (OL) Period|Lack of Efficacy|11
5946231|NCT01299272|20565786|P1|Stabilization Open-label (OL) Period|Lack of Efficacy|0
5946232|NCT01299272|20565783|P4|Stabilization Open-label (OL) Period|Sponsor Decision|0
5946233|NCT01299272|20565784|P3|Stabilization Open-label (OL) Period|Sponsor Decision|0
5946234|NCT01299272|20565785|P2|Stabilization Open-label (OL) Period|Sponsor Decision|12
5946235|NCT01299272|20565786|P1|Stabilization Open-label (OL) Period|Sponsor Decision|0
5946236|NCT01299272|20565783|P4|Stabilization Open-label (OL) Period|Withdrawal by Subject|0
5946237|NCT01299272|20565784|P3|Stabilization Open-label (OL) Period|Withdrawal by Subject|0
5946238|NCT01299272|20565785|P2|Stabilization Open-label (OL) Period|Withdrawal by Subject|42
5946239|NCT01299272|20565786|P1|Stabilization Open-label (OL) Period|Withdrawal by Subject|0
5946240|NCT01299272|20565783|P4|Stabilization Open-label (OL) Period|Adverse Event|0
5946241|NCT01299272|20565784|P3|Stabilization Open-label (OL) Period|Adverse Event|0
5946242|NCT01299272|20565785|P2|Stabilization Open-label (OL) Period|Adverse Event|42
5946243|NCT01299272|20565786|P1|Stabilization Open-label (OL) Period|Adverse Event|0
5946244|NCT01299272|20565783|P4|Stabilization Open-label (OL) Period|Protocol Violation|0
5946245|NCT01299272|20565784|P3|Stabilization Open-label (OL) Period|Protocol Violation|0
5946246|NCT01299272|20565785|P2|Stabilization Open-label (OL) Period|Protocol Violation|44
5946247|NCT01299272|20565786|P1|Stabilization Open-label (OL) Period|Protocol Violation|0
5946248|NCT01299272|20565783|P4|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0
5946249|NCT01299272|20565784|P3|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0
5946250|NCT01299272|20565785|P2|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|80
5946251|NCT01299272|20565786|P1|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0
5946252|NCT01299272|20565783|P4|Acute Open-label (OL) Period|Physician Decision|0
5946253|NCT01299272|20565784|P3|Acute Open-label (OL) Period|Physician Decision|0
5946254|NCT01299272|20565785|P2|Acute Open-label (OL) Period|Physician Decision|0
5946255|NCT01299272|20565786|P1|Acute Open-label (OL) Period|Physician Decision|5
5946256|NCT01299272|20565783|P4|Acute Open-label (OL) Period|Lack of Efficacy|0
5946257|NCT01299272|20565784|P3|Acute Open-label (OL) Period|Lack of Efficacy|0
5946258|NCT01299272|20565785|P2|Acute Open-label (OL) Period|Lack of Efficacy|0
5946259|NCT01299272|20565786|P1|Acute Open-label (OL) Period|Lack of Efficacy|10
5946260|NCT01299272|20565783|P4|Acute Open-label (OL) Period|Sponsor Decision|0
5946261|NCT01299272|20565784|P3|Acute Open-label (OL) Period|Sponsor Decision|0
5946262|NCT01299272|20565785|P2|Acute Open-label (OL) Period|Sponsor Decision|0
5946263|NCT01299272|20565786|P1|Acute Open-label (OL) Period|Sponsor Decision|13
5946264|NCT01299272|20565783|P4|Acute Open-label (OL) Period|Lost to Follow-up|0
5946265|NCT01299272|20565784|P3|Acute Open-label (OL) Period|Lost to Follow-up|0
5946266|NCT01299272|20565785|P2|Acute Open-label (OL) Period|Lost to Follow-up|0
5946267|NCT01299272|20565786|P1|Acute Open-label (OL) Period|Lost to Follow-up|14
5946268|NCT01299272|20565783|P4|Acute Open-label (OL) Period|Protocol Violation|0
5946269|NCT01299272|20565784|P3|Acute Open-label (OL) Period|Protocol Violation|0
5946270|NCT01299272|20565785|P2|Acute Open-label (OL) Period|Protocol Violation|0
5946271|NCT01299272|20565786|P1|Acute Open-label (OL) Period|Protocol Violation|36
5946272|NCT01299272|20565783|P4|Acute Open-label (OL) Period|Withdrawal by Subject|0
5946273|NCT01299272|20565784|P3|Acute Open-label (OL) Period|Withdrawal by Subject|0
5946274|NCT01299272|20565785|P2|Acute Open-label (OL) Period|Withdrawal by Subject|0
5946275|NCT01299272|20565786|P1|Acute Open-label (OL) Period|Withdrawal by Subject|56
5946276|NCT01299272|20565783|P4|Acute Open-label (OL) Period|Adverse Event|0
5946277|NCT01299272|20565784|P3|Acute Open-label (OL) Period|Adverse Event|0
5946278|NCT01299272|20565785|P2|Acute Open-label (OL) Period|Adverse Event|0
5946279|NCT01299272|20565786|P1|Acute Open-label (OL) Period|Adverse Event|140
5946280|NCT01299272|20565783|P4|Acute Open-label (OL) Period|Remission Criteria Not Met|0
5946281|NCT01299272|20565784|P3|Acute Open-label (OL) Period|Remission Criteria Not Met|0
5946282|NCT01299272|20565785|P2|Acute Open-label (OL) Period|Remission Criteria Not Met|0
5946283|NCT01299272|20565786|P1|Acute Open-label (OL) Period|Remission Criteria Not Met|140
5946284|NCT01299116|20565841|P3|Overall Study|Lost to Follow-up|11
5946285|NCT01299116|20565842|P2|Overall Study|Lost to Follow-up|9
5946286|NCT01299116|20565843|P1|Overall Study|Lost to Follow-up|65
5946287|NCT01299038|20565888|P2|Overall Study|Withdrawal by Subject|0
5946288|NCT01299038|20565889|P1|Overall Study|Withdrawal by Subject|1
5946289|NCT01299025|20565897|P2|Overall Study|Lost to Follow-up|0
5946290|NCT01299025|20565898|P1|Overall Study|Lost to Follow-up|1
5946291|NCT01299025|20565897|P2|Overall Study|Withdrawal by Subject|1
5946292|NCT01299025|20565898|P1|Overall Study|Withdrawal by Subject|2
5946293|NCT01298778|20565923|P2|Overall Study|not meet inclusion/exclusion criteria|1
5946294|NCT01298778|20565924|P1|Overall Study|not meet inclusion/exclusion criteria|0
5946295|NCT01298778|20565923|P2|Overall Study|Protocol Violation|1
5946296|NCT01298778|20565924|P1|Overall Study|Protocol Violation|0
5946297|NCT01298778|20565923|P2|Overall Study|Withdrawal by Subject|1
5946298|NCT01298778|20565924|P1|Overall Study|Withdrawal by Subject|0
5946299|NCT01298778|20565923|P2|Overall Study|Incorrect use of VAS|0
5946300|NCT01298778|20565924|P1|Overall Study|Incorrect use of VAS|1
5946301|NCT01298778|20565923|P2|Overall Study|Lost to Follow-up|3
5946302|NCT01298778|20565924|P1|Overall Study|Lost to Follow-up|2
5946303|NCT01298765|20565944|P1|Long-Term Treatment Period|Other: Not Lack of Analgesic Effect|46
5946304|NCT01298765|20565944|P1|Long-Term Treatment Period|Physician Decision|1
5946305|NCT01298765|20565944|P1|Long-Term Treatment Period|Withdrawal by Subject|19
5946306|NCT01298765|20565944|P1|Long-Term Treatment Period|Lost to Follow-up|8
5946307|NCT01298765|20565944|P1|Long-Term Treatment Period|Lack of Efficacy|6
5946308|NCT01298765|20565944|P1|Long-Term Treatment Period|Adverse Event|19
5946309|NCT01298765|20565944|P1|Titration Period|Other: Not Lack of Analgesic Effect|8
5946310|NCT01298765|20565944|P1|Titration Period|Withdrawal by Subject|10
5946311|NCT01298765|20565944|P1|Titration Period|Physician Decision|1
5946312|NCT01298765|20565944|P1|Titration Period|Lost to Follow-up|9
5946313|NCT01298765|20565944|P1|Titration Period|Lack of Efficacy|21
5946314|NCT01298765|20565944|P1|Titration Period|Death|1
5946315|NCT01298765|20565944|P1|Titration Period|Adverse Event|26
5946316|NCT01298700|20565965|P2|Overall Study|Did not Receive Study Drug|5
5946317|NCT01298700|20565966|P1|Overall Study|Did not Receive Study Drug|3
5946318|NCT01298700|20565965|P2|Overall Study|Other Miscellaneous Reasons|15
5946319|NCT01298700|20565966|P1|Overall Study|Other Miscellaneous Reasons|16
5946320|NCT01298700|20565965|P2|Overall Study|Protocol Violation|4
5946321|NCT01298700|20565966|P1|Overall Study|Protocol Violation|6
5946322|NCT01298700|20565965|P2|Overall Study|Withdrawal by Subject|9
5946323|NCT01298700|20565966|P1|Overall Study|Withdrawal by Subject|12
5946324|NCT01298700|20565965|P2|Overall Study|Lost to Follow-up|2
5946325|NCT01298700|20565966|P1|Overall Study|Lost to Follow-up|5
5946326|NCT01298700|20565965|P2|Overall Study|Lack of Efficacy|14
5946327|NCT01298700|20565966|P1|Overall Study|Lack of Efficacy|9
5946328|NCT01298700|20565965|P2|Overall Study|Adverse Event|51
5946329|NCT01298700|20565966|P1|Overall Study|Adverse Event|50
5946330|NCT01298661|20565977|P3|Overall Study|Withdrawal by Subject|2
5946331|NCT01298661|20565978|P2|Overall Study|Withdrawal by Subject|0
5946332|NCT01298661|20565979|P1|Overall Study|Withdrawal by Subject|2
5946333|NCT01298648|20566057|P1|Overall Study|Lost to Follow-up|21
5946334|NCT01298648|20566057|P1|Overall Study|Withdrawal by Subject|2
5946335|NCT01298596|20566068|P2|Overall Study|Referred for further management|15
5946336|NCT01298596|20566069|P1|Overall Study|Referred for further management|16
5946337|NCT01298596|20566068|P2|Overall Study|Lost to Follow-up|14
5946338|NCT01298596|20566069|P1|Overall Study|Lost to Follow-up|6
5946339|NCT01298596|20566068|P2|Overall Study|Death|3
5946340|NCT01298596|20566069|P1|Overall Study|Death|5
5946341|NCT01298596|20566068|P2|Overall Study|Withdrawal by Subject|1
5946342|NCT01298596|20566069|P1|Overall Study|Withdrawal by Subject|1
5946343|NCT01298570|20566079|P2|Overall Study|Ineligibility|1
5946344|NCT01298570|20566080|P1|Overall Study|Ineligibility|0
5946345|NCT01298570|20566079|P2|Overall Study|Death|1
5946346|NCT01298570|20566080|P1|Overall Study|Death|0
5946347|NCT01298570|20566079|P2|Overall Study|Symptomatic progression/deterioration|2
5946348|NCT01298570|20566080|P1|Overall Study|Symptomatic progression/deterioration|3
5946349|NCT01298570|20566079|P2|Overall Study|Surgery|1
5946350|NCT01298570|20566080|P1|Overall Study|Surgery|2
5946351|NCT01298570|20566079|P2|Overall Study|Other complicating disease|1
5946352|NCT01298570|20566080|P1|Overall Study|Other complicating disease|2
5946353|NCT01298570|20566079|P2|Overall Study|Physician Decision|2
5946354|NCT01298570|20566080|P1|Overall Study|Physician Decision|4
5946355|NCT01298570|20566079|P2|Overall Study|Treatment delay > 4 weeks|5
5946356|NCT01298570|20566080|P1|Overall Study|Treatment delay > 4 weeks|4
5946357|NCT01298570|20566079|P2|Overall Study|Withdrawal by Subject|6
5946358|NCT01298570|20566080|P1|Overall Study|Withdrawal by Subject|21
5946359|NCT01298570|20566079|P2|Overall Study|Adverse Event|2
5946360|NCT01298570|20566080|P1|Overall Study|Adverse Event|20
5946361|NCT01298570|20566079|P2|Overall Study|Disease progression, relapse during acti|40
5946362|NCT01298570|20566080|P1|Overall Study|Disease progression, relapse during acti|64
5946363|NCT01298531|20566107|P2|Overall Study|Other|1
5946364|NCT01298531|20566108|P1|Overall Study|Other|2
5946365|NCT01298531|20566107|P2|Overall Study|Does not meet entrance criteria|1
5946366|NCT01298531|20566108|P1|Overall Study|Does not meet entrance criteria|0
5946367|NCT01298531|20566107|P2|Overall Study|Adverse Event|3
5946368|NCT01298531|20566108|P1|Overall Study|Adverse Event|4
5946369|NCT01298531|20566107|P2|Overall Study|Protocol Violation|1
5946370|NCT01298531|20566108|P1|Overall Study|Protocol Violation|1
5946371|NCT01298531|20566107|P2|Overall Study|Lost to Follow-up|0
5946372|NCT01298531|20566108|P1|Overall Study|Lost to Follow-up|2
5946373|NCT01298531|20566107|P2|Overall Study|Lack of Efficacy|1
5946374|NCT01298531|20566108|P1|Overall Study|Lack of Efficacy|0
5946375|NCT01298518|20566237|P3|Overall Study|Withdrawal by Subject|1
5946376|NCT01298518|20566238|P2|Overall Study|Withdrawal by Subject|0
5946377|NCT01298518|20566239|P1|Overall Study|Withdrawal by Subject|0
5946378|NCT01298492|20566291|P1|Overall Study|Adverse Event(Not Related to Study Drug)|18
5946379|NCT01298492|20566291|P1|Overall Study|Adverse Event(Related to Study Drug)|8
5946380|NCT01298492|20566291|P1|Overall Study|Protocol Violation|2
5946381|NCT01298492|20566291|P1|Overall Study|Withdrawn Due to Pregnancy|1
5946382|NCT01298492|20566291|P1|Overall Study|Other (Unspecified)|7
5946383|NCT01298492|20566291|P1|Overall Study|Withdrawal by Subject|47
5946384|NCT01298492|20566291|P1|Overall Study|Lost to Follow-up|12
5946385|NCT01298492|20566291|P1|Overall Study|Insufficient Clinical Response|22
5946386|NCT01298492|20566291|P1|Overall Study|Death|2
5946387|NCT01298362|20566299|P2|Overall Study|Did not provide 12month BMD measurements|43
5946388|NCT01298362|20566300|P1|Overall Study|Did not provide 12month BMD measurements|38
5946389|NCT01298323|20566320|P2|Overall Study|Eligibility criteria not fulfilled|1
5946390|NCT01298323|20566321|P1|Overall Study|Eligibility criteria not fulfilled|0
5946391|NCT01298323|20566320|P2|Overall Study|Ongoing|55
5946392|NCT01298323|20566321|P1|Overall Study|Ongoing|55
5946393|NCT01298323|20566320|P2|Overall Study|Other|9
5946394|NCT01298323|20566321|P1|Overall Study|Other|10
5946395|NCT01298323|20566320|P2|Overall Study|Protocol Violation|0
5946396|NCT01298323|20566321|P1|Overall Study|Protocol Violation|1
5946397|NCT01298323|20566320|P2|Overall Study|Withdrawal by Subject|3
5946398|NCT01298323|20566321|P1|Overall Study|Withdrawal by Subject|6
5946399|NCT01298323|20566320|P2|Overall Study|Lost to Follow-up|0
5946400|NCT01298323|20566321|P1|Overall Study|Lost to Follow-up|1
5946401|NCT01298323|20566320|P2|Overall Study|Death|16
5946402|NCT01298323|20566321|P1|Overall Study|Death|11
5946403|NCT01298323|20566320|P2|Overall Study|Adverse Event|4
5946404|NCT01298323|20566321|P1|Overall Study|Adverse Event|2
5946405|NCT01298193|20566344|P1|Efficacy Phase (Second Cycle)|Death|1
5946406|NCT01298193|20566344|P1|Observational Phase (First Cycle)|previous emetogenic chemotherapy|9
5946407|NCT01298193|20566344|P1|Observational Phase (First Cycle)|Received TC at a different dose|16
5946408|NCT01298193|20566344|P1|Observational Phase (First Cycle)|Withdrawal by Subject|2
5946409|NCT01298141|20566366|P1|Overall Study|Not treated|4
5946410|NCT01298141|20566366|P1|Overall Study|Death|6
5946411|NCT01298141|20566366|P1|Overall Study|Lost to Follow-up|1
5946412|NCT01298141|20566366|P1|Overall Study|Other|5
5946413|NCT01298141|20566366|P1|Overall Study|Termination of Study by the Investigator|5
5946414|NCT01298141|20566366|P1|Overall Study|Withdrawal by Subject|6
5946415|NCT01298141|20566366|P1|Overall Study|Refusal of Required Study Procedures|1
5946416|NCT01298141|20566366|P1|Overall Study|Adverse Event|3
5946429|NCT01297920|20566490|P3|Overall Study|Patient Did Not Meet Entrance Criteria|0
5946430|NCT01297920|20566491|P2|Overall Study|Patient Did Not Meet Entrance Criteria|0
5946431|NCT01297920|20566492|P1|Overall Study|Patient Did Not Meet Entrance Criteria|1
5946432|NCT01297920|20566490|P3|Overall Study|Inadequate Control of IOP|17
5946433|NCT01297920|20566491|P2|Overall Study|Inadequate Control of IOP|9
5946434|NCT01297920|20566492|P1|Overall Study|Inadequate Control of IOP|7
5946435|NCT01297920|20566490|P3|Overall Study|Protocol Violation|0
5946436|NCT01297920|20566491|P2|Overall Study|Protocol Violation|3
5946437|NCT01297920|20566492|P1|Overall Study|Protocol Violation|1
5946438|NCT01297920|20566490|P3|Overall Study|Noncompliance|0
5946439|NCT01297920|20566491|P2|Overall Study|Noncompliance|0
5946440|NCT01297920|20566492|P1|Overall Study|Noncompliance|1
5946441|NCT01297920|20566490|P3|Overall Study|Patient Decision Unrelated to AE|2
5946442|NCT01297920|20566491|P2|Overall Study|Patient Decision Unrelated to AE|5
5946443|NCT01297920|20566492|P1|Overall Study|Patient Decision Unrelated to AE|6
5946444|NCT01297920|20566490|P3|Overall Study|Adverse Event|38
5946445|NCT01297920|20566491|P2|Overall Study|Adverse Event|10
5946446|NCT01297920|20566492|P1|Overall Study|Adverse Event|42
5946447|NCT01297517|20566536|P3|Overall Study|Inadequate Control of IOP|2
5946448|NCT01297517|20566537|P2|Overall Study|Inadequate Control of IOP|1
5946449|NCT01297517|20566538|P1|Overall Study|Inadequate Control of IOP|1
5946450|NCT01297517|20566536|P3|Overall Study|Protocol Violation|1
5946451|NCT01297517|20566537|P2|Overall Study|Protocol Violation|1
5946452|NCT01297517|20566538|P1|Overall Study|Protocol Violation|1
5946453|NCT01297517|20566536|P3|Overall Study|Noncompliance|0
5946454|NCT01297517|20566537|P2|Overall Study|Noncompliance|0
5946455|NCT01297517|20566538|P1|Overall Study|Noncompliance|1
5946456|NCT01297517|20566536|P3|Overall Study|Patient Decision Unrelated to AE|7
5946457|NCT01297517|20566537|P2|Overall Study|Patient Decision Unrelated to AE|3
5946458|NCT01297517|20566538|P1|Overall Study|Patient Decision Unrelated to AE|2
5946459|NCT01297517|20566536|P3|Overall Study|Lost to Follow-up|1
5946460|NCT01297517|20566537|P2|Overall Study|Lost to Follow-up|0
5946461|NCT01297517|20566538|P1|Overall Study|Lost to Follow-up|1
5946462|NCT01297517|20566536|P3|Overall Study|Adverse Event|16
5946463|NCT01297517|20566537|P2|Overall Study|Adverse Event|7
5946464|NCT01297517|20566538|P1|Overall Study|Adverse Event|21
5946465|NCT01297504|20566546|P1|Overall Study|Protocol Violation|3
5946466|NCT01297504|20566546|P1|Overall Study|Site Closure|3
5946467|NCT01297504|20566546|P1|Overall Study|Withdrawal by Subject|9
5946468|NCT01297504|20566546|P1|Overall Study|Lost to Follow-up|43
5946469|NCT01297504|20566546|P1|Overall Study|Death|3
5946470|NCT01297504|20566546|P1|Overall Study|No Study Visits|4
5946471|NCT01297504|20566546|P1|Overall Study|Received Palivizumab in Previous Season|1
5946472|NCT01297504|20566546|P1|Overall Study|Invalid Consent|1
5946473|NCT01297491|20566560|P2|Overall Study|Death|1
5946474|NCT01297491|20566561|P1|Overall Study|Death|2
5946475|NCT01297491|20566560|P2|Overall Study|Patient/Guardian decision|4
5946476|NCT01297491|20566561|P1|Overall Study|Patient/Guardian decision|3
5946477|NCT01297491|20566560|P2|Overall Study|Progressive disease|20
5946478|NCT01297491|20566561|P1|Overall Study|Progressive disease|11
5946479|NCT01297491|20566560|P2|Overall Study|Physician Decision|2
5946480|NCT01297491|20566561|P1|Overall Study|Physician Decision|3
5946481|NCT01297491|20566560|P2|Overall Study|Adverse Event|6
5946482|NCT01297491|20566561|P1|Overall Study|Adverse Event|11
5946483|NCT01297465|20566579|P2|Overall Study|Intention to Freeze all Embryos|1
5946484|NCT01297465|20566580|P1|Overall Study|Intention to Freeze all Embryos|0
5946485|NCT01297465|20566579|P2|Overall Study|All Embryos Discarded|1
5946486|NCT01297465|20566580|P1|Overall Study|All Embryos Discarded|0
5946487|NCT01297465|20566579|P2|Overall Study|No Fertilization|4
5946488|NCT01297465|20566580|P1|Overall Study|No Fertilization|6
5946489|NCT01297465|20566579|P2|Overall Study|Poor oocyte quality|1
5946490|NCT01297465|20566580|P1|Overall Study|Poor oocyte quality|0
5946491|NCT01297465|20566579|P2|Overall Study|No Oocytes Retrieved|1
5946492|NCT01297465|20566580|P1|Overall Study|No Oocytes Retrieved|1
5946493|NCT01297465|20566579|P2|Overall Study|Ovarian hyperstimulation syndrome risk|1
5946494|NCT01297465|20566580|P1|Overall Study|Ovarian hyperstimulation syndrome risk|0
5946495|NCT01297465|20566579|P2|Overall Study|Lack of Ovarian Response|1
5946496|NCT01297465|20566580|P1|Overall Study|Lack of Ovarian Response|1
5946497|NCT01297322|20566633|P2|Overall Study|Protocol Violation|3
5946498|NCT01297322|20566634|P1|Overall Study|Protocol Violation|0
5946499|NCT01297322|20566633|P2|Overall Study|Withdrawal by Subject|1
5946500|NCT01297322|20566634|P1|Overall Study|Withdrawal by Subject|0
5946501|NCT01297322|20566633|P2|Overall Study|Lost to Follow-up|0
5946502|NCT01297322|20566634|P1|Overall Study|Lost to Follow-up|1
5946503|NCT01297309|20566653|P1|Overall Study|Participant not entering extensionperiod|1
5946504|NCT01297309|20566653|P1|Overall Study|Death|1
5946505|NCT01297309|20566653|P1|Overall Study|Investigator Decision|2
5946506|NCT01297309|20566653|P1|Overall Study|Adverse Event|1
5946507|NCT01297309|20566653|P1|Overall Study|Withdrawal by Subject|5
5946508|NCT01297309|20566653|P1|Overall Study|Screen failure|2
5946509|NCT01297309|20566653|P1|Overall Study|Eligibility failure|2
5946510|NCT01297270|20566678|P3|Overall Study|Not treated|0
5946511|NCT01297270|20566679|P2|Overall Study|Not treated|1
5946512|NCT01297270|20566680|P1|Overall Study|Not treated|0
5946513|NCT01297270|20566678|P3|Overall Study|Other reason not defined above|1
5946514|NCT01297270|20566679|P2|Overall Study|Other reason not defined above|3
5946515|NCT01297270|20566680|P1|Overall Study|Other reason not defined above|3
5946516|NCT01297270|20566678|P3|Overall Study|Withdrawal by Subject|7
5946517|NCT01297270|20566679|P2|Overall Study|Withdrawal by Subject|15
5946518|NCT01297270|20566680|P1|Overall Study|Withdrawal by Subject|7
5946519|NCT01297270|20566678|P3|Overall Study|Protocol Violation|0
5946520|NCT01297270|20566679|P2|Overall Study|Protocol Violation|2
5946521|NCT01297270|20566680|P1|Overall Study|Protocol Violation|0
5946522|NCT01297270|20566678|P3|Overall Study|Lost to Follow-up|1
5946523|NCT01297270|20566679|P2|Overall Study|Lost to Follow-up|2
5946524|NCT01297270|20566680|P1|Overall Study|Lost to Follow-up|1
5946525|NCT01297270|20566678|P3|Overall Study|Lack of Efficacy|15
5946526|NCT01297270|20566679|P2|Overall Study|Lack of Efficacy|17
5946527|NCT01297270|20566680|P1|Overall Study|Lack of Efficacy|15
5946528|NCT01297270|20566678|P3|Overall Study|Adverse Event|5
5946529|NCT01297270|20566679|P2|Overall Study|Adverse Event|32
5946530|NCT01297270|20566680|P1|Overall Study|Adverse Event|19
5946531|NCT01297244|20566725|P2|Overall Study|Withdrawal by Subject|0
5946532|NCT01297244|20566726|P1|Overall Study|Withdrawal by Subject|2
5946533|NCT01297244|20566725|P2|Overall Study|Clinical progression|1
5946534|NCT01297244|20566726|P1|Overall Study|Clinical progression|1
5946535|NCT01297244|20566725|P2|Overall Study|Death|1
5946536|NCT01297244|20566726|P1|Overall Study|Death|1
5946537|NCT01297244|20566725|P2|Overall Study|Adverse Event|1
5946538|NCT01297244|20566726|P1|Overall Study|Adverse Event|9
5946539|NCT01297244|20566725|P2|Overall Study|Progressive disease|3
5946540|NCT01297244|20566726|P1|Overall Study|Progressive disease|22
5946541|NCT01297062|20566746|P7|Overall Study|Subject Decision|2
5946542|NCT01297062|20566747|P6|Overall Study|Subject Decision|1
5946543|NCT01297062|20566748|P5|Overall Study|Subject Decision|1
5946544|NCT01297062|20566749|P4|Overall Study|Subject Decision|1
5946545|NCT01297062|20566750|P3|Overall Study|Subject Decision|0
5946546|NCT01297062|20566751|P2|Overall Study|Subject Decision|1
5946547|NCT01297062|20566752|P1|Overall Study|Subject Decision|1
5946548|NCT01297062|20566746|P7|Overall Study|Protocol Violation|0
5946549|NCT01297062|20566747|P6|Overall Study|Protocol Violation|0
5946550|NCT01297062|20566748|P5|Overall Study|Protocol Violation|1
5946551|NCT01297062|20566749|P4|Overall Study|Protocol Violation|0
5946552|NCT01297062|20566750|P3|Overall Study|Protocol Violation|0
5946553|NCT01297062|20566751|P2|Overall Study|Protocol Violation|0
5946554|NCT01297062|20566752|P1|Overall Study|Protocol Violation|0
5946555|NCT01297062|20566746|P7|Overall Study|Physician Decision|6
5946556|NCT01297062|20566747|P6|Overall Study|Physician Decision|0
5946557|NCT01297062|20566748|P5|Overall Study|Physician Decision|0
5946558|NCT01297062|20566749|P4|Overall Study|Physician Decision|0
5946559|NCT01297062|20566750|P3|Overall Study|Physician Decision|1
5946560|NCT01297062|20566751|P2|Overall Study|Physician Decision|0
5946561|NCT01297062|20566752|P1|Overall Study|Physician Decision|1
5946562|NCT01297062|20566746|P7|Overall Study|Adverse Event|0
5946563|NCT01297062|20566747|P6|Overall Study|Adverse Event|0
5946564|NCT01297062|20566748|P5|Overall Study|Adverse Event|0
5946565|NCT01297062|20566749|P4|Overall Study|Adverse Event|0
5946566|NCT01297062|20566750|P3|Overall Study|Adverse Event|1
5946567|NCT01297062|20566751|P2|Overall Study|Adverse Event|0
5946568|NCT01297062|20566752|P1|Overall Study|Adverse Event|2
5946569|NCT01296932|20566783|P9|Overall Study|Dosage already reduced, AE still present|1
5946570|NCT01296932|20566784|P8|Overall Study|Dosage already reduced, AE still present|0
5946571|NCT01296932|20566785|P7|Overall Study|Dosage already reduced, AE still present|0
5946572|NCT01296932|20566786|P6|Overall Study|Dosage already reduced, AE still present|0
5946573|NCT01296932|20566787|P5|Overall Study|Dosage already reduced, AE still present|0
5946574|NCT01296932|20566788|P4|Overall Study|Dosage already reduced, AE still present|0
5946575|NCT01296932|20566789|P3|Overall Study|Dosage already reduced, AE still present|0
5946576|NCT01296932|20566790|P2|Overall Study|Dosage already reduced, AE still present|0
5946577|NCT01296932|20566791|P1|Overall Study|Dosage already reduced, AE still present|0
5946578|NCT01296932|20566783|P9|Overall Study|No adequate treatment response|0
5946579|NCT01296932|20566784|P8|Overall Study|No adequate treatment response|1
5946580|NCT01296932|20566785|P7|Overall Study|No adequate treatment response|0
5946581|NCT01296932|20566786|P6|Overall Study|No adequate treatment response|0
5946582|NCT01296932|20566787|P5|Overall Study|No adequate treatment response|0
5946583|NCT01296932|20566788|P4|Overall Study|No adequate treatment response|0
5946584|NCT01296932|20566789|P3|Overall Study|No adequate treatment response|0
5946585|NCT01296932|20566790|P2|Overall Study|No adequate treatment response|0
5946586|NCT01296932|20566791|P1|Overall Study|No adequate treatment response|0
5946587|NCT01296932|20566783|P9|Overall Study|Low benefit and too many side effects|0
5946588|NCT01296932|20566784|P8|Overall Study|Low benefit and too many side effects|1
5946589|NCT01296932|20566785|P7|Overall Study|Low benefit and too many side effects|0
5946590|NCT01296932|20566786|P6|Overall Study|Low benefit and too many side effects|0
5946591|NCT01296932|20566787|P5|Overall Study|Low benefit and too many side effects|0
5946592|NCT01296932|20566788|P4|Overall Study|Low benefit and too many side effects|0
5946593|NCT01296932|20566789|P3|Overall Study|Low benefit and too many side effects|0
5946594|NCT01296932|20566790|P2|Overall Study|Low benefit and too many side effects|0
5946595|NCT01296932|20566791|P1|Overall Study|Low benefit and too many side effects|0
5946596|NCT01296932|20566783|P9|Overall Study|per protocol|0
5946597|NCT01296932|20566784|P8|Overall Study|per protocol|0
5946598|NCT01296932|20566785|P7|Overall Study|per protocol|0
5946599|NCT01296932|20566786|P6|Overall Study|per protocol|0
5946600|NCT01296932|20566787|P5|Overall Study|per protocol|0
5946601|NCT01296932|20566788|P4|Overall Study|per protocol|1
5946602|NCT01296932|20566789|P3|Overall Study|per protocol|1
5946603|NCT01296932|20566790|P2|Overall Study|per protocol|0
5946604|NCT01296932|20566791|P1|Overall Study|per protocol|0
5946605|NCT01296932|20566783|P9|Overall Study|IV problems, administration not possible|0
5946606|NCT01296932|20566784|P8|Overall Study|IV problems, administration not possible|0
5946607|NCT01296932|20566785|P7|Overall Study|IV problems, administration not possible|0
5946608|NCT01296932|20566786|P6|Overall Study|IV problems, administration not possible|0
5946609|NCT01296932|20566787|P5|Overall Study|IV problems, administration not possible|0
5946610|NCT01296932|20566788|P4|Overall Study|IV problems, administration not possible|0
5946611|NCT01296932|20566789|P3|Overall Study|IV problems, administration not possible|1
5946612|NCT01296932|20566790|P2|Overall Study|IV problems, administration not possible|0
5946613|NCT01296932|20566791|P1|Overall Study|IV problems, administration not possible|0
5946614|NCT01296932|20566783|P9|Overall Study|Physician Decision|0
5946615|NCT01296932|20566784|P8|Overall Study|Physician Decision|0
5946616|NCT01296932|20566785|P7|Overall Study|Physician Decision|0
5946617|NCT01296932|20566786|P6|Overall Study|Physician Decision|0
5946618|NCT01296932|20566787|P5|Overall Study|Physician Decision|0
5946619|NCT01296932|20566788|P4|Overall Study|Physician Decision|0
5946620|NCT01296932|20566789|P3|Overall Study|Physician Decision|1
5946621|NCT01296932|20566790|P2|Overall Study|Physician Decision|0
5946622|NCT01296932|20566791|P1|Overall Study|Physician Decision|0
5946623|NCT01296932|20566783|P9|Overall Study|No clinical benefit anymore|0
5946624|NCT01296932|20566784|P8|Overall Study|No clinical benefit anymore|0
5946625|NCT01296932|20566785|P7|Overall Study|No clinical benefit anymore|0
5946626|NCT01296932|20566786|P6|Overall Study|No clinical benefit anymore|0
5946627|NCT01296932|20566787|P5|Overall Study|No clinical benefit anymore|0
5946628|NCT01296932|20566788|P4|Overall Study|No clinical benefit anymore|0
5946629|NCT01296932|20566789|P3|Overall Study|No clinical benefit anymore|0
5946630|NCT01296932|20566790|P2|Overall Study|No clinical benefit anymore|1
5946631|NCT01296932|20566791|P1|Overall Study|No clinical benefit anymore|0
5946632|NCT01296932|20566783|P9|Overall Study|Investigator decision|1
5946633|NCT01296932|20566784|P8|Overall Study|Investigator decision|0
5946634|NCT01296932|20566785|P7|Overall Study|Investigator decision|1
5946635|NCT01296932|20566786|P6|Overall Study|Investigator decision|0
5946636|NCT01296932|20566787|P5|Overall Study|Investigator decision|0
5946637|NCT01296932|20566788|P4|Overall Study|Investigator decision|1
5946638|NCT01296932|20566789|P3|Overall Study|Investigator decision|0
5946639|NCT01296932|20566790|P2|Overall Study|Investigator decision|1
5946640|NCT01296932|20566791|P1|Overall Study|Investigator decision|0
5946641|NCT01296932|20566783|P9|Overall Study|Adverse Event|1
5946642|NCT01296932|20566784|P8|Overall Study|Adverse Event|0
5946643|NCT01296932|20566785|P7|Overall Study|Adverse Event|0
5946644|NCT01296932|20566786|P6|Overall Study|Adverse Event|0
5946645|NCT01296932|20566787|P5|Overall Study|Adverse Event|1
5946646|NCT01296932|20566788|P4|Overall Study|Adverse Event|2
5946647|NCT01296932|20566789|P3|Overall Study|Adverse Event|1
5946648|NCT01296932|20566790|P2|Overall Study|Adverse Event|1
5946649|NCT01296932|20566791|P1|Overall Study|Adverse Event|1
5946650|NCT01296932|20566783|P9|Overall Study|Withdrawal by Subject|0
5946651|NCT01296932|20566784|P8|Overall Study|Withdrawal by Subject|0
5946652|NCT01296932|20566785|P7|Overall Study|Withdrawal by Subject|3
5946653|NCT01296932|20566786|P6|Overall Study|Withdrawal by Subject|0
5946654|NCT01296932|20566787|P5|Overall Study|Withdrawal by Subject|0
5946655|NCT01296932|20566788|P4|Overall Study|Withdrawal by Subject|1
5946656|NCT01296932|20566789|P3|Overall Study|Withdrawal by Subject|1
5946657|NCT01296932|20566790|P2|Overall Study|Withdrawal by Subject|0
5946658|NCT01296932|20566791|P1|Overall Study|Withdrawal by Subject|0
5946659|NCT01296932|20566783|P9|Overall Study|Progressive disease|0
5946660|NCT01296932|20566784|P8|Overall Study|Progressive disease|0
5946661|NCT01296932|20566785|P7|Overall Study|Progressive disease|1
5946662|NCT01296932|20566786|P6|Overall Study|Progressive disease|3
5946663|NCT01296932|20566787|P5|Overall Study|Progressive disease|2
5946664|NCT01296932|20566788|P4|Overall Study|Progressive disease|1
5946665|NCT01296932|20566789|P3|Overall Study|Progressive disease|1
5946666|NCT01296932|20566790|P2|Overall Study|Progressive disease|0
5946667|NCT01296932|20566791|P1|Overall Study|Progressive disease|2
5946668|NCT01296932|20566783|P9|Overall Study|Dose limiting toxicity|1
5946669|NCT01296932|20566784|P8|Overall Study|Dose limiting toxicity|0
5946670|NCT01296932|20566785|P7|Overall Study|Dose limiting toxicity|1
5946671|NCT01296932|20566786|P6|Overall Study|Dose limiting toxicity|0
5946672|NCT01296932|20566787|P5|Overall Study|Dose limiting toxicity|0
5946673|NCT01296932|20566788|P4|Overall Study|Dose limiting toxicity|0
5946674|NCT01296932|20566789|P3|Overall Study|Dose limiting toxicity|0
5946675|NCT01296932|20566790|P2|Overall Study|Dose limiting toxicity|0
5946676|NCT01296932|20566791|P1|Overall Study|Dose limiting toxicity|0
5946677|NCT01296698|20566915|P2|Overall Study|Study Terminated by Sponsor|12
5946678|NCT01296698|20566916|P1|Overall Study|Study Terminated by Sponsor|209
5946679|NCT01296698|20566915|P2|Overall Study|Difficulty Contacting Subject|0
5946680|NCT01296698|20566916|P1|Overall Study|Difficulty Contacting Subject|2
5946681|NCT01296698|20566915|P2|Overall Study|Withdrawal by Subject|0
5946682|NCT01296698|20566916|P1|Overall Study|Withdrawal by Subject|12
5946683|NCT01296698|20566915|P2|Overall Study|Lost to Follow-up|1
5946684|NCT01296698|20566916|P1|Overall Study|Lost to Follow-up|19
5946685|NCT01296698|20566915|P2|Overall Study|Death|0
5946686|NCT01296698|20566916|P1|Overall Study|Death|1
5946687|NCT01296698|20566915|P2|Overall Study|Adverse Event|0
5946688|NCT01296698|20566916|P1|Overall Study|Adverse Event|1
5946689|NCT01296672|20566970|P2|Overall Study|Lost to Follow-up|18
5946690|NCT01296672|20566971|P1|Overall Study|Lost to Follow-up|73
5946691|NCT01296568|20566992|P1|Continued Access Phase|Disease Progression|1
5946692|NCT01296568|20566992|P1|Continued Access Phase|Withdrawal by Subject|1
5946693|NCT01296568|20566992|P1|Continued Access Phase|Lost to Follow-up|1
5946694|NCT01296412|20567017|P2|Overall Study|Withdrawal by Subject|13
5946695|NCT01296412|20567018|P1|Overall Study|Withdrawal by Subject|10
5946696|NCT01296412|20567017|P2|Overall Study|Pregnancy|1
5946697|NCT01296412|20567018|P1|Overall Study|Pregnancy|0
5946698|NCT01296412|20567017|P2|Overall Study|Physician Decision|3
5946699|NCT01296412|20567018|P1|Overall Study|Physician Decision|1
5946700|NCT01296412|20567017|P2|Overall Study|Other reason not specified|15
5946701|NCT01296412|20567018|P1|Overall Study|Other reason not specified|20
5946702|NCT01296412|20567017|P2|Overall Study|Non-compliance with study drug|2
5946703|NCT01296412|20567018|P1|Overall Study|Non-compliance with study drug|1
5946704|NCT01296412|20567017|P2|Overall Study|Lost to Follow-up|7
5946705|NCT01296412|20567018|P1|Overall Study|Lost to Follow-up|10
5946706|NCT01296412|20567017|P2|Overall Study|Lack of Efficacy|0
5946707|NCT01296412|20567018|P1|Overall Study|Lack of Efficacy|1
5946708|NCT01296412|20567017|P2|Overall Study|Adverse Event|29
5946709|NCT01296412|20567018|P1|Overall Study|Adverse Event|8
5946710|NCT01296347|20567041|P2|12 Month Follow up|Withdrawal by Subject|1
5946711|NCT01296347|20567042|P1|12 Month Follow up|Withdrawal by Subject|0
5946712|NCT01296347|20567041|P2|12 Month Follow up|Death|1
5946713|NCT01296347|20567042|P1|12 Month Follow up|Death|1
5946714|NCT01296347|20567041|P2|12 Month Follow up|Lost to Follow-up|1
5946715|NCT01296347|20567042|P1|12 Month Follow up|Lost to Follow-up|3
5946716|NCT01296347|20567041|P2|6 Month Follow up|Lost to Follow-up|1
5946717|NCT01296347|20567042|P1|6 Month Follow up|Lost to Follow-up|0
5946718|NCT01296347|20567041|P2|6 Month Follow up|Death|1
5946719|NCT01296347|20567042|P1|6 Month Follow up|Death|2
5946720|NCT01296347|20567041|P2|3 Month Follow up|Lost to Follow-up|1
5946721|NCT01296347|20567042|P1|3 Month Follow up|Lost to Follow-up|0
5946722|NCT01296347|20567041|P2|3 Month Follow up|Death|0
5946723|NCT01296347|20567042|P1|3 Month Follow up|Death|1
5946724|NCT01296347|20567041|P2|6 Week Follow up|Death|1
5946725|NCT01296347|20567042|P1|6 Week Follow up|Death|0
5946726|NCT01296347|20567041|P2|Allocation|not received infusion|0
5946727|NCT01296347|20567042|P1|Allocation|not received infusion|1
5946728|NCT01296347|20567041|P2|Allocation|Lack of Efficacy|2
5946729|NCT01296347|20567042|P1|Allocation|Lack of Efficacy|1
5946730|NCT01296347|20567041|P2|Allocation|Withdrawal by Subject|2
5946731|NCT01296347|20567042|P1|Allocation|Withdrawal by Subject|1
5946732|NCT01296152|20567067|P1|Overall Study|Unwilling to adhere to study requirement|1
5946733|NCT01296035|20567094|P1|Overall Study|Withdrawal by Subject|1
5946734|NCT01295905|20567101|P2|Overall Study|Met exclusion criteria|0
5946735|NCT01295905|20567102|P1|Overall Study|Met exclusion criteria|1
5946736|NCT01295905|20567101|P2|Overall Study|Did not meet inclusion criteria|0
5946737|NCT01295905|20567102|P1|Overall Study|Did not meet inclusion criteria|1
5946738|NCT01295827|20567146|P15|Overall Study|Other|0
5946739|NCT01295827|20567147|P14|Overall Study|Other|0
5946740|NCT01295827|20567148|P13|Overall Study|Other|0
5946741|NCT01295827|20567149|P12|Overall Study|Other|0
5946742|NCT01295827|20567150|P11|Overall Study|Other|2
5946743|NCT01295827|20567151|P10|Overall Study|Other|0
5946744|NCT01295827|20567152|P9|Overall Study|Other|1
5946745|NCT01295827|20567153|P8|Overall Study|Other|1
5946746|NCT01295827|20567154|P7|Overall Study|Other|1
5946747|NCT01295827|20567155|P6|Overall Study|Other|0
5946748|NCT01295827|20567156|P5|Overall Study|Other|0
5946749|NCT01295827|20567157|P4|Overall Study|Other|0
5946750|NCT01295827|20567158|P3|Overall Study|Other|0
5946751|NCT01295827|20567159|P2|Overall Study|Other|0
5946752|NCT01295827|20567160|P1|Overall Study|Other|0
5946753|NCT01295827|20567146|P15|Overall Study|Withdrawal by Subject|0
5946754|NCT01295827|20567147|P14|Overall Study|Withdrawal by Subject|0
5946755|NCT01295827|20567148|P13|Overall Study|Withdrawal by Subject|0
5946756|NCT01295827|20567149|P12|Overall Study|Withdrawal by Subject|13
5946757|NCT01295827|20567150|P11|Overall Study|Withdrawal by Subject|18
5946758|NCT01295827|20567151|P10|Overall Study|Withdrawal by Subject|2
5946759|NCT01295827|20567152|P9|Overall Study|Withdrawal by Subject|11
5946760|NCT01295827|20567153|P8|Overall Study|Withdrawal by Subject|35
5946761|NCT01295827|20567154|P7|Overall Study|Withdrawal by Subject|13
5946762|NCT01295827|20567155|P6|Overall Study|Withdrawal by Subject|1
5946763|NCT01295827|20567156|P5|Overall Study|Withdrawal by Subject|0
5946764|NCT01295827|20567157|P4|Overall Study|Withdrawal by Subject|0
5946765|NCT01295827|20567158|P3|Overall Study|Withdrawal by Subject|2
5946766|NCT01295827|20567159|P2|Overall Study|Withdrawal by Subject|0
5946767|NCT01295827|20567160|P1|Overall Study|Withdrawal by Subject|1
5946768|NCT01295827|20567146|P15|Overall Study|Screen Failure|0
5946769|NCT01295827|20567147|P14|Overall Study|Screen Failure|0
5946770|NCT01295827|20567148|P13|Overall Study|Screen Failure|0
5946771|NCT01295827|20567149|P12|Overall Study|Screen Failure|0
5946772|NCT01295827|20567150|P11|Overall Study|Screen Failure|1
5946773|NCT01295827|20567151|P10|Overall Study|Screen Failure|0
5946774|NCT01295827|20567152|P9|Overall Study|Screen Failure|2
5946775|NCT01295827|20567153|P8|Overall Study|Screen Failure|2
5946776|NCT01295827|20567154|P7|Overall Study|Screen Failure|2
5946777|NCT01295827|20567155|P6|Overall Study|Screen Failure|0
5946778|NCT01295827|20567156|P5|Overall Study|Screen Failure|0
5946779|NCT01295827|20567157|P4|Overall Study|Screen Failure|0
5946780|NCT01295827|20567158|P3|Overall Study|Screen Failure|0
5946781|NCT01295827|20567159|P2|Overall Study|Screen Failure|0
5946782|NCT01295827|20567160|P1|Overall Study|Screen Failure|0
5946783|NCT01295827|20567146|P15|Overall Study|Progressive Disease|0
5946784|NCT01295827|20567147|P14|Overall Study|Progressive Disease|0
5946785|NCT01295827|20567148|P13|Overall Study|Progressive Disease|0
5946786|NCT01295827|20567149|P12|Overall Study|Progressive Disease|136
5946787|NCT01295827|20567150|P11|Overall Study|Progressive Disease|175
5946788|NCT01295827|20567151|P10|Overall Study|Progressive Disease|40
5946789|NCT01295827|20567152|P9|Overall Study|Progressive Disease|85
5946790|NCT01295827|20567153|P8|Overall Study|Progressive Disease|144
5946791|NCT01295827|20567154|P7|Overall Study|Progressive Disease|87
5946792|NCT01295827|20567155|P6|Overall Study|Progressive Disease|1
5946793|NCT01295827|20567156|P5|Overall Study|Progressive Disease|0
5946794|NCT01295827|20567157|P4|Overall Study|Progressive Disease|2
5946795|NCT01295827|20567158|P3|Overall Study|Progressive Disease|5
5946796|NCT01295827|20567159|P2|Overall Study|Progressive Disease|1
5946797|NCT01295827|20567160|P1|Overall Study|Progressive Disease|2
5946798|NCT01295827|20567146|P15|Overall Study|Not Reported|0
5946799|NCT01295827|20567147|P14|Overall Study|Not Reported|0
5946800|NCT01295827|20567148|P13|Overall Study|Not Reported|0
5946801|NCT01295827|20567149|P12|Overall Study|Not Reported|13
5946802|NCT01295827|20567150|P11|Overall Study|Not Reported|23
5946803|NCT01295827|20567151|P10|Overall Study|Not Reported|2
5946804|NCT01295827|20567152|P9|Overall Study|Not Reported|41
5946805|NCT01295827|20567153|P8|Overall Study|Not Reported|58
5946806|NCT01295827|20567154|P7|Overall Study|Not Reported|24
5946807|NCT01295827|20567155|P6|Overall Study|Not Reported|0
5946808|NCT01295827|20567156|P5|Overall Study|Not Reported|0
5946809|NCT01295827|20567157|P4|Overall Study|Not Reported|1
5946810|NCT01295827|20567158|P3|Overall Study|Not Reported|0
5946811|NCT01295827|20567159|P2|Overall Study|Not Reported|0
5946812|NCT01295827|20567160|P1|Overall Study|Not Reported|0
5946813|NCT01295827|20567146|P15|Overall Study|Lost to Follow-up|0
5946814|NCT01295827|20567147|P14|Overall Study|Lost to Follow-up|0
5946815|NCT01295827|20567148|P13|Overall Study|Lost to Follow-up|0
5946816|NCT01295827|20567149|P12|Overall Study|Lost to Follow-up|3
5946817|NCT01295827|20567150|P11|Overall Study|Lost to Follow-up|7
5946818|NCT01295827|20567151|P10|Overall Study|Lost to Follow-up|4
5946819|NCT01295827|20567152|P9|Overall Study|Lost to Follow-up|7
5946820|NCT01295827|20567153|P8|Overall Study|Lost to Follow-up|8
5946821|NCT01295827|20567154|P7|Overall Study|Lost to Follow-up|4
5946822|NCT01295827|20567155|P6|Overall Study|Lost to Follow-up|0
5946823|NCT01295827|20567156|P5|Overall Study|Lost to Follow-up|1
5946824|NCT01295827|20567157|P4|Overall Study|Lost to Follow-up|0
5946825|NCT01295827|20567158|P3|Overall Study|Lost to Follow-up|3
5946826|NCT01295827|20567159|P2|Overall Study|Lost to Follow-up|0
5946827|NCT01295827|20567160|P1|Overall Study|Lost to Follow-up|0
5946828|NCT01295827|20567146|P15|Overall Study|Adverse Event|0
5946829|NCT01295827|20567147|P14|Overall Study|Adverse Event|0
5946830|NCT01295827|20567148|P13|Overall Study|Adverse Event|0
5946831|NCT01295827|20567149|P12|Overall Study|Adverse Event|21
5946832|NCT01295827|20567150|P11|Overall Study|Adverse Event|50
5946833|NCT01295827|20567151|P10|Overall Study|Adverse Event|7
5946834|NCT01295827|20567152|P9|Overall Study|Adverse Event|22
5946835|NCT01295827|20567153|P8|Overall Study|Adverse Event|49
5946836|NCT01295827|20567154|P7|Overall Study|Adverse Event|15
5946837|NCT01295827|20567155|P6|Overall Study|Adverse Event|4
5946838|NCT01295827|20567156|P5|Overall Study|Adverse Event|1
5946839|NCT01295827|20567157|P4|Overall Study|Adverse Event|1
5946840|NCT01295827|20567158|P3|Overall Study|Adverse Event|2
5946841|NCT01295827|20567159|P2|Overall Study|Adverse Event|2
5946842|NCT01295827|20567160|P1|Overall Study|Adverse Event|1
5946843|NCT01295814|20567533|P2|Overall Study|Withdrawal by Subject|0
5946844|NCT01295814|20567534|P1|Overall Study|Withdrawal by Subject|2
5946845|NCT01295814|20567533|P2|Overall Study|Lack of Efficacy|2
5946846|NCT01295814|20567534|P1|Overall Study|Lack of Efficacy|0
5946847|NCT01295671|20567614|P3|Overall Study|Withdrawal by Subject|0
5946848|NCT01295671|20567615|P2|Overall Study|Withdrawal by Subject|1
5946849|NCT01295671|20567616|P1|Overall Study|Withdrawal by Subject|3
5946850|NCT01295671|20567614|P3|Overall Study|Lost to Follow-up|3
5946851|NCT01295671|20567615|P2|Overall Study|Lost to Follow-up|6
5946852|NCT01295671|20567616|P1|Overall Study|Lost to Follow-up|4
5946853|NCT01295320|20567662|P1|Overall Study|Unable to travel|1
5946854|NCT01295320|20567662|P1|Overall Study|Subject was bedridden|1
5946855|NCT01295320|20567662|P1|Overall Study|Withdrawal by Subject|2
5946856|NCT01295320|20567662|P1|Overall Study|Lost to Follow-up|4
5946857|NCT01295320|20567662|P1|Overall Study|Adverse Event|2
5946858|NCT01295281|20567679|P2|First Intervention (7 Days)|Death|1
5946859|NCT01295281|20567680|P1|First Intervention (7 Days)|Death|0
5946860|NCT01295034|20567718|P2|Overall Study|Lost to Follow-up|5
5946861|NCT01295034|20567719|P1|Overall Study|Lost to Follow-up|5
5946862|NCT01294917|20567727|P1|Overall Study|Inconvenience|1
5946863|NCT01294917|20567727|P1|Overall Study|Relocation|5
5946864|NCT01294800|20567737|P4|Overall Study|Did Not Meet Protocol Eligibility|0
5946865|NCT01294800|20567738|P3|Overall Study|Did Not Meet Protocol Eligibility|1
5946866|NCT01294800|20567739|P2|Overall Study|Did Not Meet Protocol Eligibility|1
5946867|NCT01294800|20567740|P1|Overall Study|Did Not Meet Protocol Eligibility|2
5946868|NCT01294800|20567737|P4|Overall Study|Non-compliance With Protocol|0
5946869|NCT01294800|20567738|P3|Overall Study|Non-compliance With Protocol|1
5946870|NCT01294800|20567739|P2|Overall Study|Non-compliance With Protocol|1
5946871|NCT01294800|20567740|P1|Overall Study|Non-compliance With Protocol|0
5946872|NCT01294800|20567737|P4|Overall Study|Lost to Follow-up|0
5946873|NCT01294800|20567738|P3|Overall Study|Lost to Follow-up|1
5946874|NCT01294800|20567739|P2|Overall Study|Lost to Follow-up|0
5946875|NCT01294800|20567740|P1|Overall Study|Lost to Follow-up|0
5946876|NCT01294800|20567737|P4|Overall Study|Subject Withdrew Consent|11
5946877|NCT01294800|20567738|P3|Overall Study|Subject Withdrew Consent|2
5946878|NCT01294800|20567739|P2|Overall Study|Subject Withdrew Consent|2
5946879|NCT01294800|20567740|P1|Overall Study|Subject Withdrew Consent|2
5946880|NCT01294800|20567737|P4|Overall Study|Adverse Event|5
5946881|NCT01294800|20567738|P3|Overall Study|Adverse Event|12
5946882|NCT01294800|20567739|P2|Overall Study|Adverse Event|6
5946883|NCT01294800|20567740|P1|Overall Study|Adverse Event|7
5946884|NCT01294787|20567766|P6|Period 3|Adverse Event|0
5946885|NCT01294787|20567767|P5|Period 3|Adverse Event|1
5946886|NCT01294787|20567768|P4|Period 3|Adverse Event|0
5946887|NCT01294787|20567769|P3|Period 3|Adverse Event|0
5946888|NCT01294787|20567770|P2|Period 3|Adverse Event|0
5946889|NCT01294787|20567771|P1|Period 3|Adverse Event|0
5946890|NCT01294787|20567766|P6|Period 2|No longer needs study drug|0
5946891|NCT01294787|20567767|P5|Period 2|No longer needs study drug|0
5946892|NCT01294787|20567768|P4|Period 2|No longer needs study drug|1
5946893|NCT01294787|20567769|P3|Period 2|No longer needs study drug|0
5946894|NCT01294787|20567770|P2|Period 2|No longer needs study drug|0
5946895|NCT01294787|20567771|P1|Period 2|No longer needs study drug|0
5946896|NCT01294787|20567766|P6|Period 2|Adverse Event|0
5946897|NCT01294787|20567767|P5|Period 2|Adverse Event|0
5946898|NCT01294787|20567768|P4|Period 2|Adverse Event|1
5946899|NCT01294787|20567769|P3|Period 2|Adverse Event|0
5946900|NCT01294787|20567770|P2|Period 2|Adverse Event|3
5946901|NCT01294787|20567771|P1|Period 2|Adverse Event|0
5946902|NCT01294787|20567766|P6|Period 1|Administrative problem|1
5946903|NCT01294787|20567767|P5|Period 1|Administrative problem|0
5946904|NCT01294787|20567768|P4|Period 1|Administrative problem|0
5946905|NCT01294787|20567769|P3|Period 1|Administrative problem|1
5946906|NCT01294787|20567770|P2|Period 1|Administrative problem|0
5946907|NCT01294787|20567771|P1|Period 1|Administrative problem|0
5946908|NCT01294787|20567766|P6|Period 1|Withdrawal by Subject|1
5946909|NCT01294787|20567767|P5|Period 1|Withdrawal by Subject|1
5946910|NCT01294787|20567768|P4|Period 1|Withdrawal by Subject|1
5946911|NCT01294787|20567769|P3|Period 1|Withdrawal by Subject|0
5946912|NCT01294787|20567770|P2|Period 1|Withdrawal by Subject|0
5946913|NCT01294787|20567771|P1|Period 1|Withdrawal by Subject|0
5946914|NCT01294787|20567766|P6|Period 1|Adverse Event|0
5946915|NCT01294787|20567767|P5|Period 1|Adverse Event|1
5946916|NCT01294787|20567768|P4|Period 1|Adverse Event|0
5946917|NCT01294787|20567769|P3|Period 1|Adverse Event|0
5946918|NCT01294787|20567770|P2|Period 1|Adverse Event|0
5946919|NCT01294787|20567771|P1|Period 1|Adverse Event|0
5946920|NCT01294696|20567862|P1|Overall Study|Site closure|52
5946921|NCT01294696|20567862|P1|Overall Study|Missing BPI Response|7
5946922|NCT01294696|20567862|P1|Overall Study|Protocol Violation|8
5946923|NCT01294696|20567862|P1|Overall Study|Screening failures|7
5946924|NCT01294683|20567876|P2|Post Crossover (Period III)|Withdrawal by Subject|2
5946925|NCT01294683|20567877|P1|Post Crossover (Period III)|Withdrawal by Subject|3
5946926|NCT01294683|20567876|P2|Post Crossover (Period III)|Study Terminated by Sponsor|21
5946927|NCT01294683|20567877|P1|Post Crossover (Period III)|Study Terminated by Sponsor|23
5946928|NCT01294683|20567876|P2|Post Crossover (Period III)|Lost to Follow-up|3
5946929|NCT01294683|20567877|P1|Post Crossover (Period III)|Lost to Follow-up|1
5946930|NCT01294683|20567876|P2|Post Crossover (Period III)|Adverse Event|6
5946931|NCT01294683|20567877|P1|Post Crossover (Period III)|Adverse Event|6
5946932|NCT01294683|20567876|P2|Precrossover (Periods I/II)|Withdrawal by Subject|9
5946933|NCT01294683|20567877|P1|Precrossover (Periods I/II)|Withdrawal by Subject|11
5946934|NCT01294683|20567876|P2|Precrossover (Periods I/II)|Technical Problems|1
5946935|NCT01294683|20567877|P1|Precrossover (Periods I/II)|Technical Problems|0
5946936|NCT01294683|20567876|P2|Precrossover (Periods I/II)|Study Terminated by Sponsor|192
5946937|NCT01294683|20567877|P1|Precrossover (Periods I/II)|Study Terminated by Sponsor|187
5946938|NCT01294683|20567876|P2|Precrossover (Periods I/II)|Protocol Violation|5
5946939|NCT01294683|20567877|P1|Precrossover (Periods I/II)|Protocol Violation|5
5946940|NCT01294683|20567876|P2|Precrossover (Periods I/II)|Physician Decision|0
5946941|NCT01294683|20567877|P1|Precrossover (Periods I/II)|Physician Decision|1
5946942|NCT01294683|20567876|P2|Precrossover (Periods I/II)|Non-compliance with Study Drug|1
5946943|NCT01294683|20567877|P1|Precrossover (Periods I/II)|Non-compliance with Study Drug|1
5946944|NCT01294683|20567876|P2|Precrossover (Periods I/II)|Lost to Follow-up|6
5946945|NCT01294683|20567877|P1|Precrossover (Periods I/II)|Lost to Follow-up|3
5946946|NCT01294683|20567876|P2|Precrossover (Periods I/II)|Adverse Event|52
5946947|NCT01294683|20567877|P1|Precrossover (Periods I/II)|Adverse Event|49
5946948|NCT01294644|20567930|P3|Overall Study|Miscellaneous Reason|4
5946949|NCT01294644|20567931|P2|Overall Study|Miscellaneous Reason|1
5946950|NCT01294644|20567932|P1|Overall Study|Miscellaneous Reason|2
5946951|NCT01294644|20567930|P3|Overall Study|Lost to Follow-up|5
5946952|NCT01294644|20567931|P2|Overall Study|Lost to Follow-up|2
5946953|NCT01294644|20567932|P1|Overall Study|Lost to Follow-up|3
5946954|NCT01294644|20567930|P3|Overall Study|Withdrawal by Subject|4
5946955|NCT01294644|20567931|P2|Overall Study|Withdrawal by Subject|7
5946956|NCT01294644|20567932|P1|Overall Study|Withdrawal by Subject|3
5946957|NCT01294644|20567930|P3|Overall Study|Adverse Event|1
5946958|NCT01294644|20567931|P2|Overall Study|Adverse Event|0
5946959|NCT01294644|20567932|P1|Overall Study|Adverse Event|2
5946960|NCT01294592|20567963|P2|Overall Study|Withdrawal by Subject|28
5946961|NCT01294592|20567964|P1|Overall Study|Withdrawal by Subject|28
5946962|NCT01294592|20567963|P2|Overall Study|Physician Decision|11
5946963|NCT01294592|20567964|P1|Overall Study|Physician Decision|6
5946964|NCT01294592|20567963|P2|Overall Study|Lost to Follow-up|9
5946965|NCT01294592|20567964|P1|Overall Study|Lost to Follow-up|7
5946966|NCT01294592|20567963|P2|Overall Study|Protocol Violation|7
5946967|NCT01294592|20567964|P1|Overall Study|Protocol Violation|1
5946968|NCT01294592|20567963|P2|Overall Study|Lack of Efficacy|5
5946969|NCT01294592|20567964|P1|Overall Study|Lack of Efficacy|7
5946970|NCT01294592|20567963|P2|Overall Study|Adverse Event|13
5946971|NCT01294592|20567964|P1|Overall Study|Adverse Event|28
5946972|NCT01294579|20567992|P1|Overall Study|Withdrawal by Subject|5
5946973|NCT01294579|20567992|P1|Overall Study|Physician Decision|3
5946974|NCT01294579|20567992|P1|Overall Study|Lost to Follow-up|1
5946975|NCT01294579|20567992|P1|Overall Study|Study closed/terminated|3
5946976|NCT01294579|20567992|P1|Overall Study|Adverse Event|11
5946977|NCT01294579|20567992|P1|Overall Study|Disease progression|12
5946978|NCT01294553|20568002|P1|Overall Study|Protocol Violation|268
5946979|NCT01294553|20568002|P1|Overall Study|Duplicated Participants|1
5946980|NCT01294514|20568008|P1|Overall Study|Excluded due to Arrhythmia|1
5946981|NCT01294462|20568018|P2|Overall Study|Withdrawal by Subject|63
5946982|NCT01294462|20568019|P1|Overall Study|Withdrawal by Subject|65
5946983|NCT01294462|20568018|P2|Overall Study|Lost to Follow-up|0
5946984|NCT01294462|20568019|P1|Overall Study|Lost to Follow-up|1
5946985|NCT01294449|20568033|P2|Overall Study|Withdrawal by Subject|3
5946986|NCT01294449|20568034|P1|Overall Study|Withdrawal by Subject|1
5946987|NCT01294449|20568033|P2|Overall Study|Death|12
5946988|NCT01294449|20568034|P1|Overall Study|Death|11
5946989|NCT01294436|20568042|P2|Overall Study|poor/non-compliance|5
5946990|NCT01294436|20568043|P1|Overall Study|poor/non-compliance|2
5946991|NCT01294436|20568042|P2|Overall Study|subject no longer meets study criteria|20
5946992|NCT01294436|20568043|P1|Overall Study|subject no longer meets study criteria|5
5946993|NCT01294436|20568042|P2|Overall Study|Withdrawal by Subject|28
5946994|NCT01294436|20568043|P1|Overall Study|Withdrawal by Subject|11
5946995|NCT01294436|20568042|P2|Overall Study|Adverse Event|17
5946996|NCT01294436|20568043|P1|Overall Study|Adverse Event|10
5946997|NCT01294423|20568078|P3|Overall Study|poor/non-compliance|1
5946998|NCT01294423|20568079|P2|Overall Study|poor/non-compliance|0
5946999|NCT01294423|20568080|P1|Overall Study|poor/non-compliance|1
5947000|NCT01294423|20568078|P3|Overall Study|subject no longer meets study criteria|2
5947001|NCT01294423|20568079|P2|Overall Study|subject no longer meets study criteria|5
5947002|NCT01294423|20568080|P1|Overall Study|subject no longer meets study criteria|2
5947003|NCT01294423|20568078|P3|Overall Study|Withdrawal by Subject|2
5947004|NCT01294423|20568079|P2|Overall Study|Withdrawal by Subject|2
5947005|NCT01294423|20568080|P1|Overall Study|Withdrawal by Subject|1
5947006|NCT01294423|20568078|P3|Overall Study|Adverse Event|3
5947007|NCT01294423|20568079|P2|Overall Study|Adverse Event|2
5947008|NCT01294423|20568080|P1|Overall Study|Adverse Event|1
5947009|NCT01294397|20568094|P1|Overall Study|Administrative Decision|1
5947010|NCT01294397|20568094|P1|Overall Study|Withdrawal by Subject|1
5947011|NCT01294371|20568138|P1|Overall Study|Other|14
5947012|NCT01294371|20568138|P1|Overall Study|Administrative Reason|1
5947013|NCT01294371|20568138|P1|Overall Study|Lost to Follow-up|6
5947014|NCT01294371|20568138|P1|Overall Study|Withdrawal by Subject|12
5947015|NCT01294371|20568138|P1|Overall Study|Adverse Event|1
5947016|NCT01294358|20568146|P5|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|1
5947017|NCT01294358|20568147|P4|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0
5947018|NCT01294358|20568148|P3|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0
5947019|NCT01294358|20568149|P2|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0
5947020|NCT01294358|20568150|P1|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0
5947021|NCT01294358|20568146|P5|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0
5947022|NCT01294358|20568147|P4|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|1
5947023|NCT01294358|20568148|P3|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0
5947024|NCT01294358|20568149|P2|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0
5947025|NCT01294358|20568150|P1|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0
5947026|NCT01294358|20568146|P5|Cohort 3: 12/1/11-10/6/12|Disease progression|0
5947027|NCT01294358|20568147|P4|Cohort 3: 12/1/11-10/6/12|Disease progression|0
5947028|NCT01294358|20568148|P3|Cohort 3: 12/1/11-10/6/12|Disease progression|2
5947029|NCT01294358|20568149|P2|Cohort 3: 12/1/11-10/6/12|Disease progression|0
5947030|NCT01294358|20568150|P1|Cohort 3: 12/1/11-10/6/12|Disease progression|0
5947031|NCT01294358|20568146|P5|Cohort 2: 6/9/11-9/17/12|Disease progression|0
5947032|NCT01294358|20568147|P4|Cohort 2: 6/9/11-9/17/12|Disease progression|0
5947033|NCT01294358|20568148|P3|Cohort 2: 6/9/11-9/17/12|Disease progression|0
5947034|NCT01294358|20568149|P2|Cohort 2: 6/9/11-9/17/12|Disease progression|2
5947035|NCT01294358|20568150|P1|Cohort 2: 6/9/11-9/17/12|Disease progression|0
5947036|NCT01294150|20568278|P2|Overall Study|Physician Decision|2
5947037|NCT01294150|20568279|P1|Overall Study|Physician Decision|2
5947038|NCT01294046|20568308|P1|Overall Study|Stimulation response inadqequate|1
5947039|NCT01294046|20568308|P1|Overall Study|Eligibility criteria expanded|1
5947040|NCT01294046|20568308|P1|Overall Study|Infection and surgical explant|1
5947041|NCT01293968|20568323|P2|Overall Study|non-cooperation|3
5947042|NCT01293968|20568324|P1|Overall Study|non-cooperation|3
5947043|NCT01293695|20568344|P2|Overall Study|Lost to Follow-up|6
5947044|NCT01293695|20568345|P1|Overall Study|Lost to Follow-up|8
5947045|NCT01293695|20568344|P2|Overall Study|Withdrawal by Subject|1
5947046|NCT01293695|20568345|P1|Overall Study|Withdrawal by Subject|7
5947047|NCT01293539|20568364|P1|Overall Study|Physician Decision|1
5947048|NCT01293240|20568368|P1|Overall Study|Noncompliance|2
5947049|NCT01293123|20568385|P2|Overall Study|Lost to Follow-up|1
5947050|NCT01293123|20568386|P1|Overall Study|Lost to Follow-up|0
5947051|NCT01293084|20568400|P1|Overall Study|Withdrawal by Subject|2
5947052|NCT01293084|20568400|P1|Overall Study|Physician Decision|3
5947053|NCT01293032|20568412|P4|Treatment|Disease Progression, relapse|0
5947054|NCT01293032|20568413|P3|Treatment|Disease Progression, relapse|0
5947055|NCT01293032|20568414|P2|Treatment|Disease Progression, relapse|1
5947056|NCT01293032|20568415|P1|Treatment|Disease Progression, relapse|0
5947057|NCT01293032|20568412|P4|Treatment|Withdrawal by Subject|0
5947058|NCT01293032|20568413|P3|Treatment|Withdrawal by Subject|0
5947059|NCT01293032|20568414|P2|Treatment|Withdrawal by Subject|4
5947060|NCT01293032|20568415|P1|Treatment|Withdrawal by Subject|2
5947061|NCT01293032|20568412|P4|Treatment|Adverse Event|1
5947062|NCT01293032|20568413|P3|Treatment|Adverse Event|1
5947063|NCT01293032|20568414|P2|Treatment|Adverse Event|0
5947064|NCT01293032|20568415|P1|Treatment|Adverse Event|0
5947065|NCT01293032|20568412|P4|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0
5947066|NCT01293032|20568413|P3|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|5
5947067|NCT01293032|20568414|P2|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0
5947068|NCT01293032|20568415|P1|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0
5947069|NCT01293006|20568426|P4|Period 2|Lost to Follow-up|0
5947070|NCT01293006|20568427|P3|Period 2|Lost to Follow-up|0
5947071|NCT01293006|20568428|P2|Period 2|Lost to Follow-up|0
5947072|NCT01293006|20568429|P1|Period 2|Lost to Follow-up|1
5947073|NCT01292928|20568450|P1|Overall Study|Physician Decision|2
5947074|NCT01292928|20568450|P1|Overall Study|Lost to Follow-up|6
5947075|NCT01292928|20568450|P1|Overall Study|Withdrawal by Subject|8
5947076|NCT01292928|20568450|P1|Overall Study|Death|8
5947077|NCT01292876|20568467|P1|Overall Study|Physician Decision|4
5947078|NCT01292837|20568473|P1|Overall Study|Further treatment determined|1
5947079|NCT01292837|20568473|P1|Overall Study|Adverse Event|1
5947080|NCT01292603|20568510|P6|Overall Survival Status|Death|10
5947081|NCT01292603|20568511|P5|Overall Survival Status|Death|16
5947082|NCT01292603|20568512|P4|Overall Survival Status|Death|1
5947083|NCT01292603|20568513|P3|Overall Survival Status|Death|3
5947084|NCT01292603|20568514|P2|Overall Survival Status|Death|1
5947085|NCT01292603|20568515|P1|Overall Survival Status|Death|3
5947086|NCT01292603|20568510|P6|Part 2: Regular Follow-Up|Adverse Event|2
5947087|NCT01292603|20568511|P5|Part 2: Regular Follow-Up|Adverse Event|2
5947088|NCT01292603|20568512|P4|Part 2: Regular Follow-Up|Adverse Event|0
5947089|NCT01292603|20568513|P3|Part 2: Regular Follow-Up|Adverse Event|0
5947090|NCT01292603|20568514|P2|Part 2: Regular Follow-Up|Adverse Event|0
5947091|NCT01292603|20568515|P1|Part 2: Regular Follow-Up|Adverse Event|0
5947092|NCT01292603|20568510|P6|Part 2: Regular Follow-Up|Lost to Follow-up|1
5947093|NCT01292603|20568511|P5|Part 2: Regular Follow-Up|Lost to Follow-up|1
5947094|NCT01292603|20568512|P4|Part 2: Regular Follow-Up|Lost to Follow-up|0
5947095|NCT01292603|20568513|P3|Part 2: Regular Follow-Up|Lost to Follow-up|0
5947096|NCT01292603|20568514|P2|Part 2: Regular Follow-Up|Lost to Follow-up|0
5947097|NCT01292603|20568515|P1|Part 2: Regular Follow-Up|Lost to Follow-up|0
5947098|NCT01292603|20568510|P6|Part 2: Regular Follow-Up|Physician Decision|0
5947099|NCT01292603|20568511|P5|Part 2: Regular Follow-Up|Physician Decision|2
5947100|NCT01292603|20568512|P4|Part 2: Regular Follow-Up|Physician Decision|0
5947101|NCT01292603|20568513|P3|Part 2: Regular Follow-Up|Physician Decision|0
5947102|NCT01292603|20568514|P2|Part 2: Regular Follow-Up|Physician Decision|0
5947103|NCT01292603|20568515|P1|Part 2: Regular Follow-Up|Physician Decision|0
5947104|NCT01292603|20568510|P6|Part 2: Regular Follow-Up|Protocol Violation|0
5947105|NCT01292603|20568511|P5|Part 2: Regular Follow-Up|Protocol Violation|2
5947106|NCT01292603|20568512|P4|Part 2: Regular Follow-Up|Protocol Violation|0
5947107|NCT01292603|20568513|P3|Part 2: Regular Follow-Up|Protocol Violation|0
5947108|NCT01292603|20568514|P2|Part 2: Regular Follow-Up|Protocol Violation|0
5947109|NCT01292603|20568515|P1|Part 2: Regular Follow-Up|Protocol Violation|0
5947110|NCT01292603|20568510|P6|Part 2: Regular Follow-Up|Withdrawal by Subject|1
5947111|NCT01292603|20568511|P5|Part 2: Regular Follow-Up|Withdrawal by Subject|0
5947112|NCT01292603|20568512|P4|Part 2: Regular Follow-Up|Withdrawal by Subject|0
5947113|NCT01292603|20568513|P3|Part 2: Regular Follow-Up|Withdrawal by Subject|0
5947114|NCT01292603|20568514|P2|Part 2: Regular Follow-Up|Withdrawal by Subject|0
5947115|NCT01292603|20568515|P1|Part 2: Regular Follow-Up|Withdrawal by Subject|0
5947116|NCT01292603|20568510|P6|Part 2: Regular Follow-Up|Noncompliance|0
5947117|NCT01292603|20568511|P5|Part 2: Regular Follow-Up|Noncompliance|1
5947118|NCT01292603|20568512|P4|Part 2: Regular Follow-Up|Noncompliance|0
5947119|NCT01292603|20568513|P3|Part 2: Regular Follow-Up|Noncompliance|0
5947120|NCT01292603|20568514|P2|Part 2: Regular Follow-Up|Noncompliance|0
5947121|NCT01292603|20568515|P1|Part 2: Regular Follow-Up|Noncompliance|0
5947122|NCT01292603|20568510|P6|Part 2: Regular Follow-Up|Disease Progression|5
5947123|NCT01292603|20568511|P5|Part 2: Regular Follow-Up|Disease Progression|5
5947124|NCT01292603|20568512|P4|Part 2: Regular Follow-Up|Disease Progression|0
5947125|NCT01292603|20568513|P3|Part 2: Regular Follow-Up|Disease Progression|0
5947126|NCT01292603|20568514|P2|Part 2: Regular Follow-Up|Disease Progression|0
5947127|NCT01292603|20568515|P1|Part 2: Regular Follow-Up|Disease Progression|0
5947128|NCT01292603|20568510|P6|Part 2: Regular Follow-Up|Death|3
5947129|NCT01292603|20568511|P5|Part 2: Regular Follow-Up|Death|6
5947130|NCT01292603|20568512|P4|Part 2: Regular Follow-Up|Death|0
5947131|NCT01292603|20568513|P3|Part 2: Regular Follow-Up|Death|0
5947132|NCT01292603|20568514|P2|Part 2: Regular Follow-Up|Death|0
5947133|NCT01292603|20568515|P1|Part 2: Regular Follow-Up|Death|0
5947134|NCT01292603|20568510|P6|Part 2: Dose Confirmation Period|Withdrawal by Subject|2
5947135|NCT01292603|20568511|P5|Part 2: Dose Confirmation Period|Withdrawal by Subject|0
5947136|NCT01292603|20568512|P4|Part 2: Dose Confirmation Period|Withdrawal by Subject|0
5947137|NCT01292603|20568513|P3|Part 2: Dose Confirmation Period|Withdrawal by Subject|0
5947138|NCT01292603|20568514|P2|Part 2: Dose Confirmation Period|Withdrawal by Subject|0
5947139|NCT01292603|20568515|P1|Part 2: Dose Confirmation Period|Withdrawal by Subject|0
5947140|NCT01292603|20568510|P6|Part 2: Dose Confirmation Period|Protocol Violation|3
5947141|NCT01292603|20568511|P5|Part 2: Dose Confirmation Period|Protocol Violation|5
5947142|NCT01292603|20568512|P4|Part 2: Dose Confirmation Period|Protocol Violation|0
5947143|NCT01292603|20568513|P3|Part 2: Dose Confirmation Period|Protocol Violation|0
5947144|NCT01292603|20568514|P2|Part 2: Dose Confirmation Period|Protocol Violation|0
5947145|NCT01292603|20568515|P1|Part 2: Dose Confirmation Period|Protocol Violation|0
5947146|NCT01292603|20568510|P6|Part 2: Dose Confirmation Period|Adverse Event|9
5947147|NCT01292603|20568511|P5|Part 2: Dose Confirmation Period|Adverse Event|7
5947148|NCT01292603|20568512|P4|Part 2: Dose Confirmation Period|Adverse Event|0
5947149|NCT01292603|20568513|P3|Part 2: Dose Confirmation Period|Adverse Event|0
5947150|NCT01292603|20568514|P2|Part 2: Dose Confirmation Period|Adverse Event|0
5947151|NCT01292603|20568515|P1|Part 2: Dose Confirmation Period|Adverse Event|0
5947152|NCT01292603|20568510|P6|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1
5947153|NCT01292603|20568511|P5|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1
5947154|NCT01292603|20568512|P4|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0
5947155|NCT01292603|20568513|P3|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0
5947156|NCT01292603|20568514|P2|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0
5947157|NCT01292603|20568515|P1|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0
5947158|NCT01292603|20568510|P6|Part 2: Dose Confirmation Period|Physician Decision|0
5947159|NCT01292603|20568511|P5|Part 2: Dose Confirmation Period|Physician Decision|2
5947160|NCT01292603|20568512|P4|Part 2: Dose Confirmation Period|Physician Decision|0
5947161|NCT01292603|20568513|P3|Part 2: Dose Confirmation Period|Physician Decision|0
5947162|NCT01292603|20568514|P2|Part 2: Dose Confirmation Period|Physician Decision|0
5947163|NCT01292603|20568515|P1|Part 2: Dose Confirmation Period|Physician Decision|0
5947164|NCT01292603|20568510|P6|Part 2: Dose Confirmation Period|Death|0
5947165|NCT01292603|20568511|P5|Part 2: Dose Confirmation Period|Death|1
5947166|NCT01292603|20568512|P4|Part 2: Dose Confirmation Period|Death|0
5947167|NCT01292603|20568513|P3|Part 2: Dose Confirmation Period|Death|0
5947168|NCT01292603|20568514|P2|Part 2: Dose Confirmation Period|Death|0
5947169|NCT01292603|20568515|P1|Part 2: Dose Confirmation Period|Death|0
5947170|NCT01292603|20568510|P6|Part 1: Regular Follow-Up Period|Disease Progression|0
5947171|NCT01292603|20568511|P5|Part 1: Regular Follow-Up Period|Disease Progression|0
5947172|NCT01292603|20568512|P4|Part 1: Regular Follow-Up Period|Disease Progression|0
5947173|NCT01292603|20568513|P3|Part 1: Regular Follow-Up Period|Disease Progression|3
5947174|NCT01292603|20568514|P2|Part 1: Regular Follow-Up Period|Disease Progression|6
5947175|NCT01292603|20568515|P1|Part 1: Regular Follow-Up Period|Disease Progression|3
5947176|NCT01292603|20568510|P6|Part 1: Regular Follow-Up Period|Death|0
5947177|NCT01292603|20568511|P5|Part 1: Regular Follow-Up Period|Death|0
5947178|NCT01292603|20568512|P4|Part 1: Regular Follow-Up Period|Death|1
5947179|NCT01292603|20568513|P3|Part 1: Regular Follow-Up Period|Death|3
5947180|NCT01292603|20568514|P2|Part 1: Regular Follow-Up Period|Death|1
5947181|NCT01292603|20568515|P1|Part 1: Regular Follow-Up Period|Death|3
5947182|NCT01292603|20568510|P6|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0
5947183|NCT01292603|20568511|P5|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0
5947184|NCT01292603|20568512|P4|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|1
5947185|NCT01292603|20568513|P3|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0
5947186|NCT01292603|20568514|P2|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0
5947187|NCT01292603|20568515|P1|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0
5947188|NCT01292603|20568510|P6|Part 1: Pilot Dose Selection Period|Protocol Violation|0
5947189|NCT01292603|20568511|P5|Part 1: Pilot Dose Selection Period|Protocol Violation|0
5947190|NCT01292603|20568512|P4|Part 1: Pilot Dose Selection Period|Protocol Violation|2
5947191|NCT01292603|20568513|P3|Part 1: Pilot Dose Selection Period|Protocol Violation|0
5947192|NCT01292603|20568514|P2|Part 1: Pilot Dose Selection Period|Protocol Violation|0
5947193|NCT01292603|20568515|P1|Part 1: Pilot Dose Selection Period|Protocol Violation|0
5947194|NCT01292603|20568510|P6|Part 1: Pilot Dose Selection Period|Death|0
5947195|NCT01292603|20568511|P5|Part 1: Pilot Dose Selection Period|Death|0
5947196|NCT01292603|20568512|P4|Part 1: Pilot Dose Selection Period|Death|1
5947197|NCT01292603|20568513|P3|Part 1: Pilot Dose Selection Period|Death|0
5947198|NCT01292603|20568514|P2|Part 1: Pilot Dose Selection Period|Death|0
5947199|NCT01292603|20568515|P1|Part 1: Pilot Dose Selection Period|Death|0
5947200|NCT01292603|20568510|P6|Part 1: Pilot Dose Selection Period|Adverse Event|0
5947201|NCT01292603|20568511|P5|Part 1: Pilot Dose Selection Period|Adverse Event|0
5947202|NCT01292603|20568512|P4|Part 1: Pilot Dose Selection Period|Adverse Event|4
5947203|NCT01292603|20568513|P3|Part 1: Pilot Dose Selection Period|Adverse Event|0
5947204|NCT01292603|20568514|P2|Part 1: Pilot Dose Selection Period|Adverse Event|0
5947205|NCT01292603|20568515|P1|Part 1: Pilot Dose Selection Period|Adverse Event|0
5947206|NCT01292486|20568568|P1|Overall Study|Physician Decision|1
5947207|NCT01292486|20568568|P1|Overall Study|Adverse Event|1
5947208|NCT01292486|20568568|P1|Overall Study|Did not meet screening criteria|2
5947209|NCT01292486|20568568|P1|Overall Study|Protocol Violation|2
5947210|NCT01292473|20568582|P4|Overall Study|Disease Progression|6
5947211|NCT01292473|20568583|P3|Overall Study|Disease Progression|3
5947212|NCT01292473|20568584|P2|Overall Study|Disease Progression|1
5947213|NCT01292473|20568585|P1|Overall Study|Disease Progression|0
5947214|NCT01292473|20568582|P4|Overall Study|Physician Decision|0
5947215|NCT01292473|20568583|P3|Overall Study|Physician Decision|0
5947216|NCT01292473|20568584|P2|Overall Study|Physician Decision|1
5947217|NCT01292473|20568585|P1|Overall Study|Physician Decision|0
5947218|NCT01292473|20568582|P4|Overall Study|Withdrawal by Subject|3
5947219|NCT01292473|20568583|P3|Overall Study|Withdrawal by Subject|3
5947220|NCT01292473|20568584|P2|Overall Study|Withdrawal by Subject|4
5947221|NCT01292473|20568585|P1|Overall Study|Withdrawal by Subject|3
5947222|NCT01292473|20568582|P4|Overall Study|Lost to Follow-up|2
5947223|NCT01292473|20568583|P3|Overall Study|Lost to Follow-up|2
5947224|NCT01292473|20568584|P2|Overall Study|Lost to Follow-up|1
5947225|NCT01292473|20568585|P1|Overall Study|Lost to Follow-up|1
5947226|NCT01292473|20568582|P4|Overall Study|Adverse Event|1
5947227|NCT01292473|20568583|P3|Overall Study|Adverse Event|1
5947228|NCT01292473|20568584|P2|Overall Study|Adverse Event|0
5947229|NCT01292473|20568585|P1|Overall Study|Adverse Event|1
5947230|NCT01292239|20568653|P2|Overall Study|Withdrawal by Subject|6
5947231|NCT01292239|20568654|P1|Overall Study|Withdrawal by Subject|3
5947232|NCT01292239|20568653|P2|Overall Study|Other|1
5947233|NCT01292239|20568654|P1|Overall Study|Other|1
5947234|NCT01292226|20568675|P1|Overall Study|Other|2
5947235|NCT01292226|20568675|P1|Overall Study|Withdrawal by Subject|1
5947236|NCT01292226|20568675|P1|Overall Study|Protocol Violation|3
5947237|NCT01292226|20568675|P1|Overall Study|Graft loss|1
5947238|NCT01292226|20568675|P1|Overall Study|Death|1
5947239|NCT01292226|20568675|P1|Overall Study|Adverse Event|5
5947240|NCT01292187|20568708|P2|Overall Study|All other reasons|3
5947241|NCT01292187|20568709|P1|Overall Study|All other reasons|1
5947242|NCT01292187|20568708|P2|Overall Study|Withdrawal by Subject|5
5947243|NCT01292187|20568709|P1|Overall Study|Withdrawal by Subject|6
5947244|NCT01292187|20568708|P2|Overall Study|Adverse Event|5
5947245|NCT01292187|20568709|P1|Overall Study|Adverse Event|10
5947246|NCT01292057|20568744|P2|Overall Study|Lost to Follow-up|1
5947247|NCT01292057|20568745|P1|Overall Study|Lost to Follow-up|1
5947248|NCT01292057|20568744|P2|Overall Study|Protocol Violation|1
5947249|NCT01292057|20568745|P1|Overall Study|Protocol Violation|1
5947250|NCT01291277|20568817|P2|Overall Study|Lost to Follow-up|1
5947251|NCT01291277|20568818|P1|Overall Study|Lost to Follow-up|3
5947252|NCT01291277|20568817|P2|Overall Study|Death|2
5947253|NCT01291277|20568818|P1|Overall Study|Death|2
5947254|NCT01291225|20568830|P2|Overall Study|Lost to Follow-up|39
5947255|NCT01291225|20568831|P1|Overall Study|Lost to Follow-up|85
5947256|NCT01291173|20568845|P4|Overall Study|Excluded therapy|0
5947257|NCT01291173|20568846|P3|Overall Study|Excluded therapy|1
5947258|NCT01291173|20568847|P2|Overall Study|Excluded therapy|0
5947259|NCT01291173|20568848|P1|Overall Study|Excluded therapy|0
5947260|NCT01291173|20568845|P4|Overall Study|Subject was unblinded|0
5947261|NCT01291173|20568846|P3|Overall Study|Subject was unblinded|1
5947262|NCT01291173|20568847|P2|Overall Study|Subject was unblinded|0
5947263|NCT01291173|20568848|P1|Overall Study|Subject was unblinded|0
5947264|NCT01291173|20568845|P4|Overall Study|Lack of compliance|1
5947265|NCT01291173|20568846|P3|Overall Study|Lack of compliance|0
5947266|NCT01291173|20568847|P2|Overall Study|Lack of compliance|0
5947267|NCT01291173|20568848|P1|Overall Study|Lack of compliance|0
5947268|NCT01291173|20568845|P4|Overall Study|Unable to meet visit schedule|0
5947269|NCT01291173|20568846|P3|Overall Study|Unable to meet visit schedule|1
5947270|NCT01291173|20568847|P2|Overall Study|Unable to meet visit schedule|0
5947271|NCT01291173|20568848|P1|Overall Study|Unable to meet visit schedule|0
5947272|NCT01291173|20568845|P4|Overall Study|Lost to Follow-up|2
5947273|NCT01291173|20568846|P3|Overall Study|Lost to Follow-up|3
5947274|NCT01291173|20568847|P2|Overall Study|Lost to Follow-up|6
5947275|NCT01291173|20568848|P1|Overall Study|Lost to Follow-up|4
5947276|NCT01291173|20568845|P4|Overall Study|Withdrawal by Subject|2
5947277|NCT01291173|20568846|P3|Overall Study|Withdrawal by Subject|4
5947278|NCT01291173|20568847|P2|Overall Study|Withdrawal by Subject|4
5947279|NCT01291173|20568848|P1|Overall Study|Withdrawal by Subject|6
5947280|NCT01291173|20568845|P4|Overall Study|Protocol Violation|5
5947281|NCT01291173|20568846|P3|Overall Study|Protocol Violation|2
5947282|NCT01291173|20568847|P2|Overall Study|Protocol Violation|2
5947283|NCT01291173|20568848|P1|Overall Study|Protocol Violation|7
5947284|NCT01291173|20568845|P4|Overall Study|Adverse Event|3
5947285|NCT01291173|20568846|P3|Overall Study|Adverse Event|1
5947286|NCT01291173|20568847|P2|Overall Study|Adverse Event|3
5947287|NCT01291173|20568848|P1|Overall Study|Adverse Event|0
5947288|NCT01291017|20568957|P1|Overall Study|Withdrawal by Subject|3
5947289|NCT01291017|20568957|P1|Overall Study|Lost to Follow-up|2
5947290|NCT01290887|20568990|P2|Overall Study|Other|6
5947291|NCT01290887|20568991|P1|Overall Study|Other|3
5947292|NCT01290887|20568990|P2|Overall Study|Sponsor closure of study|476
5947293|NCT01290887|20568991|P1|Overall Study|Sponsor closure of study|420
5947294|NCT01290887|20568990|P2|Overall Study|Non-compliance to study medications|0
5947295|NCT01290887|20568991|P1|Overall Study|Non-compliance to study medications|1
5947296|NCT01290887|20568990|P2|Overall Study|Non-compliance to study procedures|1
5947297|NCT01290887|20568991|P1|Overall Study|Non-compliance to study procedures|0
5947298|NCT01290887|20568990|P2|Overall Study|Lost to Follow-up|4
5947299|NCT01290887|20568991|P1|Overall Study|Lost to Follow-up|4
5947300|NCT01290887|20568990|P2|Overall Study|Protocol Violation|1
5947301|NCT01290887|20568991|P1|Overall Study|Protocol Violation|2
5947302|NCT01290887|20568990|P2|Overall Study|Withdrawal by Subject|32
5947303|NCT01290887|20568991|P1|Overall Study|Withdrawal by Subject|26
5947304|NCT01290887|20568990|P2|Overall Study|Lack of Efficacy|5
5947305|NCT01290887|20568991|P1|Overall Study|Lack of Efficacy|4
5947306|NCT01290887|20568990|P2|Overall Study|Adverse Event|11
5947307|NCT01290887|20568991|P1|Overall Study|Adverse Event|6
5947308|NCT01290822|20569052|P1|Overall Study|Physician Decision|10
5947309|NCT01290822|20569052|P1|Overall Study|Withdrawal by Subject|1
5947310|NCT01290796|20569061|P1|Overall Study|Withdrawal by Sponsor|1
5947311|NCT01290796|20569061|P1|Overall Study|Secondary Surgical Intervention|2
5947312|NCT01290796|20569061|P1|Overall Study|Physician Decision|2
5947313|NCT01290796|20569061|P1|Overall Study|Withdrawal by Subject|4
5947314|NCT01290796|20569061|P1|Overall Study|Lost to Follow-up|21
5947315|NCT01290757|20569077|P2|Overall Study|Other|1
5947316|NCT01290757|20569078|P1|Overall Study|Other|0
5947317|NCT01290757|20569077|P2|Overall Study|Protocol Violation|1
5947318|NCT01290757|20569078|P1|Overall Study|Protocol Violation|1
5947319|NCT01290757|20569077|P2|Overall Study|Adverse Event|0
5947320|NCT01290757|20569078|P1|Overall Study|Adverse Event|1
5947321|NCT01290731|20569094|P1|Overall Study|Withdrawal by Subject|1
5947322|NCT01290718|20569106|P1|Overall Study|Early termination of the study|4
5947323|NCT01290679|20569115|P2|Overall Study|Subject Entered Another Trial|5
5947324|NCT01290679|20569116|P1|Overall Study|Subject Entered Another Trial|0
5947325|NCT01290679|20569115|P2|Overall Study|Withdrawal by Subject|5
5947326|NCT01290679|20569116|P1|Overall Study|Withdrawal by Subject|6
5947327|NCT01290679|20569115|P2|Overall Study|Protocol Violation|1
5947328|NCT01290679|20569116|P1|Overall Study|Protocol Violation|0
5947329|NCT01290679|20569115|P2|Overall Study|Lost to Follow-up|10
5947330|NCT01290679|20569116|P1|Overall Study|Lost to Follow-up|8
5947331|NCT01290679|20569115|P2|Overall Study|Adverse Event|0
5947332|NCT01290679|20569116|P1|Overall Study|Adverse Event|2
5947333|NCT01290666|20569185|P1|Overall Study|Early Termination of Study|4
5947334|NCT01290666|20569185|P1|Overall Study|Withdrawal by Subject|23
5947335|NCT01290666|20569185|P1|Overall Study|Lost to Follow-up|11
5947336|NCT01290601|20569238|P4|Overall Study|Protocol Violation|0
5947337|NCT01290601|20569239|P3|Overall Study|Protocol Violation|0
5947338|NCT01290601|20569240|P2|Overall Study|Protocol Violation|0
5947339|NCT01290601|20569241|P1|Overall Study|Protocol Violation|1
5947340|NCT01290601|20569238|P4|Overall Study|Other|0
5947341|NCT01290601|20569239|P3|Overall Study|Other|0
5947342|NCT01290601|20569240|P2|Overall Study|Other|0
5947343|NCT01290601|20569241|P1|Overall Study|Other|1
5947344|NCT01290601|20569238|P4|Overall Study|Lost to Follow-up|0
5947345|NCT01290601|20569239|P3|Overall Study|Lost to Follow-up|0
5947346|NCT01290601|20569240|P2|Overall Study|Lost to Follow-up|2
5947347|NCT01290601|20569241|P1|Overall Study|Lost to Follow-up|7
5947348|NCT01290601|20569238|P4|Overall Study|Lack of Efficacy|0
5947349|NCT01290601|20569239|P3|Overall Study|Lack of Efficacy|0
5947350|NCT01290601|20569240|P2|Overall Study|Lack of Efficacy|1
5947351|NCT01290601|20569241|P1|Overall Study|Lack of Efficacy|2
5947352|NCT01290601|20569238|P4|Overall Study|Adverse Event|0
5947353|NCT01290601|20569239|P3|Overall Study|Adverse Event|0
5947354|NCT01290601|20569240|P2|Overall Study|Adverse Event|2
5947355|NCT01290601|20569241|P1|Overall Study|Adverse Event|0
5947356|NCT01290523|20569262|P1|Overall Study|Death|3
5947357|NCT01290341|20569301|P2|Overall Study|Negative baseline culture and others|11
5947358|NCT01290341|20569302|P1|Overall Study|Negative baseline culture and others|44
5947359|NCT01290341|20569301|P2|Overall Study|Withdrawal by Subject|5
5947360|NCT01290341|20569302|P1|Overall Study|Withdrawal by Subject|19
5947361|NCT01290341|20569301|P2|Overall Study|Lost to Follow-up|10
5947362|NCT01290341|20569302|P1|Overall Study|Lost to Follow-up|21
5947363|NCT01290341|20569301|P2|Overall Study|Adverse Event|0
5947364|NCT01290341|20569302|P1|Overall Study|Adverse Event|1
5947365|NCT01290341|20569301|P2|Overall Study|Protocol Violation|3
5947366|NCT01290341|20569302|P1|Overall Study|Protocol Violation|7
5947367|NCT01290315|20569314|P4|Overall Study|Withdrawal by Subject|0
5947368|NCT01290315|20569315|P3|Overall Study|Withdrawal by Subject|0
5947369|NCT01290315|20569316|P2|Overall Study|Withdrawal by Subject|1
5947370|NCT01290315|20569317|P1|Overall Study|Withdrawal by Subject|1
5947371|NCT01290315|20569314|P4|Overall Study|Lost to Follow-up|0
5947372|NCT01290315|20569315|P3|Overall Study|Lost to Follow-up|0
5947373|NCT01290315|20569316|P2|Overall Study|Lost to Follow-up|1
5947374|NCT01290315|20569317|P1|Overall Study|Lost to Follow-up|0
5947375|NCT01290315|20569314|P4|Overall Study|Selection criteria/compliance|2
5947376|NCT01290315|20569315|P3|Overall Study|Selection criteria/compliance|0
5947377|NCT01290315|20569316|P2|Overall Study|Selection criteria/compliance|1
5947378|NCT01290315|20569317|P1|Overall Study|Selection criteria/compliance|2
5947379|NCT01290315|20569314|P4|Overall Study|Adverse Event|3
5947380|NCT01290315|20569315|P3|Overall Study|Adverse Event|0
5947381|NCT01290315|20569316|P2|Overall Study|Adverse Event|0
5947382|NCT01290315|20569317|P1|Overall Study|Adverse Event|0
5947383|NCT01290263|20569339|P5|Overall Study|Participant Non-Compliance|1
5947384|NCT01290263|20569340|P4|Overall Study|Participant Non-Compliance|1
5947385|NCT01290263|20569341|P3|Overall Study|Participant Non-Compliance|0
5947386|NCT01290263|20569342|P2|Overall Study|Participant Non-Compliance|0
5947387|NCT01290263|20569343|P1|Overall Study|Participant Non-Compliance|0
5947388|NCT01290263|20569339|P5|Overall Study|Withdrawal by Subject|2
5947389|NCT01290263|20569340|P4|Overall Study|Withdrawal by Subject|1
5947390|NCT01290263|20569341|P3|Overall Study|Withdrawal by Subject|0
5947391|NCT01290263|20569342|P2|Overall Study|Withdrawal by Subject|1
5947392|NCT01290263|20569343|P1|Overall Study|Withdrawal by Subject|3
5947393|NCT01290263|20569339|P5|Overall Study|Lack of Efficacy|33
5947394|NCT01290263|20569340|P4|Overall Study|Lack of Efficacy|24
5947395|NCT01290263|20569341|P3|Overall Study|Lack of Efficacy|7
5947396|NCT01290263|20569342|P2|Overall Study|Lack of Efficacy|2
5947397|NCT01290263|20569343|P1|Overall Study|Lack of Efficacy|8
5947398|NCT01290263|20569339|P5|Overall Study|Adverse Event|1
5947399|NCT01290263|20569340|P4|Overall Study|Adverse Event|1
5947400|NCT01290263|20569341|P3|Overall Study|Adverse Event|0
5947401|NCT01290263|20569342|P2|Overall Study|Adverse Event|0
5947402|NCT01290263|20569343|P1|Overall Study|Adverse Event|0
5947403|NCT01290224|20569370|P1|Overall Study|Refused Further Treatment|4
5947404|NCT01290224|20569370|P1|Overall Study|Adverse Event|1
5947405|NCT01290094|20569381|P1|Overall Study|Lost to Follow-up|5
5947406|NCT01290094|20569381|P1|Overall Study|Withdrawal by Subject|1
5947407|NCT01290068|20569394|P2|Overall Study|Other|1
5947408|NCT01290068|20569395|P1|Overall Study|Other|3
5947409|NCT01290068|20569394|P2|Overall Study|Withdrawal by subject prior to implant|2
5947410|NCT01290068|20569395|P1|Overall Study|Withdrawal by subject prior to implant|0
5947411|NCT01290068|20569394|P2|Overall Study|Lost to Follow-up|0
5947412|NCT01290068|20569395|P1|Overall Study|Lost to Follow-up|3
5947413|NCT01290068|20569394|P2|Overall Study|Adverse Event|3
5947414|NCT01290068|20569395|P1|Overall Study|Adverse Event|1
5947415|NCT01290029|20569407|P1|Overall Study|Other|2
5947416|NCT01289990|20569433|P13|Overall Study|Not treated|0
5947417|NCT01289990|20569434|P12|Overall Study|Not treated|2
5947418|NCT01289990|20569435|P11|Overall Study|Not treated|1
5947419|NCT01289990|20569436|P10|Overall Study|Not treated|0
5947420|NCT01289990|20569437|P9|Overall Study|Not treated|1
5947421|NCT01289990|20569438|P8|Overall Study|Not treated|0
5947422|NCT01289990|20569439|P7|Overall Study|Not treated|1
5947423|NCT01289990|20569440|P6|Overall Study|Not treated|0
5947424|NCT01289990|20569441|P5|Overall Study|Not treated|0
5947425|NCT01289990|20569442|P4|Overall Study|Not treated|0
5947426|NCT01289990|20569443|P3|Overall Study|Not treated|0
5947427|NCT01289990|20569444|P2|Overall Study|Not treated|0
5947428|NCT01289990|20569445|P1|Overall Study|Not treated|0
5947429|NCT01289990|20569433|P13|Overall Study|did not continue in extension|56
5947430|NCT01289990|20569434|P12|Overall Study|did not continue in extension|34
5947431|NCT01289990|20569435|P11|Overall Study|did not continue in extension|45
5947432|NCT01289990|20569436|P10|Overall Study|did not continue in extension|48
5947433|NCT01289990|20569437|P9|Overall Study|did not continue in extension|44
5947434|NCT01289990|20569438|P8|Overall Study|did not continue in extension|36
5947435|NCT01289990|20569439|P7|Overall Study|did not continue in extension|54
5947436|NCT01289990|20569440|P6|Overall Study|did not continue in extension|50
5947437|NCT01289990|20569441|P5|Overall Study|did not continue in extension|48
5947438|NCT01289990|20569442|P4|Overall Study|did not continue in extension|51
5947439|NCT01289990|20569443|P3|Overall Study|did not continue in extension|51
5947440|NCT01289990|20569444|P2|Overall Study|did not continue in extension|45
5947441|NCT01289990|20569445|P1|Overall Study|did not continue in extension|41
5947442|NCT01289990|20569433|P13|Overall Study|discontinued in preceding trial|24
5947443|NCT01289990|20569434|P12|Overall Study|discontinued in preceding trial|17
5947444|NCT01289990|20569435|P11|Overall Study|discontinued in preceding trial|17
5947445|NCT01289990|20569436|P10|Overall Study|discontinued in preceding trial|21
5947446|NCT01289990|20569437|P9|Overall Study|discontinued in preceding trial|17
5947447|NCT01289990|20569438|P8|Overall Study|discontinued in preceding trial|8
5947448|NCT01289990|20569439|P7|Overall Study|discontinued in preceding trial|18
5947449|NCT01289990|20569440|P6|Overall Study|discontinued in preceding trial|12
5947450|NCT01289990|20569441|P5|Overall Study|discontinued in preceding trial|11
5947451|NCT01289990|20569442|P4|Overall Study|discontinued in preceding trial|17
5947452|NCT01289990|20569443|P3|Overall Study|discontinued in preceding trial|41
5947453|NCT01289990|20569444|P2|Overall Study|discontinued in preceding trial|20
5947454|NCT01289990|20569445|P1|Overall Study|discontinued in preceding trial|18
5947455|NCT01289990|20569433|P13|Overall Study|Withdrawal by Subject|16
5947456|NCT01289990|20569434|P12|Overall Study|Withdrawal by Subject|13
5947457|NCT01289990|20569435|P11|Overall Study|Withdrawal by Subject|11
5947458|NCT01289990|20569436|P10|Overall Study|Withdrawal by Subject|13
5947459|NCT01289990|20569437|P9|Overall Study|Withdrawal by Subject|12
5947460|NCT01289990|20569438|P8|Overall Study|Withdrawal by Subject|9
5947461|NCT01289990|20569439|P7|Overall Study|Withdrawal by Subject|13
5947462|NCT01289990|20569440|P6|Overall Study|Withdrawal by Subject|7
5947463|NCT01289990|20569441|P5|Overall Study|Withdrawal by Subject|8
5947464|NCT01289990|20569442|P4|Overall Study|Withdrawal by Subject|13
5947465|NCT01289990|20569443|P3|Overall Study|Withdrawal by Subject|12
5947466|NCT01289990|20569444|P2|Overall Study|Withdrawal by Subject|14
5947467|NCT01289990|20569445|P1|Overall Study|Withdrawal by Subject|15
5947468|NCT01289990|20569433|P13|Overall Study|Lost to Follow-up|2
5947469|NCT01289990|20569434|P12|Overall Study|Lost to Follow-up|1
5947470|NCT01289990|20569435|P11|Overall Study|Lost to Follow-up|2
5947471|NCT01289990|20569436|P10|Overall Study|Lost to Follow-up|4
5947472|NCT01289990|20569437|P9|Overall Study|Lost to Follow-up|1
5947473|NCT01289990|20569438|P8|Overall Study|Lost to Follow-up|2
5947474|NCT01289990|20569439|P7|Overall Study|Lost to Follow-up|2
5947475|NCT01289990|20569440|P6|Overall Study|Lost to Follow-up|4
5947476|NCT01289990|20569441|P5|Overall Study|Lost to Follow-up|3
5947477|NCT01289990|20569442|P4|Overall Study|Lost to Follow-up|5
5947478|NCT01289990|20569443|P3|Overall Study|Lost to Follow-up|5
5947479|NCT01289990|20569444|P2|Overall Study|Lost to Follow-up|2
5947480|NCT01289990|20569445|P1|Overall Study|Lost to Follow-up|3
5947481|NCT01289990|20569433|P13|Overall Study|Death|0
5947482|NCT01289990|20569434|P12|Overall Study|Death|1
5947483|NCT01289990|20569435|P11|Overall Study|Death|0
5947484|NCT01289990|20569436|P10|Overall Study|Death|0
5947485|NCT01289990|20569437|P9|Overall Study|Death|0
5947486|NCT01289990|20569438|P8|Overall Study|Death|0
5947487|NCT01289990|20569439|P7|Overall Study|Death|0
5947488|NCT01289990|20569440|P6|Overall Study|Death|1
5947489|NCT01289990|20569441|P5|Overall Study|Death|2
5947490|NCT01289990|20569442|P4|Overall Study|Death|1
5947491|NCT01289990|20569443|P3|Overall Study|Death|0
5947492|NCT01289990|20569444|P2|Overall Study|Death|0
5947493|NCT01289990|20569445|P1|Overall Study|Death|0
5947494|NCT01289847|20569662|P1|Overall Study|Patient could not comply with visits|1
5947495|NCT01289821|20569671|P1|Survival Follow-up Period|Clinical endpoint reached|16
5947496|NCT01289821|20569671|P1|Survival Follow-up Period|Lost to Follow-up|1
5947497|NCT01289821|20569671|P1|Survival Follow-up Period|Protocol Violation|1
5947498|NCT01289821|20569671|P1|Safety Follow-up Period|Unspecified reason|1
5947499|NCT01289821|20569671|P1|Safety Follow-up Period|Protocol Violation|3
5947500|NCT01289821|20569671|P1|Safety Follow-up Period|Withdrawal by Subject|1
5947501|NCT01289821|20569671|P1|Treatment Period|Therapeutic procedure required|1
5947502|NCT01289821|20569671|P1|Treatment Period|Clinical Progression|2
5947503|NCT01289821|20569671|P1|Treatment Period|Radiological Progression|43
5947504|NCT01289821|20569671|P1|Treatment Period|Adverse Event|4
5947505|NCT01289821|20569671|P1|Treatment Period|Physician Decision|3
5947506|NCT01289821|20569671|P1|Treatment Period|Withdrawal by Subject|1
5947507|NCT01289782|20569682|P2|Overall Study|Reason not specified|2
5947508|NCT01289782|20569683|P1|Overall Study|Reason not specified|1
5947509|NCT01289782|20569682|P2|Overall Study|Sponsor's Decision|0
5947510|NCT01289782|20569683|P1|Overall Study|Sponsor's Decision|1
5947511|NCT01289782|20569682|P2|Overall Study|Withdrawal by Subject|2
5947512|NCT01289782|20569683|P1|Overall Study|Withdrawal by Subject|8
5947513|NCT01289782|20569682|P2|Overall Study|Protocol Violation|1
5947514|NCT01289782|20569683|P1|Overall Study|Protocol Violation|1
5947515|NCT01289782|20569682|P2|Overall Study|Lost to Follow-up|7
5947516|NCT01289782|20569683|P1|Overall Study|Lost to Follow-up|14
5947517|NCT01289678|20569752|P1|Overall Study|Physician Decision|6
5947518|NCT01289639|20569768|P3|Overall Study|Lost to Follow-up|0
5947519|NCT01289639|20569769|P2|Overall Study|Lost to Follow-up|0
5947520|NCT01289639|20569770|P1|Overall Study|Lost to Follow-up|1
5947521|NCT01289574|20569796|P3|Overall Study|Subject wanted alternate treatment|0
5947522|NCT01289574|20569797|P2|Overall Study|Subject wanted alternate treatment|1
5947523|NCT01289574|20569798|P1|Overall Study|Subject wanted alternate treatment|0
5947524|NCT01289574|20569796|P3|Overall Study|Adverse Event|0
5947525|NCT01289574|20569797|P2|Overall Study|Adverse Event|1
5947526|NCT01289574|20569798|P1|Overall Study|Adverse Event|0
5947527|NCT01289574|20569796|P3|Overall Study|Withdrawal by Subject|1
5947528|NCT01289574|20569797|P2|Overall Study|Withdrawal by Subject|1
5947529|NCT01289574|20569798|P1|Overall Study|Withdrawal by Subject|1
5947530|NCT01289574|20569796|P3|Overall Study|Lost to Follow-up|1
5947531|NCT01289574|20569797|P2|Overall Study|Lost to Follow-up|0
5947532|NCT01289574|20569798|P1|Overall Study|Lost to Follow-up|2
5947533|NCT01289574|20569796|P3|Overall Study|Lack of Efficacy|1
5947534|NCT01289574|20569797|P2|Overall Study|Lack of Efficacy|0
5947535|NCT01289574|20569798|P1|Overall Study|Lack of Efficacy|4
5947536|NCT01289418|20569942|P1|Day 29 Survey|participants did not complete the survey|2185
5947537|NCT01289418|20569942|P1|Day 29 Survey|email address invalid|283
5947538|NCT01289418|20569942|P1|Day 8 Survey|participants did not complete the survey|1935
5947539|NCT01289418|20569942|P1|Day 8 Survey|email address invalid|283
5947540|NCT01289353|20569961|P1|Overall Study|Lost to Follow-up|2
5947541|NCT01289210|20569996|P1|Overall Study|Adverse Event|1
5947542|NCT01289119|20570006|P6|Overall Study|Other|0
5947543|NCT01289119|20570007|P5|Overall Study|Other|0
5947544|NCT01289119|20570008|P4|Overall Study|Other|0
5947545|NCT01289119|20570009|P3|Overall Study|Other|1
5947546|NCT01289119|20570010|P2|Overall Study|Other|0
5947547|NCT01289119|20570011|P1|Overall Study|Other|1
5947548|NCT01289119|20570006|P6|Overall Study|Lack of Efficacy|1
5947549|NCT01289119|20570007|P5|Overall Study|Lack of Efficacy|1
5947550|NCT01289119|20570008|P4|Overall Study|Lack of Efficacy|1
5947551|NCT01289119|20570009|P3|Overall Study|Lack of Efficacy|1
5947552|NCT01289119|20570010|P2|Overall Study|Lack of Efficacy|1
5947553|NCT01289119|20570011|P1|Overall Study|Lack of Efficacy|0
5947554|NCT01289119|20570006|P6|Overall Study|Pregnancy|0
5947555|NCT01289119|20570007|P5|Overall Study|Pregnancy|0
5947556|NCT01289119|20570008|P4|Overall Study|Pregnancy|0
5947557|NCT01289119|20570009|P3|Overall Study|Pregnancy|0
5947558|NCT01289119|20570010|P2|Overall Study|Pregnancy|1
5947559|NCT01289119|20570011|P1|Overall Study|Pregnancy|0
5947560|NCT01289119|20570006|P6|Overall Study|Withdrawal by Subject|1
5947561|NCT01289119|20570007|P5|Overall Study|Withdrawal by Subject|1
5947562|NCT01289119|20570008|P4|Overall Study|Withdrawal by Subject|3
5947563|NCT01289119|20570009|P3|Overall Study|Withdrawal by Subject|4
5947564|NCT01289119|20570010|P2|Overall Study|Withdrawal by Subject|2
5947565|NCT01289119|20570011|P1|Overall Study|Withdrawal by Subject|4
5947566|NCT01289119|20570006|P6|Overall Study|Lost to Follow-up|1
5947567|NCT01289119|20570007|P5|Overall Study|Lost to Follow-up|0
5947568|NCT01289119|20570008|P4|Overall Study|Lost to Follow-up|0
5947569|NCT01289119|20570009|P3|Overall Study|Lost to Follow-up|0
5947570|NCT01289119|20570010|P2|Overall Study|Lost to Follow-up|3
5947571|NCT01289119|20570011|P1|Overall Study|Lost to Follow-up|0
5947572|NCT01289119|20570006|P6|Overall Study|Major Protocol Deviation|1
5947573|NCT01289119|20570007|P5|Overall Study|Major Protocol Deviation|2
5947574|NCT01289119|20570008|P4|Overall Study|Major Protocol Deviation|0
5947575|NCT01289119|20570009|P3|Overall Study|Major Protocol Deviation|3
5947576|NCT01289119|20570010|P2|Overall Study|Major Protocol Deviation|1
5947577|NCT01289119|20570011|P1|Overall Study|Major Protocol Deviation|2
5947578|NCT01289119|20570006|P6|Overall Study|Adverse Event|0
5947579|NCT01289119|20570007|P5|Overall Study|Adverse Event|1
5947580|NCT01289119|20570008|P4|Overall Study|Adverse Event|2
5947581|NCT01289119|20570009|P3|Overall Study|Adverse Event|0
5947582|NCT01289119|20570010|P2|Overall Study|Adverse Event|1
5947583|NCT01289119|20570011|P1|Overall Study|Adverse Event|2
5947584|NCT01289041|20570132|P1|Overall Study|Death|1
5947585|NCT01289041|20570132|P1|Overall Study|Withdrawal by Subject|3
5947586|NCT01289041|20570132|P1|Overall Study|Progressive Disease|41
5947587|NCT01289041|20570132|P1|Overall Study|Physician Decision|1
5947588|NCT01289041|20570132|P1|Overall Study|Adverse Event|24
5947589|NCT01289028|20570144|P1|Overall Study|Missing reason for discon|1
5947590|NCT01289028|20570144|P1|Overall Study|Abnormal Lab Value|1
5947591|NCT01289028|20570144|P1|Overall Study|New Cancer Therapy|2
5947592|NCT01289028|20570144|P1|Overall Study|Lost to Follow-up|2
5947593|NCT01289028|20570144|P1|Overall Study|No longer required|2
5947594|NCT01289028|20570144|P1|Overall Study|Lack of Efficacy|2
5947595|NCT01289028|20570144|P1|Overall Study|Death|4
5947596|NCT01289028|20570144|P1|Overall Study|Withdrawal by Subject|6
5947597|NCT01289028|20570144|P1|Overall Study|Adverse Event|14
5947598|NCT01289028|20570144|P1|Overall Study|Progressive Disease|49
5947599|NCT01289015|20570158|P2|Overall Study|Negative baseline culture and others|20
5947600|NCT01289015|20570159|P1|Overall Study|Negative baseline culture and others|33
5947601|NCT01289015|20570158|P2|Overall Study|Disease progression|0
5947602|NCT01289015|20570159|P1|Overall Study|Disease progression|1
5947603|NCT01289015|20570158|P2|Overall Study|Withdrawal by Subject|8
5947604|NCT01289015|20570159|P1|Overall Study|Withdrawal by Subject|17
5947605|NCT01289015|20570158|P2|Overall Study|Lost to Follow-up|17
5947606|NCT01289015|20570159|P1|Overall Study|Lost to Follow-up|33
5947607|NCT01289015|20570158|P2|Overall Study|Adverse Event|0
5947608|NCT01289015|20570159|P1|Overall Study|Adverse Event|3
5947609|NCT01289015|20570158|P2|Overall Study|Protocol Violation|9
5947610|NCT01289015|20570159|P1|Overall Study|Protocol Violation|12
5947611|NCT01288989|20570172|P5|Overall Study|Withdrawal by Subject|3
5947612|NCT01288989|20570173|P4|Overall Study|Withdrawal by Subject|0
5947613|NCT01288989|20570174|P3|Overall Study|Withdrawal by Subject|0
5947614|NCT01288989|20570175|P2|Overall Study|Withdrawal by Subject|0
5947615|NCT01288989|20570176|P1|Overall Study|Withdrawal by Subject|0
5947616|NCT01288989|20570172|P5|Overall Study|Physician Decision|1
5947617|NCT01288989|20570173|P4|Overall Study|Physician Decision|0
5947618|NCT01288989|20570174|P3|Overall Study|Physician Decision|0
5947619|NCT01288989|20570175|P2|Overall Study|Physician Decision|0
5947620|NCT01288989|20570176|P1|Overall Study|Physician Decision|0
5947621|NCT01288989|20570172|P5|Overall Study|Adverse Event|2
5947622|NCT01288989|20570173|P4|Overall Study|Adverse Event|0
5947623|NCT01288989|20570174|P3|Overall Study|Adverse Event|0
5947624|NCT01288989|20570175|P2|Overall Study|Adverse Event|0
5947625|NCT01288989|20570176|P1|Overall Study|Adverse Event|0
5947626|NCT01288989|20570172|P5|Overall Study|Dose limiting toxicity|0
5947627|NCT01288989|20570173|P4|Overall Study|Dose limiting toxicity|0
5947628|NCT01288989|20570174|P3|Overall Study|Dose limiting toxicity|0
5947629|NCT01288989|20570175|P2|Overall Study|Dose limiting toxicity|0
5947630|NCT01288989|20570176|P1|Overall Study|Dose limiting toxicity|1
5947631|NCT01288989|20570172|P5|Overall Study|Death|0
5947632|NCT01288989|20570173|P4|Overall Study|Death|1
5947633|NCT01288989|20570174|P3|Overall Study|Death|0
5947634|NCT01288989|20570175|P2|Overall Study|Death|0
5947635|NCT01288989|20570176|P1|Overall Study|Death|0
5947636|NCT01288976|20570237|P3|Overall Study|Data unavailable|7
5947637|NCT01288976|20570238|P2|Overall Study|Data unavailable|9
5947638|NCT01288976|20570239|P1|Overall Study|Data unavailable|22
5947639|NCT01288976|20570237|P3|Overall Study|Death|4
5947640|NCT01288976|20570238|P2|Overall Study|Death|6
5947641|NCT01288976|20570239|P1|Overall Study|Death|98
5947642|NCT01288976|20570237|P3|Overall Study|Withdrawal by Subject|9
5947643|NCT01288976|20570238|P2|Overall Study|Withdrawal by Subject|12
5947644|NCT01288976|20570239|P1|Overall Study|Withdrawal by Subject|58
5947645|NCT01288937|20570268|P2|Overall Study|Adverse Event|0
5947646|NCT01288937|20570269|P1|Overall Study|Adverse Event|1
5947647|NCT01288911|20570277|P2|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|5
5947648|NCT01288911|20570278|P1|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|17
5947649|NCT01288911|20570277|P2|Open-label Period (All Enzalutamide)|Miscellaneous Reason|0
5947650|NCT01288911|20570278|P1|Open-label Period (All Enzalutamide)|Miscellaneous Reason|5
5947651|NCT01288911|20570277|P2|Open-label Period (All Enzalutamide)|Withdrawal by Subject|0
5947652|NCT01288911|20570278|P1|Open-label Period (All Enzalutamide)|Withdrawal by Subject|1
5947653|NCT01288911|20570277|P2|Open-label Period (All Enzalutamide)|Progressive disease|3
5947654|NCT01288911|20570278|P1|Open-label Period (All Enzalutamide)|Progressive disease|18
5947655|NCT01288911|20570277|P2|Open-label Period (All Enzalutamide)|Lost to Follow-up|0
5947656|NCT01288911|20570278|P1|Open-label Period (All Enzalutamide)|Lost to Follow-up|1
5947657|NCT01288911|20570277|P2|Open-label Period (All Enzalutamide)|Death|1
5947658|NCT01288911|20570278|P1|Open-label Period (All Enzalutamide)|Death|0
5947659|NCT01288911|20570277|P2|Double-blind Period|Randomized but never received study drug|2
5947660|NCT01288911|20570278|P1|Double-blind Period|Randomized but never received study drug|1
5947661|NCT01288911|20570277|P2|Double-blind Period|Miscellaneous Reason|42
5947662|NCT01288911|20570278|P1|Double-blind Period|Miscellaneous Reason|29
5947663|NCT01288911|20570277|P2|Double-blind Period|Withdrawal by Subject|26
5947664|NCT01288911|20570278|P1|Double-blind Period|Withdrawal by Subject|25
5947665|NCT01288911|20570277|P2|Double-blind Period|Protocol Violation|0
5947666|NCT01288911|20570278|P1|Double-blind Period|Protocol Violation|1
5947667|NCT01288911|20570277|P2|Double-blind Period|Progressive Disease|103
5947668|NCT01288911|20570278|P1|Double-blind Period|Progressive Disease|75
5947669|NCT01288911|20570277|P2|Double-blind Period|Lost to Follow-up|2
5947670|NCT01288911|20570278|P1|Double-blind Period|Lost to Follow-up|0
5947671|NCT01288911|20570277|P2|Double-blind Period|Death|7
5947672|NCT01288911|20570278|P1|Double-blind Period|Death|11
5947673|NCT01288729|20570388|P2|Overall Study|Withdrawal by Subject|0
5947674|NCT01288729|20570389|P1|Overall Study|Withdrawal by Subject|1
5947675|NCT01288612|20570398|P3|Overall Study|Unable to intubate|0
5947676|NCT01288612|20570399|P2|Overall Study|Unable to intubate|3
5947677|NCT01288612|20570400|P1|Overall Study|Unable to intubate|0
5947678|NCT01288612|20570398|P3|Overall Study|Declined|62
5947679|NCT01288612|20570399|P2|Overall Study|Declined|63
5947680|NCT01288612|20570400|P1|Overall Study|Declined|78
5947681|NCT01288612|20570398|P3|Overall Study|Unable to contact|20
5947682|NCT01288612|20570399|P2|Overall Study|Unable to contact|16
5947683|NCT01288612|20570400|P1|Overall Study|Unable to contact|11
5947684|NCT01288469|20570449|P3|Overall Study|Exclusion criteria finally met|0
5947685|NCT01288469|20570450|P2|Overall Study|Exclusion criteria finally met|0
5947686|NCT01288469|20570451|P1|Overall Study|Exclusion criteria finally met|1
5947687|NCT01288469|20570449|P3|Overall Study|Consent withdrawn by subject|1
5947688|NCT01288469|20570450|P2|Overall Study|Consent withdrawn by subject|1
5947689|NCT01288469|20570451|P1|Overall Study|Consent withdrawn by subject|1
5947690|NCT01288469|20570449|P3|Overall Study|Participant Moved|0
5947691|NCT01288469|20570450|P2|Overall Study|Participant Moved|0
5947692|NCT01288469|20570451|P1|Overall Study|Participant Moved|1
5947693|NCT01288469|20570449|P3|Overall Study|Poor compliance to protocol|0
5947694|NCT01288469|20570450|P2|Overall Study|Poor compliance to protocol|1
5947695|NCT01288469|20570451|P1|Overall Study|Poor compliance to protocol|0
5947696|NCT01288469|20570449|P3|Overall Study|Adverse Event|1
5947697|NCT01288469|20570450|P2|Overall Study|Adverse Event|1
5947698|NCT01288469|20570451|P1|Overall Study|Adverse Event|4
5947699|NCT01288443|20570483|P6|Overall Study|Other than above|0
5947700|NCT01288443|20570484|P5|Overall Study|Other than above|1
5947701|NCT01288443|20570485|P4|Overall Study|Other than above|2
5947702|NCT01288443|20570486|P3|Overall Study|Other than above|0
5947703|NCT01288443|20570487|P2|Overall Study|Other than above|0
5947704|NCT01288443|20570488|P1|Overall Study|Other than above|0
5947705|NCT01288443|20570483|P6|Overall Study|Study drug auto-injector administration|1
5947706|NCT01288443|20570484|P5|Overall Study|Study drug auto-injector administration|1
5947707|NCT01288443|20570485|P4|Overall Study|Study drug auto-injector administration|0
5947708|NCT01288443|20570486|P3|Overall Study|Study drug auto-injector administration|0
5947709|NCT01288443|20570487|P2|Overall Study|Study drug auto-injector administration|0
5947710|NCT01288443|20570488|P1|Overall Study|Study drug auto-injector administration|0
5947711|NCT01288443|20570483|P6|Overall Study|Lost to Follow-up|0
5947712|NCT01288443|20570484|P5|Overall Study|Lost to Follow-up|0
5947713|NCT01288443|20570485|P4|Overall Study|Lost to Follow-up|0
5947714|NCT01288443|20570486|P3|Overall Study|Lost to Follow-up|0
5947715|NCT01288443|20570487|P2|Overall Study|Lost to Follow-up|1
5947716|NCT01288443|20570488|P1|Overall Study|Lost to Follow-up|0
5947717|NCT01288443|20570483|P6|Overall Study|Consent withdrawn by Participant|1
5947718|NCT01288443|20570484|P5|Overall Study|Consent withdrawn by Participant|0
5947719|NCT01288443|20570485|P4|Overall Study|Consent withdrawn by Participant|0
5947720|NCT01288443|20570486|P3|Overall Study|Consent withdrawn by Participant|0
5947721|NCT01288443|20570487|P2|Overall Study|Consent withdrawn by Participant|0
5947722|NCT01288443|20570488|P1|Overall Study|Consent withdrawn by Participant|0
5947723|NCT01288443|20570483|P6|Overall Study|Participant Moved|1
5947724|NCT01288443|20570484|P5|Overall Study|Participant Moved|2
5947725|NCT01288443|20570485|P4|Overall Study|Participant Moved|1
5947726|NCT01288443|20570486|P3|Overall Study|Participant Moved|0
5947727|NCT01288443|20570487|P2|Overall Study|Participant Moved|0
5947728|NCT01288443|20570488|P1|Overall Study|Participant Moved|0
5947729|NCT01288443|20570483|P6|Overall Study|Poor compliance to protocol|1
5947730|NCT01288443|20570484|P5|Overall Study|Poor compliance to protocol|0
5947731|NCT01288443|20570485|P4|Overall Study|Poor compliance to protocol|0
5947732|NCT01288443|20570486|P3|Overall Study|Poor compliance to protocol|0
5947733|NCT01288443|20570487|P2|Overall Study|Poor compliance to protocol|0
5947734|NCT01288443|20570488|P1|Overall Study|Poor compliance to protocol|0
5947735|NCT01288443|20570483|P6|Overall Study|Adverse Event|1
5947736|NCT01288443|20570484|P5|Overall Study|Adverse Event|3
5947737|NCT01288443|20570485|P4|Overall Study|Adverse Event|1
5947738|NCT01288443|20570486|P3|Overall Study|Adverse Event|1
5947739|NCT01288443|20570487|P2|Overall Study|Adverse Event|0
5947740|NCT01288443|20570488|P1|Overall Study|Adverse Event|0
5947741|NCT01288430|20570548|P10|Part 2|Other|1
5947742|NCT01288430|20570549|P9|Part 2|Other|0
5947743|NCT01288430|20570550|P8|Part 2|Other|0
5947744|NCT01288430|20570551|P7|Part 2|Other|0
5947745|NCT01288430|20570552|P6|Part 2|Other|0
5947746|NCT01288430|20570553|P5|Part 2|Other|0
5947747|NCT01288430|20570554|P4|Part 2|Other|0
5947748|NCT01288430|20570555|P3|Part 2|Other|0
5947749|NCT01288430|20570556|P2|Part 2|Other|0
5947750|NCT01288430|20570557|P1|Part 2|Other|0
5947751|NCT01288430|20570548|P10|Part 2|Adverse Event|0
5947752|NCT01288430|20570549|P9|Part 2|Adverse Event|1
5947753|NCT01288430|20570550|P8|Part 2|Adverse Event|1
5947754|NCT01288430|20570551|P7|Part 2|Adverse Event|0
5947755|NCT01288430|20570552|P6|Part 2|Adverse Event|0
5947756|NCT01288430|20570553|P5|Part 2|Adverse Event|0
5947757|NCT01288430|20570554|P4|Part 2|Adverse Event|0
5947758|NCT01288430|20570555|P3|Part 2|Adverse Event|0
5947759|NCT01288430|20570556|P2|Part 2|Adverse Event|0
5947760|NCT01288430|20570557|P1|Part 2|Adverse Event|0
5947761|NCT01288430|20570548|P10|Part 2|Withdrawal by Subject|0
5947762|NCT01288430|20570549|P9|Part 2|Withdrawal by Subject|4
5947763|NCT01288430|20570550|P8|Part 2|Withdrawal by Subject|1
5947764|NCT01288430|20570551|P7|Part 2|Withdrawal by Subject|0
5947765|NCT01288430|20570552|P6|Part 2|Withdrawal by Subject|0
5947766|NCT01288430|20570553|P5|Part 2|Withdrawal by Subject|0
5947767|NCT01288430|20570554|P4|Part 2|Withdrawal by Subject|0
5947768|NCT01288430|20570555|P3|Part 2|Withdrawal by Subject|0
5947769|NCT01288430|20570556|P2|Part 2|Withdrawal by Subject|0
5947770|NCT01288430|20570557|P1|Part 2|Withdrawal by Subject|0
5947771|NCT01288430|20570548|P10|Part 2|Clinical disease progression|0
5947772|NCT01288430|20570549|P9|Part 2|Clinical disease progression|0
5947773|NCT01288430|20570550|P8|Part 2|Clinical disease progression|2
5947774|NCT01288430|20570551|P7|Part 2|Clinical disease progression|0
5947775|NCT01288430|20570552|P6|Part 2|Clinical disease progression|0
5947776|NCT01288430|20570553|P5|Part 2|Clinical disease progression|0
5947777|NCT01288430|20570554|P4|Part 2|Clinical disease progression|0
5947778|NCT01288430|20570555|P3|Part 2|Clinical disease progression|0
5947779|NCT01288430|20570556|P2|Part 2|Clinical disease progression|0
5947780|NCT01288430|20570557|P1|Part 2|Clinical disease progression|0
5947781|NCT01288430|20570548|P10|Part 2|Progressive disease|2
5947782|NCT01288430|20570549|P9|Part 2|Progressive disease|7
5947783|NCT01288430|20570550|P8|Part 2|Progressive disease|8
5947784|NCT01288430|20570551|P7|Part 2|Progressive disease|0
5947785|NCT01288430|20570552|P6|Part 2|Progressive disease|0
5947786|NCT01288430|20570553|P5|Part 2|Progressive disease|0
5947787|NCT01288430|20570554|P4|Part 2|Progressive disease|0
5947788|NCT01288430|20570555|P3|Part 2|Progressive disease|0
5947789|NCT01288430|20570556|P2|Part 2|Progressive disease|0
5947790|NCT01288430|20570557|P1|Part 2|Progressive disease|0
5947791|NCT01288430|20570548|P10|Part 1|Other|0
5947792|NCT01288430|20570549|P9|Part 1|Other|0
5947793|NCT01288430|20570550|P8|Part 1|Other|0
5947794|NCT01288430|20570551|P7|Part 1|Other|1
5947795|NCT01288430|20570552|P6|Part 1|Other|0
5947796|NCT01288430|20570553|P5|Part 1|Other|0
5947797|NCT01288430|20570554|P4|Part 1|Other|0
5947798|NCT01288430|20570555|P3|Part 1|Other|0
5947799|NCT01288430|20570556|P2|Part 1|Other|2
5947800|NCT01288430|20570557|P1|Part 1|Other|0
5947801|NCT01288430|20570548|P10|Part 1|Adverse Event|0
5947802|NCT01288430|20570549|P9|Part 1|Adverse Event|0
5947803|NCT01288430|20570550|P8|Part 1|Adverse Event|0
5947804|NCT01288430|20570551|P7|Part 1|Adverse Event|2
5947805|NCT01288430|20570552|P6|Part 1|Adverse Event|0
5947806|NCT01288430|20570553|P5|Part 1|Adverse Event|0
5947807|NCT01288430|20570554|P4|Part 1|Adverse Event|1
5947808|NCT01288430|20570555|P3|Part 1|Adverse Event|3
5947809|NCT01288430|20570556|P2|Part 1|Adverse Event|0
5947810|NCT01288430|20570557|P1|Part 1|Adverse Event|0
5947811|NCT01288430|20570548|P10|Part 1|Death due to disease progression|0
5947812|NCT01288430|20570549|P9|Part 1|Death due to disease progression|0
5947813|NCT01288430|20570550|P8|Part 1|Death due to disease progression|0
5947814|NCT01288430|20570551|P7|Part 1|Death due to disease progression|0
5947815|NCT01288430|20570552|P6|Part 1|Death due to disease progression|0
5947816|NCT01288430|20570553|P5|Part 1|Death due to disease progression|1
5947817|NCT01288430|20570554|P4|Part 1|Death due to disease progression|0
5947818|NCT01288430|20570555|P3|Part 1|Death due to disease progression|0
5947819|NCT01288430|20570556|P2|Part 1|Death due to disease progression|0
5947820|NCT01288430|20570557|P1|Part 1|Death due to disease progression|0
5947821|NCT01288430|20570548|P10|Part 1|Clinical disease progression|0
5947822|NCT01288430|20570549|P9|Part 1|Clinical disease progression|0
5947823|NCT01288430|20570550|P8|Part 1|Clinical disease progression|0
5947824|NCT01288430|20570551|P7|Part 1|Clinical disease progression|2
5947825|NCT01288430|20570552|P6|Part 1|Clinical disease progression|2
5947826|NCT01288430|20570553|P5|Part 1|Clinical disease progression|0
5947827|NCT01288430|20570554|P4|Part 1|Clinical disease progression|0
5947828|NCT01288430|20570555|P3|Part 1|Clinical disease progression|1
5947829|NCT01288430|20570556|P2|Part 1|Clinical disease progression|0
5947830|NCT01288430|20570557|P1|Part 1|Clinical disease progression|0
5947831|NCT01288430|20570548|P10|Part 1|Progressive disease|0
5947832|NCT01288430|20570549|P9|Part 1|Progressive disease|0
5947833|NCT01288430|20570550|P8|Part 1|Progressive disease|0
5947834|NCT01288430|20570551|P7|Part 1|Progressive disease|2
5947835|NCT01288430|20570552|P6|Part 1|Progressive disease|4
5947836|NCT01288430|20570553|P5|Part 1|Progressive disease|2
5947837|NCT01288430|20570554|P4|Part 1|Progressive disease|6
5947838|NCT01288430|20570555|P3|Part 1|Progressive disease|1
5947839|NCT01288430|20570556|P2|Part 1|Progressive disease|1
5947840|NCT01288430|20570557|P1|Part 1|Progressive disease|2
5947841|NCT01288287|20570681|P1|Overall Study|Unknown Status|7
5947842|NCT01288287|20570681|P1|Overall Study|Unknown Reason|1
5947843|NCT01288287|20570681|P1|Overall Study|Other Reason|13
5947844|NCT01288287|20570681|P1|Overall Study|Lack of Efficacy|13
5947845|NCT01288287|20570681|P1|Overall Study|Withdrawal by Subject|4
5947846|NCT01288287|20570681|P1|Overall Study|Lost to Follow-up|8
5947847|NCT01288209|20570696|P2|Overall Study|Other|0
5947848|NCT01288209|20570697|P1|Overall Study|Other|1
5947849|NCT01288209|20570696|P2|Overall Study|Withdrawal by Subject|3
5947850|NCT01288209|20570697|P1|Overall Study|Withdrawal by Subject|1
5947851|NCT01288079|20570727|P4|Overall Study|Other or Study Termination|8
5947852|NCT01288079|20570728|P3|Overall Study|Other or Study Termination|14
5947853|NCT01288079|20570729|P2|Overall Study|Other or Study Termination|15
5947854|NCT01288079|20570730|P1|Overall Study|Other or Study Termination|11
5947855|NCT01288079|20570727|P4|Overall Study|Lost to Follow-up|0
5947856|NCT01288079|20570728|P3|Overall Study|Lost to Follow-up|1
5947857|NCT01288079|20570729|P2|Overall Study|Lost to Follow-up|1
5947858|NCT01288079|20570730|P1|Overall Study|Lost to Follow-up|1
5947859|NCT01288079|20570727|P4|Overall Study|Study-Specific Withdrawal Criteria|0
5947860|NCT01288079|20570728|P3|Overall Study|Study-Specific Withdrawal Criteria|0
5947861|NCT01288079|20570729|P2|Overall Study|Study-Specific Withdrawal Criteria|1
5947862|NCT01288079|20570730|P1|Overall Study|Study-Specific Withdrawal Criteria|1
5947863|NCT01288079|20570727|P4|Overall Study|Lack of Efficacy|2
5947864|NCT01288079|20570728|P3|Overall Study|Lack of Efficacy|0
5947865|NCT01288079|20570729|P2|Overall Study|Lack of Efficacy|2
5947866|NCT01288079|20570730|P1|Overall Study|Lack of Efficacy|2
5947867|NCT01288079|20570727|P4|Overall Study|Condition under Investigation Worsened|1
5947868|NCT01288079|20570728|P3|Overall Study|Condition under Investigation Worsened|0
5947869|NCT01288079|20570729|P2|Overall Study|Condition under Investigation Worsened|0
5947870|NCT01288079|20570730|P1|Overall Study|Condition under Investigation Worsened|0
5947871|NCT01288079|20570727|P4|Overall Study|Severe Non-Compliance to Protocol|3
5947872|NCT01288079|20570728|P3|Overall Study|Severe Non-Compliance to Protocol|1
5947873|NCT01288079|20570729|P2|Overall Study|Severe Non-Compliance to Protocol|3
5947874|NCT01288079|20570730|P1|Overall Study|Severe Non-Compliance to Protocol|1
5947875|NCT01288079|20570727|P4|Overall Study|Adverse Event|3
5947876|NCT01288079|20570728|P3|Overall Study|Adverse Event|2
5947877|NCT01288079|20570729|P2|Overall Study|Adverse Event|1
5947878|NCT01288079|20570730|P1|Overall Study|Adverse Event|2
5947879|NCT01288079|20570727|P4|Overall Study|Withdrawal by Subject|0
5947880|NCT01288079|20570728|P3|Overall Study|Withdrawal by Subject|1
5947881|NCT01288079|20570729|P2|Overall Study|Withdrawal by Subject|4
5947882|NCT01288079|20570730|P1|Overall Study|Withdrawal by Subject|2
5947883|NCT01288053|20570740|P1|Overall Study|Death|1
5947884|NCT01287897|20570758|P4|Overall Study|Other|0
5947885|NCT01287897|20570759|P3|Overall Study|Other|1
5947886|NCT01287897|20570760|P2|Overall Study|Other|0
5947887|NCT01287897|20570761|P1|Overall Study|Other|1
5947888|NCT01287897|20570758|P4|Overall Study|Not meeting entrance criteria|0
5947889|NCT01287897|20570759|P3|Overall Study|Not meeting entrance criteria|0
5947890|NCT01287897|20570760|P2|Overall Study|Not meeting entrance criteria|1
5947891|NCT01287897|20570761|P1|Overall Study|Not meeting entrance criteria|1
5947892|NCT01287897|20570758|P4|Overall Study|Not consented properly|0
5947893|NCT01287897|20570759|P3|Overall Study|Not consented properly|0
5947894|NCT01287897|20570760|P2|Overall Study|Not consented properly|1
5947895|NCT01287897|20570761|P1|Overall Study|Not consented properly|0
5947896|NCT01287897|20570758|P4|Overall Study|Withdrawal by Subject|2
5947897|NCT01287897|20570759|P3|Overall Study|Withdrawal by Subject|3
5947898|NCT01287897|20570760|P2|Overall Study|Withdrawal by Subject|5
5947899|NCT01287897|20570761|P1|Overall Study|Withdrawal by Subject|1
5947900|NCT01287897|20570758|P4|Overall Study|Lost to Follow-up|0
5947901|NCT01287897|20570759|P3|Overall Study|Lost to Follow-up|2
5947902|NCT01287897|20570760|P2|Overall Study|Lost to Follow-up|0
5947903|NCT01287897|20570761|P1|Overall Study|Lost to Follow-up|0
5947904|NCT01287897|20570758|P4|Overall Study|Protocol Violation|1
5947905|NCT01287897|20570759|P3|Overall Study|Protocol Violation|0
5947906|NCT01287897|20570760|P2|Overall Study|Protocol Violation|1
5947907|NCT01287897|20570761|P1|Overall Study|Protocol Violation|1
5947908|NCT01287897|20570758|P4|Overall Study|Lack of Efficacy|0
5947909|NCT01287897|20570759|P3|Overall Study|Lack of Efficacy|0
5947910|NCT01287897|20570760|P2|Overall Study|Lack of Efficacy|0
5947911|NCT01287897|20570761|P1|Overall Study|Lack of Efficacy|2
5947912|NCT01287897|20570758|P4|Overall Study|Adverse Event|4
5947913|NCT01287897|20570759|P3|Overall Study|Adverse Event|6
5947914|NCT01287897|20570760|P2|Overall Study|Adverse Event|3
5947915|NCT01287897|20570761|P1|Overall Study|Adverse Event|5
5947916|NCT01287832|20570812|P2|Overall Study|Death|1
5947917|NCT01287832|20570813|P1|Overall Study|Death|0
5947918|NCT01287832|20570812|P2|Overall Study|Adverse Event|0
5947919|NCT01287832|20570813|P1|Overall Study|Adverse Event|1
5947920|NCT01287754|20570821|P2|Overall Study|Protocol Violation|3
5947921|NCT01287754|20570822|P1|Overall Study|Protocol Violation|0
5947922|NCT01287754|20570821|P2|Overall Study|Lost to Follow-up|6
5947923|NCT01287754|20570822|P1|Overall Study|Lost to Follow-up|1
5947924|NCT01287754|20570821|P2|Overall Study|Death|12
5947925|NCT01287754|20570822|P1|Overall Study|Death|2
5947926|NCT01287741|20570834|P2|Overall Study|Reason not specified|9
5947927|NCT01287741|20570835|P1|Overall Study|Reason not specified|23
5947928|NCT01287741|20570834|P2|Overall Study|Progressive disease|166
5947929|NCT01287741|20570835|P1|Overall Study|Progressive disease|190
5947930|NCT01287741|20570834|P2|Overall Study|Study terminated by Sponsor|315
5947931|NCT01287741|20570835|P1|Overall Study|Study terminated by Sponsor|307
5947932|NCT01287741|20570834|P2|Overall Study|Adverse Event|6
5947933|NCT01287741|20570835|P1|Overall Study|Adverse Event|4
5947934|NCT01287741|20570834|P2|Overall Study|Death|44
5947935|NCT01287741|20570835|P1|Overall Study|Death|32
5947936|NCT01287741|20570834|P2|Overall Study|Lost to Follow-up|8
5947937|NCT01287741|20570835|P1|Overall Study|Lost to Follow-up|10
5947938|NCT01287741|20570834|P2|Overall Study|Non-compliance|6
5947939|NCT01287741|20570835|P1|Overall Study|Non-compliance|8
5947940|NCT01287741|20570834|P2|Overall Study|Physician Decision|23
5947941|NCT01287741|20570835|P1|Overall Study|Physician Decision|15
5947942|NCT01287741|20570834|P2|Overall Study|Protocol Violation|0
5947943|NCT01287741|20570835|P1|Overall Study|Protocol Violation|2
5947944|NCT01287741|20570834|P2|Overall Study|Withdrawal by Subject|38
5947945|NCT01287741|20570835|P1|Overall Study|Withdrawal by Subject|35
5947946|NCT01287611|20570871|P2|Overall Study|Exclusion due to expanded Kerr incision|3
5947947|NCT01287611|20570872|P1|Overall Study|Exclusion due to expanded Kerr incision|4
5947948|NCT01287611|20570871|P2|Overall Study|Lost to Follow-up|16
5947949|NCT01287611|20570872|P1|Overall Study|Lost to Follow-up|29
5947950|NCT01287520|20570889|P9|Overall Study|Withdrawal by Subject|1
5947951|NCT01287520|20570890|P8|Overall Study|Withdrawal by Subject|0
5947952|NCT01287520|20570891|P7|Overall Study|Withdrawal by Subject|0
5947953|NCT01287520|20570892|P6|Overall Study|Withdrawal by Subject|1
5947954|NCT01287520|20570893|P5|Overall Study|Withdrawal by Subject|0
5947955|NCT01287520|20570894|P4|Overall Study|Withdrawal by Subject|0
5947956|NCT01287520|20570895|P3|Overall Study|Withdrawal by Subject|0
5947957|NCT01287520|20570896|P2|Overall Study|Withdrawal by Subject|0
5947958|NCT01287520|20570897|P1|Overall Study|Withdrawal by Subject|0
5947959|NCT01287520|20570889|P9|Overall Study|Progressive disease|4
5947960|NCT01287520|20570890|P8|Overall Study|Progressive disease|2
5947961|NCT01287520|20570891|P7|Overall Study|Progressive disease|2
5947962|NCT01287520|20570892|P6|Overall Study|Progressive disease|0
5947963|NCT01287520|20570893|P5|Overall Study|Progressive disease|1
5947964|NCT01287520|20570894|P4|Overall Study|Progressive disease|6
5947965|NCT01287520|20570895|P3|Overall Study|Progressive disease|1
5947966|NCT01287520|20570896|P2|Overall Study|Progressive disease|4
5947967|NCT01287520|20570897|P1|Overall Study|Progressive disease|0
5947968|NCT01287520|20570889|P9|Overall Study|Physician Decision|0
5947969|NCT01287520|20570890|P8|Overall Study|Physician Decision|1
5947970|NCT01287520|20570891|P7|Overall Study|Physician Decision|0
5947971|NCT01287520|20570892|P6|Overall Study|Physician Decision|1
5947972|NCT01287520|20570893|P5|Overall Study|Physician Decision|1
5947973|NCT01287520|20570894|P4|Overall Study|Physician Decision|0
5947974|NCT01287520|20570895|P3|Overall Study|Physician Decision|2
5947975|NCT01287520|20570896|P2|Overall Study|Physician Decision|1
5947976|NCT01287520|20570897|P1|Overall Study|Physician Decision|1
5947977|NCT01287520|20570889|P9|Overall Study|Adverse Event|0
5947978|NCT01287520|20570890|P8|Overall Study|Adverse Event|2
5947979|NCT01287520|20570891|P7|Overall Study|Adverse Event|0
5947980|NCT01287520|20570892|P6|Overall Study|Adverse Event|2
5947981|NCT01287520|20570893|P5|Overall Study|Adverse Event|1
5947982|NCT01287520|20570894|P4|Overall Study|Adverse Event|1
5947983|NCT01287520|20570895|P3|Overall Study|Adverse Event|2
5947984|NCT01287520|20570896|P2|Overall Study|Adverse Event|2
5947985|NCT01287520|20570897|P1|Overall Study|Adverse Event|2
5947986|NCT01287416|20570961|P2|6 Month Follow-up|Lost to Follow-up|2
5947987|NCT01287416|20570962|P1|6 Month Follow-up|Lost to Follow-up|3
5947988|NCT01287416|20570961|P2|Pre-post Training|Lost to Follow-up|1
5947989|NCT01287416|20570962|P1|Pre-post Training|Lost to Follow-up|5
5947990|NCT01287416|20570961|P2|Pre-post Training|Withdrawal by Subject|24
5947991|NCT01287416|20570962|P1|Pre-post Training|Withdrawal by Subject|17
5947992|NCT01287403|20570998|P1|1st Intervention (1 Day)|Adverse Event|1
5947993|NCT01287364|20571030|P2|Overall Study|Other Reason|2
5947994|NCT01287364|20571031|P1|Overall Study|Other Reason|4
5947995|NCT01287364|20571030|P2|Overall Study|Protocol Violation|5
5947996|NCT01287364|20571031|P1|Overall Study|Protocol Violation|5
5947997|NCT01287364|20571030|P2|Overall Study|Adverse Event|3
5947998|NCT01287364|20571031|P1|Overall Study|Adverse Event|0
5947999|NCT01287221|20571053|P2|Overall Study|Withdrawal by Subject|1
5948000|NCT01287221|20571054|P1|Overall Study|Withdrawal by Subject|0
5948001|NCT01287221|20571053|P2|Overall Study|Adverse Event|3
5948002|NCT01287221|20571054|P1|Overall Study|Adverse Event|3
5948003|NCT01287221|20571053|P2|Overall Study|Lack of Perceived Benefit|1
5948004|NCT01287221|20571054|P1|Overall Study|Lack of Perceived Benefit|1
5948005|NCT01287195|20571089|P1|Overall Study|Withdrawal by Subject|2
5948006|NCT01287117|20571104|P4|Overall Study|Disease Progression|5
5948007|NCT01287117|20571105|P3|Overall Study|Disease Progression|6
5948008|NCT01287117|20571106|P2|Overall Study|Disease Progression|5
5948009|NCT01287117|20571107|P1|Overall Study|Disease Progression|10
5948010|NCT01287117|20571104|P4|Overall Study|Patient/Legal Guardian's Decision|5
5948011|NCT01287117|20571105|P3|Overall Study|Patient/Legal Guardian's Decision|8
5948012|NCT01287117|20571106|P2|Overall Study|Patient/Legal Guardian's Decision|6
5948013|NCT01287117|20571107|P1|Overall Study|Patient/Legal Guardian's Decision|2
5948014|NCT01287117|20571104|P4|Overall Study|Physician Decision|1
5948015|NCT01287117|20571105|P3|Overall Study|Physician Decision|1
5948016|NCT01287117|20571106|P2|Overall Study|Physician Decision|1
5948017|NCT01287117|20571107|P1|Overall Study|Physician Decision|0
5948018|NCT01287117|20571104|P4|Overall Study|Lost to Follow-up|0
5948019|NCT01287117|20571105|P3|Overall Study|Lost to Follow-up|0
5948020|NCT01287117|20571106|P2|Overall Study|Lost to Follow-up|1
5948021|NCT01287117|20571107|P1|Overall Study|Lost to Follow-up|1
5948022|NCT01287117|20571104|P4|Overall Study|Adverse Event|1
5948023|NCT01287117|20571105|P3|Overall Study|Adverse Event|1
5948024|NCT01287117|20571106|P2|Overall Study|Adverse Event|1
5948025|NCT01287117|20571107|P1|Overall Study|Adverse Event|2
5948026|NCT01287104|20571157|P4|Overall Study|NK cells did not meet release criteria|0
5948027|NCT01287104|20571158|P3|Overall Study|NK cells did not meet release criteria|0
5948028|NCT01287104|20571159|P2|Overall Study|NK cells did not meet release criteria|1
5948029|NCT01287104|20571160|P1|Overall Study|NK cells did not meet release criteria|0
5948030|NCT01287104|20571157|P4|Overall Study|Low donor chimerism|0
5948031|NCT01287104|20571158|P3|Overall Study|Low donor chimerism|0
5948032|NCT01287104|20571159|P2|Overall Study|Low donor chimerism|1
5948033|NCT01287104|20571160|P1|Overall Study|Low donor chimerism|0
5948034|NCT01287104|20571157|P4|Overall Study|Developed GVHD or complications of BMT|0
5948035|NCT01287104|20571158|P3|Overall Study|Developed GVHD or complications of BMT|4
5948036|NCT01287104|20571159|P2|Overall Study|Developed GVHD or complications of BMT|1
5948037|NCT01287104|20571160|P1|Overall Study|Developed GVHD or complications of BMT|0
5948038|NCT01287104|20571157|P4|Overall Study|Donor anaphylaxis|1
5948039|NCT01287104|20571158|P3|Overall Study|Donor anaphylaxis|0
5948040|NCT01287104|20571159|P2|Overall Study|Donor anaphylaxis|1
5948041|NCT01287104|20571160|P1|Overall Study|Donor anaphylaxis|0
5948042|NCT01287104|20571157|P4|Overall Study|Patient developed progressive disease|2
5948043|NCT01287104|20571158|P3|Overall Study|Patient developed progressive disease|3
5948044|NCT01287104|20571159|P2|Overall Study|Patient developed progressive disease|1
5948045|NCT01287104|20571160|P1|Overall Study|Patient developed progressive disease|1
5948046|NCT01287065|20571216|P6|Treatment Period 1|Withdrawal by Subject|1
5948047|NCT01287065|20571217|P5|Treatment Period 1|Withdrawal by Subject|0
5948048|NCT01287065|20571218|P4|Treatment Period 1|Withdrawal by Subject|0
5948049|NCT01287065|20571219|P3|Treatment Period 1|Withdrawal by Subject|0
5948050|NCT01287065|20571220|P2|Treatment Period 1|Withdrawal by Subject|0
5948051|NCT01287065|20571221|P1|Treatment Period 1|Withdrawal by Subject|0
5948052|NCT01287065|20571216|P6|Treatment Period 1|Adverse Event|0
5948053|NCT01287065|20571217|P5|Treatment Period 1|Adverse Event|1
5948054|NCT01287065|20571218|P4|Treatment Period 1|Adverse Event|0
5948055|NCT01287065|20571219|P3|Treatment Period 1|Adverse Event|0
5948056|NCT01287065|20571220|P2|Treatment Period 1|Adverse Event|0
5948057|NCT01287065|20571221|P1|Treatment Period 1|Adverse Event|0
5948058|NCT01287039|20571240|P2|Overall Study|Lost to Follow-up|2
5948059|NCT01287039|20571241|P1|Overall Study|Lost to Follow-up|3
5948060|NCT01287039|20571240|P2|Overall Study|Withdrawal by Subject|11
5948061|NCT01287039|20571241|P1|Overall Study|Withdrawal by Subject|14
5948062|NCT01287039|20571240|P2|Overall Study|Adverse Event|4
5948063|NCT01287039|20571241|P1|Overall Study|Adverse Event|7
5948064|NCT01287039|20571240|P2|Overall Study|Change of residence|0
5948065|NCT01287039|20571241|P1|Overall Study|Change of residence|1
5948066|NCT01287039|20571240|P2|Overall Study|Death|0
5948067|NCT01287039|20571241|P1|Overall Study|Death|1
5948068|NCT01287039|20571240|P2|Overall Study|Problem with travel|1
5948069|NCT01287039|20571241|P1|Overall Study|Problem with travel|0
5948070|NCT01287039|20571240|P2|Overall Study|Noncompliance with study medication|1
5948071|NCT01287039|20571241|P1|Overall Study|Noncompliance with study medication|0
5948072|NCT01287039|20571240|P2|Overall Study|Excluded medication taken|0
5948073|NCT01287039|20571241|P1|Overall Study|Excluded medication taken|1
5948074|NCT01287039|20571240|P2|Overall Study|Protocol Violation|3
5948075|NCT01287039|20571241|P1|Overall Study|Protocol Violation|2
5948076|NCT01287039|20571240|P2|Overall Study|Elective surgery|1
5948077|NCT01287039|20571241|P1|Overall Study|Elective surgery|0
5948078|NCT01287039|20571240|P2|Overall Study|Change of location/residence|3
5948079|NCT01287039|20571241|P1|Overall Study|Change of location/residence|0
5948080|NCT01287039|20571240|P2|Overall Study|Noncompliance with study procedures|1
5948081|NCT01287039|20571241|P1|Overall Study|Noncompliance with study procedures|0
5948082|NCT01287013|20571274|P3|Overall Study|Non-evaluable|21
5948083|NCT01287013|20571275|P2|Overall Study|Non-evaluable|5
5948084|NCT01287013|20571276|P1|Overall Study|Non-evaluable|3
5948085|NCT01286987|20571306|P15|Part 2: Dose Expansion|Withdrawal by Subject|0
5948086|NCT01286987|20571307|P14|Part 2: Dose Expansion|Withdrawal by Subject|0
5948087|NCT01286987|20571308|P13|Part 2: Dose Expansion|Withdrawal by Subject|0
5948088|NCT01286987|20571309|P12|Part 2: Dose Expansion|Withdrawal by Subject|0
5948089|NCT01286987|20571310|P11|Part 2: Dose Expansion|Withdrawal by Subject|1
5948090|NCT01286987|20571311|P10|Part 2: Dose Expansion|Withdrawal by Subject|0
5948091|NCT01286987|20571312|P9|Part 2: Dose Expansion|Withdrawal by Subject|0
5948092|NCT01286987|20571313|P8|Part 2: Dose Expansion|Withdrawal by Subject|0
5948093|NCT01286987|20571314|P7|Part 2: Dose Expansion|Withdrawal by Subject|0
5948094|NCT01286987|20571315|P6|Part 2: Dose Expansion|Withdrawal by Subject|0
5948095|NCT01286987|20571316|P5|Part 2: Dose Expansion|Withdrawal by Subject|0
5948096|NCT01286987|20571317|P4|Part 2: Dose Expansion|Withdrawal by Subject|0
5948097|NCT01286987|20571318|P3|Part 2: Dose Expansion|Withdrawal by Subject|0
5948098|NCT01286987|20571319|P2|Part 2: Dose Expansion|Withdrawal by Subject|0
5948099|NCT01286987|20571320|P1|Part 2: Dose Expansion|Withdrawal by Subject|0
5948100|NCT01286987|20571306|P15|Part 2: Dose Expansion|Clinical Progression|0
5948101|NCT01286987|20571307|P14|Part 2: Dose Expansion|Clinical Progression|2
5948102|NCT01286987|20571308|P13|Part 2: Dose Expansion|Clinical Progression|0
5948103|NCT01286987|20571309|P12|Part 2: Dose Expansion|Clinical Progression|2
5948104|NCT01286987|20571310|P11|Part 2: Dose Expansion|Clinical Progression|2
5948105|NCT01286987|20571311|P10|Part 2: Dose Expansion|Clinical Progression|0
5948106|NCT01286987|20571312|P9|Part 2: Dose Expansion|Clinical Progression|0
5948107|NCT01286987|20571313|P8|Part 2: Dose Expansion|Clinical Progression|0
5948108|NCT01286987|20571314|P7|Part 2: Dose Expansion|Clinical Progression|0
5948109|NCT01286987|20571315|P6|Part 2: Dose Expansion|Clinical Progression|0
5948110|NCT01286987|20571316|P5|Part 2: Dose Expansion|Clinical Progression|0
5948111|NCT01286987|20571317|P4|Part 2: Dose Expansion|Clinical Progression|0
5948112|NCT01286987|20571318|P3|Part 2: Dose Expansion|Clinical Progression|0
5948113|NCT01286987|20571319|P2|Part 2: Dose Expansion|Clinical Progression|0
5948114|NCT01286987|20571320|P1|Part 2: Dose Expansion|Clinical Progression|0
5948115|NCT01286987|20571306|P15|Part 2: Dose Expansion|Progressive Disease|2
5948116|NCT01286987|20571307|P14|Part 2: Dose Expansion|Progressive Disease|19
5948117|NCT01286987|20571308|P13|Part 2: Dose Expansion|Progressive Disease|11
5948118|NCT01286987|20571309|P12|Part 2: Dose Expansion|Progressive Disease|7
5948119|NCT01286987|20571310|P11|Part 2: Dose Expansion|Progressive Disease|6
5948120|NCT01286987|20571311|P10|Part 2: Dose Expansion|Progressive Disease|11
5948121|NCT01286987|20571312|P9|Part 2: Dose Expansion|Progressive Disease|0
5948122|NCT01286987|20571313|P8|Part 2: Dose Expansion|Progressive Disease|0
5948123|NCT01286987|20571314|P7|Part 2: Dose Expansion|Progressive Disease|0
5948124|NCT01286987|20571315|P6|Part 2: Dose Expansion|Progressive Disease|0
5948125|NCT01286987|20571316|P5|Part 2: Dose Expansion|Progressive Disease|0
5948126|NCT01286987|20571317|P4|Part 2: Dose Expansion|Progressive Disease|0
5948127|NCT01286987|20571318|P3|Part 2: Dose Expansion|Progressive Disease|0
5948128|NCT01286987|20571319|P2|Part 2: Dose Expansion|Progressive Disease|0
5948129|NCT01286987|20571320|P1|Part 2: Dose Expansion|Progressive Disease|0
5948130|NCT01286987|20571306|P15|Part 2: Dose Expansion|Other|0
5948131|NCT01286987|20571307|P14|Part 2: Dose Expansion|Other|1
5948132|NCT01286987|20571308|P13|Part 2: Dose Expansion|Other|0
5948133|NCT01286987|20571309|P12|Part 2: Dose Expansion|Other|0
5948134|NCT01286987|20571310|P11|Part 2: Dose Expansion|Other|0
5948135|NCT01286987|20571311|P10|Part 2: Dose Expansion|Other|0
5948136|NCT01286987|20571312|P9|Part 2: Dose Expansion|Other|0
5948137|NCT01286987|20571313|P8|Part 2: Dose Expansion|Other|0
5948138|NCT01286987|20571314|P7|Part 2: Dose Expansion|Other|0
5948139|NCT01286987|20571315|P6|Part 2: Dose Expansion|Other|0
5948140|NCT01286987|20571316|P5|Part 2: Dose Expansion|Other|0
5948141|NCT01286987|20571317|P4|Part 2: Dose Expansion|Other|0
5948142|NCT01286987|20571318|P3|Part 2: Dose Expansion|Other|0
5948143|NCT01286987|20571319|P2|Part 2: Dose Expansion|Other|0
5948144|NCT01286987|20571320|P1|Part 2: Dose Expansion|Other|0
5948145|NCT01286987|20571306|P15|Part 2: Dose Expansion|Physician Decision|0
5948146|NCT01286987|20571307|P14|Part 2: Dose Expansion|Physician Decision|1
5948147|NCT01286987|20571308|P13|Part 2: Dose Expansion|Physician Decision|0
5948148|NCT01286987|20571309|P12|Part 2: Dose Expansion|Physician Decision|1
5948149|NCT01286987|20571310|P11|Part 2: Dose Expansion|Physician Decision|1
5948150|NCT01286987|20571311|P10|Part 2: Dose Expansion|Physician Decision|0
5948151|NCT01286987|20571312|P9|Part 2: Dose Expansion|Physician Decision|0
5948152|NCT01286987|20571313|P8|Part 2: Dose Expansion|Physician Decision|0
5948153|NCT01286987|20571314|P7|Part 2: Dose Expansion|Physician Decision|0
5948154|NCT01286987|20571315|P6|Part 2: Dose Expansion|Physician Decision|0
5948155|NCT01286987|20571316|P5|Part 2: Dose Expansion|Physician Decision|0
5948156|NCT01286987|20571317|P4|Part 2: Dose Expansion|Physician Decision|0
5948157|NCT01286987|20571318|P3|Part 2: Dose Expansion|Physician Decision|0
5948158|NCT01286987|20571319|P2|Part 2: Dose Expansion|Physician Decision|0
5948159|NCT01286987|20571320|P1|Part 2: Dose Expansion|Physician Decision|0
5948160|NCT01286987|20571306|P15|Part 2: Dose Expansion|Death|0
5948161|NCT01286987|20571307|P14|Part 2: Dose Expansion|Death|1
5948162|NCT01286987|20571308|P13|Part 2: Dose Expansion|Death|1
5948163|NCT01286987|20571309|P12|Part 2: Dose Expansion|Death|0
5948164|NCT01286987|20571310|P11|Part 2: Dose Expansion|Death|0
5948165|NCT01286987|20571311|P10|Part 2: Dose Expansion|Death|0
5948166|NCT01286987|20571312|P9|Part 2: Dose Expansion|Death|0
5948167|NCT01286987|20571313|P8|Part 2: Dose Expansion|Death|0
5948168|NCT01286987|20571314|P7|Part 2: Dose Expansion|Death|0
5948169|NCT01286987|20571315|P6|Part 2: Dose Expansion|Death|0
5948170|NCT01286987|20571316|P5|Part 2: Dose Expansion|Death|0
5948171|NCT01286987|20571317|P4|Part 2: Dose Expansion|Death|0
5948172|NCT01286987|20571318|P3|Part 2: Dose Expansion|Death|0
5948173|NCT01286987|20571319|P2|Part 2: Dose Expansion|Death|0
5948174|NCT01286987|20571320|P1|Part 2: Dose Expansion|Death|0
5948175|NCT01286987|20571306|P15|Part 1: Dose Escalation|Physician Decision|0
5948176|NCT01286987|20571307|P14|Part 1: Dose Escalation|Physician Decision|0
5948177|NCT01286987|20571308|P13|Part 1: Dose Escalation|Physician Decision|0
5948178|NCT01286987|20571309|P12|Part 1: Dose Escalation|Physician Decision|0
5948179|NCT01286987|20571310|P11|Part 1: Dose Escalation|Physician Decision|0
5948180|NCT01286987|20571311|P10|Part 1: Dose Escalation|Physician Decision|0
5948181|NCT01286987|20571312|P9|Part 1: Dose Escalation|Physician Decision|0
5948182|NCT01286987|20571313|P8|Part 1: Dose Escalation|Physician Decision|0
5948183|NCT01286987|20571314|P7|Part 1: Dose Escalation|Physician Decision|0
5948184|NCT01286987|20571315|P6|Part 1: Dose Escalation|Physician Decision|0
5948185|NCT01286987|20571316|P5|Part 1: Dose Escalation|Physician Decision|1
5948186|NCT01286987|20571317|P4|Part 1: Dose Escalation|Physician Decision|0
5948187|NCT01286987|20571318|P3|Part 1: Dose Escalation|Physician Decision|0
5948188|NCT01286987|20571319|P2|Part 1: Dose Escalation|Physician Decision|0
5948189|NCT01286987|20571320|P1|Part 1: Dose Escalation|Physician Decision|0
5948190|NCT01286987|20571306|P15|Part 1: Dose Escalation|Progressive Disease|0
5948191|NCT01286987|20571307|P14|Part 1: Dose Escalation|Progressive Disease|0
5948192|NCT01286987|20571308|P13|Part 1: Dose Escalation|Progressive Disease|0
5948193|NCT01286987|20571309|P12|Part 1: Dose Escalation|Progressive Disease|0
5948194|NCT01286987|20571310|P11|Part 1: Dose Escalation|Progressive Disease|0
5948195|NCT01286987|20571311|P10|Part 1: Dose Escalation|Progressive Disease|0
5948196|NCT01286987|20571312|P9|Part 1: Dose Escalation|Progressive Disease|5
5948197|NCT01286987|20571313|P8|Part 1: Dose Escalation|Progressive Disease|3
5948198|NCT01286987|20571314|P7|Part 1: Dose Escalation|Progressive Disease|5
5948199|NCT01286987|20571315|P6|Part 1: Dose Escalation|Progressive Disease|5
5948200|NCT01286987|20571316|P5|Part 1: Dose Escalation|Progressive Disease|1
5948201|NCT01286987|20571317|P4|Part 1: Dose Escalation|Progressive Disease|2
5948202|NCT01286987|20571318|P3|Part 1: Dose Escalation|Progressive Disease|3
5948203|NCT01286987|20571319|P2|Part 1: Dose Escalation|Progressive Disease|2
5948204|NCT01286987|20571320|P1|Part 1: Dose Escalation|Progressive Disease|2
5948205|NCT01286987|20571306|P15|Part 1: Dose Escalation|Clinical Progression|0
5948206|NCT01286987|20571307|P14|Part 1: Dose Escalation|Clinical Progression|0
5948207|NCT01286987|20571308|P13|Part 1: Dose Escalation|Clinical Progression|0
5948208|NCT01286987|20571309|P12|Part 1: Dose Escalation|Clinical Progression|0
5948209|NCT01286987|20571310|P11|Part 1: Dose Escalation|Clinical Progression|0
5948210|NCT01286987|20571311|P10|Part 1: Dose Escalation|Clinical Progression|0
5948211|NCT01286987|20571312|P9|Part 1: Dose Escalation|Clinical Progression|1
5948212|NCT01286987|20571313|P8|Part 1: Dose Escalation|Clinical Progression|2
5948213|NCT01286987|20571314|P7|Part 1: Dose Escalation|Clinical Progression|0
5948214|NCT01286987|20571315|P6|Part 1: Dose Escalation|Clinical Progression|1
5948215|NCT01286987|20571316|P5|Part 1: Dose Escalation|Clinical Progression|1
5948216|NCT01286987|20571317|P4|Part 1: Dose Escalation|Clinical Progression|1
5948217|NCT01286987|20571318|P3|Part 1: Dose Escalation|Clinical Progression|0
5948218|NCT01286987|20571319|P2|Part 1: Dose Escalation|Clinical Progression|1
5948219|NCT01286987|20571320|P1|Part 1: Dose Escalation|Clinical Progression|1
5948220|NCT01286779|20571501|P1|Overall Study|Discontinued by sponsor|1
5948221|NCT01286779|20571501|P1|Overall Study|Participant moved to another country|1
5948222|NCT01286779|20571501|P1|Overall Study|Participant had scheduled surgery|1
5948223|NCT01286779|20571501|P1|Overall Study|Physician Decision|2
5948224|NCT01286779|20571501|P1|Overall Study|Protocol Violation|5
5948225|NCT01286779|20571501|P1|Overall Study|Withdrawal by Subject|9
5948226|NCT01286753|20571553|P2|Overall Study|Participant to Receive Radiotherapy|0
5948227|NCT01286753|20571554|P1|Overall Study|Participant to Receive Radiotherapy|1
5948228|NCT01286753|20571553|P2|Overall Study|Discontinued to Join Extension Study|4
5948229|NCT01286753|20571554|P1|Overall Study|Discontinued to Join Extension Study|6
5948230|NCT01286753|20571553|P2|Overall Study|Withdrawal of Consent|2
5948231|NCT01286753|20571554|P1|Overall Study|Withdrawal of Consent|0
5948232|NCT01286753|20571553|P2|Overall Study|Refused Treatment|0
5948233|NCT01286753|20571554|P1|Overall Study|Refused Treatment|1
5948234|NCT01286753|20571553|P2|Overall Study|Progression|13
5948235|NCT01286753|20571554|P1|Overall Study|Progression|11
5948236|NCT01286753|20571553|P2|Overall Study|Adverse Event|6
5948237|NCT01286753|20571554|P1|Overall Study|Adverse Event|7
5948238|NCT01286740|20571572|P1|Overall Study|Protocol Violation|1
5948239|NCT01286740|20571572|P1|Overall Study|Enrolled but not treated|1
5948240|NCT01286558|20571590|P2|Overall Study|Withdrawal by Subject|1
5948241|NCT01286558|20571591|P1|Overall Study|Withdrawal by Subject|0
5948242|NCT01286558|20571590|P2|Overall Study|Adverse Event|1
5948243|NCT01286558|20571591|P1|Overall Study|Adverse Event|1
5948244|NCT01286480|20571627|P2|Overall Study|Withdrawal by Subject|3
5948245|NCT01286480|20571628|P1|Overall Study|Withdrawal by Subject|5
5948246|NCT01286311|20571735|P2|Overall Study|Physician did not want outreach sent|0
5948247|NCT01286311|20571736|P1|Overall Study|Physician did not want outreach sent|14
5948248|NCT01286272|20571752|P2|Overall Study|Ineligible after beginning treatment|3
5948249|NCT01286272|20571753|P1|Overall Study|Ineligible after beginning treatment|1
5948250|NCT01286207|20571773|P3|Overall Study|Other|13
5948251|NCT01286207|20571774|P2|Overall Study|Other|47
5948252|NCT01286207|20571775|P1|Overall Study|Other|37
5948253|NCT01286207|20571773|P3|Overall Study|Lack of Response|8
5948254|NCT01286207|20571774|P2|Overall Study|Lack of Response|38
5948255|NCT01286207|20571775|P1|Overall Study|Lack of Response|92
5948256|NCT01286207|20571773|P3|Overall Study|Withdrawal by Subject|41
5948257|NCT01286207|20571774|P2|Overall Study|Withdrawal by Subject|79
5948258|NCT01286207|20571775|P1|Overall Study|Withdrawal by Subject|93
5948259|NCT01286207|20571773|P3|Overall Study|Lost to Follow-up|20
5948260|NCT01286207|20571774|P2|Overall Study|Lost to Follow-up|43
5948261|NCT01286207|20571775|P1|Overall Study|Lost to Follow-up|49
5948262|NCT01286207|20571773|P3|Overall Study|Adverse Event|8
5948263|NCT01286207|20571774|P2|Overall Study|Adverse Event|41
5948264|NCT01286207|20571775|P1|Overall Study|Adverse Event|27
5948265|NCT01286168|20571795|P1|Overall Study|Surgical Drains Fell Out at Home|2
5948266|NCT01286168|20571795|P1|Overall Study|Withdrawal by Subject|1
5948267|NCT01286129|20571809|P2|Overall Study|Could not comply with study requirements|4
5948268|NCT01286129|20571810|P1|Overall Study|Could not comply with study requirements|4
5948269|NCT01286129|20571809|P2|Overall Study|Withdrawal by Subject|1
5948270|NCT01286129|20571810|P1|Overall Study|Withdrawal by Subject|4
5948271|NCT01286077|20571820|P2|Overall Study|refill medication not received in time|0
5948272|NCT01286077|20571821|P1|Overall Study|refill medication not received in time|1
5948273|NCT01286077|20571820|P2|Overall Study|Progression of disease|1
5948274|NCT01286077|20571821|P1|Overall Study|Progression of disease|0
5948275|NCT01286077|20571820|P2|Overall Study|Patient's decision to stop treatment|0
5948276|NCT01286077|20571821|P1|Overall Study|Patient's decision to stop treatment|3
5948277|NCT01286077|20571820|P2|Overall Study|The subject starts with alternative MMY|3
5948278|NCT01286077|20571821|P1|Overall Study|The subject starts with alternative MMY|0
5948279|NCT01286077|20571820|P2|Overall Study|Non-compliance|0
5948280|NCT01286077|20571821|P1|Overall Study|Non-compliance|1
5948281|NCT01286077|20571820|P2|Overall Study|Intercurrent illness|0
5948282|NCT01286077|20571821|P1|Overall Study|Intercurrent illness|1
5948283|NCT01286077|20571820|P2|Overall Study|Withdrawal by Subject|2
5948284|NCT01286077|20571821|P1|Overall Study|Withdrawal by Subject|0
5948285|NCT01286077|20571820|P2|Overall Study|Protocol Violation|1
5948286|NCT01286077|20571821|P1|Overall Study|Protocol Violation|1
5948287|NCT01286077|20571820|P2|Overall Study|Death|0
5948288|NCT01286077|20571821|P1|Overall Study|Death|1
5948289|NCT01286077|20571820|P2|Overall Study|Adverse Event|0
5948290|NCT01286077|20571821|P1|Overall Study|Adverse Event|2
5948291|NCT01286012|20571857|P2|Overall Study|peritoneal dialysis, randomized in error|3
5948292|NCT01286012|20571858|P1|Overall Study|peritoneal dialysis, randomized in error|1
5948293|NCT01286012|20571857|P2|Overall Study|Physician Decision|0
5948294|NCT01286012|20571858|P1|Overall Study|Physician Decision|2
5948295|NCT01286012|20571857|P2|Overall Study|Withdrawal by Subject|4
5948296|NCT01286012|20571858|P1|Overall Study|Withdrawal by Subject|4
5948297|NCT01286012|20571857|P2|Overall Study|Protocol Violation|1
5948298|NCT01286012|20571858|P1|Overall Study|Protocol Violation|1
5948299|NCT01286012|20571857|P2|Overall Study|Death|3
5948300|NCT01286012|20571858|P1|Overall Study|Death|2
5948301|NCT01286012|20571857|P2|Overall Study|Adverse Event|3
5948302|NCT01286012|20571858|P1|Overall Study|Adverse Event|3
5948303|NCT01285960|20571872|P1|Overall Study|2 subjects received less 10 sonications|2
5948304|NCT01285960|20571872|P1|Overall Study|Lost to Follow-up|2
5948305|NCT01285960|20571872|P1|Overall Study|Withdrawal by Subject|2
5948306|NCT01285908|20571885|P3|Baseline Measurement|unable to tolerate procedure|0
5948307|NCT01285908|20571886|P2|Baseline Measurement|unable to tolerate procedure|0
5948308|NCT01285908|20571887|P1|Baseline Measurement|unable to tolerate procedure|1
5948309|NCT01285908|20571885|P3|Baseline Measurement|History of stroke, exclusion criteria|0
5948310|NCT01285908|20571886|P2|Baseline Measurement|History of stroke, exclusion criteria|0
5948311|NCT01285908|20571887|P1|Baseline Measurement|History of stroke, exclusion criteria|1
5948312|NCT01285908|20571885|P3|Baseline Measurement|unable to insert catheter|0
5948313|NCT01285908|20571886|P2|Baseline Measurement|unable to insert catheter|0
5948314|NCT01285908|20571887|P1|Baseline Measurement|unable to insert catheter|1
5948315|NCT01285609|20571981|P2|Treated With Blinded Therapy|Worsening of general condition|1
5948316|NCT01285609|20571982|P1|Treated With Blinded Therapy|Worsening of general condition|0
5948317|NCT01285609|20571981|P2|Treated With Blinded Therapy|PI decision to discontinue|1
5948318|NCT01285609|20571982|P1|Treated With Blinded Therapy|PI decision to discontinue|0
5948319|NCT01285609|20571981|P2|Treated With Blinded Therapy|Investigator's assessment|0
5948320|NCT01285609|20571982|P1|Treated With Blinded Therapy|Investigator's assessment|1
5948321|NCT01285609|20571981|P2|Treated With Blinded Therapy|Participant hospitalized|0
5948322|NCT01285609|20571982|P1|Treated With Blinded Therapy|Participant hospitalized|1
5948323|NCT01285609|20571981|P2|Treated With Blinded Therapy|Participant started radiotherapy|0
5948324|NCT01285609|20571982|P1|Treated With Blinded Therapy|Participant started radiotherapy|1
5948325|NCT01285609|20571981|P2|Treated With Blinded Therapy|Participant refused participation|0
5948326|NCT01285609|20571982|P1|Treated With Blinded Therapy|Participant refused participation|1
5948327|NCT01285609|20571981|P2|Treated With Blinded Therapy|Physician and Patient decision|3
5948328|NCT01285609|20571982|P1|Treated With Blinded Therapy|Physician and Patient decision|1
5948329|NCT01285609|20571981|P2|Treated With Blinded Therapy|Administrative Reason by Sponsor|3
5948330|NCT01285609|20571982|P1|Treated With Blinded Therapy|Administrative Reason by Sponsor|1
5948331|NCT01285609|20571981|P2|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|0
5948332|NCT01285609|20571982|P1|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|1
5948333|NCT01285609|20571981|P2|Treated With Blinded Therapy|Poor/Non-Compliance|2
5948334|NCT01285609|20571982|P1|Treated With Blinded Therapy|Poor/Non-Compliance|1
5948335|NCT01285609|20571981|P2|Treated With Blinded Therapy|Not Reported|2
5948336|NCT01285609|20571982|P1|Treated With Blinded Therapy|Not Reported|0
5948337|NCT01285609|20571981|P2|Treated With Blinded Therapy|Maximum Clinical Benefit|4
5948338|NCT01285609|20571982|P1|Treated With Blinded Therapy|Maximum Clinical Benefit|2
5948339|NCT01285609|20571981|P2|Treated With Blinded Therapy|Death|3
5948340|NCT01285609|20571982|P1|Treated With Blinded Therapy|Death|11
5948341|NCT01285609|20571981|P2|Treated With Blinded Therapy|Withdrawal by Subject|7
5948342|NCT01285609|20571982|P1|Treated With Blinded Therapy|Withdrawal by Subject|20
5948343|NCT01285609|20571981|P2|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|14
5948344|NCT01285609|20571982|P1|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|36
5948345|NCT01285609|20571981|P2|Treated With Blinded Therapy|Study Drug Toxicity|14
5948346|NCT01285609|20571982|P1|Treated With Blinded Therapy|Study Drug Toxicity|87
5948347|NCT01285609|20571981|P2|Treated With Blinded Therapy|Progressive Disease|305
5948348|NCT01285609|20571982|P1|Treated With Blinded Therapy|Progressive Disease|223
5948349|NCT01285609|20571981|P2|Randomized|Randomized but not Treated|4
5948350|NCT01285609|20571982|P1|Randomized|Randomized but not Treated|4
5948351|NCT01285609|20571981|P2|Randomized|Undisclosed Reasons|0
5948352|NCT01285609|20571982|P1|Randomized|Undisclosed Reasons|1
5948353|NCT01285609|20571981|P2|Randomized|Subject No Longer Met Study Criteria|1
5948354|NCT01285609|20571982|P1|Randomized|Subject No Longer Met Study Criteria|1
5948355|NCT01285609|20571981|P2|Randomized|Withdrawal by Subject|11
5948356|NCT01285609|20571982|P1|Randomized|Withdrawal by Subject|8
5948357|NCT01285609|20571981|P2|Randomized|Death|7
5948358|NCT01285609|20571982|P1|Randomized|Death|5
5948359|NCT01285609|20571981|P2|Randomized|Study Drug Toxicity|14
5948360|NCT01285609|20571982|P1|Randomized|Study Drug Toxicity|13
5948361|NCT01285609|20571981|P2|Randomized|Adverse Event Unrelated to Study Drug|18
5948362|NCT01285609|20571982|P1|Randomized|Adverse Event Unrelated to Study Drug|18
5948363|NCT01285609|20571981|P2|Randomized|Progressive Disease|61
5948364|NCT01285609|20571982|P1|Randomized|Progressive Disease|41
5948365|NCT01285518|20572000|P8|Overall Study|Lost to Follow-up|0
5948366|NCT01285518|20572001|P7|Overall Study|Lost to Follow-up|0
5948367|NCT01285518|20572002|P6|Overall Study|Lost to Follow-up|1
5948368|NCT01285518|20572003|P5|Overall Study|Lost to Follow-up|0
5948369|NCT01285518|20572004|P4|Overall Study|Lost to Follow-up|0
5948370|NCT01285518|20572005|P3|Overall Study|Lost to Follow-up|0
5948371|NCT01285518|20572006|P2|Overall Study|Lost to Follow-up|0
5948372|NCT01285518|20572007|P1|Overall Study|Lost to Follow-up|0
5948373|NCT01285492|20572267|P2|Overall Study|Death|0
5948374|NCT01285492|20572268|P1|Overall Study|Death|1
5948375|NCT01285492|20572267|P2|Overall Study|Withdrawal by Subject|1
5948376|NCT01285492|20572268|P1|Overall Study|Withdrawal by Subject|2
5948377|NCT01285492|20572267|P2|Overall Study|Protocol Violation|0
5948378|NCT01285492|20572268|P1|Overall Study|Protocol Violation|3
5948379|NCT01285492|20572267|P2|Overall Study|Adverse Event|0
5948380|NCT01285492|20572268|P1|Overall Study|Adverse Event|11
5948381|NCT01285401|20572300|P2|Overall Study|Prematurely withdrawn from the study|29
5948382|NCT01285401|20572301|P1|Overall Study|Prematurely withdrawn from the study|17
5948383|NCT01285349|20572342|P3|Overall Study|Lost to Follow-up|27
5948384|NCT01285349|20572343|P2|Overall Study|Lost to Follow-up|20
5948385|NCT01285349|20572344|P1|Overall Study|Lost to Follow-up|27
5948386|NCT01285323|20572357|P2|Overall Study|Other|3
5948387|NCT01285323|20572358|P1|Overall Study|Other|1
5948388|NCT01285323|20572357|P2|Overall Study|Lost to Follow-up|1
5948389|NCT01285323|20572358|P1|Overall Study|Lost to Follow-up|1
5948390|NCT01285323|20572357|P2|Overall Study|Non-compliance with study procedures|3
5948391|NCT01285323|20572358|P1|Overall Study|Non-compliance with study procedures|2
5948392|NCT01285323|20572357|P2|Overall Study|Protocol Violation|2
5948393|NCT01285323|20572358|P1|Overall Study|Protocol Violation|1
5948394|NCT01285323|20572357|P2|Overall Study|Withdrawal by Subject|11
5948395|NCT01285323|20572358|P1|Overall Study|Withdrawal by Subject|15
5948396|NCT01285323|20572357|P2|Overall Study|Lack of Efficacy|2
5948397|NCT01285323|20572358|P1|Overall Study|Lack of Efficacy|4
5948398|NCT01285323|20572357|P2|Overall Study|Adverse Event|8
5948399|NCT01285323|20572358|P1|Overall Study|Adverse Event|9
5948400|NCT01285310|20572393|P5|Active Treatment Phase: Weeks 25-52|Non-compliance|0
5948401|NCT01285310|20572394|P4|Active Treatment Phase: Weeks 25-52|Non-compliance|1
5948402|NCT01285310|20572395|P3|Active Treatment Phase: Weeks 25-52|Non-compliance|1
5948403|NCT01285310|20572396|P2|Active Treatment Phase: Weeks 25-52|Non-compliance|1
5948404|NCT01285310|20572397|P1|Active Treatment Phase: Weeks 25-52|Non-compliance|0
5948405|NCT01285310|20572393|P5|Active Treatment Phase: Weeks 25-52|Other|0
5948406|NCT01285310|20572394|P4|Active Treatment Phase: Weeks 25-52|Other|0
5948407|NCT01285310|20572395|P3|Active Treatment Phase: Weeks 25-52|Other|0
5948408|NCT01285310|20572396|P2|Active Treatment Phase: Weeks 25-52|Other|1
5948409|NCT01285310|20572397|P1|Active Treatment Phase: Weeks 25-52|Other|0
5948410|NCT01285310|20572393|P5|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|15
5948411|NCT01285310|20572394|P4|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|6
5948412|NCT01285310|20572395|P3|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|19
5948413|NCT01285310|20572396|P2|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|21
5948414|NCT01285310|20572397|P1|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|0
5948415|NCT01285310|20572393|P5|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2
5948416|NCT01285310|20572394|P4|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2
5948417|NCT01285310|20572395|P3|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0
5948418|NCT01285310|20572396|P2|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|3
5948419|NCT01285310|20572397|P1|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0
5948420|NCT01285310|20572393|P5|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0
5948421|NCT01285310|20572394|P4|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|1
5948422|NCT01285310|20572395|P3|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|3
5948423|NCT01285310|20572396|P2|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|4
5948424|NCT01285310|20572397|P1|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0
5948425|NCT01285310|20572393|P5|Active Treatment Phase: Weeks 25-52|Adverse Event|2
5948426|NCT01285310|20572394|P4|Active Treatment Phase: Weeks 25-52|Adverse Event|0
5948427|NCT01285310|20572395|P3|Active Treatment Phase: Weeks 25-52|Adverse Event|3
5948428|NCT01285310|20572396|P2|Active Treatment Phase: Weeks 25-52|Adverse Event|2
5948429|NCT01285310|20572397|P1|Active Treatment Phase: Weeks 25-52|Adverse Event|0
5948430|NCT01285310|20572393|P5|Placebo Controlled Phase: Weeks 0-24|Other|0
5948431|NCT01285310|20572394|P4|Placebo Controlled Phase: Weeks 0-24|Other|0
5948432|NCT01285310|20572395|P3|Placebo Controlled Phase: Weeks 0-24|Other|1
5948433|NCT01285310|20572396|P2|Placebo Controlled Phase: Weeks 0-24|Other|0
5948434|NCT01285310|20572397|P1|Placebo Controlled Phase: Weeks 0-24|Other|1
5948435|NCT01285310|20572393|P5|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0
5948436|NCT01285310|20572394|P4|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0
5948437|NCT01285310|20572395|P3|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1
5948438|NCT01285310|20572396|P2|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1
5948439|NCT01285310|20572397|P1|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0
5948440|NCT01285310|20572393|P5|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0
5948441|NCT01285310|20572394|P4|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0
5948442|NCT01285310|20572395|P3|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|2
5948443|NCT01285310|20572396|P2|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3
5948444|NCT01285310|20572397|P1|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3
5948445|NCT01285310|20572393|P5|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0
5948446|NCT01285310|20572394|P4|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0
5948447|NCT01285310|20572395|P3|Placebo Controlled Phase: Weeks 0-24|Non-compliance|2
5948448|NCT01285310|20572396|P2|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0
5948449|NCT01285310|20572397|P1|Placebo Controlled Phase: Weeks 0-24|Non-compliance|1
5948450|NCT01285310|20572393|P5|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0
5948451|NCT01285310|20572394|P4|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0
5948452|NCT01285310|20572395|P3|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|3
5948453|NCT01285310|20572396|P2|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|7
5948454|NCT01285310|20572397|P1|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|1
5948455|NCT01285310|20572393|P5|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0
5948456|NCT01285310|20572394|P4|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0
5948457|NCT01285310|20572395|P3|Placebo Controlled Phase: Weeks 0-24|Adverse Event|6
5948458|NCT01285310|20572396|P2|Placebo Controlled Phase: Weeks 0-24|Adverse Event|4
5948459|NCT01285310|20572397|P1|Placebo Controlled Phase: Weeks 0-24|Adverse Event|3
5948460|NCT01284959|20572662|P3|Overall Study|Adverse Event|1
5948461|NCT01284959|20572663|P2|Overall Study|Adverse Event|0
5948462|NCT01284959|20572664|P1|Overall Study|Adverse Event|0
5948463|NCT01284959|20572662|P3|Overall Study|Withdrawal by Subject|0
5948464|NCT01284959|20572663|P2|Overall Study|Withdrawal by Subject|0
5948465|NCT01284959|20572664|P1|Overall Study|Withdrawal by Subject|1
5948466|NCT01284634|20572694|P4|Overall Study|Adverse Event|1
5948467|NCT01284634|20572695|P3|Overall Study|Adverse Event|2
5948468|NCT01284634|20572696|P2|Overall Study|Adverse Event|0
5948469|NCT01284634|20572697|P1|Overall Study|Adverse Event|1
5948470|NCT01284621|20572727|P6|Washout Period 1 (7 Days)|Required unexpected medical treatment|0
5948471|NCT01284621|20572728|P5|Washout Period 1 (7 Days)|Required unexpected medical treatment|1
5948472|NCT01284621|20572729|P4|Washout Period 1 (7 Days)|Required unexpected medical treatment|0
5948473|NCT01284621|20572730|P3|Washout Period 1 (7 Days)|Required unexpected medical treatment|0
5948474|NCT01284621|20572731|P2|Washout Period 1 (7 Days)|Required unexpected medical treatment|0
5948475|NCT01284621|20572732|P1|Washout Period 1 (7 Days)|Required unexpected medical treatment|0
5948476|NCT01284491|20572800|P1|Overall Study|Study termination|13
5948477|NCT01284361|20572810|P1|Overall Study|Lost to Follow-up|2
5948478|NCT01284361|20572810|P1|Overall Study|Adverse Event|1
5948479|NCT01284361|20572810|P1|Overall Study|Protocol Violation|5
5948480|NCT01284361|20572810|P1|Overall Study|Withdrawal by Subject|1
5948481|NCT01284140|20572906|P2|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|1
5948482|NCT01284140|20572907|P1|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|0
5948483|NCT01284140|20572906|P2|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5
5948484|NCT01284140|20572907|P1|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5
5948485|NCT01284127|20572921|P1|Overall Study|Physician Decision|1
5948486|NCT01284127|20572921|P1|Overall Study|Withdrawal by Subject|4
5948487|NCT01284127|20572921|P1|Overall Study|Adverse Event|2
5948488|NCT01284114|20572930|P1|Overall Study|dizziness|1
5948489|NCT01284114|20572930|P1|Overall Study|Symptomatic hypotension|1
5948490|NCT01284114|20572930|P1|Overall Study|From the results of ALLTITUDE study|1
5948491|NCT01284114|20572930|P1|Overall Study|viral infection|1
5948492|NCT01284062|20572942|P4|Overall Study|Site Closed|0
5948493|NCT01284062|20572943|P3|Overall Study|Site Closed|1
5948494|NCT01284062|20572944|P2|Overall Study|Site Closed|0
5948495|NCT01284062|20572945|P1|Overall Study|Site Closed|0
5948496|NCT01284062|20572942|P4|Overall Study|Other|1
5948497|NCT01284062|20572943|P3|Overall Study|Other|0
5948498|NCT01284062|20572944|P2|Overall Study|Other|0
5948499|NCT01284062|20572945|P1|Overall Study|Other|0
5948500|NCT01284062|20572942|P4|Overall Study|Withdrawal by Subject|5
5948501|NCT01284062|20572943|P3|Overall Study|Withdrawal by Subject|2
5948502|NCT01284062|20572944|P2|Overall Study|Withdrawal by Subject|1
5948503|NCT01284062|20572945|P1|Overall Study|Withdrawal by Subject|3
5948504|NCT01284062|20572942|P4|Overall Study|Protocol Violation|2
5948505|NCT01284062|20572943|P3|Overall Study|Protocol Violation|0
5948506|NCT01284062|20572944|P2|Overall Study|Protocol Violation|0
5948507|NCT01284062|20572945|P1|Overall Study|Protocol Violation|1
5948508|NCT01284062|20572942|P4|Overall Study|Medication error without adverse event|0
5948509|NCT01284062|20572943|P3|Overall Study|Medication error without adverse event|1
5948510|NCT01284062|20572944|P2|Overall Study|Medication error without adverse event|0
5948511|NCT01284062|20572945|P1|Overall Study|Medication error without adverse event|0
5948512|NCT01284062|20572942|P4|Overall Study|Lack of Efficacy|1
5948513|NCT01284062|20572943|P3|Overall Study|Lack of Efficacy|2
5948514|NCT01284062|20572944|P2|Overall Study|Lack of Efficacy|2
5948515|NCT01284062|20572945|P1|Overall Study|Lack of Efficacy|3
5948516|NCT01284062|20572942|P4|Overall Study|Adverse Event|5
5948517|NCT01284062|20572943|P3|Overall Study|Adverse Event|0
5948518|NCT01284062|20572944|P2|Overall Study|Adverse Event|5
5948519|NCT01284062|20572945|P1|Overall Study|Adverse Event|4
5948520|NCT01283971|20573019|P2|Overall Study|Administrative reasons|1
5948521|NCT01283971|20573020|P1|Overall Study|Administrative reasons|1
5948522|NCT01283971|20573019|P2|Overall Study|Failure to return|1
5948523|NCT01283971|20573020|P1|Overall Study|Failure to return|0
5948524|NCT01283971|20573019|P2|Overall Study|Refused treatment|1
5948525|NCT01283971|20573020|P1|Overall Study|Refused treatment|3
5948526|NCT01283971|20573019|P2|Overall Study|Protocol Violation|1
5948527|NCT01283971|20573020|P1|Overall Study|Protocol Violation|5
5948528|NCT01283971|20573019|P2|Overall Study|Insufficient therapeutic responses|3
5948529|NCT01283971|20573020|P1|Overall Study|Insufficient therapeutic responses|3
5948530|NCT01283971|20573019|P2|Overall Study|Adverse Event|5
5948531|NCT01283971|20573020|P1|Overall Study|Adverse Event|3
5948532|NCT01283581|20573067|P3|Overall Study|"Early termination"|1
5948533|NCT01283581|20573068|P2|Overall Study|"Early termination"|0
5948534|NCT01283581|20573069|P1|Overall Study|"Early termination"|0
5948535|NCT01283581|20573067|P3|Overall Study|Investigator unblinded|1
5948536|NCT01283581|20573068|P2|Overall Study|Investigator unblinded|0
5948537|NCT01283581|20573069|P1|Overall Study|Investigator unblinded|0
5948538|NCT01283581|20573067|P3|Overall Study|Noncompliance|0
5948539|NCT01283581|20573068|P2|Overall Study|Noncompliance|0
5948540|NCT01283581|20573069|P1|Overall Study|Noncompliance|1
5948541|NCT01283581|20573067|P3|Overall Study|Protocol Violation|2
5948542|NCT01283581|20573068|P2|Overall Study|Protocol Violation|1
5948543|NCT01283581|20573069|P1|Overall Study|Protocol Violation|0
5948544|NCT01283581|20573067|P3|Overall Study|Physician Decision|2
5948545|NCT01283581|20573068|P2|Overall Study|Physician Decision|1
5948546|NCT01283581|20573069|P1|Overall Study|Physician Decision|0
5948547|NCT01283581|20573067|P3|Overall Study|Adverse Event|4
5948548|NCT01283581|20573068|P2|Overall Study|Adverse Event|1
5948549|NCT01283581|20573069|P1|Overall Study|Adverse Event|1
5948550|NCT01283581|20573067|P3|Overall Study|Withdrawal by Subject|2
5948551|NCT01283581|20573068|P2|Overall Study|Withdrawal by Subject|5
5948552|NCT01283581|20573069|P1|Overall Study|Withdrawal by Subject|2
5948553|NCT01283581|20573067|P3|Overall Study|Lost to Follow-up|8
5948554|NCT01283581|20573068|P2|Overall Study|Lost to Follow-up|6
5948555|NCT01283581|20573069|P1|Overall Study|Lost to Follow-up|8
5948556|NCT01283542|20573139|P1|Extension Phase|Administrative problems|1
5948557|NCT01283542|20573139|P1|Extension Phase|Adverse Event|1
5948558|NCT01283542|20573139|P1|Extension Phase|Physician Decision|1
5948559|NCT01283542|20573139|P1|Main Phase|abnormal laboratory values|5
5948560|NCT01283542|20573139|P1|Main Phase|Uncontrolled diabetes mellitus|1
5948561|NCT01283542|20573139|P1|Main Phase|Acute or progressive vision loss|1
5948562|NCT01283516|20573204|P9|Overall Study|Lost to Follow-up|1
5948563|NCT01283516|20573205|P8|Overall Study|Lost to Follow-up|0
5948564|NCT01283516|20573206|P7|Overall Study|Lost to Follow-up|0
5948565|NCT01283516|20573207|P6|Overall Study|Lost to Follow-up|0
5948566|NCT01283516|20573208|P5|Overall Study|Lost to Follow-up|0
5948567|NCT01283516|20573209|P4|Overall Study|Lost to Follow-up|0
5948568|NCT01283516|20573210|P3|Overall Study|Lost to Follow-up|0
5948569|NCT01283516|20573211|P2|Overall Study|Lost to Follow-up|0
5948570|NCT01283516|20573212|P1|Overall Study|Lost to Follow-up|0
5948571|NCT01283516|20573204|P9|Overall Study|Administrative problems|39
5948572|NCT01283516|20573205|P8|Overall Study|Administrative problems|1
5948573|NCT01283516|20573206|P7|Overall Study|Administrative problems|1
5948574|NCT01283516|20573207|P6|Overall Study|Administrative problems|1
5948575|NCT01283516|20573208|P5|Overall Study|Administrative problems|0
5948576|NCT01283516|20573209|P4|Overall Study|Administrative problems|0
5948577|NCT01283516|20573210|P3|Overall Study|Administrative problems|0
5948578|NCT01283516|20573211|P2|Overall Study|Administrative problems|0
5948579|NCT01283516|20573212|P1|Overall Study|Administrative problems|0
5948580|NCT01283516|20573204|P9|Overall Study|Withdrawal by Subject|36
5948581|NCT01283516|20573205|P8|Overall Study|Withdrawal by Subject|0
5948582|NCT01283516|20573206|P7|Overall Study|Withdrawal by Subject|1
5948583|NCT01283516|20573207|P6|Overall Study|Withdrawal by Subject|0
5948584|NCT01283516|20573208|P5|Overall Study|Withdrawal by Subject|1
5948585|NCT01283516|20573209|P4|Overall Study|Withdrawal by Subject|0
5948586|NCT01283516|20573210|P3|Overall Study|Withdrawal by Subject|0
5948587|NCT01283516|20573211|P2|Overall Study|Withdrawal by Subject|0
5948588|NCT01283516|20573212|P1|Overall Study|Withdrawal by Subject|0
5948589|NCT01283516|20573204|P9|Overall Study|Disease Progression|139
5948590|NCT01283516|20573205|P8|Overall Study|Disease Progression|3
5948591|NCT01283516|20573206|P7|Overall Study|Disease Progression|6
5948592|NCT01283516|20573207|P6|Overall Study|Disease Progression|8
5948593|NCT01283516|20573208|P5|Overall Study|Disease Progression|13
5948594|NCT01283516|20573209|P4|Overall Study|Disease Progression|3
5948595|NCT01283516|20573210|P3|Overall Study|Disease Progression|3
5948596|NCT01283516|20573211|P2|Overall Study|Disease Progression|2
5948597|NCT01283516|20573212|P1|Overall Study|Disease Progression|2
5948598|NCT01283516|20573204|P9|Overall Study|Death|12
5948599|NCT01283516|20573205|P8|Overall Study|Death|1
5948600|NCT01283516|20573206|P7|Overall Study|Death|0
5948601|NCT01283516|20573207|P6|Overall Study|Death|1
5948602|NCT01283516|20573208|P5|Overall Study|Death|0
5948603|NCT01283516|20573209|P4|Overall Study|Death|0
5948604|NCT01283516|20573210|P3|Overall Study|Death|0
5948605|NCT01283516|20573211|P2|Overall Study|Death|0
5948606|NCT01283516|20573212|P1|Overall Study|Death|0
5948607|NCT01283516|20573204|P9|Overall Study|Adverse Event|28
5948608|NCT01283516|20573205|P8|Overall Study|Adverse Event|0
5948609|NCT01283516|20573206|P7|Overall Study|Adverse Event|2
5948610|NCT01283516|20573207|P6|Overall Study|Adverse Event|0
5948611|NCT01283516|20573208|P5|Overall Study|Adverse Event|0
5948612|NCT01283516|20573209|P4|Overall Study|Adverse Event|0
5948613|NCT01283516|20573210|P3|Overall Study|Adverse Event|0
5948614|NCT01283516|20573211|P2|Overall Study|Adverse Event|0
5948615|NCT01283516|20573212|P1|Overall Study|Adverse Event|0
5948616|NCT01283464|20573334|P2|Overall Study|Physician Decision|0
5948617|NCT01283464|20573335|P1|Overall Study|Physician Decision|1
5948618|NCT01283464|20573334|P2|Overall Study|Withdrawal by Subject|0
5948619|NCT01283464|20573335|P1|Overall Study|Withdrawal by Subject|1
5948620|NCT01283464|20573334|P2|Overall Study|Lost to Follow-up|1
5948621|NCT01283464|20573335|P1|Overall Study|Lost to Follow-up|0
5948622|NCT01283386|20573343|P2|Overall Study|Protocol Violation|1
5948623|NCT01283386|20573344|P1|Overall Study|Protocol Violation|0
5948624|NCT01283386|20573343|P2|Overall Study|Reason not specified|0
5948625|NCT01283386|20573344|P1|Overall Study|Reason not specified|1
5948626|NCT01283386|20573343|P2|Overall Study|Progression of underlying disease|7
5948627|NCT01283386|20573344|P1|Overall Study|Progression of underlying disease|2
5948628|NCT01283386|20573343|P2|Overall Study|Relapse of underlying disease|3
5948629|NCT01283386|20573344|P1|Overall Study|Relapse of underlying disease|1
5948630|NCT01283386|20573343|P2|Overall Study|Withdrawal by Subject|1
5948631|NCT01283386|20573344|P1|Overall Study|Withdrawal by Subject|2
5948632|NCT01283386|20573343|P2|Overall Study|Death|0
5948633|NCT01283386|20573344|P1|Overall Study|Death|2
5948634|NCT01283334|20573368|P1|Overall Study|Physician Decision|1
5948635|NCT01283334|20573368|P1|Overall Study|Adverse Event|4
5948636|NCT01283334|20573368|P1|Overall Study|Inability to Swallow Everolimus Pills|1
5948637|NCT01283334|20573368|P1|Overall Study|Withdrawal by Subject|1
5948638|NCT01283282|20573391|P2|First Intervention (6 Weeks)|Lost to Follow-up|0
5948639|NCT01283282|20573392|P1|First Intervention (6 Weeks)|Lost to Follow-up|1
5948640|NCT01283282|20573391|P2|First Intervention (6 Weeks)|Withdrawal by Subject|3
5948641|NCT01283282|20573392|P1|First Intervention (6 Weeks)|Withdrawal by Subject|2
5948642|NCT01283282|20573391|P2|First Intervention (6 Weeks)|Physician Decision|1
5948643|NCT01283282|20573392|P1|First Intervention (6 Weeks)|Physician Decision|0
5948644|NCT01283152|20573412|P2|Overall Study|Refused HESA|0
5948645|NCT01283152|20573413|P1|Overall Study|Refused HESA|1
5948646|NCT01283152|20573412|P2|Overall Study|Discharged prior to 24 hr assessment|0
5948647|NCT01283152|20573413|P1|Overall Study|Discharged prior to 24 hr assessment|1
5948648|NCT01283139|20573427|P4|Overall Study|Participant randomized in error|0
5948649|NCT01283139|20573428|P3|Overall Study|Participant randomized in error|1
5948650|NCT01283139|20573429|P2|Overall Study|Participant randomized in error|0
5948651|NCT01283139|20573430|P1|Overall Study|Participant randomized in error|0
5948652|NCT01283139|20573427|P4|Overall Study|Missed follow-up visit|2
5948653|NCT01283139|20573428|P3|Overall Study|Missed follow-up visit|2
5948654|NCT01283139|20573429|P2|Overall Study|Missed follow-up visit|1
5948655|NCT01283139|20573430|P1|Overall Study|Missed follow-up visit|0
5948656|NCT01283139|20573427|P4|Overall Study|Pregnancy|0
5948657|NCT01283139|20573428|P3|Overall Study|Pregnancy|1
5948658|NCT01283139|20573429|P2|Overall Study|Pregnancy|1
5948659|NCT01283139|20573430|P1|Overall Study|Pregnancy|0
5948660|NCT01283139|20573427|P4|Overall Study|Participant's refusal to continue|1
5948661|NCT01283139|20573428|P3|Overall Study|Participant's refusal to continue|1
5948662|NCT01283139|20573429|P2|Overall Study|Participant's refusal to continue|3
5948663|NCT01283139|20573430|P1|Overall Study|Participant's refusal to continue|0
5948664|NCT01283139|20573427|P4|Overall Study|Early termination due to AE/SAE|0
5948665|NCT01283139|20573428|P3|Overall Study|Early termination due to AE/SAE|0
5948666|NCT01283139|20573429|P2|Overall Study|Early termination due to AE/SAE|1
5948667|NCT01283139|20573430|P1|Overall Study|Early termination due to AE/SAE|1
5948668|NCT01283139|20573427|P4|Overall Study|Lack of Efficacy|1
5948669|NCT01283139|20573428|P3|Overall Study|Lack of Efficacy|2
5948670|NCT01283139|20573429|P2|Overall Study|Lack of Efficacy|2
5948671|NCT01283139|20573430|P1|Overall Study|Lack of Efficacy|1
5948672|NCT01283139|20573427|P4|Overall Study|Death|2
5948673|NCT01283139|20573428|P3|Overall Study|Death|2
5948674|NCT01283139|20573429|P2|Overall Study|Death|0
5948675|NCT01283139|20573430|P1|Overall Study|Death|2
5948676|NCT01283139|20573427|P4|Overall Study|Withdrawal by Subject|8
5948677|NCT01283139|20573428|P3|Overall Study|Withdrawal by Subject|6
5948678|NCT01283139|20573429|P2|Overall Study|Withdrawal by Subject|8
5948679|NCT01283139|20573430|P1|Overall Study|Withdrawal by Subject|8
5948680|NCT01283139|20573427|P4|Overall Study|Lost to Follow-up|1
5948681|NCT01283139|20573428|P3|Overall Study|Lost to Follow-up|3
5948682|NCT01283139|20573429|P2|Overall Study|Lost to Follow-up|2
5948683|NCT01283139|20573430|P1|Overall Study|Lost to Follow-up|5
5948684|NCT01283035|20573472|P1|Overall Study|Subject later found ineligible|1
5948685|NCT01283009|20573489|P2|Overall Study|Patient Withdrawn by LAR/DPOA|4
5948686|NCT01283009|20573490|P1|Overall Study|Patient Withdrawn by LAR/DPOA|0
5948687|NCT01283009|20573489|P2|Overall Study|Lost to Follow-up|0
5948688|NCT01283009|20573490|P1|Overall Study|Lost to Follow-up|1
5948689|NCT01283009|20573489|P2|Overall Study|Physician Decision|1
5948690|NCT01283009|20573490|P1|Overall Study|Physician Decision|1
5948691|NCT01283009|20573489|P2|Overall Study|Withdrawal by Subject|8
5948692|NCT01283009|20573490|P1|Overall Study|Withdrawal by Subject|10
5948693|NCT01283009|20573489|P2|Overall Study|Study ended early|26
5948694|NCT01283009|20573490|P1|Overall Study|Study ended early|23
5948695|NCT01283009|20573489|P2|Overall Study|Death|78
5948696|NCT01283009|20573490|P1|Overall Study|Death|83
5948697|NCT01282866|20573496|P1|Overall Study|Adverse Event|1
5948698|NCT01282814|20573504|P2|Washout of 7 Days|Withdrawal by Subject|0
5948699|NCT01282814|20573505|P1|Washout of 7 Days|Withdrawal by Subject|2
5948700|NCT01282814|20573504|P2|First Intervention|Emesis During Dosing Interval|3
5948701|NCT01282814|20573505|P1|First Intervention|Emesis During Dosing Interval|0
5948702|NCT01282801|20573517|P2|Second Intervention|Emesis During Critical Breakfast|1
5948703|NCT01282801|20573518|P1|Second Intervention|Emesis During Critical Breakfast|0
5948704|NCT01282476|20573542|P1|Overall Study|Death|11
5948705|NCT01282463|20573551|P3|Overall Study|Physician Decision|0
5948706|NCT01282463|20573552|P2|Overall Study|Physician Decision|0
5948707|NCT01282463|20573553|P1|Overall Study|Physician Decision|1
5948708|NCT01282463|20573551|P3|Overall Study|Protocol Violation|1
5948709|NCT01282463|20573552|P2|Overall Study|Protocol Violation|0
5948710|NCT01282463|20573553|P1|Overall Study|Protocol Violation|0
5948711|NCT01282463|20573551|P3|Overall Study|"Never Treated PD"|0
5948712|NCT01282463|20573552|P2|Overall Study|"Never Treated PD"|1
5948713|NCT01282463|20573553|P1|Overall Study|"Never Treated PD"|0
5948714|NCT01282463|20573551|P3|Overall Study|"Never Treated Death"|0
5948715|NCT01282463|20573552|P2|Overall Study|"Never Treated Death"|1
5948716|NCT01282463|20573553|P1|Overall Study|"Never Treated Death"|0
5948717|NCT01282463|20573551|P3|Overall Study|Withdrawal by Subject|3
5948718|NCT01282463|20573552|P2|Overall Study|Withdrawal by Subject|2
5948719|NCT01282463|20573553|P1|Overall Study|Withdrawal by Subject|6
5948720|NCT01282463|20573551|P3|Overall Study|Lost to Follow-up|0
5948721|NCT01282463|20573552|P2|Overall Study|Lost to Follow-up|0
5948722|NCT01282463|20573553|P1|Overall Study|Lost to Follow-up|1
5948723|NCT01282424|20573591|P1|Long-term Follow-up Period (5 Years)|Other (Unknown)|21
5948724|NCT01282424|20573591|P1|Long-term Follow-up Period (5 Years)|Lost to Follow-up|1
5948725|NCT01282424|20573591|P1|Long-term Follow-up Period (5 Years)|Death|40
5948726|NCT01282424|20573591|P1|Long-term Follow-up Period (5 Years)|Withdrew Consent|2
5948727|NCT01282424|20573591|P1|Treatment Period (TP) (81 Months)|Other (Unknown)|3
5948728|NCT01282424|20573591|P1|Treatment Period (TP) (81 Months)|Investigator Request|7
5948729|NCT01282424|20573591|P1|Treatment Period (TP) (81 Months)|Withdrew Consent|6
5948730|NCT01282424|20573591|P1|Treatment Period (TP) (81 Months)|Adverse Event|30
5948731|NCT01282372|20573608|P1|Overall Study|Adverse Event|12
5948732|NCT01282372|20573608|P1|Overall Study|Refer Pre-Assignment Detail for Reason 2|1
5948733|NCT01282372|20573608|P1|Overall Study|Presence of AE, Regression of Symptoms|1
5948734|NCT01282372|20573608|P1|Overall Study|Presence of AE, Lack of Efficacy|1
5948735|NCT01282372|20573608|P1|Overall Study|Death|1
5948736|NCT01282372|20573608|P1|Overall Study|Refer Pre-Assignment Detail for Reason 1|4
5948737|NCT01282372|20573608|P1|Overall Study|Withdrawal by Subject|11
5948738|NCT01282372|20573608|P1|Overall Study|Lost to Follow-up|23
5948739|NCT01282372|20573608|P1|Overall Study|Lack of Efficacy / Exacerbation|25
5948740|NCT01282294|20573636|P1|Overall Study|Physician Decision|1
5948741|NCT01282294|20573636|P1|Overall Study|Patient non-compliance|2
5948742|NCT01282294|20573636|P1|Overall Study|Adverse Event|1
5948743|NCT01282294|20573636|P1|Overall Study|Screening failure|1
5948744|NCT01282294|20573636|P1|Overall Study|Lost to Follow-up|14
5948745|NCT01282229|20573665|P1|Overall Study|Protocol Violation|2
5948746|NCT01282216|20573697|P4|Overall Study|Death|0
5948747|NCT01282216|20573698|P3|Overall Study|Death|2
5948748|NCT01282216|20573699|P2|Overall Study|Death|0
5948749|NCT01282216|20573700|P1|Overall Study|Death|0
5948750|NCT01282216|20573697|P4|Overall Study|Relapse|6
5948751|NCT01282216|20573698|P3|Overall Study|Relapse|17
5948752|NCT01282216|20573699|P2|Overall Study|Relapse|0
5948753|NCT01282216|20573700|P1|Overall Study|Relapse|0
5948754|NCT01282216|20573697|P4|Overall Study|Physician Decision|0
5948755|NCT01282216|20573698|P3|Overall Study|Physician Decision|11
5948756|NCT01282216|20573699|P2|Overall Study|Physician Decision|0
5948757|NCT01282216|20573700|P1|Overall Study|Physician Decision|0
5948758|NCT01282216|20573697|P4|Overall Study|Graft failure|2
5948759|NCT01282216|20573698|P3|Overall Study|Graft failure|3
5948760|NCT01282216|20573699|P2|Overall Study|Graft failure|0
5948761|NCT01282216|20573700|P1|Overall Study|Graft failure|0
5948762|NCT01282203|20573710|P1|Overall Study|Adverse Event|1
5948763|NCT01282164|20573732|P2|Overall Study|Lack of hypoglycemia during ITT|0
5948764|NCT01282164|20573733|P1|Overall Study|Lack of hypoglycemia during ITT|1
5948765|NCT01281969|20573786|P3|Overall Study|not randomized, child consent not given|2
5948766|NCT01281969|20573787|P2|Overall Study|not randomized, child consent not given|0
5948767|NCT01281969|20573788|P1|Overall Study|not randomized, child consent not given|0
5948768|NCT01281969|20573786|P3|Overall Study|AE during LP prior to IVIG admin|3
5948769|NCT01281969|20573787|P2|Overall Study|AE during LP prior to IVIG admin|0
5948770|NCT01281969|20573788|P1|Overall Study|AE during LP prior to IVIG admin|1
5948771|NCT01281969|20573786|P3|Overall Study|not randomized didn't meet criteria|7
5948772|NCT01281969|20573787|P2|Overall Study|not randomized didn't meet criteria|0
5948773|NCT01281969|20573788|P1|Overall Study|not randomized didn't meet criteria|0
5948774|NCT01281956|20573800|P2|2nd Intervention (3 Months)|Withdrawal by Subject|0
5948775|NCT01281956|20573801|P1|2nd Intervention (3 Months)|Withdrawal by Subject|1
5948776|NCT01281917|20573832|P1|Overall Study|Withdrawal by Subject|1
5948777|NCT01281865|20573844|P2|Overall Study|Lack of Efficacy|0
5948778|NCT01281865|20573845|P1|Overall Study|Lack of Efficacy|1
5948779|NCT01281865|20573844|P2|Overall Study|Withdrawal by Subject|0
5948780|NCT01281865|20573845|P1|Overall Study|Withdrawal by Subject|1
5948781|NCT01281865|20573844|P2|Overall Study|Adverse Event|1
5948782|NCT01281865|20573845|P1|Overall Study|Adverse Event|1
5948783|NCT01281839|20573853|P2|Overall Study|Reason not specified|1
5948784|NCT01281839|20573854|P1|Overall Study|Reason not specified|0
5948785|NCT01281839|20573853|P2|Overall Study|Withdrawal by Subject|10
5948786|NCT01281839|20573854|P1|Overall Study|Withdrawal by Subject|4
5948787|NCT01281839|20573853|P2|Overall Study|Lost to Follow-up|3
5948788|NCT01281839|20573854|P1|Overall Study|Lost to Follow-up|6
5948789|NCT01281644|20573915|P1|Overall Study|Withdrawal by Subject|2
5948790|NCT01281644|20573915|P1|Overall Study|Lost to Follow-up|3
5948791|NCT01281306|20573956|P7|Overall Study|Randomized in error|0
5948792|NCT01281306|20573957|P6|Overall Study|Randomized in error|0
5948793|NCT01281306|20573958|P5|Overall Study|Randomized in error|0
5948794|NCT01281306|20573959|P4|Overall Study|Randomized in error|1
5948795|NCT01281306|20573960|P3|Overall Study|Randomized in error|0
5948796|NCT01281306|20573961|P2|Overall Study|Randomized in error|0
5948797|NCT01281306|20573962|P1|Overall Study|Randomized in error|1
5948798|NCT01281306|20573956|P7|Overall Study|Adverse Event|3
5948799|NCT01281306|20573957|P6|Overall Study|Adverse Event|3
5948800|NCT01281306|20573958|P5|Overall Study|Adverse Event|5
5948801|NCT01281306|20573959|P4|Overall Study|Adverse Event|3
5948802|NCT01281306|20573960|P3|Overall Study|Adverse Event|2
5948803|NCT01281306|20573961|P2|Overall Study|Adverse Event|2
5948804|NCT01281306|20573962|P1|Overall Study|Adverse Event|3
5948805|NCT01281306|20573956|P7|Overall Study|Death|0
5948806|NCT01281306|20573957|P6|Overall Study|Death|0
5948807|NCT01281306|20573958|P5|Overall Study|Death|0
5948808|NCT01281306|20573959|P4|Overall Study|Death|0
5948809|NCT01281306|20573960|P3|Overall Study|Death|0
5948810|NCT01281306|20573961|P2|Overall Study|Death|0
5948811|NCT01281306|20573962|P1|Overall Study|Death|1
5948812|NCT01281306|20573956|P7|Overall Study|Lost to Follow-up|1
5948813|NCT01281306|20573957|P6|Overall Study|Lost to Follow-up|0
5948814|NCT01281306|20573958|P5|Overall Study|Lost to Follow-up|0
5948815|NCT01281306|20573959|P4|Overall Study|Lost to Follow-up|2
5948816|NCT01281306|20573960|P3|Overall Study|Lost to Follow-up|0
5948817|NCT01281306|20573961|P2|Overall Study|Lost to Follow-up|0
5948818|NCT01281306|20573962|P1|Overall Study|Lost to Follow-up|1
5948819|NCT01281306|20573956|P7|Overall Study|Condition no longer requires study drug|1
5948820|NCT01281306|20573957|P6|Overall Study|Condition no longer requires study drug|1
5948821|NCT01281306|20573958|P5|Overall Study|Condition no longer requires study drug|0
5948822|NCT01281306|20573959|P4|Overall Study|Condition no longer requires study drug|0
5948823|NCT01281306|20573960|P3|Overall Study|Condition no longer requires study drug|0
5948824|NCT01281306|20573961|P2|Overall Study|Condition no longer requires study drug|0
5948825|NCT01281306|20573962|P1|Overall Study|Condition no longer requires study drug|1
5948826|NCT01281306|20573956|P7|Overall Study|Protocol deviation|0
5948827|NCT01281306|20573957|P6|Overall Study|Protocol deviation|0
5948828|NCT01281306|20573958|P5|Overall Study|Protocol deviation|1
5948829|NCT01281306|20573959|P4|Overall Study|Protocol deviation|1
5948830|NCT01281306|20573960|P3|Overall Study|Protocol deviation|1
5948831|NCT01281306|20573961|P2|Overall Study|Protocol deviation|1
5948832|NCT01281306|20573962|P1|Overall Study|Protocol deviation|0
5948833|NCT01281306|20573956|P7|Overall Study|Withdrawal by Subject|1
5948834|NCT01281306|20573957|P6|Overall Study|Withdrawal by Subject|3
5948835|NCT01281306|20573958|P5|Overall Study|Withdrawal by Subject|1
5948836|NCT01281306|20573959|P4|Overall Study|Withdrawal by Subject|4
5948837|NCT01281306|20573960|P3|Overall Study|Withdrawal by Subject|2
5948838|NCT01281306|20573961|P2|Overall Study|Withdrawal by Subject|0
5948839|NCT01281306|20573962|P1|Overall Study|Withdrawal by Subject|1
5948840|NCT01281306|20573956|P7|Overall Study|Lack of Efficacy|1
5948841|NCT01281306|20573957|P6|Overall Study|Lack of Efficacy|0
5948842|NCT01281306|20573958|P5|Overall Study|Lack of Efficacy|2
5948843|NCT01281306|20573959|P4|Overall Study|Lack of Efficacy|0
5948844|NCT01281306|20573960|P3|Overall Study|Lack of Efficacy|3
5948845|NCT01281306|20573961|P2|Overall Study|Lack of Efficacy|1
5948846|NCT01281306|20573962|P1|Overall Study|Lack of Efficacy|0
5948847|NCT01281202|20574078|P2|Overall Study|Incarceration|3
5948848|NCT01281202|20574079|P1|Overall Study|Incarceration|0
5948849|NCT01281202|20574078|P2|Overall Study|Lost to Follow-up|13
5948850|NCT01281202|20574079|P1|Overall Study|Lost to Follow-up|11
5948851|NCT01281202|20574078|P2|Overall Study|Administrative|8
5948852|NCT01281202|20574079|P1|Overall Study|Administrative|2
5948853|NCT01281202|20574078|P2|Overall Study|Protocol Violation|10
5948854|NCT01281202|20574079|P1|Overall Study|Protocol Violation|11
5948855|NCT01281202|20574078|P2|Overall Study|Withdrawal by Subject|2
5948856|NCT01281202|20574079|P1|Overall Study|Withdrawal by Subject|2
5948857|NCT01281202|20574078|P2|Overall Study|Adverse Event|0
5948858|NCT01281202|20574079|P1|Overall Study|Adverse Event|2
5948859|NCT01281124|20574087|P1|Overall Study|Death|1
5948860|NCT01280981|20574102|P1|Overall Study|Study site closure|1
5948861|NCT01280981|20574102|P1|Overall Study|Elective surgery|2
5948862|NCT01280981|20574102|P1|Overall Study|Withdrawal of consent|3
5948863|NCT01280981|20574102|P1|Overall Study|Non-compliance with protocol|3
5948864|NCT01280981|20574102|P1|Overall Study|Failed to return|45
5948865|NCT01280981|20574102|P1|Overall Study|Irregular or discontinued menses|3
5948866|NCT01280981|20574102|P1|Overall Study|Adverse Event|6
5948867|NCT01280981|20574102|P1|Overall Study|Lost to Follow-up|3
5948868|NCT01280981|20574102|P1|Overall Study|Lack of Efficacy|13
5948869|NCT01280981|20574102|P1|Overall Study|Protocol Violation|2
5948870|NCT01280981|20574102|P1|Overall Study|Withdrawal by Subject|11
5948871|NCT01280968|20574113|P2|Overall Study|Unable to Smoke in Supine Position|0
5948872|NCT01280968|20574114|P1|Overall Study|Unable to Smoke in Supine Position|1
5948873|NCT01280968|20574113|P2|Overall Study|Pre-existing Neurological Condition|0
5948874|NCT01280968|20574114|P1|Overall Study|Pre-existing Neurological Condition|1
5948875|NCT01280968|20574113|P2|Overall Study|Scheduling Conflicts|1
5948876|NCT01280968|20574114|P1|Overall Study|Scheduling Conflicts|1
5948877|NCT01280968|20574113|P2|Overall Study|Adverse Event|0
5948878|NCT01280968|20574114|P1|Overall Study|Adverse Event|1
5948879|NCT01280968|20574113|P2|Overall Study|Anxiety|0
5948880|NCT01280968|20574114|P1|Overall Study|Anxiety|2
5948881|NCT01280968|20574113|P2|Overall Study|Commuting Problems|0
5948882|NCT01280968|20574114|P1|Overall Study|Commuting Problems|2
5948883|NCT01280968|20574113|P2|Overall Study|Unable to Follow Experimental Protocol|0
5948884|NCT01280968|20574114|P1|Overall Study|Unable to Follow Experimental Protocol|2
5948885|NCT01280968|20574113|P2|Overall Study|Lost to Follow-up|2
5948886|NCT01280968|20574114|P1|Overall Study|Lost to Follow-up|8
5948887|NCT01280955|20574130|P1|Overall Study|Withdrawal by Subject|1
5948888|NCT01280955|20574130|P1|Overall Study|Death|2
5948889|NCT01280903|20574174|P2|Overall Study|Lost to Follow-up|16
5948890|NCT01280903|20574175|P1|Overall Study|Lost to Follow-up|23
5948891|NCT01280812|20574242|P3|Overall Study|Lost to Follow-up|1
5948892|NCT01280812|20574243|P2|Overall Study|Lost to Follow-up|1
5948893|NCT01280812|20574244|P1|Overall Study|Lost to Follow-up|1
5948894|NCT01280812|20574242|P3|Overall Study|Withdrawal by Subject|0
5948895|NCT01280812|20574243|P2|Overall Study|Withdrawal by Subject|1
5948896|NCT01280812|20574244|P1|Overall Study|Withdrawal by Subject|2
5948897|NCT01280721|20574267|P1|Overall Study|No tolerability for the lowest dose|2
5948898|NCT01280721|20574267|P1|Overall Study|eGFR under the withdrawal criteria|7
5948899|NCT01280721|20574267|P1|Overall Study|Withdrawal by Subject|6
5948900|NCT01280721|20574267|P1|Overall Study|Physician Decision|3
5948901|NCT01280721|20574267|P1|Overall Study|Adverse Event|4
5948902|NCT01280656|20574331|P3|Overall Study|Other|7
5948903|NCT01280656|20574332|P2|Overall Study|Other|7
5948904|NCT01280656|20574333|P1|Overall Study|Other|1
5948905|NCT01280656|20574331|P3|Overall Study|Treatment shortening (RGT)|5
5948906|NCT01280656|20574332|P2|Overall Study|Treatment shortening (RGT)|4
5948907|NCT01280656|20574333|P1|Overall Study|Treatment shortening (RGT)|0
5948908|NCT01280656|20574331|P3|Overall Study|Lack of Efficacy|38
5948909|NCT01280656|20574332|P2|Overall Study|Lack of Efficacy|22
5948910|NCT01280656|20574333|P1|Overall Study|Lack of Efficacy|1
5948911|NCT01280656|20574331|P3|Overall Study|Adverse Event|13
5948912|NCT01280656|20574332|P2|Overall Study|Adverse Event|14
5948913|NCT01280656|20574333|P1|Overall Study|Adverse Event|1
5948914|NCT01280591|20574400|P4|Overall Study|Does not meet exclusion #27 criteria|1
5948915|NCT01280591|20574401|P3|Overall Study|Does not meet exclusion #27 criteria|0
5948916|NCT01280591|20574402|P2|Overall Study|Does not meet exclusion #27 criteria|0
5948917|NCT01280591|20574403|P1|Overall Study|Does not meet exclusion #27 criteria|0
5948918|NCT01280591|20574400|P4|Overall Study|Withdrawal by Subject|2
5948919|NCT01280591|20574401|P3|Overall Study|Withdrawal by Subject|0
5948920|NCT01280591|20574402|P2|Overall Study|Withdrawal by Subject|0
5948921|NCT01280591|20574403|P1|Overall Study|Withdrawal by Subject|0
5948922|NCT01280357|20574541|P1|Overall Study|IInsufficient data/No data supplied|12
5948923|NCT01280357|20574541|P1|Overall Study|Excluded no internal monitoring|14
5948924|NCT01280266|20574550|P2|First Intervention (Week 1-4)|Withdrawal by Subject|2
5948925|NCT01280266|20574551|P1|First Intervention (Week 1-4)|Withdrawal by Subject|0
5948926|NCT01280266|20574550|P2|First Intervention (Week 1-4)|Adverse Event|0
5948927|NCT01280266|20574551|P1|First Intervention (Week 1-4)|Adverse Event|1
5948928|NCT01279954|20574642|P2|Overall Study|Lack of Efficacy|4
5948929|NCT01279954|20574643|P1|Overall Study|Lack of Efficacy|3
5948930|NCT01279850|20574654|P1|Overall Study|No Visit After Treatment|34
5948931|NCT01279850|20574654|P1|Overall Study|No Drug Administration Information|7
5948932|NCT01279850|20574654|P1|Overall Study|Protocol Violation|50
5948933|NCT01279681|20574670|P2|Overall Study|Other Reason|2
5948934|NCT01279681|20574671|P1|Overall Study|Other Reason|0
5948935|NCT01279681|20574670|P2|Overall Study|Physician Decision|0
5948936|NCT01279681|20574671|P1|Overall Study|Physician Decision|1
5948937|NCT01279681|20574670|P2|Overall Study|Withdrawal Prior to Beginning Treatment|1
5948938|NCT01279681|20574671|P1|Overall Study|Withdrawal Prior to Beginning Treatment|0
5948939|NCT01279681|20574670|P2|Overall Study|Death|1
5948940|NCT01279681|20574671|P1|Overall Study|Death|0
5948941|NCT01279681|20574670|P2|Overall Study|Adverse Event|3
5948942|NCT01279681|20574671|P1|Overall Study|Adverse Event|2
5948943|NCT01279681|20574670|P2|Overall Study|Withdrawal by Subject|4
5948944|NCT01279681|20574671|P1|Overall Study|Withdrawal by Subject|3
5948945|NCT01279681|20574670|P2|Overall Study|Disease Progression|6
5948946|NCT01279681|20574671|P1|Overall Study|Disease Progression|9
5948947|NCT01279616|20574683|P1|Overall Study|no signs of sickle cell disease|2
5948948|NCT01279616|20574683|P1|Overall Study|donor could not be located|5
5948949|NCT01279486|20574696|P1|Overall Study|Lost to Follow-up|1
5948950|NCT01279447|20574702|P2|Overall Study|Lost to Follow-up|1
5948951|NCT01279447|20574703|P1|Overall Study|Lost to Follow-up|3
5948952|NCT01279343|20574711|P2|Overall Study|Did not receive treatment|6
5948953|NCT01279343|20574712|P1|Overall Study|Did not receive treatment|2
5948954|NCT01279200|20574757|P2|Overall Study|Adverse Event|0
5948955|NCT01279200|20574758|P1|Overall Study|Adverse Event|1
5948956|NCT01279200|20574757|P2|Overall Study|Lost to Follow-up|1
5948957|NCT01279200|20574758|P1|Overall Study|Lost to Follow-up|0
5948958|NCT01279200|20574757|P2|Overall Study|ultrasound screening failure|1
5948959|NCT01279200|20574758|P1|Overall Study|ultrasound screening failure|0
5948960|NCT01279200|20574757|P2|Overall Study|Inconvenience of ultrasound visit|1
5948961|NCT01279200|20574758|P1|Overall Study|Inconvenience of ultrasound visit|0
5948962|NCT01279200|20574757|P2|Overall Study|Patient withdrawal due to high cost|1
5948963|NCT01279200|20574758|P1|Overall Study|Patient withdrawal due to high cost|0
5948964|NCT01279200|20574757|P2|Overall Study|Withdrawal by Subject|3
5948965|NCT01279200|20574758|P1|Overall Study|Withdrawal by Subject|1
5948966|NCT01279070|20574796|P2|Overall Study|Acute exacerbation|1
5948967|NCT01279070|20574797|P1|Overall Study|Acute exacerbation|3
5948968|NCT01279070|20574796|P2|Overall Study|Withdrawal by Subject|3
5948969|NCT01279070|20574797|P1|Overall Study|Withdrawal by Subject|2
5948970|NCT01279044|20574816|P3|PHASE 2 - Randmonized Controlled Trial|Death|1
5948971|NCT01279044|20574817|P2|PHASE 2 - Randmonized Controlled Trial|Death|0
5948972|NCT01279044|20574818|P1|PHASE 2 - Randmonized Controlled Trial|Death|0
5948973|NCT01279044|20574816|P3|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0
5948974|NCT01279044|20574817|P2|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|8
5948975|NCT01279044|20574818|P1|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0
5948976|NCT01279044|20574816|P3|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|2
5948977|NCT01279044|20574817|P2|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|3
5948978|NCT01279044|20574818|P1|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|0
5948979|NCT01278862|20574894|P2|Overall Study|Lost to Follow-up|1
5948980|NCT01278862|20574895|P1|Overall Study|Lost to Follow-up|1
5948981|NCT01278797|20574903|P2|Period 1|Protocol Violation|0
5948982|NCT01278797|20574904|P1|Period 1|Protocol Violation|1
5948983|NCT01278797|20574903|P2|Period 1|Adverse Event|1
5948984|NCT01278797|20574904|P1|Period 1|Adverse Event|0
5948985|NCT01278745|20574916|P4|Overall Study|Moves,enrollment in mx studies, et al.|1
5948986|NCT01278745|20574917|P3|Overall Study|Moves,enrollment in mx studies, et al.|5
5948987|NCT01278745|20574918|P2|Overall Study|Moves,enrollment in mx studies, et al.|0
5948988|NCT01278745|20574919|P1|Overall Study|Moves,enrollment in mx studies, et al.|0
5948989|NCT01278745|20574916|P4|Overall Study|Ineligible|61
5948990|NCT01278745|20574917|P3|Overall Study|Ineligible|42
5948991|NCT01278745|20574918|P2|Overall Study|Ineligible|0
5948992|NCT01278745|20574919|P1|Overall Study|Ineligible|0
5948993|NCT01278745|20574916|P4|Overall Study|Sponsor Decision|6
5948994|NCT01278745|20574917|P3|Overall Study|Sponsor Decision|62
5948995|NCT01278745|20574918|P2|Overall Study|Sponsor Decision|0
5948996|NCT01278745|20574919|P1|Overall Study|Sponsor Decision|1
5948997|NCT01278745|20574916|P4|Overall Study|Withdrawal by Subject|1
5948998|NCT01278745|20574917|P3|Overall Study|Withdrawal by Subject|5
5948999|NCT01278745|20574918|P2|Overall Study|Withdrawal by Subject|1
5949000|NCT01278745|20574919|P1|Overall Study|Withdrawal by Subject|1
5949001|NCT01278745|20574916|P4|Overall Study|Physician Decision|9
5949002|NCT01278745|20574917|P3|Overall Study|Physician Decision|0
5949003|NCT01278745|20574918|P2|Overall Study|Physician Decision|0
5949004|NCT01278745|20574919|P1|Overall Study|Physician Decision|1
5949005|NCT01278745|20574916|P4|Overall Study|Death|0
5949006|NCT01278745|20574917|P3|Overall Study|Death|7
5949007|NCT01278745|20574918|P2|Overall Study|Death|5
5949008|NCT01278745|20574919|P1|Overall Study|Death|2
5949009|NCT01278615|20574951|P1|Overall Study|Withdrawal by Subject|2
5949010|NCT01278407|20574977|P5|Extension Phase|Other|3
5949011|NCT01278407|20574978|P4|Extension Phase|Other|1
5949012|NCT01278407|20574979|P3|Extension Phase|Other|0
5949013|NCT01278407|20574980|P2|Extension Phase|Other|0
5949014|NCT01278407|20574981|P1|Extension Phase|Other|0
5949015|NCT01278407|20574977|P5|Extension Phase|Participant's Choice|11
5949016|NCT01278407|20574978|P4|Extension Phase|Participant's Choice|4
5949017|NCT01278407|20574979|P3|Extension Phase|Participant's Choice|0
5949018|NCT01278407|20574980|P2|Extension Phase|Participant's Choice|0
5949019|NCT01278407|20574981|P1|Extension Phase|Participant's Choice|0
5949020|NCT01278407|20574977|P5|Extension Phase|Adverse Event|16
5949021|NCT01278407|20574978|P4|Extension Phase|Adverse Event|7
5949022|NCT01278407|20574979|P3|Extension Phase|Adverse Event|0
5949023|NCT01278407|20574980|P2|Extension Phase|Adverse Event|0
5949024|NCT01278407|20574981|P1|Extension Phase|Adverse Event|0
5949025|NCT01278407|20574977|P5|Confirmatory Phase|Other|0
5949026|NCT01278407|20574978|P4|Confirmatory Phase|Other|0
5949027|NCT01278407|20574979|P3|Confirmatory Phase|Other|2
5949028|NCT01278407|20574980|P2|Confirmatory Phase|Other|1
5949029|NCT01278407|20574981|P1|Confirmatory Phase|Other|1
5949030|NCT01278407|20574977|P5|Confirmatory Phase|Participant's Choice|0
5949031|NCT01278407|20574978|P4|Confirmatory Phase|Participant's Choice|0
5949032|NCT01278407|20574979|P3|Confirmatory Phase|Participant's Choice|3
5949033|NCT01278407|20574980|P2|Confirmatory Phase|Participant's Choice|5
5949034|NCT01278407|20574981|P1|Confirmatory Phase|Participant's Choice|3
5949035|NCT01278407|20574977|P5|Confirmatory Phase|Adverse Event|0
5949036|NCT01278407|20574978|P4|Confirmatory Phase|Adverse Event|0
5949037|NCT01278407|20574979|P3|Confirmatory Phase|Adverse Event|1
5949038|NCT01278407|20574980|P2|Confirmatory Phase|Adverse Event|10
5949039|NCT01278407|20574981|P1|Confirmatory Phase|Adverse Event|5
5949040|NCT01278394|20574994|P1|Overall Study|Lost to Follow-up|1
5949041|NCT01278342|20575007|P3|Overall Study|Other|0
5949042|NCT01278342|20575008|P2|Overall Study|Other|0
5949043|NCT01278342|20575009|P1|Overall Study|Other|1
5949044|NCT01278342|20575007|P3|Overall Study|Administrative problems|0
5949045|NCT01278342|20575008|P2|Overall Study|Administrative problems|0
5949046|NCT01278342|20575009|P1|Overall Study|Administrative problems|2
5949047|NCT01278342|20575007|P3|Overall Study|Lost to Follow-up|0
5949048|NCT01278342|20575008|P2|Overall Study|Lost to Follow-up|0
5949049|NCT01278342|20575009|P1|Overall Study|Lost to Follow-up|1
5949050|NCT01278342|20575007|P3|Overall Study|Physician Decision|0
5949051|NCT01278342|20575008|P2|Overall Study|Physician Decision|1
5949052|NCT01278342|20575009|P1|Overall Study|Physician Decision|0
5949053|NCT01278173|20575029|P1|Overall Study|Withdrawal by Subject|1
5949054|NCT01278173|20575029|P1|Overall Study|Protocol Violation|1
5949055|NCT01278173|20575029|P1|Overall Study|Administrative or other reason|4
5949056|NCT01278173|20575029|P1|Overall Study|Adverse Event|8
5949057|NCT01278173|20575029|P1|Overall Study|Lack of Efficacy|13
5949058|NCT01278160|20575036|P2|Overall Study|Unclassified|2
5949059|NCT01278160|20575037|P1|Overall Study|Unclassified|1
5949060|NCT01278160|20575036|P2|Overall Study|Withdrawal by Subject|2
5949061|NCT01278160|20575037|P1|Overall Study|Withdrawal by Subject|3
5949062|NCT01278160|20575036|P2|Overall Study|Lost to Follow-up|1
5949063|NCT01278160|20575037|P1|Overall Study|Lost to Follow-up|0
5949064|NCT01278160|20575036|P2|Overall Study|Adverse Event|1
5949065|NCT01278160|20575037|P1|Overall Study|Adverse Event|1
5949066|NCT01278030|20575053|P2|Overall Study|Withdrawal by Subject|4
5949067|NCT01278030|20575054|P1|Overall Study|Withdrawal by Subject|8
5949068|NCT01277887|20575062|P2|Post-Quit Treatment Phase|No longer interested in treatment|5
5949069|NCT01277887|20575063|P1|Post-Quit Treatment Phase|No longer interested in treatment|3
5949070|NCT01277887|20575062|P2|Pre-Quit Treatment Phase|Withdrawal by Subject|0
5949071|NCT01277887|20575063|P1|Pre-Quit Treatment Phase|Withdrawal by Subject|2
5949072|NCT01277887|20575062|P2|Pre-Quit Treatment Phase|No longer interested in treatment|0
5949073|NCT01277887|20575063|P1|Pre-Quit Treatment Phase|No longer interested in treatment|1
5949074|NCT01277861|20575075|P2|Overall Study|Physician Decision|2
5949075|NCT01277861|20575076|P1|Overall Study|Physician Decision|2
5949076|NCT01277822|20575088|P2|Overall Study|Participant moved|0
5949077|NCT01277822|20575089|P1|Overall Study|Participant moved|1
5949078|NCT01277822|20575088|P2|Overall Study|Contraindicated medication used|1
5949079|NCT01277822|20575089|P1|Overall Study|Contraindicated medication used|2
5949080|NCT01277822|20575088|P2|Overall Study|Lost to Follow-up|1
5949081|NCT01277822|20575089|P1|Overall Study|Lost to Follow-up|2
5949082|NCT01277822|20575088|P2|Overall Study|Protocol Violation|0
5949083|NCT01277822|20575089|P1|Overall Study|Protocol Violation|1
5949084|NCT01277822|20575088|P2|Overall Study|Physician Decision|1
5949085|NCT01277822|20575089|P1|Overall Study|Physician Decision|1
5949086|NCT01277822|20575088|P2|Overall Study|Withdrawal by Subject|7
5949087|NCT01277822|20575089|P1|Overall Study|Withdrawal by Subject|6
5949088|NCT01277822|20575088|P2|Overall Study|Adverse Event|1
5949089|NCT01277822|20575089|P1|Overall Study|Adverse Event|2
5949090|NCT01277757|20575125|P1|Overall Study|Withdrawal by Subject|1
5949091|NCT01277757|20575125|P1|Overall Study|Disease Progression|1
5949092|NCT01277744|20575132|P1|Overall Study|Physician Decision|2
5949093|NCT01277718|20575137|P2|Period 2 - Second Intervention|Physician Decision|2
5949094|NCT01277718|20575138|P1|Period 2 - Second Intervention|Physician Decision|0
5949095|NCT01277718|20575137|P2|Period 2 - Second Intervention|Protocol Violation|1
5949096|NCT01277718|20575138|P1|Period 2 - Second Intervention|Protocol Violation|0
5949097|NCT01277666|20575152|P3|Overall Study|Death|1
5949098|NCT01277666|20575153|P2|Overall Study|Death|0
5949099|NCT01277666|20575154|P1|Overall Study|Death|0
5949100|NCT01277666|20575152|P3|Overall Study|Withdrawal by Subject|6
5949101|NCT01277666|20575153|P2|Overall Study|Withdrawal by Subject|8
5949102|NCT01277666|20575154|P1|Overall Study|Withdrawal by Subject|7
5949103|NCT01277666|20575152|P3|Overall Study|Lost to Follow-up|2
5949104|NCT01277666|20575153|P2|Overall Study|Lost to Follow-up|1
5949105|NCT01277666|20575154|P1|Overall Study|Lost to Follow-up|1
5949106|NCT01277666|20575152|P3|Overall Study|Protocol Defined Stopping criteria|6
5949107|NCT01277666|20575153|P2|Overall Study|Protocol Defined Stopping criteria|2
5949108|NCT01277666|20575154|P1|Overall Study|Protocol Defined Stopping criteria|1
5949109|NCT01277666|20575152|P3|Overall Study|Protocol Violation|2
5949110|NCT01277666|20575153|P2|Overall Study|Protocol Violation|3
5949111|NCT01277666|20575154|P1|Overall Study|Protocol Violation|2
5949112|NCT01277666|20575152|P3|Overall Study|Lack of Efficacy|12
5949113|NCT01277666|20575153|P2|Overall Study|Lack of Efficacy|20
5949114|NCT01277666|20575154|P1|Overall Study|Lack of Efficacy|8
5949115|NCT01277666|20575152|P3|Overall Study|Adverse Event|20
5949116|NCT01277666|20575153|P2|Overall Study|Adverse Event|25
5949117|NCT01277666|20575154|P1|Overall Study|Adverse Event|26
5949118|NCT01277601|20575187|P4|Overall Study|Subject Terminated from Study by Sponsor|2
5949119|NCT01277601|20575188|P3|Overall Study|Subject Terminated from Study by Sponsor|0
5949120|NCT01277601|20575189|P2|Overall Study|Subject Terminated from Study by Sponsor|1
5949121|NCT01277601|20575190|P1|Overall Study|Subject Terminated from Study by Sponsor|0
5949122|NCT01277601|20575187|P4|Overall Study|Protocol Violation|0
5949123|NCT01277601|20575188|P3|Overall Study|Protocol Violation|5
5949124|NCT01277601|20575189|P2|Overall Study|Protocol Violation|2
5949125|NCT01277601|20575190|P1|Overall Study|Protocol Violation|0
5949126|NCT01277601|20575187|P4|Overall Study|Subject Never Dosed with Study Drug|1
5949127|NCT01277601|20575188|P3|Overall Study|Subject Never Dosed with Study Drug|3
5949128|NCT01277601|20575189|P2|Overall Study|Subject Never Dosed with Study Drug|2
5949129|NCT01277601|20575190|P1|Overall Study|Subject Never Dosed with Study Drug|1
5949130|NCT01277601|20575187|P4|Overall Study|Noncompliance with Study Drug|0
5949131|NCT01277601|20575188|P3|Overall Study|Noncompliance with Study Drug|2
5949132|NCT01277601|20575189|P2|Overall Study|Noncompliance with Study Drug|3
5949133|NCT01277601|20575190|P1|Overall Study|Noncompliance with Study Drug|1
5949134|NCT01277601|20575187|P4|Overall Study|Pregnancy|1
5949135|NCT01277601|20575188|P3|Overall Study|Pregnancy|4
5949136|NCT01277601|20575189|P2|Overall Study|Pregnancy|2
5949137|NCT01277601|20575190|P1|Overall Study|Pregnancy|2
5949138|NCT01277601|20575187|P4|Overall Study|Physician Decision|6
5949139|NCT01277601|20575188|P3|Overall Study|Physician Decision|1
5949140|NCT01277601|20575189|P2|Overall Study|Physician Decision|5
5949141|NCT01277601|20575190|P1|Overall Study|Physician Decision|3
5949142|NCT01277601|20575187|P4|Overall Study|Lost to Follow-up|2
5949143|NCT01277601|20575188|P3|Overall Study|Lost to Follow-up|4
5949144|NCT01277601|20575189|P2|Overall Study|Lost to Follow-up|9
5949145|NCT01277601|20575190|P1|Overall Study|Lost to Follow-up|7
5949146|NCT01277601|20575187|P4|Overall Study|Withdrawal by Subject|17
5949147|NCT01277601|20575188|P3|Overall Study|Withdrawal by Subject|8
5949148|NCT01277601|20575189|P2|Overall Study|Withdrawal by Subject|21
5949149|NCT01277601|20575190|P1|Overall Study|Withdrawal by Subject|18
5949150|NCT01277601|20575187|P4|Overall Study|Adverse Event|7
5949151|NCT01277601|20575188|P3|Overall Study|Adverse Event|0
5949152|NCT01277601|20575189|P2|Overall Study|Adverse Event|3
5949153|NCT01277601|20575190|P1|Overall Study|Adverse Event|5
5949154|NCT01277549|20575281|P2|Overall Study|Physician Decision|1
5949155|NCT01277549|20575282|P1|Overall Study|Physician Decision|2
5949156|NCT01277549|20575281|P2|Overall Study|Protocol Violation|1
5949157|NCT01277549|20575282|P1|Overall Study|Protocol Violation|10
5949158|NCT01277549|20575281|P2|Overall Study|Withdrawal by Subject|3
5949159|NCT01277549|20575282|P1|Overall Study|Withdrawal by Subject|1
5949160|NCT01277549|20575281|P2|Overall Study|Failed to meet eligibility criteria|9
5949161|NCT01277549|20575282|P1|Overall Study|Failed to meet eligibility criteria|13
5949162|NCT01277523|20575299|P3|Overall Study|Other Reason not Defined|0
5949163|NCT01277523|20575300|P2|Overall Study|Other Reason not Defined|1
5949164|NCT01277523|20575301|P1|Overall Study|Other Reason not Defined|0
5949165|NCT01277523|20575299|P3|Overall Study|Protocol Violation|0
5949166|NCT01277523|20575300|P2|Overall Study|Protocol Violation|0
5949167|NCT01277523|20575301|P1|Overall Study|Protocol Violation|2
5949168|NCT01277523|20575299|P3|Overall Study|Adverse Event|0
5949169|NCT01277523|20575300|P2|Overall Study|Adverse Event|0
5949170|NCT01277523|20575301|P1|Overall Study|Adverse Event|1
5949171|NCT01277510|20575353|P2|Open-label Phase|Never received investigational product|0
5949172|NCT01277510|20575354|P1|Open-label Phase|Never received investigational product|2
5949173|NCT01277510|20575353|P2|Open-label Phase|Protocol-specified criteria|0
5949174|NCT01277510|20575354|P1|Open-label Phase|Protocol-specified criteria|1
5949175|NCT01277510|20575353|P2|Open-label Phase|Administrative decision|3
5949176|NCT01277510|20575354|P1|Open-label Phase|Administrative decision|4
5949177|NCT01277510|20575353|P2|Double-blind Phase|Other|1
5949178|NCT01277510|20575354|P1|Double-blind Phase|Other|1
5949179|NCT01277510|20575353|P2|Double-blind Phase|Protocol-specified criteria|6
5949180|NCT01277510|20575354|P1|Double-blind Phase|Protocol-specified criteria|2
5949181|NCT01277510|20575353|P2|Double-blind Phase|Death|1
5949182|NCT01277510|20575354|P1|Double-blind Phase|Death|0
5949183|NCT01277510|20575353|P2|Double-blind Phase|Administrative decision|9
5949184|NCT01277510|20575354|P1|Double-blind Phase|Administrative decision|7
5949185|NCT01277510|20575353|P2|Double-blind Phase|Withdrawal by Subject|0
5949186|NCT01277510|20575354|P1|Double-blind Phase|Withdrawal by Subject|2
5949187|NCT01277510|20575353|P2|Double-blind Phase|Adverse Event|0
5949188|NCT01277510|20575354|P1|Double-blind Phase|Adverse Event|1
5949189|NCT01277510|20575353|P2|Double-blind Phase|Non-compliance|1
5949190|NCT01277510|20575354|P1|Double-blind Phase|Non-compliance|0
5949191|NCT01277302|20575405|P3|8-Month Alternate Dose Regimen Period|Relocation|1
5949192|NCT01277302|20575406|P2|8-Month Alternate Dose Regimen Period|Relocation|0
5949193|NCT01277302|20575407|P1|8-Month Alternate Dose Regimen Period|Relocation|1
5949194|NCT01277302|20575405|P3|8-Month Alternate Dose Regimen Period|Subject Non-compliance|1
5949195|NCT01277302|20575406|P2|8-Month Alternate Dose Regimen Period|Subject Non-compliance|2
5949196|NCT01277302|20575407|P1|8-Month Alternate Dose Regimen Period|Subject Non-compliance|0
5949197|NCT01277302|20575405|P3|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|1
5949198|NCT01277302|20575406|P2|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|0
5949199|NCT01277302|20575407|P1|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|3
5949200|NCT01277302|20575405|P3|8-Month Alternate Dose Regimen Period|Lost to Follow-up|3
5949201|NCT01277302|20575406|P2|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1
5949202|NCT01277302|20575407|P1|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1
5949203|NCT01277302|20575405|P3|8-Month Alternate Dose Regimen Period|Death|0
5949204|NCT01277302|20575406|P2|8-Month Alternate Dose Regimen Period|Death|1
5949205|NCT01277302|20575407|P1|8-Month Alternate Dose Regimen Period|Death|0
5949206|NCT01277302|20575405|P3|7-Month Fixed Treatment Period|Subject Non-compliance|1
5949207|NCT01277302|20575406|P2|7-Month Fixed Treatment Period|Subject Non-compliance|0
5949208|NCT01277302|20575407|P1|7-Month Fixed Treatment Period|Subject Non-compliance|0
5949209|NCT01277302|20575405|P3|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|1
5949210|NCT01277302|20575406|P2|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0
5949211|NCT01277302|20575407|P1|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0
5949212|NCT01277302|20575405|P3|7-Month Fixed Treatment Period|Lost to Follow-up|2
5949213|NCT01277302|20575406|P2|7-Month Fixed Treatment Period|Lost to Follow-up|0
5949214|NCT01277302|20575407|P1|7-Month Fixed Treatment Period|Lost to Follow-up|0
5949215|NCT01277302|20575405|P3|7-Month Fixed Treatment Period|Subject Decision to Withdraw|8
5949216|NCT01277302|20575406|P2|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0
5949217|NCT01277302|20575407|P1|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0
5949218|NCT01277211|20575439|P2|Overall Study|Discontinued prior to treatment|13
5949219|NCT01277211|20575440|P1|Overall Study|Discontinued prior to treatment|24
5949220|NCT01277211|20575439|P2|Overall Study|Pregnancy wish|2
5949221|NCT01277211|20575440|P1|Overall Study|Pregnancy wish|0
5949222|NCT01277211|20575439|P2|Overall Study|Administrative|0
5949223|NCT01277211|20575440|P1|Overall Study|Administrative|3
5949224|NCT01277211|20575439|P2|Overall Study|Did not meet protocol eligibility|0
5949225|NCT01277211|20575440|P1|Overall Study|Did not meet protocol eligibility|1
5949226|NCT01277211|20575439|P2|Overall Study|Non-compliance with protocol|4
5949227|NCT01277211|20575440|P1|Overall Study|Non-compliance with protocol|13
5949228|NCT01277211|20575439|P2|Overall Study|Withdrew Consent|9
5949229|NCT01277211|20575440|P1|Overall Study|Withdrew Consent|9
5949230|NCT01277211|20575439|P2|Overall Study|Did not wish to continue|0
5949231|NCT01277211|20575440|P1|Overall Study|Did not wish to continue|17
5949232|NCT01277211|20575439|P2|Overall Study|Lost to Follow-up|9
5949233|NCT01277211|20575440|P1|Overall Study|Lost to Follow-up|14
5949234|NCT01277211|20575439|P2|Overall Study|Pregnancy|4
5949235|NCT01277211|20575440|P1|Overall Study|Pregnancy|9
5949236|NCT01277211|20575439|P2|Overall Study|Adverse Event|22
5949237|NCT01277211|20575440|P1|Overall Study|Adverse Event|60
5949238|NCT01277042|20575492|P2|Overall Study|Withdrawal by Subject|0
5949239|NCT01277042|20575493|P1|Overall Study|Withdrawal by Subject|2
5949240|NCT01277042|20575492|P2|Overall Study|Lost to Follow-up|2
5949241|NCT01277042|20575493|P1|Overall Study|Lost to Follow-up|2
5949242|NCT01277042|20575492|P2|Overall Study|Adverse Event|3
5949243|NCT01277042|20575493|P1|Overall Study|Adverse Event|4
5949244|NCT01276847|20575529|P3|Overall Study|Withdrawal by Subject|0
5949245|NCT01276847|20575530|P2|Overall Study|Withdrawal by Subject|0
5949246|NCT01276847|20575531|P1|Overall Study|Withdrawal by Subject|1
5949247|NCT01276821|20575541|P2|Overall Study|Protocol Violation|1
5949248|NCT01276821|20575542|P1|Overall Study|Protocol Violation|0
5949249|NCT01276756|20575562|P2|Overall Study|Adverse Event|2
5949250|NCT01276756|20575563|P1|Overall Study|Adverse Event|3
5949251|NCT01276756|20575562|P2|Overall Study|Lost to Follow-up|0
5949252|NCT01276756|20575563|P1|Overall Study|Lost to Follow-up|2
5949253|NCT01276639|20575608|P5|Week 16 to 52|Other|3
5949254|NCT01276639|20575609|P4|Week 16 to 52|Other|1
5949255|NCT01276639|20575610|P3|Week 16 to 52|Other|0
5949256|NCT01276639|20575611|P2|Week 16 to 52|Other|12
5949257|NCT01276639|20575612|P1|Week 16 to 52|Other|10
5949258|NCT01276639|20575608|P5|Week 16 to 52|Withdrawal by Subject|1
5949259|NCT01276639|20575609|P4|Week 16 to 52|Withdrawal by Subject|0
5949260|NCT01276639|20575610|P3|Week 16 to 52|Withdrawal by Subject|0
5949261|NCT01276639|20575611|P2|Week 16 to 52|Withdrawal by Subject|4
5949262|NCT01276639|20575612|P1|Week 16 to 52|Withdrawal by Subject|4
5949263|NCT01276639|20575608|P5|Week 16 to 52|Lost to Follow-up|1
5949264|NCT01276639|20575609|P4|Week 16 to 52|Lost to Follow-up|0
5949265|NCT01276639|20575610|P3|Week 16 to 52|Lost to Follow-up|0
5949266|NCT01276639|20575611|P2|Week 16 to 52|Lost to Follow-up|1
5949267|NCT01276639|20575612|P1|Week 16 to 52|Lost to Follow-up|3
5949268|NCT01276639|20575608|P5|Week 16 to 52|Lack of Efficacy|13
5949269|NCT01276639|20575609|P4|Week 16 to 52|Lack of Efficacy|14
5949270|NCT01276639|20575610|P3|Week 16 to 52|Lack of Efficacy|0
5949271|NCT01276639|20575611|P2|Week 16 to 52|Lack of Efficacy|71
5949272|NCT01276639|20575612|P1|Week 16 to 52|Lack of Efficacy|99
5949273|NCT01276639|20575608|P5|Week 16 to 52|Adverse Event|3
5949274|NCT01276639|20575609|P4|Week 16 to 52|Adverse Event|1
5949275|NCT01276639|20575610|P3|Week 16 to 52|Adverse Event|0
5949276|NCT01276639|20575611|P2|Week 16 to 52|Adverse Event|13
5949277|NCT01276639|20575612|P1|Week 16 to 52|Adverse Event|10
5949278|NCT01276639|20575608|P5|Week 16 to 52|Death|0
5949279|NCT01276639|20575609|P4|Week 16 to 52|Death|0
5949280|NCT01276639|20575610|P3|Week 16 to 52|Death|0
5949281|NCT01276639|20575611|P2|Week 16 to 52|Death|0
5949282|NCT01276639|20575612|P1|Week 16 to 52|Death|1
5949283|NCT01276639|20575608|P5|Week 0 to 16|Randomized, But Not Treated|0
5949284|NCT01276639|20575609|P4|Week 0 to 16|Randomized, But Not Treated|0
5949285|NCT01276639|20575610|P3|Week 0 to 16|Randomized, But Not Treated|0
5949286|NCT01276639|20575611|P2|Week 0 to 16|Randomized, But Not Treated|1
5949287|NCT01276639|20575612|P1|Week 0 to 16|Randomized, But Not Treated|0
5949288|NCT01276639|20575608|P5|Week 0 to 16|Other|0
5949289|NCT01276639|20575609|P4|Week 0 to 16|Other|0
5949290|NCT01276639|20575610|P3|Week 0 to 16|Other|2
5949291|NCT01276639|20575611|P2|Week 0 to 16|Other|7
5949292|NCT01276639|20575612|P1|Week 0 to 16|Other|7
5949293|NCT01276639|20575608|P5|Week 0 to 16|Withdrawal by Subject|0
5949294|NCT01276639|20575609|P4|Week 0 to 16|Withdrawal by Subject|0
5949295|NCT01276639|20575610|P3|Week 0 to 16|Withdrawal by Subject|4
5949296|NCT01276639|20575611|P2|Week 0 to 16|Withdrawal by Subject|5
5949297|NCT01276639|20575612|P1|Week 0 to 16|Withdrawal by Subject|8
5949298|NCT01276639|20575608|P5|Week 0 to 16|Lost to Follow-up|0
5949299|NCT01276639|20575609|P4|Week 0 to 16|Lost to Follow-up|0
5949300|NCT01276639|20575610|P3|Week 0 to 16|Lost to Follow-up|3
5949301|NCT01276639|20575611|P2|Week 0 to 16|Lost to Follow-up|5
5949302|NCT01276639|20575612|P1|Week 0 to 16|Lost to Follow-up|3
5949303|NCT01276639|20575608|P5|Week 0 to 16|Lack of Efficacy|0
5949304|NCT01276639|20575609|P4|Week 0 to 16|Lack of Efficacy|0
5949305|NCT01276639|20575610|P3|Week 0 to 16|Lack of Efficacy|25
5949306|NCT01276639|20575611|P2|Week 0 to 16|Lack of Efficacy|15
5949307|NCT01276639|20575612|P1|Week 0 to 16|Lack of Efficacy|20
5949308|NCT01276639|20575608|P5|Week 0 to 16|Adverse Event|0
5949309|NCT01276639|20575609|P4|Week 0 to 16|Adverse Event|0
5949310|NCT01276639|20575610|P3|Week 0 to 16|Adverse Event|11
5949311|NCT01276639|20575611|P2|Week 0 to 16|Adverse Event|8
5949312|NCT01276639|20575612|P1|Week 0 to 16|Adverse Event|11
5949313|NCT01276639|20575608|P5|Week 0 to 16|Death|0
5949314|NCT01276639|20575609|P4|Week 0 to 16|Death|0
5949315|NCT01276639|20575610|P3|Week 0 to 16|Death|0
5949316|NCT01276639|20575611|P2|Week 0 to 16|Death|0
5949317|NCT01276639|20575612|P1|Week 0 to 16|Death|1
5949318|NCT01276509|20575817|P4|Overall Study|Other|0
5949319|NCT01276509|20575818|P3|Overall Study|Other|0
5949320|NCT01276509|20575819|P2|Overall Study|Other|1
5949321|NCT01276509|20575820|P1|Overall Study|Other|0
5949322|NCT01276509|20575817|P4|Overall Study|Withdrawal by Subject|0
5949323|NCT01276509|20575818|P3|Overall Study|Withdrawal by Subject|0
5949324|NCT01276509|20575819|P2|Overall Study|Withdrawal by Subject|2
5949325|NCT01276509|20575820|P1|Overall Study|Withdrawal by Subject|1
5949326|NCT01276509|20575817|P4|Overall Study|Pregnancy|0
5949327|NCT01276509|20575818|P3|Overall Study|Pregnancy|0
5949328|NCT01276509|20575819|P2|Overall Study|Pregnancy|0
5949329|NCT01276509|20575820|P1|Overall Study|Pregnancy|1
5949330|NCT01276509|20575817|P4|Overall Study|Lack of Efficacy|2
5949331|NCT01276509|20575818|P3|Overall Study|Lack of Efficacy|1
5949332|NCT01276509|20575819|P2|Overall Study|Lack of Efficacy|1
5949333|NCT01276509|20575820|P1|Overall Study|Lack of Efficacy|2
5949334|NCT01276509|20575817|P4|Overall Study|Adverse Event|3
5949335|NCT01276509|20575818|P3|Overall Study|Adverse Event|4
5949336|NCT01276509|20575819|P2|Overall Study|Adverse Event|8
5949337|NCT01276509|20575820|P1|Overall Study|Adverse Event|9
5949338|NCT01276457|20575873|P2|Extension Study|Lack of Efficacy|1
5949339|NCT01276457|20575874|P1|Extension Study|Lack of Efficacy|3
5949340|NCT01276457|20575873|P2|Extension Study|Death|1
5949341|NCT01276457|20575874|P1|Extension Study|Death|0
5949342|NCT01276457|20575873|P2|Extension Study|Lost to Follow-up|0
5949343|NCT01276457|20575874|P1|Extension Study|Lost to Follow-up|3
5949344|NCT01276457|20575873|P2|Core Study|Lack of Efficacy|12
5949345|NCT01276457|20575874|P1|Core Study|Lack of Efficacy|3
5949346|NCT01276457|20575873|P2|Core Study|Death|2
5949347|NCT01276457|20575874|P1|Core Study|Death|2
5949348|NCT01276457|20575873|P2|Core Study|Administrative problems|1
5949349|NCT01276457|20575874|P1|Core Study|Administrative problems|1
5949350|NCT01276457|20575873|P2|Core Study|Lost to Follow-up|2
5949351|NCT01276457|20575874|P1|Core Study|Lost to Follow-up|1
5949352|NCT01276457|20575873|P2|Core Study|Adverse Event|3
5949353|NCT01276457|20575874|P1|Core Study|Adverse Event|6
5949354|NCT01276353|20575888|P2|Extension|Prohibited concomitant medications|1
5949355|NCT01276353|20575889|P1|Extension|Prohibited concomitant medications|0
5949356|NCT01276353|20575888|P2|Extension|Physician Decision|0
5949357|NCT01276353|20575889|P1|Extension|Physician Decision|1
5949358|NCT01276353|20575888|P2|Extension|Withdrawal of study drug 4 days in a row|1
5949359|NCT01276353|20575889|P1|Extension|Withdrawal of study drug 4 days in a row|3
5949360|NCT01276353|20575888|P2|Extension|Withdrawal by Subject|2
5949361|NCT01276353|20575889|P1|Extension|Withdrawal by Subject|1
5949362|NCT01276353|20575888|P2|Extension|Adverse Event|5
5949363|NCT01276353|20575889|P1|Extension|Adverse Event|2
5949364|NCT01276353|20575888|P2|Double-blind|Withdrawal by Subject|0
5949365|NCT01276353|20575889|P1|Double-blind|Withdrawal by Subject|1
5949366|NCT01276353|20575888|P2|Double-blind|Adverse Event|0
5949367|NCT01276353|20575889|P1|Double-blind|Adverse Event|2
5949368|NCT01276327|20575901|P2|Overall Study|Withdrawal by Subject|0
5949369|NCT01276327|20575902|P1|Overall Study|Withdrawal by Subject|1
5949370|NCT01276327|20575901|P2|Overall Study|Adverse Event|3
5949371|NCT01276327|20575902|P1|Overall Study|Adverse Event|1
5949372|NCT01276288|20575969|P4|Overall Study|not treated|0
5949373|NCT01276288|20575970|P3|Overall Study|not treated|0
5949374|NCT01276288|20575971|P2|Overall Study|not treated|0
5949375|NCT01276288|20575972|P1|Overall Study|not treated|1
5949376|NCT01276288|20575969|P4|Overall Study|Adverse Event|0
5949377|NCT01276288|20575970|P3|Overall Study|Adverse Event|0
5949378|NCT01276288|20575971|P2|Overall Study|Adverse Event|1
5949379|NCT01276288|20575972|P1|Overall Study|Adverse Event|1
5949380|NCT01276223|20576099|P3|Overall Study|Protocol Violation|0
5949381|NCT01276223|20576100|P2|Overall Study|Protocol Violation|0
5949382|NCT01276223|20576101|P1|Overall Study|Protocol Violation|1
5949383|NCT01276223|20576099|P3|Overall Study|Pt Decision Unrelated to Adverse Event|0
5949384|NCT01276223|20576100|P2|Overall Study|Pt Decision Unrelated to Adverse Event|0
5949385|NCT01276223|20576101|P1|Overall Study|Pt Decision Unrelated to Adverse Event|3
5949386|NCT01276223|20576099|P3|Overall Study|Other|1
5949387|NCT01276223|20576100|P2|Overall Study|Other|0
5949388|NCT01276223|20576101|P1|Overall Study|Other|0
5949389|NCT01276223|20576099|P3|Overall Study|Lost to Follow-up|1
5949390|NCT01276223|20576100|P2|Overall Study|Lost to Follow-up|0
5949391|NCT01276223|20576101|P1|Overall Study|Lost to Follow-up|0
5949392|NCT01276223|20576099|P3|Overall Study|Adverse Event|1
5949393|NCT01276223|20576100|P2|Overall Study|Adverse Event|4
5949394|NCT01276223|20576101|P1|Overall Study|Adverse Event|7
5949395|NCT01276106|20576142|P4|Overall Study|Insufficient therapeutic effects|0
5949396|NCT01276106|20576143|P3|Overall Study|Insufficient therapeutic effects|2
5949397|NCT01276106|20576144|P2|Overall Study|Insufficient therapeutic effects|0
5949398|NCT01276106|20576145|P1|Overall Study|Insufficient therapeutic effects|0
5949399|NCT01276106|20576142|P4|Overall Study|Protocol Violation|2
5949400|NCT01276106|20576143|P3|Overall Study|Protocol Violation|0
5949401|NCT01276106|20576144|P2|Overall Study|Protocol Violation|1
5949402|NCT01276106|20576145|P1|Overall Study|Protocol Violation|1
5949403|NCT01276106|20576142|P4|Overall Study|Physician Decision|1
5949404|NCT01276106|20576143|P3|Overall Study|Physician Decision|1
5949405|NCT01276106|20576144|P2|Overall Study|Physician Decision|0
5949406|NCT01276106|20576145|P1|Overall Study|Physician Decision|0
5949407|NCT01276106|20576142|P4|Overall Study|Lost to Follow-up|0
5949408|NCT01276106|20576143|P3|Overall Study|Lost to Follow-up|1
5949409|NCT01276106|20576144|P2|Overall Study|Lost to Follow-up|1
5949410|NCT01276106|20576145|P1|Overall Study|Lost to Follow-up|2
5949411|NCT01276106|20576142|P4|Overall Study|Lack of Efficacy|1
5949412|NCT01276106|20576143|P3|Overall Study|Lack of Efficacy|0
5949413|NCT01276106|20576144|P2|Overall Study|Lack of Efficacy|1
5949414|NCT01276106|20576145|P1|Overall Study|Lack of Efficacy|0
5949415|NCT01276106|20576142|P4|Overall Study|Withdrawal by Subject|6
5949416|NCT01276106|20576143|P3|Overall Study|Withdrawal by Subject|1
5949417|NCT01276106|20576144|P2|Overall Study|Withdrawal by Subject|3
5949418|NCT01276106|20576145|P1|Overall Study|Withdrawal by Subject|6
5949419|NCT01276106|20576142|P4|Overall Study|Adverse Event|3
5949420|NCT01276106|20576143|P3|Overall Study|Adverse Event|11
5949421|NCT01276106|20576144|P2|Overall Study|Adverse Event|3
5949422|NCT01276106|20576145|P1|Overall Study|Adverse Event|3
5949423|NCT01276054|20576157|P2|Overall Study|No one to oversee trial after P.I. left|2
5949424|NCT01276054|20576158|P1|Overall Study|No one to oversee trial after P.I. left|2
5949425|NCT01276041|20576164|P1|Overall Study|Protocol Violation|1
5949426|NCT01276041|20576164|P1|Overall Study|Adverse Event|2
5949427|NCT01275833|20576173|P2|Overall Study|Study terminated|1
5949428|NCT01275833|20576174|P1|Overall Study|Study terminated|1
5949429|NCT01275755|20576182|P2|Run-out Placebo Period|Lost to Follow-up|0
5949430|NCT01275755|20576183|P1|Run-out Placebo Period|Lost to Follow-up|1
5949431|NCT01275755|20576182|P2|Double-blind Treatment Period|Withdrawal by Subject|0
5949432|NCT01275755|20576183|P1|Double-blind Treatment Period|Withdrawal by Subject|1
5949433|NCT01275755|20576182|P2|Double-blind Treatment Period|Lost to Follow-up|1
5949434|NCT01275755|20576183|P1|Double-blind Treatment Period|Lost to Follow-up|1
5949435|NCT01275755|20576182|P2|Double-blind Treatment Period|Adverse Event|2
5949436|NCT01275755|20576183|P1|Double-blind Treatment Period|Adverse Event|0
5949443|NCT01275625|20576218|P1|Overall Study|Other|1
5949444|NCT01275625|20576218|P1|Overall Study|Adverse Event|4
5949445|NCT01275625|20576218|P1|Overall Study|Protocol Violation|1
5949446|NCT01275625|20576218|P1|Overall Study|Withdrawal by Subject|3
5949447|NCT01275625|20576218|P1|Overall Study|Lost to Follow-up|1
5949448|NCT01275625|20576218|P1|Overall Study|Lack of Efficacy|2
5949449|NCT01275625|20576218|P1|Overall Study|Death|1
5949450|NCT01275430|20576236|P1|Overall Study|Inability to achieve maximum p-wave|1
5949451|NCT01275430|20576236|P1|Overall Study|Device Malfunction|1
5949452|NCT01275430|20576236|P1|Overall Study|No Contrast Injection|6
5949453|NCT01275430|20576236|P1|Overall Study|Adverse Event|1
5949454|NCT01275339|20576301|P4|Overall Study|Withdrawal by Subject|0
5949455|NCT01275339|20576302|P3|Overall Study|Withdrawal by Subject|1
5949456|NCT01275339|20576303|P2|Overall Study|Withdrawal by Subject|0
5949457|NCT01275339|20576304|P1|Overall Study|Withdrawal by Subject|0
5949458|NCT01275339|20576301|P4|Overall Study|Referred for surgery for AS symptoms|0
5949459|NCT01275339|20576302|P3|Overall Study|Referred for surgery for AS symptoms|0
5949460|NCT01275339|20576303|P2|Overall Study|Referred for surgery for AS symptoms|0
5949461|NCT01275339|20576304|P1|Overall Study|Referred for surgery for AS symptoms|1
5949462|NCT01275196|20576332|P2|Overall Study|Suboptimal response/treatment failure|6
5949463|NCT01275196|20576333|P1|Overall Study|Suboptimal response/treatment failure|5
5949464|NCT01275196|20576332|P2|Overall Study|Protocol Violation|0
5949465|NCT01275196|20576333|P1|Overall Study|Protocol Violation|1
5949466|NCT01275196|20576332|P2|Overall Study|Disease Progression|5
5949467|NCT01275196|20576333|P1|Overall Study|Disease Progression|6
5949468|NCT01275196|20576332|P2|Overall Study|Lost to Follow-up|0
5949469|NCT01275196|20576333|P1|Overall Study|Lost to Follow-up|1
5949470|NCT01275196|20576332|P2|Overall Study|Withdrawal by Subject|5
5949471|NCT01275196|20576333|P1|Overall Study|Withdrawal by Subject|4
5949472|NCT01275196|20576332|P2|Overall Study|Adverse Event|5
5949473|NCT01275196|20576333|P1|Overall Study|Adverse Event|3
5949474|NCT01275170|20576380|P8|Part 1: Period 1|Equipment malfunction before study drug|0
5949475|NCT01275170|20576381|P7|Part 1: Period 1|Equipment malfunction before study drug|0
5949476|NCT01275170|20576382|P6|Part 1: Period 1|Equipment malfunction before study drug|0
5949477|NCT01275170|20576383|P5|Part 1: Period 1|Equipment malfunction before study drug|0
5949478|NCT01275170|20576384|P4|Part 1: Period 1|Equipment malfunction before study drug|0
5949479|NCT01275170|20576385|P3|Part 1: Period 1|Equipment malfunction before study drug|0
5949480|NCT01275170|20576386|P2|Part 1: Period 1|Equipment malfunction before study drug|0
5949481|NCT01275170|20576387|P1|Part 1: Period 1|Equipment malfunction before study drug|1
5949482|NCT01275144|20576605|P2|Second Intervention (6 Days)|Withdrawal by Subject|0
5949483|NCT01275144|20576606|P1|Second Intervention (6 Days)|Withdrawal by Subject|1
5949484|NCT01275131|20576664|P4|Period 2 (Crossover)|Withdrawal by Subject|2
5949485|NCT01275131|20576665|P3|Period 2 (Crossover)|Withdrawal by Subject|1
5949486|NCT01275131|20576666|P2|Period 2 (Crossover)|Withdrawal by Subject|0
5949487|NCT01275131|20576667|P1|Period 2 (Crossover)|Withdrawal by Subject|1
5949488|NCT01275131|20576664|P4|Period 2 (Crossover)|Adverse Event|0
5949489|NCT01275131|20576665|P3|Period 2 (Crossover)|Adverse Event|0
5949490|NCT01275131|20576666|P2|Period 2 (Crossover)|Adverse Event|1
5949491|NCT01275131|20576667|P1|Period 2 (Crossover)|Adverse Event|0
5949492|NCT01275131|20576664|P4|Period 1|Physician Decision|0
5949493|NCT01275131|20576665|P3|Period 1|Physician Decision|0
5949494|NCT01275131|20576666|P2|Period 1|Physician Decision|0
5949495|NCT01275131|20576667|P1|Period 1|Physician Decision|1
5949496|NCT01275131|20576664|P4|Period 1|Withdrawal by Subject|2
5949497|NCT01275131|20576665|P3|Period 1|Withdrawal by Subject|3
5949498|NCT01275131|20576666|P2|Period 1|Withdrawal by Subject|0
5949499|NCT01275131|20576667|P1|Period 1|Withdrawal by Subject|1
5949500|NCT01275066|20576710|P3|Overall Study|Not Diagnosed w/ Disease|0
5949501|NCT01275066|20576711|P2|Overall Study|Not Diagnosed w/ Disease|0
5949502|NCT01275066|20576712|P1|Overall Study|Not Diagnosed w/ Disease|1
5949503|NCT01275066|20576710|P3|Overall Study|Withdrawal by Subject|1
5949504|NCT01275066|20576711|P2|Overall Study|Withdrawal by Subject|0
5949505|NCT01275066|20576712|P1|Overall Study|Withdrawal by Subject|0
5949506|NCT01274715|20576745|P1|Overall Study|After consent, met exclusion criteria.|1
5949507|NCT01274715|20576745|P1|Overall Study|After consent, met exclusion criteria.|1
5949508|NCT01274715|20576745|P1|Overall Study|After consent, met exclusion criteria.|1
5949509|NCT01274715|20576745|P1|Overall Study|Lost to Follow-up|1
5949510|NCT01274637|20576752|P2|Overall Study|Lost to Follow-up|1
5949511|NCT01274637|20576753|P1|Overall Study|Lost to Follow-up|0
5949512|NCT01274637|20576752|P2|Overall Study|Withdrawal by Subject|1
5949513|NCT01274637|20576753|P1|Overall Study|Withdrawal by Subject|0
5949514|NCT01274559|20576792|P2|Overall Study|Withdrawal by Subject|13
5949515|NCT01274559|20576793|P1|Overall Study|Withdrawal by Subject|25
5949516|NCT01274559|20576792|P2|Overall Study|Study Terminated by Sponsor|87
5949517|NCT01274559|20576793|P1|Overall Study|Study Terminated by Sponsor|79
5949518|NCT01274559|20576792|P2|Overall Study|Protocol Violation|23
5949519|NCT01274559|20576793|P1|Overall Study|Protocol Violation|28
5949520|NCT01274559|20576792|P2|Overall Study|Physician Decision|1
5949521|NCT01274559|20576793|P1|Overall Study|Physician Decision|2
5949522|NCT01274559|20576792|P2|Overall Study|Non-compliance with Study Drug|4
5949523|NCT01274559|20576793|P1|Overall Study|Non-compliance with Study Drug|2
5949524|NCT01274559|20576792|P2|Overall Study|Lost to Follow-up|3
5949525|NCT01274559|20576793|P1|Overall Study|Lost to Follow-up|3
5949526|NCT01274559|20576792|P2|Overall Study|Death|1
5949527|NCT01274559|20576793|P1|Overall Study|Death|1
5949528|NCT01274559|20576792|P2|Overall Study|Adverse Event|13
5949529|NCT01274559|20576793|P1|Overall Study|Adverse Event|57
5949530|NCT01274533|20576843|P1|Overall Study|Disease progression|2
5949531|NCT01274533|20576843|P1|Overall Study|Non-compliance|1
5949532|NCT01274533|20576843|P1|Overall Study|Withdrawal by Subject|1
5949533|NCT01274429|20576879|P1|Overall Study|Study closed do to lack of funding|5
5949534|NCT01274351|20576884|P1|Overall Study|hospitalization|1
5949535|NCT01274351|20576884|P1|Overall Study|progression of disease|3
5949536|NCT01274351|20576884|P1|Overall Study|Adverse Event|8
5949537|NCT01274351|20576884|P1|Overall Study|Withdrawal by Subject|3
5949538|NCT01274351|20576884|P1|Overall Study|Death|2
5949539|NCT01274351|20576884|P1|Overall Study|Pregnancy|1
5949540|NCT01274351|20576884|P1|Overall Study|patient not compliant with the protocol|1
5949541|NCT01274351|20576884|P1|Overall Study|Lost to Follow-up|1
5949542|NCT01274182|20576896|P3|Overall Study|Death|1
5949543|NCT01274182|20576897|P2|Overall Study|Death|0
5949544|NCT01274182|20576898|P1|Overall Study|Death|1
5949545|NCT01274182|20576896|P3|Overall Study|Protocol Violation|0
5949546|NCT01274182|20576897|P2|Overall Study|Protocol Violation|2
5949547|NCT01274182|20576898|P1|Overall Study|Protocol Violation|3
5949548|NCT01274182|20576896|P3|Overall Study|Lost to Follow-up|1
5949549|NCT01274182|20576897|P2|Overall Study|Lost to Follow-up|3
5949550|NCT01274182|20576898|P1|Overall Study|Lost to Follow-up|2
5949551|NCT01274182|20576896|P3|Overall Study|Withdrawal by Subject|3
5949552|NCT01274182|20576897|P2|Overall Study|Withdrawal by Subject|5
5949553|NCT01274182|20576898|P1|Overall Study|Withdrawal by Subject|5
5949554|NCT01274182|20576896|P3|Overall Study|Adverse Event|3
5949555|NCT01274182|20576897|P2|Overall Study|Adverse Event|5
5949556|NCT01274182|20576898|P1|Overall Study|Adverse Event|4
5949557|NCT01274182|20576896|P3|Overall Study|Unsatisfactory therapeutic effect|4
5949558|NCT01274182|20576897|P2|Overall Study|Unsatisfactory therapeutic effect|3
5949559|NCT01274182|20576898|P1|Overall Study|Unsatisfactory therapeutic effect|6
5949560|NCT01273883|20576939|P2|Second Intervention|Lack of Efficacy|0
5949561|NCT01273883|20576940|P1|Second Intervention|Lack of Efficacy|1
5949562|NCT01273883|20576939|P2|Second Intervention|Lost to Follow-up|1
5949563|NCT01273883|20576940|P1|Second Intervention|Lost to Follow-up|1
5949564|NCT01273883|20576939|P2|First Intervention|Adverse Event|1
5949565|NCT01273883|20576940|P1|First Intervention|Adverse Event|2
5949566|NCT01273818|20576966|P3|Overall Study|Physician Decision|9
5949567|NCT01273818|20576967|P2|Overall Study|Physician Decision|2
5949568|NCT01273818|20576968|P1|Overall Study|Physician Decision|13
5949569|NCT01273805|20576978|P2|Overall Study|Radiologic PD or Symptom Deterioration|10
5949570|NCT01273805|20576979|P1|Overall Study|Radiologic PD or Symptom Deterioration|10
5949571|NCT01273623|20577010|P1|Overall Study|did not meet IVUS criteria|29
5949572|NCT01273597|20577017|P1|Overall Study|Reason Not Reported|1
5949573|NCT01273597|20577017|P1|Overall Study|Underwent Kidney Transplantation|2
5949574|NCT01273597|20577017|P1|Overall Study|Adverse Event|5
5949575|NCT01273519|20577032|P3|Overall Study|Other|1
5949576|NCT01273519|20577033|P2|Overall Study|Other|1
5949577|NCT01273519|20577034|P1|Overall Study|Other|6
5949578|NCT01273519|20577032|P3|Overall Study|Lack of Efficacy|4
5949579|NCT01273519|20577033|P2|Overall Study|Lack of Efficacy|3
5949580|NCT01273519|20577034|P1|Overall Study|Lack of Efficacy|8
5949581|NCT01273519|20577032|P3|Overall Study|Lost to Follow-up|3
5949582|NCT01273519|20577033|P2|Overall Study|Lost to Follow-up|1
5949583|NCT01273519|20577034|P1|Overall Study|Lost to Follow-up|2
5949584|NCT01273519|20577032|P3|Overall Study|Adverse Event|0
5949585|NCT01273519|20577033|P2|Overall Study|Adverse Event|0
5949586|NCT01273519|20577034|P1|Overall Study|Adverse Event|3
5949587|NCT01273181|20577077|P4|Phase 2, Dose 2|Death during treatment|1
5949588|NCT01273181|20577078|P3|Phase 2, Dose 2|Death during treatment|0
5949589|NCT01273181|20577079|P2|Phase 2, Dose 2|Death during treatment|0
5949590|NCT01273181|20577080|P1|Phase 2, Dose 2|Death during treatment|0
5949591|NCT01273181|20577077|P4|Phase 2, Dose 1|Study termination|0
5949592|NCT01273181|20577078|P3|Phase 2, Dose 1|Study termination|1
5949593|NCT01273181|20577079|P2|Phase 2, Dose 1|Study termination|0
5949594|NCT01273181|20577080|P1|Phase 2, Dose 1|Study termination|0
5949595|NCT01273181|20577077|P4|Phase I, Dose 2|Death during treatment|0
5949596|NCT01273181|20577078|P3|Phase I, Dose 2|Death during treatment|0
5949597|NCT01273181|20577079|P2|Phase I, Dose 2|Death during treatment|1
5949598|NCT01273181|20577080|P1|Phase I, Dose 2|Death during treatment|0
5949599|NCT01273181|20577077|P4|Phase I, Dose 1|Study termination|0
5949600|NCT01273181|20577078|P3|Phase I, Dose 1|Study termination|0
5949601|NCT01273181|20577079|P2|Phase I, Dose 1|Study termination|0
5949602|NCT01273181|20577080|P1|Phase I, Dose 1|Study termination|1
5949603|NCT01273155|20577098|P7|Overall Study|Withdrew during C1/refused further trmt|0
5949604|NCT01273155|20577099|P6|Overall Study|Withdrew during C1/refused further trmt|1
5949605|NCT01273155|20577100|P5|Overall Study|Withdrew during C1/refused further trmt|1
5949606|NCT01273155|20577101|P4|Overall Study|Withdrew during C1/refused further trmt|0
5949607|NCT01273155|20577102|P3|Overall Study|Withdrew during C1/refused further trmt|1
5949608|NCT01273155|20577103|P2|Overall Study|Withdrew during C1/refused further trmt|0
5949609|NCT01273155|20577104|P1|Overall Study|Withdrew during C1/refused further trmt|0
5949610|NCT01273155|20577098|P7|Overall Study|Died during Cycle 1|2
5949611|NCT01273155|20577099|P6|Overall Study|Died during Cycle 1|2
5949612|NCT01273155|20577100|P5|Overall Study|Died during Cycle 1|0
5949613|NCT01273155|20577101|P4|Overall Study|Died during Cycle 1|1
5949614|NCT01273155|20577102|P3|Overall Study|Died during Cycle 1|1
5949615|NCT01273155|20577103|P2|Overall Study|Died during Cycle 1|0
5949616|NCT01273155|20577104|P1|Overall Study|Died during Cycle 1|0
5949617|NCT01273155|20577098|P7|Overall Study|Off study prior to C1/due to toxicity|1
5949618|NCT01273155|20577099|P6|Overall Study|Off study prior to C1/due to toxicity|0
5949619|NCT01273155|20577100|P5|Overall Study|Off study prior to C1/due to toxicity|0
5949620|NCT01273155|20577101|P4|Overall Study|Off study prior to C1/due to toxicity|0
5949621|NCT01273155|20577102|P3|Overall Study|Off study prior to C1/due to toxicity|2
5949622|NCT01273155|20577103|P2|Overall Study|Off study prior to C1/due to toxicity|0
5949623|NCT01273155|20577104|P1|Overall Study|Off study prior to C1/due to toxicity|0
5949624|NCT01273155|20577098|P7|Overall Study|Change in liver function/no longer eval.|0
5949625|NCT01273155|20577099|P6|Overall Study|Change in liver function/no longer eval.|0
5949626|NCT01273155|20577100|P5|Overall Study|Change in liver function/no longer eval.|1
5949627|NCT01273155|20577101|P4|Overall Study|Change in liver function/no longer eval.|0
5949628|NCT01273155|20577102|P3|Overall Study|Change in liver function/no longer eval.|0
5949629|NCT01273155|20577103|P2|Overall Study|Change in liver function/no longer eval.|1
5949630|NCT01273155|20577104|P1|Overall Study|Change in liver function/no longer eval.|0
5949631|NCT01273155|20577098|P7|Overall Study|Off study trmt prior to end of C1/PD|3
5949632|NCT01273155|20577099|P6|Overall Study|Off study trmt prior to end of C1/PD|2
5949633|NCT01273155|20577100|P5|Overall Study|Off study trmt prior to end of C1/PD|0
5949634|NCT01273155|20577101|P4|Overall Study|Off study trmt prior to end of C1/PD|0
5949635|NCT01273155|20577102|P3|Overall Study|Off study trmt prior to end of C1/PD|8
5949636|NCT01273155|20577103|P2|Overall Study|Off study trmt prior to end of C1/PD|3
5949637|NCT01273155|20577104|P1|Overall Study|Off study trmt prior to end of C1/PD|2
5949638|NCT01273064|20577181|P5|Overall Study|Physician Decision|1
5949639|NCT01273064|20577182|P4|Overall Study|Physician Decision|0
5949640|NCT01273064|20577183|P3|Overall Study|Physician Decision|0
5949641|NCT01273064|20577184|P2|Overall Study|Physician Decision|0
5949642|NCT01273064|20577185|P1|Overall Study|Physician Decision|0
5949643|NCT01273064|20577181|P5|Overall Study|Lost to Follow-up|0
5949644|NCT01273064|20577182|P4|Overall Study|Lost to Follow-up|0
5949645|NCT01273064|20577183|P3|Overall Study|Lost to Follow-up|0
5949646|NCT01273064|20577184|P2|Overall Study|Lost to Follow-up|0
5949647|NCT01273064|20577185|P1|Overall Study|Lost to Follow-up|1
5949648|NCT01273064|20577181|P5|Overall Study|Study Termination|8
5949649|NCT01273064|20577182|P4|Overall Study|Study Termination|16
5949650|NCT01273064|20577183|P3|Overall Study|Study Termination|26
5949651|NCT01273064|20577184|P2|Overall Study|Study Termination|27
5949652|NCT01273064|20577185|P1|Overall Study|Study Termination|13
5949653|NCT01273064|20577181|P5|Overall Study|Withdrawal by Subject|0
5949654|NCT01273064|20577182|P4|Overall Study|Withdrawal by Subject|2
5949655|NCT01273064|20577183|P3|Overall Study|Withdrawal by Subject|2
5949656|NCT01273064|20577184|P2|Overall Study|Withdrawal by Subject|2
5949657|NCT01273064|20577185|P1|Overall Study|Withdrawal by Subject|4
5949658|NCT01273064|20577181|P5|Overall Study|Adverse Event|1
5949659|NCT01273064|20577182|P4|Overall Study|Adverse Event|2
5949660|NCT01273064|20577183|P3|Overall Study|Adverse Event|3
5949661|NCT01273064|20577184|P2|Overall Study|Adverse Event|1
5949662|NCT01273064|20577185|P1|Overall Study|Adverse Event|5
5949663|NCT01273038|20577204|P2|Second Intervention (14 Days)|Withdrawal by Subject|1
5949664|NCT01273038|20577205|P1|Second Intervention (14 Days)|Withdrawal by Subject|0
5949665|NCT01273038|20577204|P2|Second Intervention (14 Days)|Adverse Event|1
5949666|NCT01273038|20577205|P1|Second Intervention (14 Days)|Adverse Event|0
5949667|NCT01272947|20577255|P2|Overall Study|Abnormal Laboratory Value|2
5949668|NCT01272947|20577256|P1|Overall Study|Abnormal Laboratory Value|2
5949669|NCT01272934|20577266|P2|Overall Study|Abnormal Laboratory Value|1
5949670|NCT01272934|20577267|P1|Overall Study|Abnormal Laboratory Value|0
5949671|NCT01272934|20577266|P2|Overall Study|Adverse Event|1
5949672|NCT01272934|20577267|P1|Overall Study|Adverse Event|0
5949673|NCT01272921|20577277|P2|Overall Study|Protocol Violation|1
5949674|NCT01272921|20577278|P1|Overall Study|Protocol Violation|2
5949675|NCT01272908|20577286|P1|Re-Treatment Period|Withdrawal by Subject|1
5949676|NCT01272908|20577286|P1|Re-Treatment Period|Lack of Efficacy|3
5949677|NCT01272908|20577286|P1|Re-Treatment Period|Adverse Event|2
5949678|NCT01272908|20577286|P1|Initial Treatment Period|Withdrawal by Subject|1
5949679|NCT01272908|20577286|P1|Initial Treatment Period|Protocol Violation|1
5949680|NCT01272908|20577286|P1|Initial Treatment Period|Lack of Efficacy|5
5949681|NCT01272908|20577286|P1|Initial Treatment Period|Adverse Event|1
5949682|NCT01272869|20577326|P2|Period 2 (14 Days)|Adverse Event|0
5949683|NCT01272869|20577327|P1|Period 2 (14 Days)|Adverse Event|1
5949684|NCT01272804|20577354|P6|Overall Study|Adverse Event|1
5949685|NCT01272804|20577355|P5|Overall Study|Adverse Event|2
5949686|NCT01272804|20577356|P4|Overall Study|Adverse Event|0
5949687|NCT01272804|20577357|P3|Overall Study|Adverse Event|0
5949688|NCT01272804|20577358|P2|Overall Study|Adverse Event|0
5949689|NCT01272804|20577359|P1|Overall Study|Adverse Event|1
5949690|NCT01272661|20577517|P3|Overall Study|lost to followup/case closed/ no birth|72
5949691|NCT01272661|20577518|P2|Overall Study|lost to followup/case closed/ no birth|209
5949692|NCT01272661|20577519|P1|Overall Study|lost to followup/case closed/ no birth|126
5949693|NCT01272635|20577544|P4|Overall Study|Lost to Follow-up|23
5949694|NCT01272635|20577545|P3|Overall Study|Lost to Follow-up|31
5949695|NCT01272635|20577546|P2|Overall Study|Lost to Follow-up|20
5949696|NCT01272635|20577547|P1|Overall Study|Lost to Follow-up|31
5949697|NCT01272232|20577631|P3|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|0
5949698|NCT01272232|20577632|P2|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2
5949699|NCT01272232|20577633|P1|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2
5949700|NCT01272232|20577631|P3|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|4
5949701|NCT01272232|20577632|P2|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|7
5949702|NCT01272232|20577633|P1|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|9
5949857|NCT01271933|20577831|P3|Double-Blind Phase|Adverse Event|0
5949703|NCT01272232|20577631|P3|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1
5949704|NCT01272232|20577632|P2|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|0
5949705|NCT01272232|20577633|P1|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1
5949706|NCT01272232|20577631|P3|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0
5949707|NCT01272232|20577632|P2|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0
5949708|NCT01272232|20577633|P1|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|1
5949709|NCT01272232|20577631|P3|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|0
5949710|NCT01272232|20577632|P2|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1
5949711|NCT01272232|20577633|P1|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1
5949712|NCT01272232|20577631|P3|Weeks 0-56|Unclassified|12
5949713|NCT01272232|20577632|P2|Weeks 0-56|Unclassified|7
5949714|NCT01272232|20577633|P1|Weeks 0-56|Unclassified|16
5949715|NCT01272232|20577631|P3|Weeks 0-56|Withdrawal criteria|37
5949716|NCT01272232|20577632|P2|Weeks 0-56|Withdrawal criteria|14
5949717|NCT01272232|20577633|P1|Weeks 0-56|Withdrawal criteria|32
5949718|NCT01272232|20577631|P3|Weeks 0-56|Protocol Violation|13
5949719|NCT01272232|20577632|P2|Weeks 0-56|Protocol Violation|8
5949720|NCT01272232|20577633|P1|Weeks 0-56|Protocol Violation|12
5949721|NCT01272232|20577631|P3|Weeks 0-56|Lack of Efficacy|3
5949722|NCT01272232|20577632|P2|Weeks 0-56|Lack of Efficacy|0
5949723|NCT01272232|20577633|P1|Weeks 0-56|Lack of Efficacy|0
5949724|NCT01272232|20577631|P3|Weeks 0-56|Adverse Event|7
5949725|NCT01272232|20577632|P2|Weeks 0-56|Adverse Event|18
5949726|NCT01272232|20577633|P1|Weeks 0-56|Adverse Event|39
5949727|NCT01272219|20577678|P6|Main + Extension Period: Week 0-172|Unclassified|51
5949728|NCT01272219|20577679|P5|Main + Extension Period: Week 0-172|Unclassified|61
5949729|NCT01272219|20577680|P4|Main + Extension Period: Week 0-172|Unclassified|0
5949730|NCT01272219|20577681|P3|Main + Extension Period: Week 0-172|Unclassified|0
5949731|NCT01272219|20577682|P2|Main + Extension Period: Week 0-172|Unclassified|0
5949732|NCT01272219|20577683|P1|Main + Extension Period: Week 0-172|Unclassified|0
5949733|NCT01272219|20577678|P6|Main + Extension Period: Week 0-172|Missing reason|0
5949734|NCT01272219|20577679|P5|Main + Extension Period: Week 0-172|Missing reason|1
5949735|NCT01272219|20577680|P4|Main + Extension Period: Week 0-172|Missing reason|0
5949736|NCT01272219|20577681|P3|Main + Extension Period: Week 0-172|Missing reason|0
5949737|NCT01272219|20577682|P2|Main + Extension Period: Week 0-172|Missing reason|0
5949738|NCT01272219|20577683|P1|Main + Extension Period: Week 0-172|Missing reason|0
5949739|NCT01272219|20577678|P6|Main + Extension Period: Week 0-172|Withdrawal criteria|256
5949740|NCT01272219|20577679|P5|Main + Extension Period: Week 0-172|Withdrawal criteria|364
5949741|NCT01272219|20577680|P4|Main + Extension Period: Week 0-172|Withdrawal criteria|0
5949742|NCT01272219|20577681|P3|Main + Extension Period: Week 0-172|Withdrawal criteria|0
5949743|NCT01272219|20577682|P2|Main + Extension Period: Week 0-172|Withdrawal criteria|0
5949744|NCT01272219|20577683|P1|Main + Extension Period: Week 0-172|Withdrawal criteria|0
5949745|NCT01272219|20577678|P6|Main + Extension Period: Week 0-172|Protocol Violation|36
5949746|NCT01272219|20577679|P5|Main + Extension Period: Week 0-172|Protocol Violation|76
5949747|NCT01272219|20577680|P4|Main + Extension Period: Week 0-172|Protocol Violation|0
5949748|NCT01272219|20577681|P3|Main + Extension Period: Week 0-172|Protocol Violation|0
5949749|NCT01272219|20577682|P2|Main + Extension Period: Week 0-172|Protocol Violation|0
5949750|NCT01272219|20577683|P1|Main + Extension Period: Week 0-172|Protocol Violation|0
5949751|NCT01272219|20577678|P6|Main + Extension Period: Week 0-172|Lack of Efficacy|36
5949752|NCT01272219|20577679|P5|Main + Extension Period: Week 0-172|Lack of Efficacy|29
5949753|NCT01272219|20577680|P4|Main + Extension Period: Week 0-172|Lack of Efficacy|0
5949754|NCT01272219|20577681|P3|Main + Extension Period: Week 0-172|Lack of Efficacy|0
5949755|NCT01272219|20577682|P2|Main + Extension Period: Week 0-172|Lack of Efficacy|0
5949756|NCT01272219|20577683|P1|Main + Extension Period: Week 0-172|Lack of Efficacy|0
5949757|NCT01272219|20577678|P6|Main + Extension Period: Week 0-172|Adverse Event|43
5949758|NCT01272219|20577679|P5|Main + Extension Period: Week 0-172|Adverse Event|191
5949759|NCT01272219|20577680|P4|Main + Extension Period: Week 0-172|Adverse Event|0
5949760|NCT01272219|20577681|P3|Main + Extension Period: Week 0-172|Adverse Event|0
5949761|NCT01272219|20577682|P2|Main + Extension Period: Week 0-172|Adverse Event|0
5949762|NCT01272219|20577683|P1|Main + Extension Period: Week 0-172|Adverse Event|0
5949763|NCT01272219|20577678|P6|Re-randomised Period: Week 56 to Week 68|Unclassified|0
5949764|NCT01272219|20577679|P5|Re-randomised Period: Week 56 to Week 68|Unclassified|0
5949765|NCT01272219|20577680|P4|Re-randomised Period: Week 56 to Week 68|Unclassified|2
5949766|NCT01272219|20577681|P3|Re-randomised Period: Week 56 to Week 68|Unclassified|2
5949767|NCT01272219|20577682|P2|Re-randomised Period: Week 56 to Week 68|Unclassified|1
5949768|NCT01272219|20577683|P1|Re-randomised Period: Week 56 to Week 68|Unclassified|0
5949769|NCT01272219|20577678|P6|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0
5949770|NCT01272219|20577679|P5|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0
5949771|NCT01272219|20577680|P4|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|7
5949772|NCT01272219|20577681|P3|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|4
5949773|NCT01272219|20577682|P2|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|6
5949774|NCT01272219|20577683|P1|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0
5949775|NCT01272219|20577678|P6|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0
5949776|NCT01272219|20577679|P5|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0
5949777|NCT01272219|20577680|P4|Re-randomised Period: Week 56 to Week 68|Protocol Violation|3
5949778|NCT01272219|20577681|P3|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0
5949779|NCT01272219|20577682|P2|Re-randomised Period: Week 56 to Week 68|Protocol Violation|1
5949780|NCT01272219|20577683|P1|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0
5949781|NCT01272219|20577678|P6|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0
5949782|NCT01272219|20577679|P5|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0
5949783|NCT01272219|20577680|P4|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|1
5949784|NCT01272219|20577681|P3|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0
5949785|NCT01272219|20577682|P2|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0
5949786|NCT01272219|20577683|P1|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0
5949787|NCT01272219|20577678|P6|Re-randomised Period: Week 56 to Week 68|Adverse Event|0
5949788|NCT01272219|20577679|P5|Re-randomised Period: Week 56 to Week 68|Adverse Event|0
5949789|NCT01272219|20577680|P4|Re-randomised Period: Week 56 to Week 68|Adverse Event|2
5949790|NCT01272219|20577681|P3|Re-randomised Period: Week 56 to Week 68|Adverse Event|1
5949791|NCT01272219|20577682|P2|Re-randomised Period: Week 56 to Week 68|Adverse Event|1
5949792|NCT01272219|20577683|P1|Re-randomised Period: Week 56 to Week 68|Adverse Event|0
5949793|NCT01272219|20577678|P6|Main Period: Week 0 to Week 56|Unclassified|34
5949794|NCT01272219|20577679|P5|Main Period: Week 0 to Week 56|Unclassified|42
5949795|NCT01272219|20577680|P4|Main Period: Week 0 to Week 56|Unclassified|29
5949796|NCT01272219|20577681|P3|Main Period: Week 0 to Week 56|Unclassified|0
5949797|NCT01272219|20577682|P2|Main Period: Week 0 to Week 56|Unclassified|0
5949798|NCT01272219|20577683|P1|Main Period: Week 0 to Week 56|Unclassified|36
5949799|NCT01272219|20577678|P6|Main Period: Week 0 to Week 56|Withdrawal criteria|147
5949800|NCT01272219|20577679|P5|Main Period: Week 0 to Week 56|Withdrawal criteria|172
5949801|NCT01272219|20577680|P4|Main Period: Week 0 to Week 56|Withdrawal criteria|114
5949802|NCT01272219|20577681|P3|Main Period: Week 0 to Week 56|Withdrawal criteria|0
5949803|NCT01272219|20577682|P2|Main Period: Week 0 to Week 56|Withdrawal criteria|0
5949804|NCT01272219|20577683|P1|Main Period: Week 0 to Week 56|Withdrawal criteria|122
5949805|NCT01272219|20577678|P6|Main Period: Week 0 to Week 56|Protocol Violation|20
5949806|NCT01272219|20577679|P5|Main Period: Week 0 to Week 56|Protocol Violation|40
5949807|NCT01272219|20577680|P4|Main Period: Week 0 to Week 56|Protocol Violation|18
5949808|NCT01272219|20577681|P3|Main Period: Week 0 to Week 56|Protocol Violation|0
5949809|NCT01272219|20577682|P2|Main Period: Week 0 to Week 56|Protocol Violation|0
5949810|NCT01272219|20577683|P1|Main Period: Week 0 to Week 56|Protocol Violation|25
5949811|NCT01272219|20577678|P6|Main Period: Week 0 to Week 56|Lack of Efficacy|22
5949812|NCT01272219|20577679|P5|Main Period: Week 0 to Week 56|Lack of Efficacy|12
5949813|NCT01272219|20577680|P4|Main Period: Week 0 to Week 56|Lack of Efficacy|14
5949814|NCT01272219|20577681|P3|Main Period: Week 0 to Week 56|Lack of Efficacy|0
5949815|NCT01272219|20577682|P2|Main Period: Week 0 to Week 56|Lack of Efficacy|0
5949816|NCT01272219|20577683|P1|Main Period: Week 0 to Week 56|Lack of Efficacy|11
5949817|NCT01272219|20577678|P6|Main Period: Week 0 to Week 56|Adverse Event|29
5949818|NCT01272219|20577679|P5|Main Period: Week 0 to Week 56|Adverse Event|152
5949819|NCT01272219|20577680|P4|Main Period: Week 0 to Week 56|Adverse Event|16
5949820|NCT01272219|20577681|P3|Main Period: Week 0 to Week 56|Adverse Event|0
5949821|NCT01272219|20577682|P2|Main Period: Week 0 to Week 56|Adverse Event|0
5949822|NCT01272219|20577683|P1|Main Period: Week 0 to Week 56|Adverse Event|86
5949823|NCT01272193|20577717|P2|Overall Study|Unclassified|7
5949824|NCT01272193|20577718|P1|Overall Study|Unclassified|8
5949825|NCT01272193|20577717|P2|Overall Study|Withdrawal Criteria|1
5949826|NCT01272193|20577718|P1|Overall Study|Withdrawal Criteria|1
5949827|NCT01272193|20577717|P2|Overall Study|Lack of Efficacy|3
5949828|NCT01272193|20577718|P1|Overall Study|Lack of Efficacy|0
5949829|NCT01272193|20577717|P2|Overall Study|Adverse Event|1
5949830|NCT01272193|20577718|P1|Overall Study|Adverse Event|1
5949831|NCT01272180|20577738|P4|Overall Study|Protocol Violation|1
5949832|NCT01272180|20577739|P3|Overall Study|Protocol Violation|0
5949833|NCT01272180|20577740|P2|Overall Study|Protocol Violation|1
5949834|NCT01272180|20577741|P1|Overall Study|Protocol Violation|0
5949835|NCT01272180|20577738|P4|Overall Study|Inappropriate enrollment|1
5949836|NCT01272180|20577739|P3|Overall Study|Inappropriate enrollment|1
5949837|NCT01272180|20577740|P2|Overall Study|Inappropriate enrollment|0
5949838|NCT01272180|20577741|P1|Overall Study|Inappropriate enrollment|0
5949839|NCT01272180|20577738|P4|Overall Study|Lost to Follow-up|10
5949840|NCT01272180|20577739|P3|Overall Study|Lost to Follow-up|8
5949841|NCT01272180|20577740|P2|Overall Study|Lost to Follow-up|14
5949842|NCT01272180|20577741|P1|Overall Study|Lost to Follow-up|15
5949843|NCT01272180|20577738|P4|Overall Study|Withdrawal by Subject|2
5949844|NCT01272180|20577739|P3|Overall Study|Withdrawal by Subject|3
5949845|NCT01272180|20577740|P2|Overall Study|Withdrawal by Subject|6
5949846|NCT01272180|20577741|P1|Overall Study|Withdrawal by Subject|2
5949847|NCT01272180|20577738|P4|Overall Study|Adverse Event|0
5949848|NCT01272180|20577739|P3|Overall Study|Adverse Event|1
5949849|NCT01272180|20577740|P2|Overall Study|Adverse Event|0
5949850|NCT01272180|20577741|P1|Overall Study|Adverse Event|0
5949851|NCT01272011|20577793|P3|Overall Study|Withdrawal By Subject or Failed Screen|0
5949852|NCT01272011|20577794|P2|Overall Study|Withdrawal By Subject or Failed Screen|2
5949853|NCT01272011|20577795|P1|Overall Study|Withdrawal By Subject or Failed Screen|0
5949854|NCT01271933|20577831|P3|Double-Blind Phase|Participant request-personal reason|0
5949855|NCT01271933|20577832|P2|Double-Blind Phase|Participant request-personal reason|1
5949856|NCT01271933|20577833|P1|Double-Blind Phase|Participant request-personal reason|0
5949858|NCT01271933|20577832|P2|Double-Blind Phase|Adverse Event|3
5949859|NCT01271933|20577833|P1|Double-Blind Phase|Adverse Event|0
5949860|NCT01271933|20577831|P3|Double-Blind Phase|Withdrawal by Subject|1
5949861|NCT01271933|20577832|P2|Double-Blind Phase|Withdrawal by Subject|6
5949862|NCT01271933|20577833|P1|Double-Blind Phase|Withdrawal by Subject|0
5949863|NCT01271933|20577831|P3|Double-Blind Phase|Lost to Follow-up|1
5949864|NCT01271933|20577832|P2|Double-Blind Phase|Lost to Follow-up|1
5949865|NCT01271933|20577833|P1|Double-Blind Phase|Lost to Follow-up|0
5949866|NCT01271933|20577831|P3|Double-Blind Phase|Lack of Efficacy|9
5949867|NCT01271933|20577832|P2|Double-Blind Phase|Lack of Efficacy|6
5949868|NCT01271933|20577833|P1|Double-Blind Phase|Lack of Efficacy|0
5949869|NCT01271933|20577831|P3|Double-Blind Phase|Randomized but not treated|1
5949870|NCT01271933|20577832|P2|Double-Blind Phase|Randomized but not treated|0
5949871|NCT01271933|20577833|P1|Double-Blind Phase|Randomized but not treated|0
5949872|NCT01271933|20577831|P3|Single-Blind Phase|(Participant request-personal reason)|0
5949873|NCT01271933|20577832|P2|Single-Blind Phase|(Participant request-personal reason)|0
5949874|NCT01271933|20577833|P1|Single-Blind Phase|(Participant request-personal reason)|1
5949875|NCT01271933|20577831|P3|Single-Blind Phase|(Protocol non-compliance)|0
5949876|NCT01271933|20577832|P2|Single-Blind Phase|(Protocol non-compliance)|0
5949877|NCT01271933|20577833|P1|Single-Blind Phase|(Protocol non-compliance)|2
5949878|NCT01271933|20577831|P3|Single-Blind Phase|(Failed to meet dosing requirement)|0
5949879|NCT01271933|20577832|P2|Single-Blind Phase|(Failed to meet dosing requirement)|0
5949880|NCT01271933|20577833|P1|Single-Blind Phase|(Failed to meet dosing requirement)|1
5949881|NCT01271933|20577831|P3|Single-Blind Phase|Adverse Event|0
5949882|NCT01271933|20577832|P2|Single-Blind Phase|Adverse Event|0
5949883|NCT01271933|20577833|P1|Single-Blind Phase|Adverse Event|52
5949884|NCT01271933|20577831|P3|Single-Blind Phase|Protocol Violation|0
5949885|NCT01271933|20577832|P2|Single-Blind Phase|Protocol Violation|0
5949886|NCT01271933|20577833|P1|Single-Blind Phase|Protocol Violation|3
5949887|NCT01271933|20577831|P3|Single-Blind Phase|Withdrawal by Subject|0
5949888|NCT01271933|20577832|P2|Single-Blind Phase|Withdrawal by Subject|0
5949889|NCT01271933|20577833|P1|Single-Blind Phase|Withdrawal by Subject|15
5949890|NCT01271933|20577831|P3|Single-Blind Phase|Lost to Follow-up|0
5949891|NCT01271933|20577832|P2|Single-Blind Phase|Lost to Follow-up|0
5949892|NCT01271933|20577833|P1|Single-Blind Phase|Lost to Follow-up|10
5949893|NCT01271933|20577831|P3|Single-Blind Phase|Lack of Efficacy|0
5949894|NCT01271933|20577832|P2|Single-Blind Phase|Lack of Efficacy|0
5949895|NCT01271933|20577833|P1|Single-Blind Phase|Lack of Efficacy|37
5949896|NCT01271803|20577976|P3|Overall Study|Lost to Follow-up|0
5949897|NCT01271803|20577977|P2|Overall Study|Lost to Follow-up|0
5949898|NCT01271803|20577978|P1|Overall Study|Lost to Follow-up|1
5949899|NCT01271803|20577976|P3|Overall Study|Withdrawal by Subject|0
5949900|NCT01271803|20577977|P2|Overall Study|Withdrawal by Subject|5
5949901|NCT01271803|20577978|P1|Overall Study|Withdrawal by Subject|1
5949902|NCT01271803|20577976|P3|Overall Study|Death|0
5949903|NCT01271803|20577977|P2|Overall Study|Death|34
5949904|NCT01271803|20577978|P1|Overall Study|Death|53
5949905|NCT01271803|20577976|P3|Overall Study|Progressive disease|2
5949906|NCT01271803|20577977|P2|Overall Study|Progressive disease|0
5949907|NCT01271803|20577978|P1|Overall Study|Progressive disease|0
5949908|NCT01271725|20578140|P2|Part B|Withdrawal by Subject|6
5949909|NCT01271725|20578141|P1|Part B|Withdrawal by Subject|0
5949910|NCT01271725|20578140|P2|Part B|Protocol Violation|1
5949911|NCT01271725|20578141|P1|Part B|Protocol Violation|0
5949912|NCT01271725|20578140|P2|Part B|Other Adverse Event|1
5949913|NCT01271725|20578141|P1|Part B|Other Adverse Event|0
5949914|NCT01271725|20578140|P2|Part B|Clinical signs/symptoms of progression|2
5949915|NCT01271725|20578141|P1|Part B|Clinical signs/symptoms of progression|0
5949916|NCT01271725|20578140|P2|Part B|Other than specified|2
5949917|NCT01271725|20578141|P1|Part B|Other than specified|0
5949918|NCT01271725|20578140|P2|Part A|Protocol Violation|0
5949919|NCT01271725|20578141|P1|Part A|Protocol Violation|1
5949920|NCT01271725|20578140|P2|Part A|Other than specified|0
5949921|NCT01271725|20578141|P1|Part A|Other than specified|3
5949922|NCT01271725|20578140|P2|Part A|Withdrawal by Subject|0
5949923|NCT01271725|20578141|P1|Part A|Withdrawal by Subject|12
5949924|NCT01271725|20578140|P2|Part A|Lost to Follow-up|0
5949925|NCT01271725|20578141|P1|Part A|Lost to Follow-up|1
5949926|NCT01271725|20578140|P2|Part A|Other Adverse Event|0
5949927|NCT01271725|20578141|P1|Part A|Other Adverse Event|8
5949928|NCT01271725|20578140|P2|Part A|Clinical signs/symptoms of progression|0
5949929|NCT01271725|20578141|P1|Part A|Clinical signs/symptoms of progression|2
5949930|NCT01271725|20578140|P2|Part A|Progressive disease according to RECIST|0
5949931|NCT01271725|20578141|P1|Part A|Progressive disease according to RECIST|8
5949932|NCT01271010|20578243|P1|Overall Study|Disease progression|27
5949933|NCT01271010|20578243|P1|Overall Study|Withdrawal by Subject|18
5949934|NCT01271010|20578243|P1|Overall Study|Progression and relapse of disease|1
5949935|NCT01271010|20578243|P1|Overall Study|Death|2
5949936|NCT01271010|20578243|P1|Overall Study|Protocol Violation|1
5949937|NCT01271010|20578243|P1|Overall Study|Start of new CLL therapy|1
5949938|NCT01271010|20578243|P1|Overall Study|Reason not specified|11
5949939|NCT01270971|20578258|P2|Overall Study|Non-specific|3
5949940|NCT01270971|20578259|P1|Overall Study|Non-specific|7
5949941|NCT01270971|20578258|P2|Overall Study|Non compliance|2
5949942|NCT01270971|20578259|P1|Overall Study|Non compliance|2
5949943|NCT01270971|20578258|P2|Overall Study|Adverse Event|2
5949944|NCT01270971|20578259|P1|Overall Study|Adverse Event|1
5949945|NCT01270971|20578258|P2|Overall Study|Lost to Follow-up|5
5949946|NCT01270971|20578259|P1|Overall Study|Lost to Follow-up|18
5949947|NCT01270971|20578258|P2|Overall Study|Withdrawal by Subject|11
5949948|NCT01270971|20578259|P1|Overall Study|Withdrawal by Subject|24
5949949|NCT01270958|20578271|P1|Overall Study|Did not meet inclusion criteria for age|2
5949950|NCT01270958|20578271|P1|Overall Study|Lost to Follow-up|2
5949951|NCT01270880|20578300|P1|Overall Study|Never rec'd treatment, but registered.|1
5949952|NCT01270841|20578330|P4|Overall Study|Enrolled in error|0
5949953|NCT01270841|20578331|P3|Overall Study|Enrolled in error|0
5949954|NCT01270841|20578332|P2|Overall Study|Enrolled in error|1
5949955|NCT01270841|20578333|P1|Overall Study|Enrolled in error|0
5949956|NCT01270841|20578330|P4|Overall Study|Protocol Violation|0
5949957|NCT01270841|20578331|P3|Overall Study|Protocol Violation|0
5949958|NCT01270841|20578332|P2|Overall Study|Protocol Violation|5
5949959|NCT01270841|20578333|P1|Overall Study|Protocol Violation|1
5949960|NCT01270841|20578330|P4|Overall Study|Did not qualify|5
5949961|NCT01270841|20578331|P3|Overall Study|Did not qualify|4
5949962|NCT01270841|20578332|P2|Overall Study|Did not qualify|3
5949963|NCT01270841|20578333|P1|Overall Study|Did not qualify|6
5949964|NCT01270841|20578330|P4|Overall Study|Physician Decision|0
5949965|NCT01270841|20578331|P3|Overall Study|Physician Decision|0
5949966|NCT01270841|20578332|P2|Overall Study|Physician Decision|1
5949967|NCT01270841|20578333|P1|Overall Study|Physician Decision|0
5949968|NCT01270841|20578330|P4|Overall Study|Lost to Follow-up|2
5949969|NCT01270841|20578331|P3|Overall Study|Lost to Follow-up|4
5949970|NCT01270841|20578332|P2|Overall Study|Lost to Follow-up|1
5949971|NCT01270841|20578333|P1|Overall Study|Lost to Follow-up|3
5949972|NCT01270841|20578330|P4|Overall Study|Withdrawal by Subject|3
5949973|NCT01270841|20578331|P3|Overall Study|Withdrawal by Subject|3
5949974|NCT01270841|20578332|P2|Overall Study|Withdrawal by Subject|2
5949975|NCT01270841|20578333|P1|Overall Study|Withdrawal by Subject|3
5949976|NCT01270841|20578330|P4|Overall Study|Adverse Event|3
5949977|NCT01270841|20578331|P3|Overall Study|Adverse Event|0
5949978|NCT01270841|20578332|P2|Overall Study|Adverse Event|1
5949979|NCT01270841|20578333|P1|Overall Study|Adverse Event|0
5949980|NCT01270802|20578357|P2|Overall Study|Lost to Follow-up|1
5949981|NCT01270802|20578358|P1|Overall Study|Lost to Follow-up|0
5949982|NCT01270802|20578357|P2|Overall Study|Adverse Event|0
5949983|NCT01270802|20578358|P1|Overall Study|Adverse Event|1
5949984|NCT01270802|20578357|P2|Overall Study|Withdrawal by Subject|0
5949985|NCT01270802|20578358|P1|Overall Study|Withdrawal by Subject|1
5949986|NCT01270620|20578505|P2|Overall Study|Withdrawal by Subject|3
5949987|NCT01270620|20578506|P1|Overall Study|Withdrawal by Subject|1
5949988|NCT01270503|20578601|P1|Overall Study|Lost to Follow-up|1
5949989|NCT01270464|20578609|P3|Overall Study|Other|3
5949990|NCT01270464|20578610|P2|Overall Study|Other|1
5949991|NCT01270464|20578611|P1|Overall Study|Other|1
5949992|NCT01270464|20578609|P3|Overall Study|Lost to Follow-up|1
5949993|NCT01270464|20578610|P2|Overall Study|Lost to Follow-up|3
5949994|NCT01270464|20578611|P1|Overall Study|Lost to Follow-up|2
5949995|NCT01270464|20578609|P3|Overall Study|Withdrawal by Subject|4
5949996|NCT01270464|20578610|P2|Overall Study|Withdrawal by Subject|1
5949997|NCT01270464|20578611|P1|Overall Study|Withdrawal by Subject|2
5949998|NCT01270464|20578609|P3|Overall Study|Adverse Event|7
5949999|NCT01270464|20578610|P2|Overall Study|Adverse Event|1
5950000|NCT01270464|20578611|P1|Overall Study|Adverse Event|9
5950001|NCT01270464|20578609|P3|Overall Study|Lack of Efficacy|1
5950002|NCT01270464|20578610|P2|Overall Study|Lack of Efficacy|3
5950003|NCT01270464|20578611|P1|Overall Study|Lack of Efficacy|2
5950004|NCT01270464|20578609|P3|Overall Study|Protocol Violation|2
5950005|NCT01270464|20578610|P2|Overall Study|Protocol Violation|3
5950006|NCT01270464|20578611|P1|Overall Study|Protocol Violation|4
5950013|NCT01270256|20578676|P2|Overall Study|Withdrawal by Subject|0
5950014|NCT01270256|20578677|P1|Overall Study|Withdrawal by Subject|1
5950015|NCT01270139|20578686|P3|Overall Study|Lost to Follow-up|2
5950016|NCT01270139|20578687|P2|Overall Study|Lost to Follow-up|9
5950017|NCT01270139|20578688|P1|Overall Study|Lost to Follow-up|10
5950018|NCT01270139|20578686|P3|Overall Study|Adverse Event|18
5950019|NCT01270139|20578687|P2|Overall Study|Adverse Event|17
5950020|NCT01270139|20578688|P1|Overall Study|Adverse Event|8
5950021|NCT01269918|20578757|P2|Overall Study|Did not receive study drug|3
5950022|NCT01269918|20578758|P1|Overall Study|Did not receive study drug|0
5950023|NCT01269385|20578833|P4|Overall Study|Adverse Event|0
5950024|NCT01269385|20578834|P3|Overall Study|Adverse Event|0
5950025|NCT01269385|20578835|P2|Overall Study|Adverse Event|1
5950026|NCT01269385|20578836|P1|Overall Study|Adverse Event|1
5950027|NCT01269346|20578861|P1|Extension Phase|Started a prohibited con med|1
5950028|NCT01269346|20578861|P1|Extension Phase|Clinical progression|1
5950029|NCT01269346|20578861|P1|Extension Phase|Physician decision or participant choice|9
5950030|NCT01269346|20578861|P1|Extension Phase|Disease progression|22
5950031|NCT01269346|20578861|P1|Extension Phase|Withdrawal by Subject|4
5950032|NCT01269346|20578861|P1|Extension Phase|Adverse Event|6
5950033|NCT01269346|20578861|P1|Treatment Phase|Other|2
5950034|NCT01269346|20578861|P1|Treatment Phase|Withdrawal by Subject|1
5950035|NCT01269346|20578861|P1|Treatment Phase|Adverse Event|3
5950036|NCT01269346|20578861|P1|Treatment Phase|Disease progression|3
5950037|NCT01269125|20578872|P3|Overall Study|Lost to Follow-up|0
5950038|NCT01269125|20578873|P2|Overall Study|Lost to Follow-up|0
5950039|NCT01269125|20578874|P1|Overall Study|Lost to Follow-up|4
5950040|NCT01269125|20578872|P3|Overall Study|Adverse Event|0
5950041|NCT01269125|20578873|P2|Overall Study|Adverse Event|5
5950042|NCT01269125|20578874|P1|Overall Study|Adverse Event|3
5950043|NCT01268891|20578933|P2|Overall Study|Administrative or other reason(s)|0
5950044|NCT01268891|20578934|P1|Overall Study|Administrative or other reason(s)|1
5950045|NCT01268891|20578933|P2|Overall Study|Withdrawal of Consent|1
5950046|NCT01268891|20578934|P1|Overall Study|Withdrawal of Consent|3
5950047|NCT01268891|20578933|P2|Overall Study|Lack of Efficacy|0
5950048|NCT01268891|20578934|P1|Overall Study|Lack of Efficacy|1
5950049|NCT01268891|20578933|P2|Overall Study|Adverse Event|7
5950050|NCT01268891|20578934|P1|Overall Study|Adverse Event|3
5950051|NCT01268566|20578960|P1|Overall Study|Death|30
5950052|NCT01268566|20578960|P1|Overall Study|Withdrawal by Subject|12
5950053|NCT01268566|20578960|P1|Overall Study|Lost to Follow-up|1
5950054|NCT01268514|20578987|P1|Overall Study|Withdrawal by Surgeon|5
5950055|NCT01268514|20578987|P1|Overall Study|Withdrawal by Subject|3
5950056|NCT01268514|20578987|P1|Overall Study|Lost to Follow-up|5
5950057|NCT01268514|20578987|P1|Overall Study|Death|8
5950058|NCT01268514|20578987|P1|Overall Study|Adverse Event|20
5950059|NCT01268501|20578996|P1|Overall Study|Handling Difficulties|2
5950060|NCT01268501|20578996|P1|Overall Study|Unacceptable Subjective Vision|3
5950061|NCT01268501|20578996|P1|Overall Study|Withdrawal by Subject|3
5950062|NCT01268501|20578996|P1|Overall Study|Lost to Follow-up|1
5950063|NCT01268488|20579000|P1|Overall Study|Physician Decision|2
5950064|NCT01268488|20579000|P1|Overall Study|Adverse Event|3
5950065|NCT01268306|20579007|P1|Overall Study|Lost to Follow-up|1
5950066|NCT01268293|20579011|P1|Overall Study|Subject choice|1
5950067|NCT01268293|20579011|P1|Overall Study|Adverse Event|1
5950068|NCT01268293|20579011|P1|Overall Study|Disease progression|7
5950069|NCT01268267|20579016|P1|Overall Study|Protocol Violation|1
5950070|NCT01268150|20579037|P1|Extension Phase|Other|6
5950071|NCT01268150|20579037|P1|Extension Phase|Disease progression|18
5950072|NCT01268150|20579037|P1|Extension Phase|Adverse Event|3
5950073|NCT01268150|20579037|P1|Treatment Phase|Other|4
5950074|NCT01268150|20579037|P1|Treatment Phase|Withdrawal by Subject|3
5950075|NCT01268150|20579037|P1|Treatment Phase|Adverse Event|3
5950076|NCT01268150|20579037|P1|Treatment Phase|Progression of disease|18
5950077|NCT01268098|20579056|P2|Overall Study|Adverse Event|0
5950078|NCT01268098|20579057|P1|Overall Study|Adverse Event|1
5950079|NCT01268059|20579069|P4|Overall Study|Progression of disease|0
5950080|NCT01268059|20579070|P3|Overall Study|Progression of disease|0
5950081|NCT01268059|20579071|P2|Overall Study|Progression of disease|0
5950082|NCT01268059|20579072|P1|Overall Study|Progression of disease|1
5950083|NCT01268059|20579069|P4|Overall Study|Death|5
5950084|NCT01268059|20579070|P3|Overall Study|Death|3
5950085|NCT01268059|20579071|P2|Overall Study|Death|30
5950086|NCT01268059|20579072|P1|Overall Study|Death|20
5950087|NCT01268059|20579069|P4|Overall Study|Withdrawal by Subject|0
5950088|NCT01268059|20579070|P3|Overall Study|Withdrawal by Subject|0
5950089|NCT01268059|20579071|P2|Overall Study|Withdrawal by Subject|4
5950090|NCT01268059|20579072|P1|Overall Study|Withdrawal by Subject|7
5950091|NCT01268059|20579069|P4|Overall Study|Lost to Follow-up|0
5950092|NCT01268059|20579070|P3|Overall Study|Lost to Follow-up|0
5950093|NCT01268059|20579071|P2|Overall Study|Lost to Follow-up|1
5950094|NCT01268059|20579072|P1|Overall Study|Lost to Follow-up|0
5950095|NCT01268046|20579133|P4|Overall Study|Lost to Follow-up|0
5950096|NCT01268046|20579134|P3|Overall Study|Lost to Follow-up|1
5950097|NCT01268046|20579135|P2|Overall Study|Lost to Follow-up|0
5950098|NCT01268046|20579136|P1|Overall Study|Lost to Follow-up|0
5950099|NCT01268046|20579133|P4|Overall Study|Withdrawal by Subject|1
5950100|NCT01268046|20579134|P3|Overall Study|Withdrawal by Subject|0
5950101|NCT01268046|20579135|P2|Overall Study|Withdrawal by Subject|0
5950102|NCT01268046|20579136|P1|Overall Study|Withdrawal by Subject|1
5950103|NCT01267994|20579146|P1|Overall Study|Adverse Event|2
5950104|NCT01267955|20579151|P1|Stage 2 (6 Months)|Protocol Violation|1
5950105|NCT01267955|20579151|P1|Stage 2 (6 Months)|Death|5
5950106|NCT01267955|20579151|P1|Stage 1 (6 Months)|Death|3
5950107|NCT01267825|20579188|P2|Overall Study|study terminated. no data collected.|0
5950108|NCT01267825|20579189|P1|Overall Study|study terminated. no data collected.|1
5950109|NCT01267266|20579271|P2|Lead-in Phase|Withdrawal by Subject|0
5950110|NCT01267266|20579272|P1|Lead-in Phase|Withdrawal by Subject|1
5950111|NCT01267266|20579271|P2|Lead-in Phase|Adverse Event|0
5950112|NCT01267266|20579272|P1|Lead-in Phase|Adverse Event|2
5950113|NCT01267266|20579271|P2|Lead-in Phase|Lack of Efficacy|0
5950114|NCT01267266|20579272|P1|Lead-in Phase|Lack of Efficacy|20
5950115|NCT01267266|20579271|P2|Enrollment Phase|Withdrawal by Subject|0
5950116|NCT01267266|20579272|P1|Enrollment Phase|Withdrawal by Subject|2
5950117|NCT01267253|20579285|P1|Overall Study|Inevaluable-never received study treatme|2
5950118|NCT01267253|20579285|P1|Overall Study|Ineligible - required test not done|1
5950119|NCT01267201|20579324|P6|Second Intervention Period|Withdrawal by Subject|0
5950120|NCT01267201|20579325|P5|Second Intervention Period|Withdrawal by Subject|0
5950121|NCT01267201|20579326|P4|Second Intervention Period|Withdrawal by Subject|0
5950122|NCT01267201|20579327|P3|Second Intervention Period|Withdrawal by Subject|0
5950123|NCT01267201|20579328|P2|Second Intervention Period|Withdrawal by Subject|1
5950124|NCT01267201|20579329|P1|Second Intervention Period|Withdrawal by Subject|0
5950125|NCT01267201|20579324|P6|First Intervention Period|Withdrawal by Subject|0
5950126|NCT01267201|20579325|P5|First Intervention Period|Withdrawal by Subject|0
5950127|NCT01267201|20579326|P4|First Intervention Period|Withdrawal by Subject|0
5950128|NCT01267201|20579327|P3|First Intervention Period|Withdrawal by Subject|0
5950129|NCT01267201|20579328|P2|First Intervention Period|Withdrawal by Subject|0
5950130|NCT01267201|20579329|P1|First Intervention Period|Withdrawal by Subject|1
5950131|NCT01267175|20579346|P1|Overall Study|Lost to Follow-up|1
5950132|NCT01267175|20579346|P1|Overall Study|Withdrawal by Subject|1
5950133|NCT01266993|20579418|P2|Booster Phase (Month 68-69)|Withdrawal by Subject|1
5950134|NCT01266993|20579419|P1|Booster Phase (Month 68-69)|Withdrawal by Subject|0
5950135|NCT01266993|20579418|P2|Booster Phase (Month 68-69)|Lost to Follow-up|1
5950136|NCT01266993|20579419|P1|Booster Phase (Month 68-69)|Lost to Follow-up|5
5950137|NCT01266967|20579489|P2|Overall Study|Withdrawal by Subject|3
5950138|NCT01266967|20579490|P1|Overall Study|Withdrawal by Subject|3
5950139|NCT01266967|20579489|P2|Overall Study|Physician Decision|1
5950140|NCT01266967|20579490|P1|Overall Study|Physician Decision|0
5950141|NCT01266967|20579489|P2|Overall Study|Lost to Follow-up|1
5950142|NCT01266967|20579490|P1|Overall Study|Lost to Follow-up|2
5950143|NCT01266967|20579489|P2|Overall Study|Study Closed/Terminated|17
5950144|NCT01266967|20579490|P1|Overall Study|Study Closed/Terminated|15
5950145|NCT01266967|20579489|P2|Overall Study|Death|61
5950146|NCT01266967|20579490|P1|Overall Study|Death|69
5950147|NCT01266876|20579542|P5|Overall Study|Adverse Event|0
5950148|NCT01266876|20579543|P4|Overall Study|Adverse Event|1
5950149|NCT01266876|20579544|P3|Overall Study|Adverse Event|0
5950150|NCT01266876|20579545|P2|Overall Study|Adverse Event|0
5950151|NCT01266876|20579546|P1|Overall Study|Adverse Event|0
5950152|NCT01266850|20579653|P5|Overall Study|Site Closure|0
5950153|NCT01266850|20579654|P4|Overall Study|Site Closure|1
5950154|NCT01266850|20579655|P3|Overall Study|Site Closure|1
5950155|NCT01266850|20579656|P2|Overall Study|Site Closure|1
5950156|NCT01266850|20579657|P1|Overall Study|Site Closure|0
5950157|NCT01266850|20579653|P5|Overall Study|Adverse Event|1
5950158|NCT01266850|20579654|P4|Overall Study|Adverse Event|0
5950159|NCT01266850|20579655|P3|Overall Study|Adverse Event|0
5950160|NCT01266850|20579656|P2|Overall Study|Adverse Event|0
5950161|NCT01266850|20579657|P1|Overall Study|Adverse Event|0
5950162|NCT01266850|20579653|P5|Overall Study|Protocol Violation|2
5950163|NCT01266850|20579654|P4|Overall Study|Protocol Violation|1
5950164|NCT01266850|20579655|P3|Overall Study|Protocol Violation|0
5950165|NCT01266850|20579656|P2|Overall Study|Protocol Violation|1
5950166|NCT01266850|20579657|P1|Overall Study|Protocol Violation|0
5950167|NCT01266850|20579653|P5|Overall Study|Physician Decision|3
5950168|NCT01266850|20579654|P4|Overall Study|Physician Decision|4
5950169|NCT01266850|20579655|P3|Overall Study|Physician Decision|4
5950170|NCT01266850|20579656|P2|Overall Study|Physician Decision|6
5950171|NCT01266850|20579657|P1|Overall Study|Physician Decision|3
5950172|NCT01266850|20579653|P5|Overall Study|Withdrawal by Subject|12
5950173|NCT01266850|20579654|P4|Overall Study|Withdrawal by Subject|9
5950174|NCT01266850|20579655|P3|Overall Study|Withdrawal by Subject|6
5950175|NCT01266850|20579656|P2|Overall Study|Withdrawal by Subject|9
5950176|NCT01266850|20579657|P1|Overall Study|Withdrawal by Subject|8
5950177|NCT01266850|20579653|P5|Overall Study|Lost to Follow-up|12
5950178|NCT01266850|20579654|P4|Overall Study|Lost to Follow-up|13
5950179|NCT01266850|20579655|P3|Overall Study|Lost to Follow-up|13
5950180|NCT01266850|20579656|P2|Overall Study|Lost to Follow-up|19
5950181|NCT01266850|20579657|P1|Overall Study|Lost to Follow-up|19
5950182|NCT01266824|20579711|P2|Overall Study|Study terminated prior to completion|3
5950183|NCT01266824|20579712|P1|Overall Study|Study terminated prior to completion|2
5950184|NCT01266603|20579724|P1|Overall Study|Failed screening; MAGE-A3 negative|26
5950185|NCT01266603|20579724|P1|Overall Study|Withdrawal by Subject|1
5950186|NCT01266603|20579724|P1|Overall Study|Lack of Efficacy|14
5950187|NCT01266603|20579724|P1|Overall Study|Adverse Event|1
5950188|NCT01266590|20579730|P1|Overall Study|Physician Decision|1
5950189|NCT01266590|20579730|P1|Overall Study|Withdrawal by Subject|1
5950190|NCT01266590|20579730|P1|Overall Study|Lost to Follow-up|1
5950191|NCT01266590|20579730|P1|Overall Study|Adverse Event|3
5950192|NCT01266460|20579741|P1|Overall Study|Not otherwise specified|8
5950193|NCT01266460|20579741|P1|Overall Study|Disease Progression|18
5950194|NCT01266460|20579741|P1|Overall Study|Withdrawal by Subject|5
5950195|NCT01266460|20579741|P1|Overall Study|Adverse Event|3
5950196|NCT01266317|20579759|P1|Overall Study|Withdrawal by Subject|2
5950197|NCT01266291|20579764|P1|Overall Study|Adverse Event|1
5950198|NCT01266265|20579771|P2|Overall Study|Clinical worsening|1
5950199|NCT01266265|20579772|P1|Overall Study|Clinical worsening|1
5950200|NCT01266265|20579771|P2|Overall Study|Site closed early|3
5950201|NCT01266265|20579772|P1|Overall Study|Site closed early|4
5950202|NCT01266265|20579771|P2|Overall Study|Lung transplant|5
5950203|NCT01266265|20579772|P1|Overall Study|Lung transplant|6
5950204|NCT01266265|20579771|P2|Overall Study|Non-compliance|5
5950205|NCT01266265|20579772|P1|Overall Study|Non-compliance|8
5950206|NCT01266265|20579771|P2|Overall Study|Enrolled in another clinical study|26
5950207|NCT01266265|20579772|P1|Overall Study|Enrolled in another clinical study|15
5950208|NCT01266265|20579771|P2|Overall Study|Stopped/changed PAH medication(s)|9
5950209|NCT01266265|20579772|P1|Overall Study|Stopped/changed PAH medication(s)|16
5950210|NCT01266265|20579771|P2|Overall Study|Transferred care to another provider|28
5950211|NCT01266265|20579772|P1|Overall Study|Transferred care to another provider|22
5950212|NCT01266265|20579771|P2|Overall Study|Respiratory-related adverse event|1
5950213|NCT01266265|20579772|P1|Overall Study|Respiratory-related adverse event|2
5950214|NCT01266265|20579771|P2|Overall Study|Withdrawal by Subject|11
5950215|NCT01266265|20579772|P1|Overall Study|Withdrawal by Subject|13
5950216|NCT01266265|20579771|P2|Overall Study|Lost to Follow-up|28
5950217|NCT01266265|20579772|P1|Overall Study|Lost to Follow-up|23
5950218|NCT01266265|20579771|P2|Overall Study|Death|73
5950219|NCT01266265|20579772|P1|Overall Study|Death|95
5950220|NCT01266161|20579780|P2|Overall Study|Vomited within 4 hours of dosing|0
5950221|NCT01266161|20579781|P1|Overall Study|Vomited within 4 hours of dosing|3
5950222|NCT01266161|20579780|P2|Overall Study|Lack of Efficacy|1
5950223|NCT01266161|20579781|P1|Overall Study|Lack of Efficacy|0
5950224|NCT01266161|20579780|P2|Overall Study|Ineligible|0
5950225|NCT01266161|20579781|P1|Overall Study|Ineligible|1
5950226|NCT01266148|20579813|P2|Overall Study|missing mGFR value + AE|0
5950227|NCT01266148|20579814|P1|Overall Study|missing mGFR value + AE|1
5950228|NCT01266148|20579813|P2|Overall Study|Death|3
5950229|NCT01266148|20579814|P1|Overall Study|Death|2
5950230|NCT01266148|20579813|P2|Overall Study|2 2R rejections|0
5950231|NCT01266148|20579814|P1|Overall Study|2 2R rejections|1
5950232|NCT01266148|20579813|P2|Overall Study|Ongoing rejection|0
5950233|NCT01266148|20579814|P1|Overall Study|Ongoing rejection|1
5950234|NCT01266148|20579813|P2|Overall Study|Adverse Event|0
5950235|NCT01266148|20579814|P1|Overall Study|Adverse Event|2
5950236|NCT01266122|20579842|P2|Overall Study|Lost to Follow-up|6
5950237|NCT01266122|20579843|P1|Overall Study|Lost to Follow-up|6
5950238|NCT01266070|20579851|P1|Overall Study|Protocol Violation|1
5950239|NCT01266070|20579851|P1|Overall Study|Adverse Event|3
5950240|NCT01266031|20579859|P3|Overall Study|Not treated|2
5950241|NCT01266031|20579860|P2|Overall Study|Not treated|3
5950242|NCT01266031|20579861|P1|Overall Study|Not treated|0
5950243|NCT01266018|20579888|P2|Overall Study|Progressive disease|1
5950244|NCT01266018|20579889|P1|Overall Study|Progressive disease|0
5950245|NCT01266018|20579888|P2|Overall Study|Physician Decision|0
5950246|NCT01266018|20579889|P1|Overall Study|Physician Decision|1
5950247|NCT01265992|20579900|P1|Overall Study|Did not receive treatment|1
5950248|NCT01265992|20579900|P1|Overall Study|Stopped treatment|3
5950249|NCT01265992|20579900|P1|Overall Study|Administrative reasons|2
5950250|NCT01265992|20579900|P1|Overall Study|Adverse Event|1
5950251|NCT01265992|20579900|P1|Overall Study|Withdrawal by Subject|1
5950252|NCT01265992|20579900|P1|Overall Study|Lost to Follow-up|1
5950253|NCT01265953|20579928|P2|Overall Study|Non compliance|3
5950254|NCT01265953|20579929|P1|Overall Study|Non compliance|5
5950255|NCT01265875|20579941|P1|Overall Study|Uncooperative/unreliable|1
5950256|NCT01265823|20579949|P1|Overall Study|Participant Request|1
5950257|NCT01265823|20579949|P1|Overall Study|Protocol Violation|1
5950258|NCT01265823|20579949|P1|Overall Study|Failure to Return|4
5950259|NCT01265823|20579949|P1|Overall Study|Unsatisfactory Response Efficacy|1
5950260|NCT01265797|20579978|P2|Open Label Month|Lost to Follow-up|1
5950261|NCT01265797|20579979|P1|Open Label Month|Lost to Follow-up|0
5950262|NCT01265797|20579978|P2|Blinded Month|Diary data incomplete|1
5950263|NCT01265797|20579979|P1|Blinded Month|Diary data incomplete|0
5950264|NCT01265797|20579978|P2|Blinded Month|Adverse Event|0
5950265|NCT01265797|20579979|P1|Blinded Month|Adverse Event|2
5950266|NCT01265797|20579978|P2|Blinded Month|Protocol Violation|1
5950267|NCT01265797|20579979|P1|Blinded Month|Protocol Violation|2
5950268|NCT01265797|20579978|P2|Blinded Month|Lost to Follow-up|0
5950269|NCT01265797|20579979|P1|Blinded Month|Lost to Follow-up|1
5950270|NCT01265797|20579978|P2|Blinded Month|Lack of Efficacy|0
5950271|NCT01265797|20579979|P1|Blinded Month|Lack of Efficacy|5
5950272|NCT01265797|20579978|P2|Run-in Month|1st seizure during run-in month|1
5950273|NCT01265797|20579979|P1|Run-in Month|1st seizure during run-in month|0
5950274|NCT01265797|20579978|P2|Run-in Month|Withdrawal by Subject|4
5950275|NCT01265797|20579979|P1|Run-in Month|Withdrawal by Subject|0
5950276|NCT01265784|20580010|P3|Overall Study|Incorrectly Randomized|1
5950277|NCT01265784|20580011|P2|Overall Study|Incorrectly Randomized|0
5950278|NCT01265784|20580012|P1|Overall Study|Incorrectly Randomized|0
5950279|NCT01265784|20580010|P3|Overall Study|Protocol Violation|0
5950280|NCT01265784|20580011|P2|Overall Study|Protocol Violation|0
5950281|NCT01265784|20580012|P1|Overall Study|Protocol Violation|2
5950282|NCT01265784|20580010|P3|Overall Study|Death|0
5950283|NCT01265784|20580011|P2|Overall Study|Death|0
5950284|NCT01265784|20580012|P1|Overall Study|Death|3
5950285|NCT01265784|20580010|P3|Overall Study|Adverse Event|0
5950286|NCT01265784|20580011|P2|Overall Study|Adverse Event|0
5950287|NCT01265784|20580012|P1|Overall Study|Adverse Event|1
5950288|NCT01265784|20580010|P3|Overall Study|Physician Decision|1
5950289|NCT01265784|20580011|P2|Overall Study|Physician Decision|0
5950290|NCT01265784|20580012|P1|Overall Study|Physician Decision|1
5950291|NCT01265784|20580010|P3|Overall Study|Withdrawal by Subject|0
5950292|NCT01265784|20580011|P2|Overall Study|Withdrawal by Subject|5
5950293|NCT01265784|20580012|P1|Overall Study|Withdrawal by Subject|0
5950294|NCT01265784|20580010|P3|Overall Study|Lost to Follow-up|2
5950295|NCT01265784|20580011|P2|Overall Study|Lost to Follow-up|3
5950296|NCT01265784|20580012|P1|Overall Study|Lost to Follow-up|5
5950307|NCT01265615|20580132|P4|Overall Study|Protocol Violation|3
5950308|NCT01265615|20580133|P3|Overall Study|Protocol Violation|4
5950309|NCT01265615|20580134|P2|Overall Study|Protocol Violation|2
5950310|NCT01265615|20580135|P1|Overall Study|Protocol Violation|2
5950311|NCT01265563|20580186|P5|Overall Study|Withdrawal by Subject|2
5950312|NCT01265563|20580187|P4|Overall Study|Withdrawal by Subject|0
5950313|NCT01265563|20580188|P3|Overall Study|Withdrawal by Subject|1
5950314|NCT01265563|20580189|P2|Overall Study|Withdrawal by Subject|1
5950315|NCT01265563|20580190|P1|Overall Study|Withdrawal by Subject|0
5950316|NCT01265550|20580216|P4|Pre Randomization|Functional heartburn|99
5950317|NCT01265550|20580217|P3|Pre Randomization|Functional heartburn|0
5950318|NCT01265550|20580218|P2|Pre Randomization|Functional heartburn|0
5950319|NCT01265550|20580219|P1|Pre Randomization|Functional heartburn|0
5950320|NCT01265550|20580216|P4|Pre Randomization|Non-GERD organic disorders|23
5950321|NCT01265550|20580217|P3|Pre Randomization|Non-GERD organic disorders|0
5950322|NCT01265550|20580218|P2|Pre Randomization|Non-GERD organic disorders|0
5950323|NCT01265550|20580219|P1|Pre Randomization|Non-GERD organic disorders|0
5950324|NCT01265550|20580216|P4|Pre Randomization|GERD, PPI-Responsive|42
5950325|NCT01265550|20580217|P3|Pre Randomization|GERD, PPI-Responsive|0
5950326|NCT01265550|20580218|P2|Pre Randomization|GERD, PPI-Responsive|0
5950327|NCT01265550|20580219|P1|Pre Randomization|GERD, PPI-Responsive|0
5950328|NCT01265550|20580216|P4|Pre Randomization|Technical Exclusions|54
5950329|NCT01265550|20580217|P3|Pre Randomization|Technical Exclusions|0
5950330|NCT01265550|20580218|P2|Pre Randomization|Technical Exclusions|0
5950331|NCT01265550|20580219|P1|Pre Randomization|Technical Exclusions|0
5950332|NCT01265550|20580216|P4|Pre Randomization|Withdrawal by Subject|70
5950333|NCT01265550|20580217|P3|Pre Randomization|Withdrawal by Subject|0
5950334|NCT01265550|20580218|P2|Pre Randomization|Withdrawal by Subject|0
5950335|NCT01265550|20580219|P1|Pre Randomization|Withdrawal by Subject|0
5950336|NCT01265537|20580311|P2|Overall Study|Physician Decision|1
5950337|NCT01265537|20580312|P1|Overall Study|Physician Decision|0
5950338|NCT01265537|20580311|P2|Overall Study|Adverse Event|1
5950339|NCT01265537|20580312|P1|Overall Study|Adverse Event|2
5950340|NCT01265511|20580363|P2|Overall Study|Met stopping rules|2
5950341|NCT01265511|20580364|P1|Overall Study|Met stopping rules|0
5950342|NCT01265511|20580363|P2|Overall Study|Lack of Efficacy|1
5950343|NCT01265511|20580364|P1|Overall Study|Lack of Efficacy|2
5950344|NCT01265498|20580378|P2|Overall Study|Protocol modified to eliminate wk72 bx|33
5950345|NCT01265498|20580379|P1|Overall Study|Protocol modified to eliminate wk72 bx|31
5950346|NCT01265420|20580515|P1|Overall Study|Lost to Follow-up|1
5950347|NCT01265394|20580519|P1|Overall Study|Subjects withdrawn|37
5950348|NCT01265056|20580526|P2|Follow up|Lost to Follow-up|3
5950349|NCT01265056|20580527|P1|Follow up|Lost to Follow-up|7
5950350|NCT01265056|20580526|P2|Initial Study Period|Withdrawal by Subject|1
5950351|NCT01265056|20580527|P1|Initial Study Period|Withdrawal by Subject|1
5950352|NCT01265056|20580526|P2|Initial Study Period|Withdrawal by Subject|1
5950353|NCT01265056|20580527|P1|Initial Study Period|Withdrawal by Subject|1
5950354|NCT01264965|20580537|P1|Overall Study|Withdrawal by Subject|10
5950355|NCT01264939|20580563|P2|Overall Study|Disease Progression|11
5950356|NCT01264939|20580564|P1|Overall Study|Disease Progression|8
5950357|NCT01264939|20580563|P2|Overall Study|Patient/Guardian Decision|10
5950358|NCT01264939|20580564|P1|Overall Study|Patient/Guardian Decision|8
5950359|NCT01264939|20580563|P2|Overall Study|Physician Decision|1
5950360|NCT01264939|20580564|P1|Overall Study|Physician Decision|1
5950361|NCT01264939|20580563|P2|Overall Study|Lost to Follow-up|3
5950362|NCT01264939|20580564|P1|Overall Study|Lost to Follow-up|0
5950363|NCT01264939|20580563|P2|Overall Study|Adverse Event|3
5950364|NCT01264939|20580564|P1|Overall Study|Adverse Event|1
5950365|NCT01264887|20580590|P1|Overall Study|Other|2
5950366|NCT01264887|20580590|P1|Overall Study|Sponsor Decision Administrative Reasons|2
5950367|NCT01264887|20580590|P1|Overall Study|Withdrawal by Subject|6
5950368|NCT01264887|20580590|P1|Overall Study|Physician Decision|4
5950369|NCT01264887|20580590|P1|Overall Study|Lack of Efficacy|5
5950370|NCT01264887|20580590|P1|Overall Study|Death|7
5950371|NCT01264887|20580590|P1|Overall Study|Adverse Event|5
5950372|NCT01264835|20580601|P1|Overall Study|Lost to Follow-up|1
5950373|NCT01264770|20580611|P6|Overall Study|Adverse Event|1
5950374|NCT01264770|20580612|P5|Overall Study|Adverse Event|2
5950375|NCT01264770|20580613|P4|Overall Study|Adverse Event|0
5950376|NCT01264770|20580614|P3|Overall Study|Adverse Event|8
5950377|NCT01264770|20580615|P2|Overall Study|Adverse Event|7
5950378|NCT01264770|20580616|P1|Overall Study|Adverse Event|7
5950379|NCT01264770|20580611|P6|Overall Study|Lost to Follow-up|0
5950380|NCT01264770|20580612|P5|Overall Study|Lost to Follow-up|0
5950381|NCT01264770|20580613|P4|Overall Study|Lost to Follow-up|1
5950382|NCT01264770|20580614|P3|Overall Study|Lost to Follow-up|1
5950383|NCT01264770|20580615|P2|Overall Study|Lost to Follow-up|0
5950384|NCT01264770|20580616|P1|Overall Study|Lost to Follow-up|0
5950469|NCT01263925|20580823|P1|Overall Study|Lack of Efficacy|0
5950385|NCT01264770|20580611|P6|Overall Study|Dev. of study specific discont. criteria|1
5950386|NCT01264770|20580612|P5|Overall Study|Dev. of study specific discont. criteria|1
5950387|NCT01264770|20580613|P4|Overall Study|Dev. of study specific discont. criteria|0
5950388|NCT01264770|20580614|P3|Overall Study|Dev. of study specific discont. criteria|0
5950389|NCT01264770|20580615|P2|Overall Study|Dev. of study specific discont. criteria|0
5950390|NCT01264770|20580616|P1|Overall Study|Dev. of study specific discont. criteria|2
5950391|NCT01264770|20580611|P6|Overall Study|Lack of therapeutic response|0
5950392|NCT01264770|20580612|P5|Overall Study|Lack of therapeutic response|1
5950393|NCT01264770|20580613|P4|Overall Study|Lack of therapeutic response|1
5950394|NCT01264770|20580614|P3|Overall Study|Lack of therapeutic response|2
5950395|NCT01264770|20580615|P2|Overall Study|Lack of therapeutic response|0
5950396|NCT01264770|20580616|P1|Overall Study|Lack of therapeutic response|1
5950397|NCT01264770|20580611|P6|Overall Study|Severe non-compliance to protocol|0
5950398|NCT01264770|20580612|P5|Overall Study|Severe non-compliance to protocol|0
5950399|NCT01264770|20580613|P4|Overall Study|Severe non-compliance to protocol|1
5950400|NCT01264770|20580614|P3|Overall Study|Severe non-compliance to protocol|1
5950401|NCT01264770|20580615|P2|Overall Study|Severe non-compliance to protocol|0
5950402|NCT01264770|20580616|P1|Overall Study|Severe non-compliance to protocol|0
5950403|NCT01264770|20580611|P6|Overall Study|e.g., change in circumstances|4
5950404|NCT01264770|20580612|P5|Overall Study|e.g., change in circumstances|4
5950405|NCT01264770|20580613|P4|Overall Study|e.g., change in circumstances|3
5950406|NCT01264770|20580614|P3|Overall Study|e.g., change in circumstances|3
5950407|NCT01264770|20580615|P2|Overall Study|e.g., change in circumstances|3
5950408|NCT01264770|20580616|P1|Overall Study|e.g., change in circumstances|8
5950409|NCT01264770|20580611|P6|Overall Study|Not reported|0
5950410|NCT01264770|20580612|P5|Overall Study|Not reported|0
5950411|NCT01264770|20580613|P4|Overall Study|Not reported|0
5950412|NCT01264770|20580614|P3|Overall Study|Not reported|1
5950413|NCT01264770|20580615|P2|Overall Study|Not reported|0
5950414|NCT01264770|20580616|P1|Overall Study|Not reported|0
5950415|NCT01264718|20580702|P2|Overall Study|Loss of Medicaid/CHIP eligibility|26
5950416|NCT01264718|20580703|P1|Overall Study|Loss of Medicaid/CHIP eligibility|37
5950417|NCT01264718|20580702|P2|Overall Study|Withdrawal by Subject|15
5950418|NCT01264718|20580703|P1|Overall Study|Withdrawal by Subject|9
5950419|NCT01264718|20580702|P2|Overall Study|Lost to Follow-up|2
5950420|NCT01264718|20580703|P1|Overall Study|Lost to Follow-up|3
5950421|NCT01264679|20580740|P1|Overall Study|Withdrawal by Subject|1
5950422|NCT01264679|20580740|P1|Overall Study|Sponsor's Suspension of Dosing|2
5950423|NCT01264679|20580740|P1|Overall Study|Physician Decision|1
5950424|NCT01264679|20580740|P1|Overall Study|Participation in Another Clinical Trial|1
5950425|NCT01264419|20580774|P1|Overall Study|Lost to Follow-up|3
5950426|NCT01264380|20580779|P3|Period C|Adverse Event|1
5950427|NCT01264380|20580780|P2|Period C|Adverse Event|0
5950428|NCT01264380|20580781|P1|Period C|Adverse Event|0
5950429|NCT01264380|20580779|P3|Period C|Withdrawal by Subject|1
5950430|NCT01264380|20580780|P2|Period C|Withdrawal by Subject|0
5950431|NCT01264380|20580781|P1|Period C|Withdrawal by Subject|0
5950432|NCT01264380|20580779|P3|Period C|Follow-up for survival status|6
5950433|NCT01264380|20580780|P2|Period C|Follow-up for survival status|0
5950434|NCT01264380|20580781|P1|Period C|Follow-up for survival status|0
5950435|NCT01264380|20580779|P3|Period C|Death|2
5950436|NCT01264380|20580780|P2|Period C|Death|0
5950437|NCT01264380|20580781|P1|Period C|Death|0
5950438|NCT01264380|20580779|P3|Period C|Disease Progression|4
5950439|NCT01264380|20580780|P2|Period C|Disease Progression|0
5950440|NCT01264380|20580781|P1|Period C|Disease Progression|0
5950441|NCT01264081|20580802|P1|Started Treatment|Not complete cycle 1 due to death|1
5950442|NCT01264081|20580802|P1|Started Treatment|Withdrawal by Subject|1
5950443|NCT01264081|20580802|P1|Participants Screened|Screening failures|30
5950444|NCT01264016|20580807|P1|Overall Study|Felt faint at sight of blood|1
5950445|NCT01264016|20580807|P1|Overall Study|Withdrawal by Subject|1
5950446|NCT01263925|20580822|P2|Overall Study|Withdrawal/ Not specified|1
5950447|NCT01263925|20580823|P1|Overall Study|Withdrawal/ Not specified|0
5950448|NCT01263925|20580822|P2|Overall Study|Unsatisfactory Compl./ Lost to Follow up|2
5950449|NCT01263925|20580823|P1|Overall Study|Unsatisfactory Compl./ Lost to Follow up|1
5950450|NCT01263925|20580822|P2|Overall Study|Unsatisfactory Compliance/ Withdrawal|1
5950451|NCT01263925|20580823|P1|Overall Study|Unsatisfactory Compliance/ Withdrawal|1
5950452|NCT01263925|20580822|P2|Overall Study|AE/ Withdrawal|4
5950453|NCT01263925|20580823|P1|Overall Study|AE/ Withdrawal|1
5950454|NCT01263925|20580822|P2|Overall Study|AE/ Unsatisfactory Compliance|2
5950455|NCT01263925|20580823|P1|Overall Study|AE/ Unsatisfactory Compliance|2
5950456|NCT01263925|20580822|P2|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1
5950457|NCT01263925|20580823|P1|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1
5950458|NCT01263925|20580822|P2|Overall Study|Lost to Follow-up|1
5950459|NCT01263925|20580823|P1|Overall Study|Lost to Follow-up|3
5950460|NCT01263925|20580822|P2|Overall Study|Other|4
5950461|NCT01263925|20580823|P1|Overall Study|Other|4
5950462|NCT01263925|20580822|P2|Overall Study|Withdrawal by Subject|8
5950463|NCT01263925|20580823|P1|Overall Study|Withdrawal by Subject|6
5950464|NCT01263925|20580822|P2|Overall Study|Unsatisfactory Compliance of Subject|5
5950465|NCT01263925|20580823|P1|Overall Study|Unsatisfactory Compliance of Subject|8
5950466|NCT01263925|20580822|P2|Overall Study|Adverse Event|22
5950467|NCT01263925|20580823|P1|Overall Study|Adverse Event|23
5950468|NCT01263925|20580822|P2|Overall Study|Lack of Efficacy|1
5950470|NCT01263925|20580822|P2|Overall Study|Protocol Violation|0
5950471|NCT01263925|20580823|P1|Overall Study|Protocol Violation|1
5950472|NCT01263873|20580857|P2|Overall Study|One provider unable to complete numbers|1
5950473|NCT01263873|20580858|P1|Overall Study|One provider unable to complete numbers|1
5950474|NCT01263782|20580872|P4|Overall Study|Inevaluable|0
5950475|NCT01263782|20580873|P3|Overall Study|Inevaluable|1
5950476|NCT01263782|20580874|P2|Overall Study|Inevaluable|0
5950477|NCT01263782|20580875|P1|Overall Study|Inevaluable|0
5950478|NCT01263782|20580872|P4|Overall Study|Too early|0
5950479|NCT01263782|20580873|P3|Overall Study|Too early|1
5950480|NCT01263782|20580874|P2|Overall Study|Too early|0
5950481|NCT01263782|20580875|P1|Overall Study|Too early|0
5950482|NCT01263782|20580872|P4|Overall Study|Progressive disease|1
5950483|NCT01263782|20580873|P3|Overall Study|Progressive disease|0
5950484|NCT01263782|20580874|P2|Overall Study|Progressive disease|0
5950485|NCT01263782|20580875|P1|Overall Study|Progressive disease|0
5950486|NCT01263782|20580872|P4|Overall Study|Death|0
5950487|NCT01263782|20580873|P3|Overall Study|Death|1
5950488|NCT01263782|20580874|P2|Overall Study|Death|0
5950489|NCT01263782|20580875|P1|Overall Study|Death|0
5950490|NCT01263704|20580920|P1|Overall Study|Principal Investigator (PI) decision|1
5950491|NCT01263704|20580920|P1|Overall Study|Colon metastases|1
5950492|NCT01263704|20580920|P1|Overall Study|Lost to Follow-up|1
5950493|NCT01263704|20580920|P1|Overall Study|Eligibility criteria not fulfilled|1
5950494|NCT01263704|20580920|P1|Overall Study|Patient withdrew consent|2
5950495|NCT01263704|20580920|P1|Overall Study|Death|2
5950496|NCT01263704|20580920|P1|Overall Study|Adverse Event|3
5950497|NCT01263704|20580920|P1|Overall Study|Progressive disease|18
5950498|NCT01263691|20580935|P6|Overall Study|Adverse Event|0
5950499|NCT01263691|20580936|P5|Overall Study|Adverse Event|0
5950500|NCT01263691|20580937|P4|Overall Study|Adverse Event|0
5950501|NCT01263691|20580938|P3|Overall Study|Adverse Event|0
5950502|NCT01263691|20580939|P2|Overall Study|Adverse Event|0
5950503|NCT01263691|20580940|P1|Overall Study|Adverse Event|1
5950504|NCT01263691|20580935|P6|Overall Study|Withdrawal by Subject|0
5950505|NCT01263691|20580936|P5|Overall Study|Withdrawal by Subject|0
5950506|NCT01263691|20580937|P4|Overall Study|Withdrawal by Subject|0
5950507|NCT01263691|20580938|P3|Overall Study|Withdrawal by Subject|0
5950508|NCT01263691|20580939|P2|Overall Study|Withdrawal by Subject|0
5950509|NCT01263691|20580940|P1|Overall Study|Withdrawal by Subject|1
5950510|NCT01263691|20580935|P6|Overall Study|Lost to Follow-up|0
5950511|NCT01263691|20580936|P5|Overall Study|Lost to Follow-up|0
5950512|NCT01263691|20580937|P4|Overall Study|Lost to Follow-up|1
5950513|NCT01263691|20580938|P3|Overall Study|Lost to Follow-up|1
5950514|NCT01263691|20580939|P2|Overall Study|Lost to Follow-up|0
5950515|NCT01263691|20580940|P1|Overall Study|Lost to Follow-up|1
5950516|NCT01263665|20581050|P1|Overall Study|Surgical Bypass|2
5950517|NCT01263665|20581050|P1|Overall Study|Amputation above the ankle|1
5950518|NCT01263665|20581050|P1|Overall Study|Death|2
5950519|NCT01263665|20581050|P1|Overall Study|Lost to Follow-up|3
5950520|NCT01263665|20581050|P1|Overall Study|Withdrew Consent|1
5950521|NCT01263639|20581057|P2|Overall Study|Exclusion =Admission greater than 7 days|9
5950522|NCT01263639|20581058|P1|Overall Study|Exclusion =Admission greater than 7 days|7
5950523|NCT01263639|20581057|P2|Overall Study|Lost to Follow-up|70
5950524|NCT01263639|20581058|P1|Overall Study|Lost to Follow-up|66
5950525|NCT01263561|20581066|P2|Overall Study|Death|2
5950526|NCT01263561|20581067|P1|Overall Study|Death|1
5950527|NCT01263509|20581079|P4|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|1
5950528|NCT01263509|20581080|P3|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0
5950529|NCT01263509|20581081|P2|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0
5950530|NCT01263509|20581082|P1|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0
5950531|NCT01263509|20581079|P4|Entered - Long-Term Extension Study|Participant Unavailability|0
5950532|NCT01263509|20581080|P3|Entered - Long-Term Extension Study|Participant Unavailability|0
5950533|NCT01263509|20581081|P2|Entered - Long-Term Extension Study|Participant Unavailability|1
5950534|NCT01263509|20581082|P1|Entered - Long-Term Extension Study|Participant Unavailability|1
5950535|NCT01263509|20581079|P4|Entered - Long-Term Extension Study|Withdrawal by Subject|0
5950536|NCT01263509|20581080|P3|Entered - Long-Term Extension Study|Withdrawal by Subject|0
5950537|NCT01263509|20581081|P2|Entered - Long-Term Extension Study|Withdrawal by Subject|2
5950538|NCT01263509|20581082|P1|Entered - Long-Term Extension Study|Withdrawal by Subject|1
5950539|NCT01263509|20581079|P4|Entered - Long-Term Extension Study|Lack of Efficacy|0
5950540|NCT01263509|20581080|P3|Entered - Long-Term Extension Study|Lack of Efficacy|1
5950541|NCT01263509|20581081|P2|Entered - Long-Term Extension Study|Lack of Efficacy|4
5950542|NCT01263509|20581082|P1|Entered - Long-Term Extension Study|Lack of Efficacy|1
5950543|NCT01263509|20581079|P4|Entered - Long-Term Extension Study|Adverse Event|1
5950544|NCT01263509|20581080|P3|Entered - Long-Term Extension Study|Adverse Event|4
5950545|NCT01263509|20581081|P2|Entered - Long-Term Extension Study|Adverse Event|5
5950546|NCT01263509|20581082|P1|Entered - Long-Term Extension Study|Adverse Event|5
5950547|NCT01263496|20581211|P9|Entered - Long-Term Extension Study|Participant Unavailability|0
5950548|NCT01263496|20581212|P8|Entered - Long-Term Extension Study|Participant Unavailability|1
5950549|NCT01263496|20581213|P7|Entered - Long-Term Extension Study|Participant Unavailability|0
5950550|NCT01263496|20581214|P6|Entered - Long-Term Extension Study|Participant Unavailability|0
5950551|NCT01263496|20581215|P5|Entered - Long-Term Extension Study|Participant Unavailability|0
5950552|NCT01263496|20581216|P4|Entered - Long-Term Extension Study|Participant Unavailability|0
5950553|NCT01263496|20581217|P3|Entered - Long-Term Extension Study|Participant Unavailability|0
5950554|NCT01263496|20581218|P2|Entered - Long-Term Extension Study|Participant Unavailability|0
5950555|NCT01263496|20581219|P1|Entered - Long-Term Extension Study|Participant Unavailability|0
5950556|NCT01263496|20581211|P9|Entered - Long-Term Extension Study|Lack of Efficacy|1
5950557|NCT01263496|20581212|P8|Entered - Long-Term Extension Study|Lack of Efficacy|0
5950558|NCT01263496|20581213|P7|Entered - Long-Term Extension Study|Lack of Efficacy|0
5950559|NCT01263496|20581214|P6|Entered - Long-Term Extension Study|Lack of Efficacy|0
5950560|NCT01263496|20581215|P5|Entered - Long-Term Extension Study|Lack of Efficacy|5
5950561|NCT01263496|20581216|P4|Entered - Long-Term Extension Study|Lack of Efficacy|1
5950562|NCT01263496|20581217|P3|Entered - Long-Term Extension Study|Lack of Efficacy|4
5950563|NCT01263496|20581218|P2|Entered - Long-Term Extension Study|Lack of Efficacy|4
5950564|NCT01263496|20581219|P1|Entered - Long-Term Extension Study|Lack of Efficacy|8
5950565|NCT01263496|20581211|P9|Entered - Long-Term Extension Study|Withdrawal by Subject|1
5950566|NCT01263496|20581212|P8|Entered - Long-Term Extension Study|Withdrawal by Subject|0
5950567|NCT01263496|20581213|P7|Entered - Long-Term Extension Study|Withdrawal by Subject|1
5950568|NCT01263496|20581214|P6|Entered - Long-Term Extension Study|Withdrawal by Subject|1
5950569|NCT01263496|20581215|P5|Entered - Long-Term Extension Study|Withdrawal by Subject|4
5950570|NCT01263496|20581216|P4|Entered - Long-Term Extension Study|Withdrawal by Subject|2
5950571|NCT01263496|20581217|P3|Entered - Long-Term Extension Study|Withdrawal by Subject|0
5950572|NCT01263496|20581218|P2|Entered - Long-Term Extension Study|Withdrawal by Subject|2
5950573|NCT01263496|20581219|P1|Entered - Long-Term Extension Study|Withdrawal by Subject|1
5950574|NCT01263496|20581211|P9|Entered - Long-Term Extension Study|Lost to Follow-up|0
5950575|NCT01263496|20581212|P8|Entered - Long-Term Extension Study|Lost to Follow-up|0
5950576|NCT01263496|20581213|P7|Entered - Long-Term Extension Study|Lost to Follow-up|0
5950577|NCT01263496|20581214|P6|Entered - Long-Term Extension Study|Lost to Follow-up|0
5950578|NCT01263496|20581215|P5|Entered - Long-Term Extension Study|Lost to Follow-up|0
5950579|NCT01263496|20581216|P4|Entered - Long-Term Extension Study|Lost to Follow-up|0
5950580|NCT01263496|20581217|P3|Entered - Long-Term Extension Study|Lost to Follow-up|0
5950581|NCT01263496|20581218|P2|Entered - Long-Term Extension Study|Lost to Follow-up|2
5950582|NCT01263496|20581219|P1|Entered - Long-Term Extension Study|Lost to Follow-up|0
5950583|NCT01263496|20581211|P9|Entered - Long-Term Extension Study|Adverse Event|1
5950584|NCT01263496|20581212|P8|Entered - Long-Term Extension Study|Adverse Event|0
5950585|NCT01263496|20581213|P7|Entered - Long-Term Extension Study|Adverse Event|0
5950586|NCT01263496|20581214|P6|Entered - Long-Term Extension Study|Adverse Event|0
5950587|NCT01263496|20581215|P5|Entered - Long-Term Extension Study|Adverse Event|1
5950588|NCT01263496|20581216|P4|Entered - Long-Term Extension Study|Adverse Event|3
5950589|NCT01263496|20581217|P3|Entered - Long-Term Extension Study|Adverse Event|6
5950590|NCT01263496|20581218|P2|Entered - Long-Term Extension Study|Adverse Event|5
5950591|NCT01263496|20581219|P1|Entered - Long-Term Extension Study|Adverse Event|0
5950592|NCT01263496|20581211|P9|Enrolled - Long-Term Extension Study|Adverse Event|0
5950593|NCT01263496|20581212|P8|Enrolled - Long-Term Extension Study|Adverse Event|0
5950594|NCT01263496|20581213|P7|Enrolled - Long-Term Extension Study|Adverse Event|0
5950595|NCT01263496|20581214|P6|Enrolled - Long-Term Extension Study|Adverse Event|0
5950596|NCT01263496|20581215|P5|Enrolled - Long-Term Extension Study|Adverse Event|2
5950597|NCT01263496|20581216|P4|Enrolled - Long-Term Extension Study|Adverse Event|1
5950598|NCT01263496|20581217|P3|Enrolled - Long-Term Extension Study|Adverse Event|0
5950599|NCT01263496|20581218|P2|Enrolled - Long-Term Extension Study|Adverse Event|0
5950600|NCT01263496|20581219|P1|Enrolled - Long-Term Extension Study|Adverse Event|0
5950601|NCT01263496|20581211|P9|Enrolled - Long-Term Extension Study|Protocol Violation|0
5950602|NCT01263496|20581212|P8|Enrolled - Long-Term Extension Study|Protocol Violation|0
5950603|NCT01263496|20581213|P7|Enrolled - Long-Term Extension Study|Protocol Violation|0
5950604|NCT01263496|20581214|P6|Enrolled - Long-Term Extension Study|Protocol Violation|0
5950605|NCT01263496|20581215|P5|Enrolled - Long-Term Extension Study|Protocol Violation|0
5950606|NCT01263496|20581216|P4|Enrolled - Long-Term Extension Study|Protocol Violation|0
5950607|NCT01263496|20581217|P3|Enrolled - Long-Term Extension Study|Protocol Violation|0
5950608|NCT01263496|20581218|P2|Enrolled - Long-Term Extension Study|Protocol Violation|0
5950609|NCT01263496|20581219|P1|Enrolled - Long-Term Extension Study|Protocol Violation|1
5950610|NCT01263483|20581514|P3|Overall Study|Participant Unavailability|1
5950611|NCT01263483|20581515|P2|Overall Study|Participant Unavailability|1
5950612|NCT01263483|20581516|P1|Overall Study|Participant Unavailability|0
5950613|NCT01263483|20581514|P3|Overall Study|Protocol Violation|1
5950614|NCT01263483|20581515|P2|Overall Study|Protocol Violation|1
5950615|NCT01263483|20581516|P1|Overall Study|Protocol Violation|0
5950616|NCT01263483|20581514|P3|Overall Study|Lack of Efficacy|0
5950617|NCT01263483|20581515|P2|Overall Study|Lack of Efficacy|0
5950618|NCT01263483|20581516|P1|Overall Study|Lack of Efficacy|2
5950619|NCT01263483|20581514|P3|Overall Study|Withdrawal by Subject|0
5950620|NCT01263483|20581515|P2|Overall Study|Withdrawal by Subject|0
5950621|NCT01263483|20581516|P1|Overall Study|Withdrawal by Subject|1
5950622|NCT01263483|20581514|P3|Overall Study|Adverse Event|3
5950623|NCT01263483|20581515|P2|Overall Study|Adverse Event|0
5950624|NCT01263483|20581516|P1|Overall Study|Adverse Event|4
5950625|NCT01263470|20581578|P6|Overall Study|Study Drug Non-compliance|0
5950626|NCT01263470|20581579|P5|Overall Study|Study Drug Non-compliance|1
5950627|NCT01263470|20581580|P4|Overall Study|Study Drug Non-compliance|0
5950628|NCT01263470|20581581|P3|Overall Study|Study Drug Non-compliance|0
5950629|NCT01263470|20581582|P2|Overall Study|Study Drug Non-compliance|0
5950630|NCT01263470|20581583|P1|Overall Study|Study Drug Non-compliance|0
5950631|NCT01263470|20581578|P6|Overall Study|Participant Unavailability|0
5950632|NCT01263470|20581579|P5|Overall Study|Participant Unavailability|0
5950633|NCT01263470|20581580|P4|Overall Study|Participant Unavailability|0
5950634|NCT01263470|20581581|P3|Overall Study|Participant Unavailability|0
5950635|NCT01263470|20581582|P2|Overall Study|Participant Unavailability|1
5950636|NCT01263470|20581583|P1|Overall Study|Participant Unavailability|0
5950637|NCT01263470|20581578|P6|Overall Study|Lack of Efficacy|0
5950638|NCT01263470|20581579|P5|Overall Study|Lack of Efficacy|0
5950639|NCT01263470|20581580|P4|Overall Study|Lack of Efficacy|0
5950640|NCT01263470|20581581|P3|Overall Study|Lack of Efficacy|2
5950641|NCT01263470|20581582|P2|Overall Study|Lack of Efficacy|0
5950642|NCT01263470|20581583|P1|Overall Study|Lack of Efficacy|0
5950643|NCT01263470|20581578|P6|Overall Study|Withdrawal by Subject|2
5950644|NCT01263470|20581579|P5|Overall Study|Withdrawal by Subject|0
5950645|NCT01263470|20581580|P4|Overall Study|Withdrawal by Subject|2
5950646|NCT01263470|20581581|P3|Overall Study|Withdrawal by Subject|1
5950647|NCT01263470|20581582|P2|Overall Study|Withdrawal by Subject|1
5950648|NCT01263470|20581583|P1|Overall Study|Withdrawal by Subject|0
5950649|NCT01263470|20581578|P6|Overall Study|Protocol Violation|1
5950650|NCT01263470|20581579|P5|Overall Study|Protocol Violation|0
5950651|NCT01263470|20581580|P4|Overall Study|Protocol Violation|0
5950652|NCT01263470|20581581|P3|Overall Study|Protocol Violation|0
5950653|NCT01263470|20581582|P2|Overall Study|Protocol Violation|1
5950654|NCT01263470|20581583|P1|Overall Study|Protocol Violation|0
5950655|NCT01263470|20581578|P6|Overall Study|Adverse Event|2
5950656|NCT01263470|20581579|P5|Overall Study|Adverse Event|2
5950657|NCT01263470|20581580|P4|Overall Study|Adverse Event|1
5950658|NCT01263470|20581581|P3|Overall Study|Adverse Event|1
5950659|NCT01263470|20581582|P2|Overall Study|Adverse Event|2
5950660|NCT01263470|20581583|P1|Overall Study|Adverse Event|2
5950661|NCT01263444|20581693|P1|Overall Study|Protocol Violation|1
5950662|NCT01263444|20581693|P1|Overall Study|Withdrawal by Subject|1
5950663|NCT01263444|20581693|P1|Overall Study|Adverse Event|8
5950664|NCT01263223|20581830|P2|7-day Follow-up|Lost to Follow-up|0
5950665|NCT01263223|20581831|P1|7-day Follow-up|Lost to Follow-up|1
5950666|NCT01263223|20581830|P2|7-day Follow-up|Withdrawal by Subject|1
5950667|NCT01263223|20581831|P1|7-day Follow-up|Withdrawal by Subject|0
5950668|NCT01263223|20581830|P2|Period 2|Withdrawal by Subject|1
5950669|NCT01263223|20581831|P1|Period 2|Withdrawal by Subject|0
5950670|NCT01263197|20581854|P6|Third Intervention (Period 3)|Adverse Event|0
5950671|NCT01263197|20581855|P5|Third Intervention (Period 3)|Adverse Event|0
5950672|NCT01263197|20581856|P4|Third Intervention (Period 3)|Adverse Event|0
5950673|NCT01263197|20581857|P3|Third Intervention (Period 3)|Adverse Event|0
5950674|NCT01263197|20581858|P2|Third Intervention (Period 3)|Adverse Event|1
5950675|NCT01263197|20581859|P1|Third Intervention (Period 3)|Adverse Event|0
5950676|NCT01263197|20581854|P6|Washout Period 2|Protocol Violation|0
5950677|NCT01263197|20581855|P5|Washout Period 2|Protocol Violation|0
5950678|NCT01263197|20581856|P4|Washout Period 2|Protocol Violation|1
5950679|NCT01263197|20581857|P3|Washout Period 2|Protocol Violation|0
5950680|NCT01263197|20581858|P2|Washout Period 2|Protocol Violation|0
5950681|NCT01263197|20581859|P1|Washout Period 2|Protocol Violation|0
5950682|NCT01263197|20581854|P6|Washout Period 2|Physician Decision|1
5950683|NCT01263197|20581855|P5|Washout Period 2|Physician Decision|0
5950684|NCT01263197|20581856|P4|Washout Period 2|Physician Decision|0
5950685|NCT01263197|20581857|P3|Washout Period 2|Physician Decision|0
5950686|NCT01263197|20581858|P2|Washout Period 2|Physician Decision|0
5950687|NCT01263197|20581859|P1|Washout Period 2|Physician Decision|0
5950688|NCT01263197|20581854|P6|Washout Period 1|Protocol Violation|0
5950689|NCT01263197|20581855|P5|Washout Period 1|Protocol Violation|1
5950690|NCT01263197|20581856|P4|Washout Period 1|Protocol Violation|0
5950691|NCT01263197|20581857|P3|Washout Period 1|Protocol Violation|0
5950692|NCT01263197|20581858|P2|Washout Period 1|Protocol Violation|0
5950693|NCT01263197|20581859|P1|Washout Period 1|Protocol Violation|0
5950694|NCT01263197|20581854|P6|First Intervention (Period 1)|Adverse Event|1
5950695|NCT01263197|20581855|P5|First Intervention (Period 1)|Adverse Event|0
5950696|NCT01263197|20581856|P4|First Intervention (Period 1)|Adverse Event|0
5950697|NCT01263197|20581857|P3|First Intervention (Period 1)|Adverse Event|0
5950698|NCT01263197|20581858|P2|First Intervention (Period 1)|Adverse Event|0
5950699|NCT01263197|20581859|P1|First Intervention (Period 1)|Adverse Event|0
5950700|NCT01263119|20581902|P1|Period 2|Adverse Event|2
5950701|NCT01263119|20581902|P1|Period 1|Protocol Violation|2
5950702|NCT01263106|20581923|P2|Washout (at Least 7 Days)|Lost to Follow-up|1
5950703|NCT01263106|20581924|P1|Washout (at Least 7 Days)|Lost to Follow-up|1
5950704|NCT01263093|20581939|P2|Period 2|Adverse Event|0
5950705|NCT01263093|20581940|P1|Period 2|Adverse Event|1
5950706|NCT01263093|20581939|P2|Washout|Physician Decision|0
5950707|NCT01263093|20581940|P1|Washout|Physician Decision|1
5950708|NCT01263054|20581957|P2|Overall Study|Other|1
5950709|NCT01263054|20581958|P1|Overall Study|Other|0
5950710|NCT01263054|20581957|P2|Overall Study|Qualification Violation|0
5950711|NCT01263054|20581958|P1|Overall Study|Qualification Violation|1
5950712|NCT01263054|20581957|P2|Overall Study|Withdrawal by Subject|3
5950713|NCT01263054|20581958|P1|Overall Study|Withdrawal by Subject|1
5950714|NCT01263054|20581957|P2|Overall Study|Lost to Follow-up|2
5950715|NCT01263054|20581958|P1|Overall Study|Lost to Follow-up|2
5950716|NCT01263054|20581957|P2|Overall Study|Death|0
5950717|NCT01263054|20581958|P1|Overall Study|Death|1
5950718|NCT01263028|20581976|P1|Overall Study|Study terminated due to low enrollment.|4
5950719|NCT01263028|20581976|P1|Overall Study|Adverse Event|1
5950720|NCT01263028|20581976|P1|Overall Study|Withdrawal by Subject|1
5950721|NCT01263015|20581986|P2|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|7
5950722|NCT01263015|20581987|P1|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|3
5950723|NCT01263015|20581986|P2|Open-label Phase: 48 Weeks Duration|Physician Decision|2
5950724|NCT01263015|20581987|P1|Open-label Phase: 48 Weeks Duration|Physician Decision|0
5950725|NCT01263015|20581986|P2|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8
5950726|NCT01263015|20581987|P1|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8
5950727|NCT01263015|20581986|P2|Open-label Phase: 48 Weeks Duration|Protocol Violation|2
5950728|NCT01263015|20581987|P1|Open-label Phase: 48 Weeks Duration|Protocol Violation|3
5950729|NCT01263015|20581986|P2|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|2
5950730|NCT01263015|20581987|P1|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|7
5950731|NCT01263015|20581986|P2|Open-label Phase: 48 Weeks Duration|Adverse Event|10
5950732|NCT01263015|20581987|P1|Open-label Phase: 48 Weeks Duration|Adverse Event|3
5950733|NCT01263015|20581986|P2|Double-blind Phase: 96 Weeks Duration|Physician Decision|2
5950734|NCT01263015|20581987|P1|Double-blind Phase: 96 Weeks Duration|Physician Decision|1
5950735|NCT01263015|20581986|P2|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|15
5950736|NCT01263015|20581987|P1|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|9
5950737|NCT01263015|20581986|P2|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|18
5950738|NCT01263015|20581987|P1|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|17
5950739|NCT01263015|20581986|P2|Double-blind Phase: 96 Weeks Duration|Protocol Violation|12
5950740|NCT01263015|20581987|P1|Double-blind Phase: 96 Weeks Duration|Protocol Violation|14
5950741|NCT01263015|20581986|P2|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|14
5950742|NCT01263015|20581987|P1|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|18
5950743|NCT01263015|20581986|P2|Double-blind Phase: 96 Weeks Duration|Adverse Event|48
5950744|NCT01263015|20581987|P1|Double-blind Phase: 96 Weeks Duration|Adverse Event|13
5950745|NCT01262989|20582013|P2|Period 2|Intercurrent disease|1
5950746|NCT01262989|20582014|P1|Period 2|Intercurrent disease|0
5950747|NCT01262989|20582013|P2|Period 1|Positive answer for exclusion criteria|1
5950748|NCT01262989|20582014|P1|Period 1|Positive answer for exclusion criteria|0
5950749|NCT01262989|20582013|P2|Period 1|Intercurrent disease|1
5950750|NCT01262989|20582014|P1|Period 1|Intercurrent disease|0
5950751|NCT01262989|20582013|P2|Period 1|Lost to Follow-up|1
5950752|NCT01262989|20582014|P1|Period 1|Lost to Follow-up|1
5950753|NCT01262976|20582030|P6|Up to Year 3|Other|0
5950754|NCT01262976|20582031|P5|Up to Year 3|Other|0
5950755|NCT01262976|20582032|P4|Up to Year 3|Other|0
5950756|NCT01262976|20582033|P3|Up to Year 3|Other|0
5950757|NCT01262976|20582034|P2|Up to Year 3|Other|0
5950758|NCT01262976|20582035|P1|Up to Year 3|Other|3
5950759|NCT01262976|20582030|P6|Up to Year 3|Subjects with unknown completion status|0
5950760|NCT01262976|20582031|P5|Up to Year 3|Subjects with unknown completion status|0
5950761|NCT01262976|20582032|P4|Up to Year 3|Subjects with unknown completion status|0
5950762|NCT01262976|20582033|P3|Up to Year 3|Subjects with unknown completion status|1
5950763|NCT01262976|20582034|P2|Up to Year 3|Subjects with unknown completion status|0
5950764|NCT01262976|20582035|P1|Up to Year 3|Subjects with unknown completion status|0
5950765|NCT01262976|20582030|P6|Up to Year 3|Lost to Follow-up|3
5950766|NCT01262976|20582031|P5|Up to Year 3|Lost to Follow-up|1
5950767|NCT01262976|20582032|P4|Up to Year 3|Lost to Follow-up|3
5950768|NCT01262976|20582033|P3|Up to Year 3|Lost to Follow-up|4
5950769|NCT01262976|20582034|P2|Up to Year 3|Lost to Follow-up|2
5950770|NCT01262976|20582035|P1|Up to Year 3|Lost to Follow-up|2
5950771|NCT01262976|20582030|P6|Up to Year 3|Migrated/moved from study area|1
5950772|NCT01262976|20582031|P5|Up to Year 3|Migrated/moved from study area|1
5950773|NCT01262976|20582032|P4|Up to Year 3|Migrated/moved from study area|2
5950774|NCT01262976|20582033|P3|Up to Year 3|Migrated/moved from study area|0
5950775|NCT01262976|20582034|P2|Up to Year 3|Migrated/moved from study area|0
5950776|NCT01262976|20582035|P1|Up to Year 3|Migrated/moved from study area|0
5950777|NCT01262976|20582030|P6|Up to Year 3|Withdrawal by Subject|0
5950778|NCT01262976|20582031|P5|Up to Year 3|Withdrawal by Subject|0
5950779|NCT01262976|20582032|P4|Up to Year 3|Withdrawal by Subject|0
5950780|NCT01262976|20582033|P3|Up to Year 3|Withdrawal by Subject|0
5950781|NCT01262976|20582034|P2|Up to Year 3|Withdrawal by Subject|0
5950782|NCT01262976|20582035|P1|Up to Year 3|Withdrawal by Subject|1
5950783|NCT01262976|20582030|P6|Up to Year 3|Serious Adverse Event|0
5950784|NCT01262976|20582031|P5|Up to Year 3|Serious Adverse Event|0
5950785|NCT01262976|20582032|P4|Up to Year 3|Serious Adverse Event|0
5950786|NCT01262976|20582033|P3|Up to Year 3|Serious Adverse Event|2
5950787|NCT01262976|20582034|P2|Up to Year 3|Serious Adverse Event|0
5950788|NCT01262976|20582035|P1|Up to Year 3|Serious Adverse Event|0
5950789|NCT01262976|20582030|P6|Up to Year 2|Other|0
5950790|NCT01262976|20582031|P5|Up to Year 2|Other|0
5950791|NCT01262976|20582032|P4|Up to Year 2|Other|0
5950792|NCT01262976|20582033|P3|Up to Year 2|Other|0
5950793|NCT01262976|20582034|P2|Up to Year 2|Other|0
5950794|NCT01262976|20582035|P1|Up to Year 2|Other|3
5950795|NCT01262976|20582030|P6|Up to Year 2|Subjects with unknown completion status|0
5950796|NCT01262976|20582031|P5|Up to Year 2|Subjects with unknown completion status|0
5950797|NCT01262976|20582032|P4|Up to Year 2|Subjects with unknown completion status|0
5950798|NCT01262976|20582033|P3|Up to Year 2|Subjects with unknown completion status|1
5950799|NCT01262976|20582034|P2|Up to Year 2|Subjects with unknown completion status|0
5950800|NCT01262976|20582035|P1|Up to Year 2|Subjects with unknown completion status|0
5950801|NCT01262976|20582030|P6|Up to Year 2|Lost to Follow-up|3
5950802|NCT01262976|20582031|P5|Up to Year 2|Lost to Follow-up|3
5950803|NCT01262976|20582032|P4|Up to Year 2|Lost to Follow-up|2
5950804|NCT01262976|20582033|P3|Up to Year 2|Lost to Follow-up|2
5950805|NCT01262976|20582034|P2|Up to Year 2|Lost to Follow-up|1
5950806|NCT01262976|20582035|P1|Up to Year 2|Lost to Follow-up|1
5950807|NCT01262976|20582030|P6|Up to Year 2|Migrated/moved from study area|2
5950808|NCT01262976|20582031|P5|Up to Year 2|Migrated/moved from study area|1
5950809|NCT01262976|20582032|P4|Up to Year 2|Migrated/moved from study area|2
5950810|NCT01262976|20582033|P3|Up to Year 2|Migrated/moved from study area|0
5950811|NCT01262976|20582034|P2|Up to Year 2|Migrated/moved from study area|0
5950812|NCT01262976|20582035|P1|Up to Year 2|Migrated/moved from study area|0
5950813|NCT01262976|20582030|P6|Up to Year 2|Withdrawal by Subject|0
5950814|NCT01262976|20582031|P5|Up to Year 2|Withdrawal by Subject|0
5950815|NCT01262976|20582032|P4|Up to Year 2|Withdrawal by Subject|0
5950816|NCT01262976|20582033|P3|Up to Year 2|Withdrawal by Subject|0
5950817|NCT01262976|20582034|P2|Up to Year 2|Withdrawal by Subject|0
5950818|NCT01262976|20582035|P1|Up to Year 2|Withdrawal by Subject|1
5950819|NCT01262976|20582030|P6|Up to Year 2|Serious Adverse Event|0
5950820|NCT01262976|20582031|P5|Up to Year 2|Serious Adverse Event|0
5950821|NCT01262976|20582032|P4|Up to Year 2|Serious Adverse Event|0
5950822|NCT01262976|20582033|P3|Up to Year 2|Serious Adverse Event|2
5950823|NCT01262976|20582034|P2|Up to Year 2|Serious Adverse Event|0
5950824|NCT01262976|20582035|P1|Up to Year 2|Serious Adverse Event|0
5950825|NCT01262976|20582030|P6|Up to Year 1|Subjects with unknown completion status|1
5950826|NCT01262976|20582031|P5|Up to Year 1|Subjects with unknown completion status|0
5950827|NCT01262976|20582032|P4|Up to Year 1|Subjects with unknown completion status|0
5950828|NCT01262976|20582033|P3|Up to Year 1|Subjects with unknown completion status|1
5950829|NCT01262976|20582034|P2|Up to Year 1|Subjects with unknown completion status|0
5950830|NCT01262976|20582035|P1|Up to Year 1|Subjects with unknown completion status|0
5950831|NCT01262976|20582030|P6|Up to Year 1|Other|1
5950832|NCT01262976|20582031|P5|Up to Year 1|Other|2
5950833|NCT01262976|20582032|P4|Up to Year 1|Other|0
5950834|NCT01262976|20582033|P3|Up to Year 1|Other|0
5950835|NCT01262976|20582034|P2|Up to Year 1|Other|1
5950836|NCT01262976|20582035|P1|Up to Year 1|Other|3
5950837|NCT01262976|20582030|P6|Up to Year 1|Lost to Follow-up|5
5950838|NCT01262976|20582031|P5|Up to Year 1|Lost to Follow-up|6
5950839|NCT01262976|20582032|P4|Up to Year 1|Lost to Follow-up|1
5950840|NCT01262976|20582033|P3|Up to Year 1|Lost to Follow-up|0
5950841|NCT01262976|20582034|P2|Up to Year 1|Lost to Follow-up|0
5950842|NCT01262976|20582035|P1|Up to Year 1|Lost to Follow-up|4
5950843|NCT01262976|20582030|P6|Up to Year 1|Migrated/moved from study area|2
5950844|NCT01262976|20582031|P5|Up to Year 1|Migrated/moved from study area|3
5950845|NCT01262976|20582032|P4|Up to Year 1|Migrated/moved from study area|3
5950846|NCT01262976|20582033|P3|Up to Year 1|Migrated/moved from study area|0
5950847|NCT01262976|20582034|P2|Up to Year 1|Migrated/moved from study area|0
5950848|NCT01262976|20582035|P1|Up to Year 1|Migrated/moved from study area|1
5950849|NCT01262976|20582030|P6|Up to Year 1|Withdrawal by Subject|0
5950850|NCT01262976|20582031|P5|Up to Year 1|Withdrawal by Subject|0
5950851|NCT01262976|20582032|P4|Up to Year 1|Withdrawal by Subject|0
5950852|NCT01262976|20582033|P3|Up to Year 1|Withdrawal by Subject|0
5950853|NCT01262976|20582034|P2|Up to Year 1|Withdrawal by Subject|0
5950854|NCT01262976|20582035|P1|Up to Year 1|Withdrawal by Subject|1
5950855|NCT01262976|20582030|P6|Up to Year 1|Serious Adverse Event|0
5950856|NCT01262976|20582031|P5|Up to Year 1|Serious Adverse Event|0
5950857|NCT01262976|20582032|P4|Up to Year 1|Serious Adverse Event|0
5950858|NCT01262976|20582033|P3|Up to Year 1|Serious Adverse Event|2
5950859|NCT01262976|20582034|P2|Up to Year 1|Serious Adverse Event|0
5950860|NCT01262976|20582035|P1|Up to Year 1|Serious Adverse Event|0
5950861|NCT01262976|20582030|P6|Up to Month 7|Other|0
5950862|NCT01262976|20582031|P5|Up to Month 7|Other|0
5950863|NCT01262976|20582032|P4|Up to Month 7|Other|0
5950864|NCT01262976|20582033|P3|Up to Month 7|Other|2
5950865|NCT01262976|20582034|P2|Up to Month 7|Other|0
5950866|NCT01262976|20582035|P1|Up to Month 7|Other|3
5950867|NCT01262976|20582030|P6|Up to Month 7|Lost to Follow-up|3
5950868|NCT01262976|20582031|P5|Up to Month 7|Lost to Follow-up|1
5950869|NCT01262976|20582032|P4|Up to Month 7|Lost to Follow-up|3
5950870|NCT01262976|20582033|P3|Up to Month 7|Lost to Follow-up|1
5950871|NCT01262976|20582034|P2|Up to Month 7|Lost to Follow-up|0
5950872|NCT01262976|20582035|P1|Up to Month 7|Lost to Follow-up|1
5950873|NCT01262976|20582030|P6|Up to Month 7|Migrated/moved from study area|1
5950874|NCT01262976|20582031|P5|Up to Month 7|Migrated/moved from study area|1
5950875|NCT01262976|20582032|P4|Up to Month 7|Migrated/moved from study area|3
5950876|NCT01262976|20582033|P3|Up to Month 7|Migrated/moved from study area|1
5950877|NCT01262976|20582034|P2|Up to Month 7|Migrated/moved from study area|0
5950878|NCT01262976|20582035|P1|Up to Month 7|Migrated/moved from study area|0
5950879|NCT01262976|20582030|P6|Up to Month 7|Withdrawal by Subject|0
5950880|NCT01262976|20582031|P5|Up to Month 7|Withdrawal by Subject|0
5950881|NCT01262976|20582032|P4|Up to Month 7|Withdrawal by Subject|0
5950882|NCT01262976|20582033|P3|Up to Month 7|Withdrawal by Subject|0
5950883|NCT01262976|20582034|P2|Up to Month 7|Withdrawal by Subject|0
5950884|NCT01262976|20582035|P1|Up to Month 7|Withdrawal by Subject|1
5950885|NCT01262976|20582030|P6|Up to Month 7|Serious Adverse Event|0
5950886|NCT01262976|20582031|P5|Up to Month 7|Serious Adverse Event|0
5950887|NCT01262976|20582032|P4|Up to Month 7|Serious Adverse Event|0
5950888|NCT01262976|20582033|P3|Up to Month 7|Serious Adverse Event|2
5950889|NCT01262976|20582034|P2|Up to Month 7|Serious Adverse Event|0
5950890|NCT01262976|20582035|P1|Up to Month 7|Serious Adverse Event|0
5950891|NCT01262976|20582030|P6|Up to Month 2|Other|2
5950892|NCT01262976|20582031|P5|Up to Month 2|Other|0
5950893|NCT01262976|20582032|P4|Up to Month 2|Other|1
5950894|NCT01262976|20582033|P3|Up to Month 2|Other|0
5950895|NCT01262976|20582034|P2|Up to Month 2|Other|0
5950896|NCT01262976|20582035|P1|Up to Month 2|Other|1
5950897|NCT01262976|20582030|P6|Up to Month 2|Lost to Follow-up|1
5950898|NCT01262976|20582031|P5|Up to Month 2|Lost to Follow-up|1
5950899|NCT01262976|20582032|P4|Up to Month 2|Lost to Follow-up|1
5950900|NCT01262976|20582033|P3|Up to Month 2|Lost to Follow-up|0
5950901|NCT01262976|20582034|P2|Up to Month 2|Lost to Follow-up|0
5950902|NCT01262976|20582035|P1|Up to Month 2|Lost to Follow-up|1
5950903|NCT01262976|20582030|P6|Up to Month 2|Migrated/moved from study area|1
5950904|NCT01262976|20582031|P5|Up to Month 2|Migrated/moved from study area|1
5950905|NCT01262976|20582032|P4|Up to Month 2|Migrated/moved from study area|0
5950906|NCT01262976|20582033|P3|Up to Month 2|Migrated/moved from study area|0
5950907|NCT01262976|20582034|P2|Up to Month 2|Migrated/moved from study area|1
5950908|NCT01262976|20582035|P1|Up to Month 2|Migrated/moved from study area|0
5950909|NCT01262976|20582030|P6|Up to Month 2|Withdrawal by Subject|0
5950910|NCT01262976|20582031|P5|Up to Month 2|Withdrawal by Subject|0
5950911|NCT01262976|20582032|P4|Up to Month 2|Withdrawal by Subject|0
5950912|NCT01262976|20582033|P3|Up to Month 2|Withdrawal by Subject|0
5950913|NCT01262976|20582034|P2|Up to Month 2|Withdrawal by Subject|0
5950914|NCT01262976|20582035|P1|Up to Month 2|Withdrawal by Subject|1
5950915|NCT01262976|20582030|P6|Up to Month 2|Serious Adverse Event|0
5950916|NCT01262976|20582031|P5|Up to Month 2|Serious Adverse Event|0
5950917|NCT01262976|20582032|P4|Up to Month 2|Serious Adverse Event|0
5950918|NCT01262976|20582033|P3|Up to Month 2|Serious Adverse Event|1
5950919|NCT01262976|20582034|P2|Up to Month 2|Serious Adverse Event|0
5950920|NCT01262976|20582035|P1|Up to Month 2|Serious Adverse Event|0
5950921|NCT01262898|20582191|P4|Overall Study|Withdrawal by Subject|0
5950922|NCT01262898|20582192|P3|Overall Study|Withdrawal by Subject|0
5950923|NCT01262898|20582193|P2|Overall Study|Withdrawal by Subject|1
5950924|NCT01262898|20582194|P1|Overall Study|Withdrawal by Subject|1
5950925|NCT01262898|20582191|P4|Overall Study|Lost to Follow-up|0
5950926|NCT01262898|20582192|P3|Overall Study|Lost to Follow-up|0
5950927|NCT01262898|20582193|P2|Overall Study|Lost to Follow-up|0
5950928|NCT01262898|20582194|P1|Overall Study|Lost to Follow-up|1
5950929|NCT01262898|20582191|P4|Overall Study|Protocol Violation|0
5950930|NCT01262898|20582192|P3|Overall Study|Protocol Violation|0
5950931|NCT01262898|20582193|P2|Overall Study|Protocol Violation|1
5950932|NCT01262898|20582194|P1|Overall Study|Protocol Violation|1
5950933|NCT01262872|20582322|P8|Step 2|Migrated/moved from study area|3
5950934|NCT01262872|20582323|P7|Step 2|Migrated/moved from study area|2
5950935|NCT01262872|20582324|P6|Step 2|Migrated/moved from study area|6
5950936|NCT01262872|20582325|P5|Step 2|Migrated/moved from study area|2
5950937|NCT01262872|20582326|P4|Step 2|Migrated/moved from study area|3
5950938|NCT01262872|20582327|P3|Step 2|Migrated/moved from study area|4
5950939|NCT01262872|20582328|P2|Step 2|Migrated/moved from study area|0
5950940|NCT01262872|20582329|P1|Step 2|Migrated/moved from study area|0
5950941|NCT01262872|20582322|P8|Step 2|Withdrawal by Subject|1
5950942|NCT01262872|20582323|P7|Step 2|Withdrawal by Subject|2
5950943|NCT01262872|20582324|P6|Step 2|Withdrawal by Subject|1
5950944|NCT01262872|20582325|P5|Step 2|Withdrawal by Subject|3
5950945|NCT01262872|20582326|P4|Step 2|Withdrawal by Subject|6
5950946|NCT01262872|20582327|P3|Step 2|Withdrawal by Subject|4
5950947|NCT01262872|20582328|P2|Step 2|Withdrawal by Subject|0
5950948|NCT01262872|20582329|P1|Step 2|Withdrawal by Subject|0
5950949|NCT01262872|20582322|P8|Step 2|Protocol Violation|1
5950950|NCT01262872|20582323|P7|Step 2|Protocol Violation|3
5950951|NCT01262872|20582324|P6|Step 2|Protocol Violation|0
5950952|NCT01262872|20582325|P5|Step 2|Protocol Violation|0
5950953|NCT01262872|20582326|P4|Step 2|Protocol Violation|0
5950954|NCT01262872|20582327|P3|Step 2|Protocol Violation|1
5950955|NCT01262872|20582328|P2|Step 2|Protocol Violation|0
5950956|NCT01262872|20582329|P1|Step 2|Protocol Violation|0
5950957|NCT01262872|20582322|P8|Step 2|Death|1
5950958|NCT01262872|20582323|P7|Step 2|Death|2
5950959|NCT01262872|20582324|P6|Step 2|Death|2
5950960|NCT01262872|20582325|P5|Step 2|Death|0
5950961|NCT01262872|20582326|P4|Step 2|Death|1
5950962|NCT01262872|20582327|P3|Step 2|Death|0
5950963|NCT01262872|20582328|P2|Step 2|Death|0
5950964|NCT01262872|20582329|P1|Step 2|Death|0
5950965|NCT01262820|20582603|P1|Overall Study|Drug held for 21+ days|1
5950966|NCT01262820|20582603|P1|Overall Study|Lack of Efficacy|9
5950967|NCT01262820|20582603|P1|Overall Study|Adverse Event|5
5950968|NCT01262677|20582617|P3|Overall Study|Adverse Event (AE) related to study drug|3
5950969|NCT01262677|20582618|P2|Overall Study|Adverse Event (AE) related to study drug|8
5950970|NCT01262677|20582619|P1|Overall Study|Adverse Event (AE) related to study drug|3
5950971|NCT01262677|20582617|P3|Overall Study|Protocol Violation|1
5950972|NCT01262677|20582618|P2|Overall Study|Protocol Violation|1
5950973|NCT01262677|20582619|P1|Overall Study|Protocol Violation|0
5950974|NCT01262677|20582617|P3|Overall Study|Reason not provided|3
5950975|NCT01262677|20582618|P2|Overall Study|Reason not provided|1
5950976|NCT01262677|20582619|P1|Overall Study|Reason not provided|2
5950977|NCT01262677|20582617|P3|Overall Study|No longer willing to participate|2
5950978|NCT01262677|20582618|P2|Overall Study|No longer willing to participate|3
5950979|NCT01262677|20582619|P1|Overall Study|No longer willing to participate|3
5950980|NCT01262677|20582617|P3|Overall Study|Lost to Follow-up|2
5950981|NCT01262677|20582618|P2|Overall Study|Lost to Follow-up|0
5950982|NCT01262677|20582619|P1|Overall Study|Lost to Follow-up|1
5950983|NCT01262677|20582617|P3|Overall Study|Insufficient clinical response|1
5950984|NCT01262677|20582618|P2|Overall Study|Insufficient clinical response|0
5950985|NCT01262677|20582619|P1|Overall Study|Insufficient clinical response|0
5950986|NCT01262677|20582617|P3|Overall Study|Does not meet entrance criteria|0
5950987|NCT01262677|20582618|P2|Overall Study|Does not meet entrance criteria|2
5950988|NCT01262677|20582619|P1|Overall Study|Does not meet entrance criteria|0
5950989|NCT01262651|20582710|P2|Overall Study|Met Withdrawal Criteria|0
5950990|NCT01262651|20582711|P1|Overall Study|Met Withdrawal Criteria|1
5950991|NCT01262651|20582710|P2|Overall Study|Withdrawal by Investigator|2
5950992|NCT01262651|20582711|P1|Overall Study|Withdrawal by Investigator|2
5950993|NCT01262651|20582710|P2|Overall Study|Withdrawal by Subject|11
5950994|NCT01262651|20582711|P1|Overall Study|Withdrawal by Subject|15
5950995|NCT01262651|20582710|P2|Overall Study|Adverse Event|35
5950996|NCT01262651|20582711|P1|Overall Study|Adverse Event|40
5950997|NCT01262573|20582752|P2|Overall Study|Withdrawal by Subject|1
5950998|NCT01262573|20582753|P1|Overall Study|Withdrawal by Subject|0
5950999|NCT01262560|20582764|P3|Overall Study|Protocol Violation|2
5951000|NCT01262560|20582765|P2|Overall Study|Protocol Violation|1
5951001|NCT01262560|20582766|P1|Overall Study|Protocol Violation|0
5951002|NCT01262456|20582815|P3|1-Month Open-Label Extension Period|Other Reason|0
5951003|NCT01262456|20582816|P2|1-Month Open-Label Extension Period|Other Reason|1
5951004|NCT01262456|20582817|P1|1-Month Open-Label Extension Period|Other Reason|0
5951005|NCT01262456|20582815|P3|1-Month Open-Label Extension Period|Protocol Violation|2
5951006|NCT01262456|20582816|P2|1-Month Open-Label Extension Period|Protocol Violation|0
5951007|NCT01262456|20582817|P1|1-Month Open-Label Extension Period|Protocol Violation|1
5951008|NCT01262456|20582815|P3|1-Month Open-Label Extension Period|Adverse Event|2
5951009|NCT01262456|20582816|P2|1-Month Open-Label Extension Period|Adverse Event|0
5951010|NCT01262456|20582817|P1|1-Month Open-Label Extension Period|Adverse Event|2
5951011|NCT01262456|20582815|P3|1-Month Open-Label Extension Period|Lost to Follow-up|0
5951012|NCT01262456|20582816|P2|1-Month Open-Label Extension Period|Lost to Follow-up|1
5951013|NCT01262456|20582817|P1|1-Month Open-Label Extension Period|Lost to Follow-up|0
5951014|NCT01262456|20582815|P3|1-Month Open-Label Extension Period|Withdrawal by Subject|1
5951015|NCT01262456|20582816|P2|1-Month Open-Label Extension Period|Withdrawal by Subject|1
5951016|NCT01262456|20582817|P1|1-Month Open-Label Extension Period|Withdrawal by Subject|1
5951017|NCT01262456|20582815|P3|3-Month Double-Blind Period|Protocol Violation|6
5951018|NCT01262456|20582816|P2|3-Month Double-Blind Period|Protocol Violation|6
5951019|NCT01262456|20582817|P1|3-Month Double-Blind Period|Protocol Violation|3
5951020|NCT01262456|20582815|P3|3-Month Double-Blind Period|Adverse Event|8
5951021|NCT01262456|20582816|P2|3-Month Double-Blind Period|Adverse Event|4
5951022|NCT01262456|20582817|P1|3-Month Double-Blind Period|Adverse Event|6
5951023|NCT01262456|20582815|P3|3-Month Double-Blind Period|Lost to Follow-up|3
5951024|NCT01262456|20582816|P2|3-Month Double-Blind Period|Lost to Follow-up|5
5951025|NCT01262456|20582817|P1|3-Month Double-Blind Period|Lost to Follow-up|4
5951026|NCT01262456|20582815|P3|3-Month Double-Blind Period|Withdrawal by Subject|9
5951027|NCT01262456|20582816|P2|3-Month Double-Blind Period|Withdrawal by Subject|8
5951028|NCT01262456|20582817|P1|3-Month Double-Blind Period|Withdrawal by Subject|6
5951029|NCT01262365|20582861|P3|Overall Study|Patient unavailable|1
5951030|NCT01262365|20582862|P2|Overall Study|Patient unavailable|0
5951031|NCT01262365|20582863|P1|Overall Study|Patient unavailable|0
5951032|NCT01262365|20582861|P3|Overall Study|Cannot tolerate the protocol|0
5951033|NCT01262365|20582862|P2|Overall Study|Cannot tolerate the protocol|1
5951034|NCT01262365|20582863|P1|Overall Study|Cannot tolerate the protocol|0
5951035|NCT01262365|20582861|P3|Overall Study|Toxicity related to study drug|0
5951036|NCT01262365|20582862|P2|Overall Study|Toxicity related to study drug|1
5951037|NCT01262365|20582863|P1|Overall Study|Toxicity related to study drug|0
5951038|NCT01262365|20582861|P3|Overall Study|Patient pregnant|1
5951039|NCT01262365|20582862|P2|Overall Study|Patient pregnant|0
5951040|NCT01262365|20582863|P1|Overall Study|Patient pregnant|1
5951041|NCT01262365|20582861|P3|Overall Study|Suspected pregnancy|0
5951042|NCT01262365|20582862|P2|Overall Study|Suspected pregnancy|0
5951043|NCT01262365|20582863|P1|Overall Study|Suspected pregnancy|1
5951044|NCT01262365|20582861|P3|Overall Study|Non-compliance|2
5951045|NCT01262365|20582862|P2|Overall Study|Non-compliance|0
5951046|NCT01262365|20582863|P1|Overall Study|Non-compliance|1
5951047|NCT01262365|20582861|P3|Overall Study|Randomization error|2
5951048|NCT01262365|20582862|P2|Overall Study|Randomization error|0
5951049|NCT01262365|20582863|P1|Overall Study|Randomization error|1
5951050|NCT01262365|20582861|P3|Overall Study|sponsor decision|0
5951051|NCT01262365|20582862|P2|Overall Study|sponsor decision|1
5951052|NCT01262365|20582863|P1|Overall Study|sponsor decision|1
5951053|NCT01262365|20582861|P3|Overall Study|Adverse Event|11
5951054|NCT01262365|20582862|P2|Overall Study|Adverse Event|16
5951055|NCT01262365|20582863|P1|Overall Study|Adverse Event|26
5951056|NCT01262365|20582861|P3|Overall Study|Death|1
5951057|NCT01262365|20582862|P2|Overall Study|Death|2
5951058|NCT01262365|20582863|P1|Overall Study|Death|1
5951059|NCT01262365|20582861|P3|Overall Study|Withdrawal by Subject|22
5951060|NCT01262365|20582862|P2|Overall Study|Withdrawal by Subject|22
5951061|NCT01262365|20582863|P1|Overall Study|Withdrawal by Subject|17
5951062|NCT01262365|20582861|P3|Overall Study|Lost to Follow-up|6
5951063|NCT01262365|20582862|P2|Overall Study|Lost to Follow-up|7
5951064|NCT01262365|20582863|P1|Overall Study|Lost to Follow-up|3
5951065|NCT01262365|20582861|P3|Overall Study|Protocol Violation|1
5951066|NCT01262365|20582862|P2|Overall Study|Protocol Violation|1
5951067|NCT01262365|20582863|P1|Overall Study|Protocol Violation|3
5951068|NCT01262365|20582861|P3|Overall Study|Lack of Efficacy|47
5951069|NCT01262365|20582862|P2|Overall Study|Lack of Efficacy|30
5951070|NCT01262365|20582863|P1|Overall Study|Lack of Efficacy|35
5951071|NCT01262352|20582888|P2|Washout|Extended Washout|1
5951072|NCT01262352|20582889|P1|Washout|Extended Washout|0
5951073|NCT01262352|20582888|P2|Washout|Adverse Event|1
5951074|NCT01262352|20582889|P1|Washout|Adverse Event|1
5951075|NCT01262352|20582888|P2|Period 1|Illness after randomization|0
5951076|NCT01262352|20582889|P1|Period 1|Illness after randomization|1
5951077|NCT01262287|20582907|P2|Overall Study|Lost to Follow-up|1
5951078|NCT01262287|20582908|P1|Overall Study|Lost to Follow-up|2
5951079|NCT01262092|20582969|P2|Gabapentin Taper|noncompliance - missed medications|0
5951080|NCT01262092|20582970|P1|Gabapentin Taper|noncompliance - missed medications|1
5951081|NCT01262092|20582969|P2|Buprenorphine Taper|noncompliance - missed medication|1
5951082|NCT01262092|20582970|P1|Buprenorphine Taper|noncompliance - missed medication|1
5951083|NCT01262092|20582969|P2|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|0
5951084|NCT01262092|20582970|P1|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|1
5951085|NCT01262092|20582969|P2|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|1
5951086|NCT01262092|20582970|P1|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|2
5951087|NCT01262027|20582976|P1|Overall Study|Protocol Violation|1
5951088|NCT01262027|20582976|P1|Overall Study|Withdrawal by Subject|3
5951089|NCT01262027|20582976|P1|Overall Study|Adverse Event|1
5951090|NCT01261975|20582981|P1|Overall Study|Surgical complication|1
5951091|NCT01261793|20583012|P3|Overall Study|Patient unable to start IV line|1
5951092|NCT01261793|20583013|P2|Overall Study|Patient unable to start IV line|0
5951093|NCT01261793|20583014|P1|Overall Study|Patient unable to start IV line|0
5951094|NCT01261793|20583012|P3|Overall Study|Randomization error|0
5951095|NCT01261793|20583013|P2|Overall Study|Randomization error|1
5951096|NCT01261793|20583014|P1|Overall Study|Randomization error|0
5951097|NCT01261793|20583012|P3|Overall Study|Patient withdrew after cardiology visit|0
5951098|NCT01261793|20583013|P2|Overall Study|Patient withdrew after cardiology visit|1
5951099|NCT01261793|20583014|P1|Overall Study|Patient withdrew after cardiology visit|0
5951100|NCT01261793|20583012|P3|Overall Study|Lack of efficacy & patient not available|0
5951101|NCT01261793|20583013|P2|Overall Study|Lack of efficacy & patient not available|1
5951102|NCT01261793|20583014|P1|Overall Study|Lack of efficacy & patient not available|0
5951103|NCT01261793|20583012|P3|Overall Study|Outside the study area|1
5951104|NCT01261793|20583013|P2|Overall Study|Outside the study area|2
5951105|NCT01261793|20583014|P1|Overall Study|Outside the study area|0
5951106|NCT01261793|20583012|P3|Overall Study|Patient pregnant|0
5951107|NCT01261793|20583013|P2|Overall Study|Patient pregnant|0
5951108|NCT01261793|20583014|P1|Overall Study|Patient pregnant|1
5951109|NCT01261793|20583012|P3|Overall Study|Patient non-compliance|1
5951110|NCT01261793|20583013|P2|Overall Study|Patient non-compliance|0
5951111|NCT01261793|20583014|P1|Overall Study|Patient non-compliance|1
5951112|NCT01261793|20583012|P3|Overall Study|Suspected pregnancy|0
5951113|NCT01261793|20583013|P2|Overall Study|Suspected pregnancy|1
5951114|NCT01261793|20583014|P1|Overall Study|Suspected pregnancy|1
5951115|NCT01261793|20583012|P3|Overall Study|Patient non-availability|1
5951116|NCT01261793|20583013|P2|Overall Study|Patient non-availability|1
5951117|NCT01261793|20583014|P1|Overall Study|Patient non-availability|1
5951118|NCT01261793|20583012|P3|Overall Study|Adverse Event|19
5951119|NCT01261793|20583013|P2|Overall Study|Adverse Event|24
5951120|NCT01261793|20583014|P1|Overall Study|Adverse Event|9
5951121|NCT01261793|20583012|P3|Overall Study|Death|0
5951122|NCT01261793|20583013|P2|Overall Study|Death|1
5951123|NCT01261793|20583014|P1|Overall Study|Death|3
5951124|NCT01261793|20583012|P3|Overall Study|Withdrawal by Subject|14
5951125|NCT01261793|20583013|P2|Overall Study|Withdrawal by Subject|14
5951126|NCT01261793|20583014|P1|Overall Study|Withdrawal by Subject|12
5951127|NCT01261793|20583012|P3|Overall Study|Lost to Follow-up|7
5951128|NCT01261793|20583013|P2|Overall Study|Lost to Follow-up|3
5951129|NCT01261793|20583014|P1|Overall Study|Lost to Follow-up|10
5951130|NCT01261793|20583012|P3|Overall Study|Protocol Violation|6
5951131|NCT01261793|20583013|P2|Overall Study|Protocol Violation|5
5951132|NCT01261793|20583014|P1|Overall Study|Protocol Violation|3
5951133|NCT01261793|20583012|P3|Overall Study|Lack of Efficacy|32
5951134|NCT01261793|20583013|P2|Overall Study|Lack of Efficacy|37
5951135|NCT01261793|20583014|P1|Overall Study|Lack of Efficacy|44
5951136|NCT01261780|20583039|P2|Overall Study|Event not related to subject|2
5951137|NCT01261780|20583040|P1|Overall Study|Event not related to subject|1
5951138|NCT01261780|20583039|P2|Overall Study|Withdrawal by Subject|0
5951139|NCT01261780|20583040|P1|Overall Study|Withdrawal by Subject|1
5951140|NCT01261624|20583050|P2|Week 13 to Week 24|Insufficient Response|1
5951141|NCT01261624|20583051|P1|Week 13 to Week 24|Insufficient Response|0
5951142|NCT01261624|20583050|P2|Week 0 to Week 12|Insufficient Response|2
5951143|NCT01261624|20583051|P1|Week 0 to Week 12|Insufficient Response|0
5951144|NCT01261624|20583050|P2|Week 0 to Week 12|Disease Progression|1
5951145|NCT01261624|20583051|P1|Week 0 to Week 12|Disease Progression|1
5951146|NCT01261611|20583071|P3|Treatment Cycle 5|Lost to Follow-up|0
5951147|NCT01261611|20583072|P2|Treatment Cycle 5|Lost to Follow-up|0
5951148|NCT01261611|20583073|P1|Treatment Cycle 5|Lost to Follow-up|1
5951149|NCT01261611|20583071|P3|Treatment Cycle 5|Adverse Event|0
5951150|NCT01261611|20583072|P2|Treatment Cycle 5|Adverse Event|0
5951151|NCT01261611|20583073|P1|Treatment Cycle 5|Adverse Event|1
5951152|NCT01261611|20583071|P3|Treatment Cycle 5|Withdrawal by Subject|0
5951153|NCT01261611|20583072|P2|Treatment Cycle 5|Withdrawal by Subject|0
5951154|NCT01261611|20583073|P1|Treatment Cycle 5|Withdrawal by Subject|1
5951155|NCT01261611|20583071|P3|Treatment Cycle 4|Not otherwise specified|0
5951156|NCT01261611|20583072|P2|Treatment Cycle 4|Not otherwise specified|0
5951157|NCT01261611|20583073|P1|Treatment Cycle 4|Not otherwise specified|3
5951158|NCT01261611|20583071|P3|Treatment Cycle 4|Lost to Follow-up|0
5951159|NCT01261611|20583072|P2|Treatment Cycle 4|Lost to Follow-up|0
5951160|NCT01261611|20583073|P1|Treatment Cycle 4|Lost to Follow-up|2
5951161|NCT01261611|20583071|P3|Treatment Cycle 4|Adverse Event|0
5951162|NCT01261611|20583072|P2|Treatment Cycle 4|Adverse Event|0
5951163|NCT01261611|20583073|P1|Treatment Cycle 4|Adverse Event|1
5951164|NCT01261611|20583071|P3|Treatment Cycle 4|Withdrawal by Subject|0
5951165|NCT01261611|20583072|P2|Treatment Cycle 4|Withdrawal by Subject|0
5951166|NCT01261611|20583073|P1|Treatment Cycle 4|Withdrawal by Subject|3
5951167|NCT01261611|20583071|P3|Treatment Cycle 4|Completed study|0
5951168|NCT01261611|20583072|P2|Treatment Cycle 4|Completed study|0
5951169|NCT01261611|20583073|P1|Treatment Cycle 4|Completed study|87
5951170|NCT01261611|20583071|P3|Treatment Cycle 3|Lost to Follow-up|0
5951171|NCT01261611|20583072|P2|Treatment Cycle 3|Lost to Follow-up|0
5951172|NCT01261611|20583073|P1|Treatment Cycle 3|Lost to Follow-up|1
5951173|NCT01261611|20583071|P3|Treatment Cycle 3|Adverse Event|0
5951174|NCT01261611|20583072|P2|Treatment Cycle 3|Adverse Event|0
5951175|NCT01261611|20583073|P1|Treatment Cycle 3|Adverse Event|1
5951176|NCT01261611|20583071|P3|Treatment Cycle 3|Withdrawal by Subject|0
5951177|NCT01261611|20583072|P2|Treatment Cycle 3|Withdrawal by Subject|0
5951178|NCT01261611|20583073|P1|Treatment Cycle 3|Withdrawal by Subject|4
5951179|NCT01261611|20583071|P3|Treatment Cycle 3|Completed study|0
5951180|NCT01261611|20583072|P2|Treatment Cycle 3|Completed study|0
5951181|NCT01261611|20583073|P1|Treatment Cycle 3|Completed study|24
5951182|NCT01261611|20583071|P3|Treatment Cycle 2|Not otherwise specified|0
5951183|NCT01261611|20583072|P2|Treatment Cycle 2|Not otherwise specified|0
5951184|NCT01261611|20583073|P1|Treatment Cycle 2|Not otherwise specified|2
5951185|NCT01261611|20583071|P3|Treatment Cycle 2|Protocol Violation|0
5951186|NCT01261611|20583072|P2|Treatment Cycle 2|Protocol Violation|0
5951187|NCT01261611|20583073|P1|Treatment Cycle 2|Protocol Violation|2
5951188|NCT01261611|20583071|P3|Treatment Cycle 2|Adverse Event|0
5951189|NCT01261611|20583072|P2|Treatment Cycle 2|Adverse Event|0
5951190|NCT01261611|20583073|P1|Treatment Cycle 2|Adverse Event|1
5951191|NCT01261611|20583071|P3|Treatment Cycle 2|Withdrawal by Subject|0
5951192|NCT01261611|20583072|P2|Treatment Cycle 2|Withdrawal by Subject|0
5951193|NCT01261611|20583073|P1|Treatment Cycle 2|Withdrawal by Subject|4
5951194|NCT01261611|20583071|P3|Treatment Cycle 2|Completed study|0
5951195|NCT01261611|20583072|P2|Treatment Cycle 2|Completed study|0
5951196|NCT01261611|20583073|P1|Treatment Cycle 2|Completed study|4
5951197|NCT01261611|20583071|P3|Treatment Cycle 1|Protocol Violation|2
5951198|NCT01261611|20583072|P2|Treatment Cycle 1|Protocol Violation|0
5951199|NCT01261611|20583073|P1|Treatment Cycle 1|Protocol Violation|0
5951200|NCT01261611|20583071|P3|Treatment Cycle 1|Adverse Event|0
5951201|NCT01261611|20583072|P2|Treatment Cycle 1|Adverse Event|1
5951202|NCT01261611|20583073|P1|Treatment Cycle 1|Adverse Event|0
5951203|NCT01261611|20583071|P3|Treatment Cycle 1|Lost to Follow-up|0
5951204|NCT01261611|20583072|P2|Treatment Cycle 1|Lost to Follow-up|0
5951205|NCT01261611|20583073|P1|Treatment Cycle 1|Lost to Follow-up|1
5951206|NCT01261611|20583071|P3|Treatment Cycle 1|Withdrawal by Subject|0
5951207|NCT01261611|20583072|P2|Treatment Cycle 1|Withdrawal by Subject|2
5951208|NCT01261611|20583073|P1|Treatment Cycle 1|Withdrawal by Subject|3
5951209|NCT01261390|20583137|P4|Overall Study|Lost to Follow-up|6
5951210|NCT01261390|20583138|P3|Overall Study|Lost to Follow-up|5
5951211|NCT01261390|20583139|P2|Overall Study|Lost to Follow-up|6
5951212|NCT01261390|20583140|P1|Overall Study|Lost to Follow-up|1
5951213|NCT01261390|20583137|P4|Overall Study|Loss of Interest in the Study|0
5951214|NCT01261390|20583138|P3|Overall Study|Loss of Interest in the Study|0
5951215|NCT01261390|20583139|P2|Overall Study|Loss of Interest in the Study|1
5951216|NCT01261390|20583140|P1|Overall Study|Loss of Interest in the Study|3
5951217|NCT01261390|20583137|P4|Overall Study|Relocation|0
5951218|NCT01261390|20583138|P3|Overall Study|Relocation|0
5951219|NCT01261390|20583139|P2|Overall Study|Relocation|1
5951220|NCT01261390|20583140|P1|Overall Study|Relocation|0
5951221|NCT01261390|20583137|P4|Overall Study|Dissatisfaction with Treatment|2
5951222|NCT01261390|20583138|P3|Overall Study|Dissatisfaction with Treatment|1
5951223|NCT01261390|20583139|P2|Overall Study|Dissatisfaction with Treatment|1
5951224|NCT01261390|20583140|P1|Overall Study|Dissatisfaction with Treatment|2
5951225|NCT01261390|20583137|P4|Overall Study|Significant Concurrent Illness|0
5951226|NCT01261390|20583138|P3|Overall Study|Significant Concurrent Illness|1
5951227|NCT01261390|20583139|P2|Overall Study|Significant Concurrent Illness|0
5951228|NCT01261390|20583140|P1|Overall Study|Significant Concurrent Illness|1
5951229|NCT01261338|20583304|P2|Overall Study|Withdrawal by Subject|2
5951230|NCT01261338|20583305|P1|Overall Study|Withdrawal by Subject|3
5951231|NCT01261325|20583316|P3|Overall Study|AE, serious fatal|2
5951232|NCT01261325|20583317|P2|Overall Study|AE, serious fatal|0
5951233|NCT01261325|20583318|P1|Overall Study|AE, serious fatal|0
5951234|NCT01261325|20583316|P3|Overall Study|Lost to Follow-up|3
5951235|NCT01261325|20583317|P2|Overall Study|Lost to Follow-up|1
5951236|NCT01261325|20583318|P1|Overall Study|Lost to Follow-up|0
5951237|NCT01261325|20583316|P3|Overall Study|Protocol Violation|1
5951238|NCT01261325|20583317|P2|Overall Study|Protocol Violation|3
5951239|NCT01261325|20583318|P1|Overall Study|Protocol Violation|0
5951240|NCT01261325|20583316|P3|Overall Study|Randomized in Error|1
5951241|NCT01261325|20583317|P2|Overall Study|Randomized in Error|0
5951242|NCT01261325|20583318|P1|Overall Study|Randomized in Error|0
5951243|NCT01261325|20583316|P3|Overall Study|Screen Failure|0
5951244|NCT01261325|20583317|P2|Overall Study|Screen Failure|0
5951245|NCT01261325|20583318|P1|Overall Study|Screen Failure|1
5951246|NCT01261325|20583316|P3|Overall Study|Erroneously Randomized|0
5951247|NCT01261325|20583317|P2|Overall Study|Erroneously Randomized|0
5951248|NCT01261325|20583318|P1|Overall Study|Erroneously Randomized|1
5951249|NCT01261325|20583316|P3|Overall Study|Patient Randomized by Mistake|0
5951250|NCT01261325|20583317|P2|Overall Study|Patient Randomized by Mistake|1
5951251|NCT01261325|20583318|P1|Overall Study|Patient Randomized by Mistake|0
5951252|NCT01261325|20583316|P3|Overall Study|Non Compliance|0
5951253|NCT01261325|20583317|P2|Overall Study|Non Compliance|0
5951254|NCT01261325|20583318|P1|Overall Study|Non Compliance|2
5951255|NCT01261325|20583316|P3|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
5951256|NCT01261325|20583317|P2|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
5951257|NCT01261325|20583318|P1|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0
5951258|NCT01261325|20583316|P3|Overall Study|AE, non-serious non-fatal|13
5951259|NCT01261325|20583317|P2|Overall Study|AE, non-serious non-fatal|15
5951260|NCT01261325|20583318|P1|Overall Study|AE, non-serious non-fatal|9
5951261|NCT01261325|20583316|P3|Overall Study|SAE, non-fatal|1
5951262|NCT01261325|20583317|P2|Overall Study|SAE, non-fatal|5
5951263|NCT01261325|20583318|P1|Overall Study|SAE, non-fatal|1
5951264|NCT01261325|20583316|P3|Overall Study|Withdrawal by Subject|4
5951265|NCT01261325|20583317|P2|Overall Study|Withdrawal by Subject|2
5951266|NCT01261325|20583318|P1|Overall Study|Withdrawal by Subject|2
5951267|NCT01261325|20583316|P3|Overall Study|Lack of Efficacy|0
5951268|NCT01261325|20583317|P2|Overall Study|Lack of Efficacy|1
5951269|NCT01261325|20583318|P1|Overall Study|Lack of Efficacy|1
5951270|NCT01261247|20583350|P1|Overall Study|Ineligible|2
5951271|NCT01261000|20583363|P1|Overall Study|Screen failure|1
5951272|NCT01260948|20583369|P2|Second Intervention|Emesis|1
5951273|NCT01260948|20583370|P1|Second Intervention|Emesis|0
5951274|NCT01260948|20583369|P2|Washout of 28 Days|Withdrawal by Subject|3
5951275|NCT01260948|20583370|P1|Washout of 28 Days|Withdrawal by Subject|1
5951276|NCT01260922|20583380|P2|Second Intervention|Emesis|2
5951277|NCT01260922|20583381|P1|Second Intervention|Emesis|0
5951278|NCT01260922|20583380|P2|Washout of 28 Days|Withdrawal by Subject|2
5951279|NCT01260922|20583381|P1|Washout of 28 Days|Withdrawal by Subject|4
5951280|NCT01260922|20583380|P2|First Intervention|Withdrawal by Subject|1
5951281|NCT01260922|20583381|P1|First Intervention|Withdrawal by Subject|0
5951282|NCT01260896|20583391|P2|First Intervention|Withdrawn Due to Emesis|0
5951283|NCT01260896|20583392|P1|First Intervention|Withdrawn Due to Emesis|2
5951284|NCT01260701|20583450|P1|Overall Study|Did not begin protocol therapy|1
5951285|NCT01260701|20583450|P1|Overall Study|Ineligible|4
5951286|NCT01260701|20583450|P1|Overall Study|Under review|1
5951287|NCT01260701|20583450|P1|Overall Study|Not protocol specified|3
5951288|NCT01260701|20583450|P1|Overall Study|Death|2
5951289|NCT01260701|20583450|P1|Overall Study|Progression|53
5951290|NCT01260701|20583450|P1|Overall Study|Withdrawal by Subject|2
5951291|NCT01260701|20583450|P1|Overall Study|Adverse Event|9
5951292|NCT01260584|20583531|P4|Period 2|Withdrawal by Subject|0
5951293|NCT01260584|20583532|P3|Period 2|Withdrawal by Subject|0
5951294|NCT01260584|20583533|P2|Period 2|Withdrawal by Subject|1
5951295|NCT01260584|20583534|P1|Period 2|Withdrawal by Subject|0
5951296|NCT01260584|20583531|P4|Period 2|Adverse Event|0
5951297|NCT01260584|20583532|P3|Period 2|Adverse Event|2
5951298|NCT01260584|20583533|P2|Period 2|Adverse Event|0
5951299|NCT01260584|20583534|P1|Period 2|Adverse Event|1
5951300|NCT01260584|20583531|P4|Period 2|Protocol Violation|1
5951301|NCT01260584|20583532|P3|Period 2|Protocol Violation|3
5951302|NCT01260584|20583533|P2|Period 2|Protocol Violation|2
5951303|NCT01260584|20583534|P1|Period 2|Protocol Violation|0
5951304|NCT01260584|20583531|P4|Period 1|Adverse Event|0
5951305|NCT01260584|20583532|P3|Period 1|Adverse Event|1
5951306|NCT01260584|20583533|P2|Period 1|Adverse Event|0
5951307|NCT01260584|20583534|P1|Period 1|Adverse Event|0
5951308|NCT01260584|20583531|P4|Period 1|Protocol Violation|1
5951309|NCT01260584|20583532|P3|Period 1|Protocol Violation|1
5951310|NCT01260584|20583533|P2|Period 1|Protocol Violation|0
5951311|NCT01260584|20583534|P1|Period 1|Protocol Violation|0
5951312|NCT01260467|20583577|P1|Overall Study|Withdrawal by Subject|2
5951313|NCT01260350|20583609|P22|Overall Study|Did Not Complete Follow-up 12 Visit|0
5951314|NCT01260350|20583610|P21|Overall Study|Did Not Complete Follow-up 12 Visit|0
5951315|NCT01260350|20583611|P20|Overall Study|Did Not Complete Follow-up 12 Visit|0
5951316|NCT01260350|20583612|P19|Overall Study|Did Not Complete Follow-up 12 Visit|0
5951317|NCT01260350|20583613|P18|Overall Study|Did Not Complete Follow-up 12 Visit|0
5951318|NCT01260350|20583614|P17|Overall Study|Did Not Complete Follow-up 12 Visit|0
5951319|NCT01260350|20583615|P16|Overall Study|Did Not Complete Follow-up 12 Visit|0
5951320|NCT01260350|20583616|P15|Overall Study|Did Not Complete Follow-up 12 Visit|0
5951321|NCT01260350|20583617|P14|Overall Study|Did Not Complete Follow-up 12 Visit|0
5951322|NCT01260350|20583618|P13|Overall Study|Did Not Complete Follow-up 12 Visit|0
5951323|NCT01260350|20583619|P12|Overall Study|Did Not Complete Follow-up 12 Visit|0
5951324|NCT01260350|20583620|P11|Overall Study|Did Not Complete Follow-up 12 Visit|0
5951325|NCT01260350|20583621|P10|Overall Study|Did Not Complete Follow-up 12 Visit|0
5951326|NCT01260350|20583622|P9|Overall Study|Did Not Complete Follow-up 12 Visit|1
5951327|NCT01260350|20583623|P8|Overall Study|Did Not Complete Follow-up 12 Visit|0
5951328|NCT01260350|20583624|P7|Overall Study|Did Not Complete Follow-up 12 Visit|0
5951329|NCT01260350|20583625|P6|Overall Study|Did Not Complete Follow-up 12 Visit|0
5951330|NCT01260350|20583626|P5|Overall Study|Did Not Complete Follow-up 12 Visit|0
5951331|NCT01260350|20583627|P4|Overall Study|Did Not Complete Follow-up 12 Visit|0
5951332|NCT01260350|20583628|P3|Overall Study|Did Not Complete Follow-up 12 Visit|0
5951333|NCT01260350|20583629|P2|Overall Study|Did Not Complete Follow-up 12 Visit|0
5951334|NCT01260350|20583630|P1|Overall Study|Did Not Complete Follow-up 12 Visit|0
5951335|NCT01260350|20583609|P22|Overall Study|Lack of Efficacy|0
5951336|NCT01260350|20583610|P21|Overall Study|Lack of Efficacy|3
5951337|NCT01260350|20583611|P20|Overall Study|Lack of Efficacy|0
5951338|NCT01260350|20583612|P19|Overall Study|Lack of Efficacy|0
5951339|NCT01260350|20583613|P18|Overall Study|Lack of Efficacy|1
5951340|NCT01260350|20583614|P17|Overall Study|Lack of Efficacy|0
5951341|NCT01260350|20583615|P16|Overall Study|Lack of Efficacy|0
5951342|NCT01260350|20583616|P15|Overall Study|Lack of Efficacy|0
5951343|NCT01260350|20583617|P14|Overall Study|Lack of Efficacy|0
5951344|NCT01260350|20583618|P13|Overall Study|Lack of Efficacy|0
5951345|NCT01260350|20583619|P12|Overall Study|Lack of Efficacy|0
5951346|NCT01260350|20583620|P11|Overall Study|Lack of Efficacy|0
5951347|NCT01260350|20583621|P10|Overall Study|Lack of Efficacy|0
5951348|NCT01260350|20583622|P9|Overall Study|Lack of Efficacy|0
5951349|NCT01260350|20583623|P8|Overall Study|Lack of Efficacy|0
5951350|NCT01260350|20583624|P7|Overall Study|Lack of Efficacy|0
5951351|NCT01260350|20583625|P6|Overall Study|Lack of Efficacy|0
5951352|NCT01260350|20583626|P5|Overall Study|Lack of Efficacy|0
5951353|NCT01260350|20583627|P4|Overall Study|Lack of Efficacy|0
5951354|NCT01260350|20583628|P3|Overall Study|Lack of Efficacy|0
5951355|NCT01260350|20583629|P2|Overall Study|Lack of Efficacy|0
5951356|NCT01260350|20583630|P1|Overall Study|Lack of Efficacy|0
5951357|NCT01260311|20583837|P1|Overall Study|Fesoterodine Started Before Enrollment|1
5951358|NCT01260311|20583837|P1|Overall Study|Medication Stopped|1
5951359|NCT01260311|20583837|P1|Overall Study|Gone to Province|2
5951360|NCT01260311|20583837|P1|Overall Study|Financial Constraints|77
5951361|NCT01260311|20583837|P1|Overall Study|Withdrawal by Subject|6
5951362|NCT01260311|20583837|P1|Overall Study|Lost to Follow-up|25
5951363|NCT01260311|20583837|P1|Overall Study|Lack of Efficacy|4
5951364|NCT01260311|20583837|P1|Overall Study|Adverse Event|11
5951365|NCT01260194|20583868|P1|Overall Study|Withdrawal of Consent|1
5951366|NCT01260181|20583880|P1|Overall Study|Decision of Investigator|1
5951367|NCT01260142|20583895|P6|Treatment Period 1|Withdrawal by Subject|1
5951368|NCT01260142|20583896|P5|Treatment Period 1|Withdrawal by Subject|0
5951369|NCT01260142|20583897|P4|Treatment Period 1|Withdrawal by Subject|0
5951370|NCT01260142|20583898|P3|Treatment Period 1|Withdrawal by Subject|0
5951371|NCT01260142|20583899|P2|Treatment Period 1|Withdrawal by Subject|0
5951372|NCT01260142|20583900|P1|Treatment Period 1|Withdrawal by Subject|0
5951373|NCT01260142|20583895|P6|Treatment Period 1|Unexplained elevated sys. BP|0
5951374|NCT01260142|20583896|P5|Treatment Period 1|Unexplained elevated sys. BP|1
5951375|NCT01260142|20583897|P4|Treatment Period 1|Unexplained elevated sys. BP|0
5951376|NCT01260142|20583898|P3|Treatment Period 1|Unexplained elevated sys. BP|0
5951377|NCT01260142|20583899|P2|Treatment Period 1|Unexplained elevated sys. BP|0
5951378|NCT01260142|20583900|P1|Treatment Period 1|Unexplained elevated sys. BP|0
5951379|NCT01260142|20583895|P6|Treatment Period 1|Study on hold|2
5951380|NCT01260142|20583896|P5|Treatment Period 1|Study on hold|1
5951381|NCT01260142|20583897|P4|Treatment Period 1|Study on hold|0
5951382|NCT01260142|20583898|P3|Treatment Period 1|Study on hold|0
5951383|NCT01260142|20583899|P2|Treatment Period 1|Study on hold|1
5951384|NCT01260142|20583900|P1|Treatment Period 1|Study on hold|1
5951385|NCT01259869|20583950|P1|Overall Study|Duplicated registration|1
5951386|NCT01259856|20583956|P2|Overall Study|Unknown/missing|2
5951387|NCT01259856|20583957|P1|Overall Study|Unknown/missing|2
5951388|NCT01259856|20583956|P2|Overall Study|Transfer to another study|1
5951389|NCT01259856|20583957|P1|Overall Study|Transfer to another study|0
5951390|NCT01259856|20583956|P2|Overall Study|Patient developed other disease|1
5951391|NCT01259856|20583957|P1|Overall Study|Patient developed other disease|0
5951392|NCT01259856|20583956|P2|Overall Study|Study closure by sponsor|41
5951393|NCT01259856|20583957|P1|Overall Study|Study closure by sponsor|40
5951394|NCT01259856|20583956|P2|Overall Study|Treatment never started|6
5951395|NCT01259856|20583957|P1|Overall Study|Treatment never started|0
5951396|NCT01259856|20583956|P2|Overall Study|Withdrawal by Subject|10
5951397|NCT01259856|20583957|P1|Overall Study|Withdrawal by Subject|9
5951398|NCT01259856|20583956|P2|Overall Study|Physician Decision|1
5951399|NCT01259856|20583957|P1|Overall Study|Physician Decision|2
5951400|NCT01259856|20583956|P2|Overall Study|Lost to Follow-up|1
5951401|NCT01259856|20583957|P1|Overall Study|Lost to Follow-up|1
5951402|NCT01259856|20583956|P2|Overall Study|Lack of Efficacy|1
5951403|NCT01259856|20583957|P1|Overall Study|Lack of Efficacy|3
5951404|NCT01259856|20583956|P2|Overall Study|Death|1
5951405|NCT01259856|20583957|P1|Overall Study|Death|0
5951406|NCT01259856|20583956|P2|Overall Study|Adverse Event|9
5951407|NCT01259856|20583957|P1|Overall Study|Adverse Event|12
5951408|NCT01259726|20583981|P4|Overall Study|Lost to Follow-up|3
5951409|NCT01259726|20583982|P3|Overall Study|Lost to Follow-up|1
5951410|NCT01259726|20583983|P2|Overall Study|Lost to Follow-up|1
5951411|NCT01259726|20583984|P1|Overall Study|Lost to Follow-up|1
5951412|NCT01259726|20583981|P4|Overall Study|Withdrawal by Subject|1
5951413|NCT01259726|20583982|P3|Overall Study|Withdrawal by Subject|2
5951414|NCT01259726|20583983|P2|Overall Study|Withdrawal by Subject|3
5951415|NCT01259726|20583984|P1|Overall Study|Withdrawal by Subject|1
5951416|NCT01259726|20583981|P4|Overall Study|Physician Decision|1
5951417|NCT01259726|20583982|P3|Overall Study|Physician Decision|1
5951418|NCT01259726|20583983|P2|Overall Study|Physician Decision|0
5951419|NCT01259726|20583984|P1|Overall Study|Physician Decision|2
5951420|NCT01259726|20583981|P4|Overall Study|Death|0
5951421|NCT01259726|20583982|P3|Overall Study|Death|0
5951422|NCT01259726|20583983|P2|Overall Study|Death|0
5951423|NCT01259726|20583984|P1|Overall Study|Death|1
5951424|NCT01259713|20584016|P2|Overall Study|Subject Withdrew Consent|7
5951425|NCT01259713|20584017|P1|Overall Study|Subject Withdrew Consent|12
5951426|NCT01259713|20584016|P2|Overall Study|Protocol Violation|4
5951427|NCT01259713|20584017|P1|Overall Study|Protocol Violation|5
5951428|NCT01259713|20584016|P2|Overall Study|Lack of Efficacy|0
5951429|NCT01259713|20584017|P1|Overall Study|Lack of Efficacy|2
5951430|NCT01259713|20584016|P2|Overall Study|Investigators Discretion|6
5951431|NCT01259713|20584017|P1|Overall Study|Investigators Discretion|14
5951432|NCT01259713|20584016|P2|Overall Study|Death Not Related to IFI|1
5951433|NCT01259713|20584017|P1|Overall Study|Death Not Related to IFI|8
5951434|NCT01259713|20584016|P2|Overall Study|Adverse Event|23
5951435|NCT01259713|20584017|P1|Overall Study|Adverse Event|54
5951436|NCT01259492|20584064|P4|Period 3 (Week 15 to End of Week 40)|Protocol Violation|7
5951437|NCT01259492|20584065|P3|Period 3 (Week 15 to End of Week 40)|Protocol Violation|3
5951438|NCT01259492|20584066|P2|Period 3 (Week 15 to End of Week 40)|Protocol Violation|6
5951439|NCT01259492|20584067|P1|Period 3 (Week 15 to End of Week 40)|Protocol Violation|5
5951440|NCT01259492|20584064|P4|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0
5951441|NCT01259492|20584065|P3|Period 3 (Week 15 to End of Week 40)|Administrative Problems|1
5951442|NCT01259492|20584066|P2|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0
5951443|NCT01259492|20584067|P1|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0
5951444|NCT01259492|20584064|P4|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3
5951445|NCT01259492|20584065|P3|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|6
5951446|NCT01259492|20584066|P2|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|4
5951447|NCT01259492|20584067|P1|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3
5951448|NCT01259492|20584064|P4|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|3
5951449|NCT01259492|20584065|P3|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|4
5951450|NCT01259492|20584066|P2|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|6
5951451|NCT01259492|20584067|P1|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|12
5951452|NCT01259492|20584064|P4|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0
5951453|NCT01259492|20584065|P3|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0
5951454|NCT01259492|20584066|P2|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0
5951455|NCT01259492|20584067|P1|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|1
5951456|NCT01259492|20584064|P4|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|62
5951457|NCT01259492|20584065|P3|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|29
5951458|NCT01259492|20584066|P2|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|42
5951459|NCT01259492|20584067|P1|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|28
5951460|NCT01259492|20584064|P4|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0
5951461|NCT01259492|20584065|P3|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|1
5951462|NCT01259492|20584066|P2|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0
5951463|NCT01259492|20584067|P1|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0
5951464|NCT01259492|20584064|P4|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|1
5951465|NCT01259492|20584065|P3|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0
5951466|NCT01259492|20584066|P2|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0
5951467|NCT01259492|20584067|P1|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0
5951468|NCT01259492|20584064|P4|Period 3 (Week 15 to End of Week 40)|Adverse Event|5
5951469|NCT01259492|20584065|P3|Period 3 (Week 15 to End of Week 40)|Adverse Event|6
5951470|NCT01259492|20584066|P2|Period 3 (Week 15 to End of Week 40)|Adverse Event|11
5951471|NCT01259492|20584067|P1|Period 3 (Week 15 to End of Week 40)|Adverse Event|5
5951472|NCT01259492|20584064|P4|Period 2 (Week 10 to Week 14)|Protocol Violation|0
5951473|NCT01259492|20584065|P3|Period 2 (Week 10 to Week 14)|Protocol Violation|1
5951474|NCT01259492|20584066|P2|Period 2 (Week 10 to Week 14)|Protocol Violation|2
5951475|NCT01259492|20584067|P1|Period 2 (Week 10 to Week 14)|Protocol Violation|0
5951476|NCT01259492|20584064|P4|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3
5951477|NCT01259492|20584065|P3|Period 2 (Week 10 to Week 14)|Lost to Follow-up|1
5951478|NCT01259492|20584066|P2|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3
5951479|NCT01259492|20584067|P1|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3
5951480|NCT01259492|20584064|P4|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|4
5951481|NCT01259492|20584065|P3|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|8
5951482|NCT01259492|20584066|P2|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|2
5951483|NCT01259492|20584067|P1|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|6
5951484|NCT01259492|20584064|P4|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13
5951485|NCT01259492|20584065|P3|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7
5951486|NCT01259492|20584066|P2|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7
5951487|NCT01259492|20584067|P1|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13
5951488|NCT01259492|20584064|P4|Period 2 (Week 10 to Week 14)|Adverse Event|8
5951489|NCT01259492|20584065|P3|Period 2 (Week 10 to Week 14)|Adverse Event|7
5951490|NCT01259492|20584066|P2|Period 2 (Week 10 to Week 14)|Adverse Event|4
5951491|NCT01259492|20584067|P1|Period 2 (Week 10 to Week 14)|Adverse Event|3
5951492|NCT01259492|20584064|P4|Period 1 (9 Weeks)|Protocol Violation|1
5951493|NCT01259492|20584065|P3|Period 1 (9 Weeks)|Protocol Violation|3
5951494|NCT01259492|20584066|P2|Period 1 (9 Weeks)|Protocol Violation|6
5951495|NCT01259492|20584067|P1|Period 1 (9 Weeks)|Protocol Violation|5
5951496|NCT01259492|20584064|P4|Period 1 (9 Weeks)|Administrative Problems|2
5951497|NCT01259492|20584065|P3|Period 1 (9 Weeks)|Administrative Problems|1
5951498|NCT01259492|20584066|P2|Period 1 (9 Weeks)|Administrative Problems|1
5951499|NCT01259492|20584067|P1|Period 1 (9 Weeks)|Administrative Problems|0
5951500|NCT01259492|20584064|P4|Period 1 (9 Weeks)|Lost to Follow-up|4
5951501|NCT01259492|20584065|P3|Period 1 (9 Weeks)|Lost to Follow-up|3
5951502|NCT01259492|20584066|P2|Period 1 (9 Weeks)|Lost to Follow-up|6
5951503|NCT01259492|20584067|P1|Period 1 (9 Weeks)|Lost to Follow-up|4
5951504|NCT01259492|20584064|P4|Period 1 (9 Weeks)|Withdrawal by Subject|7
5951505|NCT01259492|20584065|P3|Period 1 (9 Weeks)|Withdrawal by Subject|6
5951506|NCT01259492|20584066|P2|Period 1 (9 Weeks)|Withdrawal by Subject|8
5951507|NCT01259492|20584067|P1|Period 1 (9 Weeks)|Withdrawal by Subject|5
5951508|NCT01259492|20584064|P4|Period 1 (9 Weeks)|Lack of Efficacy|11
5951509|NCT01259492|20584065|P3|Period 1 (9 Weeks)|Lack of Efficacy|4
5951510|NCT01259492|20584066|P2|Period 1 (9 Weeks)|Lack of Efficacy|2
5951511|NCT01259492|20584067|P1|Period 1 (9 Weeks)|Lack of Efficacy|2
5951512|NCT01259492|20584064|P4|Period 1 (9 Weeks)|Adverse Event|3
5951513|NCT01259492|20584065|P3|Period 1 (9 Weeks)|Adverse Event|26
5951514|NCT01259492|20584066|P2|Period 1 (9 Weeks)|Adverse Event|18
5951515|NCT01259492|20584067|P1|Period 1 (9 Weeks)|Adverse Event|13
5951516|NCT01259466|20584116|P2|Overall Study|Withdrawal by Subject|9
5951517|NCT01259466|20584117|P1|Overall Study|Withdrawal by Subject|1
5951518|NCT01259401|20584155|P2|4-month Follow-up|Lost to Follow-up|1
5951519|NCT01259401|20584156|P1|4-month Follow-up|Lost to Follow-up|0
5951520|NCT01259401|20584155|P2|4-month Follow-up|Death|1
5951521|NCT01259401|20584156|P1|4-month Follow-up|Death|0
5951522|NCT01259388|20584166|P2|Overall Study|Physician Decision|0
5951523|NCT01259388|20584167|P1|Overall Study|Physician Decision|1
5951524|NCT01259388|20584166|P2|Overall Study|Withdrawal by Subject|1
5951525|NCT01259388|20584167|P1|Overall Study|Withdrawal by Subject|1
5951526|NCT01259388|20584166|P2|Overall Study|Adverse Event|0
5951527|NCT01259388|20584167|P1|Overall Study|Adverse Event|3
5951528|NCT01259375|20584177|P1|Overall Study|Adverse Event|1
5951529|NCT01259297|20584194|P8|Double Blind Randomized Period|Other reasons|1
5951530|NCT01259297|20584195|P7|Double Blind Randomized Period|Other reasons|3
5951531|NCT01259297|20584196|P6|Double Blind Randomized Period|Other reasons|2
5951532|NCT01259297|20584197|P5|Double Blind Randomized Period|Other reasons|1
5951533|NCT01259297|20584198|P4|Double Blind Randomized Period|Other reasons|0
5951534|NCT01259297|20584199|P3|Double Blind Randomized Period|Other reasons|0
5951535|NCT01259297|20584200|P2|Double Blind Randomized Period|Other reasons|1
5951536|NCT01259297|20584201|P1|Double Blind Randomized Period|Other reasons|0
5951537|NCT01259297|20584194|P8|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1
5951538|NCT01259297|20584195|P7|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1
5951539|NCT01259297|20584196|P6|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1
5951540|NCT01259297|20584197|P5|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2
5951541|NCT01259297|20584198|P4|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2
5951542|NCT01259297|20584199|P3|Double Blind Randomized Period|Withdrew informed consent/ refused visit|0
5951543|NCT01259297|20584200|P2|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1
5951544|NCT01259297|20584201|P1|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1
5951545|NCT01259297|20584194|P8|Double Blind Randomized Period|Death|1
5951546|NCT01259297|20584195|P7|Double Blind Randomized Period|Death|2
5951547|NCT01259297|20584196|P6|Double Blind Randomized Period|Death|5
5951548|NCT01259297|20584197|P5|Double Blind Randomized Period|Death|1
5951549|NCT01259297|20584198|P4|Double Blind Randomized Period|Death|2
5951550|NCT01259297|20584199|P3|Double Blind Randomized Period|Death|1
5951551|NCT01259297|20584200|P2|Double Blind Randomized Period|Death|1
5951552|NCT01259297|20584201|P1|Double Blind Randomized Period|Death|1
5951553|NCT01259284|20584232|P3|Overall Study|Study Termination|0
5951554|NCT01259284|20584233|P2|Overall Study|Study Termination|0
5951555|NCT01259284|20584234|P1|Overall Study|Study Termination|2
5951556|NCT01259245|20584244|P2|Overall Study|Death|2
5951557|NCT01259245|20584245|P1|Overall Study|Death|1
5951558|NCT01259245|20584244|P2|Overall Study|Withdrawal by Subject|24
5951559|NCT01259245|20584245|P1|Overall Study|Withdrawal by Subject|27
5951560|NCT01259115|20584282|P2|Period 2|Adverse Event|0
5951561|NCT01259115|20584283|P1|Period 2|Adverse Event|1
5951562|NCT01259115|20584282|P2|Period 1|Lost to Follow-up|1
5951563|NCT01259115|20584283|P1|Period 1|Lost to Follow-up|0
5951564|NCT01259115|20584282|P2|Period 1|Protocol Violation|0
5951565|NCT01259115|20584283|P1|Period 1|Protocol Violation|2
5951566|NCT01259115|20584282|P2|Period 1|Adverse Event|0
5951567|NCT01259115|20584283|P1|Period 1|Adverse Event|1
5951568|NCT01259102|20584319|P5|Overall Study|Other|1
5951569|NCT01259102|20584320|P4|Overall Study|Other|1
5951570|NCT01259102|20584321|P3|Overall Study|Other|1
5951571|NCT01259102|20584322|P2|Overall Study|Other|0
5951572|NCT01259102|20584323|P1|Overall Study|Other|0
5951573|NCT01259102|20584319|P5|Overall Study|Adverse Event|0
5951574|NCT01259102|20584320|P4|Overall Study|Adverse Event|1
5951575|NCT01259102|20584321|P3|Overall Study|Adverse Event|1
5951576|NCT01259102|20584322|P2|Overall Study|Adverse Event|0
5951577|NCT01259102|20584323|P1|Overall Study|Adverse Event|1
5951578|NCT01259089|20584380|P6|Survival Follow up for Two Years|stopped being followed as study closed|4
5951579|NCT01259089|20584381|P5|Survival Follow up for Two Years|stopped being followed as study closed|0
5951580|NCT01259089|20584382|P4|Survival Follow up for Two Years|stopped being followed as study closed|0
5951581|NCT01259089|20584383|P3|Survival Follow up for Two Years|stopped being followed as study closed|0
5951582|NCT01259089|20584384|P2|Survival Follow up for Two Years|stopped being followed as study closed|0
5951583|NCT01259089|20584385|P1|Survival Follow up for Two Years|stopped being followed as study closed|0
5951584|NCT01259089|20584380|P6|Survival Follow up for Two Years|Lost to Follow-up|2
5951585|NCT01259089|20584381|P5|Survival Follow up for Two Years|Lost to Follow-up|0
5951586|NCT01259089|20584382|P4|Survival Follow up for Two Years|Lost to Follow-up|0
5951587|NCT01259089|20584383|P3|Survival Follow up for Two Years|Lost to Follow-up|0
5951588|NCT01259089|20584384|P2|Survival Follow up for Two Years|Lost to Follow-up|0
5951589|NCT01259089|20584385|P1|Survival Follow up for Two Years|Lost to Follow-up|0
5951590|NCT01259089|20584380|P6|Survival Follow up for Two Years|Death|13
5951591|NCT01259089|20584381|P5|Survival Follow up for Two Years|Death|6
5951592|NCT01259089|20584382|P4|Survival Follow up for Two Years|Death|3
5951593|NCT01259089|20584383|P3|Survival Follow up for Two Years|Death|2
5951594|NCT01259089|20584384|P2|Survival Follow up for Two Years|Death|2
5951595|NCT01259089|20584385|P1|Survival Follow up for Two Years|Death|3
5951596|NCT01259089|20584380|P6|Continued Treatment After 8 Weeks|Progressive disease|0
5951597|NCT01259089|20584381|P5|Continued Treatment After 8 Weeks|Progressive disease|0
5951598|NCT01259089|20584382|P4|Continued Treatment After 8 Weeks|Progressive disease|1
5951599|NCT01259089|20584383|P3|Continued Treatment After 8 Weeks|Progressive disease|1
5951600|NCT01259089|20584384|P2|Continued Treatment After 8 Weeks|Progressive disease|1
5951601|NCT01259089|20584385|P1|Continued Treatment After 8 Weeks|Progressive disease|1
5951602|NCT01259089|20584380|P6|Continued Treatment After 8 Weeks|Adverse Event|1
5951603|NCT01259089|20584381|P5|Continued Treatment After 8 Weeks|Adverse Event|2
5951604|NCT01259089|20584382|P4|Continued Treatment After 8 Weeks|Adverse Event|0
5951605|NCT01259089|20584383|P3|Continued Treatment After 8 Weeks|Adverse Event|0
5951606|NCT01259089|20584384|P2|Continued Treatment After 8 Weeks|Adverse Event|0
5951607|NCT01259089|20584385|P1|Continued Treatment After 8 Weeks|Adverse Event|0
5951608|NCT01259089|20584380|P6|Continued Treatment After 8 Weeks|Withdrawal by Subject|0
5951609|NCT01259089|20584381|P5|Continued Treatment After 8 Weeks|Withdrawal by Subject|0
5951610|NCT01259089|20584382|P4|Continued Treatment After 8 Weeks|Withdrawal by Subject|0
5951611|NCT01259089|20584383|P3|Continued Treatment After 8 Weeks|Withdrawal by Subject|0
5951612|NCT01259089|20584384|P2|Continued Treatment After 8 Weeks|Withdrawal by Subject|0
5951613|NCT01259089|20584385|P1|Continued Treatment After 8 Weeks|Withdrawal by Subject|1
5951614|NCT01259089|20584380|P6|Confirmed Response at 8 Weeks|Progressive disease|7
5951615|NCT01259089|20584381|P5|Confirmed Response at 8 Weeks|Progressive disease|3
5951616|NCT01259089|20584382|P4|Confirmed Response at 8 Weeks|Progressive disease|1
5951617|NCT01259089|20584383|P3|Confirmed Response at 8 Weeks|Progressive disease|1
5951618|NCT01259089|20584384|P2|Confirmed Response at 8 Weeks|Progressive disease|0
5951619|NCT01259089|20584385|P1|Confirmed Response at 8 Weeks|Progressive disease|0
5951620|NCT01259089|20584380|P6|Confirmed Response at 8 Weeks|Adverse Event|2
5951621|NCT01259089|20584381|P5|Confirmed Response at 8 Weeks|Adverse Event|1
5951622|NCT01259089|20584382|P4|Confirmed Response at 8 Weeks|Adverse Event|0
5951623|NCT01259089|20584383|P3|Confirmed Response at 8 Weeks|Adverse Event|0
5951624|NCT01259089|20584384|P2|Confirmed Response at 8 Weeks|Adverse Event|0
5951625|NCT01259089|20584385|P1|Confirmed Response at 8 Weeks|Adverse Event|0
5951626|NCT01259089|20584380|P6|Confirmed Response at 8 Weeks|Withdrawal by Subject|1
5951627|NCT01259089|20584381|P5|Confirmed Response at 8 Weeks|Withdrawal by Subject|0
5951628|NCT01259089|20584382|P4|Confirmed Response at 8 Weeks|Withdrawal by Subject|0
5951629|NCT01259089|20584383|P3|Confirmed Response at 8 Weeks|Withdrawal by Subject|0
5951630|NCT01259089|20584384|P2|Confirmed Response at 8 Weeks|Withdrawal by Subject|0
5951631|NCT01259089|20584385|P1|Confirmed Response at 8 Weeks|Withdrawal by Subject|0
5951632|NCT01259089|20584380|P6|Reached First Response at 4 Weeks|Adverse Event|1
5951633|NCT01259089|20584381|P5|Reached First Response at 4 Weeks|Adverse Event|0
5951634|NCT01259089|20584382|P4|Reached First Response at 4 Weeks|Adverse Event|0
5951635|NCT01259089|20584383|P3|Reached First Response at 4 Weeks|Adverse Event|0
5951636|NCT01259089|20584384|P2|Reached First Response at 4 Weeks|Adverse Event|0
5951637|NCT01259089|20584385|P1|Reached First Response at 4 Weeks|Adverse Event|0
5951638|NCT01259089|20584380|P6|Reached First Response at 4 Weeks|Patient not treated on study|1
5951639|NCT01259089|20584381|P5|Reached First Response at 4 Weeks|Patient not treated on study|0
5951640|NCT01259089|20584382|P4|Reached First Response at 4 Weeks|Patient not treated on study|0
5951641|NCT01259089|20584383|P3|Reached First Response at 4 Weeks|Patient not treated on study|0
5951642|NCT01259089|20584384|P2|Reached First Response at 4 Weeks|Patient not treated on study|0
5951643|NCT01259089|20584385|P1|Reached First Response at 4 Weeks|Patient not treated on study|0
5951644|NCT01259024|20584413|P1|Overall Study|Physician Decision|1
5951645|NCT01258998|20584433|P1|Overall Study|Ineligible|1
5951646|NCT01258803|20584494|P6|Treatment Period 3 (1 Dose)|Protocol Violation|0
5951647|NCT01258803|20584495|P5|Treatment Period 3 (1 Dose)|Protocol Violation|0
5951648|NCT01258803|20584496|P4|Treatment Period 3 (1 Dose)|Protocol Violation|0
5951649|NCT01258803|20584497|P3|Treatment Period 3 (1 Dose)|Protocol Violation|1
5951650|NCT01258803|20584498|P2|Treatment Period 3 (1 Dose)|Protocol Violation|0
5951651|NCT01258803|20584499|P1|Treatment Period 3 (1 Dose)|Protocol Violation|0
5951652|NCT01258803|20584494|P6|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0
5951653|NCT01258803|20584495|P5|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0
5951654|NCT01258803|20584496|P4|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0
5951655|NCT01258803|20584497|P3|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0
5951656|NCT01258803|20584498|P2|Treatment Period 2 (1 Dose)|Withdrawal by Subject|1
5951657|NCT01258803|20584499|P1|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0
5951658|NCT01258803|20584494|P6|Treatment Period 2 (1 Dose)|Protocol Violation|1
5951659|NCT01258803|20584495|P5|Treatment Period 2 (1 Dose)|Protocol Violation|0
5951660|NCT01258803|20584496|P4|Treatment Period 2 (1 Dose)|Protocol Violation|0
5951661|NCT01258803|20584497|P3|Treatment Period 2 (1 Dose)|Protocol Violation|0
5951662|NCT01258803|20584498|P2|Treatment Period 2 (1 Dose)|Protocol Violation|1
5951663|NCT01258803|20584499|P1|Treatment Period 2 (1 Dose)|Protocol Violation|1
5951664|NCT01258738|20584536|P2|Open-label Period|Withdrawn due to pregnancy|1
5951665|NCT01258738|20584537|P1|Open-label Period|Withdrawn due to pregnancy|1
5951666|NCT01258738|20584536|P2|Open-label Period|Other Reasons|1
5951667|NCT01258738|20584537|P1|Open-label Period|Other Reasons|0
5951668|NCT01258738|20584536|P2|Open-label Period|Adverse Event|5
5951669|NCT01258738|20584537|P1|Open-label Period|Adverse Event|4
5951670|NCT01258738|20584536|P2|Open-label Period|Protocol Violation|2
5951671|NCT01258738|20584537|P1|Open-label Period|Protocol Violation|2
5951672|NCT01258738|20584536|P2|Open-label Period|Withdrawal by Subject|6
5951673|NCT01258738|20584537|P1|Open-label Period|Withdrawal by Subject|5
5951674|NCT01258738|20584536|P2|Open-label Period|Lost to Follow-up|2
5951675|NCT01258738|20584537|P1|Open-label Period|Lost to Follow-up|0
5951676|NCT01258738|20584536|P2|Open-label Period|Insufficient clinical response|3
5951677|NCT01258738|20584537|P1|Open-label Period|Insufficient clinical response|5
5951678|NCT01258738|20584536|P2|Open-label Period|Did not meet inclusion criteria|1
5951679|NCT01258738|20584537|P1|Open-label Period|Did not meet inclusion criteria|0
5951680|NCT01258738|20584536|P2|Double-blind Period|Adverse Event|1
5951681|NCT01258738|20584537|P1|Double-blind Period|Adverse Event|3
5951682|NCT01258738|20584536|P2|Double-blind Period|Protocol Violation|1
5951683|NCT01258738|20584537|P1|Double-blind Period|Protocol Violation|1
5951684|NCT01258738|20584536|P2|Double-blind Period|Withdrawal by Subject|2
5951685|NCT01258738|20584537|P1|Double-blind Period|Withdrawal by Subject|2
5951686|NCT01258738|20584536|P2|Double-blind Period|Did not meet inclusion criteria|3
5951687|NCT01258738|20584537|P1|Double-blind Period|Did not meet inclusion criteria|3
5951688|NCT01258660|20584675|P2|Overall Study|Invalid for primary analysis data set|6
5951689|NCT01258660|20584676|P1|Overall Study|Invalid for primary analysis data set|4
5951690|NCT01258660|20584675|P2|Overall Study|Protocol Violation|1
5951691|NCT01258660|20584676|P1|Overall Study|Protocol Violation|0
5951692|NCT01258660|20584675|P2|Overall Study|due to relocation|0
5951693|NCT01258660|20584676|P1|Overall Study|due to relocation|2
5951694|NCT01258660|20584675|P2|Overall Study|Withdrawal by Subject|0
5951695|NCT01258660|20584676|P1|Overall Study|Withdrawal by Subject|3
5951696|NCT01258660|20584675|P2|Overall Study|Adverse Event|4
5951697|NCT01258660|20584676|P1|Overall Study|Adverse Event|2
5951698|NCT01258608|20584695|P2|Overall Study|Withdrawal by Subject|5
5951699|NCT01258608|20584696|P1|Overall Study|Withdrawal by Subject|6
5951700|NCT01258608|20584695|P2|Overall Study|Adverse Event|10
5951701|NCT01258608|20584696|P1|Overall Study|Adverse Event|6
5951702|NCT01258608|20584695|P2|Overall Study|Lack of Efficacy|1
5951703|NCT01258608|20584696|P1|Overall Study|Lack of Efficacy|0
5951704|NCT01258608|20584695|P2|Overall Study|Lack of compliance|0
5951705|NCT01258608|20584696|P1|Overall Study|Lack of compliance|1
5951706|NCT01258608|20584695|P2|Overall Study|Lost to Follow-up|1
5951707|NCT01258608|20584696|P1|Overall Study|Lost to Follow-up|0
5951708|NCT01258608|20584695|P2|Overall Study|Physician Decision|1
5951709|NCT01258608|20584696|P1|Overall Study|Physician Decision|6
5951710|NCT01258608|20584695|P2|Overall Study|Sponsor decision|1
5951711|NCT01258608|20584696|P1|Overall Study|Sponsor decision|0
5951712|NCT01258608|20584695|P2|Overall Study|Clinical progression|0
5951713|NCT01258608|20584696|P1|Overall Study|Clinical progression|1
5951714|NCT01258608|20584695|P2|Overall Study|Metastatic Hepatocellular Carcinoma|0
5951715|NCT01258608|20584696|P1|Overall Study|Metastatic Hepatocellular Carcinoma|1
5951716|NCT01258595|20584744|P2|Overall Study|Withdrawal by Subject|1
5951717|NCT01258595|20584745|P1|Overall Study|Withdrawal by Subject|0
5951718|NCT01258595|20584744|P2|Overall Study|Lost to Follow-up|0
5951719|NCT01258595|20584745|P1|Overall Study|Lost to Follow-up|1
5951720|NCT01258348|20584842|P5|Overall Study|Withdrawal by Subject|0
5951721|NCT01258348|20584843|P4|Overall Study|Withdrawal by Subject|0
5951722|NCT01258348|20584844|P3|Overall Study|Withdrawal by Subject|0
5951723|NCT01258348|20584845|P2|Overall Study|Withdrawal by Subject|1
5951724|NCT01258348|20584846|P1|Overall Study|Withdrawal by Subject|0
5951725|NCT01258348|20584842|P5|Overall Study|Physician Decision|0
5951726|NCT01258348|20584843|P4|Overall Study|Physician Decision|2
5951727|NCT01258348|20584844|P3|Overall Study|Physician Decision|0
5951728|NCT01258348|20584845|P2|Overall Study|Physician Decision|0
5951729|NCT01258348|20584846|P1|Overall Study|Physician Decision|0
5951730|NCT01258348|20584842|P5|Overall Study|Progressive Disease|2
5951731|NCT01258348|20584843|P4|Overall Study|Progressive Disease|2
5951732|NCT01258348|20584844|P3|Overall Study|Progressive Disease|0
5951733|NCT01258348|20584845|P2|Overall Study|Progressive Disease|3
5951734|NCT01258348|20584846|P1|Overall Study|Progressive Disease|0
5951735|NCT01258348|20584842|P5|Overall Study|Adverse Event|4
5951736|NCT01258348|20584843|P4|Overall Study|Adverse Event|2
5951737|NCT01258348|20584844|P3|Overall Study|Adverse Event|3
5951738|NCT01258348|20584845|P2|Overall Study|Adverse Event|1
5951739|NCT01258348|20584846|P1|Overall Study|Adverse Event|1
5951740|NCT01258101|20584903|P4|Overall Study|Other reason|8
5951741|NCT01258101|20584904|P3|Overall Study|Other reason|1
5951742|NCT01258101|20584905|P2|Overall Study|Other reason|8
5951743|NCT01258101|20584906|P1|Overall Study|Other reason|7
5951744|NCT01258101|20584903|P4|Overall Study|PCR positive at week 24|1
5951745|NCT01258101|20584904|P3|Overall Study|PCR positive at week 24|0
5951746|NCT01258101|20584905|P2|Overall Study|PCR positive at week 24|0
5951747|NCT01258101|20584906|P1|Overall Study|PCR positive at week 24|0
5951748|NCT01258101|20584903|P4|Overall Study|Lost to Follow-up|6
5951749|NCT01258101|20584904|P3|Overall Study|Lost to Follow-up|0
5951750|NCT01258101|20584905|P2|Overall Study|Lost to Follow-up|5
5951751|NCT01258101|20584906|P1|Overall Study|Lost to Follow-up|5
5951752|NCT01258101|20584903|P4|Overall Study|Patient´s compliance|2
5951753|NCT01258101|20584904|P3|Overall Study|Patient´s compliance|1
5951754|NCT01258101|20584905|P2|Overall Study|Patient´s compliance|3
5951755|NCT01258101|20584906|P1|Overall Study|Patient´s compliance|4
5951756|NCT01258101|20584903|P4|Overall Study|Patient is not able to attend visits|6
5951757|NCT01258101|20584904|P3|Overall Study|Patient is not able to attend visits|7
5951758|NCT01258101|20584905|P2|Overall Study|Patient is not able to attend visits|9
5951759|NCT01258101|20584906|P1|Overall Study|Patient is not able to attend visits|8
5951760|NCT01258101|20584903|P4|Overall Study|Informed consent has been withdrawn|1
5951761|NCT01258101|20584904|P3|Overall Study|Informed consent has been withdrawn|1
5951762|NCT01258101|20584905|P2|Overall Study|Informed consent has been withdrawn|2
5951763|NCT01258101|20584906|P1|Overall Study|Informed consent has been withdrawn|2
5951764|NCT01258101|20584903|P4|Overall Study|Extra exclusion criterion amended|1
5951765|NCT01258101|20584904|P3|Overall Study|Extra exclusion criterion amended|1
5951766|NCT01258101|20584905|P2|Overall Study|Extra exclusion criterion amended|1
5951767|NCT01258101|20584906|P1|Overall Study|Extra exclusion criterion amended|2
5951768|NCT01258101|20584903|P4|Overall Study|Adverse Event|0
5951769|NCT01258101|20584904|P3|Overall Study|Adverse Event|0
5951770|NCT01258101|20584905|P2|Overall Study|Adverse Event|6
5951771|NCT01258101|20584906|P1|Overall Study|Adverse Event|5
5951782|NCT01257737|20585045|P2|Overall Study|Withdrew from study|1
5951783|NCT01257737|20585046|P1|Overall Study|Withdrew from study|0
5951784|NCT01257737|20585045|P2|Overall Study|Relocation out of the country|1
5951785|NCT01257737|20585046|P1|Overall Study|Relocation out of the country|0
5951786|NCT01257737|20585045|P2|Overall Study|Liver transplant|0
5951787|NCT01257737|20585046|P1|Overall Study|Liver transplant|1
5951788|NCT01257737|20585045|P2|Overall Study|Lost to Follow-up|2
5951789|NCT01257737|20585046|P1|Overall Study|Lost to Follow-up|1
5951790|NCT01257698|20585066|P2|Overall Study|Protocol Violation|0
5951791|NCT01257698|20585067|P1|Overall Study|Protocol Violation|4
5951792|NCT01257581|20585076|P3|Overall Study|Death|4
5951793|NCT01257581|20585077|P2|Overall Study|Death|2
5951794|NCT01257581|20585078|P1|Overall Study|Death|2
5951795|NCT01257581|20585076|P3|Overall Study|Early Termination|2
5951796|NCT01257581|20585077|P2|Overall Study|Early Termination|1
5951797|NCT01257581|20585078|P1|Overall Study|Early Termination|3
5951798|NCT01257568|20585116|P1|Overall Study|Component Revision|24
5951799|NCT01257568|20585116|P1|Overall Study|Terminated|1
5951800|NCT01257568|20585116|P1|Overall Study|Withdrawal by Subject|6
5951801|NCT01257568|20585116|P1|Overall Study|Lost to Follow-up|2
5951802|NCT01257542|20585130|P2|Overall Study|Withdrawal by Subject|2
5951803|NCT01257542|20585131|P1|Overall Study|Withdrawal by Subject|0
5951804|NCT01257542|20585130|P2|Overall Study|Protocol Violation|5
5951805|NCT01257542|20585131|P1|Overall Study|Protocol Violation|3
5951806|NCT01257503|20585151|P2|Overall Study|strep culture positive at enrollment|0
5951807|NCT01257503|20585152|P1|Overall Study|strep culture positive at enrollment|1
5951808|NCT01257503|20585151|P2|Overall Study|Over 5 years old at enrollment|1
5951809|NCT01257503|20585152|P1|Overall Study|Over 5 years old at enrollment|0
5951810|NCT01257503|20585151|P2|Overall Study|Lost to Follow-up|10
5951811|NCT01257503|20585152|P1|Overall Study|Lost to Follow-up|7
5951812|NCT01257425|20585181|P2|Overall Study|Death|0
5951813|NCT01257425|20585182|P1|Overall Study|Death|1
5951814|NCT01257425|20585181|P2|Overall Study|Withdrawal by Subject|1
5951815|NCT01257425|20585182|P1|Overall Study|Withdrawal by Subject|0
5951816|NCT01257425|20585181|P2|Overall Study|Protocol Violation|1
5951817|NCT01257425|20585182|P1|Overall Study|Protocol Violation|1
5951818|NCT01257425|20585181|P2|Overall Study|Adverse Event|1
5951819|NCT01257425|20585182|P1|Overall Study|Adverse Event|1
5951820|NCT01257425|20585181|P2|Overall Study|Lack of Efficacy|3
5951821|NCT01257425|20585182|P1|Overall Study|Lack of Efficacy|3
5951822|NCT01257230|20585224|P3|Overall Study|Other reason not defined above|3
5951823|NCT01257230|20585225|P2|Overall Study|Other reason not defined above|5
5951824|NCT01257230|20585226|P1|Overall Study|Other reason not defined above|1
5951825|NCT01257230|20585224|P3|Overall Study|Withdrawal by Subject|1
5951826|NCT01257230|20585225|P2|Overall Study|Withdrawal by Subject|4
5951827|NCT01257230|20585226|P1|Overall Study|Withdrawal by Subject|0
5951828|NCT01257230|20585224|P3|Overall Study|Protocol Violation|1
5951829|NCT01257230|20585225|P2|Overall Study|Protocol Violation|0
5951830|NCT01257230|20585226|P1|Overall Study|Protocol Violation|3
5951831|NCT01257230|20585224|P3|Overall Study|Lack of Efficacy|0
5951832|NCT01257230|20585225|P2|Overall Study|Lack of Efficacy|1
5951833|NCT01257230|20585226|P1|Overall Study|Lack of Efficacy|0
5951834|NCT01257230|20585224|P3|Overall Study|Adverse Event|0
5951835|NCT01257230|20585225|P2|Overall Study|Adverse Event|0
5951836|NCT01257230|20585226|P1|Overall Study|Adverse Event|2
5951837|NCT01257230|20585224|P3|Overall Study|Not Treated|1
5951838|NCT01257230|20585225|P2|Overall Study|Not Treated|0
5951839|NCT01257230|20585226|P1|Overall Study|Not Treated|0
5951840|NCT01257204|20585303|P3|Follow-up Period (up to Week 48)|Other|5
5951841|NCT01257204|20585304|P2|Follow-up Period (up to Week 48)|Other|0
5951842|NCT01257204|20585305|P1|Follow-up Period (up to Week 48)|Other|0
5951843|NCT01257204|20585303|P3|Follow-up Period (up to Week 48)|Lost to Follow-up|4
5951844|NCT01257204|20585304|P2|Follow-up Period (up to Week 48)|Lost to Follow-up|4
5951845|NCT01257204|20585305|P1|Follow-up Period (up to Week 48)|Lost to Follow-up|1
5951846|NCT01257204|20585303|P3|Follow-up Period (up to Week 48)|Withdrawal by Subject|1
5951847|NCT01257204|20585304|P2|Follow-up Period (up to Week 48)|Withdrawal by Subject|2
5951848|NCT01257204|20585305|P1|Follow-up Period (up to Week 48)|Withdrawal by Subject|0
5951849|NCT01257204|20585303|P3|Treatment Period (up to Week 24)|Participant's request to discontinue|2
5951850|NCT01257204|20585304|P2|Treatment Period (up to Week 24)|Participant's request to discontinue|2
5951851|NCT01257204|20585305|P1|Treatment Period (up to Week 24)|Participant's request to discontinue|1
5951852|NCT01257204|20585303|P3|Treatment Period (up to Week 24)|Poor compliance/noncompliance|1
5951853|NCT01257204|20585304|P2|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0
5951854|NCT01257204|20585305|P1|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0
5951855|NCT01257204|20585303|P3|Treatment Period (up to Week 24)|Lost to Follow-up|0
5951856|NCT01257204|20585304|P2|Treatment Period (up to Week 24)|Lost to Follow-up|2
5951857|NCT01257204|20585305|P1|Treatment Period (up to Week 24)|Lost to Follow-up|0
5951858|NCT01257204|20585303|P3|Treatment Period (up to Week 24)|Withdrawal by Subject|1
5951859|NCT01257204|20585304|P2|Treatment Period (up to Week 24)|Withdrawal by Subject|0
5951860|NCT01257204|20585305|P1|Treatment Period (up to Week 24)|Withdrawal by Subject|1
5951861|NCT01257204|20585303|P3|Treatment Period (up to Week 24)|Adverse Event|2
5951862|NCT01257204|20585304|P2|Treatment Period (up to Week 24)|Adverse Event|1
5951863|NCT01257204|20585305|P1|Treatment Period (up to Week 24)|Adverse Event|3
5951864|NCT01257204|20585303|P3|Treatment Period (up to Week 24)|Lack of Efficacy|3
5951865|NCT01257204|20585304|P2|Treatment Period (up to Week 24)|Lack of Efficacy|1
5951866|NCT01257204|20585305|P1|Treatment Period (up to Week 24)|Lack of Efficacy|0
5951867|NCT01256879|20585413|P1|Overall Study|Withdrawal by Subject|1
5951868|NCT01256788|20585439|P3|Overall Study|Lost to Follow-up|3
5951869|NCT01256788|20585440|P2|Overall Study|Lost to Follow-up|8
5951870|NCT01256788|20585441|P1|Overall Study|Lost to Follow-up|5
5951871|NCT01256684|20585452|P3|Overall Study|Entry criteria not met/non-compliance|6
5951872|NCT01256684|20585453|P2|Overall Study|Entry criteria not met/non-compliance|7
5951873|NCT01256684|20585454|P1|Overall Study|Entry criteria not met/non-compliance|4
5951874|NCT01256684|20585452|P3|Overall Study|Lack of Efficacy|1
5951875|NCT01256684|20585453|P2|Overall Study|Lack of Efficacy|1
5951876|NCT01256684|20585454|P1|Overall Study|Lack of Efficacy|0
5951877|NCT01256684|20585452|P3|Overall Study|Physician Decision|0
5951878|NCT01256684|20585453|P2|Overall Study|Physician Decision|1
5951879|NCT01256684|20585454|P1|Overall Study|Physician Decision|0
5951880|NCT01256684|20585452|P3|Overall Study|Withdrawal by Subject|2
5951881|NCT01256684|20585453|P2|Overall Study|Withdrawal by Subject|0
5951882|NCT01256684|20585454|P1|Overall Study|Withdrawal by Subject|4
5951883|NCT01256684|20585452|P3|Overall Study|Adverse Event|2
5951884|NCT01256684|20585453|P2|Overall Study|Adverse Event|4
5951885|NCT01256684|20585454|P1|Overall Study|Adverse Event|1
5951886|NCT01256671|20585486|P1|Overall Study|Non-compliance/Sponsor Decision/Other|12
5951887|NCT01256671|20585486|P1|Overall Study|Lack of Efficacy|4
5951888|NCT01256671|20585486|P1|Overall Study|Physician Decision|3
5951889|NCT01256671|20585486|P1|Overall Study|Withdrawal by Subject|31
5951890|NCT01256671|20585486|P1|Overall Study|Lost to Follow-up|16
5951891|NCT01256671|20585486|P1|Overall Study|Adverse Event|29
5951892|NCT01256658|20585499|P2|Period 1|Death|44
5951893|NCT01256658|20585500|P1|Period 1|Death|48
5951894|NCT01256658|20585499|P2|Period 1|Withdrawal by Subject|43
5951895|NCT01256658|20585500|P1|Period 1|Withdrawal by Subject|35
5951896|NCT01256658|20585499|P2|Period 1|Lost to Follow-up|661
5951897|NCT01256658|20585500|P1|Period 1|Lost to Follow-up|837
5951898|NCT01256593|20585550|P1|Overall Study|No Visit After Treatment|186
5951899|NCT01256593|20585550|P1|Overall Study|No Drug Administration Information|2
5951900|NCT01256593|20585550|P1|Overall Study|Protocol Violation|26
5951901|NCT01256567|20585564|P1|Overall Study|Withdrawal by Subject|1
5951902|NCT01256502|20585574|P1|Overall Study|Protocol deviation|1
5951903|NCT01256502|20585574|P1|Overall Study|Personal reasons|5
5951904|NCT01256502|20585574|P1|Overall Study|Had scaffold removed|4
5951905|NCT01256476|20585586|P2|Overall Study|LDL-C elevation exceeding 250 mg/dL|1
5951906|NCT01256476|20585587|P1|Overall Study|LDL-C elevation exceeding 250 mg/dL|0
5951907|NCT01256476|20585586|P2|Overall Study|Subject non-compliance|1
5951908|NCT01256476|20585587|P1|Overall Study|Subject non-compliance|0
5951909|NCT01256476|20585586|P2|Overall Study|Physician Decision|1
5951910|NCT01256476|20585587|P1|Overall Study|Physician Decision|0
5951911|NCT01256476|20585586|P2|Overall Study|Persistent ALT or AST elevation|0
5951912|NCT01256476|20585587|P1|Overall Study|Persistent ALT or AST elevation|1
5951913|NCT01256476|20585586|P2|Overall Study|Lost to Follow-up|2
5951914|NCT01256476|20585587|P1|Overall Study|Lost to Follow-up|1
5951915|NCT01256476|20585586|P2|Overall Study|Withdrawal by Subject|1
5951916|NCT01256476|20585587|P1|Overall Study|Withdrawal by Subject|2
5951917|NCT01256476|20585586|P2|Overall Study|Adverse Event|1
5951918|NCT01256476|20585587|P1|Overall Study|Adverse Event|2
5951919|NCT01256450|20585595|P3|Double-blind Treatment|Other|12
5951920|NCT01256450|20585596|P2|Double-blind Treatment|Other|9
5951921|NCT01256450|20585597|P1|Double-blind Treatment|Other|0
5951922|NCT01256450|20585595|P3|Double-blind Treatment|Opioid withdrawal symptoms|1
5951923|NCT01256450|20585596|P2|Double-blind Treatment|Opioid withdrawal symptoms|0
5951924|NCT01256450|20585597|P1|Double-blind Treatment|Opioid withdrawal symptoms|0
5951925|NCT01256450|20585595|P3|Double-blind Treatment|Non-compliance|4
5951926|NCT01256450|20585596|P2|Double-blind Treatment|Non-compliance|5
5951927|NCT01256450|20585597|P1|Double-blind Treatment|Non-compliance|0
5951928|NCT01256450|20585595|P3|Double-blind Treatment|Lack of analgesic effect|6
5951929|NCT01256450|20585596|P2|Double-blind Treatment|Lack of analgesic effect|5
5951930|NCT01256450|20585597|P1|Double-blind Treatment|Lack of analgesic effect|0
5951931|NCT01256450|20585595|P3|Double-blind Treatment|Withdrawal by Subject|1
5951932|NCT01256450|20585596|P2|Double-blind Treatment|Withdrawal by Subject|0
5951933|NCT01256450|20585597|P1|Double-blind Treatment|Withdrawal by Subject|0
5951934|NCT01256450|20585595|P3|Double-blind Treatment|Lost to Follow-up|7
5951935|NCT01256450|20585596|P2|Double-blind Treatment|Lost to Follow-up|1
5951936|NCT01256450|20585597|P1|Double-blind Treatment|Lost to Follow-up|0
5951937|NCT01256450|20585595|P3|Double-blind Treatment|Adverse Event|6
5951938|NCT01256450|20585596|P2|Double-blind Treatment|Adverse Event|8
5951939|NCT01256450|20585597|P1|Double-blind Treatment|Adverse Event|0
5951940|NCT01256450|20585595|P3|Open-label Titration|Other|0
5951941|NCT01256450|20585596|P2|Open-label Titration|Other|0
5951942|NCT01256450|20585597|P1|Open-label Titration|Other|13
5951943|NCT01256450|20585595|P3|Open-label Titration|Screen failure|0
5951944|NCT01256450|20585596|P2|Open-label Titration|Screen failure|0
5951945|NCT01256450|20585597|P1|Open-label Titration|Screen failure|1
5951946|NCT01256450|20585595|P3|Open-label Titration|Non-compliance|0
5951947|NCT01256450|20585596|P2|Open-label Titration|Non-compliance|0
5951948|NCT01256450|20585597|P1|Open-label Titration|Non-compliance|9
5951949|NCT01256450|20585595|P3|Open-label Titration|Lack of analgesic effect|0
5951950|NCT01256450|20585596|P2|Open-label Titration|Lack of analgesic effect|0
5951951|NCT01256450|20585597|P1|Open-label Titration|Lack of analgesic effect|30
5951952|NCT01256450|20585595|P3|Open-label Titration|Lost to Follow-up|0
5951953|NCT01256450|20585596|P2|Open-label Titration|Lost to Follow-up|0
5951954|NCT01256450|20585597|P1|Open-label Titration|Lost to Follow-up|7
5951955|NCT01256450|20585595|P3|Open-label Titration|Adverse Event|0
5951956|NCT01256450|20585596|P2|Open-label Titration|Adverse Event|0
5951957|NCT01256450|20585597|P1|Open-label Titration|Adverse Event|39
5951958|NCT01256411|20585655|P6|Extension by Mono or Combination Therapy|Lack of Efficacy|1
5951959|NCT01256411|20585656|P5|Extension by Mono or Combination Therapy|Lack of Efficacy|1
5951960|NCT01256411|20585657|P4|Extension by Mono or Combination Therapy|Lack of Efficacy|0
5951961|NCT01256411|20585658|P3|Extension by Mono or Combination Therapy|Lack of Efficacy|0
5951962|NCT01256411|20585659|P2|Extension by Mono or Combination Therapy|Lack of Efficacy|0
5951963|NCT01256411|20585660|P1|Extension by Mono or Combination Therapy|Lack of Efficacy|0
5951964|NCT01256411|20585655|P6|Extension by Mono or Combination Therapy|Withdrawal by Subject|1
5951965|NCT01256411|20585656|P5|Extension by Mono or Combination Therapy|Withdrawal by Subject|7
5951966|NCT01256411|20585657|P4|Extension by Mono or Combination Therapy|Withdrawal by Subject|0
5951967|NCT01256411|20585658|P3|Extension by Mono or Combination Therapy|Withdrawal by Subject|0
5951968|NCT01256411|20585659|P2|Extension by Mono or Combination Therapy|Withdrawal by Subject|0
5952047|NCT01256060|20585810|P2|Overall Study|Lost to Follow-up|1
5951969|NCT01256411|20585660|P1|Extension by Mono or Combination Therapy|Withdrawal by Subject|0
5951970|NCT01256411|20585655|P6|Extension by Mono or Combination Therapy|Lost to Follow-up|0
5951971|NCT01256411|20585656|P5|Extension by Mono or Combination Therapy|Lost to Follow-up|3
5951972|NCT01256411|20585657|P4|Extension by Mono or Combination Therapy|Lost to Follow-up|0
5951973|NCT01256411|20585658|P3|Extension by Mono or Combination Therapy|Lost to Follow-up|0
5951974|NCT01256411|20585659|P2|Extension by Mono or Combination Therapy|Lost to Follow-up|0
5951975|NCT01256411|20585660|P1|Extension by Mono or Combination Therapy|Lost to Follow-up|0
5951976|NCT01256411|20585655|P6|Extension by Mono or Combination Therapy|Protocol deviation|1
5951977|NCT01256411|20585656|P5|Extension by Mono or Combination Therapy|Protocol deviation|0
5951978|NCT01256411|20585657|P4|Extension by Mono or Combination Therapy|Protocol deviation|0
5951979|NCT01256411|20585658|P3|Extension by Mono or Combination Therapy|Protocol deviation|0
5951980|NCT01256411|20585659|P2|Extension by Mono or Combination Therapy|Protocol deviation|0
5951981|NCT01256411|20585660|P1|Extension by Mono or Combination Therapy|Protocol deviation|0
5951982|NCT01256411|20585655|P6|Extension by Mono or Combination Therapy|Adverse Event|1
5951983|NCT01256411|20585656|P5|Extension by Mono or Combination Therapy|Adverse Event|6
5951984|NCT01256411|20585657|P4|Extension by Mono or Combination Therapy|Adverse Event|0
5951985|NCT01256411|20585658|P3|Extension by Mono or Combination Therapy|Adverse Event|0
5951986|NCT01256411|20585659|P2|Extension by Mono or Combination Therapy|Adverse Event|0
5951987|NCT01256411|20585660|P1|Extension by Mono or Combination Therapy|Adverse Event|0
5951988|NCT01256411|20585655|P6|Extension by Maximum Treatment|Adverse Event|0
5951989|NCT01256411|20585656|P5|Extension by Maximum Treatment|Adverse Event|0
5951990|NCT01256411|20585657|P4|Extension by Maximum Treatment|Adverse Event|0
5951991|NCT01256411|20585658|P3|Extension by Maximum Treatment|Adverse Event|1
5951992|NCT01256411|20585659|P2|Extension by Maximum Treatment|Adverse Event|2
5951993|NCT01256411|20585660|P1|Extension by Maximum Treatment|Adverse Event|4
5951994|NCT01256411|20585655|P6|Extension by Maximum Treatment|Lack of Efficacy|0
5951995|NCT01256411|20585656|P5|Extension by Maximum Treatment|Lack of Efficacy|0
5951996|NCT01256411|20585657|P4|Extension by Maximum Treatment|Lack of Efficacy|0
5951997|NCT01256411|20585658|P3|Extension by Maximum Treatment|Lack of Efficacy|1
5951998|NCT01256411|20585659|P2|Extension by Maximum Treatment|Lack of Efficacy|0
5951999|NCT01256411|20585660|P1|Extension by Maximum Treatment|Lack of Efficacy|1
5952000|NCT01256411|20585655|P6|Extension by Maximum Treatment|Withdrawal by Subject|0
5952001|NCT01256411|20585656|P5|Extension by Maximum Treatment|Withdrawal by Subject|0
5952002|NCT01256411|20585657|P4|Extension by Maximum Treatment|Withdrawal by Subject|0
5952003|NCT01256411|20585658|P3|Extension by Maximum Treatment|Withdrawal by Subject|1
5952004|NCT01256411|20585659|P2|Extension by Maximum Treatment|Withdrawal by Subject|6
5952005|NCT01256411|20585660|P1|Extension by Maximum Treatment|Withdrawal by Subject|1
5952006|NCT01256411|20585655|P6|Extension by Maximum Treatment|Lost to Follow-up|0
5952007|NCT01256411|20585656|P5|Extension by Maximum Treatment|Lost to Follow-up|0
5952008|NCT01256411|20585657|P4|Extension by Maximum Treatment|Lost to Follow-up|0
5952009|NCT01256411|20585658|P3|Extension by Maximum Treatment|Lost to Follow-up|0
5952010|NCT01256411|20585659|P2|Extension by Maximum Treatment|Lost to Follow-up|2
5952011|NCT01256411|20585660|P1|Extension by Maximum Treatment|Lost to Follow-up|1
5952012|NCT01256411|20585655|P6|Extension by Maximum Treatment|Protocol deviation|0
5952013|NCT01256411|20585656|P5|Extension by Maximum Treatment|Protocol deviation|0
5952014|NCT01256411|20585657|P4|Extension by Maximum Treatment|Protocol deviation|0
5952015|NCT01256411|20585658|P3|Extension by Maximum Treatment|Protocol deviation|1
5952016|NCT01256411|20585659|P2|Extension by Maximum Treatment|Protocol deviation|0
5952017|NCT01256411|20585660|P1|Extension by Maximum Treatment|Protocol deviation|0
5952018|NCT01256398|20585684|P1|Overall Study|Withdrawal by Subject|1
5952019|NCT01256385|20585690|P2|Overall Study|Withdrawal by Subject|2
5952020|NCT01256385|20585691|P1|Overall Study|Withdrawal by Subject|2
5952021|NCT01256385|20585690|P2|Overall Study|Physician Decision|1
5952022|NCT01256385|20585691|P1|Overall Study|Physician Decision|1
5952023|NCT01256294|20585711|P2|Overall Study|Protocol deviation|1
5952024|NCT01256294|20585712|P1|Overall Study|Protocol deviation|2
5952025|NCT01256294|20585711|P2|Overall Study|Withdrawal by Subject|1
5952026|NCT01256294|20585712|P1|Overall Study|Withdrawal by Subject|1
5952027|NCT01256294|20585711|P2|Overall Study|Adverse Event|0
5952028|NCT01256294|20585712|P1|Overall Study|Adverse Event|1
5952029|NCT01256190|20585734|P2|Overall Study|Lost to Follow-up|0
5952030|NCT01256190|20585735|P1|Overall Study|Lost to Follow-up|2
5952031|NCT01256177|20585751|P2|Overall Study|TG=593mg/dL, not fit to participate.|0
5952032|NCT01256177|20585752|P1|Overall Study|TG=593mg/dL, not fit to participate.|1
5952033|NCT01256177|20585751|P2|Overall Study|Lack of Efficacy|2
5952034|NCT01256177|20585752|P1|Overall Study|Lack of Efficacy|11
5952035|NCT01256177|20585751|P2|Overall Study|Condition under Investigation Worsened|0
5952036|NCT01256177|20585752|P1|Overall Study|Condition under Investigation Worsened|1
5952037|NCT01256177|20585751|P2|Overall Study|Severe Non-Compliance to Protocol|2
5952038|NCT01256177|20585752|P1|Overall Study|Severe Non-Compliance to Protocol|4
5952039|NCT01256177|20585751|P2|Overall Study|Adverse Event|9
5952040|NCT01256177|20585752|P1|Overall Study|Adverse Event|8
5952041|NCT01256177|20585751|P2|Overall Study|Lost to Follow-up|2
5952042|NCT01256177|20585752|P1|Overall Study|Lost to Follow-up|2
5952043|NCT01256177|20585751|P2|Overall Study|Withdrawal by Subject|22
5952044|NCT01256177|20585752|P1|Overall Study|Withdrawal by Subject|23
5952045|NCT01256060|20585808|P4|Overall Study|Lost to Follow-up|0
5952046|NCT01256060|20585809|P3|Overall Study|Lost to Follow-up|0
5952048|NCT01256060|20585811|P1|Overall Study|Lost to Follow-up|0
5952049|NCT01256008|20585830|P3|Overall Study|Withdrawal by Subject|10
5952050|NCT01256008|20585831|P2|Overall Study|Withdrawal by Subject|3
5952051|NCT01256008|20585832|P1|Overall Study|Withdrawal by Subject|2
5952052|NCT01256008|20585830|P3|Overall Study|Lost to Follow-up|11
5952053|NCT01256008|20585831|P2|Overall Study|Lost to Follow-up|4
5952054|NCT01256008|20585832|P1|Overall Study|Lost to Follow-up|6
5952055|NCT01255904|20585854|P2|Overall Study|Physician Decision|4
5952056|NCT01255904|20585855|P1|Overall Study|Physician Decision|1
5952057|NCT01255787|20585894|P4|Overall Study|Noncompliance with Study Drug|0
5952058|NCT01255787|20585895|P3|Overall Study|Noncompliance with Study Drug|0
5952059|NCT01255787|20585896|P2|Overall Study|Noncompliance with Study Drug|1
5952060|NCT01255787|20585897|P1|Overall Study|Noncompliance with Study Drug|3
5952061|NCT01255787|20585894|P4|Overall Study|Lack of Efficacy|2
5952062|NCT01255787|20585895|P3|Overall Study|Lack of Efficacy|2
5952063|NCT01255787|20585896|P2|Overall Study|Lack of Efficacy|2
5952064|NCT01255787|20585897|P1|Overall Study|Lack of Efficacy|2
5952065|NCT01255787|20585894|P4|Overall Study|Pregnancy|1
5952066|NCT01255787|20585895|P3|Overall Study|Pregnancy|0
5952067|NCT01255787|20585896|P2|Overall Study|Pregnancy|0
5952068|NCT01255787|20585897|P1|Overall Study|Pregnancy|0
5952069|NCT01255787|20585894|P4|Overall Study|Withdrawal of Consent|4
5952070|NCT01255787|20585895|P3|Overall Study|Withdrawal of Consent|3
5952071|NCT01255787|20585896|P2|Overall Study|Withdrawal of Consent|9
5952072|NCT01255787|20585897|P1|Overall Study|Withdrawal of Consent|3
5952073|NCT01255787|20585894|P4|Overall Study|Lost to Follow-up|2
5952074|NCT01255787|20585895|P3|Overall Study|Lost to Follow-up|4
5952075|NCT01255787|20585896|P2|Overall Study|Lost to Follow-up|2
5952076|NCT01255787|20585897|P1|Overall Study|Lost to Follow-up|1
5952077|NCT01255787|20585894|P4|Overall Study|Major Protocol Deviation|4
5952078|NCT01255787|20585895|P3|Overall Study|Major Protocol Deviation|0
5952079|NCT01255787|20585896|P2|Overall Study|Major Protocol Deviation|1
5952080|NCT01255787|20585897|P1|Overall Study|Major Protocol Deviation|1
5952081|NCT01255787|20585894|P4|Overall Study|Pretreatment Event or Adverse Event (AE)|9
5952082|NCT01255787|20585895|P3|Overall Study|Pretreatment Event or Adverse Event (AE)|9
5952083|NCT01255787|20585896|P2|Overall Study|Pretreatment Event or Adverse Event (AE)|2
5952084|NCT01255787|20585897|P1|Overall Study|Pretreatment Event or Adverse Event (AE)|6
5952085|NCT01255761|20585925|P2|Overall Study|Other Reasons|18
5952086|NCT01255761|20585926|P1|Overall Study|Other Reasons|37
5952087|NCT01255761|20585925|P2|Overall Study|Withdrawal by Subject|27
5952088|NCT01255761|20585926|P1|Overall Study|Withdrawal by Subject|11
5952089|NCT01255761|20585925|P2|Overall Study|Lost to Follow-up|8
5952090|NCT01255761|20585926|P1|Overall Study|Lost to Follow-up|10
5952091|NCT01255761|20585925|P2|Overall Study|Protocol Violation|5
5952092|NCT01255761|20585926|P1|Overall Study|Protocol Violation|9
5952093|NCT01255761|20585925|P2|Overall Study|Lack of Efficacy|74
5952094|NCT01255761|20585926|P1|Overall Study|Lack of Efficacy|86
5952095|NCT01255761|20585925|P2|Overall Study|Adverse Event|43
5952096|NCT01255761|20585926|P1|Overall Study|Adverse Event|29
5952097|NCT01255722|20586011|P3|Overall Study|beta-blocker contraindicated|0
5952098|NCT01255722|20586012|P2|Overall Study|beta-blocker contraindicated|0
5952099|NCT01255722|20586013|P1|Overall Study|beta-blocker contraindicated|2
5952100|NCT01255722|20586011|P3|Overall Study|asymptomatic patient|0
5952101|NCT01255722|20586012|P2|Overall Study|asymptomatic patient|0
5952102|NCT01255722|20586013|P1|Overall Study|asymptomatic patient|1
5952103|NCT01255722|20586011|P3|Overall Study|Adverse Event|1
5952104|NCT01255722|20586012|P2|Overall Study|Adverse Event|1
5952105|NCT01255722|20586013|P1|Overall Study|Adverse Event|0
5952106|NCT01255631|20586038|P2|Overall Study|poor enrollment, no data analyzed|6
5952107|NCT01255631|20586039|P1|Overall Study|poor enrollment, no data analyzed|9
5952108|NCT01255592|20586057|P2|Overall Study|Other|1
5952109|NCT01255592|20586058|P1|Overall Study|Other|0
5952110|NCT01255592|20586057|P2|Overall Study|Withdrawal by Subject|0
5952111|NCT01255592|20586058|P1|Overall Study|Withdrawal by Subject|1
5952112|NCT01255592|20586057|P2|Overall Study|Adverse Event|0
5952113|NCT01255592|20586058|P1|Overall Study|Adverse Event|5
5952114|NCT01255436|20586121|P2|Overall Study|Death, stroke, or MI|3
5952115|NCT01255436|20586122|P1|Overall Study|Death, stroke, or MI|4
5952116|NCT01255436|20586121|P2|Overall Study|Lost to Follow-up|191
5952117|NCT01255436|20586122|P1|Overall Study|Lost to Follow-up|178
5952118|NCT01255423|20586136|P2|Overall Study|Use of prohibited medications|1
5952119|NCT01255423|20586137|P1|Overall Study|Use of prohibited medications|0
5952120|NCT01255423|20586136|P2|Overall Study|Abnormal Laboratory value|2
5952121|NCT01255423|20586137|P1|Overall Study|Abnormal Laboratory value|3
5952122|NCT01255306|20586153|P2|Overall Study|Physician Decision|1
5952123|NCT01255306|20586154|P1|Overall Study|Physician Decision|1
5952124|NCT01255163|20586165|P2|Overall Study|AstraZeneca stopped support of the study|3
5952125|NCT01255163|20586166|P1|Overall Study|AstraZeneca stopped support of the study|1
5952126|NCT01255163|20586165|P2|Overall Study|Adverse Event|2
5952127|NCT01255163|20586166|P1|Overall Study|Adverse Event|0
5952128|NCT01255163|20586165|P2|Overall Study|Lost to Follow-up|0
5952129|NCT01255163|20586166|P1|Overall Study|Lost to Follow-up|2
5952130|NCT01255163|20586165|P2|Overall Study|Withdrawal by Subject|0
5952131|NCT01255163|20586166|P1|Overall Study|Withdrawal by Subject|1
5952132|NCT01254890|20586195|P2|Overall Study|Disease Progression|5
5952133|NCT01254890|20586196|P1|Overall Study|Disease Progression|0
5952134|NCT01254890|20586195|P2|Overall Study|Withdrawal by Subject|2
5952135|NCT01254890|20586196|P1|Overall Study|Withdrawal by Subject|1
5952136|NCT01254890|20586195|P2|Overall Study|Ineligible|3
5952137|NCT01254890|20586196|P1|Overall Study|Ineligible|0
5952138|NCT01254747|20586258|P4|Overall Study|Discomfort|0
5952139|NCT01254747|20586259|P3|Overall Study|Discomfort|0
5952140|NCT01254747|20586260|P2|Overall Study|Discomfort|4
5952141|NCT01254747|20586261|P1|Overall Study|Discomfort|0
5952142|NCT01254747|20586258|P4|Overall Study|Biomicroscopy|0
5952143|NCT01254747|20586259|P3|Overall Study|Biomicroscopy|1
5952144|NCT01254747|20586260|P2|Overall Study|Biomicroscopy|0
5952145|NCT01254747|20586261|P1|Overall Study|Biomicroscopy|0
5952146|NCT01254747|20586258|P4|Overall Study|Lost to Follow-up|0
5952147|NCT01254747|20586259|P3|Overall Study|Lost to Follow-up|1
5952148|NCT01254747|20586260|P2|Overall Study|Lost to Follow-up|0
5952149|NCT01254747|20586261|P1|Overall Study|Lost to Follow-up|0
5952150|NCT01254747|20586258|P4|Overall Study|Symptoms and problems|0
5952151|NCT01254747|20586259|P3|Overall Study|Symptoms and problems|1
5952152|NCT01254747|20586260|P2|Overall Study|Symptoms and problems|2
5952153|NCT01254747|20586261|P1|Overall Study|Symptoms and problems|0
5952154|NCT01254747|20586258|P4|Overall Study|Difficult removal handling|0
5952155|NCT01254747|20586259|P3|Overall Study|Difficult removal handling|1
5952156|NCT01254747|20586260|P2|Overall Study|Difficult removal handling|0
5952157|NCT01254747|20586261|P1|Overall Study|Difficult removal handling|0
5952158|NCT01254747|20586258|P4|Overall Study|Unacceptable subjective vision|2
5952159|NCT01254747|20586259|P3|Overall Study|Unacceptable subjective vision|0
5952160|NCT01254747|20586260|P2|Overall Study|Unacceptable subjective vision|0
5952161|NCT01254747|20586261|P1|Overall Study|Unacceptable subjective vision|0
5952162|NCT01254721|20586301|P2|Overall Study|Wrongly randomization|1
5952163|NCT01254721|20586302|P1|Overall Study|Wrongly randomization|0
5952164|NCT01254721|20586301|P2|Overall Study|Withdrawal by Subject|11
5952165|NCT01254721|20586302|P1|Overall Study|Withdrawal by Subject|8
5952166|NCT01254721|20586301|P2|Overall Study|Adverse Event|3
5952167|NCT01254721|20586302|P1|Overall Study|Adverse Event|2
5952168|NCT01254721|20586301|P2|Overall Study|technical problum|0
5952169|NCT01254721|20586302|P1|Overall Study|technical problum|1
5952170|NCT01254721|20586301|P2|Overall Study|Death|1
5952171|NCT01254721|20586302|P1|Overall Study|Death|0
5952172|NCT01254721|20586301|P2|Overall Study|Lack of Efficacy|2
5952173|NCT01254721|20586302|P1|Overall Study|Lack of Efficacy|4
5952174|NCT01254721|20586301|P2|Overall Study|Lost to Follow-up|4
5952175|NCT01254721|20586302|P1|Overall Study|Lost to Follow-up|0
5952176|NCT01254669|20586312|P2|Overall Study|called to clinic during intervention|1
5952177|NCT01254669|20586313|P1|Overall Study|called to clinic during intervention|1
5952178|NCT01254669|20586312|P2|Overall Study|time constraint|2
5952179|NCT01254669|20586313|P1|Overall Study|time constraint|2
5952180|NCT01254669|20586312|P2|Overall Study|Withdrawal by Subject|1
5952181|NCT01254669|20586313|P1|Overall Study|Withdrawal by Subject|0
5952182|NCT01254656|20586324|P3|Overall Study|Death|0
5952183|NCT01254656|20586325|P2|Overall Study|Death|1
5952184|NCT01254656|20586326|P1|Overall Study|Death|0
5952185|NCT01254656|20586324|P3|Overall Study|Adverse Event|0
5952186|NCT01254656|20586325|P2|Overall Study|Adverse Event|1
5952187|NCT01254656|20586326|P1|Overall Study|Adverse Event|1
5952188|NCT01254656|20586324|P3|Overall Study|Pregnancy|2
5952189|NCT01254656|20586325|P2|Overall Study|Pregnancy|0
5952190|NCT01254656|20586326|P1|Overall Study|Pregnancy|0
5952191|NCT01254656|20586324|P3|Overall Study|Withdrawal by Subject|1
5952192|NCT01254656|20586325|P2|Overall Study|Withdrawal by Subject|2
5952193|NCT01254656|20586326|P1|Overall Study|Withdrawal by Subject|2
5952194|NCT01254656|20586324|P3|Overall Study|Lost to Follow-up|2
5952195|NCT01254656|20586325|P2|Overall Study|Lost to Follow-up|0
5952196|NCT01254656|20586326|P1|Overall Study|Lost to Follow-up|1
5952197|NCT01254656|20586324|P3|Overall Study|Lack of Efficacy|0
5952198|NCT01254656|20586325|P2|Overall Study|Lack of Efficacy|0
5952199|NCT01254656|20586326|P1|Overall Study|Lack of Efficacy|3
5952200|NCT01254656|20586324|P3|Overall Study|Discontinued due to termination of study|13
5952201|NCT01254656|20586325|P2|Overall Study|Discontinued due to termination of study|39
5952202|NCT01254656|20586326|P1|Overall Study|Discontinued due to termination of study|40
5952203|NCT01254643|20586352|P1|Overall Study|Withdrawal by Subject|1
5952204|NCT01254630|20586364|P4|Overall Study|Status not recorded|0
5952205|NCT01254630|20586365|P3|Overall Study|Status not recorded|1
5952206|NCT01254630|20586366|P2|Overall Study|Status not recorded|0
5952207|NCT01254630|20586367|P1|Overall Study|Status not recorded|0
5952208|NCT01254630|20586364|P4|Overall Study|Study terminated by sponsor|1010
5952209|NCT01254630|20586365|P3|Overall Study|Study terminated by sponsor|0
5952210|NCT01254630|20586366|P2|Overall Study|Study terminated by sponsor|994
5952211|NCT01254630|20586367|P1|Overall Study|Study terminated by sponsor|0
5952212|NCT01254630|20586364|P4|Overall Study|Withdrawal by Subject|89
5952213|NCT01254630|20586365|P3|Overall Study|Withdrawal by Subject|188
5952214|NCT01254630|20586366|P2|Overall Study|Withdrawal by Subject|94
5952215|NCT01254630|20586367|P1|Overall Study|Withdrawal by Subject|201
5952216|NCT01254630|20586364|P4|Overall Study|Physician Decision|7
5952217|NCT01254630|20586365|P3|Overall Study|Physician Decision|16
5952218|NCT01254630|20586366|P2|Overall Study|Physician Decision|8
5952219|NCT01254630|20586367|P1|Overall Study|Physician Decision|24
5952220|NCT01254630|20586364|P4|Overall Study|Lost to Follow-up|32
5952221|NCT01254630|20586365|P3|Overall Study|Lost to Follow-up|89
5952222|NCT01254630|20586366|P2|Overall Study|Lost to Follow-up|26
5952223|NCT01254630|20586367|P1|Overall Study|Lost to Follow-up|80
5952224|NCT01254630|20586364|P4|Overall Study|Death|139
5952225|NCT01254630|20586365|P3|Overall Study|Death|478
5952226|NCT01254630|20586366|P2|Overall Study|Death|151
5952227|NCT01254630|20586367|P1|Overall Study|Death|461
5952228|NCT01254630|20586364|P4|Overall Study|Adverse Event|8
5952229|NCT01254630|20586365|P3|Overall Study|Adverse Event|40
5952230|NCT01254630|20586366|P2|Overall Study|Adverse Event|15
5952231|NCT01254630|20586367|P1|Overall Study|Adverse Event|36
5952232|NCT01254604|20586387|P2|Overall Study|Adverse Event|2
5952233|NCT01254604|20586388|P1|Overall Study|Adverse Event|3
5952234|NCT01254604|20586387|P2|Overall Study|Withdrawal by Subject|4
5952235|NCT01254604|20586388|P1|Overall Study|Withdrawal by Subject|2
5952236|NCT01254604|20586387|P2|Overall Study|Protocol Violation|2
5952237|NCT01254604|20586388|P1|Overall Study|Protocol Violation|2
5952238|NCT01254604|20586387|P2|Overall Study|Lost to Follow-up|1
5952239|NCT01254604|20586388|P1|Overall Study|Lost to Follow-up|1
5952240|NCT01254565|20586406|P6|Overall Study|Other|0
5952241|NCT01254565|20586407|P5|Overall Study|Other|0
5952242|NCT01254565|20586408|P4|Overall Study|Other|1
5952243|NCT01254565|20586409|P3|Overall Study|Other|0
5952244|NCT01254565|20586410|P2|Overall Study|Other|0
5952245|NCT01254565|20586411|P1|Overall Study|Other|0
5952246|NCT01254565|20586406|P6|Overall Study|Did not Receive Treatment|4
5952247|NCT01254565|20586407|P5|Overall Study|Did not Receive Treatment|3
5952248|NCT01254565|20586408|P4|Overall Study|Did not Receive Treatment|0
5952249|NCT01254565|20586409|P3|Overall Study|Did not Receive Treatment|0
5952250|NCT01254565|20586410|P2|Overall Study|Did not Receive Treatment|1
5952251|NCT01254565|20586411|P1|Overall Study|Did not Receive Treatment|1
5952252|NCT01254565|20586406|P6|Overall Study|Non-compliance to Study Procedures|0
5952253|NCT01254565|20586407|P5|Overall Study|Non-compliance to Study Procedures|1
5952254|NCT01254565|20586408|P4|Overall Study|Non-compliance to Study Procedures|0
5952255|NCT01254565|20586409|P3|Overall Study|Non-compliance to Study Procedures|0
5952256|NCT01254565|20586410|P2|Overall Study|Non-compliance to Study Procedures|0
5952257|NCT01254565|20586411|P1|Overall Study|Non-compliance to Study Procedures|0
5952258|NCT01254422|20586471|P2|Overall Study|Lost to Follow-up|0
5952259|NCT01254422|20586472|P1|Overall Study|Lost to Follow-up|1
5952260|NCT01254422|20586471|P2|Overall Study|Serious adverse event|1
5952261|NCT01254422|20586472|P1|Overall Study|Serious adverse event|0
5952262|NCT01254422|20586471|P2|Overall Study|Adverse Event|0
5952263|NCT01254422|20586472|P1|Overall Study|Adverse Event|1
5952264|NCT01254422|20586471|P2|Overall Study|Protocol Violation|0
5952265|NCT01254422|20586472|P1|Overall Study|Protocol Violation|1
5952270|NCT01254344|20586572|P2|Overall Study|Withdrawal by Subject|6
5952271|NCT01254344|20586573|P1|Overall Study|Withdrawal by Subject|3
5952272|NCT01254344|20586572|P2|Overall Study|Protocol Violation|4
5952273|NCT01254344|20586573|P1|Overall Study|Protocol Violation|1
5952274|NCT01254344|20586572|P2|Overall Study|Physician Decision|4
5952275|NCT01254344|20586573|P1|Overall Study|Physician Decision|7
5952276|NCT01254344|20586572|P2|Overall Study|Adverse Event|5
5952277|NCT01254344|20586573|P1|Overall Study|Adverse Event|2
5952278|NCT01254331|20586581|P1|Extension Phase|Lost to Follow-up|3
5952279|NCT01254331|20586581|P1|Extension Phase|Lack of Efficacy|1
5952280|NCT01254331|20586581|P1|Initial Phase|Pregnancy|1
5952281|NCT01254331|20586581|P1|Initial Phase|Withdrawal by Subject|1
5952282|NCT01254331|20586581|P1|Initial Phase|Adverse Event|3
5952283|NCT01254318|20586599|P1|Overall Study|Death|47
5952284|NCT01254318|20586599|P1|Overall Study|Lost to Follow-up|5
5952285|NCT01254305|20586608|P3|Overall Study|Other Reasons|2
5952286|NCT01254305|20586609|P2|Overall Study|Other Reasons|0
5952287|NCT01254305|20586610|P1|Overall Study|Other Reasons|0
5952288|NCT01254305|20586608|P3|Overall Study|Lost to Follow-up|5
5952289|NCT01254305|20586609|P2|Overall Study|Lost to Follow-up|6
5952290|NCT01254305|20586610|P1|Overall Study|Lost to Follow-up|10
5952291|NCT01254305|20586608|P3|Overall Study|Withdrawal by Subject|4
5952292|NCT01254305|20586609|P2|Overall Study|Withdrawal by Subject|2
5952293|NCT01254305|20586610|P1|Overall Study|Withdrawal by Subject|4
5952294|NCT01254305|20586608|P3|Overall Study|Protocol Violation|3
5952295|NCT01254305|20586609|P2|Overall Study|Protocol Violation|7
5952296|NCT01254305|20586610|P1|Overall Study|Protocol Violation|1
5952297|NCT01254305|20586608|P3|Overall Study|Lack of Efficacy|1
5952298|NCT01254305|20586609|P2|Overall Study|Lack of Efficacy|0
5952299|NCT01254305|20586610|P1|Overall Study|Lack of Efficacy|1
5952300|NCT01254305|20586608|P3|Overall Study|Adverse Event|2
5952301|NCT01254305|20586609|P2|Overall Study|Adverse Event|3
5952302|NCT01254305|20586610|P1|Overall Study|Adverse Event|6
5952303|NCT01254292|20586626|P2|LCS12 Extension Phase|Lost to Follow-up|0
5952304|NCT01254292|20586627|P1|LCS12 Extension Phase|Lost to Follow-up|1
5952305|NCT01254292|20586626|P2|LCS12 Extension Phase|Pregnancy|0
5952306|NCT01254292|20586627|P1|LCS12 Extension Phase|Pregnancy|2
5952307|NCT01254292|20586626|P2|LCS12 Extension Phase|Other unknown|0
5952308|NCT01254292|20586627|P1|LCS12 Extension Phase|Other unknown|4
5952309|NCT01254292|20586626|P2|LCS12 Extension Phase|Withdrawal by Subject|0
5952310|NCT01254292|20586627|P1|LCS12 Extension Phase|Withdrawal by Subject|7
5952311|NCT01254292|20586626|P2|LCS12 Extension Phase|Adverse Event|0
5952312|NCT01254292|20586627|P1|LCS12 Extension Phase|Adverse Event|9
5952313|NCT01254292|20586626|P2|LCS12 Extension Phase|Wish for pregnancy|0
5952314|NCT01254292|20586627|P1|LCS12 Extension Phase|Wish for pregnancy|14
5952315|NCT01254292|20586626|P2|Comparative Phase|Wish for pregnancy|6
5952316|NCT01254292|20586627|P1|Comparative Phase|Wish for pregnancy|4
5952317|NCT01254292|20586626|P2|Comparative Phase|Protocol Violation|2
5952318|NCT01254292|20586627|P1|Comparative Phase|Protocol Violation|1
5952319|NCT01254292|20586626|P2|Comparative Phase|Withdrawal by Subject|21
5952320|NCT01254292|20586627|P1|Comparative Phase|Withdrawal by Subject|20
5952321|NCT01254292|20586626|P2|Comparative Phase|Pregnancy|6
5952322|NCT01254292|20586627|P1|Comparative Phase|Pregnancy|2
5952323|NCT01254292|20586626|P2|Comparative Phase|Lost to Follow-up|21
5952324|NCT01254292|20586627|P1|Comparative Phase|Lost to Follow-up|3
5952325|NCT01254292|20586626|P2|Comparative Phase|Adverse Event|25
5952326|NCT01254292|20586627|P1|Comparative Phase|Adverse Event|25
5952327|NCT01254188|20586704|P1|Overall Study|per investigator discretion|20
5952328|NCT01254188|20586704|P1|Overall Study|Adverse Event|43
5952329|NCT01254188|20586704|P1|Overall Study|Withdrawal by Subject|7
5952330|NCT01254188|20586704|P1|Overall Study|Lost to Follow-up|5
5952331|NCT01254188|20586704|P1|Overall Study|Death|4
5952332|NCT01254188|20586704|P1|Overall Study|Pregnancy|2
5952333|NCT01254188|20586704|P1|Overall Study|Protocol Violation|6
5952334|NCT01254188|20586704|P1|Overall Study|Disease Progression|6
5952335|NCT01254045|20586715|P6|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0
5952336|NCT01254045|20586716|P5|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0
5952337|NCT01254045|20586717|P4|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0
5952338|NCT01254045|20586718|P3|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0
5952339|NCT01254045|20586719|P2|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0
5952340|NCT01254045|20586720|P1|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|1
5952341|NCT01254019|20586733|P2|Overall Study|Withdrawal by Subject|2
5952342|NCT01254019|20586734|P1|Overall Study|Withdrawal by Subject|0
5952343|NCT01254019|20586733|P2|Overall Study|Protocol Violation|0
5952344|NCT01254019|20586734|P1|Overall Study|Protocol Violation|1
5952345|NCT01254019|20586733|P2|Overall Study|Adverse Event|2
5952346|NCT01254019|20586734|P1|Overall Study|Adverse Event|0
5952347|NCT01253811|20586828|P1|Overall Study|Withdrawal criteria|1
5952348|NCT01253577|20586859|P1|Overall Study|Lost to Follow-up|3
5952349|NCT01253564|20586867|P1|Overall Study|Serious Adverse Event|1
5952350|NCT01253564|20586867|P1|Overall Study|Withdrawal by Subject|1
5952351|NCT01253564|20586867|P1|Overall Study|Disease Progression|22
5952352|NCT01253447|20586916|P1|Overall Study|Adverse Event|2
5952353|NCT01253421|20586926|P5|Drug+Scanning Visit|Physician Decision|1
5952354|NCT01253421|20586927|P4|Drug+Scanning Visit|Physician Decision|0
5952355|NCT01253421|20586928|P3|Drug+Scanning Visit|Physician Decision|0
5952356|NCT01253421|20586929|P2|Drug+Scanning Visit|Physician Decision|0
5952357|NCT01253421|20586930|P1|Drug+Scanning Visit|Physician Decision|0
5952358|NCT01253421|20586926|P5|Assessment and Scheduling|Physician Decision|0
5952359|NCT01253421|20586927|P4|Assessment and Scheduling|Physician Decision|0
5952360|NCT01253421|20586928|P3|Assessment and Scheduling|Physician Decision|0
5952361|NCT01253421|20586929|P2|Assessment and Scheduling|Physician Decision|0
5952362|NCT01253421|20586930|P1|Assessment and Scheduling|Physician Decision|1
5952363|NCT01253421|20586926|P5|Assessment and Scheduling|Withdrawal by Subject|0
5952364|NCT01253421|20586927|P4|Assessment and Scheduling|Withdrawal by Subject|0
5952365|NCT01253421|20586928|P3|Assessment and Scheduling|Withdrawal by Subject|0
5952366|NCT01253421|20586929|P2|Assessment and Scheduling|Withdrawal by Subject|0
5952367|NCT01253421|20586930|P1|Assessment and Scheduling|Withdrawal by Subject|7
5952368|NCT01253421|20586926|P5|Assessment and Scheduling|Lost to Follow-up|0
5952369|NCT01253421|20586927|P4|Assessment and Scheduling|Lost to Follow-up|0
5952370|NCT01253421|20586928|P3|Assessment and Scheduling|Lost to Follow-up|0
5952371|NCT01253421|20586929|P2|Assessment and Scheduling|Lost to Follow-up|0
5952372|NCT01253421|20586930|P1|Assessment and Scheduling|Lost to Follow-up|17
5952373|NCT01253421|20586926|P5|Assessment and Scheduling|Found to be Ineligible|0
5952374|NCT01253421|20586927|P4|Assessment and Scheduling|Found to be Ineligible|0
5952375|NCT01253421|20586928|P3|Assessment and Scheduling|Found to be Ineligible|0
5952376|NCT01253421|20586929|P2|Assessment and Scheduling|Found to be Ineligible|0
5952377|NCT01253421|20586930|P1|Assessment and Scheduling|Found to be Ineligible|74
5952378|NCT01253408|20586979|P3|Overall Study|Adverse Event|0
5952379|NCT01253408|20586980|P2|Overall Study|Adverse Event|1
5952380|NCT01253408|20586981|P1|Overall Study|Adverse Event|0
5952381|NCT01253369|20587004|P1|Overall Study|Not Evaluable|3
5952382|NCT01253369|20587004|P1|Overall Study|Progressive disease|23
5952383|NCT01253369|20587004|P1|Overall Study|Death|1
5952384|NCT01253369|20587004|P1|Overall Study|Withdrawal by Subject|2
5952385|NCT01253369|20587004|P1|Overall Study|Adverse Event|4
5952386|NCT01253317|20587034|P1|Overall Study|Adverse Event|2
5952387|NCT01253304|20587046|P4|Overall Study|Adverse Event|1
5952388|NCT01253304|20587047|P3|Overall Study|Adverse Event|0
5952389|NCT01253304|20587048|P2|Overall Study|Adverse Event|0
5952390|NCT01253304|20587049|P1|Overall Study|Adverse Event|0
5952391|NCT01253291|20587088|P5|Overall Study|Physician Decision|2
5952392|NCT01253291|20587089|P4|Overall Study|Physician Decision|0
5952393|NCT01253291|20587090|P3|Overall Study|Physician Decision|0
5952394|NCT01253291|20587091|P2|Overall Study|Physician Decision|0
5952395|NCT01253291|20587092|P1|Overall Study|Physician Decision|2
5952396|NCT01253291|20587088|P5|Overall Study|Lack of Efficacy|0
5952397|NCT01253291|20587089|P4|Overall Study|Lack of Efficacy|0
5952398|NCT01253291|20587090|P3|Overall Study|Lack of Efficacy|0
5952399|NCT01253291|20587091|P2|Overall Study|Lack of Efficacy|0
5952400|NCT01253291|20587092|P1|Overall Study|Lack of Efficacy|1
5952401|NCT01253291|20587088|P5|Overall Study|Adverse Event|0
5952402|NCT01253291|20587089|P4|Overall Study|Adverse Event|0
5952403|NCT01253291|20587090|P3|Overall Study|Adverse Event|0
5952404|NCT01253291|20587091|P2|Overall Study|Adverse Event|1
5952405|NCT01253291|20587092|P1|Overall Study|Adverse Event|0
5952406|NCT01253291|20587088|P5|Overall Study|Withdrawal by Subject|0
5952407|NCT01253291|20587089|P4|Overall Study|Withdrawal by Subject|0
5952408|NCT01253291|20587090|P3|Overall Study|Withdrawal by Subject|0
5952409|NCT01253291|20587091|P2|Overall Study|Withdrawal by Subject|1
5952410|NCT01253291|20587092|P1|Overall Study|Withdrawal by Subject|1
5952411|NCT01253265|20587116|P5|Overall Study|Withdrawal by Subject|1
5952412|NCT01253265|20587117|P4|Overall Study|Withdrawal by Subject|0
5952413|NCT01253265|20587118|P3|Overall Study|Withdrawal by Subject|0
5952414|NCT01253265|20587119|P2|Overall Study|Withdrawal by Subject|0
5952415|NCT01253265|20587120|P1|Overall Study|Withdrawal by Subject|0
5952416|NCT01253265|20587116|P5|Overall Study|Met Predefined Discontinuation Criteria|0
5952417|NCT01253265|20587117|P4|Overall Study|Met Predefined Discontinuation Criteria|0
5952418|NCT01253265|20587118|P3|Overall Study|Met Predefined Discontinuation Criteria|0
5952419|NCT01253265|20587119|P2|Overall Study|Met Predefined Discontinuation Criteria|0
5952420|NCT01253265|20587120|P1|Overall Study|Met Predefined Discontinuation Criteria|1
5952421|NCT01253226|20587169|P5|Overall Study|Withdrawal by Subject|0
5952422|NCT01253226|20587170|P4|Overall Study|Withdrawal by Subject|1
5952423|NCT01253226|20587171|P3|Overall Study|Withdrawal by Subject|0
5952424|NCT01253226|20587172|P2|Overall Study|Withdrawal by Subject|0
5952425|NCT01253226|20587173|P1|Overall Study|Withdrawal by Subject|0
5952426|NCT01253226|20587169|P5|Overall Study|Physician Decision|2
5952427|NCT01253226|20587170|P4|Overall Study|Physician Decision|0
5952428|NCT01253226|20587171|P3|Overall Study|Physician Decision|0
5952429|NCT01253226|20587172|P2|Overall Study|Physician Decision|0
5952430|NCT01253226|20587173|P1|Overall Study|Physician Decision|0
5952431|NCT01253226|20587169|P5|Overall Study|Death|0
5952432|NCT01253226|20587170|P4|Overall Study|Death|0
5952433|NCT01253226|20587171|P3|Overall Study|Death|0
5952434|NCT01253226|20587172|P2|Overall Study|Death|1
5952435|NCT01253226|20587173|P1|Overall Study|Death|0
5952436|NCT01253226|20587169|P5|Overall Study|Adverse Event|0
5952437|NCT01253226|20587170|P4|Overall Study|Adverse Event|0
5952438|NCT01253226|20587171|P3|Overall Study|Adverse Event|1
5952439|NCT01253226|20587172|P2|Overall Study|Adverse Event|0
5952440|NCT01253226|20587173|P1|Overall Study|Adverse Event|0
5952441|NCT01253200|20587233|P5|Overall Study|Attempts|0
5952442|NCT01253200|20587234|P4|Overall Study|Attempts|2
5952443|NCT01253200|20587235|P3|Overall Study|Attempts|1
5952444|NCT01253200|20587236|P2|Overall Study|Attempts|4
5952445|NCT01253200|20587237|P1|Overall Study|Attempts|6
5952446|NCT01253200|20587233|P5|Overall Study|intents|0
5952447|NCT01253200|20587234|P4|Overall Study|intents|3
5952448|NCT01253200|20587235|P3|Overall Study|intents|1
5952449|NCT01253200|20587236|P2|Overall Study|intents|10
5952450|NCT01253200|20587237|P1|Overall Study|intents|10
5952451|NCT01253200|20587233|P5|Overall Study|Protocol Violation|5
5952452|NCT01253200|20587234|P4|Overall Study|Protocol Violation|0
5952453|NCT01253200|20587235|P3|Overall Study|Protocol Violation|0
5952454|NCT01253200|20587236|P2|Overall Study|Protocol Violation|4
5952455|NCT01253200|20587237|P1|Overall Study|Protocol Violation|1
5952456|NCT01253200|20587233|P5|Overall Study|Withdrawal by Subject|0
5952457|NCT01253200|20587234|P4|Overall Study|Withdrawal by Subject|0
5952458|NCT01253200|20587235|P3|Overall Study|Withdrawal by Subject|0
5952459|NCT01253200|20587236|P2|Overall Study|Withdrawal by Subject|0
5952460|NCT01253200|20587237|P1|Overall Study|Withdrawal by Subject|2
5952461|NCT01253200|20587233|P5|Overall Study|Lost to Follow-up|0
5952462|NCT01253200|20587234|P4|Overall Study|Lost to Follow-up|0
5952463|NCT01253200|20587235|P3|Overall Study|Lost to Follow-up|0
5952464|NCT01253200|20587236|P2|Overall Study|Lost to Follow-up|1
5952465|NCT01253200|20587237|P1|Overall Study|Lost to Follow-up|1
5952466|NCT01253200|20587233|P5|Overall Study|Death|0
5952467|NCT01253200|20587234|P4|Overall Study|Death|0
5952468|NCT01253200|20587235|P3|Overall Study|Death|0
5952469|NCT01253200|20587236|P2|Overall Study|Death|0
5952470|NCT01253200|20587237|P1|Overall Study|Death|1
5952471|NCT01253187|20587252|P6|Period 3|non-compliance|0
5952472|NCT01253187|20587253|P5|Period 3|non-compliance|1
5952473|NCT01253187|20587254|P4|Period 3|non-compliance|0
5952474|NCT01253187|20587255|P3|Period 3|non-compliance|0
5952475|NCT01253187|20587256|P2|Period 3|non-compliance|0
5952476|NCT01253187|20587257|P1|Period 3|non-compliance|0
5952477|NCT01253187|20587252|P6|Period 3|difficulty with blood sampling|0
5952478|NCT01253187|20587253|P5|Period 3|difficulty with blood sampling|0
5952479|NCT01253187|20587254|P4|Period 3|difficulty with blood sampling|0
5952480|NCT01253187|20587255|P3|Period 3|difficulty with blood sampling|0
5952481|NCT01253187|20587256|P2|Period 3|difficulty with blood sampling|1
5952482|NCT01253187|20587257|P1|Period 3|difficulty with blood sampling|0
5952483|NCT01253187|20587252|P6|Period 3|Pregnancy|0
5952484|NCT01253187|20587253|P5|Period 3|Pregnancy|0
5952485|NCT01253187|20587254|P4|Period 3|Pregnancy|0
5952486|NCT01253187|20587255|P3|Period 3|Pregnancy|0
5952487|NCT01253187|20587256|P2|Period 3|Pregnancy|0
5952488|NCT01253187|20587257|P1|Period 3|Pregnancy|1
5952489|NCT01253187|20587252|P6|Period 2|Withdrawal by Subject|0
5952490|NCT01253187|20587253|P5|Period 2|Withdrawal by Subject|1
5952491|NCT01253187|20587254|P4|Period 2|Withdrawal by Subject|0
5952492|NCT01253187|20587255|P3|Period 2|Withdrawal by Subject|0
5952493|NCT01253187|20587256|P2|Period 2|Withdrawal by Subject|0
5952494|NCT01253187|20587257|P1|Period 2|Withdrawal by Subject|0
5952495|NCT01253174|20587286|P6|Period 3|Pregnancy|0
5952496|NCT01253174|20587287|P5|Period 3|Pregnancy|0
5952497|NCT01253174|20587288|P4|Period 3|Pregnancy|0
5952498|NCT01253174|20587289|P3|Period 3|Pregnancy|1
5952499|NCT01253174|20587290|P2|Period 3|Pregnancy|0
5952500|NCT01253174|20587291|P1|Period 3|Pregnancy|0
5952501|NCT01253174|20587286|P6|Period 3|Withdrawal by Subject|0
5952502|NCT01253174|20587287|P5|Period 3|Withdrawal by Subject|1
5952503|NCT01253174|20587288|P4|Period 3|Withdrawal by Subject|0
5952504|NCT01253174|20587289|P3|Period 3|Withdrawal by Subject|0
5952505|NCT01253174|20587290|P2|Period 3|Withdrawal by Subject|1
5952506|NCT01253174|20587291|P1|Period 3|Withdrawal by Subject|0
5952507|NCT01253174|20587286|P6|Period 2|Adverse Event|0
5952508|NCT01253174|20587287|P5|Period 2|Adverse Event|0
5952509|NCT01253174|20587288|P4|Period 2|Adverse Event|0
5952510|NCT01253174|20587289|P3|Period 2|Adverse Event|1
5952511|NCT01253174|20587290|P2|Period 2|Adverse Event|0
5952512|NCT01253174|20587291|P1|Period 2|Adverse Event|0
5952513|NCT01253174|20587286|P6|Period 1|Randomized but not treated|0
5952514|NCT01253174|20587287|P5|Period 1|Randomized but not treated|1
5952515|NCT01253174|20587288|P4|Period 1|Randomized but not treated|0
5952516|NCT01253174|20587289|P3|Period 1|Randomized but not treated|1
5952517|NCT01253174|20587290|P2|Period 1|Randomized but not treated|1
5952518|NCT01253174|20587291|P1|Period 1|Randomized but not treated|0
5952519|NCT01253135|20587326|P1|Amended Protocol|Non-compliance|1
5952520|NCT01253135|20587326|P1|Original Protocol|Protocol Amendment|15
5952521|NCT01253044|20587345|P2|Overall Study|Lost to Follow-up|29
5952522|NCT01253044|20587346|P1|Overall Study|Lost to Follow-up|38
5952523|NCT01253018|20587356|P2|Overall Study|Withdrawal by Subject|1
5952524|NCT01253018|20587357|P1|Overall Study|Withdrawal by Subject|1
5952525|NCT01253018|20587356|P2|Overall Study|Robot Repair Issues|0
5952526|NCT01253018|20587357|P1|Overall Study|Robot Repair Issues|2
5952527|NCT01253018|20587356|P2|Overall Study|Lost to Follow-up|1
5952528|NCT01253018|20587357|P1|Overall Study|Lost to Follow-up|1
5952529|NCT01252966|20587371|P2|Overall Study|Withdrawal by Subject|3
5952530|NCT01252966|20587372|P1|Overall Study|Withdrawal by Subject|7
5952531|NCT01252966|20587371|P2|Overall Study|Lost to Follow-up|10
5952532|NCT01252966|20587372|P1|Overall Study|Lost to Follow-up|16
5952533|NCT01252953|20587388|P2|Overall Study|Lost to Follow-up|21
5952534|NCT01252953|20587389|P1|Overall Study|Lost to Follow-up|22
5952535|NCT01252953|20587388|P2|Overall Study|Withdrawal by Subject|17
5952536|NCT01252953|20587389|P1|Overall Study|Withdrawal by Subject|16
5952537|NCT01252940|20587403|P2|Extension Phase|Withdrawal by Subject|1
5952538|NCT01252940|20587404|P1|Extension Phase|Withdrawal by Subject|1
5952539|NCT01252940|20587403|P2|Extension Phase|Subject Non-compliance|0
5952540|NCT01252940|20587404|P1|Extension Phase|Subject Non-compliance|1
5952541|NCT01252940|20587403|P2|Extension Phase|Physician Decision|1
5952542|NCT01252940|20587404|P1|Extension Phase|Physician Decision|0
5952543|NCT01252940|20587403|P2|Extension Phase|Lost to Follow-up|0
5952544|NCT01252940|20587404|P1|Extension Phase|Lost to Follow-up|5
5952545|NCT01252940|20587403|P2|Extension Phase|Lack of Efficacy|0
5952546|NCT01252940|20587404|P1|Extension Phase|Lack of Efficacy|1
5952547|NCT01252940|20587403|P2|Extension Phase|Adverse Event|1
5952548|NCT01252940|20587404|P1|Extension Phase|Adverse Event|2
5952549|NCT01252940|20587403|P2|Main Study Phase|Subject Non-compliance|1
5952550|NCT01252940|20587404|P1|Main Study Phase|Subject Non-compliance|1
5952551|NCT01252940|20587403|P2|Main Study Phase|Withdrawal by Subject|5
5952552|NCT01252940|20587404|P1|Main Study Phase|Withdrawal by Subject|6
5952553|NCT01252940|20587403|P2|Main Study Phase|Protocol Violation|2
5952554|NCT01252940|20587404|P1|Main Study Phase|Protocol Violation|4
5952555|NCT01252940|20587403|P2|Main Study Phase|Physician Decision|0
5952556|NCT01252940|20587404|P1|Main Study Phase|Physician Decision|1
5952557|NCT01252940|20587403|P2|Main Study Phase|Lost to Follow-up|1
5952558|NCT01252940|20587404|P1|Main Study Phase|Lost to Follow-up|6
5952559|NCT01252940|20587403|P2|Main Study Phase|Lack of Efficacy|0
5952560|NCT01252940|20587404|P1|Main Study Phase|Lack of Efficacy|1
5952561|NCT01252940|20587403|P2|Main Study Phase|Adverse Event|1
5952562|NCT01252940|20587404|P1|Main Study Phase|Adverse Event|3
5952563|NCT01252940|20587403|P2|Main Study Phase|Randomized but not treated|2
5952564|NCT01252940|20587404|P1|Main Study Phase|Randomized but not treated|4
5952565|NCT01252810|20587435|P2|Overall Study|Various reasons|0
5952566|NCT01252810|20587436|P1|Overall Study|Various reasons|8
5952567|NCT01252810|20587435|P2|Overall Study|Physician Decision|1
5952568|NCT01252810|20587436|P1|Overall Study|Physician Decision|2
5952569|NCT01252810|20587435|P2|Overall Study|Lost to Follow-up|1
5952570|NCT01252810|20587436|P1|Overall Study|Lost to Follow-up|0
5952571|NCT01252810|20587435|P2|Overall Study|Withdrawal by Subject|1
5952572|NCT01252810|20587436|P1|Overall Study|Withdrawal by Subject|4
5952573|NCT01252667|20587471|P6|Overall Study|Transplant aborted post-conditioning|1
5952574|NCT01252667|20587472|P5|Overall Study|Transplant aborted post-conditioning|0
5952575|NCT01252667|20587473|P4|Overall Study|Transplant aborted post-conditioning|0
5952576|NCT01252667|20587474|P3|Overall Study|Transplant aborted post-conditioning|0
5952577|NCT01252667|20587475|P2|Overall Study|Transplant aborted post-conditioning|0
5952578|NCT01252667|20587476|P1|Overall Study|Transplant aborted post-conditioning|0
5952579|NCT01252355|20587541|P3|Overall Study|Other Than Above|7
5952580|NCT01252355|20587542|P2|Overall Study|Other Than Above|7
5952581|NCT01252355|20587543|P1|Overall Study|Other Than Above|8
5952582|NCT01252355|20587541|P3|Overall Study|Randomized but not Treated|0
5952583|NCT01252355|20587542|P2|Overall Study|Randomized but not Treated|0
5952584|NCT01252355|20587543|P1|Overall Study|Randomized but not Treated|2
5952585|NCT01252355|20587541|P3|Overall Study|Sponsor Early Termination of Study|146
5952586|NCT01252355|20587542|P2|Overall Study|Sponsor Early Termination of Study|149
5952587|NCT01252355|20587543|P1|Overall Study|Sponsor Early Termination of Study|149
5952588|NCT01252355|20587541|P3|Overall Study|Progressive Disease|0
5952589|NCT01252355|20587542|P2|Overall Study|Progressive Disease|0
5952590|NCT01252355|20587543|P1|Overall Study|Progressive Disease|2
5952591|NCT01252355|20587541|P3|Overall Study|Poor Compliance to Protocol|1
5952592|NCT01252355|20587542|P2|Overall Study|Poor Compliance to Protocol|1
5952593|NCT01252355|20587543|P1|Overall Study|Poor Compliance to Protocol|1
5952594|NCT01252355|20587541|P3|Overall Study|Lost to Follow-up|1
5952595|NCT01252355|20587542|P2|Overall Study|Lost to Follow-up|0
5952596|NCT01252355|20587543|P1|Overall Study|Lost to Follow-up|0
5952597|NCT01252355|20587541|P3|Overall Study|Lack of Efficacy|2
5952598|NCT01252355|20587542|P2|Overall Study|Lack of Efficacy|4
5952599|NCT01252355|20587543|P1|Overall Study|Lack of Efficacy|6
5952600|NCT01252355|20587541|P3|Overall Study|Adverse Event|22
5952601|NCT01252355|20587542|P2|Overall Study|Adverse Event|17
5952602|NCT01252355|20587543|P1|Overall Study|Adverse Event|9
5952603|NCT01252290|20587581|P1|Overall Study|Withdrawal by Subject|1
5952604|NCT01252251|20587597|P1|Overall Study|Withdrawal by Subject|1
5952605|NCT01252238|20587609|P3|Overall Study|Sponsor terminated study|4
5952606|NCT01252238|20587610|P2|Overall Study|Sponsor terminated study|4
5952607|NCT01252238|20587611|P1|Overall Study|Sponsor terminated study|4
5952608|NCT01252186|20587628|P3|Overall Study|Other - Miscellaneous Reasons|7
5952609|NCT01252186|20587629|P2|Overall Study|Other - Miscellaneous Reasons|5
5952610|NCT01252186|20587630|P1|Overall Study|Other - Miscellaneous Reasons|5
5952611|NCT01252186|20587628|P3|Overall Study|Lost to Follow-up|11
5952612|NCT01252186|20587629|P2|Overall Study|Lost to Follow-up|10
5952613|NCT01252186|20587630|P1|Overall Study|Lost to Follow-up|10
5952614|NCT01252186|20587628|P3|Overall Study|Sponsor Request|0
5952615|NCT01252186|20587629|P2|Overall Study|Sponsor Request|1
5952616|NCT01252186|20587630|P1|Overall Study|Sponsor Request|2
5952617|NCT01252186|20587628|P3|Overall Study|Pregnancy|0
5952618|NCT01252186|20587629|P2|Overall Study|Pregnancy|2
5952619|NCT01252186|20587630|P1|Overall Study|Pregnancy|2
5952620|NCT01252186|20587628|P3|Overall Study|Protocol Violation|1
5952621|NCT01252186|20587629|P2|Overall Study|Protocol Violation|0
5952622|NCT01252186|20587630|P1|Overall Study|Protocol Violation|0
5952623|NCT01252186|20587628|P3|Overall Study|Non-compliance|4
5952624|NCT01252186|20587629|P2|Overall Study|Non-compliance|3
5952625|NCT01252186|20587630|P1|Overall Study|Non-compliance|0
5952626|NCT01252186|20587628|P3|Overall Study|Physician Decision|1
5952627|NCT01252186|20587629|P2|Overall Study|Physician Decision|0
5952628|NCT01252186|20587630|P1|Overall Study|Physician Decision|0
5952629|NCT01252186|20587628|P3|Overall Study|Withdrawal by Subject|2
5952630|NCT01252186|20587629|P2|Overall Study|Withdrawal by Subject|5
5952631|NCT01252186|20587630|P1|Overall Study|Withdrawal by Subject|2
5952632|NCT01252186|20587628|P3|Overall Study|Adverse Event|8
5952633|NCT01252186|20587629|P2|Overall Study|Adverse Event|6
5952634|NCT01252186|20587630|P1|Overall Study|Adverse Event|9
5952635|NCT01252134|20587703|P6|Period 1, 8 Hours|Personal Reasons|0
5952636|NCT01252134|20587704|P5|Period 1, 8 Hours|Personal Reasons|0
5952637|NCT01252134|20587705|P4|Period 1, 8 Hours|Personal Reasons|0
5952638|NCT01252134|20587706|P3|Period 1, 8 Hours|Personal Reasons|1
5952639|NCT01252134|20587707|P2|Period 1, 8 Hours|Personal Reasons|1
5952640|NCT01252134|20587708|P1|Period 1, 8 Hours|Personal Reasons|0
5952641|NCT01252095|20587727|P2|Overall Study|Disease progression|0
5952642|NCT01252095|20587728|P1|Overall Study|Disease progression|1
5952643|NCT01251965|20587749|P3|Overall Study|Death|11
5952644|NCT01251965|20587750|P2|Overall Study|Death|0
5952645|NCT01251965|20587751|P1|Overall Study|Death|0
5952646|NCT01251965|20587749|P3|Overall Study|Participant/physician decision|0
5952647|NCT01251965|20587750|P2|Overall Study|Participant/physician decision|2
5952648|NCT01251965|20587751|P1|Overall Study|Participant/physician decision|1
5952649|NCT01251952|20587763|P1|Overall Study|Adverse Event|1
5952670|NCT01251770|20587798|P2|Overall Study|Protocol Violation|7
5952671|NCT01251770|20587799|P1|Overall Study|Protocol Violation|13
5952672|NCT01251744|20587843|P2|Overall Study|Lost to Follow-up|0
5952673|NCT01251744|20587844|P1|Overall Study|Lost to Follow-up|1
5952674|NCT01251653|20587902|P9|Overall Study|Other reason not mentioned above|0
5952675|NCT01251653|20587903|P8|Overall Study|Other reason not mentioned above|2
5952676|NCT01251653|20587904|P7|Overall Study|Other reason not mentioned above|0
5952677|NCT01251653|20587905|P6|Overall Study|Other reason not mentioned above|0
5952678|NCT01251653|20587906|P5|Overall Study|Other reason not mentioned above|0
5952679|NCT01251653|20587907|P4|Overall Study|Other reason not mentioned above|0
5952680|NCT01251653|20587908|P3|Overall Study|Other reason not mentioned above|0
5952681|NCT01251653|20587909|P2|Overall Study|Other reason not mentioned above|0
5952682|NCT01251653|20587910|P1|Overall Study|Other reason not mentioned above|0
5952683|NCT01251653|20587902|P9|Overall Study|Withdrawal by Subject|0
5952684|NCT01251653|20587903|P8|Overall Study|Withdrawal by Subject|1
5952685|NCT01251653|20587904|P7|Overall Study|Withdrawal by Subject|0
5952686|NCT01251653|20587905|P6|Overall Study|Withdrawal by Subject|1
5952687|NCT01251653|20587906|P5|Overall Study|Withdrawal by Subject|1
5952688|NCT01251653|20587907|P4|Overall Study|Withdrawal by Subject|0
5952689|NCT01251653|20587908|P3|Overall Study|Withdrawal by Subject|1
5952690|NCT01251653|20587909|P2|Overall Study|Withdrawal by Subject|0
5952691|NCT01251653|20587910|P1|Overall Study|Withdrawal by Subject|1
5952692|NCT01251653|20587902|P9|Overall Study|Adverse Event|1
5952693|NCT01251653|20587903|P8|Overall Study|Adverse Event|2
5952694|NCT01251653|20587904|P7|Overall Study|Adverse Event|2
5952695|NCT01251653|20587905|P6|Overall Study|Adverse Event|0
5952696|NCT01251653|20587906|P5|Overall Study|Adverse Event|1
5952697|NCT01251653|20587907|P4|Overall Study|Adverse Event|1
5952698|NCT01251653|20587908|P3|Overall Study|Adverse Event|2
5952699|NCT01251653|20587909|P2|Overall Study|Adverse Event|0
5952700|NCT01251653|20587910|P1|Overall Study|Adverse Event|1
5952701|NCT01251653|20587902|P9|Overall Study|Dose-limiting toxicity|0
5952702|NCT01251653|20587903|P8|Overall Study|Dose-limiting toxicity|0
5952703|NCT01251653|20587904|P7|Overall Study|Dose-limiting toxicity|2
5952704|NCT01251653|20587905|P6|Overall Study|Dose-limiting toxicity|0
5952705|NCT01251653|20587906|P5|Overall Study|Dose-limiting toxicity|0
5952706|NCT01251653|20587907|P4|Overall Study|Dose-limiting toxicity|1
5952707|NCT01251653|20587908|P3|Overall Study|Dose-limiting toxicity|1
5952708|NCT01251653|20587909|P2|Overall Study|Dose-limiting toxicity|1
5952709|NCT01251653|20587910|P1|Overall Study|Dose-limiting toxicity|0
5952710|NCT01251653|20587902|P9|Overall Study|Progressive Disease|5
5952711|NCT01251653|20587903|P8|Overall Study|Progressive Disease|7
5952712|NCT01251653|20587904|P7|Overall Study|Progressive Disease|14
5952713|NCT01251653|20587905|P6|Overall Study|Progressive Disease|17
5952714|NCT01251653|20587906|P5|Overall Study|Progressive Disease|0
5952715|NCT01251653|20587907|P4|Overall Study|Progressive Disease|4
5952716|NCT01251653|20587908|P3|Overall Study|Progressive Disease|16
5952717|NCT01251653|20587909|P2|Overall Study|Progressive Disease|7
5952718|NCT01251653|20587910|P1|Overall Study|Progressive Disease|1
5952719|NCT01251614|20588038|P3|Overall Study|Lost to Follow-up|0
5952720|NCT01251614|20588039|P2|Overall Study|Lost to Follow-up|1
5952721|NCT01251614|20588040|P1|Overall Study|Lost to Follow-up|0
5952722|NCT01251614|20588038|P3|Overall Study|Withdrawal by Subject|1
5952723|NCT01251614|20588039|P2|Overall Study|Withdrawal by Subject|2
5952724|NCT01251614|20588040|P1|Overall Study|Withdrawal by Subject|0
5952725|NCT01251614|20588038|P3|Overall Study|Loss of Disease Control|0
5952726|NCT01251614|20588039|P2|Overall Study|Loss of Disease Control|1
5952727|NCT01251614|20588040|P1|Overall Study|Loss of Disease Control|0
5952728|NCT01251614|20588038|P3|Overall Study|Pregnancy|2
5952729|NCT01251614|20588039|P2|Overall Study|Pregnancy|0
5952730|NCT01251614|20588040|P1|Overall Study|Pregnancy|0
5952731|NCT01251614|20588038|P3|Overall Study|Clearing of Psoriatic Lesions|0
5952732|NCT01251614|20588039|P2|Overall Study|Clearing of Psoriatic Lesions|0
5952733|NCT01251614|20588040|P1|Overall Study|Clearing of Psoriatic Lesions|1
5952734|NCT01251614|20588038|P3|Overall Study|Lack of Efficacy|4
5952735|NCT01251614|20588039|P2|Overall Study|Lack of Efficacy|9
5952736|NCT01251614|20588040|P1|Overall Study|Lack of Efficacy|1
5952737|NCT01251614|20588038|P3|Overall Study|Adverse Event|1
5952738|NCT01251614|20588039|P2|Overall Study|Adverse Event|0
5952739|NCT01251614|20588040|P1|Overall Study|Adverse Event|1
5952740|NCT01251380|20588238|P1|Overall Study|Lost to Follow-up|2
5952741|NCT01251380|20588238|P1|Overall Study|Adverse Event|1
5952742|NCT01251380|20588238|P1|Overall Study|Lack of Efficacy|1
5952743|NCT01251380|20588238|P1|Overall Study|Withdrawal by Subject|6
5952744|NCT01251380|20588238|P1|Overall Study|Other (Not otherwise specified)|12
5952745|NCT01251367|20588262|P1|Overall Study|End of Study Visit Performed in Error|1
5952746|NCT01251367|20588262|P1|Overall Study|Subject had Personal or Medical Issues|4
5952747|NCT01251367|20588262|P1|Overall Study|No Study Drug Available|1
5952748|NCT01251367|20588262|P1|Overall Study|Subject Required Alternative Treatment|7
5952749|NCT01251367|20588262|P1|Overall Study|Lost to Follow-up|5
5952750|NCT01251367|20588262|P1|Overall Study|Withdrawal by Subject|36
5952751|NCT01251367|20588262|P1|Overall Study|Adverse Event|19
5952752|NCT01251367|20588262|P1|Overall Study|Lack of Efficacy|2
5952753|NCT01251367|20588262|P1|Overall Study|Protocol Violation|1
5952754|NCT01251354|20588297|P1|Overall Study|Disease Progression|4
5952755|NCT01251354|20588297|P1|Overall Study|Investigator's Decision|1
5952756|NCT01251354|20588297|P1|Overall Study|Adverse Event|1
5952757|NCT01251276|20588340|P2|Overall Study|Lost to Follow-up|1
5952758|NCT01251276|20588341|P1|Overall Study|Lost to Follow-up|0
5952759|NCT01251276|20588340|P2|Overall Study|Protocol Violation|0
5952760|NCT01251276|20588341|P1|Overall Study|Protocol Violation|1
5952761|NCT01251146|20588359|P2|Overall Study|Lost to Follow-up|10
5952762|NCT01251146|20588360|P1|Overall Study|Lost to Follow-up|3
5952763|NCT01251120|20588382|P2|Overall Study|Lack of Efficacy|1
5952764|NCT01251120|20588383|P1|Overall Study|Lack of Efficacy|0
5952765|NCT01250925|20588463|P3|Overall Study|Adverse Event|1
5952766|NCT01250925|20588464|P2|Overall Study|Adverse Event|0
5952767|NCT01250925|20588465|P1|Overall Study|Adverse Event|0
5952768|NCT01250925|20588463|P3|Overall Study|Physician Decision|1
5952769|NCT01250925|20588464|P2|Overall Study|Physician Decision|2
5952770|NCT01250925|20588465|P1|Overall Study|Physician Decision|0
5952771|NCT01250925|20588463|P3|Overall Study|Protocol Violation|0
5952772|NCT01250925|20588464|P2|Overall Study|Protocol Violation|0
5952773|NCT01250925|20588465|P1|Overall Study|Protocol Violation|2
5952774|NCT01250925|20588463|P3|Overall Study|Withdrawal by Subject|0
5952775|NCT01250925|20588464|P2|Overall Study|Withdrawal by Subject|0
5952776|NCT01250925|20588465|P1|Overall Study|Withdrawal by Subject|2
5952777|NCT01250925|20588463|P3|Overall Study|Lost to Follow-up|0
5952778|NCT01250925|20588464|P2|Overall Study|Lost to Follow-up|1
5952779|NCT01250925|20588465|P1|Overall Study|Lost to Follow-up|1
5952781|NCT01250873|20588517|P1|Period 3:LY2216684+Sertraline(Days11-13)|Adverse Event|1
5952782|NCT01250873|20588517|P1|Period 1: LY2216684 (Days 1-3)|Adverse Event|2
5952783|NCT01250769|20588549|P4|Overall Study|Adverse Event|0
5952784|NCT01250769|20588550|P3|Overall Study|Adverse Event|1
5952785|NCT01250769|20588551|P2|Overall Study|Adverse Event|0
5952786|NCT01250769|20588552|P1|Overall Study|Adverse Event|0
5952787|NCT01250769|20588549|P4|Overall Study|Withdrawal by Subject|0
5952788|NCT01250769|20588550|P3|Overall Study|Withdrawal by Subject|1
5952789|NCT01250769|20588551|P2|Overall Study|Withdrawal by Subject|1
5952790|NCT01250769|20588552|P1|Overall Study|Withdrawal by Subject|0
5952791|NCT01250756|20588584|P2|After Toddler Dose|Adverse Event|1
5952792|NCT01250756|20588585|P1|After Toddler Dose|Adverse Event|0
5952793|NCT01250756|20588584|P2|Toddler Dose|Adverse Event|1
5952794|NCT01250756|20588585|P1|Toddler Dose|Adverse Event|0
5952795|NCT01250756|20588584|P2|After Infant Series|Other|1
5952796|NCT01250756|20588585|P1|After Infant Series|Other|2
5952797|NCT01250756|20588584|P2|After Infant Series|Withdrawal by Subject|1
5952798|NCT01250756|20588585|P1|After Infant Series|Withdrawal by Subject|4
5952799|NCT01250756|20588584|P2|After Infant Series|Adverse Event|2
5952800|NCT01250756|20588585|P1|After Infant Series|Adverse Event|5
5952801|NCT01250756|20588584|P2|Infant Series|Other|0
5952802|NCT01250756|20588585|P1|Infant Series|Other|22
5952803|NCT01250756|20588584|P2|Infant Series|Randomized, Not Vaccinated|2
5952804|NCT01250756|20588585|P1|Infant Series|Randomized, Not Vaccinated|2
5952805|NCT01250756|20588584|P2|Infant Series|Withdrawal by Subject|5
5952806|NCT01250756|20588585|P1|Infant Series|Withdrawal by Subject|4
5952807|NCT01250509|20588702|P2|Overall Study|Lost to Follow-up|2
5952808|NCT01250509|20588703|P1|Overall Study|Lost to Follow-up|5
5952809|NCT01250418|20588717|P2|Overall Study|monitor data failure|1
5952810|NCT01250418|20588718|P1|Overall Study|monitor data failure|1
5952811|NCT01250379|20588726|P2|Overall Study|Participant noncompliance|0
5952812|NCT01250379|20588727|P1|Overall Study|Participant noncompliance|2
5952813|NCT01250379|20588726|P2|Overall Study|Other|4
5952814|NCT01250379|20588727|P1|Overall Study|Other|0
5952815|NCT01250379|20588726|P2|Overall Study|Adverse Event|4
5952816|NCT01250379|20588727|P1|Overall Study|Adverse Event|5
5952817|NCT01250379|20588726|P2|Overall Study|Lost to Follow-up|6
5952818|NCT01250379|20588727|P1|Overall Study|Lost to Follow-up|9
5952819|NCT01250379|20588726|P2|Overall Study|Protocol Violation|8
5952820|NCT01250379|20588727|P1|Overall Study|Protocol Violation|2
5952821|NCT01250379|20588726|P2|Overall Study|Physician Decision|3
5952822|NCT01250379|20588727|P1|Overall Study|Physician Decision|11
5952823|NCT01250379|20588726|P2|Overall Study|Withdrawal by Subject|20
5952824|NCT01250379|20588727|P1|Overall Study|Withdrawal by Subject|32
5952825|NCT01250379|20588726|P2|Overall Study|Death|148
5952826|NCT01250379|20588727|P1|Overall Study|Death|141
5952827|NCT01250171|20588832|P3|Overall Study|Administrative reasons|0
5952828|NCT01250171|20588833|P2|Overall Study|Administrative reasons|0
5952829|NCT01250171|20588834|P1|Overall Study|Administrative reasons|1
5952830|NCT01250145|20588865|P2|Overall Study|Withdrawal by Subject|4
5952831|NCT01250145|20588866|P1|Overall Study|Withdrawal by Subject|0
5952832|NCT01250145|20588865|P2|Overall Study|Adverse Event|1
5952833|NCT01250145|20588866|P1|Overall Study|Adverse Event|2
5952834|NCT01250119|20588886|P2|Treatment Phase|Unknown reason|4
5952835|NCT01250119|20588887|P1|Treatment Phase|Unknown reason|0
5952836|NCT01250119|20588886|P2|Treatment Phase|Adverse Event|2
5952837|NCT01250119|20588887|P1|Treatment Phase|Adverse Event|0
5952838|NCT01250119|20588886|P2|Treatment Phase|Withdrawal by Subject|1
5952839|NCT01250119|20588887|P1|Treatment Phase|Withdrawal by Subject|0
5952840|NCT01250119|20588886|P2|Treatment Phase|Death|2
5952841|NCT01250119|20588887|P1|Treatment Phase|Death|0
5952842|NCT01250119|20588886|P2|Treatment Phase|Progressive Disease|32
5952843|NCT01250119|20588887|P1|Treatment Phase|Progressive Disease|0
5952844|NCT01250119|20588886|P2|Diagnostic Phase|Participants Not Tested|0
5952845|NCT01250119|20588887|P1|Diagnostic Phase|Participants Not Tested|44
5952846|NCT01250119|20588886|P2|Diagnostic Phase|Failed to Produce a Test Results|0
5952847|NCT01250119|20588887|P1|Diagnostic Phase|Failed to Produce a Test Results|69
5952848|NCT01250054|20588902|P2|Period 2, One Week of Wear|Unacceptable subjective vision|0
5952849|NCT01250054|20588903|P1|Period 2, One Week of Wear|Unacceptable subjective vision|1
5952850|NCT01250002|20588911|P2|Overall Study|Change to open surgical procedure|3
5952851|NCT01250002|20588912|P1|Overall Study|Change to open surgical procedure|4
5952852|NCT01249833|20588977|P2|Overall Study|Lost to Follow-up|1
5952853|NCT01249833|20588978|P1|Overall Study|Lost to Follow-up|0
5952854|NCT01249664|20588992|P2|Overall Study|Adverse Event|0
5952855|NCT01249664|20588993|P1|Overall Study|Adverse Event|1
5952856|NCT01249664|20588992|P2|Overall Study|Withdrawal by Subject|0
5952857|NCT01249664|20588993|P1|Overall Study|Withdrawal by Subject|5
5952858|NCT01249651|20589043|P1|Overall Study|Sponsor Decision|1
5952859|NCT01249651|20589043|P1|Overall Study|Protocol Violation|1
5952860|NCT01249651|20589043|P1|Overall Study|Adverse Event|1
5952861|NCT01249651|20589043|P1|Overall Study|Withdrawal by Subject|4
5952862|NCT01249417|20589072|P3|Treatment Phase - ITT Population|Lost to Follow-up|1
5952863|NCT01249417|20589073|P2|Treatment Phase - ITT Population|Lost to Follow-up|1
5952864|NCT01249417|20589074|P1|Treatment Phase - ITT Population|Lost to Follow-up|0
5952865|NCT01249417|20589072|P3|Treatment Phase - ITT Population|Withdrawal by Subject|1
5952866|NCT01249417|20589073|P2|Treatment Phase - ITT Population|Withdrawal by Subject|3
5952867|NCT01249417|20589074|P1|Treatment Phase - ITT Population|Withdrawal by Subject|1
5952868|NCT01249417|20589072|P3|Treatment Phase - ITT Population|Adverse Event|1
5952869|NCT01249417|20589073|P2|Treatment Phase - ITT Population|Adverse Event|0
5952870|NCT01249417|20589074|P1|Treatment Phase - ITT Population|Adverse Event|0
5952871|NCT01249417|20589072|P3|Treatment Phase - ITT Population|Other|1
5952872|NCT01249417|20589073|P2|Treatment Phase - ITT Population|Other|0
5952873|NCT01249417|20589074|P1|Treatment Phase - ITT Population|Other|0
5952874|NCT01249417|20589072|P3|Randomised Population|No MAS score at baseline and/or Week 4|2
5952875|NCT01249417|20589073|P2|Randomised Population|No MAS score at baseline and/or Week 4|1
5952876|NCT01249417|20589074|P1|Randomised Population|No MAS score at baseline and/or Week 4|1
5952877|NCT01249417|20589072|P3|Randomised Population|Study treatment not received|2
5952878|NCT01249417|20589073|P2|Randomised Population|Study treatment not received|0
5952879|NCT01249417|20589074|P1|Randomised Population|Study treatment not received|0
5952880|NCT01249404|20589091|P3|Overall Study|Non compliance to visit schedule|0
5952881|NCT01249404|20589092|P2|Overall Study|Non compliance to visit schedule|1
5952882|NCT01249404|20589093|P1|Overall Study|Non compliance to visit schedule|0
5952883|NCT01249404|20589091|P3|Overall Study|Botulinum toxin (BTX) in upper limb|1
5952884|NCT01249404|20589092|P2|Overall Study|Botulinum toxin (BTX) in upper limb|2
5952885|NCT01249404|20589093|P1|Overall Study|Botulinum toxin (BTX) in upper limb|1
5952886|NCT01249404|20589091|P3|Overall Study|Withdrawal by Subject|0
5952887|NCT01249404|20589092|P2|Overall Study|Withdrawal by Subject|2
5952888|NCT01249404|20589093|P1|Overall Study|Withdrawal by Subject|2
5952889|NCT01249404|20589091|P3|Overall Study|Adverse Event|2
5952890|NCT01249404|20589092|P2|Overall Study|Adverse Event|2
5952891|NCT01249404|20589093|P1|Overall Study|Adverse Event|2
5952892|NCT01249404|20589091|P3|Overall Study|No MAS Score at baseline and/or Week 4|2
5952893|NCT01249404|20589092|P2|Overall Study|No MAS Score at baseline and/or Week 4|0
5952894|NCT01249404|20589093|P1|Overall Study|No MAS Score at baseline and/or Week 4|2
5952895|NCT01249404|20589091|P3|Overall Study|Study treatment not received|2
5952896|NCT01249404|20589092|P2|Overall Study|Study treatment not received|1
5952897|NCT01249404|20589093|P1|Overall Study|Study treatment not received|0
5952898|NCT01249365|20589170|P1|Overall Study|Lost to Follow-up|1
5952899|NCT01249274|20589178|P2|Overall Study|Received inpatient substance treatment|2
5952900|NCT01249274|20589179|P1|Overall Study|Received inpatient substance treatment|1
5952901|NCT01249274|20589178|P2|Overall Study|Lost to Follow-up|4
5952902|NCT01249274|20589179|P1|Overall Study|Lost to Follow-up|3
5952903|NCT01249261|20589205|P2|Overall Study|Withdrawal by Subject|0
5952904|NCT01249261|20589206|P1|Overall Study|Withdrawal by Subject|1
5952905|NCT01249157|20589234|P1|Overall Study|Withdrawal by Subject|1
5952906|NCT01249131|20589238|P6|Washout Period of 10 Days|Adverse Event|0
5952907|NCT01249131|20589239|P5|Washout Period of 10 Days|Adverse Event|1
5952908|NCT01249131|20589240|P4|Washout Period of 10 Days|Adverse Event|0
5952909|NCT01249131|20589241|P3|Washout Period of 10 Days|Adverse Event|0
5952910|NCT01249131|20589242|P2|Washout Period of 10 Days|Adverse Event|0
5952911|NCT01249131|20589243|P1|Washout Period of 10 Days|Adverse Event|0
5952912|NCT01249118|20589263|P3|First Washout Period|Physician Decision|0
5952913|NCT01249118|20589264|P2|First Washout Period|Physician Decision|1
5952914|NCT01249118|20589265|P1|First Washout Period|Physician Decision|0
5952915|NCT01249092|20589299|P1|Overall Study|Unable to tolerate expected SE -nausea|1
5952916|NCT01249092|20589299|P1|Overall Study|Expected side effect of nausea/dyspepsia|1
5952917|NCT01248962|20589376|P2|Overall Study|Progression of Disease prior to 5 Cycles|13
5952918|NCT01248962|20589377|P1|Overall Study|Progression of Disease prior to 5 Cycles|12
5952919|NCT01248962|20589376|P2|Overall Study|Complete Response after 3 Cycles|1
5952920|NCT01248962|20589377|P1|Overall Study|Complete Response after 3 Cycles|0
5952921|NCT01248962|20589376|P2|Overall Study|Complete Response after 4 Cycles|0
5952922|NCT01248962|20589377|P1|Overall Study|Complete Response after 4 Cycles|1
5952923|NCT01248962|20589376|P2|Overall Study|Adverse Event|1
5952924|NCT01248962|20589377|P1|Overall Study|Adverse Event|2
5952925|NCT01248962|20589376|P2|Overall Study|Withdrawal by Subject|1
5952926|NCT01248962|20589377|P1|Overall Study|Withdrawal by Subject|1
5952927|NCT01248949|20589393|P5|Overall Study|Lesion In ThoracicSpine Requires Therapy|0
5952928|NCT01248949|20589394|P4|Overall Study|Lesion In ThoracicSpine Requires Therapy|0
5952929|NCT01248949|20589395|P3|Overall Study|Lesion In ThoracicSpine Requires Therapy|1
5952930|NCT01248949|20589396|P2|Overall Study|Lesion In ThoracicSpine Requires Therapy|0
5952931|NCT01248949|20589397|P1|Overall Study|Lesion In ThoracicSpine Requires Therapy|0
5952932|NCT01248949|20589393|P5|Overall Study|Pi Discretion Due To Hospitalisation|0
5952933|NCT01248949|20589394|P4|Overall Study|Pi Discretion Due To Hospitalisation|0
5952934|NCT01248949|20589395|P3|Overall Study|Pi Discretion Due To Hospitalisation|0
5952935|NCT01248949|20589396|P2|Overall Study|Pi Discretion Due To Hospitalisation|1
5952936|NCT01248949|20589397|P1|Overall Study|Pi Discretion Due To Hospitalisation|0
5952937|NCT01248949|20589393|P5|Overall Study|Pi Decision Due To Declining Status|0
5952938|NCT01248949|20589394|P4|Overall Study|Pi Decision Due To Declining Status|0
5952939|NCT01248949|20589395|P3|Overall Study|Pi Decision Due To Declining Status|1
5952940|NCT01248949|20589396|P2|Overall Study|Pi Decision Due To Declining Status|0
5952941|NCT01248949|20589397|P1|Overall Study|Pi Decision Due To Declining Status|0
5952942|NCT01248949|20589393|P5|Overall Study|Per Sponsor Request o Discontinue Drug|0
5952943|NCT01248949|20589394|P4|Overall Study|Per Sponsor Request o Discontinue Drug|0
5952944|NCT01248949|20589395|P3|Overall Study|Per Sponsor Request o Discontinue Drug|0
5952945|NCT01248949|20589396|P2|Overall Study|Per Sponsor Request o Discontinue Drug|0
5952946|NCT01248949|20589397|P1|Overall Study|Per Sponsor Request o Discontinue Drug|1
5952947|NCT01248949|20589393|P5|Overall Study|Participant Went To Hospice|0
5952948|NCT01248949|20589394|P4|Overall Study|Participant Went To Hospice|0
5952949|NCT01248949|20589395|P3|Overall Study|Participant Went To Hospice|1
5952950|NCT01248949|20589396|P2|Overall Study|Participant Went To Hospice|0
5952951|NCT01248949|20589397|P1|Overall Study|Participant Went To Hospice|0
5952952|NCT01248949|20589393|P5|Overall Study|Entered Hospice And Refused Follow Up|1
5952953|NCT01248949|20589394|P4|Overall Study|Entered Hospice And Refused Follow Up|0
5952954|NCT01248949|20589395|P3|Overall Study|Entered Hospice And Refused Follow Up|0
5952955|NCT01248949|20589396|P2|Overall Study|Entered Hospice And Refused Follow Up|0
5952956|NCT01248949|20589397|P1|Overall Study|Entered Hospice And Refused Follow Up|0
5952957|NCT01248949|20589393|P5|Overall Study|Palliative Radiation To Brain Metastases|0
5952958|NCT01248949|20589394|P4|Overall Study|Palliative Radiation To Brain Metastases|0
5952959|NCT01248949|20589395|P3|Overall Study|Palliative Radiation To Brain Metastases|0
5952960|NCT01248949|20589396|P2|Overall Study|Palliative Radiation To Brain Metastases|0
5952961|NCT01248949|20589397|P1|Overall Study|Palliative Radiation To Brain Metastases|1
5952962|NCT01248949|20589393|P5|Overall Study|Alternative Therapy.|0
5952963|NCT01248949|20589394|P4|Overall Study|Alternative Therapy.|0
5952964|NCT01248949|20589395|P3|Overall Study|Alternative Therapy.|0
5952965|NCT01248949|20589396|P2|Overall Study|Alternative Therapy.|0
5952966|NCT01248949|20589397|P1|Overall Study|Alternative Therapy.|1
5952967|NCT01248949|20589393|P5|Overall Study|Alternative Therapy|0
5952968|NCT01248949|20589394|P4|Overall Study|Alternative Therapy|0
5952969|NCT01248949|20589395|P3|Overall Study|Alternative Therapy|0
5952970|NCT01248949|20589396|P2|Overall Study|Alternative Therapy|0
5952971|NCT01248949|20589397|P1|Overall Study|Alternative Therapy|1
5952972|NCT01248949|20589393|P5|Overall Study|Death|2
5952973|NCT01248949|20589394|P4|Overall Study|Death|6
5952974|NCT01248949|20589395|P3|Overall Study|Death|21
5952975|NCT01248949|20589396|P2|Overall Study|Death|7
5952976|NCT01248949|20589397|P1|Overall Study|Death|22
5952977|NCT01248949|20589393|P5|Overall Study|Withdrawal by Subject|1
5952978|NCT01248949|20589394|P4|Overall Study|Withdrawal by Subject|3
5952979|NCT01248949|20589395|P3|Overall Study|Withdrawal by Subject|11
5952980|NCT01248949|20589396|P2|Overall Study|Withdrawal by Subject|3
5952981|NCT01248949|20589397|P1|Overall Study|Withdrawal by Subject|5
5952982|NCT01248949|20589393|P5|Overall Study|Lost to Follow-up|0
5952983|NCT01248949|20589394|P4|Overall Study|Lost to Follow-up|1
5952984|NCT01248949|20589395|P3|Overall Study|Lost to Follow-up|2
5952985|NCT01248949|20589396|P2|Overall Study|Lost to Follow-up|2
5952986|NCT01248949|20589397|P1|Overall Study|Lost to Follow-up|2
5952987|NCT01248936|20589509|P1|Overall Study|Other reason|3
5952988|NCT01248936|20589509|P1|Overall Study|Refused Treatment|1
5952989|NCT01248936|20589509|P1|Overall Study|Lost to Follow-up|7
5952990|NCT01248936|20589509|P1|Overall Study|Adverse Event|8
5952991|NCT01248936|20589509|P1|Overall Study|Withdrawal of Consent|20
5952992|NCT01248936|20589509|P1|Overall Study|Death|26
5952993|NCT01248936|20589509|P1|Overall Study|Progression of Disease|50
5952994|NCT01248936|20589509|P1|Overall Study|Sponsor Decision|259
5952995|NCT01248884|20589522|P3|Overall Study|Adverse Event|0
5952996|NCT01248884|20589523|P2|Overall Study|Adverse Event|0
5952997|NCT01248884|20589524|P1|Overall Study|Adverse Event|1
5952998|NCT01248884|20589522|P3|Overall Study|Withdrawal by Subject|1
5952999|NCT01248884|20589523|P2|Overall Study|Withdrawal by Subject|3
5953000|NCT01248884|20589524|P1|Overall Study|Withdrawal by Subject|1
5953001|NCT01248793|20589582|P2|Overall Study|Withdrawal by Subject|3
5953002|NCT01248793|20589583|P1|Overall Study|Withdrawal by Subject|3
5953003|NCT01248793|20589582|P2|Overall Study|Protocol Violation|1
5953004|NCT01248793|20589583|P1|Overall Study|Protocol Violation|0
5953005|NCT01248793|20589582|P2|Overall Study|Adverse Event|1
5953006|NCT01248793|20589583|P1|Overall Study|Adverse Event|1
5953007|NCT01248793|20589582|P2|Overall Study|Lost to Follow-up|1
5953008|NCT01248793|20589583|P1|Overall Study|Lost to Follow-up|0
5953009|NCT01248780|20589597|P2|Overall Study|Not treated|1
5953010|NCT01248780|20589598|P1|Overall Study|Not treated|0
5953011|NCT01248780|20589597|P2|Overall Study|Withdrawal by Subject|4
5953012|NCT01248780|20589598|P1|Overall Study|Withdrawal by Subject|4
5953013|NCT01248780|20589597|P2|Overall Study|Protocol Violation|1
5953014|NCT01248780|20589598|P1|Overall Study|Protocol Violation|1
5953015|NCT01248780|20589597|P2|Overall Study|Adverse Event|7
5953016|NCT01248780|20589598|P1|Overall Study|Adverse Event|2
5953017|NCT01248780|20589597|P2|Overall Study|Death|1
5953018|NCT01248780|20589598|P1|Overall Study|Death|0
5953019|NCT01248780|20589597|P2|Overall Study|Lost to Follow-up|1
5953020|NCT01248780|20589598|P1|Overall Study|Lost to Follow-up|0
5953021|NCT01248780|20589597|P2|Overall Study|Lack of Efficacy|0
5953022|NCT01248780|20589598|P1|Overall Study|Lack of Efficacy|2
5953023|NCT01248728|20589616|P2|Overall Study|Lack of Efficacy|0
5953024|NCT01248728|20589617|P1|Overall Study|Lack of Efficacy|1
5953025|NCT01248728|20589616|P2|Overall Study|Withdrawal by Subject|1
5953026|NCT01248728|20589617|P1|Overall Study|Withdrawal by Subject|2
5953027|NCT01248728|20589616|P2|Overall Study|Adverse Event|1
5953028|NCT01248728|20589617|P1|Overall Study|Adverse Event|1
5953029|NCT01248715|20589633|P2|Overall Study|Not influenza positive|510
5953030|NCT01248715|20589634|P1|Overall Study|Not influenza positive|501
5953031|NCT01248468|20589672|P3|Overall Study|Withdrawal by Subject|0
5953032|NCT01248468|20589673|P2|Overall Study|Withdrawal by Subject|2
5953033|NCT01248468|20589674|P1|Overall Study|Withdrawal by Subject|4
5953034|NCT01248468|20589672|P3|Overall Study|Pregnancy|0
5953035|NCT01248468|20589673|P2|Overall Study|Pregnancy|0
5953036|NCT01248468|20589674|P1|Overall Study|Pregnancy|1
5953037|NCT01248468|20589672|P3|Overall Study|Lost to Follow-up|4
5953038|NCT01248468|20589673|P2|Overall Study|Lost to Follow-up|12
5953039|NCT01248468|20589674|P1|Overall Study|Lost to Follow-up|9
5953040|NCT01248468|20589672|P3|Overall Study|Administrative problem|0
5953041|NCT01248468|20589673|P2|Overall Study|Administrative problem|0
5953042|NCT01248468|20589674|P1|Overall Study|Administrative problem|1
5953043|NCT01248455|20589691|P1|Overall Study|switched to alternate treatment|1
5953044|NCT01248364|20589736|P4|Overall Study|Adverse Event|0
5953045|NCT01248364|20589737|P3|Overall Study|Adverse Event|0
5953046|NCT01248364|20589738|P2|Overall Study|Adverse Event|1
5953047|NCT01248364|20589739|P1|Overall Study|Adverse Event|0
5953048|NCT01248130|20589802|P2|Overall Study|Ineligible|0
5953049|NCT01248130|20589803|P1|Overall Study|Ineligible|1
5953050|NCT01248130|20589802|P2|Overall Study|Protocol Violation|0
5953051|NCT01248130|20589803|P1|Overall Study|Protocol Violation|1
5953052|NCT01248065|20589822|P2|Overall Study|Other|5
5953053|NCT01248065|20589823|P1|Overall Study|Other|3
5953054|NCT01248065|20589822|P2|Overall Study|Third treatment failure event|1
5953055|NCT01248065|20589823|P1|Overall Study|Third treatment failure event|3
5953056|NCT01248065|20589822|P2|Overall Study|Adverse Event|0
5953057|NCT01248065|20589823|P1|Overall Study|Adverse Event|3
5953058|NCT01248065|20589822|P2|Overall Study|Withdrawal by Subject|11
5953059|NCT01248065|20589823|P1|Overall Study|Withdrawal by Subject|14
5953060|NCT01248065|20589822|P2|Overall Study|Lost to Follow-up|5
5953061|NCT01248065|20589823|P1|Overall Study|Lost to Follow-up|3
5953062|NCT01248013|20589833|P1|Overall Study|Withdrawal by Subject|14
5953063|NCT01247922|20589848|P1|Overall Study|Disease progression|4
5953064|NCT01247350|20589946|P5|Overall Study|Entry criteria not met|1
5953065|NCT01247350|20589947|P4|Overall Study|Entry criteria not met|0
5953066|NCT01247350|20589948|P3|Overall Study|Entry criteria not met|0
5953067|NCT01247350|20589949|P2|Overall Study|Entry criteria not met|0
5953068|NCT01247350|20589950|P1|Overall Study|Entry criteria not met|0
5953069|NCT01247350|20589946|P5|Overall Study|Withdrawal by Subject|0
5953070|NCT01247350|20589947|P4|Overall Study|Withdrawal by Subject|1
5953071|NCT01247350|20589948|P3|Overall Study|Withdrawal by Subject|0
5953072|NCT01247350|20589949|P2|Overall Study|Withdrawal by Subject|0
5953073|NCT01247350|20589950|P1|Overall Study|Withdrawal by Subject|0
5953074|NCT01247350|20589946|P5|Overall Study|Adverse Event|0
5953075|NCT01247350|20589947|P4|Overall Study|Adverse Event|0
5953076|NCT01247350|20589948|P3|Overall Study|Adverse Event|1
5953077|NCT01247350|20589949|P2|Overall Study|Adverse Event|0
5953078|NCT01247350|20589950|P1|Overall Study|Adverse Event|0
5953079|NCT01247324|20590008|P2|Overall Study|Lost to Follow-up|1
5953080|NCT01247324|20590009|P1|Overall Study|Lost to Follow-up|1
5953081|NCT01247324|20590008|P2|Overall Study|Adverse Event|13
5953082|NCT01247324|20590009|P1|Overall Study|Adverse Event|25
5953083|NCT01247324|20590008|P2|Overall Study|Consent withdrawn by participant|8
5953084|NCT01247324|20590009|P1|Overall Study|Consent withdrawn by participant|13
5953085|NCT01247324|20590008|P2|Overall Study|Reason not specified|8
5953086|NCT01247324|20590009|P1|Overall Study|Reason not specified|11
5953087|NCT01247324|20590008|P2|Overall Study|Protocol Violation|2
5953088|NCT01247324|20590009|P1|Overall Study|Protocol Violation|1
5953089|NCT01247324|20590008|P2|Overall Study|Pregnancy|3
5953090|NCT01247324|20590009|P1|Overall Study|Pregnancy|2
5953091|NCT01247324|20590008|P2|Overall Study|Non-compliance|0
5953092|NCT01247324|20590009|P1|Overall Study|Non-compliance|2
5953093|NCT01247324|20590008|P2|Overall Study|Lack of Efficacy|8
5953094|NCT01247324|20590009|P1|Overall Study|Lack of Efficacy|12
5953095|NCT01247324|20590008|P2|Overall Study|Non-compliance with study drug|0
5953096|NCT01247324|20590009|P1|Overall Study|Non-compliance with study drug|3
5953097|NCT01247324|20590008|P2|Overall Study|Physician Decision|1
5953098|NCT01247324|20590009|P1|Overall Study|Physician Decision|0
5953099|NCT01247324|20590008|P2|Overall Study|Death|0
5953100|NCT01247324|20590009|P1|Overall Study|Death|1
5953101|NCT01247090|20590102|P3|Overall Study|Withdrawal by Subject|0
5953102|NCT01247090|20590103|P2|Overall Study|Withdrawal by Subject|1
5953103|NCT01247090|20590104|P1|Overall Study|Withdrawal by Subject|0
5953104|NCT01247090|20590102|P3|Overall Study|Physician Decision|0
5953105|NCT01247090|20590103|P2|Overall Study|Physician Decision|0
5953106|NCT01247090|20590104|P1|Overall Study|Physician Decision|1
5953107|NCT01246999|20590133|P4|Overall Study|Withdrawal by Subject|2
5953108|NCT01246999|20590134|P3|Overall Study|Withdrawal by Subject|0
5953109|NCT01246999|20590135|P2|Overall Study|Withdrawal by Subject|0
5953110|NCT01246999|20590136|P1|Overall Study|Withdrawal by Subject|0
5953111|NCT01246999|20590133|P4|Overall Study|Lost to Follow-up|0
5953112|NCT01246999|20590134|P3|Overall Study|Lost to Follow-up|0
5953113|NCT01246999|20590135|P2|Overall Study|Lost to Follow-up|1
5953114|NCT01246999|20590136|P1|Overall Study|Lost to Follow-up|0
5953115|NCT01246986|20590176|P7|Overall Study|Withdrawal by Subject|0
5953116|NCT01246986|20590177|P6|Overall Study|Withdrawal by Subject|0
5953117|NCT01246986|20590178|P5|Overall Study|Withdrawal by Subject|4
5953118|NCT01246986|20590179|P4|Overall Study|Withdrawal by Subject|0
5953119|NCT01246986|20590180|P3|Overall Study|Withdrawal by Subject|3
5953120|NCT01246986|20590181|P2|Overall Study|Withdrawal by Subject|4
5953121|NCT01246986|20590182|P1|Overall Study|Withdrawal by Subject|3
5953122|NCT01246986|20590176|P7|Overall Study|Lost to Follow-up|0
5953123|NCT01246986|20590177|P6|Overall Study|Lost to Follow-up|1
5953124|NCT01246986|20590178|P5|Overall Study|Lost to Follow-up|0
5953125|NCT01246986|20590179|P4|Overall Study|Lost to Follow-up|0
5953126|NCT01246986|20590180|P3|Overall Study|Lost to Follow-up|3
5953127|NCT01246986|20590181|P2|Overall Study|Lost to Follow-up|1
5953128|NCT01246986|20590182|P1|Overall Study|Lost to Follow-up|0
5953129|NCT01246973|20590242|P2|Overall Study|Withdrawal by Subject|13
5953130|NCT01246973|20590243|P1|Overall Study|Withdrawal by Subject|7
5953131|NCT01246973|20590242|P2|Overall Study|Adverse Event|9
5953132|NCT01246973|20590243|P1|Overall Study|Adverse Event|16
5953133|NCT01246973|20590242|P2|Overall Study|Other|25
5953134|NCT01246973|20590243|P1|Overall Study|Other|38
5953135|NCT01246960|20590253|P2|Overall Study|Withdrawal (by participant or physician)|3
5953136|NCT01246960|20590254|P1|Overall Study|Withdrawal (by participant or physician)|3
5953137|NCT01246960|20590253|P2|Overall Study|Lost to Follow-up|1
5953138|NCT01246960|20590254|P1|Overall Study|Lost to Follow-up|3
5953139|NCT01246583|20590315|P4|Overall Study|Withdrawal by Subject|0
5953140|NCT01246583|20590316|P3|Overall Study|Withdrawal by Subject|0
5953141|NCT01246583|20590317|P2|Overall Study|Withdrawal by Subject|0
5953142|NCT01246583|20590318|P1|Overall Study|Withdrawal by Subject|1
5953143|NCT01246583|20590315|P4|Overall Study|Protocol Violation|0
5953144|NCT01246583|20590316|P3|Overall Study|Protocol Violation|1
5953145|NCT01246583|20590317|P2|Overall Study|Protocol Violation|0
5953146|NCT01246583|20590318|P1|Overall Study|Protocol Violation|0
5953147|NCT01246583|20590315|P4|Overall Study|Lost to Follow-up|1
5953148|NCT01246583|20590316|P3|Overall Study|Lost to Follow-up|0
5953149|NCT01246583|20590317|P2|Overall Study|Lost to Follow-up|0
5953150|NCT01246583|20590318|P1|Overall Study|Lost to Follow-up|0
5953151|NCT01246206|20590457|P1|Overall Study|Patient did not receive study regiments.|1
5953152|NCT01246011|20590535|P3|Overall Study|Withdrawal by Subject|1
5953153|NCT01246011|20590536|P2|Overall Study|Withdrawal by Subject|0
5953154|NCT01246011|20590537|P1|Overall Study|Withdrawal by Subject|0
5953155|NCT01246011|20590535|P3|Overall Study|If needed warfarin clinically, withdrawn|3
5953156|NCT01246011|20590536|P2|Overall Study|If needed warfarin clinically, withdrawn|0
5953157|NCT01246011|20590537|P1|Overall Study|If needed warfarin clinically, withdrawn|0
5953158|NCT01245764|20590565|P4|Study Phase A|Lost to Follow-up|0
5953159|NCT01245764|20590566|P3|Study Phase A|Lost to Follow-up|5
5953160|NCT01245764|20590567|P2|Study Phase A|Lost to Follow-up|0
5953161|NCT01245764|20590568|P1|Study Phase A|Lost to Follow-up|0
5953162|NCT01245764|20590565|P4|Study Phase A|Protocol Violation|2
5953163|NCT01245764|20590566|P3|Study Phase A|Protocol Violation|2
5953164|NCT01245764|20590567|P2|Study Phase A|Protocol Violation|3
5953165|NCT01245764|20590568|P1|Study Phase A|Protocol Violation|6
5953166|NCT01245764|20590565|P4|Study Phase A|Other|1
5953167|NCT01245764|20590566|P3|Study Phase A|Other|3
5953168|NCT01245764|20590567|P2|Study Phase A|Other|2
5953169|NCT01245764|20590568|P1|Study Phase A|Other|3
5953170|NCT01245751|20590606|P4|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0
5953171|NCT01245751|20590607|P3|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0
5953172|NCT01245751|20590608|P2|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|4
5953173|NCT01245751|20590609|P1|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0
5953174|NCT01245751|20590606|P4|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|2
5953175|NCT01245751|20590607|P3|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0
5953176|NCT01245751|20590608|P2|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0
5953177|NCT01245751|20590609|P1|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0
5953178|NCT01245751|20590606|P4|Part 1: Day 1 to Week 52 (1 Year)|Death|0
5953179|NCT01245751|20590607|P3|Part 1: Day 1 to Week 52 (1 Year)|Death|0
5953180|NCT01245751|20590608|P2|Part 1: Day 1 to Week 52 (1 Year)|Death|1
5953181|NCT01245751|20590609|P1|Part 1: Day 1 to Week 52 (1 Year)|Death|2
5953182|NCT01245673|20590658|P1|MAGE-A3, Hiltonol®, PVC After T Cells|Off Study due to Disease Progression|1
5953183|NCT01245387|20590726|P1|Overall Study|Missing discontinuation status|369
5953184|NCT01245387|20590726|P1|Overall Study|Other|131
5953185|NCT01245387|20590726|P1|Overall Study|Death|3
5953186|NCT01245387|20590726|P1|Overall Study|Adverse Event|9
5953187|NCT01245387|20590726|P1|Overall Study|Lack of Efficacy|195
5953188|NCT01245387|20590726|P1|Overall Study|Lost to Follow-up|106
5953189|NCT01245374|20590775|P1|Overall Study|Withdrawal by Subject|3
5953190|NCT01245374|20590775|P1|Overall Study|Protocol Violation|1
5953191|NCT01245283|20590798|P3|Overall Study|Lost to Follow-up|11
5953192|NCT01245283|20590799|P2|Overall Study|Lost to Follow-up|11
5953193|NCT01245283|20590800|P1|Overall Study|Lost to Follow-up|14
5953194|NCT01245140|20590845|P2|Overall Study|Refused Treatment/Did Not Coopera|1
5953195|NCT01245140|20590846|P1|Overall Study|Refused Treatment/Did Not Coopera|0
5953196|NCT01245140|20590845|P2|Overall Study|Withdrawal by Subject|1
5953197|NCT01245140|20590846|P1|Overall Study|Withdrawal by Subject|0
5953198|NCT01245140|20590845|P2|Overall Study|Protocol Violation|1
5953199|NCT01245140|20590846|P1|Overall Study|Protocol Violation|0
5953200|NCT01245140|20590845|P2|Overall Study|Lack of Efficacy|4
5953201|NCT01245140|20590846|P1|Overall Study|Lack of Efficacy|2
5953202|NCT01245140|20590845|P2|Overall Study|Adverse Event|3
5953203|NCT01245140|20590846|P1|Overall Study|Adverse Event|1
5953204|NCT01245101|20590902|P2|Period 3 (Treatment)|Withdrawal by Subject|0
5953205|NCT01245101|20590903|P1|Period 3 (Treatment)|Withdrawal by Subject|1
5953206|NCT01245101|20590902|P2|Period 2 (Washout)|Withdrawal by Subject|0
5953207|NCT01245101|20590903|P1|Period 2 (Washout)|Withdrawal by Subject|1
5953208|NCT01245101|20590902|P2|Period 1 (Treatment)|Withdrawal by Subject|0
5953209|NCT01245101|20590903|P1|Period 1 (Treatment)|Withdrawal by Subject|2
5953210|NCT01245062|20590913|P3|Cross-over Phase|Study closed/ terminated|11
5953211|NCT01245062|20590914|P2|Cross-over Phase|Study closed/ terminated|0
5953212|NCT01245062|20590915|P1|Cross-over Phase|Study closed/ terminated|0
5953213|NCT01245062|20590913|P3|Cross-over Phase|Withdrew Consent|4
5953214|NCT01245062|20590914|P2|Cross-over Phase|Withdrew Consent|0
5953215|NCT01245062|20590915|P1|Cross-over Phase|Withdrew Consent|0
5953216|NCT01245062|20590913|P3|Cross-over Phase|Physician Decision|1
5953217|NCT01245062|20590914|P2|Cross-over Phase|Physician Decision|0
5953218|NCT01245062|20590915|P1|Cross-over Phase|Physician Decision|0
5953219|NCT01245062|20590913|P3|Cross-over Phase|Lost to Follow-up|1
5953220|NCT01245062|20590914|P2|Cross-over Phase|Lost to Follow-up|0
5953221|NCT01245062|20590915|P1|Cross-over Phase|Lost to Follow-up|0
5953222|NCT01245062|20590913|P3|Randomization and Crossover Phase|Study closed/ terminated|0
5953223|NCT01245062|20590914|P2|Randomization and Crossover Phase|Study closed/ terminated|14
5953224|NCT01245062|20590915|P1|Randomization and Crossover Phase|Study closed/ terminated|23
5953225|NCT01245062|20590913|P3|Randomization and Crossover Phase|Withdrew Consent|0
5953226|NCT01245062|20590914|P2|Randomization and Crossover Phase|Withdrew Consent|11
5953227|NCT01245062|20590915|P1|Randomization and Crossover Phase|Withdrew Consent|12
5953228|NCT01245062|20590913|P3|Randomization and Crossover Phase|Physician Decision|0
5953229|NCT01245062|20590914|P2|Randomization and Crossover Phase|Physician Decision|4
5953230|NCT01245062|20590915|P1|Randomization and Crossover Phase|Physician Decision|2
5953231|NCT01245062|20590913|P3|Randomization and Crossover Phase|Lost to Follow-up|0
5953232|NCT01245062|20590914|P2|Randomization and Crossover Phase|Lost to Follow-up|2
5953233|NCT01245062|20590915|P1|Randomization and Crossover Phase|Lost to Follow-up|4
5953234|NCT01245049|20590953|P2|Overall Study|Lost to Follow-up|2
5953235|NCT01245049|20590954|P1|Overall Study|Lost to Follow-up|1
5953236|NCT01245049|20590953|P2|Overall Study|Withdrawal by Subject|1
5953237|NCT01245049|20590954|P1|Overall Study|Withdrawal by Subject|0
5953238|NCT01245049|20590953|P2|Overall Study|Migrated/moved from study area|1
5953239|NCT01245049|20590954|P1|Overall Study|Migrated/moved from study area|0
5953240|NCT01244984|20591007|P3|Overall Study|Withdrawal by Subject|2
5953241|NCT01244984|20591008|P2|Overall Study|Withdrawal by Subject|2
5953242|NCT01244984|20591009|P1|Overall Study|Withdrawal by Subject|1
5953243|NCT01244984|20591007|P3|Overall Study|Protocol Defined Stopping Criteria|0
5953244|NCT01244984|20591008|P2|Overall Study|Protocol Defined Stopping Criteria|1
5953245|NCT01244984|20591009|P1|Overall Study|Protocol Defined Stopping Criteria|1
5953246|NCT01244984|20591007|P3|Overall Study|Protocol Violation|0
5953247|NCT01244984|20591008|P2|Overall Study|Protocol Violation|0
5953248|NCT01244984|20591009|P1|Overall Study|Protocol Violation|1
5953249|NCT01244984|20591007|P3|Overall Study|Adverse Event|2
5953250|NCT01244984|20591008|P2|Overall Study|Adverse Event|11
5953251|NCT01244984|20591009|P1|Overall Study|Adverse Event|2
5953252|NCT01244906|20591083|P1|Overall Study|Progression of disease post treatment|6
5953253|NCT01244906|20591083|P1|Overall Study|Death|2
5953254|NCT01244893|20591092|P2|1-Week Follow Up|Lost to Follow-up|0
5953255|NCT01244893|20591093|P1|1-Week Follow Up|Lost to Follow-up|1
5953256|NCT01244893|20591092|P2|Baseline|Protocol Violation|1
5953257|NCT01244893|20591093|P1|Baseline|Protocol Violation|0
5953258|NCT01244828|20591105|P1|Overall Study|Other reason (not specified)|1
5953259|NCT01244828|20591105|P1|Overall Study|Lost to Follow-up|2
5953260|NCT01244828|20591105|P1|Overall Study|Lack of Efficacy|7
5953261|NCT01244828|20591105|P1|Overall Study|Withdrawal by Subject|31
5953262|NCT01244828|20591105|P1|Overall Study|Adverse Event|37
5953263|NCT01244815|20591121|P4|Overall Study|Did Not Meet Protocol Eligibility|0
5953264|NCT01244815|20591122|P3|Overall Study|Did Not Meet Protocol Eligibility|0
5953265|NCT01244815|20591123|P2|Overall Study|Did Not Meet Protocol Eligibility|1
5953266|NCT01244815|20591124|P1|Overall Study|Did Not Meet Protocol Eligibility|0
5953267|NCT01244815|20591121|P4|Overall Study|Protocol Violation|1
5953268|NCT01244815|20591122|P3|Overall Study|Protocol Violation|3
5953269|NCT01244815|20591123|P2|Overall Study|Protocol Violation|4
5953270|NCT01244815|20591124|P1|Overall Study|Protocol Violation|7
5953271|NCT01244815|20591121|P4|Overall Study|Withdrawal by Subject|3
5953272|NCT01244815|20591122|P3|Overall Study|Withdrawal by Subject|0
5953273|NCT01244815|20591123|P2|Overall Study|Withdrawal by Subject|2
5953274|NCT01244815|20591124|P1|Overall Study|Withdrawal by Subject|0
5953275|NCT01244815|20591121|P4|Overall Study|Lost to Follow-up|2
5953276|NCT01244815|20591122|P3|Overall Study|Lost to Follow-up|3
5953277|NCT01244815|20591123|P2|Overall Study|Lost to Follow-up|2
5953278|NCT01244815|20591124|P1|Overall Study|Lost to Follow-up|3
5953279|NCT01244815|20591121|P4|Overall Study|Treatment Failure|1
5953280|NCT01244815|20591122|P3|Overall Study|Treatment Failure|0
5953281|NCT01244815|20591123|P2|Overall Study|Treatment Failure|0
5953282|NCT01244815|20591124|P1|Overall Study|Treatment Failure|0
5953283|NCT01244815|20591121|P4|Overall Study|Adverse Event|5
5953284|NCT01244815|20591122|P3|Overall Study|Adverse Event|5
5953285|NCT01244815|20591123|P2|Overall Study|Adverse Event|7
5953286|NCT01244815|20591124|P1|Overall Study|Adverse Event|4
5953287|NCT01244815|20591121|P4|Overall Study|Not Treated|0
5953288|NCT01244815|20591122|P3|Overall Study|Not Treated|0
5953289|NCT01244815|20591123|P2|Overall Study|Not Treated|1
5953290|NCT01244815|20591124|P1|Overall Study|Not Treated|0
5953291|NCT01244620|20591211|P4|Overall Study|Study terminated|4
5953292|NCT01244620|20591212|P3|Overall Study|Study terminated|4
5953293|NCT01244620|20591213|P2|Overall Study|Study terminated|4
5953294|NCT01244620|20591214|P1|Overall Study|Study terminated|4
5953295|NCT01244516|20591273|P3|Period 2 (1-week to 2-week Visit)|Poor Comfort|1
5953296|NCT01244516|20591274|P2|Period 2 (1-week to 2-week Visit)|Poor Comfort|0
5953297|NCT01244516|20591275|P1|Period 2 (1-week to 2-week Visit)|Poor Comfort|0
5953298|NCT01244516|20591273|P3|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0
5953299|NCT01244516|20591274|P2|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|1
5953300|NCT01244516|20591275|P1|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0
5953301|NCT01244516|20591273|P3|Period 2 (1-week to 2-week Visit)|Protocol Violation|1
5953302|NCT01244516|20591274|P2|Period 2 (1-week to 2-week Visit)|Protocol Violation|0
5953303|NCT01244516|20591275|P1|Period 2 (1-week to 2-week Visit)|Protocol Violation|1
5953304|NCT01244516|20591273|P3|Period 2 (1-week to 2-week Visit)|Adverse Event|0
5953305|NCT01244516|20591274|P2|Period 2 (1-week to 2-week Visit)|Adverse Event|0
5953306|NCT01244516|20591275|P1|Period 2 (1-week to 2-week Visit)|Adverse Event|2
5953307|NCT01244516|20591273|P3|Period 1 (Baseline to 1-week Visit)|Poor comfort|1
5953308|NCT01244516|20591274|P2|Period 1 (Baseline to 1-week Visit)|Poor comfort|0
5953309|NCT01244516|20591275|P1|Period 1 (Baseline to 1-week Visit)|Poor comfort|0
5953310|NCT01244516|20591273|P3|Period 1 (Baseline to 1-week Visit)|Poor Vision|0
5953311|NCT01244516|20591274|P2|Period 1 (Baseline to 1-week Visit)|Poor Vision|1
5953312|NCT01244516|20591275|P1|Period 1 (Baseline to 1-week Visit)|Poor Vision|0
5953313|NCT01244516|20591273|P3|Period 1 (Baseline to 1-week Visit)|Protocol Violation|2
5953314|NCT01244516|20591274|P2|Period 1 (Baseline to 1-week Visit)|Protocol Violation|5
5953315|NCT01244516|20591275|P1|Period 1 (Baseline to 1-week Visit)|Protocol Violation|4
5953316|NCT01244490|20591296|P3|Overall Study|Other|1
5953317|NCT01244490|20591297|P2|Overall Study|Other|0
5953318|NCT01244490|20591298|P1|Overall Study|Other|0
5953319|NCT01244490|20591296|P3|Overall Study|Lost to Follow-up|3
5953320|NCT01244490|20591297|P2|Overall Study|Lost to Follow-up|6
5953321|NCT01244490|20591298|P1|Overall Study|Lost to Follow-up|0
5953322|NCT01244490|20591296|P3|Overall Study|Adverse Event|5
5953323|NCT01244490|20591297|P2|Overall Study|Adverse Event|9
5953324|NCT01244490|20591298|P1|Overall Study|Adverse Event|1
5953325|NCT01244490|20591296|P3|Overall Study|Withdrawal by Subject|9
5953326|NCT01244490|20591297|P2|Overall Study|Withdrawal by Subject|4
5953327|NCT01244490|20591298|P1|Overall Study|Withdrawal by Subject|4
5953328|NCT01244490|20591296|P3|Overall Study|Lack of Efficacy|5
5953329|NCT01244490|20591297|P2|Overall Study|Lack of Efficacy|5
5953330|NCT01244490|20591298|P1|Overall Study|Lack of Efficacy|14
5953331|NCT01244425|20591375|P2|Overall Study|Adverse Event|1
5953332|NCT01244425|20591376|P1|Overall Study|Adverse Event|1
5953333|NCT01244425|20591375|P2|Overall Study|Withdrawal by Subject|2
5953334|NCT01244425|20591376|P1|Overall Study|Withdrawal by Subject|2
5953335|NCT01244191|20591407|P2|Overall Study|'Missing' or 'Terminated by sponsor'|8
5953336|NCT01244191|20591408|P1|Overall Study|'Missing' or 'Terminated by sponsor'|12
5953337|NCT01244191|20591407|P2|Overall Study|Withdrawal by Subject|23
5953338|NCT01244191|20591408|P1|Overall Study|Withdrawal by Subject|31
5953339|NCT01244191|20591407|P2|Overall Study|Protocol Violation|2
5953340|NCT01244191|20591408|P1|Overall Study|Protocol Violation|1
5953341|NCT01244191|20591407|P2|Overall Study|Lost to Follow-up|2
5953342|NCT01244191|20591408|P1|Overall Study|Lost to Follow-up|0
5953343|NCT01244191|20591407|P2|Overall Study|Death|29
5953344|NCT01244191|20591408|P1|Overall Study|Death|22
5953345|NCT01244191|20591407|P2|Overall Study|Adverse Event|48
5953346|NCT01244191|20591408|P1|Overall Study|Adverse Event|65
5953347|NCT01244191|20591407|P2|Overall Study|Clinical disease progression|36
5953348|NCT01244191|20591408|P1|Overall Study|Clinical disease progression|54
5953349|NCT01244191|20591407|P2|Overall Study|Progressive disease|350
5953350|NCT01244191|20591408|P1|Overall Study|Progressive disease|295
5953351|NCT01244126|20591431|P3|Overall Study|Protocol Violation|9
5953352|NCT01244126|20591432|P2|Overall Study|Protocol Violation|3
5953353|NCT01244126|20591433|P1|Overall Study|Protocol Violation|3
5953354|NCT01244061|20591446|P2|Overall Study|Randomized but not treated|2
5953355|NCT01244061|20591447|P1|Overall Study|Randomized but not treated|2
5953356|NCT01244061|20591446|P2|Overall Study|Adverse Event|2
5953357|NCT01244061|20591447|P1|Overall Study|Adverse Event|5
5953358|NCT01244061|20591446|P2|Overall Study|Protocol Violation|1
5953359|NCT01244061|20591447|P1|Overall Study|Protocol Violation|1
5953360|NCT01244061|20591446|P2|Overall Study|Other|19
5953361|NCT01244061|20591447|P1|Overall Study|Other|8
5953362|NCT01244061|20591446|P2|Overall Study|Withdrawal by Subject|46
5953363|NCT01244061|20591447|P1|Overall Study|Withdrawal by Subject|29
5953364|NCT01244061|20591446|P2|Overall Study|Lost to Follow-up|30
5953365|NCT01244061|20591447|P1|Overall Study|Lost to Follow-up|34
5953366|NCT01244061|20591446|P2|Overall Study|Lack of Efficacy|3
5953367|NCT01244061|20591447|P1|Overall Study|Lack of Efficacy|1
5953368|NCT01244061|20591446|P2|Overall Study|Did not meet entrance criteria|0
5953369|NCT01244061|20591447|P1|Overall Study|Did not meet entrance criteria|1
5953370|NCT01244061|20591446|P2|Overall Study|Death|0
5953371|NCT01244061|20591447|P1|Overall Study|Death|1
5953372|NCT01244035|20591459|P6|Part 1: Period 3|Protocol Deviation|0
5953373|NCT01244035|20591460|P5|Part 1: Period 3|Protocol Deviation|0
5953374|NCT01244035|20591461|P4|Part 1: Period 3|Protocol Deviation|0
5953375|NCT01244035|20591462|P3|Part 1: Period 3|Protocol Deviation|0
5953376|NCT01244035|20591463|P2|Part 1: Period 3|Protocol Deviation|1
5953377|NCT01244035|20591464|P1|Part 1: Period 3|Protocol Deviation|0
5953378|NCT01244035|20591459|P6|Part 1: Period 3|Withdrawal by Subject|0
5953379|NCT01244035|20591460|P5|Part 1: Period 3|Withdrawal by Subject|1
5953380|NCT01244035|20591461|P4|Part 1: Period 3|Withdrawal by Subject|0
5953381|NCT01244035|20591462|P3|Part 1: Period 3|Withdrawal by Subject|0
5953382|NCT01244035|20591463|P2|Part 1: Period 3|Withdrawal by Subject|0
5953383|NCT01244035|20591464|P1|Part 1: Period 3|Withdrawal by Subject|0
5953384|NCT01244035|20591459|P6|Part 1: Period 3|Adverse Event|1
5953385|NCT01244035|20591460|P5|Part 1: Period 3|Adverse Event|0
5953386|NCT01244035|20591461|P4|Part 1: Period 3|Adverse Event|0
5953387|NCT01244035|20591462|P3|Part 1: Period 3|Adverse Event|0
5953388|NCT01244035|20591463|P2|Part 1: Period 3|Adverse Event|0
5953389|NCT01244035|20591464|P1|Part 1: Period 3|Adverse Event|0
5953390|NCT01244035|20591459|P6|Part 1: Period 2|Fulfilled Stopping Criteria|0
5953391|NCT01244035|20591460|P5|Part 1: Period 2|Fulfilled Stopping Criteria|0
5953392|NCT01244035|20591461|P4|Part 1: Period 2|Fulfilled Stopping Criteria|0
5953393|NCT01244035|20591462|P3|Part 1: Period 2|Fulfilled Stopping Criteria|1
5953394|NCT01244035|20591463|P2|Part 1: Period 2|Fulfilled Stopping Criteria|0
5953395|NCT01244035|20591464|P1|Part 1: Period 2|Fulfilled Stopping Criteria|0
5953396|NCT01244035|20591459|P6|Part 1: Period 1|Fulfilled Stopping Criteria|1
5953397|NCT01244035|20591460|P5|Part 1: Period 1|Fulfilled Stopping Criteria|1
5953398|NCT01244035|20591461|P4|Part 1: Period 1|Fulfilled Stopping Criteria|0
5953399|NCT01244035|20591462|P3|Part 1: Period 1|Fulfilled Stopping Criteria|2
5953400|NCT01244035|20591463|P2|Part 1: Period 1|Fulfilled Stopping Criteria|0
5953401|NCT01244035|20591464|P1|Part 1: Period 1|Fulfilled Stopping Criteria|1
5953402|NCT01244035|20591459|P6|Part 1: Period 1|Withdrawal by Subject|0
5953403|NCT01244035|20591460|P5|Part 1: Period 1|Withdrawal by Subject|0
5953404|NCT01244035|20591461|P4|Part 1: Period 1|Withdrawal by Subject|0
5953405|NCT01244035|20591462|P3|Part 1: Period 1|Withdrawal by Subject|0
5953406|NCT01244035|20591463|P2|Part 1: Period 1|Withdrawal by Subject|2
5953407|NCT01244035|20591464|P1|Part 1: Period 1|Withdrawal by Subject|0
5953408|NCT01244035|20591459|P6|Part 1: Period 1|Adverse Event|1
5953409|NCT01244035|20591460|P5|Part 1: Period 1|Adverse Event|0
5953410|NCT01244035|20591461|P4|Part 1: Period 1|Adverse Event|0
5953411|NCT01244035|20591462|P3|Part 1: Period 1|Adverse Event|0
5953412|NCT01244035|20591463|P2|Part 1: Period 1|Adverse Event|0
5953413|NCT01244035|20591464|P1|Part 1: Period 1|Adverse Event|0
5953414|NCT01243944|20591505|P2|Overall Study|Non-compliance with study treatment|0
5953415|NCT01243944|20591506|P1|Overall Study|Non-compliance with study treatment|1
5953416|NCT01243944|20591505|P2|Overall Study|Death|3
5953417|NCT01243944|20591506|P1|Overall Study|Death|2
5953418|NCT01243944|20591505|P2|Overall Study|Participant decision|15
5953419|NCT01243944|20591506|P1|Overall Study|Participant decision|10
5953420|NCT01243944|20591505|P2|Overall Study|Protocol deviation|1
5953421|NCT01243944|20591506|P1|Overall Study|Protocol deviation|1
5953422|NCT01243944|20591505|P2|Overall Study|Disease progression|11
5953423|NCT01243944|20591506|P1|Overall Study|Disease progression|12
5953424|NCT01243944|20591505|P2|Overall Study|Physician Decision|7
5953425|NCT01243944|20591506|P1|Overall Study|Physician Decision|2
5953426|NCT01243944|20591505|P2|Overall Study|Lost to Follow-up|1
5953427|NCT01243944|20591506|P1|Overall Study|Lost to Follow-up|2
5953428|NCT01243944|20591505|P2|Overall Study|Adverse Event|13
5953429|NCT01243944|20591506|P1|Overall Study|Adverse Event|15
5953430|NCT01243892|20591534|P2|Overall Study|Did not meet eligibility criteria|0
5953431|NCT01243892|20591535|P1|Overall Study|Did not meet eligibility criteria|2
5953432|NCT01243775|20591545|P1|Overall Study|Withdrawal by Subject|2
5953433|NCT01243762|20591559|P7|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0
5953434|NCT01243762|20591560|P6|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0
5953435|NCT01243762|20591561|P5|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1
5953436|NCT01243762|20591562|P4|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1
5953437|NCT01243762|20591563|P3|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0
5953438|NCT01243762|20591564|P2|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0
5953439|NCT01243762|20591565|P1|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0
5953440|NCT01243762|20591559|P7|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0
5953441|NCT01243762|20591560|P6|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0
5953442|NCT01243762|20591561|P5|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1
5953443|NCT01243762|20591562|P4|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0
5953444|NCT01243762|20591563|P3|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0
5953445|NCT01243762|20591564|P2|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1
5953446|NCT01243762|20591565|P1|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0
5953447|NCT01243762|20591559|P7|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3
5953448|NCT01243762|20591560|P6|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0
5953449|NCT01243762|20591561|P5|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|2
5953450|NCT01243762|20591562|P4|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1
5953451|NCT01243762|20591563|P3|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0
5953452|NCT01243762|20591564|P2|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3
5953453|NCT01243762|20591565|P1|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1
5953454|NCT01243762|20591559|P7|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|3
5953455|NCT01243762|20591560|P6|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0
5953456|NCT01243762|20591561|P5|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0
5953457|NCT01243762|20591562|P4|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0
5953458|NCT01243762|20591563|P3|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0
5953459|NCT01243762|20591564|P2|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|1
5953460|NCT01243762|20591565|P1|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0
5953461|NCT01243762|20591559|P7|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0
5953462|NCT01243762|20591560|P6|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0
5953463|NCT01243762|20591561|P5|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0
5953464|NCT01243762|20591562|P4|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0
5953465|NCT01243762|20591563|P3|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0
5953466|NCT01243762|20591564|P2|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|3
5953467|NCT01243762|20591565|P1|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0
5953468|NCT01243762|20591559|P7|Part 1 (Dose Escalation/MTD)|Progressive Disease|0
5953469|NCT01243762|20591560|P6|Part 1 (Dose Escalation/MTD)|Progressive Disease|2
5953470|NCT01243762|20591561|P5|Part 1 (Dose Escalation/MTD)|Progressive Disease|5
5953471|NCT01243762|20591562|P4|Part 1 (Dose Escalation/MTD)|Progressive Disease|5
5953472|NCT01243762|20591563|P3|Part 1 (Dose Escalation/MTD)|Progressive Disease|3
5953473|NCT01243762|20591564|P2|Part 1 (Dose Escalation/MTD)|Progressive Disease|2
5953474|NCT01243762|20591565|P1|Part 1 (Dose Escalation/MTD)|Progressive Disease|3
5953475|NCT01243762|20591559|P7|Part 1 (Dose Escalation/MTD)|Physician Decision|0
5953476|NCT01243762|20591560|P6|Part 1 (Dose Escalation/MTD)|Physician Decision|0
5953477|NCT01243762|20591561|P5|Part 1 (Dose Escalation/MTD)|Physician Decision|0
5953478|NCT01243762|20591562|P4|Part 1 (Dose Escalation/MTD)|Physician Decision|1
5953479|NCT01243762|20591563|P3|Part 1 (Dose Escalation/MTD)|Physician Decision|0
5953480|NCT01243762|20591564|P2|Part 1 (Dose Escalation/MTD)|Physician Decision|1
5953481|NCT01243762|20591565|P1|Part 1 (Dose Escalation/MTD)|Physician Decision|0
5953482|NCT01243762|20591559|P7|Part 1 (Dose Escalation/MTD)|Adverse Event|0
5953483|NCT01243762|20591560|P6|Part 1 (Dose Escalation/MTD)|Adverse Event|1
5953484|NCT01243762|20591561|P5|Part 1 (Dose Escalation/MTD)|Adverse Event|1
5953485|NCT01243762|20591562|P4|Part 1 (Dose Escalation/MTD)|Adverse Event|0
5953486|NCT01243762|20591563|P3|Part 1 (Dose Escalation/MTD)|Adverse Event|0
5953487|NCT01243762|20591564|P2|Part 1 (Dose Escalation/MTD)|Adverse Event|2
5953488|NCT01243762|20591565|P1|Part 1 (Dose Escalation/MTD)|Adverse Event|0
5953489|NCT01243671|20591584|P1|Overall Study|Other|1
5953490|NCT01243671|20591584|P1|Overall Study|Anti-adalimumab antibody positive|1
5953491|NCT01243671|20591584|P1|Overall Study|Adverse Event|3
5953492|NCT01243424|20591663|P2|Discontinuation From Treatment|Other than listed above|211
5953493|NCT01243424|20591664|P1|Discontinuation From Treatment|Other than listed above|230
5953494|NCT01243424|20591663|P2|Discontinuation From Treatment|Withdrawal by Subject|328
5953495|NCT01243424|20591664|P1|Discontinuation From Treatment|Withdrawal by Subject|309
5953496|NCT01243424|20591663|P2|Discontinuation From Treatment|Lost to Follow-up|28
5953497|NCT01243424|20591664|P1|Discontinuation From Treatment|Lost to Follow-up|24
5953498|NCT01243424|20591663|P2|Discontinuation From Treatment|Protocol Violation|47
5953499|NCT01243424|20591664|P1|Discontinuation From Treatment|Protocol Violation|46
5953500|NCT01243424|20591663|P2|Discontinuation From Treatment|Lack of Efficacy|41
5953501|NCT01243424|20591664|P1|Discontinuation From Treatment|Lack of Efficacy|61
5953502|NCT01243424|20591663|P2|Discontinuation From Treatment|Adverse Event|523
5953503|NCT01243424|20591664|P1|Discontinuation From Treatment|Adverse Event|457
5953504|NCT01243424|20591663|P2|Discontinuation From Treatment|Not treated|4
5953505|NCT01243424|20591664|P1|Discontinuation From Treatment|Not treated|5
5953506|NCT01243424|20591663|P2|Discontinuation From Study (Treated Set)|Not treated|4
5953507|NCT01243424|20591664|P1|Discontinuation From Study (Treated Set)|Not treated|5
5953508|NCT01243424|20591663|P2|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusUnknown)|8
5953509|NCT01243424|20591664|P1|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusUnknown)|8
5953510|NCT01243424|20591663|P2|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusAlive)|35
5953511|NCT01243424|20591664|P1|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusAlive)|38
5953512|NCT01243424|20591663|P2|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|1
5953513|NCT01243424|20591664|P1|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|0
5953514|NCT01243424|20591663|P2|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|22
5953515|NCT01243424|20591664|P1|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|15
5953516|NCT01243424|20591663|P2|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|12
5953517|NCT01243424|20591664|P1|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|14
5953518|NCT01243424|20591663|P2|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|37
5953519|NCT01243424|20591664|P1|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|49
5953520|NCT01243411|20591706|P1|Overall Study|Other|8
5953521|NCT01243411|20591706|P1|Overall Study|Adverse Event|5
5953522|NCT01243411|20591706|P1|Overall Study|Lost to Follow-up|10
5953523|NCT01243411|20591706|P1|Overall Study|Withdrawal by Subject|18
5953524|NCT01243268|20591817|P1|Overall Study|Duplicate subject|2
5953525|NCT01243268|20591817|P1|Overall Study|Deviation with contract date|7
5953526|NCT01243268|20591817|P1|Overall Study|Protocol Violation|51
5953527|NCT01243268|20591817|P1|Overall Study|Lost to Follow-up|4
5953528|NCT01243242|20591827|P2|Overall Study|non compliance|0
5953529|NCT01243242|20591828|P1|Overall Study|non compliance|1
5953530|NCT01243242|20591827|P2|Overall Study|sponsor decision|1
5953531|NCT01243242|20591828|P1|Overall Study|sponsor decision|0
5953532|NCT01243242|20591827|P2|Overall Study|Physician Decision|1
5953533|NCT01243242|20591828|P1|Overall Study|Physician Decision|0
5953534|NCT01243242|20591827|P2|Overall Study|Withdrawal by Subject|1
5953535|NCT01243242|20591828|P1|Overall Study|Withdrawal by Subject|1
5953536|NCT01243242|20591827|P2|Overall Study|Adverse Event|1
5953537|NCT01243242|20591828|P1|Overall Study|Adverse Event|1
5953558|NCT01243151|20591864|P5|Overall Study|Randomized but not treated|0
5953559|NCT01243151|20591865|P4|Overall Study|Randomized but not treated|1
5953560|NCT01243151|20591866|P3|Overall Study|Randomized but not treated|0
5953561|NCT01243151|20591867|P2|Overall Study|Randomized but not treated|0
5953562|NCT01243151|20591868|P1|Overall Study|Randomized but not treated|0
5953563|NCT01243151|20591864|P5|Overall Study|Other|0
5953564|NCT01243151|20591865|P4|Overall Study|Other|1
5953565|NCT01243151|20591866|P3|Overall Study|Other|0
5953566|NCT01243151|20591867|P2|Overall Study|Other|0
5953567|NCT01243151|20591868|P1|Overall Study|Other|0
5953568|NCT01243151|20591864|P5|Overall Study|Protocol Violation|0
5953569|NCT01243151|20591865|P4|Overall Study|Protocol Violation|0
5953570|NCT01243151|20591866|P3|Overall Study|Protocol Violation|1
5953571|NCT01243151|20591867|P2|Overall Study|Protocol Violation|0
5953572|NCT01243151|20591868|P1|Overall Study|Protocol Violation|0
5953573|NCT01243151|20591864|P5|Overall Study|Adverse Event|0
5953574|NCT01243151|20591865|P4|Overall Study|Adverse Event|0
5953575|NCT01243151|20591866|P3|Overall Study|Adverse Event|0
5953576|NCT01243151|20591867|P2|Overall Study|Adverse Event|1
5953577|NCT01243151|20591868|P1|Overall Study|Adverse Event|0
5953578|NCT01242813|20592112|P1|Overall Study|Lost to Follow-up|2
5953579|NCT01242748|20592134|P2|Overall Study|Miscellaneous reasons|3
5953580|NCT01242748|20592135|P1|Overall Study|Miscellaneous reasons|8
5953581|NCT01242748|20592134|P2|Overall Study|Withdrawal by Subject|2
5953582|NCT01242748|20592135|P1|Overall Study|Withdrawal by Subject|10
5953583|NCT01242748|20592134|P2|Overall Study|Protocol Violation|0
5953584|NCT01242748|20592135|P1|Overall Study|Protocol Violation|1
5953585|NCT01242748|20592134|P2|Overall Study|Physician Decision|2
5953586|NCT01242748|20592135|P1|Overall Study|Physician Decision|3
5953587|NCT01242748|20592134|P2|Overall Study|Lost to Follow-up|2
5953588|NCT01242748|20592135|P1|Overall Study|Lost to Follow-up|6
5953589|NCT01242748|20592134|P2|Overall Study|Adverse Event|5
5953590|NCT01242748|20592135|P1|Overall Study|Adverse Event|10
5953591|NCT01242514|20592209|P3|Overall Study|Adverse Event|19
5953592|NCT01242514|20592210|P2|Overall Study|Adverse Event|18
5953593|NCT01242514|20592211|P1|Overall Study|Adverse Event|129
5953594|NCT01242514|20592209|P3|Overall Study|Lost to Follow-up|4
5953595|NCT01242514|20592210|P2|Overall Study|Lost to Follow-up|5
5953596|NCT01242514|20592211|P1|Overall Study|Lost to Follow-up|14
5953597|NCT01242514|20592209|P3|Overall Study|Dev. of study specific discont. criteria|5
5953598|NCT01242514|20592210|P2|Overall Study|Dev. of study specific discont. criteria|3
5953599|NCT01242514|20592211|P1|Overall Study|Dev. of study specific discont. criteria|21
5953600|NCT01242514|20592209|P3|Overall Study|Lack of therapeutic response|10
5953601|NCT01242514|20592210|P2|Overall Study|Lack of therapeutic response|16
5953602|NCT01242514|20592211|P1|Overall Study|Lack of therapeutic response|99
5953603|NCT01242514|20592209|P3|Overall Study|Severe non-compliance to protocol|1
5953604|NCT01242514|20592210|P2|Overall Study|Severe non-compliance to protocol|2
5953605|NCT01242514|20592211|P1|Overall Study|Severe non-compliance to protocol|5
5953606|NCT01242514|20592209|P3|Overall Study|Subject decision|2
5953607|NCT01242514|20592210|P2|Overall Study|Subject decision|8
5953608|NCT01242514|20592211|P1|Overall Study|Subject decision|33
5953609|NCT01242514|20592209|P3|Overall Study|e.g., project closure|171
5953610|NCT01242514|20592210|P2|Overall Study|e.g., project closure|305
5953611|NCT01242514|20592211|P1|Overall Study|e.g., project closure|1042
5953612|NCT01242371|20592230|P2|Overall Study|Protocol Violation|3
5953613|NCT01242371|20592231|P1|Overall Study|Protocol Violation|0
5953614|NCT01242371|20592230|P2|Overall Study|Withdrawal by Subject|2
5953615|NCT01242371|20592231|P1|Overall Study|Withdrawal by Subject|2
5953616|NCT01242176|20592248|P2|Washout Period of 7 Days|Non-compliant with protocol|0
5953617|NCT01242176|20592249|P1|Washout Period of 7 Days|Non-compliant with protocol|1
5953618|NCT01242176|20592248|P2|Washout Period of 7 Days|Adverse Event|2
5953619|NCT01242176|20592249|P1|Washout Period of 7 Days|Adverse Event|0
5953620|NCT01242111|20592259|P1|Overall Study|Did not consent to MOR-100 follow-up|1
5953621|NCT01242111|20592259|P1|Overall Study|Withdrawal by Subject|1
5953622|NCT01242111|20592259|P1|Overall Study|Adverse Event|1
5953623|NCT01242085|20592271|P3|Overall Study|medically unable to have surgery|0
5953624|NCT01242085|20592272|P2|Overall Study|medically unable to have surgery|5
5953625|NCT01242085|20592273|P1|Overall Study|medically unable to have surgery|4
5953626|NCT01242085|20592271|P3|Overall Study|Withdrawal by Subject|0
5953627|NCT01242085|20592272|P2|Overall Study|Withdrawal by Subject|2
5953628|NCT01242085|20592273|P1|Overall Study|Withdrawal by Subject|4
5953629|NCT01242020|20592283|P2|Overall Study|Failed screening|0
5953630|NCT01242020|20592284|P1|Overall Study|Failed screening|1
5953631|NCT01242020|20592283|P2|Overall Study|Withdrawal by Subject|0
5953632|NCT01242020|20592284|P1|Overall Study|Withdrawal by Subject|2
5953633|NCT01241760|20592314|P2|Overall Study|Other|1
5953634|NCT01241760|20592315|P1|Overall Study|Other|1
5953635|NCT01241760|20592314|P2|Overall Study|Switch To Commercially Available Medicat|4
5953636|NCT01241760|20592315|P1|Overall Study|Switch To Commercially Available Medicat|1
5953637|NCT01241760|20592314|P2|Overall Study|Withdrawal by Subject|13
5953638|NCT01241760|20592315|P1|Overall Study|Withdrawal by Subject|13
5953639|NCT01241760|20592314|P2|Overall Study|Lost to Follow-up|22
5953640|NCT01241760|20592315|P1|Overall Study|Lost to Follow-up|18
5953641|NCT01241760|20592314|P2|Overall Study|Adverse Event|0
5953642|NCT01241760|20592315|P1|Overall Study|Adverse Event|1
5953643|NCT01241604|20592334|P3|Screening Period|Screen Failure|0
5953644|NCT01241604|20592335|P2|Screening Period|Screen Failure|0
5953645|NCT01241604|20592336|P1|Screening Period|Screen Failure|3
5953646|NCT01241591|20592381|P4|Overall Study|Adverse Event|4
5953647|NCT01241591|20592382|P3|Overall Study|Adverse Event|12
5953648|NCT01241591|20592383|P2|Overall Study|Adverse Event|11
5953649|NCT01241591|20592384|P1|Overall Study|Adverse Event|3
5953650|NCT01241591|20592381|P4|Overall Study|Other|1
5953651|NCT01241591|20592382|P3|Overall Study|Other|0
5953652|NCT01241591|20592383|P2|Overall Study|Other|1
5953653|NCT01241591|20592384|P1|Overall Study|Other|0
5953654|NCT01241591|20592381|P4|Overall Study|Withdrawal by Subject|2
5953655|NCT01241591|20592382|P3|Overall Study|Withdrawal by Subject|2
5953656|NCT01241591|20592383|P2|Overall Study|Withdrawal by Subject|4
5953657|NCT01241591|20592384|P1|Overall Study|Withdrawal by Subject|6
5953658|NCT01241591|20592381|P4|Overall Study|Screen Failure|0
5953659|NCT01241591|20592382|P3|Overall Study|Screen Failure|1
5953660|NCT01241591|20592383|P2|Overall Study|Screen Failure|2
5953661|NCT01241591|20592384|P1|Overall Study|Screen Failure|3
5953662|NCT01241591|20592381|P4|Overall Study|Lost to Follow-up|2
5953663|NCT01241591|20592382|P3|Overall Study|Lost to Follow-up|2
5953664|NCT01241591|20592383|P2|Overall Study|Lost to Follow-up|2
5953665|NCT01241591|20592384|P1|Overall Study|Lost to Follow-up|1
5953666|NCT01241591|20592381|P4|Overall Study|Protocol Violation|0
5953667|NCT01241591|20592382|P3|Overall Study|Protocol Violation|3
5953668|NCT01241591|20592383|P2|Overall Study|Protocol Violation|2
5953669|NCT01241591|20592384|P1|Overall Study|Protocol Violation|5
5953670|NCT01241591|20592381|P4|Overall Study|Lack of Efficacy|3
5953671|NCT01241591|20592382|P3|Overall Study|Lack of Efficacy|2
5953672|NCT01241591|20592383|P2|Overall Study|Lack of Efficacy|2
5953673|NCT01241591|20592384|P1|Overall Study|Lack of Efficacy|5
5953674|NCT01241552|20592587|P4|Overall Study|Lost to Follow-up|16
5953675|NCT01241552|20592588|P3|Overall Study|Lost to Follow-up|15
5953676|NCT01241552|20592589|P2|Overall Study|Lost to Follow-up|11
5953677|NCT01241552|20592590|P1|Overall Study|Lost to Follow-up|2
5953678|NCT01241552|20592587|P4|Overall Study|Physician Decision|3
5953679|NCT01241552|20592588|P3|Overall Study|Physician Decision|2
5953680|NCT01241552|20592589|P2|Overall Study|Physician Decision|4
5953681|NCT01241552|20592590|P1|Overall Study|Physician Decision|2
5953682|NCT01241552|20592587|P4|Overall Study|Withdrawal by Subject|15
5953683|NCT01241552|20592588|P3|Overall Study|Withdrawal by Subject|14
5953684|NCT01241552|20592589|P2|Overall Study|Withdrawal by Subject|15
5953685|NCT01241552|20592590|P1|Overall Study|Withdrawal by Subject|7
5953686|NCT01241552|20592587|P4|Overall Study|Protocol Violation|1
5953687|NCT01241552|20592588|P3|Overall Study|Protocol Violation|6
5953688|NCT01241552|20592589|P2|Overall Study|Protocol Violation|2
5953689|NCT01241552|20592590|P1|Overall Study|Protocol Violation|0
5953690|NCT01241552|20592587|P4|Overall Study|Progressive Disease|2
5953691|NCT01241552|20592588|P3|Overall Study|Progressive Disease|1
5953692|NCT01241552|20592589|P2|Overall Study|Progressive Disease|0
5953693|NCT01241552|20592590|P1|Overall Study|Progressive Disease|0
5953694|NCT01241552|20592587|P4|Overall Study|Technical Problems|2
5953695|NCT01241552|20592588|P3|Overall Study|Technical Problems|2
5953696|NCT01241552|20592589|P2|Overall Study|Technical Problems|0
5953697|NCT01241552|20592590|P1|Overall Study|Technical Problems|2
5953698|NCT01241552|20592587|P4|Overall Study|Adverse Event|0
5953699|NCT01241552|20592588|P3|Overall Study|Adverse Event|0
5953700|NCT01241552|20592589|P2|Overall Study|Adverse Event|1
5953701|NCT01241552|20592590|P1|Overall Study|Adverse Event|1
5953702|NCT01241552|20592587|P4|Overall Study|Death|25
5953703|NCT01241552|20592588|P3|Overall Study|Death|20
5953704|NCT01241552|20592589|P2|Overall Study|Death|30
5953705|NCT01241552|20592590|P1|Overall Study|Death|26
5953706|NCT01241552|20592587|P4|Overall Study|Lack of Efficacy|0
5953707|NCT01241552|20592588|P3|Overall Study|Lack of Efficacy|0
5953708|NCT01241552|20592589|P2|Overall Study|Lack of Efficacy|0
5953709|NCT01241552|20592590|P1|Overall Study|Lack of Efficacy|1
5953710|NCT01241461|20592685|P2|Overall Study|Progressive Disease|6
5953711|NCT01241461|20592686|P1|Overall Study|Progressive Disease|3
5953712|NCT01241448|20592706|P4|Overall Study|Excluded due to data integrity issues|2
5953713|NCT01241448|20592707|P3|Overall Study|Excluded due to data integrity issues|2
5953714|NCT01241448|20592708|P2|Overall Study|Excluded due to data integrity issues|2
5953715|NCT01241448|20592709|P1|Overall Study|Excluded due to data integrity issues|3
5953716|NCT01241448|20592706|P4|Overall Study|Withdrawal by Subject|6
5953717|NCT01241448|20592707|P3|Overall Study|Withdrawal by Subject|3
5953718|NCT01241448|20592708|P2|Overall Study|Withdrawal by Subject|5
5953719|NCT01241448|20592709|P1|Overall Study|Withdrawal by Subject|4
5953720|NCT01241448|20592706|P4|Overall Study|Sponsor Decision|6
5953721|NCT01241448|20592707|P3|Overall Study|Sponsor Decision|12
5953722|NCT01241448|20592708|P2|Overall Study|Sponsor Decision|14
5953723|NCT01241448|20592709|P1|Overall Study|Sponsor Decision|17
5953724|NCT01241448|20592706|P4|Overall Study|Protocol Violation|6
5953725|NCT01241448|20592707|P3|Overall Study|Protocol Violation|3
5953726|NCT01241448|20592708|P2|Overall Study|Protocol Violation|5
5953727|NCT01241448|20592709|P1|Overall Study|Protocol Violation|10
5953728|NCT01241448|20592706|P4|Overall Study|Physician Decision|0
5953729|NCT01241448|20592707|P3|Overall Study|Physician Decision|0
5953730|NCT01241448|20592708|P2|Overall Study|Physician Decision|2
5953731|NCT01241448|20592709|P1|Overall Study|Physician Decision|0
5953732|NCT01241448|20592706|P4|Overall Study|Lost to Follow-up|1
5953733|NCT01241448|20592707|P3|Overall Study|Lost to Follow-up|1
5953734|NCT01241448|20592708|P2|Overall Study|Lost to Follow-up|1
5953735|NCT01241448|20592709|P1|Overall Study|Lost to Follow-up|2
5953736|NCT01241448|20592706|P4|Overall Study|Adverse Event|2
5953737|NCT01241448|20592707|P3|Overall Study|Adverse Event|2
5953738|NCT01241448|20592708|P2|Overall Study|Adverse Event|0
5953739|NCT01241448|20592709|P1|Overall Study|Adverse Event|1
5953740|NCT01241318|20592800|P2|Overall Study|Woman: Stillborn infant|146
5953741|NCT01241318|20592801|P1|Overall Study|Woman: Stillborn infant|129
5953742|NCT01241318|20592800|P2|Overall Study|Withdrew/Lost to Follow after delivery|38
5953743|NCT01241318|20592801|P1|Overall Study|Withdrew/Lost to Follow after delivery|60
5953744|NCT01241318|20592800|P2|Overall Study|Death|4
5953745|NCT01241318|20592801|P1|Overall Study|Death|2
5953746|NCT01241318|20592800|P2|Overall Study|Lost to Follow-up|455
5953747|NCT01241318|20592801|P1|Overall Study|Lost to Follow-up|740
5953748|NCT01241318|20592800|P2|Overall Study|Withdrawal by Subject|46
5953749|NCT01241318|20592801|P1|Overall Study|Withdrawal by Subject|175
5953750|NCT01241318|20592800|P2|Overall Study|Woman: miscarriage/abortion|38
5953751|NCT01241318|20592801|P1|Overall Study|Woman: miscarriage/abortion|46
5953752|NCT01241318|20592800|P2|Overall Study|Woman: false pregnancies|15
5953753|NCT01241318|20592801|P1|Overall Study|Woman: false pregnancies|27
5953754|NCT01241292|20592818|P2|Overall Study|Participant Discontinued Treatment|2
5953755|NCT01241292|20592819|P1|Overall Study|Participant Discontinued Treatment|0
5953756|NCT01241292|20592818|P2|Overall Study|Study Drug Toxicity|1
5953757|NCT01241292|20592819|P1|Overall Study|Study Drug Toxicity|0
5953758|NCT01241292|20592818|P2|Overall Study|Disease Progression|0
5953759|NCT01241292|20592819|P1|Overall Study|Disease Progression|2
5953760|NCT01241292|20592818|P2|Overall Study|Administrative Reason by Sponsor|0
5953761|NCT01241292|20592819|P1|Overall Study|Administrative Reason by Sponsor|1
5953762|NCT01241279|20592843|P2|Overall Study|Lost to Follow-up|1
5953763|NCT01241279|20592844|P1|Overall Study|Lost to Follow-up|0
5953764|NCT01241240|20592854|P2|Overall Study|Personal Reasons|1
5953765|NCT01241240|20592855|P1|Overall Study|Personal Reasons|1
5953766|NCT01241240|20592854|P2|Overall Study|Lost to Follow-up|4
5953767|NCT01241240|20592855|P1|Overall Study|Lost to Follow-up|2
5953768|NCT01241240|20592854|P2|Overall Study|Adverse Event|4
5953769|NCT01241240|20592855|P1|Overall Study|Adverse Event|5
5953770|NCT01240915|20592873|P9|Overall Study|Insufficient Clinical Response|3
5953771|NCT01240915|20592874|P8|Overall Study|Insufficient Clinical Response|0
5953772|NCT01240915|20592875|P7|Overall Study|Insufficient Clinical Response|6
5953773|NCT01240915|20592876|P6|Overall Study|Insufficient Clinical Response|3
5953774|NCT01240915|20592877|P5|Overall Study|Insufficient Clinical Response|1
5953775|NCT01240915|20592878|P4|Overall Study|Insufficient Clinical Response|0
5953776|NCT01240915|20592879|P3|Overall Study|Insufficient Clinical Response|0
5953777|NCT01240915|20592880|P2|Overall Study|Insufficient Clinical Response|0
5953778|NCT01240915|20592881|P1|Overall Study|Insufficient Clinical Response|0
5953779|NCT01240915|20592873|P9|Overall Study|Other|0
5953780|NCT01240915|20592874|P8|Overall Study|Other|0
5953781|NCT01240915|20592875|P7|Overall Study|Other|0
5953782|NCT01240915|20592876|P6|Overall Study|Other|0
5953783|NCT01240915|20592877|P5|Overall Study|Other|2
5953784|NCT01240915|20592878|P4|Overall Study|Other|0
5953785|NCT01240915|20592879|P3|Overall Study|Other|0
5953786|NCT01240915|20592880|P2|Overall Study|Other|0
5953787|NCT01240915|20592881|P1|Overall Study|Other|0
5953788|NCT01240915|20592873|P9|Overall Study|Withdrawal by Subject|3
5953789|NCT01240915|20592874|P8|Overall Study|Withdrawal by Subject|3
5953790|NCT01240915|20592875|P7|Overall Study|Withdrawal by Subject|2
5953791|NCT01240915|20592876|P6|Overall Study|Withdrawal by Subject|4
5953792|NCT01240915|20592877|P5|Overall Study|Withdrawal by Subject|0
5953793|NCT01240915|20592878|P4|Overall Study|Withdrawal by Subject|2
5953794|NCT01240915|20592879|P3|Overall Study|Withdrawal by Subject|0
5953795|NCT01240915|20592880|P2|Overall Study|Withdrawal by Subject|1
5953796|NCT01240915|20592881|P1|Overall Study|Withdrawal by Subject|2
5953797|NCT01240915|20592873|P9|Overall Study|Lost to Follow-up|1
5953798|NCT01240915|20592874|P8|Overall Study|Lost to Follow-up|1
5953799|NCT01240915|20592875|P7|Overall Study|Lost to Follow-up|0
5953800|NCT01240915|20592876|P6|Overall Study|Lost to Follow-up|1
5953801|NCT01240915|20592877|P5|Overall Study|Lost to Follow-up|1
5953802|NCT01240915|20592878|P4|Overall Study|Lost to Follow-up|0
5953803|NCT01240915|20592879|P3|Overall Study|Lost to Follow-up|0
5953804|NCT01240915|20592880|P2|Overall Study|Lost to Follow-up|0
5953805|NCT01240915|20592881|P1|Overall Study|Lost to Follow-up|0
5953806|NCT01240915|20592873|P9|Overall Study|Adverse Event|1
5953807|NCT01240915|20592874|P8|Overall Study|Adverse Event|0
5953808|NCT01240915|20592875|P7|Overall Study|Adverse Event|0
5953809|NCT01240915|20592876|P6|Overall Study|Adverse Event|2
5953810|NCT01240915|20592877|P5|Overall Study|Adverse Event|0
5953811|NCT01240915|20592878|P4|Overall Study|Adverse Event|1
5953812|NCT01240915|20592879|P3|Overall Study|Adverse Event|0
5953813|NCT01240915|20592880|P2|Overall Study|Adverse Event|0
5953814|NCT01240915|20592881|P1|Overall Study|Adverse Event|0
5953815|NCT01240863|20593155|P3|Double-blind Treatment Period (12 Weeks)|Physician Decision|0
5953816|NCT01240863|20593156|P2|Double-blind Treatment Period (12 Weeks)|Physician Decision|1
5953817|NCT01240863|20593157|P1|Double-blind Treatment Period (12 Weeks)|Physician Decision|0
5953818|NCT01240863|20593155|P3|Double-blind Treatment Period (12 Weeks)|Other|5
5953819|NCT01240863|20593156|P2|Double-blind Treatment Period (12 Weeks)|Other|1
5953820|NCT01240863|20593157|P1|Double-blind Treatment Period (12 Weeks)|Other|0
5953821|NCT01240863|20593155|P3|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2
5953822|NCT01240863|20593156|P2|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2
5953823|NCT01240863|20593157|P1|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|0
5953824|NCT01240863|20593155|P3|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|11
5953825|NCT01240863|20593156|P2|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|9
5953826|NCT01240863|20593157|P1|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0
5953827|NCT01240863|20593155|P3|Double-blind Treatment Period (12 Weeks)|Protocol Violation|14
5953828|NCT01240863|20593156|P2|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9
5953829|NCT01240863|20593157|P1|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0
5953830|NCT01240863|20593155|P3|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|5
5953831|NCT01240863|20593156|P2|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|3
5953832|NCT01240863|20593157|P1|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0
5953833|NCT01240863|20593155|P3|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5
5953834|NCT01240863|20593156|P2|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17
5953835|NCT01240863|20593157|P1|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0
5953836|NCT01240863|20593155|P3|Double-blind Treatment Period (12 Weeks)|Adverse Event|10
5953837|NCT01240863|20593156|P2|Double-blind Treatment Period (12 Weeks)|Adverse Event|4
5953838|NCT01240863|20593157|P1|Double-blind Treatment Period (12 Weeks)|Adverse Event|0
5953839|NCT01240863|20593155|P3|Open-label Titration Period|Other|0
5953840|NCT01240863|20593156|P2|Open-label Titration Period|Other|0
5953841|NCT01240863|20593157|P1|Open-label Titration Period|Other|7
5953842|NCT01240863|20593155|P3|Open-label Titration Period|Dropped out prior to dosing|0
5953843|NCT01240863|20593156|P2|Open-label Titration Period|Dropped out prior to dosing|0
5953844|NCT01240863|20593157|P1|Open-label Titration Period|Dropped out prior to dosing|2
5953845|NCT01240863|20593155|P3|Open-label Titration Period|Noncompliance to study procedures|0
5953846|NCT01240863|20593156|P2|Open-label Titration Period|Noncompliance to study procedures|0
5953847|NCT01240863|20593157|P1|Open-label Titration Period|Noncompliance to study procedures|3
5953848|NCT01240863|20593155|P3|Open-label Titration Period|Noncompliance to study drug admin|0
5953849|NCT01240863|20593156|P2|Open-label Titration Period|Noncompliance to study drug admin|0
5953850|NCT01240863|20593157|P1|Open-label Titration Period|Noncompliance to study drug admin|3
5953851|NCT01240863|20593155|P3|Open-label Titration Period|Protocol Violation|0
5953852|NCT01240863|20593156|P2|Open-label Titration Period|Protocol Violation|0
5953853|NCT01240863|20593157|P1|Open-label Titration Period|Protocol Violation|7
5953939|NCT01239732|20593470|P1|Overall Study|Protocol Violation|3
5953854|NCT01240863|20593155|P3|Open-label Titration Period|Withdrawal by Subject|0
5953855|NCT01240863|20593156|P2|Open-label Titration Period|Withdrawal by Subject|0
5953856|NCT01240863|20593157|P1|Open-label Titration Period|Withdrawal by Subject|9
5953857|NCT01240863|20593155|P3|Open-label Titration Period|Lack of Efficacy|0
5953858|NCT01240863|20593156|P2|Open-label Titration Period|Lack of Efficacy|0
5953859|NCT01240863|20593157|P1|Open-label Titration Period|Lack of Efficacy|19
5953860|NCT01240863|20593155|P3|Open-label Titration Period|Adverse Event|0
5953861|NCT01240863|20593156|P2|Open-label Titration Period|Adverse Event|0
5953862|NCT01240863|20593157|P1|Open-label Titration Period|Adverse Event|47
5953863|NCT01240811|20593219|P3|Overall Study|Withdrawal by Subject|1
5953864|NCT01240811|20593220|P2|Overall Study|Withdrawal by Subject|0
5953865|NCT01240811|20593221|P1|Overall Study|Withdrawal by Subject|0
5953866|NCT01240811|20593219|P3|Overall Study|Physician Decision|0
5953867|NCT01240811|20593220|P2|Overall Study|Physician Decision|1
5953868|NCT01240811|20593221|P1|Overall Study|Physician Decision|0
5953869|NCT01240785|20593237|P2|Overall Study|Protocol Violation|3
5953870|NCT01240785|20593238|P1|Overall Study|Protocol Violation|0
5953871|NCT01240785|20593237|P2|Overall Study|Lost to Follow-up|0
5953872|NCT01240785|20593238|P1|Overall Study|Lost to Follow-up|1
5953873|NCT01240746|20593269|P3|Overall Study|Withdrawal by Subject|59
5953874|NCT01240746|20593270|P2|Overall Study|Withdrawal by Subject|13
5953875|NCT01240746|20593271|P1|Overall Study|Withdrawal by Subject|10
5953876|NCT01240746|20593269|P3|Overall Study|Protocol Violation|72
5953877|NCT01240746|20593270|P2|Overall Study|Protocol Violation|15
5953878|NCT01240746|20593271|P1|Overall Study|Protocol Violation|24
5953879|NCT01240746|20593269|P3|Overall Study|Lost to Follow-up|102
5953880|NCT01240746|20593270|P2|Overall Study|Lost to Follow-up|20
5953881|NCT01240746|20593271|P1|Overall Study|Lost to Follow-up|23
5953882|NCT01240746|20593269|P3|Overall Study|Adverse Event|10
5953883|NCT01240746|20593270|P2|Overall Study|Adverse Event|0
5953884|NCT01240746|20593271|P1|Overall Study|Adverse Event|2
5953885|NCT01240590|20593326|P5|Phase II|Refused further treatment|1
5953886|NCT01240590|20593327|P4|Phase II|Refused further treatment|2
5953887|NCT01240590|20593328|P3|Phase II|Refused further treatment|0
5953888|NCT01240590|20593329|P2|Phase II|Refused further treatment|0
5953889|NCT01240590|20593330|P1|Phase II|Refused further treatment|0
5953890|NCT01240590|20593326|P5|Phase I|Refused further treatment|0
5953891|NCT01240590|20593327|P4|Phase I|Refused further treatment|0
5953892|NCT01240590|20593328|P3|Phase I|Refused further treatment|3
5953893|NCT01240590|20593329|P2|Phase I|Refused further treatment|0
5953894|NCT01240590|20593330|P1|Phase I|Refused further treatment|0
5953895|NCT01240551|20593358|P2|Overall Study|Lost to Follow-up|1
5953896|NCT01240551|20593359|P1|Overall Study|Lost to Follow-up|1
5953897|NCT01240551|20593358|P2|Overall Study|Refused further treatment|2
5953898|NCT01240551|20593359|P1|Overall Study|Refused further treatment|3
5953899|NCT01240382|20593369|P2|Overall Study|Fear of adverse events|1
5953900|NCT01240382|20593370|P1|Overall Study|Fear of adverse events|0
5953901|NCT01240382|20593369|P2|Overall Study|Lack of Efficacy|2
5953902|NCT01240382|20593370|P1|Overall Study|Lack of Efficacy|0
5953903|NCT01240382|20593369|P2|Overall Study|Adverse Event|1
5953904|NCT01240382|20593370|P1|Overall Study|Adverse Event|2
5953905|NCT01240356|20593380|P2|Overall Study|MRI contraindication|0
5953906|NCT01240356|20593381|P1|Overall Study|MRI contraindication|1
5953907|NCT01240356|20593380|P2|Overall Study|Withdrawal by Subject|0
5953908|NCT01240356|20593381|P1|Overall Study|Withdrawal by Subject|2
5953909|NCT01240200|20593404|P2|12-week Crossover Phase - Period 1|Withdrawal by Subject|1
5953910|NCT01240200|20593405|P1|12-week Crossover Phase - Period 1|Withdrawal by Subject|2
5953911|NCT01240135|20593423|P2|Period Two, 14 Days of Wear|Adverse Event|1
5953912|NCT01240135|20593424|P1|Period Two, 14 Days of Wear|Adverse Event|0
5953913|NCT01240135|20593423|P2|Period Two, 14 Days of Wear|Withdrawal by Subject|1
5953914|NCT01240135|20593424|P1|Period Two, 14 Days of Wear|Withdrawal by Subject|1
5953915|NCT01239992|20593441|P1|Overall Study|Withdrawal by Subject|2
5953916|NCT01239797|20593450|P2|Treated Participants|Poor/Non-compliance|1
5953917|NCT01239797|20593451|P1|Treated Participants|Poor/Non-compliance|0
5953918|NCT01239797|20593450|P2|Treated Participants|Subject No Longer Meets Study Criteria|1
5953919|NCT01239797|20593451|P1|Treated Participants|Subject No Longer Meets Study Criteria|1
5953920|NCT01239797|20593450|P2|Treated Participants|Death|1
5953921|NCT01239797|20593451|P1|Treated Participants|Death|1
5953922|NCT01239797|20593450|P2|Treated Participants|Non-specified|11
5953923|NCT01239797|20593451|P1|Treated Participants|Non-specified|1
5953924|NCT01239797|20593450|P2|Treated Participants|Withdrawal by Subject|23
5953925|NCT01239797|20593451|P1|Treated Participants|Withdrawal by Subject|27
5953926|NCT01239797|20593450|P2|Treated Participants|Adverse Event Unrelated to Study Drug|32
5953927|NCT01239797|20593451|P1|Treated Participants|Adverse Event Unrelated to Study Drug|22
5953928|NCT01239797|20593450|P2|Treated Participants|Study Drug Toxicity|44
5953929|NCT01239797|20593451|P1|Treated Participants|Study Drug Toxicity|30
5953930|NCT01239797|20593450|P2|Treated Participants|Disease Progression|161
5953931|NCT01239797|20593451|P1|Treated Participants|Disease Progression|153
5953932|NCT01239745|20593459|P1|Overall Study|Adverse Event|1
5953933|NCT01239745|20593459|P1|Overall Study|Study terminated by sponsor|45
5953934|NCT01239732|20593470|P1|Overall Study|Other|19
5953935|NCT01239732|20593470|P1|Overall Study|Treatment failure|2
5953936|NCT01239732|20593470|P1|Overall Study|Investigator's decision|4
5953937|NCT01239732|20593470|P1|Overall Study|Study termination by sponsor|2
5953938|NCT01239732|20593470|P1|Overall Study|Participant non compliance|5
5953940|NCT01239732|20593470|P1|Overall Study|Adverse Event|6
5953941|NCT01239732|20593470|P1|Overall Study|Withdrawal by Subject|87
5953942|NCT01239732|20593470|P1|Overall Study|Death|226
5953943|NCT01239732|20593470|P1|Overall Study|Termination of study per protocol|667
5953944|NCT01239680|20593483|P2|Overall Study|Withdrawal by Subject|0
5953945|NCT01239680|20593484|P1|Overall Study|Withdrawal by Subject|2
5953946|NCT01239472|20593509|P2|Overall Study|Lack of Efficacy|1
5953947|NCT01239472|20593510|P1|Overall Study|Lack of Efficacy|0
5953948|NCT01239472|20593509|P2|Overall Study|Adverse Event|1
5953949|NCT01239472|20593510|P1|Overall Study|Adverse Event|0
5953950|NCT01239472|20593509|P2|Overall Study|Withdrawal by Subject|1
5953951|NCT01239472|20593510|P1|Overall Study|Withdrawal by Subject|5
5953952|NCT01239394|20593518|P1|Overall Study|Adverse Event|1
5953953|NCT01239381|20593525|P1|Overall Study|Withdrawal by Subject|1
5953954|NCT01239381|20593525|P1|Overall Study|Protocol Violation|1
5953955|NCT01239368|20593545|P10|Overall Study|Death|0
5953956|NCT01239368|20593546|P9|Overall Study|Death|0
5953957|NCT01239368|20593547|P8|Overall Study|Death|0
5953958|NCT01239368|20593548|P7|Overall Study|Death|1
5953959|NCT01239368|20593549|P6|Overall Study|Death|0
5953960|NCT01239368|20593550|P5|Overall Study|Death|0
5953961|NCT01239368|20593551|P4|Overall Study|Death|0
5953962|NCT01239368|20593552|P3|Overall Study|Death|0
5953963|NCT01239368|20593553|P2|Overall Study|Death|0
5953964|NCT01239368|20593554|P1|Overall Study|Death|0
5953965|NCT01239368|20593545|P10|Overall Study|Refused further treatment|1
5953966|NCT01239368|20593546|P9|Overall Study|Refused further treatment|0
5953967|NCT01239368|20593547|P8|Overall Study|Refused further treatment|0
5953968|NCT01239368|20593548|P7|Overall Study|Refused further treatment|0
5953969|NCT01239368|20593549|P6|Overall Study|Refused further treatment|0
5953970|NCT01239368|20593550|P5|Overall Study|Refused further treatment|0
5953971|NCT01239368|20593551|P4|Overall Study|Refused further treatment|0
5953972|NCT01239368|20593552|P3|Overall Study|Refused further treatment|0
5953973|NCT01239368|20593553|P2|Overall Study|Refused further treatment|0
5953974|NCT01239368|20593554|P1|Overall Study|Refused further treatment|0
5953975|NCT01239368|20593545|P10|Overall Study|Disease progression on study|2
5953976|NCT01239368|20593546|P9|Overall Study|Disease progression on study|0
5953977|NCT01239368|20593547|P8|Overall Study|Disease progression on study|0
5953978|NCT01239368|20593548|P7|Overall Study|Disease progression on study|5
5953979|NCT01239368|20593549|P6|Overall Study|Disease progression on study|2
5953980|NCT01239368|20593550|P5|Overall Study|Disease progression on study|4
5953981|NCT01239368|20593551|P4|Overall Study|Disease progression on study|1
5953982|NCT01239368|20593552|P3|Overall Study|Disease progression on study|1
5953983|NCT01239368|20593553|P2|Overall Study|Disease progression on study|1
5953984|NCT01239368|20593554|P1|Overall Study|Disease progression on study|1
5953985|NCT01239368|20593545|P10|Overall Study|Principal investigator discretion|1
5953986|NCT01239368|20593546|P9|Overall Study|Principal investigator discretion|0
5953987|NCT01239368|20593547|P8|Overall Study|Principal investigator discretion|0
5953988|NCT01239368|20593548|P7|Overall Study|Principal investigator discretion|0
5953989|NCT01239368|20593549|P6|Overall Study|Principal investigator discretion|2
5953990|NCT01239368|20593550|P5|Overall Study|Principal investigator discretion|1
5953991|NCT01239368|20593551|P4|Overall Study|Principal investigator discretion|0
5953992|NCT01239368|20593552|P3|Overall Study|Principal investigator discretion|0
5953993|NCT01239368|20593553|P2|Overall Study|Principal investigator discretion|0
5953994|NCT01239368|20593554|P1|Overall Study|Principal investigator discretion|1
5953995|NCT01239342|20593606|P2|Overall Study|Reason Unknown|1
5953996|NCT01239342|20593607|P1|Overall Study|Reason Unknown|1
5953997|NCT01239342|20593606|P2|Overall Study|Withdrawal by Subject|5
5953998|NCT01239342|20593607|P1|Overall Study|Withdrawal by Subject|1
5953999|NCT01239342|20593606|P2|Overall Study|Adverse Event|0
5954000|NCT01239342|20593607|P1|Overall Study|Adverse Event|1
5954001|NCT01239316|20593623|P1|Overall Study|Adverse Event|1
5954002|NCT01239316|20593623|P1|Overall Study|Progression/Relapse|11
5954003|NCT01239160|20593637|P3|Overall Study|Early Termination Due to Study Closure|6
5954004|NCT01239160|20593638|P2|Overall Study|Early Termination Due to Study Closure|1
5954005|NCT01239160|20593639|P1|Overall Study|Early Termination Due to Study Closure|0
5954006|NCT01239160|20593637|P3|Overall Study|Physician Decision|2
5954007|NCT01239160|20593638|P2|Overall Study|Physician Decision|7
5954008|NCT01239160|20593639|P1|Overall Study|Physician Decision|5
5954009|NCT01239160|20593637|P3|Overall Study|Withdrawal by Subject|2
5954010|NCT01239160|20593638|P2|Overall Study|Withdrawal by Subject|6
5954011|NCT01239160|20593639|P1|Overall Study|Withdrawal by Subject|17
5954012|NCT01239160|20593637|P3|Overall Study|Lost to Follow-up|0
5954013|NCT01239160|20593638|P2|Overall Study|Lost to Follow-up|5
5954014|NCT01239160|20593639|P1|Overall Study|Lost to Follow-up|3
5954015|NCT01239121|20593652|P3|Overall Study|Withdrawal by Subject|0
5954016|NCT01239121|20593653|P2|Overall Study|Withdrawal by Subject|4
5954017|NCT01239121|20593654|P1|Overall Study|Withdrawal by Subject|2
5954018|NCT01239043|20593676|P2|Overall Study|Protocol Violation|1
5954019|NCT01239043|20593677|P1|Overall Study|Protocol Violation|2
5954020|NCT01238991|20593705|P10|Overall Study|Admission to a nursing home|0
5954021|NCT01238991|20593706|P9|Overall Study|Admission to a nursing home|0
5954022|NCT01238991|20593707|P8|Overall Study|Admission to a nursing home|0
5954023|NCT01238991|20593708|P7|Overall Study|Admission to a nursing home|0
5954024|NCT01238991|20593709|P6|Overall Study|Admission to a nursing home|0
5954025|NCT01238991|20593710|P5|Overall Study|Admission to a nursing home|0
5954026|NCT01238991|20593711|P4|Overall Study|Admission to a nursing home|0
5954027|NCT01238991|20593712|P3|Overall Study|Admission to a nursing home|1
5954028|NCT01238991|20593713|P2|Overall Study|Admission to a nursing home|0
5954029|NCT01238991|20593714|P1|Overall Study|Admission to a nursing home|1
5954030|NCT01238991|20593705|P10|Overall Study|Caregiver's request|0
5954031|NCT01238991|20593706|P9|Overall Study|Caregiver's request|1
5954032|NCT01238991|20593707|P8|Overall Study|Caregiver's request|0
5954033|NCT01238991|20593708|P7|Overall Study|Caregiver's request|0
5954034|NCT01238991|20593709|P6|Overall Study|Caregiver's request|0
5954035|NCT01238991|20593710|P5|Overall Study|Caregiver's request|0
5954036|NCT01238991|20593711|P4|Overall Study|Caregiver's request|0
5954037|NCT01238991|20593712|P3|Overall Study|Caregiver's request|0
5954038|NCT01238991|20593713|P2|Overall Study|Caregiver's request|0
5954039|NCT01238991|20593714|P1|Overall Study|Caregiver's request|0
5954040|NCT01238991|20593705|P10|Overall Study|Study Terminated by Sponsor|2
5954041|NCT01238991|20593706|P9|Overall Study|Study Terminated by Sponsor|2
5954042|NCT01238991|20593707|P8|Overall Study|Study Terminated by Sponsor|4
5954043|NCT01238991|20593708|P7|Overall Study|Study Terminated by Sponsor|7
5954044|NCT01238991|20593709|P6|Overall Study|Study Terminated by Sponsor|0
5954045|NCT01238991|20593710|P5|Overall Study|Study Terminated by Sponsor|1
5954046|NCT01238991|20593711|P4|Overall Study|Study Terminated by Sponsor|0
5954047|NCT01238991|20593712|P3|Overall Study|Study Terminated by Sponsor|0
5954048|NCT01238991|20593713|P2|Overall Study|Study Terminated by Sponsor|0
5954049|NCT01238991|20593714|P1|Overall Study|Study Terminated by Sponsor|0
5954050|NCT01238991|20593705|P10|Overall Study|Withdrawal by Subject|0
5954051|NCT01238991|20593706|P9|Overall Study|Withdrawal by Subject|0
5954052|NCT01238991|20593707|P8|Overall Study|Withdrawal by Subject|0
5954053|NCT01238991|20593708|P7|Overall Study|Withdrawal by Subject|0
5954054|NCT01238991|20593709|P6|Overall Study|Withdrawal by Subject|0
5954055|NCT01238991|20593710|P5|Overall Study|Withdrawal by Subject|0
5954056|NCT01238991|20593711|P4|Overall Study|Withdrawal by Subject|0
5954057|NCT01238991|20593712|P3|Overall Study|Withdrawal by Subject|1
5954058|NCT01238991|20593713|P2|Overall Study|Withdrawal by Subject|0
5954059|NCT01238991|20593714|P1|Overall Study|Withdrawal by Subject|0
5954060|NCT01238991|20593705|P10|Overall Study|Lack of Efficacy|0
5954061|NCT01238991|20593706|P9|Overall Study|Lack of Efficacy|1
5954062|NCT01238991|20593707|P8|Overall Study|Lack of Efficacy|0
5954063|NCT01238991|20593708|P7|Overall Study|Lack of Efficacy|0
5954064|NCT01238991|20593709|P6|Overall Study|Lack of Efficacy|0
5954065|NCT01238991|20593710|P5|Overall Study|Lack of Efficacy|0
5954066|NCT01238991|20593711|P4|Overall Study|Lack of Efficacy|0
5954067|NCT01238991|20593712|P3|Overall Study|Lack of Efficacy|1
5954068|NCT01238991|20593713|P2|Overall Study|Lack of Efficacy|0
5954069|NCT01238991|20593714|P1|Overall Study|Lack of Efficacy|0
5954070|NCT01238991|20593705|P10|Overall Study|Death|0
5954071|NCT01238991|20593706|P9|Overall Study|Death|0
5954072|NCT01238991|20593707|P8|Overall Study|Death|0
5954073|NCT01238991|20593708|P7|Overall Study|Death|0
5954074|NCT01238991|20593709|P6|Overall Study|Death|0
5954075|NCT01238991|20593710|P5|Overall Study|Death|0
5954076|NCT01238991|20593711|P4|Overall Study|Death|1
5954077|NCT01238991|20593712|P3|Overall Study|Death|0
5954078|NCT01238991|20593713|P2|Overall Study|Death|0
5954079|NCT01238991|20593714|P1|Overall Study|Death|0
5954080|NCT01238991|20593705|P10|Overall Study|Adverse Event|0
5954081|NCT01238991|20593706|P9|Overall Study|Adverse Event|0
5954082|NCT01238991|20593707|P8|Overall Study|Adverse Event|1
5954083|NCT01238991|20593708|P7|Overall Study|Adverse Event|1
5954084|NCT01238991|20593709|P6|Overall Study|Adverse Event|0
5954085|NCT01238991|20593710|P5|Overall Study|Adverse Event|1
5954086|NCT01238991|20593711|P4|Overall Study|Adverse Event|1
5954087|NCT01238991|20593712|P3|Overall Study|Adverse Event|3
5954088|NCT01238991|20593713|P2|Overall Study|Adverse Event|0
5954089|NCT01238991|20593714|P1|Overall Study|Adverse Event|1
5954090|NCT01238900|20593801|P1|<12 Months Post Stent Removal|persistent stricture after stenting|1
5954091|NCT01238900|20593801|P1|<12 Months Post Stent Removal|Lost to Follow-up|4
5954092|NCT01238861|20593815|P6|Overall Study|Withdrawal by Subject|9
5954093|NCT01238861|20593816|P5|Overall Study|Withdrawal by Subject|10
5954094|NCT01238861|20593817|P4|Overall Study|Withdrawal by Subject|8
5954095|NCT01238861|20593818|P3|Overall Study|Withdrawal by Subject|4
5954096|NCT01238861|20593819|P2|Overall Study|Withdrawal by Subject|5
5954097|NCT01238861|20593820|P1|Overall Study|Withdrawal by Subject|6
5954098|NCT01238861|20593815|P6|Overall Study|Adverse Event|0
5954099|NCT01238861|20593816|P5|Overall Study|Adverse Event|0
5954100|NCT01238861|20593817|P4|Overall Study|Adverse Event|0
5954101|NCT01238861|20593818|P3|Overall Study|Adverse Event|0
5954102|NCT01238861|20593819|P2|Overall Study|Adverse Event|1
5954103|NCT01238861|20593820|P1|Overall Study|Adverse Event|0
5954104|NCT01238861|20593815|P6|Overall Study|Lack of compliance|1
5954105|NCT01238861|20593816|P5|Overall Study|Lack of compliance|0
5954106|NCT01238861|20593817|P4|Overall Study|Lack of compliance|0
5954107|NCT01238861|20593818|P3|Overall Study|Lack of compliance|0
5954108|NCT01238861|20593819|P2|Overall Study|Lack of compliance|0
5954109|NCT01238861|20593820|P1|Overall Study|Lack of compliance|0
5954110|NCT01238861|20593815|P6|Overall Study|Serious adverse event|1
5954111|NCT01238861|20593816|P5|Overall Study|Serious adverse event|0
5954112|NCT01238861|20593817|P4|Overall Study|Serious adverse event|0
5954113|NCT01238861|20593818|P3|Overall Study|Serious adverse event|0
5954114|NCT01238861|20593819|P2|Overall Study|Serious adverse event|0
5954115|NCT01238861|20593820|P1|Overall Study|Serious adverse event|0
5954116|NCT01238861|20593815|P6|Overall Study|Unable to continue visits|1
5954117|NCT01238861|20593816|P5|Overall Study|Unable to continue visits|0
5954118|NCT01238861|20593817|P4|Overall Study|Unable to continue visits|1
5954119|NCT01238861|20593818|P3|Overall Study|Unable to continue visits|0
5954120|NCT01238861|20593819|P2|Overall Study|Unable to continue visits|0
5954121|NCT01238861|20593820|P1|Overall Study|Unable to continue visits|0
5954122|NCT01238861|20593815|P6|Overall Study|Personal problems|0
5954123|NCT01238861|20593816|P5|Overall Study|Personal problems|0
5954124|NCT01238861|20593817|P4|Overall Study|Personal problems|1
5954125|NCT01238861|20593818|P3|Overall Study|Personal problems|0
5954126|NCT01238861|20593819|P2|Overall Study|Personal problems|0
5954127|NCT01238861|20593820|P1|Overall Study|Personal problems|0
5954128|NCT01238861|20593815|P6|Overall Study|Strongyloides stercoralis antibodies +|0
5954129|NCT01238861|20593816|P5|Overall Study|Strongyloides stercoralis antibodies +|0
5954130|NCT01238861|20593817|P4|Overall Study|Strongyloides stercoralis antibodies +|1
5954131|NCT01238861|20593818|P3|Overall Study|Strongyloides stercoralis antibodies +|0
5954132|NCT01238861|20593819|P2|Overall Study|Strongyloides stercoralis antibodies +|0
5954133|NCT01238861|20593820|P1|Overall Study|Strongyloides stercoralis antibodies +|0
5954134|NCT01238861|20593815|P6|Overall Study|Subject moved out of state/area|0
5954135|NCT01238861|20593816|P5|Overall Study|Subject moved out of state/area|0
5954136|NCT01238861|20593817|P4|Overall Study|Subject moved out of state/area|1
5954137|NCT01238861|20593818|P3|Overall Study|Subject moved out of state/area|1
5954138|NCT01238861|20593819|P2|Overall Study|Subject moved out of state/area|0
5954139|NCT01238861|20593820|P1|Overall Study|Subject moved out of state/area|0
5954140|NCT01238861|20593815|P6|Overall Study|Subject traveled to Argentina by 1 year|0
5954141|NCT01238861|20593816|P5|Overall Study|Subject traveled to Argentina by 1 year|0
5954142|NCT01238861|20593817|P4|Overall Study|Subject traveled to Argentina by 1 year|0
5954143|NCT01238861|20593818|P3|Overall Study|Subject traveled to Argentina by 1 year|1
5954144|NCT01238861|20593819|P2|Overall Study|Subject traveled to Argentina by 1 year|0
5954145|NCT01238861|20593820|P1|Overall Study|Subject traveled to Argentina by 1 year|0
5954146|NCT01238861|20593815|P6|Overall Study|Incorrect enrollment/randomization|0
5954147|NCT01238861|20593816|P5|Overall Study|Incorrect enrollment/randomization|1
5954148|NCT01238861|20593817|P4|Overall Study|Incorrect enrollment/randomization|0
5954149|NCT01238861|20593818|P3|Overall Study|Incorrect enrollment/randomization|1
5954150|NCT01238861|20593819|P2|Overall Study|Incorrect enrollment/randomization|0
5954151|NCT01238861|20593820|P1|Overall Study|Incorrect enrollment/randomization|0
5954152|NCT01238861|20593815|P6|Overall Study|Did not meet entry ACQ-6 criteria|1
5954153|NCT01238861|20593816|P5|Overall Study|Did not meet entry ACQ-6 criteria|1
5954154|NCT01238861|20593817|P4|Overall Study|Did not meet entry ACQ-6 criteria|0
5954155|NCT01238861|20593818|P3|Overall Study|Did not meet entry ACQ-6 criteria|1
5954156|NCT01238861|20593819|P2|Overall Study|Did not meet entry ACQ-6 criteria|0
5954157|NCT01238861|20593820|P1|Overall Study|Did not meet entry ACQ-6 criteria|0
5954158|NCT01238861|20593815|P6|Overall Study|Unplanned surgery|0
5954159|NCT01238861|20593816|P5|Overall Study|Unplanned surgery|0
5954160|NCT01238861|20593817|P4|Overall Study|Unplanned surgery|0
5954161|NCT01238861|20593818|P3|Overall Study|Unplanned surgery|0
5954162|NCT01238861|20593819|P2|Overall Study|Unplanned surgery|0
5954163|NCT01238861|20593820|P1|Overall Study|Unplanned surgery|1
5954164|NCT01238861|20593815|P6|Overall Study|Lost to Follow-up|2
5954165|NCT01238861|20593816|P5|Overall Study|Lost to Follow-up|1
5954166|NCT01238861|20593817|P4|Overall Study|Lost to Follow-up|1
5954167|NCT01238861|20593818|P3|Overall Study|Lost to Follow-up|3
5954168|NCT01238861|20593819|P2|Overall Study|Lost to Follow-up|2
5954169|NCT01238861|20593820|P1|Overall Study|Lost to Follow-up|4
5954170|NCT01238848|20593900|P2|Overall Study|Physician Decision|5
5954171|NCT01238848|20593901|P1|Overall Study|Physician Decision|13
5954172|NCT01238835|20593909|P1|Overall Study|Site early discontinuation|2
5954173|NCT01238835|20593909|P1|Overall Study|Lost to Follow-up|1
5954174|NCT01238835|20593909|P1|Overall Study|Withdrawal by Subject|9
5954175|NCT01238835|20593909|P1|Overall Study|Death|124
5954176|NCT01238822|20593914|P1|Overall Study|COULD NOT SWALLOW PILLS|3
5954177|NCT01238588|20593941|P1|Overall Study|Physician Decision|2
5954178|NCT01238588|20593941|P1|Overall Study|Withdrawal by Subject|1
5954179|NCT01238575|20593954|P2|Overall Study|Adverse Event|0
5954180|NCT01238575|20593955|P1|Overall Study|Adverse Event|2
5954181|NCT01238575|20593954|P2|Overall Study|Lack of Efficacy|4
5954182|NCT01238575|20593955|P1|Overall Study|Lack of Efficacy|2
5954183|NCT01238211|20594039|P1|Overall Study|Investigator/Patient Decision|3
5954184|NCT01238211|20594039|P1|Overall Study|Non-protocol treatment|4
5954185|NCT01238211|20594039|P1|Overall Study|Withdrawal by Subject|7
5954186|NCT01238211|20594039|P1|Overall Study|Relapse/Progression|2
5954187|NCT01238211|20594039|P1|Overall Study|Death|4
5954188|NCT01238211|20594039|P1|Overall Study|Adverse Event|7
5954189|NCT01238211|20594039|P1|Overall Study|Continues active treatment|31
5954190|NCT01238172|20594045|P2|Overall Study|Ineligible: based on Central Path Review|19
5954191|NCT01238172|20594046|P1|Overall Study|Ineligible: based on Central Path Review|9
5954192|NCT01238172|20594045|P2|Overall Study|Ineligible: based on Eligibility Review|5
5954193|NCT01238172|20594046|P1|Overall Study|Ineligible: based on Eligibility Review|2
5954194|NCT01237951|20594058|P1|Overall Study|Death|1
5954195|NCT01237899|20594076|P11|Washout Period of at Least 7 Days|Adverse Event|0
5954196|NCT01237899|20594077|P10|Washout Period of at Least 7 Days|Adverse Event|0
5954197|NCT01237899|20594078|P9|Washout Period of at Least 7 Days|Adverse Event|0
5954198|NCT01237899|20594079|P8|Washout Period of at Least 7 Days|Adverse Event|0
5954199|NCT01237899|20594080|P7|Washout Period of at Least 7 Days|Adverse Event|0
5954200|NCT01237899|20594081|P6|Washout Period of at Least 7 Days|Adverse Event|0
5954201|NCT01237899|20594082|P5|Washout Period of at Least 7 Days|Adverse Event|0
5954202|NCT01237899|20594083|P4|Washout Period of at Least 7 Days|Adverse Event|0
5954203|NCT01237899|20594084|P3|Washout Period of at Least 7 Days|Adverse Event|1
5954204|NCT01237899|20594085|P2|Washout Period of at Least 7 Days|Adverse Event|0
5954205|NCT01237899|20594086|P1|Washout Period of at Least 7 Days|Adverse Event|0
5954206|NCT01237678|20594166|P3|Phase II|Randomized but were not treated|3
5954207|NCT01237678|20594167|P2|Phase II|Randomized but were not treated|4
5954208|NCT01237678|20594168|P1|Phase II|Randomized but were not treated|0
5954209|NCT01237678|20594166|P3|Phase II|Sponsor Decision/Study Closed|7
5954210|NCT01237678|20594167|P2|Phase II|Sponsor Decision/Study Closed|18
5954211|NCT01237678|20594168|P1|Phase II|Sponsor Decision/Study Closed|0
5954212|NCT01237678|20594166|P3|Phase II|Completed Cycles 4-6|21
5954213|NCT01237678|20594167|P2|Phase II|Completed Cycles 4-6|11
5954214|NCT01237678|20594168|P1|Phase II|Completed Cycles 4-6|0
5954215|NCT01237678|20594166|P3|Phase II|Withdrawal by Subject|5
5954216|NCT01237678|20594167|P2|Phase II|Withdrawal by Subject|1
5954217|NCT01237678|20594168|P1|Phase II|Withdrawal by Subject|0
5954218|NCT01237678|20594166|P3|Phase II|Lack of Efficacy|3
5954219|NCT01237678|20594167|P2|Phase II|Lack of Efficacy|25
5954220|NCT01237678|20594168|P1|Phase II|Lack of Efficacy|0
5954221|NCT01237678|20594166|P3|Phase II|Death|2
5954222|NCT01237678|20594167|P2|Phase II|Death|0
5954223|NCT01237678|20594168|P1|Phase II|Death|0
5954224|NCT01237678|20594166|P3|Phase II|Adverse Event|9
5954225|NCT01237678|20594167|P2|Phase II|Adverse Event|39
5954226|NCT01237678|20594168|P1|Phase II|Adverse Event|0
5954227|NCT01237678|20594166|P3|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0
5954228|NCT01237678|20594167|P2|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0
5954229|NCT01237678|20594168|P1|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|1
5954230|NCT01237678|20594166|P3|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0
5954231|NCT01237678|20594167|P2|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0
5954232|NCT01237678|20594168|P1|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|3
5954233|NCT01237678|20594166|P3|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0
5954234|NCT01237678|20594167|P2|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0
5954235|NCT01237678|20594168|P1|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|24
5954236|NCT01237678|20594166|P3|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0
5954237|NCT01237678|20594167|P2|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0
5954238|NCT01237678|20594168|P1|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|5
5954239|NCT01237587|20594213|P2|Taper Phase|Withdrawal by Subject|1
5954240|NCT01237587|20594214|P1|Taper Phase|Withdrawal by Subject|0
5954241|NCT01237587|20594213|P2|Taper Phase|Sponsor Decision|0
5954242|NCT01237587|20594214|P1|Taper Phase|Sponsor Decision|1
5954243|NCT01237587|20594213|P2|Taper Phase|Parent/Guardian Decision|2
5954244|NCT01237587|20594214|P1|Taper Phase|Parent/Guardian Decision|0
5954245|NCT01237587|20594213|P2|Taper Phase|Lack of Efficacy|5
5954246|NCT01237587|20594214|P1|Taper Phase|Lack of Efficacy|2
5954247|NCT01237587|20594213|P2|Taper Phase|Protocol Violation|0
5954248|NCT01237587|20594214|P1|Taper Phase|Protocol Violation|2
5954249|NCT01237587|20594213|P2|Taper Phase|Adverse Event|2
5954250|NCT01237587|20594214|P1|Taper Phase|Adverse Event|0
5954251|NCT01237587|20594213|P2|Open Label Treatment (Extension Phase)|Physician Decision|4
5954252|NCT01237587|20594214|P1|Open Label Treatment (Extension Phase)|Physician Decision|4
5954253|NCT01237587|20594213|P2|Open Label Treatment (Extension Phase)|Sponsor Decision|0
5954254|NCT01237587|20594214|P1|Open Label Treatment (Extension Phase)|Sponsor Decision|1
5954255|NCT01237587|20594213|P2|Open Label Treatment (Extension Phase)|Withdrawal by Subject|5
5954256|NCT01237587|20594214|P1|Open Label Treatment (Extension Phase)|Withdrawal by Subject|0
5954257|NCT01237587|20594213|P2|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|4
5954258|NCT01237587|20594214|P1|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|2
5954259|NCT01237587|20594213|P2|Open Label Treatment (Extension Phase)|Lack of Efficacy|4
5954260|NCT01237587|20594214|P1|Open Label Treatment (Extension Phase)|Lack of Efficacy|2
5954261|NCT01237587|20594213|P2|Open Label Treatment (Extension Phase)|Adverse Event|5
5954262|NCT01237587|20594214|P1|Open Label Treatment (Extension Phase)|Adverse Event|5
5954263|NCT01237587|20594213|P2|Open Label Treatment (Extension Phase)|Lost to Follow-up|3
5954264|NCT01237587|20594214|P1|Open Label Treatment (Extension Phase)|Lost to Follow-up|4
5954265|NCT01237587|20594213|P2|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|4
5954266|NCT01237587|20594214|P1|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|3
5954267|NCT01237587|20594213|P2|Double Blind Treatment (Acute Phase)|Protocol Violation|3
5954268|NCT01237587|20594214|P1|Double Blind Treatment (Acute Phase)|Protocol Violation|4
5954269|NCT01237587|20594213|P2|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|4
5954270|NCT01237587|20594214|P1|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|2
5954271|NCT01237587|20594213|P2|Double Blind Treatment (Acute Phase)|Lost to Follow-up|3
5954272|NCT01237587|20594214|P1|Double Blind Treatment (Acute Phase)|Lost to Follow-up|2
5954273|NCT01237587|20594213|P2|Double Blind Treatment (Acute Phase)|Lack of Efficacy|3
5954274|NCT01237587|20594214|P1|Double Blind Treatment (Acute Phase)|Lack of Efficacy|1
5954275|NCT01237587|20594213|P2|Double Blind Treatment (Acute Phase)|Adverse Event|1
5954276|NCT01237587|20594214|P1|Double Blind Treatment (Acute Phase)|Adverse Event|5
5954277|NCT01237340|20594266|P1|Overall Study|Early termination of the trial|36
5954278|NCT01237340|20594266|P1|Overall Study|Withdrawal by Subject|1
5954279|NCT01237340|20594266|P1|Overall Study|Adverse Event|3
5954280|NCT01237327|20594280|P2|Overall Study|Lost to Follow-up|0
5954281|NCT01237327|20594281|P1|Overall Study|Lost to Follow-up|3
5954282|NCT01237327|20594280|P2|Overall Study|Withdrawal by Subject|3
5954283|NCT01237327|20594281|P1|Overall Study|Withdrawal by Subject|1
5954284|NCT01237327|20594280|P2|Overall Study|Protocol Specific Withdrawal Criteria|0
5954285|NCT01237327|20594281|P1|Overall Study|Protocol Specific Withdrawal Criteria|1
5954286|NCT01237327|20594280|P2|Overall Study|Progression of Disease: Extension Study|13
5954287|NCT01237327|20594281|P1|Overall Study|Progression of Disease: Extension Study|15
5954288|NCT01237327|20594280|P2|Overall Study|Progression of Disease: Core Study|22
5954289|NCT01237327|20594281|P1|Overall Study|Progression of Disease: Core Study|18
5954290|NCT01237327|20594280|P2|Overall Study|Completed 26 weeks treatment:Core Study|2
5954291|NCT01237327|20594281|P1|Overall Study|Completed 26 weeks treatment:Core Study|3
5954292|NCT01237327|20594280|P2|Overall Study|Protocol Violation: Core Study|0
5954293|NCT01237327|20594281|P1|Overall Study|Protocol Violation: Core Study|1
5954294|NCT01237223|20594316|P6|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1
5954295|NCT01237223|20594317|P5|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1
5954296|NCT01237223|20594318|P4|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|2
5954297|NCT01237223|20594319|P3|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1
5954298|NCT01237223|20594320|P2|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1
5954299|NCT01237223|20594321|P1|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|0
5954300|NCT01237223|20594316|P6|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|1
5954301|NCT01237223|20594317|P5|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0
5954302|NCT01237223|20594318|P4|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0
5954303|NCT01237223|20594319|P3|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0
5954304|NCT01237223|20594320|P2|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0
5954305|NCT01237223|20594321|P1|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0
5954306|NCT01237223|20594316|P6|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1
5954307|NCT01237223|20594317|P5|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1
5954308|NCT01237223|20594318|P4|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|0
5954309|NCT01237223|20594319|P3|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4
5954310|NCT01237223|20594320|P2|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4
5954311|NCT01237223|20594321|P1|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1
5954312|NCT01237223|20594316|P6|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1
5954313|NCT01237223|20594317|P5|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|0
5954314|NCT01237223|20594318|P4|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1
5954315|NCT01237223|20594319|P3|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|7
5954316|NCT01237223|20594320|P2|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|6
5954317|NCT01237223|20594321|P1|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|20
5954318|NCT01237223|20594316|P6|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|1
5954319|NCT01237223|20594317|P5|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2
5954320|NCT01237223|20594318|P4|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2
5954321|NCT01237223|20594319|P3|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|3
5954322|NCT01237223|20594320|P2|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|4
5954323|NCT01237223|20594321|P1|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|12
5954324|NCT01237223|20594316|P6|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0
5954325|NCT01237223|20594317|P5|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0
5954326|NCT01237223|20594318|P4|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0
5954327|NCT01237223|20594319|P3|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0
5954328|NCT01237223|20594320|P2|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0
5954329|NCT01237223|20594321|P1|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|8
5954330|NCT01237223|20594316|P6|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0
5954331|NCT01237223|20594317|P5|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0
5954332|NCT01237223|20594318|P4|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0
5954333|NCT01237223|20594319|P3|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0
5954334|NCT01237223|20594320|P2|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0
5954335|NCT01237223|20594321|P1|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|28
5954336|NCT01237223|20594316|P6|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0
5954337|NCT01237223|20594317|P5|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0
5954338|NCT01237223|20594318|P4|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0
5954339|NCT01237223|20594319|P3|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0
5954340|NCT01237223|20594320|P2|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0
5954341|NCT01237223|20594321|P1|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|308
5954342|NCT01237223|20594316|P6|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0
5954343|NCT01237223|20594317|P5|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0
5954344|NCT01237223|20594318|P4|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0
5954345|NCT01237223|20594319|P3|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0
5954346|NCT01237223|20594320|P2|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0
5954347|NCT01237223|20594321|P1|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|25
5954348|NCT01237223|20594316|P6|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0
5954349|NCT01237223|20594317|P5|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0
5954350|NCT01237223|20594318|P4|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0
5954351|NCT01237223|20594319|P3|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0
5954352|NCT01237223|20594320|P2|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0
5954353|NCT01237223|20594321|P1|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|29
5954354|NCT01237054|20594380|P1|Overall Study|imaging 10C0096|1
5954355|NCT01236755|20594449|P1|Orthokeratology Wearing Phase|Poor Refractive Correction / Centration|3
5954356|NCT01236755|20594449|P1|Orthokeratology Wearing Phase|Withdrawal by Subject|5
5954357|NCT01236755|20594449|P1|Spectacles Wearing Phase|Lost to Follow-up|9
5954358|NCT01236755|20594449|P1|Spectacles Wearing Phase|Withdrawal by Subject|8
5954359|NCT01236534|20594472|P2|Overall Study|Adverse Event|0
5954360|NCT01236534|20594473|P1|Overall Study|Adverse Event|3
5954361|NCT01236365|20594491|P2|Overall Study|Dropped at Randomization due to high LFT|0
5954362|NCT01236365|20594492|P1|Overall Study|Dropped at Randomization due to high LFT|1
5954363|NCT01236365|20594491|P2|Overall Study|Moved Out of State|0
5954364|NCT01236365|20594492|P1|Overall Study|Moved Out of State|1
5954365|NCT01236365|20594491|P2|Overall Study|Lost to Follow-up|2
5954366|NCT01236365|20594492|P1|Overall Study|Lost to Follow-up|0
5954367|NCT01236339|20594516|P2|Overall Study|Termination of study by sponsor|13
5954368|NCT01236339|20594517|P1|Overall Study|Termination of study by sponsor|11
5954369|NCT01235793|20594546|P1|Overall Study|Death|6
5954370|NCT01236573|20594562|P11|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|1
5954371|NCT01236573|20594563|P10|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
5954372|NCT01236573|20594564|P9|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
5954373|NCT01236573|20594565|P8|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
5954374|NCT01236573|20594566|P7|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
5954375|NCT01236573|20594567|P6|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
5954376|NCT01236573|20594568|P5|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
5954377|NCT01236573|20594569|P4|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
5954378|NCT01236573|20594570|P3|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
5954379|NCT01236573|20594571|P2|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
5954380|NCT01236573|20594572|P1|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
5954381|NCT01236573|20594562|P11|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
5954382|NCT01236573|20594563|P10|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
5954383|NCT01236573|20594564|P9|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|1
5954384|NCT01236573|20594565|P8|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
5954385|NCT01236573|20594566|P7|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
5954386|NCT01236573|20594567|P6|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
5954387|NCT01236573|20594568|P5|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
5954388|NCT01236573|20594569|P4|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
5954389|NCT01236573|20594570|P3|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
5954390|NCT01236573|20594571|P2|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
5954391|NCT01236573|20594572|P1|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
5954392|NCT01236573|20594562|P11|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
5954393|NCT01236573|20594563|P10|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1
5954394|NCT01236573|20594564|P9|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1
5954395|NCT01236573|20594565|P8|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
5954396|NCT01236573|20594566|P7|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1
5954397|NCT01236573|20594567|P6|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
5954398|NCT01236573|20594568|P5|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
5954399|NCT01236573|20594569|P4|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
5954400|NCT01236573|20594570|P3|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
5954401|NCT01236573|20594571|P2|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
5954402|NCT01236573|20594572|P1|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
5954439|NCT01236521|20594640|P2|Overall Study|Lost to Follow-up|7
5954440|NCT01236521|20594641|P1|Overall Study|Lost to Follow-up|7
5954441|NCT01236521|20594640|P2|Overall Study|Death|1
5954442|NCT01236521|20594641|P1|Overall Study|Death|2
5954443|NCT01236521|20594640|P2|Overall Study|Withdrawal by Subject|17
5954444|NCT01236521|20594641|P1|Overall Study|Withdrawal by Subject|12
5954445|NCT01236352|20594692|P11|Overall Study|Patient transferred to IST|6
5954446|NCT01236352|20594693|P10|Overall Study|Patient transferred to IST|2
5954447|NCT01236352|20594694|P9|Overall Study|Patient transferred to IST|0
5954448|NCT01236352|20594695|P8|Overall Study|Patient transferred to IST|0
5954449|NCT01236352|20594696|P7|Overall Study|Patient transferred to IST|0
5954450|NCT01236352|20594697|P6|Overall Study|Patient transferred to IST|0
5954451|NCT01236352|20594698|P5|Overall Study|Patient transferred to IST|0
5954452|NCT01236352|20594699|P4|Overall Study|Patient transferred to IST|0
5954453|NCT01236352|20594700|P3|Overall Study|Patient transferred to IST|0
5954454|NCT01236352|20594701|P2|Overall Study|Patient transferred to IST|0
5954455|NCT01236352|20594702|P1|Overall Study|Patient transferred to IST|0
5954456|NCT01236352|20594692|P11|Overall Study|Lack of response to drug|1
5954457|NCT01236352|20594693|P10|Overall Study|Lack of response to drug|1
5954458|NCT01236352|20594694|P9|Overall Study|Lack of response to drug|0
5954459|NCT01236352|20594695|P8|Overall Study|Lack of response to drug|0
5954460|NCT01236352|20594696|P7|Overall Study|Lack of response to drug|0
5954461|NCT01236352|20594697|P6|Overall Study|Lack of response to drug|0
5954462|NCT01236352|20594698|P5|Overall Study|Lack of response to drug|0
5954463|NCT01236352|20594699|P4|Overall Study|Lack of response to drug|0
5954464|NCT01236352|20594700|P3|Overall Study|Lack of response to drug|0
5954465|NCT01236352|20594701|P2|Overall Study|Lack of response to drug|0
5954466|NCT01236352|20594702|P1|Overall Study|Lack of response to drug|0
5954467|NCT01236352|20594692|P11|Overall Study|Relapse of Splenomegaly and symptoms|1
5954468|NCT01236352|20594693|P10|Overall Study|Relapse of Splenomegaly and symptoms|0
5954469|NCT01236352|20594694|P9|Overall Study|Relapse of Splenomegaly and symptoms|0
5954470|NCT01236352|20594695|P8|Overall Study|Relapse of Splenomegaly and symptoms|0
5954471|NCT01236352|20594696|P7|Overall Study|Relapse of Splenomegaly and symptoms|0
5954472|NCT01236352|20594697|P6|Overall Study|Relapse of Splenomegaly and symptoms|0
5954473|NCT01236352|20594698|P5|Overall Study|Relapse of Splenomegaly and symptoms|0
5954474|NCT01236352|20594699|P4|Overall Study|Relapse of Splenomegaly and symptoms|0
5954475|NCT01236352|20594700|P3|Overall Study|Relapse of Splenomegaly and symptoms|0
5954476|NCT01236352|20594701|P2|Overall Study|Relapse of Splenomegaly and symptoms|0
5954477|NCT01236352|20594702|P1|Overall Study|Relapse of Splenomegaly and symptoms|0
5954478|NCT01236352|20594692|P11|Overall Study|Patient moving to allogeneic transplant|0
5954479|NCT01236352|20594693|P10|Overall Study|Patient moving to allogeneic transplant|0
5954480|NCT01236352|20594694|P9|Overall Study|Patient moving to allogeneic transplant|0
5954481|NCT01236352|20594695|P8|Overall Study|Patient moving to allogeneic transplant|0
5954482|NCT01236352|20594696|P7|Overall Study|Patient moving to allogeneic transplant|1
5954483|NCT01236352|20594697|P6|Overall Study|Patient moving to allogeneic transplant|0
5954484|NCT01236352|20594698|P5|Overall Study|Patient moving to allogeneic transplant|0
5954485|NCT01236352|20594699|P4|Overall Study|Patient moving to allogeneic transplant|0
5954486|NCT01236352|20594700|P3|Overall Study|Patient moving to allogeneic transplant|0
5954487|NCT01236352|20594701|P2|Overall Study|Patient moving to allogeneic transplant|0
5954488|NCT01236352|20594702|P1|Overall Study|Patient moving to allogeneic transplant|0
5954489|NCT01236352|20594692|P11|Overall Study|Subject to receive drug via EAP|0
5954490|NCT01236352|20594693|P10|Overall Study|Subject to receive drug via EAP|4
5954491|NCT01236352|20594694|P9|Overall Study|Subject to receive drug via EAP|0
5954492|NCT01236352|20594695|P8|Overall Study|Subject to receive drug via EAP|2
5954493|NCT01236352|20594696|P7|Overall Study|Subject to receive drug via EAP|0
5954494|NCT01236352|20594697|P6|Overall Study|Subject to receive drug via EAP|0
5954495|NCT01236352|20594698|P5|Overall Study|Subject to receive drug via EAP|0
5954496|NCT01236352|20594699|P4|Overall Study|Subject to receive drug via EAP|0
5954497|NCT01236352|20594700|P3|Overall Study|Subject to receive drug via EAP|1
5954498|NCT01236352|20594701|P2|Overall Study|Subject to receive drug via EAP|1
5954499|NCT01236352|20594702|P1|Overall Study|Subject to receive drug via EAP|1
5954500|NCT01236352|20594692|P11|Overall Study|Subject request to discontinue treatment|4
5954501|NCT01236352|20594693|P10|Overall Study|Subject request to discontinue treatment|1
5954502|NCT01236352|20594694|P9|Overall Study|Subject request to discontinue treatment|0
5954503|NCT01236352|20594695|P8|Overall Study|Subject request to discontinue treatment|0
5954504|NCT01236352|20594696|P7|Overall Study|Subject request to discontinue treatment|0
5954505|NCT01236352|20594697|P6|Overall Study|Subject request to discontinue treatment|1
5954506|NCT01236352|20594698|P5|Overall Study|Subject request to discontinue treatment|0
5954507|NCT01236352|20594699|P4|Overall Study|Subject request to discontinue treatment|1
5954508|NCT01236352|20594700|P3|Overall Study|Subject request to discontinue treatment|1
5954509|NCT01236352|20594701|P2|Overall Study|Subject request to discontinue treatment|0
5954510|NCT01236352|20594702|P1|Overall Study|Subject request to discontinue treatment|0
5954511|NCT01236352|20594692|P11|Overall Study|Maximum clinical benefit|2
5954512|NCT01236352|20594693|P10|Overall Study|Maximum clinical benefit|4
5954513|NCT01236352|20594694|P9|Overall Study|Maximum clinical benefit|1
5954514|NCT01236352|20594695|P8|Overall Study|Maximum clinical benefit|1
5954515|NCT01236352|20594696|P7|Overall Study|Maximum clinical benefit|3
5954516|NCT01236352|20594697|P6|Overall Study|Maximum clinical benefit|0
5954517|NCT01236352|20594698|P5|Overall Study|Maximum clinical benefit|2
5954518|NCT01236352|20594699|P4|Overall Study|Maximum clinical benefit|0
5954519|NCT01236352|20594700|P3|Overall Study|Maximum clinical benefit|1
5954520|NCT01236352|20594701|P2|Overall Study|Maximum clinical benefit|1
5954521|NCT01236352|20594702|P1|Overall Study|Maximum clinical benefit|1
5954522|NCT01236352|20594692|P11|Overall Study|Poor/Non-compliance|0
5954523|NCT01236352|20594693|P10|Overall Study|Poor/Non-compliance|0
5954524|NCT01236352|20594694|P9|Overall Study|Poor/Non-compliance|0
5954525|NCT01236352|20594695|P8|Overall Study|Poor/Non-compliance|0
5954526|NCT01236352|20594696|P7|Overall Study|Poor/Non-compliance|0
5954527|NCT01236352|20594697|P6|Overall Study|Poor/Non-compliance|0
5954528|NCT01236352|20594698|P5|Overall Study|Poor/Non-compliance|0
5954529|NCT01236352|20594699|P4|Overall Study|Poor/Non-compliance|0
5954530|NCT01236352|20594700|P3|Overall Study|Poor/Non-compliance|0
5954531|NCT01236352|20594701|P2|Overall Study|Poor/Non-compliance|0
5954532|NCT01236352|20594702|P1|Overall Study|Poor/Non-compliance|1
5954533|NCT01236352|20594692|P11|Overall Study|Disease progression|2
5954534|NCT01236352|20594693|P10|Overall Study|Disease progression|2
5954535|NCT01236352|20594694|P9|Overall Study|Disease progression|2
5954536|NCT01236352|20594695|P8|Overall Study|Disease progression|3
5954537|NCT01236352|20594696|P7|Overall Study|Disease progression|1
5954538|NCT01236352|20594697|P6|Overall Study|Disease progression|2
5954539|NCT01236352|20594698|P5|Overall Study|Disease progression|2
5954540|NCT01236352|20594699|P4|Overall Study|Disease progression|2
5954541|NCT01236352|20594700|P3|Overall Study|Disease progression|1
5954542|NCT01236352|20594701|P2|Overall Study|Disease progression|2
5954543|NCT01236352|20594702|P1|Overall Study|Disease progression|1
5954544|NCT01236352|20594692|P11|Overall Study|Study drug toxicity|2
5954545|NCT01236352|20594693|P10|Overall Study|Study drug toxicity|2
5954546|NCT01236352|20594694|P9|Overall Study|Study drug toxicity|0
5954547|NCT01236352|20594695|P8|Overall Study|Study drug toxicity|0
5954548|NCT01236352|20594696|P7|Overall Study|Study drug toxicity|1
5954549|NCT01236352|20594697|P6|Overall Study|Study drug toxicity|1
5954550|NCT01236352|20594698|P5|Overall Study|Study drug toxicity|0
5954551|NCT01236352|20594699|P4|Overall Study|Study drug toxicity|0
5954552|NCT01236352|20594700|P3|Overall Study|Study drug toxicity|0
5954553|NCT01236352|20594701|P2|Overall Study|Study drug toxicity|0
5954554|NCT01236352|20594702|P1|Overall Study|Study drug toxicity|0
5954555|NCT01236352|20594692|P11|Overall Study|Adverse Event|1
5954556|NCT01236352|20594693|P10|Overall Study|Adverse Event|4
5954557|NCT01236352|20594694|P9|Overall Study|Adverse Event|0
5954558|NCT01236352|20594695|P8|Overall Study|Adverse Event|0
5954559|NCT01236352|20594696|P7|Overall Study|Adverse Event|2
5954560|NCT01236352|20594697|P6|Overall Study|Adverse Event|0
5954561|NCT01236352|20594698|P5|Overall Study|Adverse Event|0
5954562|NCT01236352|20594699|P4|Overall Study|Adverse Event|0
5954563|NCT01236352|20594700|P3|Overall Study|Adverse Event|0
5954564|NCT01236352|20594701|P2|Overall Study|Adverse Event|0
5954565|NCT01236352|20594702|P1|Overall Study|Adverse Event|0
5954566|NCT01236352|20594692|P11|Overall Study|Withdrawal by Subject|1
5954567|NCT01236352|20594693|P10|Overall Study|Withdrawal by Subject|2
5954568|NCT01236352|20594694|P9|Overall Study|Withdrawal by Subject|0
5954569|NCT01236352|20594695|P8|Overall Study|Withdrawal by Subject|0
5954570|NCT01236352|20594696|P7|Overall Study|Withdrawal by Subject|0
5954571|NCT01236352|20594697|P6|Overall Study|Withdrawal by Subject|0
5954572|NCT01236352|20594698|P5|Overall Study|Withdrawal by Subject|0
5954573|NCT01236352|20594699|P4|Overall Study|Withdrawal by Subject|0
5954574|NCT01236352|20594700|P3|Overall Study|Withdrawal by Subject|0
5954575|NCT01236352|20594701|P2|Overall Study|Withdrawal by Subject|0
5954576|NCT01236352|20594702|P1|Overall Study|Withdrawal by Subject|0
5954577|NCT01236352|20594692|P11|Overall Study|Death|0
5954578|NCT01236352|20594693|P10|Overall Study|Death|0
5954579|NCT01236352|20594694|P9|Overall Study|Death|0
5954580|NCT01236352|20594695|P8|Overall Study|Death|1
5954581|NCT01236352|20594696|P7|Overall Study|Death|0
5954582|NCT01236352|20594697|P6|Overall Study|Death|0
5954583|NCT01236352|20594698|P5|Overall Study|Death|0
5954584|NCT01236352|20594699|P4|Overall Study|Death|0
5954585|NCT01236352|20594700|P3|Overall Study|Death|0
5954586|NCT01236352|20594701|P2|Overall Study|Death|0
5954587|NCT01236352|20594702|P1|Overall Study|Death|0
5954588|NCT01236118|20594920|P3|Overall Study|Withdrawal by Subject|1
5954589|NCT01236118|20594921|P2|Overall Study|Withdrawal by Subject|0
5954590|NCT01236118|20594922|P1|Overall Study|Withdrawal by Subject|0
5954591|NCT01236118|20594920|P3|Overall Study|Physician Decision|0
5954592|NCT01236118|20594921|P2|Overall Study|Physician Decision|1
5954593|NCT01236118|20594922|P1|Overall Study|Physician Decision|0
5954594|NCT01236118|20594920|P3|Overall Study|Adverse Event|2
5954595|NCT01236118|20594921|P2|Overall Study|Adverse Event|0
5954596|NCT01236118|20594922|P1|Overall Study|Adverse Event|2
5954597|NCT01236001|20595123|P2|Overall Study|Planned Visit After End of Study|1
5954598|NCT01236001|20595124|P1|Overall Study|Planned Visit After End of Study|0
5954599|NCT01236001|20595123|P2|Overall Study|Incompliance|0
5954600|NCT01236001|20595124|P1|Overall Study|Incompliance|1
5954601|NCT01236001|20595123|P2|Overall Study|Lost to Follow-up|1
5954602|NCT01236001|20595124|P1|Overall Study|Lost to Follow-up|6
5954603|NCT01236001|20595123|P2|Overall Study|Lack of Efficacy|6
5954604|NCT01236001|20595124|P1|Overall Study|Lack of Efficacy|6
5954605|NCT01236001|20595123|P2|Overall Study|Adverse Event|14
5954606|NCT01236001|20595124|P1|Overall Study|Adverse Event|5
5954607|NCT01235975|20595156|P2|Overall Study|Lost to Follow-up|3
5954608|NCT01235975|20595157|P1|Overall Study|Lost to Follow-up|7
5954609|NCT01235975|20595156|P2|Overall Study|Migrated/moved from study area|1
5954610|NCT01235975|20595157|P1|Overall Study|Migrated/moved from study area|2
5954611|NCT01235975|20595156|P2|Overall Study|Withdrawal by Subject|2
5954612|NCT01235975|20595157|P1|Overall Study|Withdrawal by Subject|8
5954613|NCT01235975|20595156|P2|Overall Study|Serious Adverse Event|1
5954614|NCT01235975|20595157|P1|Overall Study|Serious Adverse Event|0
5954615|NCT01235962|20595193|P4|Overall Study|Physician Decision|5
5954616|NCT01235962|20595194|P3|Overall Study|Physician Decision|9
5954617|NCT01235962|20595195|P2|Overall Study|Physician Decision|0
5954618|NCT01235962|20595196|P1|Overall Study|Physician Decision|5
5954619|NCT01235962|20595193|P4|Overall Study|Lost to Follow-up|32
5954620|NCT01235962|20595194|P3|Overall Study|Lost to Follow-up|47
5954621|NCT01235962|20595195|P2|Overall Study|Lost to Follow-up|16
5954622|NCT01235962|20595196|P1|Overall Study|Lost to Follow-up|21
5954623|NCT01235962|20595193|P4|Overall Study|Withdrawal by Subject|49
5954624|NCT01235962|20595194|P3|Overall Study|Withdrawal by Subject|62
5954625|NCT01235962|20595195|P2|Overall Study|Withdrawal by Subject|19
5954626|NCT01235962|20595196|P1|Overall Study|Withdrawal by Subject|20
5954627|NCT01235949|20595266|P18|Booster Phase|Lost to Follow-up|1
5954628|NCT01235949|20595267|P17|Booster Phase|Lost to Follow-up|0
5954629|NCT01235949|20595268|P16|Booster Phase|Lost to Follow-up|0
5954630|NCT01235949|20595269|P15|Booster Phase|Lost to Follow-up|0
5954631|NCT01235949|20595270|P14|Booster Phase|Lost to Follow-up|0
5954632|NCT01235949|20595271|P13|Booster Phase|Lost to Follow-up|0
5954633|NCT01235949|20595272|P12|Booster Phase|Lost to Follow-up|1
5954634|NCT01235949|20595273|P11|Booster Phase|Lost to Follow-up|1
5954635|NCT01235949|20595274|P10|Booster Phase|Lost to Follow-up|1
5954636|NCT01235949|20595275|P9|Booster Phase|Lost to Follow-up|1
5954637|NCT01235949|20595276|P8|Booster Phase|Lost to Follow-up|0
5954638|NCT01235949|20595277|P7|Booster Phase|Lost to Follow-up|0
5954639|NCT01235949|20595278|P6|Booster Phase|Lost to Follow-up|0
5954640|NCT01235949|20595279|P5|Booster Phase|Lost to Follow-up|0
5954641|NCT01235949|20595280|P4|Booster Phase|Lost to Follow-up|0
5954642|NCT01235949|20595281|P3|Booster Phase|Lost to Follow-up|0
5954643|NCT01235949|20595282|P2|Booster Phase|Lost to Follow-up|0
5954644|NCT01235949|20595283|P1|Booster Phase|Lost to Follow-up|0
5954645|NCT01235949|20595266|P18|Booster Phase|Withdrawal by Subject|0
5954646|NCT01235949|20595267|P17|Booster Phase|Withdrawal by Subject|0
5954647|NCT01235949|20595268|P16|Booster Phase|Withdrawal by Subject|0
5954648|NCT01235949|20595269|P15|Booster Phase|Withdrawal by Subject|2
5954649|NCT01235949|20595270|P14|Booster Phase|Withdrawal by Subject|0
5954650|NCT01235949|20595271|P13|Booster Phase|Withdrawal by Subject|2
5954651|NCT01235949|20595272|P12|Booster Phase|Withdrawal by Subject|1
5954652|NCT01235949|20595273|P11|Booster Phase|Withdrawal by Subject|1
5954653|NCT01235949|20595274|P10|Booster Phase|Withdrawal by Subject|0
5954654|NCT01235949|20595275|P9|Booster Phase|Withdrawal by Subject|1
5954655|NCT01235949|20595276|P8|Booster Phase|Withdrawal by Subject|1
5954656|NCT01235949|20595277|P7|Booster Phase|Withdrawal by Subject|0
5954657|NCT01235949|20595278|P6|Booster Phase|Withdrawal by Subject|0
5954658|NCT01235949|20595279|P5|Booster Phase|Withdrawal by Subject|0
5954659|NCT01235949|20595280|P4|Booster Phase|Withdrawal by Subject|0
5954660|NCT01235949|20595281|P3|Booster Phase|Withdrawal by Subject|0
5954661|NCT01235949|20595282|P2|Booster Phase|Withdrawal by Subject|0
5954662|NCT01235949|20595283|P1|Booster Phase|Withdrawal by Subject|0
5954663|NCT01235949|20595266|P18|Booster Phase|Adverse Event|0
5954664|NCT01235949|20595267|P17|Booster Phase|Adverse Event|0
5954665|NCT01235949|20595268|P16|Booster Phase|Adverse Event|1
5954666|NCT01235949|20595269|P15|Booster Phase|Adverse Event|0
5954667|NCT01235949|20595270|P14|Booster Phase|Adverse Event|0
5954668|NCT01235949|20595271|P13|Booster Phase|Adverse Event|0
5954669|NCT01235949|20595272|P12|Booster Phase|Adverse Event|0
5954670|NCT01235949|20595273|P11|Booster Phase|Adverse Event|0
5954671|NCT01235949|20595274|P10|Booster Phase|Adverse Event|0
5954672|NCT01235949|20595275|P9|Booster Phase|Adverse Event|0
5954673|NCT01235949|20595276|P8|Booster Phase|Adverse Event|0
5954674|NCT01235949|20595277|P7|Booster Phase|Adverse Event|0
5954675|NCT01235949|20595278|P6|Booster Phase|Adverse Event|0
5954676|NCT01235949|20595279|P5|Booster Phase|Adverse Event|0
5954677|NCT01235949|20595280|P4|Booster Phase|Adverse Event|0
5954678|NCT01235949|20595281|P3|Booster Phase|Adverse Event|0
5954679|NCT01235949|20595282|P2|Booster Phase|Adverse Event|0
5954680|NCT01235949|20595283|P1|Booster Phase|Adverse Event|0
5954681|NCT01235949|20595266|P18|Booster Phase|Migrated/moved from study area|1
5954682|NCT01235949|20595267|P17|Booster Phase|Migrated/moved from study area|0
5954683|NCT01235949|20595268|P16|Booster Phase|Migrated/moved from study area|0
5954684|NCT01235949|20595269|P15|Booster Phase|Migrated/moved from study area|0
5954685|NCT01235949|20595270|P14|Booster Phase|Migrated/moved from study area|0
5954686|NCT01235949|20595271|P13|Booster Phase|Migrated/moved from study area|1
5954687|NCT01235949|20595272|P12|Booster Phase|Migrated/moved from study area|1
5954688|NCT01235949|20595273|P11|Booster Phase|Migrated/moved from study area|0
5954689|NCT01235949|20595274|P10|Booster Phase|Migrated/moved from study area|0
5954690|NCT01235949|20595275|P9|Booster Phase|Migrated/moved from study area|0
5954691|NCT01235949|20595276|P8|Booster Phase|Migrated/moved from study area|0
5954692|NCT01235949|20595277|P7|Booster Phase|Migrated/moved from study area|0
5954693|NCT01235949|20595278|P6|Booster Phase|Migrated/moved from study area|0
5954694|NCT01235949|20595279|P5|Booster Phase|Migrated/moved from study area|0
5954695|NCT01235949|20595280|P4|Booster Phase|Migrated/moved from study area|0
5954696|NCT01235949|20595281|P3|Booster Phase|Migrated/moved from study area|0
5954697|NCT01235949|20595282|P2|Booster Phase|Migrated/moved from study area|0
5954698|NCT01235949|20595283|P1|Booster Phase|Migrated/moved from study area|0
5954699|NCT01235949|20595266|P18|Primary Phase|Lost to Follow-up|0
5954700|NCT01235949|20595267|P17|Primary Phase|Lost to Follow-up|0
5954701|NCT01235949|20595268|P16|Primary Phase|Lost to Follow-up|0
5954702|NCT01235949|20595269|P15|Primary Phase|Lost to Follow-up|0
5954703|NCT01235949|20595270|P14|Primary Phase|Lost to Follow-up|0
5954704|NCT01235949|20595271|P13|Primary Phase|Lost to Follow-up|0
5954705|NCT01235949|20595272|P12|Primary Phase|Lost to Follow-up|0
5954706|NCT01235949|20595273|P11|Primary Phase|Lost to Follow-up|0
5954707|NCT01235949|20595274|P10|Primary Phase|Lost to Follow-up|0
5954708|NCT01235949|20595275|P9|Primary Phase|Lost to Follow-up|0
5954709|NCT01235949|20595276|P8|Primary Phase|Lost to Follow-up|0
5954710|NCT01235949|20595277|P7|Primary Phase|Lost to Follow-up|0
5954711|NCT01235949|20595278|P6|Primary Phase|Lost to Follow-up|2
5954712|NCT01235949|20595279|P5|Primary Phase|Lost to Follow-up|0
5954713|NCT01235949|20595280|P4|Primary Phase|Lost to Follow-up|1
5954714|NCT01235949|20595281|P3|Primary Phase|Lost to Follow-up|1
5954715|NCT01235949|20595282|P2|Primary Phase|Lost to Follow-up|0
5954716|NCT01235949|20595283|P1|Primary Phase|Lost to Follow-up|0
5954717|NCT01235949|20595266|P18|Primary Phase|Withdrawal by Subject|0
5954718|NCT01235949|20595267|P17|Primary Phase|Withdrawal by Subject|0
5954719|NCT01235949|20595268|P16|Primary Phase|Withdrawal by Subject|0
5954720|NCT01235949|20595269|P15|Primary Phase|Withdrawal by Subject|0
5954721|NCT01235949|20595270|P14|Primary Phase|Withdrawal by Subject|0
5954722|NCT01235949|20595271|P13|Primary Phase|Withdrawal by Subject|0
5954723|NCT01235949|20595272|P12|Primary Phase|Withdrawal by Subject|0
5954724|NCT01235949|20595273|P11|Primary Phase|Withdrawal by Subject|0
5954725|NCT01235949|20595274|P10|Primary Phase|Withdrawal by Subject|0
5954726|NCT01235949|20595275|P9|Primary Phase|Withdrawal by Subject|0
5954727|NCT01235949|20595276|P8|Primary Phase|Withdrawal by Subject|0
5954728|NCT01235949|20595277|P7|Primary Phase|Withdrawal by Subject|0
5954729|NCT01235949|20595278|P6|Primary Phase|Withdrawal by Subject|3
5954730|NCT01235949|20595279|P5|Primary Phase|Withdrawal by Subject|0
5954731|NCT01235949|20595280|P4|Primary Phase|Withdrawal by Subject|0
5954732|NCT01235949|20595281|P3|Primary Phase|Withdrawal by Subject|2
5954733|NCT01235949|20595282|P2|Primary Phase|Withdrawal by Subject|2
5954734|NCT01235949|20595283|P1|Primary Phase|Withdrawal by Subject|3
5954735|NCT01235949|20595266|P18|Primary Phase|Adverse Event|0
5954736|NCT01235949|20595267|P17|Primary Phase|Adverse Event|0
5954737|NCT01235949|20595268|P16|Primary Phase|Adverse Event|0
5954738|NCT01235949|20595269|P15|Primary Phase|Adverse Event|0
5954739|NCT01235949|20595270|P14|Primary Phase|Adverse Event|0
5954740|NCT01235949|20595271|P13|Primary Phase|Adverse Event|0
5954741|NCT01235949|20595272|P12|Primary Phase|Adverse Event|0
5954742|NCT01235949|20595273|P11|Primary Phase|Adverse Event|0
5954743|NCT01235949|20595274|P10|Primary Phase|Adverse Event|0
5954744|NCT01235949|20595275|P9|Primary Phase|Adverse Event|0
5954745|NCT01235949|20595276|P8|Primary Phase|Adverse Event|0
5954746|NCT01235949|20595277|P7|Primary Phase|Adverse Event|0
5954747|NCT01235949|20595278|P6|Primary Phase|Adverse Event|0
5954748|NCT01235949|20595279|P5|Primary Phase|Adverse Event|0
5954749|NCT01235949|20595280|P4|Primary Phase|Adverse Event|1
5954750|NCT01235949|20595281|P3|Primary Phase|Adverse Event|0
5954751|NCT01235949|20595282|P2|Primary Phase|Adverse Event|0
5954752|NCT01235949|20595283|P1|Primary Phase|Adverse Event|0
5954753|NCT01235949|20595266|P18|Primary Phase|Migrated/moved from study area|0
5954754|NCT01235949|20595267|P17|Primary Phase|Migrated/moved from study area|0
5954755|NCT01235949|20595268|P16|Primary Phase|Migrated/moved from study area|0
5954756|NCT01235949|20595269|P15|Primary Phase|Migrated/moved from study area|0
5954757|NCT01235949|20595270|P14|Primary Phase|Migrated/moved from study area|0
5954758|NCT01235949|20595271|P13|Primary Phase|Migrated/moved from study area|0
5954759|NCT01235949|20595272|P12|Primary Phase|Migrated/moved from study area|0
5954760|NCT01235949|20595273|P11|Primary Phase|Migrated/moved from study area|0
5954761|NCT01235949|20595274|P10|Primary Phase|Migrated/moved from study area|0
5954762|NCT01235949|20595275|P9|Primary Phase|Migrated/moved from study area|0
5954763|NCT01235949|20595276|P8|Primary Phase|Migrated/moved from study area|0
5954764|NCT01235949|20595277|P7|Primary Phase|Migrated/moved from study area|0
5954765|NCT01235949|20595278|P6|Primary Phase|Migrated/moved from study area|2
5954766|NCT01235949|20595279|P5|Primary Phase|Migrated/moved from study area|1
5954767|NCT01235949|20595280|P4|Primary Phase|Migrated/moved from study area|0
5954768|NCT01235949|20595281|P3|Primary Phase|Migrated/moved from study area|0
5954769|NCT01235949|20595282|P2|Primary Phase|Migrated/moved from study area|1
5954770|NCT01235949|20595283|P1|Primary Phase|Migrated/moved from study area|1
5954771|NCT01235741|20595533|P3|Follow-Up Post Treatment up to Month 6|Other|0
5954772|NCT01235741|20595534|P2|Follow-Up Post Treatment up to Month 6|Other|1
5954773|NCT01235741|20595535|P1|Follow-Up Post Treatment up to Month 6|Other|0
5954774|NCT01235741|20595533|P3|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|1
5954775|NCT01235741|20595534|P2|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|5
5954776|NCT01235741|20595535|P1|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|0
5954777|NCT01235741|20595533|P3|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|6
5954778|NCT01235741|20595534|P2|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|3
5954779|NCT01235741|20595535|P1|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|0
5954780|NCT01235741|20595533|P3|Randomized to Treatment|Sponsor terminated study|34
5954781|NCT01235741|20595534|P2|Randomized to Treatment|Sponsor terminated study|35
5954782|NCT01235741|20595535|P1|Randomized to Treatment|Sponsor terminated study|0
5954783|NCT01235741|20595533|P3|Randomized to Treatment|Adverse Event|1
5954784|NCT01235741|20595534|P2|Randomized to Treatment|Adverse Event|1
5954785|NCT01235741|20595535|P1|Randomized to Treatment|Adverse Event|0
5954786|NCT01235741|20595533|P3|Randomized to Treatment|Withdrawal by Subject|1
5954787|NCT01235741|20595534|P2|Randomized to Treatment|Withdrawal by Subject|0
5954788|NCT01235741|20595535|P1|Randomized to Treatment|Withdrawal by Subject|0
5954789|NCT01235741|20595533|P3|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0
5954790|NCT01235741|20595534|P2|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0
5954791|NCT01235741|20595535|P1|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|4
5954792|NCT01235741|20595533|P3|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0
5954793|NCT01235741|20595534|P2|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0
5954794|NCT01235741|20595535|P1|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|5
5954795|NCT01235741|20595533|P3|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0
5954796|NCT01235741|20595534|P2|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0
5954797|NCT01235741|20595535|P1|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|1
5954798|NCT01235741|20595533|P3|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0
5954799|NCT01235741|20595534|P2|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0
5954800|NCT01235741|20595535|P1|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|1
5954801|NCT01235741|20595533|P3|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0
5954802|NCT01235741|20595534|P2|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0
5954803|NCT01235741|20595535|P1|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|121
5954804|NCT01235741|20595533|P3|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0
5954805|NCT01235741|20595534|P2|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0
5954806|NCT01235741|20595535|P1|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|9
5954807|NCT01235728|20595562|P8|Overall Study|Protocol Violation|0
5954808|NCT01235728|20595563|P7|Overall Study|Protocol Violation|0
5954809|NCT01235728|20595564|P6|Overall Study|Protocol Violation|0
5954810|NCT01235728|20595565|P5|Overall Study|Protocol Violation|0
5954811|NCT01235728|20595566|P4|Overall Study|Protocol Violation|1
5954812|NCT01235728|20595567|P3|Overall Study|Protocol Violation|0
5954813|NCT01235728|20595568|P2|Overall Study|Protocol Violation|0
5954814|NCT01235728|20595569|P1|Overall Study|Protocol Violation|0
5954815|NCT01235715|20595579|P2|Overall Study|Physician Decision|2
5954816|NCT01235715|20595580|P1|Overall Study|Physician Decision|0
5954817|NCT01235689|20595620|P2|Overall Study|Miscellaneous|5
5954818|NCT01235689|20595621|P1|Overall Study|Miscellaneous|1
5954819|NCT01235689|20595620|P2|Overall Study|Lost to Follow-up|2
5954820|NCT01235689|20595621|P1|Overall Study|Lost to Follow-up|1
5954821|NCT01235689|20595620|P2|Overall Study|Withdrawal by Subject|4
5954822|NCT01235689|20595621|P1|Overall Study|Withdrawal by Subject|3
5954823|NCT01235689|20595620|P2|Overall Study|Lack of Efficacy|5
5954824|NCT01235689|20595621|P1|Overall Study|Lack of Efficacy|12
5954825|NCT01235689|20595620|P2|Overall Study|Adverse Event|16
5954826|NCT01235689|20595621|P1|Overall Study|Adverse Event|12
5954827|NCT01235598|20595693|P2|Overall Study|Withdrawal by Subject|0
5954828|NCT01235598|20595694|P1|Overall Study|Withdrawal by Subject|1
5954829|NCT01235598|20595693|P2|Overall Study|Lack of Efficacy|1
5954830|NCT01235598|20595694|P1|Overall Study|Lack of Efficacy|0
5954831|NCT01235598|20595693|P2|Overall Study|Adverse Event|3
5954832|NCT01235598|20595694|P1|Overall Study|Adverse Event|0
5954833|NCT01235546|20595739|P2|Overall Study|Protocol Violation|1
5954834|NCT01235546|20595740|P1|Overall Study|Protocol Violation|1
5954835|NCT01235546|20595739|P2|Overall Study|Staff error, medication not administered|0
5954836|NCT01235546|20595740|P1|Overall Study|Staff error, medication not administered|1
5954837|NCT01235507|20595764|P1|Overall Study|Withdrawal by Subject|1
5954838|NCT01235507|20595764|P1|Overall Study|Adverse Event|1
5954839|NCT01235442|20595778|P2|Overall Study|Other unspecified|2
5954840|NCT01235442|20595779|P1|Overall Study|Other unspecified|1
5954841|NCT01235442|20595778|P2|Overall Study|Administrative decision|2
5954842|NCT01235442|20595779|P1|Overall Study|Administrative decision|1
5954843|NCT01235442|20595778|P2|Overall Study|Noncompliance|2
5954844|NCT01235442|20595779|P1|Overall Study|Noncompliance|1
5954845|NCT01235442|20595778|P2|Overall Study|Lack of Efficacy|3
5954846|NCT01235442|20595779|P1|Overall Study|Lack of Efficacy|1
5954847|NCT01235442|20595778|P2|Overall Study|Withdrawal by Subject|9
5954848|NCT01235442|20595779|P1|Overall Study|Withdrawal by Subject|15
5954849|NCT01235442|20595778|P2|Overall Study|Adverse Event|6
5954850|NCT01235442|20595779|P1|Overall Study|Adverse Event|4
5954851|NCT01235442|20595778|P2|Overall Study|Protocol Violation|3
5954852|NCT01235442|20595779|P1|Overall Study|Protocol Violation|3
5954853|NCT01235442|20595778|P2|Overall Study|Ineligibility determined|4
5954854|NCT01235442|20595779|P1|Overall Study|Ineligibility determined|5
5954855|NCT01235442|20595778|P2|Overall Study|Pregnancy|1
5954856|NCT01235442|20595779|P1|Overall Study|Pregnancy|1
5954857|NCT01235442|20595778|P2|Overall Study|Death|2
5954858|NCT01235442|20595779|P1|Overall Study|Death|0
5954859|NCT01235442|20595778|P2|Overall Study|Lost to Follow-up|10
5954860|NCT01235442|20595779|P1|Overall Study|Lost to Follow-up|12
5954861|NCT01235403|20595797|P1|Overall Study|Other reasons for premature termination|4
5954862|NCT01235403|20595797|P1|Overall Study|Lack of Efficacy|2
5954863|NCT01235403|20595797|P1|Overall Study|Withdrawal by Subject|4
5954864|NCT01235403|20595797|P1|Overall Study|Lost to Follow-up|2
5954865|NCT01235403|20595797|P1|Overall Study|Adverse Event|14
5954866|NCT01235351|20595814|P2|Initial Treatment With 75 mg and 150 mg|No follow-up sample|4
5954867|NCT01235351|20595815|P1|Initial Treatment With 75 mg and 150 mg|No follow-up sample|10
5954868|NCT01235338|20595827|P2|Overall Study|Prohibited meds|0
5954869|NCT01235338|20595828|P1|Overall Study|Prohibited meds|1
5954870|NCT01235338|20595827|P2|Overall Study|Positive drug screen|1
5954871|NCT01235338|20595828|P1|Overall Study|Positive drug screen|0
5954872|NCT01235338|20595827|P2|Overall Study|Exclusion criteria violations|1
5954873|NCT01235338|20595828|P1|Overall Study|Exclusion criteria violations|1
5954874|NCT01235338|20595827|P2|Overall Study|Withdrawal by Subject|0
5954875|NCT01235338|20595828|P1|Overall Study|Withdrawal by Subject|5
5954876|NCT01235338|20595827|P2|Overall Study|Protocol Violation|1
5954877|NCT01235338|20595828|P1|Overall Study|Protocol Violation|1
5954878|NCT01235338|20595827|P2|Overall Study|Adverse Event|2
5954879|NCT01235338|20595828|P1|Overall Study|Adverse Event|3
5954880|NCT01235234|20595873|P3|Overall Study|Adverse Event|1
5954881|NCT01235234|20595874|P2|Overall Study|Adverse Event|2
5954882|NCT01235234|20595875|P1|Overall Study|Adverse Event|2
5954883|NCT01234883|20595923|P2|Overall Study|Inclusion/exclusion failure|0
5954884|NCT01234883|20595924|P1|Overall Study|Inclusion/exclusion failure|1
5954885|NCT01234883|20595923|P2|Overall Study|Technical difficulties with IV infusion|1
5954886|NCT01234883|20595924|P1|Overall Study|Technical difficulties with IV infusion|0
5954887|NCT01234883|20595923|P2|Overall Study|Parent/guardian withdrew consent|2
5954888|NCT01234883|20595924|P1|Overall Study|Parent/guardian withdrew consent|1
5954889|NCT01234883|20595923|P2|Overall Study|Early treatment release|10
5954890|NCT01234883|20595924|P1|Overall Study|Early treatment release|8
5954891|NCT01234675|20595971|P2|First Intervention (6 Weeks)|Withdrawal by Subject|0
5954892|NCT01234675|20595972|P1|First Intervention (6 Weeks)|Withdrawal by Subject|1
5954893|NCT01234675|20595971|P2|First Intervention (6 Weeks)|Adverse Event|1
5954894|NCT01234675|20595972|P1|First Intervention (6 Weeks)|Adverse Event|0
5954895|NCT01234649|20596004|P2|Overall Study|Lack of Efficacy|3
5954896|NCT01234649|20596005|P1|Overall Study|Lack of Efficacy|0
5954897|NCT01234649|20596004|P2|Overall Study|Allergic reaction|0
5954898|NCT01234649|20596005|P1|Overall Study|Allergic reaction|1
5954899|NCT01234649|20596004|P2|Overall Study|intolerant to side effects|3
5954900|NCT01234649|20596005|P1|Overall Study|intolerant to side effects|4
5954901|NCT01234649|20596004|P2|Overall Study|Pregnancy|6
5954902|NCT01234649|20596005|P1|Overall Study|Pregnancy|6
5954903|NCT01234649|20596004|P2|Overall Study|Withdrawal by Subject|26
5954904|NCT01234649|20596005|P1|Overall Study|Withdrawal by Subject|32
5954905|NCT01234467|20596053|P1|Overall Study|Other complicating disease (stroke)|1
5954906|NCT01234467|20596053|P1|Overall Study|Physician Decision|1
5954907|NCT01234467|20596053|P1|Overall Study|Clinical deterioration|1
5954908|NCT01234467|20596053|P1|Overall Study|Disease Progression|2
5954909|NCT01234467|20596053|P1|Overall Study|Withdrawal by Subject|2
5954910|NCT01234467|20596053|P1|Overall Study|Death|2
5954911|NCT01234467|20596053|P1|Overall Study|Adverse Event|3
5954912|NCT01234402|20596065|P3|Overall Study|Never treated: Insurance Denied Xeloda|0
5954913|NCT01234402|20596066|P2|Overall Study|Never treated: Insurance Denied Xeloda|1
5954914|NCT01234402|20596067|P1|Overall Study|Never treated: Insurance Denied Xeloda|0
5954915|NCT01234402|20596065|P3|Overall Study|Never treated: Withdrawal By Subject|0
5954916|NCT01234402|20596066|P2|Overall Study|Never treated: Withdrawal By Subject|1
5954917|NCT01234402|20596067|P1|Overall Study|Never treated: Withdrawal By Subject|0
5954918|NCT01234402|20596065|P3|Overall Study|Never treated: Death|1
5954919|NCT01234402|20596066|P2|Overall Study|Never treated: Death|0
5954920|NCT01234402|20596067|P1|Overall Study|Never treated: Death|0
5954921|NCT01234402|20596065|P3|Overall Study|Withdrawal by Subject|4
5954922|NCT01234402|20596066|P2|Overall Study|Withdrawal by Subject|3
5954923|NCT01234402|20596067|P1|Overall Study|Withdrawal by Subject|1
5954924|NCT01234402|20596065|P3|Overall Study|Lost to Follow-up|3
5954925|NCT01234402|20596066|P2|Overall Study|Lost to Follow-up|1
5954926|NCT01234402|20596067|P1|Overall Study|Lost to Follow-up|0
5954927|NCT01234350|20596108|P2|Overall Study|Covers a diverse set of reasons|92
5954928|NCT01234350|20596109|P1|Overall Study|Covers a diverse set of reasons|234
5954929|NCT01234350|20596108|P2|Overall Study|Lost to Follow-up|47
5954930|NCT01234350|20596109|P1|Overall Study|Lost to Follow-up|115
5954931|NCT01234350|20596108|P2|Overall Study|Withdrawal by Subject|36
5954932|NCT01234350|20596109|P1|Overall Study|Withdrawal by Subject|61
5954933|NCT01234350|20596108|P2|Overall Study|Adverse Event|92
5954934|NCT01234350|20596109|P1|Overall Study|Adverse Event|277
5954935|NCT01234337|20596135|P2|Overall Study|Switch to commercial drug|1
5954936|NCT01234337|20596136|P1|Overall Study|Switch to commercial drug|0
5954937|NCT01234337|20596135|P2|Overall Study|Death|1
5954938|NCT01234337|20596136|P1|Overall Study|Death|0
5954939|NCT01234337|20596135|P2|Overall Study|Withdrawal by Subject|9
5954940|NCT01234337|20596136|P1|Overall Study|Withdrawal by Subject|11
5954941|NCT01234337|20596135|P2|Overall Study|Protocol Violation|3
5954942|NCT01234337|20596136|P1|Overall Study|Protocol Violation|2
5954943|NCT01234337|20596135|P2|Overall Study|Lost to Follow-up|1
5954944|NCT01234337|20596136|P1|Overall Study|Lost to Follow-up|0
5954945|NCT01234337|20596135|P2|Overall Study|Randomized but not treated|4
5954946|NCT01234337|20596136|P1|Overall Study|Randomized but not treated|6
5954947|NCT01234337|20596135|P2|Overall Study|Non-compliant with study medication|2
5954948|NCT01234337|20596136|P1|Overall Study|Non-compliant with study medication|3
5954949|NCT01234337|20596135|P2|Overall Study|Investi. decision not protocol driven|6
5954950|NCT01234337|20596136|P1|Overall Study|Investi. decision not protocol driven|5
5954951|NCT01234337|20596135|P2|Overall Study|Disease progression/recurrence/relapse|223
5954952|NCT01234337|20596136|P1|Overall Study|Disease progression/recurrence/relapse|181
5954953|NCT01234337|20596135|P2|Overall Study|Adverse Event|21
5954954|NCT01234337|20596136|P1|Overall Study|Adverse Event|58
5954955|NCT01233999|20596196|P1|Overall Study|Lost to Follow-up|1
5954956|NCT01233999|20596196|P1|Overall Study|Withdrawal by Subject|1
5954957|NCT01233869|20596215|P4|Extended Treatment Period (46 Months)|Adverse Event|1
5954958|NCT01233869|20596216|P3|Extended Treatment Period (46 Months)|Adverse Event|0
5954959|NCT01233869|20596217|P2|Extended Treatment Period (46 Months)|Adverse Event|0
5954960|NCT01233869|20596218|P1|Extended Treatment Period (46 Months)|Adverse Event|1
5954961|NCT01233869|20596215|P4|Extended Treatment Period (46 Months)|Other|3
5954962|NCT01233869|20596216|P3|Extended Treatment Period (46 Months)|Other|0
5954963|NCT01233869|20596217|P2|Extended Treatment Period (46 Months)|Other|0
5954964|NCT01233869|20596218|P1|Extended Treatment Period (46 Months)|Other|3
5954965|NCT01233869|20596215|P4|Extended Treatment Period (46 Months)|Withdrawal by Subject|11
5954966|NCT01233869|20596216|P3|Extended Treatment Period (46 Months)|Withdrawal by Subject|5
5954967|NCT01233869|20596217|P2|Extended Treatment Period (46 Months)|Withdrawal by Subject|3
5954968|NCT01233869|20596218|P1|Extended Treatment Period (46 Months)|Withdrawal by Subject|10
5954969|NCT01233869|20596215|P4|Extended Treatment Period (46 Months)|Lost to Follow-up|1
5954970|NCT01233869|20596216|P3|Extended Treatment Period (46 Months)|Lost to Follow-up|0
5954971|NCT01233869|20596217|P2|Extended Treatment Period (46 Months)|Lost to Follow-up|0
5954972|NCT01233869|20596218|P1|Extended Treatment Period (46 Months)|Lost to Follow-up|0
5954973|NCT01233869|20596215|P4|Initial Treatment Period (24 Months)|Not Related to Study Drug|19
5954974|NCT01233869|20596216|P3|Initial Treatment Period (24 Months)|Not Related to Study Drug|2
5954975|NCT01233869|20596217|P2|Initial Treatment Period (24 Months)|Not Related to Study Drug|11
5954976|NCT01233869|20596218|P1|Initial Treatment Period (24 Months)|Not Related to Study Drug|14
5954977|NCT01233869|20596215|P4|Initial Treatment Period (24 Months)|Adverse Event|3
5954978|NCT01233869|20596216|P3|Initial Treatment Period (24 Months)|Adverse Event|0
5954979|NCT01233869|20596217|P2|Initial Treatment Period (24 Months)|Adverse Event|17
5954980|NCT01233869|20596218|P1|Initial Treatment Period (24 Months)|Adverse Event|9
5954981|NCT01233869|20596215|P4|Initial Treatment Period (24 Months)|Death|0
5954982|NCT01233869|20596216|P3|Initial Treatment Period (24 Months)|Death|0
5954983|NCT01233869|20596217|P2|Initial Treatment Period (24 Months)|Death|0
5954984|NCT01233869|20596218|P1|Initial Treatment Period (24 Months)|Death|1
5954985|NCT01233817|20596304|P1|Overall Study|Withdrawal by Subject|2
5954986|NCT01233817|20596304|P1|Overall Study|Lost to Follow-up|1
5954987|NCT01233687|20596351|P1|Phase II AMG 102 + Erlotinib|Withdrawal by Subject|1
5954988|NCT01233687|20596351|P1|Phase II AMG 102 + Erlotinib|Physician Decision|2
5954989|NCT01233687|20596351|P1|Phase II AMG 102 + Erlotinib|Death|1
5954990|NCT01233609|20596361|P2|Overall Study|Withdrawal by Subject|0
5954991|NCT01233609|20596362|P1|Overall Study|Withdrawal by Subject|3
5954992|NCT01233609|20596361|P2|Overall Study|Adverse Event|1
5954993|NCT01233609|20596362|P1|Overall Study|Adverse Event|2
5954994|NCT01233609|20596361|P2|Overall Study|Lost to Follow-up|1
5954995|NCT01233609|20596362|P1|Overall Study|Lost to Follow-up|3
5954996|NCT01233609|20596361|P2|Overall Study|Death|0
5954997|NCT01233609|20596362|P1|Overall Study|Death|1
5954998|NCT01233284|20596391|P5|Period 4 (4 Weeks)|Lost to Follow-up|0
5954999|NCT01233284|20596392|P4|Period 4 (4 Weeks)|Lost to Follow-up|1
5955000|NCT01233284|20596393|P3|Period 4 (4 Weeks)|Lost to Follow-up|0
5955001|NCT01233284|20596394|P2|Period 4 (4 Weeks)|Lost to Follow-up|0
5955002|NCT01233284|20596395|P1|Period 4 (4 Weeks)|Lost to Follow-up|0
5955003|NCT01233284|20596391|P5|Period 4 (4 Weeks)|Adverse Event|0
5955004|NCT01233284|20596392|P4|Period 4 (4 Weeks)|Adverse Event|0
5955005|NCT01233284|20596393|P3|Period 4 (4 Weeks)|Adverse Event|0
5955006|NCT01233284|20596394|P2|Period 4 (4 Weeks)|Adverse Event|1
5955007|NCT01233284|20596395|P1|Period 4 (4 Weeks)|Adverse Event|0
5955008|NCT01233284|20596391|P5|Period 3 (4 Weeks)|Other|0
5955009|NCT01233284|20596392|P4|Period 3 (4 Weeks)|Other|1
5955010|NCT01233284|20596393|P3|Period 3 (4 Weeks)|Other|0
5955011|NCT01233284|20596394|P2|Period 3 (4 Weeks)|Other|0
5955012|NCT01233284|20596395|P1|Period 3 (4 Weeks)|Other|0
5955013|NCT01233284|20596391|P5|Period 3 (4 Weeks)|Withdrawal by Subject|0
5955014|NCT01233284|20596392|P4|Period 3 (4 Weeks)|Withdrawal by Subject|0
5955015|NCT01233284|20596393|P3|Period 3 (4 Weeks)|Withdrawal by Subject|1
5955016|NCT01233284|20596394|P2|Period 3 (4 Weeks)|Withdrawal by Subject|0
5955017|NCT01233284|20596395|P1|Period 3 (4 Weeks)|Withdrawal by Subject|0
5955018|NCT01233284|20596391|P5|Period 2 (4 Weeks)|Withdrawal by Subject|0
5955019|NCT01233284|20596392|P4|Period 2 (4 Weeks)|Withdrawal by Subject|0
5955020|NCT01233284|20596393|P3|Period 2 (4 Weeks)|Withdrawal by Subject|1
5955021|NCT01233284|20596394|P2|Period 2 (4 Weeks)|Withdrawal by Subject|0
5955022|NCT01233284|20596395|P1|Period 2 (4 Weeks)|Withdrawal by Subject|0
5955023|NCT01233284|20596391|P5|Period 1 (4 Weeks)|Other|0
5955024|NCT01233284|20596392|P4|Period 1 (4 Weeks)|Other|0
5955025|NCT01233284|20596393|P3|Period 1 (4 Weeks)|Other|1
5955026|NCT01233284|20596394|P2|Period 1 (4 Weeks)|Other|0
5955027|NCT01233284|20596395|P1|Period 1 (4 Weeks)|Other|0
5955028|NCT01233284|20596391|P5|Period 1 (4 Weeks)|Withdrawal by Subject|0
5955029|NCT01233284|20596392|P4|Period 1 (4 Weeks)|Withdrawal by Subject|0
5955030|NCT01233284|20596393|P3|Period 1 (4 Weeks)|Withdrawal by Subject|0
5955031|NCT01233284|20596394|P2|Period 1 (4 Weeks)|Withdrawal by Subject|1
5955032|NCT01233284|20596395|P1|Period 1 (4 Weeks)|Withdrawal by Subject|0
5955033|NCT01233284|20596391|P5|Period 1 (4 Weeks)|Lost to Follow-up|0
5955034|NCT01233284|20596392|P4|Period 1 (4 Weeks)|Lost to Follow-up|0
5955035|NCT01233284|20596393|P3|Period 1 (4 Weeks)|Lost to Follow-up|0
5955036|NCT01233284|20596394|P2|Period 1 (4 Weeks)|Lost to Follow-up|0
5955037|NCT01233284|20596395|P1|Period 1 (4 Weeks)|Lost to Follow-up|1
5955038|NCT01233258|20596476|P6|First Intervention (6 Months)|Non-compliance with study medication|0
5955039|NCT01233258|20596477|P5|First Intervention (6 Months)|Non-compliance with study medication|0
5955040|NCT01233258|20596478|P4|First Intervention (6 Months)|Non-compliance with study medication|0
5955041|NCT01233258|20596479|P3|First Intervention (6 Months)|Non-compliance with study medication|0
5955042|NCT01233258|20596480|P2|First Intervention (6 Months)|Non-compliance with study medication|0
5955043|NCT01233258|20596481|P1|First Intervention (6 Months)|Non-compliance with study medication|1
5955044|NCT01233258|20596476|P6|First Intervention (6 Months)|Protocol Violation|0
5955045|NCT01233258|20596477|P5|First Intervention (6 Months)|Protocol Violation|0
5955046|NCT01233258|20596478|P4|First Intervention (6 Months)|Protocol Violation|0
5955047|NCT01233258|20596479|P3|First Intervention (6 Months)|Protocol Violation|1
5955048|NCT01233258|20596480|P2|First Intervention (6 Months)|Protocol Violation|0
5955049|NCT01233258|20596481|P1|First Intervention (6 Months)|Protocol Violation|0
5955050|NCT01233258|20596476|P6|First Intervention (6 Months)|Withdrawal by Subject|1
5955051|NCT01233258|20596477|P5|First Intervention (6 Months)|Withdrawal by Subject|0
5955052|NCT01233258|20596478|P4|First Intervention (6 Months)|Withdrawal by Subject|1
5955053|NCT01233258|20596479|P3|First Intervention (6 Months)|Withdrawal by Subject|0
5955054|NCT01233258|20596480|P2|First Intervention (6 Months)|Withdrawal by Subject|0
5955055|NCT01233258|20596481|P1|First Intervention (6 Months)|Withdrawal by Subject|0
5955056|NCT01233232|20596501|P3|Overall Study|Voluntary Discontinuation by Subject|0
5955057|NCT01233232|20596502|P2|Overall Study|Voluntary Discontinuation by Subject|0
5955058|NCT01233232|20596503|P1|Overall Study|Voluntary Discontinuation by Subject|1
5955059|NCT01233076|20596556|P2|Period 2, One Week|Lost to Follow-up|0
5955060|NCT01233076|20596557|P1|Period 2, One Week|Lost to Follow-up|1
5955061|NCT01233050|20596565|P2|Overall Study|protocol deviation (inclusion/exclusion)|6
5955062|NCT01233050|20596566|P1|Overall Study|protocol deviation (inclusion/exclusion)|8
5955063|NCT01232894|20596618|P2|Overall Study|Physician Decision|1
5955064|NCT01232894|20596619|P1|Overall Study|Physician Decision|2
5955065|NCT01232894|20596618|P2|Overall Study|Withdrawal by Subject|5
5955066|NCT01232894|20596619|P1|Overall Study|Withdrawal by Subject|8
5955067|NCT01232894|20596618|P2|Overall Study|Protocol Violation|1
5955068|NCT01232894|20596619|P1|Overall Study|Protocol Violation|1
5955069|NCT01232894|20596618|P2|Overall Study|Death|0
5955070|NCT01232894|20596619|P1|Overall Study|Death|1
5955071|NCT01232894|20596618|P2|Overall Study|Lost to Follow-up|1
5955072|NCT01232894|20596619|P1|Overall Study|Lost to Follow-up|0
5955073|NCT01232868|20596627|P2|Overall Study|Lost to Follow-up|4
5955074|NCT01232868|20596628|P1|Overall Study|Lost to Follow-up|2
5955075|NCT01232790|20596642|P2|Second Crossover|Withdrawal by Subject|2
5955076|NCT01232790|20596643|P1|Second Crossover|Withdrawal by Subject|1
5955077|NCT01232790|20596642|P2|First Crossover|Withdrawal by Subject|0
5955078|NCT01232790|20596643|P1|First Crossover|Withdrawal by Subject|1
5955079|NCT01232790|20596642|P2|Initial Assessment|Withdrawal by Subject|1
5955080|NCT01232790|20596643|P1|Initial Assessment|Withdrawal by Subject|0
5955081|NCT01232790|20596642|P2|Randomization|Physician Decision|1
5955082|NCT01232790|20596643|P1|Randomization|Physician Decision|0
5955083|NCT01232790|20596642|P2|Randomization|Protocol Violation|1
5955084|NCT01232790|20596643|P1|Randomization|Protocol Violation|0
5955085|NCT01232790|20596642|P2|Randomization|Withdrawal by Subject|0
5955086|NCT01232790|20596643|P1|Randomization|Withdrawal by Subject|2
5955087|NCT01232738|20596697|P1|Overall Study|Adverse Event|5
5955088|NCT01232738|20596697|P1|Overall Study|Withdrawal by Subject|2
5955089|NCT01232738|20596697|P1|Overall Study|Lost to Follow-up|1
5955090|NCT01232738|20596697|P1|Overall Study|Physician Decision|2
5955091|NCT01232738|20596697|P1|Overall Study|Death|3
5955092|NCT01232569|20596713|P4|Double-blind Treatment Period|Death|0
5955093|NCT01232569|20596714|P3|Double-blind Treatment Period|Death|0
5955094|NCT01232569|20596715|P2|Double-blind Treatment Period|Death|0
5955095|NCT01232569|20596716|P1|Double-blind Treatment Period|Death|2
5955096|NCT01232569|20596713|P4|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0
5955097|NCT01232569|20596714|P3|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0
5955098|NCT01232569|20596715|P2|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|3
5955099|NCT01232569|20596716|P1|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|9
5955100|NCT01232569|20596713|P4|Double-blind Treatment Period|Physician Decision|0
5955101|NCT01232569|20596714|P3|Double-blind Treatment Period|Physician Decision|0
5955102|NCT01232569|20596715|P2|Double-blind Treatment Period|Physician Decision|0
5955103|NCT01232569|20596716|P1|Double-blind Treatment Period|Physician Decision|1
5955104|NCT01232569|20596713|P4|Double-blind Treatment Period|Lack of Efficacy|0
5955105|NCT01232569|20596714|P3|Double-blind Treatment Period|Lack of Efficacy|0
5955106|NCT01232569|20596715|P2|Double-blind Treatment Period|Lack of Efficacy|2
5955107|NCT01232569|20596716|P1|Double-blind Treatment Period|Lack of Efficacy|1
5955108|NCT01232569|20596713|P4|Double-blind Treatment Period|Lost to Follow-up|0
5955109|NCT01232569|20596714|P3|Double-blind Treatment Period|Lost to Follow-up|0
5955110|NCT01232569|20596715|P2|Double-blind Treatment Period|Lost to Follow-up|0
5955111|NCT01232569|20596716|P1|Double-blind Treatment Period|Lost to Follow-up|4
5955112|NCT01232569|20596713|P4|Double-blind Treatment Period|Escape|0
5955113|NCT01232569|20596714|P3|Double-blind Treatment Period|Escape|0
5955114|NCT01232569|20596715|P2|Double-blind Treatment Period|Escape|2
5955115|NCT01232569|20596716|P1|Double-blind Treatment Period|Escape|2
5955116|NCT01232569|20596713|P4|Double-blind Treatment Period|Withdrawal by Subject|0
5955117|NCT01232569|20596714|P3|Double-blind Treatment Period|Withdrawal by Subject|0
5955118|NCT01232569|20596715|P2|Double-blind Treatment Period|Withdrawal by Subject|2
5955119|NCT01232569|20596716|P1|Double-blind Treatment Period|Withdrawal by Subject|9
5955120|NCT01232556|20596759|P2|Overall Study|Other|4
5955121|NCT01232556|20596760|P1|Overall Study|Other|6
5955122|NCT01232556|20596759|P2|Overall Study|Terminated by Sponsor|51
5955123|NCT01232556|20596760|P1|Overall Study|Terminated by Sponsor|35
5955124|NCT01232556|20596759|P2|Overall Study|Lost to Follow-up|2
5955125|NCT01232556|20596760|P1|Overall Study|Lost to Follow-up|0
5955126|NCT01232556|20596759|P2|Overall Study|Death|97
5955127|NCT01232556|20596760|P1|Overall Study|Death|97
5955128|NCT01232556|20596759|P2|Overall Study|Withdrawal by Subject|17
5955129|NCT01232556|20596760|P1|Overall Study|Withdrawal by Subject|21
5955130|NCT01232491|20596819|P2|Overall Study|Other|18
5955131|NCT01232491|20596820|P1|Overall Study|Other|21
5955132|NCT01232491|20596819|P2|Overall Study|Withdrawal Criteria|21
5955133|NCT01232491|20596820|P1|Overall Study|Withdrawal Criteria|12
5955134|NCT01232491|20596819|P2|Overall Study|Protocol Violation|11
5955135|NCT01232491|20596820|P1|Overall Study|Protocol Violation|13
5955136|NCT01232491|20596819|P2|Overall Study|Lack of Efficacy|5
5955137|NCT01232491|20596820|P1|Overall Study|Lack of Efficacy|1
5955138|NCT01232491|20596819|P2|Overall Study|Adverse Event|8
5955139|NCT01232491|20596820|P1|Overall Study|Adverse Event|13
5955140|NCT01232452|20596849|P2|Overall Study|Protocol Violation|1
5955141|NCT01232452|20596850|P1|Overall Study|Protocol Violation|0
5955142|NCT01232452|20596849|P2|Overall Study|Sponsor Decision|1
5955143|NCT01232452|20596850|P1|Overall Study|Sponsor Decision|3
5955144|NCT01232452|20596849|P2|Overall Study|Protocol entry criterion not met|2
5955145|NCT01232452|20596850|P1|Overall Study|Protocol entry criterion not met|0
5955146|NCT01232452|20596849|P2|Overall Study|Physician Decision|12
5955147|NCT01232452|20596850|P1|Overall Study|Physician Decision|8
5955148|NCT01232452|20596849|P2|Overall Study|Withdrawal by Subject|8
5955149|NCT01232452|20596850|P1|Overall Study|Withdrawal by Subject|11
5955150|NCT01232452|20596849|P2|Overall Study|Adverse Event|15
5955151|NCT01232452|20596850|P1|Overall Study|Adverse Event|17
5955152|NCT01232296|20596876|P2|Overall Study|Death|6
5955153|NCT01232296|20596877|P1|Overall Study|Death|1
5955154|NCT01232296|20596876|P2|Overall Study|Subject/guardian decision|2
5955155|NCT01232296|20596877|P1|Overall Study|Subject/guardian decision|10
5955156|NCT01232296|20596876|P2|Overall Study|Technical problems|0
5955157|NCT01232296|20596877|P1|Overall Study|Technical problems|3
5955158|NCT01232296|20596876|P2|Overall Study|Study terminated by sponsor|1
5955159|NCT01232296|20596877|P1|Overall Study|Study terminated by sponsor|0
5955160|NCT01232296|20596876|P2|Overall Study|Progressive disease|61
5955161|NCT01232296|20596877|P1|Overall Study|Progressive disease|43
5955162|NCT01232296|20596876|P2|Overall Study|Physician Decision|1
5955163|NCT01232296|20596877|P1|Overall Study|Physician Decision|1
5955164|NCT01232296|20596876|P2|Overall Study|Adverse Event|12
5955165|NCT01232296|20596877|P1|Overall Study|Adverse Event|24
5955166|NCT01232283|20596894|P10|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|3
5955167|NCT01232283|20596895|P9|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|7
5955168|NCT01232283|20596896|P8|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
5955169|NCT01232283|20596897|P7|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
5955170|NCT01232283|20596898|P6|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
5955171|NCT01232283|20596899|P5|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
5955172|NCT01232283|20596900|P4|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
5955173|NCT01232283|20596901|P3|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
5955174|NCT01232283|20596902|P2|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
5955175|NCT01232283|20596903|P1|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
5955317|NCT01232283|20596895|P9|Maintenance Phase (Weeks16-32)|Other|0
5955176|NCT01232283|20596894|P10|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
5955177|NCT01232283|20596895|P9|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|1
5955178|NCT01232283|20596896|P8|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
5955179|NCT01232283|20596897|P7|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
5955180|NCT01232283|20596898|P6|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
5955181|NCT01232283|20596899|P5|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
5955182|NCT01232283|20596900|P4|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
5955183|NCT01232283|20596901|P3|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
5955184|NCT01232283|20596902|P2|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
5955185|NCT01232283|20596903|P1|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
5955186|NCT01232283|20596894|P10|Long-Term Extension Phase (Weeks 52-260)|Death|0
5955187|NCT01232283|20596895|P9|Long-Term Extension Phase (Weeks 52-260)|Death|1
5955188|NCT01232283|20596896|P8|Long-Term Extension Phase (Weeks 52-260)|Death|0
5955189|NCT01232283|20596897|P7|Long-Term Extension Phase (Weeks 52-260)|Death|0
5955190|NCT01232283|20596898|P6|Long-Term Extension Phase (Weeks 52-260)|Death|0
5955191|NCT01232283|20596899|P5|Long-Term Extension Phase (Weeks 52-260)|Death|0
5955192|NCT01232283|20596900|P4|Long-Term Extension Phase (Weeks 52-260)|Death|0
5955193|NCT01232283|20596901|P3|Long-Term Extension Phase (Weeks 52-260)|Death|0
5955194|NCT01232283|20596902|P2|Long-Term Extension Phase (Weeks 52-260)|Death|0
5955195|NCT01232283|20596903|P1|Long-Term Extension Phase (Weeks 52-260)|Death|0
5955196|NCT01232283|20596894|P10|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|6
5955197|NCT01232283|20596895|P9|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|9
5955198|NCT01232283|20596896|P8|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
5955199|NCT01232283|20596897|P7|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
5955200|NCT01232283|20596898|P6|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
5955201|NCT01232283|20596899|P5|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
5955202|NCT01232283|20596900|P4|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
5955203|NCT01232283|20596901|P3|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
5955204|NCT01232283|20596902|P2|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
5955205|NCT01232283|20596903|P1|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
5955206|NCT01232283|20596894|P10|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|14
5955207|NCT01232283|20596895|P9|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|30
5955208|NCT01232283|20596896|P8|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
5955209|NCT01232283|20596897|P7|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
5955210|NCT01232283|20596898|P6|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
5955211|NCT01232283|20596899|P5|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
5955212|NCT01232283|20596900|P4|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
5955213|NCT01232283|20596901|P3|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
5955214|NCT01232283|20596902|P2|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
5955215|NCT01232283|20596903|P1|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
5955216|NCT01232283|20596894|P10|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|2
5955217|NCT01232283|20596895|P9|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|3
5955218|NCT01232283|20596896|P8|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
5955219|NCT01232283|20596897|P7|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
5955220|NCT01232283|20596898|P6|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
5955221|NCT01232283|20596899|P5|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
5955222|NCT01232283|20596900|P4|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
5955223|NCT01232283|20596901|P3|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
5955224|NCT01232283|20596902|P2|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
5955225|NCT01232283|20596903|P1|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
5955226|NCT01232283|20596894|P10|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|30
5955227|NCT01232283|20596895|P9|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|46
5955228|NCT01232283|20596896|P8|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
5955229|NCT01232283|20596897|P7|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
5955230|NCT01232283|20596898|P6|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
5955231|NCT01232283|20596899|P5|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
5955232|NCT01232283|20596900|P4|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
5955233|NCT01232283|20596901|P3|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
5955234|NCT01232283|20596902|P2|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
5955235|NCT01232283|20596903|P1|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
5955236|NCT01232283|20596894|P10|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|6
5955237|NCT01232283|20596895|P9|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|11
5955238|NCT01232283|20596896|P8|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
5955239|NCT01232283|20596897|P7|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
5955240|NCT01232283|20596898|P6|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
5955241|NCT01232283|20596899|P5|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
5955242|NCT01232283|20596900|P4|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
5955243|NCT01232283|20596901|P3|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
5955244|NCT01232283|20596902|P2|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
5955245|NCT01232283|20596903|P1|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
5955246|NCT01232283|20596894|P10|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
5955247|NCT01232283|20596895|P9|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
5955248|NCT01232283|20596896|P8|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
5955249|NCT01232283|20596897|P7|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
5955250|NCT01232283|20596898|P6|Randomized Withdrawal Phase(Weeks 32-52)|Other|1
5955251|NCT01232283|20596899|P5|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
5955252|NCT01232283|20596900|P4|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
5955253|NCT01232283|20596901|P3|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
5955254|NCT01232283|20596902|P2|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
5955255|NCT01232283|20596903|P1|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
5955256|NCT01232283|20596894|P10|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
5955257|NCT01232283|20596895|P9|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
5955258|NCT01232283|20596896|P8|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|1
5955259|NCT01232283|20596897|P7|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
5955260|NCT01232283|20596898|P6|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
5955261|NCT01232283|20596899|P5|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
5955262|NCT01232283|20596900|P4|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
5955263|NCT01232283|20596901|P3|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
5955264|NCT01232283|20596902|P2|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
5955265|NCT01232283|20596903|P1|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
5955266|NCT01232283|20596894|P10|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
5955267|NCT01232283|20596895|P9|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
5955268|NCT01232283|20596896|P8|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1
5955269|NCT01232283|20596897|P7|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1
5955270|NCT01232283|20596898|P6|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
5955271|NCT01232283|20596899|P5|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|2
5955272|NCT01232283|20596900|P4|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
5955273|NCT01232283|20596901|P3|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
5955274|NCT01232283|20596902|P2|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
5955275|NCT01232283|20596903|P1|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
5955276|NCT01232283|20596894|P10|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
5955277|NCT01232283|20596895|P9|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
5955278|NCT01232283|20596896|P8|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
5955279|NCT01232283|20596897|P7|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
5955280|NCT01232283|20596898|P6|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
5955281|NCT01232283|20596899|P5|Randomized Withdrawal Phase(Weeks 32-52)|Death|1
5955282|NCT01232283|20596900|P4|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
5955283|NCT01232283|20596901|P3|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
5955284|NCT01232283|20596902|P2|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
5955285|NCT01232283|20596903|P1|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
5955286|NCT01232283|20596894|P10|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
5955287|NCT01232283|20596895|P9|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
5955288|NCT01232283|20596896|P8|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|4
5955289|NCT01232283|20596897|P7|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3
5955290|NCT01232283|20596898|P6|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3
5955291|NCT01232283|20596899|P5|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3
5955292|NCT01232283|20596900|P4|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
5955293|NCT01232283|20596901|P3|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
5955294|NCT01232283|20596902|P2|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
5955295|NCT01232283|20596903|P1|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
5955296|NCT01232283|20596894|P10|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
5955297|NCT01232283|20596895|P9|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
5955298|NCT01232283|20596896|P8|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|5
5955299|NCT01232283|20596897|P7|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|13
5955300|NCT01232283|20596898|P6|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
5955301|NCT01232283|20596899|P5|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|4
5955302|NCT01232283|20596900|P4|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
5955303|NCT01232283|20596901|P3|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
5955304|NCT01232283|20596902|P2|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
5955305|NCT01232283|20596903|P1|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
5955306|NCT01232283|20596894|P10|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
5955307|NCT01232283|20596895|P9|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
5955308|NCT01232283|20596896|P8|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1
5955309|NCT01232283|20596897|P7|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
5955310|NCT01232283|20596898|P6|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1
5955311|NCT01232283|20596899|P5|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|2
5955312|NCT01232283|20596900|P4|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
5955313|NCT01232283|20596901|P3|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
5955314|NCT01232283|20596902|P2|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
5955315|NCT01232283|20596903|P1|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
5955316|NCT01232283|20596894|P10|Maintenance Phase (Weeks16-32)|Other|0
5955318|NCT01232283|20596896|P8|Maintenance Phase (Weeks16-32)|Other|0
5955319|NCT01232283|20596897|P7|Maintenance Phase (Weeks16-32)|Other|0
5955320|NCT01232283|20596898|P6|Maintenance Phase (Weeks16-32)|Other|0
5955321|NCT01232283|20596899|P5|Maintenance Phase (Weeks16-32)|Other|0
5955322|NCT01232283|20596900|P4|Maintenance Phase (Weeks16-32)|Other|0
5955323|NCT01232283|20596901|P3|Maintenance Phase (Weeks16-32)|Other|2
5955324|NCT01232283|20596902|P2|Maintenance Phase (Weeks16-32)|Other|0
5955325|NCT01232283|20596903|P1|Maintenance Phase (Weeks16-32)|Other|0
5955326|NCT01232283|20596894|P10|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
5955327|NCT01232283|20596895|P9|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
5955328|NCT01232283|20596896|P8|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
5955329|NCT01232283|20596897|P7|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
5955330|NCT01232283|20596898|P6|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
5955331|NCT01232283|20596899|P5|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
5955332|NCT01232283|20596900|P4|Maintenance Phase (Weeks16-32)|Lost to Follow-up|2
5955333|NCT01232283|20596901|P3|Maintenance Phase (Weeks16-32)|Lost to Follow-up|3
5955334|NCT01232283|20596902|P2|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
5955335|NCT01232283|20596903|P1|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
5955336|NCT01232283|20596894|P10|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
5955337|NCT01232283|20596895|P9|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
5955338|NCT01232283|20596896|P8|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
5955339|NCT01232283|20596897|P7|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
5955340|NCT01232283|20596898|P6|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
5955341|NCT01232283|20596899|P5|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
5955342|NCT01232283|20596900|P4|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|1
5955343|NCT01232283|20596901|P3|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|7
5955344|NCT01232283|20596902|P2|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
5955345|NCT01232283|20596903|P1|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
5955346|NCT01232283|20596894|P10|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
5955347|NCT01232283|20596895|P9|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
5955348|NCT01232283|20596896|P8|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
5955349|NCT01232283|20596897|P7|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
5955350|NCT01232283|20596898|P6|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
5955351|NCT01232283|20596899|P5|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
5955352|NCT01232283|20596900|P4|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
5955353|NCT01232283|20596901|P3|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|1
5955354|NCT01232283|20596902|P2|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
5955355|NCT01232283|20596903|P1|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
5955356|NCT01232283|20596894|P10|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
5955357|NCT01232283|20596895|P9|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
5955358|NCT01232283|20596896|P8|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
5955359|NCT01232283|20596897|P7|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
5955360|NCT01232283|20596898|P6|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
5955361|NCT01232283|20596899|P5|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
5955362|NCT01232283|20596900|P4|Maintenance Phase (Weeks16-32)|Lack of Efficacy|3
5955363|NCT01232283|20596901|P3|Maintenance Phase (Weeks16-32)|Lack of Efficacy|19
5955364|NCT01232283|20596902|P2|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
5955365|NCT01232283|20596903|P1|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
5955366|NCT01232283|20596894|P10|Maintenance Phase (Weeks16-32)|Adverse Event|0
5955367|NCT01232283|20596895|P9|Maintenance Phase (Weeks16-32)|Adverse Event|0
5955368|NCT01232283|20596896|P8|Maintenance Phase (Weeks16-32)|Adverse Event|0
5955369|NCT01232283|20596897|P7|Maintenance Phase (Weeks16-32)|Adverse Event|0
5955370|NCT01232283|20596898|P6|Maintenance Phase (Weeks16-32)|Adverse Event|0
5955371|NCT01232283|20596899|P5|Maintenance Phase (Weeks16-32)|Adverse Event|0
5955372|NCT01232283|20596900|P4|Maintenance Phase (Weeks16-32)|Adverse Event|2
5955373|NCT01232283|20596901|P3|Maintenance Phase (Weeks16-32)|Adverse Event|8
5955374|NCT01232283|20596902|P2|Maintenance Phase (Weeks16-32)|Adverse Event|0
5955375|NCT01232283|20596903|P1|Maintenance Phase (Weeks16-32)|Adverse Event|0
5955376|NCT01232283|20596894|P10|Placebo Controlled Phase (Weeks 0-16)|Other|0
5955377|NCT01232283|20596895|P9|Placebo Controlled Phase (Weeks 0-16)|Other|0
5955378|NCT01232283|20596896|P8|Placebo Controlled Phase (Weeks 0-16)|Other|0
5955379|NCT01232283|20596897|P7|Placebo Controlled Phase (Weeks 0-16)|Other|0
5955380|NCT01232283|20596898|P6|Placebo Controlled Phase (Weeks 0-16)|Other|0
5955381|NCT01232283|20596899|P5|Placebo Controlled Phase (Weeks 0-16)|Other|0
5955382|NCT01232283|20596900|P4|Placebo Controlled Phase (Weeks 0-16)|Other|0
5955383|NCT01232283|20596901|P3|Placebo Controlled Phase (Weeks 0-16)|Other|0
5955384|NCT01232283|20596902|P2|Placebo Controlled Phase (Weeks 0-16)|Other|1
5955385|NCT01232283|20596903|P1|Placebo Controlled Phase (Weeks 0-16)|Other|2
5955386|NCT01232283|20596894|P10|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
5955387|NCT01232283|20596895|P9|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
5955388|NCT01232283|20596896|P8|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
5955389|NCT01232283|20596897|P7|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
5955390|NCT01232283|20596898|P6|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
5955391|NCT01232283|20596899|P5|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
5955392|NCT01232283|20596900|P4|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
5955393|NCT01232283|20596901|P3|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
5955394|NCT01232283|20596902|P2|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|2
5955395|NCT01232283|20596903|P1|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|3
5955396|NCT01232283|20596894|P10|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
5955397|NCT01232283|20596895|P9|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
5955398|NCT01232283|20596896|P8|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
5955399|NCT01232283|20596897|P7|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
5955400|NCT01232283|20596898|P6|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
5955401|NCT01232283|20596899|P5|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
5955402|NCT01232283|20596900|P4|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
5955403|NCT01232283|20596901|P3|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
5955404|NCT01232283|20596902|P2|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6
5955405|NCT01232283|20596903|P1|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6
5955406|NCT01232283|20596894|P10|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
5955407|NCT01232283|20596895|P9|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
5955408|NCT01232283|20596896|P8|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
5955409|NCT01232283|20596897|P7|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
5955410|NCT01232283|20596898|P6|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
5955411|NCT01232283|20596899|P5|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
5955412|NCT01232283|20596900|P4|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
5955413|NCT01232283|20596901|P3|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
5955414|NCT01232283|20596902|P2|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|7
5955415|NCT01232283|20596903|P1|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|9
5955416|NCT01232283|20596894|P10|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
5955417|NCT01232283|20596895|P9|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
5955418|NCT01232283|20596896|P8|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
5955419|NCT01232283|20596897|P7|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
5955420|NCT01232283|20596898|P6|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
5955421|NCT01232283|20596899|P5|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
5955422|NCT01232283|20596900|P4|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
5955423|NCT01232283|20596901|P3|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
5955424|NCT01232283|20596902|P2|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
5955425|NCT01232283|20596903|P1|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|1
5955426|NCT01232283|20596894|P10|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
5955427|NCT01232283|20596895|P9|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
5955428|NCT01232283|20596896|P8|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
5955429|NCT01232283|20596897|P7|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
5955430|NCT01232283|20596898|P6|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
5955431|NCT01232283|20596899|P5|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
5955432|NCT01232283|20596900|P4|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
5955433|NCT01232283|20596901|P3|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
5955434|NCT01232283|20596902|P2|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|2
5955435|NCT01232283|20596903|P1|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|3
5955436|NCT01232283|20596894|P10|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
5955437|NCT01232283|20596895|P9|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
5955438|NCT01232283|20596896|P8|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
5955439|NCT01232283|20596897|P7|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
5955440|NCT01232283|20596898|P6|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
5955441|NCT01232283|20596899|P5|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
5955442|NCT01232283|20596900|P4|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
5955443|NCT01232283|20596901|P3|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
5955444|NCT01232283|20596902|P2|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|8
5955445|NCT01232283|20596903|P1|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|12
5955446|NCT01232127|20596944|P3|Period 1: Days 1-10|Discontinued due to dosing error|0
5955447|NCT01232127|20596945|P2|Period 1: Days 1-10|Discontinued due to dosing error|0
5955448|NCT01232127|20596946|P1|Period 1: Days 1-10|Discontinued due to dosing error|1
5955449|NCT01231984|20596970|P4|Study Period 2|Did not continue to meet I/E Criteria|1
5955450|NCT01231984|20596971|P3|Study Period 2|Did not continue to meet I/E Criteria|0
5955451|NCT01231984|20596972|P2|Study Period 2|Did not continue to meet I/E Criteria|1
5955452|NCT01231984|20596973|P1|Study Period 2|Did not continue to meet I/E Criteria|1
5955453|NCT01231984|20596970|P4|Study Period 2|Lost to Follow-up|3
5955454|NCT01231984|20596971|P3|Study Period 2|Lost to Follow-up|0
5955455|NCT01231984|20596972|P2|Study Period 2|Lost to Follow-up|0
5955456|NCT01231984|20596973|P1|Study Period 2|Lost to Follow-up|1
5955457|NCT01231984|20596970|P4|Study Period 2|Withdrawal by Subject|0
5955458|NCT01231984|20596971|P3|Study Period 2|Withdrawal by Subject|0
5955459|NCT01231984|20596972|P2|Study Period 2|Withdrawal by Subject|1
5955460|NCT01231984|20596973|P1|Study Period 2|Withdrawal by Subject|1
5955461|NCT01231984|20596970|P4|Study Period 1|Other|1
5955462|NCT01231984|20596971|P3|Study Period 1|Other|0
5955463|NCT01231984|20596972|P2|Study Period 1|Other|0
5955464|NCT01231984|20596973|P1|Study Period 1|Other|0
5955465|NCT01231984|20596970|P4|Study Period 1|Adverse Event|0
5955466|NCT01231984|20596971|P3|Study Period 1|Adverse Event|0
5955467|NCT01231984|20596972|P2|Study Period 1|Adverse Event|0
5955468|NCT01231984|20596973|P1|Study Period 1|Adverse Event|1
5955469|NCT01231984|20596970|P4|Study Period 1|Protocol Violation|3
5955470|NCT01231984|20596971|P3|Study Period 1|Protocol Violation|2
5955471|NCT01231984|20596972|P2|Study Period 1|Protocol Violation|4
5955472|NCT01231984|20596973|P1|Study Period 1|Protocol Violation|3
5955473|NCT01231984|20596970|P4|Study Period 1|Non-compliance with study requirements|1
5955474|NCT01231984|20596971|P3|Study Period 1|Non-compliance with study requirements|2
5955475|NCT01231984|20596972|P2|Study Period 1|Non-compliance with study requirements|0
5955476|NCT01231984|20596973|P1|Study Period 1|Non-compliance with study requirements|5
5955477|NCT01231984|20596970|P4|Study Period 1|Screen Failure|1
5955478|NCT01231984|20596971|P3|Study Period 1|Screen Failure|0
5955479|NCT01231984|20596972|P2|Study Period 1|Screen Failure|0
5955480|NCT01231984|20596973|P1|Study Period 1|Screen Failure|0
5955481|NCT01231984|20596970|P4|Study Period 1|Did not continue to meet I/E Criteria|2
5955482|NCT01231984|20596971|P3|Study Period 1|Did not continue to meet I/E Criteria|2
5955483|NCT01231984|20596972|P2|Study Period 1|Did not continue to meet I/E Criteria|2
5955484|NCT01231984|20596973|P1|Study Period 1|Did not continue to meet I/E Criteria|2
5955485|NCT01231984|20596970|P4|Study Period 1|Lost to Follow-up|0
5955486|NCT01231984|20596971|P3|Study Period 1|Lost to Follow-up|1
5955487|NCT01231984|20596972|P2|Study Period 1|Lost to Follow-up|1
5955488|NCT01231984|20596973|P1|Study Period 1|Lost to Follow-up|1
5955489|NCT01231984|20596970|P4|Study Period 1|Withdrawal by Subject|1
5955490|NCT01231984|20596971|P3|Study Period 1|Withdrawal by Subject|0
5955491|NCT01231984|20596972|P2|Study Period 1|Withdrawal by Subject|0
5955492|NCT01231984|20596973|P1|Study Period 1|Withdrawal by Subject|0
5955493|NCT01231620|20597042|P3|Overall Study|Lost to Follow-up|9
5955494|NCT01231620|20597043|P2|Overall Study|Lost to Follow-up|4
5955495|NCT01231620|20597044|P1|Overall Study|Lost to Follow-up|3
5955496|NCT01231620|20597042|P3|Overall Study|Withdrawal by Subject|8
5955497|NCT01231620|20597043|P2|Overall Study|Withdrawal by Subject|6
5955498|NCT01231620|20597044|P1|Overall Study|Withdrawal by Subject|6
5955499|NCT01231620|20597042|P3|Overall Study|Adverse Event|1
5955500|NCT01231620|20597043|P2|Overall Study|Adverse Event|2
5955501|NCT01231620|20597044|P1|Overall Study|Adverse Event|2
5955502|NCT01231620|20597042|P3|Overall Study|Death|11
5955503|NCT01231620|20597043|P2|Overall Study|Death|14
5955504|NCT01231620|20597044|P1|Overall Study|Death|12
5955505|NCT01231620|20597042|P3|Overall Study|Physician Decision|10
5955506|NCT01231620|20597043|P2|Overall Study|Physician Decision|5
5955507|NCT01231620|20597044|P1|Overall Study|Physician Decision|3
5955508|NCT01231607|20597150|P5|Overall Study|Withdrawal by Subject|9
5955509|NCT01231607|20597151|P4|Overall Study|Withdrawal by Subject|17
5955510|NCT01231607|20597152|P3|Overall Study|Withdrawal by Subject|14
5955511|NCT01231607|20597153|P2|Overall Study|Withdrawal by Subject|9
5955512|NCT01231607|20597154|P1|Overall Study|Withdrawal by Subject|9
5955513|NCT01231607|20597150|P5|Overall Study|Protocol Violation|2
5955514|NCT01231607|20597151|P4|Overall Study|Protocol Violation|2
5955515|NCT01231607|20597152|P3|Overall Study|Protocol Violation|0
5955516|NCT01231607|20597153|P2|Overall Study|Protocol Violation|2
5955517|NCT01231607|20597154|P1|Overall Study|Protocol Violation|3
5955518|NCT01231607|20597150|P5|Overall Study|Physician Decision|4
5955519|NCT01231607|20597151|P4|Overall Study|Physician Decision|5
5955520|NCT01231607|20597152|P3|Overall Study|Physician Decision|3
5955521|NCT01231607|20597153|P2|Overall Study|Physician Decision|4
5955522|NCT01231607|20597154|P1|Overall Study|Physician Decision|4
5955523|NCT01231607|20597150|P5|Overall Study|Lost to Follow-up|4
5955524|NCT01231607|20597151|P4|Overall Study|Lost to Follow-up|10
5955525|NCT01231607|20597152|P3|Overall Study|Lost to Follow-up|10
5955526|NCT01231607|20597153|P2|Overall Study|Lost to Follow-up|11
5955527|NCT01231607|20597154|P1|Overall Study|Lost to Follow-up|13
5955528|NCT01231607|20597150|P5|Overall Study|Adverse Event|5
5955529|NCT01231607|20597151|P4|Overall Study|Adverse Event|4
5955530|NCT01231607|20597152|P3|Overall Study|Adverse Event|4
5955531|NCT01231607|20597153|P2|Overall Study|Adverse Event|8
5955532|NCT01231607|20597154|P1|Overall Study|Adverse Event|0
5955533|NCT01231581|20597246|P2|Overall Study|Ongoing|0
5955534|NCT01231581|20597247|P1|Overall Study|Ongoing|1
5955535|NCT01231581|20597246|P2|Overall Study|Death|64
5955536|NCT01231581|20597247|P1|Overall Study|Death|65
5955537|NCT01231581|20597246|P2|Overall Study|Study Closed/Terminated|5
5955538|NCT01231581|20597247|P1|Overall Study|Study Closed/Terminated|6
5955539|NCT01231581|20597246|P2|Overall Study|Withdrawal by Subject|9
5955540|NCT01231581|20597247|P1|Overall Study|Withdrawal by Subject|6
5955541|NCT01231581|20597246|P2|Overall Study|Lost to Follow-up|2
5955542|NCT01231581|20597247|P1|Overall Study|Lost to Follow-up|2
5955543|NCT01231555|20597268|P3|Overall Study|Withdrawal by Subject|0
5955544|NCT01231555|20597269|P2|Overall Study|Withdrawal by Subject|2
5955545|NCT01231555|20597270|P1|Overall Study|Withdrawal by Subject|0
5955546|NCT01231555|20597268|P3|Overall Study|Study terminated|8
5955547|NCT01231555|20597269|P2|Overall Study|Study terminated|5
5955548|NCT01231555|20597270|P1|Overall Study|Study terminated|8
5955575|NCT01231503|20597332|P8|Overall Study|Protocol Violation|0
5955576|NCT01231503|20597333|P7|Overall Study|Protocol Violation|0
5955577|NCT01231503|20597334|P6|Overall Study|Protocol Violation|0
5955578|NCT01231503|20597335|P5|Overall Study|Protocol Violation|0
5955579|NCT01231503|20597336|P4|Overall Study|Protocol Violation|1
5955580|NCT01231503|20597337|P3|Overall Study|Protocol Violation|0
5955581|NCT01231503|20597338|P2|Overall Study|Protocol Violation|0
5955582|NCT01231503|20597339|P1|Overall Study|Protocol Violation|0
5955583|NCT01231503|20597332|P8|Overall Study|Lost to Follow-up|6
5955584|NCT01231503|20597333|P7|Overall Study|Lost to Follow-up|6
5955585|NCT01231503|20597334|P6|Overall Study|Lost to Follow-up|9
5955586|NCT01231503|20597335|P5|Overall Study|Lost to Follow-up|7
5955587|NCT01231503|20597336|P4|Overall Study|Lost to Follow-up|5
5955588|NCT01231503|20597337|P3|Overall Study|Lost to Follow-up|8
5955589|NCT01231503|20597338|P2|Overall Study|Lost to Follow-up|10
5955590|NCT01231503|20597339|P1|Overall Study|Lost to Follow-up|8
5955591|NCT01231503|20597332|P8|Overall Study|Withdrawal by Subject|2
5955592|NCT01231503|20597333|P7|Overall Study|Withdrawal by Subject|1
5955593|NCT01231503|20597334|P6|Overall Study|Withdrawal by Subject|5
5955594|NCT01231503|20597335|P5|Overall Study|Withdrawal by Subject|3
5955595|NCT01231503|20597336|P4|Overall Study|Withdrawal by Subject|1
5955596|NCT01231503|20597337|P3|Overall Study|Withdrawal by Subject|3
5955597|NCT01231503|20597338|P2|Overall Study|Withdrawal by Subject|3
5955598|NCT01231503|20597339|P1|Overall Study|Withdrawal by Subject|6
5955599|NCT01231503|20597332|P8|Overall Study|Adverse event, serious fatal|0
5955600|NCT01231503|20597333|P7|Overall Study|Adverse event, serious fatal|0
5955601|NCT01231503|20597334|P6|Overall Study|Adverse event, serious fatal|1
5955602|NCT01231503|20597335|P5|Overall Study|Adverse event, serious fatal|0
5955603|NCT01231503|20597336|P4|Overall Study|Adverse event, serious fatal|1
5955604|NCT01231503|20597337|P3|Overall Study|Adverse event, serious fatal|1
5955605|NCT01231503|20597338|P2|Overall Study|Adverse event, serious fatal|0
5955606|NCT01231503|20597339|P1|Overall Study|Adverse event, serious fatal|0
5955607|NCT01231503|20597332|P8|Overall Study|Adverse Event|0
5955608|NCT01231503|20597333|P7|Overall Study|Adverse Event|0
5955609|NCT01231503|20597334|P6|Overall Study|Adverse Event|1
5955610|NCT01231503|20597335|P5|Overall Study|Adverse Event|0
5955611|NCT01231503|20597336|P4|Overall Study|Adverse Event|0
5955612|NCT01231503|20597337|P3|Overall Study|Adverse Event|0
5955613|NCT01231503|20597338|P2|Overall Study|Adverse Event|0
5955614|NCT01231503|20597339|P1|Overall Study|Adverse Event|0
5955615|NCT01231464|20597579|P2|Overall Study|Withdrawal by Subject|2
5955616|NCT01231464|20597580|P1|Overall Study|Withdrawal by Subject|3
5955617|NCT01231464|20597579|P2|Overall Study|Lost to Follow-up|2
5955618|NCT01231464|20597580|P1|Overall Study|Lost to Follow-up|1
5955619|NCT01231464|20597579|P2|Overall Study|Protocol Violation|2
5955620|NCT01231464|20597580|P1|Overall Study|Protocol Violation|1
5955621|NCT01231464|20597579|P2|Overall Study|Adverse Event|1
5955622|NCT01231464|20597580|P1|Overall Study|Adverse Event|0
5955623|NCT01231373|20597629|P4|Overall Study|Withdrew Consent|0
5955624|NCT01231373|20597630|P3|Overall Study|Withdrew Consent|0
5955625|NCT01231373|20597631|P2|Overall Study|Withdrew Consent|0
5955626|NCT01231373|20597632|P1|Overall Study|Withdrew Consent|1
5955627|NCT01231373|20597629|P4|Overall Study|Lost to Follow-up|1
5955628|NCT01231373|20597630|P3|Overall Study|Lost to Follow-up|0
5955629|NCT01231373|20597631|P2|Overall Study|Lost to Follow-up|0
5955630|NCT01231373|20597632|P1|Overall Study|Lost to Follow-up|0
5955631|NCT01231373|20597629|P4|Overall Study|Withdrew consent prior to randomization|0
5955632|NCT01231373|20597630|P3|Overall Study|Withdrew consent prior to randomization|0
5955633|NCT01231373|20597631|P2|Overall Study|Withdrew consent prior to randomization|1
5955634|NCT01231373|20597632|P1|Overall Study|Withdrew consent prior to randomization|2
5955635|NCT01231321|20597671|P1|Overall Study|Lack of Efficacy|2
5955636|NCT01231321|20597671|P1|Overall Study|Adverse Event|3
5955637|NCT01230892|20597719|P2|Overall Study|Lost to Follow-up|0
5955638|NCT01230892|20597720|P1|Overall Study|Lost to Follow-up|2
5955639|NCT01230892|20597719|P2|Overall Study|Withdrawal by Subject|1
5955640|NCT01230892|20597720|P1|Overall Study|Withdrawal by Subject|1
5955641|NCT01230827|20597730|P4|Overall Study|Study terminated by Sponsor|63
5955642|NCT01230827|20597731|P3|Overall Study|Study terminated by Sponsor|56
5955643|NCT01230827|20597732|P2|Overall Study|Study terminated by Sponsor|2
5955644|NCT01230827|20597733|P1|Overall Study|Study terminated by Sponsor|0
5955645|NCT01230827|20597730|P4|Overall Study|Recovery|0
5955646|NCT01230827|20597731|P3|Overall Study|Recovery|0
5955647|NCT01230827|20597732|P2|Overall Study|Recovery|6
5955648|NCT01230827|20597733|P1|Overall Study|Recovery|0
5955649|NCT01230827|20597730|P4|Overall Study|Adverse Event|7
5955650|NCT01230827|20597731|P3|Overall Study|Adverse Event|3
5955651|NCT01230827|20597732|P2|Overall Study|Adverse Event|2
5955652|NCT01230827|20597733|P1|Overall Study|Adverse Event|4
5955653|NCT01230827|20597730|P4|Overall Study|Lack of Efficacy|3
5955654|NCT01230827|20597731|P3|Overall Study|Lack of Efficacy|2
5955655|NCT01230827|20597732|P2|Overall Study|Lack of Efficacy|1
5955656|NCT01230827|20597733|P1|Overall Study|Lack of Efficacy|14
5955657|NCT01230827|20597730|P4|Overall Study|Withdrawal by Subject|2
5955658|NCT01230827|20597731|P3|Overall Study|Withdrawal by Subject|3
5955659|NCT01230827|20597732|P2|Overall Study|Withdrawal by Subject|0
5955660|NCT01230827|20597733|P1|Overall Study|Withdrawal by Subject|1
5955661|NCT01230827|20597730|P4|Overall Study|Lost to Follow-up|3
5955662|NCT01230827|20597731|P3|Overall Study|Lost to Follow-up|1
5955663|NCT01230827|20597732|P2|Overall Study|Lost to Follow-up|0
5955664|NCT01230827|20597733|P1|Overall Study|Lost to Follow-up|0
5955665|NCT01230814|20597749|P2|Overall Study|Discontinued (not due to adverse event)|1
5955666|NCT01230814|20597750|P1|Overall Study|Discontinued (not due to adverse event)|2
5955667|NCT01230814|20597749|P2|Overall Study|Lost to Follow-up|3
5955668|NCT01230814|20597750|P1|Overall Study|Lost to Follow-up|11
5955669|NCT01230788|20597800|P1|Overall Study|Prescribed exclusion drug|1
5955670|NCT01230749|20597812|P4|Overall Study|Fasting glucose more than 270 mg/dL|1
5955671|NCT01230749|20597813|P3|Overall Study|Fasting glucose more than 270 mg/dL|1
5955672|NCT01230749|20597814|P2|Overall Study|Fasting glucose more than 270 mg/dL|1
5955673|NCT01230749|20597815|P1|Overall Study|Fasting glucose more than 270 mg/dL|0
5955674|NCT01230749|20597812|P4|Overall Study|Withdrawal by Subject|0
5955675|NCT01230749|20597813|P3|Overall Study|Withdrawal by Subject|0
5955676|NCT01230749|20597814|P2|Overall Study|Withdrawal by Subject|1
5955677|NCT01230749|20597815|P1|Overall Study|Withdrawal by Subject|0
5955678|NCT01230749|20597812|P4|Overall Study|Physician Decision|0
5955679|NCT01230749|20597813|P3|Overall Study|Physician Decision|1
5955680|NCT01230749|20597814|P2|Overall Study|Physician Decision|0
5955681|NCT01230749|20597815|P1|Overall Study|Physician Decision|0
5955682|NCT01230749|20597812|P4|Overall Study|Adverse Event|1
5955683|NCT01230749|20597813|P3|Overall Study|Adverse Event|0
5955684|NCT01230749|20597814|P2|Overall Study|Adverse Event|0
5955685|NCT01230749|20597815|P1|Overall Study|Adverse Event|0
5955686|NCT01230710|20597850|P1|Overall Study|Withdrawal of Consent|1
5955687|NCT01230710|20597850|P1|Overall Study|Death|4
5955688|NCT01230710|20597850|P1|Overall Study|Lost to Follow-up|3
5955689|NCT01230710|20597850|P1|Overall Study|Disease Progression|41
5955690|NCT01230554|20597874|P1|Overall Study|Inability to maintain visit schedule|1
5955691|NCT01230554|20597874|P1|Overall Study|Lost to Follow-up|2
5955692|NCT01230489|20597897|P1|Overall Study|Treatment modality changed|1
5955693|NCT01230489|20597897|P1|Overall Study|Adverse Event|2
5955694|NCT01230489|20597897|P1|Overall Study|Death|2
5955695|NCT01230307|20597932|P2|Overall Study|LVAD Placement|2
5955696|NCT01230307|20597933|P1|Overall Study|LVAD Placement|0
5955697|NCT01230060|20597966|P1|Overall Study|Withdrawal by Subject|1
5955698|NCT01229735|20598039|P2|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0
5955699|NCT01229735|20598040|P1|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
5955700|NCT01229735|20598039|P2|Overall Study|AE, non-serious non-fatal|17
5955701|NCT01229735|20598040|P1|Overall Study|AE, non-serious non-fatal|13
5955702|NCT01229735|20598039|P2|Overall Study|SAE, non-fatal|4
5955703|NCT01229735|20598040|P1|Overall Study|SAE, non-fatal|0
5955704|NCT01229735|20598039|P2|Overall Study|Other Reason|10
5955705|NCT01229735|20598040|P1|Overall Study|Other Reason|13
5955706|NCT01229735|20598039|P2|Overall Study|Withdrawal by Subject|17
5955707|NCT01229735|20598040|P1|Overall Study|Withdrawal by Subject|18
5955708|NCT01229735|20598039|P2|Overall Study|Lost to Follow-up|2
5955709|NCT01229735|20598040|P1|Overall Study|Lost to Follow-up|0
5955710|NCT01229735|20598039|P2|Overall Study|Protocol Violation|8
5955711|NCT01229735|20598040|P1|Overall Study|Protocol Violation|13
5955712|NCT01229735|20598039|P2|Overall Study|Lack of Efficacy|8
5955713|NCT01229735|20598040|P1|Overall Study|Lack of Efficacy|8
5955714|NCT01229449|20598097|P5|Overall Study|Physician Decision|0
5955715|NCT01229449|20598098|P4|Overall Study|Physician Decision|0
5955716|NCT01229449|20598099|P3|Overall Study|Physician Decision|1
5955717|NCT01229449|20598100|P2|Overall Study|Physician Decision|0
5955718|NCT01229449|20598101|P1|Overall Study|Physician Decision|0
5955719|NCT01229449|20598097|P5|Overall Study|Lost to Follow-up|0
5955720|NCT01229449|20598098|P4|Overall Study|Lost to Follow-up|0
5955721|NCT01229449|20598099|P3|Overall Study|Lost to Follow-up|1
5955722|NCT01229449|20598100|P2|Overall Study|Lost to Follow-up|1
5955723|NCT01229449|20598101|P1|Overall Study|Lost to Follow-up|1
5955724|NCT01229449|20598097|P5|Overall Study|Withdrawal by Subject|1
5955725|NCT01229449|20598098|P4|Overall Study|Withdrawal by Subject|1
5955726|NCT01229449|20598099|P3|Overall Study|Withdrawal by Subject|0
5955727|NCT01229449|20598100|P2|Overall Study|Withdrawal by Subject|3
5955728|NCT01229449|20598101|P1|Overall Study|Withdrawal by Subject|0
5955729|NCT01229436|20598158|P1|Overall Study|Lost to Follow-up|3
5955730|NCT01229436|20598158|P1|Overall Study|Withdrawal by Subject|2
5955731|NCT01229397|20598220|P2|Overall Study|Migrated/moved from study area|0
5955732|NCT01229397|20598221|P1|Overall Study|Migrated/moved from study area|1
5955733|NCT01229397|20598220|P2|Overall Study|Lost to Follow-up|6
5955734|NCT01229397|20598221|P1|Overall Study|Lost to Follow-up|7
5955735|NCT01229397|20598220|P2|Overall Study|Withdrawal by Subject|3
5955736|NCT01229397|20598221|P1|Overall Study|Withdrawal by Subject|3
5955737|NCT01229371|20598239|P4|Overall Study|Withdrawal by Subject|0
5955738|NCT01229371|20598240|P3|Overall Study|Withdrawal by Subject|0
5955739|NCT01229371|20598241|P2|Overall Study|Withdrawal by Subject|1
5955740|NCT01229371|20598242|P1|Overall Study|Withdrawal by Subject|0
5955741|NCT01229267|20598269|P5|Overall Study|Lost to Follow-up|22
5955742|NCT01229267|20598270|P4|Overall Study|Lost to Follow-up|3
5955743|NCT01229267|20598271|P3|Overall Study|Lost to Follow-up|8
5955744|NCT01229267|20598272|P2|Overall Study|Lost to Follow-up|5
5955745|NCT01229267|20598273|P1|Overall Study|Lost to Follow-up|6
5955746|NCT01229267|20598269|P5|Overall Study|Physician Decision|25
5955747|NCT01229267|20598270|P4|Overall Study|Physician Decision|3
5955748|NCT01229267|20598271|P3|Overall Study|Physician Decision|8
5955749|NCT01229267|20598272|P2|Overall Study|Physician Decision|11
5955750|NCT01229267|20598273|P1|Overall Study|Physician Decision|8
5955751|NCT01229267|20598269|P5|Overall Study|Progressive disease|1
5955752|NCT01229267|20598270|P4|Overall Study|Progressive disease|0
5955753|NCT01229267|20598271|P3|Overall Study|Progressive disease|0
5955754|NCT01229267|20598272|P2|Overall Study|Progressive disease|0
5955755|NCT01229267|20598273|P1|Overall Study|Progressive disease|0
5955756|NCT01229267|20598269|P5|Overall Study|Protocol Violation|0
5955757|NCT01229267|20598270|P4|Overall Study|Protocol Violation|0
5955758|NCT01229267|20598271|P3|Overall Study|Protocol Violation|0
5955759|NCT01229267|20598272|P2|Overall Study|Protocol Violation|1
5955760|NCT01229267|20598273|P1|Overall Study|Protocol Violation|0
5955761|NCT01229267|20598269|P5|Overall Study|Withdrawal by Subject|59
5955762|NCT01229267|20598270|P4|Overall Study|Withdrawal by Subject|14
5955763|NCT01229267|20598271|P3|Overall Study|Withdrawal by Subject|32
5955764|NCT01229267|20598272|P2|Overall Study|Withdrawal by Subject|22
5955765|NCT01229267|20598273|P1|Overall Study|Withdrawal by Subject|23
5955766|NCT01229267|20598269|P5|Overall Study|Death|103
5955767|NCT01229267|20598270|P4|Overall Study|Death|13
5955768|NCT01229267|20598271|P3|Overall Study|Death|35
5955769|NCT01229267|20598272|P2|Overall Study|Death|37
5955770|NCT01229267|20598273|P1|Overall Study|Death|40
5955771|NCT01229267|20598269|P5|Overall Study|Adverse Event|10
5955772|NCT01229267|20598270|P4|Overall Study|Adverse Event|2
5955773|NCT01229267|20598271|P3|Overall Study|Adverse Event|3
5955774|NCT01229267|20598272|P2|Overall Study|Adverse Event|6
5955775|NCT01229267|20598273|P1|Overall Study|Adverse Event|4
5955776|NCT01229254|20598292|P3|Overall Study|Non-compliance with Study Drug|1
5955777|NCT01229254|20598293|P2|Overall Study|Non-compliance with Study Drug|1
5955778|NCT01229254|20598294|P1|Overall Study|Non-compliance with Study Drug|0
5955779|NCT01229254|20598292|P3|Overall Study|Withdrawal by Subject|1
5955780|NCT01229254|20598293|P2|Overall Study|Withdrawal by Subject|0
5955781|NCT01229254|20598294|P1|Overall Study|Withdrawal by Subject|1
5955782|NCT01229254|20598292|P3|Overall Study|Protocol Violation|5
5955783|NCT01229254|20598293|P2|Overall Study|Protocol Violation|6
5955784|NCT01229254|20598294|P1|Overall Study|Protocol Violation|4
5955785|NCT01229254|20598292|P3|Overall Study|Physician Decision|0
5955786|NCT01229254|20598293|P2|Overall Study|Physician Decision|3
5955787|NCT01229254|20598294|P1|Overall Study|Physician Decision|0
5955788|NCT01229254|20598292|P3|Overall Study|Lost to Follow-up|1
5955789|NCT01229254|20598293|P2|Overall Study|Lost to Follow-up|0
5955790|NCT01229254|20598294|P1|Overall Study|Lost to Follow-up|3
5955791|NCT01229254|20598292|P3|Overall Study|Adverse Event|3
5955792|NCT01229254|20598293|P2|Overall Study|Adverse Event|5
5955793|NCT01229254|20598294|P1|Overall Study|Adverse Event|4
5955794|NCT01229254|20598292|P3|Overall Study|Not Continuing Into Safety Extension|1
5955795|NCT01229254|20598293|P2|Overall Study|Not Continuing Into Safety Extension|1
5955796|NCT01229254|20598294|P1|Overall Study|Not Continuing Into Safety Extension|3
5955797|NCT01229176|20598332|P8|Overall Study|Lost to Follow-up|2
5955798|NCT01229176|20598333|P7|Overall Study|Lost to Follow-up|0
5955799|NCT01229176|20598334|P6|Overall Study|Lost to Follow-up|1
5955800|NCT01229176|20598335|P5|Overall Study|Lost to Follow-up|1
5955801|NCT01229176|20598336|P4|Overall Study|Lost to Follow-up|0
5955802|NCT01229176|20598337|P3|Overall Study|Lost to Follow-up|0
5955803|NCT01229176|20598338|P2|Overall Study|Lost to Follow-up|3
5955804|NCT01229176|20598339|P1|Overall Study|Lost to Follow-up|0
5955805|NCT01229176|20598332|P8|Overall Study|Withdrawal by Subject|1
5955806|NCT01229176|20598333|P7|Overall Study|Withdrawal by Subject|0
5955807|NCT01229176|20598334|P6|Overall Study|Withdrawal by Subject|1
5955808|NCT01229176|20598335|P5|Overall Study|Withdrawal by Subject|1
5955809|NCT01229176|20598336|P4|Overall Study|Withdrawal by Subject|1
5955810|NCT01229176|20598337|P3|Overall Study|Withdrawal by Subject|0
5955811|NCT01229176|20598338|P2|Overall Study|Withdrawal by Subject|0
5955812|NCT01229176|20598339|P1|Overall Study|Withdrawal by Subject|0
5955813|NCT01229150|20598393|P4|Overall Study|Toxicity|0
5955814|NCT01229150|20598394|P3|Overall Study|Toxicity|0
5955815|NCT01229150|20598395|P2|Overall Study|Toxicity|2
5955816|NCT01229150|20598396|P1|Overall Study|Toxicity|2
5955817|NCT01229111|20598453|P1|Overall Study|Death|1
5955818|NCT01228747|20598502|P2|Overall Study|Other Reason|5
5955819|NCT01228747|20598503|P1|Overall Study|Other Reason|2
5955820|NCT01228747|20598502|P2|Overall Study|Withdrawal by Subject|1
5955821|NCT01228747|20598503|P1|Overall Study|Withdrawal by Subject|5
5955822|NCT01228747|20598502|P2|Overall Study|Lost to Follow-up|3
5955823|NCT01228747|20598503|P1|Overall Study|Lost to Follow-up|4
5955824|NCT01228747|20598502|P2|Overall Study|Protocol Violation|5
5955825|NCT01228747|20598503|P1|Overall Study|Protocol Violation|6
5955826|NCT01228747|20598502|P2|Overall Study|Lack of Efficacy|27
5955827|NCT01228747|20598503|P1|Overall Study|Lack of Efficacy|40
5955828|NCT01228747|20598502|P2|Overall Study|Adverse Event|4
5955829|NCT01228747|20598503|P1|Overall Study|Adverse Event|8
5955830|NCT01228734|20598519|P2|Overall Study|Randomized, but not treated|4
5955831|NCT01228734|20598520|P1|Overall Study|Randomized, but not treated|0
5955832|NCT01228591|20598534|P2|Baseline|Lack of Efficacy|2
5955833|NCT01228591|20598535|P1|Baseline|Lack of Efficacy|1
5955834|NCT01228318|20598564|P2|Overall Study|Incarcerated|0
5955835|NCT01228318|20598565|P1|Overall Study|Incarcerated|1
5955836|NCT01228318|20598564|P2|Overall Study|Moved|2
5955837|NCT01228318|20598565|P1|Overall Study|Moved|0
5955838|NCT01228318|20598564|P2|Overall Study|Unable to contact|5
5955839|NCT01228318|20598565|P1|Overall Study|Unable to contact|2
5955840|NCT01228318|20598564|P2|Overall Study|Clinic no show to receive intervention|0
5955841|NCT01228318|20598565|P1|Overall Study|Clinic no show to receive intervention|1
5955842|NCT01228175|20598581|P2|Overall Study|Physician Decision|1
5955843|NCT01228175|20598582|P1|Overall Study|Physician Decision|1
5955844|NCT01228175|20598581|P2|Overall Study|Withdrawal by Subject|2
5955845|NCT01228175|20598582|P1|Overall Study|Withdrawal by Subject|1
5955846|NCT01228175|20598581|P2|Overall Study|Lost to Follow-up|50
5955847|NCT01228175|20598582|P1|Overall Study|Lost to Follow-up|64
5955848|NCT01228071|20598624|P1|Overall Study|Withdrawal by Subject|1
5955849|NCT01228071|20598624|P1|Overall Study|Protocol Violation|1
5955850|NCT01228019|20598630|P1|Overall Study|Violation of Entry Criterion|9
5955851|NCT01228019|20598630|P1|Overall Study|Triglyceride Entry Criteria Not Met|152
5955852|NCT01228019|20598630|P1|Overall Study|Missing pre-treatment data|72
5955853|NCT01228019|20598630|P1|Overall Study|Duplicate enrollment|1
5955854|NCT01228019|20598630|P1|Overall Study|Dose Violation|70
5955855|NCT01227967|20598696|P2|Overall Study|Taking Additional Antiviral Drug|0
5955856|NCT01227967|20598697|P1|Overall Study|Taking Additional Antiviral Drug|1
5955857|NCT01227967|20598696|P2|Overall Study|Never Started Treatment|4
5955858|NCT01227967|20598697|P1|Overall Study|Never Started Treatment|0
5955859|NCT01227967|20598696|P2|Overall Study|Physician Decision|1
5955860|NCT01227967|20598697|P1|Overall Study|Physician Decision|0
5955861|NCT01227967|20598696|P2|Overall Study|Withdrawal by Subject|3
5955862|NCT01227967|20598697|P1|Overall Study|Withdrawal by Subject|4
5955863|NCT01227967|20598696|P2|Overall Study|Lost to Follow-up|3
5955864|NCT01227967|20598697|P1|Overall Study|Lost to Follow-up|8
5955865|NCT01227967|20598696|P2|Overall Study|Death|1
5955866|NCT01227967|20598697|P1|Overall Study|Death|0
5955867|NCT01227967|20598696|P2|Overall Study|Protocol Violation|1
5955868|NCT01227967|20598697|P1|Overall Study|Protocol Violation|3
5955869|NCT01227954|20598731|P1|Overall Study|No protocol treatment|7
5955870|NCT01227954|20598731|P1|Overall Study|Protocol Violation|6
5955871|NCT01227928|20598745|P2|Overall Study|Death|12
5955872|NCT01227928|20598746|P1|Overall Study|Death|14
5955873|NCT01227928|20598745|P2|Overall Study|Withdrawal by Subject|3
5955874|NCT01227928|20598746|P1|Overall Study|Withdrawal by Subject|4
5955875|NCT01227928|20598745|P2|Overall Study|Lost to Follow-up|2
5955876|NCT01227928|20598746|P1|Overall Study|Lost to Follow-up|4
5955877|NCT01227902|20598784|P4|Overall Study|Withdrawal by Subject|3
5955878|NCT01227902|20598785|P3|Overall Study|Withdrawal by Subject|4
5955879|NCT01227902|20598786|P2|Overall Study|Withdrawal by Subject|2
5955880|NCT01227902|20598787|P1|Overall Study|Withdrawal by Subject|4
5955881|NCT01227902|20598784|P4|Overall Study|Physician Decision|0
5955882|NCT01227902|20598785|P3|Overall Study|Physician Decision|1
5955883|NCT01227902|20598786|P2|Overall Study|Physician Decision|1
5955884|NCT01227902|20598787|P1|Overall Study|Physician Decision|0
5955885|NCT01227902|20598784|P4|Overall Study|Lost to Follow-up|2
5955886|NCT01227902|20598785|P3|Overall Study|Lost to Follow-up|1
5955887|NCT01227902|20598786|P2|Overall Study|Lost to Follow-up|0
5955888|NCT01227902|20598787|P1|Overall Study|Lost to Follow-up|0
5955889|NCT01227902|20598784|P4|Overall Study|Protocol Violation|0
5955890|NCT01227902|20598785|P3|Overall Study|Protocol Violation|0
5955891|NCT01227902|20598786|P2|Overall Study|Protocol Violation|0
5955892|NCT01227902|20598787|P1|Overall Study|Protocol Violation|1
5955893|NCT01227902|20598784|P4|Overall Study|Lack of Efficacy|1
5955894|NCT01227902|20598785|P3|Overall Study|Lack of Efficacy|2
5955895|NCT01227902|20598786|P2|Overall Study|Lack of Efficacy|2
5955896|NCT01227902|20598787|P1|Overall Study|Lack of Efficacy|1
5955897|NCT01227902|20598784|P4|Overall Study|Adverse Event|4
5955898|NCT01227902|20598785|P3|Overall Study|Adverse Event|11
5955899|NCT01227902|20598786|P2|Overall Study|Adverse Event|8
5955900|NCT01227902|20598787|P1|Overall Study|Adverse Event|12
5955901|NCT01227889|20598880|P2|Crossover Phase|Withdrawal by Subject|1
5955902|NCT01227889|20598881|P1|Crossover Phase|Withdrawal by Subject|0
5955903|NCT01227889|20598880|P2|Crossover Phase|Study Terminated By Sponsor|1
5955904|NCT01227889|20598881|P1|Crossover Phase|Study Terminated By Sponsor|0
5955905|NCT01227889|20598880|P2|Crossover Phase|Progressive Disease|31
5955906|NCT01227889|20598881|P1|Crossover Phase|Progressive Disease|0
5955907|NCT01227889|20598880|P2|Crossover Phase|Physician Decision|3
5955908|NCT01227889|20598881|P1|Crossover Phase|Physician Decision|0
5955909|NCT01227889|20598880|P2|Crossover Phase|Adverse Event|1
5955910|NCT01227889|20598881|P1|Crossover Phase|Adverse Event|0
5955911|NCT01227889|20598880|P2|Randomized Phase (RP)|Withdrawal by Subject|3
5955912|NCT01227889|20598881|P1|Randomized Phase (RP)|Withdrawal by Subject|15
5955913|NCT01227889|20598880|P2|Randomized Phase (RP)|Missing|3
5955914|NCT01227889|20598881|P1|Randomized Phase (RP)|Missing|1
5955915|NCT01227889|20598880|P2|Randomized Phase (RP)|Study terminated by sponsor|0
5955916|NCT01227889|20598881|P1|Randomized Phase (RP)|Study terminated by sponsor|10
5955917|NCT01227889|20598880|P2|Randomized Phase (RP)|Progressive Disease|52
5955918|NCT01227889|20598881|P1|Randomized Phase (RP)|Progressive Disease|135
5955919|NCT01227889|20598880|P2|Randomized Phase (RP)|Physician Decision|5
5955920|NCT01227889|20598881|P1|Randomized Phase (RP)|Physician Decision|13
5955921|NCT01227889|20598880|P2|Randomized Phase (RP)|Adverse Event|0
5955922|NCT01227889|20598881|P1|Randomized Phase (RP)|Adverse Event|13
5955923|NCT01227824|20598908|P3|Open-label Phase: Median of 1267 Days|Physician Decision|3
5955924|NCT01227824|20598909|P2|Open-label Phase: Median of 1267 Days|Physician Decision|0
5955925|NCT01227824|20598910|P1|Open-label Phase: Median of 1267 Days|Physician Decision|0
5955926|NCT01227824|20598908|P3|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|8
5955927|NCT01227824|20598909|P2|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0
5955928|NCT01227824|20598910|P1|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0
5955929|NCT01227824|20598908|P3|Open-label Phase: Median of 1267 Days|Lost to Follow-up|15
5955930|NCT01227824|20598909|P2|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0
5955931|NCT01227824|20598910|P1|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0
5955932|NCT01227824|20598908|P3|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|4
5955933|NCT01227824|20598909|P2|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0
5955934|NCT01227824|20598910|P1|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0
5955935|NCT01227824|20598908|P3|Open-label Phase: Median of 1267 Days|Protocol Violation|5
5955936|NCT01227824|20598909|P2|Open-label Phase: Median of 1267 Days|Protocol Violation|0
5955937|NCT01227824|20598910|P1|Open-label Phase: Median of 1267 Days|Protocol Violation|0
5955938|NCT01227824|20598908|P3|Open-label Phase: Median of 1267 Days|Lack of Efficacy|5
5955939|NCT01227824|20598909|P2|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0
5955940|NCT01227824|20598910|P1|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0
5955941|NCT01227824|20598908|P3|Open-label Phase: Median of 1267 Days|Adverse Event|4
5955942|NCT01227824|20598909|P2|Open-label Phase: Median of 1267 Days|Adverse Event|0
5955943|NCT01227824|20598910|P1|Open-label Phase: Median of 1267 Days|Adverse Event|0
5955944|NCT01227824|20598908|P3|Double-blind Phase: 96 Weeks Duration|Physician Decision|0
5955945|NCT01227824|20598909|P2|Double-blind Phase: 96 Weeks Duration|Physician Decision|0
5955946|NCT01227824|20598910|P1|Double-blind Phase: 96 Weeks Duration|Physician Decision|3
5955947|NCT01227824|20598908|P3|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|0
5955948|NCT01227824|20598909|P2|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|14
5955949|NCT01227824|20598910|P1|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|18
5955950|NCT01227824|20598908|P3|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|0
5955951|NCT01227824|20598909|P2|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|10
5955952|NCT01227824|20598910|P1|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|22
5955953|NCT01227824|20598908|P3|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|0
5955954|NCT01227824|20598909|P2|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|4
5955955|NCT01227824|20598910|P1|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|6
5955956|NCT01227824|20598908|P3|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|0
5955957|NCT01227824|20598909|P2|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|3
5955958|NCT01227824|20598910|P1|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|6
5955959|NCT01227824|20598908|P3|Double-blind Phase: 96 Weeks Duration|Protocol Violation|0
5955960|NCT01227824|20598909|P2|Double-blind Phase: 96 Weeks Duration|Protocol Violation|16
5955961|NCT01227824|20598910|P1|Double-blind Phase: 96 Weeks Duration|Protocol Violation|18
5955962|NCT01227824|20598908|P3|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|0
5955963|NCT01227824|20598909|P2|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|25
5955964|NCT01227824|20598910|P1|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|22
5955965|NCT01227824|20598908|P3|Double-blind Phase: 96 Weeks Duration|Adverse Event|0
5955966|NCT01227824|20598909|P2|Double-blind Phase: 96 Weeks Duration|Adverse Event|7
5955967|NCT01227824|20598910|P1|Double-blind Phase: 96 Weeks Duration|Adverse Event|12
5955968|NCT01227707|20599005|P1|Overall Study|Death|1
5955969|NCT01227707|20599005|P1|Overall Study|Medical decision|6
5955970|NCT01227707|20599005|P1|Overall Study|Patient non-compliance|3
5955971|NCT01227707|20599005|P1|Overall Study|Withdrawal by Subject|1
5955972|NCT01227707|20599005|P1|Overall Study|Progression of disease|3
5955973|NCT01227707|20599005|P1|Overall Study|Adverse Event|10
5955974|NCT01227668|20599032|P2|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|1
5955975|NCT01227668|20599033|P1|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|0
5955976|NCT01227668|20599032|P2|Phase 2 (Randomization Phase)|Lack of Efficacy|23
5955977|NCT01227668|20599033|P1|Phase 2 (Randomization Phase)|Lack of Efficacy|13
5955978|NCT01227668|20599032|P2|Phase 2 (Randomization Phase)|Lost to Follow-up|0
5955979|NCT01227668|20599033|P1|Phase 2 (Randomization Phase)|Lost to Follow-up|1
5955980|NCT01227668|20599032|P2|Phase 2 (Randomization Phase)|Withdrawal by Subject|0
5955981|NCT01227668|20599033|P1|Phase 2 (Randomization Phase)|Withdrawal by Subject|5
5955982|NCT01227668|20599032|P2|Phase 2 (Randomization Phase)|Adverse Event|1
5955983|NCT01227668|20599033|P1|Phase 2 (Randomization Phase)|Adverse Event|0
5955984|NCT01227668|20599032|P2|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|0
5955985|NCT01227668|20599033|P1|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|2
5955986|NCT01227668|20599032|P2|Phase 1 (Stabilization Phase)|Lack of Efficacy|0
5955987|NCT01227668|20599033|P1|Phase 1 (Stabilization Phase)|Lack of Efficacy|25
5955988|NCT01227668|20599032|P2|Phase 1 (Stabilization Phase)|No longer meets study criteria|0
5955989|NCT01227668|20599033|P1|Phase 1 (Stabilization Phase)|No longer meets study criteria|7
5955990|NCT01227668|20599032|P2|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|0
5955991|NCT01227668|20599033|P1|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|11
5955992|NCT01227668|20599032|P2|Phase 1 (Stabilization Phase)|Lost to Follow-up|0
5955993|NCT01227668|20599033|P1|Phase 1 (Stabilization Phase)|Lost to Follow-up|8
5955994|NCT01227668|20599032|P2|Phase 1 (Stabilization Phase)|Withdrawal by Subject|0
5955995|NCT01227668|20599033|P1|Phase 1 (Stabilization Phase)|Withdrawal by Subject|7
5955996|NCT01227668|20599032|P2|Phase 1 (Stabilization Phase)|Adverse Event|0
5955997|NCT01227668|20599033|P1|Phase 1 (Stabilization Phase)|Adverse Event|12
5955998|NCT01227629|20599079|P10|Overall Study|Other|1
5955999|NCT01227629|20599080|P9|Overall Study|Other|2
5956000|NCT01227629|20599081|P8|Overall Study|Other|0
5956001|NCT01227629|20599082|P7|Overall Study|Other|0
5956002|NCT01227629|20599083|P6|Overall Study|Other|0
5956003|NCT01227629|20599084|P5|Overall Study|Other|0
5956004|NCT01227629|20599085|P4|Overall Study|Other|1
5956005|NCT01227629|20599086|P3|Overall Study|Other|0
5956006|NCT01227629|20599087|P2|Overall Study|Other|0
5956007|NCT01227629|20599088|P1|Overall Study|Other|0
5956008|NCT01227629|20599079|P10|Overall Study|Withdrawal by Subject|1
5956009|NCT01227629|20599080|P9|Overall Study|Withdrawal by Subject|0
5956010|NCT01227629|20599081|P8|Overall Study|Withdrawal by Subject|0
5956011|NCT01227629|20599082|P7|Overall Study|Withdrawal by Subject|2
5956012|NCT01227629|20599083|P6|Overall Study|Withdrawal by Subject|0
5956013|NCT01227629|20599084|P5|Overall Study|Withdrawal by Subject|0
5956014|NCT01227629|20599085|P4|Overall Study|Withdrawal by Subject|0
5956015|NCT01227629|20599086|P3|Overall Study|Withdrawal by Subject|0
5956016|NCT01227629|20599087|P2|Overall Study|Withdrawal by Subject|0
5956017|NCT01227629|20599088|P1|Overall Study|Withdrawal by Subject|0
5956018|NCT01227629|20599079|P10|Overall Study|Lost to Follow-up|0
5956019|NCT01227629|20599080|P9|Overall Study|Lost to Follow-up|0
5956020|NCT01227629|20599081|P8|Overall Study|Lost to Follow-up|0
5956021|NCT01227629|20599082|P7|Overall Study|Lost to Follow-up|0
5956022|NCT01227629|20599083|P6|Overall Study|Lost to Follow-up|0
5956023|NCT01227629|20599084|P5|Overall Study|Lost to Follow-up|1
5956024|NCT01227629|20599085|P4|Overall Study|Lost to Follow-up|0
5956025|NCT01227629|20599086|P3|Overall Study|Lost to Follow-up|0
5956026|NCT01227629|20599087|P2|Overall Study|Lost to Follow-up|0
5956027|NCT01227629|20599088|P1|Overall Study|Lost to Follow-up|0
5956028|NCT01227629|20599079|P10|Overall Study|Protocol Violation|0
5956029|NCT01227629|20599080|P9|Overall Study|Protocol Violation|0
5956030|NCT01227629|20599081|P8|Overall Study|Protocol Violation|0
5956031|NCT01227629|20599082|P7|Overall Study|Protocol Violation|0
5956032|NCT01227629|20599083|P6|Overall Study|Protocol Violation|0
5956033|NCT01227629|20599084|P5|Overall Study|Protocol Violation|0
5956034|NCT01227629|20599085|P4|Overall Study|Protocol Violation|1
5956035|NCT01227629|20599086|P3|Overall Study|Protocol Violation|0
5956036|NCT01227629|20599087|P2|Overall Study|Protocol Violation|0
5956037|NCT01227629|20599088|P1|Overall Study|Protocol Violation|0
5956038|NCT01227629|20599079|P10|Overall Study|Adverse Event|0
5956039|NCT01227629|20599080|P9|Overall Study|Adverse Event|4
5956040|NCT01227629|20599081|P8|Overall Study|Adverse Event|6
5956041|NCT01227629|20599082|P7|Overall Study|Adverse Event|6
5956042|NCT01227629|20599083|P6|Overall Study|Adverse Event|1
5956043|NCT01227629|20599084|P5|Overall Study|Adverse Event|1
5956044|NCT01227629|20599085|P4|Overall Study|Adverse Event|6
5956045|NCT01227629|20599086|P3|Overall Study|Adverse Event|1
5956046|NCT01227629|20599087|P2|Overall Study|Adverse Event|2
5956047|NCT01227629|20599088|P1|Overall Study|Adverse Event|2
5956048|NCT01227577|20599337|P1|Overall Study|Adverse Event|17
5956049|NCT01227577|20599337|P1|Overall Study|Lack of Efficacy|5
5956050|NCT01227577|20599337|P1|Overall Study|Withdrawal by Subject|4
5956051|NCT01227577|20599337|P1|Overall Study|Lost to Follow-up|1
5956052|NCT01227577|20599337|P1|Overall Study|Administrative problems|2
5956053|NCT01227577|20599337|P1|Overall Study|Death|3
5956054|NCT01227577|20599337|P1|Overall Study|Protocol deviation|3
5956055|NCT01227564|20599352|P3|Overall Study|Participant moved to another town|1
5956056|NCT01227564|20599353|P2|Overall Study|Participant moved to another town|0
5956057|NCT01227564|20599354|P1|Overall Study|Participant moved to another town|0
5956058|NCT01227564|20599352|P3|Overall Study|No Longer Willing to Participate|5
5956059|NCT01227564|20599353|P2|Overall Study|No Longer Willing to Participate|2
5956060|NCT01227564|20599354|P1|Overall Study|No Longer Willing to Participate|4
5956061|NCT01227512|20599492|P2|Overall Study|Participant met withdrawal criteria|1
5956062|NCT01227512|20599493|P1|Overall Study|Participant met withdrawal criteria|0
5956063|NCT01227512|20599492|P2|Overall Study|Withdrawal by Subject|0
5956064|NCT01227512|20599493|P1|Overall Study|Withdrawal by Subject|3
5956065|NCT01227512|20599492|P2|Overall Study|Adverse Event|3
5956066|NCT01227512|20599493|P1|Overall Study|Adverse Event|4
5956067|NCT01227512|20599492|P2|Overall Study|Physician Decision|6
5956068|NCT01227512|20599493|P1|Overall Study|Physician Decision|6
5956069|NCT01227421|20599527|P3|Overall Study|Randomized in error|0
5956070|NCT01227421|20599528|P2|Overall Study|Randomized in error|1
5956071|NCT01227421|20599529|P1|Overall Study|Randomized in error|1
5956072|NCT01227421|20599527|P3|Overall Study|Protocol Violation|2
5956073|NCT01227421|20599528|P2|Overall Study|Protocol Violation|1
5956074|NCT01227421|20599529|P1|Overall Study|Protocol Violation|1
5956075|NCT01227421|20599527|P3|Overall Study|Withdrawal by Subject|1
5956076|NCT01227421|20599528|P2|Overall Study|Withdrawal by Subject|2
5956077|NCT01227421|20599529|P1|Overall Study|Withdrawal by Subject|1
5956078|NCT01227421|20599527|P3|Overall Study|Adverse Event|2
5956079|NCT01227421|20599528|P2|Overall Study|Adverse Event|7
5956080|NCT01227421|20599529|P1|Overall Study|Adverse Event|2
5956081|NCT01227421|20599527|P3|Overall Study|Lost to Follow-up|5
5956082|NCT01227421|20599528|P2|Overall Study|Lost to Follow-up|7
5956083|NCT01227421|20599529|P1|Overall Study|Lost to Follow-up|6
5956084|NCT01227395|20599581|P2|Overall Study|Protocol Violation|1
5956085|NCT01227395|20599582|P1|Overall Study|Protocol Violation|0
5956086|NCT01227278|20599622|P2|Overall Study|Other|2
5956087|NCT01227278|20599623|P1|Overall Study|Other|1
5956088|NCT01227278|20599622|P2|Overall Study|Death|2
5956089|NCT01227278|20599623|P1|Overall Study|Death|0
5956090|NCT01227278|20599622|P2|Overall Study|Withdrawal by Subject|4
5956091|NCT01227278|20599623|P1|Overall Study|Withdrawal by Subject|4
5956092|NCT01227265|20599650|P3|Overall Study|Adverse Event|5
5956093|NCT01227265|20599651|P2|Overall Study|Adverse Event|10
5956094|NCT01227265|20599652|P1|Overall Study|Adverse Event|6
5956095|NCT01227265|20599650|P3|Overall Study|Lost to Follow-up|3
5956096|NCT01227265|20599651|P2|Overall Study|Lost to Follow-up|0
5956097|NCT01227265|20599652|P1|Overall Study|Lost to Follow-up|2
5956098|NCT01227265|20599650|P3|Overall Study|Withdrawal by Subject|3
5956099|NCT01227265|20599651|P2|Overall Study|Withdrawal by Subject|7
5956100|NCT01227265|20599652|P1|Overall Study|Withdrawal by Subject|7
5956101|NCT01227265|20599650|P3|Overall Study|Protocol Violation|0
5956102|NCT01227265|20599651|P2|Overall Study|Protocol Violation|1
5956103|NCT01227265|20599652|P1|Overall Study|Protocol Violation|2
5956104|NCT01227265|20599650|P3|Overall Study|Did Not Meet Protocol Eligibility|1
5956105|NCT01227265|20599651|P2|Overall Study|Did Not Meet Protocol Eligibility|0
5956106|NCT01227265|20599652|P1|Overall Study|Did Not Meet Protocol Eligibility|0
5956107|NCT01227265|20599650|P3|Overall Study|Administrative|2
5956108|NCT01227265|20599651|P2|Overall Study|Administrative|0
5956109|NCT01227265|20599652|P1|Overall Study|Administrative|1
5956110|NCT01227265|20599650|P3|Overall Study|Did Not Receive Treatment|0
5956111|NCT01227265|20599651|P2|Overall Study|Did Not Receive Treatment|2
5956112|NCT01227265|20599652|P1|Overall Study|Did Not Receive Treatment|1
5956113|NCT01227252|20599682|P4|Overall Study|Withdrawal by Subject|0
5956114|NCT01227252|20599683|P3|Overall Study|Withdrawal by Subject|0
5956115|NCT01227252|20599684|P2|Overall Study|Withdrawal by Subject|1
5956116|NCT01227252|20599685|P1|Overall Study|Withdrawal by Subject|0
5956117|NCT01227252|20599682|P4|Overall Study|Lost to Follow-up|0
5956118|NCT01227252|20599683|P3|Overall Study|Lost to Follow-up|0
5956119|NCT01227252|20599684|P2|Overall Study|Lost to Follow-up|1
5956120|NCT01227252|20599685|P1|Overall Study|Lost to Follow-up|0
5956121|NCT01227252|20599682|P4|Overall Study|Sponsor Decision|0
5956122|NCT01227252|20599683|P3|Overall Study|Sponsor Decision|0
5956123|NCT01227252|20599684|P2|Overall Study|Sponsor Decision|1
5956124|NCT01227252|20599685|P1|Overall Study|Sponsor Decision|0
5956125|NCT01227044|20599727|P2|Overall Study|Discontinued Intervention|2
5956126|NCT01227044|20599728|P1|Overall Study|Discontinued Intervention|1
5956127|NCT01227044|20599727|P2|Overall Study|Lost to Follow-up|7
5956128|NCT01227044|20599728|P1|Overall Study|Lost to Follow-up|5
5956129|NCT01227018|20599736|P1|Overall Study|Withdrew after beginning treatment|4
5956130|NCT01227018|20599736|P1|Overall Study|Toxicity|2
5956131|NCT01227018|20599736|P1|Overall Study|Disease progression|9
5956132|NCT01226745|20599781|P6|Overall Study|Other|1
5956133|NCT01226745|20599782|P5|Overall Study|Other|3
5956134|NCT01226745|20599783|P4|Overall Study|Other|4
5956135|NCT01226745|20599784|P3|Overall Study|Other|8
5956136|NCT01226745|20599785|P2|Overall Study|Other|7
5956137|NCT01226745|20599786|P1|Overall Study|Other|6
5956138|NCT01226745|20599781|P6|Overall Study|Death|1
5956139|NCT01226745|20599782|P5|Overall Study|Death|0
5956140|NCT01226745|20599783|P4|Overall Study|Death|0
5956141|NCT01226745|20599784|P3|Overall Study|Death|0
5956142|NCT01226745|20599785|P2|Overall Study|Death|0
5956143|NCT01226745|20599786|P1|Overall Study|Death|1
5956144|NCT01226745|20599781|P6|Overall Study|Lost to Follow-up|2
5956145|NCT01226745|20599782|P5|Overall Study|Lost to Follow-up|1
5956146|NCT01226745|20599783|P4|Overall Study|Lost to Follow-up|1
5956147|NCT01226745|20599784|P3|Overall Study|Lost to Follow-up|6
5956148|NCT01226745|20599785|P2|Overall Study|Lost to Follow-up|6
5956149|NCT01226745|20599786|P1|Overall Study|Lost to Follow-up|2
5956150|NCT01226745|20599781|P6|Overall Study|Did not complete schedule of assessments|1
5956151|NCT01226745|20599782|P5|Overall Study|Did not complete schedule of assessments|0
5956152|NCT01226745|20599783|P4|Overall Study|Did not complete schedule of assessments|0
5956153|NCT01226745|20599784|P3|Overall Study|Did not complete schedule of assessments|6
5956154|NCT01226745|20599785|P2|Overall Study|Did not complete schedule of assessments|3
5956155|NCT01226745|20599786|P1|Overall Study|Did not complete schedule of assessments|8
5956156|NCT01226511|20599982|P2|Taper Period|Parent/Caregiver Decision|1
5956157|NCT01226511|20599983|P1|Taper Period|Parent/Caregiver Decision|1
5956158|NCT01226511|20599982|P2|Taper Period|Protocol Violation|0
5956159|NCT01226511|20599983|P1|Taper Period|Protocol Violation|1
5956160|NCT01226511|20599982|P2|Taper Period|Lost to Follow-up|2
5956161|NCT01226511|20599983|P1|Taper Period|Lost to Follow-up|2
5956162|NCT01226511|20599982|P2|Taper Period|Adverse Event|0
5956163|NCT01226511|20599983|P1|Taper Period|Adverse Event|1
5956164|NCT01226511|20599982|P2|Extension Treatment Period|Sponsor Decision|1
5956165|NCT01226511|20599983|P1|Extension Treatment Period|Sponsor Decision|1
5956166|NCT01226511|20599982|P2|Extension Treatment Period|Parent/Caregiver Decision|8
5956167|NCT01226511|20599983|P1|Extension Treatment Period|Parent/Caregiver Decision|8
5956168|NCT01226511|20599982|P2|Extension Treatment Period|Withdrawal by Subject|3
5956169|NCT01226511|20599983|P1|Extension Treatment Period|Withdrawal by Subject|1
5956170|NCT01226511|20599982|P2|Extension Treatment Period|Protocol Violation|2
5956171|NCT01226511|20599983|P1|Extension Treatment Period|Protocol Violation|2
5956172|NCT01226511|20599982|P2|Extension Treatment Period|Lost to Follow-up|3
5956173|NCT01226511|20599983|P1|Extension Treatment Period|Lost to Follow-up|4
5956174|NCT01226511|20599982|P2|Extension Treatment Period|Lack of Efficacy|2
5956175|NCT01226511|20599983|P1|Extension Treatment Period|Lack of Efficacy|3
5956176|NCT01226511|20599982|P2|Extension Treatment Period|Adverse Event|8
5956177|NCT01226511|20599983|P1|Extension Treatment Period|Adverse Event|8
5956178|NCT01226511|20599982|P2|Acute Treatment Period|Withdrawal by Subject|6
5956179|NCT01226511|20599983|P1|Acute Treatment Period|Withdrawal by Subject|10
5956180|NCT01226511|20599982|P2|Acute Treatment Period|Protocol Violation|5
5956181|NCT01226511|20599983|P1|Acute Treatment Period|Protocol Violation|5
5956182|NCT01226511|20599982|P2|Acute Treatment Period|Parent/caregiver decision|7
5956183|NCT01226511|20599983|P1|Acute Treatment Period|Parent/caregiver decision|5
5956184|NCT01226511|20599982|P2|Acute Treatment Period|Lost to Follow-up|6
5956185|NCT01226511|20599983|P1|Acute Treatment Period|Lost to Follow-up|3
5956186|NCT01226511|20599982|P2|Acute Treatment Period|Lack of Efficacy|1
5956187|NCT01226511|20599983|P1|Acute Treatment Period|Lack of Efficacy|2
5956188|NCT01226511|20599982|P2|Acute Treatment Period|Adverse Event|6
5956189|NCT01226511|20599983|P1|Acute Treatment Period|Adverse Event|7
5956190|NCT01226472|20600081|P1|Overall Study|Progressive Disease|1
5956191|NCT01226459|20600088|P2|Overall Study|Pregnancy|0
5956192|NCT01226459|20600089|P1|Overall Study|Pregnancy|1
5956193|NCT01226459|20600088|P2|Overall Study|Lost to Follow-up|8
5956194|NCT01226459|20600089|P1|Overall Study|Lost to Follow-up|4
5956195|NCT01226459|20600088|P2|Overall Study|Withdrawal by Subject|13
5956196|NCT01226459|20600089|P1|Overall Study|Withdrawal by Subject|10
5956197|NCT01226459|20600088|P2|Overall Study|Protocol Violation|3
5956198|NCT01226459|20600089|P1|Overall Study|Protocol Violation|4
5956199|NCT01226459|20600088|P2|Overall Study|Adverse Event|8
5956200|NCT01226459|20600089|P1|Overall Study|Adverse Event|2
5956201|NCT01226121|20600107|P3|Overall Study|Lost to Follow-up|1
5956202|NCT01226121|20600108|P2|Overall Study|Lost to Follow-up|0
5956203|NCT01226121|20600109|P1|Overall Study|Lost to Follow-up|2
5956204|NCT01226095|20600120|P1|Overall Study|Poor compliance|1
5956205|NCT01226043|20600145|P4|30-week Observational Phase|Physician Decision|2
5956206|NCT01226043|20600146|P3|30-week Observational Phase|Physician Decision|2
5956207|NCT01226043|20600147|P2|30-week Observational Phase|Physician Decision|0
5956208|NCT01226043|20600148|P1|30-week Observational Phase|Physician Decision|0
5956209|NCT01226043|20600145|P4|30-week Observational Phase|Withdrawal by Subject|7
5956210|NCT01226043|20600146|P3|30-week Observational Phase|Withdrawal by Subject|1
5956211|NCT01226043|20600147|P2|30-week Observational Phase|Withdrawal by Subject|0
5956212|NCT01226043|20600148|P1|30-week Observational Phase|Withdrawal by Subject|0
5956213|NCT01226043|20600145|P4|30-week Observational Phase|Lost to Follow-up|2
5956214|NCT01226043|20600146|P3|30-week Observational Phase|Lost to Follow-up|2
5956215|NCT01226043|20600147|P2|30-week Observational Phase|Lost to Follow-up|0
5956216|NCT01226043|20600148|P1|30-week Observational Phase|Lost to Follow-up|0
5956217|NCT01226043|20600145|P4|30-week Observational Phase|Protocol Violation|1
5956218|NCT01226043|20600146|P3|30-week Observational Phase|Protocol Violation|0
5956219|NCT01226043|20600147|P2|30-week Observational Phase|Protocol Violation|0
5956220|NCT01226043|20600148|P1|30-week Observational Phase|Protocol Violation|0
5956221|NCT01226043|20600145|P4|30-week Observational Phase|Adverse Event|1
5956222|NCT01226043|20600146|P3|30-week Observational Phase|Adverse Event|1
5956223|NCT01226043|20600147|P2|30-week Observational Phase|Adverse Event|0
5956224|NCT01226043|20600148|P1|30-week Observational Phase|Adverse Event|0
5956225|NCT01226043|20600145|P4|6-week Re-randomization Phase|completed in error|1
5956226|NCT01226043|20600146|P3|6-week Re-randomization Phase|completed in error|0
5956227|NCT01226043|20600147|P2|6-week Re-randomization Phase|completed in error|0
5956228|NCT01226043|20600148|P1|6-week Re-randomization Phase|completed in error|0
5956229|NCT01226043|20600145|P4|6-week Re-randomization Phase|Physician Decision|2
5956230|NCT01226043|20600146|P3|6-week Re-randomization Phase|Physician Decision|3
5956231|NCT01226043|20600147|P2|6-week Re-randomization Phase|Physician Decision|0
5956232|NCT01226043|20600148|P1|6-week Re-randomization Phase|Physician Decision|0
5956233|NCT01226043|20600145|P4|6-week Re-randomization Phase|Withdrawal by Subject|3
5956234|NCT01226043|20600146|P3|6-week Re-randomization Phase|Withdrawal by Subject|1
5956235|NCT01226043|20600147|P2|6-week Re-randomization Phase|Withdrawal by Subject|0
5956236|NCT01226043|20600148|P1|6-week Re-randomization Phase|Withdrawal by Subject|0
5956237|NCT01226043|20600145|P4|6-week Re-randomization Phase|Lost to Follow-up|3
5956238|NCT01226043|20600146|P3|6-week Re-randomization Phase|Lost to Follow-up|1
5957893|NCT01214655|20606183|P1|Part C|Death|0
5956239|NCT01226043|20600147|P2|6-week Re-randomization Phase|Lost to Follow-up|0
5956240|NCT01226043|20600148|P1|6-week Re-randomization Phase|Lost to Follow-up|0
5956241|NCT01226043|20600145|P4|6-week Re-randomization Phase|Protocol Violation|1
5956242|NCT01226043|20600146|P3|6-week Re-randomization Phase|Protocol Violation|1
5956243|NCT01226043|20600147|P2|6-week Re-randomization Phase|Protocol Violation|0
5956244|NCT01226043|20600148|P1|6-week Re-randomization Phase|Protocol Violation|0
5956245|NCT01226043|20600145|P4|6-week Re-randomization Phase|Adverse Event|1
5956246|NCT01226043|20600146|P3|6-week Re-randomization Phase|Adverse Event|1
5956247|NCT01226043|20600147|P2|6-week Re-randomization Phase|Adverse Event|0
5956248|NCT01226043|20600148|P1|6-week Re-randomization Phase|Adverse Event|0
5956249|NCT01226043|20600145|P4|4-week Crossover Phase - Period 2|Physician Decision|0
5956250|NCT01226043|20600146|P3|4-week Crossover Phase - Period 2|Physician Decision|0
5956251|NCT01226043|20600147|P2|4-week Crossover Phase - Period 2|Physician Decision|5
5956252|NCT01226043|20600148|P1|4-week Crossover Phase - Period 2|Physician Decision|4
5956253|NCT01226043|20600145|P4|4-week Crossover Phase - Period 2|Withdrawal by Subject|0
5956254|NCT01226043|20600146|P3|4-week Crossover Phase - Period 2|Withdrawal by Subject|0
5956255|NCT01226043|20600147|P2|4-week Crossover Phase - Period 2|Withdrawal by Subject|1
5956256|NCT01226043|20600148|P1|4-week Crossover Phase - Period 2|Withdrawal by Subject|0
5956257|NCT01226043|20600145|P4|4-week Crossover Phase - Period 1|Physician Decision|0
5956258|NCT01226043|20600146|P3|4-week Crossover Phase - Period 1|Physician Decision|0
5956259|NCT01226043|20600147|P2|4-week Crossover Phase - Period 1|Physician Decision|6
5956260|NCT01226043|20600148|P1|4-week Crossover Phase - Period 1|Physician Decision|0
5956261|NCT01226043|20600145|P4|4-week Crossover Phase - Period 1|Withdrawal by Subject|0
5956262|NCT01226043|20600146|P3|4-week Crossover Phase - Period 1|Withdrawal by Subject|0
5956263|NCT01226043|20600147|P2|4-week Crossover Phase - Period 1|Withdrawal by Subject|0
5956264|NCT01226043|20600148|P1|4-week Crossover Phase - Period 1|Withdrawal by Subject|2
5956265|NCT01226043|20600145|P4|4-week Crossover Phase - Period 1|Lost to Follow-up|0
5956266|NCT01226043|20600146|P3|4-week Crossover Phase - Period 1|Lost to Follow-up|0
5956267|NCT01226043|20600147|P2|4-week Crossover Phase - Period 1|Lost to Follow-up|1
5956268|NCT01226043|20600148|P1|4-week Crossover Phase - Period 1|Lost to Follow-up|0
5956269|NCT01226043|20600145|P4|4-week Crossover Phase - Period 1|Protocol Violation|0
5956270|NCT01226043|20600146|P3|4-week Crossover Phase - Period 1|Protocol Violation|0
5956271|NCT01226043|20600147|P2|4-week Crossover Phase - Period 1|Protocol Violation|2
5956272|NCT01226043|20600148|P1|4-week Crossover Phase - Period 1|Protocol Violation|1
5956273|NCT01225991|20600186|P1|Overall Study|Withdrawal by Subject|6
5956274|NCT01225952|20600197|P3|Overall Study|Surgical complications|0
5956275|NCT01225952|20600198|P2|Overall Study|Surgical complications|0
5956276|NCT01225952|20600199|P1|Overall Study|Surgical complications|1
5956277|NCT01225952|20600197|P3|Overall Study|Withdrawal by Subject|5
5956278|NCT01225952|20600198|P2|Overall Study|Withdrawal by Subject|4
5956279|NCT01225952|20600199|P1|Overall Study|Withdrawal by Subject|4
5956280|NCT01225952|20600197|P3|Overall Study|Study Eye Explanted|1
5956281|NCT01225952|20600198|P2|Overall Study|Study Eye Explanted|0
5956282|NCT01225952|20600199|P1|Overall Study|Study Eye Explanted|0
5956283|NCT01225952|20600197|P3|Overall Study|Lost to Follow-up|0
5956284|NCT01225952|20600198|P2|Overall Study|Lost to Follow-up|0
5956285|NCT01225952|20600199|P1|Overall Study|Lost to Follow-up|1
5956286|NCT01225887|20600291|P1|Overall Study|Ineligible:inadequate pathology|2
5956287|NCT01225887|20600291|P1|Overall Study|Ineligible;improper pre-protocol therapy|1
5956288|NCT01225887|20600291|P1|Overall Study|Ineligible:required test not done|2
5956289|NCT01225835|20600301|P2|Overall Study|Other|1
5956290|NCT01225835|20600302|P1|Overall Study|Other|1
5956291|NCT01225835|20600301|P2|Overall Study|Adverse Event|1
5956292|NCT01225835|20600302|P1|Overall Study|Adverse Event|2
5956293|NCT01225835|20600301|P2|Overall Study|Did not meet hCG criterion|0
5956294|NCT01225835|20600302|P1|Overall Study|Did not meet hCG criterion|2
5956295|NCT01225835|20600301|P2|Overall Study|Completed protocol|1
5956296|NCT01225835|20600302|P1|Overall Study|Completed protocol|2
5956297|NCT01225822|20600350|P5|Overall Study|Other|7
5956298|NCT01225822|20600351|P4|Overall Study|Other|10
5956299|NCT01225822|20600352|P3|Overall Study|Other|7
5956300|NCT01225822|20600353|P2|Overall Study|Other|10
5956301|NCT01225822|20600354|P1|Overall Study|Other|13
5956302|NCT01225822|20600350|P5|Overall Study|Withdrawal by Subject|6
5956303|NCT01225822|20600351|P4|Overall Study|Withdrawal by Subject|11
5956304|NCT01225822|20600352|P3|Overall Study|Withdrawal by Subject|7
5956305|NCT01225822|20600353|P2|Overall Study|Withdrawal by Subject|7
5956306|NCT01225822|20600354|P1|Overall Study|Withdrawal by Subject|6
5956307|NCT01225822|20600350|P5|Overall Study|Lost to Follow-up|0
5956308|NCT01225822|20600351|P4|Overall Study|Lost to Follow-up|1
5956309|NCT01225822|20600352|P3|Overall Study|Lost to Follow-up|0
5956310|NCT01225822|20600353|P2|Overall Study|Lost to Follow-up|0
5956311|NCT01225822|20600354|P1|Overall Study|Lost to Follow-up|0
5956312|NCT01225822|20600350|P5|Overall Study|Protocol Violation|4
5956313|NCT01225822|20600351|P4|Overall Study|Protocol Violation|7
5956314|NCT01225822|20600352|P3|Overall Study|Protocol Violation|6
5956315|NCT01225822|20600353|P2|Overall Study|Protocol Violation|8
5956316|NCT01225822|20600354|P1|Overall Study|Protocol Violation|6
5956317|NCT01225822|20600350|P5|Overall Study|Adverse Event|14
5956318|NCT01225822|20600351|P4|Overall Study|Adverse Event|23
5956319|NCT01225822|20600352|P3|Overall Study|Adverse Event|18
5956320|NCT01225822|20600353|P2|Overall Study|Adverse Event|31
5956321|NCT01225822|20600354|P1|Overall Study|Adverse Event|13
5956322|NCT01225731|20600421|P13|Part 3|Withdrawal by Subject|4
5956323|NCT01225731|20600422|P12|Part 3|Withdrawal by Subject|6
5956324|NCT01225731|20600423|P11|Part 3|Withdrawal by Subject|4
5956325|NCT01225731|20600424|P10|Part 3|Withdrawal by Subject|0
5956326|NCT01225731|20600425|P9|Part 3|Withdrawal by Subject|0
5956327|NCT01225731|20600426|P8|Part 3|Withdrawal by Subject|0
5956328|NCT01225731|20600427|P7|Part 3|Withdrawal by Subject|0
5956329|NCT01225731|20600428|P6|Part 3|Withdrawal by Subject|0
5956330|NCT01225731|20600429|P5|Part 3|Withdrawal by Subject|0
5956331|NCT01225731|20600430|P4|Part 3|Withdrawal by Subject|0
5956332|NCT01225731|20600431|P3|Part 3|Withdrawal by Subject|0
5956333|NCT01225731|20600432|P2|Part 3|Withdrawal by Subject|0
5956334|NCT01225731|20600433|P1|Part 3|Withdrawal by Subject|0
5956335|NCT01225731|20600421|P13|Part 3|Physician Decision|2
5956336|NCT01225731|20600422|P12|Part 3|Physician Decision|1
5956337|NCT01225731|20600423|P11|Part 3|Physician Decision|0
5956338|NCT01225731|20600424|P10|Part 3|Physician Decision|0
5956339|NCT01225731|20600425|P9|Part 3|Physician Decision|0
5956340|NCT01225731|20600426|P8|Part 3|Physician Decision|0
5956341|NCT01225731|20600427|P7|Part 3|Physician Decision|0
5956342|NCT01225731|20600428|P6|Part 3|Physician Decision|0
5956343|NCT01225731|20600429|P5|Part 3|Physician Decision|0
5956344|NCT01225731|20600430|P4|Part 3|Physician Decision|0
5956345|NCT01225731|20600431|P3|Part 3|Physician Decision|0
5956346|NCT01225731|20600432|P2|Part 3|Physician Decision|0
5956347|NCT01225731|20600433|P1|Part 3|Physician Decision|0
5956348|NCT01225731|20600421|P13|Part 3|Lost to Follow-up|1
5956349|NCT01225731|20600422|P12|Part 3|Lost to Follow-up|2
5956350|NCT01225731|20600423|P11|Part 3|Lost to Follow-up|1
5956351|NCT01225731|20600424|P10|Part 3|Lost to Follow-up|0
5956352|NCT01225731|20600425|P9|Part 3|Lost to Follow-up|0
5956353|NCT01225731|20600426|P8|Part 3|Lost to Follow-up|0
5956354|NCT01225731|20600427|P7|Part 3|Lost to Follow-up|0
5956355|NCT01225731|20600428|P6|Part 3|Lost to Follow-up|0
5956356|NCT01225731|20600429|P5|Part 3|Lost to Follow-up|0
5956357|NCT01225731|20600430|P4|Part 3|Lost to Follow-up|0
5956358|NCT01225731|20600431|P3|Part 3|Lost to Follow-up|0
5956359|NCT01225731|20600432|P2|Part 3|Lost to Follow-up|0
5956360|NCT01225731|20600433|P1|Part 3|Lost to Follow-up|0
5956361|NCT01225731|20600421|P13|Part 3|Adverse Event|0
5956362|NCT01225731|20600422|P12|Part 3|Adverse Event|1
5956363|NCT01225731|20600423|P11|Part 3|Adverse Event|1
5956364|NCT01225731|20600424|P10|Part 3|Adverse Event|0
5956365|NCT01225731|20600425|P9|Part 3|Adverse Event|0
5956366|NCT01225731|20600426|P8|Part 3|Adverse Event|0
5956367|NCT01225731|20600427|P7|Part 3|Adverse Event|0
5956368|NCT01225731|20600428|P6|Part 3|Adverse Event|0
5956369|NCT01225731|20600429|P5|Part 3|Adverse Event|0
5956370|NCT01225731|20600430|P4|Part 3|Adverse Event|0
5956371|NCT01225731|20600431|P3|Part 3|Adverse Event|0
5956372|NCT01225731|20600432|P2|Part 3|Adverse Event|0
5956373|NCT01225731|20600433|P1|Part 3|Adverse Event|0
5956374|NCT01225731|20600421|P13|Part 2|Withdrawal by Subject|0
5956375|NCT01225731|20600422|P12|Part 2|Withdrawal by Subject|0
5956376|NCT01225731|20600423|P11|Part 2|Withdrawal by Subject|0
5956377|NCT01225731|20600424|P10|Part 2|Withdrawal by Subject|0
5956378|NCT01225731|20600425|P9|Part 2|Withdrawal by Subject|1
5956379|NCT01225731|20600426|P8|Part 2|Withdrawal by Subject|4
5956380|NCT01225731|20600427|P7|Part 2|Withdrawal by Subject|3
5956381|NCT01225731|20600428|P6|Part 2|Withdrawal by Subject|1
5956382|NCT01225731|20600429|P5|Part 2|Withdrawal by Subject|0
5956383|NCT01225731|20600430|P4|Part 2|Withdrawal by Subject|0
5956384|NCT01225731|20600431|P3|Part 2|Withdrawal by Subject|0
5956385|NCT01225731|20600432|P2|Part 2|Withdrawal by Subject|0
5956386|NCT01225731|20600433|P1|Part 2|Withdrawal by Subject|0
5956387|NCT01225731|20600421|P13|Part 2|Physician Decision|0
5956388|NCT01225731|20600422|P12|Part 2|Physician Decision|0
5956389|NCT01225731|20600423|P11|Part 2|Physician Decision|0
5956390|NCT01225731|20600424|P10|Part 2|Physician Decision|0
5956391|NCT01225731|20600425|P9|Part 2|Physician Decision|2
5956392|NCT01225731|20600426|P8|Part 2|Physician Decision|2
5956393|NCT01225731|20600427|P7|Part 2|Physician Decision|0
5956394|NCT01225731|20600428|P6|Part 2|Physician Decision|0
5956395|NCT01225731|20600429|P5|Part 2|Physician Decision|0
5956396|NCT01225731|20600430|P4|Part 2|Physician Decision|0
5956397|NCT01225731|20600431|P3|Part 2|Physician Decision|0
5956398|NCT01225731|20600432|P2|Part 2|Physician Decision|0
5956399|NCT01225731|20600433|P1|Part 2|Physician Decision|0
5956400|NCT01225731|20600421|P13|Part 2|Lost to Follow-up|0
5956401|NCT01225731|20600422|P12|Part 2|Lost to Follow-up|0
5956402|NCT01225731|20600423|P11|Part 2|Lost to Follow-up|0
5956403|NCT01225731|20600424|P10|Part 2|Lost to Follow-up|0
5956404|NCT01225731|20600425|P9|Part 2|Lost to Follow-up|1
5956405|NCT01225731|20600426|P8|Part 2|Lost to Follow-up|3
5956406|NCT01225731|20600427|P7|Part 2|Lost to Follow-up|0
5956407|NCT01225731|20600428|P6|Part 2|Lost to Follow-up|0
5956408|NCT01225731|20600429|P5|Part 2|Lost to Follow-up|0
5956409|NCT01225731|20600430|P4|Part 2|Lost to Follow-up|0
5956410|NCT01225731|20600431|P3|Part 2|Lost to Follow-up|0
5956411|NCT01225731|20600432|P2|Part 2|Lost to Follow-up|0
5956412|NCT01225731|20600433|P1|Part 2|Lost to Follow-up|0
5956413|NCT01225731|20600421|P13|Part 2|Pregnancy|0
5956414|NCT01225731|20600422|P12|Part 2|Pregnancy|0
5956415|NCT01225731|20600423|P11|Part 2|Pregnancy|0
5956416|NCT01225731|20600424|P10|Part 2|Pregnancy|0
5956417|NCT01225731|20600425|P9|Part 2|Pregnancy|1
5956418|NCT01225731|20600426|P8|Part 2|Pregnancy|0
5956419|NCT01225731|20600427|P7|Part 2|Pregnancy|1
5956420|NCT01225731|20600428|P6|Part 2|Pregnancy|0
5956421|NCT01225731|20600429|P5|Part 2|Pregnancy|0
5956422|NCT01225731|20600430|P4|Part 2|Pregnancy|0
5956423|NCT01225731|20600431|P3|Part 2|Pregnancy|0
5956424|NCT01225731|20600432|P2|Part 2|Pregnancy|0
5956425|NCT01225731|20600433|P1|Part 2|Pregnancy|0
5956426|NCT01225731|20600421|P13|Part 2|Lack of Efficacy|0
5956427|NCT01225731|20600422|P12|Part 2|Lack of Efficacy|0
5956428|NCT01225731|20600423|P11|Part 2|Lack of Efficacy|0
5956429|NCT01225731|20600424|P10|Part 2|Lack of Efficacy|0
5956430|NCT01225731|20600425|P9|Part 2|Lack of Efficacy|3
5956431|NCT01225731|20600426|P8|Part 2|Lack of Efficacy|12
5956432|NCT01225731|20600427|P7|Part 2|Lack of Efficacy|0
5956433|NCT01225731|20600428|P6|Part 2|Lack of Efficacy|1
5956434|NCT01225731|20600429|P5|Part 2|Lack of Efficacy|0
5956435|NCT01225731|20600430|P4|Part 2|Lack of Efficacy|0
5956436|NCT01225731|20600431|P3|Part 2|Lack of Efficacy|0
5956437|NCT01225731|20600432|P2|Part 2|Lack of Efficacy|0
5956438|NCT01225731|20600433|P1|Part 2|Lack of Efficacy|0
5956439|NCT01225731|20600421|P13|Part 2|Adverse Event|0
5956440|NCT01225731|20600422|P12|Part 2|Adverse Event|0
5956441|NCT01225731|20600423|P11|Part 2|Adverse Event|0
5956442|NCT01225731|20600424|P10|Part 2|Adverse Event|0
5956443|NCT01225731|20600425|P9|Part 2|Adverse Event|2
5956444|NCT01225731|20600426|P8|Part 2|Adverse Event|4
5956445|NCT01225731|20600427|P7|Part 2|Adverse Event|4
5956446|NCT01225731|20600428|P6|Part 2|Adverse Event|0
5956447|NCT01225731|20600429|P5|Part 2|Adverse Event|0
5956448|NCT01225731|20600430|P4|Part 2|Adverse Event|0
5956449|NCT01225731|20600431|P3|Part 2|Adverse Event|0
5956450|NCT01225731|20600432|P2|Part 2|Adverse Event|0
5956451|NCT01225731|20600433|P1|Part 2|Adverse Event|0
5956452|NCT01225731|20600421|P13|Part 2|Protocol Violation|0
5956453|NCT01225731|20600422|P12|Part 2|Protocol Violation|0
5956454|NCT01225731|20600423|P11|Part 2|Protocol Violation|0
5956455|NCT01225731|20600424|P10|Part 2|Protocol Violation|0
5956456|NCT01225731|20600425|P9|Part 2|Protocol Violation|1
5956457|NCT01225731|20600426|P8|Part 2|Protocol Violation|0
5956458|NCT01225731|20600427|P7|Part 2|Protocol Violation|0
5956459|NCT01225731|20600428|P6|Part 2|Protocol Violation|1
5956460|NCT01225731|20600429|P5|Part 2|Protocol Violation|0
5956461|NCT01225731|20600430|P4|Part 2|Protocol Violation|0
5956462|NCT01225731|20600431|P3|Part 2|Protocol Violation|0
5956463|NCT01225731|20600432|P2|Part 2|Protocol Violation|0
5956464|NCT01225731|20600433|P1|Part 2|Protocol Violation|0
5956465|NCT01225731|20600421|P13|Part 1|Protocol Violation|0
5956466|NCT01225731|20600422|P12|Part 1|Protocol Violation|0
5956467|NCT01225731|20600423|P11|Part 1|Protocol Violation|0
5956468|NCT01225731|20600424|P10|Part 1|Protocol Violation|0
5956469|NCT01225731|20600425|P9|Part 1|Protocol Violation|0
5956470|NCT01225731|20600426|P8|Part 1|Protocol Violation|0
5956471|NCT01225731|20600427|P7|Part 1|Protocol Violation|0
5956472|NCT01225731|20600428|P6|Part 1|Protocol Violation|0
5956473|NCT01225731|20600429|P5|Part 1|Protocol Violation|0
5956474|NCT01225731|20600430|P4|Part 1|Protocol Violation|1
5956475|NCT01225731|20600431|P3|Part 1|Protocol Violation|0
5956476|NCT01225731|20600432|P2|Part 1|Protocol Violation|0
5956477|NCT01225731|20600433|P1|Part 1|Protocol Violation|0
5956478|NCT01225731|20600421|P13|Part 1|Withdrawal by Subject|0
5956479|NCT01225731|20600422|P12|Part 1|Withdrawal by Subject|0
5956480|NCT01225731|20600423|P11|Part 1|Withdrawal by Subject|0
5956481|NCT01225731|20600424|P10|Part 1|Withdrawal by Subject|0
5956482|NCT01225731|20600425|P9|Part 1|Withdrawal by Subject|0
5956483|NCT01225731|20600426|P8|Part 1|Withdrawal by Subject|0
5956484|NCT01225731|20600427|P7|Part 1|Withdrawal by Subject|0
5956485|NCT01225731|20600428|P6|Part 1|Withdrawal by Subject|0
5956486|NCT01225731|20600429|P5|Part 1|Withdrawal by Subject|4
5956487|NCT01225731|20600430|P4|Part 1|Withdrawal by Subject|0
5956488|NCT01225731|20600431|P3|Part 1|Withdrawal by Subject|0
5956489|NCT01225731|20600432|P2|Part 1|Withdrawal by Subject|3
5956490|NCT01225731|20600433|P1|Part 1|Withdrawal by Subject|0
5956491|NCT01225731|20600421|P13|Part 1|Adverse Event|0
5956492|NCT01225731|20600422|P12|Part 1|Adverse Event|0
5956493|NCT01225731|20600423|P11|Part 1|Adverse Event|0
5956494|NCT01225731|20600424|P10|Part 1|Adverse Event|0
5956495|NCT01225731|20600425|P9|Part 1|Adverse Event|0
5956496|NCT01225731|20600426|P8|Part 1|Adverse Event|0
5956497|NCT01225731|20600427|P7|Part 1|Adverse Event|0
5956498|NCT01225731|20600428|P6|Part 1|Adverse Event|0
5956499|NCT01225731|20600429|P5|Part 1|Adverse Event|1
5956500|NCT01225731|20600430|P4|Part 1|Adverse Event|1
5956501|NCT01225731|20600431|P3|Part 1|Adverse Event|1
5956502|NCT01225731|20600432|P2|Part 1|Adverse Event|2
5956503|NCT01225731|20600433|P1|Part 1|Adverse Event|1
5956504|NCT01225731|20600421|P13|Part 1|Did not meet eligibility criteria|0
5956505|NCT01225731|20600422|P12|Part 1|Did not meet eligibility criteria|0
5956506|NCT01225731|20600423|P11|Part 1|Did not meet eligibility criteria|0
5956507|NCT01225731|20600424|P10|Part 1|Did not meet eligibility criteria|0
5956508|NCT01225731|20600425|P9|Part 1|Did not meet eligibility criteria|0
5956509|NCT01225731|20600426|P8|Part 1|Did not meet eligibility criteria|0
5956510|NCT01225731|20600427|P7|Part 1|Did not meet eligibility criteria|0
5956511|NCT01225731|20600428|P6|Part 1|Did not meet eligibility criteria|0
5956512|NCT01225731|20600429|P5|Part 1|Did not meet eligibility criteria|1
5956513|NCT01225731|20600430|P4|Part 1|Did not meet eligibility criteria|0
5956514|NCT01225731|20600431|P3|Part 1|Did not meet eligibility criteria|0
5956515|NCT01225731|20600432|P2|Part 1|Did not meet eligibility criteria|0
5956516|NCT01225731|20600433|P1|Part 1|Did not meet eligibility criteria|1
5956517|NCT01225562|20600528|P3|Overall Study|Lost to Follow-up|1
5956518|NCT01225562|20600529|P2|Overall Study|Lost to Follow-up|6
5956519|NCT01225562|20600530|P1|Overall Study|Lost to Follow-up|3
5956520|NCT01225562|20600528|P3|Overall Study|Withdrawal by Subject|52
5956521|NCT01225562|20600529|P2|Overall Study|Withdrawal by Subject|50
5956522|NCT01225562|20600530|P1|Overall Study|Withdrawal by Subject|52
5956523|NCT01225549|20600547|P10|Period 6 - Washout|Disallowed medication|0
5956524|NCT01225549|20600548|P9|Period 6 - Washout|Disallowed medication|0
5956525|NCT01225549|20600549|P8|Period 6 - Washout|Disallowed medication|0
5956526|NCT01225549|20600550|P7|Period 6 - Washout|Disallowed medication|0
5956527|NCT01225549|20600551|P6|Period 6 - Washout|Disallowed medication|0
5956528|NCT01225549|20600552|P5|Period 6 - Washout|Disallowed medication|0
5956529|NCT01225549|20600553|P4|Period 6 - Washout|Disallowed medication|1
5956530|NCT01225549|20600554|P3|Period 6 - Washout|Disallowed medication|0
5956531|NCT01225549|20600555|P2|Period 6 - Washout|Disallowed medication|0
5956532|NCT01225549|20600556|P1|Period 6 - Washout|Disallowed medication|0
5956533|NCT01225549|20600547|P10|Period 4 - Washout|Disallowed medication|0
5956534|NCT01225549|20600548|P9|Period 4 - Washout|Disallowed medication|0
5956535|NCT01225549|20600549|P8|Period 4 - Washout|Disallowed medication|0
5956536|NCT01225549|20600550|P7|Period 4 - Washout|Disallowed medication|0
5956537|NCT01225549|20600551|P6|Period 4 - Washout|Disallowed medication|0
5956538|NCT01225549|20600552|P5|Period 4 - Washout|Disallowed medication|0
5956539|NCT01225549|20600553|P4|Period 4 - Washout|Disallowed medication|0
5956540|NCT01225549|20600554|P3|Period 4 - Washout|Disallowed medication|0
5956541|NCT01225549|20600555|P2|Period 4 - Washout|Disallowed medication|1
5956542|NCT01225549|20600556|P1|Period 4 - Washout|Disallowed medication|0
5956543|NCT01225211|20600677|P10|Overall Study|Other|1
5956544|NCT01225211|20600678|P9|Overall Study|Other|0
5956545|NCT01225211|20600679|P8|Overall Study|Other|0
5956546|NCT01225211|20600680|P7|Overall Study|Other|0
5956547|NCT01225211|20600681|P6|Overall Study|Other|0
5956548|NCT01225211|20600682|P5|Overall Study|Other|0
5956549|NCT01225211|20600683|P4|Overall Study|Other|0
5956550|NCT01225211|20600684|P3|Overall Study|Other|0
5956551|NCT01225211|20600685|P2|Overall Study|Other|0
5956552|NCT01225211|20600686|P1|Overall Study|Other|0
5956553|NCT01225211|20600677|P10|Overall Study|Withdrawal by Subject|3
5956554|NCT01225211|20600678|P9|Overall Study|Withdrawal by Subject|1
5956555|NCT01225211|20600679|P8|Overall Study|Withdrawal by Subject|0
5956556|NCT01225211|20600680|P7|Overall Study|Withdrawal by Subject|1
5956557|NCT01225211|20600681|P6|Overall Study|Withdrawal by Subject|0
5956558|NCT01225211|20600682|P5|Overall Study|Withdrawal by Subject|0
5956559|NCT01225211|20600683|P4|Overall Study|Withdrawal by Subject|0
5956560|NCT01225211|20600684|P3|Overall Study|Withdrawal by Subject|0
5956561|NCT01225211|20600685|P2|Overall Study|Withdrawal by Subject|0
5956562|NCT01225211|20600686|P1|Overall Study|Withdrawal by Subject|0
5956563|NCT01225211|20600677|P10|Overall Study|Adverse Event|1
5956564|NCT01225211|20600678|P9|Overall Study|Adverse Event|0
5956565|NCT01225211|20600679|P8|Overall Study|Adverse Event|0
5956566|NCT01225211|20600680|P7|Overall Study|Adverse Event|0
5956567|NCT01225211|20600681|P6|Overall Study|Adverse Event|0
5956568|NCT01225211|20600682|P5|Overall Study|Adverse Event|0
5956569|NCT01225211|20600683|P4|Overall Study|Adverse Event|0
5956570|NCT01225211|20600684|P3|Overall Study|Adverse Event|1
5956571|NCT01225211|20600685|P2|Overall Study|Adverse Event|0
5956572|NCT01225211|20600686|P1|Overall Study|Adverse Event|0
5956573|NCT01225172|20600789|P2|Overall Study|Withdrawal by Subject|0
5956574|NCT01225172|20600790|P1|Overall Study|Withdrawal by Subject|1
5956575|NCT01225172|20600789|P2|Overall Study|Subject no longer meets study criteria|0
5956576|NCT01225172|20600790|P1|Overall Study|Subject no longer meets study criteria|1
5956577|NCT01225172|20600789|P2|Overall Study|Subject request to discontinue treatment|1
5956578|NCT01225172|20600790|P1|Overall Study|Subject request to discontinue treatment|3
5956579|NCT01225172|20600789|P2|Overall Study|Subject decision to stop|0
5956580|NCT01225172|20600790|P1|Overall Study|Subject decision to stop|1
5956581|NCT01225159|20600812|P2|Overall Study|Change operation|0
5956582|NCT01225159|20600813|P1|Overall Study|Change operation|1
5956583|NCT01225146|20600823|P2|Overall Study|Sponsor discontinued making 2mg drug|2
5956584|NCT01225146|20600824|P1|Overall Study|Sponsor discontinued making 2mg drug|0
5956585|NCT01224925|20600892|P2|Overall Study|Lost to Follow-up|2
5956586|NCT01224925|20600893|P1|Overall Study|Lost to Follow-up|3
5956587|NCT01224821|20600901|P1|Long-Term Follow-Up|Completion of 10 Year Follow-up|9
5956588|NCT01224821|20600901|P1|Long-Term Follow-Up|Death|2
5956589|NCT01224821|20600901|P1|Dosimetric and Therapeutic Treatment|Started Other Treatment|1
5956590|NCT01224821|20600901|P1|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|1
5956591|NCT01224821|20600901|P1|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2
5956592|NCT01224821|20600901|P1|Dosimetric and Therapeutic Treatment|Continued Follow-up in Study BEX104526|3
5956593|NCT01224821|20600901|P1|Dosimetric and Therapeutic Treatment|Progressive Disease|38
5956594|NCT01224821|20600901|P1|Dosimetric and Therapeutic Treatment|Adverse Event|1
5956595|NCT01224782|20600920|P1|Overall Study|Transplantation|1
5956596|NCT01224782|20600920|P1|Overall Study|Deterioration|1
5956597|NCT01224782|20600920|P1|Overall Study|Financial Reasons|1
5956598|NCT01224782|20600920|P1|Overall Study|Change of Treatment|1
5956599|NCT01224782|20600920|P1|Overall Study|Start of Dialysis|3
5956600|NCT01224782|20600920|P1|Overall Study|Other|4
5956601|NCT01224782|20600920|P1|Overall Study|Noncompliance|10
5956602|NCT01224782|20600920|P1|Overall Study|Adverse Reaction|11
5956603|NCT01224782|20600920|P1|Overall Study|Adverse Event|12
5956604|NCT01224782|20600920|P1|Overall Study|Improvement|13
5956605|NCT01224782|20600920|P1|Overall Study|Death|14
5956606|NCT01224782|20600920|P1|Overall Study|Withdrawal by Subject|16
5956607|NCT01224782|20600920|P1|Overall Study|Lost to Follow-up|177
5956608|NCT01224639|20600946|P8|Overall Study|Adverse Event|1
5956609|NCT01224639|20600947|P7|Overall Study|Adverse Event|0
5956610|NCT01224639|20600948|P6|Overall Study|Adverse Event|0
5956611|NCT01224639|20600949|P5|Overall Study|Adverse Event|0
5956612|NCT01224639|20600950|P4|Overall Study|Adverse Event|0
5956613|NCT01224639|20600951|P3|Overall Study|Adverse Event|0
5956614|NCT01224639|20600952|P2|Overall Study|Adverse Event|0
5956615|NCT01224639|20600953|P1|Overall Study|Adverse Event|0
5956616|NCT01224639|20600946|P8|Overall Study|Withdrawal by Subject|1
5956617|NCT01224639|20600947|P7|Overall Study|Withdrawal by Subject|1
5956618|NCT01224639|20600948|P6|Overall Study|Withdrawal by Subject|0
5956619|NCT01224639|20600949|P5|Overall Study|Withdrawal by Subject|2
5956620|NCT01224639|20600950|P4|Overall Study|Withdrawal by Subject|0
5956621|NCT01224639|20600951|P3|Overall Study|Withdrawal by Subject|0
5956622|NCT01224639|20600952|P2|Overall Study|Withdrawal by Subject|0
5956623|NCT01224639|20600953|P1|Overall Study|Withdrawal by Subject|0
5956624|NCT01224431|20601071|P2|Overall Study|no video record|1
5956625|NCT01224431|20601072|P1|Overall Study|no video record|0
5956626|NCT01224431|20601071|P2|Overall Study|not randomized|4
5956627|NCT01224431|20601072|P1|Overall Study|not randomized|0
5956628|NCT01224171|20601098|P2|Overall Study|Lost to Follow-up|3
5956629|NCT01224171|20601099|P1|Overall Study|Lost to Follow-up|0
5956630|NCT01224171|20601098|P2|Overall Study|Withdrawal of Consent|4
5956631|NCT01224171|20601099|P1|Overall Study|Withdrawal of Consent|2
5956632|NCT01224171|20601098|P2|Overall Study|Lack of Efficacy|1
5956633|NCT01224171|20601099|P1|Overall Study|Lack of Efficacy|5
5956634|NCT01224171|20601098|P2|Overall Study|Protocol Violation|1
5956635|NCT01224171|20601099|P1|Overall Study|Protocol Violation|0
5956636|NCT01224171|20601098|P2|Overall Study|Adverse Event|4
5956637|NCT01224171|20601099|P1|Overall Study|Adverse Event|8
5956638|NCT01224158|20601121|P2|Overall Study|Withdrawal by Subject|0
5956639|NCT01224158|20601122|P1|Overall Study|Withdrawal by Subject|1
5956640|NCT01223937|20601166|P2|Overall Study|Other|1
5956641|NCT01223937|20601167|P1|Overall Study|Other|4
5956642|NCT01223937|20601166|P2|Overall Study|Protocol Violation|7
5956643|NCT01223937|20601167|P1|Overall Study|Protocol Violation|8
5956644|NCT01223937|20601166|P2|Overall Study|Adverse Event|4
5956645|NCT01223937|20601167|P1|Overall Study|Adverse Event|1
5956646|NCT01223937|20601166|P2|Overall Study|Lost to Follow-up|4
5956647|NCT01223937|20601167|P1|Overall Study|Lost to Follow-up|1
5956648|NCT01223937|20601166|P2|Overall Study|Withdrawal by Subject|2
5956649|NCT01223937|20601167|P1|Overall Study|Withdrawal by Subject|3
5956650|NCT01223404|20601213|P6|Third Intervention (1 Day)|Non-compliance (slept)|0
5956651|NCT01223404|20601214|P5|Third Intervention (1 Day)|Non-compliance (slept)|0
5956652|NCT01223404|20601215|P4|Third Intervention (1 Day)|Non-compliance (slept)|1
5956653|NCT01223404|20601216|P3|Third Intervention (1 Day)|Non-compliance (slept)|0
5956654|NCT01223404|20601217|P2|Third Intervention (1 Day)|Non-compliance (slept)|0
5956655|NCT01223404|20601218|P1|Third Intervention (1 Day)|Non-compliance (slept)|0
5956656|NCT01223404|20601213|P6|Second Intervention (1 Day)|Adverse Event|0
5956657|NCT01223404|20601214|P5|Second Intervention (1 Day)|Adverse Event|0
5956658|NCT01223404|20601215|P4|Second Intervention (1 Day)|Adverse Event|0
5956659|NCT01223404|20601216|P3|Second Intervention (1 Day)|Adverse Event|0
5956660|NCT01223404|20601217|P2|Second Intervention (1 Day)|Adverse Event|0
5956661|NCT01223404|20601218|P1|Second Intervention (1 Day)|Adverse Event|1
5956662|NCT01223404|20601213|P6|First Intervention (1 Day)|Adverse Event|0
5956663|NCT01223404|20601214|P5|First Intervention (1 Day)|Adverse Event|0
5956664|NCT01223404|20601215|P4|First Intervention (1 Day)|Adverse Event|1
5956665|NCT01223404|20601216|P3|First Intervention (1 Day)|Adverse Event|0
5956666|NCT01223404|20601217|P2|First Intervention (1 Day)|Adverse Event|0
5956667|NCT01223404|20601218|P1|First Intervention (1 Day)|Adverse Event|0
5956668|NCT01223365|20601282|P1|Open-label Treatment Period|Physician Decision|2
5956669|NCT01223365|20601282|P1|Open-label Treatment Period|Starting physical therapy|1
5956670|NCT01223365|20601282|P1|Open-label Treatment Period|"Out of window"|1
5956671|NCT01223365|20601282|P1|Open-label Treatment Period|Negative urine drug screen when on treat|1
5956672|NCT01223365|20601282|P1|Open-label Treatment Period|Moved out of area|2
5956673|NCT01223365|20601282|P1|Open-label Treatment Period|Noncompliance with study procedures|6
5956674|NCT01223365|20601282|P1|Open-label Treatment Period|Noncompliance with study drug admin|7
5956675|NCT01223365|20601282|P1|Open-label Treatment Period|Lost to Follow-up|7
5956676|NCT01223365|20601282|P1|Open-label Treatment Period|Protocol Violation|15
5956677|NCT01223365|20601282|P1|Open-label Treatment Period|Withdrawal by Subject|19
5956678|NCT01223365|20601282|P1|Open-label Treatment Period|Lack of Efficacy|2
5956679|NCT01223365|20601282|P1|Open-label Treatment Period|Adverse Event|39
5956680|NCT01223365|20601282|P1|Open-label Titration Period|Starting physical therapy|1
5956681|NCT01223365|20601282|P1|Open-label Titration Period|Noncompliance with study procedures|2
5956682|NCT01223365|20601282|P1|Open-label Titration Period|Noncompliance with study drug admin|1
5956683|NCT01223365|20601282|P1|Open-label Titration Period|Lost to Follow-up|2
5956684|NCT01223365|20601282|P1|Open-label Titration Period|Protocol Violation|1
5956685|NCT01223365|20601282|P1|Open-label Titration Period|Withdrawal by Subject|5
5956686|NCT01223365|20601282|P1|Open-label Titration Period|Lack of Efficacy|3
5956687|NCT01223365|20601282|P1|Open-label Titration Period|Adverse Event|23
5956688|NCT01223365|20601282|P1|Open-label Titration Period|Enrolled but not treated|1
5956689|NCT01223235|20601346|P1|Overall Study|Withdrawal by Subject|1
5956690|NCT01223196|20601354|P2|Overall Study|Withdrawal by Subject|0
5956691|NCT01223196|20601355|P1|Overall Study|Withdrawal by Subject|1
5956692|NCT01223196|20601354|P2|Overall Study|Physician Decision|0
5956693|NCT01223196|20601355|P1|Overall Study|Physician Decision|1
5956694|NCT01223196|20601354|P2|Overall Study|Lost to Follow-up|0
5956695|NCT01223196|20601355|P1|Overall Study|Lost to Follow-up|2
5956696|NCT01223183|20601367|P2|Washout Period (5-24 Days)|Physician Decision|0
5956697|NCT01223183|20601368|P1|Washout Period (5-24 Days)|Physician Decision|1
5956698|NCT01223183|20601367|P2|Washout Period (5-24 Days)|Lost to Follow-up|0
5956699|NCT01223183|20601368|P1|Washout Period (5-24 Days)|Lost to Follow-up|1
5956700|NCT01223183|20601367|P2|Imaging Day 1|Physician Decision|1
5956701|NCT01223183|20601368|P1|Imaging Day 1|Physician Decision|0
5956702|NCT01223027|20601378|P2|Overall Study|Study terminated by sponsor|8
5956703|NCT01223027|20601379|P1|Overall Study|Study terminated by sponsor|2
5956704|NCT01223027|20601378|P2|Overall Study|New therapy for study indication|8
5956705|NCT01223027|20601379|P1|Overall Study|New therapy for study indication|17
5956706|NCT01223027|20601378|P2|Overall Study|Subject/guardian decicion|16
5956707|NCT01223027|20601379|P1|Overall Study|Subject/guardian decicion|18
5956708|NCT01223027|20601378|P2|Overall Study|Protocol Violation|1
5956709|NCT01223027|20601379|P1|Overall Study|Protocol Violation|2
5956710|NCT01223027|20601378|P2|Overall Study|Progressive Disease|183
5956711|NCT01223027|20601379|P1|Overall Study|Progressive Disease|167
5956712|NCT01223027|20601378|P2|Overall Study|Physician Decision|8
5956713|NCT01223027|20601379|P1|Overall Study|Physician Decision|4
5956714|NCT01223027|20601378|P2|Overall Study|Lost to Follow-up|1
5956715|NCT01223027|20601379|P1|Overall Study|Lost to Follow-up|2
5956716|NCT01223027|20601378|P2|Overall Study|Death|42
5956717|NCT01223027|20601379|P1|Overall Study|Death|42
5956718|NCT01223027|20601378|P2|Overall Study|Adverse Event|10
5956719|NCT01223027|20601379|P1|Overall Study|Adverse Event|20
5956720|NCT01222715|20601441|P2|Overall Study|Surgery or radiation therapy in 1st 6 wk|0
5956721|NCT01222715|20601442|P1|Overall Study|Surgery or radiation therapy in 1st 6 wk|1
5956722|NCT01222715|20601441|P2|Overall Study|Ineligible|1
5956723|NCT01222715|20601442|P1|Overall Study|Ineligible|0
5956724|NCT01222715|20601441|P2|Overall Study|Pt cannot receive treatment for >9 wks|1
5956725|NCT01222715|20601442|P1|Overall Study|Pt cannot receive treatment for >9 wks|1
5956726|NCT01222715|20601441|P2|Overall Study|Refusal of further protocol therapy|4
5956727|NCT01222715|20601442|P1|Overall Study|Refusal of further protocol therapy|0
5956728|NCT01222715|20601441|P2|Overall Study|Physician Decision|2
5956729|NCT01222715|20601442|P1|Overall Study|Physician Decision|12
5956730|NCT01222715|20601441|P2|Overall Study|Lack of Efficacy|14
5956731|NCT01222715|20601442|P1|Overall Study|Lack of Efficacy|22
5956732|NCT01222715|20601441|P2|Overall Study|Death|1
5956733|NCT01222715|20601442|P1|Overall Study|Death|0
5956734|NCT01222715|20601441|P2|Overall Study|Adverse Event|4
5956735|NCT01222715|20601442|P1|Overall Study|Adverse Event|0
5956736|NCT01222533|20601481|P1|Overall Study|Other|4
5956737|NCT01222533|20601481|P1|Overall Study|Withdrawal by Subject|5
5956738|NCT01222533|20601481|P1|Overall Study|Adverse Event|5
5956739|NCT01222520|20601620|P2|Double-blind Period|Study medication stolen|0
5956740|NCT01222520|20601621|P1|Double-blind Period|Study medication stolen|1
5956741|NCT01222520|20601620|P2|Double-blind Period|Lack of Efficacy|1
5956742|NCT01222520|20601621|P1|Double-blind Period|Lack of Efficacy|0
5956743|NCT01222520|20601620|P2|Double-blind Period|Adverse Event|1
5956744|NCT01222520|20601621|P1|Double-blind Period|Adverse Event|0
5956745|NCT01222520|20601620|P2|Open-label run-in Period|Number of patients fulfilled|3
5956746|NCT01222520|20601621|P1|Open-label run-in Period|Number of patients fulfilled|0
5956747|NCT01222520|20601620|P2|Open-label run-in Period|Blood pressure criteria not met|18
5956748|NCT01222520|20601621|P1|Open-label run-in Period|Blood pressure criteria not met|0
5956749|NCT01222520|20601620|P2|Open-label run-in Period|Withdrawal by Subject|2
5956750|NCT01222520|20601621|P1|Open-label run-in Period|Withdrawal by Subject|0
5956751|NCT01222507|20601639|P1|Overall Study|Withdrawal by Subject|1
5956752|NCT01222507|20601639|P1|Overall Study|Physician Decision|1
5956753|NCT01222416|20601667|P2|Overall Study|Death|0
5956754|NCT01222416|20601668|P1|Overall Study|Death|1
5956755|NCT01222416|20601667|P2|Overall Study|missed view/scan|0
5956756|NCT01222416|20601668|P1|Overall Study|missed view/scan|1
5956757|NCT01222416|20601667|P2|Overall Study|scheduling|0
5956758|NCT01222416|20601668|P1|Overall Study|scheduling|6
5956759|NCT01222416|20601667|P2|Overall Study|Withdrawal by Subject|0
5956760|NCT01222416|20601668|P1|Overall Study|Withdrawal by Subject|5
5956761|NCT01222416|20601667|P2|Overall Study|Adverse Event|0
5956762|NCT01222416|20601668|P1|Overall Study|Adverse Event|4
5956763|NCT01222416|20601667|P2|Overall Study|ineligible;metastasis|0
5956764|NCT01222416|20601668|P1|Overall Study|ineligible;metastasis|3
5956765|NCT01222403|20601678|P2|Overall Study|Inappropriate enrollment|2
5956766|NCT01222403|20601679|P1|Overall Study|Inappropriate enrollment|0
5956767|NCT01222247|20601740|P2|Overall Study|Lost to Follow-up|2
5956768|NCT01222247|20601741|P1|Overall Study|Lost to Follow-up|2
5956769|NCT01222104|20601877|P1|Overall Study|Death|10
5956770|NCT01222104|20601877|P1|Overall Study|Lost to Follow-up|37
5956771|NCT01222078|20601900|P1|Overall Study|Early termination of the study|1
5956772|NCT01221948|20601934|P1|Overall Study|Protocol Violation|4
5956773|NCT01221948|20601934|P1|Overall Study|Death|1
5956774|NCT01221948|20601934|P1|Overall Study|not disclosed|2
5956775|NCT01221948|20601934|P1|Overall Study|Withdrawal by Subject|2
5956776|NCT01221948|20601934|P1|Overall Study|Physician Decision|5
5956777|NCT01221753|20601953|P1|Overall Study|Adverse Event|1
5956778|NCT01221727|20601960|P2|Overall Study|Withdrawal by Subject|1
5956779|NCT01221727|20601961|P1|Overall Study|Withdrawal by Subject|1
5956780|NCT01221727|20601960|P2|Overall Study|Physician Decision|0
5956781|NCT01221727|20601961|P1|Overall Study|Physician Decision|2
5956782|NCT01221623|20601982|P2|Overall Study|Other|2
5956783|NCT01221623|20601983|P1|Overall Study|Other|5
5956784|NCT01221623|20601982|P2|Overall Study|Death|0
5956785|NCT01221623|20601983|P1|Overall Study|Death|1
5956786|NCT01221623|20601982|P2|Overall Study|Adverse Event|3
5956787|NCT01221623|20601983|P1|Overall Study|Adverse Event|6
5956788|NCT01221623|20601982|P2|Overall Study|Lost to Follow-up|1
5956789|NCT01221623|20601983|P1|Overall Study|Lost to Follow-up|7
5956790|NCT01221623|20601982|P2|Overall Study|Withdrawal by Subject|8
5956791|NCT01221623|20601983|P1|Overall Study|Withdrawal by Subject|19
5956792|NCT01221597|20602007|P2|Overall Study|Death|0
5956793|NCT01221597|20602008|P1|Overall Study|Death|2
5956794|NCT01221597|20602007|P2|Overall Study|Other|4
5956795|NCT01221597|20602008|P1|Overall Study|Other|3
5956796|NCT01221597|20602007|P2|Overall Study|Protocol Violation|0
5956797|NCT01221597|20602008|P1|Overall Study|Protocol Violation|1
5956798|NCT01221597|20602007|P2|Overall Study|Lost to Follow-up|5
5956799|NCT01221597|20602008|P1|Overall Study|Lost to Follow-up|6
5956800|NCT01221597|20602007|P2|Overall Study|Withdrawal by Subject|6
5956801|NCT01221597|20602008|P1|Overall Study|Withdrawal by Subject|20
5956802|NCT01221597|20602007|P2|Overall Study|Adverse Event|1
5956803|NCT01221597|20602008|P1|Overall Study|Adverse Event|4
5956804|NCT01221363|20602065|P2|Overall Study|Withdrawal by Subject|5
5956805|NCT01221363|20602066|P1|Overall Study|Withdrawal by Subject|11
5956806|NCT01221363|20602065|P2|Overall Study|Pregnancy|0
5956807|NCT01221363|20602066|P1|Overall Study|Pregnancy|1
5956808|NCT01221350|20602076|P2|Overall Study|Withdrawal by Subject|2
5956809|NCT01221350|20602077|P1|Overall Study|Withdrawal by Subject|4
5956810|NCT01221350|20602076|P2|Overall Study|Exclusion criteria, asthma exacerbation|1
5956811|NCT01221350|20602077|P1|Overall Study|Exclusion criteria, asthma exacerbation|0
5956812|NCT01221350|20602076|P2|Overall Study|Discontinued intervention (GERD)|0
5956813|NCT01221350|20602077|P1|Overall Study|Discontinued intervention (GERD)|1
5956814|NCT01221285|20602136|P1|Overall Study|Withdrawal by Subject|1
5956815|NCT01221272|20602145|P2|Period 2|Adverse Event|2
5956816|NCT01221272|20602146|P1|Period 2|Adverse Event|0
5956817|NCT01221272|20602145|P2|Period 1|Significant Dosing Noncompliance|1
5956818|NCT01221272|20602146|P1|Period 1|Significant Dosing Noncompliance|0
5956819|NCT01221272|20602145|P2|Period 1|Consent Withdrawal|1
5956820|NCT01221272|20602146|P1|Period 1|Consent Withdrawal|0
5956821|NCT01221272|20602145|P2|Period 1|Adverse Event|0
5956822|NCT01221272|20602146|P1|Period 1|Adverse Event|2
5956823|NCT01221233|20602163|P2|Overall Study|Withdrawal by Subject|1
5956824|NCT01221233|20602164|P1|Overall Study|Withdrawal by Subject|3
5956825|NCT01221181|20602192|P1|Overall Study|Lost to Follow-up|1
5956826|NCT01221090|20602200|P4|Overall Study|Withdrawal by Subject|2
5956827|NCT01221090|20602201|P3|Overall Study|Withdrawal by Subject|27
5956828|NCT01221090|20602202|P2|Overall Study|Withdrawal by Subject|22
5956829|NCT01221090|20602203|P1|Overall Study|Withdrawal by Subject|0
5956830|NCT01221090|20602200|P4|Overall Study|Non-Compliant or Unable to Contact|20
5956831|NCT01221090|20602201|P3|Overall Study|Non-Compliant or Unable to Contact|15
5956832|NCT01221090|20602202|P2|Overall Study|Non-Compliant or Unable to Contact|12
5956833|NCT01221090|20602203|P1|Overall Study|Non-Compliant or Unable to Contact|15
5956834|NCT01220999|20602234|P5|Overall Study|Progressive disease|0
5956835|NCT01220999|20602235|P4|Overall Study|Progressive disease|0
5956836|NCT01220999|20602236|P3|Overall Study|Progressive disease|1
5956837|NCT01220999|20602237|P2|Overall Study|Progressive disease|0
5956838|NCT01220999|20602238|P1|Overall Study|Progressive disease|0
5956839|NCT01220609|20602388|P1|Overall Study|Ineligible-Never treated|1
5956840|NCT01220609|20602388|P1|Overall Study|Ineligible- Wrong cell type|1
5956841|NCT01220609|20602388|P1|Overall Study|Ineligible-Wrong primary cancer site|1
5956842|NCT01220557|20602402|P2|Overall Study|attended less than 6 lessons|2
5956843|NCT01220557|20602403|P1|Overall Study|attended less than 6 lessons|1
5956844|NCT01220557|20602402|P2|Overall Study|Lost to Follow-up|3
5956845|NCT01220557|20602403|P1|Overall Study|Lost to Follow-up|5
5956846|NCT01220414|20602436|P4|Overall Study|Withdrawal by Subject|1
5956847|NCT01220414|20602437|P3|Overall Study|Withdrawal by Subject|0
5956848|NCT01220414|20602438|P2|Overall Study|Withdrawal by Subject|0
5956849|NCT01220414|20602439|P1|Overall Study|Withdrawal by Subject|1
5956850|NCT01220401|20602446|P1|Overall Study|Protocol Violation|1
5956851|NCT01220401|20602446|P1|Overall Study|Withdrawal by Subject|2
5956852|NCT01220297|20602455|P1|Overall Study|Lost to Follow-up|1
5956853|NCT01220297|20602455|P1|Overall Study|Death|2
5956854|NCT01220180|20602472|P1|Overall Study|Randomized but not treated|1
5956855|NCT01220180|20602472|P1|Overall Study|Death|1
5956856|NCT01220180|20602472|P1|Overall Study|Lack of Efficacy|22
5956857|NCT01220180|20602472|P1|Overall Study|Adverse Event|35
5956858|NCT01220180|20602472|P1|Overall Study|Other|72
5956859|NCT01220180|20602472|P1|Overall Study|Lost to Follow-up|76
5956860|NCT01220167|20602498|P3|Period 3|Urine positive for substance abuse|0
5956861|NCT01220167|20602499|P2|Period 3|Urine positive for substance abuse|1
5956862|NCT01220167|20602500|P1|Period 3|Urine positive for substance abuse|0
5956863|NCT01220128|20602513|P7|Overall Study|Consent withdrawn by subject|0
5956864|NCT01220128|20602514|P6|Overall Study|Consent withdrawn by subject|0
5956865|NCT01220128|20602515|P5|Overall Study|Consent withdrawn by subject|0
5956866|NCT01220128|20602516|P4|Overall Study|Consent withdrawn by subject|0
5956867|NCT01220128|20602517|P3|Overall Study|Consent withdrawn by subject|0
5956868|NCT01220128|20602518|P2|Overall Study|Consent withdrawn by subject|0
5956869|NCT01220128|20602519|P1|Overall Study|Consent withdrawn by subject|1
5956870|NCT01220128|20602513|P7|Overall Study|Other|0
5956871|NCT01220128|20602514|P6|Overall Study|Other|0
5956872|NCT01220128|20602515|P5|Overall Study|Other|0
5956873|NCT01220128|20602516|P4|Overall Study|Other|0
5956874|NCT01220128|20602517|P3|Overall Study|Other|1
5956875|NCT01220128|20602518|P2|Overall Study|Other|0
5956876|NCT01220128|20602519|P1|Overall Study|Other|0
5956877|NCT01220128|20602513|P7|Overall Study|Adverse event, non-fatal|3
5956878|NCT01220128|20602514|P6|Overall Study|Adverse event, non-fatal|0
5956879|NCT01220128|20602515|P5|Overall Study|Adverse event, non-fatal|0
5956880|NCT01220128|20602516|P4|Overall Study|Adverse event, non-fatal|0
5956881|NCT01220128|20602517|P3|Overall Study|Adverse event, non-fatal|0
5956882|NCT01220128|20602518|P2|Overall Study|Adverse event, non-fatal|0
5956883|NCT01220128|20602519|P1|Overall Study|Adverse event, non-fatal|1
5956884|NCT01220128|20602513|P7|Overall Study|Adverse event, serious fatal|1
5956885|NCT01220128|20602514|P6|Overall Study|Adverse event, serious fatal|0
5956886|NCT01220128|20602515|P5|Overall Study|Adverse event, serious fatal|0
5956887|NCT01220128|20602516|P4|Overall Study|Adverse event, serious fatal|0
5956888|NCT01220128|20602517|P3|Overall Study|Adverse event, serious fatal|0
5956889|NCT01220128|20602518|P2|Overall Study|Adverse event, serious fatal|0
5956890|NCT01220128|20602519|P1|Overall Study|Adverse event, serious fatal|2
5956891|NCT01220128|20602513|P7|Overall Study|Sponsor study termination|1
5956892|NCT01220128|20602514|P6|Overall Study|Sponsor study termination|0
5956893|NCT01220128|20602515|P5|Overall Study|Sponsor study termination|0
5956894|NCT01220128|20602516|P4|Overall Study|Sponsor study termination|0
5956895|NCT01220128|20602517|P3|Overall Study|Sponsor study termination|0
5956896|NCT01220128|20602518|P2|Overall Study|Sponsor study termination|1
5956897|NCT01220128|20602519|P1|Overall Study|Sponsor study termination|0
5956898|NCT01220128|20602513|P7|Overall Study|Progressive disease|0
5956899|NCT01220128|20602514|P6|Overall Study|Progressive disease|0
5956900|NCT01220128|20602515|P5|Overall Study|Progressive disease|0
5956901|NCT01220128|20602516|P4|Overall Study|Progressive disease|0
5956902|NCT01220128|20602517|P3|Overall Study|Progressive disease|2
5956903|NCT01220128|20602518|P2|Overall Study|Progressive disease|0
5956904|NCT01220128|20602519|P1|Overall Study|Progressive disease|0
5956905|NCT01219985|20602724|P1|Overall Study|Physician Decision|20
5956906|NCT01219959|20602732|P2|Overall Study|Other|0
5956907|NCT01219959|20602733|P1|Overall Study|Other|1
5956908|NCT01219959|20602732|P2|Overall Study|Renal Transplantation|3
5956909|NCT01219959|20602733|P1|Overall Study|Renal Transplantation|0
5956910|NCT01219959|20602732|P2|Overall Study|Withdrawal by Subject|2
5956911|NCT01219959|20602733|P1|Overall Study|Withdrawal by Subject|0
5956912|NCT01219959|20602732|P2|Overall Study|Physician Decision|4
5956913|NCT01219959|20602733|P1|Overall Study|Physician Decision|0
5956914|NCT01219959|20602732|P2|Overall Study|Adverse Event|14
5956915|NCT01219959|20602733|P1|Overall Study|Adverse Event|6
5956916|NCT01219933|20602781|P1|Overall Study|Lack of Efficacy|1
5956917|NCT01219933|20602781|P1|Overall Study|Protocol Violation|8
5956918|NCT01219933|20602781|P1|Overall Study|Withdrawal by Subject|5
5956919|NCT01219933|20602781|P1|Overall Study|GC free|1
5956920|NCT01219933|20602781|P1|Overall Study|Lost to Follow-up|3
5956921|NCT01219933|20602781|P1|Overall Study|No LDA maintained|7
5956922|NCT01219933|20602781|P1|Overall Study|No LDA reached|5
5956923|NCT01219933|20602781|P1|Overall Study|Adverse Event|8
5956924|NCT01218867|20602991|P11|Overall Study|Death during treatment|0
5956925|NCT01218867|20602992|P10|Overall Study|Death during treatment|0
5956926|NCT01218867|20602993|P9|Overall Study|Death during treatment|0
5956927|NCT01218867|20602994|P8|Overall Study|Death during treatment|0
5956928|NCT01218867|20602995|P7|Overall Study|Death during treatment|1
5956929|NCT01218867|20602996|P6|Overall Study|Death during treatment|0
5956930|NCT01218867|20602997|P5|Overall Study|Death during treatment|0
5956931|NCT01218867|20602998|P4|Overall Study|Death during treatment|0
5956932|NCT01218867|20602999|P3|Overall Study|Death during treatment|0
5956933|NCT01218867|20603000|P2|Overall Study|Death during treatment|0
5956934|NCT01218867|20603001|P1|Overall Study|Death during treatment|0
5956935|NCT01218802|20603049|P2|Overall Study|Incarcerated|0
5956936|NCT01218802|20603050|P1|Overall Study|Incarcerated|2
5956937|NCT01218802|20603049|P2|Overall Study|Adverse Event|2
5956938|NCT01218802|20603050|P1|Overall Study|Adverse Event|0
5956939|NCT01218802|20603049|P2|Overall Study|Withdrawal by Subject|10
5956940|NCT01218802|20603050|P1|Overall Study|Withdrawal by Subject|3
5956941|NCT01218802|20603049|P2|Overall Study|Lost to Follow-up|6
5956942|NCT01218802|20603050|P1|Overall Study|Lost to Follow-up|5
5956943|NCT01218659|20603087|P3|12-Month OLE|Declined to participate in the OLE|4
5956944|NCT01218659|20603088|P2|12-Month OLE|Declined to participate in the OLE|0
5956945|NCT01218659|20603089|P1|12-Month OLE|Declined to participate in the OLE|0
5956946|NCT01218659|20603087|P3|12-Month OLE|Lack of Efficacy|1
5956947|NCT01218659|20603088|P2|12-Month OLE|Lack of Efficacy|0
5956948|NCT01218659|20603089|P1|12-Month OLE|Lack of Efficacy|0
5956949|NCT01218659|20603087|P3|12-Month OLE|Pregnancy|1
5956950|NCT01218659|20603088|P2|12-Month OLE|Pregnancy|0
5956951|NCT01218659|20603089|P1|12-Month OLE|Pregnancy|0
5956952|NCT01218659|20603087|P3|12-Month OLE|Lost to Follow-up|1
5956953|NCT01218659|20603088|P2|12-Month OLE|Lost to Follow-up|0
5956954|NCT01218659|20603089|P1|12-Month OLE|Lost to Follow-up|0
5956955|NCT01218659|20603087|P3|12-Month OLE|Physician Decision|1
5956956|NCT01218659|20603088|P2|12-Month OLE|Physician Decision|0
5956957|NCT01218659|20603089|P1|12-Month OLE|Physician Decision|0
5956958|NCT01218659|20603087|P3|12-Month OLE|Withdrawal by Subject|2
5956959|NCT01218659|20603088|P2|12-Month OLE|Withdrawal by Subject|0
5956960|NCT01218659|20603089|P1|12-Month OLE|Withdrawal by Subject|0
5956961|NCT01218659|20603087|P3|18-Month Randomized Period|Did not receive study drug|0
5956962|NCT01218659|20603088|P2|18-Month Randomized Period|Did not receive study drug|3
5956963|NCT01218659|20603089|P1|18-Month Randomized Period|Did not receive study drug|0
5956964|NCT01218659|20603087|P3|18-Month Randomized Period|Withdrawal by Subject|0
5956965|NCT01218659|20603088|P2|18-Month Randomized Period|Withdrawal by Subject|3
5956966|NCT01218659|20603089|P1|18-Month Randomized Period|Withdrawal by Subject|2
5956967|NCT01218646|20603104|P4|Overall Study|Protocol Violation|1
5956968|NCT01218646|20603105|P3|Overall Study|Protocol Violation|1
5956969|NCT01218646|20603106|P2|Overall Study|Protocol Violation|0
5956970|NCT01218646|20603107|P1|Overall Study|Protocol Violation|0
5956971|NCT01218646|20603104|P4|Overall Study|Lost to Follow-up|0
5956972|NCT01218646|20603105|P3|Overall Study|Lost to Follow-up|0
5956973|NCT01218646|20603106|P2|Overall Study|Lost to Follow-up|0
5956974|NCT01218646|20603107|P1|Overall Study|Lost to Follow-up|1
5956975|NCT01218646|20603104|P4|Overall Study|Adverse Event|0
5956976|NCT01218646|20603105|P3|Overall Study|Adverse Event|1
5956977|NCT01218646|20603106|P2|Overall Study|Adverse Event|0
5956978|NCT01218646|20603107|P1|Overall Study|Adverse Event|0
5956979|NCT01218594|20603145|P1|Overall Study|Physician Decision|6
5956980|NCT01218594|20603145|P1|Overall Study|Adverse Event|2
5956981|NCT01218594|20603145|P1|Overall Study|Withdrawal by Subject|3
5956982|NCT01218594|20603145|P1|Overall Study|Death|1
5956983|NCT01218516|20603151|P4|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|0
5956984|NCT01218516|20603152|P3|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|0
5956985|NCT01218516|20603153|P2|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|1
5956986|NCT01218516|20603154|P1|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|1
5956987|NCT01218516|20603151|P4|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|0
5956988|NCT01218516|20603152|P3|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|0
5956989|NCT01218516|20603153|P2|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|3
5956990|NCT01218516|20603154|P1|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|2
5956991|NCT01218516|20603151|P4|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0
5956992|NCT01218516|20603152|P3|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0
5956993|NCT01218516|20603153|P2|Combination Therapy (up to 4.5 Months)|Toxicity to TA|1
5956994|NCT01218516|20603154|P1|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0
5956995|NCT01218516|20603151|P4|Combination Therapy (up to 4.5 Months)|Other|0
5956996|NCT01218516|20603152|P3|Combination Therapy (up to 4.5 Months)|Other|0
5956997|NCT01218516|20603153|P2|Combination Therapy (up to 4.5 Months)|Other|4
5956998|NCT01218516|20603154|P1|Combination Therapy (up to 4.5 Months)|Other|3
5956999|NCT01218516|20603151|P4|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0
5957000|NCT01218516|20603152|P3|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0
5957001|NCT01218516|20603153|P2|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|3
5957002|NCT01218516|20603154|P1|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0
5957003|NCT01218516|20603151|P4|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0
5957004|NCT01218516|20603152|P3|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0
5957005|NCT01218516|20603153|P2|Combination Therapy (up to 4.5 Months)|Withdrew Consent|1
5957006|NCT01218516|20603154|P1|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0
5957007|NCT01218516|20603151|P4|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0
5957008|NCT01218516|20603152|P3|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0
5957009|NCT01218516|20603153|P2|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|1
5957010|NCT01218516|20603154|P1|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0
5957011|NCT01218516|20603151|P4|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|0
5957012|NCT01218516|20603152|P3|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|0
5957013|NCT01218516|20603153|P2|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|15
5957014|NCT01218516|20603154|P1|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|17
5957015|NCT01218516|20603151|P4|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0
5957016|NCT01218516|20603152|P3|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0
5957017|NCT01218516|20603153|P2|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0
5957018|NCT01218516|20603154|P1|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|2
5957019|NCT01218516|20603151|P4|Combination Therapy (up to 4.5 Months)|Physician Decision|0
5957020|NCT01218516|20603152|P3|Combination Therapy (up to 4.5 Months)|Physician Decision|0
5957021|NCT01218516|20603153|P2|Combination Therapy (up to 4.5 Months)|Physician Decision|2
5957022|NCT01218516|20603154|P1|Combination Therapy (up to 4.5 Months)|Physician Decision|2
5957023|NCT01218516|20603151|P4|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0
5957024|NCT01218516|20603152|P3|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0
5957025|NCT01218516|20603153|P2|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|3
5957026|NCT01218516|20603154|P1|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0
5957027|NCT01218516|20603151|P4|Combination Therapy (up to 4.5 Months)|Death|0
5957028|NCT01218516|20603152|P3|Combination Therapy (up to 4.5 Months)|Death|0
5957029|NCT01218516|20603153|P2|Combination Therapy (up to 4.5 Months)|Death|1
5957030|NCT01218516|20603154|P1|Combination Therapy (up to 4.5 Months)|Death|2
5957031|NCT01218477|20603176|P4|Overall Study|Maximum clinical benefit|0
5957032|NCT01218477|20603177|P3|Overall Study|Maximum clinical benefit|0
5957033|NCT01218477|20603178|P2|Overall Study|Maximum clinical benefit|2
5957034|NCT01218477|20603179|P1|Overall Study|Maximum clinical benefit|0
5957035|NCT01218477|20603176|P4|Overall Study|Administrative reason by sponsor|0
5957036|NCT01218477|20603177|P3|Overall Study|Administrative reason by sponsor|1
5957037|NCT01218477|20603178|P2|Overall Study|Administrative reason by sponsor|0
5957038|NCT01218477|20603179|P1|Overall Study|Administrative reason by sponsor|0
5957039|NCT01218477|20603176|P4|Overall Study|Prepared for cell transplantation|0
5957040|NCT01218477|20603177|P3|Overall Study|Prepared for cell transplantation|1
5957041|NCT01218477|20603178|P2|Overall Study|Prepared for cell transplantation|1
5957042|NCT01218477|20603179|P1|Overall Study|Prepared for cell transplantation|0
5957043|NCT01218477|20603176|P4|Overall Study|Withdrawal by Subject|0
5957044|NCT01218477|20603177|P3|Overall Study|Withdrawal by Subject|1
5957045|NCT01218477|20603178|P2|Overall Study|Withdrawal by Subject|0
5957046|NCT01218477|20603179|P1|Overall Study|Withdrawal by Subject|0
5957047|NCT01218477|20603176|P4|Overall Study|No longer meets study criteria|0
5957048|NCT01218477|20603177|P3|Overall Study|No longer meets study criteria|0
5957049|NCT01218477|20603178|P2|Overall Study|No longer meets study criteria|0
5957050|NCT01218477|20603179|P1|Overall Study|No longer meets study criteria|1
5957051|NCT01218477|20603176|P4|Overall Study|Study drug toxicity|0
5957052|NCT01218477|20603177|P3|Overall Study|Study drug toxicity|5
5957053|NCT01218477|20603178|P2|Overall Study|Study drug toxicity|2
5957054|NCT01218477|20603179|P1|Overall Study|Study drug toxicity|0
5957055|NCT01218477|20603176|P4|Overall Study|Disease progression|2
5957056|NCT01218477|20603177|P3|Overall Study|Disease progression|6
5957057|NCT01218477|20603178|P2|Overall Study|Disease progression|3
5957058|NCT01218477|20603179|P1|Overall Study|Disease progression|2
5957059|NCT01218438|20603196|P1|Epoch 4|Withdrawal by Subject|2
5957060|NCT01218438|20603196|P1|Epoch 4|Physician Decision|1
5957061|NCT01218438|20603196|P1|Epoch 3|Adverse Event|1
5957062|NCT01218438|20603196|P1|Epoch 3|Withdrawal by Subject|3
5957063|NCT01218438|20603196|P1|Epoch 1|Adverse Event|1
5957064|NCT01218438|20603196|P1|Epoch 1|Physician Decision|2
5957065|NCT01218308|20603362|P2|Overall Study|Other|21
5957066|NCT01218308|20603363|P1|Overall Study|Other|14
5957067|NCT01218308|20603362|P2|Overall Study|Lost to Follow-up|31
5957068|NCT01218308|20603363|P1|Overall Study|Lost to Follow-up|27
5957069|NCT01218308|20603362|P2|Overall Study|Withdrawal by Subject|64
5957070|NCT01218308|20603363|P1|Overall Study|Withdrawal by Subject|61
5957071|NCT01218308|20603362|P2|Overall Study|Protocol Violation|2
5957072|NCT01218308|20603363|P1|Overall Study|Protocol Violation|0
5957073|NCT01218308|20603362|P2|Overall Study|Adverse Event|2
5957074|NCT01218308|20603363|P1|Overall Study|Adverse Event|1
5957075|NCT01218243|20603407|P2|Overall Study|Protocol Violation|10
5957076|NCT01218243|20603408|P1|Overall Study|Protocol Violation|5
5957077|NCT01218243|20603407|P2|Overall Study|Lost to Follow-up|3
5957078|NCT01218243|20603408|P1|Overall Study|Lost to Follow-up|3
5957079|NCT01218243|20603407|P2|Overall Study|Lack of Efficacy|1
5957080|NCT01218243|20603408|P1|Overall Study|Lack of Efficacy|1
5957081|NCT01218204|20603424|P4|Part B Pooled Treatment Arm|Protocol Violation|1
5957082|NCT01218204|20603425|P3|Part B Pooled Treatment Arm|Protocol Violation|0
5957083|NCT01218204|20603426|P2|Part B Pooled Treatment Arm|Protocol Violation|0
5957084|NCT01218204|20603427|P1|Part B Pooled Treatment Arm|Protocol Violation|0
5957085|NCT01218204|20603424|P4|Part B Pooled Treatment Arm|Adverse Event|2
5957086|NCT01218204|20603425|P3|Part B Pooled Treatment Arm|Adverse Event|0
5957087|NCT01218204|20603426|P2|Part B Pooled Treatment Arm|Adverse Event|0
5957088|NCT01218204|20603427|P1|Part B Pooled Treatment Arm|Adverse Event|0
5957089|NCT01218204|20603424|P4|Part B Run-in|Withdrawal by Subject|0
5957090|NCT01218204|20603425|P3|Part B Run-in|Withdrawal by Subject|3
5957091|NCT01218204|20603426|P2|Part B Run-in|Withdrawal by Subject|0
5957092|NCT01218204|20603427|P1|Part B Run-in|Withdrawal by Subject|0
5957093|NCT01218204|20603424|P4|Part B Run-in|Protocol Violation|0
5957094|NCT01218204|20603425|P3|Part B Run-in|Protocol Violation|2
5957095|NCT01218204|20603426|P2|Part B Run-in|Protocol Violation|0
5957096|NCT01218204|20603427|P1|Part B Run-in|Protocol Violation|0
5957097|NCT01218204|20603424|P4|Part B Run-in|Adverse Event|0
5957098|NCT01218204|20603425|P3|Part B Run-in|Adverse Event|1
5957099|NCT01218204|20603426|P2|Part B Run-in|Adverse Event|0
5957100|NCT01218204|20603427|P1|Part B Run-in|Adverse Event|0
5957101|NCT01218204|20603424|P4|Part B Washout|Did not meet continuation criteria|0
5957102|NCT01218204|20603425|P3|Part B Washout|Did not meet continuation criteria|0
5957103|NCT01218204|20603426|P2|Part B Washout|Did not meet continuation criteria|112
5957104|NCT01218204|20603427|P1|Part B Washout|Did not meet continuation criteria|0
5957105|NCT01218204|20603424|P4|Part B Washout|Reached defined stopping criteria|0
5957106|NCT01218204|20603425|P3|Part B Washout|Reached defined stopping criteria|0
5957107|NCT01218204|20603426|P2|Part B Washout|Reached defined stopping criteria|2
5957108|NCT01218204|20603427|P1|Part B Washout|Reached defined stopping criteria|0
5957109|NCT01218204|20603424|P4|Part B Washout|Withdrawal by Subject|0
5957110|NCT01218204|20603425|P3|Part B Washout|Withdrawal by Subject|0
5957111|NCT01218204|20603426|P2|Part B Washout|Withdrawal by Subject|14
5957112|NCT01218204|20603427|P1|Part B Washout|Withdrawal by Subject|0
5957113|NCT01218204|20603424|P4|Part B Washout|Physician Decision|0
5957114|NCT01218204|20603425|P3|Part B Washout|Physician Decision|0
5957115|NCT01218204|20603426|P2|Part B Washout|Physician Decision|14
5957116|NCT01218204|20603427|P1|Part B Washout|Physician Decision|0
5957117|NCT01218204|20603424|P4|Part B Washout|Lost to Follow-up|0
5957118|NCT01218204|20603425|P3|Part B Washout|Lost to Follow-up|0
5957119|NCT01218204|20603426|P2|Part B Washout|Lost to Follow-up|2
5957120|NCT01218204|20603427|P1|Part B Washout|Lost to Follow-up|0
5957121|NCT01218204|20603424|P4|Part B Washout|Adverse Event|0
5957122|NCT01218204|20603425|P3|Part B Washout|Adverse Event|0
5957123|NCT01218204|20603426|P2|Part B Washout|Adverse Event|1
5957124|NCT01218204|20603427|P1|Part B Washout|Adverse Event|0
5957125|NCT01218126|20603691|P4|Overall Study|Withdrawal by Subject|6
5957126|NCT01218126|20603692|P3|Overall Study|Withdrawal by Subject|4
5957127|NCT01218126|20603693|P2|Overall Study|Withdrawal by Subject|5
5957128|NCT01218126|20603694|P1|Overall Study|Withdrawal by Subject|2
5957129|NCT01218126|20603691|P4|Overall Study|Physician Decision|2
5957130|NCT01218126|20603692|P3|Overall Study|Physician Decision|4
5957131|NCT01218126|20603693|P2|Overall Study|Physician Decision|2
5957132|NCT01218126|20603694|P1|Overall Study|Physician Decision|1
5957133|NCT01218126|20603691|P4|Overall Study|Lost to Follow-up|2
5957134|NCT01218126|20603692|P3|Overall Study|Lost to Follow-up|0
5957135|NCT01218126|20603693|P2|Overall Study|Lost to Follow-up|0
5957136|NCT01218126|20603694|P1|Overall Study|Lost to Follow-up|0
5957137|NCT01218126|20603691|P4|Overall Study|Protocol-defined stopping criteria|0
5957138|NCT01218126|20603692|P3|Overall Study|Protocol-defined stopping criteria|0
5957139|NCT01218126|20603693|P2|Overall Study|Protocol-defined stopping criteria|1
5957140|NCT01218126|20603694|P1|Overall Study|Protocol-defined stopping criteria|1
5957141|NCT01218126|20603691|P4|Overall Study|Protocol Violation|3
5957142|NCT01218126|20603692|P3|Overall Study|Protocol Violation|2
5957143|NCT01218126|20603693|P2|Overall Study|Protocol Violation|2
5957144|NCT01218126|20603694|P1|Overall Study|Protocol Violation|5
5957145|NCT01218126|20603691|P4|Overall Study|Lack of Efficacy|6
5957146|NCT01218126|20603692|P3|Overall Study|Lack of Efficacy|2
5957147|NCT01218126|20603693|P2|Overall Study|Lack of Efficacy|2
5957148|NCT01218126|20603694|P1|Overall Study|Lack of Efficacy|7
5957149|NCT01218126|20603691|P4|Overall Study|Adverse Event|16
5957150|NCT01218126|20603692|P3|Overall Study|Adverse Event|12
5957151|NCT01218126|20603693|P2|Overall Study|Adverse Event|10
5957152|NCT01218126|20603694|P1|Overall Study|Adverse Event|8
5957153|NCT01218113|20603735|P3|Overall Study|Protocol Deviation Eligibility Criteria|1
5957154|NCT01218113|20603736|P2|Overall Study|Protocol Deviation Eligibility Criteria|0
5957155|NCT01218113|20603737|P1|Overall Study|Protocol Deviation Eligibility Criteria|0
5957156|NCT01218113|20603735|P3|Overall Study|Lost to Follow-up|4
5957157|NCT01218113|20603736|P2|Overall Study|Lost to Follow-up|1
5957158|NCT01218113|20603737|P1|Overall Study|Lost to Follow-up|4
5957159|NCT01218113|20603735|P3|Overall Study|Withdrawal by Subject|1
5957160|NCT01218113|20603736|P2|Overall Study|Withdrawal by Subject|0
5957161|NCT01218113|20603737|P1|Overall Study|Withdrawal by Subject|1
5957162|NCT01218100|20603918|P4|Overall Study|Other Reason|4
5957163|NCT01218100|20603919|P3|Overall Study|Other Reason|6
5957164|NCT01218100|20603920|P2|Overall Study|Other Reason|2
5957165|NCT01218100|20603921|P1|Overall Study|Other Reason|2
5957166|NCT01218100|20603918|P4|Overall Study|Lost to Follow-up|1
5957167|NCT01218100|20603919|P3|Overall Study|Lost to Follow-up|2
5957168|NCT01218100|20603920|P2|Overall Study|Lost to Follow-up|8
5957169|NCT01218100|20603921|P1|Overall Study|Lost to Follow-up|3
5957170|NCT01218100|20603918|P4|Overall Study|Withdrawal by Subject|7
5957171|NCT01218100|20603919|P3|Overall Study|Withdrawal by Subject|6
5957172|NCT01218100|20603920|P2|Overall Study|Withdrawal by Subject|2
5957173|NCT01218100|20603921|P1|Overall Study|Withdrawal by Subject|5
5957174|NCT01218100|20603918|P4|Overall Study|Protocol Violation|1
5957175|NCT01218100|20603919|P3|Overall Study|Protocol Violation|1
5957176|NCT01218100|20603920|P2|Overall Study|Protocol Violation|0
5957177|NCT01218100|20603921|P1|Overall Study|Protocol Violation|0
5957178|NCT01218100|20603918|P4|Overall Study|Lack of Efficacy|12
5957179|NCT01218100|20603919|P3|Overall Study|Lack of Efficacy|5
5957180|NCT01218100|20603920|P2|Overall Study|Lack of Efficacy|6
5957181|NCT01218100|20603921|P1|Overall Study|Lack of Efficacy|9
5957182|NCT01218100|20603918|P4|Overall Study|Adverse Event|7
5957183|NCT01218100|20603919|P3|Overall Study|Adverse Event|6
5957184|NCT01218100|20603920|P2|Overall Study|Adverse Event|6
5957185|NCT01218100|20603921|P1|Overall Study|Adverse Event|4
5957186|NCT01218100|20603918|P4|Overall Study|Did not meet InclusionExclusion criteria|2
5957187|NCT01218100|20603919|P3|Overall Study|Did not meet InclusionExclusion criteria|1
5957188|NCT01218100|20603920|P2|Overall Study|Did not meet InclusionExclusion criteria|1
5957189|NCT01218100|20603921|P1|Overall Study|Did not meet InclusionExclusion criteria|1
5957190|NCT01218087|20603937|P2|Overall Study|Transferred|5
5957191|NCT01218087|20603938|P1|Overall Study|Transferred|8
5957192|NCT01218087|20603937|P2|Overall Study|Withdrawal by Subject|0
5957193|NCT01218087|20603938|P1|Overall Study|Withdrawal by Subject|5
5957194|NCT01218087|20603937|P2|Overall Study|Death|1
5957195|NCT01218087|20603938|P1|Overall Study|Death|2
5957196|NCT01218009|20603960|P2|Overall Study|Sponsor terminated study|163
5957197|NCT01218009|20603961|P1|Overall Study|Sponsor terminated study|161
5957198|NCT01218009|20603960|P2|Overall Study|Withdrawal by Subject|1
5957199|NCT01218009|20603961|P1|Overall Study|Withdrawal by Subject|3
5957200|NCT01218009|20603960|P2|Overall Study|Protocol Violation|1
5957201|NCT01218009|20603961|P1|Overall Study|Protocol Violation|2
5957202|NCT01217957|20603984|P5|Phase 2|Withdrawal by Patient|1
5957203|NCT01217957|20603985|P4|Phase 2|Withdrawal by Patient|0
5957204|NCT01217957|20603986|P3|Phase 2|Withdrawal by Patient|0
5957205|NCT01217957|20603987|P2|Phase 2|Withdrawal by Patient|0
5957206|NCT01217957|20603988|P1|Phase 2|Withdrawal by Patient|0
5957207|NCT01217957|20603984|P5|Phase 1|Withdrawal by Patient|0
5957208|NCT01217957|20603985|P4|Phase 1|Withdrawal by Patient|1
5957209|NCT01217957|20603986|P3|Phase 1|Withdrawal by Patient|1
5957210|NCT01217957|20603987|P2|Phase 1|Withdrawal by Patient|0
5957211|NCT01217957|20603988|P1|Phase 1|Withdrawal by Patient|1
5957212|NCT01217944|20604047|P3|Overall Study|Lack of Efficacy|0
5957213|NCT01217944|20604048|P2|Overall Study|Lack of Efficacy|0
5957214|NCT01217944|20604049|P1|Overall Study|Lack of Efficacy|1
5957215|NCT01217944|20604047|P3|Overall Study|Withdrawal by Subject|0
5957216|NCT01217944|20604048|P2|Overall Study|Withdrawal by Subject|2
5957217|NCT01217944|20604049|P1|Overall Study|Withdrawal by Subject|1
5957218|NCT01217944|20604047|P3|Overall Study|Lost to Follow-up|0
5957219|NCT01217944|20604048|P2|Overall Study|Lost to Follow-up|1
5957220|NCT01217944|20604049|P1|Overall Study|Lost to Follow-up|3
5957221|NCT01217944|20604047|P3|Overall Study|Protocol Violation|0
5957222|NCT01217944|20604048|P2|Overall Study|Protocol Violation|1
5957223|NCT01217944|20604049|P1|Overall Study|Protocol Violation|1
5957224|NCT01217892|20604092|P4|Overall Study|Poor/Non-Compliance|0
5957225|NCT01217892|20604093|P3|Overall Study|Poor/Non-Compliance|1
5957226|NCT01217892|20604094|P2|Overall Study|Poor/Non-Compliance|0
5957227|NCT01217892|20604095|P1|Overall Study|Poor/Non-Compliance|0
5957228|NCT01217892|20604092|P4|Overall Study|Incorrect enrollment|0
5957229|NCT01217892|20604093|P3|Overall Study|Incorrect enrollment|1
5957230|NCT01217892|20604094|P2|Overall Study|Incorrect enrollment|1
5957231|NCT01217892|20604095|P1|Overall Study|Incorrect enrollment|0
5957232|NCT01217892|20604092|P4|Overall Study|Subject no longer meets study criteria|8
5957233|NCT01217892|20604093|P3|Overall Study|Subject no longer meets study criteria|4
5957234|NCT01217892|20604094|P2|Overall Study|Subject no longer meets study criteria|2
5957235|NCT01217892|20604095|P1|Overall Study|Subject no longer meets study criteria|5
5957236|NCT01217892|20604092|P4|Overall Study|Lab value|0
5957237|NCT01217892|20604093|P3|Overall Study|Lab value|1
5957238|NCT01217892|20604094|P2|Overall Study|Lab value|0
5957239|NCT01217892|20604095|P1|Overall Study|Lab value|1
5957240|NCT01217892|20604092|P4|Overall Study|Withdrawal by Subject|0
5957241|NCT01217892|20604093|P3|Overall Study|Withdrawal by Subject|1
5957242|NCT01217892|20604094|P2|Overall Study|Withdrawal by Subject|2
5957243|NCT01217892|20604095|P1|Overall Study|Withdrawal by Subject|0
5957244|NCT01217892|20604092|P4|Overall Study|Adverse Event|0
5957245|NCT01217892|20604093|P3|Overall Study|Adverse Event|1
5957246|NCT01217892|20604094|P2|Overall Study|Adverse Event|1
5957247|NCT01217892|20604095|P1|Overall Study|Adverse Event|1
5957248|NCT01217814|20604158|P3|Overall Study|Lack of Efficacy|1
5957249|NCT01217814|20604159|P2|Overall Study|Lack of Efficacy|0
5957250|NCT01217814|20604160|P1|Overall Study|Lack of Efficacy|0
5957251|NCT01217814|20604158|P3|Overall Study|Adverse Event|0
5957252|NCT01217814|20604159|P2|Overall Study|Adverse Event|1
5957253|NCT01217814|20604160|P1|Overall Study|Adverse Event|1
5957254|NCT01217801|20604186|P2|Period 1|Withdrawal by Subject|1
5957255|NCT01217801|20604187|P1|Period 1|Withdrawal by Subject|0
5957256|NCT01217801|20604186|P2|Period 1|Protocol Violation|1
5957257|NCT01217801|20604187|P1|Period 1|Protocol Violation|1
5957258|NCT01217606|20604216|P2|9-Month Masked Extension|Lack of Efficacy|0
5957259|NCT01217606|20604217|P1|9-Month Masked Extension|Lack of Efficacy|2
5957260|NCT01217606|20604216|P2|9-Month Masked Extension|Pregnancy|0
5957261|NCT01217606|20604217|P1|9-Month Masked Extension|Pregnancy|1
5957262|NCT01217606|20604216|P2|9-Month Masked Extension|Lost to Follow-up|0
5957263|NCT01217606|20604217|P1|9-Month Masked Extension|Lost to Follow-up|1
5957264|NCT01217606|20604216|P2|9-Month Masked Extension|Personal Reasons|1
5957265|NCT01217606|20604217|P1|9-Month Masked Extension|Personal Reasons|2
5957266|NCT01217606|20604216|P2|9-Month Masked Extension|Other Reasons|4
5957267|NCT01217606|20604217|P1|9-Month Masked Extension|Other Reasons|4
5957268|NCT01217606|20604216|P2|9-Month Masked Extension|Adverse Event|6
5957269|NCT01217606|20604217|P1|9-Month Masked Extension|Adverse Event|3
5957270|NCT01217606|20604216|P2|Initial Treatment Phase|Adverse Event|6
5957271|NCT01217606|20604217|P1|Initial Treatment Phase|Adverse Event|10
5957272|NCT01217606|20604216|P2|Initial Treatment Phase|Lack of Efficacy|0
5957273|NCT01217606|20604217|P1|Initial Treatment Phase|Lack of Efficacy|1
5957274|NCT01217606|20604216|P2|Initial Treatment Phase|Personal Reasons|2
5957275|NCT01217606|20604217|P1|Initial Treatment Phase|Personal Reasons|0
5957276|NCT01217606|20604216|P2|Initial Treatment Phase|Protocol Violation|2
5957277|NCT01217606|20604217|P1|Initial Treatment Phase|Protocol Violation|3
5957278|NCT01217606|20604216|P2|Initial Treatment Phase|Other Reasons|2
5957279|NCT01217606|20604217|P1|Initial Treatment Phase|Other Reasons|0
5957280|NCT01217476|20604248|P2|Overall Study|Other|0
5957281|NCT01217476|20604249|P1|Overall Study|Other|2
5957282|NCT01217476|20604248|P2|Overall Study|Protocol Deviation|0
5957283|NCT01217476|20604249|P1|Overall Study|Protocol Deviation|1
5957284|NCT01217476|20604248|P2|Overall Study|Surgery on the Target Limb|2
5957285|NCT01217476|20604249|P1|Overall Study|Surgery on the Target Limb|0
5957286|NCT01217476|20604248|P2|Overall Study|Withdrawal by Subject|3
5957287|NCT01217476|20604249|P1|Overall Study|Withdrawal by Subject|3
5957288|NCT01217476|20604248|P2|Overall Study|Physician Decision|1
5957289|NCT01217476|20604249|P1|Overall Study|Physician Decision|0
5957290|NCT01217476|20604248|P2|Overall Study|Adverse Event|1
5957291|NCT01217476|20604249|P1|Overall Study|Adverse Event|6
5957292|NCT01217463|20604259|P2|Overall Study|Other|1
5957293|NCT01217463|20604260|P1|Overall Study|Other|1
5957294|NCT01217463|20604259|P2|Overall Study|Patient Non-compliant|0
5957295|NCT01217463|20604260|P1|Overall Study|Patient Non-compliant|1
5957296|NCT01217463|20604259|P2|Overall Study|Surgery on the Target Limb|1
5957297|NCT01217463|20604260|P1|Overall Study|Surgery on the Target Limb|0
5957298|NCT01217463|20604259|P2|Overall Study|Withdrawal by Subject|0
5957299|NCT01217463|20604260|P1|Overall Study|Withdrawal by Subject|3
5957300|NCT01217463|20604259|P2|Overall Study|Physician Decision|1
5957301|NCT01217463|20604260|P1|Overall Study|Physician Decision|0
5957302|NCT01217463|20604259|P2|Overall Study|Adverse Event|5
5957303|NCT01217463|20604260|P1|Overall Study|Adverse Event|8
5957316|NCT01217385|20604292|P1|Overall Study|Normal Breast TOI not available|10
5957317|NCT01217385|20604292|P1|Overall Study|Central Path not Available|1
5957318|NCT01217385|20604292|P1|Overall Study|DOSI not performed/not eval|12
5957319|NCT01217385|20604292|P1|Overall Study|Withdrawal by Subject|3
5957320|NCT01217307|20604304|P2|Overall Study|Withdrawal by Subject|1
5957321|NCT01217307|20604305|P1|Overall Study|Withdrawal by Subject|0
5957322|NCT01217229|20604311|P1|Overall Study|Disease progression not confirmed|2
5957323|NCT01217229|20604311|P1|Overall Study|Protocol Violation|1
5957324|NCT01217229|20604311|P1|Overall Study|Disease progression, Cheson criteria|14
5957325|NCT01217229|20604311|P1|Overall Study|Disease progression, deterioration|2
5957326|NCT01217229|20604311|P1|Overall Study|Adverse Event|1
5957327|NCT01217190|20604320|P2|Second Dosing|Withdrawal by Subject|2
5957328|NCT01217190|20604321|P1|Second Dosing|Withdrawal by Subject|0
5957329|NCT01217112|20604336|P5|Overall Study|Physician Decision|1
5957330|NCT01217112|20604337|P4|Overall Study|Physician Decision|0
5957331|NCT01217112|20604338|P3|Overall Study|Physician Decision|0
5957332|NCT01217112|20604339|P2|Overall Study|Physician Decision|0
5957333|NCT01217112|20604340|P1|Overall Study|Physician Decision|0
5957334|NCT01217112|20604336|P5|Overall Study|Withdrawal by Subject|0
5957335|NCT01217112|20604337|P4|Overall Study|Withdrawal by Subject|0
5957336|NCT01217112|20604338|P3|Overall Study|Withdrawal by Subject|1
5957337|NCT01217112|20604339|P2|Overall Study|Withdrawal by Subject|0
5957338|NCT01217112|20604340|P1|Overall Study|Withdrawal by Subject|0
5957339|NCT01217112|20604336|P5|Overall Study|Adverse Event|0
5957340|NCT01217112|20604337|P4|Overall Study|Adverse Event|2
5957341|NCT01217112|20604338|P3|Overall Study|Adverse Event|0
5957342|NCT01217112|20604339|P2|Overall Study|Adverse Event|2
5957343|NCT01217112|20604340|P1|Overall Study|Adverse Event|0
5957344|NCT01217073|20604573|P8|Extension Period|Withdrawal by Subject|8
5957345|NCT01217073|20604574|P7|Extension Period|Withdrawal by Subject|30
5957346|NCT01217073|20604575|P6|Extension Period|Withdrawal by Subject|0
5957347|NCT01217073|20604576|P5|Extension Period|Withdrawal by Subject|0
5957348|NCT01217073|20604577|P4|Extension Period|Withdrawal by Subject|0
5957349|NCT01217073|20604578|P3|Extension Period|Withdrawal by Subject|0
5957350|NCT01217073|20604579|P2|Extension Period|Withdrawal by Subject|0
5957351|NCT01217073|20604580|P1|Extension Period|Withdrawal by Subject|0
5957352|NCT01217073|20604573|P8|Extension Period|Site discontinued study participation|2
5957353|NCT01217073|20604574|P7|Extension Period|Site discontinued study participation|7
5957354|NCT01217073|20604575|P6|Extension Period|Site discontinued study participation|0
5957355|NCT01217073|20604576|P5|Extension Period|Site discontinued study participation|0
5957356|NCT01217073|20604577|P4|Extension Period|Site discontinued study participation|0
5957357|NCT01217073|20604578|P3|Extension Period|Site discontinued study participation|0
5957358|NCT01217073|20604579|P2|Extension Period|Site discontinued study participation|0
5957359|NCT01217073|20604580|P1|Extension Period|Site discontinued study participation|0
5957360|NCT01217073|20604573|P8|Extension Period|Protocol Violation|1
5957361|NCT01217073|20604574|P7|Extension Period|Protocol Violation|2
5957362|NCT01217073|20604575|P6|Extension Period|Protocol Violation|0
5957363|NCT01217073|20604576|P5|Extension Period|Protocol Violation|0
5957364|NCT01217073|20604577|P4|Extension Period|Protocol Violation|0
5957365|NCT01217073|20604578|P3|Extension Period|Protocol Violation|0
5957366|NCT01217073|20604579|P2|Extension Period|Protocol Violation|0
5957367|NCT01217073|20604580|P1|Extension Period|Protocol Violation|0
5957368|NCT01217073|20604573|P8|Extension Period|Physician Decision|1
5957369|NCT01217073|20604574|P7|Extension Period|Physician Decision|4
5957370|NCT01217073|20604575|P6|Extension Period|Physician Decision|0
5957371|NCT01217073|20604576|P5|Extension Period|Physician Decision|0
5957372|NCT01217073|20604577|P4|Extension Period|Physician Decision|0
5957373|NCT01217073|20604578|P3|Extension Period|Physician Decision|0
5957374|NCT01217073|20604579|P2|Extension Period|Physician Decision|0
5957375|NCT01217073|20604580|P1|Extension Period|Physician Decision|0
5957376|NCT01217073|20604573|P8|Extension Period|Non-compliance with study drug|1
5957377|NCT01217073|20604574|P7|Extension Period|Non-compliance with study drug|0
5957378|NCT01217073|20604575|P6|Extension Period|Non-compliance with study drug|0
5957379|NCT01217073|20604576|P5|Extension Period|Non-compliance with study drug|0
5957380|NCT01217073|20604577|P4|Extension Period|Non-compliance with study drug|0
5957381|NCT01217073|20604578|P3|Extension Period|Non-compliance with study drug|0
5957382|NCT01217073|20604579|P2|Extension Period|Non-compliance with study drug|0
5957383|NCT01217073|20604580|P1|Extension Period|Non-compliance with study drug|0
5957384|NCT01217073|20604573|P8|Extension Period|Lost to Follow-up|1
5957385|NCT01217073|20604574|P7|Extension Period|Lost to Follow-up|9
5957386|NCT01217073|20604575|P6|Extension Period|Lost to Follow-up|0
5957387|NCT01217073|20604576|P5|Extension Period|Lost to Follow-up|0
5957388|NCT01217073|20604577|P4|Extension Period|Lost to Follow-up|0
5957389|NCT01217073|20604578|P3|Extension Period|Lost to Follow-up|0
5957390|NCT01217073|20604579|P2|Extension Period|Lost to Follow-up|0
5957391|NCT01217073|20604580|P1|Extension Period|Lost to Follow-up|0
5957392|NCT01217073|20604573|P8|Extension Period|Lack of Efficacy|0
5957393|NCT01217073|20604574|P7|Extension Period|Lack of Efficacy|3
5957394|NCT01217073|20604575|P6|Extension Period|Lack of Efficacy|0
5957395|NCT01217073|20604576|P5|Extension Period|Lack of Efficacy|0
5957396|NCT01217073|20604577|P4|Extension Period|Lack of Efficacy|0
5957397|NCT01217073|20604578|P3|Extension Period|Lack of Efficacy|0
5957398|NCT01217073|20604579|P2|Extension Period|Lack of Efficacy|0
5957399|NCT01217073|20604580|P1|Extension Period|Lack of Efficacy|0
5957400|NCT01217073|20604573|P8|Extension Period|Excluded medication|0
5957401|NCT01217073|20604574|P7|Extension Period|Excluded medication|2
5957402|NCT01217073|20604575|P6|Extension Period|Excluded medication|0
5957403|NCT01217073|20604576|P5|Extension Period|Excluded medication|0
5957404|NCT01217073|20604577|P4|Extension Period|Excluded medication|0
5957405|NCT01217073|20604578|P3|Extension Period|Excluded medication|0
5957406|NCT01217073|20604579|P2|Extension Period|Excluded medication|0
5957407|NCT01217073|20604580|P1|Extension Period|Excluded medication|0
5957408|NCT01217073|20604573|P8|Extension Period|Death|0
5957409|NCT01217073|20604574|P7|Extension Period|Death|1
5957410|NCT01217073|20604575|P6|Extension Period|Death|0
5957411|NCT01217073|20604576|P5|Extension Period|Death|0
5957412|NCT01217073|20604577|P4|Extension Period|Death|0
5957413|NCT01217073|20604578|P3|Extension Period|Death|0
5957414|NCT01217073|20604579|P2|Extension Period|Death|0
5957415|NCT01217073|20604580|P1|Extension Period|Death|0
5957416|NCT01217073|20604573|P8|Extension Period|Creatinine/eGFR|1
5957417|NCT01217073|20604574|P7|Extension Period|Creatinine/eGFR|11
5957418|NCT01217073|20604575|P6|Extension Period|Creatinine/eGFR|0
5957419|NCT01217073|20604576|P5|Extension Period|Creatinine/eGFR|0
5957420|NCT01217073|20604577|P4|Extension Period|Creatinine/eGFR|0
5957421|NCT01217073|20604578|P3|Extension Period|Creatinine/eGFR|0
5957422|NCT01217073|20604579|P2|Extension Period|Creatinine/eGFR|0
5957423|NCT01217073|20604580|P1|Extension Period|Creatinine/eGFR|0
5957424|NCT01217073|20604573|P8|Extension Period|Contraindication to study medication|0
5957425|NCT01217073|20604574|P7|Extension Period|Contraindication to study medication|1
5957426|NCT01217073|20604575|P6|Extension Period|Contraindication to study medication|0
5957427|NCT01217073|20604576|P5|Extension Period|Contraindication to study medication|0
5957428|NCT01217073|20604577|P4|Extension Period|Contraindication to study medication|0
5957429|NCT01217073|20604578|P3|Extension Period|Contraindication to study medication|0
5957430|NCT01217073|20604579|P2|Extension Period|Contraindication to study medication|0
5957431|NCT01217073|20604580|P1|Extension Period|Contraindication to study medication|0
5957432|NCT01217073|20604573|P8|Extension Period|ALT/AST|0
5957433|NCT01217073|20604574|P7|Extension Period|ALT/AST|2
5957434|NCT01217073|20604575|P6|Extension Period|ALT/AST|0
5957435|NCT01217073|20604576|P5|Extension Period|ALT/AST|0
5957436|NCT01217073|20604577|P4|Extension Period|ALT/AST|0
5957437|NCT01217073|20604578|P3|Extension Period|ALT/AST|0
5957438|NCT01217073|20604579|P2|Extension Period|ALT/AST|0
5957439|NCT01217073|20604580|P1|Extension Period|ALT/AST|0
5957440|NCT01217073|20604573|P8|Extension Period|Adverse Event|5
5957441|NCT01217073|20604574|P7|Extension Period|Adverse Event|19
5957442|NCT01217073|20604575|P6|Extension Period|Adverse Event|0
5957443|NCT01217073|20604576|P5|Extension Period|Adverse Event|0
5957444|NCT01217073|20604577|P4|Extension Period|Adverse Event|0
5957445|NCT01217073|20604578|P3|Extension Period|Adverse Event|0
5957446|NCT01217073|20604579|P2|Extension Period|Adverse Event|0
5957447|NCT01217073|20604580|P1|Extension Period|Adverse Event|0
5957448|NCT01217073|20604573|P8|Base Period|Withdrawal by Subject|0
5957449|NCT01217073|20604574|P7|Base Period|Withdrawal by Subject|0
5957450|NCT01217073|20604575|P6|Base Period|Withdrawal by Subject|5
5957451|NCT01217073|20604576|P5|Base Period|Withdrawal by Subject|5
5957452|NCT01217073|20604577|P4|Base Period|Withdrawal by Subject|1
5957453|NCT01217073|20604578|P3|Base Period|Withdrawal by Subject|5
5957454|NCT01217073|20604579|P2|Base Period|Withdrawal by Subject|5
5957455|NCT01217073|20604580|P1|Base Period|Withdrawal by Subject|4
5957456|NCT01217073|20604573|P8|Base Period|Protocol Violation|0
5957457|NCT01217073|20604574|P7|Base Period|Protocol Violation|0
5957458|NCT01217073|20604575|P6|Base Period|Protocol Violation|2
5957459|NCT01217073|20604576|P5|Base Period|Protocol Violation|1
5957460|NCT01217073|20604577|P4|Base Period|Protocol Violation|0
5957461|NCT01217073|20604578|P3|Base Period|Protocol Violation|0
5957462|NCT01217073|20604579|P2|Base Period|Protocol Violation|0
5957463|NCT01217073|20604580|P1|Base Period|Protocol Violation|1
5957464|NCT01217073|20604573|P8|Base Period|Physician Decision|0
5957465|NCT01217073|20604574|P7|Base Period|Physician Decision|0
5957466|NCT01217073|20604575|P6|Base Period|Physician Decision|0
5957467|NCT01217073|20604576|P5|Base Period|Physician Decision|1
5957468|NCT01217073|20604577|P4|Base Period|Physician Decision|0
5957469|NCT01217073|20604578|P3|Base Period|Physician Decision|0
5957470|NCT01217073|20604579|P2|Base Period|Physician Decision|0
5957471|NCT01217073|20604580|P1|Base Period|Physician Decision|0
5957472|NCT01217073|20604573|P8|Base Period|Lost to Follow-up|0
5957473|NCT01217073|20604574|P7|Base Period|Lost to Follow-up|0
5957474|NCT01217073|20604575|P6|Base Period|Lost to Follow-up|0
5957475|NCT01217073|20604576|P5|Base Period|Lost to Follow-up|3
5957476|NCT01217073|20604577|P4|Base Period|Lost to Follow-up|1
5957477|NCT01217073|20604578|P3|Base Period|Lost to Follow-up|1
5957478|NCT01217073|20604579|P2|Base Period|Lost to Follow-up|0
5957479|NCT01217073|20604580|P1|Base Period|Lost to Follow-up|0
5957480|NCT01217073|20604573|P8|Base Period|Lack of Efficacy|0
5957481|NCT01217073|20604574|P7|Base Period|Lack of Efficacy|0
5957482|NCT01217073|20604575|P6|Base Period|Lack of Efficacy|1
5957483|NCT01217073|20604576|P5|Base Period|Lack of Efficacy|0
5957484|NCT01217073|20604577|P4|Base Period|Lack of Efficacy|0
5957485|NCT01217073|20604578|P3|Base Period|Lack of Efficacy|0
5957486|NCT01217073|20604579|P2|Base Period|Lack of Efficacy|0
5957487|NCT01217073|20604580|P1|Base Period|Lack of Efficacy|0
5957488|NCT01217073|20604573|P8|Base Period|Excluded medication|0
5957489|NCT01217073|20604574|P7|Base Period|Excluded medication|0
5957490|NCT01217073|20604575|P6|Base Period|Excluded medication|0
5957491|NCT01217073|20604576|P5|Base Period|Excluded medication|1
5957492|NCT01217073|20604577|P4|Base Period|Excluded medication|0
5957493|NCT01217073|20604578|P3|Base Period|Excluded medication|0
5957494|NCT01217073|20604579|P2|Base Period|Excluded medication|0
5957495|NCT01217073|20604580|P1|Base Period|Excluded medication|0
5957496|NCT01217073|20604573|P8|Base Period|Alanine aminotransferase (ALT)/AST|0
5957497|NCT01217073|20604574|P7|Base Period|Alanine aminotransferase (ALT)/AST|0
5957498|NCT01217073|20604575|P6|Base Period|Alanine aminotransferase (ALT)/AST|0
5957499|NCT01217073|20604576|P5|Base Period|Alanine aminotransferase (ALT)/AST|0
5957500|NCT01217073|20604577|P4|Base Period|Alanine aminotransferase (ALT)/AST|0
5957501|NCT01217073|20604578|P3|Base Period|Alanine aminotransferase (ALT)/AST|0
5957502|NCT01217073|20604579|P2|Base Period|Alanine aminotransferase (ALT)/AST|0
5957503|NCT01217073|20604580|P1|Base Period|Alanine aminotransferase (ALT)/AST|1
5957504|NCT01217073|20604573|P8|Base Period|Adverse Event|0
5957505|NCT01217073|20604574|P7|Base Period|Adverse Event|0
5957506|NCT01217073|20604575|P6|Base Period|Adverse Event|1
5957507|NCT01217073|20604576|P5|Base Period|Adverse Event|4
5957508|NCT01217073|20604577|P4|Base Period|Adverse Event|0
5957509|NCT01217073|20604578|P3|Base Period|Adverse Event|1
5957510|NCT01217073|20604579|P2|Base Period|Adverse Event|0
5957511|NCT01217073|20604580|P1|Base Period|Adverse Event|1
5957512|NCT01217047|20604652|P3|Overall Study|Lost to Follow-up|0
5957513|NCT01217047|20604653|P2|Overall Study|Lost to Follow-up|1
5957514|NCT01217047|20604654|P1|Overall Study|Lost to Follow-up|0
5957515|NCT01216332|20604818|P2|Overall Study|Withdrawal by Subject|0
5957516|NCT01216332|20604819|P1|Overall Study|Withdrawal by Subject|4
5957517|NCT01216319|20604837|P1|Overall Study|Unanticipated chemo for breast cancer|2
5957518|NCT01216319|20604837|P1|Overall Study|Lost to Follow-up|2
5957519|NCT01216176|20604854|P3|Overall Study|Physician Decision|1
5957520|NCT01216176|20604855|P2|Overall Study|Physician Decision|0
5957521|NCT01216176|20604856|P1|Overall Study|Physician Decision|0
5957522|NCT01216176|20604854|P3|Overall Study|Adverse Event|0
5957523|NCT01216176|20604855|P2|Overall Study|Adverse Event|8
5957524|NCT01216176|20604856|P1|Overall Study|Adverse Event|0
5957525|NCT01216163|20604879|P3|Overall Study|Withdrawal by Subject|0
5957526|NCT01216163|20604880|P2|Overall Study|Withdrawal by Subject|1
5957527|NCT01216163|20604881|P1|Overall Study|Withdrawal by Subject|1
5957528|NCT01216072|20604933|P2|Open-Label Extension Period (3 Months)|Withdrawal by Subject|3
5957529|NCT01216072|20604934|P1|Open-Label Extension Period (3 Months)|Withdrawal by Subject|0
5957530|NCT01216072|20604933|P2|Open-Label Extension Period (3 Months)|Abnormal test procedure results|1
5957531|NCT01216072|20604934|P1|Open-Label Extension Period (3 Months)|Abnormal test procedure results|0
5957532|NCT01216072|20604933|P2|Open-Label Extension Period (3 Months)|Adverse Event|10
5957533|NCT01216072|20604934|P1|Open-Label Extension Period (3 Months)|Adverse Event|0
5957534|NCT01216072|20604933|P2|Open-Label Core Period ( 6 Months)|Protocol Deviation|4
5957535|NCT01216072|20604934|P1|Open-Label Core Period ( 6 Months)|Protocol Deviation|11
5957536|NCT01216072|20604933|P2|Open-Label Core Period ( 6 Months)|Lost to Follow-up|0
5957537|NCT01216072|20604934|P1|Open-Label Core Period ( 6 Months)|Lost to Follow-up|5
5957538|NCT01216072|20604933|P2|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|22
5957539|NCT01216072|20604934|P1|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|12
5957540|NCT01216072|20604933|P2|Open-Label Core Period ( 6 Months)|Lack of Efficacy|4
5957541|NCT01216072|20604934|P1|Open-Label Core Period ( 6 Months)|Lack of Efficacy|3
5957542|NCT01216072|20604933|P2|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|0
5957543|NCT01216072|20604934|P1|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|3
5957544|NCT01216072|20604933|P2|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|0
5957545|NCT01216072|20604934|P1|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|2
5957546|NCT01216072|20604933|P2|Open-Label Core Period ( 6 Months)|Adverse Event|4
5957547|NCT01216072|20604934|P1|Open-Label Core Period ( 6 Months)|Adverse Event|40
5957548|NCT01215981|20604962|P2|Overall Study|Withdrawal by Subject|0
5957549|NCT01215981|20604963|P1|Overall Study|Withdrawal by Subject|1
5957550|NCT01215981|20604962|P2|Overall Study|Protocol Violation|0
5957551|NCT01215981|20604963|P1|Overall Study|Protocol Violation|1
5957552|NCT01215981|20604962|P2|Overall Study|Physician Decision|1
5957553|NCT01215981|20604963|P1|Overall Study|Physician Decision|0
5957554|NCT01215968|20604973|P2|Overall Study|Not received study drug|1
5957555|NCT01215968|20604974|P1|Overall Study|Not received study drug|0
5957556|NCT01215968|20604973|P2|Overall Study|Protocol Violation|4
5957557|NCT01215968|20604974|P1|Overall Study|Protocol Violation|2
5957558|NCT01215968|20604973|P2|Overall Study|Adverse Event|2
5957559|NCT01215968|20604974|P1|Overall Study|Adverse Event|0
5957560|NCT01215955|20604994|P4|Overall Study|Quality Issues|2
5957561|NCT01215955|20604995|P3|Overall Study|Quality Issues|3
5957562|NCT01215955|20604996|P2|Overall Study|Quality Issues|0
5957563|NCT01215955|20604997|P1|Overall Study|Quality Issues|0
5957564|NCT01215955|20604994|P4|Overall Study|Withdrawal by Subject|9
5957565|NCT01215955|20604995|P3|Overall Study|Withdrawal by Subject|13
5957566|NCT01215955|20604996|P2|Overall Study|Withdrawal by Subject|15
5957567|NCT01215955|20604997|P1|Overall Study|Withdrawal by Subject|14
5957568|NCT01215955|20604994|P4|Overall Study|Sponsor Decision|1
5957569|NCT01215955|20604995|P3|Overall Study|Sponsor Decision|0
5957570|NCT01215955|20604996|P2|Overall Study|Sponsor Decision|2
5957571|NCT01215955|20604997|P1|Overall Study|Sponsor Decision|1
5957572|NCT01215955|20604994|P4|Overall Study|Protocol Violation|8
5957573|NCT01215955|20604995|P3|Overall Study|Protocol Violation|8
5957574|NCT01215955|20604996|P2|Overall Study|Protocol Violation|13
5957575|NCT01215955|20604997|P1|Overall Study|Protocol Violation|17
5957576|NCT01215955|20604994|P4|Overall Study|Physician Decision|11
5957577|NCT01215955|20604995|P3|Overall Study|Physician Decision|8
5957578|NCT01215955|20604996|P2|Overall Study|Physician Decision|10
5957579|NCT01215955|20604997|P1|Overall Study|Physician Decision|4
5957580|NCT01215955|20604994|P4|Overall Study|Lost to Follow-up|9
5957581|NCT01215955|20604995|P3|Overall Study|Lost to Follow-up|8
5957582|NCT01215955|20604996|P2|Overall Study|Lost to Follow-up|4
5957583|NCT01215955|20604997|P1|Overall Study|Lost to Follow-up|4
5957584|NCT01215955|20604994|P4|Overall Study|Lack of Efficacy|0
5957585|NCT01215955|20604995|P3|Overall Study|Lack of Efficacy|1
5957586|NCT01215955|20604996|P2|Overall Study|Lack of Efficacy|2
5957587|NCT01215955|20604997|P1|Overall Study|Lack of Efficacy|1
5957588|NCT01215955|20604994|P4|Overall Study|Entry Criteria Not Met|7
5957589|NCT01215955|20604995|P3|Overall Study|Entry Criteria Not Met|4
5957590|NCT01215955|20604996|P2|Overall Study|Entry Criteria Not Met|3
5957591|NCT01215955|20604997|P1|Overall Study|Entry Criteria Not Met|1
5957592|NCT01215955|20604994|P4|Overall Study|Death|3
5957593|NCT01215955|20604995|P3|Overall Study|Death|1
5957594|NCT01215955|20604996|P2|Overall Study|Death|0
5957595|NCT01215955|20604997|P1|Overall Study|Death|2
5957596|NCT01215955|20604994|P4|Overall Study|Adverse Event|3
5957597|NCT01215955|20604995|P3|Overall Study|Adverse Event|2
5957598|NCT01215955|20604996|P2|Overall Study|Adverse Event|4
5957599|NCT01215955|20604997|P1|Overall Study|Adverse Event|1
5957600|NCT01215942|20605065|P2|Post-Treatment Follow-Up Period|Sponsor Decision|61
5957601|NCT01215942|20605066|P1|Post-Treatment Follow-Up Period|Sponsor Decision|28
5957602|NCT01215942|20605065|P2|Post-Treatment Follow-Up Period|Physician Decision|2
5957603|NCT01215942|20605066|P1|Post-Treatment Follow-Up Period|Physician Decision|1
5957604|NCT01215942|20605065|P2|Post-Treatment Follow-Up Period|Withdrawal by Subject|69
5957605|NCT01215942|20605066|P1|Post-Treatment Follow-Up Period|Withdrawal by Subject|43
5957606|NCT01215942|20605065|P2|Post-Treatment Follow-Up Period|Lost to Follow-up|13
5957607|NCT01215942|20605066|P1|Post-Treatment Follow-Up Period|Lost to Follow-up|13
5957608|NCT01215942|20605065|P2|Post-Treatment Follow-Up Period|Death|1
5957609|NCT01215942|20605066|P1|Post-Treatment Follow-Up Period|Death|0
5957610|NCT01215942|20605065|P2|Treatment Period|Sponsor Decision|530
5957611|NCT01215942|20605066|P1|Treatment Period|Sponsor Decision|349
5957612|NCT01215942|20605065|P2|Treatment Period|Protocol Violation|1
5957613|NCT01215942|20605066|P1|Treatment Period|Protocol Violation|0
5957614|NCT01215942|20605065|P2|Treatment Period|Physician Decision|5
5957615|NCT01215942|20605066|P1|Treatment Period|Physician Decision|5
5957616|NCT01215942|20605065|P2|Treatment Period|Withdrawal by Subject|40
5957617|NCT01215942|20605066|P1|Treatment Period|Withdrawal by Subject|17
5957618|NCT01215942|20605065|P2|Treatment Period|Lost to Follow-up|4
5957619|NCT01215942|20605066|P1|Treatment Period|Lost to Follow-up|3
5957620|NCT01215942|20605065|P2|Treatment Period|Lack of Efficacy|62
5957621|NCT01215942|20605066|P1|Treatment Period|Lack of Efficacy|23
5957622|NCT01215942|20605065|P2|Treatment Period|Death|4
5957623|NCT01215942|20605066|P1|Treatment Period|Death|2
5957624|NCT01215942|20605065|P2|Treatment Period|Adverse Event|26
5957625|NCT01215942|20605066|P1|Treatment Period|Adverse Event|15
5957626|NCT01215916|20605199|P9|Overall Study|Physician Decision|0
5957627|NCT01215916|20605200|P8|Overall Study|Physician Decision|0
5957628|NCT01215916|20605201|P7|Overall Study|Physician Decision|0
5957629|NCT01215916|20605202|P6|Overall Study|Physician Decision|0
5957630|NCT01215916|20605203|P5|Overall Study|Physician Decision|0
5957631|NCT01215916|20605204|P4|Overall Study|Physician Decision|1
5957632|NCT01215916|20605205|P3|Overall Study|Physician Decision|1
5957633|NCT01215916|20605206|P2|Overall Study|Physician Decision|0
5957634|NCT01215916|20605207|P1|Overall Study|Physician Decision|0
5957635|NCT01215916|20605199|P9|Overall Study|Death|1
5957636|NCT01215916|20605200|P8|Overall Study|Death|0
5957637|NCT01215916|20605201|P7|Overall Study|Death|0
5957638|NCT01215916|20605202|P6|Overall Study|Death|0
5957639|NCT01215916|20605203|P5|Overall Study|Death|1
5957640|NCT01215916|20605204|P4|Overall Study|Death|0
5957641|NCT01215916|20605205|P3|Overall Study|Death|0
5957642|NCT01215916|20605206|P2|Overall Study|Death|1
5957643|NCT01215916|20605207|P1|Overall Study|Death|0
5957644|NCT01215916|20605199|P9|Overall Study|Withdrawal by Subject|0
5957645|NCT01215916|20605200|P8|Overall Study|Withdrawal by Subject|0
5957646|NCT01215916|20605201|P7|Overall Study|Withdrawal by Subject|1
5957647|NCT01215916|20605202|P6|Overall Study|Withdrawal by Subject|0
5957648|NCT01215916|20605203|P5|Overall Study|Withdrawal by Subject|0
5957649|NCT01215916|20605204|P4|Overall Study|Withdrawal by Subject|2
5957650|NCT01215916|20605205|P3|Overall Study|Withdrawal by Subject|1
5957651|NCT01215916|20605206|P2|Overall Study|Withdrawal by Subject|1
5957652|NCT01215916|20605207|P1|Overall Study|Withdrawal by Subject|0
5957653|NCT01215916|20605199|P9|Overall Study|Adverse Event|0
5957654|NCT01215916|20605200|P8|Overall Study|Adverse Event|0
5957655|NCT01215916|20605201|P7|Overall Study|Adverse Event|3
5957656|NCT01215916|20605202|P6|Overall Study|Adverse Event|0
5957657|NCT01215916|20605203|P5|Overall Study|Adverse Event|0
5957658|NCT01215916|20605204|P4|Overall Study|Adverse Event|1
5957659|NCT01215916|20605205|P3|Overall Study|Adverse Event|0
5957660|NCT01215916|20605206|P2|Overall Study|Adverse Event|1
5957661|NCT01215916|20605207|P1|Overall Study|Adverse Event|1
5957662|NCT01215916|20605199|P9|Overall Study|Progressive Disease|1
5957663|NCT01215916|20605200|P8|Overall Study|Progressive Disease|3
5957664|NCT01215916|20605201|P7|Overall Study|Progressive Disease|5
5957665|NCT01215916|20605202|P6|Overall Study|Progressive Disease|4
5957666|NCT01215916|20605203|P5|Overall Study|Progressive Disease|5
5957667|NCT01215916|20605204|P4|Overall Study|Progressive Disease|2
5957668|NCT01215916|20605205|P3|Overall Study|Progressive Disease|1
5957669|NCT01215916|20605206|P2|Overall Study|Progressive Disease|2
5957670|NCT01215916|20605207|P1|Overall Study|Progressive Disease|0
5957671|NCT01215851|20605241|P6|Follow up Period|Lost to Follow-up|1
5957672|NCT01215851|20605242|P5|Follow up Period|Lost to Follow-up|0
5957673|NCT01215851|20605243|P4|Follow up Period|Lost to Follow-up|0
5957674|NCT01215851|20605244|P3|Follow up Period|Lost to Follow-up|0
5957675|NCT01215851|20605245|P2|Follow up Period|Lost to Follow-up|0
5957676|NCT01215851|20605246|P1|Follow up Period|Lost to Follow-up|0
5957677|NCT01215851|20605241|P6|Treatment Period|Adverse Event|1
5957678|NCT01215851|20605242|P5|Treatment Period|Adverse Event|0
5957679|NCT01215851|20605243|P4|Treatment Period|Adverse Event|3
5957680|NCT01215851|20605244|P3|Treatment Period|Adverse Event|1
5957681|NCT01215851|20605245|P2|Treatment Period|Adverse Event|1
5957682|NCT01215851|20605246|P1|Treatment Period|Adverse Event|1
5957683|NCT01215734|20605305|P2|Overall Study|Death|1
5957684|NCT01215734|20605306|P1|Overall Study|Death|0
5957685|NCT01215721|20605314|P1|Overall Study|Adverse Event|2
5957686|NCT01215513|20605446|P1|Overall Study|Miscellaneous reasons (CS42A)|2
5957687|NCT01215513|20605446|P1|Overall Study|Withdrawal by subject (CS42A)|5
5957688|NCT01215513|20605446|P1|Overall Study|Physician decision (CS42A)|6
5957689|NCT01215513|20605446|P1|Overall Study|Adverse event (CS42A)|2
5957690|NCT01215513|20605446|P1|Overall Study|Not enrolled from CS42 to CS42A|21
5957691|NCT01215513|20605446|P1|Overall Study|Not completed CS42|9
5957692|NCT01215435|20605455|P2|Overall Study|Unclassified|5
5957693|NCT01215435|20605456|P1|Overall Study|Unclassified|5
5957694|NCT01215435|20605455|P2|Overall Study|Lost to Follow-up|0
5957695|NCT01215435|20605456|P1|Overall Study|Lost to Follow-up|3
5957696|NCT01215435|20605455|P2|Overall Study|Withdrawal Criteria|11
5957697|NCT01215435|20605456|P1|Overall Study|Withdrawal Criteria|8
5957698|NCT01215435|20605455|P2|Overall Study|Protocol Violation|0
5957699|NCT01215435|20605456|P1|Overall Study|Protocol Violation|2
5957700|NCT01215435|20605455|P2|Overall Study|Adverse Event|0
5957701|NCT01215435|20605456|P1|Overall Study|Adverse Event|1
5957702|NCT01215422|20605470|P4|Overall Study|Did not complete all intubations|0
5957703|NCT01215422|20605471|P3|Overall Study|Did not complete all intubations|0
5957704|NCT01215422|20605472|P2|Overall Study|Did not complete all intubations|0
5957705|NCT01215422|20605473|P1|Overall Study|Did not complete all intubations|7
5957706|NCT01215422|20605470|P4|Overall Study|Failed intubations|8
5957707|NCT01215422|20605471|P3|Overall Study|Failed intubations|3
5957708|NCT01215422|20605472|P2|Overall Study|Failed intubations|0
5957709|NCT01215422|20605473|P1|Overall Study|Failed intubations|0
5957710|NCT01215422|20605470|P4|Overall Study|Relocation|0
5957711|NCT01215422|20605471|P3|Overall Study|Relocation|0
5957712|NCT01215422|20605472|P2|Overall Study|Relocation|0
5957713|NCT01215422|20605473|P1|Overall Study|Relocation|1
5957714|NCT01215357|20605495|P1|Overall Study|Protocol Violation|9
5957715|NCT01215357|20605495|P1|Overall Study|Withdrawal by Subject|3
5957716|NCT01215253|20605621|P2|Overall Study|Other|12
5957717|NCT01215253|20605622|P1|Overall Study|Other|14
5957718|NCT01215253|20605621|P2|Overall Study|Lost to Follow-up|4
5957719|NCT01215253|20605622|P1|Overall Study|Lost to Follow-up|6
5957720|NCT01215253|20605621|P2|Overall Study|Physician Decision|12
5957721|NCT01215253|20605622|P1|Overall Study|Physician Decision|9
5957722|NCT01215253|20605621|P2|Overall Study|Withdrawal by Subject|35
5957723|NCT01215253|20605622|P1|Overall Study|Withdrawal by Subject|57
5957724|NCT01215227|20605675|P6|Overall Study|Randomized but not treated|1
5957725|NCT01215227|20605676|P5|Overall Study|Randomized but not treated|0
5957726|NCT01215227|20605677|P4|Overall Study|Randomized but not treated|1
5957727|NCT01215227|20605678|P3|Overall Study|Randomized but not treated|1
5957728|NCT01215227|20605679|P2|Overall Study|Randomized but not treated|0
5957729|NCT01215227|20605680|P1|Overall Study|Randomized but not treated|0
5957730|NCT01215227|20605675|P6|Overall Study|Missing Status|0
5957731|NCT01215227|20605676|P5|Overall Study|Missing Status|0
5957732|NCT01215227|20605677|P4|Overall Study|Missing Status|0
5957733|NCT01215227|20605678|P3|Overall Study|Missing Status|0
5957734|NCT01215227|20605679|P2|Overall Study|Missing Status|1
5957735|NCT01215227|20605680|P1|Overall Study|Missing Status|0
5957736|NCT01215227|20605675|P6|Overall Study|Administrative|40
5957737|NCT01215227|20605676|P5|Overall Study|Administrative|28
5957738|NCT01215227|20605677|P4|Overall Study|Administrative|24
5957739|NCT01215227|20605678|P3|Overall Study|Administrative|42
5957740|NCT01215227|20605679|P2|Overall Study|Administrative|73
5957741|NCT01215227|20605680|P1|Overall Study|Administrative|83
5957742|NCT01215227|20605675|P6|Overall Study|Non-Compliance With Protocol|0
5957743|NCT01215227|20605676|P5|Overall Study|Non-Compliance With Protocol|0
5957744|NCT01215227|20605677|P4|Overall Study|Non-Compliance With Protocol|0
5957745|NCT01215227|20605678|P3|Overall Study|Non-Compliance With Protocol|1
5957746|NCT01215227|20605679|P2|Overall Study|Non-Compliance With Protocol|6
5957747|NCT01215227|20605680|P1|Overall Study|Non-Compliance With Protocol|2
5957748|NCT01215227|20605675|P6|Overall Study|Subject Withdrew Consent|8
5957749|NCT01215227|20605676|P5|Overall Study|Subject Withdrew Consent|11
5957750|NCT01215227|20605677|P4|Overall Study|Subject Withdrew Consent|10
5957751|NCT01215227|20605678|P3|Overall Study|Subject Withdrew Consent|7
5957752|NCT01215227|20605679|P2|Overall Study|Subject Withdrew Consent|20
5957753|NCT01215227|20605680|P1|Overall Study|Subject Withdrew Consent|16
5957754|NCT01215227|20605675|P6|Overall Study|Lost to Follow-up|2
5957755|NCT01215227|20605676|P5|Overall Study|Lost to Follow-up|1
5957756|NCT01215227|20605677|P4|Overall Study|Lost to Follow-up|1
5957757|NCT01215227|20605678|P3|Overall Study|Lost to Follow-up|1
5957758|NCT01215227|20605679|P2|Overall Study|Lost to Follow-up|4
5957759|NCT01215227|20605680|P1|Overall Study|Lost to Follow-up|1
5957760|NCT01215227|20605675|P6|Overall Study|Treatment Failure|1
5957761|NCT01215227|20605676|P5|Overall Study|Treatment Failure|1
5957762|NCT01215227|20605677|P4|Overall Study|Treatment Failure|5
5957763|NCT01215227|20605678|P3|Overall Study|Treatment Failure|1
5957764|NCT01215227|20605679|P2|Overall Study|Treatment Failure|4
5957765|NCT01215227|20605680|P1|Overall Study|Treatment Failure|8
5957766|NCT01215227|20605675|P6|Overall Study|Adverse Event|6
5957767|NCT01215227|20605676|P5|Overall Study|Adverse Event|7
5957768|NCT01215227|20605677|P4|Overall Study|Adverse Event|8
5957769|NCT01215227|20605678|P3|Overall Study|Adverse Event|4
5957770|NCT01215227|20605679|P2|Overall Study|Adverse Event|11
5957771|NCT01215227|20605680|P1|Overall Study|Adverse Event|11
5957772|NCT01215188|20605727|P3|Overall Study|Withdrawal by Subject|31
5957773|NCT01215188|20605728|P2|Overall Study|Withdrawal by Subject|34
5957774|NCT01215188|20605729|P1|Overall Study|Withdrawal by Subject|32
5957775|NCT01215188|20605727|P3|Overall Study|Protocol Violation|1
5957776|NCT01215188|20605728|P2|Overall Study|Protocol Violation|1
5957777|NCT01215188|20605729|P1|Overall Study|Protocol Violation|1
5957778|NCT01215188|20605727|P3|Overall Study|Lack of Efficacy|1
5957779|NCT01215188|20605728|P2|Overall Study|Lack of Efficacy|0
5957780|NCT01215188|20605729|P1|Overall Study|Lack of Efficacy|0
5957781|NCT01215188|20605727|P3|Overall Study|Physician Decision|0
5957782|NCT01215188|20605728|P2|Overall Study|Physician Decision|1
5957783|NCT01215188|20605729|P1|Overall Study|Physician Decision|2
5957784|NCT01215188|20605727|P3|Overall Study|Adverse Event|3
5957785|NCT01215188|20605728|P2|Overall Study|Adverse Event|1
5957786|NCT01215188|20605729|P1|Overall Study|Adverse Event|1
5957787|NCT01215188|20605727|P3|Overall Study|Lost to Follow-up|16
5957788|NCT01215188|20605728|P2|Overall Study|Lost to Follow-up|22
5957789|NCT01215188|20605729|P1|Overall Study|Lost to Follow-up|22
5957790|NCT01215175|20605781|P5|Overall Study|Lost to Follow-up|0
5957791|NCT01215175|20605782|P4|Overall Study|Lost to Follow-up|1
5957792|NCT01215175|20605783|P3|Overall Study|Lost to Follow-up|0
5957793|NCT01215175|20605784|P2|Overall Study|Lost to Follow-up|1
5957794|NCT01215175|20605785|P1|Overall Study|Lost to Follow-up|0
5957795|NCT01215097|20605902|P2|Overall Study|patient's private reason|1
5957796|NCT01215097|20605903|P1|Overall Study|patient's private reason|1
5957797|NCT01215097|20605902|P2|Overall Study|patient's refusal to come|2
5957798|NCT01215097|20605903|P1|Overall Study|patient's refusal to come|2
5957799|NCT01215097|20605902|P2|Overall Study|Lack of Efficacy|3
5957800|NCT01215097|20605903|P1|Overall Study|Lack of Efficacy|0
5957801|NCT01215097|20605902|P2|Overall Study|Withdrawal by Subject|3
5957802|NCT01215097|20605903|P1|Overall Study|Withdrawal by Subject|6
5957803|NCT01215097|20605902|P2|Overall Study|Lost to Follow-up|0
5957804|NCT01215097|20605903|P1|Overall Study|Lost to Follow-up|2
5957805|NCT01215097|20605902|P2|Overall Study|Protocol Violation|2
5957806|NCT01215097|20605903|P1|Overall Study|Protocol Violation|0
5957807|NCT01215097|20605902|P2|Overall Study|Adverse Event|3
5957808|NCT01215097|20605903|P1|Overall Study|Adverse Event|1
5957809|NCT01215032|20605935|P1|Overall Study|Lack of Efficacy|17
5957810|NCT01215032|20605935|P1|Overall Study|Adverse Event|3
5957811|NCT01214915|20605960|P1|Overall Study|Lack of Efficacy|3
5957812|NCT01214915|20605960|P1|Overall Study|Adverse Event|8
5957813|NCT01214850|20605971|P3|Overall Study|Unable to classify|1
5957814|NCT01214850|20605972|P2|Overall Study|Unable to classify|1
5957815|NCT01214850|20605973|P1|Overall Study|Unable to classify|2
5957816|NCT01214850|20605971|P3|Overall Study|Administrative reason|0
5957817|NCT01214850|20605972|P2|Overall Study|Administrative reason|0
5957818|NCT01214850|20605973|P1|Overall Study|Administrative reason|1
5957819|NCT01214850|20605971|P3|Overall Study|Inappropriate enrollment|0
5957820|NCT01214850|20605972|P2|Overall Study|Inappropriate enrollment|1
5957821|NCT01214850|20605973|P1|Overall Study|Inappropriate enrollment|2
5957822|NCT01214850|20605971|P3|Overall Study|Adverse event or death|3
5957823|NCT01214850|20605972|P2|Overall Study|Adverse event or death|8
5957824|NCT01214850|20605973|P1|Overall Study|Adverse event or death|11
5957825|NCT01214850|20605971|P3|Overall Study|Protocol Violation|6
5957826|NCT01214850|20605972|P2|Overall Study|Protocol Violation|5
5957827|NCT01214850|20605973|P1|Overall Study|Protocol Violation|5
5957828|NCT01214850|20605971|P3|Overall Study|Lost to Follow-up|123
5957829|NCT01214850|20605972|P2|Overall Study|Lost to Follow-up|98
5957830|NCT01214850|20605973|P1|Overall Study|Lost to Follow-up|124
5957831|NCT01214850|20605971|P3|Overall Study|Withdrawal by Subject|28
5957832|NCT01214850|20605972|P2|Overall Study|Withdrawal by Subject|31
5957833|NCT01214850|20605973|P1|Overall Study|Withdrawal by Subject|38
5957834|NCT01214837|20606057|P3|Overall Study|Unable to Classify|0
5957835|NCT01214837|20606058|P2|Overall Study|Unable to Classify|3
5957836|NCT01214837|20606059|P1|Overall Study|Unable to Classify|1
5957837|NCT01214837|20606057|P3|Overall Study|Protocol Violation|5
5957838|NCT01214837|20606058|P2|Overall Study|Protocol Violation|1
5957839|NCT01214837|20606059|P1|Overall Study|Protocol Violation|3
5957840|NCT01214837|20606057|P3|Overall Study|Administrative Reason|4
5957841|NCT01214837|20606058|P2|Overall Study|Administrative Reason|6
5957842|NCT01214837|20606059|P1|Overall Study|Administrative Reason|2
5957843|NCT01214837|20606057|P3|Overall Study|Inappropriate Enrolment|2
5957844|NCT01214837|20606058|P2|Overall Study|Inappropriate Enrolment|1
5957845|NCT01214837|20606059|P1|Overall Study|Inappropriate Enrolment|0
5957846|NCT01214837|20606057|P3|Overall Study|Lost to Follow-up|21
5957847|NCT01214837|20606058|P2|Overall Study|Lost to Follow-up|15
5957848|NCT01214837|20606059|P1|Overall Study|Lost to Follow-up|20
5957849|NCT01214837|20606057|P3|Overall Study|Withdrawal by Subject|28
5957850|NCT01214837|20606058|P2|Overall Study|Withdrawal by Subject|36
5957851|NCT01214837|20606059|P1|Overall Study|Withdrawal by Subject|27
5957852|NCT01214837|20606057|P3|Overall Study|Adverse Event|1
5957853|NCT01214837|20606058|P2|Overall Study|Adverse Event|2
5957854|NCT01214837|20606059|P1|Overall Study|Adverse Event|1
5957855|NCT01214837|20606057|P3|Overall Study|Death|1
5957856|NCT01214837|20606058|P2|Overall Study|Death|0
5957857|NCT01214837|20606059|P1|Overall Study|Death|0
5957858|NCT01214720|20606115|P2|Overall Study|Lost to Follow-up|2
5957859|NCT01214720|20606116|P1|Overall Study|Lost to Follow-up|6
5957860|NCT01214720|20606115|P2|Overall Study|Alive and in follow-up|48
5957861|NCT01214720|20606116|P1|Overall Study|Alive and in follow-up|45
5957862|NCT01214720|20606115|P2|Overall Study|Alive and still on treatment|18
5957863|NCT01214720|20606116|P1|Overall Study|Alive and still on treatment|34
5957864|NCT01214668|20606139|P6|Overall Study|Withdrawal by Subject|0
5957865|NCT01214668|20606140|P5|Overall Study|Withdrawal by Subject|1
5957866|NCT01214668|20606141|P4|Overall Study|Withdrawal by Subject|0
5957867|NCT01214668|20606142|P3|Overall Study|Withdrawal by Subject|0
5957868|NCT01214668|20606143|P2|Overall Study|Withdrawal by Subject|0
5957869|NCT01214668|20606144|P1|Overall Study|Withdrawal by Subject|0
5957870|NCT01214668|20606139|P6|Overall Study|Progressive Disease|5
5957871|NCT01214668|20606140|P5|Overall Study|Progressive Disease|4
5957872|NCT01214668|20606141|P4|Overall Study|Progressive Disease|4
5957873|NCT01214668|20606142|P3|Overall Study|Progressive Disease|5
5957874|NCT01214668|20606143|P2|Overall Study|Progressive Disease|2
5957875|NCT01214668|20606144|P1|Overall Study|Progressive Disease|4
5957876|NCT01214668|20606139|P6|Overall Study|Death|0
5957877|NCT01214668|20606140|P5|Overall Study|Death|0
5957878|NCT01214668|20606141|P4|Overall Study|Death|0
5957879|NCT01214668|20606142|P3|Overall Study|Death|1
5957880|NCT01214668|20606143|P2|Overall Study|Death|0
5957881|NCT01214668|20606144|P1|Overall Study|Death|0
5957882|NCT01214668|20606139|P6|Overall Study|Adverse Event|1
5957883|NCT01214668|20606140|P5|Overall Study|Adverse Event|1
5957884|NCT01214668|20606141|P4|Overall Study|Adverse Event|2
5957885|NCT01214668|20606142|P3|Overall Study|Adverse Event|0
5957886|NCT01214668|20606143|P2|Overall Study|Adverse Event|1
5957887|NCT01214668|20606144|P1|Overall Study|Adverse Event|0
5957888|NCT01214655|20606181|P3|Part C|Physician Decision|1
5957889|NCT01214655|20606182|P2|Part C|Physician Decision|0
5957890|NCT01214655|20606183|P1|Part C|Physician Decision|0
5957891|NCT01214655|20606181|P3|Part C|Death|1
5957892|NCT01214655|20606182|P2|Part C|Death|0
5957894|NCT01214655|20606181|P3|Part C|Progressive Disease|5
5957895|NCT01214655|20606182|P2|Part C|Progressive Disease|0
5957896|NCT01214655|20606183|P1|Part C|Progressive Disease|0
5957897|NCT01214655|20606181|P3|Part B|Withdrawal by Subject|0
5957898|NCT01214655|20606182|P2|Part B|Withdrawal by Subject|2
5957899|NCT01214655|20606183|P1|Part B|Withdrawal by Subject|0
5957900|NCT01214655|20606181|P3|Part B|Death|0
5957901|NCT01214655|20606182|P2|Part B|Death|1
5957902|NCT01214655|20606183|P1|Part B|Death|0
5957903|NCT01214655|20606181|P3|Part B|Progressive disease|0
5957904|NCT01214655|20606182|P2|Part B|Progressive disease|10
5957905|NCT01214655|20606183|P1|Part B|Progressive disease|0
5957906|NCT01214655|20606181|P3|Part A|Physician Decision|0
5957907|NCT01214655|20606182|P2|Part A|Physician Decision|0
5957908|NCT01214655|20606183|P1|Part A|Physician Decision|1
5957909|NCT01214655|20606181|P3|Part A|Progressive Disease|0
5957910|NCT01214655|20606182|P2|Part A|Progressive Disease|0
5957911|NCT01214655|20606183|P1|Part A|Progressive Disease|7
5957912|NCT01214642|20606256|P12|Overall Study|Physician Decision|2
5957913|NCT01214642|20606257|P11|Overall Study|Physician Decision|0
5957914|NCT01214642|20606258|P10|Overall Study|Physician Decision|0
5957915|NCT01214642|20606259|P9|Overall Study|Physician Decision|0
5957916|NCT01214642|20606260|P8|Overall Study|Physician Decision|0
5957917|NCT01214642|20606261|P7|Overall Study|Physician Decision|0
5957918|NCT01214642|20606262|P6|Overall Study|Physician Decision|0
5957919|NCT01214642|20606263|P5|Overall Study|Physician Decision|1
5957920|NCT01214642|20606264|P4|Overall Study|Physician Decision|1
5957921|NCT01214642|20606265|P3|Overall Study|Physician Decision|1
5957922|NCT01214642|20606266|P2|Overall Study|Physician Decision|0
5957923|NCT01214642|20606267|P1|Overall Study|Physician Decision|0
5957924|NCT01214642|20606256|P12|Overall Study|Withdrawal by Subject|0
5957925|NCT01214642|20606257|P11|Overall Study|Withdrawal by Subject|1
5957926|NCT01214642|20606258|P10|Overall Study|Withdrawal by Subject|1
5957927|NCT01214642|20606259|P9|Overall Study|Withdrawal by Subject|3
5957928|NCT01214642|20606260|P8|Overall Study|Withdrawal by Subject|0
5957929|NCT01214642|20606261|P7|Overall Study|Withdrawal by Subject|0
5957930|NCT01214642|20606262|P6|Overall Study|Withdrawal by Subject|0
5957931|NCT01214642|20606263|P5|Overall Study|Withdrawal by Subject|0
5957932|NCT01214642|20606264|P4|Overall Study|Withdrawal by Subject|0
5957933|NCT01214642|20606265|P3|Overall Study|Withdrawal by Subject|1
5957934|NCT01214642|20606266|P2|Overall Study|Withdrawal by Subject|0
5957935|NCT01214642|20606267|P1|Overall Study|Withdrawal by Subject|0
5957936|NCT01214642|20606256|P12|Overall Study|Death|0
5957937|NCT01214642|20606257|P11|Overall Study|Death|1
5957938|NCT01214642|20606258|P10|Overall Study|Death|0
5957939|NCT01214642|20606259|P9|Overall Study|Death|0
5957940|NCT01214642|20606260|P8|Overall Study|Death|0
5957941|NCT01214642|20606261|P7|Overall Study|Death|0
5957942|NCT01214642|20606262|P6|Overall Study|Death|0
5957943|NCT01214642|20606263|P5|Overall Study|Death|0
5957944|NCT01214642|20606264|P4|Overall Study|Death|0
5957945|NCT01214642|20606265|P3|Overall Study|Death|1
5957946|NCT01214642|20606266|P2|Overall Study|Death|0
5957947|NCT01214642|20606267|P1|Overall Study|Death|0
5957948|NCT01214642|20606256|P12|Overall Study|Adverse Event|0
5957949|NCT01214642|20606257|P11|Overall Study|Adverse Event|1
5957950|NCT01214642|20606258|P10|Overall Study|Adverse Event|1
5957951|NCT01214642|20606259|P9|Overall Study|Adverse Event|0
5957952|NCT01214642|20606260|P8|Overall Study|Adverse Event|0
5957953|NCT01214642|20606261|P7|Overall Study|Adverse Event|1
5957954|NCT01214642|20606262|P6|Overall Study|Adverse Event|0
5957955|NCT01214642|20606263|P5|Overall Study|Adverse Event|0
5957956|NCT01214642|20606264|P4|Overall Study|Adverse Event|0
5957957|NCT01214642|20606265|P3|Overall Study|Adverse Event|0
5957958|NCT01214642|20606266|P2|Overall Study|Adverse Event|1
5957959|NCT01214642|20606267|P1|Overall Study|Adverse Event|0
5957960|NCT01214642|20606256|P12|Overall Study|Progressive Disease|4
5957961|NCT01214642|20606257|P11|Overall Study|Progressive Disease|1
5957962|NCT01214642|20606258|P10|Overall Study|Progressive Disease|2
5957963|NCT01214642|20606259|P9|Overall Study|Progressive Disease|10
5957964|NCT01214642|20606260|P8|Overall Study|Progressive Disease|3
5957965|NCT01214642|20606261|P7|Overall Study|Progressive Disease|5
5957966|NCT01214642|20606262|P6|Overall Study|Progressive Disease|3
5957967|NCT01214642|20606263|P5|Overall Study|Progressive Disease|5
5957968|NCT01214642|20606264|P4|Overall Study|Progressive Disease|5
5957969|NCT01214642|20606265|P3|Overall Study|Progressive Disease|3
5957970|NCT01214642|20606266|P2|Overall Study|Progressive Disease|2
5957971|NCT01214642|20606267|P1|Overall Study|Progressive Disease|3
5957972|NCT01214629|20606347|P11|Overall Study|Withdrawal by Subject|0
5957973|NCT01214629|20606348|P10|Overall Study|Withdrawal by Subject|1
5957974|NCT01214629|20606349|P9|Overall Study|Withdrawal by Subject|0
5957975|NCT01214629|20606350|P8|Overall Study|Withdrawal by Subject|0
5957976|NCT01214629|20606351|P7|Overall Study|Withdrawal by Subject|0
5957977|NCT01214629|20606352|P6|Overall Study|Withdrawal by Subject|0
5957978|NCT01214629|20606353|P5|Overall Study|Withdrawal by Subject|0
5957979|NCT01214629|20606354|P4|Overall Study|Withdrawal by Subject|0
5957980|NCT01214629|20606355|P3|Overall Study|Withdrawal by Subject|0
5957981|NCT01214629|20606356|P2|Overall Study|Withdrawal by Subject|0
5957982|NCT01214629|20606357|P1|Overall Study|Withdrawal by Subject|0
5957983|NCT01214629|20606347|P11|Overall Study|Physician Decision|1
5957984|NCT01214629|20606348|P10|Overall Study|Physician Decision|0
5957985|NCT01214629|20606349|P9|Overall Study|Physician Decision|0
5957986|NCT01214629|20606350|P8|Overall Study|Physician Decision|0
5957987|NCT01214629|20606351|P7|Overall Study|Physician Decision|0
5957988|NCT01214629|20606352|P6|Overall Study|Physician Decision|0
5957989|NCT01214629|20606353|P5|Overall Study|Physician Decision|0
5957990|NCT01214629|20606354|P4|Overall Study|Physician Decision|0
5957991|NCT01214629|20606355|P3|Overall Study|Physician Decision|0
5957992|NCT01214629|20606356|P2|Overall Study|Physician Decision|0
5957993|NCT01214629|20606357|P1|Overall Study|Physician Decision|0
5957994|NCT01214629|20606347|P11|Overall Study|Adverse Event|0
5957995|NCT01214629|20606348|P10|Overall Study|Adverse Event|1
5957996|NCT01214629|20606349|P9|Overall Study|Adverse Event|0
5957997|NCT01214629|20606350|P8|Overall Study|Adverse Event|0
5957998|NCT01214629|20606351|P7|Overall Study|Adverse Event|0
5957999|NCT01214629|20606352|P6|Overall Study|Adverse Event|1
5958000|NCT01214629|20606353|P5|Overall Study|Adverse Event|0
5958001|NCT01214629|20606354|P4|Overall Study|Adverse Event|1
5958002|NCT01214629|20606355|P3|Overall Study|Adverse Event|0
5958003|NCT01214629|20606356|P2|Overall Study|Adverse Event|0
5958004|NCT01214629|20606357|P1|Overall Study|Adverse Event|0
5958005|NCT01214629|20606347|P11|Overall Study|Progressive Disease|1
5958006|NCT01214629|20606348|P10|Overall Study|Progressive Disease|5
5958007|NCT01214629|20606349|P9|Overall Study|Progressive Disease|1
5958008|NCT01214629|20606350|P8|Overall Study|Progressive Disease|1
5958009|NCT01214629|20606351|P7|Overall Study|Progressive Disease|1
5958010|NCT01214629|20606352|P6|Overall Study|Progressive Disease|3
5958011|NCT01214629|20606353|P5|Overall Study|Progressive Disease|2
5958012|NCT01214629|20606354|P4|Overall Study|Progressive Disease|1
5958013|NCT01214629|20606355|P3|Overall Study|Progressive Disease|0
5958014|NCT01214629|20606356|P2|Overall Study|Progressive Disease|1
5958015|NCT01214629|20606357|P1|Overall Study|Progressive Disease|1
5958016|NCT01214616|20606422|P4|Overall Study|Withdrawal by Subject|1
5958017|NCT01214616|20606423|P3|Overall Study|Withdrawal by Subject|0
5958018|NCT01214616|20606424|P2|Overall Study|Withdrawal by Subject|0
5958019|NCT01214616|20606425|P1|Overall Study|Withdrawal by Subject|1
5958020|NCT01214616|20606422|P4|Overall Study|Other adverse events|1
5958021|NCT01214616|20606423|P3|Overall Study|Other adverse events|1
5958022|NCT01214616|20606424|P2|Overall Study|Other adverse events|1
5958023|NCT01214616|20606425|P1|Overall Study|Other adverse events|0
5958024|NCT01214616|20606422|P4|Overall Study|Dose limiting toxicity|0
5958025|NCT01214616|20606423|P3|Overall Study|Dose limiting toxicity|0
5958026|NCT01214616|20606424|P2|Overall Study|Dose limiting toxicity|2
5958027|NCT01214616|20606425|P1|Overall Study|Dose limiting toxicity|0
5958028|NCT01214616|20606422|P4|Overall Study|Progressive disease|4
5958029|NCT01214616|20606423|P3|Overall Study|Progressive disease|2
5958030|NCT01214616|20606424|P2|Overall Study|Progressive disease|2
5958031|NCT01214616|20606425|P1|Overall Study|Progressive disease|2
5958032|NCT01214603|20606462|P3|Overall Study|Progressive Disease|3
5958033|NCT01214603|20606463|P2|Overall Study|Progressive Disease|1
5958034|NCT01214603|20606464|P1|Overall Study|Progressive Disease|4
5958035|NCT01214603|20606462|P3|Overall Study|Death|0
5958036|NCT01214603|20606463|P2|Overall Study|Death|0
5958037|NCT01214603|20606464|P1|Overall Study|Death|1
5958038|NCT01214603|20606462|P3|Overall Study|Adverse Event|1
5958039|NCT01214603|20606463|P2|Overall Study|Adverse Event|0
5958040|NCT01214603|20606464|P1|Overall Study|Adverse Event|0
5958041|NCT01214434|20606487|P2|Overall Study|Site error|0
5958042|NCT01214434|20606488|P1|Overall Study|Site error|1
5958043|NCT01214434|20606487|P2|Overall Study|Lost to Follow-up|2
5958044|NCT01214434|20606488|P1|Overall Study|Lost to Follow-up|2
5958045|NCT01214434|20606487|P2|Overall Study|Withdrawal by Subject|0
5958046|NCT01214434|20606488|P1|Overall Study|Withdrawal by Subject|1
5958047|NCT01214395|20606504|P1|Overall Study|All patients had infection|5
5958048|NCT01214252|20606533|P1|Overall Study|Not eligible per protocol|82
5958049|NCT01214239|20606541|P2|Overall Study|patient's private reason|1
5958050|NCT01214239|20606542|P1|Overall Study|patient's private reason|1
5958051|NCT01214239|20606541|P2|Overall Study|Lack of Efficacy|2
5958052|NCT01214239|20606542|P1|Overall Study|Lack of Efficacy|1
5958053|NCT01214239|20606541|P2|Overall Study|Withdrawal by Subject|9
5958054|NCT01214239|20606542|P1|Overall Study|Withdrawal by Subject|4
5958055|NCT01214239|20606541|P2|Overall Study|Lost to Follow-up|1
5958056|NCT01214239|20606542|P1|Overall Study|Lost to Follow-up|1
5958057|NCT01214239|20606541|P2|Overall Study|Protocol Violation|1
5958058|NCT01214239|20606542|P1|Overall Study|Protocol Violation|2
5958059|NCT01214239|20606541|P2|Overall Study|Adverse Event|4
5958060|NCT01214239|20606542|P1|Overall Study|Adverse Event|3
5958061|NCT01214200|20606574|P1|Overall Study|Withdrawal by Subject|2
5958062|NCT01214200|20606574|P1|Overall Study|Did not meet inclusion/exclusion|9
5958063|NCT01214187|20606588|P2|Overall Study|Withdrawal by Subject|3
5958064|NCT01214187|20606589|P1|Overall Study|Withdrawal by Subject|0
5958065|NCT01214187|20606588|P2|Overall Study|Death|1
5958066|NCT01214187|20606589|P1|Overall Study|Death|1
5958067|NCT01214187|20606588|P2|Overall Study|Adverse Event|2
5958068|NCT01214187|20606589|P1|Overall Study|Adverse Event|6
5958069|NCT01214174|20606606|P3|Overall Study|Withdrawal by Subject|1
5958070|NCT01214174|20606607|P2|Overall Study|Withdrawal by Subject|0
5958071|NCT01214174|20606608|P1|Overall Study|Withdrawal by Subject|0
5958072|NCT01214044|20606758|P1|Visits 6-11: Escitalopram 20 mg Daily|Adverse Event|1
5958073|NCT01214044|20606758|P1|Visits 6-11: Escitalopram 20 mg Daily|Withdrawal by Subject|3
5958074|NCT01214044|20606758|P1|Visits 3-5: Escitalopram 10 mg Daily|Withdrawal by Subject|3
5958075|NCT01214044|20606758|P1|Visit 1: Screening and Consent, Washout|Lost to Follow-up|4
5958076|NCT01214044|20606758|P1|Visit 1: Screening and Consent, Washout|Ineligible|3
5958077|NCT01214044|20606758|P1|Visit 1: Screening and Consent, Washout|Withdrawal by Subject|5
5958078|NCT01213966|20606772|P4|Overall Study|Protocol Violation|1
5958079|NCT01213966|20606773|P3|Overall Study|Protocol Violation|3
5958080|NCT01213966|20606774|P2|Overall Study|Protocol Violation|0
5958081|NCT01213966|20606775|P1|Overall Study|Protocol Violation|1
5958082|NCT01213836|20606796|P2|Period 1, First Intervention|Withdrawal by Subject|1
5958083|NCT01213836|20606797|P1|Period 1, First Intervention|Withdrawal by Subject|1
5958084|NCT01213836|20606796|P2|Period 1, First Intervention|Protocol Violation|1
5958085|NCT01213836|20606797|P1|Period 1, First Intervention|Protocol Violation|0
5958086|NCT01213836|20606796|P2|Period 1, First Intervention|Adverse Event|1
5958087|NCT01213836|20606797|P1|Period 1, First Intervention|Adverse Event|2
5958088|NCT01213524|20606884|P1|Session 4|Withdrawal by Subject|2
5958089|NCT01213524|20606884|P1|Session 4|Physician Decision|1
5958090|NCT01213524|20606884|P1|Session 3|Withdrawal by Subject|4
5958091|NCT01213524|20606884|P1|Session 2|Withdrawal by Subject|5
5958092|NCT01213524|20606884|P1|Baseline|Physician Decision|1
5958093|NCT01213524|20606884|P1|Baseline|high breath alcohol levels|1
5958094|NCT01213524|20606884|P1|Baseline|Withdrawal by Subject|5
5958095|NCT01213472|20606898|P1|Overall Study|Physician Decision|1
5958096|NCT01213472|20606898|P1|Overall Study|Withdrawal by Subject|1
5958097|NCT01213472|20606898|P1|Overall Study|Recurrence/Progressive disease|25
5958098|NCT01213264|20606947|P3|Overall Study|Lost to Follow-up|6
5958099|NCT01213264|20606948|P2|Overall Study|Lost to Follow-up|2
5958100|NCT01213264|20606949|P1|Overall Study|Lost to Follow-up|1
5958101|NCT01213264|20606947|P3|Overall Study|Adverse Event|0
5958102|NCT01213264|20606948|P2|Overall Study|Adverse Event|0
5958103|NCT01213264|20606949|P1|Overall Study|Adverse Event|1
5958104|NCT01213251|20606969|P3|Overall Study|Missed 18-Month Follow-up|1
5958105|NCT01213251|20606970|P2|Overall Study|Missed 18-Month Follow-up|0
5958106|NCT01213251|20606971|P1|Overall Study|Missed 18-Month Follow-up|0
5958107|NCT01213251|20606969|P3|Overall Study|Protocol Violation|0
5958108|NCT01213251|20606970|P2|Overall Study|Protocol Violation|1
5958109|NCT01213251|20606971|P1|Overall Study|Protocol Violation|1
5958110|NCT01213251|20606969|P3|Overall Study|Exit|8
5958111|NCT01213251|20606970|P2|Overall Study|Exit|2
5958112|NCT01213251|20606971|P1|Overall Study|Exit|3
5958113|NCT01213251|20606969|P3|Overall Study|Death|2
5958114|NCT01213251|20606970|P2|Overall Study|Death|1
5958115|NCT01213251|20606971|P1|Overall Study|Death|2
5958116|NCT01213173|20606998|P2|Overall Study|Incorrect Enrollment|3
5958117|NCT01213173|20606999|P1|Overall Study|Incorrect Enrollment|1
5958118|NCT01213173|20606998|P2|Overall Study|Withdrawal by Subject|5
5958119|NCT01213173|20606999|P1|Overall Study|Withdrawal by Subject|5
5958120|NCT01213173|20606998|P2|Overall Study|Adverse Event|8
5958121|NCT01213173|20606999|P1|Overall Study|Adverse Event|4
5958122|NCT01213173|20606998|P2|Overall Study|Protocol Violation|0
5958123|NCT01213173|20606999|P1|Overall Study|Protocol Violation|2
5958124|NCT01213082|20607032|P3|Overall Study|Physician Decision|1
5958125|NCT01213082|20607033|P2|Overall Study|Physician Decision|0
5958126|NCT01213082|20607034|P1|Overall Study|Physician Decision|0
5958127|NCT01213082|20607032|P3|Overall Study|Lost to Follow-up|4
5958128|NCT01213082|20607033|P2|Overall Study|Lost to Follow-up|7
5958129|NCT01213082|20607034|P1|Overall Study|Lost to Follow-up|6
5958130|NCT01212991|20607076|P3|Open-label|Other|3
5958131|NCT01212991|20607077|P2|Open-label|Other|0
5958132|NCT01212991|20607078|P1|Open-label|Other|0
5958133|NCT01212991|20607076|P3|Open-label|Sponsor decision|53
5958134|NCT01212991|20607077|P2|Open-label|Sponsor decision|0
5958135|NCT01212991|20607078|P1|Open-label|Sponsor decision|0
5958136|NCT01212991|20607076|P3|Open-label|Withdrawal by Subject|7
5958137|NCT01212991|20607077|P2|Open-label|Withdrawal by Subject|0
5958138|NCT01212991|20607078|P1|Open-label|Withdrawal by Subject|0
5958139|NCT01212991|20607076|P3|Open-label|Lost to Follow-up|5
5958140|NCT01212991|20607077|P2|Open-label|Lost to Follow-up|0
5958141|NCT01212991|20607078|P1|Open-label|Lost to Follow-up|0
5958142|NCT01212991|20607076|P3|Open-label|Death|166
5958143|NCT01212991|20607077|P2|Open-label|Death|0
5958144|NCT01212991|20607078|P1|Open-label|Death|0
5958145|NCT01212991|20607076|P3|Double-blind|Sponsor decision|0
5958146|NCT01212991|20607077|P2|Double-blind|Sponsor decision|38
5958147|NCT01212991|20607078|P1|Double-blind|Sponsor decision|142
5958148|NCT01212991|20607076|P3|Double-blind|Other|0
5958149|NCT01212991|20607077|P2|Double-blind|Other|0
5958150|NCT01212991|20607078|P1|Double-blind|Other|7
5958151|NCT01212991|20607076|P3|Double-blind|Withdrawal by Subject|0
5958152|NCT01212991|20607077|P2|Double-blind|Withdrawal by Subject|19
5958153|NCT01212991|20607078|P1|Double-blind|Withdrawal by Subject|16
5958154|NCT01212991|20607076|P3|Double-blind|Death|0
5958155|NCT01212991|20607077|P2|Double-blind|Death|550
5958156|NCT01212991|20607078|P1|Double-blind|Death|699
5958157|NCT01212991|20607076|P3|Double-blind|Lost to Follow-up|0
5958158|NCT01212991|20607077|P2|Double-blind|Lost to Follow-up|4
5958159|NCT01212991|20607078|P1|Double-blind|Lost to Follow-up|8
5958160|NCT01212770|20607150|P9|Long-term Safety Phase (Year 5)|Death|0
5958161|NCT01212770|20607151|P8|Long-term Safety Phase (Year 5)|Death|1
5958162|NCT01212770|20607152|P7|Long-term Safety Phase (Year 5)|Death|0
5958163|NCT01212770|20607153|P6|Long-term Safety Phase (Year 5)|Death|0
5958164|NCT01212770|20607154|P5|Long-term Safety Phase (Year 5)|Death|0
5958165|NCT01212770|20607155|P4|Long-term Safety Phase (Year 5)|Death|0
5958166|NCT01212770|20607156|P3|Long-term Safety Phase (Year 5)|Death|0
5958167|NCT01212770|20607157|P2|Long-term Safety Phase (Year 5)|Death|0
5958168|NCT01212770|20607158|P1|Long-term Safety Phase (Year 5)|Death|0
5958169|NCT01212770|20607150|P9|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
5958170|NCT01212770|20607151|P8|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1
5958171|NCT01212770|20607152|P7|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
5958172|NCT01212770|20607153|P6|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
5958173|NCT01212770|20607154|P5|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
5958174|NCT01212770|20607155|P4|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
5958175|NCT01212770|20607156|P3|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1
5958176|NCT01212770|20607157|P2|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2
5958177|NCT01212770|20607158|P1|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
5958178|NCT01212770|20607150|P9|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
5958179|NCT01212770|20607151|P8|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
5958180|NCT01212770|20607152|P7|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
5958181|NCT01212770|20607153|P6|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
5958182|NCT01212770|20607154|P5|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
5958183|NCT01212770|20607155|P4|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
5958184|NCT01212770|20607156|P3|Long-term Safety Phase (Year 5)|Lack of Efficacy|4
5958185|NCT01212770|20607157|P2|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
5958186|NCT01212770|20607158|P1|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
5958187|NCT01212770|20607150|P9|Long-term Safety Phase (Year 5)|Adverse Event|1
5958188|NCT01212770|20607151|P8|Long-term Safety Phase (Year 5)|Adverse Event|0
5958189|NCT01212770|20607152|P7|Long-term Safety Phase (Year 5)|Adverse Event|0
5958190|NCT01212770|20607153|P6|Long-term Safety Phase (Year 5)|Adverse Event|0
5958191|NCT01212770|20607154|P5|Long-term Safety Phase (Year 5)|Adverse Event|0
5958192|NCT01212770|20607155|P4|Long-term Safety Phase (Year 5)|Adverse Event|0
5958193|NCT01212770|20607156|P3|Long-term Safety Phase (Year 5)|Adverse Event|2
5958194|NCT01212770|20607157|P2|Long-term Safety Phase (Year 5)|Adverse Event|0
5958195|NCT01212770|20607158|P1|Long-term Safety Phase (Year 5)|Adverse Event|0
5958196|NCT01212770|20607150|P9|Long-term Safety Phase (Year 5)|Miscellaneous|0
5958197|NCT01212770|20607151|P8|Long-term Safety Phase (Year 5)|Miscellaneous|0
5958198|NCT01212770|20607152|P7|Long-term Safety Phase (Year 5)|Miscellaneous|0
5958199|NCT01212770|20607153|P6|Long-term Safety Phase (Year 5)|Miscellaneous|0
5958200|NCT01212770|20607154|P5|Long-term Safety Phase (Year 5)|Miscellaneous|0
5958201|NCT01212770|20607155|P4|Long-term Safety Phase (Year 5)|Miscellaneous|0
5958202|NCT01212770|20607156|P3|Long-term Safety Phase (Year 5)|Miscellaneous|3
5958203|NCT01212770|20607157|P2|Long-term Safety Phase (Year 5)|Miscellaneous|0
5958204|NCT01212770|20607158|P1|Long-term Safety Phase (Year 5)|Miscellaneous|0
5958205|NCT01212770|20607150|P9|Long-term Safety Phase (Year 5)|Missing|0
5958206|NCT01212770|20607151|P8|Long-term Safety Phase (Year 5)|Missing|0
5958207|NCT01212770|20607152|P7|Long-term Safety Phase (Year 5)|Missing|0
5958208|NCT01212770|20607153|P6|Long-term Safety Phase (Year 5)|Missing|0
5958209|NCT01212770|20607154|P5|Long-term Safety Phase (Year 5)|Missing|0
5958210|NCT01212770|20607155|P4|Long-term Safety Phase (Year 5)|Missing|0
5958211|NCT01212770|20607156|P3|Long-term Safety Phase (Year 5)|Missing|1
5958212|NCT01212770|20607157|P2|Long-term Safety Phase (Year 5)|Missing|0
5958213|NCT01212770|20607158|P1|Long-term Safety Phase (Year 5)|Missing|0
5958214|NCT01212770|20607150|P9|Long-term Safety Phase (Year 4)|Miscellaneous|1
5958215|NCT01212770|20607151|P8|Long-term Safety Phase (Year 4)|Miscellaneous|0
5958216|NCT01212770|20607152|P7|Long-term Safety Phase (Year 4)|Miscellaneous|0
5958217|NCT01212770|20607153|P6|Long-term Safety Phase (Year 4)|Miscellaneous|0
5958218|NCT01212770|20607154|P5|Long-term Safety Phase (Year 4)|Miscellaneous|0
5958219|NCT01212770|20607155|P4|Long-term Safety Phase (Year 4)|Miscellaneous|0
5958220|NCT01212770|20607156|P3|Long-term Safety Phase (Year 4)|Miscellaneous|0
5958221|NCT01212770|20607157|P2|Long-term Safety Phase (Year 4)|Miscellaneous|1
5958222|NCT01212770|20607158|P1|Long-term Safety Phase (Year 4)|Miscellaneous|0
5958223|NCT01212770|20607150|P9|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
5958224|NCT01212770|20607151|P8|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
5958225|NCT01212770|20607152|P7|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
5958226|NCT01212770|20607153|P6|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
5958227|NCT01212770|20607154|P5|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
5958228|NCT01212770|20607155|P4|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
5958229|NCT01212770|20607156|P3|Long-term Safety Phase (Year 4)|Lost to Follow-up|1
5958230|NCT01212770|20607157|P2|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
5958231|NCT01212770|20607158|P1|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
5958232|NCT01212770|20607150|P9|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
5958233|NCT01212770|20607151|P8|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
5958234|NCT01212770|20607152|P7|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
5958235|NCT01212770|20607153|P6|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
5958236|NCT01212770|20607154|P5|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
5958237|NCT01212770|20607155|P4|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
5958238|NCT01212770|20607156|P3|Long-term Safety Phase (Year 4)|Withdrawal by Subject|3
5958239|NCT01212770|20607157|P2|Long-term Safety Phase (Year 4)|Withdrawal by Subject|2
5958240|NCT01212770|20607158|P1|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
5958750|NCT01212757|20607360|P4|Placebo-controlled Phase (Week 0 - 24)|Other|0
5958241|NCT01212770|20607150|P9|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0
5958242|NCT01212770|20607151|P8|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1
5958243|NCT01212770|20607152|P7|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0
5958244|NCT01212770|20607153|P6|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0
5958245|NCT01212770|20607154|P5|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0
5958246|NCT01212770|20607155|P4|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0
5958247|NCT01212770|20607156|P3|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1
5958248|NCT01212770|20607157|P2|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1
5958249|NCT01212770|20607158|P1|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0
5958250|NCT01212770|20607150|P9|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
5958251|NCT01212770|20607151|P8|Long-term Safety Phase (Year 4)|Lack of Efficacy|2
5958252|NCT01212770|20607152|P7|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
5958253|NCT01212770|20607153|P6|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
5958254|NCT01212770|20607154|P5|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
5958255|NCT01212770|20607155|P4|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
5958256|NCT01212770|20607156|P3|Long-term Safety Phase (Year 4)|Lack of Efficacy|5
5958257|NCT01212770|20607157|P2|Long-term Safety Phase (Year 4)|Lack of Efficacy|1
5958258|NCT01212770|20607158|P1|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
5958259|NCT01212770|20607150|P9|Long-term Safety Phase (Year 4)|Adverse Event|1
5958260|NCT01212770|20607151|P8|Long-term Safety Phase (Year 4)|Adverse Event|0
5958261|NCT01212770|20607152|P7|Long-term Safety Phase (Year 4)|Adverse Event|0
5958262|NCT01212770|20607153|P6|Long-term Safety Phase (Year 4)|Adverse Event|0
5958263|NCT01212770|20607154|P5|Long-term Safety Phase (Year 4)|Adverse Event|0
5958264|NCT01212770|20607155|P4|Long-term Safety Phase (Year 4)|Adverse Event|0
5958265|NCT01212770|20607156|P3|Long-term Safety Phase (Year 4)|Adverse Event|1
5958266|NCT01212770|20607157|P2|Long-term Safety Phase (Year 4)|Adverse Event|1
5958267|NCT01212770|20607158|P1|Long-term Safety Phase (Year 4)|Adverse Event|0
5958268|NCT01212770|20607150|P9|Long-term Safety Phase (Year 3)|Miscellaneous|1
5958269|NCT01212770|20607151|P8|Long-term Safety Phase (Year 3)|Miscellaneous|1
5958270|NCT01212770|20607152|P7|Long-term Safety Phase (Year 3)|Miscellaneous|0
5958271|NCT01212770|20607153|P6|Long-term Safety Phase (Year 3)|Miscellaneous|0
5958272|NCT01212770|20607154|P5|Long-term Safety Phase (Year 3)|Miscellaneous|0
5958273|NCT01212770|20607155|P4|Long-term Safety Phase (Year 3)|Miscellaneous|0
5958274|NCT01212770|20607156|P3|Long-term Safety Phase (Year 3)|Miscellaneous|1
5958275|NCT01212770|20607157|P2|Long-term Safety Phase (Year 3)|Miscellaneous|2
5958276|NCT01212770|20607158|P1|Long-term Safety Phase (Year 3)|Miscellaneous|0
5958277|NCT01212770|20607150|P9|Long-term Safety Phase (Year 3)|Protocol Violation|0
5958278|NCT01212770|20607151|P8|Long-term Safety Phase (Year 3)|Protocol Violation|1
5958279|NCT01212770|20607152|P7|Long-term Safety Phase (Year 3)|Protocol Violation|0
5958280|NCT01212770|20607153|P6|Long-term Safety Phase (Year 3)|Protocol Violation|0
5958281|NCT01212770|20607154|P5|Long-term Safety Phase (Year 3)|Protocol Violation|0
5958282|NCT01212770|20607155|P4|Long-term Safety Phase (Year 3)|Protocol Violation|0
5958283|NCT01212770|20607156|P3|Long-term Safety Phase (Year 3)|Protocol Violation|0
5958284|NCT01212770|20607157|P2|Long-term Safety Phase (Year 3)|Protocol Violation|0
5958285|NCT01212770|20607158|P1|Long-term Safety Phase (Year 3)|Protocol Violation|0
5958286|NCT01212770|20607150|P9|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
5958287|NCT01212770|20607151|P8|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
5958288|NCT01212770|20607152|P7|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
5958289|NCT01212770|20607153|P6|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
5958290|NCT01212770|20607154|P5|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
5958291|NCT01212770|20607155|P4|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
5958292|NCT01212770|20607156|P3|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
5958293|NCT01212770|20607157|P2|Long-term Safety Phase (Year 3)|Lost to Follow-up|1
5958294|NCT01212770|20607158|P1|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
5958295|NCT01212770|20607150|P9|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1
5958296|NCT01212770|20607151|P8|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1
5958297|NCT01212770|20607152|P7|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
5958298|NCT01212770|20607153|P6|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
5958299|NCT01212770|20607154|P5|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
5958300|NCT01212770|20607155|P4|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
5958301|NCT01212770|20607156|P3|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4
5958302|NCT01212770|20607157|P2|Long-term Safety Phase (Year 3)|Withdrawal by Subject|3
5958303|NCT01212770|20607158|P1|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
5958304|NCT01212770|20607150|P9|Long-term Safety Phase (Year 3)|Lack of Efficacy|2
5958305|NCT01212770|20607151|P8|Long-term Safety Phase (Year 3)|Lack of Efficacy|2
5958306|NCT01212770|20607152|P7|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
5958307|NCT01212770|20607153|P6|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
5958308|NCT01212770|20607154|P5|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
5958309|NCT01212770|20607155|P4|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
5958310|NCT01212770|20607156|P3|Long-term Safety Phase (Year 3)|Lack of Efficacy|4
5958311|NCT01212770|20607157|P2|Long-term Safety Phase (Year 3)|Lack of Efficacy|3
5958312|NCT01212770|20607158|P1|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
5958313|NCT01212770|20607150|P9|Long-term Safety Phase (Year 3)|Adverse Event|1
5958314|NCT01212770|20607151|P8|Long-term Safety Phase (Year 3)|Adverse Event|2
5958315|NCT01212770|20607152|P7|Long-term Safety Phase (Year 3)|Adverse Event|0
5958316|NCT01212770|20607153|P6|Long-term Safety Phase (Year 3)|Adverse Event|0
5958317|NCT01212770|20607154|P5|Long-term Safety Phase (Year 3)|Adverse Event|0
5958318|NCT01212770|20607155|P4|Long-term Safety Phase (Year 3)|Adverse Event|0
5958319|NCT01212770|20607156|P3|Long-term Safety Phase (Year 3)|Adverse Event|2
5958320|NCT01212770|20607157|P2|Long-term Safety Phase (Year 3)|Adverse Event|2
5958321|NCT01212770|20607158|P1|Long-term Safety Phase (Year 3)|Adverse Event|0
5958322|NCT01212770|20607150|P9|Long-term Safety Phase (Year 2)|Miscellaneous|1
5958323|NCT01212770|20607151|P8|Long-term Safety Phase (Year 2)|Miscellaneous|0
5958324|NCT01212770|20607152|P7|Long-term Safety Phase (Year 2)|Miscellaneous|0
5958325|NCT01212770|20607153|P6|Long-term Safety Phase (Year 2)|Miscellaneous|0
5958326|NCT01212770|20607154|P5|Long-term Safety Phase (Year 2)|Miscellaneous|0
5958327|NCT01212770|20607155|P4|Long-term Safety Phase (Year 2)|Miscellaneous|0
5958328|NCT01212770|20607156|P3|Long-term Safety Phase (Year 2)|Miscellaneous|1
5958329|NCT01212770|20607157|P2|Long-term Safety Phase (Year 2)|Miscellaneous|2
5958330|NCT01212770|20607158|P1|Long-term Safety Phase (Year 2)|Miscellaneous|0
5958331|NCT01212770|20607150|P9|Long-term Safety Phase (Year 2)|Lost to Follow-up|1
5958332|NCT01212770|20607151|P8|Long-term Safety Phase (Year 2)|Lost to Follow-up|1
5958333|NCT01212770|20607152|P7|Long-term Safety Phase (Year 2)|Lost to Follow-up|0
5958334|NCT01212770|20607153|P6|Long-term Safety Phase (Year 2)|Lost to Follow-up|0
5958335|NCT01212770|20607154|P5|Long-term Safety Phase (Year 2)|Lost to Follow-up|0
5958336|NCT01212770|20607155|P4|Long-term Safety Phase (Year 2)|Lost to Follow-up|0
5958337|NCT01212770|20607156|P3|Long-term Safety Phase (Year 2)|Lost to Follow-up|1
5958338|NCT01212770|20607157|P2|Long-term Safety Phase (Year 2)|Lost to Follow-up|2
5958339|NCT01212770|20607158|P1|Long-term Safety Phase (Year 2)|Lost to Follow-up|0
5958340|NCT01212770|20607150|P9|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4
5958341|NCT01212770|20607151|P8|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4
5958342|NCT01212770|20607152|P7|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
5958343|NCT01212770|20607153|P6|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
5958344|NCT01212770|20607154|P5|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
5958345|NCT01212770|20607155|P4|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
5958346|NCT01212770|20607156|P3|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3
5958347|NCT01212770|20607157|P2|Long-term Safety Phase (Year 2)|Withdrawal by Subject|9
5958348|NCT01212770|20607158|P1|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
5958349|NCT01212770|20607150|P9|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
5958350|NCT01212770|20607151|P8|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
5958351|NCT01212770|20607152|P7|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
5958352|NCT01212770|20607153|P6|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
5958353|NCT01212770|20607154|P5|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
5958354|NCT01212770|20607155|P4|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
5958355|NCT01212770|20607156|P3|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
5958356|NCT01212770|20607157|P2|Long-term Safety Phase (Year 2)|Non-compliance to study drug|1
5958357|NCT01212770|20607158|P1|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
5958358|NCT01212770|20607150|P9|Long-term Safety Phase (Year 2)|Lack of Efficacy|6
5958359|NCT01212770|20607151|P8|Long-term Safety Phase (Year 2)|Lack of Efficacy|4
5958360|NCT01212770|20607152|P7|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
5958361|NCT01212770|20607153|P6|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
5958362|NCT01212770|20607154|P5|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
5958363|NCT01212770|20607155|P4|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
5958364|NCT01212770|20607156|P3|Long-term Safety Phase (Year 2)|Lack of Efficacy|7
5958365|NCT01212770|20607157|P2|Long-term Safety Phase (Year 2)|Lack of Efficacy|6
5958366|NCT01212770|20607158|P1|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
5958367|NCT01212770|20607150|P9|Long-term Safety Phase (Year 2)|Adverse Event|2
5958368|NCT01212770|20607151|P8|Long-term Safety Phase (Year 2)|Adverse Event|0
5958369|NCT01212770|20607152|P7|Long-term Safety Phase (Year 2)|Adverse Event|0
5958370|NCT01212770|20607153|P6|Long-term Safety Phase (Year 2)|Adverse Event|0
5958371|NCT01212770|20607154|P5|Long-term Safety Phase (Year 2)|Adverse Event|0
5958372|NCT01212770|20607155|P4|Long-term Safety Phase (Year 2)|Adverse Event|0
5958373|NCT01212770|20607156|P3|Long-term Safety Phase (Year 2)|Adverse Event|3
5958374|NCT01212770|20607157|P2|Long-term Safety Phase (Year 2)|Adverse Event|3
5958375|NCT01212770|20607158|P1|Long-term Safety Phase (Year 2)|Adverse Event|0
5958376|NCT01212770|20607150|P9|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
5958377|NCT01212770|20607151|P8|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
5958378|NCT01212770|20607152|P7|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
5958379|NCT01212770|20607153|P6|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
5958380|NCT01212770|20607154|P5|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
5958381|NCT01212770|20607155|P4|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1
5958382|NCT01212770|20607156|P3|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1
5958383|NCT01212770|20607157|P2|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
5958384|NCT01212770|20607158|P1|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
5958385|NCT01212770|20607150|P9|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
5958386|NCT01212770|20607151|P8|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
5958387|NCT01212770|20607152|P7|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
5958388|NCT01212770|20607153|P6|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
5958389|NCT01212770|20607154|P5|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
5958390|NCT01212770|20607155|P4|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|1
5958391|NCT01212770|20607156|P3|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
5958392|NCT01212770|20607157|P2|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
5958393|NCT01212770|20607158|P1|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
5958394|NCT01212770|20607150|P9|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
5958395|NCT01212770|20607151|P8|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
5958396|NCT01212770|20607152|P7|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
5958397|NCT01212770|20607153|P6|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
5958398|NCT01212770|20607154|P5|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
5958399|NCT01212770|20607155|P4|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
5958400|NCT01212770|20607156|P3|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|1
5958401|NCT01212770|20607157|P2|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
5958402|NCT01212770|20607158|P1|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
5958403|NCT01212770|20607150|P9|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0
5958404|NCT01212770|20607151|P8|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0
5958405|NCT01212770|20607152|P7|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1
5958406|NCT01212770|20607153|P6|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1
5958407|NCT01212770|20607154|P5|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1
5958408|NCT01212770|20607155|P4|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3
5958409|NCT01212770|20607156|P3|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3
5958410|NCT01212770|20607157|P2|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|6
5958411|NCT01212770|20607158|P1|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0
5958412|NCT01212770|20607150|P9|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0
5958413|NCT01212770|20607151|P8|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0
5958414|NCT01212770|20607152|P7|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0
5958415|NCT01212770|20607153|P6|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|2
5958416|NCT01212770|20607154|P5|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|1
5958417|NCT01212770|20607155|P4|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|4
5958418|NCT01212770|20607156|P3|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|5
5958419|NCT01212770|20607157|P2|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|7
5958420|NCT01212770|20607158|P1|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0
5958421|NCT01212770|20607150|P9|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0
5958422|NCT01212770|20607151|P8|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0
5958423|NCT01212770|20607152|P7|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|1
5958424|NCT01212770|20607153|P6|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0
5958425|NCT01212770|20607154|P5|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0
5958426|NCT01212770|20607155|P4|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2
5958427|NCT01212770|20607156|P3|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2
5958428|NCT01212770|20607157|P2|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|6
5958429|NCT01212770|20607158|P1|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0
5958430|NCT01212770|20607150|P9|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0
5958431|NCT01212770|20607151|P8|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0
5958432|NCT01212770|20607152|P7|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0
5958433|NCT01212770|20607153|P6|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0
5958434|NCT01212770|20607154|P5|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0
5958435|NCT01212770|20607155|P4|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0
5958436|NCT01212770|20607156|P3|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|2
5958437|NCT01212770|20607157|P2|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|1
5958438|NCT01212770|20607158|P1|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|3
5958439|NCT01212770|20607150|P9|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
5958440|NCT01212770|20607151|P8|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
5958441|NCT01212770|20607152|P7|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
5958442|NCT01212770|20607153|P6|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
5958443|NCT01212770|20607154|P5|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
5958444|NCT01212770|20607155|P4|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
5958445|NCT01212770|20607156|P3|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1
5958446|NCT01212770|20607157|P2|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
5958447|NCT01212770|20607158|P1|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
5958448|NCT01212770|20607150|P9|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
5958449|NCT01212770|20607151|P8|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
5958450|NCT01212770|20607152|P7|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
5958451|NCT01212770|20607153|P6|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
5958452|NCT01212770|20607154|P5|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
5958453|NCT01212770|20607155|P4|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
5958454|NCT01212770|20607156|P3|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|3
5958455|NCT01212770|20607157|P2|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
5958456|NCT01212770|20607158|P1|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1
5958457|NCT01212770|20607150|P9|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
5958458|NCT01212770|20607151|P8|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
5958459|NCT01212770|20607152|P7|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
5958460|NCT01212770|20607153|P6|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
5958461|NCT01212770|20607154|P5|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
5958462|NCT01212770|20607155|P4|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
5958463|NCT01212770|20607156|P3|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1
5958464|NCT01212770|20607157|P2|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4
5958465|NCT01212770|20607158|P1|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3
5958466|NCT01212770|20607150|P9|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
5958467|NCT01212770|20607151|P8|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
5958468|NCT01212770|20607152|P7|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
5958469|NCT01212770|20607153|P6|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
5958470|NCT01212770|20607154|P5|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
5958471|NCT01212770|20607155|P4|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
5958472|NCT01212770|20607156|P3|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|7
5958473|NCT01212770|20607157|P2|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|5
5958474|NCT01212770|20607158|P1|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6
5958475|NCT01212770|20607150|P9|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
5958476|NCT01212770|20607151|P8|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
5958477|NCT01212770|20607152|P7|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
5958478|NCT01212770|20607153|P6|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
5958479|NCT01212770|20607154|P5|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
5958480|NCT01212770|20607155|P4|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
5958481|NCT01212770|20607156|P3|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|8
5958482|NCT01212770|20607157|P2|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12
5958483|NCT01212770|20607158|P1|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10
5958484|NCT01212757|20607355|P9|Long-Term Safety Phase (Year 5)|Miscellaneous|0
5958485|NCT01212757|20607356|P8|Long-Term Safety Phase (Year 5)|Miscellaneous|0
5958486|NCT01212757|20607357|P7|Long-Term Safety Phase (Year 5)|Miscellaneous|0
5958487|NCT01212757|20607358|P6|Long-Term Safety Phase (Year 5)|Miscellaneous|0
5958488|NCT01212757|20607359|P5|Long-Term Safety Phase (Year 5)|Miscellaneous|0
5958489|NCT01212757|20607360|P4|Long-Term Safety Phase (Year 5)|Miscellaneous|0
5958490|NCT01212757|20607361|P3|Long-Term Safety Phase (Year 5)|Miscellaneous|1
5958491|NCT01212757|20607362|P2|Long-Term Safety Phase (Year 5)|Miscellaneous|1
5958492|NCT01212757|20607363|P1|Long-Term Safety Phase (Year 5)|Miscellaneous|0
5958493|NCT01212757|20607355|P9|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
5958494|NCT01212757|20607356|P8|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
5958495|NCT01212757|20607357|P7|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
5958496|NCT01212757|20607358|P6|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
5958497|NCT01212757|20607359|P5|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
5958498|NCT01212757|20607360|P4|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
5958499|NCT01212757|20607361|P3|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
5958500|NCT01212757|20607362|P2|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|1
5958501|NCT01212757|20607363|P1|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
5958502|NCT01212757|20607355|P9|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1
5958503|NCT01212757|20607356|P8|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2
5958504|NCT01212757|20607357|P7|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0
5958505|NCT01212757|20607358|P6|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0
5958506|NCT01212757|20607359|P5|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0
5958507|NCT01212757|20607360|P4|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0
5958508|NCT01212757|20607361|P3|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2
5958509|NCT01212757|20607362|P2|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1
5958510|NCT01212757|20607363|P1|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0
5958511|NCT01212757|20607355|P9|Long-Term Safety Phase (Year 5)|Adverse Event|0
5958512|NCT01212757|20607356|P8|Long-Term Safety Phase (Year 5)|Adverse Event|2
5958513|NCT01212757|20607357|P7|Long-Term Safety Phase (Year 5)|Adverse Event|0
5958514|NCT01212757|20607358|P6|Long-Term Safety Phase (Year 5)|Adverse Event|0
5958515|NCT01212757|20607359|P5|Long-Term Safety Phase (Year 5)|Adverse Event|0
5958516|NCT01212757|20607360|P4|Long-Term Safety Phase (Year 5)|Adverse Event|0
5958517|NCT01212757|20607361|P3|Long-Term Safety Phase (Year 5)|Adverse Event|2
5958518|NCT01212757|20607362|P2|Long-Term Safety Phase (Year 5)|Adverse Event|2
5958519|NCT01212757|20607363|P1|Long-Term Safety Phase (Year 5)|Adverse Event|0
5958520|NCT01212757|20607355|P9|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1
5958521|NCT01212757|20607356|P8|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1
5958522|NCT01212757|20607357|P7|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0
5958523|NCT01212757|20607358|P6|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0
5958524|NCT01212757|20607359|P5|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0
5958525|NCT01212757|20607360|P4|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0
5958526|NCT01212757|20607361|P3|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3
5958527|NCT01212757|20607362|P2|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3
5958528|NCT01212757|20607363|P1|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0
5958529|NCT01212757|20607355|P9|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
5958530|NCT01212757|20607356|P8|Long-Term Safety Phase (Year 4)|Lost to Follow-up|1
5958531|NCT01212757|20607357|P7|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
5958532|NCT01212757|20607358|P6|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
5958533|NCT01212757|20607359|P5|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
5958534|NCT01212757|20607360|P4|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
5958535|NCT01212757|20607361|P3|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
5958536|NCT01212757|20607362|P2|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
5958537|NCT01212757|20607363|P1|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
5958538|NCT01212757|20607355|P9|Long-Term Safety Phase (Year 4)|Death|1
5958539|NCT01212757|20607356|P8|Long-Term Safety Phase (Year 4)|Death|0
5958540|NCT01212757|20607357|P7|Long-Term Safety Phase (Year 4)|Death|0
5958541|NCT01212757|20607358|P6|Long-Term Safety Phase (Year 4)|Death|0
5958542|NCT01212757|20607359|P5|Long-Term Safety Phase (Year 4)|Death|0
5958543|NCT01212757|20607360|P4|Long-Term Safety Phase (Year 4)|Death|0
5958544|NCT01212757|20607361|P3|Long-Term Safety Phase (Year 4)|Death|1
5958545|NCT01212757|20607362|P2|Long-Term Safety Phase (Year 4)|Death|0
5958546|NCT01212757|20607363|P1|Long-Term Safety Phase (Year 4)|Death|0
5958547|NCT01212757|20607355|P9|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|3
5958548|NCT01212757|20607356|P8|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|1
5958549|NCT01212757|20607357|P7|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0
5958550|NCT01212757|20607358|P6|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0
5958551|NCT01212757|20607359|P5|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0
5958552|NCT01212757|20607360|P4|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0
5958553|NCT01212757|20607361|P3|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|2
5958554|NCT01212757|20607362|P2|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|4
5958555|NCT01212757|20607363|P1|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0
5958556|NCT01212757|20607355|P9|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1
5958557|NCT01212757|20607356|P8|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1
5958558|NCT01212757|20607357|P7|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0
5958559|NCT01212757|20607358|P6|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0
5958560|NCT01212757|20607359|P5|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0
5958561|NCT01212757|20607360|P4|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0
5958562|NCT01212757|20607361|P3|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2
5958563|NCT01212757|20607362|P2|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2
5958564|NCT01212757|20607363|P1|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0
5958565|NCT01212757|20607355|P9|Long-Term Safety Phase (Year 4)|Adverse Event|1
5958566|NCT01212757|20607356|P8|Long-Term Safety Phase (Year 4)|Adverse Event|1
5958567|NCT01212757|20607357|P7|Long-Term Safety Phase (Year 4)|Adverse Event|0
5958568|NCT01212757|20607358|P6|Long-Term Safety Phase (Year 4)|Adverse Event|0
5958569|NCT01212757|20607359|P5|Long-Term Safety Phase (Year 4)|Adverse Event|0
5958570|NCT01212757|20607360|P4|Long-Term Safety Phase (Year 4)|Adverse Event|0
5958571|NCT01212757|20607361|P3|Long-Term Safety Phase (Year 4)|Adverse Event|2
5958572|NCT01212757|20607362|P2|Long-Term Safety Phase (Year 4)|Adverse Event|1
5958573|NCT01212757|20607363|P1|Long-Term Safety Phase (Year 4)|Adverse Event|0
5958574|NCT01212757|20607355|P9|Long-Term Safety Phase (Year 4)|Miscellaneous|1
5958575|NCT01212757|20607356|P8|Long-Term Safety Phase (Year 4)|Miscellaneous|0
5958576|NCT01212757|20607357|P7|Long-Term Safety Phase (Year 4)|Miscellaneous|0
5958577|NCT01212757|20607358|P6|Long-Term Safety Phase (Year 4)|Miscellaneous|0
5958578|NCT01212757|20607359|P5|Long-Term Safety Phase (Year 4)|Miscellaneous|0
5958579|NCT01212757|20607360|P4|Long-Term Safety Phase (Year 4)|Miscellaneous|0
5958580|NCT01212757|20607361|P3|Long-Term Safety Phase (Year 4)|Miscellaneous|0
5958581|NCT01212757|20607362|P2|Long-Term Safety Phase (Year 4)|Miscellaneous|2
5958582|NCT01212757|20607363|P1|Long-Term Safety Phase (Year 4)|Miscellaneous|0
5958583|NCT01212757|20607355|P9|Long-Term Safety Phase (Year 3)|Miscellaneous|2
5958584|NCT01212757|20607356|P8|Long-Term Safety Phase (Year 3)|Miscellaneous|0
5958585|NCT01212757|20607357|P7|Long-Term Safety Phase (Year 3)|Miscellaneous|0
5958586|NCT01212757|20607358|P6|Long-Term Safety Phase (Year 3)|Miscellaneous|0
5958587|NCT01212757|20607359|P5|Long-Term Safety Phase (Year 3)|Miscellaneous|0
5958588|NCT01212757|20607360|P4|Long-Term Safety Phase (Year 3)|Miscellaneous|0
5958589|NCT01212757|20607361|P3|Long-Term Safety Phase (Year 3)|Miscellaneous|3
5958590|NCT01212757|20607362|P2|Long-Term Safety Phase (Year 3)|Miscellaneous|0
5958591|NCT01212757|20607363|P1|Long-Term Safety Phase (Year 3)|Miscellaneous|0
5958592|NCT01212757|20607355|P9|Long-Term Safety Phase (Year 3)|Protocol Violation|0
5958593|NCT01212757|20607356|P8|Long-Term Safety Phase (Year 3)|Protocol Violation|0
5958594|NCT01212757|20607357|P7|Long-Term Safety Phase (Year 3)|Protocol Violation|0
5958595|NCT01212757|20607358|P6|Long-Term Safety Phase (Year 3)|Protocol Violation|0
5958596|NCT01212757|20607359|P5|Long-Term Safety Phase (Year 3)|Protocol Violation|0
5958597|NCT01212757|20607360|P4|Long-Term Safety Phase (Year 3)|Protocol Violation|0
5958598|NCT01212757|20607361|P3|Long-Term Safety Phase (Year 3)|Protocol Violation|0
5958599|NCT01212757|20607362|P2|Long-Term Safety Phase (Year 3)|Protocol Violation|1
5958600|NCT01212757|20607363|P1|Long-Term Safety Phase (Year 3)|Protocol Violation|0
5958601|NCT01212757|20607355|P9|Long-Term Safety Phase (Year 3)|Lost to Follow-up|1
5958602|NCT01212757|20607356|P8|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
5958603|NCT01212757|20607357|P7|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
5958604|NCT01212757|20607358|P6|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
5958605|NCT01212757|20607359|P5|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
5958606|NCT01212757|20607360|P4|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
5958607|NCT01212757|20607361|P3|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
5958608|NCT01212757|20607362|P2|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
5958609|NCT01212757|20607363|P1|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
5958610|NCT01212757|20607355|P9|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1
5958611|NCT01212757|20607356|P8|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1
5958612|NCT01212757|20607357|P7|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0
5958613|NCT01212757|20607358|P6|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0
5958614|NCT01212757|20607359|P5|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0
5958615|NCT01212757|20607360|P4|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0
5958616|NCT01212757|20607361|P3|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1
5958617|NCT01212757|20607362|P2|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|5
5958618|NCT01212757|20607363|P1|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0
5958619|NCT01212757|20607355|P9|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
5958620|NCT01212757|20607356|P8|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
5958621|NCT01212757|20607357|P7|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
5958622|NCT01212757|20607358|P6|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
5958623|NCT01212757|20607359|P5|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
5958624|NCT01212757|20607360|P4|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
5958625|NCT01212757|20607361|P3|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|1
5958626|NCT01212757|20607362|P2|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
5958627|NCT01212757|20607363|P1|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
5958628|NCT01212757|20607355|P9|Long-Term Safety Phase (Year 3)|Lack of Efficacy|1
5958629|NCT01212757|20607356|P8|Long-Term Safety Phase (Year 3)|Lack of Efficacy|3
5958630|NCT01212757|20607357|P7|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0
5958631|NCT01212757|20607358|P6|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0
5958632|NCT01212757|20607359|P5|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0
5958633|NCT01212757|20607360|P4|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0
5958634|NCT01212757|20607361|P3|Long-Term Safety Phase (Year 3)|Lack of Efficacy|5
5958635|NCT01212757|20607362|P2|Long-Term Safety Phase (Year 3)|Lack of Efficacy|8
5958636|NCT01212757|20607363|P1|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0
5958637|NCT01212757|20607355|P9|Long-Term Safety Phase (Year 3)|Adverse Event|0
5958638|NCT01212757|20607356|P8|Long-Term Safety Phase (Year 3)|Adverse Event|2
5958639|NCT01212757|20607357|P7|Long-Term Safety Phase (Year 3)|Adverse Event|0
5958640|NCT01212757|20607358|P6|Long-Term Safety Phase (Year 3)|Adverse Event|0
5958641|NCT01212757|20607359|P5|Long-Term Safety Phase (Year 3)|Adverse Event|0
5958642|NCT01212757|20607360|P4|Long-Term Safety Phase (Year 3)|Adverse Event|0
5958643|NCT01212757|20607361|P3|Long-Term Safety Phase (Year 3)|Adverse Event|1
5958644|NCT01212757|20607362|P2|Long-Term Safety Phase (Year 3)|Adverse Event|4
5958645|NCT01212757|20607363|P1|Long-Term Safety Phase (Year 3)|Adverse Event|0
5958646|NCT01212757|20607355|P9|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
5958647|NCT01212757|20607356|P8|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
5958648|NCT01212757|20607357|P7|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
5958649|NCT01212757|20607358|P6|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
5958650|NCT01212757|20607359|P5|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
5958651|NCT01212757|20607360|P4|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
5958652|NCT01212757|20607361|P3|Long-Term Safety Phase (Year 2)|Lost to Follow-up|2
5958653|NCT01212757|20607362|P2|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
5958654|NCT01212757|20607363|P1|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
5958655|NCT01212757|20607355|P9|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|6
5958656|NCT01212757|20607356|P8|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|4
5958657|NCT01212757|20607357|P7|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0
5958658|NCT01212757|20607358|P6|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0
5958659|NCT01212757|20607359|P5|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0
5958660|NCT01212757|20607360|P4|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0
5958661|NCT01212757|20607361|P3|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|9
5958662|NCT01212757|20607362|P2|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|7
5958663|NCT01212757|20607363|P1|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0
5958664|NCT01212757|20607355|P9|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0
5958665|NCT01212757|20607356|P8|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4
5958666|NCT01212757|20607357|P7|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0
5958667|NCT01212757|20607358|P6|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0
5958668|NCT01212757|20607359|P5|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0
5958669|NCT01212757|20607360|P4|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0
5958670|NCT01212757|20607361|P3|Long-Term Safety Phase (Year 2)|Lack of Efficacy|2
5958671|NCT01212757|20607362|P2|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4
5958672|NCT01212757|20607363|P1|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0
5958673|NCT01212757|20607355|P9|Long-Term Safety Phase (Year 2)|Adverse Event|2
5958674|NCT01212757|20607356|P8|Long-Term Safety Phase (Year 2)|Adverse Event|2
5958675|NCT01212757|20607357|P7|Long-Term Safety Phase (Year 2)|Adverse Event|0
5958676|NCT01212757|20607358|P6|Long-Term Safety Phase (Year 2)|Adverse Event|0
5958677|NCT01212757|20607359|P5|Long-Term Safety Phase (Year 2)|Adverse Event|0
5958751|NCT01212757|20607361|P3|Placebo-controlled Phase (Week 0 - 24)|Other|0
5958678|NCT01212757|20607360|P4|Long-Term Safety Phase (Year 2)|Adverse Event|0
5958679|NCT01212757|20607361|P3|Long-Term Safety Phase (Year 2)|Adverse Event|1
5958680|NCT01212757|20607362|P2|Long-Term Safety Phase (Year 2)|Adverse Event|1
5958681|NCT01212757|20607363|P1|Long-Term Safety Phase (Year 2)|Adverse Event|0
5958682|NCT01212757|20607355|P9|Long-Term Safety Phase (Year 2)|Miscellaneous|1
5958683|NCT01212757|20607356|P8|Long-Term Safety Phase (Year 2)|Miscellaneous|0
5958684|NCT01212757|20607357|P7|Long-Term Safety Phase (Year 2)|Miscellaneous|0
5958685|NCT01212757|20607358|P6|Long-Term Safety Phase (Year 2)|Miscellaneous|0
5958686|NCT01212757|20607359|P5|Long-Term Safety Phase (Year 2)|Miscellaneous|0
5958687|NCT01212757|20607360|P4|Long-Term Safety Phase (Year 2)|Miscellaneous|0
5958688|NCT01212757|20607361|P3|Long-Term Safety Phase (Year 2)|Miscellaneous|0
5958689|NCT01212757|20607362|P2|Long-Term Safety Phase (Year 2)|Miscellaneous|0
5958690|NCT01212757|20607363|P1|Long-Term Safety Phase (Year 2)|Miscellaneous|0
5958691|NCT01212757|20607355|P9|Active Treatment Phase (Weeks 24 - 52)|Other|0
5958692|NCT01212757|20607356|P8|Active Treatment Phase (Weeks 24 - 52)|Other|0
5958693|NCT01212757|20607357|P7|Active Treatment Phase (Weeks 24 - 52)|Other|0
5958694|NCT01212757|20607358|P6|Active Treatment Phase (Weeks 24 - 52)|Other|0
5958695|NCT01212757|20607359|P5|Active Treatment Phase (Weeks 24 - 52)|Other|0
5958696|NCT01212757|20607360|P4|Active Treatment Phase (Weeks 24 - 52)|Other|0
5958697|NCT01212757|20607361|P3|Active Treatment Phase (Weeks 24 - 52)|Other|1
5958698|NCT01212757|20607362|P2|Active Treatment Phase (Weeks 24 - 52)|Other|1
5958699|NCT01212757|20607363|P1|Active Treatment Phase (Weeks 24 - 52)|Other|0
5958700|NCT01212757|20607355|P9|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
5958701|NCT01212757|20607356|P8|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
5958702|NCT01212757|20607357|P7|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
5958703|NCT01212757|20607358|P6|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
5958704|NCT01212757|20607359|P5|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1
5958705|NCT01212757|20607360|P4|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
5958706|NCT01212757|20607361|P3|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
5958707|NCT01212757|20607362|P2|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1
5958708|NCT01212757|20607363|P1|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
5958709|NCT01212757|20607355|P9|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
5958710|NCT01212757|20607356|P8|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
5958711|NCT01212757|20607357|P7|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
5958712|NCT01212757|20607358|P6|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3
5958713|NCT01212757|20607359|P5|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|1
5958714|NCT01212757|20607360|P4|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3
5958715|NCT01212757|20607361|P3|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|7
5958716|NCT01212757|20607362|P2|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3
5958717|NCT01212757|20607363|P1|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
5958718|NCT01212757|20607355|P9|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
5958719|NCT01212757|20607356|P8|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
5958720|NCT01212757|20607357|P7|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
5958721|NCT01212757|20607358|P6|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
5958722|NCT01212757|20607359|P5|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
5958723|NCT01212757|20607360|P4|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
5958724|NCT01212757|20607361|P3|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|2
5958725|NCT01212757|20607362|P2|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
5958726|NCT01212757|20607363|P1|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
5958727|NCT01212757|20607355|P9|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0
5958728|NCT01212757|20607356|P8|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0
5958729|NCT01212757|20607357|P7|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0
5958730|NCT01212757|20607358|P6|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|2
5958731|NCT01212757|20607359|P5|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0
5958732|NCT01212757|20607360|P4|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|4
5958733|NCT01212757|20607361|P3|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|7
5958734|NCT01212757|20607362|P2|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|5
5958735|NCT01212757|20607363|P1|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0
5958736|NCT01212757|20607355|P9|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0
5958737|NCT01212757|20607356|P8|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0
5958738|NCT01212757|20607357|P7|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0
5958739|NCT01212757|20607358|P6|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2
5958740|NCT01212757|20607359|P5|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0
5958741|NCT01212757|20607360|P4|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|1
5958742|NCT01212757|20607361|P3|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|3
5958743|NCT01212757|20607362|P2|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2
5958744|NCT01212757|20607363|P1|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0
5958745|NCT01212757|20607355|P9|Placebo-controlled Phase (Week 0 - 24)|Other|0
5958746|NCT01212757|20607356|P8|Placebo-controlled Phase (Week 0 - 24)|Other|0
5958747|NCT01212757|20607357|P7|Placebo-controlled Phase (Week 0 - 24)|Other|0
5958748|NCT01212757|20607358|P6|Placebo-controlled Phase (Week 0 - 24)|Other|0
5958749|NCT01212757|20607359|P5|Placebo-controlled Phase (Week 0 - 24)|Other|0
5958752|NCT01212757|20607362|P2|Placebo-controlled Phase (Week 0 - 24)|Other|2
5958753|NCT01212757|20607363|P1|Placebo-controlled Phase (Week 0 - 24)|Other|1
5958754|NCT01212757|20607355|P9|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
5958755|NCT01212757|20607356|P8|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
5958756|NCT01212757|20607357|P7|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
5958757|NCT01212757|20607358|P6|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
5958758|NCT01212757|20607359|P5|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
5958759|NCT01212757|20607360|P4|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
5958760|NCT01212757|20607361|P3|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1
5958761|NCT01212757|20607362|P2|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1
5958762|NCT01212757|20607363|P1|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
5958763|NCT01212757|20607355|P9|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
5958764|NCT01212757|20607356|P8|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
5958765|NCT01212757|20607357|P7|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
5958766|NCT01212757|20607358|P6|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
5958767|NCT01212757|20607359|P5|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
5958768|NCT01212757|20607360|P4|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
5958769|NCT01212757|20607361|P3|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2
5958770|NCT01212757|20607362|P2|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1
5958771|NCT01212757|20607363|P1|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1
5958772|NCT01212757|20607355|P9|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
5958773|NCT01212757|20607356|P8|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
5958774|NCT01212757|20607357|P7|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
5958775|NCT01212757|20607358|P6|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
5958776|NCT01212757|20607359|P5|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
5958777|NCT01212757|20607360|P4|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
5958778|NCT01212757|20607361|P3|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1
5958779|NCT01212757|20607362|P2|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
5958780|NCT01212757|20607363|P1|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|3
5958781|NCT01212757|20607355|P9|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
5958782|NCT01212757|20607356|P8|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
5958783|NCT01212757|20607357|P7|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
5958784|NCT01212757|20607358|P6|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
5958785|NCT01212757|20607359|P5|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
5958786|NCT01212757|20607360|P4|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
5958787|NCT01212757|20607361|P3|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3
5958788|NCT01212757|20607362|P2|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|9
5958789|NCT01212757|20607363|P1|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|7
5958790|NCT01212757|20607355|P9|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
5958791|NCT01212757|20607356|P8|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
5958792|NCT01212757|20607357|P7|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
5958793|NCT01212757|20607358|P6|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
5958794|NCT01212757|20607359|P5|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
5958795|NCT01212757|20607360|P4|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
5958796|NCT01212757|20607361|P3|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2
5958797|NCT01212757|20607362|P2|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2
5958798|NCT01212757|20607363|P1|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3
5958799|NCT01212757|20607355|P9|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
5958800|NCT01212757|20607356|P8|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
5958801|NCT01212757|20607357|P7|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
5958802|NCT01212757|20607358|P6|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
5958803|NCT01212757|20607359|P5|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
5958804|NCT01212757|20607360|P4|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
5958805|NCT01212757|20607361|P3|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12
5958806|NCT01212757|20607362|P2|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5
5958807|NCT01212757|20607363|P1|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4
5958808|NCT01212744|20607547|P1|Overall Study|Withdrawal by Subject|1
5958809|NCT01212588|20607566|P2|Overall Study|Protocol Violation|1
5958810|NCT01212588|20607567|P1|Overall Study|Protocol Violation|1
5958811|NCT01212588|20607566|P2|Overall Study|Physician Decision|1
5958812|NCT01212588|20607567|P1|Overall Study|Physician Decision|0
5958813|NCT01212185|20607665|P2|Overall Study|Protocol Violation|1
5958814|NCT01212185|20607666|P1|Overall Study|Protocol Violation|2
5958815|NCT01212159|20607685|P2|Overall Study|Withdrawal by Subject|12
5958816|NCT01212159|20607686|P1|Overall Study|Withdrawal by Subject|12
5958817|NCT01212094|20607785|P3|Years 2 & 3: Treatment Randomization|Adverse Event|1
5958818|NCT01212094|20607786|P2|Years 2 & 3: Treatment Randomization|Adverse Event|0
5958819|NCT01212094|20607787|P1|Years 2 & 3: Treatment Randomization|Adverse Event|0
5958820|NCT01212094|20607785|P3|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|3
5958821|NCT01212094|20607786|P2|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0
5958822|NCT01212094|20607787|P1|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0
5958823|NCT01212094|20607785|P3|Years 2 & 3: Treatment Randomization|Study terminated|7
5958824|NCT01212094|20607786|P2|Years 2 & 3: Treatment Randomization|Study terminated|4
5958825|NCT01212094|20607787|P1|Years 2 & 3: Treatment Randomization|Study terminated|0
5958826|NCT01212094|20607785|P3|Year 1: Baseline Monitoring|Started on DMT|0
5958827|NCT01212094|20607786|P2|Year 1: Baseline Monitoring|Started on DMT|0
5958828|NCT01212094|20607787|P1|Year 1: Baseline Monitoring|Started on DMT|2
5958829|NCT01212094|20607785|P3|Year 1: Baseline Monitoring|Withdrawal by Subject|0
5958830|NCT01212094|20607786|P2|Year 1: Baseline Monitoring|Withdrawal by Subject|0
5958831|NCT01212094|20607787|P1|Year 1: Baseline Monitoring|Withdrawal by Subject|7
5958832|NCT01212094|20607785|P3|Year 1: Baseline Monitoring|Study terminated|0
5958833|NCT01212094|20607786|P2|Year 1: Baseline Monitoring|Study terminated|0
5958834|NCT01212094|20607787|P1|Year 1: Baseline Monitoring|Study terminated|7
5958835|NCT01211769|20607846|P4|Overall Study|Adverse Event|1
5958836|NCT01211769|20607847|P3|Overall Study|Adverse Event|1
5958837|NCT01211769|20607848|P2|Overall Study|Adverse Event|1
5958838|NCT01211769|20607849|P1|Overall Study|Adverse Event|0
5958839|NCT01211769|20607846|P4|Overall Study|Physician Decision|1
5958840|NCT01211769|20607847|P3|Overall Study|Physician Decision|2
5958841|NCT01211769|20607848|P2|Overall Study|Physician Decision|0
5958842|NCT01211769|20607849|P1|Overall Study|Physician Decision|2
5958843|NCT01211769|20607846|P4|Overall Study|Lost to Follow-up|9
5958844|NCT01211769|20607847|P3|Overall Study|Lost to Follow-up|5
5958845|NCT01211769|20607848|P2|Overall Study|Lost to Follow-up|9
5958846|NCT01211769|20607849|P1|Overall Study|Lost to Follow-up|7
5958847|NCT01211665|20607904|P2|Overall Study|Death|0
5958848|NCT01211665|20607905|P1|Overall Study|Death|1
5958849|NCT01211665|20607904|P2|Overall Study|Withdrawal by Subject|0
5958850|NCT01211665|20607905|P1|Overall Study|Withdrawal by Subject|1
5958851|NCT01211613|20607932|P3|Overall Study|Withdrawal by Subject|0
5958852|NCT01211613|20607933|P2|Overall Study|Withdrawal by Subject|0
5958853|NCT01211613|20607934|P1|Overall Study|Withdrawal by Subject|1
5958854|NCT01211613|20607932|P3|Overall Study|Lost to Follow-up|2
5958855|NCT01211613|20607933|P2|Overall Study|Lost to Follow-up|2
5958856|NCT01211613|20607934|P1|Overall Study|Lost to Follow-up|2
5958857|NCT01211535|20607980|P2|Overall Study|Adverse Event|1
5958858|NCT01211535|20607981|P1|Overall Study|Adverse Event|0
5958859|NCT01211522|20607990|P3|Overall Study|Withdrawal by Subject|5
5958860|NCT01211522|20607991|P2|Overall Study|Withdrawal by Subject|7
5958861|NCT01211522|20607992|P1|Overall Study|Withdrawal by Subject|3
5958862|NCT01211288|20608042|P2|Overall Study|Lost to Follow-up|1
5958863|NCT01211288|20608043|P1|Overall Study|Lost to Follow-up|1
5958864|NCT01211262|20608061|P2|Overall Study|Other|1
5958865|NCT01211262|20608062|P1|Overall Study|Other|0
5958866|NCT01211262|20608061|P2|Overall Study|Withdrawal of Consent|0
5958867|NCT01211262|20608062|P1|Overall Study|Withdrawal of Consent|1
5958868|NCT01211262|20608061|P2|Overall Study|Adverse Event|0
5958869|NCT01211262|20608062|P1|Overall Study|Adverse Event|4
5958870|NCT01211262|20608061|P2|Overall Study|Progressive Disease|9
5958871|NCT01211262|20608062|P1|Overall Study|Progressive Disease|18
5958872|NCT01211197|20608102|P6|Washout Period 2 (7 Days)|Adverse Event|0
5958873|NCT01211197|20608103|P5|Washout Period 2 (7 Days)|Adverse Event|0
5958874|NCT01211197|20608104|P4|Washout Period 2 (7 Days)|Adverse Event|0
5958875|NCT01211197|20608105|P3|Washout Period 2 (7 Days)|Adverse Event|0
5958876|NCT01211197|20608106|P2|Washout Period 2 (7 Days)|Adverse Event|0
5958877|NCT01211197|20608107|P1|Washout Period 2 (7 Days)|Adverse Event|1
5958878|NCT01211197|20608102|P6|Washout Period 1 (7 Days)|Withdrawal by Subject|0
5958879|NCT01211197|20608103|P5|Washout Period 1 (7 Days)|Withdrawal by Subject|0
5958880|NCT01211197|20608104|P4|Washout Period 1 (7 Days)|Withdrawal by Subject|0
5958881|NCT01211197|20608105|P3|Washout Period 1 (7 Days)|Withdrawal by Subject|1
5958882|NCT01211197|20608106|P2|Washout Period 1 (7 Days)|Withdrawal by Subject|0
5958883|NCT01211197|20608107|P1|Washout Period 1 (7 Days)|Withdrawal by Subject|0
5958884|NCT01211184|20608154|P3|Overall Study|Withdrawal by Subject|1
5958885|NCT01211184|20608155|P2|Overall Study|Withdrawal by Subject|2
5958886|NCT01211184|20608156|P1|Overall Study|Withdrawal by Subject|0
5958887|NCT01211145|20608171|P4|Overall Study|Patient decision|2
5958888|NCT01211145|20608172|P3|Overall Study|Patient decision|0
5958889|NCT01211145|20608173|P2|Overall Study|Patient decision|1
5958890|NCT01211145|20608174|P1|Overall Study|Patient decision|2
5958891|NCT01211145|20608171|P4|Overall Study|Eligibility criteria not fulfilled|15
5958892|NCT01211145|20608172|P3|Overall Study|Eligibility criteria not fulfilled|10
5958893|NCT01211145|20608173|P2|Overall Study|Eligibility criteria not fulfilled|12
5958894|NCT01211145|20608174|P1|Overall Study|Eligibility criteria not fulfilled|16
5958895|NCT01211145|20608171|P4|Overall Study|Severe noncompliance to protocol|0
5958896|NCT01211145|20608172|P3|Overall Study|Severe noncompliance to protocol|0
5958897|NCT01211145|20608173|P2|Overall Study|Severe noncompliance to protocol|0
5958898|NCT01211145|20608174|P1|Overall Study|Severe noncompliance to protocol|1
5958899|NCT01211145|20608171|P4|Overall Study|Study-specific withdrawal criteria|0
5958900|NCT01211145|20608172|P3|Overall Study|Study-specific withdrawal criteria|0
5958901|NCT01211145|20608173|P2|Overall Study|Study-specific withdrawal criteria|0
5958902|NCT01211145|20608174|P1|Overall Study|Study-specific withdrawal criteria|1
5958903|NCT01211145|20608171|P4|Overall Study|Lost to Follow-up|2
5958904|NCT01211145|20608172|P3|Overall Study|Lost to Follow-up|1
5958905|NCT01211145|20608173|P2|Overall Study|Lost to Follow-up|2
5958906|NCT01211145|20608174|P1|Overall Study|Lost to Follow-up|3
5958907|NCT01211145|20608171|P4|Overall Study|Reason not specified|1
5958908|NCT01211145|20608172|P3|Overall Study|Reason not specified|2
5958909|NCT01211145|20608173|P2|Overall Study|Reason not specified|2
5958910|NCT01211145|20608174|P1|Overall Study|Reason not specified|3
5958911|NCT01210807|20608228|P2|Overall Study|Not implanted bilaterally|1
5958912|NCT01210807|20608229|P1|Overall Study|Not implanted bilaterally|2
5958913|NCT01210807|20608228|P2|Overall Study|Lost to Follow-up|2
5958914|NCT01210807|20608229|P1|Overall Study|Lost to Follow-up|1
5958915|NCT01210690|20608244|P1|Overall Study|Patient could not take glucose|1
5958916|NCT01210690|20608244|P1|Overall Study|Patient refused to swallow|1
5958917|NCT01210690|20608244|P1|Overall Study|Withdrawal by Subject|1
5958918|NCT01210690|20608244|P1|Overall Study|Disease Remission|1
5958919|NCT01210690|20608244|P1|Overall Study|Lost to Follow-up|3
5958920|NCT01210690|20608244|P1|Overall Study|Lack of Efficacy|12
5958921|NCT01210690|20608244|P1|Overall Study|Adverse Event|7
5958922|NCT01210664|20608257|P4|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|1
5958923|NCT01210664|20608258|P3|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0
5958924|NCT01210664|20608259|P2|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0
5958925|NCT01210664|20608260|P1|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0
5958926|NCT01210664|20608257|P4|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0
5958927|NCT01210664|20608258|P3|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|1
5958928|NCT01210664|20608259|P2|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0
5958929|NCT01210664|20608260|P1|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0
5958930|NCT01210664|20608257|P4|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0
5958931|NCT01210664|20608258|P3|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|1
5958932|NCT01210664|20608259|P2|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0
5958933|NCT01210664|20608260|P1|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0
5958934|NCT01210651|20608288|P2|Overall Study|Injury outside study|0
5958935|NCT01210651|20608289|P1|Overall Study|Injury outside study|2
5958936|NCT01210651|20608288|P2|Overall Study|Withdrawal by Subject|1
5958937|NCT01210651|20608289|P1|Overall Study|Withdrawal by Subject|1
5958938|NCT01210651|20608288|P2|Overall Study|Withdrawn by PI for disruptive behavior|1
5958939|NCT01210651|20608289|P1|Overall Study|Withdrawn by PI for disruptive behavior|0
5958940|NCT01210651|20608288|P2|Overall Study|schedule conflicts|5
5958941|NCT01210651|20608289|P1|Overall Study|schedule conflicts|1
5958942|NCT01210651|20608288|P2|Overall Study|Lost to Follow-up|1
5958943|NCT01210651|20608289|P1|Overall Study|Lost to Follow-up|1
5958944|NCT01210495|20608409|P4|Overall Study|Other unspecified|0
5958945|NCT01210495|20608410|P3|Overall Study|Other unspecified|6
5958946|NCT01210495|20608411|P2|Overall Study|Other unspecified|0
5958947|NCT01210495|20608412|P1|Overall Study|Other unspecified|0
5958948|NCT01210495|20608409|P4|Overall Study|Lost to Follow-up|1
5958949|NCT01210495|20608410|P3|Overall Study|Lost to Follow-up|1
5958950|NCT01210495|20608411|P2|Overall Study|Lost to Follow-up|0
5958951|NCT01210495|20608412|P1|Overall Study|Lost to Follow-up|0
5958952|NCT01210495|20608409|P4|Overall Study|Study Terminated by Sponsor|11
5958953|NCT01210495|20608410|P3|Overall Study|Study Terminated by Sponsor|4
5958954|NCT01210495|20608411|P2|Overall Study|Study Terminated by Sponsor|0
5958955|NCT01210495|20608412|P1|Overall Study|Study Terminated by Sponsor|0
5958956|NCT01210495|20608409|P4|Overall Study|Death|54
5958957|NCT01210495|20608410|P3|Overall Study|Death|112
5958958|NCT01210495|20608411|P2|Overall Study|Death|7
5958959|NCT01210495|20608412|P1|Overall Study|Death|14
5958960|NCT01210495|20608409|P4|Overall Study|Participant Refused Further Follow-Up|2
5958961|NCT01210495|20608410|P3|Overall Study|Participant Refused Further Follow-Up|11
5958962|NCT01210495|20608411|P2|Overall Study|Participant Refused Further Follow-Up|0
5958963|NCT01210495|20608412|P1|Overall Study|Participant Refused Further Follow-Up|1
5958964|NCT01210443|20608474|P1|Overall Study|Study terminated by sponsor|2
5958965|NCT01210352|20608491|P9|Overall Study|Patient Discharged Early|0
5958966|NCT01210352|20608492|P8|Overall Study|Patient Discharged Early|0
5958967|NCT01210352|20608493|P7|Overall Study|Patient Discharged Early|0
5958968|NCT01210352|20608494|P6|Overall Study|Patient Discharged Early|0
5958969|NCT01210352|20608495|P5|Overall Study|Patient Discharged Early|0
5958970|NCT01210352|20608496|P4|Overall Study|Patient Discharged Early|0
5958971|NCT01210352|20608497|P3|Overall Study|Patient Discharged Early|1
5958972|NCT01210352|20608498|P2|Overall Study|Patient Discharged Early|0
5958973|NCT01210352|20608499|P1|Overall Study|Patient Discharged Early|0
5958974|NCT01210352|20608491|P9|Overall Study|Withdrawal by Subject|1
5958975|NCT01210352|20608492|P8|Overall Study|Withdrawal by Subject|0
5958976|NCT01210352|20608493|P7|Overall Study|Withdrawal by Subject|1
5958977|NCT01210352|20608494|P6|Overall Study|Withdrawal by Subject|0
5958978|NCT01210352|20608495|P5|Overall Study|Withdrawal by Subject|0
5958979|NCT01210352|20608496|P4|Overall Study|Withdrawal by Subject|0
5958980|NCT01210352|20608497|P3|Overall Study|Withdrawal by Subject|1
5958981|NCT01210352|20608498|P2|Overall Study|Withdrawal by Subject|0
5958982|NCT01210352|20608499|P1|Overall Study|Withdrawal by Subject|0
5958983|NCT01210352|20608491|P9|Overall Study|Physician Decision|2
5958984|NCT01210352|20608492|P8|Overall Study|Physician Decision|1
5958985|NCT01210352|20608493|P7|Overall Study|Physician Decision|0
5958986|NCT01210352|20608494|P6|Overall Study|Physician Decision|0
5958987|NCT01210352|20608495|P5|Overall Study|Physician Decision|0
5958988|NCT01210352|20608496|P4|Overall Study|Physician Decision|0
5958989|NCT01210352|20608497|P3|Overall Study|Physician Decision|0
5958990|NCT01210352|20608498|P2|Overall Study|Physician Decision|0
5958991|NCT01210352|20608499|P1|Overall Study|Physician Decision|0
5958992|NCT01210352|20608491|P9|Overall Study|Lack of Efficacy|0
5958993|NCT01210352|20608492|P8|Overall Study|Lack of Efficacy|0
5958994|NCT01210352|20608493|P7|Overall Study|Lack of Efficacy|1
5958995|NCT01210352|20608494|P6|Overall Study|Lack of Efficacy|0
5958996|NCT01210352|20608495|P5|Overall Study|Lack of Efficacy|0
5958997|NCT01210352|20608496|P4|Overall Study|Lack of Efficacy|0
5958998|NCT01210352|20608497|P3|Overall Study|Lack of Efficacy|0
5958999|NCT01210352|20608498|P2|Overall Study|Lack of Efficacy|0
5959000|NCT01210352|20608499|P1|Overall Study|Lack of Efficacy|0
5959001|NCT01210352|20608491|P9|Overall Study|Adverse Event|1
5959002|NCT01210352|20608492|P8|Overall Study|Adverse Event|2
5959003|NCT01210352|20608493|P7|Overall Study|Adverse Event|0
5959004|NCT01210352|20608494|P6|Overall Study|Adverse Event|0
5959005|NCT01210352|20608495|P5|Overall Study|Adverse Event|0
5959006|NCT01210352|20608496|P4|Overall Study|Adverse Event|0
5959007|NCT01210352|20608497|P3|Overall Study|Adverse Event|0
5959008|NCT01210352|20608498|P2|Overall Study|Adverse Event|0
5959009|NCT01210352|20608499|P1|Overall Study|Adverse Event|0
5959010|NCT01210222|20608690|P1|Overall Study|Never treated|1
5959011|NCT01210222|20608690|P1|Overall Study|Ineligible|2
5959012|NCT01210144|20608726|P2|Overall Study|No transfer|0
5959013|NCT01210144|20608727|P1|Overall Study|No transfer|1
5959014|NCT01210144|20608726|P2|Overall Study|No fertilization|0
5959015|NCT01210144|20608727|P1|Overall Study|No fertilization|1
5959016|NCT01210144|20608726|P2|Overall Study|Lack of ovarian response|0
5959017|NCT01210144|20608727|P1|Overall Study|Lack of ovarian response|1
5959018|NCT01210118|20608749|P2|Overall Study|Spontaneous abortion|3
5959019|NCT01210118|20608750|P1|Overall Study|Spontaneous abortion|1
5959020|NCT01210118|20608749|P2|Overall Study|Protocol Violation|1
5959021|NCT01210118|20608750|P1|Overall Study|Protocol Violation|1
5959022|NCT01210118|20608749|P2|Overall Study|Lost to Follow-up|1
5959023|NCT01210118|20608750|P1|Overall Study|Lost to Follow-up|1
5959024|NCT01210001|20608774|P3|Overall Study|Other reason not defined above|1
5959025|NCT01210001|20608775|P2|Overall Study|Other reason not defined above|2
5959026|NCT01210001|20608776|P1|Overall Study|Other reason not defined above|2
5959027|NCT01210001|20608774|P3|Overall Study|Patient refusal to continue,not due toAE|1
5959028|NCT01210001|20608775|P2|Overall Study|Patient refusal to continue,not due toAE|2
5959029|NCT01210001|20608776|P1|Overall Study|Patient refusal to continue,not due toAE|6
5959030|NCT01210001|20608774|P3|Overall Study|Lost to Follow-up|2
5959031|NCT01210001|20608775|P2|Overall Study|Lost to Follow-up|3
5959032|NCT01210001|20608776|P1|Overall Study|Lost to Follow-up|4
5959033|NCT01210001|20608774|P3|Overall Study|Non compliant with protocol|3
5959034|NCT01210001|20608775|P2|Overall Study|Non compliant with protocol|2
5959035|NCT01210001|20608776|P1|Overall Study|Non compliant with protocol|2
5959036|NCT01210001|20608774|P3|Overall Study|Adverse Event|5
5959037|NCT01210001|20608775|P2|Overall Study|Adverse Event|2
5959038|NCT01210001|20608776|P1|Overall Study|Adverse Event|4
5959039|NCT01210001|20608774|P3|Overall Study|Not treated|0
5959040|NCT01210001|20608775|P2|Overall Study|Not treated|0
5959041|NCT01210001|20608776|P1|Overall Study|Not treated|1
5959042|NCT01209949|20608796|P1|Overall Study|Lost to Follow-up|3
5959043|NCT01209832|20608802|P1|Period 2|Sponsor Decision|1
5959044|NCT01209832|20608802|P1|Period 1|Sponsor Decision and was not dosed|1
5959045|NCT01209780|20608821|P5|Overall Study|Inappropriate enrollment|1
5959046|NCT01209780|20608822|P4|Overall Study|Inappropriate enrollment|0
5959047|NCT01209780|20608823|P3|Overall Study|Inappropriate enrollment|0
5959048|NCT01209780|20608824|P2|Overall Study|Inappropriate enrollment|2
5959049|NCT01209780|20608825|P1|Overall Study|Inappropriate enrollment|0
5959050|NCT01209780|20608821|P5|Overall Study|Protocol Violation|0
5959051|NCT01209780|20608822|P4|Overall Study|Protocol Violation|0
5959052|NCT01209780|20608823|P3|Overall Study|Protocol Violation|0
5959053|NCT01209780|20608824|P2|Overall Study|Protocol Violation|1
5959054|NCT01209780|20608825|P1|Overall Study|Protocol Violation|0
5959055|NCT01209780|20608821|P5|Overall Study|Lost to Follow-up|4
5959056|NCT01209780|20608822|P4|Overall Study|Lost to Follow-up|9
5959057|NCT01209780|20608823|P3|Overall Study|Lost to Follow-up|3
5959058|NCT01209780|20608824|P2|Overall Study|Lost to Follow-up|12
5959059|NCT01209780|20608825|P1|Overall Study|Lost to Follow-up|17
5959060|NCT01209780|20608821|P5|Overall Study|Withdrawal by Subject|0
5959061|NCT01209780|20608822|P4|Overall Study|Withdrawal by Subject|1
5959062|NCT01209780|20608823|P3|Overall Study|Withdrawal by Subject|1
5959063|NCT01209780|20608824|P2|Overall Study|Withdrawal by Subject|2
5959064|NCT01209780|20608825|P1|Overall Study|Withdrawal by Subject|9
5959065|NCT01209780|20608821|P5|Overall Study|Adverse Event|0
5959066|NCT01209780|20608822|P4|Overall Study|Adverse Event|0
5959067|NCT01209780|20608823|P3|Overall Study|Adverse Event|0
5959068|NCT01209780|20608824|P2|Overall Study|Adverse Event|1
5959069|NCT01209780|20608825|P1|Overall Study|Adverse Event|0
5959070|NCT01209767|20608851|P1|Overall Study|Lost to Follow-up|3
5959071|NCT01209767|20608851|P1|Overall Study|Withdrawal by Subject|1
5959072|NCT01209689|20608920|P2|Overall Study|Sponsor's Decision to Stop the Study|17
5959073|NCT01209689|20608921|P1|Overall Study|Sponsor's Decision to Stop the Study|68
5959074|NCT01209689|20608920|P2|Overall Study|Failure to Return|0
5959075|NCT01209689|20608921|P1|Overall Study|Failure to Return|3
5959076|NCT01209689|20608920|P2|Overall Study|Violation of Selection Criteria at Entry|0
5959077|NCT01209689|20608921|P1|Overall Study|Violation of Selection Criteria at Entry|1
5959078|NCT01209689|20608920|P2|Overall Study|Adverse Event|0
5959079|NCT01209689|20608921|P1|Overall Study|Adverse Event|4
5959080|NCT01209689|20608920|P2|Overall Study|Refused Treatment|3
5959081|NCT01209689|20608921|P1|Overall Study|Refused Treatment|8
5959082|NCT01209689|20608920|P2|Overall Study|Insufficient Therapeutic Response|2
5959083|NCT01209689|20608921|P1|Overall Study|Insufficient Therapeutic Response|7
5959089|NCT01209598|20608960|P2|Overall Study|Withdrawal by Subject|0
5959090|NCT01209598|20608961|P1|Overall Study|Withdrawal by Subject|1
5959091|NCT01209520|20608969|P1|Overall Study|Withdrawal by Subject|3
5959092|NCT01209325|20608979|P1|Overall Study|Incarceration|2
5959093|NCT01209325|20608979|P1|Overall Study|Refusal prior to therapy|1
5959094|NCT01209325|20608979|P1|Overall Study|Protocol Violation|4
5959095|NCT01209325|20608979|P1|Overall Study|Refusal after starting therapy|8
5959096|NCT01209325|20608979|P1|Overall Study|Relocated|3
5959097|NCT01209325|20608979|P1|Overall Study|Adverse Event|1
5959098|NCT01209325|20608979|P1|Overall Study|Lost to Follow-up|24
5959099|NCT01209286|20609034|P3|Overall Study|Other|0
5959100|NCT01209286|20609035|P2|Overall Study|Other|1
5959101|NCT01209286|20609036|P1|Overall Study|Other|0
5959102|NCT01209286|20609034|P3|Overall Study|Physician Decision|0
5959103|NCT01209286|20609035|P2|Overall Study|Physician Decision|2
5959104|NCT01209286|20609036|P1|Overall Study|Physician Decision|0
5959105|NCT01209286|20609034|P3|Overall Study|Remission Not Achieved in 2 Cycles|1
5959106|NCT01209286|20609035|P2|Overall Study|Remission Not Achieved in 2 Cycles|3
5959107|NCT01209286|20609036|P1|Overall Study|Remission Not Achieved in 2 Cycles|1
5959108|NCT01209286|20609034|P3|Overall Study|Hematological Relapse After Remission|1
5959109|NCT01209286|20609035|P2|Overall Study|Hematological Relapse After Remission|1
5959110|NCT01209286|20609036|P1|Overall Study|Hematological Relapse After Remission|0
5959111|NCT01209286|20609034|P3|Overall Study|Adverse Event|1
5959112|NCT01209286|20609035|P2|Overall Study|Adverse Event|3
5959113|NCT01209286|20609036|P1|Overall Study|Adverse Event|4
5959114|NCT01209143|20609156|P2|Overall Study|Disease progression|16
5959115|NCT01209143|20609157|P1|Overall Study|Disease progression|11
5959116|NCT01209143|20609156|P2|Overall Study|Withdrawal by Subject|1
5959117|NCT01209143|20609157|P1|Overall Study|Withdrawal by Subject|2
5959118|NCT01209143|20609156|P2|Overall Study|Lost to Follow-up|0
5959119|NCT01209143|20609157|P1|Overall Study|Lost to Follow-up|1
5959120|NCT01209143|20609156|P2|Overall Study|Physician Decision|1
5959121|NCT01209143|20609157|P1|Overall Study|Physician Decision|3
5959122|NCT01209143|20609156|P2|Overall Study|Death|1
5959123|NCT01209143|20609157|P1|Overall Study|Death|0
5959124|NCT01209143|20609156|P2|Overall Study|Adverse Event|1
5959125|NCT01209143|20609157|P1|Overall Study|Adverse Event|2
5959126|NCT01209078|20609167|P2|Overall Study|Withdrawal by Subject|1
5959127|NCT01209078|20609168|P1|Overall Study|Withdrawal by Subject|2
5959128|NCT01209078|20609167|P2|Overall Study|Physician Decision|2
5959129|NCT01209078|20609168|P1|Overall Study|Physician Decision|5
5959130|NCT01209078|20609167|P2|Overall Study|Lost to Follow-up|0
5959131|NCT01209078|20609168|P1|Overall Study|Lost to Follow-up|4
5959132|NCT01209078|20609167|P2|Overall Study|Adverse Event|0
5959133|NCT01209078|20609168|P1|Overall Study|Adverse Event|5
5959134|NCT01208961|20609243|P2|High-Fat Period III|Protocol Violation|0
5959135|NCT01208961|20609244|P1|High-Fat Period III|Protocol Violation|1
5959136|NCT01208870|20609266|P2|Overall Study|Lost to Follow-up|8
5959137|NCT01208870|20609267|P1|Overall Study|Lost to Follow-up|2
5959138|NCT01208415|20609283|P1|Overall Study|Still be eligible for follow-up|33
5959139|NCT01208415|20609283|P1|Overall Study|Device not placed|1
5959140|NCT01208415|20609283|P1|Overall Study|Withdrawal by Subject|3
5959141|NCT01208415|20609283|P1|Overall Study|Lost to Follow-up|2
5959142|NCT01208415|20609283|P1|Overall Study|Death|1
5959143|NCT01208402|20609289|P2|Overall Study|Withdrawal by Subject|0
5959144|NCT01208402|20609290|P1|Overall Study|Withdrawal by Subject|1
5959145|NCT01208337|20609306|P1|Overall Study|Death|3
5959146|NCT01208233|20609320|P6|Overall Study|Withdrawal by Subject|2
5959147|NCT01208233|20609321|P5|Overall Study|Withdrawal by Subject|4
5959148|NCT01208233|20609322|P4|Overall Study|Withdrawal by Subject|1
5959149|NCT01208233|20609323|P3|Overall Study|Withdrawal by Subject|1
5959150|NCT01208233|20609324|P2|Overall Study|Withdrawal by Subject|0
5959151|NCT01208233|20609325|P1|Overall Study|Withdrawal by Subject|1
5959152|NCT01208233|20609320|P6|Overall Study|Other|1
5959153|NCT01208233|20609321|P5|Overall Study|Other|0
5959154|NCT01208233|20609322|P4|Overall Study|Other|0
5959155|NCT01208233|20609323|P3|Overall Study|Other|0
5959156|NCT01208233|20609324|P2|Overall Study|Other|1
5959157|NCT01208233|20609325|P1|Overall Study|Other|2
5959158|NCT01208233|20609320|P6|Overall Study|Protocol Violation|0
5959159|NCT01208233|20609321|P5|Overall Study|Protocol Violation|3
5959160|NCT01208233|20609322|P4|Overall Study|Protocol Violation|0
5959161|NCT01208233|20609323|P3|Overall Study|Protocol Violation|0
5959162|NCT01208233|20609324|P2|Overall Study|Protocol Violation|0
5959163|NCT01208233|20609325|P1|Overall Study|Protocol Violation|0
5959164|NCT01208233|20609320|P6|Overall Study|Study terminated by sponsor|7
5959165|NCT01208233|20609321|P5|Overall Study|Study terminated by sponsor|10
5959166|NCT01208233|20609322|P4|Overall Study|Study terminated by sponsor|0
5959167|NCT01208233|20609323|P3|Overall Study|Study terminated by sponsor|0
5959168|NCT01208233|20609324|P2|Overall Study|Study terminated by sponsor|0
5959169|NCT01208233|20609325|P1|Overall Study|Study terminated by sponsor|0
5959170|NCT01208233|20609320|P6|Overall Study|Medication error without adverse event|1
5959171|NCT01208233|20609321|P5|Overall Study|Medication error without adverse event|0
5959172|NCT01208233|20609322|P4|Overall Study|Medication error without adverse event|0
5959173|NCT01208233|20609323|P3|Overall Study|Medication error without adverse event|0
5959174|NCT01208233|20609324|P2|Overall Study|Medication error without adverse event|0
5959175|NCT01208233|20609325|P1|Overall Study|Medication error without adverse event|0
5959176|NCT01208233|20609320|P6|Overall Study|Did not meet entrance criteria|0
5959177|NCT01208233|20609321|P5|Overall Study|Did not meet entrance criteria|1
5959178|NCT01208233|20609322|P4|Overall Study|Did not meet entrance criteria|0
5959179|NCT01208233|20609323|P3|Overall Study|Did not meet entrance criteria|1
5959180|NCT01208233|20609324|P2|Overall Study|Did not meet entrance criteria|1
5959181|NCT01208233|20609325|P1|Overall Study|Did not meet entrance criteria|2
5959182|NCT01208233|20609320|P6|Overall Study|Death|5
5959183|NCT01208233|20609321|P5|Overall Study|Death|3
5959184|NCT01208233|20609322|P4|Overall Study|Death|0
5959185|NCT01208233|20609323|P3|Overall Study|Death|0
5959186|NCT01208233|20609324|P2|Overall Study|Death|0
5959187|NCT01208233|20609325|P1|Overall Study|Death|0
5959188|NCT01208233|20609320|P6|Overall Study|Adverse Event|5
5959189|NCT01208233|20609321|P5|Overall Study|Adverse Event|3
5959190|NCT01208233|20609322|P4|Overall Study|Adverse Event|0
5959191|NCT01208233|20609323|P3|Overall Study|Adverse Event|2
5959192|NCT01208233|20609324|P2|Overall Study|Adverse Event|1
5959193|NCT01208233|20609325|P1|Overall Study|Adverse Event|0
5959194|NCT01208207|20609450|P7|Part II|Technical Problems|0
5959195|NCT01208207|20609451|P6|Part II|Technical Problems|1
5959196|NCT01208207|20609452|P5|Part II|Technical Problems|0
5959197|NCT01208207|20609453|P4|Part II|Technical Problems|1
5959198|NCT01208207|20609454|P3|Part II|Technical Problems|0
5959199|NCT01208207|20609455|P2|Part II|Technical Problems|0
5959200|NCT01208207|20609456|P1|Part II|Technical Problems|0
5959201|NCT01208207|20609450|P7|Part II|Protocol Violation|0
5959202|NCT01208207|20609451|P6|Part II|Protocol Violation|0
5959203|NCT01208207|20609452|P5|Part II|Protocol Violation|0
5959204|NCT01208207|20609453|P4|Part II|Protocol Violation|1
5959205|NCT01208207|20609454|P3|Part II|Protocol Violation|0
5959206|NCT01208207|20609455|P2|Part II|Protocol Violation|0
5959207|NCT01208207|20609456|P1|Part II|Protocol Violation|0
5959208|NCT01208207|20609450|P7|Part II|Physician Decision|0
5959209|NCT01208207|20609451|P6|Part II|Physician Decision|2
5959210|NCT01208207|20609452|P5|Part II|Physician Decision|0
5959211|NCT01208207|20609453|P4|Part II|Physician Decision|1
5959212|NCT01208207|20609454|P3|Part II|Physician Decision|0
5959213|NCT01208207|20609455|P2|Part II|Physician Decision|0
5959214|NCT01208207|20609456|P1|Part II|Physician Decision|0
5959215|NCT01208207|20609450|P7|Part II|Non-Compliance With Study Drug|0
5959216|NCT01208207|20609451|P6|Part II|Non-Compliance With Study Drug|1
5959217|NCT01208207|20609452|P5|Part II|Non-Compliance With Study Drug|1
5959218|NCT01208207|20609453|P4|Part II|Non-Compliance With Study Drug|4
5959219|NCT01208207|20609454|P3|Part II|Non-Compliance With Study Drug|0
5959220|NCT01208207|20609455|P2|Part II|Non-Compliance With Study Drug|0
5959221|NCT01208207|20609456|P1|Part II|Non-Compliance With Study Drug|0
5959222|NCT01208207|20609450|P7|Part II|Lost to Follow-up|1
5959223|NCT01208207|20609451|P6|Part II|Lost to Follow-up|2
5959224|NCT01208207|20609452|P5|Part II|Lost to Follow-up|0
5959225|NCT01208207|20609453|P4|Part II|Lost to Follow-up|4
5959226|NCT01208207|20609454|P3|Part II|Lost to Follow-up|0
5959227|NCT01208207|20609455|P2|Part II|Lost to Follow-up|0
5959228|NCT01208207|20609456|P1|Part II|Lost to Follow-up|0
5959229|NCT01208207|20609450|P7|Part II|Lack of Efficacy|3
5959230|NCT01208207|20609451|P6|Part II|Lack of Efficacy|3
5959231|NCT01208207|20609452|P5|Part II|Lack of Efficacy|4
5959232|NCT01208207|20609453|P4|Part II|Lack of Efficacy|6
5959233|NCT01208207|20609454|P3|Part II|Lack of Efficacy|0
5959234|NCT01208207|20609455|P2|Part II|Lack of Efficacy|0
5959235|NCT01208207|20609456|P1|Part II|Lack of Efficacy|0
5959236|NCT01208207|20609450|P7|Part II|Adverse Event|2
5959237|NCT01208207|20609451|P6|Part II|Adverse Event|4
5959238|NCT01208207|20609452|P5|Part II|Adverse Event|9
5959239|NCT01208207|20609453|P4|Part II|Adverse Event|5
5959240|NCT01208207|20609454|P3|Part II|Adverse Event|0
5959241|NCT01208207|20609455|P2|Part II|Adverse Event|0
5959242|NCT01208207|20609456|P1|Part II|Adverse Event|0
5959243|NCT01208207|20609450|P7|Part II|Withdrawal by Subject|5
5959244|NCT01208207|20609451|P6|Part II|Withdrawal by Subject|3
5959245|NCT01208207|20609452|P5|Part II|Withdrawal by Subject|9
5959246|NCT01208207|20609453|P4|Part II|Withdrawal by Subject|10
5959247|NCT01208207|20609454|P3|Part II|Withdrawal by Subject|0
5959248|NCT01208207|20609455|P2|Part II|Withdrawal by Subject|0
5959249|NCT01208207|20609456|P1|Part II|Withdrawal by Subject|0
5959250|NCT01208207|20609450|P7|Part I|Withdrawal by Subject|0
5959251|NCT01208207|20609451|P6|Part I|Withdrawal by Subject|0
5959252|NCT01208207|20609452|P5|Part I|Withdrawal by Subject|0
5959253|NCT01208207|20609453|P4|Part I|Withdrawal by Subject|0
5959254|NCT01208207|20609454|P3|Part I|Withdrawal by Subject|4
5959255|NCT01208207|20609455|P2|Part I|Withdrawal by Subject|4
5959256|NCT01208207|20609456|P1|Part I|Withdrawal by Subject|14
5959257|NCT01208207|20609450|P7|Part I|Protocol Violation|0
5959258|NCT01208207|20609451|P6|Part I|Protocol Violation|0
5959259|NCT01208207|20609452|P5|Part I|Protocol Violation|0
5959260|NCT01208207|20609453|P4|Part I|Protocol Violation|0
5959261|NCT01208207|20609454|P3|Part I|Protocol Violation|2
5959262|NCT01208207|20609455|P2|Part I|Protocol Violation|0
5959263|NCT01208207|20609456|P1|Part I|Protocol Violation|8
5959264|NCT01208207|20609450|P7|Part I|Progressive Disease|0
5959265|NCT01208207|20609451|P6|Part I|Progressive Disease|0
5959266|NCT01208207|20609452|P5|Part I|Progressive Disease|0
5959267|NCT01208207|20609453|P4|Part I|Progressive Disease|0
5959268|NCT01208207|20609454|P3|Part I|Progressive Disease|0
5959269|NCT01208207|20609455|P2|Part I|Progressive Disease|0
5959270|NCT01208207|20609456|P1|Part I|Progressive Disease|1
5959271|NCT01208207|20609450|P7|Part I|Physician Decision|0
5959272|NCT01208207|20609451|P6|Part I|Physician Decision|0
5959273|NCT01208207|20609452|P5|Part I|Physician Decision|0
5959274|NCT01208207|20609453|P4|Part I|Physician Decision|0
5959275|NCT01208207|20609454|P3|Part I|Physician Decision|0
5959276|NCT01208207|20609455|P2|Part I|Physician Decision|1
5959277|NCT01208207|20609456|P1|Part I|Physician Decision|0
5959278|NCT01208207|20609450|P7|Part I|Non-Compliance With Study Drug|0
5959279|NCT01208207|20609451|P6|Part I|Non-Compliance With Study Drug|0
5959280|NCT01208207|20609452|P5|Part I|Non-Compliance With Study Drug|0
5959281|NCT01208207|20609453|P4|Part I|Non-Compliance With Study Drug|0
5959282|NCT01208207|20609454|P3|Part I|Non-Compliance With Study Drug|1
5959283|NCT01208207|20609455|P2|Part I|Non-Compliance With Study Drug|0
5959284|NCT01208207|20609456|P1|Part I|Non-Compliance With Study Drug|1
5959285|NCT01208207|20609450|P7|Part I|Lost to Follow-up|0
5959286|NCT01208207|20609451|P6|Part I|Lost to Follow-up|0
5959287|NCT01208207|20609452|P5|Part I|Lost to Follow-up|0
5959288|NCT01208207|20609453|P4|Part I|Lost to Follow-up|0
5959289|NCT01208207|20609454|P3|Part I|Lost to Follow-up|0
5959290|NCT01208207|20609455|P2|Part I|Lost to Follow-up|1
5959291|NCT01208207|20609456|P1|Part I|Lost to Follow-up|6
5959292|NCT01208207|20609450|P7|Part I|Lack of Efficacy|0
5959293|NCT01208207|20609451|P6|Part I|Lack of Efficacy|0
5959294|NCT01208207|20609452|P5|Part I|Lack of Efficacy|0
5959295|NCT01208207|20609453|P4|Part I|Lack of Efficacy|0
5959296|NCT01208207|20609454|P3|Part I|Lack of Efficacy|2
5959297|NCT01208207|20609455|P2|Part I|Lack of Efficacy|3
5959298|NCT01208207|20609456|P1|Part I|Lack of Efficacy|21
5959299|NCT01208207|20609450|P7|Part I|Adverse Event|0
5959300|NCT01208207|20609451|P6|Part I|Adverse Event|0
5959301|NCT01208207|20609452|P5|Part I|Adverse Event|0
5959302|NCT01208207|20609453|P4|Part I|Adverse Event|0
5959303|NCT01208207|20609454|P3|Part I|Adverse Event|6
5959304|NCT01208207|20609455|P2|Part I|Adverse Event|2
5959305|NCT01208207|20609456|P1|Part I|Adverse Event|19
5959306|NCT01208181|20609483|P5|Part 2|Lack of Efficacy|0
5959307|NCT01208181|20609484|P4|Part 2|Lack of Efficacy|7
5959308|NCT01208181|20609485|P3|Part 2|Lack of Efficacy|5
5959309|NCT01208181|20609486|P2|Part 2|Lack of Efficacy|0
5959310|NCT01208181|20609487|P1|Part 2|Lack of Efficacy|0
5959311|NCT01208181|20609483|P5|Part 2|Lost to Follow-up|0
5959312|NCT01208181|20609484|P4|Part 2|Lost to Follow-up|2
5959313|NCT01208181|20609485|P3|Part 2|Lost to Follow-up|1
5959314|NCT01208181|20609486|P2|Part 2|Lost to Follow-up|0
5959315|NCT01208181|20609487|P1|Part 2|Lost to Follow-up|0
5959316|NCT01208181|20609483|P5|Part 2|Non-compliance with study drug|0
5959317|NCT01208181|20609484|P4|Part 2|Non-compliance with study drug|1
5959318|NCT01208181|20609485|P3|Part 2|Non-compliance with study drug|1
5959319|NCT01208181|20609486|P2|Part 2|Non-compliance with study drug|0
5959320|NCT01208181|20609487|P1|Part 2|Non-compliance with study drug|0
5959321|NCT01208181|20609483|P5|Part 2|Physician Decision|0
5959322|NCT01208181|20609484|P4|Part 2|Physician Decision|2
5959323|NCT01208181|20609485|P3|Part 2|Physician Decision|1
5959324|NCT01208181|20609486|P2|Part 2|Physician Decision|0
5959325|NCT01208181|20609487|P1|Part 2|Physician Decision|0
5959326|NCT01208181|20609483|P5|Part 2|Protocol Violation|0
5959327|NCT01208181|20609484|P4|Part 2|Protocol Violation|0
5959328|NCT01208181|20609485|P3|Part 2|Protocol Violation|1
5959329|NCT01208181|20609486|P2|Part 2|Protocol Violation|0
5959330|NCT01208181|20609487|P1|Part 2|Protocol Violation|0
5959331|NCT01208181|20609483|P5|Part 2|Withdrawal by Subject|0
5959332|NCT01208181|20609484|P4|Part 2|Withdrawal by Subject|1
5959333|NCT01208181|20609485|P3|Part 2|Withdrawal by Subject|1
5959334|NCT01208181|20609486|P2|Part 2|Withdrawal by Subject|0
5959335|NCT01208181|20609487|P1|Part 2|Withdrawal by Subject|0
5959336|NCT01208181|20609483|P5|Part 2|Adverse Event|0
5959337|NCT01208181|20609484|P4|Part 2|Adverse Event|7
5959338|NCT01208181|20609485|P3|Part 2|Adverse Event|6
5959339|NCT01208181|20609486|P2|Part 2|Adverse Event|0
5959340|NCT01208181|20609487|P1|Part 2|Adverse Event|0
5959341|NCT01208181|20609483|P5|Part 1|Adverse Event|4
5959342|NCT01208181|20609484|P4|Part 1|Adverse Event|0
5959343|NCT01208181|20609485|P3|Part 1|Adverse Event|0
5959344|NCT01208181|20609486|P2|Part 1|Adverse Event|24
5959345|NCT01208181|20609487|P1|Part 1|Adverse Event|26
5959346|NCT01208181|20609483|P5|Part 1|Lack of Efficacy|17
5959347|NCT01208181|20609484|P4|Part 1|Lack of Efficacy|0
5959348|NCT01208181|20609485|P3|Part 1|Lack of Efficacy|0
5959349|NCT01208181|20609486|P2|Part 1|Lack of Efficacy|12
5959350|NCT01208181|20609487|P1|Part 1|Lack of Efficacy|37
5959351|NCT01208181|20609483|P5|Part 1|Lost to Follow-up|1
5959352|NCT01208181|20609484|P4|Part 1|Lost to Follow-up|0
5959353|NCT01208181|20609485|P3|Part 1|Lost to Follow-up|0
5959354|NCT01208181|20609486|P2|Part 1|Lost to Follow-up|3
5959355|NCT01208181|20609487|P1|Part 1|Lost to Follow-up|5
5959356|NCT01208181|20609483|P5|Part 1|Non-compliance with study drug|0
5959357|NCT01208181|20609484|P4|Part 1|Non-compliance with study drug|0
5959358|NCT01208181|20609485|P3|Part 1|Non-compliance with study drug|0
5959359|NCT01208181|20609486|P2|Part 1|Non-compliance with study drug|1
5959360|NCT01208181|20609487|P1|Part 1|Non-compliance with study drug|1
5959361|NCT01208181|20609483|P5|Part 1|Physician Decision|0
5959362|NCT01208181|20609484|P4|Part 1|Physician Decision|0
5959363|NCT01208181|20609485|P3|Part 1|Physician Decision|0
5959364|NCT01208181|20609486|P2|Part 1|Physician Decision|0
5959365|NCT01208181|20609487|P1|Part 1|Physician Decision|4
5959366|NCT01208181|20609483|P5|Part 1|Protocol Violation|0
5959367|NCT01208181|20609484|P4|Part 1|Protocol Violation|0
5959368|NCT01208181|20609485|P3|Part 1|Protocol Violation|0
5959369|NCT01208181|20609486|P2|Part 1|Protocol Violation|5
5959370|NCT01208181|20609487|P1|Part 1|Protocol Violation|10
5959371|NCT01208181|20609483|P5|Part 1|Technical problem|0
5959372|NCT01208181|20609484|P4|Part 1|Technical problem|0
5959373|NCT01208181|20609485|P3|Part 1|Technical problem|0
5959374|NCT01208181|20609486|P2|Part 1|Technical problem|0
5959375|NCT01208181|20609487|P1|Part 1|Technical problem|5
5959376|NCT01208181|20609483|P5|Part 1|Withdrawal by Subject|0
5959377|NCT01208181|20609484|P4|Part 1|Withdrawal by Subject|0
5959378|NCT01208181|20609485|P3|Part 1|Withdrawal by Subject|0
5959379|NCT01208181|20609486|P2|Part 1|Withdrawal by Subject|10
5959380|NCT01208181|20609487|P1|Part 1|Withdrawal by Subject|11
5959381|NCT01208103|20609516|P1|Overall Study|Withdrawal by Subject|1
5959382|NCT01208103|20609516|P1|Overall Study|Adverse Event|1
5959383|NCT01208038|20609524|P1|Overall Study|Withdrawal by Subject|1
5959384|NCT01207687|20609593|P1|Overall Study|Withdrawal by Subject|1
5959385|NCT01207687|20609593|P1|Overall Study|Adverse Event|1
5959386|NCT01207596|20609631|P1|Overall Study|Withdrawal by Subject|1
5959387|NCT01207596|20609631|P1|Overall Study|Adverse Event|3
5959388|NCT01207596|20609631|P1|Overall Study|Lack of Efficacy|1
5959389|NCT01207596|20609631|P1|Overall Study|Physician Decision|4
5959390|NCT01207583|20609644|P3|Overall Study|Lost to Follow-up|0
5959391|NCT01207583|20609645|P2|Overall Study|Lost to Follow-up|2
5959392|NCT01207583|20609646|P1|Overall Study|Lost to Follow-up|0
5959393|NCT01207583|20609644|P3|Overall Study|Participant failed to return|0
5959394|NCT01207583|20609645|P2|Overall Study|Participant failed to return|0
5959395|NCT01207583|20609646|P1|Overall Study|Participant failed to return|1
5959396|NCT01207583|20609644|P3|Overall Study|Withdrawal by Subject|1
5959397|NCT01207583|20609645|P2|Overall Study|Withdrawal by Subject|3
5959398|NCT01207583|20609646|P1|Overall Study|Withdrawal by Subject|0
5959399|NCT01207492|20609699|P1|Overall Study|Toxicity|1
5959400|NCT01207492|20609699|P1|Overall Study|Progressive disease|3
5959401|NCT01207492|20609699|P1|Overall Study|Physician Decision|1
5959402|NCT01207492|20609699|P1|Overall Study|Withdrawal by Subject|9
5959403|NCT01207492|20609699|P1|Overall Study|Still on study|1
5959404|NCT01207453|20609714|P2|2nd Intervention|Lost to Follow-up|0
5959405|NCT01207453|20609715|P1|2nd Intervention|Lost to Follow-up|1
5959406|NCT01207453|20609714|P2|2nd Intervention|Adverse Event|2
5959407|NCT01207453|20609715|P1|2nd Intervention|Adverse Event|1
5959408|NCT01207453|20609714|P2|Washout|Lost to Follow-up|0
5959409|NCT01207453|20609715|P1|Washout|Lost to Follow-up|1
5959410|NCT01207453|20609714|P2|Washout|Adverse Event|0
5959411|NCT01207453|20609715|P1|Washout|Adverse Event|1
5959412|NCT01207453|20609714|P2|First Intervention|Adverse Event|1
5959413|NCT01207453|20609715|P1|First Intervention|Adverse Event|2
5959491|NCT01207427|20609814|P3|Double-blind Treatment Period|Withdrawal by Subject|0
5959492|NCT01207427|20609815|P2|Double-blind Treatment Period|Withdrawal by Subject|0
5959493|NCT01207427|20609816|P1|Double-blind Treatment Period|Withdrawal by Subject|1
5959494|NCT01207427|20609814|P3|Double-blind Treatment Period|Protocol Violation|1
5959495|NCT01207427|20609815|P2|Double-blind Treatment Period|Protocol Violation|1
5959496|NCT01207427|20609816|P1|Double-blind Treatment Period|Protocol Violation|2
5959497|NCT01207427|20609814|P3|Double-blind Treatment Period|Lost to Follow-up|1
5959498|NCT01207427|20609815|P2|Double-blind Treatment Period|Lost to Follow-up|0
5959499|NCT01207427|20609816|P1|Double-blind Treatment Period|Lost to Follow-up|0
5959500|NCT01207427|20609814|P3|Double-blind Treatment Period|Adverse Event|0
5959501|NCT01207427|20609815|P2|Double-blind Treatment Period|Adverse Event|1
5959502|NCT01207427|20609816|P1|Double-blind Treatment Period|Adverse Event|0
5959503|NCT01207414|20609826|P2|Overall Study|Randomized in error|0
5959504|NCT01207414|20609827|P1|Overall Study|Randomized in error|1
5959505|NCT01207414|20609826|P2|Overall Study|Protocol deviation|9
5959506|NCT01207414|20609827|P1|Overall Study|Protocol deviation|12
5959507|NCT01207414|20609826|P2|Overall Study|Administrative problems|1
5959508|NCT01207414|20609827|P1|Overall Study|Administrative problems|1
5959509|NCT01207414|20609826|P2|Overall Study|Lost to Follow-up|17
5959510|NCT01207414|20609827|P1|Overall Study|Lost to Follow-up|15
5959511|NCT01207414|20609826|P2|Overall Study|Patient withdrew consent|11
5959512|NCT01207414|20609827|P1|Overall Study|Patient withdrew consent|14
5959513|NCT01207414|20609826|P2|Overall Study|Unsatisfactory therapeutic effect|4
5959514|NCT01207414|20609827|P1|Overall Study|Unsatisfactory therapeutic effect|5
5959515|NCT01207414|20609826|P2|Overall Study|Abnormal test procedure results|1
5959516|NCT01207414|20609827|P1|Overall Study|Abnormal test procedure results|0
5959517|NCT01207414|20609826|P2|Overall Study|Adverse Event|39
5959518|NCT01207414|20609827|P1|Overall Study|Adverse Event|25
5959519|NCT01207388|20609852|P1|Overall Study|Withdrawal by Subject|1
5959520|NCT01207388|20609852|P1|Overall Study|Death|67
5959521|NCT01207219|20609877|P3|Overall Study|Lost to Follow-up|6
5959522|NCT01207219|20609878|P2|Overall Study|Lost to Follow-up|8
5959523|NCT01207219|20609879|P1|Overall Study|Lost to Follow-up|6
5959524|NCT01207219|20609877|P3|Overall Study|changed diagnosis during study period|1
5959525|NCT01207219|20609878|P2|Overall Study|changed diagnosis during study period|3
5959526|NCT01207219|20609879|P1|Overall Study|changed diagnosis during study period|5
5959527|NCT01207102|20609899|P1|Overall Study|Withdrawal by Treating Physician|1
5959528|NCT01207102|20609899|P1|Overall Study|progression|2
5959529|NCT01207102|20609899|P1|Overall Study|Adverse Event|2
5959530|NCT01207102|20609899|P1|Overall Study|Withdrawal by Subject|5
5959531|NCT01206816|20609911|P7|Overall Study|other than stated above|1
5959532|NCT01206816|20609912|P6|Overall Study|other than stated above|0
5959533|NCT01206816|20609913|P5|Overall Study|other than stated above|0
5959534|NCT01206816|20609914|P4|Overall Study|other than stated above|0
5959535|NCT01206816|20609915|P3|Overall Study|other than stated above|1
5959536|NCT01206816|20609916|P2|Overall Study|other than stated above|0
5959537|NCT01206816|20609917|P1|Overall Study|other than stated above|0
5959538|NCT01206816|20609911|P7|Overall Study|Other AE|2
5959539|NCT01206816|20609912|P6|Overall Study|Other AE|3
5959540|NCT01206816|20609913|P5|Overall Study|Other AE|0
5959541|NCT01206816|20609914|P4|Overall Study|Other AE|0
5959542|NCT01206816|20609915|P3|Overall Study|Other AE|4
5959543|NCT01206816|20609916|P2|Overall Study|Other AE|0
5959544|NCT01206816|20609917|P1|Overall Study|Other AE|0
5959545|NCT01206816|20609911|P7|Overall Study|Progressive disease|3
5959546|NCT01206816|20609912|P6|Overall Study|Progressive disease|16
5959547|NCT01206816|20609913|P5|Overall Study|Progressive disease|3
5959548|NCT01206816|20609914|P4|Overall Study|Progressive disease|3
5959549|NCT01206816|20609915|P3|Overall Study|Progressive disease|13
5959550|NCT01206816|20609916|P2|Overall Study|Progressive disease|3
5959551|NCT01206816|20609917|P1|Overall Study|Progressive disease|3
5959552|NCT01206816|20609911|P7|Overall Study|Withdrawal by Subject|0
5959553|NCT01206816|20609912|P6|Overall Study|Withdrawal by Subject|0
5959554|NCT01206816|20609913|P5|Overall Study|Withdrawal by Subject|0
5959555|NCT01206816|20609914|P4|Overall Study|Withdrawal by Subject|0
5959556|NCT01206816|20609915|P3|Overall Study|Withdrawal by Subject|1
5959557|NCT01206816|20609916|P2|Overall Study|Withdrawal by Subject|0
5959558|NCT01206816|20609917|P1|Overall Study|Withdrawal by Subject|0
5959559|NCT01206816|20609911|P7|Overall Study|Protocol Violation|0
5959560|NCT01206816|20609912|P6|Overall Study|Protocol Violation|0
5959561|NCT01206816|20609913|P5|Overall Study|Protocol Violation|0
5959562|NCT01206816|20609914|P4|Overall Study|Protocol Violation|0
5959563|NCT01206816|20609915|P3|Overall Study|Protocol Violation|1
5959564|NCT01206816|20609916|P2|Overall Study|Protocol Violation|0
5959565|NCT01206816|20609917|P1|Overall Study|Protocol Violation|0
5959566|NCT01206777|20609963|P1|Overall Study|Adverse Event|1
5959567|NCT01206777|20609963|P1|Overall Study|Death|1
5959568|NCT01206764|20609969|P1|Overall Study|Protocol deviation|3
5959569|NCT01206764|20609969|P1|Overall Study|Disease progression|88
5959570|NCT01206764|20609969|P1|Overall Study|New cancer therapy|2
5959571|NCT01206764|20609969|P1|Overall Study|Death|11
5959572|NCT01206764|20609969|P1|Overall Study|Lost to Follow-up|6
5959573|NCT01206764|20609969|P1|Overall Study|Patient withdrew consent|5
5959574|NCT01206764|20609969|P1|Overall Study|Abnormal test procedure result|1
5959575|NCT01206764|20609969|P1|Overall Study|Abnormal laboratory value|2
5959576|NCT01206764|20609969|P1|Overall Study|Adverse Event|20
5959577|NCT01206582|20610027|P2|Overall Study|Discontinued intervention before week 8|2
5959578|NCT01206582|20610028|P1|Overall Study|Discontinued intervention before week 8|1
5959579|NCT01206582|20610027|P2|Overall Study|Withdrew prior to study|0
5959580|NCT01206582|20610028|P1|Overall Study|Withdrew prior to study|1
5959581|NCT01206517|20610060|P6|Overall Study|Withdrawal by Subject|0
5959582|NCT01206517|20610061|P5|Overall Study|Withdrawal by Subject|1
5959583|NCT01206517|20610062|P4|Overall Study|Withdrawal by Subject|0
5959584|NCT01206517|20610063|P3|Overall Study|Withdrawal by Subject|2
5959585|NCT01206517|20610064|P2|Overall Study|Withdrawal by Subject|0
5959586|NCT01206517|20610065|P1|Overall Study|Withdrawal by Subject|0
5959587|NCT01206439|20610145|P1|Overall Study|subject did not meet inclusion criteria|1
5959588|NCT01206322|20610168|P4|Overall Study|Adverse Event|1
5959589|NCT01206322|20610169|P3|Overall Study|Adverse Event|0
5959590|NCT01206322|20610170|P2|Overall Study|Adverse Event|0
5959591|NCT01206322|20610171|P1|Overall Study|Adverse Event|0
5959592|NCT01206140|20610187|P2|Overall Study|Deemed ineligible due to incorrect diag.|0
5959593|NCT01206140|20610188|P1|Overall Study|Deemed ineligible due to incorrect diag.|1
5959594|NCT01206101|20610200|P2|Overall Study|Unclassified|0
5959595|NCT01206101|20610201|P1|Overall Study|Unclassified|1
5959596|NCT01206101|20610200|P2|Overall Study|Physician Decision|1
5959597|NCT01206101|20610201|P1|Overall Study|Physician Decision|0
5959598|NCT01206101|20610200|P2|Overall Study|Adverse Event|0
5959599|NCT01206101|20610201|P1|Overall Study|Adverse Event|1
5959600|NCT01205776|20610246|P2|Overall Study|Withdrawal by Subject|34
5959601|NCT01205776|20610247|P1|Overall Study|Withdrawal by Subject|11
5959602|NCT01205776|20610246|P2|Overall Study|Lost to Follow-up|61
5959603|NCT01205776|20610247|P1|Overall Study|Lost to Follow-up|53
5959604|NCT01205685|20610435|P1|Overall Study|Withdrawal by Subject|1
5959605|NCT01205685|20610435|P1|Overall Study|Disease Progression|10
5959606|NCT01205581|20610455|P6|Overall Study|Withdrawal by Subject|0
5959607|NCT01205581|20610456|P5|Overall Study|Withdrawal by Subject|0
5959608|NCT01205581|20610457|P4|Overall Study|Withdrawal by Subject|0
5959609|NCT01205581|20610458|P3|Overall Study|Withdrawal by Subject|0
5959610|NCT01205581|20610459|P2|Overall Study|Withdrawal by Subject|0
5959611|NCT01205581|20610460|P1|Overall Study|Withdrawal by Subject|1
5959612|NCT01205529|20610530|P1|Overall Study|No longer met criteria|30
5959613|NCT01205529|20610530|P1|Overall Study|Unstable post op|15
5959614|NCT01205529|20610530|P1|Overall Study|Physician Decision|4
5959615|NCT01205529|20610530|P1|Overall Study|Withdrawal by Subject|2
5959616|NCT01205529|20610530|P1|Overall Study|Procedure Cancelled|4
5959617|NCT01205451|20610553|P2|Overall Study|Withdrawal by Subject|9
5959618|NCT01205451|20610554|P1|Overall Study|Withdrawal by Subject|5
5959619|NCT01205451|20610553|P2|Overall Study|Lost to Follow-up|1
5959620|NCT01205451|20610554|P1|Overall Study|Lost to Follow-up|1
5959621|NCT01205438|20610599|P3|Overall Study|Sponsor Decision|1
5959622|NCT01205438|20610600|P2|Overall Study|Sponsor Decision|1
5959623|NCT01205438|20610601|P1|Overall Study|Sponsor Decision|0
5959624|NCT01205438|20610599|P3|Overall Study|Protocol Violation|4
5959625|NCT01205438|20610600|P2|Overall Study|Protocol Violation|7
5959626|NCT01205438|20610601|P1|Overall Study|Protocol Violation|2
5959627|NCT01205438|20610599|P3|Overall Study|Physician Decision|2
5959628|NCT01205438|20610600|P2|Overall Study|Physician Decision|3
5959629|NCT01205438|20610601|P1|Overall Study|Physician Decision|0
5959630|NCT01205438|20610599|P3|Overall Study|Withdrawal by Subject|19
5959631|NCT01205438|20610600|P2|Overall Study|Withdrawal by Subject|25
5959632|NCT01205438|20610601|P1|Overall Study|Withdrawal by Subject|19
5959633|NCT01205438|20610599|P3|Overall Study|Lost to Follow-up|8
5959634|NCT01205438|20610600|P2|Overall Study|Lost to Follow-up|7
5959635|NCT01205438|20610601|P1|Overall Study|Lost to Follow-up|6
5959636|NCT01205438|20610599|P3|Overall Study|Lack of Efficacy|14
5959637|NCT01205438|20610600|P2|Overall Study|Lack of Efficacy|11
5959638|NCT01205438|20610601|P1|Overall Study|Lack of Efficacy|14
5959639|NCT01205438|20610599|P3|Overall Study|Entry Criteria Not Met|13
5959640|NCT01205438|20610600|P2|Overall Study|Entry Criteria Not Met|15
5959641|NCT01205438|20610601|P1|Overall Study|Entry Criteria Not Met|16
5959642|NCT01205438|20610599|P3|Overall Study|Death|3
5959643|NCT01205438|20610600|P2|Overall Study|Death|1
5959644|NCT01205438|20610601|P1|Overall Study|Death|1
5959645|NCT01205438|20610599|P3|Overall Study|Adverse Event|24
5959646|NCT01205438|20610600|P2|Overall Study|Adverse Event|17
5959647|NCT01205438|20610601|P1|Overall Study|Adverse Event|19
5959648|NCT01205269|20610657|P6|Period 4 - Washout|Eligibility criteria not fulfilled|0
5959649|NCT01205269|20610658|P5|Period 4 - Washout|Eligibility criteria not fulfilled|0
5959650|NCT01205269|20610659|P4|Period 4 - Washout|Eligibility criteria not fulfilled|1
5959651|NCT01205269|20610660|P3|Period 4 - Washout|Eligibility criteria not fulfilled|0
5959652|NCT01205269|20610661|P2|Period 4 - Washout|Eligibility criteria not fulfilled|0
5959653|NCT01205269|20610662|P1|Period 4 - Washout|Eligibility criteria not fulfilled|0
5959654|NCT01205230|20610702|P2|Overall Study|Physician Decision|0
5959655|NCT01205230|20610703|P1|Overall Study|Physician Decision|1
5959656|NCT01205230|20610702|P2|Overall Study|Adverse Event|0
5959657|NCT01205230|20610703|P1|Overall Study|Adverse Event|4
5959658|NCT01205165|20610746|P1|Overall Study|Lost to Follow-up|2
5959659|NCT01205152|20610759|P1|Overall Study|Death|1
5959660|NCT01205126|20610772|P2|Maintenance Phase|Withdrawal by Subject|11
5959661|NCT01205126|20610773|P1|Maintenance Phase|Withdrawal by Subject|8
5959662|NCT01205126|20610772|P2|Maintenance Phase|Lost to Follow-up|5
5959663|NCT01205126|20610773|P1|Maintenance Phase|Lost to Follow-up|5
5959664|NCT01205126|20610772|P2|Maintenance Phase|Other|8
5959665|NCT01205126|20610773|P1|Maintenance Phase|Other|11
5959666|NCT01205126|20610772|P2|Maintenance Phase|Prohibited drugs used|0
5959667|NCT01205126|20610773|P1|Maintenance Phase|Prohibited drugs used|1
5959668|NCT01205126|20610772|P2|Maintenance Phase|More than the maximum dosage required|5
5959669|NCT01205126|20610773|P1|Maintenance Phase|More than the maximum dosage required|5
5959670|NCT01205126|20610772|P2|Maintenance Phase|Death|4
5959671|NCT01205126|20610773|P1|Maintenance Phase|Death|4
5959672|NCT01205126|20610772|P2|Maintenance Phase|Adverse Event|7
5959673|NCT01205126|20610773|P1|Maintenance Phase|Adverse Event|3
5959674|NCT01205126|20610772|P2|Between Titration & Maintenance Phase|Other|4
5959675|NCT01205126|20610773|P1|Between Titration & Maintenance Phase|Other|0
5959676|NCT01205126|20610772|P2|Titration Phase|Other|6
5959677|NCT01205126|20610773|P1|Titration Phase|Other|8
5959678|NCT01205126|20610772|P2|Titration Phase|More than maximum dosage required|3
5959679|NCT01205126|20610773|P1|Titration Phase|More than maximum dosage required|2
5959680|NCT01205126|20610772|P2|Titration Phase|No stable titration dose|0
5959681|NCT01205126|20610773|P1|Titration Phase|No stable titration dose|1
5959682|NCT01205126|20610772|P2|Titration Phase|Lost to Follow-up|2
5959683|NCT01205126|20610773|P1|Titration Phase|Lost to Follow-up|2
5959684|NCT01205126|20610772|P2|Titration Phase|Withdrawal by Subject|5
5959685|NCT01205126|20610773|P1|Titration Phase|Withdrawal by Subject|5
5959686|NCT01205126|20610772|P2|Titration Phase|Adverse Event|3
5959687|NCT01205126|20610773|P1|Titration Phase|Adverse Event|5
5959688|NCT01205035|20610791|P2|Overall Study|Physician Decision|0
5959689|NCT01205035|20610792|P1|Overall Study|Physician Decision|1
5959690|NCT01205035|20610791|P2|Overall Study|Withdrawal by Subject|0
5959691|NCT01205035|20610792|P1|Overall Study|Withdrawal by Subject|1
5959692|NCT01204918|20610809|P3|Overall Study|Withdrawal by Subject|5
5959693|NCT01204918|20610810|P2|Overall Study|Withdrawal by Subject|10
5959694|NCT01204918|20610811|P1|Overall Study|Withdrawal by Subject|4
5959695|NCT01204775|20610854|P2|Overall Study|Withdrawal by Subject|0
5959696|NCT01204775|20610855|P1|Overall Study|Withdrawal by Subject|1
5959697|NCT01204775|20610854|P2|Overall Study|Poor/non-compliance|1
5959698|NCT01204775|20610855|P1|Overall Study|Poor/non-compliance|0
5959699|NCT01204710|20610880|P2|Optional Olaratumab Monotherapy|Withdrawal by Subject|1
5959700|NCT01204710|20610881|P1|Optional Olaratumab Monotherapy|Withdrawal by Subject|0
5959701|NCT01204710|20610880|P2|Optional Olaratumab Monotherapy|Physician Decision|1
5959702|NCT01204710|20610881|P1|Optional Olaratumab Monotherapy|Physician Decision|0
5959703|NCT01204710|20610880|P2|Optional Olaratumab Monotherapy|Olaratumab Intolerance|1
5959704|NCT01204710|20610881|P1|Optional Olaratumab Monotherapy|Olaratumab Intolerance|0
5959705|NCT01204710|20610880|P2|Randomization Treatment|Moved and Followed for Survival|1
5959706|NCT01204710|20610881|P1|Randomization Treatment|Moved and Followed for Survival|0
5959707|NCT01204710|20610880|P2|Randomization Treatment|Worsening of General condition|1
5959708|NCT01204710|20610881|P1|Randomization Treatment|Worsening of General condition|0
5959709|NCT01204710|20610880|P2|Randomization Treatment|Sponsor Decision|1
5959710|NCT01204710|20610881|P1|Randomization Treatment|Sponsor Decision|0
5959711|NCT01204710|20610880|P2|Randomization Treatment|Adverse Event|2
5959712|NCT01204710|20610881|P1|Randomization Treatment|Adverse Event|4
5959713|NCT01204710|20610880|P2|Randomization Treatment|Entry criteria not met|1
5959714|NCT01204710|20610881|P1|Randomization Treatment|Entry criteria not met|0
5959715|NCT01204710|20610880|P2|Randomization Treatment|Physician Decision|2
5959716|NCT01204710|20610881|P1|Randomization Treatment|Physician Decision|3
5959717|NCT01204710|20610880|P2|Randomization Treatment|Withdrawal by Subject|5
5959718|NCT01204710|20610881|P1|Randomization Treatment|Withdrawal by Subject|6
5959719|NCT01204710|20610880|P2|Randomization Treatment|Lost to Follow-up|0
5959720|NCT01204710|20610881|P1|Randomization Treatment|Lost to Follow-up|1
5959721|NCT01204697|20610917|P2|Overall Study|Randomized, but not treated|1
5959722|NCT01204697|20610918|P1|Overall Study|Randomized, but not treated|0
5959723|NCT01204697|20610917|P2|Overall Study|Withdrawal by Subject|4
5959724|NCT01204697|20610918|P1|Overall Study|Withdrawal by Subject|2
5959725|NCT01204697|20610917|P2|Overall Study|Lost to Follow-up|4
5959726|NCT01204697|20610918|P1|Overall Study|Lost to Follow-up|3
5959727|NCT01204697|20610917|P2|Overall Study|Death|27
5959728|NCT01204697|20610918|P1|Overall Study|Death|26
5959729|NCT01204671|20610939|P5|Overall Study|Physician Decision|0
5959730|NCT01204671|20610940|P4|Overall Study|Physician Decision|1
5959731|NCT01204671|20610941|P3|Overall Study|Physician Decision|0
5959732|NCT01204671|20610942|P2|Overall Study|Physician Decision|0
5959733|NCT01204671|20610943|P1|Overall Study|Physician Decision|0
5959734|NCT01204671|20610939|P5|Overall Study|Unknown Completion Status|0
5959735|NCT01204671|20610940|P4|Overall Study|Unknown Completion Status|0
5959736|NCT01204671|20610941|P3|Overall Study|Unknown Completion Status|0
5959737|NCT01204671|20610942|P2|Overall Study|Unknown Completion Status|1
5959738|NCT01204671|20610943|P1|Overall Study|Unknown Completion Status|1
5959739|NCT01204671|20610939|P5|Overall Study|Lost to Follow-up|0
5959740|NCT01204671|20610940|P4|Overall Study|Lost to Follow-up|4
5959741|NCT01204671|20610941|P3|Overall Study|Lost to Follow-up|6
5959742|NCT01204671|20610942|P2|Overall Study|Lost to Follow-up|8
5959743|NCT01204671|20610943|P1|Overall Study|Lost to Follow-up|7
5959744|NCT01204671|20610939|P5|Overall Study|Withdrawal by Subject|3
5959745|NCT01204671|20610940|P4|Overall Study|Withdrawal by Subject|5
5959746|NCT01204671|20610941|P3|Overall Study|Withdrawal by Subject|4
5959747|NCT01204671|20610942|P2|Overall Study|Withdrawal by Subject|3
5959748|NCT01204671|20610943|P1|Overall Study|Withdrawal by Subject|2
5959749|NCT01204671|20610939|P5|Overall Study|Adverse Event|1
5959750|NCT01204671|20610940|P4|Overall Study|Adverse Event|3
5959751|NCT01204671|20610941|P3|Overall Study|Adverse Event|3
5959752|NCT01204671|20610942|P2|Overall Study|Adverse Event|3
5959753|NCT01204671|20610943|P1|Overall Study|Adverse Event|4
5959754|NCT01204658|20611005|P4|Primary Phase|Adverse Event|0
5959755|NCT01204658|20611006|P3|Primary Phase|Adverse Event|1
5959756|NCT01204658|20611007|P2|Primary Phase|Adverse Event|0
5959757|NCT01204658|20611008|P1|Primary Phase|Adverse Event|0
5959758|NCT01204398|20611126|P1|Overall Study|Adverse Event|1
5959759|NCT01204294|20611143|P7|Overall Study|Other (house moving)|0
5959760|NCT01204294|20611144|P6|Overall Study|Other (house moving)|0
5959761|NCT01204294|20611145|P5|Overall Study|Other (house moving)|0
5959762|NCT01204294|20611146|P4|Overall Study|Other (house moving)|0
5959763|NCT01204294|20611147|P3|Overall Study|Other (house moving)|1
5959764|NCT01204294|20611148|P2|Overall Study|Other (house moving)|0
5959765|NCT01204294|20611149|P1|Overall Study|Other (house moving)|0
5959766|NCT01204294|20611143|P7|Overall Study|Lack of Efficacy|0
5959767|NCT01204294|20611144|P6|Overall Study|Lack of Efficacy|0
5959768|NCT01204294|20611145|P5|Overall Study|Lack of Efficacy|0
5959769|NCT01204294|20611146|P4|Overall Study|Lack of Efficacy|2
5959770|NCT01204294|20611147|P3|Overall Study|Lack of Efficacy|0
5959771|NCT01204294|20611148|P2|Overall Study|Lack of Efficacy|0
5959772|NCT01204294|20611149|P1|Overall Study|Lack of Efficacy|0
5959773|NCT01204294|20611143|P7|Overall Study|Withdrawal by Subject|2
5959774|NCT01204294|20611144|P6|Overall Study|Withdrawal by Subject|1
5959775|NCT01204294|20611145|P5|Overall Study|Withdrawal by Subject|1
5959776|NCT01204294|20611146|P4|Overall Study|Withdrawal by Subject|1
5959777|NCT01204294|20611147|P3|Overall Study|Withdrawal by Subject|2
5959778|NCT01204294|20611148|P2|Overall Study|Withdrawal by Subject|2
5959779|NCT01204294|20611149|P1|Overall Study|Withdrawal by Subject|0
5959780|NCT01204294|20611143|P7|Overall Study|Protocol Violation|0
5959781|NCT01204294|20611144|P6|Overall Study|Protocol Violation|0
5959782|NCT01204294|20611145|P5|Overall Study|Protocol Violation|0
5959783|NCT01204294|20611146|P4|Overall Study|Protocol Violation|1
5959784|NCT01204294|20611147|P3|Overall Study|Protocol Violation|2
5959785|NCT01204294|20611148|P2|Overall Study|Protocol Violation|0
5959786|NCT01204294|20611149|P1|Overall Study|Protocol Violation|1
5959787|NCT01204294|20611143|P7|Overall Study|Adverse Event|0
5959788|NCT01204294|20611144|P6|Overall Study|Adverse Event|4
5959789|NCT01204294|20611145|P5|Overall Study|Adverse Event|1
5959790|NCT01204294|20611146|P4|Overall Study|Adverse Event|7
5959791|NCT01204294|20611147|P3|Overall Study|Adverse Event|0
5959792|NCT01204294|20611148|P2|Overall Study|Adverse Event|6
5959793|NCT01204294|20611149|P1|Overall Study|Adverse Event|2
5959794|NCT01203956|20611183|P2|Second Two-week Period|Non-compliant: no evaluable results|6
5959795|NCT01203956|20611184|P1|Second Two-week Period|Non-compliant: no evaluable results|5
5959796|NCT01203930|20611193|P2|Overall Study|Adverse Event|5
5959797|NCT01203930|20611194|P1|Overall Study|Adverse Event|17
5959798|NCT01203930|20611193|P2|Overall Study|Poor tolerance of study drug|1
5959799|NCT01203930|20611194|P1|Overall Study|Poor tolerance of study drug|0
5959800|NCT01203930|20611193|P2|Overall Study|Study Terminated by Sponsor|12
5959801|NCT01203930|20611194|P1|Overall Study|Study Terminated by Sponsor|0
5959802|NCT01203930|20611193|P2|Overall Study|Investigator Request|8
5959803|NCT01203930|20611194|P1|Overall Study|Investigator Request|0
5959804|NCT01203930|20611193|P2|Overall Study|Withdrew Consent|10
5959805|NCT01203930|20611194|P1|Overall Study|Withdrew Consent|1
5959806|NCT01203930|20611193|P2|Overall Study|Death|1
5959807|NCT01203930|20611194|P1|Overall Study|Death|3
5959808|NCT01203930|20611193|P2|Overall Study|Disease Progression|4
5959809|NCT01203930|20611194|P1|Overall Study|Disease Progression|0
5959810|NCT01203917|20611216|P1|Overall Study|Due to EGFR M+I patient|1
5959811|NCT01203917|20611216|P1|Overall Study|Due to objective disease progression|1
5959812|NCT01203917|20611216|P1|Overall Study|Withdrawal by Subject|3
5959813|NCT01203917|20611216|P1|Overall Study|Lost to Follow-up|2
5959814|NCT01203917|20611216|P1|Overall Study|Death|29
5959815|NCT01203878|20611229|P3|Overall Study|Adverse Event|2
5959816|NCT01203878|20611230|P2|Overall Study|Adverse Event|0
5959817|NCT01203878|20611231|P1|Overall Study|Adverse Event|0
5959818|NCT01203878|20611229|P3|Overall Study|Withdrawal by Subject|1
5959819|NCT01203878|20611230|P2|Overall Study|Withdrawal by Subject|0
5959820|NCT01203878|20611231|P1|Overall Study|Withdrawal by Subject|0
5959821|NCT01203852|20611242|P1|Washout 2 Weeks|Physician Decision|46
5959822|NCT01203852|20611242|P1|Metoprolol 8 Weeks|Physician Decision|470
5959823|NCT01203787|20611260|P2|Overall Study|Adverse Event|15
5959824|NCT01203787|20611261|P1|Overall Study|Adverse Event|11
5959825|NCT01203787|20611260|P2|Overall Study|Lost to Follow-up|0
5959826|NCT01203787|20611261|P1|Overall Study|Lost to Follow-up|2
5959827|NCT01203787|20611260|P2|Overall Study|Withdrawal by Subject|2
5959828|NCT01203787|20611261|P1|Overall Study|Withdrawal by Subject|6
5959829|NCT01203787|20611260|P2|Overall Study|Death|10
5959830|NCT01203787|20611261|P1|Overall Study|Death|12
5959831|NCT01203098|20611332|P3|Overall Study|Withdrawal by Subject|3
5959832|NCT01203098|20611333|P2|Overall Study|Withdrawal by Subject|1
5959833|NCT01203098|20611334|P1|Overall Study|Withdrawal by Subject|1
5959834|NCT01203098|20611332|P3|Overall Study|Physician Decision|0
5959835|NCT01203098|20611333|P2|Overall Study|Physician Decision|2
5959836|NCT01203098|20611334|P1|Overall Study|Physician Decision|2
5959837|NCT01203098|20611332|P3|Overall Study|Lost to Follow-up|1
5959838|NCT01203098|20611333|P2|Overall Study|Lost to Follow-up|0
5959839|NCT01203098|20611334|P1|Overall Study|Lost to Follow-up|0
5959840|NCT01203098|20611332|P3|Overall Study|Adverse Event|7
5959841|NCT01203098|20611333|P2|Overall Study|Adverse Event|1
5959842|NCT01203098|20611334|P1|Overall Study|Adverse Event|3
5959843|NCT01203072|20611350|P5|Overall Study|Withdrawal by Subject|3
5959844|NCT01203072|20611351|P4|Overall Study|Withdrawal by Subject|2
5959845|NCT01203072|20611352|P3|Overall Study|Withdrawal by Subject|1
5959846|NCT01203072|20611353|P2|Overall Study|Withdrawal by Subject|2
5959847|NCT01203072|20611354|P1|Overall Study|Withdrawal by Subject|2
5959848|NCT01203072|20611350|P5|Overall Study|Protocol Violation|1
5959849|NCT01203072|20611351|P4|Overall Study|Protocol Violation|0
5959850|NCT01203072|20611352|P3|Overall Study|Protocol Violation|0
5959851|NCT01203072|20611353|P2|Overall Study|Protocol Violation|0
5959852|NCT01203072|20611354|P1|Overall Study|Protocol Violation|2
5959853|NCT01203072|20611350|P5|Overall Study|Lost to Follow-up|0
5959854|NCT01203072|20611351|P4|Overall Study|Lost to Follow-up|0
5959855|NCT01203072|20611352|P3|Overall Study|Lost to Follow-up|0
5959856|NCT01203072|20611353|P2|Overall Study|Lost to Follow-up|1
5959857|NCT01203072|20611354|P1|Overall Study|Lost to Follow-up|0
5959858|NCT01203072|20611350|P5|Overall Study|Lack of Efficacy|0
5959859|NCT01203072|20611351|P4|Overall Study|Lack of Efficacy|0
5959860|NCT01203072|20611352|P3|Overall Study|Lack of Efficacy|0
5959861|NCT01203072|20611353|P2|Overall Study|Lack of Efficacy|0
5959862|NCT01203072|20611354|P1|Overall Study|Lack of Efficacy|1
5959863|NCT01203072|20611350|P5|Overall Study|Adverse Event|2
5959864|NCT01203072|20611351|P4|Overall Study|Adverse Event|4
5959865|NCT01203072|20611352|P3|Overall Study|Adverse Event|2
5959866|NCT01203072|20611353|P2|Overall Study|Adverse Event|3
5959867|NCT01203072|20611354|P1|Overall Study|Adverse Event|5
5959868|NCT01202955|20611389|P2|Period 1: 10 Days|Withdrawal by Subject|2
5959869|NCT01202955|20611390|P1|Period 1: 10 Days|Withdrawal by Subject|0
5959870|NCT01202903|20611402|P2|Overall Study|Withdrawal by Subject|4
5959871|NCT01202903|20611403|P1|Overall Study|Withdrawal by Subject|4
5959872|NCT01202903|20611402|P2|Overall Study|Adverse Event|3
5959873|NCT01202903|20611403|P1|Overall Study|Adverse Event|3
5959874|NCT01202903|20611402|P2|Overall Study|Lack of Efficacy|3
5959875|NCT01202903|20611403|P1|Overall Study|Lack of Efficacy|1
5959876|NCT01202903|20611402|P2|Overall Study|Lost to Follow-up|1
5959877|NCT01202903|20611403|P1|Overall Study|Lost to Follow-up|1
5959878|NCT01202903|20611402|P2|Overall Study|Death|0
5959879|NCT01202903|20611403|P1|Overall Study|Death|1
5959880|NCT01202903|20611402|P2|Overall Study|Protocol Violation|1
5959881|NCT01202903|20611403|P1|Overall Study|Protocol Violation|0
5959882|NCT01202903|20611402|P2|Overall Study|Administrative Probelms|4
5959883|NCT01202903|20611403|P1|Overall Study|Administrative Probelms|1
5959884|NCT01202877|20611430|P3|Overall Study|Death|1
5959885|NCT01202877|20611431|P2|Overall Study|Death|0
5959886|NCT01202877|20611432|P1|Overall Study|Death|0
5959887|NCT01202877|20611430|P3|Overall Study|Withdrawal by Subject|1
5959888|NCT01202877|20611431|P2|Overall Study|Withdrawal by Subject|0
5959889|NCT01202877|20611432|P1|Overall Study|Withdrawal by Subject|0
5959890|NCT01202877|20611430|P3|Overall Study|Adverse Event|2
5959891|NCT01202877|20611431|P2|Overall Study|Adverse Event|0
5959892|NCT01202877|20611432|P1|Overall Study|Adverse Event|0
5959893|NCT01202877|20611430|P3|Overall Study|Disease Progression|2
5959894|NCT01202877|20611431|P2|Overall Study|Disease Progression|1
5959895|NCT01202877|20611432|P1|Overall Study|Disease Progression|0
5959896|NCT01202773|20611446|P3|Overall Study|Sponsor Decision|23
5959897|NCT01202773|20611447|P2|Overall Study|Sponsor Decision|20
5959898|NCT01202773|20611448|P1|Overall Study|Sponsor Decision|19
5959899|NCT01202773|20611446|P3|Overall Study|Protocol Violation|10
5959900|NCT01202773|20611447|P2|Overall Study|Protocol Violation|6
5959901|NCT01202773|20611448|P1|Overall Study|Protocol Violation|11
5959902|NCT01202773|20611446|P3|Overall Study|Physician Decision|0
5959903|NCT01202773|20611447|P2|Overall Study|Physician Decision|0
5959904|NCT01202773|20611448|P1|Overall Study|Physician Decision|2
5959905|NCT01202773|20611446|P3|Overall Study|Withdrawal by Subject|5
5959906|NCT01202773|20611447|P2|Overall Study|Withdrawal by Subject|6
5959907|NCT01202773|20611448|P1|Overall Study|Withdrawal by Subject|13
5959908|NCT01202773|20611446|P3|Overall Study|Lost to Follow-up|2
5959909|NCT01202773|20611447|P2|Overall Study|Lost to Follow-up|2
5959910|NCT01202773|20611448|P1|Overall Study|Lost to Follow-up|1
5959911|NCT01202773|20611446|P3|Overall Study|Entry Criteria Not Met|1
5959912|NCT01202773|20611447|P2|Overall Study|Entry Criteria Not Met|0
5959913|NCT01202773|20611448|P1|Overall Study|Entry Criteria Not Met|2
5959914|NCT01202773|20611446|P3|Overall Study|Lack of Efficacy|9
5959915|NCT01202773|20611447|P2|Overall Study|Lack of Efficacy|4
5959916|NCT01202773|20611448|P1|Overall Study|Lack of Efficacy|5
5959917|NCT01202773|20611446|P3|Overall Study|Adverse Event|5
5959918|NCT01202773|20611447|P2|Overall Study|Adverse Event|5
5959919|NCT01202773|20611448|P1|Overall Study|Adverse Event|4
5959920|NCT01202760|20611525|P3|Overall Study|Sponsor Decision|0
5959921|NCT01202760|20611526|P2|Overall Study|Sponsor Decision|4
5959922|NCT01202760|20611527|P1|Overall Study|Sponsor Decision|4
5959923|NCT01202760|20611525|P3|Overall Study|Protocol Violation|2
5959924|NCT01202760|20611526|P2|Overall Study|Protocol Violation|5
5959925|NCT01202760|20611527|P1|Overall Study|Protocol Violation|7
5959926|NCT01202760|20611525|P3|Overall Study|Physician Decision|0
5959927|NCT01202760|20611526|P2|Overall Study|Physician Decision|1
5959928|NCT01202760|20611527|P1|Overall Study|Physician Decision|0
5959929|NCT01202760|20611525|P3|Overall Study|Withdrawal by Subject|14
5959930|NCT01202760|20611526|P2|Overall Study|Withdrawal by Subject|18
5959931|NCT01202760|20611527|P1|Overall Study|Withdrawal by Subject|17
5959932|NCT01202760|20611525|P3|Overall Study|Parent / Caregiver Decision|0
5959933|NCT01202760|20611526|P2|Overall Study|Parent / Caregiver Decision|1
5959934|NCT01202760|20611527|P1|Overall Study|Parent / Caregiver Decision|0
5959935|NCT01202760|20611525|P3|Overall Study|Lost to Follow-up|1
5959936|NCT01202760|20611526|P2|Overall Study|Lost to Follow-up|2
5959937|NCT01202760|20611527|P1|Overall Study|Lost to Follow-up|0
5959938|NCT01202760|20611525|P3|Overall Study|Lack of Efficacy|7
5959939|NCT01202760|20611526|P2|Overall Study|Lack of Efficacy|8
5959940|NCT01202760|20611527|P1|Overall Study|Lack of Efficacy|6
5959941|NCT01202760|20611525|P3|Overall Study|Death|0
5959942|NCT01202760|20611526|P2|Overall Study|Death|1
5959943|NCT01202760|20611527|P1|Overall Study|Death|2
5959944|NCT01202760|20611525|P3|Overall Study|Adverse Event|10
5959945|NCT01202760|20611526|P2|Overall Study|Adverse Event|9
5959946|NCT01202760|20611527|P1|Overall Study|Adverse Event|11
5959947|NCT01202760|20611525|P3|Overall Study|Entry Criteria Not Met|1
5959948|NCT01202760|20611526|P2|Overall Study|Entry Criteria Not Met|3
5959949|NCT01202760|20611527|P1|Overall Study|Entry Criteria Not Met|0
5959950|NCT01202747|20611595|P1|Overall Study|Withdrawal by Subject|1
5959951|NCT01202591|20611648|P6|Overall Study|Objective Disease Progression|0
5959952|NCT01202591|20611649|P5|Overall Study|Objective Disease Progression|2
5959953|NCT01202591|20611650|P4|Overall Study|Objective Disease Progression|0
5959954|NCT01202591|20611651|P3|Overall Study|Objective Disease Progression|0
5959955|NCT01202591|20611652|P2|Overall Study|Objective Disease Progression|0
5959956|NCT01202591|20611653|P1|Overall Study|Objective Disease Progression|0
5959957|NCT01202591|20611648|P6|Overall Study|Withdrawal by Subject|1
5959958|NCT01202591|20611649|P5|Overall Study|Withdrawal by Subject|2
5959959|NCT01202591|20611650|P4|Overall Study|Withdrawal by Subject|0
5959960|NCT01202591|20611651|P3|Overall Study|Withdrawal by Subject|0
5959961|NCT01202591|20611652|P2|Overall Study|Withdrawal by Subject|0
5959962|NCT01202591|20611653|P1|Overall Study|Withdrawal by Subject|0
5959963|NCT01202591|20611648|P6|Overall Study|Other reason as per investigator|3
5959964|NCT01202591|20611649|P5|Overall Study|Other reason as per investigator|1
5959965|NCT01202591|20611650|P4|Overall Study|Other reason as per investigator|3
5959966|NCT01202591|20611651|P3|Overall Study|Other reason as per investigator|7
5959967|NCT01202591|20611652|P2|Overall Study|Other reason as per investigator|4
5959968|NCT01202591|20611653|P1|Overall Study|Other reason as per investigator|3
5959969|NCT01202591|20611648|P6|Overall Study|Adverse Event|0
5959970|NCT01202591|20611649|P5|Overall Study|Adverse Event|0
5959971|NCT01202591|20611650|P4|Overall Study|Adverse Event|4
5959972|NCT01202591|20611651|P3|Overall Study|Adverse Event|4
5959973|NCT01202591|20611652|P2|Overall Study|Adverse Event|1
5959974|NCT01202591|20611653|P1|Overall Study|Adverse Event|2
5959975|NCT01202409|20611697|P1|Overall Study|Ineligible - KRAS mutants|7
5959976|NCT01202409|20611697|P1|Overall Study|Adverse Event|1
5959977|NCT01202279|20611704|P2|Overall Study|study compliance|2
5959978|NCT01202279|20611705|P1|Overall Study|study compliance|5
5959979|NCT01202279|20611704|P2|Overall Study|Protocol Violation|1
5959980|NCT01202279|20611705|P1|Overall Study|Protocol Violation|1
5959981|NCT01202279|20611704|P2|Overall Study|Lost to Follow-up|7
5959982|NCT01202279|20611705|P1|Overall Study|Lost to Follow-up|10
5959983|NCT01202279|20611704|P2|Overall Study|Physician Decision|1
5959984|NCT01202279|20611705|P1|Overall Study|Physician Decision|0
5959985|NCT01202279|20611704|P2|Overall Study|Withdrawal by Subject|10
5959986|NCT01202279|20611705|P1|Overall Study|Withdrawal by Subject|13
5959987|NCT01202279|20611704|P2|Overall Study|Adverse Event|6
5959988|NCT01202279|20611705|P1|Overall Study|Adverse Event|8
5959989|NCT01202188|20611762|P5|Overall Study|Abnormal test procedure result (s)|0
5959990|NCT01202188|20611763|P4|Overall Study|Abnormal test procedure result (s)|0
5959991|NCT01202188|20611764|P3|Overall Study|Abnormal test procedure result (s)|2
5959992|NCT01202188|20611765|P2|Overall Study|Abnormal test procedure result (s)|0
5959993|NCT01202188|20611766|P1|Overall Study|Abnormal test procedure result (s)|0
5959994|NCT01202188|20611762|P5|Overall Study|Death|0
5959995|NCT01202188|20611763|P4|Overall Study|Death|1
5959996|NCT01202188|20611764|P3|Overall Study|Death|1
5959997|NCT01202188|20611765|P2|Overall Study|Death|1
5959998|NCT01202188|20611766|P1|Overall Study|Death|1
5959999|NCT01202188|20611762|P5|Overall Study|Lost to Follow-up|1
5960000|NCT01202188|20611763|P4|Overall Study|Lost to Follow-up|4
5960001|NCT01202188|20611764|P3|Overall Study|Lost to Follow-up|0
5960002|NCT01202188|20611765|P2|Overall Study|Lost to Follow-up|1
5960003|NCT01202188|20611766|P1|Overall Study|Lost to Follow-up|1
5960004|NCT01202188|20611762|P5|Overall Study|Unsatisfactory therapeutic effect|8
5960005|NCT01202188|20611763|P4|Overall Study|Unsatisfactory therapeutic effect|5
5960006|NCT01202188|20611764|P3|Overall Study|Unsatisfactory therapeutic effect|2
5960007|NCT01202188|20611765|P2|Overall Study|Unsatisfactory therapeutic effect|8
5960008|NCT01202188|20611766|P1|Overall Study|Unsatisfactory therapeutic effect|2
5960009|NCT01202188|20611762|P5|Overall Study|Administrative problems|2
5960010|NCT01202188|20611763|P4|Overall Study|Administrative problems|1
5960011|NCT01202188|20611764|P3|Overall Study|Administrative problems|1
5960012|NCT01202188|20611765|P2|Overall Study|Administrative problems|2
5960013|NCT01202188|20611766|P1|Overall Study|Administrative problems|3
5960014|NCT01202188|20611762|P5|Overall Study|Adverse Event|10
5960015|NCT01202188|20611763|P4|Overall Study|Adverse Event|10
5960016|NCT01202188|20611764|P3|Overall Study|Adverse Event|13
5960017|NCT01202188|20611765|P2|Overall Study|Adverse Event|23
5960018|NCT01202188|20611766|P1|Overall Study|Adverse Event|5
5960019|NCT01202188|20611762|P5|Overall Study|Subject withdrew consent|13
5960020|NCT01202188|20611763|P4|Overall Study|Subject withdrew consent|11
5960021|NCT01202188|20611764|P3|Overall Study|Subject withdrew consent|22
5960022|NCT01202188|20611765|P2|Overall Study|Subject withdrew consent|13
5960023|NCT01202188|20611766|P1|Overall Study|Subject withdrew consent|12
5960024|NCT01202188|20611762|P5|Overall Study|Protocol deviation|11
5960025|NCT01202188|20611763|P4|Overall Study|Protocol deviation|10
5960026|NCT01202188|20611764|P3|Overall Study|Protocol deviation|12
5960027|NCT01202188|20611765|P2|Overall Study|Protocol deviation|8
5960028|NCT01202188|20611766|P1|Overall Study|Protocol deviation|14
5960029|NCT01202175|20611874|P1|Overall Study|Adverse Event|2
5960030|NCT01202175|20611874|P1|Overall Study|Withdrawal by Subject|1
5960031|NCT01202175|20611874|P1|Overall Study|Lost to Follow-up|2
5960032|NCT01201967|20611942|P2|Overall Study|Lost to Follow-up|5
5960033|NCT01201967|20611943|P1|Overall Study|Lost to Follow-up|6
5960034|NCT01201915|20611968|P3|Overall Study|Target Lesion Progression|0
5960035|NCT01201915|20611969|P2|Overall Study|Target Lesion Progression|3
5960036|NCT01201915|20611970|P1|Overall Study|Target Lesion Progression|0
5960037|NCT01201915|20611968|P3|Overall Study|Subject Decision|5
5960038|NCT01201915|20611969|P2|Overall Study|Subject Decision|3
5960039|NCT01201915|20611970|P1|Overall Study|Subject Decision|3
5960040|NCT01201915|20611968|P3|Overall Study|Physician Decision|0
5960041|NCT01201915|20611969|P2|Overall Study|Physician Decision|0
5960042|NCT01201915|20611970|P1|Overall Study|Physician Decision|3
5960043|NCT01201915|20611968|P3|Overall Study|Lost to Follow-up|0
5960044|NCT01201915|20611969|P2|Overall Study|Lost to Follow-up|4
5960045|NCT01201915|20611970|P1|Overall Study|Lost to Follow-up|0
5960046|NCT01201915|20611968|P3|Overall Study|Adverse Event|1
5960047|NCT01201915|20611969|P2|Overall Study|Adverse Event|1
5960048|NCT01201915|20611970|P1|Overall Study|Adverse Event|2
5960049|NCT01201811|20611981|P1|Overall Study|Physician Decision|1
5960050|NCT01201811|20611981|P1|Overall Study|Treatment Failure|2
5960051|NCT01201811|20611981|P1|Overall Study|Death|4
5960052|NCT01201811|20611981|P1|Overall Study|Withdrawal by Subject|3
5960053|NCT01201811|20611981|P1|Overall Study|Disease progression|3
5960054|NCT01201811|20611981|P1|Overall Study|Adverse Event|6
5960055|NCT01201798|20612003|P2|Overall Study|Treatment Failure|8
5960056|NCT01201798|20612004|P1|Overall Study|Treatment Failure|1
5960057|NCT01201798|20612003|P2|Overall Study|Protocol Violation|1
5960058|NCT01201798|20612004|P1|Overall Study|Protocol Violation|1
5960059|NCT01201798|20612003|P2|Overall Study|Noncompliance|0
5960060|NCT01201798|20612004|P1|Overall Study|Noncompliance|1
5960061|NCT01201798|20612003|P2|Overall Study|Decision Unrelated to an Adverse Event|1
5960062|NCT01201798|20612004|P1|Overall Study|Decision Unrelated to an Adverse Event|1
5960063|NCT01201798|20612003|P2|Overall Study|Lost to Follow-up|5
5960064|NCT01201798|20612004|P1|Overall Study|Lost to Follow-up|3
5960065|NCT01201798|20612003|P2|Overall Study|Adverse Event|0
5960066|NCT01201798|20612004|P1|Overall Study|Adverse Event|2
5960067|NCT01201785|20612028|P1|Overall Study|Lost to Follow-up|16
5960068|NCT01201759|20612045|P2|Visit 4 Crossover|Lost to Follow-up|1
5960069|NCT01201759|20612046|P1|Visit 4 Crossover|Lost to Follow-up|0
5960070|NCT01201759|20612045|P2|Visit 3 - Washout|Lost to Follow-up|0
5960071|NCT01201759|20612046|P1|Visit 3 - Washout|Lost to Follow-up|1
5960072|NCT01201759|20612045|P2|Visit 3 - Washout|Adverse Event|3
5960073|NCT01201759|20612046|P1|Visit 3 - Washout|Adverse Event|0
5960074|NCT01201759|20612045|P2|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|1
5960075|NCT01201759|20612046|P1|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|2
5960076|NCT01201356|20612075|P1|Overall Study|Protocol Violation|12
5960077|NCT01201356|20612075|P1|Overall Study|Death|16
5960078|NCT01201356|20612075|P1|Overall Study|administrative problems|74
5960079|NCT01201356|20612075|P1|Overall Study|Lost to Follow-up|50
5960080|NCT01201356|20612075|P1|Overall Study|Withdrawal by Subject|144
5960081|NCT01201356|20612075|P1|Overall Study|Condition no longer requires study drug|12
5960082|NCT01201356|20612075|P1|Overall Study|Unsatisfactory therapeutic effect|112
5960083|NCT01201356|20612075|P1|Overall Study|Abnormal test procedure result(s)|3
5960084|NCT01201356|20612075|P1|Overall Study|Abnormal laboratory value(s)|51
5960085|NCT01201356|20612075|P1|Overall Study|Adverse Event|170
5960086|NCT01201343|20612089|P1|Overall Study|Randomized, not treated|3
5960087|NCT01201343|20612089|P1|Overall Study|Participant wrongly included in trial|1
5960088|NCT01201343|20612089|P1|Overall Study|Lack of Efficacy|2
5960089|NCT01201343|20612089|P1|Overall Study|Lost to Follow-up|2
5960090|NCT01201343|20612089|P1|Overall Study|Withdrawal by Subject|5
5960091|NCT01201343|20612089|P1|Overall Study|Adverse Event|6
5960092|NCT01201317|20612103|P3|Overall Study|Safety, possible history of tuberculosis|1
5960093|NCT01201317|20612104|P2|Overall Study|Safety, possible history of tuberculosis|0
5960094|NCT01201317|20612105|P1|Overall Study|Safety, possible history of tuberculosis|0
5960095|NCT01201317|20612103|P3|Overall Study|Lack of Efficacy|0
5960096|NCT01201317|20612104|P2|Overall Study|Lack of Efficacy|0
5960097|NCT01201317|20612105|P1|Overall Study|Lack of Efficacy|1
5960098|NCT01201317|20612103|P3|Overall Study|Decrease in renal function|0
5960099|NCT01201317|20612104|P2|Overall Study|Decrease in renal function|1
5960100|NCT01201317|20612105|P1|Overall Study|Decrease in renal function|0
5960101|NCT01201317|20612103|P3|Overall Study|Painful Diabetic Neuropathy worsening|0
5960102|NCT01201317|20612104|P2|Overall Study|Painful Diabetic Neuropathy worsening|1
5960103|NCT01201317|20612105|P1|Overall Study|Painful Diabetic Neuropathy worsening|0
5960104|NCT01201317|20612103|P3|Overall Study|Study-specific withdrawal criteria|1
5960105|NCT01201317|20612104|P2|Overall Study|Study-specific withdrawal criteria|0
5960106|NCT01201317|20612105|P1|Overall Study|Study-specific withdrawal criteria|0
5960107|NCT01201317|20612103|P3|Overall Study|Death|0
5960108|NCT01201317|20612104|P2|Overall Study|Death|1
5960109|NCT01201317|20612105|P1|Overall Study|Death|0
5960110|NCT01201317|20612103|P3|Overall Study|Protocol Violation|1
5960111|NCT01201317|20612104|P2|Overall Study|Protocol Violation|1
5960112|NCT01201317|20612105|P1|Overall Study|Protocol Violation|0
5960113|NCT01201317|20612103|P3|Overall Study|Screen failure|0
5960114|NCT01201317|20612104|P2|Overall Study|Screen failure|1
5960115|NCT01201317|20612105|P1|Overall Study|Screen failure|1
5960116|NCT01201317|20612103|P3|Overall Study|Adverse Event|2
5960117|NCT01201317|20612104|P2|Overall Study|Adverse Event|2
5960118|NCT01201317|20612105|P1|Overall Study|Adverse Event|2
5960119|NCT01201317|20612103|P3|Overall Study|Withdrawal by Subject|3
5960120|NCT01201317|20612104|P2|Overall Study|Withdrawal by Subject|0
5960121|NCT01201317|20612105|P1|Overall Study|Withdrawal by Subject|5
5960122|NCT01201265|20612125|P1|Overall Study|Disease Progression|4
5960123|NCT01201265|20612125|P1|Overall Study|Withdrawal by Subject|7
5960124|NCT01201265|20612125|P1|Overall Study|Lost to Follow-up|10
5960125|NCT01201265|20612125|P1|Overall Study|Insufficient Therapeutic Response|3
5960126|NCT01201265|20612125|P1|Overall Study|Death|14
5960127|NCT01200992|20612172|P2|Overall Study|Randomized but not treated|0
5960128|NCT01200992|20612173|P1|Overall Study|Randomized but not treated|2
5960129|NCT01200992|20612172|P2|Overall Study|Study terminated early|41
5960130|NCT01200992|20612173|P1|Overall Study|Study terminated early|35
5960131|NCT01200810|20612204|P2|Overall Study|Sponsor stopped making study drug|3
5960132|NCT01200810|20612205|P1|Overall Study|Sponsor stopped making study drug|3
5960133|NCT01200810|20612204|P2|Overall Study|Withdrawal by Subject|2
5960134|NCT01200810|20612205|P1|Overall Study|Withdrawal by Subject|1
5960135|NCT01200810|20612204|P2|Overall Study|Physician Decision|0
5960136|NCT01200810|20612205|P1|Overall Study|Physician Decision|1
5960137|NCT01200797|20612225|P1|Overall Study|Disease Progression|13
5960138|NCT01200797|20612225|P1|Overall Study|Adverse Event|4
5960139|NCT01200797|20612225|P1|Overall Study|symptomatic deterioration|2
5960140|NCT01200758|20612235|P4|Stage 2|Death|5
5960141|NCT01200758|20612236|P3|Stage 2|Death|3
5960142|NCT01200758|20612237|P2|Stage 2|Death|0
5960143|NCT01200758|20612238|P1|Stage 2|Death|0
5960144|NCT01200758|20612235|P4|Stage 2|Protocol Violation|4
5960145|NCT01200758|20612236|P3|Stage 2|Protocol Violation|1
5960146|NCT01200758|20612237|P2|Stage 2|Protocol Violation|0
5960147|NCT01200758|20612238|P1|Stage 2|Protocol Violation|0
5960148|NCT01200758|20612235|P4|Stage 2|Lost to Follow-up|1
5960149|NCT01200758|20612236|P3|Stage 2|Lost to Follow-up|3
5960150|NCT01200758|20612237|P2|Stage 2|Lost to Follow-up|0
5960151|NCT01200758|20612238|P1|Stage 2|Lost to Follow-up|0
5960152|NCT01200758|20612235|P4|Stage 2|Withdrawal by Subject|1
5960153|NCT01200758|20612236|P3|Stage 2|Withdrawal by Subject|4
5960154|NCT01200758|20612237|P2|Stage 2|Withdrawal by Subject|0
5960155|NCT01200758|20612238|P1|Stage 2|Withdrawal by Subject|0
5960156|NCT01200758|20612235|P4|Stage 2|Adverse Event|9
5960157|NCT01200758|20612236|P3|Stage 2|Adverse Event|5
5960158|NCT01200758|20612237|P2|Stage 2|Adverse Event|0
5960159|NCT01200758|20612238|P1|Stage 2|Adverse Event|0
5960160|NCT01200758|20612235|P4|Stage 2|Physician Decision|7
5960161|NCT01200758|20612236|P3|Stage 2|Physician Decision|5
5960162|NCT01200758|20612237|P2|Stage 2|Physician Decision|0
5960163|NCT01200758|20612238|P1|Stage 2|Physician Decision|0
5960164|NCT01200758|20612235|P4|Stage 2|Lack of Efficacy|2
5960165|NCT01200758|20612236|P3|Stage 2|Lack of Efficacy|4
5960166|NCT01200758|20612237|P2|Stage 2|Lack of Efficacy|0
5960167|NCT01200758|20612238|P1|Stage 2|Lack of Efficacy|0
5960168|NCT01200758|20612235|P4|Stage 2|Disease Progression|21
5960169|NCT01200758|20612236|P3|Stage 2|Disease Progression|16
5960170|NCT01200758|20612237|P2|Stage 2|Disease Progression|0
5960171|NCT01200758|20612238|P1|Stage 2|Disease Progression|0
5960172|NCT01200758|20612235|P4|Stage I|Disease Progression|0
5960173|NCT01200758|20612236|P3|Stage I|Disease Progression|0
5960174|NCT01200758|20612237|P2|Stage I|Disease Progression|7
5960175|NCT01200758|20612238|P1|Stage I|Disease Progression|9
5960176|NCT01200758|20612235|P4|Stage I|Withdrawal by Subject|0
5960177|NCT01200758|20612236|P3|Stage I|Withdrawal by Subject|0
5960178|NCT01200758|20612237|P2|Stage I|Withdrawal by Subject|2
5960179|NCT01200758|20612238|P1|Stage I|Withdrawal by Subject|1
5960180|NCT01200758|20612235|P4|Stage I|Adverse Event|0
5960181|NCT01200758|20612236|P3|Stage I|Adverse Event|0
5960182|NCT01200758|20612237|P2|Stage I|Adverse Event|5
5960183|NCT01200758|20612238|P1|Stage I|Adverse Event|5
5960184|NCT01200758|20612235|P4|Stage I|Lack of Efficacy|0
5960185|NCT01200758|20612236|P3|Stage I|Lack of Efficacy|0
5960186|NCT01200758|20612237|P2|Stage I|Lack of Efficacy|1
5960187|NCT01200758|20612238|P1|Stage I|Lack of Efficacy|2
5960188|NCT01200758|20612235|P4|Stage I|Physician Decision|0
5960189|NCT01200758|20612236|P3|Stage I|Physician Decision|0
5960190|NCT01200758|20612237|P2|Stage I|Physician Decision|1
5960191|NCT01200758|20612238|P1|Stage I|Physician Decision|1
5960192|NCT01200758|20612235|P4|Stage I|Death|0
5960193|NCT01200758|20612236|P3|Stage I|Death|0
5960194|NCT01200758|20612237|P2|Stage I|Death|1
5960195|NCT01200758|20612238|P1|Stage I|Death|0
5960196|NCT01200589|20612311|P2|Overall Study|Study terminated|172
5960197|NCT01200589|20612312|P1|Overall Study|Study terminated|170
5960198|NCT01200589|20612311|P2|Overall Study|Lost to Follow-up|4
5960199|NCT01200589|20612312|P1|Overall Study|Lost to Follow-up|5
5960200|NCT01200589|20612311|P2|Overall Study|Physician Decision|2
5960201|NCT01200589|20612312|P1|Overall Study|Physician Decision|2
5960202|NCT01200589|20612311|P2|Overall Study|Withdrawal by Subject|11
5960203|NCT01200589|20612312|P1|Overall Study|Withdrawal by Subject|13
5960204|NCT01200524|20612339|P3|Overall Study|Non availability of study nurse|1
5960205|NCT01200524|20612340|P2|Overall Study|Non availability of study nurse|0
5960206|NCT01200524|20612341|P1|Overall Study|Non availability of study nurse|0
5960207|NCT01200524|20612339|P3|Overall Study|Adverse Event|0
5960208|NCT01200524|20612340|P2|Overall Study|Adverse Event|0
5960209|NCT01200524|20612341|P1|Overall Study|Adverse Event|1
5960210|NCT01200524|20612339|P3|Overall Study|Withdrawal by Subject|3
5960211|NCT01200524|20612340|P2|Overall Study|Withdrawal by Subject|1
5960212|NCT01200524|20612341|P1|Overall Study|Withdrawal by Subject|1
5960213|NCT01200511|20612361|P1|Overall Study|Adverse Event|1
5960214|NCT01200511|20612361|P1|Overall Study|Withdrawal by Subject|1
5960215|NCT01200511|20612361|P1|Overall Study|Lost to Follow-up|3
5960216|NCT01200485|20612373|P3|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0
5960217|NCT01200485|20612374|P2|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0
5960218|NCT01200485|20612375|P1|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|2
5960219|NCT01200485|20612373|P3|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0
5960220|NCT01200485|20612374|P2|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0
5960221|NCT01200485|20612375|P1|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|1
5960222|NCT01200394|20612409|P2|Overall Study|Other|1
5960223|NCT01200394|20612410|P1|Overall Study|Other|0
5960224|NCT01200394|20612409|P2|Overall Study|Withdrawal by Subject|5
5960225|NCT01200394|20612410|P1|Overall Study|Withdrawal by Subject|0
5960226|NCT01200394|20612409|P2|Overall Study|Protocol Violation|3
5960227|NCT01200394|20612410|P1|Overall Study|Protocol Violation|0
5960228|NCT01200394|20612409|P2|Overall Study|Did Not Meet Entrance Criteria|4
5960229|NCT01200394|20612410|P1|Overall Study|Did Not Meet Entrance Criteria|1
5960230|NCT01200394|20612409|P2|Overall Study|Lost to Follow-up|1
5960231|NCT01200394|20612410|P1|Overall Study|Lost to Follow-up|0
5960232|NCT01200394|20612409|P2|Overall Study|Death|0
5960233|NCT01200394|20612410|P1|Overall Study|Death|1
5960234|NCT01200394|20612409|P2|Overall Study|Adverse Event|14
5960235|NCT01200394|20612410|P1|Overall Study|Adverse Event|0
5960236|NCT01200368|20612448|P3|Toddler Dose|Adverse Event|1
5960237|NCT01200368|20612449|P2|Toddler Dose|Adverse Event|3
5960238|NCT01200368|20612450|P1|Toddler Dose|Adverse Event|0
5960239|NCT01200368|20612448|P3|After Infant Series|Other|2
5960240|NCT01200368|20612449|P2|After Infant Series|Other|2
5960241|NCT01200368|20612450|P1|After Infant Series|Other|1
5960242|NCT01200368|20612448|P3|After Infant Series|Lost to Follow-up|0
5960243|NCT01200368|20612449|P2|After Infant Series|Lost to Follow-up|0
5960244|NCT01200368|20612450|P1|After Infant Series|Lost to Follow-up|1
5960245|NCT01200368|20612448|P3|After Infant Series|Withdrawal by Subject|4
5960246|NCT01200368|20612449|P2|After Infant Series|Withdrawal by Subject|8
5960247|NCT01200368|20612450|P1|After Infant Series|Withdrawal by Subject|10
5960248|NCT01200368|20612448|P3|After Infant Series|Adverse Event|3
5960249|NCT01200368|20612449|P2|After Infant Series|Adverse Event|6
5960250|NCT01200368|20612450|P1|After Infant Series|Adverse Event|6
5960251|NCT01200368|20612448|P3|Infant Series|Other|0
5960252|NCT01200368|20612449|P2|Infant Series|Other|0
5960253|NCT01200368|20612450|P1|Infant Series|Other|1
5960254|NCT01200368|20612448|P3|Infant Series|Randomized, not vaccinated|1
5960255|NCT01200368|20612449|P2|Infant Series|Randomized, not vaccinated|1
5960256|NCT01200368|20612450|P1|Infant Series|Randomized, not vaccinated|0
5960257|NCT01200368|20612448|P3|Infant Series|Did not meet entrance criteria|0
5960258|NCT01200368|20612449|P2|Infant Series|Did not meet entrance criteria|1
5960259|NCT01200368|20612450|P1|Infant Series|Did not meet entrance criteria|0
5960260|NCT01200368|20612448|P3|Infant Series|Withdrawal by Subject|2
5960261|NCT01200368|20612449|P2|Infant Series|Withdrawal by Subject|2
5960262|NCT01200368|20612450|P1|Infant Series|Withdrawal by Subject|0
5960263|NCT01200368|20612448|P3|Infant Series|Adverse Event|3
5960264|NCT01200368|20612449|P2|Infant Series|Adverse Event|2
5960265|NCT01200368|20612450|P1|Infant Series|Adverse Event|2
5960266|NCT01200355|20612516|P2|Overall Study|Death|2
5960267|NCT01200355|20612517|P1|Overall Study|Death|7
5960268|NCT01200342|20612531|P1|Overall Study|Disease Progression|1
5960269|NCT01200329|20612536|P1|Overall Study|Progressive disease|1
5960270|NCT01200329|20612536|P1|Overall Study|Lack of financial coverage|2
5960271|NCT01200290|20612541|P1|Post-Treatment Follow-Up Period|Death|2
5960272|NCT01200290|20612541|P1|Treatment Period|Adverse Event|1
5960273|NCT01200238|20612554|P2|Overall Study|Withdrawal by Subject|1
5960274|NCT01200238|20612555|P1|Overall Study|Withdrawal by Subject|0
5960275|NCT01200238|20612554|P2|Overall Study|Progressive Disease|8
5960276|NCT01200238|20612555|P1|Overall Study|Progressive Disease|5
5960277|NCT01200238|20612554|P2|Overall Study|Adverse Event|1
5960278|NCT01200238|20612555|P1|Overall Study|Adverse Event|2
5960279|NCT01200069|20612579|P2|Overall Study|Withdrawal by Subject|1
5960280|NCT01200069|20612580|P1|Overall Study|Withdrawal by Subject|0
5960281|NCT01199939|20612676|P1|Overall Study|Reached a virologic endpoint|4
5960282|NCT01199939|20612676|P1|Overall Study|Lost to Follow-up|2
5960283|NCT01199939|20612676|P1|Overall Study|Protocol Violation|3
5960284|NCT01199939|20612676|P1|Overall Study|Adverse Event|4
5960285|NCT01199861|20612708|P2|Overall Study|Adverse Event|0
5960286|NCT01199861|20612709|P1|Overall Study|Adverse Event|1
5960287|NCT01199861|20612708|P2|Overall Study|Administrative problems|0
5960288|NCT01199861|20612709|P1|Overall Study|Administrative problems|1
5960289|NCT01199822|20612730|P3|Overall Study|Investigator discontinued therapy|0
5960290|NCT01199822|20612731|P2|Overall Study|Investigator discontinued therapy|1
5960291|NCT01199822|20612732|P1|Overall Study|Investigator discontinued therapy|0
5960292|NCT01199731|20612781|P3|Overall Study|Withdrawal by Subject|0
5960293|NCT01199731|20612782|P2|Overall Study|Withdrawal by Subject|0
5960294|NCT01199731|20612783|P1|Overall Study|Withdrawal by Subject|2
5960295|NCT01199731|20612781|P3|Overall Study|Physician Decision|1
5960296|NCT01199731|20612782|P2|Overall Study|Physician Decision|1
5960297|NCT01199731|20612783|P1|Overall Study|Physician Decision|0
5960298|NCT01199731|20612781|P3|Overall Study|Lost to Follow-up|2
5960299|NCT01199731|20612782|P2|Overall Study|Lost to Follow-up|0
5960300|NCT01199731|20612783|P1|Overall Study|Lost to Follow-up|0
5960301|NCT01199731|20612781|P3|Overall Study|Study closed/terminated|7
5960302|NCT01199731|20612782|P2|Overall Study|Study closed/terminated|9
5960303|NCT01199731|20612783|P1|Overall Study|Study closed/terminated|7
5960304|NCT01199731|20612781|P3|Overall Study|Adverse Event|0
5960305|NCT01199731|20612782|P2|Overall Study|Adverse Event|1
5960306|NCT01199731|20612783|P1|Overall Study|Adverse Event|0
5960307|NCT01199705|20612821|P1|SCIG Treatment (Wash-in/Wash-out)|Transfer of Residence|1
5960308|NCT01199601|20612853|P2|Overall Study|Insecurity prevented staff interviewing.|9
5960309|NCT01199601|20612854|P1|Overall Study|Insecurity prevented staff interviewing.|7
5960310|NCT01199601|20612853|P2|Overall Study|Withdrawal by Subject|3
5960311|NCT01199601|20612854|P1|Overall Study|Withdrawal by Subject|15
5960312|NCT01199601|20612853|P2|Overall Study|Lost to Follow-up|66
5960313|NCT01199601|20612854|P1|Overall Study|Lost to Follow-up|47
5960314|NCT01199575|20612864|P1|Overall Study|Withdrawal by Subject|5
5960315|NCT01199471|20612869|P1|Overall Study|Physician Decision|1
5960316|NCT01199471|20612869|P1|Overall Study|Withdrawal by Subject|1
5960317|NCT01199471|20612869|P1|Overall Study|Protocol Violation|4
5960318|NCT01199263|20612889|P2|Overall Study|Never Treated|0
5960319|NCT01199263|20612890|P1|Overall Study|Never Treated|6
5960320|NCT01199263|20612889|P2|Overall Study|Ineligible|2
5960321|NCT01199263|20612890|P1|Overall Study|Ineligible|0
5960322|NCT01199198|20612923|P2|Overall Study|Hospice-care transfer|2
5960323|NCT01199198|20612924|P1|Overall Study|Hospice-care transfer|1
5960324|NCT01199198|20612923|P2|Overall Study|ICU Transfer|2
5960325|NCT01199198|20612924|P1|Overall Study|ICU Transfer|1
5960326|NCT01199198|20612923|P2|Overall Study|Withdrawal by Subject|2
5960327|NCT01199198|20612924|P1|Overall Study|Withdrawal by Subject|1
5960328|NCT01199198|20612923|P2|Overall Study|Lost to Follow-up|5
5960329|NCT01199198|20612924|P1|Overall Study|Lost to Follow-up|1
5960330|NCT01199198|20612923|P2|Overall Study|Adverse Event|0
5960331|NCT01199198|20612924|P1|Overall Study|Adverse Event|3
5960332|NCT01199068|20612941|P3|Overall Study|Withdrawal by Subject|1
5960333|NCT01199068|20612942|P2|Overall Study|Withdrawal by Subject|0
5960334|NCT01199068|20612943|P1|Overall Study|Withdrawal by Subject|0
5960335|NCT01199068|20612941|P3|Overall Study|Progressive disease|6
5960336|NCT01199068|20612942|P2|Overall Study|Progressive disease|3
5960337|NCT01199068|20612943|P1|Overall Study|Progressive disease|3
5960338|NCT01199068|20612941|P3|Overall Study|Unacceptable toxicity|2
5960339|NCT01199068|20612942|P2|Overall Study|Unacceptable toxicity|0
5960340|NCT01199068|20612943|P1|Overall Study|Unacceptable toxicity|0
5960341|NCT01199055|20612977|P3|Overall Study|Withdrawal by Subject|1
5960342|NCT01199055|20612978|P2|Overall Study|Withdrawal by Subject|0
5960343|NCT01199055|20612979|P1|Overall Study|Withdrawal by Subject|0
5960344|NCT01199055|20612977|P3|Overall Study|Progressive disease|2
5960345|NCT01199055|20612978|P2|Overall Study|Progressive disease|1
5960346|NCT01199055|20612979|P1|Overall Study|Progressive disease|2
5960347|NCT01199055|20612977|P3|Overall Study|Physician Decision|1
5960348|NCT01199055|20612978|P2|Overall Study|Physician Decision|1
5960349|NCT01199055|20612979|P1|Overall Study|Physician Decision|0
5960350|NCT01199055|20612977|P3|Overall Study|Death|0
5960351|NCT01199055|20612978|P2|Overall Study|Death|1
5960352|NCT01199055|20612979|P1|Overall Study|Death|0
5960353|NCT01199042|20613004|P1|At Home (3 Months)|Lost to Follow-up|1
5960354|NCT01199042|20613004|P1|Sleep Laboratory (3 Nights)|Didn't meet inclusion/exclusion criteria|2
5960355|NCT01199016|20613013|P1|Overall Study|Lost to Follow-up|25
5960356|NCT01199016|20613013|P1|Overall Study|Withdrawal by Subject|21
5960357|NCT01199016|20613013|P1|Overall Study|Other|13
5960358|NCT01199016|20613013|P1|Overall Study|Protocol Violation|9
5960359|NCT01199016|20613013|P1|Overall Study|Entrance criteria|5
5960360|NCT01199016|20613013|P1|Overall Study|No longer meets eligibility criteria|4
5960361|NCT01198977|20613022|P2|Overall Study|Lost to Follow-up|0
5960362|NCT01198977|20613023|P1|Overall Study|Lost to Follow-up|1
5960363|NCT01198873|20613035|P2|Overall Study|Other than above|2
5960364|NCT01198873|20613036|P1|Overall Study|Other than above|4
5960365|NCT01198873|20613035|P2|Overall Study|Study closure|23
5960366|NCT01198873|20613036|P1|Overall Study|Study closure|29
5960367|NCT01198873|20613035|P2|Overall Study|Adverse Event|7
5960368|NCT01198873|20613036|P1|Overall Study|Adverse Event|4
5960369|NCT01198795|20613050|P1|Overall Study|Other Reason|4
5960370|NCT01198795|20613050|P1|Overall Study|Protocol Violation|2
5960371|NCT01198795|20613050|P1|Overall Study|Lack of Efficacy|5
5960372|NCT01198795|20613050|P1|Overall Study|Adverse Event|9
5960373|NCT01198795|20613050|P1|Overall Study|Lost to Follow-up|15
5960374|NCT01198795|20613050|P1|Overall Study|Withdrawal by Subject|17
5960375|NCT01198795|20613050|P1|Overall Study|Did not meet InclusionExclusion criteria|30
5960376|NCT01198756|20613067|P4|Overall Study|Lost to Follow-up|18
5960377|NCT01198756|20613068|P3|Overall Study|Lost to Follow-up|23
5960378|NCT01198756|20613069|P2|Overall Study|Lost to Follow-up|36
5960379|NCT01198756|20613070|P1|Overall Study|Lost to Follow-up|29
5960380|NCT01198756|20613067|P4|Overall Study|Withdrawal by Subject|5
5960381|NCT01198756|20613068|P3|Overall Study|Withdrawal by Subject|7
5960382|NCT01198756|20613069|P2|Overall Study|Withdrawal by Subject|4
5960383|NCT01198756|20613070|P1|Overall Study|Withdrawal by Subject|9
5960384|NCT01198756|20613067|P4|Overall Study|Protocol Violation|2
5960385|NCT01198756|20613068|P3|Overall Study|Protocol Violation|0
5960386|NCT01198756|20613069|P2|Overall Study|Protocol Violation|0
5960387|NCT01198756|20613070|P1|Overall Study|Protocol Violation|0
5960388|NCT01198756|20613067|P4|Overall Study|Adverse Event|1
5960389|NCT01198756|20613068|P3|Overall Study|Adverse Event|0
5960390|NCT01198756|20613069|P2|Overall Study|Adverse Event|0
5960391|NCT01198756|20613070|P1|Overall Study|Adverse Event|0
5960392|NCT01198600|20613181|P4|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0
5960393|NCT01198600|20613182|P3|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|1
5960394|NCT01198600|20613183|P2|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0
5960395|NCT01198600|20613184|P1|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0
5960396|NCT01198600|20613181|P4|Phase 2: 56 Days of Wear|Relocation|0
5960397|NCT01198600|20613182|P3|Phase 2: 56 Days of Wear|Relocation|2
5960398|NCT01198600|20613183|P2|Phase 2: 56 Days of Wear|Relocation|0
5960399|NCT01198600|20613184|P1|Phase 2: 56 Days of Wear|Relocation|0
5960400|NCT01198600|20613181|P4|Phase 2: 56 Days of Wear|Inconvenience|0
5960401|NCT01198600|20613182|P3|Phase 2: 56 Days of Wear|Inconvenience|2
5960402|NCT01198600|20613183|P2|Phase 2: 56 Days of Wear|Inconvenience|0
5960403|NCT01198600|20613184|P1|Phase 2: 56 Days of Wear|Inconvenience|0
5960404|NCT01198600|20613181|P4|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0
5960405|NCT01198600|20613182|P3|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0
5960406|NCT01198600|20613183|P2|Phase 1: Period Two, 30 Days of Wear|Inconvenience|1
5960407|NCT01198600|20613184|P1|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0
5960408|NCT01198600|20613181|P4|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0
5960409|NCT01198600|20613182|P3|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0
5960410|NCT01198600|20613183|P2|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|1
5960411|NCT01198600|20613184|P1|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0
5960412|NCT01198600|20613181|P4|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0
5960413|NCT01198600|20613182|P3|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0
5960414|NCT01198600|20613183|P2|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0
5960415|NCT01198600|20613184|P1|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|1
5960416|NCT01198600|20613181|P4|Phase 1: Period One, 30 Days of Wear|Inconvenience|0
5960417|NCT01198600|20613182|P3|Phase 1: Period One, 30 Days of Wear|Inconvenience|0
5960418|NCT01198600|20613183|P2|Phase 1: Period One, 30 Days of Wear|Inconvenience|0
5960419|NCT01198600|20613184|P1|Phase 1: Period One, 30 Days of Wear|Inconvenience|1
5960420|NCT01198587|20613210|P4|Overall Study|Lost to Follow-up|0
5960421|NCT01198587|20613211|P3|Overall Study|Lost to Follow-up|9
5960422|NCT01198587|20613212|P2|Overall Study|Lost to Follow-up|0
5960423|NCT01198587|20613213|P1|Overall Study|Lost to Follow-up|8
5960424|NCT01198574|20613235|P4|Overall Study|Resigned from schools|4
5960425|NCT01198574|20613236|P3|Overall Study|Resigned from schools|1
5960426|NCT01198574|20613237|P2|Overall Study|Resigned from schools|1
5960427|NCT01198574|20613238|P1|Overall Study|Resigned from schools|4
5960428|NCT01198548|20613256|P1|Overall Study|Administrative Decision|1
5960429|NCT01198548|20613256|P1|Overall Study|Disease Progression|9
5960430|NCT01198509|20613271|P6|Overall Study|Withdrawal by Subject|0
5960431|NCT01198509|20613272|P5|Overall Study|Withdrawal by Subject|0
5960432|NCT01198509|20613273|P4|Overall Study|Withdrawal by Subject|0
5960433|NCT01198509|20613274|P3|Overall Study|Withdrawal by Subject|0
5960434|NCT01198509|20613275|P2|Overall Study|Withdrawal by Subject|0
5960435|NCT01198509|20613276|P1|Overall Study|Withdrawal by Subject|1
5960436|NCT01198470|20613293|P1|Overall Study|Adverse Event|2
5960437|NCT01198275|20613359|P2|Overall Study|spontaneous return to sinus rhythm|2
5960438|NCT01198275|20613360|P1|Overall Study|spontaneous return to sinus rhythm|4
5960439|NCT01198275|20613359|P2|Overall Study|Adverse Event|3
5960440|NCT01198275|20613360|P1|Overall Study|Adverse Event|2
5960441|NCT01198145|20613383|P2|Overall Study|Withdrawal by Subject|1
5960442|NCT01198145|20613384|P1|Overall Study|Withdrawal by Subject|1
5960443|NCT01198132|20613406|P2|Overall Study|Protocol Violation|0
5960444|NCT01198132|20613407|P1|Overall Study|Protocol Violation|1
5960445|NCT01198132|20613406|P2|Overall Study|Adverse Event|1
5960446|NCT01198132|20613407|P1|Overall Study|Adverse Event|0
5960447|NCT01198132|20613406|P2|Overall Study|Abnormal/clinically significant biologic|1
5960448|NCT01198132|20613407|P1|Overall Study|Abnormal/clinically significant biologic|1
5960449|NCT01198132|20613406|P2|Overall Study|Sign/symptoms of underlying disease|1
5960450|NCT01198132|20613407|P1|Overall Study|Sign/symptoms of underlying disease|2
5960451|NCT01198132|20613406|P2|Overall Study|Lack of Efficacy|3
5960452|NCT01198132|20613407|P1|Overall Study|Lack of Efficacy|2
5960453|NCT01198132|20613406|P2|Overall Study|Other Unspecified|6
5960454|NCT01198132|20613407|P1|Overall Study|Other Unspecified|3
5960455|NCT01198132|20613406|P2|Overall Study|Physician Decision|4
5960456|NCT01198132|20613407|P1|Overall Study|Physician Decision|5
5960457|NCT01198132|20613406|P2|Overall Study|Withdrawal by Subject|5
5960458|NCT01198132|20613407|P1|Overall Study|Withdrawal by Subject|4
5960459|NCT01198028|20613431|P1|Overall Study|Physician Decision|2
5960460|NCT01198028|20613431|P1|Overall Study|Death|3
5960461|NCT01198028|20613431|P1|Overall Study|Adverse Event|5
5960462|NCT01198002|20613443|P3|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|75
5960463|NCT01198002|20613444|P2|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|70
5960464|NCT01198002|20613445|P1|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|62
5960465|NCT01198002|20613443|P3|Treatment Period 2 (Weeks 52-100)|Physician Decision|1
5960466|NCT01198002|20613444|P2|Treatment Period 2 (Weeks 52-100)|Physician Decision|0
5960467|NCT01198002|20613445|P1|Treatment Period 2 (Weeks 52-100)|Physician Decision|1
5960468|NCT01198002|20613443|P3|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0
5960469|NCT01198002|20613444|P2|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|2
5960470|NCT01198002|20613445|P1|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0
5960471|NCT01198002|20613443|P3|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0
5960472|NCT01198002|20613444|P2|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0
5960473|NCT01198002|20613445|P1|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|1
5960474|NCT01198002|20613443|P3|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1
5960475|NCT01198002|20613444|P2|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1
5960476|NCT01198002|20613445|P1|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|3
5960477|NCT01198002|20613443|P3|Treatment Period 2 (Weeks 52-100)|Adverse Event|1
5960478|NCT01198002|20613444|P2|Treatment Period 2 (Weeks 52-100)|Adverse Event|0
5960479|NCT01198002|20613445|P1|Treatment Period 2 (Weeks 52-100)|Adverse Event|2
5960480|NCT01198002|20613443|P3|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|224
5960481|NCT01198002|20613444|P2|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|216
5960482|NCT01198002|20613445|P1|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|213
5960483|NCT01198002|20613443|P3|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10
5960484|NCT01198002|20613444|P2|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10
5960485|NCT01198002|20613445|P1|Treatment Period 1 (Weeks 0-52)|Protocol Violation|14
5960486|NCT01198002|20613443|P3|Treatment Period 1 (Weeks 0-52)|Physician Decision|2
5960487|NCT01198002|20613444|P2|Treatment Period 1 (Weeks 0-52)|Physician Decision|2
5960488|NCT01198002|20613445|P1|Treatment Period 1 (Weeks 0-52)|Physician Decision|1
5960489|NCT01198002|20613443|P3|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|12
5960490|NCT01198002|20613444|P2|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|21
5960491|NCT01198002|20613445|P1|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|16
5960492|NCT01198002|20613443|P3|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0
5960493|NCT01198002|20613444|P2|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|2
5960494|NCT01198002|20613445|P1|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0
5960495|NCT01198002|20613443|P3|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3
5960496|NCT01198002|20613444|P2|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3
5960497|NCT01198002|20613445|P1|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|1
5960498|NCT01198002|20613443|P3|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|6
5960499|NCT01198002|20613444|P2|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|9
5960500|NCT01198002|20613445|P1|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|10
5960501|NCT01198002|20613443|P3|Treatment Period 1 (Weeks 0-52)|Death|1
5960502|NCT01198002|20613444|P2|Treatment Period 1 (Weeks 0-52)|Death|0
5960503|NCT01198002|20613445|P1|Treatment Period 1 (Weeks 0-52)|Death|2
5960504|NCT01198002|20613443|P3|Treatment Period 1 (Weeks 0-52)|Adverse Event|11
5960505|NCT01198002|20613444|P2|Treatment Period 1 (Weeks 0-52)|Adverse Event|11
5960506|NCT01198002|20613445|P1|Treatment Period 1 (Weeks 0-52)|Adverse Event|18
5960507|NCT01197911|20613560|P3|Overall Study|Adverse Event|1
5960508|NCT01197911|20613561|P2|Overall Study|Adverse Event|0
5960509|NCT01197911|20613562|P1|Overall Study|Adverse Event|0
5960510|NCT01197794|20613677|P7|Overall Study|Other|4
5960511|NCT01197794|20613678|P6|Overall Study|Other|2
5960512|NCT01197794|20613679|P5|Overall Study|Other|2
5960513|NCT01197794|20613680|P4|Overall Study|Other|0
5960514|NCT01197794|20613681|P3|Overall Study|Other|3
5960515|NCT01197794|20613682|P2|Overall Study|Other|1
5960516|NCT01197794|20613683|P1|Overall Study|Other|1
5960517|NCT01197794|20613677|P7|Overall Study|Lost to Follow-up|0
5960518|NCT01197794|20613678|P6|Overall Study|Lost to Follow-up|1
5960519|NCT01197794|20613679|P5|Overall Study|Lost to Follow-up|0
5960520|NCT01197794|20613680|P4|Overall Study|Lost to Follow-up|1
5960521|NCT01197794|20613681|P3|Overall Study|Lost to Follow-up|0
5960522|NCT01197794|20613682|P2|Overall Study|Lost to Follow-up|1
5960523|NCT01197794|20613683|P1|Overall Study|Lost to Follow-up|1
5960524|NCT01197794|20613677|P7|Overall Study|Withdrawal by Subject|6
5960525|NCT01197794|20613678|P6|Overall Study|Withdrawal by Subject|5
5960526|NCT01197794|20613679|P5|Overall Study|Withdrawal by Subject|1
5960527|NCT01197794|20613680|P4|Overall Study|Withdrawal by Subject|1
5960528|NCT01197794|20613681|P3|Overall Study|Withdrawal by Subject|4
5960529|NCT01197794|20613682|P2|Overall Study|Withdrawal by Subject|3
5960530|NCT01197794|20613683|P1|Overall Study|Withdrawal by Subject|3
5960531|NCT01197794|20613677|P7|Overall Study|Eligibility criteria not fulfilled|6
5960532|NCT01197794|20613678|P6|Overall Study|Eligibility criteria not fulfilled|9
5960533|NCT01197794|20613679|P5|Overall Study|Eligibility criteria not fulfilled|5
5960534|NCT01197794|20613680|P4|Overall Study|Eligibility criteria not fulfilled|5
5960535|NCT01197794|20613681|P3|Overall Study|Eligibility criteria not fulfilled|2
5960536|NCT01197794|20613682|P2|Overall Study|Eligibility criteria not fulfilled|8
5960537|NCT01197794|20613683|P1|Overall Study|Eligibility criteria not fulfilled|5
5960538|NCT01197794|20613677|P7|Overall Study|Development of study withdrawal criteria|1
5960539|NCT01197794|20613678|P6|Overall Study|Development of study withdrawal criteria|0
5960540|NCT01197794|20613679|P5|Overall Study|Development of study withdrawal criteria|0
5960541|NCT01197794|20613680|P4|Overall Study|Development of study withdrawal criteria|1
5960542|NCT01197794|20613681|P3|Overall Study|Development of study withdrawal criteria|0
5960543|NCT01197794|20613682|P2|Overall Study|Development of study withdrawal criteria|0
5960544|NCT01197794|20613683|P1|Overall Study|Development of study withdrawal criteria|3
5960545|NCT01197794|20613677|P7|Overall Study|Protocol Violation|1
5960546|NCT01197794|20613678|P6|Overall Study|Protocol Violation|0
5960547|NCT01197794|20613679|P5|Overall Study|Protocol Violation|2
5960548|NCT01197794|20613680|P4|Overall Study|Protocol Violation|0
5960549|NCT01197794|20613681|P3|Overall Study|Protocol Violation|0
5960550|NCT01197794|20613682|P2|Overall Study|Protocol Violation|0
5960551|NCT01197794|20613683|P1|Overall Study|Protocol Violation|0
5960552|NCT01197794|20613677|P7|Overall Study|Adverse Event|3
5960553|NCT01197794|20613678|P6|Overall Study|Adverse Event|2
5960554|NCT01197794|20613679|P5|Overall Study|Adverse Event|4
5960555|NCT01197794|20613680|P4|Overall Study|Adverse Event|4
5960556|NCT01197794|20613681|P3|Overall Study|Adverse Event|4
5960557|NCT01197794|20613682|P2|Overall Study|Adverse Event|2
5960558|NCT01197794|20613683|P1|Overall Study|Adverse Event|3
5960559|NCT01197755|20613765|P3|Overall Study|eg, change in circumstances|2
5960560|NCT01197755|20613766|P2|Overall Study|eg, change in circumstances|3
5960561|NCT01197755|20613767|P1|Overall Study|eg, change in circumstances|7
5960562|NCT01197755|20613765|P3|Overall Study|Lost to Follow-up|1
5960563|NCT01197755|20613766|P2|Overall Study|Lost to Follow-up|0
5960564|NCT01197755|20613767|P1|Overall Study|Lost to Follow-up|0
5960565|NCT01197755|20613765|P3|Overall Study|Withdrawal by Subject|0
5960566|NCT01197755|20613766|P2|Overall Study|Withdrawal by Subject|0
5960567|NCT01197755|20613767|P1|Overall Study|Withdrawal by Subject|1
5960568|NCT01197755|20613765|P3|Overall Study|Severe non-compliance to the protocol|2
5960569|NCT01197755|20613766|P2|Overall Study|Severe non-compliance to the protocol|1
5960570|NCT01197755|20613767|P1|Overall Study|Severe non-compliance to the protocol|2
5960571|NCT01197755|20613765|P3|Overall Study|Lack of therapeutic response|4
5960572|NCT01197755|20613766|P2|Overall Study|Lack of therapeutic response|7
5960573|NCT01197755|20613767|P1|Overall Study|Lack of therapeutic response|0
5960574|NCT01197755|20613765|P3|Overall Study|Entered the long-term extension study|35
5960575|NCT01197755|20613766|P2|Overall Study|Entered the long-term extension study|21
5960576|NCT01197755|20613767|P1|Overall Study|Entered the long-term extension study|18
5960577|NCT01197755|20613765|P3|Overall Study|Study-specific discontinuation criteria|0
5960578|NCT01197755|20613766|P2|Overall Study|Study-specific discontinuation criteria|1
5960579|NCT01197755|20613767|P1|Overall Study|Study-specific discontinuation criteria|2
5960580|NCT01197755|20613765|P3|Overall Study|Adverse Event|10
5960581|NCT01197755|20613766|P2|Overall Study|Adverse Event|10
5960582|NCT01197755|20613767|P1|Overall Study|Adverse Event|8
5960583|NCT01197560|20613839|P2|Overall Study|Missing|1
5960584|NCT01197560|20613840|P1|Overall Study|Missing|0
5960585|NCT01197560|20613839|P2|Overall Study|Miscellaneous|3
5960586|NCT01197560|20613840|P1|Overall Study|Miscellaneous|4
5960587|NCT01197560|20613839|P2|Overall Study|Disease progression|35
5960588|NCT01197560|20613840|P1|Overall Study|Disease progression|40
5960589|NCT01197560|20613839|P2|Overall Study|Withdrawal by Subject|1
5960590|NCT01197560|20613840|P1|Overall Study|Withdrawal by Subject|1
5960591|NCT01197560|20613839|P2|Overall Study|Death|5
5960592|NCT01197560|20613840|P1|Overall Study|Death|3
5960593|NCT01197560|20613839|P2|Overall Study|Adverse Event|8
5960594|NCT01197560|20613840|P1|Overall Study|Adverse Event|6
5960595|NCT01197534|20613887|P3|Overall Study|Adverse Event|24
5960596|NCT01197534|20613888|P2|Overall Study|Adverse Event|36
5960597|NCT01197534|20613889|P1|Overall Study|Adverse Event|35
5960598|NCT01197534|20613887|P3|Overall Study|Lost to Follow-up|2
5960599|NCT01197534|20613888|P2|Overall Study|Lost to Follow-up|4
5960600|NCT01197534|20613889|P1|Overall Study|Lost to Follow-up|1
5960601|NCT01197534|20613887|P3|Overall Study|Dev. of study specific discont. criteria|2
5960602|NCT01197534|20613888|P2|Overall Study|Dev. of study specific discont. criteria|6
5960603|NCT01197534|20613889|P1|Overall Study|Dev. of study specific discont. criteria|13
5960604|NCT01197534|20613887|P3|Overall Study|Lack of therapeutic response|9
5960605|NCT01197534|20613888|P2|Overall Study|Lack of therapeutic response|4
5960606|NCT01197534|20613889|P1|Overall Study|Lack of therapeutic response|9
5960607|NCT01197534|20613887|P3|Overall Study|Severe non-compliance to protocol|1
5960608|NCT01197534|20613888|P2|Overall Study|Severe non-compliance to protocol|4
5960609|NCT01197534|20613889|P1|Overall Study|Severe non-compliance to protocol|3
5960610|NCT01197534|20613887|P3|Overall Study|Enrolment in long term extension|119
5960611|NCT01197534|20613888|P2|Overall Study|Enrolment in long term extension|66
5960612|NCT01197534|20613889|P1|Overall Study|Enrolment in long term extension|57
5960613|NCT01197534|20613887|P3|Overall Study|Not reported|16
5960614|NCT01197534|20613888|P2|Overall Study|Not reported|10
5960615|NCT01197534|20613889|P1|Overall Study|Not reported|16
5960616|NCT01197521|20613933|P3|Overall Study|Adverse Event|24
5960617|NCT01197521|20613934|P2|Overall Study|Adverse Event|28
5960618|NCT01197521|20613935|P1|Overall Study|Adverse Event|25
5960619|NCT01197521|20613933|P3|Overall Study|Lost to Follow-up|2
5960620|NCT01197521|20613934|P2|Overall Study|Lost to Follow-up|2
5960621|NCT01197521|20613935|P1|Overall Study|Lost to Follow-up|3
5960622|NCT01197521|20613933|P3|Overall Study|Dev. of study specific discont. criteria|2
5960623|NCT01197521|20613934|P2|Overall Study|Dev. of study specific discont. criteria|16
5960624|NCT01197521|20613935|P1|Overall Study|Dev. of study specific discont. criteria|6
5960625|NCT01197521|20613933|P3|Overall Study|Lack of therapeutic response|4
5960626|NCT01197521|20613934|P2|Overall Study|Lack of therapeutic response|3
5960627|NCT01197521|20613935|P1|Overall Study|Lack of therapeutic response|2
5960628|NCT01197521|20613933|P3|Overall Study|Severe non-compliance to protocol|3
5960629|NCT01197521|20613934|P2|Overall Study|Severe non-compliance to protocol|3
5960630|NCT01197521|20613935|P1|Overall Study|Severe non-compliance to protocol|1
5960631|NCT01197521|20613933|P3|Overall Study|Enrolment in long term extension|87
5960632|NCT01197521|20613934|P2|Overall Study|Enrolment in long term extension|36
5960633|NCT01197521|20613935|P1|Overall Study|Enrolment in long term extension|42
5960634|NCT01197521|20613933|P3|Overall Study|Not reported|21
5960635|NCT01197521|20613934|P2|Overall Study|Not reported|25
5960636|NCT01197521|20613935|P1|Overall Study|Not reported|24
5960637|NCT01197508|20613980|P4|Overall Study|Other|2
5960638|NCT01197508|20613981|P3|Overall Study|Other|2
5960639|NCT01197508|20613982|P2|Overall Study|Other|3
5960640|NCT01197508|20613983|P1|Overall Study|Other|2
5960641|NCT01197508|20613980|P4|Overall Study|Lost to Follow-up|0
5960642|NCT01197508|20613981|P3|Overall Study|Lost to Follow-up|2
5960643|NCT01197508|20613982|P2|Overall Study|Lost to Follow-up|1
5960644|NCT01197508|20613983|P1|Overall Study|Lost to Follow-up|1
5960645|NCT01197508|20613980|P4|Overall Study|Study-specific withdrawal criteria|2
5960646|NCT01197508|20613981|P3|Overall Study|Study-specific withdrawal criteria|1
5960647|NCT01197508|20613982|P2|Overall Study|Study-specific withdrawal criteria|0
5960648|NCT01197508|20613983|P1|Overall Study|Study-specific withdrawal criteria|0
5960649|NCT01197508|20613980|P4|Overall Study|Lack of Efficacy|1
5960650|NCT01197508|20613981|P3|Overall Study|Lack of Efficacy|2
5960651|NCT01197508|20613982|P2|Overall Study|Lack of Efficacy|2
5960652|NCT01197508|20613983|P1|Overall Study|Lack of Efficacy|1
5960653|NCT01197508|20613980|P4|Overall Study|Condition under investigation worsened|1
5960654|NCT01197508|20613981|P3|Overall Study|Condition under investigation worsened|1
5960655|NCT01197508|20613982|P2|Overall Study|Condition under investigation worsened|1
5960656|NCT01197508|20613983|P1|Overall Study|Condition under investigation worsened|1
5960657|NCT01197508|20613980|P4|Overall Study|Severe non-compliance to protocol|3
5960658|NCT01197508|20613981|P3|Overall Study|Severe non-compliance to protocol|1
5960659|NCT01197508|20613982|P2|Overall Study|Severe non-compliance to protocol|3
5960660|NCT01197508|20613983|P1|Overall Study|Severe non-compliance to protocol|0
5960661|NCT01197508|20613980|P4|Overall Study|Adverse Event|3
5960662|NCT01197508|20613981|P3|Overall Study|Adverse Event|23
5960663|NCT01197508|20613982|P2|Overall Study|Adverse Event|13
5960664|NCT01197508|20613983|P1|Overall Study|Adverse Event|10
5960665|NCT01197508|20613980|P4|Overall Study|Eligiblity criteria not fulfilled|0
5960666|NCT01197508|20613981|P3|Overall Study|Eligiblity criteria not fulfilled|2
5960667|NCT01197508|20613982|P2|Overall Study|Eligiblity criteria not fulfilled|0
5960668|NCT01197508|20613983|P1|Overall Study|Eligiblity criteria not fulfilled|0
5960669|NCT01197508|20613980|P4|Overall Study|Withdrawal by Subject|4
5960670|NCT01197508|20613981|P3|Overall Study|Withdrawal by Subject|15
5960671|NCT01197508|20613982|P2|Overall Study|Withdrawal by Subject|7
5960672|NCT01197508|20613983|P1|Overall Study|Withdrawal by Subject|8
5960673|NCT01197417|20614104|P2|Overall Study|No 25-hour magnesium level|2
5960674|NCT01197417|20614105|P1|Overall Study|No 25-hour magnesium level|0
5960675|NCT01197417|20614104|P2|Overall Study|Found to be ineligible|5
5960676|NCT01197417|20614105|P1|Overall Study|Found to be ineligible|2
5960677|NCT01197417|20614104|P2|Overall Study|Hypotension|2
5960678|NCT01197417|20614105|P1|Overall Study|Hypotension|1
5960679|NCT01197417|20614104|P2|Overall Study|Not consented in time to receive drug|1
5960680|NCT01197417|20614105|P1|Overall Study|Not consented in time to receive drug|0
5960681|NCT01197417|20614104|P2|Overall Study|Subject transferred to intensive care|1
5960682|NCT01197417|20614105|P1|Overall Study|Subject transferred to intensive care|0
5960683|NCT01197417|20614104|P2|Overall Study|Site miscommunication|1
5960684|NCT01197417|20614105|P1|Overall Study|Site miscommunication|0
5960685|NCT01197417|20614104|P2|Overall Study|Withdrawal by Subject|4
5960686|NCT01197417|20614105|P1|Overall Study|Withdrawal by Subject|2
5960687|NCT01197417|20614104|P2|Overall Study|Physician Decision|2
5960688|NCT01197417|20614105|P1|Overall Study|Physician Decision|3
5960689|NCT01197378|20614123|P1|Overall Study|Other|2
5960690|NCT01197378|20614123|P1|Overall Study|Physician Decision|1
5960691|NCT01197378|20614123|P1|Overall Study|Withdrawal by Subject|1
5960692|NCT01197378|20614123|P1|Overall Study|Adverse Event|3
5960693|NCT01197300|20614142|P2|Overall Study|Protocol Violation|1
5960694|NCT01197300|20614143|P1|Overall Study|Protocol Violation|0
5960695|NCT01197300|20614142|P2|Overall Study|Lost to Follow-up|1
5960696|NCT01197300|20614143|P1|Overall Study|Lost to Follow-up|0
5960697|NCT01196988|20614175|P4|Overall Study|Other|0
5960698|NCT01196988|20614176|P3|Overall Study|Other|0
5960699|NCT01196988|20614177|P2|Overall Study|Other|0
5960700|NCT01196988|20614178|P1|Overall Study|Other|2
5960701|NCT01196988|20614175|P4|Overall Study|Lost to Follow-up|1
5960702|NCT01196988|20614176|P3|Overall Study|Lost to Follow-up|21
5960703|NCT01196988|20614177|P2|Overall Study|Lost to Follow-up|29
5960704|NCT01196988|20614178|P1|Overall Study|Lost to Follow-up|16
5960705|NCT01196988|20614175|P4|Overall Study|Withdrawal by Subject|0
5960706|NCT01196988|20614176|P3|Overall Study|Withdrawal by Subject|4
5960707|NCT01196988|20614177|P2|Overall Study|Withdrawal by Subject|1
5960708|NCT01196988|20614178|P1|Overall Study|Withdrawal by Subject|5
5960709|NCT01196988|20614175|P4|Overall Study|Adverse Event|0
5960710|NCT01196988|20614176|P3|Overall Study|Adverse Event|0
5960711|NCT01196988|20614177|P2|Overall Study|Adverse Event|2
5960712|NCT01196988|20614178|P1|Overall Study|Adverse Event|1
5960713|NCT01196975|20614272|P5|Overall Study|Lost to Follow-up|11
5960714|NCT01196975|20614273|P4|Overall Study|Lost to Follow-up|5
5960715|NCT01196975|20614274|P3|Overall Study|Lost to Follow-up|5
5960716|NCT01196975|20614275|P2|Overall Study|Lost to Follow-up|6
5960717|NCT01196975|20614276|P1|Overall Study|Lost to Follow-up|11
5960718|NCT01196975|20614272|P5|Overall Study|Withdrawal by Subject|0
5960719|NCT01196975|20614273|P4|Overall Study|Withdrawal by Subject|1
5960720|NCT01196975|20614274|P3|Overall Study|Withdrawal by Subject|0
5960721|NCT01196975|20614275|P2|Overall Study|Withdrawal by Subject|1
5960722|NCT01196975|20614276|P1|Overall Study|Withdrawal by Subject|2
5960723|NCT01196975|20614272|P5|Overall Study|Adverse Event|2
5960724|NCT01196975|20614273|P4|Overall Study|Adverse Event|0
5960725|NCT01196975|20614274|P3|Overall Study|Adverse Event|0
5960726|NCT01196975|20614275|P2|Overall Study|Adverse Event|2
5960727|NCT01196975|20614276|P1|Overall Study|Adverse Event|2
5960728|NCT01196741|20614560|P2|Overall Study|Protocol Violation|1
5960729|NCT01196741|20614561|P1|Overall Study|Protocol Violation|2
5960730|NCT01196741|20614560|P2|Overall Study|Other|2
5960731|NCT01196741|20614561|P1|Overall Study|Other|3
5960732|NCT01196741|20614560|P2|Overall Study|Other reason|3
5960733|NCT01196741|20614561|P1|Overall Study|Other reason|3
5960734|NCT01196741|20614560|P2|Overall Study|Withdrawal by Subject|0
5960735|NCT01196741|20614561|P1|Overall Study|Withdrawal by Subject|3
5960736|NCT01196741|20614560|P2|Overall Study|Dose limiting Adverse Event|1
5960737|NCT01196741|20614561|P1|Overall Study|Dose limiting Adverse Event|2
5960738|NCT01196741|20614560|P2|Overall Study|Serious Adverse Event|1
5960739|NCT01196741|20614561|P1|Overall Study|Serious Adverse Event|3
5960740|NCT01196741|20614560|P2|Overall Study|Adverse Event|6
5960741|NCT01196741|20614561|P1|Overall Study|Adverse Event|10
5960742|NCT01196741|20614560|P2|Overall Study|Disease progression|14
5960743|NCT01196741|20614561|P1|Overall Study|Disease progression|34
5960744|NCT01196429|20614591|P2|Overall Study|Refused - Never Treated|0
5960745|NCT01196429|20614592|P1|Overall Study|Refused - Never Treated|1
5960746|NCT01196429|20614591|P2|Overall Study|Ineligible - wrong cell type|0
5960747|NCT01196429|20614592|P1|Overall Study|Ineligible - wrong cell type|1
5960748|NCT01196429|20614591|P2|Overall Study|Ineligible - inadequate pathology|0
5960749|NCT01196429|20614592|P1|Overall Study|Ineligible - inadequate pathology|1
5960750|NCT01196416|20614608|P1|Overall Study|Withdrawal by Subject|2
5960751|NCT01196104|20614666|P2|Overall Study|Various|1
5960752|NCT01196104|20614667|P1|Overall Study|Various|0
5960753|NCT01196104|20614666|P2|Overall Study|Withdrawal by Subject|3
5960754|NCT01196104|20614667|P1|Overall Study|Withdrawal by Subject|3
5960755|NCT01196104|20614666|P2|Overall Study|Physician Decision|1
5960756|NCT01196104|20614667|P1|Overall Study|Physician Decision|0
5960757|NCT01196104|20614666|P2|Overall Study|Lost to Follow-up|0
5960758|NCT01196104|20614667|P1|Overall Study|Lost to Follow-up|1
5960759|NCT01196091|20614710|P3|Overall Study|Randomized, No Study Drug Received|1
5960760|NCT01196091|20614711|P2|Overall Study|Randomized, No Study Drug Received|0
5960761|NCT01196091|20614712|P1|Overall Study|Randomized, No Study Drug Received|1
5960762|NCT01196091|20614710|P3|Overall Study|Excluded Site|8
5960763|NCT01196091|20614711|P2|Overall Study|Excluded Site|11
5960764|NCT01196091|20614712|P1|Overall Study|Excluded Site|5
5960765|NCT01196091|20614710|P3|Overall Study|Sponsor Decision|4
5960766|NCT01196091|20614711|P2|Overall Study|Sponsor Decision|5
5960767|NCT01196091|20614712|P1|Overall Study|Sponsor Decision|6
5960768|NCT01196091|20614710|P3|Overall Study|Protocol Violation|3
5960769|NCT01196091|20614711|P2|Overall Study|Protocol Violation|3
5960770|NCT01196091|20614712|P1|Overall Study|Protocol Violation|1
5960771|NCT01196091|20614710|P3|Overall Study|Physician Decision|4
5960772|NCT01196091|20614711|P2|Overall Study|Physician Decision|3
5960773|NCT01196091|20614712|P1|Overall Study|Physician Decision|3
5960774|NCT01196091|20614710|P3|Overall Study|Withdrawal by Subject|22
5960775|NCT01196091|20614711|P2|Overall Study|Withdrawal by Subject|19
5960776|NCT01196091|20614712|P1|Overall Study|Withdrawal by Subject|16
5960777|NCT01196091|20614710|P3|Overall Study|Parent/Caregiver Decision|1
5960778|NCT01196091|20614711|P2|Overall Study|Parent/Caregiver Decision|0
5960779|NCT01196091|20614712|P1|Overall Study|Parent/Caregiver Decision|0
5960780|NCT01196091|20614710|P3|Overall Study|Lost to Follow-up|6
5960781|NCT01196091|20614711|P2|Overall Study|Lost to Follow-up|5
5960782|NCT01196091|20614712|P1|Overall Study|Lost to Follow-up|5
5960783|NCT01196091|20614710|P3|Overall Study|Lack of Efficacy|17
5960784|NCT01196091|20614711|P2|Overall Study|Lack of Efficacy|12
5960785|NCT01196091|20614712|P1|Overall Study|Lack of Efficacy|15
5960786|NCT01196091|20614710|P3|Overall Study|Entry Criteria Not Met|10
5960787|NCT01196091|20614711|P2|Overall Study|Entry Criteria Not Met|11
5960788|NCT01196091|20614712|P1|Overall Study|Entry Criteria Not Met|11
5960789|NCT01196091|20614710|P3|Overall Study|Death|2
5960790|NCT01196091|20614711|P2|Overall Study|Death|2
5960791|NCT01196091|20614712|P1|Overall Study|Death|3
5960792|NCT01196091|20614710|P3|Overall Study|Adverse Event|26
5960793|NCT01196091|20614711|P2|Overall Study|Adverse Event|27
5960794|NCT01196091|20614712|P1|Overall Study|Adverse Event|22
5960795|NCT01196078|20614764|P2|Overall Study|Death|4
5960796|NCT01196078|20614765|P1|Overall Study|Death|6
5960797|NCT01196078|20614764|P2|Overall Study|Lost to Follow-up|0
5960798|NCT01196078|20614765|P1|Overall Study|Lost to Follow-up|1
5960799|NCT01196078|20614764|P2|Overall Study|Lack of Efficacy|23
5960800|NCT01196078|20614765|P1|Overall Study|Lack of Efficacy|17
5960801|NCT01196078|20614764|P2|Overall Study|Protocol Violation|1
5960802|NCT01196078|20614765|P1|Overall Study|Protocol Violation|2
5960803|NCT01196078|20614764|P2|Overall Study|Adverse Event|4
5960804|NCT01196078|20614765|P1|Overall Study|Adverse Event|4
5960805|NCT01196078|20614764|P2|Overall Study|Withdrawal by Subject|5
5960806|NCT01196078|20614765|P1|Overall Study|Withdrawal by Subject|3
5960807|NCT01196052|20614793|P1|Overall Study|Withdrawal by Subject|6
5960808|NCT01196052|20614793|P1|Overall Study|Reason not Specified|5
5960809|NCT01196052|20614793|P1|Overall Study|Noncompliance to Protocol Requirements|2
5960810|NCT01196052|20614793|P1|Overall Study|Lost to Follow-up|1
5960811|NCT01196052|20614793|P1|Overall Study|Adverse Event|9
5960812|NCT01196026|20614810|P6|Overall Study|Other|0
5960813|NCT01196026|20614811|P5|Overall Study|Other|0
5960814|NCT01196026|20614812|P4|Overall Study|Other|0
5960815|NCT01196026|20614813|P3|Overall Study|Other|0
5960816|NCT01196026|20614814|P2|Overall Study|Other|1
5960817|NCT01196026|20614815|P1|Overall Study|Other|0
5960818|NCT01196026|20614810|P6|Overall Study|Lost to Follow-up|0
5960819|NCT01196026|20614811|P5|Overall Study|Lost to Follow-up|1
5960820|NCT01196026|20614812|P4|Overall Study|Lost to Follow-up|0
5960821|NCT01196026|20614813|P3|Overall Study|Lost to Follow-up|0
5960822|NCT01196026|20614814|P2|Overall Study|Lost to Follow-up|3
5960823|NCT01196026|20614815|P1|Overall Study|Lost to Follow-up|0
5960824|NCT01196026|20614810|P6|Overall Study|Withdrawal by Subject|0
5960825|NCT01196026|20614811|P5|Overall Study|Withdrawal by Subject|0
5960826|NCT01196026|20614812|P4|Overall Study|Withdrawal by Subject|0
5960827|NCT01196026|20614813|P3|Overall Study|Withdrawal by Subject|0
5960828|NCT01196026|20614814|P2|Overall Study|Withdrawal by Subject|4
5960829|NCT01196026|20614815|P1|Overall Study|Withdrawal by Subject|1
5960830|NCT01195948|20615049|P3|Overall Study|Lost to Follow-up|2
5960831|NCT01195948|20615050|P2|Overall Study|Lost to Follow-up|1
5960832|NCT01195948|20615051|P1|Overall Study|Lost to Follow-up|0
5960833|NCT01195844|20615104|P1|Overall Study|Fecal sample not collected|40
5960834|NCT01195831|20615121|P2|Overall Study|Protocol Violation|2
5960835|NCT01195831|20615122|P1|Overall Study|Protocol Violation|0
5960836|NCT01195831|20615121|P2|Overall Study|Adverse Event|2
5960837|NCT01195831|20615122|P1|Overall Study|Adverse Event|4
5960838|NCT01195831|20615121|P2|Overall Study|Withdrawal by Subject|2
5960839|NCT01195831|20615122|P1|Overall Study|Withdrawal by Subject|2
5960840|NCT01195831|20615121|P2|Overall Study|Lost to Follow-up|4
5960841|NCT01195831|20615122|P1|Overall Study|Lost to Follow-up|2
5960842|NCT01195675|20615362|P1|Overall Study|Withdrawal by Subject|2
5960843|NCT01195675|20615362|P1|Overall Study|Adverse Event|1
5960844|NCT01195662|20615395|P3|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0
5960845|NCT01195662|20615396|P2|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0
5960846|NCT01195662|20615397|P1|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|1
5960847|NCT01195662|20615395|P3|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|1
5960848|NCT01195662|20615396|P2|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|0
5960849|NCT01195662|20615397|P1|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|2
5960850|NCT01195662|20615395|P3|Double Blind Treatment Period|Missing disposition information|1
5960851|NCT01195662|20615396|P2|Double Blind Treatment Period|Missing disposition information|1
5960852|NCT01195662|20615397|P1|Double Blind Treatment Period|Missing disposition information|0
5960853|NCT01195662|20615395|P3|Double Blind Treatment Period|Non-specified|0
5960854|NCT01195662|20615396|P2|Double Blind Treatment Period|Non-specified|0
5960855|NCT01195662|20615397|P1|Double Blind Treatment Period|Non-specified|3
5960856|NCT01195662|20615395|P3|Double Blind Treatment Period|Lack of Efficacy|0
5960857|NCT01195662|20615396|P2|Double Blind Treatment Period|Lack of Efficacy|0
5960858|NCT01195662|20615397|P1|Double Blind Treatment Period|Lack of Efficacy|2
5960859|NCT01195662|20615395|P3|Double Blind Treatment Period|No Longer Meets Criteria|2
5960860|NCT01195662|20615396|P2|Double Blind Treatment Period|No Longer Meets Criteria|5
5960861|NCT01195662|20615397|P1|Double Blind Treatment Period|No Longer Meets Criteria|1
5960862|NCT01195662|20615395|P3|Double Blind Treatment Period|Requested discontinue treatment|1
5960863|NCT01195662|20615396|P2|Double Blind Treatment Period|Requested discontinue treatment|0
5960864|NCT01195662|20615397|P1|Double Blind Treatment Period|Requested discontinue treatment|1
5960865|NCT01195662|20615395|P3|Double Blind Treatment Period|Administrative reason|1
5960866|NCT01195662|20615396|P2|Double Blind Treatment Period|Administrative reason|1
5960867|NCT01195662|20615397|P1|Double Blind Treatment Period|Administrative reason|2
5960868|NCT01195662|20615395|P3|Double Blind Treatment Period|Lost to Follow-up|3
5960869|NCT01195662|20615396|P2|Double Blind Treatment Period|Lost to Follow-up|2
5960870|NCT01195662|20615397|P1|Double Blind Treatment Period|Lost to Follow-up|3
5960871|NCT01195662|20615395|P3|Double Blind Treatment Period|Withdrawal by Subject|4
5960872|NCT01195662|20615396|P2|Double Blind Treatment Period|Withdrawal by Subject|4
5960873|NCT01195662|20615397|P1|Double Blind Treatment Period|Withdrawal by Subject|6
5960874|NCT01195662|20615395|P3|Double Blind Treatment Period|Adverse Event|2
5960875|NCT01195662|20615396|P2|Double Blind Treatment Period|Adverse Event|1
5960876|NCT01195662|20615397|P1|Double Blind Treatment Period|Adverse Event|4
5960877|NCT01195636|20615427|P2|Second Intervention (3 Weeks)|Withdrawal by Subject|1
5960878|NCT01195636|20615428|P1|Second Intervention (3 Weeks)|Withdrawal by Subject|0
5960879|NCT01195636|20615427|P2|Second Intervention (3 Weeks)|Adverse Event|1
5960880|NCT01195636|20615428|P1|Second Intervention (3 Weeks)|Adverse Event|1
5960881|NCT01195636|20615427|P2|Washout Period (2 Weeks)|Withdrawal by Subject|2
5960882|NCT01195636|20615428|P1|Washout Period (2 Weeks)|Withdrawal by Subject|1
5960883|NCT01195636|20615427|P2|Washout Period (2 Weeks)|Adverse Event|1
5960884|NCT01195636|20615428|P1|Washout Period (2 Weeks)|Adverse Event|1
5960885|NCT01195636|20615427|P2|First Intervention (3 Weeks)|Lost to Follow-up|0
5960886|NCT01195636|20615428|P1|First Intervention (3 Weeks)|Lost to Follow-up|1
5960887|NCT01195636|20615427|P2|First Intervention (3 Weeks)|Withdrawal by Subject|0
5960888|NCT01195636|20615428|P1|First Intervention (3 Weeks)|Withdrawal by Subject|1
5960889|NCT01195636|20615427|P2|First Intervention (3 Weeks)|Protocol Violation|0
5960890|NCT01195636|20615428|P1|First Intervention (3 Weeks)|Protocol Violation|1
5960891|NCT01195636|20615427|P2|First Intervention (3 Weeks)|Adverse Event|3
5960892|NCT01195636|20615428|P1|First Intervention (3 Weeks)|Adverse Event|2
5960893|NCT01195623|20615454|P2|Overall Study|Lost to Follow-up|37
5960894|NCT01195623|20615455|P1|Overall Study|Lost to Follow-up|35
5960895|NCT01195545|20615484|P1|Overall Study|Protocol Violation|4
5960896|NCT01195415|20615496|P1|Overall Study|No repeat biopsy due to progression|2
5960897|NCT01195363|20615505|P2|Overall Study|incarceration|0
5960898|NCT01195363|20615506|P1|Overall Study|incarceration|1
5960899|NCT01195363|20615505|P2|Overall Study|Lack of Efficacy|4
5960900|NCT01195363|20615506|P1|Overall Study|Lack of Efficacy|0
5960901|NCT01195363|20615505|P2|Overall Study|Adverse Event|1
5960902|NCT01195363|20615506|P1|Overall Study|Adverse Event|3
5960903|NCT01195363|20615505|P2|Overall Study|Lost to Follow-up|4
5960904|NCT01195363|20615506|P1|Overall Study|Lost to Follow-up|7
5960905|NCT01195272|20615512|P1|Overall Study|Lack of Efficacy|3
5960906|NCT01195272|20615512|P1|Overall Study|Adverse Event|1
5960907|NCT01195103|20615541|P3|Overall Study|Withdrawal by Subject|0
5960908|NCT01195103|20615542|P2|Overall Study|Withdrawal by Subject|0
5960909|NCT01195103|20615543|P1|Overall Study|Withdrawal by Subject|1
5960910|NCT01195090|20615553|P2|Overall Study|Protocol Violation|4
5960911|NCT01195090|20615554|P1|Overall Study|Protocol Violation|3
5960912|NCT01195090|20615553|P2|Overall Study|Lost to Follow-up|2
5960913|NCT01195090|20615554|P1|Overall Study|Lost to Follow-up|2
5960914|NCT01195090|20615553|P2|Overall Study|Adverse Event|2
5960915|NCT01195090|20615554|P1|Overall Study|Adverse Event|1
5960916|NCT01194999|20615623|P1|Overall Study|Lost to Follow-up|17
5960917|NCT01194973|20615627|P1|26 Week Treatment Period|Pregnancy|1
5960918|NCT01194973|20615627|P1|26 Week Treatment Period|Lack of Efficacy|1
5960919|NCT01194973|20615627|P1|26 Week Treatment Period|Adverse Event|1
5960920|NCT01194973|20615627|P1|Screening Period|Screen Failure|3
5960921|NCT01194869|20615647|P1|Overall Study|Toxicity|2
5960922|NCT01194869|20615647|P1|Overall Study|Disease Progression|2
5960923|NCT01194830|20615678|P2|Overall Study|Other Reason|8
5960924|NCT01194830|20615679|P1|Overall Study|Other Reason|12
5960925|NCT01194830|20615678|P2|Overall Study|Non-compliance issues|4
5960926|NCT01194830|20615679|P1|Overall Study|Non-compliance issues|4
5960927|NCT01194830|20615678|P2|Overall Study|Lack of Efficacy|1
5960928|NCT01194830|20615679|P1|Overall Study|Lack of Efficacy|1
5960929|NCT01194830|20615678|P2|Overall Study|Withdrawal by Subject|1
5960930|NCT01194830|20615679|P1|Overall Study|Withdrawal by Subject|2
5960931|NCT01194830|20615678|P2|Overall Study|Lost to Follow-up|7
5960932|NCT01194830|20615679|P1|Overall Study|Lost to Follow-up|9
5960933|NCT01194830|20615678|P2|Overall Study|Protocol Violation|4
5960934|NCT01194830|20615679|P1|Overall Study|Protocol Violation|5
5960935|NCT01194830|20615678|P2|Overall Study|Adverse Event|2
5960936|NCT01194830|20615679|P1|Overall Study|Adverse Event|3
5960937|NCT01194804|20615701|P1|Overall Study|Withdrawal by Subject|1
5960938|NCT01194570|20615723|P2|Overall Study|Lost to Follow-up|4
5960939|NCT01194570|20615724|P1|Overall Study|Lost to Follow-up|1
5960940|NCT01194570|20615723|P2|Overall Study|Pregnancy|1
5960941|NCT01194570|20615724|P1|Overall Study|Pregnancy|1
5960942|NCT01194570|20615723|P2|Overall Study|Withdrawal by Subject|22
5960943|NCT01194570|20615724|P1|Overall Study|Withdrawal by Subject|21
5960944|NCT01194570|20615723|P2|Overall Study|Lack of Efficacy|21
5960945|NCT01194570|20615724|P1|Overall Study|Lack of Efficacy|27
5960946|NCT01194570|20615723|P2|Overall Study|Non-compliance|2
5960947|NCT01194570|20615724|P1|Overall Study|Non-compliance|2
5960948|NCT01194570|20615723|P2|Overall Study|Adverse Event|18
5960949|NCT01194570|20615724|P1|Overall Study|Adverse Event|12
5960950|NCT01194570|20615723|P2|Overall Study|Non-compliance with study drug|2
5960951|NCT01194570|20615724|P1|Overall Study|Non-compliance with study drug|2
5960952|NCT01194570|20615723|P2|Overall Study|Protocol Violation|2
5960953|NCT01194570|20615724|P1|Overall Study|Protocol Violation|0
5960954|NCT01194570|20615723|P2|Overall Study|Reason not specified|20
5960955|NCT01194570|20615724|P1|Overall Study|Reason not specified|13
5960956|NCT01194570|20615723|P2|Overall Study|Physician Decision|6
5960957|NCT01194570|20615724|P1|Overall Study|Physician Decision|2
5960958|NCT01194570|20615723|P2|Overall Study|Ongoing at CCOD|387
5960959|NCT01194570|20615724|P1|Overall Study|Ongoing at CCOD|162
5960960|NCT01194570|20615723|P2|Overall Study|Death|3
5960961|NCT01194570|20615724|P1|Overall Study|Death|1
5960962|NCT01194531|20615744|P2|Overall Study|Physician Decision|2
5960963|NCT01194531|20615745|P1|Overall Study|Physician Decision|0
5960964|NCT01194531|20615744|P2|Overall Study|Protocol Violation|1
5960965|NCT01194531|20615745|P1|Overall Study|Protocol Violation|4
5960966|NCT01194531|20615744|P2|Overall Study|Withdrawal by Subject|0
5960967|NCT01194531|20615745|P1|Overall Study|Withdrawal by Subject|1
5960968|NCT01194440|20615799|P1|6-months (2nd Dose)|Change in therapy|4
5960969|NCT01194440|20615799|P1|Baseline (First Dose)|Adverse Event|1
5960970|NCT01194440|20615799|P1|Baseline (First Dose)|Change in therapy|1
5960971|NCT01194440|20615799|P1|Baseline (First Dose)|Lack of Efficacy|1
5960972|NCT01194440|20615799|P1|Baseline (First Dose)|Reason not specified|4
5960973|NCT01194414|20615812|P4|72 Weeks Open Label Extension|Death|2
5960974|NCT01194414|20615813|P3|72 Weeks Open Label Extension|Death|0
5960975|NCT01194414|20615814|P2|72 Weeks Open Label Extension|Death|2
5960976|NCT01194414|20615815|P1|72 Weeks Open Label Extension|Death|1
5960977|NCT01194414|20615812|P4|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0
5960978|NCT01194414|20615813|P3|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0
5960979|NCT01194414|20615814|P2|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1
5960980|NCT01194414|20615815|P1|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1
5960981|NCT01194414|20615812|P4|72 Weeks Open Label Extension|Adverse Event|12
5960982|NCT01194414|20615813|P3|72 Weeks Open Label Extension|Adverse Event|2
5960983|NCT01194414|20615814|P2|72 Weeks Open Label Extension|Adverse Event|21
5960984|NCT01194414|20615815|P1|72 Weeks Open Label Extension|Adverse Event|35
5960985|NCT01194414|20615812|P4|72 Weeks Open Label Extension|Protocol Violation|1
5960986|NCT01194414|20615813|P3|72 Weeks Open Label Extension|Protocol Violation|0
5960987|NCT01194414|20615814|P2|72 Weeks Open Label Extension|Protocol Violation|0
5960988|NCT01194414|20615815|P1|72 Weeks Open Label Extension|Protocol Violation|0
5960989|NCT01194414|20615812|P4|72 Weeks Open Label Extension|Other|0
5960990|NCT01194414|20615813|P3|72 Weeks Open Label Extension|Other|0
5960991|NCT01194414|20615814|P2|72 Weeks Open Label Extension|Other|1
5960992|NCT01194414|20615815|P1|72 Weeks Open Label Extension|Other|2
5960993|NCT01194414|20615812|P4|72 Weeks Open Label Extension|Pregnancy|1
5960994|NCT01194414|20615813|P3|72 Weeks Open Label Extension|Pregnancy|1
5960995|NCT01194414|20615814|P2|72 Weeks Open Label Extension|Pregnancy|3
5960996|NCT01194414|20615815|P1|72 Weeks Open Label Extension|Pregnancy|1
5960997|NCT01194414|20615812|P4|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0
5960998|NCT01194414|20615813|P3|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0
5960999|NCT01194414|20615814|P2|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|5
5961075|NCT01194258|20615890|P5|Period 1 (12 Weeks)|Death|1
5961000|NCT01194414|20615815|P1|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|3
5961001|NCT01194414|20615812|P4|72 Weeks Open Label Extension|Lost to Follow-up|1
5961002|NCT01194414|20615813|P3|72 Weeks Open Label Extension|Lost to Follow-up|2
5961003|NCT01194414|20615814|P2|72 Weeks Open Label Extension|Lost to Follow-up|3
5961004|NCT01194414|20615815|P1|72 Weeks Open Label Extension|Lost to Follow-up|4
5961005|NCT01194414|20615812|P4|72 Weeks Open Label Extension|Insufficient Therapeutic Response|3
5961006|NCT01194414|20615813|P3|72 Weeks Open Label Extension|Insufficient Therapeutic Response|2
5961007|NCT01194414|20615814|P2|72 Weeks Open Label Extension|Insufficient Therapeutic Response|11
5961008|NCT01194414|20615815|P1|72 Weeks Open Label Extension|Insufficient Therapeutic Response|9
5961009|NCT01194414|20615812|P4|72 Weeks Open Label Extension|Subject/legal Guardian Decision|6
5961010|NCT01194414|20615813|P3|72 Weeks Open Label Extension|Subject/legal Guardian Decision|1
5961011|NCT01194414|20615814|P2|72 Weeks Open Label Extension|Subject/legal Guardian Decision|14
5961012|NCT01194414|20615815|P1|72 Weeks Open Label Extension|Subject/legal Guardian Decision|20
5961013|NCT01194414|20615812|P4|72 Weeks Open Label Extension|Randomized but not Treated|0
5961014|NCT01194414|20615813|P3|72 Weeks Open Label Extension|Randomized but not Treated|0
5961015|NCT01194414|20615814|P2|72 Weeks Open Label Extension|Randomized but not Treated|5
5961016|NCT01194414|20615815|P1|72 Weeks Open Label Extension|Randomized but not Treated|3
5961017|NCT01194414|20615812|P4|24 Weeks Double Blind Period|Death|0
5961018|NCT01194414|20615813|P3|24 Weeks Double Blind Period|Death|0
5961019|NCT01194414|20615814|P2|24 Weeks Double Blind Period|Death|1
5961020|NCT01194414|20615815|P1|24 Weeks Double Blind Period|Death|0
5961021|NCT01194414|20615812|P4|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0
5961022|NCT01194414|20615813|P3|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0
5961023|NCT01194414|20615814|P2|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|1
5961024|NCT01194414|20615815|P1|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|2
5961025|NCT01194414|20615812|P4|24 Weeks Double Blind Period|Adverse Event|0
5961026|NCT01194414|20615813|P3|24 Weeks Double Blind Period|Adverse Event|0
5961027|NCT01194414|20615814|P2|24 Weeks Double Blind Period|Adverse Event|40
5961028|NCT01194414|20615815|P1|24 Weeks Double Blind Period|Adverse Event|28
5961029|NCT01194414|20615812|P4|24 Weeks Double Blind Period|Other|0
5961030|NCT01194414|20615813|P3|24 Weeks Double Blind Period|Other|0
5961031|NCT01194414|20615814|P2|24 Weeks Double Blind Period|Other|1
5961032|NCT01194414|20615815|P1|24 Weeks Double Blind Period|Other|0
5961033|NCT01194414|20615812|P4|24 Weeks Double Blind Period|Lost to Follow-up|0
5961034|NCT01194414|20615813|P3|24 Weeks Double Blind Period|Lost to Follow-up|0
5961035|NCT01194414|20615814|P2|24 Weeks Double Blind Period|Lost to Follow-up|1
5961036|NCT01194414|20615815|P1|24 Weeks Double Blind Period|Lost to Follow-up|2
5961037|NCT01194414|20615812|P4|24 Weeks Double Blind Period|Pregnancy|0
5961038|NCT01194414|20615813|P3|24 Weeks Double Blind Period|Pregnancy|0
5961039|NCT01194414|20615814|P2|24 Weeks Double Blind Period|Pregnancy|2
5961040|NCT01194414|20615815|P1|24 Weeks Double Blind Period|Pregnancy|2
5961041|NCT01194414|20615812|P4|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0
5961042|NCT01194414|20615813|P3|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0
5961043|NCT01194414|20615814|P2|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|5
5961044|NCT01194414|20615815|P1|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0
5961045|NCT01194414|20615812|P4|24 Weeks Double Blind Period|Protocol Violation|0
5961046|NCT01194414|20615813|P3|24 Weeks Double Blind Period|Protocol Violation|0
5961047|NCT01194414|20615814|P2|24 Weeks Double Blind Period|Protocol Violation|3
5961048|NCT01194414|20615815|P1|24 Weeks Double Blind Period|Protocol Violation|5
5961049|NCT01194414|20615812|P4|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0
5961050|NCT01194414|20615813|P3|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0
5961051|NCT01194414|20615814|P2|24 Weeks Double Blind Period|Subject/legal Guardian Decision|5
5961052|NCT01194414|20615815|P1|24 Weeks Double Blind Period|Subject/legal Guardian Decision|9
5961053|NCT01194414|20615812|P4|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0
5961054|NCT01194414|20615813|P3|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0
5961055|NCT01194414|20615814|P2|24 Weeks Double Blind Period|Insufficient Therapeutic Response|8
5961056|NCT01194414|20615815|P1|24 Weeks Double Blind Period|Insufficient Therapeutic Response|11
5961057|NCT01194271|20615886|P1|Overall Study|Death|1
5961058|NCT01194271|20615886|P1|Overall Study|Ineligible, Screen Failure|1
5961059|NCT01194271|20615886|P1|Overall Study|Withdrawal by Subject|1
5961060|NCT01194258|20615890|P5|Period 2 (12 Weeks)|Withdrawal by Subject|0
5961061|NCT01194258|20615891|P4|Period 2 (12 Weeks)|Withdrawal by Subject|0
5961062|NCT01194258|20615892|P3|Period 2 (12 Weeks)|Withdrawal by Subject|1
5961063|NCT01194258|20615893|P2|Period 2 (12 Weeks)|Withdrawal by Subject|1
5961064|NCT01194258|20615894|P1|Period 2 (12 Weeks)|Withdrawal by Subject|0
5961065|NCT01194258|20615890|P5|Period 2 (12 Weeks)|Adverse Event|0
5961066|NCT01194258|20615891|P4|Period 2 (12 Weeks)|Adverse Event|0
5961067|NCT01194258|20615892|P3|Period 2 (12 Weeks)|Adverse Event|0
5961068|NCT01194258|20615893|P2|Period 2 (12 Weeks)|Adverse Event|1
5961069|NCT01194258|20615894|P1|Period 2 (12 Weeks)|Adverse Event|0
5961070|NCT01194258|20615890|P5|Period 2 (12 Weeks)|Lost to Follow-up|2
5961071|NCT01194258|20615891|P4|Period 2 (12 Weeks)|Lost to Follow-up|0
5961072|NCT01194258|20615892|P3|Period 2 (12 Weeks)|Lost to Follow-up|0
5961073|NCT01194258|20615893|P2|Period 2 (12 Weeks)|Lost to Follow-up|0
5961074|NCT01194258|20615894|P1|Period 2 (12 Weeks)|Lost to Follow-up|0
5961076|NCT01194258|20615891|P4|Period 1 (12 Weeks)|Death|0
5961077|NCT01194258|20615892|P3|Period 1 (12 Weeks)|Death|0
5961078|NCT01194258|20615893|P2|Period 1 (12 Weeks)|Death|0
5961079|NCT01194258|20615894|P1|Period 1 (12 Weeks)|Death|0
5961080|NCT01194258|20615890|P5|Titration Period|Titration failure|0
5961081|NCT01194258|20615891|P4|Titration Period|Titration failure|0
5961082|NCT01194258|20615892|P3|Titration Period|Titration failure|0
5961083|NCT01194258|20615893|P2|Titration Period|Titration failure|0
5961084|NCT01194258|20615894|P1|Titration Period|Titration failure|3
5961085|NCT01194258|20615890|P5|Titration Period|Lost to Follow-up|0
5961086|NCT01194258|20615891|P4|Titration Period|Lost to Follow-up|0
5961087|NCT01194258|20615892|P3|Titration Period|Lost to Follow-up|0
5961088|NCT01194258|20615893|P2|Titration Period|Lost to Follow-up|0
5961089|NCT01194258|20615894|P1|Titration Period|Lost to Follow-up|2
5961090|NCT01194258|20615890|P5|Titration Period|Withdrawal by Subject|0
5961091|NCT01194258|20615891|P4|Titration Period|Withdrawal by Subject|0
5961092|NCT01194258|20615892|P3|Titration Period|Withdrawal by Subject|0
5961093|NCT01194258|20615893|P2|Titration Period|Withdrawal by Subject|0
5961094|NCT01194258|20615894|P1|Titration Period|Withdrawal by Subject|6
5961095|NCT01194245|20615918|P5|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1
5961096|NCT01194245|20615919|P4|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1
5961097|NCT01194245|20615920|P3|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1
5961098|NCT01194245|20615921|P2|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0
5961099|NCT01194245|20615922|P1|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0
5961100|NCT01194245|20615918|P5|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|1
5961101|NCT01194245|20615919|P4|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
5961102|NCT01194245|20615920|P3|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
5961103|NCT01194245|20615921|P2|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
5961104|NCT01194245|20615922|P1|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
5961105|NCT01194245|20615918|P5|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0
5961106|NCT01194245|20615919|P4|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0
5961107|NCT01194245|20615920|P3|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0
5961108|NCT01194245|20615921|P2|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0
5961109|NCT01194245|20615922|P1|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|7
5961110|NCT01194245|20615918|P5|Titration Period (4 to 6 Weeks)|Titration Failure|0
5961111|NCT01194245|20615919|P4|Titration Period (4 to 6 Weeks)|Titration Failure|0
5961112|NCT01194245|20615920|P3|Titration Period (4 to 6 Weeks)|Titration Failure|0
5961113|NCT01194245|20615921|P2|Titration Period (4 to 6 Weeks)|Titration Failure|0
5961114|NCT01194245|20615922|P1|Titration Period (4 to 6 Weeks)|Titration Failure|3
5961115|NCT01194245|20615918|P5|Titration Period (4 to 6 Weeks)|Physician Decision|0
5961116|NCT01194245|20615919|P4|Titration Period (4 to 6 Weeks)|Physician Decision|0
5961117|NCT01194245|20615920|P3|Titration Period (4 to 6 Weeks)|Physician Decision|0
5961118|NCT01194245|20615921|P2|Titration Period (4 to 6 Weeks)|Physician Decision|0
5961119|NCT01194245|20615922|P1|Titration Period (4 to 6 Weeks)|Physician Decision|3
5961120|NCT01194245|20615918|P5|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0
5961121|NCT01194245|20615919|P4|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0
5961122|NCT01194245|20615920|P3|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0
5961123|NCT01194245|20615921|P2|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0
5961124|NCT01194245|20615922|P1|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|5
5961125|NCT01194219|20615943|P10|Long-Term Extension Weeks 52 to 260|Miscellaneous|2
5961126|NCT01194219|20615944|P9|Long-Term Extension Weeks 52 to 260|Miscellaneous|11
5961127|NCT01194219|20615945|P8|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
5961128|NCT01194219|20615946|P7|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
5961129|NCT01194219|20615947|P6|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
5961130|NCT01194219|20615948|P5|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
5961131|NCT01194219|20615949|P4|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
5961132|NCT01194219|20615950|P3|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
5961133|NCT01194219|20615951|P2|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
5961134|NCT01194219|20615952|P1|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
5961135|NCT01194219|20615943|P10|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
5961136|NCT01194219|20615944|P9|Long-Term Extension Weeks 52 to 260|Protocol Violation|3
5961137|NCT01194219|20615945|P8|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
5961138|NCT01194219|20615946|P7|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
5961139|NCT01194219|20615947|P6|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
5961140|NCT01194219|20615948|P5|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
5961141|NCT01194219|20615949|P4|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
5961142|NCT01194219|20615950|P3|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
5961143|NCT01194219|20615951|P2|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
5961144|NCT01194219|20615952|P1|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
5961145|NCT01194219|20615943|P10|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|10
5961146|NCT01194219|20615944|P9|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|24
5961147|NCT01194219|20615945|P8|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
5961148|NCT01194219|20615946|P7|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
5961149|NCT01194219|20615947|P6|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
5961150|NCT01194219|20615948|P5|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
5961151|NCT01194219|20615949|P4|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
5961152|NCT01194219|20615950|P3|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
5961153|NCT01194219|20615951|P2|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
5961154|NCT01194219|20615952|P1|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
5961155|NCT01194219|20615943|P10|Long-Term Extension Weeks 52 to 260|Death|1
5961156|NCT01194219|20615944|P9|Long-Term Extension Weeks 52 to 260|Death|1
5961157|NCT01194219|20615945|P8|Long-Term Extension Weeks 52 to 260|Death|0
5961158|NCT01194219|20615946|P7|Long-Term Extension Weeks 52 to 260|Death|0
5961159|NCT01194219|20615947|P6|Long-Term Extension Weeks 52 to 260|Death|0
5961160|NCT01194219|20615948|P5|Long-Term Extension Weeks 52 to 260|Death|0
5961161|NCT01194219|20615949|P4|Long-Term Extension Weeks 52 to 260|Death|0
5961162|NCT01194219|20615950|P3|Long-Term Extension Weeks 52 to 260|Death|0
5961163|NCT01194219|20615951|P2|Long-Term Extension Weeks 52 to 260|Death|0
5961164|NCT01194219|20615952|P1|Long-Term Extension Weeks 52 to 260|Death|0
5961165|NCT01194219|20615943|P10|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|32
5961166|NCT01194219|20615944|P9|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|66
5961167|NCT01194219|20615945|P8|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
5961168|NCT01194219|20615946|P7|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
5961169|NCT01194219|20615947|P6|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
5961170|NCT01194219|20615948|P5|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
5961171|NCT01194219|20615949|P4|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
5961172|NCT01194219|20615950|P3|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
5961173|NCT01194219|20615951|P2|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
5961174|NCT01194219|20615952|P1|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
5961175|NCT01194219|20615943|P10|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|4
5961176|NCT01194219|20615944|P9|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|9
5961177|NCT01194219|20615945|P8|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
5961178|NCT01194219|20615946|P7|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
5961179|NCT01194219|20615947|P6|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
5961180|NCT01194219|20615948|P5|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
5961181|NCT01194219|20615949|P4|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
5961182|NCT01194219|20615950|P3|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
5961183|NCT01194219|20615951|P2|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
5961184|NCT01194219|20615952|P1|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
5961185|NCT01194219|20615943|P10|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|49
5961186|NCT01194219|20615944|P9|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|81
5961187|NCT01194219|20615945|P8|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
5961188|NCT01194219|20615946|P7|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
5961189|NCT01194219|20615947|P6|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
5961190|NCT01194219|20615948|P5|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
5961191|NCT01194219|20615949|P4|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
5961192|NCT01194219|20615950|P3|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
5961193|NCT01194219|20615951|P2|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
5961194|NCT01194219|20615952|P1|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
5961195|NCT01194219|20615943|P10|Long-Term Extension Weeks 52 to 260|Adverse Event|14
5961196|NCT01194219|20615944|P9|Long-Term Extension Weeks 52 to 260|Adverse Event|25
5961197|NCT01194219|20615945|P8|Long-Term Extension Weeks 52 to 260|Adverse Event|0
5961198|NCT01194219|20615946|P7|Long-Term Extension Weeks 52 to 260|Adverse Event|0
5961199|NCT01194219|20615947|P6|Long-Term Extension Weeks 52 to 260|Adverse Event|0
5961200|NCT01194219|20615948|P5|Long-Term Extension Weeks 52 to 260|Adverse Event|0
5961201|NCT01194219|20615949|P4|Long-Term Extension Weeks 52 to 260|Adverse Event|0
5961202|NCT01194219|20615950|P3|Long-Term Extension Weeks 52 to 260|Adverse Event|0
5961203|NCT01194219|20615951|P2|Long-Term Extension Weeks 52 to 260|Adverse Event|0
5961204|NCT01194219|20615952|P1|Long-Term Extension Weeks 52 to 260|Adverse Event|0
5961205|NCT01194219|20615943|P10|Randomized Withdrawal Phase-Weeks 32-52|Other|0
5961206|NCT01194219|20615944|P9|Randomized Withdrawal Phase-Weeks 32-52|Other|0
5961207|NCT01194219|20615945|P8|Randomized Withdrawal Phase-Weeks 32-52|Other|0
5961208|NCT01194219|20615946|P7|Randomized Withdrawal Phase-Weeks 32-52|Other|1
5961209|NCT01194219|20615947|P6|Randomized Withdrawal Phase-Weeks 32-52|Other|0
5961210|NCT01194219|20615948|P5|Randomized Withdrawal Phase-Weeks 32-52|Other|0
5961211|NCT01194219|20615949|P4|Randomized Withdrawal Phase-Weeks 32-52|Other|0
5961212|NCT01194219|20615950|P3|Randomized Withdrawal Phase-Weeks 32-52|Other|0
5961213|NCT01194219|20615951|P2|Randomized Withdrawal Phase-Weeks 32-52|Other|0
5961214|NCT01194219|20615952|P1|Randomized Withdrawal Phase-Weeks 32-52|Other|0
5961215|NCT01194219|20615943|P10|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
5961216|NCT01194219|20615944|P9|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
5961217|NCT01194219|20615945|P8|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|1
5961218|NCT01194219|20615946|P7|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
5961219|NCT01194219|20615947|P6|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
5961220|NCT01194219|20615948|P5|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
5961221|NCT01194219|20615949|P4|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
5961222|NCT01194219|20615950|P3|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
5961223|NCT01194219|20615951|P2|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
5961224|NCT01194219|20615952|P1|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
5961225|NCT01194219|20615943|P10|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
5961226|NCT01194219|20615944|P9|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
5961227|NCT01194219|20615945|P8|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
5961228|NCT01194219|20615946|P7|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|5
5961229|NCT01194219|20615947|P6|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|2
5961230|NCT01194219|20615948|P5|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|1
5961231|NCT01194219|20615949|P4|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
5961232|NCT01194219|20615950|P3|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
5961233|NCT01194219|20615951|P2|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
5961234|NCT01194219|20615952|P1|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
5961235|NCT01194219|20615943|P10|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
5961236|NCT01194219|20615944|P9|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
5961237|NCT01194219|20615945|P8|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|6
5961238|NCT01194219|20615946|P7|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|12
5961239|NCT01194219|20615947|P6|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
5961240|NCT01194219|20615948|P5|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|1
5961241|NCT01194219|20615949|P4|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
5961242|NCT01194219|20615950|P3|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
5961243|NCT01194219|20615951|P2|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
5961244|NCT01194219|20615952|P1|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
5961245|NCT01194219|20615943|P10|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
5961246|NCT01194219|20615944|P9|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
5961247|NCT01194219|20615945|P8|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
5961248|NCT01194219|20615946|P7|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|2
5961249|NCT01194219|20615947|P6|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
5961250|NCT01194219|20615948|P5|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|1
5961251|NCT01194219|20615949|P4|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
5961252|NCT01194219|20615950|P3|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
5961253|NCT01194219|20615951|P2|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
5961254|NCT01194219|20615952|P1|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
5961255|NCT01194219|20615943|P10|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0
5961256|NCT01194219|20615944|P9|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0
5961257|NCT01194219|20615945|P8|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|33
5961258|NCT01194219|20615946|P7|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|35
5961259|NCT01194219|20615947|P6|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1
5961260|NCT01194219|20615948|P5|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1
5961261|NCT01194219|20615949|P4|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0
5961262|NCT01194219|20615950|P3|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0
5961263|NCT01194219|20615951|P2|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0
5961264|NCT01194219|20615952|P1|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0
5961265|NCT01194219|20615943|P10|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
5961266|NCT01194219|20615944|P9|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
5961267|NCT01194219|20615945|P8|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|5
5961268|NCT01194219|20615946|P7|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|6
5961269|NCT01194219|20615947|P6|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|1
5961270|NCT01194219|20615948|P5|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
5961271|NCT01194219|20615949|P4|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
5961272|NCT01194219|20615950|P3|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
5961273|NCT01194219|20615951|P2|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
5961274|NCT01194219|20615952|P1|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
5961275|NCT01194219|20615943|P10|Maintenance Phase Weeks16-32|Other|0
5961276|NCT01194219|20615944|P9|Maintenance Phase Weeks16-32|Other|0
5961277|NCT01194219|20615945|P8|Maintenance Phase Weeks16-32|Other|0
5961278|NCT01194219|20615946|P7|Maintenance Phase Weeks16-32|Other|0
5961279|NCT01194219|20615947|P6|Maintenance Phase Weeks16-32|Other|0
5961280|NCT01194219|20615948|P5|Maintenance Phase Weeks16-32|Other|0
5961281|NCT01194219|20615949|P4|Maintenance Phase Weeks16-32|Other|1
5961282|NCT01194219|20615950|P3|Maintenance Phase Weeks16-32|Other|2
5961283|NCT01194219|20615951|P2|Maintenance Phase Weeks16-32|Other|0
5961284|NCT01194219|20615952|P1|Maintenance Phase Weeks16-32|Other|0
5961285|NCT01194219|20615943|P10|Maintenance Phase Weeks16-32|Protocol Violation|0
5961286|NCT01194219|20615944|P9|Maintenance Phase Weeks16-32|Protocol Violation|0
5961287|NCT01194219|20615945|P8|Maintenance Phase Weeks16-32|Protocol Violation|0
5961288|NCT01194219|20615946|P7|Maintenance Phase Weeks16-32|Protocol Violation|0
5961289|NCT01194219|20615947|P6|Maintenance Phase Weeks16-32|Protocol Violation|0
5961290|NCT01194219|20615948|P5|Maintenance Phase Weeks16-32|Protocol Violation|0
5961291|NCT01194219|20615949|P4|Maintenance Phase Weeks16-32|Protocol Violation|1
5961292|NCT01194219|20615950|P3|Maintenance Phase Weeks16-32|Protocol Violation|0
5961293|NCT01194219|20615951|P2|Maintenance Phase Weeks16-32|Protocol Violation|0
5961294|NCT01194219|20615952|P1|Maintenance Phase Weeks16-32|Protocol Violation|0
5961295|NCT01194219|20615943|P10|Maintenance Phase Weeks16-32|Lost to Follow-up|0
5961296|NCT01194219|20615944|P9|Maintenance Phase Weeks16-32|Lost to Follow-up|0
5961297|NCT01194219|20615945|P8|Maintenance Phase Weeks16-32|Lost to Follow-up|0
5961298|NCT01194219|20615946|P7|Maintenance Phase Weeks16-32|Lost to Follow-up|0
5961299|NCT01194219|20615947|P6|Maintenance Phase Weeks16-32|Lost to Follow-up|0
5961300|NCT01194219|20615948|P5|Maintenance Phase Weeks16-32|Lost to Follow-up|0
5961301|NCT01194219|20615949|P4|Maintenance Phase Weeks16-32|Lost to Follow-up|0
5961302|NCT01194219|20615950|P3|Maintenance Phase Weeks16-32|Lost to Follow-up|9
5961303|NCT01194219|20615951|P2|Maintenance Phase Weeks16-32|Lost to Follow-up|0
5961304|NCT01194219|20615952|P1|Maintenance Phase Weeks16-32|Lost to Follow-up|0
5961305|NCT01194219|20615943|P10|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
5961306|NCT01194219|20615944|P9|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
5961307|NCT01194219|20615945|P8|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
5961308|NCT01194219|20615946|P7|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
5961309|NCT01194219|20615947|P6|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
5961310|NCT01194219|20615948|P5|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
5961311|NCT01194219|20615949|P4|Maintenance Phase Weeks16-32|Withdrawal by Subject|3
5961312|NCT01194219|20615950|P3|Maintenance Phase Weeks16-32|Withdrawal by Subject|12
5961313|NCT01194219|20615951|P2|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
5961314|NCT01194219|20615952|P1|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
5961315|NCT01194219|20615943|P10|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
5961316|NCT01194219|20615944|P9|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
5961317|NCT01194219|20615945|P8|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
5961318|NCT01194219|20615946|P7|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
5961319|NCT01194219|20615947|P6|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
5961320|NCT01194219|20615948|P5|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
5961321|NCT01194219|20615949|P4|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|1
5961322|NCT01194219|20615950|P3|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|2
5961323|NCT01194219|20615951|P2|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
5961324|NCT01194219|20615952|P1|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
5961325|NCT01194219|20615943|P10|Maintenance Phase Weeks16-32|Lack of Efficacy|0
5961326|NCT01194219|20615944|P9|Maintenance Phase Weeks16-32|Lack of Efficacy|0
5961327|NCT01194219|20615945|P8|Maintenance Phase Weeks16-32|Lack of Efficacy|0
5961328|NCT01194219|20615946|P7|Maintenance Phase Weeks16-32|Lack of Efficacy|0
5961329|NCT01194219|20615947|P6|Maintenance Phase Weeks16-32|Lack of Efficacy|0
5961330|NCT01194219|20615948|P5|Maintenance Phase Weeks16-32|Lack of Efficacy|0
5961331|NCT01194219|20615949|P4|Maintenance Phase Weeks16-32|Lack of Efficacy|15
5961332|NCT01194219|20615950|P3|Maintenance Phase Weeks16-32|Lack of Efficacy|37
5961333|NCT01194219|20615951|P2|Maintenance Phase Weeks16-32|Lack of Efficacy|0
5961334|NCT01194219|20615952|P1|Maintenance Phase Weeks16-32|Lack of Efficacy|0
5961335|NCT01194219|20615943|P10|Maintenance Phase Weeks16-32|Adverse Event|0
5961336|NCT01194219|20615944|P9|Maintenance Phase Weeks16-32|Adverse Event|0
5961337|NCT01194219|20615945|P8|Maintenance Phase Weeks16-32|Adverse Event|0
5961338|NCT01194219|20615946|P7|Maintenance Phase Weeks16-32|Adverse Event|0
5961339|NCT01194219|20615947|P6|Maintenance Phase Weeks16-32|Adverse Event|0
5961340|NCT01194219|20615948|P5|Maintenance Phase Weeks16-32|Adverse Event|0
5961341|NCT01194219|20615949|P4|Maintenance Phase Weeks16-32|Adverse Event|9
5961342|NCT01194219|20615950|P3|Maintenance Phase Weeks16-32|Adverse Event|8
5961343|NCT01194219|20615951|P2|Maintenance Phase Weeks16-32|Adverse Event|0
5961344|NCT01194219|20615952|P1|Maintenance Phase Weeks16-32|Adverse Event|0
5961345|NCT01194219|20615943|P10|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
5961346|NCT01194219|20615944|P9|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
5961347|NCT01194219|20615945|P8|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
5961348|NCT01194219|20615946|P7|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
5961349|NCT01194219|20615947|P6|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
5961350|NCT01194219|20615948|P5|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
5961351|NCT01194219|20615949|P4|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
5961352|NCT01194219|20615950|P3|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
5961353|NCT01194219|20615951|P2|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1
5961354|NCT01194219|20615952|P1|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1
5961355|NCT01194219|20615943|P10|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
5961356|NCT01194219|20615944|P9|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
5961357|NCT01194219|20615945|P8|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
5961358|NCT01194219|20615946|P7|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
5961359|NCT01194219|20615947|P6|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
5961360|NCT01194219|20615948|P5|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
5961361|NCT01194219|20615949|P4|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
5961362|NCT01194219|20615950|P3|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
5961363|NCT01194219|20615951|P2|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|1
5961364|NCT01194219|20615952|P1|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|7
5961365|NCT01194219|20615943|P10|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
5961366|NCT01194219|20615944|P9|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
5961367|NCT01194219|20615945|P8|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
5961368|NCT01194219|20615946|P7|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
5961369|NCT01194219|20615947|P6|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
5961370|NCT01194219|20615948|P5|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
5961371|NCT01194219|20615949|P4|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
5961372|NCT01194219|20615950|P3|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
5961373|NCT01194219|20615951|P2|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|9
5961374|NCT01194219|20615952|P1|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|7
5961375|NCT01194219|20615943|P10|Placebo-Controlled Phase Weeks 0-16|Death|0
5961376|NCT01194219|20615944|P9|Placebo-Controlled Phase Weeks 0-16|Death|0
5961377|NCT01194219|20615945|P8|Placebo-Controlled Phase Weeks 0-16|Death|0
5961378|NCT01194219|20615946|P7|Placebo-Controlled Phase Weeks 0-16|Death|0
5961379|NCT01194219|20615947|P6|Placebo-Controlled Phase Weeks 0-16|Death|0
5961380|NCT01194219|20615948|P5|Placebo-Controlled Phase Weeks 0-16|Death|0
5961381|NCT01194219|20615949|P4|Placebo-Controlled Phase Weeks 0-16|Death|0
5961382|NCT01194219|20615950|P3|Placebo-Controlled Phase Weeks 0-16|Death|0
5961383|NCT01194219|20615951|P2|Placebo-Controlled Phase Weeks 0-16|Death|1
5961384|NCT01194219|20615952|P1|Placebo-Controlled Phase Weeks 0-16|Death|0
5961385|NCT01194219|20615943|P10|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
5961386|NCT01194219|20615944|P9|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
5961387|NCT01194219|20615945|P8|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
5961388|NCT01194219|20615946|P7|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
5961389|NCT01194219|20615947|P6|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
5961390|NCT01194219|20615948|P5|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
5961391|NCT01194219|20615949|P4|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
5961392|NCT01194219|20615950|P3|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
5961393|NCT01194219|20615951|P2|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|9
5961394|NCT01194219|20615952|P1|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|12
5961395|NCT01194219|20615943|P10|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
5961396|NCT01194219|20615944|P9|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
5961397|NCT01194219|20615945|P8|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
5961398|NCT01194219|20615946|P7|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
5961399|NCT01194219|20615947|P6|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
5961400|NCT01194219|20615948|P5|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
5961401|NCT01194219|20615949|P4|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
5961402|NCT01194219|20615950|P3|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
5961403|NCT01194219|20615951|P2|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
5961404|NCT01194219|20615952|P1|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|7
5961405|NCT01194219|20615943|P10|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
5961406|NCT01194219|20615944|P9|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
5961407|NCT01194219|20615945|P8|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
5961408|NCT01194219|20615946|P7|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
5961409|NCT01194219|20615947|P6|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
5961410|NCT01194219|20615948|P5|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
5961411|NCT01194219|20615949|P4|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
5961412|NCT01194219|20615950|P3|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
5961413|NCT01194219|20615951|P2|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|7
5961414|NCT01194219|20615952|P1|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|2
5961415|NCT01194219|20615943|P10|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
5961416|NCT01194219|20615944|P9|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
5961417|NCT01194219|20615945|P8|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
5961418|NCT01194219|20615946|P7|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
5961419|NCT01194219|20615947|P6|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
5961420|NCT01194219|20615948|P5|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
5961421|NCT01194219|20615949|P4|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
5961422|NCT01194219|20615950|P3|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
5961423|NCT01194219|20615951|P2|Placebo-Controlled Phase Weeks 0-16|Adverse Event|5
5961424|NCT01194219|20615952|P1|Placebo-Controlled Phase Weeks 0-16|Adverse Event|23
5961425|NCT01194154|20615986|P2|Overall Study|Did not receive study medication|4
5961426|NCT01194154|20615987|P1|Overall Study|Did not receive study medication|2
5961427|NCT01194154|20615986|P2|Overall Study|Other|0
5961428|NCT01194154|20615987|P1|Overall Study|Other|4
5961429|NCT01194154|20615986|P2|Overall Study|Treatment with prohibited medication|5
5961430|NCT01194154|20615987|P1|Overall Study|Treatment with prohibited medication|4
5961431|NCT01194154|20615986|P2|Overall Study|Skipping of CERA treatment at two visits|0
5961432|NCT01194154|20615987|P1|Overall Study|Skipping of CERA treatment at two visits|3
5961433|NCT01194154|20615986|P2|Overall Study|Hemoglobin increase|3
5961434|NCT01194154|20615987|P1|Overall Study|Hemoglobin increase|12
5961435|NCT01194154|20615986|P2|Overall Study|Hemoglobin decrease|1
5961436|NCT01194154|20615987|P1|Overall Study|Hemoglobin decrease|0
5961437|NCT01194154|20615986|P2|Overall Study|Blood pressure increase|3
5961438|NCT01194154|20615987|P1|Overall Study|Blood pressure increase|5
5961439|NCT01194154|20615986|P2|Overall Study|Withdrawal by Subject|6
5961440|NCT01194154|20615987|P1|Overall Study|Withdrawal by Subject|5
5961441|NCT01194154|20615986|P2|Overall Study|Protocol Violation|1
5961442|NCT01194154|20615987|P1|Overall Study|Protocol Violation|0
5961443|NCT01194154|20615986|P2|Overall Study|Lost to Follow-up|3
5961444|NCT01194154|20615987|P1|Overall Study|Lost to Follow-up|2
5961445|NCT01194154|20615986|P2|Overall Study|Adverse Event|7
5961446|NCT01194154|20615987|P1|Overall Study|Adverse Event|12
5961447|NCT01193920|20616028|P10|Overall Study|Unable to classify|0
5961448|NCT01193920|20616029|P9|Overall Study|Unable to classify|0
5961449|NCT01193920|20616030|P8|Overall Study|Unable to classify|1
5961450|NCT01193920|20616031|P7|Overall Study|Unable to classify|0
5961451|NCT01193920|20616032|P6|Overall Study|Unable to classify|0
5961452|NCT01193920|20616033|P5|Overall Study|Unable to classify|0
5961453|NCT01193920|20616034|P4|Overall Study|Unable to classify|1
5961454|NCT01193920|20616035|P3|Overall Study|Unable to classify|0
5961455|NCT01193920|20616036|P2|Overall Study|Unable to classify|0
5961456|NCT01193920|20616037|P1|Overall Study|Unable to classify|0
5961457|NCT01193920|20616028|P10|Overall Study|Death|4
5961458|NCT01193920|20616029|P9|Overall Study|Death|2
5961459|NCT01193920|20616030|P8|Overall Study|Death|3
5961460|NCT01193920|20616031|P7|Overall Study|Death|2
5961461|NCT01193920|20616032|P6|Overall Study|Death|0
5961462|NCT01193920|20616033|P5|Overall Study|Death|0
5961463|NCT01193920|20616034|P4|Overall Study|Death|1
5961464|NCT01193920|20616035|P3|Overall Study|Death|0
5961465|NCT01193920|20616036|P2|Overall Study|Death|0
5961466|NCT01193920|20616037|P1|Overall Study|Death|0
5961467|NCT01193920|20616028|P10|Overall Study|Protocol Violation|0
5961468|NCT01193920|20616029|P9|Overall Study|Protocol Violation|0
5961469|NCT01193920|20616030|P8|Overall Study|Protocol Violation|0
5961470|NCT01193920|20616031|P7|Overall Study|Protocol Violation|0
5961471|NCT01193920|20616032|P6|Overall Study|Protocol Violation|0
5961472|NCT01193920|20616033|P5|Overall Study|Protocol Violation|0
5961473|NCT01193920|20616034|P4|Overall Study|Protocol Violation|0
5961474|NCT01193920|20616035|P3|Overall Study|Protocol Violation|0
5961475|NCT01193920|20616036|P2|Overall Study|Protocol Violation|0
5961476|NCT01193920|20616037|P1|Overall Study|Protocol Violation|1
5961477|NCT01193920|20616028|P10|Overall Study|Lost to Follow-up|3
5961478|NCT01193920|20616029|P9|Overall Study|Lost to Follow-up|2
5961479|NCT01193920|20616030|P8|Overall Study|Lost to Follow-up|0
5961480|NCT01193920|20616031|P7|Overall Study|Lost to Follow-up|1
5961481|NCT01193920|20616032|P6|Overall Study|Lost to Follow-up|3
5961482|NCT01193920|20616033|P5|Overall Study|Lost to Follow-up|3
5961483|NCT01193920|20616034|P4|Overall Study|Lost to Follow-up|1
5961484|NCT01193920|20616035|P3|Overall Study|Lost to Follow-up|1
5961485|NCT01193920|20616036|P2|Overall Study|Lost to Follow-up|0
5961486|NCT01193920|20616037|P1|Overall Study|Lost to Follow-up|1
5961487|NCT01193920|20616028|P10|Overall Study|Withdrawal by Subject|0
5961488|NCT01193920|20616029|P9|Overall Study|Withdrawal by Subject|1
5961489|NCT01193920|20616030|P8|Overall Study|Withdrawal by Subject|0
5961490|NCT01193920|20616031|P7|Overall Study|Withdrawal by Subject|3
5961491|NCT01193920|20616032|P6|Overall Study|Withdrawal by Subject|1
5961492|NCT01193920|20616033|P5|Overall Study|Withdrawal by Subject|3
5961493|NCT01193920|20616034|P4|Overall Study|Withdrawal by Subject|1
5961494|NCT01193920|20616035|P3|Overall Study|Withdrawal by Subject|5
5961495|NCT01193920|20616036|P2|Overall Study|Withdrawal by Subject|0
5961496|NCT01193920|20616037|P1|Overall Study|Withdrawal by Subject|1
5961497|NCT01193842|20616133|P5|Phase II: Randomized Groups|Disease progression/relapse on treatment|3
5961498|NCT01193842|20616134|P4|Phase II: Randomized Groups|Disease progression/relapse on treatment|5
5961499|NCT01193842|20616135|P3|Phase II: Randomized Groups|Disease progression/relapse on treatment|0
5961500|NCT01193842|20616136|P2|Phase II: Randomized Groups|Disease progression/relapse on treatment|0
5961501|NCT01193842|20616137|P1|Phase II: Randomized Groups|Disease progression/relapse on treatment|0
5961502|NCT01193842|20616133|P5|Phase II: Randomized Groups|Ineligible|1
5961503|NCT01193842|20616134|P4|Phase II: Randomized Groups|Ineligible|0
5961504|NCT01193842|20616135|P3|Phase II: Randomized Groups|Ineligible|0
5961505|NCT01193842|20616136|P2|Phase II: Randomized Groups|Ineligible|0
5961506|NCT01193842|20616137|P1|Phase II: Randomized Groups|Ineligible|0
5961507|NCT01193842|20616133|P5|Phase II: Randomized Groups|Withdrawal by Subject|2
5961508|NCT01193842|20616134|P4|Phase II: Randomized Groups|Withdrawal by Subject|1
5961509|NCT01193842|20616135|P3|Phase II: Randomized Groups|Withdrawal by Subject|0
5961510|NCT01193842|20616136|P2|Phase II: Randomized Groups|Withdrawal by Subject|0
5961511|NCT01193842|20616137|P1|Phase II: Randomized Groups|Withdrawal by Subject|0
5961512|NCT01193842|20616133|P5|Phase II: Randomized Groups|Adverse Event|3
5961513|NCT01193842|20616134|P4|Phase II: Randomized Groups|Adverse Event|5
5961514|NCT01193842|20616135|P3|Phase II: Randomized Groups|Adverse Event|0
5961515|NCT01193842|20616136|P2|Phase II: Randomized Groups|Adverse Event|0
5961516|NCT01193842|20616137|P1|Phase II: Randomized Groups|Adverse Event|0
5961517|NCT01193842|20616133|P5|Phase II: Randomized Groups|Death|1
5961518|NCT01193842|20616134|P4|Phase II: Randomized Groups|Death|1
5961519|NCT01193842|20616135|P3|Phase II: Randomized Groups|Death|0
5961520|NCT01193842|20616136|P2|Phase II: Randomized Groups|Death|0
5961521|NCT01193842|20616137|P1|Phase II: Randomized Groups|Death|0
5961522|NCT01193842|20616133|P5|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0
5961523|NCT01193842|20616134|P4|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0
5961524|NCT01193842|20616135|P3|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|1
5961525|NCT01193842|20616136|P2|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0
5961526|NCT01193842|20616137|P1|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0
5961527|NCT01193842|20616133|P5|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0
5961528|NCT01193842|20616134|P4|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0
5961529|NCT01193842|20616135|P3|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0
5961530|NCT01193842|20616136|P2|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0
5961531|NCT01193842|20616137|P1|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|1
5961532|NCT01193842|20616133|P5|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0
5961533|NCT01193842|20616134|P4|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0
5961534|NCT01193842|20616135|P3|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0
5961535|NCT01193842|20616136|P2|Phase I: VR-DA-EPOCH, DL 2|Ineligible|1
5961536|NCT01193842|20616137|P1|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0
5961537|NCT01193686|20616172|P2|Overall Study|Removed by Investigators; unable to matc|0
5961538|NCT01193686|20616173|P1|Overall Study|Removed by Investigators; unable to matc|3
5961539|NCT01193686|20616172|P2|Overall Study|Withdrawal by Subject|1
5961540|NCT01193686|20616173|P1|Overall Study|Withdrawal by Subject|4
5961541|NCT01193660|20616190|P3|Overall Study|Physician Decision|1
5961542|NCT01193660|20616191|P2|Overall Study|Physician Decision|0
5961543|NCT01193660|20616192|P1|Overall Study|Physician Decision|1
5961544|NCT01193660|20616190|P3|Overall Study|Death|0
5961545|NCT01193660|20616191|P2|Overall Study|Death|0
5961546|NCT01193660|20616192|P1|Overall Study|Death|1
5961547|NCT01193660|20616190|P3|Overall Study|Withdrawal by Subject|1
5961548|NCT01193660|20616191|P2|Overall Study|Withdrawal by Subject|3
5961549|NCT01193660|20616192|P1|Overall Study|Withdrawal by Subject|2
5961550|NCT01193608|20616236|P6|Overall Study|Adverse Event|0
5961551|NCT01193608|20616237|P5|Overall Study|Adverse Event|1
5961552|NCT01193608|20616238|P4|Overall Study|Adverse Event|0
5961553|NCT01193608|20616239|P3|Overall Study|Adverse Event|0
5961554|NCT01193608|20616240|P2|Overall Study|Adverse Event|0
5961555|NCT01193608|20616241|P1|Overall Study|Adverse Event|0
5961556|NCT01193608|20616236|P6|Overall Study|Lost to Follow-up|2
5961557|NCT01193608|20616237|P5|Overall Study|Lost to Follow-up|1
5961558|NCT01193608|20616238|P4|Overall Study|Lost to Follow-up|0
5961559|NCT01193608|20616239|P3|Overall Study|Lost to Follow-up|0
5961560|NCT01193608|20616240|P2|Overall Study|Lost to Follow-up|0
5961561|NCT01193608|20616241|P1|Overall Study|Lost to Follow-up|0
5961562|NCT01193608|20616236|P6|Overall Study|Withdrawal by Subject|0
5961563|NCT01193608|20616237|P5|Overall Study|Withdrawal by Subject|3
5961564|NCT01193608|20616238|P4|Overall Study|Withdrawal by Subject|3
5961565|NCT01193608|20616239|P3|Overall Study|Withdrawal by Subject|2
5961566|NCT01193608|20616240|P2|Overall Study|Withdrawal by Subject|1
5961567|NCT01193608|20616241|P1|Overall Study|Withdrawal by Subject|0
5961568|NCT01193608|20616236|P6|Overall Study|Other|0
5961569|NCT01193608|20616237|P5|Overall Study|Other|0
5961570|NCT01193608|20616238|P4|Overall Study|Other|0
5961571|NCT01193608|20616239|P3|Overall Study|Other|0
5961572|NCT01193608|20616240|P2|Overall Study|Other|1
5961573|NCT01193608|20616241|P1|Overall Study|Other|0
5961574|NCT01193582|20616478|P4|12 Month Follow-up|Withdrawal by Subject|11
5961575|NCT01193582|20616479|P3|12 Month Follow-up|Withdrawal by Subject|3
5961576|NCT01193582|20616480|P2|12 Month Follow-up|Withdrawal by Subject|0
5961577|NCT01193582|20616481|P1|12 Month Follow-up|Withdrawal by Subject|6
5961578|NCT01193582|20616478|P4|12 Month Follow-up|Death|0
5961579|NCT01193582|20616479|P3|12 Month Follow-up|Death|1
5961580|NCT01193582|20616480|P2|12 Month Follow-up|Death|0
5961581|NCT01193582|20616481|P1|12 Month Follow-up|Death|0
5961582|NCT01193582|20616478|P4|Vaccination Series|Withdrawal by Subject|3
5961583|NCT01193582|20616479|P3|Vaccination Series|Withdrawal by Subject|8
5961584|NCT01193582|20616480|P2|Vaccination Series|Withdrawal by Subject|13
5961585|NCT01193582|20616481|P1|Vaccination Series|Withdrawal by Subject|11
5961586|NCT01193556|20616511|P2|Overall Study|Study termination|25
5961587|NCT01193556|20616512|P1|Overall Study|Study termination|26
5961588|NCT01193530|20616522|P2|Overall Study|Non-Compliance|1
5961589|NCT01193530|20616523|P1|Overall Study|Non-Compliance|0
5961590|NCT01193530|20616522|P2|Overall Study|Returned home - out of state|1
5961591|NCT01193530|20616523|P1|Overall Study|Returned home - out of state|0
5961592|NCT01193530|20616522|P2|Overall Study|Lost Light Box|1
5961593|NCT01193530|20616523|P1|Overall Study|Lost Light Box|0
5961594|NCT01193530|20616522|P2|Overall Study|Began Contraindicated Therapy|0
5961595|NCT01193530|20616523|P1|Overall Study|Began Contraindicated Therapy|1
5961596|NCT01193530|20616522|P2|Overall Study|Withdrawal by Subject|2
5961597|NCT01193530|20616523|P1|Overall Study|Withdrawal by Subject|2
5961598|NCT01193517|20616532|P3|Overall Study|Early Progression|0
5961599|NCT01193517|20616533|P2|Overall Study|Early Progression|0
5961600|NCT01193517|20616534|P1|Overall Study|Early Progression|1
5961601|NCT01193348|20616543|P1|Post Treatment Period (Patients Who Disc|Patient did not return for visit|2
5961602|NCT01193348|20616543|P1|Extension Treatment Period|Physician Decision|1
5961603|NCT01193348|20616543|P1|Treatment Period (26 Weeks)|Patient Requested to Withdraw|1
5961604|NCT01193348|20616543|P1|Treatment Period (26 Weeks)|Serious Adverse Event|1
5961605|NCT01193348|20616543|P1|Treatment Period (26 Weeks)|Positive Shiga-Toxin Result vial Local|1
5961606|NCT01193348|20616543|P1|Screening Period|Screen Failure|5
5961607|NCT01193335|20616563|P2|2-Year Follow-up|No Longer Met Eligibility Criteria|2
5961608|NCT01193335|20616564|P1|2-Year Follow-up|No Longer Met Eligibility Criteria|2
5961609|NCT01193335|20616563|P2|2-Year Follow-up|No Longer Willing to Participate|6
5961610|NCT01193335|20616564|P1|2-Year Follow-up|No Longer Willing to Participate|5
5961611|NCT01193335|20616563|P2|1-Year Follow-up|Lost to Follow-up|0
5961612|NCT01193335|20616564|P1|1-Year Follow-up|Lost to Follow-up|4
5961613|NCT01193335|20616563|P2|1-Year Follow-up|No Longer Willing to Participate|9
5961614|NCT01193335|20616564|P1|1-Year Follow-up|No Longer Willing to Participate|7
5961615|NCT01193335|20616563|P2|After Infant Series|No Longer Met Eligibility Criteria|1
5961616|NCT01193335|20616564|P1|After Infant Series|No Longer Met Eligibility Criteria|0
5961617|NCT01193335|20616563|P2|After Infant Series|Lost to Follow-up|2
5961618|NCT01193335|20616564|P1|After Infant Series|Lost to Follow-up|1
5961619|NCT01193283|20616659|P1|Overall Study|Death|1
5961620|NCT01193257|20616665|P2|Overall Study|Unblinded due to futility|251
5961621|NCT01193257|20616666|P1|Overall Study|Unblinded due to futility|135
5961622|NCT01193257|20616665|P2|Overall Study|Lost to Follow-up|3
5961623|NCT01193257|20616666|P1|Overall Study|Lost to Follow-up|2
5961624|NCT01193257|20616665|P2|Overall Study|Withdrawal by Subject|86
5961625|NCT01193257|20616666|P1|Overall Study|Withdrawal by Subject|26
5961626|NCT01193257|20616665|P2|Overall Study|Study termination by sponsor|3
5961627|NCT01193257|20616666|P1|Overall Study|Study termination by sponsor|0
5961628|NCT01193257|20616665|P2|Overall Study|Death|391
5961629|NCT01193257|20616666|P1|Overall Study|Death|202
5961630|NCT01193244|20616716|P2|Overall Study|Lost to Follow-up|15
5961631|NCT01193244|20616717|P1|Overall Study|Lost to Follow-up|6
5961632|NCT01193244|20616716|P2|Overall Study|Other|278
5961633|NCT01193244|20616717|P1|Overall Study|Other|303
5961634|NCT01193244|20616716|P2|Overall Study|Withdrawal by Subject|97
5961635|NCT01193244|20616717|P1|Overall Study|Withdrawal by Subject|79
5961636|NCT01193218|20616772|P8|12-52 Weeks|Other reason than above|0
5961637|NCT01193218|20616773|P7|12-52 Weeks|Other reason than above|0
5961638|NCT01193218|20616774|P6|12-52 Weeks|Other reason than above|0
5961639|NCT01193218|20616775|P5|12-52 Weeks|Other reason than above|1
5961640|NCT01193218|20616776|P4|12-52 Weeks|Other reason than above|1
5961641|NCT01193218|20616777|P3|12-52 Weeks|Other reason than above|0
5961642|NCT01193218|20616778|P2|12-52 Weeks|Other reason than above|0
5961643|NCT01193218|20616779|P1|12-52 Weeks|Other reason than above|1
5961644|NCT01193218|20616772|P8|12-52 Weeks|Withdrawal by Subject|2
5961645|NCT01193218|20616773|P7|12-52 Weeks|Withdrawal by Subject|1
5961646|NCT01193218|20616774|P6|12-52 Weeks|Withdrawal by Subject|2
5961647|NCT01193218|20616775|P5|12-52 Weeks|Withdrawal by Subject|0
5961648|NCT01193218|20616776|P4|12-52 Weeks|Withdrawal by Subject|0
5961649|NCT01193218|20616777|P3|12-52 Weeks|Withdrawal by Subject|3
5961650|NCT01193218|20616778|P2|12-52 Weeks|Withdrawal by Subject|0
5961651|NCT01193218|20616779|P1|12-52 Weeks|Withdrawal by Subject|3
5961652|NCT01193218|20616772|P8|12-52 Weeks|Lack of Efficacy|0
5961653|NCT01193218|20616773|P7|12-52 Weeks|Lack of Efficacy|1
5961654|NCT01193218|20616774|P6|12-52 Weeks|Lack of Efficacy|0
5961655|NCT01193218|20616775|P5|12-52 Weeks|Lack of Efficacy|0
5961656|NCT01193218|20616776|P4|12-52 Weeks|Lack of Efficacy|0
5961657|NCT01193218|20616777|P3|12-52 Weeks|Lack of Efficacy|0
5961658|NCT01193218|20616778|P2|12-52 Weeks|Lack of Efficacy|0
5961659|NCT01193218|20616779|P1|12-52 Weeks|Lack of Efficacy|0
5961660|NCT01193218|20616772|P8|12-52 Weeks|Adverse Event|2
5961661|NCT01193218|20616773|P7|12-52 Weeks|Adverse Event|1
5961662|NCT01193218|20616774|P6|12-52 Weeks|Adverse Event|3
5961663|NCT01193218|20616775|P5|12-52 Weeks|Adverse Event|3
5961664|NCT01193218|20616776|P4|12-52 Weeks|Adverse Event|2
5961665|NCT01193218|20616777|P3|12-52 Weeks|Adverse Event|1
5961666|NCT01193218|20616778|P2|12-52 Weeks|Adverse Event|0
5961667|NCT01193218|20616779|P1|12-52 Weeks|Adverse Event|1
5961668|NCT01193218|20616772|P8|0-12 Weeks|Withdrawal by Subject|0
5961669|NCT01193218|20616773|P7|0-12 Weeks|Withdrawal by Subject|1
5961670|NCT01193218|20616774|P6|0-12 Weeks|Withdrawal by Subject|0
5961671|NCT01193218|20616775|P5|0-12 Weeks|Withdrawal by Subject|0
5961672|NCT01193218|20616776|P4|0-12 Weeks|Withdrawal by Subject|0
5961673|NCT01193218|20616777|P3|0-12 Weeks|Withdrawal by Subject|2
5961674|NCT01193218|20616778|P2|0-12 Weeks|Withdrawal by Subject|0
5961675|NCT01193218|20616779|P1|0-12 Weeks|Withdrawal by Subject|3
5961676|NCT01193218|20616772|P8|0-12 Weeks|Protocol Violation|0
5961677|NCT01193218|20616773|P7|0-12 Weeks|Protocol Violation|0
5961678|NCT01193218|20616774|P6|0-12 Weeks|Protocol Violation|1
5961679|NCT01193218|20616775|P5|0-12 Weeks|Protocol Violation|1
5961680|NCT01193218|20616776|P4|0-12 Weeks|Protocol Violation|0
5961681|NCT01193218|20616777|P3|0-12 Weeks|Protocol Violation|0
5961682|NCT01193218|20616778|P2|0-12 Weeks|Protocol Violation|0
5961683|NCT01193218|20616779|P1|0-12 Weeks|Protocol Violation|0
5961684|NCT01193218|20616772|P8|0-12 Weeks|Adverse Event|0
5961685|NCT01193218|20616773|P7|0-12 Weeks|Adverse Event|2
5961686|NCT01193218|20616774|P6|0-12 Weeks|Adverse Event|2
5961687|NCT01193218|20616775|P5|0-12 Weeks|Adverse Event|0
5961688|NCT01193218|20616776|P4|0-12 Weeks|Adverse Event|0
5961689|NCT01193218|20616777|P3|0-12 Weeks|Adverse Event|1
5961690|NCT01193218|20616778|P2|0-12 Weeks|Adverse Event|0
5961691|NCT01193218|20616779|P1|0-12 Weeks|Adverse Event|6
5961692|NCT01193153|20616810|P2|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|3
5961693|NCT01193153|20616811|P1|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|1
5961694|NCT01193153|20616810|P2|Double Blind Relapse Prevention Period|Experienced Relapse|57
5961695|NCT01193153|20616811|P1|Double Blind Relapse Prevention Period|Experienced Relapse|25
5961696|NCT01193153|20616810|P2|Double Blind Relapse Prevention Period|Withdrawal by Subject|30
5961697|NCT01193153|20616811|P1|Double Blind Relapse Prevention Period|Withdrawal by Subject|19
5961698|NCT01193153|20616810|P2|Double Blind Relapse Prevention Period|Pregnancy|0
5961699|NCT01193153|20616811|P1|Double Blind Relapse Prevention Period|Pregnancy|1
5961700|NCT01193153|20616810|P2|Double Blind Relapse Prevention Period|Lost to Follow-up|9
5961701|NCT01193153|20616811|P1|Double Blind Relapse Prevention Period|Lost to Follow-up|2
5961702|NCT01193153|20616810|P2|Double Blind Relapse Prevention Period|Death|0
5961703|NCT01193153|20616811|P1|Double Blind Relapse Prevention Period|Death|2
5961704|NCT01193153|20616810|P2|Double Blind Relapse Prevention Period|Adverse Event|3
5961705|NCT01193153|20616811|P1|Double Blind Relapse Prevention Period|Adverse Event|12
5961706|NCT01193153|20616810|P2|Double Blind Relapse Prevention Period|Other|3
5961707|NCT01193153|20616811|P1|Double Blind Relapse Prevention Period|Other|2
5961708|NCT01193153|20616810|P2|Open-label Stabilization Period|Other|0
5961709|NCT01193153|20616811|P1|Open-label Stabilization Period|Other|8
5961710|NCT01193153|20616810|P2|Open-label Stabilization Period|Subject Failed Stabilization Criteria|0
5961711|NCT01193153|20616811|P1|Open-label Stabilization Period|Subject Failed Stabilization Criteria|35
5961712|NCT01193153|20616810|P2|Open-label Stabilization Period|Withdrawal by Subject|0
5961713|NCT01193153|20616811|P1|Open-label Stabilization Period|Withdrawal by Subject|29
5961714|NCT01193153|20616810|P2|Open-label Stabilization Period|Lack of Efficacy|0
5961715|NCT01193153|20616811|P1|Open-label Stabilization Period|Lack of Efficacy|5
5961716|NCT01193153|20616810|P2|Open-label Stabilization Period|Lost to Follow-up|0
5961717|NCT01193153|20616811|P1|Open-label Stabilization Period|Lost to Follow-up|10
5961718|NCT01193153|20616810|P2|Open-label Stabilization Period|Death|0
5961719|NCT01193153|20616811|P1|Open-label Stabilization Period|Death|2
5961720|NCT01193153|20616810|P2|Open-label Stabilization Period|Adverse Event|0
5961721|NCT01193153|20616811|P1|Open-label Stabilization Period|Adverse Event|9
5961722|NCT01193153|20616810|P2|Open-label Lead in Period|Lack of Efficacy|0
5961723|NCT01193153|20616811|P1|Open-label Lead in Period|Lack of Efficacy|26
5961724|NCT01193153|20616810|P2|Open-label Lead in Period|Death|0
5961725|NCT01193153|20616811|P1|Open-label Lead in Period|Death|1
5961726|NCT01193153|20616810|P2|Open-label Lead in Period|Adverse Event|0
5961727|NCT01193153|20616811|P1|Open-label Lead in Period|Adverse Event|41
5961728|NCT01193153|20616810|P2|Open-label Lead in Period|Subject Failed Stabilization Criteria|0
5961729|NCT01193153|20616811|P1|Open-label Lead in Period|Subject Failed Stabilization Criteria|47
5961730|NCT01193153|20616810|P2|Open-label Lead in Period|Other|0
5961731|NCT01193153|20616811|P1|Open-label Lead in Period|Other|14
5961732|NCT01193153|20616810|P2|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|0
5961733|NCT01193153|20616811|P1|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|4
5961734|NCT01193153|20616810|P2|Open-label Lead in Period|Withdrawal by Subject|0
5961735|NCT01193153|20616811|P1|Open-label Lead in Period|Withdrawal by Subject|69
5961736|NCT01193153|20616810|P2|Open-label Lead in Period|Pregnancy|0
5961737|NCT01193153|20616811|P1|Open-label Lead in Period|Pregnancy|1
5961738|NCT01193153|20616810|P2|Open-label Lead in Period|Lost to Follow-up|0
5961739|NCT01193153|20616811|P1|Open-label Lead in Period|Lost to Follow-up|32
5961740|NCT01193127|20616846|P4|Treated|Withdrawal by Subject|1
5961741|NCT01193127|20616847|P3|Treated|Withdrawal by Subject|0
5961742|NCT01193127|20616848|P2|Treated|Withdrawal by Subject|0
5961743|NCT01193127|20616849|P1|Treated|Withdrawal by Subject|0
5961744|NCT01193127|20616846|P4|Randomized|Surgery Cancelled|1
5961745|NCT01193127|20616847|P3|Randomized|Surgery Cancelled|0
5961746|NCT01193127|20616848|P2|Randomized|Surgery Cancelled|0
5961747|NCT01193127|20616849|P1|Randomized|Surgery Cancelled|0
5961748|NCT01193101|20617174|P4|Overall Study|Abnormal test procedure results|0
5961749|NCT01193101|20617175|P3|Overall Study|Abnormal test procedure results|0
5961750|NCT01193101|20617176|P2|Overall Study|Abnormal test procedure results|1
5961751|NCT01193101|20617177|P1|Overall Study|Abnormal test procedure results|0
5961752|NCT01193101|20617174|P4|Overall Study|Administrative problems|0
5961753|NCT01193101|20617175|P3|Overall Study|Administrative problems|1
5961754|NCT01193101|20617176|P2|Overall Study|Administrative problems|0
5961755|NCT01193101|20617177|P1|Overall Study|Administrative problems|0
5961756|NCT01193101|20617174|P4|Overall Study|Withdrawal by Subject|1
5961757|NCT01193101|20617175|P3|Overall Study|Withdrawal by Subject|1
5961758|NCT01193101|20617176|P2|Overall Study|Withdrawal by Subject|4
5961759|NCT01193101|20617177|P1|Overall Study|Withdrawal by Subject|2
5961760|NCT01193101|20617174|P4|Overall Study|Lack of Efficacy|8
5961761|NCT01193101|20617175|P3|Overall Study|Lack of Efficacy|0
5961762|NCT01193101|20617176|P2|Overall Study|Lack of Efficacy|1
5961763|NCT01193101|20617177|P1|Overall Study|Lack of Efficacy|3
5961764|NCT01193101|20617174|P4|Overall Study|Adverse Event|3
5961765|NCT01193101|20617175|P3|Overall Study|Adverse Event|1
5961766|NCT01193101|20617176|P2|Overall Study|Adverse Event|1
5961767|NCT01193101|20617177|P1|Overall Study|Adverse Event|0
5961768|NCT01192815|20617294|P1|Overall Study|Lack of Efficacy|1
5961769|NCT01192815|20617294|P1|Overall Study|Withdrawal by Subject|1
5961770|NCT01192776|20617309|P4|Overall Study|Lost to Follow-up|5
5961771|NCT01192776|20617310|P3|Overall Study|Lost to Follow-up|3
5961772|NCT01192776|20617311|P2|Overall Study|Lost to Follow-up|6
5961773|NCT01192776|20617312|P1|Overall Study|Lost to Follow-up|3
5961774|NCT01192776|20617309|P4|Overall Study|Death|15
5961775|NCT01192776|20617310|P3|Overall Study|Death|18
5961776|NCT01192776|20617311|P2|Overall Study|Death|15
5961777|NCT01192776|20617312|P1|Overall Study|Death|8
5961778|NCT01192516|20617390|P3|Overall Study|Unable to follow Actiwatch instructions|0
5961779|NCT01192516|20617391|P2|Overall Study|Unable to follow Actiwatch instructions|2
5961780|NCT01192516|20617392|P1|Overall Study|Unable to follow Actiwatch instructions|4
5961781|NCT01192516|20617390|P3|Overall Study|started new treatment|0
5961782|NCT01192516|20617391|P2|Overall Study|started new treatment|1
5961783|NCT01192516|20617392|P1|Overall Study|started new treatment|5
5961784|NCT01192516|20617390|P3|Overall Study|Withdrawal by Subject|1
5961785|NCT01192516|20617391|P2|Overall Study|Withdrawal by Subject|4
5961786|NCT01192516|20617392|P1|Overall Study|Withdrawal by Subject|4
5961787|NCT01192516|20617390|P3|Overall Study|Lost to Follow-up|7
5961788|NCT01192516|20617391|P2|Overall Study|Lost to Follow-up|10
5961789|NCT01192516|20617392|P1|Overall Study|Lost to Follow-up|7
5961790|NCT01192412|20617426|P2|Overall Study|Withdrawal by Subject|1
5961791|NCT01192412|20617427|P1|Overall Study|Withdrawal by Subject|2
5961792|NCT01192412|20617426|P2|Overall Study|Lost to Follow-up|1
5961793|NCT01192412|20617427|P1|Overall Study|Lost to Follow-up|2
5961794|NCT01192399|20617435|P1|Overall Study|Lack of Efficacy|2
5961795|NCT01192347|20617445|P1|Overall Study|Patient did not show up for visits|1
5961796|NCT01192347|20617445|P1|Overall Study|Patient not visiting hospital regularly|1
5961797|NCT01192347|20617445|P1|Overall Study|Patient seen in different hospital|1
5961798|NCT01192347|20617445|P1|Overall Study|Suspected serious adverse drug reaction|1
5961799|NCT01192347|20617445|P1|Overall Study|Adverse Event|1
5961800|NCT01192347|20617445|P1|Overall Study|Withdrawal by Subject|1
5961801|NCT01192347|20617445|P1|Overall Study|Lost to Follow-up|3
5961802|NCT01192347|20617445|P1|Overall Study|Death|3
5961803|NCT01192295|20617468|P2|Overall Study|Administrative|6
5961804|NCT01192295|20617469|P1|Overall Study|Administrative|4
5961805|NCT01192295|20617468|P2|Overall Study|Lack of Efficacy|5
5961806|NCT01192295|20617469|P1|Overall Study|Lack of Efficacy|0
5961807|NCT01192295|20617468|P2|Overall Study|Lost to Follow-up|1
5961808|NCT01192295|20617469|P1|Overall Study|Lost to Follow-up|0
5961809|NCT01192295|20617468|P2|Overall Study|Withdrawal by Subject|4
5961810|NCT01192295|20617469|P1|Overall Study|Withdrawal by Subject|3
5961811|NCT01192295|20617468|P2|Overall Study|Adverse Event|7
5961812|NCT01192295|20617469|P1|Overall Study|Adverse Event|3
5961813|NCT01192204|20617507|P2|Overall Study|could not keep recall appointments|0
5961814|NCT01192204|20617508|P1|Overall Study|could not keep recall appointments|1
5961815|NCT01192191|20617520|P2|Overall Study|Withdrawal by Subject|6
5961816|NCT01192191|20617521|P1|Overall Study|Withdrawal by Subject|1
5961817|NCT01192191|20617520|P2|Overall Study|Lost to Follow-up|1
5961818|NCT01192191|20617521|P1|Overall Study|Lost to Follow-up|0
5961819|NCT01192191|20617520|P2|Overall Study|Participants Reached Stopping Criteria|2
5961820|NCT01192191|20617521|P1|Overall Study|Participants Reached Stopping Criteria|3
5961821|NCT01192191|20617520|P2|Overall Study|Adverse Event|12
5961822|NCT01192191|20617521|P1|Overall Study|Adverse Event|7
5961823|NCT01192178|20617547|P2|Overall Study|Lack of Efficacy|2
5961824|NCT01192178|20617548|P1|Overall Study|Lack of Efficacy|1
5961825|NCT01192178|20617547|P2|Overall Study|Adverse Event|1
5961826|NCT01192178|20617548|P1|Overall Study|Adverse Event|2
5961827|NCT01192178|20617547|P2|Overall Study|Lost to Follow-up|3
5961828|NCT01192178|20617548|P1|Overall Study|Lost to Follow-up|3
5961829|NCT01192178|20617547|P2|Overall Study|Physician Decision|4
5961830|NCT01192178|20617548|P1|Overall Study|Physician Decision|2
5961831|NCT01192178|20617547|P2|Overall Study|Protocol Violation|3
5961832|NCT01192178|20617548|P1|Overall Study|Protocol Violation|10
5961833|NCT01192178|20617547|P2|Overall Study|Withdrawal by Subject|10
5961834|NCT01192178|20617548|P1|Overall Study|Withdrawal by Subject|6
5961835|NCT01192152|20617568|P2|Period 3|family emergency|0
5961836|NCT01192152|20617569|P1|Period 3|family emergency|1
5961837|NCT01192152|20617568|P2|Period 1|left prematurely (while on treatment B)|1
5961838|NCT01192152|20617569|P1|Period 1|left prematurely (while on treatment B)|0
5961839|NCT01192126|20617740|P2|First Intervention (1 Week)|Lost to Follow-up|1
5961840|NCT01192126|20617741|P1|First Intervention (1 Week)|Lost to Follow-up|1
5961841|NCT01192126|20617740|P2|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|0
5961842|NCT01192126|20617741|P1|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|1
5961843|NCT01192100|20617749|P6|Overall Study|Protocol Violation|0
5961844|NCT01192100|20617750|P5|Overall Study|Protocol Violation|0
5961845|NCT01192100|20617751|P4|Overall Study|Protocol Violation|1
5961846|NCT01192100|20617752|P3|Overall Study|Protocol Violation|0
5961847|NCT01192100|20617753|P2|Overall Study|Protocol Violation|0
5961848|NCT01192100|20617754|P1|Overall Study|Protocol Violation|0
5961849|NCT01192100|20617749|P6|Overall Study|Withdrawal by Subject|0
5961850|NCT01192100|20617750|P5|Overall Study|Withdrawal by Subject|1
5961851|NCT01192100|20617751|P4|Overall Study|Withdrawal by Subject|0
5961852|NCT01192100|20617752|P3|Overall Study|Withdrawal by Subject|0
5961853|NCT01192100|20617753|P2|Overall Study|Withdrawal by Subject|0
5961854|NCT01192100|20617754|P1|Overall Study|Withdrawal by Subject|0
5961855|NCT01192022|20617774|P5|Overall Study|Parents did not allow all follow up|0
5961856|NCT01192022|20617775|P4|Overall Study|Parents did not allow all follow up|1
5961857|NCT01192022|20617776|P3|Overall Study|Parents did not allow all follow up|0
5961858|NCT01192022|20617777|P2|Overall Study|Parents did not allow all follow up|0
5961859|NCT01192022|20617778|P1|Overall Study|Parents did not allow all follow up|0
5961860|NCT01192022|20617774|P5|Overall Study|Patient needed surgery|0
5961861|NCT01192022|20617775|P4|Overall Study|Patient needed surgery|0
5961862|NCT01192022|20617776|P3|Overall Study|Patient needed surgery|0
5961863|NCT01192022|20617777|P2|Overall Study|Patient needed surgery|1
5961864|NCT01192022|20617778|P1|Overall Study|Patient needed surgery|0
5961865|NCT01192022|20617774|P5|Overall Study|Patient too sick from chemotherapy|0
5961866|NCT01192022|20617775|P4|Overall Study|Patient too sick from chemotherapy|0
5961867|NCT01192022|20617776|P3|Overall Study|Patient too sick from chemotherapy|0
5961868|NCT01192022|20617777|P2|Overall Study|Patient too sick from chemotherapy|1
5961869|NCT01192022|20617778|P1|Overall Study|Patient too sick from chemotherapy|0
5961870|NCT01192022|20617774|P5|Overall Study|Physician withdrew-patient hardship|0
5961871|NCT01192022|20617775|P4|Overall Study|Physician withdrew-patient hardship|0
5961872|NCT01192022|20617776|P3|Overall Study|Physician withdrew-patient hardship|0
5961873|NCT01192022|20617777|P2|Overall Study|Physician withdrew-patient hardship|0
5961874|NCT01192022|20617778|P1|Overall Study|Physician withdrew-patient hardship|1
5961875|NCT01192022|20617774|P5|Overall Study|Fatal Adverse Event|1
5961876|NCT01192022|20617775|P4|Overall Study|Fatal Adverse Event|0
5961877|NCT01192022|20617776|P3|Overall Study|Fatal Adverse Event|0
5961878|NCT01192022|20617777|P2|Overall Study|Fatal Adverse Event|6
5961879|NCT01192022|20617778|P1|Overall Study|Fatal Adverse Event|4
5961880|NCT01192022|20617774|P5|Overall Study|Adverse Event|0
5961881|NCT01192022|20617775|P4|Overall Study|Adverse Event|0
5961882|NCT01192022|20617776|P3|Overall Study|Adverse Event|0
5961883|NCT01192022|20617777|P2|Overall Study|Adverse Event|0
5961884|NCT01192022|20617778|P1|Overall Study|Adverse Event|1
5961885|NCT01192022|20617774|P5|Overall Study|Lost to Follow-up|0
5961886|NCT01192022|20617775|P4|Overall Study|Lost to Follow-up|1
5961887|NCT01192022|20617776|P3|Overall Study|Lost to Follow-up|1
5961888|NCT01192022|20617777|P2|Overall Study|Lost to Follow-up|2
5961889|NCT01192022|20617778|P1|Overall Study|Lost to Follow-up|4
5961890|NCT01192022|20617774|P5|Overall Study|Withdrawal of Consent|0
5961891|NCT01192022|20617775|P4|Overall Study|Withdrawal of Consent|0
5961892|NCT01192022|20617776|P3|Overall Study|Withdrawal of Consent|0
5961893|NCT01192022|20617777|P2|Overall Study|Withdrawal of Consent|1
5961894|NCT01192022|20617778|P1|Overall Study|Withdrawal of Consent|3
5961895|NCT01191944|20617801|P2|Overall Study|Other|3
5961896|NCT01191944|20617802|P1|Overall Study|Other|1
5961897|NCT01191944|20617801|P2|Overall Study|Withdrawal by Subject|2
5961898|NCT01191944|20617802|P1|Overall Study|Withdrawal by Subject|4
5961899|NCT01191944|20617801|P2|Overall Study|Protocol Violation|2
5961900|NCT01191944|20617802|P1|Overall Study|Protocol Violation|1
5961901|NCT01191944|20617801|P2|Overall Study|Adverse Event|12
5961902|NCT01191944|20617802|P1|Overall Study|Adverse Event|11
5961903|NCT01191840|20617848|P2|Overall Study|Withdrawal by Subject|0
5961904|NCT01191840|20617849|P1|Overall Study|Withdrawal by Subject|2
5961905|NCT01191840|20617848|P2|Overall Study|lab error speciation - non Staph infecti|1
5961906|NCT01191840|20617849|P1|Overall Study|lab error speciation - non Staph infecti|0
5961907|NCT01191840|20617848|P2|Overall Study|IRB approval lapse|2
5961908|NCT01191840|20617849|P1|Overall Study|IRB approval lapse|0
5961909|NCT01191840|20617848|P2|Overall Study|ineligible at enrollment|0
5961910|NCT01191840|20617849|P1|Overall Study|ineligible at enrollment|1
5961911|NCT01191840|20617848|P2|Overall Study|Non Staph Infection|3
5961912|NCT01191840|20617849|P1|Overall Study|Non Staph Infection|4
5961913|NCT01191840|20617848|P2|Overall Study|Lost to Follow-up|6
5961914|NCT01191840|20617849|P1|Overall Study|Lost to Follow-up|4
5961915|NCT01191840|20617848|P2|Overall Study|Subject discontinued treatment|2
5961916|NCT01191840|20617849|P1|Overall Study|Subject discontinued treatment|1
5961917|NCT01191840|20617848|P2|Overall Study|withdrew consent|1
5961918|NCT01191840|20617849|P1|Overall Study|withdrew consent|2
5961919|NCT01191801|20617874|P2|Overall Study|Not Provided|27
5961920|NCT01191801|20617875|P1|Overall Study|Not Provided|45
5961921|NCT01191801|20617874|P2|Overall Study|Withdrawal by Subject|4
5961922|NCT01191801|20617875|P1|Overall Study|Withdrawal by Subject|1
5961923|NCT01191801|20617874|P2|Overall Study|Physician Decision|24
5961924|NCT01191801|20617875|P1|Overall Study|Physician Decision|47
5961925|NCT01191801|20617874|P2|Overall Study|Protocol Violation|4
5961926|NCT01191801|20617875|P1|Overall Study|Protocol Violation|2
5961927|NCT01191801|20617874|P2|Overall Study|Adverse Event|8
5961928|NCT01191801|20617875|P1|Overall Study|Adverse Event|9
5961929|NCT01191801|20617874|P2|Overall Study|Lack of Efficacy|258
5961930|NCT01191801|20617875|P1|Overall Study|Lack of Efficacy|176
5961931|NCT01191801|20617874|P2|Overall Study|Death|12
5961932|NCT01191801|20617875|P1|Overall Study|Death|36
5961933|NCT01191788|20617895|P2|Overall Study|Lost to Follow-up|22
5961934|NCT01191788|20617896|P1|Overall Study|Lost to Follow-up|21
5961935|NCT01191762|20617906|P2|Overall Study|Adverse Event|0
5961936|NCT01191762|20617907|P1|Overall Study|Adverse Event|1
5961937|NCT01191268|20618065|P3|Overall Study|Sponsor Decision|0
5961938|NCT01191268|20618066|P2|Overall Study|Sponsor Decision|2
5961939|NCT01191268|20618067|P1|Overall Study|Sponsor Decision|0
5961940|NCT01191268|20618065|P3|Overall Study|Protocol Violation|1
5961941|NCT01191268|20618066|P2|Overall Study|Protocol Violation|0
5961942|NCT01191268|20618067|P1|Overall Study|Protocol Violation|1
5961943|NCT01191268|20618065|P3|Overall Study|Death|3
5961944|NCT01191268|20618066|P2|Overall Study|Death|1
5961945|NCT01191268|20618067|P1|Overall Study|Death|0
5961946|NCT01191268|20618065|P3|Overall Study|Entry Criteria Not Met|1
5961947|NCT01191268|20618066|P2|Overall Study|Entry Criteria Not Met|1
5961948|NCT01191268|20618067|P1|Overall Study|Entry Criteria Not Met|3
5961949|NCT01191268|20618065|P3|Overall Study|Lost to Follow-up|9
5961950|NCT01191268|20618066|P2|Overall Study|Lost to Follow-up|5
5961951|NCT01191268|20618067|P1|Overall Study|Lost to Follow-up|8
5961952|NCT01191268|20618065|P3|Overall Study|Physician Decision|9
5961953|NCT01191268|20618066|P2|Overall Study|Physician Decision|8
5961954|NCT01191268|20618067|P1|Overall Study|Physician Decision|6
5961955|NCT01191268|20618065|P3|Overall Study|Adverse Event|8
5961956|NCT01191268|20618066|P2|Overall Study|Adverse Event|13
5961957|NCT01191268|20618067|P1|Overall Study|Adverse Event|21
5961958|NCT01191268|20618065|P3|Overall Study|Withdrawal by Subject|21
5961959|NCT01191268|20618066|P2|Overall Study|Withdrawal by Subject|25
5961960|NCT01191268|20618067|P1|Overall Study|Withdrawal by Subject|19
5961961|NCT01191190|20618208|P1|Overall Study|Withdrawal by Subject|1
5961962|NCT01191086|20618221|P1|Overall Study|Other|1
5961963|NCT01191086|20618221|P1|Overall Study|Discontinuation criterion met|1
5961964|NCT01191086|20618221|P1|Overall Study|Withdrawal by Subject|24
5961965|NCT01191086|20618221|P1|Overall Study|Physician Decision|2
5961966|NCT01191086|20618221|P1|Overall Study|Lost to Follow-up|4
5961967|NCT01191086|20618221|P1|Overall Study|Lack of Efficacy|10
5961968|NCT01191086|20618221|P1|Overall Study|Adverse Event|20
5961971|NCT01190930|20618233|P10|Maintenance|Still on therapy|0
5961972|NCT01190930|20618234|P9|Maintenance|Still on therapy|0
5961973|NCT01190930|20618235|P8|Maintenance|Still on therapy|0
5961974|NCT01190930|20618236|P7|Maintenance|Still on therapy|0
5961975|NCT01190930|20618237|P6|Maintenance|Still on therapy|0
5961976|NCT01190930|20618238|P5|Maintenance|Still on therapy|0
5961977|NCT01190930|20618239|P4|Maintenance|Still on therapy|29
5961978|NCT01190930|20618240|P3|Maintenance|Still on therapy|0
5961979|NCT01190930|20618241|P2|Maintenance|Still on therapy|8
5961980|NCT01190930|20618242|P1|Maintenance|Still on therapy|0
5961981|NCT01190930|20618233|P10|Maintenance|Relapse|11
5961982|NCT01190930|20618234|P9|Maintenance|Relapse|11
5961983|NCT01190930|20618235|P8|Maintenance|Relapse|13
5961984|NCT01190930|20618236|P7|Maintenance|Relapse|6
5961985|NCT01190930|20618237|P6|Maintenance|Relapse|1
5961986|NCT01190930|20618238|P5|Maintenance|Relapse|0
5961987|NCT01190930|20618239|P4|Maintenance|Relapse|2
5961988|NCT01190930|20618240|P3|Maintenance|Relapse|0
5961989|NCT01190930|20618241|P2|Maintenance|Relapse|0
5961990|NCT01190930|20618242|P1|Maintenance|Relapse|0
5961991|NCT01190930|20618233|P10|Maintenance|Enrollment onto another COG Protocol|0
5961992|NCT01190930|20618234|P9|Maintenance|Enrollment onto another COG Protocol|1
5961993|NCT01190930|20618235|P8|Maintenance|Enrollment onto another COG Protocol|0
5961994|NCT01190930|20618236|P7|Maintenance|Enrollment onto another COG Protocol|0
5961995|NCT01190930|20618237|P6|Maintenance|Enrollment onto another COG Protocol|0
5961996|NCT01190930|20618238|P5|Maintenance|Enrollment onto another COG Protocol|0
5961997|NCT01190930|20618239|P4|Maintenance|Enrollment onto another COG Protocol|0
5961998|NCT01190930|20618240|P3|Maintenance|Enrollment onto another COG Protocol|0
5961999|NCT01190930|20618241|P2|Maintenance|Enrollment onto another COG Protocol|0
5962000|NCT01190930|20618242|P1|Maintenance|Enrollment onto another COG Protocol|0
5962001|NCT01190930|20618233|P10|Maintenance|Inevaluable|0
5962002|NCT01190930|20618234|P9|Maintenance|Inevaluable|0
5962003|NCT01190930|20618235|P8|Maintenance|Inevaluable|1
5962004|NCT01190930|20618236|P7|Maintenance|Inevaluable|1
5962005|NCT01190930|20618237|P6|Maintenance|Inevaluable|1
5962006|NCT01190930|20618238|P5|Maintenance|Inevaluable|0
5962007|NCT01190930|20618239|P4|Maintenance|Inevaluable|0
5962008|NCT01190930|20618240|P3|Maintenance|Inevaluable|0
5962009|NCT01190930|20618241|P2|Maintenance|Inevaluable|0
5962010|NCT01190930|20618242|P1|Maintenance|Inevaluable|0
5962011|NCT01190930|20618233|P10|Maintenance|second malignant neoplasm|0
5962012|NCT01190930|20618234|P9|Maintenance|second malignant neoplasm|1
5962013|NCT01190930|20618235|P8|Maintenance|second malignant neoplasm|0
5962014|NCT01190930|20618236|P7|Maintenance|second malignant neoplasm|0
5962015|NCT01190930|20618237|P6|Maintenance|second malignant neoplasm|1
5962016|NCT01190930|20618238|P5|Maintenance|second malignant neoplasm|0
5962017|NCT01190930|20618239|P4|Maintenance|second malignant neoplasm|1
5962018|NCT01190930|20618240|P3|Maintenance|second malignant neoplasm|0
5962019|NCT01190930|20618241|P2|Maintenance|second malignant neoplasm|0
5962020|NCT01190930|20618242|P1|Maintenance|second malignant neoplasm|0
5962021|NCT01190930|20618233|P10|Maintenance|Refusal|6
5962022|NCT01190930|20618234|P9|Maintenance|Refusal|13
5962023|NCT01190930|20618235|P8|Maintenance|Refusal|17
5962024|NCT01190930|20618236|P7|Maintenance|Refusal|5
5962025|NCT01190930|20618237|P6|Maintenance|Refusal|4
5962026|NCT01190930|20618238|P5|Maintenance|Refusal|0
5962027|NCT01190930|20618239|P4|Maintenance|Refusal|2
5962028|NCT01190930|20618240|P3|Maintenance|Refusal|0
5962029|NCT01190930|20618241|P2|Maintenance|Refusal|1
5962030|NCT01190930|20618242|P1|Maintenance|Refusal|0
5962031|NCT01190930|20618233|P10|Maintenance|Withdrawal by Subject|1
5962032|NCT01190930|20618234|P9|Maintenance|Withdrawal by Subject|4
5962033|NCT01190930|20618235|P8|Maintenance|Withdrawal by Subject|1
5962034|NCT01190930|20618236|P7|Maintenance|Withdrawal by Subject|2
5962035|NCT01190930|20618237|P6|Maintenance|Withdrawal by Subject|0
5962036|NCT01190930|20618238|P5|Maintenance|Withdrawal by Subject|0
5962037|NCT01190930|20618239|P4|Maintenance|Withdrawal by Subject|0
5962038|NCT01190930|20618240|P3|Maintenance|Withdrawal by Subject|0
5962039|NCT01190930|20618241|P2|Maintenance|Withdrawal by Subject|0
5962040|NCT01190930|20618242|P1|Maintenance|Withdrawal by Subject|0
5962041|NCT01190930|20618233|P10|Maintenance|Physician Decision|17
5962042|NCT01190930|20618234|P9|Maintenance|Physician Decision|10
5962043|NCT01190930|20618235|P8|Maintenance|Physician Decision|8
5962044|NCT01190930|20618236|P7|Maintenance|Physician Decision|8
5962045|NCT01190930|20618237|P6|Maintenance|Physician Decision|4
5962046|NCT01190930|20618238|P5|Maintenance|Physician Decision|9
5962047|NCT01190930|20618239|P4|Maintenance|Physician Decision|5
5962048|NCT01190930|20618240|P3|Maintenance|Physician Decision|0
5962049|NCT01190930|20618241|P2|Maintenance|Physician Decision|1
5962050|NCT01190930|20618242|P1|Maintenance|Physician Decision|0
5962051|NCT01190930|20618233|P10|Maintenance|Lost to Follow-up|0
5962052|NCT01190930|20618234|P9|Maintenance|Lost to Follow-up|1
5962053|NCT01190930|20618235|P8|Maintenance|Lost to Follow-up|1
5962054|NCT01190930|20618236|P7|Maintenance|Lost to Follow-up|1
5962055|NCT01190930|20618237|P6|Maintenance|Lost to Follow-up|0
5962056|NCT01190930|20618238|P5|Maintenance|Lost to Follow-up|0
5962057|NCT01190930|20618239|P4|Maintenance|Lost to Follow-up|0
5962058|NCT01190930|20618240|P3|Maintenance|Lost to Follow-up|0
5962059|NCT01190930|20618241|P2|Maintenance|Lost to Follow-up|0
5962060|NCT01190930|20618242|P1|Maintenance|Lost to Follow-up|0
5962061|NCT01190930|20618233|P10|Maintenance|Death|2
5962062|NCT01190930|20618234|P9|Maintenance|Death|2
5962063|NCT01190930|20618235|P8|Maintenance|Death|2
5962064|NCT01190930|20618236|P7|Maintenance|Death|2
5962065|NCT01190930|20618237|P6|Maintenance|Death|0
5962066|NCT01190930|20618238|P5|Maintenance|Death|0
5962067|NCT01190930|20618239|P4|Maintenance|Death|1
5962068|NCT01190930|20618240|P3|Maintenance|Death|0
5962069|NCT01190930|20618241|P2|Maintenance|Death|0
5962070|NCT01190930|20618242|P1|Maintenance|Death|0
5962071|NCT01190930|20618233|P10|Maintenance|Adverse Event|0
5962072|NCT01190930|20618234|P9|Maintenance|Adverse Event|3
5962073|NCT01190930|20618235|P8|Maintenance|Adverse Event|3
5962074|NCT01190930|20618236|P7|Maintenance|Adverse Event|1
5962075|NCT01190930|20618237|P6|Maintenance|Adverse Event|1
5962076|NCT01190930|20618238|P5|Maintenance|Adverse Event|0
5962077|NCT01190930|20618239|P4|Maintenance|Adverse Event|0
5962078|NCT01190930|20618240|P3|Maintenance|Adverse Event|0
5962079|NCT01190930|20618241|P2|Maintenance|Adverse Event|0
5962080|NCT01190930|20618242|P1|Maintenance|Adverse Event|0
5962081|NCT01190930|20618233|P10|Post Induction Pre-Maintenance|Relapse|0
5962082|NCT01190930|20618234|P9|Post Induction Pre-Maintenance|Relapse|0
5962083|NCT01190930|20618235|P8|Post Induction Pre-Maintenance|Relapse|0
5962084|NCT01190930|20618236|P7|Post Induction Pre-Maintenance|Relapse|0
5962085|NCT01190930|20618237|P6|Post Induction Pre-Maintenance|Relapse|0
5962086|NCT01190930|20618238|P5|Post Induction Pre-Maintenance|Relapse|0
5962087|NCT01190930|20618239|P4|Post Induction Pre-Maintenance|Relapse|0
5962088|NCT01190930|20618240|P3|Post Induction Pre-Maintenance|Relapse|1
5962089|NCT01190930|20618241|P2|Post Induction Pre-Maintenance|Relapse|0
5962090|NCT01190930|20618242|P1|Post Induction Pre-Maintenance|Relapse|0
5962091|NCT01190930|20618233|P10|Post Induction Pre-Maintenance|Progressive disease|0
5962092|NCT01190930|20618234|P9|Post Induction Pre-Maintenance|Progressive disease|0
5962093|NCT01190930|20618235|P8|Post Induction Pre-Maintenance|Progressive disease|0
5962094|NCT01190930|20618236|P7|Post Induction Pre-Maintenance|Progressive disease|0
5962095|NCT01190930|20618237|P6|Post Induction Pre-Maintenance|Progressive disease|0
5962096|NCT01190930|20618238|P5|Post Induction Pre-Maintenance|Progressive disease|0
5962097|NCT01190930|20618239|P4|Post Induction Pre-Maintenance|Progressive disease|0
5962098|NCT01190930|20618240|P3|Post Induction Pre-Maintenance|Progressive disease|1
5962099|NCT01190930|20618241|P2|Post Induction Pre-Maintenance|Progressive disease|0
5962100|NCT01190930|20618242|P1|Post Induction Pre-Maintenance|Progressive disease|0
5962101|NCT01190930|20618233|P10|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0
5962102|NCT01190930|20618234|P9|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0
5962103|NCT01190930|20618235|P8|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0
5962104|NCT01190930|20618236|P7|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0
5962105|NCT01190930|20618237|P6|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0
5962106|NCT01190930|20618238|P5|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0
5962107|NCT01190930|20618239|P4|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0
5962108|NCT01190930|20618240|P3|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0
5962109|NCT01190930|20618241|P2|Post Induction Pre-Maintenance|CR failure at the end of consolidation|1
5962110|NCT01190930|20618242|P1|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0
5962111|NCT01190930|20618233|P10|Post Induction Pre-Maintenance|Inevaluable|0
5962112|NCT01190930|20618234|P9|Post Induction Pre-Maintenance|Inevaluable|0
5962113|NCT01190930|20618235|P8|Post Induction Pre-Maintenance|Inevaluable|0
5962114|NCT01190930|20618236|P7|Post Induction Pre-Maintenance|Inevaluable|0
5962115|NCT01190930|20618237|P6|Post Induction Pre-Maintenance|Inevaluable|0
5962116|NCT01190930|20618238|P5|Post Induction Pre-Maintenance|Inevaluable|0
5962117|NCT01190930|20618239|P4|Post Induction Pre-Maintenance|Inevaluable|0
5962118|NCT01190930|20618240|P3|Post Induction Pre-Maintenance|Inevaluable|6
5962119|NCT01190930|20618241|P2|Post Induction Pre-Maintenance|Inevaluable|0
5962120|NCT01190930|20618242|P1|Post Induction Pre-Maintenance|Inevaluable|0
5962121|NCT01190930|20618233|P10|Post Induction Pre-Maintenance|Refusal|0
5962122|NCT01190930|20618234|P9|Post Induction Pre-Maintenance|Refusal|0
5962123|NCT01190930|20618235|P8|Post Induction Pre-Maintenance|Refusal|0
5962124|NCT01190930|20618236|P7|Post Induction Pre-Maintenance|Refusal|0
5962125|NCT01190930|20618237|P6|Post Induction Pre-Maintenance|Refusal|3
5962126|NCT01190930|20618238|P5|Post Induction Pre-Maintenance|Refusal|0
5962127|NCT01190930|20618239|P4|Post Induction Pre-Maintenance|Refusal|4
5962128|NCT01190930|20618240|P3|Post Induction Pre-Maintenance|Refusal|694
5962129|NCT01190930|20618241|P2|Post Induction Pre-Maintenance|Refusal|2
5962130|NCT01190930|20618242|P1|Post Induction Pre-Maintenance|Refusal|0
5962131|NCT01190930|20618233|P10|Post Induction Pre-Maintenance|Withdrawal by Subject|0
5962132|NCT01190930|20618234|P9|Post Induction Pre-Maintenance|Withdrawal by Subject|0
5962133|NCT01190930|20618235|P8|Post Induction Pre-Maintenance|Withdrawal by Subject|0
5962134|NCT01190930|20618236|P7|Post Induction Pre-Maintenance|Withdrawal by Subject|0
5962135|NCT01190930|20618237|P6|Post Induction Pre-Maintenance|Withdrawal by Subject|0
5962136|NCT01190930|20618238|P5|Post Induction Pre-Maintenance|Withdrawal by Subject|0
5962137|NCT01190930|20618239|P4|Post Induction Pre-Maintenance|Withdrawal by Subject|2
5962138|NCT01190930|20618240|P3|Post Induction Pre-Maintenance|Withdrawal by Subject|5
5962139|NCT01190930|20618241|P2|Post Induction Pre-Maintenance|Withdrawal by Subject|1
5962140|NCT01190930|20618242|P1|Post Induction Pre-Maintenance|Withdrawal by Subject|0
5962141|NCT01190930|20618233|P10|Post Induction Pre-Maintenance|Physician Decision|0
5962142|NCT01190930|20618234|P9|Post Induction Pre-Maintenance|Physician Decision|0
5962143|NCT01190930|20618235|P8|Post Induction Pre-Maintenance|Physician Decision|0
5962144|NCT01190930|20618236|P7|Post Induction Pre-Maintenance|Physician Decision|0
5962145|NCT01190930|20618237|P6|Post Induction Pre-Maintenance|Physician Decision|3
5962146|NCT01190930|20618238|P5|Post Induction Pre-Maintenance|Physician Decision|5
5962147|NCT01190930|20618239|P4|Post Induction Pre-Maintenance|Physician Decision|7
5962148|NCT01190930|20618240|P3|Post Induction Pre-Maintenance|Physician Decision|35
5962149|NCT01190930|20618241|P2|Post Induction Pre-Maintenance|Physician Decision|2
5962150|NCT01190930|20618242|P1|Post Induction Pre-Maintenance|Physician Decision|0
5962151|NCT01190930|20618233|P10|Post Induction Pre-Maintenance|Death|0
5962152|NCT01190930|20618234|P9|Post Induction Pre-Maintenance|Death|0
5962153|NCT01190930|20618235|P8|Post Induction Pre-Maintenance|Death|0
5962154|NCT01190930|20618236|P7|Post Induction Pre-Maintenance|Death|0
5962155|NCT01190930|20618237|P6|Post Induction Pre-Maintenance|Death|0
5962156|NCT01190930|20618238|P5|Post Induction Pre-Maintenance|Death|0
5962157|NCT01190930|20618239|P4|Post Induction Pre-Maintenance|Death|4
5962158|NCT01190930|20618240|P3|Post Induction Pre-Maintenance|Death|8
5962159|NCT01190930|20618241|P2|Post Induction Pre-Maintenance|Death|0
5962160|NCT01190930|20618242|P1|Post Induction Pre-Maintenance|Death|0
5962161|NCT01190930|20618233|P10|Post Induction Pre-Maintenance|Adverse Event|0
5962162|NCT01190930|20618234|P9|Post Induction Pre-Maintenance|Adverse Event|0
5962163|NCT01190930|20618235|P8|Post Induction Pre-Maintenance|Adverse Event|0
5962164|NCT01190930|20618236|P7|Post Induction Pre-Maintenance|Adverse Event|0
5962165|NCT01190930|20618237|P6|Post Induction Pre-Maintenance|Adverse Event|0
5962166|NCT01190930|20618238|P5|Post Induction Pre-Maintenance|Adverse Event|0
5962167|NCT01190930|20618239|P4|Post Induction Pre-Maintenance|Adverse Event|0
5962168|NCT01190930|20618240|P3|Post Induction Pre-Maintenance|Adverse Event|8
5962169|NCT01190930|20618241|P2|Post Induction Pre-Maintenance|Adverse Event|0
5962170|NCT01190930|20618242|P1|Post Induction Pre-Maintenance|Adverse Event|0
5962171|NCT01190930|20618233|P10|Induction|Ineligible|0
5962172|NCT01190930|20618234|P9|Induction|Ineligible|0
5962173|NCT01190930|20618235|P8|Induction|Ineligible|0
5962174|NCT01190930|20618236|P7|Induction|Ineligible|0
5962175|NCT01190930|20618237|P6|Induction|Ineligible|0
5962176|NCT01190930|20618238|P5|Induction|Ineligible|0
5962177|NCT01190930|20618239|P4|Induction|Ineligible|0
5962178|NCT01190930|20618240|P3|Induction|Ineligible|0
5962179|NCT01190930|20618241|P2|Induction|Ineligible|4
5962180|NCT01190930|20618242|P1|Induction|Ineligible|69
5962181|NCT01190930|20618233|P10|Induction|No treatment|0
5962182|NCT01190930|20618234|P9|Induction|No treatment|0
5962183|NCT01190930|20618235|P8|Induction|No treatment|0
5962184|NCT01190930|20618236|P7|Induction|No treatment|0
5962185|NCT01190930|20618237|P6|Induction|No treatment|0
5962186|NCT01190930|20618238|P5|Induction|No treatment|0
5962187|NCT01190930|20618239|P4|Induction|No treatment|0
5962188|NCT01190930|20618240|P3|Induction|No treatment|0
5962189|NCT01190930|20618241|P2|Induction|No treatment|0
5962190|NCT01190930|20618242|P1|Induction|No treatment|3
5962191|NCT01190930|20618233|P10|Induction|Progressive disease|0
5962192|NCT01190930|20618234|P9|Induction|Progressive disease|0
5962193|NCT01190930|20618235|P8|Induction|Progressive disease|0
5962194|NCT01190930|20618236|P7|Induction|Progressive disease|0
5962195|NCT01190930|20618237|P6|Induction|Progressive disease|0
5962196|NCT01190930|20618238|P5|Induction|Progressive disease|0
5962197|NCT01190930|20618239|P4|Induction|Progressive disease|0
5962198|NCT01190930|20618240|P3|Induction|Progressive disease|0
5962199|NCT01190930|20618241|P2|Induction|Progressive disease|1
5962200|NCT01190930|20618242|P1|Induction|Progressive disease|0
5962201|NCT01190930|20618233|P10|Induction|Incomplete Induction data|0
5962202|NCT01190930|20618234|P9|Induction|Incomplete Induction data|0
5962203|NCT01190930|20618235|P8|Induction|Incomplete Induction data|0
5962204|NCT01190930|20618236|P7|Induction|Incomplete Induction data|0
5962205|NCT01190930|20618237|P6|Induction|Incomplete Induction data|0
5962206|NCT01190930|20618238|P5|Induction|Incomplete Induction data|0
5962207|NCT01190930|20618239|P4|Induction|Incomplete Induction data|0
5962208|NCT01190930|20618240|P3|Induction|Incomplete Induction data|0
5962209|NCT01190930|20618241|P2|Induction|Incomplete Induction data|0
5962210|NCT01190930|20618242|P1|Induction|Incomplete Induction data|63
5962211|NCT01190930|20618233|P10|Induction|Philadelphia chromosome-positive|0
5962212|NCT01190930|20618234|P9|Induction|Philadelphia chromosome-positive|0
5962213|NCT01190930|20618235|P8|Induction|Philadelphia chromosome-positive|0
5962214|NCT01190930|20618236|P7|Induction|Philadelphia chromosome-positive|0
5962215|NCT01190930|20618237|P6|Induction|Philadelphia chromosome-positive|0
5962216|NCT01190930|20618238|P5|Induction|Philadelphia chromosome-positive|0
5962217|NCT01190930|20618239|P4|Induction|Philadelphia chromosome-positive|0
5962218|NCT01190930|20618240|P3|Induction|Philadelphia chromosome-positive|0
5962219|NCT01190930|20618241|P2|Induction|Philadelphia chromosome-positive|0
5962220|NCT01190930|20618242|P1|Induction|Philadelphia chromosome-positive|99
5962221|NCT01190930|20618233|P10|Induction|Very High Risk|0
5962222|NCT01190930|20618234|P9|Induction|Very High Risk|0
5962223|NCT01190930|20618235|P8|Induction|Very High Risk|0
5962224|NCT01190930|20618236|P7|Induction|Very High Risk|0
5962225|NCT01190930|20618237|P6|Induction|Very High Risk|0
5962226|NCT01190930|20618238|P5|Induction|Very High Risk|0
5962227|NCT01190930|20618239|P4|Induction|Very High Risk|0
5962228|NCT01190930|20618240|P3|Induction|Very High Risk|0
5962229|NCT01190930|20618241|P2|Induction|Very High Risk|0
5962230|NCT01190930|20618242|P1|Induction|Very High Risk|1012
5962231|NCT01190930|20618233|P10|Induction|Low Risk|0
5962232|NCT01190930|20618234|P9|Induction|Low Risk|0
5962233|NCT01190930|20618235|P8|Induction|Low Risk|0
5962234|NCT01190930|20618236|P7|Induction|Low Risk|0
5962235|NCT01190930|20618237|P6|Induction|Low Risk|0
5962236|NCT01190930|20618238|P5|Induction|Low Risk|0
5962237|NCT01190930|20618239|P4|Induction|Low Risk|0
5962238|NCT01190930|20618240|P3|Induction|Low Risk|0
5962239|NCT01190930|20618241|P2|Induction|Low Risk|0
5962240|NCT01190930|20618242|P1|Induction|Low Risk|443
5962241|NCT01190930|20618233|P10|Induction|High Risk|0
5962242|NCT01190930|20618234|P9|Induction|High Risk|0
5962243|NCT01190930|20618235|P8|Induction|High Risk|0
5962244|NCT01190930|20618236|P7|Induction|High Risk|0
5962245|NCT01190930|20618237|P6|Induction|High Risk|0
5962246|NCT01190930|20618238|P5|Induction|High Risk|0
5962247|NCT01190930|20618239|P4|Induction|High Risk|0
5962248|NCT01190930|20618240|P3|Induction|High Risk|0
5962249|NCT01190930|20618241|P2|Induction|High Risk|0
5962250|NCT01190930|20618242|P1|Induction|High Risk|1227
5962251|NCT01190930|20618233|P10|Induction|Average Risk|0
5962252|NCT01190930|20618234|P9|Induction|Average Risk|0
5962253|NCT01190930|20618235|P8|Induction|Average Risk|0
5962254|NCT01190930|20618236|P7|Induction|Average Risk|0
5962255|NCT01190930|20618237|P6|Induction|Average Risk|0
5962256|NCT01190930|20618238|P5|Induction|Average Risk|0
5962257|NCT01190930|20618239|P4|Induction|Average Risk|0
5962258|NCT01190930|20618240|P3|Induction|Average Risk|0
5962259|NCT01190930|20618241|P2|Induction|Average Risk|0
5962260|NCT01190930|20618242|P1|Induction|Average Risk|1847
5962261|NCT01190930|20618233|P10|Induction|Enrollment onto another COG Protocol|0
5962262|NCT01190930|20618234|P9|Induction|Enrollment onto another COG Protocol|0
5962263|NCT01190930|20618235|P8|Induction|Enrollment onto another COG Protocol|0
5962264|NCT01190930|20618236|P7|Induction|Enrollment onto another COG Protocol|0
5962265|NCT01190930|20618237|P6|Induction|Enrollment onto another COG Protocol|0
5962266|NCT01190930|20618238|P5|Induction|Enrollment onto another COG Protocol|0
5962267|NCT01190930|20618239|P4|Induction|Enrollment onto another COG Protocol|0
5962268|NCT01190930|20618240|P3|Induction|Enrollment onto another COG Protocol|0
5962269|NCT01190930|20618241|P2|Induction|Enrollment onto another COG Protocol|0
5962270|NCT01190930|20618242|P1|Induction|Enrollment onto another COG Protocol|1
5962271|NCT01190930|20618233|P10|Induction|High Risk Downs|0
5962272|NCT01190930|20618234|P9|Induction|High Risk Downs|0
5962273|NCT01190930|20618235|P8|Induction|High Risk Downs|0
5962274|NCT01190930|20618236|P7|Induction|High Risk Downs|0
5962275|NCT01190930|20618237|P6|Induction|High Risk Downs|0
5962276|NCT01190930|20618238|P5|Induction|High Risk Downs|0
5962277|NCT01190930|20618239|P4|Induction|High Risk Downs|0
5962278|NCT01190930|20618240|P3|Induction|High Risk Downs|0
5962279|NCT01190930|20618241|P2|Induction|High Risk Downs|0
5962280|NCT01190930|20618242|P1|Induction|High Risk Downs|80
5962281|NCT01190930|20618233|P10|Induction|BM MRD >= 0.01% on Day 29 of Induction|0
5962282|NCT01190930|20618234|P9|Induction|BM MRD >= 0.01% on Day 29 of Induction|0
5962283|NCT01190930|20618235|P8|Induction|BM MRD >= 0.01% on Day 29 of Induction|0
5962284|NCT01190930|20618236|P7|Induction|BM MRD >= 0.01% on Day 29 of Induction|0
5962285|NCT01190930|20618237|P6|Induction|BM MRD >= 0.01% on Day 29 of Induction|0
5962286|NCT01190930|20618238|P5|Induction|BM MRD >= 0.01% on Day 29 of Induction|0
5962287|NCT01190930|20618239|P4|Induction|BM MRD >= 0.01% on Day 29 of Induction|0
5962288|NCT01190930|20618240|P3|Induction|BM MRD >= 0.01% on Day 29 of Induction|0
5962289|NCT01190930|20618241|P2|Induction|BM MRD >= 0.01% on Day 29 of Induction|0
5962290|NCT01190930|20618242|P1|Induction|BM MRD >= 0.01% on Day 29 of Induction|61
5962291|NCT01190930|20618233|P10|Induction|Inevaluable|0
5962292|NCT01190930|20618234|P9|Induction|Inevaluable|0
5962293|NCT01190930|20618235|P8|Induction|Inevaluable|0
5962294|NCT01190930|20618236|P7|Induction|Inevaluable|0
5962295|NCT01190930|20618237|P6|Induction|Inevaluable|0
5962296|NCT01190930|20618238|P5|Induction|Inevaluable|0
5962297|NCT01190930|20618239|P4|Induction|Inevaluable|0
5962298|NCT01190930|20618240|P3|Induction|Inevaluable|0
5962299|NCT01190930|20618241|P2|Induction|Inevaluable|1
5962300|NCT01190930|20618242|P1|Induction|Inevaluable|23
5962301|NCT01190930|20618233|P10|Induction|Refusal|0
5962302|NCT01190930|20618234|P9|Induction|Refusal|0
5962303|NCT01190930|20618235|P8|Induction|Refusal|0
5962304|NCT01190930|20618236|P7|Induction|Refusal|0
5962305|NCT01190930|20618237|P6|Induction|Refusal|0
5962306|NCT01190930|20618238|P5|Induction|Refusal|0
5962307|NCT01190930|20618239|P4|Induction|Refusal|0
5962308|NCT01190930|20618240|P3|Induction|Refusal|0
5962309|NCT01190930|20618241|P2|Induction|Refusal|0
5962310|NCT01190930|20618242|P1|Induction|Refusal|235
5962311|NCT01190930|20618233|P10|Induction|Withdrawal by Subject|0
5962312|NCT01190930|20618234|P9|Induction|Withdrawal by Subject|0
5962313|NCT01190930|20618235|P8|Induction|Withdrawal by Subject|0
5962314|NCT01190930|20618236|P7|Induction|Withdrawal by Subject|0
5962315|NCT01190930|20618237|P6|Induction|Withdrawal by Subject|0
5962316|NCT01190930|20618238|P5|Induction|Withdrawal by Subject|0
5962317|NCT01190930|20618239|P4|Induction|Withdrawal by Subject|0
5962318|NCT01190930|20618240|P3|Induction|Withdrawal by Subject|0
5962319|NCT01190930|20618241|P2|Induction|Withdrawal by Subject|0
5962320|NCT01190930|20618242|P1|Induction|Withdrawal by Subject|9
5962321|NCT01190930|20618233|P10|Induction|Physician Decision|0
5962322|NCT01190930|20618234|P9|Induction|Physician Decision|0
5962323|NCT01190930|20618235|P8|Induction|Physician Decision|0
5962324|NCT01190930|20618236|P7|Induction|Physician Decision|0
5962325|NCT01190930|20618237|P6|Induction|Physician Decision|0
5962326|NCT01190930|20618238|P5|Induction|Physician Decision|0
5962327|NCT01190930|20618239|P4|Induction|Physician Decision|0
5962328|NCT01190930|20618240|P3|Induction|Physician Decision|0
5962329|NCT01190930|20618241|P2|Induction|Physician Decision|3
5962330|NCT01190930|20618242|P1|Induction|Physician Decision|125
5962331|NCT01190930|20618233|P10|Induction|Lost to Follow-up|0
5962332|NCT01190930|20618234|P9|Induction|Lost to Follow-up|0
5962333|NCT01190930|20618235|P8|Induction|Lost to Follow-up|0
5962334|NCT01190930|20618236|P7|Induction|Lost to Follow-up|0
5962335|NCT01190930|20618237|P6|Induction|Lost to Follow-up|0
5962336|NCT01190930|20618238|P5|Induction|Lost to Follow-up|0
5962337|NCT01190930|20618239|P4|Induction|Lost to Follow-up|0
5962338|NCT01190930|20618240|P3|Induction|Lost to Follow-up|0
5962339|NCT01190930|20618241|P2|Induction|Lost to Follow-up|0
5962340|NCT01190930|20618242|P1|Induction|Lost to Follow-up|1
5962341|NCT01190930|20618233|P10|Induction|Death|0
5962342|NCT01190930|20618234|P9|Induction|Death|0
5962343|NCT01190930|20618235|P8|Induction|Death|0
5962344|NCT01190930|20618236|P7|Induction|Death|0
5962345|NCT01190930|20618237|P6|Induction|Death|0
5962346|NCT01190930|20618238|P5|Induction|Death|0
5962347|NCT01190930|20618239|P4|Induction|Death|0
5962348|NCT01190930|20618240|P3|Induction|Death|0
5962349|NCT01190930|20618241|P2|Induction|Death|0
5962350|NCT01190930|20618242|P1|Induction|Death|34
5962351|NCT01190930|20618233|P10|Induction|Adverse Event|0
5962352|NCT01190930|20618234|P9|Induction|Adverse Event|0
5962353|NCT01190930|20618235|P8|Induction|Adverse Event|0
5962354|NCT01190930|20618236|P7|Induction|Adverse Event|0
5962355|NCT01190930|20618237|P6|Induction|Adverse Event|0
5962356|NCT01190930|20618238|P5|Induction|Adverse Event|0
5962357|NCT01190930|20618239|P4|Induction|Adverse Event|0
5962358|NCT01190930|20618240|P3|Induction|Adverse Event|0
5962359|NCT01190930|20618241|P2|Induction|Adverse Event|0
5962360|NCT01190930|20618242|P1|Induction|Adverse Event|17
5962361|NCT01190891|20618266|P2|Overall Study|Withdrawal by Subject|0
5962362|NCT01190891|20618267|P1|Overall Study|Withdrawal by Subject|5
5962363|NCT01190891|20618266|P2|Overall Study|Protocol Violation|0
5962364|NCT01190891|20618267|P1|Overall Study|Protocol Violation|1
5962365|NCT01190865|20618292|P1|Overall Study|Non-compliance|2
5962366|NCT01190865|20618292|P1|Overall Study|Withdrawal by Subject|1
5962367|NCT01190839|20618299|P2|Overall Study|Randomized but not treated|4
5962368|NCT01190839|20618300|P1|Overall Study|Randomized but not treated|2
5962369|NCT01190839|20618299|P2|Overall Study|Undefined|31
5962370|NCT01190839|20618300|P1|Overall Study|Undefined|35
5962371|NCT01190839|20618299|P2|Overall Study|Trial stopped by Sponsor|68
5962372|NCT01190839|20618300|P1|Overall Study|Trial stopped by Sponsor|71
5962373|NCT01190839|20618299|P2|Overall Study|Death|0
5962374|NCT01190839|20618300|P1|Overall Study|Death|1
5962375|NCT01190839|20618299|P2|Overall Study|Lost to Follow-up|1
5962376|NCT01190839|20618300|P1|Overall Study|Lost to Follow-up|7
5962377|NCT01190839|20618299|P2|Overall Study|Protocol Violation|2
5962378|NCT01190839|20618300|P1|Overall Study|Protocol Violation|2
5962379|NCT01190839|20618299|P2|Overall Study|Adverse Event|41
5962380|NCT01190839|20618300|P1|Overall Study|Adverse Event|32
5962381|NCT01190813|20618314|P2|Overall Study|Adverse Event|1
5962382|NCT01190813|20618315|P1|Overall Study|Adverse Event|0
5962383|NCT01190813|20618314|P2|Overall Study|Refused study treatment after randomized|0
5962384|NCT01190813|20618315|P1|Overall Study|Refused study treatment after randomized|1
5962385|NCT01190813|20618314|P2|Overall Study|Withdrawal by Subject|1
5962386|NCT01190813|20618315|P1|Overall Study|Withdrawal by Subject|2
5962387|NCT01190813|20618314|P2|Overall Study|Lost to Follow-up|2
5962388|NCT01190813|20618315|P1|Overall Study|Lost to Follow-up|1
5962389|NCT01190514|20618436|P4|Third Intervention (Period 3)|Adverse Event|0
5962390|NCT01190514|20618437|P3|Third Intervention (Period 3)|Adverse Event|0
5962391|NCT01190514|20618438|P2|Third Intervention (Period 3)|Adverse Event|0
5962392|NCT01190514|20618439|P1|Third Intervention (Period 3)|Adverse Event|1
5962393|NCT01190514|20618436|P4|First Intervention (Period 1)|Adverse Event|0
5962394|NCT01190514|20618437|P3|First Intervention (Period 1)|Adverse Event|0
5962395|NCT01190514|20618438|P2|First Intervention (Period 1)|Adverse Event|0
5962396|NCT01190514|20618439|P1|First Intervention (Period 1)|Adverse Event|1
5962397|NCT01190475|20618472|P3|Overall Study|Withdrawal by Subject|1
5962398|NCT01190475|20618473|P2|Overall Study|Withdrawal by Subject|0
5962399|NCT01190475|20618474|P1|Overall Study|Withdrawal by Subject|0
5962400|NCT01190449|20618490|P2|Overall Study|Ineligible|4
5962401|NCT01190449|20618491|P1|Overall Study|Ineligible|0
5962402|NCT01190436|20618499|P1|Overall Study|Other|4
5962403|NCT01190436|20618499|P1|Overall Study|Lost to Follow-up|35
5962404|NCT01190410|20618515|P2|Overall Study|PI discretion|2
5962405|NCT01190410|20618516|P1|Overall Study|PI discretion|0
5962406|NCT01190410|20618515|P2|Overall Study|Administrative decision|0
5962407|NCT01190410|20618516|P1|Overall Study|Administrative decision|1
5962408|NCT01190410|20618515|P2|Overall Study|Withdrawal by Subject|2
5962409|NCT01190410|20618516|P1|Overall Study|Withdrawal by Subject|0
5962410|NCT01190410|20618515|P2|Overall Study|Lack of Efficacy|2
5962411|NCT01190410|20618516|P1|Overall Study|Lack of Efficacy|0
5962412|NCT01190410|20618515|P2|Overall Study|Adverse Event|3
5962413|NCT01190410|20618516|P1|Overall Study|Adverse Event|0
5962424|NCT01190254|20618556|P3|Overall Study|Did not meet protocol eligibility|0
5962425|NCT01190254|20618557|P2|Overall Study|Did not meet protocol eligibility|0
5962426|NCT01190254|20618558|P1|Overall Study|Did not meet protocol eligibility|1
5962427|NCT01190254|20618556|P3|Overall Study|Protocol Violation|2
5962428|NCT01190254|20618557|P2|Overall Study|Protocol Violation|0
5962429|NCT01190254|20618558|P1|Overall Study|Protocol Violation|2
5962430|NCT01190254|20618556|P3|Overall Study|Withdrawal by Subject|7
5962431|NCT01190254|20618557|P2|Overall Study|Withdrawal by Subject|5
5962432|NCT01190254|20618558|P1|Overall Study|Withdrawal by Subject|4
5962433|NCT01190254|20618556|P3|Overall Study|Lost to Follow-up|0
5962434|NCT01190254|20618557|P2|Overall Study|Lost to Follow-up|2
5962435|NCT01190254|20618558|P1|Overall Study|Lost to Follow-up|4
5962436|NCT01190254|20618556|P3|Overall Study|Lack of Efficacy|5
5962437|NCT01190254|20618557|P2|Overall Study|Lack of Efficacy|4
5962438|NCT01190254|20618558|P1|Overall Study|Lack of Efficacy|7
5962439|NCT01190254|20618556|P3|Overall Study|Adverse Event|8
5962440|NCT01190254|20618557|P2|Overall Study|Adverse Event|6
5962441|NCT01190254|20618558|P1|Overall Study|Adverse Event|3
5962442|NCT01190228|20618623|P3|Overall Study|Withdrawal by Subject|0
5962443|NCT01190228|20618624|P2|Overall Study|Withdrawal by Subject|0
5962444|NCT01190228|20618625|P1|Overall Study|Withdrawal by Subject|1
5962445|NCT01190228|20618623|P3|Overall Study|Protocol Violation|0
5962446|NCT01190228|20618624|P2|Overall Study|Protocol Violation|0
5962447|NCT01190228|20618625|P1|Overall Study|Protocol Violation|4
5962448|NCT01190215|20618648|P2|Up to Month 6|Lost to Follow-up|0
5962449|NCT01190215|20618649|P1|Up to Month 6|Lost to Follow-up|2
5962450|NCT01190189|20618982|P1|Overall Study|Migrated/moved from study area|1
5962451|NCT01190189|20618982|P1|Overall Study|Withdrawal by Subject|1
5962452|NCT01190189|20618982|P1|Overall Study|Lost to Follow-up|4
5962453|NCT01190176|20618989|P1|Overall Study|Lost to Follow-up|1
5962454|NCT01190176|20618989|P1|Overall Study|Withdrawal by Subject|1
5962455|NCT01190150|20619010|P2|Washout|Difficulty in adherence|1
5962456|NCT01190150|20619011|P1|Washout|Difficulty in adherence|0
5962457|NCT01190150|20619010|P2|Washout|Withdrawal by Subject|1
5962458|NCT01190150|20619011|P1|Washout|Withdrawal by Subject|0
5962459|NCT01190150|20619010|P2|First Treatment|Withdrawal by Subject|0
5962460|NCT01190150|20619011|P1|First Treatment|Withdrawal by Subject|1
5962461|NCT01190124|20619038|P3|Overall Study|Lost to Follow-up|0
5962462|NCT01190124|20619039|P2|Overall Study|Lost to Follow-up|0
5962463|NCT01190124|20619040|P1|Overall Study|Lost to Follow-up|2
5962464|NCT01190124|20619038|P3|Overall Study|Therapeutic Failure|1
5962465|NCT01190124|20619039|P2|Overall Study|Therapeutic Failure|0
5962466|NCT01190124|20619040|P1|Overall Study|Therapeutic Failure|12
5962467|NCT01190124|20619038|P3|Overall Study|Death|0
5962468|NCT01190124|20619039|P2|Overall Study|Death|0
5962469|NCT01190124|20619040|P1|Overall Study|Death|3
5962470|NCT01190098|20619078|P2|Overall Study|Other|1
5962471|NCT01190098|20619079|P1|Overall Study|Other|0
5962472|NCT01190098|20619078|P2|Overall Study|Lack of transportation|0
5962473|NCT01190098|20619079|P1|Overall Study|Lack of transportation|1
5962474|NCT01190098|20619078|P2|Overall Study|Patient coomorbidity|1
5962475|NCT01190098|20619079|P1|Overall Study|Patient coomorbidity|0
5962476|NCT01190098|20619078|P2|Overall Study|Adverse Event|0
5962477|NCT01190098|20619079|P1|Overall Study|Adverse Event|2
5962478|NCT01190020|20619120|P2|Overall Study|Withdrawal by Subject|0
5962479|NCT01190020|20619121|P1|Overall Study|Withdrawal by Subject|3
5962480|NCT01190020|20619120|P2|Overall Study|Lost to Follow-up|0
5962481|NCT01190020|20619121|P1|Overall Study|Lost to Follow-up|2
5962482|NCT01190020|20619120|P2|Overall Study|Adverse Event|0
5962483|NCT01190020|20619121|P1|Overall Study|Adverse Event|2
5962484|NCT01189890|20619135|P2|Overall Study|Hyperglycemia Discontinuation Criteria|5
5962485|NCT01189890|20619136|P1|Overall Study|Hyperglycemia Discontinuation Criteria|5
5962486|NCT01189890|20619135|P2|Overall Study|Physician Decision|4
5962487|NCT01189890|20619136|P1|Overall Study|Physician Decision|5
5962488|NCT01189890|20619135|P2|Overall Study|Non Compliance|1
5962489|NCT01189890|20619136|P1|Overall Study|Non Compliance|0
5962490|NCT01189890|20619135|P2|Overall Study|Withdrawal by Subject|11
5962491|NCT01189890|20619136|P1|Overall Study|Withdrawal by Subject|15
5962492|NCT01189890|20619135|P2|Overall Study|Protocol Violation|5
5962493|NCT01189890|20619136|P1|Overall Study|Protocol Violation|1
5962494|NCT01189890|20619135|P2|Overall Study|Lost to Follow-up|7
5962495|NCT01189890|20619136|P1|Overall Study|Lost to Follow-up|1
5962496|NCT01189890|20619135|P2|Overall Study|Lack of Efficacy|2
5962497|NCT01189890|20619136|P1|Overall Study|Lack of Efficacy|7
5962498|NCT01189890|20619135|P2|Overall Study|Adverse Event|4
5962499|NCT01189890|20619136|P1|Overall Study|Adverse Event|3
5962500|NCT01189812|20619158|P2|Overall Study|Moved out of State|2
5962501|NCT01189812|20619159|P1|Overall Study|Moved out of State|1
5962502|NCT01189812|20619158|P2|Overall Study|Out of Window|3
5962503|NCT01189812|20619159|P1|Overall Study|Out of Window|4
5962504|NCT01189812|20619158|P2|Overall Study|Adverse Event|0
5962505|NCT01189812|20619159|P1|Overall Study|Adverse Event|1
5962506|NCT01189812|20619158|P2|Overall Study|Withdrawal by Subject|3
5962507|NCT01189812|20619159|P1|Overall Study|Withdrawal by Subject|2
5962508|NCT01189604|20619243|P7|Overall Study|Withdrawal by Subject|0
5962509|NCT01189604|20619244|P6|Overall Study|Withdrawal by Subject|0
5962510|NCT01189604|20619245|P5|Overall Study|Withdrawal by Subject|0
5962511|NCT01189604|20619246|P4|Overall Study|Withdrawal by Subject|0
5962512|NCT01189604|20619247|P3|Overall Study|Withdrawal by Subject|0
5962513|NCT01189604|20619248|P2|Overall Study|Withdrawal by Subject|0
5962514|NCT01189604|20619249|P1|Overall Study|Withdrawal by Subject|1
5962515|NCT01189604|20619243|P7|Overall Study|Adverse Event|1
5962516|NCT01189604|20619244|P6|Overall Study|Adverse Event|0
5962517|NCT01189604|20619245|P5|Overall Study|Adverse Event|2
5962518|NCT01189604|20619246|P4|Overall Study|Adverse Event|0
5962519|NCT01189604|20619247|P3|Overall Study|Adverse Event|0
5962520|NCT01189604|20619248|P2|Overall Study|Adverse Event|1
5962521|NCT01189604|20619249|P1|Overall Study|Adverse Event|0
5962522|NCT01189604|20619243|P7|Overall Study|Impossible to visit|0
5962523|NCT01189604|20619244|P6|Overall Study|Impossible to visit|1
5962524|NCT01189604|20619245|P5|Overall Study|Impossible to visit|0
5962525|NCT01189604|20619246|P4|Overall Study|Impossible to visit|0
5962526|NCT01189604|20619247|P3|Overall Study|Impossible to visit|0
5962527|NCT01189604|20619248|P2|Overall Study|Impossible to visit|0
5962528|NCT01189604|20619249|P1|Overall Study|Impossible to visit|0
5962529|NCT01189500|20619293|P1|Period 2: Coadministration TAMOX+DVS SR|Withdrawal by Subject|1
5962530|NCT01189500|20619293|P1|Period 1: TAMOX Alone|Adverse Event|1
5962531|NCT01189487|20619354|P1|Overall Study|Adverse Event|1
5962532|NCT01189487|20619354|P1|Overall Study|Lack of Efficacy|2
5962533|NCT01189461|20619362|P1|Overall Study|Other|8
5962534|NCT01189461|20619362|P1|Overall Study|Did not meet entrance criteria|3
5962535|NCT01189461|20619362|P1|Overall Study|Adverse Event|2
5962536|NCT01189461|20619362|P1|Overall Study|Protocol Violation|1
5962537|NCT01189461|20619362|P1|Overall Study|Withdrawal by Subject|6
5962538|NCT01189461|20619362|P1|Overall Study|Lost to Follow-up|1
5962539|NCT01189461|20619362|P1|Overall Study|Lack of Efficacy|13
5962540|NCT01189435|20619369|P1|Overall Study|Physician Decision|1
5962541|NCT01189435|20619369|P1|Overall Study|Withdrawal by Subject|1
5962542|NCT01189266|20619449|P3|Overall Study|No treatment|1
5962543|NCT01189266|20619450|P2|Overall Study|No treatment|0
5962544|NCT01189266|20619451|P1|Overall Study|No treatment|0
5962545|NCT01189266|20619449|P3|Overall Study|Patient refuses further therapy|7
5962546|NCT01189266|20619450|P2|Overall Study|Patient refuses further therapy|0
5962547|NCT01189266|20619451|P1|Overall Study|Patient refuses further therapy|1
5962548|NCT01189266|20619449|P3|Overall Study|Withdrawal by Subject|1
5962549|NCT01189266|20619450|P2|Overall Study|Withdrawal by Subject|0
5962550|NCT01189266|20619451|P1|Overall Study|Withdrawal by Subject|0
5962551|NCT01189266|20619449|P3|Overall Study|Protocol Violation|1
5962552|NCT01189266|20619450|P2|Overall Study|Protocol Violation|1
5962553|NCT01189266|20619451|P1|Overall Study|Protocol Violation|0
5962554|NCT01189266|20619449|P3|Overall Study|Physician Decision|1
5962555|NCT01189266|20619450|P2|Overall Study|Physician Decision|0
5962556|NCT01189266|20619451|P1|Overall Study|Physician Decision|0
5962557|NCT01189266|20619449|P3|Overall Study|Lack of Efficacy|44
5962558|NCT01189266|20619450|P2|Overall Study|Lack of Efficacy|5
5962559|NCT01189266|20619451|P1|Overall Study|Lack of Efficacy|4
5962560|NCT01189266|20619449|P3|Overall Study|Death|5
5962561|NCT01189266|20619450|P2|Overall Study|Death|0
5962562|NCT01189266|20619451|P1|Overall Study|Death|0
5962563|NCT01189266|20619449|P3|Overall Study|Adverse Event|5
5962564|NCT01189266|20619450|P2|Overall Study|Adverse Event|0
5962565|NCT01189266|20619451|P1|Overall Study|Adverse Event|1
5962566|NCT01189227|20619501|P2|Overall Study|Study terminated due to low accrual|3
5962567|NCT01189227|20619502|P1|Overall Study|Study terminated due to low accrual|6
5962568|NCT01189201|20619508|P1|Overall Study|Adverse Event|1
5962569|NCT01189032|20619611|P3|Overall Study|Protocol Violation|1
5962570|NCT01189032|20619612|P2|Overall Study|Protocol Violation|1
5962571|NCT01189032|20619613|P1|Overall Study|Protocol Violation|1
5962572|NCT01189032|20619611|P3|Overall Study|Withdrawal by Subject|1
5962573|NCT01189032|20619612|P2|Overall Study|Withdrawal by Subject|0
5962574|NCT01189032|20619613|P1|Overall Study|Withdrawal by Subject|1
5962575|NCT01189032|20619611|P3|Overall Study|Lack of Efficacy|0
5962576|NCT01189032|20619612|P2|Overall Study|Lack of Efficacy|3
5962577|NCT01189032|20619613|P1|Overall Study|Lack of Efficacy|2
5962578|NCT01189032|20619611|P3|Overall Study|Adverse Event|4
5962579|NCT01189032|20619612|P2|Overall Study|Adverse Event|3
5962580|NCT01189032|20619613|P1|Overall Study|Adverse Event|1
5962581|NCT01188967|20619623|P2|Overall Study|Lost to Follow-up|2
5962582|NCT01188967|20619624|P1|Overall Study|Lost to Follow-up|3
5962583|NCT01188967|20619623|P2|Overall Study|Physician Decision|1
5962584|NCT01188967|20619624|P1|Overall Study|Physician Decision|1
5962585|NCT01188967|20619623|P2|Overall Study|Withdrawal by Subject|1
5962586|NCT01188967|20619624|P1|Overall Study|Withdrawal by Subject|1
5962587|NCT01188811|20619677|P2|Overall Study|Adverse Event|0
5962588|NCT01188811|20619678|P1|Overall Study|Adverse Event|6
5962589|NCT01188811|20619677|P2|Overall Study|Withdrawal by Subject|2
5962590|NCT01188811|20619678|P1|Overall Study|Withdrawal by Subject|0
5962591|NCT01188798|20619690|P2|Overall Study|Protocol closure|1
5962592|NCT01188798|20619691|P1|Overall Study|Protocol closure|1
5962593|NCT01188798|20619690|P2|Overall Study|Required additional transplant|1
5962594|NCT01188798|20619691|P1|Overall Study|Required additional transplant|1
5962595|NCT01188798|20619690|P2|Overall Study|Death|1
5962596|NCT01188798|20619691|P1|Overall Study|Death|0
5962597|NCT01188772|20619703|P4|Overall Study|Withdrawal by Subject|0
5962598|NCT01188772|20619704|P3|Overall Study|Withdrawal by Subject|2
5962599|NCT01188772|20619705|P2|Overall Study|Withdrawal by Subject|0
5962600|NCT01188772|20619706|P1|Overall Study|Withdrawal by Subject|0
5962601|NCT01188772|20619703|P4|Overall Study|Virologic Failure|0
5962602|NCT01188772|20619704|P3|Overall Study|Virologic Failure|0
5962603|NCT01188772|20619705|P2|Overall Study|Virologic Failure|0
5962604|NCT01188772|20619706|P1|Overall Study|Virologic Failure|1
5962605|NCT01188772|20619703|P4|Overall Study|Treatment Failure|0
5962606|NCT01188772|20619704|P3|Overall Study|Treatment Failure|1
5962607|NCT01188772|20619705|P2|Overall Study|Treatment Failure|0
5962608|NCT01188772|20619706|P1|Overall Study|Treatment Failure|0
5962609|NCT01188772|20619703|P4|Overall Study|Terminated by Sponsor|0
5962610|NCT01188772|20619704|P3|Overall Study|Terminated by Sponsor|1
5962611|NCT01188772|20619705|P2|Overall Study|Terminated by Sponsor|0
5962612|NCT01188772|20619706|P1|Overall Study|Terminated by Sponsor|0
5962613|NCT01188772|20619703|P4|Overall Study|Physician Decision|0
5962614|NCT01188772|20619704|P3|Overall Study|Physician Decision|1
5962615|NCT01188772|20619705|P2|Overall Study|Physician Decision|0
5962616|NCT01188772|20619706|P1|Overall Study|Physician Decision|0
5962617|NCT01188772|20619703|P4|Overall Study|Non-responder|0
5962618|NCT01188772|20619704|P3|Overall Study|Non-responder|3
5962619|NCT01188772|20619705|P2|Overall Study|Non-responder|0
5962620|NCT01188772|20619706|P1|Overall Study|Non-responder|0
5962621|NCT01188772|20619703|P4|Overall Study|Lost to Follow-up|1
5962622|NCT01188772|20619704|P3|Overall Study|Lost to Follow-up|1
5962623|NCT01188772|20619705|P2|Overall Study|Lost to Follow-up|1
5962624|NCT01188772|20619706|P1|Overall Study|Lost to Follow-up|4
5962625|NCT01188772|20619703|P4|Overall Study|Adverse Event|0
5962626|NCT01188772|20619704|P3|Overall Study|Adverse Event|2
5962627|NCT01188772|20619705|P2|Overall Study|Adverse Event|1
5962628|NCT01188772|20619706|P1|Overall Study|Adverse Event|0
5962629|NCT01188772|20619703|P4|Overall Study|Randomized but Not Treated|0
5962630|NCT01188772|20619704|P3|Overall Study|Randomized but Not Treated|0
5962631|NCT01188772|20619705|P2|Overall Study|Randomized but Not Treated|1
5962632|NCT01188772|20619706|P1|Overall Study|Randomized but Not Treated|0
5962633|NCT01188681|20619778|P4|Overall Study|Withdrawal by Subject|1
5962634|NCT01188681|20619779|P3|Overall Study|Withdrawal by Subject|0
5962635|NCT01188681|20619780|P2|Overall Study|Withdrawal by Subject|0
5962636|NCT01188681|20619781|P1|Overall Study|Withdrawal by Subject|0
5962637|NCT01188681|20619778|P4|Overall Study|bladder cancer|0
5962638|NCT01188681|20619779|P3|Overall Study|bladder cancer|1
5962639|NCT01188681|20619780|P2|Overall Study|bladder cancer|0
5962640|NCT01188681|20619781|P1|Overall Study|bladder cancer|0
5962641|NCT01188668|20619795|P1|Period 2: Coadministration ARIP + DVS SR|Withdrawal by Subject|1
5962642|NCT01188668|20619795|P1|Period 2: Coadministration ARIP + DVS SR|Lost to Follow-up|2
5962643|NCT01188668|20619795|P1|Period 1: ARIP Alone|Protocol Violation|2
5962644|NCT01188655|20619828|P1|Overall Study|Other|11
5962645|NCT01188655|20619828|P1|Overall Study|Lost to Follow-up|1
5962646|NCT01188655|20619828|P1|Overall Study|Lack of Efficacy|1
5962647|NCT01188564|20619872|P2|Double-blind Phase|randomized not treated|0
5962648|NCT01188564|20619873|P1|Double-blind Phase|randomized not treated|1
5962649|NCT01188551|20619885|P4|Overall Study|Pharmacy issues|0
5962650|NCT01188551|20619886|P3|Overall Study|Pharmacy issues|0
5962651|NCT01188551|20619887|P2|Overall Study|Pharmacy issues|0
5962652|NCT01188551|20619888|P1|Overall Study|Pharmacy issues|1
5962655|NCT01188343|20620001|P3|Overall Study|Withdrawal by Subject|0
5962656|NCT01188343|20620002|P2|Overall Study|Withdrawal by Subject|24
5962657|NCT01188343|20620003|P1|Overall Study|Withdrawal by Subject|1
5962658|NCT01188343|20620001|P3|Overall Study|Not vaccinated|1
5962659|NCT01188343|20620002|P2|Overall Study|Not vaccinated|2
5962660|NCT01188343|20620003|P1|Overall Study|Not vaccinated|0
5962661|NCT01188226|20620029|P1|Overall Study|Withdrawal by Subject|4
5962662|NCT01187953|20620075|P2|Overall Study|Withdrawal by Subject|3
5962663|NCT01187953|20620076|P1|Overall Study|Withdrawal by Subject|3
5962664|NCT01187953|20620075|P2|Overall Study|Lost to Follow-up|3
5962665|NCT01187953|20620076|P1|Overall Study|Lost to Follow-up|0
5962666|NCT01187953|20620075|P2|Overall Study|Adverse Event|2
5962667|NCT01187953|20620076|P1|Overall Study|Adverse Event|1
5962668|NCT01187953|20620075|P2|Overall Study|Death|13
5962669|NCT01187953|20620076|P1|Overall Study|Death|11
5962670|NCT01187901|20620090|P2|Overall Study|Pregnancy|2
5962671|NCT01187901|20620091|P1|Overall Study|Pregnancy|0
5962672|NCT01187901|20620090|P2|Overall Study|No Endpoint due to Early Study Halt|3
5962673|NCT01187901|20620091|P1|Overall Study|No Endpoint due to Early Study Halt|2
5962674|NCT01187901|20620090|P2|Overall Study|Adverse Event|0
5962675|NCT01187901|20620091|P1|Overall Study|Adverse Event|3
5962676|NCT01187901|20620090|P2|Overall Study|Suspected Allergic Reaction|1
5962677|NCT01187901|20620091|P1|Overall Study|Suspected Allergic Reaction|1
5962678|NCT01187901|20620090|P2|Overall Study|Unrelated Health Reasons|2
5962679|NCT01187901|20620091|P1|Overall Study|Unrelated Health Reasons|1
5962680|NCT01187901|20620090|P2|Overall Study|Lost to Follow-up|2
5962681|NCT01187901|20620091|P1|Overall Study|Lost to Follow-up|1
5962682|NCT01187901|20620090|P2|Overall Study|Protocol Violation|0
5962683|NCT01187901|20620091|P1|Overall Study|Protocol Violation|1
5962684|NCT01187550|20620132|P2|Overall Study|Randomized but not treated|0
5962685|NCT01187550|20620133|P1|Overall Study|Randomized but not treated|8
5962686|NCT01187550|20620132|P2|Overall Study|Other|0
5962687|NCT01187550|20620133|P1|Overall Study|Other|3
5962688|NCT01187550|20620132|P2|Overall Study|Protocol Violation|1
5962689|NCT01187550|20620133|P1|Overall Study|Protocol Violation|3
5962690|NCT01187446|20620289|P2|Overall Study|Patient started non-protocol therapy|1
5962691|NCT01187446|20620290|P1|Overall Study|Patient started non-protocol therapy|0
5962692|NCT01187433|20620306|P2|Overall Study|Withdrawal by Subject|2
5962693|NCT01187433|20620307|P1|Overall Study|Withdrawal by Subject|5
5962694|NCT01187433|20620306|P2|Overall Study|Protocol Violation|2
5962695|NCT01187433|20620307|P1|Overall Study|Protocol Violation|6
5962696|NCT01187407|20620337|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7
5962697|NCT01187407|20620338|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2
5962698|NCT01187407|20620339|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2
5962699|NCT01187407|20620340|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2
5962700|NCT01187407|20620341|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0
5962701|NCT01187407|20620337|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|22
5962702|NCT01187407|20620338|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|11
5962703|NCT01187407|20620339|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9
5962704|NCT01187407|20620340|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9
5962705|NCT01187407|20620341|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0
5962706|NCT01187407|20620337|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|10
5962707|NCT01187407|20620338|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|3
5962708|NCT01187407|20620339|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5
5962709|NCT01187407|20620340|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|6
5962710|NCT01187407|20620341|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0
5962711|NCT01187407|20620337|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2
5962712|NCT01187407|20620338|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1
5962713|NCT01187407|20620339|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
5962714|NCT01187407|20620340|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
5962715|NCT01187407|20620341|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
5962716|NCT01187407|20620337|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9
5962717|NCT01187407|20620338|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2
5962718|NCT01187407|20620339|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5
5962719|NCT01187407|20620340|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3
5962720|NCT01187407|20620341|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0
5962721|NCT01187407|20620337|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|13
5962722|NCT01187407|20620338|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|5
5962723|NCT01187407|20620339|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8
5962724|NCT01187407|20620340|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|3
5962725|NCT01187407|20620341|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0
5962726|NCT01187407|20620337|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|12
5962727|NCT01187407|20620338|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|5
5962728|NCT01187407|20620339|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|6
5962729|NCT01187407|20620340|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13
5962730|NCT01187407|20620341|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0
5962731|NCT01187407|20620337|P5|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
5962732|NCT01187407|20620338|P4|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
5962733|NCT01187407|20620339|P3|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
5962734|NCT01187407|20620340|P2|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
5962735|NCT01187407|20620341|P1|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|4
5962736|NCT01187407|20620337|P5|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
5962737|NCT01187407|20620338|P4|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
5962738|NCT01187407|20620339|P3|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
5962739|NCT01187407|20620340|P2|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
5962740|NCT01187407|20620341|P1|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|29
5962741|NCT01187407|20620337|P5|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
5962742|NCT01187407|20620338|P4|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
5962743|NCT01187407|20620339|P3|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
5962744|NCT01187407|20620340|P2|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
5962745|NCT01187407|20620341|P1|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|13
5962746|NCT01187407|20620337|P5|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
5962747|NCT01187407|20620338|P4|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
5962748|NCT01187407|20620339|P3|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
5962749|NCT01187407|20620340|P2|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
5962750|NCT01187407|20620341|P1|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2
5962751|NCT01187407|20620337|P5|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
5962752|NCT01187407|20620338|P4|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
5962753|NCT01187407|20620339|P3|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
5962754|NCT01187407|20620340|P2|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
5962755|NCT01187407|20620341|P1|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|9
5962756|NCT01187407|20620337|P5|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
5962757|NCT01187407|20620338|P4|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
5962758|NCT01187407|20620339|P3|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
5962759|NCT01187407|20620340|P2|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
5962760|NCT01187407|20620341|P1|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|4
5962761|NCT01187407|20620337|P5|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
5962762|NCT01187407|20620338|P4|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
5962763|NCT01187407|20620339|P3|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
5962764|NCT01187407|20620340|P2|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
5962765|NCT01187407|20620341|P1|Confirmation (CF) Phase, 3 Weeks|Adverse Event|29
5962766|NCT01187043|20620454|P5|Overall Study|Unable to make scheduled visits|1
5962767|NCT01187043|20620455|P4|Overall Study|Unable to make scheduled visits|0
5962768|NCT01187043|20620456|P3|Overall Study|Unable to make scheduled visits|4
5962769|NCT01187043|20620457|P2|Overall Study|Unable to make scheduled visits|0
5962770|NCT01187043|20620458|P1|Overall Study|Unable to make scheduled visits|1
5962771|NCT01187043|20620454|P5|Overall Study|Adverse Event|1
5962772|NCT01187043|20620455|P4|Overall Study|Adverse Event|0
5962773|NCT01187043|20620456|P3|Overall Study|Adverse Event|0
5962774|NCT01187043|20620457|P2|Overall Study|Adverse Event|0
5962775|NCT01187043|20620458|P1|Overall Study|Adverse Event|0
5962776|NCT01186978|20620484|P1|Overall Study|Withdrawal by Subject|1
5962777|NCT01186939|20620491|P1|Overall Study|Transformation to AML|1
5962778|NCT01186939|20620491|P1|Overall Study|Bone marrow transplant|1
5962779|NCT01186939|20620491|P1|Overall Study|Myocardial infarction|1
5962780|NCT01186939|20620491|P1|Overall Study|NCI CTC Grade 3 or 4 toxicity|1
5962781|NCT01186939|20620491|P1|Overall Study|Started additional treatment|1
5962782|NCT01186939|20620491|P1|Overall Study|Sponsor decision|4
5962783|NCT01186939|20620491|P1|Overall Study|Program closed|5
5962784|NCT01186939|20620491|P1|Overall Study|No longer receiving clinical benefit|17
5962785|NCT01186939|20620491|P1|Overall Study|Withdrawal by Subject|2
5962786|NCT01186939|20620491|P1|Overall Study|Death|7
5962787|NCT01186848|20620495|P1|Overall Study|Adverse Event|2
5962788|NCT01186848|20620495|P1|Overall Study|Withdrawal by Subject|2
5962789|NCT01186848|20620495|P1|Overall Study|Lost to Follow-up|4
5962790|NCT01186809|20620501|P1|Overall Study|Death|30
5962791|NCT01186796|20620507|P2|Overall Study|Protocol Violation|1
5962792|NCT01186796|20620508|P1|Overall Study|Protocol Violation|0
5962793|NCT01186796|20620507|P2|Overall Study|Withdrawal by Subject|1
5962794|NCT01186796|20620508|P1|Overall Study|Withdrawal by Subject|1
5962795|NCT01186796|20620507|P2|Overall Study|Adverse Event|0
5962796|NCT01186796|20620508|P1|Overall Study|Adverse Event|3
5962797|NCT01186770|20620526|P4|Overall Study|Other than specified|2
5962798|NCT01186770|20620527|P3|Overall Study|Other than specified|1
5962799|NCT01186770|20620528|P2|Overall Study|Other than specified|1
5962800|NCT01186770|20620529|P1|Overall Study|Other than specified|0
5962801|NCT01186770|20620526|P4|Overall Study|Insufficient response to treatment|7
5962802|NCT01186770|20620527|P3|Overall Study|Insufficient response to treatment|5
5962803|NCT01186770|20620528|P2|Overall Study|Insufficient response to treatment|8
5962804|NCT01186770|20620529|P1|Overall Study|Insufficient response to treatment|7
5962805|NCT01186770|20620526|P4|Overall Study|Lost to Follow-up|9
5962806|NCT01186770|20620527|P3|Overall Study|Lost to Follow-up|14
5962807|NCT01186770|20620528|P2|Overall Study|Lost to Follow-up|6
5962808|NCT01186770|20620529|P1|Overall Study|Lost to Follow-up|10
5962809|NCT01186770|20620526|P4|Overall Study|Withdrawal by Subject|17
5962810|NCT01186770|20620527|P3|Overall Study|Withdrawal by Subject|11
5962811|NCT01186770|20620528|P2|Overall Study|Withdrawal by Subject|13
5962812|NCT01186770|20620529|P1|Overall Study|Withdrawal by Subject|15
5962813|NCT01186770|20620526|P4|Overall Study|Adverse Event|9
5962814|NCT01186770|20620527|P3|Overall Study|Adverse Event|7
5962815|NCT01186770|20620528|P2|Overall Study|Adverse Event|9
5962816|NCT01186770|20620529|P1|Overall Study|Adverse Event|2
5962817|NCT01186770|20620526|P4|Overall Study|Protocol Violation|14
5962818|NCT01186770|20620527|P3|Overall Study|Protocol Violation|12
5962819|NCT01186770|20620528|P2|Overall Study|Protocol Violation|9
5962820|NCT01186770|20620529|P1|Overall Study|Protocol Violation|7
5962821|NCT01186770|20620526|P4|Overall Study|Ineligibility|0
5962822|NCT01186770|20620527|P3|Overall Study|Ineligibility|2
5962823|NCT01186770|20620528|P2|Overall Study|Ineligibility|0
5962824|NCT01186770|20620529|P1|Overall Study|Ineligibility|0
5962825|NCT01186744|20620553|P6|Overall Study|Death|0
5962826|NCT01186744|20620554|P5|Overall Study|Death|0
5962827|NCT01186744|20620555|P4|Overall Study|Death|0
5962828|NCT01186744|20620556|P3|Overall Study|Death|0
5962829|NCT01186744|20620557|P2|Overall Study|Death|0
5962830|NCT01186744|20620558|P1|Overall Study|Death|1
5962831|NCT01186744|20620553|P6|Overall Study|Adverse Event|4
5962832|NCT01186744|20620554|P5|Overall Study|Adverse Event|1
5962833|NCT01186744|20620555|P4|Overall Study|Adverse Event|0
5962834|NCT01186744|20620556|P3|Overall Study|Adverse Event|1
5962835|NCT01186744|20620557|P2|Overall Study|Adverse Event|14
5962836|NCT01186744|20620558|P1|Overall Study|Adverse Event|10
5962837|NCT01186744|20620553|P6|Overall Study|Other|5
5962838|NCT01186744|20620554|P5|Overall Study|Other|1
5962839|NCT01186744|20620555|P4|Overall Study|Other|2
5962840|NCT01186744|20620556|P3|Overall Study|Other|1
5962841|NCT01186744|20620557|P2|Overall Study|Other|10
5962842|NCT01186744|20620558|P1|Overall Study|Other|9
5962843|NCT01186744|20620553|P6|Overall Study|Study terminated by Sponsor|0
5962844|NCT01186744|20620554|P5|Overall Study|Study terminated by Sponsor|0
5962845|NCT01186744|20620555|P4|Overall Study|Study terminated by Sponsor|0
5962846|NCT01186744|20620556|P3|Overall Study|Study terminated by Sponsor|0
5962847|NCT01186744|20620557|P2|Overall Study|Study terminated by Sponsor|0
5962848|NCT01186744|20620558|P1|Overall Study|Study terminated by Sponsor|1
5962849|NCT01186744|20620553|P6|Overall Study|Withdrawal by Subject|6
5962850|NCT01186744|20620554|P5|Overall Study|Withdrawal by Subject|0
5962851|NCT01186744|20620555|P4|Overall Study|Withdrawal by Subject|5
5962852|NCT01186744|20620556|P3|Overall Study|Withdrawal by Subject|2
5962853|NCT01186744|20620557|P2|Overall Study|Withdrawal by Subject|10
5962854|NCT01186744|20620558|P1|Overall Study|Withdrawal by Subject|14
5962855|NCT01186744|20620553|P6|Overall Study|Screen failure|0
5962856|NCT01186744|20620554|P5|Overall Study|Screen failure|0
5962857|NCT01186744|20620555|P4|Overall Study|Screen failure|1
5962858|NCT01186744|20620556|P3|Overall Study|Screen failure|0
5962859|NCT01186744|20620557|P2|Overall Study|Screen failure|1
5962860|NCT01186744|20620558|P1|Overall Study|Screen failure|1
5962861|NCT01186744|20620553|P6|Overall Study|Lost to Follow-up|4
5962862|NCT01186744|20620554|P5|Overall Study|Lost to Follow-up|1
5962863|NCT01186744|20620555|P4|Overall Study|Lost to Follow-up|1
5962864|NCT01186744|20620556|P3|Overall Study|Lost to Follow-up|2
5962865|NCT01186744|20620557|P2|Overall Study|Lost to Follow-up|16
5962866|NCT01186744|20620558|P1|Overall Study|Lost to Follow-up|15
5962867|NCT01186744|20620553|P6|Overall Study|Protocol Violation|2
5962868|NCT01186744|20620554|P5|Overall Study|Protocol Violation|1
5962869|NCT01186744|20620555|P4|Overall Study|Protocol Violation|1
5962870|NCT01186744|20620556|P3|Overall Study|Protocol Violation|0
5962871|NCT01186744|20620557|P2|Overall Study|Protocol Violation|2
5962872|NCT01186744|20620558|P1|Overall Study|Protocol Violation|1
5962873|NCT01186744|20620553|P6|Overall Study|Lack of Efficacy|5
5962874|NCT01186744|20620554|P5|Overall Study|Lack of Efficacy|2
5962875|NCT01186744|20620555|P4|Overall Study|Lack of Efficacy|2
5962876|NCT01186744|20620556|P3|Overall Study|Lack of Efficacy|0
5962877|NCT01186744|20620557|P2|Overall Study|Lack of Efficacy|99
5962878|NCT01186744|20620558|P1|Overall Study|Lack of Efficacy|156
5962879|NCT01186692|20620978|P1|Overall Study|Adverse Event|2
5962880|NCT01186692|20620978|P1|Overall Study|Futher testing contraindicated implant|19
5962881|NCT01186692|20620978|P1|Overall Study|Not Catheterized|11
5962882|NCT01186458|20621005|P1|Overall Study|Adverse Event|1
5962883|NCT01186419|20621014|P2|Overall Study|Other|1
5962884|NCT01186419|20621015|P1|Overall Study|Other|1
5962885|NCT01186419|20621014|P2|Overall Study|Physician Decision|3
5962886|NCT01186419|20621015|P1|Overall Study|Physician Decision|0
5962887|NCT01186419|20621014|P2|Overall Study|Adverse Event|2
5962888|NCT01186419|20621015|P1|Overall Study|Adverse Event|1
5962889|NCT01186419|20621014|P2|Overall Study|Withdrawal by Subject|3
5962890|NCT01186419|20621015|P1|Overall Study|Withdrawal by Subject|5
5962891|NCT01186328|20621029|P3|Overall Study|Death|0
5962892|NCT01186328|20621030|P2|Overall Study|Death|0
5962893|NCT01186328|20621031|P1|Overall Study|Death|1
5962894|NCT01185964|20621061|P4|Optional Olaratumab Monotherapy on Dox|On Study Treatment|2
5962895|NCT01185964|20621062|P3|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0
5962896|NCT01185964|20621063|P2|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0
5962897|NCT01185964|20621064|P1|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0
5962898|NCT01185964|20621061|P4|Optional Olaratumab Monotherapy on Dox|Adverse Event|1
5962899|NCT01185964|20621062|P3|Optional Olaratumab Monotherapy on Dox|Adverse Event|0
5962900|NCT01185964|20621063|P2|Optional Olaratumab Monotherapy on Dox|Adverse Event|0
5962901|NCT01185964|20621064|P1|Optional Olaratumab Monotherapy on Dox|Adverse Event|0
5962902|NCT01185964|20621061|P4|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|2
5962903|NCT01185964|20621062|P3|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0
5962904|NCT01185964|20621063|P2|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0
5962905|NCT01185964|20621064|P1|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0
5962906|NCT01185964|20621061|P4|Phase 1b and Phase 2|Off Treatment but alive and on study|0
5962907|NCT01185964|20621062|P3|Phase 1b and Phase 2|Off Treatment but alive and on study|1
5962908|NCT01185964|20621063|P2|Phase 1b and Phase 2|Off Treatment but alive and on study|1
5962909|NCT01185964|20621064|P1|Phase 1b and Phase 2|Off Treatment but alive and on study|0
5962910|NCT01185964|20621061|P4|Phase 1b and Phase 2|Adverse Event|0
5962911|NCT01185964|20621062|P3|Phase 1b and Phase 2|Adverse Event|2
5962912|NCT01185964|20621063|P2|Phase 1b and Phase 2|Adverse Event|0
5962913|NCT01185964|20621064|P1|Phase 1b and Phase 2|Adverse Event|1
5962914|NCT01185964|20621061|P4|Phase 1b and Phase 2|Participant was beyond maximum weight|0
5962915|NCT01185964|20621062|P3|Phase 1b and Phase 2|Participant was beyond maximum weight|1
5962916|NCT01185964|20621063|P2|Phase 1b and Phase 2|Participant was beyond maximum weight|0
5962917|NCT01185964|20621064|P1|Phase 1b and Phase 2|Participant was beyond maximum weight|0
5962918|NCT01185964|20621061|P4|Phase 1b and Phase 2|Other Therapy Started|0
5962919|NCT01185964|20621062|P3|Phase 1b and Phase 2|Other Therapy Started|3
5962920|NCT01185964|20621063|P2|Phase 1b and Phase 2|Other Therapy Started|3
5962921|NCT01185964|20621064|P1|Phase 1b and Phase 2|Other Therapy Started|0
5962922|NCT01185964|20621061|P4|Phase 1b and Phase 2|Withdrawal by Subject|0
5962923|NCT01185964|20621062|P3|Phase 1b and Phase 2|Withdrawal by Subject|2
5962924|NCT01185964|20621063|P2|Phase 1b and Phase 2|Withdrawal by Subject|6
5962925|NCT01185964|20621064|P1|Phase 1b and Phase 2|Withdrawal by Subject|1
5962926|NCT01185834|20621090|P1|Overall Study|Early exit - Site error|2
5962927|NCT01185834|20621090|P1|Overall Study|Time/Job Conflict|2
5962928|NCT01185834|20621090|P1|Overall Study|Biomicroscopy|4
5962929|NCT01185834|20621090|P1|Overall Study|Discomfort|4
5962930|NCT01185834|20621090|P1|Overall Study|Lost to Follow-up|2
5962931|NCT01185821|20621100|P5|Overall Study|Administrative problems|2
5962932|NCT01185821|20621101|P4|Overall Study|Administrative problems|1
5962933|NCT01185821|20621102|P3|Overall Study|Administrative problems|1
5962934|NCT01185821|20621103|P2|Overall Study|Administrative problems|0
5962935|NCT01185821|20621104|P1|Overall Study|Administrative problems|0
5962936|NCT01185821|20621100|P5|Overall Study|Lost to Follow-up|2
5962937|NCT01185821|20621101|P4|Overall Study|Lost to Follow-up|1
5962938|NCT01185821|20621102|P3|Overall Study|Lost to Follow-up|2
5962939|NCT01185821|20621103|P2|Overall Study|Lost to Follow-up|1
5962940|NCT01185821|20621104|P1|Overall Study|Lost to Follow-up|1
5962941|NCT01185821|20621100|P5|Overall Study|Withdrawal by Subject|3
5962942|NCT01185821|20621101|P4|Overall Study|Withdrawal by Subject|1
5962943|NCT01185821|20621102|P3|Overall Study|Withdrawal by Subject|2
5962944|NCT01185821|20621103|P2|Overall Study|Withdrawal by Subject|2
5962945|NCT01185821|20621104|P1|Overall Study|Withdrawal by Subject|3
5962946|NCT01185821|20621100|P5|Overall Study|Lack of Efficacy|9
5962947|NCT01185821|20621101|P4|Overall Study|Lack of Efficacy|0
5962948|NCT01185821|20621102|P3|Overall Study|Lack of Efficacy|3
5962949|NCT01185821|20621103|P2|Overall Study|Lack of Efficacy|0
5962950|NCT01185821|20621104|P1|Overall Study|Lack of Efficacy|0
5962951|NCT01185821|20621100|P5|Overall Study|Adverse Event|5
5962952|NCT01185821|20621101|P4|Overall Study|Adverse Event|2
5962953|NCT01185821|20621102|P3|Overall Study|Adverse Event|1
5962954|NCT01185821|20621103|P2|Overall Study|Adverse Event|3
5962955|NCT01185821|20621104|P1|Overall Study|Adverse Event|2
5962956|NCT01185821|20621100|P5|Overall Study|Condition no longer required study drug|1
5962957|NCT01185821|20621101|P4|Overall Study|Condition no longer required study drug|0
5962958|NCT01185821|20621102|P3|Overall Study|Condition no longer required study drug|0
5962959|NCT01185821|20621103|P2|Overall Study|Condition no longer required study drug|0
5962960|NCT01185821|20621104|P1|Overall Study|Condition no longer required study drug|0
5962961|NCT01185821|20621100|P5|Overall Study|Death|0
5962962|NCT01185821|20621101|P4|Overall Study|Death|0
5962963|NCT01185821|20621102|P3|Overall Study|Death|0
5962964|NCT01185821|20621103|P2|Overall Study|Death|1
5962965|NCT01185821|20621104|P1|Overall Study|Death|0
5962966|NCT01185821|20621100|P5|Overall Study|Abnormal test procedure result|1
5962967|NCT01185821|20621101|P4|Overall Study|Abnormal test procedure result|0
5962968|NCT01185821|20621102|P3|Overall Study|Abnormal test procedure result|0
5962969|NCT01185821|20621103|P2|Overall Study|Abnormal test procedure result|0
5962970|NCT01185821|20621104|P1|Overall Study|Abnormal test procedure result|0
5962971|NCT01185821|20621100|P5|Overall Study|Protocol Violation|1
5962972|NCT01185821|20621101|P4|Overall Study|Protocol Violation|1
5962973|NCT01185821|20621102|P3|Overall Study|Protocol Violation|0
5962974|NCT01185821|20621103|P2|Overall Study|Protocol Violation|0
5962975|NCT01185821|20621104|P1|Overall Study|Protocol Violation|0
5962976|NCT01185821|20621100|P5|Overall Study|Abnormal laboratory value(s)|0
5962977|NCT01185821|20621101|P4|Overall Study|Abnormal laboratory value(s)|0
5962978|NCT01185821|20621102|P3|Overall Study|Abnormal laboratory value(s)|1
5962979|NCT01185821|20621103|P2|Overall Study|Abnormal laboratory value(s)|2
5962980|NCT01185821|20621104|P1|Overall Study|Abnormal laboratory value(s)|1
5962981|NCT01185782|20621155|P2|Overall Study|Randomized but not treated|4
5962982|NCT01185782|20621156|P1|Overall Study|Randomized but not treated|0
5962983|NCT01185782|20621155|P2|Overall Study|Other|5
5962984|NCT01185782|20621156|P1|Overall Study|Other|2
5962985|NCT01185782|20621155|P2|Overall Study|Poor Response to Treatment|1
5962986|NCT01185782|20621156|P1|Overall Study|Poor Response to Treatment|3
5962987|NCT01185782|20621155|P2|Overall Study|Protocol Violation|0
5962988|NCT01185782|20621156|P1|Overall Study|Protocol Violation|1
5962989|NCT01185782|20621155|P2|Overall Study|Adverse Event|1
5962990|NCT01185782|20621156|P1|Overall Study|Adverse Event|0
5962991|NCT01185704|20621184|P2|Overall Study|Ectopic pregnancy|1
5962992|NCT01185704|20621185|P1|Overall Study|Ectopic pregnancy|0
5962993|NCT01185704|20621184|P2|Overall Study|Ovarian hyperstimulation syndrome risk|3
5962994|NCT01185704|20621185|P1|Overall Study|Ovarian hyperstimulation syndrome risk|5
5962995|NCT01185704|20621184|P2|Overall Study|Lack of ovarian response|1
5962996|NCT01185704|20621185|P1|Overall Study|Lack of ovarian response|5
5962997|NCT01185704|20621184|P2|Overall Study|Randomized but not treated|3
5962998|NCT01185704|20621185|P1|Overall Study|Randomized but not treated|3
5962999|NCT01185639|20621219|P1|Overall Study|Progressed and didn't receive therapy|2
5963000|NCT01185600|20621229|P2|Overall Study|Hold by DSMB|2
5963001|NCT01185600|20621230|P1|Overall Study|Hold by DSMB|1
5963002|NCT01185600|20621229|P2|Overall Study|Withdrawal by Subject|1
5963003|NCT01185600|20621230|P1|Overall Study|Withdrawal by Subject|1
5963004|NCT01185600|20621229|P2|Overall Study|Physician Decision|35
5963005|NCT01185600|20621230|P1|Overall Study|Physician Decision|29
5963006|NCT01185600|20621229|P2|Overall Study|Lost to Follow-up|5
5963007|NCT01185600|20621230|P1|Overall Study|Lost to Follow-up|0
5963008|NCT01185600|20621229|P2|Overall Study|Death|1
5963009|NCT01185600|20621230|P1|Overall Study|Death|0
5963010|NCT01185600|20621229|P2|Overall Study|Adverse Event|1
5963011|NCT01185600|20621230|P1|Overall Study|Adverse Event|1
5963012|NCT01185561|20621252|P2|Overall Study|Withdrawal by Subject|8
5963013|NCT01185561|20621253|P1|Overall Study|Withdrawal by Subject|2
5963014|NCT01185561|20621252|P2|Overall Study|Lost to Follow-up|4
5963015|NCT01185561|20621253|P1|Overall Study|Lost to Follow-up|0
5963016|NCT01185548|20621265|P1|Period 2: Tasisulam and Tolbutamide|Sponsor Decision|2
5963017|NCT01185522|20621278|P1|Overall Study|Other reasons|12
5963018|NCT01185522|20621278|P1|Overall Study|Poor tolerance|39
5963019|NCT01185522|20621278|P1|Overall Study|Withdrawal by Subject|10
5963020|NCT01185522|20621278|P1|Overall Study|Lost to Follow-up|19
5963021|NCT01185522|20621278|P1|Overall Study|Lack of Efficacy|28
5963022|NCT01185509|20621304|P2|Overall Study|Intercurrent Illness|1
5963023|NCT01185509|20621305|P1|Overall Study|Intercurrent Illness|0
5963024|NCT01185509|20621304|P2|Overall Study|Death|1
5963025|NCT01185509|20621305|P1|Overall Study|Death|0
5963026|NCT01185509|20621304|P2|Overall Study|Withdrawal by Subject|1
5963027|NCT01185509|20621305|P1|Overall Study|Withdrawal by Subject|0
5963028|NCT01185509|20621304|P2|Overall Study|Physician Decision|2
5963029|NCT01185509|20621305|P1|Overall Study|Physician Decision|2
5963030|NCT01185509|20621304|P2|Overall Study|Progression/Relapse|15
5963031|NCT01185509|20621305|P1|Overall Study|Progression/Relapse|9
5963032|NCT01185353|20621321|P10|Part D (Weeks 76 Through 128)|Adverse Event|0
5963033|NCT01185353|20621322|P9|Part D (Weeks 76 Through 128)|Adverse Event|2
5963034|NCT01185353|20621323|P8|Part D (Weeks 76 Through 128)|Adverse Event|1
5963035|NCT01185353|20621324|P7|Part D (Weeks 76 Through 128)|Adverse Event|0
5963036|NCT01185353|20621325|P6|Part D (Weeks 76 Through 128)|Adverse Event|0
5963037|NCT01185353|20621326|P5|Part D (Weeks 76 Through 128)|Adverse Event|0
5963038|NCT01185353|20621327|P4|Part D (Weeks 76 Through 128)|Adverse Event|0
5963039|NCT01185353|20621328|P3|Part D (Weeks 76 Through 128)|Adverse Event|0
5963040|NCT01185353|20621329|P2|Part D (Weeks 76 Through 128)|Adverse Event|0
5963041|NCT01185353|20621330|P1|Part D (Weeks 76 Through 128)|Adverse Event|0
5963042|NCT01185353|20621321|P10|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1
5963043|NCT01185353|20621322|P9|Part D (Weeks 76 Through 128)|Withdrawal by Subject|2
5963044|NCT01185353|20621323|P8|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1
5963045|NCT01185353|20621324|P7|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
5963046|NCT01185353|20621325|P6|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
5963047|NCT01185353|20621326|P5|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
5963048|NCT01185353|20621327|P4|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
5963049|NCT01185353|20621328|P3|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
5963050|NCT01185353|20621329|P2|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
5963051|NCT01185353|20621330|P1|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
5963052|NCT01185353|20621321|P10|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
5963053|NCT01185353|20621322|P9|Part D (Weeks 76 Through 128)|Lost to Follow-up|3
5963054|NCT01185353|20621323|P8|Part D (Weeks 76 Through 128)|Lost to Follow-up|1
5963055|NCT01185353|20621324|P7|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
5963056|NCT01185353|20621325|P6|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
5963057|NCT01185353|20621326|P5|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
5963058|NCT01185353|20621327|P4|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
5963059|NCT01185353|20621328|P3|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
5963060|NCT01185353|20621329|P2|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
5963061|NCT01185353|20621330|P1|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
5963062|NCT01185353|20621321|P10|Part C (Weeks 24 Through 76)|Reason missing|0
5963063|NCT01185353|20621322|P9|Part C (Weeks 24 Through 76)|Reason missing|1
5963064|NCT01185353|20621323|P8|Part C (Weeks 24 Through 76)|Reason missing|0
5963065|NCT01185353|20621324|P7|Part C (Weeks 24 Through 76)|Reason missing|0
5963066|NCT01185353|20621325|P6|Part C (Weeks 24 Through 76)|Reason missing|0
5963067|NCT01185353|20621326|P5|Part C (Weeks 24 Through 76)|Reason missing|0
5963068|NCT01185353|20621327|P4|Part C (Weeks 24 Through 76)|Reason missing|0
5963069|NCT01185353|20621328|P3|Part C (Weeks 24 Through 76)|Reason missing|0
5963070|NCT01185353|20621329|P2|Part C (Weeks 24 Through 76)|Reason missing|0
5963071|NCT01185353|20621330|P1|Part C (Weeks 24 Through 76)|Reason missing|0
5963072|NCT01185353|20621321|P10|Part C (Weeks 24 Through 76)|Physician Decision|1
5963073|NCT01185353|20621322|P9|Part C (Weeks 24 Through 76)|Physician Decision|0
5963074|NCT01185353|20621323|P8|Part C (Weeks 24 Through 76)|Physician Decision|0
5963075|NCT01185353|20621324|P7|Part C (Weeks 24 Through 76)|Physician Decision|0
5963076|NCT01185353|20621325|P6|Part C (Weeks 24 Through 76)|Physician Decision|0
5963077|NCT01185353|20621326|P5|Part C (Weeks 24 Through 76)|Physician Decision|0
5963078|NCT01185353|20621327|P4|Part C (Weeks 24 Through 76)|Physician Decision|0
5963079|NCT01185353|20621328|P3|Part C (Weeks 24 Through 76)|Physician Decision|0
5963080|NCT01185353|20621329|P2|Part C (Weeks 24 Through 76)|Physician Decision|0
5963081|NCT01185353|20621330|P1|Part C (Weeks 24 Through 76)|Physician Decision|0
5963082|NCT01185353|20621321|P10|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|1
5963083|NCT01185353|20621322|P9|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
5963084|NCT01185353|20621323|P8|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
5963085|NCT01185353|20621324|P7|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
5963086|NCT01185353|20621325|P6|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
5963087|NCT01185353|20621326|P5|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
5963088|NCT01185353|20621327|P4|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
5963089|NCT01185353|20621328|P3|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
5963090|NCT01185353|20621329|P2|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
5963091|NCT01185353|20621330|P1|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
5963092|NCT01185353|20621321|P10|Part C (Weeks 24 Through 76)|Death|1
5963093|NCT01185353|20621322|P9|Part C (Weeks 24 Through 76)|Death|0
5963094|NCT01185353|20621323|P8|Part C (Weeks 24 Through 76)|Death|0
5963095|NCT01185353|20621324|P7|Part C (Weeks 24 Through 76)|Death|0
5963096|NCT01185353|20621325|P6|Part C (Weeks 24 Through 76)|Death|0
5963097|NCT01185353|20621326|P5|Part C (Weeks 24 Through 76)|Death|0
5963098|NCT01185353|20621327|P4|Part C (Weeks 24 Through 76)|Death|0
5963099|NCT01185353|20621328|P3|Part C (Weeks 24 Through 76)|Death|0
5963100|NCT01185353|20621329|P2|Part C (Weeks 24 Through 76)|Death|0
5963101|NCT01185353|20621330|P1|Part C (Weeks 24 Through 76)|Death|0
5963102|NCT01185353|20621321|P10|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
5963103|NCT01185353|20621322|P9|Part C (Weeks 24 Through 76)|Lack of Efficacy|2
5963104|NCT01185353|20621323|P8|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
5963105|NCT01185353|20621324|P7|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
5963106|NCT01185353|20621325|P6|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
5963107|NCT01185353|20621326|P5|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
5963108|NCT01185353|20621327|P4|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
5963109|NCT01185353|20621328|P3|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
5963110|NCT01185353|20621329|P2|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
5963111|NCT01185353|20621330|P1|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
5963112|NCT01185353|20621321|P10|Part C (Weeks 24 Through 76)|Lost to Follow-up|1
5963113|NCT01185353|20621322|P9|Part C (Weeks 24 Through 76)|Lost to Follow-up|1
5963114|NCT01185353|20621323|P8|Part C (Weeks 24 Through 76)|Lost to Follow-up|2
5963115|NCT01185353|20621324|P7|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
5963116|NCT01185353|20621325|P6|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
5963117|NCT01185353|20621326|P5|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
5963118|NCT01185353|20621327|P4|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
5963119|NCT01185353|20621328|P3|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
5963120|NCT01185353|20621329|P2|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
5963121|NCT01185353|20621330|P1|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
5963122|NCT01185353|20621321|P10|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2
5963123|NCT01185353|20621322|P9|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2
5963124|NCT01185353|20621323|P8|Part C (Weeks 24 Through 76)|Withdrawal by Subject|6
5963125|NCT01185353|20621324|P7|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
5963126|NCT01185353|20621325|P6|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
5963127|NCT01185353|20621326|P5|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
5963128|NCT01185353|20621327|P4|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
5963129|NCT01185353|20621328|P3|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
5963130|NCT01185353|20621329|P2|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
5963131|NCT01185353|20621330|P1|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
5963132|NCT01185353|20621321|P10|Part C (Weeks 24 Through 76)|Adverse Event|2
5963133|NCT01185353|20621322|P9|Part C (Weeks 24 Through 76)|Adverse Event|2
5963134|NCT01185353|20621323|P8|Part C (Weeks 24 Through 76)|Adverse Event|8
5963135|NCT01185353|20621324|P7|Part C (Weeks 24 Through 76)|Adverse Event|0
5963136|NCT01185353|20621325|P6|Part C (Weeks 24 Through 76)|Adverse Event|0
5963137|NCT01185353|20621326|P5|Part C (Weeks 24 Through 76)|Adverse Event|0
5963138|NCT01185353|20621327|P4|Part C (Weeks 24 Through 76)|Adverse Event|0
5963139|NCT01185353|20621328|P3|Part C (Weeks 24 Through 76)|Adverse Event|0
5963140|NCT01185353|20621329|P2|Part C (Weeks 24 Through 76)|Adverse Event|0
5963141|NCT01185353|20621330|P1|Part C (Weeks 24 Through 76)|Adverse Event|0
5963142|NCT01185353|20621321|P10|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
5963143|NCT01185353|20621322|P9|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
5963144|NCT01185353|20621323|P8|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
5963145|NCT01185353|20621324|P7|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|1
5963146|NCT01185353|20621325|P6|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
5963147|NCT01185353|20621326|P5|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
5963148|NCT01185353|20621327|P4|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
5963149|NCT01185353|20621328|P3|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
5963150|NCT01185353|20621329|P2|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
5963151|NCT01185353|20621330|P1|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
5963152|NCT01185353|20621321|P10|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
5963153|NCT01185353|20621322|P9|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
5963154|NCT01185353|20621323|P8|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
5963155|NCT01185353|20621324|P7|Part B (Weeks 12 Through 24)|Withdrawal by Subject|4
5963156|NCT01185353|20621325|P6|Part B (Weeks 12 Through 24)|Withdrawal by Subject|3
5963157|NCT01185353|20621326|P5|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
5963158|NCT01185353|20621327|P4|Part B (Weeks 12 Through 24)|Withdrawal by Subject|2
5963159|NCT01185353|20621328|P3|Part B (Weeks 12 Through 24)|Withdrawal by Subject|1
5963160|NCT01185353|20621329|P2|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
5963161|NCT01185353|20621330|P1|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
5963162|NCT01185353|20621321|P10|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
5963163|NCT01185353|20621322|P9|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
5963164|NCT01185353|20621323|P8|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
5963165|NCT01185353|20621324|P7|Part B (Weeks 12 Through 24)|Lost to Follow-up|1
5963166|NCT01185353|20621325|P6|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
5963167|NCT01185353|20621326|P5|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
5963168|NCT01185353|20621327|P4|Part B (Weeks 12 Through 24)|Lost to Follow-up|1
5963169|NCT01185353|20621328|P3|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
5963170|NCT01185353|20621329|P2|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
5963171|NCT01185353|20621330|P1|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
5963172|NCT01185353|20621321|P10|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
5963173|NCT01185353|20621322|P9|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
5963174|NCT01185353|20621323|P8|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
5963175|NCT01185353|20621324|P7|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
5963176|NCT01185353|20621325|P6|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
5963177|NCT01185353|20621326|P5|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
5963178|NCT01185353|20621327|P4|Part B (Weeks 12 Through 24)|Lack of Efficacy|1
5963179|NCT01185353|20621328|P3|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
5963180|NCT01185353|20621329|P2|Part B (Weeks 12 Through 24)|Lack of Efficacy|1
5963181|NCT01185353|20621330|P1|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
5963182|NCT01185353|20621321|P10|Part B (Weeks 12 Through 24)|Adverse Event|0
5963183|NCT01185353|20621322|P9|Part B (Weeks 12 Through 24)|Adverse Event|0
5963184|NCT01185353|20621323|P8|Part B (Weeks 12 Through 24)|Adverse Event|0
5963185|NCT01185353|20621324|P7|Part B (Weeks 12 Through 24)|Adverse Event|0
5963186|NCT01185353|20621325|P6|Part B (Weeks 12 Through 24)|Adverse Event|1
5963187|NCT01185353|20621326|P5|Part B (Weeks 12 Through 24)|Adverse Event|0
5963188|NCT01185353|20621327|P4|Part B (Weeks 12 Through 24)|Adverse Event|0
5963189|NCT01185353|20621328|P3|Part B (Weeks 12 Through 24)|Adverse Event|1
5963190|NCT01185353|20621329|P2|Part B (Weeks 12 Through 24)|Adverse Event|0
5963191|NCT01185353|20621330|P1|Part B (Weeks 12 Through 24)|Adverse Event|0
5963192|NCT01185353|20621321|P10|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
5963193|NCT01185353|20621322|P9|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
5963194|NCT01185353|20621323|P8|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
5963195|NCT01185353|20621324|P7|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
5963196|NCT01185353|20621325|P6|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
5963197|NCT01185353|20621326|P5|Part A (Weeks 0 Through 12)|Withdrawal by Subject|3
5963198|NCT01185353|20621327|P4|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
5963199|NCT01185353|20621328|P3|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
5963200|NCT01185353|20621329|P2|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
5963201|NCT01185353|20621330|P1|Part A (Weeks 0 Through 12)|Withdrawal by Subject|2
5963202|NCT01185353|20621321|P10|Part A (Weeks 0 Through 12)|Protocol Violation|0
5963203|NCT01185353|20621322|P9|Part A (Weeks 0 Through 12)|Protocol Violation|0
5963204|NCT01185353|20621323|P8|Part A (Weeks 0 Through 12)|Protocol Violation|0
5963205|NCT01185353|20621324|P7|Part A (Weeks 0 Through 12)|Protocol Violation|0
5963206|NCT01185353|20621325|P6|Part A (Weeks 0 Through 12)|Protocol Violation|0
5963207|NCT01185353|20621326|P5|Part A (Weeks 0 Through 12)|Protocol Violation|1
5963208|NCT01185353|20621327|P4|Part A (Weeks 0 Through 12)|Protocol Violation|0
5963209|NCT01185353|20621328|P3|Part A (Weeks 0 Through 12)|Protocol Violation|0
5963210|NCT01185353|20621329|P2|Part A (Weeks 0 Through 12)|Protocol Violation|0
5963211|NCT01185353|20621330|P1|Part A (Weeks 0 Through 12)|Protocol Violation|0
5963212|NCT01185353|20621321|P10|Part A (Weeks 0 Through 12)|Physician Decision|0
5963213|NCT01185353|20621322|P9|Part A (Weeks 0 Through 12)|Physician Decision|0
5963214|NCT01185353|20621323|P8|Part A (Weeks 0 Through 12)|Physician Decision|0
5963215|NCT01185353|20621324|P7|Part A (Weeks 0 Through 12)|Physician Decision|0
5963216|NCT01185353|20621325|P6|Part A (Weeks 0 Through 12)|Physician Decision|0
5963217|NCT01185353|20621326|P5|Part A (Weeks 0 Through 12)|Physician Decision|2
5963218|NCT01185353|20621327|P4|Part A (Weeks 0 Through 12)|Physician Decision|0
5963219|NCT01185353|20621328|P3|Part A (Weeks 0 Through 12)|Physician Decision|1
5963220|NCT01185353|20621329|P2|Part A (Weeks 0 Through 12)|Physician Decision|0
5963221|NCT01185353|20621330|P1|Part A (Weeks 0 Through 12)|Physician Decision|0
5963222|NCT01185353|20621321|P10|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
5963223|NCT01185353|20621322|P9|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
5963224|NCT01185353|20621323|P8|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
5963225|NCT01185353|20621324|P7|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
5963226|NCT01185353|20621325|P6|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
5963227|NCT01185353|20621326|P5|Part A (Weeks 0 Through 12)|Lack of Efficacy|1
5963228|NCT01185353|20621327|P4|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
5963229|NCT01185353|20621328|P3|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
5963230|NCT01185353|20621329|P2|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
5963231|NCT01185353|20621330|P1|Part A (Weeks 0 Through 12)|Lack of Efficacy|2
5963232|NCT01185353|20621321|P10|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
5963233|NCT01185353|20621322|P9|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
5963234|NCT01185353|20621323|P8|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
5963235|NCT01185353|20621324|P7|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
5963236|NCT01185353|20621325|P6|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
5963237|NCT01185353|20621326|P5|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|4
5963238|NCT01185353|20621327|P4|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
5963239|NCT01185353|20621328|P3|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
5963240|NCT01185353|20621329|P2|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
5963241|NCT01185353|20621330|P1|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
5963242|NCT01185353|20621321|P10|Part A (Weeks 0 Through 12)|Adverse Event|0
5963243|NCT01185353|20621322|P9|Part A (Weeks 0 Through 12)|Adverse Event|0
5963244|NCT01185353|20621323|P8|Part A (Weeks 0 Through 12)|Adverse Event|0
5963245|NCT01185353|20621324|P7|Part A (Weeks 0 Through 12)|Adverse Event|0
5963246|NCT01185353|20621325|P6|Part A (Weeks 0 Through 12)|Adverse Event|0
5963247|NCT01185353|20621326|P5|Part A (Weeks 0 Through 12)|Adverse Event|5
5963248|NCT01185353|20621327|P4|Part A (Weeks 0 Through 12)|Adverse Event|1
5963249|NCT01185353|20621328|P3|Part A (Weeks 0 Through 12)|Adverse Event|1
5963250|NCT01185353|20621329|P2|Part A (Weeks 0 Through 12)|Adverse Event|1
5963251|NCT01185353|20621330|P1|Part A (Weeks 0 Through 12)|Adverse Event|1
5963252|NCT01185340|20621491|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7
5963253|NCT01185340|20621492|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|3
5963254|NCT01185340|20621493|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0
5963255|NCT01185340|20621494|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0
5963256|NCT01185340|20621491|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24
5963257|NCT01185340|20621492|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8
5963258|NCT01185340|20621493|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8
5963259|NCT01185340|20621494|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0
5963260|NCT01185340|20621491|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5
5963261|NCT01185340|20621492|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|2
5963262|NCT01185340|20621493|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5
5963263|NCT01185340|20621494|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0
5963264|NCT01185340|20621491|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1
5963265|NCT01185340|20621492|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
5963266|NCT01185340|20621493|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1
5963267|NCT01185340|20621494|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
5963268|NCT01185340|20621491|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|7
5963269|NCT01185340|20621492|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5
5963270|NCT01185340|20621493|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|4
5963271|NCT01185340|20621494|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0
5963272|NCT01185340|20621491|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4
5963273|NCT01185340|20621492|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|7
5963274|NCT01185340|20621493|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4
5963275|NCT01185340|20621494|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0
5963276|NCT01185340|20621491|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13
5963277|NCT01185340|20621492|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|8
5963278|NCT01185340|20621493|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13
5963279|NCT01185340|20621494|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0
5963280|NCT01185340|20621491|P4|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
5963281|NCT01185340|20621492|P3|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
5963282|NCT01185340|20621493|P2|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
5963283|NCT01185340|20621494|P1|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|3
5963284|NCT01185340|20621491|P4|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
5963285|NCT01185340|20621492|P3|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
5963286|NCT01185340|20621493|P2|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
5963287|NCT01185340|20621494|P1|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|32
5963288|NCT01185340|20621491|P4|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
5963289|NCT01185340|20621492|P3|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
5963290|NCT01185340|20621493|P2|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
5963291|NCT01185340|20621494|P1|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|16
5963292|NCT01185340|20621491|P4|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
5963293|NCT01185340|20621492|P3|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
5963294|NCT01185340|20621493|P2|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
5963295|NCT01185340|20621494|P1|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2
5963296|NCT01185340|20621491|P4|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
5963297|NCT01185340|20621492|P3|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
5963298|NCT01185340|20621493|P2|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
5963299|NCT01185340|20621494|P1|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|5
5963300|NCT01185340|20621491|P4|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
5963301|NCT01185340|20621492|P3|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
5963302|NCT01185340|20621493|P2|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
5963303|NCT01185340|20621494|P1|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|6
5963304|NCT01185340|20621491|P4|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
5963305|NCT01185340|20621492|P3|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
5963306|NCT01185340|20621493|P2|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
5963307|NCT01185340|20621494|P1|Confirmation (CF) Phase, 3 Weeks|Adverse Event|24
5963308|NCT01185301|20621546|P4|Overall Study|Other Reason|2
5963309|NCT01185301|20621547|P3|Overall Study|Other Reason|2
5963310|NCT01185301|20621548|P2|Overall Study|Other Reason|2
5963311|NCT01185301|20621549|P1|Overall Study|Other Reason|3
5963312|NCT01185301|20621546|P4|Overall Study|Lost to Follow-up|1
5963313|NCT01185301|20621547|P3|Overall Study|Lost to Follow-up|0
5963314|NCT01185301|20621548|P2|Overall Study|Lost to Follow-up|0
5963315|NCT01185301|20621549|P1|Overall Study|Lost to Follow-up|2
5963316|NCT01185301|20621546|P4|Overall Study|Withdrawal by Subject|3
5963317|NCT01185301|20621547|P3|Overall Study|Withdrawal by Subject|2
5963318|NCT01185301|20621548|P2|Overall Study|Withdrawal by Subject|5
5963319|NCT01185301|20621549|P1|Overall Study|Withdrawal by Subject|7
5963320|NCT01185301|20621546|P4|Overall Study|Adverse Event|3
5963321|NCT01185301|20621547|P3|Overall Study|Adverse Event|2
5963322|NCT01185301|20621548|P2|Overall Study|Adverse Event|0
5963323|NCT01185301|20621549|P1|Overall Study|Adverse Event|3
5963324|NCT01185288|20621609|P2|Overall Study|Noncompliance|1
5963325|NCT01185288|20621610|P1|Overall Study|Noncompliance|0
5963326|NCT01185288|20621609|P2|Overall Study|Did not meet inclusion criteria|0
5963327|NCT01185288|20621610|P1|Overall Study|Did not meet inclusion criteria|1
5963328|NCT01185288|20621609|P2|Overall Study|Investigator discretion|0
5963329|NCT01185288|20621610|P1|Overall Study|Investigator discretion|1
5963330|NCT01185288|20621609|P2|Overall Study|Lack of Efficacy|0
5963331|NCT01185288|20621610|P1|Overall Study|Lack of Efficacy|2
5963332|NCT01185288|20621609|P2|Overall Study|Lost to Follow-up|5
5963333|NCT01185288|20621610|P1|Overall Study|Lost to Follow-up|2
5963334|NCT01185288|20621609|P2|Overall Study|Withdrawal by Subject|4
5963335|NCT01185288|20621610|P1|Overall Study|Withdrawal by Subject|6
5963336|NCT01185288|20621609|P2|Overall Study|Adverse Event|6
5963337|NCT01185288|20621610|P1|Overall Study|Adverse Event|7
5963338|NCT01185249|20621628|P1|Overall Study|Patients discharged or change in status|42
5963339|NCT01185171|20621633|P1|Maintenance|Disease Recurrence|1
5963340|NCT01185171|20621633|P1|Maintenance|Withdrawal by Subject|1
5963341|NCT01185171|20621633|P1|Maintenance|Comorbid Illness|2
5963342|NCT01185171|20621633|P1|Maintenance|Nausea|1
5963343|NCT01185171|20621633|P1|Maintenance|Xerostomia|1
5963344|NCT01185171|20621633|P1|Maintenance|Diarrhea|1
5963345|NCT01185171|20621633|P1|Maintenance|Rush|2
5963346|NCT01185171|20621633|P1|Maintenance|Elevated liver transaminases|3
5963347|NCT01185171|20621633|P1|Concurrent Chemo and Radiation Treatment|Death|3
5963348|NCT01185171|20621633|P1|Induction Chemotherapy|Duodenal Ulcer|1
5963349|NCT01185171|20621633|P1|Induction Chemotherapy|Withdrawal by Subject|1
5963350|NCT01185080|20621643|P3|Overall Study|Personal reasons|1
5963351|NCT01185080|20621644|P2|Overall Study|Personal reasons|0
5963352|NCT01185080|20621645|P1|Overall Study|Personal reasons|0
5963353|NCT01185080|20621643|P3|Overall Study|Adverse Event|0
5963354|NCT01185080|20621644|P2|Overall Study|Adverse Event|1
5963355|NCT01185080|20621645|P1|Overall Study|Adverse Event|1
5963356|NCT01184989|20621697|P1|Overall Study|Withdrawal by Subject|1
5963357|NCT01184989|20621697|P1|Overall Study|Adverse Event|11
5963358|NCT01184872|20621717|P2|Overall Study|Protocol deviation|0
5963359|NCT01184872|20621718|P1|Overall Study|Protocol deviation|1
5963360|NCT01184872|20621717|P2|Overall Study|Administrative problems|1
5963361|NCT01184872|20621718|P1|Overall Study|Administrative problems|1
5963362|NCT01184872|20621717|P2|Overall Study|Lost to Follow-up|1
5963363|NCT01184872|20621718|P1|Overall Study|Lost to Follow-up|0
5963364|NCT01184872|20621717|P2|Overall Study|Withdrawal by Subject|0
5963365|NCT01184872|20621718|P1|Overall Study|Withdrawal by Subject|2
5963366|NCT01184872|20621717|P2|Overall Study|Unsatisfactory therapeutic effect|2
5963367|NCT01184872|20621718|P1|Overall Study|Unsatisfactory therapeutic effect|3
5963368|NCT01184872|20621717|P2|Overall Study|Adverse Event|4
5963369|NCT01184872|20621718|P1|Overall Study|Adverse Event|3
5963370|NCT01184859|20621737|P5|Period 2: Daily Dose for 28 Days|Adverse Event|0
5963371|NCT01184859|20621738|P4|Period 2: Daily Dose for 28 Days|Adverse Event|0
5963372|NCT01184859|20621739|P3|Period 2: Daily Dose for 28 Days|Adverse Event|0
5963373|NCT01184859|20621740|P2|Period 2: Daily Dose for 28 Days|Adverse Event|0
5963374|NCT01184859|20621741|P1|Period 2: Daily Dose for 28 Days|Adverse Event|1
5963375|NCT01184859|20621737|P5|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|1
5963376|NCT01184859|20621738|P4|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0
5963377|NCT01184859|20621739|P3|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0
5963378|NCT01184859|20621740|P2|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0
5963379|NCT01184859|20621741|P1|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0
5963380|NCT01184859|20621737|P5|Period 1: Single Dose|Adverse Event|1
5963381|NCT01184859|20621738|P4|Period 1: Single Dose|Adverse Event|0
5963382|NCT01184859|20621739|P3|Period 1: Single Dose|Adverse Event|0
5963383|NCT01184859|20621740|P2|Period 1: Single Dose|Adverse Event|0
5963384|NCT01184859|20621741|P1|Period 1: Single Dose|Adverse Event|0
5963385|NCT01184859|20621737|P5|Period 1: Single Dose|Protocol Violation|0
5963386|NCT01184859|20621738|P4|Period 1: Single Dose|Protocol Violation|0
5963387|NCT01184859|20621739|P3|Period 1: Single Dose|Protocol Violation|0
5963388|NCT01184859|20621740|P2|Period 1: Single Dose|Protocol Violation|1
5963389|NCT01184859|20621741|P1|Period 1: Single Dose|Protocol Violation|0
5963390|NCT01184859|20621737|P5|Period 1: Single Dose|Insufficient urine production|0
5963391|NCT01184859|20621738|P4|Period 1: Single Dose|Insufficient urine production|0
5963392|NCT01184859|20621739|P3|Period 1: Single Dose|Insufficient urine production|0
5963393|NCT01184859|20621740|P2|Period 1: Single Dose|Insufficient urine production|1
5963394|NCT01184859|20621741|P1|Period 1: Single Dose|Insufficient urine production|0
5963395|NCT01184846|20621833|P1|Overall Study|Insufficient response|1
5963396|NCT01184846|20621833|P1|Overall Study|Adverse Event|2
5963397|NCT01184508|20621866|P2|Overall Study|Randomized, Not Treated|1
5963398|NCT01184508|20621867|P1|Overall Study|Randomized, Not Treated|0
5963399|NCT01184508|20621866|P2|Overall Study|Withdrawal by Subject|3
5963400|NCT01184508|20621867|P1|Overall Study|Withdrawal by Subject|1
5963401|NCT01184508|20621866|P2|Overall Study|Sponsor Decision|2
5963402|NCT01184508|20621867|P1|Overall Study|Sponsor Decision|5
5963403|NCT01184508|20621866|P2|Overall Study|Protocol Violation|1
5963404|NCT01184508|20621867|P1|Overall Study|Protocol Violation|3
5963405|NCT01184508|20621866|P2|Overall Study|Physician Decision|0
5963406|NCT01184508|20621867|P1|Overall Study|Physician Decision|1
5963407|NCT01184508|20621866|P2|Overall Study|Lost to Follow-up|1
5963408|NCT01184508|20621867|P1|Overall Study|Lost to Follow-up|1
5963409|NCT01184508|20621866|P2|Overall Study|Lack of Efficacy|1
5963410|NCT01184508|20621867|P1|Overall Study|Lack of Efficacy|1
5963411|NCT01184508|20621866|P2|Overall Study|Adverse Event|6
5963412|NCT01184508|20621867|P1|Overall Study|Adverse Event|4
5963413|NCT01184326|20621927|P3|Overall Study|Disease Progression|12
5963414|NCT01184326|20621928|P2|Overall Study|Disease Progression|3
5963415|NCT01184326|20621929|P1|Overall Study|Disease Progression|1
5963416|NCT01184326|20621927|P3|Overall Study|Physician Decision|0
5963417|NCT01184326|20621928|P2|Overall Study|Physician Decision|1
5963418|NCT01184326|20621929|P1|Overall Study|Physician Decision|1
5963419|NCT01184326|20621927|P3|Overall Study|Withdrawal by Subject|1
5963420|NCT01184326|20621928|P2|Overall Study|Withdrawal by Subject|0
5963421|NCT01184326|20621929|P1|Overall Study|Withdrawal by Subject|0
5963422|NCT01184326|20621927|P3|Overall Study|Death|1
5963423|NCT01184326|20621928|P2|Overall Study|Death|0
5963424|NCT01184326|20621929|P1|Overall Study|Death|0
5963425|NCT01184326|20621927|P3|Overall Study|Adverse Event|0
5963426|NCT01184326|20621928|P2|Overall Study|Adverse Event|2
5963427|NCT01184326|20621929|P1|Overall Study|Adverse Event|1
5963428|NCT01184118|20621943|P1|Overall Study|Withdrawal by Subject|5
5963429|NCT01184118|20621943|P1|Overall Study|Exclusionary medical condition|2
5963430|NCT01184118|20621943|P1|Overall Study|FEV1 <60% predicted|2
5963431|NCT01184118|20621943|P1|Overall Study|No physiologic confirmation of asthma|8
5963432|NCT01184118|20621943|P1|Overall Study|Only asthma step 1 - screen fail|1
5963433|NCT01184079|20621951|P2|Overall Study|Lost to Follow-up|2
5963434|NCT01184079|20621952|P1|Overall Study|Lost to Follow-up|14
5963435|NCT01184053|20621962|P1|Overall Study|progression while on treatment|3
5963436|NCT01183975|20621978|P1|Overall Study|Lost to Follow-up|73
5963437|NCT01183884|20621995|P1|Overall Study|Other|4
5963438|NCT01183884|20621995|P1|Overall Study|Not Treated|1
5963439|NCT01183884|20621995|P1|Overall Study|Other Complicating Disease|3
5963440|NCT01183884|20621995|P1|Overall Study|Withdrawal by Subject|1
5963441|NCT01183884|20621995|P1|Overall Study|Adverse Event|3
5963442|NCT01183884|20621995|P1|Overall Study|Progressive Disease|26
5963443|NCT01183858|20622003|P2|Overall Study|Lost to Follow-up|1
5963444|NCT01183858|20622004|P1|Overall Study|Lost to Follow-up|1
5963445|NCT01183858|20622003|P2|Overall Study|Death related to Progressive Disease|5
5963446|NCT01183858|20622004|P1|Overall Study|Death related to Progressive Disease|4
5963447|NCT01183858|20622003|P2|Overall Study|Progressive Disease|115
5963448|NCT01183858|20622004|P1|Overall Study|Progressive Disease|112
5963449|NCT01183858|20622003|P2|Overall Study|Administrative/Other|6
5963450|NCT01183858|20622004|P1|Overall Study|Administrative/Other|6
5963451|NCT01183858|20622003|P2|Overall Study|Protocol Violation|0
5963452|NCT01183858|20622004|P1|Overall Study|Protocol Violation|1
5963453|NCT01183858|20622003|P2|Overall Study|Discontinued Smoking|1
5963454|NCT01183858|20622004|P1|Overall Study|Discontinued Smoking|3
5963455|NCT01183858|20622003|P2|Overall Study|Withdrew Consent|4
5963456|NCT01183858|20622004|P1|Overall Study|Withdrew Consent|4
5963457|NCT01183858|20622003|P2|Overall Study|Refused Treatment|4
5963458|NCT01183858|20622004|P1|Overall Study|Refused Treatment|1
5963459|NCT01183858|20622003|P2|Overall Study|Insufficient Therapeutic Response|0
5963460|NCT01183858|20622004|P1|Overall Study|Insufficient Therapeutic Response|2
5963461|NCT01183858|20622003|P2|Overall Study|Investigator's Decision|3
5963462|NCT01183858|20622004|P1|Overall Study|Investigator's Decision|0
5963463|NCT01183858|20622003|P2|Overall Study|Adverse Event|11
5963464|NCT01183858|20622004|P1|Overall Study|Adverse Event|14
5963465|NCT01183858|20622003|P2|Overall Study|Death not related to Progressive Disease|6
5963466|NCT01183858|20622004|P1|Overall Study|Death not related to Progressive Disease|5
5963467|NCT01183780|20622026|P2|Overall Study|Lost to Follow-up|11
5963468|NCT01183780|20622027|P1|Overall Study|Lost to Follow-up|6
5963469|NCT01183780|20622026|P2|Overall Study|Withdrawal by Subject|14
5963470|NCT01183780|20622027|P1|Overall Study|Withdrawal by Subject|25
5963471|NCT01183468|20622165|P4|Overall Study|Withdrawal by Subject|0
5963472|NCT01183468|20622166|P3|Overall Study|Withdrawal by Subject|0
5963473|NCT01183468|20622167|P2|Overall Study|Withdrawal by Subject|1
5963474|NCT01183468|20622168|P1|Overall Study|Withdrawal by Subject|0
5963475|NCT01183468|20622165|P4|Overall Study|Physician Decision|0
5963476|NCT01183468|20622166|P3|Overall Study|Physician Decision|0
5963477|NCT01183468|20622167|P2|Overall Study|Physician Decision|0
5963478|NCT01183468|20622168|P1|Overall Study|Physician Decision|1
5963479|NCT01183468|20622165|P4|Overall Study|Lost to Follow-up|0
5963480|NCT01183468|20622166|P3|Overall Study|Lost to Follow-up|0
5963481|NCT01183468|20622167|P2|Overall Study|Lost to Follow-up|1
5963482|NCT01183468|20622168|P1|Overall Study|Lost to Follow-up|2
5963483|NCT01183390|20622190|P2|First Intervention|Adverse Event|1
5963484|NCT01183390|20622191|P1|First Intervention|Adverse Event|0
5963485|NCT01183260|20622224|P2|Overall Study|Death|0
5963486|NCT01183260|20622225|P1|Overall Study|Death|1
5963487|NCT01183260|20622224|P2|Overall Study|Revised within 30 days|1
5963488|NCT01183260|20622225|P1|Overall Study|Revised within 30 days|0
5963489|NCT01183260|20622224|P2|Overall Study|Withdrawal by Subject|1
5963490|NCT01183260|20622225|P1|Overall Study|Withdrawal by Subject|1
5963491|NCT01183260|20622224|P2|Overall Study|Intraop screen failure|0
5963492|NCT01183260|20622225|P1|Overall Study|Intraop screen failure|2
5963493|NCT01183234|20622235|P2|First Intervention|Adverse Event|0
5963494|NCT01183234|20622236|P1|First Intervention|Adverse Event|1
5963495|NCT01183143|20622328|P1|Overall Study|Subjects enrolled, but not treated|11
5963496|NCT01183143|20622328|P1|Overall Study|Subject Questionnaires not returned|5
5963497|NCT01183143|20622328|P1|Overall Study|Withdrawal by Subject|19
5963498|NCT01183143|20622328|P1|Overall Study|Protocol Violation|115
5963499|NCT01183104|20622344|P2|Overall Study|Did not receive study drug|9
5963500|NCT01183104|20622345|P1|Overall Study|Did not receive study drug|5
5963501|NCT01183104|20622344|P2|Overall Study|Nonparticipation in Extension Study|50
5963502|NCT01183104|20622345|P1|Overall Study|Nonparticipation in Extension Study|39
5963503|NCT01183104|20622344|P2|Overall Study|Withdrawal by Subject|11
5963504|NCT01183104|20622345|P1|Overall Study|Withdrawal by Subject|6
5963505|NCT01183104|20622344|P2|Overall Study|Physician Decision|8
5963506|NCT01183104|20622345|P1|Overall Study|Physician Decision|5
5963507|NCT01183104|20622344|P2|Overall Study|Lost to Follow-up|7
5963508|NCT01183104|20622345|P1|Overall Study|Lost to Follow-up|14
5963509|NCT01183104|20622344|P2|Overall Study|Death|1
5963510|NCT01183104|20622345|P1|Overall Study|Death|0
5963511|NCT01183104|20622344|P2|Overall Study|Adverse Event|6
5963512|NCT01183104|20622345|P1|Overall Study|Adverse Event|8
5963513|NCT01183065|20622361|P1|Overall Study|Patient no longer fits eligibility crite|1
5963514|NCT01183013|20622372|P7|Overall Study|Reasons other than stated above|13
5963515|NCT01183013|20622373|P6|Overall Study|Reasons other than stated above|15
5963516|NCT01183013|20622374|P5|Overall Study|Reasons other than stated above|12
5963517|NCT01183013|20622375|P4|Overall Study|Reasons other than stated above|12
5963518|NCT01183013|20622376|P3|Overall Study|Reasons other than stated above|17
5963519|NCT01183013|20622377|P2|Overall Study|Reasons other than stated above|11
5963520|NCT01183013|20622378|P1|Overall Study|Reasons other than stated above|15
5963521|NCT01183013|20622372|P7|Overall Study|Withdrawal by Subject|10
5963522|NCT01183013|20622373|P6|Overall Study|Withdrawal by Subject|9
5963523|NCT01183013|20622374|P5|Overall Study|Withdrawal by Subject|7
5963524|NCT01183013|20622375|P4|Overall Study|Withdrawal by Subject|8
5963525|NCT01183013|20622376|P3|Overall Study|Withdrawal by Subject|10
5963526|NCT01183013|20622377|P2|Overall Study|Withdrawal by Subject|13
5963527|NCT01183013|20622378|P1|Overall Study|Withdrawal by Subject|9
5963528|NCT01183013|20622372|P7|Overall Study|Lost to Follow-up|5
5963529|NCT01183013|20622373|P6|Overall Study|Lost to Follow-up|6
5963530|NCT01183013|20622374|P5|Overall Study|Lost to Follow-up|2
5963531|NCT01183013|20622375|P4|Overall Study|Lost to Follow-up|3
5963532|NCT01183013|20622376|P3|Overall Study|Lost to Follow-up|4
5963533|NCT01183013|20622377|P2|Overall Study|Lost to Follow-up|3
5963534|NCT01183013|20622378|P1|Overall Study|Lost to Follow-up|7
5963535|NCT01183013|20622372|P7|Overall Study|Protocol Violation|3
5963536|NCT01183013|20622373|P6|Overall Study|Protocol Violation|3
5963537|NCT01183013|20622374|P5|Overall Study|Protocol Violation|4
5963538|NCT01183013|20622375|P4|Overall Study|Protocol Violation|0
5963539|NCT01183013|20622376|P3|Overall Study|Protocol Violation|4
5963540|NCT01183013|20622377|P2|Overall Study|Protocol Violation|2
5963541|NCT01183013|20622378|P1|Overall Study|Protocol Violation|5
5963542|NCT01183013|20622372|P7|Overall Study|Lack of Efficacy|0
5963543|NCT01183013|20622373|P6|Overall Study|Lack of Efficacy|2
5963544|NCT01183013|20622374|P5|Overall Study|Lack of Efficacy|1
5963545|NCT01183013|20622375|P4|Overall Study|Lack of Efficacy|2
5963546|NCT01183013|20622376|P3|Overall Study|Lack of Efficacy|1
5963547|NCT01183013|20622377|P2|Overall Study|Lack of Efficacy|2
5963548|NCT01183013|20622378|P1|Overall Study|Lack of Efficacy|3
5963549|NCT01183013|20622372|P7|Overall Study|Adverse Event|6
5963550|NCT01183013|20622373|P6|Overall Study|Adverse Event|10
5963551|NCT01183013|20622374|P5|Overall Study|Adverse Event|10
5963552|NCT01183013|20622375|P4|Overall Study|Adverse Event|5
5963553|NCT01183013|20622376|P3|Overall Study|Adverse Event|5
5963554|NCT01183013|20622377|P2|Overall Study|Adverse Event|8
5963555|NCT01183013|20622378|P1|Overall Study|Adverse Event|6
5963556|NCT01182844|20622459|P2|Overall Study|Withdrawal by Subject|2
5963557|NCT01182844|20622460|P1|Overall Study|Withdrawal by Subject|0
5963558|NCT01182441|20622545|P2|Overall Study|Physician Decision|1
5963559|NCT01182441|20622546|P1|Overall Study|Physician Decision|1
5963560|NCT01182441|20622545|P2|Overall Study|Adverse Event|0
5963561|NCT01182441|20622546|P1|Overall Study|Adverse Event|2
5963562|NCT01182441|20622545|P2|Overall Study|Implant Not Attempted|0
5963563|NCT01182441|20622546|P1|Overall Study|Implant Not Attempted|4
5963564|NCT01182441|20622545|P2|Overall Study|Withdrawal by Subject|13
5963565|NCT01182441|20622546|P1|Overall Study|Withdrawal by Subject|6
5963566|NCT01182441|20622545|P2|Overall Study|Lost to Follow-up|8
5963567|NCT01182441|20622546|P1|Overall Study|Lost to Follow-up|5
5963568|NCT01182441|20622545|P2|Overall Study|Implant Attempt Unsuccessful|0
5963569|NCT01182441|20622546|P1|Overall Study|Implant Attempt Unsuccessful|13
5963570|NCT01182441|20622545|P2|Overall Study|Death|25
5963571|NCT01182441|20622546|P1|Overall Study|Death|37
5963572|NCT01182441|20622545|P2|Overall Study|Patient Still in Follow-up|72
5963573|NCT01182441|20622546|P1|Overall Study|Patient Still in Follow-up|152
5963574|NCT01182428|20622557|P2|Overall Study|Withdrawal by Subject|0
5963575|NCT01182428|20622558|P1|Overall Study|Withdrawal by Subject|1
5963576|NCT01182428|20622557|P2|Overall Study|Lost to Follow-up|1
5963577|NCT01182428|20622558|P1|Overall Study|Lost to Follow-up|9
5963578|NCT01182428|20622557|P2|Overall Study|Physician Decision|0
5963579|NCT01182428|20622558|P1|Overall Study|Physician Decision|1
5963580|NCT01182415|20622622|P1|Overall Study|Lost to Follow-up|1
5963581|NCT01182350|20622638|P5|Overall Study|Unevaluable for Biopsy|3
5963582|NCT01182350|20622639|P4|Overall Study|Unevaluable for Biopsy|0
5963583|NCT01182350|20622640|P3|Overall Study|Unevaluable for Biopsy|0
5963584|NCT01182350|20622641|P2|Overall Study|Unevaluable for Biopsy|0
5963585|NCT01182350|20622642|P1|Overall Study|Unevaluable for Biopsy|0
5963586|NCT01182350|20622638|P5|Overall Study|Travel Issue/Prefer Treatment at Home|0
5963587|NCT01182350|20622639|P4|Overall Study|Travel Issue/Prefer Treatment at Home|1
5963588|NCT01182350|20622640|P3|Overall Study|Travel Issue/Prefer Treatment at Home|1
5963589|NCT01182350|20622641|P2|Overall Study|Travel Issue/Prefer Treatment at Home|0
5963590|NCT01182350|20622642|P1|Overall Study|Travel Issue/Prefer Treatment at Home|2
5963591|NCT01182350|20622638|P5|Overall Study|Alternative Therapy|0
5963592|NCT01182350|20622639|P4|Overall Study|Alternative Therapy|0
5963593|NCT01182350|20622640|P3|Overall Study|Alternative Therapy|1
5963594|NCT01182350|20622641|P2|Overall Study|Alternative Therapy|0
5963595|NCT01182350|20622642|P1|Overall Study|Alternative Therapy|2
5963596|NCT01182350|20622638|P5|Overall Study|Withdrawal by Subject|0
5963597|NCT01182350|20622639|P4|Overall Study|Withdrawal by Subject|1
5963598|NCT01182350|20622640|P3|Overall Study|Withdrawal by Subject|0
5963599|NCT01182350|20622641|P2|Overall Study|Withdrawal by Subject|1
5963600|NCT01182350|20622642|P1|Overall Study|Withdrawal by Subject|3
5963601|NCT01182350|20622638|P5|Overall Study|Death|0
5963602|NCT01182350|20622639|P4|Overall Study|Death|0
5963603|NCT01182350|20622640|P3|Overall Study|Death|1
5963604|NCT01182350|20622641|P2|Overall Study|Death|1
5963605|NCT01182350|20622642|P1|Overall Study|Death|0
5963606|NCT01182350|20622638|P5|Overall Study|Disease Progression|0
5963607|NCT01182350|20622639|P4|Overall Study|Disease Progression|1
5963608|NCT01182350|20622640|P3|Overall Study|Disease Progression|0
5963609|NCT01182350|20622641|P2|Overall Study|Disease Progression|12
5963610|NCT01182350|20622642|P1|Overall Study|Disease Progression|15
5963611|NCT01182350|20622638|P5|Overall Study|Adverse Event|0
5963612|NCT01182350|20622639|P4|Overall Study|Adverse Event|0
5963613|NCT01182350|20622640|P3|Overall Study|Adverse Event|0
5963614|NCT01182350|20622641|P2|Overall Study|Adverse Event|0
5963615|NCT01182350|20622642|P1|Overall Study|Adverse Event|5
5963616|NCT01182337|20622664|P2|Overall Study|Lost to Follow-up|1
5963617|NCT01182337|20622665|P1|Overall Study|Lost to Follow-up|0
5963618|NCT01182337|20622664|P2|Overall Study|Withdrawal by Subject|1
5963619|NCT01182337|20622665|P1|Overall Study|Withdrawal by Subject|3
5963620|NCT01182298|20622683|P1|Overall Study|Withdrawal by Subject|2
5963621|NCT01182298|20622683|P1|Overall Study|Lack of Efficacy|4
5963622|NCT01182285|20622687|P3|Third Intervention Week 11-52|Other|2
5963623|NCT01182285|20622688|P2|Third Intervention Week 11-52|Other|0
5963624|NCT01182285|20622689|P1|Third Intervention Week 11-52|Other|0
5963625|NCT01182285|20622687|P3|Third Intervention Week 11-52|Disease Progression|6
5963626|NCT01182285|20622688|P2|Third Intervention Week 11-52|Disease Progression|0
5963627|NCT01182285|20622689|P1|Third Intervention Week 11-52|Disease Progression|0
5963628|NCT01182285|20622687|P3|First Intervention Week 1-10|Non-compliance|0
5963629|NCT01182285|20622688|P2|First Intervention Week 1-10|Non-compliance|0
5963630|NCT01182285|20622689|P1|First Intervention Week 1-10|Non-compliance|1
5963631|NCT01182285|20622687|P3|First Intervention Week 1-10|Adverse Event|0
5963632|NCT01182285|20622688|P2|First Intervention Week 1-10|Adverse Event|0
5963633|NCT01182285|20622689|P1|First Intervention Week 1-10|Adverse Event|1
5963634|NCT01182285|20622687|P3|First Intervention Week 1-10|Disease progression|0
5963635|NCT01182285|20622688|P2|First Intervention Week 1-10|Disease progression|0
5963636|NCT01182285|20622689|P1|First Intervention Week 1-10|Disease progression|1
5963637|NCT01182207|20622699|P2|Second Intervention|Emeses within 1 hour of dosing|0
5963638|NCT01182207|20622700|P1|Second Intervention|Emeses within 1 hour of dosing|1
5963639|NCT01182207|20622699|P2|First Intervention|Positive Hepatitis Results|1
5963640|NCT01182207|20622700|P1|First Intervention|Positive Hepatitis Results|0
5963641|NCT01182194|20622718|P2|Washout of 28 Days|Withdrawal by Subject|0
5963642|NCT01182194|20622719|P1|Washout of 28 Days|Withdrawal by Subject|1
5963643|NCT01182181|20622737|P2|Washout of 21 Days|Withdrawal by Subject|1
5963644|NCT01182181|20622738|P1|Washout of 21 Days|Withdrawal by Subject|0
5963645|NCT01182181|20622737|P2|First Intervention|Adverse Event|0
5963646|NCT01182181|20622738|P1|First Intervention|Adverse Event|1
5963647|NCT01181986|20622763|P3|Phase 2|Medical condition|0
5963648|NCT01181986|20622764|P2|Phase 2|Medical condition|1
5963649|NCT01181986|20622765|P1|Phase 2|Medical condition|0
5963650|NCT01181986|20622763|P3|Phase 2|Adverse Event|0
5963651|NCT01181986|20622764|P2|Phase 2|Adverse Event|3
5963652|NCT01181986|20622765|P1|Phase 2|Adverse Event|0
5963653|NCT01181986|20622763|P3|Phase 1|Protocol Violation|0
5963654|NCT01181986|20622764|P2|Phase 1|Protocol Violation|0
5963655|NCT01181986|20622765|P1|Phase 1|Protocol Violation|1
5963656|NCT01181986|20622763|P3|Phase 1|Adverse Event|1
5963657|NCT01181986|20622764|P2|Phase 1|Adverse Event|0
5963658|NCT01181986|20622765|P1|Phase 1|Adverse Event|0
5963659|NCT01181986|20622763|P3|Phase 1|Lost to Follow-up|1
5963660|NCT01181986|20622764|P2|Phase 1|Lost to Follow-up|1
5963661|NCT01181986|20622765|P1|Phase 1|Lost to Follow-up|0
5963662|NCT01181921|20622786|P1|Overall Study|Lost to Follow-up|1
5963663|NCT01181895|20622793|P3|Overall Study|Withdrawal by Subject|5
5963664|NCT01181895|20622794|P2|Overall Study|Withdrawal by Subject|0
5963665|NCT01181895|20622795|P1|Overall Study|Withdrawal by Subject|3
5963666|NCT01181895|20622793|P3|Overall Study|Investigator Discretion|1
5963667|NCT01181895|20622794|P2|Overall Study|Investigator Discretion|2
5963668|NCT01181895|20622795|P1|Overall Study|Investigator Discretion|1
5963669|NCT01181895|20622793|P3|Overall Study|Lost to Follow-up|2
5963670|NCT01181895|20622794|P2|Overall Study|Lost to Follow-up|1
5963671|NCT01181895|20622795|P1|Overall Study|Lost to Follow-up|0
5963672|NCT01181895|20622793|P3|Overall Study|Protocol Violation|0
5963673|NCT01181895|20622794|P2|Overall Study|Protocol Violation|1
5963674|NCT01181895|20622795|P1|Overall Study|Protocol Violation|2
5963675|NCT01181895|20622793|P3|Overall Study|Lack of Efficacy|9
5963676|NCT01181895|20622794|P2|Overall Study|Lack of Efficacy|9
5963677|NCT01181895|20622795|P1|Overall Study|Lack of Efficacy|8
5963678|NCT01181895|20622793|P3|Overall Study|Adverse Event|1
5963679|NCT01181895|20622794|P2|Overall Study|Adverse Event|1
5963680|NCT01181895|20622795|P1|Overall Study|Adverse Event|3
5963681|NCT01181778|20622853|P1|Overall Study|Physician Decision|48
5963682|NCT01181726|20622861|P2|First Intervention|Adverse Event|0
5963683|NCT01181726|20622862|P1|First Intervention|Adverse Event|1
5963684|NCT01181609|20622942|P1|Overall Study|Death|50
5963685|NCT01181609|20622942|P1|Overall Study|Lost to Follow-up|1
5963686|NCT01181609|20622942|P1|Overall Study|Withdrawal by Subject|1
5963687|NCT01181609|20622942|P1|Overall Study|Adverse Event|1
5963688|NCT01181531|20622960|P2|Overall Study|Adverse Event|1
5963689|NCT01181531|20622961|P1|Overall Study|Adverse Event|0
5963690|NCT01181531|20622960|P2|Overall Study|Death|12
5963691|NCT01181531|20622961|P1|Overall Study|Death|9
5963692|NCT01181531|20622960|P2|Overall Study|Protocol Violation|6
5963693|NCT01181531|20622961|P1|Overall Study|Protocol Violation|6
5963694|NCT01181531|20622960|P2|Overall Study|Withdrawal by Subject|7
5963695|NCT01181531|20622961|P1|Overall Study|Withdrawal by Subject|8
5963696|NCT01181531|20622960|P2|Overall Study|Pregnancy|1
5963697|NCT01181531|20622961|P1|Overall Study|Pregnancy|0
5963698|NCT01181531|20622960|P2|Overall Study|Protocol Specified Criteria|8
5963699|NCT01181531|20622961|P1|Overall Study|Protocol Specified Criteria|15
5963700|NCT01181531|20622960|P2|Overall Study|Ineligibility determined|2
5963701|NCT01181531|20622961|P1|Overall Study|Ineligibility determined|1
5963702|NCT01181531|20622960|P2|Overall Study|Noncompliance|2
5963703|NCT01181531|20622961|P1|Overall Study|Noncompliance|2
5963704|NCT01181531|20622960|P2|Overall Study|Physician Decision|1
5963705|NCT01181531|20622961|P1|Overall Study|Physician Decision|3
5963706|NCT01181531|20622960|P2|Overall Study|Partial consent by subject withdrawn|1
5963707|NCT01181531|20622961|P1|Overall Study|Partial consent by subject withdrawn|0
5963708|NCT01181531|20622960|P2|Overall Study|Other|12
5963709|NCT01181531|20622961|P1|Overall Study|Other|17
5963710|NCT01181271|20623103|P1|Evaluation for Allogeneic Transplant|therapy-related AML diagnosed|1
5963711|NCT01181271|20623103|P1|Evaluation for Allogeneic Transplant|No suitable donor|2
5963712|NCT01181271|20623103|P1|Evaluation for Allogeneic Transplant|Withdrawal by Subject|4
5963713|NCT01181271|20623103|P1|Evaluation for Allogeneic Transplant|Lack of Efficacy|6
5963714|NCT01181167|20623127|P2|Overall Study|Withdrawal by Subject|8
5963715|NCT01181167|20623128|P1|Overall Study|Withdrawal by Subject|6
5963716|NCT01181167|20623127|P2|Overall Study|Protocol Violation|0
5963717|NCT01181167|20623128|P1|Overall Study|Protocol Violation|3
5963718|NCT01181167|20623127|P2|Overall Study|Physician Decision|3
5963719|NCT01181167|20623128|P1|Overall Study|Physician Decision|2
5963720|NCT01181167|20623127|P2|Overall Study|Lost to Follow-up|0
5963721|NCT01181167|20623128|P1|Overall Study|Lost to Follow-up|1
5963722|NCT01181167|20623127|P2|Overall Study|Adverse Event|21
5963723|NCT01181167|20623128|P1|Overall Study|Adverse Event|11
5963724|NCT01181141|20623138|P2|Overall Study|Withdrawal by Subject|1
5963725|NCT01181141|20623139|P1|Overall Study|Withdrawal by Subject|3
5963726|NCT01181141|20623138|P2|Overall Study|Protocol Violation|1
5963727|NCT01181141|20623139|P1|Overall Study|Protocol Violation|3
5963728|NCT01181141|20623138|P2|Overall Study|Physician Decision|0
5963729|NCT01181141|20623139|P1|Overall Study|Physician Decision|2
5963730|NCT01181141|20623138|P2|Overall Study|Lost to Follow-up|1
5963731|NCT01181141|20623139|P1|Overall Study|Lost to Follow-up|1
5963732|NCT01181141|20623138|P2|Overall Study|Lack of Efficacy|0
5963733|NCT01181141|20623139|P1|Overall Study|Lack of Efficacy|1
5963734|NCT01181141|20623138|P2|Overall Study|Adverse Event|1
5963735|NCT01181141|20623139|P1|Overall Study|Adverse Event|2
5963736|NCT01181128|20623148|P3|Overall Study|Other|1
5963737|NCT01181128|20623149|P2|Overall Study|Other|1
5963738|NCT01181128|20623150|P1|Overall Study|Other|1
5963739|NCT01181128|20623148|P3|Overall Study|Adverse Event|0
5963740|NCT01181128|20623149|P2|Overall Study|Adverse Event|2
5963741|NCT01181128|20623150|P1|Overall Study|Adverse Event|0
5963742|NCT01181128|20623148|P3|Overall Study|Physician Decision|0
5963743|NCT01181128|20623149|P2|Overall Study|Physician Decision|0
5963744|NCT01181128|20623150|P1|Overall Study|Physician Decision|2
5963745|NCT01181128|20623148|P3|Overall Study|Death|0
5963746|NCT01181128|20623149|P2|Overall Study|Death|0
5963747|NCT01181128|20623150|P1|Overall Study|Death|1
5963748|NCT01181128|20623148|P3|Overall Study|Withdrawal by Subject|0
5963749|NCT01181128|20623149|P2|Overall Study|Withdrawal by Subject|2
5963750|NCT01181128|20623150|P1|Overall Study|Withdrawal by Subject|2
5963751|NCT01181102|20623238|P2|Overall Study|Withdrawal by Subject|12
5963752|NCT01181102|20623239|P1|Overall Study|Withdrawal by Subject|10
5963753|NCT01181102|20623238|P2|Overall Study|Protocol Violation|6
5963754|NCT01181102|20623239|P1|Overall Study|Protocol Violation|5
5963755|NCT01181102|20623238|P2|Overall Study|Physician Decision|1
5963756|NCT01181102|20623239|P1|Overall Study|Physician Decision|3
5963757|NCT01181102|20623238|P2|Overall Study|Lost to Follow-up|0
5963758|NCT01181102|20623239|P1|Overall Study|Lost to Follow-up|2
5963759|NCT01181102|20623238|P2|Overall Study|Lack of Efficacy|1
5963760|NCT01181102|20623239|P1|Overall Study|Lack of Efficacy|3
5963761|NCT01181102|20623238|P2|Overall Study|Adverse Event|26
5963762|NCT01181102|20623239|P1|Overall Study|Adverse Event|28
5963763|NCT01181011|20623283|P1|Overall Study|Lost to Follow-up|1
5963764|NCT01181011|20623283|P1|Overall Study|Adverse Event|2
5963765|NCT01180998|20623333|P3|Overall Study|Poor lens handling|2
5963766|NCT01180998|20623334|P2|Overall Study|Poor lens handling|0
5963767|NCT01180998|20623335|P1|Overall Study|Poor lens handling|0
5963768|NCT01180998|20623333|P3|Overall Study|Poor comfort|4
5963769|NCT01180998|20623334|P2|Overall Study|Poor comfort|0
5963770|NCT01180998|20623335|P1|Overall Study|Poor comfort|3
5963771|NCT01180998|20623333|P3|Overall Study|Withdrawal by Subject|1
5963772|NCT01180998|20623334|P2|Overall Study|Withdrawal by Subject|0
5963773|NCT01180998|20623335|P1|Overall Study|Withdrawal by Subject|0
5963774|NCT01180998|20623333|P3|Overall Study|Protocol Violation|0
5963775|NCT01180998|20623334|P2|Overall Study|Protocol Violation|2
5963776|NCT01180998|20623335|P1|Overall Study|Protocol Violation|1
5963777|NCT01180998|20623333|P3|Overall Study|Lost to Follow-up|1
5963778|NCT01180998|20623334|P2|Overall Study|Lost to Follow-up|0
5963779|NCT01180998|20623335|P1|Overall Study|Lost to Follow-up|0
5963780|NCT01180998|20623333|P3|Overall Study|Poor Vision|2
5963781|NCT01180998|20623334|P2|Overall Study|Poor Vision|2
5963782|NCT01180998|20623335|P1|Overall Study|Poor Vision|0
5963783|NCT01180985|20623349|P2|Period 2 (7 +/- 1 Days)|Lost to Follow-up|0
5963784|NCT01180985|20623350|P1|Period 2 (7 +/- 1 Days)|Lost to Follow-up|1
5963785|NCT01180790|20623389|P7|Overall Study|Severe coronary atherosclerosis (death)|0
5963786|NCT01180790|20623390|P6|Overall Study|Severe coronary atherosclerosis (death)|0
5963787|NCT01180790|20623391|P5|Overall Study|Severe coronary atherosclerosis (death)|0
5963788|NCT01180790|20623392|P4|Overall Study|Severe coronary atherosclerosis (death)|0
5963789|NCT01180790|20623393|P3|Overall Study|Severe coronary atherosclerosis (death)|1
5963790|NCT01180790|20623394|P2|Overall Study|Severe coronary atherosclerosis (death)|0
5963791|NCT01180790|20623395|P1|Overall Study|Severe coronary atherosclerosis (death)|0
5963792|NCT01180790|20623389|P7|Overall Study|compliance|0
5963793|NCT01180790|20623390|P6|Overall Study|compliance|0
5963794|NCT01180790|20623391|P5|Overall Study|compliance|0
5963795|NCT01180790|20623392|P4|Overall Study|compliance|0
5963796|NCT01180790|20623393|P3|Overall Study|compliance|0
5963797|NCT01180790|20623394|P2|Overall Study|compliance|1
5963798|NCT01180790|20623395|P1|Overall Study|compliance|0
5963799|NCT01180790|20623389|P7|Overall Study|Lack of Efficacy|0
5963800|NCT01180790|20623390|P6|Overall Study|Lack of Efficacy|3
5963801|NCT01180790|20623391|P5|Overall Study|Lack of Efficacy|1
5963802|NCT01180790|20623392|P4|Overall Study|Lack of Efficacy|6
5963803|NCT01180790|20623393|P3|Overall Study|Lack of Efficacy|5
5963804|NCT01180790|20623394|P2|Overall Study|Lack of Efficacy|2
5963805|NCT01180790|20623395|P1|Overall Study|Lack of Efficacy|1
5963806|NCT01180790|20623389|P7|Overall Study|Physician Decision|0
5963807|NCT01180790|20623390|P6|Overall Study|Physician Decision|0
5963808|NCT01180790|20623391|P5|Overall Study|Physician Decision|0
5963809|NCT01180790|20623392|P4|Overall Study|Physician Decision|1
5963810|NCT01180790|20623393|P3|Overall Study|Physician Decision|0
5963811|NCT01180790|20623394|P2|Overall Study|Physician Decision|0
5963812|NCT01180790|20623395|P1|Overall Study|Physician Decision|1
5963813|NCT01180790|20623389|P7|Overall Study|Lost to Follow-up|1
5963814|NCT01180790|20623390|P6|Overall Study|Lost to Follow-up|0
5963815|NCT01180790|20623391|P5|Overall Study|Lost to Follow-up|1
5963816|NCT01180790|20623392|P4|Overall Study|Lost to Follow-up|2
5963817|NCT01180790|20623393|P3|Overall Study|Lost to Follow-up|0
5963818|NCT01180790|20623394|P2|Overall Study|Lost to Follow-up|1
5963819|NCT01180790|20623395|P1|Overall Study|Lost to Follow-up|3
5963820|NCT01180790|20623389|P7|Overall Study|Withdrawal by Subject|0
5963821|NCT01180790|20623390|P6|Overall Study|Withdrawal by Subject|1
5963822|NCT01180790|20623391|P5|Overall Study|Withdrawal by Subject|2
5963823|NCT01180790|20623392|P4|Overall Study|Withdrawal by Subject|0
5963824|NCT01180790|20623393|P3|Overall Study|Withdrawal by Subject|5
5963825|NCT01180790|20623394|P2|Overall Study|Withdrawal by Subject|0
5963826|NCT01180790|20623395|P1|Overall Study|Withdrawal by Subject|3
5963827|NCT01180790|20623389|P7|Overall Study|Adverse Event|0
5963828|NCT01180790|20623390|P6|Overall Study|Adverse Event|3
5963829|NCT01180790|20623391|P5|Overall Study|Adverse Event|1
5963830|NCT01180790|20623392|P4|Overall Study|Adverse Event|0
5963831|NCT01180790|20623393|P3|Overall Study|Adverse Event|2
5963832|NCT01180790|20623394|P2|Overall Study|Adverse Event|1
5963833|NCT01180790|20623395|P1|Overall Study|Adverse Event|1
5963834|NCT01180777|20623460|P1|Overall Study|Adverse Event|1
5963835|NCT01180777|20623460|P1|Overall Study|Lost to Follow-up|1
5963836|NCT01180777|20623460|P1|Overall Study|Poor lens fit|4
5963837|NCT01180777|20623460|P1|Overall Study|Protocol Violation|6
5963838|NCT01180660|20623474|P2|Overall Study|Changed to open surgery|0
5963839|NCT01180660|20623475|P1|Overall Study|Changed to open surgery|1
5963840|NCT01180647|20623485|P2|Overall Study|Lost to Follow-up|6
5963841|NCT01180647|20623486|P1|Overall Study|Lost to Follow-up|5
5963842|NCT01180400|20623521|P2|Overall Study|Other|1
5963843|NCT01180400|20623522|P1|Overall Study|Other|0
5963844|NCT01180400|20623521|P2|Overall Study|Lost to Follow-up|3
5963845|NCT01180400|20623522|P1|Overall Study|Lost to Follow-up|2
5963846|NCT01180400|20623521|P2|Overall Study|Study-specific withdrawal criteria|2
5963847|NCT01180400|20623522|P1|Overall Study|Study-specific withdrawal criteria|1
5963848|NCT01180400|20623521|P2|Overall Study|Lack of Efficacy|0
5963849|NCT01180400|20623522|P1|Overall Study|Lack of Efficacy|2
5963850|NCT01180400|20623521|P2|Overall Study|Condition under investigation worsened|1
5963851|NCT01180400|20623522|P1|Overall Study|Condition under investigation worsened|2
5963852|NCT01180400|20623521|P2|Overall Study|Severe non-compliance to protocol|2
5963853|NCT01180400|20623522|P1|Overall Study|Severe non-compliance to protocol|1
5963854|NCT01180400|20623521|P2|Overall Study|Adverse Event|10
5963855|NCT01180400|20623522|P1|Overall Study|Adverse Event|12
5963856|NCT01180400|20623521|P2|Overall Study|Eligibility criteria not fulfilled|2
5963857|NCT01180400|20623522|P1|Overall Study|Eligibility criteria not fulfilled|0
5963858|NCT01180400|20623521|P2|Overall Study|Withdrawal by Subject|6
5963859|NCT01180400|20623522|P1|Overall Study|Withdrawal by Subject|5
5963860|NCT01180296|20623570|P2|Overall Study|Protocol Violation|2
5963861|NCT01180296|20623571|P1|Overall Study|Protocol Violation|1
5963862|NCT01180244|20623581|P2|Overall Study|Lost to Follow-up|0
5963863|NCT01180244|20623582|P1|Overall Study|Lost to Follow-up|1
5963864|NCT01180244|20623581|P2|Overall Study|Protocol Violation|0
5963865|NCT01180244|20623582|P1|Overall Study|Protocol Violation|1
5963866|NCT01180244|20623581|P2|Overall Study|Withdrawal by Subject|1
5963867|NCT01180244|20623582|P1|Overall Study|Withdrawal by Subject|0
5963868|NCT01180244|20623581|P2|Overall Study|Adverse Event|0
5963869|NCT01180244|20623582|P1|Overall Study|Adverse Event|1
5963870|NCT01180244|20623581|P2|Overall Study|Physician Decision|0
5963871|NCT01180244|20623582|P1|Overall Study|Physician Decision|3
5963872|NCT01180244|20623581|P2|Overall Study|Lack of Efficacy|7
5963873|NCT01180244|20623582|P1|Overall Study|Lack of Efficacy|0
5963874|NCT01180049|20623627|P2|Overall Study|Death|35
5963875|NCT01180049|20623628|P1|Overall Study|Death|36
5963876|NCT01180049|20623627|P2|Overall Study|Lost to Follow-up|6
5963877|NCT01180049|20623628|P1|Overall Study|Lost to Follow-up|8
5963878|NCT01180049|20623627|P2|Overall Study|Other|7
5963879|NCT01180049|20623628|P1|Overall Study|Other|9
5963880|NCT01179919|20623665|P1|Overall Study|Adverse Event|1
5963881|NCT01179919|20623665|P1|Overall Study|Protocol Violation|1
5963882|NCT01179737|20623674|P4|Extension|The study was terminated|0
5963883|NCT01179737|20623675|P3|Extension|The study was terminated|0
5963884|NCT01179737|20623676|P2|Extension|The study was terminated|0
5963885|NCT01179737|20623677|P1|Extension|The study was terminated|3
5963886|NCT01179737|20623674|P4|Cohort 1 & Cohort 2 Expansion|Death|0
5963887|NCT01179737|20623675|P3|Cohort 1 & Cohort 2 Expansion|Death|0
5963888|NCT01179737|20623676|P2|Cohort 1 & Cohort 2 Expansion|Death|0
5963889|NCT01179737|20623677|P1|Cohort 1 & Cohort 2 Expansion|Death|1
5963890|NCT01179737|20623674|P4|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0
5963891|NCT01179737|20623675|P3|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0
5963892|NCT01179737|20623676|P2|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|1
5963893|NCT01179737|20623677|P1|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0
5963894|NCT01179737|20623674|P4|Cohort 1 & Cohort 2|Death|0
5963895|NCT01179737|20623675|P3|Cohort 1 & Cohort 2|Death|1
5963896|NCT01179737|20623676|P2|Cohort 1 & Cohort 2|Death|0
5963897|NCT01179737|20623677|P1|Cohort 1 & Cohort 2|Death|0
5963898|NCT01179737|20623674|P4|Cohort 1 & Cohort 2|Administrative problems|4
5963899|NCT01179737|20623675|P3|Cohort 1 & Cohort 2|Administrative problems|2
5963900|NCT01179737|20623676|P2|Cohort 1 & Cohort 2|Administrative problems|0
5963901|NCT01179737|20623677|P1|Cohort 1 & Cohort 2|Administrative problems|0
5963902|NCT01179737|20623674|P4|Cohort 1 & Cohort 2|Withdrew consent|0
5963903|NCT01179737|20623675|P3|Cohort 1 & Cohort 2|Withdrew consent|0
5963904|NCT01179737|20623676|P2|Cohort 1 & Cohort 2|Withdrew consent|0
5963905|NCT01179737|20623677|P1|Cohort 1 & Cohort 2|Withdrew consent|2
5963906|NCT01179737|20623674|P4|Cohort 1 & Cohort 2|Adverse Event|0
5963907|NCT01179737|20623675|P3|Cohort 1 & Cohort 2|Adverse Event|1
5963908|NCT01179737|20623676|P2|Cohort 1 & Cohort 2|Adverse Event|1
5963909|NCT01179737|20623677|P1|Cohort 1 & Cohort 2|Adverse Event|3
5963910|NCT01179672|20623688|P2|Overall Study|Physician Decision|1
5963911|NCT01179672|20623689|P1|Overall Study|Physician Decision|1
5963912|NCT01179672|20623688|P2|Overall Study|Protocol Violation|2
5963913|NCT01179672|20623689|P1|Overall Study|Protocol Violation|2
5963914|NCT01179672|20623688|P2|Overall Study|Lost to Follow-up|1
5963915|NCT01179672|20623689|P1|Overall Study|Lost to Follow-up|0
5963916|NCT01179672|20623688|P2|Overall Study|Entry Criteria Not Met|2
5963917|NCT01179672|20623689|P1|Overall Study|Entry Criteria Not Met|0
5963918|NCT01179672|20623688|P2|Overall Study|Withdrawal by Subject|12
5963919|NCT01179672|20623689|P1|Overall Study|Withdrawal by Subject|10
5963920|NCT01179672|20623688|P2|Overall Study|Adverse Event|8
5963921|NCT01179672|20623689|P1|Overall Study|Adverse Event|17
5963922|NCT01179516|20623745|P3|Overall Study|Other|2
5963923|NCT01179516|20623746|P2|Overall Study|Other|0
5963924|NCT01179516|20623747|P1|Overall Study|Other|2
5963925|NCT01179516|20623745|P3|Overall Study|Lost to Follow-up|3
5963926|NCT01179516|20623746|P2|Overall Study|Lost to Follow-up|7
5963927|NCT01179516|20623747|P1|Overall Study|Lost to Follow-up|7
5963928|NCT01179516|20623745|P3|Overall Study|Withdrawal of Consent|10
5963929|NCT01179516|20623746|P2|Overall Study|Withdrawal of Consent|6
5963930|NCT01179516|20623747|P1|Overall Study|Withdrawal of Consent|2
5963931|NCT01179516|20623745|P3|Overall Study|Protocol Deviations|3
5963932|NCT01179516|20623746|P2|Overall Study|Protocol Deviations|3
5963933|NCT01179516|20623747|P1|Overall Study|Protocol Deviations|4
5963934|NCT01179516|20623745|P3|Overall Study|Noncompliance with Study Drug|1
5963935|NCT01179516|20623746|P2|Overall Study|Noncompliance with Study Drug|0
5963936|NCT01179516|20623747|P1|Overall Study|Noncompliance with Study Drug|2
5963937|NCT01179516|20623745|P3|Overall Study|Lack of Efficacy|0
5963938|NCT01179516|20623746|P2|Overall Study|Lack of Efficacy|2
5963939|NCT01179516|20623747|P1|Overall Study|Lack of Efficacy|4
5963940|NCT01179516|20623745|P3|Overall Study|Pretreatment Event or Adverse Event|12
5963941|NCT01179516|20623746|P2|Overall Study|Pretreatment Event or Adverse Event|8
5963942|NCT01179516|20623747|P1|Overall Study|Pretreatment Event or Adverse Event|6
5963943|NCT01179477|20623791|P1|Overall Study|Did not complete final visit|27
5963944|NCT01179477|20623791|P1|Overall Study|Non-death withdrawal|438
5963945|NCT01179477|20623791|P1|Overall Study|Unsuccessful implant|80
5963946|NCT01179477|20623791|P1|Overall Study|Death|542
5963947|NCT01179399|20623796|P1|Overall Study|Withdrawal by Subject|1
5963948|NCT01179399|20623796|P1|Overall Study|Lack of Efficacy|30
5963949|NCT01179399|20623796|P1|Overall Study|Adverse Event|1
5963950|NCT01179347|20623802|P2|Open-label Period (12 Weeks)|Other|4
5963951|NCT01179347|20623803|P1|Open-label Period (12 Weeks)|Other|7
5963952|NCT01179347|20623802|P2|Open-label Period (12 Weeks)|Protocol Violation|0
5963953|NCT01179347|20623803|P1|Open-label Period (12 Weeks)|Protocol Violation|1
5963954|NCT01179347|20623802|P2|Open-label Period (12 Weeks)|Withdrawal by Subject|1
5963955|NCT01179347|20623803|P1|Open-label Period (12 Weeks)|Withdrawal by Subject|1
5963956|NCT01179347|20623802|P2|Open-label Period (12 Weeks)|Lost to Follow-up|0
5963957|NCT01179347|20623803|P1|Open-label Period (12 Weeks)|Lost to Follow-up|1
5963958|NCT01179347|20623802|P2|Open-label Period (12 Weeks)|Lack of Efficacy|2
5963959|NCT01179347|20623803|P1|Open-label Period (12 Weeks)|Lack of Efficacy|0
5963960|NCT01179347|20623802|P2|Open-label Period (12 Weeks)|Adverse Event|9
5963961|NCT01179347|20623803|P1|Open-label Period (12 Weeks)|Adverse Event|5
5963962|NCT01179347|20623802|P2|Double-blind Period (12 Weeks)|Other|4
5963963|NCT01179347|20623803|P1|Double-blind Period (12 Weeks)|Other|2
5963964|NCT01179347|20623802|P2|Double-blind Period (12 Weeks)|Withdrawal by Subject|2
5963965|NCT01179347|20623803|P1|Double-blind Period (12 Weeks)|Withdrawal by Subject|1
5963966|NCT01179347|20623802|P2|Double-blind Period (12 Weeks)|Lost to Follow-up|2
5963967|NCT01179347|20623803|P1|Double-blind Period (12 Weeks)|Lost to Follow-up|1
5963968|NCT01179347|20623802|P2|Double-blind Period (12 Weeks)|Protocol Violation|0
5963969|NCT01179347|20623803|P1|Double-blind Period (12 Weeks)|Protocol Violation|2
5963970|NCT01179347|20623802|P2|Double-blind Period (12 Weeks)|Adverse Event|6
5963971|NCT01179347|20623803|P1|Double-blind Period (12 Weeks)|Adverse Event|2
5963972|NCT01179334|20623825|P2|Long-term Extension (LTE) Period|Adverse Event|4
5963973|NCT01179334|20623826|P1|Long-term Extension (LTE) Period|Adverse Event|2
5963974|NCT01179334|20623825|P2|Long-term Extension (LTE) Period|Death|0
5963975|NCT01179334|20623826|P1|Long-term Extension (LTE) Period|Death|3
5963976|NCT01179334|20623825|P2|Long-term Extension (LTE) Period|Study terminated by sponsor|2
5963977|NCT01179334|20623826|P1|Long-term Extension (LTE) Period|Study terminated by sponsor|6
5963978|NCT01179334|20623825|P2|Treatment Period|Adverse Event|0
5963979|NCT01179334|20623826|P1|Treatment Period|Adverse Event|1
5963980|NCT01179191|20623881|P1|Maintenance Phase (8 Weeks)|Other|66
5963981|NCT01179191|20623881|P1|Maintenance Phase (8 Weeks)|Withdrawal by Subject|29
5963982|NCT01179191|20623881|P1|Maintenance Phase (8 Weeks)|Physician Decision|3
5963983|NCT01179191|20623881|P1|Maintenance Phase (8 Weeks)|Lost to Follow-up|9
5963984|NCT01179191|20623881|P1|Maintenance Phase (8 Weeks)|Adverse Event|10
5963985|NCT01179191|20623881|P1|Titration Phase (up to 6 Weeks)|Other|62
5963986|NCT01179191|20623881|P1|Titration Phase (up to 6 Weeks)|Participant did not reach stable dose|13
5963987|NCT01179191|20623881|P1|Titration Phase (up to 6 Weeks)|Withdrawal by Subject|162
5963988|NCT01179191|20623881|P1|Titration Phase (up to 6 Weeks)|Physician Decision|30
5963989|NCT01179191|20623881|P1|Titration Phase (up to 6 Weeks)|Lost to Follow-up|19
5963990|NCT01179191|20623881|P1|Titration Phase (up to 6 Weeks)|Adverse Event|47
5963991|NCT01179048|20623913|P2|Overall Study|Alive|142
5963992|NCT01179048|20623914|P1|Overall Study|Alive|127
5963993|NCT01179048|20623913|P2|Overall Study|Lost to Follow-up|9
5963994|NCT01179048|20623914|P1|Overall Study|Lost to Follow-up|8
5963995|NCT01179048|20623913|P2|Overall Study|Withdrawn - does not allow contact|8
5963996|NCT01179048|20623914|P1|Overall Study|Withdrawn - does not allow contact|4
5963997|NCT01178853|20623941|P2|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|1
5963998|NCT01178853|20623942|P1|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|0
5963999|NCT01178853|20623941|P2|Period 4 (Warfarin + Study Drug)|Adverse Event|2
5964000|NCT01178853|20623942|P1|Period 4 (Warfarin + Study Drug)|Adverse Event|0
5964001|NCT01178853|20623941|P2|Period 3 (Warfarin Titration)|Adverse Event|0
5964002|NCT01178853|20623942|P1|Period 3 (Warfarin Titration)|Adverse Event|1
5964003|NCT01178853|20623941|P2|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|0
5964004|NCT01178853|20623942|P1|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|1
5964005|NCT01178853|20623941|P2|Period 1 (Warfarin Titration)|INR Out of Range|2
5964006|NCT01178853|20623942|P1|Period 1 (Warfarin Titration)|INR Out of Range|1
5964007|NCT01178762|20623982|P1|Overall Study|Lost to Follow-up|15
5964008|NCT01178671|20623988|P2|Overall Study|Physician Decision|6
5964009|NCT01178671|20623989|P1|Overall Study|Physician Decision|4
5964010|NCT01178671|20623988|P2|Overall Study|Lost to Follow-up|1
5964011|NCT01178671|20623989|P1|Overall Study|Lost to Follow-up|3
5964012|NCT01178671|20623988|P2|Overall Study|Lack of Efficacy|1
5964013|NCT01178671|20623989|P1|Overall Study|Lack of Efficacy|0
5964014|NCT01178671|20623988|P2|Overall Study|Protocol Violation|1
5964015|NCT01178671|20623989|P1|Overall Study|Protocol Violation|1
5964016|NCT01178671|20623988|P2|Overall Study|Adverse Event|6
5964017|NCT01178671|20623989|P1|Overall Study|Adverse Event|4
5964018|NCT01178385|20624037|P2|Overall Study|Withdrawal by Subject|0
5964019|NCT01178385|20624038|P1|Overall Study|Withdrawal by Subject|2
5964020|NCT01178294|20624107|P1|Overall Study|Completion status could not be verified|1
5964021|NCT01178294|20624107|P1|Overall Study|Subject status is terminal|1
5964022|NCT01178294|20624107|P1|Overall Study|Development of inhibitors to OBI-1|1
5964023|NCT01178294|20624107|P1|Overall Study|Death|1
5964024|NCT01178294|20624107|P1|Overall Study|Lack of Efficacy|1
5964025|NCT01178294|20624107|P1|Overall Study|Lost to Follow-up|2
5964026|NCT01178294|20624107|P1|Overall Study|Adverse Event|4
5964027|NCT01178138|20624387|P1|Overall Study|Physician Decision|8
5964028|NCT01178138|20624387|P1|Overall Study|Withdrawal by Subject|7
5964029|NCT01178138|20624387|P1|Overall Study|Lost to Follow-up|8
5964030|NCT01178125|20624408|P1|Overall Study|Investigator Decision|5
5964031|NCT01178125|20624408|P1|Overall Study|Protocol Violation|17
5964032|NCT01178125|20624408|P1|Overall Study|Sponsor Decision|28
5964033|NCT01178125|20624408|P1|Overall Study|Other Reason|39
5964034|NCT01178125|20624408|P1|Overall Study|Pregnancy|55
5964035|NCT01178125|20624408|P1|Overall Study|Noncompliance|184
5964036|NCT01178125|20624408|P1|Overall Study|Withdrawal by Subject|209
5964037|NCT01178125|20624408|P1|Overall Study|Adverse Event|244
5964038|NCT01178125|20624408|P1|Overall Study|Lost to Follow-up|397
5964039|NCT01178099|20624439|P2|Overall Study|Physician Decision|1
5964040|NCT01178099|20624440|P1|Overall Study|Physician Decision|0
5964041|NCT01178086|20624480|P1|Overall Study|Excluded from EAS|20
5964042|NCT01178086|20624480|P1|Overall Study|Other unspecified|89
5964043|NCT01178086|20624480|P1|Overall Study|Death|59
5964044|NCT01178086|20624480|P1|Overall Study|Switch to other CLL therapy|113
5964045|NCT01178086|20624480|P1|Overall Study|Physician Decision|44
5964046|NCT01178086|20624480|P1|Overall Study|Participant refusal|7
5964047|NCT01178073|20624507|P3|Overall Study|Missing Completion Status|0
5964048|NCT01178073|20624508|P2|Overall Study|Missing Completion Status|0
5964049|NCT01178073|20624509|P1|Overall Study|Missing Completion Status|1
5964050|NCT01178073|20624507|P3|Overall Study|Withdrawal by Subject|8
5964051|NCT01178073|20624508|P2|Overall Study|Withdrawal by Subject|6
5964052|NCT01178073|20624509|P1|Overall Study|Withdrawal by Subject|10
5964053|NCT01178073|20624507|P3|Overall Study|Physician Decision|10
5964054|NCT01178073|20624508|P2|Overall Study|Physician Decision|10
5964055|NCT01178073|20624509|P1|Overall Study|Physician Decision|14
5964056|NCT01178073|20624507|P3|Overall Study|Lost to Follow-up|3
5964057|NCT01178073|20624508|P2|Overall Study|Lost to Follow-up|0
5964058|NCT01178073|20624509|P1|Overall Study|Lost to Follow-up|2
5964059|NCT01178073|20624507|P3|Overall Study|Protocol Violation|1
5964060|NCT01178073|20624508|P2|Overall Study|Protocol Violation|1
5964061|NCT01178073|20624509|P1|Overall Study|Protocol Violation|1
5964062|NCT01178073|20624507|P3|Overall Study|Adverse Event|24
5964063|NCT01178073|20624508|P2|Overall Study|Adverse Event|27
5964064|NCT01178073|20624509|P1|Overall Study|Adverse Event|34
5964065|NCT01177969|20624540|P2|Overall Study|Withdrawal by Subject|2
5964066|NCT01177969|20624541|P1|Overall Study|Withdrawal by Subject|1
5964067|NCT01177969|20624540|P2|Overall Study|Protocol Violation|1
5964068|NCT01177969|20624541|P1|Overall Study|Protocol Violation|2
5964069|NCT01177943|20624564|P2|First Intervention|Withdrawal by Subject|0
5964070|NCT01177943|20624565|P1|First Intervention|Withdrawal by Subject|2
5964071|NCT01177813|20624578|P5|Overall Study|Other reason not defined above|2
5964072|NCT01177813|20624579|P4|Overall Study|Other reason not defined above|3
5964073|NCT01177813|20624580|P3|Overall Study|Other reason not defined above|2
5964074|NCT01177813|20624581|P2|Overall Study|Other reason not defined above|2
5964075|NCT01177813|20624582|P1|Overall Study|Other reason not defined above|5
5964076|NCT01177813|20624578|P5|Overall Study|Withdrawal by Subject|3
5964077|NCT01177813|20624579|P4|Overall Study|Withdrawal by Subject|5
5964078|NCT01177813|20624580|P3|Overall Study|Withdrawal by Subject|6
5964079|NCT01177813|20624581|P2|Overall Study|Withdrawal by Subject|7
5964080|NCT01177813|20624582|P1|Overall Study|Withdrawal by Subject|12
5964081|NCT01177813|20624578|P5|Overall Study|Lost to Follow-up|0
5964082|NCT01177813|20624579|P4|Overall Study|Lost to Follow-up|3
5964083|NCT01177813|20624580|P3|Overall Study|Lost to Follow-up|6
5964084|NCT01177813|20624581|P2|Overall Study|Lost to Follow-up|5
5964085|NCT01177813|20624582|P1|Overall Study|Lost to Follow-up|12
5964086|NCT01177813|20624578|P5|Overall Study|Protocol Violation|1
5964087|NCT01177813|20624579|P4|Overall Study|Protocol Violation|0
5964088|NCT01177813|20624580|P3|Overall Study|Protocol Violation|2
5964089|NCT01177813|20624581|P2|Overall Study|Protocol Violation|2
5964090|NCT01177813|20624582|P1|Overall Study|Protocol Violation|3
5964091|NCT01177813|20624578|P5|Overall Study|Lack of Efficacy|0
5964092|NCT01177813|20624579|P4|Overall Study|Lack of Efficacy|0
5964093|NCT01177813|20624580|P3|Overall Study|Lack of Efficacy|0
5964094|NCT01177813|20624581|P2|Overall Study|Lack of Efficacy|0
5964095|NCT01177813|20624582|P1|Overall Study|Lack of Efficacy|1
5964096|NCT01177813|20624578|P5|Overall Study|Adverse Event|3
5964097|NCT01177813|20624579|P4|Overall Study|Adverse Event|6
5964098|NCT01177813|20624580|P3|Overall Study|Adverse Event|4
5964099|NCT01177813|20624581|P2|Overall Study|Adverse Event|2
5964100|NCT01177813|20624582|P1|Overall Study|Adverse Event|8
5964101|NCT01177800|20624611|P2|Overall Study|Withdrawal of informed consent|1
5964102|NCT01177800|20624612|P1|Overall Study|Withdrawal of informed consent|0
5964103|NCT01177800|20624611|P2|Overall Study|Physician Decision|0
5964104|NCT01177800|20624612|P1|Overall Study|Physician Decision|1
5964105|NCT01177800|20624611|P2|Overall Study|Protocol Violation|1
5964106|NCT01177800|20624612|P1|Overall Study|Protocol Violation|0
5964107|NCT01177800|20624611|P2|Overall Study|Adverse Event|3
5964108|NCT01177800|20624612|P1|Overall Study|Adverse Event|9
5964109|NCT01177722|20624634|P4|Overall Study|Withdrawal by Subject|6
5964110|NCT01177722|20624635|P3|Overall Study|Withdrawal by Subject|4
5964111|NCT01177722|20624636|P2|Overall Study|Withdrawal by Subject|6
5964112|NCT01177722|20624637|P1|Overall Study|Withdrawal by Subject|10
5964113|NCT01177722|20624634|P4|Overall Study|Lost to Follow-up|1
5964114|NCT01177722|20624635|P3|Overall Study|Lost to Follow-up|3
5964115|NCT01177722|20624636|P2|Overall Study|Lost to Follow-up|4
5964116|NCT01177722|20624637|P1|Overall Study|Lost to Follow-up|3
5964117|NCT01177722|20624634|P4|Overall Study|Protocol Violation|0
5964118|NCT01177722|20624635|P3|Overall Study|Protocol Violation|1
5964119|NCT01177722|20624636|P2|Overall Study|Protocol Violation|0
5964120|NCT01177722|20624637|P1|Overall Study|Protocol Violation|0
5964121|NCT01177722|20624634|P4|Overall Study|Serious Adverse Event|0
5964122|NCT01177722|20624635|P3|Overall Study|Serious Adverse Event|1
5964123|NCT01177722|20624636|P2|Overall Study|Serious Adverse Event|0
5964124|NCT01177722|20624637|P1|Overall Study|Serious Adverse Event|0
5964125|NCT01177670|20624669|P1|Overall Study|Withdrawal by Subject|4
5964126|NCT01177670|20624669|P1|Overall Study|Physician Decision|50
5964127|NCT01177670|20624669|P1|Overall Study|Study Terminated|115
5964128|NCT01177553|20624676|P2|Overall Study|babies not yet 6 months of age|0
5964129|NCT01177553|20624677|P1|Overall Study|babies not yet 6 months of age|1
5964130|NCT01177410|20624686|P3|Overall Study|Lost to Follow-up|0
5964131|NCT01177410|20624687|P2|Overall Study|Lost to Follow-up|1
5964132|NCT01177410|20624688|P1|Overall Study|Lost to Follow-up|0
5964133|NCT01177410|20624686|P3|Overall Study|Withdrawal by Subject|3
5964134|NCT01177410|20624687|P2|Overall Study|Withdrawal by Subject|4
5964135|NCT01177410|20624688|P1|Overall Study|Withdrawal by Subject|1
5964136|NCT01177410|20624686|P3|Overall Study|Adverse Event|2
5964137|NCT01177410|20624687|P2|Overall Study|Adverse Event|2
5964138|NCT01177410|20624688|P1|Overall Study|Adverse Event|0
5964139|NCT01177384|20624701|P2|Overall Study|Withdrawal by Subject|12
5964140|NCT01177384|20624702|P1|Overall Study|Withdrawal by Subject|5
5964141|NCT01177384|20624701|P2|Overall Study|Protocol Violation|2
5964142|NCT01177384|20624702|P1|Overall Study|Protocol Violation|0
5964143|NCT01177384|20624701|P2|Overall Study|Physician Decision|3
5964144|NCT01177384|20624702|P1|Overall Study|Physician Decision|0
5964145|NCT01177384|20624701|P2|Overall Study|Lost to Follow-up|4
5964146|NCT01177384|20624702|P1|Overall Study|Lost to Follow-up|3
5964147|NCT01177384|20624701|P2|Overall Study|Lack of Efficacy|1
5964148|NCT01177384|20624702|P1|Overall Study|Lack of Efficacy|0
5964149|NCT01177384|20624701|P2|Overall Study|Adverse Event|4
5964150|NCT01177384|20624702|P1|Overall Study|Adverse Event|6
5964151|NCT01177228|20624718|P4|Overall Study|Withdrawal by Subject|0
5964152|NCT01177228|20624719|P3|Overall Study|Withdrawal by Subject|0
5964153|NCT01177228|20624720|P2|Overall Study|Withdrawal by Subject|1
5964154|NCT01177228|20624721|P1|Overall Study|Withdrawal by Subject|0
5964155|NCT01177228|20624718|P4|Overall Study|Worsening disease activity|0
5964156|NCT01177228|20624719|P3|Overall Study|Worsening disease activity|0
5964157|NCT01177228|20624720|P2|Overall Study|Worsening disease activity|0
5964158|NCT01177228|20624721|P1|Overall Study|Worsening disease activity|1
5964159|NCT01177228|20624718|P4|Overall Study|Positive tuberculosis test|0
5964160|NCT01177228|20624719|P3|Overall Study|Positive tuberculosis test|0
5964161|NCT01177228|20624720|P2|Overall Study|Positive tuberculosis test|1
5964162|NCT01177228|20624721|P1|Overall Study|Positive tuberculosis test|0
5964163|NCT01177137|20624775|P3|Overall Study|Withdrawal by Subject|2
5964164|NCT01177137|20624776|P2|Overall Study|Withdrawal by Subject|10
5964165|NCT01177137|20624777|P1|Overall Study|Withdrawal by Subject|10
5964166|NCT01177059|20624861|P1|Overall Study|Lost to Follow-up|18
5964167|NCT01177059|20624861|P1|Overall Study|Withdrew consent|2
5964168|NCT01177059|20624861|P1|Overall Study|Received placebo in OTH/OZ1-INT-1 study|30
5964169|NCT01177007|20624867|P1|Overall Study|Change in treatment modality|21
5964170|NCT01177007|20624867|P1|Overall Study|Required additional Y90 treatment|6
5964171|NCT01177007|20624867|P1|Overall Study|Entered hospice care|5
5964172|NCT01177007|20624867|P1|Overall Study|Death|4
5964173|NCT01177007|20624867|P1|Overall Study|Lost to Follow-up|2
5964174|NCT01176968|20624881|P2|Overall Study|Reason not defined|3
5964175|NCT01176968|20624882|P1|Overall Study|Reason not defined|5
5964176|NCT01176968|20624881|P2|Overall Study|Study terminated by sponsor|1
5964177|NCT01176968|20624882|P1|Overall Study|Study terminated by sponsor|0
5964178|NCT01176968|20624881|P2|Overall Study|Did Not Meet Entrance Criteria|0
5964179|NCT01176968|20624882|P1|Overall Study|Did Not Meet Entrance Criteria|1
5964180|NCT01176968|20624881|P2|Overall Study|Protocol Violation|1
5964181|NCT01176968|20624882|P1|Overall Study|Protocol Violation|2
5964182|NCT01176968|20624881|P2|Overall Study|Withdrawal by Subject|48
5964183|NCT01176968|20624882|P1|Overall Study|Withdrawal by Subject|48
5964184|NCT01176968|20624881|P2|Overall Study|Lost to Follow-up|14
5964185|NCT01176968|20624882|P1|Overall Study|Lost to Follow-up|16
5964186|NCT01176968|20624881|P2|Overall Study|Lack of Efficacy|1
5964187|NCT01176968|20624882|P1|Overall Study|Lack of Efficacy|0
5964188|NCT01176968|20624881|P2|Overall Study|Death|3
5964189|NCT01176968|20624882|P1|Overall Study|Death|2
5964190|NCT01176968|20624881|P2|Overall Study|Adverse Event|11
5964191|NCT01176968|20624882|P1|Overall Study|Adverse Event|10
5964192|NCT01176916|20624928|P1|Overall Study|Withdrawal prior to Treatment|6
5964193|NCT01176916|20624928|P1|Overall Study|Other|6
5964194|NCT01176916|20624928|P1|Overall Study|Withdrawal by Subject|37
5964195|NCT01176916|20624928|P1|Overall Study|Protocol Violation|24
5964196|NCT01176916|20624928|P1|Overall Study|Objective progression or relapse|17
5964197|NCT01176916|20624928|P1|Overall Study|Lost to Follow-up|15
5964198|NCT01176916|20624928|P1|Overall Study|Death|1
5964199|NCT01176916|20624928|P1|Overall Study|Adverse Event|61
5964200|NCT01176773|20624943|P1|Overall Study|Withdrew consent|1
5964201|NCT01176773|20624943|P1|Overall Study|Screen Failure|2
5964202|NCT01176565|20624986|P2|Overall Study|Not Analyzed (any other reason)|2
5964203|NCT01176565|20624987|P1|Overall Study|Not Analyzed (any other reason)|1
5964204|NCT01176565|20624986|P2|Overall Study|Withdrawal by Subject|1
5964205|NCT01176565|20624987|P1|Overall Study|Withdrawal by Subject|7
5964206|NCT01176565|20624986|P2|Overall Study|Lost to Follow-up|16
5964207|NCT01176565|20624987|P1|Overall Study|Lost to Follow-up|12
5964208|NCT01176513|20625005|P1|Overall Study|Withdrew subjects prior to dosing|3
5964209|NCT01176292|20625033|P2|Overall Study|Has not scheduled one-year visit yet|2
5964210|NCT01176292|20625034|P1|Overall Study|Has not scheduled one-year visit yet|2
5964211|NCT01176292|20625033|P2|Overall Study|Physician Decision|2
5964212|NCT01176292|20625034|P1|Overall Study|Physician Decision|0
5964213|NCT01176292|20625033|P2|Overall Study|Adverse Event|1
5964214|NCT01176292|20625034|P1|Overall Study|Adverse Event|1
5964215|NCT01176292|20625033|P2|Overall Study|Lost to Follow-up|4
5964216|NCT01176292|20625034|P1|Overall Study|Lost to Follow-up|2
5964217|NCT01176266|20625052|P1|Overall Study|Withdrawal by Subject|3
5964218|NCT01176266|20625052|P1|Overall Study|Death|6
5964219|NCT01176240|20625076|P2|Study 306B|withdrew prior to dosing|1
5964220|NCT01176240|20625077|P1|Study 306B|withdrew prior to dosing|2
5964221|NCT01176240|20625076|P2|Study 306B|Lost to Follow-up|1
5964222|NCT01176240|20625077|P1|Study 306B|Lost to Follow-up|0
5964223|NCT01176240|20625076|P2|Study 306B|Supine Hypertension|2
5964224|NCT01176240|20625077|P1|Study 306B|Supine Hypertension|1
5964225|NCT01176240|20625076|P2|Study 306B|Physician Decision|1
5964226|NCT01176240|20625077|P1|Study 306B|Physician Decision|2
5964227|NCT01176240|20625076|P2|Study 306B|Withdrawal by Subject|1
5964228|NCT01176240|20625077|P1|Study 306B|Withdrawal by Subject|4
5964229|NCT01176240|20625076|P2|Study 306B|Protocol Violation|3
5964230|NCT01176240|20625077|P1|Study 306B|Protocol Violation|2
5964231|NCT01176240|20625076|P2|Study 306B|Adverse Event|5
5964232|NCT01176240|20625077|P1|Study 306B|Adverse Event|10
5964233|NCT01176240|20625076|P2|Study 306B|Lack of Efficacy|3
5964234|NCT01176240|20625077|P1|Study 306B|Lack of Efficacy|5
5964235|NCT01176240|20625076|P2|Study 306A|Stop due to diverse problems|0
5964236|NCT01176240|20625077|P1|Study 306A|Stop due to diverse problems|1
5964237|NCT01176240|20625076|P2|Study 306A|Withdrawal by Subject|1
5964238|NCT01176240|20625077|P1|Study 306A|Withdrawal by Subject|0
5964239|NCT01176240|20625076|P2|Study 306A|Protocol Violation|1
5964240|NCT01176240|20625077|P1|Study 306A|Protocol Violation|0
5964241|NCT01176240|20625076|P2|Study 306A|Lack of Efficacy|1
5964242|NCT01176240|20625077|P1|Study 306A|Lack of Efficacy|2
5964243|NCT01176058|20625103|P2|Overall Study|Withdrawal by Subject|0
5964244|NCT01176058|20625104|P1|Overall Study|Withdrawal by Subject|1
5964245|NCT01176058|20625103|P2|Overall Study|Insufficient mycological response|1
5964246|NCT01176058|20625104|P1|Overall Study|Insufficient mycological response|0
5964247|NCT01176058|20625103|P2|Overall Study|Insufficient clinical response|2
5964248|NCT01176058|20625104|P1|Overall Study|Insufficient clinical response|2
5964249|NCT01176058|20625103|P2|Overall Study|Adverse Event|0
5964250|NCT01176058|20625104|P1|Overall Study|Adverse Event|1
5964251|NCT01176032|20625128|P2|Overall Study|Other|0
5964252|NCT01176032|20625129|P1|Overall Study|Other|1
5964253|NCT01176032|20625128|P2|Overall Study|Informed consent withdrawn|0
5964254|NCT01176032|20625129|P1|Overall Study|Informed consent withdrawn|3
5964255|NCT01176032|20625128|P2|Overall Study|Protocol Violation|0
5964256|NCT01176032|20625129|P1|Overall Study|Protocol Violation|1
5964257|NCT01176032|20625128|P2|Overall Study|Unsatisfactory therapeutic effect|1
5964258|NCT01176032|20625129|P1|Overall Study|Unsatisfactory therapeutic effect|0
5964259|NCT01176032|20625128|P2|Overall Study|Adverse Event|0
5964260|NCT01176032|20625129|P1|Overall Study|Adverse Event|1
5964261|NCT01175824|20625270|P2|Overall Study|Entry Criteria Not Met|4
5964262|NCT01175824|20625271|P1|Overall Study|Entry Criteria Not Met|6
5964263|NCT01175824|20625270|P2|Overall Study|Sponsor Decision|0
5964264|NCT01175824|20625271|P1|Overall Study|Sponsor Decision|1
5964265|NCT01175824|20625270|P2|Overall Study|Withdrawal by Subject|7
5964266|NCT01175824|20625271|P1|Overall Study|Withdrawal by Subject|3
5964267|NCT01175824|20625270|P2|Overall Study|Protocol Violation|5
5964268|NCT01175824|20625271|P1|Overall Study|Protocol Violation|2
5964269|NCT01175824|20625270|P2|Overall Study|Physician Decision|4
5964270|NCT01175824|20625271|P1|Overall Study|Physician Decision|0
5964271|NCT01175824|20625270|P2|Overall Study|Lost to Follow-up|1
5964272|NCT01175824|20625271|P1|Overall Study|Lost to Follow-up|0
5964273|NCT01175824|20625270|P2|Overall Study|Lack of Efficacy|0
5964274|NCT01175824|20625271|P1|Overall Study|Lack of Efficacy|2
5964275|NCT01175824|20625270|P2|Overall Study|Adverse Event|1
5964276|NCT01175824|20625271|P1|Overall Study|Adverse Event|2
5964277|NCT01175811|20625305|P2|Overall Study|Withdrawal by Subject|7
5964278|NCT01175811|20625306|P1|Overall Study|Withdrawal by Subject|6
5964279|NCT01175811|20625305|P2|Overall Study|Protocol Violation|2
5964280|NCT01175811|20625306|P1|Overall Study|Protocol Violation|1
5964281|NCT01175811|20625305|P2|Overall Study|Physician Decision|1
5964282|NCT01175811|20625306|P1|Overall Study|Physician Decision|1
5964283|NCT01175811|20625305|P2|Overall Study|Lost to Follow-up|2
5964284|NCT01175811|20625306|P1|Overall Study|Lost to Follow-up|3
5964285|NCT01175811|20625305|P2|Overall Study|Lack of Efficacy|0
5964286|NCT01175811|20625306|P1|Overall Study|Lack of Efficacy|1
5964287|NCT01175811|20625305|P2|Overall Study|Entry criteria not met|1
5964288|NCT01175811|20625306|P1|Overall Study|Entry criteria not met|3
5964289|NCT01175811|20625305|P2|Overall Study|Adverse Event|1
5964290|NCT01175811|20625306|P1|Overall Study|Adverse Event|1
5964291|NCT01175707|20625341|P2|Overall Study|Adverse Event|6
5964292|NCT01175707|20625342|P1|Overall Study|Adverse Event|4
5964293|NCT01175668|20625378|P2|Overall Study|Withdrawal by Subject|0
5964294|NCT01175668|20625379|P1|Overall Study|Withdrawal by Subject|2
5964295|NCT01175590|20625389|P2|Overall Study|Protocol Violation|1
5964296|NCT01175590|20625390|P1|Overall Study|Protocol Violation|0
5964297|NCT01175590|20625389|P2|Overall Study|Herpes Simplex Dermatitis|0
5964298|NCT01175590|20625390|P1|Overall Study|Herpes Simplex Dermatitis|1
5964299|NCT01175590|20625389|P2|Overall Study|Treated not as randomized|2
5964300|NCT01175590|20625390|P1|Overall Study|Treated not as randomized|3
5964301|NCT01175590|20625389|P2|Overall Study|Residual Bacterial Conjunctivitis|0
5964302|NCT01175590|20625390|P1|Overall Study|Residual Bacterial Conjunctivitis|1
5964303|NCT01175590|20625389|P2|Overall Study|Lack of Efficacy|1
5964304|NCT01175590|20625390|P1|Overall Study|Lack of Efficacy|1
5964305|NCT01175590|20625389|P2|Overall Study|Physician Decision|4
5964306|NCT01175590|20625390|P1|Overall Study|Physician Decision|1
5964307|NCT01175590|20625389|P2|Overall Study|Adverse Event|0
5964308|NCT01175590|20625390|P1|Overall Study|Adverse Event|4
5964309|NCT01175590|20625389|P2|Overall Study|Withdrawal by Subject|2
5964310|NCT01175590|20625390|P1|Overall Study|Withdrawal by Subject|0
5964311|NCT01175590|20625389|P2|Overall Study|Lost to Follow-up|0
5964312|NCT01175590|20625390|P1|Overall Study|Lost to Follow-up|1
5964313|NCT01175473|20625424|P2|Overall Study|Adverse Event|2
5964314|NCT01175473|20625425|P1|Overall Study|Adverse Event|2
5964315|NCT01175382|20625466|P3|Overall Study|Unable to tolerate study meds|1
5964316|NCT01175382|20625467|P2|Overall Study|Unable to tolerate study meds|1
5964317|NCT01175382|20625468|P1|Overall Study|Unable to tolerate study meds|0
5964318|NCT01175382|20625466|P3|Overall Study|Unwilling to follow protocol|0
5964319|NCT01175382|20625467|P2|Overall Study|Unwilling to follow protocol|1
5964320|NCT01175382|20625468|P1|Overall Study|Unwilling to follow protocol|0
5964321|NCT01175382|20625466|P3|Overall Study|Unable/unwilling to attend visits|2
5964322|NCT01175382|20625467|P2|Overall Study|Unable/unwilling to attend visits|1
5964323|NCT01175382|20625468|P1|Overall Study|Unable/unwilling to attend visits|3
5964324|NCT01175382|20625466|P3|Overall Study|No longer having problem|1
5964325|NCT01175382|20625467|P2|Overall Study|No longer having problem|0
5964326|NCT01175382|20625468|P1|Overall Study|No longer having problem|1
5964327|NCT01175382|20625466|P3|Overall Study|Withdrawal by Subject|1
5964328|NCT01175382|20625467|P2|Overall Study|Withdrawal by Subject|0
5964329|NCT01175382|20625468|P1|Overall Study|Withdrawal by Subject|0
5964330|NCT01175382|20625466|P3|Overall Study|Physician Decision|0
5964331|NCT01175382|20625467|P2|Overall Study|Physician Decision|1
5964332|NCT01175382|20625468|P1|Overall Study|Physician Decision|0
5964333|NCT01175382|20625466|P3|Overall Study|Lost to Follow-up|1
5964334|NCT01175382|20625467|P2|Overall Study|Lost to Follow-up|3
5964335|NCT01175382|20625468|P1|Overall Study|Lost to Follow-up|4
5964336|NCT01175356|20625554|P1|Overall Study|Initiation other tx prior to completion|9
5964337|NCT01175356|20625554|P1|Overall Study|Inadequate stem cell for transplant|1
5964338|NCT01175356|20625554|P1|Overall Study|On other COG study w/tumor tx intent|7
5964339|NCT01175356|20625554|P1|Overall Study|Pts MIBG non-avid after enrollment|2
5964340|NCT01175356|20625554|P1|Overall Study|Refusal by patient/parent/guardian|6
5964341|NCT01175356|20625554|P1|Overall Study|Treatment Slot Not Available|18
5964342|NCT01175356|20625554|P1|Overall Study|Ineligible|1
5964343|NCT01175356|20625554|P1|Overall Study|Physician Decision|23
5964344|NCT01175356|20625554|P1|Overall Study|Lost to Follow-up|1
5964345|NCT01175356|20625554|P1|Overall Study|Lack of Efficacy|12
5964346|NCT01175356|20625554|P1|Overall Study|Death|1
5964347|NCT01175213|20625594|P2|Safety Follow-up|Adverse Event|0
5964348|NCT01175213|20625595|P1|Safety Follow-up|Adverse Event|1
5964349|NCT01175213|20625594|P2|IGSC, 10%/rHuPH20|site elected to exit study|0
5964350|NCT01175213|20625595|P1|IGSC, 10%/rHuPH20|site elected to exit study|3
5964351|NCT01175213|20625594|P2|IGSC, 10%/rHuPH20|clinical site closed by sponsor|0
5964352|NCT01175213|20625595|P1|IGSC, 10%/rHuPH20|clinical site closed by sponsor|6
5964353|NCT01175213|20625594|P2|IGSC, 10%/rHuPH20|bone marrow transplant|0
5964354|NCT01175213|20625595|P1|IGSC, 10%/rHuPH20|bone marrow transplant|1
5964355|NCT01175213|20625594|P2|IGSC, 10%/rHuPH20|Death|0
5964356|NCT01175213|20625595|P1|IGSC, 10%/rHuPH20|Death|1
5964357|NCT01175213|20625594|P2|IGSC, 10%/rHuPH20|Withdrawal by Subject|0
5964358|NCT01175213|20625595|P1|IGSC, 10%/rHuPH20|Withdrawal by Subject|4
5964359|NCT01175135|20625652|P4|Overall Study|Randomized But Not Treated|0
5964360|NCT01175135|20625653|P3|Overall Study|Randomized But Not Treated|1
5964361|NCT01175135|20625654|P2|Overall Study|Randomized But Not Treated|0
5964362|NCT01175135|20625655|P1|Overall Study|Randomized But Not Treated|0
5964363|NCT01175135|20625652|P4|Overall Study|Other|0
5964364|NCT01175135|20625653|P3|Overall Study|Other|3
5964365|NCT01175135|20625654|P2|Overall Study|Other|1
5964366|NCT01175135|20625655|P1|Overall Study|Other|3
5964367|NCT01175135|20625652|P4|Overall Study|Withdrawal by Subject|5
5964368|NCT01175135|20625653|P3|Overall Study|Withdrawal by Subject|5
5964369|NCT01175135|20625654|P2|Overall Study|Withdrawal by Subject|8
5964370|NCT01175135|20625655|P1|Overall Study|Withdrawal by Subject|4
5964371|NCT01175135|20625652|P4|Overall Study|Protocol Violation|0
5964372|NCT01175135|20625653|P3|Overall Study|Protocol Violation|0
5964373|NCT01175135|20625654|P2|Overall Study|Protocol Violation|1
5964374|NCT01175135|20625655|P1|Overall Study|Protocol Violation|1
5964375|NCT01175135|20625652|P4|Overall Study|Lost to Follow-up|0
5964376|NCT01175135|20625653|P3|Overall Study|Lost to Follow-up|0
5964377|NCT01175135|20625654|P2|Overall Study|Lost to Follow-up|2
5964378|NCT01175135|20625655|P1|Overall Study|Lost to Follow-up|1
5964379|NCT01175135|20625652|P4|Overall Study|Lack of Efficacy|5
5964380|NCT01175135|20625653|P3|Overall Study|Lack of Efficacy|0
5964381|NCT01175135|20625654|P2|Overall Study|Lack of Efficacy|5
5964382|NCT01175135|20625655|P1|Overall Study|Lack of Efficacy|4
5964383|NCT01175135|20625652|P4|Overall Study|Death|0
5964384|NCT01175135|20625653|P3|Overall Study|Death|0
5964385|NCT01175135|20625654|P2|Overall Study|Death|0
5964386|NCT01175135|20625655|P1|Overall Study|Death|1
5964387|NCT01175135|20625652|P4|Overall Study|Adverse Event|4
5964388|NCT01175135|20625653|P3|Overall Study|Adverse Event|3
5964389|NCT01175135|20625654|P2|Overall Study|Adverse Event|5
5964390|NCT01175135|20625655|P1|Overall Study|Adverse Event|2
5964391|NCT01175083|20625743|P6|Booster Epoch|Withdrawal by Subject|0
5964392|NCT01175083|20625744|P5|Booster Epoch|Withdrawal by Subject|0
5964393|NCT01175083|20625745|P4|Booster Epoch|Withdrawal by Subject|1
5964394|NCT01175083|20625746|P3|Booster Epoch|Withdrawal by Subject|0
5964395|NCT01175083|20625747|P2|Booster Epoch|Withdrawal by Subject|0
5964396|NCT01175083|20625748|P1|Booster Epoch|Withdrawal by Subject|0
5964397|NCT01175083|20625743|P6|Booster Epoch|Death|0
5964398|NCT01175083|20625744|P5|Booster Epoch|Death|0
5964399|NCT01175083|20625745|P4|Booster Epoch|Death|0
5964400|NCT01175083|20625746|P3|Booster Epoch|Death|1
5964401|NCT01175083|20625747|P2|Booster Epoch|Death|0
5964402|NCT01175083|20625748|P1|Booster Epoch|Death|0
5964403|NCT01175083|20625743|P6|Primary Epoch|Lost to Follow-up|1
5964404|NCT01175083|20625744|P5|Primary Epoch|Lost to Follow-up|0
5964405|NCT01175083|20625745|P4|Primary Epoch|Lost to Follow-up|0
5964406|NCT01175083|20625746|P3|Primary Epoch|Lost to Follow-up|0
5964407|NCT01175083|20625747|P2|Primary Epoch|Lost to Follow-up|0
5964408|NCT01175083|20625748|P1|Primary Epoch|Lost to Follow-up|0
5964409|NCT01175083|20625743|P6|Primary Epoch|Withdrawal by Subject|2
5964410|NCT01175083|20625744|P5|Primary Epoch|Withdrawal by Subject|0
5964411|NCT01175083|20625745|P4|Primary Epoch|Withdrawal by Subject|0
5964412|NCT01175083|20625746|P3|Primary Epoch|Withdrawal by Subject|0
5964413|NCT01175083|20625747|P2|Primary Epoch|Withdrawal by Subject|0
5964414|NCT01175083|20625748|P1|Primary Epoch|Withdrawal by Subject|0
5964415|NCT01175018|20625840|P2|Overall Study|Adverse Event|1
5964416|NCT01175018|20625841|P1|Overall Study|Adverse Event|3
5964417|NCT01174784|20625903|P1|Overall Study|Screen fails|4
5964418|NCT01174563|20625949|P1|Overall Study|Sponsor's decision|1
5964419|NCT01174563|20625949|P1|Overall Study|Rash Adverse Event|1
5964420|NCT01174563|20625949|P1|Overall Study|Participant Withdrew Consent|3
5964421|NCT01174563|20625949|P1|Overall Study|Investigator's Discretion|5
5964422|NCT01174563|20625949|P1|Overall Study|Death|5
5964423|NCT01174563|20625949|P1|Overall Study|Progressive Disease|45
5964424|NCT01174550|20625957|P2|Overall Study|Withdrawal by Subject|289
5964425|NCT01174550|20625958|P1|Overall Study|Withdrawal by Subject|543
5964426|NCT01174550|20625957|P2|Overall Study|Lost to Follow-up|510
5964427|NCT01174550|20625958|P1|Overall Study|Lost to Follow-up|652
5964428|NCT01174550|20625957|P2|Overall Study|Death|74
5964429|NCT01174550|20625958|P1|Overall Study|Death|75
5964430|NCT01174459|20625986|P1|Overall Study|case report form (CRF) not collected|5
5964431|NCT01174446|20625991|P4|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0
5964432|NCT01174446|20625992|P3|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0
5964433|NCT01174446|20625993|P2|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|1
5964434|NCT01174446|20625994|P1|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0
5964435|NCT01174446|20625991|P4|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0
5964436|NCT01174446|20625992|P3|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0
5964437|NCT01174446|20625993|P2|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0
5964438|NCT01174446|20625994|P1|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|1
5964439|NCT01174446|20625991|P4|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0
5964440|NCT01174446|20625992|P3|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|1
5964441|NCT01174446|20625993|P2|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0
5964442|NCT01174446|20625994|P1|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0
5964443|NCT01174446|20625991|P4|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0
5964444|NCT01174446|20625992|P3|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|1
5964445|NCT01174446|20625993|P2|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0
5964446|NCT01174446|20625994|P1|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0
5964447|NCT01174368|20626181|P1|Overall Study|Withdrawal by Subject|1
5964448|NCT01174342|20626187|P1|Overall Study|Conversion to cesarean section|4
5964449|NCT01174264|20626194|P3|Steady-state Pharmacokinetics|Not evaluable|2
5964450|NCT01174264|20626195|P2|Steady-state Pharmacokinetics|Not evaluable|0
5964451|NCT01174264|20626196|P1|Steady-state Pharmacokinetics|Not evaluable|6
5964452|NCT01174264|20626194|P3|Single Dose Pharmacokinetics|Patient entered hospice care|1
5964453|NCT01174264|20626195|P2|Single Dose Pharmacokinetics|Patient entered hospice care|0
5964454|NCT01174264|20626196|P1|Single Dose Pharmacokinetics|Patient entered hospice care|0
5964455|NCT01174264|20626194|P3|Single Dose Pharmacokinetics|Early progressive disease|1
5964456|NCT01174264|20626195|P2|Single Dose Pharmacokinetics|Early progressive disease|0
5964457|NCT01174264|20626196|P1|Single Dose Pharmacokinetics|Early progressive disease|1
5964458|NCT01174238|20626228|P1|Overall Study|Lost to Follow-up|2
5964459|NCT01174186|20626239|P2|Overall Study|Withdrawal by Subject|2
5964460|NCT01174186|20626240|P1|Overall Study|Withdrawal by Subject|0
5964461|NCT01174186|20626239|P2|Overall Study|Lost to Follow-up|1
5964462|NCT01174186|20626240|P1|Overall Study|Lost to Follow-up|0
5964463|NCT01174173|20626247|P1|Overall Study|drug-drug interaction|1
5964464|NCT01174160|20626258|P2|Overall Study|Withdrawal by Subject|0
5964465|NCT01174160|20626259|P1|Overall Study|Withdrawal by Subject|1
5964466|NCT01174160|20626258|P2|Overall Study|Protocol Violation|6
5964467|NCT01174160|20626259|P1|Overall Study|Protocol Violation|4
5964468|NCT01174160|20626258|P2|Overall Study|Physician Decision|0
5964469|NCT01174160|20626259|P1|Overall Study|Physician Decision|1
5964470|NCT01174160|20626258|P2|Overall Study|Lost to Follow-up|0
5964471|NCT01174160|20626259|P1|Overall Study|Lost to Follow-up|1
5964472|NCT01174160|20626258|P2|Overall Study|Adverse Event|0
5964473|NCT01174160|20626259|P1|Overall Study|Adverse Event|1
5964474|NCT01174043|20626274|P1|Overall Study|Withdrawal by Subject|2
5964475|NCT01174043|20626274|P1|Overall Study|Death|1
5964476|NCT01174043|20626274|P1|Overall Study|Adverse Event|3
5964477|NCT01174043|20626274|P1|Overall Study|Disease progression|5
5964478|NCT01174004|20626313|P2|Overall Study|Physician Decision|0
5964479|NCT01174004|20626314|P1|Overall Study|Physician Decision|1
5964480|NCT01174004|20626313|P2|Overall Study|Protocol Violation|1
5964481|NCT01174004|20626314|P1|Overall Study|Protocol Violation|0
5964482|NCT01174004|20626313|P2|Overall Study|At Discretion of Sponsor|2
5964483|NCT01174004|20626314|P1|Overall Study|At Discretion of Sponsor|2
5964484|NCT01174004|20626313|P2|Overall Study|Withdrawal by Subject|3
5964485|NCT01174004|20626314|P1|Overall Study|Withdrawal by Subject|2
5964486|NCT01174004|20626313|P2|Overall Study|Adverse Event|10
5964487|NCT01174004|20626314|P1|Overall Study|Adverse Event|2
5964488|NCT01173718|20626345|P1|Overall Study|Abandonment of study graft|27
5964489|NCT01173718|20626345|P1|Overall Study|Death|17
5964490|NCT01173679|20626354|P1|Overall Study|Death|1
5964491|NCT01173653|20626362|P2|Overall Study|Pts unwilling to provide follow-up|41
5964492|NCT01173653|20626363|P1|Overall Study|Pts unwilling to provide follow-up|53
5964493|NCT01173601|20626373|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|6
5964494|NCT01173601|20626374|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2
5964495|NCT01173601|20626375|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0
5964496|NCT01173601|20626376|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0
5964497|NCT01173601|20626377|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0
5964498|NCT01173601|20626373|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24
5964499|NCT01173601|20626374|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|5
5964500|NCT01173601|20626375|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|7
5964501|NCT01173601|20626376|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9
5964502|NCT01173601|20626377|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0
5964503|NCT01173601|20626373|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5
5964504|NCT01173601|20626374|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|4
5964505|NCT01173601|20626375|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5
5964506|NCT01173601|20626376|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|1
5964507|NCT01173601|20626377|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0
5964508|NCT01173601|20626373|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1
5964509|NCT01173601|20626374|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2
5964510|NCT01173601|20626375|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
5964511|NCT01173601|20626376|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2
5964512|NCT01173601|20626377|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
5964513|NCT01173601|20626373|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9
5964514|NCT01173601|20626374|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2
5964515|NCT01173601|20626375|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0
5964516|NCT01173601|20626376|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3
5964517|NCT01173601|20626377|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0
5964518|NCT01173601|20626373|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|9
5964519|NCT01173601|20626374|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8
5964520|NCT01173601|20626375|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|6
5964521|NCT01173601|20626376|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|10
5964522|NCT01173601|20626377|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0
5964523|NCT01173601|20626373|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|14
5964524|NCT01173601|20626374|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|7
5964525|NCT01173601|20626375|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|15
5964526|NCT01173601|20626376|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|10
5964527|NCT01173601|20626377|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0
5964528|NCT01173601|20626373|P5|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
5964529|NCT01173601|20626374|P4|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
5964530|NCT01173601|20626375|P3|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
5964531|NCT01173601|20626376|P2|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
5964532|NCT01173601|20626377|P1|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|6
5964533|NCT01173601|20626373|P5|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
5964534|NCT01173601|20626374|P4|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
5964535|NCT01173601|20626375|P3|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
5964536|NCT01173601|20626376|P2|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
5964537|NCT01173601|20626377|P1|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|25
5964538|NCT01173601|20626373|P5|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
5964539|NCT01173601|20626374|P4|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
5964540|NCT01173601|20626375|P3|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
5964541|NCT01173601|20626376|P2|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
5964542|NCT01173601|20626377|P1|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|15
5964543|NCT01173601|20626373|P5|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
5964544|NCT01173601|20626374|P4|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
5964545|NCT01173601|20626375|P3|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
5964546|NCT01173601|20626376|P2|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
5964547|NCT01173601|20626377|P1|Confirmation (CF) Phase, 3 Weeks|Physician Decision|3
5964548|NCT01173601|20626373|P5|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
5964549|NCT01173601|20626374|P4|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
5964550|NCT01173601|20626375|P3|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
5964551|NCT01173601|20626376|P2|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
5964552|NCT01173601|20626377|P1|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|7
5964553|NCT01173601|20626373|P5|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
5964554|NCT01173601|20626374|P4|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
5964555|NCT01173601|20626375|P3|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
5964556|NCT01173601|20626376|P2|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
5964557|NCT01173601|20626377|P1|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|9
5964558|NCT01173601|20626373|P5|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
5964559|NCT01173601|20626374|P4|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
5964560|NCT01173601|20626375|P3|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
5964561|NCT01173601|20626376|P2|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
5964562|NCT01173601|20626377|P1|Confirmation (CF) Phase, 3 Weeks|Adverse Event|23
5964563|NCT01173523|20626454|P2|Overall Study|Other|3
5964564|NCT01173523|20626455|P1|Overall Study|Other|2
5964565|NCT01173523|20626454|P2|Overall Study|Progressive Disease|8
5964566|NCT01173523|20626455|P1|Overall Study|Progressive Disease|10
5964567|NCT01173523|20626454|P2|Overall Study|Clinical Progression|1
5964568|NCT01173523|20626455|P1|Overall Study|Clinical Progression|1
5964569|NCT01173471|20626471|P4|Overall Study|Reason given as Other|0
5964570|NCT01173471|20626472|P3|Overall Study|Reason given as Other|1
5964571|NCT01173471|20626473|P2|Overall Study|Reason given as Other|0
5964572|NCT01173471|20626474|P1|Overall Study|Reason given as Other|0
5964573|NCT01173471|20626471|P4|Overall Study|Lost to Follow-up|0
5964574|NCT01173471|20626472|P3|Overall Study|Lost to Follow-up|1
5964575|NCT01173471|20626473|P2|Overall Study|Lost to Follow-up|0
5964576|NCT01173471|20626474|P1|Overall Study|Lost to Follow-up|0
5964577|NCT01173471|20626471|P4|Overall Study|Condition under investigation worsened|0
5964578|NCT01173471|20626472|P3|Overall Study|Condition under investigation worsened|0
5964579|NCT01173471|20626473|P2|Overall Study|Condition under investigation worsened|0
5964580|NCT01173471|20626474|P1|Overall Study|Condition under investigation worsened|2
5964581|NCT01173471|20626471|P4|Overall Study|Eligibility criteria not fulfilled|1
5964582|NCT01173471|20626472|P3|Overall Study|Eligibility criteria not fulfilled|1
5964583|NCT01173471|20626473|P2|Overall Study|Eligibility criteria not fulfilled|0
5964584|NCT01173471|20626474|P1|Overall Study|Eligibility criteria not fulfilled|0
5964585|NCT01173120|20626614|P1|Overall Study|Switch-Difficulty With Device|12
5964586|NCT01173120|20626614|P1|Overall Study|Switch-Participant Decision|12
5964587|NCT01173120|20626614|P1|Overall Study|Switch-Administrative Reason By Sponsor|33
5964588|NCT01173120|20626614|P1|Overall Study|Participant Decision|2
5964589|NCT01173120|20626614|P1|Overall Study|Lost to Follow-up|1
5964590|NCT01173120|20626614|P1|Overall Study|Lack of Efficacy|2
5964591|NCT01173055|20626632|P2|Period 2 - Day 64 to 112|Adverse Event|1
5964592|NCT01173055|20626633|P1|Period 2 - Day 64 to 112|Adverse Event|0
5964593|NCT01173055|20626632|P2|Period 1 - Day 1 to 49|Withdrawal by Subject|2
5964594|NCT01173055|20626633|P1|Period 1 - Day 1 to 49|Withdrawal by Subject|2
5964595|NCT01172938|20626684|P9|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|1
5964596|NCT01172938|20626685|P8|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
5964597|NCT01172938|20626686|P7|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
5964598|NCT01172938|20626687|P6|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
5964599|NCT01172938|20626688|P5|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
5964600|NCT01172938|20626689|P4|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
5964601|NCT01172938|20626690|P3|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
5964602|NCT01172938|20626691|P2|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
5964603|NCT01172938|20626692|P1|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
5964604|NCT01172938|20626684|P9|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
5964605|NCT01172938|20626685|P8|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
5964606|NCT01172938|20626686|P7|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
5964607|NCT01172938|20626687|P6|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
5964608|NCT01172938|20626688|P5|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
5964609|NCT01172938|20626689|P4|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
5964610|NCT01172938|20626690|P3|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|1
5964611|NCT01172938|20626691|P2|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
5964612|NCT01172938|20626692|P1|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
5964613|NCT01172938|20626684|P9|Active-Treatment Phase (Weeks 208-260)|Death|0
5964614|NCT01172938|20626685|P8|Active-Treatment Phase (Weeks 208-260)|Death|0
5964615|NCT01172938|20626686|P7|Active-Treatment Phase (Weeks 208-260)|Death|0
5964616|NCT01172938|20626687|P6|Active-Treatment Phase (Weeks 208-260)|Death|0
5964617|NCT01172938|20626688|P5|Active-Treatment Phase (Weeks 208-260)|Death|0
5964618|NCT01172938|20626689|P4|Active-Treatment Phase (Weeks 208-260)|Death|0
5964619|NCT01172938|20626690|P3|Active-Treatment Phase (Weeks 208-260)|Death|1
5964620|NCT01172938|20626691|P2|Active-Treatment Phase (Weeks 208-260)|Death|0
5964621|NCT01172938|20626692|P1|Active-Treatment Phase (Weeks 208-260)|Death|0
5964622|NCT01172938|20626684|P9|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0
5964623|NCT01172938|20626685|P8|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|1
5964624|NCT01172938|20626686|P7|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0
5964625|NCT01172938|20626687|P6|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0
5964626|NCT01172938|20626688|P5|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0
5964627|NCT01172938|20626689|P4|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0
5964628|NCT01172938|20626690|P3|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|3
5964629|NCT01172938|20626691|P2|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|2
5964630|NCT01172938|20626692|P1|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0
5964631|NCT01172938|20626684|P9|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
5964632|NCT01172938|20626685|P8|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1
5964633|NCT01172938|20626686|P7|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
5964634|NCT01172938|20626687|P6|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
5964635|NCT01172938|20626688|P5|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
5964636|NCT01172938|20626689|P4|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
5964637|NCT01172938|20626690|P3|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
5964638|NCT01172938|20626691|P2|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1
5964639|NCT01172938|20626692|P1|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
5964640|NCT01172938|20626684|P9|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
5964641|NCT01172938|20626685|P8|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
5964642|NCT01172938|20626686|P7|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
5964643|NCT01172938|20626687|P6|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
5964644|NCT01172938|20626688|P5|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
5964645|NCT01172938|20626689|P4|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
5964646|NCT01172938|20626690|P3|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|2
5964647|NCT01172938|20626691|P2|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
5964648|NCT01172938|20626692|P1|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
5964649|NCT01172938|20626684|P9|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1
5964650|NCT01172938|20626685|P8|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1
5964651|NCT01172938|20626686|P7|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0
5964652|NCT01172938|20626687|P6|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0
5964653|NCT01172938|20626688|P5|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0
5964654|NCT01172938|20626689|P4|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0
5964655|NCT01172938|20626690|P3|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1
5964656|NCT01172938|20626691|P2|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0
5964657|NCT01172938|20626692|P1|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0
5964658|NCT01172938|20626684|P9|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
5964659|NCT01172938|20626685|P8|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|1
5964660|NCT01172938|20626686|P7|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
5964661|NCT01172938|20626687|P6|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
5964662|NCT01172938|20626688|P5|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
5964663|NCT01172938|20626689|P4|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
5964664|NCT01172938|20626690|P3|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
5964665|NCT01172938|20626691|P2|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
5964666|NCT01172938|20626692|P1|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
5964667|NCT01172938|20626684|P9|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1
5964668|NCT01172938|20626685|P8|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
5964669|NCT01172938|20626686|P7|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
5964670|NCT01172938|20626687|P6|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
5964671|NCT01172938|20626688|P5|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
5964672|NCT01172938|20626689|P4|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
5964673|NCT01172938|20626690|P3|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1
5964674|NCT01172938|20626691|P2|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
5964675|NCT01172938|20626692|P1|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
5964676|NCT01172938|20626684|P9|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4
5964677|NCT01172938|20626685|P8|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2
5964678|NCT01172938|20626686|P7|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0
5964679|NCT01172938|20626687|P6|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0
5964680|NCT01172938|20626688|P5|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0
5964681|NCT01172938|20626689|P4|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0
5964682|NCT01172938|20626690|P3|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2
5964683|NCT01172938|20626691|P2|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4
5964684|NCT01172938|20626692|P1|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0
5964685|NCT01172938|20626684|P9|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|2
5964686|NCT01172938|20626685|P8|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|3
5964687|NCT01172938|20626686|P7|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0
5964688|NCT01172938|20626687|P6|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0
5964689|NCT01172938|20626688|P5|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0
5964690|NCT01172938|20626689|P4|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0
5964691|NCT01172938|20626690|P3|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1
5964692|NCT01172938|20626691|P2|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1
5964693|NCT01172938|20626692|P1|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0
5964694|NCT01172938|20626684|P9|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0
5964695|NCT01172938|20626685|P8|Active-Treatment Phase (Weeks 156-208)|Adverse Event|3
5964696|NCT01172938|20626686|P7|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0
5964697|NCT01172938|20626687|P6|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0
5964698|NCT01172938|20626688|P5|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0
5964699|NCT01172938|20626689|P4|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0
5964700|NCT01172938|20626690|P3|Active-Treatment Phase (Weeks 156-208)|Adverse Event|1
5964701|NCT01172938|20626691|P2|Active-Treatment Phase (Weeks 156-208)|Adverse Event|4
5964702|NCT01172938|20626692|P1|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0
5964703|NCT01172938|20626684|P9|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
5964704|NCT01172938|20626685|P8|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
5964705|NCT01172938|20626686|P7|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
5964706|NCT01172938|20626687|P6|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
5964707|NCT01172938|20626688|P5|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
5964708|NCT01172938|20626689|P4|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
5964709|NCT01172938|20626690|P3|Active-Treatment Phase Weeks (104-156)|Miscellaneious|2
5964710|NCT01172938|20626691|P2|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
5964711|NCT01172938|20626692|P1|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
5964712|NCT01172938|20626684|P9|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
5964713|NCT01172938|20626685|P8|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
5964714|NCT01172938|20626686|P7|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
5964715|NCT01172938|20626687|P6|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
5964716|NCT01172938|20626688|P5|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
5964717|NCT01172938|20626689|P4|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
5964718|NCT01172938|20626690|P3|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
5964719|NCT01172938|20626691|P2|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|1
5964720|NCT01172938|20626692|P1|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
5964721|NCT01172938|20626684|P9|Active-Treatment Phase Weeks (104-156)|Death|0
5964722|NCT01172938|20626685|P8|Active-Treatment Phase Weeks (104-156)|Death|1
5964723|NCT01172938|20626686|P7|Active-Treatment Phase Weeks (104-156)|Death|0
5964724|NCT01172938|20626687|P6|Active-Treatment Phase Weeks (104-156)|Death|0
5964725|NCT01172938|20626688|P5|Active-Treatment Phase Weeks (104-156)|Death|0
5964726|NCT01172938|20626689|P4|Active-Treatment Phase Weeks (104-156)|Death|0
5964727|NCT01172938|20626690|P3|Active-Treatment Phase Weeks (104-156)|Death|0
5964728|NCT01172938|20626691|P2|Active-Treatment Phase Weeks (104-156)|Death|0
5964729|NCT01172938|20626692|P1|Active-Treatment Phase Weeks (104-156)|Death|0
5964730|NCT01172938|20626684|P9|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|1
5964731|NCT01172938|20626685|P8|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|2
5964732|NCT01172938|20626686|P7|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0
5964733|NCT01172938|20626687|P6|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0
5964734|NCT01172938|20626688|P5|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0
5964735|NCT01172938|20626689|P4|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0
5964736|NCT01172938|20626690|P3|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|3
5964737|NCT01172938|20626691|P2|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|6
5964738|NCT01172938|20626692|P1|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0
5964739|NCT01172938|20626684|P9|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2
5964740|NCT01172938|20626685|P8|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2
5964741|NCT01172938|20626686|P7|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0
5964742|NCT01172938|20626687|P6|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0
5964743|NCT01172938|20626688|P5|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0
5964744|NCT01172938|20626689|P4|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0
5964745|NCT01172938|20626690|P3|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2
5964746|NCT01172938|20626691|P2|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|4
5964747|NCT01172938|20626692|P1|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0
5964748|NCT01172938|20626684|P9|Active-Treatment Phase Weeks (104-156)|Adverse Event|1
5964749|NCT01172938|20626685|P8|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
5964750|NCT01172938|20626686|P7|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
5964751|NCT01172938|20626687|P6|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
5964752|NCT01172938|20626688|P5|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
5964753|NCT01172938|20626689|P4|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
5964754|NCT01172938|20626690|P3|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
5964755|NCT01172938|20626691|P2|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
5964756|NCT01172938|20626692|P1|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
5964757|NCT01172938|20626684|P9|Active-Treatment Phase (Weeks 52-104)|Missing|0
5964758|NCT01172938|20626685|P8|Active-Treatment Phase (Weeks 52-104)|Missing|0
5964759|NCT01172938|20626686|P7|Active-Treatment Phase (Weeks 52-104)|Missing|0
5964760|NCT01172938|20626687|P6|Active-Treatment Phase (Weeks 52-104)|Missing|0
5964761|NCT01172938|20626688|P5|Active-Treatment Phase (Weeks 52-104)|Missing|0
5964762|NCT01172938|20626689|P4|Active-Treatment Phase (Weeks 52-104)|Missing|0
5964763|NCT01172938|20626690|P3|Active-Treatment Phase (Weeks 52-104)|Missing|0
5964764|NCT01172938|20626691|P2|Active-Treatment Phase (Weeks 52-104)|Missing|1
5964765|NCT01172938|20626692|P1|Active-Treatment Phase (Weeks 52-104)|Missing|0
5964766|NCT01172938|20626684|P9|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|1
5964767|NCT01172938|20626685|P8|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
5964768|NCT01172938|20626686|P7|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
5964769|NCT01172938|20626687|P6|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
5964770|NCT01172938|20626688|P5|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
5964771|NCT01172938|20626689|P4|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
5964772|NCT01172938|20626690|P3|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
5964773|NCT01172938|20626691|P2|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|2
5964774|NCT01172938|20626692|P1|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
5964775|NCT01172938|20626684|P9|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0
5964776|NCT01172938|20626685|P8|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|3
5964777|NCT01172938|20626686|P7|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0
5964778|NCT01172938|20626687|P6|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0
5964779|NCT01172938|20626688|P5|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0
5964780|NCT01172938|20626689|P4|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0
5964781|NCT01172938|20626690|P3|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1
5964782|NCT01172938|20626691|P2|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1
5964783|NCT01172938|20626692|P1|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0
5964784|NCT01172938|20626684|P9|Active-Treatment Phase (Weeks 52-104)|Death|0
5964785|NCT01172938|20626685|P8|Active-Treatment Phase (Weeks 52-104)|Death|0
5964786|NCT01172938|20626686|P7|Active-Treatment Phase (Weeks 52-104)|Death|0
5964787|NCT01172938|20626687|P6|Active-Treatment Phase (Weeks 52-104)|Death|0
5964788|NCT01172938|20626688|P5|Active-Treatment Phase (Weeks 52-104)|Death|0
5964789|NCT01172938|20626689|P4|Active-Treatment Phase (Weeks 52-104)|Death|0
5964790|NCT01172938|20626690|P3|Active-Treatment Phase (Weeks 52-104)|Death|1
5964791|NCT01172938|20626691|P2|Active-Treatment Phase (Weeks 52-104)|Death|0
5964792|NCT01172938|20626692|P1|Active-Treatment Phase (Weeks 52-104)|Death|0
5964793|NCT01172938|20626684|P9|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|2
5964794|NCT01172938|20626685|P8|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|5
5964795|NCT01172938|20626686|P7|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0
5964796|NCT01172938|20626687|P6|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0
5964797|NCT01172938|20626688|P5|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0
5964798|NCT01172938|20626689|P4|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0
5964799|NCT01172938|20626690|P3|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|8
5964800|NCT01172938|20626691|P2|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|10
5964801|NCT01172938|20626692|P1|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0
5964802|NCT01172938|20626684|P9|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
5964803|NCT01172938|20626685|P8|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
5964804|NCT01172938|20626686|P7|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
5964805|NCT01172938|20626687|P6|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
5964806|NCT01172938|20626688|P5|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
5964807|NCT01172938|20626689|P4|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
5964808|NCT01172938|20626690|P3|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|2
5964809|NCT01172938|20626691|P2|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
5964810|NCT01172938|20626692|P1|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
5964811|NCT01172938|20626684|P9|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0
5964812|NCT01172938|20626685|P8|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|4
5964813|NCT01172938|20626686|P7|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0
5964814|NCT01172938|20626687|P6|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0
5964815|NCT01172938|20626688|P5|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0
5964889|NCT01172938|20626690|P3|Placebo-controlled Phase (Week 0-24)|Other|1
5964816|NCT01172938|20626689|P4|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0
5964817|NCT01172938|20626690|P3|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|8
5964818|NCT01172938|20626691|P2|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|7
5964819|NCT01172938|20626692|P1|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0
5964820|NCT01172938|20626684|P9|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1
5964821|NCT01172938|20626685|P8|Active-Treatment Phase (Weeks 52-104)|Adverse Event|3
5964822|NCT01172938|20626686|P7|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0
5964823|NCT01172938|20626687|P6|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0
5964824|NCT01172938|20626688|P5|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0
5964825|NCT01172938|20626689|P4|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0
5964826|NCT01172938|20626690|P3|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1
5964827|NCT01172938|20626691|P2|Active-Treatment Phase (Weeks 52-104)|Adverse Event|2
5964828|NCT01172938|20626692|P1|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0
5964829|NCT01172938|20626684|P9|Active Treatment Phase (Weeks 25-52)|Other|0
5964830|NCT01172938|20626685|P8|Active Treatment Phase (Weeks 25-52)|Other|0
5964831|NCT01172938|20626686|P7|Active Treatment Phase (Weeks 25-52)|Other|1
5964832|NCT01172938|20626687|P6|Active Treatment Phase (Weeks 25-52)|Other|1
5964833|NCT01172938|20626688|P5|Active Treatment Phase (Weeks 25-52)|Other|0
5964834|NCT01172938|20626689|P4|Active Treatment Phase (Weeks 25-52)|Other|0
5964835|NCT01172938|20626690|P3|Active Treatment Phase (Weeks 25-52)|Other|0
5964836|NCT01172938|20626691|P2|Active Treatment Phase (Weeks 25-52)|Other|0
5964837|NCT01172938|20626692|P1|Active Treatment Phase (Weeks 25-52)|Other|0
5964838|NCT01172938|20626684|P9|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0
5964839|NCT01172938|20626685|P8|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0
5964840|NCT01172938|20626686|P7|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0
5964841|NCT01172938|20626687|P6|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0
5964842|NCT01172938|20626688|P5|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0
5964843|NCT01172938|20626689|P4|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1
5964844|NCT01172938|20626690|P3|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1
5964845|NCT01172938|20626691|P2|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1
5964846|NCT01172938|20626692|P1|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0
5964847|NCT01172938|20626684|P9|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0
5964848|NCT01172938|20626685|P8|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0
5964849|NCT01172938|20626686|P7|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1
5964850|NCT01172938|20626687|P6|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|9
5964851|NCT01172938|20626688|P5|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2
5964852|NCT01172938|20626689|P4|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2
5964853|NCT01172938|20626690|P3|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1
5964854|NCT01172938|20626691|P2|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|5
5964855|NCT01172938|20626692|P1|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0
5964856|NCT01172938|20626684|P9|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
5964857|NCT01172938|20626685|P8|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
5964858|NCT01172938|20626686|P7|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
5964859|NCT01172938|20626687|P6|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
5964860|NCT01172938|20626688|P5|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
5964861|NCT01172938|20626689|P4|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
5964862|NCT01172938|20626690|P3|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|1
5964863|NCT01172938|20626691|P2|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
5964864|NCT01172938|20626692|P1|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
5964865|NCT01172938|20626684|P9|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0
5964866|NCT01172938|20626685|P8|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0
5964867|NCT01172938|20626686|P7|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0
5964868|NCT01172938|20626687|P6|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3
5964869|NCT01172938|20626688|P5|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|1
5964870|NCT01172938|20626689|P4|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3
5964871|NCT01172938|20626690|P3|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|7
5964872|NCT01172938|20626691|P2|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|4
5964873|NCT01172938|20626692|P1|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0
5964874|NCT01172938|20626684|P9|Active Treatment Phase (Weeks 25-52)|Adverse Event|0
5964875|NCT01172938|20626685|P8|Active Treatment Phase (Weeks 25-52)|Adverse Event|0
5964876|NCT01172938|20626686|P7|Active Treatment Phase (Weeks 25-52)|Adverse Event|0
5964877|NCT01172938|20626687|P6|Active Treatment Phase (Weeks 25-52)|Adverse Event|2
5964878|NCT01172938|20626688|P5|Active Treatment Phase (Weeks 25-52)|Adverse Event|1
5964879|NCT01172938|20626689|P4|Active Treatment Phase (Weeks 25-52)|Adverse Event|1
5964880|NCT01172938|20626690|P3|Active Treatment Phase (Weeks 25-52)|Adverse Event|5
5964881|NCT01172938|20626691|P2|Active Treatment Phase (Weeks 25-52)|Adverse Event|2
5964882|NCT01172938|20626692|P1|Active Treatment Phase (Weeks 25-52)|Adverse Event|0
5964883|NCT01172938|20626684|P9|Placebo-controlled Phase (Week 0-24)|Other|0
5964884|NCT01172938|20626685|P8|Placebo-controlled Phase (Week 0-24)|Other|0
5964885|NCT01172938|20626686|P7|Placebo-controlled Phase (Week 0-24)|Other|0
5964886|NCT01172938|20626687|P6|Placebo-controlled Phase (Week 0-24)|Other|0
5964887|NCT01172938|20626688|P5|Placebo-controlled Phase (Week 0-24)|Other|0
5964888|NCT01172938|20626689|P4|Placebo-controlled Phase (Week 0-24)|Other|0
5964890|NCT01172938|20626691|P2|Placebo-controlled Phase (Week 0-24)|Other|2
5964891|NCT01172938|20626692|P1|Placebo-controlled Phase (Week 0-24)|Other|0
5964892|NCT01172938|20626684|P9|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
5964893|NCT01172938|20626685|P8|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
5964894|NCT01172938|20626686|P7|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
5964895|NCT01172938|20626687|P6|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
5964896|NCT01172938|20626688|P5|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
5964897|NCT01172938|20626689|P4|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
5964898|NCT01172938|20626690|P3|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
5964899|NCT01172938|20626691|P2|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
5964900|NCT01172938|20626692|P1|Placebo-controlled Phase (Week 0-24)|Protocol Violation|1
5964901|NCT01172938|20626684|P9|Placebo-controlled Phase (Week 0-24)|Death|0
5964902|NCT01172938|20626685|P8|Placebo-controlled Phase (Week 0-24)|Death|0
5964903|NCT01172938|20626686|P7|Placebo-controlled Phase (Week 0-24)|Death|0
5964904|NCT01172938|20626687|P6|Placebo-controlled Phase (Week 0-24)|Death|0
5964905|NCT01172938|20626688|P5|Placebo-controlled Phase (Week 0-24)|Death|0
5964906|NCT01172938|20626689|P4|Placebo-controlled Phase (Week 0-24)|Death|0
5964907|NCT01172938|20626690|P3|Placebo-controlled Phase (Week 0-24)|Death|0
5964908|NCT01172938|20626691|P2|Placebo-controlled Phase (Week 0-24)|Death|1
5964909|NCT01172938|20626692|P1|Placebo-controlled Phase (Week 0-24)|Death|0
5964910|NCT01172938|20626684|P9|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
5964911|NCT01172938|20626685|P8|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
5964912|NCT01172938|20626686|P7|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
5964913|NCT01172938|20626687|P6|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
5964914|NCT01172938|20626688|P5|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
5964915|NCT01172938|20626689|P4|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
5964916|NCT01172938|20626690|P3|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3
5964917|NCT01172938|20626691|P2|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5
5964918|NCT01172938|20626692|P1|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|2
5964919|NCT01172938|20626684|P9|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
5964920|NCT01172938|20626685|P8|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
5964921|NCT01172938|20626686|P7|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
5964922|NCT01172938|20626687|P6|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
5964923|NCT01172938|20626688|P5|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
5964924|NCT01172938|20626689|P4|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
5964925|NCT01172938|20626690|P3|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|2
5964926|NCT01172938|20626691|P2|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1
5964927|NCT01172938|20626692|P1|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
5964928|NCT01172938|20626684|P9|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
5964929|NCT01172938|20626685|P8|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
5964930|NCT01172938|20626686|P7|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
5964931|NCT01172938|20626687|P6|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
5964932|NCT01172938|20626688|P5|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
5964933|NCT01172938|20626689|P4|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
5964934|NCT01172938|20626690|P3|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4
5964935|NCT01172938|20626691|P2|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5
5964936|NCT01172938|20626692|P1|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4
5964937|NCT01172938|20626684|P9|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
5964938|NCT01172938|20626685|P8|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
5964939|NCT01172938|20626686|P7|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
5964940|NCT01172938|20626687|P6|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
5964941|NCT01172938|20626688|P5|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
5964942|NCT01172938|20626689|P4|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
5964943|NCT01172938|20626690|P3|Placebo-controlled Phase (Week 0-24)|Adverse Event|10
5964944|NCT01172938|20626691|P2|Placebo-controlled Phase (Week 0-24)|Adverse Event|8
5964945|NCT01172938|20626692|P1|Placebo-controlled Phase (Week 0-24)|Adverse Event|11
5964946|NCT01172873|20626878|P2|Overall Study|Withdrawal by Subject|2
5964947|NCT01172873|20626879|P1|Overall Study|Withdrawal by Subject|3
5964948|NCT01172847|20626889|P1|Overall Study|Withdrawal by Subject|3
5964949|NCT01172821|20626918|P4|Overall Study|Other|3
5964950|NCT01172821|20626919|P3|Overall Study|Other|5
5964951|NCT01172821|20626920|P2|Overall Study|Other|4
5964952|NCT01172821|20626921|P1|Overall Study|Other|3
5964953|NCT01172821|20626918|P4|Overall Study|Withdrawal by Subject|3
5964954|NCT01172821|20626919|P3|Overall Study|Withdrawal by Subject|3
5964955|NCT01172821|20626920|P2|Overall Study|Withdrawal by Subject|3
5964956|NCT01172821|20626921|P1|Overall Study|Withdrawal by Subject|2
5964957|NCT01172821|20626918|P4|Overall Study|Lost to Follow-up|2
5964958|NCT01172821|20626919|P3|Overall Study|Lost to Follow-up|2
5964959|NCT01172821|20626920|P2|Overall Study|Lost to Follow-up|1
5964960|NCT01172821|20626921|P1|Overall Study|Lost to Follow-up|4
5964961|NCT01172821|20626918|P4|Overall Study|Protocol Violation|2
5964962|NCT01172821|20626919|P3|Overall Study|Protocol Violation|1
5964963|NCT01172821|20626920|P2|Overall Study|Protocol Violation|2
5964964|NCT01172821|20626921|P1|Overall Study|Protocol Violation|0
5964965|NCT01172821|20626918|P4|Overall Study|Adverse Event|7
5964966|NCT01172821|20626919|P3|Overall Study|Adverse Event|2
5964967|NCT01172821|20626920|P2|Overall Study|Adverse Event|2
5964968|NCT01172821|20626921|P1|Overall Study|Adverse Event|5
5964969|NCT01172808|20627011|P4|Overall Study|Other|7
5964970|NCT01172808|20627012|P3|Overall Study|Other|9
5964971|NCT01172808|20627013|P2|Overall Study|Other|5
5964972|NCT01172808|20627014|P1|Overall Study|Other|6
5964973|NCT01172808|20627011|P4|Overall Study|Withdrawal by Subject|2
5964974|NCT01172808|20627012|P3|Overall Study|Withdrawal by Subject|3
5964975|NCT01172808|20627013|P2|Overall Study|Withdrawal by Subject|1
5964976|NCT01172808|20627014|P1|Overall Study|Withdrawal by Subject|4
5964977|NCT01172808|20627011|P4|Overall Study|Lost to Follow-up|3
5964978|NCT01172808|20627012|P3|Overall Study|Lost to Follow-up|1
5964979|NCT01172808|20627013|P2|Overall Study|Lost to Follow-up|1
5964980|NCT01172808|20627014|P1|Overall Study|Lost to Follow-up|0
5964981|NCT01172808|20627011|P4|Overall Study|Protocol Violation|0
5964982|NCT01172808|20627012|P3|Overall Study|Protocol Violation|2
5964983|NCT01172808|20627013|P2|Overall Study|Protocol Violation|2
5964984|NCT01172808|20627014|P1|Overall Study|Protocol Violation|2
5964985|NCT01172808|20627011|P4|Overall Study|Lack of Efficacy|0
5964986|NCT01172808|20627012|P3|Overall Study|Lack of Efficacy|0
5964987|NCT01172808|20627013|P2|Overall Study|Lack of Efficacy|0
5964988|NCT01172808|20627014|P1|Overall Study|Lack of Efficacy|1
5964989|NCT01172808|20627011|P4|Overall Study|Adverse Event|3
5964990|NCT01172808|20627012|P3|Overall Study|Adverse Event|8
5964991|NCT01172808|20627013|P2|Overall Study|Adverse Event|4
5964992|NCT01172808|20627014|P1|Overall Study|Adverse Event|8
5964993|NCT01172639|20627105|P5|Overall Study|Withdrawal by Subject|0
5964994|NCT01172639|20627106|P4|Overall Study|Withdrawal by Subject|5
5964995|NCT01172639|20627107|P3|Overall Study|Withdrawal by Subject|5
5964996|NCT01172639|20627108|P2|Overall Study|Withdrawal by Subject|3
5964997|NCT01172639|20627109|P1|Overall Study|Withdrawal by Subject|3
5964998|NCT01172639|20627105|P5|Overall Study|Lost to Follow-up|6
5964999|NCT01172639|20627106|P4|Overall Study|Lost to Follow-up|6
5965000|NCT01172639|20627107|P3|Overall Study|Lost to Follow-up|11
5965001|NCT01172639|20627108|P2|Overall Study|Lost to Follow-up|7
5965002|NCT01172639|20627109|P1|Overall Study|Lost to Follow-up|9
5965003|NCT01172639|20627105|P5|Overall Study|Death|0
5965004|NCT01172639|20627106|P4|Overall Study|Death|0
5965005|NCT01172639|20627107|P3|Overall Study|Death|0
5965006|NCT01172639|20627108|P2|Overall Study|Death|1
5965007|NCT01172639|20627109|P1|Overall Study|Death|1
5965008|NCT01172535|20627184|P1|Overall Study|Unwilling to adhere to study requirement|1
5965009|NCT01172535|20627184|P1|Overall Study|Ineligible at study entry|1
5965010|NCT01172535|20627184|P1|Overall Study|Lost to Follow-up|1
5965011|NCT01172535|20627184|P1|Overall Study|Withdrawal by Subject|2
5965012|NCT01172535|20627184|P1|Overall Study|Death|3
5965013|NCT01172288|20627237|P2|Overall Study|Protocol Violation|1
5965014|NCT01172288|20627238|P1|Overall Study|Protocol Violation|0
5965015|NCT01172288|20627237|P2|Overall Study|Adverse Event|0
5965016|NCT01172288|20627238|P1|Overall Study|Adverse Event|1
5965017|NCT01172275|20627254|P2|Overall Study|Protocol Violation|0
5965018|NCT01172275|20627255|P1|Overall Study|Protocol Violation|1
5965019|NCT01172275|20627254|P2|Overall Study|Lost to Follow-up|0
5965020|NCT01172275|20627255|P1|Overall Study|Lost to Follow-up|1
5965021|NCT01171989|20627313|P3|Overall Study|Lost to Follow-up|1
5965022|NCT01171989|20627314|P2|Overall Study|Lost to Follow-up|0
5965023|NCT01171989|20627315|P1|Overall Study|Lost to Follow-up|0
5965024|NCT01171976|20627389|P3|Overall Study|Adverse Event|5
5965025|NCT01171976|20627390|P2|Overall Study|Adverse Event|2
5965026|NCT01171976|20627391|P1|Overall Study|Adverse Event|6
5965027|NCT01171976|20627389|P3|Overall Study|Abnormal test result|0
5965028|NCT01171976|20627390|P2|Overall Study|Abnormal test result|0
5965029|NCT01171976|20627391|P1|Overall Study|Abnormal test result|1
5965030|NCT01171976|20627389|P3|Overall Study|Withdrawal by Subject|6
5965031|NCT01171976|20627390|P2|Overall Study|Withdrawal by Subject|5
5965032|NCT01171976|20627391|P1|Overall Study|Withdrawal by Subject|1
5965033|NCT01171976|20627389|P3|Overall Study|Lost to Follow-up|2
5965034|NCT01171976|20627390|P2|Overall Study|Lost to Follow-up|0
5965035|NCT01171976|20627391|P1|Overall Study|Lost to Follow-up|4
5965036|NCT01171976|20627389|P3|Overall Study|Death|1
5965037|NCT01171976|20627390|P2|Overall Study|Death|4
5965038|NCT01171976|20627391|P1|Overall Study|Death|2
5965039|NCT01171976|20627389|P3|Overall Study|Protocol Violation|1
5965040|NCT01171976|20627390|P2|Overall Study|Protocol Violation|0
5965041|NCT01171976|20627391|P1|Overall Study|Protocol Violation|0
5965042|NCT01171963|20627428|P2|Overall Study|Withdrawal by Subject|129
5965043|NCT01171963|20627429|P1|Overall Study|Withdrawal by Subject|114
5965044|NCT01171963|20627428|P2|Overall Study|Other - diarrhoea|0
5965045|NCT01171963|20627429|P1|Overall Study|Other - diarrhoea|1
5965046|NCT01171963|20627428|P2|Overall Study|Lost to Follow-up|24
5965047|NCT01171963|20627429|P1|Overall Study|Lost to Follow-up|23
5965048|NCT01171963|20627428|P2|Overall Study|Adverse Event|15
5965049|NCT01171963|20627429|P1|Overall Study|Adverse Event|10
5965050|NCT01171898|20627498|P4|Overall Study|Other|2
5965051|NCT01171898|20627499|P3|Overall Study|Other|0
5965052|NCT01171898|20627500|P2|Overall Study|Other|5
5965053|NCT01171898|20627501|P1|Overall Study|Other|1
5965054|NCT01171898|20627498|P4|Overall Study|Ongoing|0
5965055|NCT01171898|20627499|P3|Overall Study|Ongoing|3
5965056|NCT01171898|20627500|P2|Overall Study|Ongoing|9
5965057|NCT01171898|20627501|P1|Overall Study|Ongoing|1
5965058|NCT01171898|20627498|P4|Overall Study|Terminated by Sponsor|0
5965059|NCT01171898|20627499|P3|Overall Study|Terminated by Sponsor|0
5965060|NCT01171898|20627500|P2|Overall Study|Terminated by Sponsor|0
5965061|NCT01171898|20627501|P1|Overall Study|Terminated by Sponsor|1
5965062|NCT01171898|20627498|P4|Overall Study|Withdrawal by Subject|3
5965063|NCT01171898|20627499|P3|Overall Study|Withdrawal by Subject|6
5965064|NCT01171898|20627500|P2|Overall Study|Withdrawal by Subject|4
5965065|NCT01171898|20627501|P1|Overall Study|Withdrawal by Subject|1
5965066|NCT01171898|20627498|P4|Overall Study|Lost to Follow-up|1
5965067|NCT01171898|20627499|P3|Overall Study|Lost to Follow-up|1
5965068|NCT01171898|20627500|P2|Overall Study|Lost to Follow-up|1
5965069|NCT01171898|20627501|P1|Overall Study|Lost to Follow-up|0
5965070|NCT01171898|20627498|P4|Overall Study|Death|0
5965071|NCT01171898|20627499|P3|Overall Study|Death|2
5965072|NCT01171898|20627500|P2|Overall Study|Death|0
5965073|NCT01171898|20627501|P1|Overall Study|Death|0
5965074|NCT01171820|20627525|P2|Overall Study|1-Year Missed Visit|1
5965075|NCT01171820|20627526|P1|Overall Study|1-Year Missed Visit|1
5965076|NCT01171820|20627525|P2|Overall Study|Physician Decision|1
5965077|NCT01171820|20627526|P1|Overall Study|Physician Decision|0
5965078|NCT01171820|20627525|P2|Overall Study|Withdrawal by Subject|0
5965079|NCT01171820|20627526|P1|Overall Study|Withdrawal by Subject|2
5965080|NCT01171820|20627525|P2|Overall Study|Lost to Follow-up|1
5965081|NCT01171820|20627526|P1|Overall Study|Lost to Follow-up|0
5965082|NCT01171820|20627525|P2|Overall Study|Death|3
5965083|NCT01171820|20627526|P1|Overall Study|Death|3
5965084|NCT01171677|20627604|P2|Overall Study|completed <70% IntenSati classes|0
5965085|NCT01171677|20627605|P1|Overall Study|completed <70% IntenSati classes|5
5965086|NCT01171677|20627604|P2|Overall Study|Adverse Event|0
5965087|NCT01171677|20627605|P1|Overall Study|Adverse Event|1
5965088|NCT01171677|20627604|P2|Overall Study|Withdrawal by Subject|3
5965089|NCT01171677|20627605|P1|Overall Study|Withdrawal by Subject|0
5965090|NCT01171625|20627637|P1|Overall Study|Consented but did not receive device|25
5965091|NCT01171625|20627637|P1|Overall Study|Other|1
5965092|NCT01171625|20627637|P1|Overall Study|Patient received valve-in-valve|3
5965093|NCT01171625|20627637|P1|Overall Study|Lost to Follow-up|5
5965094|NCT01171625|20627637|P1|Overall Study|Explanted|10
5965095|NCT01171625|20627637|P1|Overall Study|Withdrawal by Subject|31
5965096|NCT01171625|20627637|P1|Overall Study|Death|38
5965097|NCT01171625|20627637|P1|Overall Study|On-Protocol|67
5965098|NCT01171612|20627670|P1|Overall Study|Lost to Follow-up|51
5965099|NCT01171534|20627680|P2|Overall Study|screen failure|1
5965100|NCT01171534|20627681|P1|Overall Study|screen failure|0
5965101|NCT01171534|20627680|P2|Overall Study|Lost to Follow-up|2
5965102|NCT01171534|20627681|P1|Overall Study|Lost to Follow-up|0
5965103|NCT01171521|20627693|P1|Overall Study|screen failure|1
5965104|NCT01171521|20627693|P1|Overall Study|Lost to Follow-up|5
5965105|NCT01171183|20627700|P2|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|0
5965106|NCT01171183|20627701|P1|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|1
5965107|NCT01171183|20627700|P2|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|3
5965108|NCT01171183|20627701|P1|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|7
5965109|NCT01171183|20627700|P2|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2
5965110|NCT01171183|20627701|P1|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2
5965111|NCT01171183|20627700|P2|Residential Facility (Weeks 1-2)|BP outside of study parameters|3
5965112|NCT01171183|20627701|P1|Residential Facility (Weeks 1-2)|BP outside of study parameters|0
5965113|NCT01171183|20627700|P2|Residential Facility (Weeks 1-2)|Protocol Violation|1
5965114|NCT01171183|20627701|P1|Residential Facility (Weeks 1-2)|Protocol Violation|0
5965115|NCT01171183|20627700|P2|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2
5965116|NCT01171183|20627701|P1|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2
5965117|NCT01170962|20627722|P3|Follow up Period|Others|3
5965118|NCT01170962|20627723|P2|Follow up Period|Others|7
5965119|NCT01170962|20627724|P1|Follow up Period|Others|10
5965120|NCT01170962|20627722|P3|Follow up Period|Death|0
5965121|NCT01170962|20627723|P2|Follow up Period|Death|2
5965122|NCT01170962|20627724|P1|Follow up Period|Death|2
5965123|NCT01170962|20627722|P3|Follow up Period|Lost to Follow-up|1
5965124|NCT01170962|20627723|P2|Follow up Period|Lost to Follow-up|8
5965125|NCT01170962|20627724|P1|Follow up Period|Lost to Follow-up|13
5965126|NCT01170962|20627722|P3|Follow up Period|Withdrawal by Subject|2
5965127|NCT01170962|20627723|P2|Follow up Period|Withdrawal by Subject|10
5965128|NCT01170962|20627724|P1|Follow up Period|Withdrawal by Subject|14
5965129|NCT01170962|20627722|P3|Treatment Period|Completed 24 Week treatment period only|0
5965130|NCT01170962|20627723|P2|Treatment Period|Completed 24 Week treatment period only|2
5965131|NCT01170962|20627724|P1|Treatment Period|Completed 24 Week treatment period only|10
5965132|NCT01170962|20627722|P3|Treatment Period|Request to discontinue treatment|1
5965133|NCT01170962|20627723|P2|Treatment Period|Request to discontinue treatment|3
5965134|NCT01170962|20627724|P1|Treatment Period|Request to discontinue treatment|7
5965135|NCT01170962|20627722|P3|Treatment Period|Participant no longer meets criteria|0
5965136|NCT01170962|20627723|P2|Treatment Period|Participant no longer meets criteria|1
5965137|NCT01170962|20627724|P1|Treatment Period|Participant no longer meets criteria|0
5965138|NCT01170962|20627722|P3|Treatment Period|Lost to Follow-up|1
5965139|NCT01170962|20627723|P2|Treatment Period|Lost to Follow-up|1
5965140|NCT01170962|20627724|P1|Treatment Period|Lost to Follow-up|1
5965141|NCT01170962|20627722|P3|Treatment Period|Withdrawal by Subject|0
5965142|NCT01170962|20627723|P2|Treatment Period|Withdrawal by Subject|1
5965143|NCT01170962|20627724|P1|Treatment Period|Withdrawal by Subject|2
5965144|NCT01170962|20627722|P3|Treatment Period|Adverse Event|3
5965145|NCT01170962|20627723|P2|Treatment Period|Adverse Event|12
5965146|NCT01170962|20627724|P1|Treatment Period|Adverse Event|11
5965147|NCT01170962|20627722|P3|Treatment Period|Lack of Efficacy|7
5965148|NCT01170962|20627723|P2|Treatment Period|Lack of Efficacy|91
5965149|NCT01170962|20627724|P1|Treatment Period|Lack of Efficacy|96
5965150|NCT01170663|20627819|P2|Overall Study|Withdrawal of consent without follow-up|11
5965151|NCT01170663|20627820|P1|Overall Study|Withdrawal of consent without follow-up|11
5965152|NCT01170663|20627819|P2|Overall Study|Lost to Follow-up|9
5965153|NCT01170663|20627820|P1|Overall Study|Lost to Follow-up|3
5965154|NCT01170598|20627848|P1|Overall Study|Refused|1
5965155|NCT01170598|20627848|P1|Overall Study|Lost to Follow-up|1
5965156|NCT01170598|20627848|P1|Overall Study|Death|3
5965157|NCT01170598|20627848|P1|Overall Study|Withdrawal by Subject|1
5965158|NCT01170364|20627911|P2|Overall Study|Protocol Violation|1
5965159|NCT01170364|20627912|P1|Overall Study|Protocol Violation|4
5965160|NCT01170273|20627920|P2|Overall Study|Adverse Event|1
5965161|NCT01170273|20627921|P1|Overall Study|Adverse Event|0
5965162|NCT01170273|20627920|P2|Overall Study|Death|0
5965163|NCT01170273|20627921|P1|Overall Study|Death|1
5965164|NCT01170273|20627920|P2|Overall Study|Protocol Violation|0
5965165|NCT01170273|20627921|P1|Overall Study|Protocol Violation|1
5965166|NCT01170273|20627920|P2|Overall Study|Lost to Follow-up|8
5965167|NCT01170273|20627921|P1|Overall Study|Lost to Follow-up|6
5965168|NCT01170221|20627938|P2|Overall Study|Randomized but not treated|0
5965169|NCT01170221|20627939|P1|Overall Study|Randomized but not treated|1
5965170|NCT01170221|20627938|P2|Overall Study|Subject completed only screening and LFU|0
5965171|NCT01170221|20627939|P1|Overall Study|Subject completed only screening and LFU|1
5965172|NCT01170221|20627938|P2|Overall Study|Withdrawal by Subject|7
5965173|NCT01170221|20627939|P1|Overall Study|Withdrawal by Subject|9
5965174|NCT01170221|20627938|P2|Overall Study|Lost to Follow-up|21
5965175|NCT01170221|20627939|P1|Overall Study|Lost to Follow-up|22
5965176|NCT01170208|20627962|P3|Overall Study|Protocol Violation|1
5965177|NCT01170208|20627963|P2|Overall Study|Protocol Violation|0
5965178|NCT01170208|20627964|P1|Overall Study|Protocol Violation|1
5965179|NCT01170208|20627962|P3|Overall Study|Withdrawal by Subject|1
5965180|NCT01170208|20627963|P2|Overall Study|Withdrawal by Subject|0
5965181|NCT01170208|20627964|P1|Overall Study|Withdrawal by Subject|5
5965182|NCT01170091|20627992|P1|Overall Study|Treatment duration is less than 4 weeks|21
5965183|NCT01170091|20627992|P1|Overall Study|Missing efficacy evaluation|3
5965184|NCT01170065|20628002|P3|Overall Study|Ongoing after planned observation time|10
5965185|NCT01170065|20628003|P2|Overall Study|Ongoing after planned observation time|26
5965186|NCT01170065|20628004|P1|Overall Study|Ongoing after planned observation time|5
5965187|NCT01170065|20628002|P3|Overall Study|Reason other than specified|3
5965188|NCT01170065|20628003|P2|Overall Study|Reason other than specified|8
5965189|NCT01170065|20628004|P1|Overall Study|Reason other than specified|3
5965190|NCT01170065|20628002|P3|Overall Study|Consent withdrawn, not due to AE|2
5965191|NCT01170065|20628003|P2|Overall Study|Consent withdrawn, not due to AE|4
5965192|NCT01170065|20628004|P1|Overall Study|Consent withdrawn, not due to AE|2
5965193|NCT01170065|20628002|P3|Overall Study|Lost to Follow-up|1
5965194|NCT01170065|20628003|P2|Overall Study|Lost to Follow-up|4
5965195|NCT01170065|20628004|P1|Overall Study|Lost to Follow-up|1
5965196|NCT01170065|20628002|P3|Overall Study|Adverse Event|10
5965197|NCT01170065|20628003|P2|Overall Study|Adverse Event|50
5965198|NCT01170065|20628004|P1|Overall Study|Adverse Event|17
5965199|NCT01170039|20628035|P2|Overall Study|Lack of funding, drug not available|3
5965200|NCT01170039|20628036|P1|Overall Study|Lack of funding, drug not available|3
5965201|NCT01170039|20628035|P2|Overall Study|Withdrawal by Subject|3
5965202|NCT01170039|20628036|P1|Overall Study|Withdrawal by Subject|5
5965203|NCT01169987|20628048|P1|Overall Study|Other|4
5965204|NCT01169987|20628048|P1|Overall Study|Lost to Follow-up|24
5965205|NCT01169987|20628048|P1|Overall Study|Withdrawal by Subject|3
5965206|NCT01169779|20628114|P2|Overall Study|Familial and personal reasons|3
5965207|NCT01169779|20628115|P1|Overall Study|Familial and personal reasons|3
5965208|NCT01169779|20628114|P2|Overall Study|Withdrawal by Subject|2
5965209|NCT01169779|20628115|P1|Overall Study|Withdrawal by Subject|3
5965210|NCT01169779|20628114|P2|Overall Study|Protocol Violation|1
5965211|NCT01169779|20628115|P1|Overall Study|Protocol Violation|1
5965212|NCT01169779|20628114|P2|Overall Study|Lack of Efficacy|0
5965213|NCT01169779|20628115|P1|Overall Study|Lack of Efficacy|1
5965214|NCT01169779|20628114|P2|Overall Study|Adverse Event|11
5965215|NCT01169779|20628115|P1|Overall Study|Adverse Event|3
5965216|NCT01169701|20628150|P2|Overall Study|Sponsor decision|1
5965217|NCT01169701|20628151|P1|Overall Study|Sponsor decision|0
5965218|NCT01169701|20628150|P2|Overall Study|Serious adverse event|1
5965219|NCT01169701|20628151|P1|Overall Study|Serious adverse event|0
5965220|NCT01169701|20628150|P2|Overall Study|Administrative problems|1
5965221|NCT01169701|20628151|P1|Overall Study|Administrative problems|0
5965222|NCT01169701|20628150|P2|Overall Study|Death|1
5965223|NCT01169701|20628151|P1|Overall Study|Death|0
5965224|NCT01169701|20628150|P2|Overall Study|Exclusion criteria|0
5965225|NCT01169701|20628151|P1|Overall Study|Exclusion criteria|2
5965226|NCT01169701|20628150|P2|Overall Study|Adverse Event|2
5965227|NCT01169701|20628151|P1|Overall Study|Adverse Event|1
5965228|NCT01169701|20628150|P2|Overall Study|Withdrawal by Subject|3
5965229|NCT01169701|20628151|P1|Overall Study|Withdrawal by Subject|1
5965230|NCT01169701|20628150|P2|Overall Study|Lost to Follow-up|1
5965231|NCT01169701|20628151|P1|Overall Study|Lost to Follow-up|1
5965232|NCT01169675|20628188|P5|Overall Study|Other Reason Not Defined Above|1
5965233|NCT01169675|20628189|P4|Overall Study|Other Reason Not Defined Above|1
5965234|NCT01169675|20628190|P3|Overall Study|Other Reason Not Defined Above|0
5965235|NCT01169675|20628191|P2|Overall Study|Other Reason Not Defined Above|0
5965236|NCT01169675|20628192|P1|Overall Study|Other Reason Not Defined Above|0
5965237|NCT01169675|20628188|P5|Overall Study|Withdrawal by Subject|2
5965238|NCT01169675|20628189|P4|Overall Study|Withdrawal by Subject|1
5965239|NCT01169675|20628190|P3|Overall Study|Withdrawal by Subject|0
5965240|NCT01169675|20628191|P2|Overall Study|Withdrawal by Subject|0
5965241|NCT01169675|20628192|P1|Overall Study|Withdrawal by Subject|1
5965242|NCT01169675|20628188|P5|Overall Study|Adverse Event|0
5965243|NCT01169675|20628189|P4|Overall Study|Adverse Event|0
5965244|NCT01169675|20628190|P3|Overall Study|Adverse Event|2
5965245|NCT01169675|20628191|P2|Overall Study|Adverse Event|1
5965246|NCT01169675|20628192|P1|Overall Study|Adverse Event|5
5965247|NCT01169675|20628188|P5|Overall Study|Dose Limiting Toxicity (DLT)|2
5965248|NCT01169675|20628189|P4|Overall Study|Dose Limiting Toxicity (DLT)|0
5965249|NCT01169675|20628190|P3|Overall Study|Dose Limiting Toxicity (DLT)|0
5965250|NCT01169675|20628191|P2|Overall Study|Dose Limiting Toxicity (DLT)|0
5965251|NCT01169675|20628192|P1|Overall Study|Dose Limiting Toxicity (DLT)|1
5965252|NCT01169675|20628188|P5|Overall Study|Progressive disease|1
5965253|NCT01169675|20628189|P4|Overall Study|Progressive disease|15
5965254|NCT01169675|20628190|P3|Overall Study|Progressive disease|5
5965255|NCT01169675|20628191|P2|Overall Study|Progressive disease|2
5965256|NCT01169675|20628192|P1|Overall Study|Progressive disease|13
5965257|NCT01169649|20628229|P1|Overall Study|Patient Not Treated|3
5965258|NCT01169636|20628238|P5|Overall Study|Withdrawal by Subject|3
5965259|NCT01169636|20628239|P4|Overall Study|Withdrawal by Subject|0
5965260|NCT01169636|20628240|P3|Overall Study|Withdrawal by Subject|0
5965261|NCT01169636|20628241|P2|Overall Study|Withdrawal by Subject|0
5965262|NCT01169636|20628242|P1|Overall Study|Withdrawal by Subject|0
5965263|NCT01169636|20628238|P5|Overall Study|Screen failure|0
5965264|NCT01169636|20628239|P4|Overall Study|Screen failure|0
5965265|NCT01169636|20628240|P3|Overall Study|Screen failure|2
5965266|NCT01169636|20628241|P2|Overall Study|Screen failure|0
5965267|NCT01169636|20628242|P1|Overall Study|Screen failure|0
5965268|NCT01169636|20628238|P5|Overall Study|Adverse Event|0
5965269|NCT01169636|20628239|P4|Overall Study|Adverse Event|1
5965270|NCT01169636|20628240|P3|Overall Study|Adverse Event|1
5965271|NCT01169636|20628241|P2|Overall Study|Adverse Event|0
5965272|NCT01169636|20628242|P1|Overall Study|Adverse Event|0
5965273|NCT01169558|20628264|P1|Overall Study|Partial response|2
5965274|NCT01169558|20628264|P1|Overall Study|Protocol Violation|2
5965275|NCT01169558|20628264|P1|Overall Study|Non-compliance|2
5965276|NCT01169558|20628264|P1|Overall Study|Need for Surgery|4
5965277|NCT01169558|20628264|P1|Overall Study|Lost to Follow-up|4
5965278|NCT01169558|20628264|P1|Overall Study|Stable Disease|4
5965279|NCT01169558|20628264|P1|Overall Study|Medical Decision|7
5965280|NCT01169558|20628264|P1|Overall Study|Withdrawal of Consent|8
5965281|NCT01169558|20628264|P1|Overall Study|Adverse Event|25
5965282|NCT01169558|20628264|P1|Overall Study|Disease progression|98
5965283|NCT01169493|20628289|P6|Period 3 (6 Months)|Physician Decision|0
5965284|NCT01169493|20628290|P5|Period 3 (6 Months)|Physician Decision|0
5965285|NCT01169493|20628291|P4|Period 3 (6 Months)|Physician Decision|0
5965286|NCT01169493|20628292|P3|Period 3 (6 Months)|Physician Decision|1
5965287|NCT01169493|20628293|P2|Period 3 (6 Months)|Physician Decision|1
5965288|NCT01169493|20628294|P1|Period 3 (6 Months)|Physician Decision|0
5965289|NCT01169493|20628289|P6|Period 3 (6 Months)|Adverse Event|0
5965290|NCT01169493|20628290|P5|Period 3 (6 Months)|Adverse Event|0
5965291|NCT01169493|20628291|P4|Period 3 (6 Months)|Adverse Event|0
5965292|NCT01169493|20628292|P3|Period 3 (6 Months)|Adverse Event|0
5965293|NCT01169493|20628293|P2|Period 3 (6 Months)|Adverse Event|1
5965294|NCT01169493|20628294|P1|Period 3 (6 Months)|Adverse Event|0
5965295|NCT01169493|20628289|P6|Period 1 (6 Months)|Withdrawal by Subject|3
5965296|NCT01169493|20628290|P5|Period 1 (6 Months)|Withdrawal by Subject|0
5965297|NCT01169493|20628291|P4|Period 1 (6 Months)|Withdrawal by Subject|0
5965298|NCT01169493|20628292|P3|Period 1 (6 Months)|Withdrawal by Subject|2
5965299|NCT01169493|20628293|P2|Period 1 (6 Months)|Withdrawal by Subject|1
5965300|NCT01169493|20628294|P1|Period 1 (6 Months)|Withdrawal by Subject|0
5965301|NCT01169350|20628340|P1|Overall Study|Lost to Follow-up|2
5965302|NCT01169350|20628340|P1|Overall Study|Physician Decision|3
5965303|NCT01169103|20628478|P2|Overall Study|Withdrawal by Subject|1
5965304|NCT01169103|20628479|P1|Overall Study|Withdrawal by Subject|3
5965305|NCT01169103|20628478|P2|Overall Study|Lost to Follow-up|3
5965306|NCT01169103|20628479|P1|Overall Study|Lost to Follow-up|3
5965307|NCT01169038|20628506|P1|Overall Study|Required antibiotic administration|1
5965308|NCT01169038|20628506|P1|Overall Study|Adverse Event|5
5965309|NCT01169038|20628506|P1|Overall Study|Death|1
5965310|NCT01168999|20628514|P4|Overall Study|Lost to Follow-up|0
5965311|NCT01168999|20628515|P3|Overall Study|Lost to Follow-up|0
5965312|NCT01168999|20628516|P2|Overall Study|Lost to Follow-up|1
5965313|NCT01168999|20628517|P1|Overall Study|Lost to Follow-up|2
5965314|NCT01168973|20628583|P2|Overall Study|Protocol Criterion Not Met and Deviation|9
5965315|NCT01168973|20628584|P1|Overall Study|Protocol Criterion Not Met and Deviation|7
5965316|NCT01168973|20628583|P2|Overall Study|Sponsor Decision|1
5965317|NCT01168973|20628584|P1|Overall Study|Sponsor Decision|2
5965318|NCT01168973|20628583|P2|Overall Study|Physician Decision|19
5965319|NCT01168973|20628584|P1|Overall Study|Physician Decision|37
5965320|NCT01168973|20628583|P2|Overall Study|Death|45
5965321|NCT01168973|20628584|P1|Overall Study|Death|42
5965322|NCT01168973|20628583|P2|Overall Study|Withdrawal by Subject|53
5965323|NCT01168973|20628584|P1|Overall Study|Withdrawal by Subject|90
5965324|NCT01168973|20628583|P2|Overall Study|Adverse Event|55
5965325|NCT01168973|20628584|P1|Overall Study|Adverse Event|94
5965326|NCT01168973|20628583|P2|Overall Study|Progressive Disease|429
5965327|NCT01168973|20628584|P1|Overall Study|Progressive Disease|341
5965328|NCT01168856|20628659|P2|Overall Study|Protocol Violation|6
5965329|NCT01168856|20628660|P1|Overall Study|Protocol Violation|4
5965330|NCT01168856|20628659|P2|Overall Study|Other|291
5965331|NCT01168856|20628660|P1|Overall Study|Other|1
5965332|NCT01168856|20628659|P2|Overall Study|Death|2
5965333|NCT01168856|20628660|P1|Overall Study|Death|0
5965334|NCT01168856|20628659|P2|Overall Study|Participant received anti-HCV treatment|0
5965335|NCT01168856|20628660|P1|Overall Study|Participant received anti-HCV treatment|1
5965336|NCT01168856|20628659|P2|Overall Study|Confirmed Quantifiable HCV RNA|1
5965337|NCT01168856|20628660|P1|Overall Study|Confirmed Quantifiable HCV RNA|0
5965338|NCT01168856|20628659|P2|Overall Study|Physician Decision|1
5965339|NCT01168856|20628660|P1|Overall Study|Physician Decision|2
5965340|NCT01168856|20628659|P2|Overall Study|Withdrawal by Subject|8
5965341|NCT01168856|20628660|P1|Overall Study|Withdrawal by Subject|6
5965342|NCT01168856|20628659|P2|Overall Study|Lost to Follow-up|34
5965343|NCT01168856|20628660|P1|Overall Study|Lost to Follow-up|4
5965344|NCT01168596|20628758|P2|Overall Study|Withdrawal by Subject|1
5965345|NCT01168596|20628759|P1|Overall Study|Withdrawal by Subject|3
5965346|NCT01168427|20628803|P1|Overall Study|Patient exited prior to implant|1
5965347|NCT01168401|20628819|P11|Overall Study|Withdrawal by Subject|0
5965348|NCT01168401|20628820|P10|Overall Study|Withdrawal by Subject|0
5965349|NCT01168401|20628821|P9|Overall Study|Withdrawal by Subject|0
5965350|NCT01168401|20628822|P8|Overall Study|Withdrawal by Subject|0
5965351|NCT01168401|20628823|P7|Overall Study|Withdrawal by Subject|0
5965352|NCT01168401|20628824|P6|Overall Study|Withdrawal by Subject|0
5965353|NCT01168401|20628825|P5|Overall Study|Withdrawal by Subject|0
5965354|NCT01168401|20628826|P4|Overall Study|Withdrawal by Subject|1
5965355|NCT01168401|20628827|P3|Overall Study|Withdrawal by Subject|0
5965356|NCT01168401|20628828|P2|Overall Study|Withdrawal by Subject|0
5965357|NCT01168401|20628829|P1|Overall Study|Withdrawal by Subject|0
5965358|NCT01168401|20628819|P11|Overall Study|Lost to Follow-up|0
5965359|NCT01168401|20628820|P10|Overall Study|Lost to Follow-up|0
5965360|NCT01168401|20628821|P9|Overall Study|Lost to Follow-up|0
5965361|NCT01168401|20628822|P8|Overall Study|Lost to Follow-up|0
5965362|NCT01168401|20628823|P7|Overall Study|Lost to Follow-up|0
5965363|NCT01168401|20628824|P6|Overall Study|Lost to Follow-up|0
5965364|NCT01168401|20628825|P5|Overall Study|Lost to Follow-up|0
5965365|NCT01168401|20628826|P4|Overall Study|Lost to Follow-up|1
5965366|NCT01168401|20628827|P3|Overall Study|Lost to Follow-up|2
5965367|NCT01168401|20628828|P2|Overall Study|Lost to Follow-up|1
5965368|NCT01168401|20628829|P1|Overall Study|Lost to Follow-up|1
5965369|NCT01168349|20629062|P1|Overall Study|Protocol Violation|76
5965370|NCT01168349|20629062|P1|Overall Study|Other|22
5965371|NCT01168349|20629062|P1|Overall Study|Kidney transplantation|3
5965372|NCT01168349|20629062|P1|Overall Study|Withdrawal by Subject|9
5965373|NCT01168349|20629062|P1|Overall Study|Lost to Follow-up|34
5965374|NCT01168349|20629062|P1|Overall Study|Death|157
5965375|NCT01168232|20629168|P1|Overall Study|Ineligible-Inadequate pathology|1
5965376|NCT01168232|20629168|P1|Overall Study|Ineligible- Wrong cell type|6
5965377|NCT01168232|20629168|P1|Overall Study|Ineligible-Second primary cancer site|1
5965378|NCT01168219|20629175|P1|Overall Study|ineligible due to CML|2
5965379|NCT01168219|20629175|P1|Overall Study|withdrew before transplant|1
5965380|NCT01168219|20629175|P1|Overall Study|off study before starting treatment|2
5965381|NCT01167907|20629198|P2|Overall Study|saphenous catheter dislodged before comp|1
5965382|NCT01167907|20629199|P1|Overall Study|saphenous catheter dislodged before comp|1
5965383|NCT01167907|20629198|P2|Overall Study|Protocol Violation|0
5965384|NCT01167907|20629199|P1|Overall Study|Protocol Violation|1
5965385|NCT01167881|20629217|P2|Overall Study|Other not defined above|55
5965386|NCT01167881|20629218|P1|Overall Study|Other not defined above|31
5965387|NCT01167881|20629217|P2|Overall Study|Not treated|0
5965388|NCT01167881|20629218|P1|Overall Study|Not treated|4
5965389|NCT01167881|20629217|P2|Overall Study|Patient refusal to cont., not due to AE|40
5965390|NCT01167881|20629218|P1|Overall Study|Patient refusal to cont., not due to AE|45
5965391|NCT01167881|20629217|P2|Overall Study|Lost to Follow-up|20
5965392|NCT01167881|20629218|P1|Overall Study|Lost to Follow-up|19
5965393|NCT01167881|20629217|P2|Overall Study|Non compliant with protocol|18
5965394|NCT01167881|20629218|P1|Overall Study|Non compliant with protocol|9
5965395|NCT01167881|20629217|P2|Overall Study|Lack of Efficacy|7
5965396|NCT01167881|20629218|P1|Overall Study|Lack of Efficacy|4
5965397|NCT01167881|20629217|P2|Overall Study|Adverse Event|51
5965398|NCT01167881|20629218|P1|Overall Study|Adverse Event|47
5965399|NCT01167634|20629272|P4|Overall Study|Withdrawal by Subject|0
5965400|NCT01167634|20629273|P3|Overall Study|Withdrawal by Subject|0
5965401|NCT01167634|20629274|P2|Overall Study|Withdrawal by Subject|1
5965402|NCT01167634|20629275|P1|Overall Study|Withdrawal by Subject|1
5965403|NCT01167634|20629272|P4|Overall Study|Lost to Follow-up|4
5965404|NCT01167634|20629273|P3|Overall Study|Lost to Follow-up|3
5965405|NCT01167634|20629274|P2|Overall Study|Lost to Follow-up|3
5965406|NCT01167634|20629275|P1|Overall Study|Lost to Follow-up|1
5965407|NCT01167582|20629296|P2|Overall Study|Lost to Follow-up|1
5965408|NCT01167582|20629297|P1|Overall Study|Lost to Follow-up|0
5965409|NCT01167426|20629348|P1|Overall Study|Sponsor Decision|1
5965410|NCT01167426|20629348|P1|Overall Study|Withdrawal by Subject|2
5965411|NCT01167426|20629348|P1|Overall Study|Protocol Violation|1
5965412|NCT01167426|20629348|P1|Overall Study|Lost to Follow-up|6
5965413|NCT01167257|20629356|P2|Overall Study|Withdrew consent|1
5965414|NCT01167257|20629357|P1|Overall Study|Withdrew consent|1
5965415|NCT01167257|20629356|P2|Overall Study|Lost to Follow-up|2
5965416|NCT01167257|20629357|P1|Overall Study|Lost to Follow-up|2
5965417|NCT01167192|20629379|P1|Overall Study|Insurance denial|1
5965418|NCT01167192|20629379|P1|Overall Study|Withdrawal by Subject|1
5965419|NCT01167192|20629379|P1|Overall Study|Death|1
5965420|NCT01167192|20629379|P1|Overall Study|Adverse Event|1
5965421|NCT01167179|20629396|P2|Overall Study|diverse|5
5965422|NCT01167179|20629397|P1|Overall Study|diverse|6
5965423|NCT01167179|20629396|P2|Overall Study|Withdrawal by Subject|2
5965424|NCT01167179|20629397|P1|Overall Study|Withdrawal by Subject|1
5965425|NCT01167179|20629396|P2|Overall Study|Death|10
5965426|NCT01167179|20629397|P1|Overall Study|Death|4
5965427|NCT01167179|20629396|P2|Overall Study|disease recurrence|4
5965428|NCT01167179|20629397|P1|Overall Study|disease recurrence|4
5965429|NCT01167153|20629407|P2|Overall Study|Subject initiation withdrawal, Other|8
5965430|NCT01167153|20629408|P1|Overall Study|Subject initiation withdrawal, Other|5
5965431|NCT01167153|20629407|P2|Overall Study|Withdrawal consent|1
5965432|NCT01167153|20629408|P1|Overall Study|Withdrawal consent|1
5965433|NCT01167153|20629407|P2|Overall Study|Investigator initiation withdrawal,Other|1
5965434|NCT01167153|20629408|P1|Overall Study|Investigator initiation withdrawal,Other|1
5965435|NCT01167153|20629407|P2|Overall Study|Non-compliance to concomitant medication|2
5965436|NCT01167153|20629408|P1|Overall Study|Non-compliance to concomitant medication|0
5965437|NCT01167153|20629407|P2|Overall Study|Lost to Follow-up|9
5965438|NCT01167153|20629408|P1|Overall Study|Lost to Follow-up|7
5965439|NCT01167153|20629407|P2|Overall Study|Hypotension|0
5965440|NCT01167153|20629408|P1|Overall Study|Hypotension|1
5965441|NCT01167153|20629407|P2|Overall Study|AE including clinical laboratory AE|8
5965442|NCT01167153|20629408|P1|Overall Study|AE including clinical laboratory AE|2
5965443|NCT01167153|20629407|P2|Overall Study|Non-effective therapy|4
5965444|NCT01167153|20629408|P1|Overall Study|Non-effective therapy|1
5965445|NCT01167140|20629426|P1|Overall Study|Withdrawal by Subject|1
5965446|NCT01167023|20629434|P3|Overall Study|Withdrawal by Subject|1
5965447|NCT01167023|20629435|P2|Overall Study|Withdrawal by Subject|0
5965448|NCT01167023|20629436|P1|Overall Study|Withdrawal by Subject|0
5965449|NCT01167023|20629434|P3|Overall Study|Sponsor Decision|0
5965450|NCT01167023|20629435|P2|Overall Study|Sponsor Decision|1
5965451|NCT01167023|20629436|P1|Overall Study|Sponsor Decision|0
5965452|NCT01167023|20629434|P3|Overall Study|Screen Failure|0
5965453|NCT01167023|20629435|P2|Overall Study|Screen Failure|1
5965454|NCT01167023|20629436|P1|Overall Study|Screen Failure|0
5965455|NCT01167023|20629434|P3|Overall Study|Lost to Follow-up|1
5965456|NCT01167023|20629435|P2|Overall Study|Lost to Follow-up|1
5965457|NCT01167023|20629436|P1|Overall Study|Lost to Follow-up|0
5965458|NCT01166958|20629476|P2|Overall Study|Withdrawal by Subject|0
5965459|NCT01166958|20629477|P1|Overall Study|Withdrawal by Subject|1
5965460|NCT01166945|20629493|P2|Day 30|Lost to Follow-up|3
5965461|NCT01166945|20629494|P1|Day 30|Lost to Follow-up|4
5965462|NCT01166945|20629493|P2|Day 15|NonCompliance/Lost to Follow Up|1
5965463|NCT01166945|20629494|P1|Day 15|NonCompliance/Lost to Follow Up|2
5965464|NCT01166945|20629493|P2|Day 10|NonCompliance/Lost to Follow Up|2
5965465|NCT01166945|20629494|P1|Day 10|NonCompliance/Lost to Follow Up|3
5965466|NCT01166945|20629493|P2|Randomized|diagnosed with Group A strep|4
5965467|NCT01166945|20629494|P1|Randomized|diagnosed with Group A strep|4
5965468|NCT01166763|20629502|P1|Overall Study|Withdrawal by Subject|3
5965469|NCT01166750|20629510|P2|Overall Study|Lost to Follow-up|0
5965470|NCT01166750|20629511|P1|Overall Study|Lost to Follow-up|1
5965471|NCT01166659|20629528|P1|Overall Study|Study Closed at Site|1
5965472|NCT01166659|20629528|P1|Overall Study|Lost to Follow-up|1
5965473|NCT01166659|20629528|P1|Overall Study|Death|1
5965474|NCT01166659|20629528|P1|Overall Study|Investigator Decision|2
5965475|NCT01166659|20629528|P1|Overall Study|Subject Decision|8
5965476|NCT01166646|20629537|P2|Overall Study|Adverse Event|0
5965477|NCT01166646|20629538|P1|Overall Study|Adverse Event|1
5965478|NCT01166646|20629537|P2|Overall Study|Protocol Violation|1
5965479|NCT01166646|20629538|P1|Overall Study|Protocol Violation|0
5965480|NCT01166568|20629557|P3|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1
5965481|NCT01166568|20629558|P2|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0
5965482|NCT01166568|20629559|P1|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|7
5965483|NCT01166568|20629557|P3|Implantation- Nonrandomized & Randomized|Lost to Follow-up|0
5965484|NCT01166568|20629558|P2|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1
5965485|NCT01166568|20629559|P1|Implantation- Nonrandomized & Randomized|Lost to Follow-up|7
5965486|NCT01166568|20629557|P3|Deferred Implantation- Randomized|Withdrawal by Subject|1
5965487|NCT01166568|20629558|P2|Deferred Implantation- Randomized|Withdrawal by Subject|0
5965488|NCT01166568|20629559|P1|Deferred Implantation- Randomized|Withdrawal by Subject|0
5965489|NCT01166438|20629572|P2|Off Treatment Follow-up Phase|Lack of Efficacy|52
5965490|NCT01166438|20629573|P1|Off Treatment Follow-up Phase|Lack of Efficacy|29
5965491|NCT01166438|20629572|P2|Off Treatment Follow-up Phase|Lost to Follow-up|2
5965492|NCT01166438|20629573|P1|Off Treatment Follow-up Phase|Lost to Follow-up|4
5965493|NCT01166438|20629572|P2|Off Treatment Follow-up Phase|Withdrawal by Subject|2
5965494|NCT01166438|20629573|P1|Off Treatment Follow-up Phase|Withdrawal by Subject|1
5965495|NCT01166438|20629572|P2|Double-blind Phase: 1st 6 Months|Not treated|1
5965496|NCT01166438|20629573|P1|Double-blind Phase: 1st 6 Months|Not treated|1
5965497|NCT01166438|20629572|P2|Double-blind Phase: 1st 6 Months|Lost to Follow-up|4
5965498|NCT01166438|20629573|P1|Double-blind Phase: 1st 6 Months|Lost to Follow-up|0
5965499|NCT01166438|20629572|P2|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|4
5965500|NCT01166438|20629573|P1|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|8
5965501|NCT01166373|20629591|P4|Overall Study|Physician Decision|0
5965502|NCT01166373|20629592|P3|Overall Study|Physician Decision|0
5965503|NCT01166373|20629593|P2|Overall Study|Physician Decision|0
5965504|NCT01166373|20629594|P1|Overall Study|Physician Decision|1
5965505|NCT01166373|20629591|P4|Overall Study|Withdrawal by Subject|3
5965506|NCT01166373|20629592|P3|Overall Study|Withdrawal by Subject|2
5965507|NCT01166373|20629593|P2|Overall Study|Withdrawal by Subject|2
5965508|NCT01166373|20629594|P1|Overall Study|Withdrawal by Subject|1
5965509|NCT01166373|20629591|P4|Overall Study|Lost to Follow-up|2
5965510|NCT01166373|20629592|P3|Overall Study|Lost to Follow-up|2
5965511|NCT01166373|20629593|P2|Overall Study|Lost to Follow-up|2
5965512|NCT01166373|20629594|P1|Overall Study|Lost to Follow-up|3
5965513|NCT01166282|20629727|P3|Open-label Period|Irregular Compliance|1
5965514|NCT01166282|20629728|P2|Open-label Period|Irregular Compliance|0
5965515|NCT01166282|20629729|P1|Open-label Period|Irregular Compliance|0
5965516|NCT01166282|20629727|P3|Open-label Period|Remission|4
5965517|NCT01166282|20629728|P2|Open-label Period|Remission|0
5965518|NCT01166282|20629729|P1|Open-label Period|Remission|0
5965519|NCT01166282|20629727|P3|Open-label Period|Lack of Efficacy|2
5965520|NCT01166282|20629728|P2|Open-label Period|Lack of Efficacy|0
5965521|NCT01166282|20629729|P1|Open-label Period|Lack of Efficacy|0
5965522|NCT01166282|20629727|P3|Open-label Period|Withdrawal by Subject|4
5965523|NCT01166282|20629728|P2|Open-label Period|Withdrawal by Subject|0
5965524|NCT01166282|20629729|P1|Open-label Period|Withdrawal by Subject|0
5965525|NCT01166282|20629727|P3|Open-label Period|Adverse Event|6
5965526|NCT01166282|20629728|P2|Open-label Period|Adverse Event|0
5965527|NCT01166282|20629729|P1|Open-label Period|Adverse Event|0
5965528|NCT01166178|20629768|P2|Overall Study|Study was terminated|8
5965529|NCT01166178|20629769|P1|Overall Study|Study was terminated|20
5965530|NCT01166178|20629768|P2|Overall Study|Withdrawal by Subject|0
5965531|NCT01166178|20629769|P1|Overall Study|Withdrawal by Subject|1
5965532|NCT01165996|20629808|P1|Overall Study|Physician Decision|1
5965533|NCT01165996|20629808|P1|Overall Study|Death|1
5965534|NCT01165684|20629879|P2|Overall Study|Unclassified|22
5965535|NCT01165684|20629880|P1|Overall Study|Unclassified|16
5965536|NCT01165684|20629879|P2|Overall Study|Withdrawal Criteria|13
5965537|NCT01165684|20629880|P1|Overall Study|Withdrawal Criteria|2
5965538|NCT01165684|20629879|P2|Overall Study|Protocol Violation|15
5965539|NCT01165684|20629880|P1|Overall Study|Protocol Violation|7
5965540|NCT01165684|20629879|P2|Overall Study|Lack of Efficacy|1
5965541|NCT01165684|20629880|P1|Overall Study|Lack of Efficacy|2
5965542|NCT01165684|20629879|P2|Overall Study|Adverse Event|1
5965543|NCT01165684|20629880|P1|Overall Study|Adverse Event|1
5965544|NCT01165554|20629914|P1|Overall Study|Withdrawal by Subject|23
5965545|NCT01165424|20629937|P1|Overall Study|Participant moved (relocated)|1
5965546|NCT01165424|20629937|P1|Overall Study|Did not meet entry criteria|1
5965547|NCT01165424|20629937|P1|Overall Study|Laboratory adverse experiences|1
5965548|NCT01165424|20629937|P1|Overall Study|Clinical adverse experiences|1
5965549|NCT01165320|20629944|P3|Overall Study|Reason unknown|0
5965550|NCT01165320|20629945|P2|Overall Study|Reason unknown|1
5965551|NCT01165320|20629946|P1|Overall Study|Reason unknown|0
5965552|NCT01165320|20629944|P3|Overall Study|Lack of Efficacy|0
5965553|NCT01165320|20629945|P2|Overall Study|Lack of Efficacy|2
5965554|NCT01165320|20629946|P1|Overall Study|Lack of Efficacy|0
5965555|NCT01165320|20629944|P3|Overall Study|Laboratory adverse experience|0
5965556|NCT01165320|20629945|P2|Overall Study|Laboratory adverse experience|0
5965557|NCT01165320|20629946|P1|Overall Study|Laboratory adverse experience|1
5965558|NCT01165320|20629944|P3|Overall Study|Clinical adverse experience|0
5965559|NCT01165320|20629945|P2|Overall Study|Clinical adverse experience|1
5965560|NCT01165320|20629946|P1|Overall Study|Clinical adverse experience|2
5965561|NCT01165307|20629956|P2|Overall Study|Subject not available for contact|0
5965562|NCT01165307|20629957|P1|Overall Study|Subject not available for contact|1
5965563|NCT01165307|20629956|P2|Overall Study|Withdrawal by Subject|0
5965564|NCT01165307|20629957|P1|Overall Study|Withdrawal by Subject|2
5965565|NCT01165307|20629956|P2|Overall Study|Lost to Follow-up|3
5965566|NCT01165307|20629957|P1|Overall Study|Lost to Follow-up|11
5965567|NCT01165281|20629987|P2|Overall Study|Other|0
5965568|NCT01165281|20629988|P1|Overall Study|Other|6
5965569|NCT01165281|20629987|P2|Overall Study|Progressive Disease|14
5965570|NCT01165281|20629988|P1|Overall Study|Progressive Disease|10
5965571|NCT01165281|20629987|P2|Overall Study|Noncompliance with Study Drug|4
5965572|NCT01165281|20629988|P1|Overall Study|Noncompliance with Study Drug|1
5965573|NCT01165281|20629987|P2|Overall Study|Withdrawal by Subject|7
5965574|NCT01165281|20629988|P1|Overall Study|Withdrawal by Subject|8
5965575|NCT01165281|20629987|P2|Overall Study|Protocol Violation|5
5965576|NCT01165281|20629988|P1|Overall Study|Protocol Violation|6
5965577|NCT01165281|20629987|P2|Overall Study|Physician Decision|1
5965578|NCT01165281|20629988|P1|Overall Study|Physician Decision|8
5965579|NCT01165281|20629987|P2|Overall Study|Lost to Follow-up|1
5965580|NCT01165281|20629988|P1|Overall Study|Lost to Follow-up|0
5965581|NCT01165281|20629987|P2|Overall Study|Lack of Efficacy|1
5965582|NCT01165281|20629988|P1|Overall Study|Lack of Efficacy|4
5965583|NCT01165281|20629987|P2|Overall Study|Death|4
5965584|NCT01165281|20629988|P1|Overall Study|Death|3
5965585|NCT01165281|20629987|P2|Overall Study|Adverse Event|14
5965586|NCT01165281|20629988|P1|Overall Study|Adverse Event|12
5965587|NCT01165242|20630009|P3|Overall Study|Lost to Follow-up|10
5965588|NCT01165242|20630010|P2|Overall Study|Lost to Follow-up|7
5965589|NCT01165242|20630011|P1|Overall Study|Lost to Follow-up|9
5965590|NCT01165242|20630009|P3|Overall Study|Extended Holiday|1
5965591|NCT01165242|20630010|P2|Overall Study|Extended Holiday|0
5965592|NCT01165242|20630011|P1|Overall Study|Extended Holiday|0
5965593|NCT01165242|20630009|P3|Overall Study|Withdrawal by Subject|2
5965594|NCT01165242|20630010|P2|Overall Study|Withdrawal by Subject|2
5965595|NCT01165242|20630011|P1|Overall Study|Withdrawal by Subject|0
5965596|NCT01165242|20630009|P3|Overall Study|Visit 2 Declined by Subject|1
5965597|NCT01165242|20630010|P2|Overall Study|Visit 2 Declined by Subject|0
5965598|NCT01165242|20630011|P1|Overall Study|Visit 2 Declined by Subject|0
5965599|NCT01165242|20630009|P3|Overall Study|Incarcerated Subjects|0
5965600|NCT01165242|20630010|P2|Overall Study|Incarcerated Subjects|1
5965601|NCT01165242|20630011|P1|Overall Study|Incarcerated Subjects|0
5965602|NCT01165242|20630009|P3|Overall Study|Unreachable Subjects|0
5965603|NCT01165242|20630010|P2|Overall Study|Unreachable Subjects|0
5965604|NCT01165242|20630011|P1|Overall Study|Unreachable Subjects|1
5965605|NCT01165229|20630045|P2|Overall Study|Unknown completion status|1
5965606|NCT01165229|20630046|P1|Overall Study|Unknown completion status|0
5965607|NCT01165229|20630045|P2|Overall Study|No reason from the subject|102
5965608|NCT01165229|20630046|P1|Overall Study|No reason from the subject|108
5965609|NCT01165229|20630045|P2|Overall Study|Suspected HZ Episode|2
5965610|NCT01165229|20630046|P1|Overall Study|Suspected HZ Episode|2
5965611|NCT01165229|20630045|P2|Overall Study|Lost to Follow-up|133
5965612|NCT01165229|20630046|P1|Overall Study|Lost to Follow-up|123
5965613|NCT01165229|20630045|P2|Overall Study|Migrated/moved from study area|46
5965614|NCT01165229|20630046|P1|Overall Study|Migrated/moved from study area|51
5965615|NCT01165229|20630045|P2|Overall Study|Withdrawal by Subject|396
5965616|NCT01165229|20630046|P1|Overall Study|Withdrawal by Subject|387
5965617|NCT01165229|20630045|P2|Overall Study|Protocol Violation|8
5965618|NCT01165229|20630046|P1|Overall Study|Protocol Violation|6
5965619|NCT01165229|20630045|P2|Overall Study|Non-Serious Adverse Event|15
5965620|NCT01165229|20630046|P1|Overall Study|Non-Serious Adverse Event|47
5965621|NCT01165229|20630045|P2|Overall Study|Serious Adverse Event|487
5965622|NCT01165229|20630046|P1|Overall Study|Serious Adverse Event|456
5965623|NCT01165216|20630180|P2|Overall Study|Disease progression|3
5965624|NCT01165216|20630181|P1|Overall Study|Disease progression|1
5965625|NCT01165216|20630180|P2|Overall Study|Withdrawal by Subject|1
5965626|NCT01165216|20630181|P1|Overall Study|Withdrawal by Subject|1
5965627|NCT01165216|20630180|P2|Overall Study|Adverse Event|3
5965628|NCT01165216|20630181|P1|Overall Study|Adverse Event|6
5965629|NCT01165203|20630203|P2|Extended Safety Follow-up Phase|Other-subjects business reasons|1
5965630|NCT01165203|20630204|P1|Extended Safety Follow-up Phase|Other-subjects business reasons|0
5965631|NCT01165203|20630203|P2|Extended Safety Follow-up Phase|Lost to Follow-up|0
5965632|NCT01165203|20630204|P1|Extended Safety Follow-up Phase|Lost to Follow-up|2
5965633|NCT01165203|20630203|P2|Extended Safety Follow-up Phase|Migrated/moved from study area|1
5965634|NCT01165203|20630204|P1|Extended Safety Follow-up Phase|Migrated/moved from study area|2
5965635|NCT01165203|20630203|P2|Extended Safety Follow-up Phase|Withdrawal by Subject|2
5965636|NCT01165203|20630204|P1|Extended Safety Follow-up Phase|Withdrawal by Subject|2
5965637|NCT01165203|20630203|P2|Extended Safety Follow-up Phase|Serious Adverse Event|0
5965638|NCT01165203|20630204|P1|Extended Safety Follow-up Phase|Serious Adverse Event|1
5965639|NCT01165203|20630203|P2|Active Phase|Lost to Follow-up|0
5965640|NCT01165203|20630204|P1|Active Phase|Lost to Follow-up|2
5965641|NCT01165203|20630203|P2|Active Phase|Migrated/moved from study area|1
5965642|NCT01165203|20630204|P1|Active Phase|Migrated/moved from study area|0
5965643|NCT01165203|20630203|P2|Active Phase|Withdrawal by Subject|1
5965644|NCT01165203|20630204|P1|Active Phase|Withdrawal by Subject|2
5965645|NCT01165203|20630203|P2|Active Phase|Serious Adverse Event|0
5965646|NCT01165203|20630204|P1|Active Phase|Serious Adverse Event|1
5965663|NCT01165138|20630424|P4|Overall Study|Withdrawal by Subject|3
5965664|NCT01165138|20630425|P3|Overall Study|Withdrawal by Subject|6
5965665|NCT01165138|20630426|P2|Overall Study|Withdrawal by Subject|6
5965666|NCT01165138|20630427|P1|Overall Study|Withdrawal by Subject|0
5965667|NCT01165138|20630424|P4|Overall Study|Physician Decision|6
5965668|NCT01165138|20630425|P3|Overall Study|Physician Decision|7
5965669|NCT01165138|20630426|P2|Overall Study|Physician Decision|6
5965670|NCT01165138|20630427|P1|Overall Study|Physician Decision|0
5965671|NCT01165138|20630424|P4|Overall Study|Lost to Follow-up|2
5965672|NCT01165138|20630425|P3|Overall Study|Lost to Follow-up|1
5965673|NCT01165138|20630426|P2|Overall Study|Lost to Follow-up|0
5965674|NCT01165138|20630427|P1|Overall Study|Lost to Follow-up|0
5965675|NCT01165138|20630424|P4|Overall Study|Protocol Violation|2
5965676|NCT01165138|20630425|P3|Overall Study|Protocol Violation|0
5965677|NCT01165138|20630426|P2|Overall Study|Protocol Violation|7
5965678|NCT01165138|20630427|P1|Overall Study|Protocol Violation|0
5965679|NCT01165138|20630424|P4|Overall Study|Lack of Efficacy|7
5965680|NCT01165138|20630425|P3|Overall Study|Lack of Efficacy|6
5965681|NCT01165138|20630426|P2|Overall Study|Lack of Efficacy|32
5965682|NCT01165138|20630427|P1|Overall Study|Lack of Efficacy|0
5965683|NCT01165138|20630424|P4|Overall Study|Adverse Event|2
5965684|NCT01165138|20630425|P3|Overall Study|Adverse Event|0
5965685|NCT01165138|20630426|P2|Overall Study|Adverse Event|1
5965686|NCT01165138|20630427|P1|Overall Study|Adverse Event|0
5965687|NCT01165021|20630497|P1|Overall Study|Death|1
5965688|NCT01164956|20630505|P3|Overall Study|Side Effects|1
5965689|NCT01164956|20630506|P2|Overall Study|Side Effects|0
5965690|NCT01164956|20630507|P1|Overall Study|Side Effects|1
5965691|NCT01164891|20630515|P1|Overall Study|Adverse Event|1
5965692|NCT01164891|20630515|P1|Overall Study|Disease Progression|5
5965693|NCT01164865|20630535|P2|Overall Study|Lost to Follow-up|1
5965694|NCT01164865|20630536|P1|Overall Study|Lost to Follow-up|2
5965695|NCT01164722|20630546|P2|Overall Study|enrolled on other study, concomitant med|3
5965696|NCT01164722|20630547|P1|Overall Study|enrolled on other study, concomitant med|1
5965697|NCT01164722|20630546|P2|Overall Study|met protocol criteria for non-treatment|1
5965698|NCT01164722|20630547|P1|Overall Study|met protocol criteria for non-treatment|11
5965699|NCT01164722|20630546|P2|Overall Study|Lost to Follow-up|6
5965700|NCT01164722|20630547|P1|Overall Study|Lost to Follow-up|3
5965701|NCT01164722|20630546|P2|Overall Study|Withdrawal by Subject|4
5965702|NCT01164722|20630547|P1|Overall Study|Withdrawal by Subject|3
5965703|NCT01164722|20630546|P2|Overall Study|Adverse Event|1
5965704|NCT01164722|20630547|P1|Overall Study|Adverse Event|0
5965705|NCT01164579|20630577|P3|Overall Study|Reason not specified|0
5965706|NCT01164579|20630578|P2|Overall Study|Reason not specified|0
5965707|NCT01164579|20630579|P1|Overall Study|Reason not specified|1
5965708|NCT01164579|20630577|P3|Overall Study|Adverse Event|5
5965709|NCT01164579|20630578|P2|Overall Study|Adverse Event|2
5965710|NCT01164579|20630579|P1|Overall Study|Adverse Event|4
5965711|NCT01164579|20630577|P3|Overall Study|Protocol Violation|2
5965712|NCT01164579|20630578|P2|Overall Study|Protocol Violation|1
5965713|NCT01164579|20630579|P1|Overall Study|Protocol Violation|0
5965714|NCT01164579|20630577|P3|Overall Study|Withdrawal by Subject|3
5965715|NCT01164579|20630578|P2|Overall Study|Withdrawal by Subject|5
5965716|NCT01164579|20630579|P1|Overall Study|Withdrawal by Subject|2
5965717|NCT01164579|20630577|P3|Overall Study|Lost to Follow-up|0
5965718|NCT01164579|20630578|P2|Overall Study|Lost to Follow-up|1
5965719|NCT01164579|20630579|P1|Overall Study|Lost to Follow-up|1
5965720|NCT01164579|20630577|P3|Overall Study|Lack of Efficacy|6
5965721|NCT01164579|20630578|P2|Overall Study|Lack of Efficacy|0
5965722|NCT01164579|20630579|P1|Overall Study|Lack of Efficacy|0
5965723|NCT01164501|20630659|P3|Overall Study|Other reason not defined above|4
5965724|NCT01164501|20630660|P2|Overall Study|Other reason not defined above|1
5965725|NCT01164501|20630661|P1|Overall Study|Other reason not defined above|9
5965726|NCT01164501|20630659|P3|Overall Study|Patient refusal to continue,not due toAE|8
5965727|NCT01164501|20630660|P2|Overall Study|Patient refusal to continue,not due toAE|4
5965728|NCT01164501|20630661|P1|Overall Study|Patient refusal to continue,not due toAE|10
5965729|NCT01164501|20630659|P3|Overall Study|Lost to Follow-up|3
5965730|NCT01164501|20630660|P2|Overall Study|Lost to Follow-up|0
5965731|NCT01164501|20630661|P1|Overall Study|Lost to Follow-up|3
5965732|NCT01164501|20630659|P3|Overall Study|Non compliant with protocol|4
5965733|NCT01164501|20630660|P2|Overall Study|Non compliant with protocol|1
5965734|NCT01164501|20630661|P1|Overall Study|Non compliant with protocol|1
5965735|NCT01164501|20630659|P3|Overall Study|Lack of Efficacy|1
5965736|NCT01164501|20630660|P2|Overall Study|Lack of Efficacy|0
5965737|NCT01164501|20630661|P1|Overall Study|Lack of Efficacy|0
5965738|NCT01164501|20630659|P3|Overall Study|Adverse Event|21
5965739|NCT01164501|20630660|P2|Overall Study|Adverse Event|4
5965740|NCT01164501|20630661|P1|Overall Study|Adverse Event|18
5965741|NCT01164501|20630659|P3|Overall Study|Not treated|1
5965742|NCT01164501|20630660|P2|Overall Study|Not treated|0
5965743|NCT01164501|20630661|P1|Overall Study|Not treated|2
5965744|NCT01164475|20630678|P2|Overall Study|Protocol Violation|0
5965745|NCT01164475|20630679|P1|Overall Study|Protocol Violation|1
5965746|NCT01164475|20630678|P2|Overall Study|Progressive disease|1
5965747|NCT01164475|20630679|P1|Overall Study|Progressive disease|0
5965748|NCT01164475|20630678|P2|Overall Study|Other|1
5965749|NCT01164475|20630679|P1|Overall Study|Other|0
5965750|NCT01164475|20630678|P2|Overall Study|Lack of Efficacy|0
5965751|NCT01164475|20630679|P1|Overall Study|Lack of Efficacy|1
5965752|NCT01164007|20630733|P1|Overall Study|Medical Decision|3
5965753|NCT01164007|20630733|P1|Overall Study|Withdrawal by Subject|1
5965754|NCT01164007|20630733|P1|Overall Study|Protocol Violation|1
5965755|NCT01164007|20630733|P1|Overall Study|Progression of Disease|30
5965756|NCT01164007|20630733|P1|Overall Study|Adverse Event|5
5965757|NCT01163916|20630759|P3|Overall Study|Other|16
5965758|NCT01163916|20630760|P2|Overall Study|Other|4
5965759|NCT01163916|20630761|P1|Overall Study|Other|24
5965760|NCT01163916|20630759|P3|Overall Study|Lack of Efficacy|1
5965761|NCT01163916|20630760|P2|Overall Study|Lack of Efficacy|0
5965762|NCT01163916|20630761|P1|Overall Study|Lack of Efficacy|2
5965763|NCT01163916|20630759|P3|Overall Study|Adverse Event|1
5965764|NCT01163916|20630760|P2|Overall Study|Adverse Event|0
5965765|NCT01163916|20630761|P1|Overall Study|Adverse Event|2
5965766|NCT01163916|20630759|P3|Overall Study|Withdrawal by Subject|2
5965767|NCT01163916|20630760|P2|Overall Study|Withdrawal by Subject|0
5965768|NCT01163916|20630761|P1|Overall Study|Withdrawal by Subject|2
5965769|NCT01163851|20630799|P2|Overall Study|Enrolled but not treated|0
5965770|NCT01163851|20630800|P1|Overall Study|Enrolled but not treated|1
5965771|NCT01163851|20630799|P2|Overall Study|Site Closure|1
5965772|NCT01163851|20630800|P1|Overall Study|Site Closure|0
5965773|NCT01163786|20630878|P1|Completed Follow up (Visit 9 and 10)|Other|1
5965774|NCT01163786|20630878|P1|Treatment With Bortezomib|Adverse Event|2
5965775|NCT01163786|20630878|P1|Treatment With Bortezomib|Withdrawal by Subject|1
5965776|NCT01163747|20630901|P2|Overall Study|Refused Treatment|4
5965777|NCT01163747|20630902|P1|Overall Study|Refused Treatment|6
5965778|NCT01163747|20630901|P2|Overall Study|Protocol Violation|1
5965779|NCT01163747|20630902|P1|Overall Study|Protocol Violation|0
5965780|NCT01163747|20630901|P2|Overall Study|Insufficient Therapeutic Response|1
5965781|NCT01163747|20630902|P1|Overall Study|Insufficient Therapeutic Response|0
5965782|NCT01163747|20630901|P2|Overall Study|Adverse Event|5
5965783|NCT01163747|20630902|P1|Overall Study|Adverse Event|0
5965784|NCT01163721|20630922|P2|Overall Study|Physician Decision|1
5965785|NCT01163721|20630923|P1|Overall Study|Physician Decision|0
5965786|NCT01163721|20630922|P2|Overall Study|Lost to Follow-up|1
5965787|NCT01163721|20630923|P1|Overall Study|Lost to Follow-up|0
5965788|NCT01163721|20630922|P2|Overall Study|Withdrawal by Subject|4
5965789|NCT01163721|20630923|P1|Overall Study|Withdrawal by Subject|3
5965790|NCT01163721|20630922|P2|Overall Study|Adverse Event|6
5965791|NCT01163721|20630923|P1|Overall Study|Adverse Event|5
5965792|NCT01163617|20630973|P8|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
5965793|NCT01163617|20630974|P7|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
5965794|NCT01163617|20630975|P6|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
5965795|NCT01163617|20630976|P5|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
5965796|NCT01163617|20630977|P4|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
5965797|NCT01163617|20630978|P3|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|1
5965798|NCT01163617|20630979|P2|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
5965799|NCT01163617|20630980|P1|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
5965800|NCT01163617|20630973|P8|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
5965801|NCT01163617|20630974|P7|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
5965802|NCT01163617|20630975|P6|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
5965803|NCT01163617|20630976|P5|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
5965804|NCT01163617|20630977|P4|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
5965805|NCT01163617|20630978|P3|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
5965806|NCT01163617|20630979|P2|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|1
5965807|NCT01163617|20630980|P1|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
5965808|NCT01163617|20630973|P8|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
5965809|NCT01163617|20630974|P7|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
5965810|NCT01163617|20630975|P6|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
5965811|NCT01163617|20630976|P5|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
5965812|NCT01163617|20630977|P4|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
5965813|NCT01163617|20630978|P3|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
5965814|NCT01163617|20630979|P2|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|1
5965815|NCT01163617|20630980|P1|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
5965816|NCT01163474|20631009|P1|Overall Study|Lost to Follow-up|3
5965817|NCT01163474|20631009|P1|Overall Study|Tech barriers to videoteleconference vis|12
5965818|NCT01163474|20631009|P1|Overall Study|Withdrawal by Subject|1
5965819|NCT01163318|20631021|P1|Overall Study|Multiple Reasons Per Participant|224
5965820|NCT01163318|20631021|P1|Overall Study|Participants Without Case Report Form|7
5965821|NCT01163318|20631021|P1|Overall Study|History/comorbidity of malignant tumor|3
5965822|NCT01163318|20631021|P1|Overall Study|Did Not Continue Use of Adalimumab|26
5965823|NCT01163318|20631021|P1|Overall Study|Off-Label Use of Adalimumab|8
5965824|NCT01163292|20631030|P2|Overall Study|No further visits|7
5965825|NCT01163292|20631031|P1|Overall Study|No further visits|5
5965826|NCT01163292|20631030|P2|Overall Study|Economic reasons|0
5965827|NCT01163292|20631031|P1|Overall Study|Economic reasons|6
5965828|NCT01163292|20631030|P2|Overall Study|Refusal to receive adalimumab|0
5965829|NCT01163292|20631031|P1|Overall Study|Refusal to receive adalimumab|7
5965830|NCT01163292|20631030|P2|Overall Study|Sufficient response to adalimumab|0
5965831|NCT01163292|20631031|P1|Overall Study|Sufficient response to adalimumab|8
5965832|NCT01163292|20631030|P2|Overall Study|Initiation of biological therapy|15
5965833|NCT01163292|20631031|P1|Overall Study|Initiation of biological therapy|0
5965834|NCT01163292|20631030|P2|Overall Study|Adverse Event|0
5965835|NCT01163292|20631031|P1|Overall Study|Adverse Event|6
5965836|NCT01163292|20631030|P2|Overall Study|Lack of Efficacy|0
5965837|NCT01163292|20631031|P1|Overall Study|Lack of Efficacy|9
5965838|NCT01163279|20631047|P2|Overall Study|Withdrawal by Subject|0
5965839|NCT01163279|20631048|P1|Overall Study|Withdrawal by Subject|2
5965840|NCT01163266|20631077|P3|Overall Study|Other|2
5965841|NCT01163266|20631078|P2|Overall Study|Other|1
5965842|NCT01163266|20631079|P1|Overall Study|Other|1
5965843|NCT01163266|20631077|P3|Overall Study|Lost to Follow-up|10
5965844|NCT01163266|20631078|P2|Overall Study|Lost to Follow-up|7
5965845|NCT01163266|20631079|P1|Overall Study|Lost to Follow-up|7
5965846|NCT01163266|20631077|P3|Overall Study|Withdrawal of Consent|3
5965847|NCT01163266|20631078|P2|Overall Study|Withdrawal of Consent|7
5965848|NCT01163266|20631079|P1|Overall Study|Withdrawal of Consent|5
5965849|NCT01163266|20631077|P3|Overall Study|Protocol Deviations|5
5965850|NCT01163266|20631078|P2|Overall Study|Protocol Deviations|2
5965851|NCT01163266|20631079|P1|Overall Study|Protocol Deviations|2
5965852|NCT01163266|20631077|P3|Overall Study|Noncompliance with Study Drug|0
5965853|NCT01163266|20631078|P2|Overall Study|Noncompliance with Study Drug|2
5965854|NCT01163266|20631079|P1|Overall Study|Noncompliance with Study Drug|0
5965855|NCT01163266|20631077|P3|Overall Study|Lack of Efficacy|1
5965856|NCT01163266|20631078|P2|Overall Study|Lack of Efficacy|3
5965857|NCT01163266|20631079|P1|Overall Study|Lack of Efficacy|1
5965858|NCT01163266|20631077|P3|Overall Study|Pretreatment Event or Adverse Event|7
5965859|NCT01163266|20631078|P2|Overall Study|Pretreatment Event or Adverse Event|9
5965860|NCT01163266|20631079|P1|Overall Study|Pretreatment Event or Adverse Event|2
5965861|NCT01163253|20631104|P2|Overall Study|Other Unspecified|34
5965862|NCT01163253|20631105|P1|Overall Study|Other Unspecified|170
5965863|NCT01163253|20631104|P2|Overall Study|Ongoing|4
5965864|NCT01163253|20631105|P1|Overall Study|Ongoing|13
5965865|NCT01163253|20631104|P2|Overall Study|Death|5
5965866|NCT01163253|20631105|P1|Overall Study|Death|17
5965867|NCT01163253|20631104|P2|Overall Study|Adverse Event|78
5965868|NCT01163253|20631105|P1|Overall Study|Adverse Event|300
5965869|NCT01163253|20631104|P2|Overall Study|Insufficient Clinical Response|29
5965870|NCT01163253|20631105|P1|Overall Study|Insufficient Clinical Response|423
5965871|NCT01163253|20631104|P2|Overall Study|Lost to Follow-up|23
5965872|NCT01163253|20631105|P1|Overall Study|Lost to Follow-up|125
5965873|NCT01163253|20631104|P2|Overall Study|Medication Error|0
5965874|NCT01163253|20631105|P1|Overall Study|Medication Error|1
5965875|NCT01163253|20631104|P2|Overall Study|Withdrawal by Subject|50
5965876|NCT01163253|20631105|P1|Overall Study|Withdrawal by Subject|199
5965877|NCT01163253|20631104|P2|Overall Study|Protocol Violation|12
5965878|NCT01163253|20631105|P1|Overall Study|Protocol Violation|43
5965879|NCT01163253|20631104|P2|Overall Study|Study Terminated by Sponsor|349
5965880|NCT01163253|20631105|P1|Overall Study|Study Terminated by Sponsor|978
5965881|NCT01163253|20631104|P2|Overall Study|Withdrawn Due to Pregnancy|2
5965882|NCT01163253|20631105|P1|Overall Study|Withdrawn Due to Pregnancy|12
5965883|NCT01163149|20631293|P3|Extension Treatment Period|Noncompliance|1
5965884|NCT01163149|20631294|P2|Extension Treatment Period|Noncompliance|0
5965885|NCT01163149|20631295|P1|Extension Treatment Period|Noncompliance|0
5965886|NCT01163149|20631293|P3|Extension Treatment Period|Adverse Event|0
5965887|NCT01163149|20631294|P2|Extension Treatment Period|Adverse Event|1
5965888|NCT01163149|20631295|P1|Extension Treatment Period|Adverse Event|0
5965889|NCT01163149|20631293|P3|Extension Treatment Period|Withdrawal by Subject|1
5965890|NCT01163149|20631294|P2|Extension Treatment Period|Withdrawal by Subject|0
5965891|NCT01163149|20631295|P1|Extension Treatment Period|Withdrawal by Subject|2
5965892|NCT01163032|20631404|P3|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|2
5965893|NCT01163032|20631405|P2|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0
5965894|NCT01163032|20631406|P1|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0
5965895|NCT01163032|20631404|P3|Open Label Extension Phase|Study Termination|7
5965896|NCT01163032|20631405|P2|Open Label Extension Phase|Study Termination|0
5965897|NCT01163032|20631406|P1|Open Label Extension Phase|Study Termination|0
5965898|NCT01163032|20631404|P3|Open Label Extension Phase|Protocol Violation|1
5965899|NCT01163032|20631405|P2|Open Label Extension Phase|Protocol Violation|0
5965900|NCT01163032|20631406|P1|Open Label Extension Phase|Protocol Violation|0
5965901|NCT01163032|20631404|P3|Open Label Extension Phase|Withdrawal by Subject|3
5965902|NCT01163032|20631405|P2|Open Label Extension Phase|Withdrawal by Subject|0
5965903|NCT01163032|20631406|P1|Open Label Extension Phase|Withdrawal by Subject|0
5965904|NCT01163032|20631404|P3|Open Label Extension Phase|Adverse Event|3
5965905|NCT01163032|20631405|P2|Open Label Extension Phase|Adverse Event|0
5965906|NCT01163032|20631406|P1|Open Label Extension Phase|Adverse Event|0
5965907|NCT01163032|20631404|P3|Randomization Phase|Unsatisfactory Therapeutic Effect|0
5965908|NCT01163032|20631405|P2|Randomization Phase|Unsatisfactory Therapeutic Effect|1
5965909|NCT01163032|20631406|P1|Randomization Phase|Unsatisfactory Therapeutic Effect|0
5965910|NCT01163032|20631404|P3|Randomization Phase|Various*|0
5965911|NCT01163032|20631405|P2|Randomization Phase|Various*|4
5965912|NCT01163032|20631406|P1|Randomization Phase|Various*|5
5965913|NCT01163032|20631404|P3|Randomization Phase|Protocol Violation|0
5965914|NCT01163032|20631405|P2|Randomization Phase|Protocol Violation|1
5965915|NCT01163032|20631406|P1|Randomization Phase|Protocol Violation|0
5965916|NCT01163032|20631404|P3|Randomization Phase|Adverse Event|0
5965917|NCT01163032|20631405|P2|Randomization Phase|Adverse Event|3
5965918|NCT01163032|20631406|P1|Randomization Phase|Adverse Event|3
5965919|NCT01163032|20631404|P3|Randomization Phase|Withdrawal by Subject|0
5965920|NCT01163032|20631405|P2|Randomization Phase|Withdrawal by Subject|3
5965921|NCT01163032|20631406|P1|Randomization Phase|Withdrawal by Subject|2
5965922|NCT01162863|20631439|P3|Overall Study|Adverse Event|0
5965923|NCT01162863|20631440|P2|Overall Study|Adverse Event|1
5965924|NCT01162863|20631441|P1|Overall Study|Adverse Event|0
5965925|NCT01162863|20631439|P3|Overall Study|Lack of Efficacy|0
5965926|NCT01162863|20631440|P2|Overall Study|Lack of Efficacy|0
5965927|NCT01162863|20631441|P1|Overall Study|Lack of Efficacy|1
5965928|NCT01162499|20631471|P2|Intervention 1 (4 Hours)|Unable to establish IV access|1
5965929|NCT01162499|20631472|P1|Intervention 1 (4 Hours)|Unable to establish IV access|0
5965930|NCT01162486|20631497|P5|Overall Study|Pregnancy|0
5965931|NCT01162486|20631498|P4|Overall Study|Pregnancy|1
5965932|NCT01162486|20631499|P3|Overall Study|Pregnancy|0
5965933|NCT01162486|20631500|P2|Overall Study|Pregnancy|0
5965934|NCT01162486|20631501|P1|Overall Study|Pregnancy|0
5965935|NCT01162486|20631497|P5|Overall Study|elevated LFTs|0
5965936|NCT01162486|20631498|P4|Overall Study|elevated LFTs|0
5965937|NCT01162486|20631499|P3|Overall Study|elevated LFTs|1
5965938|NCT01162486|20631500|P2|Overall Study|elevated LFTs|0
5965939|NCT01162486|20631501|P1|Overall Study|elevated LFTs|0
5965940|NCT01162486|20631497|P5|Overall Study|vomited Rifampin/ gagged with midazolam|0
5965941|NCT01162486|20631498|P4|Overall Study|vomited Rifampin/ gagged with midazolam|0
5965942|NCT01162486|20631499|P3|Overall Study|vomited Rifampin/ gagged with midazolam|0
5965943|NCT01162486|20631500|P2|Overall Study|vomited Rifampin/ gagged with midazolam|0
5965944|NCT01162486|20631501|P1|Overall Study|vomited Rifampin/ gagged with midazolam|1
5965945|NCT01162486|20631497|P5|Overall Study|low ANC|0
5965946|NCT01162486|20631498|P4|Overall Study|low ANC|0
5965947|NCT01162486|20631499|P3|Overall Study|low ANC|0
5965948|NCT01162486|20631500|P2|Overall Study|low ANC|0
5965949|NCT01162486|20631501|P1|Overall Study|low ANC|1
5965950|NCT01162473|20631534|P2|Overall Study|Withdrawal by Subject|4
5965951|NCT01162473|20631535|P1|Overall Study|Withdrawal by Subject|0
5965952|NCT01162473|20631534|P2|Overall Study|Adverse Event|1
5965953|NCT01162473|20631535|P1|Overall Study|Adverse Event|2
5965954|NCT01162421|20631543|P2|Overall Study|Other|3
5965955|NCT01162421|20631544|P1|Overall Study|Other|2
5965956|NCT01162421|20631543|P2|Overall Study|Lack of Efficacy|2
5965957|NCT01162421|20631544|P1|Overall Study|Lack of Efficacy|2
5965958|NCT01162421|20631543|P2|Overall Study|Lost to Follow-up|2
5965959|NCT01162421|20631544|P1|Overall Study|Lost to Follow-up|0
5965960|NCT01162421|20631543|P2|Overall Study|Adverse Event|5
5965961|NCT01162421|20631544|P1|Overall Study|Adverse Event|2
5965962|NCT01162421|20631543|P2|Overall Study|Did not receive study drug|1
5965963|NCT01162421|20631544|P1|Overall Study|Did not receive study drug|2
5965964|NCT01162343|20631627|P1|Overall Study|Refused psychiatrist assessment|12
5965965|NCT01162343|20631627|P1|Overall Study|Left ED prior to psychiatrist assessment|80
5965966|NCT01162304|20631642|P1|Overall Study|Beck scale to high|11
5965967|NCT01162239|20631660|P4|Extended Follow-up|Lost to Follow-up|6
5965968|NCT01162239|20631661|P3|Extended Follow-up|Lost to Follow-up|8
5965969|NCT01162239|20631662|P2|Extended Follow-up|Lost to Follow-up|13
5965970|NCT01162239|20631663|P1|Extended Follow-up|Lost to Follow-up|8
5965971|NCT01162239|20631660|P4|Treatment Phase|Lost to Follow-up|1
5965972|NCT01162239|20631661|P3|Treatment Phase|Lost to Follow-up|2
5965973|NCT01162239|20631662|P2|Treatment Phase|Lost to Follow-up|4
5965974|NCT01162239|20631663|P1|Treatment Phase|Lost to Follow-up|5
5965975|NCT01162239|20631660|P4|Treatment Phase|Death|1
5965976|NCT01162239|20631661|P3|Treatment Phase|Death|0
5965977|NCT01162239|20631662|P2|Treatment Phase|Death|0
5965978|NCT01162239|20631663|P1|Treatment Phase|Death|0
5965979|NCT01162239|20631660|P4|Treatment Phase|Withdrawal by Subject|3
5965980|NCT01162239|20631661|P3|Treatment Phase|Withdrawal by Subject|2
5965981|NCT01162239|20631662|P2|Treatment Phase|Withdrawal by Subject|3
5965982|NCT01162239|20631663|P1|Treatment Phase|Withdrawal by Subject|1
5965983|NCT01162135|20631693|P1|Overall Study|Ineligible|1
5965984|NCT01162135|20631693|P1|Overall Study|Severe back pain|1
5965985|NCT01162135|20631693|P1|Overall Study|Withdrawal by Subject|1
5965986|NCT01162122|20631699|P2|Overall Study|Missing primary reason|0
5965987|NCT01162122|20631700|P1|Overall Study|Missing primary reason|1
5965988|NCT01162122|20631699|P2|Overall Study|Unable to classify|7
5965989|NCT01162122|20631700|P1|Overall Study|Unable to classify|3
5965990|NCT01162122|20631699|P2|Overall Study|Administrative reason|1
5965991|NCT01162122|20631700|P1|Overall Study|Administrative reason|1
5965992|NCT01162122|20631699|P2|Overall Study|Inappropriate enrollment|4
5965993|NCT01162122|20631700|P1|Overall Study|Inappropriate enrollment|5
5965994|NCT01162122|20631699|P2|Overall Study|Protocol Violation|2
5965995|NCT01162122|20631700|P1|Overall Study|Protocol Violation|2
5965996|NCT01162122|20631699|P2|Overall Study|Death|46
5965997|NCT01162122|20631700|P1|Overall Study|Death|51
5965998|NCT01162122|20631699|P2|Overall Study|Adverse Event|2
5965999|NCT01162122|20631700|P1|Overall Study|Adverse Event|3
5966000|NCT01162122|20631699|P2|Overall Study|Lost to Follow-up|91
5966001|NCT01162122|20631700|P1|Overall Study|Lost to Follow-up|73
5966002|NCT01162122|20631699|P2|Overall Study|Withdrawal by Subject|43
5966003|NCT01162122|20631700|P1|Overall Study|Withdrawal by Subject|52
5966004|NCT01161628|20631806|P1|Overall Study|Lack of Efficacy|2
5966005|NCT01161628|20631806|P1|Overall Study|Death|6
5966006|NCT01161537|20631829|P1|Part B|Withdrawal by Subject|2
5966007|NCT01161524|20631847|P3|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|4
5966008|NCT01161524|20631848|P2|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0
5966009|NCT01161524|20631849|P1|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0
5966010|NCT01161524|20631847|P3|Extension Phase (Approximately 83 Weeks)|Subject Choice|5
5966011|NCT01161524|20631848|P2|Extension Phase (Approximately 83 Weeks)|Subject Choice|0
5966012|NCT01161524|20631849|P1|Extension Phase (Approximately 83 Weeks)|Subject Choice|0
5966013|NCT01161524|20631847|P3|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|1
5966014|NCT01161524|20631848|P2|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0
5966015|NCT01161524|20631849|P1|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0
5966016|NCT01161524|20631847|P3|Extension Phase (Approximately 83 Weeks)|Other|6
5966017|NCT01161524|20631848|P2|Extension Phase (Approximately 83 Weeks)|Other|0
5966018|NCT01161524|20631849|P1|Extension Phase (Approximately 83 Weeks)|Other|0
5966019|NCT01161524|20631847|P3|Extension Phase (Approximately 83 Weeks)|Adverse Event|8
5966020|NCT01161524|20631848|P2|Extension Phase (Approximately 83 Weeks)|Adverse Event|0
5966021|NCT01161524|20631849|P1|Extension Phase (Approximately 83 Weeks)|Adverse Event|0
5966022|NCT01161524|20631847|P3|Core Study (23 Weeks)|Subject Choice|0
5966023|NCT01161524|20631848|P2|Core Study (23 Weeks)|Subject Choice|2
5966024|NCT01161524|20631849|P1|Core Study (23 Weeks)|Subject Choice|3
5966025|NCT01161524|20631847|P3|Core Study (23 Weeks)|Lost to Follow-up|0
5966026|NCT01161524|20631848|P2|Core Study (23 Weeks)|Lost to Follow-up|2
5966027|NCT01161524|20631849|P1|Core Study (23 Weeks)|Lost to Follow-up|1
5966028|NCT01161524|20631847|P3|Core Study (23 Weeks)|Withdrawal of Consent|0
5966029|NCT01161524|20631848|P2|Core Study (23 Weeks)|Withdrawal of Consent|1
5966030|NCT01161524|20631849|P1|Core Study (23 Weeks)|Withdrawal of Consent|1
5966031|NCT01161524|20631847|P3|Core Study (23 Weeks)|Other|0
5966032|NCT01161524|20631848|P2|Core Study (23 Weeks)|Other|0
5966033|NCT01161524|20631849|P1|Core Study (23 Weeks)|Other|1
5966034|NCT01161524|20631847|P3|Core Study (23 Weeks)|Adverse Event|0
5966035|NCT01161524|20631848|P2|Core Study (23 Weeks)|Adverse Event|0
5966036|NCT01161524|20631849|P1|Core Study (23 Weeks)|Adverse Event|3
5966037|NCT01161498|20631888|P2|Overall Study|Disease Progression|1
5966038|NCT01161498|20631889|P1|Overall Study|Disease Progression|0
5966039|NCT01161472|20631913|P4|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0
5966040|NCT01161472|20631914|P3|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0
5966041|NCT01161472|20631915|P2|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0
5966042|NCT01161472|20631916|P1|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|1
5966043|NCT01161446|20631972|P2|Overall Study|Withdrawal by Subject|1
5966044|NCT01161446|20631973|P1|Overall Study|Withdrawal by Subject|0
5966045|NCT01161446|20631972|P2|Overall Study|Lost to Follow-up|14
5966046|NCT01161446|20631973|P1|Overall Study|Lost to Follow-up|18
5966047|NCT01161407|20631999|P2|Overall Study|Protocol Violation|1
5966048|NCT01161407|20632000|P1|Overall Study|Protocol Violation|3
5966049|NCT01161173|20632055|P1|Overall Study|Reasons Not Specified|23
5966050|NCT01161173|20632055|P1|Overall Study|End of Study|2
5966051|NCT01161173|20632055|P1|Overall Study|Death|194
5966052|NCT01161173|20632055|P1|Overall Study|Unacceptable Toxicity|21
5966053|NCT01161173|20632055|P1|Overall Study|Withdrawal of Consent|5
5966054|NCT01161173|20632055|P1|Overall Study|Progressive Disease|82
5966055|NCT01161173|20632055|P1|Overall Study|Lost to Follow-up|7
5966056|NCT01161173|20632055|P1|Overall Study|Protocol Violation|13
5966057|NCT01161043|20632150|P1|Overall Study|Withdrawal by Subject|3
5966058|NCT01160822|20632187|P7|Overall Study|Protocol deviation|0
5966059|NCT01160822|20632188|P6|Overall Study|Protocol deviation|0
5966060|NCT01160822|20632189|P5|Overall Study|Protocol deviation|2
5966061|NCT01160822|20632190|P4|Overall Study|Protocol deviation|0
5966062|NCT01160822|20632191|P3|Overall Study|Protocol deviation|0
5966063|NCT01160822|20632192|P2|Overall Study|Protocol deviation|0
5966064|NCT01160822|20632193|P1|Overall Study|Protocol deviation|0
5966065|NCT01160822|20632187|P7|Overall Study|Administrative problems|0
5966066|NCT01160822|20632188|P6|Overall Study|Administrative problems|0
5966067|NCT01160822|20632189|P5|Overall Study|Administrative problems|1
5966068|NCT01160822|20632190|P4|Overall Study|Administrative problems|0
5966069|NCT01160822|20632191|P3|Overall Study|Administrative problems|0
5966070|NCT01160822|20632192|P2|Overall Study|Administrative problems|0
5966071|NCT01160822|20632193|P1|Overall Study|Administrative problems|0
5966072|NCT01160822|20632187|P7|Overall Study|Lost to Follow-up|0
5966073|NCT01160822|20632188|P6|Overall Study|Lost to Follow-up|0
5966074|NCT01160822|20632189|P5|Overall Study|Lost to Follow-up|1
5966075|NCT01160822|20632190|P4|Overall Study|Lost to Follow-up|0
5966076|NCT01160822|20632191|P3|Overall Study|Lost to Follow-up|0
5966077|NCT01160822|20632192|P2|Overall Study|Lost to Follow-up|0
5966078|NCT01160822|20632193|P1|Overall Study|Lost to Follow-up|0
5966079|NCT01160822|20632187|P7|Overall Study|Withdrawal by Subject|1
5966080|NCT01160822|20632188|P6|Overall Study|Withdrawal by Subject|0
5966081|NCT01160822|20632189|P5|Overall Study|Withdrawal by Subject|0
5966082|NCT01160822|20632190|P4|Overall Study|Withdrawal by Subject|0
5966083|NCT01160822|20632191|P3|Overall Study|Withdrawal by Subject|0
5966084|NCT01160822|20632192|P2|Overall Study|Withdrawal by Subject|0
5966085|NCT01160822|20632193|P1|Overall Study|Withdrawal by Subject|0
5966086|NCT01160822|20632187|P7|Overall Study|Unsatisfactory therapeutic effect|3
5966087|NCT01160822|20632188|P6|Overall Study|Unsatisfactory therapeutic effect|5
5966088|NCT01160822|20632189|P5|Overall Study|Unsatisfactory therapeutic effect|4
5966089|NCT01160822|20632190|P4|Overall Study|Unsatisfactory therapeutic effect|0
5966090|NCT01160822|20632191|P3|Overall Study|Unsatisfactory therapeutic effect|0
5966091|NCT01160822|20632192|P2|Overall Study|Unsatisfactory therapeutic effect|0
5966092|NCT01160822|20632193|P1|Overall Study|Unsatisfactory therapeutic effect|0
5966093|NCT01160822|20632187|P7|Overall Study|Adverse Event|5
5966094|NCT01160822|20632188|P6|Overall Study|Adverse Event|2
5966095|NCT01160822|20632189|P5|Overall Study|Adverse Event|1
5966096|NCT01160822|20632190|P4|Overall Study|Adverse Event|0
5966097|NCT01160822|20632191|P3|Overall Study|Adverse Event|0
5966098|NCT01160822|20632192|P2|Overall Study|Adverse Event|0
5966099|NCT01160822|20632193|P1|Overall Study|Adverse Event|0
5966100|NCT01160770|20632282|P1|Overall Study|Other Reasons|1
5966101|NCT01160770|20632282|P1|Overall Study|Lack of Efficacy|15
5966102|NCT01160770|20632282|P1|Overall Study|Death|9
5966103|NCT01160770|20632282|P1|Overall Study|Study termination or sponsor request|1
5966104|NCT01160770|20632282|P1|Overall Study|Lost to Follow-up|7
5966105|NCT01160770|20632282|P1|Overall Study|Physician Decision|1
5966106|NCT01160770|20632282|P1|Overall Study|Subject/parent/caregiver request|33
5966107|NCT01160770|20632282|P1|Overall Study|Protocol Violation|2
5966108|NCT01160770|20632282|P1|Overall Study|Adverse Event|10
5966109|NCT01160744|20632295|P4|Overall Study|Not meet inclusion/exclusion criteria|0
5966110|NCT01160744|20632296|P3|Overall Study|Not meet inclusion/exclusion criteria|1
5966111|NCT01160744|20632297|P2|Overall Study|Not meet inclusion/exclusion criteria|0
5966112|NCT01160744|20632298|P1|Overall Study|Not meet inclusion/exclusion criteria|0
5966113|NCT01160744|20632295|P4|Overall Study|Withdrawal by Subject|4
5966114|NCT01160744|20632296|P3|Overall Study|Withdrawal by Subject|6
5966115|NCT01160744|20632297|P2|Overall Study|Withdrawal by Subject|5
5966116|NCT01160744|20632298|P1|Overall Study|Withdrawal by Subject|11
5966117|NCT01160640|20632334|P2|Overall Study|Withdrawal by Subject|3
5966118|NCT01160640|20632335|P1|Overall Study|Withdrawal by Subject|0
5966119|NCT01160640|20632334|P2|Overall Study|Incarceration|0
5966120|NCT01160640|20632335|P1|Overall Study|Incarceration|1
5966121|NCT01160640|20632334|P2|Overall Study|Physician Decision|3
5966122|NCT01160640|20632335|P1|Overall Study|Physician Decision|3
5966123|NCT01160614|20632351|P2|Overall Study|Withdrawal by Subject|2
5966124|NCT01160614|20632352|P1|Overall Study|Withdrawal by Subject|0
5966125|NCT01160484|20632400|P1|Overall Study|inclusion/exclusion criteria failure|1
5966126|NCT01160484|20632400|P1|Overall Study|Withdrawal by Subject|2
5966127|NCT01160484|20632400|P1|Overall Study|Adverse Event|6
5966128|NCT01160484|20632400|P1|Overall Study|Lack of Efficacy|9
5966129|NCT01160354|20632453|P3|Overall Study|Death|1
5966130|NCT01160354|20632454|P2|Overall Study|Death|1
5966131|NCT01160354|20632455|P1|Overall Study|Death|0
5966132|NCT01160289|20632474|P6|Post-Randomization Period|Sponsor Decision|0
5966133|NCT01160289|20632475|P5|Post-Randomization Period|Sponsor Decision|0
5966134|NCT01160289|20632476|P4|Post-Randomization Period|Sponsor Decision|0
5966135|NCT01160289|20632477|P3|Post-Randomization Period|Sponsor Decision|0
5966136|NCT01160289|20632478|P2|Post-Randomization Period|Sponsor Decision|1
5966137|NCT01160289|20632479|P1|Post-Randomization Period|Sponsor Decision|0
5966138|NCT01160289|20632474|P6|Post-Randomization Period|Entry Criteria Not Met|0
5966139|NCT01160289|20632475|P5|Post-Randomization Period|Entry Criteria Not Met|0
5966140|NCT01160289|20632476|P4|Post-Randomization Period|Entry Criteria Not Met|2
5966141|NCT01160289|20632477|P3|Post-Randomization Period|Entry Criteria Not Met|2
5966142|NCT01160289|20632478|P2|Post-Randomization Period|Entry Criteria Not Met|2
5966143|NCT01160289|20632479|P1|Post-Randomization Period|Entry Criteria Not Met|0
5966144|NCT01160289|20632474|P6|Post-Randomization Period|Withdrawal by Subject|7
5966145|NCT01160289|20632475|P5|Post-Randomization Period|Withdrawal by Subject|5
5966146|NCT01160289|20632476|P4|Post-Randomization Period|Withdrawal by Subject|8
5966147|NCT01160289|20632477|P3|Post-Randomization Period|Withdrawal by Subject|13
5966148|NCT01160289|20632478|P2|Post-Randomization Period|Withdrawal by Subject|5
5966149|NCT01160289|20632479|P1|Post-Randomization Period|Withdrawal by Subject|0
5966150|NCT01160289|20632474|P6|Post-Randomization Period|Protocol Violation|3
5966151|NCT01160289|20632475|P5|Post-Randomization Period|Protocol Violation|1
5966152|NCT01160289|20632476|P4|Post-Randomization Period|Protocol Violation|0
5966153|NCT01160289|20632477|P3|Post-Randomization Period|Protocol Violation|2
5966154|NCT01160289|20632478|P2|Post-Randomization Period|Protocol Violation|4
5966155|NCT01160289|20632479|P1|Post-Randomization Period|Protocol Violation|0
5966156|NCT01160289|20632474|P6|Post-Randomization Period|Physician Decision|0
5966157|NCT01160289|20632475|P5|Post-Randomization Period|Physician Decision|0
5966158|NCT01160289|20632476|P4|Post-Randomization Period|Physician Decision|0
5966159|NCT01160289|20632477|P3|Post-Randomization Period|Physician Decision|1
5966160|NCT01160289|20632478|P2|Post-Randomization Period|Physician Decision|0
5966161|NCT01160289|20632479|P1|Post-Randomization Period|Physician Decision|0
5966162|NCT01160289|20632474|P6|Post-Randomization Period|Lost to Follow-up|4
5966163|NCT01160289|20632475|P5|Post-Randomization Period|Lost to Follow-up|3
5966164|NCT01160289|20632476|P4|Post-Randomization Period|Lost to Follow-up|5
5966165|NCT01160289|20632477|P3|Post-Randomization Period|Lost to Follow-up|2
5966166|NCT01160289|20632478|P2|Post-Randomization Period|Lost to Follow-up|3
5966167|NCT01160289|20632479|P1|Post-Randomization Period|Lost to Follow-up|0
5966168|NCT01160289|20632474|P6|Post-Randomization Period|Lack of Efficacy|0
5966169|NCT01160289|20632475|P5|Post-Randomization Period|Lack of Efficacy|0
5966170|NCT01160289|20632476|P4|Post-Randomization Period|Lack of Efficacy|3
5966171|NCT01160289|20632477|P3|Post-Randomization Period|Lack of Efficacy|0
5966172|NCT01160289|20632478|P2|Post-Randomization Period|Lack of Efficacy|1
5966173|NCT01160289|20632479|P1|Post-Randomization Period|Lack of Efficacy|0
5966174|NCT01160289|20632474|P6|Post-Randomization Period|Death|0
5966175|NCT01160289|20632475|P5|Post-Randomization Period|Death|0
5966176|NCT01160289|20632476|P4|Post-Randomization Period|Death|1
5966177|NCT01160289|20632477|P3|Post-Randomization Period|Death|0
5966178|NCT01160289|20632478|P2|Post-Randomization Period|Death|0
5966179|NCT01160289|20632479|P1|Post-Randomization Period|Death|0
5966180|NCT01160289|20632474|P6|Post-Randomization Period|Adverse Event|0
5966181|NCT01160289|20632475|P5|Post-Randomization Period|Adverse Event|0
5966182|NCT01160289|20632476|P4|Post-Randomization Period|Adverse Event|2
5966183|NCT01160289|20632477|P3|Post-Randomization Period|Adverse Event|4
5966184|NCT01160289|20632478|P2|Post-Randomization Period|Adverse Event|4
5966185|NCT01160289|20632479|P1|Post-Randomization Period|Adverse Event|0
5966186|NCT01160289|20632474|P6|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0
5966187|NCT01160289|20632475|P5|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0
5966188|NCT01160289|20632476|P4|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0
5966189|NCT01160289|20632477|P3|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0
5966190|NCT01160289|20632478|P2|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0
5966191|NCT01160289|20632479|P1|Screening, Washout, and Lead-In Period|Withdrawal by Subject|64
5966192|NCT01160289|20632474|P6|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0
5966193|NCT01160289|20632475|P5|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0
5966194|NCT01160289|20632476|P4|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0
5966195|NCT01160289|20632477|P3|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0
5966196|NCT01160289|20632478|P2|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0
5966197|NCT01160289|20632479|P1|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|67
5966198|NCT01160289|20632474|P6|Screening, Washout, and Lead-In Period|Protocol Violation|0
5966199|NCT01160289|20632475|P5|Screening, Washout, and Lead-In Period|Protocol Violation|0
5966200|NCT01160289|20632476|P4|Screening, Washout, and Lead-In Period|Protocol Violation|0
5966201|NCT01160289|20632477|P3|Screening, Washout, and Lead-In Period|Protocol Violation|0
5966202|NCT01160289|20632478|P2|Screening, Washout, and Lead-In Period|Protocol Violation|0
5966203|NCT01160289|20632479|P1|Screening, Washout, and Lead-In Period|Protocol Violation|1
5966204|NCT01160289|20632474|P6|Screening, Washout, and Lead-In Period|Physician Decision|0
5966205|NCT01160289|20632475|P5|Screening, Washout, and Lead-In Period|Physician Decision|0
5966206|NCT01160289|20632476|P4|Screening, Washout, and Lead-In Period|Physician Decision|0
5966207|NCT01160289|20632477|P3|Screening, Washout, and Lead-In Period|Physician Decision|0
5966208|NCT01160289|20632478|P2|Screening, Washout, and Lead-In Period|Physician Decision|0
5966209|NCT01160289|20632479|P1|Screening, Washout, and Lead-In Period|Physician Decision|26
5966210|NCT01160289|20632474|P6|Screening, Washout, and Lead-In Period|Lost to Follow-up|0
5966211|NCT01160289|20632475|P5|Screening, Washout, and Lead-In Period|Lost to Follow-up|0
5966212|NCT01160289|20632476|P4|Screening, Washout, and Lead-In Period|Lost to Follow-up|0
5966213|NCT01160289|20632477|P3|Screening, Washout, and Lead-In Period|Lost to Follow-up|0
5966214|NCT01160289|20632478|P2|Screening, Washout, and Lead-In Period|Lost to Follow-up|0
5966215|NCT01160289|20632479|P1|Screening, Washout, and Lead-In Period|Lost to Follow-up|9
5966216|NCT01160289|20632474|P6|Screening, Washout, and Lead-In Period|Lack of Efficacy|0
5966217|NCT01160289|20632475|P5|Screening, Washout, and Lead-In Period|Lack of Efficacy|0
5966218|NCT01160289|20632476|P4|Screening, Washout, and Lead-In Period|Lack of Efficacy|0
5966219|NCT01160289|20632477|P3|Screening, Washout, and Lead-In Period|Lack of Efficacy|0
5966220|NCT01160289|20632478|P2|Screening, Washout, and Lead-In Period|Lack of Efficacy|0
5966221|NCT01160289|20632479|P1|Screening, Washout, and Lead-In Period|Lack of Efficacy|1
5966222|NCT01160289|20632474|P6|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0
5966223|NCT01160289|20632475|P5|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0
5966224|NCT01160289|20632476|P4|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0
5966225|NCT01160289|20632477|P3|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0
5966226|NCT01160289|20632478|P2|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0
5966227|NCT01160289|20632479|P1|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|308
5966228|NCT01160289|20632474|P6|Screening, Washout, and Lead-In Period|Adverse Event|0
5966229|NCT01160289|20632475|P5|Screening, Washout, and Lead-In Period|Adverse Event|0
5966230|NCT01160289|20632476|P4|Screening, Washout, and Lead-In Period|Adverse Event|0
5966231|NCT01160289|20632477|P3|Screening, Washout, and Lead-In Period|Adverse Event|0
5966232|NCT01160289|20632478|P2|Screening, Washout, and Lead-In Period|Adverse Event|0
5966233|NCT01160289|20632479|P1|Screening, Washout, and Lead-In Period|Adverse Event|8
5966234|NCT01160211|20632568|P3|Overall Study|Lost to Follow-up|5
5966235|NCT01160211|20632569|P2|Overall Study|Lost to Follow-up|7
5966236|NCT01160211|20632570|P1|Overall Study|Lost to Follow-up|4
5966237|NCT01160211|20632568|P3|Overall Study|Physician Decision|0
5966238|NCT01160211|20632569|P2|Overall Study|Physician Decision|0
5966239|NCT01160211|20632570|P1|Overall Study|Physician Decision|2
5966240|NCT01160211|20632568|P3|Overall Study|Withdrawal by Subject|3
5966241|NCT01160211|20632569|P2|Overall Study|Withdrawal by Subject|5
5966242|NCT01160211|20632570|P1|Overall Study|Withdrawal by Subject|3
5966243|NCT01160211|20632568|P3|Overall Study|ongoing|79
5966244|NCT01160211|20632569|P2|Overall Study|ongoing|75
5966245|NCT01160211|20632570|P1|Overall Study|ongoing|90
5966246|NCT01160198|20632603|P3|Overall Study|Participant lost drug; withdrew consent|1
5966247|NCT01160198|20632604|P2|Overall Study|Participant lost drug; withdrew consent|0
5966248|NCT01160198|20632605|P1|Overall Study|Participant lost drug; withdrew consent|0
5966249|NCT01160198|20632603|P3|Overall Study|Lost to Follow-up|0
5966250|NCT01160198|20632604|P2|Overall Study|Lost to Follow-up|1
5966251|NCT01160198|20632605|P1|Overall Study|Lost to Follow-up|0
5966252|NCT01160198|20632603|P3|Overall Study|Adverse Event|0
5966253|NCT01160198|20632604|P2|Overall Study|Adverse Event|1
5966254|NCT01160198|20632605|P1|Overall Study|Adverse Event|0
5966255|NCT01160198|20632603|P3|Overall Study|Withdrawal by Subject|0
5966256|NCT01160198|20632604|P2|Overall Study|Withdrawal by Subject|1
5966257|NCT01160198|20632605|P1|Overall Study|Withdrawal by Subject|2
5966258|NCT01159938|20632627|P5|First Study Period|Protocol Violation (Microalbuminuria)|0
5966259|NCT01159938|20632628|P4|First Study Period|Protocol Violation (Microalbuminuria)|0
5966260|NCT01159938|20632629|P3|First Study Period|Protocol Violation (Microalbuminuria)|1
5966261|NCT01159938|20632630|P2|First Study Period|Protocol Violation (Microalbuminuria)|0
5966262|NCT01159938|20632631|P1|First Study Period|Protocol Violation (Microalbuminuria)|0
5966263|NCT01159912|20632694|P3|Overall Study|Withdrawal by Subject|3
5966264|NCT01159912|20632695|P2|Overall Study|Withdrawal by Subject|3
5966265|NCT01159912|20632696|P1|Overall Study|Withdrawal by Subject|10
5966266|NCT01159912|20632694|P3|Overall Study|Physician Decision|3
5966267|NCT01159912|20632695|P2|Overall Study|Physician Decision|0
5966268|NCT01159912|20632696|P1|Overall Study|Physician Decision|0
5966269|NCT01159912|20632694|P3|Overall Study|Lost to Follow-up|0
5966270|NCT01159912|20632695|P2|Overall Study|Lost to Follow-up|0
5966271|NCT01159912|20632696|P1|Overall Study|Lost to Follow-up|4
5966272|NCT01159912|20632694|P3|Overall Study|Protocol Violation|3
5966273|NCT01159912|20632695|P2|Overall Study|Protocol Violation|2
5966274|NCT01159912|20632696|P1|Overall Study|Protocol Violation|1
5966275|NCT01159912|20632694|P3|Overall Study|Lack of Efficacy|14
5966276|NCT01159912|20632695|P2|Overall Study|Lack of Efficacy|15
5966277|NCT01159912|20632696|P1|Overall Study|Lack of Efficacy|23
5966278|NCT01159912|20632694|P3|Overall Study|Adverse Event|3
5966279|NCT01159912|20632695|P2|Overall Study|Adverse Event|2
5966280|NCT01159912|20632696|P1|Overall Study|Adverse Event|2
5966281|NCT01159769|20632719|P1|Overall Study|Adverse Event|1
5966282|NCT01159691|20632739|P1|Overall Study|Disc. Neupro lack of efficacy & unknown|1
5966283|NCT01159691|20632739|P1|Overall Study|Disc. Neupro due to AE & unknown reasons|2
5966284|NCT01159691|20632739|P1|Overall Study|Disc. Neupro other & unknown reasons|7
5966285|NCT01159691|20632739|P1|Overall Study|Disc. Neupro other & lost to follow-up|2
5966286|NCT01159691|20632739|P1|Overall Study|Discontinued Neupro due to other reasons|1
5966287|NCT01159691|20632739|P1|Overall Study|Discontinued Neupro due to Adverse Event|6
5966288|NCT01159691|20632739|P1|Overall Study|Unknown reasons|1
5966289|NCT01159691|20632739|P1|Overall Study|Lost to Follow-up|2
5966290|NCT01159665|20632752|P6|Overall Study|Withdrawal by Subject|0
5966291|NCT01159665|20632753|P5|Overall Study|Withdrawal by Subject|0
5966292|NCT01159665|20632754|P4|Overall Study|Withdrawal by Subject|0
5966293|NCT01159665|20632755|P3|Overall Study|Withdrawal by Subject|0
5966294|NCT01159665|20632756|P2|Overall Study|Withdrawal by Subject|1
5966295|NCT01159665|20632757|P1|Overall Study|Withdrawal by Subject|0
5966296|NCT01159600|20632785|P8|Overall Study|Other reason not defined above|3
5966297|NCT01159600|20632786|P7|Overall Study|Other reason not defined above|3
5966298|NCT01159600|20632787|P6|Overall Study|Other reason not defined above|7
5966299|NCT01159600|20632788|P5|Overall Study|Other reason not defined above|5
5966300|NCT01159600|20632789|P4|Overall Study|Other reason not defined above|2
5966301|NCT01159600|20632790|P3|Overall Study|Other reason not defined above|4
5966302|NCT01159600|20632791|P2|Overall Study|Other reason not defined above|0
5966303|NCT01159600|20632792|P1|Overall Study|Other reason not defined above|3
5966304|NCT01159600|20632785|P8|Overall Study|Patient refusal to continue,not due toAE|5
5966305|NCT01159600|20632786|P7|Overall Study|Patient refusal to continue,not due toAE|2
5966306|NCT01159600|20632787|P6|Overall Study|Patient refusal to continue,not due toAE|4
5966307|NCT01159600|20632788|P5|Overall Study|Patient refusal to continue,not due toAE|4
5966308|NCT01159600|20632789|P4|Overall Study|Patient refusal to continue,not due toAE|5
5966309|NCT01159600|20632790|P3|Overall Study|Patient refusal to continue,not due toAE|4
5966310|NCT01159600|20632791|P2|Overall Study|Patient refusal to continue,not due toAE|2
5966311|NCT01159600|20632792|P1|Overall Study|Patient refusal to continue,not due toAE|7
5966312|NCT01159600|20632785|P8|Overall Study|Lost to Follow-up|2
5966313|NCT01159600|20632786|P7|Overall Study|Lost to Follow-up|3
5966314|NCT01159600|20632787|P6|Overall Study|Lost to Follow-up|0
5966315|NCT01159600|20632788|P5|Overall Study|Lost to Follow-up|3
5966316|NCT01159600|20632789|P4|Overall Study|Lost to Follow-up|3
5966317|NCT01159600|20632790|P3|Overall Study|Lost to Follow-up|4
5966318|NCT01159600|20632791|P2|Overall Study|Lost to Follow-up|3
5966319|NCT01159600|20632792|P1|Overall Study|Lost to Follow-up|2
5966320|NCT01159600|20632785|P8|Overall Study|Non compliant with protocol|0
5966321|NCT01159600|20632786|P7|Overall Study|Non compliant with protocol|2
5966322|NCT01159600|20632787|P6|Overall Study|Non compliant with protocol|0
5966323|NCT01159600|20632788|P5|Overall Study|Non compliant with protocol|2
5966324|NCT01159600|20632789|P4|Overall Study|Non compliant with protocol|0
5966325|NCT01159600|20632790|P3|Overall Study|Non compliant with protocol|0
5966326|NCT01159600|20632791|P2|Overall Study|Non compliant with protocol|1
5966327|NCT01159600|20632792|P1|Overall Study|Non compliant with protocol|2
5966328|NCT01159600|20632785|P8|Overall Study|Lack of Efficacy|1
5966329|NCT01159600|20632786|P7|Overall Study|Lack of Efficacy|0
5966330|NCT01159600|20632787|P6|Overall Study|Lack of Efficacy|0
5966331|NCT01159600|20632788|P5|Overall Study|Lack of Efficacy|2
5966332|NCT01159600|20632789|P4|Overall Study|Lack of Efficacy|0
5966333|NCT01159600|20632790|P3|Overall Study|Lack of Efficacy|0
5966334|NCT01159600|20632791|P2|Overall Study|Lack of Efficacy|0
5966335|NCT01159600|20632792|P1|Overall Study|Lack of Efficacy|0
5966336|NCT01159600|20632785|P8|Overall Study|Adverse Event|5
5966337|NCT01159600|20632786|P7|Overall Study|Adverse Event|7
5966338|NCT01159600|20632787|P6|Overall Study|Adverse Event|6
5966339|NCT01159600|20632788|P5|Overall Study|Adverse Event|8
5966340|NCT01159600|20632789|P4|Overall Study|Adverse Event|1
5966341|NCT01159600|20632790|P3|Overall Study|Adverse Event|5
5966342|NCT01159600|20632791|P2|Overall Study|Adverse Event|2
5966343|NCT01159600|20632792|P1|Overall Study|Adverse Event|7
5966344|NCT01159600|20632785|P8|Overall Study|Not treated|2
5966345|NCT01159600|20632786|P7|Overall Study|Not treated|2
5966346|NCT01159600|20632787|P6|Overall Study|Not treated|1
5966347|NCT01159600|20632788|P5|Overall Study|Not treated|0
5966348|NCT01159600|20632789|P4|Overall Study|Not treated|0
5966349|NCT01159600|20632790|P3|Overall Study|Not treated|1
5966350|NCT01159600|20632791|P2|Overall Study|Not treated|0
5966351|NCT01159600|20632792|P1|Overall Study|Not treated|0
5966352|NCT01159574|20632834|P1|Follow Up Phase|still being followed for overall surviva|18
5966353|NCT01159574|20632834|P1|Follow Up Phase|Lost to Follow-up|2
5966354|NCT01159574|20632834|P1|Treatment Phase|still on treatment|2
5966355|NCT01159574|20632834|P1|Treatment Phase|Withdrawal by Subject|7
5966356|NCT01159574|20632834|P1|Treatment Phase|Physician Decision|2
5966357|NCT01159574|20632834|P1|Treatment Phase|Death|6
5966358|NCT01159574|20632834|P1|Treatment Phase|Adverse Event|3
5966359|NCT01159574|20632834|P1|Treatment Phase|non-evaluable/not included in analysis|1
5966360|NCT01159431|20632855|P2|Overall Study|Lack of Efficacy|3
5966361|NCT01159431|20632856|P1|Overall Study|Lack of Efficacy|0
5966362|NCT01159431|20632855|P2|Overall Study|non-compliance|1
5966363|NCT01159431|20632856|P1|Overall Study|non-compliance|1
5966364|NCT01159431|20632855|P2|Overall Study|Adverse Event|2
5966365|NCT01159431|20632856|P1|Overall Study|Adverse Event|1
5966366|NCT01159171|20632909|P1|Overall Study|Death|1
5966367|NCT01159171|20632909|P1|Overall Study|Medical Decision|4
5966368|NCT01159171|20632909|P1|Overall Study|Need for Surgery|5
5966369|NCT01159171|20632909|P1|Overall Study|Protocol Violation|1
5966370|NCT01159171|20632909|P1|Overall Study|Progression of Disease|28
5966371|NCT01159171|20632909|P1|Overall Study|Adverse Event|11
5966372|NCT01158950|20632997|P2|1st Intervention (1 Day)|Physician Decision|2
5966373|NCT01158950|20632998|P1|1st Intervention (1 Day)|Physician Decision|1
5966374|NCT01158924|20633006|P2|Overall Study|Lost to Follow-up|1
5966375|NCT01158924|20633007|P1|Overall Study|Lost to Follow-up|0
5966376|NCT01158924|20633006|P2|Overall Study|Withdrawal by Subject|2
5966377|NCT01158924|20633007|P1|Overall Study|Withdrawal by Subject|1
5966378|NCT01158534|20633112|P1|Overall Study|Other|1
5966379|NCT01158534|20633112|P1|Overall Study|Death|1
5966380|NCT01158534|20633112|P1|Overall Study|Withdrawal by Subject|1
5966381|NCT01158404|20633137|P8|Overall Study|Progressive Disease|0
5966382|NCT01158404|20633138|P7|Overall Study|Progressive Disease|1
5966383|NCT01158404|20633139|P6|Overall Study|Progressive Disease|0
5966384|NCT01158404|20633140|P5|Overall Study|Progressive Disease|0
5966385|NCT01158404|20633141|P4|Overall Study|Progressive Disease|0
5966386|NCT01158404|20633142|P3|Overall Study|Progressive Disease|0
5966387|NCT01158404|20633143|P2|Overall Study|Progressive Disease|0
5966388|NCT01158404|20633144|P1|Overall Study|Progressive Disease|0
5966389|NCT01158404|20633137|P8|Overall Study|Physician Decision|1
5966390|NCT01158404|20633138|P7|Overall Study|Physician Decision|0
5966391|NCT01158404|20633139|P6|Overall Study|Physician Decision|0
5966392|NCT01158404|20633140|P5|Overall Study|Physician Decision|0
5966393|NCT01158404|20633141|P4|Overall Study|Physician Decision|0
5966394|NCT01158404|20633142|P3|Overall Study|Physician Decision|0
5966395|NCT01158404|20633143|P2|Overall Study|Physician Decision|0
5966396|NCT01158404|20633144|P1|Overall Study|Physician Decision|0
5966397|NCT01158404|20633137|P8|Overall Study|Withdrawal by Subject|1
5966398|NCT01158404|20633138|P7|Overall Study|Withdrawal by Subject|0
5966399|NCT01158404|20633139|P6|Overall Study|Withdrawal by Subject|1
5966400|NCT01158404|20633140|P5|Overall Study|Withdrawal by Subject|3
5966401|NCT01158404|20633141|P4|Overall Study|Withdrawal by Subject|0
5966402|NCT01158404|20633142|P3|Overall Study|Withdrawal by Subject|0
5966403|NCT01158404|20633143|P2|Overall Study|Withdrawal by Subject|1
5966404|NCT01158404|20633144|P1|Overall Study|Withdrawal by Subject|0
5966405|NCT01158378|20633186|P2|Overall Study|Withdrawal by Subject|0
5966406|NCT01158378|20633187|P1|Overall Study|Withdrawal by Subject|4
5966407|NCT01158378|20633186|P2|Overall Study|Lost to Follow-up|4
5966408|NCT01158378|20633187|P1|Overall Study|Lost to Follow-up|2
5966409|NCT01158378|20633186|P2|Overall Study|Death|5
5966410|NCT01158378|20633187|P1|Overall Study|Death|4
5966411|NCT01158261|20633199|P1|Overall Study|Withdrawal by Subject|1
5966412|NCT01158261|20633199|P1|Overall Study|Death|7
5966413|NCT01158261|20633199|P1|Overall Study|Lost to Follow-up|9
5966414|NCT01158222|20633203|P1|Overall Study|Not eligible for intermediate phase|17
5966415|NCT01158118|20633215|P2|Overall Study|Death|1
5966416|NCT01158118|20633216|P1|Overall Study|Death|0
5966417|NCT01158118|20633215|P2|Overall Study|Suffered stroke prior to transplant|1
5966418|NCT01158118|20633216|P1|Overall Study|Suffered stroke prior to transplant|0
5966419|NCT01158118|20633215|P2|Overall Study|Donor match was a screen failure|1
5966420|NCT01158118|20633216|P1|Overall Study|Donor match was a screen failure|0
5966421|NCT01158118|20633215|P2|Overall Study|Screen failure|0
5966422|NCT01158118|20633216|P1|Overall Study|Screen failure|1
5966423|NCT01157897|20633236|P4|Overall Study|Relocated|0
5966424|NCT01157897|20633237|P3|Overall Study|Relocated|0
5966425|NCT01157897|20633238|P2|Overall Study|Relocated|2
5966426|NCT01157897|20633239|P1|Overall Study|Relocated|0
5966427|NCT01157897|20633236|P4|Overall Study|Lost to Follow-up|1
5966428|NCT01157897|20633237|P3|Overall Study|Lost to Follow-up|0
5966429|NCT01157897|20633238|P2|Overall Study|Lost to Follow-up|0
5966430|NCT01157897|20633239|P1|Overall Study|Lost to Follow-up|2
5966431|NCT01157845|20633264|P1|Overall Study|Device malfunction|1
5966432|NCT01157845|20633264|P1|Overall Study|Study was ended|1
5966433|NCT01157845|20633264|P1|Overall Study|Protocol Violation|13
5966434|NCT01157845|20633264|P1|Overall Study|Physician Decision|3
5966435|NCT01157845|20633264|P1|Overall Study|Withdrawal by Subject|12
5966436|NCT01157845|20633264|P1|Overall Study|Lost to Follow-up|5
5966437|NCT01157676|20633271|P2|Surgery|underwent robotic cystectomy|0
5966438|NCT01157676|20633272|P1|Surgery|underwent robotic cystectomy|1
5966439|NCT01157676|20633271|P2|Surgery|converted to open procedure|5
5966440|NCT01157676|20633272|P1|Surgery|converted to open procedure|0
5966441|NCT01157676|20633271|P2|Surgery|underwent open cystectomy|4
5966442|NCT01157676|20633272|P1|Surgery|underwent open cystectomy|0
5966443|NCT01157676|20633271|P2|Randomization|Physician Decision|0
5966444|NCT01157676|20633272|P1|Randomization|Physician Decision|1
5966445|NCT01157676|20633271|P2|Randomization|Withdrawal by Subject|13
5966446|NCT01157676|20633272|P1|Randomization|Withdrawal by Subject|17
5966447|NCT01157676|20633271|P2|Randomization|unresectable|3
5966448|NCT01157676|20633272|P1|Randomization|unresectable|2
5966449|NCT01157676|20633271|P2|Randomization|Death|1
5966450|NCT01157676|20633272|P1|Randomization|Death|1
5966451|NCT01157377|20633347|P7|Overall Study|Other Miscellaneous Reasons|1
5966452|NCT01157377|20633348|P6|Overall Study|Other Miscellaneous Reasons|1
5966453|NCT01157377|20633349|P5|Overall Study|Other Miscellaneous Reasons|1
5966454|NCT01157377|20633350|P4|Overall Study|Other Miscellaneous Reasons|0
5966455|NCT01157377|20633351|P3|Overall Study|Other Miscellaneous Reasons|0
5966456|NCT01157377|20633352|P2|Overall Study|Other Miscellaneous Reasons|2
5966457|NCT01157377|20633353|P1|Overall Study|Other Miscellaneous Reasons|0
5966458|NCT01157377|20633347|P7|Overall Study|Lack of Efficacy|1
5966459|NCT01157377|20633348|P6|Overall Study|Lack of Efficacy|0
5966460|NCT01157377|20633349|P5|Overall Study|Lack of Efficacy|0
5966461|NCT01157377|20633350|P4|Overall Study|Lack of Efficacy|0
5966462|NCT01157377|20633351|P3|Overall Study|Lack of Efficacy|0
5966463|NCT01157377|20633352|P2|Overall Study|Lack of Efficacy|0
5966464|NCT01157377|20633353|P1|Overall Study|Lack of Efficacy|0
5966465|NCT01157377|20633347|P7|Overall Study|Protocol Violation|0
5966466|NCT01157377|20633348|P6|Overall Study|Protocol Violation|1
5966467|NCT01157377|20633349|P5|Overall Study|Protocol Violation|0
5966468|NCT01157377|20633350|P4|Overall Study|Protocol Violation|0
5966469|NCT01157377|20633351|P3|Overall Study|Protocol Violation|0
5966470|NCT01157377|20633352|P2|Overall Study|Protocol Violation|0
5966471|NCT01157377|20633353|P1|Overall Study|Protocol Violation|0
5966472|NCT01157377|20633347|P7|Overall Study|Personal Reasons|0
5966473|NCT01157377|20633348|P6|Overall Study|Personal Reasons|0
5966474|NCT01157377|20633349|P5|Overall Study|Personal Reasons|0
5966475|NCT01157377|20633350|P4|Overall Study|Personal Reasons|1
5966476|NCT01157377|20633351|P3|Overall Study|Personal Reasons|0
5966477|NCT01157377|20633352|P2|Overall Study|Personal Reasons|1
5966478|NCT01157377|20633353|P1|Overall Study|Personal Reasons|2
5966479|NCT01157377|20633347|P7|Overall Study|Lost to Follow-up|0
5966480|NCT01157377|20633348|P6|Overall Study|Lost to Follow-up|1
5966481|NCT01157377|20633349|P5|Overall Study|Lost to Follow-up|1
5966482|NCT01157377|20633350|P4|Overall Study|Lost to Follow-up|0
5966483|NCT01157377|20633351|P3|Overall Study|Lost to Follow-up|1
5966484|NCT01157377|20633352|P2|Overall Study|Lost to Follow-up|0
5966485|NCT01157377|20633353|P1|Overall Study|Lost to Follow-up|0
5966486|NCT01157364|20633375|P6|Overall Study|Adverse Event|0
5966487|NCT01157364|20633376|P5|Overall Study|Adverse Event|1
5966488|NCT01157364|20633377|P4|Overall Study|Adverse Event|0
5966489|NCT01157364|20633378|P3|Overall Study|Adverse Event|1
5966490|NCT01157364|20633379|P2|Overall Study|Adverse Event|1
5966491|NCT01157364|20633380|P1|Overall Study|Adverse Event|0
5966492|NCT01157364|20633375|P6|Overall Study|Lack of Efficacy|0
5966493|NCT01157364|20633376|P5|Overall Study|Lack of Efficacy|0
5966494|NCT01157364|20633377|P4|Overall Study|Lack of Efficacy|1
5966495|NCT01157364|20633378|P3|Overall Study|Lack of Efficacy|0
5966496|NCT01157364|20633379|P2|Overall Study|Lack of Efficacy|0
5966497|NCT01157364|20633380|P1|Overall Study|Lack of Efficacy|0
5966498|NCT01157364|20633375|P6|Overall Study|Lost to Follow-up|0
5966499|NCT01157364|20633376|P5|Overall Study|Lost to Follow-up|0
5966500|NCT01157364|20633377|P4|Overall Study|Lost to Follow-up|0
5966501|NCT01157364|20633378|P3|Overall Study|Lost to Follow-up|1
5966502|NCT01157364|20633379|P2|Overall Study|Lost to Follow-up|0
5966503|NCT01157364|20633380|P1|Overall Study|Lost to Follow-up|1
5966504|NCT01157364|20633375|P6|Overall Study|Personal Reasons|1
5966505|NCT01157364|20633376|P5|Overall Study|Personal Reasons|1
5966506|NCT01157364|20633377|P4|Overall Study|Personal Reasons|0
5966507|NCT01157364|20633378|P3|Overall Study|Personal Reasons|0
5966508|NCT01157364|20633379|P2|Overall Study|Personal Reasons|2
5966509|NCT01157364|20633380|P1|Overall Study|Personal Reasons|0
5966510|NCT01157364|20633375|P6|Overall Study|Other Reasons|0
5966511|NCT01157364|20633376|P5|Overall Study|Other Reasons|0
5966512|NCT01157364|20633377|P4|Overall Study|Other Reasons|1
5966513|NCT01157364|20633378|P3|Overall Study|Other Reasons|2
5966514|NCT01157364|20633379|P2|Overall Study|Other Reasons|1
5966515|NCT01157364|20633380|P1|Overall Study|Other Reasons|1
5966516|NCT01157351|20633414|P2|Overall Study|Randomized but not Treated|2
5966517|NCT01157351|20633415|P1|Overall Study|Randomized but not Treated|4
5966518|NCT01157351|20633414|P2|Overall Study|Noncompliance with Study Drug|3
5966519|NCT01157351|20633415|P1|Overall Study|Noncompliance with Study Drug|0
5966520|NCT01157351|20633414|P2|Overall Study|Other|36
5966521|NCT01157351|20633415|P1|Overall Study|Other|32
5966522|NCT01157351|20633414|P2|Overall Study|Protocol Violation|1
5966523|NCT01157351|20633415|P1|Overall Study|Protocol Violation|0
5966524|NCT01157351|20633414|P2|Overall Study|Physician Decision|4
5966525|NCT01157351|20633415|P1|Overall Study|Physician Decision|5
5966526|NCT01157351|20633414|P2|Overall Study|Withdrawal by Subject|27
5966527|NCT01157351|20633415|P1|Overall Study|Withdrawal by Subject|37
5966528|NCT01157351|20633414|P2|Overall Study|Lost to Follow-up|55
5966529|NCT01157351|20633415|P1|Overall Study|Lost to Follow-up|53
5966530|NCT01157351|20633414|P2|Overall Study|Death|0
5966531|NCT01157351|20633415|P1|Overall Study|Death|1
5966532|NCT01157351|20633414|P2|Overall Study|Adverse Event|4
5966533|NCT01157351|20633415|P1|Overall Study|Adverse Event|5
5966534|NCT01157234|20633433|P2|Overall Study|Withdrawal by Subject|0
5966535|NCT01157234|20633434|P1|Overall Study|Withdrawal by Subject|1
5966536|NCT01157182|20633466|P2|Washout of 28 Days|Adverse Event|0
5966537|NCT01157182|20633467|P1|Washout of 28 Days|Adverse Event|2
5966538|NCT01157169|20633515|P2|Second Intervention|Emesis Within 4 hrs of Administration|1
5966539|NCT01157169|20633516|P1|Second Intervention|Emesis Within 4 hrs of Administration|0
5966540|NCT01157169|20633515|P2|First Intervention|Emesis Within 4 hrs of Administration|2
5966541|NCT01157169|20633516|P1|First Intervention|Emesis Within 4 hrs of Administration|4
5966542|NCT01157117|20633535|P3|Overall Study|Unknown (Pending Final Form Submission)|13
5966543|NCT01157117|20633536|P2|Overall Study|Unknown (Pending Final Form Submission)|5
5966544|NCT01157117|20633537|P1|Overall Study|Unknown (Pending Final Form Submission)|4
5966545|NCT01157117|20633535|P3|Overall Study|Lost to Follow-up|1
5966546|NCT01157117|20633536|P2|Overall Study|Lost to Follow-up|0
5966547|NCT01157117|20633537|P1|Overall Study|Lost to Follow-up|0
5966548|NCT01157117|20633535|P3|Overall Study|Lack of Efficacy|0
5966549|NCT01157117|20633536|P2|Overall Study|Lack of Efficacy|1
5966550|NCT01157117|20633537|P1|Overall Study|Lack of Efficacy|1
5966551|NCT01157117|20633535|P3|Overall Study|Withdrawal by Subject|1
5966552|NCT01157117|20633536|P2|Overall Study|Withdrawal by Subject|1
5966553|NCT01157117|20633537|P1|Overall Study|Withdrawal by Subject|4
5966554|NCT01157117|20633535|P3|Overall Study|Dosing Symptoms|0
5966555|NCT01157117|20633536|P2|Overall Study|Dosing Symptoms|4
5966556|NCT01157117|20633537|P1|Overall Study|Dosing Symptoms|0
5966557|NCT01157078|20633578|P2|Overall Study|Other|4
5966558|NCT01157078|20633579|P1|Overall Study|Other|2
5966559|NCT01157078|20633578|P2|Overall Study|Lost to Follow-up|5
5966560|NCT01157078|20633579|P1|Overall Study|Lost to Follow-up|7
5966561|NCT01157078|20633578|P2|Overall Study|Study-specific withdrawal criteria|2
5966562|NCT01157078|20633579|P1|Overall Study|Study-specific withdrawal criteria|2
5966563|NCT01157078|20633578|P2|Overall Study|Lack of Efficacy|0
5966564|NCT01157078|20633579|P1|Overall Study|Lack of Efficacy|2
5966565|NCT01157078|20633578|P2|Overall Study|Condition under investigation worsened|1
5966566|NCT01157078|20633579|P1|Overall Study|Condition under investigation worsened|0
5966567|NCT01157078|20633578|P2|Overall Study|Severe non-compliance to protocol|4
5966568|NCT01157078|20633579|P1|Overall Study|Severe non-compliance to protocol|2
5966569|NCT01157078|20633578|P2|Overall Study|Adverse Event|6
5966570|NCT01157078|20633579|P1|Overall Study|Adverse Event|6
5966571|NCT01157078|20633578|P2|Overall Study|Eligibility criteria not fulfilled|0
5966572|NCT01157078|20633579|P1|Overall Study|Eligibility criteria not fulfilled|2
5966573|NCT01157078|20633578|P2|Overall Study|Withdrawal by Subject|14
5966574|NCT01157078|20633579|P1|Overall Study|Withdrawal by Subject|12
5966575|NCT01157065|20633629|P2|Overall Study|Death|1
5966576|NCT01157065|20633630|P1|Overall Study|Death|0
5966577|NCT01156844|20633651|P4|Overall Study|Protocol deviation|0
5966578|NCT01156844|20633652|P3|Overall Study|Protocol deviation|0
5966579|NCT01156844|20633653|P2|Overall Study|Protocol deviation|0
5966580|NCT01156844|20633654|P1|Overall Study|Protocol deviation|2
5966581|NCT01156844|20633651|P4|Overall Study|Administrative problems|1
5966582|NCT01156844|20633652|P3|Overall Study|Administrative problems|0
5966583|NCT01156844|20633653|P2|Overall Study|Administrative problems|1
5966584|NCT01156844|20633654|P1|Overall Study|Administrative problems|0
5966585|NCT01156844|20633651|P4|Overall Study|Lost to Follow-up|0
5966586|NCT01156844|20633652|P3|Overall Study|Lost to Follow-up|1
5966587|NCT01156844|20633653|P2|Overall Study|Lost to Follow-up|0
5966588|NCT01156844|20633654|P1|Overall Study|Lost to Follow-up|0
5966589|NCT01156844|20633651|P4|Overall Study|Withdrawal by Subject|2
5966590|NCT01156844|20633652|P3|Overall Study|Withdrawal by Subject|2
5966591|NCT01156844|20633653|P2|Overall Study|Withdrawal by Subject|0
5966592|NCT01156844|20633654|P1|Overall Study|Withdrawal by Subject|0
5966593|NCT01156844|20633651|P4|Overall Study|Abnormal test procedure result(s)|2
5966594|NCT01156844|20633652|P3|Overall Study|Abnormal test procedure result(s)|2
5966595|NCT01156844|20633653|P2|Overall Study|Abnormal test procedure result(s)|1
5966596|NCT01156844|20633654|P1|Overall Study|Abnormal test procedure result(s)|0
5966597|NCT01156844|20633651|P4|Overall Study|Adverse Event|1
5966598|NCT01156844|20633652|P3|Overall Study|Adverse Event|1
5966599|NCT01156844|20633653|P2|Overall Study|Adverse Event|0
5966600|NCT01156844|20633654|P1|Overall Study|Adverse Event|0
5966601|NCT01156792|20633688|P1|Overall Study|other Sponsor Decision (Protocol Amendme|11
5966602|NCT01156792|20633688|P1|Overall Study|Withdrawal by Subject|9
5966603|NCT01156792|20633688|P1|Overall Study|Physician Decision|3
5966604|NCT01156792|20633688|P1|Overall Study|Lost to Follow-up|3
5966605|NCT01156792|20633688|P1|Overall Study|Protocol Violation|6
5966606|NCT01156792|20633688|P1|Overall Study|Lack of Efficacy|36
5966607|NCT01156792|20633688|P1|Overall Study|Adverse Event|1
5966608|NCT01156714|20633756|P3|Overall Study|Withdrawal by Subject|3
5966609|NCT01156714|20633757|P2|Overall Study|Withdrawal by Subject|4
5966610|NCT01156714|20633758|P1|Overall Study|Withdrawal by Subject|9
5966611|NCT01156675|20633821|P3|Overall Study|No data|2
5966612|NCT01156675|20633822|P2|Overall Study|No data|22
5966613|NCT01156675|20633823|P1|Overall Study|No data|29
5966614|NCT01156675|20633821|P3|Overall Study|Death|0
5966615|NCT01156675|20633822|P2|Overall Study|Death|3
5966616|NCT01156675|20633823|P1|Overall Study|Death|5
5966617|NCT01156532|20633881|P1|Overall Study|Lost to Follow-up|1
5966618|NCT01156532|20633881|P1|Overall Study|Family Reasons|1
5966619|NCT01156480|20633893|P2|Overall Study|change in diagnosis|1
5966620|NCT01156480|20633894|P1|Overall Study|change in diagnosis|0
5966621|NCT01156376|20633923|P3|Overall Study|Withdrawal by Subject|3
5966622|NCT01156376|20633924|P2|Overall Study|Withdrawal by Subject|0
5966623|NCT01156376|20633925|P1|Overall Study|Withdrawal by Subject|0
5966624|NCT01156376|20633923|P3|Overall Study|Adverse Event|1
5966625|NCT01156376|20633924|P2|Overall Study|Adverse Event|0
5966626|NCT01156376|20633925|P1|Overall Study|Adverse Event|1
5966627|NCT01156363|20634146|P1|Overall Study|Other|6
5966628|NCT01156363|20634146|P1|Overall Study|Refused Treatment|4
5966629|NCT01156363|20634146|P1|Overall Study|Failure to Return|1
5966630|NCT01156363|20634146|P1|Overall Study|Insufficient Therapeutic Response|5
5966631|NCT01156363|20634146|P1|Overall Study|Adverse Event|6
5966632|NCT01156311|20634168|P4|6-month Add-on Therapy Period|Other|2
5966633|NCT01156311|20634169|P3|6-month Add-on Therapy Period|Other|1
5966634|NCT01156311|20634170|P2|6-month Add-on Therapy Period|Other|0
5966635|NCT01156311|20634171|P1|6-month Add-on Therapy Period|Other|0
5966636|NCT01156311|20634168|P4|6-month Add-on Therapy Period|Physician Decision|0
5966637|NCT01156311|20634169|P3|6-month Add-on Therapy Period|Physician Decision|1
5966638|NCT01156311|20634170|P2|6-month Add-on Therapy Period|Physician Decision|0
5966639|NCT01156311|20634171|P1|6-month Add-on Therapy Period|Physician Decision|0
5966640|NCT01156311|20634168|P4|6-month Add-on Therapy Period|Disease Activity|2
5966641|NCT01156311|20634169|P3|6-month Add-on Therapy Period|Disease Activity|1
5966642|NCT01156311|20634170|P2|6-month Add-on Therapy Period|Disease Activity|0
5966643|NCT01156311|20634171|P1|6-month Add-on Therapy Period|Disease Activity|0
5966644|NCT01156311|20634168|P4|6-month Add-on Therapy Period|Lost to Follow-up|0
5966645|NCT01156311|20634169|P3|6-month Add-on Therapy Period|Lost to Follow-up|2
5966646|NCT01156311|20634170|P2|6-month Add-on Therapy Period|Lost to Follow-up|0
5966647|NCT01156311|20634171|P1|6-month Add-on Therapy Period|Lost to Follow-up|0
5966648|NCT01156311|20634168|P4|6-month Add-on Therapy Period|Adverse Event|6
5966649|NCT01156311|20634169|P3|6-month Add-on Therapy Period|Adverse Event|7
5966650|NCT01156311|20634170|P2|6-month Add-on Therapy Period|Adverse Event|0
5966651|NCT01156311|20634171|P1|6-month Add-on Therapy Period|Adverse Event|0
5966652|NCT01156311|20634168|P4|2-Month Monotherapy Period|Other|0
5966653|NCT01156311|20634169|P3|2-Month Monotherapy Period|Other|0
5966654|NCT01156311|20634170|P2|2-Month Monotherapy Period|Other|0
5966655|NCT01156311|20634171|P1|2-Month Monotherapy Period|Other|1
5966656|NCT01156311|20634168|P4|2-Month Monotherapy Period|Physician Decision|0
5966657|NCT01156311|20634169|P3|2-Month Monotherapy Period|Physician Decision|0
5966658|NCT01156311|20634170|P2|2-Month Monotherapy Period|Physician Decision|1
5966659|NCT01156311|20634171|P1|2-Month Monotherapy Period|Physician Decision|0
5966660|NCT01156311|20634168|P4|2-Month Monotherapy Period|Withdrawal by Subject|0
5966661|NCT01156311|20634169|P3|2-Month Monotherapy Period|Withdrawal by Subject|0
5966662|NCT01156311|20634170|P2|2-Month Monotherapy Period|Withdrawal by Subject|1
5966663|NCT01156311|20634171|P1|2-Month Monotherapy Period|Withdrawal by Subject|1
5966664|NCT01156142|20634195|P2|Overall Study|Ineligible|1
5966665|NCT01156142|20634196|P1|Overall Study|Ineligible|0
5966666|NCT01156142|20634195|P2|Overall Study|Withdrawal by Subject|6
5966667|NCT01156142|20634196|P1|Overall Study|Withdrawal by Subject|8
5966668|NCT01156116|20634214|P2|Overall Study|CPAP intolerance|0
5966669|NCT01156116|20634215|P1|Overall Study|CPAP intolerance|2
5966670|NCT01156116|20634214|P2|Overall Study|Withdrawal by Subject|1
5966671|NCT01156116|20634215|P1|Overall Study|Withdrawal by Subject|3
5966672|NCT01156051|20634229|P2|Overall Study|patient not compliant with protocol|1
5966673|NCT01156051|20634230|P1|Overall Study|patient not compliant with protocol|0
5966674|NCT01156051|20634229|P2|Overall Study|Lost to Follow-up|0
5966675|NCT01156051|20634230|P1|Overall Study|Lost to Follow-up|1
5966676|NCT01156012|20634244|P2|Overall Study|Non respect of one of inclusion criteria|1
5966677|NCT01156012|20634245|P1|Overall Study|Non respect of one of inclusion criteria|2
5966678|NCT01156012|20634244|P2|Overall Study|use of commercial drug instead of study|1
5966679|NCT01156012|20634245|P1|Overall Study|use of commercial drug instead of study|0
5966680|NCT01156012|20634244|P2|Overall Study|Withdrawal by Subject|0
5966681|NCT01156012|20634245|P1|Overall Study|Withdrawal by Subject|1
5966682|NCT01156012|20634244|P2|Overall Study|Lost to Follow-up|0
5966683|NCT01156012|20634245|P1|Overall Study|Lost to Follow-up|1
5966684|NCT01156012|20634244|P2|Overall Study|Adverse Event|1
5966685|NCT01156012|20634245|P1|Overall Study|Adverse Event|3
5966686|NCT01155869|20634262|P2|Overall Study|Lost to Follow-up|1
5966687|NCT01155869|20634263|P1|Overall Study|Lost to Follow-up|3
5966688|NCT01155726|20634372|P4|Period 1, 3 Days (Masked)|Inconvenience|0
5966689|NCT01155726|20634373|P3|Period 1, 3 Days (Masked)|Inconvenience|2
5966690|NCT01155726|20634374|P2|Period 1, 3 Days (Masked)|Inconvenience|0
5966691|NCT01155726|20634375|P1|Period 1, 3 Days (Masked)|Inconvenience|1
5966692|NCT01155661|20634397|P1|Overall Study|Sponsor Decision|13
5966693|NCT01155661|20634397|P1|Overall Study|Withdrawal by Subject|73
5966694|NCT01155661|20634397|P1|Overall Study|Protocol Violation|35
5966695|NCT01155661|20634397|P1|Overall Study|Physician Decision|3
5966696|NCT01155661|20634397|P1|Overall Study|Lost to Follow-up|22
5966697|NCT01155661|20634397|P1|Overall Study|Lack of Efficacy|32
5966698|NCT01155661|20634397|P1|Overall Study|Death|1
5966699|NCT01155661|20634397|P1|Overall Study|Adverse Event|101
5966700|NCT01155583|20634432|P9|Phase I|Withdrawal by Subject|0
5966701|NCT01155583|20634433|P8|Phase I|Withdrawal by Subject|1
5966702|NCT01155583|20634434|P7|Phase I|Withdrawal by Subject|0
5966703|NCT01155583|20634435|P6|Phase I|Withdrawal by Subject|0
5966704|NCT01155583|20634436|P5|Phase I|Withdrawal by Subject|0
5966705|NCT01155583|20634437|P4|Phase I|Withdrawal by Subject|0
5966706|NCT01155583|20634438|P3|Phase I|Withdrawal by Subject|0
5966707|NCT01155583|20634439|P2|Phase I|Withdrawal by Subject|0
5966708|NCT01155583|20634440|P1|Phase I|Withdrawal by Subject|0
5966709|NCT01155583|20634432|P9|Phase I|Screen failure - did not start treatment|0
5966710|NCT01155583|20634433|P8|Phase I|Screen failure - did not start treatment|2
5966711|NCT01155583|20634434|P7|Phase I|Screen failure - did not start treatment|0
5966712|NCT01155583|20634435|P6|Phase I|Screen failure - did not start treatment|0
5966713|NCT01155583|20634436|P5|Phase I|Screen failure - did not start treatment|1
5966714|NCT01155583|20634437|P4|Phase I|Screen failure - did not start treatment|0
5966715|NCT01155583|20634438|P3|Phase I|Screen failure - did not start treatment|0
5966716|NCT01155583|20634439|P2|Phase I|Screen failure - did not start treatment|0
5966717|NCT01155583|20634440|P1|Phase I|Screen failure - did not start treatment|0
5966718|NCT01155570|20634459|P1|Overall Study|Other Reasons|23
5966719|NCT01155570|20634459|P1|Overall Study|Participant's Economic Reasons + Other|1
5966720|NCT01155570|20634459|P1|Overall Study|Adverse Event + Other Reasons|7
5966721|NCT01155570|20634459|P1|Overall Study|Adverse Event + Lack of Efficacy|2
5966722|NCT01155570|20634459|P1|Overall Study|No Hospital Visits|7
5966723|NCT01155570|20634459|P1|Overall Study|Participant's Economic Reasons|17
5966724|NCT01155570|20634459|P1|Overall Study|Lack of Efficacy|46
5966725|NCT01155570|20634459|P1|Overall Study|Adverse Event|39
5966726|NCT01155531|20634493|P4|Overall Study|Withdrawal by Subject|0
5966727|NCT01155531|20634494|P3|Overall Study|Withdrawal by Subject|1
5966728|NCT01155531|20634495|P2|Overall Study|Withdrawal by Subject|0
5966729|NCT01155531|20634496|P1|Overall Study|Withdrawal by Subject|1
5966730|NCT01155531|20634493|P4|Overall Study|Lost to Follow-up|1
5966731|NCT01155531|20634494|P3|Overall Study|Lost to Follow-up|0
5966732|NCT01155531|20634495|P2|Overall Study|Lost to Follow-up|0
5966733|NCT01155531|20634496|P1|Overall Study|Lost to Follow-up|0
5966734|NCT01155531|20634493|P4|Overall Study|Adverse Event|0
5966735|NCT01155531|20634494|P3|Overall Study|Adverse Event|1
5966736|NCT01155531|20634495|P2|Overall Study|Adverse Event|0
5966737|NCT01155531|20634496|P1|Overall Study|Adverse Event|0
5966738|NCT01155479|20634544|P5|Part II|Non-Compliance with Protocol|0
5966739|NCT01155479|20634545|P4|Part II|Non-Compliance with Protocol|2
5966740|NCT01155479|20634546|P3|Part II|Non-Compliance with Protocol|0
5966741|NCT01155479|20634547|P2|Part II|Non-Compliance with Protocol|1
5966742|NCT01155479|20634548|P1|Part II|Non-Compliance with Protocol|0
5966743|NCT01155479|20634544|P5|Part II|Treatment Failure|1
5966744|NCT01155479|20634545|P4|Part II|Treatment Failure|0
5966745|NCT01155479|20634546|P3|Part II|Treatment Failure|2
5966746|NCT01155479|20634547|P2|Part II|Treatment Failure|1
5966747|NCT01155479|20634548|P1|Part II|Treatment Failure|0
5966748|NCT01155479|20634544|P5|Part II|Lost to Follow-up|1
5966749|NCT01155479|20634545|P4|Part II|Lost to Follow-up|0
5966750|NCT01155479|20634546|P3|Part II|Lost to Follow-up|0
5966751|NCT01155479|20634547|P2|Part II|Lost to Follow-up|0
5966752|NCT01155479|20634548|P1|Part II|Lost to Follow-up|1
5966753|NCT01155479|20634544|P5|Part II|Withdrawal by Subject|3
5966754|NCT01155479|20634545|P4|Part II|Withdrawal by Subject|7
5966755|NCT01155479|20634546|P3|Part II|Withdrawal by Subject|12
5966756|NCT01155479|20634547|P2|Part II|Withdrawal by Subject|4
5966757|NCT01155479|20634548|P1|Part II|Withdrawal by Subject|8
5966758|NCT01155479|20634544|P5|Part II|Administrative|46
5966759|NCT01155479|20634545|P4|Part II|Administrative|38
5966760|NCT01155479|20634546|P3|Part II|Administrative|36
5966761|NCT01155479|20634547|P2|Part II|Administrative|49
5966762|NCT01155479|20634548|P1|Part II|Administrative|43
5966763|NCT01155479|20634544|P5|Part II|Adverse Event|4
5966764|NCT01155479|20634545|P4|Part II|Adverse Event|3
5966765|NCT01155479|20634546|P3|Part II|Adverse Event|8
5966766|NCT01155479|20634547|P2|Part II|Adverse Event|6
5966767|NCT01155479|20634548|P1|Part II|Adverse Event|7
5966768|NCT01155479|20634544|P5|Part I|Non-Compliance with Protocol|2
5966769|NCT01155479|20634545|P4|Part I|Non-Compliance with Protocol|3
5966770|NCT01155479|20634546|P3|Part I|Non-Compliance with Protocol|3
5966771|NCT01155479|20634547|P2|Part I|Non-Compliance with Protocol|1
5966772|NCT01155479|20634548|P1|Part I|Non-Compliance with Protocol|2
5966773|NCT01155479|20634544|P5|Part I|Did Not Receive Treatment|1
5966774|NCT01155479|20634545|P4|Part I|Did Not Receive Treatment|6
5966775|NCT01155479|20634546|P3|Part I|Did Not Receive Treatment|2
5966776|NCT01155479|20634547|P2|Part I|Did Not Receive Treatment|2
5966777|NCT01155479|20634548|P1|Part I|Did Not Receive Treatment|4
5966778|NCT01155479|20634544|P5|Part I|Treatment Failure|2
5966779|NCT01155479|20634545|P4|Part I|Treatment Failure|1
5966780|NCT01155479|20634546|P3|Part I|Treatment Failure|3
5966781|NCT01155479|20634547|P2|Part I|Treatment Failure|0
5966782|NCT01155479|20634548|P1|Part I|Treatment Failure|3
5966783|NCT01155479|20634544|P5|Part I|Lost to Follow-up|0
5966784|NCT01155479|20634545|P4|Part I|Lost to Follow-up|1
5966785|NCT01155479|20634546|P3|Part I|Lost to Follow-up|1
5966786|NCT01155479|20634547|P2|Part I|Lost to Follow-up|0
5966787|NCT01155479|20634548|P1|Part I|Lost to Follow-up|0
5966788|NCT01155479|20634544|P5|Part I|Withdrawal by Subject|9
5966789|NCT01155479|20634545|P4|Part I|Withdrawal by Subject|8
5966790|NCT01155479|20634546|P3|Part I|Withdrawal by Subject|8
5966791|NCT01155479|20634547|P2|Part I|Withdrawal by Subject|13
5966792|NCT01155479|20634548|P1|Part I|Withdrawal by Subject|11
5966793|NCT01155479|20634544|P5|Part I|Did Not Meet Protocol Eligibility|3
5966794|NCT01155479|20634545|P4|Part I|Did Not Meet Protocol Eligibility|1
5966795|NCT01155479|20634546|P3|Part I|Did Not Meet Protocol Eligibility|2
5966796|NCT01155479|20634547|P2|Part I|Did Not Meet Protocol Eligibility|1
5966797|NCT01155479|20634548|P1|Part I|Did Not Meet Protocol Eligibility|3
5966798|NCT01155479|20634544|P5|Part I|Administrative|0
5966799|NCT01155479|20634545|P4|Part I|Administrative|0
5966800|NCT01155479|20634546|P3|Part I|Administrative|2
5966801|NCT01155479|20634547|P2|Part I|Administrative|2
5966802|NCT01155479|20634548|P1|Part I|Administrative|2
5966803|NCT01155479|20634544|P5|Part I|Adverse Event|6
5966804|NCT01155479|20634545|P4|Part I|Adverse Event|7
5966805|NCT01155479|20634546|P3|Part I|Adverse Event|18
5966806|NCT01155479|20634547|P2|Part I|Adverse Event|8
5966807|NCT01155479|20634548|P1|Part I|Adverse Event|13
5966808|NCT01155466|20634600|P5|Overall Study|Randomized not treated|2
5966809|NCT01155466|20634601|P4|Overall Study|Randomized not treated|0
5966810|NCT01155466|20634602|P3|Overall Study|Randomized not treated|3
5966811|NCT01155466|20634603|P2|Overall Study|Randomized not treated|2
5966812|NCT01155466|20634604|P1|Overall Study|Randomized not treated|2
5966813|NCT01155466|20634600|P5|Overall Study|Administrative|0
5966814|NCT01155466|20634601|P4|Overall Study|Administrative|0
5966815|NCT01155466|20634602|P3|Overall Study|Administrative|0
5966816|NCT01155466|20634603|P2|Overall Study|Administrative|3
5966817|NCT01155466|20634604|P1|Overall Study|Administrative|0
5966818|NCT01155466|20634600|P5|Overall Study|Protocol Violation|1
5966819|NCT01155466|20634601|P4|Overall Study|Protocol Violation|0
5966820|NCT01155466|20634602|P3|Overall Study|Protocol Violation|2
5966821|NCT01155466|20634603|P2|Overall Study|Protocol Violation|0
5966822|NCT01155466|20634604|P1|Overall Study|Protocol Violation|0
5966823|NCT01155466|20634600|P5|Overall Study|Withdrawal by Subject|4
5966824|NCT01155466|20634601|P4|Overall Study|Withdrawal by Subject|4
5966825|NCT01155466|20634602|P3|Overall Study|Withdrawal by Subject|9
5966826|NCT01155466|20634603|P2|Overall Study|Withdrawal by Subject|5
5966827|NCT01155466|20634604|P1|Overall Study|Withdrawal by Subject|7
5966828|NCT01155466|20634600|P5|Overall Study|Lost to Follow-up|2
5966829|NCT01155466|20634601|P4|Overall Study|Lost to Follow-up|0
5966830|NCT01155466|20634602|P3|Overall Study|Lost to Follow-up|0
5966831|NCT01155466|20634603|P2|Overall Study|Lost to Follow-up|0
5966832|NCT01155466|20634604|P1|Overall Study|Lost to Follow-up|0
5966833|NCT01155466|20634600|P5|Overall Study|Adverse Event|18
5966834|NCT01155466|20634601|P4|Overall Study|Adverse Event|17
5966835|NCT01155466|20634602|P3|Overall Study|Adverse Event|6
5966836|NCT01155466|20634603|P2|Overall Study|Adverse Event|15
5966837|NCT01155466|20634604|P1|Overall Study|Adverse Event|13
5966838|NCT01155388|20634658|P2|Overall Study|Adverse Event|0
5966839|NCT01155388|20634659|P1|Overall Study|Adverse Event|1
5966840|NCT01155375|20634669|P2|Overall Study|Adverse Event|0
5966841|NCT01155375|20634670|P1|Overall Study|Adverse Event|1
5966842|NCT01155323|20634689|P2|Second Intervention|Lost to Follow-up|1
5966843|NCT01155323|20634690|P1|Second Intervention|Lost to Follow-up|1
5966844|NCT01155323|20634689|P2|First Intervention|exclusion criteria|1
5966845|NCT01155323|20634690|P1|First Intervention|exclusion criteria|1
5966846|NCT01155284|20634708|P2|Overall Study|Adverse Event|0
5966847|NCT01155284|20634709|P1|Overall Study|Adverse Event|1
5966848|NCT01155284|20634708|P2|Overall Study|Physician Decision|0
5966849|NCT01155284|20634709|P1|Overall Study|Physician Decision|1
5966850|NCT01155284|20634708|P2|Overall Study|Lost to Follow-up|2
5966851|NCT01155284|20634709|P1|Overall Study|Lost to Follow-up|1
5966852|NCT01155284|20634708|P2|Overall Study|Withdrawal by Subject|3
5966853|NCT01155284|20634709|P1|Overall Study|Withdrawal by Subject|4
5966854|NCT01155219|20634719|P2|Overall Study|non-medical reason|2
5966855|NCT01155219|20634720|P1|Overall Study|non-medical reason|1
5966856|NCT01155219|20634719|P2|Overall Study|Adverse Event|1
5966857|NCT01155219|20634720|P1|Overall Study|Adverse Event|3
5966858|NCT01155167|20634769|P2|Overall Study|Access site changed to femoral artery|0
5966859|NCT01155167|20634770|P1|Overall Study|Access site changed to femoral artery|1
5966860|NCT01155167|20634769|P2|Overall Study|Insufficient ultrasound data|0
5966861|NCT01155167|20634770|P1|Overall Study|Insufficient ultrasound data|2
5966862|NCT01155141|20634793|P1|Overall Study|Screen Failure|1
5966863|NCT01155141|20634793|P1|Overall Study|Withdrawal by Subject|1
5966864|NCT01155063|20634805|P1|Overall Study|Study terminated by sponsor|87
5966865|NCT01155063|20634805|P1|Overall Study|Withdrawal by Subject|1
5966866|NCT01155063|20634805|P1|Overall Study|Adverse Event|1
5966867|NCT01155050|20634819|P4|Overall Study|Lost to Follow-up|22
5966868|NCT01155050|20634820|P3|Overall Study|Lost to Follow-up|19
5966869|NCT01155050|20634821|P2|Overall Study|Lost to Follow-up|20
5966870|NCT01155050|20634822|P1|Overall Study|Lost to Follow-up|15
5966871|NCT01155024|20634860|P2|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|2
5966872|NCT01155024|20634861|P1|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|0
5966873|NCT01155024|20634860|P2|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|2
5966874|NCT01155024|20634861|P1|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|0
5966875|NCT01155024|20634860|P2|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|2
5966876|NCT01155024|20634861|P1|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|0
5966877|NCT01155011|20634871|P2|6 to 12 Months|Death|5
5966878|NCT01155011|20634872|P1|6 to 12 Months|Death|1
5966879|NCT01155011|20634871|P2|6 to 12 Months|Withdrawal by Subject|5
5966880|NCT01155011|20634872|P1|6 to 12 Months|Withdrawal by Subject|8
5966881|NCT01155011|20634871|P2|Baseline to 6 Months|Death|1
5966882|NCT01155011|20634872|P1|Baseline to 6 Months|Death|0
5966883|NCT01155011|20634871|P2|Baseline to 6 Months|investigator decision, moved|5
5966884|NCT01155011|20634872|P1|Baseline to 6 Months|investigator decision, moved|4
5966885|NCT01155011|20634871|P2|Baseline to 6 Months|Withdrawal by Subject|19
5966886|NCT01155011|20634872|P1|Baseline to 6 Months|Withdrawal by Subject|18
5966887|NCT01154816|20634913|P12|Overall Study|Adverse Event|0
5966888|NCT01154816|20634914|P11|Overall Study|Adverse Event|0
5966889|NCT01154816|20634915|P10|Overall Study|Adverse Event|0
5966890|NCT01154816|20634916|P9|Overall Study|Adverse Event|0
5966891|NCT01154816|20634917|P8|Overall Study|Adverse Event|1
5966892|NCT01154816|20634918|P7|Overall Study|Adverse Event|1
5966893|NCT01154816|20634919|P6|Overall Study|Adverse Event|0
5966894|NCT01154816|20634920|P5|Overall Study|Adverse Event|0
5966895|NCT01154816|20634921|P4|Overall Study|Adverse Event|0
5966896|NCT01154816|20634922|P3|Overall Study|Adverse Event|0
5966897|NCT01154816|20634923|P2|Overall Study|Adverse Event|2
5966898|NCT01154816|20634924|P1|Overall Study|Adverse Event|5
5966899|NCT01154816|20634913|P12|Overall Study|Physician Decision|1
5966900|NCT01154816|20634914|P11|Overall Study|Physician Decision|1
5966901|NCT01154816|20634915|P10|Overall Study|Physician Decision|1
5966902|NCT01154816|20634916|P9|Overall Study|Physician Decision|0
5966903|NCT01154816|20634917|P8|Overall Study|Physician Decision|0
5966904|NCT01154816|20634918|P7|Overall Study|Physician Decision|0
5966905|NCT01154816|20634919|P6|Overall Study|Physician Decision|0
5966906|NCT01154816|20634920|P5|Overall Study|Physician Decision|2
5966907|NCT01154816|20634921|P4|Overall Study|Physician Decision|0
5966908|NCT01154816|20634922|P3|Overall Study|Physician Decision|1
5966909|NCT01154816|20634923|P2|Overall Study|Physician Decision|0
5966910|NCT01154816|20634924|P1|Overall Study|Physician Decision|1
5966911|NCT01154816|20634913|P12|Overall Study|Progressive Disease|3
5966912|NCT01154816|20634914|P11|Overall Study|Progressive Disease|10
5966913|NCT01154816|20634915|P10|Overall Study|Progressive Disease|6
5966914|NCT01154816|20634916|P9|Overall Study|Progressive Disease|8
5966915|NCT01154816|20634917|P8|Overall Study|Progressive Disease|6
5966916|NCT01154816|20634918|P7|Overall Study|Progressive Disease|5
5966917|NCT01154816|20634919|P6|Overall Study|Progressive Disease|8
5966918|NCT01154816|20634920|P5|Overall Study|Progressive Disease|8
5966919|NCT01154816|20634921|P4|Overall Study|Progressive Disease|9
5966920|NCT01154816|20634922|P3|Overall Study|Progressive Disease|9
5966921|NCT01154816|20634923|P2|Overall Study|Progressive Disease|8
5966922|NCT01154816|20634924|P1|Overall Study|Progressive Disease|13
5966923|NCT01154816|20634913|P12|Overall Study|Withdrawal by Subject|0
5966924|NCT01154816|20634914|P11|Overall Study|Withdrawal by Subject|0
5966925|NCT01154816|20634915|P10|Overall Study|Withdrawal by Subject|3
5966926|NCT01154816|20634916|P9|Overall Study|Withdrawal by Subject|1
5966927|NCT01154816|20634917|P8|Overall Study|Withdrawal by Subject|0
5966928|NCT01154816|20634918|P7|Overall Study|Withdrawal by Subject|0
5966929|NCT01154816|20634919|P6|Overall Study|Withdrawal by Subject|0
5966930|NCT01154816|20634920|P5|Overall Study|Withdrawal by Subject|0
5966931|NCT01154816|20634921|P4|Overall Study|Withdrawal by Subject|1
5966932|NCT01154816|20634922|P3|Overall Study|Withdrawal by Subject|0
5966933|NCT01154816|20634923|P2|Overall Study|Withdrawal by Subject|0
5966934|NCT01154816|20634924|P1|Overall Study|Withdrawal by Subject|1
5966935|NCT01154673|20635001|P2|Overall Study|moved out of province|0
5966936|NCT01154673|20635002|P1|Overall Study|moved out of province|1
5966937|NCT01154673|20635001|P2|Overall Study|Lost to Follow-up|0
5966938|NCT01154673|20635002|P1|Overall Study|Lost to Follow-up|1
5966939|NCT01154452|20635057|P4|Phase II|Adverse Event|4
5966940|NCT01154452|20635058|P3|Phase II|Adverse Event|4
5966941|NCT01154452|20635059|P2|Phase II|Adverse Event|0
5966942|NCT01154452|20635060|P1|Phase II|Adverse Event|0
5966943|NCT01154452|20635057|P4|Phase II|Withdrawal by Subject|2
5966944|NCT01154452|20635058|P3|Phase II|Withdrawal by Subject|1
5966945|NCT01154452|20635059|P2|Phase II|Withdrawal by Subject|0
5966946|NCT01154452|20635060|P1|Phase II|Withdrawal by Subject|0
5966947|NCT01154452|20635057|P4|Phase Ib|Adverse Event|0
5966948|NCT01154452|20635058|P3|Phase Ib|Adverse Event|0
5966949|NCT01154452|20635059|P2|Phase Ib|Adverse Event|1
5966950|NCT01154452|20635060|P1|Phase Ib|Adverse Event|2
5966951|NCT01154452|20635057|P4|Phase Ib|Not Treated|0
5966952|NCT01154452|20635058|P3|Phase Ib|Not Treated|0
5966953|NCT01154452|20635059|P2|Phase Ib|Not Treated|0
5966954|NCT01154452|20635060|P1|Phase Ib|Not Treated|1
5966955|NCT01154296|20635092|P2|6-month Follow-up|Declined by Study Coordinator|4
5966956|NCT01154296|20635093|P1|6-month Follow-up|Declined by Study Coordinator|5
5966957|NCT01154296|20635092|P2|6-month Follow-up|Death|2
5966958|NCT01154296|20635093|P1|6-month Follow-up|Death|3
5966959|NCT01154296|20635092|P2|6-month Follow-up|Withdrew consent|15
5966960|NCT01154296|20635093|P1|6-month Follow-up|Withdrew consent|14
5966961|NCT01154296|20635092|P2|6-month Follow-up|Incarcerated|32
5966962|NCT01154296|20635093|P1|6-month Follow-up|Incarcerated|37
5966963|NCT01154296|20635092|P2|6-month Follow-up|Lost contact|275
5966964|NCT01154296|20635093|P1|6-month Follow-up|Lost contact|269
5966965|NCT01154296|20635092|P2|Randomization and Intervention|Left clinic early|0
5966966|NCT01154296|20635093|P1|Randomization and Intervention|Left clinic early|2
5966967|NCT01154296|20635092|P2|Randomization and Intervention|Left before test|1
5966968|NCT01154296|20635093|P1|Randomization and Intervention|Left before test|0
5966969|NCT01154296|20635092|P2|Randomization and Intervention|Did not return|0
5966970|NCT01154296|20635093|P1|Randomization and Intervention|Did not return|1
5966971|NCT01154296|20635092|P2|Randomization and Intervention|Declined by staff|0
5966972|NCT01154296|20635093|P1|Randomization and Intervention|Declined by staff|1
5966973|NCT01154296|20635092|P2|Randomization and Intervention|Decided to decline|1
5966974|NCT01154296|20635093|P1|Randomization and Intervention|Decided to decline|1
5966975|NCT01154283|20635111|P2|7-12 Weeks|Withdrawal by Subject|1
5966976|NCT01154283|20635112|P1|7-12 Weeks|Withdrawal by Subject|0
5966977|NCT01154283|20635111|P2|7-12 Weeks|Death|0
5966978|NCT01154283|20635112|P1|7-12 Weeks|Death|1
5966979|NCT01154283|20635111|P2|0-6 Weeks|Death|1
5966980|NCT01154283|20635112|P1|0-6 Weeks|Death|0
5966981|NCT01154283|20635111|P2|0-6 Weeks|Withdrawal by Subject|2
5966982|NCT01154283|20635112|P1|0-6 Weeks|Withdrawal by Subject|7
5966983|NCT01154231|20635124|P1|Overall Study|No Info. After 1st Day, No Drug Admin.|1
5966984|NCT01154231|20635124|P1|Overall Study|Safety Unassessable, No Drug Admin.|1
5966985|NCT01154218|20635130|P4|Fourth Intervention Period|Withdrawal by Subject|0
5966986|NCT01154218|20635131|P3|Fourth Intervention Period|Withdrawal by Subject|0
5966987|NCT01154218|20635132|P2|Fourth Intervention Period|Withdrawal by Subject|0
5966988|NCT01154218|20635133|P1|Fourth Intervention Period|Withdrawal by Subject|1
5966989|NCT01154218|20635130|P4|Washout Period (at Least 14 Days)|Withdrawal by Subject|1
5966990|NCT01154218|20635131|P3|Washout Period (at Least 14 Days)|Withdrawal by Subject|0
5966991|NCT01154218|20635132|P2|Washout Period (at Least 14 Days)|Withdrawal by Subject|0
5966992|NCT01154218|20635133|P1|Washout Period (at Least 14 Days)|Withdrawal by Subject|0
5966993|NCT01154218|20635130|P4|Third Intervention Period|Adverse Event|0
5966994|NCT01154218|20635131|P3|Third Intervention Period|Adverse Event|0
5966995|NCT01154218|20635132|P2|Third Intervention Period|Adverse Event|1
5966996|NCT01154218|20635133|P1|Third Intervention Period|Adverse Event|0
5966997|NCT01154166|20635207|P2|Overall Study|Poor Compliance|0
5966998|NCT01154166|20635208|P1|Overall Study|Poor Compliance|1
5966999|NCT01154166|20635207|P2|Overall Study|Disease Progression|0
5967000|NCT01154166|20635208|P1|Overall Study|Disease Progression|1
5967001|NCT01154166|20635207|P2|Overall Study|Lack of Efficacy|0
5967002|NCT01154166|20635208|P1|Overall Study|Lack of Efficacy|3
5967003|NCT01154166|20635207|P2|Overall Study|Withdrawal by Subject|1
5967004|NCT01154166|20635208|P1|Overall Study|Withdrawal by Subject|10
5967005|NCT01154166|20635207|P2|Overall Study|Protocol Violation|1
5967006|NCT01154166|20635208|P1|Overall Study|Protocol Violation|4
5967007|NCT01154166|20635207|P2|Overall Study|Lost to Follow-up|1
5967008|NCT01154166|20635208|P1|Overall Study|Lost to Follow-up|1
5967009|NCT01154166|20635207|P2|Overall Study|Adverse Event|9
5967010|NCT01154166|20635208|P1|Overall Study|Adverse Event|14
5967011|NCT01154153|20635240|P2|Overall Study|Withdrew consent|0
5967012|NCT01154153|20635241|P1|Overall Study|Withdrew consent|1
5967013|NCT01154153|20635240|P2|Overall Study|Unable to use labs|3
5967014|NCT01154153|20635241|P1|Overall Study|Unable to use labs|2
5967015|NCT01154153|20635240|P2|Overall Study|Poor compliance to protocol|0
5967016|NCT01154153|20635241|P1|Overall Study|Poor compliance to protocol|2
5967017|NCT01154140|20635259|P2|Overall Study|Randomized but not treated|2
5967018|NCT01154140|20635260|P1|Overall Study|Randomized but not treated|1
5967019|NCT01154140|20635259|P2|Overall Study|Other|1
5967020|NCT01154140|20635260|P1|Overall Study|Other|3
5967021|NCT01154140|20635259|P2|Overall Study|Withdrawal by Subject|13
5967022|NCT01154140|20635260|P1|Overall Study|Withdrawal by Subject|12
5967023|NCT01154140|20635259|P2|Overall Study|Lost to Follow-up|5
5967024|NCT01154140|20635260|P1|Overall Study|Lost to Follow-up|4
5967025|NCT01154140|20635259|P2|Overall Study|Death|81
5967026|NCT01154140|20635260|P1|Overall Study|Death|71
5967027|NCT01154127|20635313|P2|Period 2 (21 Days)|Protocol Deviation|1
5967028|NCT01154127|20635314|P1|Period 2 (21 Days)|Protocol Deviation|0
5967029|NCT01154127|20635313|P2|Washout (14 - 28 Days)|Abnormal Test Procedure|0
5967030|NCT01154127|20635314|P1|Washout (14 - 28 Days)|Abnormal Test Procedure|1
5967031|NCT01154127|20635313|P2|Washout (14 - 28 Days)|Adverse Event|0
5967032|NCT01154127|20635314|P1|Washout (14 - 28 Days)|Adverse Event|2
5967033|NCT01154127|20635313|P2|Period 1 (21 Days)|Withdrawal by Subject|2
5967034|NCT01154127|20635314|P1|Period 1 (21 Days)|Withdrawal by Subject|0
5967035|NCT01154127|20635313|P2|Period 1 (21 Days)|Adverse Event|4
5967036|NCT01154127|20635314|P1|Period 1 (21 Days)|Adverse Event|3
5967037|NCT01154101|20635341|P5|Overall Study|Withdrawal by Subject|1
5967038|NCT01154101|20635342|P4|Overall Study|Withdrawal by Subject|0
5967039|NCT01154101|20635343|P3|Overall Study|Withdrawal by Subject|2
5967040|NCT01154101|20635344|P2|Overall Study|Withdrawal by Subject|1
5967041|NCT01154101|20635345|P1|Overall Study|Withdrawal by Subject|0
5967042|NCT01154101|20635341|P5|Overall Study|Lost to Follow-up|0
5967043|NCT01154101|20635342|P4|Overall Study|Lost to Follow-up|1
5967044|NCT01154101|20635343|P3|Overall Study|Lost to Follow-up|0
5967045|NCT01154101|20635344|P2|Overall Study|Lost to Follow-up|1
5967046|NCT01154101|20635345|P1|Overall Study|Lost to Follow-up|0
5967047|NCT01154101|20635341|P5|Overall Study|Adverse Event|0
5967048|NCT01154101|20635342|P4|Overall Study|Adverse Event|1
5967049|NCT01154101|20635343|P3|Overall Study|Adverse Event|1
5967050|NCT01154101|20635344|P2|Overall Study|Adverse Event|2
5967051|NCT01154101|20635345|P1|Overall Study|Adverse Event|0
5967052|NCT01154088|20635400|P3|Overall Study|Lost to Follow-up|7
5967053|NCT01154088|20635401|P2|Overall Study|Lost to Follow-up|6
5967054|NCT01154088|20635402|P1|Overall Study|Lost to Follow-up|4
5967055|NCT01154036|20635442|P8|Phase II|Withdrawal by Subject|4
5967056|NCT01154036|20635443|P7|Phase II|Withdrawal by Subject|5
5967057|NCT01154036|20635444|P6|Phase II|Withdrawal by Subject|2
5967058|NCT01154036|20635445|P5|Phase II|Withdrawal by Subject|4
5967059|NCT01154036|20635446|P4|Phase II|Withdrawal by Subject|0
5967060|NCT01154036|20635447|P3|Phase II|Withdrawal by Subject|0
5967061|NCT01154036|20635448|P2|Phase II|Withdrawal by Subject|0
5967062|NCT01154036|20635449|P1|Phase II|Withdrawal by Subject|0
5967063|NCT01154036|20635442|P8|Phase II|Protocol Violation|0
5967064|NCT01154036|20635443|P7|Phase II|Protocol Violation|0
5967065|NCT01154036|20635444|P6|Phase II|Protocol Violation|2
5967066|NCT01154036|20635445|P5|Phase II|Protocol Violation|1
5967067|NCT01154036|20635446|P4|Phase II|Protocol Violation|0
5967068|NCT01154036|20635447|P3|Phase II|Protocol Violation|0
5967069|NCT01154036|20635448|P2|Phase II|Protocol Violation|0
5967070|NCT01154036|20635449|P1|Phase II|Protocol Violation|0
5967071|NCT01154036|20635442|P8|Phase II|Lost to Follow-up|1
5967072|NCT01154036|20635443|P7|Phase II|Lost to Follow-up|2
5967073|NCT01154036|20635444|P6|Phase II|Lost to Follow-up|0
5967074|NCT01154036|20635445|P5|Phase II|Lost to Follow-up|2
5967075|NCT01154036|20635446|P4|Phase II|Lost to Follow-up|1
5967076|NCT01154036|20635447|P3|Phase II|Lost to Follow-up|0
5967077|NCT01154036|20635448|P2|Phase II|Lost to Follow-up|0
5967078|NCT01154036|20635449|P1|Phase II|Lost to Follow-up|0
5967079|NCT01154036|20635442|P8|Phase II|Physician Decision|0
5967080|NCT01154036|20635443|P7|Phase II|Physician Decision|1
5967081|NCT01154036|20635444|P6|Phase II|Physician Decision|0
5967082|NCT01154036|20635445|P5|Phase II|Physician Decision|0
5967083|NCT01154036|20635446|P4|Phase II|Physician Decision|0
5967084|NCT01154036|20635447|P3|Phase II|Physician Decision|0
5967085|NCT01154036|20635448|P2|Phase II|Physician Decision|0
5967086|NCT01154036|20635449|P1|Phase II|Physician Decision|0
5967087|NCT01154036|20635442|P8|Phase II|Adverse Event|1
5967088|NCT01154036|20635443|P7|Phase II|Adverse Event|1
5967089|NCT01154036|20635444|P6|Phase II|Adverse Event|1
5967090|NCT01154036|20635445|P5|Phase II|Adverse Event|1
5967091|NCT01154036|20635446|P4|Phase II|Adverse Event|0
5967092|NCT01154036|20635447|P3|Phase II|Adverse Event|0
5967093|NCT01154036|20635448|P2|Phase II|Adverse Event|0
5967094|NCT01154036|20635449|P1|Phase II|Adverse Event|0
5967095|NCT01154036|20635442|P8|Phase I|Adverse Event|0
5967096|NCT01154036|20635443|P7|Phase I|Adverse Event|0
5967097|NCT01154036|20635444|P6|Phase I|Adverse Event|0
5967098|NCT01154036|20635445|P5|Phase I|Adverse Event|0
5967099|NCT01154036|20635446|P4|Phase I|Adverse Event|0
5967100|NCT01154036|20635447|P3|Phase I|Adverse Event|12
5967101|NCT01154036|20635448|P2|Phase I|Adverse Event|11
5967102|NCT01154036|20635449|P1|Phase I|Adverse Event|1
5967103|NCT01154036|20635442|P8|Phase I|Withdrawal by Subject|0
5967104|NCT01154036|20635443|P7|Phase I|Withdrawal by Subject|0
5967105|NCT01154036|20635444|P6|Phase I|Withdrawal by Subject|0
5967106|NCT01154036|20635445|P5|Phase I|Withdrawal by Subject|0
5967107|NCT01154036|20635446|P4|Phase I|Withdrawal by Subject|0
5967108|NCT01154036|20635447|P3|Phase I|Withdrawal by Subject|29
5967109|NCT01154036|20635448|P2|Phase I|Withdrawal by Subject|10
5967110|NCT01154036|20635449|P1|Phase I|Withdrawal by Subject|2
5967111|NCT01154036|20635442|P8|Phase I|Protocol Violation|0
5967112|NCT01154036|20635443|P7|Phase I|Protocol Violation|0
5967113|NCT01154036|20635444|P6|Phase I|Protocol Violation|0
5967114|NCT01154036|20635445|P5|Phase I|Protocol Violation|0
5967115|NCT01154036|20635446|P4|Phase I|Protocol Violation|0
5967116|NCT01154036|20635447|P3|Phase I|Protocol Violation|9
5967117|NCT01154036|20635448|P2|Phase I|Protocol Violation|3
5967118|NCT01154036|20635449|P1|Phase I|Protocol Violation|0
5967119|NCT01154036|20635442|P8|Phase I|Lost to Follow-up|0
5967120|NCT01154036|20635443|P7|Phase I|Lost to Follow-up|0
5967121|NCT01154036|20635444|P6|Phase I|Lost to Follow-up|0
5967122|NCT01154036|20635445|P5|Phase I|Lost to Follow-up|0
5967123|NCT01154036|20635446|P4|Phase I|Lost to Follow-up|0
5967124|NCT01154036|20635447|P3|Phase I|Lost to Follow-up|6
5967125|NCT01154036|20635448|P2|Phase I|Lost to Follow-up|3
5967126|NCT01154036|20635449|P1|Phase I|Lost to Follow-up|0
5967127|NCT01154036|20635442|P8|Phase I|Physician Decision|0
5967128|NCT01154036|20635443|P7|Phase I|Physician Decision|0
5967129|NCT01154036|20635444|P6|Phase I|Physician Decision|0
5967130|NCT01154036|20635445|P5|Phase I|Physician Decision|0
5967131|NCT01154036|20635446|P4|Phase I|Physician Decision|0
5967132|NCT01154036|20635447|P3|Phase I|Physician Decision|0
5967133|NCT01154036|20635448|P2|Phase I|Physician Decision|1
5967134|NCT01154036|20635449|P1|Phase I|Physician Decision|0
5967135|NCT01154010|20635573|P2|Overall Study|Lost to Follow-up|1
5967136|NCT01154010|20635574|P1|Overall Study|Lost to Follow-up|0
5967137|NCT01153984|20635580|P1|Overall Study|Adverse Event|1
5967138|NCT01153984|20635580|P1|Overall Study|Withdrawal by Subject|1
5967139|NCT01153971|20635591|P1|Follow-up (Months 17-40 of Study)|Disease progression|2
5967140|NCT01153971|20635591|P1|Follow-up (Months 17-40 of Study)|Protocol Violation|1
5967141|NCT01153971|20635591|P1|Follow-up (Months 17-40 of Study)|Adverse Event|1
5967142|NCT01153971|20635591|P1|Maintenance Phase (Months 8-16 of Study)|Clinical relapse|1
5967143|NCT01153971|20635591|P1|Maintenance Phase (Months 8-16 of Study)|Adverse Event|2
5967144|NCT01153971|20635591|P1|Induction Phase (Months 1 to 7 of Study)|Withdrawal by Subject|1
5967145|NCT01153971|20635591|P1|Induction Phase (Months 1 to 7 of Study)|Adverse Event|2
5967146|NCT01153958|20635614|P2|Overall Study|Study Terminated|32
5967147|NCT01153958|20635615|P1|Overall Study|Study Terminated|36
5967148|NCT01153893|20635633|P2|Overall Study|Adverse Event|0
5967149|NCT01153893|20635634|P1|Overall Study|Adverse Event|1
5967150|NCT01153841|20635660|P2|Overall Study|Lost to Follow-up|0
5967151|NCT01153841|20635661|P1|Overall Study|Lost to Follow-up|2
5967152|NCT01153841|20635660|P2|Overall Study|Protocol Violation|0
5967153|NCT01153841|20635661|P1|Overall Study|Protocol Violation|2
5967154|NCT01153841|20635660|P2|Overall Study|Withdrawal by Subject|0
5967155|NCT01153841|20635661|P1|Overall Study|Withdrawal by Subject|1
5967156|NCT01153841|20635660|P2|Overall Study|Adverse Event|0
5967157|NCT01153841|20635661|P1|Overall Study|Adverse Event|1
5967158|NCT01153815|20635677|P2|Overall Study|Withdrawal by Subject|4
5967159|NCT01153815|20635678|P1|Overall Study|Withdrawal by Subject|6
5967160|NCT01153815|20635677|P2|Overall Study|Adverse Event|1
5967161|NCT01153815|20635678|P1|Overall Study|Adverse Event|3
5967162|NCT01153763|20635700|P1|Overall Study|Withdrawal by Subject|2
5967163|NCT01153763|20635700|P1|Overall Study|Physician Decision|2
5967164|NCT01153763|20635700|P1|Overall Study|Lost to Follow-up|1
5967165|NCT01153763|20635700|P1|Overall Study|Study Closed|16
5967166|NCT01153724|20635716|P1|Treatment Period 2|Other reason not defined above|1
5967167|NCT01153724|20635716|P1|Treatment Period 2|Adverse Event|1
5967168|NCT01153724|20635716|P1|Treatment Period 1|Withdrawal by Subject|1
5967169|NCT01153698|20635756|P1|Overall Study|Not treated with Pradaxa|5
5967170|NCT01153698|20635756|P1|Overall Study|Other|2
5967171|NCT01153698|20635756|P1|Overall Study|Switch to other anticoagulants|4
5967172|NCT01153698|20635756|P1|Overall Study|Withdrawal by Subject|2
5967173|NCT01153698|20635756|P1|Overall Study|Lost to Follow-up|4
5967174|NCT01153698|20635756|P1|Overall Study|Adverse Event|12
5967175|NCT01153633|20635807|P2|Overall Study|Therapeutic failure|3
5967176|NCT01153633|20635808|P1|Overall Study|Therapeutic failure|3
5967177|NCT01153633|20635807|P2|Overall Study|Protocol Violation|1
5967178|NCT01153633|20635808|P1|Overall Study|Protocol Violation|1
5967179|NCT01153516|20635845|P2|Overall Study|Both subjects refused surgery|0
5967180|NCT01153516|20635846|P1|Overall Study|Both subjects refused surgery|2
5967181|NCT01153425|20635871|P2|Overall Study|Withdrawal by Subject|3
5967182|NCT01153425|20635872|P1|Overall Study|Withdrawal by Subject|3
5967183|NCT01153347|20635884|P4|Overall Study|Death|0
5967184|NCT01153347|20635885|P3|Overall Study|Death|0
5967185|NCT01153347|20635886|P2|Overall Study|Death|0
5967186|NCT01153347|20635887|P1|Overall Study|Death|1
5967187|NCT01153347|20635884|P4|Overall Study|Other|0
5967188|NCT01153347|20635885|P3|Overall Study|Other|4
5967189|NCT01153347|20635886|P2|Overall Study|Other|5
5967190|NCT01153347|20635887|P1|Overall Study|Other|5
5967191|NCT01153347|20635884|P4|Overall Study|Lost to Follow-up|8
5967192|NCT01153347|20635885|P3|Overall Study|Lost to Follow-up|11
5967193|NCT01153347|20635886|P2|Overall Study|Lost to Follow-up|9
5967194|NCT01153347|20635887|P1|Overall Study|Lost to Follow-up|4
5967195|NCT01153347|20635884|P4|Overall Study|Study-specific withdrawal criteria|2
5967196|NCT01153347|20635885|P3|Overall Study|Study-specific withdrawal criteria|1
5967197|NCT01153347|20635886|P2|Overall Study|Study-specific withdrawal criteria|3
5967198|NCT01153347|20635887|P1|Overall Study|Study-specific withdrawal criteria|4
5967199|NCT01153347|20635884|P4|Overall Study|Lack of Efficacy|4
5967200|NCT01153347|20635885|P3|Overall Study|Lack of Efficacy|0
5967201|NCT01153347|20635886|P2|Overall Study|Lack of Efficacy|2
5967202|NCT01153347|20635887|P1|Overall Study|Lack of Efficacy|2
5967203|NCT01153347|20635884|P4|Overall Study|Condition under investigation worsened|0
5967204|NCT01153347|20635885|P3|Overall Study|Condition under investigation worsened|0
5967205|NCT01153347|20635886|P2|Overall Study|Condition under investigation worsened|1
5967206|NCT01153347|20635887|P1|Overall Study|Condition under investigation worsened|1
5967207|NCT01153347|20635884|P4|Overall Study|Severe non-compliance to protocol|3
5967208|NCT01153347|20635885|P3|Overall Study|Severe non-compliance to protocol|4
5967209|NCT01153347|20635886|P2|Overall Study|Severe non-compliance to protocol|7
5967210|NCT01153347|20635887|P1|Overall Study|Severe non-compliance to protocol|6
5967211|NCT01153347|20635884|P4|Overall Study|Adverse Event|7
5967212|NCT01153347|20635885|P3|Overall Study|Adverse Event|21
5967213|NCT01153347|20635886|P2|Overall Study|Adverse Event|9
5967214|NCT01153347|20635887|P1|Overall Study|Adverse Event|3
5967215|NCT01153347|20635884|P4|Overall Study|Eligibility criteria not fulfilled|1
5967216|NCT01153347|20635885|P3|Overall Study|Eligibility criteria not fulfilled|2
5967217|NCT01153347|20635886|P2|Overall Study|Eligibility criteria not fulfilled|1
5967218|NCT01153347|20635887|P1|Overall Study|Eligibility criteria not fulfilled|0
5967219|NCT01153347|20635884|P4|Overall Study|Withdrawal by Subject|7
5967220|NCT01153347|20635885|P3|Overall Study|Withdrawal by Subject|7
5967221|NCT01153347|20635886|P2|Overall Study|Withdrawal by Subject|7
5967222|NCT01153347|20635887|P1|Overall Study|Withdrawal by Subject|7
5967223|NCT01153321|20635987|P2|Overall Study|Adverse Event|1
5967224|NCT01153321|20635988|P1|Overall Study|Adverse Event|1
5967225|NCT01153321|20635987|P2|Overall Study|Withdrawal by Subject|1
5967226|NCT01153321|20635988|P1|Overall Study|Withdrawal by Subject|0
5967227|NCT01153321|20635987|P2|Overall Study|Development of study withdrawal criteria|1
5967228|NCT01153321|20635988|P1|Overall Study|Development of study withdrawal criteria|0
5967229|NCT01153269|20636100|P1|Overall Study|Antiretroviral therapy break|1
5967230|NCT01153269|20636100|P1|Overall Study|Withdrawal by Subject|1
5967231|NCT01153009|20636163|P4|Overall Study|Other|2
5967232|NCT01153009|20636164|P3|Overall Study|Other|3
5967233|NCT01153009|20636165|P2|Overall Study|Other|1
5967234|NCT01153009|20636166|P1|Overall Study|Other|1
5967235|NCT01153009|20636163|P4|Overall Study|Lost to Follow-up|15
5967236|NCT01153009|20636164|P3|Overall Study|Lost to Follow-up|11
5967237|NCT01153009|20636165|P2|Overall Study|Lost to Follow-up|8
5967238|NCT01153009|20636166|P1|Overall Study|Lost to Follow-up|8
5967239|NCT01153009|20636163|P4|Overall Study|Withdrawal of Consent|6
5967240|NCT01153009|20636164|P3|Overall Study|Withdrawal of Consent|4
5967241|NCT01153009|20636165|P2|Overall Study|Withdrawal of Consent|5
5967242|NCT01153009|20636166|P1|Overall Study|Withdrawal of Consent|5
5967243|NCT01153009|20636163|P4|Overall Study|Protocol Deviations|2
5967244|NCT01153009|20636164|P3|Overall Study|Protocol Deviations|3
5967245|NCT01153009|20636165|P2|Overall Study|Protocol Deviations|3
5967246|NCT01153009|20636166|P1|Overall Study|Protocol Deviations|4
5967247|NCT01153009|20636163|P4|Overall Study|Noncompliance with Study Medication|1
5967248|NCT01153009|20636164|P3|Overall Study|Noncompliance with Study Medication|4
5967249|NCT01153009|20636165|P2|Overall Study|Noncompliance with Study Medication|3
5967250|NCT01153009|20636166|P1|Overall Study|Noncompliance with Study Medication|1
5967251|NCT01153009|20636163|P4|Overall Study|Lack of Efficacy|1
5967252|NCT01153009|20636164|P3|Overall Study|Lack of Efficacy|2
5967253|NCT01153009|20636165|P2|Overall Study|Lack of Efficacy|0
5967254|NCT01153009|20636166|P1|Overall Study|Lack of Efficacy|9
5967255|NCT01153009|20636163|P4|Overall Study|Adverse Event|10
5967256|NCT01153009|20636164|P3|Overall Study|Adverse Event|14
5967257|NCT01153009|20636165|P2|Overall Study|Adverse Event|14
5967258|NCT01153009|20636166|P1|Overall Study|Adverse Event|4
5967259|NCT01152996|20636196|P1|Overall Study|Elevated liver enzymes|1
5967260|NCT01152996|20636196|P1|Overall Study|Protocol Violation|22
5967261|NCT01152996|20636196|P1|Overall Study|Other|36
5967262|NCT01152996|20636196|P1|Overall Study|Noncompliance|41
5967263|NCT01152996|20636196|P1|Overall Study|Lack of Efficacy|68
5967264|NCT01152996|20636196|P1|Overall Study|Lost to Follow-up|112
5967265|NCT01152996|20636196|P1|Overall Study|Adverse Event|115
5967266|NCT01152996|20636196|P1|Overall Study|Withdrawal by Subject|142
5967267|NCT01152814|20636209|P1|Overall Study|Lost to Follow-up|2
5967268|NCT01152788|20636218|P2|Overall Study|No treatment|1
5967269|NCT01152788|20636219|P1|Overall Study|No treatment|0
5967270|NCT01152788|20636218|P2|Overall Study|Withdrawal by Subject|3
5967271|NCT01152788|20636219|P1|Overall Study|Withdrawal by Subject|0
5967272|NCT01152580|20636256|P2|Overall Study|Withdrawal by Subject|1
5967273|NCT01152580|20636257|P1|Overall Study|Withdrawal by Subject|0
5967274|NCT01152554|20636279|P2|Overall Study|Death|1
5967275|NCT01152554|20636280|P1|Overall Study|Death|1
5967276|NCT01152554|20636279|P2|Overall Study|Other|8
5967277|NCT01152554|20636280|P1|Overall Study|Other|28
5967278|NCT01152554|20636279|P2|Overall Study|Lost to Follow-up|32
5967279|NCT01152554|20636280|P1|Overall Study|Lost to Follow-up|87
5967280|NCT01152554|20636279|P2|Overall Study|Study-specific withdrawal criteria|8
5967281|NCT01152554|20636280|P1|Overall Study|Study-specific withdrawal criteria|17
5967282|NCT01152554|20636279|P2|Overall Study|Lack of Efficacy|3
5967283|NCT01152554|20636280|P1|Overall Study|Lack of Efficacy|20
5967284|NCT01152554|20636279|P2|Overall Study|Condition under investigation worsened|2
5967285|NCT01152554|20636280|P1|Overall Study|Condition under investigation worsened|5
5967286|NCT01152554|20636279|P2|Overall Study|Severe non-compliance to protocol|14
5967287|NCT01152554|20636280|P1|Overall Study|Severe non-compliance to protocol|36
5967288|NCT01152554|20636279|P2|Overall Study|Adverse Event|14
5967289|NCT01152554|20636280|P1|Overall Study|Adverse Event|67
5967290|NCT01152554|20636279|P2|Overall Study|Eligiblity criteria not fulfilled|1
5967291|NCT01152554|20636280|P1|Overall Study|Eligiblity criteria not fulfilled|0
5967292|NCT01152554|20636279|P2|Overall Study|Withdrawal by Subject|28
5967293|NCT01152554|20636280|P1|Overall Study|Withdrawal by Subject|73
5967294|NCT01152450|20636319|P6|Period 1 (4 Weeks)|Lost to Follow-up|0
5967295|NCT01152450|20636320|P5|Period 1 (4 Weeks)|Lost to Follow-up|0
5967296|NCT01152450|20636321|P4|Period 1 (4 Weeks)|Lost to Follow-up|0
5967297|NCT01152450|20636322|P3|Period 1 (4 Weeks)|Lost to Follow-up|1
5967298|NCT01152450|20636323|P2|Period 1 (4 Weeks)|Lost to Follow-up|1
5967299|NCT01152450|20636324|P1|Period 1 (4 Weeks)|Lost to Follow-up|0
5967300|NCT01152450|20636319|P6|Period 1 (4 Weeks)|Protocol Violation|0
5967301|NCT01152450|20636320|P5|Period 1 (4 Weeks)|Protocol Violation|1
5967302|NCT01152450|20636321|P4|Period 1 (4 Weeks)|Protocol Violation|0
5967303|NCT01152450|20636322|P3|Period 1 (4 Weeks)|Protocol Violation|0
5967304|NCT01152450|20636323|P2|Period 1 (4 Weeks)|Protocol Violation|0
5967305|NCT01152450|20636324|P1|Period 1 (4 Weeks)|Protocol Violation|0
5967306|NCT01152450|20636319|P6|Period 1 (4 Weeks)|Adverse Event|1
5967307|NCT01152450|20636320|P5|Period 1 (4 Weeks)|Adverse Event|1
5967308|NCT01152450|20636321|P4|Period 1 (4 Weeks)|Adverse Event|0
5967309|NCT01152450|20636322|P3|Period 1 (4 Weeks)|Adverse Event|0
5967310|NCT01152450|20636323|P2|Period 1 (4 Weeks)|Adverse Event|0
5967311|NCT01152450|20636324|P1|Period 1 (4 Weeks)|Adverse Event|0
5967312|NCT01152437|20636395|P3|Overall Study|Refusal to continue taking trial medicat|2
5967313|NCT01152437|20636396|P2|Overall Study|Refusal to continue taking trial medicat|0
5967314|NCT01152437|20636397|P1|Overall Study|Refusal to continue taking trial medicat|1
5967315|NCT01152437|20636395|P3|Overall Study|Progressive disease|32
5967316|NCT01152437|20636396|P2|Overall Study|Progressive disease|13
5967317|NCT01152437|20636397|P1|Overall Study|Progressive disease|27
5967318|NCT01152437|20636395|P3|Overall Study|Not treated|2
5967319|NCT01152437|20636396|P2|Overall Study|Not treated|1
5967320|NCT01152437|20636397|P1|Overall Study|Not treated|0
5967321|NCT01152437|20636395|P3|Overall Study|Other Adverse Event|7
5967322|NCT01152437|20636396|P2|Overall Study|Other Adverse Event|1
5967323|NCT01152437|20636397|P1|Overall Study|Other Adverse Event|8
5967324|NCT01152385|20636417|P4|Overall Study|Other|3
5967325|NCT01152385|20636418|P3|Overall Study|Other|2
5967326|NCT01152385|20636419|P2|Overall Study|Other|3
5967327|NCT01152385|20636420|P1|Overall Study|Other|4
5967328|NCT01152385|20636417|P4|Overall Study|Study-specific withdrawal criteria|0
5967329|NCT01152385|20636418|P3|Overall Study|Study-specific withdrawal criteria|2
5967330|NCT01152385|20636419|P2|Overall Study|Study-specific withdrawal criteria|1
5967331|NCT01152385|20636420|P1|Overall Study|Study-specific withdrawal criteria|1
5967332|NCT01152385|20636417|P4|Overall Study|Adverse Event|0
5967333|NCT01152385|20636418|P3|Overall Study|Adverse Event|0
5967334|NCT01152385|20636419|P2|Overall Study|Adverse Event|1
5967335|NCT01152385|20636420|P1|Overall Study|Adverse Event|1
5967336|NCT01152385|20636417|P4|Overall Study|Protocol Violation|1
5967337|NCT01152385|20636418|P3|Overall Study|Protocol Violation|0
5967338|NCT01152385|20636419|P2|Overall Study|Protocol Violation|0
5967339|NCT01152385|20636420|P1|Overall Study|Protocol Violation|0
5967340|NCT01152385|20636417|P4|Overall Study|Withdrawal by Subject|1
5967341|NCT01152385|20636418|P3|Overall Study|Withdrawal by Subject|1
5967342|NCT01152385|20636419|P2|Overall Study|Withdrawal by Subject|1
5967343|NCT01152385|20636420|P1|Overall Study|Withdrawal by Subject|3
5967344|NCT01152190|20636491|P2|Overall Study|Withdrawal by Subject|3
5967345|NCT01152190|20636492|P1|Overall Study|Withdrawal by Subject|1
5967346|NCT01152190|20636491|P2|Overall Study|Protocol Violation|1
5967347|NCT01152190|20636492|P1|Overall Study|Protocol Violation|1
5967348|NCT01152190|20636491|P2|Overall Study|Death|0
5967349|NCT01152190|20636492|P1|Overall Study|Death|1
5967350|NCT01152190|20636491|P2|Overall Study|Adverse Event|4
5967351|NCT01152190|20636492|P1|Overall Study|Adverse Event|2
5967352|NCT01152021|20636515|P2|Overall Study|No access to study drug in Pharmacy|1
5967353|NCT01152021|20636516|P1|Overall Study|No access to study drug in Pharmacy|0
5967354|NCT01152021|20636515|P2|Overall Study|Physician Decision|1
5967355|NCT01152021|20636516|P1|Overall Study|Physician Decision|1
5967356|NCT01152021|20636515|P2|Overall Study|Study drug had expired|0
5967357|NCT01152021|20636516|P1|Overall Study|Study drug had expired|1
5967358|NCT01152021|20636515|P2|Overall Study|Adverse Event|4
5967359|NCT01152021|20636516|P1|Overall Study|Adverse Event|4
5967360|NCT01151618|20636573|P1|Overall Study|Withdrawal by Subject|7
5967361|NCT01151618|20636573|P1|Overall Study|Adverse Event|2
5967362|NCT01151579|20636581|P2|Overall Study|Not meet inclusion criteria|4
5967363|NCT01151579|20636582|P1|Overall Study|Not meet inclusion criteria|6
5967364|NCT01151579|20636581|P2|Overall Study|Withdrawal by Subject|2
5967365|NCT01151579|20636582|P1|Overall Study|Withdrawal by Subject|3
5967366|NCT01151579|20636581|P2|Overall Study|Physician Decision|1
5967367|NCT01151579|20636582|P1|Overall Study|Physician Decision|3
5967368|NCT01151540|20636596|P1|Overall Study|Withdrawal by Subject|7
5967369|NCT01151540|20636596|P1|Overall Study|Adverse event, non-fatal|4
5967370|NCT01151540|20636596|P1|Overall Study|Other|2
5967371|NCT01151423|20636645|P2|Overall Study|Participated in other clinical trial|0
5967372|NCT01151423|20636646|P1|Overall Study|Participated in other clinical trial|1
5967373|NCT01151423|20636645|P2|Overall Study|Diagnosed as non-TTP patient|1
5967374|NCT01151423|20636646|P1|Overall Study|Diagnosed as non-TTP patient|0
5967375|NCT01151423|20636645|P2|Overall Study|Lost to Follow-up|0
5967376|NCT01151423|20636646|P1|Overall Study|Lost to Follow-up|1
5967377|NCT01151423|20636645|P2|Overall Study|Withdrawal by Subject|3
5967378|NCT01151423|20636646|P1|Overall Study|Withdrawal by Subject|1
5967379|NCT01151423|20636645|P2|Overall Study|Adverse Event|0
5967380|NCT01151423|20636646|P1|Overall Study|Adverse Event|3
5967381|NCT01151423|20636645|P2|Overall Study|Death|1
5967382|NCT01151423|20636646|P1|Overall Study|Death|0
5967383|NCT01151423|20636645|P2|Overall Study|Pregnancy|1
5967384|NCT01151423|20636646|P1|Overall Study|Pregnancy|0
5967385|NCT01151423|20636645|P2|Overall Study|Physician Decision|1
5967386|NCT01151423|20636646|P1|Overall Study|Physician Decision|1
5967387|NCT01151423|20636645|P2|Overall Study|Protocol Violation|1
5967388|NCT01151423|20636646|P1|Overall Study|Protocol Violation|0
5967389|NCT01151423|20636645|P2|Overall Study|Study terminated by Sponsor|10
5967390|NCT01151423|20636646|P1|Overall Study|Study terminated by Sponsor|9
5967391|NCT01151410|20636694|P2|Overall Study|Abnormal laboratory value(s)|1
5967392|NCT01151410|20636695|P1|Overall Study|Abnormal laboratory value(s)|0
5967393|NCT01151410|20636694|P2|Overall Study|Unsatisfactory therapeutic effect|1
5967394|NCT01151410|20636695|P1|Overall Study|Unsatisfactory therapeutic effect|1
5967395|NCT01151410|20636694|P2|Overall Study|Administrative problems|1
5967396|NCT01151410|20636695|P1|Overall Study|Administrative problems|1
5967397|NCT01151410|20636694|P2|Overall Study|Protocol deviation|1
5967398|NCT01151410|20636695|P1|Overall Study|Protocol deviation|2
5967399|NCT01151410|20636694|P2|Overall Study|Adverse Event|2
5967400|NCT01151410|20636695|P1|Overall Study|Adverse Event|1
5967401|NCT01151410|20636694|P2|Overall Study|Lost to Follow-up|4
5967402|NCT01151410|20636695|P1|Overall Study|Lost to Follow-up|3
5967403|NCT01151410|20636694|P2|Overall Study|Withdrawal by Subject|5
5967404|NCT01151410|20636695|P1|Overall Study|Withdrawal by Subject|3
5967405|NCT01151345|20636739|P2|First Intervention Period|Protocol Violation|1
5967406|NCT01151345|20636740|P1|First Intervention Period|Protocol Violation|0
5967407|NCT01151280|20636754|P1|Overall Study|Lack of Efficacy|3
5967408|NCT01151280|20636754|P1|Overall Study|Adverse Event|1
5967409|NCT01151215|20636767|P3|Overall Study|Safety as judged by the investigator|1
5967410|NCT01151215|20636768|P2|Overall Study|Safety as judged by the investigator|0
5967411|NCT01151215|20636769|P1|Overall Study|Safety as judged by the investigator|0
5967412|NCT01151215|20636767|P3|Overall Study|Disease progression|1
5967413|NCT01151215|20636768|P2|Overall Study|Disease progression|1
5967414|NCT01151215|20636769|P1|Overall Study|Disease progression|0
5967415|NCT01151215|20636767|P3|Overall Study|Withdrawal by Subject|2
5967416|NCT01151215|20636768|P2|Overall Study|Withdrawal by Subject|1
5967417|NCT01151215|20636769|P1|Overall Study|Withdrawal by Subject|3
5967418|NCT01151215|20636767|P3|Overall Study|Lost to Follow-up|3
5967419|NCT01151215|20636768|P2|Overall Study|Lost to Follow-up|0
5967420|NCT01151215|20636769|P1|Overall Study|Lost to Follow-up|0
5967421|NCT01151215|20636767|P3|Overall Study|Death|11
5967422|NCT01151215|20636768|P2|Overall Study|Death|20
5967423|NCT01151215|20636769|P1|Overall Study|Death|16
5967424|NCT01151215|20636767|P3|Overall Study|Worsening of condition under study|1
5967425|NCT01151215|20636768|P2|Overall Study|Worsening of condition under study|1
5967426|NCT01151215|20636769|P1|Overall Study|Worsening of condition under study|1
5967427|NCT01151137|20636807|P2|Overall Study|Lost to Follow-up|1
5967428|NCT01151137|20636808|P1|Overall Study|Lost to Follow-up|1
5967429|NCT01151137|20636807|P2|Overall Study|Death|27
5967430|NCT01151137|20636808|P1|Overall Study|Death|15
5967431|NCT01151098|20636826|P1|Overall Study|Miscellaneous|13
5967432|NCT01151098|20636826|P1|Overall Study|Protocol Violation|1
5967433|NCT01151098|20636826|P1|Overall Study|Lack of Efficacy|15
5967434|NCT01151098|20636826|P1|Overall Study|Lost to Follow-up|6
5967435|NCT01151098|20636826|P1|Overall Study|Adverse Event|82
5967436|NCT01151085|20636830|P1|Overall Study|Protocol Violation|25
5967437|NCT01151085|20636830|P1|Overall Study|Lost to Follow-up|31
5967438|NCT01151020|20636861|P1|Overall Study|Patients did not receive the device|2
5967439|NCT01151020|20636861|P1|Overall Study|Withdrawal by Subject|22
5967440|NCT01151020|20636861|P1|Overall Study|Lost to Follow-up|4
5967441|NCT01151020|20636861|P1|Overall Study|Conversion to open repair|1
5967442|NCT01151020|20636861|P1|Overall Study|Death|25
5967443|NCT01150474|20636940|P2|Overall Study|Surgery Changed|0
5967444|NCT01150474|20636941|P1|Overall Study|Surgery Changed|1
5967445|NCT01150474|20636940|P2|Overall Study|Drug not administered|0
5967446|NCT01150474|20636941|P1|Overall Study|Drug not administered|1
5967447|NCT01150474|20636940|P2|Overall Study|Drug did not arrive in time|0
5967448|NCT01150474|20636941|P1|Overall Study|Drug did not arrive in time|1
5967449|NCT01150474|20636940|P2|Overall Study|Rectotomy|0
5967450|NCT01150474|20636941|P1|Overall Study|Rectotomy|1
5967451|NCT01150474|20636940|P2|Overall Study|Multiple Studies|1
5967452|NCT01150474|20636941|P1|Overall Study|Multiple Studies|0
5967453|NCT01150474|20636940|P2|Overall Study|Cancer found|0
5967454|NCT01150474|20636941|P1|Overall Study|Cancer found|1
5967455|NCT01150474|20636940|P2|Overall Study|Withdrawal by Subject|2
5967456|NCT01150474|20636941|P1|Overall Study|Withdrawal by Subject|5
5967457|NCT01150357|20636986|P3|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0
5967458|NCT01150357|20636987|P2|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0
5967459|NCT01150357|20636988|P1|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|1
5967460|NCT01150357|20636986|P3|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0
5967461|NCT01150357|20636987|P2|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0
5967462|NCT01150357|20636988|P1|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|2
5967463|NCT01150357|20636986|P3|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|2
5967464|NCT01150357|20636987|P2|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0
5967465|NCT01150357|20636988|P1|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0
5967466|NCT01150357|20636986|P3|Dose Response Phase (Phase 1)|Withdrawal by Participants|1
5967467|NCT01150357|20636987|P2|Dose Response Phase (Phase 1)|Withdrawal by Participants|2
5967468|NCT01150357|20636988|P1|Dose Response Phase (Phase 1)|Withdrawal by Participants|0
5967469|NCT01150357|20636986|P3|Dose Response Phase (Phase 1)|Adverse Event|1
5967470|NCT01150357|20636987|P2|Dose Response Phase (Phase 1)|Adverse Event|0
5967471|NCT01150357|20636988|P1|Dose Response Phase (Phase 1)|Adverse Event|0
5967472|NCT01150357|20636986|P3|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0
5967473|NCT01150357|20636987|P2|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0
5967474|NCT01150357|20636988|P1|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|1
5967475|NCT01150357|20636986|P3|Dose Response Phase (Phase 1)|Protocol Violation|1
5967476|NCT01150357|20636987|P2|Dose Response Phase (Phase 1)|Protocol Violation|1
5967477|NCT01150357|20636988|P1|Dose Response Phase (Phase 1)|Protocol Violation|0
5967478|NCT01150123|20637068|P18|Overall Study|Lost to Follow-up|0
5967479|NCT01150123|20637069|P17|Overall Study|Lost to Follow-up|0
5967480|NCT01150123|20637070|P16|Overall Study|Lost to Follow-up|0
5967481|NCT01150123|20637071|P15|Overall Study|Lost to Follow-up|0
5967482|NCT01150123|20637072|P14|Overall Study|Lost to Follow-up|0
5967483|NCT01150123|20637073|P13|Overall Study|Lost to Follow-up|2
5967484|NCT01150123|20637074|P12|Overall Study|Lost to Follow-up|1
5967485|NCT01150123|20637075|P11|Overall Study|Lost to Follow-up|1
5967486|NCT01150123|20637076|P10|Overall Study|Lost to Follow-up|1
5967487|NCT01150123|20637077|P9|Overall Study|Lost to Follow-up|3
5967488|NCT01150123|20637078|P8|Overall Study|Lost to Follow-up|0
5967489|NCT01150123|20637079|P7|Overall Study|Lost to Follow-up|0
5967490|NCT01150123|20637080|P6|Overall Study|Lost to Follow-up|5
5967491|NCT01150123|20637081|P5|Overall Study|Lost to Follow-up|2
5967492|NCT01150123|20637082|P4|Overall Study|Lost to Follow-up|2
5967493|NCT01150123|20637083|P3|Overall Study|Lost to Follow-up|2
5967494|NCT01150123|20637084|P2|Overall Study|Lost to Follow-up|1
5967495|NCT01150123|20637085|P1|Overall Study|Lost to Follow-up|2
5967496|NCT01150123|20637068|P18|Overall Study|Withdrawal by Subject|1
5967497|NCT01150123|20637069|P17|Overall Study|Withdrawal by Subject|0
5967498|NCT01150123|20637070|P16|Overall Study|Withdrawal by Subject|1
5967499|NCT01150123|20637071|P15|Overall Study|Withdrawal by Subject|0
5967500|NCT01150123|20637072|P14|Overall Study|Withdrawal by Subject|0
5967501|NCT01150123|20637073|P13|Overall Study|Withdrawal by Subject|1
5967502|NCT01150123|20637074|P12|Overall Study|Withdrawal by Subject|0
5967503|NCT01150123|20637075|P11|Overall Study|Withdrawal by Subject|1
5967504|NCT01150123|20637076|P10|Overall Study|Withdrawal by Subject|0
5967505|NCT01150123|20637077|P9|Overall Study|Withdrawal by Subject|2
5967506|NCT01150123|20637078|P8|Overall Study|Withdrawal by Subject|3
5967507|NCT01150123|20637079|P7|Overall Study|Withdrawal by Subject|0
5967508|NCT01150123|20637080|P6|Overall Study|Withdrawal by Subject|1
5967509|NCT01150123|20637081|P5|Overall Study|Withdrawal by Subject|1
5967510|NCT01150123|20637082|P4|Overall Study|Withdrawal by Subject|1
5967511|NCT01150123|20637083|P3|Overall Study|Withdrawal by Subject|2
5967512|NCT01150123|20637084|P2|Overall Study|Withdrawal by Subject|1
5967513|NCT01150123|20637085|P1|Overall Study|Withdrawal by Subject|1
5967514|NCT01150097|20637261|P3|Months 24 to 48 Post-transplantation|Death|0
5967515|NCT01150097|20637262|P2|Months 24 to 48 Post-transplantation|Death|0
5967516|NCT01150097|20637263|P1|Months 24 to 48 Post-transplantation|Death|2
5967517|NCT01150097|20637261|P3|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0
5967518|NCT01150097|20637262|P2|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0
5967519|NCT01150097|20637263|P1|Months 24 to 48 Post-transplantation|Withdrawal by Subject|4
5967520|NCT01150097|20637261|P3|Months 24 to 48 Post-transplantation|Administrative problems|0
5967521|NCT01150097|20637262|P2|Months 24 to 48 Post-transplantation|Administrative problems|4
5967522|NCT01150097|20637263|P1|Months 24 to 48 Post-transplantation|Administrative problems|5
5967523|NCT01150097|20637261|P3|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3
5967524|NCT01150097|20637262|P2|Months 24 to 36 Post-transplantation|Withdrawal by Subject|0
5967525|NCT01150097|20637263|P1|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3
5967526|NCT01150097|20637261|P3|Months 24 to 36 Post-transplantation|Lost to Follow-up|3
5967527|NCT01150097|20637262|P2|Months 24 to 36 Post-transplantation|Lost to Follow-up|0
5967528|NCT01150097|20637263|P1|Months 24 to 36 Post-transplantation|Lost to Follow-up|0
5967529|NCT01150097|20637261|P3|Months 24 to 36 Post-transplantation|Administrative problems|2
5967530|NCT01150097|20637262|P2|Months 24 to 36 Post-transplantation|Administrative problems|2
5967531|NCT01150097|20637263|P1|Months 24 to 36 Post-transplantation|Administrative problems|5
5967532|NCT01150097|20637261|P3|Months 24 to 36 Post-transplantation|Death|0
5967533|NCT01150097|20637262|P2|Months 24 to 36 Post-transplantation|Death|0
5967534|NCT01150097|20637263|P1|Months 24 to 36 Post-transplantation|Death|2
5967535|NCT01149863|20637307|P1|Overall Study|Missing data or Not receiveing studydrug|3
5967536|NCT01149681|20637382|P1|Overall Study|adverse events nonrelated study drug|2
5967537|NCT01149681|20637382|P1|Overall Study|Physician Decision|2
5967538|NCT01149681|20637382|P1|Overall Study|Progressive disease|1
5967539|NCT01149681|20637382|P1|Overall Study|Withdrawal by Subject|7
5967540|NCT01149655|20637390|P4|Period 3-DB Maintenance Phase|Relapse With AE|18
5967541|NCT01149655|20637391|P3|Period 3-DB Maintenance Phase|Relapse With AE|19
5967542|NCT01149655|20637392|P2|Period 3-DB Maintenance Phase|Relapse With AE|0
5967543|NCT01149655|20637393|P1|Period 3-DB Maintenance Phase|Relapse With AE|0
5967544|NCT01149655|20637390|P4|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1
5967545|NCT01149655|20637391|P3|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1
5967546|NCT01149655|20637392|P2|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0
5967547|NCT01149655|20637393|P1|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0
5967548|NCT01149655|20637390|P4|Period 3-DB Maintenance Phase|Withdrawal by Subject|4
5967549|NCT01149655|20637391|P3|Period 3-DB Maintenance Phase|Withdrawal by Subject|4
5967550|NCT01149655|20637392|P2|Period 3-DB Maintenance Phase|Withdrawal by Subject|0
5967551|NCT01149655|20637393|P1|Period 3-DB Maintenance Phase|Withdrawal by Subject|0
5967552|NCT01149655|20637390|P4|Period 3-DB Maintenance Phase|Physician Decision|0
5967553|NCT01149655|20637391|P3|Period 3-DB Maintenance Phase|Physician Decision|1
5967554|NCT01149655|20637392|P2|Period 3-DB Maintenance Phase|Physician Decision|0
5967555|NCT01149655|20637393|P1|Period 3-DB Maintenance Phase|Physician Decision|0
5967556|NCT01149655|20637390|P4|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|19
5967557|NCT01149655|20637391|P3|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|58
5967558|NCT01149655|20637392|P2|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0
5967559|NCT01149655|20637393|P1|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0
5967560|NCT01149655|20637390|P4|Period 2-Stabilization Phase|Adverse Event Without Relapse|0
5967561|NCT01149655|20637391|P3|Period 2-Stabilization Phase|Adverse Event Without Relapse|0
5967562|NCT01149655|20637392|P2|Period 2-Stabilization Phase|Adverse Event Without Relapse|6
5967563|NCT01149655|20637393|P1|Period 2-Stabilization Phase|Adverse Event Without Relapse|0
5967564|NCT01149655|20637390|P4|Period 2-Stabilization Phase|Withdrawal by Subject|0
5967565|NCT01149655|20637391|P3|Period 2-Stabilization Phase|Withdrawal by Subject|0
5967566|NCT01149655|20637392|P2|Period 2-Stabilization Phase|Withdrawal by Subject|5
5967567|NCT01149655|20637393|P1|Period 2-Stabilization Phase|Withdrawal by Subject|0
5967568|NCT01149655|20637390|P4|Period 2-Stabilization Phase|Physician Decision|0
5967569|NCT01149655|20637391|P3|Period 2-Stabilization Phase|Physician Decision|0
5967570|NCT01149655|20637392|P2|Period 2-Stabilization Phase|Physician Decision|3
5967571|NCT01149655|20637393|P1|Period 2-Stabilization Phase|Physician Decision|0
5967572|NCT01149655|20637390|P4|Period 2-Stabilization Phase|Met Withdrawal Criteria|0
5967573|NCT01149655|20637391|P3|Period 2-Stabilization Phase|Met Withdrawal Criteria|0
5967574|NCT01149655|20637392|P2|Period 2-Stabilization Phase|Met Withdrawal Criteria|7
5967575|NCT01149655|20637393|P1|Period 2-Stabilization Phase|Met Withdrawal Criteria|0
5967576|NCT01149655|20637390|P4|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0
5967577|NCT01149655|20637391|P3|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0
5967578|NCT01149655|20637392|P2|Period 2-Stabilization Phase|Sponsor Discontinued Trial|16
5967579|NCT01149655|20637393|P1|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0
5967580|NCT01149655|20637390|P4|Period 1 - Conversion Phase|Adverse Event Without Relapse|0
5967581|NCT01149655|20637391|P3|Period 1 - Conversion Phase|Adverse Event Without Relapse|0
5967582|NCT01149655|20637392|P2|Period 1 - Conversion Phase|Adverse Event Without Relapse|0
5967583|NCT01149655|20637393|P1|Period 1 - Conversion Phase|Adverse Event Without Relapse|3
5967584|NCT01149655|20637390|P4|Period 1 - Conversion Phase|Withdrawal by Subject|0
5967585|NCT01149655|20637391|P3|Period 1 - Conversion Phase|Withdrawal by Subject|0
5967586|NCT01149655|20637392|P2|Period 1 - Conversion Phase|Withdrawal by Subject|0
5967587|NCT01149655|20637393|P1|Period 1 - Conversion Phase|Withdrawal by Subject|7
5967588|NCT01149655|20637390|P4|Period 1 - Conversion Phase|Physician Decision|0
5967589|NCT01149655|20637391|P3|Period 1 - Conversion Phase|Physician Decision|0
5967590|NCT01149655|20637392|P2|Period 1 - Conversion Phase|Physician Decision|0
5967591|NCT01149655|20637393|P1|Period 1 - Conversion Phase|Physician Decision|2
5967592|NCT01149655|20637390|P4|Period 1 - Conversion Phase|Met Withdrawal Criteria|0
5967593|NCT01149655|20637391|P3|Period 1 - Conversion Phase|Met Withdrawal Criteria|0
5967594|NCT01149655|20637392|P2|Period 1 - Conversion Phase|Met Withdrawal Criteria|0
5967595|NCT01149655|20637393|P1|Period 1 - Conversion Phase|Met Withdrawal Criteria|1
5967596|NCT01149655|20637390|P4|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0
5967597|NCT01149655|20637391|P3|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0
5967598|NCT01149655|20637392|P2|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0
5967599|NCT01149655|20637393|P1|Period 1 - Conversion Phase|Sponsor Discontinued Trial|4
5967600|NCT01149655|20637390|P4|Period 1 - Conversion Phase|Lost to Follow-up|0
5967601|NCT01149655|20637391|P3|Period 1 - Conversion Phase|Lost to Follow-up|0
5967602|NCT01149655|20637392|P2|Period 1 - Conversion Phase|Lost to Follow-up|0
5967603|NCT01149655|20637393|P1|Period 1 - Conversion Phase|Lost to Follow-up|1
5967604|NCT01149538|20637436|P2|Overall Study|Withdrawal by Subject|3
5967605|NCT01149538|20637437|P1|Overall Study|Withdrawal by Subject|5
5967606|NCT01149538|20637436|P2|Overall Study|Lost to Follow-up|1
5967607|NCT01149538|20637437|P1|Overall Study|Lost to Follow-up|0
5967608|NCT01149486|20637458|P2|First Intervention|Adverse Event|1
5967609|NCT01149486|20637459|P1|First Intervention|Adverse Event|0
5967610|NCT01149473|20637483|P2|Washout of 7 Days|Withdrawal by Subject|1
5967611|NCT01149473|20637484|P1|Washout of 7 Days|Withdrawal by Subject|1
5967612|NCT01149473|20637483|P2|First Intervention|Adverse Event|1
5967613|NCT01149473|20637484|P1|First Intervention|Adverse Event|1
5967614|NCT01149460|20637502|P2|Overall Study|Withdrawal by Subject|2
5967615|NCT01149460|20637503|P1|Overall Study|Withdrawal by Subject|0
5967616|NCT01149421|20637536|P3|Overall Study|Protocol Violation|6
5967617|NCT01149421|20637537|P2|Overall Study|Protocol Violation|2
5967618|NCT01149421|20637538|P1|Overall Study|Protocol Violation|2
5967619|NCT01149421|20637536|P3|Overall Study|Entry Criteria Not Met|2
5967620|NCT01149421|20637537|P2|Overall Study|Entry Criteria Not Met|1
5967621|NCT01149421|20637538|P1|Overall Study|Entry Criteria Not Met|1
5967622|NCT01149421|20637536|P3|Overall Study|Physician Decision|6
5967623|NCT01149421|20637537|P2|Overall Study|Physician Decision|3
5967624|NCT01149421|20637538|P1|Overall Study|Physician Decision|5
5967625|NCT01149421|20637536|P3|Overall Study|Lost to Follow-up|5
5967626|NCT01149421|20637537|P2|Overall Study|Lost to Follow-up|4
5967627|NCT01149421|20637538|P1|Overall Study|Lost to Follow-up|2
5967628|NCT01149421|20637536|P3|Overall Study|Sponsor Decision|1
5967629|NCT01149421|20637537|P2|Overall Study|Sponsor Decision|1
5967630|NCT01149421|20637538|P1|Overall Study|Sponsor Decision|0
5967631|NCT01149421|20637536|P3|Overall Study|Withdrawal by Subject|13
5967632|NCT01149421|20637537|P2|Overall Study|Withdrawal by Subject|12
5967633|NCT01149421|20637538|P1|Overall Study|Withdrawal by Subject|20
5967634|NCT01149421|20637536|P3|Overall Study|Adverse Event|11
5967635|NCT01149421|20637537|P2|Overall Study|Adverse Event|6
5967636|NCT01149421|20637538|P1|Overall Study|Adverse Event|22
5967637|NCT01149369|20637619|P2|Overall Study|Adverse Event|3
5967638|NCT01149369|20637620|P1|Overall Study|Adverse Event|6
5967639|NCT01149343|20637788|P4|Overall Study|Recurrence / Progressive disease|0
5967640|NCT01149343|20637789|P3|Overall Study|Recurrence / Progressive disease|1
5967641|NCT01149343|20637790|P2|Overall Study|Recurrence / Progressive disease|0
5967642|NCT01149343|20637791|P1|Overall Study|Recurrence / Progressive disease|0
5967643|NCT01149343|20637788|P4|Overall Study|Sponsor study termination|2
5967644|NCT01149343|20637789|P3|Overall Study|Sponsor study termination|0
5967645|NCT01149343|20637790|P2|Overall Study|Sponsor study termination|0
5967646|NCT01149343|20637791|P1|Overall Study|Sponsor study termination|0
5967647|NCT01149343|20637788|P4|Overall Study|Other|14
5967648|NCT01149343|20637789|P3|Overall Study|Other|2
5967649|NCT01149343|20637790|P2|Overall Study|Other|10
5967650|NCT01149343|20637791|P1|Overall Study|Other|8
5967651|NCT01149343|20637788|P4|Overall Study|Lost to Follow-up|1
5967652|NCT01149343|20637789|P3|Overall Study|Lost to Follow-up|0
5967653|NCT01149343|20637790|P2|Overall Study|Lost to Follow-up|0
5967654|NCT01149343|20637791|P1|Overall Study|Lost to Follow-up|1
5967655|NCT01149343|20637788|P4|Overall Study|Death|18
5967656|NCT01149343|20637789|P3|Overall Study|Death|18
5967657|NCT01149343|20637790|P2|Overall Study|Death|13
5967658|NCT01149343|20637791|P1|Overall Study|Death|10
5967659|NCT01149343|20637788|P4|Overall Study|Withdrawal by Subject|5
5967660|NCT01149343|20637789|P3|Overall Study|Withdrawal by Subject|1
5967661|NCT01149343|20637790|P2|Overall Study|Withdrawal by Subject|1
5967662|NCT01149343|20637791|P1|Overall Study|Withdrawal by Subject|1
5967663|NCT01149148|20637876|P2|Overall Study|Death|0
5967664|NCT01149148|20637877|P1|Overall Study|Death|1
5967665|NCT01149148|20637876|P2|Overall Study|Lost to Follow-up|2
5967666|NCT01149148|20637877|P1|Overall Study|Lost to Follow-up|1
5967667|NCT01149096|20637887|P2|Overall Study|Lost to Follow-up|1
5967668|NCT01149096|20637888|P1|Overall Study|Lost to Follow-up|0
5967669|NCT01149057|20637912|P1|Overall Study|Other|6
5967670|NCT01149057|20637912|P1|Overall Study|High Parathyroid Hormone Value|1
5967671|NCT01149057|20637912|P1|Overall Study|Lost to Follow-up|1
5967672|NCT01149057|20637912|P1|Overall Study|Participant Non-Compliance|2
5967673|NCT01149057|20637912|P1|Overall Study|B Cell Depletion|4
5967674|NCT01149057|20637912|P1|Overall Study|Positive Hepatitis B Core Antibody|5
5967675|NCT01149057|20637912|P1|Overall Study|Withdrawal by Subject|9
5967676|NCT01149057|20637912|P1|Overall Study|Adverse Event|13
5967677|NCT01149057|20637912|P1|Overall Study|Lack of Efficacy|16
5967678|NCT01148979|20637939|P2|Overall Study|Lost to Follow-up|1
5967679|NCT01148979|20637940|P1|Overall Study|Lost to Follow-up|0
5967680|NCT01148862|20637958|P2|Second Intervention|Withdrawal by Subject|2
5967681|NCT01148862|20637959|P1|Second Intervention|Withdrawal by Subject|0
5967682|NCT01148810|20637991|P2|Overall Study|Protocol Violation|0
5967683|NCT01148810|20637992|P1|Overall Study|Protocol Violation|1
5967684|NCT01148810|20637991|P2|Overall Study|Withdrawal by Subject|2
5967685|NCT01148810|20637992|P1|Overall Study|Withdrawal by Subject|0
5967686|NCT01148810|20637991|P2|Overall Study|Lack of Efficacy|1
5967687|NCT01148810|20637992|P1|Overall Study|Lack of Efficacy|0
5967688|NCT01148810|20637991|P2|Overall Study|Adverse Event|2
5967689|NCT01148810|20637992|P1|Overall Study|Adverse Event|0
5967690|NCT01148771|20638019|P2|Washout Period|Withdrawal by Subject|1
5967691|NCT01148771|20638020|P1|Washout Period|Withdrawal by Subject|0
5967692|NCT01148693|20638040|P2|Overall Study|Attempts for cannulation were failed|10
5967693|NCT01148693|20638041|P1|Overall Study|Attempts for cannulation were failed|13
5967694|NCT01148537|20638061|P3|Overall Study|Adverse Event|1
5967695|NCT01148537|20638062|P2|Overall Study|Adverse Event|0
5967696|NCT01148537|20638063|P1|Overall Study|Adverse Event|2
5967697|NCT01148537|20638061|P3|Overall Study|Withdrawal by Subject|2
5967698|NCT01148537|20638062|P2|Overall Study|Withdrawal by Subject|0
5967699|NCT01148537|20638063|P1|Overall Study|Withdrawal by Subject|1
5967700|NCT01148511|20638149|P3|Randomized|Other|1
5967701|NCT01148511|20638150|P2|Randomized|Other|1
5967702|NCT01148511|20638151|P1|Randomized|Other|0
5967703|NCT01148511|20638149|P3|Randomized|Consent withdrawal|3
5967704|NCT01148511|20638150|P2|Randomized|Consent withdrawal|5
5967705|NCT01148511|20638151|P1|Randomized|Consent withdrawal|0
5967706|NCT01148511|20638149|P3|Randomized|Lost to Follow-up|1
5967707|NCT01148511|20638150|P2|Randomized|Lost to Follow-up|1
5967708|NCT01148511|20638151|P1|Randomized|Lost to Follow-up|0
5967709|NCT01148511|20638149|P3|Randomized|Protocol Violation|1
5967710|NCT01148511|20638150|P2|Randomized|Protocol Violation|2
5967711|NCT01148511|20638151|P1|Randomized|Protocol Violation|0
5967712|NCT01148511|20638149|P3|Randomized|Adverse Event|0
5967713|NCT01148511|20638150|P2|Randomized|Adverse Event|1
5967714|NCT01148511|20638151|P1|Randomized|Adverse Event|0
5967715|NCT01148511|20638149|P3|Exposed to Study Drug|Lost to Follow-up|0
5967716|NCT01148511|20638150|P2|Exposed to Study Drug|Lost to Follow-up|0
5967717|NCT01148511|20638151|P1|Exposed to Study Drug|Lost to Follow-up|4
5967718|NCT01148511|20638149|P3|Exposed to Study Drug|Protocol Violation|0
5967719|NCT01148511|20638150|P2|Exposed to Study Drug|Protocol Violation|0
5967720|NCT01148511|20638151|P1|Exposed to Study Drug|Protocol Violation|2
5967721|NCT01148459|20638172|P2|Overall Study|Failure to comply with study procedures|1
5967722|NCT01148459|20638173|P1|Overall Study|Failure to comply with study procedures|0
5967723|NCT01148459|20638172|P2|Overall Study|Refusal|0
5967724|NCT01148459|20638173|P1|Overall Study|Refusal|1
5967725|NCT01148459|20638172|P2|Overall Study|Lost to Follow-up|0
5967726|NCT01148459|20638173|P1|Overall Study|Lost to Follow-up|2
5967727|NCT01148459|20638172|P2|Overall Study|Migrated/moved from study area|6
5967728|NCT01148459|20638173|P1|Overall Study|Migrated/moved from study area|3
5967729|NCT01148459|20638172|P2|Overall Study|Withdrawal by Subject|0
5967730|NCT01148459|20638173|P1|Overall Study|Withdrawal by Subject|1
5967731|NCT01148459|20638172|P2|Overall Study|Serious Adverse Event|4
5967732|NCT01148459|20638173|P1|Overall Study|Serious Adverse Event|5
5967733|NCT01148225|20638221|P1|Overall Study|Other|185
5967734|NCT01148017|20638272|P4|Overall Study|Unable to classify|0
5967735|NCT01148017|20638273|P3|Overall Study|Unable to classify|0
5967736|NCT01148017|20638274|P2|Overall Study|Unable to classify|1
5967737|NCT01148017|20638275|P1|Overall Study|Unable to classify|3
5967738|NCT01148017|20638272|P4|Overall Study|Administrative reason|0
5967739|NCT01148017|20638273|P3|Overall Study|Administrative reason|0
5967740|NCT01148017|20638274|P2|Overall Study|Administrative reason|9
5967741|NCT01148017|20638275|P1|Overall Study|Administrative reason|22
5967742|NCT01148017|20638272|P4|Overall Study|Inappropriate enrollment|0
5967743|NCT01148017|20638273|P3|Overall Study|Inappropriate enrollment|0
5967744|NCT01148017|20638274|P2|Overall Study|Inappropriate enrollment|0
5967745|NCT01148017|20638275|P1|Overall Study|Inappropriate enrollment|1
5967746|NCT01148017|20638272|P4|Overall Study|Lost to Follow-up|0
5967747|NCT01148017|20638273|P3|Overall Study|Lost to Follow-up|0
5967748|NCT01148017|20638274|P2|Overall Study|Lost to Follow-up|10
5967749|NCT01148017|20638275|P1|Overall Study|Lost to Follow-up|23
5967750|NCT01148017|20638272|P4|Overall Study|Withdrawal by Subject|0
5967751|NCT01148017|20638273|P3|Overall Study|Withdrawal by Subject|0
5967752|NCT01148017|20638274|P2|Overall Study|Withdrawal by Subject|14
5967753|NCT01148017|20638275|P1|Overall Study|Withdrawal by Subject|31
5967754|NCT01147926|20638314|P2|Overall Study|Colonoscopy result|1
5967755|NCT01147926|20638315|P1|Overall Study|Colonoscopy result|0
5967756|NCT01147926|20638314|P2|Overall Study|Went on holiday|1
5967757|NCT01147926|20638315|P1|Overall Study|Went on holiday|0
5967758|NCT01147926|20638314|P2|Overall Study|Too busy, no time for study|0
5967759|NCT01147926|20638315|P1|Overall Study|Too busy, no time for study|1
5967760|NCT01147926|20638314|P2|Overall Study|Lack of Efficacy|0
5967761|NCT01147926|20638315|P1|Overall Study|Lack of Efficacy|1
5967762|NCT01147926|20638314|P2|Overall Study|Sponsor's Decision|1
5967763|NCT01147926|20638315|P1|Overall Study|Sponsor's Decision|0
5967764|NCT01147926|20638314|P2|Overall Study|Lost to Follow-up|2
5967765|NCT01147926|20638315|P1|Overall Study|Lost to Follow-up|0
5967766|NCT01147926|20638314|P2|Overall Study|Selection criteria not met|1
5967767|NCT01147926|20638315|P1|Overall Study|Selection criteria not met|3
5967768|NCT01147926|20638314|P2|Overall Study|Principal investigator left hospital|3
5967769|NCT01147926|20638315|P1|Overall Study|Principal investigator left hospital|1
5967770|NCT01147926|20638314|P2|Overall Study|Subject Non-Compliant|4
5967771|NCT01147926|20638315|P1|Overall Study|Subject Non-Compliant|5
5967772|NCT01147926|20638314|P2|Overall Study|Adverse Event|6
5967773|NCT01147926|20638315|P1|Overall Study|Adverse Event|7
5967774|NCT01147926|20638314|P2|Overall Study|Subject Withdrew Consent|10
5967775|NCT01147926|20638315|P1|Overall Study|Subject Withdrew Consent|9
5967776|NCT01147900|20638350|P3|At Year 10|Lost to Follow-up|0
5967777|NCT01147900|20638351|P2|At Year 10|Lost to Follow-up|1
5967778|NCT01147900|20638352|P1|At Year 10|Lost to Follow-up|0
5967779|NCT01147874|20638411|P1|Overall Study|Withdrawal by Subject|24
5967780|NCT01147874|20638411|P1|Overall Study|Sponsor's Decision|2
5967781|NCT01147874|20638411|P1|Overall Study|Protocol Violation|5
5967782|NCT01147874|20638411|P1|Overall Study|Other|5
5967783|NCT01147874|20638411|P1|Overall Study|Lost to Follow-up|25
5967784|NCT01147874|20638411|P1|Overall Study|Investigator's Request|1
5967785|NCT01147874|20638411|P1|Overall Study|Adverse Event|5
5967786|NCT01147848|20638419|P3|Randomized Phase|Withdrawal by Subject|9
5967787|NCT01147848|20638420|P2|Randomized Phase|Withdrawal by Subject|7
5967788|NCT01147848|20638421|P1|Randomized Phase|Withdrawal by Subject|0
5967789|NCT01147848|20638419|P3|Randomized Phase|Physician Decision|1
5967790|NCT01147848|20638420|P2|Randomized Phase|Physician Decision|0
5967791|NCT01147848|20638421|P1|Randomized Phase|Physician Decision|0
5967792|NCT01147848|20638419|P3|Randomized Phase|Lost to Follow-up|7
5967793|NCT01147848|20638420|P2|Randomized Phase|Lost to Follow-up|5
5967794|NCT01147848|20638421|P1|Randomized Phase|Lost to Follow-up|0
5967795|NCT01147848|20638419|P3|Randomized Phase|Protocol Violation|10
5967796|NCT01147848|20638420|P2|Randomized Phase|Protocol Violation|7
5967797|NCT01147848|20638421|P1|Randomized Phase|Protocol Violation|0
5967798|NCT01147848|20638419|P3|Randomized Phase|Lack of Efficacy|11
5967799|NCT01147848|20638420|P2|Randomized Phase|Lack of Efficacy|20
5967800|NCT01147848|20638421|P1|Randomized Phase|Lack of Efficacy|0
5967801|NCT01147848|20638419|P3|Randomized Phase|Adverse Event|8
5967802|NCT01147848|20638420|P2|Randomized Phase|Adverse Event|6
5967803|NCT01147848|20638421|P1|Randomized Phase|Adverse Event|0
5967804|NCT01147848|20638419|P3|Run-in Period|Run-in Failure|0
5967805|NCT01147848|20638420|P2|Run-in Period|Run-in Failure|0
5967806|NCT01147848|20638421|P1|Run-in Period|Run-in Failure|135
5967807|NCT01147848|20638419|P3|Run-in Period|Screen Failure|0
5967808|NCT01147848|20638420|P2|Run-in Period|Screen Failure|0
5967809|NCT01147848|20638421|P1|Run-in Period|Screen Failure|623
5967810|NCT01147822|20638453|P2|Overall Study|Not Completed/Ongoing|102
5967811|NCT01147822|20638454|P1|Overall Study|Not Completed/Ongoing|111
5967812|NCT01147822|20638453|P2|Overall Study|Withdrawal by Subject|13
5967813|NCT01147822|20638454|P1|Overall Study|Withdrawal by Subject|8
5967814|NCT01147822|20638453|P2|Overall Study|Physician Decision|2
5967815|NCT01147822|20638454|P1|Overall Study|Physician Decision|0
5967816|NCT01147822|20638453|P2|Overall Study|Lost to Follow-up|2
5967817|NCT01147822|20638454|P1|Overall Study|Lost to Follow-up|3
5967818|NCT01147822|20638453|P2|Overall Study|Protocol Violation|1
5967819|NCT01147822|20638454|P1|Overall Study|Protocol Violation|0
5967820|NCT01147822|20638453|P2|Overall Study|Death|59
5967821|NCT01147822|20638454|P1|Overall Study|Death|66
5967822|NCT01147809|20638474|P6|Phase II (168 Days)|Ongoing|0
5967823|NCT01147809|20638475|P5|Phase II (168 Days)|Ongoing|1
5967824|NCT01147809|20638476|P4|Phase II (168 Days)|Ongoing|0
5967825|NCT01147809|20638477|P3|Phase II (168 Days)|Ongoing|0
5967826|NCT01147809|20638478|P2|Phase II (168 Days)|Ongoing|0
5967827|NCT01147809|20638479|P1|Phase II (168 Days)|Ongoing|0
5967828|NCT01147809|20638474|P6|Phase II (168 Days)|Withdrawal by Subject|15
5967829|NCT01147809|20638475|P5|Phase II (168 Days)|Withdrawal by Subject|7
5967830|NCT01147809|20638476|P4|Phase II (168 Days)|Withdrawal by Subject|0
5967831|NCT01147809|20638477|P3|Phase II (168 Days)|Withdrawal by Subject|0
5967832|NCT01147809|20638478|P2|Phase II (168 Days)|Withdrawal by Subject|0
5967833|NCT01147809|20638479|P1|Phase II (168 Days)|Withdrawal by Subject|0
5967834|NCT01147809|20638474|P6|Phase II (168 Days)|Physician Decision|11
5967835|NCT01147809|20638475|P5|Phase II (168 Days)|Physician Decision|5
5967836|NCT01147809|20638476|P4|Phase II (168 Days)|Physician Decision|0
5967837|NCT01147809|20638477|P3|Phase II (168 Days)|Physician Decision|0
5967838|NCT01147809|20638478|P2|Phase II (168 Days)|Physician Decision|0
5967839|NCT01147809|20638479|P1|Phase II (168 Days)|Physician Decision|0
5967840|NCT01147809|20638474|P6|Phase II (168 Days)|Protocol Violation|1
5967841|NCT01147809|20638475|P5|Phase II (168 Days)|Protocol Violation|0
5967842|NCT01147809|20638476|P4|Phase II (168 Days)|Protocol Violation|0
5967843|NCT01147809|20638477|P3|Phase II (168 Days)|Protocol Violation|0
5967844|NCT01147809|20638478|P2|Phase II (168 Days)|Protocol Violation|0
5967845|NCT01147809|20638479|P1|Phase II (168 Days)|Protocol Violation|0
5967846|NCT01147809|20638474|P6|Phase II (168 Days)|Adverse Event|6
5967847|NCT01147809|20638475|P5|Phase II (168 Days)|Adverse Event|3
5967848|NCT01147809|20638476|P4|Phase II (168 Days)|Adverse Event|0
5967849|NCT01147809|20638477|P3|Phase II (168 Days)|Adverse Event|0
5967850|NCT01147809|20638478|P2|Phase II (168 Days)|Adverse Event|0
5967851|NCT01147809|20638479|P1|Phase II (168 Days)|Adverse Event|0
5967852|NCT01147809|20638474|P6|Phase I (168 Days)|Withdrawal by Subject|0
5967853|NCT01147809|20638475|P5|Phase I (168 Days)|Withdrawal by Subject|0
5967854|NCT01147809|20638476|P4|Phase I (168 Days)|Withdrawal by Subject|3
5967855|NCT01147809|20638477|P3|Phase I (168 Days)|Withdrawal by Subject|0
5967856|NCT01147809|20638478|P2|Phase I (168 Days)|Withdrawal by Subject|0
5967857|NCT01147809|20638479|P1|Phase I (168 Days)|Withdrawal by Subject|0
5967858|NCT01147809|20638474|P6|Phase I (168 Days)|Physician Decision|0
5967859|NCT01147809|20638475|P5|Phase I (168 Days)|Physician Decision|0
5967860|NCT01147809|20638476|P4|Phase I (168 Days)|Physician Decision|0
5967861|NCT01147809|20638477|P3|Phase I (168 Days)|Physician Decision|2
5967862|NCT01147809|20638478|P2|Phase I (168 Days)|Physician Decision|1
5967863|NCT01147809|20638479|P1|Phase I (168 Days)|Physician Decision|0
5967864|NCT01147809|20638474|P6|Phase I (168 Days)|Lost to Follow-up|0
5967865|NCT01147809|20638475|P5|Phase I (168 Days)|Lost to Follow-up|0
5967866|NCT01147809|20638476|P4|Phase I (168 Days)|Lost to Follow-up|1
5967867|NCT01147809|20638477|P3|Phase I (168 Days)|Lost to Follow-up|0
5967868|NCT01147809|20638478|P2|Phase I (168 Days)|Lost to Follow-up|0
5967869|NCT01147809|20638479|P1|Phase I (168 Days)|Lost to Follow-up|1
5967870|NCT01147809|20638474|P6|Phase I (168 Days)|Adverse Event|0
5967871|NCT01147809|20638475|P5|Phase I (168 Days)|Adverse Event|0
5967872|NCT01147809|20638476|P4|Phase I (168 Days)|Adverse Event|1
5967873|NCT01147809|20638477|P3|Phase I (168 Days)|Adverse Event|0
5967874|NCT01147809|20638478|P2|Phase I (168 Days)|Adverse Event|0
5967875|NCT01147809|20638479|P1|Phase I (168 Days)|Adverse Event|0
5967876|NCT01147744|20638600|P7|Overall Study|Met Protocol-defined Stopping Criteria|0
5967877|NCT01147744|20638601|P6|Overall Study|Met Protocol-defined Stopping Criteria|1
5967878|NCT01147744|20638602|P5|Overall Study|Met Protocol-defined Stopping Criteria|0
5967879|NCT01147744|20638603|P4|Overall Study|Met Protocol-defined Stopping Criteria|0
5967880|NCT01147744|20638604|P3|Overall Study|Met Protocol-defined Stopping Criteria|0
5967881|NCT01147744|20638605|P2|Overall Study|Met Protocol-defined Stopping Criteria|0
5967882|NCT01147744|20638606|P1|Overall Study|Met Protocol-defined Stopping Criteria|1
5967883|NCT01147744|20638600|P7|Overall Study|Sponsor decision to amend protocol|6
5967884|NCT01147744|20638601|P6|Overall Study|Sponsor decision to amend protocol|2
5967885|NCT01147744|20638602|P5|Overall Study|Sponsor decision to amend protocol|7
5967886|NCT01147744|20638603|P4|Overall Study|Sponsor decision to amend protocol|5
5967887|NCT01147744|20638604|P3|Overall Study|Sponsor decision to amend protocol|2
5967888|NCT01147744|20638605|P2|Overall Study|Sponsor decision to amend protocol|4
5967889|NCT01147744|20638606|P1|Overall Study|Sponsor decision to amend protocol|7
5967890|NCT01147744|20638600|P7|Overall Study|Lost to Follow-up|0
5967891|NCT01147744|20638601|P6|Overall Study|Lost to Follow-up|0
5967892|NCT01147744|20638602|P5|Overall Study|Lost to Follow-up|0
5967893|NCT01147744|20638603|P4|Overall Study|Lost to Follow-up|0
5967894|NCT01147744|20638604|P3|Overall Study|Lost to Follow-up|0
5967895|NCT01147744|20638605|P2|Overall Study|Lost to Follow-up|1
5967896|NCT01147744|20638606|P1|Overall Study|Lost to Follow-up|0
5967897|NCT01147744|20638600|P7|Overall Study|Withdrawal by Subject|2
5967898|NCT01147744|20638601|P6|Overall Study|Withdrawal by Subject|5
5967899|NCT01147744|20638602|P5|Overall Study|Withdrawal by Subject|2
5967900|NCT01147744|20638603|P4|Overall Study|Withdrawal by Subject|2
5967901|NCT01147744|20638604|P3|Overall Study|Withdrawal by Subject|2
5967902|NCT01147744|20638605|P2|Overall Study|Withdrawal by Subject|4
5967903|NCT01147744|20638606|P1|Overall Study|Withdrawal by Subject|8
5967904|NCT01147744|20638600|P7|Overall Study|Adverse Event|2
5967905|NCT01147744|20638601|P6|Overall Study|Adverse Event|1
5967906|NCT01147744|20638602|P5|Overall Study|Adverse Event|2
5967907|NCT01147744|20638603|P4|Overall Study|Adverse Event|0
5967908|NCT01147744|20638604|P3|Overall Study|Adverse Event|3
5967909|NCT01147744|20638605|P2|Overall Study|Adverse Event|2
5967910|NCT01147744|20638606|P1|Overall Study|Adverse Event|1
5967911|NCT01147744|20638600|P7|Overall Study|Lack of Efficacy|7
5967912|NCT01147744|20638601|P6|Overall Study|Lack of Efficacy|8
5967913|NCT01147744|20638602|P5|Overall Study|Lack of Efficacy|13
5967914|NCT01147744|20638603|P4|Overall Study|Lack of Efficacy|11
5967915|NCT01147744|20638604|P3|Overall Study|Lack of Efficacy|9
5967916|NCT01147744|20638605|P2|Overall Study|Lack of Efficacy|11
5967917|NCT01147744|20638606|P1|Overall Study|Lack of Efficacy|11
5967918|NCT01147744|20638600|P7|Overall Study|Physician Decision|1
5967919|NCT01147744|20638601|P6|Overall Study|Physician Decision|0
5967920|NCT01147744|20638602|P5|Overall Study|Physician Decision|0
5967921|NCT01147744|20638603|P4|Overall Study|Physician Decision|0
5967922|NCT01147744|20638604|P3|Overall Study|Physician Decision|1
5967923|NCT01147744|20638605|P2|Overall Study|Physician Decision|1
5967924|NCT01147744|20638606|P1|Overall Study|Physician Decision|0
5967925|NCT01147744|20638600|P7|Overall Study|Protocol Violation|1
5967926|NCT01147744|20638601|P6|Overall Study|Protocol Violation|3
5967927|NCT01147744|20638602|P5|Overall Study|Protocol Violation|1
5967928|NCT01147744|20638603|P4|Overall Study|Protocol Violation|0
5967929|NCT01147744|20638604|P3|Overall Study|Protocol Violation|1
5967930|NCT01147744|20638605|P2|Overall Study|Protocol Violation|0
5967931|NCT01147744|20638606|P1|Overall Study|Protocol Violation|1
5967932|NCT01147653|20638701|P2|Year 2|Withdrawal by Subject|3
5967933|NCT01147653|20638702|P1|Year 2|Withdrawal by Subject|2
5967934|NCT01147640|20638763|P2|Overall Study|Didn't meet eligibility criteria|0
5967935|NCT01147640|20638764|P1|Overall Study|Didn't meet eligibility criteria|1
5967936|NCT01147640|20638763|P2|Overall Study|Lost to Follow-up|1
5967937|NCT01147640|20638764|P1|Overall Study|Lost to Follow-up|0
5967938|NCT01147640|20638763|P2|Overall Study|Withdrawal by Subject|0
5967939|NCT01147640|20638764|P1|Overall Study|Withdrawal by Subject|1
5967940|NCT01147640|20638763|P2|Overall Study|Physician Decision|0
5967941|NCT01147640|20638764|P1|Overall Study|Physician Decision|1
5967942|NCT01147640|20638763|P2|Overall Study|Adverse Event|0
5967943|NCT01147640|20638764|P1|Overall Study|Adverse Event|2
5967944|NCT01147497|20638796|P2|Overall Study|failed insertion|0
5967945|NCT01147497|20638797|P1|Overall Study|failed insertion|2
5967946|NCT01147471|20638817|P2|6 Month Follow Up|Lost to Follow-up|2
5967947|NCT01147471|20638818|P1|6 Month Follow Up|Lost to Follow-up|4
5967948|NCT01147471|20638817|P2|3 Month Follow Up|Physician Decision|1
5967949|NCT01147471|20638818|P1|3 Month Follow Up|Physician Decision|0
5967950|NCT01147471|20638817|P2|3 Month Follow Up|Lost to Follow-up|1
5967951|NCT01147471|20638818|P1|3 Month Follow Up|Lost to Follow-up|1
5967952|NCT01147471|20638817|P2|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|1
5967953|NCT01147471|20638818|P1|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|0
5967954|NCT01147471|20638817|P2|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|1
5967955|NCT01147471|20638818|P1|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|0
5967956|NCT01147471|20638817|P2|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|1
5967957|NCT01147471|20638818|P1|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|0
5967958|NCT01147458|20638832|P4|Second Intervention|Other|0
5967959|NCT01147458|20638833|P3|Second Intervention|Other|1
5967960|NCT01147458|20638834|P2|Second Intervention|Other|0
5967961|NCT01147458|20638835|P1|Second Intervention|Other|0
5967962|NCT01147458|20638832|P4|Second Intervention|Adverse Event|1
5967963|NCT01147458|20638833|P3|Second Intervention|Adverse Event|1
5967964|NCT01147458|20638834|P2|Second Intervention|Adverse Event|0
5967965|NCT01147458|20638835|P1|Second Intervention|Adverse Event|2
5967966|NCT01147458|20638832|P4|Second Intervention|Withdrawal by Subject|0
5967967|NCT01147458|20638833|P3|Second Intervention|Withdrawal by Subject|0
5967968|NCT01147458|20638834|P2|Second Intervention|Withdrawal by Subject|1
5967969|NCT01147458|20638835|P1|Second Intervention|Withdrawal by Subject|0
5967970|NCT01147458|20638832|P4|Second Intervention|Protocol Violation|0
5967971|NCT01147458|20638833|P3|Second Intervention|Protocol Violation|1
5967972|NCT01147458|20638834|P2|Second Intervention|Protocol Violation|1
5967973|NCT01147458|20638835|P1|Second Intervention|Protocol Violation|0
5967974|NCT01147458|20638832|P4|Second Intervention|Study terminated by sponsor|3
5967975|NCT01147458|20638833|P3|Second Intervention|Study terminated by sponsor|5
5967976|NCT01147458|20638834|P2|Second Intervention|Study terminated by sponsor|5
5967977|NCT01147458|20638835|P1|Second Intervention|Study terminated by sponsor|7
5967978|NCT01147458|20638832|P4|First Intervention|Other|0
5967979|NCT01147458|20638833|P3|First Intervention|Other|0
5967980|NCT01147458|20638834|P2|First Intervention|Other|2
5967981|NCT01147458|20638835|P1|First Intervention|Other|1
5967982|NCT01147458|20638832|P4|First Intervention|Adverse Event|3
5967983|NCT01147458|20638833|P3|First Intervention|Adverse Event|2
5967984|NCT01147458|20638834|P2|First Intervention|Adverse Event|3
5967985|NCT01147458|20638835|P1|First Intervention|Adverse Event|0
5967986|NCT01147458|20638832|P4|First Intervention|Withdrawal by Subject|0
5967987|NCT01147458|20638833|P3|First Intervention|Withdrawal by Subject|1
5967988|NCT01147458|20638834|P2|First Intervention|Withdrawal by Subject|0
5967989|NCT01147458|20638835|P1|First Intervention|Withdrawal by Subject|3
5967990|NCT01147458|20638832|P4|First Intervention|Protocol Violation|3
5967991|NCT01147458|20638833|P3|First Intervention|Protocol Violation|2
5967992|NCT01147458|20638834|P2|First Intervention|Protocol Violation|3
5967993|NCT01147458|20638835|P1|First Intervention|Protocol Violation|2
5967994|NCT01147458|20638832|P4|First Intervention|Study terminated by sponsor|8
5967995|NCT01147458|20638833|P3|First Intervention|Study terminated by sponsor|7
5967996|NCT01147458|20638834|P2|First Intervention|Study terminated by sponsor|8
5967997|NCT01147458|20638835|P1|First Intervention|Study terminated by sponsor|8
5967998|NCT01147393|20638914|P1|Dose Level -1|Dose Limited Toxicity|1
5967999|NCT01147393|20638914|P1|Dose Level 1|Dose limiting Toxicity|2
5968000|NCT01147341|20638935|P2|Open Label Period|Subject moved|0
5968001|NCT01147341|20638936|P1|Open Label Period|Subject moved|1
5968002|NCT01147341|20638935|P2|Open Label Period|Lack of Efficacy|0
5968003|NCT01147341|20638936|P1|Open Label Period|Lack of Efficacy|3
5968004|NCT01147341|20638935|P2|Double Blind Period|Withdrawal by Subject|1
5968005|NCT01147341|20638936|P1|Double Blind Period|Withdrawal by Subject|0
5968006|NCT01147341|20638935|P2|Double Blind Period|Lack of Efficacy|1
5968007|NCT01147341|20638936|P1|Double Blind Period|Lack of Efficacy|1
5968008|NCT01147250|20638999|P2|Overall Study|Other than specified|1
5968009|NCT01147250|20639000|P1|Overall Study|Other than specified|0
5968010|NCT01147250|20638999|P2|Overall Study|Site termination by sponsor|5
5968011|NCT01147250|20639000|P1|Overall Study|Site termination by sponsor|13
5968012|NCT01147250|20638999|P2|Overall Study|Withdrawal by Subject|88
5968013|NCT01147250|20639000|P1|Overall Study|Withdrawal by Subject|83
5968014|NCT01147250|20638999|P2|Overall Study|Lost to Follow-up|11
5968015|NCT01147250|20639000|P1|Overall Study|Lost to Follow-up|14
5968016|NCT01147172|20639012|P1|Overall Study|Lost to Follow-up|2
5968017|NCT01147172|20639012|P1|Overall Study|Withdrawal by Subject|2
5968018|NCT01147068|20639030|P7|Subjects That Completed Safety Follow-up|Ineligible|0
5968019|NCT01147068|20639031|P6|Subjects That Completed Safety Follow-up|Ineligible|0
5968020|NCT01147068|20639032|P5|Subjects That Completed Safety Follow-up|Ineligible|0
5968021|NCT01147068|20639033|P4|Subjects That Completed Safety Follow-up|Ineligible|0
5968022|NCT01147068|20639034|P3|Subjects That Completed Safety Follow-up|Ineligible|0
5968023|NCT01147068|20639035|P2|Subjects That Completed Safety Follow-up|Ineligible|1
5968024|NCT01147068|20639036|P1|Subjects That Completed Safety Follow-up|Ineligible|0
5968025|NCT01147068|20639030|P7|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
5968026|NCT01147068|20639031|P6|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
5968027|NCT01147068|20639032|P5|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
5968028|NCT01147068|20639033|P4|Subjects That Completed Safety Follow-up|Withdrawal by Subject|2
5968029|NCT01147068|20639034|P3|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
5968030|NCT01147068|20639035|P2|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
5968031|NCT01147068|20639036|P1|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
5968032|NCT01147068|20639030|P7|Subjects That Completed Safety Follow-up|Lost to Follow-up|1
5968033|NCT01147068|20639031|P6|Subjects That Completed Safety Follow-up|Lost to Follow-up|1
5968034|NCT01147068|20639032|P5|Subjects That Completed Safety Follow-up|Lost to Follow-up|0
5968035|NCT01147068|20639033|P4|Subjects That Completed Safety Follow-up|Lost to Follow-up|0
5968036|NCT01147068|20639034|P3|Subjects That Completed Safety Follow-up|Lost to Follow-up|0
5968037|NCT01147068|20639035|P2|Subjects That Completed Safety Follow-up|Lost to Follow-up|0
5968038|NCT01147068|20639036|P1|Subjects That Completed Safety Follow-up|Lost to Follow-up|1
5968039|NCT01147068|20639030|P7|Subjects That Received 2nd Dose|Other|0
5968040|NCT01147068|20639031|P6|Subjects That Received 2nd Dose|Other|0
5968041|NCT01147068|20639032|P5|Subjects That Received 2nd Dose|Other|1
5968042|NCT01147068|20639033|P4|Subjects That Received 2nd Dose|Other|0
5968043|NCT01147068|20639034|P3|Subjects That Received 2nd Dose|Other|3
5968044|NCT01147068|20639035|P2|Subjects That Received 2nd Dose|Other|3
5968045|NCT01147068|20639036|P1|Subjects That Received 2nd Dose|Other|0
5968046|NCT01147068|20639030|P7|Subjects That Received 2nd Dose|Did not complete the study|0
5968047|NCT01147068|20639031|P6|Subjects That Received 2nd Dose|Did not complete the study|1
5968048|NCT01147068|20639032|P5|Subjects That Received 2nd Dose|Did not complete the study|0
5968049|NCT01147068|20639033|P4|Subjects That Received 2nd Dose|Did not complete the study|0
5968050|NCT01147068|20639034|P3|Subjects That Received 2nd Dose|Did not complete the study|0
5968051|NCT01147068|20639035|P2|Subjects That Received 2nd Dose|Did not complete the study|1
5968052|NCT01147068|20639036|P1|Subjects That Received 2nd Dose|Did not complete the study|0
5968053|NCT01147068|20639030|P7|Subjects That Received 2nd Dose|Ineligible|0
5968054|NCT01147068|20639031|P6|Subjects That Received 2nd Dose|Ineligible|0
5968055|NCT01147068|20639032|P5|Subjects That Received 2nd Dose|Ineligible|0
5968056|NCT01147068|20639033|P4|Subjects That Received 2nd Dose|Ineligible|0
5968057|NCT01147068|20639034|P3|Subjects That Received 2nd Dose|Ineligible|0
5968058|NCT01147068|20639035|P2|Subjects That Received 2nd Dose|Ineligible|1
5968059|NCT01147068|20639036|P1|Subjects That Received 2nd Dose|Ineligible|0
5968060|NCT01147068|20639030|P7|Subjects That Received 2nd Dose|Lost to Follow-up|0
5968061|NCT01147068|20639031|P6|Subjects That Received 2nd Dose|Lost to Follow-up|1
5968062|NCT01147068|20639032|P5|Subjects That Received 2nd Dose|Lost to Follow-up|0
5968063|NCT01147068|20639033|P4|Subjects That Received 2nd Dose|Lost to Follow-up|0
5968064|NCT01147068|20639034|P3|Subjects That Received 2nd Dose|Lost to Follow-up|0
5968065|NCT01147068|20639035|P2|Subjects That Received 2nd Dose|Lost to Follow-up|0
5968066|NCT01147068|20639036|P1|Subjects That Received 2nd Dose|Lost to Follow-up|1
5968067|NCT01147055|20639066|P2|First Intervention Period|Lost to Follow-up|0
5968068|NCT01147055|20639067|P1|First Intervention Period|Lost to Follow-up|1
5968069|NCT01146951|20639109|P2|Overall Study|Adverse Event|1
5968070|NCT01146951|20639110|P1|Overall Study|Adverse Event|4
5968071|NCT01146912|20639131|P8|Overall Study|Duplicate patient|0
5968072|NCT01146912|20639132|P7|Overall Study|Duplicate patient|0
5968073|NCT01146912|20639133|P6|Overall Study|Duplicate patient|0
5968074|NCT01146912|20639134|P5|Overall Study|Duplicate patient|0
5968075|NCT01146912|20639135|P4|Overall Study|Duplicate patient|0
5968076|NCT01146912|20639136|P3|Overall Study|Duplicate patient|1
5968077|NCT01146912|20639137|P2|Overall Study|Duplicate patient|0
5968078|NCT01146912|20639138|P1|Overall Study|Duplicate patient|0
5968079|NCT01146912|20639131|P8|Overall Study|< 14 weeks gestational age|0
5968080|NCT01146912|20639132|P7|Overall Study|< 14 weeks gestational age|0
5968081|NCT01146912|20639133|P6|Overall Study|< 14 weeks gestational age|0
5968082|NCT01146912|20639134|P5|Overall Study|< 14 weeks gestational age|0
5968083|NCT01146912|20639135|P4|Overall Study|< 14 weeks gestational age|2
5968084|NCT01146912|20639136|P3|Overall Study|< 14 weeks gestational age|3
5968085|NCT01146912|20639137|P2|Overall Study|< 14 weeks gestational age|0
5968086|NCT01146912|20639138|P1|Overall Study|< 14 weeks gestational age|0
5968087|NCT01146912|20639131|P8|Overall Study|Already received influenza vaccination|0
5968088|NCT01146912|20639132|P7|Overall Study|Already received influenza vaccination|56
5968089|NCT01146912|20639133|P6|Overall Study|Already received influenza vaccination|61
5968090|NCT01146912|20639134|P5|Overall Study|Already received influenza vaccination|41
5968091|NCT01146912|20639135|P4|Overall Study|Already received influenza vaccination|15
5968092|NCT01146912|20639136|P3|Overall Study|Already received influenza vaccination|13
5968093|NCT01146912|20639137|P2|Overall Study|Already received influenza vaccination|822
5968094|NCT01146912|20639138|P1|Overall Study|Already received influenza vaccination|817
5968095|NCT01146873|20639160|P2|Overall Study|Transfer out|6
5968096|NCT01146873|20639161|P1|Overall Study|Transfer out|0
5968097|NCT01146860|20639177|P2|Overall Study|Withdrawal by Subject|1
5968098|NCT01146860|20639178|P1|Overall Study|Withdrawal by Subject|0
5968099|NCT01146782|20639229|P1|Primary Endpoint Cohort|Physician Decision|1
5968100|NCT01146782|20639229|P1|Primary Endpoint Cohort|Withdrawal by Subject|5
5968101|NCT01146782|20639229|P1|Safety Cohort|TST <4 hrs|14
5968102|NCT01146782|20639229|P1|Safety Cohort|Control AHI <5|4
5968103|NCT01146782|20639229|P1|Safety Cohort|Withdrawal by Subject|4
5968104|NCT01146782|20639229|P1|Safety Cohort|Screen Failure|61
5968105|NCT01146782|20639229|P1|Screening Cohort|Withdrawal by Subject|29
5968106|NCT01146782|20639229|P1|Screening Cohort|Physician Decision|1
5968107|NCT01146782|20639229|P1|Screening Cohort|Lost to Follow-up|4
5968108|NCT01146782|20639229|P1|Screening Cohort|Screen Failure|187
5968109|NCT01146665|20639247|P2|Overall Study|Withdrawal by Subject|16
5968110|NCT01146665|20639248|P1|Overall Study|Withdrawal by Subject|10
5968111|NCT01146613|20639280|P2|Overall Study|Outpatient detox|0
5968112|NCT01146613|20639281|P1|Overall Study|Outpatient detox|1
5968113|NCT01146613|20639280|P2|Overall Study|schedule conflict|0
5968114|NCT01146613|20639281|P1|Overall Study|schedule conflict|1
5968115|NCT01146613|20639280|P2|Overall Study|Withdrawal by Subject|3
5968116|NCT01146613|20639281|P1|Overall Study|Withdrawal by Subject|0
5968117|NCT01146613|20639280|P2|Overall Study|Physician Decision|0
5968118|NCT01146613|20639281|P1|Overall Study|Physician Decision|1
5968119|NCT01146613|20639280|P2|Overall Study|Death|0
5968120|NCT01146613|20639281|P1|Overall Study|Death|1
5968121|NCT01146613|20639280|P2|Overall Study|Lack of Efficacy|1
5968122|NCT01146613|20639281|P1|Overall Study|Lack of Efficacy|0
5968123|NCT01146613|20639280|P2|Overall Study|Lost to Follow-up|8
5968124|NCT01146613|20639281|P1|Overall Study|Lost to Follow-up|3
5968125|NCT01146288|20639391|P2|First Intervention(1 Day)|Adverse Event|1
5968126|NCT01146288|20639392|P1|First Intervention(1 Day)|Adverse Event|0
5968127|NCT01146054|20639406|P1|Overall Study|Lost to Follow-up|1
5968128|NCT01146054|20639406|P1|Overall Study|Other illness precluded treatment|2
5968129|NCT01146054|20639406|P1|Overall Study|Rapid tumor progression|2
5968130|NCT01146054|20639406|P1|Overall Study|Did not meet dose constraints for SBRT|5
5968131|NCT01145898|20639416|P2|3-year Treatment|medication change by treating physician|16
5968132|NCT01145898|20639417|P1|3-year Treatment|medication change by treating physician|3
5968133|NCT01145885|20639448|P1|Overall Study|Progressive Disease|7
5968134|NCT01145755|20639494|P3|Overall Study|Positive urine ethanol|0
5968135|NCT01145755|20639495|P2|Overall Study|Positive urine ethanol|1
5968136|NCT01145755|20639496|P1|Overall Study|Positive urine ethanol|0
5968137|NCT01145755|20639494|P3|Overall Study|Withdrawal by Subject|1
5968138|NCT01145755|20639495|P2|Overall Study|Withdrawal by Subject|0
5968139|NCT01145755|20639496|P1|Overall Study|Withdrawal by Subject|0
5968140|NCT01145755|20639494|P3|Overall Study|Patient could not swollow medication|1
5968141|NCT01145755|20639495|P2|Overall Study|Patient could not swollow medication|0
5968142|NCT01145755|20639496|P1|Overall Study|Patient could not swollow medication|0
5968143|NCT01145755|20639494|P3|Overall Study|Lack of Efficacy|0
5968144|NCT01145755|20639495|P2|Overall Study|Lack of Efficacy|1
5968145|NCT01145755|20639496|P1|Overall Study|Lack of Efficacy|0
5968146|NCT01145755|20639494|P3|Overall Study|Study Closure|17
5968147|NCT01145755|20639495|P2|Overall Study|Study Closure|14
5968148|NCT01145755|20639496|P1|Overall Study|Study Closure|14
5968149|NCT01145755|20639494|P3|Overall Study|Protocol Violation|1
5968150|NCT01145755|20639495|P2|Overall Study|Protocol Violation|3
5968151|NCT01145755|20639496|P1|Overall Study|Protocol Violation|0
5968152|NCT01145755|20639494|P3|Overall Study|Lost to Follow-up|1
5968153|NCT01145755|20639495|P2|Overall Study|Lost to Follow-up|3
5968154|NCT01145755|20639496|P1|Overall Study|Lost to Follow-up|2
5968155|NCT01145755|20639494|P3|Overall Study|Withdrawal by Subject|2
5968156|NCT01145755|20639495|P2|Overall Study|Withdrawal by Subject|2
5968157|NCT01145755|20639496|P1|Overall Study|Withdrawal by Subject|2
5968158|NCT01145755|20639494|P3|Overall Study|Adverse Event|2
5968159|NCT01145755|20639495|P2|Overall Study|Adverse Event|4
5968160|NCT01145755|20639496|P1|Overall Study|Adverse Event|2
5968161|NCT01145625|20639523|P2|Overall Study|Pregnancy|1
5968162|NCT01145625|20639524|P1|Overall Study|Pregnancy|0
5968163|NCT01145625|20639523|P2|Overall Study|Withdrawal by Subject|16
5968164|NCT01145625|20639524|P1|Overall Study|Withdrawal by Subject|7
5968165|NCT01145625|20639523|P2|Overall Study|Protocol Violation|1
5968166|NCT01145625|20639524|P1|Overall Study|Protocol Violation|3
5968167|NCT01145625|20639523|P2|Overall Study|Adverse Event|4
5968168|NCT01145625|20639524|P1|Overall Study|Adverse Event|6
5968169|NCT01145625|20639523|P2|Overall Study|Lost to Follow-up|9
5968170|NCT01145625|20639524|P1|Overall Study|Lost to Follow-up|8
5968171|NCT01145560|20639537|P3|Overall Study|Withdrawal of therapy|1
5968172|NCT01145560|20639538|P2|Overall Study|Withdrawal of therapy|0
5968173|NCT01145560|20639539|P1|Overall Study|Withdrawal of therapy|0
5968174|NCT01145560|20639537|P3|Overall Study|False insurance information|0
5968175|NCT01145560|20639538|P2|Overall Study|False insurance information|1
5968176|NCT01145560|20639539|P1|Overall Study|False insurance information|0
5968177|NCT01145560|20639537|P3|Overall Study|Accidental unblinding of study treatment|0
5968178|NCT01145560|20639538|P2|Overall Study|Accidental unblinding of study treatment|1
5968179|NCT01145560|20639539|P1|Overall Study|Accidental unblinding of study treatment|0
5968180|NCT01145560|20639537|P3|Overall Study|No study drug by 24h after organ failure|0
5968181|NCT01145560|20639538|P2|Overall Study|No study drug by 24h after organ failure|0
5968182|NCT01145560|20639539|P1|Overall Study|No study drug by 24h after organ failure|1
5968183|NCT01145560|20639537|P3|Overall Study|Lost to Follow-up|1
5968184|NCT01145560|20639538|P2|Overall Study|Lost to Follow-up|1
5968185|NCT01145560|20639539|P1|Overall Study|Lost to Follow-up|1
5968186|NCT01145560|20639537|P3|Overall Study|Withdrawal by Subject|0
5968187|NCT01145560|20639538|P2|Overall Study|Withdrawal by Subject|1
5968188|NCT01145560|20639539|P1|Overall Study|Withdrawal by Subject|2
5968189|NCT01145508|20639565|P2|Overall Study|Never started treatment|1
5968190|NCT01145508|20639566|P1|Overall Study|Never started treatment|1
5968191|NCT01145508|20639565|P2|Overall Study|Physician Decision|1
5968192|NCT01145508|20639566|P1|Overall Study|Physician Decision|2
5968193|NCT01145508|20639565|P2|Overall Study|Death|0
5968194|NCT01145508|20639566|P1|Overall Study|Death|1
5968195|NCT01145508|20639565|P2|Overall Study|Adverse Event|0
5968196|NCT01145508|20639566|P1|Overall Study|Adverse Event|1
5968197|NCT01145495|20639572|P1|Overall Study|Disease progression after respone|1
5968198|NCT01145495|20639572|P1|Overall Study|Withdrawal by Subject|5
5968199|NCT01145495|20639572|P1|Overall Study|Adverse Event|6
5968200|NCT01145482|20639578|P2|First Intervention (1 Day)|Withdrawal by Subject|1
5968201|NCT01145482|20639579|P1|First Intervention (1 Day)|Withdrawal by Subject|0
5968202|NCT01145352|20639598|P1|Overall Study|Syringe formulation was used|1
5968203|NCT01145352|20639598|P1|Overall Study|Treated before marketing approval|4
5968204|NCT01145352|20639598|P1|Overall Study|Found to have been registered twice|6
5968205|NCT01145222|20639610|P4|Overall Study|Poor bowel preparation|1
5968206|NCT01145222|20639611|P3|Overall Study|Poor bowel preparation|0
5968207|NCT01145222|20639612|P2|Overall Study|Poor bowel preparation|0
5968208|NCT01145222|20639613|P1|Overall Study|Poor bowel preparation|0
5968209|NCT01145222|20639610|P4|Overall Study|Procedure not done (no anesthesiologist)|0
5968210|NCT01145222|20639611|P3|Overall Study|Procedure not done (no anesthesiologist)|1
5968211|NCT01145222|20639612|P2|Overall Study|Procedure not done (no anesthesiologist)|0
5968212|NCT01145222|20639613|P1|Overall Study|Procedure not done (no anesthesiologist)|0
5968213|NCT01145066|20639660|P3|Overall Study|Low platelet count|0
5968214|NCT01145066|20639661|P2|Overall Study|Low platelet count|1
5968215|NCT01145066|20639662|P1|Overall Study|Low platelet count|0
5968216|NCT01145066|20639660|P3|Overall Study|Abdominal discomfort|0
5968217|NCT01145066|20639661|P2|Overall Study|Abdominal discomfort|1
5968218|NCT01145066|20639662|P1|Overall Study|Abdominal discomfort|0
5968219|NCT01145066|20639660|P3|Overall Study|problems swallowing capsule|0
5968220|NCT01145066|20639661|P2|Overall Study|problems swallowing capsule|0
5968221|NCT01145066|20639662|P1|Overall Study|problems swallowing capsule|1
5968222|NCT01145066|20639660|P3|Overall Study|To start new med|0
5968223|NCT01145066|20639661|P2|Overall Study|To start new med|0
5968224|NCT01145066|20639662|P1|Overall Study|To start new med|1
5968225|NCT01145066|20639660|P3|Overall Study|Withdrawal by Subject|2
5968226|NCT01145066|20639661|P2|Overall Study|Withdrawal by Subject|0
5968227|NCT01145066|20639662|P1|Overall Study|Withdrawal by Subject|0
5968228|NCT01145066|20639660|P3|Overall Study|Non-related surgery|1
5968229|NCT01145066|20639661|P2|Overall Study|Non-related surgery|0
5968230|NCT01145066|20639662|P1|Overall Study|Non-related surgery|0
5968231|NCT01145066|20639660|P3|Overall Study|To resume NSAIDs|1
5968232|NCT01145066|20639661|P2|Overall Study|To resume NSAIDs|2
5968233|NCT01145066|20639662|P1|Overall Study|To resume NSAIDs|2
5968234|NCT01145053|20639730|P1|Overall Study|Other|18
5968235|NCT01145053|20639730|P1|Overall Study|Withdrawal by Subject|25
5968236|NCT01145053|20639730|P1|Overall Study|Lost to Follow-up|28
5968237|NCT01145053|20639730|P1|Overall Study|Adverse Event|22
5968238|NCT01144715|20639782|P2|Overall Study|Adverse Event|1
5968239|NCT01144715|20639783|P1|Overall Study|Adverse Event|0
5968240|NCT01144715|20639782|P2|Overall Study|Withdrawal by Subject|1
5968241|NCT01144715|20639783|P1|Overall Study|Withdrawal by Subject|2
5968242|NCT01144715|20639782|P2|Overall Study|Lost to Follow-up|1
5968243|NCT01144715|20639783|P1|Overall Study|Lost to Follow-up|2
5968244|NCT01144663|20639799|P4|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|0
5968245|NCT01144663|20639800|P3|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|5
5968246|NCT01144663|20639801|P2|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|6
5968247|NCT01144663|20639802|P1|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|4
5968248|NCT01144663|20639799|P4|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|0
5968249|NCT01144663|20639800|P3|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1
5968250|NCT01144663|20639801|P2|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|3
5968251|NCT01144663|20639802|P1|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1
5968252|NCT01144663|20639799|P4|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1
5968253|NCT01144663|20639800|P3|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1
5968254|NCT01144663|20639801|P2|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0
5968255|NCT01144663|20639802|P1|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0
5968256|NCT01144663|20639799|P4|Booster Vaccination Phase|Lost to Follow-up|0
5968257|NCT01144663|20639800|P3|Booster Vaccination Phase|Lost to Follow-up|3
5968258|NCT01144663|20639801|P2|Booster Vaccination Phase|Lost to Follow-up|1
5968259|NCT01144663|20639802|P1|Booster Vaccination Phase|Lost to Follow-up|2
5968260|NCT01144663|20639799|P4|Booster Vaccination Phase|Migrated/moved from study area|0
5968261|NCT01144663|20639800|P3|Booster Vaccination Phase|Migrated/moved from study area|1
5968262|NCT01144663|20639801|P2|Booster Vaccination Phase|Migrated/moved from study area|1
5968263|NCT01144663|20639802|P1|Booster Vaccination Phase|Migrated/moved from study area|1
5968264|NCT01144663|20639799|P4|Booster Vaccination Phase|Withdrawal by Subject|1
5968265|NCT01144663|20639800|P3|Booster Vaccination Phase|Withdrawal by Subject|1
5968266|NCT01144663|20639801|P2|Booster Vaccination Phase|Withdrawal by Subject|0
5968267|NCT01144663|20639802|P1|Booster Vaccination Phase|Withdrawal by Subject|0
5968268|NCT01144663|20639799|P4|Primary Vaccination Phase|Other|2
5968269|NCT01144663|20639800|P3|Primary Vaccination Phase|Other|0
5968270|NCT01144663|20639801|P2|Primary Vaccination Phase|Other|1
5968271|NCT01144663|20639802|P1|Primary Vaccination Phase|Other|0
5968272|NCT01144663|20639799|P4|Primary Vaccination Phase|Lost to Follow-up|2
5968273|NCT01144663|20639800|P3|Primary Vaccination Phase|Lost to Follow-up|1
5968274|NCT01144663|20639801|P2|Primary Vaccination Phase|Lost to Follow-up|0
5968275|NCT01144663|20639802|P1|Primary Vaccination Phase|Lost to Follow-up|2
5968276|NCT01144663|20639799|P4|Primary Vaccination Phase|Migrated/moved from study area|3
5968277|NCT01144663|20639800|P3|Primary Vaccination Phase|Migrated/moved from study area|2
5968278|NCT01144663|20639801|P2|Primary Vaccination Phase|Migrated/moved from study area|1
5968279|NCT01144663|20639802|P1|Primary Vaccination Phase|Migrated/moved from study area|4
5968280|NCT01144663|20639799|P4|Primary Vaccination Phase|Withdrawal by Subject|10
5968281|NCT01144663|20639800|P3|Primary Vaccination Phase|Withdrawal by Subject|3
5968282|NCT01144663|20639801|P2|Primary Vaccination Phase|Withdrawal by Subject|5
5968283|NCT01144663|20639802|P1|Primary Vaccination Phase|Withdrawal by Subject|9
5968284|NCT01144663|20639799|P4|Primary Vaccination Phase|Protocol Violation|0
5968285|NCT01144663|20639800|P3|Primary Vaccination Phase|Protocol Violation|1
5968286|NCT01144663|20639801|P2|Primary Vaccination Phase|Protocol Violation|0
5968287|NCT01144663|20639802|P1|Primary Vaccination Phase|Protocol Violation|2
5968288|NCT01144663|20639799|P4|Primary Vaccination Phase|Adverse Event|1
5968289|NCT01144663|20639800|P3|Primary Vaccination Phase|Adverse Event|0
5968290|NCT01144663|20639801|P2|Primary Vaccination Phase|Adverse Event|0
5968291|NCT01144663|20639802|P1|Primary Vaccination Phase|Adverse Event|1
5968292|NCT01144663|20639799|P4|Primary Vaccination Phase|Serious adverse event, fatal|0
5968293|NCT01144663|20639800|P3|Primary Vaccination Phase|Serious adverse event, fatal|1
5968294|NCT01144663|20639801|P2|Primary Vaccination Phase|Serious adverse event, fatal|0
5968295|NCT01144663|20639802|P1|Primary Vaccination Phase|Serious adverse event, fatal|2
5968296|NCT01144416|20640140|P2|Intervention Period|Other|5
5968297|NCT01144416|20640141|P1|Intervention Period|Other|7
5968298|NCT01144416|20640140|P2|Intervention Period|No/too few/bad quality embryos|3
5968299|NCT01144416|20640141|P1|Intervention Period|No/too few/bad quality embryos|3
5968300|NCT01144416|20640140|P2|Intervention Period|No or abnormal fertilization|10
5968301|NCT01144416|20640141|P1|Intervention Period|No or abnormal fertilization|25
5968302|NCT01144416|20640140|P2|Intervention Period|No/too few/bad oocytes|5
5968303|NCT01144416|20640141|P1|Intervention Period|No/too few/bad oocytes|7
5968304|NCT01144416|20640140|P2|Intervention Period|Too high ovarian response|2
5968305|NCT01144416|20640141|P1|Intervention Period|Too high ovarian response|4
5968306|NCT01144416|20640140|P2|Intervention Period|Risk of OHSS|1
5968307|NCT01144416|20640141|P1|Intervention Period|Risk of OHSS|0
5968308|NCT01144416|20640140|P2|Intervention Period|Insufficient ovarian response|17
5968309|NCT01144416|20640141|P1|Intervention Period|Insufficient ovarian response|11
5968310|NCT01144416|20640140|P2|Intervention Period|Adverse Event|6
5968311|NCT01144416|20640141|P1|Intervention Period|Adverse Event|5
5968312|NCT01144403|20640157|P1|Overall Study|Adverse Event|1
5968313|NCT01144403|20640157|P1|Overall Study|Death|1
5968314|NCT01144403|20640157|P1|Overall Study|Lost to Follow-up|3
5968315|NCT01144377|20640169|P5|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0
5968316|NCT01144377|20640170|P4|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0
5968317|NCT01144377|20640171|P3|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0
5968318|NCT01144377|20640172|P2|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0
5968319|NCT01144377|20640173|P1|Optional 40 Week Safety Follow-up Period|Sponsor Decision|1
5968320|NCT01144377|20640169|P5|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|1
5968321|NCT01144377|20640170|P4|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0
5968322|NCT01144377|20640171|P3|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0
5968323|NCT01144377|20640172|P2|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0
5968324|NCT01144377|20640173|P1|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0
5968325|NCT01144377|20640169|P5|Optional 40 Week Safety Follow-up Period|Adverse Event|1
5968326|NCT01144377|20640170|P4|Optional 40 Week Safety Follow-up Period|Adverse Event|0
5968327|NCT01144377|20640171|P3|Optional 40 Week Safety Follow-up Period|Adverse Event|0
5968328|NCT01144377|20640172|P2|Optional 40 Week Safety Follow-up Period|Adverse Event|1
5968329|NCT01144377|20640173|P1|Optional 40 Week Safety Follow-up Period|Adverse Event|0
5968330|NCT01144377|20640169|P5|52 Week Treatment Period|Sponsor Decision|1
5968331|NCT01144377|20640170|P4|52 Week Treatment Period|Sponsor Decision|0
5968332|NCT01144377|20640171|P3|52 Week Treatment Period|Sponsor Decision|0
5968333|NCT01144377|20640172|P2|52 Week Treatment Period|Sponsor Decision|0
5968334|NCT01144377|20640173|P1|52 Week Treatment Period|Sponsor Decision|0
5968335|NCT01144377|20640169|P5|52 Week Treatment Period|Withdrawal by Subject|0
5968336|NCT01144377|20640170|P4|52 Week Treatment Period|Withdrawal by Subject|1
5968337|NCT01144377|20640171|P3|52 Week Treatment Period|Withdrawal by Subject|1
5968338|NCT01144377|20640172|P2|52 Week Treatment Period|Withdrawal by Subject|1
5968339|NCT01144377|20640173|P1|52 Week Treatment Period|Withdrawal by Subject|4
5968340|NCT01144377|20640169|P5|52 Week Treatment Period|Lost to Follow-up|0
5968341|NCT01144377|20640170|P4|52 Week Treatment Period|Lost to Follow-up|0
5968342|NCT01144377|20640171|P3|52 Week Treatment Period|Lost to Follow-up|0
5968343|NCT01144377|20640172|P2|52 Week Treatment Period|Lost to Follow-up|0
5968344|NCT01144377|20640173|P1|52 Week Treatment Period|Lost to Follow-up|1
5968345|NCT01144377|20640169|P5|52 Week Treatment Period|Protocol Violation|1
5968346|NCT01144377|20640170|P4|52 Week Treatment Period|Protocol Violation|0
5968347|NCT01144377|20640171|P3|52 Week Treatment Period|Protocol Violation|0
5968348|NCT01144377|20640172|P2|52 Week Treatment Period|Protocol Violation|0
5968349|NCT01144377|20640173|P1|52 Week Treatment Period|Protocol Violation|0
5968350|NCT01144377|20640169|P5|52 Week Treatment Period|Entry Criteria Not Met|0
5968351|NCT01144377|20640170|P4|52 Week Treatment Period|Entry Criteria Not Met|1
5968352|NCT01144377|20640171|P3|52 Week Treatment Period|Entry Criteria Not Met|1
5968353|NCT01144377|20640172|P2|52 Week Treatment Period|Entry Criteria Not Met|0
5968354|NCT01144377|20640173|P1|52 Week Treatment Period|Entry Criteria Not Met|0
5968355|NCT01144377|20640169|P5|52 Week Treatment Period|Adverse Event|1
5968356|NCT01144377|20640170|P4|52 Week Treatment Period|Adverse Event|2
5968357|NCT01144377|20640171|P3|52 Week Treatment Period|Adverse Event|3
5968358|NCT01144377|20640172|P2|52 Week Treatment Period|Adverse Event|0
5968359|NCT01144377|20640173|P1|52 Week Treatment Period|Adverse Event|0
5968360|NCT01144364|20640222|P3|Follow-Up/Maintenance Phase|Physician Decision|1
5968361|NCT01144364|20640223|P2|Follow-Up/Maintenance Phase|Physician Decision|0
5968362|NCT01144364|20640224|P1|Follow-Up/Maintenance Phase|Physician Decision|0
5968363|NCT01144364|20640222|P3|Follow-Up/Maintenance Phase|Relapse|5
5968364|NCT01144364|20640223|P2|Follow-Up/Maintenance Phase|Relapse|5
5968365|NCT01144364|20640224|P1|Follow-Up/Maintenance Phase|Relapse|0
5968366|NCT01144364|20640222|P3|Follow-Up/Maintenance Phase|Lost to Follow-up|4
5968367|NCT01144364|20640223|P2|Follow-Up/Maintenance Phase|Lost to Follow-up|1
5968368|NCT01144364|20640224|P1|Follow-Up/Maintenance Phase|Lost to Follow-up|0
5968369|NCT01144364|20640222|P3|Follow-Up/Maintenance Phase|Withdrawal by Subject|1
5968370|NCT01144364|20640223|P2|Follow-Up/Maintenance Phase|Withdrawal by Subject|1
5968371|NCT01144364|20640224|P1|Follow-Up/Maintenance Phase|Withdrawal by Subject|0
5968372|NCT01144364|20640222|P3|Follow-Up/Maintenance Phase|Death|0
5968373|NCT01144364|20640223|P2|Follow-Up/Maintenance Phase|Death|2
5968374|NCT01144364|20640224|P1|Follow-Up/Maintenance Phase|Death|0
5968375|NCT01144364|20640222|P3|Follow-Up/Maintenance Phase|Adverse Event|1
5968376|NCT01144364|20640223|P2|Follow-Up/Maintenance Phase|Adverse Event|3
5968377|NCT01144364|20640224|P1|Follow-Up/Maintenance Phase|Adverse Event|0
5968378|NCT01144364|20640222|P3|Follow-Up/Maintenance Phase|Disease progression|29
5968379|NCT01144364|20640223|P2|Follow-Up/Maintenance Phase|Disease progression|23
5968380|NCT01144364|20640224|P1|Follow-Up/Maintenance Phase|Disease progression|0
5968381|NCT01144364|20640222|P3|Induction Phase|Protocol Violation|0
5968382|NCT01144364|20640223|P2|Induction Phase|Protocol Violation|0
5968383|NCT01144364|20640224|P1|Induction Phase|Protocol Violation|1
5968384|NCT01144364|20640222|P3|Induction Phase|Secondary neoplasia|0
5968385|NCT01144364|20640223|P2|Induction Phase|Secondary neoplasia|0
5968386|NCT01144364|20640224|P1|Induction Phase|Secondary neoplasia|1
5968387|NCT01144364|20640222|P3|Induction Phase|Stable disease|0
5968388|NCT01144364|20640223|P2|Induction Phase|Stable disease|0
5968389|NCT01144364|20640224|P1|Induction Phase|Stable disease|2
5968390|NCT01144364|20640222|P3|Induction Phase|Physician Decision|0
5968391|NCT01144364|20640223|P2|Induction Phase|Physician Decision|0
5968392|NCT01144364|20640224|P1|Induction Phase|Physician Decision|1
5968393|NCT01144364|20640222|P3|Induction Phase|Lost to Follow-up|0
5968394|NCT01144364|20640223|P2|Induction Phase|Lost to Follow-up|0
5968395|NCT01144364|20640224|P1|Induction Phase|Lost to Follow-up|2
5968396|NCT01144364|20640222|P3|Induction Phase|Withdrawal by Subject|0
5968397|NCT01144364|20640223|P2|Induction Phase|Withdrawal by Subject|0
5968398|NCT01144364|20640224|P1|Induction Phase|Withdrawal by Subject|1
5968399|NCT01144364|20640222|P3|Induction Phase|Death|0
5968400|NCT01144364|20640223|P2|Induction Phase|Death|0
5968401|NCT01144364|20640224|P1|Induction Phase|Death|1
5968402|NCT01144364|20640222|P3|Induction Phase|Adverse Event|0
5968403|NCT01144364|20640223|P2|Induction Phase|Adverse Event|0
5968404|NCT01144364|20640224|P1|Induction Phase|Adverse Event|9
5968405|NCT01144364|20640222|P3|Induction Phase|Disease progression|0
5968406|NCT01144364|20640223|P2|Induction Phase|Disease progression|0
5968407|NCT01144364|20640224|P1|Induction Phase|Disease progression|14
5968408|NCT01144299|20640273|P2|Overall Study|Withdrawal by Subject|0
5968409|NCT01144299|20640274|P1|Overall Study|Withdrawal by Subject|1
5968410|NCT01144299|20640273|P2|Overall Study|Lost to Follow-up|0
5968411|NCT01144299|20640274|P1|Overall Study|Lost to Follow-up|1
5968412|NCT01144182|20640319|P2|Overall Study|Lost to Follow-up|9
5968413|NCT01144182|20640320|P1|Overall Study|Lost to Follow-up|9
5968414|NCT01144182|20640319|P2|Overall Study|Withdrawal by Subject|6
5968415|NCT01144182|20640320|P1|Overall Study|Withdrawal by Subject|3
5968416|NCT01144182|20640319|P2|Overall Study|Death|6
5968417|NCT01144182|20640320|P1|Overall Study|Death|5
5968418|NCT01144052|20640380|P2|Overall Study|Withdrawal by Subject|1
5968419|NCT01144052|20640381|P1|Overall Study|Withdrawal by Subject|1
5968420|NCT01143896|20640412|P2|Overall Study|Death|3
5968421|NCT01143896|20640413|P1|Overall Study|Death|6
5968422|NCT01143896|20640412|P2|Overall Study|Withdrawal by Subject|5
5968423|NCT01143896|20640413|P1|Overall Study|Withdrawal by Subject|13
5968424|NCT01143896|20640412|P2|Overall Study|Lost to Follow-up|13
5968425|NCT01143896|20640413|P1|Overall Study|Lost to Follow-up|18
5968426|NCT01143896|20640412|P2|Overall Study|Did not complete Baseline Interview|4
5968427|NCT01143896|20640413|P1|Overall Study|Did not complete Baseline Interview|5
5968428|NCT01143714|20640525|P2|Overall Study|wound size increased|0
5968429|NCT01143714|20640526|P1|Overall Study|wound size increased|1
5968430|NCT01143714|20640525|P2|Overall Study|wound closed = deemed healed|0
5968431|NCT01143714|20640526|P1|Overall Study|wound closed = deemed healed|1
5968432|NCT01143714|20640525|P2|Overall Study|Subject non-compliance|1
5968433|NCT01143714|20640526|P1|Overall Study|Subject non-compliance|0
5968434|NCT01143714|20640525|P2|Overall Study|Withdrawal by Subject|0
5968435|NCT01143714|20640526|P1|Overall Study|Withdrawal by Subject|1
5968436|NCT01143714|20640525|P2|Overall Study|Adverse Event|2
5968437|NCT01143714|20640526|P1|Overall Study|Adverse Event|4
5968438|NCT01143402|20640631|P3|Overall Study|Not Treated|1
5968439|NCT01143402|20640632|P2|Overall Study|Not Treated|0
5968440|NCT01143402|20640633|P1|Overall Study|Not Treated|0
5968441|NCT01143402|20640631|P3|Overall Study|Rapid clinical decline|0
5968442|NCT01143402|20640632|P2|Overall Study|Rapid clinical decline|1
5968443|NCT01143402|20640633|P1|Overall Study|Rapid clinical decline|1
5968444|NCT01143389|20640644|P2|Overall Study|Lost to Follow-up|25
5968445|NCT01143389|20640645|P1|Overall Study|Lost to Follow-up|26
5968446|NCT01143337|20640659|P3|Overall Study|Other reason|5
5968447|NCT01143337|20640660|P2|Overall Study|Other reason|0
5968448|NCT01143337|20640661|P1|Overall Study|Other reason|0
5968449|NCT01143337|20640659|P3|Overall Study|Withdrawal by Subject|1
5968450|NCT01143337|20640660|P2|Overall Study|Withdrawal by Subject|0
5968451|NCT01143337|20640661|P1|Overall Study|Withdrawal by Subject|0
5968452|NCT01143337|20640659|P3|Overall Study|Protocol Violation|0
5968453|NCT01143337|20640660|P2|Overall Study|Protocol Violation|0
5968454|NCT01143337|20640661|P1|Overall Study|Protocol Violation|1
5968455|NCT01143337|20640659|P3|Overall Study|Lack of Efficacy|1
5968456|NCT01143337|20640660|P2|Overall Study|Lack of Efficacy|2
5968457|NCT01143337|20640661|P1|Overall Study|Lack of Efficacy|6
5968458|NCT01143337|20640659|P3|Overall Study|Adverse Event|5
5968459|NCT01143337|20640660|P2|Overall Study|Adverse Event|9
5968460|NCT01143337|20640661|P1|Overall Study|Adverse Event|3
5968461|NCT01143324|20640675|P1|Overall Study|Explant of the device|4
5968462|NCT01143324|20640675|P1|Overall Study|Withdrawal by Subject|4
5968463|NCT01143324|20640675|P1|Overall Study|Lost to Follow-up|11
5968464|NCT01143259|20640714|P2|Overall Study|Screen Failure|9
5968465|NCT01143259|20640715|P1|Overall Study|Screen Failure|7
5968466|NCT01143259|20640714|P2|Overall Study|Protocol Violation|9
5968467|NCT01143259|20640715|P1|Overall Study|Protocol Violation|13
5968468|NCT01143259|20640714|P2|Overall Study|Withdrawal by Subject|2
5968469|NCT01143259|20640715|P1|Overall Study|Withdrawal by Subject|3
5968470|NCT01143207|20640723|P1|Overall Study|Lost to Follow-up|2
5968471|NCT01143090|20640743|P1|Overall Study|Administrative|1
5968472|NCT01143090|20640743|P1|Overall Study|Failure to meet eligibility criteria|1
5968473|NCT01143090|20640743|P1|Overall Study|Non-compliance with study drug|1
5968474|NCT01143090|20640743|P1|Overall Study|Withdrawal by Subject|18
5968475|NCT01143090|20640743|P1|Overall Study|Protocol Violation|2
5968476|NCT01143090|20640743|P1|Overall Study|Lost to Follow-up|9
5968477|NCT01143090|20640743|P1|Overall Study|Adverse Event|17
5968478|NCT01143090|20640743|P1|Overall Study|Lack of Efficacy|2
5968479|NCT01143077|20640750|P3|Overall Study|Principal Investigator Decision|1
5968480|NCT01143077|20640751|P2|Overall Study|Principal Investigator Decision|0
5968481|NCT01143077|20640752|P1|Overall Study|Principal Investigator Decision|2
5968482|NCT01143077|20640750|P3|Overall Study|Administrative|0
5968483|NCT01143077|20640751|P2|Overall Study|Administrative|0
5968484|NCT01143077|20640752|P1|Overall Study|Administrative|1
5968485|NCT01143077|20640750|P3|Overall Study|Non-compliance with study drug|1
5968486|NCT01143077|20640751|P2|Overall Study|Non-compliance with study drug|1
5968487|NCT01143077|20640752|P1|Overall Study|Non-compliance with study drug|0
5968488|NCT01143077|20640750|P3|Overall Study|Withdrawal by Subject|3
5968489|NCT01143077|20640751|P2|Overall Study|Withdrawal by Subject|3
5968490|NCT01143077|20640752|P1|Overall Study|Withdrawal by Subject|4
5968491|NCT01143077|20640750|P3|Overall Study|Protocol Violation|0
5968492|NCT01143077|20640751|P2|Overall Study|Protocol Violation|0
5968493|NCT01143077|20640752|P1|Overall Study|Protocol Violation|2
5968494|NCT01143077|20640750|P3|Overall Study|Lost to Follow-up|4
5968495|NCT01143077|20640751|P2|Overall Study|Lost to Follow-up|3
5968496|NCT01143077|20640752|P1|Overall Study|Lost to Follow-up|2
5968497|NCT01143077|20640750|P3|Overall Study|Adverse Event|5
5968498|NCT01143077|20640751|P2|Overall Study|Adverse Event|6
5968499|NCT01143077|20640752|P1|Overall Study|Adverse Event|5
5968500|NCT01143077|20640750|P3|Overall Study|Lack of Efficacy|1
5968501|NCT01143077|20640751|P2|Overall Study|Lack of Efficacy|2
5968502|NCT01143077|20640752|P1|Overall Study|Lack of Efficacy|0
5968503|NCT01143051|20640769|P6|3-14 Day Washout|Withdrawal by Subject|1
5968504|NCT01143051|20640770|P5|3-14 Day Washout|Withdrawal by Subject|0
5968505|NCT01143051|20640771|P4|3-14 Day Washout|Withdrawal by Subject|0
5968506|NCT01143051|20640772|P3|3-14 Day Washout|Withdrawal by Subject|0
5968507|NCT01143051|20640773|P2|3-14 Day Washout|Withdrawal by Subject|0
5968508|NCT01143051|20640774|P1|3-14 Day Washout|Withdrawal by Subject|0
5968509|NCT01143051|20640769|P6|3-14 Day Washout|Withdrawal by Subject|0
5968510|NCT01143051|20640770|P5|3-14 Day Washout|Withdrawal by Subject|0
5968511|NCT01143051|20640771|P4|3-14 Day Washout|Withdrawal by Subject|0
5968512|NCT01143051|20640772|P3|3-14 Day Washout|Withdrawal by Subject|1
5968513|NCT01143051|20640773|P2|3-14 Day Washout|Withdrawal by Subject|0
5968514|NCT01143051|20640774|P1|3-14 Day Washout|Withdrawal by Subject|0
5968515|NCT01143038|20640823|P1|Overall Study|Death|1
5968516|NCT01143038|20640823|P1|Overall Study|Protocol Deviation|1
5968517|NCT01143038|20640823|P1|Overall Study|Lost to Follow-up|2
5968518|NCT01143038|20640823|P1|Overall Study|Adverse Event|3
5968519|NCT01143038|20640823|P1|Overall Study|Requirement for alternative therapy|5
5968520|NCT01143038|20640823|P1|Overall Study|Withdrawal by Subject|4
5968521|NCT01142908|20640837|P2|Overall Study|Withdrawal by Subject|0
5968522|NCT01142908|20640838|P1|Overall Study|Withdrawal by Subject|3
5968523|NCT01142908|20640837|P2|Overall Study|Excluded - did not meet criteria|5
5968524|NCT01142908|20640838|P1|Overall Study|Excluded - did not meet criteria|9
5968525|NCT01142908|20640837|P2|Overall Study|Death|4
5968526|NCT01142908|20640838|P1|Overall Study|Death|1
5968527|NCT01142908|20640837|P2|Overall Study|Lost to Follow-up|13
5968528|NCT01142908|20640838|P1|Overall Study|Lost to Follow-up|19
5968529|NCT01142791|20640884|P2|Overall Study|Received only 1 sonication|6
5968530|NCT01142791|20640885|P1|Overall Study|Received only 1 sonication|0
5968531|NCT01142791|20640884|P2|Overall Study|Withdrawal by Subject|0
5968532|NCT01142791|20640885|P1|Overall Study|Withdrawal by Subject|5
5968533|NCT01142791|20640884|P2|Overall Study|Lost to Follow-up|0
5968534|NCT01142791|20640885|P1|Overall Study|Lost to Follow-up|1
5968535|NCT01142791|20640884|P2|Overall Study|Alternative Treatment|0
5968536|NCT01142791|20640885|P1|Overall Study|Alternative Treatment|1
5968537|NCT01142726|20640892|P3|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0
5968538|NCT01142726|20640893|P2|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|1
5968539|NCT01142726|20640894|P1|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0
5968540|NCT01142726|20640892|P3|Re-Exposure Phase: Months 24 up to 30|Pregnancy|1
5968541|NCT01142726|20640893|P2|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0
5968542|NCT01142726|20640894|P1|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0
5968543|NCT01142726|20640892|P3|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1
5968544|NCT01142726|20640893|P2|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1
5968545|NCT01142726|20640894|P1|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1
5968546|NCT01142726|20640892|P3|Re-Exposure Phase: Months 24 up to 30|Adverse Event|1
5968547|NCT01142726|20640893|P2|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0
5968548|NCT01142726|20640894|P1|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0
5968549|NCT01142726|20640892|P3|Withdrawal Phase: Months 12 up to 24|non-specified|1
5968550|NCT01142726|20640893|P2|Withdrawal Phase: Months 12 up to 24|non-specified|1
5968551|NCT01142726|20640894|P1|Withdrawal Phase: Months 12 up to 24|non-specified|0
5968552|NCT01142726|20640892|P3|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|53
5968553|NCT01142726|20640893|P2|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|54
5968554|NCT01142726|20640894|P1|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|65
5968555|NCT01142726|20640892|P3|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0
5968556|NCT01142726|20640893|P2|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0
5968557|NCT01142726|20640894|P1|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|1
5968558|NCT01142726|20640892|P3|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0
5968559|NCT01142726|20640893|P2|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0
5968560|NCT01142726|20640894|P1|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|2
5968561|NCT01142726|20640892|P3|Withdrawal Phase: Months 12 up to 24|Pregnancy|1
5968562|NCT01142726|20640893|P2|Withdrawal Phase: Months 12 up to 24|Pregnancy|0
5968563|NCT01142726|20640894|P1|Withdrawal Phase: Months 12 up to 24|Pregnancy|1
5968564|NCT01142726|20640892|P3|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|2
5968565|NCT01142726|20640893|P2|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1
5968566|NCT01142726|20640894|P1|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1
5968567|NCT01142726|20640892|P3|Withdrawal Phase: Months 12 up to 24|Adverse Event|1
5968568|NCT01142726|20640893|P2|Withdrawal Phase: Months 12 up to 24|Adverse Event|0
5968569|NCT01142726|20640894|P1|Withdrawal Phase: Months 12 up to 24|Adverse Event|0
5968570|NCT01142726|20640892|P3|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|11
5968571|NCT01142726|20640893|P2|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|6
5968572|NCT01142726|20640894|P1|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|5
5968573|NCT01142726|20640892|P3|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0
5968574|NCT01142726|20640893|P2|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0
5968575|NCT01142726|20640894|P1|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|1
5968576|NCT01142726|20640892|P3|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1
5968577|NCT01142726|20640893|P2|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|2
5968578|NCT01142726|20640894|P1|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1
5968579|NCT01142726|20640892|P3|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|3
5968580|NCT01142726|20640893|P2|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|9
5968581|NCT01142726|20640894|P1|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|4
5968582|NCT01142726|20640892|P3|Treatment Phase: Day 1 Through Month 12|Adverse Event|5
5968583|NCT01142726|20640893|P2|Treatment Phase: Day 1 Through Month 12|Adverse Event|8
5968584|NCT01142726|20640894|P1|Treatment Phase: Day 1 Through Month 12|Adverse Event|5
5968585|NCT01142661|20640957|P1|Overall Study|Physician Decision|1
5968586|NCT01142661|20640957|P1|Overall Study|Withdrawal by Subject|1
5968587|NCT01142661|20640957|P1|Overall Study|Adverse Event|2
5968588|NCT01142596|20640964|P2|Overall Study|Other reason (not specified)|4
5968589|NCT01142596|20640965|P1|Overall Study|Other reason (not specified)|5
5968590|NCT01142596|20640964|P2|Overall Study|Lost to Follow-up|3
5968591|NCT01142596|20640965|P1|Overall Study|Lost to Follow-up|2
5968592|NCT01142596|20640964|P2|Overall Study|Lack of Efficacy|9
5968593|NCT01142596|20640965|P1|Overall Study|Lack of Efficacy|5
5968594|NCT01142596|20640964|P2|Overall Study|Adverse Event|35
5968595|NCT01142596|20640965|P1|Overall Study|Adverse Event|8
5968596|NCT01142596|20640964|P2|Overall Study|Withdrawal by Subject|35
5968597|NCT01142596|20640965|P1|Overall Study|Withdrawal by Subject|9
5968598|NCT01142466|20641017|P2|Overall Study|Withdrawal by Subject|1
5968599|NCT01142466|20641018|P1|Overall Study|Withdrawal by Subject|1
5968600|NCT01142466|20641017|P2|Overall Study|Adverse Event|1
5968601|NCT01142466|20641018|P1|Overall Study|Adverse Event|2
5968618|NCT01142336|20641051|P2|Overall Study|Lost to Follow-up|1
5968619|NCT01142336|20641052|P1|Overall Study|Lost to Follow-up|0
5968620|NCT01142336|20641051|P2|Overall Study|Adverse Event|1
5968621|NCT01142336|20641052|P1|Overall Study|Adverse Event|1
5968622|NCT01142232|20641089|P5|Overall Study|Noncompliance|2
5968623|NCT01142232|20641090|P4|Overall Study|Noncompliance|0
5968624|NCT01142232|20641091|P3|Overall Study|Noncompliance|0
5968625|NCT01142232|20641092|P2|Overall Study|Noncompliance|0
5968626|NCT01142232|20641093|P1|Overall Study|Noncompliance|0
5968627|NCT01142232|20641089|P5|Overall Study|Off Trt for other complicating disease|1
5968628|NCT01142232|20641090|P4|Overall Study|Off Trt for other complicating disease|0
5968629|NCT01142232|20641091|P3|Overall Study|Off Trt for other complicating disease|0
5968630|NCT01142232|20641092|P2|Overall Study|Off Trt for other complicating disease|0
5968631|NCT01142232|20641093|P1|Overall Study|Off Trt for other complicating disease|0
5968632|NCT01142232|20641089|P5|Overall Study|Alternative Therapy|1
5968633|NCT01142232|20641090|P4|Overall Study|Alternative Therapy|0
5968634|NCT01142232|20641091|P3|Overall Study|Alternative Therapy|1
5968635|NCT01142232|20641092|P2|Overall Study|Alternative Therapy|1
5968636|NCT01142232|20641093|P1|Overall Study|Alternative Therapy|0
5968637|NCT01142232|20641089|P5|Overall Study|Physician Decision|10
5968638|NCT01142232|20641090|P4|Overall Study|Physician Decision|2
5968639|NCT01142232|20641091|P3|Overall Study|Physician Decision|0
5968640|NCT01142232|20641092|P2|Overall Study|Physician Decision|1
5968641|NCT01142232|20641093|P1|Overall Study|Physician Decision|0
5968642|NCT01142232|20641089|P5|Overall Study|Withdrawal by Subject|3
5968643|NCT01142232|20641090|P4|Overall Study|Withdrawal by Subject|1
5968644|NCT01142232|20641091|P3|Overall Study|Withdrawal by Subject|0
5968645|NCT01142232|20641092|P2|Overall Study|Withdrawal by Subject|0
5968646|NCT01142232|20641093|P1|Overall Study|Withdrawal by Subject|0
5968647|NCT01142232|20641089|P5|Overall Study|Disease Progression|12
5968648|NCT01142232|20641090|P4|Overall Study|Disease Progression|2
5968649|NCT01142232|20641091|P3|Overall Study|Disease Progression|1
5968650|NCT01142232|20641092|P2|Overall Study|Disease Progression|0
5968651|NCT01142232|20641093|P1|Overall Study|Disease Progression|2
5968652|NCT01142232|20641089|P5|Overall Study|Death|1
5968653|NCT01142232|20641090|P4|Overall Study|Death|0
5968654|NCT01142232|20641091|P3|Overall Study|Death|0
5968655|NCT01142232|20641092|P2|Overall Study|Death|0
5968656|NCT01142232|20641093|P1|Overall Study|Death|0
5968657|NCT01142232|20641089|P5|Overall Study|Adverse Event|4
5968658|NCT01142232|20641090|P4|Overall Study|Adverse Event|0
5968659|NCT01142232|20641091|P3|Overall Study|Adverse Event|1
5968660|NCT01142232|20641092|P2|Overall Study|Adverse Event|2
5968661|NCT01142232|20641093|P1|Overall Study|Adverse Event|1
5968662|NCT01142193|20641108|P2|Overall Study|Other|2
5968663|NCT01142193|20641109|P1|Overall Study|Other|1
5968664|NCT01142193|20641108|P2|Overall Study|Protocol Discontinuation Criterion Met|0
5968665|NCT01142193|20641109|P1|Overall Study|Protocol Discontinuation Criterion Met|1
5968666|NCT01142193|20641108|P2|Overall Study|Withdrawal by Subject|3
5968667|NCT01142193|20641109|P1|Overall Study|Withdrawal by Subject|4
5968668|NCT01142193|20641108|P2|Overall Study|Physician Decision|1
5968669|NCT01142193|20641109|P1|Overall Study|Physician Decision|1
5968670|NCT01142193|20641108|P2|Overall Study|Lack of Efficacy|1
5968671|NCT01142193|20641109|P1|Overall Study|Lack of Efficacy|2
5968672|NCT01142193|20641108|P2|Overall Study|Adverse Event|4
5968673|NCT01142193|20641109|P1|Overall Study|Adverse Event|12
5968674|NCT01142128|20641137|P1|Overall Study|Withdrawal by Subject|2
5968675|NCT01142128|20641137|P1|Overall Study|Lost to Follow-up|1
5968676|NCT01142128|20641137|P1|Overall Study|Physician Decision|1
5968677|NCT01142115|20641147|P2|First Intervention|Adverse Event|0
5968678|NCT01142115|20641148|P1|First Intervention|Adverse Event|1
5968679|NCT01142115|20641147|P2|First Intervention|Lack of Efficacy|1
5968680|NCT01142115|20641148|P1|First Intervention|Lack of Efficacy|1
5968681|NCT01142089|20641165|P2|Overall Study|Patient required rescue medication|17
5968682|NCT01142089|20641166|P1|Overall Study|Patient required rescue medication|8
5968683|NCT01142089|20641165|P2|Overall Study|Noncompliance with study procedures|1
5968684|NCT01142089|20641166|P1|Overall Study|Noncompliance with study procedures|2
5968685|NCT01142089|20641165|P2|Overall Study|Use of prohibited medications|1
5968686|NCT01142089|20641166|P1|Overall Study|Use of prohibited medications|0
5968687|NCT01142089|20641165|P2|Overall Study|Withdrawal by Subject|2
5968688|NCT01142089|20641166|P1|Overall Study|Withdrawal by Subject|1
5968689|NCT01142089|20641165|P2|Overall Study|Physician Decision|0
5968690|NCT01142089|20641166|P1|Overall Study|Physician Decision|1
5968691|NCT01141712|20641197|P1|Overall Study|Disease progression|3
5968692|NCT01141660|20641218|P2|Overall Study|Physician Decision|12
5968693|NCT01141660|20641219|P1|Overall Study|Physician Decision|0
5968694|NCT01141283|20641287|P1|Overall Study|Lack of Efficacy|10
5968695|NCT01141283|20641287|P1|Overall Study|Administrative|4
5968696|NCT01141283|20641287|P1|Overall Study|Withdrawal by Subject|14
5968697|NCT01141283|20641287|P1|Overall Study|Lost to Follow-up|4
5968698|NCT01141283|20641287|P1|Overall Study|Adverse Event|56
5968699|NCT01141205|20641293|P2|Overall Study|Withdrawal by Subject|1
5968700|NCT01141205|20641294|P1|Overall Study|Withdrawal by Subject|1
5968701|NCT01141205|20641293|P2|Overall Study|Lost to Follow-up|0
5968702|NCT01141205|20641294|P1|Overall Study|Lost to Follow-up|1
5968703|NCT01141205|20641293|P2|Overall Study|Physician Decision|1
5968704|NCT01141205|20641294|P1|Overall Study|Physician Decision|1
5968705|NCT01140906|20641333|P4|Overall Study|Administrative or other reason|2
5968706|NCT01140906|20641334|P3|Overall Study|Administrative or other reason|3
5968707|NCT01140906|20641335|P2|Overall Study|Administrative or other reason|5
5968708|NCT01140906|20641336|P1|Overall Study|Administrative or other reason|0
5968709|NCT01140906|20641333|P4|Overall Study|Lost to Follow-up|2
5968710|NCT01140906|20641334|P3|Overall Study|Lost to Follow-up|0
5968711|NCT01140906|20641335|P2|Overall Study|Lost to Follow-up|1
5968712|NCT01140906|20641336|P1|Overall Study|Lost to Follow-up|1
5968713|NCT01140906|20641333|P4|Overall Study|Withdrawal of consent|2
5968714|NCT01140906|20641334|P3|Overall Study|Withdrawal of consent|2
5968715|NCT01140906|20641335|P2|Overall Study|Withdrawal of consent|6
5968716|NCT01140906|20641336|P1|Overall Study|Withdrawal of consent|6
5968717|NCT01140906|20641333|P4|Overall Study|Protocol Violation|1
5968718|NCT01140906|20641334|P3|Overall Study|Protocol Violation|2
5968719|NCT01140906|20641335|P2|Overall Study|Protocol Violation|3
5968720|NCT01140906|20641336|P1|Overall Study|Protocol Violation|5
5968721|NCT01140906|20641333|P4|Overall Study|Non-compliance|1
5968722|NCT01140906|20641334|P3|Overall Study|Non-compliance|0
5968723|NCT01140906|20641335|P2|Overall Study|Non-compliance|1
5968724|NCT01140906|20641336|P1|Overall Study|Non-compliance|0
5968725|NCT01140906|20641333|P4|Overall Study|Lack of Efficacy|1
5968726|NCT01140906|20641334|P3|Overall Study|Lack of Efficacy|2
5968727|NCT01140906|20641335|P2|Overall Study|Lack of Efficacy|8
5968728|NCT01140906|20641336|P1|Overall Study|Lack of Efficacy|6
5968729|NCT01140906|20641333|P4|Overall Study|Adverse Event|7
5968730|NCT01140906|20641334|P3|Overall Study|Adverse Event|17
5968731|NCT01140906|20641335|P2|Overall Study|Adverse Event|10
5968732|NCT01140906|20641336|P1|Overall Study|Adverse Event|7
5968733|NCT01140880|20641376|P2|Overall Study|Protocol Violation|30
5968734|NCT01140880|20641377|P1|Overall Study|Protocol Violation|0
5968735|NCT01140880|20641376|P2|Overall Study|Lost to Follow-up|10
5968736|NCT01140880|20641377|P1|Overall Study|Lost to Follow-up|8
5968737|NCT01140880|20641376|P2|Overall Study|Withdrawal by Subject|3
5968738|NCT01140880|20641377|P1|Overall Study|Withdrawal by Subject|6
5968739|NCT01140880|20641376|P2|Overall Study|Death|1
5968740|NCT01140880|20641377|P1|Overall Study|Death|0
5968741|NCT01140867|20641389|P1|Overall Study|Medication Noncompliance|2
5968742|NCT01140867|20641389|P1|Overall Study|Uncooperative patient|2
5968743|NCT01140867|20641389|P1|Overall Study|Protocol Violation|1
5968744|NCT01140867|20641389|P1|Overall Study|Withdrawal by Subject|1
5968745|NCT01140867|20641389|P1|Overall Study|Lost to Follow-up|2
5968746|NCT01140867|20641389|P1|Overall Study|Lack of Efficacy|3
5968747|NCT01140867|20641389|P1|Overall Study|Adverse Event|22
5968748|NCT01140646|20641429|P1|Overall Study|Refused Further Treatment|5
5968749|NCT01140646|20641429|P1|Overall Study|Adverse Event|4
5968750|NCT01140568|20641437|P1|Overall Study|Screen Fail|4
5968751|NCT01140568|20641437|P1|Overall Study|Withdrawal by Subject|1
5968752|NCT01140568|20641437|P1|Overall Study|disease progression|31
5968753|NCT01140503|20641442|P1|Overall Study|Withdrawal by Subject|1
5968754|NCT01140477|20641450|P2|Overall Study|Subject explanted|1
5968755|NCT01140477|20641451|P1|Overall Study|Subject explanted|0
5968756|NCT01140477|20641450|P2|Overall Study|Death|1
5968757|NCT01140477|20641451|P1|Overall Study|Death|1
5968758|NCT01140477|20641450|P2|Overall Study|Surgical complication preventing implant|0
5968759|NCT01140477|20641451|P1|Overall Study|Surgical complication preventing implant|2
5968760|NCT01140477|20641450|P2|Overall Study|Withdrawal by Subject|4
5968761|NCT01140477|20641451|P1|Overall Study|Withdrawal by Subject|1
5968762|NCT01140477|20641450|P2|Overall Study|Lost to Follow-up|0
5968763|NCT01140477|20641451|P1|Overall Study|Lost to Follow-up|4
5968764|NCT01140451|20641462|P2|Overall Study|Participants Planning Pregnancy|0
5968765|NCT01140451|20641463|P1|Overall Study|Participants Planning Pregnancy|3
5968766|NCT01140451|20641462|P2|Overall Study|Lost to Follow-up|0
5968767|NCT01140451|20641463|P1|Overall Study|Lost to Follow-up|2
5968768|NCT01140451|20641462|P2|Overall Study|Physician Decision|3
5968769|NCT01140451|20641463|P1|Overall Study|Physician Decision|5
5968770|NCT01140451|20641462|P2|Overall Study|Adverse Event|6
5968771|NCT01140451|20641463|P1|Overall Study|Adverse Event|2
5968772|NCT01140451|20641462|P2|Overall Study|Withdrawal by Subject|33
5968773|NCT01140451|20641463|P1|Overall Study|Withdrawal by Subject|26
5968774|NCT01140347|20641528|P2|Overall Study|Withdrawal by Subject|8
5968775|NCT01140347|20641529|P1|Overall Study|Withdrawal by Subject|13
5968776|NCT01140347|20641528|P2|Overall Study|Lost to Follow-up|6
5968777|NCT01140347|20641529|P1|Overall Study|Lost to Follow-up|5
5968778|NCT01140061|20641582|P10|Extension|Laboratory Adverse Event|1
5968779|NCT01140061|20641583|P9|Extension|Laboratory Adverse Event|0
5968780|NCT01140061|20641584|P8|Extension|Laboratory Adverse Event|0
5968781|NCT01140061|20641585|P7|Extension|Laboratory Adverse Event|0
5968782|NCT01140061|20641586|P6|Extension|Laboratory Adverse Event|0
5968783|NCT01140061|20641587|P5|Extension|Laboratory Adverse Event|0
5968784|NCT01140061|20641588|P4|Extension|Laboratory Adverse Event|0
5968785|NCT01140061|20641589|P3|Extension|Laboratory Adverse Event|0
5968786|NCT01140061|20641590|P2|Extension|Laboratory Adverse Event|0
5968787|NCT01140061|20641591|P1|Extension|Laboratory Adverse Event|0
5968788|NCT01140061|20641582|P10|Part I|Adverse Event|0
5968789|NCT01140061|20641583|P9|Part I|Adverse Event|0
5968790|NCT01140061|20641584|P8|Part I|Adverse Event|0
5968791|NCT01140061|20641585|P7|Part I|Adverse Event|0
5968792|NCT01140061|20641586|P6|Part I|Adverse Event|0
5968793|NCT01140061|20641587|P5|Part I|Adverse Event|0
5968794|NCT01140061|20641588|P4|Part I|Adverse Event|0
5968795|NCT01140061|20641589|P3|Part I|Adverse Event|0
5968796|NCT01140061|20641590|P2|Part I|Adverse Event|0
5968797|NCT01140061|20641591|P1|Part I|Adverse Event|1
5968798|NCT01140048|20641618|P1|Overall Study|Lost to Follow-up|31
5968799|NCT01140048|20641618|P1|Overall Study|Withdrawal by Subject|13
5968800|NCT01140048|20641618|P1|Overall Study|Physician Decision|1
5968801|NCT01139775|20641658|P3|Overall Study|Physician Decision|2
5968802|NCT01139775|20641659|P2|Overall Study|Physician Decision|2
5968803|NCT01139775|20641660|P1|Overall Study|Physician Decision|0
5968804|NCT01139775|20641658|P3|Overall Study|Withdrawal by Subject|2
5968805|NCT01139775|20641659|P2|Overall Study|Withdrawal by Subject|0
5968806|NCT01139775|20641660|P1|Overall Study|Withdrawal by Subject|1
5968807|NCT01139775|20641658|P3|Overall Study|Protocol Violation|0
5968808|NCT01139775|20641659|P2|Overall Study|Protocol Violation|5
5968809|NCT01139775|20641660|P1|Overall Study|Protocol Violation|0
5968810|NCT01139775|20641658|P3|Overall Study|Adverse Event|2
5968811|NCT01139775|20641659|P2|Overall Study|Adverse Event|6
5968812|NCT01139775|20641660|P1|Overall Study|Adverse Event|0
5968813|NCT01139762|20641692|P3|Double-Blind Randomized Active Treatment|Lost to Follow-up|4
5968814|NCT01139762|20641693|P2|Double-Blind Randomized Active Treatment|Lost to Follow-up|3
5968815|NCT01139762|20641694|P1|Double-Blind Randomized Active Treatment|Lost to Follow-up|0
5968816|NCT01139762|20641692|P3|Double-Blind Randomized Active Treatment|Lack of Efficacy|5
5968817|NCT01139762|20641693|P2|Double-Blind Randomized Active Treatment|Lack of Efficacy|3
5968818|NCT01139762|20641694|P1|Double-Blind Randomized Active Treatment|Lack of Efficacy|0
5968819|NCT01139762|20641692|P3|Double-Blind Randomized Active Treatment|Sponsor Decision|6
5968820|NCT01139762|20641693|P2|Double-Blind Randomized Active Treatment|Sponsor Decision|5
5968821|NCT01139762|20641694|P1|Double-Blind Randomized Active Treatment|Sponsor Decision|0
5968822|NCT01139762|20641692|P3|Double-Blind Randomized Active Treatment|Physician Decision|0
5968823|NCT01139762|20641693|P2|Double-Blind Randomized Active Treatment|Physician Decision|2
5968824|NCT01139762|20641694|P1|Double-Blind Randomized Active Treatment|Physician Decision|0
5968825|NCT01139762|20641692|P3|Double-Blind Randomized Active Treatment|Withdrawal by Subject|13
5968826|NCT01139762|20641693|P2|Double-Blind Randomized Active Treatment|Withdrawal by Subject|6
5968827|NCT01139762|20641694|P1|Double-Blind Randomized Active Treatment|Withdrawal by Subject|0
5968828|NCT01139762|20641692|P3|Double-Blind Randomized Active Treatment|Protocol Violation|8
5968829|NCT01139762|20641693|P2|Double-Blind Randomized Active Treatment|Protocol Violation|2
5968830|NCT01139762|20641694|P1|Double-Blind Randomized Active Treatment|Protocol Violation|0
5968831|NCT01139762|20641692|P3|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|17
5968832|NCT01139762|20641693|P2|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|14
5968833|NCT01139762|20641694|P1|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|0
5968834|NCT01139762|20641692|P3|Double-Blind Randomized Active Treatment|Death|1
5968835|NCT01139762|20641693|P2|Double-Blind Randomized Active Treatment|Death|1
5968836|NCT01139762|20641694|P1|Double-Blind Randomized Active Treatment|Death|0
5968837|NCT01139762|20641692|P3|Double-Blind Randomized Active Treatment|Adverse Event|10
5968838|NCT01139762|20641693|P2|Double-Blind Randomized Active Treatment|Adverse Event|4
5968839|NCT01139762|20641694|P1|Double-Blind Randomized Active Treatment|Adverse Event|0
5968840|NCT01139762|20641692|P3|Washout and Placebo Lead-In Period|Lost to Follow-up|0
5968841|NCT01139762|20641693|P2|Washout and Placebo Lead-In Period|Lost to Follow-up|0
5968842|NCT01139762|20641694|P1|Washout and Placebo Lead-In Period|Lost to Follow-up|10
5968843|NCT01139762|20641692|P3|Washout and Placebo Lead-In Period|Sponsor Decision|0
5968844|NCT01139762|20641693|P2|Washout and Placebo Lead-In Period|Sponsor Decision|0
5968845|NCT01139762|20641694|P1|Washout and Placebo Lead-In Period|Sponsor Decision|10
5968846|NCT01139762|20641692|P3|Washout and Placebo Lead-In Period|Physician Decision|0
5968847|NCT01139762|20641693|P2|Washout and Placebo Lead-In Period|Physician Decision|0
5968848|NCT01139762|20641694|P1|Washout and Placebo Lead-In Period|Physician Decision|12
5968849|NCT01139762|20641692|P3|Washout and Placebo Lead-In Period|Withdrawal by Subject|0
5968850|NCT01139762|20641693|P2|Washout and Placebo Lead-In Period|Withdrawal by Subject|0
5968851|NCT01139762|20641694|P1|Washout and Placebo Lead-In Period|Withdrawal by Subject|83
5968852|NCT01139762|20641692|P3|Washout and Placebo Lead-In Period|Adverse Event|0
5968853|NCT01139762|20641693|P2|Washout and Placebo Lead-In Period|Adverse Event|0
5968854|NCT01139762|20641694|P1|Washout and Placebo Lead-In Period|Adverse Event|1
5968855|NCT01139762|20641692|P3|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0
5968856|NCT01139762|20641693|P2|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0
5968857|NCT01139762|20641694|P1|Washout and Placebo Lead-In Period|Entry Criteria Not Met|258
5968858|NCT01139658|20641729|P2|Overall Study|Other|75
5968859|NCT01139658|20641730|P1|Overall Study|Other|28
5968860|NCT01139658|20641729|P2|Overall Study|No documentation of treatment|0
5968861|NCT01139658|20641730|P1|Overall Study|No documentation of treatment|1
5968862|NCT01139658|20641729|P2|Overall Study|Withdrawal by Subject|4
5968863|NCT01139658|20641730|P1|Overall Study|Withdrawal by Subject|2
5968864|NCT01139658|20641729|P2|Overall Study|Lack of Efficacy|7
5968865|NCT01139658|20641730|P1|Overall Study|Lack of Efficacy|15
5968866|NCT01139658|20641729|P2|Overall Study|Adverse Event|27
5968867|NCT01139658|20641730|P1|Overall Study|Adverse Event|10
5968868|NCT01139580|20641768|P2|Overall Study|Participant Randomization in Error|1
5968869|NCT01139580|20641769|P1|Overall Study|Participant Randomization in Error|0
5968870|NCT01139580|20641768|P2|Overall Study|Beginning Study Exclusion Treatment|1
5968871|NCT01139580|20641769|P1|Overall Study|Beginning Study Exclusion Treatment|0
5968872|NCT01139580|20641768|P2|Overall Study|Misrandomized|0
5968873|NCT01139580|20641769|P1|Overall Study|Misrandomized|1
5968874|NCT01139580|20641768|P2|Overall Study|Did Not Meet Exclusion Criteria|0
5968875|NCT01139580|20641769|P1|Overall Study|Did Not Meet Exclusion Criteria|1
5968876|NCT01139580|20641768|P2|Overall Study|Used Excluded Medicine After Enrollment|0
5968877|NCT01139580|20641769|P1|Overall Study|Used Excluded Medicine After Enrollment|1
5968878|NCT01139580|20641768|P2|Overall Study|Withdrawal by Subject|9
5968879|NCT01139580|20641769|P1|Overall Study|Withdrawal by Subject|6
5968880|NCT01139580|20641768|P2|Overall Study|Lack of Efficacy|2
5968881|NCT01139580|20641769|P1|Overall Study|Lack of Efficacy|0
5968882|NCT01139580|20641768|P2|Overall Study|Lost to Follow-up|1
5968883|NCT01139580|20641769|P1|Overall Study|Lost to Follow-up|9
5968884|NCT01139580|20641768|P2|Overall Study|Adverse Event|4
5968885|NCT01139580|20641769|P1|Overall Study|Adverse Event|5
5968886|NCT01139450|20641788|P3|Overall Study|Adverse Event|3
5968887|NCT01139450|20641789|P2|Overall Study|Adverse Event|2
5968888|NCT01139450|20641790|P1|Overall Study|Adverse Event|2
5968889|NCT01139450|20641788|P3|Overall Study|Administrative|1
5968890|NCT01139450|20641789|P2|Overall Study|Administrative|0
5968891|NCT01139450|20641790|P1|Overall Study|Administrative|0
5968892|NCT01139450|20641788|P3|Overall Study|Lost to Follow-up|11
5968893|NCT01139450|20641789|P2|Overall Study|Lost to Follow-up|7
5968894|NCT01139450|20641790|P1|Overall Study|Lost to Follow-up|9
5968895|NCT01139450|20641788|P3|Overall Study|Protocol Violation|2
5968896|NCT01139450|20641789|P2|Overall Study|Protocol Violation|5
5968897|NCT01139450|20641790|P1|Overall Study|Protocol Violation|6
5968898|NCT01139450|20641788|P3|Overall Study|Lack of Efficacy|8
5968899|NCT01139450|20641789|P2|Overall Study|Lack of Efficacy|1
5968900|NCT01139450|20641790|P1|Overall Study|Lack of Efficacy|3
5968901|NCT01139450|20641788|P3|Overall Study|Withdrawal by Subject|13
5968902|NCT01139450|20641789|P2|Overall Study|Withdrawal by Subject|10
5968903|NCT01139450|20641790|P1|Overall Study|Withdrawal by Subject|7
5968904|NCT01139164|20641842|P3|Overall Study|Withdrawn prior to study start|0
5968905|NCT01139164|20641843|P2|Overall Study|Withdrawn prior to study start|2
5968906|NCT01139164|20641844|P1|Overall Study|Withdrawn prior to study start|0
5968907|NCT01139125|20641858|P1|Overall Study|Withdrawal by Subject|1
5968908|NCT01139047|20641862|P1|Overall Study|Withdrawal by Subject|1
5968909|NCT01139021|20641877|P6|Overall Study|Withdrawal by Subject|0
5968910|NCT01139021|20641878|P5|Overall Study|Withdrawal by Subject|4
5968911|NCT01139021|20641879|P4|Overall Study|Withdrawal by Subject|1
5968912|NCT01139021|20641880|P3|Overall Study|Withdrawal by Subject|0
5968913|NCT01139021|20641881|P2|Overall Study|Withdrawal by Subject|0
5968914|NCT01139021|20641882|P1|Overall Study|Withdrawal by Subject|0
5968915|NCT01139021|20641877|P6|Overall Study|Protocol Violation|0
5968916|NCT01139021|20641878|P5|Overall Study|Protocol Violation|2
5968917|NCT01139021|20641879|P4|Overall Study|Protocol Violation|0
5968918|NCT01139021|20641880|P3|Overall Study|Protocol Violation|0
5968919|NCT01139021|20641881|P2|Overall Study|Protocol Violation|0
5968920|NCT01139021|20641882|P1|Overall Study|Protocol Violation|1
5968921|NCT01139021|20641877|P6|Overall Study|Lost to Follow-up|0
5968922|NCT01139021|20641878|P5|Overall Study|Lost to Follow-up|2
5968923|NCT01139021|20641879|P4|Overall Study|Lost to Follow-up|0
5968924|NCT01139021|20641880|P3|Overall Study|Lost to Follow-up|0
5968925|NCT01139021|20641881|P2|Overall Study|Lost to Follow-up|0
5968926|NCT01139021|20641882|P1|Overall Study|Lost to Follow-up|0
5968927|NCT01139021|20641877|P6|Overall Study|Adverse Event|0
5968928|NCT01139021|20641878|P5|Overall Study|Adverse Event|1
5968929|NCT01139021|20641879|P4|Overall Study|Adverse Event|0
5968930|NCT01139021|20641880|P3|Overall Study|Adverse Event|0
5968931|NCT01139021|20641881|P2|Overall Study|Adverse Event|0
5968932|NCT01139021|20641882|P1|Overall Study|Adverse Event|0
5968933|NCT01139008|20641918|P1|Overall Study|Non-compliant, lost product|1
5968934|NCT01139008|20641918|P1|Overall Study|Withdrawal by Subject|5
5968935|NCT01138657|20641982|P2|Overall Study|Miscellaneous Reasons|4
5968936|NCT01138657|20641983|P1|Overall Study|Miscellaneous Reasons|3
5968937|NCT01138657|20641982|P2|Overall Study|Lost to Follow-up|3
5968938|NCT01138657|20641983|P1|Overall Study|Lost to Follow-up|0
5968939|NCT01138657|20641982|P2|Overall Study|Lack of Efficacy|1
5968940|NCT01138657|20641983|P1|Overall Study|Lack of Efficacy|2
5968941|NCT01138657|20641982|P2|Overall Study|Adverse Event|10
5968942|NCT01138657|20641983|P1|Overall Study|Adverse Event|3
5968943|NCT01138501|20642046|P1|Overall Study|Withdrawal by Subject|3
5968944|NCT01138501|20642046|P1|Overall Study|Protocol Violation|2
5968945|NCT01138150|20642090|P2|Overall Study|Physician Decision|0
5968946|NCT01138150|20642091|P1|Overall Study|Physician Decision|1
5968947|NCT01138150|20642090|P2|Overall Study|blood unable to be processed|1
5968948|NCT01138150|20642091|P1|Overall Study|blood unable to be processed|0
5968949|NCT01138111|20642172|P1|Overall Study|Lost to Follow-up|2
5968950|NCT01138111|20642172|P1|Overall Study|Death|1
5968951|NCT01138111|20642172|P1|Overall Study|Adverse Event|1
5968952|NCT01138111|20642172|P1|Overall Study|Withdrawal by Subject|5
5968953|NCT01138046|20642226|P1|Overall Study|Withdrawal due to death|6
5968954|NCT01138007|20642246|P3|Overall Study|Withdrawal by Subject|15
5968955|NCT01138007|20642247|P2|Overall Study|Withdrawal by Subject|6
5968956|NCT01138007|20642248|P1|Overall Study|Withdrawal by Subject|5
5968957|NCT01138007|20642246|P3|Overall Study|Physician Decision|3
5968958|NCT01138007|20642247|P2|Overall Study|Physician Decision|5
5968959|NCT01138007|20642248|P1|Overall Study|Physician Decision|0
5968960|NCT01138007|20642246|P3|Overall Study|Lost to Follow-up|5
5968961|NCT01138007|20642247|P2|Overall Study|Lost to Follow-up|3
5968962|NCT01138007|20642248|P1|Overall Study|Lost to Follow-up|3
5968963|NCT01138007|20642246|P3|Overall Study|Protocol-Defined Stopping Criteria|8
5968964|NCT01138007|20642247|P2|Overall Study|Protocol-Defined Stopping Criteria|1
5968965|NCT01138007|20642248|P1|Overall Study|Protocol-Defined Stopping Criteria|6
5968966|NCT01138007|20642246|P3|Overall Study|Protocol Violation|2
5968967|NCT01138007|20642247|P2|Overall Study|Protocol Violation|3
5968968|NCT01138007|20642248|P1|Overall Study|Protocol Violation|2
5968969|NCT01138007|20642246|P3|Overall Study|Lack of Efficacy|6
5968970|NCT01138007|20642247|P2|Overall Study|Lack of Efficacy|0
5968971|NCT01138007|20642248|P1|Overall Study|Lack of Efficacy|2
5968972|NCT01138007|20642246|P3|Overall Study|Adverse Event|9
5968973|NCT01138007|20642247|P2|Overall Study|Adverse Event|12
5968974|NCT01138007|20642248|P1|Overall Study|Adverse Event|4
5968975|NCT01137812|20642355|P2|Overall Study|Other|27
5968976|NCT01137812|20642356|P1|Overall Study|Other|19
5968977|NCT01137812|20642355|P2|Overall Study|Patient met glycemic withdrawal criteria|85
5968978|NCT01137812|20642356|P1|Overall Study|Patient met glycemic withdrawal criteria|40
5968979|NCT01137812|20642355|P2|Overall Study|Death|0
5968980|NCT01137812|20642356|P1|Overall Study|Death|2
5968981|NCT01137812|20642355|P2|Overall Study|Withdrawal by Subject|13
5968982|NCT01137812|20642356|P1|Overall Study|Withdrawal by Subject|5
5968983|NCT01137812|20642355|P2|Overall Study|Protocol Violation|4
5968984|NCT01137812|20642356|P1|Overall Study|Protocol Violation|5
5968985|NCT01137812|20642355|P2|Overall Study|Physician Decision|17
5968986|NCT01137812|20642356|P1|Overall Study|Physician Decision|25
5968987|NCT01137812|20642355|P2|Overall Study|Lost to Follow-up|8
5968988|NCT01137812|20642356|P1|Overall Study|Lost to Follow-up|6
5968989|NCT01137812|20642355|P2|Overall Study|Adverse Event|14
5968990|NCT01137812|20642356|P1|Overall Study|Adverse Event|21
5968991|NCT01137786|20642376|P2|Overall Study|Withdrawal by Subject|1
5968992|NCT01137786|20642377|P1|Overall Study|Withdrawal by Subject|1
5968993|NCT01137786|20642376|P2|Overall Study|Lost to Follow-up|2
5968994|NCT01137786|20642377|P1|Overall Study|Lost to Follow-up|0
5968995|NCT01137773|20642387|P2|Overall Study|Lost to Follow-up|0
5968996|NCT01137773|20642388|P1|Overall Study|Lost to Follow-up|6
5968997|NCT01137773|20642387|P2|Overall Study|Death|3
5968998|NCT01137773|20642388|P1|Overall Study|Death|3
5968999|NCT01137682|20642399|P3|Overall Study|Did not receive treatment in extension|1
5969000|NCT01137682|20642400|P2|Overall Study|Did not receive treatment in extension|0
5969001|NCT01137682|20642401|P1|Overall Study|Did not receive treatment in extension|0
5969002|NCT01137682|20642399|P3|Overall Study|Did not enter extension|2
5969003|NCT01137682|20642400|P2|Overall Study|Did not enter extension|3
5969004|NCT01137682|20642401|P1|Overall Study|Did not enter extension|2
5969005|NCT01137682|20642399|P3|Overall Study|Protocol Violation-Extension|0
5969006|NCT01137682|20642400|P2|Overall Study|Protocol Violation-Extension|1
5969007|NCT01137682|20642401|P1|Overall Study|Protocol Violation-Extension|2
5969008|NCT01137682|20642399|P3|Overall Study|Death-Extension|0
5969009|NCT01137682|20642400|P2|Overall Study|Death-Extension|0
5969010|NCT01137682|20642401|P1|Overall Study|Death-Extension|2
5969011|NCT01137682|20642399|P3|Overall Study|Administrative problems-Extension|0
5969012|NCT01137682|20642400|P2|Overall Study|Administrative problems-Extension|2
5969013|NCT01137682|20642401|P1|Overall Study|Administrative problems-Extension|0
5969014|NCT01137682|20642399|P3|Overall Study|Lost to Follow Up-Extension|0
5969015|NCT01137682|20642400|P2|Overall Study|Lost to Follow Up-Extension|1
5969016|NCT01137682|20642401|P1|Overall Study|Lost to Follow Up-Extension|0
5969017|NCT01137682|20642399|P3|Overall Study|Withdrawal by Subject-Extension|8
5969018|NCT01137682|20642400|P2|Overall Study|Withdrawal by Subject-Extension|8
5969019|NCT01137682|20642401|P1|Overall Study|Withdrawal by Subject-Extension|6
5969020|NCT01137682|20642399|P3|Overall Study|Lack of Efficacy-Extension|13
5969021|NCT01137682|20642400|P2|Overall Study|Lack of Efficacy-Extension|9
5969022|NCT01137682|20642401|P1|Overall Study|Lack of Efficacy-Extension|15
5969023|NCT01137682|20642399|P3|Overall Study|Adverse Event-Extension|7
5969024|NCT01137682|20642400|P2|Overall Study|Adverse Event-Extension|8
5969025|NCT01137682|20642401|P1|Overall Study|Adverse Event-Extension|4
5969026|NCT01137682|20642399|P3|Overall Study|Protocol Violation-CORE|1
5969027|NCT01137682|20642400|P2|Overall Study|Protocol Violation-CORE|1
5969028|NCT01137682|20642401|P1|Overall Study|Protocol Violation-CORE|0
5969029|NCT01137682|20642399|P3|Overall Study|Administrative problems-CORE|0
5969030|NCT01137682|20642400|P2|Overall Study|Administrative problems-CORE|1
5969031|NCT01137682|20642401|P1|Overall Study|Administrative problems-CORE|2
5969032|NCT01137682|20642399|P3|Overall Study|Withdrawal by Subject-CORE|2
5969033|NCT01137682|20642400|P2|Overall Study|Withdrawal by Subject-CORE|2
5969034|NCT01137682|20642401|P1|Overall Study|Withdrawal by Subject-CORE|2
5969035|NCT01137682|20642399|P3|Overall Study|Adverse Event-CORE|0
5969036|NCT01137682|20642400|P2|Overall Study|Adverse Event-CORE|4
5969037|NCT01137682|20642401|P1|Overall Study|Adverse Event-CORE|2
5969038|NCT01137604|20642451|P4|Overall Study|Clinical Decline|1
5969039|NCT01137604|20642452|P3|Overall Study|Clinical Decline|1
5969040|NCT01137604|20642453|P2|Overall Study|Clinical Decline|0
5969041|NCT01137604|20642454|P1|Overall Study|Clinical Decline|0
5969042|NCT01137604|20642451|P4|Overall Study|Participant's Decision|0
5969043|NCT01137604|20642452|P3|Overall Study|Participant's Decision|0
5969044|NCT01137604|20642453|P2|Overall Study|Participant's Decision|0
5969045|NCT01137604|20642454|P1|Overall Study|Participant's Decision|1
5969046|NCT01137604|20642451|P4|Overall Study|Clinical Progression|0
5969047|NCT01137604|20642452|P3|Overall Study|Clinical Progression|1
5969048|NCT01137604|20642453|P2|Overall Study|Clinical Progression|2
5969049|NCT01137604|20642454|P1|Overall Study|Clinical Progression|0
5969050|NCT01137604|20642451|P4|Overall Study|Withdrawal by Subject|1
5969051|NCT01137604|20642452|P3|Overall Study|Withdrawal by Subject|2
5969052|NCT01137604|20642453|P2|Overall Study|Withdrawal by Subject|2
5969053|NCT01137604|20642454|P1|Overall Study|Withdrawal by Subject|0
5969054|NCT01137604|20642451|P4|Overall Study|Adverse Event|9
5969055|NCT01137604|20642452|P3|Overall Study|Adverse Event|9
5969056|NCT01137604|20642453|P2|Overall Study|Adverse Event|6
5969057|NCT01137604|20642454|P1|Overall Study|Adverse Event|1
5969058|NCT01137578|20642488|P3|Overall Study|Other|6
5969059|NCT01137578|20642489|P2|Overall Study|Other|2
5969060|NCT01137578|20642490|P1|Overall Study|Other|12
5969061|NCT01137578|20642488|P3|Overall Study|Withdrawal by Subject|0
5969062|NCT01137578|20642489|P2|Overall Study|Withdrawal by Subject|0
5969063|NCT01137578|20642490|P1|Overall Study|Withdrawal by Subject|1
5969064|NCT01137578|20642488|P3|Overall Study|Participant requested to Discontinue|0
5969065|NCT01137578|20642489|P2|Overall Study|Participant requested to Discontinue|0
5969066|NCT01137578|20642490|P1|Overall Study|Participant requested to Discontinue|3
5969067|NCT01137474|20642539|P4|Overall Study|Administrative reason by sponsor|0
5969068|NCT01137474|20642540|P3|Overall Study|Administrative reason by sponsor|0
5969069|NCT01137474|20642541|P2|Overall Study|Administrative reason by sponsor|1
5969070|NCT01137474|20642542|P1|Overall Study|Administrative reason by sponsor|0
5969071|NCT01137474|20642539|P4|Overall Study|Pregnancy|0
5969072|NCT01137474|20642540|P3|Overall Study|Pregnancy|0
5969073|NCT01137474|20642541|P2|Overall Study|Pregnancy|1
5969074|NCT01137474|20642542|P1|Overall Study|Pregnancy|0
5969075|NCT01137474|20642539|P4|Overall Study|Other|0
5969076|NCT01137474|20642540|P3|Overall Study|Other|0
5969077|NCT01137474|20642541|P2|Overall Study|Other|1
5969078|NCT01137474|20642542|P1|Overall Study|Other|3
5969079|NCT01137474|20642539|P4|Overall Study|Lack of Efficacy|2
5969080|NCT01137474|20642540|P3|Overall Study|Lack of Efficacy|0
5969081|NCT01137474|20642541|P2|Overall Study|Lack of Efficacy|0
5969082|NCT01137474|20642542|P1|Overall Study|Lack of Efficacy|0
5969083|NCT01137474|20642539|P4|Overall Study|Lost to Follow-up|2
5969084|NCT01137474|20642540|P3|Overall Study|Lost to Follow-up|0
5969085|NCT01137474|20642541|P2|Overall Study|Lost to Follow-up|1
5969086|NCT01137474|20642542|P1|Overall Study|Lost to Follow-up|5
5969087|NCT01137474|20642539|P4|Overall Study|No longer met study criteria|5
5969088|NCT01137474|20642540|P3|Overall Study|No longer met study criteria|0
5969089|NCT01137474|20642541|P2|Overall Study|No longer met study criteria|1
5969090|NCT01137474|20642542|P1|Overall Study|No longer met study criteria|6
5969091|NCT01137474|20642539|P4|Overall Study|Withdrawal by Subject|9
5969092|NCT01137474|20642540|P3|Overall Study|Withdrawal by Subject|6
5969093|NCT01137474|20642541|P2|Overall Study|Withdrawal by Subject|2
5969094|NCT01137474|20642542|P1|Overall Study|Withdrawal by Subject|7
5969095|NCT01137474|20642539|P4|Overall Study|Adverse Event|3
5969096|NCT01137474|20642540|P3|Overall Study|Adverse Event|1
5969097|NCT01137474|20642541|P2|Overall Study|Adverse Event|5
5969098|NCT01137474|20642542|P1|Overall Study|Adverse Event|3
5969099|NCT01137435|20642560|P1|Overall Study|Off label usage|4
5969100|NCT01137435|20642560|P1|Overall Study|Lost to Follow-up|24
5969101|NCT01137292|20642587|P1|Overall Study|Other|7
5969102|NCT01137292|20642587|P1|Overall Study|Lost to Follow-up|1
5969103|NCT01137292|20642587|P1|Overall Study|Lack of Efficacy|13
5969104|NCT01137292|20642587|P1|Overall Study|Adverse Event|3
5969105|NCT01137292|20642587|P1|Overall Study|Death|30
5969106|NCT01137110|20642596|P2|Overall Study|Protocol Violation|0
5969107|NCT01137110|20642597|P1|Overall Study|Protocol Violation|1
5969108|NCT01137071|20642603|P1|Overall Study|Wrongly Included|1
5969109|NCT01137071|20642603|P1|Overall Study|Withdrawal by Subject|2
5969110|NCT01137071|20642603|P1|Overall Study|Disease Progression|11
5969111|NCT01136967|20642759|P2|Overall Study|Diagnosis of Second Primary Cancer|1
5969112|NCT01136967|20642760|P1|Overall Study|Diagnosis of Second Primary Cancer|0
5969113|NCT01136967|20642759|P2|Overall Study|Increase in Lesion Size|2
5969114|NCT01136967|20642760|P1|Overall Study|Increase in Lesion Size|0
5969115|NCT01136967|20642759|P2|Overall Study|Investigator's Choice|1
5969116|NCT01136967|20642760|P1|Overall Study|Investigator's Choice|1
5969117|NCT01136967|20642759|P2|Overall Study|Non-compliance|0
5969118|NCT01136967|20642760|P1|Overall Study|Non-compliance|1
5969119|NCT01136967|20642759|P2|Overall Study|Radiation|0
5969120|NCT01136967|20642760|P1|Overall Study|Radiation|1
5969121|NCT01136967|20642759|P2|Overall Study|Clinical Progression|5
5969122|NCT01136967|20642760|P1|Overall Study|Clinical Progression|3
5969123|NCT01136967|20642759|P2|Overall Study|Withdrawal by Subject|2
5969124|NCT01136967|20642760|P1|Overall Study|Withdrawal by Subject|1
5969125|NCT01136967|20642759|P2|Overall Study|Lost to Follow-up|1
5969126|NCT01136967|20642760|P1|Overall Study|Lost to Follow-up|0
5969127|NCT01136967|20642759|P2|Overall Study|Participant Choice|3
5969128|NCT01136967|20642760|P1|Overall Study|Participant Choice|8
5969129|NCT01136967|20642759|P2|Overall Study|Adverse Event|12
5969130|NCT01136967|20642760|P1|Overall Study|Adverse Event|9
5969131|NCT01136954|20642782|P2|Overall Study|Other|3
5969132|NCT01136954|20642783|P1|Overall Study|Other|1
5969133|NCT01136954|20642782|P2|Overall Study|Physician Decision|1
5969134|NCT01136954|20642783|P1|Overall Study|Physician Decision|0
5969135|NCT01136954|20642782|P2|Overall Study|Lack of Efficacy|13
5969136|NCT01136954|20642783|P1|Overall Study|Lack of Efficacy|14
5969137|NCT01136954|20642782|P2|Overall Study|Withdrawal by Subject|2
5969138|NCT01136954|20642783|P1|Overall Study|Withdrawal by Subject|6
5969139|NCT01136954|20642782|P2|Overall Study|Adverse Event|2
5969140|NCT01136954|20642783|P1|Overall Study|Adverse Event|3
5969141|NCT01136915|20642797|P2|Overall Study|Exclusion criterion met|1
5969142|NCT01136915|20642798|P1|Overall Study|Exclusion criterion met|0
5969143|NCT01136915|20642797|P2|Overall Study|Lost to Follow-up|0
5969144|NCT01136915|20642798|P1|Overall Study|Lost to Follow-up|2
5969145|NCT01136876|20642808|P2|Overall Study|Missing NGAL measurement|5
5969146|NCT01136876|20642809|P1|Overall Study|Missing NGAL measurement|2
5969147|NCT01136876|20642808|P2|Overall Study|Physician Decision|5
5969148|NCT01136876|20642809|P1|Overall Study|Physician Decision|3
5969149|NCT01136876|20642808|P2|Overall Study|Lost to Follow-up|1
5969150|NCT01136876|20642809|P1|Overall Study|Lost to Follow-up|0
5969151|NCT01136785|20642838|P2|Overall Study|Protocol Violation|1
5969152|NCT01136785|20642839|P1|Overall Study|Protocol Violation|2
5969153|NCT01136772|20642854|P2|Overall Study|Did not follow up after first injection|2
5969154|NCT01136772|20642855|P1|Overall Study|Did not follow up after first injection|2
5969155|NCT01136772|20642854|P2|Overall Study|Did not receive injection|7
5969156|NCT01136772|20642855|P1|Overall Study|Did not receive injection|10
5969157|NCT01136772|20642854|P2|Overall Study|Withdrawal by Subject|36
5969158|NCT01136772|20642855|P1|Overall Study|Withdrawal by Subject|33
5969159|NCT01136772|20642854|P2|Overall Study|Administrative|12
5969160|NCT01136772|20642855|P1|Overall Study|Administrative|14
5969161|NCT01136772|20642854|P2|Overall Study|Lack of Efficacy|39
5969162|NCT01136772|20642855|P1|Overall Study|Lack of Efficacy|42
5969163|NCT01136772|20642854|P2|Overall Study|Adverse Event|14
5969164|NCT01136772|20642855|P1|Overall Study|Adverse Event|15
5969165|NCT01136746|20642865|P2|Overall Study|Death|0
5969166|NCT01136746|20642866|P1|Overall Study|Death|1
5969167|NCT01136746|20642865|P2|Overall Study|Protocol Violation|1
5969168|NCT01136746|20642866|P1|Overall Study|Protocol Violation|2
5969169|NCT01136746|20642865|P2|Overall Study|Lost to Follow-up|2
5969170|NCT01136746|20642866|P1|Overall Study|Lost to Follow-up|0
5969171|NCT01136733|20642933|P7|Phase 2|Other|6
5969172|NCT01136733|20642934|P6|Phase 2|Other|7
5969173|NCT01136733|20642935|P5|Phase 2|Other|6
5969174|NCT01136733|20642936|P4|Phase 2|Other|0
5969175|NCT01136733|20642937|P3|Phase 2|Other|0
5969176|NCT01136733|20642938|P2|Phase 2|Other|0
5969177|NCT01136733|20642939|P1|Phase 2|Other|0
5969178|NCT01136733|20642933|P7|Phase 2|Administrative-Withdrew Consent|0
5969179|NCT01136733|20642934|P6|Phase 2|Administrative-Withdrew Consent|0
5969180|NCT01136733|20642935|P5|Phase 2|Administrative-Withdrew Consent|1
5969181|NCT01136733|20642936|P4|Phase 2|Administrative-Withdrew Consent|0
5969182|NCT01136733|20642937|P3|Phase 2|Administrative-Withdrew Consent|0
5969183|NCT01136733|20642938|P2|Phase 2|Administrative-Withdrew Consent|0
5969184|NCT01136733|20642939|P1|Phase 2|Administrative-Withdrew Consent|0
5969185|NCT01136733|20642933|P7|Phase 2|Participant Choice|1
5969186|NCT01136733|20642934|P6|Phase 2|Participant Choice|0
5969187|NCT01136733|20642935|P5|Phase 2|Participant Choice|3
5969188|NCT01136733|20642936|P4|Phase 2|Participant Choice|0
5969189|NCT01136733|20642937|P3|Phase 2|Participant Choice|0
5969190|NCT01136733|20642938|P2|Phase 2|Participant Choice|0
5969191|NCT01136733|20642939|P1|Phase 2|Participant Choice|0
5969192|NCT01136733|20642933|P7|Phase 2|Adverse Event|5
5969193|NCT01136733|20642934|P6|Phase 2|Adverse Event|13
5969194|NCT01136733|20642935|P5|Phase 2|Adverse Event|11
5969195|NCT01136733|20642936|P4|Phase 2|Adverse Event|0
5969196|NCT01136733|20642937|P3|Phase 2|Adverse Event|0
5969197|NCT01136733|20642938|P2|Phase 2|Adverse Event|0
5969198|NCT01136733|20642939|P1|Phase 2|Adverse Event|0
5969199|NCT01136733|20642933|P7|Phase 2|Disease Progression|38
5969200|NCT01136733|20642934|P6|Phase 2|Disease Progression|32
5969201|NCT01136733|20642935|P5|Phase 2|Disease Progression|30
5969202|NCT01136733|20642936|P4|Phase 2|Disease Progression|0
5969203|NCT01136733|20642937|P3|Phase 2|Disease Progression|0
5969204|NCT01136733|20642938|P2|Phase 2|Disease Progression|0
5969205|NCT01136733|20642939|P1|Phase 2|Disease Progression|0
5969206|NCT01136733|20642933|P7|Phase 1b|Clinical Progression|0
5969207|NCT01136733|20642934|P6|Phase 1b|Clinical Progression|0
5969208|NCT01136733|20642935|P5|Phase 1b|Clinical Progression|0
5969209|NCT01136733|20642936|P4|Phase 1b|Clinical Progression|0
5969210|NCT01136733|20642937|P3|Phase 1b|Clinical Progression|0
5969211|NCT01136733|20642938|P2|Phase 1b|Clinical Progression|1
5969212|NCT01136733|20642939|P1|Phase 1b|Clinical Progression|1
5969213|NCT01136733|20642933|P7|Phase 1b|Administrative-Withdrew Consent|0
5969214|NCT01136733|20642934|P6|Phase 1b|Administrative-Withdrew Consent|0
5969215|NCT01136733|20642935|P5|Phase 1b|Administrative-Withdrew Consent|0
5969216|NCT01136733|20642936|P4|Phase 1b|Administrative-Withdrew Consent|0
5969217|NCT01136733|20642937|P3|Phase 1b|Administrative-Withdrew Consent|0
5969218|NCT01136733|20642938|P2|Phase 1b|Administrative-Withdrew Consent|1
5969219|NCT01136733|20642939|P1|Phase 1b|Administrative-Withdrew Consent|0
5969220|NCT01136733|20642933|P7|Phase 1b|Participant Choice|0
5969221|NCT01136733|20642934|P6|Phase 1b|Participant Choice|0
5969222|NCT01136733|20642935|P5|Phase 1b|Participant Choice|0
5969223|NCT01136733|20642936|P4|Phase 1b|Participant Choice|0
5969224|NCT01136733|20642937|P3|Phase 1b|Participant Choice|1
5969225|NCT01136733|20642938|P2|Phase 1b|Participant Choice|0
5969226|NCT01136733|20642939|P1|Phase 1b|Participant Choice|0
5969227|NCT01136733|20642933|P7|Phase 1b|Adverse Event|0
5969228|NCT01136733|20642934|P6|Phase 1b|Adverse Event|0
5969229|NCT01136733|20642935|P5|Phase 1b|Adverse Event|0
5969230|NCT01136733|20642936|P4|Phase 1b|Adverse Event|0
5969231|NCT01136733|20642937|P3|Phase 1b|Adverse Event|1
5969232|NCT01136733|20642938|P2|Phase 1b|Adverse Event|3
5969233|NCT01136733|20642939|P1|Phase 1b|Adverse Event|0
5969234|NCT01136655|20643022|P1|Washout After BUD 160/FM 9.0 (7 Days)|Adverse Event|1
5969235|NCT01136655|20643022|P1|Washout After BUD 160/FM 9.0 (7 Days)|Withdrawal by Subject|1
5969236|NCT01136655|20643022|P1|Washout After BUD 160/FM 4.5 (7 Days)|Adverse Event|1
5969237|NCT01136655|20643022|P1|Washout After BUD 160/FM 2.25 (7 Days)|Withdrawal by Subject|1
5969238|NCT01136408|20643055|P3|Overall Study|Protocol Violation|1
5969239|NCT01136408|20643056|P2|Overall Study|Protocol Violation|1
5969240|NCT01136408|20643057|P1|Overall Study|Protocol Violation|1
5969241|NCT01136408|20643055|P3|Overall Study|Adverse Event|4
5969242|NCT01136408|20643056|P2|Overall Study|Adverse Event|8
5969243|NCT01136408|20643057|P1|Overall Study|Adverse Event|4
5969244|NCT01136382|20643114|P2|Overall Study|Withdrawal by Subject|1
5969245|NCT01136382|20643115|P1|Overall Study|Withdrawal by Subject|4
5969246|NCT01136382|20643114|P2|Overall Study|Severe Non-Compliance to Protocol|2
5969247|NCT01136382|20643115|P1|Overall Study|Severe Non-Compliance to Protocol|0
5969248|NCT01136382|20643114|P2|Overall Study|Study-Specific Withdrawal Criteria|25
5969249|NCT01136382|20643115|P1|Overall Study|Study-Specific Withdrawal Criteria|48
5969250|NCT01136382|20643114|P2|Overall Study|Other|3
5969251|NCT01136382|20643115|P1|Overall Study|Other|8
5969252|NCT01136356|20643141|P2|Second 18-day Withdrawal|Withdrawal by Subject|1
5969253|NCT01136356|20643142|P1|Second 18-day Withdrawal|Withdrawal by Subject|0
5969254|NCT01136356|20643141|P2|First 18-day Withdrawal|Physician Decision|0
5969255|NCT01136356|20643142|P1|First 18-day Withdrawal|Physician Decision|1
5969256|NCT01136356|20643141|P2|First 18-day Withdrawal|Withdrawal by Subject|0
5969257|NCT01136356|20643142|P1|First 18-day Withdrawal|Withdrawal by Subject|3
5969258|NCT01136291|20643153|P2|Overall Study|Lost to Follow-up|1
5969259|NCT01136291|20643154|P1|Overall Study|Lost to Follow-up|1
5969260|NCT01136174|20643173|P4|Overall Study|Adverse Event|4
5969261|NCT01136174|20643174|P3|Overall Study|Adverse Event|0
5969262|NCT01136174|20643175|P2|Overall Study|Adverse Event|0
5969263|NCT01136174|20643176|P1|Overall Study|Adverse Event|0
5969264|NCT01135992|20643256|P1|Overall Study|Unclassified|7
5969265|NCT01135992|20643256|P1|Overall Study|Withdrawal criteria|10
5969266|NCT01135992|20643256|P1|Overall Study|Protocol Violation|2
5969267|NCT01135992|20643256|P1|Overall Study|Lack of Efficacy|1
5969268|NCT01135992|20643256|P1|Overall Study|Adverse Event|1
5969269|NCT01135914|20643268|P3|Overall Study|Adverse Event|2
5969270|NCT01135914|20643269|P2|Overall Study|Adverse Event|1
5969271|NCT01135914|20643270|P1|Overall Study|Adverse Event|0
5969272|NCT01135914|20643268|P3|Overall Study|Lack of Efficacy|10
5969273|NCT01135914|20643269|P2|Overall Study|Lack of Efficacy|1
5969274|NCT01135914|20643270|P1|Overall Study|Lack of Efficacy|2
5969275|NCT01135914|20643268|P3|Overall Study|Protocol Violation|3
5969276|NCT01135914|20643269|P2|Overall Study|Protocol Violation|0
5969277|NCT01135914|20643270|P1|Overall Study|Protocol Violation|0
5969278|NCT01135914|20643268|P3|Overall Study|Lost to Follow-up|1
5969279|NCT01135914|20643269|P2|Overall Study|Lost to Follow-up|0
5969280|NCT01135914|20643270|P1|Overall Study|Lost to Follow-up|1
5969281|NCT01135914|20643268|P3|Overall Study|Withdrawal by Subject|6
5969282|NCT01135914|20643269|P2|Overall Study|Withdrawal by Subject|3
5969283|NCT01135914|20643270|P1|Overall Study|Withdrawal by Subject|1
5969284|NCT01135524|20643303|P1|Overall Study|Lack of Efficacy|8
5969285|NCT01135524|20643303|P1|Overall Study|Administrative|151
5969286|NCT01135524|20643303|P1|Overall Study|Lost to Follow-up|3
5969287|NCT01135524|20643303|P1|Overall Study|Adverse Event|20
5969288|NCT01135524|20643303|P1|Overall Study|Withdrawal by Subject|14
5969289|NCT01135511|20643316|P9|Overall Study|Withdrawal by Subject|1
5969290|NCT01135511|20643317|P8|Overall Study|Withdrawal by Subject|0
5969291|NCT01135511|20643318|P7|Overall Study|Withdrawal by Subject|1
5969292|NCT01135511|20643319|P6|Overall Study|Withdrawal by Subject|0
5969293|NCT01135511|20643320|P5|Overall Study|Withdrawal by Subject|0
5969294|NCT01135511|20643321|P4|Overall Study|Withdrawal by Subject|0
5969295|NCT01135511|20643322|P3|Overall Study|Withdrawal by Subject|0
5969296|NCT01135511|20643323|P2|Overall Study|Withdrawal by Subject|0
5969297|NCT01135511|20643324|P1|Overall Study|Withdrawal by Subject|0
5969298|NCT01135511|20643316|P9|Overall Study|noncompliance with study drug taken|0
5969299|NCT01135511|20643317|P8|Overall Study|noncompliance with study drug taken|0
5969300|NCT01135511|20643318|P7|Overall Study|noncompliance with study drug taken|0
5969301|NCT01135511|20643319|P6|Overall Study|noncompliance with study drug taken|0
5969302|NCT01135511|20643320|P5|Overall Study|noncompliance with study drug taken|1
5969303|NCT01135511|20643321|P4|Overall Study|noncompliance with study drug taken|0
5969304|NCT01135511|20643322|P3|Overall Study|noncompliance with study drug taken|0
5969305|NCT01135511|20643323|P2|Overall Study|noncompliance with study drug taken|0
5969306|NCT01135511|20643324|P1|Overall Study|noncompliance with study drug taken|0
5969307|NCT01135511|20643316|P9|Overall Study|could not visit the clinic|0
5969308|NCT01135511|20643317|P8|Overall Study|could not visit the clinic|0
5969309|NCT01135511|20643318|P7|Overall Study|could not visit the clinic|0
5969310|NCT01135511|20643319|P6|Overall Study|could not visit the clinic|0
5969311|NCT01135511|20643320|P5|Overall Study|could not visit the clinic|0
5969312|NCT01135511|20643321|P4|Overall Study|could not visit the clinic|0
5969313|NCT01135511|20643322|P3|Overall Study|could not visit the clinic|2
5969314|NCT01135511|20643323|P2|Overall Study|could not visit the clinic|1
5969315|NCT01135511|20643324|P1|Overall Study|could not visit the clinic|0
5969316|NCT01135511|20643316|P9|Overall Study|Pregnancy|0
5969317|NCT01135511|20643317|P8|Overall Study|Pregnancy|0
5969318|NCT01135511|20643318|P7|Overall Study|Pregnancy|0
5969319|NCT01135511|20643319|P6|Overall Study|Pregnancy|0
5969320|NCT01135511|20643320|P5|Overall Study|Pregnancy|0
5969321|NCT01135511|20643321|P4|Overall Study|Pregnancy|1
5969322|NCT01135511|20643322|P3|Overall Study|Pregnancy|0
5969323|NCT01135511|20643323|P2|Overall Study|Pregnancy|0
5969324|NCT01135511|20643324|P1|Overall Study|Pregnancy|0
5969325|NCT01135511|20643316|P9|Overall Study|Protocol Violation|0
5969326|NCT01135511|20643317|P8|Overall Study|Protocol Violation|0
5969327|NCT01135511|20643318|P7|Overall Study|Protocol Violation|0
5969328|NCT01135511|20643319|P6|Overall Study|Protocol Violation|0
5969329|NCT01135511|20643320|P5|Overall Study|Protocol Violation|0
5969330|NCT01135511|20643321|P4|Overall Study|Protocol Violation|0
5969331|NCT01135511|20643322|P3|Overall Study|Protocol Violation|3
5969332|NCT01135511|20643323|P2|Overall Study|Protocol Violation|0
5969333|NCT01135511|20643324|P1|Overall Study|Protocol Violation|0
5969334|NCT01135511|20643316|P9|Overall Study|Lack of Efficacy|0
5969335|NCT01135511|20643317|P8|Overall Study|Lack of Efficacy|0
5969336|NCT01135511|20643318|P7|Overall Study|Lack of Efficacy|0
5969337|NCT01135511|20643319|P6|Overall Study|Lack of Efficacy|0
5969338|NCT01135511|20643320|P5|Overall Study|Lack of Efficacy|0
5969339|NCT01135511|20643321|P4|Overall Study|Lack of Efficacy|2
5969340|NCT01135511|20643322|P3|Overall Study|Lack of Efficacy|1
5969341|NCT01135511|20643323|P2|Overall Study|Lack of Efficacy|1
5969342|NCT01135511|20643324|P1|Overall Study|Lack of Efficacy|0
5969343|NCT01135511|20643316|P9|Overall Study|Adverse Event|0
5969344|NCT01135511|20643317|P8|Overall Study|Adverse Event|1
5969345|NCT01135511|20643318|P7|Overall Study|Adverse Event|0
5969346|NCT01135511|20643319|P6|Overall Study|Adverse Event|1
5969347|NCT01135511|20643320|P5|Overall Study|Adverse Event|0
5969348|NCT01135511|20643321|P4|Overall Study|Adverse Event|0
5969349|NCT01135511|20643322|P3|Overall Study|Adverse Event|2
5969350|NCT01135511|20643323|P2|Overall Study|Adverse Event|1
5969351|NCT01135511|20643324|P1|Overall Study|Adverse Event|0
5969352|NCT01135498|20643606|P1|Overall Study|Ongoing at time of analysis|2
5969353|NCT01135498|20643606|P1|Overall Study|Death|1
5969354|NCT01135498|20643606|P1|Overall Study|Withdrawal by Subject|4
5969355|NCT01135498|20643606|P1|Overall Study|Investigator judgement|25
5969356|NCT01135498|20643606|P1|Overall Study|Progressive disease|38
5969357|NCT01135498|20643606|P1|Overall Study|Adverse Event|20
5969358|NCT01135134|20643785|P2|Overall Study|Did not meet protocol eligibility|0
5969359|NCT01135134|20643786|P1|Overall Study|Did not meet protocol eligibility|1
5969360|NCT01135134|20643785|P2|Overall Study|Adverse Event|1
5969361|NCT01135134|20643786|P1|Overall Study|Adverse Event|1
5969362|NCT01135017|20643813|P2|Overall Study|Other than above|4
5969363|NCT01135017|20643814|P1|Overall Study|Other than above|3
5969364|NCT01135017|20643813|P2|Overall Study|Adverse Event|8
5969365|NCT01135017|20643814|P1|Overall Study|Adverse Event|3
5969366|NCT01134939|20643852|P8|Overall Study|Termination page not available|0
5969367|NCT01134939|20643853|P7|Overall Study|Termination page not available|7
5969368|NCT01134939|20643854|P6|Overall Study|Termination page not available|3
5969369|NCT01134939|20643855|P5|Overall Study|Termination page not available|0
5969370|NCT01134939|20643856|P4|Overall Study|Termination page not available|8
5969371|NCT01134939|20643857|P3|Overall Study|Termination page not available|5
5969372|NCT01134939|20643858|P2|Overall Study|Termination page not available|6
5969373|NCT01134939|20643859|P1|Overall Study|Termination page not available|4
5969374|NCT01134939|20643852|P8|Overall Study|Death|0
5969375|NCT01134939|20643853|P7|Overall Study|Death|0
5969376|NCT01134939|20643854|P6|Overall Study|Death|0
5969377|NCT01134939|20643855|P5|Overall Study|Death|0
5969378|NCT01134939|20643856|P4|Overall Study|Death|0
5969379|NCT01134939|20643857|P3|Overall Study|Death|0
5969380|NCT01134939|20643858|P2|Overall Study|Death|1
5969381|NCT01134939|20643859|P1|Overall Study|Death|0
5969382|NCT01134939|20643852|P8|Overall Study|Lost to Follow-up|0
5969383|NCT01134939|20643853|P7|Overall Study|Lost to Follow-up|0
5969384|NCT01134939|20643854|P6|Overall Study|Lost to Follow-up|1
5969385|NCT01134939|20643855|P5|Overall Study|Lost to Follow-up|2
5969386|NCT01134939|20643856|P4|Overall Study|Lost to Follow-up|1
5969387|NCT01134939|20643857|P3|Overall Study|Lost to Follow-up|0
5969388|NCT01134939|20643858|P2|Overall Study|Lost to Follow-up|3
5969389|NCT01134939|20643859|P1|Overall Study|Lost to Follow-up|2
5969390|NCT01134939|20643852|P8|Overall Study|Lack of Efficacy|0
5969391|NCT01134939|20643853|P7|Overall Study|Lack of Efficacy|1
5969392|NCT01134939|20643854|P6|Overall Study|Lack of Efficacy|0
5969393|NCT01134939|20643855|P5|Overall Study|Lack of Efficacy|3
5969394|NCT01134939|20643856|P4|Overall Study|Lack of Efficacy|0
5969395|NCT01134939|20643857|P3|Overall Study|Lack of Efficacy|1
5969396|NCT01134939|20643858|P2|Overall Study|Lack of Efficacy|5
5969397|NCT01134939|20643859|P1|Overall Study|Lack of Efficacy|2
5969398|NCT01134939|20643852|P8|Overall Study|Adverse Event|0
5969399|NCT01134939|20643853|P7|Overall Study|Adverse Event|1
5969400|NCT01134939|20643854|P6|Overall Study|Adverse Event|5
5969401|NCT01134939|20643855|P5|Overall Study|Adverse Event|5
5969402|NCT01134939|20643856|P4|Overall Study|Adverse Event|5
5969403|NCT01134939|20643857|P3|Overall Study|Adverse Event|4
5969404|NCT01134939|20643858|P2|Overall Study|Adverse Event|3
5969405|NCT01134939|20643859|P1|Overall Study|Adverse Event|9
5969406|NCT01134783|20643997|P2|Overall Study|Lost to Follow-up|20
5969407|NCT01134783|20643998|P1|Overall Study|Lost to Follow-up|5
5969408|NCT01134783|20643997|P2|Overall Study|Withdrawal by Subject|9
5969409|NCT01134783|20643998|P1|Overall Study|Withdrawal by Subject|15
5969410|NCT01134783|20643997|P2|Overall Study|Pregnancy|8
5969411|NCT01134783|20643998|P1|Overall Study|Pregnancy|16
5969412|NCT01134731|20644017|P3|Overall Study|Lost to Follow-up|3
5969413|NCT01134731|20644018|P2|Overall Study|Lost to Follow-up|4
5969414|NCT01134731|20644019|P1|Overall Study|Lost to Follow-up|5
5969415|NCT01134731|20644017|P3|Overall Study|Withdrawal by Subject|1
5969416|NCT01134731|20644018|P2|Overall Study|Withdrawal by Subject|3
5969417|NCT01134731|20644019|P1|Overall Study|Withdrawal by Subject|3
5969418|NCT01134731|20644017|P3|Overall Study|Lack of Efficacy|1
5969419|NCT01134731|20644018|P2|Overall Study|Lack of Efficacy|0
5969420|NCT01134731|20644019|P1|Overall Study|Lack of Efficacy|0
5969421|NCT01134731|20644017|P3|Overall Study|Physician Decision|2
5969422|NCT01134731|20644018|P2|Overall Study|Physician Decision|2
5969423|NCT01134731|20644019|P1|Overall Study|Physician Decision|2
5969424|NCT01134731|20644017|P3|Overall Study|Adverse Event|1
5969425|NCT01134731|20644018|P2|Overall Study|Adverse Event|2
5969426|NCT01134731|20644019|P1|Overall Study|Adverse Event|3
5969427|NCT01134705|20644032|P2|Overall Study|Other|6
5969428|NCT01134705|20644033|P1|Overall Study|Other|1
5969429|NCT01134705|20644032|P2|Overall Study|Protocol Violation|1
5969430|NCT01134705|20644033|P1|Overall Study|Protocol Violation|1
5969431|NCT01134705|20644032|P2|Overall Study|Lost to Follow-up|2
5969432|NCT01134705|20644033|P1|Overall Study|Lost to Follow-up|5
5969433|NCT01134705|20644032|P2|Overall Study|Pregnancy|0
5969434|NCT01134705|20644033|P1|Overall Study|Pregnancy|1
5969435|NCT01134705|20644032|P2|Overall Study|Withdrawal by Subject|6
5969436|NCT01134705|20644033|P1|Overall Study|Withdrawal by Subject|6
5969437|NCT01134705|20644032|P2|Overall Study|Adverse Event|7
5969438|NCT01134705|20644033|P1|Overall Study|Adverse Event|1
5969439|NCT01134627|20644045|P2|Overall Study|Other|14
5969440|NCT01134627|20644046|P1|Overall Study|Other|11
5969441|NCT01134627|20644045|P2|Overall Study|Planning to become pregnant/pregnancy|0
5969442|NCT01134627|20644046|P1|Overall Study|Planning to become pregnant/pregnancy|1
5969443|NCT01134627|20644045|P2|Overall Study|Withdrawal by Subject|3
5969444|NCT01134627|20644046|P1|Overall Study|Withdrawal by Subject|4
5969445|NCT01134627|20644045|P2|Overall Study|Lack of Efficacy|12
5969446|NCT01134627|20644046|P1|Overall Study|Lack of Efficacy|2
5969447|NCT01134627|20644045|P2|Overall Study|Protocol Violation|5
5969448|NCT01134627|20644046|P1|Overall Study|Protocol Violation|3
5969449|NCT01134627|20644045|P2|Overall Study|Lost to Follow-up|2
5969450|NCT01134627|20644046|P1|Overall Study|Lost to Follow-up|1
5969451|NCT01134627|20644045|P2|Overall Study|Adverse Event|31
5969452|NCT01134627|20644046|P1|Overall Study|Adverse Event|47
5969477|NCT01134562|20644105|P5|Overall Study|Adverse Event|0
5969478|NCT01134562|20644106|P4|Overall Study|Adverse Event|0
5969479|NCT01134562|20644107|P3|Overall Study|Adverse Event|0
5969480|NCT01134562|20644108|P2|Overall Study|Adverse Event|1
5969481|NCT01134562|20644109|P1|Overall Study|Adverse Event|0
5969482|NCT01134393|20644281|P1|Overall Study|Other|6
5969483|NCT01134393|20644281|P1|Overall Study|Withdrawal by Subject|11
5969484|NCT01134393|20644281|P1|Overall Study|Lost to Follow-up|3
5969485|NCT01134393|20644281|P1|Overall Study|Protocol Violation|12
5969486|NCT01134393|20644281|P1|Overall Study|Lack of Efficacy|2
5969487|NCT01134393|20644281|P1|Overall Study|Adverse Event|18
5969488|NCT01134315|20644402|P2|Overall Study|Other Reason|17
5969489|NCT01134315|20644403|P1|Overall Study|Other Reason|8
5969490|NCT01134315|20644402|P2|Overall Study|Adverse Event|2
5969491|NCT01134315|20644403|P1|Overall Study|Adverse Event|1
5969492|NCT01134263|20644441|P5|Overall Study|Enrolled, but not treated|0
5969493|NCT01134263|20644442|P4|Overall Study|Enrolled, but not treated|1
5969494|NCT01134263|20644443|P3|Overall Study|Enrolled, but not treated|0
5969495|NCT01134263|20644444|P2|Overall Study|Enrolled, but not treated|1
5969496|NCT01134263|20644445|P1|Overall Study|Enrolled, but not treated|1
5969497|NCT01134263|20644441|P5|Overall Study|Withdrawal by Subject|5
5969498|NCT01134263|20644442|P4|Overall Study|Withdrawal by Subject|7
5969499|NCT01134263|20644443|P3|Overall Study|Withdrawal by Subject|16
5969500|NCT01134263|20644444|P2|Overall Study|Withdrawal by Subject|6
5969501|NCT01134263|20644445|P1|Overall Study|Withdrawal by Subject|8
5969502|NCT01134263|20644441|P5|Overall Study|Lost to Follow-up|1
5969503|NCT01134263|20644442|P4|Overall Study|Lost to Follow-up|3
5969504|NCT01134263|20644443|P3|Overall Study|Lost to Follow-up|5
5969505|NCT01134263|20644444|P2|Overall Study|Lost to Follow-up|3
5969506|NCT01134263|20644445|P1|Overall Study|Lost to Follow-up|4
5969507|NCT01134263|20644441|P5|Overall Study|Protocol Violation|2
5969508|NCT01134263|20644442|P4|Overall Study|Protocol Violation|4
5969509|NCT01134263|20644443|P3|Overall Study|Protocol Violation|2
5969510|NCT01134263|20644444|P2|Overall Study|Protocol Violation|7
5969511|NCT01134263|20644445|P1|Overall Study|Protocol Violation|8
5969512|NCT01134263|20644441|P5|Overall Study|Other adverse event|0
5969513|NCT01134263|20644442|P4|Overall Study|Other adverse event|3
5969514|NCT01134263|20644443|P3|Overall Study|Other adverse event|5
5969515|NCT01134263|20644444|P2|Overall Study|Other adverse event|2
5969516|NCT01134263|20644445|P1|Overall Study|Other adverse event|1
5969517|NCT01134263|20644441|P5|Overall Study|Serious adverse event|1
5969518|NCT01134263|20644442|P4|Overall Study|Serious adverse event|1
5969519|NCT01134263|20644443|P3|Overall Study|Serious adverse event|1
5969520|NCT01134263|20644444|P2|Overall Study|Serious adverse event|1
5969521|NCT01134263|20644445|P1|Overall Study|Serious adverse event|2
5969522|NCT01134107|20644478|P2|Period 2-Second Treatment Intervention|Sponsor Decision|0
5969523|NCT01134107|20644479|P1|Period 2-Second Treatment Intervention|Sponsor Decision|1
5969524|NCT01134107|20644478|P2|Period 2-Second Treatment Intervention|Physician Decision|0
5969525|NCT01134107|20644479|P1|Period 2-Second Treatment Intervention|Physician Decision|1
5969526|NCT01134107|20644478|P2|Period 2-Second Treatment Intervention|Withdrawal by Subject|0
5969527|NCT01134107|20644479|P1|Period 2-Second Treatment Intervention|Withdrawal by Subject|2
5969528|NCT01134107|20644478|P2|Period 1-First Treatment Intervention|Physician Decision|0
5969529|NCT01134107|20644479|P1|Period 1-First Treatment Intervention|Physician Decision|1
5969530|NCT01134107|20644478|P2|Period 1-First Treatment Intervention|Withdrawal by Subject|4
5969531|NCT01134107|20644479|P1|Period 1-First Treatment Intervention|Withdrawal by Subject|3
5969532|NCT01134107|20644478|P2|Period 1-First Treatment Intervention|Entry Criteria Not Met|1
5969533|NCT01134107|20644479|P1|Period 1-First Treatment Intervention|Entry Criteria Not Met|1
5969534|NCT01134107|20644478|P2|Period 1-First Treatment Intervention|Adverse Event|0
5969535|NCT01134107|20644479|P1|Period 1-First Treatment Intervention|Adverse Event|1
5969536|NCT01134055|20644526|P7|Overall Study|Physician Decision|1
5969537|NCT01134055|20644527|P6|Overall Study|Physician Decision|0
5969538|NCT01134055|20644528|P5|Overall Study|Physician Decision|0
5969539|NCT01134055|20644529|P4|Overall Study|Physician Decision|0
5969540|NCT01134055|20644530|P3|Overall Study|Physician Decision|0
5969541|NCT01134055|20644531|P2|Overall Study|Physician Decision|0
5969542|NCT01134055|20644532|P1|Overall Study|Physician Decision|0
5969543|NCT01134055|20644526|P7|Overall Study|Protocol Violation|0
5969544|NCT01134055|20644527|P6|Overall Study|Protocol Violation|0
5969545|NCT01134055|20644528|P5|Overall Study|Protocol Violation|1
5969546|NCT01134055|20644529|P4|Overall Study|Protocol Violation|1
5969547|NCT01134055|20644530|P3|Overall Study|Protocol Violation|0
5969548|NCT01134055|20644531|P2|Overall Study|Protocol Violation|0
5969549|NCT01134055|20644532|P1|Overall Study|Protocol Violation|0
5969550|NCT01134055|20644526|P7|Overall Study|Withdrawal by Subject|8
5969551|NCT01134055|20644527|P6|Overall Study|Withdrawal by Subject|0
5969552|NCT01134055|20644528|P5|Overall Study|Withdrawal by Subject|0
5969553|NCT01134055|20644529|P4|Overall Study|Withdrawal by Subject|2
5969554|NCT01134055|20644530|P3|Overall Study|Withdrawal by Subject|1
5969555|NCT01134055|20644531|P2|Overall Study|Withdrawal by Subject|3
5969556|NCT01134055|20644532|P1|Overall Study|Withdrawal by Subject|3
5969557|NCT01134055|20644526|P7|Overall Study|Lost to Follow-up|0
5969558|NCT01134055|20644527|P6|Overall Study|Lost to Follow-up|0
5969559|NCT01134055|20644528|P5|Overall Study|Lost to Follow-up|0
5969560|NCT01134055|20644529|P4|Overall Study|Lost to Follow-up|1
5969561|NCT01134055|20644530|P3|Overall Study|Lost to Follow-up|0
5969562|NCT01134055|20644531|P2|Overall Study|Lost to Follow-up|1
5969563|NCT01134055|20644532|P1|Overall Study|Lost to Follow-up|0
5969564|NCT01134055|20644526|P7|Overall Study|Adverse Event|2
5969565|NCT01134055|20644527|P6|Overall Study|Adverse Event|7
5969566|NCT01134055|20644528|P5|Overall Study|Adverse Event|5
5969567|NCT01134055|20644529|P4|Overall Study|Adverse Event|2
5969568|NCT01134055|20644530|P3|Overall Study|Adverse Event|2
5969569|NCT01134055|20644531|P2|Overall Study|Adverse Event|2
5969570|NCT01134055|20644532|P1|Overall Study|Adverse Event|5
5969571|NCT01134042|20644666|P3|Overall Study|Withdrawal by Subject|7
5969572|NCT01134042|20644667|P2|Overall Study|Withdrawal by Subject|4
5969573|NCT01134042|20644668|P1|Overall Study|Withdrawal by Subject|13
5969574|NCT01134042|20644666|P3|Overall Study|Physician Decision|1
5969575|NCT01134042|20644667|P2|Overall Study|Physician Decision|8
5969576|NCT01134042|20644668|P1|Overall Study|Physician Decision|4
5969577|NCT01134042|20644666|P3|Overall Study|Lost to Follow-up|1
5969578|NCT01134042|20644667|P2|Overall Study|Lost to Follow-up|0
5969579|NCT01134042|20644668|P1|Overall Study|Lost to Follow-up|2
5969580|NCT01134042|20644666|P3|Overall Study|Protocol Violation|5
5969581|NCT01134042|20644667|P2|Overall Study|Protocol Violation|3
5969582|NCT01134042|20644668|P1|Overall Study|Protocol Violation|5
5969583|NCT01134042|20644666|P3|Overall Study|Lack of Efficacy|18
5969584|NCT01134042|20644667|P2|Overall Study|Lack of Efficacy|6
5969585|NCT01134042|20644668|P1|Overall Study|Lack of Efficacy|21
5969586|NCT01134042|20644666|P3|Overall Study|Adverse Event|2
5969587|NCT01134042|20644667|P2|Overall Study|Adverse Event|7
5969588|NCT01134042|20644668|P1|Overall Study|Adverse Event|3
5969589|NCT01133977|20644744|P5|Overall Study|Withdrawal by Subject|1
5969590|NCT01133977|20644745|P4|Overall Study|Withdrawal by Subject|5
5969591|NCT01133977|20644746|P3|Overall Study|Withdrawal by Subject|0
5969592|NCT01133977|20644747|P2|Overall Study|Withdrawal by Subject|0
5969593|NCT01133977|20644748|P1|Overall Study|Withdrawal by Subject|0
5969594|NCT01133977|20644744|P5|Overall Study|Lost to Follow-up|1
5969595|NCT01133977|20644745|P4|Overall Study|Lost to Follow-up|2
5969596|NCT01133977|20644746|P3|Overall Study|Lost to Follow-up|0
5969597|NCT01133977|20644747|P2|Overall Study|Lost to Follow-up|0
5969598|NCT01133977|20644748|P1|Overall Study|Lost to Follow-up|0
5969599|NCT01133977|20644744|P5|Overall Study|Started a New Line of Therapy|33
5969600|NCT01133977|20644745|P4|Overall Study|Started a New Line of Therapy|25
5969601|NCT01133977|20644746|P3|Overall Study|Started a New Line of Therapy|4
5969602|NCT01133977|20644747|P2|Overall Study|Started a New Line of Therapy|6
5969603|NCT01133977|20644748|P1|Overall Study|Started a New Line of Therapy|2
5969604|NCT01133977|20644744|P5|Overall Study|Death|3
5969605|NCT01133977|20644745|P4|Overall Study|Death|7
5969606|NCT01133977|20644746|P3|Overall Study|Death|1
5969607|NCT01133977|20644747|P2|Overall Study|Death|1
5969608|NCT01133977|20644748|P1|Overall Study|Death|1
5969609|NCT01133977|20644744|P5|Overall Study|Adverse Event|0
5969610|NCT01133977|20644745|P4|Overall Study|Adverse Event|0
5969611|NCT01133977|20644746|P3|Overall Study|Adverse Event|1
5969612|NCT01133977|20644747|P2|Overall Study|Adverse Event|0
5969613|NCT01133977|20644748|P1|Overall Study|Adverse Event|0
5969614|NCT01133847|20644775|P3|Follow-Up Phase|Lost to Follow-up|7
5969615|NCT01133847|20644776|P2|Follow-Up Phase|Lost to Follow-up|3
5969616|NCT01133847|20644777|P1|Follow-Up Phase|Lost to Follow-up|1
5969617|NCT01133847|20644775|P3|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|3
5969618|NCT01133847|20644776|P2|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|1
5969619|NCT01133847|20644777|P1|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|5
5969620|NCT01133821|20644817|P2|Overall Study|Refused participation|3
5969621|NCT01133821|20644818|P1|Overall Study|Refused participation|1
5969622|NCT01133821|20644817|P2|Overall Study|Protocol Violation|1
5969623|NCT01133821|20644818|P1|Overall Study|Protocol Violation|0
5969624|NCT01133821|20644817|P2|Overall Study|preferred other treatment|1
5969625|NCT01133821|20644818|P1|Overall Study|preferred other treatment|1
5969626|NCT01133821|20644817|P2|Overall Study|Withdrawal by Subject|3
5969627|NCT01133821|20644818|P1|Overall Study|Withdrawal by Subject|8
5969628|NCT01133821|20644817|P2|Overall Study|Lost to Follow-up|11
5969629|NCT01133821|20644818|P1|Overall Study|Lost to Follow-up|8
5969630|NCT01133756|20644829|P3|Overall Study|Progression of Disease|1
5969631|NCT01133756|20644830|P2|Overall Study|Progression of Disease|0
5969632|NCT01133756|20644831|P1|Overall Study|Progression of Disease|0
5969633|NCT01133756|20644829|P3|Overall Study|Withdrawal by Subject|0
5969634|NCT01133756|20644830|P2|Overall Study|Withdrawal by Subject|1
5969635|NCT01133756|20644831|P1|Overall Study|Withdrawal by Subject|0
5969636|NCT01133756|20644829|P3|Overall Study|Investigator Decision|0
5969637|NCT01133756|20644830|P2|Overall Study|Investigator Decision|0
5969638|NCT01133756|20644831|P1|Overall Study|Investigator Decision|1
5969639|NCT01133756|20644829|P3|Overall Study|Adverse Event|1
5969640|NCT01133756|20644830|P2|Overall Study|Adverse Event|2
5969641|NCT01133756|20644831|P1|Overall Study|Adverse Event|1
5969642|NCT01133704|20644847|P2|Overall Study|Study Closure|0
5969643|NCT01133704|20644848|P1|Overall Study|Study Closure|1
5969644|NCT01133704|20644847|P2|Overall Study|Patient refused to continue|0
5969645|NCT01133704|20644848|P1|Overall Study|Patient refused to continue|4
5969646|NCT01133704|20644847|P2|Overall Study|Death|26
5969647|NCT01133704|20644848|P1|Overall Study|Death|44
5969648|NCT01133678|20644858|P2|Overall Study|Death|1
5969649|NCT01133678|20644859|P1|Overall Study|Death|1
5969650|NCT01133665|20644865|P1|Overall Study|Physician Decision|2
5969651|NCT01133626|20644925|P3|Overall Study|Other|0
5969652|NCT01133626|20644926|P2|Overall Study|Other|2
5969653|NCT01133626|20644927|P1|Overall Study|Other|0
5969654|NCT01133626|20644925|P3|Overall Study|Withdrawal by Subject|2
5969655|NCT01133626|20644926|P2|Overall Study|Withdrawal by Subject|2
5969656|NCT01133626|20644927|P1|Overall Study|Withdrawal by Subject|1
5969657|NCT01133626|20644925|P3|Overall Study|Adverse Event|0
5969658|NCT01133626|20644926|P2|Overall Study|Adverse Event|1
5969659|NCT01133626|20644927|P1|Overall Study|Adverse Event|0
5969660|NCT01133522|20644945|P10|Overall Study|Physician Decision|0
5969661|NCT01133522|20644946|P9|Overall Study|Physician Decision|0
5969662|NCT01133522|20644947|P8|Overall Study|Physician Decision|0
5969663|NCT01133522|20644948|P7|Overall Study|Physician Decision|0
5969664|NCT01133522|20644949|P6|Overall Study|Physician Decision|0
5969665|NCT01133522|20644950|P5|Overall Study|Physician Decision|1
5969666|NCT01133522|20644951|P4|Overall Study|Physician Decision|0
5969667|NCT01133522|20644952|P3|Overall Study|Physician Decision|0
5969668|NCT01133522|20644953|P2|Overall Study|Physician Decision|0
5969669|NCT01133522|20644954|P1|Overall Study|Physician Decision|0
5969670|NCT01133522|20644945|P10|Overall Study|Withdrawal by Subject|0
5969671|NCT01133522|20644946|P9|Overall Study|Withdrawal by Subject|0
5969672|NCT01133522|20644947|P8|Overall Study|Withdrawal by Subject|0
5969673|NCT01133522|20644948|P7|Overall Study|Withdrawal by Subject|0
5969674|NCT01133522|20644949|P6|Overall Study|Withdrawal by Subject|0
5969675|NCT01133522|20644950|P5|Overall Study|Withdrawal by Subject|0
5969676|NCT01133522|20644951|P4|Overall Study|Withdrawal by Subject|1
5969677|NCT01133522|20644952|P3|Overall Study|Withdrawal by Subject|0
5969678|NCT01133522|20644953|P2|Overall Study|Withdrawal by Subject|1
5969679|NCT01133522|20644954|P1|Overall Study|Withdrawal by Subject|0
5969680|NCT01133418|20645022|P2|Overall Study|Lost to Follow-up|6
5969681|NCT01133418|20645023|P1|Overall Study|Lost to Follow-up|5
5969682|NCT01133405|20645045|P10|Period 2|Physician Decision|0
5969683|NCT01133405|20645046|P9|Period 2|Physician Decision|0
5969684|NCT01133405|20645047|P8|Period 2|Physician Decision|0
5969685|NCT01133405|20645048|P7|Period 2|Physician Decision|0
5969686|NCT01133405|20645049|P6|Period 2|Physician Decision|1
5969687|NCT01133405|20645050|P5|Period 2|Physician Decision|0
5969688|NCT01133405|20645051|P4|Period 2|Physician Decision|0
5969689|NCT01133405|20645052|P3|Period 2|Physician Decision|0
5969690|NCT01133405|20645053|P2|Period 2|Physician Decision|0
5969691|NCT01133405|20645054|P1|Period 2|Physician Decision|0
5969692|NCT01133405|20645045|P10|Period 2|Entry Criteria Not Met|0
5969693|NCT01133405|20645046|P9|Period 2|Entry Criteria Not Met|0
5969694|NCT01133405|20645047|P8|Period 2|Entry Criteria Not Met|0
5969695|NCT01133405|20645048|P7|Period 2|Entry Criteria Not Met|0
5969696|NCT01133405|20645049|P6|Period 2|Entry Criteria Not Met|0
5969697|NCT01133405|20645050|P5|Period 2|Entry Criteria Not Met|0
5969698|NCT01133405|20645051|P4|Period 2|Entry Criteria Not Met|0
5969699|NCT01133405|20645052|P3|Period 2|Entry Criteria Not Met|0
5969700|NCT01133405|20645053|P2|Period 2|Entry Criteria Not Met|1
5969701|NCT01133405|20645054|P1|Period 2|Entry Criteria Not Met|0
5969702|NCT01133405|20645045|P10|Period 2|Withdrawal by Subject|0
5969703|NCT01133405|20645046|P9|Period 2|Withdrawal by Subject|0
5969704|NCT01133405|20645047|P8|Period 2|Withdrawal by Subject|0
5969705|NCT01133405|20645048|P7|Period 2|Withdrawal by Subject|0
5969706|NCT01133405|20645049|P6|Period 2|Withdrawal by Subject|1
5969707|NCT01133405|20645050|P5|Period 2|Withdrawal by Subject|0
5969708|NCT01133405|20645051|P4|Period 2|Withdrawal by Subject|1
5969709|NCT01133405|20645052|P3|Period 2|Withdrawal by Subject|0
5969710|NCT01133405|20645053|P2|Period 2|Withdrawal by Subject|0
5969711|NCT01133405|20645054|P1|Period 2|Withdrawal by Subject|0
5969712|NCT01133405|20645045|P10|Period 2|Adverse Event|0
5969713|NCT01133405|20645046|P9|Period 2|Adverse Event|0
5969714|NCT01133405|20645047|P8|Period 2|Adverse Event|0
5969715|NCT01133405|20645048|P7|Period 2|Adverse Event|0
5969716|NCT01133405|20645049|P6|Period 2|Adverse Event|0
5969717|NCT01133405|20645050|P5|Period 2|Adverse Event|0
5969718|NCT01133405|20645051|P4|Period 2|Adverse Event|0
5969719|NCT01133405|20645052|P3|Period 2|Adverse Event|1
5969720|NCT01133405|20645053|P2|Period 2|Adverse Event|0
5969721|NCT01133405|20645054|P1|Period 2|Adverse Event|0
5969722|NCT01133405|20645045|P10|Period 1|Received drug only in period 3|0
5969723|NCT01133405|20645046|P9|Period 1|Received drug only in period 3|0
5969724|NCT01133405|20645047|P8|Period 1|Received drug only in period 3|0
5969725|NCT01133405|20645048|P7|Period 1|Received drug only in period 3|0
5969726|NCT01133405|20645049|P6|Period 1|Received drug only in period 3|0
5969727|NCT01133405|20645050|P5|Period 1|Received drug only in period 3|0
5969728|NCT01133405|20645051|P4|Period 1|Received drug only in period 3|0
5969729|NCT01133405|20645052|P3|Period 1|Received drug only in period 3|1
5969730|NCT01133405|20645053|P2|Period 1|Received drug only in period 3|1
5969731|NCT01133405|20645054|P1|Period 1|Received drug only in period 3|0
5969732|NCT01133405|20645045|P10|Period 1|Received drug only in period 2|0
5969733|NCT01133405|20645046|P9|Period 1|Received drug only in period 2|0
5969734|NCT01133405|20645047|P8|Period 1|Received drug only in period 2|0
5969735|NCT01133405|20645048|P7|Period 1|Received drug only in period 2|0
5969736|NCT01133405|20645049|P6|Period 1|Received drug only in period 2|1
5969737|NCT01133405|20645050|P5|Period 1|Received drug only in period 2|0
5969738|NCT01133405|20645051|P4|Period 1|Received drug only in period 2|2
5969739|NCT01133405|20645052|P3|Period 1|Received drug only in period 2|0
5969740|NCT01133405|20645053|P2|Period 1|Received drug only in period 2|1
5969741|NCT01133405|20645054|P1|Period 1|Received drug only in period 2|0
5969742|NCT01133405|20645045|P10|Period 1|Discontinued after randomization|0
5969743|NCT01133405|20645046|P9|Period 1|Discontinued after randomization|0
5969744|NCT01133405|20645047|P8|Period 1|Discontinued after randomization|0
5969745|NCT01133405|20645048|P7|Period 1|Discontinued after randomization|1
5969746|NCT01133405|20645049|P6|Period 1|Discontinued after randomization|0
5969747|NCT01133405|20645050|P5|Period 1|Discontinued after randomization|0
5969748|NCT01133405|20645051|P4|Period 1|Discontinued after randomization|0
5969749|NCT01133405|20645052|P3|Period 1|Discontinued after randomization|0
5969750|NCT01133405|20645053|P2|Period 1|Discontinued after randomization|0
5969751|NCT01133405|20645054|P1|Period 1|Discontinued after randomization|1
5969752|NCT01133405|20645045|P10|Period 1|Physician Decision|0
5969753|NCT01133405|20645046|P9|Period 1|Physician Decision|0
5969754|NCT01133405|20645047|P8|Period 1|Physician Decision|0
5969755|NCT01133405|20645048|P7|Period 1|Physician Decision|0
5969756|NCT01133405|20645049|P6|Period 1|Physician Decision|0
5969757|NCT01133405|20645050|P5|Period 1|Physician Decision|0
5969758|NCT01133405|20645051|P4|Period 1|Physician Decision|1
5969759|NCT01133405|20645052|P3|Period 1|Physician Decision|0
5969760|NCT01133405|20645053|P2|Period 1|Physician Decision|0
5969761|NCT01133405|20645054|P1|Period 1|Physician Decision|0
5969762|NCT01133405|20645045|P10|Period 1|Withdrawal by Subject|0
5969763|NCT01133405|20645046|P9|Period 1|Withdrawal by Subject|0
5969764|NCT01133405|20645047|P8|Period 1|Withdrawal by Subject|0
5969765|NCT01133405|20645048|P7|Period 1|Withdrawal by Subject|0
5969766|NCT01133405|20645049|P6|Period 1|Withdrawal by Subject|1
5969767|NCT01133405|20645050|P5|Period 1|Withdrawal by Subject|0
5969768|NCT01133405|20645051|P4|Period 1|Withdrawal by Subject|1
5969769|NCT01133405|20645052|P3|Period 1|Withdrawal by Subject|0
5969770|NCT01133405|20645053|P2|Period 1|Withdrawal by Subject|1
5969771|NCT01133405|20645054|P1|Period 1|Withdrawal by Subject|0
5969772|NCT01133392|20645105|P2|Interval Between Dosing (4-7 Days)|Protocol Violation|1
5969773|NCT01133392|20645106|P1|Interval Between Dosing (4-7 Days)|Protocol Violation|0
5969774|NCT01133392|20645105|P2|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|1
5969775|NCT01133392|20645106|P1|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|0
5969776|NCT01133379|20645123|P3|Overall Study|Lost to Follow-up|1
5969777|NCT01133379|20645124|P2|Overall Study|Lost to Follow-up|1
5969778|NCT01133379|20645125|P1|Overall Study|Lost to Follow-up|1
5969779|NCT01133379|20645123|P3|Overall Study|Withdrawal by Subject|1
5969780|NCT01133379|20645124|P2|Overall Study|Withdrawal by Subject|1
5969781|NCT01133379|20645125|P1|Overall Study|Withdrawal by Subject|0
5969782|NCT01133288|20645178|P1|Intervention Allocation|study terminated|2
5969783|NCT01133288|20645178|P1|Eligibility Assessment|met exclusion criteria|5
5969784|NCT01133275|20645183|P1|Overall Study|Cerebrovascular accident (CVA)|1
5969785|NCT01133275|20645183|P1|Overall Study|Withdrawal by Subject|1
5969786|NCT01133171|20645191|P3|Overall Study|Withdrawal by Subject|0
5969787|NCT01133171|20645192|P2|Overall Study|Withdrawal by Subject|2
5969788|NCT01133171|20645193|P1|Overall Study|Withdrawal by Subject|1
5969789|NCT01133067|20645209|P1|Overall Study|Lost to Follow-up|3
5969790|NCT01133067|20645209|P1|Overall Study|Death|136
5969791|NCT01132820|20645269|P1|Overall Study|Inadequate data|1
5969792|NCT01132820|20645269|P1|Overall Study|Never treated|1
5969793|NCT01132820|20645269|P1|Overall Study|Ineligible:Inadequate pathology|1
5969794|NCT01132820|20645269|P1|Overall Study|Ineligible:Improper pre-protocol therapy|1
5969795|NCT01132820|20645269|P1|Overall Study|Ineligible: wrong cell type|1
5969796|NCT01132755|20645278|P1|Overall Study|Withdrawal by Subject|4
5969797|NCT01132755|20645278|P1|Overall Study|Protocol Violation|15
5969798|NCT01132755|20645278|P1|Overall Study|Procedure not done due to medical reason|23
5969799|NCT01132664|20645307|P5|BM Cohort|Withdrawal by Subject|1
5969800|NCT01132664|20645308|P4|BM Cohort|Withdrawal by Subject|0
5969801|NCT01132664|20645309|P3|BM Cohort|Withdrawal by Subject|0
5969802|NCT01132664|20645310|P2|BM Cohort|Withdrawal by Subject|0
5969803|NCT01132664|20645311|P1|BM Cohort|Withdrawal by Subject|0
5969804|NCT01132664|20645307|P5|BM Cohort|Adverse Event|1
5969805|NCT01132664|20645308|P4|BM Cohort|Adverse Event|0
5969806|NCT01132664|20645309|P3|BM Cohort|Adverse Event|0
5969807|NCT01132664|20645310|P2|BM Cohort|Adverse Event|0
5969808|NCT01132664|20645311|P1|BM Cohort|Adverse Event|0
5969809|NCT01132664|20645307|P5|BM Cohort|Disease progression|4
5969810|NCT01132664|20645308|P4|BM Cohort|Disease progression|3
5969811|NCT01132664|20645309|P3|BM Cohort|Disease progression|0
5969812|NCT01132664|20645310|P2|BM Cohort|Disease progression|0
5969813|NCT01132664|20645311|P1|BM Cohort|Disease progression|0
5969814|NCT01132664|20645307|P5|Phase ll|Disease progression|0
5969815|NCT01132664|20645308|P4|Phase ll|Disease progression|0
5969816|NCT01132664|20645309|P3|Phase ll|Disease progression|35
5969817|NCT01132664|20645310|P2|Phase ll|Disease progression|0
5969818|NCT01132664|20645311|P1|Phase ll|Disease progression|0
5969819|NCT01132664|20645307|P5|Phase ll|Withdrawal by Subject|0
5969820|NCT01132664|20645308|P4|Phase ll|Withdrawal by Subject|0
5969821|NCT01132664|20645309|P3|Phase ll|Withdrawal by Subject|3
5969822|NCT01132664|20645310|P2|Phase ll|Withdrawal by Subject|0
5969823|NCT01132664|20645311|P1|Phase ll|Withdrawal by Subject|0
5969824|NCT01132664|20645307|P5|Phase ll|Adverse Event|0
5969825|NCT01132664|20645308|P4|Phase ll|Adverse Event|0
5969826|NCT01132664|20645309|P3|Phase ll|Adverse Event|10
5969827|NCT01132664|20645310|P2|Phase ll|Adverse Event|0
5969828|NCT01132664|20645311|P1|Phase ll|Adverse Event|0
5969829|NCT01132664|20645307|P5|Phase ll|Death|0
5969830|NCT01132664|20645308|P4|Phase ll|Death|0
5969831|NCT01132664|20645309|P3|Phase ll|Death|2
5969832|NCT01132664|20645310|P2|Phase ll|Death|0
5969833|NCT01132664|20645311|P1|Phase ll|Death|0
5969834|NCT01132664|20645307|P5|Phase lb|Disease Progression|0
5969835|NCT01132664|20645308|P4|Phase lb|Disease Progression|0
5969836|NCT01132664|20645309|P3|Phase lb|Disease Progression|0
5969837|NCT01132664|20645310|P2|Phase lb|Disease Progression|9
5969838|NCT01132664|20645311|P1|Phase lb|Disease Progression|4
5969839|NCT01132664|20645307|P5|Phase lb|Withdrawal by Subject|0
5969840|NCT01132664|20645308|P4|Phase lb|Withdrawal by Subject|0
5969841|NCT01132664|20645309|P3|Phase lb|Withdrawal by Subject|0
5969842|NCT01132664|20645310|P2|Phase lb|Withdrawal by Subject|2
5969843|NCT01132664|20645311|P1|Phase lb|Withdrawal by Subject|1
5969844|NCT01132664|20645307|P5|Phase lb|Adverse Event|0
5969845|NCT01132664|20645308|P4|Phase lb|Adverse Event|0
5969846|NCT01132664|20645309|P3|Phase lb|Adverse Event|0
5969847|NCT01132664|20645310|P2|Phase lb|Adverse Event|1
5969848|NCT01132664|20645311|P1|Phase lb|Adverse Event|0
5969849|NCT01132651|20645345|P2|Overall Study|Lost to Follow-up|1
5969850|NCT01132651|20645346|P1|Overall Study|Lost to Follow-up|1
5969851|NCT01132612|20645357|P3|Overall Study|Lack of Efficacy|73
5969852|NCT01132612|20645358|P2|Overall Study|Lack of Efficacy|22
5969853|NCT01132612|20645359|P1|Overall Study|Lack of Efficacy|23
5969854|NCT01132612|20645357|P3|Overall Study|Administrative problems|52
5969855|NCT01132612|20645358|P2|Overall Study|Administrative problems|1
5969856|NCT01132612|20645359|P1|Overall Study|Administrative problems|5
5969857|NCT01132612|20645357|P3|Overall Study|Withdrawal by Subject|19
5969858|NCT01132612|20645358|P2|Overall Study|Withdrawal by Subject|8
5969859|NCT01132612|20645359|P1|Overall Study|Withdrawal by Subject|5
5969860|NCT01132612|20645357|P3|Overall Study|Adverse Event|15
5969861|NCT01132612|20645358|P2|Overall Study|Adverse Event|2
5969862|NCT01132612|20645359|P1|Overall Study|Adverse Event|5
5969863|NCT01132612|20645357|P3|Overall Study|Lost to Follow-up|7
5969864|NCT01132612|20645358|P2|Overall Study|Lost to Follow-up|2
5969865|NCT01132612|20645359|P1|Overall Study|Lost to Follow-up|2
5969866|NCT01132612|20645357|P3|Overall Study|Protocol deviation|3
5969867|NCT01132612|20645358|P2|Overall Study|Protocol deviation|0
5969868|NCT01132612|20645359|P1|Overall Study|Protocol deviation|0
5969869|NCT01132612|20645357|P3|Overall Study|Death|1
5969870|NCT01132612|20645358|P2|Overall Study|Death|0
5969871|NCT01132612|20645359|P1|Overall Study|Death|0
5969872|NCT01132547|20645375|P2|Overall Study|Death|0
5969873|NCT01132547|20645376|P1|Overall Study|Death|1
5969874|NCT01132547|20645375|P2|Overall Study|Withdrawal by Subject|1
5969875|NCT01132547|20645376|P1|Overall Study|Withdrawal by Subject|3
5969876|NCT01132495|20645446|P4|Overall Study|Various reasons|12
5969877|NCT01132495|20645447|P3|Overall Study|Various reasons|20
5969878|NCT01132495|20645448|P2|Overall Study|Various reasons|38
5969879|NCT01132495|20645449|P1|Overall Study|Various reasons|40
5969880|NCT01132482|20645462|P2|Overall Study|Adverse Event|0
5969881|NCT01132482|20645463|P1|Overall Study|Adverse Event|1
5969882|NCT01132326|20645486|P1|Overall Study|Subject Unable to Come To Visits|1
5969883|NCT01132326|20645486|P1|Overall Study|Death|5
5969884|NCT01132326|20645486|P1|Overall Study|Caregiver Withdrew Consent|1
5969885|NCT01132326|20645486|P1|Overall Study|Pregnancy|1
5969886|NCT01132326|20645486|P1|Overall Study|Declining Health|1
5969887|NCT01132326|20645486|P1|Overall Study|Study Termination|80
5969888|NCT01132326|20645486|P1|Overall Study|Physician Decision|10
5969889|NCT01132326|20645486|P1|Overall Study|Withdrawal by Subject|40
5969890|NCT01132326|20645486|P1|Overall Study|Lost to Follow-up|16
5969891|NCT01132326|20645486|P1|Overall Study|Protocol Violation|1
5969892|NCT01132326|20645486|P1|Overall Study|Adverse Event|37
5969893|NCT01132326|20645486|P1|Overall Study|Lack of Efficacy|25
5969894|NCT01132313|20645502|P12|Overall Study|Other reason not defined above|0
5969895|NCT01132313|20645503|P11|Overall Study|Other reason not defined above|0
5969896|NCT01132313|20645504|P10|Overall Study|Other reason not defined above|0
5969897|NCT01132313|20645505|P9|Overall Study|Other reason not defined above|0
5969898|NCT01132313|20645506|P8|Overall Study|Other reason not defined above|1
5969899|NCT01132313|20645507|P7|Overall Study|Other reason not defined above|0
5969900|NCT01132313|20645508|P6|Overall Study|Other reason not defined above|0
5969901|NCT01132313|20645509|P5|Overall Study|Other reason not defined above|0
5969902|NCT01132313|20645510|P4|Overall Study|Other reason not defined above|0
5969903|NCT01132313|20645511|P3|Overall Study|Other reason not defined above|0
5969904|NCT01132313|20645512|P2|Overall Study|Other reason not defined above|0
5969905|NCT01132313|20645513|P1|Overall Study|Other reason not defined above|0
5969906|NCT01132313|20645502|P12|Overall Study|Lack of antiviral response|0
5969907|NCT01132313|20645503|P11|Overall Study|Lack of antiviral response|1
5969908|NCT01132313|20645504|P10|Overall Study|Lack of antiviral response|0
5969909|NCT01132313|20645505|P9|Overall Study|Lack of antiviral response|0
5969910|NCT01132313|20645506|P8|Overall Study|Lack of antiviral response|0
5969911|NCT01132313|20645507|P7|Overall Study|Lack of antiviral response|21
5969912|NCT01132313|20645508|P6|Overall Study|Lack of antiviral response|18
5969913|NCT01132313|20645509|P5|Overall Study|Lack of antiviral response|18
5969914|NCT01132313|20645510|P4|Overall Study|Lack of antiviral response|18
5969915|NCT01132313|20645511|P3|Overall Study|Lack of antiviral response|12
5969916|NCT01132313|20645512|P2|Overall Study|Lack of antiviral response|0
5969917|NCT01132313|20645513|P1|Overall Study|Lack of antiviral response|0
5969918|NCT01132313|20645502|P12|Overall Study|Withdrawal by Subject|0
5969919|NCT01132313|20645503|P11|Overall Study|Withdrawal by Subject|0
5969920|NCT01132313|20645504|P10|Overall Study|Withdrawal by Subject|2
5969921|NCT01132313|20645505|P9|Overall Study|Withdrawal by Subject|0
5969922|NCT01132313|20645506|P8|Overall Study|Withdrawal by Subject|0
5969923|NCT01132313|20645507|P7|Overall Study|Withdrawal by Subject|1
5969924|NCT01132313|20645508|P6|Overall Study|Withdrawal by Subject|0
5969925|NCT01132313|20645509|P5|Overall Study|Withdrawal by Subject|6
5969926|NCT01132313|20645510|P4|Overall Study|Withdrawal by Subject|3
5969927|NCT01132313|20645511|P3|Overall Study|Withdrawal by Subject|3
5969928|NCT01132313|20645512|P2|Overall Study|Withdrawal by Subject|0
5969929|NCT01132313|20645513|P1|Overall Study|Withdrawal by Subject|0
5969930|NCT01132313|20645502|P12|Overall Study|Lost to Follow-up|0
5969931|NCT01132313|20645503|P11|Overall Study|Lost to Follow-up|0
5969932|NCT01132313|20645504|P10|Overall Study|Lost to Follow-up|0
5969933|NCT01132313|20645505|P9|Overall Study|Lost to Follow-up|0
5969934|NCT01132313|20645506|P8|Overall Study|Lost to Follow-up|1
5969935|NCT01132313|20645507|P7|Overall Study|Lost to Follow-up|0
5969936|NCT01132313|20645508|P6|Overall Study|Lost to Follow-up|0
5969937|NCT01132313|20645509|P5|Overall Study|Lost to Follow-up|0
5969938|NCT01132313|20645510|P4|Overall Study|Lost to Follow-up|0
5969939|NCT01132313|20645511|P3|Overall Study|Lost to Follow-up|1
5969940|NCT01132313|20645512|P2|Overall Study|Lost to Follow-up|0
5969941|NCT01132313|20645513|P1|Overall Study|Lost to Follow-up|0
5969942|NCT01132313|20645502|P12|Overall Study|Protocol Violation|0
5969943|NCT01132313|20645503|P11|Overall Study|Protocol Violation|0
5969944|NCT01132313|20645504|P10|Overall Study|Protocol Violation|0
5969945|NCT01132313|20645505|P9|Overall Study|Protocol Violation|0
5969946|NCT01132313|20645506|P8|Overall Study|Protocol Violation|0
5969947|NCT01132313|20645507|P7|Overall Study|Protocol Violation|0
5969948|NCT01132313|20645508|P6|Overall Study|Protocol Violation|0
5969949|NCT01132313|20645509|P5|Overall Study|Protocol Violation|0
5969950|NCT01132313|20645510|P4|Overall Study|Protocol Violation|1
5969951|NCT01132313|20645511|P3|Overall Study|Protocol Violation|0
5969952|NCT01132313|20645512|P2|Overall Study|Protocol Violation|0
5969953|NCT01132313|20645513|P1|Overall Study|Protocol Violation|0
5969954|NCT01132313|20645502|P12|Overall Study|Adverse Event|0
5969955|NCT01132313|20645503|P11|Overall Study|Adverse Event|0
5969956|NCT01132313|20645504|P10|Overall Study|Adverse Event|2
5969957|NCT01132313|20645505|P9|Overall Study|Adverse Event|7
5969958|NCT01132313|20645506|P8|Overall Study|Adverse Event|3
5969959|NCT01132313|20645507|P7|Overall Study|Adverse Event|5
5969960|NCT01132313|20645508|P6|Overall Study|Adverse Event|6
5969961|NCT01132313|20645509|P5|Overall Study|Adverse Event|19
5969962|NCT01132313|20645510|P4|Overall Study|Adverse Event|10
5969963|NCT01132313|20645511|P3|Overall Study|Adverse Event|4
5969964|NCT01132313|20645512|P2|Overall Study|Adverse Event|0
5969965|NCT01132313|20645513|P1|Overall Study|Adverse Event|0
5969966|NCT01132313|20645502|P12|Overall Study|Not treated|0
5969967|NCT01132313|20645503|P11|Overall Study|Not treated|0
5969968|NCT01132313|20645504|P10|Overall Study|Not treated|0
5969969|NCT01132313|20645505|P9|Overall Study|Not treated|0
5969970|NCT01132313|20645506|P8|Overall Study|Not treated|0
5969971|NCT01132313|20645507|P7|Overall Study|Not treated|3
5969972|NCT01132313|20645508|P6|Overall Study|Not treated|1
5969973|NCT01132313|20645509|P5|Overall Study|Not treated|2
5969974|NCT01132313|20645510|P4|Overall Study|Not treated|0
5969975|NCT01132313|20645511|P3|Overall Study|Not treated|0
5969976|NCT01132313|20645512|P2|Overall Study|Not treated|0
5969977|NCT01132313|20645513|P1|Overall Study|Not treated|2
5969978|NCT01132313|20645502|P12|Overall Study|Lack of Efficacy|0
5969979|NCT01132313|20645503|P11|Overall Study|Lack of Efficacy|0
5969980|NCT01132313|20645504|P10|Overall Study|Lack of Efficacy|16
5969981|NCT01132313|20645505|P9|Overall Study|Lack of Efficacy|14
5969982|NCT01132313|20645506|P8|Overall Study|Lack of Efficacy|3
5969983|NCT01132313|20645507|P7|Overall Study|Lack of Efficacy|0
5969984|NCT01132313|20645508|P6|Overall Study|Lack of Efficacy|0
5969985|NCT01132313|20645509|P5|Overall Study|Lack of Efficacy|0
5969986|NCT01132313|20645510|P4|Overall Study|Lack of Efficacy|0
5969987|NCT01132313|20645511|P3|Overall Study|Lack of Efficacy|0
5969988|NCT01132313|20645512|P2|Overall Study|Lack of Efficacy|0
5969989|NCT01132313|20645513|P1|Overall Study|Lack of Efficacy|1
5969990|NCT01132118|20645593|P2|Second Intervention (8 Weeks)|Adverse Event|1
5969991|NCT01132118|20645594|P1|Second Intervention (8 Weeks)|Adverse Event|0
5969992|NCT01132118|20645593|P2|First Intervention (8 Weeks)|Withdrawal by Subject|3
5969993|NCT01132118|20645594|P1|First Intervention (8 Weeks)|Withdrawal by Subject|2
5969994|NCT01132118|20645593|P2|First Intervention (8 Weeks)|Adverse Event|0
5969995|NCT01132118|20645594|P1|First Intervention (8 Weeks)|Adverse Event|1
5969996|NCT01131676|20645624|P3|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|2
5969997|NCT01131676|20645625|P2|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4
5969998|NCT01131676|20645626|P1|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4
5969999|NCT01131676|20645624|P3|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|5
5970000|NCT01131676|20645625|P2|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|6
5970001|NCT01131676|20645626|P1|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|7
5970002|NCT01131676|20645624|P3|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|7
5970003|NCT01131676|20645625|P2|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|9
5970004|NCT01131676|20645626|P1|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|5
5970005|NCT01131676|20645624|P3|Discontinuation From Study (Treated Set)|Site closure: Final VS available|19
5970006|NCT01131676|20645625|P2|Discontinuation From Study (Treated Set)|Site closure: Final VS available|21
5970007|NCT01131676|20645626|P1|Discontinuation From Study (Treated Set)|Site closure: Final VS available|20
5970008|NCT01131676|20645624|P3|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|5
5970009|NCT01131676|20645625|P2|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|6
5970010|NCT01131676|20645626|P1|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|8
5970011|NCT01131676|20645624|P3|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|25
5970012|NCT01131676|20645625|P2|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|35
5970013|NCT01131676|20645626|P1|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|23
5970014|NCT01131676|20645624|P3|Discontinuation From Treatment|Adverse Event|273
5970015|NCT01131676|20645625|P2|Discontinuation From Treatment|Adverse Event|267
5970016|NCT01131676|20645626|P1|Discontinuation From Treatment|Adverse Event|303
5970017|NCT01131676|20645624|P3|Discontinuation From Treatment|Other than those specified|125
5970018|NCT01131676|20645625|P2|Discontinuation From Treatment|Other than those specified|142
5970019|NCT01131676|20645626|P1|Discontinuation From Treatment|Other than those specified|162
5970020|NCT01131676|20645624|P3|Discontinuation From Treatment|Refusal to continue, not due to AE|122
5970021|NCT01131676|20645625|P2|Discontinuation From Treatment|Refusal to continue, not due to AE|118
5970022|NCT01131676|20645626|P1|Discontinuation From Treatment|Refusal to continue, not due to AE|172
5970023|NCT01131676|20645624|P3|Discontinuation From Treatment|Lost to Follow-up|6
5970024|NCT01131676|20645625|P2|Discontinuation From Treatment|Lost to Follow-up|9
5970025|NCT01131676|20645626|P1|Discontinuation From Treatment|Lost to Follow-up|15
5970026|NCT01131676|20645624|P3|Discontinuation From Treatment|Non compliant with protocol|12
5970027|NCT01131676|20645625|P2|Discontinuation From Treatment|Non compliant with protocol|15
5970028|NCT01131676|20645626|P1|Discontinuation From Treatment|Non compliant with protocol|15
5970029|NCT01131676|20645624|P3|Discontinuation From Treatment|Lack of Efficacy|0
5970030|NCT01131676|20645625|P2|Discontinuation From Treatment|Lack of Efficacy|1
5970031|NCT01131676|20645626|P1|Discontinuation From Treatment|Lack of Efficacy|11
5970032|NCT01131676|20645624|P3|Discontinuation From Treatment|Not treated|2
5970033|NCT01131676|20645625|P2|Discontinuation From Treatment|Not treated|2
5970034|NCT01131676|20645626|P1|Discontinuation From Treatment|Not treated|4
5970035|NCT01131676|20645624|P3|Discontinuation From Treatment|Study drug stopped, reason missing|4
5970036|NCT01131676|20645625|P2|Discontinuation From Treatment|Study drug stopped, reason missing|3
5970037|NCT01131676|20645626|P1|Discontinuation From Treatment|Study drug stopped, reason missing|5
5970038|NCT01131585|20645661|P2|Overall Study|Study termination|32
5970039|NCT01131585|20645662|P1|Overall Study|Study termination|78
5970040|NCT01131585|20645661|P2|Overall Study|Administrative problems|1
5970041|NCT01131585|20645662|P1|Overall Study|Administrative problems|1
5970042|NCT01131585|20645661|P2|Overall Study|Lost to Follow-up|1
5970043|NCT01131585|20645662|P1|Overall Study|Lost to Follow-up|0
5970044|NCT01131585|20645661|P2|Overall Study|Withdrawal by Subject|3
5970045|NCT01131585|20645662|P1|Overall Study|Withdrawal by Subject|3
5970046|NCT01131585|20645661|P2|Overall Study|Protocol Violation|1
5970047|NCT01131585|20645662|P1|Overall Study|Protocol Violation|2
5970048|NCT01131585|20645661|P2|Overall Study|Unsatisfactory therapeutic effect|3
5970049|NCT01131585|20645662|P1|Overall Study|Unsatisfactory therapeutic effect|0
5970050|NCT01131585|20645661|P2|Overall Study|Abnormal laboratory value|0
5970051|NCT01131585|20645662|P1|Overall Study|Abnormal laboratory value|1
5970052|NCT01131585|20645661|P2|Overall Study|Adverse Event|2
5970053|NCT01131585|20645662|P1|Overall Study|Adverse Event|0
5970054|NCT01131520|20645670|P2|Overall Study|Subject changed history after enrollment|1
5970055|NCT01131520|20645671|P1|Overall Study|Subject changed history after enrollment|0
5970056|NCT01131520|20645670|P2|Overall Study|Counselor not available|3
5970057|NCT01131520|20645671|P1|Overall Study|Counselor not available|0
5970058|NCT01131520|20645670|P2|Overall Study|Computer problem|0
5970059|NCT01131520|20645671|P1|Overall Study|Computer problem|1
5970060|NCT01131507|20645693|P1|Overall Study|Withdrawal by Subject|1
5970061|NCT01131507|20645693|P1|Overall Study|Lost to Follow-up|1
5970062|NCT01131507|20645693|P1|Overall Study|Adverse Event|1
5970063|NCT01131494|20645698|P1|Overall Study|Withdrawal by Subject|2
5970064|NCT01131455|20645708|P3|Overall Study|Death of PI|0
5970065|NCT01131455|20645709|P2|Overall Study|Death of PI|4
5970066|NCT01131455|20645710|P1|Overall Study|Death of PI|6
5970067|NCT01131312|20645721|P3|Overall Study|Lost to Follow-up|351
5970068|NCT01131312|20645722|P2|Overall Study|Lost to Follow-up|229
5970069|NCT01131312|20645723|P1|Overall Study|Lost to Follow-up|425
5970070|NCT01131299|20645734|P2|Overall Study|Withdrawal by Subject|7
5970071|NCT01131299|20645735|P1|Overall Study|Withdrawal by Subject|4
5970072|NCT01131260|20645748|P2|Overall Study|Ineligible|2
5970073|NCT01131260|20645749|P1|Overall Study|Ineligible|0
5970074|NCT01131260|20645748|P2|Overall Study|Staff error|1
5970075|NCT01131260|20645749|P1|Overall Study|Staff error|2
5970076|NCT01131260|20645748|P2|Overall Study|Technical problems|6
5970077|NCT01131260|20645749|P1|Overall Study|Technical problems|7
5970078|NCT01131260|20645748|P2|Overall Study|Physician Decision|24
5970079|NCT01131260|20645749|P1|Overall Study|Physician Decision|22
5970080|NCT01131260|20645748|P2|Overall Study|Declined to continue participation|13
5970081|NCT01131260|20645749|P1|Overall Study|Declined to continue participation|8
5970082|NCT01131260|20645748|P2|Overall Study|Randomization error|1
5970083|NCT01131260|20645749|P1|Overall Study|Randomization error|5
5970084|NCT01131182|20645797|P2|Overall Study|Other Reason|0
5970085|NCT01131182|20645798|P1|Overall Study|Other Reason|1
5970086|NCT01131182|20645797|P2|Overall Study|Lost to Follow-up|15
5970087|NCT01131182|20645798|P1|Overall Study|Lost to Follow-up|14
5970088|NCT01131182|20645797|P2|Overall Study|Withdrawal by Subject|1
5970089|NCT01131182|20645798|P1|Overall Study|Withdrawal by Subject|1
5970090|NCT01131130|20645806|P1|Period 3- Crossover|+ Slit lamp finding|1
5970091|NCT01131130|20645806|P1|Period 1 - Baseline|Pregnancy|1
5970092|NCT01131104|20645819|P1|Overall Study|No Information on Index Date of Onset|1
5970093|NCT01131104|20645819|P1|Overall Study|Information Not Available|5
5970094|NCT01131104|20645819|P1|Overall Study|Physician Decision|4
5970095|NCT01131104|20645819|P1|Overall Study|Withdrawal by Subject|3
5970096|NCT01131078|20645826|P3|Overall Study|Other|0
5970097|NCT01131078|20645827|P2|Overall Study|Other|1
5970098|NCT01131078|20645828|P1|Overall Study|Other|0
5970099|NCT01131078|20645826|P3|Overall Study|Death|2
5970100|NCT01131078|20645827|P2|Overall Study|Death|0
5970101|NCT01131078|20645828|P1|Overall Study|Death|4
5970102|NCT01131078|20645826|P3|Overall Study|Physician Decision|8
5970103|NCT01131078|20645827|P2|Overall Study|Physician Decision|6
5970104|NCT01131078|20645828|P1|Overall Study|Physician Decision|10
5970105|NCT01131078|20645826|P3|Overall Study|Non-compliance|0
5970106|NCT01131078|20645827|P2|Overall Study|Non-compliance|0
5970107|NCT01131078|20645828|P1|Overall Study|Non-compliance|3
5970108|NCT01131078|20645826|P3|Overall Study|Withdrawal by Subject|3
5970109|NCT01131078|20645827|P2|Overall Study|Withdrawal by Subject|4
5970110|NCT01131078|20645828|P1|Overall Study|Withdrawal by Subject|2
5970111|NCT01131078|20645826|P3|Overall Study|Lost to Follow-up|1
5970112|NCT01131078|20645827|P2|Overall Study|Lost to Follow-up|1
5970113|NCT01131078|20645828|P1|Overall Study|Lost to Follow-up|1
5970114|NCT01131078|20645826|P3|Overall Study|Protocol Violation|0
5970115|NCT01131078|20645827|P2|Overall Study|Protocol Violation|0
5970116|NCT01131078|20645828|P1|Overall Study|Protocol Violation|1
5970117|NCT01131078|20645826|P3|Overall Study|Progressive Disease|71
5970118|NCT01131078|20645827|P2|Overall Study|Progressive Disease|77
5970119|NCT01131078|20645828|P1|Overall Study|Progressive Disease|58
5970120|NCT01131078|20645826|P3|Overall Study|Adverse Event|17
5970121|NCT01131078|20645827|P2|Overall Study|Adverse Event|12
5970122|NCT01131078|20645828|P1|Overall Study|Adverse Event|22
5970123|NCT01130974|20645915|P2|Overall Study|Ineligibility criteria|2
5970124|NCT01130974|20645916|P1|Overall Study|Ineligibility criteria|5
5970125|NCT01130974|20645915|P2|Overall Study|Withdrawal by Subject|1
5970126|NCT01130974|20645916|P1|Overall Study|Withdrawal by Subject|0
5970127|NCT01130974|20645915|P2|Overall Study|Protocol Violation|10
5970128|NCT01130974|20645916|P1|Overall Study|Protocol Violation|10
5970129|NCT01130883|20645942|P1|Overall Study|Adverse Event|3
5970130|NCT01130883|20645942|P1|Overall Study|Reason Unknown|1
5970131|NCT01130883|20645942|P1|Overall Study|Patient Noncompliance|6
5970132|NCT01130831|20645999|P1|Overall Study|Information was missing|3
5970133|NCT01130831|20645999|P1|Overall Study|Death|4
5970134|NCT01130831|20645999|P1|Overall Study|Withdrawal by Subject|7
5970135|NCT01130597|20646038|P1|Overall Study|Protocol Violation|1
5970136|NCT01130597|20646038|P1|Overall Study|Death|1
5970137|NCT01130597|20646038|P1|Overall Study|Adverse Event|4
5970138|NCT01130597|20646038|P1|Overall Study|Protocol-specified (High K+)|1
5970139|NCT01130532|20646063|P4|Period IV (Weeks 13-16)|Withdrawal by Subject|3
5970140|NCT01130532|20646064|P3|Period IV (Weeks 13-16)|Withdrawal by Subject|0
5970141|NCT01130532|20646065|P2|Period IV (Weeks 13-16)|Withdrawal by Subject|0
5970142|NCT01130532|20646066|P1|Period IV (Weeks 13-16)|Withdrawal by Subject|0
5970143|NCT01130532|20646063|P4|Period IV (Weeks 13-16)|Lost to Follow-up|5
5970144|NCT01130532|20646064|P3|Period IV (Weeks 13-16)|Lost to Follow-up|0
5970145|NCT01130532|20646065|P2|Period IV (Weeks 13-16)|Lost to Follow-up|0
5970146|NCT01130532|20646066|P1|Period IV (Weeks 13-16)|Lost to Follow-up|0
5970147|NCT01130532|20646063|P4|Period IV (Weeks 13-16)|Entry Criteria Not Met|1
5970148|NCT01130532|20646064|P3|Period IV (Weeks 13-16)|Entry Criteria Not Met|0
5970149|NCT01130532|20646065|P2|Period IV (Weeks 13-16)|Entry Criteria Not Met|0
5970150|NCT01130532|20646066|P1|Period IV (Weeks 13-16)|Entry Criteria Not Met|0
5970151|NCT01130532|20646063|P4|Period IV (Weeks 13-16)|Adverse Event|1
5970152|NCT01130532|20646064|P3|Period IV (Weeks 13-16)|Adverse Event|0
5970153|NCT01130532|20646065|P2|Period IV (Weeks 13-16)|Adverse Event|0
5970154|NCT01130532|20646066|P1|Period IV (Weeks 13-16)|Adverse Event|0
5970155|NCT01130532|20646063|P4|Period III (Weeks 0-12)|Withdrawal by Subject|0
5970156|NCT01130532|20646064|P3|Period III (Weeks 0-12)|Withdrawal by Subject|6
5970157|NCT01130532|20646065|P2|Period III (Weeks 0-12)|Withdrawal by Subject|7
5970158|NCT01130532|20646066|P1|Period III (Weeks 0-12)|Withdrawal by Subject|7
5970159|NCT01130532|20646063|P4|Period III (Weeks 0-12)|Sponsor Decision|0
5970160|NCT01130532|20646064|P3|Period III (Weeks 0-12)|Sponsor Decision|2
5970161|NCT01130532|20646065|P2|Period III (Weeks 0-12)|Sponsor Decision|4
5970162|NCT01130532|20646066|P1|Period III (Weeks 0-12)|Sponsor Decision|3
5970163|NCT01130532|20646063|P4|Period III (Weeks 0-12)|Protocol Violation|0
5970164|NCT01130532|20646064|P3|Period III (Weeks 0-12)|Protocol Violation|1
5970165|NCT01130532|20646065|P2|Period III (Weeks 0-12)|Protocol Violation|0
5970166|NCT01130532|20646066|P1|Period III (Weeks 0-12)|Protocol Violation|0
5970167|NCT01130532|20646063|P4|Period III (Weeks 0-12)|Lost to Follow-up|0
5970168|NCT01130532|20646064|P3|Period III (Weeks 0-12)|Lost to Follow-up|3
5970169|NCT01130532|20646065|P2|Period III (Weeks 0-12)|Lost to Follow-up|2
5970170|NCT01130532|20646066|P1|Period III (Weeks 0-12)|Lost to Follow-up|2
5970171|NCT01130532|20646063|P4|Period III (Weeks 0-12)|Lack of Efficacy|0
5970172|NCT01130532|20646064|P3|Period III (Weeks 0-12)|Lack of Efficacy|1
5970173|NCT01130532|20646065|P2|Period III (Weeks 0-12)|Lack of Efficacy|0
5970174|NCT01130532|20646066|P1|Period III (Weeks 0-12)|Lack of Efficacy|2
5970175|NCT01130532|20646063|P4|Period III (Weeks 0-12)|Entry Criteria Not Met|0
5970176|NCT01130532|20646064|P3|Period III (Weeks 0-12)|Entry Criteria Not Met|4
5970177|NCT01130532|20646065|P2|Period III (Weeks 0-12)|Entry Criteria Not Met|2
5970178|NCT01130532|20646066|P1|Period III (Weeks 0-12)|Entry Criteria Not Met|4
5970179|NCT01130532|20646063|P4|Period III (Weeks 0-12)|Adverse Event|0
5970180|NCT01130532|20646064|P3|Period III (Weeks 0-12)|Adverse Event|2
5970181|NCT01130532|20646065|P2|Period III (Weeks 0-12)|Adverse Event|3
5970182|NCT01130532|20646066|P1|Period III (Weeks 0-12)|Adverse Event|3
5970183|NCT01130493|20646111|P3|Part 2: OLE|Withdrawal by Subject|4
5970184|NCT01130493|20646112|P2|Part 2: OLE|Withdrawal by Subject|1
5970185|NCT01130493|20646113|P1|Part 2: OLE|Withdrawal by Subject|0
5970186|NCT01130493|20646111|P3|Part 2: OLE|Adverse Event|1
5970187|NCT01130493|20646112|P2|Part 2: OLE|Adverse Event|2
5970188|NCT01130493|20646113|P1|Part 2: OLE|Adverse Event|0
5970189|NCT01130493|20646111|P3|Part 1: Double-blind Treatment Period 2|Noncompliance|1
5970190|NCT01130493|20646112|P2|Part 1: Double-blind Treatment Period 2|Noncompliance|0
5970191|NCT01130493|20646113|P1|Part 1: Double-blind Treatment Period 2|Noncompliance|0
5970192|NCT01130493|20646111|P3|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|1
5970193|NCT01130493|20646112|P2|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0
5970194|NCT01130493|20646113|P1|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0
5970195|NCT01130493|20646111|P3|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|1
5970196|NCT01130493|20646112|P2|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0
5970197|NCT01130493|20646113|P1|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0
5970198|NCT01130493|20646111|P3|Part 1: Open-Label IPX066 Washout|Adverse Event|1
5970199|NCT01130493|20646112|P2|Part 1: Open-Label IPX066 Washout|Adverse Event|0
5970200|NCT01130493|20646113|P1|Part 1: Open-Label IPX066 Washout|Adverse Event|0
5970201|NCT01130493|20646111|P3|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0
5970202|NCT01130493|20646112|P2|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|1
5970203|NCT01130493|20646113|P1|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0
5970204|NCT01130493|20646111|P3|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0
5970205|NCT01130493|20646112|P2|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|1
5970206|NCT01130493|20646113|P1|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0
5970207|NCT01130493|20646111|P3|Part 1: Double-blind Treatment Period 1|Protocol Violation|0
5970208|NCT01130493|20646112|P2|Part 1: Double-blind Treatment Period 1|Protocol Violation|1
5970209|NCT01130493|20646113|P1|Part 1: Double-blind Treatment Period 1|Protocol Violation|0
5970210|NCT01130493|20646111|P3|Open-label Dose Conversion to IPX066|Diary imcomplete|0
5970211|NCT01130493|20646112|P2|Open-label Dose Conversion to IPX066|Diary imcomplete|0
5970212|NCT01130493|20646113|P1|Open-label Dose Conversion to IPX066|Diary imcomplete|1
5970213|NCT01130493|20646111|P3|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0
5970214|NCT01130493|20646112|P2|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0
5970215|NCT01130493|20646113|P1|Open-label Dose Conversion to IPX066|Withdrawal by Subject|7
5970216|NCT01130493|20646111|P3|Open-label Dose Conversion to IPX066|Lack of Efficacy|0
5970217|NCT01130493|20646112|P2|Open-label Dose Conversion to IPX066|Lack of Efficacy|0
5970218|NCT01130493|20646113|P1|Open-label Dose Conversion to IPX066|Lack of Efficacy|7
5970219|NCT01130493|20646111|P3|Open-label Dose Conversion to IPX066|Protocol Violation|0
5970220|NCT01130493|20646112|P2|Open-label Dose Conversion to IPX066|Protocol Violation|0
5970221|NCT01130493|20646113|P1|Open-label Dose Conversion to IPX066|Protocol Violation|3
5970222|NCT01130493|20646111|P3|Open-label Dose Conversion to IPX066|Adverse Event|0
5970223|NCT01130493|20646112|P2|Open-label Dose Conversion to IPX066|Adverse Event|0
5970224|NCT01130493|20646113|P1|Open-label Dose Conversion to IPX066|Adverse Event|1
5970225|NCT01130337|20646130|P1|Overall Study|Surgical resection (R2)|1
5970226|NCT01130337|20646130|P1|Overall Study|Toxicity, AE/intercurrent disease|7
5970227|NCT01130337|20646130|P1|Overall Study|Disease progression|1
5970228|NCT01130337|20646130|P1|Overall Study|Death|1
5970229|NCT01130337|20646130|P1|Overall Study|Principal investigator decision|1
5970230|NCT01130337|20646130|P1|Overall Study|Withdrawal by Subject|3
5970231|NCT01130272|20646142|P5|Overall Study|Study arm discontinued|0
5970232|NCT01130272|20646143|P4|Overall Study|Study arm discontinued|0
5970233|NCT01130272|20646144|P3|Overall Study|Study arm discontinued|0
5970234|NCT01130272|20646145|P2|Overall Study|Study arm discontinued|0
5970235|NCT01130272|20646146|P1|Overall Study|Study arm discontinued|38
5970236|NCT01130272|20646142|P5|Overall Study|Sponsor decision|16
5970237|NCT01130272|20646143|P4|Overall Study|Sponsor decision|13
5970238|NCT01130272|20646144|P3|Overall Study|Sponsor decision|16
5970239|NCT01130272|20646145|P2|Overall Study|Sponsor decision|15
5970240|NCT01130272|20646146|P1|Overall Study|Sponsor decision|6
5970241|NCT01130272|20646142|P5|Overall Study|Physician Decision|2
5970242|NCT01130272|20646143|P4|Overall Study|Physician Decision|1
5970243|NCT01130272|20646144|P3|Overall Study|Physician Decision|0
5970244|NCT01130272|20646145|P2|Overall Study|Physician Decision|1
5970245|NCT01130272|20646146|P1|Overall Study|Physician Decision|1
5970246|NCT01130272|20646142|P5|Overall Study|Withdrawal by Subject|8
5970247|NCT01130272|20646143|P4|Overall Study|Withdrawal by Subject|9
5970248|NCT01130272|20646144|P3|Overall Study|Withdrawal by Subject|10
5970249|NCT01130272|20646145|P2|Overall Study|Withdrawal by Subject|11
5970250|NCT01130272|20646146|P1|Overall Study|Withdrawal by Subject|4
5970251|NCT01130272|20646142|P5|Overall Study|Lost to Follow-up|6
5970252|NCT01130272|20646143|P4|Overall Study|Lost to Follow-up|7
5970253|NCT01130272|20646144|P3|Overall Study|Lost to Follow-up|4
5970254|NCT01130272|20646145|P2|Overall Study|Lost to Follow-up|3
5970255|NCT01130272|20646146|P1|Overall Study|Lost to Follow-up|4
5970256|NCT01130272|20646142|P5|Overall Study|Protocol Violation|5
5970257|NCT01130272|20646143|P4|Overall Study|Protocol Violation|5
5970258|NCT01130272|20646144|P3|Overall Study|Protocol Violation|3
5970259|NCT01130272|20646145|P2|Overall Study|Protocol Violation|0
5970260|NCT01130272|20646146|P1|Overall Study|Protocol Violation|0
5970261|NCT01130272|20646142|P5|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0
5970262|NCT01130272|20646143|P4|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|1
5970263|NCT01130272|20646144|P3|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0
5970264|NCT01130272|20646145|P2|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0
5970265|NCT01130272|20646146|P1|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0
5970266|NCT01130272|20646142|P5|Overall Study|Lack of efficacy- uncontrolled diarrhea|2
5970267|NCT01130272|20646143|P4|Overall Study|Lack of efficacy- uncontrolled diarrhea|0
5970268|NCT01130272|20646144|P3|Overall Study|Lack of efficacy- uncontrolled diarrhea|0
5970269|NCT01130272|20646145|P2|Overall Study|Lack of efficacy- uncontrolled diarrhea|1
5970270|NCT01130272|20646146|P1|Overall Study|Lack of efficacy- uncontrolled diarrhea|1
5970271|NCT01130272|20646142|P5|Overall Study|Rescue medications due to diarrhea|6
5970272|NCT01130272|20646143|P4|Overall Study|Rescue medications due to diarrhea|8
5970273|NCT01130272|20646144|P3|Overall Study|Rescue medications due to diarrhea|8
5970274|NCT01130272|20646145|P2|Overall Study|Rescue medications due to diarrhea|5
5970275|NCT01130272|20646146|P1|Overall Study|Rescue medications due to diarrhea|3
5970276|NCT01130272|20646142|P5|Overall Study|IVRS-confirmed constipation|0
5970277|NCT01130272|20646143|P4|Overall Study|IVRS-confirmed constipation|2
5970278|NCT01130272|20646144|P3|Overall Study|IVRS-confirmed constipation|1
5970279|NCT01130272|20646145|P2|Overall Study|IVRS-confirmed constipation|1
5970280|NCT01130272|20646146|P1|Overall Study|IVRS-confirmed constipation|0
5970281|NCT01130272|20646142|P5|Overall Study|Adverse Event|7
5970282|NCT01130272|20646143|P4|Overall Study|Adverse Event|22
5970283|NCT01130272|20646144|P3|Overall Study|Adverse Event|6
5970284|NCT01130272|20646145|P2|Overall Study|Adverse Event|5
5970285|NCT01130272|20646146|P1|Overall Study|Adverse Event|2
5970286|NCT01130168|20646183|P6|Period 1|Adverse Event|0
5970287|NCT01130168|20646184|P5|Period 1|Adverse Event|0
5970288|NCT01130168|20646185|P4|Period 1|Adverse Event|1
5970289|NCT01130168|20646186|P3|Period 1|Adverse Event|0
5970290|NCT01130168|20646187|P2|Period 1|Adverse Event|0
5970291|NCT01130168|20646188|P1|Period 1|Adverse Event|0
5970292|NCT01130168|20646183|P6|Period 1|Discontinued For Other Reason|0
5970293|NCT01130168|20646184|P5|Period 1|Discontinued For Other Reason|0
5970294|NCT01130168|20646185|P4|Period 1|Discontinued For Other Reason|1
5970295|NCT01130168|20646186|P3|Period 1|Discontinued For Other Reason|1
5970296|NCT01130168|20646187|P2|Period 1|Discontinued For Other Reason|0
5970297|NCT01130168|20646188|P1|Period 1|Discontinued For Other Reason|0
5970298|NCT01130168|20646183|P6|Period 1|Withdrawal by Subject|0
5970299|NCT01130168|20646184|P5|Period 1|Withdrawal by Subject|0
5970300|NCT01130168|20646185|P4|Period 1|Withdrawal by Subject|1
5970301|NCT01130168|20646186|P3|Period 1|Withdrawal by Subject|0
5970302|NCT01130168|20646187|P2|Period 1|Withdrawal by Subject|1
5970303|NCT01130168|20646188|P1|Period 1|Withdrawal by Subject|0
5970304|NCT01130103|20646225|P2|Maintenance Treatment|Withdrawal by Subject|0
5970305|NCT01130103|20646226|P1|Maintenance Treatment|Withdrawal by Subject|1
5970306|NCT01130103|20646225|P2|Maintenance Treatment|Lost to Follow-up|1
5970307|NCT01130103|20646226|P1|Maintenance Treatment|Lost to Follow-up|1
5970308|NCT01130103|20646225|P2|Maintenance Treatment|Lack of Efficacy|1
5970309|NCT01130103|20646226|P1|Maintenance Treatment|Lack of Efficacy|0
5970310|NCT01130103|20646225|P2|Randomized Treatment|Withdrawal by Subject|2
5970311|NCT01130103|20646226|P1|Randomized Treatment|Withdrawal by Subject|1
5970312|NCT01130103|20646225|P2|Randomized Treatment|Protocol Violation|2
5970313|NCT01130103|20646226|P1|Randomized Treatment|Protocol Violation|3
5970314|NCT01130103|20646225|P2|Randomized Treatment|Lost to Follow-up|0
5970315|NCT01130103|20646226|P1|Randomized Treatment|Lost to Follow-up|1
5970316|NCT01130103|20646225|P2|Randomized Treatment|Adverse Event|1
5970317|NCT01130103|20646226|P1|Randomized Treatment|Adverse Event|1
5970318|NCT01130051|20646240|P2|Washout Period of 14 Days|Protocol Violation|1
5970319|NCT01130051|20646241|P1|Washout Period of 14 Days|Protocol Violation|1
5970320|NCT01130051|20646240|P2|Washout Period of 14 Days|Withdrawal by Subject|1
5970321|NCT01130051|20646241|P1|Washout Period of 14 Days|Withdrawal by Subject|0
5970322|NCT01129960|20646255|P4|Overall Study|Pregnancy|0
5970323|NCT01129960|20646256|P3|Overall Study|Pregnancy|0
5970324|NCT01129960|20646257|P2|Overall Study|Pregnancy|0
5970325|NCT01129960|20646258|P1|Overall Study|Pregnancy|1
5970326|NCT01129960|20646255|P4|Overall Study|Physician Decision|0
5970327|NCT01129960|20646256|P3|Overall Study|Physician Decision|0
5970328|NCT01129960|20646257|P2|Overall Study|Physician Decision|0
5970329|NCT01129960|20646258|P1|Overall Study|Physician Decision|1
5970330|NCT01129960|20646255|P4|Overall Study|Discontinuation of the study by Sponsor|0
5970331|NCT01129960|20646256|P3|Overall Study|Discontinuation of the study by Sponsor|0
5970332|NCT01129960|20646257|P2|Overall Study|Discontinuation of the study by Sponsor|1
5970333|NCT01129960|20646258|P1|Overall Study|Discontinuation of the study by Sponsor|0
5970334|NCT01129960|20646255|P4|Overall Study|Lost to Follow-up|3
5970335|NCT01129960|20646256|P3|Overall Study|Lost to Follow-up|3
5970336|NCT01129960|20646257|P2|Overall Study|Lost to Follow-up|2
5970337|NCT01129960|20646258|P1|Overall Study|Lost to Follow-up|0
5970338|NCT01129960|20646255|P4|Overall Study|Protocol Violation|0
5970339|NCT01129960|20646256|P3|Overall Study|Protocol Violation|3
5970340|NCT01129960|20646257|P2|Overall Study|Protocol Violation|2
5970341|NCT01129960|20646258|P1|Overall Study|Protocol Violation|1
5970342|NCT01129960|20646255|P4|Overall Study|Adverse Event|7
5970343|NCT01129960|20646256|P3|Overall Study|Adverse Event|16
5970344|NCT01129960|20646257|P2|Overall Study|Adverse Event|16
5970345|NCT01129960|20646258|P1|Overall Study|Adverse Event|23
5970346|NCT01129960|20646255|P4|Overall Study|Lack of Efficacy|1
5970347|NCT01129960|20646256|P3|Overall Study|Lack of Efficacy|1
5970348|NCT01129960|20646257|P2|Overall Study|Lack of Efficacy|1
5970349|NCT01129960|20646258|P1|Overall Study|Lack of Efficacy|1
5970350|NCT01129960|20646255|P4|Overall Study|Withdrawal by Subject|2
5970351|NCT01129960|20646256|P3|Overall Study|Withdrawal by Subject|3
5970352|NCT01129960|20646257|P2|Overall Study|Withdrawal by Subject|0
5970353|NCT01129960|20646258|P1|Overall Study|Withdrawal by Subject|3
5970354|NCT01129921|20646270|P2|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|1
5970355|NCT01129921|20646271|P1|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|0
5970356|NCT01129921|20646270|P2|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|4
5970357|NCT01129921|20646271|P1|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|0
5970358|NCT01129921|20646270|P2|After Sham Cross-over to Mild, One Year|Lack of Efficacy|1
5970359|NCT01129921|20646271|P1|After Sham Cross-over to Mild, One Year|Lack of Efficacy|0
5970360|NCT01129921|20646270|P2|After Sham Cross-over to Mild, One Year|Lost to Follow-up|1
5970361|NCT01129921|20646271|P1|After Sham Cross-over to Mild, One Year|Lost to Follow-up|2
5970362|NCT01129882|20646281|P1|Overall Study|Withdrawal by Subject|160
5970363|NCT01129882|20646281|P1|Overall Study|Trial Termination by Sponsor|6
5970364|NCT01129882|20646281|P1|Overall Study|Withdrawal Criteria Met|19
5970365|NCT01129882|20646281|P1|Overall Study|Protocol Deviation|3
5970366|NCT01129882|20646281|P1|Overall Study|Physician Decision|27
5970367|NCT01129882|20646281|P1|Overall Study|Lost to Follow-up|13
5970368|NCT01129882|20646281|P1|Overall Study|Lack of Efficacy|5
5970369|NCT01129882|20646281|P1|Overall Study|Death|6
5970370|NCT01129882|20646281|P1|Overall Study|Adverse Event|39
5970371|NCT01129622|20646300|P1|Overall Study|Withdrawal by Subject|2
5970372|NCT01129583|20646311|P2|Overall Study|Ipsilateral Upper Extremity Injury|1
5970373|NCT01129583|20646312|P1|Overall Study|Ipsilateral Upper Extremity Injury|1
5970374|NCT01129583|20646311|P2|Overall Study|Lost to Follow-up|1
5970375|NCT01129583|20646312|P1|Overall Study|Lost to Follow-up|1
5970376|NCT01129583|20646311|P2|Overall Study|Death|0
5970377|NCT01129583|20646312|P1|Overall Study|Death|1
5970378|NCT01129557|20646325|P3|Overall Study|Novartis terminated study early|2
5970379|NCT01129557|20646326|P2|Overall Study|Novartis terminated study early|3
5970380|NCT01129557|20646327|P1|Overall Study|Novartis terminated study early|3
5970381|NCT01129557|20646325|P3|Overall Study|Adverse Event|2
5970382|NCT01129557|20646326|P2|Overall Study|Adverse Event|2
5970383|NCT01129557|20646327|P1|Overall Study|Adverse Event|1
5970384|NCT01129336|20646440|P2|Overall Study|Death|4
5970385|NCT01129336|20646441|P1|Overall Study|Death|0
5970386|NCT01129336|20646440|P2|Overall Study|Missing Study Completion Status|3
5970387|NCT01129336|20646441|P1|Overall Study|Missing Study Completion Status|2
5970388|NCT01129336|20646440|P2|Overall Study|Adverse Event|1
5970389|NCT01129336|20646441|P1|Overall Study|Adverse Event|0
5970390|NCT01129336|20646440|P2|Overall Study|Withdrawal by Subject|4
5970391|NCT01129336|20646441|P1|Overall Study|Withdrawal by Subject|7
5970392|NCT01129336|20646440|P2|Overall Study|Lost to Follow-up|0
5970393|NCT01129336|20646441|P1|Overall Study|Lost to Follow-up|1
5970394|NCT01129336|20646440|P2|Overall Study|Disease Progression|4
5970395|NCT01129336|20646441|P1|Overall Study|Disease Progression|1
5970396|NCT01129336|20646440|P2|Overall Study|Protocol Violation|0
5970397|NCT01129336|20646441|P1|Overall Study|Protocol Violation|1
5970398|NCT01129284|20646456|P3|Overall Study|Adverse Event|1
5970399|NCT01129284|20646457|P2|Overall Study|Adverse Event|0
5970400|NCT01129284|20646458|P1|Overall Study|Adverse Event|2
5970401|NCT01129128|20646506|P3|Overall Study|Physician Decision|0
5970402|NCT01129128|20646507|P2|Overall Study|Physician Decision|0
5970403|NCT01129128|20646508|P1|Overall Study|Physician Decision|1
5970404|NCT01129128|20646506|P3|Overall Study|Withdrawal by Subject|3
5970405|NCT01129128|20646507|P2|Overall Study|Withdrawal by Subject|1
5970406|NCT01129128|20646508|P1|Overall Study|Withdrawal by Subject|0
5970407|NCT01129128|20646506|P3|Overall Study|Protocol Violation|0
5970408|NCT01129128|20646507|P2|Overall Study|Protocol Violation|1
5970409|NCT01129128|20646508|P1|Overall Study|Protocol Violation|0
5970410|NCT01129128|20646506|P3|Overall Study|Lost to Follow-up|1
5970411|NCT01129128|20646507|P2|Overall Study|Lost to Follow-up|2
5970412|NCT01129128|20646508|P1|Overall Study|Lost to Follow-up|2
5970413|NCT01129115|20646532|P4|Overall Study|Protocol Violation|2
5970414|NCT01129115|20646533|P3|Overall Study|Protocol Violation|2
5970415|NCT01129115|20646534|P2|Overall Study|Protocol Violation|2
5970416|NCT01129115|20646535|P1|Overall Study|Protocol Violation|0
5970417|NCT01129115|20646532|P4|Overall Study|Withdrawal by Subject|4
5970418|NCT01129115|20646533|P3|Overall Study|Withdrawal by Subject|1
5970419|NCT01129115|20646534|P2|Overall Study|Withdrawal by Subject|3
5970420|NCT01129115|20646535|P1|Overall Study|Withdrawal by Subject|1
5970421|NCT01129115|20646532|P4|Overall Study|Adverse Event|3
5970422|NCT01129115|20646533|P3|Overall Study|Adverse Event|3
5970423|NCT01129115|20646534|P2|Overall Study|Adverse Event|2
5970424|NCT01129115|20646535|P1|Overall Study|Adverse Event|1
5970425|NCT01129102|20646572|P3|Overall Study|Lost to Follow-up|0
5970426|NCT01129102|20646573|P2|Overall Study|Lost to Follow-up|0
5970427|NCT01129102|20646574|P1|Overall Study|Lost to Follow-up|2
5970428|NCT01129102|20646572|P3|Overall Study|Adverse Event|1
5970429|NCT01129102|20646573|P2|Overall Study|Adverse Event|2
5970430|NCT01129102|20646574|P1|Overall Study|Adverse Event|2
5970431|NCT01129102|20646572|P3|Overall Study|Pregnancy|1
5970432|NCT01129102|20646573|P2|Overall Study|Pregnancy|0
5970433|NCT01129102|20646574|P1|Overall Study|Pregnancy|0
5970434|NCT01129102|20646572|P3|Overall Study|Protocol Violation|1
5970435|NCT01129102|20646573|P2|Overall Study|Protocol Violation|1
5970436|NCT01129102|20646574|P1|Overall Study|Protocol Violation|0
5970437|NCT01129102|20646572|P3|Overall Study|Withdrawal by Subject|3
5970438|NCT01129102|20646573|P2|Overall Study|Withdrawal by Subject|0
5970439|NCT01129102|20646574|P1|Overall Study|Withdrawal by Subject|2
5970440|NCT01129102|20646572|P3|Overall Study|No study drug treatment|1
5970441|NCT01129102|20646573|P2|Overall Study|No study drug treatment|3
5970442|NCT01129102|20646574|P1|Overall Study|No study drug treatment|2
5970443|NCT01129011|20646585|P2|Overall Study|misc|4
5970444|NCT01129011|20646586|P1|Overall Study|misc|7
5970445|NCT01129011|20646585|P2|Overall Study|Duodenal Ulcer|8
5970446|NCT01129011|20646586|P1|Overall Study|Duodenal Ulcer|2
5970447|NCT01129011|20646585|P2|Overall Study|Lost to Follow-up|7
5970448|NCT01129011|20646586|P1|Overall Study|Lost to Follow-up|6
5970449|NCT01129011|20646585|P2|Overall Study|Withdrawal by Subject|8
5970450|NCT01129011|20646586|P1|Overall Study|Withdrawal by Subject|24
5970451|NCT01129011|20646585|P2|Overall Study|Adverse Event|30
5970452|NCT01129011|20646586|P1|Overall Study|Adverse Event|20
5970453|NCT01128959|20646641|P1|Treatment Period|Withdrawal by Subject|1
5970454|NCT01128959|20646641|P1|Treatment Period|Adverse Event|3
5970455|NCT01128959|20646641|P1|Lead in Period|Adverse Event|3
5970456|NCT01128946|20646647|P4|Period III|Protocol Violation|0
5970457|NCT01128946|20646648|P3|Period III|Protocol Violation|0
5970458|NCT01128946|20646649|P2|Period III|Protocol Violation|0
5970459|NCT01128946|20646650|P1|Period III|Protocol Violation|1
5970460|NCT01128946|20646647|P4|Period II|Withdrawal by Subject|1
5970461|NCT01128946|20646648|P3|Period II|Withdrawal by Subject|0
5970462|NCT01128946|20646649|P2|Period II|Withdrawal by Subject|0
5970463|NCT01128946|20646650|P1|Period II|Withdrawal by Subject|0
5970464|NCT01128946|20646647|P4|Period II|Protocol Violation|0
5970465|NCT01128946|20646648|P3|Period II|Protocol Violation|0
5970466|NCT01128946|20646649|P2|Period II|Protocol Violation|1
5970467|NCT01128946|20646650|P1|Period II|Protocol Violation|0
5970468|NCT01128946|20646647|P4|Period I|Withdrawal by Subject|1
5970469|NCT01128946|20646648|P3|Period I|Withdrawal by Subject|1
5970470|NCT01128946|20646649|P2|Period I|Withdrawal by Subject|0
5970471|NCT01128946|20646650|P1|Period I|Withdrawal by Subject|0
5970472|NCT01128946|20646647|P4|Period I|Protocol Violation|0
5970473|NCT01128946|20646648|P3|Period I|Protocol Violation|0
5970474|NCT01128946|20646649|P2|Period I|Protocol Violation|1
5970475|NCT01128946|20646650|P1|Period I|Protocol Violation|0
5970476|NCT01128894|20646668|P2|Overall Study|Conflicting HbA1c Results at Screening|0
5970477|NCT01128894|20646669|P1|Overall Study|Conflicting HbA1c Results at Screening|1
5970478|NCT01128894|20646668|P2|Overall Study|Physician Decision|1
5970479|NCT01128894|20646669|P1|Overall Study|Physician Decision|2
5970480|NCT01128894|20646668|P2|Overall Study|Withdrawal by Subject|12
5970481|NCT01128894|20646669|P1|Overall Study|Withdrawal by Subject|10
5970482|NCT01128894|20646668|P2|Overall Study|Lost to Follow-up|8
5970483|NCT01128894|20646669|P1|Overall Study|Lost to Follow-up|8
5970484|NCT01128894|20646668|P2|Overall Study|Noncompliance|5
5970485|NCT01128894|20646669|P1|Overall Study|Noncompliance|4
5970486|NCT01128894|20646668|P2|Overall Study|Protocol Violation|1
5970487|NCT01128894|20646669|P1|Overall Study|Protocol Violation|2
5970488|NCT01128894|20646668|P2|Overall Study|Adverse Event|41
5970489|NCT01128894|20646669|P1|Overall Study|Adverse Event|31
5970490|NCT01128842|20646687|P1|Overall Study|Disease Progression|6
5970491|NCT01128842|20646687|P1|Overall Study|Adverse Event|1
5970492|NCT01128738|20646704|P2|Second TP|Withdrawal by Subject|2
5970493|NCT01128738|20646705|P1|Second TP|Withdrawal by Subject|0
5970494|NCT01128738|20646704|P2|Second TP|Lost to Follow-up|1
5970495|NCT01128738|20646705|P1|Second TP|Lost to Follow-up|0
5970496|NCT01128738|20646704|P2|First Treatment Phase (TP)|Withdrawal by Subject|1
5970497|NCT01128738|20646705|P1|First Treatment Phase (TP)|Withdrawal by Subject|3
5970498|NCT01128738|20646704|P2|First Treatment Phase (TP)|Lost to Follow-up|0
5970499|NCT01128738|20646705|P1|First Treatment Phase (TP)|Lost to Follow-up|1
5970500|NCT01128621|20646830|P2|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|2
5970501|NCT01128621|20646831|P1|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|0
5970502|NCT01128595|20646952|P4|Treatment Period 3|Withdrawal by Subject|0
5970503|NCT01128595|20646953|P3|Treatment Period 3|Withdrawal by Subject|0
5970504|NCT01128595|20646954|P2|Treatment Period 3|Withdrawal by Subject|1
5970505|NCT01128595|20646955|P1|Treatment Period 3|Withdrawal by Subject|0
5970506|NCT01128569|20646985|P6|Treatment Period 2|Withdrawal by Subject|0
5970507|NCT01128569|20646986|P5|Treatment Period 2|Withdrawal by Subject|0
5970508|NCT01128569|20646987|P4|Treatment Period 2|Withdrawal by Subject|0
5970509|NCT01128569|20646988|P3|Treatment Period 2|Withdrawal by Subject|0
5970510|NCT01128569|20646989|P2|Treatment Period 2|Withdrawal by Subject|1
5970511|NCT01128569|20646990|P1|Treatment Period 2|Withdrawal by Subject|0
5970512|NCT01128569|20646985|P6|Washout Period 1|Adverse Event|0
5970513|NCT01128569|20646986|P5|Washout Period 1|Adverse Event|0
5970514|NCT01128569|20646987|P4|Washout Period 1|Adverse Event|0
5970515|NCT01128569|20646988|P3|Washout Period 1|Adverse Event|1
5970516|NCT01128569|20646989|P2|Washout Period 1|Adverse Event|0
5970517|NCT01128569|20646990|P1|Washout Period 1|Adverse Event|0
5970518|NCT01128543|20647007|P1|Overall Study|Protocol Violation|1
5970519|NCT01128543|20647007|P1|Overall Study|Withdrawal by Subject|3
5970520|NCT01128413|20647033|P2|Overall Study|Pt made DNR|0
5970521|NCT01128413|20647034|P1|Overall Study|Pt made DNR|1
5970522|NCT01128413|20647033|P2|Overall Study|NICOM Monitor Problems|1
5970523|NCT01128413|20647034|P1|Overall Study|NICOM Monitor Problems|2
5970524|NCT01128413|20647033|P2|Overall Study|Withdrawal by Subject|0
5970525|NCT01128413|20647034|P1|Overall Study|Withdrawal by Subject|1
5970526|NCT01128400|20647043|P3|Overall Study|Excluded due to sinus problems|0
5970527|NCT01128400|20647044|P2|Overall Study|Excluded due to sinus problems|1
5970528|NCT01128400|20647045|P1|Overall Study|Excluded due to sinus problems|0
5970529|NCT01128400|20647043|P3|Overall Study|were not invited to participate on taste|15
5970530|NCT01128400|20647044|P2|Overall Study|were not invited to participate on taste|0
5970531|NCT01128400|20647045|P1|Overall Study|were not invited to participate on taste|0
5970532|NCT01128400|20647043|P3|Overall Study|Screening failure|0
5970533|NCT01128400|20647044|P2|Overall Study|Screening failure|0
5970534|NCT01128400|20647045|P1|Overall Study|Screening failure|1
5970535|NCT01128400|20647043|P3|Overall Study|Lost to Follow-up|1
5970536|NCT01128400|20647044|P2|Overall Study|Lost to Follow-up|0
5970537|NCT01128400|20647045|P1|Overall Study|Lost to Follow-up|1
5970538|NCT01128387|20647058|P2|Overall Study|Physician Decision|1
5970539|NCT01128387|20647059|P1|Overall Study|Physician Decision|0
5970540|NCT01128361|20647069|P2|Overall Study|Withdrawal by Subject|2
5970541|NCT01128361|20647070|P1|Overall Study|Withdrawal by Subject|5
5970542|NCT01128361|20647069|P2|Overall Study|Lost to Follow-up|1
5970543|NCT01128361|20647070|P1|Overall Study|Lost to Follow-up|0
5970544|NCT01128296|20647082|P6|Overall Study|Withdrawal by Subject|2
5970545|NCT01128296|20647083|P5|Overall Study|Withdrawal by Subject|0
5970546|NCT01128296|20647084|P4|Overall Study|Withdrawal by Subject|0
5970547|NCT01128296|20647085|P3|Overall Study|Withdrawal by Subject|0
5970548|NCT01128296|20647086|P2|Overall Study|Withdrawal by Subject|0
5970549|NCT01128296|20647087|P1|Overall Study|Withdrawal by Subject|0
5970550|NCT01128296|20647082|P6|Overall Study|Physician Decision|3
5970551|NCT01128296|20647083|P5|Overall Study|Physician Decision|0
5970552|NCT01128296|20647084|P4|Overall Study|Physician Decision|0
5970553|NCT01128296|20647085|P3|Overall Study|Physician Decision|0
5970554|NCT01128296|20647086|P2|Overall Study|Physician Decision|0
5970555|NCT01128296|20647087|P1|Overall Study|Physician Decision|0
5970556|NCT01128244|20647118|P1|Overall Study|Scheduling conflict|2
5970557|NCT01128244|20647118|P1|Overall Study|Adverse Event|1
5970558|NCT01128179|20647159|P2|Overall Study|Protocol Violation|0
5970559|NCT01128179|20647160|P1|Overall Study|Protocol Violation|1
5970560|NCT01128179|20647159|P2|Overall Study|Death|0
5970561|NCT01128179|20647160|P1|Overall Study|Death|1
5970562|NCT01128153|20647180|P2|Overall Study|Developed discontinuation criteria|1
5970563|NCT01128153|20647181|P1|Overall Study|Developed discontinuation criteria|1
5970564|NCT01128153|20647180|P2|Overall Study|Protocol Violation|0
5970565|NCT01128153|20647181|P1|Overall Study|Protocol Violation|2
5970566|NCT01128153|20647180|P2|Overall Study|Incorrect enrolment to study|1
5970567|NCT01128153|20647181|P1|Overall Study|Incorrect enrolment to study|2
5970568|NCT01128153|20647180|P2|Overall Study|Withdrawal by Subject|3
5970569|NCT01128153|20647181|P1|Overall Study|Withdrawal by Subject|2
5970570|NCT01128153|20647180|P2|Overall Study|Condition under investigation worsened|7
5970571|NCT01128153|20647181|P1|Overall Study|Condition under investigation worsened|8
5970572|NCT01128153|20647180|P2|Overall Study|Adverse Event|3
5970573|NCT01128153|20647181|P1|Overall Study|Adverse Event|1
5970574|NCT01128114|20647197|P1|Overall Study|Screening Failed|2
5970575|NCT01128114|20647197|P1|Overall Study|Treatment Withdrawn|6
5970576|NCT01127763|20647214|P1|Overall Study|Physician Decision|2
5970577|NCT01127763|20647214|P1|Overall Study|Withdrawal by Subject|1
5970578|NCT01127763|20647214|P1|Overall Study|Adverse Event|2
5970579|NCT01127646|20647259|P2|Overall Study|Protocol Violation|1
5970580|NCT01127646|20647260|P1|Overall Study|Protocol Violation|0
5970581|NCT01127646|20647259|P2|Overall Study|Entry Criteria Not Met|0
5970582|NCT01127646|20647260|P1|Overall Study|Entry Criteria Not Met|1
5970583|NCT01127633|20647294|P2|Overall Study|Not treated|0
5970584|NCT01127633|20647295|P1|Overall Study|Not treated|1
5970585|NCT01127633|20647294|P2|Overall Study|Abnormal Lab/ECG Result|1
5970586|NCT01127633|20647295|P1|Overall Study|Abnormal Lab/ECG Result|0
5970587|NCT01127633|20647294|P2|Overall Study|Protocol Violation|16
5970588|NCT01127633|20647295|P1|Overall Study|Protocol Violation|8
5970589|NCT01127633|20647294|P2|Overall Study|Sponsor Decision|195
5970590|NCT01127633|20647295|P1|Overall Study|Sponsor Decision|163
5970591|NCT01127633|20647294|P2|Overall Study|Withdrawal by Subject|72
5970592|NCT01127633|20647295|P1|Overall Study|Withdrawal by Subject|57
5970593|NCT01127633|20647294|P2|Overall Study|Physician Decision|45
5970594|NCT01127633|20647295|P1|Overall Study|Physician Decision|60
5970595|NCT01127633|20647294|P2|Overall Study|Parent/Caregiver Decision|228
5970596|NCT01127633|20647295|P1|Overall Study|Parent/Caregiver Decision|246
5970597|NCT01127633|20647294|P2|Overall Study|Lost to Follow-up|0
5970598|NCT01127633|20647295|P1|Overall Study|Lost to Follow-up|4
5970599|NCT01127633|20647294|P2|Overall Study|Death|43
5970600|NCT01127633|20647295|P1|Overall Study|Death|40
5970601|NCT01127633|20647294|P2|Overall Study|Adverse Event|73
5970602|NCT01127633|20647295|P1|Overall Study|Adverse Event|74
5970603|NCT01127607|20647327|P2|Phase II (Between Subjects)|Withdrawal by Subject|0
5970604|NCT01127607|20647328|P1|Phase II (Between Subjects)|Withdrawal by Subject|1
5970605|NCT01127607|20647327|P2|Phase II (Between Subjects)|Lost to Follow-up|2
5970606|NCT01127607|20647328|P1|Phase II (Between Subjects)|Lost to Follow-up|0
5970607|NCT01127256|20647505|P2|Overall Study|Protocol Violation|0
5970608|NCT01127256|20647506|P1|Overall Study|Protocol Violation|1
5970609|NCT01127256|20647505|P2|Overall Study|Withdrawal by Subject|9
5970610|NCT01127256|20647506|P1|Overall Study|Withdrawal by Subject|5
5970611|NCT01127256|20647505|P2|Overall Study|Lost to Follow-up|17
5970612|NCT01127256|20647506|P1|Overall Study|Lost to Follow-up|16
5970613|NCT01127256|20647505|P2|Overall Study|Lack of Efficacy|0
5970614|NCT01127256|20647506|P1|Overall Study|Lack of Efficacy|4
5970615|NCT01127256|20647505|P2|Overall Study|Adverse Event|13
5970616|NCT01127256|20647506|P1|Overall Study|Adverse Event|13
5970617|NCT01127165|20647518|P2|Overall Study|Protocol Violation|1
5970618|NCT01127165|20647519|P1|Overall Study|Protocol Violation|0
5970619|NCT01127165|20647518|P2|Overall Study|Withdrawal by Subject|3
5970620|NCT01127165|20647519|P1|Overall Study|Withdrawal by Subject|1
5970621|NCT01127165|20647518|P2|Overall Study|Lost to Follow-up|5
5970622|NCT01127165|20647519|P1|Overall Study|Lost to Follow-up|3
5970623|NCT01127165|20647518|P2|Overall Study|Lack of Efficacy|8
5970624|NCT01127165|20647519|P1|Overall Study|Lack of Efficacy|10
5970625|NCT01127165|20647518|P2|Overall Study|Adverse Event|2
5970626|NCT01127165|20647519|P1|Overall Study|Adverse Event|2
5970627|NCT01127139|20647531|P1|Overall Study|Reason not specified|1
5970628|NCT01127139|20647531|P1|Overall Study|Lack of Efficacy|4
5970629|NCT01127139|20647531|P1|Overall Study|Incompliance|12
5970630|NCT01127139|20647531|P1|Overall Study|Adverse Event|40
5970631|NCT01127061|20647559|P2|Overall Study|Physician Decision|3
5970632|NCT01127061|20647560|P1|Overall Study|Physician Decision|3
5970633|NCT01127061|20647559|P2|Overall Study|Lost to Follow-up|10
5970634|NCT01127061|20647560|P1|Overall Study|Lost to Follow-up|7
5970635|NCT01126879|20647597|P2|Overall Study|Physician Decision|0
5970636|NCT01126879|20647598|P1|Overall Study|Physician Decision|1
5970637|NCT01126879|20647597|P2|Overall Study|Adverse Event|1
5970638|NCT01126879|20647598|P1|Overall Study|Adverse Event|0
5970639|NCT01126879|20647597|P2|Overall Study|Withdrawal by Subject|0
5970640|NCT01126879|20647598|P1|Overall Study|Withdrawal by Subject|1
5970641|NCT01126879|20647597|P2|Overall Study|Progressive Disease|1
5970642|NCT01126879|20647598|P1|Overall Study|Progressive Disease|3
5970643|NCT01126619|20647645|P1|Overall Study|Non-compliance|1
5970644|NCT01126619|20647645|P1|Overall Study|Withdrawal by Subject|9
5970645|NCT01126619|20647645|P1|Overall Study|Serious adverse event|1
5970646|NCT01126619|20647645|P1|Overall Study|Investigator decision|4
5970647|NCT01126619|20647645|P1|Overall Study|Not eligible for the study|2
5970648|NCT01126580|20647673|P3|Overall Study|Treatment Non-compliance|3
5970649|NCT01126580|20647674|P2|Overall Study|Treatment Non-compliance|2
5970650|NCT01126580|20647675|P1|Overall Study|Treatment Non-compliance|0
5970651|NCT01126580|20647673|P3|Overall Study|Lost to Follow-up|9
5970652|NCT01126580|20647674|P2|Overall Study|Lost to Follow-up|13
5970653|NCT01126580|20647675|P1|Overall Study|Lost to Follow-up|15
5970654|NCT01126580|20647673|P3|Overall Study|Protocol Violation|2
5970655|NCT01126580|20647674|P2|Overall Study|Protocol Violation|1
5970656|NCT01126580|20647675|P1|Overall Study|Protocol Violation|0
5970657|NCT01126580|20647673|P3|Overall Study|Lack of Efficacy|4
5970658|NCT01126580|20647674|P2|Overall Study|Lack of Efficacy|3
5970659|NCT01126580|20647675|P1|Overall Study|Lack of Efficacy|2
5970660|NCT01126580|20647673|P3|Overall Study|Entry Criteria Not Met|2
5970661|NCT01126580|20647674|P2|Overall Study|Entry Criteria Not Met|1
5970662|NCT01126580|20647675|P1|Overall Study|Entry Criteria Not Met|1
5970663|NCT01126580|20647673|P3|Overall Study|Physician Decision|2
5970664|NCT01126580|20647674|P2|Overall Study|Physician Decision|1
5970665|NCT01126580|20647675|P1|Overall Study|Physician Decision|1
5970666|NCT01126580|20647673|P3|Overall Study|Sponsor Decision|7
5970667|NCT01126580|20647674|P2|Overall Study|Sponsor Decision|4
5970668|NCT01126580|20647675|P1|Overall Study|Sponsor Decision|5
5970669|NCT01126580|20647673|P3|Overall Study|Withdrawal by Subject|14
5970670|NCT01126580|20647674|P2|Overall Study|Withdrawal by Subject|19
5970671|NCT01126580|20647675|P1|Overall Study|Withdrawal by Subject|11
5970672|NCT01126580|20647673|P3|Overall Study|Adverse Event|12
5970673|NCT01126580|20647674|P2|Overall Study|Adverse Event|8
5970674|NCT01126580|20647675|P1|Overall Study|Adverse Event|14
5970675|NCT01126541|20647770|P3|Overall Study|Administrative reason or other|2
5970676|NCT01126541|20647771|P2|Overall Study|Administrative reason or other|1
5970677|NCT01126541|20647772|P1|Overall Study|Administrative reason or other|1
5970678|NCT01126541|20647770|P3|Overall Study|Protocol Violation|1
5970679|NCT01126541|20647771|P2|Overall Study|Protocol Violation|0
5970680|NCT01126541|20647772|P1|Overall Study|Protocol Violation|0
5970681|NCT01126541|20647770|P3|Overall Study|Withdrawal by Subject|6
5970682|NCT01126541|20647771|P2|Overall Study|Withdrawal by Subject|5
5970683|NCT01126541|20647772|P1|Overall Study|Withdrawal by Subject|2
5970684|NCT01126541|20647770|P3|Overall Study|Lost to Follow-up|2
5970685|NCT01126541|20647771|P2|Overall Study|Lost to Follow-up|2
5970686|NCT01126541|20647772|P1|Overall Study|Lost to Follow-up|1
5970687|NCT01126541|20647770|P3|Overall Study|Lack of Efficacy|11
5970688|NCT01126541|20647771|P2|Overall Study|Lack of Efficacy|1
5970689|NCT01126541|20647772|P1|Overall Study|Lack of Efficacy|6
5970690|NCT01126541|20647770|P3|Overall Study|Death|0
5970691|NCT01126541|20647771|P2|Overall Study|Death|1
5970692|NCT01126541|20647772|P1|Overall Study|Death|0
5970693|NCT01126541|20647770|P3|Overall Study|Adverse Event|4
5970694|NCT01126541|20647771|P2|Overall Study|Adverse Event|2
5970695|NCT01126541|20647772|P1|Overall Study|Adverse Event|0
5970696|NCT01126437|20647856|P3|Overall Study|Other reason not specified|178
5970697|NCT01126437|20647857|P2|Overall Study|Other reason not specified|176
5970698|NCT01126437|20647858|P1|Overall Study|Other reason not specified|210
5970699|NCT01126437|20647856|P3|Overall Study|Withdrawal by Subject|319
5970700|NCT01126437|20647857|P2|Overall Study|Withdrawal by Subject|335
5970701|NCT01126437|20647858|P1|Overall Study|Withdrawal by Subject|331
5970702|NCT01126437|20647856|P3|Overall Study|Lost to Follow-up|55
5970703|NCT01126437|20647857|P2|Overall Study|Lost to Follow-up|63
5970704|NCT01126437|20647858|P1|Overall Study|Lost to Follow-up|52
5970705|NCT01126437|20647856|P3|Overall Study|Protocol Violation|41
5970706|NCT01126437|20647857|P2|Overall Study|Protocol Violation|66
5970707|NCT01126437|20647858|P1|Overall Study|Protocol Violation|64
5970708|NCT01126437|20647856|P3|Overall Study|Lack of Efficacy|59
5970709|NCT01126437|20647857|P2|Overall Study|Lack of Efficacy|60
5970710|NCT01126437|20647858|P1|Overall Study|Lack of Efficacy|65
5970711|NCT01126437|20647856|P3|Overall Study|Adverse Event|635
5970712|NCT01126437|20647857|P2|Overall Study|Adverse Event|606
5970713|NCT01126437|20647858|P1|Overall Study|Adverse Event|602
5970714|NCT01126437|20647856|P3|Overall Study|Sites with data irregularities/fraud|7
5970715|NCT01126437|20647857|P2|Overall Study|Sites with data irregularities/fraud|6
5970716|NCT01126437|20647858|P1|Overall Study|Sites with data irregularities/fraud|6
5970717|NCT01126437|20647856|P3|Overall Study|Not treated|19
5970718|NCT01126437|20647857|P2|Overall Study|Not treated|18
5970719|NCT01126437|20647858|P1|Overall Study|Not treated|11
5970720|NCT01126424|20647896|P6|Overall Study|Withdrawal by Subject|0
5970721|NCT01126424|20647897|P5|Overall Study|Withdrawal by Subject|1
5970722|NCT01126424|20647898|P4|Overall Study|Withdrawal by Subject|3
5970723|NCT01126424|20647899|P3|Overall Study|Withdrawal by Subject|1
5970724|NCT01126424|20647900|P2|Overall Study|Withdrawal by Subject|0
5970725|NCT01126424|20647901|P1|Overall Study|Withdrawal by Subject|0
5970726|NCT01126424|20647896|P6|Overall Study|Adverse Event|0
5970727|NCT01126424|20647897|P5|Overall Study|Adverse Event|1
5970728|NCT01126424|20647898|P4|Overall Study|Adverse Event|0
5970729|NCT01126424|20647899|P3|Overall Study|Adverse Event|0
5970730|NCT01126424|20647900|P2|Overall Study|Adverse Event|0
5970731|NCT01126424|20647901|P1|Overall Study|Adverse Event|0
5970732|NCT01126359|20647924|P2|First Intervention (20-minutes)|Physician Decision|1
5970733|NCT01126359|20647925|P1|First Intervention (20-minutes)|Physician Decision|0
5970734|NCT01126268|20647937|P1|Overall Study|Adverse Event|1
5970735|NCT01126060|20647976|P2|Overall Study|Protocol Violation|2
5970736|NCT01126060|20647977|P1|Overall Study|Protocol Violation|0
5970737|NCT01125930|20647985|P2|Overall Study|Lost to Follow-up|2
5970738|NCT01125930|20647986|P1|Overall Study|Lost to Follow-up|0
5970739|NCT01125930|20647985|P2|Overall Study|Protocol Violation|1
5970740|NCT01125930|20647986|P1|Overall Study|Protocol Violation|0
5970741|NCT01125930|20647985|P2|Overall Study|Withdrawal by Subject|6
5970742|NCT01125930|20647986|P1|Overall Study|Withdrawal by Subject|1
5970743|NCT01125930|20647985|P2|Overall Study|Adverse Event|1
5970744|NCT01125930|20647986|P1|Overall Study|Adverse Event|0
5970745|NCT01125917|20648140|P1|Overall Study|Lack of Efficacy|19
5970746|NCT01125917|20648140|P1|Overall Study|Administrative|223
5970747|NCT01125917|20648140|P1|Overall Study|Withdrawal by Subject|31
5970748|NCT01125917|20648140|P1|Overall Study|Lost to Follow-up|23
5970749|NCT01125917|20648140|P1|Overall Study|Adverse Event|43
5970750|NCT01125813|20648144|P1|Overall Study|Screen Failures|4
5970751|NCT01125813|20648144|P1|Overall Study|Withdrawal by Subject|1
5970752|NCT01125813|20648144|P1|Overall Study|Death|1
5970753|NCT01125800|20648154|P5|Phase II|Disease progression|8
5970754|NCT01125800|20648155|P4|Phase II|Disease progression|1
5970755|NCT01125800|20648156|P3|Phase II|Disease progression|0
5970756|NCT01125800|20648157|P2|Phase II|Disease progression|0
5970757|NCT01125800|20648158|P1|Phase II|Disease progression|0
5970758|NCT01125800|20648154|P5|Phase II|Adverse Event|2
5970759|NCT01125800|20648155|P4|Phase II|Adverse Event|0
5970760|NCT01125800|20648156|P3|Phase II|Adverse Event|0
5970761|NCT01125800|20648157|P2|Phase II|Adverse Event|0
5970762|NCT01125800|20648158|P1|Phase II|Adverse Event|0
5970763|NCT01125800|20648154|P5|Phase II|Protocol Violation|1
5970764|NCT01125800|20648155|P4|Phase II|Protocol Violation|0
5970765|NCT01125800|20648156|P3|Phase II|Protocol Violation|0
5970766|NCT01125800|20648157|P2|Phase II|Protocol Violation|0
5970767|NCT01125800|20648158|P1|Phase II|Protocol Violation|0
5970768|NCT01125800|20648154|P5|Phase I|Disease progression|0
5970769|NCT01125800|20648155|P4|Phase I|Disease progression|3
5970770|NCT01125800|20648156|P3|Phase I|Disease progression|1
5970771|NCT01125800|20648157|P2|Phase I|Disease progression|4
5970772|NCT01125800|20648158|P1|Phase I|Disease progression|5
5970773|NCT01125800|20648154|P5|Phase I|Withdrawal by Subject|0
5970774|NCT01125800|20648155|P4|Phase I|Withdrawal by Subject|0
5970775|NCT01125800|20648156|P3|Phase I|Withdrawal by Subject|1
5970776|NCT01125800|20648157|P2|Phase I|Withdrawal by Subject|0
5970777|NCT01125800|20648158|P1|Phase I|Withdrawal by Subject|0
5970778|NCT01125800|20648154|P5|Phase I|Administrative problems|0
5970779|NCT01125800|20648155|P4|Phase I|Administrative problems|0
5970780|NCT01125800|20648156|P3|Phase I|Administrative problems|0
5970781|NCT01125800|20648157|P2|Phase I|Administrative problems|0
5970782|NCT01125800|20648158|P1|Phase I|Administrative problems|1
5970783|NCT01125800|20648154|P5|Phase I|Adverse Event|0
5970784|NCT01125800|20648155|P4|Phase I|Adverse Event|7
5970785|NCT01125800|20648156|P3|Phase I|Adverse Event|1
5970786|NCT01125800|20648157|P2|Phase I|Adverse Event|2
5970787|NCT01125800|20648158|P1|Phase I|Adverse Event|2
5970788|NCT01125800|20648154|P5|Phase I|Protocol Violation|0
5970789|NCT01125800|20648155|P4|Phase I|Protocol Violation|1
5970790|NCT01125800|20648156|P3|Phase I|Protocol Violation|1
5970791|NCT01125800|20648157|P2|Phase I|Protocol Violation|3
5970792|NCT01125800|20648158|P1|Phase I|Protocol Violation|0
5970793|NCT01125748|20648224|P2|Overall Study|Patient Decision to Withdraw|4
5970794|NCT01125748|20648225|P1|Overall Study|Patient Decision to Withdraw|2
5970795|NCT01125748|20648224|P2|Overall Study|Physician Decision|7
5970796|NCT01125748|20648225|P1|Overall Study|Physician Decision|8
5970797|NCT01125748|20648224|P2|Overall Study|Lost to Follow-up|1
5970798|NCT01125748|20648225|P1|Overall Study|Lost to Follow-up|0
5970799|NCT01125748|20648224|P2|Overall Study|Adverse Event|2
5970800|NCT01125748|20648225|P1|Overall Study|Adverse Event|0
5970801|NCT01125722|20648235|P2|Overall Study|Lost to Follow-up|0
5970802|NCT01125722|20648236|P1|Overall Study|Lost to Follow-up|1
5970803|NCT01125722|20648235|P2|Overall Study|Withdrawal by Subject|1
5970804|NCT01125722|20648236|P1|Overall Study|Withdrawal by Subject|2
5970805|NCT01125566|20648283|P3|Patients Who Switched From AV to TV|Other than listed above|4
5970806|NCT01125566|20648284|P2|Patients Who Switched From AV to TV|Other than listed above|0
5970807|NCT01125566|20648285|P1|Patients Who Switched From AV to TV|Other than listed above|0
5970808|NCT01125566|20648283|P3|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|3
5970809|NCT01125566|20648284|P2|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0
5970810|NCT01125566|20648285|P1|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0
5970811|NCT01125566|20648283|P3|Patients Who Switched From AV to TV|Refused to continue taking medication|7
5970812|NCT01125566|20648284|P2|Patients Who Switched From AV to TV|Refused to continue taking medication|0
5970813|NCT01125566|20648285|P1|Patients Who Switched From AV to TV|Refused to continue taking medication|0
5970814|NCT01125566|20648283|P3|Patients Who Switched From AV to TV|Progressive disease according to RECIST|59
5970815|NCT01125566|20648284|P2|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0
5970816|NCT01125566|20648285|P1|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0
5970817|NCT01125566|20648283|P3|Patients Before the Switch (26Apr2013)|Lost to Follow-up|0
5970818|NCT01125566|20648284|P2|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1
5970819|NCT01125566|20648285|P1|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1
5970820|NCT01125566|20648283|P3|Patients Before the Switch (26Apr2013)|Other than listed above|0
5970821|NCT01125566|20648284|P2|Patients Before the Switch (26Apr2013)|Other than listed above|13
5970822|NCT01125566|20648285|P1|Patients Before the Switch (26Apr2013)|Other than listed above|25
5970823|NCT01125566|20648283|P3|Patients Before the Switch (26Apr2013)|Not treated|0
5970824|NCT01125566|20648284|P2|Patients Before the Switch (26Apr2013)|Not treated|0
5970825|NCT01125566|20648285|P1|Patients Before the Switch (26Apr2013)|Not treated|2
5970826|NCT01125566|20648283|P3|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|0
5970827|NCT01125566|20648284|P2|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|23
5970828|NCT01125566|20648285|P1|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|24
5970829|NCT01125566|20648283|P3|Patients Before the Switch (26Apr2013)|Protocol Violation|0
5970830|NCT01125566|20648284|P2|Patients Before the Switch (26Apr2013)|Protocol Violation|2
5970831|NCT01125566|20648285|P1|Patients Before the Switch (26Apr2013)|Protocol Violation|0
5970832|NCT01125566|20648283|P3|Patients Before the Switch (26Apr2013)|Adverse Event|0
5970833|NCT01125566|20648284|P2|Patients Before the Switch (26Apr2013)|Adverse Event|5
5970834|NCT01125566|20648285|P1|Patients Before the Switch (26Apr2013)|Adverse Event|25
5970835|NCT01125566|20648283|P3|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|0
5970836|NCT01125566|20648284|P2|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6
5970837|NCT01125566|20648285|P1|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6
5970838|NCT01125566|20648283|P3|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|0
5970839|NCT01125566|20648284|P2|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|119
5970840|NCT01125566|20648285|P1|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|182
5970841|NCT01125514|20648298|P1|Treatment Period2(Day9-Day27) and Day 28|Withdrawal by Subject|1
5970842|NCT01125514|20648298|P1|Treatment Period2(Day9-Day27) and Day 28|Protocol Deviation|1
5970843|NCT01125514|20648298|P1|Treatment Period2(Day9-Day27) and Day 28|Adverse Event|2
5970844|NCT01125514|20648298|P1|Treatment Period 2 (Day 8 - Day 17)|Adverse Event|3
5970845|NCT01125514|20648298|P1|Treatment Period 1 (Day 1 - Day 7)|Administrative problems|1
5970846|NCT01125514|20648298|P1|Treatment Period 1 (Day 1 - Day 7)|Adverse Event|1
5970847|NCT01125189|20648398|P3|Follow up Period|Other reasons|5
5970848|NCT01125189|20648399|P2|Follow up Period|Other reasons|4
5970849|NCT01125189|20648400|P1|Follow up Period|Other reasons|4
5970850|NCT01125189|20648398|P3|Follow up Period|Lost to Follow-up|6
5970851|NCT01125189|20648399|P2|Follow up Period|Lost to Follow-up|9
5970852|NCT01125189|20648400|P1|Follow up Period|Lost to Follow-up|12
5970853|NCT01125189|20648398|P3|Follow up Period|Death|0
5970854|NCT01125189|20648399|P2|Follow up Period|Death|0
5970855|NCT01125189|20648400|P1|Follow up Period|Death|1
5970856|NCT01125189|20648398|P3|Follow up Period|Withdrawal by Subject|5
5970857|NCT01125189|20648399|P2|Follow up Period|Withdrawal by Subject|2
5970858|NCT01125189|20648400|P1|Follow up Period|Withdrawal by Subject|3
5970859|NCT01125189|20648398|P3|Treatment Period|Completed 24 week treatment period only|2
5970860|NCT01125189|20648399|P2|Treatment Period|Completed 24 week treatment period only|1
5970861|NCT01125189|20648400|P1|Treatment Period|Completed 24 week treatment period only|2
5970862|NCT01125189|20648398|P3|Treatment Period|Other reasons|0
5970863|NCT01125189|20648399|P2|Treatment Period|Other reasons|1
5970864|NCT01125189|20648400|P1|Treatment Period|Other reasons|1
5970865|NCT01125189|20648398|P3|Treatment Period|Participants requested to discontinue|4
5970866|NCT01125189|20648399|P2|Treatment Period|Participants requested to discontinue|3
5970867|NCT01125189|20648400|P1|Treatment Period|Participants requested to discontinue|1
5970868|NCT01125189|20648398|P3|Treatment Period|Poor compliance/noncompliance|0
5970869|NCT01125189|20648399|P2|Treatment Period|Poor compliance/noncompliance|1
5970870|NCT01125189|20648400|P1|Treatment Period|Poor compliance/noncompliance|0
5970871|NCT01125189|20648398|P3|Treatment Period|Lost to Follow-up|1
5970872|NCT01125189|20648399|P2|Treatment Period|Lost to Follow-up|2
5970873|NCT01125189|20648400|P1|Treatment Period|Lost to Follow-up|1
5970874|NCT01125189|20648398|P3|Treatment Period|Death|0
5970875|NCT01125189|20648399|P2|Treatment Period|Death|0
5970876|NCT01125189|20648400|P1|Treatment Period|Death|1
5970877|NCT01125189|20648398|P3|Treatment Period|Withdrawal by Subject|1
5970878|NCT01125189|20648399|P2|Treatment Period|Withdrawal by Subject|1
5970879|NCT01125189|20648400|P1|Treatment Period|Withdrawal by Subject|3
5970880|NCT01125189|20648398|P3|Treatment Period|Adverse Event|8
5970881|NCT01125189|20648399|P2|Treatment Period|Adverse Event|8
5970882|NCT01125189|20648400|P1|Treatment Period|Adverse Event|7
5970883|NCT01125189|20648398|P3|Treatment Period|Lack of Efficacy|25
5970884|NCT01125189|20648399|P2|Treatment Period|Lack of Efficacy|18
5970885|NCT01125189|20648400|P1|Treatment Period|Lack of Efficacy|15
5970886|NCT01125046|20648450|P1|Follow-up/Data Cut Off Point|Lost to Follow-up|4
5970887|NCT01125046|20648450|P1|Follow-up/Data Cut Off Point|Death|29
5970888|NCT01125046|20648450|P1|Continued Treatment After 6 Months|Adverse Event|1
5970889|NCT01125046|20648450|P1|Continued Treatment After 6 Months|Progressive Disease|2
5970890|NCT01125046|20648450|P1|First 6 Months of Treatment|Adverse Event|2
5970891|NCT01125046|20648450|P1|First 6 Months of Treatment|Progressive Disease|7
5970892|NCT01125046|20648450|P1|First 6 Months of Treatment|Surgery|1
5970893|NCT01125046|20648450|P1|First 6 Months of Treatment|Non-compliance|1
5970894|NCT01125046|20648450|P1|First 6 Months of Treatment|Withdrawal by Subject|2
5970895|NCT01125046|20648450|P1|First 6 Months of Treatment|Death|1
5970896|NCT01124916|20648477|P2|Overall Study|Lost to Follow-up|2
5970897|NCT01124916|20648478|P1|Overall Study|Lost to Follow-up|3
5970898|NCT01124864|20648492|P6|Overall Study|Protocol Violation|0
5970899|NCT01124864|20648493|P5|Overall Study|Protocol Violation|1
5970900|NCT01124864|20648494|P4|Overall Study|Protocol Violation|0
5970901|NCT01124864|20648495|P3|Overall Study|Protocol Violation|0
5970902|NCT01124864|20648496|P2|Overall Study|Protocol Violation|0
5970903|NCT01124864|20648497|P1|Overall Study|Protocol Violation|1
5970904|NCT01124864|20648492|P6|Overall Study|Lost to Follow-up|0
5970905|NCT01124864|20648493|P5|Overall Study|Lost to Follow-up|0
5970906|NCT01124864|20648494|P4|Overall Study|Lost to Follow-up|1
5970907|NCT01124864|20648495|P3|Overall Study|Lost to Follow-up|0
5970908|NCT01124864|20648496|P2|Overall Study|Lost to Follow-up|1
5970909|NCT01124864|20648497|P1|Overall Study|Lost to Follow-up|1
5970910|NCT01124864|20648492|P6|Overall Study|Withdrawal by Subject|1
5970911|NCT01124864|20648493|P5|Overall Study|Withdrawal by Subject|2
5970912|NCT01124864|20648494|P4|Overall Study|Withdrawal by Subject|0
5970913|NCT01124864|20648495|P3|Overall Study|Withdrawal by Subject|4
5970914|NCT01124864|20648496|P2|Overall Study|Withdrawal by Subject|3
5970915|NCT01124864|20648497|P1|Overall Study|Withdrawal by Subject|2
5970916|NCT01124864|20648492|P6|Overall Study|Death|0
5970917|NCT01124864|20648493|P5|Overall Study|Death|1
5970918|NCT01124864|20648494|P4|Overall Study|Death|2
5970919|NCT01124864|20648495|P3|Overall Study|Death|6
5970920|NCT01124864|20648496|P2|Overall Study|Death|9
5970921|NCT01124864|20648497|P1|Overall Study|Death|6
5970922|NCT01124864|20648492|P6|Overall Study|Follow up phase competed as per protocol|2
5970923|NCT01124864|20648493|P5|Overall Study|Follow up phase competed as per protocol|26
5970924|NCT01124864|20648494|P4|Overall Study|Follow up phase competed as per protocol|18
5970925|NCT01124864|20648495|P3|Overall Study|Follow up phase competed as per protocol|24
5970926|NCT01124864|20648496|P2|Overall Study|Follow up phase competed as per protocol|22
5970927|NCT01124864|20648497|P1|Overall Study|Follow up phase competed as per protocol|18
5970928|NCT01124838|20648531|P2|Overall Study|Lost to Follow-up|0
5970929|NCT01124838|20648532|P1|Overall Study|Lost to Follow-up|2
5970930|NCT01124838|20648531|P2|Overall Study|Withdrawal by Subject|2
5970931|NCT01124838|20648532|P1|Overall Study|Withdrawal by Subject|3
5970932|NCT01124838|20648531|P2|Overall Study|Lack of Efficacy|0
5970933|NCT01124838|20648532|P1|Overall Study|Lack of Efficacy|2
5970934|NCT01124838|20648531|P2|Overall Study|Adverse Event|11
5970935|NCT01124838|20648532|P1|Overall Study|Adverse Event|7
5970936|NCT01124838|20648531|P2|Overall Study|Miscellaneous|2
5970937|NCT01124838|20648532|P1|Overall Study|Miscellaneous|4
5970938|NCT01124734|20648599|P1|Overall Study|Elected for alternative treatment|2
5970939|NCT01124734|20648599|P1|Overall Study|Withdrawal by Subject|1
5970940|NCT01124734|20648599|P1|Overall Study|Adverse Event|1
5970941|NCT01124734|20648599|P1|Overall Study|Disease progression|13
5970942|NCT01124643|20648610|P1|Overall Study|Death|1
5970943|NCT01124617|20648624|P2|Overall Study|Other|1
5970944|NCT01124617|20648625|P1|Overall Study|Other|2
5970945|NCT01124617|20648624|P2|Overall Study|Withdrawal by Subject|1
5970946|NCT01124617|20648625|P1|Overall Study|Withdrawal by Subject|9
5970947|NCT01124617|20648624|P2|Overall Study|Protocol Violation|1
5970948|NCT01124617|20648625|P1|Overall Study|Protocol Violation|1
5970949|NCT01124617|20648624|P2|Overall Study|Lack of Efficacy|1
5970950|NCT01124617|20648625|P1|Overall Study|Lack of Efficacy|2
5970951|NCT01124617|20648624|P2|Overall Study|Adverse Event|2
5970952|NCT01124617|20648625|P1|Overall Study|Adverse Event|5
5970953|NCT01124604|20648657|P2|Overall Study|Disease Progression|1
5970954|NCT01124604|20648658|P1|Overall Study|Disease Progression|0
5970955|NCT01124604|20648657|P2|Overall Study|Withdrawal by Subject|0
5970956|NCT01124604|20648658|P1|Overall Study|Withdrawal by Subject|4
5970957|NCT01124604|20648657|P2|Overall Study|Lack of Efficacy|0
5970958|NCT01124604|20648658|P1|Overall Study|Lack of Efficacy|1
5970959|NCT01124604|20648657|P2|Overall Study|Adverse Event|1
5970960|NCT01124604|20648658|P1|Overall Study|Adverse Event|10
5970961|NCT01124448|20648697|P2|Overall Study|Protocol Violation|0
5970962|NCT01124448|20648698|P1|Overall Study|Protocol Violation|2
5970963|NCT01124448|20648697|P2|Overall Study|Lost to Follow-up|3
5970964|NCT01124448|20648698|P1|Overall Study|Lost to Follow-up|0
5970965|NCT01124422|20648706|P3|4-Week Double-blind Treatment Phase|Lost to Follow-up|1
5970966|NCT01124422|20648707|P2|4-Week Double-blind Treatment Phase|Lost to Follow-up|0
5970967|NCT01124422|20648708|P1|4-Week Double-blind Treatment Phase|Lost to Follow-up|0
5970968|NCT01124422|20648706|P3|4-Week Double-blind Treatment Phase|Physician Decision|2
5970969|NCT01124422|20648707|P2|4-Week Double-blind Treatment Phase|Physician Decision|5
5970970|NCT01124422|20648708|P1|4-Week Double-blind Treatment Phase|Physician Decision|0
5970971|NCT01124422|20648706|P3|4-Week Double-blind Treatment Phase|Adverse Event|3
5970972|NCT01124422|20648707|P2|4-Week Double-blind Treatment Phase|Adverse Event|6
5970973|NCT01124422|20648708|P1|4-Week Double-blind Treatment Phase|Adverse Event|0
5970974|NCT01124422|20648706|P3|4-Week Double-blind Treatment Phase|Withdrawal by Subject|3
5970975|NCT01124422|20648707|P2|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0
5970976|NCT01124422|20648708|P1|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0
5970977|NCT01124422|20648706|P3|4-Week Open-label Run-in Phase|Protocol Violation|0
5970978|NCT01124422|20648707|P2|4-Week Open-label Run-in Phase|Protocol Violation|0
5970979|NCT01124422|20648708|P1|4-Week Open-label Run-in Phase|Protocol Violation|5
5970980|NCT01124422|20648706|P3|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0
5970981|NCT01124422|20648707|P2|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0
5970982|NCT01124422|20648708|P1|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|61
5970983|NCT01124422|20648706|P3|4-Week Open-label Run-in Phase|Lost to Follow-up|0
5970984|NCT01124422|20648707|P2|4-Week Open-label Run-in Phase|Lost to Follow-up|0
5970985|NCT01124422|20648708|P1|4-Week Open-label Run-in Phase|Lost to Follow-up|1
5970986|NCT01124422|20648706|P3|4-Week Open-label Run-in Phase|Physician Decision|0
5970987|NCT01124422|20648707|P2|4-Week Open-label Run-in Phase|Physician Decision|0
5970988|NCT01124422|20648708|P1|4-Week Open-label Run-in Phase|Physician Decision|4
5970989|NCT01124422|20648706|P3|4-Week Open-label Run-in Phase|Adverse Event|0
5970990|NCT01124422|20648707|P2|4-Week Open-label Run-in Phase|Adverse Event|0
5970991|NCT01124422|20648708|P1|4-Week Open-label Run-in Phase|Adverse Event|7
5970992|NCT01124422|20648706|P3|4-Week Open-label Run-in Phase|Withdrawal by Subject|0
5970993|NCT01124422|20648707|P2|4-Week Open-label Run-in Phase|Withdrawal by Subject|0
5970994|NCT01124422|20648708|P1|4-Week Open-label Run-in Phase|Withdrawal by Subject|5
5970995|NCT01124292|20648778|P3|Overall Study|piercing track closed|1
5970996|NCT01124292|20648779|P2|Overall Study|piercing track closed|2
5970997|NCT01124292|20648780|P1|Overall Study|piercing track closed|0
5970998|NCT01124292|20648778|P3|Overall Study|medical issue unrelated to the study|2
5970999|NCT01124292|20648779|P2|Overall Study|medical issue unrelated to the study|0
5971000|NCT01124292|20648780|P1|Overall Study|medical issue unrelated to the study|0
5971001|NCT01124292|20648778|P3|Overall Study|Withdrawal by Subject|2
5971002|NCT01124292|20648779|P2|Overall Study|Withdrawal by Subject|6
5971003|NCT01124292|20648780|P1|Overall Study|Withdrawal by Subject|0
5971004|NCT01124292|20648778|P3|Overall Study|Physician Decision|2
5971005|NCT01124292|20648779|P2|Overall Study|Physician Decision|3
5971006|NCT01124292|20648780|P1|Overall Study|Physician Decision|0
5971007|NCT01124292|20648778|P3|Overall Study|Lost to Follow-up|3
5971008|NCT01124292|20648779|P2|Overall Study|Lost to Follow-up|4
5971009|NCT01124292|20648780|P1|Overall Study|Lost to Follow-up|2
5971010|NCT01124175|20648851|P2|Washout of 7 Days|Withdrawal by Subject|2
5971011|NCT01124175|20648852|P1|Washout of 7 Days|Withdrawal by Subject|0
5971012|NCT01124162|20648870|P2|Washout of 7 Days|Withdrawal by Subject|0
5971013|NCT01124162|20648871|P1|Washout of 7 Days|Withdrawal by Subject|1
5971014|NCT01124162|20648870|P2|First Intervention|Adverse Event|0
5971015|NCT01124162|20648871|P1|First Intervention|Adverse Event|2
5971016|NCT01124149|20648887|P1|Maintenance Phase|Non-compliance|1
5971017|NCT01124149|20648887|P1|Maintenance Phase|Coordinator error|1
5971018|NCT01124149|20648887|P1|Maintenance Phase|Protocol Violation|5
5971019|NCT01124149|20648887|P1|Maintenance Phase|Withdrawal by Subject|10
5971020|NCT01124149|20648887|P1|Maintenance Phase|Lost to Follow-up|15
5971021|NCT01124149|20648887|P1|Maintenance Phase|Adverse Event|24
5971022|NCT01124149|20648887|P1|Maintenance Phase|Lack of Efficacy|40
5971023|NCT01124149|20648887|P1|Acute Phase|Sponsor decision|1
5971024|NCT01124149|20648887|P1|Acute Phase|Travelling to another country|1
5971025|NCT01124149|20648887|P1|Acute Phase|Low hemoglobin|1
5971026|NCT01124149|20648887|P1|Acute Phase|Non-compliance|1
5971027|NCT01124149|20648887|P1|Acute Phase|UC symptoms not ameliorated|1
5971028|NCT01124149|20648887|P1|Acute Phase|Sponsor request|1
5971029|NCT01124149|20648887|P1|Acute Phase|Prolonged antibiotic therapy|1
5971030|NCT01124149|20648887|P1|Acute Phase|Lost to Follow-up|2
5971031|NCT01124149|20648887|P1|Acute Phase|Protocol Violation|14
5971032|NCT01124149|20648887|P1|Acute Phase|Lack of Efficacy|17
5971033|NCT01124149|20648887|P1|Acute Phase|Adverse Event|21
5971034|NCT01124149|20648887|P1|Acute Phase|Withdrawal by Subject|22
5971035|NCT01124097|20648907|P4|Overall Study|Physician Decision|0
5971036|NCT01124097|20648908|P3|Overall Study|Physician Decision|0
5971037|NCT01124097|20648909|P2|Overall Study|Physician Decision|1
5971038|NCT01124097|20648910|P1|Overall Study|Physician Decision|2
5971039|NCT01124097|20648907|P4|Overall Study|Protocol Violation|1
5971040|NCT01124097|20648908|P3|Overall Study|Protocol Violation|2
5971041|NCT01124097|20648909|P2|Overall Study|Protocol Violation|0
5971042|NCT01124097|20648910|P1|Overall Study|Protocol Violation|2
5971043|NCT01124097|20648907|P4|Overall Study|Adverse Event|7
5971044|NCT01124097|20648908|P3|Overall Study|Adverse Event|15
5971045|NCT01124097|20648909|P2|Overall Study|Adverse Event|15
5971046|NCT01124097|20648910|P1|Overall Study|Adverse Event|24
5971047|NCT01124097|20648907|P4|Overall Study|Lack of Efficacy|3
5971048|NCT01124097|20648908|P3|Overall Study|Lack of Efficacy|1
5971049|NCT01124097|20648909|P2|Overall Study|Lack of Efficacy|3
5971050|NCT01124097|20648910|P1|Overall Study|Lack of Efficacy|2
5971051|NCT01124097|20648907|P4|Overall Study|Withdrawal by Subject|3
5971052|NCT01124097|20648908|P3|Overall Study|Withdrawal by Subject|2
5971053|NCT01124097|20648909|P2|Overall Study|Withdrawal by Subject|3
5971054|NCT01124097|20648910|P1|Overall Study|Withdrawal by Subject|4
5971055|NCT01124045|20648922|P2|Overall Study|Physician Decision|2
5971056|NCT01124045|20648923|P1|Overall Study|Physician Decision|0
5971057|NCT01124045|20648922|P2|Overall Study|Lost to Follow-up|1
5971058|NCT01124045|20648923|P1|Overall Study|Lost to Follow-up|0
5971059|NCT01124006|20648956|P3|Overall Study|Other|1
5971060|NCT01124006|20648957|P2|Overall Study|Other|0
5971061|NCT01124006|20648958|P1|Overall Study|Other|0
5971062|NCT01124006|20648956|P3|Overall Study|Lost to Follow-up|1
5971063|NCT01124006|20648957|P2|Overall Study|Lost to Follow-up|0
5971064|NCT01124006|20648958|P1|Overall Study|Lost to Follow-up|1
5971065|NCT01124006|20648956|P3|Overall Study|Withdrawal by Subject|0
5971066|NCT01124006|20648957|P2|Overall Study|Withdrawal by Subject|2
5971067|NCT01124006|20648958|P1|Overall Study|Withdrawal by Subject|2
5971068|NCT01123980|20648986|P2|Overall Study|Unclassified|7
5971069|NCT01123980|20648987|P1|Overall Study|Unclassified|6
5971070|NCT01123980|20648986|P2|Overall Study|Withdrawal by Subject|3
5971071|NCT01123980|20648987|P1|Overall Study|Withdrawal by Subject|5
5971072|NCT01123980|20648986|P2|Overall Study|Protocol Violation|6
5971073|NCT01123980|20648987|P1|Overall Study|Protocol Violation|6
5971074|NCT01123980|20648986|P2|Overall Study|Lost to Follow-up|6
5971075|NCT01123980|20648987|P1|Overall Study|Lost to Follow-up|0
5971076|NCT01123980|20648986|P2|Overall Study|Physician Decision|1
5971077|NCT01123980|20648987|P1|Overall Study|Physician Decision|0
5971078|NCT01123980|20648986|P2|Overall Study|Lack of Efficacy|0
5971079|NCT01123980|20648987|P1|Overall Study|Lack of Efficacy|1
5971080|NCT01123980|20648986|P2|Overall Study|Adverse Event|1
5971081|NCT01123980|20648987|P1|Overall Study|Adverse Event|1
5971082|NCT01123941|20649007|P2|Overall Study|Lost to Follow-up|1
5971083|NCT01123941|20649008|P1|Overall Study|Lost to Follow-up|2
5971084|NCT01123889|20649043|P2|Overall Study|Lost to Follow-up|1
5971085|NCT01123889|20649044|P1|Overall Study|Lost to Follow-up|3
5971086|NCT01123850|20649054|P1|Overall Study|Slow enrollment|45
5971087|NCT01123655|20649061|P3|Overall Study|began prohibitive drug|1
5971088|NCT01123655|20649062|P2|Overall Study|began prohibitive drug|0
5971089|NCT01123655|20649063|P1|Overall Study|began prohibitive drug|0
5971090|NCT01123655|20649061|P3|Overall Study|new illness|0
5971091|NCT01123655|20649062|P2|Overall Study|new illness|1
5971092|NCT01123655|20649063|P1|Overall Study|new illness|0
5971093|NCT01123655|20649061|P3|Overall Study|Medication for RA had to be changed|0
5971094|NCT01123655|20649062|P2|Overall Study|Medication for RA had to be changed|0
5971095|NCT01123655|20649063|P1|Overall Study|Medication for RA had to be changed|1
5971096|NCT01123642|20649135|P1|Overall Study|ineligible at baseline assessment|36
5971097|NCT01123642|20649135|P1|Overall Study|Withdrawal by Subject|9
5971098|NCT01123642|20649135|P1|Overall Study|Lost to Follow-up|23
5971099|NCT01123395|20649151|P2|Washout Period of 14 Days|Withdrawal by Subject|1
5971100|NCT01123395|20649152|P1|Washout Period of 14 Days|Withdrawal by Subject|0
5971101|NCT01123382|20649164|P2|Overall Study|Lost to Follow-up|2
5971102|NCT01123382|20649165|P1|Overall Study|Lost to Follow-up|1
5971103|NCT01123382|20649164|P2|Overall Study|Withdrawal by Subject|4
5971104|NCT01123382|20649165|P1|Overall Study|Withdrawal by Subject|1
5971105|NCT01123356|20649187|P1|Overall Study|Withdrawal by Subject|1
5971106|NCT01123356|20649187|P1|Overall Study|Lack of Efficacy|4
5971107|NCT01123356|20649187|P1|Overall Study|Adverse Event|2
5971108|NCT01123200|20649195|P1|Overall Study|Withdrawal by Subject|1
5971109|NCT01123161|20649202|P2|Overall Study|Withdrawal by Subject|0
5971110|NCT01123161|20649203|P1|Overall Study|Withdrawal by Subject|1
5971111|NCT01123161|20649202|P2|Overall Study|Lost to Follow-up|0
5971112|NCT01123161|20649203|P1|Overall Study|Lost to Follow-up|1
5971113|NCT01123148|20649221|P1|Overall Study|Didn't meet milestone criteria|1
5971114|NCT01123148|20649221|P1|Overall Study|Coughing caused unacceptable EEG quality|1
5971115|NCT01123083|20649227|P2|Overall Study|Participant/legal representative request|3
5971116|NCT01123083|20649228|P1|Overall Study|Participant/legal representative request|7
5971117|NCT01123083|20649227|P2|Overall Study|Withdrew for another reason not covered|1
5971118|NCT01123083|20649228|P1|Overall Study|Withdrew for another reason not covered|0
5971119|NCT01123083|20649227|P2|Overall Study|Adverse Event|0
5971120|NCT01123083|20649228|P1|Overall Study|Adverse Event|1
5971121|NCT01123083|20649227|P2|Overall Study|Lost to Follow-up|6
5971122|NCT01123083|20649228|P1|Overall Study|Lost to Follow-up|2
5971123|NCT01123083|20649227|P2|Overall Study|Administrative reasons|4
5971124|NCT01123083|20649228|P1|Overall Study|Administrative reasons|0
5971125|NCT01123083|20649227|P2|Overall Study|Investigator recommendation|1
5971126|NCT01123083|20649228|P1|Overall Study|Investigator recommendation|1
5971127|NCT01122927|20649252|P2|Period 2- Open-label Treatment Phase|Lack of Efficacy|7
5971128|NCT01122927|20649253|P1|Period 2- Open-label Treatment Phase|Lack of Efficacy|0
5971129|NCT01122927|20649252|P2|Period 2- Open-label Treatment Phase|Withdrawal by Subject|65
5971130|NCT01122927|20649253|P1|Period 2- Open-label Treatment Phase|Withdrawal by Subject|0
5971131|NCT01122927|20649252|P2|Period 2- Open-label Treatment Phase|Physician Decision|12
5971132|NCT01122927|20649253|P1|Period 2- Open-label Treatment Phase|Physician Decision|0
5971133|NCT01122927|20649252|P2|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|9
5971134|NCT01122927|20649253|P1|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|0
5971135|NCT01122927|20649252|P2|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|165
5971136|NCT01122927|20649253|P1|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|0
5971137|NCT01122927|20649252|P2|Period 2- Open-label Treatment Phase|Adverse Event|33
5971138|NCT01122927|20649253|P1|Period 2- Open-label Treatment Phase|Adverse Event|0
5971139|NCT01122927|20649252|P2|Period 2- Open-label Treatment Phase|Lost to Follow-up|21
5971140|NCT01122927|20649253|P1|Period 2- Open-label Treatment Phase|Lost to Follow-up|0
5971141|NCT01122927|20649252|P2|Period 1 - Conversion Phase|Protocol Deviation|0
5971142|NCT01122927|20649253|P1|Period 1 - Conversion Phase|Protocol Deviation|1
5971143|NCT01122927|20649252|P2|Period 1 - Conversion Phase|Withdrawal by Subject|0
5971144|NCT01122927|20649253|P1|Period 1 - Conversion Phase|Withdrawal by Subject|7
5971145|NCT01122927|20649252|P2|Period 1 - Conversion Phase|Physician Decision|0
5971146|NCT01122927|20649253|P1|Period 1 - Conversion Phase|Physician Decision|2
5971147|NCT01122927|20649252|P2|Period 1 - Conversion Phase|Met Withdrawal Criteria|0
5971148|NCT01122927|20649253|P1|Period 1 - Conversion Phase|Met Withdrawal Criteria|1
5971149|NCT01122927|20649252|P2|Period 1 - Conversion Phase|Adverse Event|0
5971150|NCT01122927|20649253|P1|Period 1 - Conversion Phase|Adverse Event|3
5971151|NCT01122862|20649305|P3|Period 2|Adverse Event|1
5971152|NCT01122862|20649306|P2|Period 2|Adverse Event|0
5971153|NCT01122862|20649307|P1|Period 2|Adverse Event|0
5971154|NCT01122862|20649305|P3|Period 1|Protocol Violation|0
5971155|NCT01122862|20649306|P2|Period 1|Protocol Violation|1
5971156|NCT01122862|20649307|P1|Period 1|Protocol Violation|0
5971157|NCT01122680|20649413|P4|Period 3 (4 Weeks)|Withdrawal by Subject|0
5971158|NCT01122680|20649414|P3|Period 3 (4 Weeks)|Withdrawal by Subject|0
5971159|NCT01122680|20649415|P2|Period 3 (4 Weeks)|Withdrawal by Subject|1
5971160|NCT01122680|20649416|P1|Period 3 (4 Weeks)|Withdrawal by Subject|0
5971161|NCT01122680|20649413|P4|Period 3 (4 Weeks)|Adverse Event|0
5971162|NCT01122680|20649414|P3|Period 3 (4 Weeks)|Adverse Event|0
5971163|NCT01122680|20649415|P2|Period 3 (4 Weeks)|Adverse Event|0
5971164|NCT01122680|20649416|P1|Period 3 (4 Weeks)|Adverse Event|1
5971165|NCT01122680|20649413|P4|Period 2 (4 Weeks)|Other|0
5971166|NCT01122680|20649414|P3|Period 2 (4 Weeks)|Other|0
5971167|NCT01122680|20649415|P2|Period 2 (4 Weeks)|Other|0
5971168|NCT01122680|20649416|P1|Period 2 (4 Weeks)|Other|1
5971169|NCT01122680|20649413|P4|Period 2 (4 Weeks)|Protocol Violation|1
5971170|NCT01122680|20649414|P3|Period 2 (4 Weeks)|Protocol Violation|0
5971171|NCT01122680|20649415|P2|Period 2 (4 Weeks)|Protocol Violation|0
5971172|NCT01122680|20649416|P1|Period 2 (4 Weeks)|Protocol Violation|0
5971173|NCT01122680|20649413|P4|Period 1 (4 Weeks)|Other|0
5971174|NCT01122680|20649414|P3|Period 1 (4 Weeks)|Other|0
5971175|NCT01122680|20649415|P2|Period 1 (4 Weeks)|Other|1
5971176|NCT01122680|20649416|P1|Period 1 (4 Weeks)|Other|1
5971177|NCT01122680|20649413|P4|Period 1 (4 Weeks)|Protocol Violation|0
5971178|NCT01122680|20649414|P3|Period 1 (4 Weeks)|Protocol Violation|0
5971179|NCT01122680|20649415|P2|Period 1 (4 Weeks)|Protocol Violation|0
5971180|NCT01122680|20649416|P1|Period 1 (4 Weeks)|Protocol Violation|1
5971181|NCT01122680|20649413|P4|Period 1 (4 Weeks)|Adverse Event|0
5971182|NCT01122680|20649414|P3|Period 1 (4 Weeks)|Adverse Event|0
5971183|NCT01122680|20649415|P2|Period 1 (4 Weeks)|Adverse Event|0
5971184|NCT01122680|20649416|P1|Period 1 (4 Weeks)|Adverse Event|1
5971185|NCT01122576|20649481|P3|Post-Cataract Surgery|Fellow Eye Explanted|1
5971186|NCT01122576|20649482|P2|Post-Cataract Surgery|Fellow Eye Explanted|0
5971187|NCT01122576|20649483|P1|Post-Cataract Surgery|Fellow Eye Explanted|0
5971188|NCT01122576|20649481|P3|Post-Cataract Surgery|Central Macular Edema|1
5971189|NCT01122576|20649482|P2|Post-Cataract Surgery|Central Macular Edema|0
5971190|NCT01122576|20649483|P1|Post-Cataract Surgery|Central Macular Edema|0
5971191|NCT01122576|20649481|P3|Pre-Cataract Surgery|Withdrawal by Subject|2
5971192|NCT01122576|20649482|P2|Pre-Cataract Surgery|Withdrawal by Subject|1
5971193|NCT01122576|20649483|P1|Pre-Cataract Surgery|Withdrawal by Subject|0
5971194|NCT01122394|20649664|P2|Overall Study|Adverse Event|1
5971195|NCT01122394|20649665|P1|Overall Study|Adverse Event|0
5971196|NCT01122394|20649664|P2|Overall Study|Lost to Follow-up|2
5971197|NCT01122394|20649665|P1|Overall Study|Lost to Follow-up|2
5971198|NCT01122394|20649664|P2|Overall Study|Withdrawal by Subject|1
5971199|NCT01122394|20649665|P1|Overall Study|Withdrawal by Subject|1
5971200|NCT01122381|20649681|P2|Overall Study|study terminated early|1
5971201|NCT01122381|20649682|P1|Overall Study|study terminated early|0
5971202|NCT01122264|20649698|P3|Overall Study|Lack of Efficacy|1
5971203|NCT01122264|20649699|P2|Overall Study|Lack of Efficacy|1
5971204|NCT01122264|20649700|P1|Overall Study|Lack of Efficacy|3
5971205|NCT01122264|20649698|P3|Overall Study|Physician Decision|1
5971206|NCT01122264|20649699|P2|Overall Study|Physician Decision|1
5971207|NCT01122264|20649700|P1|Overall Study|Physician Decision|3
5971208|NCT01122264|20649698|P3|Overall Study|Withdrawal by Subject|16
5971209|NCT01122264|20649699|P2|Overall Study|Withdrawal by Subject|6
5971210|NCT01122264|20649700|P1|Overall Study|Withdrawal by Subject|6
5971211|NCT01122264|20649698|P3|Overall Study|Protocol Violation|9
5971212|NCT01122264|20649699|P2|Overall Study|Protocol Violation|7
5971213|NCT01122264|20649700|P1|Overall Study|Protocol Violation|7
5971214|NCT01122264|20649698|P3|Overall Study|Entry Criteria Not Met|0
5971215|NCT01122264|20649699|P2|Overall Study|Entry Criteria Not Met|0
5971216|NCT01122264|20649700|P1|Overall Study|Entry Criteria Not Met|1
5971217|NCT01122264|20649698|P3|Overall Study|Lost to Follow-up|13
5971218|NCT01122264|20649699|P2|Overall Study|Lost to Follow-up|9
5971219|NCT01122264|20649700|P1|Overall Study|Lost to Follow-up|5
5971220|NCT01122264|20649698|P3|Overall Study|Death|0
5971221|NCT01122264|20649699|P2|Overall Study|Death|0
5971222|NCT01122264|20649700|P1|Overall Study|Death|1
5971223|NCT01122264|20649698|P3|Overall Study|Adverse Event|7
5971224|NCT01122264|20649699|P2|Overall Study|Adverse Event|5
5971225|NCT01122264|20649700|P1|Overall Study|Adverse Event|6
5971226|NCT01122173|20649810|P1|Overall Study|Left study for other reasons|3
5971227|NCT01122173|20649810|P1|Overall Study|Withdrawal by Subject|3
5971228|NCT01122173|20649810|P1|Overall Study|Lost to Follow-up|3
5971229|NCT01121991|20650033|P1|Overall Study|No Fertilization|1
5971230|NCT01121991|20650033|P1|Overall Study|No Oocytes Retrieved|3
5971231|NCT01121991|20650033|P1|Overall Study|Lack of Ovarian Response|2
5971232|NCT01121926|20650058|P2|Washout Period|Positive pregnancy test|1
5971233|NCT01121926|20650059|P1|Washout Period|Positive pregnancy test|0
5971234|NCT01121926|20650058|P2|Washout Period|Adverse Event|1
5971235|NCT01121926|20650059|P1|Washout Period|Adverse Event|0
5971236|NCT01121926|20650058|P2|First Intervention Period|Adverse Event|0
5971237|NCT01121926|20650059|P1|First Intervention Period|Adverse Event|1
5971238|NCT01121913|20650077|P4|Third Washout Period|Adverse Event|0
5971239|NCT01121913|20650078|P3|Third Washout Period|Adverse Event|0
5971240|NCT01121913|20650079|P2|Third Washout Period|Adverse Event|0
5971241|NCT01121913|20650080|P1|Third Washout Period|Adverse Event|1
5971242|NCT01121913|20650077|P4|Second Washout Period|Withdrawal by Subject|0
5971243|NCT01121913|20650078|P3|Second Washout Period|Withdrawal by Subject|1
5971244|NCT01121913|20650079|P2|Second Washout Period|Withdrawal by Subject|0
5971245|NCT01121913|20650080|P1|Second Washout Period|Withdrawal by Subject|0
5971246|NCT01121913|20650077|P4|Second Intervention Period|Adverse Event|0
5971247|NCT01121913|20650078|P3|Second Intervention Period|Adverse Event|1
5971248|NCT01121913|20650079|P2|Second Intervention Period|Adverse Event|0
5971249|NCT01121913|20650080|P1|Second Intervention Period|Adverse Event|0
5971250|NCT01121913|20650077|P4|First Washout Period|Withdrawal by Subject|0
5971251|NCT01121913|20650078|P3|First Washout Period|Withdrawal by Subject|0
5971252|NCT01121913|20650079|P2|First Washout Period|Withdrawal by Subject|0
5971253|NCT01121913|20650080|P1|First Washout Period|Withdrawal by Subject|1
5971254|NCT01121913|20650077|P4|First Intervention Period|Adverse Event|0
5971255|NCT01121913|20650078|P3|First Intervention Period|Adverse Event|1
5971256|NCT01121913|20650079|P2|First Intervention Period|Adverse Event|0
5971257|NCT01121913|20650080|P1|First Intervention Period|Adverse Event|0
5971258|NCT01121900|20650110|P2|Washout Period of 7 Days|Withdrawal by Subject|1
5971259|NCT01121900|20650111|P1|Washout Period of 7 Days|Withdrawal by Subject|0
5971260|NCT01121900|20650110|P2|First Intervention Period|Adverse Event|1
5971261|NCT01121900|20650111|P1|First Intervention Period|Adverse Event|1
5971262|NCT01121757|20650131|P2|Combination|Disease Progression|0
5971263|NCT01121757|20650132|P1|Combination|Disease Progression|2
5971264|NCT01121757|20650131|P2|Combination|Physician Decision|1
5971265|NCT01121757|20650132|P1|Combination|Physician Decision|0
5971266|NCT01121757|20650131|P2|First Drug|Disease Progression|2
5971267|NCT01121757|20650132|P1|First Drug|Disease Progression|0
5971268|NCT01121757|20650131|P2|First Drug|Death|0
5971269|NCT01121757|20650132|P1|First Drug|Death|1
5971270|NCT01121666|20650148|P2|Overall Study|Protocol Violation|10
5971271|NCT01121666|20650149|P1|Overall Study|Protocol Violation|29
5971272|NCT01121575|20650205|P6|Overall Study|Death|1
5971273|NCT01121575|20650206|P5|Overall Study|Death|7
5971274|NCT01121575|20650207|P4|Overall Study|Death|1
5971275|NCT01121575|20650208|P3|Overall Study|Death|0
5971276|NCT01121575|20650209|P2|Overall Study|Death|0
5971277|NCT01121575|20650210|P1|Overall Study|Death|6
5971278|NCT01121575|20650205|P6|Overall Study|Unspecified Reasons|10
5971279|NCT01121575|20650206|P5|Overall Study|Unspecified Reasons|13
5971280|NCT01121575|20650207|P4|Overall Study|Unspecified Reasons|5
5971281|NCT01121575|20650208|P3|Overall Study|Unspecified Reasons|7
5971282|NCT01121575|20650209|P2|Overall Study|Unspecified Reasons|6
5971283|NCT01121575|20650210|P1|Overall Study|Unspecified Reasons|8
5971284|NCT01121575|20650205|P6|Overall Study|Participant Refused Further Follow-Up|1
5971285|NCT01121575|20650206|P5|Overall Study|Participant Refused Further Follow-Up|5
5971286|NCT01121575|20650207|P4|Overall Study|Participant Refused Further Follow-Up|0
5971287|NCT01121575|20650208|P3|Overall Study|Participant Refused Further Follow-Up|0
5971288|NCT01121575|20650209|P2|Overall Study|Participant Refused Further Follow-Up|0
5971289|NCT01121575|20650210|P1|Overall Study|Participant Refused Further Follow-Up|0
5971290|NCT01121562|20650334|P1|Overall Study|Met study discontinuation criteria|1
5971291|NCT01121562|20650334|P1|Overall Study|Sponsor Decision|1
5971292|NCT01121562|20650334|P1|Overall Study|Adverse Event|1
5971293|NCT01121562|20650334|P1|Overall Study|Withdrawal by Subject|1
5971294|NCT01121562|20650334|P1|Overall Study|Objective progression or relapse|8
5971295|NCT01121549|20650343|P1|Overall Study|Other|58
5971296|NCT01121549|20650343|P1|Overall Study|Withdrawal by Subject|16
5971297|NCT01121549|20650343|P1|Overall Study|Protocol Violation|33
5971298|NCT01121549|20650343|P1|Overall Study|Pregnancy|1
5971299|NCT01121549|20650343|P1|Overall Study|Study terminated by sponsor|197
5971300|NCT01121549|20650343|P1|Overall Study|Did not meet entrance criteria|9
5971301|NCT01121549|20650343|P1|Overall Study|Lost to Follow-up|12
5971302|NCT01121549|20650343|P1|Overall Study|Lack of Efficacy|11
5971303|NCT01121549|20650343|P1|Overall Study|Adverse Event|10
5971304|NCT01121536|20650354|P1|Overall Study|Other|118
5971305|NCT01121536|20650354|P1|Overall Study|Lost to Follow-up|39
5971306|NCT01121536|20650354|P1|Overall Study|Noncompliance with study procedures|9
5971307|NCT01121536|20650354|P1|Overall Study|Noncompliance with study medication|12
5971308|NCT01121536|20650354|P1|Overall Study|Protocol Violation|20
5971309|NCT01121536|20650354|P1|Overall Study|Withdrawal by Subject|65
5971310|NCT01121536|20650354|P1|Overall Study|Lack of Efficacy|35
5971311|NCT01121536|20650354|P1|Overall Study|Adverse Event|63
5971312|NCT01121484|20650375|P2|Overall Study|Randomized, not treated|4
5971313|NCT01121484|20650376|P1|Overall Study|Randomized, not treated|1
5971314|NCT01121484|20650375|P2|Overall Study|Other|3
5971315|NCT01121484|20650376|P1|Overall Study|Other|3
5971316|NCT01121484|20650375|P2|Overall Study|Discontinuation of study by sponsor|1
5971317|NCT01121484|20650376|P1|Overall Study|Discontinuation of study by sponsor|0
5971318|NCT01121484|20650375|P2|Overall Study|Withdrawal by Subject|7
5971319|NCT01121484|20650376|P1|Overall Study|Withdrawal by Subject|8
5971320|NCT01121484|20650375|P2|Overall Study|Protocol Violation|0
5971321|NCT01121484|20650376|P1|Overall Study|Protocol Violation|1
5971322|NCT01121484|20650375|P2|Overall Study|Physician Decision|3
5971323|NCT01121484|20650376|P1|Overall Study|Physician Decision|0
5971324|NCT01121484|20650375|P2|Overall Study|Lost to Follow-up|9
5971325|NCT01121484|20650376|P1|Overall Study|Lost to Follow-up|5
5971326|NCT01121484|20650375|P2|Overall Study|Lack of Efficacy|11
5971327|NCT01121484|20650376|P1|Overall Study|Lack of Efficacy|3
5971328|NCT01121484|20650375|P2|Overall Study|Adverse Event|5
5971329|NCT01121484|20650376|P1|Overall Study|Adverse Event|12
5971330|NCT01121406|20650394|P2|Overall Study|Not treated|0
5971331|NCT01121406|20650395|P1|Overall Study|Not treated|1
5971332|NCT01121406|20650394|P2|Overall Study|Reason other than specified above|6
5971333|NCT01121406|20650395|P1|Overall Study|Reason other than specified above|2
5971334|NCT01121406|20650394|P2|Overall Study|Refused continuation of study med.|2
5971335|NCT01121406|20650395|P1|Overall Study|Refused continuation of study med.|1
5971336|NCT01121406|20650394|P2|Overall Study|Lost to Follow-up|1
5971337|NCT01121406|20650395|P1|Overall Study|Lost to Follow-up|0
5971338|NCT01121406|20650394|P2|Overall Study|Non-compliant with protocol|2
5971339|NCT01121406|20650395|P1|Overall Study|Non-compliant with protocol|0
5971340|NCT01121406|20650394|P2|Overall Study|Other AE|10
5971341|NCT01121406|20650395|P1|Overall Study|Other AE|3
5971342|NCT01121406|20650394|P2|Overall Study|Wors. or AE of underlying cancer disease|6
5971343|NCT01121406|20650395|P1|Overall Study|Wors. or AE of underlying cancer disease|4
5971344|NCT01121406|20650394|P2|Overall Study|Progressive disease RECIST|28
5971345|NCT01121406|20650395|P1|Overall Study|Progressive disease RECIST|44
5971346|NCT01121393|20650445|P2|Overall Study|Other than listed|0
5971347|NCT01121393|20650446|P1|Overall Study|Other than listed|6
5971348|NCT01121393|20650445|P2|Overall Study|Not treated|9
5971349|NCT01121393|20650446|P1|Overall Study|Not treated|3
5971350|NCT01121393|20650445|P2|Overall Study|Refused cont. medication|7
5971351|NCT01121393|20650446|P1|Overall Study|Refused cont. medication|7
5971352|NCT01121393|20650445|P2|Overall Study|Lost to Follow-up|0
5971353|NCT01121393|20650446|P1|Overall Study|Lost to Follow-up|1
5971354|NCT01121393|20650445|P2|Overall Study|Non-compliant with protocol|3
5971355|NCT01121393|20650446|P1|Overall Study|Non-compliant with protocol|0
5971356|NCT01121393|20650445|P2|Overall Study|Other Adverse events|45
5971357|NCT01121393|20650446|P1|Overall Study|Other Adverse events|24
5971358|NCT01121393|20650445|P2|Overall Study|Progressive disease|20
5971359|NCT01121393|20650446|P1|Overall Study|Progressive disease|201
5971360|NCT01121263|20650491|P2|Overall Study|Withdrawal by Subject|1
5971361|NCT01121263|20650492|P1|Overall Study|Withdrawal by Subject|0
5971362|NCT01121263|20650491|P2|Overall Study|Lost to Follow-up|12
5971363|NCT01121263|20650492|P1|Overall Study|Lost to Follow-up|22
5971364|NCT01121263|20650491|P2|Overall Study|Death|2
5971365|NCT01121263|20650492|P1|Overall Study|Death|3
5971366|NCT01121185|20650583|P2|Overall Study|Not transplanted|0
5971367|NCT01121185|20650584|P1|Overall Study|Not transplanted|1
5971368|NCT01121185|20650583|P2|Overall Study|Not infused|1
5971369|NCT01121185|20650584|P1|Overall Study|Not infused|0
5971370|NCT01121146|20650618|P2|Overall Study|Lost to Follow-up|16
5971371|NCT01121146|20650619|P1|Overall Study|Lost to Follow-up|7
5971372|NCT01121146|20650618|P2|Overall Study|Adverse Event|11
5971373|NCT01121146|20650619|P1|Overall Study|Adverse Event|2
5971374|NCT01121146|20650618|P2|Overall Study|Death|15
5971375|NCT01121146|20650619|P1|Overall Study|Death|17
5971376|NCT01120899|20650640|P1|Overall Study|Withdrawal by Subject|3
5971377|NCT01120782|20650668|P1|Overall Study|Test article shipping error|11
5971378|NCT01120756|20650674|P2|Overall Study|Withdrawal by Subject|1
5971379|NCT01120756|20650675|P1|Overall Study|Withdrawal by Subject|1
5971380|NCT01120717|20650685|P2|Overall Study|Abnormal Test Procedure Result(s)|0
5971381|NCT01120717|20650686|P1|Overall Study|Abnormal Test Procedure Result(s)|1
5971382|NCT01120717|20650685|P2|Overall Study|Death|1
5971383|NCT01120717|20650686|P1|Overall Study|Death|3
5971384|NCT01120717|20650685|P2|Overall Study|Lost to Follow-up|3
5971385|NCT01120717|20650686|P1|Overall Study|Lost to Follow-up|2
5971386|NCT01120717|20650685|P2|Overall Study|Unsatisfactory Therapeutic Effect|3
5971387|NCT01120717|20650686|P1|Overall Study|Unsatisfactory Therapeutic Effect|3
5971388|NCT01120717|20650685|P2|Overall Study|Protocol Deviation|5
5971389|NCT01120717|20650686|P1|Overall Study|Protocol Deviation|2
5971390|NCT01120717|20650685|P2|Overall Study|Adverse Event|6
5971391|NCT01120717|20650686|P1|Overall Study|Adverse Event|10
5971392|NCT01120717|20650685|P2|Overall Study|Withdrawal by Subject|6
5971393|NCT01120717|20650686|P1|Overall Study|Withdrawal by Subject|11
5971394|NCT01120691|20650792|P3|Overall Study|Abnormal laboratory value(s)|4
5971395|NCT01120691|20650793|P2|Overall Study|Abnormal laboratory value(s)|3
5971396|NCT01120691|20650794|P1|Overall Study|Abnormal laboratory value(s)|1
5971397|NCT01120691|20650792|P3|Overall Study|Patient's inability to use the device|0
5971398|NCT01120691|20650793|P2|Overall Study|Patient's inability to use the device|1
5971399|NCT01120691|20650794|P1|Overall Study|Patient's inability to use the device|3
5971400|NCT01120691|20650792|P3|Overall Study|Abnormal test procedure result(s)|1
5971401|NCT01120691|20650793|P2|Overall Study|Abnormal test procedure result(s)|2
5971402|NCT01120691|20650794|P1|Overall Study|Abnormal test procedure result(s)|3
5971403|NCT01120691|20650792|P3|Overall Study|Lost to Follow-up|4
5971404|NCT01120691|20650793|P2|Overall Study|Lost to Follow-up|6
5971405|NCT01120691|20650794|P1|Overall Study|Lost to Follow-up|5
5971406|NCT01120691|20650792|P3|Overall Study|Protocol deviation|12
5971407|NCT01120691|20650793|P2|Overall Study|Protocol deviation|12
5971408|NCT01120691|20650794|P1|Overall Study|Protocol deviation|13
5971409|NCT01120691|20650792|P3|Overall Study|Administrative problems|9
5971410|NCT01120691|20650793|P2|Overall Study|Administrative problems|8
5971411|NCT01120691|20650794|P1|Overall Study|Administrative problems|15
5971412|NCT01120691|20650792|P3|Overall Study|Unsatisfactory therapeutic effect|38
5971413|NCT01120691|20650793|P2|Overall Study|Unsatisfactory therapeutic effect|32
5971414|NCT01120691|20650794|P1|Overall Study|Unsatisfactory therapeutic effect|18
5971415|NCT01120691|20650792|P3|Overall Study|Death|24
5971416|NCT01120691|20650793|P2|Overall Study|Death|22
5971417|NCT01120691|20650794|P1|Overall Study|Death|21
5971418|NCT01120691|20650792|P3|Overall Study|Subject withdrew consent|44
5971419|NCT01120691|20650793|P2|Overall Study|Subject withdrew consent|50
5971420|NCT01120691|20650794|P1|Overall Study|Subject withdrew consent|33
5971421|NCT01120691|20650792|P3|Overall Study|Adverse Event|47
5971422|NCT01120691|20650793|P2|Overall Study|Adverse Event|67
5971423|NCT01120691|20650794|P1|Overall Study|Adverse Event|59
5971424|NCT01120626|20650891|P2|Overall Study|Withdrawal by Subject|0
5971425|NCT01120626|20650892|P1|Overall Study|Withdrawal by Subject|1
5971426|NCT01120600|20650902|P2|Overall Study|Withdrawal by Subject|11
5971427|NCT01120600|20650903|P1|Overall Study|Withdrawal by Subject|10
5971428|NCT01120600|20650902|P2|Overall Study|Protocol Violation|4
5971429|NCT01120600|20650903|P1|Overall Study|Protocol Violation|0
5971430|NCT01120600|20650902|P2|Overall Study|Physician Decision|3
5971431|NCT01120600|20650903|P1|Overall Study|Physician Decision|1
5971432|NCT01120600|20650902|P2|Overall Study|Lost to Follow-up|3
5971433|NCT01120600|20650903|P1|Overall Study|Lost to Follow-up|1
5971434|NCT01120600|20650902|P2|Overall Study|Excessive Bone Loss|4
5971435|NCT01120600|20650903|P1|Overall Study|Excessive Bone Loss|0
5971436|NCT01120600|20650902|P2|Overall Study|Adverse Event|7
5971437|NCT01120600|20650903|P1|Overall Study|Adverse Event|7
5971438|NCT01120379|20650958|P1|Four Year Timepoint|Any other reason for early termination|217
5971439|NCT01120379|20650958|P1|Four Year Timepoint|Physician Decision|5
5971440|NCT01120379|20650958|P1|Four Year Timepoint|Death|131
5971441|NCT01120379|20650958|P1|Four Year Timepoint|Lost to Follow-up|10
5971442|NCT01120379|20650958|P1|Four Year Timepoint|Withdrawal by Subject|5
5971443|NCT01120379|20650958|P1|Three Year Timepoint|Any other reason for early termination|17
5971444|NCT01120379|20650958|P1|Three Year Timepoint|Physician Decision|9
5971445|NCT01120379|20650958|P1|Three Year Timepoint|Death|120
5971446|NCT01120379|20650958|P1|Three Year Timepoint|Lost to Follow-up|43
5971447|NCT01120379|20650958|P1|Three Year Timepoint|Withdrawal by Subject|25
5971448|NCT01120379|20650958|P1|Two Year Timepoint|Any other reason for early termination|4
5971449|NCT01120379|20650958|P1|Two Year Timepoint|Physician Decision|12
5971450|NCT01120379|20650958|P1|Two Year Timepoint|Death|123
5971451|NCT01120379|20650958|P1|Two Year Timepoint|Lost to Follow-up|87
5971452|NCT01120379|20650958|P1|Two Year Timepoint|Withdrawal by Subject|11
5971453|NCT01120379|20650958|P1|One Year Timepoint|Any other reason for early termination|5
5971454|NCT01120379|20650958|P1|One Year Timepoint|Physician Decision|9
5971455|NCT01120379|20650958|P1|One Year Timepoint|Death|108
5971456|NCT01120379|20650958|P1|One Year Timepoint|Lost to Follow-up|115
5971457|NCT01120379|20650958|P1|One Year Timepoint|Withdrawal by Subject|41
5971458|NCT01120275|20650994|P1|Overall Study|Not specific|1
5971459|NCT01120275|20650994|P1|Overall Study|Refusal|1
5971460|NCT01120275|20650994|P1|Overall Study|Withdrawal by Subject|1
5971461|NCT01120275|20650994|P1|Overall Study|Ineligible|3
5971462|NCT01120275|20650994|P1|Overall Study|Progression|27
5971463|NCT01120275|20650994|P1|Overall Study|Adverse Event|3
5971464|NCT01120210|20651061|P2|MAIN INFUSION|Withdrawal by Subject|1
5971465|NCT01120210|20651062|P1|MAIN INFUSION|Withdrawal by Subject|0
5971466|NCT01120210|20651061|P2|MAIN INFUSION|Adverse Event|0
5971467|NCT01120210|20651062|P1|MAIN INFUSION|Adverse Event|1
5971468|NCT01120184|20651112|P3|Overall Study|Death|169
5971469|NCT01120184|20651113|P2|Overall Study|Death|176
5971470|NCT01120184|20651114|P1|Overall Study|Death|170
5971471|NCT01120184|20651112|P3|Overall Study|Subject/ Guardian Decision to Withdraw|25
5971472|NCT01120184|20651113|P2|Overall Study|Subject/ Guardian Decision to Withdraw|29
5971473|NCT01120184|20651114|P1|Overall Study|Subject/ Guardian Decision to Withdraw|32
5971474|NCT01120184|20651112|P3|Overall Study|Sponsor Decision to Terminate Study|143
5971475|NCT01120184|20651113|P2|Overall Study|Sponsor Decision to Terminate Study|144
5971476|NCT01120184|20651114|P1|Overall Study|Sponsor Decision to Terminate Study|133
5971477|NCT01120184|20651112|P3|Overall Study|Reason not Specified|12
5971478|NCT01120184|20651113|P2|Overall Study|Reason not Specified|3
5971479|NCT01120184|20651114|P1|Overall Study|Reason not Specified|8
5971480|NCT01120184|20651112|P3|Overall Study|Physician Decision|3
5971481|NCT01120184|20651113|P2|Overall Study|Physician Decision|1
5971482|NCT01120184|20651114|P1|Overall Study|Physician Decision|9
5971483|NCT01120184|20651112|P3|Overall Study|Lost to Follow-up|11
5971484|NCT01120184|20651113|P2|Overall Study|Lost to Follow-up|13
5971485|NCT01120184|20651114|P1|Overall Study|Lost to Follow-up|13
5971486|NCT01120184|20651112|P3|Overall Study|Adverse Event|0
5971487|NCT01120184|20651113|P2|Overall Study|Adverse Event|1
5971488|NCT01120184|20651114|P1|Overall Study|Adverse Event|0
5971489|NCT01120093|20651236|P5|Treatment Period 5|Adverse Event|0
5971490|NCT01120093|20651237|P4|Treatment Period 5|Adverse Event|1
5971491|NCT01120093|20651238|P3|Treatment Period 5|Adverse Event|0
5971492|NCT01120093|20651239|P2|Treatment Period 5|Adverse Event|1
5971493|NCT01120093|20651240|P1|Treatment Period 5|Adverse Event|0
5971494|NCT01120093|20651236|P5|Treatment Period 4|Adverse Event|0
5971495|NCT01120093|20651237|P4|Treatment Period 4|Adverse Event|0
5971496|NCT01120093|20651238|P3|Treatment Period 4|Adverse Event|0
5971497|NCT01120093|20651239|P2|Treatment Period 4|Adverse Event|0
5971498|NCT01120093|20651240|P1|Treatment Period 4|Adverse Event|1
5971499|NCT01120093|20651236|P5|Treatment Period 3|Withdrawal by Subject|0
5971500|NCT01120093|20651237|P4|Treatment Period 3|Withdrawal by Subject|0
5971501|NCT01120093|20651238|P3|Treatment Period 3|Withdrawal by Subject|1
5971502|NCT01120093|20651239|P2|Treatment Period 3|Withdrawal by Subject|0
5971503|NCT01120093|20651240|P1|Treatment Period 3|Withdrawal by Subject|0
5971504|NCT01120093|20651236|P5|Treatment Period 3|Adverse Event|1
5971505|NCT01120093|20651237|P4|Treatment Period 3|Adverse Event|0
5971506|NCT01120093|20651238|P3|Treatment Period 3|Adverse Event|0
5971507|NCT01120093|20651239|P2|Treatment Period 3|Adverse Event|0
5971508|NCT01120093|20651240|P1|Treatment Period 3|Adverse Event|0
5971509|NCT01120093|20651236|P5|Treatment Period 3|Lack of Efficacy|0
5971510|NCT01120093|20651237|P4|Treatment Period 3|Lack of Efficacy|1
5971511|NCT01120093|20651238|P3|Treatment Period 3|Lack of Efficacy|0
5971512|NCT01120093|20651239|P2|Treatment Period 3|Lack of Efficacy|0
5971513|NCT01120093|20651240|P1|Treatment Period 3|Lack of Efficacy|0
5971514|NCT01120093|20651236|P5|Treatment Period 2|Withdrawal by Subject|1
5971515|NCT01120093|20651237|P4|Treatment Period 2|Withdrawal by Subject|0
5971516|NCT01120093|20651238|P3|Treatment Period 2|Withdrawal by Subject|0
5971517|NCT01120093|20651239|P2|Treatment Period 2|Withdrawal by Subject|0
5971518|NCT01120093|20651240|P1|Treatment Period 2|Withdrawal by Subject|0
5971519|NCT01120093|20651236|P5|Treatment Period 2|Adverse Event|0
5971520|NCT01120093|20651237|P4|Treatment Period 2|Adverse Event|1
5971521|NCT01120093|20651238|P3|Treatment Period 2|Adverse Event|0
5971522|NCT01120093|20651239|P2|Treatment Period 2|Adverse Event|0
5971523|NCT01120093|20651240|P1|Treatment Period 2|Adverse Event|0
5971524|NCT01120093|20651236|P5|Treatment Period 1|Withdrawal by Subject|0
5971525|NCT01120093|20651237|P4|Treatment Period 1|Withdrawal by Subject|0
5971526|NCT01120093|20651238|P3|Treatment Period 1|Withdrawal by Subject|0
5971527|NCT01120093|20651239|P2|Treatment Period 1|Withdrawal by Subject|1
5971528|NCT01120093|20651240|P1|Treatment Period 1|Withdrawal by Subject|0
5971529|NCT01120093|20651236|P5|Treatment Period 1|Adverse Event|1
5971530|NCT01120093|20651237|P4|Treatment Period 1|Adverse Event|0
5971531|NCT01120093|20651238|P3|Treatment Period 1|Adverse Event|1
5971532|NCT01120093|20651239|P2|Treatment Period 1|Adverse Event|0
5971533|NCT01120093|20651240|P1|Treatment Period 1|Adverse Event|0
5971534|NCT01120067|20651269|P2|Overall Study|fail to engage >3 sessions|0
5971535|NCT01120067|20651270|P1|Overall Study|fail to engage >3 sessions|2
5971536|NCT01120067|20651269|P2|Overall Study|Lost to Follow-up|1
5971537|NCT01120067|20651270|P1|Overall Study|Lost to Follow-up|3
5971538|NCT01120028|20651280|P4|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0
5971539|NCT01120028|20651281|P3|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0
5971540|NCT01120028|20651282|P2|Period 1: Alemtuzumab or Basiliximab|Not transplanted|18
5971541|NCT01120028|20651283|P1|Period 1: Alemtuzumab or Basiliximab|Not transplanted|14
5971542|NCT01120028|20651280|P4|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0
5971543|NCT01120028|20651281|P3|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0
5971544|NCT01120028|20651282|P2|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|5
5971545|NCT01120028|20651283|P1|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0
5971546|NCT01119963|20651307|P2|Overall Study|Lost to Follow-up|1
5971547|NCT01119963|20651308|P1|Overall Study|Lost to Follow-up|1
5971548|NCT01119950|20651318|P1|Overall Study|Death|1
5971549|NCT01119950|20651318|P1|Overall Study|Abnormal lab value|1
5971550|NCT01119950|20651318|P1|Overall Study|Administrative|2
5971551|NCT01119950|20651318|P1|Overall Study|Lost to Follow-up|4
5971552|NCT01119950|20651318|P1|Overall Study|Protocol Violation|5
5971553|NCT01119950|20651318|P1|Overall Study|Withdrawal by Subject|9
5971554|NCT01119950|20651318|P1|Overall Study|Adverse Event|25
5971555|NCT01119937|20651565|P2|Overall Study|Withdrawal by Subject|1
5971556|NCT01119937|20651566|P1|Overall Study|Withdrawal by Subject|2
5971557|NCT01119937|20651565|P2|Overall Study|Unsatisfactory therapeutic effect|0
5971558|NCT01119937|20651566|P1|Overall Study|Unsatisfactory therapeutic effect|3
5971559|NCT01119937|20651565|P2|Overall Study|Protocol deviation|1
5971560|NCT01119937|20651566|P1|Overall Study|Protocol deviation|3
5971561|NCT01119937|20651565|P2|Overall Study|Adverse Event|5
5971562|NCT01119937|20651566|P1|Overall Study|Adverse Event|11
5971563|NCT01119898|20651594|P2|Overall Study|Randomized in error did not participate|0
5971564|NCT01119898|20651595|P1|Overall Study|Randomized in error did not participate|1
5971565|NCT01119898|20651594|P2|Overall Study|Medical procedure|0
5971566|NCT01119898|20651595|P1|Overall Study|Medical procedure|1
5971567|NCT01119898|20651594|P2|Overall Study|Protocol Violation|1
5971568|NCT01119898|20651595|P1|Overall Study|Protocol Violation|1
5971569|NCT01119898|20651594|P2|Overall Study|Lack of Efficacy|2
5971570|NCT01119898|20651595|P1|Overall Study|Lack of Efficacy|0
5971571|NCT01119898|20651594|P2|Overall Study|Withdrawal by Subject|4
5971572|NCT01119898|20651595|P1|Overall Study|Withdrawal by Subject|1
5971573|NCT01119898|20651594|P2|Overall Study|Adverse Event|5
5971574|NCT01119898|20651595|P1|Overall Study|Adverse Event|4
5971575|NCT01119859|20651621|P2|Overall Study|Failure to return|0
5971576|NCT01119859|20651622|P1|Overall Study|Failure to return|3
5971577|NCT01119859|20651621|P2|Overall Study|Refused treatment|6
5971578|NCT01119859|20651622|P1|Overall Study|Refused treatment|3
5971579|NCT01119859|20651621|P2|Overall Study|Insufficient therapeutic response|14
5971580|NCT01119859|20651622|P1|Overall Study|Insufficient therapeutic response|7
5971581|NCT01119859|20651621|P2|Overall Study|Death|0
5971582|NCT01119859|20651622|P1|Overall Study|Death|2
5971583|NCT01119859|20651621|P2|Overall Study|Adverse Event|10
5971584|NCT01119859|20651622|P1|Overall Study|Adverse Event|9
5971585|NCT01119846|20651641|P3|Overall Study|Withdrawal by Subject|4
5971586|NCT01119846|20651642|P2|Overall Study|Withdrawal by Subject|0
5971587|NCT01119846|20651643|P1|Overall Study|Withdrawal by Subject|0
5971588|NCT01119846|20651641|P3|Overall Study|Protocol Violation|1
5971589|NCT01119846|20651642|P2|Overall Study|Protocol Violation|0
5971590|NCT01119846|20651643|P1|Overall Study|Protocol Violation|0
5971591|NCT01119846|20651641|P3|Overall Study|Physician Decision|0
5971592|NCT01119846|20651642|P2|Overall Study|Physician Decision|0
5971593|NCT01119846|20651643|P1|Overall Study|Physician Decision|1
5971594|NCT01119846|20651641|P3|Overall Study|Adverse Event|6
5971595|NCT01119846|20651642|P2|Overall Study|Adverse Event|0
5971596|NCT01119846|20651643|P1|Overall Study|Adverse Event|1
5971597|NCT01119768|20651857|P2|Treatment Period|Lack of Efficacy|25
5971598|NCT01119768|20651858|P1|Treatment Period|Lack of Efficacy|18
5971599|NCT01119703|20651914|P2|Overall Study|Adverse Event|1
5971600|NCT01119703|20651915|P1|Overall Study|Adverse Event|0
5971601|NCT01119625|20651929|P2|Overall Study|Other|1
5971602|NCT01119625|20651930|P1|Overall Study|Other|0
5971603|NCT01119625|20651929|P2|Overall Study|Withdrawal by Subject|1
5971604|NCT01119625|20651930|P1|Overall Study|Withdrawal by Subject|2
5971605|NCT01119625|20651929|P2|Overall Study|Lost to Follow-up|2
5971606|NCT01119625|20651930|P1|Overall Study|Lost to Follow-up|1
5971607|NCT01119508|20651970|P1|Overall Study|Died before tumor response evaluation|1
5971608|NCT01119508|20651970|P1|Overall Study|Withdrawal by Subject|2
5971609|NCT01119508|20651970|P1|Overall Study|Adverse Event|56
5971610|NCT01119443|20652050|P2|Crossover Period 1 (5 Days)|Adverse Event|1
5971611|NCT01119443|20652051|P1|Crossover Period 1 (5 Days)|Adverse Event|0
5971612|NCT01119287|20652094|P6|Overall Study|Patient Decision, not related to AE|0
5971613|NCT01119287|20652095|P5|Overall Study|Patient Decision, not related to AE|1
5971614|NCT01119287|20652096|P4|Overall Study|Patient Decision, not related to AE|2
5971615|NCT01119287|20652097|P3|Overall Study|Patient Decision, not related to AE|2
5971616|NCT01119287|20652098|P2|Overall Study|Patient Decision, not related to AE|0
5971617|NCT01119287|20652099|P1|Overall Study|Patient Decision, not related to AE|0
5971618|NCT01119248|20652112|P1|Overall Study|Physician Decision|5
5971619|NCT01119131|20652162|P3|Overall Study|Physician Decision|1
5971620|NCT01119131|20652163|P2|Overall Study|Physician Decision|0
5971621|NCT01119131|20652164|P1|Overall Study|Physician Decision|0
5971622|NCT01119131|20652162|P3|Overall Study|Non-Compliance|4
5971623|NCT01119131|20652163|P2|Overall Study|Non-Compliance|0
5971624|NCT01119131|20652164|P1|Overall Study|Non-Compliance|1
5971625|NCT01119131|20652162|P3|Overall Study|Adverse Event|1
5971626|NCT01119131|20652163|P2|Overall Study|Adverse Event|1
5971627|NCT01119131|20652164|P1|Overall Study|Adverse Event|1
5971628|NCT01119118|20652193|P1|Overall Study|Adverse Event|1
5971629|NCT01119105|20652204|P3|Overall Study|Other|0
5971630|NCT01119105|20652205|P2|Overall Study|Other|1
5971631|NCT01119105|20652206|P1|Overall Study|Other|1
5971632|NCT01119105|20652204|P3|Overall Study|study drug missed on 2 consecutive days|1
5971633|NCT01119105|20652205|P2|Overall Study|study drug missed on 2 consecutive days|2
5971634|NCT01119105|20652206|P1|Overall Study|study drug missed on 2 consecutive days|1
5971635|NCT01119105|20652204|P3|Overall Study|Adverse Event|1
5971636|NCT01119105|20652205|P2|Overall Study|Adverse Event|0
5971637|NCT01119105|20652206|P1|Overall Study|Adverse Event|1
5971638|NCT01119105|20652204|P3|Overall Study|Lost to Follow-up|5
5971639|NCT01119105|20652205|P2|Overall Study|Lost to Follow-up|2
5971640|NCT01119105|20652206|P1|Overall Study|Lost to Follow-up|0
5971641|NCT01119105|20652204|P3|Overall Study|Withdrawal by Subject|1
5971642|NCT01119105|20652205|P2|Overall Study|Withdrawal by Subject|1
5971643|NCT01119105|20652206|P1|Overall Study|Withdrawal by Subject|1
5971644|NCT01119001|20652221|P1|Overall Study|Withdrawal by Subject|2
5971645|NCT01118975|20652265|P2|Overall Study|Adverse Event|1
5971646|NCT01118975|20652266|P1|Overall Study|Adverse Event|0
5971647|NCT01118962|20652272|P1|Overall Study|Non-compliance with Medicinal Product|1
5971648|NCT01118962|20652272|P1|Overall Study|Pregnancy|1
5971649|NCT01118962|20652272|P1|Overall Study|Withdrawal by Subject|4
5971650|NCT01118962|20652272|P1|Overall Study|Protocol Violation|1
5971651|NCT01118962|20652272|P1|Overall Study|Lack of Efficacy|1
5971652|NCT01118962|20652272|P1|Overall Study|Adverse Event|2
5971653|NCT01118949|20652277|P1|Overall Study|Withdrawal by Subject|4
5971654|NCT01118949|20652277|P1|Overall Study|Adverse Event|5
5971655|NCT01118780|20652307|P2|Overall Study|Withdrawal by Subject|8
5971656|NCT01118780|20652308|P1|Overall Study|Withdrawal by Subject|13
5971657|NCT01118780|20652307|P2|Overall Study|Protocol Violation|6
5971658|NCT01118780|20652308|P1|Overall Study|Protocol Violation|3
5971659|NCT01118780|20652307|P2|Overall Study|Physician Decision|0
5971660|NCT01118780|20652308|P1|Overall Study|Physician Decision|2
5971661|NCT01118780|20652307|P2|Overall Study|Lack of Efficacy|6
5971662|NCT01118780|20652308|P1|Overall Study|Lack of Efficacy|2
5971663|NCT01118780|20652307|P2|Overall Study|Death|0
5971664|NCT01118780|20652308|P1|Overall Study|Death|1
5971665|NCT01118780|20652307|P2|Overall Study|Adverse Event|15
5971666|NCT01118780|20652308|P1|Overall Study|Adverse Event|15
5971667|NCT01118728|20652366|P1|Overall Study|Lost to Follow-up|4
5971668|NCT01118728|20652366|P1|Overall Study|Withdrawal by Subject|3
5971669|NCT01118728|20652366|P1|Overall Study|Sponsor's decision to discontinue study|172
5971670|NCT01118728|20652366|P1|Overall Study|Lack of Efficacy|27
5971671|NCT01118728|20652366|P1|Overall Study|Adverse Event|17
5971672|NCT01118663|20652403|P2|Overall Study|Withdrawal by Subject|1
5971673|NCT01118663|20652404|P1|Overall Study|Withdrawal by Subject|0
5971674|NCT01118663|20652403|P2|Overall Study|Adverse Event|1
5971675|NCT01118663|20652404|P1|Overall Study|Adverse Event|2
5971676|NCT01118520|20652428|P3|Overall Study|Withdrawal by Subject|8
5971677|NCT01118520|20652429|P2|Overall Study|Withdrawal by Subject|13
5971678|NCT01118520|20652430|P1|Overall Study|Withdrawal by Subject|8
5971679|NCT01118520|20652428|P3|Overall Study|Adverse Event|3
5971680|NCT01118520|20652429|P2|Overall Study|Adverse Event|3
5971681|NCT01118520|20652430|P1|Overall Study|Adverse Event|3
5971682|NCT01118520|20652428|P3|Overall Study|AAA repair|9
5971683|NCT01118520|20652429|P2|Overall Study|AAA repair|7
5971684|NCT01118520|20652430|P1|Overall Study|AAA repair|9
5971685|NCT01118455|20652443|P2|Baseline [Visits 1 & 2]|Adverse Event|0
5971686|NCT01118455|20652444|P1|Baseline [Visits 1 & 2]|Adverse Event|1
5971687|NCT01118377|20652472|P1|Overall Study|Failure to Return|3
5971688|NCT01118377|20652472|P1|Overall Study|Death|38
5971689|NCT01118377|20652472|P1|Overall Study|Did Not Receive Study Medication|1
5971690|NCT01118351|20652478|P1|Overall Study|Withdrawal by Subject|1
5971691|NCT01118351|20652478|P1|Overall Study|Adverse Event|3
5971692|NCT01118325|20652502|P3|Overall Study|Adverse Event|1
5971693|NCT01118325|20652503|P2|Overall Study|Adverse Event|0
5971694|NCT01118325|20652504|P1|Overall Study|Adverse Event|1
5971695|NCT01118312|20652550|P2|Overall Study|Withdrawal by Subject|3
5971696|NCT01118312|20652551|P1|Overall Study|Withdrawal by Subject|1
5971697|NCT01118312|20652550|P2|Overall Study|Lost to Follow-up|32
5971698|NCT01118312|20652551|P1|Overall Study|Lost to Follow-up|33
5971699|NCT01118299|20652561|P2|Overall Study|Enrollment Closure, Protocol Amendment|15
5971700|NCT01118299|20652562|P1|Overall Study|Enrollment Closure, Protocol Amendment|6
5971701|NCT01118299|20652561|P2|Overall Study|Lost to Follow-up|1
5971702|NCT01118299|20652562|P1|Overall Study|Lost to Follow-up|2
5971703|NCT01118299|20652561|P2|Overall Study|Withdrawal by Subject|8
5971704|NCT01118299|20652562|P1|Overall Study|Withdrawal by Subject|8
5971705|NCT01118299|20652561|P2|Overall Study|Death|5
5971706|NCT01118299|20652562|P1|Overall Study|Death|7
5971707|NCT01118143|20652759|P2|Overall Study|Withdrawal by Subject|5
5971708|NCT01118143|20652760|P1|Overall Study|Withdrawal by Subject|2
5971709|NCT01118117|20652770|P2|Overall Study|Missed 12 Month Visit|0
5971710|NCT01118117|20652771|P1|Overall Study|Missed 12 Month Visit|7
5971711|NCT01118117|20652770|P2|Overall Study|Lost to Follow-up|0
5971712|NCT01118117|20652771|P1|Overall Study|Lost to Follow-up|6
5971713|NCT01118117|20652770|P2|Overall Study|Death|0
5971714|NCT01118117|20652771|P1|Overall Study|Death|8
5971715|NCT01118052|20652803|P1|Overall Study|Never treated|2
5971716|NCT01117987|20652826|P2|Overall Study|Administrative problems|22
5971717|NCT01117987|20652827|P1|Overall Study|Administrative problems|25
5971718|NCT01117987|20652826|P2|Overall Study|Adverse Event|26
5971719|NCT01117987|20652827|P1|Overall Study|Adverse Event|19
5971720|NCT01117987|20652826|P2|Overall Study|Withdrawal by Subject|10
5971721|NCT01117987|20652827|P1|Overall Study|Withdrawal by Subject|5
5971722|NCT01117987|20652826|P2|Overall Study|Death|10
5971723|NCT01117987|20652827|P1|Overall Study|Death|5
5971724|NCT01117987|20652826|P2|Overall Study|Lack of Efficacy|4
5971725|NCT01117987|20652827|P1|Overall Study|Lack of Efficacy|3
5971726|NCT01117987|20652826|P2|Overall Study|Abnormal test procedure result|0
5971727|NCT01117987|20652827|P1|Overall Study|Abnormal test procedure result|2
5971728|NCT01117987|20652826|P2|Overall Study|Lost to Follow-up|1
5971729|NCT01117987|20652827|P1|Overall Study|Lost to Follow-up|1
5971730|NCT01117987|20652826|P2|Overall Study|Subject no longer requires study drug|0
5971731|NCT01117987|20652827|P1|Overall Study|Subject no longer requires study drug|1
5971732|NCT01117987|20652826|P2|Overall Study|Protocol deviation|1
5971733|NCT01117987|20652827|P1|Overall Study|Protocol deviation|0
5971734|NCT01117870|20652848|P2|Overall Study|Inability to place needle|0
5971735|NCT01117870|20652849|P1|Overall Study|Inability to place needle|1
5971736|NCT01117857|20652863|P1|Overall Study|Physician Decision|1
5971737|NCT01117857|20652863|P1|Overall Study|Withdrawal by Subject|4
5971738|NCT01117857|20652863|P1|Overall Study|Lost to Follow-up|4
5971739|NCT01117766|20652871|P2|Second Intervention|Withdrawal by Subject|1
5971740|NCT01117766|20652872|P1|Second Intervention|Withdrawal by Subject|0
5971741|NCT01117766|20652871|P2|Second Intervention|Adverse Event|2
5971742|NCT01117766|20652872|P1|Second Intervention|Adverse Event|0
5971743|NCT01117766|20652871|P2|Second Intervention|Other|2
5971744|NCT01117766|20652872|P1|Second Intervention|Other|1
5971745|NCT01117766|20652871|P2|Second Intervention|Lost to Follow-up|0
5971746|NCT01117766|20652872|P1|Second Intervention|Lost to Follow-up|1
5971747|NCT01117766|20652871|P2|Washout Period|Protocol Violation|2
5971748|NCT01117766|20652872|P1|Washout Period|Protocol Violation|0
5971749|NCT01117766|20652871|P2|First Intervention|Protocol Violation|0
5971750|NCT01117766|20652872|P1|First Intervention|Protocol Violation|1
5971751|NCT01117766|20652871|P2|First Intervention|Adverse Event|1
5971752|NCT01117766|20652872|P1|First Intervention|Adverse Event|0
5971753|NCT01117623|20652909|P8|Overall Study|Invest. text: completed all planned txs|0
5971754|NCT01117623|20652910|P7|Overall Study|Invest. text: completed all planned txs|0
5971755|NCT01117623|20652911|P6|Overall Study|Invest. text: completed all planned txs|1
5971756|NCT01117623|20652912|P5|Overall Study|Invest. text: completed all planned txs|0
5971757|NCT01117623|20652913|P4|Overall Study|Invest. text: completed all planned txs|0
5971758|NCT01117623|20652914|P3|Overall Study|Invest. text: completed all planned txs|0
5971759|NCT01117623|20652915|P2|Overall Study|Invest. text: completed all planned txs|0
5971760|NCT01117623|20652916|P1|Overall Study|Invest. text: completed all planned txs|0
5971761|NCT01117623|20652909|P8|Overall Study|Non-compliance with study medication|1
5971762|NCT01117623|20652910|P7|Overall Study|Non-compliance with study medication|0
5971763|NCT01117623|20652911|P6|Overall Study|Non-compliance with study medication|0
5971764|NCT01117623|20652912|P5|Overall Study|Non-compliance with study medication|0
5971765|NCT01117623|20652913|P4|Overall Study|Non-compliance with study medication|0
5971766|NCT01117623|20652914|P3|Overall Study|Non-compliance with study medication|0
5971767|NCT01117623|20652915|P2|Overall Study|Non-compliance with study medication|0
5971768|NCT01117623|20652916|P1|Overall Study|Non-compliance with study medication|0
5971769|NCT01117623|20652909|P8|Overall Study|Withdrawal by Subject|1
5971770|NCT01117623|20652910|P7|Overall Study|Withdrawal by Subject|1
5971771|NCT01117623|20652911|P6|Overall Study|Withdrawal by Subject|1
5971772|NCT01117623|20652912|P5|Overall Study|Withdrawal by Subject|0
5971773|NCT01117623|20652913|P4|Overall Study|Withdrawal by Subject|0
5971774|NCT01117623|20652914|P3|Overall Study|Withdrawal by Subject|2
5971775|NCT01117623|20652915|P2|Overall Study|Withdrawal by Subject|0
5971776|NCT01117623|20652916|P1|Overall Study|Withdrawal by Subject|0
5971777|NCT01117623|20652909|P8|Overall Study|Disease progression, recurrence, relapse|22
5971778|NCT01117623|20652910|P7|Overall Study|Disease progression, recurrence, relapse|5
5971779|NCT01117623|20652911|P6|Overall Study|Disease progression, recurrence, relapse|14
5971780|NCT01117623|20652912|P5|Overall Study|Disease progression, recurrence, relapse|8
5971781|NCT01117623|20652913|P4|Overall Study|Disease progression, recurrence, relapse|6
5971782|NCT01117623|20652914|P3|Overall Study|Disease progression, recurrence, relapse|5
5971783|NCT01117623|20652915|P2|Overall Study|Disease progression, recurrence, relapse|6
5971784|NCT01117623|20652916|P1|Overall Study|Disease progression, recurrence, relapse|3
5971785|NCT01117623|20652909|P8|Overall Study|Adverse Event|2
5971786|NCT01117623|20652910|P7|Overall Study|Adverse Event|0
5971787|NCT01117623|20652911|P6|Overall Study|Adverse Event|0
5971788|NCT01117623|20652912|P5|Overall Study|Adverse Event|2
5971789|NCT01117623|20652913|P4|Overall Study|Adverse Event|0
5971790|NCT01117623|20652914|P3|Overall Study|Adverse Event|4
5971791|NCT01117623|20652915|P2|Overall Study|Adverse Event|2
5971792|NCT01117623|20652916|P1|Overall Study|Adverse Event|0
5971793|NCT01117480|20653068|P1|Overall Study|Did Not Start Adalimumab Therapy|20
5971794|NCT01117480|20653068|P1|Overall Study|Protocol Violation|8
5971795|NCT01117454|20653076|P2|Overall Study|Pregnancy|1
5971796|NCT01117454|20653077|P1|Overall Study|Pregnancy|0
5971797|NCT01117428|20653089|P6|Overall Study|Progressive disease|17
5971798|NCT01117428|20653090|P5|Overall Study|Progressive disease|16
5971799|NCT01117428|20653091|P4|Overall Study|Progressive disease|12
5971800|NCT01117428|20653092|P3|Overall Study|Progressive disease|10
5971801|NCT01117428|20653093|P2|Overall Study|Progressive disease|27
5971802|NCT01117428|20653094|P1|Overall Study|Progressive disease|15
5971803|NCT01117428|20653089|P6|Overall Study|Withdrawal by Subject|0
5971804|NCT01117428|20653090|P5|Overall Study|Withdrawal by Subject|0
5971805|NCT01117428|20653091|P4|Overall Study|Withdrawal by Subject|0
5971806|NCT01117428|20653092|P3|Overall Study|Withdrawal by Subject|1
5971807|NCT01117428|20653093|P2|Overall Study|Withdrawal by Subject|0
5971808|NCT01117428|20653094|P1|Overall Study|Withdrawal by Subject|0
5971809|NCT01117428|20653089|P6|Overall Study|Physician Decision|0
5971810|NCT01117428|20653090|P5|Overall Study|Physician Decision|0
5971811|NCT01117428|20653091|P4|Overall Study|Physician Decision|0
5971812|NCT01117428|20653092|P3|Overall Study|Physician Decision|0
5971813|NCT01117428|20653093|P2|Overall Study|Physician Decision|1
5971814|NCT01117428|20653094|P1|Overall Study|Physician Decision|0
5971815|NCT01117428|20653089|P6|Overall Study|Death|1
5971816|NCT01117428|20653090|P5|Overall Study|Death|0
5971817|NCT01117428|20653091|P4|Overall Study|Death|0
5971818|NCT01117428|20653092|P3|Overall Study|Death|2
5971819|NCT01117428|20653093|P2|Overall Study|Death|1
5971820|NCT01117428|20653094|P1|Overall Study|Death|0
5971821|NCT01117428|20653089|P6|Overall Study|Adverse Event|2
5971822|NCT01117428|20653090|P5|Overall Study|Adverse Event|1
5971823|NCT01117428|20653091|P4|Overall Study|Adverse Event|0
5971824|NCT01117428|20653092|P3|Overall Study|Adverse Event|0
5971825|NCT01117428|20653093|P2|Overall Study|Adverse Event|0
5971826|NCT01117428|20653094|P1|Overall Study|Adverse Event|4
5971827|NCT01117428|20653089|P6|Overall Study|Lack of Efficacy|0
5971828|NCT01117428|20653090|P5|Overall Study|Lack of Efficacy|0
5971829|NCT01117428|20653091|P4|Overall Study|Lack of Efficacy|0
5971830|NCT01117428|20653092|P3|Overall Study|Lack of Efficacy|0
5971831|NCT01117428|20653093|P2|Overall Study|Lack of Efficacy|0
5971832|NCT01117428|20653094|P1|Overall Study|Lack of Efficacy|1
5971833|NCT01117350|20653128|P2|Extension Period|Prohibited medication|1
5971834|NCT01117350|20653129|P1|Extension Period|Prohibited medication|0
5971835|NCT01117350|20653128|P2|Extension Period|Inclusion criteria not respected|1
5971836|NCT01117350|20653129|P1|Extension Period|Inclusion criteria not respected|0
5971837|NCT01117350|20653128|P2|Extension Period|Lack of Efficacy|2
5971838|NCT01117350|20653129|P1|Extension Period|Lack of Efficacy|0
5971839|NCT01117350|20653128|P2|Extension Period|Withdrawal by Subject|3
5971840|NCT01117350|20653129|P1|Extension Period|Withdrawal by Subject|0
5971841|NCT01117350|20653128|P2|Extension Period|Lost to Follow-up|2
5971842|NCT01117350|20653129|P1|Extension Period|Lost to Follow-up|0
5971843|NCT01117350|20653128|P2|Extension Period|Protocol Violation|2
5971844|NCT01117350|20653129|P1|Extension Period|Protocol Violation|0
5971845|NCT01117350|20653128|P2|Extension Period|Adverse Event|2
5971846|NCT01117350|20653129|P1|Extension Period|Adverse Event|0
5971847|NCT01117350|20653128|P2|Extension Period|Not included in extension, not treated|50
5971848|NCT01117350|20653129|P1|Extension Period|Not included in extension, not treated|0
5971849|NCT01117350|20653128|P2|Comparative Period|Move to another city/country|1
5971850|NCT01117350|20653129|P1|Comparative Period|Move to another city/country|2
5971851|NCT01117350|20653128|P2|Comparative Period|Physician Decision|1
5971852|NCT01117350|20653129|P1|Comparative Period|Physician Decision|0
5971853|NCT01117350|20653128|P2|Comparative Period|Lack of Efficacy|0
5971854|NCT01117350|20653129|P1|Comparative Period|Lack of Efficacy|1
5971855|NCT01117350|20653128|P2|Comparative Period|Protocol Violation|12
5971856|NCT01117350|20653129|P1|Comparative Period|Protocol Violation|8
5971857|NCT01117350|20653128|P2|Comparative Period|Withdrawal by Subject|13
5971858|NCT01117350|20653129|P1|Comparative Period|Withdrawal by Subject|9
5971859|NCT01117350|20653128|P2|Comparative Period|Lost to Follow-up|7
5971860|NCT01117350|20653129|P1|Comparative Period|Lost to Follow-up|11
5971861|NCT01117350|20653128|P2|Comparative Period|Adverse Event|33
5971862|NCT01117350|20653129|P1|Comparative Period|Adverse Event|6
5971863|NCT01117350|20653128|P2|Comparative Period|Not Treated|8
5971864|NCT01117350|20653129|P1|Comparative Period|Not Treated|5
5971865|NCT01117337|20653161|P2|Overall Study|Lost to Follow-up|0
5971866|NCT01117337|20653162|P1|Overall Study|Lost to Follow-up|4
5971867|NCT01117181|20653183|P2|Overall Study|Withdrawal by Subject|2
5971868|NCT01117181|20653184|P1|Overall Study|Withdrawal by Subject|0
5971869|NCT01117181|20653183|P2|Overall Study|Lost to Follow-up|0
5971870|NCT01117181|20653184|P1|Overall Study|Lost to Follow-up|1
5971871|NCT01117051|20653217|P2|Overall Study|Convenience issue|0
5971872|NCT01117051|20653218|P1|Overall Study|Convenience issue|1
5971873|NCT01117051|20653217|P2|Overall Study|Randomized by mistake|1
5971874|NCT01117051|20653218|P1|Overall Study|Randomized by mistake|0
5971875|NCT01117051|20653217|P2|Overall Study|Surgical procedure|1
5971876|NCT01117051|20653218|P1|Overall Study|Surgical procedure|0
5971877|NCT01117051|20653217|P2|Overall Study|Sponsor's decision|1
5971878|NCT01117051|20653218|P1|Overall Study|Sponsor's decision|3
5971879|NCT01117051|20653217|P2|Overall Study|Did not meet in-/exclusion criteria|1
5971880|NCT01117051|20653218|P1|Overall Study|Did not meet in-/exclusion criteria|0
5971881|NCT01117051|20653217|P2|Overall Study|Lost to Follow-up|1
5971882|NCT01117051|20653218|P1|Overall Study|Lost to Follow-up|0
5971883|NCT01117051|20653217|P2|Overall Study|Adverse Event|3
5971884|NCT01117051|20653218|P1|Overall Study|Adverse Event|4
5971885|NCT01117051|20653217|P2|Overall Study|Withdrawal by Subject|3
5971886|NCT01117051|20653218|P1|Overall Study|Withdrawal by Subject|5
5971887|NCT01117012|20653228|P2|Overall Study|Undefined|3
5971888|NCT01117012|20653229|P1|Overall Study|Undefined|4
5971889|NCT01117012|20653228|P2|Overall Study|Withdrawal by Subject|0
5971890|NCT01117012|20653229|P1|Overall Study|Withdrawal by Subject|3
5971891|NCT01117012|20653228|P2|Overall Study|Death|1
5971892|NCT01117012|20653229|P1|Overall Study|Death|1
5971893|NCT01117012|20653228|P2|Overall Study|Adverse Event|1
5971894|NCT01117012|20653229|P1|Overall Study|Adverse Event|0
5971895|NCT01116882|20653403|P2|12-month|Withdrawal by Subject|8
5971896|NCT01116882|20653404|P1|12-month|Withdrawal by Subject|5
5971897|NCT01116882|20653403|P2|12-month|Other Reasons|49
5971898|NCT01116882|20653404|P1|12-month|Other Reasons|151
5971899|NCT01116882|20653403|P2|12-month|Lost to Follow-up|42
5971900|NCT01116882|20653404|P1|12-month|Lost to Follow-up|111
5971901|NCT01116882|20653403|P2|30-day|Other Reasons|6
5971902|NCT01116882|20653404|P1|30-day|Other Reasons|16
5971903|NCT01116882|20653403|P2|30-day|Withdrawal by Subject|4
5971904|NCT01116882|20653404|P1|30-day|Withdrawal by Subject|2
5971905|NCT01116882|20653403|P2|30-day|Lost to Follow-up|21
5971906|NCT01116882|20653404|P1|30-day|Lost to Follow-up|50
5971907|NCT01116687|20653442|P1|Overall Study|Withdrawal by Subject|4
5971923|NCT01116544|20653510|P2|Overall Study|Withdrawal by Subject|1
5971924|NCT01116544|20653511|P1|Overall Study|Withdrawal by Subject|1
5971925|NCT01116544|20653510|P2|Overall Study|Protocol Violation|0
5971926|NCT01116544|20653511|P1|Overall Study|Protocol Violation|1
5971927|NCT01116440|20653537|P2|Follow-up|Withdrawal by Subject|1
5971928|NCT01116440|20653538|P1|Follow-up|Withdrawal by Subject|0
5971929|NCT01116440|20653537|P2|Follow-up|Lost to Follow-up|1
5971930|NCT01116440|20653538|P1|Follow-up|Lost to Follow-up|0
5971931|NCT01116440|20653537|P2|Withdrawal|Lost to Follow-up|1
5971932|NCT01116440|20653538|P1|Withdrawal|Lost to Follow-up|0
5971933|NCT01116440|20653537|P2|Withdrawal|Withdrawal by Subject|1
5971934|NCT01116440|20653538|P1|Withdrawal|Withdrawal by Subject|0
5971935|NCT01116440|20653537|P2|Treatment|Adverse Event|1
5971936|NCT01116440|20653538|P1|Treatment|Adverse Event|0
5971937|NCT01116440|20653537|P2|Treatment|Lack of Efficacy|1
5971938|NCT01116440|20653538|P1|Treatment|Lack of Efficacy|0
5971939|NCT01116440|20653537|P2|Treatment|Protocol Violation|2
5971940|NCT01116440|20653538|P1|Treatment|Protocol Violation|0
5971941|NCT01116440|20653537|P2|Treatment|Lost to Follow-up|1
5971942|NCT01116440|20653538|P1|Treatment|Lost to Follow-up|1
5971943|NCT01116440|20653537|P2|Treatment|Withdrawal by Subject|2
5971944|NCT01116440|20653538|P1|Treatment|Withdrawal by Subject|2
5971945|NCT01116427|20653554|P2|Extension Phase|Not using appropriate birth control|0
5971946|NCT01116427|20653555|P1|Extension Phase|Not using appropriate birth control|1
5971947|NCT01116427|20653554|P2|Extension Phase|Withdrawal by Subject|1
5971948|NCT01116427|20653555|P1|Extension Phase|Withdrawal by Subject|5
5971949|NCT01116427|20653554|P2|Extension Phase|Lost to Follow-up|0
5971950|NCT01116427|20653555|P1|Extension Phase|Lost to Follow-up|2
5971951|NCT01116427|20653554|P2|Extension Phase|Adverse Event|1
5971952|NCT01116427|20653555|P1|Extension Phase|Adverse Event|1
5971953|NCT01116427|20653554|P2|Core Phase|Worsening Multiple Sclerosis|0
5971954|NCT01116427|20653555|P1|Core Phase|Worsening Multiple Sclerosis|1
5971955|NCT01116427|20653554|P2|Core Phase|Withdrawal by Subject|0
5971956|NCT01116427|20653555|P1|Core Phase|Withdrawal by Subject|3
5971957|NCT01116427|20653554|P2|Core Phase|Lost to Follow-up|0
5971958|NCT01116427|20653555|P1|Core Phase|Lost to Follow-up|1
5971959|NCT01116427|20653554|P2|Core Phase|Adverse Event|1
5971960|NCT01116427|20653555|P1|Core Phase|Adverse Event|0
5971961|NCT01116232|20653596|P1|Overall Study|Progressive diease|4
5971962|NCT01115998|20653710|P2|Overall Study|Lost to Follow-up|6
5971963|NCT01115998|20653711|P1|Overall Study|Lost to Follow-up|6
5971964|NCT01115933|20653721|P1|Overall Study|Did not receive XIENCE PRIME SV|1
5971965|NCT01115855|20653818|P2|Overall Study|Other|6
5971966|NCT01115855|20653819|P1|Overall Study|Other|8
5971967|NCT01115855|20653818|P2|Overall Study|Withdrawal by Subject|5
5971968|NCT01115855|20653819|P1|Overall Study|Withdrawal by Subject|5
5971969|NCT01115855|20653818|P2|Overall Study|Protocol Violation|1
5971970|NCT01115855|20653819|P1|Overall Study|Protocol Violation|0
5971971|NCT01115855|20653818|P2|Overall Study|Lab Abnormality|1
5971972|NCT01115855|20653819|P1|Overall Study|Lab Abnormality|1
5971973|NCT01115855|20653818|P2|Overall Study|Death|5
5971974|NCT01115855|20653819|P1|Overall Study|Death|6
5971975|NCT01115855|20653818|P2|Overall Study|Adverse Event|18
5971976|NCT01115855|20653819|P1|Overall Study|Adverse Event|16
5971977|NCT01115803|20653874|P7|Overall Study|Progressive Disease during Cycle1|1
5971978|NCT01115803|20653875|P6|Overall Study|Progressive Disease during Cycle1|0
5971979|NCT01115803|20653876|P5|Overall Study|Progressive Disease during Cycle1|0
5971980|NCT01115803|20653877|P4|Overall Study|Progressive Disease during Cycle1|0
5971981|NCT01115803|20653878|P3|Overall Study|Progressive Disease during Cycle1|0
5971982|NCT01115803|20653879|P2|Overall Study|Progressive Disease during Cycle1|0
5971983|NCT01115803|20653880|P1|Overall Study|Progressive Disease during Cycle1|0
5971984|NCT01115803|20653874|P7|Overall Study|Lost to Follow-up|0
5971985|NCT01115803|20653875|P6|Overall Study|Lost to Follow-up|0
5971986|NCT01115803|20653876|P5|Overall Study|Lost to Follow-up|0
5971987|NCT01115803|20653877|P4|Overall Study|Lost to Follow-up|0
5971988|NCT01115803|20653878|P3|Overall Study|Lost to Follow-up|1
5971989|NCT01115803|20653879|P2|Overall Study|Lost to Follow-up|0
5971990|NCT01115803|20653880|P1|Overall Study|Lost to Follow-up|0
5971991|NCT01115803|20653874|P7|Overall Study|Withdrawal by Subject|1
5971992|NCT01115803|20653875|P6|Overall Study|Withdrawal by Subject|0
5971993|NCT01115803|20653876|P5|Overall Study|Withdrawal by Subject|0
5971994|NCT01115803|20653877|P4|Overall Study|Withdrawal by Subject|0
5971995|NCT01115803|20653878|P3|Overall Study|Withdrawal by Subject|0
5971996|NCT01115803|20653879|P2|Overall Study|Withdrawal by Subject|0
5971997|NCT01115803|20653880|P1|Overall Study|Withdrawal by Subject|0
5971998|NCT01115738|20653943|P3|Overall Study|Withdrawal by Subject|9
5971999|NCT01115738|20653944|P2|Overall Study|Withdrawal by Subject|6
5972000|NCT01115738|20653945|P1|Overall Study|Withdrawal by Subject|6
5972001|NCT01115738|20653943|P3|Overall Study|Physician Decision|17
5972002|NCT01115738|20653944|P2|Overall Study|Physician Decision|15
5972003|NCT01115738|20653945|P1|Overall Study|Physician Decision|18
5972004|NCT01115738|20653943|P3|Overall Study|Lost to Follow-up|1
5972005|NCT01115738|20653944|P2|Overall Study|Lost to Follow-up|0
5972006|NCT01115738|20653945|P1|Overall Study|Lost to Follow-up|0
5972007|NCT01115738|20653943|P3|Overall Study|Death|0
5972008|NCT01115738|20653944|P2|Overall Study|Death|0
5972009|NCT01115738|20653945|P1|Overall Study|Death|1
5972010|NCT01115569|20654143|P2|Maintenance Phase|Administrative|1
5972011|NCT01115569|20654144|P1|Maintenance Phase|Administrative|0
5972012|NCT01115569|20654143|P2|Maintenance Phase|Non-Compliance with Study Drug|48
5972013|NCT01115569|20654144|P1|Maintenance Phase|Non-Compliance with Study Drug|0
5972014|NCT01115569|20654143|P2|Maintenance Phase|Withdrawal by Subject|27
5972015|NCT01115569|20654144|P1|Maintenance Phase|Withdrawal by Subject|0
5972016|NCT01115569|20654143|P2|Maintenance Phase|Protocol Violation|9
5972017|NCT01115569|20654144|P1|Maintenance Phase|Protocol Violation|0
5972018|NCT01115569|20654143|P2|Maintenance Phase|Physician Decision|3
5972019|NCT01115569|20654144|P1|Maintenance Phase|Physician Decision|0
5972020|NCT01115569|20654143|P2|Maintenance Phase|Lost to Follow-up|8
5972021|NCT01115569|20654144|P1|Maintenance Phase|Lost to Follow-up|0
5972022|NCT01115569|20654143|P2|Maintenance Phase|Adverse Event|43
5972023|NCT01115569|20654144|P1|Maintenance Phase|Adverse Event|0
5972024|NCT01115569|20654143|P2|Conversion/Titration Phase|Non-Compliance with Study Drug|0
5972025|NCT01115569|20654144|P1|Conversion/Titration Phase|Non-Compliance with Study Drug|53
5972026|NCT01115569|20654143|P2|Conversion/Titration Phase|Withdrawal by Subject|0
5972027|NCT01115569|20654144|P1|Conversion/Titration Phase|Withdrawal by Subject|26
5972028|NCT01115569|20654143|P2|Conversion/Titration Phase|Protocol Violation|0
5972029|NCT01115569|20654144|P1|Conversion/Titration Phase|Protocol Violation|68
5972030|NCT01115569|20654143|P2|Conversion/Titration Phase|Physician Decision|0
5972031|NCT01115569|20654144|P1|Conversion/Titration Phase|Physician Decision|5
5972032|NCT01115569|20654143|P2|Conversion/Titration Phase|Lost to Follow-up|0
5972033|NCT01115569|20654144|P1|Conversion/Titration Phase|Lost to Follow-up|3
5972034|NCT01115569|20654143|P2|Conversion/Titration Phase|Adverse Event|0
5972035|NCT01115569|20654144|P1|Conversion/Titration Phase|Adverse Event|59
5972036|NCT01115491|20654173|P1|Overall Study|Physician Decision|1
5972037|NCT01115491|20654173|P1|Overall Study|Withdrawal by Subject|1
5972038|NCT01115491|20654173|P1|Overall Study|Lost to Follow-up|3
5972039|NCT01115491|20654173|P1|Overall Study|Adverse Event|3
5972040|NCT01115491|20654173|P1|Overall Study|Death|22
5972041|NCT01115309|20654232|P1|Long-term Follow-up|Lost to Follow-up|6
5972042|NCT01115309|20654232|P1|Procedure Safety (1-Month)|Withdrawal by Subject|1
5972043|NCT01115309|20654232|P1|Procedure Safety (1-Month)|Lost to Follow-up|2
5972044|NCT01114880|20654399|P2|Period 2 (Week 12 to Week 24)|Lost to Follow-up|2
5972045|NCT01114880|20654400|P1|Period 2 (Week 12 to Week 24)|Lost to Follow-up|0
5972046|NCT01114880|20654399|P2|Period 2 (Week 12 to Week 24)|Adverse Event|0
5972047|NCT01114880|20654400|P1|Period 2 (Week 12 to Week 24)|Adverse Event|3
5972048|NCT01114880|20654399|P2|Period 1 (Week 0 to Week 12)|Poor subject compliance|1
5972049|NCT01114880|20654400|P1|Period 1 (Week 0 to Week 12)|Poor subject compliance|0
5972050|NCT01114880|20654399|P2|Period 1 (Week 0 to Week 12)|Lost to Follow-up|1
5972051|NCT01114880|20654400|P1|Period 1 (Week 0 to Week 12)|Lost to Follow-up|0
5972052|NCT01114880|20654399|P2|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|0
5972053|NCT01114880|20654400|P1|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|1
5972054|NCT01114880|20654399|P2|Period 1 (Week 0 to Week 12)|Adverse Event|0
5972055|NCT01114880|20654400|P1|Period 1 (Week 0 to Week 12)|Adverse Event|4
5972056|NCT01114828|20654452|P2|Overall Study|Withdrawal by Subject|1
5972057|NCT01114828|20654453|P1|Overall Study|Withdrawal by Subject|0
5972058|NCT01114828|20654452|P2|Overall Study|Protocol Violation|0
5972059|NCT01114828|20654453|P1|Overall Study|Protocol Violation|2
5972060|NCT01114828|20654452|P2|Overall Study|Lack of Efficacy|2
5972061|NCT01114828|20654453|P1|Overall Study|Lack of Efficacy|0
5972062|NCT01114828|20654452|P2|Overall Study|Adverse Event|1
5972063|NCT01114828|20654453|P1|Overall Study|Adverse Event|1
5972064|NCT01114737|20654463|P2|Open-Label Treatment Period|Difficult Personal Events|0
5972065|NCT01114737|20654464|P1|Open-Label Treatment Period|Difficult Personal Events|1
5972066|NCT01114737|20654463|P2|Open-Label Treatment Period|Lost to Follow-up|1
5972067|NCT01114737|20654464|P1|Open-Label Treatment Period|Lost to Follow-up|3
5972068|NCT01114737|20654463|P2|Open-Label Treatment Period|Withdrawal by Subject|1
5972069|NCT01114737|20654464|P1|Open-Label Treatment Period|Withdrawal by Subject|1
5972070|NCT01114737|20654463|P2|Randomized Treatment Period|Pregnancy|0
5972071|NCT01114737|20654464|P1|Randomized Treatment Period|Pregnancy|1
5972072|NCT01114737|20654463|P2|Randomized Treatment Period|Lost to Follow-up|1
5972073|NCT01114737|20654464|P1|Randomized Treatment Period|Lost to Follow-up|1
5972074|NCT01114737|20654463|P2|Randomized Treatment Period|Withdrawal by Subject|0
5972075|NCT01114737|20654464|P1|Randomized Treatment Period|Withdrawal by Subject|1
5972076|NCT01114724|20654512|P1|Overall Study|Withdrawal by Subject|1
5972077|NCT01114724|20654512|P1|Overall Study|Lost to Follow-up|1
5972078|NCT01114724|20654512|P1|Overall Study|Death|8
5972079|NCT01114672|20654532|P2|Overall Study|transplanted|0
5972080|NCT01114672|20654533|P1|Overall Study|transplanted|1
5972081|NCT01114672|20654532|P2|Overall Study|Lost to Follow-up|0
5972082|NCT01114672|20654533|P1|Overall Study|Lost to Follow-up|1
5972083|NCT01114672|20654532|P2|Overall Study|Withdrawal by Subject|1
5972084|NCT01114672|20654533|P1|Overall Study|Withdrawal by Subject|2
5972085|NCT01114672|20654532|P2|Overall Study|Death|1
5972086|NCT01114672|20654533|P1|Overall Study|Death|0
5972087|NCT01114646|20654541|P2|Overall Study|Withdrawal by Subject|2
5972088|NCT01114646|20654542|P1|Overall Study|Withdrawal by Subject|3
5972089|NCT01114529|20654602|P3|Completed Study Phase at Month 24|Missing|0
5972090|NCT01114529|20654603|P2|Completed Study Phase at Month 24|Missing|0
5972091|NCT01114529|20654604|P1|Completed Study Phase at Month 24|Missing|2
5972092|NCT01114529|20654602|P3|Completed Study Phase at Month 24|Other|0
5972093|NCT01114529|20654603|P2|Completed Study Phase at Month 24|Other|0
5972094|NCT01114529|20654604|P1|Completed Study Phase at Month 24|Other|2
5972095|NCT01114529|20654602|P3|Completed Study Phase at Month 24|Death|4
5972096|NCT01114529|20654603|P2|Completed Study Phase at Month 24|Death|5
5972097|NCT01114529|20654604|P1|Completed Study Phase at Month 24|Death|8
5972098|NCT01114529|20654602|P3|Completed Study Phase at Month 24|Lost to Follow-up|7
5972099|NCT01114529|20654603|P2|Completed Study Phase at Month 24|Lost to Follow-up|5
5972100|NCT01114529|20654604|P1|Completed Study Phase at Month 24|Lost to Follow-up|10
5972101|NCT01114529|20654602|P3|Completed Study Phase at Month 24|Withdrawal by Subject|3
5972102|NCT01114529|20654603|P2|Completed Study Phase at Month 24|Withdrawal by Subject|6
5972103|NCT01114529|20654604|P1|Completed Study Phase at Month 24|Withdrawal by Subject|18
5972104|NCT01114529|20654602|P3|Completed Study Medication at Month 24|Missing|0
5972105|NCT01114529|20654603|P2|Completed Study Medication at Month 24|Missing|0
5972106|NCT01114529|20654604|P1|Completed Study Medication at Month 24|Missing|2
5972107|NCT01114529|20654602|P3|Completed Study Medication at Month 24|Protocol Violation|2
5972108|NCT01114529|20654603|P2|Completed Study Medication at Month 24|Protocol Violation|5
5972109|NCT01114529|20654604|P1|Completed Study Medication at Month 24|Protocol Violation|0
5972110|NCT01114529|20654602|P3|Completed Study Medication at Month 24|Graft loss|0
5972111|NCT01114529|20654603|P2|Completed Study Medication at Month 24|Graft loss|2
5972112|NCT01114529|20654604|P1|Completed Study Medication at Month 24|Graft loss|0
5972113|NCT01114529|20654602|P3|Completed Study Medication at Month 24|Death|2
5972114|NCT01114529|20654603|P2|Completed Study Medication at Month 24|Death|1
5972115|NCT01114529|20654604|P1|Completed Study Medication at Month 24|Death|2
5972116|NCT01114529|20654602|P3|Completed Study Medication at Month 24|Administrative problems|2
5972117|NCT01114529|20654603|P2|Completed Study Medication at Month 24|Administrative problems|1
5972118|NCT01114529|20654604|P1|Completed Study Medication at Month 24|Administrative problems|2
5972119|NCT01114529|20654602|P3|Completed Study Medication at Month 24|Lost to Follow-up|2
5972120|NCT01114529|20654603|P2|Completed Study Medication at Month 24|Lost to Follow-up|4
5972121|NCT01114529|20654604|P1|Completed Study Medication at Month 24|Lost to Follow-up|1
5972122|NCT01114529|20654602|P3|Completed Study Medication at Month 24|Withdrawal by Subject|2
5972123|NCT01114529|20654603|P2|Completed Study Medication at Month 24|Withdrawal by Subject|8
5972124|NCT01114529|20654604|P1|Completed Study Medication at Month 24|Withdrawal by Subject|18
5972125|NCT01114529|20654602|P3|Completed Study Medication at Month 24|Subject's no longer required drug|1
5972126|NCT01114529|20654603|P2|Completed Study Medication at Month 24|Subject's no longer required drug|1
5972127|NCT01114529|20654604|P1|Completed Study Medication at Month 24|Subject's no longer required drug|1
5972128|NCT01114529|20654602|P3|Completed Study Medication at Month 24|Lack of Efficacy|2
5972129|NCT01114529|20654603|P2|Completed Study Medication at Month 24|Lack of Efficacy|1
5972130|NCT01114529|20654604|P1|Completed Study Medication at Month 24|Lack of Efficacy|2
5972131|NCT01114529|20654602|P3|Completed Study Medication at Month 24|Abnormal test procedure result(s)|1
5972132|NCT01114529|20654603|P2|Completed Study Medication at Month 24|Abnormal test procedure result(s)|0
5972133|NCT01114529|20654604|P1|Completed Study Medication at Month 24|Abnormal test procedure result(s)|3
5972134|NCT01114529|20654602|P3|Completed Study Medication at Month 24|Abnormal laboratory value(s)|1
5972135|NCT01114529|20654603|P2|Completed Study Medication at Month 24|Abnormal laboratory value(s)|0
5972136|NCT01114529|20654604|P1|Completed Study Medication at Month 24|Abnormal laboratory value(s)|6
5972137|NCT01114529|20654602|P3|Completed Study Medication at Month 24|Adverse Event|17
5972138|NCT01114529|20654603|P2|Completed Study Medication at Month 24|Adverse Event|18
5972139|NCT01114529|20654604|P1|Completed Study Medication at Month 24|Adverse Event|87
5972140|NCT01114516|20654623|P2|Overall Study|Lost to Follow-up|1
5972141|NCT01114516|20654624|P1|Overall Study|Lost to Follow-up|2
5972142|NCT01114438|20654659|P1|Overall Study|Withdrawal by Subject|2
5972143|NCT01114438|20654659|P1|Overall Study|Physician Decision|1
5972144|NCT01114438|20654659|P1|Overall Study|concomitant medication|1
5972145|NCT01114438|20654659|P1|Overall Study|Adverse Event|10
5972146|NCT01114373|20654669|P2|Intervention 2 (4 Weeks)|Lost to Follow-up|1
5972147|NCT01114373|20654670|P1|Intervention 2 (4 Weeks)|Lost to Follow-up|0
5972148|NCT01114373|20654669|P2|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|0
5972149|NCT01114373|20654670|P1|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|1
5972150|NCT01114373|20654669|P2|Intervention 1 (4 Weeks)|Incarceration|0
5972151|NCT01114373|20654670|P1|Intervention 1 (4 Weeks)|Incarceration|1
5972152|NCT01114373|20654669|P2|Intervention 1 (4 Weeks)|Lost to Follow-up|0
5972153|NCT01114373|20654670|P1|Intervention 1 (4 Weeks)|Lost to Follow-up|1
5972154|NCT01114360|20654702|P2|Intervention 1 (4 Weeks)|Physician Decision|1
5972155|NCT01114360|20654703|P1|Intervention 1 (4 Weeks)|Physician Decision|0
5972156|NCT01114217|20654754|P2|Overall Study|Other-Withdrawal by Subject|1
5972157|NCT01114217|20654755|P1|Overall Study|Other-Withdrawal by Subject|1
5972158|NCT01114217|20654754|P2|Overall Study|Other-Lost to Follow-up|0
5972159|NCT01114217|20654755|P1|Overall Study|Other-Lost to Follow-up|1
5972160|NCT01114217|20654754|P2|Overall Study|Other-Site Stopped Communicating|0
5972161|NCT01114217|20654755|P1|Overall Study|Other-Site Stopped Communicating|2
5972162|NCT01114217|20654754|P2|Overall Study|Other-Study Withdrawn|1
5972163|NCT01114217|20654755|P1|Overall Study|Other-Study Withdrawn|1
5972164|NCT01114217|20654754|P2|Overall Study|Other-Study Termination|1
5972165|NCT01114217|20654755|P1|Overall Study|Other-Study Termination|0
5972166|NCT01114217|20654754|P2|Overall Study|Other-Sponsor Decision|12
5972167|NCT01114217|20654755|P1|Overall Study|Other-Sponsor Decision|10
5972168|NCT01114217|20654754|P2|Overall Study|Other-Physician Decision|1
5972169|NCT01114217|20654755|P1|Overall Study|Other-Physician Decision|1
5972170|NCT01114217|20654754|P2|Overall Study|Other-Non Compliance|0
5972171|NCT01114217|20654755|P1|Overall Study|Other-Non Compliance|2
5972172|NCT01114217|20654754|P2|Overall Study|Other-Lack of Efficacy|0
5972173|NCT01114217|20654755|P1|Overall Study|Other-Lack of Efficacy|1
5972174|NCT01114217|20654754|P2|Overall Study|Other-Protocol Violation|3
5972175|NCT01114217|20654755|P1|Overall Study|Other-Protocol Violation|1
5972176|NCT01114217|20654754|P2|Overall Study|Other-Pregnancy|4
5972177|NCT01114217|20654755|P1|Overall Study|Other-Pregnancy|2
5972178|NCT01114217|20654754|P2|Overall Study|Other-Procedure|1
5972179|NCT01114217|20654755|P1|Overall Study|Other-Procedure|1
5972180|NCT01114217|20654754|P2|Overall Study|Other-Early termination|10
5972181|NCT01114217|20654755|P1|Overall Study|Other-Early termination|6
5972182|NCT01114217|20654754|P2|Overall Study|Other-Clerical Error|0
5972183|NCT01114217|20654755|P1|Overall Study|Other-Clerical Error|3
5972184|NCT01114217|20654754|P2|Overall Study|Withdrawal by Subject|28
5972185|NCT01114217|20654755|P1|Overall Study|Withdrawal by Subject|21
5972186|NCT01114217|20654754|P2|Overall Study|Lost to Follow-up|33
5972187|NCT01114217|20654755|P1|Overall Study|Lost to Follow-up|17
5972188|NCT01114217|20654754|P2|Overall Study|Adverse Event|3
5972189|NCT01114217|20654755|P1|Overall Study|Adverse Event|5
5972190|NCT01114204|20654767|P2|Overall Study|Other-Protocol Violation|0
5972191|NCT01114204|20654768|P1|Overall Study|Other-Protocol Violation|1
5972192|NCT01114204|20654767|P2|Overall Study|Other-Participant request|0
5972193|NCT01114204|20654768|P1|Overall Study|Other-Participant request|2
5972194|NCT01114204|20654767|P2|Overall Study|Other-Medical monitor request|0
5972195|NCT01114204|20654768|P1|Overall Study|Other-Medical monitor request|1
5972196|NCT01114204|20654767|P2|Overall Study|Other-Personal reasons|0
5972197|NCT01114204|20654768|P1|Overall Study|Other-Personal reasons|2
5972198|NCT01114204|20654767|P2|Overall Study|Death|0
5972199|NCT01114204|20654768|P1|Overall Study|Death|1
5972200|NCT01114204|20654767|P2|Overall Study|Withdrawal by Subject|6
5972201|NCT01114204|20654768|P1|Overall Study|Withdrawal by Subject|10
5972202|NCT01114204|20654767|P2|Overall Study|Lost to Follow-up|0
5972203|NCT01114204|20654768|P1|Overall Study|Lost to Follow-up|1
5972204|NCT01114204|20654767|P2|Overall Study|Adverse Event|2
5972205|NCT01114204|20654768|P1|Overall Study|Adverse Event|3
5972206|NCT01114139|20654786|P2|Overall Study|Other-Withdrew prior to receiving dose|3
5972207|NCT01114139|20654787|P1|Overall Study|Other-Withdrew prior to receiving dose|1
5972208|NCT01114139|20654786|P2|Overall Study|Other-Physician changed treatment|0
5972209|NCT01114139|20654787|P1|Overall Study|Other-Physician changed treatment|1
5972210|NCT01114139|20654786|P2|Overall Study|Other-Participant went on hospice|1
5972211|NCT01114139|20654787|P1|Overall Study|Other-Participant went on hospice|0
5972212|NCT01114139|20654786|P2|Overall Study|Other-Participant falsified records|1
5972213|NCT01114139|20654787|P1|Overall Study|Other-Participant falsified records|0
5972214|NCT01114139|20654786|P2|Overall Study|Other-Out of window for study drug dose|0
5972215|NCT01114139|20654787|P1|Overall Study|Other-Out of window for study drug dose|1
5972216|NCT01114139|20654786|P2|Overall Study|Other-Protocol Violation|0
5972217|NCT01114139|20654787|P1|Overall Study|Other-Protocol Violation|1
5972218|NCT01114139|20654786|P2|Overall Study|Other-Missed 1 visit|0
5972219|NCT01114139|20654787|P1|Overall Study|Other-Missed 1 visit|1
5972220|NCT01114139|20654786|P2|Overall Study|Withdrawal by Subject|6
5972221|NCT01114139|20654787|P1|Overall Study|Withdrawal by Subject|17
5972222|NCT01114139|20654786|P2|Overall Study|Lost to Follow-up|3
5972223|NCT01114139|20654787|P1|Overall Study|Lost to Follow-up|15
5972224|NCT01114139|20654786|P2|Overall Study|Adverse Event|2
5972225|NCT01114139|20654787|P1|Overall Study|Adverse Event|3
5972226|NCT01113931|20654816|P2|Overall Study|Withdrawal by Subject|0
5972227|NCT01113931|20654817|P1|Overall Study|Withdrawal by Subject|3
5972228|NCT01113931|20654816|P2|Overall Study|Various|4
5972229|NCT01113931|20654817|P1|Overall Study|Various|2
5972230|NCT01113931|20654816|P2|Overall Study|Lost to Follow-up|9
5972231|NCT01113931|20654817|P1|Overall Study|Lost to Follow-up|12
5972232|NCT01113931|20654816|P2|Overall Study|Physician Decision|2
5972233|NCT01113931|20654817|P1|Overall Study|Physician Decision|0
5972234|NCT01113931|20654816|P2|Overall Study|Adverse Event|2
5972235|NCT01113931|20654817|P1|Overall Study|Adverse Event|2
5972236|NCT01113892|20654831|P2|Overall Study|Graft no longer evaluable|9
5972237|NCT01113892|20654832|P1|Overall Study|Graft no longer evaluable|9
5972238|NCT01113892|20654831|P2|Overall Study|Death|4
5972239|NCT01113892|20654832|P1|Overall Study|Death|2
5972240|NCT01113892|20654831|P2|Overall Study|Withdrawal by Subject|1
5972241|NCT01113892|20654832|P1|Overall Study|Withdrawal by Subject|1
5972242|NCT01113892|20654831|P2|Overall Study|Lost to Follow-up|2
5972243|NCT01113892|20654832|P1|Overall Study|Lost to Follow-up|2
5972244|NCT01113879|20654860|P2|Period 1: Block 1|Withdrawal by Subject|0
5972245|NCT01113879|20654861|P1|Period 1: Block 1|Withdrawal by Subject|2
5972246|NCT01113801|20654873|P4|Overall Study|Clinical Endpoint (ESRD)|5
5972247|NCT01113801|20654874|P3|Overall Study|Clinical Endpoint (ESRD)|2
5972248|NCT01113801|20654875|P2|Overall Study|Clinical Endpoint (ESRD)|4
5972249|NCT01113801|20654876|P1|Overall Study|Clinical Endpoint (ESRD)|7
5972250|NCT01113801|20654873|P4|Overall Study|Sponsor Decision|15
5972251|NCT01113801|20654874|P3|Overall Study|Sponsor Decision|20
5972252|NCT01113801|20654875|P2|Overall Study|Sponsor Decision|21
5972253|NCT01113801|20654876|P1|Overall Study|Sponsor Decision|15
5972254|NCT01113801|20654873|P4|Overall Study|Physician Decision|3
5972255|NCT01113801|20654874|P3|Overall Study|Physician Decision|3
5972256|NCT01113801|20654875|P2|Overall Study|Physician Decision|2
5972257|NCT01113801|20654876|P1|Overall Study|Physician Decision|2
5972258|NCT01113801|20654873|P4|Overall Study|Withdrawal by Subject|8
5972259|NCT01113801|20654874|P3|Overall Study|Withdrawal by Subject|7
5972260|NCT01113801|20654875|P2|Overall Study|Withdrawal by Subject|7
5972261|NCT01113801|20654876|P1|Overall Study|Withdrawal by Subject|9
5972262|NCT01113801|20654873|P4|Overall Study|Protocol Violation|0
5972263|NCT01113801|20654874|P3|Overall Study|Protocol Violation|0
5972264|NCT01113801|20654875|P2|Overall Study|Protocol Violation|1
5972265|NCT01113801|20654876|P1|Overall Study|Protocol Violation|0
5972266|NCT01113801|20654873|P4|Overall Study|Death|4
5972267|NCT01113801|20654874|P3|Overall Study|Death|3
5972268|NCT01113801|20654875|P2|Overall Study|Death|5
5972269|NCT01113801|20654876|P1|Overall Study|Death|4
5972270|NCT01113801|20654873|P4|Overall Study|Adverse Event|6
5972271|NCT01113801|20654874|P3|Overall Study|Adverse Event|2
5972272|NCT01113801|20654875|P2|Overall Study|Adverse Event|0
5972273|NCT01113801|20654876|P1|Overall Study|Adverse Event|4
5972274|NCT01113749|20654904|P2|Overall Study|Lost to Follow-up|2
5972275|NCT01113749|20654905|P1|Overall Study|Lost to Follow-up|1
5972276|NCT01113710|20654928|P1|Overall Study|Subject Did Not Receive Neupro|3
5972277|NCT01113710|20654928|P1|Overall Study|Compliance/Subject Withdrawal/AE|1
5972278|NCT01113710|20654928|P1|Overall Study|Lack of Patient's Compliance/Other|1
5972279|NCT01113710|20654928|P1|Overall Study|Compliance/Lost to Follow up/Efficacy/AE|1
5972280|NCT01113710|20654928|P1|Overall Study|Compliance/Efficacy/Subject Withdrawal|1
5972281|NCT01113710|20654928|P1|Overall Study|Compliance/Efficacy/AE/Other|1
5972282|NCT01113710|20654928|P1|Overall Study|Compliance/Efficacy/Adverse Event|1
5972283|NCT01113710|20654928|P1|Overall Study|Efficacy/Withdrawal by Subject/Other|1
5972284|NCT01113710|20654928|P1|Overall Study|Lost to Follow up/Withdrawal by Subject|2
5972285|NCT01113710|20654928|P1|Overall Study|Compliance/Lost to Follow up/Pt Withdraw|2
5972286|NCT01113710|20654928|P1|Overall Study|Efficacy/Subject Withdrawal/AE|2
5972287|NCT01113710|20654928|P1|Overall Study|Lack of Efficacy/Adverse Event|3
5972288|NCT01113710|20654928|P1|Overall Study|Patient Compliance/Withdrawal by Subject|4
5972289|NCT01113710|20654928|P1|Overall Study|Lack of Efficacy/Other|4
5972290|NCT01113710|20654928|P1|Overall Study|Patient's Compliance/Lost to Follow up|5
5972291|NCT01113710|20654928|P1|Overall Study|Adverse Event/Other|5
5972292|NCT01113710|20654928|P1|Overall Study|Other|7
5972293|NCT01113710|20654928|P1|Overall Study|Lack of Patient's Compliance|8
5972294|NCT01113710|20654928|P1|Overall Study|Withdrawal by Subject/Adverse Event|11
5972295|NCT01113710|20654928|P1|Overall Study|Lack of Efficacy/Withdrawal by Subject|13
5972296|NCT01113710|20654928|P1|Overall Study|Lost to Follow-up|20
5972297|NCT01113710|20654928|P1|Overall Study|Withdrawal by Subject|28
5972298|NCT01113710|20654928|P1|Overall Study|No Information Available|40
5972299|NCT01113710|20654928|P1|Overall Study|Lack of Efficacy|41
5972300|NCT01113710|20654928|P1|Overall Study|Adverse Event|64
5972301|NCT01113580|20654956|P2|Overall Study|Protocol Violation|0
5972302|NCT01113580|20654957|P1|Overall Study|Protocol Violation|1
5972303|NCT01113541|20654971|P1|Overall Study|Adverse Event|4
5972304|NCT01113541|20654971|P1|Overall Study|Study Terminated by Sponsor|7
5972305|NCT01113541|20654971|P1|Overall Study|Protocol Violation|1
5972306|NCT01113541|20654971|P1|Overall Study|Withdrawal by Subject|1
5972307|NCT01113463|20655004|P1|Overall Study|Physician Decision|5
5972308|NCT01112982|20655034|P1|Overall Study|exceeded weight limit to complete MRI|1
5972309|NCT01112982|20655034|P1|Overall Study|Withdrawal by Subject|1
5972310|NCT01112917|20655046|P2|Overall Study|Unable to Convert Filter|0
5972311|NCT01112917|20655047|P1|Overall Study|Unable to Convert Filter|3
5972312|NCT01112917|20655046|P2|Overall Study|Withdrawal by Subject|3
5972313|NCT01112917|20655047|P1|Overall Study|Withdrawal by Subject|1
5972314|NCT01112917|20655046|P2|Overall Study|Lost to Follow-up|1
5972315|NCT01112917|20655047|P1|Overall Study|Lost to Follow-up|1
5972316|NCT01112917|20655046|P2|Overall Study|Death|11
5972317|NCT01112917|20655047|P1|Overall Study|Death|2
5972318|NCT01112579|20655151|P2|Overall Study|Death|2
5972319|NCT01112579|20655152|P1|Overall Study|Death|0
5972320|NCT01112579|20655151|P2|Overall Study|Missed Visit|1
5972321|NCT01112579|20655152|P1|Overall Study|Missed Visit|1
5972322|NCT01112514|20655162|P1|Overall Study|Lost to Follow-up|1
5972323|NCT01112267|20655218|P2|Overall Study|Participants not receive any study drug|2
5972324|NCT01112267|20655219|P1|Overall Study|Participants not receive any study drug|1
5972325|NCT01112267|20655218|P2|Overall Study|Participants not compliant|2
5972326|NCT01112267|20655219|P1|Overall Study|Participants not compliant|1
5972327|NCT01112267|20655218|P2|Overall Study|Protocol Violation|3
5972328|NCT01112267|20655219|P1|Overall Study|Protocol Violation|5
5972329|NCT01112267|20655218|P2|Overall Study|Withdrawal by Subject|5
5972330|NCT01112267|20655219|P1|Overall Study|Withdrawal by Subject|3
5972331|NCT01112267|20655218|P2|Overall Study|Adverse Event|6
5972332|NCT01112267|20655219|P1|Overall Study|Adverse Event|24
5972333|NCT01112059|20655258|P2|Overall Study|Withdrawal by Subject|0
5972334|NCT01112059|20655259|P1|Overall Study|Withdrawal by Subject|1
5972335|NCT01111851|20655273|P2|Overall Study|All planned PET scans were not obtained.|0
5972336|NCT01111851|20655274|P1|Overall Study|All planned PET scans were not obtained.|2
5972337|NCT01111838|20655286|P1|Overall Study|Other Complicating Disease|1
5972338|NCT01111838|20655286|P1|Overall Study|Clinical deterioration|1
5972339|NCT01111838|20655286|P1|Overall Study|Not Treated|3
5972340|NCT01111838|20655286|P1|Overall Study|Patient Ineligible|2
5972341|NCT01111825|20655294|P4|Overall Study|Discontinuation by Sponsor|20
5972342|NCT01111825|20655295|P3|Overall Study|Discontinuation by Sponsor|0
5972343|NCT01111825|20655296|P2|Overall Study|Discontinuation by Sponsor|0
5972344|NCT01111825|20655297|P1|Overall Study|Discontinuation by Sponsor|0
5972345|NCT01111825|20655294|P4|Overall Study|Disease Progression|0
5972346|NCT01111825|20655295|P3|Overall Study|Disease Progression|0
5972347|NCT01111825|20655296|P2|Overall Study|Disease Progression|0
5972348|NCT01111825|20655297|P1|Overall Study|Disease Progression|1
5972349|NCT01111825|20655294|P4|Overall Study|Adverse Event|0
5972350|NCT01111825|20655295|P3|Overall Study|Adverse Event|4
5972351|NCT01111825|20655296|P2|Overall Study|Adverse Event|1
5972352|NCT01111825|20655297|P1|Overall Study|Adverse Event|2
5972353|NCT01111825|20655294|P4|Overall Study|Lost to Follow-up|1
5972354|NCT01111825|20655295|P3|Overall Study|Lost to Follow-up|3
5972355|NCT01111825|20655296|P2|Overall Study|Lost to Follow-up|0
5972356|NCT01111825|20655297|P1|Overall Study|Lost to Follow-up|0
5972357|NCT01111825|20655294|P4|Overall Study|Withdrawal by Subject|0
5972358|NCT01111825|20655295|P3|Overall Study|Withdrawal by Subject|1
5972359|NCT01111825|20655296|P2|Overall Study|Withdrawal by Subject|0
5972360|NCT01111825|20655297|P1|Overall Study|Withdrawal by Subject|0
5972361|NCT01111604|20655319|P3|Overall Study|Met Exclusion Criteria|0
5972362|NCT01111604|20655320|P2|Overall Study|Met Exclusion Criteria|0
5972363|NCT01111604|20655321|P1|Overall Study|Met Exclusion Criteria|2
5972364|NCT01111604|20655319|P3|Overall Study|Death|0
5972365|NCT01111604|20655320|P2|Overall Study|Death|0
5972366|NCT01111604|20655321|P1|Overall Study|Death|1
5972367|NCT01111604|20655319|P3|Overall Study|Withdrawal by Subject|0
5972368|NCT01111604|20655320|P2|Overall Study|Withdrawal by Subject|0
5972369|NCT01111604|20655321|P1|Overall Study|Withdrawal by Subject|2
5972370|NCT01111604|20655319|P3|Overall Study|Withdrew Consent|2
5972371|NCT01111604|20655320|P2|Overall Study|Withdrew Consent|0
5972372|NCT01111604|20655321|P1|Overall Study|Withdrew Consent|3
5972373|NCT01111604|20655319|P3|Overall Study|Lost to Follow-up|1
5972374|NCT01111604|20655320|P2|Overall Study|Lost to Follow-up|0
5972375|NCT01111604|20655321|P1|Overall Study|Lost to Follow-up|0
5972376|NCT01111526|20655359|P3|Overall Study|GVHD Disease Progression|2
5972377|NCT01111526|20655360|P2|Overall Study|GVHD Disease Progression|1
5972378|NCT01111526|20655361|P1|Overall Study|GVHD Disease Progression|0
5972379|NCT01111474|20655373|P1|Overall Study|Lost to Follow-up|12
5972380|NCT01111461|20655381|P1|Overall Study|Other|6
5972381|NCT01111461|20655381|P1|Overall Study|Withdrawal by Subject|1
5972382|NCT01111461|20655381|P1|Overall Study|Lost to Follow-up|1
5972383|NCT01111461|20655381|P1|Overall Study|Participant choice|11
5972384|NCT01111461|20655381|P1|Overall Study|Adverse Event|32
5972385|NCT01111292|20655561|P2|Treatment|Physician Decision|1
5972386|NCT01111292|20655562|P1|Treatment|Physician Decision|1
5972387|NCT01111240|20655568|P1|Overall Study|Other|312
5972388|NCT01111240|20655568|P1|Overall Study|Lack of Efficacy and Adverse Event|19
5972389|NCT01111240|20655568|P1|Overall Study|Lack of Efficacy|545
5972390|NCT01111240|20655568|P1|Overall Study|Adverse Event|190
5972391|NCT01111149|20655598|P3|Overall Study|Withdrawal by Subject|2
5972392|NCT01111149|20655599|P2|Overall Study|Withdrawal by Subject|0
5972393|NCT01111149|20655600|P1|Overall Study|Withdrawal by Subject|1
5972394|NCT01111149|20655598|P3|Overall Study|Protocol Violation|2
5972395|NCT01111149|20655599|P2|Overall Study|Protocol Violation|1
5972396|NCT01111149|20655600|P1|Overall Study|Protocol Violation|1
5972397|NCT01111123|20655676|P2|Maintenance Phase|Lost to Follow-up|2
5972398|NCT01111123|20655677|P1|Maintenance Phase|Lost to Follow-up|0
5972399|NCT01111123|20655676|P2|Open- Label Phase|Failed to be clear or almost cleared|0
5972400|NCT01111123|20655677|P1|Open- Label Phase|Failed to be clear or almost cleared|14
5972401|NCT01111019|20655723|P1|Overall Study|Other|1
5972402|NCT01111019|20655723|P1|Overall Study|Withdrew Prematurely|2
5972403|NCT01110915|20655755|P2|Overall Study|Withdrawal by Subject|1
5972404|NCT01110915|20655756|P1|Overall Study|Withdrawal by Subject|7
5972405|NCT01110915|20655755|P2|Overall Study|Lost to Follow-up|0
5972406|NCT01110915|20655756|P1|Overall Study|Lost to Follow-up|1
5972407|NCT01110915|20655755|P2|Overall Study|Death|1
5972408|NCT01110915|20655756|P1|Overall Study|Death|2
5972409|NCT01110707|20655773|P2|Overall Study|Protocol Violation|3
5972410|NCT01110707|20655774|P1|Overall Study|Protocol Violation|0
5972411|NCT01110408|20655875|P2|Overall Study|Protocol Violation|0
5972412|NCT01110408|20655876|P1|Overall Study|Protocol Violation|1
5972413|NCT01110382|20655900|P2|Overall Study|Protocol Violation|1
5972414|NCT01110382|20655901|P1|Overall Study|Protocol Violation|0
5972415|NCT01110382|20655900|P2|Overall Study|Withdrawal by Subject|1
5972416|NCT01110382|20655901|P1|Overall Study|Withdrawal by Subject|0
5972417|NCT01110330|20655922|P3|Overall Study|Other|1
5972418|NCT01110330|20655923|P2|Overall Study|Other|1
5972419|NCT01110330|20655924|P1|Overall Study|Other|1
5972420|NCT01110330|20655922|P3|Overall Study|Withdrawal by Subject|2
5972421|NCT01110330|20655923|P2|Overall Study|Withdrawal by Subject|6
5972422|NCT01110330|20655924|P1|Overall Study|Withdrawal by Subject|0
5972423|NCT01110330|20655922|P3|Overall Study|Protocol Violation|4
5972424|NCT01110330|20655923|P2|Overall Study|Protocol Violation|0
5972425|NCT01110330|20655924|P1|Overall Study|Protocol Violation|2
5972426|NCT01110330|20655922|P3|Overall Study|Physician Decision|0
5972427|NCT01110330|20655923|P2|Overall Study|Physician Decision|1
5972428|NCT01110330|20655924|P1|Overall Study|Physician Decision|0
5972429|NCT01110330|20655922|P3|Overall Study|Lost to Follow-up|15
5972430|NCT01110330|20655923|P2|Overall Study|Lost to Follow-up|10
5972431|NCT01110330|20655924|P1|Overall Study|Lost to Follow-up|9
5972432|NCT01110330|20655922|P3|Overall Study|Lack of Efficacy|1
5972433|NCT01110330|20655923|P2|Overall Study|Lack of Efficacy|1
5972434|NCT01110330|20655924|P1|Overall Study|Lack of Efficacy|3
5972435|NCT01110330|20655922|P3|Overall Study|Adverse Event|3
5972436|NCT01110330|20655923|P2|Overall Study|Adverse Event|4
5972437|NCT01110330|20655924|P1|Overall Study|Adverse Event|0
5972438|NCT01110239|20655952|P4|7.5 Min Ischemia|Withdrawal by Subject|0
5972439|NCT01110239|20655953|P3|7.5 Min Ischemia|Withdrawal by Subject|1
5972440|NCT01110239|20655954|P2|7.5 Min Ischemia|Withdrawal by Subject|0
5972441|NCT01110239|20655955|P1|7.5 Min Ischemia|Withdrawal by Subject|0
5972442|NCT01110239|20655952|P4|Sham Preconditioning|Withdrawal by Subject|0
5972443|NCT01110239|20655953|P3|Sham Preconditioning|Withdrawal by Subject|1
5972444|NCT01110239|20655954|P2|Sham Preconditioning|Withdrawal by Subject|0
5972445|NCT01110239|20655955|P1|Sham Preconditioning|Withdrawal by Subject|0
5972446|NCT01110200|20655971|P2|Overall Study|Lost to Follow-up|7
5972447|NCT01110200|20655972|P1|Overall Study|Lost to Follow-up|10
5972448|NCT01110200|20655971|P2|Overall Study|Physician Decision|17
5972449|NCT01110200|20655972|P1|Overall Study|Physician Decision|13
5972450|NCT01110200|20655971|P2|Overall Study|Protocol Violation|12
5972451|NCT01110200|20655972|P1|Overall Study|Protocol Violation|14
5972452|NCT01110200|20655971|P2|Overall Study|Lack of Efficacy|25
5972453|NCT01110200|20655972|P1|Overall Study|Lack of Efficacy|16
5972454|NCT01110200|20655971|P2|Overall Study|Withdrawal by Subject|32
5972455|NCT01110200|20655972|P1|Overall Study|Withdrawal by Subject|25
5972456|NCT01110200|20655971|P2|Overall Study|Adverse Event|28
5972457|NCT01110200|20655972|P1|Overall Study|Adverse Event|28
5972458|NCT01110005|20656008|P2|Overall Study|Withdrawal by Subject|1
5972459|NCT01110005|20656009|P1|Overall Study|Withdrawal by Subject|0
5972460|NCT01110005|20656008|P2|Overall Study|missing consent|2
5972461|NCT01110005|20656009|P1|Overall Study|missing consent|3
5972462|NCT01110005|20656008|P2|Overall Study|ineligible|2
5972463|NCT01110005|20656009|P1|Overall Study|ineligible|1
5972464|NCT01109992|20656021|P2|Overall Study|Movement during rest scan.|1
5972465|NCT01109992|20656022|P1|Overall Study|Movement during rest scan.|0
5972466|NCT01109992|20656021|P2|Overall Study|Withdrawal by Subject|1
5972467|NCT01109992|20656022|P1|Overall Study|Withdrawal by Subject|0
5972468|NCT01109979|20656036|P2|Overall Study|Withdrawal by Subject|1
5972469|NCT01109979|20656037|P1|Overall Study|Withdrawal by Subject|0
5972470|NCT01109979|20656036|P2|Overall Study|Physician Decision|0
5972471|NCT01109979|20656037|P1|Overall Study|Physician Decision|2
5972472|NCT01109849|20656045|P5|Adaptive Randomization: Weight Recovery|moved away|0
5972473|NCT01109849|20656046|P4|Adaptive Randomization: Weight Recovery|moved away|2
5972474|NCT01109849|20656047|P3|Adaptive Randomization: Weight Recovery|moved away|0
5972475|NCT01109849|20656048|P2|Adaptive Randomization: Weight Recovery|moved away|0
5972476|NCT01109849|20656049|P1|Adaptive Randomization: Weight Recovery|moved away|0
5972477|NCT01109849|20656045|P5|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1
5972478|NCT01109849|20656046|P4|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1
5972479|NCT01109849|20656047|P3|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1
5972480|NCT01109849|20656048|P2|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0
5972481|NCT01109849|20656049|P1|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0
5972482|NCT01109849|20656045|P5|Initial Randomization: ADHD Treatment|move away|0
5972483|NCT01109849|20656046|P4|Initial Randomization: ADHD Treatment|move away|0
5972484|NCT01109849|20656047|P3|Initial Randomization: ADHD Treatment|move away|0
5972485|NCT01109849|20656048|P2|Initial Randomization: ADHD Treatment|move away|7
5972486|NCT01109849|20656049|P1|Initial Randomization: ADHD Treatment|move away|2
5972487|NCT01109849|20656045|P5|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0
5972488|NCT01109849|20656046|P4|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0
5972489|NCT01109849|20656047|P3|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0
5972490|NCT01109849|20656048|P2|Initial Randomization: ADHD Treatment|Withdrawal by Subject|7
5972491|NCT01109849|20656049|P1|Initial Randomization: ADHD Treatment|Withdrawal by Subject|6
5972492|NCT01109849|20656045|P5|Initial Randomization: ADHD Treatment|Protocol Violation|0
5972493|NCT01109849|20656046|P4|Initial Randomization: ADHD Treatment|Protocol Violation|0
5972494|NCT01109849|20656047|P3|Initial Randomization: ADHD Treatment|Protocol Violation|0
5972495|NCT01109849|20656048|P2|Initial Randomization: ADHD Treatment|Protocol Violation|0
5972496|NCT01109849|20656049|P1|Initial Randomization: ADHD Treatment|Protocol Violation|1
5972497|NCT01109849|20656045|P5|Initial Randomization: ADHD Treatment|Lost to Follow-up|0
5972498|NCT01109849|20656046|P4|Initial Randomization: ADHD Treatment|Lost to Follow-up|0
5972499|NCT01109849|20656047|P3|Initial Randomization: ADHD Treatment|Lost to Follow-up|0
5972500|NCT01109849|20656048|P2|Initial Randomization: ADHD Treatment|Lost to Follow-up|35
5972501|NCT01109849|20656049|P1|Initial Randomization: ADHD Treatment|Lost to Follow-up|9
5972502|NCT01109524|20656118|P1|Overall Study|Other|5
5972503|NCT01109524|20656118|P1|Overall Study|Participant requested to end treatment|4
5972504|NCT01109524|20656118|P1|Overall Study|No longer meets criteria|2
5972505|NCT01109524|20656118|P1|Overall Study|Death|2
5972506|NCT01109524|20656118|P1|Overall Study|Maximum clinical benefit|3
5972507|NCT01109524|20656118|P1|Overall Study|Withdrawal by Subject|2
5972508|NCT01109524|20656118|P1|Overall Study|Adverse Event|4
5972509|NCT01109524|20656118|P1|Overall Study|Study Drug toxicity|6
5972510|NCT01109524|20656118|P1|Overall Study|Disease Progression|29
5972511|NCT01109316|20656140|P6|Study Period 3|Withdrawal by Subject|0
5972512|NCT01109316|20656141|P5|Study Period 3|Withdrawal by Subject|1
5972513|NCT01109316|20656142|P4|Study Period 3|Withdrawal by Subject|0
5972514|NCT01109316|20656143|P3|Study Period 3|Withdrawal by Subject|0
5972515|NCT01109316|20656144|P2|Study Period 3|Withdrawal by Subject|0
5972516|NCT01109316|20656145|P1|Study Period 3|Withdrawal by Subject|1
5972517|NCT01109316|20656140|P6|Study Period 3|Lost to Follow-up|0
5972518|NCT01109316|20656141|P5|Study Period 3|Lost to Follow-up|1
5972519|NCT01109316|20656142|P4|Study Period 3|Lost to Follow-up|0
5972520|NCT01109316|20656143|P3|Study Period 3|Lost to Follow-up|0
5972521|NCT01109316|20656144|P2|Study Period 3|Lost to Follow-up|0
5972522|NCT01109316|20656145|P1|Study Period 3|Lost to Follow-up|0
5972523|NCT01109316|20656140|P6|Study Period 2|Withdrawal by Subject|1
5972524|NCT01109316|20656141|P5|Study Period 2|Withdrawal by Subject|0
5972525|NCT01109316|20656142|P4|Study Period 2|Withdrawal by Subject|0
5972526|NCT01109316|20656143|P3|Study Period 2|Withdrawal by Subject|1
5972527|NCT01109316|20656144|P2|Study Period 2|Withdrawal by Subject|0
5972528|NCT01109316|20656145|P1|Study Period 2|Withdrawal by Subject|0
5972529|NCT01109316|20656140|P6|Study Period 2|Protocol Violation|0
5972530|NCT01109316|20656141|P5|Study Period 2|Protocol Violation|0
5972531|NCT01109316|20656142|P4|Study Period 2|Protocol Violation|0
5972532|NCT01109316|20656143|P3|Study Period 2|Protocol Violation|0
5972533|NCT01109316|20656144|P2|Study Period 2|Protocol Violation|0
5972534|NCT01109316|20656145|P1|Study Period 2|Protocol Violation|1
5972535|NCT01109316|20656140|P6|Study Period 2|Physician Decision|0
5972536|NCT01109316|20656141|P5|Study Period 2|Physician Decision|0
5972537|NCT01109316|20656142|P4|Study Period 2|Physician Decision|1
5972538|NCT01109316|20656143|P3|Study Period 2|Physician Decision|0
5972539|NCT01109316|20656144|P2|Study Period 2|Physician Decision|0
5972540|NCT01109316|20656145|P1|Study Period 2|Physician Decision|0
5972541|NCT01109316|20656140|P6|Study Period 2|Entry Criteria Not Met|0
5972542|NCT01109316|20656141|P5|Study Period 2|Entry Criteria Not Met|0
5972543|NCT01109316|20656142|P4|Study Period 2|Entry Criteria Not Met|0
5972544|NCT01109316|20656143|P3|Study Period 2|Entry Criteria Not Met|0
5972545|NCT01109316|20656144|P2|Study Period 2|Entry Criteria Not Met|1
5972546|NCT01109316|20656145|P1|Study Period 2|Entry Criteria Not Met|0
5972547|NCT01109316|20656140|P6|Study Period 1|Sponsor Decision|2
5972548|NCT01109316|20656141|P5|Study Period 1|Sponsor Decision|0
5972549|NCT01109316|20656142|P4|Study Period 1|Sponsor Decision|0
5972550|NCT01109316|20656143|P3|Study Period 1|Sponsor Decision|0
5972551|NCT01109316|20656144|P2|Study Period 1|Sponsor Decision|0
5972552|NCT01109316|20656145|P1|Study Period 1|Sponsor Decision|0
5972553|NCT01109316|20656140|P6|Study Period 1|Withdrawal by Subject|0
5972554|NCT01109316|20656141|P5|Study Period 1|Withdrawal by Subject|2
5972555|NCT01109316|20656142|P4|Study Period 1|Withdrawal by Subject|0
5972556|NCT01109316|20656143|P3|Study Period 1|Withdrawal by Subject|1
5972557|NCT01109316|20656144|P2|Study Period 1|Withdrawal by Subject|0
5972558|NCT01109316|20656145|P1|Study Period 1|Withdrawal by Subject|0
5972559|NCT01109316|20656140|P6|Study Period 1|Lost to Follow-up|0
5972560|NCT01109316|20656141|P5|Study Period 1|Lost to Follow-up|0
5972561|NCT01109316|20656142|P4|Study Period 1|Lost to Follow-up|1
5972562|NCT01109316|20656143|P3|Study Period 1|Lost to Follow-up|1
5972563|NCT01109316|20656144|P2|Study Period 1|Lost to Follow-up|0
5972564|NCT01109316|20656145|P1|Study Period 1|Lost to Follow-up|0
5972565|NCT01109316|20656140|P6|Study Period 1|Adverse Event|0
5972566|NCT01109316|20656141|P5|Study Period 1|Adverse Event|0
5972567|NCT01109316|20656142|P4|Study Period 1|Adverse Event|0
5972568|NCT01109316|20656143|P3|Study Period 1|Adverse Event|1
5972569|NCT01109316|20656144|P2|Study Period 1|Adverse Event|0
5972570|NCT01109316|20656145|P1|Study Period 1|Adverse Event|0
5972571|NCT01109173|20656193|P4|Overall Study|Not Specifiied|14
5972572|NCT01109173|20656194|P3|Overall Study|Not Specifiied|9
5972573|NCT01109173|20656195|P2|Overall Study|Not Specifiied|4
5972574|NCT01109173|20656196|P1|Overall Study|Not Specifiied|5
5972662|NCT01107925|20656612|P5|Period 2|Withdrawal by Subject|0
5972575|NCT01109173|20656193|P4|Overall Study|Patient Did Not Use Study Medication|7
5972576|NCT01109173|20656194|P3|Overall Study|Patient Did Not Use Study Medication|11
5972577|NCT01109173|20656195|P2|Overall Study|Patient Did Not Use Study Medication|26
5972578|NCT01109173|20656196|P1|Overall Study|Patient Did Not Use Study Medication|34
5972579|NCT01109173|20656193|P4|Overall Study|Protocol Violation|2
5972580|NCT01109173|20656194|P3|Overall Study|Protocol Violation|1
5972581|NCT01109173|20656195|P2|Overall Study|Protocol Violation|5
5972582|NCT01109173|20656196|P1|Overall Study|Protocol Violation|4
5972583|NCT01109173|20656193|P4|Overall Study|Treatment Failure|64
5972584|NCT01109173|20656194|P3|Overall Study|Treatment Failure|69
5972585|NCT01109173|20656195|P2|Overall Study|Treatment Failure|32
5972586|NCT01109173|20656196|P1|Overall Study|Treatment Failure|25
5972587|NCT01109173|20656193|P4|Overall Study|Noncompliance|0
5972588|NCT01109173|20656194|P3|Overall Study|Noncompliance|0
5972589|NCT01109173|20656195|P2|Overall Study|Noncompliance|1
5972590|NCT01109173|20656196|P1|Overall Study|Noncompliance|0
5972591|NCT01109173|20656193|P4|Overall Study|Patient Decision Unrelated to Advrs Evnt|0
5972592|NCT01109173|20656194|P3|Overall Study|Patient Decision Unrelated to Advrs Evnt|2
5972593|NCT01109173|20656195|P2|Overall Study|Patient Decision Unrelated to Advrs Evnt|0
5972594|NCT01109173|20656196|P1|Overall Study|Patient Decision Unrelated to Advrs Evnt|5
5972595|NCT01109173|20656193|P4|Overall Study|Lost to Follow-up|0
5972596|NCT01109173|20656194|P3|Overall Study|Lost to Follow-up|0
5972597|NCT01109173|20656195|P2|Overall Study|Lost to Follow-up|1
5972598|NCT01109173|20656196|P1|Overall Study|Lost to Follow-up|0
5972599|NCT01109173|20656193|P4|Overall Study|Adverse Event|6
5972600|NCT01109173|20656194|P3|Overall Study|Adverse Event|9
5972601|NCT01109173|20656195|P2|Overall Study|Adverse Event|17
5972602|NCT01109173|20656196|P1|Overall Study|Adverse Event|15
5972603|NCT01108809|20656309|P1|Overall Study|Lost to Follow-up|1
5972604|NCT01108809|20656309|P1|Overall Study|Adverse Event|3
5972605|NCT01108796|20656326|P2|Overall Study|Lost to Follow-up|6
5972606|NCT01108796|20656327|P1|Overall Study|Lost to Follow-up|7
5972607|NCT01108796|20656326|P2|Overall Study|Adverse Event|1
5972608|NCT01108796|20656327|P1|Overall Study|Adverse Event|0
5972609|NCT01108731|20656370|P2|Overall Study|Adverse Event|3
5972610|NCT01108731|20656371|P1|Overall Study|Adverse Event|3
5972611|NCT01108731|20656370|P2|Overall Study|Withdrawal by Subject|1
5972612|NCT01108731|20656371|P1|Overall Study|Withdrawal by Subject|1
5972613|NCT01108718|20656383|P2|Received Second Intervention (2 Months)|Withdrawal by Subject|0
5972614|NCT01108718|20656384|P1|Received Second Intervention (2 Months)|Withdrawal by Subject|1
5972615|NCT01108523|20656396|P1|Overall Study|Protocol Violation|4
5972616|NCT01108510|20656403|P2|Overall Study|Death|1
5972617|NCT01108510|20656404|P1|Overall Study|Death|1
5972618|NCT01108510|20656403|P2|Overall Study|Pregnancy|3
5972619|NCT01108510|20656404|P1|Overall Study|Pregnancy|0
5972620|NCT01108510|20656403|P2|Overall Study|Lack of Efficacy|0
5972621|NCT01108510|20656404|P1|Overall Study|Lack of Efficacy|3
5972622|NCT01108510|20656403|P2|Overall Study|Participant Noncompliance|7
5972623|NCT01108510|20656404|P1|Overall Study|Participant Noncompliance|5
5972624|NCT01108510|20656403|P2|Overall Study|Investigator's Discretion|10
5972625|NCT01108510|20656404|P1|Overall Study|Investigator's Discretion|12
5972626|NCT01108510|20656403|P2|Overall Study|Withdrew Consent|15
5972627|NCT01108510|20656404|P1|Overall Study|Withdrew Consent|21
5972628|NCT01108510|20656403|P2|Overall Study|Lost to Follow-up|17
5972629|NCT01108510|20656404|P1|Overall Study|Lost to Follow-up|20
5972630|NCT01108510|20656403|P2|Overall Study|Adverse Event|19
5972631|NCT01108510|20656404|P1|Overall Study|Adverse Event|26
5972632|NCT01108510|20656403|P2|Overall Study|Joined Another Gilead-sponsored Study|195
5972633|NCT01108510|20656404|P1|Overall Study|Joined Another Gilead-sponsored Study|186
5972634|NCT01108510|20656403|P2|Overall Study|Randomized but Not Treated|1
5972635|NCT01108510|20656404|P1|Overall Study|Randomized but Not Treated|5
5972636|NCT01108458|20656424|P1|Overall Study|Withdrawal by Subject|1
5972637|NCT01108341|20656476|P1|Overall Study|Other|1
5972638|NCT01108341|20656476|P1|Overall Study|Lost to Follow-up|1
5972639|NCT01108341|20656476|P1|Overall Study|Withdrawal by Subject|1
5972640|NCT01108341|20656476|P1|Overall Study|Death|2
5972641|NCT01108263|20656483|P2|Overall Study|Adverse Event|1
5972642|NCT01108263|20656484|P1|Overall Study|Adverse Event|0
5972643|NCT01108237|20656494|P2|Overall Study|Did not meet criteria for analysis|0
5972644|NCT01108237|20656495|P1|Overall Study|Did not meet criteria for analysis|7
5972645|NCT01108237|20656494|P2|Overall Study|No alignment data|17
5972646|NCT01108237|20656495|P1|Overall Study|No alignment data|2
5972647|NCT01108185|20656501|P1|Overall Study|Lost to Follow-up|12
5972648|NCT01108185|20656501|P1|Overall Study|Non-compliance|15
5972649|NCT01108094|20656518|P4|Overall Study|Withdrawal by Subject|0
5972650|NCT01108094|20656519|P3|Overall Study|Withdrawal by Subject|0
5972651|NCT01108094|20656520|P2|Overall Study|Withdrawal by Subject|0
5972652|NCT01108094|20656521|P1|Overall Study|Withdrawal by Subject|1
5972653|NCT01108094|20656518|P4|Overall Study|Adverse Event|0
5972654|NCT01108094|20656519|P3|Overall Study|Adverse Event|0
5972655|NCT01108094|20656520|P2|Overall Study|Adverse Event|0
5972656|NCT01108094|20656521|P1|Overall Study|Adverse Event|2
5972657|NCT01108068|20656565|P2|Overall Study|5 not started, 1 stop due to side effect|0
5972658|NCT01108068|20656566|P1|Overall Study|5 not started, 1 stop due to side effect|6
5972659|NCT01108055|20656573|P1|Overall Study|Not evaluable- didn't complete treatment|4
5972660|NCT01108055|20656573|P1|Overall Study|Ineligible|11
5972661|NCT01107925|20656611|P6|Period 2|Withdrawal by Subject|1
5972663|NCT01107925|20656613|P4|Period 2|Withdrawal by Subject|0
5972664|NCT01107925|20656614|P3|Period 2|Withdrawal by Subject|0
5972665|NCT01107925|20656615|P2|Period 2|Withdrawal by Subject|1
5972666|NCT01107925|20656616|P1|Period 2|Withdrawal by Subject|0
5972667|NCT01107925|20656611|P6|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0
5972668|NCT01107925|20656612|P5|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1
5972669|NCT01107925|20656613|P4|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0
5972670|NCT01107925|20656614|P3|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0
5972671|NCT01107925|20656615|P2|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0
5972672|NCT01107925|20656616|P1|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1
5972673|NCT01107912|20656654|P6|Period 3|Withdrawal by Subject|0
5972674|NCT01107912|20656655|P5|Period 3|Withdrawal by Subject|0
5972675|NCT01107912|20656656|P4|Period 3|Withdrawal by Subject|1
5972676|NCT01107912|20656657|P3|Period 3|Withdrawal by Subject|0
5972677|NCT01107912|20656658|P2|Period 3|Withdrawal by Subject|0
5972678|NCT01107912|20656659|P1|Period 3|Withdrawal by Subject|0
5972679|NCT01107912|20656654|P6|Period 3|Adverse Event|0
5972680|NCT01107912|20656655|P5|Period 3|Adverse Event|0
5972681|NCT01107912|20656656|P4|Period 3|Adverse Event|0
5972682|NCT01107912|20656657|P3|Period 3|Adverse Event|1
5972683|NCT01107912|20656658|P2|Period 3|Adverse Event|1
5972684|NCT01107912|20656659|P1|Period 3|Adverse Event|0
5972685|NCT01107912|20656654|P6|Period 2|Physician Decision|0
5972686|NCT01107912|20656655|P5|Period 2|Physician Decision|0
5972687|NCT01107912|20656656|P4|Period 2|Physician Decision|0
5972688|NCT01107912|20656657|P3|Period 2|Physician Decision|1
5972689|NCT01107912|20656658|P2|Period 2|Physician Decision|0
5972690|NCT01107912|20656659|P1|Period 2|Physician Decision|0
5972691|NCT01107912|20656654|P6|Period 1|Withdrawal by Subject|0
5972692|NCT01107912|20656655|P5|Period 1|Withdrawal by Subject|0
5972693|NCT01107912|20656656|P4|Period 1|Withdrawal by Subject|0
5972694|NCT01107912|20656657|P3|Period 1|Withdrawal by Subject|0
5972695|NCT01107912|20656658|P2|Period 1|Withdrawal by Subject|0
5972696|NCT01107912|20656659|P1|Period 1|Withdrawal by Subject|1
5972697|NCT01107912|20656654|P6|Period 1|Physician Decision|0
5972698|NCT01107912|20656655|P5|Period 1|Physician Decision|1
5972699|NCT01107912|20656656|P4|Period 1|Physician Decision|0
5972700|NCT01107912|20656657|P3|Period 1|Physician Decision|0
5972701|NCT01107912|20656658|P2|Period 1|Physician Decision|0
5972702|NCT01107912|20656659|P1|Period 1|Physician Decision|0
5972703|NCT01107912|20656654|P6|Period 1|Adverse Event|0
5972704|NCT01107912|20656655|P5|Period 1|Adverse Event|2
5972705|NCT01107912|20656656|P4|Period 1|Adverse Event|0
5972706|NCT01107912|20656657|P3|Period 1|Adverse Event|0
5972707|NCT01107912|20656658|P2|Period 1|Adverse Event|0
5972708|NCT01107912|20656659|P1|Period 1|Adverse Event|0
5972709|NCT01107899|20656696|P3|Overall Study|Withdrawal by Subject|1
5972710|NCT01107899|20656697|P2|Overall Study|Withdrawal by Subject|0
5972711|NCT01107899|20656698|P1|Overall Study|Withdrawal by Subject|0
5972712|NCT01107899|20656696|P3|Overall Study|Physician Decision|3
5972713|NCT01107899|20656697|P2|Overall Study|Physician Decision|0
5972714|NCT01107899|20656698|P1|Overall Study|Physician Decision|5
5972715|NCT01107886|20656744|P2|Overall Study|Administrative withdrawal of consent|5
5972716|NCT01107886|20656745|P1|Overall Study|Administrative withdrawal of consent|7
5972717|NCT01107886|20656744|P2|Overall Study|Withdrawal by Subject|196
5972718|NCT01107886|20656745|P1|Overall Study|Withdrawal by Subject|180
5972719|NCT01107886|20656744|P2|Overall Study|Lost to Follow-up|13
5972720|NCT01107886|20656745|P1|Overall Study|Lost to Follow-up|15
5972721|NCT01107535|20656806|P1|Overall Study|Death|5
5972722|NCT01107457|20656819|P6|Part B and C|Clinical Relapse|4
5972723|NCT01107457|20656820|P5|Part B and C|Clinical Relapse|0
5972724|NCT01107457|20656821|P4|Part B and C|Clinical Relapse|0
5972725|NCT01107457|20656822|P3|Part B and C|Clinical Relapse|0
5972726|NCT01107457|20656823|P2|Part B and C|Clinical Relapse|0
5972727|NCT01107457|20656824|P1|Part B and C|Clinical Relapse|0
5972728|NCT01107457|20656819|P6|Part B and C|Withdrawal by Subject|16
5972729|NCT01107457|20656820|P5|Part B and C|Withdrawal by Subject|0
5972730|NCT01107457|20656821|P4|Part B and C|Withdrawal by Subject|0
5972731|NCT01107457|20656822|P3|Part B and C|Withdrawal by Subject|0
5972732|NCT01107457|20656823|P2|Part B and C|Withdrawal by Subject|0
5972733|NCT01107457|20656824|P1|Part B and C|Withdrawal by Subject|0
5972734|NCT01107457|20656819|P6|Part B and C|Sponsor Decision|66
5972735|NCT01107457|20656820|P5|Part B and C|Sponsor Decision|0
5972736|NCT01107457|20656821|P4|Part B and C|Sponsor Decision|0
5972737|NCT01107457|20656822|P3|Part B and C|Sponsor Decision|0
5972738|NCT01107457|20656823|P2|Part B and C|Sponsor Decision|0
5972739|NCT01107457|20656824|P1|Part B and C|Sponsor Decision|0
5972740|NCT01107457|20656819|P6|Part B and C|Protocol Violation|1
5972741|NCT01107457|20656820|P5|Part B and C|Protocol Violation|0
5972742|NCT01107457|20656821|P4|Part B and C|Protocol Violation|0
5972743|NCT01107457|20656822|P3|Part B and C|Protocol Violation|0
5972744|NCT01107457|20656823|P2|Part B and C|Protocol Violation|0
5972745|NCT01107457|20656824|P1|Part B and C|Protocol Violation|0
5972746|NCT01107457|20656819|P6|Part B and C|Lost to Follow-up|10
5972747|NCT01107457|20656820|P5|Part B and C|Lost to Follow-up|0
5972748|NCT01107457|20656821|P4|Part B and C|Lost to Follow-up|0
5972749|NCT01107457|20656822|P3|Part B and C|Lost to Follow-up|0
5972750|NCT01107457|20656823|P2|Part B and C|Lost to Follow-up|0
5972751|NCT01107457|20656824|P1|Part B and C|Lost to Follow-up|0
5972752|NCT01107457|20656819|P6|Part B and C|Lack of Efficacy|7
5972753|NCT01107457|20656820|P5|Part B and C|Lack of Efficacy|0
5972754|NCT01107457|20656821|P4|Part B and C|Lack of Efficacy|0
5972755|NCT01107457|20656822|P3|Part B and C|Lack of Efficacy|0
5972756|NCT01107457|20656823|P2|Part B and C|Lack of Efficacy|0
5972757|NCT01107457|20656824|P1|Part B and C|Lack of Efficacy|0
5972758|NCT01107457|20656819|P6|Part B and C|Physician Decision|3
5972759|NCT01107457|20656820|P5|Part B and C|Physician Decision|0
5972760|NCT01107457|20656821|P4|Part B and C|Physician Decision|0
5972761|NCT01107457|20656822|P3|Part B and C|Physician Decision|0
5972762|NCT01107457|20656823|P2|Part B and C|Physician Decision|0
5972763|NCT01107457|20656824|P1|Part B and C|Physician Decision|0
5972764|NCT01107457|20656819|P6|Part B and C|Inclusion/Exclusion Criteria Not Met|1
5972765|NCT01107457|20656820|P5|Part B and C|Inclusion/Exclusion Criteria Not Met|0
5972766|NCT01107457|20656821|P4|Part B and C|Inclusion/Exclusion Criteria Not Met|0
5972767|NCT01107457|20656822|P3|Part B and C|Inclusion/Exclusion Criteria Not Met|0
5972768|NCT01107457|20656823|P2|Part B and C|Inclusion/Exclusion Criteria Not Met|0
5972769|NCT01107457|20656824|P1|Part B and C|Inclusion/Exclusion Criteria Not Met|0
5972770|NCT01107457|20656819|P6|Part B and C|Adverse Event|12
5972771|NCT01107457|20656820|P5|Part B and C|Adverse Event|0
5972772|NCT01107457|20656821|P4|Part B and C|Adverse Event|0
5972773|NCT01107457|20656822|P3|Part B and C|Adverse Event|0
5972774|NCT01107457|20656823|P2|Part B and C|Adverse Event|0
5972775|NCT01107457|20656824|P1|Part B and C|Adverse Event|0
5972776|NCT01107457|20656819|P6|Part A|Protocol Violation|0
5972777|NCT01107457|20656820|P5|Part A|Protocol Violation|0
5972778|NCT01107457|20656821|P4|Part A|Protocol Violation|0
5972779|NCT01107457|20656822|P3|Part A|Protocol Violation|0
5972780|NCT01107457|20656823|P2|Part A|Protocol Violation|1
5972781|NCT01107457|20656824|P1|Part A|Protocol Violation|0
5972782|NCT01107457|20656819|P6|Part A|Lack of Efficacy|0
5972783|NCT01107457|20656820|P5|Part A|Lack of Efficacy|0
5972784|NCT01107457|20656821|P4|Part A|Lack of Efficacy|0
5972785|NCT01107457|20656822|P3|Part A|Lack of Efficacy|0
5972786|NCT01107457|20656823|P2|Part A|Lack of Efficacy|0
5972787|NCT01107457|20656824|P1|Part A|Lack of Efficacy|1
5972788|NCT01107457|20656819|P6|Part A|Lost to Follow-up|0
5972789|NCT01107457|20656820|P5|Part A|Lost to Follow-up|0
5972790|NCT01107457|20656821|P4|Part A|Lost to Follow-up|0
5972791|NCT01107457|20656822|P3|Part A|Lost to Follow-up|0
5972792|NCT01107457|20656823|P2|Part A|Lost to Follow-up|1
5972793|NCT01107457|20656824|P1|Part A|Lost to Follow-up|0
5972794|NCT01107457|20656819|P6|Part A|Withdrawal by Subject|0
5972795|NCT01107457|20656820|P5|Part A|Withdrawal by Subject|1
5972796|NCT01107457|20656821|P4|Part A|Withdrawal by Subject|3
5972797|NCT01107457|20656822|P3|Part A|Withdrawal by Subject|0
5972798|NCT01107457|20656823|P2|Part A|Withdrawal by Subject|3
5972799|NCT01107457|20656824|P1|Part A|Withdrawal by Subject|3
5972800|NCT01107457|20656819|P6|Part A|Adverse Event|0
5972801|NCT01107457|20656820|P5|Part A|Adverse Event|0
5972802|NCT01107457|20656821|P4|Part A|Adverse Event|0
5972803|NCT01107457|20656822|P3|Part A|Adverse Event|1
5972804|NCT01107457|20656823|P2|Part A|Adverse Event|2
5972805|NCT01107457|20656824|P1|Part A|Adverse Event|1
5972806|NCT01107444|20656952|P2|Overall Study|Protocol Entry Criteria Not Met|1
5972807|NCT01107444|20656953|P1|Overall Study|Protocol Entry Criteria Not Met|0
5972808|NCT01107444|20656952|P2|Overall Study|Withdrawal by Subject|12
5972809|NCT01107444|20656953|P1|Overall Study|Withdrawal by Subject|8
5972810|NCT01107418|20656987|P1|Overall Study|Entered Extension Study|1
5972811|NCT01107418|20656987|P1|Overall Study|Started Other Therapy|1
5972812|NCT01107418|20656987|P1|Overall Study|Study Closing|1
5972813|NCT01107418|20656987|P1|Overall Study|Withdrawal by Subject|1
5972814|NCT01107418|20656987|P1|Overall Study|Adverse Event|3
5972815|NCT01107418|20656987|P1|Overall Study|Disease Progression|45
5972816|NCT01107405|20657060|P5|Overall Study|Protocol Violation|0
5972817|NCT01107405|20657061|P4|Overall Study|Protocol Violation|1
5972818|NCT01107405|20657062|P3|Overall Study|Protocol Violation|1
5972819|NCT01107405|20657063|P2|Overall Study|Protocol Violation|0
5972820|NCT01107405|20657064|P1|Overall Study|Protocol Violation|0
5972821|NCT01107405|20657060|P5|Overall Study|Withdrawal by Subject|1
5972822|NCT01107405|20657061|P4|Overall Study|Withdrawal by Subject|2
5972823|NCT01107405|20657062|P3|Overall Study|Withdrawal by Subject|1
5972824|NCT01107405|20657063|P2|Overall Study|Withdrawal by Subject|0
5972825|NCT01107405|20657064|P1|Overall Study|Withdrawal by Subject|1
5972826|NCT01107405|20657060|P5|Overall Study|Adverse Event|2
5972827|NCT01107405|20657061|P4|Overall Study|Adverse Event|0
5972828|NCT01107405|20657062|P3|Overall Study|Adverse Event|0
5972829|NCT01107405|20657063|P2|Overall Study|Adverse Event|1
5972830|NCT01107405|20657064|P1|Overall Study|Adverse Event|1
5972831|NCT01107392|20657103|P2|Overall Study|Administrative decision|0
5972832|NCT01107392|20657104|P1|Overall Study|Administrative decision|1
5972833|NCT01107392|20657103|P2|Overall Study|Personal Reasons|3
5972834|NCT01107392|20657104|P1|Overall Study|Personal Reasons|2
5972835|NCT01107392|20657103|P2|Overall Study|Adverse Event|0
5972836|NCT01107392|20657104|P1|Overall Study|Adverse Event|2
5972837|NCT01107379|20657116|P1|Overall Study|Lost to Follow-up|3
5972838|NCT01107379|20657116|P1|Overall Study|Withdrawal by Subject|18
5972839|NCT01107353|20657127|P2|Overall Study|Positive Drug Screen|0
5972840|NCT01107353|20657128|P1|Overall Study|Positive Drug Screen|1
5972841|NCT01107197|20657136|P2|Overall Study|Withdrawal by Subject|5
5972842|NCT01107197|20657137|P1|Overall Study|Withdrawal by Subject|3
5972843|NCT01107197|20657136|P2|Overall Study|Lost to Follow-up|8
5972844|NCT01107197|20657137|P1|Overall Study|Lost to Follow-up|5
5972845|NCT01107197|20657136|P2|Overall Study|Death|10
5972846|NCT01107197|20657137|P1|Overall Study|Death|12
5972847|NCT01106976|20657172|P1|Overall Study|Lost to Follow-up|8
5972848|NCT01106911|20657186|P1|Overall Study|deemed ineligible after screening|3
5972849|NCT01106911|20657186|P1|Overall Study|Physician Decision|2
5972850|NCT01106898|20657190|P1|Overall Study|Adverse Event|6
5972851|NCT01106846|20657235|P2|Overall Study|Change in surgical procedure|1
5972852|NCT01106846|20657236|P1|Overall Study|Change in surgical procedure|0
5972853|NCT01106690|20657286|P3|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
5972854|NCT01106690|20657287|P2|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
5972855|NCT01106690|20657288|P1|Extension Period: Week 26 to Week 52|Lost to Follow-up|1
5972856|NCT01106690|20657286|P3|Extension Period: Week 26 to Week 52|Other|4
5972857|NCT01106690|20657287|P2|Extension Period: Week 26 to Week 52|Other|3
5972858|NCT01106690|20657288|P1|Extension Period: Week 26 to Week 52|Other|8
5972859|NCT01106690|20657286|P3|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
5972860|NCT01106690|20657287|P2|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1
5972861|NCT01106690|20657288|P1|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1
5972862|NCT01106690|20657286|P3|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1
5972863|NCT01106690|20657287|P2|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0
5972864|NCT01106690|20657288|P1|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0
5972865|NCT01106690|20657286|P3|Extension Period: Week 26 to Week 52|Physician Decision|2
5972866|NCT01106690|20657287|P2|Extension Period: Week 26 to Week 52|Physician Decision|2
5972867|NCT01106690|20657288|P1|Extension Period: Week 26 to Week 52|Physician Decision|0
5972868|NCT01106690|20657286|P3|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
5972869|NCT01106690|20657287|P2|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
5972870|NCT01106690|20657288|P1|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
5972871|NCT01106690|20657286|P3|Extension Period: Week 26 to Week 52|Adverse Event|0
5972872|NCT01106690|20657287|P2|Extension Period: Week 26 to Week 52|Adverse Event|1
5972873|NCT01106690|20657288|P1|Extension Period: Week 26 to Week 52|Adverse Event|1
5972874|NCT01106690|20657286|P3|Core Period: Baseline to Week 26|Other|6
5972875|NCT01106690|20657287|P2|Core Period: Baseline to Week 26|Other|2
5972876|NCT01106690|20657288|P1|Core Period: Baseline to Week 26|Other|10
5972877|NCT01106690|20657286|P3|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0
5972878|NCT01106690|20657287|P2|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0
5972879|NCT01106690|20657288|P1|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1
5972880|NCT01106690|20657286|P3|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
5972881|NCT01106690|20657287|P2|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
5972882|NCT01106690|20657288|P1|Core Period: Baseline to Week 26|Unable to take rescue therapy|1
5972883|NCT01106690|20657286|P3|Core Period: Baseline to Week 26|Noncompliance with study drug|0
5972884|NCT01106690|20657287|P2|Core Period: Baseline to Week 26|Noncompliance with study drug|1
5972885|NCT01106690|20657288|P1|Core Period: Baseline to Week 26|Noncompliance with study drug|0
5972886|NCT01106690|20657286|P3|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1
5972887|NCT01106690|20657287|P2|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3
5972888|NCT01106690|20657288|P1|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|0
5972889|NCT01106690|20657286|P3|Core Period: Baseline to Week 26|Withdrawal by Subject|0
5972890|NCT01106690|20657287|P2|Core Period: Baseline to Week 26|Withdrawal by Subject|1
5972891|NCT01106690|20657288|P1|Core Period: Baseline to Week 26|Withdrawal by Subject|4
5972892|NCT01106690|20657286|P3|Core Period: Baseline to Week 26|Protocol Violation|0
5972893|NCT01106690|20657287|P2|Core Period: Baseline to Week 26|Protocol Violation|0
5972894|NCT01106690|20657288|P1|Core Period: Baseline to Week 26|Protocol Violation|1
5972895|NCT01106690|20657286|P3|Core Period: Baseline to Week 26|Lost to Follow-up|2
5972896|NCT01106690|20657287|P2|Core Period: Baseline to Week 26|Lost to Follow-up|1
5972897|NCT01106690|20657288|P1|Core Period: Baseline to Week 26|Lost to Follow-up|1
5972898|NCT01106690|20657286|P3|Core Period: Baseline to Week 26|Adverse Event|4
5972899|NCT01106690|20657287|P2|Core Period: Baseline to Week 26|Adverse Event|1
5972900|NCT01106690|20657288|P1|Core Period: Baseline to Week 26|Adverse Event|6
5972901|NCT01106677|20657324|P4|Extension Period: Week 26 to Week 52|Other|5
5972902|NCT01106677|20657325|P3|Extension Period: Week 26 to Week 52|Other|8
5972903|NCT01106677|20657326|P2|Extension Period: Week 26 to Week 52|Other|5
5972904|NCT01106677|20657327|P1|Extension Period: Week 26 to Week 52|Other|6
5972905|NCT01106677|20657324|P4|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1
5972906|NCT01106677|20657325|P3|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
5972907|NCT01106677|20657326|P2|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
5972908|NCT01106677|20657327|P1|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
5972909|NCT01106677|20657324|P4|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2
5972910|NCT01106677|20657325|P3|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|3
5972911|NCT01106677|20657326|P2|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4
5972912|NCT01106677|20657327|P1|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2
5972913|NCT01106677|20657324|P4|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
5972914|NCT01106677|20657325|P3|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2
5972915|NCT01106677|20657326|P2|Extension Period: Week 26 to Week 52|Withdrawal by Subject|3
5972916|NCT01106677|20657327|P1|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
5972917|NCT01106677|20657324|P4|Extension Period: Week 26 to Week 52|Protocol Violation|0
5972918|NCT01106677|20657325|P3|Extension Period: Week 26 to Week 52|Protocol Violation|0
5972919|NCT01106677|20657326|P2|Extension Period: Week 26 to Week 52|Protocol Violation|0
5972920|NCT01106677|20657327|P1|Extension Period: Week 26 to Week 52|Protocol Violation|1
5972921|NCT01106677|20657324|P4|Extension Period: Week 26 to Week 52|Physician Decision|3
5972922|NCT01106677|20657325|P3|Extension Period: Week 26 to Week 52|Physician Decision|2
5972923|NCT01106677|20657326|P2|Extension Period: Week 26 to Week 52|Physician Decision|3
5972924|NCT01106677|20657327|P1|Extension Period: Week 26 to Week 52|Physician Decision|2
5972925|NCT01106677|20657324|P4|Extension Period: Week 26 to Week 52|Lost to Follow-up|2
5972926|NCT01106677|20657325|P3|Extension Period: Week 26 to Week 52|Lost to Follow-up|2
5972927|NCT01106677|20657326|P2|Extension Period: Week 26 to Week 52|Lost to Follow-up|2
5972928|NCT01106677|20657327|P1|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
5972929|NCT01106677|20657324|P4|Extension Period: Week 26 to Week 52|Lack of Efficacy|4
5972930|NCT01106677|20657325|P3|Extension Period: Week 26 to Week 52|Lack of Efficacy|0
5972931|NCT01106677|20657326|P2|Extension Period: Week 26 to Week 52|Lack of Efficacy|0
5972932|NCT01106677|20657327|P1|Extension Period: Week 26 to Week 52|Lack of Efficacy|2
5972933|NCT01106677|20657324|P4|Extension Period: Week 26 to Week 52|Death|1
5972934|NCT01106677|20657325|P3|Extension Period: Week 26 to Week 52|Death|0
5972935|NCT01106677|20657326|P2|Extension Period: Week 26 to Week 52|Death|0
5972936|NCT01106677|20657327|P1|Extension Period: Week 26 to Week 52|Death|0
5972937|NCT01106677|20657324|P4|Extension Period: Week 26 to Week 52|Adverse Event|9
5972938|NCT01106677|20657325|P3|Extension Period: Week 26 to Week 52|Adverse Event|5
5972939|NCT01106677|20657326|P2|Extension Period: Week 26 to Week 52|Adverse Event|1
5972940|NCT01106677|20657327|P1|Extension Period: Week 26 to Week 52|Adverse Event|1
5972941|NCT01106677|20657324|P4|Core Period: Baseline to Week 26|Pregnancy|0
5972942|NCT01106677|20657325|P3|Core Period: Baseline to Week 26|Pregnancy|0
5972943|NCT01106677|20657326|P2|Core Period: Baseline to Week 26|Pregnancy|1
5972944|NCT01106677|20657327|P1|Core Period: Baseline to Week 26|Pregnancy|0
5972945|NCT01106677|20657324|P4|Core Period: Baseline to Week 26|Other|23
5972946|NCT01106677|20657325|P3|Core Period: Baseline to Week 26|Other|8
5972947|NCT01106677|20657326|P2|Core Period: Baseline to Week 26|Other|14
5972948|NCT01106677|20657327|P1|Core Period: Baseline to Week 26|Other|8
5972949|NCT01106677|20657324|P4|Core Period: Baseline to Week 26|Product quality complaint|0
5972950|NCT01106677|20657325|P3|Core Period: Baseline to Week 26|Product quality complaint|1
5972951|NCT01106677|20657326|P2|Core Period: Baseline to Week 26|Product quality complaint|1
5972952|NCT01106677|20657327|P1|Core Period: Baseline to Week 26|Product quality complaint|0
5972953|NCT01106677|20657324|P4|Core Period: Baseline to Week 26|Study terminated by sponsor|0
5972954|NCT01106677|20657325|P3|Core Period: Baseline to Week 26|Study terminated by sponsor|2
5972955|NCT01106677|20657326|P2|Core Period: Baseline to Week 26|Study terminated by sponsor|1
5972956|NCT01106677|20657327|P1|Core Period: Baseline to Week 26|Study terminated by sponsor|0
5972957|NCT01106677|20657324|P4|Core Period: Baseline to Week 26|Noncompliance with study drug|0
5972958|NCT01106677|20657325|P3|Core Period: Baseline to Week 26|Noncompliance with study drug|0
5972959|NCT01106677|20657326|P2|Core Period: Baseline to Week 26|Noncompliance with study drug|3
5972960|NCT01106677|20657327|P1|Core Period: Baseline to Week 26|Noncompliance with study drug|1
5972961|NCT01106677|20657324|P4|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3
5972962|NCT01106677|20657325|P3|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2
5972963|NCT01106677|20657326|P2|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2
5972964|NCT01106677|20657327|P1|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1
5972965|NCT01106677|20657324|P4|Core Period: Baseline to Week 26|Withdrawal by Subject|6
5972966|NCT01106677|20657325|P3|Core Period: Baseline to Week 26|Withdrawal by Subject|15
5972967|NCT01106677|20657326|P2|Core Period: Baseline to Week 26|Withdrawal by Subject|3
5972968|NCT01106677|20657327|P1|Core Period: Baseline to Week 26|Withdrawal by Subject|5
5972969|NCT01106677|20657324|P4|Core Period: Baseline to Week 26|Protocol Violation|3
5972970|NCT01106677|20657325|P3|Core Period: Baseline to Week 26|Protocol Violation|0
5972971|NCT01106677|20657326|P2|Core Period: Baseline to Week 26|Protocol Violation|1
5972972|NCT01106677|20657327|P1|Core Period: Baseline to Week 26|Protocol Violation|0
5972973|NCT01106677|20657324|P4|Core Period: Baseline to Week 26|Physician Decision|1
5972974|NCT01106677|20657325|P3|Core Period: Baseline to Week 26|Physician Decision|3
5972975|NCT01106677|20657326|P2|Core Period: Baseline to Week 26|Physician Decision|1
5972976|NCT01106677|20657327|P1|Core Period: Baseline to Week 26|Physician Decision|2
5972977|NCT01106677|20657324|P4|Core Period: Baseline to Week 26|Lost to Follow-up|3
5972978|NCT01106677|20657325|P3|Core Period: Baseline to Week 26|Lost to Follow-up|6
5972979|NCT01106677|20657326|P2|Core Period: Baseline to Week 26|Lost to Follow-up|1
5972980|NCT01106677|20657327|P1|Core Period: Baseline to Week 26|Lost to Follow-up|3
5972981|NCT01106677|20657324|P4|Core Period: Baseline to Week 26|Lack of Efficacy|0
5972982|NCT01106677|20657325|P3|Core Period: Baseline to Week 26|Lack of Efficacy|0
5972983|NCT01106677|20657326|P2|Core Period: Baseline to Week 26|Lack of Efficacy|0
5972984|NCT01106677|20657327|P1|Core Period: Baseline to Week 26|Lack of Efficacy|1
5972985|NCT01106677|20657324|P4|Core Period: Baseline to Week 26|Death|0
5972986|NCT01106677|20657325|P3|Core Period: Baseline to Week 26|Death|1
5972987|NCT01106677|20657326|P2|Core Period: Baseline to Week 26|Death|0
5972988|NCT01106677|20657327|P1|Core Period: Baseline to Week 26|Death|0
5972989|NCT01106677|20657324|P4|Core Period: Baseline to Week 26|Adverse Event|8
5972990|NCT01106677|20657325|P3|Core Period: Baseline to Week 26|Adverse Event|6
5972991|NCT01106677|20657326|P2|Core Period: Baseline to Week 26|Adverse Event|18
5972992|NCT01106677|20657327|P1|Core Period: Baseline to Week 26|Adverse Event|7
5972993|NCT01106651|20657390|P3|Overall Study|Death|0
5972994|NCT01106651|20657391|P2|Overall Study|Death|3
5972995|NCT01106651|20657392|P1|Overall Study|Death|0
5972996|NCT01106651|20657390|P3|Overall Study|Other|21
5972997|NCT01106651|20657391|P2|Overall Study|Other|31
5972998|NCT01106651|20657392|P1|Overall Study|Other|34
5972999|NCT01106651|20657390|P3|Overall Study|Noncompliance with study drug|2
5973000|NCT01106651|20657391|P2|Overall Study|Noncompliance with study drug|0
5973001|NCT01106651|20657392|P1|Overall Study|Noncompliance with study drug|1
5973002|NCT01106651|20657390|P3|Overall Study|Withdrawal by Subject|4
5973003|NCT01106651|20657391|P2|Overall Study|Withdrawal by Subject|7
5973004|NCT01106651|20657392|P1|Overall Study|Withdrawal by Subject|14
5973005|NCT01106651|20657390|P3|Overall Study|Protocol Violation|1
5973006|NCT01106651|20657391|P2|Overall Study|Protocol Violation|2
5973007|NCT01106651|20657392|P1|Overall Study|Protocol Violation|1
5973008|NCT01106651|20657390|P3|Overall Study|Physician Decision|1
5973009|NCT01106651|20657391|P2|Overall Study|Physician Decision|3
5973010|NCT01106651|20657392|P1|Overall Study|Physician Decision|4
5973011|NCT01106651|20657390|P3|Overall Study|Lost to Follow-up|6
5973012|NCT01106651|20657391|P2|Overall Study|Lost to Follow-up|2
5973013|NCT01106651|20657392|P1|Overall Study|Lost to Follow-up|8
5973014|NCT01106651|20657390|P3|Overall Study|Adverse Event|23
5973015|NCT01106651|20657391|P2|Overall Study|Adverse Event|9
5973016|NCT01106651|20657392|P1|Overall Study|Adverse Event|17
5973017|NCT01106625|20657445|P3|Extension Period: Week 26 to Week 52|Other|4
5973018|NCT01106625|20657446|P2|Extension Period: Week 26 to Week 52|Other|5
5973019|NCT01106625|20657447|P1|Extension Period: Week 26 to Week 52|Other|5
5973020|NCT01106625|20657445|P3|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2
5973021|NCT01106625|20657446|P2|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1
5973022|NCT01106625|20657447|P1|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1
5973023|NCT01106625|20657445|P3|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|4
5973024|NCT01106625|20657446|P2|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|5
5973025|NCT01106625|20657447|P1|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|14
5973026|NCT01106625|20657445|P3|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
5973027|NCT01106625|20657446|P2|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
5973028|NCT01106625|20657447|P1|Extension Period: Week 26 to Week 52|Withdrawal by Subject|4
5973029|NCT01106625|20657445|P3|Extension Period: Week 26 to Week 52|Protocol Violation|0
5973030|NCT01106625|20657446|P2|Extension Period: Week 26 to Week 52|Protocol Violation|1
5973031|NCT01106625|20657447|P1|Extension Period: Week 26 to Week 52|Protocol Violation|0
5973032|NCT01106625|20657445|P3|Extension Period: Week 26 to Week 52|Physician Decision|1
5973033|NCT01106625|20657446|P2|Extension Period: Week 26 to Week 52|Physician Decision|0
5973034|NCT01106625|20657447|P1|Extension Period: Week 26 to Week 52|Physician Decision|2
5973035|NCT01106625|20657445|P3|Extension Period: Week 26 to Week 52|Lost to Follow-up|2
5973036|NCT01106625|20657446|P2|Extension Period: Week 26 to Week 52|Lost to Follow-up|3
5973037|NCT01106625|20657447|P1|Extension Period: Week 26 to Week 52|Lost to Follow-up|1
5973038|NCT01106625|20657445|P3|Extension Period: Week 26 to Week 52|Adverse Event|3
5973039|NCT01106625|20657446|P2|Extension Period: Week 26 to Week 52|Adverse Event|2
5973040|NCT01106625|20657447|P1|Extension Period: Week 26 to Week 52|Adverse Event|2
5973041|NCT01106625|20657445|P3|Core Period: Baseline to Week 26|Other|4
5973042|NCT01106625|20657446|P2|Core Period: Baseline to Week 26|Other|7
5973043|NCT01106625|20657447|P1|Core Period: Baseline to Week 26|Other|8
5973044|NCT01106625|20657445|P3|Core Period: Baseline to Week 26|Noncompliance with study drug|0
5973045|NCT01106625|20657446|P2|Core Period: Baseline to Week 26|Noncompliance with study drug|1
5973046|NCT01106625|20657447|P1|Core Period: Baseline to Week 26|Noncompliance with study drug|1
5973047|NCT01106625|20657445|P3|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1
5973048|NCT01106625|20657446|P2|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1
5973049|NCT01106625|20657447|P1|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|0
5973050|NCT01106625|20657445|P3|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
5973051|NCT01106625|20657446|P2|Core Period: Baseline to Week 26|Unable to take rescue therapy|1
5973052|NCT01106625|20657447|P1|Core Period: Baseline to Week 26|Unable to take rescue therapy|4
5973053|NCT01106625|20657445|P3|Core Period: Baseline to Week 26|Withdrawal by Subject|7
5973054|NCT01106625|20657446|P2|Core Period: Baseline to Week 26|Withdrawal by Subject|9
5973055|NCT01106625|20657447|P1|Core Period: Baseline to Week 26|Withdrawal by Subject|6
5973056|NCT01106625|20657445|P3|Core Period: Baseline to Week 26|Protocol Violation|3
5973057|NCT01106625|20657446|P2|Core Period: Baseline to Week 26|Protocol Violation|1
5973058|NCT01106625|20657447|P1|Core Period: Baseline to Week 26|Protocol Violation|2
5973059|NCT01106625|20657445|P3|Core Period: Baseline to Week 26|Physician Decision|0
5973060|NCT01106625|20657446|P2|Core Period: Baseline to Week 26|Physician Decision|0
5973061|NCT01106625|20657447|P1|Core Period: Baseline to Week 26|Physician Decision|1
5973147|NCT01106352|20657576|P5|Overall Study|Death|1
5973062|NCT01106625|20657445|P3|Core Period: Baseline to Week 26|Lost to Follow-up|4
5973063|NCT01106625|20657446|P2|Core Period: Baseline to Week 26|Lost to Follow-up|0
5973064|NCT01106625|20657447|P1|Core Period: Baseline to Week 26|Lost to Follow-up|5
5973065|NCT01106625|20657445|P3|Core Period: Baseline to Week 26|Adverse Event|8
5973066|NCT01106625|20657446|P2|Core Period: Baseline to Week 26|Adverse Event|8
5973067|NCT01106625|20657447|P1|Core Period: Baseline to Week 26|Adverse Event|6
5973068|NCT01106586|20657478|P2|Overall Study|Participant Transferred to Another Study|197
5973069|NCT01106586|20657479|P1|Overall Study|Participant Transferred to Another Study|212
5973070|NCT01106586|20657478|P2|Overall Study|Protocol Violation|0
5973071|NCT01106586|20657479|P1|Overall Study|Protocol Violation|1
5973072|NCT01106586|20657478|P2|Overall Study|Participant Noncompliance|10
5973073|NCT01106586|20657479|P1|Overall Study|Participant Noncompliance|12
5973074|NCT01106586|20657478|P2|Overall Study|Lost to Follow-up|20
5973075|NCT01106586|20657479|P1|Overall Study|Lost to Follow-up|24
5973076|NCT01106586|20657478|P2|Overall Study|Withdrew Consent|30
5973077|NCT01106586|20657479|P1|Overall Study|Withdrew Consent|18
5973078|NCT01106586|20657478|P2|Overall Study|Investigator's Discretion|8
5973079|NCT01106586|20657479|P1|Overall Study|Investigator's Discretion|5
5973080|NCT01106586|20657478|P2|Overall Study|Lack of Efficacy|0
5973081|NCT01106586|20657479|P1|Overall Study|Lack of Efficacy|1
5973082|NCT01106586|20657478|P2|Overall Study|Pregnancy|2
5973083|NCT01106586|20657479|P1|Overall Study|Pregnancy|2
5973084|NCT01106586|20657478|P2|Overall Study|Death|3
5973085|NCT01106586|20657479|P1|Overall Study|Death|1
5973086|NCT01106586|20657478|P2|Overall Study|Adverse Event|15
5973087|NCT01106586|20657479|P1|Overall Study|Adverse Event|9
5973088|NCT01106534|20657497|P1|Overall Study|Physician Decision|1
5973089|NCT01106534|20657497|P1|Overall Study|Death|16
5973090|NCT01106534|20657497|P1|Overall Study|Lost to Follow-up|2
5973091|NCT01106534|20657497|P1|Overall Study|Withdrawal by Subject|18
5973092|NCT01106430|20657529|P2|Overall Study|Withdrawal by Subject|4
5973093|NCT01106430|20657530|P1|Overall Study|Withdrawal by Subject|8
5973094|NCT01106430|20657529|P2|Overall Study|Protocol Violation|2
5973095|NCT01106430|20657530|P1|Overall Study|Protocol Violation|7
5973096|NCT01106430|20657529|P2|Overall Study|Previous Use Of Marijuana|0
5973097|NCT01106430|20657530|P1|Overall Study|Previous Use Of Marijuana|1
5973098|NCT01106430|20657529|P2|Overall Study|Hard Time Swallowing The Pills|0
5973099|NCT01106430|20657530|P1|Overall Study|Hard Time Swallowing The Pills|1
5973100|NCT01106430|20657529|P2|Overall Study|Noncompliance|1
5973101|NCT01106430|20657530|P1|Overall Study|Noncompliance|0
5973102|NCT01106430|20657529|P2|Overall Study|Refused To Take Medication|1
5973103|NCT01106430|20657530|P1|Overall Study|Refused To Take Medication|0
5973104|NCT01106430|20657529|P2|Overall Study|Moved Out Of State|1
5973105|NCT01106430|20657530|P1|Overall Study|Moved Out Of State|0
5973106|NCT01106430|20657529|P2|Overall Study|Early Termination Requested By Sponsor|0
5973107|NCT01106430|20657530|P1|Overall Study|Early Termination Requested By Sponsor|1
5973108|NCT01106430|20657529|P2|Overall Study|Lost to Follow-up|1
5973109|NCT01106430|20657530|P1|Overall Study|Lost to Follow-up|5
5973110|NCT01106430|20657529|P2|Overall Study|Lack of Efficacy|13
5973111|NCT01106430|20657530|P1|Overall Study|Lack of Efficacy|2
5973112|NCT01106430|20657529|P2|Overall Study|Adverse Event|10
5973113|NCT01106430|20657530|P1|Overall Study|Adverse Event|8
5973114|NCT01106404|20657552|P2|Period I (First 6 Weeks)|Lack of Efficacy|1
5973115|NCT01106404|20657553|P1|Period I (First 6 Weeks)|Lack of Efficacy|0
5973116|NCT01106404|20657552|P2|Period I (First 6 Weeks)|Lost to Follow-up|1
5973117|NCT01106404|20657553|P1|Period I (First 6 Weeks)|Lost to Follow-up|0
5973118|NCT01106404|20657552|P2|Period I (First 6 Weeks)|Physician Decision|0
5973119|NCT01106404|20657553|P1|Period I (First 6 Weeks)|Physician Decision|1
5973120|NCT01106404|20657552|P2|Period I (First 6 Weeks)|Adverse Event|0
5973121|NCT01106404|20657553|P1|Period I (First 6 Weeks)|Adverse Event|2
5973122|NCT01106352|20657576|P5|Overall Study|Home hospice since July 2013|0
5973123|NCT01106352|20657577|P4|Overall Study|Home hospice since July 2013|1
5973124|NCT01106352|20657578|P3|Overall Study|Home hospice since July 2013|0
5973125|NCT01106352|20657579|P2|Overall Study|Home hospice since July 2013|0
5973126|NCT01106352|20657580|P1|Overall Study|Home hospice since July 2013|0
5973127|NCT01106352|20657576|P5|Overall Study|Subject entered hospice|0
5973128|NCT01106352|20657577|P4|Overall Study|Subject entered hospice|1
5973129|NCT01106352|20657578|P3|Overall Study|Subject entered hospice|0
5973130|NCT01106352|20657579|P2|Overall Study|Subject entered hospice|0
5973131|NCT01106352|20657580|P1|Overall Study|Subject entered hospice|0
5973132|NCT01106352|20657576|P5|Overall Study|Went on hospice|0
5973133|NCT01106352|20657577|P4|Overall Study|Went on hospice|1
5973134|NCT01106352|20657578|P3|Overall Study|Went on hospice|0
5973135|NCT01106352|20657579|P2|Overall Study|Went on hospice|0
5973136|NCT01106352|20657580|P1|Overall Study|Went on hospice|0
5973137|NCT01106352|20657576|P5|Overall Study|Withdrawal by Subject|2
5973138|NCT01106352|20657577|P4|Overall Study|Withdrawal by Subject|3
5973139|NCT01106352|20657578|P3|Overall Study|Withdrawal by Subject|0
5973140|NCT01106352|20657579|P2|Overall Study|Withdrawal by Subject|0
5973141|NCT01106352|20657580|P1|Overall Study|Withdrawal by Subject|0
5973142|NCT01106352|20657576|P5|Overall Study|Disease progression|0
5973143|NCT01106352|20657577|P4|Overall Study|Disease progression|1
5973144|NCT01106352|20657578|P3|Overall Study|Disease progression|0
5973145|NCT01106352|20657579|P2|Overall Study|Disease progression|0
5973146|NCT01106352|20657580|P1|Overall Study|Disease progression|0
5973148|NCT01106352|20657577|P4|Overall Study|Death|3
5973149|NCT01106352|20657578|P3|Overall Study|Death|1
5973150|NCT01106352|20657579|P2|Overall Study|Death|0
5973151|NCT01106352|20657580|P1|Overall Study|Death|0
5973152|NCT01106352|20657576|P5|Overall Study|Lost to Follow-up|1
5973153|NCT01106352|20657577|P4|Overall Study|Lost to Follow-up|0
5973154|NCT01106352|20657578|P3|Overall Study|Lost to Follow-up|0
5973155|NCT01106352|20657579|P2|Overall Study|Lost to Follow-up|0
5973156|NCT01106352|20657580|P1|Overall Study|Lost to Follow-up|0
5973157|NCT01106352|20657576|P5|Overall Study|Too ill to come in for the visit|0
5973158|NCT01106352|20657577|P4|Overall Study|Too ill to come in for the visit|0
5973159|NCT01106352|20657578|P3|Overall Study|Too ill to come in for the visit|1
5973160|NCT01106352|20657579|P2|Overall Study|Too ill to come in for the visit|0
5973161|NCT01106352|20657580|P1|Overall Study|Too ill to come in for the visit|0
5973162|NCT01106352|20657576|P5|Overall Study|Sponsor Decision|0
5973163|NCT01106352|20657577|P4|Overall Study|Sponsor Decision|0
5973164|NCT01106352|20657578|P3|Overall Study|Sponsor Decision|0
5973165|NCT01106352|20657579|P2|Overall Study|Sponsor Decision|0
5973166|NCT01106352|20657580|P1|Overall Study|Sponsor Decision|1
5973167|NCT01106352|20657576|P5|Overall Study|Subjects untreated|4
5973168|NCT01106352|20657577|P4|Overall Study|Subjects untreated|3
5973169|NCT01106352|20657578|P3|Overall Study|Subjects untreated|0
5973170|NCT01106352|20657579|P2|Overall Study|Subjects untreated|0
5973171|NCT01106352|20657580|P1|Overall Study|Subjects untreated|0
5973172|NCT01106287|20657676|P4|Overall Study|Adverse Event|0
5973173|NCT01106287|20657677|P3|Overall Study|Adverse Event|0
5973174|NCT01106287|20657678|P2|Overall Study|Adverse Event|0
5973175|NCT01106287|20657679|P1|Overall Study|Adverse Event|1
5973176|NCT01106248|20657699|P1|Overall Study|Administrative|2
5973177|NCT01106248|20657699|P1|Overall Study|Adverse Event|1
5973178|NCT01106157|20657707|P2|Overall Study|Withdrawal by Subject|0
5973179|NCT01106157|20657708|P1|Overall Study|Withdrawal by Subject|1
5973180|NCT01106092|20657736|P4|Overall Study|Withdrawal by Subject|1
5973181|NCT01106092|20657737|P3|Overall Study|Withdrawal by Subject|0
5973182|NCT01106092|20657738|P2|Overall Study|Withdrawal by Subject|0
5973183|NCT01106092|20657739|P1|Overall Study|Withdrawal by Subject|0
5973184|NCT01106027|20657822|P1|Overall Study|Lost graft early, discontinued|1
5973185|NCT01106014|20657828|P2|Overall Study|Lost to Follow-up|3
5973186|NCT01106014|20657829|P1|Overall Study|Lost to Follow-up|2
5973187|NCT01106014|20657828|P2|Overall Study|Administrative reason|6
5973188|NCT01106014|20657829|P1|Overall Study|Administrative reason|7
5973189|NCT01106014|20657828|P2|Overall Study|Withdrawal by Subject|37
5973190|NCT01106014|20657829|P1|Overall Study|Withdrawal by Subject|43
5973191|NCT01106014|20657828|P2|Overall Study|Adverse Event|42
5973192|NCT01106014|20657829|P1|Overall Study|Adverse Event|78
5973193|NCT01106014|20657828|P2|Overall Study|Morbidity or Mortality primary endpoint|242
5973194|NCT01106014|20657829|P1|Overall Study|Morbidity or Mortality primary endpoint|155
5973195|NCT01105975|20657849|P10|Overall Study|Abnormal Lab/Electrocardiogram Result|0
5973196|NCT01105975|20657850|P9|Overall Study|Abnormal Lab/Electrocardiogram Result|2
5973197|NCT01105975|20657851|P8|Overall Study|Abnormal Lab/Electrocardiogram Result|1
5973198|NCT01105975|20657852|P7|Overall Study|Abnormal Lab/Electrocardiogram Result|1
5973199|NCT01105975|20657853|P6|Overall Study|Abnormal Lab/Electrocardiogram Result|2
5973200|NCT01105975|20657854|P5|Overall Study|Abnormal Lab/Electrocardiogram Result|0
5973201|NCT01105975|20657855|P4|Overall Study|Abnormal Lab/Electrocardiogram Result|0
5973202|NCT01105975|20657856|P3|Overall Study|Abnormal Lab/Electrocardiogram Result|1
5973203|NCT01105975|20657857|P2|Overall Study|Abnormal Lab/Electrocardiogram Result|0
5973204|NCT01105975|20657858|P1|Overall Study|Abnormal Lab/Electrocardiogram Result|0
5973205|NCT01105975|20657849|P10|Overall Study|Protocol Violation|2
5973206|NCT01105975|20657850|P9|Overall Study|Protocol Violation|2
5973207|NCT01105975|20657851|P8|Overall Study|Protocol Violation|1
5973208|NCT01105975|20657852|P7|Overall Study|Protocol Violation|1
5973209|NCT01105975|20657853|P6|Overall Study|Protocol Violation|1
5973210|NCT01105975|20657854|P5|Overall Study|Protocol Violation|1
5973211|NCT01105975|20657855|P4|Overall Study|Protocol Violation|0
5973212|NCT01105975|20657856|P3|Overall Study|Protocol Violation|2
5973213|NCT01105975|20657857|P2|Overall Study|Protocol Violation|2
5973214|NCT01105975|20657858|P1|Overall Study|Protocol Violation|0
5973215|NCT01105975|20657849|P10|Overall Study|Physician Decision|0
5973216|NCT01105975|20657850|P9|Overall Study|Physician Decision|0
5973217|NCT01105975|20657851|P8|Overall Study|Physician Decision|0
5973218|NCT01105975|20657852|P7|Overall Study|Physician Decision|2
5973219|NCT01105975|20657853|P6|Overall Study|Physician Decision|0
5973220|NCT01105975|20657854|P5|Overall Study|Physician Decision|0
5973221|NCT01105975|20657855|P4|Overall Study|Physician Decision|0
5973222|NCT01105975|20657856|P3|Overall Study|Physician Decision|0
5973223|NCT01105975|20657857|P2|Overall Study|Physician Decision|0
5973224|NCT01105975|20657858|P1|Overall Study|Physician Decision|0
5973225|NCT01105975|20657849|P10|Overall Study|Lost to Follow-up|0
5973226|NCT01105975|20657850|P9|Overall Study|Lost to Follow-up|1
5973227|NCT01105975|20657851|P8|Overall Study|Lost to Follow-up|0
5973228|NCT01105975|20657852|P7|Overall Study|Lost to Follow-up|0
5973229|NCT01105975|20657853|P6|Overall Study|Lost to Follow-up|0
5973230|NCT01105975|20657854|P5|Overall Study|Lost to Follow-up|1
5973231|NCT01105975|20657855|P4|Overall Study|Lost to Follow-up|1
5973232|NCT01105975|20657856|P3|Overall Study|Lost to Follow-up|0
5973233|NCT01105975|20657857|P2|Overall Study|Lost to Follow-up|0
5973234|NCT01105975|20657858|P1|Overall Study|Lost to Follow-up|1
5973235|NCT01105975|20657849|P10|Overall Study|Withdrawal by Subject|3
5973236|NCT01105975|20657850|P9|Overall Study|Withdrawal by Subject|0
5973237|NCT01105975|20657851|P8|Overall Study|Withdrawal by Subject|1
5973238|NCT01105975|20657852|P7|Overall Study|Withdrawal by Subject|2
5973239|NCT01105975|20657853|P6|Overall Study|Withdrawal by Subject|1
5973240|NCT01105975|20657854|P5|Overall Study|Withdrawal by Subject|4
5973241|NCT01105975|20657855|P4|Overall Study|Withdrawal by Subject|0
5973242|NCT01105975|20657856|P3|Overall Study|Withdrawal by Subject|2
5973243|NCT01105975|20657857|P2|Overall Study|Withdrawal by Subject|2
5973244|NCT01105975|20657858|P1|Overall Study|Withdrawal by Subject|2
5973245|NCT01105975|20657849|P10|Overall Study|Adverse Event|4
5973246|NCT01105975|20657850|P9|Overall Study|Adverse Event|1
5973247|NCT01105975|20657851|P8|Overall Study|Adverse Event|4
5973248|NCT01105975|20657852|P7|Overall Study|Adverse Event|2
5973249|NCT01105975|20657853|P6|Overall Study|Adverse Event|1
5973250|NCT01105975|20657854|P5|Overall Study|Adverse Event|0
5973251|NCT01105975|20657855|P4|Overall Study|Adverse Event|1
5973252|NCT01105975|20657856|P3|Overall Study|Adverse Event|5
5973253|NCT01105975|20657857|P2|Overall Study|Adverse Event|1
5973254|NCT01105975|20657858|P1|Overall Study|Adverse Event|2
5973255|NCT01105936|20658006|P4|Period 3|Protocol Violation|0
5973256|NCT01105936|20658007|P3|Period 3|Protocol Violation|0
5973257|NCT01105936|20658008|P2|Period 3|Protocol Violation|2
5973258|NCT01105936|20658009|P1|Period 3|Protocol Violation|0
5973259|NCT01105936|20658006|P4|Period 2|Adverse Event|0
5973260|NCT01105936|20658007|P3|Period 2|Adverse Event|0
5973261|NCT01105936|20658008|P2|Period 2|Adverse Event|0
5973262|NCT01105936|20658009|P1|Period 2|Adverse Event|1
5973263|NCT01105936|20658006|P4|Period 1|Adverse Event|1
5973264|NCT01105936|20658007|P3|Period 1|Adverse Event|0
5973265|NCT01105936|20658008|P2|Period 1|Adverse Event|0
5973266|NCT01105936|20658009|P1|Period 1|Adverse Event|0
5973267|NCT01105767|20658038|P3|Overall Study|Lost to Follow-up|1184
5973268|NCT01105767|20658039|P2|Overall Study|Lost to Follow-up|1614
5973269|NCT01105767|20658040|P1|Overall Study|Lost to Follow-up|1160
5973270|NCT01105533|20658092|P9|Overall Study|Physician Decision|0
5973271|NCT01105533|20658093|P8|Overall Study|Physician Decision|1
5973272|NCT01105533|20658094|P7|Overall Study|Physician Decision|0
5973273|NCT01105533|20658095|P6|Overall Study|Physician Decision|0
5973274|NCT01105533|20658096|P5|Overall Study|Physician Decision|0
5973275|NCT01105533|20658097|P4|Overall Study|Physician Decision|0
5973276|NCT01105533|20658098|P3|Overall Study|Physician Decision|0
5973277|NCT01105533|20658099|P2|Overall Study|Physician Decision|0
5973278|NCT01105533|20658100|P1|Overall Study|Physician Decision|0
5973279|NCT01105533|20658092|P9|Overall Study|Other|2
5973280|NCT01105533|20658093|P8|Overall Study|Other|1
5973281|NCT01105533|20658094|P7|Overall Study|Other|3
5973282|NCT01105533|20658095|P6|Overall Study|Other|0
5973283|NCT01105533|20658096|P5|Overall Study|Other|1
5973284|NCT01105533|20658097|P4|Overall Study|Other|0
5973285|NCT01105533|20658098|P3|Overall Study|Other|0
5973286|NCT01105533|20658099|P2|Overall Study|Other|0
5973287|NCT01105533|20658100|P1|Overall Study|Other|0
5973288|NCT01105533|20658092|P9|Overall Study|Adverse Event|1
5973289|NCT01105533|20658093|P8|Overall Study|Adverse Event|0
5973290|NCT01105533|20658094|P7|Overall Study|Adverse Event|2
5973291|NCT01105533|20658095|P6|Overall Study|Adverse Event|2
5973292|NCT01105533|20658096|P5|Overall Study|Adverse Event|1
5973293|NCT01105533|20658097|P4|Overall Study|Adverse Event|0
5973294|NCT01105533|20658098|P3|Overall Study|Adverse Event|0
5973295|NCT01105533|20658099|P2|Overall Study|Adverse Event|0
5973296|NCT01105533|20658100|P1|Overall Study|Adverse Event|0
5973297|NCT01105533|20658092|P9|Overall Study|Lack of Efficacy|9
5973298|NCT01105533|20658093|P8|Overall Study|Lack of Efficacy|2
5973299|NCT01105533|20658094|P7|Overall Study|Lack of Efficacy|3
5973300|NCT01105533|20658095|P6|Overall Study|Lack of Efficacy|5
5973301|NCT01105533|20658096|P5|Overall Study|Lack of Efficacy|4
5973302|NCT01105533|20658097|P4|Overall Study|Lack of Efficacy|3
5973303|NCT01105533|20658098|P3|Overall Study|Lack of Efficacy|3
5973304|NCT01105533|20658099|P2|Overall Study|Lack of Efficacy|1
5973305|NCT01105533|20658100|P1|Overall Study|Lack of Efficacy|1
5973306|NCT01105533|20658092|P9|Overall Study|Death|0
5973307|NCT01105533|20658093|P8|Overall Study|Death|0
5973308|NCT01105533|20658094|P7|Overall Study|Death|0
5973309|NCT01105533|20658095|P6|Overall Study|Death|0
5973310|NCT01105533|20658096|P5|Overall Study|Death|1
5973311|NCT01105533|20658097|P4|Overall Study|Death|0
5973312|NCT01105533|20658098|P3|Overall Study|Death|0
5973313|NCT01105533|20658099|P2|Overall Study|Death|0
5973314|NCT01105533|20658100|P1|Overall Study|Death|0
5973315|NCT01105377|20658190|P2|Overall Study|Withdrawal by Subject|1
5973316|NCT01105377|20658191|P1|Overall Study|Withdrawal by Subject|0
5973317|NCT01105130|20658239|P3|Overall Study|Multiple Reasons|2
5973318|NCT01105130|20658240|P2|Overall Study|Multiple Reasons|0
5973319|NCT01105130|20658241|P1|Overall Study|Multiple Reasons|3
5973320|NCT01105130|20658239|P3|Overall Study|Toxicity|2
5973321|NCT01105130|20658240|P2|Overall Study|Toxicity|3
5973322|NCT01105130|20658241|P1|Overall Study|Toxicity|1
5973323|NCT01105130|20658239|P3|Overall Study|Never Started|4
5973324|NCT01105130|20658240|P2|Overall Study|Never Started|2
5973325|NCT01105130|20658241|P1|Overall Study|Never Started|2
5973326|NCT01105130|20658239|P3|Overall Study|Withdrawal by Subject|2
5973327|NCT01105130|20658240|P2|Overall Study|Withdrawal by Subject|6
5973328|NCT01105130|20658241|P1|Overall Study|Withdrawal by Subject|4
5973329|NCT01105091|20658271|P2|Overall Study|Death|0
5973330|NCT01105091|20658272|P1|Overall Study|Death|2
5973331|NCT01105065|20658296|P1|Overall Study|Technical Problems|1
5973332|NCT01105065|20658296|P1|Overall Study|Adverse Event|5
5973333|NCT01104870|20658305|P3|Overall Study|Withdrawal by Subject|1
5973334|NCT01104870|20658306|P2|Overall Study|Withdrawal by Subject|0
5973335|NCT01104870|20658307|P1|Overall Study|Withdrawal by Subject|0
5973336|NCT01104870|20658305|P3|Overall Study|Death|1
5973337|NCT01104870|20658306|P2|Overall Study|Death|0
5973338|NCT01104870|20658307|P1|Overall Study|Death|0
5973339|NCT01104870|20658305|P3|Overall Study|Adverse Event|0
5973340|NCT01104870|20658306|P2|Overall Study|Adverse Event|1
5973341|NCT01104870|20658307|P1|Overall Study|Adverse Event|1
5973342|NCT01104792|20658336|P1|Overall Study|Did Not Meet Eligibility Criteria|133
5973343|NCT01104792|20658336|P1|Overall Study|Reasons Not Specified|27
5973344|NCT01104792|20658336|P1|Overall Study|Lost to Follow-up|43
5973345|NCT01104792|20658336|P1|Overall Study|Withdrawal of Consent|179
5973346|NCT01104792|20658336|P1|Overall Study|Protocol Violation|45
5973347|NCT01104792|20658336|P1|Overall Study|Insufficient Therapeutic Response|22
5973348|NCT01104792|20658336|P1|Overall Study|Adverse Event|77
5973349|NCT01104779|20658344|P3|Overall Study|Withdrawal by Subject|32
5973350|NCT01104779|20658345|P2|Overall Study|Withdrawal by Subject|25
5973351|NCT01104779|20658346|P1|Overall Study|Withdrawal by Subject|16
5973352|NCT01104779|20658344|P3|Overall Study|Lost to Follow-up|1
5973353|NCT01104779|20658345|P2|Overall Study|Lost to Follow-up|0
5973354|NCT01104779|20658346|P1|Overall Study|Lost to Follow-up|2
5973355|NCT01104779|20658344|P3|Overall Study|Other reasons|0
5973356|NCT01104779|20658345|P2|Overall Study|Other reasons|1
5973357|NCT01104779|20658346|P1|Overall Study|Other reasons|0
5973358|NCT01104779|20658344|P3|Overall Study|Did not meet inc/exc criteria|1
5973359|NCT01104779|20658345|P2|Overall Study|Did not meet inc/exc criteria|1
5973360|NCT01104779|20658346|P1|Overall Study|Did not meet inc/exc criteria|1
5973361|NCT01104779|20658344|P3|Overall Study|Adverse Event|13
5973362|NCT01104779|20658345|P2|Overall Study|Adverse Event|14
5973363|NCT01104779|20658346|P1|Overall Study|Adverse Event|13
5973364|NCT01104779|20658344|P3|Overall Study|Lack of Efficacy|13
5973365|NCT01104779|20658345|P2|Overall Study|Lack of Efficacy|12
5973366|NCT01104779|20658346|P1|Overall Study|Lack of Efficacy|26
5973367|NCT01104779|20658344|P3|Overall Study|Protocol Violation|2
5973368|NCT01104779|20658345|P2|Overall Study|Protocol Violation|2
5973369|NCT01104779|20658346|P1|Overall Study|Protocol Violation|1
5973370|NCT01104766|20658361|P4|Overall Study|Lost to Follow-up|1
5973371|NCT01104766|20658362|P3|Overall Study|Lost to Follow-up|1
5973372|NCT01104766|20658363|P2|Overall Study|Lost to Follow-up|2
5973373|NCT01104766|20658364|P1|Overall Study|Lost to Follow-up|1
5973374|NCT01104766|20658361|P4|Overall Study|Withdrawal by Subject|15
5973375|NCT01104766|20658362|P3|Overall Study|Withdrawal by Subject|25
5973376|NCT01104766|20658363|P2|Overall Study|Withdrawal by Subject|19
5973377|NCT01104766|20658364|P1|Overall Study|Withdrawal by Subject|17
5973378|NCT01104766|20658361|P4|Overall Study|Protocol Violation|0
5973379|NCT01104766|20658362|P3|Overall Study|Protocol Violation|0
5973380|NCT01104766|20658363|P2|Overall Study|Protocol Violation|0
5973381|NCT01104766|20658364|P1|Overall Study|Protocol Violation|2
5973382|NCT01104766|20658361|P4|Overall Study|Lack of Efficacy|8
5973383|NCT01104766|20658362|P3|Overall Study|Lack of Efficacy|14
5973384|NCT01104766|20658363|P2|Overall Study|Lack of Efficacy|15
5973385|NCT01104766|20658364|P1|Overall Study|Lack of Efficacy|20
5973386|NCT01104766|20658361|P4|Overall Study|Adverse Event|14
5973387|NCT01104766|20658362|P3|Overall Study|Adverse Event|20
5973388|NCT01104766|20658363|P2|Overall Study|Adverse Event|15
5973389|NCT01104766|20658364|P1|Overall Study|Adverse Event|17
5973390|NCT01104766|20658361|P4|Overall Study|Did not meet inc/exc criteria|0
5973391|NCT01104766|20658362|P3|Overall Study|Did not meet inc/exc criteria|0
5973392|NCT01104766|20658363|P2|Overall Study|Did not meet inc/exc criteria|0
5973393|NCT01104766|20658364|P1|Overall Study|Did not meet inc/exc criteria|1
5973394|NCT01104701|20658382|P4|Overall Study|Physician Decision|0
5973395|NCT01104701|20658383|P3|Overall Study|Physician Decision|0
5973396|NCT01104701|20658384|P2|Overall Study|Physician Decision|2
5973397|NCT01104701|20658385|P1|Overall Study|Physician Decision|0
5973398|NCT01104701|20658382|P4|Overall Study|Adverse Event|1
5973399|NCT01104701|20658383|P3|Overall Study|Adverse Event|0
5973400|NCT01104701|20658384|P2|Overall Study|Adverse Event|0
5973401|NCT01104701|20658385|P1|Overall Study|Adverse Event|0
5973402|NCT01104701|20658382|P4|Overall Study|Withdrawal by Subject|1
5973403|NCT01104701|20658383|P3|Overall Study|Withdrawal by Subject|2
5973404|NCT01104701|20658384|P2|Overall Study|Withdrawal by Subject|1
5973405|NCT01104701|20658385|P1|Overall Study|Withdrawal by Subject|0
5973406|NCT01104662|20658447|P8|Overall Study|Randomized but not treated|0
5973407|NCT01104662|20658448|P7|Overall Study|Randomized but not treated|0
5973408|NCT01104662|20658449|P6|Overall Study|Randomized but not treated|1
5973409|NCT01104662|20658450|P5|Overall Study|Randomized but not treated|0
5973410|NCT01104662|20658451|P4|Overall Study|Randomized but not treated|0
5973411|NCT01104662|20658452|P3|Overall Study|Randomized but not treated|1
5973412|NCT01104662|20658453|P2|Overall Study|Randomized but not treated|4
5973413|NCT01104662|20658454|P1|Overall Study|Randomized but not treated|3
5973414|NCT01104662|20658447|P8|Overall Study|Reason not specified|0
5973415|NCT01104662|20658448|P7|Overall Study|Reason not specified|0
5973416|NCT01104662|20658449|P6|Overall Study|Reason not specified|1
5973417|NCT01104662|20658450|P5|Overall Study|Reason not specified|0
5973418|NCT01104662|20658451|P4|Overall Study|Reason not specified|0
5973419|NCT01104662|20658452|P3|Overall Study|Reason not specified|0
5973420|NCT01104662|20658453|P2|Overall Study|Reason not specified|3
5973421|NCT01104662|20658454|P1|Overall Study|Reason not specified|3
5973422|NCT01104662|20658447|P8|Overall Study|Participant left investigator's care|0
5973423|NCT01104662|20658448|P7|Overall Study|Participant left investigator's care|0
5973424|NCT01104662|20658449|P6|Overall Study|Participant left investigator's care|0
5973425|NCT01104662|20658450|P5|Overall Study|Participant left investigator's care|0
5973426|NCT01104662|20658451|P4|Overall Study|Participant left investigator's care|0
5973427|NCT01104662|20658452|P3|Overall Study|Participant left investigator's care|0
5973428|NCT01104662|20658453|P2|Overall Study|Participant left investigator's care|1
5973429|NCT01104662|20658454|P1|Overall Study|Participant left investigator's care|1
5973430|NCT01104662|20658447|P8|Overall Study|Clinical Failure|0
5973431|NCT01104662|20658448|P7|Overall Study|Clinical Failure|0
5973432|NCT01104662|20658449|P6|Overall Study|Clinical Failure|1
5973433|NCT01104662|20658450|P5|Overall Study|Clinical Failure|0
5973434|NCT01104662|20658451|P4|Overall Study|Clinical Failure|0
5973435|NCT01104662|20658452|P3|Overall Study|Clinical Failure|0
5973436|NCT01104662|20658453|P2|Overall Study|Clinical Failure|0
5973437|NCT01104662|20658454|P1|Overall Study|Clinical Failure|1
5973438|NCT01104662|20658447|P8|Overall Study|Adverse Event|0
5973439|NCT01104662|20658448|P7|Overall Study|Adverse Event|0
5973440|NCT01104662|20658449|P6|Overall Study|Adverse Event|1
5973441|NCT01104662|20658450|P5|Overall Study|Adverse Event|1
5973442|NCT01104662|20658451|P4|Overall Study|Adverse Event|1
5973443|NCT01104662|20658452|P3|Overall Study|Adverse Event|0
5973444|NCT01104662|20658453|P2|Overall Study|Adverse Event|2
5973445|NCT01104662|20658454|P1|Overall Study|Adverse Event|2
5973446|NCT01104636|20658480|P1|Overall Study|Ongoing|21
5973447|NCT01104636|20658480|P1|Overall Study|Adverse Event|40
5973448|NCT01104636|20658480|P1|Overall Study|Pregnancy|2
5973449|NCT01104636|20658480|P1|Overall Study|Study terminated by sponsor|1
5973450|NCT01104636|20658480|P1|Overall Study|Other|43
5973451|NCT01104636|20658480|P1|Overall Study|Withdrawal by Subject|4
5973452|NCT01104636|20658480|P1|Overall Study|Lost to Follow-up|24
5973453|NCT01104636|20658480|P1|Overall Study|Lack of Efficacy|43
5973454|NCT01104584|20658485|P1|Overall Study|Study prematurely discontinued|2
5973455|NCT01104584|20658485|P1|Overall Study|Study drug never administered|21
5973456|NCT01104558|20658555|P1|Overall Study|Missing of genetic analysis results|1
5973457|NCT01104558|20658555|P1|Overall Study|Missing of primary efficacy assessment|10
5973458|NCT01104558|20658555|P1|Overall Study|Protocol Violation|6
5973459|NCT01104545|20658599|P3|Overall Study|Adverse Event|2
5973460|NCT01104545|20658600|P2|Overall Study|Adverse Event|1
5973461|NCT01104545|20658601|P1|Overall Study|Adverse Event|0
5973462|NCT01104493|20658758|P2|Overall Study|Lost to Follow-up|2
5973463|NCT01104493|20658759|P1|Overall Study|Lost to Follow-up|0
5973464|NCT01104415|20658777|P2|Extension Period|Heart surgery/feeling miserable|1
5973465|NCT01104415|20658778|P1|Extension Period|Heart surgery/feeling miserable|0
5973466|NCT01104415|20658777|P2|Extension Period|Transition to Study LX1606.302|4
5973467|NCT01104415|20658778|P1|Extension Period|Transition to Study LX1606.302|0
5973468|NCT01104415|20658777|P2|Extension Period|Physician Decision|1
5973469|NCT01104415|20658778|P1|Extension Period|Physician Decision|0
5973470|NCT01104415|20658777|P2|Extension Period|Death|1
5973471|NCT01104415|20658778|P1|Extension Period|Death|0
5973472|NCT01104415|20658777|P2|Extension Period|Progressive disease|4
5973473|NCT01104415|20658778|P1|Extension Period|Progressive disease|0
5973474|NCT01104415|20658777|P2|Core Phase|Consent withdrawn by subjects|0
5973475|NCT01104415|20658778|P1|Core Phase|Consent withdrawn by subjects|1
5973476|NCT01104376|20658822|P1|Overall Study|Consented but excluded after labs|13
5973477|NCT01104376|20658822|P1|Overall Study|Withdrawal by Subject|15
5973478|NCT01104311|20658828|P2|Overall Study|Adverse Event|2
5973479|NCT01104311|20658829|P1|Overall Study|Adverse Event|1
5973480|NCT01104311|20658828|P2|Overall Study|low compliance|1
5973481|NCT01104311|20658829|P1|Overall Study|low compliance|1
5973482|NCT01104311|20658828|P2|Overall Study|Physician Decision|2
5973483|NCT01104311|20658829|P1|Overall Study|Physician Decision|2
5973484|NCT01104311|20658828|P2|Overall Study|Protocol Violation|1
5973485|NCT01104311|20658829|P1|Overall Study|Protocol Violation|0
5973486|NCT01104311|20658828|P2|Overall Study|Withdrawal by Subject|6
5973487|NCT01104311|20658829|P1|Overall Study|Withdrawal by Subject|6
5973488|NCT01104246|20658856|P1|Overall Study|did not meet inclusion criteria|4
5973489|NCT01104246|20658856|P1|Overall Study|Withdrawal by Subject|1
5973490|NCT01104155|20658871|P2|Overall Study|Other|4
5973491|NCT01104155|20658872|P1|Overall Study|Other|3
5973492|NCT01104155|20658871|P2|Overall Study|Withdrawal of consent|1
5973493|NCT01104155|20658872|P1|Overall Study|Withdrawal of consent|1
5973494|NCT01104155|20658871|P2|Overall Study|Participant choice|5
5973495|NCT01104155|20658872|P1|Overall Study|Participant choice|6
5973496|NCT01104155|20658871|P2|Overall Study|Adverse Event|8
5973497|NCT01104155|20658872|P1|Overall Study|Adverse Event|15
5973498|NCT01103960|20658924|P2|Overall Study|Other|0
5973499|NCT01103960|20658925|P1|Overall Study|Other|1
5973500|NCT01103960|20658924|P2|Overall Study|Withdrawal by Subject|1
5973501|NCT01103960|20658925|P1|Overall Study|Withdrawal by Subject|2
5973502|NCT01103960|20658924|P2|Overall Study|Adverse Event|1
5973503|NCT01103960|20658925|P1|Overall Study|Adverse Event|2
5973504|NCT01103778|20658960|P1|Overall Study|Screen failure|1
5973505|NCT01103778|20658960|P1|Overall Study|Proteinuria improved prior to enrollment|1
5973506|NCT01103778|20658960|P1|Overall Study|Lost to Follow-up|1
5973507|NCT01103713|20658967|P1|Overall Study|Other|1
5973508|NCT01103713|20658967|P1|Overall Study|Study terminated by sponsor|2
5973509|NCT01103713|20658967|P1|Overall Study|Withdrawal by Subject|8
5973510|NCT01103713|20658967|P1|Overall Study|Lost to Follow-up|2
5973511|NCT01103479|20659017|P3|Overall Study|Saw non-study physician|0
5973512|NCT01103479|20659018|P2|Overall Study|Saw non-study physician|0
5973513|NCT01103479|20659019|P1|Overall Study|Saw non-study physician|2
5973514|NCT01103479|20659017|P3|Overall Study|Active cancer|0
5973515|NCT01103479|20659018|P2|Overall Study|Active cancer|0
5973516|NCT01103479|20659019|P1|Overall Study|Active cancer|1
5973517|NCT01103479|20659017|P3|Overall Study|Family history of CRC|2
5973518|NCT01103479|20659018|P2|Overall Study|Family history of CRC|0
5973519|NCT01103479|20659019|P1|Overall Study|Family history of CRC|1
5973520|NCT01103479|20659017|P3|Overall Study|Up to date with CRC screening|12
5973521|NCT01103479|20659018|P2|Overall Study|Up to date with CRC screening|9
5973522|NCT01103479|20659019|P1|Overall Study|Up to date with CRC screening|1
5973523|NCT01103466|20659032|P3|Third Period (14 +/- 3 Days)|not satisfied with product|1
5973524|NCT01103466|20659033|P2|Third Period (14 +/- 3 Days)|not satisfied with product|0
5973525|NCT01103466|20659034|P1|Third Period (14 +/- 3 Days)|not satisfied with product|0
5973526|NCT01103466|20659032|P3|Third Period (14 +/- 3 Days)|Lack of Efficacy|0
5973527|NCT01103466|20659033|P2|Third Period (14 +/- 3 Days)|Lack of Efficacy|0
5973528|NCT01103466|20659034|P1|Third Period (14 +/- 3 Days)|Lack of Efficacy|1
5973529|NCT01103466|20659032|P3|Third Period (14 +/- 3 Days)|Adverse Event|0
5973530|NCT01103466|20659033|P2|Third Period (14 +/- 3 Days)|Adverse Event|0
5973531|NCT01103466|20659034|P1|Third Period (14 +/- 3 Days)|Adverse Event|1
5973532|NCT01103466|20659032|P3|Second Period (14 +/- 3 Days)|Lack of Efficacy|1
5973533|NCT01103466|20659033|P2|Second Period (14 +/- 3 Days)|Lack of Efficacy|1
5973534|NCT01103466|20659034|P1|Second Period (14 +/- 3 Days)|Lack of Efficacy|0
5973535|NCT01103466|20659032|P3|Second Period (14 +/- 3 Days)|Adverse Event|0
5973536|NCT01103466|20659033|P2|Second Period (14 +/- 3 Days)|Adverse Event|1
5973537|NCT01103466|20659034|P1|Second Period (14 +/- 3 Days)|Adverse Event|2
5973538|NCT01103466|20659032|P3|First Period (14 +/- 3 Days)|Protocol Violation|0
5973539|NCT01103466|20659033|P2|First Period (14 +/- 3 Days)|Protocol Violation|0
5973540|NCT01103466|20659034|P1|First Period (14 +/- 3 Days)|Protocol Violation|2
5973541|NCT01103362|20659124|P1|Overall Study|study terminated|596
5973542|NCT01103323|20659130|P2|Switched From Placebo to Regorafenib|Adverse Event|1
5973543|NCT01103323|20659131|P1|Switched From Placebo to Regorafenib|Adverse Event|0
5973544|NCT01103323|20659130|P2|Without/Before Drug Switch|Switch to Regorafenib|4
5973545|NCT01103323|20659131|P1|Without/Before Drug Switch|Switch to Regorafenib|0
5973546|NCT01103323|20659130|P2|Without/Before Drug Switch|did not receive study treatment|2
5973547|NCT01103323|20659131|P1|Without/Before Drug Switch|did not receive study treatment|5
5973548|NCT01103323|20659130|P2|Without/Before Drug Switch|Physician Decision|0
5973549|NCT01103323|20659131|P1|Without/Before Drug Switch|Physician Decision|2
5973550|NCT01103323|20659130|P2|Without/Before Drug Switch|Protocol Violation|0
5973551|NCT01103323|20659131|P1|Without/Before Drug Switch|Protocol Violation|2
5973552|NCT01103323|20659130|P2|Without/Before Drug Switch|Withdrawal by Subject|5
5973553|NCT01103323|20659131|P1|Without/Before Drug Switch|Withdrawal by Subject|17
5973554|NCT01103323|20659130|P2|Without/Before Drug Switch|Adverse Event|7
5973555|NCT01103323|20659131|P1|Without/Before Drug Switch|Adverse Event|50
5973556|NCT01103284|20659148|P2|Overall Study|Missing CRF entries for study completion|2
5973557|NCT01103284|20659149|P1|Overall Study|Missing CRF entries for study completion|0
5973558|NCT01103284|20659148|P2|Overall Study|Not described|1
5973559|NCT01103284|20659149|P1|Overall Study|Not described|2
5973560|NCT01103284|20659148|P2|Overall Study|Termination by the Sponsor|1
5973561|NCT01103284|20659149|P1|Overall Study|Termination by the Sponsor|0
5973562|NCT01103284|20659148|P2|Overall Study|Dermal Hypersensitivity|1
5973563|NCT01103284|20659149|P1|Overall Study|Dermal Hypersensitivity|0
5973564|NCT01103284|20659148|P2|Overall Study|Withdrawal by Subject|18
5973565|NCT01103284|20659149|P1|Overall Study|Withdrawal by Subject|14
5973566|NCT01103284|20659148|P2|Overall Study|Adverse Event|5
5973567|NCT01103284|20659149|P1|Overall Study|Adverse Event|0
5973568|NCT01103284|20659148|P2|Overall Study|Protocol Violation|5
5973569|NCT01103284|20659149|P1|Overall Study|Protocol Violation|12
5973570|NCT01103284|20659148|P2|Overall Study|Pregnancy|1
5973571|NCT01103284|20659149|P1|Overall Study|Pregnancy|3
5973572|NCT01103284|20659148|P2|Overall Study|Lost to Follow-up|10
5973573|NCT01103284|20659149|P1|Overall Study|Lost to Follow-up|9
5973574|NCT01103284|20659148|P2|Overall Study|Death|0
5973575|NCT01103284|20659149|P1|Overall Study|Death|2
5973576|NCT01103245|20659177|P4|Overall Study|Physician Decision|0
5973577|NCT01103245|20659178|P3|Overall Study|Physician Decision|0
5973578|NCT01103245|20659179|P2|Overall Study|Physician Decision|0
5973579|NCT01103245|20659180|P1|Overall Study|Physician Decision|1
5973580|NCT01103245|20659177|P4|Overall Study|Adverse Event|0
5973581|NCT01103245|20659178|P3|Overall Study|Adverse Event|1
5973582|NCT01103245|20659179|P2|Overall Study|Adverse Event|2
5973583|NCT01103245|20659180|P1|Overall Study|Adverse Event|0
5973584|NCT01103245|20659177|P4|Overall Study|Inadequate IV access|0
5973585|NCT01103245|20659178|P3|Overall Study|Inadequate IV access|0
5973586|NCT01103245|20659179|P2|Overall Study|Inadequate IV access|0
5973587|NCT01103245|20659180|P1|Overall Study|Inadequate IV access|1
5973588|NCT01103245|20659177|P4|Overall Study|Withdrawal by Subject|0
5973589|NCT01103245|20659178|P3|Overall Study|Withdrawal by Subject|3
5973590|NCT01103245|20659179|P2|Overall Study|Withdrawal by Subject|0
5973591|NCT01103245|20659180|P1|Overall Study|Withdrawal by Subject|1
5973592|NCT01103232|20659196|P2|Overall Study|Protocol Violation|1
5973593|NCT01103232|20659197|P1|Overall Study|Protocol Violation|0
5973594|NCT01103232|20659196|P2|Overall Study|Withdrawal by Subject|1
5973595|NCT01103232|20659197|P1|Overall Study|Withdrawal by Subject|1
5973596|NCT01103180|20659205|P2|Overall Study|Protocol Violation|1
5973597|NCT01103180|20659206|P1|Overall Study|Protocol Violation|0
5973598|NCT01103180|20659205|P2|Overall Study|Physician Decision|0
5973599|NCT01103180|20659206|P1|Overall Study|Physician Decision|1
5973600|NCT01103180|20659205|P2|Overall Study|Lost to Follow-up|7
5973601|NCT01103180|20659206|P1|Overall Study|Lost to Follow-up|13
5973602|NCT01103180|20659205|P2|Overall Study|Withdrawal by Subject|13
5973603|NCT01103180|20659206|P1|Overall Study|Withdrawal by Subject|8
5973604|NCT01103141|20659216|P2|Overall Study|Lost to Follow-up|1
5973605|NCT01103141|20659217|P1|Overall Study|Lost to Follow-up|2
5973606|NCT01103141|20659216|P2|Overall Study|Death|1
5973607|NCT01103141|20659217|P1|Overall Study|Death|0
5973608|NCT01103063|20659225|P2|Overall Study|Death|1
5973609|NCT01103063|20659226|P1|Overall Study|Death|3
5973610|NCT01103063|20659225|P2|Overall Study|Study terminated by Sponsor|342
5973611|NCT01103063|20659226|P1|Overall Study|Study terminated by Sponsor|326
5973612|NCT01103063|20659225|P2|Overall Study|Protocol Violation|0
5973613|NCT01103063|20659226|P1|Overall Study|Protocol Violation|1
5973614|NCT01103063|20659225|P2|Overall Study|Other|11
5973615|NCT01103063|20659226|P1|Overall Study|Other|16
5973616|NCT01103063|20659225|P2|Overall Study|Withdrawal by Subject|15
5973617|NCT01103063|20659226|P1|Overall Study|Withdrawal by Subject|60
5973618|NCT01103063|20659225|P2|Overall Study|Lost to Follow-up|51
5973619|NCT01103063|20659226|P1|Overall Study|Lost to Follow-up|68
5973620|NCT01103063|20659225|P2|Overall Study|Adverse Event|1
5973621|NCT01103063|20659226|P1|Overall Study|Adverse Event|3
5973622|NCT01102972|20659294|P2|Overall Study|Withdrawal by Subject|6
5973623|NCT01102972|20659295|P1|Overall Study|Withdrawal by Subject|6
5973624|NCT01102972|20659294|P2|Overall Study|Investigator Discretion|0
5973625|NCT01102972|20659295|P1|Overall Study|Investigator Discretion|2
5973626|NCT01102972|20659294|P2|Overall Study|Lost to Follow-up|5
5973627|NCT01102972|20659295|P1|Overall Study|Lost to Follow-up|10
5973628|NCT01102972|20659294|P2|Overall Study|Protocol Violation|0
5973629|NCT01102972|20659295|P1|Overall Study|Protocol Violation|1
5973630|NCT01102972|20659294|P2|Overall Study|Lack of Efficacy|1
5973631|NCT01102972|20659295|P1|Overall Study|Lack of Efficacy|2
5973632|NCT01102972|20659294|P2|Overall Study|Adverse Event|2
5973633|NCT01102972|20659295|P1|Overall Study|Adverse Event|8
5973634|NCT01102803|20659359|P2|Post to Follow-Up|Lost to Follow-up|3
5973635|NCT01102803|20659360|P1|Post to Follow-Up|Lost to Follow-up|1
5973636|NCT01102803|20659359|P2|Baseline to Post-Treatment|Lost to Follow-up|0
5973637|NCT01102803|20659360|P1|Baseline to Post-Treatment|Lost to Follow-up|3
5973638|NCT01102777|20659374|P2|Overall Study|Lost to Follow-up|10
5973639|NCT01102777|20659375|P1|Overall Study|Lost to Follow-up|7
5973640|NCT01102777|20659374|P2|Overall Study|Death|6
5973641|NCT01102777|20659375|P1|Overall Study|Death|2
5973642|NCT01102491|20659434|P2|Overall Study|Protocol Violation|12
5973643|NCT01102491|20659435|P1|Overall Study|Protocol Violation|11
5973644|NCT01102426|20659443|P2|Overall Study|Death (non-related to the study|8
5973645|NCT01102426|20659444|P1|Overall Study|Death (non-related to the study|19
5973646|NCT01102426|20659443|P2|Overall Study|Death (due to adverse events|1
5973647|NCT01102426|20659444|P1|Overall Study|Death (due to adverse events|0
5973648|NCT01102426|20659443|P2|Overall Study|Patient Refusal|12
5973649|NCT01102426|20659444|P1|Overall Study|Patient Refusal|24
5973650|NCT01102426|20659443|P2|Overall Study|Adverse Events (unrelated to|1
5973651|NCT01102426|20659444|P1|Overall Study|Adverse Events (unrelated to|9
5973652|NCT01102426|20659443|P2|Overall Study|Progressive Disease|44
5973653|NCT01102426|20659444|P1|Overall Study|Progressive Disease|85
5973654|NCT01102426|20659443|P2|Overall Study|Physician Decision|6
5973655|NCT01102426|20659444|P1|Overall Study|Physician Decision|9
5973656|NCT01102426|20659443|P2|Overall Study|Adverse Events (treatment-related)|8
5973657|NCT01102426|20659444|P1|Overall Study|Adverse Events (treatment-related)|15
5973658|NCT01102426|20659443|P2|Overall Study|Randomized but not treated|1
5973659|NCT01102426|20659444|P1|Overall Study|Randomized but not treated|4
5973660|NCT01102374|20659495|P2|Overall Study|Lost to Follow-up|6
5973661|NCT01102374|20659496|P1|Overall Study|Lost to Follow-up|7
5973662|NCT01102374|20659495|P2|Overall Study|Death|13
5973663|NCT01102374|20659496|P1|Overall Study|Death|9
5973664|NCT01102257|20659545|P2|Overall Study|Adverse Event|0
5973665|NCT01102257|20659546|P1|Overall Study|Adverse Event|1
5973666|NCT01102257|20659545|P2|Overall Study|Adverse Event|0
5973667|NCT01102257|20659546|P1|Overall Study|Adverse Event|1
5973668|NCT01102140|20659563|P2|Overall Study|Investigator terminated study|2
5973669|NCT01102140|20659564|P1|Overall Study|Investigator terminated study|2
5973670|NCT01102140|20659563|P2|Overall Study|Lost to Follow-up|0
5973671|NCT01102140|20659564|P1|Overall Study|Lost to Follow-up|1
5973672|NCT01101997|20659576|P1|Overall Study|Withdrawal by Subject|2
5973673|NCT01101841|20659625|P2|Overall Study|Eligibility Criteria|2
5973674|NCT01101841|20659626|P1|Overall Study|Eligibility Criteria|1
5973675|NCT01101841|20659625|P2|Overall Study|Suicidality Tracking Scale|1
5973676|NCT01101841|20659626|P1|Overall Study|Suicidality Tracking Scale|3
5973677|NCT01101841|20659625|P2|Overall Study|Other|1
5973678|NCT01101841|20659626|P1|Overall Study|Other|0
5973679|NCT01101841|20659625|P2|Overall Study|Lack of Efficacy|2
5973680|NCT01101841|20659626|P1|Overall Study|Lack of Efficacy|0
5973681|NCT01101841|20659625|P2|Overall Study|Physician Decision|2
5973682|NCT01101841|20659626|P1|Overall Study|Physician Decision|0
5973683|NCT01101841|20659625|P2|Overall Study|Protocol Violation|1
5973684|NCT01101841|20659626|P1|Overall Study|Protocol Violation|1
5973685|NCT01101841|20659625|P2|Overall Study|Withdrawal by Subject|40
5973686|NCT01101841|20659626|P1|Overall Study|Withdrawal by Subject|21
5973687|NCT01101841|20659625|P2|Overall Study|Lost to Follow-up|3
5973688|NCT01101841|20659626|P1|Overall Study|Lost to Follow-up|9
5973689|NCT01101841|20659625|P2|Overall Study|Adverse Event|15
5973690|NCT01101841|20659626|P1|Overall Study|Adverse Event|15
5973691|NCT01101542|20659668|P1|Year 6 Surveillance Period|Withdrawal by Subject|4
5973692|NCT01101542|20659668|P1|Year 6 Surveillance Period|Pregnancy|1
5973693|NCT01101542|20659668|P1|Year 6 Surveillance Period|Lost to Follow-up|986
5973694|NCT01101542|20659668|P1|Year 5 Surveillance Period|Pregnancy|1
5973695|NCT01101542|20659668|P1|Year 5 Surveillance Period|Lost to Follow-up|140
5973696|NCT01101542|20659668|P1|Year 4 Surveillance Period|Other|287
5973697|NCT01101542|20659668|P1|Year 3 Surveillance Period|Withdrawal by Subject|4
5973698|NCT01101542|20659668|P1|Year 3 Surveillance Period|Lost to Follow-up|7
5973699|NCT01101477|20659684|P3|Overall Study|Protocol Violation|1
5973700|NCT01101477|20659685|P2|Overall Study|Protocol Violation|3
5973701|NCT01101477|20659686|P1|Overall Study|Protocol Violation|5
5973702|NCT01101334|20659709|P2|Overall Study|Other|1
5973703|NCT01101334|20659710|P1|Overall Study|Other|2
5973704|NCT01101334|20659709|P2|Overall Study|Progressive Disease|35
5973705|NCT01101334|20659710|P1|Overall Study|Progressive Disease|22
5973706|NCT01101334|20659709|P2|Overall Study|Withdrawal by Sponsor|1
5973707|NCT01101334|20659710|P1|Overall Study|Withdrawal by Sponsor|1
5973708|NCT01101334|20659709|P2|Overall Study|Withdrawal by Subject|3
5973709|NCT01101334|20659710|P1|Overall Study|Withdrawal by Subject|4
5973710|NCT01101334|20659709|P2|Overall Study|Death|1
5973711|NCT01101334|20659710|P1|Overall Study|Death|7
5973712|NCT01101334|20659709|P2|Overall Study|Adverse Event|4
5973713|NCT01101334|20659710|P1|Overall Study|Adverse Event|9
5973714|NCT01101321|20659722|P2|Period 1|Adverse Event|3
5973715|NCT01101321|20659723|P1|Period 1|Adverse Event|3
5973716|NCT01101321|20659722|P2|Period 1|Withdrawal by Subject|1
5973717|NCT01101321|20659723|P1|Period 1|Withdrawal by Subject|1
5973718|NCT01101308|20659733|P2|Period 1|Positive for cotinine|0
5973719|NCT01101308|20659734|P1|Period 1|Positive for cotinine|1
5973720|NCT01101308|20659733|P2|Period 1|Adverse Event|1
5973721|NCT01101308|20659734|P1|Period 1|Adverse Event|2
5973722|NCT01101191|20659745|P2|Period 1|Adverse Event|2
5973723|NCT01101191|20659746|P1|Period 1|Adverse Event|1
5973724|NCT01101191|20659745|P2|Period 1|Withdrawal by Subject|0
5973725|NCT01101191|20659746|P1|Period 1|Withdrawal by Subject|1
5973726|NCT01101178|20659757|P2|Period 2|Withdrawal by Subject|1
5973727|NCT01101178|20659758|P1|Period 2|Withdrawal by Subject|0
5973728|NCT01101178|20659757|P2|Period 1|Adverse Event|1
5973729|NCT01101178|20659758|P1|Period 1|Adverse Event|2
5973730|NCT01101178|20659757|P2|Period 1|Positive drug screen|1
5973731|NCT01101178|20659758|P1|Period 1|Positive drug screen|1
5973732|NCT01101178|20659757|P2|Period 1|Withdrawal by Subject|2
5973733|NCT01101178|20659758|P1|Period 1|Withdrawal by Subject|1
5973734|NCT01101165|20659769|P2|Period 2|Adverse Event|0
5973735|NCT01101165|20659770|P1|Period 2|Adverse Event|1
5973736|NCT01101165|20659769|P2|Period 2|Withdrawal by Subject|1
5973737|NCT01101165|20659770|P1|Period 2|Withdrawal by Subject|3
5973738|NCT01101165|20659769|P2|Period 1|Lost to Follow-up|0
5973739|NCT01101165|20659770|P1|Period 1|Lost to Follow-up|1
5973740|NCT01101165|20659769|P2|Period 1|Positive Drug Screen|1
5973741|NCT01101165|20659770|P1|Period 1|Positive Drug Screen|0
5973742|NCT01101165|20659769|P2|Period 1|Withdrawal by Subject|2
5973743|NCT01101165|20659770|P1|Period 1|Withdrawal by Subject|0
5973744|NCT01101165|20659769|P2|Period 1|Adverse Event|2
5973745|NCT01101165|20659770|P1|Period 1|Adverse Event|1
5973746|NCT01101061|20659791|P6|Overall Study|Adverse Event|0
5973747|NCT01101061|20659792|P5|Overall Study|Adverse Event|0
5973748|NCT01101061|20659793|P4|Overall Study|Adverse Event|0
5973749|NCT01101061|20659794|P3|Overall Study|Adverse Event|1
5973750|NCT01101061|20659795|P2|Overall Study|Adverse Event|0
5973751|NCT01101061|20659796|P1|Overall Study|Adverse Event|0
5973752|NCT01101035|20659876|P2|Overall Study|Reason not Specified|363
5973753|NCT01101035|20659877|P1|Overall Study|Reason not Specified|333
5973754|NCT01101035|20659876|P2|Overall Study|Voluntary Withdrawal|587
5973755|NCT01101035|20659877|P1|Overall Study|Voluntary Withdrawal|595
5973756|NCT01101035|20659876|P2|Overall Study|Lost to Follow-up|223
5973757|NCT01101035|20659877|P1|Overall Study|Lost to Follow-up|226
5973758|NCT01101035|20659876|P2|Overall Study|Major Protocol Deviation|46
5973759|NCT01101035|20659877|P1|Overall Study|Major Protocol Deviation|52
5973760|NCT01101035|20659876|P2|Overall Study|Adverse Event|172
5973761|NCT01101035|20659877|P1|Overall Study|Adverse Event|191
5973762|NCT01101022|20659897|P2|Overall Study|Vacation|1
5973763|NCT01101022|20659898|P1|Overall Study|Vacation|0
5973764|NCT01101022|20659897|P2|Overall Study|Work schedule|1
5973765|NCT01101022|20659898|P1|Overall Study|Work schedule|1
5973766|NCT01101022|20659897|P2|Overall Study|Non-compliance|0
5973767|NCT01101022|20659898|P1|Overall Study|Non-compliance|1
5973768|NCT01101022|20659897|P2|Overall Study|Sponsor decision|1
5973769|NCT01101022|20659898|P1|Overall Study|Sponsor decision|1
5973770|NCT01101022|20659897|P2|Overall Study|Lack of Efficacy|7
5973771|NCT01101022|20659898|P1|Overall Study|Lack of Efficacy|0
5973772|NCT01101022|20659897|P2|Overall Study|Lost to Follow-up|4
5973773|NCT01101022|20659898|P1|Overall Study|Lost to Follow-up|1
5973774|NCT01101022|20659897|P2|Overall Study|Withdrawal by Subject|8
5973775|NCT01101022|20659898|P1|Overall Study|Withdrawal by Subject|3
5973776|NCT01101022|20659897|P2|Overall Study|Protocol Violation|3
5973777|NCT01101022|20659898|P1|Overall Study|Protocol Violation|4
5973778|NCT01101022|20659897|P2|Overall Study|Adverse Event|2
5973779|NCT01101022|20659898|P1|Overall Study|Adverse Event|6
5973780|NCT01100944|20659932|P3|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0
5973781|NCT01100944|20659933|P2|Dose Escalation Phase 1 Dose Level 2|Adverse Event|2
5973782|NCT01100944|20659934|P1|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0
5973783|NCT01100944|20659932|P3|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0
5973784|NCT01100944|20659933|P2|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0
5973785|NCT01100944|20659934|P1|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|1
5973786|NCT01100944|20659932|P3|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0
5973787|NCT01100944|20659933|P2|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0
5973788|NCT01100944|20659934|P1|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|1
5973789|NCT01100944|20659932|P3|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0
5973790|NCT01100944|20659933|P2|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0
5973791|NCT01100944|20659934|P1|Dose Escalation Phase 1 Dose Level 1|Adverse Event|2
5973792|NCT01100853|20659992|P2|Overall Study|Withdrawal by Subject|4
5973793|NCT01100853|20659993|P1|Overall Study|Withdrawal by Subject|6
5973794|NCT01100853|20659992|P2|Overall Study|Received <4 study injections|13
5973795|NCT01100853|20659993|P1|Overall Study|Received <4 study injections|10
5973796|NCT01100853|20659992|P2|Overall Study|Lost to Follow-up|6
5973797|NCT01100853|20659993|P1|Overall Study|Lost to Follow-up|11
5973798|NCT01100658|20660039|P1|Overall Study|Withdrawal by Subject|1
5973799|NCT01100567|20660071|P2|Overall Study|Deemed ineligible after consent|1
5973800|NCT01100567|20660072|P1|Overall Study|Deemed ineligible after consent|0
5973801|NCT01100567|20660071|P2|Overall Study|Physician Decision|1
5973802|NCT01100567|20660072|P1|Overall Study|Physician Decision|0
5973803|NCT01100567|20660071|P2|Overall Study|Lost to Follow-up|2
5973804|NCT01100567|20660072|P1|Overall Study|Lost to Follow-up|1
5973805|NCT01100567|20660071|P2|Overall Study|Early Hospital Discharge|4
5973806|NCT01100567|20660072|P1|Overall Study|Early Hospital Discharge|6
5973807|NCT01100567|20660071|P2|Overall Study|Withdrawal by Subject|8
5973808|NCT01100567|20660072|P1|Overall Study|Withdrawal by Subject|5
5973809|NCT01100528|20660080|P1|Overall Study|Withdrawal by Subject|2
5973810|NCT01100528|20660080|P1|Overall Study|Death|1
5973811|NCT01100502|20660088|P2|Long-Term Follow-up|Continuing in long-term follow-up|129
5973812|NCT01100502|20660089|P1|Long-Term Follow-up|Continuing in long-term follow-up|122
5973813|NCT01100502|20660088|P2|Long-Term Follow-up|Lost to Follow-up|2
5973814|NCT01100502|20660089|P1|Long-Term Follow-up|Lost to Follow-up|5
5973815|NCT01100502|20660088|P2|Long-Term Follow-up|Withdrawal by Subject|8
5973816|NCT01100502|20660089|P1|Long-Term Follow-up|Withdrawal by Subject|10
5973817|NCT01100502|20660088|P2|Treatment Period|Progressive Disease|69
5973818|NCT01100502|20660089|P1|Treatment Period|Progressive Disease|24
5973819|NCT01100502|20660088|P2|Treatment Period|Withdrawal by Subject|4
5973820|NCT01100502|20660089|P1|Treatment Period|Withdrawal by Subject|9
5973821|NCT01100502|20660088|P2|Treatment Period|Adverse Event|10
5973822|NCT01100502|20660089|P1|Treatment Period|Adverse Event|54
5973823|NCT01100437|20660099|P3|Maintenance|Sponsor termination of study|1
5973824|NCT01100437|20660100|P2|Maintenance|Sponsor termination of study|0
5973825|NCT01100437|20660101|P1|Maintenance|Sponsor termination of study|0
5973826|NCT01100437|20660099|P3|Maintenance|Withdrawal by Subject|1
5973827|NCT01100437|20660100|P2|Maintenance|Withdrawal by Subject|0
5973828|NCT01100437|20660101|P1|Maintenance|Withdrawal by Subject|0
5973829|NCT01100437|20660099|P3|Titration/Stabilization|Sponsor canceled study|1
5973830|NCT01100437|20660100|P2|Titration/Stabilization|Sponsor canceled study|0
5973831|NCT01100437|20660101|P1|Titration/Stabilization|Sponsor canceled study|0
5973832|NCT01100437|20660099|P3|Titration/Stabilization|Non-compliance|1
5973833|NCT01100437|20660100|P2|Titration/Stabilization|Non-compliance|0
5973834|NCT01100437|20660101|P1|Titration/Stabilization|Non-compliance|0
5973835|NCT01100437|20660099|P3|Titration/Stabilization|Adverse Event|4
5973836|NCT01100437|20660100|P2|Titration/Stabilization|Adverse Event|0
5973837|NCT01100437|20660101|P1|Titration/Stabilization|Adverse Event|0
5973838|NCT01100320|20660138|P2|Period 2|Withdrawal by Subject|1
5973839|NCT01100320|20660139|P1|Period 2|Withdrawal by Subject|1
5973840|NCT01100320|20660138|P2|Period 1|Adverse Event|2
5973841|NCT01100320|20660139|P1|Period 1|Adverse Event|2
5973842|NCT01100320|20660138|P2|Period 1|Positive Drug Screen|1
5973843|NCT01100320|20660139|P1|Period 1|Positive Drug Screen|1
5973844|NCT01100320|20660138|P2|Period 1|Withdrawal by Subject|4
5973845|NCT01100320|20660139|P1|Period 1|Withdrawal by Subject|2
5973846|NCT01100307|20660151|P2|Open Phase (Week 24 up to Week 54)|Adverse Event|8
5973847|NCT01100307|20660152|P1|Open Phase (Week 24 up to Week 54)|Adverse Event|3
5973848|NCT01100307|20660151|P2|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|3
5973849|NCT01100307|20660152|P1|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|2
5973850|NCT01100307|20660151|P2|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|2
5973851|NCT01100307|20660152|P1|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|1
5973852|NCT01100307|20660151|P2|Double Masked Phase (Up to Week 24)|Adverse Event|2
5973853|NCT01100307|20660152|P1|Double Masked Phase (Up to Week 24)|Adverse Event|5
5973854|NCT01100307|20660151|P2|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|1
5973855|NCT01100307|20660152|P1|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|0
5973856|NCT01100307|20660151|P2|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1
5973857|NCT01100307|20660152|P1|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1
5973858|NCT01100086|20660221|P2|Period 1|Withdrawal by Subject|0
5973859|NCT01100086|20660222|P1|Period 1|Withdrawal by Subject|1
5973860|NCT01100073|20660232|P1|Overall Study|Missing|5
5973861|NCT01100073|20660232|P1|Overall Study|Other|8
5973862|NCT01100073|20660232|P1|Overall Study|Insufficient tolerability +patients wish|8
5973863|NCT01100073|20660232|P1|Overall Study|Lack of effect + patient's wish|2
5973864|NCT01100073|20660232|P1|Overall Study|Lost to Follow-up|39
5973865|NCT01100073|20660232|P1|Overall Study|Withdrawal by Subject|13
5973866|NCT01100073|20660232|P1|Overall Study|Insufficient Tolerability|21
5973867|NCT01100073|20660232|P1|Overall Study|Lack of Efficacy|4
5973868|NCT01100034|20660247|P1|Overall Study|Site closed due to non-responsiveness|1
5973869|NCT01100034|20660247|P1|Overall Study|Participants moved to another hospital|4
5973870|NCT01100034|20660247|P1|Overall Study|Participated in another clinical trial|1
5973871|NCT01100034|20660247|P1|Overall Study|Sponsor decision|21
5973872|NCT01100034|20660247|P1|Overall Study|Withdrawal by Subject|4
5973873|NCT01100034|20660247|P1|Overall Study|Withdrawal of parent/guardian consent|1
5973874|NCT01100034|20660247|P1|Overall Study|Lost to Follow-up|11
5973875|NCT01099917|20660285|P1|Overall Study|Not Treated|24
5973876|NCT01099917|20660285|P1|Overall Study|Adverse Event|3
5973877|NCT01099709|20660347|P2|Period 1|Adverse Event|0
5973878|NCT01099709|20660348|P1|Period 1|Adverse Event|1
5973879|NCT01099709|20660347|P2|Period 1|Positive cotinine test|1
5973880|NCT01099709|20660348|P1|Period 1|Positive cotinine test|0
5973881|NCT01099709|20660347|P2|Period 1|Withdrawal by Subject|1
5973882|NCT01099709|20660348|P1|Period 1|Withdrawal by Subject|0
5973883|NCT01099579|20660417|P3|Stage 2 (ATV Capsule)|Adverse Event|0
5973884|NCT01099579|20660418|P2|Stage 2 (ATV Capsule)|Adverse Event|1
5973885|NCT01099579|20660419|P1|Stage 2 (ATV Capsule)|Adverse Event|0
5973886|NCT01099579|20660417|P3|Stage 2 (ATV Capsule)|Poor/Non-Compliance|1
5973887|NCT01099579|20660418|P2|Stage 2 (ATV Capsule)|Poor/Non-Compliance|0
5973888|NCT01099579|20660419|P1|Stage 2 (ATV Capsule)|Poor/Non-Compliance|2
5973889|NCT01099579|20660417|P3|Stage 2 (ATV Capsule)|Withdrawal by Subject|1
5973890|NCT01099579|20660418|P2|Stage 2 (ATV Capsule)|Withdrawal by Subject|1
5973891|NCT01099579|20660419|P1|Stage 2 (ATV Capsule)|Withdrawal by Subject|1
5973892|NCT01099579|20660417|P3|Stage 2 (ATV Capsule)|Lack of Efficacy|2
5973893|NCT01099579|20660418|P2|Stage 2 (ATV Capsule)|Lack of Efficacy|0
5973894|NCT01099579|20660419|P1|Stage 2 (ATV Capsule)|Lack of Efficacy|0
5973895|NCT01099579|20660417|P3|Stage 2 (ATV Capsule)|Lost to Follow-up|1
5973896|NCT01099579|20660418|P2|Stage 2 (ATV Capsule)|Lost to Follow-up|1
5973897|NCT01099579|20660419|P1|Stage 2 (ATV Capsule)|Lost to Follow-up|1
5973898|NCT01099579|20660417|P3|Stage 2 (ATV Capsule)|No longer met study criteria|1
5973899|NCT01099579|20660418|P2|Stage 2 (ATV Capsule)|No longer met study criteria|2
5973900|NCT01099579|20660419|P1|Stage 2 (ATV Capsule)|No longer met study criteria|2
5973901|NCT01099579|20660417|P3|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0
5973902|NCT01099579|20660418|P2|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|2
5973903|NCT01099579|20660419|P1|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0
5973904|NCT01099579|20660417|P3|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0
5973905|NCT01099579|20660418|P2|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|2
5973906|NCT01099579|20660419|P1|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0
5973907|NCT01099579|20660417|P3|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|1
5973908|NCT01099579|20660418|P2|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0
5973909|NCT01099579|20660419|P1|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0
5973910|NCT01099579|20660417|P3|Stage 1 (ATV Powder Formulation)|Adverse Event|0
5973911|NCT01099579|20660418|P2|Stage 1 (ATV Powder Formulation)|Adverse Event|1
5973912|NCT01099579|20660419|P1|Stage 1 (ATV Powder Formulation)|Adverse Event|4
5973913|NCT01099397|20660528|P1|Overall Study|Withdrawal by Subject|5
5973914|NCT01099397|20660528|P1|Overall Study|Protocol Violation|4
5973915|NCT01099397|20660528|P1|Overall Study|Lost to Follow-up|4
5973916|NCT01099267|20660555|P1|MDS-003 Study|Secondary Malign Disease|1
5973917|NCT01099267|20660555|P1|MDS-003 Study|Loss of Response|1
5973918|NCT01099267|20660555|P1|MDS-003 Study|Non-Compliance|2
5973919|NCT01099267|20660555|P1|MDS-003 Study|Investigator Decision|2
5973920|NCT01099267|20660555|P1|MDS-003 Study|Disease Progression|7
5973921|NCT01099267|20660555|P1|MDS-003 Study|Study Closed by Sponsor|2
5973922|NCT01099267|20660555|P1|MDS-003 Study|Death|11
5973923|NCT01099267|20660555|P1|MDS-003 Study|Lost to Follow-up|1
5973924|NCT01099267|20660555|P1|MDS-003 Study|Withdrawal by Subject|8
5973925|NCT01099267|20660555|P1|MDS-003 Study|Lack of Efficacy|52
5973926|NCT01099267|20660555|P1|MDS-003 Study|Adverse Event|37
5973927|NCT01099215|20660565|P2|Overall Study|Adverse Event|1
5973928|NCT01099215|20660566|P1|Overall Study|Adverse Event|0
5973929|NCT01099215|20660565|P2|Overall Study|Withdrawal by Subject|0
5973930|NCT01099215|20660566|P1|Overall Study|Withdrawal by Subject|1
5973931|NCT01098851|20660636|P2|Overall Study|Equipment failure|0
5973932|NCT01098851|20660637|P1|Overall Study|Equipment failure|1
5973933|NCT01098812|20660648|P3|Overall Study|Lost to Follow-up|0
5973934|NCT01098812|20660649|P2|Overall Study|Lost to Follow-up|1
5973935|NCT01098812|20660650|P1|Overall Study|Lost to Follow-up|0
5973936|NCT01098812|20660648|P3|Overall Study|Death|1
5973937|NCT01098812|20660649|P2|Overall Study|Death|0
5973938|NCT01098812|20660650|P1|Overall Study|Death|2
5973939|NCT01098539|20660726|P2|Overall Study|Physician Decision|3
5973940|NCT01098539|20660727|P1|Overall Study|Physician Decision|5
5973941|NCT01098539|20660726|P2|Overall Study|Withdrawal by Subject|26
5973942|NCT01098539|20660727|P1|Overall Study|Withdrawal by Subject|12
5973943|NCT01098539|20660726|P2|Overall Study|Lost to Follow-up|4
5973944|NCT01098539|20660727|P1|Overall Study|Lost to Follow-up|4
5973945|NCT01098539|20660726|P2|Overall Study|Noncompliance|5
5973946|NCT01098539|20660727|P1|Overall Study|Noncompliance|3
5973947|NCT01098539|20660726|P2|Overall Study|Protocol Violation|4
5973948|NCT01098539|20660727|P1|Overall Study|Protocol Violation|1
5973949|NCT01098539|20660726|P2|Overall Study|Adverse Event|26
5973950|NCT01098539|20660727|P1|Overall Study|Adverse Event|26
5973951|NCT01098487|20660778|P1|Overall Study|Physician Decision|1
5973952|NCT01098487|20660778|P1|Overall Study|Lost to Follow-up|3
5973953|NCT01098487|20660778|P1|Overall Study|Withdrawal by Subject|7
5973954|NCT01098487|20660778|P1|Overall Study|Lack of Efficacy|11
5973955|NCT01098487|20660778|P1|Overall Study|Adverse Event|22
5973956|NCT01098474|20660796|P6|Follow Up Phase|Lost to Follow-up|0
5973957|NCT01098474|20660797|P5|Follow Up Phase|Lost to Follow-up|1
5973958|NCT01098474|20660798|P4|Follow Up Phase|Lost to Follow-up|0
5973959|NCT01098474|20660799|P3|Follow Up Phase|Lost to Follow-up|0
5973960|NCT01098474|20660800|P2|Follow Up Phase|Lost to Follow-up|0
5973961|NCT01098474|20660801|P1|Follow Up Phase|Lost to Follow-up|0
5973962|NCT01098474|20660796|P6|Follow Up Phase|Withdrawal by Subject|1
5973963|NCT01098474|20660797|P5|Follow Up Phase|Withdrawal by Subject|0
5973964|NCT01098474|20660798|P4|Follow Up Phase|Withdrawal by Subject|2
5973965|NCT01098474|20660799|P3|Follow Up Phase|Withdrawal by Subject|0
5973966|NCT01098474|20660800|P2|Follow Up Phase|Withdrawal by Subject|0
5973967|NCT01098474|20660801|P1|Follow Up Phase|Withdrawal by Subject|0
5973968|NCT01098474|20660796|P6|Follow Up Phase|Other|4
5973969|NCT01098474|20660797|P5|Follow Up Phase|Other|0
5973970|NCT01098474|20660798|P4|Follow Up Phase|Other|0
5973971|NCT01098474|20660799|P3|Follow Up Phase|Other|0
5973972|NCT01098474|20660800|P2|Follow Up Phase|Other|0
5973973|NCT01098474|20660801|P1|Follow Up Phase|Other|0
5973974|NCT01098474|20660796|P6|Follow Up Phase|Travelled out of study area|0
5973975|NCT01098474|20660797|P5|Follow Up Phase|Travelled out of study area|1
5973976|NCT01098474|20660798|P4|Follow Up Phase|Travelled out of study area|0
5973977|NCT01098474|20660799|P3|Follow Up Phase|Travelled out of study area|0
5973978|NCT01098474|20660800|P2|Follow Up Phase|Travelled out of study area|0
5973979|NCT01098474|20660801|P1|Follow Up Phase|Travelled out of study area|0
5973980|NCT01098474|20660796|P6|Active Phase|Lost to Follow-up|0
5973981|NCT01098474|20660797|P5|Active Phase|Lost to Follow-up|0
5973982|NCT01098474|20660798|P4|Active Phase|Lost to Follow-up|0
5973983|NCT01098474|20660799|P3|Active Phase|Lost to Follow-up|0
5973984|NCT01098474|20660800|P2|Active Phase|Lost to Follow-up|0
5973985|NCT01098474|20660801|P1|Active Phase|Lost to Follow-up|1
5973986|NCT01098474|20660796|P6|Active Phase|Withdrawal by Subject|0
5973987|NCT01098474|20660797|P5|Active Phase|Withdrawal by Subject|0
5973988|NCT01098474|20660798|P4|Active Phase|Withdrawal by Subject|0
5973989|NCT01098474|20660799|P3|Active Phase|Withdrawal by Subject|2
5973990|NCT01098474|20660800|P2|Active Phase|Withdrawal by Subject|1
5973991|NCT01098474|20660801|P1|Active Phase|Withdrawal by Subject|1
5973992|NCT01098474|20660796|P6|Active Phase|Other|0
5973993|NCT01098474|20660797|P5|Active Phase|Other|0
5973994|NCT01098474|20660798|P4|Active Phase|Other|0
5973995|NCT01098474|20660799|P3|Active Phase|Other|3
5973996|NCT01098474|20660800|P2|Active Phase|Other|0
5973997|NCT01098474|20660801|P1|Active Phase|Other|0
5973998|NCT01098461|20661035|P4|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0
5973999|NCT01098461|20661036|P3|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1
5974000|NCT01098461|20661037|P2|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1
5974001|NCT01098461|20661038|P1|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0
5974002|NCT01098461|20661035|P4|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0
5974003|NCT01098461|20661036|P3|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0
5974004|NCT01098461|20661037|P2|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|1
5974005|NCT01098461|20661038|P1|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0
5974006|NCT01098461|20661035|P4|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0
5974007|NCT01098461|20661036|P3|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0
5974008|NCT01098461|20661037|P2|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|1
5974009|NCT01098461|20661038|P1|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0
5974010|NCT01098461|20661035|P4|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0
5974011|NCT01098461|20661036|P3|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0
5974012|NCT01098461|20661037|P2|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|1
5974013|NCT01098461|20661038|P1|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0
5974014|NCT01098461|20661035|P4|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0
5974015|NCT01098461|20661036|P3|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0
5974016|NCT01098461|20661037|P2|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|2
5974017|NCT01098461|20661038|P1|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|1
5974018|NCT01098461|20661035|P4|Treatment Period (TP) (16 Weeks)|Adverse Event|3
5974019|NCT01098461|20661036|P3|Treatment Period (TP) (16 Weeks)|Adverse Event|1
5974020|NCT01098461|20661037|P2|Treatment Period (TP) (16 Weeks)|Adverse Event|2
5974021|NCT01098461|20661038|P1|Treatment Period (TP) (16 Weeks)|Adverse Event|1
5974022|NCT01098461|20661035|P4|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0
5974023|NCT01098461|20661036|P3|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0
5974024|NCT01098461|20661037|P2|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|2
5974025|NCT01098461|20661038|P1|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|10
5974026|NCT01098305|20661098|P2|Overall Study|Lost to Follow-up|33
5974027|NCT01098305|20661099|P1|Overall Study|Lost to Follow-up|31
5974028|NCT01098266|20661109|P2|Overall Study|Withdrawal by Subject|5
5974029|NCT01098266|20661110|P1|Overall Study|Withdrawal by Subject|3
5974030|NCT01098266|20661109|P2|Overall Study|Death|2
5974031|NCT01098266|20661110|P1|Overall Study|Death|3
5974032|NCT01098266|20661109|P2|Overall Study|Physician Decision|0
5974033|NCT01098266|20661110|P1|Overall Study|Physician Decision|1
5974034|NCT01098240|20661139|P3|Double-Blind Phase|Adverse Event|3
5974035|NCT01098240|20661140|P2|Double-Blind Phase|Adverse Event|3
5974036|NCT01098240|20661141|P1|Double-Blind Phase|Adverse Event|0
5974037|NCT01098240|20661139|P3|Double-Blind Phase|Withdrawal by Subject|3
5974038|NCT01098240|20661140|P2|Double-Blind Phase|Withdrawal by Subject|1
5974039|NCT01098240|20661141|P1|Double-Blind Phase|Withdrawal by Subject|0
5974040|NCT01098240|20661139|P3|Double-Blind Phase|Insufficient Clinical Response|2
5974041|NCT01098240|20661140|P2|Double-Blind Phase|Insufficient Clinical Response|1
5974042|NCT01098240|20661141|P1|Double-Blind Phase|Insufficient Clinical Response|0
5974043|NCT01098240|20661139|P3|Double-Blind Phase|Did Not Meet Entrance Criteria|0
5974044|NCT01098240|20661140|P2|Double-Blind Phase|Did Not Meet Entrance Criteria|1
5974045|NCT01098240|20661141|P1|Double-Blind Phase|Did Not Meet Entrance Criteria|0
5974046|NCT01098240|20661139|P3|Double-Blind Phase|Other|2
5974047|NCT01098240|20661140|P2|Double-Blind Phase|Other|2
5974048|NCT01098240|20661141|P1|Double-Blind Phase|Other|0
5974049|NCT01098240|20661139|P3|Double-Blind Phase|Lost to Follow-up|0
5974050|NCT01098240|20661140|P2|Double-Blind Phase|Lost to Follow-up|2
5974051|NCT01098240|20661141|P1|Double-Blind Phase|Lost to Follow-up|0
5974052|NCT01098240|20661139|P3|Double-Blind Phase|Protocol Violation|4
5974053|NCT01098240|20661140|P2|Double-Blind Phase|Protocol Violation|2
5974054|NCT01098240|20661141|P1|Double-Blind Phase|Protocol Violation|0
5974055|NCT01098240|20661139|P3|Double-Blind Phase|Study Terminated by Sponsor|8
5974056|NCT01098240|20661140|P2|Double-Blind Phase|Study Terminated by Sponsor|5
5974057|NCT01098240|20661141|P1|Double-Blind Phase|Study Terminated by Sponsor|0
5974058|NCT01098240|20661139|P3|Open-Label Phase|Adverse Event|0
5974059|NCT01098240|20661140|P2|Open-Label Phase|Adverse Event|0
5974060|NCT01098240|20661141|P1|Open-Label Phase|Adverse Event|12
5974061|NCT01098240|20661139|P3|Open-Label Phase|Withdrawal by Subject|0
5974062|NCT01098240|20661140|P2|Open-Label Phase|Withdrawal by Subject|0
5974063|NCT01098240|20661141|P1|Open-Label Phase|Withdrawal by Subject|9
5974064|NCT01098240|20661139|P3|Open-Label Phase|Pregnancy|0
5974065|NCT01098240|20661140|P2|Open-Label Phase|Pregnancy|0
5974066|NCT01098240|20661141|P1|Open-Label Phase|Pregnancy|1
5974067|NCT01098240|20661139|P3|Open-Label Phase|Did Not Meet Entrance Criteria|0
5974068|NCT01098240|20661140|P2|Open-Label Phase|Did Not Meet Entrance Criteria|0
5974069|NCT01098240|20661141|P1|Open-Label Phase|Did Not Meet Entrance Criteria|50
5974070|NCT01098240|20661139|P3|Open-Label Phase|Other|0
5974071|NCT01098240|20661140|P2|Open-Label Phase|Other|0
5974072|NCT01098240|20661141|P1|Open-Label Phase|Other|19
5974073|NCT01098240|20661139|P3|Open-Label Phase|Lost to Follow-up|0
5974074|NCT01098240|20661140|P2|Open-Label Phase|Lost to Follow-up|0
5974075|NCT01098240|20661141|P1|Open-Label Phase|Lost to Follow-up|13
5974076|NCT01098240|20661139|P3|Open-Label Phase|Protocol Violation|0
5974077|NCT01098240|20661140|P2|Open-Label Phase|Protocol Violation|0
5974078|NCT01098240|20661141|P1|Open-Label Phase|Protocol Violation|4
5974079|NCT01098240|20661139|P3|Open-Label Phase|Study Terminated by Sponsor|0
5974080|NCT01098240|20661140|P2|Open-Label Phase|Study Terminated by Sponsor|0
5974081|NCT01098240|20661141|P1|Open-Label Phase|Study Terminated by Sponsor|27
5974082|NCT01098162|20661171|P1|Overall Study|Reason Unknown|26
5974083|NCT01098162|20661171|P1|Overall Study|Other Reason|1
5974084|NCT01098162|20661171|P1|Overall Study|Wish of Patient & Lost to Follow-up|1
5974085|NCT01098162|20661171|P1|Overall Study|AE & Lack of Efficacy & Wish of Patient|1
5974086|NCT01098162|20661171|P1|Overall Study|Adverse Event & Lost to Follow-up|2
5974087|NCT01098162|20661171|P1|Overall Study|Adverse Event & Wish of Patient|13
5974088|NCT01098162|20661171|P1|Overall Study|Adverse Event & Lack of Efficacy|6
5974089|NCT01098162|20661171|P1|Overall Study|Lack of Efficacy & Wish of Patient|5
5974090|NCT01098162|20661171|P1|Overall Study|Lost to Follow-up|9
5974091|NCT01098162|20661171|P1|Overall Study|Wish of Patient|7
5974092|NCT01098162|20661171|P1|Overall Study|Lack of Efficacy|4
5974093|NCT01098162|20661171|P1|Overall Study|Adverse Event|37
5974094|NCT01098110|20661183|P3|Overall Study|Untreated|0
5974095|NCT01098110|20661184|P2|Overall Study|Untreated|1
5974096|NCT01098110|20661185|P1|Overall Study|Untreated|1
5974097|NCT01098110|20661183|P3|Overall Study|Other|5
5974098|NCT01098110|20661184|P2|Overall Study|Other|7
5974099|NCT01098110|20661185|P1|Overall Study|Other|4
5974100|NCT01098110|20661183|P3|Overall Study|Lack of Efficacy|27
5974101|NCT01098110|20661184|P2|Overall Study|Lack of Efficacy|9
5974102|NCT01098110|20661185|P1|Overall Study|Lack of Efficacy|13
5974103|NCT01098110|20661183|P3|Overall Study|Adverse Event|43
5974104|NCT01098110|20661184|P2|Overall Study|Adverse Event|32
5974105|NCT01098110|20661185|P1|Overall Study|Adverse Event|30
5974106|NCT01098110|20661183|P3|Overall Study|Withdrawal by Subject|19
5974107|NCT01098110|20661184|P2|Overall Study|Withdrawal by Subject|24
5974108|NCT01098110|20661185|P1|Overall Study|Withdrawal by Subject|14
5974109|NCT01098097|20661226|P1|Overall Study|No reason reported|31
5974110|NCT01098097|20661226|P1|Overall Study|Status unknown|16
5974111|NCT01098097|20661226|P1|Overall Study|Lost to Follow-up|18
5974112|NCT01098097|20661226|P1|Overall Study|Adverse Event|17
5974113|NCT01098071|20661235|P1|Overall Study|Lost to Follow-up|13
5974114|NCT01098071|20661235|P1|Overall Study|Surgery (adenoidectomy)|2
5974115|NCT01098032|20661248|P2|Overall Study|Withdrawal by Subject|1
5974116|NCT01098032|20661249|P1|Overall Study|Withdrawal by Subject|1
5974117|NCT01097863|20661366|P3|Overall Study|Did not return for final visit|1
5974118|NCT01097863|20661367|P2|Overall Study|Did not return for final visit|0
5974119|NCT01097863|20661368|P1|Overall Study|Did not return for final visit|0
5974120|NCT01097863|20661366|P3|Overall Study|Discomfort|1
5974121|NCT01097863|20661367|P2|Overall Study|Discomfort|0
5974122|NCT01097863|20661368|P1|Overall Study|Discomfort|1
5974123|NCT01097707|20661392|P5|Overall Study|Reason unknown|1
5974124|NCT01097707|20661393|P4|Overall Study|Reason unknown|0
5974125|NCT01097707|20661394|P3|Overall Study|Reason unknown|0
5974126|NCT01097707|20661395|P2|Overall Study|Reason unknown|0
5974127|NCT01097707|20661396|P1|Overall Study|Reason unknown|0
5974128|NCT01097707|20661392|P5|Overall Study|Withdrawal by Subject|3
5974129|NCT01097707|20661393|P4|Overall Study|Withdrawal by Subject|4
5974130|NCT01097707|20661394|P3|Overall Study|Withdrawal by Subject|1
5974131|NCT01097707|20661395|P2|Overall Study|Withdrawal by Subject|6
5974132|NCT01097707|20661396|P1|Overall Study|Withdrawal by Subject|3
5974133|NCT01097707|20661392|P5|Overall Study|Sponsor Decision|36
5974134|NCT01097707|20661393|P4|Overall Study|Sponsor Decision|35
5974135|NCT01097707|20661394|P3|Overall Study|Sponsor Decision|34
5974136|NCT01097707|20661395|P2|Overall Study|Sponsor Decision|31
5974137|NCT01097707|20661396|P1|Overall Study|Sponsor Decision|31
5974138|NCT01097707|20661392|P5|Overall Study|Protocol Violation|2
5974139|NCT01097707|20661393|P4|Overall Study|Protocol Violation|2
5974140|NCT01097707|20661394|P3|Overall Study|Protocol Violation|3
5974141|NCT01097707|20661395|P2|Overall Study|Protocol Violation|2
5974142|NCT01097707|20661396|P1|Overall Study|Protocol Violation|2
5974143|NCT01097707|20661392|P5|Overall Study|Lost to Follow-up|3
5974144|NCT01097707|20661393|P4|Overall Study|Lost to Follow-up|0
5974145|NCT01097707|20661394|P3|Overall Study|Lost to Follow-up|2
5974146|NCT01097707|20661395|P2|Overall Study|Lost to Follow-up|1
5974147|NCT01097707|20661396|P1|Overall Study|Lost to Follow-up|1
5974148|NCT01097707|20661392|P5|Overall Study|Lack of Efficacy|0
5974149|NCT01097707|20661393|P4|Overall Study|Lack of Efficacy|1
5974150|NCT01097707|20661394|P3|Overall Study|Lack of Efficacy|0
5974151|NCT01097707|20661395|P2|Overall Study|Lack of Efficacy|0
5974152|NCT01097707|20661396|P1|Overall Study|Lack of Efficacy|1
5974153|NCT01097707|20661392|P5|Overall Study|Entry Criteria Not Met|1
5974154|NCT01097707|20661393|P4|Overall Study|Entry Criteria Not Met|0
5974155|NCT01097707|20661394|P3|Overall Study|Entry Criteria Not Met|1
5974156|NCT01097707|20661395|P2|Overall Study|Entry Criteria Not Met|1
5974157|NCT01097707|20661396|P1|Overall Study|Entry Criteria Not Met|2
5974158|NCT01097707|20661392|P5|Overall Study|Adverse Event|3
5974159|NCT01097707|20661393|P4|Overall Study|Adverse Event|1
5974160|NCT01097707|20661394|P3|Overall Study|Adverse Event|3
5974161|NCT01097707|20661395|P2|Overall Study|Adverse Event|2
5974162|NCT01097707|20661396|P1|Overall Study|Adverse Event|4
5974163|NCT01097707|20661392|P5|Overall Study|Abnormal Lab/Electrocardiogram Result|1
5974164|NCT01097707|20661393|P4|Overall Study|Abnormal Lab/Electrocardiogram Result|1
5974165|NCT01097707|20661394|P3|Overall Study|Abnormal Lab/Electrocardiogram Result|1
5974166|NCT01097707|20661395|P2|Overall Study|Abnormal Lab/Electrocardiogram Result|0
5974167|NCT01097707|20661396|P1|Overall Study|Abnormal Lab/Electrocardiogram Result|0
5974168|NCT01097694|20661445|P2|Overall Study|Withdrawal by Subject|1
5974169|NCT01097694|20661446|P1|Overall Study|Withdrawal by Subject|3
5974170|NCT01097694|20661445|P2|Overall Study|Lost to Follow-up|3
5974171|NCT01097694|20661446|P1|Overall Study|Lost to Follow-up|0
5974172|NCT01097694|20661445|P2|Overall Study|Adverse Event|0
5974173|NCT01097694|20661446|P1|Overall Study|Adverse Event|5
5974174|NCT01097668|20661508|P2|Overall Study|Lost to Follow-up|0
5974175|NCT01097668|20661509|P1|Overall Study|Lost to Follow-up|1
5974176|NCT01097668|20661508|P2|Overall Study|Withdrawal by Subject|2
5974177|NCT01097668|20661509|P1|Overall Study|Withdrawal by Subject|1
5974178|NCT01097655|20661519|P1|Overall Study|Did Not Meet Inclusion Criteria|8
5974179|NCT01097655|20661519|P1|Overall Study|Subject Documented Twice|1
5974180|NCT01097655|20661519|P1|Overall Study|Withdrawal by Subject|1
5974181|NCT01097629|20661529|P8|DB RO Phase|Lost to Follow-up|0
5974182|NCT01097629|20661530|P7|DB RO Phase|Lost to Follow-up|2
5974183|NCT01097629|20661531|P6|DB RO Phase|Lost to Follow-up|0
5974184|NCT01097629|20661532|P5|DB RO Phase|Lost to Follow-up|0
5974185|NCT01097629|20661533|P4|DB RO Phase|Lost to Follow-up|0
5974186|NCT01097629|20661534|P3|DB RO Phase|Lost to Follow-up|0
5974187|NCT01097629|20661535|P2|DB RO Phase|Lost to Follow-up|0
5974188|NCT01097629|20661536|P1|DB RO Phase|Lost to Follow-up|0
5974189|NCT01097629|20661529|P8|DB RO Phase|Protocol Violation|0
5974190|NCT01097629|20661530|P7|DB RO Phase|Protocol Violation|1
5974191|NCT01097629|20661531|P6|DB RO Phase|Protocol Violation|1
5974192|NCT01097629|20661532|P5|DB RO Phase|Protocol Violation|0
5974193|NCT01097629|20661533|P4|DB RO Phase|Protocol Violation|1
5974194|NCT01097629|20661534|P3|DB RO Phase|Protocol Violation|0
5974195|NCT01097629|20661535|P2|DB RO Phase|Protocol Violation|0
5974196|NCT01097629|20661536|P1|DB RO Phase|Protocol Violation|0
5974197|NCT01097629|20661529|P8|DB RO Phase|Withdrawal by Subject|1
5974198|NCT01097629|20661530|P7|DB RO Phase|Withdrawal by Subject|0
5974199|NCT01097629|20661531|P6|DB RO Phase|Withdrawal by Subject|0
5974200|NCT01097629|20661532|P5|DB RO Phase|Withdrawal by Subject|0
5974201|NCT01097629|20661533|P4|DB RO Phase|Withdrawal by Subject|0
5974202|NCT01097629|20661534|P3|DB RO Phase|Withdrawal by Subject|0
5974203|NCT01097629|20661535|P2|DB RO Phase|Withdrawal by Subject|0
5974204|NCT01097629|20661536|P1|DB RO Phase|Withdrawal by Subject|0
5974205|NCT01097629|20661529|P8|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
5974206|NCT01097629|20661530|P7|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
5974207|NCT01097629|20661531|P6|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
5974208|NCT01097629|20661532|P5|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
5974209|NCT01097629|20661533|P4|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
5974210|NCT01097629|20661534|P3|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|4
5974211|NCT01097629|20661535|P2|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|5
5974212|NCT01097629|20661536|P1|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1
5974213|NCT01097629|20661529|P8|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
5974214|NCT01097629|20661530|P7|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
5974215|NCT01097629|20661531|P6|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
5974216|NCT01097629|20661532|P5|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
5974217|NCT01097629|20661533|P4|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
5974218|NCT01097629|20661534|P3|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
5974219|NCT01097629|20661535|P2|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|1
5974220|NCT01097629|20661536|P1|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|2
5974221|NCT01097629|20661529|P8|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
5974222|NCT01097629|20661530|P7|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
5974223|NCT01097629|20661531|P6|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
5974224|NCT01097629|20661532|P5|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
5974225|NCT01097629|20661533|P4|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
5974226|NCT01097629|20661534|P3|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|8
5974227|NCT01097629|20661535|P2|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|4
5974228|NCT01097629|20661536|P1|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7
5974229|NCT01097629|20661529|P8|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
5974230|NCT01097629|20661530|P7|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
5974231|NCT01097629|20661531|P6|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
5974232|NCT01097629|20661532|P5|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
5974233|NCT01097629|20661533|P4|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
5974234|NCT01097629|20661534|P3|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1
5974235|NCT01097629|20661535|P2|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|4
5974236|NCT01097629|20661536|P1|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|2
5974237|NCT01097629|20661529|P8|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
5974238|NCT01097629|20661530|P7|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
5974239|NCT01097629|20661531|P6|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
5974240|NCT01097629|20661532|P5|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
5974241|NCT01097629|20661533|P4|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
5974242|NCT01097629|20661534|P3|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|8
5974243|NCT01097629|20661535|P2|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|4
5974244|NCT01097629|20661536|P1|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5
5974245|NCT01097629|20661529|P8|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
5974246|NCT01097629|20661530|P7|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
5974247|NCT01097629|20661531|P6|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
5974248|NCT01097629|20661532|P5|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
5974249|NCT01097629|20661533|P4|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
5974250|NCT01097629|20661534|P3|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|19
5974251|NCT01097629|20661535|P2|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|9
5974252|NCT01097629|20661536|P1|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8
5974253|NCT01097629|20661529|P8|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
5974254|NCT01097629|20661530|P7|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
5974255|NCT01097629|20661531|P6|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
5974256|NCT01097629|20661532|P5|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
5974257|NCT01097629|20661533|P4|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
5974258|NCT01097629|20661534|P3|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|17
5974259|NCT01097629|20661535|P2|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|19
5974260|NCT01097629|20661536|P1|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|10
5974261|NCT01097616|20661587|P8|DB RO Phase|Not Treated in RO|0
5974262|NCT01097616|20661588|P7|DB RO Phase|Not Treated in RO|0
5974263|NCT01097616|20661589|P6|DB RO Phase|Not Treated in RO|1
5974264|NCT01097616|20661590|P5|DB RO Phase|Not Treated in RO|0
5974265|NCT01097616|20661591|P4|DB RO Phase|Not Treated in RO|0
5974266|NCT01097616|20661592|P3|DB RO Phase|Not Treated in RO|0
5974267|NCT01097616|20661593|P2|DB RO Phase|Not Treated in RO|0
5974268|NCT01097616|20661594|P1|DB RO Phase|Not Treated in RO|0
5974269|NCT01097616|20661587|P8|DB RO Phase|Lost to Follow-up|1
5974270|NCT01097616|20661588|P7|DB RO Phase|Lost to Follow-up|0
5974271|NCT01097616|20661589|P6|DB RO Phase|Lost to Follow-up|0
5974272|NCT01097616|20661590|P5|DB RO Phase|Lost to Follow-up|1
5974273|NCT01097616|20661591|P4|DB RO Phase|Lost to Follow-up|1
5974274|NCT01097616|20661592|P3|DB RO Phase|Lost to Follow-up|0
5974275|NCT01097616|20661593|P2|DB RO Phase|Lost to Follow-up|0
5974276|NCT01097616|20661594|P1|DB RO Phase|Lost to Follow-up|0
5974277|NCT01097616|20661587|P8|DB RO Phase|Withdrawal by Subject|0
5974278|NCT01097616|20661588|P7|DB RO Phase|Withdrawal by Subject|0
5974279|NCT01097616|20661589|P6|DB RO Phase|Withdrawal by Subject|1
5974280|NCT01097616|20661590|P5|DB RO Phase|Withdrawal by Subject|0
5974281|NCT01097616|20661591|P4|DB RO Phase|Withdrawal by Subject|0
5974282|NCT01097616|20661592|P3|DB RO Phase|Withdrawal by Subject|0
5974283|NCT01097616|20661593|P2|DB RO Phase|Withdrawal by Subject|0
5974284|NCT01097616|20661594|P1|DB RO Phase|Withdrawal by Subject|0
5974285|NCT01097616|20661587|P8|DB RO Phase|Adverse Event|0
5974286|NCT01097616|20661588|P7|DB RO Phase|Adverse Event|1
5974287|NCT01097616|20661589|P6|DB RO Phase|Adverse Event|0
5974288|NCT01097616|20661590|P5|DB RO Phase|Adverse Event|0
5974289|NCT01097616|20661591|P4|DB RO Phase|Adverse Event|0
5974290|NCT01097616|20661592|P3|DB RO Phase|Adverse Event|0
5974291|NCT01097616|20661593|P2|DB RO Phase|Adverse Event|0
5974292|NCT01097616|20661594|P1|DB RO Phase|Adverse Event|0
5974293|NCT01097616|20661587|P8|Optional DB EXT Phase|Physician Decision|0
5974294|NCT01097616|20661588|P7|Optional DB EXT Phase|Physician Decision|0
5974295|NCT01097616|20661589|P6|Optional DB EXT Phase|Physician Decision|0
5974296|NCT01097616|20661590|P5|Optional DB EXT Phase|Physician Decision|0
5974297|NCT01097616|20661591|P4|Optional DB EXT Phase|Physician Decision|0
5974298|NCT01097616|20661592|P3|Optional DB EXT Phase|Physician Decision|0
5974299|NCT01097616|20661593|P2|Optional DB EXT Phase|Physician Decision|0
5974300|NCT01097616|20661594|P1|Optional DB EXT Phase|Physician Decision|1
5974301|NCT01097616|20661587|P8|Optional DB EXT Phase|Lack of Efficacy|0
5974302|NCT01097616|20661588|P7|Optional DB EXT Phase|Lack of Efficacy|0
5974303|NCT01097616|20661589|P6|Optional DB EXT Phase|Lack of Efficacy|0
5974304|NCT01097616|20661590|P5|Optional DB EXT Phase|Lack of Efficacy|0
5974305|NCT01097616|20661591|P4|Optional DB EXT Phase|Lack of Efficacy|0
5974306|NCT01097616|20661592|P3|Optional DB EXT Phase|Lack of Efficacy|1
5974307|NCT01097616|20661593|P2|Optional DB EXT Phase|Lack of Efficacy|1
5974308|NCT01097616|20661594|P1|Optional DB EXT Phase|Lack of Efficacy|1
5974309|NCT01097616|20661587|P8|Optional DB EXT Phase|Lost to Follow-up|0
5974310|NCT01097616|20661588|P7|Optional DB EXT Phase|Lost to Follow-up|0
5974311|NCT01097616|20661589|P6|Optional DB EXT Phase|Lost to Follow-up|0
5974312|NCT01097616|20661590|P5|Optional DB EXT Phase|Lost to Follow-up|0
5974313|NCT01097616|20661591|P4|Optional DB EXT Phase|Lost to Follow-up|0
5974314|NCT01097616|20661592|P3|Optional DB EXT Phase|Lost to Follow-up|1
5974315|NCT01097616|20661593|P2|Optional DB EXT Phase|Lost to Follow-up|5
5974316|NCT01097616|20661594|P1|Optional DB EXT Phase|Lost to Follow-up|1
5974317|NCT01097616|20661587|P8|Optional DB EXT Phase|Protocol Violation|0
5974318|NCT01097616|20661588|P7|Optional DB EXT Phase|Protocol Violation|0
5974319|NCT01097616|20661589|P6|Optional DB EXT Phase|Protocol Violation|0
5974320|NCT01097616|20661590|P5|Optional DB EXT Phase|Protocol Violation|0
5974321|NCT01097616|20661591|P4|Optional DB EXT Phase|Protocol Violation|0
5974322|NCT01097616|20661592|P3|Optional DB EXT Phase|Protocol Violation|3
5974323|NCT01097616|20661593|P2|Optional DB EXT Phase|Protocol Violation|2
5974324|NCT01097616|20661594|P1|Optional DB EXT Phase|Protocol Violation|0
5974325|NCT01097616|20661587|P8|Optional DB EXT Phase|Withdrawal by Subject|0
5974326|NCT01097616|20661588|P7|Optional DB EXT Phase|Withdrawal by Subject|0
5974327|NCT01097616|20661589|P6|Optional DB EXT Phase|Withdrawal by Subject|0
5974328|NCT01097616|20661590|P5|Optional DB EXT Phase|Withdrawal by Subject|0
5974329|NCT01097616|20661591|P4|Optional DB EXT Phase|Withdrawal by Subject|0
5974330|NCT01097616|20661592|P3|Optional DB EXT Phase|Withdrawal by Subject|3
5974331|NCT01097616|20661593|P2|Optional DB EXT Phase|Withdrawal by Subject|6
5974332|NCT01097616|20661594|P1|Optional DB EXT Phase|Withdrawal by Subject|12
5974333|NCT01097616|20661587|P8|Optional DB EXT Phase|Adverse Event|0
5974334|NCT01097616|20661588|P7|Optional DB EXT Phase|Adverse Event|0
5974335|NCT01097616|20661589|P6|Optional DB EXT Phase|Adverse Event|0
5974336|NCT01097616|20661590|P5|Optional DB EXT Phase|Adverse Event|0
5974337|NCT01097616|20661591|P4|Optional DB EXT Phase|Adverse Event|0
5974338|NCT01097616|20661592|P3|Optional DB EXT Phase|Adverse Event|2
5974339|NCT01097616|20661593|P2|Optional DB EXT Phase|Adverse Event|7
5974340|NCT01097616|20661594|P1|Optional DB EXT Phase|Adverse Event|0
5974341|NCT01097616|20661587|P8|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
5974342|NCT01097616|20661588|P7|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
5974343|NCT01097616|20661589|P6|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
5974344|NCT01097616|20661590|P5|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
5974345|NCT01097616|20661591|P4|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
5974346|NCT01097616|20661592|P3|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1
5974347|NCT01097616|20661593|P2|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
5974348|NCT01097616|20661594|P1|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
5974349|NCT01097616|20661587|P8|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
5974350|NCT01097616|20661588|P7|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
5974351|NCT01097616|20661589|P6|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
5974352|NCT01097616|20661590|P5|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
5974353|NCT01097616|20661591|P4|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
5974354|NCT01097616|20661592|P3|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
5974355|NCT01097616|20661593|P2|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|3
5974356|NCT01097616|20661594|P1|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|4
5974357|NCT01097616|20661587|P8|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
5974358|NCT01097616|20661588|P7|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
5974359|NCT01097616|20661589|P6|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
5974360|NCT01097616|20661590|P5|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
5974361|NCT01097616|20661591|P4|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
5974362|NCT01097616|20661592|P3|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
5974363|NCT01097616|20661593|P2|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1
5974364|NCT01097616|20661594|P1|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1
5974365|NCT01097616|20661587|P8|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
5974366|NCT01097616|20661588|P7|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
5974367|NCT01097616|20661589|P6|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
5974368|NCT01097616|20661590|P5|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
5974369|NCT01097616|20661591|P4|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
5974370|NCT01097616|20661592|P3|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|9
5974371|NCT01097616|20661593|P2|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7
5974372|NCT01097616|20661594|P1|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|1
5974373|NCT01097616|20661587|P8|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
5974374|NCT01097616|20661588|P7|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
5974375|NCT01097616|20661589|P6|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
5974376|NCT01097616|20661590|P5|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
5974377|NCT01097616|20661591|P4|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
5974378|NCT01097616|20661592|P3|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
5974379|NCT01097616|20661593|P2|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1
5974380|NCT01097616|20661594|P1|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1
5974381|NCT01097616|20661587|P8|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
5974382|NCT01097616|20661588|P7|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
5974383|NCT01097616|20661589|P6|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
5974384|NCT01097616|20661590|P5|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
5974385|NCT01097616|20661591|P4|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
5974386|NCT01097616|20661592|P3|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|1
5974387|NCT01097616|20661593|P2|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|3
5974388|NCT01097616|20661594|P1|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5
5974389|NCT01097616|20661587|P8|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
5974390|NCT01097616|20661588|P7|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
5974391|NCT01097616|20661589|P6|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
5974392|NCT01097616|20661590|P5|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
5974393|NCT01097616|20661591|P4|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
5974394|NCT01097616|20661592|P3|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|12
5974395|NCT01097616|20661593|P2|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8
5974396|NCT01097616|20661594|P1|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|6
5974397|NCT01097616|20661587|P8|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
5974398|NCT01097616|20661588|P7|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
5974399|NCT01097616|20661589|P6|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
5974400|NCT01097616|20661590|P5|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
5974401|NCT01097616|20661591|P4|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
5974402|NCT01097616|20661592|P3|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|21
5974403|NCT01097616|20661593|P2|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|15
5974404|NCT01097616|20661594|P1|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|6
5974405|NCT01097577|20661667|P2|Overall Study|Adverse Event|1
5974406|NCT01097577|20661668|P1|Overall Study|Adverse Event|0
5974407|NCT01097421|20661688|P1|Overall Study|Withdrawal by Subject|3
5974408|NCT01097421|20661688|P1|Overall Study|Lost to Follow-up|1
5974409|NCT01097421|20661688|P1|Overall Study|Protocol Violation|2
5974410|NCT01097421|20661688|P1|Overall Study|Adverse Event|8
5974411|NCT01097330|20661707|P2|Overall Study|Study terminated early|5
5974412|NCT01097330|20661708|P1|Overall Study|Study terminated early|7
5974413|NCT01097057|20661725|P1|Overall Study|Physician Decision|3
5974414|NCT01097044|20661734|P2|Overall Study|Withdrawal by Sponsor|1
5974415|NCT01097044|20661735|P1|Overall Study|Withdrawal by Sponsor|0
5974416|NCT01097044|20661734|P2|Overall Study|Lost to Follow-up|0
5974417|NCT01097044|20661735|P1|Overall Study|Lost to Follow-up|1
5974418|NCT01097044|20661734|P2|Overall Study|Withdrawal by Subject|4
5974419|NCT01097044|20661735|P1|Overall Study|Withdrawal by Subject|4
5974420|NCT01097005|20661753|P1|Overall Study|Discontinuance by complication|50
5974421|NCT01097005|20661753|P1|Overall Study|Adverse Event|14
5974422|NCT01097005|20661753|P1|Overall Study|Deviation from exclusion criteria|37
5974423|NCT01097005|20661753|P1|Overall Study|No examination data available|244
5974424|NCT01097005|20661753|P1|Overall Study|Poor medication compliance|1
5974425|NCT01097005|20661753|P1|Overall Study|Subjects cannot visit the hospital|1
5974426|NCT01097005|20661753|P1|Overall Study|Case Report Form not collected|18
5974427|NCT01096849|20661799|P3|Overall Study|Lost to Follow-up|1
5974428|NCT01096849|20661800|P2|Overall Study|Lost to Follow-up|3
5974429|NCT01096849|20661801|P1|Overall Study|Lost to Follow-up|1
5974430|NCT01096849|20661799|P3|Overall Study|Administrative Reasons|2
5974431|NCT01096849|20661800|P2|Overall Study|Administrative Reasons|1
5974432|NCT01096849|20661801|P1|Overall Study|Administrative Reasons|0
5974433|NCT01096849|20661799|P3|Overall Study|Investigator or Medical Monitor Decision|0
5974434|NCT01096849|20661800|P2|Overall Study|Investigator or Medical Monitor Decision|1
5974435|NCT01096849|20661801|P1|Overall Study|Investigator or Medical Monitor Decision|0
5974436|NCT01096849|20661799|P3|Overall Study|Unacceptable/ Intolerable AE(s)|1
5974437|NCT01096849|20661800|P2|Overall Study|Unacceptable/ Intolerable AE(s)|1
5974438|NCT01096849|20661801|P1|Overall Study|Unacceptable/ Intolerable AE(s)|0
5974439|NCT01096849|20661799|P3|Overall Study|Lack of Efficacy|0
5974440|NCT01096849|20661800|P2|Overall Study|Lack of Efficacy|2
5974441|NCT01096849|20661801|P1|Overall Study|Lack of Efficacy|0
5974442|NCT01096849|20661799|P3|Overall Study|Consent Withdrawn|2
5974443|NCT01096849|20661800|P2|Overall Study|Consent Withdrawn|4
5974444|NCT01096849|20661801|P1|Overall Study|Consent Withdrawn|1
5974445|NCT01096784|20661877|P2|Overall Study|Other Unspecified|1
5974446|NCT01096784|20661878|P1|Overall Study|Other Unspecified|0
5974447|NCT01096784|20661877|P2|Overall Study|Administrative Decision|1
5974448|NCT01096784|20661878|P1|Overall Study|Administrative Decision|0
5974449|NCT01096784|20661877|P2|Overall Study|Protocol Deviation|2
5974450|NCT01096784|20661878|P1|Overall Study|Protocol Deviation|2
5974451|NCT01096784|20661877|P2|Overall Study|Adverse Event|9
5974452|NCT01096784|20661878|P1|Overall Study|Adverse Event|11
5974453|NCT01096784|20661877|P2|Overall Study|Withdrawal by Subject|1
5974454|NCT01096784|20661878|P1|Overall Study|Withdrawal by Subject|2
5974455|NCT01096667|20661983|P5|Overall Study|Not treated|0
5974456|NCT01096667|20661984|P4|Overall Study|Not treated|0
5974457|NCT01096667|20661985|P3|Overall Study|Not treated|0
5974458|NCT01096667|20661986|P2|Overall Study|Not treated|0
5974459|NCT01096667|20661987|P1|Overall Study|Not treated|1
5974460|NCT01096667|20661983|P5|Overall Study|Protocol Violation|0
5974461|NCT01096667|20661984|P4|Overall Study|Protocol Violation|1
5974462|NCT01096667|20661985|P3|Overall Study|Protocol Violation|0
5974463|NCT01096667|20661986|P2|Overall Study|Protocol Violation|0
5974464|NCT01096667|20661987|P1|Overall Study|Protocol Violation|0
5974465|NCT01096667|20661983|P5|Overall Study|Reason not available|0
5974466|NCT01096667|20661984|P4|Overall Study|Reason not available|1
5974467|NCT01096667|20661985|P3|Overall Study|Reason not available|1
5974468|NCT01096667|20661986|P2|Overall Study|Reason not available|1
5974469|NCT01096667|20661987|P1|Overall Study|Reason not available|0
5974470|NCT01096667|20661983|P5|Overall Study|Withdrawal by Subject|0
5974471|NCT01096667|20661984|P4|Overall Study|Withdrawal by Subject|1
5974472|NCT01096667|20661985|P3|Overall Study|Withdrawal by Subject|0
5974473|NCT01096667|20661986|P2|Overall Study|Withdrawal by Subject|0
5974474|NCT01096667|20661987|P1|Overall Study|Withdrawal by Subject|1
5974475|NCT01096667|20661983|P5|Overall Study|Lost to Follow-up|0
5974476|NCT01096667|20661984|P4|Overall Study|Lost to Follow-up|0
5974477|NCT01096667|20661985|P3|Overall Study|Lost to Follow-up|1
5974478|NCT01096667|20661986|P2|Overall Study|Lost to Follow-up|1
5974479|NCT01096667|20661987|P1|Overall Study|Lost to Follow-up|1
5974480|NCT01096589|20662129|P4|Overall Study|found treatment exhausting|1
5974481|NCT01096589|20662130|P3|Overall Study|found treatment exhausting|0
5974482|NCT01096589|20662131|P2|Overall Study|found treatment exhausting|0
5974483|NCT01096589|20662132|P1|Overall Study|found treatment exhausting|0
5974484|NCT01096589|20662129|P4|Overall Study|Compliance with protocol|0
5974485|NCT01096589|20662130|P3|Overall Study|Compliance with protocol|1
5974486|NCT01096589|20662131|P2|Overall Study|Compliance with protocol|0
5974487|NCT01096589|20662132|P1|Overall Study|Compliance with protocol|0
5974488|NCT01096589|20662129|P4|Overall Study|Withdrawal by Subject|1
5974489|NCT01096589|20662130|P3|Overall Study|Withdrawal by Subject|1
5974490|NCT01096589|20662131|P2|Overall Study|Withdrawal by Subject|1
5974491|NCT01096589|20662132|P1|Overall Study|Withdrawal by Subject|2
5974492|NCT01096589|20662129|P4|Overall Study|Adverse Event|1
5974493|NCT01096589|20662130|P3|Overall Study|Adverse Event|2
5974494|NCT01096589|20662131|P2|Overall Study|Adverse Event|1
5974495|NCT01096589|20662132|P1|Overall Study|Adverse Event|2
5974496|NCT01096550|20662148|P2|Overall Study|Lost to Follow-up|9
5974497|NCT01096550|20662149|P1|Overall Study|Lost to Follow-up|12
5974498|NCT01096550|20662148|P2|Overall Study|non-African American participant|6
5974499|NCT01096550|20662149|P1|Overall Study|non-African American participant|13
5974500|NCT01096550|20662148|P2|Overall Study|Withdrawal by Subject|1
5974501|NCT01096550|20662149|P1|Overall Study|Withdrawal by Subject|0
5974502|NCT01096550|20662148|P2|Overall Study|clinic readmission|1
5974503|NCT01096550|20662149|P1|Overall Study|clinic readmission|1
5974504|NCT01096550|20662148|P2|Overall Study|non-regular treatment track at clinic|1
5974505|NCT01096550|20662149|P1|Overall Study|non-regular treatment track at clinic|1
5974506|NCT01096550|20662148|P2|Overall Study|discontinued site|11
5974507|NCT01096550|20662149|P1|Overall Study|discontinued site|10
5974508|NCT01096446|20662157|P2|Overall Study|Protocol Violation|0
5974509|NCT01096446|20662158|P1|Overall Study|Protocol Violation|2
5974510|NCT01096446|20662157|P2|Overall Study|Death|0
5974511|NCT01096446|20662158|P1|Overall Study|Death|1
5974512|NCT01096342|20662163|P1|Overall Study|Protocol Violation|1
5974513|NCT01096316|20662171|P2|Overall Study|Lost to Follow-up|9
5974514|NCT01096316|20662172|P1|Overall Study|Lost to Follow-up|15
5974515|NCT01096186|20662193|P1|Overall Study|Noncompliance with study drug|1
5974516|NCT01096186|20662193|P1|Overall Study|Physician Decision|1
5974517|NCT01096186|20662193|P1|Overall Study|Withdrawal by Subject|22
5974518|NCT01096186|20662193|P1|Overall Study|Lost to Follow-up|2
5974519|NCT01096186|20662193|P1|Overall Study|Lack of Efficacy|4
5974520|NCT01096186|20662193|P1|Overall Study|Death|4
5974521|NCT01096186|20662193|P1|Overall Study|Adverse Event|16
5974522|NCT01096160|20662209|P10|Overall Study|Met stopping criteria per protocol|0
5974523|NCT01096160|20662210|P9|Overall Study|Met stopping criteria per protocol|2
5974524|NCT01096160|20662211|P8|Overall Study|Met stopping criteria per protocol|0
5974525|NCT01096160|20662212|P7|Overall Study|Met stopping criteria per protocol|2
5974526|NCT01096160|20662213|P6|Overall Study|Met stopping criteria per protocol|0
5974527|NCT01096160|20662214|P5|Overall Study|Met stopping criteria per protocol|1
5974528|NCT01096160|20662215|P4|Overall Study|Met stopping criteria per protocol|0
5974529|NCT01096160|20662216|P3|Overall Study|Met stopping criteria per protocol|0
5974530|NCT01096160|20662217|P2|Overall Study|Met stopping criteria per protocol|0
5974531|NCT01096160|20662218|P1|Overall Study|Met stopping criteria per protocol|0
5974532|NCT01096160|20662209|P10|Overall Study|Adverse Event|1
5974533|NCT01096160|20662210|P9|Overall Study|Adverse Event|0
5974534|NCT01096160|20662211|P8|Overall Study|Adverse Event|0
5974535|NCT01096160|20662212|P7|Overall Study|Adverse Event|0
5974536|NCT01096160|20662213|P6|Overall Study|Adverse Event|0
5974537|NCT01096160|20662214|P5|Overall Study|Adverse Event|0
5974538|NCT01096160|20662215|P4|Overall Study|Adverse Event|0
5974539|NCT01096160|20662216|P3|Overall Study|Adverse Event|1
5974540|NCT01096160|20662217|P2|Overall Study|Adverse Event|0
5974541|NCT01096160|20662218|P1|Overall Study|Adverse Event|0
5974542|NCT01096056|20662276|P2|Overall Study|Lost to Follow-up|1
5974543|NCT01096056|20662277|P1|Overall Study|Lost to Follow-up|0
5974544|NCT01096017|20662309|P2|Treatment Period 2|Eligibility criteria not fulfilled|1
5974545|NCT01096017|20662310|P1|Treatment Period 2|Eligibility criteria not fulfilled|1
5974546|NCT01095978|20662338|P1|Overall Study|Adverse Event|1
5974547|NCT01095978|20662338|P1|Overall Study|Did not take Klacid SR|2
5974548|NCT01095835|20662372|P3|Overall Study|Protocol Violation|0
5974549|NCT01095835|20662373|P2|Overall Study|Protocol Violation|2
5974550|NCT01095835|20662374|P1|Overall Study|Protocol Violation|1
5974551|NCT01095835|20662372|P3|Overall Study|Non study compliance|1
5974552|NCT01095835|20662373|P2|Overall Study|Non study compliance|0
5974553|NCT01095835|20662374|P1|Overall Study|Non study compliance|0
5974554|NCT01095835|20662372|P3|Overall Study|Withdrawal by Subject|0
5974555|NCT01095835|20662373|P2|Overall Study|Withdrawal by Subject|3
5974556|NCT01095835|20662374|P1|Overall Study|Withdrawal by Subject|1
5974557|NCT01095835|20662372|P3|Overall Study|Physician Decision|1
5974558|NCT01095835|20662373|P2|Overall Study|Physician Decision|0
5974559|NCT01095835|20662374|P1|Overall Study|Physician Decision|0
5974560|NCT01095835|20662372|P3|Overall Study|Lack of Efficacy|0
5974561|NCT01095835|20662373|P2|Overall Study|Lack of Efficacy|1
5974562|NCT01095835|20662374|P1|Overall Study|Lack of Efficacy|0
5974563|NCT01095835|20662372|P3|Overall Study|Adverse Event|6
5974564|NCT01095835|20662373|P2|Overall Study|Adverse Event|6
5974565|NCT01095835|20662374|P1|Overall Study|Adverse Event|8
5974566|NCT01095796|20662412|P2|Overall Study|Participant Transferred to Another Study|200
5974567|NCT01095796|20662413|P1|Overall Study|Participant Transferred to Another Study|215
5974568|NCT01095796|20662412|P2|Overall Study|Protocol Violation|0
5974569|NCT01095796|20662413|P1|Overall Study|Protocol Violation|1
5974570|NCT01095796|20662412|P2|Overall Study|Participant Noncompliance|10
5974571|NCT01095796|20662413|P1|Overall Study|Participant Noncompliance|5
5974572|NCT01095796|20662412|P2|Overall Study|Lost to Follow-up|29
5974573|NCT01095796|20662413|P1|Overall Study|Lost to Follow-up|27
5974574|NCT01095796|20662412|P2|Overall Study|Withdrew Consent|22
5974575|NCT01095796|20662413|P1|Overall Study|Withdrew Consent|16
5974576|NCT01095796|20662412|P2|Overall Study|Investigator's Discretion|2
5974577|NCT01095796|20662413|P1|Overall Study|Investigator's Discretion|7
5974578|NCT01095796|20662412|P2|Overall Study|Lack of Efficacy|3
5974579|NCT01095796|20662413|P1|Overall Study|Lack of Efficacy|5
5974580|NCT01095796|20662412|P2|Overall Study|Pregnancy|0
5974581|NCT01095796|20662413|P1|Overall Study|Pregnancy|2
5974582|NCT01095796|20662412|P2|Overall Study|Death|2
5974583|NCT01095796|20662413|P1|Overall Study|Death|3
5974584|NCT01095796|20662412|P2|Overall Study|Adverse Event|19
5974585|NCT01095796|20662413|P1|Overall Study|Adverse Event|9
5974586|NCT01095796|20662412|P2|Overall Study|Randomized but Not Treated|2
5974587|NCT01095796|20662413|P1|Overall Study|Randomized but Not Treated|5
5974588|NCT01095666|20662443|P3|Overall Study|Non-compliance, not met criteria etc.|2
5974589|NCT01095666|20662444|P2|Overall Study|Non-compliance, not met criteria etc.|2
5974590|NCT01095666|20662445|P1|Overall Study|Non-compliance, not met criteria etc.|7
5974591|NCT01095666|20662443|P3|Overall Study|Withdrawal by Subject|1
5974592|NCT01095666|20662444|P2|Overall Study|Withdrawal by Subject|6
5974593|NCT01095666|20662445|P1|Overall Study|Withdrawal by Subject|6
5974594|NCT01095666|20662443|P3|Overall Study|Lost to Follow-up|0
5974595|NCT01095666|20662444|P2|Overall Study|Lost to Follow-up|2
5974596|NCT01095666|20662445|P1|Overall Study|Lost to Follow-up|2
5974597|NCT01095666|20662443|P3|Overall Study|Adverse Event|3
5974598|NCT01095666|20662444|P2|Overall Study|Adverse Event|1
5974599|NCT01095666|20662445|P1|Overall Study|Adverse Event|2
5974600|NCT01095666|20662443|P3|Overall Study|Lack of Efficacy|1
5974601|NCT01095666|20662444|P2|Overall Study|Lack of Efficacy|0
5974602|NCT01095666|20662445|P1|Overall Study|Lack of Efficacy|0
5974603|NCT01095653|20662468|P3|Overall Study|non-compliance, not met criteria, etc.|5
5974604|NCT01095653|20662469|P2|Overall Study|non-compliance, not met criteria, etc.|6
5974605|NCT01095653|20662470|P1|Overall Study|non-compliance, not met criteria, etc.|10
5974606|NCT01095653|20662468|P3|Overall Study|Withdrawal by Subject|3
5974607|NCT01095653|20662469|P2|Overall Study|Withdrawal by Subject|5
5974608|NCT01095653|20662470|P1|Overall Study|Withdrawal by Subject|4
5974609|NCT01095653|20662468|P3|Overall Study|Lost to Follow-up|4
5974610|NCT01095653|20662469|P2|Overall Study|Lost to Follow-up|0
5974611|NCT01095653|20662470|P1|Overall Study|Lost to Follow-up|1
5974612|NCT01095653|20662468|P3|Overall Study|Adverse Event|4
5974613|NCT01095653|20662469|P2|Overall Study|Adverse Event|4
5974614|NCT01095653|20662470|P1|Overall Study|Adverse Event|1
5974615|NCT01095653|20662468|P3|Overall Study|Lack of Efficacy|0
5974616|NCT01095653|20662469|P2|Overall Study|Lack of Efficacy|0
5974617|NCT01095653|20662470|P1|Overall Study|Lack of Efficacy|3
5974618|NCT01095250|20662528|P4|Overall Study|Withdrawal by Subject|0
5974619|NCT01095250|20662529|P3|Overall Study|Withdrawal by Subject|1
5974620|NCT01095250|20662530|P2|Overall Study|Withdrawal by Subject|0
5974621|NCT01095250|20662531|P1|Overall Study|Withdrawal by Subject|0
5974622|NCT01095250|20662528|P4|Overall Study|administrative reasons|5
5974623|NCT01095250|20662529|P3|Overall Study|administrative reasons|7
5974624|NCT01095250|20662530|P2|Overall Study|administrative reasons|10
5974625|NCT01095250|20662531|P1|Overall Study|administrative reasons|8
5974626|NCT01095094|20662561|P1|Overall Study|Physician Decision|1
5974627|NCT01095094|20662561|P1|Overall Study|Death|1
5974628|NCT01095094|20662561|P1|Overall Study|Withdrawal by Subject|1
5974629|NCT01094886|20662583|P1|Overall Study|Withdrawal by Subject|5
5974630|NCT01094886|20662583|P1|Overall Study|Adverse Event|2
5974631|NCT01094808|20662593|P3|Overall Study|Withdrawal by Subject|0
5974632|NCT01094808|20662594|P2|Overall Study|Withdrawal by Subject|1
5974633|NCT01094808|20662595|P1|Overall Study|Withdrawal by Subject|1
5974634|NCT01094782|20662636|P6|Overall Study|Noncompliance With Study Schedule|0
5974635|NCT01094782|20662637|P5|Overall Study|Noncompliance With Study Schedule|0
5974636|NCT01094782|20662638|P4|Overall Study|Noncompliance With Study Schedule|1
5974637|NCT01094782|20662639|P3|Overall Study|Noncompliance With Study Schedule|0
5974638|NCT01094782|20662640|P2|Overall Study|Noncompliance With Study Schedule|0
5974639|NCT01094782|20662641|P1|Overall Study|Noncompliance With Study Schedule|0
5974640|NCT01094782|20662636|P6|Overall Study|Low Visual Analog Scale (VAS) Score|0
5974641|NCT01094782|20662637|P5|Overall Study|Low Visual Analog Scale (VAS) Score|1
5974642|NCT01094782|20662638|P4|Overall Study|Low Visual Analog Scale (VAS) Score|0
5974643|NCT01094782|20662639|P3|Overall Study|Low Visual Analog Scale (VAS) Score|0
5974644|NCT01094782|20662640|P2|Overall Study|Low Visual Analog Scale (VAS) Score|0
5974645|NCT01094782|20662641|P1|Overall Study|Low Visual Analog Scale (VAS) Score|0
5974646|NCT01094782|20662636|P6|Overall Study|Recent Interventional Injection|1
5974647|NCT01094782|20662637|P5|Overall Study|Recent Interventional Injection|0
5974648|NCT01094782|20662638|P4|Overall Study|Recent Interventional Injection|0
5974649|NCT01094782|20662639|P3|Overall Study|Recent Interventional Injection|0
5974650|NCT01094782|20662640|P2|Overall Study|Recent Interventional Injection|0
5974651|NCT01094782|20662641|P1|Overall Study|Recent Interventional Injection|0
5974652|NCT01094782|20662636|P6|Overall Study|Wrong Pain Condition|1
5974653|NCT01094782|20662637|P5|Overall Study|Wrong Pain Condition|1
5974654|NCT01094782|20662638|P4|Overall Study|Wrong Pain Condition|2
5974655|NCT01094782|20662639|P3|Overall Study|Wrong Pain Condition|0
5974656|NCT01094782|20662640|P2|Overall Study|Wrong Pain Condition|0
5974657|NCT01094782|20662641|P1|Overall Study|Wrong Pain Condition|0
5974658|NCT01094782|20662636|P6|Overall Study|Hypertension|0
5974659|NCT01094782|20662637|P5|Overall Study|Hypertension|0
5974660|NCT01094782|20662638|P4|Overall Study|Hypertension|0
5974661|NCT01094782|20662639|P3|Overall Study|Hypertension|1
5974662|NCT01094782|20662640|P2|Overall Study|Hypertension|0
5974663|NCT01094782|20662641|P1|Overall Study|Hypertension|0
5974664|NCT01094782|20662636|P6|Overall Study|Healthy Subject Had Pain|0
5974665|NCT01094782|20662637|P5|Overall Study|Healthy Subject Had Pain|0
5974666|NCT01094782|20662638|P4|Overall Study|Healthy Subject Had Pain|0
5974667|NCT01094782|20662639|P3|Overall Study|Healthy Subject Had Pain|0
5974668|NCT01094782|20662640|P2|Overall Study|Healthy Subject Had Pain|1
5974669|NCT01094782|20662641|P1|Overall Study|Healthy Subject Had Pain|0
5974670|NCT01094782|20662636|P6|Overall Study|Unable to Complete Questionnaires|0
5974671|NCT01094782|20662637|P5|Overall Study|Unable to Complete Questionnaires|0
5974672|NCT01094782|20662638|P4|Overall Study|Unable to Complete Questionnaires|0
5974673|NCT01094782|20662639|P3|Overall Study|Unable to Complete Questionnaires|0
5974674|NCT01094782|20662640|P2|Overall Study|Unable to Complete Questionnaires|1
5974675|NCT01094782|20662641|P1|Overall Study|Unable to Complete Questionnaires|0
5974676|NCT01094782|20662636|P6|Overall Study|Sensory Deficit at Site of QST|0
5974677|NCT01094782|20662637|P5|Overall Study|Sensory Deficit at Site of QST|0
5974678|NCT01094782|20662638|P4|Overall Study|Sensory Deficit at Site of QST|0
5974679|NCT01094782|20662639|P3|Overall Study|Sensory Deficit at Site of QST|0
5974680|NCT01094782|20662640|P2|Overall Study|Sensory Deficit at Site of QST|1
5974681|NCT01094782|20662641|P1|Overall Study|Sensory Deficit at Site of QST|0
5974682|NCT01094782|20662636|P6|Overall Study|Positive Drug Screen|2
5974683|NCT01094782|20662637|P5|Overall Study|Positive Drug Screen|3
5974684|NCT01094782|20662638|P4|Overall Study|Positive Drug Screen|1
5974685|NCT01094782|20662639|P3|Overall Study|Positive Drug Screen|1
5974686|NCT01094782|20662640|P2|Overall Study|Positive Drug Screen|2
5974687|NCT01094782|20662641|P1|Overall Study|Positive Drug Screen|2
5974688|NCT01094782|20662636|P6|Overall Study|Lost to Follow-up|4
5974689|NCT01094782|20662637|P5|Overall Study|Lost to Follow-up|1
5974690|NCT01094782|20662638|P4|Overall Study|Lost to Follow-up|2
5974691|NCT01094782|20662639|P3|Overall Study|Lost to Follow-up|0
5974692|NCT01094782|20662640|P2|Overall Study|Lost to Follow-up|0
5974693|NCT01094782|20662641|P1|Overall Study|Lost to Follow-up|1
5974694|NCT01094782|20662636|P6|Overall Study|Withdrawal by Subject|0
5974695|NCT01094782|20662637|P5|Overall Study|Withdrawal by Subject|5
5974696|NCT01094782|20662638|P4|Overall Study|Withdrawal by Subject|5
5974697|NCT01094782|20662639|P3|Overall Study|Withdrawal by Subject|1
5974698|NCT01094782|20662640|P2|Overall Study|Withdrawal by Subject|5
5974699|NCT01094782|20662641|P1|Overall Study|Withdrawal by Subject|5
5974700|NCT01094743|20662685|P1|Period 1|Unsatisfactory comfort at lens fitting|2
5974701|NCT01094730|20662702|P2|Period 2 (14 Days)|Unsatisfactory lens fitting|1
5974702|NCT01094730|20662703|P1|Period 2 (14 Days)|Unsatisfactory lens fitting|0
5974703|NCT01094730|20662702|P2|Period 2 (14 Days)|Adverse Event|1
5974704|NCT01094730|20662703|P1|Period 2 (14 Days)|Adverse Event|0
5974705|NCT01094730|20662702|P2|Period 2 (14 Days)|No time for the follow-up visit|0
5974706|NCT01094730|20662703|P1|Period 2 (14 Days)|No time for the follow-up visit|1
5974707|NCT01094730|20662702|P2|Period 2 (14 Days)|Protocol Violation|0
5974708|NCT01094730|20662703|P1|Period 2 (14 Days)|Protocol Violation|2
5974709|NCT01094730|20662702|P2|Period 1 (14 Days)|Unsatisfactory visual response|0
5974710|NCT01094730|20662703|P1|Period 1 (14 Days)|Unsatisfactory visual response|1
5974711|NCT01094730|20662702|P2|Period 1 (14 Days)|No time for the follow-up visit|0
5974712|NCT01094730|20662703|P1|Period 1 (14 Days)|No time for the follow-up visit|1
5974713|NCT01094730|20662702|P2|Period 1 (14 Days)|Withdrawal by Subject|1
5974714|NCT01094730|20662703|P1|Period 1 (14 Days)|Withdrawal by Subject|0
5974715|NCT01094730|20662702|P2|Period 1 (14 Days)|Lost to Follow-up|1
5974716|NCT01094730|20662703|P1|Period 1 (14 Days)|Lost to Follow-up|0
5974717|NCT01094301|20662839|P1|Implant Stage|No return of pain|4
5974718|NCT01094301|20662839|P1|Implant Stage|Withdrawal by Subject|2
5974719|NCT01094301|20662839|P1|Implant Stage|Protocol Violation|1
5974720|NCT01094301|20662839|P1|Implant Stage|Adverse Event|1
5974721|NCT01094301|20662839|P1|Trial Stage|Withdrawal by Subject|1
5974722|NCT01094288|20662869|P8|Overall Study|Ongoing Participants|0
5974723|NCT01094288|20662870|P7|Overall Study|Ongoing Participants|0
5974724|NCT01094288|20662871|P6|Overall Study|Ongoing Participants|0
5974725|NCT01094288|20662872|P5|Overall Study|Ongoing Participants|0
5974726|NCT01094288|20662873|P4|Overall Study|Ongoing Participants|0
5974727|NCT01094288|20662874|P3|Overall Study|Ongoing Participants|0
5974728|NCT01094288|20662875|P2|Overall Study|Ongoing Participants|3
5974729|NCT01094288|20662876|P1|Overall Study|Ongoing Participants|0
5974730|NCT01094288|20662869|P8|Overall Study|Reason not Specified|0
5974731|NCT01094288|20662870|P7|Overall Study|Reason not Specified|0
5974732|NCT01094288|20662871|P6|Overall Study|Reason not Specified|0
5974733|NCT01094288|20662872|P5|Overall Study|Reason not Specified|0
5974734|NCT01094288|20662873|P4|Overall Study|Reason not Specified|1
5974735|NCT01094288|20662874|P3|Overall Study|Reason not Specified|0
5974736|NCT01094288|20662875|P2|Overall Study|Reason not Specified|3
5974737|NCT01094288|20662876|P1|Overall Study|Reason not Specified|2
5974738|NCT01094288|20662869|P8|Overall Study|Initiation of Alternative Therapy|0
5974739|NCT01094288|20662870|P7|Overall Study|Initiation of Alternative Therapy|0
5974740|NCT01094288|20662871|P6|Overall Study|Initiation of Alternative Therapy|0
5974741|NCT01094288|20662872|P5|Overall Study|Initiation of Alternative Therapy|0
5974742|NCT01094288|20662873|P4|Overall Study|Initiation of Alternative Therapy|0
5974743|NCT01094288|20662874|P3|Overall Study|Initiation of Alternative Therapy|1
5974744|NCT01094288|20662875|P2|Overall Study|Initiation of Alternative Therapy|0
5974745|NCT01094288|20662876|P1|Overall Study|Initiation of Alternative Therapy|0
5974746|NCT01094288|20662869|P8|Overall Study|Withdrawal by Subject|2
5974747|NCT01094288|20662870|P7|Overall Study|Withdrawal by Subject|0
5974748|NCT01094288|20662871|P6|Overall Study|Withdrawal by Subject|0
5974749|NCT01094288|20662872|P5|Overall Study|Withdrawal by Subject|0
5974750|NCT01094288|20662873|P4|Overall Study|Withdrawal by Subject|0
5974751|NCT01094288|20662874|P3|Overall Study|Withdrawal by Subject|2
5974752|NCT01094288|20662875|P2|Overall Study|Withdrawal by Subject|1
5974753|NCT01094288|20662876|P1|Overall Study|Withdrawal by Subject|0
5974754|NCT01094288|20662869|P8|Overall Study|Adverse Event|0
5974755|NCT01094288|20662870|P7|Overall Study|Adverse Event|0
5974756|NCT01094288|20662871|P6|Overall Study|Adverse Event|0
5974757|NCT01094288|20662872|P5|Overall Study|Adverse Event|0
5974758|NCT01094288|20662873|P4|Overall Study|Adverse Event|1
5974759|NCT01094288|20662874|P3|Overall Study|Adverse Event|1
5974760|NCT01094288|20662875|P2|Overall Study|Adverse Event|3
5974761|NCT01094288|20662876|P1|Overall Study|Adverse Event|0
5974762|NCT01094184|20662988|P2|Overall Study|Death|11
5974763|NCT01094184|20662989|P1|Overall Study|Death|35
5974764|NCT01094171|20663223|P1|Overall Study|Other|1
5974765|NCT01094171|20663223|P1|Overall Study|Migration from the study area|3
5974766|NCT01094171|20663223|P1|Overall Study|Informed consent withdrawal|4
5974767|NCT01094171|20663223|P1|Overall Study|Lost to Follow-up|2
5974768|NCT01094119|20663232|P2|Overall Study|Lack of Efficacy|4
5974769|NCT01094119|20663233|P1|Overall Study|Lack of Efficacy|2
5974770|NCT01093885|20663258|P1|Overall Study|Lost to Follow-up|1
5974771|NCT01093885|20663258|P1|Overall Study|Adverse Event|4
5974772|NCT01093846|20663266|P3|Overall Study|Administrative Problems|15
5974773|NCT01093846|20663267|P2|Overall Study|Administrative Problems|17
5974774|NCT01093846|20663268|P1|Overall Study|Administrative Problems|18
5974775|NCT01093846|20663266|P3|Overall Study|Condition no longer required study drug|1
5974776|NCT01093846|20663267|P2|Overall Study|Condition no longer required study drug|1
5974777|NCT01093846|20663268|P1|Overall Study|Condition no longer required study drug|1
5974778|NCT01093846|20663266|P3|Overall Study|Lack of Efficacy|4
5974779|NCT01093846|20663267|P2|Overall Study|Lack of Efficacy|0
5974780|NCT01093846|20663268|P1|Overall Study|Lack of Efficacy|0
5974781|NCT01093846|20663266|P3|Overall Study|Adverse Event|1
5974782|NCT01093846|20663267|P2|Overall Study|Adverse Event|0
5974783|NCT01093846|20663268|P1|Overall Study|Adverse Event|0
5974784|NCT01093755|20663293|P2|Overall Study|Withdrawal by Subject|4
5974785|NCT01093755|20663294|P1|Overall Study|Withdrawal by Subject|3
5974786|NCT01093625|20663334|P2|1-Year Visit|Lost to Follow-up|3
5974787|NCT01093625|20663335|P1|1-Year Visit|Lost to Follow-up|5
5974788|NCT01093625|20663334|P2|6-Month Visit|Lost to Follow-up|2
5974789|NCT01093625|20663335|P1|6-Month Visit|Lost to Follow-up|2
5974790|NCT01093625|20663334|P2|6-Month Visit|Withdrawal by Subject|7
5974791|NCT01093625|20663335|P1|6-Month Visit|Withdrawal by Subject|6
5974792|NCT01093625|20663334|P2|3-Month Visit|Lost to Follow-up|0
5974793|NCT01093625|20663335|P1|3-Month Visit|Lost to Follow-up|2
5974794|NCT01093625|20663334|P2|1-Month Visit|Lost to Follow-up|0
5974795|NCT01093625|20663335|P1|1-Month Visit|Lost to Follow-up|2
5974796|NCT01093625|20663334|P2|2-Week Visit|Withdrawal by Subject|0
5974797|NCT01093625|20663335|P1|2-Week Visit|Withdrawal by Subject|1
5974798|NCT01093625|20663334|P2|Baseline and Dispensed|Withdrawal by Subject|0
5974799|NCT01093625|20663335|P1|Baseline and Dispensed|Withdrawal by Subject|2
5974800|NCT01093599|20663355|P2|Overall Study|Lost to Follow-up|46
5974801|NCT01093599|20663356|P1|Overall Study|Lost to Follow-up|32
5974802|NCT01093586|20663362|P1|Overall Study|Failed to engraft|3
5974803|NCT01093573|20663383|P3|Overall Study|Insurance Denied|1
5974804|NCT01093573|20663384|P2|Overall Study|Insurance Denied|0
5974805|NCT01093573|20663385|P1|Overall Study|Insurance Denied|0
5974806|NCT01093573|20663383|P3|Overall Study|Physician Decision|1
5974807|NCT01093573|20663384|P2|Overall Study|Physician Decision|0
5974808|NCT01093573|20663385|P1|Overall Study|Physician Decision|0
5974809|NCT01093534|20663402|P3|Overall Study|Other|4
5974810|NCT01093534|20663403|P2|Overall Study|Other|3
5974811|NCT01093534|20663404|P1|Overall Study|Other|1
5974812|NCT01093534|20663402|P3|Overall Study|Withdrawal by Subject|2
5974813|NCT01093534|20663403|P2|Overall Study|Withdrawal by Subject|7
5974814|NCT01093534|20663404|P1|Overall Study|Withdrawal by Subject|5
5974815|NCT01093534|20663402|P3|Overall Study|Lack of Efficacy|1
5974816|NCT01093534|20663403|P2|Overall Study|Lack of Efficacy|1
5974817|NCT01093534|20663404|P1|Overall Study|Lack of Efficacy|2
5974818|NCT01093534|20663402|P3|Overall Study|Adverse Event|2
5974819|NCT01093534|20663403|P2|Overall Study|Adverse Event|5
5974820|NCT01093534|20663404|P1|Overall Study|Adverse Event|2
5974821|NCT01093222|20663552|P1|Overall Study|Not protocol specified|1
5974822|NCT01093222|20663552|P1|Overall Study|Death|2
5974823|NCT01093222|20663552|P1|Overall Study|Progression/relapse|24
5974824|NCT01093222|20663552|P1|Overall Study|Adverse Event|7
5974825|NCT01093222|20663552|P1|Overall Study|Ineligible|6
5974826|NCT01092832|20663628|P2|Overall Study|Other|0
5974827|NCT01092832|20663629|P1|Overall Study|Other|1
5974828|NCT01092780|20663641|P4|Washout Period 2|Adverse Event|0
5974829|NCT01092780|20663642|P3|Washout Period 2|Adverse Event|1
5974830|NCT01092780|20663643|P2|Washout Period 2|Adverse Event|1
5974831|NCT01092780|20663644|P1|Washout Period 2|Adverse Event|0
5974832|NCT01092780|20663641|P4|Washout Period 1|Noncompliance with nCPAP|0
5974833|NCT01092780|20663642|P3|Washout Period 1|Noncompliance with nCPAP|0
5974834|NCT01092780|20663643|P2|Washout Period 1|Noncompliance with nCPAP|0
5974835|NCT01092780|20663644|P1|Washout Period 1|Noncompliance with nCPAP|1
5974836|NCT01092780|20663641|P4|Washout Period 1|Adverse Event|0
5974837|NCT01092780|20663642|P3|Washout Period 1|Adverse Event|0
5974838|NCT01092780|20663643|P2|Washout Period 1|Adverse Event|1
5974839|NCT01092780|20663644|P1|Washout Period 1|Adverse Event|0
5974840|NCT01092728|20663680|P2|Overall Study|Prohibited Concomitant Medications|0
5974841|NCT01092728|20663681|P1|Overall Study|Prohibited Concomitant Medications|1
5974842|NCT01092728|20663680|P2|Overall Study|Disease Progression|13
5974843|NCT01092728|20663681|P1|Overall Study|Disease Progression|1
5974844|NCT01092728|20663680|P2|Overall Study|Adverse Event|1
5974845|NCT01092728|20663681|P1|Overall Study|Adverse Event|0
5974846|NCT01092728|20663680|P2|Overall Study|Withdrawal by Subject|0
5974847|NCT01092728|20663681|P1|Overall Study|Withdrawal by Subject|2
5974848|NCT01092702|20663689|P1|Overall Study|Lost to Follow-up|2
5974849|NCT01092702|20663689|P1|Overall Study|Withdrawal by Subject|7
5974850|NCT01092663|20663706|P2|Overall Study|Protocol Violation|1
5974851|NCT01092663|20663707|P1|Overall Study|Protocol Violation|0
5974852|NCT01092663|20663706|P2|Overall Study|Adverse Event|1
5974853|NCT01092663|20663707|P1|Overall Study|Adverse Event|1
5974854|NCT01092663|20663706|P2|Overall Study|High fasting triglyceride|0
5974855|NCT01092663|20663707|P1|Overall Study|High fasting triglyceride|2
5974856|NCT01092663|20663706|P2|Overall Study|Glucose >300mg/dL|0
5974857|NCT01092663|20663707|P1|Overall Study|Glucose >300mg/dL|1
5974858|NCT01092663|20663706|P2|Overall Study|Withdrawal by Subject|2
5974859|NCT01092663|20663707|P1|Overall Study|Withdrawal by Subject|3
5974860|NCT01092637|20663755|P2|Overall Study|Death|49
5974861|NCT01092637|20663756|P1|Overall Study|Death|47
5974862|NCT01092546|20663771|P1|Overall Study|Subjects withdrawn prior to dosing|4
5974863|NCT01092507|20663778|P2|Overall Study|Withdrawal by Subject|0
5974864|NCT01092507|20663779|P1|Overall Study|Withdrawal by Subject|2
5974865|NCT01092416|20663814|P1|12-Month Follow-up|Data collected after close of 1Y window|2
5974866|NCT01092416|20663814|P1|12-Month Follow-up|Missed 1-year follow-up|1
5974867|NCT01092416|20663814|P1|12-Month Follow-up|Withdrawal by Subject|2
5974868|NCT01092416|20663814|P1|12-Month Follow-up|Lost to Follow-up|4
5974869|NCT01092416|20663814|P1|12-Month Follow-up|Death|16
5974870|NCT01092416|20663814|P1|30-Day Follow-up|Data collected after close of 30D window|5
5974871|NCT01092416|20663814|P1|30-Day Follow-up|Missed 30-day follow-up|3
5974872|NCT01092416|20663814|P1|30-Day Follow-up|Death|2
5974873|NCT01092416|20663814|P1|Enrollment|Atherectomy device not inserted|3
5974874|NCT01091974|20663864|P4|Overall Study|side-effects|2
5974875|NCT01091974|20663865|P3|Overall Study|side-effects|0
5974876|NCT01091974|20663866|P2|Overall Study|side-effects|1
5974877|NCT01091974|20663867|P1|Overall Study|side-effects|1
5974878|NCT01091974|20663864|P4|Overall Study|Withdrawal by Subject|2
5974879|NCT01091974|20663865|P3|Overall Study|Withdrawal by Subject|2
5974880|NCT01091974|20663866|P2|Overall Study|Withdrawal by Subject|3
5974881|NCT01091974|20663867|P1|Overall Study|Withdrawal by Subject|1
5974882|NCT01091974|20663864|P4|Overall Study|resumed sleep medication|2
5974883|NCT01091974|20663865|P3|Overall Study|resumed sleep medication|1
5974884|NCT01091974|20663866|P2|Overall Study|resumed sleep medication|0
5974885|NCT01091974|20663867|P1|Overall Study|resumed sleep medication|0
5974886|NCT01091974|20663864|P4|Overall Study|Did not start intervention|1
5974887|NCT01091974|20663865|P3|Overall Study|Did not start intervention|3
5974888|NCT01091974|20663866|P2|Overall Study|Did not start intervention|1
5974889|NCT01091974|20663867|P1|Overall Study|Did not start intervention|3
5974890|NCT01091675|20663902|P1|Overall Study|Lack of Efficacy|27
5974891|NCT01091675|20663902|P1|Overall Study|Adverse Event|7
5974892|NCT01091662|20663908|P2|Overall Study|unable to swallow capsule|1
5974893|NCT01091662|20663909|P1|Overall Study|unable to swallow capsule|0
5974894|NCT01091662|20663908|P2|Overall Study|Protocol Violation|2
5974895|NCT01091662|20663909|P1|Overall Study|Protocol Violation|0
5974896|NCT01091662|20663908|P2|Overall Study|Pregnancy|1
5974897|NCT01091662|20663909|P1|Overall Study|Pregnancy|0
5974898|NCT01091662|20663908|P2|Overall Study|Lost to Follow-up|1
5974899|NCT01091662|20663909|P1|Overall Study|Lost to Follow-up|0
5974900|NCT01091662|20663908|P2|Overall Study|met exclusion criteria|0
5974901|NCT01091662|20663909|P1|Overall Study|met exclusion criteria|1
5974902|NCT01091662|20663908|P2|Overall Study|met exit criteria|13
5974903|NCT01091662|20663909|P1|Overall Study|met exit criteria|7
5974904|NCT01091662|20663908|P2|Overall Study|Withdrawal by Subject|6
5974905|NCT01091662|20663909|P1|Overall Study|Withdrawal by Subject|7
5974906|NCT01091662|20663908|P2|Overall Study|Physician Decision|1
5974907|NCT01091662|20663909|P1|Overall Study|Physician Decision|1
5974908|NCT01091662|20663908|P2|Overall Study|Adverse Event|9
5974909|NCT01091662|20663909|P1|Overall Study|Adverse Event|1
5974910|NCT01091519|20663947|P2|Overall Study|Randomized not treated|4
5974911|NCT01091519|20663948|P1|Overall Study|Randomized not treated|4
5974912|NCT01091519|20663947|P2|Overall Study|Other|8
5974913|NCT01091519|20663948|P1|Overall Study|Other|6
5974914|NCT01091519|20663947|P2|Overall Study|Withdrawal by Subject|2
5974915|NCT01091519|20663948|P1|Overall Study|Withdrawal by Subject|2
5974916|NCT01091519|20663947|P2|Overall Study|Lost to Follow-up|24
5974917|NCT01091519|20663948|P1|Overall Study|Lost to Follow-up|14
5974918|NCT01091519|20663947|P2|Overall Study|Lack of Efficacy|19
5974919|NCT01091519|20663948|P1|Overall Study|Lack of Efficacy|16
5974920|NCT01091519|20663947|P2|Overall Study|Death|0
5974921|NCT01091519|20663948|P1|Overall Study|Death|1
5974922|NCT01091519|20663947|P2|Overall Study|Adverse Event|16
5974923|NCT01091519|20663948|P1|Overall Study|Adverse Event|12
5974924|NCT01091454|20663960|P1|Overall Study|Ineligible|1
5974925|NCT01091428|20663973|P4|Phase 2|Physician Decision|0
5974926|NCT01091428|20663974|P3|Phase 2|Physician Decision|2
5974927|NCT01091428|20663975|P2|Phase 2|Physician Decision|0
5974928|NCT01091428|20663976|P1|Phase 2|Physician Decision|0
5974929|NCT01091428|20663973|P4|Phase 2|Reason not specified|3
5974930|NCT01091428|20663974|P3|Phase 2|Reason not specified|4
5974931|NCT01091428|20663975|P2|Phase 2|Reason not specified|0
5974932|NCT01091428|20663976|P1|Phase 2|Reason not specified|0
5974933|NCT01091428|20663973|P4|Phase 2|Unsatisfactory Therapeutic Response|1
5974934|NCT01091428|20663974|P3|Phase 2|Unsatisfactory Therapeutic Response|1
5974935|NCT01091428|20663975|P2|Phase 2|Unsatisfactory Therapeutic Response|0
5974936|NCT01091428|20663976|P1|Phase 2|Unsatisfactory Therapeutic Response|0
5974937|NCT01091428|20663973|P4|Phase 2|Withdrawal by Subject|8
5974938|NCT01091428|20663974|P3|Phase 2|Withdrawal by Subject|9
5974939|NCT01091428|20663975|P2|Phase 2|Withdrawal by Subject|0
5974940|NCT01091428|20663976|P1|Phase 2|Withdrawal by Subject|0
5974941|NCT01091428|20663973|P4|Phase 2|Adverse Event|5
5974942|NCT01091428|20663974|P3|Phase 2|Adverse Event|12
5974943|NCT01091428|20663975|P2|Phase 2|Adverse Event|0
5974944|NCT01091428|20663976|P1|Phase 2|Adverse Event|0
5974945|NCT01091428|20663973|P4|Phase 2|Symptomatic Deterioration|6
5974946|NCT01091428|20663974|P3|Phase 2|Symptomatic Deterioration|1
5974947|NCT01091428|20663975|P2|Phase 2|Symptomatic Deterioration|0
5974948|NCT01091428|20663976|P1|Phase 2|Symptomatic Deterioration|0
5974949|NCT01091428|20663973|P4|Phase 2|Progressive Disease|46
5974950|NCT01091428|20663974|P3|Phase 2|Progressive Disease|44
5974951|NCT01091428|20663975|P2|Phase 2|Progressive Disease|0
5974952|NCT01091428|20663976|P1|Phase 2|Progressive Disease|0
5974953|NCT01091428|20663973|P4|Phase 1|Single-Patient IND|0
5974954|NCT01091428|20663974|P3|Phase 1|Single-Patient IND|0
5974955|NCT01091428|20663975|P2|Phase 1|Single-Patient IND|0
5974956|NCT01091428|20663976|P1|Phase 1|Single-Patient IND|2
5974957|NCT01091428|20663973|P4|Phase 1|Reason not specified|0
5974958|NCT01091428|20663974|P3|Phase 1|Reason not specified|0
5974959|NCT01091428|20663975|P2|Phase 1|Reason not specified|1
5974960|NCT01091428|20663976|P1|Phase 1|Reason not specified|0
5974961|NCT01091428|20663973|P4|Phase 1|Withdrawal by Subject|0
5974962|NCT01091428|20663974|P3|Phase 1|Withdrawal by Subject|0
5974963|NCT01091428|20663975|P2|Phase 1|Withdrawal by Subject|0
5974964|NCT01091428|20663976|P1|Phase 1|Withdrawal by Subject|7
5974965|NCT01091428|20663973|P4|Phase 1|Adverse Event|0
5974966|NCT01091428|20663974|P3|Phase 1|Adverse Event|0
5974967|NCT01091428|20663975|P2|Phase 1|Adverse Event|0
5974968|NCT01091428|20663976|P1|Phase 1|Adverse Event|2
5974969|NCT01091428|20663973|P4|Phase 1|Symptomatic Deterioration|0
5974970|NCT01091428|20663974|P3|Phase 1|Symptomatic Deterioration|0
5974971|NCT01091428|20663975|P2|Phase 1|Symptomatic Deterioration|2
5974972|NCT01091428|20663976|P1|Phase 1|Symptomatic Deterioration|3
5974973|NCT01091428|20663973|P4|Phase 1|Progressive Disease|0
5974974|NCT01091428|20663974|P3|Phase 1|Progressive Disease|0
5974975|NCT01091428|20663975|P2|Phase 1|Progressive Disease|8
5974976|NCT01091428|20663976|P1|Phase 1|Progressive Disease|24
5974977|NCT01091363|20664079|P2|Overall Study|Lost to Follow-up|2
5974978|NCT01091363|20664080|P1|Overall Study|Lost to Follow-up|2
5974979|NCT01091363|20664079|P2|Overall Study|Withdrawal by Subject|15
5974980|NCT01091363|20664080|P1|Overall Study|Withdrawal by Subject|11
5974981|NCT01091259|20664090|P1|Overall Study|Lack of Efficacy|2
5974982|NCT01091259|20664090|P1|Overall Study|Adverse Event|3
5974983|NCT01091246|20664101|P3|Overall Study|Subject not dosed|1
5974984|NCT01091246|20664102|P2|Overall Study|Subject not dosed|0
5974985|NCT01091246|20664103|P1|Overall Study|Subject not dosed|2
5974986|NCT01091246|20664101|P3|Overall Study|Withdrawal by Subject|4
5974987|NCT01091246|20664102|P2|Overall Study|Withdrawal by Subject|5
5974988|NCT01091246|20664103|P1|Overall Study|Withdrawal by Subject|9
5974989|NCT01091246|20664101|P3|Overall Study|Adverse Event|1
5974990|NCT01091246|20664102|P2|Overall Study|Adverse Event|0
5974991|NCT01091246|20664103|P1|Overall Study|Adverse Event|1
5974992|NCT01091246|20664101|P3|Overall Study|Lost to Follow-up|7
5974993|NCT01091246|20664102|P2|Overall Study|Lost to Follow-up|11
5974994|NCT01091246|20664103|P1|Overall Study|Lost to Follow-up|23
5974995|NCT01091168|20664179|P2|Overall Study|Physician, patient's decision, other|37
5974996|NCT01091168|20664180|P1|Overall Study|Physician, patient's decision, other|27
5974997|NCT01091168|20664179|P2|Overall Study|Lost to Follow-up|1
5974998|NCT01091168|20664180|P1|Overall Study|Lost to Follow-up|0
5974999|NCT01091168|20664179|P2|Overall Study|Adverse Event|24
5975000|NCT01091168|20664180|P1|Overall Study|Adverse Event|21
5975001|NCT01091168|20664179|P2|Overall Study|Progressive disease|234
5975002|NCT01091168|20664180|P1|Overall Study|Progressive disease|250
5975003|NCT01091103|20664255|P1|Overall Study|Progressive Disease|3
5975004|NCT01091103|20664255|P1|Overall Study|Adverse Event|1
5975005|NCT01090973|20664275|P1|Overall Study|Disease progression|1
5975006|NCT01090765|20664296|P6|Overall Study|Vasovagal reaction with first infusion|0
5975007|NCT01090765|20664297|P5|Overall Study|Vasovagal reaction with first infusion|1
5975008|NCT01090765|20664298|P4|Overall Study|Vasovagal reaction with first infusion|0
5975009|NCT01090765|20664299|P3|Overall Study|Vasovagal reaction with first infusion|0
5975010|NCT01090765|20664300|P2|Overall Study|Vasovagal reaction with first infusion|0
5975011|NCT01090765|20664301|P1|Overall Study|Vasovagal reaction with first infusion|0
5975012|NCT01090765|20664296|P6|Overall Study|Developed a DVT, needed anticoagulation|0
5975013|NCT01090765|20664297|P5|Overall Study|Developed a DVT, needed anticoagulation|0
5975014|NCT01090765|20664298|P4|Overall Study|Developed a DVT, needed anticoagulation|1
5975015|NCT01090765|20664299|P3|Overall Study|Developed a DVT, needed anticoagulation|0
5975016|NCT01090765|20664300|P2|Overall Study|Developed a DVT, needed anticoagulation|0
5975017|NCT01090765|20664301|P1|Overall Study|Developed a DVT, needed anticoagulation|0
5975018|NCT01090765|20664296|P6|Overall Study|Patient withdrew consent|1
5975019|NCT01090765|20664297|P5|Overall Study|Patient withdrew consent|1
5975020|NCT01090765|20664298|P4|Overall Study|Patient withdrew consent|0
5975021|NCT01090765|20664299|P3|Overall Study|Patient withdrew consent|0
5975022|NCT01090765|20664300|P2|Overall Study|Patient withdrew consent|0
5975023|NCT01090765|20664301|P1|Overall Study|Patient withdrew consent|0
5975024|NCT01090739|20664347|P1|36 Month Follow-up|Visit still pending|17
5975025|NCT01090739|20664347|P1|36 Month Follow-up|Withdrawal by Subject|6
5975026|NCT01090739|20664347|P1|24 Month Follow-up|Death|1
5975027|NCT01090739|20664347|P1|24 Month Follow-up|Lost to Follow-up|1
5975028|NCT01090739|20664347|P1|24 Month Follow-up|Withdrawal by Subject|7
5975029|NCT01090739|20664347|P1|12 Month Follow-up|Death|1
5975030|NCT01090739|20664347|P1|12 Month Follow-up|Physician Decision|1
5975031|NCT01090739|20664347|P1|12 Month Follow-up|Lost to Follow-up|1
5975032|NCT01090739|20664347|P1|12 Month Follow-up|Withdrawal by Subject|2
5975033|NCT01090739|20664347|P1|Enrollment|Adverse Event|1
5975034|NCT01090739|20664347|P1|Enrollment|Study implant limit reached|2
5975035|NCT01090739|20664347|P1|Enrollment|Sponsor termination of site|4
5975036|NCT01090739|20664347|P1|Enrollment|Physician Decision|5
5975037|NCT01090739|20664347|P1|Enrollment|Lost to Follow-up|5
5975038|NCT01090739|20664347|P1|Enrollment|Protocol Violation|14
5975039|NCT01090739|20664347|P1|Enrollment|Withdrawal by Subject|24
5975040|NCT01090492|20664372|P8|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
5975041|NCT01090492|20664373|P7|Second Intervention Period (4 Weeks)|Lost to Follow-up|1
5975042|NCT01090492|20664374|P6|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
5975043|NCT01090492|20664375|P5|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
5975044|NCT01090492|20664376|P4|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
5975045|NCT01090492|20664377|P3|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
5975046|NCT01090492|20664378|P2|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
5975047|NCT01090492|20664379|P1|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
5975048|NCT01090492|20664372|P8|Second Intervention Period (4 Weeks)|Adverse Event|1
5975049|NCT01090492|20664373|P7|Second Intervention Period (4 Weeks)|Adverse Event|7
5975050|NCT01090492|20664374|P6|Second Intervention Period (4 Weeks)|Adverse Event|1
5975051|NCT01090492|20664375|P5|Second Intervention Period (4 Weeks)|Adverse Event|1
5975052|NCT01090492|20664376|P4|Second Intervention Period (4 Weeks)|Adverse Event|0
5975053|NCT01090492|20664377|P3|Second Intervention Period (4 Weeks)|Adverse Event|1
5975054|NCT01090492|20664378|P2|Second Intervention Period (4 Weeks)|Adverse Event|0
5975055|NCT01090492|20664379|P1|Second Intervention Period (4 Weeks)|Adverse Event|0
5975056|NCT01090492|20664372|P8|Second Intervention Period (4 Weeks)|Other|0
5975057|NCT01090492|20664373|P7|Second Intervention Period (4 Weeks)|Other|0
5975058|NCT01090492|20664374|P6|Second Intervention Period (4 Weeks)|Other|0
5975059|NCT01090492|20664375|P5|Second Intervention Period (4 Weeks)|Other|0
5975060|NCT01090492|20664376|P4|Second Intervention Period (4 Weeks)|Other|0
5975061|NCT01090492|20664377|P3|Second Intervention Period (4 Weeks)|Other|1
5975062|NCT01090492|20664378|P2|Second Intervention Period (4 Weeks)|Other|1
5975063|NCT01090492|20664379|P1|Second Intervention Period (4 Weeks)|Other|0
5975064|NCT01090492|20664372|P8|Second Intervention Period (4 Weeks)|Non-compliance|0
5975065|NCT01090492|20664373|P7|Second Intervention Period (4 Weeks)|Non-compliance|0
5975066|NCT01090492|20664374|P6|Second Intervention Period (4 Weeks)|Non-compliance|0
5975067|NCT01090492|20664375|P5|Second Intervention Period (4 Weeks)|Non-compliance|0
5975068|NCT01090492|20664376|P4|Second Intervention Period (4 Weeks)|Non-compliance|0
5975069|NCT01090492|20664377|P3|Second Intervention Period (4 Weeks)|Non-compliance|0
5975070|NCT01090492|20664378|P2|Second Intervention Period (4 Weeks)|Non-compliance|1
5975071|NCT01090492|20664379|P1|Second Intervention Period (4 Weeks)|Non-compliance|0
5975072|NCT01090492|20664372|P8|Second Intervention Period (4 Weeks)|Protocol Violation|1
5975073|NCT01090492|20664373|P7|Second Intervention Period (4 Weeks)|Protocol Violation|1
5975074|NCT01090492|20664374|P6|Second Intervention Period (4 Weeks)|Protocol Violation|0
5975075|NCT01090492|20664375|P5|Second Intervention Period (4 Weeks)|Protocol Violation|1
5975076|NCT01090492|20664376|P4|Second Intervention Period (4 Weeks)|Protocol Violation|0
5975077|NCT01090492|20664377|P3|Second Intervention Period (4 Weeks)|Protocol Violation|0
5975078|NCT01090492|20664378|P2|Second Intervention Period (4 Weeks)|Protocol Violation|0
5975079|NCT01090492|20664379|P1|Second Intervention Period (4 Weeks)|Protocol Violation|1
5975080|NCT01090492|20664372|P8|First Intervention Period (4 Weeks)|Adverse Event|5
5975081|NCT01090492|20664373|P7|First Intervention Period (4 Weeks)|Adverse Event|0
5975082|NCT01090492|20664374|P6|First Intervention Period (4 Weeks)|Adverse Event|2
5975083|NCT01090492|20664375|P5|First Intervention Period (4 Weeks)|Adverse Event|1
5975084|NCT01090492|20664376|P4|First Intervention Period (4 Weeks)|Adverse Event|3
5975085|NCT01090492|20664377|P3|First Intervention Period (4 Weeks)|Adverse Event|0
5975086|NCT01090492|20664378|P2|First Intervention Period (4 Weeks)|Adverse Event|2
5975087|NCT01090492|20664379|P1|First Intervention Period (4 Weeks)|Adverse Event|0
5975088|NCT01090492|20664372|P8|First Intervention Period (4 Weeks)|Pregnancy|0
5975089|NCT01090492|20664373|P7|First Intervention Period (4 Weeks)|Pregnancy|0
5975090|NCT01090492|20664374|P6|First Intervention Period (4 Weeks)|Pregnancy|0
5975091|NCT01090492|20664375|P5|First Intervention Period (4 Weeks)|Pregnancy|1
5975092|NCT01090492|20664376|P4|First Intervention Period (4 Weeks)|Pregnancy|0
5975093|NCT01090492|20664377|P3|First Intervention Period (4 Weeks)|Pregnancy|0
5975094|NCT01090492|20664378|P2|First Intervention Period (4 Weeks)|Pregnancy|0
5975095|NCT01090492|20664379|P1|First Intervention Period (4 Weeks)|Pregnancy|0
5975096|NCT01090492|20664372|P8|First Intervention Period (4 Weeks)|Other|0
5975097|NCT01090492|20664373|P7|First Intervention Period (4 Weeks)|Other|0
5975098|NCT01090492|20664374|P6|First Intervention Period (4 Weeks)|Other|0
5975099|NCT01090492|20664375|P5|First Intervention Period (4 Weeks)|Other|2
5975100|NCT01090492|20664376|P4|First Intervention Period (4 Weeks)|Other|1
5975101|NCT01090492|20664377|P3|First Intervention Period (4 Weeks)|Other|1
5975102|NCT01090492|20664378|P2|First Intervention Period (4 Weeks)|Other|0
5975103|NCT01090492|20664379|P1|First Intervention Period (4 Weeks)|Other|0
5975104|NCT01090492|20664372|P8|First Intervention Period (4 Weeks)|Lost to Follow-up|0
5975105|NCT01090492|20664373|P7|First Intervention Period (4 Weeks)|Lost to Follow-up|0
5975106|NCT01090492|20664374|P6|First Intervention Period (4 Weeks)|Lost to Follow-up|0
5975107|NCT01090492|20664375|P5|First Intervention Period (4 Weeks)|Lost to Follow-up|0
5975108|NCT01090492|20664376|P4|First Intervention Period (4 Weeks)|Lost to Follow-up|0
5975109|NCT01090492|20664377|P3|First Intervention Period (4 Weeks)|Lost to Follow-up|1
5975110|NCT01090492|20664378|P2|First Intervention Period (4 Weeks)|Lost to Follow-up|0
5975111|NCT01090492|20664379|P1|First Intervention Period (4 Weeks)|Lost to Follow-up|0
5975112|NCT01090492|20664372|P8|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|1
5975113|NCT01090492|20664373|P7|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0
5975114|NCT01090492|20664374|P6|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0
5975115|NCT01090492|20664375|P5|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0
5975116|NCT01090492|20664376|P4|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0
5975117|NCT01090492|20664377|P3|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0
5975118|NCT01090492|20664378|P2|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|2
5975119|NCT01090492|20664379|P1|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0
5975120|NCT01090492|20664372|P8|First Intervention Period (4 Weeks)|Protocol Violation|0
5975121|NCT01090492|20664373|P7|First Intervention Period (4 Weeks)|Protocol Violation|1
5975122|NCT01090492|20664374|P6|First Intervention Period (4 Weeks)|Protocol Violation|0
5975123|NCT01090492|20664375|P5|First Intervention Period (4 Weeks)|Protocol Violation|0
5975124|NCT01090492|20664376|P4|First Intervention Period (4 Weeks)|Protocol Violation|2
5975125|NCT01090492|20664377|P3|First Intervention Period (4 Weeks)|Protocol Violation|1
5975126|NCT01090492|20664378|P2|First Intervention Period (4 Weeks)|Protocol Violation|1
5975127|NCT01090492|20664379|P1|First Intervention Period (4 Weeks)|Protocol Violation|1
5975128|NCT01090453|20664447|P2|Overall Study|Eligibility Criteria|1
5975129|NCT01090453|20664448|P1|Overall Study|Eligibility Criteria|0
5975130|NCT01090453|20664447|P2|Overall Study|Other|4
5975131|NCT01090453|20664448|P1|Overall Study|Other|2
5975132|NCT01090453|20664447|P2|Overall Study|Protocol Violation|0
5975133|NCT01090453|20664448|P1|Overall Study|Protocol Violation|2
5975134|NCT01090453|20664447|P2|Overall Study|Non serious AEs|0
5975135|NCT01090453|20664448|P1|Overall Study|Non serious AEs|1
5975136|NCT01090453|20664447|P2|Overall Study|Lost to Follow-up|7
5975137|NCT01090453|20664448|P1|Overall Study|Lost to Follow-up|7
5975138|NCT01090453|20664447|P2|Overall Study|Withdrawal by Subject|2
5975139|NCT01090453|20664448|P1|Overall Study|Withdrawal by Subject|1
5975140|NCT01090427|20664499|P7|After Controlled Period|Adverse Event|0
5975141|NCT01090427|20664500|P6|After Controlled Period|Adverse Event|1
5975142|NCT01090427|20664501|P5|After Controlled Period|Adverse Event|0
5975143|NCT01090427|20664502|P4|After Controlled Period|Adverse Event|2
5975144|NCT01090427|20664503|P3|After Controlled Period|Adverse Event|0
5975145|NCT01090427|20664504|P2|After Controlled Period|Adverse Event|0
5975146|NCT01090427|20664505|P1|After Controlled Period|Adverse Event|0
5975147|NCT01090427|20664499|P7|After Controlled Period|Lack of Efficacy|2
5975148|NCT01090427|20664500|P6|After Controlled Period|Lack of Efficacy|3
5975149|NCT01090427|20664501|P5|After Controlled Period|Lack of Efficacy|0
5975150|NCT01090427|20664502|P4|After Controlled Period|Lack of Efficacy|0
5975151|NCT01090427|20664503|P3|After Controlled Period|Lack of Efficacy|0
5975152|NCT01090427|20664504|P2|After Controlled Period|Lack of Efficacy|0
5975153|NCT01090427|20664505|P1|After Controlled Period|Lack of Efficacy|0
5975154|NCT01090427|20664499|P7|After Controlled Period|Death|0
5975155|NCT01090427|20664500|P6|After Controlled Period|Death|1
5975156|NCT01090427|20664501|P5|After Controlled Period|Death|0
5975157|NCT01090427|20664502|P4|After Controlled Period|Death|0
5975158|NCT01090427|20664503|P3|After Controlled Period|Death|0
5975159|NCT01090427|20664504|P2|After Controlled Period|Death|0
5975160|NCT01090427|20664505|P1|After Controlled Period|Death|0
5975161|NCT01090414|20664542|P4|Study 101-99|Participant Request|0
5975162|NCT01090414|20664543|P3|Study 101-99|Participant Request|0
5975163|NCT01090414|20664544|P2|Study 101-99|Participant Request|1
5975164|NCT01090414|20664545|P1|Study 101-99|Participant Request|3
5975165|NCT01090414|20664542|P4|Study 101-99|Withdrew Consent|1
5975166|NCT01090414|20664543|P3|Study 101-99|Withdrew Consent|3
5975167|NCT01090414|20664544|P2|Study 101-99|Withdrew Consent|2
5975168|NCT01090414|20664545|P1|Study 101-99|Withdrew Consent|0
5975169|NCT01090414|20664542|P4|Study 101-99|Other (Unknown Reasons)|0
5975170|NCT01090414|20664543|P3|Study 101-99|Other (Unknown Reasons)|0
5975171|NCT01090414|20664544|P2|Study 101-99|Other (Unknown Reasons)|3
5975172|NCT01090414|20664545|P1|Study 101-99|Other (Unknown Reasons)|3
5975173|NCT01090414|20664542|P4|Study 101-99|Sponsor Discontinued Study|0
5975174|NCT01090414|20664543|P3|Study 101-99|Sponsor Discontinued Study|5
5975175|NCT01090414|20664544|P2|Study 101-99|Sponsor Discontinued Study|7
5975176|NCT01090414|20664545|P1|Study 101-99|Sponsor Discontinued Study|0
5975177|NCT01090414|20664542|P4|Study 101-99|Death|0
5975178|NCT01090414|20664543|P3|Study 101-99|Death|1
5975179|NCT01090414|20664544|P2|Study 101-99|Death|8
5975180|NCT01090414|20664545|P1|Study 101-99|Death|3
5975181|NCT01090414|20664542|P4|Study 101-99|Investigator Request|0
5975182|NCT01090414|20664543|P3|Study 101-99|Investigator Request|4
5975183|NCT01090414|20664544|P2|Study 101-99|Investigator Request|11
5975184|NCT01090414|20664545|P1|Study 101-99|Investigator Request|1
5975185|NCT01090414|20664542|P4|Study 101-99|Adverse Event|0
5975186|NCT01090414|20664543|P3|Study 101-99|Adverse Event|18
5975187|NCT01090414|20664544|P2|Study 101-99|Adverse Event|28
5975188|NCT01090414|20664545|P1|Study 101-99|Adverse Event|10
5975189|NCT01090414|20664542|P4|Study 101-99|Progressive Disease|4
5975190|NCT01090414|20664543|P3|Study 101-99|Progressive Disease|10
5975191|NCT01090414|20664544|P2|Study 101-99|Progressive Disease|48
5975192|NCT01090414|20664545|P1|Study 101-99|Progressive Disease|28
5975193|NCT01090323|20664612|P2|Overall Study|Stopped end of extension 1#|1
5975194|NCT01090323|20664613|P1|Overall Study|Stopped end of extension 1#|3
5975195|NCT01090323|20664612|P2|Overall Study|Stopped end of core|0
5975196|NCT01090323|20664613|P1|Overall Study|Stopped end of core|7
5975197|NCT01090323|20664612|P2|Overall Study|Death|2
5975198|NCT01090323|20664613|P1|Overall Study|Death|1
5975199|NCT01090323|20664612|P2|Overall Study|Administrative problems|4
5975200|NCT01090323|20664613|P1|Overall Study|Administrative problems|6
5975201|NCT01090323|20664612|P2|Overall Study|Lost to Follow-up|6
5975202|NCT01090323|20664613|P1|Overall Study|Lost to Follow-up|11
5975203|NCT01090323|20664612|P2|Overall Study|Withdrew consent|11
5975204|NCT01090323|20664613|P1|Overall Study|Withdrew consent|33
5975205|NCT01090323|20664612|P2|Overall Study|Protocol Violation|1
5975206|NCT01090323|20664613|P1|Overall Study|Protocol Violation|2
5975207|NCT01090323|20664612|P2|Overall Study|Condition no longer requires drug|4
5975208|NCT01090323|20664613|P1|Overall Study|Condition no longer requires drug|5
5975209|NCT01090323|20664612|P2|Overall Study|Unsatisfactory therapeutic effect|2
5975210|NCT01090323|20664613|P1|Overall Study|Unsatisfactory therapeutic effect|4
5975211|NCT01090323|20664612|P2|Overall Study|Abnormal Test Procedure Results|0
5975212|NCT01090323|20664613|P1|Overall Study|Abnormal Test Procedure Results|2
5975213|NCT01090323|20664612|P2|Overall Study|Abnormal Lab Values|1
5975214|NCT01090323|20664613|P1|Overall Study|Abnormal Lab Values|3
5975215|NCT01090323|20664612|P2|Overall Study|Adverse Event|2
5975216|NCT01090323|20664613|P1|Overall Study|Adverse Event|12
5975217|NCT01090310|20664625|P4|Extension Study|Subject withdrew consent|0
5975218|NCT01090310|20664626|P3|Extension Study|Subject withdrew consent|0
5975219|NCT01090310|20664627|P2|Extension Study|Subject withdrew consent|1
5975220|NCT01090310|20664628|P1|Extension Study|Subject withdrew consent|0
5975221|NCT01090310|20664625|P4|Extension Study|Unsatisfactory therapeutic effect|1
5975222|NCT01090310|20664626|P3|Extension Study|Unsatisfactory therapeutic effect|1
5975223|NCT01090310|20664627|P2|Extension Study|Unsatisfactory therapeutic effect|0
5975224|NCT01090310|20664628|P1|Extension Study|Unsatisfactory therapeutic effect|1
5975225|NCT01090310|20664625|P4|Extension Study|Adverse Event|1
5975226|NCT01090310|20664626|P3|Extension Study|Adverse Event|0
5975227|NCT01090310|20664627|P2|Extension Study|Adverse Event|0
5975228|NCT01090310|20664628|P1|Extension Study|Adverse Event|0
5975229|NCT01090310|20664625|P4|Extension Study|Aministrative problems|18
5975230|NCT01090310|20664626|P3|Extension Study|Aministrative problems|14
5975231|NCT01090310|20664627|P2|Extension Study|Aministrative problems|15
5975232|NCT01090310|20664628|P1|Extension Study|Aministrative problems|13
5975233|NCT01090310|20664625|P4|Core Study|Protocol deviation|1
5975234|NCT01090310|20664626|P3|Core Study|Protocol deviation|0
5975235|NCT01090310|20664627|P2|Core Study|Protocol deviation|0
5975236|NCT01090310|20664628|P1|Core Study|Protocol deviation|1
5975237|NCT01090310|20664625|P4|Core Study|Administrative reasons|4
5975238|NCT01090310|20664626|P3|Core Study|Administrative reasons|4
5975239|NCT01090310|20664627|P2|Core Study|Administrative reasons|6
5975240|NCT01090310|20664628|P1|Core Study|Administrative reasons|5
5975241|NCT01090310|20664625|P4|Core Study|Abnormal test procedure result|0
5975242|NCT01090310|20664626|P3|Core Study|Abnormal test procedure result|1
5975243|NCT01090310|20664627|P2|Core Study|Abnormal test procedure result|0
5975244|NCT01090310|20664628|P1|Core Study|Abnormal test procedure result|0
5975245|NCT01090310|20664625|P4|Core Study|Subject withdrew consent|1
5975246|NCT01090310|20664626|P3|Core Study|Subject withdrew consent|1
5975247|NCT01090310|20664627|P2|Core Study|Subject withdrew consent|3
5975248|NCT01090310|20664628|P1|Core Study|Subject withdrew consent|0
5975249|NCT01090310|20664625|P4|Core Study|Adverse Event|1
5975250|NCT01090310|20664626|P3|Core Study|Adverse Event|1
5975251|NCT01090310|20664627|P2|Core Study|Adverse Event|2
5975252|NCT01090310|20664628|P1|Core Study|Adverse Event|2
5975253|NCT01090102|20664676|P2|Second 12 Weeks|Withdrawal by Subject|1
5975254|NCT01090102|20664677|P1|Second 12 Weeks|Withdrawal by Subject|0
5975255|NCT01090102|20664676|P2|First 12 Weeks|Death|1
5975256|NCT01090102|20664677|P1|First 12 Weeks|Death|1
5975257|NCT01090102|20664676|P2|First 12 Weeks|Adverse Event|0
5975258|NCT01090102|20664677|P1|First 12 Weeks|Adverse Event|2
5975259|NCT01090102|20664676|P2|First 12 Weeks|Withdrawal by Subject|1
5975260|NCT01090102|20664677|P1|First 12 Weeks|Withdrawal by Subject|1
5975261|NCT01090076|20664687|P2|Overall Study|Withdrawal by Subject|1
5975262|NCT01090076|20664688|P1|Overall Study|Withdrawal by Subject|0
5975263|NCT01090076|20664687|P2|Overall Study|Death|1
5975264|NCT01090076|20664688|P1|Overall Study|Death|1
5975265|NCT01090063|20664698|P1|Treatment|Withdrawal by Subject|4
5975266|NCT01090063|20664698|P1|Screen|Screen Failed|4
5975267|NCT01090050|20664714|P2|Overall Study|Physician Decision|1
5975268|NCT01090050|20664715|P1|Overall Study|Physician Decision|0
5975269|NCT01090050|20664714|P2|Overall Study|Lack of Efficacy|5
5975270|NCT01090050|20664715|P1|Overall Study|Lack of Efficacy|1
5975271|NCT01090050|20664714|P2|Overall Study|Lost to Follow-up|1
5975272|NCT01090050|20664715|P1|Overall Study|Lost to Follow-up|0
5975273|NCT01090011|20664735|P1|Overall Study|Other reason not defined above|5
5975274|NCT01090011|20664735|P1|Overall Study|Refusal to start/continue medication|5
5975275|NCT01090011|20664735|P1|Overall Study|Protocol Violation|1
5975276|NCT01090011|20664735|P1|Overall Study|Adverse Event|32
5975277|NCT01090011|20664735|P1|Overall Study|Progressive disease|128
5975278|NCT01089647|20664828|P2|Overall Study|Adverse Event|1
5975279|NCT01089647|20664829|P1|Overall Study|Adverse Event|0
5975280|NCT01089647|20664828|P2|Overall Study|Withdrawal by Subject|1
5975281|NCT01089647|20664829|P1|Overall Study|Withdrawal by Subject|2
5975282|NCT01089647|20664828|P2|Overall Study|Lost to Follow-up|2
5975283|NCT01089647|20664829|P1|Overall Study|Lost to Follow-up|2
5975284|NCT01089608|20664837|P2|Overall Study|Lost to Follow-up|2
5975285|NCT01089608|20664838|P1|Overall Study|Lost to Follow-up|0
5975286|NCT01089608|20664837|P2|Overall Study|Adverse Event|4
5975287|NCT01089608|20664838|P1|Overall Study|Adverse Event|0
5975288|NCT01089582|20664855|P1|Overall Study|Withdrawal by Subject|1
5975289|NCT01089582|20664855|P1|Overall Study|Other|4
5975290|NCT01089582|20664855|P1|Overall Study|Lost to Follow-up|8
5975291|NCT01089582|20664855|P1|Overall Study|Adverse Event|15
5975292|NCT01089582|20664855|P1|Overall Study|Death|2
5975293|NCT01089556|20664898|P6|Study Period III (Weeks 9-16)|Withdrawal by Subject|2
5975294|NCT01089556|20664899|P5|Study Period III (Weeks 9-16)|Withdrawal by Subject|1
5975295|NCT01089556|20664900|P4|Study Period III (Weeks 9-16)|Withdrawal by Subject|0
5975296|NCT01089556|20664901|P3|Study Period III (Weeks 9-16)|Withdrawal by Subject|3
5975297|NCT01089556|20664902|P2|Study Period III (Weeks 9-16)|Withdrawal by Subject|0
5975298|NCT01089556|20664903|P1|Study Period III (Weeks 9-16)|Withdrawal by Subject|0
5975299|NCT01089556|20664898|P6|Study Period III (Weeks 9-16)|Satisfactory Response|1
5975300|NCT01089556|20664899|P5|Study Period III (Weeks 9-16)|Satisfactory Response|4
5975301|NCT01089556|20664900|P4|Study Period III (Weeks 9-16)|Satisfactory Response|3
5975302|NCT01089556|20664901|P3|Study Period III (Weeks 9-16)|Satisfactory Response|4
5975303|NCT01089556|20664902|P2|Study Period III (Weeks 9-16)|Satisfactory Response|0
5975304|NCT01089556|20664903|P1|Study Period III (Weeks 9-16)|Satisfactory Response|0
5975305|NCT01089556|20664898|P6|Study Period III (Weeks 9-16)|Protocol Violation|0
5975306|NCT01089556|20664899|P5|Study Period III (Weeks 9-16)|Protocol Violation|1
5975307|NCT01089556|20664900|P4|Study Period III (Weeks 9-16)|Protocol Violation|1
5975308|NCT01089556|20664901|P3|Study Period III (Weeks 9-16)|Protocol Violation|1
5975309|NCT01089556|20664902|P2|Study Period III (Weeks 9-16)|Protocol Violation|0
5975310|NCT01089556|20664903|P1|Study Period III (Weeks 9-16)|Protocol Violation|0
5975311|NCT01089556|20664898|P6|Study Period III (Weeks 9-16)|Lost to Follow-up|0
5975312|NCT01089556|20664899|P5|Study Period III (Weeks 9-16)|Lost to Follow-up|0
5975313|NCT01089556|20664900|P4|Study Period III (Weeks 9-16)|Lost to Follow-up|0
5975314|NCT01089556|20664901|P3|Study Period III (Weeks 9-16)|Lost to Follow-up|1
5975315|NCT01089556|20664902|P2|Study Period III (Weeks 9-16)|Lost to Follow-up|0
5975316|NCT01089556|20664903|P1|Study Period III (Weeks 9-16)|Lost to Follow-up|0
5975317|NCT01089556|20664898|P6|Study Period III (Weeks 9-16)|Lack of Efficacy|0
5975318|NCT01089556|20664899|P5|Study Period III (Weeks 9-16)|Lack of Efficacy|1
5975319|NCT01089556|20664900|P4|Study Period III (Weeks 9-16)|Lack of Efficacy|2
5975320|NCT01089556|20664901|P3|Study Period III (Weeks 9-16)|Lack of Efficacy|0
5975321|NCT01089556|20664902|P2|Study Period III (Weeks 9-16)|Lack of Efficacy|0
5975322|NCT01089556|20664903|P1|Study Period III (Weeks 9-16)|Lack of Efficacy|0
5975323|NCT01089556|20664898|P6|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1
5975324|NCT01089556|20664899|P5|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1
5975325|NCT01089556|20664900|P4|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1
5975326|NCT01089556|20664901|P3|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1
5975327|NCT01089556|20664902|P2|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0
5975328|NCT01089556|20664903|P1|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0
5975329|NCT01089556|20664898|P6|Study Period III (Weeks 9-16)|Adverse Event|3
5975330|NCT01089556|20664899|P5|Study Period III (Weeks 9-16)|Adverse Event|4
5975331|NCT01089556|20664900|P4|Study Period III (Weeks 9-16)|Adverse Event|2
5975332|NCT01089556|20664901|P3|Study Period III (Weeks 9-16)|Adverse Event|4
5975333|NCT01089556|20664902|P2|Study Period III (Weeks 9-16)|Adverse Event|0
5975334|NCT01089556|20664903|P1|Study Period III (Weeks 9-16)|Adverse Event|0
5975335|NCT01089556|20664898|P6|Study Period II (Weeks 1-8)|Not received any study drug|0
5975336|NCT01089556|20664899|P5|Study Period II (Weeks 1-8)|Not received any study drug|0
5975337|NCT01089556|20664900|P4|Study Period II (Weeks 1-8)|Not received any study drug|0
5975338|NCT01089556|20664901|P3|Study Period II (Weeks 1-8)|Not received any study drug|0
5975339|NCT01089556|20664902|P2|Study Period II (Weeks 1-8)|Not received any study drug|4
5975340|NCT01089556|20664903|P1|Study Period II (Weeks 1-8)|Not received any study drug|3
5975341|NCT01089556|20664898|P6|Study Period II (Weeks 1-8)|Withdrawal by Subject|0
5975342|NCT01089556|20664899|P5|Study Period II (Weeks 1-8)|Withdrawal by Subject|0
5975343|NCT01089556|20664900|P4|Study Period II (Weeks 1-8)|Withdrawal by Subject|0
5975344|NCT01089556|20664901|P3|Study Period II (Weeks 1-8)|Withdrawal by Subject|0
5975345|NCT01089556|20664902|P2|Study Period II (Weeks 1-8)|Withdrawal by Subject|14
5975346|NCT01089556|20664903|P1|Study Period II (Weeks 1-8)|Withdrawal by Subject|12
5975347|NCT01089556|20664898|P6|Study Period II (Weeks 1-8)|Protocol Violation|0
5975348|NCT01089556|20664899|P5|Study Period II (Weeks 1-8)|Protocol Violation|0
5975349|NCT01089556|20664900|P4|Study Period II (Weeks 1-8)|Protocol Violation|0
5975350|NCT01089556|20664901|P3|Study Period II (Weeks 1-8)|Protocol Violation|0
5975351|NCT01089556|20664902|P2|Study Period II (Weeks 1-8)|Protocol Violation|4
5975352|NCT01089556|20664903|P1|Study Period II (Weeks 1-8)|Protocol Violation|4
5975353|NCT01089556|20664898|P6|Study Period II (Weeks 1-8)|Physician Decision|0
5975354|NCT01089556|20664899|P5|Study Period II (Weeks 1-8)|Physician Decision|0
5975355|NCT01089556|20664900|P4|Study Period II (Weeks 1-8)|Physician Decision|0
5975356|NCT01089556|20664901|P3|Study Period II (Weeks 1-8)|Physician Decision|0
5975357|NCT01089556|20664902|P2|Study Period II (Weeks 1-8)|Physician Decision|0
5975358|NCT01089556|20664903|P1|Study Period II (Weeks 1-8)|Physician Decision|4
5975359|NCT01089556|20664898|P6|Study Period II (Weeks 1-8)|Lost to Follow-up|0
5975360|NCT01089556|20664899|P5|Study Period II (Weeks 1-8)|Lost to Follow-up|0
5975361|NCT01089556|20664900|P4|Study Period II (Weeks 1-8)|Lost to Follow-up|0
5975362|NCT01089556|20664901|P3|Study Period II (Weeks 1-8)|Lost to Follow-up|0
5975363|NCT01089556|20664902|P2|Study Period II (Weeks 1-8)|Lost to Follow-up|3
5975364|NCT01089556|20664903|P1|Study Period II (Weeks 1-8)|Lost to Follow-up|0
5975365|NCT01089556|20664898|P6|Study Period II (Weeks 1-8)|Lack of Efficacy|0
5975366|NCT01089556|20664899|P5|Study Period II (Weeks 1-8)|Lack of Efficacy|0
5975367|NCT01089556|20664900|P4|Study Period II (Weeks 1-8)|Lack of Efficacy|0
5975368|NCT01089556|20664901|P3|Study Period II (Weeks 1-8)|Lack of Efficacy|0
5975369|NCT01089556|20664902|P2|Study Period II (Weeks 1-8)|Lack of Efficacy|2
5975370|NCT01089556|20664903|P1|Study Period II (Weeks 1-8)|Lack of Efficacy|1
5975371|NCT01089556|20664898|P6|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0
5975372|NCT01089556|20664899|P5|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0
5975373|NCT01089556|20664900|P4|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0
5975374|NCT01089556|20664901|P3|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0
5975375|NCT01089556|20664902|P2|Study Period II (Weeks 1-8)|Entry Criteria Not Met|8
5975376|NCT01089556|20664903|P1|Study Period II (Weeks 1-8)|Entry Criteria Not Met|12
5975377|NCT01089556|20664898|P6|Study Period II (Weeks 1-8)|Adverse Event|0
5975378|NCT01089556|20664899|P5|Study Period II (Weeks 1-8)|Adverse Event|0
5975379|NCT01089556|20664900|P4|Study Period II (Weeks 1-8)|Adverse Event|0
5975380|NCT01089556|20664901|P3|Study Period II (Weeks 1-8)|Adverse Event|0
5975381|NCT01089556|20664902|P2|Study Period II (Weeks 1-8)|Adverse Event|39
5975382|NCT01089556|20664903|P1|Study Period II (Weeks 1-8)|Adverse Event|35
5975383|NCT01089543|20664977|P4|Overall Study|Adverse Event|0
5975384|NCT01089543|20664978|P3|Overall Study|Adverse Event|0
5975385|NCT01089543|20664979|P2|Overall Study|Adverse Event|1
5975386|NCT01089543|20664980|P1|Overall Study|Adverse Event|0
5975387|NCT01089543|20664977|P4|Overall Study|Physician Decision|1
5975388|NCT01089543|20664978|P3|Overall Study|Physician Decision|0
5975389|NCT01089543|20664979|P2|Overall Study|Physician Decision|0
5975390|NCT01089543|20664980|P1|Overall Study|Physician Decision|1
5975391|NCT01089543|20664977|P4|Overall Study|Withdrawal by Subject|1
5975392|NCT01089543|20664978|P3|Overall Study|Withdrawal by Subject|3
5975393|NCT01089543|20664979|P2|Overall Study|Withdrawal by Subject|3
5975394|NCT01089543|20664980|P1|Overall Study|Withdrawal by Subject|2
5975395|NCT01089504|20665015|P2|Overall Study|Withdrawal by Subject|0
5975396|NCT01089504|20665016|P1|Overall Study|Withdrawal by Subject|2
5975397|NCT01089504|20665015|P2|Overall Study|Lost to Follow-up|1
5975398|NCT01089504|20665016|P1|Overall Study|Lost to Follow-up|1
5975399|NCT01089413|20665029|P1|Overall Study|Other|71
5975400|NCT01089413|20665029|P1|Overall Study|Metastasectomy|13
5975401|NCT01089413|20665029|P1|Overall Study|Death|10
5975402|NCT01089413|20665029|P1|Overall Study|Unacceptable Toxicity|12
5975403|NCT01089413|20665029|P1|Overall Study|Participant Withdrew Consent|1
5975404|NCT01089413|20665029|P1|Overall Study|Progressive Disease|93
5975405|NCT01089413|20665029|P1|Overall Study|Lost to Follow-up|1
5975406|NCT01089361|20665048|P2|Overall Study|Death|0
5975407|NCT01089361|20665049|P1|Overall Study|Death|1
5975408|NCT01089127|20665098|P6|Overall Study|Protocol deviation|0
5975409|NCT01089127|20665099|P5|Overall Study|Protocol deviation|1
5975410|NCT01089127|20665100|P4|Overall Study|Protocol deviation|0
5975411|NCT01089127|20665101|P3|Overall Study|Protocol deviation|0
5975412|NCT01089127|20665102|P2|Overall Study|Protocol deviation|1
5975413|NCT01089127|20665103|P1|Overall Study|Protocol deviation|0
5975414|NCT01089127|20665098|P6|Overall Study|Lost to Follow-up|0
5975415|NCT01089127|20665099|P5|Overall Study|Lost to Follow-up|1
5975416|NCT01089127|20665100|P4|Overall Study|Lost to Follow-up|0
5975417|NCT01089127|20665101|P3|Overall Study|Lost to Follow-up|0
5975418|NCT01089127|20665102|P2|Overall Study|Lost to Follow-up|1
5975419|NCT01089127|20665103|P1|Overall Study|Lost to Follow-up|1
5975420|NCT01089127|20665098|P6|Overall Study|Abnormal test procedure result(s)|0
5975421|NCT01089127|20665099|P5|Overall Study|Abnormal test procedure result(s)|0
5975422|NCT01089127|20665100|P4|Overall Study|Abnormal test procedure result(s)|0
5975423|NCT01089127|20665101|P3|Overall Study|Abnormal test procedure result(s)|0
5975424|NCT01089127|20665102|P2|Overall Study|Abnormal test procedure result(s)|1
5975425|NCT01089127|20665103|P1|Overall Study|Abnormal test procedure result(s)|2
5975426|NCT01089127|20665098|P6|Overall Study|Subject withdrew consent|2
5975427|NCT01089127|20665099|P5|Overall Study|Subject withdrew consent|0
5975428|NCT01089127|20665100|P4|Overall Study|Subject withdrew consent|1
5975429|NCT01089127|20665101|P3|Overall Study|Subject withdrew consent|1
5975430|NCT01089127|20665102|P2|Overall Study|Subject withdrew consent|1
5975431|NCT01089127|20665103|P1|Overall Study|Subject withdrew consent|0
5975432|NCT01089127|20665098|P6|Overall Study|Adverse Event|1
5975433|NCT01089127|20665099|P5|Overall Study|Adverse Event|0
5975434|NCT01089127|20665100|P4|Overall Study|Adverse Event|0
5975435|NCT01089127|20665101|P3|Overall Study|Adverse Event|1
5975436|NCT01089127|20665102|P2|Overall Study|Adverse Event|1
5975437|NCT01089127|20665103|P1|Overall Study|Adverse Event|5
5975438|NCT01089023|20665157|P1|Overall Study|Lack of Efficacy|1
5975439|NCT01089023|20665157|P1|Overall Study|Protocol Violation|1
5975440|NCT01089023|20665157|P1|Overall Study|Withdrawal by Subject|1
5975441|NCT01089023|20665157|P1|Overall Study|Adverse Event|1
5975442|NCT01089023|20665157|P1|Overall Study|Lost to Follow-up|3
5975443|NCT01088997|20665171|P2|Overall Study|Excluded prior to receiving drug|1
5975444|NCT01088997|20665172|P1|Overall Study|Excluded prior to receiving drug|1
5975445|NCT01088997|20665171|P2|Overall Study|Req. Extracorporeal membrane oxygenation|1
5975446|NCT01088997|20665172|P1|Overall Study|Req. Extracorporeal membrane oxygenation|1
5975447|NCT01088997|20665171|P2|Overall Study|Physician Decision|1
5975448|NCT01088997|20665172|P1|Overall Study|Physician Decision|1
5975449|NCT01088984|20665183|P2|Phase 2|Other|1
5975450|NCT01088984|20665184|P1|Phase 2|Other|0
5975451|NCT01088984|20665183|P2|Phase 2|DIsease Progression|25
5975452|NCT01088984|20665184|P1|Phase 2|DIsease Progression|0
5975453|NCT01088984|20665183|P2|Phase 2|Withdrawal by Subject|1
5975454|NCT01088984|20665184|P1|Phase 2|Withdrawal by Subject|0
5975455|NCT01088984|20665183|P2|Phase 2|Death|5
5975456|NCT01088984|20665184|P1|Phase 2|Death|0
5975457|NCT01088984|20665183|P2|Phase 1|Other|1
5975458|NCT01088984|20665184|P1|Phase 1|Other|1
5975459|NCT01088984|20665183|P2|Phase 1|Disease Progression|4
5975460|NCT01088984|20665184|P1|Phase 1|Disease Progression|2
5975461|NCT01088984|20665183|P2|Phase 1|Death|1
5975462|NCT01088984|20665184|P1|Phase 1|Death|2
5975463|NCT01088529|20665255|P2|Overall Study|Did not receive study treatment|1
5975464|NCT01088529|20665256|P1|Overall Study|Did not receive study treatment|0
5975465|NCT01088503|20665269|P3|Overall Study|Death|7
5975466|NCT01088503|20665270|P2|Overall Study|Death|358
5975467|NCT01088503|20665271|P1|Overall Study|Death|64
5975468|NCT01088503|20665269|P3|Overall Study|Withdrawal by Subject|10
5975469|NCT01088503|20665270|P2|Overall Study|Withdrawal by Subject|327
5975470|NCT01088503|20665271|P1|Overall Study|Withdrawal by Subject|118
5975471|NCT01088438|20665349|P2|Overall Study|Lost to Follow-up|30
5975472|NCT01088438|20665350|P1|Overall Study|Lost to Follow-up|18
5975473|NCT01088438|20665349|P2|Overall Study|Withdrawal by Subject|6
5975474|NCT01088438|20665350|P1|Overall Study|Withdrawal by Subject|11
5975475|NCT01088412|20665363|P3|Overall Study|Study Summary Not Completed|22
5975476|NCT01088412|20665364|P2|Overall Study|Study Summary Not Completed|64
5975477|NCT01088412|20665365|P1|Overall Study|Study Summary Not Completed|4360
5975478|NCT01088412|20665363|P3|Overall Study|Lost to Follow-up|11
5975479|NCT01088412|20665364|P2|Overall Study|Lost to Follow-up|130
5975480|NCT01088412|20665365|P1|Overall Study|Lost to Follow-up|3052
5975481|NCT01088412|20665363|P3|Overall Study|Third Party Required to Change Brand|0
5975482|NCT01088412|20665364|P2|Overall Study|Third Party Required to Change Brand|0
5975483|NCT01088412|20665365|P1|Overall Study|Third Party Required to Change Brand|487
5975484|NCT01088412|20665363|P3|Overall Study|Sponsor Decision|23
5975485|NCT01088412|20665364|P2|Overall Study|Sponsor Decision|79
5975486|NCT01088412|20665365|P1|Overall Study|Sponsor Decision|4467
5975487|NCT01088412|20665363|P3|Overall Study|Physician Decision|4
5975488|NCT01088412|20665364|P2|Overall Study|Physician Decision|8
5975489|NCT01088412|20665365|P1|Overall Study|Physician Decision|1041
5975490|NCT01088412|20665363|P3|Overall Study|Participant Moved|2
5975491|NCT01088412|20665364|P2|Overall Study|Participant Moved|21
5975492|NCT01088412|20665365|P1|Overall Study|Participant Moved|601
5975493|NCT01088412|20665363|P3|Overall Study|Received Another GH Product|0
5975494|NCT01088412|20665364|P2|Overall Study|Received Another GH Product|0
5975495|NCT01088412|20665365|P1|Overall Study|Received Another GH Product|79
5975496|NCT01088412|20665363|P3|Overall Study|Withdrawal by Subject|1
5975497|NCT01088412|20665364|P2|Overall Study|Withdrawal by Subject|25
5975498|NCT01088412|20665365|P1|Overall Study|Withdrawal by Subject|1761
5975499|NCT01088412|20665363|P3|Overall Study|Other Reason per Case Report Form|9
5975500|NCT01088412|20665364|P2|Overall Study|Other Reason per Case Report Form|103
5975501|NCT01088412|20665365|P1|Overall Study|Other Reason per Case Report Form|2089
5975502|NCT01088412|20665363|P3|Overall Study|Death|0
5975503|NCT01088412|20665364|P2|Overall Study|Death|6
5975504|NCT01088412|20665365|P1|Overall Study|Death|42
5975505|NCT01088412|20665363|P3|Overall Study|Adverse Event|0
5975506|NCT01088412|20665364|P2|Overall Study|Adverse Event|0
5975507|NCT01088412|20665365|P1|Overall Study|Adverse Event|38
5975508|NCT01088399|20665384|P3|Overall Study|Study summary visit not completed|80
5975509|NCT01088399|20665385|P2|Overall Study|Study summary visit not completed|283
5975510|NCT01088399|20665386|P1|Overall Study|Study summary visit not completed|2398
5975511|NCT01088399|20665384|P3|Overall Study|Enrollment criteria not met|70
5975512|NCT01088399|20665385|P2|Overall Study|Enrollment criteria not met|119
5975513|NCT01088399|20665386|P1|Overall Study|Enrollment criteria not met|48
5975514|NCT01088399|20665384|P3|Overall Study|Protocol Violation|0
5975515|NCT01088399|20665385|P2|Overall Study|Protocol Violation|1
5975516|NCT01088399|20665386|P1|Overall Study|Protocol Violation|10
5975517|NCT01088399|20665384|P3|Overall Study|Sponsor decision|7
5975518|NCT01088399|20665385|P2|Overall Study|Sponsor decision|298
5975519|NCT01088399|20665386|P1|Overall Study|Sponsor decision|1573
5975520|NCT01088399|20665384|P3|Overall Study|Change to or start of somatropin therapy|12
5975521|NCT01088399|20665385|P2|Overall Study|Change to or start of somatropin therapy|17
5975522|NCT01088399|20665386|P1|Overall Study|Change to or start of somatropin therapy|234
5975523|NCT01088399|20665384|P3|Overall Study|Withdrawal by Subject|33
5975524|NCT01088399|20665385|P2|Overall Study|Withdrawal by Subject|195
5975525|NCT01088399|20665386|P1|Overall Study|Withdrawal by Subject|544
5975526|NCT01088399|20665384|P3|Overall Study|Physician Decision|16
5975527|NCT01088399|20665385|P2|Overall Study|Physician Decision|88
5975528|NCT01088399|20665386|P1|Overall Study|Physician Decision|531
5975529|NCT01088399|20665384|P3|Overall Study|Lost to Follow-up|58
5975530|NCT01088399|20665385|P2|Overall Study|Lost to Follow-up|278
5975531|NCT01088399|20665386|P1|Overall Study|Lost to Follow-up|1070
5975532|NCT01088399|20665384|P3|Overall Study|Lack of Efficacy|5
5975533|NCT01088399|20665385|P2|Overall Study|Lack of Efficacy|7
5975534|NCT01088399|20665386|P1|Overall Study|Lack of Efficacy|298
5975535|NCT01088399|20665384|P3|Overall Study|Death|0
5975536|NCT01088399|20665385|P2|Overall Study|Death|45
5975537|NCT01088399|20665386|P1|Overall Study|Death|204
5975538|NCT01088399|20665384|P3|Overall Study|Adverse Event|0
5975539|NCT01088399|20665385|P2|Overall Study|Adverse Event|16
5975540|NCT01088399|20665386|P1|Overall Study|Adverse Event|211
5975541|NCT01088243|20665415|P2|Overall Study|Adverse Event|0
5975542|NCT01088243|20665416|P1|Overall Study|Adverse Event|1
5975543|NCT01087970|20665457|P1|Overall Study|Protocol Violation|2
5975544|NCT01087957|20665469|P2|Overall Study|Physician Decision|9
5975545|NCT01087957|20665470|P1|Overall Study|Physician Decision|5
5975546|NCT01087957|20665469|P2|Overall Study|Withdrawal by Subject|15
5975547|NCT01087957|20665470|P1|Overall Study|Withdrawal by Subject|18
5975548|NCT01087957|20665469|P2|Overall Study|Protocol Violation|25
5975549|NCT01087957|20665470|P1|Overall Study|Protocol Violation|13
5975550|NCT01087957|20665469|P2|Overall Study|Lost to Follow-up|4
5975551|NCT01087957|20665470|P1|Overall Study|Lost to Follow-up|3
5975552|NCT01087957|20665469|P2|Overall Study|Death|2
5975553|NCT01087957|20665470|P1|Overall Study|Death|2
5975554|NCT01087944|20665496|P2|Period 2 (Week 4-6)|Adverse Event|2
5975555|NCT01087944|20665497|P1|Period 2 (Week 4-6)|Adverse Event|0
5975556|NCT01087944|20665496|P2|Period 1 (Week 1-3)|Adverse Event|0
5975557|NCT01087944|20665497|P1|Period 1 (Week 1-3)|Adverse Event|1
5975558|NCT01087905|20665577|P8|Overall Study|Withdrawal by Subject|5
5975559|NCT01087905|20665578|P7|Overall Study|Withdrawal by Subject|3
5975560|NCT01087905|20665579|P6|Overall Study|Withdrawal by Subject|3
5975561|NCT01087905|20665580|P5|Overall Study|Withdrawal by Subject|4
5975562|NCT01087905|20665581|P4|Overall Study|Withdrawal by Subject|5
5975563|NCT01087905|20665582|P3|Overall Study|Withdrawal by Subject|4
5975564|NCT01087905|20665583|P2|Overall Study|Withdrawal by Subject|4
5975565|NCT01087905|20665584|P1|Overall Study|Withdrawal by Subject|5
5975566|NCT01087905|20665577|P8|Overall Study|Lost to Follow-up|24
5975567|NCT01087905|20665578|P7|Overall Study|Lost to Follow-up|20
5975568|NCT01087905|20665579|P6|Overall Study|Lost to Follow-up|25
5975569|NCT01087905|20665580|P5|Overall Study|Lost to Follow-up|27
5975570|NCT01087905|20665581|P4|Overall Study|Lost to Follow-up|31
5975571|NCT01087905|20665582|P3|Overall Study|Lost to Follow-up|18
5975572|NCT01087905|20665583|P2|Overall Study|Lost to Follow-up|28
5975573|NCT01087905|20665584|P1|Overall Study|Lost to Follow-up|24
5975574|NCT01087814|20665606|P2|Second Intervention (5 Days)|Physician Decision|0
5975575|NCT01087814|20665607|P1|Second Intervention (5 Days)|Physician Decision|1
5975576|NCT01087814|20665606|P2|First Intervention (5 Days)|Withdrawal by Subject|1
5975577|NCT01087814|20665607|P1|First Intervention (5 Days)|Withdrawal by Subject|3
5975578|NCT01087788|20665625|P3|Open-Label Period (OL-P)|Personal reasons|1
5975579|NCT01087788|20665626|P2|Open-Label Period (OL-P)|Personal reasons|0
5975580|NCT01087788|20665627|P1|Open-Label Period (OL-P)|Personal reasons|0
5975581|NCT01087788|20665625|P3|Open-Label Period (OL-P)|No participation in study extension|1
5975582|NCT01087788|20665626|P2|Open-Label Period (OL-P)|No participation in study extension|0
5975583|NCT01087788|20665627|P1|Open-Label Period (OL-P)|No participation in study extension|0
5975584|NCT01087788|20665625|P3|Open-Label Period (OL-P)|Principal investigator decision|2
5975585|NCT01087788|20665626|P2|Open-Label Period (OL-P)|Principal investigator decision|1
5975586|NCT01087788|20665627|P1|Open-Label Period (OL-P)|Principal investigator decision|0
5975587|NCT01087788|20665625|P3|Open-Label Period (OL-P)|Sponsor request|0
5975588|NCT01087788|20665626|P2|Open-Label Period (OL-P)|Sponsor request|0
5975589|NCT01087788|20665627|P1|Open-Label Period (OL-P)|Sponsor request|1
5975590|NCT01087788|20665625|P3|Open-Label Period (OL-P)|AE, non-serious unknown|0
5975591|NCT01087788|20665626|P2|Open-Label Period (OL-P)|AE, non-serious unknown|0
5975592|NCT01087788|20665627|P1|Open-Label Period (OL-P)|AE, non-serious unknown|1
5975593|NCT01087788|20665625|P3|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0
5975594|NCT01087788|20665626|P2|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|1
5975595|NCT01087788|20665627|P1|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0
5975596|NCT01087788|20665625|P3|Open-Label Period (OL-P)|AE, non-serious non-fatal|4
5975597|NCT01087788|20665626|P2|Open-Label Period (OL-P)|AE, non-serious non-fatal|4
5975598|NCT01087788|20665627|P1|Open-Label Period (OL-P)|AE, non-serious non-fatal|6
5975599|NCT01087788|20665625|P3|Open-Label Period (OL-P)|AE, serious non-fatal|4
5975600|NCT01087788|20665626|P2|Open-Label Period (OL-P)|AE, serious non-fatal|3
5975601|NCT01087788|20665627|P1|Open-Label Period (OL-P)|AE, serious non-fatal|1
5975602|NCT01087788|20665625|P3|Open-Label Period (OL-P)|AE, serious fatal|1
5975603|NCT01087788|20665626|P2|Open-Label Period (OL-P)|AE, serious fatal|0
5975604|NCT01087788|20665627|P1|Open-Label Period (OL-P)|AE, serious fatal|2
5975605|NCT01087788|20665625|P3|Open-Label Period (OL-P)|Withdrawal by Subject|10
5975606|NCT01087788|20665626|P2|Open-Label Period (OL-P)|Withdrawal by Subject|8
5975607|NCT01087788|20665627|P1|Open-Label Period (OL-P)|Withdrawal by Subject|13
5975608|NCT01087788|20665625|P3|Open-Label Period (OL-P)|Lost to Follow-up|2
5975609|NCT01087788|20665626|P2|Open-Label Period (OL-P)|Lost to Follow-up|4
5975610|NCT01087788|20665627|P1|Open-Label Period (OL-P)|Lost to Follow-up|0
5975611|NCT01087788|20665625|P3|Open-Label Period (OL-P)|Protocol Violation|0
5975612|NCT01087788|20665626|P2|Open-Label Period (OL-P)|Protocol Violation|1
5975613|NCT01087788|20665627|P1|Open-Label Period (OL-P)|Protocol Violation|2
5975614|NCT01087788|20665625|P3|Open-Label Period (OL-P)|Lack of Efficacy|3
5975615|NCT01087788|20665626|P2|Open-Label Period (OL-P)|Lack of Efficacy|2
5975616|NCT01087788|20665627|P1|Open-Label Period (OL-P)|Lack of Efficacy|4
5975617|NCT01087788|20665625|P3|24-weeks Dose-blind Period|Patient moved|1
5975618|NCT01087788|20665626|P2|24-weeks Dose-blind Period|Patient moved|0
5975619|NCT01087788|20665627|P1|24-weeks Dose-blind Period|Patient moved|0
5975620|NCT01087788|20665625|P3|24-weeks Dose-blind Period|Sponsor decision following missed visits|0
5975621|NCT01087788|20665626|P2|24-weeks Dose-blind Period|Sponsor decision following missed visits|0
5975622|NCT01087788|20665627|P1|24-weeks Dose-blind Period|Sponsor decision following missed visits|1
5975623|NCT01087788|20665625|P3|24-weeks Dose-blind Period|AE, non-serious non-fatal|1
5975624|NCT01087788|20665626|P2|24-weeks Dose-blind Period|AE, non-serious non-fatal|1
5975625|NCT01087788|20665627|P1|24-weeks Dose-blind Period|AE, non-serious non-fatal|2
5975626|NCT01087788|20665625|P3|24-weeks Dose-blind Period|AE, serious non-fatal|2
5975627|NCT01087788|20665626|P2|24-weeks Dose-blind Period|AE, serious non-fatal|1
5975628|NCT01087788|20665627|P1|24-weeks Dose-blind Period|AE, serious non-fatal|2
5975629|NCT01087788|20665625|P3|24-weeks Dose-blind Period|AE, serious fatal|0
5975630|NCT01087788|20665626|P2|24-weeks Dose-blind Period|AE, serious fatal|1
5975631|NCT01087788|20665627|P1|24-weeks Dose-blind Period|AE, serious fatal|0
5975632|NCT01087788|20665625|P3|24-weeks Dose-blind Period|Withdrawal by Subject|0
5975633|NCT01087788|20665626|P2|24-weeks Dose-blind Period|Withdrawal by Subject|0
5975634|NCT01087788|20665627|P1|24-weeks Dose-blind Period|Withdrawal by Subject|1
5975635|NCT01087788|20665625|P3|24-weeks Dose-blind Period|Lost to Follow-up|1
5975636|NCT01087788|20665626|P2|24-weeks Dose-blind Period|Lost to Follow-up|0
5975637|NCT01087788|20665627|P1|24-weeks Dose-blind Period|Lost to Follow-up|1
5975638|NCT01087788|20665625|P3|24-weeks Dose-blind Period|Lack of Efficacy|1
5975639|NCT01087788|20665626|P2|24-weeks Dose-blind Period|Lack of Efficacy|2
5975640|NCT01087788|20665627|P1|24-weeks Dose-blind Period|Lack of Efficacy|0
5975641|NCT01087788|20665625|P3|24-weeks Double-blind Period|P cannot comply with scheduled visits|1
5975642|NCT01087788|20665626|P2|24-weeks Double-blind Period|P cannot comply with scheduled visits|0
5975643|NCT01087788|20665627|P1|24-weeks Double-blind Period|P cannot comply with scheduled visits|0
5975644|NCT01087788|20665625|P3|24-weeks Double-blind Period|Exclusion criteria were not met|0
5975645|NCT01087788|20665626|P2|24-weeks Double-blind Period|Exclusion criteria were not met|1
5975646|NCT01087788|20665627|P1|24-weeks Double-blind Period|Exclusion criteria were not met|0
5975647|NCT01087788|20665625|P3|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0
5975648|NCT01087788|20665626|P2|24-weeks Double-blind Period|Protocol violation (decision of monitor)|1
5975649|NCT01087788|20665627|P1|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0
5975650|NCT01087788|20665625|P3|24-weeks Double-blind Period|Patient (P) does not want to attend|0
5975651|NCT01087788|20665626|P2|24-weeks Double-blind Period|Patient (P) does not want to attend|0
5975652|NCT01087788|20665627|P1|24-weeks Double-blind Period|Patient (P) does not want to attend|1
5975653|NCT01087788|20665625|P3|24-weeks Double-blind Period|AE, unknown type|1
5975654|NCT01087788|20665626|P2|24-weeks Double-blind Period|AE, unknown type|0
5975655|NCT01087788|20665627|P1|24-weeks Double-blind Period|AE, unknown type|0
5975656|NCT01087788|20665625|P3|24-weeks Double-blind Period|AE, non-serious non-fatal|2
5975657|NCT01087788|20665626|P2|24-weeks Double-blind Period|AE, non-serious non-fatal|1
5975658|NCT01087788|20665627|P1|24-weeks Double-blind Period|AE, non-serious non-fatal|2
5975659|NCT01087788|20665625|P3|24-weeks Double-blind Period|AE, serious non-fatal|3
5975660|NCT01087788|20665626|P2|24-weeks Double-blind Period|AE, serious non-fatal|2
5975661|NCT01087788|20665627|P1|24-weeks Double-blind Period|AE, serious non-fatal|0
5975662|NCT01087788|20665625|P3|24-weeks Double-blind Period|AE, serious fatal|1
5975663|NCT01087788|20665626|P2|24-weeks Double-blind Period|AE, serious fatal|1
5975664|NCT01087788|20665627|P1|24-weeks Double-blind Period|AE, serious fatal|0
5975665|NCT01087788|20665625|P3|24-weeks Double-blind Period|Withdrawal by Subject|5
5975666|NCT01087788|20665626|P2|24-weeks Double-blind Period|Withdrawal by Subject|2
5975667|NCT01087788|20665627|P1|24-weeks Double-blind Period|Withdrawal by Subject|7
5975668|NCT01087788|20665625|P3|24-weeks Double-blind Period|Lost to Follow-up|1
5975669|NCT01087788|20665626|P2|24-weeks Double-blind Period|Lost to Follow-up|1
5975670|NCT01087788|20665627|P1|24-weeks Double-blind Period|Lost to Follow-up|4
5975671|NCT01087788|20665625|P3|24-weeks Double-blind Period|Protocol Violation|0
5975672|NCT01087788|20665626|P2|24-weeks Double-blind Period|Protocol Violation|1
5975673|NCT01087788|20665627|P1|24-weeks Double-blind Period|Protocol Violation|0
5975674|NCT01087788|20665625|P3|24-weeks Double-blind Period|Lack of Efficacy|1
5975675|NCT01087788|20665626|P2|24-weeks Double-blind Period|Lack of Efficacy|0
5975676|NCT01087788|20665627|P1|24-weeks Double-blind Period|Lack of Efficacy|2
5975677|NCT01087775|20665654|P1|Overall Study|failed inclusion criteria|2
5975678|NCT01087762|20665662|P5|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|4
5975679|NCT01087762|20665663|P4|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|2
5975680|NCT01087762|20665664|P3|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0
5976011|NCT01085201|20666539|P2|Overall Study|Scheduling conflict|0
5975681|NCT01087762|20665665|P2|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0
5975682|NCT01087762|20665666|P1|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0
5975683|NCT01087762|20665662|P5|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|13
5975684|NCT01087762|20665663|P4|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|16
5975685|NCT01087762|20665664|P3|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0
5975686|NCT01087762|20665665|P2|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0
5975687|NCT01087762|20665666|P1|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0
5975688|NCT01087762|20665662|P5|Open-Label Period (Weeks 48-204)|SAE, non-fatal|4
5975689|NCT01087762|20665663|P4|Open-Label Period (Weeks 48-204)|SAE, non-fatal|7
5975690|NCT01087762|20665664|P3|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0
5975691|NCT01087762|20665665|P2|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0
5975692|NCT01087762|20665666|P1|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0
5975693|NCT01087762|20665662|P5|Open-Label Period (Weeks 48-204)|Other|4
5975694|NCT01087762|20665663|P4|Open-Label Period (Weeks 48-204)|Other|2
5975695|NCT01087762|20665664|P3|Open-Label Period (Weeks 48-204)|Other|0
5975696|NCT01087762|20665665|P2|Open-Label Period (Weeks 48-204)|Other|0
5975697|NCT01087762|20665666|P1|Open-Label Period (Weeks 48-204)|Other|0
5975698|NCT01087762|20665662|P5|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|15
5975699|NCT01087762|20665663|P4|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|22
5975700|NCT01087762|20665664|P3|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0
5975701|NCT01087762|20665665|P2|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0
5975702|NCT01087762|20665666|P1|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0
5975703|NCT01087762|20665662|P5|Open-Label Period (Weeks 48-204)|Lost to Follow-up|2
5975704|NCT01087762|20665663|P4|Open-Label Period (Weeks 48-204)|Lost to Follow-up|5
5975705|NCT01087762|20665664|P3|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0
5975706|NCT01087762|20665665|P2|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0
5975707|NCT01087762|20665666|P1|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0
5975708|NCT01087762|20665662|P5|Open-Label Period (Weeks 48-204)|Protocol Violation|1
5975709|NCT01087762|20665663|P4|Open-Label Period (Weeks 48-204)|Protocol Violation|1
5975710|NCT01087762|20665664|P3|Open-Label Period (Weeks 48-204)|Protocol Violation|0
5975711|NCT01087762|20665665|P2|Open-Label Period (Weeks 48-204)|Protocol Violation|0
5975712|NCT01087762|20665666|P1|Open-Label Period (Weeks 48-204)|Protocol Violation|0
5975713|NCT01087762|20665662|P5|Open-Label Period (Weeks 48-204)|Lack of Efficacy|14
5975714|NCT01087762|20665663|P4|Open-Label Period (Weeks 48-204)|Lack of Efficacy|4
5975715|NCT01087762|20665664|P3|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0
5975716|NCT01087762|20665665|P2|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0
5975717|NCT01087762|20665666|P1|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0
5975718|NCT01087762|20665662|P5|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0
5975719|NCT01087762|20665663|P4|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0
5975720|NCT01087762|20665664|P3|Double Blind Period (Weeks 0-24)|SAE, non-fatal|3
5975721|NCT01087762|20665665|P2|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2
5975722|NCT01087762|20665666|P1|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2
5975723|NCT01087762|20665662|P5|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0
5975724|NCT01087762|20665663|P4|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0
5975725|NCT01087762|20665664|P3|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1
5975726|NCT01087762|20665665|P2|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|2
5975727|NCT01087762|20665666|P1|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1
5975728|NCT01087762|20665662|P5|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0
5975729|NCT01087762|20665663|P4|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0
5975730|NCT01087762|20665664|P3|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1
5975731|NCT01087762|20665665|P2|Double Blind Period (Weeks 0-24)|Lost to Follow-up|2
5975732|NCT01087762|20665666|P1|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1
5975733|NCT01087762|20665662|P5|Double Blind Period (Weeks 0-24)|Protocol Violation|0
5975734|NCT01087762|20665663|P4|Double Blind Period (Weeks 0-24)|Protocol Violation|0
5975735|NCT01087762|20665664|P3|Double Blind Period (Weeks 0-24)|Protocol Violation|1
5975736|NCT01087762|20665665|P2|Double Blind Period (Weeks 0-24)|Protocol Violation|0
5975737|NCT01087762|20665666|P1|Double Blind Period (Weeks 0-24)|Protocol Violation|6
5975738|NCT01087762|20665662|P5|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0
5975739|NCT01087762|20665663|P4|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0
5975740|NCT01087762|20665664|P3|Double Blind Period (Weeks 0-24)|Lack of Efficacy|3
5975741|NCT01087762|20665665|P2|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0
5975742|NCT01087762|20665666|P1|Double Blind Period (Weeks 0-24)|Lack of Efficacy|2
5975743|NCT01087736|20665714|P2|Overall Study|Withdrawal by Subject|1
5975744|NCT01087736|20665715|P1|Overall Study|Withdrawal by Subject|0
5975745|NCT01087736|20665714|P2|Overall Study|Death|1
5975746|NCT01087736|20665715|P1|Overall Study|Death|0
5975747|NCT01087736|20665714|P2|Overall Study|Lost to Follow-up|0
5975748|NCT01087736|20665715|P1|Overall Study|Lost to Follow-up|1
5975749|NCT01087723|20665725|P2|Overall Study|Reason Not Specified|2
5975750|NCT01087723|20665726|P1|Overall Study|Reason Not Specified|1
5975751|NCT01087723|20665725|P2|Overall Study|Lost to Follow-up|4
5975752|NCT01087723|20665726|P1|Overall Study|Lost to Follow-up|1
5975753|NCT01087723|20665725|P2|Overall Study|Physician Decision|0
5975754|NCT01087723|20665726|P1|Overall Study|Physician Decision|2
5975755|NCT01087723|20665725|P2|Overall Study|Withdrawal by Subject|13
5975756|NCT01087723|20665726|P1|Overall Study|Withdrawal by Subject|10
5975757|NCT01087723|20665725|P2|Overall Study|1 Year Visit Too Early (<335 days)|1
5975758|NCT01087723|20665726|P1|Overall Study|1 Year Visit Too Early (<335 days)|0
5975759|NCT01087528|20665767|P1|Overall Study|Incomplete CE procedure|6
5975760|NCT01087528|20665767|P1|Overall Study|Withdrawal by Subject|1
5975761|NCT01087502|20665779|P2|Up to Final Analysis (Week 52)|Other reason not described above|4
5975762|NCT01087502|20665780|P1|Up to Final Analysis (Week 52)|Other reason not described above|5
5975763|NCT01087502|20665779|P2|Up to Final Analysis (Week 52)|Study site excluded from analysis|5
5975764|NCT01087502|20665780|P1|Up to Final Analysis (Week 52)|Study site excluded from analysis|1
5975765|NCT01087502|20665779|P2|Up to Final Analysis (Week 52)|Withdrawal by Subject|2
5975766|NCT01087502|20665780|P1|Up to Final Analysis (Week 52)|Withdrawal by Subject|3
5975767|NCT01087502|20665779|P2|Up to Final Analysis (Week 52)|Lost to Follow-up|0
5975768|NCT01087502|20665780|P1|Up to Final Analysis (Week 52)|Lost to Follow-up|2
5975769|NCT01087502|20665779|P2|Up to Final Analysis (Week 52)|Protocol Violation|0
5975770|NCT01087502|20665780|P1|Up to Final Analysis (Week 52)|Protocol Violation|4
5975771|NCT01087502|20665779|P2|Up to Final Analysis (Week 52)|Lack of Efficacy|2
5975772|NCT01087502|20665780|P1|Up to Final Analysis (Week 52)|Lack of Efficacy|1
5975773|NCT01087502|20665779|P2|Up to Final Analysis (Week 52)|Adverse Event|10
5975774|NCT01087502|20665780|P1|Up to Final Analysis (Week 52)|Adverse Event|17
5975775|NCT01087502|20665779|P2|Up to Interim Analysis (Week 12)|Other reason not described above|2
5975776|NCT01087502|20665780|P1|Up to Interim Analysis (Week 12)|Other reason not described above|1
5975777|NCT01087502|20665779|P2|Up to Interim Analysis (Week 12)|Lack of Efficacy|0
5975778|NCT01087502|20665780|P1|Up to Interim Analysis (Week 12)|Lack of Efficacy|1
5975779|NCT01087502|20665779|P2|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1
5975780|NCT01087502|20665780|P1|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1
5975781|NCT01087502|20665779|P2|Up to Interim Analysis (Week 12)|Protocol Violation|1
5975782|NCT01087502|20665780|P1|Up to Interim Analysis (Week 12)|Protocol Violation|1
5975783|NCT01087502|20665779|P2|Up to Interim Analysis (Week 12)|Adverse Event|4
5975784|NCT01087502|20665780|P1|Up to Interim Analysis (Week 12)|Adverse Event|5
5975785|NCT01087489|20665799|P2|Overall Study|unable to survey by telephone|1
5975786|NCT01087489|20665800|P1|Overall Study|unable to survey by telephone|0
5975787|NCT01087489|20665799|P2|Overall Study|Death|1
5975788|NCT01087489|20665800|P1|Overall Study|Death|0
5975789|NCT01087489|20665799|P2|Overall Study|enrolled in another VA study|1
5975790|NCT01087489|20665800|P1|Overall Study|enrolled in another VA study|0
5975791|NCT01086969|20665813|P3|Overall Study|Withdrawal by Subject|0
5975792|NCT01086969|20665814|P2|Overall Study|Withdrawal by Subject|2
5975793|NCT01086969|20665815|P1|Overall Study|Withdrawal by Subject|1
5975794|NCT01086540|20665911|P2|Overall Study|Addition of new therapy for PAH|0
5975795|NCT01086540|20665912|P1|Overall Study|Addition of new therapy for PAH|1
5975796|NCT01086540|20665911|P2|Overall Study|Physician Decision|1
5975797|NCT01086540|20665912|P1|Overall Study|Physician Decision|2
5975798|NCT01086540|20665911|P2|Overall Study|Death|1
5975799|NCT01086540|20665912|P1|Overall Study|Death|3
5975800|NCT01086423|20665970|P3|Overall Study|Lost to Follow-up|1
5975801|NCT01086423|20665971|P2|Overall Study|Lost to Follow-up|0
5975802|NCT01086423|20665972|P1|Overall Study|Lost to Follow-up|0
5975803|NCT01086423|20665970|P3|Overall Study|Withdrawal by Subject|3
5975804|NCT01086423|20665971|P2|Overall Study|Withdrawal by Subject|1
5975805|NCT01086423|20665972|P1|Overall Study|Withdrawal by Subject|5
5975806|NCT01086423|20665970|P3|Overall Study|Adverse event, non-fatal|0
5975807|NCT01086423|20665971|P2|Overall Study|Adverse event, non-fatal|1
5975808|NCT01086423|20665972|P1|Overall Study|Adverse event, non-fatal|2
5975809|NCT01086423|20665970|P3|Overall Study|Adverse event, fatal|0
5975810|NCT01086423|20665971|P2|Overall Study|Adverse event, fatal|1
5975811|NCT01086423|20665972|P1|Overall Study|Adverse event, fatal|1
5975812|NCT01086423|20665970|P3|Overall Study|Migrated/moved from study area|4
5975813|NCT01086423|20665971|P2|Overall Study|Migrated/moved from study area|0
5975814|NCT01086423|20665972|P1|Overall Study|Migrated/moved from study area|2
5975815|NCT01086423|20665970|P3|Overall Study|Protocol Violation|1
5975816|NCT01086423|20665971|P2|Overall Study|Protocol Violation|0
5975817|NCT01086423|20665972|P1|Overall Study|Protocol Violation|0
5975818|NCT01086410|20666017|P4|Overall Study|Lost to Follow-up|0
5975819|NCT01086410|20666018|P3|Overall Study|Lost to Follow-up|1
5975820|NCT01086410|20666019|P2|Overall Study|Lost to Follow-up|0
5975821|NCT01086410|20666020|P1|Overall Study|Lost to Follow-up|0
5975822|NCT01086410|20666017|P4|Overall Study|Protocol Violation|0
5975823|NCT01086410|20666018|P3|Overall Study|Protocol Violation|0
5975824|NCT01086410|20666019|P2|Overall Study|Protocol Violation|1
5975825|NCT01086410|20666020|P1|Overall Study|Protocol Violation|1
5975826|NCT01086410|20666017|P4|Overall Study|Lack of Efficacy|0
5975827|NCT01086410|20666018|P3|Overall Study|Lack of Efficacy|0
5975828|NCT01086410|20666019|P2|Overall Study|Lack of Efficacy|1
5975829|NCT01086410|20666020|P1|Overall Study|Lack of Efficacy|1
5975830|NCT01086410|20666017|P4|Overall Study|Adverse Event|2
5975831|NCT01086410|20666018|P3|Overall Study|Adverse Event|0
5975832|NCT01086410|20666019|P2|Overall Study|Adverse Event|0
5975833|NCT01086410|20666020|P1|Overall Study|Adverse Event|1
5975834|NCT01086384|20666116|P3|Treatment Period|Received Treatment in Error|0
5975835|NCT01086384|20666117|P2|Treatment Period|Received Treatment in Error|1
5975836|NCT01086384|20666118|P1|Treatment Period|Received Treatment in Error|0
5975837|NCT01086384|20666116|P3|Treatment Period|Protocol-Defined Stopping Criteria|1
5975838|NCT01086384|20666117|P2|Treatment Period|Protocol-Defined Stopping Criteria|0
5975839|NCT01086384|20666118|P1|Treatment Period|Protocol-Defined Stopping Criteria|0
5975840|NCT01086384|20666116|P3|Treatment Period|Study Closed/Terminated|8
5975841|NCT01086384|20666117|P2|Treatment Period|Study Closed/Terminated|7
5975842|NCT01086384|20666118|P1|Treatment Period|Study Closed/Terminated|0
5975843|NCT01086384|20666116|P3|Treatment Period|Physician Decision|6
5975844|NCT01086384|20666117|P2|Treatment Period|Physician Decision|9
5975845|NCT01086384|20666118|P1|Treatment Period|Physician Decision|0
5975846|NCT01086384|20666116|P3|Treatment Period|Lost to Follow-up|9
5975847|NCT01086384|20666117|P2|Treatment Period|Lost to Follow-up|11
5975848|NCT01086384|20666118|P1|Treatment Period|Lost to Follow-up|0
5975849|NCT01086384|20666116|P3|Treatment Period|Adverse Event|15
5975850|NCT01086384|20666117|P2|Treatment Period|Adverse Event|19
5975851|NCT01086384|20666118|P1|Treatment Period|Adverse Event|0
5975852|NCT01086384|20666116|P3|Treatment Period|Lack of Efficacy|13
5975853|NCT01086384|20666117|P2|Treatment Period|Lack of Efficacy|22
5975854|NCT01086384|20666118|P1|Treatment Period|Lack of Efficacy|0
5975855|NCT01086384|20666116|P3|Treatment Period|Protocol Violation|17
5975856|NCT01086384|20666117|P2|Treatment Period|Protocol Violation|26
5975857|NCT01086384|20666118|P1|Treatment Period|Protocol Violation|0
5975858|NCT01086384|20666116|P3|Treatment Period|Withdrawal by Subject|55
5975859|NCT01086384|20666117|P2|Treatment Period|Withdrawal by Subject|53
5975860|NCT01086384|20666118|P1|Treatment Period|Withdrawal by Subject|0
5975861|NCT01086384|20666116|P3|2-week Run-in Period|Randomized in Error|0
5975862|NCT01086384|20666117|P2|2-week Run-in Period|Randomized in Error|0
5975863|NCT01086384|20666118|P1|2-week Run-in Period|Randomized in Error|1
5975864|NCT01086384|20666116|P3|2-week Run-in Period|Continuation Criteria Not Met|0
5975865|NCT01086384|20666117|P2|2-week Run-in Period|Continuation Criteria Not Met|0
5975866|NCT01086384|20666118|P1|2-week Run-in Period|Continuation Criteria Not Met|92
5975867|NCT01086384|20666116|P3|2-week Run-in Period|Study Closed/Terminated|0
5975868|NCT01086384|20666117|P2|2-week Run-in Period|Study Closed/Terminated|0
5975869|NCT01086384|20666118|P1|2-week Run-in Period|Study Closed/Terminated|42
5975870|NCT01086384|20666116|P3|2-week Run-in Period|Withdrawal by Subject|0
5975871|NCT01086384|20666117|P2|2-week Run-in Period|Withdrawal by Subject|0
5975872|NCT01086384|20666118|P1|2-week Run-in Period|Withdrawal by Subject|19
5975873|NCT01086384|20666116|P3|2-week Run-in Period|Physician Decision|0
5975874|NCT01086384|20666117|P2|2-week Run-in Period|Physician Decision|0
5975875|NCT01086384|20666118|P1|2-week Run-in Period|Physician Decision|6
5975876|NCT01086384|20666116|P3|2-week Run-in Period|Lost to Follow-up|0
5975877|NCT01086384|20666117|P2|2-week Run-in Period|Lost to Follow-up|0
5975878|NCT01086384|20666118|P1|2-week Run-in Period|Lost to Follow-up|1
5975879|NCT01086384|20666116|P3|2-week Run-in Period|Protocol Violation|0
5975880|NCT01086384|20666117|P2|2-week Run-in Period|Protocol Violation|0
5975881|NCT01086384|20666118|P1|2-week Run-in Period|Protocol Violation|1
5975882|NCT01086384|20666116|P3|2-week Run-in Period|Adverse Event|0
5975883|NCT01086384|20666117|P2|2-week Run-in Period|Adverse Event|0
5975884|NCT01086384|20666118|P1|2-week Run-in Period|Adverse Event|1
5975885|NCT01086358|20666128|P2|Second Intervention|Lost to Follow-up|4
5975886|NCT01086358|20666129|P1|Second Intervention|Lost to Follow-up|4
5975887|NCT01086358|20666128|P2|First Intervention|Withdrawal by Subject|1
5975888|NCT01086358|20666129|P1|First Intervention|Withdrawal by Subject|0
5975889|NCT01086358|20666128|P2|First Intervention|Lost to Follow-up|4
5975890|NCT01086358|20666129|P1|First Intervention|Lost to Follow-up|9
5975891|NCT01086215|20666199|P4|Overall Study|Lost to Follow-up|2
5975892|NCT01086215|20666200|P3|Overall Study|Lost to Follow-up|18
5975893|NCT01086215|20666201|P2|Overall Study|Lost to Follow-up|39
5975894|NCT01086215|20666202|P1|Overall Study|Lost to Follow-up|22
5975895|NCT01086215|20666199|P4|Overall Study|Death|1
5975896|NCT01086215|20666200|P3|Overall Study|Death|8
5975897|NCT01086215|20666201|P2|Overall Study|Death|8
5975898|NCT01086215|20666202|P1|Overall Study|Death|14
5975899|NCT01086150|20666223|P3|Overall Study|Screen Failure|0
5975900|NCT01086150|20666224|P2|Overall Study|Screen Failure|1
5975901|NCT01086150|20666225|P1|Overall Study|Screen Failure|0
5975902|NCT01086150|20666223|P3|Overall Study|Lost to Follow-up|0
5975903|NCT01086150|20666224|P2|Overall Study|Lost to Follow-up|1
5975904|NCT01086150|20666225|P1|Overall Study|Lost to Follow-up|0
5975905|NCT01086150|20666223|P3|Overall Study|Withdrawal by Subject|1
5975906|NCT01086150|20666224|P2|Overall Study|Withdrawal by Subject|4
5975907|NCT01086150|20666225|P1|Overall Study|Withdrawal by Subject|0
5975908|NCT01086033|20666236|P1|Overall Study|AE, Withdrew Consent & Lack of Efficacy|1
5975909|NCT01086033|20666236|P1|Overall Study|AE and Other Reason|1
5975910|NCT01086033|20666236|P1|Overall Study|AE and Lost to Follow-up|1
5975911|NCT01086033|20666236|P1|Overall Study|Death|1
5975912|NCT01086033|20666236|P1|Overall Study|AE and Lack of Efficacy|4
5975913|NCT01086033|20666236|P1|Overall Study|Withdrew consent and Other Reason|4
5975914|NCT01086033|20666236|P1|Overall Study|Withdrew Consent and Lack of Efficacy|5
5975915|NCT01086033|20666236|P1|Overall Study|AE and Withdrew Consent|5
5975916|NCT01086033|20666236|P1|Overall Study|Other|13
5975917|NCT01086033|20666236|P1|Overall Study|Other|14
5975918|NCT01086033|20666236|P1|Overall Study|Withdrawal by Subject|41
5975919|NCT01086033|20666236|P1|Overall Study|Adverse Event|42
5975920|NCT01086033|20666236|P1|Overall Study|Lost to Follow-up|86
5975921|NCT01086033|20666236|P1|Overall Study|Lack of efficacy/Exacerbation of RA|86
5975922|NCT01085812|20666302|P2|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|2
5975923|NCT01085812|20666303|P1|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|0
5975924|NCT01085812|20666302|P2|Double-blind Intent-to-treat Population|Lost to Follow-up|17
5975925|NCT01085812|20666303|P1|Double-blind Intent-to-treat Population|Lost to Follow-up|4
5975926|NCT01085812|20666302|P2|Double-blind Intent-to-treat Population|Withdrawal by Subject|22
5975927|NCT01085812|20666303|P1|Double-blind Intent-to-treat Population|Withdrawal by Subject|11
5975928|NCT01085812|20666302|P2|Double-blind Intent-to-treat Population|Protocol Violation|7
5975929|NCT01085812|20666303|P1|Double-blind Intent-to-treat Population|Protocol Violation|2
5975930|NCT01085812|20666302|P2|Double-blind Intent-to-treat Population|Adverse Event|8
5975931|NCT01085812|20666303|P1|Double-blind Intent-to-treat Population|Adverse Event|3
5975932|NCT01085812|20666302|P2|Double-Blind Period|Other Reasons|2
5975933|NCT01085812|20666303|P1|Double-Blind Period|Other Reasons|0
5975934|NCT01085812|20666302|P2|Double-Blind Period|Lost to Follow-up|17
5975935|NCT01085812|20666303|P1|Double-Blind Period|Lost to Follow-up|5
5975936|NCT01085812|20666302|P2|Double-Blind Period|Withdrawal by Subject|24
5975937|NCT01085812|20666303|P1|Double-Blind Period|Withdrawal by Subject|11
5975938|NCT01085812|20666302|P2|Double-Blind Period|Protocol Violation|7
5975939|NCT01085812|20666303|P1|Double-Blind Period|Protocol Violation|2
5975940|NCT01085812|20666302|P2|Double-Blind Period|Adverse Event|8
5975941|NCT01085812|20666303|P1|Double-Blind Period|Adverse Event|3
5975942|NCT01085812|20666302|P2|Open-Label Period|Lost to Follow-up|42
5975943|NCT01085812|20666303|P1|Open-Label Period|Lost to Follow-up|0
5975944|NCT01085812|20666302|P2|Open-Label Period|Withdrawal by Subject|53
5975945|NCT01085812|20666303|P1|Open-Label Period|Withdrawal by Subject|0
5975946|NCT01085812|20666302|P2|Open-Label Period|Protocol Violation|39
5975947|NCT01085812|20666303|P1|Open-Label Period|Protocol Violation|0
5975948|NCT01085812|20666302|P2|Open-Label Period|Lack of Efficacy|26
5975949|NCT01085812|20666303|P1|Open-Label Period|Lack of Efficacy|0
5975950|NCT01085812|20666302|P2|Open-Label Period|Adverse Event|80
5975951|NCT01085812|20666303|P1|Open-Label Period|Adverse Event|0
5975952|NCT01085734|20666350|P2|Overall Study|Withdrawal by Subject|1
5975953|NCT01085734|20666351|P1|Overall Study|Withdrawal by Subject|0
5975954|NCT01085734|20666350|P2|Overall Study|Lost to Follow-up|1
5975955|NCT01085734|20666351|P1|Overall Study|Lost to Follow-up|0
5975956|NCT01085734|20666350|P2|Overall Study|Death|0
5975957|NCT01085734|20666351|P1|Overall Study|Death|1
5975958|NCT01085734|20666350|P2|Overall Study|Adverse Event|2
5975959|NCT01085734|20666351|P1|Overall Study|Adverse Event|0
5975960|NCT01085682|20666363|P2|Overall Study|Withdrawal by Subject|25
5975961|NCT01085682|20666364|P1|Overall Study|Withdrawal by Subject|25
5975962|NCT01085630|20666381|P2|Overall Study|Ineligible|0
5975963|NCT01085630|20666382|P1|Overall Study|Ineligible|3
5975964|NCT01085630|20666381|P2|Overall Study|Insufficient data|0
5975965|NCT01085630|20666382|P1|Overall Study|Insufficient data|1
5975966|NCT01085591|20666395|P3|Overall Study|Not Properly Consented|0
5975967|NCT01085591|20666396|P2|Overall Study|Not Properly Consented|0
5975968|NCT01085591|20666397|P1|Overall Study|Not Properly Consented|1
5975969|NCT01085591|20666395|P3|Overall Study|Other|0
5975970|NCT01085591|20666396|P2|Overall Study|Other|1
5975971|NCT01085591|20666397|P1|Overall Study|Other|0
5975972|NCT01085591|20666395|P3|Overall Study|Protocol Violation|1
5975973|NCT01085591|20666396|P2|Overall Study|Protocol Violation|1
5975974|NCT01085591|20666397|P1|Overall Study|Protocol Violation|1
5975975|NCT01085591|20666395|P3|Overall Study|Lost to Follow-up|1
5975976|NCT01085591|20666396|P2|Overall Study|Lost to Follow-up|1
5975977|NCT01085591|20666397|P1|Overall Study|Lost to Follow-up|0
5975978|NCT01085591|20666395|P3|Overall Study|Withdrawal by Subject|1
5975979|NCT01085591|20666396|P2|Overall Study|Withdrawal by Subject|2
5975980|NCT01085591|20666397|P1|Overall Study|Withdrawal by Subject|0
5975981|NCT01085591|20666395|P3|Overall Study|Physician Decision|1
5975982|NCT01085591|20666396|P2|Overall Study|Physician Decision|0
5975983|NCT01085591|20666397|P1|Overall Study|Physician Decision|1
5975984|NCT01085591|20666395|P3|Overall Study|Adverse Event|3
5975985|NCT01085591|20666396|P2|Overall Study|Adverse Event|1
5975986|NCT01085591|20666397|P1|Overall Study|Adverse Event|0
5975987|NCT01085357|20666450|P2|Overall Study|Lost to Follow-up|0
5975988|NCT01085357|20666451|P1|Overall Study|Lost to Follow-up|2
5975989|NCT01085357|20666450|P2|Overall Study|Death|1
5975990|NCT01085357|20666451|P1|Overall Study|Death|11
5975991|NCT01085357|20666450|P2|Overall Study|Investigator Decision|1
5975992|NCT01085357|20666451|P1|Overall Study|Investigator Decision|1
5975993|NCT01085357|20666450|P2|Overall Study|Subject Decision|3
5975994|NCT01085357|20666451|P1|Overall Study|Subject Decision|4
5975995|NCT01085357|20666450|P2|Overall Study|Adverse Event|1
5975996|NCT01085357|20666451|P1|Overall Study|Adverse Event|1
5975997|NCT01085214|20666524|P1|Overall Study|Alternate treatment required|1
5975998|NCT01085201|20666536|P5|Overall Study|Fond ineligible after consent|0
5975999|NCT01085201|20666537|P4|Overall Study|Fond ineligible after consent|0
5976000|NCT01085201|20666538|P3|Overall Study|Fond ineligible after consent|1
5976001|NCT01085201|20666539|P2|Overall Study|Fond ineligible after consent|1
5976002|NCT01085201|20666540|P1|Overall Study|Fond ineligible after consent|0
5976003|NCT01085201|20666536|P5|Overall Study|Unknown- no study drug|0
5976004|NCT01085201|20666537|P4|Overall Study|Unknown- no study drug|0
5976005|NCT01085201|20666538|P3|Overall Study|Unknown- no study drug|0
5976006|NCT01085201|20666539|P2|Overall Study|Unknown- no study drug|0
5976007|NCT01085201|20666540|P1|Overall Study|Unknown- no study drug|2
5976008|NCT01085201|20666536|P5|Overall Study|Scheduling conflict|0
5976009|NCT01085201|20666537|P4|Overall Study|Scheduling conflict|0
5976010|NCT01085201|20666538|P3|Overall Study|Scheduling conflict|1
5976012|NCT01085201|20666540|P1|Overall Study|Scheduling conflict|1
5976013|NCT01085136|20666562|P3|Part B|Other reason not defined above|3
5976014|NCT01085136|20666563|P2|Part B|Other reason not defined above|6
5976015|NCT01085136|20666564|P1|Part B|Other reason not defined above|0
5976016|NCT01085136|20666562|P3|Part B|Not treated|8
5976017|NCT01085136|20666563|P2|Part B|Not treated|4
5976018|NCT01085136|20666564|P1|Part B|Not treated|0
5976019|NCT01085136|20666562|P3|Part B|Refusal to continue trial medication|7
5976020|NCT01085136|20666563|P2|Part B|Refusal to continue trial medication|12
5976021|NCT01085136|20666564|P1|Part B|Refusal to continue trial medication|0
5976022|NCT01085136|20666562|P3|Part B|Other AE|8
5976023|NCT01085136|20666563|P2|Part B|Other AE|29
5976024|NCT01085136|20666564|P1|Part B|Other AE|0
5976025|NCT01085136|20666562|P3|Part A|Other reason not defined above|0
5976026|NCT01085136|20666563|P2|Part A|Other reason not defined above|0
5976027|NCT01085136|20666564|P1|Part A|Other reason not defined above|30
5976028|NCT01085136|20666562|P3|Part A|Refusal to continue trial medication|0
5976029|NCT01085136|20666563|P2|Part A|Refusal to continue trial medication|0
5976030|NCT01085136|20666564|P1|Part A|Refusal to continue trial medication|64
5976031|NCT01085136|20666562|P3|Part A|Lost to Follow-up|0
5976032|NCT01085136|20666563|P2|Part A|Lost to Follow-up|0
5976033|NCT01085136|20666564|P1|Part A|Lost to Follow-up|3
5976034|NCT01085136|20666562|P3|Part A|Protocol Violation|0
5976035|NCT01085136|20666563|P2|Part A|Protocol Violation|0
5976036|NCT01085136|20666564|P1|Part A|Protocol Violation|3
5976037|NCT01085136|20666562|P3|Part A|Other Adverse event|0
5976038|NCT01085136|20666563|P2|Part A|Other Adverse event|0
5976039|NCT01085136|20666564|P1|Part A|Other Adverse event|223
5976040|NCT01085045|20666580|P1|Part B|Adverse Event|6
5976041|NCT01085045|20666580|P1|Part B|Lost to Follow-up|1
5976042|NCT01085045|20666580|P1|Part B|Protocol Specified Criteria|6
5976043|NCT01085045|20666580|P1|Part B|Withdrawal by Subject|2
5976044|NCT01085045|20666580|P1|Part A|Protocol Specified Criteria|7
5976045|NCT01085045|20666580|P1|Part A|Protocol Violation|1
5976046|NCT01085045|20666580|P1|Part A|Adverse Event|6
5976047|NCT01085045|20666580|P1|Part A|Withdrawal by Subject|4
5976048|NCT01084772|20666691|P2|2 Years|Study Termination|2
5976049|NCT01084772|20666692|P1|2 Years|Study Termination|3
5976050|NCT01084772|20666691|P2|2 Years|Lost to Follow-up|2
5976051|NCT01084772|20666692|P1|2 Years|Lost to Follow-up|5
5976052|NCT01084772|20666691|P2|2 Years|Withdrawal by Subject|0
5976053|NCT01084772|20666692|P1|2 Years|Withdrawal by Subject|1
5976054|NCT01084772|20666691|P2|1 Year|Study Termination|7
5976055|NCT01084772|20666692|P1|1 Year|Study Termination|0
5976056|NCT01084772|20666691|P2|1 Year|Lost to Follow-up|0
5976057|NCT01084772|20666692|P1|1 Year|Lost to Follow-up|3
5976058|NCT01084772|20666691|P2|1 Year|Withdrawal by Subject|1
5976059|NCT01084772|20666692|P1|1 Year|Withdrawal by Subject|0
5976060|NCT01084772|20666691|P2|3 Months|Study Termination|2
5976061|NCT01084772|20666692|P1|3 Months|Study Termination|2
5976062|NCT01084772|20666691|P2|3 Months|Death|0
5976063|NCT01084772|20666692|P1|3 Months|Death|1
5976064|NCT01084772|20666691|P2|Baseline|Withdrawal by Subject|6
5976065|NCT01084772|20666692|P1|Baseline|Withdrawal by Subject|7
5976066|NCT01084707|20666728|P1|Overall Study|Withdrawal by Subject|6
5976067|NCT01084694|20666764|P2|Overall Study|eligibility not maintained|7
5976068|NCT01084694|20666765|P1|Overall Study|eligibility not maintained|2
5976069|NCT01084694|20666764|P2|Overall Study|Death|12
5976070|NCT01084694|20666765|P1|Overall Study|Death|2
5976071|NCT01084694|20666764|P2|Overall Study|Withdrawal by Subject|1
5976072|NCT01084694|20666765|P1|Overall Study|Withdrawal by Subject|2
5976073|NCT01084668|20666781|P1|Overall Study|Non-compliance|1
5976074|NCT01084668|20666781|P1|Overall Study|Pregnancy|1
5976075|NCT01084668|20666781|P1|Overall Study|Withdrawal by Subject|2
5976076|NCT01084668|20666781|P1|Overall Study|Lack of Efficacy|5
5976077|NCT01084655|20666793|P3|Overall Study|Prostate-specificAntigen(PSA)progression|1
5976078|NCT01084655|20666794|P2|Overall Study|Prostate-specificAntigen(PSA)progression|0
5976079|NCT01084655|20666795|P1|Overall Study|Prostate-specificAntigen(PSA)progression|0
5976080|NCT01084655|20666793|P3|Overall Study|Symptomatic deterioration|2
5976081|NCT01084655|20666794|P2|Overall Study|Symptomatic deterioration|0
5976082|NCT01084655|20666795|P1|Overall Study|Symptomatic deterioration|0
5976083|NCT01084655|20666793|P3|Overall Study|Other|2
5976084|NCT01084655|20666794|P2|Overall Study|Other|3
5976085|NCT01084655|20666795|P1|Overall Study|Other|0
5976086|NCT01084655|20666793|P3|Overall Study|Adverse Event|2
5976087|NCT01084655|20666794|P2|Overall Study|Adverse Event|1
5976088|NCT01084655|20666795|P1|Overall Study|Adverse Event|2
5976089|NCT01084655|20666793|P3|Overall Study|Withdrawal by Subject|4
5976090|NCT01084655|20666794|P2|Overall Study|Withdrawal by Subject|0
5976091|NCT01084655|20666795|P1|Overall Study|Withdrawal by Subject|1
5976092|NCT01084655|20666793|P3|Overall Study|Radiographic disease progression|8
5976093|NCT01084655|20666794|P2|Overall Study|Radiographic disease progression|2
5976094|NCT01084655|20666795|P1|Overall Study|Radiographic disease progression|3
5976095|NCT01084603|20666830|P1|Washout Period 4|Adverse Event|1
5976096|NCT01084603|20666830|P1|Oral Nicotine 1|Withdrawal by Subject|1
5976097|NCT01084603|20666830|P1|Nicorette® Gum|Withdrawal by Subject|1
5976098|NCT01084603|20666830|P1|NiQuitinTM Lozenge|Withdrawal by Subject|1
5976099|NCT01084603|20666830|P1|Baseline|Withdrawal by Subject|2
5976100|NCT01084551|20666866|P3|Overall Study|Physician Decision|0
5976101|NCT01084551|20666867|P2|Overall Study|Physician Decision|0
5976102|NCT01084551|20666868|P1|Overall Study|Physician Decision|1
5976103|NCT01084551|20666866|P3|Overall Study|Lost to Follow-up|3
5976104|NCT01084551|20666867|P2|Overall Study|Lost to Follow-up|0
5976105|NCT01084551|20666868|P1|Overall Study|Lost to Follow-up|0
5976106|NCT01084551|20666866|P3|Overall Study|Protocol Violation|0
5976107|NCT01084551|20666867|P2|Overall Study|Protocol Violation|4
5976108|NCT01084551|20666868|P1|Overall Study|Protocol Violation|2
5976109|NCT01084551|20666866|P3|Overall Study|Withdrawal by Subject|0
5976110|NCT01084551|20666867|P2|Overall Study|Withdrawal by Subject|1
5976111|NCT01084551|20666868|P1|Overall Study|Withdrawal by Subject|2
5976112|NCT01084551|20666866|P3|Overall Study|Lack of Efficacy|1
5976113|NCT01084551|20666867|P2|Overall Study|Lack of Efficacy|0
5976114|NCT01084551|20666868|P1|Overall Study|Lack of Efficacy|2
5976115|NCT01084551|20666866|P3|Overall Study|Adverse Event|4
5976116|NCT01084551|20666867|P2|Overall Study|Adverse Event|9
5976117|NCT01084551|20666868|P1|Overall Study|Adverse Event|2
5976118|NCT01084538|20666906|P1|Overall Study|Reason unknown|8
5976119|NCT01084538|20666906|P1|Overall Study|Over-suppression of parathyroid gland|2
5976120|NCT01084538|20666906|P1|Overall Study|Change of residence|2
5976121|NCT01084538|20666906|P1|Overall Study|Nodular hyperplasia of parathyroid gland|2
5976122|NCT01084538|20666906|P1|Overall Study|Hyperphosphatemia|2
5976123|NCT01084538|20666906|P1|Overall Study|Patient noncompliance|2
5976124|NCT01084538|20666906|P1|Overall Study|Lack of effectiveness|2
5976125|NCT01084538|20666906|P1|Overall Study|Serious Adverse Event|3
5976126|NCT01084538|20666906|P1|Overall Study|Kidney transplant|6
5976127|NCT01084538|20666906|P1|Overall Study|Adverse Event|9
5976128|NCT01084538|20666906|P1|Overall Study|Drug not available|30
5976129|NCT01084252|20667040|P14|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
5976130|NCT01084252|20667041|P13|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|1
5976131|NCT01084252|20667042|P12|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
5976132|NCT01084252|20667043|P11|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
5976133|NCT01084252|20667044|P10|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
5976134|NCT01084252|20667045|P9|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
5976135|NCT01084252|20667046|P8|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
5976136|NCT01084252|20667047|P7|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
5976137|NCT01084252|20667048|P6|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
5976138|NCT01084252|20667049|P5|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
5976139|NCT01084252|20667050|P4|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
5976140|NCT01084252|20667051|P3|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
5976141|NCT01084252|20667052|P2|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
5976142|NCT01084252|20667053|P1|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
5976143|NCT01084252|20667040|P14|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|15
5976144|NCT01084252|20667041|P13|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|13
5976145|NCT01084252|20667042|P12|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
5976146|NCT01084252|20667043|P11|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
5976147|NCT01084252|20667044|P10|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
5976148|NCT01084252|20667045|P9|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
5976149|NCT01084252|20667046|P8|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
5976150|NCT01084252|20667047|P7|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
5976151|NCT01084252|20667048|P6|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
5976152|NCT01084252|20667049|P5|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
5976153|NCT01084252|20667050|P4|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
5976154|NCT01084252|20667051|P3|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
5976155|NCT01084252|20667052|P2|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
5976156|NCT01084252|20667053|P1|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
5976157|NCT01084252|20667040|P14|Phase 2 Stage 2 (97 Weeks)|Other than specified above|2
5976158|NCT01084252|20667041|P13|Phase 2 Stage 2 (97 Weeks)|Other than specified above|12
5976159|NCT01084252|20667042|P12|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
5976160|NCT01084252|20667043|P11|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
5976161|NCT01084252|20667044|P10|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
5976162|NCT01084252|20667045|P9|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
5976163|NCT01084252|20667046|P8|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
5976164|NCT01084252|20667047|P7|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
5976165|NCT01084252|20667048|P6|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
5976166|NCT01084252|20667049|P5|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
5976167|NCT01084252|20667050|P4|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
5976168|NCT01084252|20667051|P3|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
5976169|NCT01084252|20667052|P2|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
5976170|NCT01084252|20667053|P1|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
5976171|NCT01084252|20667040|P14|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
5976172|NCT01084252|20667041|P13|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|1
5976173|NCT01084252|20667042|P12|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
5976174|NCT01084252|20667043|P11|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
5976175|NCT01084252|20667044|P10|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
5976176|NCT01084252|20667045|P9|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
5976177|NCT01084252|20667046|P8|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
5976178|NCT01084252|20667047|P7|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
5976179|NCT01084252|20667048|P6|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
5976180|NCT01084252|20667049|P5|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
5976181|NCT01084252|20667050|P4|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
5976182|NCT01084252|20667051|P3|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
5976183|NCT01084252|20667052|P2|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
5976184|NCT01084252|20667053|P1|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
5976185|NCT01084252|20667040|P14|Phase 2 Stage 2 (97 Weeks)|Progressive disease|33
5976186|NCT01084252|20667041|P13|Phase 2 Stage 2 (97 Weeks)|Progressive disease|70
5976187|NCT01084252|20667042|P12|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
5976188|NCT01084252|20667043|P11|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
5976189|NCT01084252|20667044|P10|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
5976190|NCT01084252|20667045|P9|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
5976191|NCT01084252|20667046|P8|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
5976192|NCT01084252|20667047|P7|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
5976193|NCT01084252|20667048|P6|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
5976194|NCT01084252|20667049|P5|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
5976195|NCT01084252|20667050|P4|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
5976196|NCT01084252|20667051|P3|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
5976197|NCT01084252|20667052|P2|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
5976198|NCT01084252|20667053|P1|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
5976199|NCT01084252|20667040|P14|Phase 2 Stage 2 (97 Weeks)|Adverse Event|5
5976200|NCT01084252|20667041|P13|Phase 2 Stage 2 (97 Weeks)|Adverse Event|13
5976201|NCT01084252|20667042|P12|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
5976202|NCT01084252|20667043|P11|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
5976203|NCT01084252|20667044|P10|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
5976204|NCT01084252|20667045|P9|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
5976205|NCT01084252|20667046|P8|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
5976206|NCT01084252|20667047|P7|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
5976207|NCT01084252|20667048|P6|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
5976208|NCT01084252|20667049|P5|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
5976209|NCT01084252|20667050|P4|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
5976210|NCT01084252|20667051|P3|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
5976211|NCT01084252|20667052|P2|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
5976212|NCT01084252|20667053|P1|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
5976213|NCT01084252|20667040|P14|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0
5976214|NCT01084252|20667041|P13|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0
5976215|NCT01084252|20667042|P12|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|2
5976216|NCT01084252|20667043|P11|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|2
5976217|NCT01084252|20667044|P10|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|4
5976218|NCT01084252|20667045|P9|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|1
5976219|NCT01084252|20667046|P8|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0
5976220|NCT01084252|20667047|P7|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0
5976221|NCT01084252|20667048|P6|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0
5976222|NCT01084252|20667049|P5|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0
5976223|NCT01084252|20667050|P4|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0
5976224|NCT01084252|20667051|P3|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0
5976225|NCT01084252|20667052|P2|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0
5976226|NCT01084252|20667053|P1|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0
5976227|NCT01084252|20667040|P14|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
5976228|NCT01084252|20667041|P13|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
5976229|NCT01084252|20667042|P12|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|3
5976230|NCT01084252|20667043|P11|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|4
5976231|NCT01084252|20667044|P10|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
5976232|NCT01084252|20667045|P9|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|2
5976233|NCT01084252|20667046|P8|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
5976234|NCT01084252|20667047|P7|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
5976235|NCT01084252|20667048|P6|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
5976236|NCT01084252|20667049|P5|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
5976237|NCT01084252|20667050|P4|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
5976238|NCT01084252|20667051|P3|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
5976239|NCT01084252|20667052|P2|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
5976240|NCT01084252|20667053|P1|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
5976241|NCT01084252|20667040|P14|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0
5976242|NCT01084252|20667041|P13|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0
5976243|NCT01084252|20667042|P12|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|19
5976244|NCT01084252|20667043|P11|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|17
5976245|NCT01084252|20667044|P10|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|18
5976246|NCT01084252|20667045|P9|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|20
5976247|NCT01084252|20667046|P8|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0
5976248|NCT01084252|20667047|P7|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0
5976249|NCT01084252|20667048|P6|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0
5976250|NCT01084252|20667049|P5|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0
5976251|NCT01084252|20667050|P4|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0
5976252|NCT01084252|20667051|P3|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0
5976253|NCT01084252|20667052|P2|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0
5976254|NCT01084252|20667053|P1|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0
5976255|NCT01084252|20667040|P14|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
5976256|NCT01084252|20667041|P13|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
5976257|NCT01084252|20667042|P12|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|1
5976258|NCT01084252|20667043|P11|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|2
5976259|NCT01084252|20667044|P10|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|2
5976260|NCT01084252|20667045|P9|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
5976261|NCT01084252|20667046|P8|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
5976262|NCT01084252|20667047|P7|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
5976263|NCT01084252|20667048|P6|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
5976264|NCT01084252|20667049|P5|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
5976265|NCT01084252|20667050|P4|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
5976266|NCT01084252|20667051|P3|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
5976267|NCT01084252|20667052|P2|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
5976268|NCT01084252|20667053|P1|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
5976269|NCT01084252|20667040|P14|Phase 1 (120 Weeks)|Other than specified above|0
5976270|NCT01084252|20667041|P13|Phase 1 (120 Weeks)|Other than specified above|0
5976271|NCT01084252|20667042|P12|Phase 1 (120 Weeks)|Other than specified above|0
5976272|NCT01084252|20667043|P11|Phase 1 (120 Weeks)|Other than specified above|0
5976273|NCT01084252|20667044|P10|Phase 1 (120 Weeks)|Other than specified above|0
5976274|NCT01084252|20667045|P9|Phase 1 (120 Weeks)|Other than specified above|0
5976275|NCT01084252|20667046|P8|Phase 1 (120 Weeks)|Other than specified above|1
5976276|NCT01084252|20667047|P7|Phase 1 (120 Weeks)|Other than specified above|1
5976277|NCT01084252|20667048|P6|Phase 1 (120 Weeks)|Other than specified above|0
5976278|NCT01084252|20667049|P5|Phase 1 (120 Weeks)|Other than specified above|1
5976279|NCT01084252|20667050|P4|Phase 1 (120 Weeks)|Other than specified above|3
5976280|NCT01084252|20667051|P3|Phase 1 (120 Weeks)|Other than specified above|0
5976281|NCT01084252|20667052|P2|Phase 1 (120 Weeks)|Other than specified above|1
5976282|NCT01084252|20667053|P1|Phase 1 (120 Weeks)|Other than specified above|1
5976283|NCT01084252|20667040|P14|Phase 1 (120 Weeks)|Progressive disease|0
5976284|NCT01084252|20667041|P13|Phase 1 (120 Weeks)|Progressive disease|0
5976285|NCT01084252|20667042|P12|Phase 1 (120 Weeks)|Progressive disease|0
5976286|NCT01084252|20667043|P11|Phase 1 (120 Weeks)|Progressive disease|0
5976287|NCT01084252|20667044|P10|Phase 1 (120 Weeks)|Progressive disease|0
5976288|NCT01084252|20667045|P9|Phase 1 (120 Weeks)|Progressive disease|0
5976289|NCT01084252|20667046|P8|Phase 1 (120 Weeks)|Progressive disease|6
5976290|NCT01084252|20667047|P7|Phase 1 (120 Weeks)|Progressive disease|5
5976291|NCT01084252|20667048|P6|Phase 1 (120 Weeks)|Progressive disease|6
5976292|NCT01084252|20667049|P5|Phase 1 (120 Weeks)|Progressive disease|16
5976293|NCT01084252|20667050|P4|Phase 1 (120 Weeks)|Progressive disease|22
5976294|NCT01084252|20667051|P3|Phase 1 (120 Weeks)|Progressive disease|2
5976295|NCT01084252|20667052|P2|Phase 1 (120 Weeks)|Progressive disease|5
5976296|NCT01084252|20667053|P1|Phase 1 (120 Weeks)|Progressive disease|15
5976297|NCT01084252|20667040|P14|Phase 1 (120 Weeks)|Adverse Event|0
5976298|NCT01084252|20667041|P13|Phase 1 (120 Weeks)|Adverse Event|0
5976299|NCT01084252|20667042|P12|Phase 1 (120 Weeks)|Adverse Event|0
5976300|NCT01084252|20667043|P11|Phase 1 (120 Weeks)|Adverse Event|0
5976301|NCT01084252|20667044|P10|Phase 1 (120 Weeks)|Adverse Event|0
5976302|NCT01084252|20667045|P9|Phase 1 (120 Weeks)|Adverse Event|0
5976303|NCT01084252|20667046|P8|Phase 1 (120 Weeks)|Adverse Event|0
5976304|NCT01084252|20667047|P7|Phase 1 (120 Weeks)|Adverse Event|1
5976305|NCT01084252|20667048|P6|Phase 1 (120 Weeks)|Adverse Event|0
5976306|NCT01084252|20667049|P5|Phase 1 (120 Weeks)|Adverse Event|1
5976307|NCT01084252|20667050|P4|Phase 1 (120 Weeks)|Adverse Event|1
5976308|NCT01084252|20667051|P3|Phase 1 (120 Weeks)|Adverse Event|1
5976309|NCT01084252|20667052|P2|Phase 1 (120 Weeks)|Adverse Event|0
5976310|NCT01084252|20667053|P1|Phase 1 (120 Weeks)|Adverse Event|0
5976311|NCT01084239|20667237|P2|28-Day Follow-up|Lost to Follow-up|9
5976312|NCT01084239|20667238|P1|28-Day Follow-up|Lost to Follow-up|4
5976313|NCT01084174|20667256|P2|Overall Study|Participant noncompliance|1
5976314|NCT01084174|20667257|P1|Overall Study|Participant noncompliance|0
5976315|NCT01084174|20667256|P2|Overall Study|Anaphylaxis|1
5976316|NCT01084174|20667257|P1|Overall Study|Anaphylaxis|0
5976317|NCT01084174|20667256|P2|Overall Study|Eosinophilic esophagitis|1
5976318|NCT01084174|20667257|P1|Overall Study|Eosinophilic esophagitis|0
5976319|NCT01084174|20667256|P2|Overall Study|gastrointestinal symptoms|1
5976320|NCT01084174|20667257|P1|Overall Study|gastrointestinal symptoms|1
5976321|NCT01084135|20667290|P2|20 Week|Physician Decision|1
5976322|NCT01084135|20667291|P1|20 Week|Physician Decision|0
5976323|NCT01084083|20667301|P1|Overall Study|Never started assigned therapy|1
5976324|NCT01084083|20667301|P1|Overall Study|Other|2
5976325|NCT01084083|20667301|P1|Overall Study|Complicating disease|1
5976326|NCT01084083|20667301|P1|Overall Study|Withdrawal by Subject|2
5976327|NCT01084083|20667301|P1|Overall Study|Death|1
5976328|NCT01084083|20667301|P1|Overall Study|Adverse Event|5
5976329|NCT01084005|20667309|P2|Overall Study|Withdrawal by Subject|1
5976330|NCT01084005|20667310|P1|Overall Study|Withdrawal by Subject|1
5976331|NCT01084005|20667309|P2|Overall Study|Protocol Violation|7
5976332|NCT01084005|20667310|P1|Overall Study|Protocol Violation|3
5976333|NCT01084005|20667309|P2|Overall Study|Adverse Event|8
5976334|NCT01084005|20667310|P1|Overall Study|Adverse Event|1
5976335|NCT01083810|20667391|P3|Overall Study|Virologic failure|0
5976336|NCT01083810|20667392|P2|Overall Study|Virologic failure|8
5976337|NCT01083810|20667393|P1|Overall Study|Virologic failure|1
5976338|NCT01083810|20667391|P3|Overall Study|Therapy break|2
5976339|NCT01083810|20667392|P2|Overall Study|Therapy break|2
5976340|NCT01083810|20667393|P1|Overall Study|Therapy break|1
5976341|NCT01083810|20667391|P3|Overall Study|Participation in study|0
5976342|NCT01083810|20667392|P2|Overall Study|Participation in study|0
5976343|NCT01083810|20667393|P1|Overall Study|Participation in study|1
5976344|NCT01083810|20667391|P3|Overall Study|Co-morbidities|0
5976345|NCT01083810|20667392|P2|Overall Study|Co-morbidities|0
5976346|NCT01083810|20667393|P1|Overall Study|Co-morbidities|1
5976347|NCT01083810|20667391|P3|Overall Study|Death|3
5976348|NCT01083810|20667392|P2|Overall Study|Death|2
5976349|NCT01083810|20667393|P1|Overall Study|Death|2
5976350|NCT01083810|20667391|P3|Overall Study|Simplification|0
5976351|NCT01083810|20667392|P2|Overall Study|Simplification|1
5976352|NCT01083810|20667393|P1|Overall Study|Simplification|4
5976353|NCT01083810|20667391|P3|Overall Study|Non-compliance|2
5976354|NCT01083810|20667392|P2|Overall Study|Non-compliance|7
5976355|NCT01083810|20667393|P1|Overall Study|Non-compliance|4
5976356|NCT01083810|20667391|P3|Overall Study|Reason not reported|1
5976357|NCT01083810|20667392|P2|Overall Study|Reason not reported|1
5976358|NCT01083810|20667393|P1|Overall Study|Reason not reported|6
5976359|NCT01083810|20667391|P3|Overall Study|Withdrawal by Subject|4
5976360|NCT01083810|20667392|P2|Overall Study|Withdrawal by Subject|2
5976361|NCT01083810|20667393|P1|Overall Study|Withdrawal by Subject|7
5976362|NCT01083810|20667391|P3|Overall Study|Adverse Event|4
5976363|NCT01083810|20667392|P2|Overall Study|Adverse Event|11
5976364|NCT01083810|20667393|P1|Overall Study|Adverse Event|15
5976365|NCT01083810|20667391|P3|Overall Study|Lost to Follow-up|4
5976366|NCT01083810|20667392|P2|Overall Study|Lost to Follow-up|11
5976367|NCT01083810|20667393|P1|Overall Study|Lost to Follow-up|23
5976368|NCT01083771|20667414|P1|Overall Study|Withdrawal by Subject|3
5976369|NCT01083771|20667414|P1|Overall Study|non-compliant|2
5976370|NCT01083693|20667515|P3|Overall Study|Reason unknown|1
5976371|NCT01083693|20667516|P2|Overall Study|Reason unknown|0
5976372|NCT01083693|20667517|P1|Overall Study|Reason unknown|0
5976373|NCT01083693|20667515|P3|Overall Study|Withdrawal by Subject|2
5976374|NCT01083693|20667516|P2|Overall Study|Withdrawal by Subject|0
5976375|NCT01083693|20667517|P1|Overall Study|Withdrawal by Subject|3
5976376|NCT01083693|20667515|P3|Overall Study|Other medical condition/surgery|0
5976377|NCT01083693|20667516|P2|Overall Study|Other medical condition/surgery|1
5976378|NCT01083693|20667517|P1|Overall Study|Other medical condition/surgery|1
5976379|NCT01083693|20667515|P3|Overall Study|Complete remission|0
5976380|NCT01083693|20667516|P2|Overall Study|Complete remission|1
5976381|NCT01083693|20667517|P1|Overall Study|Complete remission|0
5976382|NCT01083693|20667515|P3|Overall Study|Patient Moved|0
5976383|NCT01083693|20667516|P2|Overall Study|Patient Moved|1
5976384|NCT01083693|20667517|P1|Overall Study|Patient Moved|0
5976385|NCT01083693|20667515|P3|Overall Study|Lack of effectiveness|2
5976386|NCT01083693|20667516|P2|Overall Study|Lack of effectiveness|2
5976387|NCT01083693|20667517|P1|Overall Study|Lack of effectiveness|13
5976388|NCT01083693|20667515|P3|Overall Study|Lost to Follow-up|2
5976389|NCT01083693|20667516|P2|Overall Study|Lost to Follow-up|0
5976390|NCT01083693|20667517|P1|Overall Study|Lost to Follow-up|2
5976391|NCT01083693|20667515|P3|Overall Study|Adverse Event|0
5976392|NCT01083693|20667516|P2|Overall Study|Adverse Event|1
5976393|NCT01083693|20667517|P1|Overall Study|Adverse Event|1
5976394|NCT01083680|20667552|P1|Overall Study|Withdrawal by Subject|1086
5976395|NCT01083680|20667552|P1|Overall Study|Lost to Follow-up|2758
5976396|NCT01083641|20667575|P1|Overall Study|Withdrawal by Subject|2
5976397|NCT01083602|20667595|P1|Overall Study|Lack of Efficacy|36
5976398|NCT01083602|20667595|P1|Overall Study|Withdrawal by Subject|5
5976399|NCT01083602|20667595|P1|Overall Study|Death|1
5976400|NCT01083602|20667595|P1|Overall Study|New Cancer Therapy|2
5976401|NCT01083602|20667595|P1|Overall Study|Adverse Event|11
5976402|NCT01083576|20667606|P2|Overall Study|Treatment Failure|1
5976403|NCT01083576|20667607|P1|Overall Study|Treatment Failure|6
5976404|NCT01083485|20667637|P2|Overall Study|Other|0
5976405|NCT01083485|20667638|P1|Overall Study|Other|1
5976406|NCT01083485|20667637|P2|Overall Study|Withdrawal by Subject|2
5976407|NCT01083485|20667638|P1|Overall Study|Withdrawal by Subject|5
5976408|NCT01083485|20667637|P2|Overall Study|Protocol Violation|0
5976409|NCT01083485|20667638|P1|Overall Study|Protocol Violation|1
5976410|NCT01083485|20667637|P2|Overall Study|Adverse Event|1
5976411|NCT01083485|20667638|P1|Overall Study|Adverse Event|0
5976412|NCT01083316|20667670|P1|Overall Study|Withdrawal by Subject|1
5976413|NCT01083316|20667670|P1|Overall Study|Adverse Event|2
5976414|NCT01083186|20667682|P1|Overall Study|Non-compliance to Study Treatment|1
5976415|NCT01083186|20667682|P1|Overall Study|Administrative Reasons|2
5976416|NCT01083186|20667682|P1|Overall Study|Hemodialysis Initiation|28
5976417|NCT01083186|20667682|P1|Overall Study|Lack of Efficacy|2
5976418|NCT01083186|20667682|P1|Overall Study|Adverse Event|3
5976419|NCT01083186|20667682|P1|Overall Study|Death|3
5976420|NCT01083186|20667682|P1|Overall Study|Consent Withdrawal|7
5976421|NCT01083186|20667682|P1|Overall Study|Lost to Follow-up|48
5976422|NCT01083173|20667723|P2|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|46
5976423|NCT01083173|20667724|P1|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|0
5976424|NCT01083173|20667723|P2|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|136
5976425|NCT01083173|20667724|P1|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|0
5976426|NCT01083173|20667723|P2|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|195
5976427|NCT01083173|20667724|P1|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|0
5976428|NCT01083173|20667723|P2|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|101
5976429|NCT01083173|20667724|P1|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|0
5976430|NCT01083173|20667723|P2|Long-term Surveillance: Safety Group|Violation of the dosage|1
5976431|NCT01083173|20667724|P1|Long-term Surveillance: Safety Group|Violation of the dosage|0
5976432|NCT01083173|20667723|P2|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14
5976433|NCT01083173|20667724|P1|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0
5976434|NCT01083173|20667723|P2|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|0
5976435|NCT01083173|20667724|P1|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|13
5976436|NCT01083173|20667723|P2|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|0
5976437|NCT01083173|20667724|P1|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|168
5976438|NCT01083173|20667723|P2|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|0
5976439|NCT01083173|20667724|P1|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|201
5976440|NCT01083173|20667723|P2|Main Surveillance: Safety Group|Violation of the use/dosage|0
5976441|NCT01083173|20667724|P1|Main Surveillance: Safety Group|Violation of the use/dosage|1
5976442|NCT01083173|20667723|P2|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0
5976443|NCT01083173|20667724|P1|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14
5976444|NCT01083160|20667742|P1|Overall Study|Adverse Event|1
5976445|NCT01083121|20667749|P1|Overall Study|Use of Humira outside the approved label|81
5976446|NCT01082965|20667759|P2|Overall Study|Other|1
5976447|NCT01082965|20667760|P1|Overall Study|Other|1
5976448|NCT01082965|20667759|P2|Overall Study|Protocol Violation|1
5976449|NCT01082965|20667760|P1|Overall Study|Protocol Violation|0
5976450|NCT01082874|20667797|P4|Overall Study|Withdrawal by Subject|3
5976451|NCT01082874|20667798|P3|Overall Study|Withdrawal by Subject|5
5976452|NCT01082874|20667799|P2|Overall Study|Withdrawal by Subject|2
5976453|NCT01082874|20667800|P1|Overall Study|Withdrawal by Subject|1
5976454|NCT01082874|20667797|P4|Overall Study|Lost to Follow-up|10
5976455|NCT01082874|20667798|P3|Overall Study|Lost to Follow-up|6
5976456|NCT01082874|20667799|P2|Overall Study|Lost to Follow-up|10
5976457|NCT01082874|20667800|P1|Overall Study|Lost to Follow-up|10
5976458|NCT01082640|20667813|P3|Overall Study|Other|3
5976459|NCT01082640|20667814|P2|Overall Study|Other|1
5976460|NCT01082640|20667815|P1|Overall Study|Other|2
5976461|NCT01082640|20667813|P3|Overall Study|Lost to Follow-up|0
5976462|NCT01082640|20667814|P2|Overall Study|Lost to Follow-up|3
5976463|NCT01082640|20667815|P1|Overall Study|Lost to Follow-up|0
5976464|NCT01082640|20667813|P3|Overall Study|Major protocol deviation|0
5976465|NCT01082640|20667814|P2|Overall Study|Major protocol deviation|3
5976466|NCT01082640|20667815|P1|Overall Study|Major protocol deviation|3
5976467|NCT01082640|20667813|P3|Overall Study|Withdrawal by Subject|2
5976468|NCT01082640|20667814|P2|Overall Study|Withdrawal by Subject|3
5976469|NCT01082640|20667815|P1|Overall Study|Withdrawal by Subject|3
5976470|NCT01082640|20667813|P3|Overall Study|Adverse Event|3
5976471|NCT01082640|20667814|P2|Overall Study|Adverse Event|5
5976472|NCT01082640|20667815|P1|Overall Study|Adverse Event|9
5976473|NCT01082614|20667837|P2|Overall Study|Physician Decision|0
5976474|NCT01082614|20667838|P1|Overall Study|Physician Decision|2
5976475|NCT01082614|20667837|P2|Overall Study|Equipment Malfunction|1
5976476|NCT01082614|20667838|P1|Overall Study|Equipment Malfunction|0
5976477|NCT01082614|20667837|P2|Overall Study|Adverse Event|4
5976478|NCT01082614|20667838|P1|Overall Study|Adverse Event|1
5976479|NCT01082367|20667909|P2|Follow-up (F-U) Period|Adverse Event|1
5976480|NCT01082367|20667910|P1|Follow-up (F-U) Period|Adverse Event|0
5976481|NCT01082367|20667909|P2|Follow-up (F-U) Period|Abnormal lab values|0
5976482|NCT01082367|20667910|P1|Follow-up (F-U) Period|Abnormal lab values|1
5976483|NCT01082367|20667909|P2|Follow-up (F-U) Period|Administrative problems|0
5976484|NCT01082367|20667910|P1|Follow-up (F-U) Period|Administrative problems|1
5976485|NCT01082367|20667909|P2|Double-blind Period|Adverse Event|1
5976486|NCT01082367|20667910|P1|Double-blind Period|Adverse Event|0
5976487|NCT01082367|20667909|P2|Double-blind Period|Lack of Efficacy|11
5976488|NCT01082367|20667910|P1|Double-blind Period|Lack of Efficacy|5
5976489|NCT01082367|20667909|P2|Double-blind Period|Administrative problems|1
5976490|NCT01082367|20667910|P1|Double-blind Period|Administrative problems|0
5976491|NCT01082328|20667924|P1|Overall Study|Adverse Event|1
5976492|NCT01082211|20667933|P1|Overall Study|No protocol treatment received|3
5976493|NCT01082211|20667933|P1|Overall Study|Protocol Violation|4
5976494|NCT01082081|20667960|P3|Overall Study|Other Reason|0
5976495|NCT01082081|20667961|P2|Overall Study|Other Reason|1
5976496|NCT01082081|20667962|P1|Overall Study|Other Reason|0
5976497|NCT01082081|20667960|P3|Overall Study|Withdrawal by Subject|1
5976498|NCT01082081|20667961|P2|Overall Study|Withdrawal by Subject|0
5976499|NCT01082081|20667962|P1|Overall Study|Withdrawal by Subject|0
5976500|NCT01082081|20667960|P3|Overall Study|Lost to Follow-up|1
5976501|NCT01082081|20667961|P2|Overall Study|Lost to Follow-up|0
5976502|NCT01082081|20667962|P1|Overall Study|Lost to Follow-up|0
5976503|NCT01081951|20668014|P2|Overall Study|Lost to Follow-up|1
5976504|NCT01081951|20668015|P1|Overall Study|Lost to Follow-up|0
5976505|NCT01081951|20668014|P2|Overall Study|Allocated treatment but did not take it|1
5976506|NCT01081951|20668015|P1|Overall Study|Allocated treatment but did not take it|0
5976507|NCT01081951|20668014|P2|Overall Study|Withdrawal by Subject|6
5976508|NCT01081951|20668015|P1|Overall Study|Withdrawal by Subject|2
5976509|NCT01081951|20668014|P2|Overall Study|Death|47
5976510|NCT01081951|20668015|P1|Overall Study|Death|54
5976511|NCT01081912|20668025|P3|Maintenance Treatment|Withdrawal by Medical Monitor|1
5976512|NCT01081912|20668026|P2|Maintenance Treatment|Withdrawal by Medical Monitor|0
5976513|NCT01081912|20668027|P1|Maintenance Treatment|Withdrawal by Medical Monitor|0
5976514|NCT01081912|20668025|P3|Maintenance Treatment|Non-Compliance|7
5976515|NCT01081912|20668026|P2|Maintenance Treatment|Non-Compliance|4
5976516|NCT01081912|20668027|P1|Maintenance Treatment|Non-Compliance|0
5976517|NCT01081912|20668025|P3|Maintenance Treatment|Withdrawal by Subject|5
5976518|NCT01081912|20668026|P2|Maintenance Treatment|Withdrawal by Subject|5
5976519|NCT01081912|20668027|P1|Maintenance Treatment|Withdrawal by Subject|0
5976520|NCT01081912|20668025|P3|Maintenance Treatment|Protocol Violation|2
5976521|NCT01081912|20668026|P2|Maintenance Treatment|Protocol Violation|1
5976522|NCT01081912|20668027|P1|Maintenance Treatment|Protocol Violation|0
5976523|NCT01081912|20668025|P3|Maintenance Treatment|Physician Decision|1
5976524|NCT01081912|20668026|P2|Maintenance Treatment|Physician Decision|0
5976525|NCT01081912|20668027|P1|Maintenance Treatment|Physician Decision|0
5976526|NCT01081912|20668025|P3|Maintenance Treatment|Lost to Follow-up|0
5976527|NCT01081912|20668026|P2|Maintenance Treatment|Lost to Follow-up|1
5976528|NCT01081912|20668027|P1|Maintenance Treatment|Lost to Follow-up|0
5976529|NCT01081912|20668025|P3|Maintenance Treatment|Lack of Efficacy|64
5976530|NCT01081912|20668026|P2|Maintenance Treatment|Lack of Efficacy|14
5976531|NCT01081912|20668027|P1|Maintenance Treatment|Lack of Efficacy|0
5976532|NCT01081912|20668025|P3|Maintenance Treatment|Adverse Event|12
5976533|NCT01081912|20668026|P2|Maintenance Treatment|Adverse Event|2
5976534|NCT01081912|20668027|P1|Maintenance Treatment|Adverse Event|0
5976535|NCT01081912|20668025|P3|Conversion/Titration|Non-Compliance|0
5976536|NCT01081912|20668026|P2|Conversion/Titration|Non-Compliance|0
5976537|NCT01081912|20668027|P1|Conversion/Titration|Non-Compliance|47
5976538|NCT01081912|20668025|P3|Conversion/Titration|Withdrawal by Subject|0
5976539|NCT01081912|20668026|P2|Conversion/Titration|Withdrawal by Subject|0
5976540|NCT01081912|20668027|P1|Conversion/Titration|Withdrawal by Subject|23
5976541|NCT01081912|20668025|P3|Conversion/Titration|Protocol Violation|0
5976542|NCT01081912|20668026|P2|Conversion/Titration|Protocol Violation|0
5976543|NCT01081912|20668027|P1|Conversion/Titration|Protocol Violation|67
5976544|NCT01081912|20668025|P3|Conversion/Titration|Physician Decision|0
5976545|NCT01081912|20668026|P2|Conversion/Titration|Physician Decision|0
5976546|NCT01081912|20668027|P1|Conversion/Titration|Physician Decision|2
5976547|NCT01081912|20668025|P3|Conversion/Titration|Lost to Follow-up|0
5976548|NCT01081912|20668026|P2|Conversion/Titration|Lost to Follow-up|0
5976549|NCT01081912|20668027|P1|Conversion/Titration|Lost to Follow-up|5
5976550|NCT01081912|20668025|P3|Conversion/Titration|Lack of Efficacy|0
5976551|NCT01081912|20668026|P2|Conversion/Titration|Lack of Efficacy|0
5976552|NCT01081912|20668027|P1|Conversion/Titration|Lack of Efficacy|17
5976553|NCT01081912|20668025|P3|Conversion/Titration|Adverse Event|0
5976554|NCT01081912|20668026|P2|Conversion/Titration|Adverse Event|0
5976555|NCT01081912|20668027|P1|Conversion/Titration|Adverse Event|47
5976556|NCT01081886|20668036|P2|Overall Study|Study termination|13
5976557|NCT01081886|20668037|P1|Overall Study|Study termination|11
5976558|NCT01081873|20668045|P1|Overall Study|Other|47
5976559|NCT01081873|20668045|P1|Overall Study|Progression of prostate cancer|13
5976560|NCT01081873|20668045|P1|Overall Study|Lost to Follow-up|142
5976561|NCT01081873|20668045|P1|Overall Study|Withdrawal by Subject|10
5976562|NCT01081873|20668045|P1|Overall Study|Death|86
5976563|NCT01081834|20668117|P5|Extension Period: Week 26 to Week 52|Physician Decision|0
5976564|NCT01081834|20668118|P4|Extension Period: Week 26 to Week 52|Physician Decision|0
5976565|NCT01081834|20668119|P3|Extension Period: Week 26 to Week 52|Physician Decision|0
5976566|NCT01081834|20668120|P2|Extension Period: Week 26 to Week 52|Physician Decision|1
5976567|NCT01081834|20668121|P1|Extension Period: Week 26 to Week 52|Physician Decision|0
5976568|NCT01081834|20668117|P5|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0
5976569|NCT01081834|20668118|P4|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0
5976570|NCT01081834|20668119|P3|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0
5976571|NCT01081834|20668120|P2|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|1
5976572|NCT01081834|20668121|P1|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|7
5976573|NCT01081834|20668117|P5|Extension Period: Week 26 to Week 52|Other|0
5976574|NCT01081834|20668118|P4|Extension Period: Week 26 to Week 52|Other|0
5976575|NCT01081834|20668119|P3|Extension Period: Week 26 to Week 52|Other|4
5976576|NCT01081834|20668120|P2|Extension Period: Week 26 to Week 52|Other|5
5976577|NCT01081834|20668121|P1|Extension Period: Week 26 to Week 52|Other|4
5976578|NCT01081834|20668117|P5|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0
5976579|NCT01081834|20668118|P4|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0
5976580|NCT01081834|20668119|P3|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0
5976581|NCT01081834|20668120|P2|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4
5976582|NCT01081834|20668121|P1|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1
5976583|NCT01081834|20668117|P5|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
5976584|NCT01081834|20668118|P4|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
5976585|NCT01081834|20668119|P3|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1
5976586|NCT01081834|20668120|P2|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
5976587|NCT01081834|20668121|P1|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1
5976588|NCT01081834|20668117|P5|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
5976589|NCT01081834|20668118|P4|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
5976590|NCT01081834|20668119|P3|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
5976591|NCT01081834|20668120|P2|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2
5976592|NCT01081834|20668121|P1|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
5976593|NCT01081834|20668117|P5|Extension Period: Week 26 to Week 52|Protocol Violation|0
5976594|NCT01081834|20668118|P4|Extension Period: Week 26 to Week 52|Protocol Violation|0
5976595|NCT01081834|20668119|P3|Extension Period: Week 26 to Week 52|Protocol Violation|0
5976596|NCT01081834|20668120|P2|Extension Period: Week 26 to Week 52|Protocol Violation|1
5976597|NCT01081834|20668121|P1|Extension Period: Week 26 to Week 52|Protocol Violation|0
5976598|NCT01081834|20668117|P5|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
5976599|NCT01081834|20668118|P4|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
5976600|NCT01081834|20668119|P3|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
5976601|NCT01081834|20668120|P2|Extension Period: Week 26 to Week 52|Lost to Follow-up|4
5976602|NCT01081834|20668121|P1|Extension Period: Week 26 to Week 52|Lost to Follow-up|4
5976603|NCT01081834|20668117|P5|Extension Period: Week 26 to Week 52|Death|0
5976604|NCT01081834|20668118|P4|Extension Period: Week 26 to Week 52|Death|0
5976605|NCT01081834|20668119|P3|Extension Period: Week 26 to Week 52|Death|0
5976606|NCT01081834|20668120|P2|Extension Period: Week 26 to Week 52|Death|0
5976607|NCT01081834|20668121|P1|Extension Period: Week 26 to Week 52|Death|1
5976608|NCT01081834|20668117|P5|Extension Period: Week 26 to Week 52|Adverse Event|0
5976609|NCT01081834|20668118|P4|Extension Period: Week 26 to Week 52|Adverse Event|0
5976610|NCT01081834|20668119|P3|Extension Period: Week 26 to Week 52|Adverse Event|0
5976611|NCT01081834|20668120|P2|Extension Period: Week 26 to Week 52|Adverse Event|0
5976612|NCT01081834|20668121|P1|Extension Period: Week 26 to Week 52|Adverse Event|1
5976613|NCT01081834|20668117|P5|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0
5976614|NCT01081834|20668118|P4|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0
5976615|NCT01081834|20668119|P3|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0
5976616|NCT01081834|20668120|P2|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1
5976617|NCT01081834|20668121|P1|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|3
5976618|NCT01081834|20668117|P5|Core Period: Baseline to Week 26|Other|0
5976619|NCT01081834|20668118|P4|Core Period: Baseline to Week 26|Other|1
5976620|NCT01081834|20668119|P3|Core Period: Baseline to Week 26|Other|3
5976621|NCT01081834|20668120|P2|Core Period: Baseline to Week 26|Other|4
5976622|NCT01081834|20668121|P1|Core Period: Baseline to Week 26|Other|4
5976623|NCT01081834|20668117|P5|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
5976624|NCT01081834|20668118|P4|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
5976625|NCT01081834|20668119|P3|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
5976626|NCT01081834|20668120|P2|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
5976627|NCT01081834|20668121|P1|Core Period: Baseline to Week 26|Unable to take rescue therapy|1
5976628|NCT01081834|20668117|P5|Core Period: Baseline to Week 26|Noncompliance with study drug|0
5976629|NCT01081834|20668118|P4|Core Period: Baseline to Week 26|Noncompliance with study drug|2
5976630|NCT01081834|20668119|P3|Core Period: Baseline to Week 26|Noncompliance with study drug|2
5976631|NCT01081834|20668120|P2|Core Period: Baseline to Week 26|Noncompliance with study drug|4
5976632|NCT01081834|20668121|P1|Core Period: Baseline to Week 26|Noncompliance with study drug|3
5976633|NCT01081834|20668117|P5|Core Period: Baseline to Week 26|Withdrawal by Subject|1
5976634|NCT01081834|20668118|P4|Core Period: Baseline to Week 26|Withdrawal by Subject|3
5976635|NCT01081834|20668119|P3|Core Period: Baseline to Week 26|Withdrawal by Subject|9
5976636|NCT01081834|20668120|P2|Core Period: Baseline to Week 26|Withdrawal by Subject|3
5976637|NCT01081834|20668121|P1|Core Period: Baseline to Week 26|Withdrawal by Subject|15
5976638|NCT01081834|20668117|P5|Core Period: Baseline to Week 26|Protocol Violation|2
5976639|NCT01081834|20668118|P4|Core Period: Baseline to Week 26|Protocol Violation|0
5976640|NCT01081834|20668119|P3|Core Period: Baseline to Week 26|Protocol Violation|0
5976641|NCT01081834|20668120|P2|Core Period: Baseline to Week 26|Protocol Violation|4
5976642|NCT01081834|20668121|P1|Core Period: Baseline to Week 26|Protocol Violation|0
5976643|NCT01081834|20668117|P5|Core Period: Baseline to Week 26|Lost to Follow-up|0
5976644|NCT01081834|20668118|P4|Core Period: Baseline to Week 26|Lost to Follow-up|0
5976645|NCT01081834|20668119|P3|Core Period: Baseline to Week 26|Lost to Follow-up|5
5976646|NCT01081834|20668120|P2|Core Period: Baseline to Week 26|Lost to Follow-up|2
5976647|NCT01081834|20668121|P1|Core Period: Baseline to Week 26|Lost to Follow-up|2
5976648|NCT01081834|20668117|P5|Core Period: Baseline to Week 26|Death|0
5976649|NCT01081834|20668118|P4|Core Period: Baseline to Week 26|Death|0
5976650|NCT01081834|20668119|P3|Core Period: Baseline to Week 26|Death|0
5976651|NCT01081834|20668120|P2|Core Period: Baseline to Week 26|Death|0
5976652|NCT01081834|20668121|P1|Core Period: Baseline to Week 26|Death|1
5976653|NCT01081834|20668117|P5|Core Period: Baseline to Week 26|Adverse Event|1
5976654|NCT01081834|20668118|P4|Core Period: Baseline to Week 26|Adverse Event|1
5976655|NCT01081834|20668119|P3|Core Period: Baseline to Week 26|Adverse Event|3
5976656|NCT01081834|20668120|P2|Core Period: Baseline to Week 26|Adverse Event|5
5976657|NCT01081834|20668121|P1|Core Period: Baseline to Week 26|Adverse Event|2
5976658|NCT01081834|20668117|P5|Core Period: Baseline to Week 26|Pregnancy|0
5976659|NCT01081834|20668118|P4|Core Period: Baseline to Week 26|Pregnancy|0
5976660|NCT01081834|20668119|P3|Core Period: Baseline to Week 26|Pregnancy|0
5976661|NCT01081834|20668120|P2|Core Period: Baseline to Week 26|Pregnancy|0
5976662|NCT01081834|20668121|P1|Core Period: Baseline to Week 26|Pregnancy|1
5976663|NCT01081795|20668182|P3|Overall Study|Other|0
5976664|NCT01081795|20668183|P2|Overall Study|Other|2
5976665|NCT01081795|20668184|P1|Overall Study|Other|1
5976666|NCT01081795|20668182|P3|Overall Study|Using drug with restricted days of use|2
5976667|NCT01081795|20668183|P2|Overall Study|Using drug with restricted days of use|3
5976668|NCT01081795|20668184|P1|Overall Study|Using drug with restricted days of use|2
5976669|NCT01081795|20668182|P3|Overall Study|Use of a prohibited concomitant drug|1
5976670|NCT01081795|20668183|P2|Overall Study|Use of a prohibited concomitant drug|1
5976671|NCT01081795|20668184|P1|Overall Study|Use of a prohibited concomitant drug|1
5976672|NCT01081795|20668182|P3|Overall Study|Ineligible for participation|0
5976673|NCT01081795|20668183|P2|Overall Study|Ineligible for participation|0
5976674|NCT01081795|20668184|P1|Overall Study|Ineligible for participation|1
5976675|NCT01081795|20668182|P3|Overall Study|Revocation of informed consent|0
5976676|NCT01081795|20668183|P2|Overall Study|Revocation of informed consent|0
5976677|NCT01081795|20668184|P1|Overall Study|Revocation of informed consent|2
5976678|NCT01081795|20668182|P3|Overall Study|Subject's schedule|2
5976679|NCT01081795|20668183|P2|Overall Study|Subject's schedule|1
5976680|NCT01081795|20668184|P1|Overall Study|Subject's schedule|1
5976681|NCT01081795|20668182|P3|Overall Study|Lack of Efficacy|19
5976682|NCT01081795|20668183|P2|Overall Study|Lack of Efficacy|5
5976683|NCT01081795|20668184|P1|Overall Study|Lack of Efficacy|7
5976684|NCT01081795|20668182|P3|Overall Study|Adverse Event|6
5976685|NCT01081795|20668183|P2|Overall Study|Adverse Event|23
5976686|NCT01081795|20668184|P1|Overall Study|Adverse Event|18
5976687|NCT01081769|20668221|P2|CORE Intent-To-Treat|Patient Moved|2
5976688|NCT01081769|20668222|P1|CORE Intent-To-Treat|Patient Moved|2
5976689|NCT01081769|20668221|P2|CORE Intent-To-Treat|Visit Schedule Issues|2
5976690|NCT01081769|20668222|P1|CORE Intent-To-Treat|Visit Schedule Issues|1
5976691|NCT01081769|20668221|P2|CORE Intent-To-Treat|Ineligibility|4
5976692|NCT01081769|20668222|P1|CORE Intent-To-Treat|Ineligibility|3
5976693|NCT01081769|20668221|P2|CORE Intent-To-Treat|Other|1
5976694|NCT01081769|20668222|P1|CORE Intent-To-Treat|Other|0
5976695|NCT01081769|20668221|P2|CORE Intent-To-Treat|Noncompliance With Study Drug|5
5976696|NCT01081769|20668222|P1|CORE Intent-To-Treat|Noncompliance With Study Drug|0
5976697|NCT01081769|20668221|P2|CORE Intent-To-Treat|Withdrawal by Subject|60
5976698|NCT01081769|20668222|P1|CORE Intent-To-Treat|Withdrawal by Subject|52
5976699|NCT01081769|20668221|P2|CORE Intent-To-Treat|Pregnancy|0
5976700|NCT01081769|20668222|P1|CORE Intent-To-Treat|Pregnancy|1
5976701|NCT01081769|20668221|P2|CORE Intent-To-Treat|Lost to Follow-up|5
5976702|NCT01081769|20668222|P1|CORE Intent-To-Treat|Lost to Follow-up|4
5976703|NCT01081769|20668221|P2|CORE Intent-To-Treat|Lack of Efficacy|6
5976704|NCT01081769|20668222|P1|CORE Intent-To-Treat|Lack of Efficacy|2
5976705|NCT01081769|20668221|P2|CORE Intent-To-Treat|Death|1
5976706|NCT01081769|20668222|P1|CORE Intent-To-Treat|Death|1
5976707|NCT01081769|20668221|P2|CORE Intent-To-Treat|Adverse Event|11
5976708|NCT01081769|20668222|P1|CORE Intent-To-Treat|Adverse Event|14
5976709|NCT01081769|20668221|P2|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|0
5976710|NCT01081769|20668222|P1|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|2
5976711|NCT01081769|20668221|P2|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|7
5976712|NCT01081769|20668222|P1|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|6
5976713|NCT01081769|20668221|P2|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6
5976714|NCT01081769|20668222|P1|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6
5976715|NCT01081769|20668221|P2|Whole Intent-to-Treat|Missing Responder Assessment|12
5976716|NCT01081769|20668222|P1|Whole Intent-to-Treat|Missing Responder Assessment|10
5976717|NCT01081678|20668260|P4|Overall Study|Other|0
5976718|NCT01081678|20668261|P3|Overall Study|Other|0
5976719|NCT01081678|20668262|P2|Overall Study|Other|1
5976720|NCT01081678|20668263|P1|Overall Study|Other|0
5976721|NCT01081678|20668260|P4|Overall Study|Death|6
5976722|NCT01081678|20668261|P3|Overall Study|Death|2
5976723|NCT01081678|20668262|P2|Overall Study|Death|2
5976724|NCT01081678|20668263|P1|Overall Study|Death|2
5976725|NCT01081678|20668260|P4|Overall Study|Lost to Follow-up|3
5976726|NCT01081678|20668261|P3|Overall Study|Lost to Follow-up|4
5976727|NCT01081678|20668262|P2|Overall Study|Lost to Follow-up|1
5976728|NCT01081678|20668263|P1|Overall Study|Lost to Follow-up|4
5976729|NCT01081678|20668260|P4|Overall Study|Administrative Decision|1
5976730|NCT01081678|20668261|P3|Overall Study|Administrative Decision|0
5976731|NCT01081678|20668262|P2|Overall Study|Administrative Decision|0
5976732|NCT01081678|20668263|P1|Overall Study|Administrative Decision|1
5976733|NCT01081678|20668260|P4|Overall Study|Withdrawal by Subject|14
5976734|NCT01081678|20668261|P3|Overall Study|Withdrawal by Subject|17
5976735|NCT01081678|20668262|P2|Overall Study|Withdrawal by Subject|7
5976736|NCT01081678|20668263|P1|Overall Study|Withdrawal by Subject|15
5976737|NCT01081678|20668260|P4|Overall Study|Adverse Event|2
5976738|NCT01081678|20668261|P3|Overall Study|Adverse Event|2
5976739|NCT01081678|20668262|P2|Overall Study|Adverse Event|1
5976740|NCT01081678|20668263|P1|Overall Study|Adverse Event|2
5976741|NCT01081678|20668260|P4|Overall Study|Noncompliance|2
5976742|NCT01081678|20668261|P3|Overall Study|Noncompliance|5
5976743|NCT01081678|20668262|P2|Overall Study|Noncompliance|4
5976744|NCT01081678|20668263|P1|Overall Study|Noncompliance|3
5976745|NCT01081678|20668260|P4|Overall Study|Ineligibility Determined|1
5976746|NCT01081678|20668261|P3|Overall Study|Ineligibility Determined|1
5976747|NCT01081678|20668262|P2|Overall Study|Ineligibility Determined|0
5976748|NCT01081678|20668263|P1|Overall Study|Ineligibility Determined|0
5976749|NCT01081665|20668293|P1|Overall Study|Lack of Efficacy|1
5976750|NCT01081665|20668293|P1|Overall Study|Adverse Event|1
5976751|NCT01081665|20668293|P1|Overall Study|Change in renal replacement therapy|2
5976752|NCT01081665|20668293|P1|Overall Study|Regulation of iPTH|5
5976753|NCT01081665|20668293|P1|Overall Study|Change of dialysis unit|10
5976754|NCT01081665|20668293|P1|Overall Study|Withdrawal by Subject|17
5976755|NCT01081665|20668293|P1|Overall Study|Lost to Follow-up|18
5976756|NCT01081665|20668293|P1|Overall Study|Death|41
5976757|NCT01081626|20668305|P2|Overall Study|Other|30
5976758|NCT01081626|20668306|P1|Overall Study|Other|33
5976759|NCT01081626|20668305|P2|Overall Study|Lost to Follow-up|1
5976760|NCT01081626|20668306|P1|Overall Study|Lost to Follow-up|0
5976761|NCT01081626|20668305|P2|Overall Study|Overstimulation|1
5976762|NCT01081626|20668306|P1|Overall Study|Overstimulation|0
5976763|NCT01081626|20668305|P2|Overall Study|Low antral follicle count|0
5976764|NCT01081626|20668306|P1|Overall Study|Low antral follicle count|1
5976765|NCT01081626|20668305|P2|Overall Study|Missing Estradiol|28
5976766|NCT01081626|20668306|P1|Overall Study|Missing Estradiol|25
5976767|NCT01081626|20668305|P2|Overall Study|Dosing error|1
5976768|NCT01081626|20668306|P1|Overall Study|Dosing error|1
5976769|NCT01081301|20668332|P1|Overall Study|Lost to Follow-up|4
5976770|NCT01081301|20668332|P1|Overall Study|Patient too ill|2
5976771|NCT01081301|20668332|P1|Overall Study|Too busy|5
5976772|NCT01081301|20668332|P1|Overall Study|Bereaved|3
5976773|NCT01081249|20668407|P2|Overall Study|Diagnosed with Bipolar Disorder|1
5976774|NCT01081249|20668408|P1|Overall Study|Diagnosed with Bipolar Disorder|0
5976775|NCT01081145|20668414|P2|Double-Blind Randomized-Withdrawal Phase|Other|3
5976776|NCT01081145|20668415|P1|Double-Blind Randomized-Withdrawal Phase|Other|4
5976777|NCT01081145|20668414|P2|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|71
5976778|NCT01081145|20668415|P1|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|47
5976779|NCT01081145|20668414|P2|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|20
5976780|NCT01081145|20668415|P1|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|13
5976781|NCT01081145|20668414|P2|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|2
5976782|NCT01081145|20668415|P1|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|3
5976783|NCT01081145|20668414|P2|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|8
5976784|NCT01081145|20668415|P1|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|10
5976785|NCT01081145|20668414|P2|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|0
5976786|NCT01081145|20668415|P1|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|1
5976787|NCT01081145|20668414|P2|Double-Blind Randomized-Withdrawal Phase|Adverse Event|2
5976788|NCT01081145|20668415|P1|Double-Blind Randomized-Withdrawal Phase|Adverse Event|3
5976789|NCT01081145|20668414|P2|Open-Label Phase|Protocol Violation|0
5976790|NCT01081145|20668415|P1|Open-Label Phase|Protocol Violation|4
5976791|NCT01081145|20668414|P2|Open-Label Phase|Lost to Follow-up|0
5976792|NCT01081145|20668415|P1|Open-Label Phase|Lost to Follow-up|11
5976793|NCT01081145|20668414|P2|Open-Label Phase|Other|0
5976794|NCT01081145|20668415|P1|Open-Label Phase|Other|12
5976795|NCT01081145|20668414|P2|Open-Label Phase|Withdrawal by Subject|0
5976796|NCT01081145|20668415|P1|Open-Label Phase|Withdrawal by Subject|41
5976797|NCT01081145|20668414|P2|Open-Label Phase|Adverse Event|0
5976798|NCT01081145|20668415|P1|Open-Label Phase|Adverse Event|42
5976799|NCT01081145|20668414|P2|Open-Label Phase|Response criteria not met|0
5976800|NCT01081145|20668415|P1|Open-Label Phase|Response criteria not met|46
5976801|NCT01081145|20668414|P2|Open-Label Phase|Lack of Efficacy|0
5976802|NCT01081145|20668415|P1|Open-Label Phase|Lack of Efficacy|56
5976803|NCT01081132|20668443|P2|Overall Study|Protocol Violation|1
5976804|NCT01081132|20668444|P1|Overall Study|Protocol Violation|3
5976805|NCT01081132|20668443|P2|Overall Study|Declined Taper Phase|1
5976806|NCT01081132|20668444|P1|Overall Study|Declined Taper Phase|0
5976807|NCT01081132|20668443|P2|Overall Study|Patient Did Not Complete Wk14 and 15|1
5976808|NCT01081132|20668444|P1|Overall Study|Patient Did Not Complete Wk14 and 15|0
5976809|NCT01081132|20668443|P2|Overall Study|Stopped Taking Meds|0
5976810|NCT01081132|20668444|P1|Overall Study|Stopped Taking Meds|2
5976811|NCT01081132|20668443|P2|Overall Study|Missed Visits|1
5976812|NCT01081132|20668444|P1|Overall Study|Missed Visits|1
5976813|NCT01081132|20668443|P2|Overall Study|Lack Of Compliance|1
5976814|NCT01081132|20668444|P1|Overall Study|Lack Of Compliance|0
5976815|NCT01081132|20668443|P2|Overall Study|Non Compliance|2
5976816|NCT01081132|20668444|P1|Overall Study|Non Compliance|4
5976817|NCT01081132|20668443|P2|Overall Study|Adverse Event|9
5976818|NCT01081132|20668444|P1|Overall Study|Adverse Event|3
5976819|NCT01081132|20668443|P2|Overall Study|Lost to Follow-up|11
5976820|NCT01081132|20668444|P1|Overall Study|Lost to Follow-up|4
5976821|NCT01081132|20668443|P2|Overall Study|Withdrawal by Subject|16
5976822|NCT01081132|20668444|P1|Overall Study|Withdrawal by Subject|13
5976823|NCT01081132|20668443|P2|Overall Study|Lack of Efficacy|9
5976824|NCT01081132|20668444|P1|Overall Study|Lack of Efficacy|25
5976825|NCT01080807|20668528|P2|Overall Study|Moved away without notifying center|0
5976826|NCT01080807|20668529|P1|Overall Study|Moved away without notifying center|1
5976827|NCT01080807|20668528|P2|Overall Study|Switched to first shift|0
5976828|NCT01080807|20668529|P1|Overall Study|Switched to first shift|1
5976829|NCT01080807|20668528|P2|Overall Study|Work schedule and travel|1
5976830|NCT01080807|20668529|P1|Overall Study|Work schedule and travel|0
5976831|NCT01080807|20668528|P2|Overall Study|Work schedule changing|1
5976832|NCT01080807|20668529|P1|Overall Study|Work schedule changing|1
5976833|NCT01080807|20668528|P2|Overall Study|Stopped working consistent night shifts|1
5976834|NCT01080807|20668529|P1|Overall Study|Stopped working consistent night shifts|0
5976835|NCT01080807|20668528|P2|Overall Study|Laid off or terminated from job|2
5976836|NCT01080807|20668529|P1|Overall Study|Laid off or terminated from job|1
5976837|NCT01080807|20668528|P2|Overall Study|Began working day shift|2
5976838|NCT01080807|20668529|P1|Overall Study|Began working day shift|0
5976839|NCT01080807|20668528|P2|Overall Study|Noncompliance to study procedures|1
5976840|NCT01080807|20668529|P1|Overall Study|Noncompliance to study procedures|1
5976841|NCT01080807|20668528|P2|Overall Study|Noncompliance with drug administration|1
5976842|NCT01080807|20668529|P1|Overall Study|Noncompliance with drug administration|1
5976843|NCT01080807|20668528|P2|Overall Study|Lost to Follow-up|4
5976844|NCT01080807|20668529|P1|Overall Study|Lost to Follow-up|6
5976845|NCT01080807|20668528|P2|Overall Study|Protocol Violation|6
5976846|NCT01080807|20668529|P1|Overall Study|Protocol Violation|7
5976847|NCT01080807|20668528|P2|Overall Study|Withdrawal by Subject|2
5976848|NCT01080807|20668529|P1|Overall Study|Withdrawal by Subject|7
5976849|NCT01080807|20668528|P2|Overall Study|Lack of Efficacy|1
5976850|NCT01080807|20668529|P1|Overall Study|Lack of Efficacy|0
5976851|NCT01080807|20668528|P2|Overall Study|Adverse Event|1
5976852|NCT01080807|20668529|P1|Overall Study|Adverse Event|9
5976853|NCT01080768|20668638|P2|Overall Study|Protocol Deviation|1
5976854|NCT01080768|20668639|P1|Overall Study|Protocol Deviation|2
5976855|NCT01080716|20668649|P4|Part 1|Physician Decision|0
5976856|NCT01080716|20668650|P3|Part 1|Physician Decision|0
5976857|NCT01080716|20668651|P2|Part 1|Physician Decision|0
5976858|NCT01080716|20668652|P1|Part 1|Physician Decision|1
5976859|NCT01080625|20668691|P3|Overall Study|Physician Decision|1
5976860|NCT01080625|20668692|P2|Overall Study|Physician Decision|2
5976861|NCT01080625|20668693|P1|Overall Study|Physician Decision|0
5976862|NCT01080391|20668703|P2|Overall Study|Randomized but not treated|4
5976863|NCT01080391|20668704|P1|Overall Study|Randomized but not treated|7
5976864|NCT01080326|20668722|P1|Overall Study|Surgeon decision|1
5976865|NCT01080326|20668722|P1|Overall Study|Patient deterioration prior to procedure|3
5976866|NCT01080300|20668728|P2|Overall Study|Reasons not specified|6
5976867|NCT01080300|20668729|P1|Overall Study|Reasons not specified|4
5976868|NCT01080300|20668728|P2|Overall Study|Withdrawal by Subject|28
5976869|NCT01080300|20668729|P1|Overall Study|Withdrawal by Subject|12
5976870|NCT01080300|20668728|P2|Overall Study|Death|1
5976871|NCT01080300|20668729|P1|Overall Study|Death|0
5976872|NCT01080300|20668728|P2|Overall Study|Lost to Follow-up|6
5976873|NCT01080300|20668729|P1|Overall Study|Lost to Follow-up|10
5976874|NCT01080300|20668728|P2|Overall Study|Protocol Violation|13
5976875|NCT01080300|20668729|P1|Overall Study|Protocol Violation|7
5976876|NCT01080300|20668728|P2|Overall Study|Lack of Efficacy|15
5976877|NCT01080300|20668729|P1|Overall Study|Lack of Efficacy|12
5976878|NCT01080300|20668728|P2|Overall Study|Adverse Event|35
5976879|NCT01080300|20668729|P1|Overall Study|Adverse Event|49
5976880|NCT01080131|20668834|P2|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|5
5976881|NCT01080131|20668835|P1|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|4
5976882|NCT01080131|20668834|P2|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|4
5976883|NCT01080131|20668835|P1|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|3
5976884|NCT01080131|20668834|P2|Extension Study 2 (25-72 Weeks)|Adverse Event|2
5976885|NCT01080131|20668835|P1|Extension Study 2 (25-72 Weeks)|Adverse Event|1
5976886|NCT01080131|20668834|P2|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|0
5976887|NCT01080131|20668835|P1|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|1
5976888|NCT01080131|20668834|P2|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|3
5976889|NCT01080131|20668835|P1|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|4
5976890|NCT01080131|20668834|P2|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|1
5976891|NCT01080131|20668835|P1|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|0
5976892|NCT01080131|20668834|P2|Extension Study 1 (12 -24 Weeks)|Adverse Event|0
5976893|NCT01080131|20668835|P1|Extension Study 1 (12 -24 Weeks)|Adverse Event|1
5976894|NCT01080131|20668834|P2|Core Study (0- 12 Weeks)|Protocol deviation|2
5976895|NCT01080131|20668835|P1|Core Study (0- 12 Weeks)|Protocol deviation|0
5976896|NCT01080131|20668834|P2|Core Study (0- 12 Weeks)|Death|0
5976897|NCT01080131|20668835|P1|Core Study (0- 12 Weeks)|Death|1
5976898|NCT01080131|20668834|P2|Core Study (0- 12 Weeks)|Administrative problems|1
5976899|NCT01080131|20668835|P1|Core Study (0- 12 Weeks)|Administrative problems|0
5976900|NCT01080131|20668834|P2|Core Study (0- 12 Weeks)|Lost to Follow-up|3
5976901|NCT01080131|20668835|P1|Core Study (0- 12 Weeks)|Lost to Follow-up|5
5976902|NCT01080131|20668834|P2|Core Study (0- 12 Weeks)|Patient withdrew consent|4
5976903|NCT01080131|20668835|P1|Core Study (0- 12 Weeks)|Patient withdrew consent|6
5976904|NCT01080131|20668834|P2|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1
5976905|NCT01080131|20668835|P1|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1
5976906|NCT01079988|20668930|P5|Overall Study|Other|1
5976907|NCT01079988|20668931|P4|Overall Study|Other|2
5976908|NCT01079988|20668932|P3|Overall Study|Other|0
5976909|NCT01079988|20668933|P2|Overall Study|Other|0
5976910|NCT01079988|20668934|P1|Overall Study|Other|0
5976911|NCT01079988|20668930|P5|Overall Study|Lack of Efficacy|0
5976912|NCT01079988|20668931|P4|Overall Study|Lack of Efficacy|0
5976913|NCT01079988|20668932|P3|Overall Study|Lack of Efficacy|0
5976914|NCT01079988|20668933|P2|Overall Study|Lack of Efficacy|0
5976915|NCT01079988|20668934|P1|Overall Study|Lack of Efficacy|1
5976916|NCT01079988|20668930|P5|Overall Study|Lost to Follow-up|0
5976917|NCT01079988|20668931|P4|Overall Study|Lost to Follow-up|1
5976918|NCT01079988|20668932|P3|Overall Study|Lost to Follow-up|0
5976919|NCT01079988|20668933|P2|Overall Study|Lost to Follow-up|0
5976920|NCT01079988|20668934|P1|Overall Study|Lost to Follow-up|0
5976921|NCT01079962|20668953|P2|Overall Study|Due to arrhythmia/bradycardia|1
5976922|NCT01079962|20668954|P1|Overall Study|Due to arrhythmia/bradycardia|1
5976923|NCT01079962|20668953|P2|Overall Study|Participant not returning for next visit|0
5976924|NCT01079962|20668954|P1|Overall Study|Participant not returning for next visit|1
5976925|NCT01079962|20668953|P2|Overall Study|Inclusion/exclusion criteria|3
5976926|NCT01079962|20668954|P1|Overall Study|Inclusion/exclusion criteria|1
5976927|NCT01079962|20668953|P2|Overall Study|No blood pressure (BP) control|0
5976928|NCT01079962|20668954|P1|Overall Study|No blood pressure (BP) control|3
5976929|NCT01079962|20668953|P2|Overall Study|Protocol Violation|2
5976930|NCT01079962|20668954|P1|Overall Study|Protocol Violation|2
5976931|NCT01079962|20668953|P2|Overall Study|Withdrawal by Subject|7
5976932|NCT01079962|20668954|P1|Overall Study|Withdrawal by Subject|5
5976933|NCT01079962|20668953|P2|Overall Study|Adverse Event|2
5976934|NCT01079962|20668954|P1|Overall Study|Adverse Event|2
5976935|NCT01079949|20668982|P2|Overall Study|Randomized but not treated|0
5976936|NCT01079949|20668983|P1|Overall Study|Randomized but not treated|1
5976937|NCT01079949|20668982|P2|Overall Study|Withdrawal between OPU - embryo transfer|2
5976938|NCT01079949|20668983|P1|Overall Study|Withdrawal between OPU - embryo transfer|8
5976939|NCT01079949|20668982|P2|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|8
5976940|NCT01079949|20668983|P1|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|4
5976941|NCT01079949|20668982|P2|Overall Study|Withdrawal before r-hCG administration|3
5976942|NCT01079949|20668983|P1|Overall Study|Withdrawal before r-hCG administration|2
5976943|NCT01079936|20669029|P5|Phase II|Insurance Issue|1
5976944|NCT01079936|20669030|P4|Phase II|Insurance Issue|0
5976945|NCT01079936|20669031|P3|Phase II|Insurance Issue|0
5976946|NCT01079936|20669032|P2|Phase II|Insurance Issue|0
5976947|NCT01079936|20669033|P1|Phase II|Insurance Issue|0
5976948|NCT01079936|20669029|P5|Phase II|Adverse Event|0
5976949|NCT01079936|20669030|P4|Phase II|Adverse Event|0
5976950|NCT01079936|20669031|P3|Phase II|Adverse Event|1
5976951|NCT01079936|20669032|P2|Phase II|Adverse Event|0
5976952|NCT01079936|20669033|P1|Phase II|Adverse Event|0
5976953|NCT01079936|20669029|P5|Phase I: MTD|No Stem Cell Transplantation|0
5976954|NCT01079936|20669030|P4|Phase I: MTD|No Stem Cell Transplantation|0
5976955|NCT01079936|20669031|P3|Phase I: MTD|No Stem Cell Transplantation|0
5976956|NCT01079936|20669032|P2|Phase I: MTD|No Stem Cell Transplantation|0
5976957|NCT01079936|20669033|P1|Phase I: MTD|No Stem Cell Transplantation|2
5976958|NCT01079936|20669029|P5|Phase I: MTD|First Remission Status|0
5976959|NCT01079936|20669030|P4|Phase I: MTD|First Remission Status|0
5976960|NCT01079936|20669031|P3|Phase I: MTD|First Remission Status|0
5976961|NCT01079936|20669032|P2|Phase I: MTD|First Remission Status|0
5976962|NCT01079936|20669033|P1|Phase I: MTD|First Remission Status|2
5976963|NCT01079832|20669052|P1|Overall Study|Withdrawal by Subject|1
5976964|NCT01079806|20669062|P2|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6
5976965|NCT01079806|20669063|P1|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6
5976966|NCT01079806|20669062|P2|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|1
5976967|NCT01079806|20669063|P1|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|0
5976968|NCT01079806|20669062|P2|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|8
5976969|NCT01079806|20669063|P1|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|13
5976970|NCT01079806|20669062|P2|Day 1 to Week 96|Removal by Medical Monitor|1
5976971|NCT01079806|20669063|P1|Day 1 to Week 96|Removal by Medical Monitor|0
5976972|NCT01079806|20669062|P2|Day 1 to Week 96|Subject request to stop study treatment|0
5976973|NCT01079806|20669063|P1|Day 1 to Week 96|Subject request to stop study treatment|1
5976974|NCT01079806|20669062|P2|Day 1 to Week 96|Lost to Follow-up|0
5976975|NCT01079806|20669063|P1|Day 1 to Week 96|Lost to Follow-up|1
5976976|NCT01079806|20669062|P2|Day 1 to Week 96|Poor compliance or noncompliance|0
5976977|NCT01079806|20669063|P1|Day 1 to Week 96|Poor compliance or noncompliance|2
5976978|NCT01079806|20669062|P2|Day 1 to Week 96|Pregnancy|1
5976979|NCT01079806|20669063|P1|Day 1 to Week 96|Pregnancy|0
5976980|NCT01079806|20669062|P2|Day 1 to Week 96|Withdrawal by Subject|2
5976981|NCT01079806|20669063|P1|Day 1 to Week 96|Withdrawal by Subject|3
5976982|NCT01079806|20669062|P2|Day 1 to Week 96|Adverse Event|3
5976983|NCT01079806|20669063|P1|Day 1 to Week 96|Adverse Event|0
5976984|NCT01079741|20669098|P5|Phase 2 (Weeks 37-48)|Withdrawal by Subject|3
5976985|NCT01079741|20669099|P4|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0
5976986|NCT01079741|20669100|P3|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0
5976987|NCT01079741|20669101|P2|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0
5976988|NCT01079741|20669102|P1|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0
5976989|NCT01079741|20669098|P5|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0
5976990|NCT01079741|20669099|P4|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0
5976991|NCT01079741|20669100|P3|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0
5976992|NCT01079741|20669101|P2|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|1
5976993|NCT01079741|20669102|P1|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0
5976994|NCT01079234|20669150|P4|Extension: Week 27 to 52|Unclassified|7
5976995|NCT01079234|20669151|P3|Extension: Week 27 to 52|Unclassified|4
5976996|NCT01079234|20669152|P2|Extension: Week 27 to 52|Unclassified|0
5976997|NCT01079234|20669153|P1|Extension: Week 27 to 52|Unclassified|0
5976998|NCT01079234|20669150|P4|Extension: Week 27 to 52|Withdrawal criteria|2
5976999|NCT01079234|20669151|P3|Extension: Week 27 to 52|Withdrawal criteria|4
5977000|NCT01079234|20669152|P2|Extension: Week 27 to 52|Withdrawal criteria|0
5977001|NCT01079234|20669153|P1|Extension: Week 27 to 52|Withdrawal criteria|0
5977002|NCT01079234|20669150|P4|Extension: Week 27 to 52|Protocol Violation|5
5977003|NCT01079234|20669151|P3|Extension: Week 27 to 52|Protocol Violation|2
5977004|NCT01079234|20669152|P2|Extension: Week 27 to 52|Protocol Violation|0
5977005|NCT01079234|20669153|P1|Extension: Week 27 to 52|Protocol Violation|0
5977006|NCT01079234|20669150|P4|Extension: Week 27 to 52|Lack of Efficacy|2
5977007|NCT01079234|20669151|P3|Extension: Week 27 to 52|Lack of Efficacy|0
5977008|NCT01079234|20669152|P2|Extension: Week 27 to 52|Lack of Efficacy|0
5977009|NCT01079234|20669153|P1|Extension: Week 27 to 52|Lack of Efficacy|0
5977010|NCT01079234|20669150|P4|Extension: Week 27 to 52|Adverse Event|0
5977011|NCT01079234|20669151|P3|Extension: Week 27 to 52|Adverse Event|1
5977012|NCT01079234|20669152|P2|Extension: Week 27 to 52|Adverse Event|0
5977013|NCT01079234|20669153|P1|Extension: Week 27 to 52|Adverse Event|0
5977014|NCT01079234|20669150|P4|Main: Week 0 to 26|Unclassified|0
5977015|NCT01079234|20669151|P3|Main: Week 0 to 26|Unclassified|4
5977016|NCT01079234|20669152|P2|Main: Week 0 to 26|Unclassified|13
5977017|NCT01079234|20669153|P1|Main: Week 0 to 26|Unclassified|7
5977018|NCT01079234|20669150|P4|Main: Week 0 to 26|Withdrawal criteria|0
5977019|NCT01079234|20669151|P3|Main: Week 0 to 26|Withdrawal criteria|2
5977020|NCT01079234|20669152|P2|Main: Week 0 to 26|Withdrawal criteria|6
5977021|NCT01079234|20669153|P1|Main: Week 0 to 26|Withdrawal criteria|6
5977022|NCT01079234|20669150|P4|Main: Week 0 to 26|Protocol Violation|0
5977023|NCT01079234|20669151|P3|Main: Week 0 to 26|Protocol Violation|4
5977024|NCT01079234|20669152|P2|Main: Week 0 to 26|Protocol Violation|2
5977025|NCT01079234|20669153|P1|Main: Week 0 to 26|Protocol Violation|6
5977026|NCT01079234|20669150|P4|Main: Week 0 to 26|Lack of Efficacy|0
5977027|NCT01079234|20669151|P3|Main: Week 0 to 26|Lack of Efficacy|1
5977028|NCT01079234|20669152|P2|Main: Week 0 to 26|Lack of Efficacy|1
5977029|NCT01079234|20669153|P1|Main: Week 0 to 26|Lack of Efficacy|2
5977030|NCT01079234|20669150|P4|Main: Week 0 to 26|Adverse Event|0
5977031|NCT01079234|20669151|P3|Main: Week 0 to 26|Adverse Event|1
5977032|NCT01079234|20669152|P2|Main: Week 0 to 26|Adverse Event|4
5977033|NCT01079234|20669153|P1|Main: Week 0 to 26|Adverse Event|5
5977034|NCT01079195|20669171|P1|Overall Study|Non-compliance|2
5977035|NCT01079195|20669171|P1|Overall Study|No Follow-up Documentation Available|4
5977036|NCT01079195|20669171|P1|Overall Study|Improved Status of Participant|4
5977037|NCT01079195|20669171|P1|Overall Study|Physician Decision|4
5977038|NCT01079195|20669171|P1|Overall Study|Lack of Effectiveness|12
5977039|NCT01079195|20669171|P1|Overall Study|Financial Reasons|15
5977040|NCT01079195|20669171|P1|Overall Study|Withdrawal by Subject|18
5977041|NCT01079195|20669171|P1|Overall Study|Reason Unknown|39
5977042|NCT01079195|20669171|P1|Overall Study|Adverse Event|157
5977043|NCT01079195|20669171|P1|Overall Study|No Documentation Available|437
5977044|NCT01079195|20669171|P1|Overall Study|No Documentation of Tarka Therapy|739
5977045|NCT01079182|20669177|P1|Overall Study|Reasons not Evaluated|271
5977046|NCT01079182|20669177|P1|Overall Study|ADR and Lack of Effectiveness|39
5977047|NCT01079182|20669177|P1|Overall Study|Lack of Efficacy|514
5977048|NCT01079182|20669177|P1|Overall Study|Adverse Drug Reaction (ADR)|261
5977049|NCT01079182|20669177|P1|Overall Study|Lost to Follow-up|1634
5977050|NCT01079130|20669285|P6|Overall Study|Lost to Follow-up|0
5977051|NCT01079130|20669286|P5|Overall Study|Lost to Follow-up|1
5977052|NCT01079130|20669287|P4|Overall Study|Lost to Follow-up|0
5977053|NCT01079130|20669288|P3|Overall Study|Lost to Follow-up|0
5977054|NCT01079130|20669289|P2|Overall Study|Lost to Follow-up|0
5977055|NCT01079130|20669290|P1|Overall Study|Lost to Follow-up|0
5977056|NCT01079130|20669285|P6|Overall Study|Unsatisfactory therapeutic effect|0
5977057|NCT01079130|20669286|P5|Overall Study|Unsatisfactory therapeutic effect|0
5977058|NCT01079130|20669287|P4|Overall Study|Unsatisfactory therapeutic effect|2
5977059|NCT01079130|20669288|P3|Overall Study|Unsatisfactory therapeutic effect|0
5977060|NCT01079130|20669289|P2|Overall Study|Unsatisfactory therapeutic effect|0
5977061|NCT01079130|20669290|P1|Overall Study|Unsatisfactory therapeutic effect|0
5977062|NCT01079130|20669285|P6|Overall Study|Abnormal test procedure result(s)|0
5977063|NCT01079130|20669286|P5|Overall Study|Abnormal test procedure result(s)|1
5977064|NCT01079130|20669287|P4|Overall Study|Abnormal test procedure result(s)|0
5977065|NCT01079130|20669288|P3|Overall Study|Abnormal test procedure result(s)|0
5977066|NCT01079130|20669289|P2|Overall Study|Abnormal test procedure result(s)|0
5977067|NCT01079130|20669290|P1|Overall Study|Abnormal test procedure result(s)|0
5977068|NCT01079130|20669285|P6|Overall Study|Protocol deviation|0
5977069|NCT01079130|20669286|P5|Overall Study|Protocol deviation|0
5977070|NCT01079130|20669287|P4|Overall Study|Protocol deviation|2
5977071|NCT01079130|20669288|P3|Overall Study|Protocol deviation|1
5977072|NCT01079130|20669289|P2|Overall Study|Protocol deviation|2
5977073|NCT01079130|20669290|P1|Overall Study|Protocol deviation|0
5977074|NCT01079130|20669285|P6|Overall Study|Withdrawal by Subject|3
5977075|NCT01079130|20669286|P5|Overall Study|Withdrawal by Subject|1
5977076|NCT01079130|20669287|P4|Overall Study|Withdrawal by Subject|0
5977077|NCT01079130|20669288|P3|Overall Study|Withdrawal by Subject|0
5977078|NCT01079130|20669289|P2|Overall Study|Withdrawal by Subject|1
5977079|NCT01079130|20669290|P1|Overall Study|Withdrawal by Subject|0
5977080|NCT01079130|20669285|P6|Overall Study|Administrative problems|1
5977081|NCT01079130|20669286|P5|Overall Study|Administrative problems|0
5977082|NCT01079130|20669287|P4|Overall Study|Administrative problems|0
5977083|NCT01079130|20669288|P3|Overall Study|Administrative problems|0
5977084|NCT01079130|20669289|P2|Overall Study|Administrative problems|3
5977085|NCT01079130|20669290|P1|Overall Study|Administrative problems|1
5977086|NCT01079130|20669285|P6|Overall Study|Adverse Event|1
5977087|NCT01079130|20669286|P5|Overall Study|Adverse Event|5
5977088|NCT01079130|20669287|P4|Overall Study|Adverse Event|1
5977089|NCT01079130|20669288|P3|Overall Study|Adverse Event|0
5977090|NCT01079130|20669289|P2|Overall Study|Adverse Event|1
5977091|NCT01079130|20669290|P1|Overall Study|Adverse Event|1
5977092|NCT01078974|20669310|P1|Overall Study|Adverse Event|3
5977093|NCT01078922|20669315|P1|Overall Study|Adverse Event|1
5977094|NCT01078805|20669356|P1|Overall Study|Didn't take study drug|82
5977095|NCT01078805|20669356|P1|Overall Study|Other|173
5977096|NCT01078805|20669356|P1|Overall Study|Withdrawal by Subject|739
5977097|NCT01078805|20669356|P1|Overall Study|Sponsor decision|46
5977098|NCT01078805|20669356|P1|Overall Study|Serious adverse event|26
5977099|NCT01078805|20669356|P1|Overall Study|Physician Decision|169
5977100|NCT01078805|20669356|P1|Overall Study|Lost to Follow-up|676
5977101|NCT01078805|20669356|P1|Overall Study|Death|134
5977102|NCT01078805|20669356|P1|Overall Study|Clinically significant abnormal lab|5
5977103|NCT01078675|20669383|P2|Overall Study|Adverse Event|0
5977104|NCT01078675|20669384|P1|Overall Study|Adverse Event|3
5977105|NCT01078675|20669383|P2|Overall Study|Provided in CRF for specific reasons|3
5977106|NCT01078675|20669384|P1|Overall Study|Provided in CRF for specific reasons|2
5977107|NCT01078675|20669383|P2|Overall Study|Protocol Violation|0
5977108|NCT01078675|20669384|P1|Overall Study|Protocol Violation|56
5977109|NCT01078675|20669383|P2|Overall Study|Withdrawal by Subject|3
5977110|NCT01078675|20669384|P1|Overall Study|Withdrawal by Subject|7
5977111|NCT01078662|20669406|P5|Overall Study|Lost to Follow-up|0
5977112|NCT01078662|20669407|P4|Overall Study|Lost to Follow-up|0
5977113|NCT01078662|20669408|P3|Overall Study|Lost to Follow-up|0
5977114|NCT01078662|20669409|P2|Overall Study|Lost to Follow-up|0
5977115|NCT01078662|20669410|P1|Overall Study|Lost to Follow-up|1
5977116|NCT01078662|20669406|P5|Overall Study|Protocol Violation|0
5977117|NCT01078662|20669407|P4|Overall Study|Protocol Violation|0
5977118|NCT01078662|20669408|P3|Overall Study|Protocol Violation|0
5977119|NCT01078662|20669409|P2|Overall Study|Protocol Violation|1
5977120|NCT01078662|20669410|P1|Overall Study|Protocol Violation|0
5977121|NCT01078662|20669406|P5|Overall Study|Withdrawal by Subject|0
5977122|NCT01078662|20669407|P4|Overall Study|Withdrawal by Subject|0
5977123|NCT01078662|20669408|P3|Overall Study|Withdrawal by Subject|1
5977124|NCT01078662|20669409|P2|Overall Study|Withdrawal by Subject|11
5977125|NCT01078662|20669410|P1|Overall Study|Withdrawal by Subject|4
5977126|NCT01078662|20669406|P5|Overall Study|Patients reached data cut-off|3
5977127|NCT01078662|20669407|P4|Overall Study|Patients reached data cut-off|2
5977128|NCT01078662|20669408|P3|Overall Study|Patients reached data cut-off|2
5977129|NCT01078662|20669409|P2|Overall Study|Patients reached data cut-off|53
5977130|NCT01078662|20669410|P1|Overall Study|Patients reached data cut-off|12
5977131|NCT01078662|20669406|P5|Overall Study|Death|8
5977132|NCT01078662|20669407|P4|Overall Study|Death|5
5977133|NCT01078662|20669408|P3|Overall Study|Death|18
5977134|NCT01078662|20669409|P2|Overall Study|Death|103
5977135|NCT01078662|20669410|P1|Overall Study|Death|41
5977136|NCT01078623|20669449|P20|Treatment Period 4|Withdrawal by Subject|0
5977137|NCT01078623|20669450|P19|Treatment Period 4|Withdrawal by Subject|0
5977138|NCT01078623|20669451|P18|Treatment Period 4|Withdrawal by Subject|0
5977139|NCT01078623|20669452|P17|Treatment Period 4|Withdrawal by Subject|0
5977140|NCT01078623|20669453|P16|Treatment Period 4|Withdrawal by Subject|1
5977141|NCT01078623|20669454|P15|Treatment Period 4|Withdrawal by Subject|0
5977142|NCT01078623|20669455|P14|Treatment Period 4|Withdrawal by Subject|0
5977143|NCT01078623|20669456|P13|Treatment Period 4|Withdrawal by Subject|0
5977144|NCT01078623|20669457|P12|Treatment Period 4|Withdrawal by Subject|0
5977145|NCT01078623|20669458|P11|Treatment Period 4|Withdrawal by Subject|0
5977146|NCT01078623|20669459|P10|Treatment Period 4|Withdrawal by Subject|0
5977147|NCT01078623|20669460|P9|Treatment Period 4|Withdrawal by Subject|0
5977148|NCT01078623|20669461|P8|Treatment Period 4|Withdrawal by Subject|0
5977149|NCT01078623|20669462|P7|Treatment Period 4|Withdrawal by Subject|0
5977150|NCT01078623|20669463|P6|Treatment Period 4|Withdrawal by Subject|0
5977151|NCT01078623|20669464|P5|Treatment Period 4|Withdrawal by Subject|0
5977152|NCT01078623|20669465|P4|Treatment Period 4|Withdrawal by Subject|0
5977153|NCT01078623|20669466|P3|Treatment Period 4|Withdrawal by Subject|0
5977154|NCT01078623|20669467|P2|Treatment Period 4|Withdrawal by Subject|0
5977155|NCT01078623|20669468|P1|Treatment Period 4|Withdrawal by Subject|0
5977156|NCT01078623|20669449|P20|Treatment Period 4|Adverse Event|0
5977157|NCT01078623|20669450|P19|Treatment Period 4|Adverse Event|0
5977158|NCT01078623|20669451|P18|Treatment Period 4|Adverse Event|0
5977159|NCT01078623|20669452|P17|Treatment Period 4|Adverse Event|0
5977160|NCT01078623|20669453|P16|Treatment Period 4|Adverse Event|0
5977161|NCT01078623|20669454|P15|Treatment Period 4|Adverse Event|0
5977162|NCT01078623|20669455|P14|Treatment Period 4|Adverse Event|0
5977163|NCT01078623|20669456|P13|Treatment Period 4|Adverse Event|0
5977164|NCT01078623|20669457|P12|Treatment Period 4|Adverse Event|0
5977165|NCT01078623|20669458|P11|Treatment Period 4|Adverse Event|0
5977166|NCT01078623|20669459|P10|Treatment Period 4|Adverse Event|0
5977167|NCT01078623|20669460|P9|Treatment Period 4|Adverse Event|0
5977168|NCT01078623|20669461|P8|Treatment Period 4|Adverse Event|0
5977169|NCT01078623|20669462|P7|Treatment Period 4|Adverse Event|0
5977170|NCT01078623|20669463|P6|Treatment Period 4|Adverse Event|0
5977171|NCT01078623|20669464|P5|Treatment Period 4|Adverse Event|0
5977172|NCT01078623|20669465|P4|Treatment Period 4|Adverse Event|0
5977173|NCT01078623|20669466|P3|Treatment Period 4|Adverse Event|1
5977174|NCT01078623|20669467|P2|Treatment Period 4|Adverse Event|0
5977175|NCT01078623|20669468|P1|Treatment Period 4|Adverse Event|0
5977176|NCT01078623|20669449|P20|Treatment Period 3|Adverse Event|0
5977177|NCT01078623|20669450|P19|Treatment Period 3|Adverse Event|0
5977178|NCT01078623|20669451|P18|Treatment Period 3|Adverse Event|0
5977179|NCT01078623|20669452|P17|Treatment Period 3|Adverse Event|0
5977180|NCT01078623|20669453|P16|Treatment Period 3|Adverse Event|0
5977181|NCT01078623|20669454|P15|Treatment Period 3|Adverse Event|0
5977182|NCT01078623|20669455|P14|Treatment Period 3|Adverse Event|1
5977183|NCT01078623|20669456|P13|Treatment Period 3|Adverse Event|0
5977184|NCT01078623|20669457|P12|Treatment Period 3|Adverse Event|0
5977185|NCT01078623|20669458|P11|Treatment Period 3|Adverse Event|0
5977186|NCT01078623|20669459|P10|Treatment Period 3|Adverse Event|0
5977187|NCT01078623|20669460|P9|Treatment Period 3|Adverse Event|0
5977188|NCT01078623|20669461|P8|Treatment Period 3|Adverse Event|0
5977189|NCT01078623|20669462|P7|Treatment Period 3|Adverse Event|0
5977190|NCT01078623|20669463|P6|Treatment Period 3|Adverse Event|0
5977191|NCT01078623|20669464|P5|Treatment Period 3|Adverse Event|1
5977192|NCT01078623|20669465|P4|Treatment Period 3|Adverse Event|0
5977193|NCT01078623|20669466|P3|Treatment Period 3|Adverse Event|0
5977194|NCT01078623|20669467|P2|Treatment Period 3|Adverse Event|0
5977195|NCT01078623|20669468|P1|Treatment Period 3|Adverse Event|0
5977196|NCT01078623|20669449|P20|Treatment Period 2|Withdrawal by Subject|0
5977197|NCT01078623|20669450|P19|Treatment Period 2|Withdrawal by Subject|0
5977198|NCT01078623|20669451|P18|Treatment Period 2|Withdrawal by Subject|0
5977199|NCT01078623|20669452|P17|Treatment Period 2|Withdrawal by Subject|0
5977200|NCT01078623|20669453|P16|Treatment Period 2|Withdrawal by Subject|0
5977201|NCT01078623|20669454|P15|Treatment Period 2|Withdrawal by Subject|0
5977202|NCT01078623|20669455|P14|Treatment Period 2|Withdrawal by Subject|0
5977203|NCT01078623|20669456|P13|Treatment Period 2|Withdrawal by Subject|0
5977204|NCT01078623|20669457|P12|Treatment Period 2|Withdrawal by Subject|0
5977205|NCT01078623|20669458|P11|Treatment Period 2|Withdrawal by Subject|0
5977206|NCT01078623|20669459|P10|Treatment Period 2|Withdrawal by Subject|0
5977207|NCT01078623|20669460|P9|Treatment Period 2|Withdrawal by Subject|0
5977208|NCT01078623|20669461|P8|Treatment Period 2|Withdrawal by Subject|0
5977209|NCT01078623|20669462|P7|Treatment Period 2|Withdrawal by Subject|0
5977210|NCT01078623|20669463|P6|Treatment Period 2|Withdrawal by Subject|1
5977211|NCT01078623|20669464|P5|Treatment Period 2|Withdrawal by Subject|0
5977212|NCT01078623|20669465|P4|Treatment Period 2|Withdrawal by Subject|0
5977213|NCT01078623|20669466|P3|Treatment Period 2|Withdrawal by Subject|0
5977214|NCT01078623|20669467|P2|Treatment Period 2|Withdrawal by Subject|0
5977215|NCT01078623|20669468|P1|Treatment Period 2|Withdrawal by Subject|0
5977216|NCT01078623|20669449|P20|Treatment Period 2|Adverse Event|0
5977217|NCT01078623|20669450|P19|Treatment Period 2|Adverse Event|1
5977218|NCT01078623|20669451|P18|Treatment Period 2|Adverse Event|0
5977219|NCT01078623|20669452|P17|Treatment Period 2|Adverse Event|0
5977220|NCT01078623|20669453|P16|Treatment Period 2|Adverse Event|0
5977221|NCT01078623|20669454|P15|Treatment Period 2|Adverse Event|0
5977222|NCT01078623|20669455|P14|Treatment Period 2|Adverse Event|0
5977223|NCT01078623|20669456|P13|Treatment Period 2|Adverse Event|0
5977224|NCT01078623|20669457|P12|Treatment Period 2|Adverse Event|0
5977225|NCT01078623|20669458|P11|Treatment Period 2|Adverse Event|0
5977226|NCT01078623|20669459|P10|Treatment Period 2|Adverse Event|0
5977227|NCT01078623|20669460|P9|Treatment Period 2|Adverse Event|0
5977228|NCT01078623|20669461|P8|Treatment Period 2|Adverse Event|0
5977229|NCT01078623|20669462|P7|Treatment Period 2|Adverse Event|1
5977230|NCT01078623|20669463|P6|Treatment Period 2|Adverse Event|0
5977231|NCT01078623|20669464|P5|Treatment Period 2|Adverse Event|0
5977232|NCT01078623|20669465|P4|Treatment Period 2|Adverse Event|0
5977233|NCT01078623|20669466|P3|Treatment Period 2|Adverse Event|0
5977234|NCT01078623|20669467|P2|Treatment Period 2|Adverse Event|0
5977235|NCT01078623|20669468|P1|Treatment Period 2|Adverse Event|0
5977236|NCT01078623|20669449|P20|Treatment Period 1|Protocol Violation|0
5977237|NCT01078623|20669450|P19|Treatment Period 1|Protocol Violation|0
5977238|NCT01078623|20669451|P18|Treatment Period 1|Protocol Violation|0
5977239|NCT01078623|20669452|P17|Treatment Period 1|Protocol Violation|0
5977240|NCT01078623|20669453|P16|Treatment Period 1|Protocol Violation|0
5977241|NCT01078623|20669454|P15|Treatment Period 1|Protocol Violation|0
5977242|NCT01078623|20669455|P14|Treatment Period 1|Protocol Violation|0
5977243|NCT01078623|20669456|P13|Treatment Period 1|Protocol Violation|0
5977244|NCT01078623|20669457|P12|Treatment Period 1|Protocol Violation|0
5977245|NCT01078623|20669458|P11|Treatment Period 1|Protocol Violation|0
5977246|NCT01078623|20669459|P10|Treatment Period 1|Protocol Violation|0
5977247|NCT01078623|20669460|P9|Treatment Period 1|Protocol Violation|0
5977248|NCT01078623|20669461|P8|Treatment Period 1|Protocol Violation|0
5977249|NCT01078623|20669462|P7|Treatment Period 1|Protocol Violation|0
5977250|NCT01078623|20669463|P6|Treatment Period 1|Protocol Violation|1
5977251|NCT01078623|20669464|P5|Treatment Period 1|Protocol Violation|0
5977252|NCT01078623|20669465|P4|Treatment Period 1|Protocol Violation|0
5977253|NCT01078623|20669466|P3|Treatment Period 1|Protocol Violation|0
5977254|NCT01078623|20669467|P2|Treatment Period 1|Protocol Violation|0
5977255|NCT01078623|20669468|P1|Treatment Period 1|Protocol Violation|0
5977256|NCT01078623|20669449|P20|Treatment Period 1|Withdrawal by Subject|0
5977257|NCT01078623|20669450|P19|Treatment Period 1|Withdrawal by Subject|0
5977258|NCT01078623|20669451|P18|Treatment Period 1|Withdrawal by Subject|0
5977259|NCT01078623|20669452|P17|Treatment Period 1|Withdrawal by Subject|0
5977260|NCT01078623|20669453|P16|Treatment Period 1|Withdrawal by Subject|0
5977261|NCT01078623|20669454|P15|Treatment Period 1|Withdrawal by Subject|0
5977262|NCT01078623|20669455|P14|Treatment Period 1|Withdrawal by Subject|0
5977263|NCT01078623|20669456|P13|Treatment Period 1|Withdrawal by Subject|0
5977264|NCT01078623|20669457|P12|Treatment Period 1|Withdrawal by Subject|0
5977265|NCT01078623|20669458|P11|Treatment Period 1|Withdrawal by Subject|1
5977266|NCT01078623|20669459|P10|Treatment Period 1|Withdrawal by Subject|0
5977267|NCT01078623|20669460|P9|Treatment Period 1|Withdrawal by Subject|0
5977268|NCT01078623|20669461|P8|Treatment Period 1|Withdrawal by Subject|1
5977269|NCT01078623|20669462|P7|Treatment Period 1|Withdrawal by Subject|0
5977270|NCT01078623|20669463|P6|Treatment Period 1|Withdrawal by Subject|0
5977271|NCT01078623|20669464|P5|Treatment Period 1|Withdrawal by Subject|0
5977272|NCT01078623|20669465|P4|Treatment Period 1|Withdrawal by Subject|0
5977273|NCT01078623|20669466|P3|Treatment Period 1|Withdrawal by Subject|0
5977274|NCT01078623|20669467|P2|Treatment Period 1|Withdrawal by Subject|0
5977275|NCT01078623|20669468|P1|Treatment Period 1|Withdrawal by Subject|0
5977276|NCT01078623|20669449|P20|Treatment Period 1|Adverse Event|0
5977277|NCT01078623|20669450|P19|Treatment Period 1|Adverse Event|0
5977278|NCT01078623|20669451|P18|Treatment Period 1|Adverse Event|0
5977279|NCT01078623|20669452|P17|Treatment Period 1|Adverse Event|0
5977280|NCT01078623|20669453|P16|Treatment Period 1|Adverse Event|0
5977281|NCT01078623|20669454|P15|Treatment Period 1|Adverse Event|0
5977282|NCT01078623|20669455|P14|Treatment Period 1|Adverse Event|0
5977283|NCT01078623|20669456|P13|Treatment Period 1|Adverse Event|0
5977284|NCT01078623|20669457|P12|Treatment Period 1|Adverse Event|0
5977285|NCT01078623|20669458|P11|Treatment Period 1|Adverse Event|0
5977286|NCT01078623|20669459|P10|Treatment Period 1|Adverse Event|1
5977287|NCT01078623|20669460|P9|Treatment Period 1|Adverse Event|1
5977288|NCT01078623|20669461|P8|Treatment Period 1|Adverse Event|0
5977289|NCT01078623|20669462|P7|Treatment Period 1|Adverse Event|1
5977290|NCT01078623|20669463|P6|Treatment Period 1|Adverse Event|0
5977291|NCT01078623|20669464|P5|Treatment Period 1|Adverse Event|0
5977292|NCT01078623|20669465|P4|Treatment Period 1|Adverse Event|0
5977293|NCT01078623|20669466|P3|Treatment Period 1|Adverse Event|1
5977294|NCT01078623|20669467|P2|Treatment Period 1|Adverse Event|1
5977295|NCT01078623|20669468|P1|Treatment Period 1|Adverse Event|1
5977296|NCT01078584|20669490|P1|Overall Study|Multiple Reasons|2
5977297|NCT01078584|20669490|P1|Overall Study|Serious Adverse Event|27
5977298|NCT01078584|20669490|P1|Overall Study|Protocol Violation|75
5977299|NCT01078584|20669490|P1|Overall Study|Lack of Efficacy|98
5977300|NCT01078584|20669490|P1|Overall Study|Physician Discontinued Patient|12
5977301|NCT01078584|20669490|P1|Overall Study|Physician Switched Medication|26
5977302|NCT01078584|20669490|P1|Overall Study|Blood Pressure Controlled|49
5977303|NCT01078584|20669490|P1|Overall Study|Non-compliance|67
5977304|NCT01078584|20669490|P1|Overall Study|Physician Withdrew from Study|90
5977305|NCT01078584|20669490|P1|Overall Study|Withdrawal of Consent|244
5977306|NCT01078584|20669490|P1|Overall Study|Non-serious Adverse Event|577
5977307|NCT01078584|20669490|P1|Overall Study|Lost to Follow-up|670
5977308|NCT01078584|20669490|P1|Overall Study|Final Status Unknown|1073
5977309|NCT01078571|20669571|P1|Overall Study|Protocol Violation|2
5977310|NCT01078571|20669571|P1|Overall Study|Lost to Follow-up|8
5977311|NCT01078571|20669571|P1|Overall Study|Withdrawal by Subject|12
5977312|NCT01078571|20669571|P1|Overall Study|Reason not reported|21
5977313|NCT01078571|20669571|P1|Overall Study|Lack of effectiveness|36
5977314|NCT01078571|20669571|P1|Overall Study|Adverse Event|36
5977315|NCT01078545|20669622|P1|Overall Study|Participant moved to another physician|1
5977316|NCT01078545|20669622|P1|Overall Study|Death|3
5977317|NCT01078545|20669622|P1|Overall Study|Withdrawal by Subject|3
5977318|NCT01078545|20669622|P1|Overall Study|Physician Decision|6
5977319|NCT01078545|20669622|P1|Overall Study|Lost to Follow-up|13
5977320|NCT01078454|20669632|P2|Overall Study|Death|1
5977321|NCT01078454|20669633|P1|Overall Study|Death|0
5977322|NCT01078454|20669632|P2|Overall Study|Adverse Event|1
5977323|NCT01078454|20669633|P1|Overall Study|Adverse Event|1
5977324|NCT01078441|20669639|P1|Overall Study|Withdrawal by Subject|1
5977325|NCT01078389|20669679|P2|Overall Study|Other|2
5977326|NCT01078389|20669680|P1|Overall Study|Other|9
5977327|NCT01078389|20669679|P2|Overall Study|Voluntary Withdrawal|36
5977328|NCT01078389|20669680|P1|Overall Study|Voluntary Withdrawal|20
5977329|NCT01078389|20669679|P2|Overall Study|Lost to Follow-up|23
5977330|NCT01078389|20669680|P1|Overall Study|Lost to Follow-up|23
5977331|NCT01078389|20669679|P2|Overall Study|Major Protocol Deviation|0
5977332|NCT01078389|20669680|P1|Overall Study|Major Protocol Deviation|2
5977333|NCT01078389|20669679|P2|Overall Study|Adverse Event|6
5977334|NCT01078389|20669680|P1|Overall Study|Adverse Event|10
5977335|NCT01078298|20669841|P2|Overall Study|Other|32
5977336|NCT01078298|20669842|P1|Overall Study|Other|24
5977337|NCT01078298|20669841|P2|Overall Study|Did not meet entrance criteria|1
5977338|NCT01078298|20669842|P1|Overall Study|Did not meet entrance criteria|0
5977339|NCT01078298|20669841|P2|Overall Study|Death|0
5977340|NCT01078298|20669842|P1|Overall Study|Death|2
5977341|NCT01078298|20669841|P2|Overall Study|Adverse Event|5
5977342|NCT01078298|20669842|P1|Overall Study|Adverse Event|6
5977343|NCT01078298|20669841|P2|Overall Study|Protocol Violation|6
5977344|NCT01078298|20669842|P1|Overall Study|Protocol Violation|6
5977345|NCT01078298|20669841|P2|Overall Study|Withdrawal by Subject|33
5977346|NCT01078298|20669842|P1|Overall Study|Withdrawal by Subject|31
5977347|NCT01078298|20669841|P2|Overall Study|Lost to Follow-up|13
5977348|NCT01078298|20669842|P1|Overall Study|Lost to Follow-up|12
5977349|NCT01078168|20669952|P2|Overall Study|Physician Decision|1
5977350|NCT01078168|20669953|P1|Overall Study|Physician Decision|0
5977351|NCT01078155|20669959|P1|Overall Study|Lost to Follow-up|15
5977352|NCT01078155|20669959|P1|Overall Study|Participant's Decision|6
5977353|NCT01078155|20669959|P1|Overall Study|Lack of Efficacy|16
5977354|NCT01078155|20669959|P1|Overall Study|Adverse Event|7
5977355|NCT01078116|20669975|P1|Overall Study|Case report form not completed|3
5977356|NCT01078116|20669975|P1|Overall Study|Lack of effectiveness|15
5977357|NCT01078116|20669975|P1|Overall Study|Withdrawal by Subject|8
5977358|NCT01078116|20669975|P1|Overall Study|Adverse Event|5
5977359|NCT01078116|20669975|P1|Overall Study|Lost to Follow-up|17
5977360|NCT01078090|20669983|P1|Overall Study|Other|523
5977361|NCT01078090|20669983|P1|Overall Study|ADR and lack of efficacy|61
5977362|NCT01078090|20669983|P1|Overall Study|Lack of Efficacy|1193
5977363|NCT01078090|20669983|P1|Overall Study|Adverse drug reaction (ADR)|453
5977364|NCT01078090|20669983|P1|Overall Study|Lost to Follow-up|2363
5977365|NCT01077960|20670077|P1|Overall Study|Reason unspecified|1
5977366|NCT01077960|20670077|P1|Overall Study|Subject decision|1
5977367|NCT01077960|20670077|P1|Overall Study|Lost to Follow-up|5
5977368|NCT01077960|20670077|P1|Overall Study|Protocol Violation|3
5977369|NCT01077960|20670077|P1|Overall Study|Adverse Event|6
5977370|NCT01077804|20670327|P1|Overall Study|Other|18
5977371|NCT01077804|20670327|P1|Overall Study|Refused to continue|79
5977372|NCT01077804|20670327|P1|Overall Study|Unreachable|102
5977373|NCT01077739|20670336|P2|Overall Study|Other|2
5977374|NCT01077739|20670337|P1|Overall Study|Other|2
5977375|NCT01077739|20670336|P2|Overall Study|Unacceptable toxicity|2
5977376|NCT01077739|20670337|P1|Overall Study|Unacceptable toxicity|1
5977377|NCT01077739|20670336|P2|Overall Study|Death|3
5977378|NCT01077739|20670337|P1|Overall Study|Death|0
5977379|NCT01077739|20670336|P2|Overall Study|Withdrawal by Subject|0
5977380|NCT01077739|20670337|P1|Overall Study|Withdrawal by Subject|1
5977381|NCT01077739|20670336|P2|Overall Study|Premature withdrawal|3
5977382|NCT01077739|20670337|P1|Overall Study|Premature withdrawal|1
5977383|NCT01077713|20670351|P2|Overall Study|Other|2
5977384|NCT01077713|20670352|P1|Overall Study|Other|4
5977385|NCT01077713|20670351|P2|Overall Study|Adverse Event|1
5977386|NCT01077713|20670352|P1|Overall Study|Adverse Event|2
5977387|NCT01077713|20670351|P2|Overall Study|Lost to Follow-up|1
5977388|NCT01077713|20670352|P1|Overall Study|Lost to Follow-up|1
5977389|NCT01077713|20670351|P2|Overall Study|Death|29
5977390|NCT01077713|20670352|P1|Overall Study|Death|28
5977391|NCT01077713|20670351|P2|Overall Study|Progressive Disease (PD)|1
5977392|NCT01077713|20670352|P1|Overall Study|Progressive Disease (PD)|0
5977393|NCT01077713|20670351|P2|Overall Study|Withdrawal by Subject|2
5977394|NCT01077713|20670352|P1|Overall Study|Withdrawal by Subject|1
5977395|NCT01077622|20670376|P1|Overall Study|Withdrawal by Subject|1
5977396|NCT01077622|20670376|P1|Overall Study|Physician Decision|2
5977397|NCT01077544|20670496|P2|Overall Study|Disease Progression|1
5977398|NCT01077544|20670497|P1|Overall Study|Disease Progression|0
5977399|NCT01077544|20670496|P2|Overall Study|Adverse Event|1
5977400|NCT01077544|20670497|P1|Overall Study|Adverse Event|0
5977401|NCT01077544|20670496|P2|Overall Study|New Cancer Therapy|3
5977402|NCT01077544|20670497|P1|Overall Study|New Cancer Therapy|3
5977403|NCT01077518|20670525|P3|Optional Ofa Phase|Withdrawal by Subject|3
5977404|NCT01077518|20670526|P2|Optional Ofa Phase|Withdrawal by Subject|0
5977405|NCT01077518|20670527|P1|Optional Ofa Phase|Withdrawal by Subject|0
5977406|NCT01077518|20670525|P3|Optional Ofa Phase|Study Terminated by Sponsor|12
5977407|NCT01077518|20670526|P2|Optional Ofa Phase|Study Terminated by Sponsor|0
5977408|NCT01077518|20670527|P1|Optional Ofa Phase|Study Terminated by Sponsor|0
5977409|NCT01077518|20670525|P3|Optional Ofa Phase|Physician Decision|1
5977410|NCT01077518|20670526|P2|Optional Ofa Phase|Physician Decision|0
5977411|NCT01077518|20670527|P1|Optional Ofa Phase|Physician Decision|0
5977412|NCT01077518|20670525|P3|Treatment Phase - no Optional Ofa|Withdrawal by Subject|0
5977413|NCT01077518|20670526|P2|Treatment Phase - no Optional Ofa|Withdrawal by Subject|28
5977414|NCT01077518|20670527|P1|Treatment Phase - no Optional Ofa|Withdrawal by Subject|32
5977415|NCT01077518|20670525|P3|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|0
5977416|NCT01077518|20670526|P2|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|22
5977417|NCT01077518|20670527|P1|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|28
5977418|NCT01077518|20670525|P3|Treatment Phase - no Optional Ofa|Physician Decision|0
5977419|NCT01077518|20670526|P2|Treatment Phase - no Optional Ofa|Physician Decision|11
5977420|NCT01077518|20670527|P1|Treatment Phase - no Optional Ofa|Physician Decision|10
5977421|NCT01077518|20670525|P3|Treatment Phase - no Optional Ofa|Lost to Follow-up|0
5977422|NCT01077518|20670526|P2|Treatment Phase - no Optional Ofa|Lost to Follow-up|4
5977423|NCT01077518|20670527|P1|Treatment Phase - no Optional Ofa|Lost to Follow-up|8
5977424|NCT01077375|20670600|P2|Overall Study|Other Reason|1
5977425|NCT01077375|20670601|P1|Overall Study|Other Reason|0
5977426|NCT01077375|20670600|P2|Overall Study|Lost to Follow-up|5
5977427|NCT01077375|20670601|P1|Overall Study|Lost to Follow-up|2
5977428|NCT01077375|20670600|P2|Overall Study|Withdrawal by Subject|6
5977429|NCT01077375|20670601|P1|Overall Study|Withdrawal by Subject|0
5977430|NCT01077375|20670600|P2|Overall Study|Lack of Efficacy|8
5977431|NCT01077375|20670601|P1|Overall Study|Lack of Efficacy|6
5977432|NCT01077375|20670600|P2|Overall Study|Adverse Event|15
5977433|NCT01077375|20670601|P1|Overall Study|Adverse Event|2
5977434|NCT01077362|20670612|P3|Overall Study|Other|2
5977435|NCT01077362|20670613|P2|Overall Study|Other|1
5977436|NCT01077362|20670614|P1|Overall Study|Other|0
5977437|NCT01077362|20670612|P3|Overall Study|Withdrawal by Subject|5
5977438|NCT01077362|20670613|P2|Overall Study|Withdrawal by Subject|3
5977439|NCT01077362|20670614|P1|Overall Study|Withdrawal by Subject|5
5977440|NCT01077362|20670612|P3|Overall Study|Adverse Event|4
5977441|NCT01077362|20670613|P2|Overall Study|Adverse Event|7
5977442|NCT01077362|20670614|P1|Overall Study|Adverse Event|12
5977443|NCT01077362|20670612|P3|Overall Study|Lost to Follow-up|3
5977444|NCT01077362|20670613|P2|Overall Study|Lost to Follow-up|0
5977445|NCT01077362|20670614|P1|Overall Study|Lost to Follow-up|1
5977446|NCT01077362|20670612|P3|Overall Study|Lack of Efficacy|10
5977447|NCT01077362|20670613|P2|Overall Study|Lack of Efficacy|8
5977448|NCT01077362|20670614|P1|Overall Study|Lack of Efficacy|13
5977449|NCT01077323|20670650|P3|Overall Study|Baseline diagnosis of pancreatic disease|120
5977450|NCT01077323|20670651|P2|Overall Study|Baseline diagnosis of pancreatic disease|2080
5977451|NCT01077323|20670652|P1|Overall Study|Baseline diagnosis of pancreatic disease|152
5977452|NCT01077323|20670650|P3|Overall Study|Dispensing of drug in baseline period|256446
5977453|NCT01077323|20670651|P2|Overall Study|Dispensing of drug in baseline period|120229
5977454|NCT01077323|20670652|P1|Overall Study|Dispensing of drug in baseline period|0
5977455|NCT01077323|20670650|P3|Overall Study|<9 months enroll before drug dispensed|11655523
5977456|NCT01077323|20670651|P2|Overall Study|<9 months enroll before drug dispensed|263954
5977457|NCT01077323|20670652|P1|Overall Study|<9 months enroll before drug dispensed|11226
5977458|NCT01077284|20670695|P3|Overall Study|Other|1
5977459|NCT01077284|20670696|P2|Overall Study|Other|0
5977460|NCT01077284|20670697|P1|Overall Study|Other|0
5977461|NCT01077284|20670695|P3|Overall Study|Withdrawal by Subject|1
5977462|NCT01077284|20670696|P2|Overall Study|Withdrawal by Subject|3
5977463|NCT01077284|20670697|P1|Overall Study|Withdrawal by Subject|2
5977464|NCT01077284|20670695|P3|Overall Study|Lost to Follow-up|0
5977465|NCT01077284|20670696|P2|Overall Study|Lost to Follow-up|2
5977466|NCT01077284|20670697|P1|Overall Study|Lost to Follow-up|1
5977467|NCT01077284|20670695|P3|Overall Study|Adverse Event|1
5977468|NCT01077284|20670696|P2|Overall Study|Adverse Event|0
5977469|NCT01077284|20670697|P1|Overall Study|Adverse Event|2
5977470|NCT01077271|20670718|P1|Overall Study|Mother unconvinced of the necessity|1
5977471|NCT01077271|20670718|P1|Overall Study|End of RSV season nearly reached|1
5977472|NCT01077271|20670718|P1|Overall Study|Parents thought too many injections|2
5977473|NCT01077271|20670718|P1|Overall Study|Changed doctors|2
5977474|NCT01077271|20670718|P1|Overall Study|Quota used up (insurance reimb issue)|2
5977475|NCT01077271|20670718|P1|Overall Study|Noncompliance|2
5977476|NCT01077271|20670718|P1|Overall Study|Screen failure, did not take palivizumab|4
5977477|NCT01077271|20670718|P1|Overall Study|Parental desire|8
5977478|NCT01077258|20670756|P1|Overall Study|Other reasons|260
5977479|NCT01077258|20670756|P1|Overall Study|Clinical remission|37
5977480|NCT01077258|20670756|P1|Overall Study|Lack of Efficacy|663
5977481|NCT01077258|20670756|P1|Overall Study|Adverse drug reaction|218
5977482|NCT01077258|20670756|P1|Overall Study|Lost to Follow-up|1390
5977483|NCT01077193|20670792|P1|Overall Study|Study Terminated by Sponsor|40
5977484|NCT01077193|20670792|P1|Overall Study|Lack of Efficacy|1
5977485|NCT01077193|20670792|P1|Overall Study|Withdrawal by Subject|2
5977486|NCT01077193|20670792|P1|Overall Study|Lost to Follow-up|1
5977487|NCT01077154|20670798|P2|Overall Study|Protocol Deviation|0
5977488|NCT01077154|20670799|P1|Overall Study|Protocol Deviation|1
5977489|NCT01077154|20670798|P2|Overall Study|Administrative Decision|6
5977490|NCT01077154|20670799|P1|Overall Study|Administrative Decision|1
5977491|NCT01077154|20670798|P2|Overall Study|Adverse Event|9
5977492|NCT01077154|20670799|P1|Overall Study|Adverse Event|9
5977493|NCT01077154|20670798|P2|Overall Study|Other|11
5977494|NCT01077154|20670799|P1|Overall Study|Other|14
5977495|NCT01077154|20670798|P2|Overall Study|Ineligibility Determined|14
5977496|NCT01077154|20670799|P1|Overall Study|Ineligibility Determined|10
5977497|NCT01077154|20670798|P2|Overall Study|Disease Progression|20
5977498|NCT01077154|20670799|P1|Overall Study|Disease Progression|18
5977499|NCT01077154|20670798|P2|Overall Study|Noncompliance|20
5977500|NCT01077154|20670799|P1|Overall Study|Noncompliance|22
5977501|NCT01077154|20670798|P2|Overall Study|Lost to Follow-up|35
5977502|NCT01077154|20670799|P1|Overall Study|Lost to Follow-up|43
5977503|NCT01077154|20670798|P2|Overall Study|Death|214
5977504|NCT01077154|20670799|P1|Overall Study|Death|215
5977505|NCT01077154|20670798|P2|Overall Study|Withdrawal by Subject|385
5977506|NCT01077154|20670799|P1|Overall Study|Withdrawal by Subject|369
5977507|NCT01077154|20670798|P2|Overall Study|Protocol-specified Criteria: Study Ended|1514
5977508|NCT01077154|20670799|P1|Overall Study|Protocol-specified Criteria: Study Ended|1524
5977509|NCT01077128|20670813|P1|Overall Study|Other|54
5977510|NCT01077128|20670813|P1|Overall Study|Lack of efficacy/disease exacerbation|1
5977511|NCT01077128|20670813|P1|Overall Study|Adverse event and disease exacerbation|1
5977512|NCT01077128|20670813|P1|Overall Study|Adverse event and consent withdrawal|1
5977513|NCT01077128|20670813|P1|Overall Study|Disease exacerbation|1
5977514|NCT01077128|20670813|P1|Overall Study|Lack of Efficacy|1
5977515|NCT01077128|20670813|P1|Overall Study|Adverse Event|8
5977516|NCT01077076|20670871|P6|Third Intervention|Death in the participant's family|1
5977517|NCT01077076|20670872|P5|Third Intervention|Death in the participant's family|0
5977518|NCT01077076|20670873|P4|Third Intervention|Death in the participant's family|0
5977519|NCT01077076|20670874|P3|Third Intervention|Death in the participant's family|0
5977520|NCT01077076|20670875|P2|Third Intervention|Death in the participant's family|0
5977521|NCT01077076|20670876|P1|Third Intervention|Death in the participant's family|0
5977522|NCT01077076|20670871|P6|First Intervention|Withdrawal by Subject|0
5977523|NCT01077076|20670872|P5|First Intervention|Withdrawal by Subject|0
5977524|NCT01077076|20670873|P4|First Intervention|Withdrawal by Subject|0
5977525|NCT01077076|20670874|P3|First Intervention|Withdrawal by Subject|0
5977526|NCT01077076|20670875|P2|First Intervention|Withdrawal by Subject|0
5977527|NCT01077076|20670876|P1|First Intervention|Withdrawal by Subject|1
5977528|NCT01077063|20670886|P2|Overall Study|Withdrawal by Subject|2
5977529|NCT01077063|20670887|P1|Overall Study|Withdrawal by Subject|0
5977530|NCT01077063|20670886|P2|Overall Study|Death|1
5977531|NCT01077063|20670887|P1|Overall Study|Death|1
5977532|NCT01077063|20670886|P2|Overall Study|Adverse Event|0
5977533|NCT01077063|20670887|P1|Overall Study|Adverse Event|3
5977534|NCT01077050|20670893|P1|Overall Study|Screen failure|8
5977535|NCT01077050|20670893|P1|Overall Study|Subjects signed ICF could not be located|1
5977536|NCT01077024|20670899|P2|Overall Study|Other|4
5977537|NCT01077024|20670900|P1|Overall Study|Other|4
5977538|NCT01077024|20670899|P2|Overall Study|Incarcerated|8
5977539|NCT01077024|20670900|P1|Overall Study|Incarcerated|7
5977540|NCT01077024|20670899|P2|Overall Study|Withdrawal by Subject|2
5977541|NCT01077024|20670900|P1|Overall Study|Withdrawal by Subject|0
5977542|NCT01077024|20670899|P2|Overall Study|Lost to Follow-up|14
5977543|NCT01077024|20670900|P1|Overall Study|Lost to Follow-up|20
5977544|NCT01076959|20670939|P1|Overall Study|Other|119
5977545|NCT01076959|20670939|P1|Overall Study|Lost to Follow-up|241
5977546|NCT01076959|20670939|P1|Overall Study|Non-compliance|274
5977547|NCT01076959|20670939|P1|Overall Study|Lack of Efficacy|849
5977548|NCT01076959|20670939|P1|Overall Study|Adverse Event|767
5977549|NCT01076647|20670975|P2|Overall Study|Unclassified|12
5977550|NCT01076647|20670976|P1|Overall Study|Unclassified|12
5977551|NCT01076647|20670975|P2|Overall Study|Withdrawal criteria|2
5977552|NCT01076647|20670976|P1|Overall Study|Withdrawal criteria|2
5977553|NCT01076647|20670975|P2|Overall Study|Protocol Violation|9
5977554|NCT01076647|20670976|P1|Overall Study|Protocol Violation|7
5977555|NCT01076647|20670975|P2|Overall Study|Lack of Efficacy|1
5977556|NCT01076647|20670976|P1|Overall Study|Lack of Efficacy|0
5977557|NCT01076647|20670975|P2|Overall Study|Adverse Event|1
5977558|NCT01076647|20670976|P1|Overall Study|Adverse Event|4
5977559|NCT01076543|20670990|P6|Overall Study|Withdrawal by Subject|0
5977560|NCT01076543|20670991|P5|Overall Study|Withdrawal by Subject|0
5977561|NCT01076543|20670992|P4|Overall Study|Withdrawal by Subject|0
5977562|NCT01076543|20670993|P3|Overall Study|Withdrawal by Subject|0
5977563|NCT01076543|20670994|P2|Overall Study|Withdrawal by Subject|0
5977564|NCT01076543|20670995|P1|Overall Study|Withdrawal by Subject|2
5977565|NCT01076400|20671056|P3|Overall Study|Progressive Disease|0
5977566|NCT01076400|20671057|P2|Overall Study|Progressive Disease|0
5977567|NCT01076400|20671058|P1|Overall Study|Progressive Disease|5
5977568|NCT01076400|20671056|P3|Overall Study|Adverse Event|0
5977569|NCT01076400|20671057|P2|Overall Study|Adverse Event|0
5977570|NCT01076400|20671058|P1|Overall Study|Adverse Event|2
5977571|NCT01076361|20671064|P1|Overall Study|22 leads were excluded from analysis|21
5977572|NCT01076335|20671072|P1|Overall Study|Withdrawal without treatment|1
5977573|NCT01076335|20671072|P1|Overall Study|Withdrawal by Subject|3
5977574|NCT01076205|20671124|P1|Overall Study|Lost to Follow-up|3151
5977575|NCT01076205|20671124|P1|Overall Study|Unknown Reason|71
5977576|NCT01076205|20671124|P1|Overall Study|Other Reason|1075
5977577|NCT01076205|20671124|P1|Overall Study|Lack of Effectiveness|1423
5977578|NCT01076205|20671124|P1|Overall Study|Adverse Drug Reaction|299
5977579|NCT01076192|20671177|P1|Overall Study|Other|197
5977580|NCT01076179|20671192|P1|Overall Study|Withdrawal by Subject|1
5977581|NCT01076166|20671215|P1|Overall Study|Symptoms improved/resolved|6
5977582|NCT01076166|20671215|P1|Overall Study|Adverse Event|3
5977583|NCT01076153|20671222|P1|Overall Study|Adverse Event|1
5977584|NCT01076153|20671222|P1|Overall Study|Symptoms improved/resolved|10
5977585|NCT01076088|20671236|P6|Overall Study|Other protocol specified criteria|1
5977586|NCT01076088|20671237|P5|Overall Study|Other protocol specified criteria|0
5977587|NCT01076088|20671238|P4|Overall Study|Other protocol specified criteria|0
5977588|NCT01076088|20671239|P3|Overall Study|Other protocol specified criteria|0
5977589|NCT01076088|20671240|P2|Overall Study|Other protocol specified criteria|0
5977590|NCT01076088|20671241|P1|Overall Study|Other protocol specified criteria|0
5977591|NCT01076088|20671236|P6|Overall Study|Withdrawal by Subject|17
5977592|NCT01076088|20671237|P5|Overall Study|Withdrawal by Subject|11
5977593|NCT01076088|20671238|P4|Overall Study|Withdrawal by Subject|10
5977594|NCT01076088|20671239|P3|Overall Study|Withdrawal by Subject|14
5977595|NCT01076088|20671240|P2|Overall Study|Withdrawal by Subject|8
5977596|NCT01076088|20671241|P1|Overall Study|Withdrawal by Subject|8
5977597|NCT01076088|20671236|P6|Overall Study|Physician Decision|0
5977598|NCT01076088|20671237|P5|Overall Study|Physician Decision|1
5977599|NCT01076088|20671238|P4|Overall Study|Physician Decision|1
5977600|NCT01076088|20671239|P3|Overall Study|Physician Decision|0
5977601|NCT01076088|20671240|P2|Overall Study|Physician Decision|3
5977602|NCT01076088|20671241|P1|Overall Study|Physician Decision|1
5977603|NCT01076088|20671236|P6|Overall Study|Non-compliance with study drug|0
5977604|NCT01076088|20671237|P5|Overall Study|Non-compliance with study drug|0
5977605|NCT01076088|20671238|P4|Overall Study|Non-compliance with study drug|1
5977606|NCT01076088|20671239|P3|Overall Study|Non-compliance with study drug|0
5977607|NCT01076088|20671240|P2|Overall Study|Non-compliance with study drug|0
5977608|NCT01076088|20671241|P1|Overall Study|Non-compliance with study drug|0
5977609|NCT01076088|20671236|P6|Overall Study|Lost to Follow-up|2
5977610|NCT01076088|20671237|P5|Overall Study|Lost to Follow-up|1
5977611|NCT01076088|20671238|P4|Overall Study|Lost to Follow-up|1
5977612|NCT01076088|20671239|P3|Overall Study|Lost to Follow-up|0
5977613|NCT01076088|20671240|P2|Overall Study|Lost to Follow-up|1
5977614|NCT01076088|20671241|P1|Overall Study|Lost to Follow-up|1
5977615|NCT01076088|20671236|P6|Overall Study|Adverse Event|3
5977616|NCT01076088|20671237|P5|Overall Study|Adverse Event|3
5977617|NCT01076088|20671238|P4|Overall Study|Adverse Event|2
5977618|NCT01076088|20671239|P3|Overall Study|Adverse Event|3
5977619|NCT01076088|20671240|P2|Overall Study|Adverse Event|6
5977620|NCT01076088|20671241|P1|Overall Study|Adverse Event|1
5977621|NCT01076075|20671269|P2|Overall Study|Withdrawal by Subject|19
5977622|NCT01076075|20671270|P1|Overall Study|Withdrawal by Subject|8
5977623|NCT01076075|20671269|P2|Overall Study|Protocol Violation|1
5977624|NCT01076075|20671270|P1|Overall Study|Protocol Violation|0
5977625|NCT01076075|20671269|P2|Overall Study|other|9
5977626|NCT01076075|20671270|P1|Overall Study|other|19
5977627|NCT01076075|20671269|P2|Overall Study|Lost to Follow-up|5
5977628|NCT01076075|20671270|P1|Overall Study|Lost to Follow-up|6
5977629|NCT01076075|20671269|P2|Overall Study|Lack of Efficacy|4
5977630|NCT01076075|20671270|P1|Overall Study|Lack of Efficacy|5
5977631|NCT01076075|20671269|P2|Overall Study|Adverse Event|9
5977632|NCT01076075|20671270|P1|Overall Study|Adverse Event|3
5977633|NCT01076036|20671284|P1|Overall Study|Didn't meet inclusion/exclusion criteria|2
5977634|NCT01076010|20671292|P3|Overall Study|Other|0
5977635|NCT01076010|20671293|P2|Overall Study|Other|2
5977636|NCT01076010|20671294|P1|Overall Study|Other|5
5977637|NCT01076010|20671292|P3|Overall Study|Withdrawal by Subject|1
5977638|NCT01076010|20671293|P2|Overall Study|Withdrawal by Subject|0
5977639|NCT01076010|20671294|P1|Overall Study|Withdrawal by Subject|3
5977640|NCT01076010|20671292|P3|Overall Study|Noncompliance|0
5977641|NCT01076010|20671293|P2|Overall Study|Noncompliance|1
5977642|NCT01076010|20671294|P1|Overall Study|Noncompliance|1
5977643|NCT01076010|20671292|P3|Overall Study|Protocol Violation|0
5977644|NCT01076010|20671293|P2|Overall Study|Protocol Violation|1
5977645|NCT01076010|20671294|P1|Overall Study|Protocol Violation|0
5977646|NCT01076010|20671292|P3|Overall Study|Significant Surgical Procedure|0
5977647|NCT01076010|20671293|P2|Overall Study|Significant Surgical Procedure|1
5977648|NCT01076010|20671294|P1|Overall Study|Significant Surgical Procedure|0
5977649|NCT01076010|20671292|P3|Overall Study|Treatment Interruption for > 2 Weeks|0
5977650|NCT01076010|20671293|P2|Overall Study|Treatment Interruption for > 2 Weeks|1
5977651|NCT01076010|20671294|P1|Overall Study|Treatment Interruption for > 2 Weeks|0
5977652|NCT01076010|20671292|P3|Overall Study|Lack of Efficacy|0
5977653|NCT01076010|20671293|P2|Overall Study|Lack of Efficacy|0
5977654|NCT01076010|20671294|P1|Overall Study|Lack of Efficacy|4
5977655|NCT01076010|20671292|P3|Overall Study|Progressive disease|1
5977656|NCT01076010|20671293|P2|Overall Study|Progressive disease|30
5977657|NCT01076010|20671294|P1|Overall Study|Progressive disease|90
5977658|NCT01076010|20671292|P3|Overall Study|Adverse Event|0
5977659|NCT01076010|20671293|P2|Overall Study|Adverse Event|2
5977660|NCT01076010|20671294|P1|Overall Study|Adverse Event|7
5977661|NCT01076010|20671292|P3|Overall Study|Death|0
5977662|NCT01076010|20671293|P2|Overall Study|Death|1
5977663|NCT01076010|20671294|P1|Overall Study|Death|15
5977664|NCT01075984|20671334|P5|Follow-up Phase|Treatment failure|4
5977665|NCT01075984|20671335|P4|Follow-up Phase|Treatment failure|0
5977666|NCT01075984|20671336|P3|Follow-up Phase|Treatment failure|0
5977667|NCT01075984|20671337|P2|Follow-up Phase|Treatment failure|0
5977668|NCT01075984|20671338|P1|Follow-up Phase|Treatment failure|0
5977669|NCT01075984|20671334|P5|Follow-up Phase|Progression of disease|2
5977670|NCT01075984|20671335|P4|Follow-up Phase|Progression of disease|0
5977671|NCT01075984|20671336|P3|Follow-up Phase|Progression of disease|0
5977672|NCT01075984|20671337|P2|Follow-up Phase|Progression of disease|0
5977673|NCT01075984|20671338|P1|Follow-up Phase|Progression of disease|0
5977674|NCT01075984|20671334|P5|Follow-up Phase|Withdrawal by Subject|10
5977675|NCT01075984|20671335|P4|Follow-up Phase|Withdrawal by Subject|0
5977676|NCT01075984|20671336|P3|Follow-up Phase|Withdrawal by Subject|0
5977677|NCT01075984|20671337|P2|Follow-up Phase|Withdrawal by Subject|0
5977678|NCT01075984|20671338|P1|Follow-up Phase|Withdrawal by Subject|0
5977679|NCT01075984|20671334|P5|Follow-up Phase|Administrative|1
5977680|NCT01075984|20671335|P4|Follow-up Phase|Administrative|0
5977681|NCT01075984|20671336|P3|Follow-up Phase|Administrative|0
5977682|NCT01075984|20671337|P2|Follow-up Phase|Administrative|0
5977683|NCT01075984|20671338|P1|Follow-up Phase|Administrative|0
5977684|NCT01075984|20671334|P5|Follow-up Phase|Adverse Event|27
5977685|NCT01075984|20671335|P4|Follow-up Phase|Adverse Event|2
5977686|NCT01075984|20671336|P3|Follow-up Phase|Adverse Event|0
5977687|NCT01075984|20671337|P2|Follow-up Phase|Adverse Event|0
5977688|NCT01075984|20671338|P1|Follow-up Phase|Adverse Event|0
5977689|NCT01075984|20671334|P5|Follow-up Phase|Protocol Violation|3
5977690|NCT01075984|20671335|P4|Follow-up Phase|Protocol Violation|0
5977691|NCT01075984|20671336|P3|Follow-up Phase|Protocol Violation|1
5977692|NCT01075984|20671337|P2|Follow-up Phase|Protocol Violation|0
5977693|NCT01075984|20671338|P1|Follow-up Phase|Protocol Violation|0
5977694|NCT01075984|20671334|P5|Treatment Phase|Progression of disease|2
5977695|NCT01075984|20671335|P4|Treatment Phase|Progression of disease|0
5977696|NCT01075984|20671336|P3|Treatment Phase|Progression of disease|0
5977697|NCT01075984|20671337|P2|Treatment Phase|Progression of disease|0
5977698|NCT01075984|20671338|P1|Treatment Phase|Progression of disease|0
5977699|NCT01075984|20671334|P5|Treatment Phase|Treatment Failure|5
5977700|NCT01075984|20671335|P4|Treatment Phase|Treatment Failure|0
5977701|NCT01075984|20671336|P3|Treatment Phase|Treatment Failure|1
5977702|NCT01075984|20671337|P2|Treatment Phase|Treatment Failure|0
5977703|NCT01075984|20671338|P1|Treatment Phase|Treatment Failure|0
5977704|NCT01075984|20671334|P5|Treatment Phase|Withdrawal by Subject|15
5977705|NCT01075984|20671335|P4|Treatment Phase|Withdrawal by Subject|0
5977706|NCT01075984|20671336|P3|Treatment Phase|Withdrawal by Subject|2
5977707|NCT01075984|20671337|P2|Treatment Phase|Withdrawal by Subject|0
5977708|NCT01075984|20671338|P1|Treatment Phase|Withdrawal by Subject|0
5977709|NCT01075984|20671334|P5|Treatment Phase|Protocol Violation|3
5977710|NCT01075984|20671335|P4|Treatment Phase|Protocol Violation|0
5977711|NCT01075984|20671336|P3|Treatment Phase|Protocol Violation|1
5977712|NCT01075984|20671337|P2|Treatment Phase|Protocol Violation|0
5977713|NCT01075984|20671338|P1|Treatment Phase|Protocol Violation|0
5977714|NCT01075984|20671334|P5|Treatment Phase|Adverse Event|35
5977715|NCT01075984|20671335|P4|Treatment Phase|Adverse Event|7
5977716|NCT01075984|20671336|P3|Treatment Phase|Adverse Event|3
5977717|NCT01075984|20671337|P2|Treatment Phase|Adverse Event|1
5977718|NCT01075984|20671338|P1|Treatment Phase|Adverse Event|0
5977719|NCT01075958|20671396|P1|Overall Study|Blood sample could not be obtained|44
5977720|NCT01075815|20671412|P2|Overall Study|Withdrawal between OPU - embryo transfer|2
5977721|NCT01075815|20671413|P1|Overall Study|Withdrawal between OPU - embryo transfer|3
5977722|NCT01075815|20671412|P2|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1
5977723|NCT01075815|20671413|P1|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1
5977724|NCT01075815|20671412|P2|Overall Study|Withdrawal before r-hCG administration|1
5977725|NCT01075815|20671413|P1|Overall Study|Withdrawal before r-hCG administration|6
5977726|NCT01075763|20671451|P2|Overall Study|Withdrawal by Subject|2
5977727|NCT01075763|20671452|P1|Overall Study|Withdrawal by Subject|2
5977728|NCT01075763|20671451|P2|Overall Study|Lack of Efficacy|1
5977729|NCT01075763|20671452|P1|Overall Study|Lack of Efficacy|0
5977730|NCT01075763|20671451|P2|Overall Study|Lost to Follow-up|1
5977731|NCT01075763|20671452|P1|Overall Study|Lost to Follow-up|2
5977732|NCT01075685|20671476|P2|Overall Study|Lost to Follow-up|220
5977733|NCT01075685|20671477|P1|Overall Study|Lost to Follow-up|563
5977734|NCT01075685|20671476|P2|Overall Study|Withdrawal by Subject|5
5977735|NCT01075685|20671477|P1|Overall Study|Withdrawal by Subject|20
5977736|NCT01075685|20671476|P2|Overall Study|Protocol Violation|1
5977737|NCT01075685|20671477|P1|Overall Study|Protocol Violation|9
5977738|NCT01075646|20671493|P4|Overall Study|Lost to Follow-up|2
5977739|NCT01075646|20671494|P3|Overall Study|Lost to Follow-up|1
5977740|NCT01075646|20671495|P2|Overall Study|Lost to Follow-up|3
5977741|NCT01075646|20671496|P1|Overall Study|Lost to Follow-up|4
5977742|NCT01075412|20671528|P2|Overall Study|Withdrawal by Subject|1
5977743|NCT01075412|20671529|P1|Overall Study|Withdrawal by Subject|0
5977744|NCT01075321|20671554|P4|Overall Study|Ineligible (miscalculated lab value)|1
5977745|NCT01075321|20671555|P3|Overall Study|Ineligible (miscalculated lab value)|0
5977746|NCT01075321|20671556|P2|Overall Study|Ineligible (miscalculated lab value)|0
5977747|NCT01075321|20671557|P1|Overall Study|Ineligible (miscalculated lab value)|0
5977748|NCT01075321|20671554|P4|Overall Study|Treatment Incomplete due to progression|0
5977749|NCT01075321|20671555|P3|Overall Study|Treatment Incomplete due to progression|0
5977750|NCT01075321|20671556|P2|Overall Study|Treatment Incomplete due to progression|0
5977751|NCT01075321|20671557|P1|Overall Study|Treatment Incomplete due to progression|1
5977752|NCT01075321|20671554|P4|Overall Study|Protocol Violation|0
5977753|NCT01075321|20671555|P3|Overall Study|Protocol Violation|1
5977754|NCT01075321|20671556|P2|Overall Study|Protocol Violation|0
5977755|NCT01075321|20671557|P1|Overall Study|Protocol Violation|0
5977756|NCT01075321|20671554|P4|Overall Study|Withdrawal by Subject|1
5977757|NCT01075321|20671555|P3|Overall Study|Withdrawal by Subject|1
5977758|NCT01075321|20671556|P2|Overall Study|Withdrawal by Subject|0
5977759|NCT01075321|20671557|P1|Overall Study|Withdrawal by Subject|0
5977760|NCT01075282|20671575|P3|Overall Study|Death|2
5977761|NCT01075282|20671576|P2|Overall Study|Death|1
5977762|NCT01075282|20671577|P1|Overall Study|Death|0
5977763|NCT01075282|20671575|P3|Overall Study|Protocol Violation|1
5977764|NCT01075282|20671576|P2|Overall Study|Protocol Violation|2
5977765|NCT01075282|20671577|P1|Overall Study|Protocol Violation|0
5977766|NCT01075282|20671575|P3|Overall Study|Treatment Non-compliance|2
5977767|NCT01075282|20671576|P2|Overall Study|Treatment Non-compliance|2
5977768|NCT01075282|20671577|P1|Overall Study|Treatment Non-compliance|1
5977769|NCT01075282|20671575|P3|Overall Study|Lack of Efficacy|0
5977770|NCT01075282|20671576|P2|Overall Study|Lack of Efficacy|1
5977771|NCT01075282|20671577|P1|Overall Study|Lack of Efficacy|1
5977772|NCT01075282|20671575|P3|Overall Study|Physician Decision|3
5977773|NCT01075282|20671576|P2|Overall Study|Physician Decision|3
5977774|NCT01075282|20671577|P1|Overall Study|Physician Decision|3
5977775|NCT01075282|20671575|P3|Overall Study|Lost to Follow-up|3
5977776|NCT01075282|20671576|P2|Overall Study|Lost to Follow-up|3
5977777|NCT01075282|20671577|P1|Overall Study|Lost to Follow-up|3
5977778|NCT01075282|20671575|P3|Overall Study|Entry Criteria Not Met|0
5977779|NCT01075282|20671576|P2|Overall Study|Entry Criteria Not Met|2
5977780|NCT01075282|20671577|P1|Overall Study|Entry Criteria Not Met|3
5977781|NCT01075282|20671575|P3|Overall Study|Adverse Event|5
5977782|NCT01075282|20671576|P2|Overall Study|Adverse Event|8
5977783|NCT01075282|20671577|P1|Overall Study|Adverse Event|9
5977784|NCT01075282|20671575|P3|Overall Study|Withdrawal by Subject|11
5977785|NCT01075282|20671576|P2|Overall Study|Withdrawal by Subject|7
5977786|NCT01075282|20671577|P1|Overall Study|Withdrawal by Subject|11
5977787|NCT01075256|20671660|P3|Overall Study|Withdrawal by Subject|0
5977788|NCT01075256|20671661|P2|Overall Study|Withdrawal by Subject|0
5977789|NCT01075256|20671662|P1|Overall Study|Withdrawal by Subject|1
5977790|NCT01075243|20671694|P3|Overall Study|Withdrawal by Subject|0
5977791|NCT01075243|20671695|P2|Overall Study|Withdrawal by Subject|1
5977792|NCT01075243|20671696|P1|Overall Study|Withdrawal by Subject|1
5977793|NCT01075243|20671694|P3|Overall Study|Lost to Follow-up|0
5977794|NCT01075243|20671695|P2|Overall Study|Lost to Follow-up|2
5977795|NCT01075243|20671696|P1|Overall Study|Lost to Follow-up|5
5977796|NCT01075217|20671748|P2|Overall Study|Physician Decision|0
5977797|NCT01075217|20671749|P1|Overall Study|Physician Decision|1
5977798|NCT01075217|20671748|P2|Overall Study|Adverse Event|1
5977799|NCT01075217|20671749|P1|Overall Study|Adverse Event|1
5977800|NCT01075191|20671782|P1|Overall Study|Unknown Reasons|1
5977801|NCT01075191|20671782|P1|Overall Study|Patient's Wish|2
5977802|NCT01075191|20671782|P1|Overall Study|Therapy Break|3
5977803|NCT01075191|20671782|P1|Overall Study|Noncompliance|3
5977804|NCT01075191|20671782|P1|Overall Study|Adverse Event|4
5977805|NCT01075191|20671782|P1|Overall Study|Co-morbidities|1
5977806|NCT01075191|20671782|P1|Overall Study|Intensification|3
5977807|NCT01075191|20671782|P1|Overall Study|Death|1
5977808|NCT01075178|20671793|P2|Subject Chart Review|matched partner excluded (reasons above)|3
5977809|NCT01075178|20671794|P1|Subject Chart Review|matched partner excluded (reasons above)|6
5977810|NCT01075178|20671793|P2|Subject Chart Review|no data collected due to site closure|4
5977811|NCT01075178|20671794|P1|Subject Chart Review|no data collected due to site closure|3
5977812|NCT01075178|20671793|P2|Subject Chart Review|died before chart review period|2
5977813|NCT01075178|20671794|P1|Subject Chart Review|died before chart review period|0
5977814|NCT01075178|20671793|P2|Subject Matching|eligible but not matched|403
5977815|NCT01075178|20671794|P1|Subject Matching|eligible but not matched|130
5977816|NCT01075152|20671808|P2|Overall Study|Withdrawal by Subject|0
5977817|NCT01075152|20671809|P1|Overall Study|Withdrawal by Subject|1
5977818|NCT01075100|20671835|P2|Overall Study|Other|1
5977819|NCT01075100|20671836|P1|Overall Study|Other|3
5977820|NCT01075100|20671835|P2|Overall Study|Disease Progression|29
5977821|NCT01075100|20671836|P1|Overall Study|Disease Progression|25
5977822|NCT01075100|20671835|P2|Overall Study|Investigator Request|1
5977823|NCT01075100|20671836|P1|Overall Study|Investigator Request|2
5977824|NCT01075100|20671835|P2|Overall Study|Patient Request|4
5977825|NCT01075100|20671836|P1|Overall Study|Patient Request|4
5977826|NCT01075100|20671835|P2|Overall Study|Adverse Event|18
5977827|NCT01075100|20671836|P1|Overall Study|Adverse Event|15
5977828|NCT01075074|20671866|P3|Overall Study|Surgeon changed to open incisional case|2
5977829|NCT01075074|20671867|P2|Overall Study|Surgeon changed to open incisional case|2
5977830|NCT01075074|20671868|P1|Overall Study|Surgeon changed to open incisional case|1
5977831|NCT01075048|20671888|P3|Overall Study|Lost to Follow-up|1
5977832|NCT01075048|20671889|P2|Overall Study|Lost to Follow-up|1
5977833|NCT01075048|20671890|P1|Overall Study|Lost to Follow-up|0
5977834|NCT01075048|20671888|P3|Overall Study|Withdrawal by Subject|3
5977835|NCT01075048|20671889|P2|Overall Study|Withdrawal by Subject|6
5977836|NCT01075048|20671890|P1|Overall Study|Withdrawal by Subject|1
5977837|NCT01075048|20671888|P3|Overall Study|Start of other or new therapy|46
5977838|NCT01075048|20671889|P2|Overall Study|Start of other or new therapy|36
5977839|NCT01075048|20671890|P1|Overall Study|Start of other or new therapy|4
5977840|NCT01075048|20671888|P3|Overall Study|Death|12
5977841|NCT01075048|20671889|P2|Overall Study|Death|17
5977842|NCT01075048|20671890|P1|Overall Study|Death|4
5977843|NCT01074944|20671913|P5|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|3
5977844|NCT01074944|20671914|P4|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0
5977845|NCT01074944|20671915|P3|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0
5977846|NCT01074944|20671916|P2|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0
5977847|NCT01074944|20671917|P1|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0
5977848|NCT01074944|20671913|P5|Extended Treatment (up to 42 Months)|Pregnancy|2
5977849|NCT01074944|20671914|P4|Extended Treatment (up to 42 Months)|Pregnancy|0
5977850|NCT01074944|20671915|P3|Extended Treatment (up to 42 Months)|Pregnancy|0
5977851|NCT01074944|20671916|P2|Extended Treatment (up to 42 Months)|Pregnancy|0
5977852|NCT01074944|20671917|P1|Extended Treatment (up to 42 Months)|Pregnancy|0
5977853|NCT01074944|20671913|P5|Long Term Treatment|Withdrawal by Subject|0
5977854|NCT01074944|20671914|P4|Long Term Treatment|Withdrawal by Subject|2
5977855|NCT01074944|20671915|P3|Long Term Treatment|Withdrawal by Subject|0
5977856|NCT01074944|20671916|P2|Long Term Treatment|Withdrawal by Subject|0
5977857|NCT01074944|20671917|P1|Long Term Treatment|Withdrawal by Subject|0
5977858|NCT01074944|20671913|P5|Long Term Treatment|Entered in Period, But Not Treated|0
5977859|NCT01074944|20671914|P4|Long Term Treatment|Entered in Period, But Not Treated|1
5977860|NCT01074944|20671915|P3|Long Term Treatment|Entered in Period, But Not Treated|0
5977861|NCT01074944|20671916|P2|Long Term Treatment|Entered in Period, But Not Treated|0
5977862|NCT01074944|20671917|P1|Long Term Treatment|Entered in Period, But Not Treated|0
5977863|NCT01074944|20671913|P5|Long Term Treatment|Transitioned to Commercial Eliglustat|0
5977864|NCT01074944|20671914|P4|Long Term Treatment|Transitioned to Commercial Eliglustat|18
5977865|NCT01074944|20671915|P3|Long Term Treatment|Transitioned to Commercial Eliglustat|0
5977866|NCT01074944|20671916|P2|Long Term Treatment|Transitioned to Commercial Eliglustat|0
5977867|NCT01074944|20671917|P1|Long Term Treatment|Transitioned to Commercial Eliglustat|0
5977868|NCT01074944|20671913|P5|Long Term Treatment|Lost to Follow-up|0
5977869|NCT01074944|20671914|P4|Long Term Treatment|Lost to Follow-up|2
5977870|NCT01074944|20671915|P3|Long Term Treatment|Lost to Follow-up|0
5977871|NCT01074944|20671916|P2|Long Term Treatment|Lost to Follow-up|0
5977872|NCT01074944|20671917|P1|Long Term Treatment|Lost to Follow-up|0
5977873|NCT01074944|20671913|P5|Long Term Treatment|Adverse Event|0
5977874|NCT01074944|20671914|P4|Long Term Treatment|Adverse Event|3
5977875|NCT01074944|20671915|P3|Long Term Treatment|Adverse Event|0
5977876|NCT01074944|20671916|P2|Long Term Treatment|Adverse Event|0
5977877|NCT01074944|20671917|P1|Long Term Treatment|Adverse Event|0
5977878|NCT01074944|20671913|P5|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0
5977879|NCT01074944|20671914|P4|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0
5977880|NCT01074944|20671915|P3|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1
5977881|NCT01074944|20671916|P2|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1
5977882|NCT01074944|20671917|P1|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0
5977883|NCT01074944|20671913|P5|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0
5977884|NCT01074944|20671914|P4|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0
5977885|NCT01074944|20671915|P3|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0
5977886|NCT01074944|20671916|P2|Primary Analysis Period (up to 52 Weeks)|Pregnancy|1
5977887|NCT01074944|20671917|P1|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0
5977888|NCT01074944|20671913|P5|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0
5977889|NCT01074944|20671914|P4|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0
5977890|NCT01074944|20671915|P3|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1
5977891|NCT01074944|20671916|P2|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1
5977892|NCT01074944|20671917|P1|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0
5977893|NCT01074944|20671913|P5|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0
5977894|NCT01074944|20671914|P4|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0
5977895|NCT01074944|20671915|P3|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|1
5977896|NCT01074944|20671916|P2|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|6
5977897|NCT01074944|20671917|P1|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0
5977898|NCT01074944|20671913|P5|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0
5977899|NCT01074944|20671914|P4|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0
5977900|NCT01074944|20671915|P3|Primary Analysis Period (up to 52 Weeks)|Adverse Event|3
5977901|NCT01074944|20671916|P2|Primary Analysis Period (up to 52 Weeks)|Adverse Event|2
5977902|NCT01074944|20671917|P1|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0
5977903|NCT01074944|20671913|P5|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0
5977904|NCT01074944|20671914|P4|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0
5977905|NCT01074944|20671915|P3|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0
5977906|NCT01074944|20671916|P2|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0
5977907|NCT01074944|20671917|P1|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|6
5977908|NCT01074944|20671913|P5|Lead-in Period (up to 78 Weeks)|Pregnancy|0
5977909|NCT01074944|20671914|P4|Lead-in Period (up to 78 Weeks)|Pregnancy|0
5977910|NCT01074944|20671915|P3|Lead-in Period (up to 78 Weeks)|Pregnancy|0
5977911|NCT01074944|20671916|P2|Lead-in Period (up to 78 Weeks)|Pregnancy|0
5977912|NCT01074944|20671917|P1|Lead-in Period (up to 78 Weeks)|Pregnancy|4
5977913|NCT01074944|20671913|P5|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0
5977914|NCT01074944|20671914|P4|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0
5977915|NCT01074944|20671915|P3|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0
5977916|NCT01074944|20671916|P2|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0
5977917|NCT01074944|20671917|P1|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|1
5977918|NCT01074944|20671913|P5|Lead-in Period (up to 78 Weeks)|Adverse Event|0
5977919|NCT01074944|20671914|P4|Lead-in Period (up to 78 Weeks)|Adverse Event|0
5977920|NCT01074944|20671915|P3|Lead-in Period (up to 78 Weeks)|Adverse Event|0
5977921|NCT01074944|20671916|P2|Lead-in Period (up to 78 Weeks)|Adverse Event|0
5977922|NCT01074944|20671917|P1|Lead-in Period (up to 78 Weeks)|Adverse Event|2
5977923|NCT01074931|20671971|P1|Overall Study|Death|5
5977924|NCT01074931|20671971|P1|Overall Study|Economic reasons|1
5977925|NCT01074658|20671983|P1|Overall Study|No implant attempted|19
5977926|NCT01074554|20671991|P2|Overall Study|Lost to Follow-up|1
5977927|NCT01074554|20671992|P1|Overall Study|Lost to Follow-up|0
5977928|NCT01074554|20671991|P2|Overall Study|Adverse Event|3
5977929|NCT01074554|20671992|P1|Overall Study|Adverse Event|3
5977930|NCT01074502|20672002|P1|Overall Study|Withdrawal by Subject|1
5977931|NCT01074450|20672026|P2|Second Intervention|Physician Decision|1
5977932|NCT01074450|20672027|P1|Second Intervention|Physician Decision|0
5977933|NCT01074450|20672026|P2|Second Intervention|Protocol Violation|0
5977934|NCT01074450|20672027|P1|Second Intervention|Protocol Violation|1
5977935|NCT01074450|20672026|P2|First Intervention|Emesis in Dosing Interval|2
5977936|NCT01074450|20672027|P1|First Intervention|Emesis in Dosing Interval|0
5977937|NCT01074307|20672056|P2|Overall Study|Protocol Violation|5
5977938|NCT01074307|20672057|P1|Overall Study|Protocol Violation|8
5977939|NCT01074307|20672056|P2|Overall Study|Exclusion criterion|1
5977940|NCT01074307|20672057|P1|Overall Study|Exclusion criterion|0
5977941|NCT01074307|20672056|P2|Overall Study|No primary endpoint evaluation|6
5977942|NCT01074307|20672057|P1|Overall Study|No primary endpoint evaluation|14
5977943|NCT01074268|20672079|P2|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|2
5977944|NCT01074268|20672080|P1|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|3
5977945|NCT01074268|20672079|P2|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2
5977946|NCT01074268|20672080|P1|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2
5977947|NCT01074268|20672079|P2|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|2
5977948|NCT01074268|20672080|P1|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|0
5977949|NCT01074268|20672079|P2|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1
5977950|NCT01074268|20672080|P1|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1
5977951|NCT01074268|20672079|P2|Main: Week 0 to 26 (NN1250-3585)|Unclassified|5
5977952|NCT01074268|20672080|P1|Main: Week 0 to 26 (NN1250-3585)|Unclassified|8
5977953|NCT01074268|20672079|P2|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|3
5977954|NCT01074268|20672080|P1|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|6
5977955|NCT01074268|20672079|P2|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|4
5977956|NCT01074268|20672080|P1|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|3
5977957|NCT01074268|20672079|P2|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|2
5977958|NCT01074268|20672080|P1|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|0
5977959|NCT01074268|20672079|P2|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|1
5977960|NCT01074268|20672080|P1|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|3
5977961|NCT01074255|20672106|P1|Overall Study|Did not receive EMEND|2
5977962|NCT01074242|20672110|P1|Overall Study|Duplicate Case Report Form|5
5977963|NCT01074242|20672110|P1|Overall Study|Violation of vaccine dose or dosage|351
5977964|NCT01074242|20672110|P1|Overall Study|Case report unclear|6
5977965|NCT01074242|20672110|P1|Overall Study|Lost to Follow-up|1
5977966|NCT01074242|20672110|P1|Overall Study|Case report before date of contract|40
5977967|NCT01074229|20672118|P3|Overall Study|Change to open surgical procedure|4
5977968|NCT01074229|20672119|P2|Overall Study|Change to open surgical procedure|3
5977969|NCT01074229|20672120|P1|Overall Study|Change to open surgical procedure|1
5977970|NCT01074229|20672118|P3|Overall Study|Lost to Follow-up|0
5977971|NCT01074229|20672119|P2|Overall Study|Lost to Follow-up|0
5977972|NCT01074229|20672120|P1|Overall Study|Lost to Follow-up|1
5977973|NCT01074216|20672131|P1|Overall Study|Not Treated|12
5977974|NCT01074216|20672131|P1|Overall Study|Physician Decision|1
5977975|NCT01074047|20672195|P2|Extension Phase|Death|0
5977976|NCT01074047|20672196|P1|Extension Phase|Death|5
5977977|NCT01074047|20672195|P2|Extension Phase|Withdrawal by Subject|0
5977978|NCT01074047|20672196|P1|Extension Phase|Withdrawal by Subject|2
5977979|NCT01074047|20672195|P2|Extension Phase|Disease Progression|0
5977980|NCT01074047|20672196|P1|Extension Phase|Disease Progression|9
5977981|NCT01074047|20672195|P2|Extension Phase|Adverse Event|0
5977982|NCT01074047|20672196|P1|Extension Phase|Adverse Event|5
5977983|NCT01074047|20672195|P2|Extension Phase|Physician Decision|0
5977984|NCT01074047|20672196|P1|Extension Phase|Physician Decision|1
5977985|NCT01074047|20672195|P2|Survival Follow-Up Phase|Alive at study closure|3
5977986|NCT01074047|20672196|P1|Survival Follow-Up Phase|Alive at study closure|1
5977987|NCT01074047|20672195|P2|Survival Follow-Up Phase|Death|124
5977988|NCT01074047|20672196|P1|Survival Follow-Up Phase|Death|116
5977989|NCT01074047|20672195|P2|Survival Follow-Up Phase|Lost to Follow-up|1
5977990|NCT01074047|20672196|P1|Survival Follow-Up Phase|Lost to Follow-up|2
5977991|NCT01074047|20672195|P2|Survival Follow-Up Phase|Withdrawal by Subject|8
5977992|NCT01074047|20672196|P1|Survival Follow-Up Phase|Withdrawal by Subject|5
5977993|NCT01074047|20672195|P2|Treatment Phase|Miscellaneous|39
5977994|NCT01074047|20672196|P1|Treatment Phase|Miscellaneous|32
5977995|NCT01074047|20672195|P2|Treatment Phase|Protocol Violation|1
5977996|NCT01074047|20672196|P1|Treatment Phase|Protocol Violation|0
5977997|NCT01074047|20672195|P2|Treatment Phase|Lost to Follow-up|1
5977998|NCT01074047|20672196|P1|Treatment Phase|Lost to Follow-up|0
5977999|NCT01074047|20672195|P2|Treatment Phase|Death|58
5978000|NCT01074047|20672196|P1|Treatment Phase|Death|53
5978001|NCT01074047|20672195|P2|Treatment Phase|Withdrawal by Subject|48
5978002|NCT01074047|20672196|P1|Treatment Phase|Withdrawal by Subject|27
5978003|NCT01074047|20672195|P2|Treatment Phase|Disease Progression|21
5978004|NCT01074047|20672196|P1|Treatment Phase|Disease Progression|16
5978005|NCT01074047|20672195|P2|Treatment Phase|Adverse Event|66
5978006|NCT01074047|20672196|P1|Treatment Phase|Adverse Event|89
5978007|NCT01074008|20672284|P9|Overall Study|Lost to Follow-up|4
5978008|NCT01074008|20672285|P8|Overall Study|Lost to Follow-up|0
5978009|NCT01074008|20672286|P7|Overall Study|Lost to Follow-up|1
5978010|NCT01074008|20672287|P6|Overall Study|Lost to Follow-up|0
5978011|NCT01074008|20672288|P5|Overall Study|Lost to Follow-up|1
5978012|NCT01074008|20672289|P4|Overall Study|Lost to Follow-up|1
5978013|NCT01074008|20672290|P3|Overall Study|Lost to Follow-up|1
5978014|NCT01074008|20672291|P2|Overall Study|Lost to Follow-up|1
5978015|NCT01074008|20672292|P1|Overall Study|Lost to Follow-up|0
5978016|NCT01074008|20672284|P9|Overall Study|Withdrawal by Subject|0
5978017|NCT01074008|20672285|P8|Overall Study|Withdrawal by Subject|0
5978018|NCT01074008|20672286|P7|Overall Study|Withdrawal by Subject|0
5978019|NCT01074008|20672287|P6|Overall Study|Withdrawal by Subject|0
5978020|NCT01074008|20672288|P5|Overall Study|Withdrawal by Subject|1
5978021|NCT01074008|20672289|P4|Overall Study|Withdrawal by Subject|0
5978022|NCT01074008|20672290|P3|Overall Study|Withdrawal by Subject|1
5978023|NCT01074008|20672291|P2|Overall Study|Withdrawal by Subject|1
5978024|NCT01074008|20672292|P1|Overall Study|Withdrawal by Subject|1
5978025|NCT01074008|20672284|P9|Overall Study|Adverse Event|0
5978026|NCT01074008|20672285|P8|Overall Study|Adverse Event|0
5978027|NCT01074008|20672286|P7|Overall Study|Adverse Event|0
5978028|NCT01074008|20672287|P6|Overall Study|Adverse Event|0
5978029|NCT01074008|20672288|P5|Overall Study|Adverse Event|0
5978030|NCT01074008|20672289|P4|Overall Study|Adverse Event|0
5978031|NCT01074008|20672290|P3|Overall Study|Adverse Event|0
5978032|NCT01074008|20672291|P2|Overall Study|Adverse Event|1
5978033|NCT01074008|20672292|P1|Overall Study|Adverse Event|0
5978034|NCT01073943|20672402|P2|Overall Study|Could not tolerate prep|0
5978035|NCT01073943|20672403|P1|Overall Study|Could not tolerate prep|1
5978036|NCT01073943|20672402|P2|Overall Study|Unable to return for follow-up|1
5978037|NCT01073943|20672403|P1|Overall Study|Unable to return for follow-up|0
5978038|NCT01073943|20672402|P2|Overall Study|Subject forgot|1
5978039|NCT01073943|20672403|P1|Overall Study|Subject forgot|0
5978040|NCT01073943|20672402|P2|Overall Study|Power outage; colonoscopy not done|0
5978041|NCT01073943|20672403|P1|Overall Study|Power outage; colonoscopy not done|1
5978042|NCT01073943|20672402|P2|Overall Study|Lost to Follow-up|2
5978043|NCT01073943|20672403|P1|Overall Study|Lost to Follow-up|0
5978044|NCT01073943|20672402|P2|Overall Study|Adverse Event|1
5978045|NCT01073943|20672403|P1|Overall Study|Adverse Event|1
5978046|NCT01073943|20672402|P2|Overall Study|Protocol Violation|1
5978047|NCT01073943|20672403|P1|Overall Study|Protocol Violation|2
5978048|NCT01073943|20672402|P2|Overall Study|Withdrawal by Subject|2
5978049|NCT01073943|20672403|P1|Overall Study|Withdrawal by Subject|8
5978050|NCT01073930|20672429|P2|Overall Study|Inadequate prep; unable to do procedure|1
5978051|NCT01073930|20672430|P1|Overall Study|Inadequate prep; unable to do procedure|0
5978052|NCT01073930|20672429|P2|Overall Study|Noncompliance with study drug|1
5978053|NCT01073930|20672430|P1|Overall Study|Noncompliance with study drug|0
5978054|NCT01073930|20672429|P2|Overall Study|Adverse Event|1
5978055|NCT01073930|20672430|P1|Overall Study|Adverse Event|0
5978056|NCT01073930|20672429|P2|Overall Study|Lost to Follow-up|1
5978057|NCT01073930|20672430|P1|Overall Study|Lost to Follow-up|0
5978058|NCT01073930|20672429|P2|Overall Study|Withdrawal by Subject|2
5978059|NCT01073930|20672430|P1|Overall Study|Withdrawal by Subject|3
5978060|NCT01073865|20672454|P2|Overall Study|Withdrawal by Subject|5
5978061|NCT01073865|20672455|P1|Overall Study|Withdrawal by Subject|5
5978062|NCT01073865|20672454|P2|Overall Study|Death|2
5978063|NCT01073865|20672455|P1|Overall Study|Death|3
5978064|NCT01073865|20672454|P2|Overall Study|Lost to Follow-up|1
5978065|NCT01073865|20672455|P1|Overall Study|Lost to Follow-up|1
5978066|NCT01073865|20672454|P2|Overall Study|Reasons other than below|31
5978067|NCT01073865|20672455|P1|Overall Study|Reasons other than below|19
5978068|NCT01073631|20672474|P1|Overall Study|Other|63
5978069|NCT01073631|20672474|P1|Overall Study|Adverse Event|24
5978070|NCT01073631|20672474|P1|Overall Study|Death|82
5978071|NCT01073618|20672479|P1|Overall Study|Other|80
5978072|NCT01073618|20672479|P1|Overall Study|Adverse Event|19
5978073|NCT01073618|20672479|P1|Overall Study|Death|208
5978074|NCT01073605|20672487|P3|Overall Study|Randomized But Not Treated|1
5978075|NCT01073605|20672488|P2|Overall Study|Randomized But Not Treated|1
5978076|NCT01073605|20672489|P1|Overall Study|Randomized But Not Treated|0
5978077|NCT01073605|20672487|P3|Overall Study|Withdrawal by Subject|22
5978078|NCT01073605|20672488|P2|Overall Study|Withdrawal by Subject|39
5978079|NCT01073605|20672489|P1|Overall Study|Withdrawal by Subject|31
5978080|NCT01073605|20672487|P3|Overall Study|Other|29
5978081|NCT01073605|20672488|P2|Overall Study|Other|21
5978082|NCT01073605|20672489|P1|Overall Study|Other|25
5978083|NCT01073605|20672487|P3|Overall Study|Lost to Follow-up|9
5978084|NCT01073605|20672488|P2|Overall Study|Lost to Follow-up|4
5978085|NCT01073605|20672489|P1|Overall Study|Lost to Follow-up|3
5978086|NCT01073605|20672487|P3|Overall Study|Adverse Event|0
5978087|NCT01073605|20672488|P2|Overall Study|Adverse Event|1
5978088|NCT01073605|20672489|P1|Overall Study|Adverse Event|2
5978089|NCT01073605|20672487|P3|Overall Study|Ongoing at Cutoff Date|0
5978090|NCT01073605|20672488|P2|Overall Study|Ongoing at Cutoff Date|1
5978091|NCT01073605|20672489|P1|Overall Study|Ongoing at Cutoff Date|1
5978092|NCT01073566|20672535|P2|Period 2 (6 Weeks)|Adverse Event|0
5978093|NCT01073566|20672536|P1|Period 2 (6 Weeks)|Adverse Event|1
5978094|NCT01073462|20672548|P1|Overall Study|Lost to Follow-up|7
5978095|NCT01073462|20672548|P1|Overall Study|Serious adverse event|2
5978096|NCT01073462|20672548|P1|Overall Study|Low parathyroid hormone levels|8
5978097|NCT01073462|20672548|P1|Overall Study|Kidney transplant|10
5978098|NCT01073462|20672548|P1|Overall Study|Death|14
5978099|NCT01073293|20672567|P2|Overall Study|Withdrawal by Subject|10
5978100|NCT01073293|20672568|P1|Overall Study|Withdrawal by Subject|5
5978101|NCT01073293|20672567|P2|Overall Study|Lost to Follow-up|1
5978102|NCT01073293|20672568|P1|Overall Study|Lost to Follow-up|0
5978103|NCT01073267|20672590|P1|Overall Study|Disease Progression|3
5978104|NCT01073163|20672594|P1|Overall Study|Early termination|1
5978105|NCT01073163|20672594|P1|Overall Study|Disease Progression|1
5978106|NCT01073163|20672594|P1|Overall Study|Adverse Event|1
5978107|NCT01072929|20672617|P3|Overall Study|Other|0
5978108|NCT01072929|20672618|P2|Overall Study|Other|3
5978109|NCT01072929|20672619|P1|Overall Study|Other|0
5978110|NCT01072929|20672617|P3|Overall Study|Noncompliance with study procedures|1
5978111|NCT01072929|20672618|P2|Overall Study|Noncompliance with study procedures|0
5978112|NCT01072929|20672619|P1|Overall Study|Noncompliance with study procedures|1
5978113|NCT01072929|20672617|P3|Overall Study|Noncompliance with study medication|0
5978114|NCT01072929|20672618|P2|Overall Study|Noncompliance with study medication|3
5978115|NCT01072929|20672619|P1|Overall Study|Noncompliance with study medication|0
5978116|NCT01072929|20672617|P3|Overall Study|Lost to Follow-up|1
5978117|NCT01072929|20672618|P2|Overall Study|Lost to Follow-up|4
5978118|NCT01072929|20672619|P1|Overall Study|Lost to Follow-up|8
5978119|NCT01072929|20672617|P3|Overall Study|Protocol Violation|2
5978120|NCT01072929|20672618|P2|Overall Study|Protocol Violation|11
5978121|NCT01072929|20672619|P1|Overall Study|Protocol Violation|13
5978122|NCT01072929|20672617|P3|Overall Study|Withdrawal by Subject|3
5978123|NCT01072929|20672618|P2|Overall Study|Withdrawal by Subject|15
5978124|NCT01072929|20672619|P1|Overall Study|Withdrawal by Subject|7
5978125|NCT01072929|20672617|P3|Overall Study|Lack of Efficacy|0
5978126|NCT01072929|20672618|P2|Overall Study|Lack of Efficacy|4
5978127|NCT01072929|20672619|P1|Overall Study|Lack of Efficacy|7
5978128|NCT01072929|20672617|P3|Overall Study|Adverse Event|2
5978129|NCT01072929|20672618|P2|Overall Study|Adverse Event|11
5978130|NCT01072929|20672619|P1|Overall Study|Adverse Event|8
5978131|NCT01072877|20672698|P5|Overall Study|Lost to Follow-up|0
5978132|NCT01072877|20672699|P4|Overall Study|Lost to Follow-up|2
5978133|NCT01072877|20672700|P3|Overall Study|Lost to Follow-up|0
5978134|NCT01072877|20672701|P2|Overall Study|Lost to Follow-up|1
5978135|NCT01072877|20672702|P1|Overall Study|Lost to Follow-up|1
5978136|NCT01072630|20672781|P3|Overall Study|Other|1
5978137|NCT01072630|20672782|P2|Overall Study|Other|2
5978138|NCT01072630|20672783|P1|Overall Study|Other|3
5978139|NCT01072630|20672781|P3|Overall Study|Noncompliance with study procedures|1
5978140|NCT01072630|20672782|P2|Overall Study|Noncompliance with study procedures|2
5978141|NCT01072630|20672783|P1|Overall Study|Noncompliance with study procedures|1
5978142|NCT01072630|20672781|P3|Overall Study|Noncompliance with study medication|1
5978143|NCT01072630|20672782|P2|Overall Study|Noncompliance with study medication|1
5978144|NCT01072630|20672783|P1|Overall Study|Noncompliance with study medication|1
5978145|NCT01072630|20672781|P3|Overall Study|Lost to Follow-up|1
5978146|NCT01072630|20672782|P2|Overall Study|Lost to Follow-up|11
5978147|NCT01072630|20672783|P1|Overall Study|Lost to Follow-up|11
5978148|NCT01072630|20672781|P3|Overall Study|Protocol Violation|4
5978149|NCT01072630|20672782|P2|Overall Study|Protocol Violation|8
5978150|NCT01072630|20672783|P1|Overall Study|Protocol Violation|10
5978151|NCT01072630|20672781|P3|Overall Study|Withdrawal by Subject|2
5978152|NCT01072630|20672782|P2|Overall Study|Withdrawal by Subject|7
5978153|NCT01072630|20672783|P1|Overall Study|Withdrawal by Subject|8
5978154|NCT01072630|20672781|P3|Overall Study|Lack of Efficacy|1
5978155|NCT01072630|20672782|P2|Overall Study|Lack of Efficacy|10
5978156|NCT01072630|20672783|P1|Overall Study|Lack of Efficacy|10
5978157|NCT01072630|20672781|P3|Overall Study|Adverse Event|2
5978158|NCT01072630|20672782|P2|Overall Study|Adverse Event|19
5978159|NCT01072630|20672783|P1|Overall Study|Adverse Event|11
5978160|NCT01072539|20672864|P1|Overall Study|Protocol Violation|2
5978161|NCT01072539|20672864|P1|Overall Study|Treated prior to the Site Initiation|1
5978162|NCT01072500|20672888|P2|Overall Study|Withdrawal by Subject|10
5978163|NCT01072500|20672889|P1|Overall Study|Withdrawal by Subject|17
5978164|NCT01072500|20672888|P2|Overall Study|Lost to Follow-up|2
5978165|NCT01072500|20672889|P1|Overall Study|Lost to Follow-up|5
5978166|NCT01072500|20672888|P2|Overall Study|Death|2
5978167|NCT01072500|20672889|P1|Overall Study|Death|2
5978168|NCT01072448|20672899|P2|Overall Study|Death|2
5978169|NCT01072448|20672900|P1|Overall Study|Death|0
5978170|NCT01072448|20672899|P2|Overall Study|Abnormal laboratory value(s)|1
5978171|NCT01072448|20672900|P1|Overall Study|Abnormal laboratory value(s)|0
5978172|NCT01072448|20672899|P2|Overall Study|Lost to Follow-up|1
5978173|NCT01072448|20672900|P1|Overall Study|Lost to Follow-up|1
5978174|NCT01072448|20672899|P2|Overall Study|Unsatisfactory therapeutic effect|3
5978175|NCT01072448|20672900|P1|Overall Study|Unsatisfactory therapeutic effect|1
5978176|NCT01072448|20672899|P2|Overall Study|Abnormal test procedure result(s)|0
5978177|NCT01072448|20672900|P1|Overall Study|Abnormal test procedure result(s)|1
5978178|NCT01072448|20672899|P2|Overall Study|Protocol deviation|4
5978179|NCT01072448|20672900|P1|Overall Study|Protocol deviation|3
5978180|NCT01072448|20672899|P2|Overall Study|Subject withdrew consent|9
5978181|NCT01072448|20672900|P1|Overall Study|Subject withdrew consent|4
5978182|NCT01072448|20672899|P2|Overall Study|Adverse Event|10
5978183|NCT01072448|20672900|P1|Overall Study|Adverse Event|9
5978184|NCT01072396|20672914|P2|Period Two|Lost to Follow-up|0
5978185|NCT01072396|20672915|P1|Period Two|Lost to Follow-up|1
5978186|NCT01072396|20672914|P2|Period Two|Adverse Event|3
5978187|NCT01072396|20672915|P1|Period Two|Adverse Event|0
5978188|NCT01072396|20672914|P2|Washout Period|Missing termination information|1
5978189|NCT01072396|20672915|P1|Washout Period|Missing termination information|0
5978190|NCT01072396|20672914|P2|Period One|Withdrawal by Subject|0
5978191|NCT01072396|20672915|P1|Period One|Withdrawal by Subject|2
5978192|NCT01072396|20672914|P2|Period One|Protocol Violation|1
5978193|NCT01072396|20672915|P1|Period One|Protocol Violation|2
5978194|NCT01072396|20672914|P2|Period One|Adverse Event|1
5978195|NCT01072396|20672915|P1|Period One|Adverse Event|1
5978196|NCT01072357|20672927|P2|Overall Study|Lost to Follow-up|1
5978197|NCT01072357|20672928|P1|Overall Study|Lost to Follow-up|0
5978198|NCT01072344|20672938|P2|Overall Study|Lost to Follow-up|4
5978199|NCT01072344|20672939|P1|Overall Study|Lost to Follow-up|3
5978200|NCT01072344|20672938|P2|Overall Study|Protocol Violation|2
5978201|NCT01072344|20672939|P1|Overall Study|Protocol Violation|1
5978202|NCT01072344|20672938|P2|Overall Study|Relasped-reached end point|12
5978203|NCT01072344|20672939|P1|Overall Study|Relasped-reached end point|7
5978204|NCT01072201|20672977|P2|Overall Study|Lost to Follow-up|1
5978205|NCT01072201|20672978|P1|Overall Study|Lost to Follow-up|0
5978206|NCT01072175|20673011|P13|Part D (HPMC Capsules)|Withdrawal by Subject|0
5978207|NCT01072175|20673012|P12|Part D (HPMC Capsules)|Withdrawal by Subject|3
5978208|NCT01072175|20673013|P11|Part D (HPMC Capsules)|Withdrawal by Subject|1
5978209|NCT01072175|20673014|P10|Part D (HPMC Capsules)|Withdrawal by Subject|0
5978210|NCT01072175|20673015|P9|Part D (HPMC Capsules)|Withdrawal by Subject|0
5978211|NCT01072175|20673016|P8|Part D (HPMC Capsules)|Withdrawal by Subject|0
5978212|NCT01072175|20673017|P7|Part D (HPMC Capsules)|Withdrawal by Subject|0
5978213|NCT01072175|20673018|P6|Part D (HPMC Capsules)|Withdrawal by Subject|0
5978214|NCT01072175|20673019|P5|Part D (HPMC Capsules)|Withdrawal by Subject|0
5978215|NCT01072175|20673020|P4|Part D (HPMC Capsules)|Withdrawal by Subject|0
5978216|NCT01072175|20673021|P3|Part D (HPMC Capsules)|Withdrawal by Subject|0
5978217|NCT01072175|20673022|P2|Part D (HPMC Capsules)|Withdrawal by Subject|0
5978218|NCT01072175|20673023|P1|Part D (HPMC Capsules)|Withdrawal by Subject|0
5978219|NCT01072175|20673011|P13|Part D (HPMC Capsules)|Study closed/terminated|9
5978220|NCT01072175|20673012|P12|Part D (HPMC Capsules)|Study closed/terminated|10
5978221|NCT01072175|20673013|P11|Part D (HPMC Capsules)|Study closed/terminated|1
5978222|NCT01072175|20673014|P10|Part D (HPMC Capsules)|Study closed/terminated|2
5978223|NCT01072175|20673015|P9|Part D (HPMC Capsules)|Study closed/terminated|0
5978224|NCT01072175|20673016|P8|Part D (HPMC Capsules)|Study closed/terminated|0
5978225|NCT01072175|20673017|P7|Part D (HPMC Capsules)|Study closed/terminated|0
5978226|NCT01072175|20673018|P6|Part D (HPMC Capsules)|Study closed/terminated|0
5978227|NCT01072175|20673019|P5|Part D (HPMC Capsules)|Study closed/terminated|0
5978228|NCT01072175|20673020|P4|Part D (HPMC Capsules)|Study closed/terminated|0
5978229|NCT01072175|20673021|P3|Part D (HPMC Capsules)|Study closed/terminated|0
5978230|NCT01072175|20673022|P2|Part D (HPMC Capsules)|Study closed/terminated|0
5978231|NCT01072175|20673023|P1|Part D (HPMC Capsules)|Study closed/terminated|0
5978232|NCT01072175|20673011|P13|Part D (HPMC Capsules)|Lost to Follow-up|3
5978233|NCT01072175|20673012|P12|Part D (HPMC Capsules)|Lost to Follow-up|1
5978234|NCT01072175|20673013|P11|Part D (HPMC Capsules)|Lost to Follow-up|1
5978235|NCT01072175|20673014|P10|Part D (HPMC Capsules)|Lost to Follow-up|0
5978236|NCT01072175|20673015|P9|Part D (HPMC Capsules)|Lost to Follow-up|0
5978237|NCT01072175|20673016|P8|Part D (HPMC Capsules)|Lost to Follow-up|0
5978238|NCT01072175|20673017|P7|Part D (HPMC Capsules)|Lost to Follow-up|0
5978239|NCT01072175|20673018|P6|Part D (HPMC Capsules)|Lost to Follow-up|0
5978240|NCT01072175|20673019|P5|Part D (HPMC Capsules)|Lost to Follow-up|0
5978241|NCT01072175|20673020|P4|Part D (HPMC Capsules)|Lost to Follow-up|0
5978242|NCT01072175|20673021|P3|Part D (HPMC Capsules)|Lost to Follow-up|0
5978243|NCT01072175|20673022|P2|Part D (HPMC Capsules)|Lost to Follow-up|0
5978244|NCT01072175|20673023|P1|Part D (HPMC Capsules)|Lost to Follow-up|0
5978245|NCT01072175|20673011|P13|Part D (HPMC Capsules)|Physician Decision|1
5978246|NCT01072175|20673012|P12|Part D (HPMC Capsules)|Physician Decision|1
5978247|NCT01072175|20673013|P11|Part D (HPMC Capsules)|Physician Decision|1
5978248|NCT01072175|20673014|P10|Part D (HPMC Capsules)|Physician Decision|0
5978249|NCT01072175|20673015|P9|Part D (HPMC Capsules)|Physician Decision|0
5978250|NCT01072175|20673016|P8|Part D (HPMC Capsules)|Physician Decision|0
5978251|NCT01072175|20673017|P7|Part D (HPMC Capsules)|Physician Decision|0
5978252|NCT01072175|20673018|P6|Part D (HPMC Capsules)|Physician Decision|0
5978253|NCT01072175|20673019|P5|Part D (HPMC Capsules)|Physician Decision|0
5978254|NCT01072175|20673020|P4|Part D (HPMC Capsules)|Physician Decision|0
5978255|NCT01072175|20673021|P3|Part D (HPMC Capsules)|Physician Decision|0
5978256|NCT01072175|20673022|P2|Part D (HPMC Capsules)|Physician Decision|0
5978257|NCT01072175|20673023|P1|Part D (HPMC Capsules)|Physician Decision|0
5978258|NCT01072175|20673011|P13|Part D (HPMC Capsules)|Death|26
5978259|NCT01072175|20673012|P12|Part D (HPMC Capsules)|Death|28
5978260|NCT01072175|20673013|P11|Part D (HPMC Capsules)|Death|12
5978261|NCT01072175|20673014|P10|Part D (HPMC Capsules)|Death|10
5978262|NCT01072175|20673015|P9|Part D (HPMC Capsules)|Death|0
5978263|NCT01072175|20673016|P8|Part D (HPMC Capsules)|Death|0
5978264|NCT01072175|20673017|P7|Part D (HPMC Capsules)|Death|0
5978265|NCT01072175|20673018|P6|Part D (HPMC Capsules)|Death|0
5978266|NCT01072175|20673019|P5|Part D (HPMC Capsules)|Death|0
5978267|NCT01072175|20673020|P4|Part D (HPMC Capsules)|Death|0
5978268|NCT01072175|20673021|P3|Part D (HPMC Capsules)|Death|0
5978269|NCT01072175|20673022|P2|Part D (HPMC Capsules)|Death|0
5978270|NCT01072175|20673023|P1|Part D (HPMC Capsules)|Death|0
5978271|NCT01072175|20673011|P13|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
5978272|NCT01072175|20673012|P12|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
5978273|NCT01072175|20673013|P11|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
5978274|NCT01072175|20673014|P10|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
5978275|NCT01072175|20673015|P9|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|3
5978276|NCT01072175|20673016|P8|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
5978277|NCT01072175|20673017|P7|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
5978278|NCT01072175|20673018|P6|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
5978279|NCT01072175|20673019|P5|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
5978280|NCT01072175|20673020|P4|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
5978281|NCT01072175|20673021|P3|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
5978282|NCT01072175|20673022|P2|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
5978283|NCT01072175|20673023|P1|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
5978284|NCT01072175|20673011|P13|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
5978285|NCT01072175|20673012|P12|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
5978286|NCT01072175|20673013|P11|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
5978287|NCT01072175|20673014|P10|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
5978288|NCT01072175|20673015|P9|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|4
5978289|NCT01072175|20673016|P8|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
5978290|NCT01072175|20673017|P7|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
5978291|NCT01072175|20673018|P6|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
5978292|NCT01072175|20673019|P5|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
5978293|NCT01072175|20673020|P4|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
5978294|NCT01072175|20673021|P3|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
5978295|NCT01072175|20673022|P2|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
5978296|NCT01072175|20673023|P1|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
5978297|NCT01072175|20673011|P13|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
5978298|NCT01072175|20673012|P12|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
5978299|NCT01072175|20673013|P11|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
5978300|NCT01072175|20673014|P10|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
5978301|NCT01072175|20673015|P9|Part C (Phase II: Crossover Phase [CP])|Physician Decision|1
5978302|NCT01072175|20673016|P8|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
5978303|NCT01072175|20673017|P7|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
5978304|NCT01072175|20673018|P6|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
5978305|NCT01072175|20673019|P5|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
5978306|NCT01072175|20673020|P4|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
5978307|NCT01072175|20673021|P3|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
5978308|NCT01072175|20673022|P2|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
5978309|NCT01072175|20673023|P1|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
5978310|NCT01072175|20673011|P13|Part C (Phase II: Crossover Phase [CP])|Death|0
5978311|NCT01072175|20673012|P12|Part C (Phase II: Crossover Phase [CP])|Death|0
5978312|NCT01072175|20673013|P11|Part C (Phase II: Crossover Phase [CP])|Death|0
5978313|NCT01072175|20673014|P10|Part C (Phase II: Crossover Phase [CP])|Death|0
5978314|NCT01072175|20673015|P9|Part C (Phase II: Crossover Phase [CP])|Death|37
5978315|NCT01072175|20673016|P8|Part C (Phase II: Crossover Phase [CP])|Death|0
5978316|NCT01072175|20673017|P7|Part C (Phase II: Crossover Phase [CP])|Death|0
5978317|NCT01072175|20673018|P6|Part C (Phase II: Crossover Phase [CP])|Death|0
5978318|NCT01072175|20673019|P5|Part C (Phase II: Crossover Phase [CP])|Death|0
5978319|NCT01072175|20673020|P4|Part C (Phase II: Crossover Phase [CP])|Death|0
5978320|NCT01072175|20673021|P3|Part C (Phase II: Crossover Phase [CP])|Death|0
5978321|NCT01072175|20673022|P2|Part C (Phase II: Crossover Phase [CP])|Death|0
5978322|NCT01072175|20673023|P1|Part C (Phase II: Crossover Phase [CP])|Death|0
5978323|NCT01072175|20673011|P13|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
5978324|NCT01072175|20673012|P12|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
5978325|NCT01072175|20673013|P11|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
5978326|NCT01072175|20673014|P10|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
5978327|NCT01072175|20673015|P9|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
5978328|NCT01072175|20673016|P8|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
5978329|NCT01072175|20673017|P7|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|7
5978330|NCT01072175|20673018|P6|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|3
5978331|NCT01072175|20673019|P5|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
5978332|NCT01072175|20673020|P4|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
5978333|NCT01072175|20673021|P3|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
5978334|NCT01072175|20673022|P2|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
5978335|NCT01072175|20673023|P1|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
5978336|NCT01072175|20673011|P13|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
5978337|NCT01072175|20673012|P12|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
5978338|NCT01072175|20673013|P11|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
5978339|NCT01072175|20673014|P10|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
5978340|NCT01072175|20673015|P9|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
5978341|NCT01072175|20673016|P8|Part C (Phase II: Randomized Phase)|Study closed/terminated|11
5978342|NCT01072175|20673017|P7|Part C (Phase II: Randomized Phase)|Study closed/terminated|9
5978343|NCT01072175|20673018|P6|Part C (Phase II: Randomized Phase)|Study closed/terminated|6
5978344|NCT01072175|20673019|P5|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
5978345|NCT01072175|20673020|P4|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
5978346|NCT01072175|20673021|P3|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
5978347|NCT01072175|20673022|P2|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
5978348|NCT01072175|20673023|P1|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
5978349|NCT01072175|20673011|P13|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
5978350|NCT01072175|20673012|P12|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
5978351|NCT01072175|20673013|P11|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
5978352|NCT01072175|20673014|P10|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
5978353|NCT01072175|20673015|P9|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
5978354|NCT01072175|20673016|P8|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3
5978355|NCT01072175|20673017|P7|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3
5978356|NCT01072175|20673018|P6|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
5978357|NCT01072175|20673019|P5|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
5978358|NCT01072175|20673020|P4|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
5978359|NCT01072175|20673021|P3|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
5978360|NCT01072175|20673022|P2|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
5978361|NCT01072175|20673023|P1|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
5978362|NCT01072175|20673011|P13|Part C (Phase II: Randomized Phase)|Physician Decision|0
5978363|NCT01072175|20673012|P12|Part C (Phase II: Randomized Phase)|Physician Decision|0
5978364|NCT01072175|20673013|P11|Part C (Phase II: Randomized Phase)|Physician Decision|0
5978365|NCT01072175|20673014|P10|Part C (Phase II: Randomized Phase)|Physician Decision|0
5978366|NCT01072175|20673015|P9|Part C (Phase II: Randomized Phase)|Physician Decision|0
5978367|NCT01072175|20673016|P8|Part C (Phase II: Randomized Phase)|Physician Decision|1
5978368|NCT01072175|20673017|P7|Part C (Phase II: Randomized Phase)|Physician Decision|1
5978369|NCT01072175|20673018|P6|Part C (Phase II: Randomized Phase)|Physician Decision|1
5978370|NCT01072175|20673019|P5|Part C (Phase II: Randomized Phase)|Physician Decision|0
5978371|NCT01072175|20673020|P4|Part C (Phase II: Randomized Phase)|Physician Decision|0
5978372|NCT01072175|20673021|P3|Part C (Phase II: Randomized Phase)|Physician Decision|0
5978373|NCT01072175|20673022|P2|Part C (Phase II: Randomized Phase)|Physician Decision|0
5978374|NCT01072175|20673023|P1|Part C (Phase II: Randomized Phase)|Physician Decision|0
5978375|NCT01072175|20673011|P13|Part C (Phase II: Randomized Phase)|Death|0
5978376|NCT01072175|20673012|P12|Part C (Phase II: Randomized Phase)|Death|0
5978377|NCT01072175|20673013|P11|Part C (Phase II: Randomized Phase)|Death|0
5978378|NCT01072175|20673014|P10|Part C (Phase II: Randomized Phase)|Death|0
5978379|NCT01072175|20673015|P9|Part C (Phase II: Randomized Phase)|Death|0
5978380|NCT01072175|20673016|P8|Part C (Phase II: Randomized Phase)|Death|39
5978381|NCT01072175|20673017|P7|Part C (Phase II: Randomized Phase)|Death|34
5978382|NCT01072175|20673018|P6|Part C (Phase II: Randomized Phase)|Death|44
5978383|NCT01072175|20673019|P5|Part C (Phase II: Randomized Phase)|Death|0
5978384|NCT01072175|20673020|P4|Part C (Phase II: Randomized Phase)|Death|0
5978385|NCT01072175|20673021|P3|Part C (Phase II: Randomized Phase)|Death|0
5978386|NCT01072175|20673022|P2|Part C (Phase II: Randomized Phase)|Death|0
5978387|NCT01072175|20673023|P1|Part C (Phase II: Randomized Phase)|Death|0
5978388|NCT01072175|20673011|P13|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
5978389|NCT01072175|20673012|P12|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
5978390|NCT01072175|20673013|P11|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
5978391|NCT01072175|20673014|P10|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
5978392|NCT01072175|20673015|P9|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
5978393|NCT01072175|20673016|P8|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
5978394|NCT01072175|20673017|P7|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
5978395|NCT01072175|20673018|P6|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
5978396|NCT01072175|20673019|P5|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|6
5978397|NCT01072175|20673020|P4|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|3
5978398|NCT01072175|20673021|P3|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
5978399|NCT01072175|20673022|P2|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|1
5978400|NCT01072175|20673023|P1|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
5978401|NCT01072175|20673011|P13|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
5978402|NCT01072175|20673012|P12|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
5978403|NCT01072175|20673013|P11|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
5978404|NCT01072175|20673014|P10|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
5978405|NCT01072175|20673015|P9|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
5978406|NCT01072175|20673016|P8|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
5978407|NCT01072175|20673017|P7|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
5978408|NCT01072175|20673018|P6|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
5978409|NCT01072175|20673019|P5|Part B (Dose Escalation and Expansion)|Study closed/terminated|10
5978410|NCT01072175|20673020|P4|Part B (Dose Escalation and Expansion)|Study closed/terminated|2
5978411|NCT01072175|20673021|P3|Part B (Dose Escalation and Expansion)|Study closed/terminated|3
5978412|NCT01072175|20673022|P2|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
5978413|NCT01072175|20673023|P1|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
5978414|NCT01072175|20673011|P13|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
5978415|NCT01072175|20673012|P12|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
5978416|NCT01072175|20673013|P11|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
5978417|NCT01072175|20673014|P10|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
5978418|NCT01072175|20673015|P9|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
5978419|NCT01072175|20673016|P8|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
5978420|NCT01072175|20673017|P7|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
5978421|NCT01072175|20673018|P6|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
5978422|NCT01072175|20673019|P5|Part B (Dose Escalation and Expansion)|Lost to Follow-up|6
5978423|NCT01072175|20673020|P4|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1
5978424|NCT01072175|20673021|P3|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
5978425|NCT01072175|20673022|P2|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1
5978426|NCT01072175|20673023|P1|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
5978427|NCT01072175|20673011|P13|Part B (Dose Escalation and Expansion)|Physician Decision|0
5978428|NCT01072175|20673012|P12|Part B (Dose Escalation and Expansion)|Physician Decision|0
5978429|NCT01072175|20673013|P11|Part B (Dose Escalation and Expansion)|Physician Decision|0
5978430|NCT01072175|20673014|P10|Part B (Dose Escalation and Expansion)|Physician Decision|0
5978431|NCT01072175|20673015|P9|Part B (Dose Escalation and Expansion)|Physician Decision|0
5978432|NCT01072175|20673016|P8|Part B (Dose Escalation and Expansion)|Physician Decision|0
5978433|NCT01072175|20673017|P7|Part B (Dose Escalation and Expansion)|Physician Decision|0
5978434|NCT01072175|20673018|P6|Part B (Dose Escalation and Expansion)|Physician Decision|0
5978435|NCT01072175|20673019|P5|Part B (Dose Escalation and Expansion)|Physician Decision|4
5978436|NCT01072175|20673020|P4|Part B (Dose Escalation and Expansion)|Physician Decision|0
5978437|NCT01072175|20673021|P3|Part B (Dose Escalation and Expansion)|Physician Decision|2
5978438|NCT01072175|20673022|P2|Part B (Dose Escalation and Expansion)|Physician Decision|0
5978439|NCT01072175|20673023|P1|Part B (Dose Escalation and Expansion)|Physician Decision|0
5978440|NCT01072175|20673011|P13|Part B (Dose Escalation and Expansion)|Death|0
5978441|NCT01072175|20673012|P12|Part B (Dose Escalation and Expansion)|Death|0
5978442|NCT01072175|20673013|P11|Part B (Dose Escalation and Expansion)|Death|0
5978443|NCT01072175|20673014|P10|Part B (Dose Escalation and Expansion)|Death|0
5978444|NCT01072175|20673015|P9|Part B (Dose Escalation and Expansion)|Death|0
5978445|NCT01072175|20673016|P8|Part B (Dose Escalation and Expansion)|Death|0
5978446|NCT01072175|20673017|P7|Part B (Dose Escalation and Expansion)|Death|0
5978447|NCT01072175|20673018|P6|Part B (Dose Escalation and Expansion)|Death|0
5978448|NCT01072175|20673019|P5|Part B (Dose Escalation and Expansion)|Death|68
5978449|NCT01072175|20673020|P4|Part B (Dose Escalation and Expansion)|Death|21
5978450|NCT01072175|20673021|P3|Part B (Dose Escalation and Expansion)|Death|18
5978451|NCT01072175|20673022|P2|Part B (Dose Escalation and Expansion)|Death|4
5978452|NCT01072175|20673023|P1|Part B (Dose Escalation and Expansion)|Death|0
5978453|NCT01072175|20673011|P13|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
5978454|NCT01072175|20673012|P12|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
5978455|NCT01072175|20673013|P11|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
5978456|NCT01072175|20673014|P10|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
5978457|NCT01072175|20673015|P9|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
5978458|NCT01072175|20673016|P8|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
5978459|NCT01072175|20673017|P7|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
5978460|NCT01072175|20673018|P6|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
5978461|NCT01072175|20673019|P5|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
5978462|NCT01072175|20673020|P4|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
5978463|NCT01072175|20673021|P3|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
5978464|NCT01072175|20673022|P2|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
5978465|NCT01072175|20673023|P1|Part A (Drug-Drug Interaction)|Withdrawal by Subject|1
5978466|NCT01072175|20673011|P13|Part A (Drug-Drug Interaction)|Physician Decision|0
5978467|NCT01072175|20673012|P12|Part A (Drug-Drug Interaction)|Physician Decision|0
5978468|NCT01072175|20673013|P11|Part A (Drug-Drug Interaction)|Physician Decision|0
5978469|NCT01072175|20673014|P10|Part A (Drug-Drug Interaction)|Physician Decision|0
5978470|NCT01072175|20673015|P9|Part A (Drug-Drug Interaction)|Physician Decision|0
5978471|NCT01072175|20673016|P8|Part A (Drug-Drug Interaction)|Physician Decision|0
5978472|NCT01072175|20673017|P7|Part A (Drug-Drug Interaction)|Physician Decision|0
5978473|NCT01072175|20673018|P6|Part A (Drug-Drug Interaction)|Physician Decision|0
5978474|NCT01072175|20673019|P5|Part A (Drug-Drug Interaction)|Physician Decision|0
5978475|NCT01072175|20673020|P4|Part A (Drug-Drug Interaction)|Physician Decision|0
5978476|NCT01072175|20673021|P3|Part A (Drug-Drug Interaction)|Physician Decision|0
5978477|NCT01072175|20673022|P2|Part A (Drug-Drug Interaction)|Physician Decision|0
5978478|NCT01072175|20673023|P1|Part A (Drug-Drug Interaction)|Physician Decision|6
5978479|NCT01072175|20673011|P13|Part A (Drug-Drug Interaction)|Death|0
5978480|NCT01072175|20673012|P12|Part A (Drug-Drug Interaction)|Death|0
5978481|NCT01072175|20673013|P11|Part A (Drug-Drug Interaction)|Death|0
5978482|NCT01072175|20673014|P10|Part A (Drug-Drug Interaction)|Death|0
5978483|NCT01072175|20673015|P9|Part A (Drug-Drug Interaction)|Death|0
5978484|NCT01072175|20673016|P8|Part A (Drug-Drug Interaction)|Death|0
5978485|NCT01072175|20673017|P7|Part A (Drug-Drug Interaction)|Death|0
5978486|NCT01072175|20673018|P6|Part A (Drug-Drug Interaction)|Death|0
5978487|NCT01072175|20673019|P5|Part A (Drug-Drug Interaction)|Death|0
5978488|NCT01072175|20673020|P4|Part A (Drug-Drug Interaction)|Death|0
5978489|NCT01072175|20673021|P3|Part A (Drug-Drug Interaction)|Death|0
5978490|NCT01072175|20673022|P2|Part A (Drug-Drug Interaction)|Death|0
5978491|NCT01072175|20673023|P1|Part A (Drug-Drug Interaction)|Death|1
5978492|NCT01072149|20673232|P18|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
5978493|NCT01072149|20673233|P17|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
5978494|NCT01072149|20673234|P16|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
5978495|NCT01072149|20673235|P15|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
5978496|NCT01072149|20673236|P14|Treatment Period 3 (28 Days)|Withdrawal by Subject|1
5978497|NCT01072149|20673237|P13|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
5978498|NCT01072149|20673238|P12|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
5978499|NCT01072149|20673239|P11|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
5978500|NCT01072149|20673240|P10|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
5978501|NCT01072149|20673241|P9|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
5978502|NCT01072149|20673242|P8|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
5978503|NCT01072149|20673243|P7|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
5978504|NCT01072149|20673244|P6|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
5978505|NCT01072149|20673245|P5|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
5978506|NCT01072149|20673246|P4|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
5978507|NCT01072149|20673247|P3|Treatment Period 3 (28 Days)|Withdrawal by Subject|1
5978508|NCT01072149|20673248|P2|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
5978509|NCT01072149|20673249|P1|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
5978510|NCT01072149|20673232|P18|Washout Period 2 (14 Days)|Lack of Efficacy|0
5978511|NCT01072149|20673233|P17|Washout Period 2 (14 Days)|Lack of Efficacy|0
5978512|NCT01072149|20673234|P16|Washout Period 2 (14 Days)|Lack of Efficacy|0
5978513|NCT01072149|20673235|P15|Washout Period 2 (14 Days)|Lack of Efficacy|0
5978514|NCT01072149|20673236|P14|Washout Period 2 (14 Days)|Lack of Efficacy|0
5978515|NCT01072149|20673237|P13|Washout Period 2 (14 Days)|Lack of Efficacy|1
5978516|NCT01072149|20673238|P12|Washout Period 2 (14 Days)|Lack of Efficacy|0
5978517|NCT01072149|20673239|P11|Washout Period 2 (14 Days)|Lack of Efficacy|0
5978518|NCT01072149|20673240|P10|Washout Period 2 (14 Days)|Lack of Efficacy|0
5978519|NCT01072149|20673241|P9|Washout Period 2 (14 Days)|Lack of Efficacy|0
5978520|NCT01072149|20673242|P8|Washout Period 2 (14 Days)|Lack of Efficacy|0
5978521|NCT01072149|20673243|P7|Washout Period 2 (14 Days)|Lack of Efficacy|0
5978522|NCT01072149|20673244|P6|Washout Period 2 (14 Days)|Lack of Efficacy|0
5978523|NCT01072149|20673245|P5|Washout Period 2 (14 Days)|Lack of Efficacy|0
5978524|NCT01072149|20673246|P4|Washout Period 2 (14 Days)|Lack of Efficacy|0
5978525|NCT01072149|20673247|P3|Washout Period 2 (14 Days)|Lack of Efficacy|0
5978526|NCT01072149|20673248|P2|Washout Period 2 (14 Days)|Lack of Efficacy|0
5978527|NCT01072149|20673249|P1|Washout Period 2 (14 Days)|Lack of Efficacy|0
5978528|NCT01072149|20673232|P18|Washout Period 2 (14 Days)|Adverse Event|0
5978529|NCT01072149|20673233|P17|Washout Period 2 (14 Days)|Adverse Event|0
5978530|NCT01072149|20673234|P16|Washout Period 2 (14 Days)|Adverse Event|1
5978531|NCT01072149|20673235|P15|Washout Period 2 (14 Days)|Adverse Event|0
5978532|NCT01072149|20673236|P14|Washout Period 2 (14 Days)|Adverse Event|0
5978533|NCT01072149|20673237|P13|Washout Period 2 (14 Days)|Adverse Event|0
5978534|NCT01072149|20673238|P12|Washout Period 2 (14 Days)|Adverse Event|0
5978535|NCT01072149|20673239|P11|Washout Period 2 (14 Days)|Adverse Event|0
5978536|NCT01072149|20673240|P10|Washout Period 2 (14 Days)|Adverse Event|0
5978537|NCT01072149|20673241|P9|Washout Period 2 (14 Days)|Adverse Event|0
5978538|NCT01072149|20673242|P8|Washout Period 2 (14 Days)|Adverse Event|0
5978539|NCT01072149|20673243|P7|Washout Period 2 (14 Days)|Adverse Event|0
5978540|NCT01072149|20673244|P6|Washout Period 2 (14 Days)|Adverse Event|0
5978541|NCT01072149|20673245|P5|Washout Period 2 (14 Days)|Adverse Event|0
5978542|NCT01072149|20673246|P4|Washout Period 2 (14 Days)|Adverse Event|0
5978543|NCT01072149|20673247|P3|Washout Period 2 (14 Days)|Adverse Event|0
5978544|NCT01072149|20673248|P2|Washout Period 2 (14 Days)|Adverse Event|0
5978545|NCT01072149|20673249|P1|Washout Period 2 (14 Days)|Adverse Event|0
5978546|NCT01072149|20673232|P18|Washout Period 2 (14 Days)|Withdrawal by Subject|0
5978547|NCT01072149|20673233|P17|Washout Period 2 (14 Days)|Withdrawal by Subject|0
5978548|NCT01072149|20673234|P16|Washout Period 2 (14 Days)|Withdrawal by Subject|1
5978549|NCT01072149|20673235|P15|Washout Period 2 (14 Days)|Withdrawal by Subject|0
5978550|NCT01072149|20673236|P14|Washout Period 2 (14 Days)|Withdrawal by Subject|0
5978551|NCT01072149|20673237|P13|Washout Period 2 (14 Days)|Withdrawal by Subject|0
5978552|NCT01072149|20673238|P12|Washout Period 2 (14 Days)|Withdrawal by Subject|0
5978553|NCT01072149|20673239|P11|Washout Period 2 (14 Days)|Withdrawal by Subject|0
5978554|NCT01072149|20673240|P10|Washout Period 2 (14 Days)|Withdrawal by Subject|0
5978555|NCT01072149|20673241|P9|Washout Period 2 (14 Days)|Withdrawal by Subject|0
5978556|NCT01072149|20673242|P8|Washout Period 2 (14 Days)|Withdrawal by Subject|0
5978557|NCT01072149|20673243|P7|Washout Period 2 (14 Days)|Withdrawal by Subject|0
5978558|NCT01072149|20673244|P6|Washout Period 2 (14 Days)|Withdrawal by Subject|0
5978559|NCT01072149|20673245|P5|Washout Period 2 (14 Days)|Withdrawal by Subject|0
5978560|NCT01072149|20673246|P4|Washout Period 2 (14 Days)|Withdrawal by Subject|0
5978561|NCT01072149|20673247|P3|Washout Period 2 (14 Days)|Withdrawal by Subject|0
5978562|NCT01072149|20673248|P2|Washout Period 2 (14 Days)|Withdrawal by Subject|0
5978563|NCT01072149|20673249|P1|Washout Period 2 (14 Days)|Withdrawal by Subject|0
5978564|NCT01072149|20673232|P18|Washout Period 2 (14 Days)|Physician Decision|0
5978565|NCT01072149|20673233|P17|Washout Period 2 (14 Days)|Physician Decision|0
5978566|NCT01072149|20673234|P16|Washout Period 2 (14 Days)|Physician Decision|0
5978567|NCT01072149|20673235|P15|Washout Period 2 (14 Days)|Physician Decision|0
5978568|NCT01072149|20673236|P14|Washout Period 2 (14 Days)|Physician Decision|0
5978569|NCT01072149|20673237|P13|Washout Period 2 (14 Days)|Physician Decision|0
5978570|NCT01072149|20673238|P12|Washout Period 2 (14 Days)|Physician Decision|0
5978571|NCT01072149|20673239|P11|Washout Period 2 (14 Days)|Physician Decision|0
5978572|NCT01072149|20673240|P10|Washout Period 2 (14 Days)|Physician Decision|0
5978573|NCT01072149|20673241|P9|Washout Period 2 (14 Days)|Physician Decision|0
5978574|NCT01072149|20673242|P8|Washout Period 2 (14 Days)|Physician Decision|0
5978575|NCT01072149|20673243|P7|Washout Period 2 (14 Days)|Physician Decision|0
5978576|NCT01072149|20673244|P6|Washout Period 2 (14 Days)|Physician Decision|0
5978577|NCT01072149|20673245|P5|Washout Period 2 (14 Days)|Physician Decision|0
5978578|NCT01072149|20673246|P4|Washout Period 2 (14 Days)|Physician Decision|0
5978579|NCT01072149|20673247|P3|Washout Period 2 (14 Days)|Physician Decision|0
5978580|NCT01072149|20673248|P2|Washout Period 2 (14 Days)|Physician Decision|0
5978581|NCT01072149|20673249|P1|Washout Period 2 (14 Days)|Physician Decision|1
5978582|NCT01072149|20673232|P18|Treatment Period 2 (28 Days)|Physician Decision|0
5978583|NCT01072149|20673233|P17|Treatment Period 2 (28 Days)|Physician Decision|0
5978584|NCT01072149|20673234|P16|Treatment Period 2 (28 Days)|Physician Decision|0
5978585|NCT01072149|20673235|P15|Treatment Period 2 (28 Days)|Physician Decision|0
5978586|NCT01072149|20673236|P14|Treatment Period 2 (28 Days)|Physician Decision|0
5978587|NCT01072149|20673237|P13|Treatment Period 2 (28 Days)|Physician Decision|0
5978588|NCT01072149|20673238|P12|Treatment Period 2 (28 Days)|Physician Decision|0
5978589|NCT01072149|20673239|P11|Treatment Period 2 (28 Days)|Physician Decision|0
5978590|NCT01072149|20673240|P10|Treatment Period 2 (28 Days)|Physician Decision|0
5978591|NCT01072149|20673241|P9|Treatment Period 2 (28 Days)|Physician Decision|0
5978592|NCT01072149|20673242|P8|Treatment Period 2 (28 Days)|Physician Decision|1
5978593|NCT01072149|20673243|P7|Treatment Period 2 (28 Days)|Physician Decision|0
5978594|NCT01072149|20673244|P6|Treatment Period 2 (28 Days)|Physician Decision|0
5978595|NCT01072149|20673245|P5|Treatment Period 2 (28 Days)|Physician Decision|0
5978596|NCT01072149|20673246|P4|Treatment Period 2 (28 Days)|Physician Decision|0
5978597|NCT01072149|20673247|P3|Treatment Period 2 (28 Days)|Physician Decision|0
5978598|NCT01072149|20673248|P2|Treatment Period 2 (28 Days)|Physician Decision|0
5978599|NCT01072149|20673249|P1|Treatment Period 2 (28 Days)|Physician Decision|0
5978600|NCT01072149|20673232|P18|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
5978601|NCT01072149|20673233|P17|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
5978602|NCT01072149|20673234|P16|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
5978603|NCT01072149|20673235|P15|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
5978604|NCT01072149|20673236|P14|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
5978605|NCT01072149|20673237|P13|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
5978606|NCT01072149|20673238|P12|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
5978607|NCT01072149|20673239|P11|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
5978608|NCT01072149|20673240|P10|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
5978609|NCT01072149|20673241|P9|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
5978610|NCT01072149|20673242|P8|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
5978611|NCT01072149|20673243|P7|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
5978612|NCT01072149|20673244|P6|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
5978613|NCT01072149|20673245|P5|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
5978614|NCT01072149|20673246|P4|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
5978615|NCT01072149|20673247|P3|Treatment Period 2 (28 Days)|Withdrawal by Subject|1
5978616|NCT01072149|20673248|P2|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
5978617|NCT01072149|20673249|P1|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
5978618|NCT01072149|20673232|P18|Treatment Period 2 (28 Days)|Lost to Follow-up|0
5978619|NCT01072149|20673233|P17|Treatment Period 2 (28 Days)|Lost to Follow-up|0
5978620|NCT01072149|20673234|P16|Treatment Period 2 (28 Days)|Lost to Follow-up|0
5978621|NCT01072149|20673235|P15|Treatment Period 2 (28 Days)|Lost to Follow-up|0
5978622|NCT01072149|20673236|P14|Treatment Period 2 (28 Days)|Lost to Follow-up|0
5978623|NCT01072149|20673237|P13|Treatment Period 2 (28 Days)|Lost to Follow-up|0
5978624|NCT01072149|20673238|P12|Treatment Period 2 (28 Days)|Lost to Follow-up|0
5978625|NCT01072149|20673239|P11|Treatment Period 2 (28 Days)|Lost to Follow-up|0
5978626|NCT01072149|20673240|P10|Treatment Period 2 (28 Days)|Lost to Follow-up|0
5978627|NCT01072149|20673241|P9|Treatment Period 2 (28 Days)|Lost to Follow-up|0
5978628|NCT01072149|20673242|P8|Treatment Period 2 (28 Days)|Lost to Follow-up|0
5978629|NCT01072149|20673243|P7|Treatment Period 2 (28 Days)|Lost to Follow-up|0
5978630|NCT01072149|20673244|P6|Treatment Period 2 (28 Days)|Lost to Follow-up|0
5978631|NCT01072149|20673245|P5|Treatment Period 2 (28 Days)|Lost to Follow-up|0
5978632|NCT01072149|20673246|P4|Treatment Period 2 (28 Days)|Lost to Follow-up|0
5978633|NCT01072149|20673247|P3|Treatment Period 2 (28 Days)|Lost to Follow-up|0
5978634|NCT01072149|20673248|P2|Treatment Period 2 (28 Days)|Lost to Follow-up|1
5978635|NCT01072149|20673249|P1|Treatment Period 2 (28 Days)|Lost to Follow-up|0
5978636|NCT01072149|20673232|P18|Treatment Period 1 (28 Days)|Lost to Follow-up|0
5978637|NCT01072149|20673233|P17|Treatment Period 1 (28 Days)|Lost to Follow-up|0
5978638|NCT01072149|20673234|P16|Treatment Period 1 (28 Days)|Lost to Follow-up|0
5978639|NCT01072149|20673235|P15|Treatment Period 1 (28 Days)|Lost to Follow-up|0
5978640|NCT01072149|20673236|P14|Treatment Period 1 (28 Days)|Lost to Follow-up|0
5978641|NCT01072149|20673237|P13|Treatment Period 1 (28 Days)|Lost to Follow-up|0
5978642|NCT01072149|20673238|P12|Treatment Period 1 (28 Days)|Lost to Follow-up|0
5978643|NCT01072149|20673239|P11|Treatment Period 1 (28 Days)|Lost to Follow-up|1
5978644|NCT01072149|20673240|P10|Treatment Period 1 (28 Days)|Lost to Follow-up|0
5978645|NCT01072149|20673241|P9|Treatment Period 1 (28 Days)|Lost to Follow-up|0
5978646|NCT01072149|20673242|P8|Treatment Period 1 (28 Days)|Lost to Follow-up|0
5978647|NCT01072149|20673243|P7|Treatment Period 1 (28 Days)|Lost to Follow-up|0
5978648|NCT01072149|20673244|P6|Treatment Period 1 (28 Days)|Lost to Follow-up|0
5978649|NCT01072149|20673245|P5|Treatment Period 1 (28 Days)|Lost to Follow-up|0
5978650|NCT01072149|20673246|P4|Treatment Period 1 (28 Days)|Lost to Follow-up|0
5978651|NCT01072149|20673247|P3|Treatment Period 1 (28 Days)|Lost to Follow-up|0
5978652|NCT01072149|20673248|P2|Treatment Period 1 (28 Days)|Lost to Follow-up|0
5978653|NCT01072149|20673249|P1|Treatment Period 1 (28 Days)|Lost to Follow-up|0
5978654|NCT01072149|20673232|P18|Treatment Period 1 (28 Days)|Protocol Violation|1
5978655|NCT01072149|20673233|P17|Treatment Period 1 (28 Days)|Protocol Violation|0
5978656|NCT01072149|20673234|P16|Treatment Period 1 (28 Days)|Protocol Violation|0
5978657|NCT01072149|20673235|P15|Treatment Period 1 (28 Days)|Protocol Violation|0
5978658|NCT01072149|20673236|P14|Treatment Period 1 (28 Days)|Protocol Violation|0
5978659|NCT01072149|20673237|P13|Treatment Period 1 (28 Days)|Protocol Violation|0
5978660|NCT01072149|20673238|P12|Treatment Period 1 (28 Days)|Protocol Violation|0
5978661|NCT01072149|20673239|P11|Treatment Period 1 (28 Days)|Protocol Violation|0
5978662|NCT01072149|20673240|P10|Treatment Period 1 (28 Days)|Protocol Violation|0
5978663|NCT01072149|20673241|P9|Treatment Period 1 (28 Days)|Protocol Violation|0
5978664|NCT01072149|20673242|P8|Treatment Period 1 (28 Days)|Protocol Violation|0
5978665|NCT01072149|20673243|P7|Treatment Period 1 (28 Days)|Protocol Violation|0
5978666|NCT01072149|20673244|P6|Treatment Period 1 (28 Days)|Protocol Violation|0
5978667|NCT01072149|20673245|P5|Treatment Period 1 (28 Days)|Protocol Violation|0
5978668|NCT01072149|20673246|P4|Treatment Period 1 (28 Days)|Protocol Violation|0
5978669|NCT01072149|20673247|P3|Treatment Period 1 (28 Days)|Protocol Violation|0
5978670|NCT01072149|20673248|P2|Treatment Period 1 (28 Days)|Protocol Violation|0
5978671|NCT01072149|20673249|P1|Treatment Period 1 (28 Days)|Protocol Violation|0
5978672|NCT01072149|20673232|P18|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
5978673|NCT01072149|20673233|P17|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
5978674|NCT01072149|20673234|P16|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
5978675|NCT01072149|20673235|P15|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
5978676|NCT01072149|20673236|P14|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
5978677|NCT01072149|20673237|P13|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
5978678|NCT01072149|20673238|P12|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
5978679|NCT01072149|20673239|P11|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
5978680|NCT01072149|20673240|P10|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
5978681|NCT01072149|20673241|P9|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
5978682|NCT01072149|20673242|P8|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
5978683|NCT01072149|20673243|P7|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
5978684|NCT01072149|20673244|P6|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
5978685|NCT01072149|20673245|P5|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
5978686|NCT01072149|20673246|P4|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
5978687|NCT01072149|20673247|P3|Treatment Period 1 (28 Days)|Withdrawal by Subject|1
5978688|NCT01072149|20673248|P2|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
5978689|NCT01072149|20673249|P1|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
5978690|NCT01071954|20673338|P1|Overall Study|Protocol Specified Criteria|1
5978691|NCT01071954|20673338|P1|Overall Study|Administrative Decision|5
5978692|NCT01071954|20673338|P1|Overall Study|Requirement for Alternative Therapy|5
5978693|NCT01071954|20673338|P1|Overall Study|Withdrawal by Subject|11
5978694|NCT01071954|20673338|P1|Overall Study|Adverse Event|1
5978695|NCT01071954|20673338|P1|Overall Study|Noncompliance|4
5978696|NCT01071915|20673347|P1|Overall Study|Miscellaneous Reasons|2
5978697|NCT01071915|20673347|P1|Overall Study|Withdrawal by Subject|2
5978698|NCT01071915|20673347|P1|Overall Study|Physician Decision|2
5978699|NCT01071915|20673347|P1|Overall Study|Adverse Event|3
5978700|NCT01071798|20673357|P1|Subpopulation Who Received Two Cycles|Patient Requirement|7
5978701|NCT01071798|20673357|P1|Subpopulation Who Received Two Cycles|Lack of Tolerability|4
5978702|NCT01071798|20673357|P1|Subpopulation Who Received Two Cycles|Lack of Efficacy|3
5978703|NCT01071798|20673357|P1|Subpopulation Who Received Two Cycles|Remission|1
5978704|NCT01071798|20673357|P1|Participants Who Received One Cycle|Severe concomitant disease|2
5978705|NCT01071798|20673357|P1|Participants Who Received One Cycle|Change of therapy|6
5978706|NCT01071798|20673357|P1|Participants Who Received One Cycle|Death|5
5978707|NCT01071798|20673357|P1|Participants Who Received One Cycle|Patient requirement|20
5978708|NCT01071798|20673357|P1|Participants Who Received One Cycle|Lack of tolerability|14
5978709|NCT01071798|20673357|P1|Participants Who Received One Cycle|Lack of Efficacy|18
5978710|NCT01071512|20673387|P1|Overall Study|positive anti-JC virus antibody test|2
5978711|NCT01071512|20673387|P1|Overall Study|Development of antibodies to drug|2
5978712|NCT01071512|20673387|P1|Overall Study|Adverse Event|1
5978713|NCT01071395|20673397|P2|Overall Study|Adverse Event|1
5978714|NCT01071395|20673398|P1|Overall Study|Adverse Event|3
5978715|NCT01071395|20673397|P2|Overall Study|Withdrawal by Subject|1
5978716|NCT01071395|20673398|P1|Overall Study|Withdrawal by Subject|2
5978717|NCT01071317|20673417|P2|Overall Study|Lost to Follow-up|2
5978718|NCT01071317|20673418|P1|Overall Study|Lost to Follow-up|2
5978719|NCT01071278|20673430|P1|Overall Study|Completion Status Unknown|459
5978720|NCT01071278|20673430|P1|Overall Study|Premature Discontinuation|254
5978721|NCT01071252|20673441|P5|Overall Study|Death|1
5978722|NCT01071252|20673442|P4|Overall Study|Death|0
5978723|NCT01071252|20673443|P3|Overall Study|Death|0
5978724|NCT01071252|20673444|P2|Overall Study|Death|0
5978725|NCT01071252|20673445|P1|Overall Study|Death|0
5978726|NCT01071252|20673441|P5|Overall Study|Adverse Event|0
5978727|NCT01071252|20673442|P4|Overall Study|Adverse Event|1
5978728|NCT01071252|20673443|P3|Overall Study|Adverse Event|0
5978729|NCT01071252|20673444|P2|Overall Study|Adverse Event|1
5978730|NCT01071252|20673445|P1|Overall Study|Adverse Event|1
5978731|NCT01071252|20673441|P5|Overall Study|Lost to Follow-up|0
5978732|NCT01071252|20673442|P4|Overall Study|Lost to Follow-up|2
5978733|NCT01071252|20673443|P3|Overall Study|Lost to Follow-up|1
5978734|NCT01071252|20673444|P2|Overall Study|Lost to Follow-up|0
5978735|NCT01071252|20673445|P1|Overall Study|Lost to Follow-up|1
5978736|NCT01071252|20673441|P5|Overall Study|administrative problems|1
5978737|NCT01071252|20673442|P4|Overall Study|administrative problems|2
5978738|NCT01071252|20673443|P3|Overall Study|administrative problems|0
5978739|NCT01071252|20673444|P2|Overall Study|administrative problems|1
5978740|NCT01071252|20673445|P1|Overall Study|administrative problems|1
5978741|NCT01071252|20673441|P5|Overall Study|Withdrawal by Subject|3
5978742|NCT01071252|20673442|P4|Overall Study|Withdrawal by Subject|2
5978743|NCT01071252|20673443|P3|Overall Study|Withdrawal by Subject|1
5978744|NCT01071252|20673444|P2|Overall Study|Withdrawal by Subject|2
5978745|NCT01071252|20673445|P1|Overall Study|Withdrawal by Subject|8
5978746|NCT01071252|20673441|P5|Overall Study|unsatisfactory therapeutic effect|6
5978747|NCT01071252|20673442|P4|Overall Study|unsatisfactory therapeutic effect|0
5978748|NCT01071252|20673443|P3|Overall Study|unsatisfactory therapeutic effect|2
5978749|NCT01071252|20673444|P2|Overall Study|unsatisfactory therapeutic effect|6
5978750|NCT01071252|20673445|P1|Overall Study|unsatisfactory therapeutic effect|4
5978751|NCT01071200|20673473|P2|Overall Study|No viable embryos|1
5978752|NCT01071200|20673474|P1|Overall Study|No viable embryos|0
5978753|NCT01071200|20673473|P2|Overall Study|Ovarian Hyper Stimulation Syndrome|0
5978754|NCT01071200|20673474|P1|Overall Study|Ovarian Hyper Stimulation Syndrome|1
5978755|NCT01071200|20673473|P2|Overall Study|No oocytes retrieved|1
5978756|NCT01071200|20673474|P1|Overall Study|No oocytes retrieved|1
5978757|NCT01071200|20673473|P2|Overall Study|No fertilization|0
5978758|NCT01071200|20673474|P1|Overall Study|No fertilization|4
5978759|NCT01071200|20673473|P2|Overall Study|Lack of ovarian response|1
5978760|NCT01071200|20673474|P1|Overall Study|Lack of ovarian response|1
5978761|NCT01071096|20673506|P2|First Intervention (90 Days)|Lost to Follow-up|0
5978762|NCT01071096|20673507|P1|First Intervention (90 Days)|Lost to Follow-up|1
5978763|NCT01071083|20673531|P5|Overall Study|Subject Refused to Continue|0
5978764|NCT01071083|20673532|P4|Overall Study|Subject Refused to Continue|0
5978765|NCT01071083|20673533|P3|Overall Study|Subject Refused to Continue|0
5978766|NCT01071083|20673534|P2|Overall Study|Subject Refused to Continue|0
5978767|NCT01071083|20673535|P1|Overall Study|Subject Refused to Continue|1
5978768|NCT01071083|20673531|P5|Overall Study|Did Not Want Per Protocol Treatment|1
5978769|NCT01071083|20673532|P4|Overall Study|Did Not Want Per Protocol Treatment|0
5978770|NCT01071083|20673533|P3|Overall Study|Did Not Want Per Protocol Treatment|1
5978771|NCT01071083|20673534|P2|Overall Study|Did Not Want Per Protocol Treatment|0
5978772|NCT01071083|20673535|P1|Overall Study|Did Not Want Per Protocol Treatment|0
5978773|NCT01071083|20673531|P5|Overall Study|Did Not Meet Eligibility Criteria|1
5978774|NCT01071083|20673532|P4|Overall Study|Did Not Meet Eligibility Criteria|1
5978775|NCT01071083|20673533|P3|Overall Study|Did Not Meet Eligibility Criteria|1
5978776|NCT01071083|20673534|P2|Overall Study|Did Not Meet Eligibility Criteria|0
5978777|NCT01071083|20673535|P1|Overall Study|Did Not Meet Eligibility Criteria|0
5978778|NCT01071083|20673531|P5|Overall Study|Images Not Usable (Motion)|0
5978779|NCT01071083|20673532|P4|Overall Study|Images Not Usable (Motion)|0
5978780|NCT01071083|20673533|P3|Overall Study|Images Not Usable (Motion)|0
5978781|NCT01071083|20673534|P2|Overall Study|Images Not Usable (Motion)|1
5978782|NCT01071083|20673535|P1|Overall Study|Images Not Usable (Motion)|0
5978783|NCT01071083|20673531|P5|Overall Study|Subject Moved|0
5978784|NCT01071083|20673532|P4|Overall Study|Subject Moved|0
5978785|NCT01071083|20673533|P3|Overall Study|Subject Moved|0
5978786|NCT01071083|20673534|P2|Overall Study|Subject Moved|1
5978787|NCT01071083|20673535|P1|Overall Study|Subject Moved|0
5978788|NCT01071083|20673531|P5|Overall Study|Early Rescue|1
5978789|NCT01071083|20673532|P4|Overall Study|Early Rescue|0
5978790|NCT01071083|20673533|P3|Overall Study|Early Rescue|0
5978791|NCT01071083|20673534|P2|Overall Study|Early Rescue|0
5978792|NCT01071083|20673535|P1|Overall Study|Early Rescue|1
5978793|NCT01071083|20673531|P5|Overall Study|Physician Decision|1
5978794|NCT01071083|20673532|P4|Overall Study|Physician Decision|1
5978795|NCT01071083|20673533|P3|Overall Study|Physician Decision|0
5978796|NCT01071083|20673534|P2|Overall Study|Physician Decision|0
5978797|NCT01071083|20673535|P1|Overall Study|Physician Decision|1
5978798|NCT01071083|20673531|P5|Overall Study|Withdrawal by Subject|3
5978799|NCT01071083|20673532|P4|Overall Study|Withdrawal by Subject|0
5978800|NCT01071083|20673533|P3|Overall Study|Withdrawal by Subject|2
5978801|NCT01071083|20673534|P2|Overall Study|Withdrawal by Subject|0
5978802|NCT01071083|20673535|P1|Overall Study|Withdrawal by Subject|3
5978803|NCT01071083|20673531|P5|Overall Study|Adverse Event|1
5978804|NCT01071083|20673532|P4|Overall Study|Adverse Event|0
5978805|NCT01071083|20673533|P3|Overall Study|Adverse Event|1
5978806|NCT01071083|20673534|P2|Overall Study|Adverse Event|0
5978807|NCT01071083|20673535|P1|Overall Study|Adverse Event|1
5978808|NCT01071070|20673554|P2|Overall Study|Hypercalcemia|0
5978809|NCT01071070|20673555|P1|Overall Study|Hypercalcemia|1
5978810|NCT01071070|20673554|P2|Overall Study|Missed 3 consecutive doses of study drug|0
5978811|NCT01071070|20673555|P1|Overall Study|Missed 3 consecutive doses of study drug|2
5978812|NCT01071070|20673554|P2|Overall Study|Withdrawal by Subject|0
5978813|NCT01071070|20673555|P1|Overall Study|Withdrawal by Subject|1
5978814|NCT01071070|20673554|P2|Overall Study|Adverse Event|3
5978815|NCT01071070|20673555|P1|Overall Study|Adverse Event|0
5978816|NCT01070979|20673601|P3|Overall Study|No study drug taken|0
5978817|NCT01070979|20673602|P2|Overall Study|No study drug taken|1
5978818|NCT01070979|20673603|P1|Overall Study|No study drug taken|0
5978819|NCT01070979|20673601|P3|Overall Study|Withdrawal by Subject|1
5978820|NCT01070979|20673602|P2|Overall Study|Withdrawal by Subject|1
5978821|NCT01070979|20673603|P1|Overall Study|Withdrawal by Subject|3
5978822|NCT01070979|20673601|P3|Overall Study|Surgery, moving, personal, abn. labs|2
5978823|NCT01070979|20673602|P2|Overall Study|Surgery, moving, personal, abn. labs|4
5978824|NCT01070979|20673603|P1|Overall Study|Surgery, moving, personal, abn. labs|4
5978825|NCT01070979|20673601|P3|Overall Study|Protocol Violation|6
5978826|NCT01070979|20673602|P2|Overall Study|Protocol Violation|2
5978827|NCT01070979|20673603|P1|Overall Study|Protocol Violation|0
5978828|NCT01070979|20673601|P3|Overall Study|Lost to Follow-up|1
5978829|NCT01070979|20673602|P2|Overall Study|Lost to Follow-up|1
5978830|NCT01070979|20673603|P1|Overall Study|Lost to Follow-up|2
5978831|NCT01070979|20673601|P3|Overall Study|Adverse Event|3
5978832|NCT01070979|20673602|P2|Overall Study|Adverse Event|3
5978833|NCT01070979|20673603|P1|Overall Study|Adverse Event|2
5978834|NCT01070966|20673629|P1|Participants for Efficacy Evaluation|Efficacy evaluation window violation|2
5978835|NCT01070966|20673629|P1|Participants for Efficacy Evaluation|No efficacy evaluation|19
5978836|NCT01070966|20673629|P1|Participants for Efficacy Evaluation|Lack of tmt period (<28 days)|61
5978837|NCT01070966|20673629|P1|Participants for Safety Evaluation|TMT given before date of contract|3
5978838|NCT01070966|20673629|P1|Participants for Safety Evaluation|Violation inclusion criteria/off label|3
5978839|NCT01070966|20673629|P1|Participants for Safety Evaluation|Duplicate Participants|4
5978840|NCT01070966|20673629|P1|Participants for Safety Evaluation|Off-label use|9
5978841|NCT01070966|20673629|P1|Participants for Safety Evaluation|Violation of inclusion criteria|59
5978842|NCT01070953|20673640|P1|Participants for Efficacy Evaluation|Unknown date of efficacy evaluation|2
5978843|NCT01070953|20673640|P1|Participants for Efficacy Evaluation|Lack of treatment period (<28 days)|106
5978844|NCT01070953|20673640|P1|Participants for Efficacy Evaluation|No efficacy evaluation|119
5978845|NCT01070953|20673640|P1|Participants for Safety Evaluation|Duplicated participants & off-label use|1
5978846|NCT01070953|20673640|P1|Participants for Safety Evaluation|Violation of inclusions & off label use|1
5978847|NCT01070953|20673640|P1|Participants for Safety Evaluation|Uncontracted participants|4
5978848|NCT01070953|20673640|P1|Participants for Safety Evaluation|Treatment prior to date of contract|8
5978849|NCT01070953|20673640|P1|Participants for Safety Evaluation|Duplicated participants|22
5978850|NCT01070953|20673640|P1|Participants for Safety Evaluation|Off-label use|283
5978851|NCT01070953|20673640|P1|Participants for Safety Evaluation|Violation of inclusion criteria|612
5978852|NCT01070888|20673653|P2|Washout (14 Days)|Physician Decision|0
5978853|NCT01070888|20673654|P1|Washout (14 Days)|Physician Decision|1
5978854|NCT01070888|20673653|P2|First Intervention (14 Days)|Lost to Follow-up|1
5978855|NCT01070888|20673654|P1|First Intervention (14 Days)|Lost to Follow-up|0
5978856|NCT01070888|20673653|P2|First Intervention (14 Days)|Adverse Event|1
5978857|NCT01070888|20673654|P1|First Intervention (14 Days)|Adverse Event|0
5978858|NCT01070784|20673679|P2|Overall Study|Adverse Event|9
5978859|NCT01070784|20673680|P1|Overall Study|Adverse Event|14
5978860|NCT01070784|20673679|P2|Overall Study|Withdrawal by Subject|9
5978861|NCT01070784|20673680|P1|Overall Study|Withdrawal by Subject|6
5978862|NCT01070771|20673768|P1|Overall Study|Protocol Violation|1
5978863|NCT01070771|20673768|P1|Overall Study|Adverse Event|2
5978864|NCT01070550|20673788|P6|Overall Study|Withdrawal by Subject|0
5978865|NCT01070550|20673789|P5|Overall Study|Withdrawal by Subject|0
5978866|NCT01070550|20673790|P4|Overall Study|Withdrawal by Subject|0
5978867|NCT01070550|20673791|P3|Overall Study|Withdrawal by Subject|3
5978868|NCT01070550|20673792|P2|Overall Study|Withdrawal by Subject|0
5978869|NCT01070550|20673793|P1|Overall Study|Withdrawal by Subject|35
5978870|NCT01070550|20673788|P6|Overall Study|Other|0
5978871|NCT01070550|20673789|P5|Overall Study|Other|0
5978872|NCT01070550|20673790|P4|Overall Study|Other|1
5978873|NCT01070550|20673791|P3|Overall Study|Other|0
5978874|NCT01070550|20673792|P2|Overall Study|Other|0
5978875|NCT01070550|20673793|P1|Overall Study|Other|5
5978876|NCT01070550|20673788|P6|Overall Study|Treatment was stopped early|0
5978877|NCT01070550|20673789|P5|Overall Study|Treatment was stopped early|0
5978878|NCT01070550|20673790|P4|Overall Study|Treatment was stopped early|0
5978879|NCT01070550|20673791|P3|Overall Study|Treatment was stopped early|0
5978880|NCT01070550|20673792|P2|Overall Study|Treatment was stopped early|0
5978881|NCT01070550|20673793|P1|Overall Study|Treatment was stopped early|7
5978882|NCT01070550|20673788|P6|Overall Study|Treatment unavailable|0
5978883|NCT01070550|20673789|P5|Overall Study|Treatment unavailable|0
5978884|NCT01070550|20673790|P4|Overall Study|Treatment unavailable|0
5978885|NCT01070550|20673791|P3|Overall Study|Treatment unavailable|0
5978886|NCT01070550|20673792|P2|Overall Study|Treatment unavailable|0
5978887|NCT01070550|20673793|P1|Overall Study|Treatment unavailable|1
5978888|NCT01070550|20673788|P6|Overall Study|Treatment stopped|0
5978889|NCT01070550|20673789|P5|Overall Study|Treatment stopped|0
5978890|NCT01070550|20673790|P4|Overall Study|Treatment stopped|0
5978891|NCT01070550|20673791|P3|Overall Study|Treatment stopped|0
5978892|NCT01070550|20673792|P2|Overall Study|Treatment stopped|0
5978893|NCT01070550|20673793|P1|Overall Study|Treatment stopped|3
5978894|NCT01070550|20673788|P6|Overall Study|Treatment restarted|0
5978895|NCT01070550|20673789|P5|Overall Study|Treatment restarted|0
5978896|NCT01070550|20673790|P4|Overall Study|Treatment restarted|0
5978897|NCT01070550|20673791|P3|Overall Study|Treatment restarted|0
5978898|NCT01070550|20673792|P2|Overall Study|Treatment restarted|1
5978899|NCT01070550|20673793|P1|Overall Study|Treatment restarted|0
5978900|NCT01070550|20673788|P6|Overall Study|Treatment not started|0
5978901|NCT01070550|20673789|P5|Overall Study|Treatment not started|0
5978902|NCT01070550|20673790|P4|Overall Study|Treatment not started|0
5978903|NCT01070550|20673791|P3|Overall Study|Treatment not started|4
5978904|NCT01070550|20673792|P2|Overall Study|Treatment not started|2
5978905|NCT01070550|20673793|P1|Overall Study|Treatment not started|14
5978906|NCT01070550|20673788|P6|Overall Study|Treatment interrupted|0
5978907|NCT01070550|20673789|P5|Overall Study|Treatment interrupted|0
5978908|NCT01070550|20673790|P4|Overall Study|Treatment interrupted|1
5978909|NCT01070550|20673791|P3|Overall Study|Treatment interrupted|1
5978910|NCT01070550|20673792|P2|Overall Study|Treatment interrupted|0
5978911|NCT01070550|20673793|P1|Overall Study|Treatment interrupted|7
5978912|NCT01070550|20673788|P6|Overall Study|Treatment duration shortened|0
5978913|NCT01070550|20673789|P5|Overall Study|Treatment duration shortened|0
5978914|NCT01070550|20673790|P4|Overall Study|Treatment duration shortened|0
5978915|NCT01070550|20673791|P3|Overall Study|Treatment duration shortened|0
5978916|NCT01070550|20673792|P2|Overall Study|Treatment duration shortened|0
5978917|NCT01070550|20673793|P1|Overall Study|Treatment duration shortened|1
5978918|NCT01070550|20673788|P6|Overall Study|Sponsor decision|0
5978919|NCT01070550|20673789|P5|Overall Study|Sponsor decision|0
5978920|NCT01070550|20673790|P4|Overall Study|Sponsor decision|0
5978921|NCT01070550|20673791|P3|Overall Study|Sponsor decision|0
5978922|NCT01070550|20673792|P2|Overall Study|Sponsor decision|0
5978923|NCT01070550|20673793|P1|Overall Study|Sponsor decision|1
5978924|NCT01070550|20673788|P6|Overall Study|Screen failure|0
5978925|NCT01070550|20673789|P5|Overall Study|Screen failure|0
5978926|NCT01070550|20673790|P4|Overall Study|Screen failure|0
5978927|NCT01070550|20673791|P3|Overall Study|Screen failure|0
5978928|NCT01070550|20673792|P2|Overall Study|Screen failure|0
5978929|NCT01070550|20673793|P1|Overall Study|Screen failure|1
5978930|NCT01070550|20673788|P6|Overall Study|Result not available|0
5978931|NCT01070550|20673789|P5|Overall Study|Result not available|0
5978932|NCT01070550|20673790|P4|Overall Study|Result not available|0
5978933|NCT01070550|20673791|P3|Overall Study|Result not available|3
5978934|NCT01070550|20673792|P2|Overall Study|Result not available|1
5978935|NCT01070550|20673793|P1|Overall Study|Result not available|3
5978936|NCT01070550|20673788|P6|Overall Study|Relapse|0
5978937|NCT01070550|20673789|P5|Overall Study|Relapse|0
5978938|NCT01070550|20673790|P4|Overall Study|Relapse|4
5978939|NCT01070550|20673791|P3|Overall Study|Relapse|14
5978940|NCT01070550|20673792|P2|Overall Study|Relapse|5
5978941|NCT01070550|20673793|P1|Overall Study|Relapse|44
5978942|NCT01070550|20673788|P6|Overall Study|Protocol Violation|0
5978943|NCT01070550|20673789|P5|Overall Study|Protocol Violation|0
5978944|NCT01070550|20673790|P4|Overall Study|Protocol Violation|1
5978945|NCT01070550|20673791|P3|Overall Study|Protocol Violation|1
5978946|NCT01070550|20673792|P2|Overall Study|Protocol Violation|1
5978947|NCT01070550|20673793|P1|Overall Study|Protocol Violation|15
5978948|NCT01070550|20673788|P6|Overall Study|Not categorized|1
5978949|NCT01070550|20673789|P5|Overall Study|Not categorized|0
5978950|NCT01070550|20673790|P4|Overall Study|Not categorized|1
5978951|NCT01070550|20673791|P3|Overall Study|Not categorized|6
5978952|NCT01070550|20673792|P2|Overall Study|Not categorized|2
5978953|NCT01070550|20673793|P1|Overall Study|Not categorized|33
5978954|NCT01070550|20673788|P6|Overall Study|Non-responders|2
5978955|NCT01070550|20673789|P5|Overall Study|Non-responders|0
5978956|NCT01070550|20673790|P4|Overall Study|Non-responders|20
5978957|NCT01070550|20673791|P3|Overall Study|Non-responders|21
5978958|NCT01070550|20673792|P2|Overall Study|Non-responders|4
5978959|NCT01070550|20673793|P1|Overall Study|Non-responders|493
5978960|NCT01070550|20673788|P6|Overall Study|New treatment started|0
5978961|NCT01070550|20673789|P5|Overall Study|New treatment started|0
5978962|NCT01070550|20673790|P4|Overall Study|New treatment started|2
5978963|NCT01070550|20673791|P3|Overall Study|New treatment started|0
5978964|NCT01070550|20673792|P2|Overall Study|New treatment started|1
5978965|NCT01070550|20673793|P1|Overall Study|New treatment started|3
5978966|NCT01070550|20673788|P6|Overall Study|Miscellaneous|0
5978967|NCT01070550|20673789|P5|Overall Study|Miscellaneous|0
5978968|NCT01070550|20673790|P4|Overall Study|Miscellaneous|1
5978969|NCT01070550|20673791|P3|Overall Study|Miscellaneous|3
5978970|NCT01070550|20673792|P2|Overall Study|Miscellaneous|2
5978971|NCT01070550|20673793|P1|Overall Study|Miscellaneous|12
5978972|NCT01070550|20673788|P6|Overall Study|Lack of Efficacy|1
5978973|NCT01070550|20673789|P5|Overall Study|Lack of Efficacy|0
5978974|NCT01070550|20673790|P4|Overall Study|Lack of Efficacy|5
5978975|NCT01070550|20673791|P3|Overall Study|Lack of Efficacy|5
5978976|NCT01070550|20673792|P2|Overall Study|Lack of Efficacy|1
5978977|NCT01070550|20673793|P1|Overall Study|Lack of Efficacy|65
5978978|NCT01070550|20673788|P6|Overall Study|Lab test not done|1
5978979|NCT01070550|20673789|P5|Overall Study|Lab test not done|0
5978980|NCT01070550|20673790|P4|Overall Study|Lab test not done|1
5978981|NCT01070550|20673791|P3|Overall Study|Lab test not done|4
5978982|NCT01070550|20673792|P2|Overall Study|Lab test not done|3
5978983|NCT01070550|20673793|P1|Overall Study|Lab test not done|22
5978984|NCT01070550|20673788|P6|Overall Study|Incomplete treatment|0
5978985|NCT01070550|20673789|P5|Overall Study|Incomplete treatment|0
5978986|NCT01070550|20673790|P4|Overall Study|Incomplete treatment|0
5978987|NCT01070550|20673791|P3|Overall Study|Incomplete treatment|0
5978988|NCT01070550|20673792|P2|Overall Study|Incomplete treatment|0
5978989|NCT01070550|20673793|P1|Overall Study|Incomplete treatment|2
5978990|NCT01070550|20673788|P6|Overall Study|Failed to return|2
5978991|NCT01070550|20673789|P5|Overall Study|Failed to return|1
5978992|NCT01070550|20673790|P4|Overall Study|Failed to return|40
5978993|NCT01070550|20673791|P3|Overall Study|Failed to return|144
5978994|NCT01070550|20673792|P2|Overall Study|Failed to return|33
5978995|NCT01070550|20673793|P1|Overall Study|Failed to return|450
5978996|NCT01070550|20673788|P6|Overall Study|Early termination|0
5978997|NCT01070550|20673789|P5|Overall Study|Early termination|0
5978998|NCT01070550|20673790|P4|Overall Study|Early termination|0
5978999|NCT01070550|20673791|P3|Overall Study|Early termination|0
5979000|NCT01070550|20673792|P2|Overall Study|Early termination|0
5979001|NCT01070550|20673793|P1|Overall Study|Early termination|3
5979002|NCT01070550|20673788|P6|Overall Study|Not meeting inclusion/exclusion criteria|0
5979003|NCT01070550|20673789|P5|Overall Study|Not meeting inclusion/exclusion criteria|0
5979004|NCT01070550|20673790|P4|Overall Study|Not meeting inclusion/exclusion criteria|0
5979005|NCT01070550|20673791|P3|Overall Study|Not meeting inclusion/exclusion criteria|1
5979006|NCT01070550|20673792|P2|Overall Study|Not meeting inclusion/exclusion criteria|1
5979007|NCT01070550|20673793|P1|Overall Study|Not meeting inclusion/exclusion criteria|2
5979008|NCT01070550|20673788|P6|Overall Study|Death|0
5979009|NCT01070550|20673789|P5|Overall Study|Death|0
5979010|NCT01070550|20673790|P4|Overall Study|Death|0
5979011|NCT01070550|20673791|P3|Overall Study|Death|3
5979012|NCT01070550|20673792|P2|Overall Study|Death|4
5979013|NCT01070550|20673793|P1|Overall Study|Death|20
5979014|NCT01070550|20673788|P6|Overall Study|Adverse Event|0
5979015|NCT01070550|20673789|P5|Overall Study|Adverse Event|0
5979016|NCT01070550|20673790|P4|Overall Study|Adverse Event|0
5979017|NCT01070550|20673791|P3|Overall Study|Adverse Event|3
5979018|NCT01070550|20673792|P2|Overall Study|Adverse Event|1
5979019|NCT01070550|20673793|P1|Overall Study|Adverse Event|43
5979020|NCT01070394|20673933|P1|Overall Study|Withdrawal by Subject|1
5979021|NCT01070394|20673933|P1|Overall Study|Adverse Event|6
5979022|NCT01070381|20673944|P2|Period 2, 1 Week of Wear|Unacceptable Vision|0
5979023|NCT01070381|20673945|P1|Period 2, 1 Week of Wear|Unacceptable Vision|1
5979024|NCT01070381|20673944|P2|Period 2, 1 Week of Wear|Handling|1
5979025|NCT01070381|20673945|P1|Period 2, 1 Week of Wear|Handling|0
5979026|NCT01070329|20673953|P2|Overall Study|Sponsor Decision|1
5979027|NCT01070329|20673954|P1|Overall Study|Sponsor Decision|0
5979028|NCT01070329|20673953|P2|Overall Study|Entry Criteria Not Met|0
5979029|NCT01070329|20673954|P1|Overall Study|Entry Criteria Not Met|1
5979030|NCT01070329|20673953|P2|Overall Study|Physician Decision|1
5979031|NCT01070329|20673954|P1|Overall Study|Physician Decision|2
5979032|NCT01070329|20673953|P2|Overall Study|Lack of Efficacy|6
5979033|NCT01070329|20673954|P1|Overall Study|Lack of Efficacy|2
5979034|NCT01070329|20673953|P2|Overall Study|Protocol Violation|8
5979035|NCT01070329|20673954|P1|Overall Study|Protocol Violation|3
5979036|NCT01070329|20673953|P2|Overall Study|Withdrawal by Subject|11
5979037|NCT01070329|20673954|P1|Overall Study|Withdrawal by Subject|9
5979038|NCT01070329|20673953|P2|Overall Study|Lost to Follow-up|12
5979039|NCT01070329|20673954|P1|Overall Study|Lost to Follow-up|22
5979040|NCT01070329|20673953|P2|Overall Study|Adverse Event|10
5979041|NCT01070329|20673954|P1|Overall Study|Adverse Event|13
5979042|NCT01070316|20673986|P1|Extension Phase|Withdrawal by Subject|1
5979043|NCT01070316|20673986|P1|Extension Phase|Lack of Efficacy|3
5979044|NCT01070303|20673993|P1|Overall Study|Other|18
5979045|NCT01070303|20673993|P1|Overall Study|Administrative Reason|1
5979046|NCT01070303|20673993|P1|Overall Study|Lack of Efficacy|2
5979047|NCT01070303|20673993|P1|Overall Study|Protocol Violation|0
5979048|NCT01070303|20673993|P1|Overall Study|Lost to Follow-up|9
5979049|NCT01070303|20673993|P1|Overall Study|Withdrawal by Subject|20
5979050|NCT01070303|20673993|P1|Overall Study|Adverse Event|39
5979051|NCT01070043|20674088|P3|Double-Blind Treatment|Adverse Event|2
5979052|NCT01070043|20674089|P2|Double-Blind Treatment|Adverse Event|0
5979053|NCT01070043|20674090|P1|Double-Blind Treatment|Adverse Event|0
5979054|NCT01070043|20674088|P3|Run-In Phase|Did not Meet Inclusion Criteria|0
5979055|NCT01070043|20674089|P2|Run-In Phase|Did not Meet Inclusion Criteria|0
5979056|NCT01070043|20674090|P1|Run-In Phase|Did not Meet Inclusion Criteria|18
5979057|NCT01069939|20674106|P2|Randomised and Included in the Analyses|Removal|0
5979058|NCT01069939|20674107|P1|Randomised and Included in the Analyses|Removal|1
5979059|NCT01069939|20674106|P2|Randomised and Included in the Analyses|Physician Decision|2
5979060|NCT01069939|20674107|P1|Randomised and Included in the Analyses|Physician Decision|0
5979061|NCT01069939|20674106|P2|Randomised and Included in the Analyses|Use of prohibited concomitant drug|2
5979062|NCT01069939|20674107|P1|Randomised and Included in the Analyses|Use of prohibited concomitant drug|4
5979063|NCT01069939|20674106|P2|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|3
5979064|NCT01069939|20674107|P1|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|4
5979065|NCT01069939|20674106|P2|Randomised and Included in the Analyses|Study-specific withdrawal criteria|33
5979066|NCT01069939|20674107|P1|Randomised and Included in the Analyses|Study-specific withdrawal criteria|7
5979067|NCT01069939|20674106|P2|Randomised and Included in the Analyses|Lack of Efficacy|1
5979068|NCT01069939|20674107|P1|Randomised and Included in the Analyses|Lack of Efficacy|0
5979069|NCT01069939|20674106|P2|Randomised and Included in the Analyses|Protocol Violation|1
5979070|NCT01069939|20674107|P1|Randomised and Included in the Analyses|Protocol Violation|0
5979071|NCT01069939|20674106|P2|Randomised and Included in the Analyses|Lost to Follow-up|1
5979072|NCT01069939|20674107|P1|Randomised and Included in the Analyses|Lost to Follow-up|1
5979073|NCT01069939|20674106|P2|Randomised and Included in the Analyses|Withdrawal by Subject|12
5979074|NCT01069939|20674107|P1|Randomised and Included in the Analyses|Withdrawal by Subject|15
5979075|NCT01069939|20674106|P2|Randomised and Included in the Analyses|Adverse Event|22
5979076|NCT01069939|20674107|P1|Randomised and Included in the Analyses|Adverse Event|17
5979077|NCT01069900|20674133|P2|Overall Study|Insufficient Therapeutic effect|0
5979078|NCT01069900|20674134|P1|Overall Study|Insufficient Therapeutic effect|1
5979079|NCT01069900|20674133|P2|Overall Study|Protocol Violation|1
5979080|NCT01069900|20674134|P1|Overall Study|Protocol Violation|4
5979081|NCT01069900|20674133|P2|Overall Study|Withdrawal by Subject|1
5979082|NCT01069900|20674134|P1|Overall Study|Withdrawal by Subject|6
5979083|NCT01069900|20674133|P2|Overall Study|Lost to Follow-up|1
5979084|NCT01069900|20674134|P1|Overall Study|Lost to Follow-up|7
5979085|NCT01069900|20674133|P2|Overall Study|Technical problems|1
5979086|NCT01069900|20674134|P1|Overall Study|Technical problems|0
5979090|NCT01069627|20674191|P1|Overall Study|Protocol Violation|1
5979091|NCT01069627|20674191|P1|Overall Study|Adverse Event|12
5979092|NCT01069627|20674191|P1|Overall Study|Disease progression|7
5979093|NCT01069523|20674241|P2|Overall Study|Withdrawal by Subject|7
5979094|NCT01069523|20674242|P1|Overall Study|Withdrawal by Subject|4
5979095|NCT01069484|20674265|P2|Overall Study|Illness mother or child|1
5979096|NCT01069484|20674266|P1|Overall Study|Illness mother or child|3
5979097|NCT01069484|20674265|P2|Overall Study|No specific reason|2
5979098|NCT01069484|20674266|P1|Overall Study|No specific reason|8
5979099|NCT01069484|20674265|P2|Overall Study|Death-in-near-family|0
5979100|NCT01069484|20674266|P1|Overall Study|Death-in-near-family|1
5979101|NCT01069419|20674274|P1|Overall Study|Missing termination information|13
5979102|NCT01069419|20674274|P1|Overall Study|Other Reason|43
5979103|NCT01069419|20674274|P1|Overall Study|Withdrawal by Subject|34
5979104|NCT01069419|20674274|P1|Overall Study|Remission of disease|11
5979105|NCT01069419|20674274|P1|Overall Study|Lost to Follow-up|49
5979106|NCT01069419|20674274|P1|Overall Study|Lack of Efficacy|332
5979107|NCT01069419|20674274|P1|Overall Study|Adverse Event|233
5979108|NCT01069341|20674303|P1|Overall Study|Lost to Follow-up|1
5979109|NCT01069289|20674345|P2|Overall Study|Due to deteriorating health condition|0
5979110|NCT01069289|20674346|P1|Overall Study|Due to deteriorating health condition|1
5979111|NCT01069289|20674345|P2|Overall Study|Severe non-compliance to protocol|2
5979112|NCT01069289|20674346|P1|Overall Study|Severe non-compliance to protocol|3
5979113|NCT01069289|20674345|P2|Overall Study|Eligibility criteria not fulfilled|0
5979114|NCT01069289|20674346|P1|Overall Study|Eligibility criteria not fulfilled|2
5979115|NCT01069289|20674345|P2|Overall Study|Adverse Event|28
5979116|NCT01069289|20674346|P1|Overall Study|Adverse Event|21
5979117|NCT01069289|20674345|P2|Overall Study|Withdrawal by Subject|26
5979118|NCT01069289|20674346|P1|Overall Study|Withdrawal by Subject|15
5979119|NCT01069172|20674395|P2|Overall Study|Withdrawal by Subject|0
5979120|NCT01069172|20674396|P1|Overall Study|Withdrawal by Subject|1
5979121|NCT01069120|20674406|P1|Overall Study|Study prematurely terminated|27
5979122|NCT01068912|20674443|P3|Overall Study|other underlying illness|3
5979123|NCT01068912|20674444|P2|Overall Study|other underlying illness|3
5979124|NCT01068912|20674445|P1|Overall Study|other underlying illness|0
5979125|NCT01068912|20674443|P3|Overall Study|aggravation influenza|1
5979126|NCT01068912|20674444|P2|Overall Study|aggravation influenza|1
5979127|NCT01068912|20674445|P1|Overall Study|aggravation influenza|1
5979128|NCT01068912|20674443|P3|Overall Study|Protocol Violation|0
5979129|NCT01068912|20674444|P2|Overall Study|Protocol Violation|2
5979130|NCT01068912|20674445|P1|Overall Study|Protocol Violation|0
5979131|NCT01068912|20674443|P3|Overall Study|Lost to Follow-up|3
5979132|NCT01068912|20674444|P2|Overall Study|Lost to Follow-up|7
5979133|NCT01068912|20674445|P1|Overall Study|Lost to Follow-up|3
5979134|NCT01068912|20674443|P3|Overall Study|Withdrawal by Subject|6
5979135|NCT01068912|20674444|P2|Overall Study|Withdrawal by Subject|6
5979136|NCT01068912|20674445|P1|Overall Study|Withdrawal by Subject|5
5979137|NCT01068912|20674443|P3|Overall Study|Adverse Event|2
5979138|NCT01068912|20674444|P2|Overall Study|Adverse Event|3
5979139|NCT01068912|20674445|P1|Overall Study|Adverse Event|2
5979140|NCT01068860|20674473|P10|Overall Study|Lost to Follow-up|0
5979141|NCT01068860|20674474|P9|Overall Study|Lost to Follow-up|0
5979142|NCT01068860|20674475|P8|Overall Study|Lost to Follow-up|0
5979143|NCT01068860|20674476|P7|Overall Study|Lost to Follow-up|0
5979144|NCT01068860|20674477|P6|Overall Study|Lost to Follow-up|0
5979145|NCT01068860|20674478|P5|Overall Study|Lost to Follow-up|0
5979146|NCT01068860|20674479|P4|Overall Study|Lost to Follow-up|0
5979147|NCT01068860|20674480|P3|Overall Study|Lost to Follow-up|0
5979148|NCT01068860|20674481|P2|Overall Study|Lost to Follow-up|1
5979149|NCT01068860|20674482|P1|Overall Study|Lost to Follow-up|0
5979150|NCT01068860|20674473|P10|Overall Study|Administrative problems; misrandomized|1
5979151|NCT01068860|20674474|P9|Overall Study|Administrative problems; misrandomized|0
5979152|NCT01068860|20674475|P8|Overall Study|Administrative problems; misrandomized|0
5979153|NCT01068860|20674476|P7|Overall Study|Administrative problems; misrandomized|0
5979154|NCT01068860|20674477|P6|Overall Study|Administrative problems; misrandomized|0
5979155|NCT01068860|20674478|P5|Overall Study|Administrative problems; misrandomized|0
5979156|NCT01068860|20674479|P4|Overall Study|Administrative problems; misrandomized|1
5979157|NCT01068860|20674480|P3|Overall Study|Administrative problems; misrandomized|0
5979158|NCT01068860|20674481|P2|Overall Study|Administrative problems; misrandomized|0
5979159|NCT01068860|20674482|P1|Overall Study|Administrative problems; misrandomized|0
5979160|NCT01068860|20674473|P10|Overall Study|Withdrawal by Subject|3
5979161|NCT01068860|20674474|P9|Overall Study|Withdrawal by Subject|0
5979162|NCT01068860|20674475|P8|Overall Study|Withdrawal by Subject|0
5979163|NCT01068860|20674476|P7|Overall Study|Withdrawal by Subject|0
5979164|NCT01068860|20674477|P6|Overall Study|Withdrawal by Subject|2
5979165|NCT01068860|20674478|P5|Overall Study|Withdrawal by Subject|0
5979166|NCT01068860|20674479|P4|Overall Study|Withdrawal by Subject|0
5979167|NCT01068860|20674480|P3|Overall Study|Withdrawal by Subject|0
5979168|NCT01068860|20674481|P2|Overall Study|Withdrawal by Subject|0
5979169|NCT01068860|20674482|P1|Overall Study|Withdrawal by Subject|0
5979170|NCT01068769|20674665|P1|Overall Study|Ineligible|1
5979171|NCT01068743|20674670|P4|Period 3|Adverse Event|0
5979172|NCT01068743|20674671|P3|Period 3|Adverse Event|0
5979173|NCT01068743|20674672|P2|Period 3|Adverse Event|1
5979174|NCT01068743|20674673|P1|Period 3|Adverse Event|0
5979175|NCT01068730|20674747|P4|Period 4|Family emergency|0
5979176|NCT01068730|20674748|P3|Period 4|Family emergency|0
5979177|NCT01068730|20674749|P2|Period 4|Family emergency|1
5979178|NCT01068730|20674750|P1|Period 4|Family emergency|0
5979179|NCT01068730|20674747|P4|Period 3|Personal reason|0
5979180|NCT01068730|20674748|P3|Period 3|Personal reason|0
5979181|NCT01068730|20674749|P2|Period 3|Personal reason|0
5979182|NCT01068730|20674750|P1|Period 3|Personal reason|1
5979183|NCT01068717|20674804|P4|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0
5979184|NCT01068717|20674805|P3|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0
5979185|NCT01068717|20674806|P2|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0
5979186|NCT01068717|20674807|P1|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|1
5979187|NCT01068678|20674863|P2|Overall Study|Unclassified|15
5979188|NCT01068678|20674864|P1|Overall Study|Unclassified|18
5979189|NCT01068678|20674863|P2|Overall Study|Withdrawal criteria|6
5979190|NCT01068678|20674864|P1|Overall Study|Withdrawal criteria|12
5979191|NCT01068678|20674863|P2|Overall Study|Protocol Violation|1
5979192|NCT01068678|20674864|P1|Overall Study|Protocol Violation|5
5979193|NCT01068678|20674863|P2|Overall Study|Lack of Efficacy|2
5979194|NCT01068678|20674864|P1|Overall Study|Lack of Efficacy|3
5979195|NCT01068665|20674874|P2|Overall Study|Other|12
5979196|NCT01068665|20674875|P1|Overall Study|Other|17
5979197|NCT01068665|20674874|P2|Overall Study|Withdrawal Criteria|9
5979198|NCT01068665|20674875|P1|Overall Study|Withdrawal Criteria|3
5979199|NCT01068665|20674874|P2|Overall Study|Protocol Violation|2
5979200|NCT01068665|20674875|P1|Overall Study|Protocol Violation|5
5979201|NCT01068665|20674874|P2|Overall Study|Lack of Efficacy|2
5979202|NCT01068665|20674875|P1|Overall Study|Lack of Efficacy|0
5979203|NCT01068665|20674874|P2|Overall Study|Adverse Event|4
5979204|NCT01068665|20674875|P1|Overall Study|Adverse Event|5
5979205|NCT01068652|20674885|P2|Overall Study|Unclassified|4
5979206|NCT01068652|20674886|P1|Overall Study|Unclassified|7
5979207|NCT01068652|20674885|P2|Overall Study|Patient was not eligible|0
5979208|NCT01068652|20674886|P1|Overall Study|Patient was not eligible|1
5979209|NCT01068652|20674885|P2|Overall Study|Withdrawal criteria|2
5979210|NCT01068652|20674886|P1|Overall Study|Withdrawal criteria|1
5979211|NCT01068652|20674885|P2|Overall Study|Protocol Violation|6
5979212|NCT01068652|20674886|P1|Overall Study|Protocol Violation|3
5979213|NCT01068652|20674885|P2|Overall Study|Lost to Follow-up|1
5979214|NCT01068652|20674886|P1|Overall Study|Lost to Follow-up|2
5979215|NCT01068652|20674885|P2|Overall Study|Lack of Efficacy|2
5979216|NCT01068652|20674886|P1|Overall Study|Lack of Efficacy|0
5979217|NCT01068652|20674885|P2|Overall Study|Adverse Event|0
5979218|NCT01068652|20674886|P1|Overall Study|Adverse Event|4
5979219|NCT01068626|20674926|P2|Overall Study|Withdrawal by Subject|2
5979220|NCT01068626|20674927|P1|Overall Study|Withdrawal by Subject|0
5979221|NCT01068626|20674926|P2|Overall Study|Adverse Event|0
5979222|NCT01068626|20674927|P1|Overall Study|Adverse Event|3
5979223|NCT01068600|20674945|P2|Overall Study|Administrative problems|1
5979224|NCT01068600|20674946|P1|Overall Study|Administrative problems|0
5979225|NCT01068600|20674945|P2|Overall Study|Unsatisfactory therapeutic effect|4
5979226|NCT01068600|20674946|P1|Overall Study|Unsatisfactory therapeutic effect|0
5979227|NCT01068600|20674945|P2|Overall Study|Protocol deviation|1
5979228|NCT01068600|20674946|P1|Overall Study|Protocol deviation|1
5979229|NCT01068600|20674945|P2|Overall Study|Lost to Follow-up|2
5979230|NCT01068600|20674946|P1|Overall Study|Lost to Follow-up|1
5979231|NCT01068600|20674945|P2|Overall Study|Abnormal laboratory value(s)|0
5979232|NCT01068600|20674946|P1|Overall Study|Abnormal laboratory value(s)|1
5979233|NCT01068600|20674945|P2|Overall Study|Adverse Event|3
5979234|NCT01068600|20674946|P1|Overall Study|Adverse Event|3
5979235|NCT01068600|20674945|P2|Overall Study|Withdrawal by Subject|6
5979236|NCT01068600|20674946|P1|Overall Study|Withdrawal by Subject|5
5979237|NCT01068509|20674968|P3|Overall Study|Reason Not Specified|0
5979238|NCT01068509|20674969|P2|Overall Study|Reason Not Specified|1
5979239|NCT01068509|20674970|P1|Overall Study|Reason Not Specified|0
5979240|NCT01068509|20674968|P3|Overall Study|Withdrew Consent|2
5979241|NCT01068509|20674969|P2|Overall Study|Withdrew Consent|1
5979242|NCT01068509|20674970|P1|Overall Study|Withdrew Consent|0
5979243|NCT01068509|20674968|P3|Overall Study|Lost to Follow-up|0
5979244|NCT01068509|20674969|P2|Overall Study|Lost to Follow-up|0
5979245|NCT01068509|20674970|P1|Overall Study|Lost to Follow-up|1
5979246|NCT01068509|20674968|P3|Overall Study|Disease Progression|18
5979247|NCT01068509|20674969|P2|Overall Study|Disease Progression|20
5979248|NCT01068509|20674970|P1|Overall Study|Disease Progression|5
5979249|NCT01068509|20674968|P3|Overall Study|Death|1
5979250|NCT01068509|20674969|P2|Overall Study|Death|0
5979251|NCT01068509|20674970|P1|Overall Study|Death|0
5979252|NCT01068418|20674983|P1|Overall Study|Physician Decision|12
5979253|NCT01068262|20674992|P4|Overall Study|Withdrawal by Subject|0
5979254|NCT01068262|20674993|P3|Overall Study|Withdrawal by Subject|0
5979255|NCT01068262|20674994|P2|Overall Study|Withdrawal by Subject|1
5979256|NCT01068262|20674995|P1|Overall Study|Withdrawal by Subject|0
5979257|NCT01068262|20674992|P4|Overall Study|Protocol Violation|0
5979258|NCT01068262|20674993|P3|Overall Study|Protocol Violation|0
5979259|NCT01068262|20674994|P2|Overall Study|Protocol Violation|0
5979260|NCT01068262|20674995|P1|Overall Study|Protocol Violation|1
5979261|NCT01068262|20674992|P4|Overall Study|Adverse Event|0
5979262|NCT01068262|20674993|P3|Overall Study|Adverse Event|1
5979263|NCT01068262|20674994|P2|Overall Study|Adverse Event|0
5979264|NCT01068262|20674995|P1|Overall Study|Adverse Event|2
5979265|NCT01068158|20675025|P2|Overall Study|Protocol Violation|2
5979266|NCT01068158|20675026|P1|Overall Study|Protocol Violation|0
5979267|NCT01068158|20675025|P2|Overall Study|Lost to Follow-up|0
5979268|NCT01068158|20675026|P1|Overall Study|Lost to Follow-up|7
5979269|NCT01068158|20675025|P2|Overall Study|Withdrawal by Subject|2
5979270|NCT01068158|20675026|P1|Overall Study|Withdrawal by Subject|1
5979271|NCT01067976|20675038|P1|Overall Study|Study prematurely discontinued|2
5979272|NCT01067976|20675038|P1|Overall Study|Study drug never administered|20
5979273|NCT01067846|20675099|P2|Overall Study|participation in other tx study|0
5979274|NCT01067846|20675100|P1|Overall Study|participation in other tx study|1
5979275|NCT01067846|20675099|P2|Overall Study|Withdrawal by Subject|0
5979276|NCT01067846|20675100|P1|Overall Study|Withdrawal by Subject|1
5979277|NCT01067846|20675099|P2|Overall Study|Lost to Follow-up|19
5979278|NCT01067846|20675100|P1|Overall Study|Lost to Follow-up|17
5979279|NCT01067521|20675170|P2|Open-Label Period|Lost to Follow-up|20
5979280|NCT01067521|20675171|P1|Open-Label Period|Lost to Follow-up|21
5979281|NCT01067521|20675170|P2|Open-Label Period|Teva requested subject to be withdrawn|2
5979282|NCT01067521|20675171|P1|Open-Label Period|Teva requested subject to be withdrawn|5
5979283|NCT01067521|20675170|P2|Open-Label Period|Pregnancy|8
5979284|NCT01067521|20675171|P1|Open-Label Period|Pregnancy|14
5979285|NCT01067521|20675170|P2|Open-Label Period|Protocol Violation|0
5979286|NCT01067521|20675171|P1|Open-Label Period|Protocol Violation|3
5979287|NCT01067521|20675170|P2|Open-Label Period|Non-compliance with study drug|0
5979288|NCT01067521|20675171|P1|Open-Label Period|Non-compliance with study drug|5
5979289|NCT01067521|20675170|P2|Open-Label Period|Physician Decision|11
5979290|NCT01067521|20675171|P1|Open-Label Period|Physician Decision|13
5979291|NCT01067521|20675170|P2|Open-Label Period|Withdrawal by Subject|88
5979292|NCT01067521|20675171|P1|Open-Label Period|Withdrawal by Subject|160
5979293|NCT01067521|20675170|P2|Open-Label Period|Adverse Event|28
5979294|NCT01067521|20675171|P1|Open-Label Period|Adverse Event|30
5979295|NCT01067521|20675170|P2|Open-Label Period|Death|1
5979296|NCT01067521|20675171|P1|Open-Label Period|Death|3
5979297|NCT01067521|20675170|P2|Double-Blind Placebo-Controlled Period|Lost to Follow-up|1
5979298|NCT01067521|20675171|P1|Double-Blind Placebo-Controlled Period|Lost to Follow-up|5
5979299|NCT01067521|20675170|P2|Double-Blind Placebo-Controlled Period|Pregnancy|4
5979300|NCT01067521|20675171|P1|Double-Blind Placebo-Controlled Period|Pregnancy|7
5979301|NCT01067521|20675170|P2|Double-Blind Placebo-Controlled Period|Protocol Violation|0
5979302|NCT01067521|20675171|P1|Double-Blind Placebo-Controlled Period|Protocol Violation|2
5979303|NCT01067521|20675170|P2|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|0
5979304|NCT01067521|20675171|P1|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|2
5979305|NCT01067521|20675170|P2|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|1
5979306|NCT01067521|20675171|P1|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|4
5979307|NCT01067521|20675170|P2|Double-Blind Placebo-Controlled Period|Physician Decision|1
5979308|NCT01067521|20675171|P1|Double-Blind Placebo-Controlled Period|Physician Decision|1
5979309|NCT01067521|20675170|P2|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|17
5979310|NCT01067521|20675171|P1|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|34
5979311|NCT01067521|20675170|P2|Double-Blind Placebo-Controlled Period|Adverse Event|6
5979312|NCT01067521|20675171|P1|Double-Blind Placebo-Controlled Period|Adverse Event|29
5979313|NCT01067521|20675170|P2|Double-Blind Placebo-Controlled Period|Death|1
5979314|NCT01067521|20675171|P1|Double-Blind Placebo-Controlled Period|Death|0
5979315|NCT01067508|20675197|P2|Overall Study|Withdrawal by Subject|1
5979316|NCT01067508|20675198|P1|Overall Study|Withdrawal by Subject|0
5979317|NCT01067508|20675197|P2|Overall Study|Physician Decision|1
5979318|NCT01067508|20675198|P1|Overall Study|Physician Decision|0
5979319|NCT01067469|20675206|P2|Overall Study|Disease Progression|1
5979320|NCT01067469|20675207|P1|Overall Study|Disease Progression|0
5979321|NCT01067469|20675206|P2|Overall Study|Withdrawal by Subject|1
5979322|NCT01067469|20675207|P1|Overall Study|Withdrawal by Subject|0
5979323|NCT01067352|20675239|P3|Overall Study|Physician Decision|0
5979324|NCT01067352|20675240|P2|Overall Study|Physician Decision|1
5979325|NCT01067352|20675241|P1|Overall Study|Physician Decision|0
5979326|NCT01067352|20675239|P3|Overall Study|Withdrawal by Subject|1
5979327|NCT01067352|20675240|P2|Overall Study|Withdrawal by Subject|2
5979328|NCT01067352|20675241|P1|Overall Study|Withdrawal by Subject|1
5979329|NCT01067339|20675257|P2|Overall Study|Withdrawal by Subject|5
5979330|NCT01067339|20675258|P1|Overall Study|Withdrawal by Subject|6
5979331|NCT01067326|20675268|P2|Overall Study|Early Study Termination|1
5979332|NCT01067326|20675269|P1|Overall Study|Early Study Termination|1
5979333|NCT01067326|20675268|P2|Overall Study|Withdrawal by Subject|0
5979334|NCT01067326|20675269|P1|Overall Study|Withdrawal by Subject|1
5979335|NCT01067326|20675268|P2|Overall Study|Adverse Event|2
5979336|NCT01067326|20675269|P1|Overall Study|Adverse Event|0
5979337|NCT01067144|20675283|P2|Follow-up|Death|1
5979338|NCT01067144|20675284|P1|Follow-up|Death|0
5979339|NCT01067144|20675283|P2|Follow-up|Surgery cancelled|1
5979340|NCT01067144|20675284|P1|Follow-up|Surgery cancelled|0
5979341|NCT01067144|20675283|P2|Follow-up|Withdrawal by Subject|14
5979342|NCT01067144|20675284|P1|Follow-up|Withdrawal by Subject|18
5979343|NCT01067144|20675283|P2|Follow-up|Censored owing to second surgery|28
5979344|NCT01067144|20675284|P1|Follow-up|Censored owing to second surgery|19
5979345|NCT01067144|20675283|P2|Follow-up|Lost to Follow-up|12
5979346|NCT01067144|20675284|P1|Follow-up|Lost to Follow-up|22
5979347|NCT01067144|20675283|P2|Treatment|Did not receive allocated intervention|7
5979348|NCT01067144|20675284|P1|Treatment|Did not receive allocated intervention|4
5979349|NCT01067105|20675300|P1|Overall Study|Other|31
5979350|NCT01067105|20675300|P1|Overall Study|Physician Decision|6
5979351|NCT01067105|20675300|P1|Overall Study|Lost to Follow-up|6
5979352|NCT01067105|20675300|P1|Overall Study|Withdrawal by Subject|36
5979353|NCT01067105|20675300|P1|Overall Study|Protocol Violation|48
5979354|NCT01067105|20675300|P1|Overall Study|Adverse Event|14
5979355|NCT01066936|20675317|P1|Overall Study|Withdrawal by Subject|4
5979356|NCT01066936|20675317|P1|Overall Study|Lost to Follow-up|3
5979357|NCT01066936|20675317|P1|Overall Study|Device revised/removed|1
5979358|NCT01066936|20675317|P1|Overall Study|Death|2
5979359|NCT01066923|20675353|P4|Overall Study|Withdrawal by Subject|8
5979360|NCT01066923|20675354|P3|Overall Study|Withdrawal by Subject|8
5979361|NCT01066923|20675355|P2|Overall Study|Withdrawal by Subject|3
5979362|NCT01066923|20675356|P1|Overall Study|Withdrawal by Subject|3
5979363|NCT01066897|20675380|P2|Overall Study|stopped study after developing the flu.|0
5979364|NCT01066897|20675381|P1|Overall Study|stopped study after developing the flu.|1
5979365|NCT01066897|20675380|P2|Overall Study|Withdrawal by Subject|0
5979366|NCT01066897|20675381|P1|Overall Study|Withdrawal by Subject|1
5979367|NCT01066871|20675395|P4|Overall Study|Other|2
5979368|NCT01066871|20675396|P3|Overall Study|Other|1
5979369|NCT01066871|20675397|P2|Overall Study|Other|2
5979370|NCT01066871|20675398|P1|Overall Study|Other|0
5979371|NCT01066871|20675395|P4|Overall Study|Withdrawal by Subject|0
5979372|NCT01066871|20675396|P3|Overall Study|Withdrawal by Subject|0
5979373|NCT01066871|20675397|P2|Overall Study|Withdrawal by Subject|1
5979374|NCT01066871|20675398|P1|Overall Study|Withdrawal by Subject|3
5979375|NCT01066871|20675395|P4|Overall Study|Lack of Efficacy|1
5979376|NCT01066871|20675396|P3|Overall Study|Lack of Efficacy|0
5979377|NCT01066871|20675397|P2|Overall Study|Lack of Efficacy|0
5979378|NCT01066871|20675398|P1|Overall Study|Lack of Efficacy|0
5979379|NCT01066871|20675395|P4|Overall Study|Protocol Violation|2
5979380|NCT01066871|20675396|P3|Overall Study|Protocol Violation|3
5979381|NCT01066871|20675397|P2|Overall Study|Protocol Violation|0
5979382|NCT01066871|20675398|P1|Overall Study|Protocol Violation|1
5979383|NCT01066871|20675395|P4|Overall Study|Lost to Follow-up|0
5979384|NCT01066871|20675396|P3|Overall Study|Lost to Follow-up|2
5979385|NCT01066871|20675397|P2|Overall Study|Lost to Follow-up|2
5979386|NCT01066871|20675398|P1|Overall Study|Lost to Follow-up|0
5979387|NCT01066819|20675462|P6|Overall Study|Other|0
5979388|NCT01066819|20675463|P5|Overall Study|Other|0
5979389|NCT01066819|20675464|P4|Overall Study|Other|0
5979390|NCT01066819|20675465|P3|Overall Study|Other|1
5979391|NCT01066819|20675466|P2|Overall Study|Other|1
5979392|NCT01066819|20675467|P1|Overall Study|Other|5
5979393|NCT01066819|20675462|P6|Overall Study|Treatment stopped|0
5979394|NCT01066819|20675463|P5|Overall Study|Treatment stopped|0
5979395|NCT01066819|20675464|P4|Overall Study|Treatment stopped|1
5979396|NCT01066819|20675465|P3|Overall Study|Treatment stopped|2
5979397|NCT01066819|20675466|P2|Overall Study|Treatment stopped|1
5979398|NCT01066819|20675467|P1|Overall Study|Treatment stopped|12
5979399|NCT01066819|20675462|P6|Overall Study|Treatment never started|2
5979400|NCT01066819|20675463|P5|Overall Study|Treatment never started|2
5979401|NCT01066819|20675464|P4|Overall Study|Treatment never started|3
5979402|NCT01066819|20675465|P3|Overall Study|Treatment never started|19
5979403|NCT01066819|20675466|P2|Overall Study|Treatment never started|19
5979404|NCT01066819|20675467|P1|Overall Study|Treatment never started|85
5979405|NCT01066819|20675462|P6|Overall Study|Spontaneous cure|0
5979406|NCT01066819|20675463|P5|Overall Study|Spontaneous cure|0
5979407|NCT01066819|20675464|P4|Overall Study|Spontaneous cure|0
5979408|NCT01066819|20675465|P3|Overall Study|Spontaneous cure|0
5979409|NCT01066819|20675466|P2|Overall Study|Spontaneous cure|0
5979410|NCT01066819|20675467|P1|Overall Study|Spontaneous cure|1
5979411|NCT01066819|20675462|P6|Overall Study|Screen failure|0
5979412|NCT01066819|20675463|P5|Overall Study|Screen failure|0
5979413|NCT01066819|20675464|P4|Overall Study|Screen failure|0
5979414|NCT01066819|20675465|P3|Overall Study|Screen failure|0
5979415|NCT01066819|20675466|P2|Overall Study|Screen failure|0
5979416|NCT01066819|20675467|P1|Overall Study|Screen failure|1
5979417|NCT01066819|20675462|P6|Overall Study|Results not available|0
5979418|NCT01066819|20675463|P5|Overall Study|Results not available|0
5979419|NCT01066819|20675464|P4|Overall Study|Results not available|0
5979420|NCT01066819|20675465|P3|Overall Study|Results not available|0
5979421|NCT01066819|20675466|P2|Overall Study|Results not available|0
5979422|NCT01066819|20675467|P1|Overall Study|Results not available|1
5979423|NCT01066819|20675462|P6|Overall Study|Relapse|0
5979424|NCT01066819|20675463|P5|Overall Study|Relapse|0
5979425|NCT01066819|20675464|P4|Overall Study|Relapse|0
5979426|NCT01066819|20675465|P3|Overall Study|Relapse|3
5979427|NCT01066819|20675466|P2|Overall Study|Relapse|4
5979428|NCT01066819|20675467|P1|Overall Study|Relapse|16
5979429|NCT01066819|20675462|P6|Overall Study|Not categorised|0
5979430|NCT01066819|20675463|P5|Overall Study|Not categorised|0
5979431|NCT01066819|20675464|P4|Overall Study|Not categorised|1
5979432|NCT01066819|20675465|P3|Overall Study|Not categorised|6
5979433|NCT01066819|20675466|P2|Overall Study|Not categorised|2
5979434|NCT01066819|20675467|P1|Overall Study|Not categorised|9
5979435|NCT01066819|20675462|P6|Overall Study|Non responders|1
5979436|NCT01066819|20675463|P5|Overall Study|Non responders|0
5979437|NCT01066819|20675464|P4|Overall Study|Non responders|2
5979438|NCT01066819|20675465|P3|Overall Study|Non responders|7
5979439|NCT01066819|20675466|P2|Overall Study|Non responders|2
5979440|NCT01066819|20675467|P1|Overall Study|Non responders|123
5979441|NCT01066819|20675462|P6|Overall Study|Miscellaneous|0
5979442|NCT01066819|20675463|P5|Overall Study|Miscellaneous|0
5979443|NCT01066819|20675464|P4|Overall Study|Miscellaneous|1
5979444|NCT01066819|20675465|P3|Overall Study|Miscellaneous|18
5979445|NCT01066819|20675466|P2|Overall Study|Miscellaneous|10
5979446|NCT01066819|20675467|P1|Overall Study|Miscellaneous|28
5979447|NCT01066819|20675462|P6|Overall Study|Lab test not done|0
5979448|NCT01066819|20675463|P5|Overall Study|Lab test not done|0
5979449|NCT01066819|20675464|P4|Overall Study|Lab test not done|1
5979450|NCT01066819|20675465|P3|Overall Study|Lab test not done|2
5979451|NCT01066819|20675466|P2|Overall Study|Lab test not done|0
5979452|NCT01066819|20675467|P1|Overall Study|Lab test not done|9
5979453|NCT01066819|20675462|P6|Overall Study|Failed to return|3
5979454|NCT01066819|20675463|P5|Overall Study|Failed to return|2
5979455|NCT01066819|20675464|P4|Overall Study|Failed to return|7
5979456|NCT01066819|20675465|P3|Overall Study|Failed to return|68
5979457|NCT01066819|20675466|P2|Overall Study|Failed to return|107
5979458|NCT01066819|20675467|P1|Overall Study|Failed to return|298
5979459|NCT01066819|20675462|P6|Overall Study|Early termination|0
5979460|NCT01066819|20675463|P5|Overall Study|Early termination|0
5979461|NCT01066819|20675464|P4|Overall Study|Early termination|0
5979462|NCT01066819|20675465|P3|Overall Study|Early termination|0
5979463|NCT01066819|20675466|P2|Overall Study|Early termination|0
5979464|NCT01066819|20675467|P1|Overall Study|Early termination|2
5979465|NCT01066819|20675462|P6|Overall Study|Not met inclusion/exclusion criteria|0
5979466|NCT01066819|20675463|P5|Overall Study|Not met inclusion/exclusion criteria|0
5979467|NCT01066819|20675464|P4|Overall Study|Not met inclusion/exclusion criteria|0
5979468|NCT01066819|20675465|P3|Overall Study|Not met inclusion/exclusion criteria|0
5979469|NCT01066819|20675466|P2|Overall Study|Not met inclusion/exclusion criteria|0
5979470|NCT01066819|20675467|P1|Overall Study|Not met inclusion/exclusion criteria|1
5979471|NCT01066819|20675462|P6|Overall Study|Administrative|0
5979472|NCT01066819|20675463|P5|Overall Study|Administrative|0
5979473|NCT01066819|20675464|P4|Overall Study|Administrative|0
5979474|NCT01066819|20675465|P3|Overall Study|Administrative|2
5979475|NCT01066819|20675466|P2|Overall Study|Administrative|4
5979476|NCT01066819|20675467|P1|Overall Study|Administrative|6
5979477|NCT01066819|20675462|P6|Overall Study|Withdrawal by Subject|0
5979478|NCT01066819|20675463|P5|Overall Study|Withdrawal by Subject|0
5979479|NCT01066819|20675464|P4|Overall Study|Withdrawal by Subject|0
5979480|NCT01066819|20675465|P3|Overall Study|Withdrawal by Subject|6
5979481|NCT01066819|20675466|P2|Overall Study|Withdrawal by Subject|11
5979482|NCT01066819|20675467|P1|Overall Study|Withdrawal by Subject|29
5979483|NCT01066819|20675462|P6|Overall Study|Protocol Violation|0
5979484|NCT01066819|20675463|P5|Overall Study|Protocol Violation|0
5979485|NCT01066819|20675464|P4|Overall Study|Protocol Violation|0
5979486|NCT01066819|20675465|P3|Overall Study|Protocol Violation|0
5979487|NCT01066819|20675466|P2|Overall Study|Protocol Violation|6
5979488|NCT01066819|20675467|P1|Overall Study|Protocol Violation|12
5979489|NCT01066819|20675462|P6|Overall Study|Physician Decision|0
5979490|NCT01066819|20675463|P5|Overall Study|Physician Decision|0
5979491|NCT01066819|20675464|P4|Overall Study|Physician Decision|0
5979492|NCT01066819|20675465|P3|Overall Study|Physician Decision|3
5979493|NCT01066819|20675466|P2|Overall Study|Physician Decision|2
5979494|NCT01066819|20675467|P1|Overall Study|Physician Decision|6
5979495|NCT01066819|20675462|P6|Overall Study|Lack of Efficacy|0
5979496|NCT01066819|20675463|P5|Overall Study|Lack of Efficacy|0
5979497|NCT01066819|20675464|P4|Overall Study|Lack of Efficacy|1
5979498|NCT01066819|20675465|P3|Overall Study|Lack of Efficacy|2
5979499|NCT01066819|20675466|P2|Overall Study|Lack of Efficacy|1
5979500|NCT01066819|20675467|P1|Overall Study|Lack of Efficacy|22
5979501|NCT01066819|20675462|P6|Overall Study|Death|0
5979502|NCT01066819|20675463|P5|Overall Study|Death|0
5979503|NCT01066819|20675464|P4|Overall Study|Death|0
5979504|NCT01066819|20675465|P3|Overall Study|Death|1
5979505|NCT01066819|20675466|P2|Overall Study|Death|0
5979506|NCT01066819|20675467|P1|Overall Study|Death|5
5979507|NCT01066819|20675462|P6|Overall Study|Adverse Event|0
5979508|NCT01066819|20675463|P5|Overall Study|Adverse Event|0
5979509|NCT01066819|20675464|P4|Overall Study|Adverse Event|0
5979510|NCT01066819|20675465|P3|Overall Study|Adverse Event|6
5979511|NCT01066819|20675466|P2|Overall Study|Adverse Event|1
5979512|NCT01066819|20675467|P1|Overall Study|Adverse Event|18
5979513|NCT01066793|20675608|P6|Overall Study|Treatment Stopped|0
5979514|NCT01066793|20675609|P5|Overall Study|Treatment Stopped|0
5979515|NCT01066793|20675610|P4|Overall Study|Treatment Stopped|1
5979516|NCT01066793|20675611|P3|Overall Study|Treatment Stopped|0
5979517|NCT01066793|20675612|P2|Overall Study|Treatment Stopped|1
5979518|NCT01066793|20675613|P1|Overall Study|Treatment Stopped|2
5979519|NCT01066793|20675608|P6|Overall Study|Treatment Never Started|0
5979520|NCT01066793|20675609|P5|Overall Study|Treatment Never Started|0
5979521|NCT01066793|20675610|P4|Overall Study|Treatment Never Started|1
5979522|NCT01066793|20675611|P3|Overall Study|Treatment Never Started|4
5979523|NCT01066793|20675612|P2|Overall Study|Treatment Never Started|5
5979524|NCT01066793|20675613|P1|Overall Study|Treatment Never Started|18
5979525|NCT01066793|20675608|P6|Overall Study|Treatment Interrupted|0
5979526|NCT01066793|20675609|P5|Overall Study|Treatment Interrupted|0
5979527|NCT01066793|20675610|P4|Overall Study|Treatment Interrupted|0
5979528|NCT01066793|20675611|P3|Overall Study|Treatment Interrupted|0
5979529|NCT01066793|20675612|P2|Overall Study|Treatment Interrupted|1
5979530|NCT01066793|20675613|P1|Overall Study|Treatment Interrupted|1
5979531|NCT01066793|20675608|P6|Overall Study|Result Not Available|0
5979532|NCT01066793|20675609|P5|Overall Study|Result Not Available|0
5979533|NCT01066793|20675610|P4|Overall Study|Result Not Available|0
5979534|NCT01066793|20675611|P3|Overall Study|Result Not Available|0
5979535|NCT01066793|20675612|P2|Overall Study|Result Not Available|0
5979536|NCT01066793|20675613|P1|Overall Study|Result Not Available|1
5979537|NCT01066793|20675608|P6|Overall Study|Relapse|0
5979538|NCT01066793|20675609|P5|Overall Study|Relapse|0
5979539|NCT01066793|20675610|P4|Overall Study|Relapse|3
5979540|NCT01066793|20675611|P3|Overall Study|Relapse|2
5979541|NCT01066793|20675612|P2|Overall Study|Relapse|8
5979542|NCT01066793|20675613|P1|Overall Study|Relapse|20
5979543|NCT01066793|20675608|P6|Overall Study|Other|0
5979544|NCT01066793|20675609|P5|Overall Study|Other|0
5979545|NCT01066793|20675610|P4|Overall Study|Other|2
5979546|NCT01066793|20675611|P3|Overall Study|Other|6
5979547|NCT01066793|20675612|P2|Overall Study|Other|5
5979548|NCT01066793|20675613|P1|Overall Study|Other|15
5979549|NCT01066793|20675608|P6|Overall Study|Non-responders|0
5979550|NCT01066793|20675609|P5|Overall Study|Non-responders|0
5979551|NCT01066793|20675610|P4|Overall Study|Non-responders|25
5979552|NCT01066793|20675611|P3|Overall Study|Non-responders|11
5979553|NCT01066793|20675612|P2|Overall Study|Non-responders|5
5979554|NCT01066793|20675613|P1|Overall Study|Non-responders|104
5979555|NCT01066793|20675608|P6|Overall Study|Miscellaneous|0
5979556|NCT01066793|20675609|P5|Overall Study|Miscellaneous|0
5979557|NCT01066793|20675610|P4|Overall Study|Miscellaneous|0
5979558|NCT01066793|20675611|P3|Overall Study|Miscellaneous|6
5979559|NCT01066793|20675612|P2|Overall Study|Miscellaneous|5
5979560|NCT01066793|20675613|P1|Overall Study|Miscellaneous|4
5979561|NCT01066793|20675608|P6|Overall Study|Lab test not done|0
5979562|NCT01066793|20675609|P5|Overall Study|Lab test not done|0
5979563|NCT01066793|20675610|P4|Overall Study|Lab test not done|1
5979564|NCT01066793|20675611|P3|Overall Study|Lab test not done|0
5979565|NCT01066793|20675612|P2|Overall Study|Lab test not done|0
5979566|NCT01066793|20675613|P1|Overall Study|Lab test not done|7
5979567|NCT01066793|20675608|P6|Overall Study|Early Termination|0
5979568|NCT01066793|20675609|P5|Overall Study|Early Termination|0
5979569|NCT01066793|20675610|P4|Overall Study|Early Termination|0
5979570|NCT01066793|20675611|P3|Overall Study|Early Termination|0
5979571|NCT01066793|20675612|P2|Overall Study|Early Termination|0
5979572|NCT01066793|20675613|P1|Overall Study|Early Termination|3
5979573|NCT01066793|20675608|P6|Overall Study|Withdrawal by Subject|0
5979574|NCT01066793|20675609|P5|Overall Study|Withdrawal by Subject|0
5979575|NCT01066793|20675610|P4|Overall Study|Withdrawal by Subject|0
5979576|NCT01066793|20675611|P3|Overall Study|Withdrawal by Subject|1
5979577|NCT01066793|20675612|P2|Overall Study|Withdrawal by Subject|4
5979578|NCT01066793|20675613|P1|Overall Study|Withdrawal by Subject|7
5979579|NCT01066793|20675608|P6|Overall Study|Protocol Violation|0
5979580|NCT01066793|20675609|P5|Overall Study|Protocol Violation|0
5979581|NCT01066793|20675610|P4|Overall Study|Protocol Violation|0
5979582|NCT01066793|20675611|P3|Overall Study|Protocol Violation|2
5979583|NCT01066793|20675612|P2|Overall Study|Protocol Violation|2
5979584|NCT01066793|20675613|P1|Overall Study|Protocol Violation|3
5979585|NCT01066793|20675608|P6|Overall Study|Physician Decision|0
5979586|NCT01066793|20675609|P5|Overall Study|Physician Decision|0
5979587|NCT01066793|20675610|P4|Overall Study|Physician Decision|0
5979588|NCT01066793|20675611|P3|Overall Study|Physician Decision|0
5979589|NCT01066793|20675612|P2|Overall Study|Physician Decision|0
5979590|NCT01066793|20675613|P1|Overall Study|Physician Decision|3
5979591|NCT01066793|20675608|P6|Overall Study|Lost to Follow-up|1
5979592|NCT01066793|20675609|P5|Overall Study|Lost to Follow-up|0
5979593|NCT01066793|20675610|P4|Overall Study|Lost to Follow-up|16
5979594|NCT01066793|20675611|P3|Overall Study|Lost to Follow-up|82
5979595|NCT01066793|20675612|P2|Overall Study|Lost to Follow-up|39
5979596|NCT01066793|20675613|P1|Overall Study|Lost to Follow-up|180
5979597|NCT01066793|20675608|P6|Overall Study|Lack of Efficacy|0
5979598|NCT01066793|20675609|P5|Overall Study|Lack of Efficacy|0
5979599|NCT01066793|20675610|P4|Overall Study|Lack of Efficacy|0
5979600|NCT01066793|20675611|P3|Overall Study|Lack of Efficacy|0
5979601|NCT01066793|20675612|P2|Overall Study|Lack of Efficacy|1
5979602|NCT01066793|20675613|P1|Overall Study|Lack of Efficacy|2
5979603|NCT01066793|20675608|P6|Overall Study|Death|0
5979604|NCT01066793|20675609|P5|Overall Study|Death|0
5979605|NCT01066793|20675610|P4|Overall Study|Death|0
5979606|NCT01066793|20675611|P3|Overall Study|Death|1
5979607|NCT01066793|20675612|P2|Overall Study|Death|1
5979608|NCT01066793|20675613|P1|Overall Study|Death|4
5979609|NCT01066780|20675753|P2|Overall Study|Withdrawn prior to ClearVoice exposure.|1
5979610|NCT01066780|20675754|P1|Overall Study|Withdrawn prior to ClearVoice exposure.|1
5979611|NCT01066585|20675784|P2|Overall Study|Withdrawal by Subject|3
5979612|NCT01066585|20675785|P1|Overall Study|Withdrawal by Subject|0
5979613|NCT01066585|20675784|P2|Overall Study|Protocol Violation|0
5979614|NCT01066585|20675785|P1|Overall Study|Protocol Violation|1
5979615|NCT01066546|20675797|P1|Overall Study|Study terminated by sponsor|5
5979616|NCT01066156|20675842|P1|Overall Study|Withdrawal by Subject|1
5979617|NCT01066156|20675842|P1|Overall Study|Lost to Follow-up|7
5979618|NCT01066156|20675842|P1|Overall Study|ineligible|2
5979619|NCT01066143|20675846|P1|Overall Study|ineligible for the study|8
5979620|NCT01066104|20675852|P2|Overall Study|Protocol Violation|0
5979621|NCT01066104|20675853|P1|Overall Study|Protocol Violation|1
5979622|NCT01066104|20675852|P2|Overall Study|Adverse Event|1
5979623|NCT01066104|20675853|P1|Overall Study|Adverse Event|1
5979624|NCT01066052|20675863|P2|Overall Study|Enrolled But Not Treated|0
5979625|NCT01066052|20675864|P1|Overall Study|Enrolled But Not Treated|3
5979626|NCT01066039|20675875|P1|Overall Study|Drug/Dose Adjustment Required|1
5979627|NCT01066039|20675875|P1|Overall Study|Failure to Control Blood Pressure|1
5979628|NCT01066039|20675875|P1|Overall Study|Volunteer Failed to Make the Next Visit|2
5979629|NCT01066039|20675875|P1|Overall Study|Additional Antihypertensive Required|4
5979630|NCT01066039|20675875|P1|Overall Study|Dropout due to Insulin Administration|1
5979631|NCT01066039|20675875|P1|Overall Study|Investigator's Request|1
5979632|NCT01066039|20675875|P1|Overall Study|Inclusion/Exclusion Criteria Violation|9
5979633|NCT01066039|20675875|P1|Overall Study|Protocol Violation|2
5979634|NCT01066039|20675875|P1|Overall Study|Withdrawal by Subject|17
5979635|NCT01066039|20675875|P1|Overall Study|Adverse Event|6
5979636|NCT01066000|20675900|P1|Overall Study|Adverse Event|1
5979637|NCT01066000|20675900|P1|Overall Study|Withdrawal by Subject|1
5979638|NCT01066000|20675900|P1|Overall Study|Death|3
5979639|NCT01066000|20675900|P1|Overall Study|Protocol Violation|4
5979640|NCT01065844|20675911|P1|Overall Study|Adverse Event|5
5979641|NCT01065818|20675915|P1|Overall Study|Not a candidate for surgery|1
5979642|NCT01065818|20675915|P1|Overall Study|Withdrawal by Subject|1
5979643|NCT01065779|20675919|P1|Overall Study|Inclusion Criteria Violation|7
5979644|NCT01065779|20675919|P1|Overall Study|Failed to Follow-up|10
5979645|NCT01065779|20675919|P1|Overall Study|Not Administered With Study Drug|17
5979646|NCT01065779|20675919|P1|Overall Study|Non-enrollment Period Administration|10
5979647|NCT01065779|20675919|P1|Overall Study|Investigation Before Contract Date|37
5979648|NCT01065779|20675919|P1|Overall Study|Duplicate Investigation|1
5979649|NCT01065766|20675930|P1|Overall Study|Violated dosage/administration|25
5979650|NCT01065766|20675930|P1|Overall Study|Contraindication to administration|6
5979651|NCT01065766|20675930|P1|Overall Study|Assessed before the contracted date|1
5979652|NCT01065597|20675949|P1|Overall Study|Adverse Event|1
5979701|NCT01065350|20676122|P2|Overall Study|Received incorrect drug allocation|1
5979702|NCT01065350|20676123|P1|Overall Study|Received incorrect drug allocation|0
5979703|NCT01064947|20676184|P1|Overall Study|negative culture|41
5979704|NCT01064856|20676225|P4|Open-label (OL) Period|Other|7
5979705|NCT01064856|20676226|P3|Open-label (OL) Period|Other|7
5979706|NCT01064856|20676227|P2|Open-label (OL) Period|Other|0
5979707|NCT01064856|20676228|P1|Open-label (OL) Period|Other|0
5979708|NCT01064856|20676225|P4|Open-label (OL) Period|Lost to Follow-up|1
5979709|NCT01064856|20676226|P3|Open-label (OL) Period|Lost to Follow-up|2
5979710|NCT01064856|20676227|P2|Open-label (OL) Period|Lost to Follow-up|0
5979711|NCT01064856|20676228|P1|Open-label (OL) Period|Lost to Follow-up|0
5979712|NCT01064856|20676225|P4|Open-label (OL) Period|Consent withdrawn by participant|6
5979713|NCT01064856|20676226|P3|Open-label (OL) Period|Consent withdrawn by participant|5
5979714|NCT01064856|20676227|P2|Open-label (OL) Period|Consent withdrawn by participant|0
5979715|NCT01064856|20676228|P1|Open-label (OL) Period|Consent withdrawn by participant|0
5979716|NCT01064856|20676225|P4|Open-label (OL) Period|Adverse Event|6
5979717|NCT01064856|20676226|P3|Open-label (OL) Period|Adverse Event|12
5979718|NCT01064856|20676227|P2|Open-label (OL) Period|Adverse Event|0
5979719|NCT01064856|20676228|P1|Open-label (OL) Period|Adverse Event|0
5979720|NCT01064856|20676225|P4|Double-blind (DB) Period|Consent withdrawn by participant|0
5979721|NCT01064856|20676226|P3|Double-blind (DB) Period|Consent withdrawn by participant|0
5979722|NCT01064856|20676227|P2|Double-blind (DB) Period|Consent withdrawn by participant|0
5979723|NCT01064856|20676228|P1|Double-blind (DB) Period|Consent withdrawn by participant|1
5979724|NCT01064856|20676225|P4|Double-blind (DB) Period|Adverse Event|0
5979725|NCT01064856|20676226|P3|Double-blind (DB) Period|Adverse Event|0
5979726|NCT01064856|20676227|P2|Double-blind (DB) Period|Adverse Event|0
5979727|NCT01064856|20676228|P1|Double-blind (DB) Period|Adverse Event|1
5979728|NCT01064817|20676272|P2|Study Completion|Withdrawal by Subject|0
5979729|NCT01064817|20676273|P1|Study Completion|Withdrawal by Subject|1
5979730|NCT01064817|20676272|P2|Study Completion|Physician Decision|0
5979731|NCT01064817|20676273|P1|Study Completion|Physician Decision|1
5979732|NCT01064739|20676285|P1|Fixed Sodium Diet + Fava Beans|Adverse Event|1
5979733|NCT01064687|20676356|P4|Overall Study|Treatment Noncompliance|0
5979734|NCT01064687|20676357|P3|Overall Study|Treatment Noncompliance|1
5979735|NCT01064687|20676358|P2|Overall Study|Treatment Noncompliance|1
5979736|NCT01064687|20676359|P1|Overall Study|Treatment Noncompliance|1
5979737|NCT01064687|20676356|P4|Overall Study|Withdrawal by Subject|5
5979738|NCT01064687|20676357|P3|Overall Study|Withdrawal by Subject|12
5979739|NCT01064687|20676358|P2|Overall Study|Withdrawal by Subject|7
5979740|NCT01064687|20676359|P1|Overall Study|Withdrawal by Subject|9
5979741|NCT01064687|20676356|P4|Overall Study|Sponsor Decision|0
5979742|NCT01064687|20676357|P3|Overall Study|Sponsor Decision|3
5979743|NCT01064687|20676358|P2|Overall Study|Sponsor Decision|0
5979744|NCT01064687|20676359|P1|Overall Study|Sponsor Decision|0
5979745|NCT01064687|20676356|P4|Overall Study|Protocol Violation|1
5979746|NCT01064687|20676357|P3|Overall Study|Protocol Violation|0
5979747|NCT01064687|20676358|P2|Overall Study|Protocol Violation|1
5979748|NCT01064687|20676359|P1|Overall Study|Protocol Violation|1
5979749|NCT01064687|20676356|P4|Overall Study|Physician Decision|0
5979750|NCT01064687|20676357|P3|Overall Study|Physician Decision|0
5979751|NCT01064687|20676358|P2|Overall Study|Physician Decision|2
5979752|NCT01064687|20676359|P1|Overall Study|Physician Decision|2
5979753|NCT01064687|20676356|P4|Overall Study|Lost to Follow-up|5
5979754|NCT01064687|20676357|P3|Overall Study|Lost to Follow-up|13
5979755|NCT01064687|20676358|P2|Overall Study|Lost to Follow-up|10
5979756|NCT01064687|20676359|P1|Overall Study|Lost to Follow-up|7
5979757|NCT01064687|20676356|P4|Overall Study|Lack of Efficacy|3
5979758|NCT01064687|20676357|P3|Overall Study|Lack of Efficacy|2
5979759|NCT01064687|20676358|P2|Overall Study|Lack of Efficacy|0
5979760|NCT01064687|20676359|P1|Overall Study|Lack of Efficacy|1
5979761|NCT01064687|20676356|P4|Overall Study|Entry Criteria Not Met|0
5979762|NCT01064687|20676357|P3|Overall Study|Entry Criteria Not Met|0
5979763|NCT01064687|20676358|P2|Overall Study|Entry Criteria Not Met|0
5979764|NCT01064687|20676359|P1|Overall Study|Entry Criteria Not Met|3
5979765|NCT01064687|20676356|P4|Overall Study|Death|0
5979766|NCT01064687|20676357|P3|Overall Study|Death|0
5979767|NCT01064687|20676358|P2|Overall Study|Death|1
5979768|NCT01064687|20676359|P1|Overall Study|Death|1
5979769|NCT01064687|20676356|P4|Overall Study|Adverse Event|3
5979770|NCT01064687|20676357|P3|Overall Study|Adverse Event|10
5979771|NCT01064687|20676358|P2|Overall Study|Adverse Event|4
5979772|NCT01064687|20676359|P1|Overall Study|Adverse Event|9
5979821|NCT01064622|20676568|P2|Randomized Phase II|Protocol Violation|1
5979822|NCT01064622|20676569|P1|Randomized Phase II|Protocol Violation|0
5979823|NCT01064622|20676568|P2|Randomized Phase II|Withdrawal by Subject|2
5979824|NCT01064622|20676569|P1|Randomized Phase II|Withdrawal by Subject|2
5979825|NCT01064531|20676592|P2|Overall Study|Death|1
5979826|NCT01064531|20676593|P1|Overall Study|Death|0
5979827|NCT01064531|20676592|P2|Overall Study|Revision due to dislocation|1
5979828|NCT01064531|20676593|P1|Overall Study|Revision due to dislocation|0
5979829|NCT01064531|20676592|P2|Overall Study|Revision due to femoral stem loosening|0
5979830|NCT01064531|20676593|P1|Overall Study|Revision due to femoral stem loosening|1
5979831|NCT01064531|20676592|P2|Overall Study|Withdrawal by Subject|2
5979832|NCT01064531|20676593|P1|Overall Study|Withdrawal by Subject|2
5979833|NCT01064531|20676592|P2|Overall Study|Physician Decision|1
5979834|NCT01064531|20676593|P1|Overall Study|Physician Decision|0
5979835|NCT01064531|20676592|P2|Overall Study|Lost to Follow-up|2
5979836|NCT01064531|20676593|P1|Overall Study|Lost to Follow-up|0
5979837|NCT01064414|20676640|P3|Extension Period: Week 26 to Week 52|Other|1
5979838|NCT01064414|20676641|P2|Extension Period: Week 26 to Week 52|Other|2
5979839|NCT01064414|20676642|P1|Extension Period: Week 26 to Week 52|Other|5
5979840|NCT01064414|20676640|P3|Extension Period: Week 26 to Week 52|Protocol Violation|1
5979841|NCT01064414|20676641|P2|Extension Period: Week 26 to Week 52|Protocol Violation|1
5979924|NCT01064310|20676712|P2|Period 1|Entered Open-label Period|1
5979842|NCT01064414|20676642|P1|Extension Period: Week 26 to Week 52|Protocol Violation|1
5979843|NCT01064414|20676640|P3|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0
5979844|NCT01064414|20676641|P2|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0
5979845|NCT01064414|20676642|P1|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1
5979846|NCT01064414|20676640|P3|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
5979847|NCT01064414|20676641|P2|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
5979848|NCT01064414|20676642|P1|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
5979849|NCT01064414|20676640|P3|Extension Period: Week 26 to Week 52|Physician Decision|0
5979850|NCT01064414|20676641|P2|Extension Period: Week 26 to Week 52|Physician Decision|0
5979851|NCT01064414|20676642|P1|Extension Period: Week 26 to Week 52|Physician Decision|1
5979852|NCT01064414|20676640|P3|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
5979853|NCT01064414|20676641|P2|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
5979854|NCT01064414|20676642|P1|Extension Period: Week 26 to Week 52|Lost to Follow-up|1
5979855|NCT01064414|20676640|P3|Extension Period: Week 26 to Week 52|Death|0
5979856|NCT01064414|20676641|P2|Extension Period: Week 26 to Week 52|Death|1
5979857|NCT01064414|20676642|P1|Extension Period: Week 26 to Week 52|Death|0
5979858|NCT01064414|20676640|P3|Extension Period: Week 26 to Week 52|Adverse Event|2
5979859|NCT01064414|20676641|P2|Extension Period: Week 26 to Week 52|Adverse Event|1
5979860|NCT01064414|20676642|P1|Extension Period: Week 26 to Week 52|Adverse Event|2
5979861|NCT01064414|20676640|P3|Core Period: Baseline to Week 26|Other|2
5979862|NCT01064414|20676641|P2|Core Period: Baseline to Week 26|Other|7
5979863|NCT01064414|20676642|P1|Core Period: Baseline to Week 26|Other|4
5979864|NCT01064414|20676640|P3|Core Period: Baseline to Week 26|Noncompliance with study drug|0
5979865|NCT01064414|20676641|P2|Core Period: Baseline to Week 26|Noncompliance with study drug|1
5979866|NCT01064414|20676642|P1|Core Period: Baseline to Week 26|Noncompliance with study drug|0
5979867|NCT01064414|20676640|P3|Core Period: Baseline to Week 26|Withdrawal by Subject|2
5979868|NCT01064414|20676641|P2|Core Period: Baseline to Week 26|Withdrawal by Subject|2
5979869|NCT01064414|20676642|P1|Core Period: Baseline to Week 26|Withdrawal by Subject|4
5979870|NCT01064414|20676640|P3|Core Period: Baseline to Week 26|Protocol Violation|1
5979871|NCT01064414|20676641|P2|Core Period: Baseline to Week 26|Protocol Violation|0
5979872|NCT01064414|20676642|P1|Core Period: Baseline to Week 26|Protocol Violation|1
5979873|NCT01064414|20676640|P3|Core Period: Baseline to Week 26|Death|0
5979874|NCT01064414|20676641|P2|Core Period: Baseline to Week 26|Death|1
5979875|NCT01064414|20676642|P1|Core Period: Baseline to Week 26|Death|0
5979876|NCT01064414|20676640|P3|Core Period: Baseline to Week 26|Adverse Event|2
5979877|NCT01064414|20676641|P2|Core Period: Baseline to Week 26|Adverse Event|4
5979878|NCT01064414|20676642|P1|Core Period: Baseline to Week 26|Adverse Event|4
5979879|NCT01064401|20676661|P2|Overall Study|Other|1
5979880|NCT01064401|20676662|P1|Overall Study|Other|2
5979881|NCT01064401|20676661|P2|Overall Study|Site Closure|5
5979882|NCT01064401|20676662|P1|Overall Study|Site Closure|4
5979883|NCT01064401|20676661|P2|Overall Study|Noncompliance|8
5979884|NCT01064401|20676662|P1|Overall Study|Noncompliance|7
5979885|NCT01064401|20676661|P2|Overall Study|Pregnancy|7
5979886|NCT01064401|20676662|P1|Overall Study|Pregnancy|4
5979887|NCT01064401|20676661|P2|Overall Study|Death|0
5979888|NCT01064401|20676662|P1|Overall Study|Death|4
5979889|NCT01064401|20676661|P2|Overall Study|Investigator Decision|6
5979890|NCT01064401|20676662|P1|Overall Study|Investigator Decision|4
5979891|NCT01064401|20676661|P2|Overall Study|Consent Withdrawn|80
5979892|NCT01064401|20676662|P1|Overall Study|Consent Withdrawn|98
5979893|NCT01064401|20676661|P2|Overall Study|Lost to Follow-up|9
5979894|NCT01064401|20676662|P1|Overall Study|Lost to Follow-up|12
5979895|NCT01064401|20676661|P2|Overall Study|Lack of Efficacy|23
5979896|NCT01064401|20676662|P1|Overall Study|Lack of Efficacy|46
5979897|NCT01064401|20676661|P2|Overall Study|Adverse Event|56
5979898|NCT01064401|20676662|P1|Overall Study|Adverse Event|47
5979899|NCT01064310|20676711|P3|Open Label Pazopinib|Physician Decision|20
5979900|NCT01064310|20676712|P2|Open Label Pazopinib|Physician Decision|0
5979901|NCT01064310|20676713|P1|Open Label Pazopinib|Physician Decision|0
5979902|NCT01064310|20676711|P3|Open Label Pazopinib|Lack of Efficacy|51
5979903|NCT01064310|20676712|P2|Open Label Pazopinib|Lack of Efficacy|0
5979904|NCT01064310|20676713|P1|Open Label Pazopinib|Lack of Efficacy|0
5979905|NCT01064310|20676711|P3|Open Label Pazopinib|Adverse Event|12
5979906|NCT01064310|20676712|P2|Open Label Pazopinib|Adverse Event|0
5979907|NCT01064310|20676713|P1|Open Label Pazopinib|Adverse Event|0
5979908|NCT01064310|20676711|P3|Open Label Pazopinib|Withdrawal by Subject|1
5979909|NCT01064310|20676712|P2|Open Label Pazopinib|Withdrawal by Subject|0
5979910|NCT01064310|20676713|P1|Open Label Pazopinib|Withdrawal by Subject|0
5979911|NCT01064310|20676711|P3|Period 2|Lack of Efficacy|0
5979912|NCT01064310|20676712|P2|Period 2|Lack of Efficacy|4
5979913|NCT01064310|20676713|P1|Period 2|Lack of Efficacy|1
5979914|NCT01064310|20676711|P3|Period 2|Entered Open-label Period|0
5979915|NCT01064310|20676712|P2|Period 2|Entered Open-label Period|0
5979916|NCT01064310|20676713|P1|Period 2|Entered Open-label Period|1
5979917|NCT01064310|20676711|P3|Period 2|Physician Decision|0
5979918|NCT01064310|20676712|P2|Period 2|Physician Decision|1
5979919|NCT01064310|20676713|P1|Period 2|Physician Decision|0
5979920|NCT01064310|20676711|P3|Period 2|Adverse Event|0
5979921|NCT01064310|20676712|P2|Period 2|Adverse Event|1
5979922|NCT01064310|20676713|P1|Period 2|Adverse Event|2
5979923|NCT01064310|20676711|P3|Period 1|Entered Open-label Period|0
5979925|NCT01064310|20676713|P1|Period 1|Entered Open-label Period|1
5979926|NCT01064310|20676711|P3|Period 1|Lack of Efficacy|0
5979927|NCT01064310|20676712|P2|Period 1|Lack of Efficacy|5
5979928|NCT01064310|20676713|P1|Period 1|Lack of Efficacy|3
5979929|NCT01064310|20676711|P3|Period 1|Withdrawal by Subject|0
5979930|NCT01064310|20676712|P2|Period 1|Withdrawal by Subject|2
5979931|NCT01064310|20676713|P1|Period 1|Withdrawal by Subject|2
5979932|NCT01064310|20676711|P3|Period 1|Physician Decision|0
5979933|NCT01064310|20676712|P2|Period 1|Physician Decision|0
5979934|NCT01064310|20676713|P1|Period 1|Physician Decision|1
5979935|NCT01064310|20676711|P3|Period 1|Adverse Event|0
5979936|NCT01064310|20676712|P2|Period 1|Adverse Event|10
5979937|NCT01064310|20676713|P1|Period 1|Adverse Event|7
5979938|NCT01064297|20676743|P3|Overall Study|Lost to Follow-up|133
5979939|NCT01064297|20676744|P2|Overall Study|Lost to Follow-up|48
5979940|NCT01064297|20676745|P1|Overall Study|Lost to Follow-up|791
5979941|NCT01064167|20676814|P2|Overall Study|Protocol Violation|15
5979942|NCT01064167|20676815|P1|Overall Study|Protocol Violation|14
5979943|NCT01063972|20676830|P2|Overall Study|Incarcerated|1
5979944|NCT01063972|20676831|P1|Overall Study|Incarcerated|2
5979945|NCT01063972|20676830|P2|Overall Study|Death|11
5979946|NCT01063972|20676831|P1|Overall Study|Death|12
5979947|NCT01063881|20676881|P3|Overall Study|Reason for not completed not specified|0
5979948|NCT01063881|20676882|P2|Overall Study|Reason for not completed not specified|1
5979949|NCT01063881|20676883|P1|Overall Study|Reason for not completed not specified|5
5979950|NCT01063881|20676881|P3|Overall Study|Withdrawal by Subject|0
5979951|NCT01063881|20676882|P2|Overall Study|Withdrawal by Subject|1
5979952|NCT01063881|20676883|P1|Overall Study|Withdrawal by Subject|25
5979953|NCT01063881|20676881|P3|Overall Study|Lost to Follow-up|1
5979954|NCT01063881|20676882|P2|Overall Study|Lost to Follow-up|7
5979955|NCT01063881|20676883|P1|Overall Study|Lost to Follow-up|13
5979956|NCT01063881|20676881|P3|Overall Study|Adverse Event|0
5979957|NCT01063881|20676882|P2|Overall Study|Adverse Event|2
5979958|NCT01063881|20676883|P1|Overall Study|Adverse Event|12
5979959|NCT01063868|20676907|P2|Overall Study|Study Terminated By Sponsor|4
5979960|NCT01063868|20676908|P1|Overall Study|Study Terminated By Sponsor|23
5979961|NCT01063868|20676907|P2|Overall Study|Withdrawal by Subject|1
5979962|NCT01063868|20676908|P1|Overall Study|Withdrawal by Subject|3
5979963|NCT01063868|20676907|P2|Overall Study|Adverse Event|7
5979964|NCT01063868|20676908|P1|Overall Study|Adverse Event|9
5979965|NCT01063855|20676916|P2|Overall Study|Reason not specified|11
5979966|NCT01063855|20676917|P1|Overall Study|Reason not specified|13
5979967|NCT01063855|20676916|P2|Overall Study|Withdrawal by Subject|8
5979968|NCT01063855|20676917|P1|Overall Study|Withdrawal by Subject|11
5979969|NCT01063855|20676916|P2|Overall Study|Lack of Efficacy|1
5979970|NCT01063855|20676917|P1|Overall Study|Lack of Efficacy|0
5979971|NCT01063855|20676916|P2|Overall Study|Pregnancy|0
5979972|NCT01063855|20676917|P1|Overall Study|Pregnancy|1
5979973|NCT01063855|20676916|P2|Overall Study|Lost to Follow-up|4
5979974|NCT01063855|20676917|P1|Overall Study|Lost to Follow-up|8
5979975|NCT01063855|20676916|P2|Overall Study|Death|1
5979976|NCT01063855|20676917|P1|Overall Study|Death|0
5979977|NCT01063855|20676916|P2|Overall Study|Adverse Event|4
5979978|NCT01063855|20676917|P1|Overall Study|Adverse Event|4
5979979|NCT01063764|20676964|P1|2nd Period (Week 22 to the End of Study)|Protocol Violation|1
5979980|NCT01063764|20676964|P1|2nd Period (Week 22 to the End of Study)|Withdrawal by Subject|7
5979981|NCT01063764|20676964|P1|2nd Period (Week 22 to the End of Study)|Lack of Efficacy|9
5979982|NCT01063764|20676964|P1|2nd Period (Week 22 to the End of Study)|Adverse Event|3
5979983|NCT01063764|20676964|P1|1st Period (From Week 8 to Week 22)|Withdrawal by Subject|1
5979984|NCT01063764|20676964|P1|1st Period (From Week 8 to Week 22)|Lack of Efficacy|6
5979985|NCT01063764|20676964|P1|1st Period (From Week 8 to Week 22)|Adverse Event|4
5979986|NCT01063595|20676983|P2|First Intervention|Reason not Specified|1
5979987|NCT01063595|20676984|P1|First Intervention|Reason not Specified|0
5979988|NCT01063595|20676983|P2|First Intervention|Withdrawal by Subject|0
5979989|NCT01063595|20676984|P1|First Intervention|Withdrawal by Subject|1
5979990|NCT01063595|20676983|P2|First Intervention|Adverse Event|4
5979991|NCT01063595|20676984|P1|First Intervention|Adverse Event|1
5979992|NCT01063595|20676983|P2|Enrolled in Study and Randomized|Withdrawn by the Investigator|1
5979993|NCT01063595|20676984|P1|Enrolled in Study and Randomized|Withdrawn by the Investigator|0
5979994|NCT01063595|20676983|P2|Enrolled in Study and Randomized|Adverse Event|1
5979995|NCT01063595|20676984|P1|Enrolled in Study and Randomized|Adverse Event|0
5979996|NCT01063595|20676983|P2|Enrolled in Study and Randomized|Reason not Specified|0
5979997|NCT01063595|20676984|P1|Enrolled in Study and Randomized|Reason not Specified|1
5979998|NCT01063517|20676996|P2|Overall Study|Death|48
5979999|NCT01063517|20676997|P1|Overall Study|Death|33
5980000|NCT01063517|20676996|P2|Overall Study|Withdrawal by Subject|2
5980001|NCT01063517|20676997|P1|Overall Study|Withdrawal by Subject|1
5980002|NCT01063517|20676996|P2|Overall Study|Lost to Follow-up|3
5980003|NCT01063517|20676997|P1|Overall Study|Lost to Follow-up|4
5980004|NCT01063517|20676996|P2|Overall Study|Study reached data cut-off|7
5980005|NCT01063517|20676997|P1|Overall Study|Study reached data cut-off|19
5980006|NCT01063517|20676996|P2|Overall Study|Consent withdrawal|0
5980007|NCT01063517|20676997|P1|Overall Study|Consent withdrawal|1
5980008|NCT01063348|20677037|P2|Overall Study|Lost to Follow-up|10
5980009|NCT01063348|20677038|P1|Overall Study|Lost to Follow-up|3
5980010|NCT01063283|20677048|P3|Cycle 1|Technical failure in data collection|0
5980011|NCT01063283|20677049|P2|Cycle 1|Technical failure in data collection|0
5980012|NCT01063283|20677050|P1|Cycle 1|Technical failure in data collection|1
5980013|NCT01063283|20677048|P3|Cycle 1|Adverse Event|0
5980014|NCT01063283|20677049|P2|Cycle 1|Adverse Event|0
5980015|NCT01063283|20677050|P1|Cycle 1|Adverse Event|2
5980016|NCT01063153|20677064|P2|Overall Study|Physician Decision|4
5980017|NCT01063153|20677065|P1|Overall Study|Physician Decision|0
5980018|NCT01063153|20677064|P2|Overall Study|Withdrawal by Subject|1
5980019|NCT01063153|20677065|P1|Overall Study|Withdrawal by Subject|0
5980020|NCT01063153|20677064|P2|Overall Study|Lost to Follow-up|7
5980021|NCT01063153|20677065|P1|Overall Study|Lost to Follow-up|0
5980022|NCT01063153|20677064|P2|Overall Study|Found Ineligible During Screening|0
5980023|NCT01063153|20677065|P1|Overall Study|Found Ineligible During Screening|2
5980024|NCT01063062|20677096|P2|Overall Study|Miscellaneous reason|1
5980025|NCT01063062|20677097|P1|Overall Study|Miscellaneous reason|0
5980026|NCT01063062|20677096|P2|Overall Study|Lost to Follow-up|2
5980027|NCT01063062|20677097|P1|Overall Study|Lost to Follow-up|0
5980028|NCT01063062|20677096|P2|Overall Study|Investigator's request|0
5980029|NCT01063062|20677097|P1|Overall Study|Investigator's request|1
5980030|NCT01063062|20677096|P2|Overall Study|Protocol Violation|4
5980031|NCT01063062|20677097|P1|Overall Study|Protocol Violation|5
5980032|NCT01063062|20677096|P2|Overall Study|Adverse Event|4
5980033|NCT01063062|20677097|P1|Overall Study|Adverse Event|2
5980034|NCT01063062|20677096|P2|Overall Study|Patient withdrew consent|1
5980035|NCT01063062|20677097|P1|Overall Study|Patient withdrew consent|0
5980036|NCT01063036|20677151|P1|Post Dosing Follow-up Through 24 Weeks|Alternative therapy started|32
5980037|NCT01063036|20677151|P1|Post Dosing Follow-up Through 24 Weeks|Withdrawal by Subject|6
5980038|NCT01063036|20677151|P1|Post Dosing Follow-up Through 24 Weeks|Lost to Follow-up|1
5980039|NCT01063036|20677151|P1|Participants Treated With Study Drug|Pregnancy|1
5980040|NCT01063036|20677151|P1|Participants Treated With Study Drug|Lost to Follow-up|1
5980041|NCT01063036|20677151|P1|Participants Treated With Study Drug|Withdrawal by Subject|2
5980042|NCT01063036|20677151|P1|Participants Treated With Study Drug|Protocol Violation|1
5980043|NCT01063036|20677151|P1|Participants Treated With Study Drug|Adverse Event|1
5980044|NCT01062971|20677167|P2|Overall Study|Lost to Follow-up|4
5980045|NCT01062971|20677168|P1|Overall Study|Lost to Follow-up|3
5980046|NCT01062971|20677167|P2|Overall Study|Protocol Violation|3
5980047|NCT01062971|20677168|P1|Overall Study|Protocol Violation|1
5980048|NCT01062841|20677207|P2|Overall Study|Withdrawal by Study|0
5980049|NCT01062841|20677208|P1|Overall Study|Withdrawal by Study|3
5980050|NCT01062841|20677207|P2|Overall Study|Withdrawal by Subject|0
5980051|NCT01062841|20677208|P1|Overall Study|Withdrawal by Subject|2
5980052|NCT01062841|20677207|P2|Overall Study|Death|5
5980053|NCT01062841|20677208|P1|Overall Study|Death|3
5980054|NCT01062841|20677207|P2|Overall Study|Indwelling Device Removed|48
5980055|NCT01062841|20677208|P1|Overall Study|Indwelling Device Removed|41
5980056|NCT01062763|20677238|P2|Overall Study|Adverse Event|4
5980057|NCT01062763|20677239|P1|Overall Study|Adverse Event|3
5980058|NCT01062555|20677265|P4|Phase 2|Physician Decision|17
5980059|NCT01062555|20677266|P3|Phase 2|Physician Decision|0
5980060|NCT01062555|20677267|P2|Phase 2|Physician Decision|0
5980061|NCT01062555|20677268|P1|Phase 2|Physician Decision|0
5980062|NCT01062555|20677265|P4|Phase 2|Protocol Violation|3
5980063|NCT01062555|20677266|P3|Phase 2|Protocol Violation|0
5980064|NCT01062555|20677267|P2|Phase 2|Protocol Violation|0
5980065|NCT01062555|20677268|P1|Phase 2|Protocol Violation|0
5980066|NCT01062555|20677265|P4|Phase 2|Withdrawal by Subject|7
5980067|NCT01062555|20677266|P3|Phase 2|Withdrawal by Subject|0
5980068|NCT01062555|20677267|P2|Phase 2|Withdrawal by Subject|0
5980069|NCT01062555|20677268|P1|Phase 2|Withdrawal by Subject|0
5980070|NCT01062555|20677265|P4|Phase 2|Graft failure|4
5980071|NCT01062555|20677266|P3|Phase 2|Graft failure|7
5980072|NCT01062555|20677267|P2|Phase 2|Graft failure|0
5980073|NCT01062555|20677268|P1|Phase 2|Graft failure|0
5980074|NCT01062555|20677265|P4|Phase 2|Death|3
5980075|NCT01062555|20677266|P3|Phase 2|Death|8
5980076|NCT01062555|20677267|P2|Phase 2|Death|0
5980077|NCT01062555|20677268|P1|Phase 2|Death|0
5980078|NCT01062555|20677265|P4|Phase 1|Withdrawal by Subject|0
5980079|NCT01062555|20677266|P3|Phase 1|Withdrawal by Subject|0
5980080|NCT01062555|20677267|P2|Phase 1|Withdrawal by Subject|1
5980081|NCT01062555|20677268|P1|Phase 1|Withdrawal by Subject|1
5980082|NCT01062555|20677265|P4|Phase 1|Graft Failure|0
5980083|NCT01062555|20677266|P3|Phase 1|Graft Failure|0
5980084|NCT01062555|20677267|P2|Phase 1|Graft Failure|8
5980085|NCT01062555|20677268|P1|Phase 1|Graft Failure|12
5980086|NCT01062555|20677265|P4|Phase 1|Death|0
5980087|NCT01062555|20677266|P3|Phase 1|Death|0
5980088|NCT01062555|20677267|P2|Phase 1|Death|17
5980089|NCT01062555|20677268|P1|Phase 1|Death|10
5980090|NCT01062425|20677288|P2|Overall Study|Protocol Violation|6
5980091|NCT01062425|20677289|P1|Overall Study|Protocol Violation|3
5980092|NCT01062399|20677306|P5|Overall Study|Protocol Violation|4
5980093|NCT01062399|20677307|P4|Overall Study|Protocol Violation|6
5980094|NCT01062399|20677308|P3|Overall Study|Protocol Violation|0
5980095|NCT01062399|20677309|P2|Overall Study|Protocol Violation|1
5980096|NCT01062399|20677310|P1|Overall Study|Protocol Violation|0
5980097|NCT01062256|20677354|P3|Overall Study|Administrative|0
5980098|NCT01062256|20677355|P2|Overall Study|Administrative|2
5980099|NCT01062256|20677356|P1|Overall Study|Administrative|0
5980100|NCT01062256|20677354|P3|Overall Study|Ineligible|3
5980101|NCT01062256|20677355|P2|Overall Study|Ineligible|4
5980102|NCT01062256|20677356|P1|Overall Study|Ineligible|1
5980103|NCT01062256|20677354|P3|Overall Study|Withdrawal by Subject|1
5980104|NCT01062256|20677355|P2|Overall Study|Withdrawal by Subject|1
5980105|NCT01062256|20677356|P1|Overall Study|Withdrawal by Subject|1
5980106|NCT01062256|20677354|P3|Overall Study|Adverse Event|0
5980107|NCT01062256|20677355|P2|Overall Study|Adverse Event|0
5980108|NCT01062256|20677356|P1|Overall Study|Adverse Event|1
5980109|NCT01062126|20677387|P1|Overall Study|All Withdrawals|324
5980110|NCT01062126|20677387|P1|Overall Study|Death|209
5980120|NCT01062061|20677414|P1|Overall Study|Failed to meet inclusion criteria|2
5980121|NCT01062061|20677414|P1|Overall Study|Outside chief indications|10
5980122|NCT01062061|20677414|P1|Overall Study|Investigated before study start|13
5980123|NCT01062061|20677414|P1|Overall Study|Enrolled more than once|2
5980124|NCT01061866|20677453|P1|Overall Study|Adverse Event|2
5980125|NCT01061775|20677457|P1|Overall Study|Lost to Follow-up|1
5980126|NCT01061775|20677457|P1|Overall Study|Physician Decision|2
5980127|NCT01061736|20677474|P10|Overall Study|Other than specified above|21
5980128|NCT01061736|20677475|P9|Overall Study|Other than specified above|15
5980129|NCT01061736|20677476|P8|Overall Study|Other than specified above|18
5980130|NCT01061736|20677477|P7|Overall Study|Other than specified above|0
5980131|NCT01061736|20677478|P6|Overall Study|Other than specified above|0
5980132|NCT01061736|20677479|P5|Overall Study|Other than specified above|1
5980133|NCT01061736|20677480|P4|Overall Study|Other than specified above|0
5980134|NCT01061736|20677481|P3|Overall Study|Other than specified above|2
5980135|NCT01061736|20677482|P2|Overall Study|Other than specified above|1
5980136|NCT01061736|20677483|P1|Overall Study|Other than specified above|0
5980137|NCT01061736|20677474|P10|Overall Study|Not treated|0
5980138|NCT01061736|20677475|P9|Overall Study|Not treated|1
5980139|NCT01061736|20677476|P8|Overall Study|Not treated|2
5980140|NCT01061736|20677477|P7|Overall Study|Not treated|0
5980141|NCT01061736|20677478|P6|Overall Study|Not treated|0
5980142|NCT01061736|20677479|P5|Overall Study|Not treated|1
5980143|NCT01061736|20677480|P4|Overall Study|Not treated|0
5980144|NCT01061736|20677481|P3|Overall Study|Not treated|0
5980145|NCT01061736|20677482|P2|Overall Study|Not treated|0
5980146|NCT01061736|20677483|P1|Overall Study|Not treated|0
5980147|NCT01061736|20677474|P10|Overall Study|Poor compliance to protocol|9
5980148|NCT01061736|20677475|P9|Overall Study|Poor compliance to protocol|5
5980149|NCT01061736|20677476|P8|Overall Study|Poor compliance to protocol|2
5980150|NCT01061736|20677477|P7|Overall Study|Poor compliance to protocol|0
5980151|NCT01061736|20677478|P6|Overall Study|Poor compliance to protocol|0
5980152|NCT01061736|20677479|P5|Overall Study|Poor compliance to protocol|0
5980153|NCT01061736|20677480|P4|Overall Study|Poor compliance to protocol|0
5980154|NCT01061736|20677481|P3|Overall Study|Poor compliance to protocol|0
5980155|NCT01061736|20677482|P2|Overall Study|Poor compliance to protocol|0
5980156|NCT01061736|20677483|P1|Overall Study|Poor compliance to protocol|0
5980157|NCT01061736|20677474|P10|Overall Study|Lack of Efficacy|10
5980158|NCT01061736|20677475|P9|Overall Study|Lack of Efficacy|9
5980159|NCT01061736|20677476|P8|Overall Study|Lack of Efficacy|9
5980160|NCT01061736|20677477|P7|Overall Study|Lack of Efficacy|1
5980161|NCT01061736|20677478|P6|Overall Study|Lack of Efficacy|2
5980162|NCT01061736|20677479|P5|Overall Study|Lack of Efficacy|1
5980163|NCT01061736|20677480|P4|Overall Study|Lack of Efficacy|1
5980164|NCT01061736|20677481|P3|Overall Study|Lack of Efficacy|1
5980165|NCT01061736|20677482|P2|Overall Study|Lack of Efficacy|2
5980166|NCT01061736|20677483|P1|Overall Study|Lack of Efficacy|0
5980167|NCT01061736|20677474|P10|Overall Study|Adverse Event|34
5980168|NCT01061736|20677475|P9|Overall Study|Adverse Event|67
5980169|NCT01061736|20677476|P8|Overall Study|Adverse Event|63
5980170|NCT01061736|20677477|P7|Overall Study|Adverse Event|4
5980171|NCT01061736|20677478|P6|Overall Study|Adverse Event|1
5980172|NCT01061736|20677479|P5|Overall Study|Adverse Event|4
5980173|NCT01061736|20677480|P4|Overall Study|Adverse Event|2
5980174|NCT01061736|20677481|P3|Overall Study|Adverse Event|3
5980175|NCT01061736|20677482|P2|Overall Study|Adverse Event|1
5980176|NCT01061736|20677483|P1|Overall Study|Adverse Event|13
5980177|NCT01061736|20677474|P10|Overall Study|Dose regimen not selected|0
5980178|NCT01061736|20677475|P9|Overall Study|Dose regimen not selected|0
5980179|NCT01061736|20677476|P8|Overall Study|Dose regimen not selected|0
5980180|NCT01061736|20677477|P7|Overall Study|Dose regimen not selected|79
5980181|NCT01061736|20677478|P6|Overall Study|Dose regimen not selected|0
5980182|NCT01061736|20677479|P5|Overall Study|Dose regimen not selected|0
5980183|NCT01061736|20677480|P4|Overall Study|Dose regimen not selected|0
5980184|NCT01061736|20677481|P3|Overall Study|Dose regimen not selected|0
5980185|NCT01061736|20677482|P2|Overall Study|Dose regimen not selected|0
5980186|NCT01061736|20677483|P1|Overall Study|Dose regimen not selected|0
5980187|NCT01061723|20677522|P6|Overall Study|Other than specified above|1
5980188|NCT01061723|20677523|P5|Overall Study|Other than specified above|0
5980189|NCT01061723|20677524|P4|Overall Study|Other than specified above|1
5980190|NCT01061723|20677525|P3|Overall Study|Other than specified above|1
5980191|NCT01061723|20677526|P2|Overall Study|Other than specified above|1
5980192|NCT01061723|20677527|P1|Overall Study|Other than specified above|2
5980193|NCT01061723|20677522|P6|Overall Study|Randomized but not treated|1
5980194|NCT01061723|20677523|P5|Overall Study|Randomized but not treated|0
5980195|NCT01061723|20677524|P4|Overall Study|Randomized but not treated|0
5980196|NCT01061723|20677525|P3|Overall Study|Randomized but not treated|0
5980197|NCT01061723|20677526|P2|Overall Study|Randomized but not treated|0
5980198|NCT01061723|20677527|P1|Overall Study|Randomized but not treated|0
5980199|NCT01061723|20677522|P6|Overall Study|Lack of Efficacy|1
5980200|NCT01061723|20677523|P5|Overall Study|Lack of Efficacy|1
5980201|NCT01061723|20677524|P4|Overall Study|Lack of Efficacy|2
5980202|NCT01061723|20677525|P3|Overall Study|Lack of Efficacy|4
5980203|NCT01061723|20677526|P2|Overall Study|Lack of Efficacy|3
5980204|NCT01061723|20677527|P1|Overall Study|Lack of Efficacy|2
5980205|NCT01061723|20677522|P6|Overall Study|Adverse Event|6
5980206|NCT01061723|20677523|P5|Overall Study|Adverse Event|2
5980207|NCT01061723|20677524|P4|Overall Study|Adverse Event|5
5980208|NCT01061723|20677525|P3|Overall Study|Adverse Event|5
5980209|NCT01061723|20677526|P2|Overall Study|Adverse Event|2
5980210|NCT01061723|20677527|P1|Overall Study|Adverse Event|0
5980211|NCT01061710|20677607|P1|Overall Study|Protocol Violation|14
5980212|NCT01061671|20677617|P2|Overall Study|Death|30
5980213|NCT01061671|20677618|P1|Overall Study|Death|28
5980214|NCT01061671|20677617|P2|Overall Study|Lost to Follow-up|5
5980215|NCT01061671|20677618|P1|Overall Study|Lost to Follow-up|3
5980216|NCT01061671|20677617|P2|Overall Study|Withdrawal by Subject|20
5980217|NCT01061671|20677618|P1|Overall Study|Withdrawal by Subject|16
5980218|NCT01061606|20677630|P1|Overall Study|alternative therapy|2
5980219|NCT01061606|20677630|P1|Overall Study|Disease Progression|4
5980220|NCT01061606|20677630|P1|Overall Study|Death|1
5980221|NCT01061606|20677630|P1|Overall Study|Adverse Event|1
5980222|NCT01061567|20677639|P1|Overall Study|Other reason than stated above|3
5980223|NCT01061567|20677639|P1|Overall Study|Withdrawal by Subject|11
5980224|NCT01061567|20677639|P1|Overall Study|Protocol Violation|1
5980225|NCT01061567|20677639|P1|Overall Study|Lost to Follow-up|24
5980226|NCT01061567|20677639|P1|Overall Study|Lack of Efficacy|3
5980227|NCT01061567|20677639|P1|Overall Study|Death|2
5980228|NCT01061567|20677639|P1|Overall Study|Adverse Event|32
5980229|NCT01061385|20677663|P2|Overall Study|subject decision not related to AE|1
5980230|NCT01061385|20677664|P1|Overall Study|subject decision not related to AE|0
5980231|NCT01061385|20677663|P2|Overall Study|Lost to Follow-up|0
5980232|NCT01061385|20677664|P1|Overall Study|Lost to Follow-up|1
5980233|NCT01061359|20677672|P1|Overall Study|Secondary neoplasm|11
5980234|NCT01061359|20677672|P1|Overall Study|Relapse|187
5980235|NCT01061359|20677672|P1|Overall Study|Lost to Follow-up|1072
5980236|NCT01061359|20677672|P1|Overall Study|Death|32
5980237|NCT01061333|20677678|P2|Period 4: 20-day Washout|Discontinued by Study Team|1
5980238|NCT01061333|20677679|P1|Period 4: 20-day Washout|Discontinued by Study Team|0
5980239|NCT01061177|20677717|P1|Overall Study|Death|4
5980240|NCT01061177|20677717|P1|Overall Study|Administratie problems|4
5980241|NCT01061177|20677717|P1|Overall Study|Abnormal test procedure results|4
5980242|NCT01061177|20677717|P1|Overall Study|Abnormal laboratory values|6
5980243|NCT01061177|20677717|P1|Overall Study|New cancer therapy|9
5980244|NCT01061177|20677717|P1|Overall Study|Lost to Follow-up|9
5980245|NCT01061177|20677717|P1|Overall Study|Protocol Violation|11
5980246|NCT01061177|20677717|P1|Overall Study|Disease progression|17
5980247|NCT01061177|20677717|P1|Overall Study|Withdrawal by Subject|27
5980248|NCT01061177|20677717|P1|Overall Study|Adverse Event|117
5980249|NCT01061151|20677740|P4|Protocol Version 3.0: 10/2012-10/2014|Other Reason|3
5980250|NCT01061151|20677741|P3|Protocol Version 3.0: 10/2012-10/2014|Other Reason|1
5980251|NCT01061151|20677742|P2|Protocol Version 3.0: 10/2012-10/2014|Other Reason|8
5980252|NCT01061151|20677743|P1|Protocol Version 3.0: 10/2012-10/2014|Other Reason|5
5980253|NCT01061151|20677740|P4|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|5
5980254|NCT01061151|20677741|P3|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|15
5980255|NCT01061151|20677742|P2|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|26
5980256|NCT01061151|20677743|P1|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|28
5980257|NCT01061151|20677740|P4|Protocol Version 3.0: 10/2012-10/2014|Site Closure|0
5980258|NCT01061151|20677741|P3|Protocol Version 3.0: 10/2012-10/2014|Site Closure|2
5980259|NCT01061151|20677742|P2|Protocol Version 3.0: 10/2012-10/2014|Site Closure|11
5980260|NCT01061151|20677743|P1|Protocol Version 3.0: 10/2012-10/2014|Site Closure|12
5980261|NCT01061151|20677740|P4|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|4
5980262|NCT01061151|20677741|P3|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|25
5980263|NCT01061151|20677742|P2|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|36
5980264|NCT01061151|20677743|P1|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|49
5980265|NCT01061151|20677740|P4|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|3
5980266|NCT01061151|20677741|P3|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|31
5980267|NCT01061151|20677742|P2|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|52
5980268|NCT01061151|20677743|P1|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|54
5980269|NCT01061151|20677740|P4|Protocol Version 3.0: 10/2012-10/2014|Death|1
5980270|NCT01061151|20677741|P3|Protocol Version 3.0: 10/2012-10/2014|Death|1
5980271|NCT01061151|20677742|P2|Protocol Version 3.0: 10/2012-10/2014|Death|5
5980272|NCT01061151|20677743|P1|Protocol Version 3.0: 10/2012-10/2014|Death|3
5980273|NCT01061151|20677740|P4|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0
5980274|NCT01061151|20677741|P3|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0
5980275|NCT01061151|20677742|P2|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0
5980276|NCT01061151|20677743|P1|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|1
5980277|NCT01061151|20677740|P4|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|4
5980278|NCT01061151|20677741|P3|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|2
5980279|NCT01061151|20677742|P2|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0
5980280|NCT01061151|20677743|P1|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0
5980281|NCT01061151|20677740|P4|Protocol Version 2.0: 04/2011-09/2012|Other Reason|0
5980282|NCT01061151|20677741|P3|Protocol Version 2.0: 04/2011-09/2012|Other Reason|1
5980283|NCT01061151|20677742|P2|Protocol Version 2.0: 04/2011-09/2012|Other Reason|5
5980284|NCT01061151|20677743|P1|Protocol Version 2.0: 04/2011-09/2012|Other Reason|3
5980285|NCT01061151|20677740|P4|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|5
5980286|NCT01061151|20677741|P3|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|2
5980287|NCT01061151|20677742|P2|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|61
5980288|NCT01061151|20677743|P1|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|44
5980289|NCT01061151|20677740|P4|Protocol Version 2.0: 04/2011-09/2012|Site Closure|0
5980290|NCT01061151|20677741|P3|Protocol Version 2.0: 04/2011-09/2012|Site Closure|1
5980291|NCT01061151|20677742|P2|Protocol Version 2.0: 04/2011-09/2012|Site Closure|19
5980292|NCT01061151|20677743|P1|Protocol Version 2.0: 04/2011-09/2012|Site Closure|15
5980293|NCT01061151|20677740|P4|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|10
5980294|NCT01061151|20677741|P3|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|2
5980295|NCT01061151|20677742|P2|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|65
5980296|NCT01061151|20677743|P1|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|73
5980297|NCT01061151|20677740|P4|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|10
5980298|NCT01061151|20677741|P3|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|2
5980299|NCT01061151|20677742|P2|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|82
5980300|NCT01061151|20677743|P1|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|89
5980301|NCT01061151|20677740|P4|Protocol Version 2.0: 04/2011-09/2012|Death|2
5980302|NCT01061151|20677741|P3|Protocol Version 2.0: 04/2011-09/2012|Death|1
5980303|NCT01061151|20677742|P2|Protocol Version 2.0: 04/2011-09/2012|Death|9
5980304|NCT01061151|20677743|P1|Protocol Version 2.0: 04/2011-09/2012|Death|6
5980305|NCT01061151|20677740|P4|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|1
5980306|NCT01061151|20677741|P3|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0
5980307|NCT01061151|20677742|P2|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0
5980308|NCT01061151|20677743|P1|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|2
5980309|NCT01061008|20677802|P2|Overall Study|Adverse Event|1
5980310|NCT01061008|20677803|P1|Overall Study|Adverse Event|0
5980311|NCT01061008|20677802|P2|Overall Study|Unable to exercise following surgery|0
5980312|NCT01061008|20677803|P1|Overall Study|Unable to exercise following surgery|1
5980313|NCT01061008|20677802|P2|Overall Study|Withdrawal by Subject|3
5980314|NCT01061008|20677803|P1|Overall Study|Withdrawal by Subject|1
5980315|NCT01061008|20677802|P2|Overall Study|Death|0
5980316|NCT01061008|20677803|P1|Overall Study|Death|1
5980317|NCT01061008|20677802|P2|Overall Study|Badiocephalic fistula failed|2
5980318|NCT01061008|20677803|P1|Overall Study|Badiocephalic fistula failed|3
5980319|NCT01060670|20677811|P2|Run In|screen failure|238
5980320|NCT01060670|20677812|P1|Run In|screen failure|0
5980321|NCT01060553|20677847|P2|Overall Study|Lack of Efficacy|0
5980322|NCT01060553|20677848|P1|Overall Study|Lack of Efficacy|1
5980323|NCT01060553|20677847|P2|Overall Study|Withdrawal by Subject|5
5980324|NCT01060553|20677848|P1|Overall Study|Withdrawal by Subject|5
5980325|NCT01060553|20677847|P2|Overall Study|Lost to Follow-up|5
5980326|NCT01060553|20677848|P1|Overall Study|Lost to Follow-up|3
5980327|NCT01060540|20677855|P2|Overall Study|Physician Decision|1
5980328|NCT01060540|20677856|P1|Overall Study|Physician Decision|0
5980329|NCT01060540|20677855|P2|Overall Study|Death|1
5980330|NCT01060540|20677856|P1|Overall Study|Death|2
5980331|NCT01060540|20677855|P2|Overall Study|Lost to Follow-up|43
5980332|NCT01060540|20677856|P1|Overall Study|Lost to Follow-up|52
5980333|NCT01060540|20677855|P2|Overall Study|Withdrawal by Subject|20
5980334|NCT01060540|20677856|P1|Overall Study|Withdrawal by Subject|10
5980335|NCT01060384|20677870|P5|Overall Study|Intercurrent illness|1
5980336|NCT01060384|20677871|P4|Overall Study|Intercurrent illness|0
5980337|NCT01060384|20677872|P3|Overall Study|Intercurrent illness|0
5980338|NCT01060384|20677873|P2|Overall Study|Intercurrent illness|0
5980339|NCT01060384|20677874|P1|Overall Study|Intercurrent illness|0
5980340|NCT01060384|20677870|P5|Overall Study|Death|1
5980341|NCT01060384|20677871|P4|Overall Study|Death|0
5980342|NCT01060384|20677872|P3|Overall Study|Death|0
5980343|NCT01060384|20677873|P2|Overall Study|Death|0
5980344|NCT01060384|20677874|P1|Overall Study|Death|0
5980345|NCT01060384|20677870|P5|Overall Study|Withdrawal by Subject|0
5980346|NCT01060384|20677871|P4|Overall Study|Withdrawal by Subject|0
5980347|NCT01060384|20677872|P3|Overall Study|Withdrawal by Subject|0
5980348|NCT01060384|20677873|P2|Overall Study|Withdrawal by Subject|1
5980349|NCT01060384|20677874|P1|Overall Study|Withdrawal by Subject|0
5980350|NCT01060150|20677893|P1|Overall Study|Enrolled, but not treated|2
5980351|NCT01060150|20677893|P1|Overall Study|Withdrawal by Subject|8
5980352|NCT01060150|20677893|P1|Overall Study|Protocol Violation|6
5980353|NCT01060150|20677893|P1|Overall Study|Lost to Follow-up|1
5980354|NCT01060150|20677893|P1|Overall Study|Adverse Event|6
5980355|NCT01060124|20677908|P1|Overall Study|Withdrawal by Subject|7
5980356|NCT01060124|20677908|P1|Overall Study|Adverse Event|14
5980357|NCT01060124|20677908|P1|Overall Study|Other|16
5980358|NCT01060111|20677919|P3|Overall Study|Other|4
5980359|NCT01060111|20677920|P2|Overall Study|Other|3
5980360|NCT01060111|20677921|P1|Overall Study|Other|2
5980361|NCT01060111|20677919|P3|Overall Study|Participants' non-cooperation|0
5980362|NCT01060111|20677920|P2|Overall Study|Participants' non-cooperation|0
5980363|NCT01060111|20677921|P1|Overall Study|Participants' non-cooperation|1
5980364|NCT01060111|20677919|P3|Overall Study|Adverse event and insufficient effect|0
5980365|NCT01060111|20677920|P2|Overall Study|Adverse event and insufficient effect|1
5980366|NCT01060111|20677921|P1|Overall Study|Adverse event and insufficient effect|0
5980367|NCT01060111|20677919|P3|Overall Study|Participants' non-cooperation|6
5980368|NCT01060111|20677920|P2|Overall Study|Participants' non-cooperation|6
5980369|NCT01060111|20677921|P1|Overall Study|Participants' non-cooperation|8
5980370|NCT01060111|20677919|P3|Overall Study|Participants' evasion for hospital visit|2
5980371|NCT01060111|20677920|P2|Overall Study|Participants' evasion for hospital visit|3
5980372|NCT01060111|20677921|P1|Overall Study|Participants' evasion for hospital visit|0
5980373|NCT01060111|20677919|P3|Overall Study|Inappropriate participant|5
5980374|NCT01060111|20677920|P2|Overall Study|Inappropriate participant|4
5980375|NCT01060111|20677921|P1|Overall Study|Inappropriate participant|5
5980376|NCT01060111|20677919|P3|Overall Study|Lack of Efficacy|0
5980377|NCT01060111|20677920|P2|Overall Study|Lack of Efficacy|1
5980378|NCT01060111|20677921|P1|Overall Study|Lack of Efficacy|2
5980379|NCT01060111|20677919|P3|Overall Study|Adverse Event|18
5980380|NCT01060111|20677920|P2|Overall Study|Adverse Event|5
5980381|NCT01060111|20677921|P1|Overall Study|Adverse Event|9
5980382|NCT01060072|20677953|P2|Overall Study|Excluded Medications|1
5980383|NCT01060072|20677954|P1|Overall Study|Excluded Medications|0
5980384|NCT01060072|20677953|P2|Overall Study|Acute cholecystitis|0
5980385|NCT01060072|20677954|P1|Overall Study|Acute cholecystitis|1
5980386|NCT01060072|20677953|P2|Overall Study|Protocol Violation|1
5980387|NCT01060072|20677954|P1|Overall Study|Protocol Violation|0
5980388|NCT01060072|20677953|P2|Overall Study|Physician Decision|2
5980389|NCT01060072|20677954|P1|Overall Study|Physician Decision|0
5980390|NCT01060072|20677953|P2|Overall Study|Adverse Event|1
5980391|NCT01060072|20677954|P1|Overall Study|Adverse Event|1
5980392|NCT01060059|20677970|P2|Overall Study|lack of compliance|2
5980393|NCT01060059|20677971|P1|Overall Study|lack of compliance|5
5980394|NCT01060059|20677970|P2|Overall Study|lack of glycemic control|1
5980395|NCT01060059|20677971|P1|Overall Study|lack of glycemic control|2
5980396|NCT01060059|20677970|P2|Overall Study|Withdrawal by Subject|23
5980397|NCT01060059|20677971|P1|Overall Study|Withdrawal by Subject|35
5980398|NCT01060059|20677970|P2|Overall Study|entry criteria not met|3
5980399|NCT01060059|20677971|P1|Overall Study|entry criteria not met|4
5980400|NCT01060059|20677970|P2|Overall Study|Lost to Follow-up|34
5980401|NCT01060059|20677971|P1|Overall Study|Lost to Follow-up|18
5980402|NCT01060059|20677970|P2|Overall Study|Death|3
5980403|NCT01060059|20677971|P1|Overall Study|Death|2
5980404|NCT01060059|20677970|P2|Overall Study|Adverse Event|1
5980405|NCT01060059|20677971|P1|Overall Study|Adverse Event|1
5980406|NCT01060007|20678029|P1|Overall Study|Inevaluable for response at surgery|3
5980407|NCT01060007|20678029|P1|Overall Study|Withdrawal by Subject|1
5980408|NCT01059903|20678097|P2|Period 1: First Intervention- 24 Hours|Adverse Event|1
5980409|NCT01059903|20678098|P1|Period 1: First Intervention- 24 Hours|Adverse Event|1
5980410|NCT01059864|20678141|P3|Double-Blind Treatment Phase|Adverse Event|3
5980411|NCT01059864|20678142|P2|Double-Blind Treatment Phase|Adverse Event|3
5980412|NCT01059864|20678143|P1|Double-Blind Treatment Phase|Adverse Event|0
5980413|NCT01059864|20678141|P3|Open-Label Run-In Phase|Protocol Violation|0
5980414|NCT01059864|20678142|P2|Open-Label Run-In Phase|Protocol Violation|0
5980415|NCT01059864|20678143|P1|Open-Label Run-In Phase|Protocol Violation|2
5980416|NCT01059864|20678141|P3|Open-Label Run-In Phase|Withdrawal by Subject|0
5980417|NCT01059864|20678142|P2|Open-Label Run-In Phase|Withdrawal by Subject|0
5980418|NCT01059864|20678143|P1|Open-Label Run-In Phase|Withdrawal by Subject|1
5980419|NCT01059864|20678141|P3|Open-Label Run-In Phase|Lost to Follow-up|0
5980420|NCT01059864|20678142|P2|Open-Label Run-In Phase|Lost to Follow-up|0
5980421|NCT01059864|20678143|P1|Open-Label Run-In Phase|Lost to Follow-up|2
5980422|NCT01059864|20678141|P3|Open-Label Run-In Phase|Lack of Efficacy|0
5980423|NCT01059864|20678142|P2|Open-Label Run-In Phase|Lack of Efficacy|0
5980424|NCT01059864|20678143|P1|Open-Label Run-In Phase|Lack of Efficacy|1
5980425|NCT01059864|20678141|P3|Open-Label Run-In Phase|Adverse Event|0
5980426|NCT01059864|20678142|P2|Open-Label Run-In Phase|Adverse Event|0
5980427|NCT01059864|20678143|P1|Open-Label Run-In Phase|Adverse Event|7
5980428|NCT01059825|20678217|P7|Treatment Period|Adverse event not related to study drug|0
5980429|NCT01059825|20678218|P6|Treatment Period|Adverse event not related to study drug|1
5980430|NCT01059825|20678219|P5|Treatment Period|Adverse event not related to study drug|1
5980431|NCT01059825|20678220|P4|Treatment Period|Adverse event not related to study drug|1
5980432|NCT01059825|20678221|P3|Treatment Period|Adverse event not related to study drug|2
5980433|NCT01059825|20678222|P2|Treatment Period|Adverse event not related to study drug|1
5980434|NCT01059825|20678223|P1|Treatment Period|Adverse event not related to study drug|0
5980435|NCT01059825|20678217|P7|Treatment Period|Insufficient clinical response|0
5980436|NCT01059825|20678218|P6|Treatment Period|Insufficient clinical response|0
5980437|NCT01059825|20678219|P5|Treatment Period|Insufficient clinical response|0
5980438|NCT01059825|20678220|P4|Treatment Period|Insufficient clinical response|0
5980439|NCT01059825|20678221|P3|Treatment Period|Insufficient clinical response|0
5980440|NCT01059825|20678222|P2|Treatment Period|Insufficient clinical response|0
5980441|NCT01059825|20678223|P1|Treatment Period|Insufficient clinical response|3
5980442|NCT01059825|20678217|P7|Treatment Period|Adverse event related to study drug|0
5980443|NCT01059825|20678218|P6|Treatment Period|Adverse event related to study drug|0
5980444|NCT01059825|20678219|P5|Treatment Period|Adverse event related to study drug|0
5980445|NCT01059825|20678220|P4|Treatment Period|Adverse event related to study drug|1
5980446|NCT01059825|20678221|P3|Treatment Period|Adverse event related to study drug|1
5980447|NCT01059825|20678222|P2|Treatment Period|Adverse event related to study drug|0
5980448|NCT01059825|20678223|P1|Treatment Period|Adverse event related to study drug|1
5980449|NCT01059825|20678217|P7|Treatment Period|Protocol Violation|0
5980450|NCT01059825|20678218|P6|Treatment Period|Protocol Violation|1
5980451|NCT01059825|20678219|P5|Treatment Period|Protocol Violation|1
5980452|NCT01059825|20678220|P4|Treatment Period|Protocol Violation|1
5980453|NCT01059825|20678221|P3|Treatment Period|Protocol Violation|1
5980454|NCT01059825|20678222|P2|Treatment Period|Protocol Violation|0
5980455|NCT01059825|20678223|P1|Treatment Period|Protocol Violation|0
5980456|NCT01059825|20678217|P7|Treatment Period|Other reason not specified|0
5980457|NCT01059825|20678218|P6|Treatment Period|Other reason not specified|0
5980458|NCT01059825|20678219|P5|Treatment Period|Other reason not specified|0
5980459|NCT01059825|20678220|P4|Treatment Period|Other reason not specified|2
5980460|NCT01059825|20678221|P3|Treatment Period|Other reason not specified|1
5980461|NCT01059825|20678222|P2|Treatment Period|Other reason not specified|2
5980462|NCT01059825|20678223|P1|Treatment Period|Other reason not specified|1
5980463|NCT01059825|20678217|P7|Treatment Period|Withdrawal by Subject|0
5980464|NCT01059825|20678218|P6|Treatment Period|Withdrawal by Subject|1
5980465|NCT01059825|20678219|P5|Treatment Period|Withdrawal by Subject|4
5980466|NCT01059825|20678220|P4|Treatment Period|Withdrawal by Subject|5
5980467|NCT01059825|20678221|P3|Treatment Period|Withdrawal by Subject|1
5980468|NCT01059825|20678222|P2|Treatment Period|Withdrawal by Subject|0
5980469|NCT01059825|20678223|P1|Treatment Period|Withdrawal by Subject|3
5980470|NCT01059825|20678217|P7|Treatment Period|Lost to Follow-up|0
5980471|NCT01059825|20678218|P6|Treatment Period|Lost to Follow-up|0
5980472|NCT01059825|20678219|P5|Treatment Period|Lost to Follow-up|2
5980473|NCT01059825|20678220|P4|Treatment Period|Lost to Follow-up|1
5980474|NCT01059825|20678221|P3|Treatment Period|Lost to Follow-up|0
5980475|NCT01059825|20678222|P2|Treatment Period|Lost to Follow-up|1
5980476|NCT01059825|20678223|P1|Treatment Period|Lost to Follow-up|2
5980477|NCT01059825|20678217|P7|Enrolled, Run-in Period|Protocol Violation|5
5980478|NCT01059825|20678218|P6|Enrolled, Run-in Period|Protocol Violation|0
5980479|NCT01059825|20678219|P5|Enrolled, Run-in Period|Protocol Violation|0
5980480|NCT01059825|20678220|P4|Enrolled, Run-in Period|Protocol Violation|0
5980481|NCT01059825|20678221|P3|Enrolled, Run-in Period|Protocol Violation|0
5980482|NCT01059825|20678222|P2|Enrolled, Run-in Period|Protocol Violation|0
5980483|NCT01059825|20678223|P1|Enrolled, Run-in Period|Protocol Violation|0
5980484|NCT01059825|20678217|P7|Enrolled, Run-in Period|Other reason not specified|7
5980485|NCT01059825|20678218|P6|Enrolled, Run-in Period|Other reason not specified|0
5980486|NCT01059825|20678219|P5|Enrolled, Run-in Period|Other reason not specified|0
5980487|NCT01059825|20678220|P4|Enrolled, Run-in Period|Other reason not specified|0
5980488|NCT01059825|20678221|P3|Enrolled, Run-in Period|Other reason not specified|0
5980489|NCT01059825|20678222|P2|Enrolled, Run-in Period|Other reason not specified|0
5980490|NCT01059825|20678223|P1|Enrolled, Run-in Period|Other reason not specified|0
5980491|NCT01059825|20678217|P7|Enrolled, Run-in Period|Withdrawal by Subject|13
5980492|NCT01059825|20678218|P6|Enrolled, Run-in Period|Withdrawal by Subject|0
5980493|NCT01059825|20678219|P5|Enrolled, Run-in Period|Withdrawal by Subject|0
5980494|NCT01059825|20678220|P4|Enrolled, Run-in Period|Withdrawal by Subject|0
5980495|NCT01059825|20678221|P3|Enrolled, Run-in Period|Withdrawal by Subject|0
5980496|NCT01059825|20678222|P2|Enrolled, Run-in Period|Withdrawal by Subject|0
5980497|NCT01059825|20678223|P1|Enrolled, Run-in Period|Withdrawal by Subject|0
5980498|NCT01059825|20678217|P7|Enrolled, Run-in Period|Lost to Follow-up|5
5980499|NCT01059825|20678218|P6|Enrolled, Run-in Period|Lost to Follow-up|0
5980500|NCT01059825|20678219|P5|Enrolled, Run-in Period|Lost to Follow-up|0
5980501|NCT01059825|20678220|P4|Enrolled, Run-in Period|Lost to Follow-up|0
5980502|NCT01059825|20678221|P3|Enrolled, Run-in Period|Lost to Follow-up|0
5980503|NCT01059825|20678222|P2|Enrolled, Run-in Period|Lost to Follow-up|0
5980504|NCT01059825|20678223|P1|Enrolled, Run-in Period|Lost to Follow-up|0
5980505|NCT01059825|20678217|P7|Enrolled, Run-in Period|Did not meet entrance criteria|14
5980506|NCT01059825|20678218|P6|Enrolled, Run-in Period|Did not meet entrance criteria|0
5980507|NCT01059825|20678219|P5|Enrolled, Run-in Period|Did not meet entrance criteria|0
5980508|NCT01059825|20678220|P4|Enrolled, Run-in Period|Did not meet entrance criteria|0
5980509|NCT01059825|20678221|P3|Enrolled, Run-in Period|Did not meet entrance criteria|0
5980510|NCT01059825|20678222|P2|Enrolled, Run-in Period|Did not meet entrance criteria|0
5980511|NCT01059825|20678223|P1|Enrolled, Run-in Period|Did not meet entrance criteria|0
5980512|NCT01059825|20678217|P7|Enrolled, Run-in Period|Adverse event not related to study drug|3
5980513|NCT01059825|20678218|P6|Enrolled, Run-in Period|Adverse event not related to study drug|0
5980598|NCT01059539|20678897|P1|Overall Study|Reason Not Specified|2
5980514|NCT01059825|20678219|P5|Enrolled, Run-in Period|Adverse event not related to study drug|0
5980515|NCT01059825|20678220|P4|Enrolled, Run-in Period|Adverse event not related to study drug|0
5980516|NCT01059825|20678221|P3|Enrolled, Run-in Period|Adverse event not related to study drug|0
5980517|NCT01059825|20678222|P2|Enrolled, Run-in Period|Adverse event not related to study drug|0
5980518|NCT01059825|20678223|P1|Enrolled, Run-in Period|Adverse event not related to study drug|0
5980519|NCT01059812|20678410|P2|Overall Study|Unclassified|4
5980520|NCT01059812|20678411|P1|Overall Study|Unclassified|14
5980521|NCT01059812|20678410|P2|Overall Study|Withdrawal Criteria|4
5980522|NCT01059812|20678411|P1|Overall Study|Withdrawal Criteria|9
5980523|NCT01059812|20678410|P2|Overall Study|Protocol Violation|1
5980524|NCT01059812|20678411|P1|Overall Study|Protocol Violation|3
5980525|NCT01059812|20678410|P2|Overall Study|Lack of Efficacy|2
5980526|NCT01059812|20678411|P1|Overall Study|Lack of Efficacy|2
5980527|NCT01059812|20678410|P2|Overall Study|Adverse Event|5
5980528|NCT01059812|20678411|P1|Overall Study|Adverse Event|9
5980529|NCT01059799|20678427|P2|Overall Study|Other|3
5980530|NCT01059799|20678428|P1|Overall Study|Other|12
5980531|NCT01059799|20678427|P2|Overall Study|Withdrawal criteria|2
5980532|NCT01059799|20678428|P1|Overall Study|Withdrawal criteria|13
5980533|NCT01059799|20678427|P2|Overall Study|Protocol Violation|2
5980534|NCT01059799|20678428|P1|Overall Study|Protocol Violation|3
5980535|NCT01059799|20678427|P2|Overall Study|Lack of Efficacy|0
5980536|NCT01059799|20678428|P1|Overall Study|Lack of Efficacy|1
5980537|NCT01059799|20678427|P2|Overall Study|Adverse Event|3
5980538|NCT01059799|20678428|P1|Overall Study|Adverse Event|2
5980539|NCT01059773|20678442|P2|Overall Study|Other|3
5980540|NCT01059773|20678443|P1|Overall Study|Other|1
5980541|NCT01059773|20678442|P2|Overall Study|Ineligible follow TB screening criteria|1
5980542|NCT01059773|20678443|P1|Overall Study|Ineligible follow TB screening criteria|0
5980543|NCT01059773|20678442|P2|Overall Study|Malignancy including squamous cell skin|1
5980544|NCT01059773|20678443|P1|Overall Study|Malignancy including squamous cell skin|0
5980545|NCT01059773|20678442|P2|Overall Study|Death|1
5980546|NCT01059773|20678443|P1|Overall Study|Death|0
5980547|NCT01059773|20678442|P2|Overall Study|Lack of Efficacy|3
5980548|NCT01059773|20678443|P1|Overall Study|Lack of Efficacy|3
5980549|NCT01059773|20678442|P2|Overall Study|Physician Decision|4
5980550|NCT01059773|20678443|P1|Overall Study|Physician Decision|5
5980551|NCT01059773|20678442|P2|Overall Study|Protocol Violation|2
5980552|NCT01059773|20678443|P1|Overall Study|Protocol Violation|6
5980553|NCT01059773|20678442|P2|Overall Study|Pregnancy|1
5980554|NCT01059773|20678443|P1|Overall Study|Pregnancy|1
5980555|NCT01059773|20678442|P2|Overall Study|Lost to Follow-up|1
5980556|NCT01059773|20678443|P1|Overall Study|Lost to Follow-up|1
5980557|NCT01059773|20678442|P2|Overall Study|Withdrawal by Subject|5
5980558|NCT01059773|20678443|P1|Overall Study|Withdrawal by Subject|1
5980559|NCT01059773|20678442|P2|Overall Study|Adverse Event|2
5980560|NCT01059773|20678443|P1|Overall Study|Adverse Event|2
5980561|NCT01059643|20678599|P1|Overall Study|Physician Decision|1
5980562|NCT01059643|20678599|P1|Overall Study|Withdrawal by Subject|2
5980563|NCT01059643|20678599|P1|Overall Study|Adverse Event|3
5980564|NCT01059630|20678614|P2|Overall Study|Withdrawal by Subject|14
5980565|NCT01059630|20678615|P1|Overall Study|Withdrawal by Subject|21
5980566|NCT01059630|20678614|P2|Overall Study|Physician Decision|4
5980567|NCT01059630|20678615|P1|Overall Study|Physician Decision|2
5980568|NCT01059630|20678614|P2|Overall Study|Lost to Follow-up|1
5980569|NCT01059630|20678615|P1|Overall Study|Lost to Follow-up|4
5980570|NCT01059630|20678614|P2|Overall Study|Death|84
5980571|NCT01059630|20678615|P1|Overall Study|Death|100
5980572|NCT01059617|20678689|P4|Overall Study|Other|6
5980573|NCT01059617|20678690|P3|Overall Study|Other|8
5980574|NCT01059617|20678691|P2|Overall Study|Other|1
5980575|NCT01059617|20678692|P1|Overall Study|Other|7
5980576|NCT01059565|20678862|P2|24-Week Open-Label Phase|Pulmonologist/participant decision|1
5980577|NCT01059565|20678863|P1|24-Week Open-Label Phase|Pulmonologist/participant decision|0
5980578|NCT01059565|20678862|P2|24-Week Open-Label Phase|Unable to clean device (hospitalization)|1
5980579|NCT01059565|20678863|P1|24-Week Open-Label Phase|Unable to clean device (hospitalization)|0
5980580|NCT01059565|20678862|P2|24-Week Open-Label Phase|Subject noncompliance|0
5980581|NCT01059565|20678863|P1|24-Week Open-Label Phase|Subject noncompliance|1
5980582|NCT01059565|20678862|P2|24-Week Open-Label Phase|Withdrawal by Subject|0
5980583|NCT01059565|20678863|P1|24-Week Open-Label Phase|Withdrawal by Subject|1
5980584|NCT01059565|20678862|P2|24-Week Open-Label Phase|Worsening health (physician decision)|1
5980585|NCT01059565|20678863|P1|24-Week Open-Label Phase|Worsening health (physician decision)|1
5980586|NCT01059565|20678862|P2|24-Week Open-Label Phase|Adverse Event|0
5980587|NCT01059565|20678863|P1|24-Week Open-Label Phase|Adverse Event|2
5980588|NCT01059565|20678862|P2|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|5
5980589|NCT01059565|20678863|P1|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|1
5980590|NCT01059565|20678862|P2|24-Week Randomized Phase|Lost to Follow-up|1
5980591|NCT01059565|20678863|P1|24-Week Randomized Phase|Lost to Follow-up|0
5980592|NCT01059565|20678862|P2|24-Week Randomized Phase|Withdrawal by Subject|1
5980593|NCT01059565|20678863|P1|24-Week Randomized Phase|Withdrawal by Subject|3
5980594|NCT01059565|20678862|P2|24-Week Randomized Phase|Adverse Event|0
5980595|NCT01059565|20678863|P1|24-Week Randomized Phase|Adverse Event|5
5980596|NCT01059565|20678862|P2|24-Week Randomized Phase|Randomized but not treated|0
5980597|NCT01059565|20678863|P1|24-Week Randomized Phase|Randomized but not treated|1
5980599|NCT01059539|20678897|P1|Overall Study|Lost to Follow-up|42
5980600|NCT01059539|20678897|P1|Overall Study|Withdrawal of Consent|80
5980601|NCT01059539|20678897|P1|Overall Study|Protocol Violation|55
5980602|NCT01059539|20678897|P1|Overall Study|Insufficient Therapeutic Response|26
5980603|NCT01059539|20678897|P1|Overall Study|Adverse Event|66
5980604|NCT01059526|20678904|P2|Overall Study|Patient found to be dermatographic|0
5980605|NCT01059526|20678905|P1|Overall Study|Patient found to be dermatographic|1
5980606|NCT01059526|20678904|P2|Overall Study|Lost to Follow-up|1
5980607|NCT01059526|20678905|P1|Overall Study|Lost to Follow-up|4
5980608|NCT01059526|20678904|P2|Overall Study|Withdrawal by Subject|1
5980609|NCT01059526|20678905|P1|Overall Study|Withdrawal by Subject|3
5980610|NCT01059526|20678904|P2|Overall Study|Protocol Violation|1
5980611|NCT01059526|20678905|P1|Overall Study|Protocol Violation|0
5980612|NCT01059526|20678904|P2|Overall Study|Adverse Event|2
5980613|NCT01059526|20678905|P1|Overall Study|Adverse Event|2
5980614|NCT01059526|20678904|P2|Overall Study|Patient enrolled but not treated|17
5980615|NCT01059526|20678905|P1|Overall Study|Patient enrolled but not treated|20
5980616|NCT01059344|20679251|P2|Overall Study|Other|6
5980617|NCT01059344|20679252|P1|Overall Study|Other|3
5980618|NCT01059344|20679251|P2|Overall Study|Lost to Follow-up|1
5980619|NCT01059344|20679252|P1|Overall Study|Lost to Follow-up|1
5980620|NCT01059344|20679251|P2|Overall Study|Withdrawal by Subject|9
5980621|NCT01059344|20679252|P1|Overall Study|Withdrawal by Subject|6
5980622|NCT01059344|20679251|P2|Overall Study|Adverse Event|30
5980623|NCT01059344|20679252|P1|Overall Study|Adverse Event|12
5980624|NCT01059318|20679270|P1|Extension (36 Week)|Adverse Event|3
5980625|NCT01059318|20679270|P1|Core Study (26 Week)|Withdrawal by Subject|1
5980626|NCT01059318|20679270|P1|Core Study (26 Week)|Adverse Event|3
5980627|NCT01059175|20679291|P2|Overall Study|Lost to Follow-up|1
5980628|NCT01059175|20679292|P1|Overall Study|Lost to Follow-up|0
5980629|NCT01059175|20679291|P2|Overall Study|Adverse Event|2
5980630|NCT01059175|20679292|P1|Overall Study|Adverse Event|4
5980631|NCT01059175|20679291|P2|Overall Study|Death|17
5980632|NCT01059175|20679292|P1|Overall Study|Death|17
5980633|NCT01059071|20679314|P4|Overall Study|Physician Decision|1
5980634|NCT01059071|20679315|P3|Overall Study|Physician Decision|0
5980635|NCT01059071|20679316|P2|Overall Study|Physician Decision|0
5980636|NCT01059071|20679317|P1|Overall Study|Physician Decision|0
5980637|NCT01059071|20679314|P4|Overall Study|Withdrawal by Subject|2
5980638|NCT01059071|20679315|P3|Overall Study|Withdrawal by Subject|0
5980639|NCT01059071|20679316|P2|Overall Study|Withdrawal by Subject|0
5980640|NCT01059071|20679317|P1|Overall Study|Withdrawal by Subject|1
5980641|NCT01059071|20679314|P4|Overall Study|Lack of Efficacy|3
5980642|NCT01059071|20679315|P3|Overall Study|Lack of Efficacy|2
5980643|NCT01059071|20679316|P2|Overall Study|Lack of Efficacy|4
5980644|NCT01059071|20679317|P1|Overall Study|Lack of Efficacy|1
5980645|NCT01058863|20679344|P1|Overall Study|Randomized in error|1
5980646|NCT01058863|20679344|P1|Overall Study|Sponsor requested withdrawal|1
5980647|NCT01058863|20679344|P1|Overall Study|Withdrawal by Subject|1
5980648|NCT01058863|20679344|P1|Overall Study|Lost to Follow-up|1
5980649|NCT01058707|20679369|P7|Overall Study|Reason Not Specified|7
5980650|NCT01058707|20679370|P6|Overall Study|Reason Not Specified|1
5980651|NCT01058707|20679371|P5|Overall Study|Reason Not Specified|7
5980652|NCT01058707|20679372|P4|Overall Study|Reason Not Specified|0
5980653|NCT01058707|20679373|P3|Overall Study|Reason Not Specified|2
5980654|NCT01058707|20679374|P2|Overall Study|Reason Not Specified|3
5980655|NCT01058707|20679375|P1|Overall Study|Reason Not Specified|0
5980656|NCT01058707|20679369|P7|Overall Study|Lost to Follow-up|0
5980657|NCT01058707|20679370|P6|Overall Study|Lost to Follow-up|0
5980658|NCT01058707|20679371|P5|Overall Study|Lost to Follow-up|0
5980659|NCT01058707|20679372|P4|Overall Study|Lost to Follow-up|0
5980660|NCT01058707|20679373|P3|Overall Study|Lost to Follow-up|1
5980661|NCT01058707|20679374|P2|Overall Study|Lost to Follow-up|0
5980662|NCT01058707|20679375|P1|Overall Study|Lost to Follow-up|0
5980663|NCT01058707|20679369|P7|Overall Study|Subject Decision|6
5980664|NCT01058707|20679370|P6|Overall Study|Subject Decision|3
5980665|NCT01058707|20679371|P5|Overall Study|Subject Decision|2
5980666|NCT01058707|20679372|P4|Overall Study|Subject Decision|1
5980667|NCT01058707|20679373|P3|Overall Study|Subject Decision|3
5980668|NCT01058707|20679374|P2|Overall Study|Subject Decision|3
5980669|NCT01058707|20679375|P1|Overall Study|Subject Decision|5
5980670|NCT01058707|20679369|P7|Overall Study|Adverse Event|1
5980671|NCT01058707|20679370|P6|Overall Study|Adverse Event|3
5980672|NCT01058707|20679371|P5|Overall Study|Adverse Event|7
5980673|NCT01058707|20679372|P4|Overall Study|Adverse Event|6
5980674|NCT01058707|20679373|P3|Overall Study|Adverse Event|7
5980675|NCT01058707|20679374|P2|Overall Study|Adverse Event|4
5980676|NCT01058707|20679375|P1|Overall Study|Adverse Event|11
5980677|NCT01058707|20679369|P7|Overall Study|Disease Progression|12
5980678|NCT01058707|20679370|P6|Overall Study|Disease Progression|10
5980679|NCT01058707|20679371|P5|Overall Study|Disease Progression|23
5980680|NCT01058707|20679372|P4|Overall Study|Disease Progression|15
5980681|NCT01058707|20679373|P3|Overall Study|Disease Progression|20
5980682|NCT01058707|20679374|P2|Overall Study|Disease Progression|20
5980683|NCT01058707|20679375|P1|Overall Study|Disease Progression|15
5980684|NCT01058668|20679541|P3|Double-blind Treatment Phase|Other Unspecified|0
5980685|NCT01058668|20679542|P2|Double-blind Treatment Phase|Other Unspecified|1
5980686|NCT01058668|20679543|P1|Double-blind Treatment Phase|Other Unspecified|1
5980770|NCT01058421|20679592|P2|1 Month Outcomes|Remained in Hospital|12
5980687|NCT01058668|20679541|P3|Double-blind Treatment Phase|Lost to Follow-up|1
5980688|NCT01058668|20679542|P2|Double-blind Treatment Phase|Lost to Follow-up|1
5980689|NCT01058668|20679543|P1|Double-blind Treatment Phase|Lost to Follow-up|0
5980690|NCT01058668|20679541|P3|Double-blind Treatment Phase|Withdrawal of Consent|17
5980691|NCT01058668|20679542|P2|Double-blind Treatment Phase|Withdrawal of Consent|18
5980692|NCT01058668|20679543|P1|Double-blind Treatment Phase|Withdrawal of Consent|14
5980693|NCT01058668|20679541|P3|Double-blind Treatment Phase|Protocol Violation|2
5980694|NCT01058668|20679542|P2|Double-blind Treatment Phase|Protocol Violation|1
5980695|NCT01058668|20679543|P1|Double-blind Treatment Phase|Protocol Violation|1
5980696|NCT01058668|20679541|P3|Double-blind Treatment Phase|Insufficient Therapeutic Response|5
5980697|NCT01058668|20679542|P2|Double-blind Treatment Phase|Insufficient Therapeutic Response|2
5980698|NCT01058668|20679543|P1|Double-blind Treatment Phase|Insufficient Therapeutic Response|15
5980699|NCT01058668|20679541|P3|Double-blind Treatment Phase|Adverse Event|25
5980700|NCT01058668|20679542|P2|Double-blind Treatment Phase|Adverse Event|15
5980701|NCT01058668|20679543|P1|Double-blind Treatment Phase|Adverse Event|8
5980702|NCT01058655|20679558|P4|Overall Study|Other|4
5980703|NCT01058655|20679559|P3|Overall Study|Other|0
5980704|NCT01058655|20679560|P2|Overall Study|Other|0
5980705|NCT01058655|20679561|P1|Overall Study|Other|0
5980706|NCT01058655|20679558|P4|Overall Study|Disease Progression|24
5980707|NCT01058655|20679559|P3|Overall Study|Disease Progression|4
5980708|NCT01058655|20679560|P2|Overall Study|Disease Progression|2
5980709|NCT01058655|20679561|P1|Overall Study|Disease Progression|1
5980710|NCT01058655|20679558|P4|Overall Study|Death|0
5980711|NCT01058655|20679559|P3|Overall Study|Death|1
5980712|NCT01058655|20679560|P2|Overall Study|Death|1
5980713|NCT01058655|20679561|P1|Overall Study|Death|0
5980714|NCT01058655|20679558|P4|Overall Study|Clinical Progression (non-RECIST)|7
5980715|NCT01058655|20679559|P3|Overall Study|Clinical Progression (non-RECIST)|0
5980716|NCT01058655|20679560|P2|Overall Study|Clinical Progression (non-RECIST)|0
5980717|NCT01058655|20679561|P1|Overall Study|Clinical Progression (non-RECIST)|1
5980718|NCT01058655|20679558|P4|Overall Study|Symptomatic Deterioration|1
5980719|NCT01058655|20679559|P3|Overall Study|Symptomatic Deterioration|0
5980720|NCT01058655|20679560|P2|Overall Study|Symptomatic Deterioration|0
5980721|NCT01058655|20679561|P1|Overall Study|Symptomatic Deterioration|0
5980722|NCT01058655|20679558|P4|Overall Study|Prolonged Treatment Delay|2
5980723|NCT01058655|20679559|P3|Overall Study|Prolonged Treatment Delay|0
5980724|NCT01058655|20679560|P2|Overall Study|Prolonged Treatment Delay|0
5980725|NCT01058655|20679561|P1|Overall Study|Prolonged Treatment Delay|0
5980726|NCT01058655|20679558|P4|Overall Study|Withdrawal by Subject|4
5980727|NCT01058655|20679559|P3|Overall Study|Withdrawal by Subject|3
5980728|NCT01058655|20679560|P2|Overall Study|Withdrawal by Subject|0
5980729|NCT01058655|20679561|P1|Overall Study|Withdrawal by Subject|1
5980730|NCT01058642|20679579|P4|Treatment Period 1|Lack of Compliance with Study Drug|0
5980731|NCT01058642|20679580|P3|Treatment Period 1|Lack of Compliance with Study Drug|0
5980732|NCT01058642|20679581|P2|Treatment Period 1|Lack of Compliance with Study Drug|0
5980733|NCT01058642|20679582|P1|Treatment Period 1|Lack of Compliance with Study Drug|1
5980734|NCT01058642|20679579|P4|Treatment Period 1|Protocol Violation|1
5980735|NCT01058642|20679580|P3|Treatment Period 1|Protocol Violation|0
5980736|NCT01058642|20679581|P2|Treatment Period 1|Protocol Violation|0
5980737|NCT01058642|20679582|P1|Treatment Period 1|Protocol Violation|0
5980738|NCT01058642|20679579|P4|Treatment Period 1|Lack of Efficacy|1
5980739|NCT01058642|20679580|P3|Treatment Period 1|Lack of Efficacy|0
5980740|NCT01058642|20679581|P2|Treatment Period 1|Lack of Efficacy|0
5980741|NCT01058642|20679582|P1|Treatment Period 1|Lack of Efficacy|0
5980742|NCT01058642|20679579|P4|Treatment Period 1|Withdrawal by Subject|0
5980743|NCT01058642|20679580|P3|Treatment Period 1|Withdrawal by Subject|0
5980744|NCT01058642|20679581|P2|Treatment Period 1|Withdrawal by Subject|0
5980745|NCT01058642|20679582|P1|Treatment Period 1|Withdrawal by Subject|1
5980746|NCT01058642|20679579|P4|Treatment Period 1|Physician Decision|0
5980747|NCT01058642|20679580|P3|Treatment Period 1|Physician Decision|1
5980748|NCT01058642|20679581|P2|Treatment Period 1|Physician Decision|0
5980749|NCT01058642|20679582|P1|Treatment Period 1|Physician Decision|0
5980750|NCT01058642|20679579|P4|Treatment Period 1|Adverse Event|0
5980751|NCT01058642|20679580|P3|Treatment Period 1|Adverse Event|1
5980752|NCT01058642|20679581|P2|Treatment Period 1|Adverse Event|1
5980753|NCT01058642|20679582|P1|Treatment Period 1|Adverse Event|0
5980754|NCT01058421|20679592|P2|6 Month Outcomes|Remained in Other Facility|3
5980755|NCT01058421|20679593|P1|6 Month Outcomes|Remained in Other Facility|1
5980756|NCT01058421|20679592|P2|6 Month Outcomes|Lost to Follow-up|21
5980757|NCT01058421|20679593|P1|6 Month Outcomes|Lost to Follow-up|16
5980758|NCT01058421|20679592|P2|6 Month Outcomes|Death|2
5980759|NCT01058421|20679593|P1|6 Month Outcomes|Death|2
5980760|NCT01058421|20679592|P2|3 Month Outcomes|Remained in Other Facility|8
5980761|NCT01058421|20679593|P1|3 Month Outcomes|Remained in Other Facility|5
5980762|NCT01058421|20679592|P2|3 Month Outcomes|Remained in Hospital|2
5980763|NCT01058421|20679593|P1|3 Month Outcomes|Remained in Hospital|0
5980764|NCT01058421|20679592|P2|3 Month Outcomes|Lost to Follow-up|11
5980765|NCT01058421|20679593|P1|3 Month Outcomes|Lost to Follow-up|12
5980766|NCT01058421|20679592|P2|3 Month Outcomes|Death|5
5980767|NCT01058421|20679593|P1|3 Month Outcomes|Death|3
5980768|NCT01058421|20679592|P2|1 Month Outcomes|Remained in Other Facility|17
5980769|NCT01058421|20679593|P1|1 Month Outcomes|Remained in Other Facility|16
5980771|NCT01058421|20679593|P1|1 Month Outcomes|Remained in Hospital|5
5980772|NCT01058421|20679592|P2|1 Month Outcomes|Lost to Follow-up|7
5980773|NCT01058421|20679593|P1|1 Month Outcomes|Lost to Follow-up|8
5980774|NCT01058421|20679592|P2|1 Month Outcomes|Death|6
5980775|NCT01058421|20679593|P1|1 Month Outcomes|Death|10
5980776|NCT01058395|20679617|P2|Overall Study|Lost to Follow-up|0
5980777|NCT01058395|20679618|P1|Overall Study|Lost to Follow-up|1
5980778|NCT01058395|20679617|P2|Overall Study|Death|1
5980779|NCT01058395|20679618|P1|Overall Study|Death|2
5980780|NCT01058369|20679627|P1|Overall Study|Early termination study|1
5980781|NCT01058369|20679627|P1|Overall Study|Adverse Event|1
5980782|NCT01058356|20679631|P1|Overall Study|Lost to Follow-up|4
5980783|NCT01058356|20679631|P1|Overall Study|Withdrawal by Subject|21
5980784|NCT01058356|20679631|P1|Overall Study|Administration of contraindicated drugs|12
5980785|NCT01058356|20679631|P1|Overall Study|Adverse Event|5
5980786|NCT01058304|20679638|P2|Overall Study|Developed exclusion criterion|12
5980787|NCT01058304|20679639|P1|Overall Study|Developed exclusion criterion|6
5980788|NCT01058304|20679638|P2|Overall Study|Lost to Follow-up|16
5980789|NCT01058304|20679639|P1|Overall Study|Lost to Follow-up|13
5980790|NCT01058304|20679638|P2|Overall Study|Withdrawal by Subject|5
5980791|NCT01058304|20679639|P1|Overall Study|Withdrawal by Subject|8
5980792|NCT01058265|20679649|P2|Overall Study|Lost to Follow-up|12
5980793|NCT01058265|20679650|P1|Overall Study|Lost to Follow-up|11
5980794|NCT01058096|20679669|P2|Double-blind Treatment Phase|Other Unspecified|0
5980795|NCT01058096|20679670|P1|Double-blind Treatment Phase|Other Unspecified|2
5980796|NCT01058096|20679669|P2|Double-blind Treatment Phase|Lost to Follow-up|1
5980797|NCT01058096|20679670|P1|Double-blind Treatment Phase|Lost to Follow-up|0
5980798|NCT01058096|20679669|P2|Double-blind Treatment Phase|Withdrawal of Consent|26
5980799|NCT01058096|20679670|P1|Double-blind Treatment Phase|Withdrawal of Consent|17
5980800|NCT01058096|20679669|P2|Double-blind Treatment Phase|Protocol Violation|1
5980801|NCT01058096|20679670|P1|Double-blind Treatment Phase|Protocol Violation|2
5980802|NCT01058096|20679669|P2|Double-blind Treatment Phase|Insufficient Therapeutic Response|7
5980803|NCT01058096|20679670|P1|Double-blind Treatment Phase|Insufficient Therapeutic Response|16
5980804|NCT01058096|20679669|P2|Double-blind Treatment Phase|Adverse Event|15
5980805|NCT01058096|20679670|P1|Double-blind Treatment Phase|Adverse Event|11
5980806|NCT01058005|20679686|P3|Overall Study|Reason Missing|1
5980807|NCT01058005|20679687|P2|Overall Study|Reason Missing|3
5980808|NCT01058005|20679688|P1|Overall Study|Reason Missing|5
5980809|NCT01058005|20679686|P3|Overall Study|Withdrawn Due to Study Termination|7
5980810|NCT01058005|20679687|P2|Overall Study|Withdrawn Due to Study Termination|13
5980811|NCT01058005|20679688|P1|Overall Study|Withdrawn Due to Study Termination|27
5980812|NCT01058005|20679686|P3|Overall Study|Withdrawal by Subject|11
5980813|NCT01058005|20679687|P2|Overall Study|Withdrawal by Subject|5
5980814|NCT01058005|20679688|P1|Overall Study|Withdrawal by Subject|4
5980815|NCT01058005|20679686|P3|Overall Study|Physician Decision|0
5980816|NCT01058005|20679687|P2|Overall Study|Physician Decision|2
5980817|NCT01058005|20679688|P1|Overall Study|Physician Decision|2
5980818|NCT01058005|20679686|P3|Overall Study|Adverse Event|1
5980819|NCT01058005|20679687|P2|Overall Study|Adverse Event|2
5980820|NCT01058005|20679688|P1|Overall Study|Adverse Event|0
5980821|NCT01057862|20679723|P2|Overall Study|Withdrawal by Subject|2
5980822|NCT01057862|20679724|P1|Overall Study|Withdrawal by Subject|1
5980823|NCT01057810|20679734|P2|Overall Study|Other|14
5980824|NCT01057810|20679735|P1|Overall Study|Other|7
5980825|NCT01057810|20679734|P2|Overall Study|No longer met study criteria|1
5980826|NCT01057810|20679735|P1|Overall Study|No longer met study criteria|0
5980827|NCT01057810|20679734|P2|Overall Study|Poor/non-compliance|1
5980828|NCT01057810|20679735|P1|Overall Study|Poor/non-compliance|0
5980829|NCT01057810|20679734|P2|Overall Study|Maximum clinical benefit|5
5980830|NCT01057810|20679735|P1|Overall Study|Maximum clinical benefit|5
5980831|NCT01057810|20679734|P2|Overall Study|Death|12
5980832|NCT01057810|20679735|P1|Overall Study|Death|2
5980833|NCT01057810|20679734|P2|Overall Study|Withdrawal by Subject|25
5980834|NCT01057810|20679735|P1|Overall Study|Withdrawal by Subject|10
5980835|NCT01057810|20679734|P2|Overall Study|Adverse event unrelated to study drug|29
5980836|NCT01057810|20679735|P1|Overall Study|Adverse event unrelated to study drug|13
5980837|NCT01057810|20679734|P2|Overall Study|Study drug toxicity|114
5980838|NCT01057810|20679735|P1|Overall Study|Study drug toxicity|5
5980839|NCT01057810|20679734|P2|Overall Study|Disease progression|197
5980840|NCT01057810|20679735|P1|Overall Study|Disease progression|156
5980841|NCT01057693|20679751|P3|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|2
5980842|NCT01057693|20679752|P2|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0
5980843|NCT01057693|20679753|P1|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0
5980844|NCT01057693|20679751|P3|Double-Blind Phase (Week 7 to Week 19)|Other|0
5980845|NCT01057693|20679752|P2|Double-Blind Phase (Week 7 to Week 19)|Other|1
5980846|NCT01057693|20679753|P1|Double-Blind Phase (Week 7 to Week 19)|Other|0
5980847|NCT01057693|20679751|P3|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|6
5980848|NCT01057693|20679752|P2|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|8
5980849|NCT01057693|20679753|P1|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|0
5980850|NCT01057693|20679751|P3|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|4
5980851|NCT01057693|20679752|P2|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0
5980852|NCT01057693|20679753|P1|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0
5980853|NCT01057693|20679751|P3|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|5
5980854|NCT01057693|20679752|P2|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|2
5980855|NCT01057693|20679753|P1|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|0
5980856|NCT01057693|20679751|P3|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|8
5980857|NCT01057693|20679752|P2|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|3
5980858|NCT01057693|20679753|P1|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|0
5980859|NCT01057693|20679751|P3|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|11
5980860|NCT01057693|20679752|P2|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|8
5980861|NCT01057693|20679753|P1|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|0
5980862|NCT01057693|20679751|P3|Between Single-Blind and Double-Blind|Other|0
5980863|NCT01057693|20679752|P2|Between Single-Blind and Double-Blind|Other|0
5980864|NCT01057693|20679753|P1|Between Single-Blind and Double-Blind|Other|6
5980865|NCT01057693|20679751|P3|Between Single-Blind and Double-Blind|Withdrawal by Subject|0
5980866|NCT01057693|20679752|P2|Between Single-Blind and Double-Blind|Withdrawal by Subject|0
5980867|NCT01057693|20679753|P1|Between Single-Blind and Double-Blind|Withdrawal by Subject|4
5980868|NCT01057693|20679751|P3|Between Single-Blind and Double-Blind|Protocol Violation|0
5980869|NCT01057693|20679752|P2|Between Single-Blind and Double-Blind|Protocol Violation|0
5980870|NCT01057693|20679753|P1|Between Single-Blind and Double-Blind|Protocol Violation|7
5980871|NCT01057693|20679751|P3|Between Single-Blind and Double-Blind|Lost to Follow-up|0
5980872|NCT01057693|20679752|P2|Between Single-Blind and Double-Blind|Lost to Follow-up|0
5980873|NCT01057693|20679753|P1|Between Single-Blind and Double-Blind|Lost to Follow-up|1
5980874|NCT01057693|20679751|P3|Between Single-Blind and Double-Blind|Lack of Efficacy|0
5980875|NCT01057693|20679752|P2|Between Single-Blind and Double-Blind|Lack of Efficacy|0
5980876|NCT01057693|20679753|P1|Between Single-Blind and Double-Blind|Lack of Efficacy|247
5980877|NCT01057693|20679751|P3|Between Single-Blind and Double-Blind|Adverse Event|0
5980878|NCT01057693|20679752|P2|Between Single-Blind and Double-Blind|Adverse Event|0
5980879|NCT01057693|20679753|P1|Between Single-Blind and Double-Blind|Adverse Event|5
5980880|NCT01057693|20679751|P3|Single-Blind Phase (Up to Week 6)|Other|0
5980881|NCT01057693|20679752|P2|Single-Blind Phase (Up to Week 6)|Other|0
5980882|NCT01057693|20679753|P1|Single-Blind Phase (Up to Week 6)|Other|2
5980883|NCT01057693|20679751|P3|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0
5980884|NCT01057693|20679752|P2|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0
5980885|NCT01057693|20679753|P1|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|22
5980886|NCT01057693|20679751|P3|Single-Blind Phase (Up to Week 6)|Protocol Violation|0
5980887|NCT01057693|20679752|P2|Single-Blind Phase (Up to Week 6)|Protocol Violation|0
5980888|NCT01057693|20679753|P1|Single-Blind Phase (Up to Week 6)|Protocol Violation|9
5980889|NCT01057693|20679751|P3|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0
5980890|NCT01057693|20679752|P2|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0
5980891|NCT01057693|20679753|P1|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|14
5980892|NCT01057693|20679751|P3|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0
5980893|NCT01057693|20679752|P2|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0
5980894|NCT01057693|20679753|P1|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|7
5980895|NCT01057693|20679751|P3|Single-Blind Phase (Up to Week 6)|Adverse Event|0
5980896|NCT01057693|20679752|P2|Single-Blind Phase (Up to Week 6)|Adverse Event|0
5980897|NCT01057693|20679753|P1|Single-Blind Phase (Up to Week 6)|Adverse Event|45
5980898|NCT01057589|20679799|P1|Overall Study|Lost to Follow-up|1
5980899|NCT01057589|20679799|P1|Overall Study|Death|8
5980900|NCT01057589|20679799|P1|Overall Study|Sponsor Decision|1
5980901|NCT01057589|20679799|P1|Overall Study|Withdrawal by Subject|3
5980902|NCT01057589|20679799|P1|Overall Study|Physician Decision|8
5980903|NCT01057589|20679799|P1|Overall Study|Adverse Event|10
5980904|NCT01057589|20679799|P1|Overall Study|Disease Progression|35
5980905|NCT01057433|20679808|P1|Overall Study|Adverse Event|1
5980906|NCT01057394|20679812|P2|Overall Study|Not eligible|2
5980907|NCT01057394|20679813|P1|Overall Study|Not eligible|0
5980908|NCT01057251|20679823|P2|Overall Study|Other Reason|1
5980909|NCT01057251|20679824|P1|Overall Study|Other Reason|1
5980910|NCT01057251|20679823|P2|Overall Study|Lost to Follow-up|6
5980911|NCT01057251|20679824|P1|Overall Study|Lost to Follow-up|7
5980912|NCT01057251|20679823|P2|Overall Study|Withdrawal by Subject|5
5980913|NCT01057251|20679824|P1|Overall Study|Withdrawal by Subject|4
5980914|NCT01057251|20679823|P2|Overall Study|Protocol Violation|2
5980915|NCT01057251|20679824|P1|Overall Study|Protocol Violation|6
5980916|NCT01057251|20679823|P2|Overall Study|Lack of Efficacy|11
5980917|NCT01057251|20679824|P1|Overall Study|Lack of Efficacy|2
5980918|NCT01057251|20679823|P2|Overall Study|Adverse Event|2
5980919|NCT01057251|20679824|P1|Overall Study|Adverse Event|4
5980920|NCT01057251|20679823|P2|Overall Study|Did not meet InclusionExclusion criteria|2
5980921|NCT01057251|20679824|P1|Overall Study|Did not meet InclusionExclusion criteria|4
5980922|NCT01056822|20679902|P2|Overall Study|Lost to Follow-up|0
5980923|NCT01056822|20679903|P1|Overall Study|Lost to Follow-up|1
5980924|NCT01056822|20679902|P2|Overall Study|Withdrawal by Subject|1
5980925|NCT01056822|20679903|P1|Overall Study|Withdrawal by Subject|1
5980926|NCT01056822|20679902|P2|Overall Study|Protocol Violation|5
5980927|NCT01056822|20679903|P1|Overall Study|Protocol Violation|6
5980928|NCT01056822|20679902|P2|Overall Study|Adverse Event|1
5980929|NCT01056822|20679903|P1|Overall Study|Adverse Event|0
5980930|NCT01056718|20679952|P1|Overall Study|Ischemia on baseline stress test|1
5980931|NCT01056718|20679952|P1|Overall Study|Withdrawal by Subject|2
5980932|NCT01056653|20679985|P3|Overall Study|Lost to Follow-up|2
5980933|NCT01056653|20679986|P2|Overall Study|Lost to Follow-up|0
5980934|NCT01056653|20679987|P1|Overall Study|Lost to Follow-up|0
5980935|NCT01056640|20680003|P2|Overall Study|Death|4
5980936|NCT01056640|20680004|P1|Overall Study|Death|15
5980937|NCT01056640|20680003|P2|Overall Study|Withdrawal by Subject|8
5980938|NCT01056640|20680004|P1|Overall Study|Withdrawal by Subject|11
5980939|NCT01056536|20680019|P3|Overall Study|Lost to Follow-up|248
5980940|NCT01056536|20680020|P2|Overall Study|Lost to Follow-up|116
5980941|NCT01056536|20680021|P1|Overall Study|Lost to Follow-up|202
5980942|NCT01056523|20680032|P7|Overall Study|Death|1
5980943|NCT01056523|20680033|P6|Overall Study|Death|0
5980944|NCT01056523|20680034|P5|Overall Study|Death|0
5980945|NCT01056523|20680035|P4|Overall Study|Death|3
5980946|NCT01056523|20680036|P3|Overall Study|Death|2
5980947|NCT01056523|20680037|P2|Overall Study|Death|0
5980948|NCT01056523|20680038|P1|Overall Study|Death|1
5980949|NCT01056510|20680048|P2|Overall Study|Missing|1
5980950|NCT01056510|20680049|P1|Overall Study|Missing|0
5980951|NCT01056510|20680048|P2|Overall Study|Other|12
5980952|NCT01056510|20680049|P1|Overall Study|Other|10
5980953|NCT01056510|20680048|P2|Overall Study|Lost to Follow-up|6
5980954|NCT01056510|20680049|P1|Overall Study|Lost to Follow-up|5
5980955|NCT01056510|20680048|P2|Overall Study|Physician Decision|5
5980956|NCT01056510|20680049|P1|Overall Study|Physician Decision|4
5980957|NCT01056510|20680048|P2|Overall Study|Noncompliance|3
5980958|NCT01056510|20680049|P1|Overall Study|Noncompliance|1
5980959|NCT01056510|20680048|P2|Overall Study|Death|34
5980960|NCT01056510|20680049|P1|Overall Study|Death|29
5980961|NCT01056510|20680048|P2|Overall Study|Withdrawal by Subject|2
5980962|NCT01056510|20680049|P1|Overall Study|Withdrawal by Subject|4
5980963|NCT01056510|20680048|P2|Overall Study|Dropout Before Start of Treatment|1
5980964|NCT01056510|20680049|P1|Overall Study|Dropout Before Start of Treatment|1
5980965|NCT01056484|20680095|P2|Follow up - Non-randomized|Withdrawal by Subject|2
5980966|NCT01056484|20680096|P1|Follow up - Non-randomized|Withdrawal by Subject|0
5980967|NCT01056484|20680095|P2|Randomized Controlled Trial|Physician Decision|0
5980968|NCT01056484|20680096|P1|Randomized Controlled Trial|Physician Decision|1
5980969|NCT01056484|20680095|P2|Randomized Controlled Trial|Withdrawal by Subject|1
5980970|NCT01056484|20680096|P1|Randomized Controlled Trial|Withdrawal by Subject|6
5980971|NCT01056380|20680112|P2|Overall Study|Lost to Follow-up|3
5980972|NCT01056380|20680113|P1|Overall Study|Lost to Follow-up|2
5980973|NCT01056341|20680140|P5|Overall Study|Other reasons|5
5980974|NCT01056341|20680141|P4|Overall Study|Other reasons|9
5980975|NCT01056341|20680142|P3|Overall Study|Other reasons|8
5980976|NCT01056341|20680143|P2|Overall Study|Other reasons|4
5980977|NCT01056341|20680144|P1|Overall Study|Other reasons|4
5980978|NCT01056341|20680140|P5|Overall Study|Lack of Efficacy|9
5980979|NCT01056341|20680141|P4|Overall Study|Lack of Efficacy|25
5980980|NCT01056341|20680142|P3|Overall Study|Lack of Efficacy|7
5980981|NCT01056341|20680143|P2|Overall Study|Lack of Efficacy|30
5980982|NCT01056341|20680144|P1|Overall Study|Lack of Efficacy|32
5980983|NCT01056341|20680140|P5|Overall Study|Treatment Intolerance|0
5980984|NCT01056341|20680141|P4|Overall Study|Treatment Intolerance|2
5980985|NCT01056341|20680142|P3|Overall Study|Treatment Intolerance|0
5980986|NCT01056341|20680143|P2|Overall Study|Treatment Intolerance|2
5980987|NCT01056341|20680144|P1|Overall Study|Treatment Intolerance|0
5980988|NCT01056289|20680223|P4|Double-blind Phase|Physician Decision|0
5980989|NCT01056289|20680224|P3|Double-blind Phase|Physician Decision|1
5980990|NCT01056289|20680225|P2|Double-blind Phase|Physician Decision|0
5980991|NCT01056289|20680226|P1|Double-blind Phase|Physician Decision|0
5980992|NCT01056289|20680223|P4|Double-blind Phase|Discontinuation symptom|2
5980993|NCT01056289|20680224|P3|Double-blind Phase|Discontinuation symptom|2
5980994|NCT01056289|20680225|P2|Double-blind Phase|Discontinuation symptom|1
5980995|NCT01056289|20680226|P1|Double-blind Phase|Discontinuation symptom|0
5980996|NCT01056289|20680223|P4|Double-blind Phase|Withdrawal by Subject|2
5980997|NCT01056289|20680224|P3|Double-blind Phase|Withdrawal by Subject|4
5980998|NCT01056289|20680225|P2|Double-blind Phase|Withdrawal by Subject|0
5980999|NCT01056289|20680226|P1|Double-blind Phase|Withdrawal by Subject|0
5981000|NCT01056289|20680223|P4|Double-blind Phase|Protocol Violation|1
5981001|NCT01056289|20680224|P3|Double-blind Phase|Protocol Violation|1
5981002|NCT01056289|20680225|P2|Double-blind Phase|Protocol Violation|0
5981003|NCT01056289|20680226|P1|Double-blind Phase|Protocol Violation|0
5981004|NCT01056289|20680223|P4|Double-blind Phase|Other|2
5981005|NCT01056289|20680224|P3|Double-blind Phase|Other|1
5981006|NCT01056289|20680225|P2|Double-blind Phase|Other|0
5981007|NCT01056289|20680226|P1|Double-blind Phase|Other|0
5981008|NCT01056289|20680223|P4|Double-blind Phase|Lost to Follow-up|2
5981009|NCT01056289|20680224|P3|Double-blind Phase|Lost to Follow-up|2
5981010|NCT01056289|20680225|P2|Double-blind Phase|Lost to Follow-up|2
5981011|NCT01056289|20680226|P1|Double-blind Phase|Lost to Follow-up|0
5981012|NCT01056289|20680223|P4|Double-blind Phase|Adverse Event|1
5981013|NCT01056289|20680224|P3|Double-blind Phase|Adverse Event|2
5981014|NCT01056289|20680225|P2|Double-blind Phase|Adverse Event|1
5981015|NCT01056289|20680226|P1|Double-blind Phase|Adverse Event|0
5981016|NCT01056289|20680223|P4|Open-label Phase|Not randomized to Double-blind phase|0
5981017|NCT01056289|20680224|P3|Open-label Phase|Not randomized to Double-blind phase|0
5981018|NCT01056289|20680225|P2|Open-label Phase|Not randomized to Double-blind phase|0
5981019|NCT01056289|20680226|P1|Open-label Phase|Not randomized to Double-blind phase|1
5981020|NCT01056289|20680223|P4|Open-label Phase|Lack of Efficacy|0
5981021|NCT01056289|20680224|P3|Open-label Phase|Lack of Efficacy|0
5981022|NCT01056289|20680225|P2|Open-label Phase|Lack of Efficacy|0
5981023|NCT01056289|20680226|P1|Open-label Phase|Lack of Efficacy|18
5981024|NCT01056289|20680223|P4|Open-label Phase|Withdrawal by Subject|0
5981025|NCT01056289|20680224|P3|Open-label Phase|Withdrawal by Subject|0
5981026|NCT01056289|20680225|P2|Open-label Phase|Withdrawal by Subject|0
5981027|NCT01056289|20680226|P1|Open-label Phase|Withdrawal by Subject|26
5981028|NCT01056289|20680223|P4|Open-label Phase|Protocol Violation|0
5981029|NCT01056289|20680224|P3|Open-label Phase|Protocol Violation|0
5981030|NCT01056289|20680225|P2|Open-label Phase|Protocol Violation|0
5981031|NCT01056289|20680226|P1|Open-label Phase|Protocol Violation|6
5981032|NCT01056289|20680223|P4|Open-label Phase|Other|0
5981033|NCT01056289|20680224|P3|Open-label Phase|Other|0
5981034|NCT01056289|20680225|P2|Open-label Phase|Other|0
5981035|NCT01056289|20680226|P1|Open-label Phase|Other|9
5981036|NCT01056289|20680223|P4|Open-label Phase|Lost to Follow-up|0
5981037|NCT01056289|20680224|P3|Open-label Phase|Lost to Follow-up|0
5981038|NCT01056289|20680225|P2|Open-label Phase|Lost to Follow-up|0
5981039|NCT01056289|20680226|P1|Open-label Phase|Lost to Follow-up|30
5981040|NCT01056289|20680223|P4|Open-label Phase|Adverse Event|0
5981041|NCT01056289|20680224|P3|Open-label Phase|Adverse Event|0
5981042|NCT01056289|20680225|P2|Open-label Phase|Adverse Event|0
5981043|NCT01056289|20680226|P1|Open-label Phase|Adverse Event|29
5981044|NCT01056276|20680243|P2|Maintenance Therapy|Continuing maintenance therapy|14
5981045|NCT01056276|20680244|P1|Maintenance Therapy|Continuing maintenance therapy|0
5981046|NCT01056276|20680243|P2|Maintenance Therapy|Intercurrent Illness|1
5981047|NCT01056276|20680244|P1|Maintenance Therapy|Intercurrent Illness|0
5981048|NCT01056276|20680243|P2|Maintenance Therapy|Withdrawal by Subject|1
5981049|NCT01056276|20680244|P1|Maintenance Therapy|Withdrawal by Subject|0
5981050|NCT01056276|20680243|P2|Maintenance Therapy|Physician Decision|1
5981051|NCT01056276|20680244|P1|Maintenance Therapy|Physician Decision|0
5981052|NCT01056276|20680243|P2|Maintenance Therapy|Progressive Disease|9
5981053|NCT01056276|20680244|P1|Maintenance Therapy|Progressive Disease|0
5981054|NCT01056276|20680243|P2|Maintenance Therapy|Toxicity|2
5981055|NCT01056276|20680244|P1|Maintenance Therapy|Toxicity|0
5981056|NCT01056276|20680243|P2|Treatment Period-Cycles 1-8|Lost to Follow-up|0
5981057|NCT01056276|20680244|P1|Treatment Period-Cycles 1-8|Lost to Follow-up|1
5981058|NCT01056276|20680243|P2|Treatment Period-Cycles 1-8|Death|1
5981059|NCT01056276|20680244|P1|Treatment Period-Cycles 1-8|Death|3
5981060|NCT01056276|20680243|P2|Treatment Period-Cycles 1-8|Physician Decision|0
5981061|NCT01056276|20680244|P1|Treatment Period-Cycles 1-8|Physician Decision|3
5981062|NCT01056276|20680243|P2|Treatment Period-Cycles 1-8|Intercurrent Illness|2
5981063|NCT01056276|20680244|P1|Treatment Period-Cycles 1-8|Intercurrent Illness|1
5981064|NCT01056276|20680243|P2|Treatment Period-Cycles 1-8|Disease Progression|2
5981065|NCT01056276|20680244|P1|Treatment Period-Cycles 1-8|Disease Progression|2
5981066|NCT01056276|20680243|P2|Treatment Period-Cycles 1-8|Withdrawal by Subject|2
5981067|NCT01056276|20680244|P1|Treatment Period-Cycles 1-8|Withdrawal by Subject|1
5981068|NCT01056276|20680243|P2|Treatment Period-Cycles 1-8|Toxicity|1
5981069|NCT01056276|20680244|P1|Treatment Period-Cycles 1-8|Toxicity|2
5981070|NCT01056263|20680258|P1|Overall Study|Ongoing in study A4061008 (NCT00828919)|5
5981071|NCT01056263|20680258|P1|Overall Study|Objective progression or relapse|1
5981072|NCT01056263|20680258|P1|Overall Study|Neoplasm progression|1
5981073|NCT01056263|20680258|P1|Overall Study|Progressive disease|2
5981074|NCT01056263|20680258|P1|Overall Study|Lack of Efficacy|29
5981075|NCT01056263|20680258|P1|Overall Study|Withdrawal by Subject|1
5981076|NCT01056263|20680258|P1|Overall Study|Death|1
5981077|NCT01056263|20680258|P1|Overall Study|Adverse Event|12
5981078|NCT01056107|20680281|P4|Overall Study|Withdrawal by Subject|0
5981079|NCT01056107|20680282|P3|Overall Study|Withdrawal by Subject|3
5981080|NCT01056107|20680283|P2|Overall Study|Withdrawal by Subject|1
5981081|NCT01056107|20680284|P1|Overall Study|Withdrawal by Subject|0
5981082|NCT01055886|20680341|P2|Overall Study|Withdrawal by PI|1
5981083|NCT01055886|20680342|P1|Overall Study|Withdrawal by PI|0
5981084|NCT01055886|20680341|P2|Overall Study|Lost to Follow-up|1
5981085|NCT01055886|20680342|P1|Overall Study|Lost to Follow-up|1
5981086|NCT01055886|20680341|P2|Overall Study|Withdrawal by Subject|9
5981087|NCT01055886|20680342|P1|Overall Study|Withdrawal by Subject|4
5981088|NCT01055834|20680354|P2|Treatment Period I|Adverse Event|0
5981089|NCT01055834|20680355|P1|Treatment Period I|Adverse Event|1
5981090|NCT01055639|20680440|P2|Overall Study|Withdrawal by Subject|11
5981091|NCT01055639|20680441|P1|Overall Study|Withdrawal by Subject|8
5981092|NCT01055639|20680440|P2|Overall Study|Protocol Violation|5
5981093|NCT01055639|20680441|P1|Overall Study|Protocol Violation|5
5981094|NCT01055639|20680440|P2|Overall Study|Lost to Follow-up|11
5981095|NCT01055639|20680441|P1|Overall Study|Lost to Follow-up|8
5981096|NCT01055639|20680440|P2|Overall Study|Lack of Efficacy|1
5981097|NCT01055639|20680441|P1|Overall Study|Lack of Efficacy|0
5981098|NCT01055639|20680440|P2|Overall Study|Adverse Event|1
5981099|NCT01055639|20680441|P1|Overall Study|Adverse Event|0
5981100|NCT01055613|20680465|P2|Overall Study|Subject Disinterest|1
5981101|NCT01055613|20680466|P1|Overall Study|Subject Disinterest|1
5981102|NCT01055613|20680465|P2|Overall Study|Protocol Violation|1
5981103|NCT01055613|20680466|P1|Overall Study|Protocol Violation|1
5981104|NCT01055613|20680465|P2|Overall Study|Lost to Follow-up|1
5981105|NCT01055613|20680466|P1|Overall Study|Lost to Follow-up|1
5981106|NCT01055613|20680465|P2|Overall Study|Discomfort|1
5981107|NCT01055613|20680466|P1|Overall Study|Discomfort|2
5981108|NCT01055613|20680465|P2|Overall Study|Unacceptable lens fit|0
5981109|NCT01055613|20680466|P1|Overall Study|Unacceptable lens fit|1
5981110|NCT01055613|20680465|P2|Overall Study|No Longer Meets Eligibility Criteria|0
5981111|NCT01055613|20680466|P1|Overall Study|No Longer Meets Eligibility Criteria|3
5981112|NCT01055496|20680476|P2|Overall Study|Other - Unspecified|1
5981113|NCT01055496|20680477|P1|Overall Study|Other - Unspecified|0
5981114|NCT01055496|20680476|P2|Overall Study|Lost to Follow-up|2
5981115|NCT01055496|20680477|P1|Overall Study|Lost to Follow-up|0
5981116|NCT01055496|20680476|P2|Overall Study|Death|23
5981117|NCT01055496|20680477|P1|Overall Study|Death|13
5981118|NCT01055496|20680476|P2|Overall Study|Withdrawal by Subject|4
5981119|NCT01055496|20680477|P1|Overall Study|Withdrawal by Subject|2
5981120|NCT01055457|20680534|P10|Overall Study|Adverse Event|0
5981121|NCT01055457|20680535|P9|Overall Study|Adverse Event|0
5981122|NCT01055457|20680536|P8|Overall Study|Adverse Event|0
5981123|NCT01055457|20680537|P7|Overall Study|Adverse Event|0
5981124|NCT01055457|20680538|P6|Overall Study|Adverse Event|0
5981125|NCT01055457|20680539|P5|Overall Study|Adverse Event|0
5981126|NCT01055457|20680540|P4|Overall Study|Adverse Event|1
5981127|NCT01055457|20680541|P3|Overall Study|Adverse Event|0
5981128|NCT01055457|20680542|P2|Overall Study|Adverse Event|0
5981129|NCT01055457|20680543|P1|Overall Study|Adverse Event|0
5981130|NCT01055457|20680534|P10|Overall Study|Pregnancy|0
5981131|NCT01055457|20680535|P9|Overall Study|Pregnancy|0
5981132|NCT01055457|20680536|P8|Overall Study|Pregnancy|0
5981133|NCT01055457|20680537|P7|Overall Study|Pregnancy|0
5981134|NCT01055457|20680538|P6|Overall Study|Pregnancy|0
5981135|NCT01055457|20680539|P5|Overall Study|Pregnancy|0
5981136|NCT01055457|20680540|P4|Overall Study|Pregnancy|1
5981137|NCT01055457|20680541|P3|Overall Study|Pregnancy|0
5981138|NCT01055457|20680542|P2|Overall Study|Pregnancy|0
5981139|NCT01055457|20680543|P1|Overall Study|Pregnancy|0
5981140|NCT01055457|20680534|P10|Overall Study|Discomfort|0
5981141|NCT01055457|20680535|P9|Overall Study|Discomfort|0
5981142|NCT01055457|20680536|P8|Overall Study|Discomfort|0
5981143|NCT01055457|20680537|P7|Overall Study|Discomfort|0
5981144|NCT01055457|20680538|P6|Overall Study|Discomfort|0
5981145|NCT01055457|20680539|P5|Overall Study|Discomfort|1
5981146|NCT01055457|20680540|P4|Overall Study|Discomfort|0
5981147|NCT01055457|20680541|P3|Overall Study|Discomfort|0
5981148|NCT01055457|20680542|P2|Overall Study|Discomfort|0
5981149|NCT01055457|20680543|P1|Overall Study|Discomfort|0
5981150|NCT01055457|20680534|P10|Overall Study|Subject Ineligible|0
5981151|NCT01055457|20680535|P9|Overall Study|Subject Ineligible|0
5981152|NCT01055457|20680536|P8|Overall Study|Subject Ineligible|0
5981153|NCT01055457|20680537|P7|Overall Study|Subject Ineligible|0
5981154|NCT01055457|20680538|P6|Overall Study|Subject Ineligible|0
5981155|NCT01055457|20680539|P5|Overall Study|Subject Ineligible|1
5981156|NCT01055457|20680540|P4|Overall Study|Subject Ineligible|0
5981157|NCT01055457|20680541|P3|Overall Study|Subject Ineligible|1
5981158|NCT01055457|20680542|P2|Overall Study|Subject Ineligible|0
5981159|NCT01055457|20680543|P1|Overall Study|Subject Ineligible|1
5981160|NCT01055457|20680534|P10|Overall Study|Subject Disinterest|0
5981161|NCT01055457|20680535|P9|Overall Study|Subject Disinterest|0
5981162|NCT01055457|20680536|P8|Overall Study|Subject Disinterest|1
5981163|NCT01055457|20680537|P7|Overall Study|Subject Disinterest|0
5981164|NCT01055457|20680538|P6|Overall Study|Subject Disinterest|0
5981165|NCT01055457|20680539|P5|Overall Study|Subject Disinterest|0
5981166|NCT01055457|20680540|P4|Overall Study|Subject Disinterest|0
5981167|NCT01055457|20680541|P3|Overall Study|Subject Disinterest|0
5981168|NCT01055457|20680542|P2|Overall Study|Subject Disinterest|0
5981169|NCT01055457|20680543|P1|Overall Study|Subject Disinterest|0
5981170|NCT01055457|20680534|P10|Overall Study|Protocol Violation|1
5981171|NCT01055457|20680535|P9|Overall Study|Protocol Violation|0
5981172|NCT01055457|20680536|P8|Overall Study|Protocol Violation|0
5981173|NCT01055457|20680537|P7|Overall Study|Protocol Violation|1
5981174|NCT01055457|20680538|P6|Overall Study|Protocol Violation|2
5981175|NCT01055457|20680539|P5|Overall Study|Protocol Violation|1
5981176|NCT01055457|20680540|P4|Overall Study|Protocol Violation|1
5981177|NCT01055457|20680541|P3|Overall Study|Protocol Violation|1
5981178|NCT01055457|20680542|P2|Overall Study|Protocol Violation|0
5981179|NCT01055457|20680543|P1|Overall Study|Protocol Violation|0
5981180|NCT01055457|20680534|P10|Overall Study|Lost to Follow-up|0
5981181|NCT01055457|20680535|P9|Overall Study|Lost to Follow-up|0
5981182|NCT01055457|20680536|P8|Overall Study|Lost to Follow-up|0
5981183|NCT01055457|20680537|P7|Overall Study|Lost to Follow-up|0
5981184|NCT01055457|20680538|P6|Overall Study|Lost to Follow-up|1
5981185|NCT01055457|20680539|P5|Overall Study|Lost to Follow-up|0
5981186|NCT01055457|20680540|P4|Overall Study|Lost to Follow-up|0
5981187|NCT01055457|20680541|P3|Overall Study|Lost to Follow-up|0
5981188|NCT01055457|20680542|P2|Overall Study|Lost to Follow-up|1
5981189|NCT01055457|20680543|P1|Overall Study|Lost to Follow-up|0
5981190|NCT01055314|20680577|P2|Overall Study|No treatment|0
5981191|NCT01055314|20680578|P1|Overall Study|No treatment|1
5981192|NCT01055314|20680577|P2|Overall Study|Refusal of further protocol therapy|4
5981193|NCT01055314|20680578|P1|Overall Study|Refusal of further protocol therapy|10
5981194|NCT01055314|20680577|P2|Overall Study|Ineligible|5
5981195|NCT01055314|20680578|P1|Overall Study|Ineligible|3
5981196|NCT01055314|20680577|P2|Overall Study|Withdrawal by Subject|0
5981197|NCT01055314|20680578|P1|Overall Study|Withdrawal by Subject|1
5981198|NCT01055314|20680577|P2|Overall Study|Physician Decision|5
5981199|NCT01055314|20680578|P1|Overall Study|Physician Decision|10
5981200|NCT01055314|20680577|P2|Overall Study|Lack of Efficacy|19
5981201|NCT01055314|20680578|P1|Overall Study|Lack of Efficacy|11
5981202|NCT01055314|20680577|P2|Overall Study|Death|1
5981203|NCT01055314|20680578|P1|Overall Study|Death|2
5981204|NCT01055314|20680577|P2|Overall Study|Adverse Event|4
5981205|NCT01055314|20680578|P1|Overall Study|Adverse Event|7
5981206|NCT01055262|20680590|P1|Overall Study|Uncooperativeness|1
5981207|NCT01055262|20680590|P1|Overall Study|Protocol Violation|3
5981208|NCT01055262|20680590|P1|Overall Study|Adverse Event|5
5981209|NCT01055197|20680631|P2|Overall Study|Withdrawal by Subject|0
5981210|NCT01055197|20680632|P1|Overall Study|Withdrawal by Subject|2
5981211|NCT01055197|20680631|P2|Overall Study|Protocol Violation|2
5981212|NCT01055197|20680632|P1|Overall Study|Protocol Violation|7
5981213|NCT01055132|20680667|P2|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|1
5981214|NCT01055132|20680668|P1|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|0
5981215|NCT01055132|20680667|P2|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|0
5981216|NCT01055132|20680668|P1|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|1
5981217|NCT01055028|20680693|P2|Inter-treatment Period|Did not start Cycle 4|3
5981218|NCT01055028|20680694|P1|Inter-treatment Period|Did not start Cycle 4|0
5981219|NCT01055028|20680693|P2|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2
5981220|NCT01055028|20680694|P1|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2
5981221|NCT01055028|20680693|P2|Treatment Cycles 1 to 3|Adverse Event|1
5981222|NCT01055028|20680694|P1|Treatment Cycles 1 to 3|Adverse Event|0
5981223|NCT01055028|20680693|P2|Screening|Screen Failure|1
5981224|NCT01055028|20680694|P1|Screening|Screen Failure|1
5981225|NCT01054976|20680708|P1|Overall Study|Other|8
5981226|NCT01054976|20680708|P1|Overall Study|Withdrawal by Subject|4
5981227|NCT01054976|20680708|P1|Overall Study|Uncooperative participations to study|7
5981228|NCT01054976|20680708|P1|Overall Study|Adverse Event|16
5981229|NCT01054885|20680729|P7|24-week, Double-blind Treatment Period|Withdrawal by Subject|2
5981230|NCT01054885|20680730|P6|24-week, Double-blind Treatment Period|Withdrawal by Subject|9
5981231|NCT01054885|20680731|P5|24-week, Double-blind Treatment Period|Withdrawal by Subject|3
5981232|NCT01054885|20680732|P4|24-week, Double-blind Treatment Period|Withdrawal by Subject|7
5981233|NCT01054885|20680733|P3|24-week, Double-blind Treatment Period|Withdrawal by Subject|9
5981234|NCT01054885|20680734|P2|24-week, Double-blind Treatment Period|Withdrawal by Subject|8
5981235|NCT01054885|20680735|P1|24-week, Double-blind Treatment Period|Withdrawal by Subject|0
5981236|NCT01054885|20680729|P7|24-week, Double-blind Treatment Period|Physician Decision|1
5981237|NCT01054885|20680730|P6|24-week, Double-blind Treatment Period|Physician Decision|1
5981238|NCT01054885|20680731|P5|24-week, Double-blind Treatment Period|Physician Decision|3
5981239|NCT01054885|20680732|P4|24-week, Double-blind Treatment Period|Physician Decision|6
5981240|NCT01054885|20680733|P3|24-week, Double-blind Treatment Period|Physician Decision|1
5981241|NCT01054885|20680734|P2|24-week, Double-blind Treatment Period|Physician Decision|4
5981242|NCT01054885|20680735|P1|24-week, Double-blind Treatment Period|Physician Decision|0
5981243|NCT01054885|20680729|P7|24-week, Double-blind Treatment Period|Lost to Follow-up|1
5981244|NCT01054885|20680730|P6|24-week, Double-blind Treatment Period|Lost to Follow-up|2
5981245|NCT01054885|20680731|P5|24-week, Double-blind Treatment Period|Lost to Follow-up|0
5981246|NCT01054885|20680732|P4|24-week, Double-blind Treatment Period|Lost to Follow-up|0
5981247|NCT01054885|20680733|P3|24-week, Double-blind Treatment Period|Lost to Follow-up|2
5981248|NCT01054885|20680734|P2|24-week, Double-blind Treatment Period|Lost to Follow-up|3
5981249|NCT01054885|20680735|P1|24-week, Double-blind Treatment Period|Lost to Follow-up|0
5981250|NCT01054885|20680729|P7|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1
5981251|NCT01054885|20680730|P6|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0
5981252|NCT01054885|20680731|P5|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0
5981253|NCT01054885|20680732|P4|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0
5981254|NCT01054885|20680733|P3|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1
5981255|NCT01054885|20680734|P2|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0
5981256|NCT01054885|20680735|P1|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0
5981257|NCT01054885|20680729|P7|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12
5981258|NCT01054885|20680730|P6|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|15
5981259|NCT01054885|20680731|P5|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7
5981260|NCT01054885|20680732|P4|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7
5981261|NCT01054885|20680733|P3|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12
5981262|NCT01054885|20680734|P2|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7
5981263|NCT01054885|20680735|P1|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|0
5981264|NCT01054885|20680729|P7|24-week, Double-blind Treatment Period|Protocol Violation|4
5981265|NCT01054885|20680730|P6|24-week, Double-blind Treatment Period|Protocol Violation|8
5981266|NCT01054885|20680731|P5|24-week, Double-blind Treatment Period|Protocol Violation|3
5981267|NCT01054885|20680732|P4|24-week, Double-blind Treatment Period|Protocol Violation|2
5981268|NCT01054885|20680733|P3|24-week, Double-blind Treatment Period|Protocol Violation|7
5981269|NCT01054885|20680734|P2|24-week, Double-blind Treatment Period|Protocol Violation|7
5981270|NCT01054885|20680735|P1|24-week, Double-blind Treatment Period|Protocol Violation|0
5981271|NCT01054885|20680729|P7|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7
5981342|NCT01054729|20680806|P3|Overall Study|Subject moved|1
5981272|NCT01054885|20680730|P6|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7
5981273|NCT01054885|20680731|P5|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|11
5981274|NCT01054885|20680732|P4|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|5
5981275|NCT01054885|20680733|P3|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|2
5981276|NCT01054885|20680734|P2|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12
5981277|NCT01054885|20680735|P1|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0
5981278|NCT01054885|20680729|P7|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
5981279|NCT01054885|20680730|P6|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1
5981280|NCT01054885|20680731|P5|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
5981281|NCT01054885|20680732|P4|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1
5981282|NCT01054885|20680733|P3|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3
5981283|NCT01054885|20680734|P2|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
5981284|NCT01054885|20680735|P1|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
5981285|NCT01054885|20680729|P7|24-week, Double-blind Treatment Period|Adverse Event|19
5981286|NCT01054885|20680730|P6|24-week, Double-blind Treatment Period|Adverse Event|17
5981287|NCT01054885|20680731|P5|24-week, Double-blind Treatment Period|Adverse Event|15
5981288|NCT01054885|20680732|P4|24-week, Double-blind Treatment Period|Adverse Event|15
5981289|NCT01054885|20680733|P3|24-week, Double-blind Treatment Period|Adverse Event|12
5981290|NCT01054885|20680734|P2|24-week, Double-blind Treatment Period|Adverse Event|18
5981291|NCT01054885|20680735|P1|24-week, Double-blind Treatment Period|Adverse Event|0
5981292|NCT01054885|20680729|P7|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
5981293|NCT01054885|20680730|P6|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
5981294|NCT01054885|20680731|P5|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
5981295|NCT01054885|20680732|P4|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
5981296|NCT01054885|20680733|P3|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
5981297|NCT01054885|20680734|P2|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
5981298|NCT01054885|20680735|P1|2-week, Single-blind Run-In Period|Study Closed/Terminated|68
5981299|NCT01054885|20680729|P7|2-week, Single-blind Run-In Period|Adverse Event|0
5981300|NCT01054885|20680730|P6|2-week, Single-blind Run-In Period|Adverse Event|0
5981301|NCT01054885|20680731|P5|2-week, Single-blind Run-In Period|Adverse Event|0
5981302|NCT01054885|20680732|P4|2-week, Single-blind Run-In Period|Adverse Event|0
5981303|NCT01054885|20680733|P3|2-week, Single-blind Run-In Period|Adverse Event|0
5981304|NCT01054885|20680734|P2|2-week, Single-blind Run-In Period|Adverse Event|0
5981305|NCT01054885|20680735|P1|2-week, Single-blind Run-In Period|Adverse Event|7
5981306|NCT01054885|20680729|P7|2-week, Single-blind Run-In Period|Lost to Follow-up|0
5981307|NCT01054885|20680730|P6|2-week, Single-blind Run-In Period|Lost to Follow-up|0
5981308|NCT01054885|20680731|P5|2-week, Single-blind Run-In Period|Lost to Follow-up|0
5981309|NCT01054885|20680732|P4|2-week, Single-blind Run-In Period|Lost to Follow-up|0
5981310|NCT01054885|20680733|P3|2-week, Single-blind Run-In Period|Lost to Follow-up|0
5981311|NCT01054885|20680734|P2|2-week, Single-blind Run-In Period|Lost to Follow-up|0
5981312|NCT01054885|20680735|P1|2-week, Single-blind Run-In Period|Lost to Follow-up|1
5981313|NCT01054885|20680729|P7|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
5981314|NCT01054885|20680730|P6|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
5981315|NCT01054885|20680731|P5|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
5981316|NCT01054885|20680732|P4|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
5981317|NCT01054885|20680733|P3|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
5981318|NCT01054885|20680734|P2|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
5981319|NCT01054885|20680735|P1|2-week, Single-blind Run-In Period|Withdrawal by Subject|23
5981320|NCT01054885|20680729|P7|2-week, Single-blind Run-In Period|Physician Decision|0
5981321|NCT01054885|20680730|P6|2-week, Single-blind Run-In Period|Physician Decision|0
5981322|NCT01054885|20680731|P5|2-week, Single-blind Run-In Period|Physician Decision|0
5981323|NCT01054885|20680732|P4|2-week, Single-blind Run-In Period|Physician Decision|0
5981324|NCT01054885|20680733|P3|2-week, Single-blind Run-In Period|Physician Decision|0
5981325|NCT01054885|20680734|P2|2-week, Single-blind Run-In Period|Physician Decision|0
5981326|NCT01054885|20680735|P1|2-week, Single-blind Run-In Period|Physician Decision|6
5981327|NCT01054885|20680729|P7|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
5981328|NCT01054885|20680730|P6|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
5981329|NCT01054885|20680731|P5|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
5981330|NCT01054885|20680732|P4|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
5981331|NCT01054885|20680733|P3|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
5981332|NCT01054885|20680734|P2|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
5981333|NCT01054885|20680735|P1|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|246
5981334|NCT01054846|20680775|P2|Overall Study|Lost to Follow-up|17
5981335|NCT01054846|20680776|P1|Overall Study|Lost to Follow-up|76
5981336|NCT01054820|20680783|P1|Overall Study|Withdrawal by Subject|2
5981337|NCT01054729|20680805|P4|Overall Study|Lack of Efficacy|1
5981338|NCT01054729|20680806|P3|Overall Study|Lack of Efficacy|0
5981339|NCT01054729|20680807|P2|Overall Study|Lack of Efficacy|0
5981340|NCT01054729|20680808|P1|Overall Study|Lack of Efficacy|0
5981341|NCT01054729|20680805|P4|Overall Study|Subject moved|0
5981343|NCT01054729|20680807|P2|Overall Study|Subject moved|0
5981344|NCT01054729|20680808|P1|Overall Study|Subject moved|0
5981345|NCT01054729|20680805|P4|Overall Study|Personal/Obligations|0
5981346|NCT01054729|20680806|P3|Overall Study|Personal/Obligations|0
5981347|NCT01054729|20680807|P2|Overall Study|Personal/Obligations|1
5981348|NCT01054729|20680808|P1|Overall Study|Personal/Obligations|0
5981349|NCT01054729|20680805|P4|Overall Study|PEG/RBV Non-responder|0
5981350|NCT01054729|20680806|P3|Overall Study|PEG/RBV Non-responder|1
5981351|NCT01054729|20680807|P2|Overall Study|PEG/RBV Non-responder|0
5981352|NCT01054729|20680808|P1|Overall Study|PEG/RBV Non-responder|1
5981353|NCT01054729|20680805|P4|Overall Study|Non-responder|1
5981354|NCT01054729|20680806|P3|Overall Study|Non-responder|1
5981355|NCT01054729|20680807|P2|Overall Study|Non-responder|0
5981356|NCT01054729|20680808|P1|Overall Study|Non-responder|1
5981357|NCT01054729|20680805|P4|Overall Study|Lost to Follow-up, Later Contacted Site|0
5981358|NCT01054729|20680806|P3|Overall Study|Lost to Follow-up, Later Contacted Site|0
5981359|NCT01054729|20680807|P2|Overall Study|Lost to Follow-up, Later Contacted Site|1
5981360|NCT01054729|20680808|P1|Overall Study|Lost to Follow-up, Later Contacted Site|0
5981361|NCT01054729|20680805|P4|Overall Study|Lost to Follow-up|0
5981362|NCT01054729|20680806|P3|Overall Study|Lost to Follow-up|0
5981363|NCT01054729|20680807|P2|Overall Study|Lost to Follow-up|1
5981364|NCT01054729|20680808|P1|Overall Study|Lost to Follow-up|0
5981365|NCT01054729|20680805|P4|Overall Study|Withdrawal by Subject|0
5981366|NCT01054729|20680806|P3|Overall Study|Withdrawal by Subject|1
5981367|NCT01054729|20680807|P2|Overall Study|Withdrawal by Subject|0
5981368|NCT01054729|20680808|P1|Overall Study|Withdrawal by Subject|1
5981369|NCT01054729|20680805|P4|Overall Study|Adverse Event|1
5981370|NCT01054729|20680806|P3|Overall Study|Adverse Event|2
5981371|NCT01054729|20680807|P2|Overall Study|Adverse Event|1
5981372|NCT01054729|20680808|P1|Overall Study|Adverse Event|1
5981373|NCT01054729|20680805|P4|Overall Study|Randomized but Not Treated|0
5981374|NCT01054729|20680806|P3|Overall Study|Randomized but Not Treated|0
5981375|NCT01054729|20680807|P2|Overall Study|Randomized but Not Treated|1
5981376|NCT01054729|20680808|P1|Overall Study|Randomized but Not Treated|0
5981377|NCT01054599|20680906|P2|Overall Study|Withdrawal by Subject|1
5981378|NCT01054599|20680907|P1|Overall Study|Withdrawal by Subject|0
5981379|NCT01054599|20680906|P2|Overall Study|Adverse Event|1
5981380|NCT01054599|20680907|P1|Overall Study|Adverse Event|0
5981381|NCT01054599|20680906|P2|Overall Study|Lost to Follow-up|2
5981382|NCT01054599|20680907|P1|Overall Study|Lost to Follow-up|0
5981383|NCT01054599|20680906|P2|Overall Study|Visual impairment, WTAR <80|1
5981384|NCT01054599|20680907|P1|Overall Study|Visual impairment, WTAR <80|0
5981385|NCT01054599|20680906|P2|Overall Study|Timing/scheduling difficulties|1
5981386|NCT01054599|20680907|P1|Overall Study|Timing/scheduling difficulties|1
5981387|NCT01054599|20680906|P2|Overall Study|Spells/seizure-like episodes|1
5981388|NCT01054599|20680907|P1|Overall Study|Spells/seizure-like episodes|1
5981389|NCT01054599|20680906|P2|Overall Study|Protocol Violation|0
5981390|NCT01054599|20680907|P1|Overall Study|Protocol Violation|1
5981391|NCT01054599|20680906|P2|Overall Study|Dizziness due to phenytoin toxicity|0
5981392|NCT01054599|20680907|P1|Overall Study|Dizziness due to phenytoin toxicity|1
5981393|NCT01054573|20681014|P4|Overall Study|Withdrawal by Subject|1
5981394|NCT01054573|20681015|P3|Overall Study|Withdrawal by Subject|2
5981395|NCT01054573|20681016|P2|Overall Study|Withdrawal by Subject|2
5981396|NCT01054573|20681017|P1|Overall Study|Withdrawal by Subject|0
5981397|NCT01054573|20681014|P4|Overall Study|Lost to Follow-up|0
5981398|NCT01054573|20681015|P3|Overall Study|Lost to Follow-up|0
5981399|NCT01054573|20681016|P2|Overall Study|Lost to Follow-up|2
5981400|NCT01054573|20681017|P1|Overall Study|Lost to Follow-up|0
5981401|NCT01054573|20681014|P4|Overall Study|Adverse Event|1
5981402|NCT01054573|20681015|P3|Overall Study|Adverse Event|1
5981403|NCT01054573|20681016|P2|Overall Study|Adverse Event|0
5981404|NCT01054573|20681017|P1|Overall Study|Adverse Event|1
5981405|NCT01054560|20681063|P2|Overall Study|Physician Decision|0
5981406|NCT01054560|20681064|P1|Overall Study|Physician Decision|1
5981407|NCT01054560|20681063|P2|Overall Study|Withdrawal by Subject|2
5981408|NCT01054560|20681064|P1|Overall Study|Withdrawal by Subject|0
5981409|NCT01054560|20681063|P2|Overall Study|Lost to Follow-up|5
5981410|NCT01054560|20681064|P1|Overall Study|Lost to Follow-up|2
5981411|NCT01054560|20681063|P2|Overall Study|Death|21
5981412|NCT01054560|20681064|P1|Overall Study|Death|10
5981413|NCT01054456|20681086|P1|Overall Study|Other|1
5981414|NCT01054300|20681134|P4|Period 2|Withdrawal by Subject|0
5981415|NCT01054300|20681135|P3|Period 2|Withdrawal by Subject|1
5981416|NCT01054300|20681136|P2|Period 2|Withdrawal by Subject|0
5981417|NCT01054300|20681137|P1|Period 2|Withdrawal by Subject|0
5981418|NCT01054300|20681134|P4|Period 1|Adverse Event|0
5981419|NCT01054300|20681135|P3|Period 1|Adverse Event|0
5981420|NCT01054300|20681136|P2|Period 1|Adverse Event|0
5981421|NCT01054300|20681137|P1|Period 1|Adverse Event|1
5981422|NCT01054222|20681187|P1|Overall Study|Withdrawal by Subject|6
5981423|NCT01054222|20681187|P1|Overall Study|Lost to Follow-up|4
5981424|NCT01054222|20681187|P1|Overall Study|Lack of Efficacy|1
5981425|NCT01054170|20681228|P2|Overall Study|Adverse Event|4
5981426|NCT01054170|20681229|P1|Overall Study|Adverse Event|0
5981427|NCT01054170|20681228|P2|Overall Study|Withdrawal by Subject|2
5981428|NCT01054170|20681229|P1|Overall Study|Withdrawal by Subject|3
5981429|NCT01054170|20681228|P2|Overall Study|Protocol Violation|0
5981430|NCT01054170|20681229|P1|Overall Study|Protocol Violation|1
5981431|NCT01053988|20681294|P6|24-week, Double-blind Treatment Period|Withdrawal by Subject|9
5981432|NCT01053988|20681295|P5|24-week, Double-blind Treatment Period|Withdrawal by Subject|10
5981433|NCT01053988|20681296|P4|24-week, Double-blind Treatment Period|Withdrawal by Subject|7
5981434|NCT01053988|20681297|P3|24-week, Double-blind Treatment Period|Withdrawal by Subject|9
5981435|NCT01053988|20681298|P2|24-week, Double-blind Treatment Period|Withdrawal by Subject|11
5981436|NCT01053988|20681299|P1|24-week, Double-blind Treatment Period|Withdrawal by Subject|0
5981437|NCT01053988|20681294|P6|24-week, Double-blind Treatment Period|Physician Decision|4
5981438|NCT01053988|20681295|P5|24-week, Double-blind Treatment Period|Physician Decision|5
5981439|NCT01053988|20681296|P4|24-week, Double-blind Treatment Period|Physician Decision|5
5981440|NCT01053988|20681297|P3|24-week, Double-blind Treatment Period|Physician Decision|2
5981441|NCT01053988|20681298|P2|24-week, Double-blind Treatment Period|Physician Decision|5
5981442|NCT01053988|20681299|P1|24-week, Double-blind Treatment Period|Physician Decision|0
5981443|NCT01053988|20681294|P6|24-week, Double-blind Treatment Period|Lost to Follow-up|3
5981444|NCT01053988|20681295|P5|24-week, Double-blind Treatment Period|Lost to Follow-up|1
5981445|NCT01053988|20681296|P4|24-week, Double-blind Treatment Period|Lost to Follow-up|2
5981446|NCT01053988|20681297|P3|24-week, Double-blind Treatment Period|Lost to Follow-up|0
5981447|NCT01053988|20681298|P2|24-week, Double-blind Treatment Period|Lost to Follow-up|4
5981448|NCT01053988|20681299|P1|24-week, Double-blind Treatment Period|Lost to Follow-up|0
5981449|NCT01053988|20681294|P6|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9
5981450|NCT01053988|20681295|P5|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13
5981451|NCT01053988|20681296|P4|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|8
5981452|NCT01053988|20681297|P3|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|5
5981453|NCT01053988|20681298|P2|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11
5981454|NCT01053988|20681299|P1|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0
5981455|NCT01053988|20681294|P6|24-week, Double-blind Treatment Period|Protocol Violation|4
5981456|NCT01053988|20681295|P5|24-week, Double-blind Treatment Period|Protocol Violation|1
5981457|NCT01053988|20681296|P4|24-week, Double-blind Treatment Period|Protocol Violation|2
5981458|NCT01053988|20681297|P3|24-week, Double-blind Treatment Period|Protocol Violation|4
5981459|NCT01053988|20681298|P2|24-week, Double-blind Treatment Period|Protocol Violation|3
5981460|NCT01053988|20681299|P1|24-week, Double-blind Treatment Period|Protocol Violation|0
5981461|NCT01053988|20681294|P6|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12
5981462|NCT01053988|20681295|P5|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|9
5981463|NCT01053988|20681296|P4|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13
5981464|NCT01053988|20681297|P3|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|16
5981465|NCT01053988|20681298|P2|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|17
5981466|NCT01053988|20681299|P1|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0
5981467|NCT01053988|20681294|P6|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
5981468|NCT01053988|20681295|P5|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3
5981469|NCT01053988|20681296|P4|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2
5981470|NCT01053988|20681297|P3|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2
5981471|NCT01053988|20681298|P2|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3
5981472|NCT01053988|20681299|P1|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
5981473|NCT01053988|20681294|P6|24-week, Double-blind Treatment Period|Adverse Event|14
5981474|NCT01053988|20681295|P5|24-week, Double-blind Treatment Period|Adverse Event|17
5981475|NCT01053988|20681296|P4|24-week, Double-blind Treatment Period|Adverse Event|24
5981476|NCT01053988|20681297|P3|24-week, Double-blind Treatment Period|Adverse Event|23
5981477|NCT01053988|20681298|P2|24-week, Double-blind Treatment Period|Adverse Event|15
5981478|NCT01053988|20681299|P1|24-week, Double-blind Treatment Period|Adverse Event|0
5981479|NCT01053988|20681294|P6|2-week, Single-blind Run-In Period|Lost to Follow-up|0
5981480|NCT01053988|20681295|P5|2-week, Single-blind Run-In Period|Lost to Follow-up|0
5981481|NCT01053988|20681296|P4|2-week, Single-blind Run-In Period|Lost to Follow-up|0
5981482|NCT01053988|20681297|P3|2-week, Single-blind Run-In Period|Lost to Follow-up|0
5981483|NCT01053988|20681298|P2|2-week, Single-blind Run-In Period|Lost to Follow-up|0
5981484|NCT01053988|20681299|P1|2-week, Single-blind Run-In Period|Lost to Follow-up|1
5981485|NCT01053988|20681294|P6|2-week, Single-blind Run-In Period|Physician Decision|0
5981486|NCT01053988|20681295|P5|2-week, Single-blind Run-In Period|Physician Decision|0
5981487|NCT01053988|20681296|P4|2-week, Single-blind Run-In Period|Physician Decision|0
5981488|NCT01053988|20681297|P3|2-week, Single-blind Run-In Period|Physician Decision|0
5981489|NCT01053988|20681298|P2|2-week, Single-blind Run-In Period|Physician Decision|0
5981490|NCT01053988|20681299|P1|2-week, Single-blind Run-In Period|Physician Decision|5
5981491|NCT01053988|20681294|P6|2-week, Single-blind Run-In Period|Adverse Event|0
5981492|NCT01053988|20681295|P5|2-week, Single-blind Run-In Period|Adverse Event|0
5981493|NCT01053988|20681296|P4|2-week, Single-blind Run-In Period|Adverse Event|0
5981494|NCT01053988|20681297|P3|2-week, Single-blind Run-In Period|Adverse Event|0
5981495|NCT01053988|20681298|P2|2-week, Single-blind Run-In Period|Adverse Event|0
5981496|NCT01053988|20681299|P1|2-week, Single-blind Run-In Period|Adverse Event|6
5981497|NCT01053988|20681294|P6|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
5981498|NCT01053988|20681295|P5|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
5981499|NCT01053988|20681296|P4|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
5981500|NCT01053988|20681297|P3|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
5981501|NCT01053988|20681298|P2|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
5981502|NCT01053988|20681299|P1|2-week, Single-blind Run-In Period|Withdrawal by Subject|30
5981503|NCT01053988|20681294|P6|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
5981504|NCT01053988|20681295|P5|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
5981505|NCT01053988|20681296|P4|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
5981506|NCT01053988|20681297|P3|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
5981507|NCT01053988|20681298|P2|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
5981508|NCT01053988|20681299|P1|2-week, Single-blind Run-In Period|Study Closed/Terminated|98
5981509|NCT01053988|20681294|P6|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
5981510|NCT01053988|20681295|P5|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
5981511|NCT01053988|20681296|P4|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
5981512|NCT01053988|20681297|P3|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
5981513|NCT01053988|20681298|P2|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
5981514|NCT01053988|20681299|P1|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|220
5981515|NCT01053962|20681336|P5|Treatment Period|Noncompliance with protocol|0
5981516|NCT01053962|20681337|P4|Treatment Period|Noncompliance with protocol|0
5981517|NCT01053962|20681338|P3|Treatment Period|Noncompliance with protocol|0
5981518|NCT01053962|20681339|P2|Treatment Period|Noncompliance with protocol|0
5981519|NCT01053962|20681340|P1|Treatment Period|Noncompliance with protocol|1
5981520|NCT01053962|20681336|P5|Treatment Period|Withdrawal by Subject|1
5981521|NCT01053962|20681337|P4|Treatment Period|Withdrawal by Subject|0
5981522|NCT01053962|20681338|P3|Treatment Period|Withdrawal by Subject|0
5981523|NCT01053962|20681339|P2|Treatment Period|Withdrawal by Subject|0
5981524|NCT01053962|20681340|P1|Treatment Period|Withdrawal by Subject|0
5981525|NCT01053962|20681336|P5|Treatment Period|Adverse Event|1
5981526|NCT01053962|20681337|P4|Treatment Period|Adverse Event|0
5981527|NCT01053962|20681338|P3|Treatment Period|Adverse Event|0
5981528|NCT01053962|20681339|P2|Treatment Period|Adverse Event|0
5981529|NCT01053962|20681340|P1|Treatment Period|Adverse Event|0
5981530|NCT01053962|20681336|P5|Treatment Period|Lack of Efficacy|1
5981531|NCT01053962|20681337|P4|Treatment Period|Lack of Efficacy|0
5981532|NCT01053962|20681338|P3|Treatment Period|Lack of Efficacy|0
5981533|NCT01053962|20681339|P2|Treatment Period|Lack of Efficacy|0
5981534|NCT01053962|20681340|P1|Treatment Period|Lack of Efficacy|0
5981535|NCT01053962|20681336|P5|Pretreatment Period|Abnormal Lab values Exl 16|0
5981536|NCT01053962|20681337|P4|Pretreatment Period|Abnormal Lab values Exl 16|1
5981537|NCT01053962|20681338|P3|Pretreatment Period|Abnormal Lab values Exl 16|0
5981538|NCT01053962|20681339|P2|Pretreatment Period|Abnormal Lab values Exl 16|0
5981539|NCT01053962|20681340|P1|Pretreatment Period|Abnormal Lab values Exl 16|0
5981540|NCT01053962|20681336|P5|Pretreatment Period|Failed Urine drug screen Day 1|0
5981541|NCT01053962|20681337|P4|Pretreatment Period|Failed Urine drug screen Day 1|0
5981542|NCT01053962|20681338|P3|Pretreatment Period|Failed Urine drug screen Day 1|0
5981543|NCT01053962|20681339|P2|Pretreatment Period|Failed Urine drug screen Day 1|1
5981544|NCT01053962|20681340|P1|Pretreatment Period|Failed Urine drug screen Day 1|0
5981545|NCT01053962|20681336|P5|Pretreatment Period|Venipuncture Failure|0
5981546|NCT01053962|20681337|P4|Pretreatment Period|Venipuncture Failure|0
5981547|NCT01053962|20681338|P3|Pretreatment Period|Venipuncture Failure|1
5981548|NCT01053962|20681339|P2|Pretreatment Period|Venipuncture Failure|0
5981549|NCT01053962|20681340|P1|Pretreatment Period|Venipuncture Failure|0
5981550|NCT01053962|20681336|P5|Pretreatment Period|Withdrew Consent (Patient/PI)|2
5981551|NCT01053962|20681337|P4|Pretreatment Period|Withdrew Consent (Patient/PI)|1
5981552|NCT01053962|20681338|P3|Pretreatment Period|Withdrew Consent (Patient/PI)|0
5981553|NCT01053962|20681339|P2|Pretreatment Period|Withdrew Consent (Patient/PI)|0
5981554|NCT01053962|20681340|P1|Pretreatment Period|Withdrew Consent (Patient/PI)|0
5981555|NCT01053741|20681391|P2|2nd Study Intervention|Physician Decision|1
5981556|NCT01053741|20681392|P1|2nd Study Intervention|Physician Decision|0
5981557|NCT01053663|20681401|P1|Overall Study|Negative Influenza Diagnosis|1
5981558|NCT01053663|20681401|P1|Overall Study|Transferred to Another Hospital|1
5981559|NCT01053663|20681401|P1|Overall Study|Poor IV Access|1
5981560|NCT01053663|20681401|P1|Overall Study|Lost to Follow-up|1
5981561|NCT01053663|20681401|P1|Overall Study|Death|2
5981562|NCT01053429|20681459|P1|Overall Study|Other|309
5981563|NCT01053429|20681459|P1|Overall Study|Adverse Event|64
5981564|NCT01053247|20681489|P3|Overall Study|Adverse Event|3
5981565|NCT01053247|20681490|P2|Overall Study|Adverse Event|9
5981566|NCT01053247|20681491|P1|Overall Study|Adverse Event|0
5981567|NCT01053247|20681489|P3|Overall Study|Lost to Follow-up|7
5981568|NCT01053247|20681490|P2|Overall Study|Lost to Follow-up|5
5981569|NCT01053247|20681491|P1|Overall Study|Lost to Follow-up|8
5981570|NCT01053247|20681489|P3|Overall Study|Protocol Violation|2
5981571|NCT01053247|20681490|P2|Overall Study|Protocol Violation|1
5981572|NCT01053247|20681491|P1|Overall Study|Protocol Violation|2
5981573|NCT01053247|20681489|P3|Overall Study|Lack of Efficacy|1
5981574|NCT01053247|20681490|P2|Overall Study|Lack of Efficacy|0
5981575|NCT01053247|20681491|P1|Overall Study|Lack of Efficacy|1
5981576|NCT01053247|20681489|P3|Overall Study|Withdrawal by Subject|15
5981577|NCT01053247|20681490|P2|Overall Study|Withdrawal by Subject|4
5981578|NCT01053247|20681491|P1|Overall Study|Withdrawal by Subject|9
5981579|NCT01053221|20681501|P2|Overall Study|The study was closed prematurely|9
5981580|NCT01053221|20681502|P1|Overall Study|The study was closed prematurely|5
5981581|NCT01052844|20681604|P2|Overall Study|Adverse Event|1
5981582|NCT01052844|20681605|P1|Overall Study|Adverse Event|0
5981583|NCT01052779|20681626|P2|Overall Study|Other-Missed Week 5 Visit|0
5981584|NCT01052779|20681627|P1|Overall Study|Other-Missed Week 5 Visit|2
5981585|NCT01052779|20681626|P2|Overall Study|Other-Surgery|2
5981586|NCT01052779|20681627|P1|Overall Study|Other-Surgery|0
5981587|NCT01052779|20681626|P2|Overall Study|Other-Protocol Violation|1
5981588|NCT01052779|20681627|P1|Overall Study|Other-Protocol Violation|1
5981589|NCT01052779|20681626|P2|Overall Study|Withdrawal by Subject|2
5981590|NCT01052779|20681627|P1|Overall Study|Withdrawal by Subject|1
5981591|NCT01052779|20681626|P2|Overall Study|Adverse Event|4
5981592|NCT01052779|20681627|P1|Overall Study|Adverse Event|1
5981593|NCT01052714|20681637|P3|Overall Study|Withdrawal by Subject|1
5981594|NCT01052714|20681638|P2|Overall Study|Withdrawal by Subject|12
5981595|NCT01052714|20681639|P1|Overall Study|Withdrawal by Subject|7
5981596|NCT01052714|20681637|P3|Overall Study|Physician Decision|1
5981597|NCT01052714|20681638|P2|Overall Study|Physician Decision|9
5981598|NCT01052714|20681639|P1|Overall Study|Physician Decision|9
5981599|NCT01052714|20681637|P3|Overall Study|Lost to Follow-up|0
5981600|NCT01052714|20681638|P2|Overall Study|Lost to Follow-up|3
5981601|NCT01052714|20681639|P1|Overall Study|Lost to Follow-up|2
5981602|NCT01052714|20681637|P3|Overall Study|Death|0
5981603|NCT01052714|20681638|P2|Overall Study|Death|2
5981604|NCT01052714|20681639|P1|Overall Study|Death|1
5981605|NCT01052714|20681637|P3|Overall Study|Adverse Event|0
5981606|NCT01052714|20681638|P2|Overall Study|Adverse Event|3
5981607|NCT01052714|20681639|P1|Overall Study|Adverse Event|6
5981608|NCT01052662|20681693|P3|Overall Study|Administrative|0
5981609|NCT01052662|20681694|P2|Overall Study|Administrative|3
5981610|NCT01052662|20681695|P1|Overall Study|Administrative|0
5981611|NCT01052662|20681693|P3|Overall Study|Legal Problem|0
5981612|NCT01052662|20681694|P2|Overall Study|Legal Problem|0
5981613|NCT01052662|20681695|P1|Overall Study|Legal Problem|2
5981614|NCT01052662|20681693|P3|Overall Study|Adverse Event|0
5981615|NCT01052662|20681694|P2|Overall Study|Adverse Event|1
5981616|NCT01052662|20681695|P1|Overall Study|Adverse Event|1
5981617|NCT01052662|20681693|P3|Overall Study|Pharmacy issue|3
5981618|NCT01052662|20681694|P2|Overall Study|Pharmacy issue|3
5981619|NCT01052662|20681695|P1|Overall Study|Pharmacy issue|1
5981620|NCT01052662|20681693|P3|Overall Study|Withdrawal by Subject|1
5981621|NCT01052662|20681694|P2|Overall Study|Withdrawal by Subject|2
5981622|NCT01052662|20681695|P1|Overall Study|Withdrawal by Subject|3
5981623|NCT01052662|20681693|P3|Overall Study|Lost to Follow-up|18
5981624|NCT01052662|20681694|P2|Overall Study|Lost to Follow-up|13
5981625|NCT01052662|20681695|P1|Overall Study|Lost to Follow-up|15
5981626|NCT01052480|20681736|P2|Overall Study|Death|5
5981627|NCT01052480|20681737|P1|Overall Study|Death|1
5981628|NCT01052480|20681736|P2|Overall Study|Physician Decision|2
5981629|NCT01052480|20681737|P1|Overall Study|Physician Decision|0
5981630|NCT01052480|20681736|P2|Overall Study|Withdrawal by Subject|7
5981631|NCT01052480|20681737|P1|Overall Study|Withdrawal by Subject|3
5981632|NCT01052480|20681736|P2|Overall Study|Protocol Violation|0
5981633|NCT01052480|20681737|P1|Overall Study|Protocol Violation|1
5981634|NCT01052480|20681736|P2|Overall Study|Lost to Follow-up|3
5981635|NCT01052480|20681737|P1|Overall Study|Lost to Follow-up|3
5981636|NCT01052428|20681787|P2|Overall Study|Withdrawal by Subject|1
5981637|NCT01052428|20681788|P1|Overall Study|Withdrawal by Subject|0
5981638|NCT01052428|20681787|P2|Overall Study|Death|0
5981639|NCT01052428|20681788|P1|Overall Study|Death|1
5981640|NCT01052272|20681810|P4|Overall Study|decline in health|0
5981641|NCT01052272|20681811|P3|Overall Study|decline in health|1
5981642|NCT01052272|20681812|P2|Overall Study|decline in health|0
5981643|NCT01052272|20681813|P1|Overall Study|decline in health|0
5981644|NCT01052272|20681810|P4|Overall Study|placed in long-term care|0
5981645|NCT01052272|20681811|P3|Overall Study|placed in long-term care|1
5981646|NCT01052272|20681812|P2|Overall Study|placed in long-term care|0
5981647|NCT01052272|20681813|P1|Overall Study|placed in long-term care|0
5981648|NCT01052272|20681810|P4|Overall Study|Withdrawal by Subject|2
5981649|NCT01052272|20681811|P3|Overall Study|Withdrawal by Subject|3
5981650|NCT01052272|20681812|P2|Overall Study|Withdrawal by Subject|2
5981651|NCT01052272|20681813|P1|Overall Study|Withdrawal by Subject|0
5981652|NCT01052272|20681810|P4|Overall Study|patient refuses follow-up|4
5981653|NCT01052272|20681811|P3|Overall Study|patient refuses follow-up|2
5981654|NCT01052272|20681812|P2|Overall Study|patient refuses follow-up|4
5981655|NCT01052272|20681813|P1|Overall Study|patient refuses follow-up|5
5981656|NCT01052272|20681810|P4|Overall Study|Physician Decision|0
5981657|NCT01052272|20681811|P3|Overall Study|Physician Decision|0
5981658|NCT01052272|20681812|P2|Overall Study|Physician Decision|1
5981659|NCT01052272|20681813|P1|Overall Study|Physician Decision|0
5981660|NCT01052272|20681810|P4|Overall Study|Death|1
5981661|NCT01052272|20681811|P3|Overall Study|Death|1
5981662|NCT01052272|20681812|P2|Overall Study|Death|0
5981663|NCT01052272|20681813|P1|Overall Study|Death|0
5981664|NCT01052116|20681858|P2|Overall Study|Spirometry not performed|4
5981665|NCT01052116|20681859|P1|Overall Study|Spirometry not performed|0
5981666|NCT01052116|20681858|P2|Overall Study|Withdrawal by Subject|6
5981667|NCT01052116|20681859|P1|Overall Study|Withdrawal by Subject|3
5981668|NCT01052116|20681858|P2|Overall Study|Lost to Follow-up|17
5981669|NCT01052116|20681859|P1|Overall Study|Lost to Follow-up|11
5981670|NCT01052077|20681867|P4|Phase A+|Withdrawal by Subject|7
5981671|NCT01052077|20681868|P3|Phase A+|Withdrawal by Subject|0
5981672|NCT01052077|20681869|P2|Phase A+|Withdrawal by Subject|0
5981673|NCT01052077|20681870|P1|Phase A+|Withdrawal by Subject|0
5981674|NCT01052077|20681867|P4|Phase A+|Met Withdrawal Criteria|2
5981675|NCT01052077|20681868|P3|Phase A+|Met Withdrawal Criteria|0
5981676|NCT01052077|20681869|P2|Phase A+|Met Withdrawal Criteria|0
5981677|NCT01052077|20681870|P1|Phase A+|Met Withdrawal Criteria|0
5981678|NCT01052077|20681867|P4|Phase A+|Adverse Event|4
5981679|NCT01052077|20681868|P3|Phase A+|Adverse Event|0
5981680|NCT01052077|20681869|P2|Phase A+|Adverse Event|0
5981681|NCT01052077|20681870|P1|Phase A+|Adverse Event|0
5981682|NCT01052077|20681867|P4|Phase A+|Lost to Follow-up|8
5981683|NCT01052077|20681868|P3|Phase A+|Lost to Follow-up|0
5981684|NCT01052077|20681869|P2|Phase A+|Lost to Follow-up|0
5981685|NCT01052077|20681870|P1|Phase A+|Lost to Follow-up|0
5981686|NCT01052077|20681867|P4|Phase B|Lack of Efficacy|0
5981687|NCT01052077|20681868|P3|Phase B|Lack of Efficacy|0
5981688|NCT01052077|20681869|P2|Phase B|Lack of Efficacy|1
5981689|NCT01052077|20681870|P1|Phase B|Lack of Efficacy|0
5981690|NCT01052077|20681867|P4|Phase B|Protocol Deviation|0
5981691|NCT01052077|20681868|P3|Phase B|Protocol Deviation|4
5981692|NCT01052077|20681869|P2|Phase B|Protocol Deviation|3
5981693|NCT01052077|20681870|P1|Phase B|Protocol Deviation|0
5981694|NCT01052077|20681867|P4|Phase B|Withdrawal by Subject|0
5981695|NCT01052077|20681868|P3|Phase B|Withdrawal by Subject|5
5981696|NCT01052077|20681869|P2|Phase B|Withdrawal by Subject|0
5981697|NCT01052077|20681870|P1|Phase B|Withdrawal by Subject|0
5981698|NCT01052077|20681867|P4|Phase B|Physician Decision|0
5981699|NCT01052077|20681868|P3|Phase B|Physician Decision|1
5981700|NCT01052077|20681869|P2|Phase B|Physician Decision|1
5981701|NCT01052077|20681870|P1|Phase B|Physician Decision|0
5981702|NCT01052077|20681867|P4|Phase B|Met Withdrawal Criteria|0
5981703|NCT01052077|20681868|P3|Phase B|Met Withdrawal Criteria|1
5981704|NCT01052077|20681869|P2|Phase B|Met Withdrawal Criteria|2
5981705|NCT01052077|20681870|P1|Phase B|Met Withdrawal Criteria|0
5981706|NCT01052077|20681867|P4|Phase B|Adverse Event|0
5981707|NCT01052077|20681868|P3|Phase B|Adverse Event|2
5981708|NCT01052077|20681869|P2|Phase B|Adverse Event|9
5981709|NCT01052077|20681870|P1|Phase B|Adverse Event|0
5981710|NCT01052077|20681867|P4|Phase B|Lost to Follow-up|0
5981711|NCT01052077|20681868|P3|Phase B|Lost to Follow-up|3
5981712|NCT01052077|20681869|P2|Phase B|Lost to Follow-up|2
5981713|NCT01052077|20681870|P1|Phase B|Lost to Follow-up|0
5981714|NCT01052077|20681867|P4|Phase A|Protocol Deviation|0
5981715|NCT01052077|20681868|P3|Phase A|Protocol Deviation|0
5981716|NCT01052077|20681869|P2|Phase A|Protocol Deviation|0
5981717|NCT01052077|20681870|P1|Phase A|Protocol Deviation|27
5981718|NCT01052077|20681867|P4|Phase A|Withdrawal by Subject|0
5981719|NCT01052077|20681868|P3|Phase A|Withdrawal by Subject|0
5981720|NCT01052077|20681869|P2|Phase A|Withdrawal by Subject|0
5981721|NCT01052077|20681870|P1|Phase A|Withdrawal by Subject|29
5981722|NCT01052077|20681867|P4|Phase A|Physician Decision|0
5981723|NCT01052077|20681868|P3|Phase A|Physician Decision|0
5981724|NCT01052077|20681869|P2|Phase A|Physician Decision|0
5981725|NCT01052077|20681870|P1|Phase A|Physician Decision|10
5981726|NCT01052077|20681867|P4|Phase A|Met Withdrawal Criteria|0
5981727|NCT01052077|20681868|P3|Phase A|Met Withdrawal Criteria|0
5981728|NCT01052077|20681869|P2|Phase A|Met Withdrawal Criteria|0
5981729|NCT01052077|20681870|P1|Phase A|Met Withdrawal Criteria|26
5981730|NCT01052077|20681867|P4|Phase A|Adverse Event|0
5981731|NCT01052077|20681868|P3|Phase A|Adverse Event|0
5981732|NCT01052077|20681869|P2|Phase A|Adverse Event|0
5981733|NCT01052077|20681870|P1|Phase A|Adverse Event|32
5981734|NCT01052077|20681867|P4|Phase A|Lost to Follow-up|0
5981735|NCT01052077|20681868|P3|Phase A|Lost to Follow-up|0
5981736|NCT01052077|20681869|P2|Phase A|Lost to Follow-up|0
5981737|NCT01052077|20681870|P1|Phase A|Lost to Follow-up|22
5981738|NCT01052038|20681897|P3|Overall Study|Protocol Violation|3
5981739|NCT01052038|20681898|P2|Overall Study|Protocol Violation|3
5981740|NCT01052038|20681899|P1|Overall Study|Protocol Violation|2
5981741|NCT01052038|20681897|P3|Overall Study|Lost to Follow-up|1
5981742|NCT01052038|20681898|P2|Overall Study|Lost to Follow-up|3
5981743|NCT01052038|20681899|P1|Overall Study|Lost to Follow-up|2
5981744|NCT01051986|20681921|P2|Overall Study|Protocol Violation|3
5981745|NCT01051986|20681922|P1|Overall Study|Protocol Violation|2
5981746|NCT01051986|20681921|P2|Overall Study|Withdrawal by Subject|1
5981747|NCT01051986|20681922|P1|Overall Study|Withdrawal by Subject|2
5981748|NCT01051986|20681921|P2|Overall Study|Death|0
5981749|NCT01051986|20681922|P1|Overall Study|Death|1
5981750|NCT01051960|20681936|P1|Overall Study|Adverse Event|1
5981751|NCT01051921|20681944|P1|Overall Study|patient moved|1
5981752|NCT01051921|20681944|P1|Overall Study|virological failure|1
5981753|NCT01051921|20681944|P1|Overall Study|Lost to Follow-up|4
5981754|NCT01051921|20681944|P1|Overall Study|Withdrawal by Subject|7
5981755|NCT01051921|20681944|P1|Overall Study|Adverse Event|8
5981756|NCT01051921|20681944|P1|Overall Study|Physician Decision|9
5981757|NCT01051856|20681951|P2|Overall Study|Withdrawal by Subject|0
5981758|NCT01051856|20681952|P1|Overall Study|Withdrawal by Subject|1
5981759|NCT01051817|20681962|P2|Overall Study|Protocol Violation|1
5981760|NCT01051817|20681963|P1|Overall Study|Protocol Violation|0
5981761|NCT01051817|20681962|P2|Overall Study|Withdrawal by Subject|5
5981762|NCT01051817|20681963|P1|Overall Study|Withdrawal by Subject|3
5981763|NCT01051817|20681962|P2|Overall Study|Abnormal Test Proceedure reults|1
5981764|NCT01051817|20681963|P1|Overall Study|Abnormal Test Proceedure reults|0
5981765|NCT01051817|20681962|P2|Overall Study|Adverse Event|2
5981766|NCT01051817|20681963|P1|Overall Study|Adverse Event|0
5981767|NCT01051791|20681973|P1|Overall Study|Withdrawal by Subject|1
5981768|NCT01051791|20681973|P1|Overall Study|Failed screening|3
5981769|NCT01051739|20681991|P2|Overall Study|Withdrawal by Subject|10
5981770|NCT01051739|20681992|P1|Overall Study|Withdrawal by Subject|25
5981771|NCT01051739|20681991|P2|Overall Study|Death|3
5981772|NCT01051739|20681992|P1|Overall Study|Death|3
5981839|NCT01051557|20682211|P7|Overall Study|Adverse Event|4
5981840|NCT01051557|20682212|P6|Overall Study|Adverse Event|3
5981841|NCT01051557|20682213|P5|Overall Study|Adverse Event|1
5981842|NCT01051557|20682214|P4|Overall Study|Adverse Event|1
5981843|NCT01051557|20682215|P3|Overall Study|Adverse Event|0
5981844|NCT01051557|20682216|P2|Overall Study|Adverse Event|0
5981845|NCT01051557|20682217|P1|Overall Study|Adverse Event|0
5981846|NCT01051557|20682211|P7|Overall Study|Withdrawal by Subject|1
5981847|NCT01051557|20682212|P6|Overall Study|Withdrawal by Subject|0
5981848|NCT01051557|20682213|P5|Overall Study|Withdrawal by Subject|2
5981849|NCT01051557|20682214|P4|Overall Study|Withdrawal by Subject|0
5981850|NCT01051557|20682215|P3|Overall Study|Withdrawal by Subject|1
5981851|NCT01051557|20682216|P2|Overall Study|Withdrawal by Subject|0
5981852|NCT01051557|20682217|P1|Overall Study|Withdrawal by Subject|0
5981853|NCT01051557|20682211|P7|Overall Study|disease progression|1
5981854|NCT01051557|20682212|P6|Overall Study|disease progression|3
5981855|NCT01051557|20682213|P5|Overall Study|disease progression|4
5981856|NCT01051557|20682214|P4|Overall Study|disease progression|2
5981857|NCT01051557|20682215|P3|Overall Study|disease progression|5
5981858|NCT01051557|20682216|P2|Overall Study|disease progression|3
5981859|NCT01051557|20682217|P1|Overall Study|disease progression|3
5981860|NCT01051557|20682211|P7|Overall Study|Physician Decision|0
5981861|NCT01051557|20682212|P6|Overall Study|Physician Decision|0
5981862|NCT01051557|20682213|P5|Overall Study|Physician Decision|0
5981863|NCT01051557|20682214|P4|Overall Study|Physician Decision|0
5981864|NCT01051557|20682215|P3|Overall Study|Physician Decision|0
5981865|NCT01051557|20682216|P2|Overall Study|Physician Decision|0
5981866|NCT01051557|20682217|P1|Overall Study|Physician Decision|1
5981867|NCT01051466|20682248|P2|Overall Study|Physician Decision|0
5981868|NCT01051466|20682249|P1|Overall Study|Physician Decision|1
5981869|NCT01051466|20682248|P2|Overall Study|Entry Criteria Not Met|3
5981870|NCT01051466|20682249|P1|Overall Study|Entry Criteria Not Met|0
5981871|NCT01051466|20682248|P2|Overall Study|Withdrawal by Subject|1
5981872|NCT01051466|20682249|P1|Overall Study|Withdrawal by Subject|5
5981873|NCT01051466|20682248|P2|Overall Study|Lost to Follow-up|1
5981874|NCT01051466|20682249|P1|Overall Study|Lost to Follow-up|1
5981875|NCT01051466|20682248|P2|Overall Study|Adverse Event|0
5981876|NCT01051466|20682249|P1|Overall Study|Adverse Event|1
5981877|NCT01051349|20682294|P1|Overall Study|Reason not Specified|12
5981878|NCT01051349|20682294|P1|Overall Study|Subject non-compliance|7
5981879|NCT01051349|20682294|P1|Overall Study|Lost to Follow-up|6
5981880|NCT01051349|20682294|P1|Overall Study|Investigator Decision|6
5981881|NCT01051349|20682294|P1|Overall Study|Consent Withdrawn|54
5981882|NCT01051349|20682294|P1|Overall Study|Adverse Event|88
5981883|NCT01051323|20682323|P1|Overall Study|Missing|37
5981884|NCT01051323|20682323|P1|Overall Study|Other|148
5981885|NCT01051323|20682323|P1|Overall Study|Hospitalization|28
5981886|NCT01051323|20682323|P1|Overall Study|Death|129
5981887|NCT01051323|20682323|P1|Overall Study|Lost to Follow-up|31
5981888|NCT01051323|20682323|P1|Overall Study|Withdrawal by Subject|13
5981889|NCT01051323|20682323|P1|Overall Study|Dialysis dependency|22
5981890|NCT01051323|20682323|P1|Overall Study|Transplantation|28
5981891|NCT01051323|20682323|P1|Overall Study|Discontinuation of treatment|103
5981892|NCT01051063|20682352|P2|Overall Study|Lost to Follow-up|1
5981893|NCT01051063|20682353|P1|Overall Study|Lost to Follow-up|0
5981894|NCT01051063|20682352|P2|Overall Study|Other|0
5981895|NCT01051063|20682353|P1|Overall Study|Other|1
5981896|NCT01051063|20682352|P2|Overall Study|Moved from the study site area|0
5981897|NCT01051063|20682353|P1|Overall Study|Moved from the study site area|1
5981898|NCT01051063|20682352|P2|Overall Study|Termination of the study|0
5981899|NCT01051063|20682353|P1|Overall Study|Termination of the study|5
5981900|NCT01051063|20682352|P2|Overall Study|Withdrawal by Subject|1
5981901|NCT01051063|20682353|P1|Overall Study|Withdrawal by Subject|1
5981902|NCT01051063|20682352|P2|Overall Study|Death|2
5981903|NCT01051063|20682353|P1|Overall Study|Death|2
5981904|NCT01050998|20682373|P5|Overall Study|Data integrity issues|4
5981905|NCT01050998|20682374|P4|Overall Study|Data integrity issues|1
5981906|NCT01050998|20682375|P3|Overall Study|Data integrity issues|1
5981907|NCT01050998|20682376|P2|Overall Study|Data integrity issues|0
5981908|NCT01050998|20682377|P1|Overall Study|Data integrity issues|0
5981909|NCT01050998|20682373|P5|Overall Study|Other|5
5981910|NCT01050998|20682374|P4|Overall Study|Other|1
5981911|NCT01050998|20682375|P3|Overall Study|Other|1
5981912|NCT01050998|20682376|P2|Overall Study|Other|2
5981913|NCT01050998|20682377|P1|Overall Study|Other|3
5981914|NCT01050998|20682373|P5|Overall Study|Withdrawal by Subject|3
5981915|NCT01050998|20682374|P4|Overall Study|Withdrawal by Subject|1
5981916|NCT01050998|20682375|P3|Overall Study|Withdrawal by Subject|0
5981917|NCT01050998|20682376|P2|Overall Study|Withdrawal by Subject|0
5981918|NCT01050998|20682377|P1|Overall Study|Withdrawal by Subject|0
5981919|NCT01050998|20682373|P5|Overall Study|Adverse Event|2
5981920|NCT01050998|20682374|P4|Overall Study|Adverse Event|0
5981921|NCT01050998|20682375|P3|Overall Study|Adverse Event|1
5981922|NCT01050998|20682376|P2|Overall Study|Adverse Event|0
5981923|NCT01050998|20682377|P1|Overall Study|Adverse Event|1
5981924|NCT01050816|20682716|P1|Overall Study|patient's refusal|2
5981925|NCT01050816|20682716|P1|Overall Study|Lost to Follow-up|2
5981926|NCT01050790|20682722|P1|Overall Study|Adverse Event|1
5981927|NCT01050764|20682732|P1|Overall Study|Death after HSCT, before T-cell infusion|1
5981928|NCT01050764|20682732|P1|Overall Study|Donor mobilization failure, death|1
5981929|NCT01050764|20682732|P1|Overall Study|Death, before HSCT|1
5981930|NCT01050673|20682743|P2|Overall Study|Physician Decision|5
5981931|NCT01050673|20682744|P1|Overall Study|Physician Decision|4
5981932|NCT01050634|20682812|P1|Overall Study|Ongoing at Date of Cut-Off|5
5981933|NCT01050634|20682812|P1|Overall Study|Other|21
5981934|NCT01050634|20682812|P1|Overall Study|Lost to Follow-up|2
5981935|NCT01050634|20682812|P1|Overall Study|Adverse Event|42
5981936|NCT01050634|20682812|P1|Overall Study|Death|2
5981937|NCT01050634|20682812|P1|Overall Study|Enrolled, but Not Treated|56
5981938|NCT01050569|20682836|P3|Overall Study|Physician Decision|3
5981939|NCT01050569|20682837|P2|Overall Study|Physician Decision|3
5981940|NCT01050569|20682838|P1|Overall Study|Physician Decision|3
5981941|NCT01050569|20682836|P3|Overall Study|Adverse Event|0
5981942|NCT01050569|20682837|P2|Overall Study|Adverse Event|0
5981943|NCT01050569|20682838|P1|Overall Study|Adverse Event|1
5981944|NCT01050569|20682836|P3|Overall Study|Lack of Efficacy|3
5981945|NCT01050569|20682837|P2|Overall Study|Lack of Efficacy|4
5981946|NCT01050569|20682838|P1|Overall Study|Lack of Efficacy|5
5981947|NCT01050569|20682836|P3|Overall Study|Withdrawal by Subject|11
5981948|NCT01050569|20682837|P2|Overall Study|Withdrawal by Subject|3
5981949|NCT01050569|20682838|P1|Overall Study|Withdrawal by Subject|9
5981950|NCT01050569|20682836|P3|Overall Study|Lost to Follow-up|16
5981951|NCT01050569|20682837|P2|Overall Study|Lost to Follow-up|14
5981952|NCT01050569|20682838|P1|Overall Study|Lost to Follow-up|20
5981953|NCT01050543|20682857|P2|Overall Study|Administrative|1
5981954|NCT01050543|20682858|P1|Overall Study|Administrative|4
5981955|NCT01050543|20682857|P2|Overall Study|Protocol Violation|1
5981956|NCT01050543|20682858|P1|Overall Study|Protocol Violation|0
5981957|NCT01050543|20682857|P2|Overall Study|Withdrawal by Subject|2
5981958|NCT01050543|20682858|P1|Overall Study|Withdrawal by Subject|0
5981959|NCT01050530|20682866|P2|Overall Study|Protocol Violation|0
5981960|NCT01050530|20682867|P1|Overall Study|Protocol Violation|1
5981961|NCT01050530|20682866|P2|Overall Study|Withdrawal by Subject|3
5981962|NCT01050530|20682867|P1|Overall Study|Withdrawal by Subject|0
5981963|NCT01050530|20682866|P2|Overall Study|Lack of Efficacy|4
5981964|NCT01050530|20682867|P1|Overall Study|Lack of Efficacy|1
5981965|NCT01050530|20682866|P2|Overall Study|Adverse Event|3
5981966|NCT01050530|20682867|P1|Overall Study|Adverse Event|6
5981967|NCT01050257|20682878|P3|Overall Study|Death|1
5981968|NCT01050257|20682879|P2|Overall Study|Death|0
5981969|NCT01050257|20682880|P1|Overall Study|Death|0
5981970|NCT01050257|20682878|P3|Overall Study|Failure to return|0
5981971|NCT01050257|20682879|P2|Overall Study|Failure to return|2
5981972|NCT01050257|20682880|P1|Overall Study|Failure to return|0
5981973|NCT01050257|20682878|P3|Overall Study|Violation criteria|0
5981974|NCT01050257|20682879|P2|Overall Study|Violation criteria|1
5981975|NCT01050257|20682880|P1|Overall Study|Violation criteria|0
5981976|NCT01050257|20682878|P3|Overall Study|Refused treatment/ Did not Cooperate|0
5981977|NCT01050257|20682879|P2|Overall Study|Refused treatment/ Did not Cooperate|1
5981978|NCT01050257|20682880|P1|Overall Study|Refused treatment/ Did not Cooperate|1
5981979|NCT01050257|20682878|P3|Overall Study|No reason specified|2
5981980|NCT01050257|20682879|P2|Overall Study|No reason specified|0
5981981|NCT01050257|20682880|P1|Overall Study|No reason specified|0
5981982|NCT01050257|20682878|P3|Overall Study|Withdrawal by Subject|0
5981983|NCT01050257|20682879|P2|Overall Study|Withdrawal by Subject|3
5981984|NCT01050257|20682880|P1|Overall Study|Withdrawal by Subject|0
5981985|NCT01050257|20682878|P3|Overall Study|Admin/Other (did not switch to oral)|2
5981986|NCT01050257|20682879|P2|Overall Study|Admin/Other (did not switch to oral)|2
5981987|NCT01050257|20682880|P1|Overall Study|Admin/Other (did not switch to oral)|6
5981988|NCT01050257|20682878|P3|Overall Study|Adverse Event|2
5981989|NCT01050257|20682879|P2|Overall Study|Adverse Event|4
5981990|NCT01050257|20682880|P1|Overall Study|Adverse Event|4
5981991|NCT01050218|20682915|P1|Overall Study|Family emergency|1
5981992|NCT01050218|20682915|P1|Overall Study|Serious Adverse Event|1
5981993|NCT01050218|20682915|P1|Overall Study|Failed to return|7
5981994|NCT01050218|20682915|P1|Overall Study|Compliance|2
5981995|NCT01050218|20682915|P1|Overall Study|Discontinued by sponsor|18
5981996|NCT01050218|20682915|P1|Overall Study|Withdrawal by Subject|18
5981997|NCT01050218|20682915|P1|Overall Study|Protocol Violation|3
5981998|NCT01050218|20682915|P1|Overall Study|Lack of Efficacy|8
5981999|NCT01050218|20682915|P1|Overall Study|Adverse Event|37
5982000|NCT01050205|20682921|P2|Overall Study|Discontinued Intervention|0
5982001|NCT01050205|20682922|P1|Overall Study|Discontinued Intervention|2
5982002|NCT01050205|20682921|P2|Overall Study|Relocated from area|2
5982003|NCT01050205|20682922|P1|Overall Study|Relocated from area|1
5982004|NCT01050205|20682921|P2|Overall Study|Withdrawal by Subject|1
5982005|NCT01050205|20682922|P1|Overall Study|Withdrawal by Subject|1
5982006|NCT01050205|20682921|P2|Overall Study|Lost to Follow-up|1
5982007|NCT01050205|20682922|P1|Overall Study|Lost to Follow-up|7
5982008|NCT01050062|20682979|P2|Overall Study|Others|11
5982009|NCT01050062|20682980|P1|Overall Study|Others|17
5982010|NCT01050062|20682979|P2|Overall Study|Physician Decision|9
5982011|NCT01050062|20682980|P1|Overall Study|Physician Decision|74
5982012|NCT01050062|20682979|P2|Overall Study|Lack of Efficacy|35
5982013|NCT01050062|20682980|P1|Overall Study|Lack of Efficacy|22
5982014|NCT01050062|20682979|P2|Overall Study|Lost to Follow-up|35
5982015|NCT01050062|20682980|P1|Overall Study|Lost to Follow-up|83
5982016|NCT01050062|20682979|P2|Overall Study|Adverse Event|22
5982017|NCT01050062|20682980|P1|Overall Study|Adverse Event|75
5982018|NCT01049984|20683002|P2|Overall Study|Treatment failure|2
5982019|NCT01049984|20683003|P1|Overall Study|Treatment failure|0
5982020|NCT01049984|20683002|P2|Overall Study|Adverse Event|7
5982021|NCT01049984|20683003|P1|Overall Study|Adverse Event|13
5982022|NCT01049984|20683002|P2|Overall Study|Lost to Follow-up|1
5982023|NCT01049984|20683003|P1|Overall Study|Lost to Follow-up|2
5982024|NCT01049984|20683002|P2|Overall Study|Protocol Violation|4
5982025|NCT01049984|20683003|P1|Overall Study|Protocol Violation|3
5982026|NCT01049984|20683002|P2|Overall Study|Withdrawal by Subject|5
5982027|NCT01049984|20683003|P1|Overall Study|Withdrawal by Subject|1
5982028|NCT01049581|20683067|P2|Overall Study|Lost to Follow-up|1
5982029|NCT01049581|20683068|P1|Overall Study|Lost to Follow-up|2
5982030|NCT01049503|20683083|P6|Overall Study|Lost to Follow-up|8
5982031|NCT01049503|20683084|P5|Overall Study|Lost to Follow-up|27
5982032|NCT01049503|20683085|P4|Overall Study|Lost to Follow-up|26
5982033|NCT01049503|20683086|P3|Overall Study|Lost to Follow-up|24
5982034|NCT01049503|20683087|P2|Overall Study|Lost to Follow-up|12
5982035|NCT01049503|20683088|P1|Overall Study|Lost to Follow-up|11
5982036|NCT01049412|20683119|P2|Period II|Lost to Follow-up|0
5982037|NCT01049412|20683120|P1|Period II|Lost to Follow-up|1
5982038|NCT01049412|20683119|P2|Period II|Adverse Event|0
5982039|NCT01049412|20683120|P1|Period II|Adverse Event|1
5982040|NCT01049412|20683119|P2|Period II|Withdrawal by Subject|3
5982041|NCT01049412|20683120|P1|Period II|Withdrawal by Subject|2
5982042|NCT01049412|20683119|P2|Period I|Adverse Event|0
5982043|NCT01049412|20683120|P1|Period I|Adverse Event|1
5982044|NCT01049412|20683119|P2|Period I|Protocol Violation|2
5982045|NCT01049412|20683120|P1|Period I|Protocol Violation|1
5982046|NCT01049412|20683119|P2|Period I|Physician Decision|3
5982047|NCT01049412|20683120|P1|Period I|Physician Decision|0
5982048|NCT01049412|20683119|P2|Period I|Lost to Follow-up|2
5982049|NCT01049412|20683120|P1|Period I|Lost to Follow-up|2
5982050|NCT01049412|20683119|P2|Period I|Withdrawal by Subject|6
5982051|NCT01049412|20683120|P1|Period I|Withdrawal by Subject|4
5982052|NCT01049373|20683149|P2|Overall Study|Non-cooperation|1
5982053|NCT01049373|20683150|P1|Overall Study|Non-cooperation|0
5982054|NCT01049373|20683149|P2|Overall Study|Other|1
5982055|NCT01049373|20683150|P1|Overall Study|Other|1
5982056|NCT01049373|20683149|P2|Overall Study|no evaluable study values|21
5982057|NCT01049373|20683150|P1|Overall Study|no evaluable study values|9
5982058|NCT01049373|20683149|P2|Overall Study|Lost to Follow-up|4
5982059|NCT01049373|20683150|P1|Overall Study|Lost to Follow-up|9
5982060|NCT01049373|20683149|P2|Overall Study|Adverse Event|3
5982061|NCT01049373|20683150|P1|Overall Study|Adverse Event|3
5982062|NCT01049373|20683149|P2|Overall Study|Withdrawal by Subject|5
5982063|NCT01049373|20683150|P1|Overall Study|Withdrawal by Subject|8
5982064|NCT01049373|20683149|P2|Overall Study|Protocol Violation|9
5982065|NCT01049373|20683150|P1|Overall Study|Protocol Violation|9
5982066|NCT01049360|20683164|P20|Period 4|Withdrawal by Subject|0
5982067|NCT01049360|20683165|P19|Period 4|Withdrawal by Subject|0
5982068|NCT01049360|20683166|P18|Period 4|Withdrawal by Subject|0
5982069|NCT01049360|20683167|P17|Period 4|Withdrawal by Subject|0
5982070|NCT01049360|20683168|P16|Period 4|Withdrawal by Subject|0
5982071|NCT01049360|20683169|P15|Period 4|Withdrawal by Subject|0
5982072|NCT01049360|20683170|P14|Period 4|Withdrawal by Subject|0
5982073|NCT01049360|20683171|P13|Period 4|Withdrawal by Subject|0
5982074|NCT01049360|20683172|P12|Period 4|Withdrawal by Subject|0
5982075|NCT01049360|20683173|P11|Period 4|Withdrawal by Subject|0
5982076|NCT01049360|20683174|P10|Period 4|Withdrawal by Subject|0
5982077|NCT01049360|20683175|P9|Period 4|Withdrawal by Subject|0
5982078|NCT01049360|20683176|P8|Period 4|Withdrawal by Subject|0
5982079|NCT01049360|20683177|P7|Period 4|Withdrawal by Subject|0
5982080|NCT01049360|20683178|P6|Period 4|Withdrawal by Subject|0
5982081|NCT01049360|20683179|P5|Period 4|Withdrawal by Subject|0
5982082|NCT01049360|20683180|P4|Period 4|Withdrawal by Subject|1
5982083|NCT01049360|20683181|P3|Period 4|Withdrawal by Subject|0
5982084|NCT01049360|20683182|P2|Period 4|Withdrawal by Subject|0
5982085|NCT01049360|20683183|P1|Period 4|Withdrawal by Subject|0
5982086|NCT01049360|20683164|P20|Period 4|Protocol Violation|0
5982087|NCT01049360|20683165|P19|Period 4|Protocol Violation|0
5982088|NCT01049360|20683166|P18|Period 4|Protocol Violation|1
5982089|NCT01049360|20683167|P17|Period 4|Protocol Violation|0
5982090|NCT01049360|20683168|P16|Period 4|Protocol Violation|0
5982091|NCT01049360|20683169|P15|Period 4|Protocol Violation|0
5982092|NCT01049360|20683170|P14|Period 4|Protocol Violation|0
5982093|NCT01049360|20683171|P13|Period 4|Protocol Violation|0
5982094|NCT01049360|20683172|P12|Period 4|Protocol Violation|0
5982095|NCT01049360|20683173|P11|Period 4|Protocol Violation|0
5982096|NCT01049360|20683174|P10|Period 4|Protocol Violation|0
5982097|NCT01049360|20683175|P9|Period 4|Protocol Violation|0
5982098|NCT01049360|20683176|P8|Period 4|Protocol Violation|0
5982099|NCT01049360|20683177|P7|Period 4|Protocol Violation|0
5982100|NCT01049360|20683178|P6|Period 4|Protocol Violation|0
5982101|NCT01049360|20683179|P5|Period 4|Protocol Violation|0
5982102|NCT01049360|20683180|P4|Period 4|Protocol Violation|0
5982103|NCT01049360|20683181|P3|Period 4|Protocol Violation|0
5982104|NCT01049360|20683182|P2|Period 4|Protocol Violation|0
5982105|NCT01049360|20683183|P1|Period 4|Protocol Violation|0
5982106|NCT01049360|20683164|P20|Period 2|Lack of Efficacy|0
5982107|NCT01049360|20683165|P19|Period 2|Lack of Efficacy|0
5982108|NCT01049360|20683166|P18|Period 2|Lack of Efficacy|0
5982109|NCT01049360|20683167|P17|Period 2|Lack of Efficacy|0
5982110|NCT01049360|20683168|P16|Period 2|Lack of Efficacy|0
5982111|NCT01049360|20683169|P15|Period 2|Lack of Efficacy|0
5982112|NCT01049360|20683170|P14|Period 2|Lack of Efficacy|0
5982113|NCT01049360|20683171|P13|Period 2|Lack of Efficacy|0
5982114|NCT01049360|20683172|P12|Period 2|Lack of Efficacy|0
5982115|NCT01049360|20683173|P11|Period 2|Lack of Efficacy|0
5982116|NCT01049360|20683174|P10|Period 2|Lack of Efficacy|0
5982117|NCT01049360|20683175|P9|Period 2|Lack of Efficacy|0
5982118|NCT01049360|20683176|P8|Period 2|Lack of Efficacy|0
5982119|NCT01049360|20683177|P7|Period 2|Lack of Efficacy|0
5982120|NCT01049360|20683178|P6|Period 2|Lack of Efficacy|1
5982121|NCT01049360|20683179|P5|Period 2|Lack of Efficacy|0
5982122|NCT01049360|20683180|P4|Period 2|Lack of Efficacy|0
5982123|NCT01049360|20683181|P3|Period 2|Lack of Efficacy|0
5982124|NCT01049360|20683182|P2|Period 2|Lack of Efficacy|0
5982125|NCT01049360|20683183|P1|Period 2|Lack of Efficacy|0
5982126|NCT01049360|20683164|P20|Period 2|Withdrawal by Subject|1
5982127|NCT01049360|20683165|P19|Period 2|Withdrawal by Subject|0
5982128|NCT01049360|20683166|P18|Period 2|Withdrawal by Subject|0
5982129|NCT01049360|20683167|P17|Period 2|Withdrawal by Subject|0
5982130|NCT01049360|20683168|P16|Period 2|Withdrawal by Subject|0
5982131|NCT01049360|20683169|P15|Period 2|Withdrawal by Subject|1
5982132|NCT01049360|20683170|P14|Period 2|Withdrawal by Subject|0
5982133|NCT01049360|20683171|P13|Period 2|Withdrawal by Subject|0
5982134|NCT01049360|20683172|P12|Period 2|Withdrawal by Subject|0
5982135|NCT01049360|20683173|P11|Period 2|Withdrawal by Subject|0
5982136|NCT01049360|20683174|P10|Period 2|Withdrawal by Subject|0
5982137|NCT01049360|20683175|P9|Period 2|Withdrawal by Subject|0
5982138|NCT01049360|20683176|P8|Period 2|Withdrawal by Subject|0
5982139|NCT01049360|20683177|P7|Period 2|Withdrawal by Subject|0
5982140|NCT01049360|20683178|P6|Period 2|Withdrawal by Subject|0
5982141|NCT01049360|20683179|P5|Period 2|Withdrawal by Subject|0
5982142|NCT01049360|20683180|P4|Period 2|Withdrawal by Subject|1
5982143|NCT01049360|20683181|P3|Period 2|Withdrawal by Subject|0
5982144|NCT01049360|20683182|P2|Period 2|Withdrawal by Subject|0
5982145|NCT01049360|20683183|P1|Period 2|Withdrawal by Subject|0
5982146|NCT01049360|20683164|P20|Period 2|Adverse Event|1
5982147|NCT01049360|20683165|P19|Period 2|Adverse Event|0
5982148|NCT01049360|20683166|P18|Period 2|Adverse Event|0
5982149|NCT01049360|20683167|P17|Period 2|Adverse Event|0
5982150|NCT01049360|20683168|P16|Period 2|Adverse Event|0
5982151|NCT01049360|20683169|P15|Period 2|Adverse Event|0
5982152|NCT01049360|20683170|P14|Period 2|Adverse Event|0
5982153|NCT01049360|20683171|P13|Period 2|Adverse Event|0
5982154|NCT01049360|20683172|P12|Period 2|Adverse Event|0
5982155|NCT01049360|20683173|P11|Period 2|Adverse Event|0
5982156|NCT01049360|20683174|P10|Period 2|Adverse Event|0
5982157|NCT01049360|20683175|P9|Period 2|Adverse Event|1
5982158|NCT01049360|20683176|P8|Period 2|Adverse Event|0
5982159|NCT01049360|20683177|P7|Period 2|Adverse Event|0
5982160|NCT01049360|20683178|P6|Period 2|Adverse Event|0
5982161|NCT01049360|20683179|P5|Period 2|Adverse Event|0
5982162|NCT01049360|20683180|P4|Period 2|Adverse Event|0
5982163|NCT01049360|20683181|P3|Period 2|Adverse Event|0
5982164|NCT01049360|20683182|P2|Period 2|Adverse Event|1
5982165|NCT01049360|20683183|P1|Period 2|Adverse Event|0
5982166|NCT01049360|20683164|P20|Period 2|Protocol Violation|0
5982167|NCT01049360|20683165|P19|Period 2|Protocol Violation|0
5982168|NCT01049360|20683166|P18|Period 2|Protocol Violation|0
5982169|NCT01049360|20683167|P17|Period 2|Protocol Violation|0
5982170|NCT01049360|20683168|P16|Period 2|Protocol Violation|1
5982171|NCT01049360|20683169|P15|Period 2|Protocol Violation|1
5982172|NCT01049360|20683170|P14|Period 2|Protocol Violation|0
5982173|NCT01049360|20683171|P13|Period 2|Protocol Violation|0
5982174|NCT01049360|20683172|P12|Period 2|Protocol Violation|0
5982175|NCT01049360|20683173|P11|Period 2|Protocol Violation|0
5982176|NCT01049360|20683174|P10|Period 2|Protocol Violation|0
5982177|NCT01049360|20683175|P9|Period 2|Protocol Violation|0
5982178|NCT01049360|20683176|P8|Period 2|Protocol Violation|0
5982179|NCT01049360|20683177|P7|Period 2|Protocol Violation|0
5982180|NCT01049360|20683178|P6|Period 2|Protocol Violation|0
5982181|NCT01049360|20683179|P5|Period 2|Protocol Violation|0
5982182|NCT01049360|20683180|P4|Period 2|Protocol Violation|1
5982183|NCT01049360|20683181|P3|Period 2|Protocol Violation|0
5982184|NCT01049360|20683182|P2|Period 2|Protocol Violation|0
5982185|NCT01049360|20683183|P1|Period 2|Protocol Violation|0
5982186|NCT01049360|20683164|P20|Period 1|Withdrawal by Subject|0
5982187|NCT01049360|20683165|P19|Period 1|Withdrawal by Subject|0
5982188|NCT01049360|20683166|P18|Period 1|Withdrawal by Subject|0
5982189|NCT01049360|20683167|P17|Period 1|Withdrawal by Subject|0
5982190|NCT01049360|20683168|P16|Period 1|Withdrawal by Subject|0
5982191|NCT01049360|20683169|P15|Period 1|Withdrawal by Subject|0
5982192|NCT01049360|20683170|P14|Period 1|Withdrawal by Subject|0
5982193|NCT01049360|20683171|P13|Period 1|Withdrawal by Subject|1
5982194|NCT01049360|20683172|P12|Period 1|Withdrawal by Subject|0
5982195|NCT01049360|20683173|P11|Period 1|Withdrawal by Subject|1
5982196|NCT01049360|20683174|P10|Period 1|Withdrawal by Subject|0
5982197|NCT01049360|20683175|P9|Period 1|Withdrawal by Subject|1
5982198|NCT01049360|20683176|P8|Period 1|Withdrawal by Subject|0
5982199|NCT01049360|20683177|P7|Period 1|Withdrawal by Subject|0
5982200|NCT01049360|20683178|P6|Period 1|Withdrawal by Subject|0
5982201|NCT01049360|20683179|P5|Period 1|Withdrawal by Subject|0
5982202|NCT01049360|20683180|P4|Period 1|Withdrawal by Subject|0
5982203|NCT01049360|20683181|P3|Period 1|Withdrawal by Subject|0
5982204|NCT01049360|20683182|P2|Period 1|Withdrawal by Subject|0
5982205|NCT01049360|20683183|P1|Period 1|Withdrawal by Subject|0
5982206|NCT01049360|20683164|P20|Period 1|Did not meet inc/exc criteria|0
5982207|NCT01049360|20683165|P19|Period 1|Did not meet inc/exc criteria|0
5982208|NCT01049360|20683166|P18|Period 1|Did not meet inc/exc criteria|0
5982209|NCT01049360|20683167|P17|Period 1|Did not meet inc/exc criteria|0
5982210|NCT01049360|20683168|P16|Period 1|Did not meet inc/exc criteria|0
5982211|NCT01049360|20683169|P15|Period 1|Did not meet inc/exc criteria|0
5982212|NCT01049360|20683170|P14|Period 1|Did not meet inc/exc criteria|0
5982213|NCT01049360|20683171|P13|Period 1|Did not meet inc/exc criteria|0
5982214|NCT01049360|20683172|P12|Period 1|Did not meet inc/exc criteria|0
5982215|NCT01049360|20683173|P11|Period 1|Did not meet inc/exc criteria|0
5982216|NCT01049360|20683174|P10|Period 1|Did not meet inc/exc criteria|0
5982217|NCT01049360|20683175|P9|Period 1|Did not meet inc/exc criteria|1
5982218|NCT01049360|20683176|P8|Period 1|Did not meet inc/exc criteria|1
5982219|NCT01049360|20683177|P7|Period 1|Did not meet inc/exc criteria|0
5982220|NCT01049360|20683178|P6|Period 1|Did not meet inc/exc criteria|0
5982221|NCT01049360|20683179|P5|Period 1|Did not meet inc/exc criteria|0
5982222|NCT01049360|20683180|P4|Period 1|Did not meet inc/exc criteria|0
5982223|NCT01049360|20683181|P3|Period 1|Did not meet inc/exc criteria|0
5982224|NCT01049360|20683182|P2|Period 1|Did not meet inc/exc criteria|0
5982225|NCT01049360|20683183|P1|Period 1|Did not meet inc/exc criteria|0
5982226|NCT01049360|20683164|P20|Period 1|Adverse Event|0
5982227|NCT01049360|20683165|P19|Period 1|Adverse Event|1
5982228|NCT01049360|20683166|P18|Period 1|Adverse Event|0
5982229|NCT01049360|20683167|P17|Period 1|Adverse Event|1
5982230|NCT01049360|20683168|P16|Period 1|Adverse Event|0
5982231|NCT01049360|20683169|P15|Period 1|Adverse Event|0
5982232|NCT01049360|20683170|P14|Period 1|Adverse Event|1
5982233|NCT01049360|20683171|P13|Period 1|Adverse Event|1
5982234|NCT01049360|20683172|P12|Period 1|Adverse Event|0
5982235|NCT01049360|20683173|P11|Period 1|Adverse Event|0
5982236|NCT01049360|20683174|P10|Period 1|Adverse Event|0
5982237|NCT01049360|20683175|P9|Period 1|Adverse Event|0
5982238|NCT01049360|20683176|P8|Period 1|Adverse Event|1
5982239|NCT01049360|20683177|P7|Period 1|Adverse Event|0
5982240|NCT01049360|20683178|P6|Period 1|Adverse Event|0
5982241|NCT01049360|20683179|P5|Period 1|Adverse Event|0
5982242|NCT01049360|20683180|P4|Period 1|Adverse Event|1
5982243|NCT01049360|20683181|P3|Period 1|Adverse Event|0
5982244|NCT01049360|20683182|P2|Period 1|Adverse Event|1
5982245|NCT01049360|20683183|P1|Period 1|Adverse Event|0
5982246|NCT01049334|20683207|P2|Overall Study|Protocol Violation|1
5982247|NCT01049334|20683208|P1|Overall Study|Protocol Violation|0
5982248|NCT01049334|20683207|P2|Overall Study|Physician Decision|0
5982249|NCT01049334|20683208|P1|Overall Study|Physician Decision|2
5982250|NCT01049334|20683207|P2|Overall Study|Adverse Event|3
5982251|NCT01049334|20683208|P1|Overall Study|Adverse Event|2
5982252|NCT01049334|20683207|P2|Overall Study|Withdrawal by Subject|3
5982253|NCT01049334|20683208|P1|Overall Study|Withdrawal by Subject|5
5982254|NCT01049308|20683244|P1|Pill Counts|Withdrawal by Subject|83
5982255|NCT01049035|20683263|P7|Overall Study|Voluntary withdrawal not due to an AE|2
5982256|NCT01049035|20683264|P6|Overall Study|Voluntary withdrawal not due to an AE|5
5982257|NCT01049035|20683265|P5|Overall Study|Voluntary withdrawal not due to an AE|1
5982258|NCT01049035|20683266|P4|Overall Study|Voluntary withdrawal not due to an AE|2
5982259|NCT01049035|20683267|P3|Overall Study|Voluntary withdrawal not due to an AE|8
5982260|NCT01049035|20683268|P2|Overall Study|Voluntary withdrawal not due to an AE|10
5982261|NCT01049035|20683269|P1|Overall Study|Voluntary withdrawal not due to an AE|16
5982262|NCT01049035|20683263|P7|Overall Study|Lost to Follow-up|3
5982263|NCT01049035|20683264|P6|Overall Study|Lost to Follow-up|3
5982264|NCT01049035|20683265|P5|Overall Study|Lost to Follow-up|0
5982265|NCT01049035|20683266|P4|Overall Study|Lost to Follow-up|1
5982266|NCT01049035|20683267|P3|Overall Study|Lost to Follow-up|4
5982267|NCT01049035|20683268|P2|Overall Study|Lost to Follow-up|4
5982268|NCT01049035|20683269|P1|Overall Study|Lost to Follow-up|5
5982269|NCT01049035|20683263|P7|Overall Study|Non-compliance with the protocol|10
5982270|NCT01049035|20683264|P6|Overall Study|Non-compliance with the protocol|4
5982271|NCT01049035|20683265|P5|Overall Study|Non-compliance with the protocol|3
5982272|NCT01049035|20683266|P4|Overall Study|Non-compliance with the protocol|5
5982273|NCT01049035|20683267|P3|Overall Study|Non-compliance with the protocol|14
5982274|NCT01049035|20683268|P2|Overall Study|Non-compliance with the protocol|6
5982275|NCT01049035|20683269|P1|Overall Study|Non-compliance with the protocol|12
5982276|NCT01049035|20683263|P7|Overall Study|Other adverse event (AE)|0
5982277|NCT01049035|20683264|P6|Overall Study|Other adverse event (AE)|0
5982278|NCT01049035|20683265|P5|Overall Study|Other adverse event (AE)|0
5982279|NCT01049035|20683266|P4|Overall Study|Other adverse event (AE)|1
5982280|NCT01049035|20683267|P3|Overall Study|Other adverse event (AE)|0
5982281|NCT01049035|20683268|P2|Overall Study|Other adverse event (AE)|0
5982282|NCT01049035|20683269|P1|Overall Study|Other adverse event (AE)|0
5982283|NCT01049035|20683263|P7|Overall Study|Serious adverse event|0
5982284|NCT01049035|20683264|P6|Overall Study|Serious adverse event|0
5982285|NCT01049035|20683265|P5|Overall Study|Serious adverse event|0
5982286|NCT01049035|20683266|P4|Overall Study|Serious adverse event|2
5982287|NCT01049035|20683267|P3|Overall Study|Serious adverse event|1
5982288|NCT01049035|20683268|P2|Overall Study|Serious adverse event|1
5982289|NCT01049035|20683269|P1|Overall Study|Serious adverse event|0
5982290|NCT01049009|20683428|P2|Treatment Period 2 (12 Weeks)|Protocol Violation|7
5982291|NCT01049009|20683429|P1|Treatment Period 2 (12 Weeks)|Protocol Violation|8
5982292|NCT01049009|20683428|P2|Treatment Period 2 (12 Weeks)|Lost to Follow-up|3
5982293|NCT01049009|20683429|P1|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2
5982294|NCT01049009|20683428|P2|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
5982295|NCT01049009|20683429|P1|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
5982296|NCT01049009|20683428|P2|Treatment Period 1 (12 Weeks)|Protocol Violation|2
5982297|NCT01049009|20683429|P1|Treatment Period 1 (12 Weeks)|Protocol Violation|2
5982298|NCT01048944|20683441|P4|Overall Study|Protocol Violation|2
5982299|NCT01048944|20683442|P3|Overall Study|Protocol Violation|10
5982300|NCT01048944|20683443|P2|Overall Study|Protocol Violation|10
5982301|NCT01048944|20683444|P1|Overall Study|Protocol Violation|8
5982302|NCT01048866|20683476|P2|Overall Study|Other|1
5982303|NCT01048866|20683477|P1|Overall Study|Other|1
5982304|NCT01048866|20683476|P2|Overall Study|Lost to Follow-up|2
5982305|NCT01048866|20683477|P1|Overall Study|Lost to Follow-up|0
5982306|NCT01048866|20683476|P2|Overall Study|Withdrawal by Subject|2
5982307|NCT01048866|20683477|P1|Overall Study|Withdrawal by Subject|0
5982308|NCT01048866|20683476|P2|Overall Study|Physician Decision|0
5982309|NCT01048866|20683477|P1|Overall Study|Physician Decision|1
5982310|NCT01048866|20683476|P2|Overall Study|Protocol Violation|0
5982311|NCT01048866|20683477|P1|Overall Study|Protocol Violation|1
5982312|NCT01048866|20683476|P2|Overall Study|Adverse Event|0
5982313|NCT01048866|20683477|P1|Overall Study|Adverse Event|1
5982314|NCT01048788|20683522|P3|Overall Study|Withdrawal by Subject|0
5982315|NCT01048788|20683523|P2|Overall Study|Withdrawal by Subject|1
5982316|NCT01048788|20683524|P1|Overall Study|Withdrawal by Subject|0
5982317|NCT01048788|20683522|P3|Overall Study|Lack of Efficacy|1
5982318|NCT01048788|20683523|P2|Overall Study|Lack of Efficacy|0
5982319|NCT01048788|20683524|P1|Overall Study|Lack of Efficacy|0
5982320|NCT01048788|20683522|P3|Overall Study|Adverse Event|1
5982321|NCT01048788|20683523|P2|Overall Study|Adverse Event|1
5982322|NCT01048788|20683524|P1|Overall Study|Adverse Event|5
5982323|NCT01048671|20683546|P3|Overall Study|Protocol Violation|1
5982324|NCT01048671|20683547|P2|Overall Study|Protocol Violation|1
5982325|NCT01048671|20683548|P1|Overall Study|Protocol Violation|0
5982326|NCT01048541|20683628|P2|Overall Study|Withdrawal by Subject|0
5982327|NCT01048541|20683629|P1|Overall Study|Withdrawal by Subject|1
5982328|NCT01048502|20683639|P4|Overall Study|Physician Decision|1
5982329|NCT01048502|20683640|P3|Overall Study|Physician Decision|0
5982330|NCT01048502|20683641|P2|Overall Study|Physician Decision|3
5982331|NCT01048502|20683642|P1|Overall Study|Physician Decision|0
5982332|NCT01048502|20683639|P4|Overall Study|Withdrawal by Subject|3
5982333|NCT01048502|20683640|P3|Overall Study|Withdrawal by Subject|5
5982334|NCT01048502|20683641|P2|Overall Study|Withdrawal by Subject|4
5982335|NCT01048502|20683642|P1|Overall Study|Withdrawal by Subject|1
5982336|NCT01048502|20683639|P4|Overall Study|Adverse Event|0
5982337|NCT01048502|20683640|P3|Overall Study|Adverse Event|0
5982338|NCT01048502|20683641|P2|Overall Study|Adverse Event|0
5982339|NCT01048502|20683642|P1|Overall Study|Adverse Event|1
5982340|NCT01048502|20683639|P4|Overall Study|Lost to Follow-up|0
5982341|NCT01048502|20683640|P3|Overall Study|Lost to Follow-up|0
5982342|NCT01048502|20683641|P2|Overall Study|Lost to Follow-up|0
5982343|NCT01048502|20683642|P1|Overall Study|Lost to Follow-up|2
5982344|NCT01048333|20683678|P6|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0
5982345|NCT01048333|20683679|P5|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0
5982346|NCT01048333|20683680|P4|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0
5982347|NCT01048333|20683681|P3|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0
5982348|NCT01048333|20683682|P2|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|1
5982349|NCT01048333|20683683|P1|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0
5982350|NCT01048242|20683705|P2|Overall Study|See study flow chart|2
5982351|NCT01048242|20683706|P1|Overall Study|See study flow chart|4
5982352|NCT01048099|20683721|P1|Patients Evaluated by PRO Onc Assay|Patients with no HER2 abnormality|202
5982353|NCT01048099|20683721|P1|Patients Enrolled and Blood Collected|Patients without circulating tumor cells|57
5982354|NCT01047553|20683769|P2|Overall Study|PI's decision|1
5982355|NCT01047553|20683770|P1|Overall Study|PI's decision|0
5982356|NCT01047553|20683769|P2|Overall Study|Sever Non-Compliance to Protocol|0
5982357|NCT01047553|20683770|P1|Overall Study|Sever Non-Compliance to Protocol|1
5982358|NCT01047553|20683769|P2|Overall Study|Lost to Follow-up|0
5982359|NCT01047553|20683770|P1|Overall Study|Lost to Follow-up|1
5982360|NCT01047553|20683769|P2|Overall Study|Development of Study-Specific Withdrawal|1
5982361|NCT01047553|20683770|P1|Overall Study|Development of Study-Specific Withdrawal|1
5982362|NCT01047553|20683769|P2|Overall Study|Withdrawal by Subject|2
5982363|NCT01047553|20683770|P1|Overall Study|Withdrawal by Subject|4
5982364|NCT01047553|20683769|P2|Overall Study|Adverse Event|5
5982365|NCT01047553|20683770|P1|Overall Study|Adverse Event|10
5982366|NCT01047436|20683877|P2|Overall Study|Protocol Violation|0
5982367|NCT01047436|20683878|P1|Overall Study|Protocol Violation|1
5982368|NCT01047345|20683903|P3|Extension|Lost to Follow-up|5
5982369|NCT01047345|20683904|P2|Extension|Lost to Follow-up|0
5982370|NCT01047345|20683905|P1|Extension|Lost to Follow-up|0
5982371|NCT01047345|20683903|P3|Extension|Withdrawal by Subject|1
5982372|NCT01047345|20683904|P2|Extension|Withdrawal by Subject|0
5982373|NCT01047345|20683905|P1|Extension|Withdrawal by Subject|0
5982374|NCT01047345|20683903|P3|Base Study|Withdrawal by Subject|0
5982375|NCT01047345|20683904|P2|Base Study|Withdrawal by Subject|4
5982376|NCT01047345|20683905|P1|Base Study|Withdrawal by Subject|12
5982377|NCT01047345|20683903|P3|Base Study|Protocol Violation|0
5982378|NCT01047345|20683904|P2|Base Study|Protocol Violation|1
5982379|NCT01047345|20683905|P1|Base Study|Protocol Violation|3
5982380|NCT01047345|20683903|P3|Base Study|Lost to Follow-up|0
5982381|NCT01047345|20683904|P2|Base Study|Lost to Follow-up|1
5982382|NCT01047345|20683905|P1|Base Study|Lost to Follow-up|4
5982383|NCT01047345|20683903|P3|Base Study|Adverse Event|0
5982384|NCT01047345|20683904|P2|Base Study|Adverse Event|0
5982385|NCT01047345|20683905|P1|Base Study|Adverse Event|3
5982386|NCT01047332|20683927|P2|Overall Study|Lost to Follow-up|3
5982387|NCT01047332|20683928|P1|Overall Study|Lost to Follow-up|8
5982388|NCT01047332|20683927|P2|Overall Study|Died Unobstructed|41
5982389|NCT01047332|20683928|P1|Overall Study|Died Unobstructed|38
5982390|NCT01047332|20683927|P2|Overall Study|SEMS Obstruction|20
5982391|NCT01047332|20683928|P1|Overall Study|SEMS Obstruction|11
5982392|NCT01047319|20683943|P3|Overall Study|Study terminated by Sponsor|203
5982393|NCT01047319|20683944|P2|Overall Study|Study terminated by Sponsor|215
5982394|NCT01047319|20683945|P1|Overall Study|Study terminated by Sponsor|198
5982395|NCT01047319|20683943|P3|Overall Study|Withdrawal by Subject|87
5982396|NCT01047319|20683944|P2|Overall Study|Withdrawal by Subject|75
5982397|NCT01047319|20683945|P1|Overall Study|Withdrawal by Subject|77
5982398|NCT01047319|20683943|P3|Overall Study|Adverse Event|21
5982399|NCT01047319|20683944|P2|Overall Study|Adverse Event|27
5982400|NCT01047319|20683945|P1|Overall Study|Adverse Event|16
5982401|NCT01047319|20683943|P3|Overall Study|Lost to Follow-up|10
5982402|NCT01047319|20683944|P2|Overall Study|Lost to Follow-up|10
5982403|NCT01047319|20683945|P1|Overall Study|Lost to Follow-up|14
5982404|NCT01047319|20683943|P3|Overall Study|Physician Decision|10
5982405|NCT01047319|20683944|P2|Overall Study|Physician Decision|9
5982406|NCT01047319|20683945|P1|Overall Study|Physician Decision|12
5982407|NCT01047319|20683943|P3|Overall Study|Pregnancy|8
5982408|NCT01047319|20683944|P2|Overall Study|Pregnancy|8
5982409|NCT01047319|20683945|P1|Overall Study|Pregnancy|13
5982410|NCT01047319|20683943|P3|Overall Study|Death|5
5982411|NCT01047319|20683944|P2|Overall Study|Death|1
5982412|NCT01047319|20683945|P1|Overall Study|Death|5
5982413|NCT01047319|20683943|P3|Overall Study|Lack of Efficacy|3
5982414|NCT01047319|20683944|P2|Overall Study|Lack of Efficacy|3
5982415|NCT01047319|20683945|P1|Overall Study|Lack of Efficacy|4
5982416|NCT01047319|20683943|P3|Overall Study|Protocol Violation|4
5982417|NCT01047319|20683944|P2|Overall Study|Protocol Violation|2
5982418|NCT01047319|20683945|P1|Overall Study|Protocol Violation|3
5982419|NCT01047319|20683943|P3|Overall Study|Teva requested participant withdrawal|1
5982420|NCT01047319|20683944|P2|Overall Study|Teva requested participant withdrawal|0
5982421|NCT01047319|20683945|P1|Overall Study|Teva requested participant withdrawal|3
5982422|NCT01047306|20683967|P2|Overall Study|Lost to Follow-up|0
5982423|NCT01047306|20683968|P1|Overall Study|Lost to Follow-up|1
5982424|NCT01047306|20683967|P2|Overall Study|Withdrawal by Subject|0
5982425|NCT01047306|20683968|P1|Overall Study|Withdrawal by Subject|2
5982426|NCT01047293|20684042|P4|Overall Study|DLT criteria not fulfilled|0
5982427|NCT01047293|20684043|P3|Overall Study|DLT criteria not fulfilled|0
5982428|NCT01047293|20684044|P2|Overall Study|DLT criteria not fulfilled|1
5982429|NCT01047293|20684045|P1|Overall Study|DLT criteria not fulfilled|1
5982430|NCT01047007|20684076|P4|Overall Study|Progressive Disease|0
5982431|NCT01047007|20684077|P3|Overall Study|Progressive Disease|1
5982432|NCT01047007|20684078|P2|Overall Study|Progressive Disease|4
5982433|NCT01047007|20684079|P1|Overall Study|Progressive Disease|2
5982434|NCT01047007|20684076|P4|Overall Study|Adverse Event|0
5982435|NCT01047007|20684077|P3|Overall Study|Adverse Event|1
5982436|NCT01047007|20684078|P2|Overall Study|Adverse Event|2
5982437|NCT01047007|20684079|P1|Overall Study|Adverse Event|0
5982438|NCT01046903|20684090|P1|Overall Study|Other|5
5982439|NCT01046903|20684090|P1|Overall Study|Withdrawal by Subject|3
5982440|NCT01046903|20684090|P1|Overall Study|Adverse Event|4
5982441|NCT01046903|20684090|P1|Overall Study|Lost to Follow-up|16
5982442|NCT01046877|20684103|P1|Overall Study|Exited voluntarily after tube extrusion|11
5982443|NCT01046877|20684103|P1|Overall Study|Exited voluntarily before tube extrusion|7
5982444|NCT01046695|20684119|P2|Overall Study|TENS interfered with the cardiac monitor|1
5982445|NCT01046695|20684120|P1|Overall Study|TENS interfered with the cardiac monitor|0
5982446|NCT01046695|20684119|P2|Overall Study|Subject had a pacemaker|1
5982447|NCT01046695|20684120|P1|Overall Study|Subject had a pacemaker|0
5982448|NCT01046682|20684132|P2|Overall Study|Adverse Event|0
5982449|NCT01046682|20684133|P1|Overall Study|Adverse Event|2
5982450|NCT01046643|20684150|P4|First Period Treatment or Placebo|Withdrawal by Subject|0
5982451|NCT01046643|20684151|P3|First Period Treatment or Placebo|Withdrawal by Subject|0
5982452|NCT01046643|20684152|P2|First Period Treatment or Placebo|Withdrawal by Subject|1
5982453|NCT01046643|20684153|P1|First Period Treatment or Placebo|Withdrawal by Subject|0
5982454|NCT01046565|20684175|P1|Overall Study|Withdrawal by Subject|7
5982455|NCT01046565|20684175|P1|Overall Study|Adverse Event|2
5982456|NCT01046396|20684184|P1|Overall Study|Withdrawal by Subject|5
5982457|NCT01046253|20684195|P2|Second Intervention|Protocol Violation|1
5982458|NCT01046253|20684196|P1|Second Intervention|Protocol Violation|0
5982459|NCT01046253|20684195|P2|Second Intervention|Adverse Event|1
5982460|NCT01046253|20684196|P1|Second Intervention|Adverse Event|0
5982461|NCT01046136|20684208|P2|Overall Study|Lost to Follow-up|3
5982462|NCT01046136|20684209|P1|Overall Study|Lost to Follow-up|3
5982463|NCT01046136|20684208|P2|Overall Study|Physician Decision|1
5982464|NCT01046136|20684209|P1|Overall Study|Physician Decision|1
5982465|NCT01046136|20684208|P2|Overall Study|Withdrawal by Subject|4
5982466|NCT01046136|20684209|P1|Overall Study|Withdrawal by Subject|0
5982467|NCT01046110|20684221|P2|Overall Study|Unclassified|35
5982468|NCT01046110|20684222|P1|Overall Study|Unclassified|36
5982469|NCT01046110|20684221|P2|Overall Study|Withdrawal Criteria|5
5982470|NCT01046110|20684222|P1|Overall Study|Withdrawal Criteria|3
5982471|NCT01046110|20684221|P2|Overall Study|Protocol Violation|12
5982472|NCT01046110|20684222|P1|Overall Study|Protocol Violation|7
5982473|NCT01046110|20684221|P2|Overall Study|Lack of Efficacy|1
5982474|NCT01046110|20684222|P1|Overall Study|Lack of Efficacy|0
5982475|NCT01046110|20684221|P2|Overall Study|Adverse Event|2
5982476|NCT01046110|20684222|P1|Overall Study|Adverse Event|9
5982477|NCT01046084|20684232|P2|Third Washout of 7 Days|Withdrawal by Subject|0
5982478|NCT01046084|20684233|P1|Third Washout of 7 Days|Withdrawal by Subject|2
5982479|NCT01045993|20684247|P4|Overall Study|Treated-later found eligibility not met|0
5982480|NCT01045993|20684248|P3|Overall Study|Treated-later found eligibility not met|0
5982481|NCT01045993|20684249|P2|Overall Study|Treated-later found eligibility not met|1
5982482|NCT01045993|20684250|P1|Overall Study|Treated-later found eligibility not met|0
5982483|NCT01045967|20684326|P2|Second Intervention|Protocol Violation|1
5982484|NCT01045967|20684327|P1|Second Intervention|Protocol Violation|0
5982485|NCT01045798|20684339|P2|Overall Study|Received Systemic Antifungal Prestudy|1
5982486|NCT01045798|20684340|P1|Overall Study|Received Systemic Antifungal Prestudy|0
5982487|NCT01045798|20684339|P2|Overall Study|Changed to Other Antifungal Therapy|2
5982488|NCT01045798|20684340|P1|Overall Study|Changed to Other Antifungal Therapy|1
5982489|NCT01045798|20684339|P2|Overall Study|Invasive Fungal Infection at Baseline|1
5982490|NCT01045798|20684340|P1|Overall Study|Invasive Fungal Infection at Baseline|0
5982491|NCT01045798|20684339|P2|Overall Study|Changed to Open-Label Caspofungin|0
5982492|NCT01045798|20684340|P1|Overall Study|Changed to Open-Label Caspofungin|1
5982493|NCT01045707|20684348|P2|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|5
5982494|NCT01045707|20684349|P1|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|6
5982495|NCT01045707|20684348|P2|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|1
5982496|NCT01045707|20684349|P1|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|2
5982497|NCT01045707|20684348|P2|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|3
5982498|NCT01045707|20684349|P1|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|2
5982499|NCT01045707|20684348|P2|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3
5982500|NCT01045707|20684349|P1|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3
5982501|NCT01045707|20684348|P2|Main: Week 0 to 26 (NN5401-3590)|Unclassified|11
5982502|NCT01045707|20684349|P1|Main: Week 0 to 26 (NN5401-3590)|Unclassified|10
5982503|NCT01045707|20684348|P2|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|11
5982504|NCT01045707|20684349|P1|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|22
5982505|NCT01045707|20684348|P2|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|5
5982506|NCT01045707|20684349|P1|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|6
5982507|NCT01045707|20684348|P2|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|2
5982508|NCT01045707|20684349|P1|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|4
5982509|NCT01045707|20684348|P2|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|3
5982510|NCT01045707|20684349|P1|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|5
5982511|NCT01045694|20684365|P1|Overall Study|Withdrawal by Subject|2
5982512|NCT01045460|20684386|P2|Overall Study|Lack of Efficacy|0
5982513|NCT01045460|20684387|P1|Overall Study|Lack of Efficacy|3
5982514|NCT01045460|20684386|P2|Overall Study|Lost to Follow-up|1
5982515|NCT01045460|20684387|P1|Overall Study|Lost to Follow-up|0
5982516|NCT01045460|20684386|P2|Overall Study|Physician Decision|2
5982517|NCT01045460|20684387|P1|Overall Study|Physician Decision|3
5982518|NCT01045447|20684399|P2|Overall Study|Unclassified|13
5982519|NCT01045447|20684400|P1|Overall Study|Unclassified|17
5982520|NCT01045447|20684399|P2|Overall Study|Withdrawal Criteria|10
5982521|NCT01045447|20684400|P1|Overall Study|Withdrawal Criteria|10
5982522|NCT01045447|20684399|P2|Overall Study|Protocol Violation|3
5982523|NCT01045447|20684400|P1|Overall Study|Protocol Violation|6
5982524|NCT01045447|20684399|P2|Overall Study|Lack of Efficacy|1
5982525|NCT01045447|20684400|P1|Overall Study|Lack of Efficacy|3
5982526|NCT01045447|20684399|P2|Overall Study|Adverse Event|1
5982527|NCT01045447|20684400|P1|Overall Study|Adverse Event|0
5982528|NCT01045421|20684414|P11|Phase 2|Other|1
5982529|NCT01045421|20684415|P10|Phase 2|Other|0
5982530|NCT01045421|20684416|P9|Phase 2|Other|0
5982531|NCT01045421|20684417|P8|Phase 2|Other|3
5982532|NCT01045421|20684418|P7|Phase 2|Other|0
5982533|NCT01045421|20684419|P6|Phase 2|Other|0
5982534|NCT01045421|20684420|P5|Phase 2|Other|0
5982535|NCT01045421|20684421|P4|Phase 2|Other|0
5982536|NCT01045421|20684422|P3|Phase 2|Other|0
5982537|NCT01045421|20684423|P2|Phase 2|Other|0
5982538|NCT01045421|20684424|P1|Phase 2|Other|0
5982539|NCT01045421|20684414|P11|Phase 2|Death|0
5982540|NCT01045421|20684415|P10|Phase 2|Death|2
5982541|NCT01045421|20684416|P9|Phase 2|Death|1
5982542|NCT01045421|20684417|P8|Phase 2|Death|1
5982543|NCT01045421|20684418|P7|Phase 2|Death|0
5982544|NCT01045421|20684419|P6|Phase 2|Death|0
5982545|NCT01045421|20684420|P5|Phase 2|Death|0
5982546|NCT01045421|20684421|P4|Phase 2|Death|0
5982547|NCT01045421|20684422|P3|Phase 2|Death|0
5982548|NCT01045421|20684423|P2|Phase 2|Death|0
5982549|NCT01045421|20684424|P1|Phase 2|Death|0
5982550|NCT01045421|20684414|P11|Phase 2|Progressive Disease|1
5982551|NCT01045421|20684415|P10|Phase 2|Progressive Disease|1
5982552|NCT01045421|20684416|P9|Phase 2|Progressive Disease|1
5982553|NCT01045421|20684417|P8|Phase 2|Progressive Disease|1
5982554|NCT01045421|20684418|P7|Phase 2|Progressive Disease|0
5982555|NCT01045421|20684419|P6|Phase 2|Progressive Disease|0
5982556|NCT01045421|20684420|P5|Phase 2|Progressive Disease|0
5982557|NCT01045421|20684421|P4|Phase 2|Progressive Disease|0
5982558|NCT01045421|20684422|P3|Phase 2|Progressive Disease|0
5982559|NCT01045421|20684423|P2|Phase 2|Progressive Disease|0
5982560|NCT01045421|20684424|P1|Phase 2|Progressive Disease|0
5982561|NCT01045421|20684414|P11|Phase 1|Withdrawal by Subject|0
5982562|NCT01045421|20684415|P10|Phase 1|Withdrawal by Subject|0
5982563|NCT01045421|20684416|P9|Phase 1|Withdrawal by Subject|0
5982564|NCT01045421|20684417|P8|Phase 1|Withdrawal by Subject|0
5982565|NCT01045421|20684418|P7|Phase 1|Withdrawal by Subject|0
5982566|NCT01045421|20684419|P6|Phase 1|Withdrawal by Subject|0
5982567|NCT01045421|20684420|P5|Phase 1|Withdrawal by Subject|0
5982568|NCT01045421|20684421|P4|Phase 1|Withdrawal by Subject|1
5982569|NCT01045421|20684422|P3|Phase 1|Withdrawal by Subject|0
5982570|NCT01045421|20684423|P2|Phase 1|Withdrawal by Subject|0
5982571|NCT01045421|20684424|P1|Phase 1|Withdrawal by Subject|0
5982572|NCT01045421|20684414|P11|Phase 1|Progressive Disease|0
5982573|NCT01045421|20684415|P10|Phase 1|Progressive Disease|0
5982574|NCT01045421|20684416|P9|Phase 1|Progressive Disease|0
5982575|NCT01045421|20684417|P8|Phase 1|Progressive Disease|0
5982576|NCT01045421|20684418|P7|Phase 1|Progressive Disease|0
5982577|NCT01045421|20684419|P6|Phase 1|Progressive Disease|0
5982578|NCT01045421|20684420|P5|Phase 1|Progressive Disease|1
5982579|NCT01045421|20684421|P4|Phase 1|Progressive Disease|0
5982580|NCT01045421|20684422|P3|Phase 1|Progressive Disease|0
5982581|NCT01045421|20684423|P2|Phase 1|Progressive Disease|0
5982582|NCT01045421|20684424|P1|Phase 1|Progressive Disease|0
5982583|NCT01045161|20684533|P3|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|6
5982584|NCT01045161|20684534|P2|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|1
5982585|NCT01045161|20684535|P1|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|5
5982586|NCT01045161|20684533|P3|Part B - 40 Additional Weeks Open Label|Protocol Violation|3
5982587|NCT01045161|20684534|P2|Part B - 40 Additional Weeks Open Label|Protocol Violation|6
5982588|NCT01045161|20684535|P1|Part B - 40 Additional Weeks Open Label|Protocol Violation|3
5982589|NCT01045161|20684533|P3|Part B - 40 Additional Weeks Open Label|Other Reason|1
5982590|NCT01045161|20684534|P2|Part B - 40 Additional Weeks Open Label|Other Reason|2
5982591|NCT01045161|20684535|P1|Part B - 40 Additional Weeks Open Label|Other Reason|4
5982592|NCT01045161|20684533|P3|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1
5982593|NCT01045161|20684534|P2|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|5
5982594|NCT01045161|20684535|P1|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1
5982595|NCT01045161|20684533|P3|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5
5982596|NCT01045161|20684534|P2|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5
5982597|NCT01045161|20684535|P1|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|3
5982598|NCT01045161|20684533|P3|Part B - 40 Additional Weeks Open Label|Adverse Event|7
5982599|NCT01045161|20684534|P2|Part B - 40 Additional Weeks Open Label|Adverse Event|10
5982600|NCT01045161|20684535|P1|Part B - 40 Additional Weeks Open Label|Adverse Event|10
5982601|NCT01045161|20684533|P3|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|9
5982602|NCT01045161|20684534|P2|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|7
5982603|NCT01045161|20684535|P1|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|10
5982604|NCT01045161|20684533|P3|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|2
5982605|NCT01045161|20684534|P2|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3
5982606|NCT01045161|20684535|P1|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3
5982607|NCT01045161|20684533|P3|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3
5982608|NCT01045161|20684534|P2|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|4
5982609|NCT01045161|20684535|P1|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3
5982610|NCT01045161|20684533|P3|Part A - 12 Weeks Double Blind Treatment|Other Reason|3
5982611|NCT01045161|20684534|P2|Part A - 12 Weeks Double Blind Treatment|Other Reason|3
5982612|NCT01045161|20684535|P1|Part A - 12 Weeks Double Blind Treatment|Other Reason|3
5982613|NCT01045161|20684533|P3|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|6
5982614|NCT01045161|20684534|P2|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|1
5982615|NCT01045161|20684535|P1|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|4
5982616|NCT01045161|20684533|P3|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|2
5982617|NCT01045161|20684534|P2|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|3
5982618|NCT01045161|20684535|P1|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|6
5982619|NCT01045161|20684533|P3|Part A - 12 Weeks Double Blind Treatment|Adverse Event|8
5982620|NCT01045161|20684534|P2|Part A - 12 Weeks Double Blind Treatment|Adverse Event|3
5982621|NCT01045161|20684535|P1|Part A - 12 Weeks Double Blind Treatment|Adverse Event|4
5982622|NCT01045161|20684533|P3|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|6
5982623|NCT01045161|20684534|P2|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|12
5982624|NCT01045161|20684535|P1|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|8
5982625|NCT01045096|20684572|P3|Overall Study|Other|0
5982626|NCT01045096|20684573|P2|Overall Study|Other|0
5982627|NCT01045096|20684574|P1|Overall Study|Other|1
5982628|NCT01045096|20684572|P3|Overall Study|Withdrawal by Subject|0
5982629|NCT01045096|20684573|P2|Overall Study|Withdrawal by Subject|0
5982630|NCT01045096|20684574|P1|Overall Study|Withdrawal by Subject|2
5982631|NCT01044745|20684691|P1|Overall Study|Ineiligible|2
5982632|NCT01044732|20684700|P2|Overall Study|Technical error or malfunction|14
5982633|NCT01044732|20684701|P1|Overall Study|Technical error or malfunction|15
5982634|NCT01044732|20684700|P2|Overall Study|Inability to reach cecum|2
5982635|NCT01044732|20684701|P1|Overall Study|Inability to reach cecum|5
5982636|NCT01044732|20684700|P2|Overall Study|Inadequate bowel preparation|17
5982637|NCT01044732|20684701|P1|Overall Study|Inadequate bowel preparation|11
5982638|NCT01044732|20684700|P2|Overall Study|Withdrawal by Subject|1
5982639|NCT01044732|20684701|P1|Overall Study|Withdrawal by Subject|0
5982640|NCT01044732|20684700|P2|Overall Study|Protocol Violation|12
5982641|NCT01044732|20684701|P1|Overall Study|Protocol Violation|11
5982642|NCT01044732|20684700|P2|Overall Study|Physician Decision|3
5982643|NCT01044732|20684701|P1|Overall Study|Physician Decision|5
5982644|NCT01044732|20684700|P2|Overall Study|Lost to Follow-up|1
5982645|NCT01044732|20684701|P1|Overall Study|Lost to Follow-up|2
5982646|NCT01044498|20684890|P2|Overall Study|Other|0
5982647|NCT01044498|20684891|P1|Overall Study|Other|1
5982648|NCT01044498|20684890|P2|Overall Study|Adverse Event|1
5982649|NCT01044498|20684891|P1|Overall Study|Adverse Event|1
5982650|NCT01044498|20684890|P2|Overall Study|Withdrew consent|1
5982651|NCT01044498|20684891|P1|Overall Study|Withdrew consent|1
5982652|NCT01044459|20684917|P2|Overall Study|Lost to Follow-up|12
5982653|NCT01044459|20684918|P1|Overall Study|Lost to Follow-up|18
5982654|NCT01044459|20684917|P2|Overall Study|COPD exacerbation|8
5982655|NCT01044459|20684918|P1|Overall Study|COPD exacerbation|9
5982656|NCT01044459|20684917|P2|Overall Study|Other Reason|14
5982657|NCT01044459|20684918|P1|Overall Study|Other Reason|7
5982658|NCT01044459|20684917|P2|Overall Study|Protocol Violation|16
5982659|NCT01044459|20684918|P1|Overall Study|Protocol Violation|11
5982660|NCT01044459|20684917|P2|Overall Study|Lack of Efficacy|12
5982661|NCT01044459|20684918|P1|Overall Study|Lack of Efficacy|23
5982662|NCT01044459|20684917|P2|Overall Study|Adverse Event|20
5982663|NCT01044459|20684918|P1|Overall Study|Adverse Event|22
5982664|NCT01044459|20684917|P2|Overall Study|Terminated by Sponsor|21
5982665|NCT01044459|20684918|P1|Overall Study|Terminated by Sponsor|22
5982666|NCT01044459|20684917|P2|Overall Study|Withdrawal by Subject|28
5982667|NCT01044459|20684918|P1|Overall Study|Withdrawal by Subject|21
5982668|NCT01044433|20684926|P1|Overall Study|Withdrawal by Subject|3
5982669|NCT01044433|20684926|P1|Overall Study|Lost to Follow-up|3
5982670|NCT01044303|20684934|P1|Overall Study|Lost to Follow-up|2
5982671|NCT01044290|20684944|P3|Follow-Up 2|Withdrawal by Subject|1
5982672|NCT01044290|20684945|P2|Follow-Up 2|Withdrawal by Subject|1
5982673|NCT01044290|20684946|P1|Follow-Up 2|Withdrawal by Subject|0
5982674|NCT01044290|20684944|P3|Follow-Up 2|Death|1
5982675|NCT01044290|20684945|P2|Follow-Up 2|Death|1
5982676|NCT01044290|20684946|P1|Follow-Up 2|Death|0
5982677|NCT01044290|20684944|P3|Follow-up 1|Withdrawal by Subject|0
5982678|NCT01044290|20684945|P2|Follow-up 1|Withdrawal by Subject|2
5982679|NCT01044290|20684946|P1|Follow-up 1|Withdrawal by Subject|2
5982680|NCT01044290|20684944|P3|Follow-up 1|Death|1
5982681|NCT01044290|20684945|P2|Follow-up 1|Death|3
5982682|NCT01044290|20684946|P1|Follow-up 1|Death|3
5982683|NCT01043874|20685066|P1|Overall Study|Administrative Problems|1
5982684|NCT01043874|20685066|P1|Overall Study|Lack of Efficacy|1
5982685|NCT01043874|20685066|P1|Overall Study|Withdrawal by Subject|1
5982686|NCT01043874|20685066|P1|Overall Study|Adverse Event|3
5982687|NCT01043705|20685076|P3|Overall Study|Other|25
5982688|NCT01043705|20685077|P2|Overall Study|Other|19
5982689|NCT01043705|20685078|P1|Overall Study|Other|0
5982690|NCT01043705|20685076|P3|Overall Study|Screen Fail|0
5982691|NCT01043705|20685077|P2|Overall Study|Screen Fail|0
5982692|NCT01043705|20685078|P1|Overall Study|Screen Fail|21
5982693|NCT01043705|20685076|P3|Overall Study|Adverse Event|0
5982694|NCT01043705|20685077|P2|Overall Study|Adverse Event|2
5982695|NCT01043705|20685078|P1|Overall Study|Adverse Event|0
5982696|NCT01043705|20685076|P3|Overall Study|Subsequent Procedure|29
5982697|NCT01043705|20685077|P2|Overall Study|Subsequent Procedure|24
5982698|NCT01043705|20685078|P1|Overall Study|Subsequent Procedure|9
5982699|NCT01043705|20685076|P3|Overall Study|Site Closure|0
5982700|NCT01043705|20685077|P2|Overall Study|Site Closure|0
5982701|NCT01043705|20685078|P1|Overall Study|Site Closure|8
5982702|NCT01043705|20685076|P3|Overall Study|Withdrawal by Subject|0
5982703|NCT01043705|20685077|P2|Overall Study|Withdrawal by Subject|6
5982704|NCT01043705|20685078|P1|Overall Study|Withdrawal by Subject|8
5982705|NCT01043705|20685076|P3|Overall Study|Protocol Violation|0
5982706|NCT01043705|20685077|P2|Overall Study|Protocol Violation|1
5982707|NCT01043705|20685078|P1|Overall Study|Protocol Violation|2
5982708|NCT01043705|20685076|P3|Overall Study|Multiple Reasons|0
5982709|NCT01043705|20685077|P2|Overall Study|Multiple Reasons|7
5982710|NCT01043705|20685078|P1|Overall Study|Multiple Reasons|4
5982711|NCT01043705|20685076|P3|Overall Study|Lost to Follow-up|0
5982712|NCT01043705|20685077|P2|Overall Study|Lost to Follow-up|12
5982713|NCT01043705|20685078|P1|Overall Study|Lost to Follow-up|27
5982714|NCT01043705|20685076|P3|Overall Study|Death|26
5982715|NCT01043705|20685077|P2|Overall Study|Death|60
5982716|NCT01043705|20685078|P1|Overall Study|Death|28
5982717|NCT01043185|20685167|P10|Period 6 - Third Washout Period|Protocol Violation|0
5982718|NCT01043185|20685168|P9|Period 6 - Third Washout Period|Protocol Violation|1
5982719|NCT01043185|20685169|P8|Period 6 - Third Washout Period|Protocol Violation|0
5982720|NCT01043185|20685170|P7|Period 6 - Third Washout Period|Protocol Violation|0
5982721|NCT01043185|20685171|P6|Period 6 - Third Washout Period|Protocol Violation|0
5982722|NCT01043185|20685172|P5|Period 6 - Third Washout Period|Protocol Violation|0
5982723|NCT01043185|20685173|P4|Period 6 - Third Washout Period|Protocol Violation|0
5982724|NCT01043185|20685174|P3|Period 6 - Third Washout Period|Protocol Violation|0
5982725|NCT01043185|20685175|P2|Period 6 - Third Washout Period|Protocol Violation|0
5982726|NCT01043185|20685176|P1|Period 6 - Third Washout Period|Protocol Violation|0
5982727|NCT01042977|20685252|P2|Overall Study|Various|0
5982728|NCT01042977|20685253|P1|Overall Study|Various|3
5982729|NCT01042977|20685252|P2|Overall Study|Administrative reason by sponsor|1
5982730|NCT01042977|20685253|P1|Overall Study|Administrative reason by sponsor|0
5982731|NCT01042977|20685252|P2|Overall Study|Safety|2
5982732|NCT01042977|20685253|P1|Overall Study|Safety|0
5982733|NCT01042977|20685252|P2|Overall Study|Incorrect enrollment|4
5982734|NCT01042977|20685253|P1|Overall Study|Incorrect enrollment|6
5982735|NCT01042977|20685252|P2|Overall Study|Subject no longer meets study criteria|13
5982736|NCT01042977|20685253|P1|Overall Study|Subject no longer meets study criteria|15
5982737|NCT01042977|20685252|P2|Overall Study|Poor/non-compliance|4
5982738|NCT01042977|20685253|P1|Overall Study|Poor/non-compliance|3
5982739|NCT01042977|20685252|P2|Overall Study|Lost to Follow-up|2
5982740|NCT01042977|20685253|P1|Overall Study|Lost to Follow-up|0
5982741|NCT01042977|20685252|P2|Overall Study|Withdrawal by Subject|16
5982742|NCT01042977|20685253|P1|Overall Study|Withdrawal by Subject|8
5982743|NCT01042977|20685252|P2|Overall Study|Death|1
5982744|NCT01042977|20685253|P1|Overall Study|Death|2
5982745|NCT01042977|20685252|P2|Overall Study|Adverse Event|12
5982746|NCT01042977|20685253|P1|Overall Study|Adverse Event|4
5982747|NCT01042938|20685273|P2|Overall Study|Ineligible: RTOG study conflict|0
5982748|NCT01042938|20685274|P1|Overall Study|Ineligible: RTOG study conflict|1
5982749|NCT01042938|20685273|P2|Overall Study|Protocol Violation|1
5982750|NCT01042938|20685274|P1|Overall Study|Protocol Violation|1
5982751|NCT01042938|20685273|P2|Overall Study|Withdrawal by Subject|1
5982752|NCT01042938|20685274|P1|Overall Study|Withdrawal by Subject|1
5982753|NCT01042678|20685293|P6|Overall Study|Physician Decision|0
5982754|NCT01042678|20685294|P5|Overall Study|Physician Decision|0
5982755|NCT01042678|20685295|P4|Overall Study|Physician Decision|0
5982756|NCT01042678|20685296|P3|Overall Study|Physician Decision|0
5982757|NCT01042678|20685297|P2|Overall Study|Physician Decision|0
5982758|NCT01042678|20685298|P1|Overall Study|Physician Decision|1
5982759|NCT01042600|20685336|P2|Overall Study|Ineligible|0
5982760|NCT01042600|20685337|P1|Overall Study|Ineligible|1
5982761|NCT01042535|20685357|P1|Overall Study|complications from other disease|2
5982762|NCT01042535|20685357|P1|Overall Study|disease progression during treatment|3
5982763|NCT01042535|20685357|P1|Overall Study|disease progression prior to treatment|3
5982764|NCT01042392|20685391|P4|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1
5982765|NCT01042392|20685392|P3|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1
5982766|NCT01042392|20685393|P2|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1
5982767|NCT01042392|20685394|P1|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|0
5982768|NCT01042392|20685391|P4|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0
5982769|NCT01042392|20685392|P3|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|2
5982770|NCT01042392|20685393|P2|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0
5982771|NCT01042392|20685394|P1|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0
5982772|NCT01042392|20685391|P4|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0
5982773|NCT01042392|20685392|P3|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0
5982774|NCT01042392|20685393|P2|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0
5982775|NCT01042392|20685394|P1|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|2
5982776|NCT01042392|20685391|P4|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0
5982777|NCT01042392|20685392|P3|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|1
5982778|NCT01042392|20685393|P2|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0
5982779|NCT01042392|20685394|P1|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0
5982780|NCT01042392|20685391|P4|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0
5982781|NCT01042392|20685392|P3|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0
5982782|NCT01042392|20685393|P2|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0
5982783|NCT01042392|20685394|P1|Period II(Randomized,Double Blinded,8wk)|Administrative problems|2
5982784|NCT01042392|20685391|P4|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0
5982785|NCT01042392|20685392|P3|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|1
5982786|NCT01042392|20685393|P2|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0
5982787|NCT01042392|20685394|P1|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0
5982788|NCT01042392|20685391|P4|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0
5982789|NCT01042392|20685392|P3|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|2
5982790|NCT01042392|20685393|P2|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0
5982791|NCT01042392|20685394|P1|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|1
5982792|NCT01042392|20685391|P4|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0
5982793|NCT01042392|20685392|P3|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0
5982794|NCT01042392|20685393|P2|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0
5982795|NCT01042392|20685394|P1|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|1
5982796|NCT01042392|20685391|P4|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0
5982797|NCT01042392|20685392|P3|Period II(Randomized,Double Blinded,8wk)|Adverse Event|5
5982798|NCT01042392|20685393|P2|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0
5982799|NCT01042392|20685394|P1|Period II(Randomized,Double Blinded,8wk)|Adverse Event|6
5982800|NCT01042236|20685442|P6|Treatment Period 3|Protocol Violation|0
5982801|NCT01042236|20685443|P5|Treatment Period 3|Protocol Violation|0
5982802|NCT01042236|20685444|P4|Treatment Period 3|Protocol Violation|1
5982803|NCT01042236|20685445|P3|Treatment Period 3|Protocol Violation|0
5982804|NCT01042236|20685446|P2|Treatment Period 3|Protocol Violation|0
5982805|NCT01042236|20685447|P1|Treatment Period 3|Protocol Violation|0
5982806|NCT01042236|20685442|P6|Treatment Period 3|Adverse Event|0
5982807|NCT01042236|20685443|P5|Treatment Period 3|Adverse Event|0
5982808|NCT01042236|20685444|P4|Treatment Period 3|Adverse Event|1
5982809|NCT01042236|20685445|P3|Treatment Period 3|Adverse Event|0
5982810|NCT01042236|20685446|P2|Treatment Period 3|Adverse Event|0
5982811|NCT01042236|20685447|P1|Treatment Period 3|Adverse Event|0
5982812|NCT01042236|20685442|P6|Treatment Period 1|Adverse Event|0
5982813|NCT01042236|20685443|P5|Treatment Period 1|Adverse Event|1
5982814|NCT01042236|20685444|P4|Treatment Period 1|Adverse Event|0
5982815|NCT01042236|20685445|P3|Treatment Period 1|Adverse Event|0
5982816|NCT01042236|20685446|P2|Treatment Period 1|Adverse Event|1
5982817|NCT01042236|20685447|P1|Treatment Period 1|Adverse Event|0
5982818|NCT01042158|20685484|P1|Overall Study|Physician Decision|1
5982819|NCT01042093|20685514|P4|Overall Study|Withdrawal by Subject|1
5982820|NCT01042093|20685515|P3|Overall Study|Withdrawal by Subject|0
5982821|NCT01042093|20685516|P2|Overall Study|Withdrawal by Subject|0
5982822|NCT01042093|20685517|P1|Overall Study|Withdrawal by Subject|0
5982823|NCT01042093|20685514|P4|Overall Study|Protocol Violation|3
5982824|NCT01042093|20685515|P3|Overall Study|Protocol Violation|2
5982825|NCT01042093|20685516|P2|Overall Study|Protocol Violation|2
5982826|NCT01042093|20685517|P1|Overall Study|Protocol Violation|2
5982827|NCT01041976|20685537|P2|Overall Study|Death|4
5982828|NCT01041976|20685538|P1|Overall Study|Death|0
5982829|NCT01041976|20685537|P2|Overall Study|Incarceration|0
5982830|NCT01041976|20685538|P1|Overall Study|Incarceration|2
5982831|NCT01041976|20685537|P2|Overall Study|Withdrawal by Subject|0
5982832|NCT01041976|20685538|P1|Overall Study|Withdrawal by Subject|3
5982833|NCT01041859|20685548|P3|Double-Blind Maintenance|Withdrawal by Subject|9
5982834|NCT01041859|20685549|P2|Double-Blind Maintenance|Withdrawal by Subject|8
5982835|NCT01041859|20685550|P1|Double-Blind Maintenance|Withdrawal by Subject|0
5982836|NCT01041859|20685548|P3|Double-Blind Maintenance|Noncompliance With Study Drug|6
5982837|NCT01041859|20685549|P2|Double-Blind Maintenance|Noncompliance With Study Drug|2
5982838|NCT01041859|20685550|P1|Double-Blind Maintenance|Noncompliance With Study Drug|0
5982839|NCT01041859|20685548|P3|Double-Blind Maintenance|Other|2
5982840|NCT01041859|20685549|P2|Double-Blind Maintenance|Other|6
5982841|NCT01041859|20685550|P1|Double-Blind Maintenance|Other|0
5982842|NCT01041859|20685548|P3|Double-Blind Maintenance|Protocol Violation|3
5982843|NCT01041859|20685549|P2|Double-Blind Maintenance|Protocol Violation|1
5982844|NCT01041859|20685550|P1|Double-Blind Maintenance|Protocol Violation|0
5982845|NCT01041859|20685548|P3|Double-Blind Maintenance|Physician Decision|1
5982846|NCT01041859|20685549|P2|Double-Blind Maintenance|Physician Decision|2
5982847|NCT01041859|20685550|P1|Double-Blind Maintenance|Physician Decision|0
5982848|NCT01041859|20685548|P3|Double-Blind Maintenance|Lost to Follow-up|0
5982849|NCT01041859|20685549|P2|Double-Blind Maintenance|Lost to Follow-up|1
5982850|NCT01041859|20685550|P1|Double-Blind Maintenance|Lost to Follow-up|0
5982851|NCT01041859|20685548|P3|Double-Blind Maintenance|Lack of Efficacy|11
5982852|NCT01041859|20685549|P2|Double-Blind Maintenance|Lack of Efficacy|3
5982853|NCT01041859|20685550|P1|Double-Blind Maintenance|Lack of Efficacy|0
5982854|NCT01041859|20685548|P3|Double-Blind Maintenance|Adverse Event|13
5982855|NCT01041859|20685549|P2|Double-Blind Maintenance|Adverse Event|23
5982856|NCT01041859|20685550|P1|Double-Blind Maintenance|Adverse Event|0
5982857|NCT01041859|20685548|P3|Open-Label Titration|Withdrawal by Subject|0
5982858|NCT01041859|20685549|P2|Open-Label Titration|Withdrawal by Subject|0
5982859|NCT01041859|20685550|P1|Open-Label Titration|Withdrawal by Subject|11
5982860|NCT01041859|20685548|P3|Open-Label Titration|Noncompliance With Study Drug|0
5982861|NCT01041859|20685549|P2|Open-Label Titration|Noncompliance With Study Drug|0
5982862|NCT01041859|20685550|P1|Open-Label Titration|Noncompliance With Study Drug|8
5982863|NCT01041859|20685548|P3|Open-Label Titration|Other|0
5982864|NCT01041859|20685549|P2|Open-Label Titration|Other|0
5982865|NCT01041859|20685550|P1|Open-Label Titration|Other|7
5982866|NCT01041859|20685548|P3|Open-Label Titration|Protocol Violation|0
5982867|NCT01041859|20685549|P2|Open-Label Titration|Protocol Violation|0
5982868|NCT01041859|20685550|P1|Open-Label Titration|Protocol Violation|1
5982869|NCT01041859|20685548|P3|Open-Label Titration|Physician Decision|0
5982870|NCT01041859|20685549|P2|Open-Label Titration|Physician Decision|0
5982871|NCT01041859|20685550|P1|Open-Label Titration|Physician Decision|1
5982872|NCT01041859|20685548|P3|Open-Label Titration|Lost to Follow-up|0
5982873|NCT01041859|20685549|P2|Open-Label Titration|Lost to Follow-up|0
5982874|NCT01041859|20685550|P1|Open-Label Titration|Lost to Follow-up|1
5982875|NCT01041859|20685548|P3|Open-Label Titration|Lack of Efficacy|0
5982876|NCT01041859|20685549|P2|Open-Label Titration|Lack of Efficacy|0
5982877|NCT01041859|20685550|P1|Open-Label Titration|Lack of Efficacy|3
5982878|NCT01041859|20685548|P3|Open-Label Titration|Adverse Event|0
5982879|NCT01041859|20685549|P2|Open-Label Titration|Adverse Event|0
5982880|NCT01041859|20685550|P1|Open-Label Titration|Adverse Event|69
5982886|NCT01041573|20685596|P4|Overall Study|positive to anti-HCV|0
5982887|NCT01041573|20685597|P3|Overall Study|positive to anti-HCV|0
5982888|NCT01041573|20685598|P2|Overall Study|positive to anti-HCV|0
5982889|NCT01041573|20685599|P1|Overall Study|positive to anti-HCV|1
5982890|NCT01041573|20685596|P4|Overall Study|further blood extraction|0
5982891|NCT01041573|20685597|P3|Overall Study|further blood extraction|0
5982892|NCT01041573|20685598|P2|Overall Study|further blood extraction|1
5982893|NCT01041573|20685599|P1|Overall Study|further blood extraction|0
5982894|NCT01041573|20685596|P4|Overall Study|relocation|1
5982895|NCT01041573|20685597|P3|Overall Study|relocation|3
5982896|NCT01041573|20685598|P2|Overall Study|relocation|4
5982897|NCT01041573|20685599|P1|Overall Study|relocation|1
5982898|NCT01041573|20685596|P4|Overall Study|Adverse Event|0
5982899|NCT01041573|20685597|P3|Overall Study|Adverse Event|0
5982900|NCT01041573|20685598|P2|Overall Study|Adverse Event|2
5982901|NCT01041573|20685599|P1|Overall Study|Adverse Event|0
5982902|NCT01041573|20685596|P4|Overall Study|Lost to Follow-up|1
5982903|NCT01041573|20685597|P3|Overall Study|Lost to Follow-up|2
5982904|NCT01041573|20685598|P2|Overall Study|Lost to Follow-up|1
5982905|NCT01041573|20685599|P1|Overall Study|Lost to Follow-up|0
5982906|NCT01041573|20685596|P4|Overall Study|Death|0
5982907|NCT01041573|20685597|P3|Overall Study|Death|0
5982908|NCT01041573|20685598|P2|Overall Study|Death|0
5982909|NCT01041573|20685599|P1|Overall Study|Death|1
5982910|NCT01041573|20685596|P4|Overall Study|Withdrawal by Subject|0
5982911|NCT01041573|20685597|P3|Overall Study|Withdrawal by Subject|2
5982912|NCT01041573|20685598|P2|Overall Study|Withdrawal by Subject|5
5982913|NCT01041573|20685599|P1|Overall Study|Withdrawal by Subject|2
5982914|NCT01041417|20685622|P2|Overall Study|Death|0
5982915|NCT01041417|20685623|P1|Overall Study|Death|1
5982916|NCT01041417|20685622|P2|Overall Study|Lost to Follow-up|1
5982917|NCT01041417|20685623|P1|Overall Study|Lost to Follow-up|1
5982918|NCT01041417|20685622|P2|Overall Study|Adverse Event|2
5982919|NCT01041417|20685623|P1|Overall Study|Adverse Event|5
5982920|NCT01041404|20685661|P2|Overall Study|Other|23
5982921|NCT01041404|20685662|P1|Overall Study|Other|11
5982922|NCT01041404|20685661|P2|Overall Study|Failure to Return|2
5982923|NCT01041404|20685662|P1|Overall Study|Failure to Return|1
5982924|NCT01041404|20685661|P2|Overall Study|Withdrawal by Subject|23
5982925|NCT01041404|20685662|P1|Overall Study|Withdrawal by Subject|29
5982926|NCT01041404|20685661|P2|Overall Study|Protocol Violation|0
5982927|NCT01041404|20685662|P1|Overall Study|Protocol Violation|4
5982928|NCT01041404|20685661|P2|Overall Study|Violation of Selection Criteria|1
5982929|NCT01041404|20685662|P1|Overall Study|Violation of Selection Criteria|0
5982930|NCT01041404|20685661|P2|Overall Study|Lack of Efficacy|210
5982931|NCT01041404|20685662|P1|Overall Study|Lack of Efficacy|200
5982932|NCT01041404|20685661|P2|Overall Study|Adverse Event|35
5982933|NCT01041404|20685662|P1|Overall Study|Adverse Event|45
5982934|NCT01041287|20685703|P2|Treatment Period 2 (3 Months)|Adverse Event|2
5982935|NCT01041287|20685704|P1|Treatment Period 2 (3 Months)|Adverse Event|0
5982936|NCT01041287|20685703|P2|Treatment Period 2 (3 Months)|Lost to Follow-up|3
5982937|NCT01041287|20685704|P1|Treatment Period 2 (3 Months)|Lost to Follow-up|3
5982938|NCT01040871|20685744|P2|Overall Study|Randomized and Not Treated|1
5982939|NCT01040871|20685745|P1|Overall Study|Randomized and Not Treated|2
5982940|NCT01040871|20685744|P2|Overall Study|drug supply issue|0
5982941|NCT01040871|20685745|P1|Overall Study|drug supply issue|1
5982942|NCT01040871|20685744|P2|Overall Study|Lack of Efficacy|1
5982943|NCT01040871|20685745|P1|Overall Study|Lack of Efficacy|1
5982944|NCT01040871|20685744|P2|Overall Study|Death|3
5982945|NCT01040871|20685745|P1|Overall Study|Death|1
5982946|NCT01040871|20685744|P2|Overall Study|Withdrawal by Subject|0
5982947|NCT01040871|20685745|P1|Overall Study|Withdrawal by Subject|2
5982948|NCT01040871|20685744|P2|Overall Study|Adverse Event|2
5982949|NCT01040871|20685745|P1|Overall Study|Adverse Event|6
5982950|NCT01040845|20685796|P2|Overall Study|Physician Decision|0
5982951|NCT01040845|20685797|P1|Overall Study|Physician Decision|1
5982952|NCT01040845|20685796|P2|Overall Study|Withdrawal by Subject|1
5982953|NCT01040845|20685797|P1|Overall Study|Withdrawal by Subject|1
5982954|NCT01040832|20685812|P2|Overall Study|Other|1
5982955|NCT01040832|20685813|P1|Overall Study|Other|2
5982956|NCT01040832|20685812|P2|Overall Study|Symptomatic deterioration|5
5982957|NCT01040832|20685813|P1|Overall Study|Symptomatic deterioration|2
5982958|NCT01040832|20685812|P2|Overall Study|Progressive disease|17
5982959|NCT01040832|20685813|P1|Overall Study|Progressive disease|32
5982960|NCT01040832|20685812|P2|Overall Study|Withdrawal by Subject|3
5982961|NCT01040832|20685813|P1|Overall Study|Withdrawal by Subject|2
5982962|NCT01040832|20685812|P2|Overall Study|Death|6
5982963|NCT01040832|20685813|P1|Overall Study|Death|4
5982964|NCT01040832|20685812|P2|Overall Study|Adverse Event|5
5982965|NCT01040832|20685813|P1|Overall Study|Adverse Event|4
5982966|NCT01040793|20685836|P6|Overall Study|Other reasons not listed above|0
5982967|NCT01040793|20685837|P5|Overall Study|Other reasons not listed above|1
5982968|NCT01040793|20685838|P4|Overall Study|Other reasons not listed above|0
5982969|NCT01040793|20685839|P3|Overall Study|Other reasons not listed above|1
5982970|NCT01040793|20685840|P2|Overall Study|Other reasons not listed above|0
5982971|NCT01040793|20685841|P1|Overall Study|Other reasons not listed above|0
5982972|NCT01040793|20685836|P6|Overall Study|Withdrawal by Subject|0
5982973|NCT01040793|20685837|P5|Overall Study|Withdrawal by Subject|0
5982974|NCT01040793|20685838|P4|Overall Study|Withdrawal by Subject|2
5982975|NCT01040793|20685839|P3|Overall Study|Withdrawal by Subject|0
5982976|NCT01040793|20685840|P2|Overall Study|Withdrawal by Subject|0
5982977|NCT01040793|20685841|P1|Overall Study|Withdrawal by Subject|0
5982978|NCT01040793|20685836|P6|Overall Study|Lost to Follow-up|0
5982979|NCT01040793|20685837|P5|Overall Study|Lost to Follow-up|0
5982980|NCT01040793|20685838|P4|Overall Study|Lost to Follow-up|0
5982981|NCT01040793|20685839|P3|Overall Study|Lost to Follow-up|1
5982982|NCT01040793|20685840|P2|Overall Study|Lost to Follow-up|1
5982983|NCT01040793|20685841|P1|Overall Study|Lost to Follow-up|0
5982984|NCT01040793|20685836|P6|Overall Study|Protocol Violation|0
5982985|NCT01040793|20685837|P5|Overall Study|Protocol Violation|1
5982986|NCT01040793|20685838|P4|Overall Study|Protocol Violation|0
5982987|NCT01040793|20685839|P3|Overall Study|Protocol Violation|1
5982988|NCT01040793|20685840|P2|Overall Study|Protocol Violation|1
5982989|NCT01040793|20685841|P1|Overall Study|Protocol Violation|1
5982990|NCT01040793|20685836|P6|Overall Study|Adverse Event|1
5982991|NCT01040793|20685837|P5|Overall Study|Adverse Event|2
5982992|NCT01040793|20685838|P4|Overall Study|Adverse Event|2
5982993|NCT01040793|20685839|P3|Overall Study|Adverse Event|0
5982994|NCT01040793|20685840|P2|Overall Study|Adverse Event|3
5982995|NCT01040793|20685841|P1|Overall Study|Adverse Event|5
5982996|NCT01040780|20685920|P2|Overall Study|Protocol Violation|3
5982997|NCT01040780|20685921|P1|Overall Study|Protocol Violation|1
5982998|NCT01040728|20685935|P4|Overall Study|Other reasons not listed above|0
5982999|NCT01040728|20685936|P3|Overall Study|Other reasons not listed above|0
5983000|NCT01040728|20685937|P2|Overall Study|Other reasons not listed above|1
5983001|NCT01040728|20685938|P1|Overall Study|Other reasons not listed above|0
5983002|NCT01040728|20685935|P4|Overall Study|Lack of Efficacy|1
5983003|NCT01040728|20685936|P3|Overall Study|Lack of Efficacy|0
5983004|NCT01040728|20685937|P2|Overall Study|Lack of Efficacy|1
5983005|NCT01040728|20685938|P1|Overall Study|Lack of Efficacy|0
5983006|NCT01040728|20685935|P4|Overall Study|Protocol Violation|1
5983007|NCT01040728|20685936|P3|Overall Study|Protocol Violation|0
5983008|NCT01040728|20685937|P2|Overall Study|Protocol Violation|0
5983009|NCT01040728|20685938|P1|Overall Study|Protocol Violation|0
5983010|NCT01040728|20685935|P4|Overall Study|Withdrawal by Subject|0
5983011|NCT01040728|20685936|P3|Overall Study|Withdrawal by Subject|1
5983012|NCT01040728|20685937|P2|Overall Study|Withdrawal by Subject|1
5983013|NCT01040728|20685938|P1|Overall Study|Withdrawal by Subject|0
5983014|NCT01040728|20685935|P4|Overall Study|Adverse Event|4
5983015|NCT01040728|20685936|P3|Overall Study|Adverse Event|0
5983016|NCT01040728|20685937|P2|Overall Study|Adverse Event|8
5983017|NCT01040728|20685938|P1|Overall Study|Adverse Event|4
5983018|NCT01040689|20686008|P4|Overall Study|Other reasons not listed above|0
5983019|NCT01040689|20686009|P3|Overall Study|Other reasons not listed above|0
5983020|NCT01040689|20686010|P2|Overall Study|Other reasons not listed above|1
5983021|NCT01040689|20686011|P1|Overall Study|Other reasons not listed above|0
5983022|NCT01040689|20686008|P4|Overall Study|Withdrawal by Subject|0
5983023|NCT01040689|20686009|P3|Overall Study|Withdrawal by Subject|1
5983024|NCT01040689|20686010|P2|Overall Study|Withdrawal by Subject|1
5983025|NCT01040689|20686011|P1|Overall Study|Withdrawal by Subject|2
5983026|NCT01040689|20686008|P4|Overall Study|Lost to Follow-up|0
5983027|NCT01040689|20686009|P3|Overall Study|Lost to Follow-up|0
5983028|NCT01040689|20686010|P2|Overall Study|Lost to Follow-up|0
5983029|NCT01040689|20686011|P1|Overall Study|Lost to Follow-up|1
5983030|NCT01040689|20686008|P4|Overall Study|Lack of Efficacy|0
5983031|NCT01040689|20686009|P3|Overall Study|Lack of Efficacy|1
5983032|NCT01040689|20686010|P2|Overall Study|Lack of Efficacy|0
5983033|NCT01040689|20686011|P1|Overall Study|Lack of Efficacy|0
5983034|NCT01040689|20686008|P4|Overall Study|Adverse Event|4
5983035|NCT01040689|20686009|P3|Overall Study|Adverse Event|2
5983036|NCT01040689|20686010|P2|Overall Study|Adverse Event|0
5983037|NCT01040689|20686011|P1|Overall Study|Adverse Event|0
5983038|NCT01040403|20686090|P1|Overall Study|Other reason not defined above|6
5983039|NCT01040403|20686090|P1|Overall Study|Not treated|1
5983040|NCT01040403|20686090|P1|Overall Study|Lost to Follow-up|1
5983041|NCT01040403|20686090|P1|Overall Study|Protocol Violation|2
5983042|NCT01040403|20686090|P1|Overall Study|Adverse Event|10
5983043|NCT01040351|20686278|P2|Overall Study|poor ovarian response|2
5983044|NCT01040351|20686279|P1|Overall Study|poor ovarian response|1
5983045|NCT01040260|20686289|P2|Overall Study|Lost to Follow-up|5
5983046|NCT01040260|20686290|P1|Overall Study|Lost to Follow-up|3
5983047|NCT01040260|20686289|P2|Overall Study|Withdrawal by Subject|6
5983048|NCT01040260|20686290|P1|Overall Study|Withdrawal by Subject|12
5983049|NCT01040169|20686317|P2|Overall Study|Lost to Follow-up|8
5983050|NCT01040169|20686318|P1|Overall Study|Lost to Follow-up|3
5983051|NCT01040130|20686326|P6|Overall Study|Other reasons not listed above|0
5983052|NCT01040130|20686327|P5|Overall Study|Other reasons not listed above|0
5983053|NCT01040130|20686328|P4|Overall Study|Other reasons not listed above|0
5983054|NCT01040130|20686329|P3|Overall Study|Other reasons not listed above|0
5983055|NCT01040130|20686330|P2|Overall Study|Other reasons not listed above|0
5983056|NCT01040130|20686331|P1|Overall Study|Other reasons not listed above|2
5983057|NCT01040130|20686326|P6|Overall Study|Withdrawal by Subject|1
5983058|NCT01040130|20686327|P5|Overall Study|Withdrawal by Subject|0
5983059|NCT01040130|20686328|P4|Overall Study|Withdrawal by Subject|0
5983060|NCT01040130|20686329|P3|Overall Study|Withdrawal by Subject|0
5983061|NCT01040130|20686330|P2|Overall Study|Withdrawal by Subject|2
5983062|NCT01040130|20686331|P1|Overall Study|Withdrawal by Subject|0
5983063|NCT01040130|20686326|P6|Overall Study|Protocol Violation|0
5983064|NCT01040130|20686327|P5|Overall Study|Protocol Violation|0
5983065|NCT01040130|20686328|P4|Overall Study|Protocol Violation|0
5983066|NCT01040130|20686329|P3|Overall Study|Protocol Violation|2
5983067|NCT01040130|20686330|P2|Overall Study|Protocol Violation|0
5983068|NCT01040130|20686331|P1|Overall Study|Protocol Violation|0
5983069|NCT01040130|20686326|P6|Overall Study|Adverse Event|3
5983070|NCT01040130|20686327|P5|Overall Study|Adverse Event|0
5983071|NCT01040130|20686328|P4|Overall Study|Adverse Event|5
5983072|NCT01040130|20686329|P3|Overall Study|Adverse Event|0
5983073|NCT01040130|20686330|P2|Overall Study|Adverse Event|1
5983074|NCT01040130|20686331|P1|Overall Study|Adverse Event|1
5983075|NCT01039688|20686424|P3|Overall Study|Death|0
5983076|NCT01039688|20686425|P2|Overall Study|Death|0
5983077|NCT01039688|20686426|P1|Overall Study|Death|2
5983078|NCT01039688|20686424|P3|Overall Study|Withdrawal by Subject|13
5983079|NCT01039688|20686425|P2|Overall Study|Withdrawal by Subject|27
5983080|NCT01039688|20686426|P1|Overall Study|Withdrawal by Subject|23
5983081|NCT01039688|20686424|P3|Overall Study|Other|12
5983082|NCT01039688|20686425|P2|Overall Study|Other|25
5983083|NCT01039688|20686426|P1|Overall Study|Other|13
5983084|NCT01039688|20686424|P3|Overall Study|Lost to Follow-up|5
5983085|NCT01039688|20686425|P2|Overall Study|Lost to Follow-up|9
5983086|NCT01039688|20686426|P1|Overall Study|Lost to Follow-up|11
5983087|NCT01039688|20686424|P3|Overall Study|Lack of Efficacy|26
5983088|NCT01039688|20686425|P2|Overall Study|Lack of Efficacy|11
5983089|NCT01039688|20686426|P1|Overall Study|Lack of Efficacy|20
5983090|NCT01039688|20686424|P3|Overall Study|Adverse Event|24
5983091|NCT01039688|20686425|P2|Overall Study|Adverse Event|39
5983092|NCT01039688|20686426|P1|Overall Study|Adverse Event|38
5983093|NCT01039675|20686697|P2|Overall Study|Physician Decision|1
5983094|NCT01039675|20686698|P1|Overall Study|Physician Decision|0
5983095|NCT01039675|20686697|P2|Overall Study|Lost to Follow-up|1
5983096|NCT01039675|20686698|P1|Overall Study|Lost to Follow-up|0
5983097|NCT01039675|20686697|P2|Overall Study|Withdrawal by Subject|1
5983098|NCT01039675|20686698|P1|Overall Study|Withdrawal by Subject|0
5983099|NCT01039675|20686697|P2|Overall Study|Lack of Efficacy|2
5983100|NCT01039675|20686698|P1|Overall Study|Lack of Efficacy|0
5983101|NCT01039675|20686697|P2|Overall Study|Adverse Event|2
5983102|NCT01039675|20686698|P1|Overall Study|Adverse Event|0
5983103|NCT01039584|20686711|P3|Overall Study|Positive for Chlamydia or gonorrhea|8
5983104|NCT01039584|20686712|P2|Overall Study|Positive for Chlamydia or gonorrhea|10
5983105|NCT01039584|20686713|P1|Overall Study|Positive for Chlamydia or gonorrhea|7
5983106|NCT01039584|20686711|P3|Overall Study|Pap smear with significant pathology|3
5983107|NCT01039584|20686712|P2|Overall Study|Pap smear with significant pathology|10
5983108|NCT01039584|20686713|P1|Overall Study|Pap smear with significant pathology|10
5983109|NCT01039584|20686711|P3|Overall Study|other|1
5983110|NCT01039584|20686712|P2|Overall Study|other|3
5983111|NCT01039584|20686713|P1|Overall Study|other|1
5983112|NCT01039584|20686711|P3|Overall Study|Lack of Efficacy|10
5983113|NCT01039584|20686712|P2|Overall Study|Lack of Efficacy|6
5983114|NCT01039584|20686713|P1|Overall Study|Lack of Efficacy|7
5983115|NCT01039584|20686711|P3|Overall Study|Negative Baseline culture for Candida|24
5983116|NCT01039584|20686712|P2|Overall Study|Negative Baseline culture for Candida|59
5983117|NCT01039584|20686713|P1|Overall Study|Negative Baseline culture for Candida|59
5983118|NCT01039584|20686711|P3|Overall Study|Lost to Follow-up|4
5983119|NCT01039584|20686712|P2|Overall Study|Lost to Follow-up|3
5983120|NCT01039584|20686713|P1|Overall Study|Lost to Follow-up|5
5983121|NCT01039584|20686711|P3|Overall Study|Protocol Violation|6
5983122|NCT01039584|20686712|P2|Overall Study|Protocol Violation|4
5983123|NCT01039584|20686713|P1|Overall Study|Protocol Violation|10
5983124|NCT01039584|20686711|P3|Overall Study|Withdrawal by Subject|1
5983125|NCT01039584|20686712|P2|Overall Study|Withdrawal by Subject|2
5983126|NCT01039584|20686713|P1|Overall Study|Withdrawal by Subject|4
5983127|NCT01039519|20686727|P1|Survival Follow-up|Sponsor decision|4
5983128|NCT01039519|20686727|P1|Survival Follow-up|Death|23
5983129|NCT01039519|20686727|P1|Treatment|Physician Decision|2
5983130|NCT01039519|20686727|P1|Treatment|Adverse Event|3
5983131|NCT01039519|20686727|P1|Treatment|Treatment failure|2
5983132|NCT01039519|20686727|P1|Treatment|Progressive disease|20
5983133|NCT01039428|20686763|P2|Overall Study|Withdrawal by Subject|0
5983134|NCT01039428|20686764|P1|Overall Study|Withdrawal by Subject|1
5983135|NCT01039428|20686763|P2|Overall Study|Protocol Violation|0
5983136|NCT01039428|20686764|P1|Overall Study|Protocol Violation|1
5983137|NCT01039376|20686788|P2|Overall Study|Study terminated by Sponsor|72
5983138|NCT01039376|20686789|P1|Overall Study|Study terminated by Sponsor|90
5983139|NCT01039376|20686788|P2|Overall Study|Withdrawal by Subject|32
5983140|NCT01039376|20686789|P1|Overall Study|Withdrawal by Subject|20
5983141|NCT01039376|20686788|P2|Overall Study|Physician Decision|10
5983142|NCT01039376|20686789|P1|Overall Study|Physician Decision|15
5983143|NCT01039376|20686788|P2|Overall Study|Lost to Follow-up|12
5983144|NCT01039376|20686789|P1|Overall Study|Lost to Follow-up|5
5983145|NCT01038921|20686858|P2|Overall Study|Physician Decision|0
5983146|NCT01038921|20686859|P1|Overall Study|Physician Decision|1
5983147|NCT01038921|20686858|P2|Overall Study|Withdrawal by Subject|0
5983148|NCT01038921|20686859|P1|Overall Study|Withdrawal by Subject|1
5983149|NCT01038869|20686865|P1|Overall Study|Lost to Follow-up|6
5983150|NCT01038869|20686865|P1|Overall Study|Withdrawal by Subject|1
5983151|NCT01038856|20686873|P1|Overall Study|Adverse Event|2
5983152|NCT01038752|20686882|P2|Overall Study|Lost to Follow-up|3
5983153|NCT01038752|20686883|P1|Overall Study|Lost to Follow-up|3
5983154|NCT01038752|20686882|P2|Overall Study|Tumor Progression|2
5983155|NCT01038752|20686883|P1|Overall Study|Tumor Progression|2
5983156|NCT01038713|20686906|P3|Overall Study|Autoimmune Pancreatitis|0
5983157|NCT01038713|20686907|P2|Overall Study|Autoimmune Pancreatitis|0
5983158|NCT01038713|20686908|P1|Overall Study|Autoimmune Pancreatitis|1
5983159|NCT01038713|20686906|P3|Overall Study|died from PEP|0
5983160|NCT01038713|20686907|P2|Overall Study|died from PEP|1
5983161|NCT01038713|20686908|P1|Overall Study|died from PEP|0
5983162|NCT01038713|20686906|P3|Overall Study|Neuroendocrine Tumor|0
5983163|NCT01038713|20686907|P2|Overall Study|Neuroendocrine Tumor|1
5983164|NCT01038713|20686908|P1|Overall Study|Neuroendocrine Tumor|0
5983165|NCT01038713|20686906|P3|Overall Study|Lost to Follow-up|0
5983166|NCT01038713|20686907|P2|Overall Study|Lost to Follow-up|0
5983167|NCT01038713|20686908|P1|Overall Study|Lost to Follow-up|3
5983168|NCT01038713|20686906|P3|Overall Study|Patient to hospice|1
5983169|NCT01038713|20686907|P2|Overall Study|Patient to hospice|1
5983170|NCT01038713|20686908|P1|Overall Study|Patient to hospice|1
5983171|NCT01038687|20686931|P3|Overall Study|Adverse Event|1
5983172|NCT01038687|20686932|P2|Overall Study|Adverse Event|2
5983173|NCT01038687|20686933|P1|Overall Study|Adverse Event|0
5983174|NCT01038635|20686974|P9|Overall Study|Death|2
5983175|NCT01038635|20686975|P8|Overall Study|Death|1
5983176|NCT01038635|20686976|P7|Overall Study|Death|1
5983177|NCT01038635|20686977|P6|Overall Study|Death|0
5983178|NCT01038635|20686978|P5|Overall Study|Death|1
5983179|NCT01038635|20686979|P4|Overall Study|Death|0
5983180|NCT01038635|20686980|P3|Overall Study|Death|0
5983181|NCT01038635|20686981|P2|Overall Study|Death|0
5983182|NCT01038635|20686982|P1|Overall Study|Death|0
5983183|NCT01038635|20686974|P9|Overall Study|Disease Progression|0
5983184|NCT01038635|20686975|P8|Overall Study|Disease Progression|4
5983185|NCT01038635|20686976|P7|Overall Study|Disease Progression|1
5983186|NCT01038635|20686977|P6|Overall Study|Disease Progression|0
5983187|NCT01038635|20686978|P5|Overall Study|Disease Progression|0
5983188|NCT01038635|20686979|P4|Overall Study|Disease Progression|0
5983189|NCT01038635|20686980|P3|Overall Study|Disease Progression|0
5983190|NCT01038635|20686981|P2|Overall Study|Disease Progression|0
5983191|NCT01038635|20686982|P1|Overall Study|Disease Progression|2
5983192|NCT01038609|20687008|P5|Overall Study|Refusal of Blood Draws|0
5983193|NCT01038609|20687009|P4|Overall Study|Refusal of Blood Draws|0
5983194|NCT01038609|20687010|P3|Overall Study|Refusal of Blood Draws|0
5983195|NCT01038609|20687011|P2|Overall Study|Refusal of Blood Draws|1
5983196|NCT01038609|20687012|P1|Overall Study|Refusal of Blood Draws|0
5983197|NCT01038609|20687008|P5|Overall Study|Death in the Family|0
5983198|NCT01038609|20687009|P4|Overall Study|Death in the Family|0
5983199|NCT01038609|20687010|P3|Overall Study|Death in the Family|0
5983200|NCT01038609|20687011|P2|Overall Study|Death in the Family|0
5983201|NCT01038609|20687012|P1|Overall Study|Death in the Family|1
5983202|NCT01038609|20687008|P5|Overall Study|Dosing Error|1
5983203|NCT01038609|20687009|P4|Overall Study|Dosing Error|1
5983204|NCT01038609|20687010|P3|Overall Study|Dosing Error|0
5983205|NCT01038609|20687011|P2|Overall Study|Dosing Error|0
5983206|NCT01038609|20687012|P1|Overall Study|Dosing Error|0
5983207|NCT01038609|20687008|P5|Overall Study|Adverse Event|0
5983208|NCT01038609|20687009|P4|Overall Study|Adverse Event|0
5983209|NCT01038609|20687010|P3|Overall Study|Adverse Event|1
5983210|NCT01038609|20687011|P2|Overall Study|Adverse Event|0
5983211|NCT01038609|20687012|P1|Overall Study|Adverse Event|0
5983212|NCT01038323|20687131|P3|Overall Study|Withdrawal by Subject|4
5983213|NCT01038323|20687132|P2|Overall Study|Withdrawal by Subject|2
5983214|NCT01038323|20687133|P1|Overall Study|Withdrawal by Subject|3
5983215|NCT01038128|20687147|P1|Overall Study|Withdrawal by Subject|2
5983216|NCT01038128|20687147|P1|Overall Study|Lost to Follow-up|1
5983217|NCT01038128|20687147|P1|Overall Study|Lack of Efficacy|1
5983218|NCT01037244|20687311|P4|Overall Study|Various|1
5983219|NCT01037244|20687312|P3|Overall Study|Various|1
5983220|NCT01037244|20687313|P2|Overall Study|Various|2
5983221|NCT01037244|20687314|P1|Overall Study|Various|3
5983222|NCT01037244|20687311|P4|Overall Study|Partner Withdrew Consent|0
5983223|NCT01037244|20687312|P3|Overall Study|Partner Withdrew Consent|0
5983224|NCT01037244|20687313|P2|Overall Study|Partner Withdrew Consent|1
5983225|NCT01037244|20687314|P1|Overall Study|Partner Withdrew Consent|2
5983226|NCT01037244|20687311|P4|Overall Study|Withdrawal by Subject|5
5983227|NCT01037244|20687312|P3|Overall Study|Withdrawal by Subject|3
5983228|NCT01037244|20687313|P2|Overall Study|Withdrawal by Subject|5
5983229|NCT01037244|20687314|P1|Overall Study|Withdrawal by Subject|1
5983230|NCT01037244|20687311|P4|Overall Study|Lost to Follow-up|4
5983231|NCT01037244|20687312|P3|Overall Study|Lost to Follow-up|4
5983232|NCT01037244|20687313|P2|Overall Study|Lost to Follow-up|3
5983233|NCT01037244|20687314|P1|Overall Study|Lost to Follow-up|3
5983234|NCT01037244|20687311|P4|Overall Study|Lack of Efficacy|1
5983235|NCT01037244|20687312|P3|Overall Study|Lack of Efficacy|0
5983236|NCT01037244|20687313|P2|Overall Study|Lack of Efficacy|1
5983237|NCT01037244|20687314|P1|Overall Study|Lack of Efficacy|1
5983238|NCT01037244|20687311|P4|Overall Study|Adverse Event|3
5983239|NCT01037244|20687312|P3|Overall Study|Adverse Event|6
5983240|NCT01037244|20687313|P2|Overall Study|Adverse Event|2
5983241|NCT01037244|20687314|P1|Overall Study|Adverse Event|3
5983242|NCT01037218|20687376|P4|Overall Study|Various|1
5983243|NCT01037218|20687377|P3|Overall Study|Various|3
5983244|NCT01037218|20687378|P2|Overall Study|Various|2
5983245|NCT01037218|20687379|P1|Overall Study|Various|3
5983246|NCT01037218|20687376|P4|Overall Study|Protocol Violation|2
5983247|NCT01037218|20687377|P3|Overall Study|Protocol Violation|2
5983248|NCT01037218|20687378|P2|Overall Study|Protocol Violation|0
5983249|NCT01037218|20687379|P1|Overall Study|Protocol Violation|0
5983250|NCT01037218|20687376|P4|Overall Study|Partner Withdrew Consent|1
5983251|NCT01037218|20687377|P3|Overall Study|Partner Withdrew Consent|2
5983252|NCT01037218|20687378|P2|Overall Study|Partner Withdrew Consent|3
5983253|NCT01037218|20687379|P1|Overall Study|Partner Withdrew Consent|0
5983254|NCT01037218|20687376|P4|Overall Study|Withdrawal by Subject|4
5983255|NCT01037218|20687377|P3|Overall Study|Withdrawal by Subject|7
5983256|NCT01037218|20687378|P2|Overall Study|Withdrawal by Subject|7
5983257|NCT01037218|20687379|P1|Overall Study|Withdrawal by Subject|6
5983258|NCT01037218|20687376|P4|Overall Study|Lost to Follow-up|2
5983259|NCT01037218|20687377|P3|Overall Study|Lost to Follow-up|4
5983260|NCT01037218|20687378|P2|Overall Study|Lost to Follow-up|5
5983261|NCT01037218|20687379|P1|Overall Study|Lost to Follow-up|3
5983262|NCT01037218|20687376|P4|Overall Study|Lack of Efficacy|5
5983263|NCT01037218|20687377|P3|Overall Study|Lack of Efficacy|1
5983264|NCT01037218|20687378|P2|Overall Study|Lack of Efficacy|2
5983265|NCT01037218|20687379|P1|Overall Study|Lack of Efficacy|0
5983266|NCT01037218|20687376|P4|Overall Study|Adverse Event|1
5983267|NCT01037218|20687377|P3|Overall Study|Adverse Event|2
5983268|NCT01037218|20687378|P2|Overall Study|Adverse Event|2
5983269|NCT01037218|20687379|P1|Overall Study|Adverse Event|4
5983270|NCT01037127|20687450|P2|Overall Study|Study Closed Terminated|17
5983271|NCT01037127|20687451|P1|Overall Study|Study Closed Terminated|2
5983272|NCT01037127|20687450|P2|Overall Study|Physician Decision|0
5983273|NCT01037127|20687451|P1|Overall Study|Physician Decision|1
5983274|NCT01037127|20687450|P2|Overall Study|Lost to Follow-up|4
5983275|NCT01037127|20687451|P1|Overall Study|Lost to Follow-up|2
5983276|NCT01037114|20687483|P1|Year 20|Others|1
5983277|NCT01037088|20687496|P1|Overall Study|Withdrawal by Subject|3
5983278|NCT01036763|20687528|P1|Overall Study|Other reason (not specified)|40
5983279|NCT01036763|20687528|P1|Overall Study|Lost to Follow-up|28
5983280|NCT01036763|20687528|P1|Overall Study|Adverse Event|25
5983281|NCT01036724|20687540|P2|Overall Study|Protocol Violation|5
5983282|NCT01036724|20687541|P1|Overall Study|Protocol Violation|4
5983283|NCT01036724|20687540|P2|Overall Study|Lack of Efficacy|1
5983284|NCT01036724|20687541|P1|Overall Study|Lack of Efficacy|1
5983285|NCT01036724|20687540|P2|Overall Study|Adverse Event|2
5983286|NCT01036724|20687541|P1|Overall Study|Adverse Event|1
5983287|NCT01036594|20687549|P2|Treatment Regiments Post Week 12|Lack of Efficacy|1
5983288|NCT01036594|20687550|P1|Treatment Regiments Post Week 12|Lack of Efficacy|0
5983289|NCT01036594|20687549|P2|Treatment Regiments Post Week 12|Non-Cancer Disease Complications|1
5983290|NCT01036594|20687550|P1|Treatment Regiments Post Week 12|Non-Cancer Disease Complications|0
5983291|NCT01036594|20687549|P2|Treatment Regiments Post Week 12|Adverse Event|1
5983292|NCT01036594|20687550|P1|Treatment Regiments Post Week 12|Adverse Event|0
5983293|NCT01036594|20687549|P2|Treatment Regiments Post Week 12|Withdrawal by Subject|0
5983294|NCT01036594|20687550|P1|Treatment Regiments Post Week 12|Withdrawal by Subject|1
5983295|NCT01036594|20687549|P2|Treatment Regiments Post Week 12|Physician Decision|1
5983296|NCT01036594|20687550|P1|Treatment Regiments Post Week 12|Physician Decision|1
5983297|NCT01036594|20687549|P2|Week 12 Evaluation|Physician Decision|0
5983298|NCT01036594|20687550|P1|Week 12 Evaluation|Physician Decision|1
5983299|NCT01036594|20687549|P2|Week 12 Evaluation|Adverse Event|0
5983300|NCT01036594|20687550|P1|Week 12 Evaluation|Adverse Event|5
5983301|NCT01036594|20687549|P2|First Treatment Regimen|Withdrawal by Subject|0
5983302|NCT01036594|20687550|P1|First Treatment Regimen|Withdrawal by Subject|1
5983303|NCT01036594|20687549|P2|Run-In: Ketoconazole Only (200 mg)|Adverse Event|0
5983304|NCT01036594|20687550|P1|Run-In: Ketoconazole Only (200 mg)|Adverse Event|1
5983305|NCT01036529|20687574|P2|Overall Study|Sponsor study termination|12
5983306|NCT01036529|20687575|P1|Overall Study|Sponsor study termination|11
5983307|NCT01036529|20687574|P2|Overall Study|Withdrawal by Subject|1
5983308|NCT01036529|20687575|P1|Overall Study|Withdrawal by Subject|1
5983309|NCT01036529|20687574|P2|Overall Study|Physician Decision|0
5983310|NCT01036529|20687575|P1|Overall Study|Physician Decision|1
5983311|NCT01036529|20687574|P2|Overall Study|Lost to Follow-up|1
5983312|NCT01036529|20687575|P1|Overall Study|Lost to Follow-up|0
5983313|NCT01036529|20687574|P2|Overall Study|Adverse Event|1
5983314|NCT01036529|20687575|P1|Overall Study|Adverse Event|0
5983315|NCT01036438|20687602|P2|Overall Study|No effect of study treatment|1
5983316|NCT01036438|20687603|P1|Overall Study|No effect of study treatment|3
5983317|NCT01036438|20687602|P2|Overall Study|Death|1
5983318|NCT01036438|20687603|P1|Overall Study|Death|0
5983319|NCT01036438|20687602|P2|Overall Study|Adverse Event|8
5983320|NCT01036438|20687603|P1|Overall Study|Adverse Event|7
5983321|NCT01036321|20687611|P2|Overall Study|Adverse Event|1
5983322|NCT01036321|20687612|P1|Overall Study|Adverse Event|2
5983323|NCT01036321|20687611|P2|Overall Study|Withdrawal by Subject|2
5983324|NCT01036321|20687612|P1|Overall Study|Withdrawal by Subject|3
5983325|NCT01036321|20687611|P2|Overall Study|Ineligible after randomization|1
5983326|NCT01036321|20687612|P1|Overall Study|Ineligible after randomization|0
5983327|NCT01036165|20687636|P1|Overall Study|Problems finding proper area to inject|1
5983328|NCT01036165|20687636|P1|Overall Study|Device Related Issues|3
5983329|NCT01036165|20687636|P1|Overall Study|Withdrawal by Subject|3
5983330|NCT01036165|20687636|P1|Overall Study|Lost to Follow-up|2
5983331|NCT01036165|20687636|P1|Overall Study|Adverse Event|6
5983332|NCT01036022|20687647|P6|Overall Study|Withdrawal by Subject|0
5983333|NCT01036022|20687648|P5|Overall Study|Withdrawal by Subject|2
5983334|NCT01036022|20687649|P4|Overall Study|Withdrawal by Subject|1
5983335|NCT01036022|20687650|P3|Overall Study|Withdrawal by Subject|0
5983336|NCT01036022|20687651|P2|Overall Study|Withdrawal by Subject|0
5983337|NCT01036022|20687652|P1|Overall Study|Withdrawal by Subject|0
5983338|NCT01036022|20687647|P6|Overall Study|Physician Decision|0
5983339|NCT01036022|20687648|P5|Overall Study|Physician Decision|0
5983340|NCT01036022|20687649|P4|Overall Study|Physician Decision|0
5983341|NCT01036022|20687650|P3|Overall Study|Physician Decision|1
5983342|NCT01036022|20687651|P2|Overall Study|Physician Decision|0
5983343|NCT01036022|20687652|P1|Overall Study|Physician Decision|0
5983344|NCT01036022|20687647|P6|Overall Study|Lack of Efficacy|1
5983345|NCT01036022|20687648|P5|Overall Study|Lack of Efficacy|1
5983346|NCT01036022|20687649|P4|Overall Study|Lack of Efficacy|0
5983347|NCT01036022|20687650|P3|Overall Study|Lack of Efficacy|1
5983348|NCT01036022|20687651|P2|Overall Study|Lack of Efficacy|1
5983349|NCT01036022|20687652|P1|Overall Study|Lack of Efficacy|1
5983350|NCT01036022|20687647|P6|Overall Study|Adverse Event|2
5983351|NCT01036022|20687648|P5|Overall Study|Adverse Event|0
5983352|NCT01036022|20687649|P4|Overall Study|Adverse Event|1
5983353|NCT01036022|20687650|P3|Overall Study|Adverse Event|2
5983354|NCT01036022|20687651|P2|Overall Study|Adverse Event|3
5983355|NCT01036022|20687652|P1|Overall Study|Adverse Event|1
5983356|NCT01035905|20687788|P2|Overall Study|Lack of Efficacy|1
5983357|NCT01035905|20687789|P1|Overall Study|Lack of Efficacy|1
5983358|NCT01035606|20687962|P3|Overall Study|change in health, job demands,family|4
5983359|NCT01035606|20687963|P2|Overall Study|change in health, job demands,family|3
5983360|NCT01035606|20687964|P1|Overall Study|change in health, job demands,family|3
5983361|NCT01035463|20687980|P6|Overall Study|Other|2
5983362|NCT01035463|20687981|P5|Overall Study|Other|0
5983363|NCT01035463|20687982|P4|Overall Study|Other|1
5983364|NCT01035463|20687983|P3|Overall Study|Other|0
5983365|NCT01035463|20687984|P2|Overall Study|Other|0
5983366|NCT01035463|20687985|P1|Overall Study|Other|0
5983367|NCT01035463|20687980|P6|Overall Study|Other Malignancy|2
5983368|NCT01035463|20687981|P5|Overall Study|Other Malignancy|0
5983369|NCT01035463|20687982|P4|Overall Study|Other Malignancy|0
5983370|NCT01035463|20687983|P3|Overall Study|Other Malignancy|0
5983371|NCT01035463|20687984|P2|Overall Study|Other Malignancy|0
5983372|NCT01035463|20687985|P1|Overall Study|Other Malignancy|0
5983373|NCT01035463|20687980|P6|Overall Study|Disease progression|3
5983374|NCT01035463|20687981|P5|Overall Study|Disease progression|0
5983375|NCT01035463|20687982|P4|Overall Study|Disease progression|0
5983376|NCT01035463|20687983|P3|Overall Study|Disease progression|0
5983377|NCT01035463|20687984|P2|Overall Study|Disease progression|0
5983378|NCT01035463|20687985|P1|Overall Study|Disease progression|0
5983379|NCT01035463|20687980|P6|Overall Study|Withdrawal by Subject|4
5983380|NCT01035463|20687981|P5|Overall Study|Withdrawal by Subject|1
5983381|NCT01035463|20687982|P4|Overall Study|Withdrawal by Subject|0
5983382|NCT01035463|20687983|P3|Overall Study|Withdrawal by Subject|1
5983383|NCT01035463|20687984|P2|Overall Study|Withdrawal by Subject|2
5983384|NCT01035463|20687985|P1|Overall Study|Withdrawal by Subject|0
5983385|NCT01035463|20687980|P6|Overall Study|Adverse Event|7
5983386|NCT01035463|20687981|P5|Overall Study|Adverse Event|5
5983387|NCT01035463|20687982|P4|Overall Study|Adverse Event|1
5983388|NCT01035463|20687983|P3|Overall Study|Adverse Event|4
5983389|NCT01035463|20687984|P2|Overall Study|Adverse Event|0
5983390|NCT01035463|20687985|P1|Overall Study|Adverse Event|0
5983391|NCT01035255|20688022|P2|Overall Study|patient's request|13
5983392|NCT01035255|20688023|P1|Overall Study|patient's request|15
5983393|NCT01035255|20688022|P2|Overall Study|Lost to Follow-up|5
5983394|NCT01035255|20688023|P1|Overall Study|Lost to Follow-up|2
5983395|NCT01035255|20688022|P2|Overall Study|Death|844
5983396|NCT01035255|20688023|P1|Overall Study|Death|724
5983397|NCT01035229|20688041|P2|Overall Study|Disease Progression|152
5983398|NCT01035229|20688042|P1|Overall Study|Disease Progression|261
5983399|NCT01035229|20688041|P2|Overall Study|Sponsor's decision to end study|3
5983400|NCT01035229|20688042|P1|Overall Study|Sponsor's decision to end study|3
5983401|NCT01035229|20688041|P2|Overall Study|Protocol Violation|2
5983402|NCT01035229|20688042|P1|Overall Study|Protocol Violation|0
5983403|NCT01035229|20688041|P2|Overall Study|New cancer therapy|0
5983404|NCT01035229|20688042|P1|Overall Study|New cancer therapy|2
5983405|NCT01035229|20688041|P2|Overall Study|Death|5
5983406|NCT01035229|20688042|P1|Overall Study|Death|13
5983407|NCT01035229|20688041|P2|Overall Study|Administrative problems|1
5983408|NCT01035229|20688042|P1|Overall Study|Administrative problems|1
5983409|NCT01035229|20688041|P2|Overall Study|Lost to Follow-up|0
5983410|NCT01035229|20688042|P1|Overall Study|Lost to Follow-up|1
5983411|NCT01035229|20688041|P2|Overall Study|Withdrawal by Subject|7
5983412|NCT01035229|20688042|P1|Overall Study|Withdrawal by Subject|20
5983413|NCT01035229|20688041|P2|Overall Study|Adverse Event|14
5983414|NCT01035229|20688042|P1|Overall Study|Adverse Event|61
5983415|NCT01035138|20688072|P3|Overall Study|Lost to Follow-up|1
5983416|NCT01035138|20688073|P2|Overall Study|Lost to Follow-up|0
5983417|NCT01035138|20688074|P1|Overall Study|Lost to Follow-up|0
5983418|NCT01035138|20688072|P3|Overall Study|Sponsor Decision|42
5983419|NCT01035138|20688073|P2|Overall Study|Sponsor Decision|60
5983420|NCT01035138|20688074|P1|Overall Study|Sponsor Decision|66
5983421|NCT01035138|20688072|P3|Overall Study|Physician Decision|1
5983422|NCT01035138|20688073|P2|Overall Study|Physician Decision|0
5983423|NCT01035138|20688074|P1|Overall Study|Physician Decision|0
5983424|NCT01035138|20688072|P3|Overall Study|Withdrawal by Subject|0
5983425|NCT01035138|20688073|P2|Overall Study|Withdrawal by Subject|0
5983426|NCT01035138|20688074|P1|Overall Study|Withdrawal by Subject|1
5983427|NCT01035138|20688072|P3|Overall Study|Caregiver Decision|1
5983428|NCT01035138|20688073|P2|Overall Study|Caregiver Decision|0
5983429|NCT01035138|20688074|P1|Overall Study|Caregiver Decision|2
5983430|NCT01035138|20688072|P3|Overall Study|Adverse Event|2
5983431|NCT01035138|20688073|P2|Overall Study|Adverse Event|0
5983432|NCT01035138|20688074|P1|Overall Study|Adverse Event|4
5983433|NCT01035060|20688174|P2|Overall Study|Physician Decision|0
5983434|NCT01035060|20688175|P1|Overall Study|Physician Decision|2
5983435|NCT01035060|20688174|P2|Overall Study|Withdrawal by Subject|6
5983436|NCT01035060|20688175|P1|Overall Study|Withdrawal by Subject|8
5983437|NCT01035060|20688174|P2|Overall Study|Did not quality after 2nd screening|1
5983438|NCT01035060|20688175|P1|Overall Study|Did not quality after 2nd screening|14
5983439|NCT01035060|20688174|P2|Overall Study|Lost to Follow-up|7
5983440|NCT01035060|20688175|P1|Overall Study|Lost to Follow-up|0
5983441|NCT01034709|20688200|P2|Overall Study|Protocol Violation|16
5983442|NCT01034709|20688201|P1|Overall Study|Protocol Violation|9
5983443|NCT01034657|20688207|P3|Randomized Phase|Adverse Event|1
5983444|NCT01034657|20688208|P2|Randomized Phase|Adverse Event|2
5983445|NCT01034657|20688209|P1|Randomized Phase|Adverse Event|0
5983446|NCT01034657|20688207|P3|Randomized Phase|Abnormal laboratory value|0
5983447|NCT01034657|20688208|P2|Randomized Phase|Abnormal laboratory value|1
5983448|NCT01034657|20688209|P1|Randomized Phase|Abnormal laboratory value|0
5983449|NCT01034657|20688207|P3|Randomized Phase|Lack of Efficacy|0
5983450|NCT01034657|20688208|P2|Randomized Phase|Lack of Efficacy|1
5983451|NCT01034657|20688209|P1|Randomized Phase|Lack of Efficacy|5
5983452|NCT01034657|20688207|P3|Randomized Phase|Withdrawal by Subject|0
5983453|NCT01034657|20688208|P2|Randomized Phase|Withdrawal by Subject|2
5983454|NCT01034657|20688209|P1|Randomized Phase|Withdrawal by Subject|0
5983455|NCT01034657|20688207|P3|Core Phase|Protocol Violation|0
5983456|NCT01034657|20688208|P2|Core Phase|Protocol Violation|0
5983457|NCT01034657|20688209|P1|Core Phase|Protocol Violation|2
5983458|NCT01034657|20688207|P3|Core Phase|Adverse Event|0
5983459|NCT01034657|20688208|P2|Core Phase|Adverse Event|0
5983460|NCT01034657|20688209|P1|Core Phase|Adverse Event|8
5983461|NCT01034657|20688207|P3|Core Phase|Abnormal laboratory value|0
5983462|NCT01034657|20688208|P2|Core Phase|Abnormal laboratory value|0
5983463|NCT01034657|20688209|P1|Core Phase|Abnormal laboratory value|1
5983464|NCT01034657|20688207|P3|Core Phase|Lack of Efficacy|0
5983465|NCT01034657|20688208|P2|Core Phase|Lack of Efficacy|0
5983466|NCT01034657|20688209|P1|Core Phase|Lack of Efficacy|2
5983467|NCT01034657|20688207|P3|Core Phase|Withdrawal by Subject|0
5983468|NCT01034657|20688208|P2|Core Phase|Withdrawal by Subject|0
5983469|NCT01034657|20688209|P1|Core Phase|Withdrawal by Subject|1
5983470|NCT01034631|20688250|P3|Phase II|Determined Ineligible per protocol|0
5983471|NCT01034631|20688251|P2|Phase II|Determined Ineligible per protocol|1
5983472|NCT01034631|20688252|P1|Phase II|Determined Ineligible per protocol|0
5983473|NCT01034631|20688250|P3|Phase II|Not Evaluable per protocol|2
5983474|NCT01034631|20688251|P2|Phase II|Not Evaluable per protocol|0
5983475|NCT01034631|20688252|P1|Phase II|Not Evaluable per protocol|0
5983476|NCT01034631|20688250|P3|Phase I|Symptomatic Deterioration before Treatme|0
5983477|NCT01034631|20688251|P2|Phase I|Symptomatic Deterioration before Treatme|0
5983478|NCT01034631|20688252|P1|Phase I|Symptomatic Deterioration before Treatme|3
5983479|NCT01034540|20688319|P2|Overall Study|Adverse Event|1
5983480|NCT01034540|20688320|P1|Overall Study|Adverse Event|0
5983481|NCT01034462|20688339|P2|Overall Study|Other reasons|2
5983482|NCT01034462|20688340|P1|Overall Study|Other reasons|1
5983483|NCT01034462|20688339|P2|Overall Study|Lost to Follow-up|16
5983484|NCT01034462|20688340|P1|Overall Study|Lost to Follow-up|14
5983485|NCT01034462|20688339|P2|Overall Study|Withdrawal by Subject|8
5983486|NCT01034462|20688340|P1|Overall Study|Withdrawal by Subject|9
5983487|NCT01034462|20688339|P2|Overall Study|Protocol Violation|7
5983488|NCT01034462|20688340|P1|Overall Study|Protocol Violation|10
5983489|NCT01034462|20688339|P2|Overall Study|Lack of Efficacy|4
5983490|NCT01034462|20688340|P1|Overall Study|Lack of Efficacy|4
5983491|NCT01034462|20688339|P2|Overall Study|Adverse Event|17
5983492|NCT01034462|20688340|P1|Overall Study|Adverse Event|7
5983493|NCT01034397|20688350|P2|Overall Study|Other|1
5983494|NCT01034397|20688351|P1|Overall Study|Other|0
5983495|NCT01034397|20688350|P2|Overall Study|Adverse Event|0
5983496|NCT01034397|20688351|P1|Overall Study|Adverse Event|4
5983497|NCT01034397|20688350|P2|Overall Study|Lack of Efficacy|0
5983498|NCT01034397|20688351|P1|Overall Study|Lack of Efficacy|3
5983499|NCT01034397|20688350|P2|Overall Study|Lack of compliance|1
5983500|NCT01034397|20688351|P1|Overall Study|Lack of compliance|0
5983501|NCT01034358|20688500|P1|Overall Study|Protocol Violation|1
5983502|NCT01034358|20688500|P1|Overall Study|Withdrawal by Subject|1
5983503|NCT01034306|20688506|P2|Overall Study|Noncomplience|0
5983504|NCT01034306|20688507|P1|Overall Study|Noncomplience|1
5983505|NCT01034306|20688506|P2|Overall Study|hospitalized and decided to stop|0
5983506|NCT01034306|20688507|P1|Overall Study|hospitalized and decided to stop|1
5983507|NCT01034306|20688506|P2|Overall Study|Withdrawal by Subject|2
5983508|NCT01034306|20688507|P1|Overall Study|Withdrawal by Subject|2
5983509|NCT01034306|20688506|P2|Overall Study|Lost to Follow-up|1
5983510|NCT01034306|20688507|P1|Overall Study|Lost to Follow-up|0
5983511|NCT01034306|20688506|P2|Overall Study|Adverse Event|0
5983512|NCT01034306|20688507|P1|Overall Study|Adverse Event|1
5983513|NCT01034176|20688515|P2|Overall Study|Lost to Follow-up|1
5983514|NCT01034176|20688516|P1|Overall Study|Lost to Follow-up|0
5983515|NCT01034176|20688515|P2|Overall Study|Withdrawal by Subject|1
5983516|NCT01034176|20688516|P1|Overall Study|Withdrawal by Subject|0
5983517|NCT01034176|20688515|P2|Overall Study|Physician Decision|0
5983518|NCT01034176|20688516|P1|Overall Study|Physician Decision|2
5983519|NCT01034163|20688526|P2|Overall Study|Abnormal laboratory value|0
5983520|NCT01034163|20688527|P1|Overall Study|Abnormal laboratory value|1
5983521|NCT01034163|20688526|P2|Overall Study|Administrative problems|1
5983522|NCT01034163|20688527|P1|Overall Study|Administrative problems|0
5983523|NCT01034163|20688526|P2|Overall Study|Adverse Event|0
5983524|NCT01034163|20688527|P1|Overall Study|Adverse Event|6
5983525|NCT01034163|20688526|P2|Overall Study|Disease progression|4
5983526|NCT01034163|20688527|P1|Overall Study|Disease progression|3
5983527|NCT01034163|20688526|P2|Overall Study|Protocol deviation|0
5983528|NCT01034163|20688527|P1|Overall Study|Protocol deviation|1
5983529|NCT01034163|20688526|P2|Overall Study|Withdrawal by Subject|2
5983530|NCT01034163|20688527|P1|Overall Study|Withdrawal by Subject|8
5983531|NCT01034163|20688526|P2|Overall Study|Treatment completed as per protocol|7
5983532|NCT01034163|20688527|P1|Overall Study|Treatment completed as per protocol|8
5983533|NCT01034137|20688536|P3|Overall Study|Administrative or other|4
5983534|NCT01034137|20688537|P2|Overall Study|Administrative or other|3
5983535|NCT01034137|20688538|P1|Overall Study|Administrative or other|2
5983536|NCT01034137|20688536|P3|Overall Study|Refused treatment or did not cooperate|1
5983537|NCT01034137|20688537|P2|Overall Study|Refused treatment or did not cooperate|0
5983538|NCT01034137|20688538|P1|Overall Study|Refused treatment or did not cooperate|2
5983539|NCT01034137|20688536|P3|Overall Study|Protocol Violation|1
5983540|NCT01034137|20688537|P2|Overall Study|Protocol Violation|2
5983541|NCT01034137|20688538|P1|Overall Study|Protocol Violation|2
5983542|NCT01034137|20688536|P3|Overall Study|Lack of Efficacy|13
5983543|NCT01034137|20688537|P2|Overall Study|Lack of Efficacy|4
5983544|NCT01034137|20688538|P1|Overall Study|Lack of Efficacy|9
5983545|NCT01034137|20688536|P3|Overall Study|Withdrawal by Subject|3
5983546|NCT01034137|20688537|P2|Overall Study|Withdrawal by Subject|3
5983547|NCT01034137|20688538|P1|Overall Study|Withdrawal by Subject|4
5983548|NCT01034137|20688536|P3|Overall Study|Adverse Event|8
5983549|NCT01034137|20688537|P2|Overall Study|Adverse Event|10
5983550|NCT01034137|20688538|P1|Overall Study|Adverse Event|9
5983551|NCT01033942|20688677|P3|Overall Study|Enrolled in Extension Study|0
5983552|NCT01033942|20688678|P2|Overall Study|Enrolled in Extension Study|3
5983553|NCT01033942|20688679|P1|Overall Study|Enrolled in Extension Study|0
5983554|NCT01033942|20688677|P3|Overall Study|Lost to Follow-up|0
5983555|NCT01033942|20688678|P2|Overall Study|Lost to Follow-up|0
5983556|NCT01033942|20688679|P1|Overall Study|Lost to Follow-up|1
5983557|NCT01033942|20688677|P3|Overall Study|Withdrawal by Subject|1
5983558|NCT01033942|20688678|P2|Overall Study|Withdrawal by Subject|1
5983559|NCT01033942|20688679|P1|Overall Study|Withdrawal by Subject|1
5983560|NCT01033851|20688977|P2|Overall Study|Withdrawal by Subject|7
5983561|NCT01033851|20688978|P1|Overall Study|Withdrawal by Subject|3
5983562|NCT01033825|20688993|P7|Overall Study|Other|0
5983563|NCT01033825|20688994|P6|Overall Study|Other|0
5983564|NCT01033825|20688995|P5|Overall Study|Other|1
5983565|NCT01033825|20688996|P4|Overall Study|Other|0
5983566|NCT01033825|20688997|P3|Overall Study|Other|0
5983567|NCT01033825|20688998|P2|Overall Study|Other|0
5983568|NCT01033825|20688999|P1|Overall Study|Other|0
5983569|NCT01033825|20688993|P7|Overall Study|Protocol Violation|0
5983570|NCT01033825|20688994|P6|Overall Study|Protocol Violation|0
5983571|NCT01033825|20688995|P5|Overall Study|Protocol Violation|0
5983572|NCT01033825|20688996|P4|Overall Study|Protocol Violation|0
5983573|NCT01033825|20688997|P3|Overall Study|Protocol Violation|0
5983574|NCT01033825|20688998|P2|Overall Study|Protocol Violation|0
5983575|NCT01033825|20688999|P1|Overall Study|Protocol Violation|1
5983576|NCT01033825|20688993|P7|Overall Study|Adverse Event|0
5983577|NCT01033825|20688994|P6|Overall Study|Adverse Event|0
5983578|NCT01033825|20688995|P5|Overall Study|Adverse Event|0
5983579|NCT01033825|20688996|P4|Overall Study|Adverse Event|1
5983580|NCT01033825|20688997|P3|Overall Study|Adverse Event|0
5983581|NCT01033825|20688998|P2|Overall Study|Adverse Event|0
5983582|NCT01033825|20688999|P1|Overall Study|Adverse Event|0
5983583|NCT01033825|20688993|P7|Overall Study|Withdrawal by Subject|0
5983584|NCT01033825|20688994|P6|Overall Study|Withdrawal by Subject|0
5983585|NCT01033825|20688995|P5|Overall Study|Withdrawal by Subject|1
5983586|NCT01033825|20688996|P4|Overall Study|Withdrawal by Subject|1
5983587|NCT01033825|20688997|P3|Overall Study|Withdrawal by Subject|2
5983588|NCT01033825|20688998|P2|Overall Study|Withdrawal by Subject|3
5983589|NCT01033825|20688999|P1|Overall Study|Withdrawal by Subject|2
5983590|NCT01033747|20689226|P2|Overall Study|Stopped at end of Extension 1|0
5983591|NCT01033747|20689227|P1|Overall Study|Stopped at end of Extension 1|2
5983592|NCT01033747|20689226|P2|Overall Study|Stopped at end of prolongation visit 1|0
5983593|NCT01033747|20689227|P1|Overall Study|Stopped at end of prolongation visit 1|1
5983594|NCT01033747|20689226|P2|Overall Study|Withdrawal by Subject|6
5983595|NCT01033747|20689227|P1|Overall Study|Withdrawal by Subject|9
5983596|NCT01033747|20689226|P2|Overall Study|Protocol Violation|0
5983597|NCT01033747|20689227|P1|Overall Study|Protocol Violation|1
5983598|NCT01033747|20689226|P2|Overall Study|Unsatisfactory therapeutic effect|4
5983599|NCT01033747|20689227|P1|Overall Study|Unsatisfactory therapeutic effect|14
5983600|NCT01033747|20689226|P2|Overall Study|Abnormal test procedure|1
5983601|NCT01033747|20689227|P1|Overall Study|Abnormal test procedure|0
5983602|NCT01033747|20689226|P2|Overall Study|Abnormal Laboratory Value|0
5983603|NCT01033747|20689227|P1|Overall Study|Abnormal Laboratory Value|1
5983604|NCT01033747|20689226|P2|Overall Study|Adverse Event|4
5983605|NCT01033747|20689227|P1|Overall Study|Adverse Event|9
5983606|NCT01033734|20689235|P1|Overall Study|Withdrawal by Subject|1
5983607|NCT01033487|20689291|P10|Fourth Intervention Period|Adverse Event|0
5983608|NCT01033487|20689292|P9|Fourth Intervention Period|Adverse Event|1
5983609|NCT01033487|20689293|P8|Fourth Intervention Period|Adverse Event|0
5983610|NCT01033487|20689294|P7|Fourth Intervention Period|Adverse Event|0
5983611|NCT01033487|20689295|P6|Fourth Intervention Period|Adverse Event|0
5983612|NCT01033487|20689296|P5|Fourth Intervention Period|Adverse Event|0
5983613|NCT01033487|20689297|P4|Fourth Intervention Period|Adverse Event|0
5983614|NCT01033487|20689298|P3|Fourth Intervention Period|Adverse Event|0
5983615|NCT01033487|20689299|P2|Fourth Intervention Period|Adverse Event|0
5983616|NCT01033487|20689300|P1|Fourth Intervention Period|Adverse Event|0
5983617|NCT01033448|20689354|P1|Overall Study|Unknown disposition|1
5983618|NCT01033448|20689354|P1|Overall Study|Withdrew due to other reasons|3
5983619|NCT01033448|20689354|P1|Overall Study|Lost to Follow-up|3
5983620|NCT01033448|20689354|P1|Overall Study|Positive HCV-RNA at week 48|1
5983621|NCT01033448|20689354|P1|Overall Study|Withdrawal by Subject|4
5983622|NCT01033136|20689413|P2|Follow-Up (3 Month)|Lost to Follow-up|2
5983623|NCT01033136|20689414|P1|Follow-Up (3 Month)|Lost to Follow-up|2
5983624|NCT01033071|20689425|P3|Overall Study|Other|3
5983625|NCT01033071|20689426|P2|Overall Study|Other|4
5983626|NCT01033071|20689427|P1|Overall Study|Other|6
5983627|NCT01033071|20689425|P3|Overall Study|Lack of Efficacy|1
5983628|NCT01033071|20689426|P2|Overall Study|Lack of Efficacy|1
5983629|NCT01033071|20689427|P1|Overall Study|Lack of Efficacy|0
5983630|NCT01033071|20689425|P3|Overall Study|Withdrawal by Subject|11
5983631|NCT01033071|20689426|P2|Overall Study|Withdrawal by Subject|14
5983632|NCT01033071|20689427|P1|Overall Study|Withdrawal by Subject|17
5983633|NCT01033071|20689425|P3|Overall Study|Lost to Follow-up|5
5983634|NCT01033071|20689426|P2|Overall Study|Lost to Follow-up|5
5983635|NCT01033071|20689427|P1|Overall Study|Lost to Follow-up|4
5983636|NCT01033071|20689425|P3|Overall Study|Protocol Violation|1
5983637|NCT01033071|20689426|P2|Overall Study|Protocol Violation|2
5983638|NCT01033071|20689427|P1|Overall Study|Protocol Violation|0
5983639|NCT01033071|20689425|P3|Overall Study|Adverse Event|26
5983640|NCT01033071|20689426|P2|Overall Study|Adverse Event|51
5983641|NCT01033071|20689427|P1|Overall Study|Adverse Event|28
5983642|NCT01033019|20689498|P2|Overall Study|Withdrawal by Subject|0
5983643|NCT01033019|20689499|P1|Overall Study|Withdrawal by Subject|1
5983644|NCT01032915|20689556|P4|Overall Study|Protocol Violation|1
5983645|NCT01032915|20689557|P3|Overall Study|Protocol Violation|0
5983646|NCT01032915|20689558|P2|Overall Study|Protocol Violation|0
5983647|NCT01032915|20689559|P1|Overall Study|Protocol Violation|1
5983648|NCT01032915|20689556|P4|Overall Study|Administrative reasons|4
5983649|NCT01032915|20689557|P3|Overall Study|Administrative reasons|4
5983650|NCT01032915|20689558|P2|Overall Study|Administrative reasons|6
5983651|NCT01032915|20689559|P1|Overall Study|Administrative reasons|5
5983652|NCT01032915|20689556|P4|Overall Study|Withdrawal by Subject|1
5983653|NCT01032915|20689557|P3|Overall Study|Withdrawal by Subject|1
5983654|NCT01032915|20689558|P2|Overall Study|Withdrawal by Subject|3
5983655|NCT01032915|20689559|P1|Overall Study|Withdrawal by Subject|0
5983656|NCT01032915|20689556|P4|Overall Study|Abnormal test procedure result|0
5983657|NCT01032915|20689557|P3|Overall Study|Abnormal test procedure result|1
5983658|NCT01032915|20689558|P2|Overall Study|Abnormal test procedure result|0
5983659|NCT01032915|20689559|P1|Overall Study|Abnormal test procedure result|0
5983660|NCT01032915|20689556|P4|Overall Study|Adverse Event|1
5983661|NCT01032915|20689557|P3|Overall Study|Adverse Event|1
5983662|NCT01032915|20689558|P2|Overall Study|Adverse Event|2
5983663|NCT01032915|20689559|P1|Overall Study|Adverse Event|2
5983664|NCT01032889|20689584|P3|Overall Study|Miscellaneous Reasons|1
5983665|NCT01032889|20689585|P2|Overall Study|Miscellaneous Reasons|1
5983666|NCT01032889|20689586|P1|Overall Study|Miscellaneous Reasons|2
5983667|NCT01032889|20689584|P3|Overall Study|Lack of Submental Fat|1
5983668|NCT01032889|20689585|P2|Overall Study|Lack of Submental Fat|8
5983669|NCT01032889|20689586|P1|Overall Study|Lack of Submental Fat|2
5983670|NCT01032889|20689584|P3|Overall Study|Lost to Follow-up|0
5983671|NCT01032889|20689585|P2|Overall Study|Lost to Follow-up|1
5983672|NCT01032889|20689586|P1|Overall Study|Lost to Follow-up|1
5983673|NCT01032889|20689584|P3|Overall Study|Patient Request|0
5983674|NCT01032889|20689585|P2|Overall Study|Patient Request|1
5983675|NCT01032889|20689586|P1|Overall Study|Patient Request|0
5983676|NCT01032889|20689584|P3|Overall Study|Withdrawal of Consent|1
5983677|NCT01032889|20689585|P2|Overall Study|Withdrawal of Consent|2
5983678|NCT01032889|20689586|P1|Overall Study|Withdrawal of Consent|1
5983679|NCT01032889|20689584|P3|Overall Study|Adverse Event|0
5983680|NCT01032889|20689585|P2|Overall Study|Adverse Event|2
5983681|NCT01032889|20689586|P1|Overall Study|Adverse Event|2
5983682|NCT01032837|20689617|P4|Overall Study|Refused treatment|1
5983683|NCT01032837|20689618|P3|Overall Study|Refused treatment|0
5983684|NCT01032837|20689619|P2|Overall Study|Refused treatment|0
5983685|NCT01032837|20689620|P1|Overall Study|Refused treatment|0
5983686|NCT01032837|20689617|P4|Overall Study|Failed to return|0
5983687|NCT01032837|20689618|P3|Overall Study|Failed to return|1
5983688|NCT01032837|20689619|P2|Overall Study|Failed to return|0
5983689|NCT01032837|20689620|P1|Overall Study|Failed to return|0
5983690|NCT01032837|20689617|P4|Overall Study|Withdrew consent|1
5983691|NCT01032837|20689618|P3|Overall Study|Withdrew consent|0
5983692|NCT01032837|20689619|P2|Overall Study|Withdrew consent|2
5983693|NCT01032837|20689620|P1|Overall Study|Withdrew consent|0
5983694|NCT01032837|20689617|P4|Overall Study|Adverse event/internal illness|1
5983695|NCT01032837|20689618|P3|Overall Study|Adverse event/internal illness|0
5983696|NCT01032837|20689619|P2|Overall Study|Adverse event/internal illness|1
5983697|NCT01032837|20689620|P1|Overall Study|Adverse event/internal illness|0
5983698|NCT01032629|20689720|P3|Overall Study|Lost to Follow-up|37
5983699|NCT01032629|20689721|P2|Overall Study|Lost to Follow-up|47
5983700|NCT01032629|20689722|P1|Overall Study|Lost to Follow-up|74
5983701|NCT01032629|20689720|P3|Overall Study|Withdrawal by Subject|35
5983702|NCT01032629|20689721|P2|Overall Study|Withdrawal by Subject|36
5983703|NCT01032629|20689722|P1|Overall Study|Withdrawal by Subject|50
5983704|NCT01032629|20689720|P3|Overall Study|Closed Site|16
5983705|NCT01032629|20689721|P2|Overall Study|Closed Site|18
5983706|NCT01032629|20689722|P1|Overall Study|Closed Site|21
5983707|NCT01032382|20689834|P2|Overall Study|Index lesion relapse|3
5983708|NCT01032382|20689835|P1|Overall Study|Index lesion relapse|1
5983709|NCT01032382|20689834|P2|Overall Study|Treatment failure|1
5983710|NCT01032382|20689835|P1|Overall Study|Treatment failure|3
5983711|NCT01032382|20689834|P2|Overall Study|Disease dissemination|1
5983712|NCT01032382|20689835|P1|Overall Study|Disease dissemination|1
5983713|NCT01032291|20689923|P3|Proof of Concept|Never Received Study Drug|0
5983714|NCT01032291|20689924|P2|Proof of Concept|Never Received Study Drug|1
5983715|NCT01032291|20689925|P1|Proof of Concept|Never Received Study Drug|0
5983716|NCT01032291|20689923|P3|Proof of Concept|Lack of Efficacy|0
5983717|NCT01032291|20689924|P2|Proof of Concept|Lack of Efficacy|1
5983718|NCT01032291|20689925|P1|Proof of Concept|Lack of Efficacy|0
5983719|NCT01032291|20689923|P3|Proof of Concept|Death|2
5983720|NCT01032291|20689924|P2|Proof of Concept|Death|1
5983721|NCT01032291|20689925|P1|Proof of Concept|Death|0
5983722|NCT01032291|20689923|P3|Proof of Concept|Adverse Event|1
5983723|NCT01032291|20689924|P2|Proof of Concept|Adverse Event|5
5983724|NCT01032291|20689925|P1|Proof of Concept|Adverse Event|0
5983725|NCT01032291|20689923|P3|Safety Lead-in|Death|0
5983726|NCT01032291|20689924|P2|Safety Lead-in|Death|0
5983727|NCT01032291|20689925|P1|Safety Lead-in|Death|1
5983728|NCT01032291|20689923|P3|Safety Lead-in|Adverse Event|0
5983729|NCT01032291|20689924|P2|Safety Lead-in|Adverse Event|0
5983730|NCT01032291|20689925|P1|Safety Lead-in|Adverse Event|1
5983731|NCT01032239|20689972|P2|Overall Study|Protocol Violation|0
5983732|NCT01032239|20689973|P1|Overall Study|Protocol Violation|1
5983733|NCT01032239|20689972|P2|Overall Study|Death|0
5983734|NCT01032239|20689973|P1|Overall Study|Death|1
5983735|NCT01032239|20689972|P2|Overall Study|Withdrawal by Subject|3
5983736|NCT01032239|20689973|P1|Overall Study|Withdrawal by Subject|2
5983737|NCT01032239|20689972|P2|Overall Study|Lost to Follow-up|2
5983738|NCT01032239|20689973|P1|Overall Study|Lost to Follow-up|3
5983739|NCT01032200|20690003|P2|Overall Study|Multiple|1
5983740|NCT01032200|20690004|P1|Overall Study|Multiple|1
5983741|NCT01032200|20690003|P2|Overall Study|Progression|0
5983742|NCT01032200|20690004|P1|Overall Study|Progression|1
5983743|NCT01032200|20690003|P2|Overall Study|Toxicity|2
5983744|NCT01032200|20690004|P1|Overall Study|Toxicity|0
5983745|NCT01032200|20690003|P2|Overall Study|Withdrawal by Subject|3
5983746|NCT01032200|20690004|P1|Overall Study|Withdrawal by Subject|1
5983747|NCT01032200|20690003|P2|Overall Study|Death|1
5983748|NCT01032200|20690004|P1|Overall Study|Death|1
5983749|NCT01032174|20690020|P2|Overall Study|Adverse Event|1
5983750|NCT01032174|20690021|P1|Overall Study|Adverse Event|0
5983751|NCT01032070|20690261|P2|Overall Study|Withdrawal by Subject|2
5983752|NCT01032070|20690262|P1|Overall Study|Withdrawal by Subject|0
5983753|NCT01032070|20690261|P2|Overall Study|Medical or ethical reasons|2
5983754|NCT01032070|20690262|P1|Overall Study|Medical or ethical reasons|0
5983755|NCT01032070|20690261|P2|Overall Study|Disease progression|8
5983756|NCT01032070|20690262|P1|Overall Study|Disease progression|13
5983757|NCT01032044|20690291|P2|Overall Study|Lost to Follow-up|11
5983758|NCT01032044|20690292|P1|Overall Study|Lost to Follow-up|11
5983759|NCT01032044|20690291|P2|Overall Study|Adverse Event|1
5983760|NCT01032044|20690292|P1|Overall Study|Adverse Event|0
5983761|NCT01032044|20690291|P2|Overall Study|Protocol Violation|8
5983762|NCT01032044|20690292|P1|Overall Study|Protocol Violation|14
5983763|NCT01032018|20690300|P2|Overall Study|Death|1
5983764|NCT01032018|20690301|P1|Overall Study|Death|0
5983765|NCT01032018|20690300|P2|Overall Study|Lost to Follow-up|5
5983766|NCT01032018|20690301|P1|Overall Study|Lost to Follow-up|6
5983767|NCT01031979|20690311|P2|Overall Study|Lost to Follow-up|4
5983768|NCT01031979|20690312|P1|Overall Study|Lost to Follow-up|5
5983769|NCT01031836|20690345|P6|Stage II|Other|0
5983770|NCT01031836|20690346|P5|Stage II|Other|1
5983771|NCT01031836|20690347|P4|Stage II|Other|1
5983772|NCT01031836|20690348|P3|Stage II|Other|0
5983773|NCT01031836|20690349|P2|Stage II|Other|0
5983774|NCT01031836|20690350|P1|Stage II|Other|2
5983775|NCT01031836|20690345|P6|Stage II|Adverse Event|1
5983776|NCT01031836|20690346|P5|Stage II|Adverse Event|1
5983777|NCT01031836|20690347|P4|Stage II|Adverse Event|2
5983778|NCT01031836|20690348|P3|Stage II|Adverse Event|2
5983779|NCT01031836|20690349|P2|Stage II|Adverse Event|0
5983780|NCT01031836|20690350|P1|Stage II|Adverse Event|0
5983781|NCT01031836|20690345|P6|Stage I|Other|1
5983782|NCT01031836|20690346|P5|Stage I|Other|0
5983783|NCT01031836|20690347|P4|Stage I|Other|0
5983784|NCT01031836|20690348|P3|Stage I|Other|0
5983785|NCT01031836|20690349|P2|Stage I|Other|1
5983786|NCT01031836|20690350|P1|Stage I|Other|0
5983787|NCT01031836|20690345|P6|Stage I|Adverse Event|0
5983788|NCT01031836|20690346|P5|Stage I|Adverse Event|0
5983789|NCT01031836|20690347|P4|Stage I|Adverse Event|0
5983790|NCT01031836|20690348|P3|Stage I|Adverse Event|0
5983791|NCT01031836|20690349|P2|Stage I|Adverse Event|1
5983792|NCT01031836|20690350|P1|Stage I|Adverse Event|1
5983793|NCT01031706|20690411|P2|Overall Study|Withdrawal by Subject|1
5983794|NCT01031706|20690412|P1|Overall Study|Withdrawal by Subject|1
5983795|NCT01031706|20690411|P2|Overall Study|Adverse Event|0
5983796|NCT01031706|20690412|P1|Overall Study|Adverse Event|1
5983797|NCT01031680|20690422|P2|Overall Study|Various|2
5983798|NCT01031680|20690423|P1|Overall Study|Various|0
5983799|NCT01031680|20690422|P2|Overall Study|Administrative Reason by Sponsor|1
5983800|NCT01031680|20690423|P1|Overall Study|Administrative Reason by Sponsor|0
5983801|NCT01031680|20690422|P2|Overall Study|Incorrect Enrolment|2
5983802|NCT01031680|20690423|P1|Overall Study|Incorrect Enrolment|1
5983803|NCT01031680|20690422|P2|Overall Study|Safety|0
5983804|NCT01031680|20690423|P1|Overall Study|Safety|1
5983805|NCT01031680|20690422|P2|Overall Study|Poor/Non-compliance|6
5983806|NCT01031680|20690423|P1|Overall Study|Poor/Non-compliance|5
5983807|NCT01031680|20690422|P2|Overall Study|Subject No Longer Meets Study Criteria|17
5983808|NCT01031680|20690423|P1|Overall Study|Subject No Longer Meets Study Criteria|26
5983809|NCT01031680|20690422|P2|Overall Study|Death|1
5983810|NCT01031680|20690423|P1|Overall Study|Death|2
5983811|NCT01031680|20690422|P2|Overall Study|Withdrawal by Subject|16
5983812|NCT01031680|20690423|P1|Overall Study|Withdrawal by Subject|12
5983813|NCT01031680|20690422|P2|Overall Study|Lost to Follow-up|10
5983814|NCT01031680|20690423|P1|Overall Study|Lost to Follow-up|2
5983815|NCT01031680|20690422|P2|Overall Study|Adverse Event|3
5983816|NCT01031680|20690423|P1|Overall Study|Adverse Event|8
5983817|NCT01031628|20690443|P4|Overall Study|Study terminated early|0
5983818|NCT01031628|20690444|P3|Overall Study|Study terminated early|3
5983819|NCT01031628|20690445|P2|Overall Study|Study terminated early|1
5983820|NCT01031628|20690446|P1|Overall Study|Study terminated early|0
5983821|NCT01031537|20690471|P1|Overall Study|PI removal, no longer met eligibility|12
5983822|NCT01031537|20690471|P1|Overall Study|Withdrawal by Subject|5
5983823|NCT01031537|20690471|P1|Overall Study|moved, met exclusion criteria|10
5983824|NCT01031537|20690471|P1|Overall Study|retired from NIH, met exclusion criteria|1
5983825|NCT01031537|20690471|P1|Overall Study|Lack of Efficacy|1
5983826|NCT01031537|20690471|P1|Overall Study|medical reasons not related to study|3
5983827|NCT01031446|20690489|P1|Overall Study|Still on treatment|1
5983828|NCT01031446|20690489|P1|Overall Study|Withdrawal by Subject|3
5983829|NCT01031446|20690489|P1|Overall Study|Physician Decision|4
5983830|NCT01031446|20690489|P1|Overall Study|Adverse Event|9
5983831|NCT01031446|20690489|P1|Overall Study|Disease Progression|38
5983832|NCT01031381|20690503|P1|Overall Study|Withdrawal by Subject|6
5983833|NCT01031381|20690503|P1|Overall Study|Physician Decision|3
5983834|NCT01031069|20690532|P4|Overall Study|Other|0
5983835|NCT01031069|20690533|P3|Overall Study|Other|1
5983836|NCT01031069|20690534|P2|Overall Study|Other|0
5983837|NCT01031069|20690535|P1|Overall Study|Other|0
5983838|NCT01031069|20690532|P4|Overall Study|Lost to Follow-up|15
5983839|NCT01031069|20690533|P3|Overall Study|Lost to Follow-up|21
5983840|NCT01031069|20690534|P2|Overall Study|Lost to Follow-up|5
5983841|NCT01031069|20690535|P1|Overall Study|Lost to Follow-up|9
5983842|NCT01031069|20690532|P4|Overall Study|Migrated/moved from study area|1
5983843|NCT01031069|20690533|P3|Overall Study|Migrated/moved from study area|1
5983844|NCT01031069|20690534|P2|Overall Study|Migrated/moved from study area|2
5983845|NCT01031069|20690535|P1|Overall Study|Migrated/moved from study area|1
5983846|NCT01031069|20690532|P4|Overall Study|Withdrawal by Subject|18
5983847|NCT01031069|20690533|P3|Overall Study|Withdrawal by Subject|18
5983848|NCT01031069|20690534|P2|Overall Study|Withdrawal by Subject|3
5983849|NCT01031069|20690535|P1|Overall Study|Withdrawal by Subject|2
5983850|NCT01031069|20690532|P4|Overall Study|Serious Adverse Event|0
5983851|NCT01031069|20690533|P3|Overall Study|Serious Adverse Event|0
5983852|NCT01031069|20690534|P2|Overall Study|Serious Adverse Event|1
5983853|NCT01031069|20690535|P1|Overall Study|Serious Adverse Event|0
5983854|NCT01031004|20690637|P2|Overall Study|Lost to Follow-up|0
5983855|NCT01031004|20690638|P1|Overall Study|Lost to Follow-up|1
5983856|NCT01031004|20690637|P2|Overall Study|Protocol Violation|1
5983857|NCT01031004|20690638|P1|Overall Study|Protocol Violation|0
5983858|NCT01030965|20690682|P4|Overall Study|Withdrawal by Subject|2
5983859|NCT01030965|20690683|P3|Overall Study|Withdrawal by Subject|0
5983860|NCT01030965|20690684|P2|Overall Study|Withdrawal by Subject|1
5983861|NCT01030965|20690685|P1|Overall Study|Withdrawal by Subject|0
5983862|NCT01030965|20690682|P4|Overall Study|Protocol-defined Stopping Criteria|0
5983863|NCT01030965|20690683|P3|Overall Study|Protocol-defined Stopping Criteria|1
5983864|NCT01030965|20690684|P2|Overall Study|Protocol-defined Stopping Criteria|1
5983865|NCT01030965|20690685|P1|Overall Study|Protocol-defined Stopping Criteria|0
5983866|NCT01030965|20690682|P4|Overall Study|Adverse Event|1
5983867|NCT01030965|20690683|P3|Overall Study|Adverse Event|2
5983868|NCT01030965|20690684|P2|Overall Study|Adverse Event|1
5983869|NCT01030965|20690685|P1|Overall Study|Adverse Event|0
5983870|NCT01030965|20690682|P4|Overall Study|Protocol Violation|1
5983871|NCT01030965|20690683|P3|Overall Study|Protocol Violation|1
5983872|NCT01030965|20690684|P2|Overall Study|Protocol Violation|1
5983873|NCT01030965|20690685|P1|Overall Study|Protocol Violation|1
5983874|NCT01030965|20690682|P4|Overall Study|Lack of Efficacy|3
5983875|NCT01030965|20690683|P3|Overall Study|Lack of Efficacy|0
5983876|NCT01030965|20690684|P2|Overall Study|Lack of Efficacy|2
5983877|NCT01030965|20690685|P1|Overall Study|Lack of Efficacy|3
5983878|NCT01030952|20690705|P2|Overall Study|Unexplained|1
5983879|NCT01030952|20690706|P1|Overall Study|Unexplained|1
5983880|NCT01030952|20690705|P2|Overall Study|Lost to Follow-up|1
5983881|NCT01030952|20690706|P1|Overall Study|Lost to Follow-up|0
5983882|NCT01030952|20690705|P2|Overall Study|Informed consent withdrawal|0
5983883|NCT01030952|20690706|P1|Overall Study|Informed consent withdrawal|1
5983884|NCT01030952|20690705|P2|Overall Study|Protocol Violation|1
5983885|NCT01030952|20690706|P1|Overall Study|Protocol Violation|0
5983886|NCT01030822|20690754|P3|Overall Study|Lost to Follow-up|7
5983887|NCT01030822|20690755|P2|Overall Study|Lost to Follow-up|4
5983888|NCT01030822|20690756|P1|Overall Study|Lost to Follow-up|9
5983889|NCT01030822|20690754|P3|Overall Study|Withdrawal by Subject|16
5983890|NCT01030822|20690755|P2|Overall Study|Withdrawal by Subject|13
5983891|NCT01030822|20690756|P1|Overall Study|Withdrawal by Subject|16
5983892|NCT01030822|20690754|P3|Overall Study|Moved/migrated from study area|3
5983893|NCT01030822|20690755|P2|Overall Study|Moved/migrated from study area|7
5983894|NCT01030822|20690756|P1|Overall Study|Moved/migrated from study area|6
5983895|NCT01030718|20690831|P3|Study CA180-036 Only|Other Reasons|0
5983896|NCT01030718|20690832|P2|Study CA180-036 Only|Other Reasons|2
5983897|NCT01030718|20690833|P1|Study CA180-036 Only|Other Reasons|0
5983898|NCT01030718|20690831|P3|Study CA180-036 Only|Death|0
5983899|NCT01030718|20690832|P2|Study CA180-036 Only|Death|1
5983900|NCT01030718|20690833|P1|Study CA180-036 Only|Death|0
5983901|NCT01030718|20690831|P3|Study CA180-036 Only|Adverse Event|0
5983902|NCT01030718|20690832|P2|Study CA180-036 Only|Adverse Event|3
5983903|NCT01030718|20690833|P1|Study CA180-036 Only|Adverse Event|2
5983904|NCT01030718|20690831|P3|Study CA180-036 Only|insufficient effect|5
5983905|NCT01030718|20690832|P2|Study CA180-036 Only|insufficient effect|1
5983906|NCT01030718|20690833|P1|Study CA180-036 Only|insufficient effect|1
5983907|NCT01030718|20690831|P3|Studies CA180-031 and -036 Combined|other reasons|0
5983908|NCT01030718|20690832|P2|Studies CA180-031 and -036 Combined|other reasons|2
5983909|NCT01030718|20690833|P1|Studies CA180-031 and -036 Combined|other reasons|0
5983910|NCT01030718|20690831|P3|Studies CA180-031 and -036 Combined|Death|0
5983911|NCT01030718|20690832|P2|Studies CA180-031 and -036 Combined|Death|1
5983912|NCT01030718|20690833|P1|Studies CA180-031 and -036 Combined|Death|0
5983913|NCT01030718|20690831|P3|Studies CA180-031 and -036 Combined|Adverse Event|1
5983914|NCT01030718|20690832|P2|Studies CA180-031 and -036 Combined|Adverse Event|5
5983915|NCT01030718|20690833|P1|Studies CA180-031 and -036 Combined|Adverse Event|3
5983916|NCT01030718|20690831|P3|Studies CA180-031 and -036 Combined|Insufficient effect|11
5983917|NCT01030718|20690832|P2|Studies CA180-031 and -036 Combined|Insufficient effect|1
5983918|NCT01030718|20690833|P1|Studies CA180-031 and -036 Combined|Insufficient effect|1
5983919|NCT01030666|20690894|P2|Overall Study|Lost to Follow-up|2
5983920|NCT01030666|20690895|P1|Overall Study|Lost to Follow-up|3
5983921|NCT01030536|20690920|P5|Overall Study|Death|0
5983922|NCT01030536|20690921|P4|Overall Study|Death|0
5983923|NCT01030536|20690922|P3|Overall Study|Death|0
5983924|NCT01030536|20690923|P2|Overall Study|Death|1
5983925|NCT01030536|20690924|P1|Overall Study|Death|0
5983926|NCT01030536|20690920|P5|Overall Study|Progressive disease|0
5983927|NCT01030536|20690921|P4|Overall Study|Progressive disease|2
5983928|NCT01030536|20690922|P3|Overall Study|Progressive disease|3
5983929|NCT01030536|20690923|P2|Overall Study|Progressive disease|2
5983930|NCT01030536|20690924|P1|Overall Study|Progressive disease|6
5983931|NCT01030536|20690920|P5|Overall Study|Adverse Event|1
5983932|NCT01030536|20690921|P4|Overall Study|Adverse Event|0
5983933|NCT01030536|20690922|P3|Overall Study|Adverse Event|1
5983934|NCT01030536|20690923|P2|Overall Study|Adverse Event|3
5983935|NCT01030536|20690924|P1|Overall Study|Adverse Event|0
5983936|NCT01030536|20690920|P5|Overall Study|undefined|0
5983937|NCT01030536|20690921|P4|Overall Study|undefined|1
5983938|NCT01030536|20690922|P3|Overall Study|undefined|1
5983939|NCT01030536|20690923|P2|Overall Study|undefined|0
5983940|NCT01030536|20690924|P1|Overall Study|undefined|1
5983941|NCT01030536|20690920|P5|Overall Study|Withdrawal by Subject|0
5983942|NCT01030536|20690921|P4|Overall Study|Withdrawal by Subject|0
5983943|NCT01030536|20690922|P3|Overall Study|Withdrawal by Subject|1
5983944|NCT01030536|20690923|P2|Overall Study|Withdrawal by Subject|0
5983945|NCT01030536|20690924|P1|Overall Study|Withdrawal by Subject|0
5983946|NCT01030523|20691029|P2|Overall Study|Withdrawal by Subject|1
5983947|NCT01030523|20691030|P1|Overall Study|Withdrawal by Subject|0
5983948|NCT01030523|20691029|P2|Overall Study|Implant failure|0
5983949|NCT01030523|20691030|P1|Overall Study|Implant failure|1
5983950|NCT01030523|20691029|P2|Overall Study|Lost to Follow-up|4
5983951|NCT01030523|20691030|P1|Overall Study|Lost to Follow-up|4
5983952|NCT01030523|20691029|P2|Overall Study|Death|0
5983953|NCT01030523|20691030|P1|Overall Study|Death|1
5983954|NCT01030458|20691044|P2|Overall Study|Side effect of medication|1
5983955|NCT01030458|20691045|P1|Overall Study|Side effect of medication|1
5983956|NCT01030458|20691044|P2|Overall Study|Moved or changed job|13
5983957|NCT01030458|20691045|P1|Overall Study|Moved or changed job|6
5983958|NCT01030458|20691044|P2|Overall Study|Logistical reasons|5
5983959|NCT01030458|20691045|P1|Overall Study|Logistical reasons|9
5983960|NCT01030458|20691044|P2|Overall Study|Withdrawal by Subject|3
5983961|NCT01030458|20691045|P1|Overall Study|Withdrawal by Subject|2
5983962|NCT01030458|20691044|P2|Overall Study|Lost to Follow-up|10
5983963|NCT01030458|20691045|P1|Overall Study|Lost to Follow-up|9
5983964|NCT01030341|20691078|P1|Overall Study|Lost to Follow-up|2
5983965|NCT01030341|20691078|P1|Overall Study|Withdrawal by Subject|1
5983966|NCT01030198|20691101|P2|Overall Study|Could not measure efficacy accurately|7
5983967|NCT01030198|20691102|P1|Overall Study|Could not measure efficacy accurately|0
5983968|NCT01030133|20691110|P2|Overall Study|failed to experience pain at level 7/10|2
5983969|NCT01030133|20691111|P1|Overall Study|failed to experience pain at level 7/10|2
5983970|NCT01029925|20691123|P1|Completion of Cycle 2 (56 Days)|off study due to disease progression|1
5983971|NCT01029925|20691123|P1|Completion of Cycle 1 (28 Days)|Withdrawal by Subject|2
5983972|NCT01029925|20691123|P1|Completion of Cycle 1 (28 Days)|Death|2
5983973|NCT01029886|20691142|P2|Overall Study|Loss Glucose Control|1
5983974|NCT01029886|20691143|P1|Overall Study|Loss Glucose Control|7
5983975|NCT01029886|20691142|P2|Overall Study|Sponsor Decision|0
5983976|NCT01029886|20691143|P1|Overall Study|Sponsor Decision|1
5983977|NCT01029886|20691142|P2|Overall Study|Entry Criteria Not Met|5
5983978|NCT01029886|20691143|P1|Overall Study|Entry Criteria Not Met|13
5983979|NCT01029886|20691142|P2|Overall Study|Withdrawal by Subject|18
5983980|NCT01029886|20691143|P1|Overall Study|Withdrawal by Subject|8
5983981|NCT01029886|20691142|P2|Overall Study|Protocol Violation|5
5983982|NCT01029886|20691143|P1|Overall Study|Protocol Violation|17
5983983|NCT01029886|20691142|P2|Overall Study|Physician Decision|6
5983984|NCT01029886|20691143|P1|Overall Study|Physician Decision|2
5983985|NCT01029886|20691142|P2|Overall Study|Lost to Follow-up|0
5983986|NCT01029886|20691143|P1|Overall Study|Lost to Follow-up|1
5983987|NCT01029886|20691142|P2|Overall Study|Adverse Event|25
5983988|NCT01029886|20691143|P1|Overall Study|Adverse Event|12
5983989|NCT01029795|20691171|P2|Overall Study|Withdrawal by Subject|3
5983990|NCT01029795|20691172|P1|Overall Study|Withdrawal by Subject|1
5983991|NCT01029795|20691171|P2|Overall Study|Sponsor Decision|17
5983992|NCT01029795|20691172|P1|Overall Study|Sponsor Decision|11
5983993|NCT01029795|20691171|P2|Overall Study|Physician Decision|1
5983994|NCT01029795|20691172|P1|Overall Study|Physician Decision|2
5983995|NCT01029795|20691171|P2|Overall Study|Entry Criteria Not Met|1
5983996|NCT01029795|20691172|P1|Overall Study|Entry Criteria Not Met|2
5983997|NCT01029782|20691226|P2|Overall Study|Withdrawal by Subject|1
5983998|NCT01029782|20691227|P1|Overall Study|Withdrawal by Subject|0
5983999|NCT01029782|20691226|P2|Overall Study|Protocol Violation|2
5984000|NCT01029782|20691227|P1|Overall Study|Protocol Violation|0
5984001|NCT01029782|20691226|P2|Overall Study|Physician Decision|1
5984002|NCT01029782|20691227|P1|Overall Study|Physician Decision|0
5984003|NCT01029782|20691226|P2|Overall Study|Adverse Event|1
5984004|NCT01029782|20691227|P1|Overall Study|Adverse Event|0
5984005|NCT01029782|20691226|P2|Overall Study|Diagnosis changed|1
5984006|NCT01029782|20691227|P1|Overall Study|Diagnosis changed|1
5984007|NCT01029782|20691226|P2|Overall Study|Lost to Follow-up|2
5984008|NCT01029782|20691227|P1|Overall Study|Lost to Follow-up|2
5984009|NCT01029691|20691279|P3|Continued APAP to Delivery|Death|1
5984010|NCT01029691|20691280|P2|Continued APAP to Delivery|Death|0
5984011|NCT01029691|20691281|P1|Continued APAP to Delivery|Death|0
5984012|NCT01029652|20691306|P2|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|1
5984013|NCT01029652|20691307|P1|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|0
5984014|NCT01029652|20691306|P2|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|1
5984015|NCT01029652|20691307|P1|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|0
5984016|NCT01029652|20691306|P2|Extension Study 2 (25-72 Weeks)|Death|1
5984017|NCT01029652|20691307|P1|Extension Study 2 (25-72 Weeks)|Death|1
5984018|NCT01029652|20691306|P2|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|1
5984019|NCT01029652|20691307|P1|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|0
5984020|NCT01029652|20691306|P2|Extension Study 1 (12-24 Weeks)|Protocol Deviation|0
5984021|NCT01029652|20691307|P1|Extension Study 1 (12-24 Weeks)|Protocol Deviation|1
5984022|NCT01029652|20691306|P2|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|3
5984023|NCT01029652|20691307|P1|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|2
5984024|NCT01029652|20691306|P2|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|1
5984025|NCT01029652|20691307|P1|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|0
5984026|NCT01029652|20691306|P2|Core Study (0-12 Weeks)|Death|1
5984027|NCT01029652|20691307|P1|Core Study (0-12 Weeks)|Death|0
5984028|NCT01029652|20691306|P2|Core Study (0-12 Weeks)|Administrative problems|1
5984029|NCT01029652|20691307|P1|Core Study (0-12 Weeks)|Administrative problems|2
5984030|NCT01029652|20691306|P2|Core Study (0-12 Weeks)|Lost to Follow-up|1
5984031|NCT01029652|20691307|P1|Core Study (0-12 Weeks)|Lost to Follow-up|3
5984032|NCT01029652|20691306|P2|Core Study (0-12 Weeks)|Patient Withdrew Consent|3
5984033|NCT01029652|20691307|P1|Core Study (0-12 Weeks)|Patient Withdrew Consent|1
5984034|NCT01029652|20691306|P2|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|4
5984035|NCT01029652|20691307|P1|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|0
5984036|NCT01029535|20691391|P1|Overall Study|Death|1
5984037|NCT01029535|20691391|P1|Overall Study|Use of Another Treatment|1
5984038|NCT01029535|20691391|P1|Overall Study|Adverse Event|1
5984039|NCT01029535|20691391|P1|Overall Study|Participant Withdrew Consent|2
5984040|NCT01029535|20691391|P1|Overall Study|Protocol Violation|2
5984041|NCT01029535|20691391|P1|Overall Study|Lost to Follow-up|24
5984042|NCT01029405|20691420|P4|Overall Study|Other|1
5984043|NCT01029405|20691421|P3|Overall Study|Other|0
5984044|NCT01029405|20691422|P2|Overall Study|Other|1
5984045|NCT01029405|20691423|P1|Overall Study|Other|0
5984046|NCT01029405|20691420|P4|Overall Study|Lost to Follow-up|2
5984047|NCT01029405|20691421|P3|Overall Study|Lost to Follow-up|1
5984048|NCT01029405|20691422|P2|Overall Study|Lost to Follow-up|1
5984049|NCT01029405|20691423|P1|Overall Study|Lost to Follow-up|2
5984050|NCT01029405|20691420|P4|Overall Study|Adverse Event|1
5984051|NCT01029405|20691421|P3|Overall Study|Adverse Event|1
5984052|NCT01029405|20691422|P2|Overall Study|Adverse Event|0
5984053|NCT01029405|20691423|P1|Overall Study|Adverse Event|0
5984054|NCT01029405|20691420|P4|Overall Study|Protocol Violation|1
5984055|NCT01029405|20691421|P3|Overall Study|Protocol Violation|0
5984056|NCT01029405|20691422|P2|Overall Study|Protocol Violation|0
5984057|NCT01029405|20691423|P1|Overall Study|Protocol Violation|0
5984058|NCT01029405|20691420|P4|Overall Study|Withdrawal by Subject|0
5984059|NCT01029405|20691421|P3|Overall Study|Withdrawal by Subject|2
5984060|NCT01029405|20691422|P2|Overall Study|Withdrawal by Subject|1
5984061|NCT01029405|20691423|P1|Overall Study|Withdrawal by Subject|0
5984062|NCT01029392|20691435|P2|Overall Study|Physician Decision|0
5984063|NCT01029392|20691436|P1|Overall Study|Physician Decision|2
5984064|NCT01029392|20691435|P2|Overall Study|Withdrawal by Subject|11
5984065|NCT01029392|20691436|P1|Overall Study|Withdrawal by Subject|18
5984066|NCT01029366|20691446|P2|Overall Study|manufacturing failure|1
5984067|NCT01029366|20691447|P1|Overall Study|manufacturing failure|0
5984068|NCT01029366|20691446|P2|Overall Study|disease progression|0
5984069|NCT01029366|20691447|P1|Overall Study|disease progression|2
5984070|NCT01029366|20691446|P2|Overall Study|Death|1
5984071|NCT01029366|20691447|P1|Overall Study|Death|1
5984072|NCT01029366|20691446|P2|Overall Study|Withdrawal by Subject|0
5984073|NCT01029366|20691447|P1|Overall Study|Withdrawal by Subject|1
5984074|NCT01029340|20691459|P6|Extension Period|Physician Decision|1
5984075|NCT01029340|20691460|P5|Extension Period|Physician Decision|0
5984076|NCT01029340|20691461|P4|Extension Period|Physician Decision|0
5984077|NCT01029340|20691462|P3|Extension Period|Physician Decision|0
5984078|NCT01029340|20691463|P2|Extension Period|Physician Decision|0
5984079|NCT01029340|20691464|P1|Extension Period|Physician Decision|0
5984080|NCT01029340|20691459|P6|Extension Period|Withdrawal by Subject|1
5984081|NCT01029340|20691460|P5|Extension Period|Withdrawal by Subject|0
5984082|NCT01029340|20691461|P4|Extension Period|Withdrawal by Subject|0
5984083|NCT01029340|20691462|P3|Extension Period|Withdrawal by Subject|0
5984084|NCT01029340|20691463|P2|Extension Period|Withdrawal by Subject|0
5984085|NCT01029340|20691464|P1|Extension Period|Withdrawal by Subject|0
5984086|NCT01029340|20691459|P6|Extension Period|non-compliance|1
5984087|NCT01029340|20691460|P5|Extension Period|non-compliance|0
5984088|NCT01029340|20691461|P4|Extension Period|non-compliance|0
5984089|NCT01029340|20691462|P3|Extension Period|non-compliance|0
5984090|NCT01029340|20691463|P2|Extension Period|non-compliance|0
5984091|NCT01029340|20691464|P1|Extension Period|non-compliance|0
5984092|NCT01029340|20691459|P6|Extension Period|starting another study|8
5984093|NCT01029340|20691460|P5|Extension Period|starting another study|0
5984094|NCT01029340|20691461|P4|Extension Period|starting another study|0
5984095|NCT01029340|20691462|P3|Extension Period|starting another study|0
5984096|NCT01029340|20691463|P2|Extension Period|starting another study|0
5984097|NCT01029340|20691464|P1|Extension Period|starting another study|0
5984098|NCT01029340|20691459|P6|Extension Period|Adverse Event|1
5984099|NCT01029340|20691460|P5|Extension Period|Adverse Event|0
5984100|NCT01029340|20691461|P4|Extension Period|Adverse Event|0
5984101|NCT01029340|20691462|P3|Extension Period|Adverse Event|0
5984102|NCT01029340|20691463|P2|Extension Period|Adverse Event|0
5984103|NCT01029340|20691464|P1|Extension Period|Adverse Event|0
5984104|NCT01029340|20691459|P6|Part B Treatment Period|Protocol Violation|0
5984105|NCT01029340|20691460|P5|Part B Treatment Period|Protocol Violation|0
5984106|NCT01029340|20691461|P4|Part B Treatment Period|Protocol Violation|0
5984107|NCT01029340|20691462|P3|Part B Treatment Period|Protocol Violation|1
5984108|NCT01029340|20691463|P2|Part B Treatment Period|Protocol Violation|0
5984109|NCT01029340|20691464|P1|Part B Treatment Period|Protocol Violation|0
5984110|NCT01029340|20691459|P6|Part B Treatment Period|Withdrawal by Subject|0
5984111|NCT01029340|20691460|P5|Part B Treatment Period|Withdrawal by Subject|0
5984112|NCT01029340|20691461|P4|Part B Treatment Period|Withdrawal by Subject|0
5984113|NCT01029340|20691462|P3|Part B Treatment Period|Withdrawal by Subject|1
5984114|NCT01029340|20691463|P2|Part B Treatment Period|Withdrawal by Subject|0
5984115|NCT01029340|20691464|P1|Part B Treatment Period|Withdrawal by Subject|0
5984116|NCT01029262|20691495|P2|Overall Study|Death|3
5984117|NCT01029262|20691496|P1|Overall Study|Death|0
5984118|NCT01029262|20691495|P2|Overall Study|Miscellaneous|9
5984119|NCT01029262|20691496|P1|Overall Study|Miscellaneous|1
5984120|NCT01029262|20691495|P2|Overall Study|Protocol Violation|3
5984121|NCT01029262|20691496|P1|Overall Study|Protocol Violation|2
5984122|NCT01029262|20691495|P2|Overall Study|Withdrawal by Subject|17
5984123|NCT01029262|20691496|P1|Overall Study|Withdrawal by Subject|10
5984124|NCT01029262|20691495|P2|Overall Study|Lack of therapeutic effect|76
5984125|NCT01029262|20691496|P1|Overall Study|Lack of therapeutic effect|57
5984126|NCT01029262|20691495|P2|Overall Study|Adverse Event|52
5984127|NCT01029262|20691496|P1|Overall Study|Adverse Event|9
5984128|NCT01028651|20691665|P1|Overall Study|Adverse Event|1
5984129|NCT01028651|20691665|P1|Overall Study|Death|2
5984130|NCT01028560|20691688|P2|Overall Study|Withdrawal by Subject|12
5984131|NCT01028560|20691689|P1|Overall Study|Withdrawal by Subject|7
5984132|NCT01028560|20691688|P2|Overall Study|Lack of Efficacy|6
5984133|NCT01028560|20691689|P1|Overall Study|Lack of Efficacy|3
5984134|NCT01028391|20691703|P2|Overall Study|Needed excluded medication|1
5984135|NCT01028391|20691704|P1|Overall Study|Needed excluded medication|1
5984136|NCT01028391|20691703|P2|Overall Study|Withdrawal by Subject|3
5984137|NCT01028391|20691704|P1|Overall Study|Withdrawal by Subject|6
5984138|NCT01028391|20691703|P2|Overall Study|Physician Decision|1
5984139|NCT01028391|20691704|P1|Overall Study|Physician Decision|0
5984140|NCT01028391|20691703|P2|Overall Study|Lost to Follow-up|4
5984141|NCT01028391|20691704|P1|Overall Study|Lost to Follow-up|3
5984142|NCT01028391|20691703|P2|Overall Study|Lack of Efficacy|2
5984143|NCT01028391|20691704|P1|Overall Study|Lack of Efficacy|0
5984144|NCT01028391|20691703|P2|Overall Study|Adverse Event|0
5984145|NCT01028391|20691704|P1|Overall Study|Adverse Event|4
5984146|NCT01028378|20691712|P1|Overall Study|Adminstrative Reasons|4
5984147|NCT01028378|20691712|P1|Overall Study|Withdrawal by Subject|1
5984148|NCT01028378|20691712|P1|Overall Study|Lost to Follow-up|12
5984149|NCT01028352|20691724|P1|Overall Study|Withdrawal by Subject|1
5984150|NCT01028352|20691724|P1|Overall Study|Ineligible due to baseline average pain|5
5984151|NCT01028300|20691729|P1|Overall Study|Study Terminated|4
5984152|NCT01028222|20691738|P2|Overall Study|Adverse Event|0
5984153|NCT01028222|20691739|P1|Overall Study|Adverse Event|2
5984154|NCT01028222|20691738|P2|Overall Study|Crossover to nilotinib w/out progression|2
5984155|NCT01028222|20691739|P1|Overall Study|Crossover to nilotinib w/out progression|0
5984156|NCT01028222|20691738|P2|Overall Study|Withdrawal by Subject|0
5984157|NCT01028222|20691739|P1|Overall Study|Withdrawal by Subject|1
5984158|NCT01028222|20691738|P2|Overall Study|Lost to Follow-up|1
5984159|NCT01028222|20691739|P1|Overall Study|Lost to Follow-up|0
5984160|NCT01028222|20691738|P2|Overall Study|Administrative problems|1
5984161|NCT01028222|20691739|P1|Overall Study|Administrative problems|1
5984162|NCT01028222|20691738|P2|Overall Study|Disease progression|9
5984163|NCT01028222|20691739|P1|Overall Study|Disease progression|33
5984164|NCT01028222|20691738|P2|Overall Study|Protocol deviation|0
5984165|NCT01028222|20691739|P1|Overall Study|Protocol deviation|1
5984166|NCT01028053|20691781|P1|Overall Study|Various reasons|4
5984167|NCT01028053|20691781|P1|Overall Study|Terminated by Sponsor|1
5984168|NCT01028053|20691781|P1|Overall Study|Technical Problem|1
5984169|NCT01028053|20691781|P1|Overall Study|Physician Decision|2
5984170|NCT01028053|20691781|P1|Overall Study|Protocol Violation|1
5984171|NCT01028053|20691781|P1|Overall Study|Patient Request|11
5984172|NCT01028053|20691781|P1|Overall Study|Screen Failure|113
5984173|NCT01028027|20691789|P2|Overall Study|Lack of Efficacy|1
5984174|NCT01028027|20691790|P1|Overall Study|Lack of Efficacy|0
5984175|NCT01028027|20691789|P2|Overall Study|Protocol Violation|1
5984176|NCT01028027|20691790|P1|Overall Study|Protocol Violation|3
5984177|NCT01028027|20691789|P2|Overall Study|Adverse Event|7
5984178|NCT01028027|20691790|P1|Overall Study|Adverse Event|4
5984179|NCT01028027|20691789|P2|Overall Study|Withdrawal by Subject|3
5984180|NCT01028027|20691790|P1|Overall Study|Withdrawal by Subject|5
5984181|NCT01028027|20691789|P2|Overall Study|Lost to Follow-up|1
5984182|NCT01028027|20691790|P1|Overall Study|Lost to Follow-up|4
5984183|NCT01028014|20691812|P6|Overall Study|Lost to Follow-up|2
5984184|NCT01028014|20691813|P5|Overall Study|Lost to Follow-up|1
5984185|NCT01028014|20691814|P4|Overall Study|Lost to Follow-up|1
5984186|NCT01028014|20691815|P3|Overall Study|Lost to Follow-up|0
5984187|NCT01028014|20691816|P2|Overall Study|Lost to Follow-up|2
5984188|NCT01028014|20691817|P1|Overall Study|Lost to Follow-up|1
5984189|NCT01027897|20691858|P1|Overall Study|Withdrawal by Subject|1
5984190|NCT01027897|20691858|P1|Overall Study|Protocol Violation|1
5984191|NCT01027884|20691866|P2|Overall Study|Spinal fixation surgery|3
5984192|NCT01027884|20691867|P1|Overall Study|Spinal fixation surgery|0
5984193|NCT01027884|20691866|P2|Overall Study|Lost to Follow-up|1
5984194|NCT01027884|20691867|P1|Overall Study|Lost to Follow-up|0
5984195|NCT01027884|20691866|P2|Overall Study|Withdrawal by Subject|1
5984196|NCT01027884|20691867|P1|Overall Study|Withdrawal by Subject|0
5984197|NCT01027884|20691866|P2|Overall Study|Non-compliance|1
5984198|NCT01027884|20691867|P1|Overall Study|Non-compliance|1
5984199|NCT01027884|20691866|P2|Overall Study|Protocol Violation|0
5984200|NCT01027884|20691867|P1|Overall Study|Protocol Violation|1
5984201|NCT01027884|20691866|P2|Overall Study|Adverse Event|1
5984202|NCT01027884|20691867|P1|Overall Study|Adverse Event|2
5984203|NCT01027871|20691884|P3|Overall Study|Discontinued Prior to Treatment|1
5984204|NCT01027871|20691885|P2|Overall Study|Discontinued Prior to Treatment|0
5984205|NCT01027871|20691886|P1|Overall Study|Discontinued Prior to Treatment|0
5984206|NCT01027871|20691884|P3|Overall Study|Sponsor Decision|0
5984207|NCT01027871|20691885|P2|Overall Study|Sponsor Decision|2
5984208|NCT01027871|20691886|P1|Overall Study|Sponsor Decision|0
5984209|NCT01027871|20691884|P3|Overall Study|Adverse Event|2
5984210|NCT01027871|20691885|P2|Overall Study|Adverse Event|2
5984211|NCT01027871|20691886|P1|Overall Study|Adverse Event|0
5984212|NCT01027871|20691884|P3|Overall Study|Withdrawal by Subject|2
5984213|NCT01027871|20691885|P2|Overall Study|Withdrawal by Subject|2
5984214|NCT01027871|20691886|P1|Overall Study|Withdrawal by Subject|1
5984215|NCT01027871|20691884|P3|Overall Study|Protocol Violation|2
5984216|NCT01027871|20691885|P2|Overall Study|Protocol Violation|2
5984217|NCT01027871|20691886|P1|Overall Study|Protocol Violation|0
5984218|NCT01027871|20691884|P3|Overall Study|Physician Decision|0
5984219|NCT01027871|20691885|P2|Overall Study|Physician Decision|5
5984220|NCT01027871|20691886|P1|Overall Study|Physician Decision|1
5984221|NCT01027845|20691945|P4|Booster Vaccination Phase|Migrated/moved from study area|0
5984222|NCT01027845|20691946|P3|Booster Vaccination Phase|Migrated/moved from study area|0
5984223|NCT01027845|20691947|P2|Booster Vaccination Phase|Migrated/moved from study area|0
5984224|NCT01027845|20691948|P1|Booster Vaccination Phase|Migrated/moved from study area|1
5984225|NCT01027845|20691945|P4|Booster Vaccination Phase|Withdrawal by Subject|0
5984226|NCT01027845|20691946|P3|Booster Vaccination Phase|Withdrawal by Subject|0
5984227|NCT01027845|20691947|P2|Booster Vaccination Phase|Withdrawal by Subject|0
5984228|NCT01027845|20691948|P1|Booster Vaccination Phase|Withdrawal by Subject|1
5984229|NCT01027845|20691945|P4|Primary Vaccination Phase|Migrated/moved from study area|0
5984230|NCT01027845|20691946|P3|Primary Vaccination Phase|Migrated/moved from study area|0
5984231|NCT01027845|20691947|P2|Primary Vaccination Phase|Migrated/moved from study area|1
5984232|NCT01027845|20691948|P1|Primary Vaccination Phase|Migrated/moved from study area|0
5984233|NCT01027845|20691945|P4|Primary Vaccination Phase|Protocol Violation|0
5984234|NCT01027845|20691946|P3|Primary Vaccination Phase|Protocol Violation|0
5984235|NCT01027845|20691947|P2|Primary Vaccination Phase|Protocol Violation|0
5984236|NCT01027845|20691948|P1|Primary Vaccination Phase|Protocol Violation|1
5984237|NCT01027845|20691945|P4|Primary Vaccination Phase|Adverse Event|0
5984238|NCT01027845|20691946|P3|Primary Vaccination Phase|Adverse Event|0
5984239|NCT01027845|20691947|P2|Primary Vaccination Phase|Adverse Event|0
5984240|NCT01027845|20691948|P1|Primary Vaccination Phase|Adverse Event|1
5984241|NCT01027845|20691945|P4|Primary Vaccination Phase|Serious Adverse Event|0
5984242|NCT01027845|20691946|P3|Primary Vaccination Phase|Serious Adverse Event|0
5984243|NCT01027845|20691947|P2|Primary Vaccination Phase|Serious Adverse Event|0
5984244|NCT01027845|20691948|P1|Primary Vaccination Phase|Serious Adverse Event|2
5984245|NCT01027754|20692046|P2|Overall Study|Withdrawal by Subject|5
5984246|NCT01027754|20692047|P1|Overall Study|Withdrawal by Subject|0
5984247|NCT01027754|20692046|P2|Overall Study|withdrew/lost to follow-up after interve|3
5984248|NCT01027754|20692047|P1|Overall Study|withdrew/lost to follow-up after interve|2
5984249|NCT01027702|20692081|P7|Overall Study|Death|0
5984250|NCT01027702|20692082|P6|Overall Study|Death|0
5984251|NCT01027702|20692083|P5|Overall Study|Death|0
5984252|NCT01027702|20692084|P4|Overall Study|Death|0
5984253|NCT01027702|20692085|P3|Overall Study|Death|1
5984254|NCT01027702|20692086|P2|Overall Study|Death|0
5984255|NCT01027702|20692087|P1|Overall Study|Death|0
5984256|NCT01027702|20692081|P7|Overall Study|Received subsequent therapy|1
5984257|NCT01027702|20692082|P6|Overall Study|Received subsequent therapy|0
5984258|NCT01027702|20692083|P5|Overall Study|Received subsequent therapy|1
5984259|NCT01027702|20692084|P4|Overall Study|Received subsequent therapy|4
5984260|NCT01027702|20692085|P3|Overall Study|Received subsequent therapy|0
5984261|NCT01027702|20692086|P2|Overall Study|Received subsequent therapy|2
5984262|NCT01027702|20692087|P1|Overall Study|Received subsequent therapy|1
5984263|NCT01027650|20692113|P8|Overall Study|Lack of Efficacy|0
5984264|NCT01027650|20692114|P7|Overall Study|Lack of Efficacy|0
5984265|NCT01027650|20692115|P6|Overall Study|Lack of Efficacy|1
5984266|NCT01027650|20692116|P5|Overall Study|Lack of Efficacy|0
5984267|NCT01027650|20692117|P4|Overall Study|Lack of Efficacy|0
5984268|NCT01027650|20692118|P3|Overall Study|Lack of Efficacy|0
5984269|NCT01027650|20692119|P2|Overall Study|Lack of Efficacy|0
5984270|NCT01027650|20692120|P1|Overall Study|Lack of Efficacy|0
5984271|NCT01027650|20692113|P8|Overall Study|Lost to Follow-up|0
5984272|NCT01027650|20692114|P7|Overall Study|Lost to Follow-up|1
5984273|NCT01027650|20692115|P6|Overall Study|Lost to Follow-up|0
5984274|NCT01027650|20692116|P5|Overall Study|Lost to Follow-up|0
5984275|NCT01027650|20692117|P4|Overall Study|Lost to Follow-up|0
5984276|NCT01027650|20692118|P3|Overall Study|Lost to Follow-up|0
5984277|NCT01027650|20692119|P2|Overall Study|Lost to Follow-up|0
5984278|NCT01027650|20692120|P1|Overall Study|Lost to Follow-up|0
5984279|NCT01027650|20692113|P8|Overall Study|Personal Reasons|0
5984280|NCT01027650|20692114|P7|Overall Study|Personal Reasons|0
5984281|NCT01027650|20692115|P6|Overall Study|Personal Reasons|1
5984282|NCT01027650|20692116|P5|Overall Study|Personal Reasons|2
5984283|NCT01027650|20692117|P4|Overall Study|Personal Reasons|0
5984284|NCT01027650|20692118|P3|Overall Study|Personal Reasons|0
5984285|NCT01027650|20692119|P2|Overall Study|Personal Reasons|0
5984286|NCT01027650|20692120|P1|Overall Study|Personal Reasons|0
5984287|NCT01027416|20692198|P2|Overall Study|Physician Decision|4
5984288|NCT01027416|20692199|P1|Overall Study|Physician Decision|1
5984289|NCT01027416|20692198|P2|Overall Study|Withdrawal by Subject|1
5984290|NCT01027416|20692199|P1|Overall Study|Withdrawal by Subject|0
5984291|NCT01027364|20692211|P4|Overall Study|Withdrawal by Subject|0
5984292|NCT01027364|20692212|P3|Overall Study|Withdrawal by Subject|0
5984293|NCT01027364|20692213|P2|Overall Study|Withdrawal by Subject|2
5984294|NCT01027364|20692214|P1|Overall Study|Withdrawal by Subject|1
5984295|NCT01027364|20692211|P4|Overall Study|Protocol Violation|1
5984296|NCT01027364|20692212|P3|Overall Study|Protocol Violation|0
5984297|NCT01027364|20692213|P2|Overall Study|Protocol Violation|0
5984298|NCT01027364|20692214|P1|Overall Study|Protocol Violation|1
5984299|NCT01027364|20692211|P4|Overall Study|Lost to Follow-up|0
5984300|NCT01027364|20692212|P3|Overall Study|Lost to Follow-up|0
5984301|NCT01027364|20692213|P2|Overall Study|Lost to Follow-up|0
5984302|NCT01027364|20692214|P1|Overall Study|Lost to Follow-up|1
5984303|NCT01027364|20692211|P4|Overall Study|Adverse Event|0
5984304|NCT01027364|20692212|P3|Overall Study|Adverse Event|1
5984305|NCT01027364|20692213|P2|Overall Study|Adverse Event|0
5984306|NCT01027364|20692214|P1|Overall Study|Adverse Event|1
5984307|NCT01027351|20692309|P6|Overall Study|Protocol Violation|0
5984308|NCT01027351|20692310|P5|Overall Study|Protocol Violation|1
5984309|NCT01027351|20692311|P4|Overall Study|Protocol Violation|1
5984310|NCT01027351|20692312|P3|Overall Study|Protocol Violation|0
5984311|NCT01027351|20692313|P2|Overall Study|Protocol Violation|0
5984312|NCT01027351|20692314|P1|Overall Study|Protocol Violation|1
5984313|NCT01027351|20692309|P6|Overall Study|Inappropriate enrollment|0
5984314|NCT01027351|20692310|P5|Overall Study|Inappropriate enrollment|1
5984315|NCT01027351|20692311|P4|Overall Study|Inappropriate enrollment|0
5984316|NCT01027351|20692312|P3|Overall Study|Inappropriate enrollment|0
5984317|NCT01027351|20692313|P2|Overall Study|Inappropriate enrollment|0
5984318|NCT01027351|20692314|P1|Overall Study|Inappropriate enrollment|0
5984319|NCT01027351|20692309|P6|Overall Study|Lost to Follow-up|0
5984320|NCT01027351|20692310|P5|Overall Study|Lost to Follow-up|6
5984321|NCT01027351|20692311|P4|Overall Study|Lost to Follow-up|1
5984322|NCT01027351|20692312|P3|Overall Study|Lost to Follow-up|0
5984323|NCT01027351|20692313|P2|Overall Study|Lost to Follow-up|1
5984324|NCT01027351|20692314|P1|Overall Study|Lost to Follow-up|1
5984325|NCT01027351|20692309|P6|Overall Study|Withdrawal by Subject|5
5984326|NCT01027351|20692310|P5|Overall Study|Withdrawal by Subject|3
5984327|NCT01027351|20692311|P4|Overall Study|Withdrawal by Subject|0
5984328|NCT01027351|20692312|P3|Overall Study|Withdrawal by Subject|1
5984329|NCT01027351|20692313|P2|Overall Study|Withdrawal by Subject|0
5984330|NCT01027351|20692314|P1|Overall Study|Withdrawal by Subject|1
5984331|NCT01027286|20692398|P2|Overall Study|Lost to Follow-up|1
5984332|NCT01027286|20692399|P1|Overall Study|Lost to Follow-up|0
5984333|NCT01027286|20692398|P2|Overall Study|Unable to Obtain Required Blood Volume|0
5984334|NCT01027286|20692399|P1|Overall Study|Unable to Obtain Required Blood Volume|1
5984335|NCT01027273|20692419|P2|Overall Study|Death|2
5984336|NCT01027273|20692420|P1|Overall Study|Death|2
5984337|NCT01027273|20692419|P2|Overall Study|Lost to Follow-up|31
5984338|NCT01027273|20692420|P1|Overall Study|Lost to Follow-up|57
5984339|NCT01026974|20692467|P4|Overall Study|Inappropriate enrollment|0
5984340|NCT01026974|20692468|P3|Overall Study|Inappropriate enrollment|1
5984341|NCT01026974|20692469|P2|Overall Study|Inappropriate enrollment|0
5984342|NCT01026974|20692470|P1|Overall Study|Inappropriate enrollment|0
5984343|NCT01026974|20692467|P4|Overall Study|Adverse Event|1
5984344|NCT01026974|20692468|P3|Overall Study|Adverse Event|0
5984345|NCT01026974|20692469|P2|Overall Study|Adverse Event|0
5984346|NCT01026974|20692470|P1|Overall Study|Adverse Event|0
5984347|NCT01026974|20692467|P4|Overall Study|Lost to Follow-up|0
5984348|NCT01026974|20692468|P3|Overall Study|Lost to Follow-up|4
5984349|NCT01026974|20692469|P2|Overall Study|Lost to Follow-up|1
5984350|NCT01026974|20692470|P1|Overall Study|Lost to Follow-up|1
5984351|NCT01026974|20692467|P4|Overall Study|Withdrawal by Subject|2
5984352|NCT01026974|20692468|P3|Overall Study|Withdrawal by Subject|7
5984353|NCT01026974|20692469|P2|Overall Study|Withdrawal by Subject|1
5984354|NCT01026974|20692470|P1|Overall Study|Withdrawal by Subject|0
5984355|NCT01026948|20692527|P1|Overall Study|Physician Decision|8
5984356|NCT01026831|20692560|P2|Overall Study|Withdrawal by Subject|5
5984357|NCT01026831|20692561|P1|Overall Study|Withdrawal by Subject|7
5984358|NCT01026831|20692560|P2|Overall Study|Protocol Violation|2
5984359|NCT01026831|20692561|P1|Overall Study|Protocol Violation|0
5984360|NCT01026831|20692560|P2|Overall Study|Physician Decision|1
5984361|NCT01026831|20692561|P1|Overall Study|Physician Decision|1
5984362|NCT01026831|20692560|P2|Overall Study|Lost to Follow-up|0
5984363|NCT01026831|20692561|P1|Overall Study|Lost to Follow-up|2
5984364|NCT01026831|20692560|P2|Overall Study|Adverse Event|3
5984365|NCT01026831|20692561|P1|Overall Study|Adverse Event|4
5984366|NCT01026818|20692572|P4|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|1
5984367|NCT01026818|20692573|P3|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0
5984368|NCT01026818|20692574|P2|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|2
5984369|NCT01026818|20692575|P1|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0
5984370|NCT01026818|20692572|P4|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1
5984371|NCT01026818|20692573|P3|OL Period (Month 10.5 - 13.5)|Protocol Deviation|3
5984372|NCT01026818|20692574|P2|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1
5984373|NCT01026818|20692575|P1|OL Period (Month 10.5 - 13.5)|Protocol Deviation|0
5984374|NCT01026818|20692572|P4|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1
5984375|NCT01026818|20692573|P3|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|2
5984376|NCT01026818|20692574|P2|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1
5984377|NCT01026818|20692575|P1|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|0
5984378|NCT01026818|20692572|P4|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0
5984379|NCT01026818|20692573|P3|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0
5984380|NCT01026818|20692574|P2|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|1
5984381|NCT01026818|20692575|P1|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0
5984382|NCT01026818|20692572|P4|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0
5984383|NCT01026818|20692573|P3|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0
5984384|NCT01026818|20692574|P2|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|2
5984385|NCT01026818|20692575|P1|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0
5984386|NCT01026818|20692572|P4|Drug-Free Washout Period (Month 9-10.5)|Death|1
5984387|NCT01026818|20692573|P3|Drug-Free Washout Period (Month 9-10.5)|Death|0
5984388|NCT01026818|20692574|P2|Drug-Free Washout Period (Month 9-10.5)|Death|0
5984389|NCT01026818|20692575|P1|Drug-Free Washout Period (Month 9-10.5)|Death|0
5984390|NCT01026818|20692572|P4|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0
5984391|NCT01026818|20692573|P3|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|2
5984392|NCT01026818|20692574|P2|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|1
5984393|NCT01026818|20692575|P1|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0
5984394|NCT01026818|20692572|P4|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0
5984395|NCT01026818|20692573|P3|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0
5984396|NCT01026818|20692574|P2|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|1
5984397|NCT01026818|20692575|P1|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0
5984398|NCT01026818|20692572|P4|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0
5984399|NCT01026818|20692573|P3|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1
5984400|NCT01026818|20692574|P2|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1
5984401|NCT01026818|20692575|P1|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0
5984402|NCT01026818|20692572|P4|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|2
5984403|NCT01026818|20692573|P3|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0
5984404|NCT01026818|20692574|P2|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|1
5984405|NCT01026818|20692575|P1|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0
5984406|NCT01026818|20692572|P4|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0
5984407|NCT01026818|20692573|P3|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0
5984408|NCT01026818|20692574|P2|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|1
5984409|NCT01026818|20692575|P1|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0
5984410|NCT01026818|20692572|P4|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2
5984411|NCT01026818|20692573|P3|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|1
5984412|NCT01026818|20692574|P2|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2
5984413|NCT01026818|20692575|P1|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|0
5984414|NCT01026818|20692572|P4|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2
5984415|NCT01026818|20692573|P3|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|1
5984416|NCT01026818|20692574|P2|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2
5984417|NCT01026818|20692575|P1|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|0
5984418|NCT01026818|20692572|P4|DB Treatment Period (Month 0 - 9)|Protocol Deviation|2
5984419|NCT01026818|20692573|P3|DB Treatment Period (Month 0 - 9)|Protocol Deviation|1
5984420|NCT01026818|20692574|P2|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0
5984421|NCT01026818|20692575|P1|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0
5984422|NCT01026818|20692572|P4|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|7
5984423|NCT01026818|20692573|P3|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|9
5984424|NCT01026818|20692574|P2|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|2
5984425|NCT01026818|20692575|P1|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|0
5984426|NCT01026818|20692572|P4|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|4
5984427|NCT01026818|20692573|P3|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0
5984428|NCT01026818|20692574|P2|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|3
5984429|NCT01026818|20692575|P1|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0
5984430|NCT01026818|20692572|P4|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|6
5984431|NCT01026818|20692573|P3|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|2
5984432|NCT01026818|20692574|P2|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|3
5984433|NCT01026818|20692575|P1|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|0
5984434|NCT01026818|20692572|P4|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3
5984435|NCT01026818|20692573|P3|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3
5984436|NCT01026818|20692574|P2|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|7
5984437|NCT01026818|20692575|P1|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|0
5984438|NCT01026818|20692572|P4|DB Treatment Period (Month 0 - 9)|Adverse Event|4
5984439|NCT01026818|20692573|P3|DB Treatment Period (Month 0 - 9)|Adverse Event|6
5984440|NCT01026818|20692574|P2|DB Treatment Period (Month 0 - 9)|Adverse Event|10
5984441|NCT01026818|20692575|P1|DB Treatment Period (Month 0 - 9)|Adverse Event|0
5984442|NCT01026818|20692572|P4|Screening Period|Physician Decision|0
5984443|NCT01026818|20692573|P3|Screening Period|Physician Decision|0
5984444|NCT01026818|20692574|P2|Screening Period|Physician Decision|0
5984445|NCT01026818|20692575|P1|Screening Period|Physician Decision|1
5984446|NCT01026818|20692572|P4|Screening Period|Adverse Event|0
5984447|NCT01026818|20692573|P3|Screening Period|Adverse Event|0
5984448|NCT01026818|20692574|P2|Screening Period|Adverse Event|0
5984449|NCT01026818|20692575|P1|Screening Period|Adverse Event|2
5984450|NCT01026818|20692572|P4|Screening Period|Protocol Deviation|0
5984451|NCT01026818|20692573|P3|Screening Period|Protocol Deviation|0
5984452|NCT01026818|20692574|P2|Screening Period|Protocol Deviation|0
5984453|NCT01026818|20692575|P1|Screening Period|Protocol Deviation|3
5984454|NCT01026818|20692572|P4|Screening Period|Withdrawal by Subject|0
5984455|NCT01026818|20692573|P3|Screening Period|Withdrawal by Subject|0
5984456|NCT01026818|20692574|P2|Screening Period|Withdrawal by Subject|0
5984457|NCT01026818|20692575|P1|Screening Period|Withdrawal by Subject|49
5984458|NCT01026818|20692572|P4|Screening Period|Entry Criteria Not Met|0
5984459|NCT01026818|20692573|P3|Screening Period|Entry Criteria Not Met|0
5984460|NCT01026818|20692574|P2|Screening Period|Entry Criteria Not Met|0
5984461|NCT01026818|20692575|P1|Screening Period|Entry Criteria Not Met|105
5984462|NCT01026792|20692663|P1|Overall Study|Protocol Violation|1
5984463|NCT01026493|20692706|P8|Overall Study|Protocol Violation|1
5984464|NCT01026493|20692707|P7|Overall Study|Protocol Violation|4
5984465|NCT01026493|20692708|P6|Overall Study|Protocol Violation|3
5984466|NCT01026493|20692709|P5|Overall Study|Protocol Violation|2
5984467|NCT01026493|20692710|P4|Overall Study|Protocol Violation|0
5984468|NCT01026493|20692711|P3|Overall Study|Protocol Violation|0
5984469|NCT01026493|20692712|P2|Overall Study|Protocol Violation|1
5984470|NCT01026493|20692713|P1|Overall Study|Protocol Violation|0
5984471|NCT01026454|20692741|P2|Second Intervention|Pregnancy|1
5984472|NCT01026454|20692742|P1|Second Intervention|Pregnancy|1
5984473|NCT01026389|20693091|P2|Overall Study|change of treatment, patient moved|2
5984474|NCT01026389|20693092|P1|Overall Study|change of treatment, patient moved|4
5984475|NCT01026389|20693091|P2|Overall Study|Withdrawal by Subject|3
5984476|NCT01026389|20693092|P1|Overall Study|Withdrawal by Subject|1
5984477|NCT01026324|20693107|P3|Follow up/Survival|Withdrawal by Subject|0
5984478|NCT01026324|20693108|P2|Follow up/Survival|Withdrawal by Subject|0
5984479|NCT01026324|20693109|P1|Follow up/Survival|Withdrawal by Subject|1
5984480|NCT01026220|20693119|P3|Consolidation Maintenance|Withdrawal by Subject|6
5984481|NCT01026220|20693120|P2|Consolidation Maintenance|Withdrawal by Subject|2
5984482|NCT01026220|20693121|P1|Consolidation Maintenance|Withdrawal by Subject|0
5984483|NCT01026220|20693119|P3|Consolidation Maintenance|Physician Decision|7
5984484|NCT01026220|20693120|P2|Consolidation Maintenance|Physician Decision|2
5984485|NCT01026220|20693121|P1|Consolidation Maintenance|Physician Decision|0
5984486|NCT01026220|20693119|P3|Consolidation Maintenance|Lack of Efficacy|1
5984487|NCT01026220|20693120|P2|Consolidation Maintenance|Lack of Efficacy|1
5984488|NCT01026220|20693121|P1|Consolidation Maintenance|Lack of Efficacy|0
5984489|NCT01026220|20693119|P3|Consolidation Maintenance|Death|0
5984490|NCT01026220|20693120|P2|Consolidation Maintenance|Death|1
5984491|NCT01026220|20693121|P1|Consolidation Maintenance|Death|0
5984492|NCT01026220|20693119|P3|Induction|Ineligible|0
5984493|NCT01026220|20693120|P2|Induction|Ineligible|0
5984494|NCT01026220|20693121|P1|Induction|Ineligible|1
5984495|NCT01026220|20693119|P3|Induction|Withdrawal by Subject|0
5984496|NCT01026220|20693120|P2|Induction|Withdrawal by Subject|0
5984497|NCT01026220|20693121|P1|Induction|Withdrawal by Subject|9
5984498|NCT01026220|20693119|P3|Induction|Physician Decision|0
5984499|NCT01026220|20693120|P2|Induction|Physician Decision|0
5984500|NCT01026220|20693121|P1|Induction|Physician Decision|12
5984501|NCT01026220|20693119|P3|Induction|Lack of Efficacy|0
5984502|NCT01026220|20693120|P2|Induction|Lack of Efficacy|0
5984503|NCT01026220|20693121|P1|Induction|Lack of Efficacy|2
5984504|NCT01026220|20693119|P3|Induction|Death|0
5984505|NCT01026220|20693120|P2|Induction|Death|0
5984506|NCT01026220|20693121|P1|Induction|Death|1
5984507|NCT01026194|20693145|P2|Period 2：Open-label Period|Withdrawal by Subject|4
5984508|NCT01026194|20693146|P1|Period 2：Open-label Period|Withdrawal by Subject|0
5984509|NCT01026194|20693145|P2|Period 2：Open-label Period|Physician Decision|1
5984510|NCT01026194|20693146|P1|Period 2：Open-label Period|Physician Decision|3
5984511|NCT01026194|20693145|P2|Period 2：Open-label Period|Adverse Event|5
5984512|NCT01026194|20693146|P1|Period 2：Open-label Period|Adverse Event|4
5984513|NCT01026194|20693145|P2|Period 1：Double Blind Period|Physician Decision|4
5984514|NCT01026194|20693146|P1|Period 1：Double Blind Period|Physician Decision|0
5984515|NCT01026194|20693145|P2|Period 1：Double Blind Period|Lack of Efficacy|0
5984516|NCT01026194|20693146|P1|Period 1：Double Blind Period|Lack of Efficacy|1
5984517|NCT01026194|20693145|P2|Period 1：Double Blind Period|Adverse Event|1
5984518|NCT01026194|20693146|P1|Period 1：Double Blind Period|Adverse Event|2
5984519|NCT01026142|20693178|P2|Overall Study|Withdrew consent or lost to follow-up|29
5984520|NCT01026142|20693179|P1|Overall Study|Withdrew consent or lost to follow-up|36
5984521|NCT01026142|20693178|P2|Overall Study|Death|134
5984522|NCT01026142|20693179|P1|Overall Study|Death|136
5984523|NCT01026103|20693201|P1|Overall Study|did not receive study device bc of error|1
5984524|NCT01026103|20693201|P1|Overall Study|Physician Decision|1
5984525|NCT01026038|20693211|P3|Overall Study|Lost to Follow-up|0
5984526|NCT01026038|20693212|P2|Overall Study|Lost to Follow-up|1
5984527|NCT01026038|20693213|P1|Overall Study|Lost to Follow-up|1
5984528|NCT01025843|20693262|P10|Washout 4|Withdrawal by Subject|0
5984529|NCT01025843|20693263|P9|Washout 4|Withdrawal by Subject|0
5984530|NCT01025843|20693264|P8|Washout 4|Withdrawal by Subject|0
5984531|NCT01025843|20693265|P7|Washout 4|Withdrawal by Subject|0
5984532|NCT01025843|20693266|P6|Washout 4|Withdrawal by Subject|0
5984533|NCT01025843|20693267|P5|Washout 4|Withdrawal by Subject|0
5984534|NCT01025843|20693268|P4|Washout 4|Withdrawal by Subject|1
5984535|NCT01025843|20693269|P3|Washout 4|Withdrawal by Subject|1
5984536|NCT01025843|20693270|P2|Washout 4|Withdrawal by Subject|0
5984537|NCT01025843|20693271|P1|Washout 4|Withdrawal by Subject|0
5984538|NCT01025817|20693365|P2|Completed Study|Lost to Follow-up|1
5984539|NCT01025817|20693366|P1|Completed Study|Lost to Follow-up|0
5984540|NCT01025817|20693365|P2|Completed Study|Missing|0
5984541|NCT01025817|20693366|P1|Completed Study|Missing|2
5984542|NCT01025817|20693365|P2|Completed Study|Death|5
5984543|NCT01025817|20693366|P1|Completed Study|Death|6
5984544|NCT01025817|20693365|P2|Completed Study|Withdrawal by Subject|16
5984545|NCT01025817|20693366|P1|Completed Study|Withdrawal by Subject|8
5984546|NCT01025817|20693365|P2|Completed Study Medication|Lost to Follow-up|1
5984547|NCT01025817|20693366|P1|Completed Study Medication|Lost to Follow-up|0
5984548|NCT01025817|20693365|P2|Completed Study Medication|Subject no longer required study drug|1
5984549|NCT01025817|20693366|P1|Completed Study Medication|Subject no longer required study drug|0
5984550|NCT01025817|20693365|P2|Completed Study Medication|Abnormal lab values|2
5984551|NCT01025817|20693366|P1|Completed Study Medication|Abnormal lab values|0
5984552|NCT01025817|20693365|P2|Completed Study Medication|Death|2
5984553|NCT01025817|20693366|P1|Completed Study Medication|Death|2
5984554|NCT01025817|20693365|P2|Completed Study Medication|Graft loss|5
5984555|NCT01025817|20693366|P1|Completed Study Medication|Graft loss|2
5984556|NCT01025817|20693365|P2|Completed Study Medication|Abnormal test procedure|0
5984557|NCT01025817|20693366|P1|Completed Study Medication|Abnormal test procedure|4
5984558|NCT01025817|20693365|P2|Completed Study Medication|Unsatisfactory therapeutic effect|0
5984559|NCT01025817|20693366|P1|Completed Study Medication|Unsatisfactory therapeutic effect|7
5984560|NCT01025817|20693365|P2|Completed Study Medication|Administrative problems|5
5984561|NCT01025817|20693366|P1|Completed Study Medication|Administrative problems|7
5984562|NCT01025817|20693365|P2|Completed Study Medication|Withdrawal by Subject|9
5984563|NCT01025817|20693366|P1|Completed Study Medication|Withdrawal by Subject|8
5984564|NCT01025817|20693365|P2|Completed Study Medication|Protocol Deviation|8
5984565|NCT01025817|20693366|P1|Completed Study Medication|Protocol Deviation|9
5984566|NCT01025817|20693365|P2|Completed Study Medication|Adverse Event|39
5984567|NCT01025817|20693366|P1|Completed Study Medication|Adverse Event|66
5984568|NCT01025752|20693532|P2|Overall Study|Physician Decision|3
5984569|NCT01025752|20693533|P1|Overall Study|Physician Decision|1
5984570|NCT01025752|20693532|P2|Overall Study|Lost to Follow-up|10
5984571|NCT01025752|20693533|P1|Overall Study|Lost to Follow-up|7
5984572|NCT01025635|20693553|P2|Overall Study|Reason not known|2
5984573|NCT01025635|20693554|P1|Overall Study|Reason not known|4
5984574|NCT01025635|20693553|P2|Overall Study|Lost to Follow-up|13
5984575|NCT01025635|20693554|P1|Overall Study|Lost to Follow-up|9
5984576|NCT01025635|20693553|P2|Overall Study|Lack of Efficacy|1
5984577|NCT01025635|20693554|P1|Overall Study|Lack of Efficacy|0
5984578|NCT01025635|20693553|P2|Overall Study|Protocol Violation|2
5984579|NCT01025635|20693554|P1|Overall Study|Protocol Violation|4
5984580|NCT01025635|20693553|P2|Overall Study|Withdrawal by Subject|7
5984581|NCT01025635|20693554|P1|Overall Study|Withdrawal by Subject|6
5984582|NCT01025336|20693586|P5|Overall Study|Protocol Violation|0
5984583|NCT01025336|20693587|P4|Overall Study|Protocol Violation|2
5984584|NCT01025336|20693588|P3|Overall Study|Protocol Violation|0
5984585|NCT01025336|20693589|P2|Overall Study|Protocol Violation|0
5984586|NCT01025336|20693590|P1|Overall Study|Protocol Violation|0
5984587|NCT01025284|20693645|P3|Overall Study|Withdrawal by Subject|0
5984588|NCT01025284|20693646|P2|Overall Study|Withdrawal by Subject|1
5984589|NCT01025284|20693647|P1|Overall Study|Withdrawal by Subject|0
5984590|NCT01025284|20693645|P3|Overall Study|Investigator Decision|0
5984591|NCT01025284|20693646|P2|Overall Study|Investigator Decision|1
5984592|NCT01025284|20693647|P1|Overall Study|Investigator Decision|0
5984593|NCT01025232|20693672|P2|Overall Study|Study drug no longer available|6
5984594|NCT01025232|20693673|P1|Overall Study|Study drug no longer available|3
5984595|NCT01025193|20693691|P1|Overall Study|Adverse Event|3
5984596|NCT01025193|20693691|P1|Overall Study|Protocol Violation|1
5984597|NCT01025154|20693701|P1|Overall Study|Withdrawal by Subject|1
5984598|NCT01025154|20693701|P1|Overall Study|Lost to Follow-up|1
5984599|NCT01025037|20693710|P1|Overall Study|Withdrawal by Subject|1
5984600|NCT01025037|20693710|P1|Overall Study|Lost to Follow-up|7
5984601|NCT01025037|20693710|P1|Overall Study|Adverse Event|3
5984602|NCT01024959|20693732|P1|Overall Study|missing results required for analysis|17
5984603|NCT01024959|20693732|P1|Overall Study|results not evaluable|12
5984604|NCT01024959|20693732|P1|Overall Study|ineligible|12
5984605|NCT01024946|20693741|P1|Overall Study|Adverse Event|1
5984606|NCT01024946|20693741|P1|Overall Study|Withdrawal by Subject|1
5984607|NCT01024946|20693741|P1|Overall Study|Screen Failure|3
5984608|NCT01024920|20693747|P2|Overall Study|Not treated|0
5984609|NCT01024920|20693748|P1|Overall Study|Not treated|3
5984610|NCT01024920|20693747|P2|Overall Study|Other reason|13
5984611|NCT01024920|20693748|P1|Overall Study|Other reason|21
5984612|NCT01024920|20693747|P2|Overall Study|Withdrawal by Subject|0
5984613|NCT01024920|20693748|P1|Overall Study|Withdrawal by Subject|2
5984614|NCT01024920|20693747|P2|Overall Study|Lost to Follow-up|4
5984615|NCT01024920|20693748|P1|Overall Study|Lost to Follow-up|4
5984616|NCT01024920|20693747|P2|Overall Study|Adverse Event|2
5984617|NCT01024920|20693748|P1|Overall Study|Adverse Event|4
5984618|NCT01024920|20693747|P2|Overall Study|Progressive disease|3
5984619|NCT01024920|20693748|P1|Overall Study|Progressive disease|11
5984620|NCT01024855|20693766|P1|Overall Study|Inclusion/exclusion criteria|1
5984621|NCT01024751|20693773|P2|Eligible Participants|Ineligible|1
5984622|NCT01024751|20693774|P1|Eligible Participants|Ineligible|0
5984623|NCT01024751|20693773|P2|Eligible Participants|Lost to Follow-up|1
5984624|NCT01024751|20693774|P1|Eligible Participants|Lost to Follow-up|0
5984625|NCT01024751|20693773|P2|Eligible Participants|Withdrawal by Subject|1
5984626|NCT01024751|20693774|P1|Eligible Participants|Withdrawal by Subject|0
5984627|NCT01024751|20693773|P2|Enrolled Participants|Ineligible at baseline|4
5984628|NCT01024751|20693774|P1|Enrolled Participants|Ineligible at baseline|3
5984629|NCT01024608|20693831|P2|Overall Study|Never received study treatment|0
5984630|NCT01024608|20693832|P1|Overall Study|Never received study treatment|2
5984631|NCT01024608|20693831|P2|Overall Study|Protocol Violation|3
5984632|NCT01024608|20693832|P1|Overall Study|Protocol Violation|0
5984633|NCT01024608|20693831|P2|Overall Study|Lost to Follow-up|1
5984634|NCT01024608|20693832|P1|Overall Study|Lost to Follow-up|0
5984635|NCT01024608|20693831|P2|Overall Study|Withdrawal by Subject|0
5984636|NCT01024608|20693832|P1|Overall Study|Withdrawal by Subject|1
5984637|NCT01024608|20693831|P2|Overall Study|Adverse Event|0
5984638|NCT01024608|20693832|P1|Overall Study|Adverse Event|1
5984639|NCT01024465|20693861|P1|Overall Study|Physician Decision|1
5984640|NCT01024465|20693861|P1|Overall Study|Adverse Event|2
5984641|NCT01024387|20693865|P1|Overall Study|Other|5
5984642|NCT01024387|20693865|P1|Overall Study|Adverse Event|3
5984643|NCT01024387|20693865|P1|Overall Study|Prolonged Treatment Delay|1
5984644|NCT01024387|20693865|P1|Overall Study|Death|2
5984645|NCT01024387|20693865|P1|Overall Study|Withdrawal by Subject|5
5984646|NCT01024387|20693865|P1|Overall Study|Physician Decision|5
5984647|NCT01024387|20693865|P1|Overall Study|Symptomatic Progression|10
5984648|NCT01024387|20693865|P1|Overall Study|Radiographic Progression|29
5984649|NCT01024309|20693886|P2|Overall Study|Withdrawal by Subject|4
5984650|NCT01024309|20693887|P1|Overall Study|Withdrawal by Subject|4
5984651|NCT01024309|20693886|P2|Overall Study|Physician Decision|0
5984652|NCT01024309|20693887|P1|Overall Study|Physician Decision|4
5984653|NCT01024244|20693919|P5|Overall Study|Withdrawal by Subject|0
5984654|NCT01024244|20693920|P4|Overall Study|Withdrawal by Subject|0
5984655|NCT01024244|20693921|P3|Overall Study|Withdrawal by Subject|0
5984656|NCT01024244|20693922|P2|Overall Study|Withdrawal by Subject|1
5984657|NCT01024244|20693923|P1|Overall Study|Withdrawal by Subject|0
5984658|NCT01024244|20693919|P5|Overall Study|Sponsor Decision|10
5984659|NCT01024244|20693920|P4|Overall Study|Sponsor Decision|12
5984660|NCT01024244|20693921|P3|Overall Study|Sponsor Decision|14
5984661|NCT01024244|20693922|P2|Overall Study|Sponsor Decision|7
5984662|NCT01024244|20693923|P1|Overall Study|Sponsor Decision|14
5984663|NCT01024244|20693919|P5|Overall Study|Protocol Violation|2
5984664|NCT01024244|20693920|P4|Overall Study|Protocol Violation|0
5984665|NCT01024244|20693921|P3|Overall Study|Protocol Violation|0
5984666|NCT01024244|20693922|P2|Overall Study|Protocol Violation|0
5984667|NCT01024244|20693923|P1|Overall Study|Protocol Violation|1
5984668|NCT01024244|20693919|P5|Overall Study|Lack of Efficacy|0
5984669|NCT01024244|20693920|P4|Overall Study|Lack of Efficacy|0
5984670|NCT01024244|20693921|P3|Overall Study|Lack of Efficacy|0
5984671|NCT01024244|20693922|P2|Overall Study|Lack of Efficacy|0
5984672|NCT01024244|20693923|P1|Overall Study|Lack of Efficacy|1
5984673|NCT01024244|20693919|P5|Overall Study|Entry Criteria Not Met|0
5984674|NCT01024244|20693920|P4|Overall Study|Entry Criteria Not Met|0
5984675|NCT01024244|20693921|P3|Overall Study|Entry Criteria Not Met|0
5984676|NCT01024244|20693922|P2|Overall Study|Entry Criteria Not Met|1
5984677|NCT01024244|20693923|P1|Overall Study|Entry Criteria Not Met|0
5984678|NCT01024244|20693919|P5|Overall Study|Adverse Event|2
5984679|NCT01024244|20693920|P4|Overall Study|Adverse Event|1
5984680|NCT01024244|20693921|P3|Overall Study|Adverse Event|0
5984681|NCT01024244|20693922|P2|Overall Study|Adverse Event|2
5984682|NCT01024244|20693923|P1|Overall Study|Adverse Event|1
5984683|NCT01024036|20694037|P2|Follow-Up Period|Adverse Event|1
5984684|NCT01024036|20694038|P1|Follow-Up Period|Adverse Event|4
5984685|NCT01024036|20694037|P2|Follow-Up Period|Withdrawal by Subject|1
5984686|NCT01024036|20694038|P1|Follow-Up Period|Withdrawal by Subject|0
5984687|NCT01024036|20694037|P2|Follow-Up Period|Lost to Follow-up|1
5984688|NCT01024036|20694038|P1|Follow-Up Period|Lost to Follow-up|1
5984689|NCT01024036|20694037|P2|Unblinded Treatment|Lack of Efficacy|2
5984690|NCT01024036|20694038|P1|Unblinded Treatment|Lack of Efficacy|0
5984691|NCT01024036|20694037|P2|Unblinded Treatment|Adverse Event|1
5984692|NCT01024036|20694038|P1|Unblinded Treatment|Adverse Event|0
5984693|NCT01024036|20694037|P2|Blinded Treatment|Withdrawal by Subject|3
5984694|NCT01024036|20694038|P1|Blinded Treatment|Withdrawal by Subject|4
5984695|NCT01024036|20694037|P2|Blinded Treatment|Death|2
5984696|NCT01024036|20694038|P1|Blinded Treatment|Death|0
5984697|NCT01024036|20694037|P2|Blinded Treatment|Physician Decision|0
5984698|NCT01024036|20694038|P1|Blinded Treatment|Physician Decision|1
5984699|NCT01024036|20694037|P2|Blinded Treatment|Lack of Efficacy|14
5984700|NCT01024036|20694038|P1|Blinded Treatment|Lack of Efficacy|16
5984701|NCT01024036|20694037|P2|Blinded Treatment|Adverse Event|1
5984702|NCT01024036|20694038|P1|Blinded Treatment|Adverse Event|1
5984703|NCT01023958|20694085|P1|Overall Study|Refused to continue medication|1
5984704|NCT01023958|20694085|P1|Overall Study|Other adverse event|1
5984705|NCT01023958|20694085|P1|Overall Study|Progressive disease|48
5984706|NCT01023815|20694133|P4|Randomized Period (Day 90 to Month 12)|Graft Loss|0
5984707|NCT01023815|20694134|P3|Randomized Period (Day 90 to Month 12)|Graft Loss|0
5984708|NCT01023815|20694135|P2|Randomized Period (Day 90 to Month 12)|Graft Loss|1
5984709|NCT01023815|20694136|P1|Randomized Period (Day 90 to Month 12)|Graft Loss|0
5984710|NCT01023815|20694133|P4|Randomized Period (Day 90 to Month 12)|Administrative Problems|2
5984711|NCT01023815|20694134|P3|Randomized Period (Day 90 to Month 12)|Administrative Problems|6
5984712|NCT01023815|20694135|P2|Randomized Period (Day 90 to Month 12)|Administrative Problems|1
5984713|NCT01023815|20694136|P1|Randomized Period (Day 90 to Month 12)|Administrative Problems|0
5984714|NCT01023815|20694133|P4|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0
5984715|NCT01023815|20694134|P3|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1
5984716|NCT01023815|20694135|P2|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1
5984717|NCT01023815|20694136|P1|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0
5984718|NCT01023815|20694133|P4|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1
5984719|NCT01023815|20694134|P3|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1
5984720|NCT01023815|20694135|P2|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0
5984721|NCT01023815|20694136|P1|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0
5984722|NCT01023815|20694133|P4|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0
5984723|NCT01023815|20694134|P3|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0
5984724|NCT01023815|20694135|P2|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0
5984725|NCT01023815|20694136|P1|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|144
5984726|NCT01023789|20694155|P1|3 - Year Visit|Lost to Follow-up|13
5984727|NCT01023789|20694155|P1|3 - Year Visit|Withdrawal of consent|1
5984728|NCT01023789|20694155|P1|3 - Year Visit|Death|29
5984729|NCT01023672|20694241|P1|Overall Study|Death|1
5984730|NCT01023672|20694241|P1|Overall Study|Worsening disease|2
5984731|NCT01023659|20694248|P3|Overall Study|Lost to Follow-up|99
5984732|NCT01023659|20694249|P2|Overall Study|Lost to Follow-up|228
5984733|NCT01023659|20694250|P1|Overall Study|Lost to Follow-up|73
5984734|NCT01023581|20694277|P7|Overall Study|Other|0
5984735|NCT01023581|20694278|P6|Overall Study|Other|0
5984736|NCT01023581|20694279|P5|Overall Study|Other|1
5984737|NCT01023581|20694280|P4|Overall Study|Other|0
5984738|NCT01023581|20694281|P3|Overall Study|Other|1
5984739|NCT01023581|20694282|P2|Overall Study|Other|0
5984740|NCT01023581|20694283|P1|Overall Study|Other|1
5984741|NCT01023581|20694277|P7|Overall Study|Physician Decision|1
5984742|NCT01023581|20694278|P6|Overall Study|Physician Decision|1
5984743|NCT01023581|20694279|P5|Overall Study|Physician Decision|1
5984744|NCT01023581|20694280|P4|Overall Study|Physician Decision|1
5984745|NCT01023581|20694281|P3|Overall Study|Physician Decision|2
5984746|NCT01023581|20694282|P2|Overall Study|Physician Decision|0
5984747|NCT01023581|20694283|P1|Overall Study|Physician Decision|2
5984748|NCT01023581|20694277|P7|Overall Study|Lack of Efficacy|1
5984749|NCT01023581|20694278|P6|Overall Study|Lack of Efficacy|2
5984750|NCT01023581|20694279|P5|Overall Study|Lack of Efficacy|1
5984751|NCT01023581|20694280|P4|Overall Study|Lack of Efficacy|2
5984752|NCT01023581|20694281|P3|Overall Study|Lack of Efficacy|6
5984753|NCT01023581|20694282|P2|Overall Study|Lack of Efficacy|3
5984754|NCT01023581|20694283|P1|Overall Study|Lack of Efficacy|9
5984755|NCT01023581|20694277|P7|Overall Study|Pregnancy|0
5984756|NCT01023581|20694278|P6|Overall Study|Pregnancy|1
5984757|NCT01023581|20694279|P5|Overall Study|Pregnancy|0
5984758|NCT01023581|20694280|P4|Overall Study|Pregnancy|2
5984759|NCT01023581|20694281|P3|Overall Study|Pregnancy|0
5984760|NCT01023581|20694282|P2|Overall Study|Pregnancy|0
5984761|NCT01023581|20694283|P1|Overall Study|Pregnancy|0
5984762|NCT01023581|20694277|P7|Overall Study|Withdrawal by Subject|5
5984763|NCT01023581|20694278|P6|Overall Study|Withdrawal by Subject|8
5984764|NCT01023581|20694279|P5|Overall Study|Withdrawal by Subject|6
5984765|NCT01023581|20694280|P4|Overall Study|Withdrawal by Subject|10
5984766|NCT01023581|20694281|P3|Overall Study|Withdrawal by Subject|16
5984767|NCT01023581|20694282|P2|Overall Study|Withdrawal by Subject|8
5984768|NCT01023581|20694283|P1|Overall Study|Withdrawal by Subject|13
5984769|NCT01023581|20694277|P7|Overall Study|Lost to Follow-up|2
5984770|NCT01023581|20694278|P6|Overall Study|Lost to Follow-up|2
5984771|NCT01023581|20694279|P5|Overall Study|Lost to Follow-up|5
5984772|NCT01023581|20694280|P4|Overall Study|Lost to Follow-up|2
5984773|NCT01023581|20694281|P3|Overall Study|Lost to Follow-up|7
5984774|NCT01023581|20694282|P2|Overall Study|Lost to Follow-up|8
5984775|NCT01023581|20694283|P1|Overall Study|Lost to Follow-up|4
5984776|NCT01023581|20694277|P7|Overall Study|Major protocol deviation|0
5984777|NCT01023581|20694278|P6|Overall Study|Major protocol deviation|0
5984778|NCT01023581|20694279|P5|Overall Study|Major protocol deviation|0
5984779|NCT01023581|20694280|P4|Overall Study|Major protocol deviation|0
5984780|NCT01023581|20694281|P3|Overall Study|Major protocol deviation|3
5984781|NCT01023581|20694282|P2|Overall Study|Major protocol deviation|0
5984782|NCT01023581|20694283|P1|Overall Study|Major protocol deviation|2
5984783|NCT01023581|20694277|P7|Overall Study|Adverse Event|11
5984784|NCT01023581|20694278|P6|Overall Study|Adverse Event|5
5984785|NCT01023581|20694279|P5|Overall Study|Adverse Event|2
5984786|NCT01023581|20694280|P4|Overall Study|Adverse Event|3
5984787|NCT01023581|20694281|P3|Overall Study|Adverse Event|7
5984788|NCT01023581|20694282|P2|Overall Study|Adverse Event|4
5984789|NCT01023581|20694283|P1|Overall Study|Adverse Event|4
5984790|NCT01023516|20694340|P2|Overall Study|Incorrect enrolment|2
5984791|NCT01023516|20694341|P1|Overall Study|Incorrect enrolment|4
5984792|NCT01023516|20694340|P2|Overall Study|Study-specific criteria|2
5984793|NCT01023516|20694341|P1|Overall Study|Study-specific criteria|4
5984794|NCT01023516|20694340|P2|Overall Study|Safety reason|3
5984795|NCT01023516|20694341|P1|Overall Study|Safety reason|0
5984796|NCT01023516|20694340|P2|Overall Study|Adverse Event|6
5984797|NCT01023516|20694341|P1|Overall Study|Adverse Event|9
5984798|NCT01023516|20694340|P2|Overall Study|Voluntary discontinuation|5
5984799|NCT01023516|20694341|P1|Overall Study|Voluntary discontinuation|7
5984800|NCT01023308|20694423|P2|Overall Study|Withdrawal by Subject|18
5984801|NCT01023308|20694424|P1|Overall Study|Withdrawal by Subject|34
5984802|NCT01023308|20694423|P2|Overall Study|Lost to Follow-up|0
5984803|NCT01023308|20694424|P1|Overall Study|Lost to Follow-up|1
5984804|NCT01023308|20694423|P2|Overall Study|Untreated|5
5984805|NCT01023308|20694424|P1|Overall Study|Untreated|5
5984806|NCT01023308|20694423|P2|Overall Study|Protocol Violation|4
5984807|NCT01023308|20694424|P1|Overall Study|Protocol Violation|3
5984808|NCT01023308|20694423|P2|Overall Study|New Cancer therapy|7
5984809|NCT01023308|20694424|P1|Overall Study|New Cancer therapy|4
5984810|NCT01023308|20694423|P2|Overall Study|Disease progression|153
5984811|NCT01023308|20694424|P1|Overall Study|Disease progression|82
5984812|NCT01023308|20694423|P2|Overall Study|Death|17
5984813|NCT01023308|20694424|P1|Overall Study|Death|21
5984814|NCT01023308|20694423|P2|Overall Study|Adverse Event|66
5984815|NCT01023308|20694424|P1|Overall Study|Adverse Event|130
5984816|NCT01023308|20694423|P2|Overall Study|Administrative problems|1
5984817|NCT01023308|20694424|P1|Overall Study|Administrative problems|2
5984818|NCT01023308|20694423|P2|Overall Study|Abnormal test proceedure results|8
5984819|NCT01023308|20694424|P1|Overall Study|Abnormal test proceedure results|3
5984820|NCT01023269|20694450|P2|Overall Study|early termination of the study|0
5984821|NCT01023269|20694451|P1|Overall Study|early termination of the study|2
5984822|NCT01023256|20694459|P4|Overall Study|Withdrawal by Subject|2
5984823|NCT01023256|20694460|P3|Overall Study|Withdrawal by Subject|0
5984824|NCT01023256|20694461|P2|Overall Study|Withdrawal by Subject|0
5984825|NCT01023256|20694462|P1|Overall Study|Withdrawal by Subject|0
5984826|NCT01023256|20694459|P4|Overall Study|Adverse Event|1
5984827|NCT01023256|20694460|P3|Overall Study|Adverse Event|0
5984828|NCT01023256|20694461|P2|Overall Study|Adverse Event|0
5984829|NCT01023256|20694462|P1|Overall Study|Adverse Event|0
5984830|NCT01023256|20694459|P4|Overall Study|Other|2
5984831|NCT01023256|20694460|P3|Overall Study|Other|0
5984832|NCT01023256|20694461|P2|Overall Study|Other|0
5984833|NCT01023256|20694462|P1|Overall Study|Other|1
5984834|NCT01023256|20694459|P4|Overall Study|Randomized but not treated|0
5984835|NCT01023256|20694460|P3|Overall Study|Randomized but not treated|1
5984836|NCT01023256|20694461|P2|Overall Study|Randomized but not treated|0
5984837|NCT01023256|20694462|P1|Overall Study|Randomized but not treated|1
5984838|NCT01023256|20694459|P4|Overall Study|Protocol Violation|0
5984839|NCT01023256|20694460|P3|Overall Study|Protocol Violation|0
5984840|NCT01023256|20694461|P2|Overall Study|Protocol Violation|3
5984841|NCT01023256|20694462|P1|Overall Study|Protocol Violation|2
5984842|NCT01023217|20694504|P2|Overall Study|Withdrawal by Subject|0
5984843|NCT01023217|20694505|P1|Overall Study|Withdrawal by Subject|1
5984844|NCT01023061|20694543|P1|Overall Study|Withdrawal prior to treatment|2
5984860|NCT01023022|20694564|P1|Overall Study|due to technical issues|2
5984861|NCT01023022|20694564|P1|Overall Study|Lost to Follow-up|7
5984862|NCT01023022|20694564|P1|Overall Study|Death|5
5984863|NCT01022996|20694570|P1|Overall Study|Protocol Violation|1
5984864|NCT01022996|20694570|P1|Overall Study|Disease Progression|32
5984865|NCT01022996|20694570|P1|Overall Study|Administrative problems|6
5984866|NCT01022996|20694570|P1|Overall Study|Lost to Follow-up|1
5984867|NCT01022996|20694570|P1|Overall Study|Withdrawal by Subject|3
5984868|NCT01022996|20694570|P1|Overall Study|Adverse Event|14
5984869|NCT01022853|20694584|P5|Overall Study|Other not stated above|0
5984870|NCT01022853|20694585|P4|Overall Study|Other not stated above|0
5984871|NCT01022853|20694586|P3|Overall Study|Other not stated above|1
5984872|NCT01022853|20694587|P2|Overall Study|Other not stated above|0
5984873|NCT01022853|20694588|P1|Overall Study|Other not stated above|1
5984874|NCT01022853|20694584|P5|Overall Study|Withdrawal by Subject|0
5984875|NCT01022853|20694585|P4|Overall Study|Withdrawal by Subject|1
5984876|NCT01022853|20694586|P3|Overall Study|Withdrawal by Subject|1
5984877|NCT01022853|20694587|P2|Overall Study|Withdrawal by Subject|1
5984878|NCT01022853|20694588|P1|Overall Study|Withdrawal by Subject|0
5984879|NCT01022853|20694584|P5|Overall Study|Dose-limiting toxicity|1
5984880|NCT01022853|20694585|P4|Overall Study|Dose-limiting toxicity|0
5984881|NCT01022853|20694586|P3|Overall Study|Dose-limiting toxicity|0
5984882|NCT01022853|20694587|P2|Overall Study|Dose-limiting toxicity|0
5984883|NCT01022853|20694588|P1|Overall Study|Dose-limiting toxicity|0
5984884|NCT01022853|20694584|P5|Overall Study|Progressive disease|1
5984885|NCT01022853|20694585|P4|Overall Study|Progressive disease|7
5984886|NCT01022853|20694586|P3|Overall Study|Progressive disease|11
5984887|NCT01022853|20694587|P2|Overall Study|Progressive disease|3
5984888|NCT01022853|20694588|P1|Overall Study|Progressive disease|2
5984889|NCT01022762|20694667|P2|Overall Study|Unclassified|20
5984890|NCT01022762|20694668|P1|Overall Study|Unclassified|12
5984891|NCT01022762|20694667|P2|Overall Study|Protocol Violation|6
5984892|NCT01022762|20694668|P1|Overall Study|Protocol Violation|7
5984893|NCT01022762|20694667|P2|Overall Study|Lack of Efficacy|1
5984894|NCT01022762|20694668|P1|Overall Study|Lack of Efficacy|0
5984895|NCT01022762|20694667|P2|Overall Study|Adverse Event|1
5984896|NCT01022762|20694668|P1|Overall Study|Adverse Event|3
5984897|NCT01022502|20694703|P1|Overall Study|Withdrawal by Subject|1
5984898|NCT01022502|20694703|P1|Overall Study|employment related reasons|1
5984899|NCT01022502|20694703|P1|Overall Study|Adverse Event|1
5984900|NCT01022424|20694717|P1|Overall Study|eGFR under the withdrawal criteria|2
5984901|NCT01022424|20694717|P1|Overall Study|Physician Decision|1
5984902|NCT01022424|20694717|P1|Overall Study|Adverse Event|1
5984903|NCT01022398|20694732|P2|Overall Study|Study terminated|2
5984904|NCT01022398|20694733|P1|Overall Study|Study terminated|2
5984905|NCT01022203|20694758|P2|Follow-Up Assessment|Lost to Follow-up|2
5984906|NCT01022203|20694759|P1|Follow-Up Assessment|Lost to Follow-up|2
5984907|NCT01022203|20694758|P2|Post Treatment Assessment|Adverse Event|2
5984908|NCT01022203|20694759|P1|Post Treatment Assessment|Adverse Event|0
5984909|NCT01022203|20694758|P2|Post Treatment Assessment|Physician Decision|0
5984910|NCT01022203|20694759|P1|Post Treatment Assessment|Physician Decision|2
5984911|NCT01022203|20694758|P2|Post Treatment Assessment|Withdrawal by Subject|12
5984912|NCT01022203|20694759|P1|Post Treatment Assessment|Withdrawal by Subject|12
5984913|NCT01022112|20694778|P5|Overall Study|Fasting plasma glucose level increased|7
5984914|NCT01022112|20694779|P4|Overall Study|Fasting plasma glucose level increased|0
5984915|NCT01022112|20694780|P3|Overall Study|Fasting plasma glucose level increased|0
5984916|NCT01022112|20694781|P2|Overall Study|Fasting plasma glucose level increased|0
5984917|NCT01022112|20694782|P1|Overall Study|Fasting plasma glucose level increased|1
5984918|NCT01022112|20694778|P5|Overall Study|Withdrawal by Subject|1
5984919|NCT01022112|20694779|P4|Overall Study|Withdrawal by Subject|2
5984920|NCT01022112|20694780|P3|Overall Study|Withdrawal by Subject|2
5984921|NCT01022112|20694781|P2|Overall Study|Withdrawal by Subject|1
5984922|NCT01022112|20694782|P1|Overall Study|Withdrawal by Subject|0
5984923|NCT01022112|20694778|P5|Overall Study|Physician Decision|1
5984924|NCT01022112|20694779|P4|Overall Study|Physician Decision|0
5984925|NCT01022112|20694780|P3|Overall Study|Physician Decision|1
5984926|NCT01022112|20694781|P2|Overall Study|Physician Decision|0
5984927|NCT01022112|20694782|P1|Overall Study|Physician Decision|0
5984928|NCT01022112|20694778|P5|Overall Study|Lack of Efficacy|1
5984929|NCT01022112|20694779|P4|Overall Study|Lack of Efficacy|0
5984930|NCT01022112|20694780|P3|Overall Study|Lack of Efficacy|0
5984931|NCT01022112|20694781|P2|Overall Study|Lack of Efficacy|0
5984932|NCT01022112|20694782|P1|Overall Study|Lack of Efficacy|1
5984933|NCT01022112|20694778|P5|Overall Study|Adverse Event|0
5984934|NCT01022112|20694779|P4|Overall Study|Adverse Event|1
5984935|NCT01022112|20694780|P3|Overall Study|Adverse Event|0
5984936|NCT01022112|20694781|P2|Overall Study|Adverse Event|2
5984937|NCT01022112|20694782|P1|Overall Study|Adverse Event|1
5984938|NCT01021878|20694831|P2|Overall Study|Transplantation|1
5984939|NCT01021878|20694832|P1|Overall Study|Transplantation|6
5984940|NCT01021878|20694831|P2|Overall Study|Adverse Event|5
5984941|NCT01021878|20694832|P1|Overall Study|Adverse Event|6
5984942|NCT01021878|20694831|P2|Overall Study|Death|1
5984943|NCT01021878|20694832|P1|Overall Study|Death|0
5984944|NCT01021878|20694831|P2|Overall Study|Lost to Follow-up|3
5984945|NCT01021878|20694832|P1|Overall Study|Lost to Follow-up|4
5984946|NCT01021852|20694854|P8|Treatment Period 2|Withdrawal by Subject|2
5984947|NCT01021852|20694855|P7|Treatment Period 2|Withdrawal by Subject|1
5984948|NCT01021852|20694856|P6|Treatment Period 2|Withdrawal by Subject|0
5984949|NCT01021852|20694857|P5|Treatment Period 2|Withdrawal by Subject|0
5984950|NCT01021852|20694858|P4|Treatment Period 2|Withdrawal by Subject|0
5984951|NCT01021852|20694859|P3|Treatment Period 2|Withdrawal by Subject|0
5984952|NCT01021852|20694860|P2|Treatment Period 2|Withdrawal by Subject|0
5984953|NCT01021852|20694861|P1|Treatment Period 2|Withdrawal by Subject|0
5984954|NCT01021852|20694854|P8|Treatment Period 2|Protocol Violation|0
5984955|NCT01021852|20694855|P7|Treatment Period 2|Protocol Violation|1
5984956|NCT01021852|20694856|P6|Treatment Period 2|Protocol Violation|0
5984957|NCT01021852|20694857|P5|Treatment Period 2|Protocol Violation|1
5984958|NCT01021852|20694858|P4|Treatment Period 2|Protocol Violation|0
5984959|NCT01021852|20694859|P3|Treatment Period 2|Protocol Violation|0
5984960|NCT01021852|20694860|P2|Treatment Period 2|Protocol Violation|0
5984961|NCT01021852|20694861|P1|Treatment Period 2|Protocol Violation|0
5984962|NCT01021852|20694854|P8|Treatment Period 2|Physician Decision|0
5984963|NCT01021852|20694855|P7|Treatment Period 2|Physician Decision|0
5984964|NCT01021852|20694856|P6|Treatment Period 2|Physician Decision|0
5984965|NCT01021852|20694857|P5|Treatment Period 2|Physician Decision|0
5984966|NCT01021852|20694858|P4|Treatment Period 2|Physician Decision|0
5984967|NCT01021852|20694859|P3|Treatment Period 2|Physician Decision|1
5984968|NCT01021852|20694860|P2|Treatment Period 2|Physician Decision|0
5984969|NCT01021852|20694861|P1|Treatment Period 2|Physician Decision|0
5984970|NCT01021852|20694854|P8|Treatment Period 2|Lack of Efficacy|0
5984971|NCT01021852|20694855|P7|Treatment Period 2|Lack of Efficacy|0
5984972|NCT01021852|20694856|P6|Treatment Period 2|Lack of Efficacy|1
5984973|NCT01021852|20694857|P5|Treatment Period 2|Lack of Efficacy|0
5984974|NCT01021852|20694858|P4|Treatment Period 2|Lack of Efficacy|0
5984975|NCT01021852|20694859|P3|Treatment Period 2|Lack of Efficacy|0
5984976|NCT01021852|20694860|P2|Treatment Period 2|Lack of Efficacy|0
5984977|NCT01021852|20694861|P1|Treatment Period 2|Lack of Efficacy|0
5984978|NCT01021852|20694854|P8|Treatment Period 2|Adverse Event|0
5984979|NCT01021852|20694855|P7|Treatment Period 2|Adverse Event|1
5984980|NCT01021852|20694856|P6|Treatment Period 2|Adverse Event|0
5984981|NCT01021852|20694857|P5|Treatment Period 2|Adverse Event|1
5984982|NCT01021852|20694858|P4|Treatment Period 2|Adverse Event|0
5984983|NCT01021852|20694859|P3|Treatment Period 2|Adverse Event|0
5984984|NCT01021852|20694860|P2|Treatment Period 2|Adverse Event|1
5984985|NCT01021852|20694861|P1|Treatment Period 2|Adverse Event|0
5984986|NCT01021852|20694854|P8|Washout Period-No Drug|Adverse Event|0
5984987|NCT01021852|20694855|P7|Washout Period-No Drug|Adverse Event|0
5984988|NCT01021852|20694856|P6|Washout Period-No Drug|Adverse Event|1
5984989|NCT01021852|20694857|P5|Washout Period-No Drug|Adverse Event|0
5984990|NCT01021852|20694858|P4|Washout Period-No Drug|Adverse Event|0
5984991|NCT01021852|20694859|P3|Washout Period-No Drug|Adverse Event|0
5984992|NCT01021852|20694860|P2|Washout Period-No Drug|Adverse Event|0
5984993|NCT01021852|20694861|P1|Washout Period-No Drug|Adverse Event|1
5984994|NCT01021852|20694854|P8|Washout Period-Placebo|Protocol Violation|0
5984995|NCT01021852|20694855|P7|Washout Period-Placebo|Protocol Violation|1
5984996|NCT01021852|20694856|P6|Washout Period-Placebo|Protocol Violation|0
5984997|NCT01021852|20694857|P5|Washout Period-Placebo|Protocol Violation|0
5984998|NCT01021852|20694858|P4|Washout Period-Placebo|Protocol Violation|0
5984999|NCT01021852|20694859|P3|Washout Period-Placebo|Protocol Violation|0
5985000|NCT01021852|20694860|P2|Washout Period-Placebo|Protocol Violation|0
5985001|NCT01021852|20694861|P1|Washout Period-Placebo|Protocol Violation|0
5985002|NCT01021852|20694854|P8|Washout Period-Placebo|Lost to Follow-up|0
5985003|NCT01021852|20694855|P7|Washout Period-Placebo|Lost to Follow-up|0
5985004|NCT01021852|20694856|P6|Washout Period-Placebo|Lost to Follow-up|0
5985005|NCT01021852|20694857|P5|Washout Period-Placebo|Lost to Follow-up|1
5985006|NCT01021852|20694858|P4|Washout Period-Placebo|Lost to Follow-up|0
5985007|NCT01021852|20694859|P3|Washout Period-Placebo|Lost to Follow-up|0
5985008|NCT01021852|20694860|P2|Washout Period-Placebo|Lost to Follow-up|0
5985009|NCT01021852|20694861|P1|Washout Period-Placebo|Lost to Follow-up|0
5985010|NCT01021852|20694854|P8|Washout Period-Placebo|Adverse Event|0
5985011|NCT01021852|20694855|P7|Washout Period-Placebo|Adverse Event|0
5985012|NCT01021852|20694856|P6|Washout Period-Placebo|Adverse Event|1
5985013|NCT01021852|20694857|P5|Washout Period-Placebo|Adverse Event|0
5985014|NCT01021852|20694858|P4|Washout Period-Placebo|Adverse Event|1
5985015|NCT01021852|20694859|P3|Washout Period-Placebo|Adverse Event|0
5985016|NCT01021852|20694860|P2|Washout Period-Placebo|Adverse Event|0
5985017|NCT01021852|20694861|P1|Washout Period-Placebo|Adverse Event|0
5985018|NCT01021852|20694854|P8|Treatment Period 1|Not Treated|0
5985019|NCT01021852|20694855|P7|Treatment Period 1|Not Treated|0
5985020|NCT01021852|20694856|P6|Treatment Period 1|Not Treated|0
5985021|NCT01021852|20694857|P5|Treatment Period 1|Not Treated|0
5985022|NCT01021852|20694858|P4|Treatment Period 1|Not Treated|2
5985023|NCT01021852|20694859|P3|Treatment Period 1|Not Treated|0
5985024|NCT01021852|20694860|P2|Treatment Period 1|Not Treated|0
5985025|NCT01021852|20694861|P1|Treatment Period 1|Not Treated|0
5985026|NCT01021852|20694854|P8|Treatment Period 1|Withdrawal by Subject|1
5985027|NCT01021852|20694855|P7|Treatment Period 1|Withdrawal by Subject|0
5985028|NCT01021852|20694856|P6|Treatment Period 1|Withdrawal by Subject|0
5985029|NCT01021852|20694857|P5|Treatment Period 1|Withdrawal by Subject|1
5985030|NCT01021852|20694858|P4|Treatment Period 1|Withdrawal by Subject|0
5985031|NCT01021852|20694859|P3|Treatment Period 1|Withdrawal by Subject|0
5985032|NCT01021852|20694860|P2|Treatment Period 1|Withdrawal by Subject|0
5985033|NCT01021852|20694861|P1|Treatment Period 1|Withdrawal by Subject|0
5985034|NCT01021852|20694854|P8|Treatment Period 1|Pregnancy|0
5985035|NCT01021852|20694855|P7|Treatment Period 1|Pregnancy|0
5985036|NCT01021852|20694856|P6|Treatment Period 1|Pregnancy|0
5985037|NCT01021852|20694857|P5|Treatment Period 1|Pregnancy|0
5985038|NCT01021852|20694858|P4|Treatment Period 1|Pregnancy|0
5985039|NCT01021852|20694859|P3|Treatment Period 1|Pregnancy|1
5985040|NCT01021852|20694860|P2|Treatment Period 1|Pregnancy|0
5985041|NCT01021852|20694861|P1|Treatment Period 1|Pregnancy|0
5985042|NCT01021852|20694854|P8|Treatment Period 1|Adverse Event|0
5985043|NCT01021852|20694855|P7|Treatment Period 1|Adverse Event|0
5985044|NCT01021852|20694856|P6|Treatment Period 1|Adverse Event|2
5985045|NCT01021852|20694857|P5|Treatment Period 1|Adverse Event|2
5985046|NCT01021852|20694858|P4|Treatment Period 1|Adverse Event|0
5985047|NCT01021852|20694859|P3|Treatment Period 1|Adverse Event|1
5985048|NCT01021852|20694860|P2|Treatment Period 1|Adverse Event|1
5985049|NCT01021852|20694861|P1|Treatment Period 1|Adverse Event|3
5985050|NCT01021813|20694897|P5|DB Randomized Discontinuation Phase|Withdrawal by Subject|3
5985051|NCT01021813|20694898|P4|DB Randomized Discontinuation Phase|Withdrawal by Subject|1
5985052|NCT01021813|20694899|P3|DB Randomized Discontinuation Phase|Withdrawal by Subject|3
5985053|NCT01021813|20694900|P2|DB Randomized Discontinuation Phase|Withdrawal by Subject|0
5985054|NCT01021813|20694901|P1|DB Randomized Discontinuation Phase|Withdrawal by Subject|0
5985055|NCT01021813|20694897|P5|DB Randomized Discontinuation Phase|Protocol Violation|0
5985056|NCT01021813|20694898|P4|DB Randomized Discontinuation Phase|Protocol Violation|0
5985057|NCT01021813|20694899|P3|DB Randomized Discontinuation Phase|Protocol Violation|1
5985058|NCT01021813|20694900|P2|DB Randomized Discontinuation Phase|Protocol Violation|0
5985059|NCT01021813|20694901|P1|DB Randomized Discontinuation Phase|Protocol Violation|0
5985060|NCT01021813|20694897|P5|DB Randomized Discontinuation Phase|Lost to Follow-up|1
5985061|NCT01021813|20694898|P4|DB Randomized Discontinuation Phase|Lost to Follow-up|0
5985062|NCT01021813|20694899|P3|DB Randomized Discontinuation Phase|Lost to Follow-up|0
5985063|NCT01021813|20694900|P2|DB Randomized Discontinuation Phase|Lost to Follow-up|0
5985064|NCT01021813|20694901|P1|DB Randomized Discontinuation Phase|Lost to Follow-up|0
5985065|NCT01021813|20694897|P5|DB Randomized Discontinuation Phase|Lack of Efficacy|0
5985066|NCT01021813|20694898|P4|DB Randomized Discontinuation Phase|Lack of Efficacy|1
5985067|NCT01021813|20694899|P3|DB Randomized Discontinuation Phase|Lack of Efficacy|0
5985068|NCT01021813|20694900|P2|DB Randomized Discontinuation Phase|Lack of Efficacy|0
5985069|NCT01021813|20694901|P1|DB Randomized Discontinuation Phase|Lack of Efficacy|0
5985070|NCT01021813|20694897|P5|DB Randomized Discontinuation Phase|Adverse Event|1
5985071|NCT01021813|20694898|P4|DB Randomized Discontinuation Phase|Adverse Event|3
5985072|NCT01021813|20694899|P3|DB Randomized Discontinuation Phase|Adverse Event|0
5985073|NCT01021813|20694900|P2|DB Randomized Discontinuation Phase|Adverse Event|0
5985074|NCT01021813|20694901|P1|DB Randomized Discontinuation Phase|Adverse Event|0
5985075|NCT01021813|20694897|P5|DB Treatment Phase|Withdrawal by Subject|0
5985076|NCT01021813|20694898|P4|DB Treatment Phase|Withdrawal by Subject|0
5985077|NCT01021813|20694899|P3|DB Treatment Phase|Withdrawal by Subject|0
5985078|NCT01021813|20694900|P2|DB Treatment Phase|Withdrawal by Subject|24
5985079|NCT01021813|20694901|P1|DB Treatment Phase|Withdrawal by Subject|60
5985080|NCT01021813|20694897|P5|DB Treatment Phase|Protocol Violation|0
5985081|NCT01021813|20694898|P4|DB Treatment Phase|Protocol Violation|0
5985082|NCT01021813|20694899|P3|DB Treatment Phase|Protocol Violation|0
5985083|NCT01021813|20694900|P2|DB Treatment Phase|Protocol Violation|3
5985084|NCT01021813|20694901|P1|DB Treatment Phase|Protocol Violation|4
5985085|NCT01021813|20694897|P5|DB Treatment Phase|Pregnancy|0
5985086|NCT01021813|20694898|P4|DB Treatment Phase|Pregnancy|0
5985087|NCT01021813|20694899|P3|DB Treatment Phase|Pregnancy|0
5985088|NCT01021813|20694900|P2|DB Treatment Phase|Pregnancy|0
5985089|NCT01021813|20694901|P1|DB Treatment Phase|Pregnancy|1
5985090|NCT01021813|20694897|P5|DB Treatment Phase|Physician Decision|0
5985091|NCT01021813|20694898|P4|DB Treatment Phase|Physician Decision|0
5985092|NCT01021813|20694899|P3|DB Treatment Phase|Physician Decision|0
5985093|NCT01021813|20694900|P2|DB Treatment Phase|Physician Decision|8
5985094|NCT01021813|20694901|P1|DB Treatment Phase|Physician Decision|17
5985095|NCT01021813|20694897|P5|DB Treatment Phase|Lost to Follow-up|0
5985096|NCT01021813|20694898|P4|DB Treatment Phase|Lost to Follow-up|0
5985097|NCT01021813|20694899|P3|DB Treatment Phase|Lost to Follow-up|0
5985098|NCT01021813|20694900|P2|DB Treatment Phase|Lost to Follow-up|12
5985099|NCT01021813|20694901|P1|DB Treatment Phase|Lost to Follow-up|14
5985100|NCT01021813|20694897|P5|DB Treatment Phase|Lack of Efficacy|0
5985101|NCT01021813|20694898|P4|DB Treatment Phase|Lack of Efficacy|0
5985102|NCT01021813|20694899|P3|DB Treatment Phase|Lack of Efficacy|0
5985103|NCT01021813|20694900|P2|DB Treatment Phase|Lack of Efficacy|28
5985104|NCT01021813|20694901|P1|DB Treatment Phase|Lack of Efficacy|44
5985105|NCT01021813|20694897|P5|DB Treatment Phase|Adverse Event|0
5985106|NCT01021813|20694898|P4|DB Treatment Phase|Adverse Event|0
5985107|NCT01021813|20694899|P3|DB Treatment Phase|Adverse Event|0
5985108|NCT01021813|20694900|P2|DB Treatment Phase|Adverse Event|22
5985109|NCT01021813|20694901|P1|DB Treatment Phase|Adverse Event|60
5985110|NCT01021748|20694962|P9|Overall Study|Not Treated|0
5985111|NCT01021748|20694963|P8|Overall Study|Not Treated|0
5985112|NCT01021748|20694964|P7|Overall Study|Not Treated|0
5985113|NCT01021748|20694965|P6|Overall Study|Not Treated|0
5985114|NCT01021748|20694966|P5|Overall Study|Not Treated|0
5985115|NCT01021748|20694967|P4|Overall Study|Not Treated|0
5985116|NCT01021748|20694968|P3|Overall Study|Not Treated|0
5985117|NCT01021748|20694969|P2|Overall Study|Not Treated|1
5985118|NCT01021748|20694970|P1|Overall Study|Not Treated|0
5985119|NCT01021748|20694962|P9|Overall Study|Withdrawal by Subject|1
5985120|NCT01021748|20694963|P8|Overall Study|Withdrawal by Subject|0
5985121|NCT01021748|20694964|P7|Overall Study|Withdrawal by Subject|1
5985122|NCT01021748|20694965|P6|Overall Study|Withdrawal by Subject|0
5985123|NCT01021748|20694966|P5|Overall Study|Withdrawal by Subject|0
5985124|NCT01021748|20694967|P4|Overall Study|Withdrawal by Subject|0
5985125|NCT01021748|20694968|P3|Overall Study|Withdrawal by Subject|0
5985126|NCT01021748|20694969|P2|Overall Study|Withdrawal by Subject|0
5985127|NCT01021748|20694970|P1|Overall Study|Withdrawal by Subject|0
5985128|NCT01021748|20694962|P9|Overall Study|Progressive Disease|6
5985129|NCT01021748|20694963|P8|Overall Study|Progressive Disease|5
5985130|NCT01021748|20694964|P7|Overall Study|Progressive Disease|0
5985131|NCT01021748|20694965|P6|Overall Study|Progressive Disease|3
5985132|NCT01021748|20694966|P5|Overall Study|Progressive Disease|7
5985133|NCT01021748|20694967|P4|Overall Study|Progressive Disease|6
5985134|NCT01021748|20694968|P3|Overall Study|Progressive Disease|4
5985135|NCT01021748|20694969|P2|Overall Study|Progressive Disease|3
5985136|NCT01021748|20694970|P1|Overall Study|Progressive Disease|3
5985137|NCT01021748|20694962|P9|Overall Study|Physician Decision|2
5985138|NCT01021748|20694963|P8|Overall Study|Physician Decision|1
5985139|NCT01021748|20694964|P7|Overall Study|Physician Decision|1
5985140|NCT01021748|20694965|P6|Overall Study|Physician Decision|0
5985141|NCT01021748|20694966|P5|Overall Study|Physician Decision|0
5985142|NCT01021748|20694967|P4|Overall Study|Physician Decision|1
5985143|NCT01021748|20694968|P3|Overall Study|Physician Decision|1
5985144|NCT01021748|20694969|P2|Overall Study|Physician Decision|0
5985145|NCT01021748|20694970|P1|Overall Study|Physician Decision|1
5985146|NCT01021748|20694962|P9|Overall Study|Adverse Event|7
5985147|NCT01021748|20694963|P8|Overall Study|Adverse Event|0
5985148|NCT01021748|20694964|P7|Overall Study|Adverse Event|1
5985149|NCT01021748|20694965|P6|Overall Study|Adverse Event|0
5985150|NCT01021748|20694966|P5|Overall Study|Adverse Event|2
5985151|NCT01021748|20694967|P4|Overall Study|Adverse Event|0
5985152|NCT01021748|20694968|P3|Overall Study|Adverse Event|2
5985153|NCT01021748|20694969|P2|Overall Study|Adverse Event|1
5985154|NCT01021748|20694970|P1|Overall Study|Adverse Event|2
5985155|NCT01021683|20695017|P1|Overall Study|Other|8
5985156|NCT01021683|20695017|P1|Overall Study|Recovery of neutrophil count|51
5985157|NCT01021683|20695017|P1|Overall Study|Lack of Efficacy|12
5985158|NCT01021553|20695043|P3|Overall Study|Withdrawal by Subject|0
5985159|NCT01021553|20695044|P2|Overall Study|Withdrawal by Subject|1
5985160|NCT01021553|20695045|P1|Overall Study|Withdrawal by Subject|1
5985161|NCT01021553|20695043|P3|Overall Study|Lost to Follow-up|1
5985162|NCT01021553|20695044|P2|Overall Study|Lost to Follow-up|0
5985163|NCT01021553|20695045|P1|Overall Study|Lost to Follow-up|0
5985164|NCT01021553|20695043|P3|Overall Study|Protocol Violation|2
5985165|NCT01021553|20695044|P2|Overall Study|Protocol Violation|2
5985166|NCT01021553|20695045|P1|Overall Study|Protocol Violation|0
5985167|NCT01021553|20695043|P3|Overall Study|Lack of Efficacy|0
5985168|NCT01021553|20695044|P2|Overall Study|Lack of Efficacy|2
5985169|NCT01021553|20695045|P1|Overall Study|Lack of Efficacy|2
5985170|NCT01021553|20695043|P3|Overall Study|Adverse Event|0
5985171|NCT01021553|20695044|P2|Overall Study|Adverse Event|0
5985172|NCT01021553|20695045|P1|Overall Study|Adverse Event|1
5985173|NCT01021423|20695099|P2|Overall Study|Study terminated|5
5985174|NCT01021423|20695100|P1|Overall Study|Study terminated|4
5985175|NCT01021332|20695116|P1|Overall Study|Miscellaneous|3
5985176|NCT01021332|20695116|P1|Overall Study|Protocol Violation|9
5985177|NCT01021332|20695116|P1|Overall Study|Lost to Follow-up|4
5985178|NCT01021332|20695116|P1|Overall Study|Withdrawal of Consent|23
5985179|NCT01021332|20695116|P1|Overall Study|Lack of Efficacy|19
5985180|NCT01021332|20695116|P1|Overall Study|Adverse Event|43
5985181|NCT01021332|20695116|P1|Overall Study|Not fulfilling incl./excl.criteria|5
5985182|NCT01021293|20695177|P2|Overall Study|Lost to Follow-up|1
5985183|NCT01021293|20695178|P1|Overall Study|Lost to Follow-up|1
5985184|NCT01021293|20695177|P2|Overall Study|Migrated/moved from study area|18
5985185|NCT01021293|20695178|P1|Overall Study|Migrated/moved from study area|6
5985186|NCT01021293|20695177|P2|Overall Study|Withdrawal by Subject|3
5985187|NCT01021293|20695178|P1|Overall Study|Withdrawal by Subject|1
5985188|NCT01021293|20695177|P2|Overall Study|Adverse Event|1
5985189|NCT01021293|20695178|P1|Overall Study|Adverse Event|2
5985190|NCT01021293|20695177|P2|Overall Study|Serious Adverse Event|1
5985191|NCT01021293|20695178|P1|Overall Study|Serious Adverse Event|2
5985192|NCT01021215|20695197|P2|Overall Study|Lost to Follow-up|0
5985193|NCT01021215|20695198|P1|Overall Study|Lost to Follow-up|3
5985194|NCT01021137|20695212|P4|Overall Study|Withdrawal by Subject|3
5985195|NCT01021137|20695213|P3|Overall Study|Withdrawal by Subject|0
5985196|NCT01021137|20695214|P2|Overall Study|Withdrawal by Subject|0
5985197|NCT01021137|20695215|P1|Overall Study|Withdrawal by Subject|1
5985198|NCT01021137|20695212|P4|Overall Study|Lost to Follow-up|6
5985199|NCT01021137|20695213|P3|Overall Study|Lost to Follow-up|2
5985200|NCT01021137|20695214|P2|Overall Study|Lost to Follow-up|4
5985201|NCT01021137|20695215|P1|Overall Study|Lost to Follow-up|9
5985202|NCT01021020|20695258|P1|14 Day Washout Period A|Physician Decision|1
5985203|NCT01021020|20695258|P1|Period I|Withdrawal by Subject|1
5985204|NCT01021020|20695258|P1|Period I|Protocol Violation|1
5985205|NCT01021007|20695274|P2|Overall Study|Adverse Event|3
5985206|NCT01021007|20695275|P1|Overall Study|Adverse Event|1
5985207|NCT01021007|20695274|P2|Overall Study|Lost to Follow-up|1
5985208|NCT01021007|20695275|P1|Overall Study|Lost to Follow-up|1
5985209|NCT01020981|20695287|P2|Overall Study|Participant declined to complete survey|0
5985210|NCT01020981|20695288|P1|Overall Study|Participant declined to complete survey|2
5985211|NCT01020981|20695287|P2|Overall Study|Survey returned undeliverable|32
5985212|NCT01020981|20695288|P1|Overall Study|Survey returned undeliverable|8
5985213|NCT01020981|20695287|P2|Overall Study|Did not return mailed survey|58
5985214|NCT01020981|20695288|P1|Overall Study|Did not return mailed survey|74
5985215|NCT01020877|20695309|P2|Second Intervention|Withdrawal by Subject|0
5985216|NCT01020877|20695310|P1|Second Intervention|Withdrawal by Subject|1
5985217|NCT01020838|20695320|P1|Overall Study|Most common: Study ended by sponsor|77
5985218|NCT01020838|20695320|P1|Overall Study|Lost to Follow-up|6
5985219|NCT01020838|20695320|P1|Overall Study|Withdrawal by Subject|9
5985220|NCT01020838|20695320|P1|Overall Study|Adverse Event|1
5985221|NCT01020838|20695320|P1|Overall Study|Death|90
5985222|NCT01020812|20695335|P1|Overall Study|Protocol Violation|1
5985223|NCT01020812|20695335|P1|Overall Study|Withdrawal by Subject|1
5985224|NCT01020812|20695335|P1|Overall Study|Physician Decision|1
5985225|NCT01020799|20695345|P3|Overall Study|Lost to Follow-up|2
5985226|NCT01020799|20695346|P2|Overall Study|Lost to Follow-up|4
5985227|NCT01020799|20695347|P1|Overall Study|Lost to Follow-up|6
5985228|NCT01020799|20695345|P3|Overall Study|Withdrawal by Subject|3
5985229|NCT01020799|20695346|P2|Overall Study|Withdrawal by Subject|2
5985230|NCT01020799|20695347|P1|Overall Study|Withdrawal by Subject|2
5985231|NCT01020799|20695345|P3|Overall Study|Protocol Violation|0
5985232|NCT01020799|20695346|P2|Overall Study|Protocol Violation|2
5985233|NCT01020799|20695347|P1|Overall Study|Protocol Violation|3
5985234|NCT01020799|20695345|P3|Overall Study|non-compliance; lack of efficacy; etc.|0
5985235|NCT01020799|20695346|P2|Overall Study|non-compliance; lack of efficacy; etc.|3
5985236|NCT01020799|20695347|P1|Overall Study|non-compliance; lack of efficacy; etc.|4
5985237|NCT01020799|20695345|P3|Overall Study|Adverse Event|2
5985238|NCT01020799|20695346|P2|Overall Study|Adverse Event|3
5985239|NCT01020799|20695347|P1|Overall Study|Adverse Event|4
5985240|NCT01020786|20695370|P1|Maintenance Period|Sponsor Decision|1
5985241|NCT01020786|20695370|P1|Maintenance Period|Withdrawal by Subject|8
5985242|NCT01020786|20695370|P1|Maintenance Period|Progressive Disease|43
5985243|NCT01020786|20695370|P1|Maintenance Period|Adverse Event|8
5985244|NCT01020786|20695370|P1|Induction Period|Withdrawal by Subject|3
5985245|NCT01020786|20695370|P1|Induction Period|Investigator Decision|3
5985246|NCT01020786|20695370|P1|Induction Period|Progressive Disease|31
5985247|NCT01020786|20695370|P1|Induction Period|Adverse Event|10
5985248|NCT01020786|20695370|P1|Induction Period|Entry Criteria Not Met|2
5985249|NCT01020773|20695384|P2|Overall Study|Withdrawal by Subject|3
5985250|NCT01020773|20695385|P1|Overall Study|Withdrawal by Subject|4
5985251|NCT01020747|20695391|P1|Overall Study|Withdrawal by Subject|1
5985252|NCT01020448|20695407|P1|Treatment|Lost to Follow-up|2
5985253|NCT01020448|20695407|P1|Treatment|Lack of Efficacy|8
5985254|NCT01020448|20695407|P1|Treatment|Disease Progression|2
5985255|NCT01020448|20695407|P1|Treatment|Consent Withdrawn|3
5985256|NCT01020448|20695407|P1|Treatment|Adverse Event|11
5985257|NCT01020448|20695407|P1|Pre-assignment|Does Not Meet Entry Criteria|2
5985258|NCT01020448|20695407|P1|Pre-assignment|Withdrawal by Subject|5
5985259|NCT01020448|20695407|P1|Pre-assignment|Adverse Event|6
5985260|NCT01020435|20695418|P2|Overall Study|Lost to Follow-up|1
5985261|NCT01020435|20695419|P1|Overall Study|Lost to Follow-up|0
5985262|NCT01020305|20695427|P1|Overall Study|Adverse Event|2
5985263|NCT01020123|20695438|P7|Extention Period|Lost to Follow-up|0
5985264|NCT01020123|20695439|P6|Extention Period|Lost to Follow-up|2
5985265|NCT01020123|20695440|P5|Extention Period|Lost to Follow-up|0
5985266|NCT01020123|20695441|P4|Extention Period|Lost to Follow-up|0
5985267|NCT01020123|20695442|P3|Extention Period|Lost to Follow-up|0
5985268|NCT01020123|20695443|P2|Extention Period|Lost to Follow-up|0
5985269|NCT01020123|20695444|P1|Extention Period|Lost to Follow-up|0
5985270|NCT01020123|20695438|P7|Extention Period|Protocol Violation|1
5985271|NCT01020123|20695439|P6|Extention Period|Protocol Violation|0
5985272|NCT01020123|20695440|P5|Extention Period|Protocol Violation|0
5985273|NCT01020123|20695441|P4|Extention Period|Protocol Violation|0
5985274|NCT01020123|20695442|P3|Extention Period|Protocol Violation|1
5985275|NCT01020123|20695443|P2|Extention Period|Protocol Violation|1
5985276|NCT01020123|20695444|P1|Extention Period|Protocol Violation|1
5985277|NCT01020123|20695438|P7|Extention Period|Adverse Event|0
5985278|NCT01020123|20695439|P6|Extention Period|Adverse Event|0
5985279|NCT01020123|20695440|P5|Extention Period|Adverse Event|0
5985280|NCT01020123|20695441|P4|Extention Period|Adverse Event|1
5985281|NCT01020123|20695442|P3|Extention Period|Adverse Event|0
5985282|NCT01020123|20695443|P2|Extention Period|Adverse Event|0
5985283|NCT01020123|20695444|P1|Extention Period|Adverse Event|0
5985284|NCT01020123|20695438|P7|Extention Period|Withdrawal by Subject|0
5985285|NCT01020123|20695439|P6|Extention Period|Withdrawal by Subject|0
5985286|NCT01020123|20695440|P5|Extention Period|Withdrawal by Subject|0
5985287|NCT01020123|20695441|P4|Extention Period|Withdrawal by Subject|0
5985288|NCT01020123|20695442|P3|Extention Period|Withdrawal by Subject|1
5985289|NCT01020123|20695443|P2|Extention Period|Withdrawal by Subject|1
5985290|NCT01020123|20695444|P1|Extention Period|Withdrawal by Subject|2
5985291|NCT01020123|20695438|P7|Main Period|Unclasified|6
5985292|NCT01020123|20695439|P6|Main Period|Unclasified|3
5985293|NCT01020123|20695440|P5|Main Period|Unclasified|1
5985294|NCT01020123|20695441|P4|Main Period|Unclasified|0
5985295|NCT01020123|20695442|P3|Main Period|Unclasified|1
5985296|NCT01020123|20695443|P2|Main Period|Unclasified|0
5985297|NCT01020123|20695444|P1|Main Period|Unclasified|2
5985298|NCT01020123|20695438|P7|Main Period|Lost to Follow-up|0
5985299|NCT01020123|20695439|P6|Main Period|Lost to Follow-up|0
5985300|NCT01020123|20695440|P5|Main Period|Lost to Follow-up|0
5985301|NCT01020123|20695441|P4|Main Period|Lost to Follow-up|0
5985302|NCT01020123|20695442|P3|Main Period|Lost to Follow-up|0
5985303|NCT01020123|20695443|P2|Main Period|Lost to Follow-up|2
5985304|NCT01020123|20695444|P1|Main Period|Lost to Follow-up|0
5985305|NCT01020123|20695438|P7|Main Period|Protocol Violation|2
5985306|NCT01020123|20695439|P6|Main Period|Protocol Violation|3
5985307|NCT01020123|20695440|P5|Main Period|Protocol Violation|2
5985308|NCT01020123|20695441|P4|Main Period|Protocol Violation|5
5985309|NCT01020123|20695442|P3|Main Period|Protocol Violation|2
5985310|NCT01020123|20695443|P2|Main Period|Protocol Violation|4
5985311|NCT01020123|20695444|P1|Main Period|Protocol Violation|4
5985312|NCT01020123|20695438|P7|Main Period|Adverse Event|1
5985313|NCT01020123|20695439|P6|Main Period|Adverse Event|2
5985314|NCT01020123|20695440|P5|Main Period|Adverse Event|1
5985315|NCT01020123|20695441|P4|Main Period|Adverse Event|1
5985316|NCT01020123|20695442|P3|Main Period|Adverse Event|2
5985317|NCT01020123|20695443|P2|Main Period|Adverse Event|2
5985318|NCT01020123|20695444|P1|Main Period|Adverse Event|5
5985319|NCT01020123|20695438|P7|Main Period|Eligibility Criteria not fullfilled|0
5985320|NCT01020123|20695439|P6|Main Period|Eligibility Criteria not fullfilled|0
5985321|NCT01020123|20695440|P5|Main Period|Eligibility Criteria not fullfilled|1
5985322|NCT01020123|20695441|P4|Main Period|Eligibility Criteria not fullfilled|0
5985323|NCT01020123|20695442|P3|Main Period|Eligibility Criteria not fullfilled|0
5985324|NCT01020123|20695443|P2|Main Period|Eligibility Criteria not fullfilled|1
5985325|NCT01020123|20695444|P1|Main Period|Eligibility Criteria not fullfilled|0
5985326|NCT01020123|20695438|P7|Main Period|Withdrawal by Subject|2
5985327|NCT01020123|20695439|P6|Main Period|Withdrawal by Subject|3
5985328|NCT01020123|20695440|P5|Main Period|Withdrawal by Subject|6
5985329|NCT01020123|20695441|P4|Main Period|Withdrawal by Subject|1
5985330|NCT01020123|20695442|P3|Main Period|Withdrawal by Subject|3
5985331|NCT01020123|20695443|P2|Main Period|Withdrawal by Subject|5
5985332|NCT01020123|20695444|P1|Main Period|Withdrawal by Subject|6
5985333|NCT01020019|20695639|P2|Overall Study|moving|2
5985334|NCT01020019|20695640|P1|Overall Study|moving|0
5985335|NCT01020019|20695639|P2|Overall Study|not interested in treatment|4
5985336|NCT01020019|20695640|P1|Overall Study|not interested in treatment|4
5985337|NCT01020019|20695639|P2|Overall Study|Adverse Event|5
5985338|NCT01020019|20695640|P1|Overall Study|Adverse Event|1
5985339|NCT01020019|20695639|P2|Overall Study|Lost to Follow-up|18
5985340|NCT01020019|20695640|P1|Overall Study|Lost to Follow-up|21
5985341|NCT01019980|20695661|P2|Overall Study|Drug not available.|0
5985342|NCT01019980|20695662|P1|Overall Study|Drug not available.|2
5985343|NCT01019694|20695725|P3|Overall Study|Other reason (not specified)|6
5985344|NCT01019694|20695726|P2|Overall Study|Other reason (not specified)|5
5985345|NCT01019694|20695727|P1|Overall Study|Other reason (not specified)|1
5985346|NCT01019694|20695725|P3|Overall Study|Not treated|3
5985347|NCT01019694|20695726|P2|Overall Study|Not treated|2
5985348|NCT01019694|20695727|P1|Overall Study|Not treated|0
5985349|NCT01019694|20695725|P3|Overall Study|Withdrawal by Subject|12
5985350|NCT01019694|20695726|P2|Overall Study|Withdrawal by Subject|6
5985351|NCT01019694|20695727|P1|Overall Study|Withdrawal by Subject|4
5985352|NCT01019694|20695725|P3|Overall Study|Lost to Follow-up|3
5985353|NCT01019694|20695726|P2|Overall Study|Lost to Follow-up|3
5985354|NCT01019694|20695727|P1|Overall Study|Lost to Follow-up|5
5985355|NCT01019694|20695725|P3|Overall Study|Protocol Violation|4
5985356|NCT01019694|20695726|P2|Overall Study|Protocol Violation|6
5985357|NCT01019694|20695727|P1|Overall Study|Protocol Violation|2
5985358|NCT01019694|20695725|P3|Overall Study|Adverse Event|19
5985359|NCT01019694|20695726|P2|Overall Study|Adverse Event|16
5985360|NCT01019694|20695727|P1|Overall Study|Adverse Event|12
5985361|NCT01019486|20695852|P3|Overall Study|Withdrawal by Subject|1
5985362|NCT01019486|20695853|P2|Overall Study|Withdrawal by Subject|1
5985363|NCT01019486|20695854|P1|Overall Study|Withdrawal by Subject|1
5985364|NCT01019369|20695868|P2|Overall Study|Withdrawal by Subject|1
5985365|NCT01019369|20695869|P1|Overall Study|Withdrawal by Subject|0
5985366|NCT01019369|20695868|P2|Overall Study|Lost to Follow-up|6
5985367|NCT01019369|20695869|P1|Overall Study|Lost to Follow-up|10
5985368|NCT01019317|20695885|P1|Overall Study|Not Eligible|4
5985369|NCT01019252|20695891|P2|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|5
5985370|NCT01019252|20695892|P1|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|0
5985371|NCT01019252|20695891|P2|Wait List Cross-over to CBT for ADHD|Time constraints|2
5985372|NCT01019252|20695892|P1|Wait List Cross-over to CBT for ADHD|Time constraints|0
5985373|NCT01019252|20695891|P2|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|0
5985374|NCT01019252|20695892|P1|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|1
5985375|NCT01019252|20695891|P2|Initial CBT for ADHD vs. Wait List|Time constraints|0
5985376|NCT01019252|20695892|P1|Initial CBT for ADHD vs. Wait List|Time constraints|2
5985377|NCT01019135|20695905|P3|Overall Study|Did not attend CR|6
5985378|NCT01019135|20695906|P2|Overall Study|Did not attend CR|13
5985379|NCT01019135|20695907|P1|Overall Study|Did not attend CR|8
5985380|NCT01019135|20695905|P3|Overall Study|Did not receive allocated intervention|25
5985381|NCT01019135|20695906|P2|Overall Study|Did not receive allocated intervention|6
5985382|NCT01019135|20695907|P1|Overall Study|Did not receive allocated intervention|12
5985383|NCT01018992|20695935|P2|Overall Study|Lost to Follow-up|1
5985384|NCT01018992|20695936|P1|Overall Study|Lost to Follow-up|5
5985385|NCT01018992|20695935|P2|Overall Study|Protocol Violation|4
5985386|NCT01018992|20695936|P1|Overall Study|Protocol Violation|0
5985387|NCT01018992|20695935|P2|Overall Study|Withdrawal by Subject|8
5985388|NCT01018992|20695936|P1|Overall Study|Withdrawal by Subject|3
5985389|NCT01018992|20695935|P2|Overall Study|Adverse Event|3
5985390|NCT01018992|20695936|P1|Overall Study|Adverse Event|8
5985391|NCT01018979|20695950|P2|Overall Study|Not received at least one dose|1
5985392|NCT01018979|20695951|P1|Overall Study|Not received at least one dose|0
5985393|NCT01018979|20695950|P2|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|9
5985394|NCT01018979|20695951|P1|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|3
5985395|NCT01018953|20695981|P1|Overall Study|Study termination by sponsor|5
5985396|NCT01018953|20695981|P1|Overall Study|Withdrawal by Subject|1
5985397|NCT01018953|20695981|P1|Overall Study|Adverse Event|2
5985398|NCT01018862|20695994|P3|Overall Study|administrative problems|4
5985399|NCT01018862|20695995|P2|Overall Study|administrative problems|4
5985400|NCT01018862|20695996|P1|Overall Study|administrative problems|5
5985401|NCT01018862|20695994|P3|Overall Study|Withdrawal by Subject|1
5985402|NCT01018862|20695995|P2|Overall Study|Withdrawal by Subject|2
5985403|NCT01018862|20695996|P1|Overall Study|Withdrawal by Subject|1
5985404|NCT01018862|20695994|P3|Overall Study|Protocol Violation|3
5985405|NCT01018862|20695995|P2|Overall Study|Protocol Violation|3
5985406|NCT01018862|20695996|P1|Overall Study|Protocol Violation|1
5985407|NCT01018862|20695994|P3|Overall Study|Lost to Follow-up|0
5985408|NCT01018862|20695995|P2|Overall Study|Lost to Follow-up|1
5985409|NCT01018862|20695996|P1|Overall Study|Lost to Follow-up|3
5985410|NCT01018862|20695994|P3|Overall Study|Lack of Efficacy|2
5985411|NCT01018862|20695995|P2|Overall Study|Lack of Efficacy|0
5985412|NCT01018862|20695996|P1|Overall Study|Lack of Efficacy|1
5985413|NCT01018862|20695994|P3|Overall Study|Adverse Event|6
5985414|NCT01018862|20695995|P2|Overall Study|Adverse Event|0
5985415|NCT01018862|20695996|P1|Overall Study|Adverse Event|2
5985416|NCT01018810|20696018|P5|Overall Study|Sponsor Decision|1
5985417|NCT01018810|20696019|P4|Overall Study|Sponsor Decision|1
5985418|NCT01018810|20696020|P3|Overall Study|Sponsor Decision|1
5985419|NCT01018810|20696021|P2|Overall Study|Sponsor Decision|0
5985420|NCT01018810|20696022|P1|Overall Study|Sponsor Decision|2
5985421|NCT01018810|20696018|P5|Overall Study|Withdrawal by Subject|0
5985422|NCT01018810|20696019|P4|Overall Study|Withdrawal by Subject|0
5985423|NCT01018810|20696020|P3|Overall Study|Withdrawal by Subject|0
5985424|NCT01018810|20696021|P2|Overall Study|Withdrawal by Subject|1
5985425|NCT01018810|20696022|P1|Overall Study|Withdrawal by Subject|0
5985426|NCT01018732|20696082|P3|Overall Study|Unable to Classify|1
5985427|NCT01018732|20696083|P2|Overall Study|Unable to Classify|0
5985428|NCT01018732|20696084|P1|Overall Study|Unable to Classify|0
5985429|NCT01018732|20696082|P3|Overall Study|Inappropriate Enrollment|0
5985430|NCT01018732|20696083|P2|Overall Study|Inappropriate Enrollment|1
5985431|NCT01018732|20696084|P1|Overall Study|Inappropriate Enrollment|0
5985432|NCT01018732|20696082|P3|Overall Study|Protocol Violation|0
5985433|NCT01018732|20696083|P2|Overall Study|Protocol Violation|1
5985434|NCT01018732|20696084|P1|Overall Study|Protocol Violation|1
5985435|NCT01018732|20696082|P3|Overall Study|Lost to Follow-up|3
5985436|NCT01018732|20696083|P2|Overall Study|Lost to Follow-up|0
5985437|NCT01018732|20696084|P1|Overall Study|Lost to Follow-up|0
5985438|NCT01018680|20696118|P2|Overall Study|Physician Decision|1
5985439|NCT01018680|20696119|P1|Overall Study|Physician Decision|3
5985440|NCT01018680|20696118|P2|Overall Study|Entry Criteria Not Met|4
5985441|NCT01018680|20696119|P1|Overall Study|Entry Criteria Not Met|1
5985442|NCT01018680|20696118|P2|Overall Study|Lost to Follow-up|3
5985443|NCT01018680|20696119|P1|Overall Study|Lost to Follow-up|5
5985444|NCT01018680|20696118|P2|Overall Study|Lack of Efficacy|2
5985445|NCT01018680|20696119|P1|Overall Study|Lack of Efficacy|8
5985446|NCT01018680|20696118|P2|Overall Study|Sponsor Decision|7
5985447|NCT01018680|20696119|P1|Overall Study|Sponsor Decision|6
5985448|NCT01018680|20696118|P2|Overall Study|Protocol Violation|8
5985449|NCT01018680|20696119|P1|Overall Study|Protocol Violation|5
5985450|NCT01018680|20696118|P2|Overall Study|Withdrawal by Subject|10
5985451|NCT01018680|20696119|P1|Overall Study|Withdrawal by Subject|10
5985452|NCT01018680|20696118|P2|Overall Study|Adverse Event|40
5985453|NCT01018680|20696119|P1|Overall Study|Adverse Event|23
5985454|NCT01020487|20696162|P3|Part 2 Open-label Period|Adverse Event|1
5985455|NCT01020487|20696163|P2|Part 2 Open-label Period|Adverse Event|4
5985456|NCT01020487|20696164|P1|Part 2 Open-label Period|Adverse Event|0
5985457|NCT01020487|20696162|P3|Part 2 Double-blind Treatment Period|Randomized in Error|1
5985458|NCT01020487|20696163|P2|Part 2 Double-blind Treatment Period|Randomized in Error|0
5985459|NCT01020487|20696164|P1|Part 2 Double-blind Treatment Period|Randomized in Error|0
5985460|NCT01020487|20696162|P3|Part 2 Double-blind Treatment Period|Required a Dose Reduction|3
5985461|NCT01020487|20696163|P2|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0
5985462|NCT01020487|20696164|P1|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0
5985463|NCT01020487|20696162|P3|Part 2 Double-blind Treatment Period|Withdrawal by Subject|1
5985464|NCT01020487|20696163|P2|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0
5985465|NCT01020487|20696164|P1|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0
5985466|NCT01020487|20696162|P3|Part 2 Double-blind Treatment Period|Adverse Event|1
5985467|NCT01020487|20696163|P2|Part 2 Double-blind Treatment Period|Adverse Event|2
5985468|NCT01020487|20696164|P1|Part 2 Double-blind Treatment Period|Adverse Event|0
5985469|NCT01018511|20696189|P4|Overall Study|Miscellaneous|0
5985470|NCT01018511|20696190|P3|Overall Study|Miscellaneous|0
5985471|NCT01018511|20696191|P2|Overall Study|Miscellaneous|2
5985472|NCT01018511|20696192|P1|Overall Study|Miscellaneous|0
5985473|NCT01018511|20696189|P4|Overall Study|Protocol Violation|9
5985474|NCT01018511|20696190|P3|Overall Study|Protocol Violation|7
5985475|NCT01018511|20696191|P2|Overall Study|Protocol Violation|8
5985476|NCT01018511|20696192|P1|Overall Study|Protocol Violation|5
5985477|NCT01018511|20696189|P4|Overall Study|Lost to Follow-up|0
5985478|NCT01018511|20696190|P3|Overall Study|Lost to Follow-up|1
5985479|NCT01018511|20696191|P2|Overall Study|Lost to Follow-up|0
5985480|NCT01018511|20696192|P1|Overall Study|Lost to Follow-up|0
5985481|NCT01018511|20696189|P4|Overall Study|Withdrawal by Subject|9
5985482|NCT01018511|20696190|P3|Overall Study|Withdrawal by Subject|11
5985483|NCT01018511|20696191|P2|Overall Study|Withdrawal by Subject|5
5985484|NCT01018511|20696192|P1|Overall Study|Withdrawal by Subject|6
5985485|NCT01018511|20696189|P4|Overall Study|Lack of Efficacy|2
5985486|NCT01018511|20696190|P3|Overall Study|Lack of Efficacy|1
5985487|NCT01018511|20696191|P2|Overall Study|Lack of Efficacy|1
5985488|NCT01018511|20696192|P1|Overall Study|Lack of Efficacy|4
5985489|NCT01018511|20696189|P4|Overall Study|Adverse Event|10
5985490|NCT01018511|20696190|P3|Overall Study|Adverse Event|13
5985491|NCT01018511|20696191|P2|Overall Study|Adverse Event|9
5985492|NCT01018511|20696192|P1|Overall Study|Adverse Event|5
5985493|NCT01018511|20696189|P4|Overall Study|Not fulfilling eligibility criteria|3
5985494|NCT01018511|20696190|P3|Overall Study|Not fulfilling eligibility criteria|7
5985495|NCT01018511|20696191|P2|Overall Study|Not fulfilling eligibility criteria|7
5985496|NCT01018511|20696192|P1|Overall Study|Not fulfilling eligibility criteria|6
5985497|NCT01018394|20696389|P2|Overall Study|Lost to Follow-up|3
5985498|NCT01018394|20696390|P1|Overall Study|Lost to Follow-up|4
5985499|NCT01018394|20696389|P2|Overall Study|Withdrawal by Subject|5
5985500|NCT01018394|20696390|P1|Overall Study|Withdrawal by Subject|5
5985501|NCT01018264|20696400|P2|Overall Study|Lost to Follow-up|1
5985502|NCT01018264|20696401|P1|Overall Study|Lost to Follow-up|0
5985503|NCT01018264|20696400|P2|Overall Study|Withdrawal by Subject|0
5985504|NCT01018264|20696401|P1|Overall Study|Withdrawal by Subject|1
5985505|NCT01018186|20696418|P4|52-week Double-blind Treatment Period|Withdrawal by Subject|9
5985506|NCT01018186|20696419|P3|52-week Double-blind Treatment Period|Withdrawal by Subject|7
5985507|NCT01018186|20696420|P2|52-week Double-blind Treatment Period|Withdrawal by Subject|10
5985508|NCT01018186|20696421|P1|52-week Double-blind Treatment Period|Withdrawal by Subject|0
5985509|NCT01018186|20696418|P4|52-week Double-blind Treatment Period|Physician Decision|3
5985510|NCT01018186|20696419|P3|52-week Double-blind Treatment Period|Physician Decision|0
5985511|NCT01018186|20696420|P2|52-week Double-blind Treatment Period|Physician Decision|1
5985512|NCT01018186|20696421|P1|52-week Double-blind Treatment Period|Physician Decision|0
5985513|NCT01018186|20696418|P4|52-week Double-blind Treatment Period|Lost to Follow-up|4
5985514|NCT01018186|20696419|P3|52-week Double-blind Treatment Period|Lost to Follow-up|3
5985515|NCT01018186|20696420|P2|52-week Double-blind Treatment Period|Lost to Follow-up|1
5985516|NCT01018186|20696421|P1|52-week Double-blind Treatment Period|Lost to Follow-up|0
5985517|NCT01018186|20696418|P4|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|4
5985518|NCT01018186|20696419|P3|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|16
5985519|NCT01018186|20696420|P2|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|14
5985520|NCT01018186|20696421|P1|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|0
5985521|NCT01018186|20696418|P4|52-week Double-blind Treatment Period|Protocol Violation|2
5985522|NCT01018186|20696419|P3|52-week Double-blind Treatment Period|Protocol Violation|8
5985523|NCT01018186|20696420|P2|52-week Double-blind Treatment Period|Protocol Violation|8
5985524|NCT01018186|20696421|P1|52-week Double-blind Treatment Period|Protocol Violation|0
5985525|NCT01018186|20696418|P4|52-week Double-blind Treatment Period|Lack of Efficacy|1
5985526|NCT01018186|20696419|P3|52-week Double-blind Treatment Period|Lack of Efficacy|4
5985527|NCT01018186|20696420|P2|52-week Double-blind Treatment Period|Lack of Efficacy|1
5985528|NCT01018186|20696421|P1|52-week Double-blind Treatment Period|Lack of Efficacy|0
5985529|NCT01018186|20696418|P4|52-week Double-blind Treatment Period|Adverse Event|6
5985530|NCT01018186|20696419|P3|52-week Double-blind Treatment Period|Adverse Event|3
5985531|NCT01018186|20696420|P2|52-week Double-blind Treatment Period|Adverse Event|5
5985532|NCT01018186|20696421|P1|52-week Double-blind Treatment Period|Adverse Event|0
5985533|NCT01018186|20696418|P4|2-week Run-in Period|Did Not Meet Continuation Criteria|0
5985534|NCT01018186|20696419|P3|2-week Run-in Period|Did Not Meet Continuation Criteria|0
5985535|NCT01018186|20696420|P2|2-week Run-in Period|Did Not Meet Continuation Criteria|0
5985536|NCT01018186|20696421|P1|2-week Run-in Period|Did Not Meet Continuation Criteria|97
5985537|NCT01018186|20696418|P4|2-week Run-in Period|Withdrawal by Subject|0
5985538|NCT01018186|20696419|P3|2-week Run-in Period|Withdrawal by Subject|0
5985539|NCT01018186|20696420|P2|2-week Run-in Period|Withdrawal by Subject|0
5985540|NCT01018186|20696421|P1|2-week Run-in Period|Withdrawal by Subject|11
5985541|NCT01018186|20696418|P4|2-week Run-in Period|Physician Decision|0
5985542|NCT01018186|20696419|P3|2-week Run-in Period|Physician Decision|0
5985543|NCT01018186|20696420|P2|2-week Run-in Period|Physician Decision|0
5985544|NCT01018186|20696421|P1|2-week Run-in Period|Physician Decision|3
5985545|NCT01018186|20696418|P4|2-week Run-in Period|Lost to Follow-up|0
5985546|NCT01018186|20696419|P3|2-week Run-in Period|Lost to Follow-up|0
5985547|NCT01018186|20696420|P2|2-week Run-in Period|Lost to Follow-up|0
5985548|NCT01018186|20696421|P1|2-week Run-in Period|Lost to Follow-up|2
5985549|NCT01018186|20696418|P4|2-week Run-in Period|Protocol Violation|0
5985550|NCT01018186|20696419|P3|2-week Run-in Period|Protocol Violation|0
5985551|NCT01018186|20696420|P2|2-week Run-in Period|Protocol Violation|0
5985552|NCT01018186|20696421|P1|2-week Run-in Period|Protocol Violation|1
5985553|NCT01018030|20696622|P3|Overall Study|Did Not Receive Study Drug|0
5985554|NCT01018030|20696623|P2|Overall Study|Did Not Receive Study Drug|3
5985555|NCT01018030|20696624|P1|Overall Study|Did Not Receive Study Drug|1
5985556|NCT01018030|20696622|P3|Overall Study|Lack of Efficacy|0
5985557|NCT01018030|20696623|P2|Overall Study|Lack of Efficacy|0
5985558|NCT01018030|20696624|P1|Overall Study|Lack of Efficacy|1
5985559|NCT01018030|20696622|P3|Overall Study|Physician Decision|1
5985560|NCT01018030|20696623|P2|Overall Study|Physician Decision|0
5985561|NCT01018030|20696624|P1|Overall Study|Physician Decision|1
5985562|NCT01018030|20696622|P3|Overall Study|Protocol Violation|0
5985563|NCT01018030|20696623|P2|Overall Study|Protocol Violation|1
5985564|NCT01018030|20696624|P1|Overall Study|Protocol Violation|2
5985565|NCT01018030|20696622|P3|Overall Study|Lost to Follow-up|3
5985566|NCT01018030|20696623|P2|Overall Study|Lost to Follow-up|0
5985567|NCT01018030|20696624|P1|Overall Study|Lost to Follow-up|2
5985568|NCT01018030|20696622|P3|Overall Study|Withdrawal by Subject|4
5985569|NCT01018030|20696623|P2|Overall Study|Withdrawal by Subject|2
5985570|NCT01018030|20696624|P1|Overall Study|Withdrawal by Subject|2
5985571|NCT01018030|20696622|P3|Overall Study|Adverse Event|5
5985572|NCT01018030|20696623|P2|Overall Study|Adverse Event|5
5985573|NCT01018030|20696624|P1|Overall Study|Adverse Event|10
5985574|NCT01017952|20696675|P5|52-week, Double-blind Treatment Period|Physician Decision|7
5985575|NCT01017952|20696676|P4|52-week, Double-blind Treatment Period|Physician Decision|9
5985576|NCT01017952|20696677|P3|52-week, Double-blind Treatment Period|Physician Decision|8
5985577|NCT01017952|20696678|P2|52-week, Double-blind Treatment Period|Physician Decision|10
5985578|NCT01017952|20696679|P1|52-week, Double-blind Treatment Period|Physician Decision|0
5985579|NCT01017952|20696675|P5|52-week, Double-blind Treatment Period|Lost to Follow-up|10
5985580|NCT01017952|20696676|P4|52-week, Double-blind Treatment Period|Lost to Follow-up|6
5985581|NCT01017952|20696677|P3|52-week, Double-blind Treatment Period|Lost to Follow-up|8
5985582|NCT01017952|20696678|P2|52-week, Double-blind Treatment Period|Lost to Follow-up|6
5985583|NCT01017952|20696679|P1|52-week, Double-blind Treatment Period|Lost to Follow-up|0
5985584|NCT01017952|20696675|P5|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
5985585|NCT01017952|20696676|P4|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
5985586|NCT01017952|20696677|P3|52-week, Double-blind Treatment Period|Study Closed/Terminated|1
5985587|NCT01017952|20696678|P2|52-week, Double-blind Treatment Period|Study Closed/Terminated|1
5985588|NCT01017952|20696679|P1|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
5985589|NCT01017952|20696675|P5|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9
5985590|NCT01017952|20696676|P4|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|12
5985591|NCT01017952|20696677|P3|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13
5985592|NCT01017952|20696678|P2|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11
5985593|NCT01017952|20696679|P1|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0
5985594|NCT01017952|20696675|P5|52-week, Double-blind Treatment Period|Protocol Violation|8
5985595|NCT01017952|20696676|P4|52-week, Double-blind Treatment Period|Protocol Violation|9
5985596|NCT01017952|20696677|P3|52-week, Double-blind Treatment Period|Protocol Violation|11
5985597|NCT01017952|20696678|P2|52-week, Double-blind Treatment Period|Protocol Violation|7
5985598|NCT01017952|20696679|P1|52-week, Double-blind Treatment Period|Protocol Violation|0
5985599|NCT01017952|20696675|P5|52-week, Double-blind Treatment Period|Lack of Efficacy|14
5985600|NCT01017952|20696676|P4|52-week, Double-blind Treatment Period|Lack of Efficacy|16
5985601|NCT01017952|20696677|P3|52-week, Double-blind Treatment Period|Lack of Efficacy|14
5985602|NCT01017952|20696678|P2|52-week, Double-blind Treatment Period|Lack of Efficacy|35
5985603|NCT01017952|20696679|P1|52-week, Double-blind Treatment Period|Lack of Efficacy|0
5985604|NCT01017952|20696675|P5|52-week, Double-blind Treatment Period|Withdrawal by Subject|25
5985605|NCT01017952|20696676|P4|52-week, Double-blind Treatment Period|Withdrawal by Subject|25
5985606|NCT01017952|20696677|P3|52-week, Double-blind Treatment Period|Withdrawal by Subject|22
5985607|NCT01017952|20696678|P2|52-week, Double-blind Treatment Period|Withdrawal by Subject|30
5985608|NCT01017952|20696679|P1|52-week, Double-blind Treatment Period|Withdrawal by Subject|0
5985609|NCT01017952|20696675|P5|52-week, Double-blind Treatment Period|Adverse Event|30
5985610|NCT01017952|20696676|P4|52-week, Double-blind Treatment Period|Adverse Event|35
5985611|NCT01017952|20696677|P3|52-week, Double-blind Treatment Period|Adverse Event|32
5985612|NCT01017952|20696678|P2|52-week, Double-blind Treatment Period|Adverse Event|25
5985613|NCT01017952|20696679|P1|52-week, Double-blind Treatment Period|Adverse Event|0
5985614|NCT01017952|20696675|P5|4-week, Open-label Run-In Period|Withdrawal by Subject|0
5985615|NCT01017952|20696676|P4|4-week, Open-label Run-In Period|Withdrawal by Subject|0
5985616|NCT01017952|20696677|P3|4-week, Open-label Run-In Period|Withdrawal by Subject|0
5985617|NCT01017952|20696678|P2|4-week, Open-label Run-In Period|Withdrawal by Subject|0
5985618|NCT01017952|20696679|P1|4-week, Open-label Run-In Period|Withdrawal by Subject|63
5985619|NCT01017952|20696675|P5|4-week, Open-label Run-In Period|Physician Decision|0
5985620|NCT01017952|20696676|P4|4-week, Open-label Run-In Period|Physician Decision|0
5985621|NCT01017952|20696677|P3|4-week, Open-label Run-In Period|Physician Decision|0
5985622|NCT01017952|20696678|P2|4-week, Open-label Run-In Period|Physician Decision|0
5985623|NCT01017952|20696679|P1|4-week, Open-label Run-In Period|Physician Decision|10
5985624|NCT01017952|20696675|P5|4-week, Open-label Run-In Period|Lost to Follow-up|0
5985625|NCT01017952|20696676|P4|4-week, Open-label Run-In Period|Lost to Follow-up|0
5985626|NCT01017952|20696677|P3|4-week, Open-label Run-In Period|Lost to Follow-up|0
5985627|NCT01017952|20696678|P2|4-week, Open-label Run-In Period|Lost to Follow-up|0
5985628|NCT01017952|20696679|P1|4-week, Open-label Run-In Period|Lost to Follow-up|6
5985629|NCT01017952|20696675|P5|4-week, Open-label Run-In Period|Study Closed/Tterminated|0
5985630|NCT01017952|20696676|P4|4-week, Open-label Run-In Period|Study Closed/Tterminated|0
5985631|NCT01017952|20696677|P3|4-week, Open-label Run-In Period|Study Closed/Tterminated|0
5985632|NCT01017952|20696678|P2|4-week, Open-label Run-In Period|Study Closed/Tterminated|0
5985633|NCT01017952|20696679|P1|4-week, Open-label Run-In Period|Study Closed/Tterminated|1
5985634|NCT01017952|20696675|P5|4-week, Open-label Run-In Period|Adverse Event|0
5985635|NCT01017952|20696676|P4|4-week, Open-label Run-In Period|Adverse Event|0
5985636|NCT01017952|20696677|P3|4-week, Open-label Run-In Period|Adverse Event|0
5985637|NCT01017952|20696678|P2|4-week, Open-label Run-In Period|Adverse Event|0
5985638|NCT01017952|20696679|P1|4-week, Open-label Run-In Period|Adverse Event|23
5985639|NCT01017952|20696675|P5|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
5985640|NCT01017952|20696676|P4|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
5985641|NCT01017952|20696677|P3|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
5985642|NCT01017952|20696678|P2|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
5985643|NCT01017952|20696679|P1|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|356
5985644|NCT01017874|20696703|P2|Overall Study|Physician Decision|3
5985645|NCT01017874|20696704|P1|Overall Study|Physician Decision|1
5985646|NCT01017874|20696703|P2|Overall Study|Lost to Follow-up|2
5985647|NCT01017874|20696704|P1|Overall Study|Lost to Follow-up|3
5985648|NCT01017874|20696703|P2|Overall Study|Sponsor decision|1
5985649|NCT01017874|20696704|P1|Overall Study|Sponsor decision|3
5985650|NCT01017874|20696703|P2|Overall Study|Withdrawal by Subject|20
5985651|NCT01017874|20696704|P1|Overall Study|Withdrawal by Subject|23
5985652|NCT01017731|20696722|P1|Overall Study|Adverse Event|1
5985653|NCT01017731|20696722|P1|Overall Study|Physician Decision|2
5985654|NCT01017731|20696722|P1|Overall Study|Withdrawal by Subject|3
5985655|NCT01017731|20696722|P1|Overall Study|Lost to Follow-up|2
5985656|NCT01017601|20696751|P2|Overall Study|Withdrawal by Subject|1
5985657|NCT01017601|20696752|P1|Overall Study|Withdrawal by Subject|0
5985658|NCT01017601|20696751|P2|Overall Study|Disease Progression|12
5985659|NCT01017601|20696752|P1|Overall Study|Disease Progression|12
5985660|NCT01017575|20696779|P5|Overall Study|Withdrawal by Subject|0
5985661|NCT01017575|20696780|P4|Overall Study|Withdrawal by Subject|0
5985662|NCT01017575|20696781|P3|Overall Study|Withdrawal by Subject|0
5985663|NCT01017575|20696782|P2|Overall Study|Withdrawal by Subject|0
5985664|NCT01017575|20696783|P1|Overall Study|Withdrawal by Subject|1
5985665|NCT01017575|20696779|P5|Overall Study|Adverse Event|2
5985666|NCT01017575|20696780|P4|Overall Study|Adverse Event|0
5985667|NCT01017575|20696781|P3|Overall Study|Adverse Event|0
5985668|NCT01017575|20696782|P2|Overall Study|Adverse Event|1
5985669|NCT01017575|20696783|P1|Overall Study|Adverse Event|0
5985670|NCT01017575|20696779|P5|Overall Study|Lack of Efficacy|1
5985671|NCT01017575|20696780|P4|Overall Study|Lack of Efficacy|1
5985672|NCT01017575|20696781|P3|Overall Study|Lack of Efficacy|0
5985673|NCT01017575|20696782|P2|Overall Study|Lack of Efficacy|1
5985674|NCT01017575|20696783|P1|Overall Study|Lack of Efficacy|0
5985675|NCT01017549|20696820|P1|5 Year Follow-up|Mastectomy|3
5985676|NCT01017549|20696820|P1|5 Year Follow-up|Lost to Follow-up|9
5985677|NCT01017549|20696820|P1|One-year Follow-up|Withdrawal by Subject|5
5985678|NCT01017549|20696820|P1|One-year Follow-up|Lost to Follow-up|2
5985679|NCT01017549|20696820|P1|Eligibility Through 6 Month Follow-up|Lost to Follow-up|1
5985680|NCT01017263|20696851|P1|Overall Study|not eligible|12
5985681|NCT01017146|20696932|P2|Overall Study|Change in Work Situation|0
5985682|NCT01017146|20696933|P1|Overall Study|Change in Work Situation|1
5985683|NCT01017146|20696932|P2|Overall Study|Did Not Meet Eligibility Criteria|2
5985684|NCT01017146|20696933|P1|Overall Study|Did Not Meet Eligibility Criteria|1
5985685|NCT01017146|20696932|P2|Overall Study|Took Excluded Medication|0
5985686|NCT01017146|20696933|P1|Overall Study|Took Excluded Medication|2
5985687|NCT01017146|20696932|P2|Overall Study|Protocol Violation|0
5985688|NCT01017146|20696933|P1|Overall Study|Protocol Violation|2
5985689|NCT01017146|20696932|P2|Overall Study|Pregnancy|1
5985690|NCT01017146|20696933|P1|Overall Study|Pregnancy|2
5985691|NCT01017146|20696932|P2|Overall Study|Relocation|4
5985692|NCT01017146|20696933|P1|Overall Study|Relocation|0
5985693|NCT01017146|20696932|P2|Overall Study|Withdrawal by Subject|16
5985694|NCT01017146|20696933|P1|Overall Study|Withdrawal by Subject|32
5985695|NCT01017146|20696932|P2|Overall Study|Noncompliance with Study Product|1
5985696|NCT01017146|20696933|P1|Overall Study|Noncompliance with Study Product|1
5985697|NCT01017146|20696932|P2|Overall Study|Lost to Follow-up|14
5985698|NCT01017146|20696933|P1|Overall Study|Lost to Follow-up|14
5985699|NCT01017146|20696932|P2|Overall Study|Adverse Event|1
5985700|NCT01017146|20696933|P1|Overall Study|Adverse Event|11
5985701|NCT01017120|20696971|P2|Overall Study|Parent Unable to Provide Transportation|0
5985702|NCT01017120|20696972|P1|Overall Study|Parent Unable to Provide Transportation|1
5985703|NCT01017120|20696971|P2|Overall Study|Protocol Violation|0
5985704|NCT01017120|20696972|P1|Overall Study|Protocol Violation|1
5985705|NCT01017120|20696971|P2|Overall Study|Relocated Out of Town|2
5985706|NCT01017120|20696972|P1|Overall Study|Relocated Out of Town|0
5985707|NCT01017120|20696971|P2|Overall Study|Did Not Meet Eligibility Criteria|0
5985708|NCT01017120|20696972|P1|Overall Study|Did Not Meet Eligibility Criteria|1
5985709|NCT01017120|20696971|P2|Overall Study|Pregnancy|1
5985710|NCT01017120|20696972|P1|Overall Study|Pregnancy|1
5985711|NCT01017120|20696971|P2|Overall Study|Withdrawal by Subject|21
5985712|NCT01017120|20696972|P1|Overall Study|Withdrawal by Subject|39
5985713|NCT01017120|20696971|P2|Overall Study|Lack of Efficacy|0
5985714|NCT01017120|20696972|P1|Overall Study|Lack of Efficacy|1
5985715|NCT01017120|20696971|P2|Overall Study|Lost to Follow-up|11
5985716|NCT01017120|20696972|P1|Overall Study|Lost to Follow-up|13
5985717|NCT01017120|20696971|P2|Overall Study|Adverse Event|0
5985718|NCT01017120|20696972|P1|Overall Study|Adverse Event|9
5985719|NCT01017029|20697033|P2|Overall Study|Death|1
5985720|NCT01017029|20697034|P1|Overall Study|Death|3
5985721|NCT01017029|20697033|P2|Overall Study|Administrative problem|1
5985722|NCT01017029|20697034|P1|Overall Study|Administrative problem|0
5985723|NCT01017029|20697033|P2|Overall Study|Lost to Follow-up|0
5985724|NCT01017029|20697034|P1|Overall Study|Lost to Follow-up|1
5985725|NCT01016977|20697062|P2|Overall Study|Withdrawal by Subject|2
5985726|NCT01016977|20697063|P1|Overall Study|Withdrawal by Subject|2
5985727|NCT01016977|20697062|P2|Overall Study|Lost to Follow-up|0
5985728|NCT01016977|20697063|P1|Overall Study|Lost to Follow-up|1
5985729|NCT01016964|20697099|P2|Overall Study|Lost to Follow-up|3
5985730|NCT01016964|20697100|P1|Overall Study|Lost to Follow-up|3
5985731|NCT01016912|20697116|P5|Follow-up Period|Other reason|0
5985732|NCT01016912|20697117|P4|Follow-up Period|Other reason|1
5985733|NCT01016912|20697118|P3|Follow-up Period|Other reason|1
5985734|NCT01016912|20697119|P2|Follow-up Period|Other reason|0
5985735|NCT01016912|20697120|P1|Follow-up Period|Other reason|0
5985736|NCT01016912|20697116|P5|End of Treatment Period|Completed double-blind period only|0
5985737|NCT01016912|20697117|P4|End of Treatment Period|Completed double-blind period only|0
5985738|NCT01016912|20697118|P3|End of Treatment Period|Completed double-blind period only|0
5985739|NCT01016912|20697119|P2|End of Treatment Period|Completed double-blind period only|1
5985740|NCT01016912|20697120|P1|End of Treatment Period|Completed double-blind period only|0
5985741|NCT01016912|20697116|P5|End of Treatment Period|Adverse Event|0
5985742|NCT01016912|20697117|P4|End of Treatment Period|Adverse Event|0
5985743|NCT01016912|20697118|P3|End of Treatment Period|Adverse Event|1
5985744|NCT01016912|20697119|P2|End of Treatment Period|Adverse Event|1
5985745|NCT01016912|20697120|P1|End of Treatment Period|Adverse Event|0
5985746|NCT01016912|20697116|P5|End of Treatment Period|Lack of Efficacy|4
5985747|NCT01016912|20697117|P4|End of Treatment Period|Lack of Efficacy|4
5985748|NCT01016912|20697118|P3|End of Treatment Period|Lack of Efficacy|0
5985749|NCT01016912|20697119|P2|End of Treatment Period|Lack of Efficacy|1
5985750|NCT01016912|20697120|P1|End of Treatment Period|Lack of Efficacy|0
5985751|NCT01016600|20697299|P4|Overall Study|Did not start treatment|0
5985752|NCT01016600|20697300|P3|Overall Study|Did not start treatment|0
5985753|NCT01016600|20697301|P2|Overall Study|Did not start treatment|0
5985754|NCT01016600|20697302|P1|Overall Study|Did not start treatment|1
5985755|NCT01016262|20697490|P6|Open-Label Phase|Withdrawal of Informed Consent|0
5985756|NCT01016262|20697491|P5|Open-Label Phase|Withdrawal of Informed Consent|1
5985757|NCT01016262|20697492|P4|Open-Label Phase|Withdrawal of Informed Consent|0
5985758|NCT01016262|20697493|P3|Open-Label Phase|Withdrawal of Informed Consent|0
5985759|NCT01016262|20697494|P2|Open-Label Phase|Withdrawal of Informed Consent|0
5985760|NCT01016262|20697495|P1|Open-Label Phase|Withdrawal of Informed Consent|0
5985761|NCT01016262|20697490|P6|Open-Label Phase|Lack of Efficacy|0
5985762|NCT01016262|20697491|P5|Open-Label Phase|Lack of Efficacy|0
5985763|NCT01016262|20697492|P4|Open-Label Phase|Lack of Efficacy|1
5985764|NCT01016262|20697493|P3|Open-Label Phase|Lack of Efficacy|0
5985765|NCT01016262|20697494|P2|Open-Label Phase|Lack of Efficacy|0
5985766|NCT01016262|20697495|P1|Open-Label Phase|Lack of Efficacy|0
5985767|NCT01016262|20697490|P6|Open-Label Phase|Lost to Follow-up|0
5985768|NCT01016262|20697491|P5|Open-Label Phase|Lost to Follow-up|1
5985769|NCT01016262|20697492|P4|Open-Label Phase|Lost to Follow-up|0
5985770|NCT01016262|20697493|P3|Open-Label Phase|Lost to Follow-up|0
5985771|NCT01016262|20697494|P2|Open-Label Phase|Lost to Follow-up|0
5985772|NCT01016262|20697495|P1|Open-Label Phase|Lost to Follow-up|0
5985773|NCT01016262|20697490|P6|Open-Label Phase|Adverse Event|0
5985774|NCT01016262|20697491|P5|Open-Label Phase|Adverse Event|0
5985775|NCT01016262|20697492|P4|Open-Label Phase|Adverse Event|1
5985776|NCT01016262|20697493|P3|Open-Label Phase|Adverse Event|0
5985777|NCT01016262|20697494|P2|Open-Label Phase|Adverse Event|0
5985778|NCT01016262|20697495|P1|Open-Label Phase|Adverse Event|0
5985779|NCT01016262|20697490|P6|Double-blind Phase|Withdrawal of Informed Consent|0
5985780|NCT01016262|20697491|P5|Double-blind Phase|Withdrawal of Informed Consent|0
5985781|NCT01016262|20697492|P4|Double-blind Phase|Withdrawal of Informed Consent|0
5985782|NCT01016262|20697493|P3|Double-blind Phase|Withdrawal of Informed Consent|1
5985783|NCT01016262|20697494|P2|Double-blind Phase|Withdrawal of Informed Consent|0
5985784|NCT01016262|20697495|P1|Double-blind Phase|Withdrawal of Informed Consent|0
5985785|NCT01016262|20697490|P6|Double-blind Phase|Disease Progression|0
5985786|NCT01016262|20697491|P5|Double-blind Phase|Disease Progression|0
5985787|NCT01016262|20697492|P4|Double-blind Phase|Disease Progression|0
5985788|NCT01016262|20697493|P3|Double-blind Phase|Disease Progression|2
5985789|NCT01016262|20697494|P2|Double-blind Phase|Disease Progression|1
5985790|NCT01016262|20697495|P1|Double-blind Phase|Disease Progression|0
5985791|NCT01016262|20697490|P6|Double-blind Phase|Lack of Efficacy|0
5985792|NCT01016262|20697491|P5|Double-blind Phase|Lack of Efficacy|0
5985793|NCT01016262|20697492|P4|Double-blind Phase|Lack of Efficacy|0
5985794|NCT01016262|20697493|P3|Double-blind Phase|Lack of Efficacy|5
5985795|NCT01016262|20697494|P2|Double-blind Phase|Lack of Efficacy|0
5985796|NCT01016262|20697495|P1|Double-blind Phase|Lack of Efficacy|1
5985797|NCT01016262|20697490|P6|Double-blind Phase|Adverse Event|0
5985798|NCT01016262|20697491|P5|Double-blind Phase|Adverse Event|0
5985799|NCT01016262|20697492|P4|Double-blind Phase|Adverse Event|0
5985800|NCT01016262|20697493|P3|Double-blind Phase|Adverse Event|1
5985801|NCT01016262|20697494|P2|Double-blind Phase|Adverse Event|0
5985802|NCT01016262|20697495|P1|Double-blind Phase|Adverse Event|0
5985803|NCT01016132|20697518|P1|Overall Study|Discomfort|1
5985804|NCT01016067|20697533|P2|Overall Study|Withdrew due to Relocation|1
5985805|NCT01016067|20697534|P1|Overall Study|Withdrew due to Relocation|0
5985806|NCT01016067|20697533|P2|Overall Study|Physician Decision|1
5985807|NCT01016067|20697534|P1|Overall Study|Physician Decision|1
5985808|NCT01016067|20697533|P2|Overall Study|Lost to Follow-up|2
5985809|NCT01016067|20697534|P1|Overall Study|Lost to Follow-up|1
5985810|NCT01016015|20697552|P1|Overall Study|Adverse Event|15
5985811|NCT01016015|20697552|P1|Overall Study|Withdrawal by Subject|1
5985812|NCT01016015|20697552|P1|Overall Study|Not Treated|3
5985813|NCT01015833|20697563|P2|Overall Study|Did not start treatment|0
5985814|NCT01015833|20697564|P1|Overall Study|Did not start treatment|1
5985815|NCT01015833|20697563|P2|Overall Study|Motor Vehicle Accidents|0
5985816|NCT01015833|20697564|P1|Overall Study|Motor Vehicle Accidents|1
5985817|NCT01015833|20697563|P2|Overall Study|Other|1
5985818|NCT01015833|20697564|P1|Overall Study|Other|5
5985819|NCT01015833|20697563|P2|Overall Study|Symptomatic deterioration|1
5985820|NCT01015833|20697564|P1|Overall Study|Symptomatic deterioration|0
5985821|NCT01015833|20697563|P2|Overall Study|Physician Decision|0
5985822|NCT01015833|20697564|P1|Overall Study|Physician Decision|2
5985823|NCT01015833|20697563|P2|Overall Study|Adverse Event|1
5985824|NCT01015833|20697564|P1|Overall Study|Adverse Event|0
5985825|NCT01015833|20697563|P2|Overall Study|Withdrawal by Subject|2
5985826|NCT01015833|20697564|P1|Overall Study|Withdrawal by Subject|3
5985827|NCT01015833|20697563|P2|Overall Study|Death|0
5985828|NCT01015833|20697564|P1|Overall Study|Death|1
5985829|NCT01015820|20697580|P2|Overall Study|Suboptimal measurements|0
5985830|NCT01015820|20697581|P1|Overall Study|Suboptimal measurements|1
5985831|NCT01015768|20697611|P2|Overall Study|Some subject data unuseable|4
5985832|NCT01015768|20697612|P1|Overall Study|Some subject data unuseable|4
5985833|NCT01015703|20697627|P5|Overall Study|Protocol Violation|0
5985834|NCT01015703|20697628|P4|Overall Study|Protocol Violation|0
5985835|NCT01015703|20697629|P3|Overall Study|Protocol Violation|0
5985836|NCT01015703|20697630|P2|Overall Study|Protocol Violation|0
5985837|NCT01015703|20697631|P1|Overall Study|Protocol Violation|1
5985838|NCT01015703|20697627|P5|Overall Study|Adverse Event|0
5985839|NCT01015703|20697628|P4|Overall Study|Adverse Event|0
5985840|NCT01015703|20697629|P3|Overall Study|Adverse Event|0
5985841|NCT01015703|20697630|P2|Overall Study|Adverse Event|0
5985842|NCT01015703|20697631|P1|Overall Study|Adverse Event|1
5985843|NCT01015703|20697627|P5|Overall Study|Withdrawal by Subject|0
5985844|NCT01015703|20697628|P4|Overall Study|Withdrawal by Subject|0
5985845|NCT01015703|20697629|P3|Overall Study|Withdrawal by Subject|0
5985846|NCT01015703|20697630|P2|Overall Study|Withdrawal by Subject|1
5985847|NCT01015703|20697631|P1|Overall Study|Withdrawal by Subject|0
5985848|NCT01015677|20697646|P3|Overall Study|Withdrawal by Subject|0
5985849|NCT01015677|20697647|P2|Overall Study|Withdrawal by Subject|1
5985850|NCT01015677|20697648|P1|Overall Study|Withdrawal by Subject|1
5985851|NCT01015677|20697646|P3|Overall Study|Protocol Violation|0
5985852|NCT01015677|20697647|P2|Overall Study|Protocol Violation|1
5985853|NCT01015677|20697648|P1|Overall Study|Protocol Violation|0
5985854|NCT01015677|20697646|P3|Overall Study|Lack of Efficacy|0
5985855|NCT01015677|20697647|P2|Overall Study|Lack of Efficacy|1
5985856|NCT01015677|20697648|P1|Overall Study|Lack of Efficacy|0
5985857|NCT01015677|20697646|P3|Overall Study|Adverse Event|0
5985858|NCT01015677|20697647|P2|Overall Study|Adverse Event|1
5985859|NCT01015677|20697648|P1|Overall Study|Adverse Event|0
5985860|NCT01015638|20697670|P2|Overall Study|Withdrawal by Subject|0
5985861|NCT01015638|20697671|P1|Overall Study|Withdrawal by Subject|1
5985862|NCT01015612|20697699|P1|Overall Study|Withdrawal by Subject|40
5985863|NCT01015612|20697699|P1|Overall Study|Death|113
5985864|NCT01015560|20697730|P1|Overall Study|Withdrawal by Subject|1
5985865|NCT01015560|20697730|P1|Overall Study|Not protocol specified|1
5985866|NCT01015560|20697730|P1|Overall Study|Adverse Event|1
5985867|NCT01015287|20697779|P2|Overall Study|Protocol Violation|1
5985868|NCT01015287|20697780|P1|Overall Study|Protocol Violation|1
5985869|NCT01015287|20697779|P2|Overall Study|Lost to Follow-up|1
5985870|NCT01015287|20697780|P1|Overall Study|Lost to Follow-up|2
5985871|NCT01015287|20697779|P2|Overall Study|Entry Criteria not Met|14
5985872|NCT01015287|20697780|P1|Overall Study|Entry Criteria not Met|11
5985873|NCT01015287|20697779|P2|Overall Study|Withdrawal by Subject|19
5985874|NCT01015287|20697780|P1|Overall Study|Withdrawal by Subject|14
5985875|NCT01015287|20697779|P2|Overall Study|Physician Decision|21
5985876|NCT01015287|20697780|P1|Overall Study|Physician Decision|19
5985877|NCT01015287|20697779|P2|Overall Study|Sponsor Decision|7
5985878|NCT01015287|20697780|P1|Overall Study|Sponsor Decision|3
5985879|NCT01015287|20697779|P2|Overall Study|Adverse Event|0
5985880|NCT01015287|20697780|P1|Overall Study|Adverse Event|1
5985881|NCT01015287|20697779|P2|Overall Study|Death|16
5985882|NCT01015287|20697780|P1|Overall Study|Death|21
5985887|NCT01015118|20697828|P2|Overall Study|Other than stated above|23
5985888|NCT01015118|20697829|P1|Overall Study|Other than stated above|42
5985889|NCT01015118|20697828|P2|Overall Study|Not treated|5
5985890|NCT01015118|20697829|P1|Overall Study|Not treated|9
5985891|NCT01015118|20697828|P2|Overall Study|Progressive disease|229
5985892|NCT01015118|20697829|P1|Overall Study|Progressive disease|364
5985893|NCT01015118|20697828|P2|Overall Study|Worsening or AE of underlying disease|4
5985894|NCT01015118|20697829|P1|Overall Study|Worsening or AE of underlying disease|5
5985895|NCT01015118|20697828|P2|Overall Study|Other Adverse Event (AE)|33
5985896|NCT01015118|20697829|P1|Overall Study|Other Adverse Event (AE)|141
5985897|NCT01015118|20697828|P2|Overall Study|Withdrawal by Subject|27
5985898|NCT01015118|20697829|P1|Overall Study|Withdrawal by Subject|103
5985899|NCT01015118|20697828|P2|Overall Study|Protocol Violation|6
5985900|NCT01015118|20697829|P1|Overall Study|Protocol Violation|5
5985901|NCT01014988|20697857|P6|Overall Study|Withdrawal by Subject|0
5985902|NCT01014988|20697858|P5|Overall Study|Withdrawal by Subject|0
5985903|NCT01014988|20697859|P4|Overall Study|Withdrawal by Subject|0
5985904|NCT01014988|20697860|P3|Overall Study|Withdrawal by Subject|0
5985905|NCT01014988|20697861|P2|Overall Study|Withdrawal by Subject|0
5985906|NCT01014988|20697862|P1|Overall Study|Withdrawal by Subject|1
5985907|NCT01014988|20697857|P6|Overall Study|Physician Decision|0
5985908|NCT01014988|20697858|P5|Overall Study|Physician Decision|0
5985909|NCT01014988|20697859|P4|Overall Study|Physician Decision|0
5985910|NCT01014988|20697860|P3|Overall Study|Physician Decision|0
5985911|NCT01014988|20697861|P2|Overall Study|Physician Decision|0
5985912|NCT01014988|20697862|P1|Overall Study|Physician Decision|1
5985913|NCT01014988|20697857|P6|Overall Study|Lost to Follow-up|0
5985914|NCT01014988|20697858|P5|Overall Study|Lost to Follow-up|0
5985915|NCT01014988|20697859|P4|Overall Study|Lost to Follow-up|0
5985916|NCT01014988|20697860|P3|Overall Study|Lost to Follow-up|1
5985917|NCT01014988|20697861|P2|Overall Study|Lost to Follow-up|0
5985918|NCT01014988|20697862|P1|Overall Study|Lost to Follow-up|1
5985919|NCT01014988|20697857|P6|Overall Study|Adverse Event|3
5985920|NCT01014988|20697858|P5|Overall Study|Adverse Event|1
5985921|NCT01014988|20697859|P4|Overall Study|Adverse Event|0
5985922|NCT01014988|20697860|P3|Overall Study|Adverse Event|1
5985923|NCT01014988|20697861|P2|Overall Study|Adverse Event|0
5985924|NCT01014988|20697862|P1|Overall Study|Adverse Event|20
5985925|NCT01014975|20698034|P3|Overall Study|Lost to Follow-up|1
5985926|NCT01014975|20698035|P2|Overall Study|Lost to Follow-up|0
5985927|NCT01014975|20698036|P1|Overall Study|Lost to Follow-up|0
5985928|NCT01014975|20698034|P3|Overall Study|Death|4
5985929|NCT01014975|20698035|P2|Overall Study|Death|3
5985930|NCT01014975|20698036|P1|Overall Study|Death|3
5985931|NCT01014975|20698034|P3|Overall Study|Withdrawal by Subject|1
5985932|NCT01014975|20698035|P2|Overall Study|Withdrawal by Subject|0
5985933|NCT01014975|20698036|P1|Overall Study|Withdrawal by Subject|1
5985934|NCT01014910|20698541|P2|Overall Study|Withdrawal by Subject|2
5985935|NCT01014910|20698542|P1|Overall Study|Withdrawal by Subject|0
5985936|NCT01014767|20698560|P4|Overall Study|PI left institution, data unavailable|1
5985937|NCT01014767|20698561|P3|Overall Study|PI left institution, data unavailable|4
5985938|NCT01014767|20698562|P2|Overall Study|PI left institution, data unavailable|1
5985939|NCT01014767|20698563|P1|Overall Study|PI left institution, data unavailable|12
5985952|NCT01014585|20698643|P4|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22
5985953|NCT01014585|20698644|P3|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22
5985954|NCT01014585|20698645|P2|Overall Study|Withdrawn Due to Worsening Fibromyalgia|23
5985955|NCT01014585|20698646|P1|Overall Study|Withdrawn Due to Worsening Fibromyalgia|18
5985956|NCT01014585|20698643|P4|Overall Study|Lost to Follow-up|2
5985957|NCT01014585|20698644|P3|Overall Study|Lost to Follow-up|0
5985958|NCT01014585|20698645|P2|Overall Study|Lost to Follow-up|0
5985959|NCT01014585|20698646|P1|Overall Study|Lost to Follow-up|0
5985960|NCT01014585|20698643|P4|Overall Study|Withdrawal by Subject|3
5985961|NCT01014585|20698644|P3|Overall Study|Withdrawal by Subject|1
5985962|NCT01014585|20698645|P2|Overall Study|Withdrawal by Subject|0
5985963|NCT01014585|20698646|P1|Overall Study|Withdrawal by Subject|2
5985964|NCT01014585|20698643|P4|Overall Study|Adverse Event|3
5985965|NCT01014585|20698644|P3|Overall Study|Adverse Event|0
5985966|NCT01014585|20698645|P2|Overall Study|Adverse Event|2
5985967|NCT01014585|20698646|P1|Overall Study|Adverse Event|0
5985968|NCT01014533|20698666|P2|Overall Study|unable to come to appointment|3
5985969|NCT01014533|20698667|P1|Overall Study|unable to come to appointment|0
5985970|NCT01014533|20698666|P2|Overall Study|Withdrawal by Subject|0
5985971|NCT01014533|20698667|P1|Overall Study|Withdrawal by Subject|2
5985972|NCT01014533|20698666|P2|Overall Study|Protocol Violation|2
5985973|NCT01014533|20698667|P1|Overall Study|Protocol Violation|3
5985974|NCT01014442|20698688|P2|Overall Study|Unspecified Reason|1
5985975|NCT01014442|20698689|P1|Overall Study|Unspecified Reason|1
5985976|NCT01014442|20698688|P2|Overall Study|Lack of Compliance|1
5985977|NCT01014442|20698689|P1|Overall Study|Lack of Compliance|0
5985978|NCT01014442|20698688|P2|Overall Study|Protocol Violation|5
5985979|NCT01014442|20698689|P1|Overall Study|Protocol Violation|2
5985980|NCT01014442|20698688|P2|Overall Study|Withdrawal by Subject|4
5985981|NCT01014442|20698689|P1|Overall Study|Withdrawal by Subject|4
5985982|NCT01014442|20698688|P2|Overall Study|Adverse Event|8
5985983|NCT01014442|20698689|P1|Overall Study|Adverse Event|0
5985984|NCT01014208|20698826|P2|Overall Study|Study Closed/terminated|83
5985985|NCT01014208|20698827|P1|Overall Study|Study Closed/terminated|78
5985986|NCT01014208|20698826|P2|Overall Study|Did Not Receive Study Drug|0
5985987|NCT01014208|20698827|P1|Overall Study|Did Not Receive Study Drug|2
5985988|NCT01014208|20698826|P2|Overall Study|Participant Withdrew Consent|12
5985989|NCT01014208|20698827|P1|Overall Study|Participant Withdrew Consent|12
5985990|NCT01014208|20698826|P2|Overall Study|Lost to Follow-up|5
5985991|NCT01014208|20698827|P1|Overall Study|Lost to Follow-up|2
5985992|NCT01014143|20698869|P3|Second Intervention|Lost to Follow-up|0
5985993|NCT01014143|20698870|P2|Second Intervention|Lost to Follow-up|0
5985994|NCT01014143|20698871|P1|Second Intervention|Lost to Follow-up|2
5985995|NCT01014013|20698966|P2|Overall Study|Inappropriate therapy duration, < 7 Days|1
5985996|NCT01014013|20698967|P1|Overall Study|Inappropriate therapy duration, < 7 Days|0
5985997|NCT01014013|20698966|P2|Overall Study|Appendectomy|0
5985998|NCT01014013|20698967|P1|Overall Study|Appendectomy|1
5985999|NCT01014013|20698966|P2|Overall Study|Another antibiotic therapy required|1
5986000|NCT01014013|20698967|P1|Overall Study|Another antibiotic therapy required|0
5986001|NCT01014013|20698966|P2|Overall Study|Physician Decision|1
5986002|NCT01014013|20698967|P1|Overall Study|Physician Decision|0
5986003|NCT01014013|20698966|P2|Overall Study|Pathogen resistant|4
5986004|NCT01014013|20698967|P1|Overall Study|Pathogen resistant|7
5986005|NCT01014013|20698966|P2|Overall Study|Negative urine culture|0
5986006|NCT01014013|20698967|P1|Overall Study|Negative urine culture|2
5986007|NCT01014013|20698966|P2|Overall Study|Pathogen culture = no growth|34
5986008|NCT01014013|20698967|P1|Overall Study|Pathogen culture = no growth|26
5986009|NCT01014013|20698966|P2|Overall Study|Clinical/microbiologic failure|2
5986010|NCT01014013|20698967|P1|Overall Study|Clinical/microbiologic failure|1
5986011|NCT01014013|20698966|P2|Overall Study|Withdrawal by Subject|4
5986012|NCT01014013|20698967|P1|Overall Study|Withdrawal by Subject|7
5986013|NCT01014013|20698966|P2|Overall Study|Protocol Violation|3
5986014|NCT01014013|20698967|P1|Overall Study|Protocol Violation|1
5986015|NCT01014013|20698966|P2|Overall Study|Laboratory adverse experience|1
5986016|NCT01014013|20698967|P1|Overall Study|Laboratory adverse experience|1
5986017|NCT01014013|20698966|P2|Overall Study|Clinical adverse experience|2
5986018|NCT01014013|20698967|P1|Overall Study|Clinical adverse experience|4
5986019|NCT01014013|20698966|P2|Overall Study|Inclusion/Exclusion criteria not met|3
5986020|NCT01014013|20698967|P1|Overall Study|Inclusion/Exclusion criteria not met|1
5986021|NCT01013961|20698979|P2|Overall Study|Physician Decision|1
5986022|NCT01013961|20698980|P1|Overall Study|Physician Decision|0
5986023|NCT01013961|20698979|P2|Overall Study|Withdrawal by Subject|0
5986024|NCT01013961|20698980|P1|Overall Study|Withdrawal by Subject|1
5986025|NCT01013961|20698979|P2|Overall Study|Adverse Event|2
5986026|NCT01013961|20698980|P1|Overall Study|Adverse Event|2
5986027|NCT01013883|20698998|P2|Overall Study|Lost to Follow-up|2
5986028|NCT01013883|20698999|P1|Overall Study|Lost to Follow-up|2
5986029|NCT01013870|20699011|P2|Overall Study|Lost to Follow-up|3
5986030|NCT01013870|20699012|P1|Overall Study|Lost to Follow-up|1
5986031|NCT01013792|20699061|P2|Overall Study|Lost to Follow-up|1
5986032|NCT01013792|20699062|P1|Overall Study|Lost to Follow-up|0
5986033|NCT01013792|20699061|P2|Overall Study|Adverse Event|3
5986034|NCT01013792|20699062|P1|Overall Study|Adverse Event|0
5986035|NCT01013792|20699061|P2|Overall Study|Study suspended|1
5986036|NCT01013792|20699062|P1|Overall Study|Study suspended|2
5986037|NCT01013753|20699068|P1|Overall Study|Other|2
5986038|NCT01013753|20699068|P1|Overall Study|Withdrawal by Subject|2
5986039|NCT01013753|20699068|P1|Overall Study|Lost to Follow-up|1
5986040|NCT01013753|20699068|P1|Overall Study|Protocol Violation|3
5986041|NCT01013753|20699068|P1|Overall Study|Adverse Event|8
5986042|NCT01013740|20699264|P2|Overall Study|Ongoing: Study records not completed|2
5986043|NCT01013740|20699265|P1|Overall Study|Ongoing: Study records not completed|0
5986044|NCT01013740|20699264|P2|Overall Study|Missing|1
5986045|NCT01013740|20699265|P1|Overall Study|Missing|2
5986046|NCT01013740|20699264|P2|Overall Study|study close / terminated : done in error|1
5986047|NCT01013740|20699265|P1|Overall Study|study close / terminated : done in error|2
5986048|NCT01013740|20699264|P2|Overall Study|Withdrawal by Subject|10
5986049|NCT01013740|20699265|P1|Overall Study|Withdrawal by Subject|2
5986050|NCT01013740|20699264|P2|Overall Study|Physician Decision|0
5986051|NCT01013740|20699265|P1|Overall Study|Physician Decision|2
5986052|NCT01013740|20699264|P2|Overall Study|Lost to Follow-up|5
5986053|NCT01013740|20699265|P1|Overall Study|Lost to Follow-up|3
5986054|NCT01013701|20699289|P1|Overall Study|study prematurely terminated|7
5986055|NCT01013597|20699296|P1|Overall Study|Withdrawal by Subject|1
5986056|NCT01013350|20699308|P2|Overall Study|Other|25
5986057|NCT01013350|20699309|P1|Overall Study|Other|1
5986058|NCT01013350|20699308|P2|Overall Study|Participant entered interventional study|8
5986059|NCT01013350|20699309|P1|Overall Study|Participant entered interventional study|0
5986060|NCT01013350|20699308|P2|Overall Study|Death|5
5986061|NCT01013350|20699309|P1|Overall Study|Death|3
5986062|NCT01013350|20699308|P2|Overall Study|Withdrawal by Subject|38
5986063|NCT01013350|20699309|P1|Overall Study|Withdrawal by Subject|15
5986064|NCT01013350|20699308|P2|Overall Study|Physician Decision|20
5986065|NCT01013350|20699309|P1|Overall Study|Physician Decision|4
5986066|NCT01013350|20699308|P2|Overall Study|Adverse Event|1
5986067|NCT01013350|20699309|P1|Overall Study|Adverse Event|0
5986068|NCT01013350|20699308|P2|Overall Study|Lost to Follow-up|95
5986069|NCT01013350|20699309|P1|Overall Study|Lost to Follow-up|15
5986070|NCT01013285|20699322|P2|Overall Study|Death|89
5986071|NCT01013285|20699323|P1|Overall Study|Death|48
5986072|NCT01013207|20699336|P1|CPAP Post Nexus (S9)|Lost to Follow-up|6
5986073|NCT01012999|20699354|P1|Overall Study|Protocol Violation|1
5986074|NCT01012973|20699360|P2|Overall Study|Withdrawal by Subject|6
5986075|NCT01012973|20699361|P1|Overall Study|Withdrawal by Subject|4
5986076|NCT01012973|20699360|P2|Overall Study|Protocol Violation|2
5986077|NCT01012973|20699361|P1|Overall Study|Protocol Violation|5
5986078|NCT01012973|20699360|P2|Overall Study|Increase in vis. acuity, never injected|1
5986079|NCT01012973|20699361|P1|Overall Study|Increase in vis. acuity, never injected|0
5986080|NCT01012973|20699360|P2|Overall Study|(Overseas travel - indefinite period)|0
5986081|NCT01012973|20699361|P1|Overall Study|(Overseas travel - indefinite period)|1
5986082|NCT01012973|20699360|P2|Overall Study|Lost to Follow-up|0
5986083|NCT01012973|20699361|P1|Overall Study|Lost to Follow-up|1
5986084|NCT01012973|20699360|P2|Overall Study|Lack of Efficacy|5
5986085|NCT01012973|20699361|P1|Overall Study|Lack of Efficacy|0
5986086|NCT01012973|20699360|P2|Overall Study|Adverse Event|5
5986087|NCT01012973|20699361|P1|Overall Study|Adverse Event|5
5986088|NCT01012947|20699386|P5|Overall Study|Lost to Follow-up|142
5986089|NCT01012947|20699387|P4|Overall Study|Lost to Follow-up|118
5986090|NCT01012947|20699388|P3|Overall Study|Lost to Follow-up|130
5986091|NCT01012947|20699389|P2|Overall Study|Lost to Follow-up|135
5986092|NCT01012947|20699390|P1|Overall Study|Lost to Follow-up|131
5986093|NCT01012765|20699411|P6|Treatment Period 2|Unsatisfactory therapeutic effect|0
5986094|NCT01012765|20699412|P5|Treatment Period 2|Unsatisfactory therapeutic effect|0
5986095|NCT01012765|20699413|P4|Treatment Period 2|Unsatisfactory therapeutic effect|0
5986096|NCT01012765|20699414|P3|Treatment Period 2|Unsatisfactory therapeutic effect|1
5986097|NCT01012765|20699415|P2|Treatment Period 2|Unsatisfactory therapeutic effect|1
5986098|NCT01012765|20699416|P1|Treatment Period 2|Unsatisfactory therapeutic effect|0
5986099|NCT01012765|20699411|P6|Treatment Period 2|Adverse Event|0
5986100|NCT01012765|20699412|P5|Treatment Period 2|Adverse Event|0
5986101|NCT01012765|20699413|P4|Treatment Period 2|Adverse Event|0
5986102|NCT01012765|20699414|P3|Treatment Period 2|Adverse Event|1
5986103|NCT01012765|20699415|P2|Treatment Period 2|Adverse Event|1
5986104|NCT01012765|20699416|P1|Treatment Period 2|Adverse Event|0
5986105|NCT01012765|20699411|P6|Treatment Period 2|Abnormal laboratory value(s)|1
5986106|NCT01012765|20699412|P5|Treatment Period 2|Abnormal laboratory value(s)|0
5986107|NCT01012765|20699413|P4|Treatment Period 2|Abnormal laboratory value(s)|0
5986108|NCT01012765|20699414|P3|Treatment Period 2|Abnormal laboratory value(s)|0
5986109|NCT01012765|20699415|P2|Treatment Period 2|Abnormal laboratory value(s)|0
5986110|NCT01012765|20699416|P1|Treatment Period 2|Abnormal laboratory value(s)|0
5986111|NCT01012765|20699411|P6|Treatment Period 2|Withdrawal by Subject|0
5986112|NCT01012765|20699412|P5|Treatment Period 2|Withdrawal by Subject|1
5986113|NCT01012765|20699413|P4|Treatment Period 2|Withdrawal by Subject|0
5986114|NCT01012765|20699414|P3|Treatment Period 2|Withdrawal by Subject|1
5986115|NCT01012765|20699415|P2|Treatment Period 2|Withdrawal by Subject|0
5986116|NCT01012765|20699416|P1|Treatment Period 2|Withdrawal by Subject|1
5986117|NCT01012765|20699411|P6|Treatment Period 1|Unsatisfactory therapeutic effect|0
5986118|NCT01012765|20699412|P5|Treatment Period 1|Unsatisfactory therapeutic effect|1
5986119|NCT01012765|20699413|P4|Treatment Period 1|Unsatisfactory therapeutic effect|0
5986120|NCT01012765|20699414|P3|Treatment Period 1|Unsatisfactory therapeutic effect|0
5986121|NCT01012765|20699415|P2|Treatment Period 1|Unsatisfactory therapeutic effect|0
5986122|NCT01012765|20699416|P1|Treatment Period 1|Unsatisfactory therapeutic effect|0
5986123|NCT01012765|20699411|P6|Treatment Period 1|Protocol Violation|0
5986124|NCT01012765|20699412|P5|Treatment Period 1|Protocol Violation|1
5986125|NCT01012765|20699413|P4|Treatment Period 1|Protocol Violation|2
5986126|NCT01012765|20699414|P3|Treatment Period 1|Protocol Violation|0
5986127|NCT01012765|20699415|P2|Treatment Period 1|Protocol Violation|0
5986128|NCT01012765|20699416|P1|Treatment Period 1|Protocol Violation|0
5986129|NCT01012765|20699411|P6|Treatment Period 1|Administrative problems|0
5986130|NCT01012765|20699412|P5|Treatment Period 1|Administrative problems|1
5986131|NCT01012765|20699413|P4|Treatment Period 1|Administrative problems|1
5986132|NCT01012765|20699414|P3|Treatment Period 1|Administrative problems|1
5986133|NCT01012765|20699415|P2|Treatment Period 1|Administrative problems|0
5986134|NCT01012765|20699416|P1|Treatment Period 1|Administrative problems|0
5986135|NCT01012765|20699411|P6|Treatment Period 1|Withdrawal by Subject|0
5986136|NCT01012765|20699412|P5|Treatment Period 1|Withdrawal by Subject|0
5986137|NCT01012765|20699413|P4|Treatment Period 1|Withdrawal by Subject|0
5986138|NCT01012765|20699414|P3|Treatment Period 1|Withdrawal by Subject|0
5986139|NCT01012765|20699415|P2|Treatment Period 1|Withdrawal by Subject|0
5986140|NCT01012765|20699416|P1|Treatment Period 1|Withdrawal by Subject|2
5986141|NCT01012765|20699411|P6|Treatment Period 1|Adverse Event|0
5986142|NCT01012765|20699412|P5|Treatment Period 1|Adverse Event|0
5986143|NCT01012765|20699413|P4|Treatment Period 1|Adverse Event|0
5986144|NCT01012765|20699414|P3|Treatment Period 1|Adverse Event|1
5986145|NCT01012765|20699415|P2|Treatment Period 1|Adverse Event|0
5986146|NCT01012765|20699416|P1|Treatment Period 1|Adverse Event|1
5986147|NCT01012739|20699445|P4|Treatment Period 2|Abnormal test procedure results|1
5986148|NCT01012739|20699446|P3|Treatment Period 2|Abnormal test procedure results|0
5986149|NCT01012739|20699447|P2|Treatment Period 2|Abnormal test procedure results|0
5986150|NCT01012739|20699448|P1|Treatment Period 2|Abnormal test procedure results|0
5986151|NCT01012739|20699445|P4|Treatment Period 1|Adverse Event|1
5986152|NCT01012739|20699446|P3|Treatment Period 1|Adverse Event|0
5986153|NCT01012739|20699447|P2|Treatment Period 1|Adverse Event|0
5986154|NCT01012739|20699448|P1|Treatment Period 1|Adverse Event|0
5986155|NCT01012713|20699476|P1|Overall Study|Lack of Efficacy|3
5986156|NCT01012622|20699502|P1|Overall Study|withdrawal of consent by a parent|2
5986157|NCT01012622|20699502|P1|Overall Study|screening failure|1
5986158|NCT01012622|20699502|P1|Overall Study|Other|1
5986159|NCT01012622|20699502|P1|Overall Study|non-compliance with the drug|9
5986160|NCT01012622|20699502|P1|Overall Study|Adverse Event|7
5986161|NCT01012622|20699502|P1|Overall Study|Lost to Follow-up|5
5986162|NCT01012622|20699502|P1|Overall Study|Withdrawal by Subject|6
5986163|NCT01012440|20699528|P1|Overall Study|Withdrawal by Subject|2
5986164|NCT01012414|20699532|P1|Overall Study|Trial was stopped before completed|7
5986165|NCT01012414|20699532|P1|Overall Study|Lost to Follow-up|1
5986166|NCT01012414|20699532|P1|Overall Study|Withdrawal by Subject|2
5986167|NCT01012323|20699573|P1|Overall Study|Investigator Judgment|1
5986168|NCT01012258|20699610|P1|Overall Study|Ongoing|29
5986169|NCT01012258|20699610|P1|Overall Study|Another Tumor Discovered|1
5986170|NCT01012258|20699610|P1|Overall Study|Another Anti-cancer Drug Received|1
5986171|NCT01012258|20699610|P1|Overall Study|Symptomatic Deterioration|1
5986172|NCT01012258|20699610|P1|Overall Study|Progressive Disease (PD)|18
5986173|NCT01012258|20699610|P1|Overall Study|Adverse Event|1
5986174|NCT01012258|20699610|P1|Overall Study|Lost to Follow-up|1
5986175|NCT01012258|20699610|P1|Overall Study|Death|14
5986176|NCT01012219|20699657|P1|Period 2|Withdrawal by Subject|1
5986177|NCT01012219|20699657|P1|Period 1|Withdrawal by Subject|1
5986178|NCT01012037|20699948|P3|Overall Study|Other reason (not specified)|1
5986179|NCT01012037|20699949|P2|Overall Study|Other reason (not specified)|1
5986180|NCT01012037|20699950|P1|Overall Study|Other reason (not specified)|1
5986181|NCT01012037|20699948|P3|Overall Study|Withdrawal by Subject|1
5986182|NCT01012037|20699949|P2|Overall Study|Withdrawal by Subject|4
5986183|NCT01012037|20699950|P1|Overall Study|Withdrawal by Subject|0
5986184|NCT01012037|20699948|P3|Overall Study|Protocol Violation|5
5986185|NCT01012037|20699949|P2|Overall Study|Protocol Violation|3
5986186|NCT01012037|20699950|P1|Overall Study|Protocol Violation|0
5986187|NCT01012037|20699948|P3|Overall Study|Adverse Event|3
5986188|NCT01012037|20699949|P2|Overall Study|Adverse Event|8
5986189|NCT01012037|20699950|P1|Overall Study|Adverse Event|0
5986190|NCT01011946|20699985|P1|Overall Study|No pathological lab value|1
5986191|NCT01011946|20699985|P1|Overall Study|Transferred to another hospital|2
5986192|NCT01011933|20699989|P1|Overall Study|Never treated|1
5986193|NCT01011933|20699989|P1|Overall Study|Inadequate pathology|1
5986194|NCT01011933|20699989|P1|Overall Study|Improper pre-protocol Rx|1
5986195|NCT01011933|20699989|P1|Overall Study|Wrong cell type|1
5986196|NCT01011907|20700006|P2|Overall Study|Adverse Event|4
5986197|NCT01011907|20700007|P1|Overall Study|Adverse Event|1
5986198|NCT01011907|20700006|P2|Overall Study|Withdrawal by Subject|11
5986199|NCT01011907|20700007|P1|Overall Study|Withdrawal by Subject|13
5986200|NCT01011868|20700024|P3|After Week 78 Follow-up|Other reason not defined above|16
5986201|NCT01011868|20700025|P2|After Week 78 Follow-up|Other reason not defined above|5
5986202|NCT01011868|20700026|P1|After Week 78 Follow-up|Other reason not defined above|5
5986203|NCT01011868|20700024|P3|After Week 78 Follow-up|Withdrawal by Subject|1
5986204|NCT01011868|20700025|P2|After Week 78 Follow-up|Withdrawal by Subject|8
5986205|NCT01011868|20700026|P1|After Week 78 Follow-up|Withdrawal by Subject|9
5986206|NCT01011868|20700024|P3|After Week 78 Follow-up|Lost to Follow-up|4
5986207|NCT01011868|20700025|P2|After Week 78 Follow-up|Lost to Follow-up|6
5986208|NCT01011868|20700026|P1|After Week 78 Follow-up|Lost to Follow-up|11
5986209|NCT01011868|20700024|P3|After Week 78 Follow-up|Protocol Violation|2
5986210|NCT01011868|20700025|P2|After Week 78 Follow-up|Protocol Violation|1
5986211|NCT01011868|20700026|P1|After Week 78 Follow-up|Protocol Violation|9
5986212|NCT01011868|20700024|P3|After Week 78 Follow-up|Lack of Efficacy|0
5986213|NCT01011868|20700025|P2|After Week 78 Follow-up|Lack of Efficacy|0
5986214|NCT01011868|20700026|P1|After Week 78 Follow-up|Lack of Efficacy|4
5986215|NCT01011868|20700024|P3|After Week 78 Follow-up|Adverse Event|21
5986216|NCT01011868|20700025|P2|After Week 78 Follow-up|Adverse Event|18
5986217|NCT01011868|20700026|P1|After Week 78 Follow-up|Adverse Event|14
5986218|NCT01011868|20700024|P3|After Week 18 Follow-up|Other reason not defined above|12
5986219|NCT01011868|20700025|P2|After Week 18 Follow-up|Other reason not defined above|3
5986220|NCT01011868|20700026|P1|After Week 18 Follow-up|Other reason not defined above|2
5986221|NCT01011868|20700024|P3|After Week 18 Follow-up|Withdrawal by Subject|0
5986222|NCT01011868|20700025|P2|After Week 18 Follow-up|Withdrawal by Subject|3
5986223|NCT01011868|20700026|P1|After Week 18 Follow-up|Withdrawal by Subject|6
5986224|NCT01011868|20700024|P3|After Week 18 Follow-up|Lost to Follow-up|0
5986225|NCT01011868|20700025|P2|After Week 18 Follow-up|Lost to Follow-up|3
5986226|NCT01011868|20700026|P1|After Week 18 Follow-up|Lost to Follow-up|5
5986227|NCT01011868|20700024|P3|After Week 18 Follow-up|Protocol Violation|1
5986228|NCT01011868|20700025|P2|After Week 18 Follow-up|Protocol Violation|1
5986229|NCT01011868|20700026|P1|After Week 18 Follow-up|Protocol Violation|1
5986230|NCT01011868|20700024|P3|After Week 18 Follow-up|Lack of Efficacy|0
5986231|NCT01011868|20700025|P2|After Week 18 Follow-up|Lack of Efficacy|0
5986232|NCT01011868|20700026|P1|After Week 18 Follow-up|Lack of Efficacy|1
5986233|NCT01011868|20700024|P3|After Week 18 Follow-up|Adverse Event|13
5986234|NCT01011868|20700025|P2|After Week 18 Follow-up|Adverse Event|6
5986235|NCT01011868|20700026|P1|After Week 18 Follow-up|Adverse Event|8
5986236|NCT01011738|20700088|P3|Overall Study|Unknown reasons|17
5986237|NCT01011738|20700089|P2|Overall Study|Unknown reasons|291
5986238|NCT01011738|20700090|P1|Overall Study|Unknown reasons|312
5986239|NCT01011738|20700088|P3|Overall Study|Death|0
5986240|NCT01011738|20700089|P2|Overall Study|Death|3
5986241|NCT01011738|20700090|P1|Overall Study|Death|12
5986242|NCT01011673|20700130|P2|24 Hour Follow-up|Lost to Follow-up|3
5986243|NCT01011673|20700131|P1|24 Hour Follow-up|Lost to Follow-up|3
5986244|NCT01011673|20700130|P2|Randomized|Secondary headache|1
5986245|NCT01011673|20700131|P1|Randomized|Secondary headache|2
5986246|NCT01011556|20700154|P4|Overall Study|Inclusion/exclusion criteria not met|5
5986247|NCT01011556|20700155|P3|Overall Study|Inclusion/exclusion criteria not met|3
5986248|NCT01011556|20700156|P2|Overall Study|Inclusion/exclusion criteria not met|1
5986249|NCT01011556|20700157|P1|Overall Study|Inclusion/exclusion criteria not met|2
5986250|NCT01011556|20700154|P4|Overall Study|Sponsor decision|2
5986251|NCT01011556|20700155|P3|Overall Study|Sponsor decision|1
5986252|NCT01011556|20700156|P2|Overall Study|Sponsor decision|1
5986253|NCT01011556|20700157|P1|Overall Study|Sponsor decision|0
5986254|NCT01011556|20700154|P4|Overall Study|Withdrawal by Subject|4
5986255|NCT01011556|20700155|P3|Overall Study|Withdrawal by Subject|4
5986256|NCT01011556|20700156|P2|Overall Study|Withdrawal by Subject|2
5986257|NCT01011556|20700157|P1|Overall Study|Withdrawal by Subject|1
5986258|NCT01011556|20700154|P4|Overall Study|Protocol Violation|0
5986259|NCT01011556|20700155|P3|Overall Study|Protocol Violation|0
5986260|NCT01011556|20700156|P2|Overall Study|Protocol Violation|1
5986261|NCT01011556|20700157|P1|Overall Study|Protocol Violation|0
5986262|NCT01011556|20700154|P4|Overall Study|Physician Decision|1
5986263|NCT01011556|20700155|P3|Overall Study|Physician Decision|0
5986264|NCT01011556|20700156|P2|Overall Study|Physician Decision|0
5986265|NCT01011556|20700157|P1|Overall Study|Physician Decision|1
5986266|NCT01011556|20700154|P4|Overall Study|Lost to Follow-up|0
5986267|NCT01011556|20700155|P3|Overall Study|Lost to Follow-up|0
5986268|NCT01011556|20700156|P2|Overall Study|Lost to Follow-up|0
5986269|NCT01011556|20700157|P1|Overall Study|Lost to Follow-up|1
5986270|NCT01011556|20700154|P4|Overall Study|Adverse Event|1
5986271|NCT01011556|20700155|P3|Overall Study|Adverse Event|2
5986272|NCT01011556|20700156|P2|Overall Study|Adverse Event|3
5986273|NCT01011556|20700157|P1|Overall Study|Adverse Event|1
5986274|NCT01011465|20700235|P8|Overall Study|Withdrawal by Subject|0
5986275|NCT01011465|20700236|P7|Overall Study|Withdrawal by Subject|1
5986276|NCT01011465|20700237|P6|Overall Study|Withdrawal by Subject|0
5986277|NCT01011465|20700238|P5|Overall Study|Withdrawal by Subject|1
5986278|NCT01011465|20700239|P4|Overall Study|Withdrawal by Subject|0
5986279|NCT01011465|20700240|P3|Overall Study|Withdrawal by Subject|0
5986280|NCT01011465|20700241|P2|Overall Study|Withdrawal by Subject|1
5986281|NCT01011465|20700242|P1|Overall Study|Withdrawal by Subject|2
5986282|NCT01011439|20700270|P1|Overall Study|Sponsor's decision|15
5986283|NCT01011439|20700270|P1|Overall Study|Withdrawal by Subject|1
5986284|NCT01011439|20700270|P1|Overall Study|Lost to Follow-up|4
5986285|NCT01011439|20700270|P1|Overall Study|Death|37
5986286|NCT01011387|20700307|P1|Overall Study|Protocol Violation|1
5986287|NCT01011387|20700307|P1|Overall Study|Adverse Event|2
5986288|NCT01011387|20700307|P1|Overall Study|Withdrawal by Subject|3
5986289|NCT01011335|20700315|P13|Overall Study|Adverse Event|1
5986290|NCT01011335|20700316|P12|Overall Study|Adverse Event|0
5986291|NCT01011335|20700317|P11|Overall Study|Adverse Event|4
5986292|NCT01011335|20700318|P10|Overall Study|Adverse Event|0
5986293|NCT01011335|20700319|P9|Overall Study|Adverse Event|0
5986294|NCT01011335|20700320|P8|Overall Study|Adverse Event|0
5986295|NCT01011335|20700321|P7|Overall Study|Adverse Event|0
5986296|NCT01011335|20700322|P6|Overall Study|Adverse Event|0
5986297|NCT01011335|20700323|P5|Overall Study|Adverse Event|0
5986298|NCT01011335|20700324|P4|Overall Study|Adverse Event|0
5986299|NCT01011335|20700325|P3|Overall Study|Adverse Event|0
5986300|NCT01011335|20700326|P2|Overall Study|Adverse Event|0
5986301|NCT01011335|20700327|P1|Overall Study|Adverse Event|0
5986302|NCT01011335|20700315|P13|Overall Study|Moved/deployed or no booster|0
5986303|NCT01011335|20700316|P12|Overall Study|Moved/deployed or no booster|0
5986304|NCT01011335|20700317|P11|Overall Study|Moved/deployed or no booster|2
5986305|NCT01011335|20700318|P10|Overall Study|Moved/deployed or no booster|0
5986306|NCT01011335|20700319|P9|Overall Study|Moved/deployed or no booster|1
5986307|NCT01011335|20700320|P8|Overall Study|Moved/deployed or no booster|0
5986308|NCT01011335|20700321|P7|Overall Study|Moved/deployed or no booster|1
5986309|NCT01011335|20700322|P6|Overall Study|Moved/deployed or no booster|0
5986310|NCT01011335|20700323|P5|Overall Study|Moved/deployed or no booster|0
5986311|NCT01011335|20700324|P4|Overall Study|Moved/deployed or no booster|1
5986312|NCT01011335|20700325|P3|Overall Study|Moved/deployed or no booster|0
5986313|NCT01011335|20700326|P2|Overall Study|Moved/deployed or no booster|0
5986314|NCT01011335|20700327|P1|Overall Study|Moved/deployed or no booster|1
5986315|NCT01011335|20700315|P13|Overall Study|Protocol Violation|0
5986316|NCT01011335|20700316|P12|Overall Study|Protocol Violation|0
5986317|NCT01011335|20700317|P11|Overall Study|Protocol Violation|0
5986318|NCT01011335|20700318|P10|Overall Study|Protocol Violation|0
5986319|NCT01011335|20700319|P9|Overall Study|Protocol Violation|0
5986320|NCT01011335|20700320|P8|Overall Study|Protocol Violation|0
5986321|NCT01011335|20700321|P7|Overall Study|Protocol Violation|0
5986322|NCT01011335|20700322|P6|Overall Study|Protocol Violation|0
5986323|NCT01011335|20700323|P5|Overall Study|Protocol Violation|0
5986324|NCT01011335|20700324|P4|Overall Study|Protocol Violation|0
5986325|NCT01011335|20700325|P3|Overall Study|Protocol Violation|0
5986326|NCT01011335|20700326|P2|Overall Study|Protocol Violation|1
5986327|NCT01011335|20700327|P1|Overall Study|Protocol Violation|0
5986328|NCT01011335|20700315|P13|Overall Study|Lost to Follow-up|2
5986329|NCT01011335|20700316|P12|Overall Study|Lost to Follow-up|1
5986330|NCT01011335|20700317|P11|Overall Study|Lost to Follow-up|0
5986331|NCT01011335|20700318|P10|Overall Study|Lost to Follow-up|0
5986332|NCT01011335|20700319|P9|Overall Study|Lost to Follow-up|1
5986333|NCT01011335|20700320|P8|Overall Study|Lost to Follow-up|2
5986334|NCT01011335|20700321|P7|Overall Study|Lost to Follow-up|2
5986335|NCT01011335|20700322|P6|Overall Study|Lost to Follow-up|1
5986336|NCT01011335|20700323|P5|Overall Study|Lost to Follow-up|1
5986337|NCT01011335|20700324|P4|Overall Study|Lost to Follow-up|1
5986338|NCT01011335|20700325|P3|Overall Study|Lost to Follow-up|1
5986339|NCT01011335|20700326|P2|Overall Study|Lost to Follow-up|0
5986340|NCT01011335|20700327|P1|Overall Study|Lost to Follow-up|0
5986341|NCT01011309|20700367|P3|Overall Study|Protocol Violation|3
5986342|NCT01011309|20700368|P2|Overall Study|Protocol Violation|1
5986343|NCT01011309|20700369|P1|Overall Study|Protocol Violation|0
5986344|NCT01011309|20700367|P3|Overall Study|Lack of Efficacy|0
5986345|NCT01011309|20700368|P2|Overall Study|Lack of Efficacy|1
5986346|NCT01011309|20700369|P1|Overall Study|Lack of Efficacy|0
5986347|NCT01011309|20700367|P3|Overall Study|Adverse Event|2
5986348|NCT01011309|20700368|P2|Overall Study|Adverse Event|1
5986349|NCT01011309|20700369|P1|Overall Study|Adverse Event|2
5986350|NCT01011283|20700385|P2|Overall Study|Other|2
5986351|NCT01011283|20700386|P1|Overall Study|Other|2
5986352|NCT01011283|20700385|P2|Overall Study|Terminated by Sponsor|5
5986353|NCT01011283|20700386|P1|Overall Study|Terminated by Sponsor|5
5986354|NCT01011283|20700385|P2|Overall Study|Progressive Disease|2
5986355|NCT01011283|20700386|P1|Overall Study|Progressive Disease|0
5986356|NCT01011283|20700385|P2|Overall Study|Adverse Event|2
5986357|NCT01011283|20700386|P1|Overall Study|Adverse Event|4
5986358|NCT01011153|20700435|P3|Overall Study|Less than 78 cases completed|9
5986359|NCT01011153|20700436|P2|Overall Study|Less than 78 cases completed|11
5986360|NCT01011153|20700437|P1|Overall Study|Less than 78 cases completed|8
5986361|NCT01011049|20700466|P4|Overall Study|Withdrawal by Subject|0
5986362|NCT01011049|20700467|P3|Overall Study|Withdrawal by Subject|1
5986363|NCT01011049|20700468|P2|Overall Study|Withdrawal by Subject|0
5986364|NCT01011049|20700469|P1|Overall Study|Withdrawal by Subject|0
5986365|NCT01011049|20700466|P4|Overall Study|Lost to Follow-up|0
5986366|NCT01011049|20700467|P3|Overall Study|Lost to Follow-up|1
5986367|NCT01011049|20700468|P2|Overall Study|Lost to Follow-up|2
5986368|NCT01011049|20700469|P1|Overall Study|Lost to Follow-up|1
5986369|NCT01011049|20700466|P4|Overall Study|Protocol Violation|0
5986370|NCT01011049|20700467|P3|Overall Study|Protocol Violation|2
5986371|NCT01011049|20700468|P2|Overall Study|Protocol Violation|0
5986372|NCT01011049|20700469|P1|Overall Study|Protocol Violation|0
5986373|NCT01010971|20700499|P3|Overall Study|Other|2
5986374|NCT01010971|20700500|P2|Overall Study|Other|0
5986375|NCT01010971|20700501|P1|Overall Study|Other|1
5986376|NCT01010971|20700499|P3|Overall Study|Lost to Follow-up|3
5986377|NCT01010971|20700500|P2|Overall Study|Lost to Follow-up|2
5986378|NCT01010971|20700501|P1|Overall Study|Lost to Follow-up|0
5986379|NCT01010971|20700499|P3|Overall Study|Withdrawal by Subject|5
5986380|NCT01010971|20700500|P2|Overall Study|Withdrawal by Subject|2
5986381|NCT01010971|20700501|P1|Overall Study|Withdrawal by Subject|0
5986382|NCT01010971|20700499|P3|Overall Study|Adverse Event|3
5986383|NCT01010971|20700500|P2|Overall Study|Adverse Event|4
5986384|NCT01010971|20700501|P1|Overall Study|Adverse Event|2
5986385|NCT01010867|20700629|P1|Overall Study|< 50% adherence to probiotic|1
5986386|NCT01010776|20700641|P1|Extension Phase|Other|3
5986387|NCT01010776|20700641|P1|In-Between Main Phase & Extension Phase|Extension phase was optional|15
5986388|NCT01010776|20700641|P1|Main Phase|Did not received study medication|5
5986389|NCT01010776|20700641|P1|Main Phase|Other|1
5986390|NCT01010776|20700641|P1|Main Phase|Inform consent withdrawal|1
5986391|NCT01010776|20700641|P1|Main Phase|Selection failure|2
5986392|NCT01010776|20700641|P1|Main Phase|Non-compliance to study medication|5
5986393|NCT01010776|20700641|P1|Main Phase|Lost to Follow-up|6
5986394|NCT01010776|20700641|P1|Main Phase|Adverse Event|7
5986395|NCT01010776|20700641|P1|Main Phase|Lack of Efficacy|8
5986396|NCT01010776|20700641|P1|Main Phase|Withdrawal by Subject|14
5986397|NCT01010750|20700698|P6|Second Intervention|Adverse Event|0
5986398|NCT01010750|20700699|P5|Second Intervention|Adverse Event|0
5986399|NCT01010750|20700700|P4|Second Intervention|Adverse Event|0
5986400|NCT01010750|20700701|P3|Second Intervention|Adverse Event|0
5986401|NCT01010750|20700702|P2|Second Intervention|Adverse Event|1
5986402|NCT01010750|20700703|P1|Second Intervention|Adverse Event|0
5986403|NCT01010633|20700728|P2|Overall Study|Investigator decision|1
5986404|NCT01010633|20700729|P1|Overall Study|Investigator decision|0
5986405|NCT01010633|20700728|P2|Overall Study|Withdrawal by Subject|1
5986406|NCT01010633|20700729|P1|Overall Study|Withdrawal by Subject|2
5986407|NCT01010633|20700728|P2|Overall Study|Protocol Violation|2
5986408|NCT01010633|20700729|P1|Overall Study|Protocol Violation|1
5986409|NCT01010633|20700728|P2|Overall Study|Adverse Event|1
5986410|NCT01010633|20700729|P1|Overall Study|Adverse Event|1
5986411|NCT01010503|20700756|P1|Overall Study|Death|1
5986412|NCT01010503|20700756|P1|Overall Study|Adverse Event|1
5986413|NCT01010230|20700815|P2|Overall Study|Lost to Follow-up|2
5986414|NCT01010230|20700816|P1|Overall Study|Lost to Follow-up|4
5986415|NCT01010230|20700815|P2|Overall Study|Withdrawal by Subject|5
5986416|NCT01010230|20700816|P1|Overall Study|Withdrawal by Subject|6
5986417|NCT01010217|20700851|P5|Overall Study|Physician Decision|3
5986418|NCT01010217|20700852|P4|Overall Study|Physician Decision|6
5986419|NCT01010217|20700853|P3|Overall Study|Physician Decision|0
5986420|NCT01010217|20700854|P2|Overall Study|Physician Decision|0
5986421|NCT01010217|20700855|P1|Overall Study|Physician Decision|0
5986422|NCT01010217|20700851|P5|Overall Study|Withdrawal by Subject|0
5986423|NCT01010217|20700852|P4|Overall Study|Withdrawal by Subject|0
5986424|NCT01010217|20700853|P3|Overall Study|Withdrawal by Subject|0
5986425|NCT01010217|20700854|P2|Overall Study|Withdrawal by Subject|0
5986426|NCT01010217|20700855|P1|Overall Study|Withdrawal by Subject|1
5986427|NCT01010217|20700851|P5|Overall Study|Lost to Follow-up|0
5986428|NCT01010217|20700852|P4|Overall Study|Lost to Follow-up|0
5986429|NCT01010217|20700853|P3|Overall Study|Lost to Follow-up|1
5986430|NCT01010217|20700854|P2|Overall Study|Lost to Follow-up|5
5986431|NCT01010217|20700855|P1|Overall Study|Lost to Follow-up|4
5986432|NCT01010204|20700894|P2|Overall Study|psychiatric hospitalization|1
5986433|NCT01010204|20700895|P1|Overall Study|psychiatric hospitalization|2
5986434|NCT01010204|20700894|P2|Overall Study|Withdrawal by Subject|3
5986435|NCT01010204|20700895|P1|Overall Study|Withdrawal by Subject|2
5986436|NCT01010204|20700894|P2|Overall Study|Adverse Event|3
5986437|NCT01010204|20700895|P1|Overall Study|Adverse Event|1
5986438|NCT01010204|20700894|P2|Overall Study|Lost to Follow-up|2
5986439|NCT01010204|20700895|P1|Overall Study|Lost to Follow-up|2
5986440|NCT01010126|20700911|P6|Overall Study|Withdrawal by Subject|0
5986441|NCT01010126|20700912|P5|Overall Study|Withdrawal by Subject|3
5986442|NCT01010126|20700913|P4|Overall Study|Withdrawal by Subject|0
5986443|NCT01010126|20700914|P3|Overall Study|Withdrawal by Subject|1
5986444|NCT01010126|20700915|P2|Overall Study|Withdrawal by Subject|0
5986445|NCT01010126|20700916|P1|Overall Study|Withdrawal by Subject|1
5986446|NCT01010061|20700968|P2|Overall Study|Did Not Receive Treatment|2
5986447|NCT01010061|20700969|P1|Overall Study|Did Not Receive Treatment|2
5986448|NCT01010061|20700968|P2|Overall Study|Violation of Selection Criteria|1
5986449|NCT01010061|20700969|P1|Overall Study|Violation of Selection Criteria|0
5986450|NCT01010061|20700968|P2|Overall Study|Insufficient Therapeutic Response|5
5986451|NCT01010061|20700969|P1|Overall Study|Insufficient Therapeutic Response|1
5986452|NCT01010061|20700968|P2|Overall Study|Refused Treatment/Did Not Cooperate|0
5986453|NCT01010061|20700969|P1|Overall Study|Refused Treatment/Did Not Cooperate|2
5986454|NCT01010061|20700968|P2|Overall Study|Administrative/Other|1
5986455|NCT01010061|20700969|P1|Overall Study|Administrative/Other|0
5986456|NCT01010061|20700968|P2|Overall Study|Death|6
5986457|NCT01010061|20700969|P1|Overall Study|Death|3
5986458|NCT01010061|20700968|P2|Overall Study|Withdrew Consent|1
5986459|NCT01010061|20700969|P1|Overall Study|Withdrew Consent|5
5986460|NCT01010061|20700968|P2|Overall Study|Disease Progression|8
5986461|NCT01010061|20700969|P1|Overall Study|Disease Progression|2
5986462|NCT01010061|20700968|P2|Overall Study|Adverse Events or Intercurrent Illness|16
5986463|NCT01010061|20700969|P1|Overall Study|Adverse Events or Intercurrent Illness|33
5986464|NCT01009983|20701020|P1|Overall Study|necessary scans not completed|1
5986465|NCT01009840|20701033|P1|Overall Study|Subject Withdrew Consent to Participate|1
5986466|NCT01009840|20701033|P1|Overall Study|Subject was Withdrawn by Investigator|1
5986467|NCT01009840|20701033|P1|Overall Study|Subject Met Withdrawal Criteria|7
5986468|NCT01009840|20701033|P1|Overall Study|Adverse Event|4
5986469|NCT01009840|20701033|P1|Overall Study|Lost to Follow-up|1
5986470|NCT01009814|20701051|P5|Overall Study|No longer met study criteria|0
5986471|NCT01009814|20701052|P4|Overall Study|No longer met study criteria|0
5986472|NCT01009814|20701053|P3|Overall Study|No longer met study criteria|0
5986473|NCT01009814|20701054|P2|Overall Study|No longer met study criteria|1
5986474|NCT01009814|20701055|P1|Overall Study|No longer met study criteria|1
5986475|NCT01009645|20701179|P4|Overall Study|Lost to Follow-up|5
5986476|NCT01009645|20701180|P3|Overall Study|Lost to Follow-up|4
5986477|NCT01009645|20701181|P2|Overall Study|Lost to Follow-up|8
5986478|NCT01009645|20701182|P1|Overall Study|Lost to Follow-up|2
5986479|NCT01009580|20701219|P2|Overall Study|Unclassified|21
5986480|NCT01009580|20701220|P1|Overall Study|Unclassified|17
5986481|NCT01009580|20701219|P2|Overall Study|Withdrawal Criteria|6
5986482|NCT01009580|20701220|P1|Overall Study|Withdrawal Criteria|4
5986483|NCT01009580|20701219|P2|Overall Study|Protocol Violation|3
5986484|NCT01009580|20701220|P1|Overall Study|Protocol Violation|2
5986485|NCT01009580|20701219|P2|Overall Study|Lack of Efficacy|1
5986486|NCT01009580|20701220|P1|Overall Study|Lack of Efficacy|0
5986487|NCT01009580|20701219|P2|Overall Study|Adverse Event|4
5986488|NCT01009580|20701220|P1|Overall Study|Adverse Event|4
5986489|NCT01009554|20701234|P2|Overall Study|Noncompliant with Study Product|3
5986490|NCT01009554|20701235|P1|Overall Study|Noncompliant with Study Product|0
5986491|NCT01009554|20701234|P2|Overall Study|Withdrawal by Subject|3
5986492|NCT01009554|20701235|P1|Overall Study|Withdrawal by Subject|1
5986493|NCT01009554|20701234|P2|Overall Study|Adverse Event|1
5986494|NCT01009554|20701235|P1|Overall Study|Adverse Event|1
5986495|NCT01009515|20701367|P1|Overall Study|Withdrawal by Subject|3
5986496|NCT01009463|20701378|P5|52-week, Double-blind Treatment Period|Physician Decision|8
5986497|NCT01009463|20701379|P4|52-week, Double-blind Treatment Period|Physician Decision|6
5986498|NCT01009463|20701380|P3|52-week, Double-blind Treatment Period|Physician Decision|6
5986499|NCT01009463|20701381|P2|52-week, Double-blind Treatment Period|Physician Decision|4
5986500|NCT01009463|20701382|P1|52-week, Double-blind Treatment Period|Physician Decision|0
5986501|NCT01009463|20701378|P5|52-week, Double-blind Treatment Period|Lost to Follow-up|5
5986502|NCT01009463|20701379|P4|52-week, Double-blind Treatment Period|Lost to Follow-up|6
5986503|NCT01009463|20701380|P3|52-week, Double-blind Treatment Period|Lost to Follow-up|7
5986504|NCT01009463|20701381|P2|52-week, Double-blind Treatment Period|Lost to Follow-up|11
5986505|NCT01009463|20701382|P1|52-week, Double-blind Treatment Period|Lost to Follow-up|0
5986506|NCT01009463|20701378|P5|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
5986507|NCT01009463|20701379|P4|52-week, Double-blind Treatment Period|Study Closed/Terminated|1
5986508|NCT01009463|20701380|P3|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
5986509|NCT01009463|20701381|P2|52-week, Double-blind Treatment Period|Study Closed/Terminated|2
5986510|NCT01009463|20701382|P1|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
5986511|NCT01009463|20701378|P5|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10
5986512|NCT01009463|20701379|P4|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13
5986513|NCT01009463|20701380|P3|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|14
5986514|NCT01009463|20701381|P2|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10
5986515|NCT01009463|20701382|P1|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0
5986516|NCT01009463|20701378|P5|52-week, Double-blind Treatment Period|Protocol Violation|7
5986517|NCT01009463|20701379|P4|52-week, Double-blind Treatment Period|Protocol Violation|8
5986518|NCT01009463|20701380|P3|52-week, Double-blind Treatment Period|Protocol Violation|7
5986519|NCT01009463|20701381|P2|52-week, Double-blind Treatment Period|Protocol Violation|8
5986520|NCT01009463|20701382|P1|52-week, Double-blind Treatment Period|Protocol Violation|0
5986521|NCT01009463|20701378|P5|52-week, Double-blind Treatment Period|Lack of Efficacy|18
5986522|NCT01009463|20701379|P4|52-week, Double-blind Treatment Period|Lack of Efficacy|11
5986523|NCT01009463|20701380|P3|52-week, Double-blind Treatment Period|Lack of Efficacy|16
5986524|NCT01009463|20701381|P2|52-week, Double-blind Treatment Period|Lack of Efficacy|24
5986525|NCT01009463|20701382|P1|52-week, Double-blind Treatment Period|Lack of Efficacy|0
5986526|NCT01009463|20701378|P5|52-week, Double-blind Treatment Period|Withdrawal by Subject|22
5986527|NCT01009463|20701379|P4|52-week, Double-blind Treatment Period|Withdrawal by Subject|17
5986528|NCT01009463|20701380|P3|52-week, Double-blind Treatment Period|Withdrawal by Subject|18
5986529|NCT01009463|20701381|P2|52-week, Double-blind Treatment Period|Withdrawal by Subject|34
5986530|NCT01009463|20701382|P1|52-week, Double-blind Treatment Period|Withdrawal by Subject|0
5986531|NCT01009463|20701378|P5|52-week, Double-blind Treatment Period|Adverse Event|31
5986532|NCT01009463|20701379|P4|52-week, Double-blind Treatment Period|Adverse Event|29
5986533|NCT01009463|20701380|P3|52-week, Double-blind Treatment Period|Adverse Event|25
5986534|NCT01009463|20701381|P2|52-week, Double-blind Treatment Period|Adverse Event|22
5986535|NCT01009463|20701382|P1|52-week, Double-blind Treatment Period|Adverse Event|0
5986536|NCT01009463|20701378|P5|4-week, Open-label Run-In Period|Withdrawal by Subject|0
5986537|NCT01009463|20701379|P4|4-week, Open-label Run-In Period|Withdrawal by Subject|0
5986538|NCT01009463|20701380|P3|4-week, Open-label Run-In Period|Withdrawal by Subject|0
5986539|NCT01009463|20701381|P2|4-week, Open-label Run-In Period|Withdrawal by Subject|0
5986540|NCT01009463|20701382|P1|4-week, Open-label Run-In Period|Withdrawal by Subject|50
5986541|NCT01009463|20701378|P5|4-week, Open-label Run-In Period|Physician Decision|0
5986542|NCT01009463|20701379|P4|4-week, Open-label Run-In Period|Physician Decision|0
5986543|NCT01009463|20701380|P3|4-week, Open-label Run-In Period|Physician Decision|0
5986544|NCT01009463|20701381|P2|4-week, Open-label Run-In Period|Physician Decision|0
5986545|NCT01009463|20701382|P1|4-week, Open-label Run-In Period|Physician Decision|10
5986546|NCT01009463|20701378|P5|4-week, Open-label Run-In Period|Lost to Follow-up|0
5986547|NCT01009463|20701379|P4|4-week, Open-label Run-In Period|Lost to Follow-up|0
5986548|NCT01009463|20701380|P3|4-week, Open-label Run-In Period|Lost to Follow-up|0
5986549|NCT01009463|20701381|P2|4-week, Open-label Run-In Period|Lost to Follow-up|0
5986550|NCT01009463|20701382|P1|4-week, Open-label Run-In Period|Lost to Follow-up|6
5986551|NCT01009463|20701378|P5|4-week, Open-label Run-In Period|Adverse Event|0
5986552|NCT01009463|20701379|P4|4-week, Open-label Run-In Period|Adverse Event|0
5986553|NCT01009463|20701380|P3|4-week, Open-label Run-In Period|Adverse Event|0
5986554|NCT01009463|20701381|P2|4-week, Open-label Run-In Period|Adverse Event|0
5986555|NCT01009463|20701382|P1|4-week, Open-label Run-In Period|Adverse Event|10
5986556|NCT01009463|20701378|P5|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
5986557|NCT01009463|20701379|P4|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
5986558|NCT01009463|20701380|P3|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
5986559|NCT01009463|20701381|P2|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
5986560|NCT01009463|20701382|P1|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|373
5986561|NCT01009346|20701404|P1|Overall Study|Adverse Event|4
5986562|NCT01009294|20701428|P1|Overall Study|Study discontinued by Sponsor|6
5986563|NCT01009203|20701449|P1|Overall Study|Treatment-unrelated death|1
5986564|NCT01009203|20701449|P1|Overall Study|Adverse Event|5
5986565|NCT01009203|20701449|P1|Overall Study|Withdrawal by Subject|1
5986566|NCT01009099|20701489|P2|Overall Study|Death|1
5986567|NCT01009099|20701490|P1|Overall Study|Death|0
5986568|NCT01009099|20701489|P2|Overall Study|Withdrawal by Subject|1
5986569|NCT01009099|20701490|P1|Overall Study|Withdrawal by Subject|1
5986570|NCT01009099|20701489|P2|Overall Study|Physician Decision|2
5986571|NCT01009099|20701490|P1|Overall Study|Physician Decision|3
5986572|NCT01009099|20701489|P2|Overall Study|Lost to Follow-up|0
5986573|NCT01009099|20701490|P1|Overall Study|Lost to Follow-up|1
5986574|NCT01009086|20701499|P3|Overall Study|Other|1
5986575|NCT01009086|20701500|P2|Overall Study|Other|5
5986576|NCT01009086|20701501|P1|Overall Study|Other|3
5986577|NCT01009086|20701499|P3|Overall Study|Withdrawal by Subject|13
5986578|NCT01009086|20701500|P2|Overall Study|Withdrawal by Subject|11
5986579|NCT01009086|20701501|P1|Overall Study|Withdrawal by Subject|9
5986580|NCT01009086|20701499|P3|Overall Study|Adverse Event|8
5986581|NCT01009086|20701500|P2|Overall Study|Adverse Event|11
5986582|NCT01009086|20701501|P1|Overall Study|Adverse Event|12
5986583|NCT01009086|20701499|P3|Overall Study|Lost to Follow-up|3
5986584|NCT01009086|20701500|P2|Overall Study|Lost to Follow-up|5
5986585|NCT01009086|20701501|P1|Overall Study|Lost to Follow-up|4
5986586|NCT01009086|20701499|P3|Overall Study|Lack of Efficacy|9
5986587|NCT01009086|20701500|P2|Overall Study|Lack of Efficacy|15
5986588|NCT01009086|20701501|P1|Overall Study|Lack of Efficacy|16
5986589|NCT01009060|20701536|P2|Overall Study|Withdrawal by Subject|1
5986590|NCT01009060|20701537|P1|Overall Study|Withdrawal by Subject|1
5986591|NCT01009060|20701536|P2|Overall Study|Physician Decision|1
5986592|NCT01009060|20701537|P1|Overall Study|Physician Decision|1
5986593|NCT01009060|20701536|P2|Overall Study|Lost to Follow-up|0
5986594|NCT01009060|20701537|P1|Overall Study|Lost to Follow-up|1
5986595|NCT01009060|20701536|P2|Overall Study|Protocol Violation|1
5986596|NCT01009060|20701537|P1|Overall Study|Protocol Violation|0
5986597|NCT01009060|20701536|P2|Overall Study|Adverse Event|2
5986598|NCT01009060|20701537|P1|Overall Study|Adverse Event|1
5986599|NCT01009047|20701575|P2|Overall Study|Other|2
5986600|NCT01009047|20701576|P1|Overall Study|Other|3
5986601|NCT01009047|20701575|P2|Overall Study|Withdrawal by consent|11
5986602|NCT01009047|20701576|P1|Overall Study|Withdrawal by consent|16
5986603|NCT01009047|20701575|P2|Overall Study|Lack of Efficacy|11
5986604|NCT01009047|20701576|P1|Overall Study|Lack of Efficacy|4
5986605|NCT01009047|20701575|P2|Overall Study|Lost to Follow-up|2
5986606|NCT01009047|20701576|P1|Overall Study|Lost to Follow-up|0
5986607|NCT01009047|20701575|P2|Overall Study|Adverse Event|0
5986608|NCT01009047|20701576|P1|Overall Study|Adverse Event|5
5986609|NCT01009034|20701598|P1|Overall Study|Withdrawal by Subject|2
5986610|NCT01009034|20701598|P1|Overall Study|Lost to Follow-up|2
5986611|NCT01008995|20701606|P4|After Controlled Period|Other|0
5986612|NCT01008995|20701607|P3|After Controlled Period|Other|1
5986613|NCT01008995|20701608|P2|After Controlled Period|Other|0
5986614|NCT01008995|20701609|P1|After Controlled Period|Other|0
5986615|NCT01008995|20701606|P4|After Controlled Period|Adverse Event|1
5986616|NCT01008995|20701607|P3|After Controlled Period|Adverse Event|1
5986617|NCT01008995|20701608|P2|After Controlled Period|Adverse Event|0
5986618|NCT01008995|20701609|P1|After Controlled Period|Adverse Event|0
5986619|NCT01008995|20701606|P4|Controlled Period|Other|0
5986620|NCT01008995|20701607|P3|Controlled Period|Other|0
5986621|NCT01008995|20701608|P2|Controlled Period|Other|1
5986622|NCT01008995|20701609|P1|Controlled Period|Other|2
5986623|NCT01008995|20701606|P4|Controlled Period|Adverse Event|0
5986624|NCT01008995|20701607|P3|Controlled Period|Adverse Event|0
5986625|NCT01008995|20701608|P2|Controlled Period|Adverse Event|2
5986626|NCT01008995|20701609|P1|Controlled Period|Adverse Event|1
5986627|NCT01008943|20701626|P1|Overall Study|Withdrawal by Subject|1
5986628|NCT01008904|20701633|P1|Overall Study|unexpected unrelated surgery|1
5986629|NCT01008904|20701633|P1|Overall Study|Adverse Event|2
5986630|NCT01008904|20701633|P1|Overall Study|Lost to Follow-up|1
5986631|NCT01008748|20701638|P1|Overall Study|Other|1
5986632|NCT01008748|20701638|P1|Overall Study|Lost to Follow-up|80
5986633|NCT01008696|20701663|P2|Overall Study|Other|2
5986634|NCT01008696|20701664|P1|Overall Study|Other|0
5986635|NCT01008696|20701663|P2|Overall Study|Other|3
5986636|NCT01008696|20701664|P1|Overall Study|Other|2
5986637|NCT01008696|20701663|P2|Overall Study|Participants' non-cooperation|3
5986638|NCT01008696|20701664|P1|Overall Study|Participants' non-cooperation|2
5986639|NCT01008696|20701663|P2|Overall Study|Adverse Event|0
5986640|NCT01008696|20701664|P1|Overall Study|Adverse Event|1
5986641|NCT01008696|20701663|P2|Overall Study|Physician Decision|1
5986642|NCT01008696|20701664|P1|Overall Study|Physician Decision|5
5986643|NCT01008696|20701663|P2|Overall Study|Withdrawal by Subject|4
5986644|NCT01008696|20701664|P1|Overall Study|Withdrawal by Subject|2
5986645|NCT01008696|20701663|P2|Overall Study|Participant's evasion of hospital visit|4
5986646|NCT01008696|20701664|P1|Overall Study|Participant's evasion of hospital visit|5
5986647|NCT01008618|20701674|P3|Period 2 (Double-Blind Period)|Not appropriate for this study|1
5986648|NCT01008618|20701675|P2|Period 2 (Double-Blind Period)|Not appropriate for this study|0
5986649|NCT01008618|20701676|P1|Period 2 (Double-Blind Period)|Not appropriate for this study|0
5986650|NCT01008618|20701674|P3|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|29
5986651|NCT01008618|20701675|P2|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|21
5986652|NCT01008618|20701676|P1|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0
5986653|NCT01008618|20701674|P3|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1
5986654|NCT01008618|20701675|P2|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0
5986655|NCT01008618|20701676|P1|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0
5986656|NCT01008618|20701674|P3|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|3
5986657|NCT01008618|20701675|P2|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0
5986658|NCT01008618|20701676|P1|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0
5986659|NCT01008618|20701674|P3|Period 2 (Double-Blind Period)|Physician Decision|0
5986660|NCT01008618|20701675|P2|Period 2 (Double-Blind Period)|Physician Decision|1
5986661|NCT01008618|20701676|P1|Period 2 (Double-Blind Period)|Physician Decision|0
5986662|NCT01008618|20701674|P3|Period 2 (Double-Blind Period)|Withdrawal by Subject|2
5986663|NCT01008618|20701675|P2|Period 2 (Double-Blind Period)|Withdrawal by Subject|3
5986664|NCT01008618|20701676|P1|Period 2 (Double-Blind Period)|Withdrawal by Subject|0
5986665|NCT01008618|20701674|P3|Period 2 (Double-Blind Period)|Adverse Event|2
5986666|NCT01008618|20701675|P2|Period 2 (Double-Blind Period)|Adverse Event|11
5986667|NCT01008618|20701676|P1|Period 2 (Double-Blind Period)|Adverse Event|0
5986668|NCT01008618|20701674|P3|Period 1 (Titration Period)|Aggravated symptom|0
5986669|NCT01008618|20701675|P2|Period 1 (Titration Period)|Aggravated symptom|0
5986670|NCT01008618|20701676|P1|Period 1 (Titration Period)|Aggravated symptom|2
5986671|NCT01008618|20701674|P3|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0
5986672|NCT01008618|20701675|P2|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0
5986673|NCT01008618|20701676|P1|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|20
5986674|NCT01008618|20701674|P3|Period 1 (Titration Period)|Withdrawal by Subject|0
5986675|NCT01008618|20701675|P2|Period 1 (Titration Period)|Withdrawal by Subject|0
5986676|NCT01008618|20701676|P1|Period 1 (Titration Period)|Withdrawal by Subject|11
5986677|NCT01008618|20701674|P3|Period 1 (Titration Period)|Adverse Event|0
5986678|NCT01008618|20701675|P2|Period 1 (Titration Period)|Adverse Event|0
5986679|NCT01008618|20701676|P1|Period 1 (Titration Period)|Adverse Event|33
5986680|NCT01008618|20701674|P3|Period 1 (Titration Period)|Physician Decision|0
5986681|NCT01008618|20701675|P2|Period 1 (Titration Period)|Physician Decision|0
5986682|NCT01008618|20701676|P1|Period 1 (Titration Period)|Physician Decision|2
5986683|NCT01008553|20701725|P3|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|35
5986684|NCT01008553|20701726|P2|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|18
5986685|NCT01008553|20701727|P1|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0
5986686|NCT01008553|20701725|P3|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1
5986687|NCT01008553|20701726|P2|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0
5986688|NCT01008553|20701727|P1|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0
5986689|NCT01008553|20701725|P3|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|3
5986690|NCT01008553|20701726|P2|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0
5986691|NCT01008553|20701727|P1|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0
5986692|NCT01008553|20701725|P3|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|4
5986693|NCT01008553|20701726|P2|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|1
5986694|NCT01008553|20701727|P1|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0
5986695|NCT01008553|20701725|P3|Period 2 (Double-Blind Period)|Impossible to perform required tests|0
5986696|NCT01008553|20701726|P2|Period 2 (Double-Blind Period)|Impossible to perform required tests|1
5986697|NCT01008553|20701727|P1|Period 2 (Double-Blind Period)|Impossible to perform required tests|0
5986698|NCT01008553|20701725|P3|Period 2 (Double-Blind Period)|Withdrawal by Subject|2
5986699|NCT01008553|20701726|P2|Period 2 (Double-Blind Period)|Withdrawal by Subject|2
5986700|NCT01008553|20701727|P1|Period 2 (Double-Blind Period)|Withdrawal by Subject|0
5986701|NCT01008553|20701725|P3|Period 2 (Double-Blind Period)|Adverse Event|4
5986702|NCT01008553|20701726|P2|Period 2 (Double-Blind Period)|Adverse Event|14
5986703|NCT01008553|20701727|P1|Period 2 (Double-Blind Period)|Adverse Event|0
5986704|NCT01008553|20701725|P3|Period 2 (Double-Blind Period)|Physician Decision|2
5986705|NCT01008553|20701726|P2|Period 2 (Double-Blind Period)|Physician Decision|1
5986706|NCT01008553|20701727|P1|Period 2 (Double-Blind Period)|Physician Decision|0
5986707|NCT01008553|20701725|P3|Period 1 (Titration Period)|Not appropriate for this study|0
5986708|NCT01008553|20701726|P2|Period 1 (Titration Period)|Not appropriate for this study|0
5986709|NCT01008553|20701727|P1|Period 1 (Titration Period)|Not appropriate for this study|1
5986710|NCT01008553|20701725|P3|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0
5986711|NCT01008553|20701726|P2|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0
5986712|NCT01008553|20701727|P1|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|50
5986713|NCT01008553|20701725|P3|Period 1 (Titration Period)|Determined to increase dosage|0
5986714|NCT01008553|20701726|P2|Period 1 (Titration Period)|Determined to increase dosage|0
5986715|NCT01008553|20701727|P1|Period 1 (Titration Period)|Determined to increase dosage|3
5986716|NCT01008553|20701725|P3|Period 1 (Titration Period)|Withdrawal by Subject|0
5986717|NCT01008553|20701726|P2|Period 1 (Titration Period)|Withdrawal by Subject|0
5986718|NCT01008553|20701727|P1|Period 1 (Titration Period)|Withdrawal by Subject|6
5986719|NCT01008553|20701725|P3|Period 1 (Titration Period)|Adverse Event|0
5986720|NCT01008553|20701726|P2|Period 1 (Titration Period)|Adverse Event|0
5986721|NCT01008553|20701727|P1|Period 1 (Titration Period)|Adverse Event|33
5986722|NCT01008553|20701725|P3|Period 1 (Titration Period)|Physician Decision|0
5986723|NCT01008553|20701726|P2|Period 1 (Titration Period)|Physician Decision|0
5986724|NCT01008553|20701727|P1|Period 1 (Titration Period)|Physician Decision|2
5986725|NCT01008475|20701759|P7|Overall Study|Ongoing treatment at data cut-off date|4
5986726|NCT01008475|20701760|P6|Overall Study|Ongoing treatment at data cut-off date|6
5986727|NCT01008475|20701761|P5|Overall Study|Ongoing treatment at data cut-off date|5
5986728|NCT01008475|20701762|P4|Overall Study|Ongoing treatment at data cut-off date|0
5986729|NCT01008475|20701763|P3|Overall Study|Ongoing treatment at data cut-off date|0
5986730|NCT01008475|20701764|P2|Overall Study|Ongoing treatment at data cut-off date|0
5986731|NCT01008475|20701765|P1|Overall Study|Ongoing treatment at data cut-off date|0
5986732|NCT01008449|20701805|P2|Overall Study|Lost to Follow-up|19
5986733|NCT01008449|20701806|P1|Overall Study|Lost to Follow-up|29
5986734|NCT01008423|20701828|P2|Overall Study|Other|1
5986735|NCT01008423|20701829|P1|Overall Study|Other|0
5986736|NCT01008423|20701828|P2|Overall Study|Personal Conflict|0
5986737|NCT01008423|20701829|P1|Overall Study|Personal Conflict|1
5986738|NCT01008423|20701828|P2|Overall Study|Disease Extent 70 centimeters (cm)|0
5986739|NCT01008423|20701829|P1|Overall Study|Disease Extent 70 centimeters (cm)|1
5986740|NCT01008423|20701828|P2|Overall Study|Lack of Efficacy|5
5986741|NCT01008423|20701829|P1|Overall Study|Lack of Efficacy|0
5986742|NCT01008423|20701828|P2|Overall Study|Low Cortisol|1
5986743|NCT01008423|20701829|P1|Overall Study|Low Cortisol|0
5986744|NCT01008423|20701828|P2|Overall Study|Lost to Follow-up|2
5986745|NCT01008423|20701829|P1|Overall Study|Lost to Follow-up|0
5986746|NCT01008423|20701828|P2|Overall Study|Withdrawal by Subject|7
5986747|NCT01008423|20701829|P1|Overall Study|Withdrawal by Subject|4
5986748|NCT01008423|20701828|P2|Overall Study|Adverse Event|6
5986749|NCT01008423|20701829|P1|Overall Study|Adverse Event|13
5986750|NCT01008410|20701855|P2|Overall Study|Met Exclusion Criterion|1
5986751|NCT01008410|20701856|P1|Overall Study|Met Exclusion Criterion|0
5986752|NCT01008410|20701855|P2|Overall Study|Lack of Efficacy|6
5986753|NCT01008410|20701856|P1|Overall Study|Lack of Efficacy|2
5986754|NCT01008410|20701855|P2|Overall Study|Low Cortisol|0
5986755|NCT01008410|20701856|P1|Overall Study|Low Cortisol|2
5986756|NCT01008410|20701855|P2|Overall Study|Noncompliance|0
5986757|NCT01008410|20701856|P1|Overall Study|Noncompliance|1
5986758|NCT01008410|20701855|P2|Overall Study|Lost to Follow-up|0
5986759|NCT01008410|20701856|P1|Overall Study|Lost to Follow-up|1
5986760|NCT01008410|20701855|P2|Overall Study|Withdrawal by Subject|2
5986761|NCT01008410|20701856|P1|Overall Study|Withdrawal by Subject|6
5986762|NCT01008410|20701855|P2|Overall Study|Adverse Event|7
5986763|NCT01008410|20701856|P1|Overall Study|Adverse Event|13
5986764|NCT01008150|20701910|P4|Overall Study|did not receive study drug|0
5986765|NCT01008150|20701911|P3|Overall Study|did not receive study drug|1
5986766|NCT01008150|20701912|P2|Overall Study|did not receive study drug|1
5986767|NCT01008150|20701913|P1|Overall Study|did not receive study drug|1
5986768|NCT01007916|20701961|P2|Period 2, 4 Weeks of Wear|Relocation|0
5986769|NCT01007916|20701962|P1|Period 2, 4 Weeks of Wear|Relocation|1
5986770|NCT01007916|20701961|P2|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|0
5986771|NCT01007916|20701962|P1|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|1
5986772|NCT01007942|20701970|P2|Overall Study|Patients untreated|3
5986773|NCT01007942|20701971|P1|Overall Study|Patients untreated|4
5986774|NCT01007942|20701970|P2|Overall Study|Death|2
5986775|NCT01007942|20701971|P1|Overall Study|Death|3
5986776|NCT01007942|20701970|P2|Overall Study|Administrative problems|0
5986777|NCT01007942|20701971|P1|Overall Study|Administrative problems|2
5986778|NCT01007942|20701970|P2|Overall Study|Lost to Follow-up|0
5986779|NCT01007942|20701971|P1|Overall Study|Lost to Follow-up|1
5986780|NCT01007942|20701970|P2|Overall Study|Withdrawal by Subject|14
5986781|NCT01007942|20701971|P1|Overall Study|Withdrawal by Subject|19
5986782|NCT01007942|20701970|P2|Overall Study|Protocol Violation|1
5986783|NCT01007942|20701971|P1|Overall Study|Protocol Violation|1
5986784|NCT01007942|20701970|P2|Overall Study|New cancer therapy|1
5986785|NCT01007942|20701971|P1|Overall Study|New cancer therapy|5
5986786|NCT01007942|20701970|P2|Overall Study|Disease progression|242
5986787|NCT01007942|20701971|P1|Overall Study|Disease progression|217
5986788|NCT01007942|20701970|P2|Overall Study|Abnormal test procedure|1
5986789|NCT01007942|20701971|P1|Overall Study|Abnormal test procedure|0
5986790|NCT01007942|20701970|P2|Overall Study|Adverse Event|14
5986791|NCT01007942|20701971|P1|Overall Study|Adverse Event|29
5986792|NCT01007838|20701997|P4|Overall Study|Started home haemodialysis|0
5986793|NCT01007838|20701998|P3|Overall Study|Started home haemodialysis|0
5986794|NCT01007838|20701999|P2|Overall Study|Started home haemodialysis|0
5986795|NCT01007838|20702000|P1|Overall Study|Started home haemodialysis|1
5986796|NCT01007838|20701997|P4|Overall Study|Physician Decision|0
5986797|NCT01007838|20701998|P3|Overall Study|Physician Decision|0
5986798|NCT01007838|20701999|P2|Overall Study|Physician Decision|0
5986799|NCT01007838|20702000|P1|Overall Study|Physician Decision|1
5986800|NCT01007838|20701997|P4|Overall Study|Withdrawal by Subject|0
5986801|NCT01007838|20701998|P3|Overall Study|Withdrawal by Subject|0
5986802|NCT01007838|20701999|P2|Overall Study|Withdrawal by Subject|0
5986803|NCT01007838|20702000|P1|Overall Study|Withdrawal by Subject|1
5986804|NCT01007812|20702010|P2|Period 1, One Week|Discomfort|0
5986805|NCT01007812|20702011|P1|Period 1, One Week|Discomfort|1
5986806|NCT01007812|20702010|P2|Period 1, One Week|Lost to Follow-up|1
5986807|NCT01007812|20702011|P1|Period 1, One Week|Lost to Follow-up|0
5986808|NCT01007552|20702061|P1|Overall Study|Withdrawal by Subject|1
5986809|NCT01007448|20702077|P2|Overall Study|Adverse Event|4
5986810|NCT01007448|20702078|P1|Overall Study|Adverse Event|1
5986811|NCT01007448|20702077|P2|Overall Study|Withdrawal by Subject|3
5986812|NCT01007448|20702078|P1|Overall Study|Withdrawal by Subject|2
5986813|NCT01007448|20702077|P2|Overall Study|Lack of Efficacy|0
5986814|NCT01007448|20702078|P1|Overall Study|Lack of Efficacy|2
5986815|NCT01007448|20702077|P2|Overall Study|Progressive Disease|2
5986816|NCT01007448|20702078|P1|Overall Study|Progressive Disease|1
5986817|NCT01007448|20702077|P2|Overall Study|Participant Given Prohibited Medication|0
5986818|NCT01007448|20702078|P1|Overall Study|Participant Given Prohibited Medication|1
5986819|NCT01007448|20702077|P2|Overall Study|Participant Leaving the Country|0
5986820|NCT01007448|20702078|P1|Overall Study|Participant Leaving the Country|1
5986821|NCT01007448|20702077|P2|Overall Study|Staph Skin Infection Flare|0
5986822|NCT01007448|20702078|P1|Overall Study|Staph Skin Infection Flare|1
5986823|NCT01007448|20702077|P2|Overall Study|Continuing Prohibited Systemic Drugs|0
5986824|NCT01007448|20702078|P1|Overall Study|Continuing Prohibited Systemic Drugs|1
5986825|NCT01007435|20702110|P4|Overall Study|Reason not Specified|1
5986826|NCT01007435|20702111|P3|Overall Study|Reason not Specified|2
5986827|NCT01007435|20702112|P2|Overall Study|Reason not Specified|1
5986828|NCT01007435|20702113|P1|Overall Study|Reason not Specified|1
5986829|NCT01007435|20702110|P4|Overall Study|Failure to Return|6
5986830|NCT01007435|20702111|P3|Overall Study|Failure to Return|3
5986831|NCT01007435|20702112|P2|Overall Study|Failure to Return|4
5986832|NCT01007435|20702113|P1|Overall Study|Failure to Return|5
5986833|NCT01007435|20702110|P4|Overall Study|Refused Treatment|8
5986834|NCT01007435|20702111|P3|Overall Study|Refused Treatment|5
5986835|NCT01007435|20702112|P2|Overall Study|Refused Treatment|13
5986836|NCT01007435|20702113|P1|Overall Study|Refused Treatment|13
5986837|NCT01007435|20702110|P4|Overall Study|Other Protocol Violation|0
5986838|NCT01007435|20702111|P3|Overall Study|Other Protocol Violation|1
5986839|NCT01007435|20702112|P2|Overall Study|Other Protocol Violation|0
5986840|NCT01007435|20702113|P1|Overall Study|Other Protocol Violation|2
5986841|NCT01007435|20702110|P4|Overall Study|Violation of Selection Criteria at Entry|0
5986842|NCT01007435|20702111|P3|Overall Study|Violation of Selection Criteria at Entry|2
5986843|NCT01007435|20702112|P2|Overall Study|Violation of Selection Criteria at Entry|5
5986844|NCT01007435|20702113|P1|Overall Study|Violation of Selection Criteria at Entry|3
5986845|NCT01007435|20702110|P4|Overall Study|Insufficient Therapeutic Response|9
5986846|NCT01007435|20702111|P3|Overall Study|Insufficient Therapeutic Response|2
5986847|NCT01007435|20702112|P2|Overall Study|Insufficient Therapeutic Response|7
5986848|NCT01007435|20702113|P1|Overall Study|Insufficient Therapeutic Response|21
5986849|NCT01007435|20702110|P4|Overall Study|Death|1
5986850|NCT01007435|20702111|P3|Overall Study|Death|2
5986851|NCT01007435|20702112|P2|Overall Study|Death|4
5986852|NCT01007435|20702113|P1|Overall Study|Death|2
5986853|NCT01007435|20702110|P4|Overall Study|Adverse Event|31
5986854|NCT01007435|20702111|P3|Overall Study|Adverse Event|47
5986855|NCT01007435|20702112|P2|Overall Study|Adverse Event|25
5986856|NCT01007435|20702113|P1|Overall Study|Adverse Event|16
5986857|NCT01007396|20702155|P1|Overall Study|Lost to Follow-up|47
5986858|NCT01007253|20702160|P4|Washout Period (2 Weeks) # 3|Physician Decision|0
5986859|NCT01007253|20702161|P3|Washout Period (2 Weeks) # 3|Physician Decision|0
5986860|NCT01007253|20702162|P2|Washout Period (2 Weeks) # 3|Physician Decision|0
5986861|NCT01007253|20702163|P1|Washout Period (2 Weeks) # 3|Physician Decision|1
5986862|NCT01007149|20702195|P2|Overall Study|Administrative problems|1
5986863|NCT01007149|20702196|P1|Overall Study|Administrative problems|0
5986864|NCT01007123|20702270|P4|Overall Study|Lost to Follow-up|0
5986865|NCT01007123|20702271|P3|Overall Study|Lost to Follow-up|0
5986866|NCT01007123|20702272|P2|Overall Study|Lost to Follow-up|1
5986867|NCT01007123|20702273|P1|Overall Study|Lost to Follow-up|0
5986868|NCT01007123|20702270|P4|Overall Study|Withdrawal by Subject|0
5986869|NCT01007123|20702271|P3|Overall Study|Withdrawal by Subject|1
5986870|NCT01007123|20702272|P2|Overall Study|Withdrawal by Subject|0
5986871|NCT01007123|20702273|P1|Overall Study|Withdrawal by Subject|1
5986872|NCT01007123|20702270|P4|Overall Study|Protocol Violation|1
5986873|NCT01007123|20702271|P3|Overall Study|Protocol Violation|2
5986874|NCT01007123|20702272|P2|Overall Study|Protocol Violation|1
5986875|NCT01007123|20702273|P1|Overall Study|Protocol Violation|1
5986876|NCT01007123|20702270|P4|Overall Study|Lack of Efficacy|4
5986877|NCT01007123|20702271|P3|Overall Study|Lack of Efficacy|1
5986878|NCT01007123|20702272|P2|Overall Study|Lack of Efficacy|0
5986879|NCT01007123|20702273|P1|Overall Study|Lack of Efficacy|1
5986880|NCT01007123|20702270|P4|Overall Study|Adverse Event|1
5986881|NCT01007123|20702271|P3|Overall Study|Adverse Event|7
5986882|NCT01007123|20702272|P2|Overall Study|Adverse Event|4
5986883|NCT01007123|20702273|P1|Overall Study|Adverse Event|3
5986884|NCT01007032|20702334|P4|Overall Study|Withdrawal by Subject|1
5986885|NCT01007032|20702335|P3|Overall Study|Withdrawal by Subject|0
5986886|NCT01007032|20702336|P2|Overall Study|Withdrawal by Subject|0
5986887|NCT01007032|20702337|P1|Overall Study|Withdrawal by Subject|0
5986888|NCT01007032|20702334|P4|Overall Study|On Study Treatment at Cut-off Date|0
5986889|NCT01007032|20702335|P3|Overall Study|On Study Treatment at Cut-off Date|1
5986890|NCT01007032|20702336|P2|Overall Study|On Study Treatment at Cut-off Date|1
5986891|NCT01007032|20702337|P1|Overall Study|On Study Treatment at Cut-off Date|0
5986892|NCT01006980|20702381|P2|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|10
5986893|NCT01006980|20702382|P1|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|0
5986894|NCT01006980|20702381|P2|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|1
5986895|NCT01006980|20702382|P1|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|0
5986896|NCT01006980|20702381|P2|Crossover: Dacarbazine to Vemurafenib|Progression|65
5986897|NCT01006980|20702382|P1|Crossover: Dacarbazine to Vemurafenib|Progression|0
5986898|NCT01006980|20702381|P2|Crossover: Dacarbazine to Vemurafenib|Death|4
5986899|NCT01006980|20702382|P1|Crossover: Dacarbazine to Vemurafenib|Death|0
5986900|NCT01006980|20702381|P2|Crossover: Dacarbazine to Vemurafenib|Adverse Event|4
5986901|NCT01006980|20702382|P1|Crossover: Dacarbazine to Vemurafenib|Adverse Event|0
5986902|NCT01006980|20702381|P2|Vemurafenib and Dacarbazine|Reason Not Specified|43
5986903|NCT01006980|20702382|P1|Vemurafenib and Dacarbazine|Reason Not Specified|26
5986904|NCT01006980|20702381|P2|Vemurafenib and Dacarbazine|Protocol Violation|3
5986905|NCT01006980|20702382|P1|Vemurafenib and Dacarbazine|Protocol Violation|2
5986906|NCT01006980|20702381|P2|Vemurafenib and Dacarbazine|Refuse Treatment|6
5986907|NCT01006980|20702382|P1|Vemurafenib and Dacarbazine|Refuse Treatment|9
5986908|NCT01006980|20702381|P2|Vemurafenib and Dacarbazine|Withdrawal of Consent|6
5986909|NCT01006980|20702382|P1|Vemurafenib and Dacarbazine|Withdrawal of Consent|4
5986910|NCT01006980|20702381|P2|Vemurafenib and Dacarbazine|Progression|218
5986911|NCT01006980|20702382|P1|Vemurafenib and Dacarbazine|Progression|257
5986912|NCT01006980|20702381|P2|Vemurafenib and Dacarbazine|Death|12
5986913|NCT01006980|20702382|P1|Vemurafenib and Dacarbazine|Death|13
5986914|NCT01006980|20702381|P2|Vemurafenib and Dacarbazine|Adverse Event|5
5986915|NCT01006980|20702382|P1|Vemurafenib and Dacarbazine|Adverse Event|25
5986916|NCT01006980|20702381|P2|Vemurafenib and Dacarbazine|Randomized but Not Treated|45
5986917|NCT01006980|20702382|P1|Vemurafenib and Dacarbazine|Randomized but Not Treated|1
5986918|NCT01006889|20702421|P1|Overall Study|Withdrawal by Subject|3
5986919|NCT01006707|20702432|P3|Study Session 1|Could not tolerate withdrawal in scanner|0
5986920|NCT01006707|20702433|P2|Study Session 1|Could not tolerate withdrawal in scanner|0
5986921|NCT01006707|20702434|P1|Study Session 1|Could not tolerate withdrawal in scanner|3
5986922|NCT01006707|20702432|P3|Study Session 1|Lost to Follow-up|0
5986923|NCT01006707|20702433|P2|Study Session 1|Lost to Follow-up|0
5986924|NCT01006707|20702434|P1|Study Session 1|Lost to Follow-up|2
5986925|NCT01006629|20702454|P1|Overall Study|Parent unable to perform site visit|4
5986926|NCT01006629|20702454|P1|Overall Study|Parent refused to continue participation|1
5986927|NCT01006629|20702454|P1|Overall Study|Adverse Event|1
5986928|NCT01006616|20702469|P4|Period 2 (18 Months)|Study Terminated|70
5986929|NCT01006616|20702470|P3|Period 2 (18 Months)|Study Terminated|44
5986930|NCT01006616|20702471|P2|Period 2 (18 Months)|Study Terminated|46
5986931|NCT01006616|20702472|P1|Period 2 (18 Months)|Study Terminated|63
5986932|NCT01006616|20702469|P4|Period 2 (18 Months)|Noncompliance With Protocol|1
5986933|NCT01006616|20702470|P3|Period 2 (18 Months)|Noncompliance With Protocol|0
5986934|NCT01006616|20702471|P2|Period 2 (18 Months)|Noncompliance With Protocol|1
5986935|NCT01006616|20702472|P1|Period 2 (18 Months)|Noncompliance With Protocol|0
5986936|NCT01006616|20702469|P4|Period 2 (18 Months)|Withdrawal by Subject|1
5986937|NCT01006616|20702470|P3|Period 2 (18 Months)|Withdrawal by Subject|0
5986938|NCT01006616|20702471|P2|Period 2 (18 Months)|Withdrawal by Subject|4
5986939|NCT01006616|20702472|P1|Period 2 (18 Months)|Withdrawal by Subject|1
5986940|NCT01006616|20702469|P4|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|2
5986941|NCT01006616|20702470|P3|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|1
5986942|NCT01006616|20702471|P2|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|6
5986943|NCT01006616|20702472|P1|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|0
5986944|NCT01006616|20702469|P4|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|2
5986945|NCT01006616|20702470|P3|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3
5986946|NCT01006616|20702471|P2|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|0
5986947|NCT01006616|20702472|P1|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3
5986948|NCT01006616|20702469|P4|Period 2 (18 Months)|Lost to Follow-up|0
5986949|NCT01006616|20702470|P3|Period 2 (18 Months)|Lost to Follow-up|0
5986950|NCT01006616|20702471|P2|Period 2 (18 Months)|Lost to Follow-up|0
5986951|NCT01006616|20702472|P1|Period 2 (18 Months)|Lost to Follow-up|2
5986952|NCT01006616|20702469|P4|Period 2 (18 Months)|Lack of Efficacy|2
5986953|NCT01006616|20702470|P3|Period 2 (18 Months)|Lack of Efficacy|1
5986954|NCT01006616|20702471|P2|Period 2 (18 Months)|Lack of Efficacy|0
5986955|NCT01006616|20702472|P1|Period 2 (18 Months)|Lack of Efficacy|0
5986956|NCT01006616|20702469|P4|Period 2 (18 Months)|Adverse Event|4
5986957|NCT01006616|20702470|P3|Period 2 (18 Months)|Adverse Event|6
5986958|NCT01006616|20702471|P2|Period 2 (18 Months)|Adverse Event|6
5986959|NCT01006616|20702472|P1|Period 2 (18 Months)|Adverse Event|6
5986960|NCT01006616|20702469|P4|Period 1 (6 Months)|Not Treated|1
5986961|NCT01006616|20702470|P3|Period 1 (6 Months)|Not Treated|1
5986962|NCT01006616|20702471|P2|Period 1 (6 Months)|Not Treated|0
5986963|NCT01006616|20702472|P1|Period 1 (6 Months)|Not Treated|0
5986964|NCT01006616|20702469|P4|Period 1 (6 Months)|Noncompliance With Protocol|3
5986965|NCT01006616|20702470|P3|Period 1 (6 Months)|Noncompliance With Protocol|2
5986966|NCT01006616|20702471|P2|Period 1 (6 Months)|Noncompliance With Protocol|2
5986967|NCT01006616|20702472|P1|Period 1 (6 Months)|Noncompliance With Protocol|0
5986968|NCT01006616|20702469|P4|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5
5986969|NCT01006616|20702470|P3|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5
5986970|NCT01006616|20702471|P2|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|7
5986971|NCT01006616|20702472|P1|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5
5986972|NCT01006616|20702469|P4|Period 1 (6 Months)|Withdrawal by Subject|0
5986973|NCT01006616|20702470|P3|Period 1 (6 Months)|Withdrawal by Subject|2
5986974|NCT01006616|20702471|P2|Period 1 (6 Months)|Withdrawal by Subject|2
5986975|NCT01006616|20702472|P1|Period 1 (6 Months)|Withdrawal by Subject|2
5986976|NCT01006616|20702469|P4|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|2
5986977|NCT01006616|20702470|P3|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|1
5986978|NCT01006616|20702471|P2|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|3
5986979|NCT01006616|20702472|P1|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|0
5986980|NCT01006616|20702469|P4|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|3
5986981|NCT01006616|20702470|P3|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|2
5986982|NCT01006616|20702471|P2|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|5
5986983|NCT01006616|20702472|P1|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|6
5986984|NCT01006616|20702469|P4|Period 1 (6 Months)|Lost to Follow-up|0
5986985|NCT01006616|20702470|P3|Period 1 (6 Months)|Lost to Follow-up|1
5986986|NCT01006616|20702471|P2|Period 1 (6 Months)|Lost to Follow-up|0
5986987|NCT01006616|20702472|P1|Period 1 (6 Months)|Lost to Follow-up|0
5986988|NCT01006616|20702469|P4|Period 1 (6 Months)|Lack of Efficacy|4
5986989|NCT01006616|20702470|P3|Period 1 (6 Months)|Lack of Efficacy|0
5986990|NCT01006616|20702471|P2|Period 1 (6 Months)|Lack of Efficacy|4
5986991|NCT01006616|20702472|P1|Period 1 (6 Months)|Lack of Efficacy|3
5986992|NCT01006616|20702469|P4|Period 1 (6 Months)|Adverse Event|9
5986993|NCT01006616|20702470|P3|Period 1 (6 Months)|Adverse Event|37
5986994|NCT01006616|20702471|P2|Period 1 (6 Months)|Adverse Event|31
5986995|NCT01006616|20702472|P1|Period 1 (6 Months)|Adverse Event|10
5986996|NCT01006603|20702608|P2|Overall Study|Other|7
5986997|NCT01006603|20702609|P1|Overall Study|Other|3
5986998|NCT01006603|20702608|P2|Overall Study|Study specific discontinuation criteria|34
5986999|NCT01006603|20702609|P1|Overall Study|Study specific discontinuation criteria|33
5987000|NCT01006603|20702608|P2|Overall Study|Death|1
5987001|NCT01006603|20702609|P1|Overall Study|Death|1
5987002|NCT01006603|20702608|P2|Overall Study|Adverse Event|7
5987003|NCT01006603|20702609|P1|Overall Study|Adverse Event|15
5987004|NCT01006603|20702608|P2|Overall Study|Incorrect enrolment|2
5987005|NCT01006603|20702609|P1|Overall Study|Incorrect enrolment|0
5987006|NCT01006603|20702608|P2|Overall Study|Protocol Violation|3
5987007|NCT01006603|20702609|P1|Overall Study|Protocol Violation|1
5987008|NCT01006603|20702608|P2|Overall Study|Safety reason|1
5987009|NCT01006603|20702609|P1|Overall Study|Safety reason|1
5987010|NCT01006603|20702608|P2|Overall Study|Lost to Follow-up|1
5987011|NCT01006603|20702609|P1|Overall Study|Lost to Follow-up|0
5987012|NCT01006603|20702608|P2|Overall Study|Withdrawal by Subject|19
5987013|NCT01006603|20702609|P1|Overall Study|Withdrawal by Subject|17
5987014|NCT01006590|20702629|P2|Overall Study|Other|2
5987015|NCT01006590|20702630|P1|Overall Study|Other|3
5987016|NCT01006590|20702629|P2|Overall Study|Study specific discontinuation criteria|23
5987017|NCT01006590|20702630|P1|Overall Study|Study specific discontinuation criteria|16
5987018|NCT01006590|20702629|P2|Overall Study|Withdrawal by Subject|2
5987019|NCT01006590|20702630|P1|Overall Study|Withdrawal by Subject|4
5987020|NCT01006590|20702629|P2|Overall Study|Protocol Violation|0
5987021|NCT01006590|20702630|P1|Overall Study|Protocol Violation|1
5987022|NCT01006590|20702629|P2|Overall Study|Lost to Follow-up|1
5987023|NCT01006590|20702630|P1|Overall Study|Lost to Follow-up|1
5987024|NCT01006590|20702629|P2|Overall Study|Death|1
5987025|NCT01006590|20702630|P1|Overall Study|Death|1
5987026|NCT01006590|20702629|P2|Overall Study|Adverse Event|3
5987027|NCT01006590|20702630|P1|Overall Study|Adverse Event|2
5987028|NCT01006356|20702669|P1|Overall Study|Other|23
5987029|NCT01006356|20702669|P1|Overall Study|Protocol Violation|3
5987030|NCT01006356|20702669|P1|Overall Study|Choice by participants|2
5987031|NCT01006356|20702669|P1|Overall Study|Withdrawal by Subject|1
5987032|NCT01006356|20702669|P1|Overall Study|Paticipants did not cooperate|6
5987033|NCT01006356|20702669|P1|Overall Study|Physician Decision|1
5987034|NCT01006356|20702669|P1|Overall Study|Adverse Event|6
5987035|NCT01006291|20702684|P3|Overall Study|Other|17
5987036|NCT01006291|20702685|P2|Overall Study|Other|14
5987037|NCT01006291|20702686|P1|Overall Study|Other|14
5987038|NCT01006291|20702684|P3|Overall Study|Withdrawal criteria|4
5987039|NCT01006291|20702685|P2|Overall Study|Withdrawal criteria|4
5987040|NCT01006291|20702686|P1|Overall Study|Withdrawal criteria|5
5987041|NCT01006291|20702684|P3|Overall Study|Protocol Violation|3
5987042|NCT01006291|20702685|P2|Overall Study|Protocol Violation|3
5987043|NCT01006291|20702686|P1|Overall Study|Protocol Violation|3
5987044|NCT01006291|20702684|P3|Overall Study|Lack of Efficacy|1
5987045|NCT01006291|20702685|P2|Overall Study|Lack of Efficacy|2
5987046|NCT01006291|20702686|P1|Overall Study|Lack of Efficacy|2
5987047|NCT01006291|20702684|P3|Overall Study|Adverse Event|2
5987048|NCT01006291|20702685|P2|Overall Study|Adverse Event|1
5987049|NCT01006291|20702686|P1|Overall Study|Adverse Event|2
5987050|NCT01006135|20702736|P1|Overall Study|Other|72
5987051|NCT01006135|20702736|P1|Overall Study|Lost to Follow-up|32
5987052|NCT01006135|20702736|P1|Overall Study|Protocol Violation|14
5987053|NCT01006135|20702736|P1|Overall Study|Adverse Event|22
5987054|NCT01006122|20702743|P2|Second Double-blind Intervention Period|Death|1
5987055|NCT01006122|20702744|P1|Second Double-blind Intervention Period|Death|0
5987056|NCT01006122|20702743|P2|Second Double-blind Intervention Period|Withdrawal by Subject|2
5987057|NCT01006122|20702744|P1|Second Double-blind Intervention Period|Withdrawal by Subject|0
5987058|NCT01006122|20702743|P2|Second Double-blind Intervention Period|Lost to Follow-up|3
5987059|NCT01006122|20702744|P1|Second Double-blind Intervention Period|Lost to Follow-up|0
5987060|NCT01006122|20702743|P2|Second Double-blind Intervention Period|Protocol Violation|0
5987061|NCT01006122|20702744|P1|Second Double-blind Intervention Period|Protocol Violation|1
5987062|NCT01006122|20702743|P2|Second Double-blind Intervention Period|Adverse Event|1
5987063|NCT01006122|20702744|P1|Second Double-blind Intervention Period|Adverse Event|1
5987064|NCT01006122|20702743|P2|First Double-blind Intervention Period|Adverse Event|4
5987065|NCT01006122|20702744|P1|First Double-blind Intervention Period|Adverse Event|0
5987066|NCT01006122|20702743|P2|First Double-blind Intervention Period|Other|0
5987067|NCT01006122|20702744|P1|First Double-blind Intervention Period|Other|3
5987068|NCT01006122|20702743|P2|First Double-blind Intervention Period|Lack of Efficacy|1
5987069|NCT01006122|20702744|P1|First Double-blind Intervention Period|Lack of Efficacy|2
5987070|NCT01006122|20702743|P2|First Double-blind Intervention Period|Does not meet entrance criteria|0
5987071|NCT01006122|20702744|P1|First Double-blind Intervention Period|Does not meet entrance criteria|1
5987072|NCT01006122|20702743|P2|First Double-blind Intervention Period|Withdrawal by Subject|8
5987073|NCT01006122|20702744|P1|First Double-blind Intervention Period|Withdrawal by Subject|9
5987074|NCT01006122|20702743|P2|First Double-blind Intervention Period|Pregnancy|1
5987075|NCT01006122|20702744|P1|First Double-blind Intervention Period|Pregnancy|0
5987076|NCT01006122|20702743|P2|First Double-blind Intervention Period|Protocol Violation|1
5987077|NCT01006122|20702744|P1|First Double-blind Intervention Period|Protocol Violation|1
5987078|NCT01006122|20702743|P2|First Double-blind Intervention Period|Lost to Follow-up|2
5987079|NCT01006122|20702744|P1|First Double-blind Intervention Period|Lost to Follow-up|0
5987080|NCT01005966|20702795|P5|Treatment Period 4 (14 Days)|Other Reason|1
5987081|NCT01005966|20702796|P4|Treatment Period 4 (14 Days)|Other Reason|0
5987082|NCT01005966|20702797|P3|Treatment Period 4 (14 Days)|Other Reason|0
5987083|NCT01005966|20702798|P2|Treatment Period 4 (14 Days)|Other Reason|0
5987084|NCT01005966|20702799|P1|Treatment Period 4 (14 Days)|Other Reason|0
5987085|NCT01005966|20702795|P5|Treatment Period 4 (14 Days)|Protocol Violation|0
5987086|NCT01005966|20702796|P4|Treatment Period 4 (14 Days)|Protocol Violation|0
5987087|NCT01005966|20702797|P3|Treatment Period 4 (14 Days)|Protocol Violation|0
5987088|NCT01005966|20702798|P2|Treatment Period 4 (14 Days)|Protocol Violation|1
5987089|NCT01005966|20702799|P1|Treatment Period 4 (14 Days)|Protocol Violation|0
5987090|NCT01005966|20702795|P5|Treatment Period 3 (14 Days)|Protocol Violation|1
5987091|NCT01005966|20702796|P4|Treatment Period 3 (14 Days)|Protocol Violation|0
5987092|NCT01005966|20702797|P3|Treatment Period 3 (14 Days)|Protocol Violation|0
5987093|NCT01005966|20702798|P2|Treatment Period 3 (14 Days)|Protocol Violation|1
5987094|NCT01005966|20702799|P1|Treatment Period 3 (14 Days)|Protocol Violation|0
5987095|NCT01005966|20702795|P5|Treatment Period 2 (14 Days)|Withdrawal by Subject|0
5987096|NCT01005966|20702796|P4|Treatment Period 2 (14 Days)|Withdrawal by Subject|0
5987097|NCT01005966|20702797|P3|Treatment Period 2 (14 Days)|Withdrawal by Subject|1
5987098|NCT01005966|20702798|P2|Treatment Period 2 (14 Days)|Withdrawal by Subject|0
5987099|NCT01005966|20702799|P1|Treatment Period 2 (14 Days)|Withdrawal by Subject|0
5987100|NCT01005966|20702795|P5|Treatment Period 2 (14 Days)|Protocol Violation|0
5987101|NCT01005966|20702796|P4|Treatment Period 2 (14 Days)|Protocol Violation|1
5987102|NCT01005966|20702797|P3|Treatment Period 2 (14 Days)|Protocol Violation|0
5987103|NCT01005966|20702798|P2|Treatment Period 2 (14 Days)|Protocol Violation|0
5987104|NCT01005966|20702799|P1|Treatment Period 2 (14 Days)|Protocol Violation|0
5987105|NCT01005966|20702795|P5|Treatment Period 2 (14 Days)|Adverse Event|0
5987106|NCT01005966|20702796|P4|Treatment Period 2 (14 Days)|Adverse Event|0
5987107|NCT01005966|20702797|P3|Treatment Period 2 (14 Days)|Adverse Event|1
5987108|NCT01005966|20702798|P2|Treatment Period 2 (14 Days)|Adverse Event|1
5987109|NCT01005966|20702799|P1|Treatment Period 2 (14 Days)|Adverse Event|0
5987110|NCT01005966|20702795|P5|Washout Period 1 (4 Days)|Withdrawal by Subject|0
5987111|NCT01005966|20702796|P4|Washout Period 1 (4 Days)|Withdrawal by Subject|1
5987112|NCT01005966|20702797|P3|Washout Period 1 (4 Days)|Withdrawal by Subject|0
5987113|NCT01005966|20702798|P2|Washout Period 1 (4 Days)|Withdrawal by Subject|0
5987114|NCT01005966|20702799|P1|Washout Period 1 (4 Days)|Withdrawal by Subject|0
5987115|NCT01005966|20702795|P5|Treatment Period 1 (14 Days)|Protocol Violation|0
5987116|NCT01005966|20702796|P4|Treatment Period 1 (14 Days)|Protocol Violation|0
5987117|NCT01005966|20702797|P3|Treatment Period 1 (14 Days)|Protocol Violation|1
5987118|NCT01005966|20702798|P2|Treatment Period 1 (14 Days)|Protocol Violation|0
5987119|NCT01005966|20702799|P1|Treatment Period 1 (14 Days)|Protocol Violation|1
5987120|NCT01005966|20702795|P5|Treatment Period 1 (14 Days)|Adverse Event|0
5987121|NCT01005966|20702796|P4|Treatment Period 1 (14 Days)|Adverse Event|0
5987122|NCT01005966|20702797|P3|Treatment Period 1 (14 Days)|Adverse Event|0
5987123|NCT01005966|20702798|P2|Treatment Period 1 (14 Days)|Adverse Event|0
5987124|NCT01005966|20702799|P1|Treatment Period 1 (14 Days)|Adverse Event|1
5987125|NCT01005914|20702819|P1|Overall Study|Withdrawal by Subject|1
5987126|NCT01005914|20702819|P1|Overall Study|Lack of Efficacy|1
5987127|NCT01005914|20702819|P1|Overall Study|Death|4
5987128|NCT01005914|20702819|P1|Overall Study|Adverse Event|4
5987129|NCT01005901|20702825|P2|Overall Study|No longer requires study drug|1
5987130|NCT01005901|20702826|P1|Overall Study|No longer requires study drug|0
5987131|NCT01005901|20702825|P2|Overall Study|Patient's inability to use the device|1
5987132|NCT01005901|20702826|P1|Overall Study|Patient's inability to use the device|1
5987133|NCT01005901|20702825|P2|Overall Study|Lost to Follow-up|2
5987134|NCT01005901|20702826|P1|Overall Study|Lost to Follow-up|1
5987135|NCT01005901|20702825|P2|Overall Study|Death|3
5987136|NCT01005901|20702826|P1|Overall Study|Death|2
5987137|NCT01005901|20702825|P2|Overall Study|Protocol Violation|3
5987138|NCT01005901|20702826|P1|Overall Study|Protocol Violation|4
5987139|NCT01005901|20702825|P2|Overall Study|Unsatisfactory therapeutic effect|5
5987140|NCT01005901|20702826|P1|Overall Study|Unsatisfactory therapeutic effect|5
5987141|NCT01005901|20702825|P2|Overall Study|Administrative problems|13
5987142|NCT01005901|20702826|P1|Overall Study|Administrative problems|21
5987143|NCT01005901|20702825|P2|Overall Study|Adverse Event|16
5987144|NCT01005901|20702826|P1|Overall Study|Adverse Event|30
5987145|NCT01005901|20702825|P2|Overall Study|Withdrawal by Subject|14
5987146|NCT01005901|20702826|P1|Overall Study|Withdrawal by Subject|38
5987147|NCT01005875|20702889|P1|Overall Study|Death|3
5987148|NCT01005745|20702906|P1|Overall Study|Inappropriate antidiuretic hormone|1
5987149|NCT01005745|20702906|P1|Overall Study|Death prior to treatment|1
5987150|NCT01005745|20702906|P1|Overall Study|Disease progressed during TIL growth|3
5987151|NCT01005745|20702906|P1|Overall Study|No TIL growth|1
5987152|NCT01005732|20702911|P1|Overall Study|Death|1
5987153|NCT01005732|20702911|P1|Overall Study|Lost to Follow-up|10
5987154|NCT01005719|20702927|P6|Period 2|Adverse Event|1
5987155|NCT01005719|20702928|P5|Period 2|Adverse Event|1
5987156|NCT01005719|20702929|P4|Period 2|Adverse Event|0
5987157|NCT01005719|20702930|P3|Period 2|Adverse Event|0
5987158|NCT01005719|20702931|P2|Period 2|Adverse Event|0
5987159|NCT01005719|20702932|P1|Period 2|Adverse Event|0
5987160|NCT01005719|20702927|P6|Period 1|Delay in completing study procedures|1
5987161|NCT01005719|20702928|P5|Period 1|Delay in completing study procedures|0
5987162|NCT01005719|20702929|P4|Period 1|Delay in completing study procedures|0
5987163|NCT01005719|20702930|P3|Period 1|Delay in completing study procedures|0
5987164|NCT01005719|20702931|P2|Period 1|Delay in completing study procedures|0
5987165|NCT01005719|20702932|P1|Period 1|Delay in completing study procedures|0
5987166|NCT01005719|20702927|P6|Period 1|Adverse Event|0
5987167|NCT01005719|20702928|P5|Period 1|Adverse Event|0
5987168|NCT01005719|20702929|P4|Period 1|Adverse Event|1
5987169|NCT01005719|20702930|P3|Period 1|Adverse Event|0
5987170|NCT01005719|20702931|P2|Period 1|Adverse Event|0
5987171|NCT01005719|20702932|P1|Period 1|Adverse Event|0
5987172|NCT01005680|20702999|P2|Overall Study|Physician Decision|1
5987173|NCT01005680|20703000|P1|Overall Study|Physician Decision|1
5987174|NCT01005680|20702999|P2|Overall Study|Withdrawal by Subject|4
5987175|NCT01005680|20703000|P1|Overall Study|Withdrawal by Subject|1
5987176|NCT01005680|20702999|P2|Overall Study|Lost to Follow-up|6
5987177|NCT01005680|20703000|P1|Overall Study|Lost to Follow-up|4
5987178|NCT01005602|20703024|P2|Overall Study|Excluded due to unreliable clinical data|0
5987179|NCT01005602|20703025|P1|Overall Study|Excluded due to unreliable clinical data|1
5987180|NCT01005329|20703113|P1|Overall Study|Ineligible or received no protocol trt.|4
5987181|NCT01005316|20703126|P4|Overall Study|Retransplanted|0
5987182|NCT01005316|20703127|P3|Overall Study|Retransplanted|0
5987183|NCT01005316|20703128|P2|Overall Study|Retransplanted|1
5987184|NCT01005316|20703129|P1|Overall Study|Retransplanted|0
5987185|NCT01005316|20703126|P4|Overall Study|Transferred Care|3
5987186|NCT01005316|20703127|P3|Overall Study|Transferred Care|1
5987187|NCT01005316|20703128|P2|Overall Study|Transferred Care|0
5987188|NCT01005316|20703129|P1|Overall Study|Transferred Care|1
5987189|NCT01005316|20703126|P4|Overall Study|Delisted|0
5987190|NCT01005316|20703127|P3|Overall Study|Delisted|0
5987191|NCT01005316|20703128|P2|Overall Study|Delisted|0
5987192|NCT01005316|20703129|P1|Overall Study|Delisted|8
5987193|NCT01005316|20703126|P4|Overall Study|Consented to Another Study|0
5987194|NCT01005316|20703127|P3|Overall Study|Consented to Another Study|0
5987195|NCT01005316|20703128|P2|Overall Study|Consented to Another Study|0
5987196|NCT01005316|20703129|P1|Overall Study|Consented to Another Study|2
5987197|NCT01005316|20703126|P4|Overall Study|Withdrawal by Subject|2
5987198|NCT01005316|20703127|P3|Overall Study|Withdrawal by Subject|0
5987199|NCT01005316|20703128|P2|Overall Study|Withdrawal by Subject|1
5987200|NCT01005316|20703129|P1|Overall Study|Withdrawal by Subject|1
5987201|NCT01005316|20703126|P4|Overall Study|Sponsor Decision|0
5987202|NCT01005316|20703127|P3|Overall Study|Sponsor Decision|0
5987203|NCT01005316|20703128|P2|Overall Study|Sponsor Decision|3
5987204|NCT01005316|20703129|P1|Overall Study|Sponsor Decision|6
5987205|NCT01005316|20703126|P4|Overall Study|Physician Decision|0
5987206|NCT01005316|20703127|P3|Overall Study|Physician Decision|0
5987207|NCT01005316|20703128|P2|Overall Study|Physician Decision|0
5987208|NCT01005316|20703129|P1|Overall Study|Physician Decision|6
5987209|NCT01005316|20703126|P4|Overall Study|Lost to Follow-up|2
5987210|NCT01005316|20703127|P3|Overall Study|Lost to Follow-up|0
5987211|NCT01005316|20703128|P2|Overall Study|Lost to Follow-up|3
5987212|NCT01005316|20703129|P1|Overall Study|Lost to Follow-up|1
5987213|NCT01005316|20703126|P4|Overall Study|Study Termination|85
5987214|NCT01005316|20703127|P3|Overall Study|Study Termination|9
5987215|NCT01005316|20703128|P2|Overall Study|Study Termination|63
5987216|NCT01005316|20703129|P1|Overall Study|Study Termination|5
5987217|NCT01005316|20703126|P4|Overall Study|Death|15
5987218|NCT01005316|20703127|P3|Overall Study|Death|1
5987219|NCT01005316|20703128|P2|Overall Study|Death|5
5987220|NCT01005316|20703129|P1|Overall Study|Death|20
5987221|NCT01005316|20703126|P4|Overall Study|Adverse Event|1
5987222|NCT01005316|20703127|P3|Overall Study|Adverse Event|0
5987223|NCT01005316|20703128|P2|Overall Study|Adverse Event|0
5987224|NCT01005316|20703129|P1|Overall Study|Adverse Event|0
5987225|NCT01005251|20703196|P5|Overall Study|Lack of Efficacy|0
5987226|NCT01005251|20703197|P4|Overall Study|Lack of Efficacy|1
5987227|NCT01005251|20703198|P3|Overall Study|Lack of Efficacy|1
5987228|NCT01005251|20703199|P2|Overall Study|Lack of Efficacy|0
5987229|NCT01005251|20703200|P1|Overall Study|Lack of Efficacy|0
5987230|NCT01005251|20703196|P5|Overall Study|Randomized in error|0
5987231|NCT01005251|20703197|P4|Overall Study|Randomized in error|1
5987232|NCT01005251|20703198|P3|Overall Study|Randomized in error|1
5987233|NCT01005251|20703199|P2|Overall Study|Randomized in error|0
5987234|NCT01005251|20703200|P1|Overall Study|Randomized in error|0
5987235|NCT01005251|20703196|P5|Overall Study|Wrong drug dispensed|0
5987236|NCT01005251|20703197|P4|Overall Study|Wrong drug dispensed|0
5987237|NCT01005251|20703198|P3|Overall Study|Wrong drug dispensed|0
5987238|NCT01005251|20703199|P2|Overall Study|Wrong drug dispensed|1
5987239|NCT01005251|20703200|P1|Overall Study|Wrong drug dispensed|0
5987240|NCT01005251|20703196|P5|Overall Study|Patient moved|0
5987241|NCT01005251|20703197|P4|Overall Study|Patient moved|0
5987242|NCT01005251|20703198|P3|Overall Study|Patient moved|0
5987243|NCT01005251|20703199|P2|Overall Study|Patient moved|0
5987244|NCT01005251|20703200|P1|Overall Study|Patient moved|1
5987245|NCT01005251|20703196|P5|Overall Study|Physician Decision|2
5987246|NCT01005251|20703197|P4|Overall Study|Physician Decision|0
5987247|NCT01005251|20703198|P3|Overall Study|Physician Decision|0
5987248|NCT01005251|20703199|P2|Overall Study|Physician Decision|0
5987249|NCT01005251|20703200|P1|Overall Study|Physician Decision|0
5987250|NCT01005251|20703196|P5|Overall Study|Lost to Follow-up|0
5987251|NCT01005251|20703197|P4|Overall Study|Lost to Follow-up|0
5987252|NCT01005251|20703198|P3|Overall Study|Lost to Follow-up|2
5987253|NCT01005251|20703199|P2|Overall Study|Lost to Follow-up|4
5987254|NCT01005251|20703200|P1|Overall Study|Lost to Follow-up|1
5987255|NCT01005251|20703196|P5|Overall Study|Developed study-specific withdrawal crit|1
5987256|NCT01005251|20703197|P4|Overall Study|Developed study-specific withdrawal crit|0
5987257|NCT01005251|20703198|P3|Overall Study|Developed study-specific withdrawal crit|3
5987258|NCT01005251|20703199|P2|Overall Study|Developed study-specific withdrawal crit|0
5987259|NCT01005251|20703200|P1|Overall Study|Developed study-specific withdrawal crit|2
5987260|NCT01005251|20703196|P5|Overall Study|Protocol Violation|2
5987261|NCT01005251|20703197|P4|Overall Study|Protocol Violation|0
5987262|NCT01005251|20703198|P3|Overall Study|Protocol Violation|0
5987263|NCT01005251|20703199|P2|Overall Study|Protocol Violation|0
5987264|NCT01005251|20703200|P1|Overall Study|Protocol Violation|1
5987265|NCT01005251|20703196|P5|Overall Study|Adverse Event|4
5987266|NCT01005251|20703197|P4|Overall Study|Adverse Event|5
5987267|NCT01005251|20703198|P3|Overall Study|Adverse Event|8
5987268|NCT01005251|20703199|P2|Overall Study|Adverse Event|6
5987269|NCT01005251|20703200|P1|Overall Study|Adverse Event|2
5987270|NCT01005251|20703196|P5|Overall Study|Eligibility criteria not fulfilled|0
5987271|NCT01005251|20703197|P4|Overall Study|Eligibility criteria not fulfilled|1
5987272|NCT01005251|20703198|P3|Overall Study|Eligibility criteria not fulfilled|4
5987273|NCT01005251|20703199|P2|Overall Study|Eligibility criteria not fulfilled|0
5987274|NCT01005251|20703200|P1|Overall Study|Eligibility criteria not fulfilled|4
5987275|NCT01005251|20703196|P5|Overall Study|Withdrawal by Subject|9
5987276|NCT01005251|20703197|P4|Overall Study|Withdrawal by Subject|4
5987277|NCT01005251|20703198|P3|Overall Study|Withdrawal by Subject|3
5987278|NCT01005251|20703199|P2|Overall Study|Withdrawal by Subject|5
5987279|NCT01005251|20703200|P1|Overall Study|Withdrawal by Subject|2
5987280|NCT01004861|20703284|P13|Overall Study|Ongoing (as of 31 Jan 2018)|0
5987281|NCT01004861|20703285|P12|Overall Study|Ongoing (as of 31 Jan 2018)|0
5987282|NCT01004861|20703286|P11|Overall Study|Ongoing (as of 31 Jan 2018)|0
5987283|NCT01004861|20703287|P10|Overall Study|Ongoing (as of 31 Jan 2018)|0
5987284|NCT01004861|20703288|P9|Overall Study|Ongoing (as of 31 Jan 2018)|13
5987285|NCT01004861|20703289|P8|Overall Study|Ongoing (as of 31 Jan 2018)|0
5987286|NCT01004861|20703290|P7|Overall Study|Ongoing (as of 31 Jan 2018)|0
5987287|NCT01004861|20703291|P6|Overall Study|Ongoing (as of 31 Jan 2018)|0
5987288|NCT01004861|20703292|P5|Overall Study|Ongoing (as of 31 Jan 2018)|0
5987289|NCT01004861|20703293|P4|Overall Study|Ongoing (as of 31 Jan 2018)|0
5987290|NCT01004861|20703294|P3|Overall Study|Ongoing (as of 31 Jan 2018)|0
5987291|NCT01004861|20703295|P2|Overall Study|Ongoing (as of 31 Jan 2018)|0
5987292|NCT01004861|20703296|P1|Overall Study|Ongoing (as of 31 Jan 2018)|0
5987293|NCT01004861|20703284|P13|Overall Study|Other|3
5987294|NCT01004861|20703285|P12|Overall Study|Other|2
5987295|NCT01004861|20703286|P11|Overall Study|Other|1
5987296|NCT01004861|20703287|P10|Overall Study|Other|2
5987297|NCT01004861|20703288|P9|Overall Study|Other|1
5987298|NCT01004861|20703289|P8|Overall Study|Other|0
5987299|NCT01004861|20703290|P7|Overall Study|Other|0
5987300|NCT01004861|20703291|P6|Overall Study|Other|0
5987301|NCT01004861|20703292|P5|Overall Study|Other|0
5987302|NCT01004861|20703293|P4|Overall Study|Other|0
5987303|NCT01004861|20703294|P3|Overall Study|Other|0
5987304|NCT01004861|20703295|P2|Overall Study|Other|0
5987305|NCT01004861|20703296|P1|Overall Study|Other|0
5987306|NCT01004861|20703284|P13|Overall Study|Non-compliance|1
5987307|NCT01004861|20703285|P12|Overall Study|Non-compliance|0
5987308|NCT01004861|20703286|P11|Overall Study|Non-compliance|0
5987309|NCT01004861|20703287|P10|Overall Study|Non-compliance|0
5987310|NCT01004861|20703288|P9|Overall Study|Non-compliance|5
5987311|NCT01004861|20703289|P8|Overall Study|Non-compliance|0
5987312|NCT01004861|20703290|P7|Overall Study|Non-compliance|0
5987313|NCT01004861|20703291|P6|Overall Study|Non-compliance|0
5987314|NCT01004861|20703292|P5|Overall Study|Non-compliance|0
5987315|NCT01004861|20703293|P4|Overall Study|Non-compliance|0
5987316|NCT01004861|20703294|P3|Overall Study|Non-compliance|0
5987317|NCT01004861|20703295|P2|Overall Study|Non-compliance|0
5987318|NCT01004861|20703296|P1|Overall Study|Non-compliance|0
5987319|NCT01004861|20703284|P13|Overall Study|Lost to Follow-up|0
5987320|NCT01004861|20703285|P12|Overall Study|Lost to Follow-up|1
5987321|NCT01004861|20703286|P11|Overall Study|Lost to Follow-up|0
5987322|NCT01004861|20703287|P10|Overall Study|Lost to Follow-up|0
5987323|NCT01004861|20703288|P9|Overall Study|Lost to Follow-up|1
5987324|NCT01004861|20703289|P8|Overall Study|Lost to Follow-up|1
5987325|NCT01004861|20703290|P7|Overall Study|Lost to Follow-up|0
5987326|NCT01004861|20703291|P6|Overall Study|Lost to Follow-up|0
5987327|NCT01004861|20703292|P5|Overall Study|Lost to Follow-up|0
5987328|NCT01004861|20703293|P4|Overall Study|Lost to Follow-up|0
5987329|NCT01004861|20703294|P3|Overall Study|Lost to Follow-up|0
5987330|NCT01004861|20703295|P2|Overall Study|Lost to Follow-up|0
5987331|NCT01004861|20703296|P1|Overall Study|Lost to Follow-up|0
5987332|NCT01004861|20703284|P13|Overall Study|Withdrawal by Subject|3
5987333|NCT01004861|20703285|P12|Overall Study|Withdrawal by Subject|2
5987334|NCT01004861|20703286|P11|Overall Study|Withdrawal by Subject|1
5987335|NCT01004861|20703287|P10|Overall Study|Withdrawal by Subject|1
5987336|NCT01004861|20703288|P9|Overall Study|Withdrawal by Subject|2
5987337|NCT01004861|20703289|P8|Overall Study|Withdrawal by Subject|0
5987338|NCT01004861|20703290|P7|Overall Study|Withdrawal by Subject|1
5987339|NCT01004861|20703291|P6|Overall Study|Withdrawal by Subject|0
5987340|NCT01004861|20703292|P5|Overall Study|Withdrawal by Subject|1
5987341|NCT01004861|20703293|P4|Overall Study|Withdrawal by Subject|0
5987342|NCT01004861|20703294|P3|Overall Study|Withdrawal by Subject|0
5987343|NCT01004861|20703295|P2|Overall Study|Withdrawal by Subject|0
5987344|NCT01004861|20703296|P1|Overall Study|Withdrawal by Subject|0
5987345|NCT01004861|20703284|P13|Overall Study|Protocol Violation|0
5987346|NCT01004861|20703285|P12|Overall Study|Protocol Violation|0
5987347|NCT01004861|20703286|P11|Overall Study|Protocol Violation|0
5987348|NCT01004861|20703287|P10|Overall Study|Protocol Violation|0
5987349|NCT01004861|20703288|P9|Overall Study|Protocol Violation|0
5987350|NCT01004861|20703289|P8|Overall Study|Protocol Violation|0
5987351|NCT01004861|20703290|P7|Overall Study|Protocol Violation|0
5987352|NCT01004861|20703291|P6|Overall Study|Protocol Violation|0
5987353|NCT01004861|20703292|P5|Overall Study|Protocol Violation|1
5987354|NCT01004861|20703293|P4|Overall Study|Protocol Violation|0
5987355|NCT01004861|20703294|P3|Overall Study|Protocol Violation|0
5987356|NCT01004861|20703295|P2|Overall Study|Protocol Violation|0
5987357|NCT01004861|20703296|P1|Overall Study|Protocol Violation|0
5987358|NCT01004861|20703284|P13|Overall Study|Adverse Event|2
5987359|NCT01004861|20703285|P12|Overall Study|Adverse Event|0
5987360|NCT01004861|20703286|P11|Overall Study|Adverse Event|1
5987361|NCT01004861|20703287|P10|Overall Study|Adverse Event|1
5987362|NCT01004861|20703288|P9|Overall Study|Adverse Event|13
5987363|NCT01004861|20703289|P8|Overall Study|Adverse Event|1
5987364|NCT01004861|20703290|P7|Overall Study|Adverse Event|1
5987365|NCT01004861|20703291|P6|Overall Study|Adverse Event|2
5987366|NCT01004861|20703292|P5|Overall Study|Adverse Event|0
5987367|NCT01004861|20703293|P4|Overall Study|Adverse Event|1
5987368|NCT01004861|20703294|P3|Overall Study|Adverse Event|0
5987369|NCT01004861|20703295|P2|Overall Study|Adverse Event|0
5987370|NCT01004861|20703296|P1|Overall Study|Adverse Event|0
5987371|NCT01004861|20703284|P13|Overall Study|Physician Decision|3
5987372|NCT01004861|20703285|P12|Overall Study|Physician Decision|0
5987373|NCT01004861|20703286|P11|Overall Study|Physician Decision|0
5987374|NCT01004861|20703287|P10|Overall Study|Physician Decision|0
5987375|NCT01004861|20703288|P9|Overall Study|Physician Decision|0
5987376|NCT01004861|20703289|P8|Overall Study|Physician Decision|1
5987377|NCT01004861|20703290|P7|Overall Study|Physician Decision|0
5987378|NCT01004861|20703291|P6|Overall Study|Physician Decision|0
5987379|NCT01004861|20703292|P5|Overall Study|Physician Decision|1
5987380|NCT01004861|20703293|P4|Overall Study|Physician Decision|1
5987381|NCT01004861|20703294|P3|Overall Study|Physician Decision|1
5987382|NCT01004861|20703295|P2|Overall Study|Physician Decision|2
5987383|NCT01004861|20703296|P1|Overall Study|Physician Decision|0
5987384|NCT01004861|20703284|P13|Overall Study|Disease progression|8
5987385|NCT01004861|20703285|P12|Overall Study|Disease progression|3
5987386|NCT01004861|20703286|P11|Overall Study|Disease progression|6
5987387|NCT01004861|20703287|P10|Overall Study|Disease progression|7
5987388|NCT01004861|20703288|P9|Overall Study|Disease progression|4
5987389|NCT01004861|20703289|P8|Overall Study|Disease progression|1
5987390|NCT01004861|20703290|P7|Overall Study|Disease progression|5
5987391|NCT01004861|20703291|P6|Overall Study|Disease progression|4
5987392|NCT01004861|20703292|P5|Overall Study|Disease progression|4
5987393|NCT01004861|20703293|P4|Overall Study|Disease progression|4
5987394|NCT01004861|20703294|P3|Overall Study|Disease progression|5
5987395|NCT01004861|20703295|P2|Overall Study|Disease progression|4
5987396|NCT01004861|20703296|P1|Overall Study|Disease progression|3
5987397|NCT01004848|20703362|P2|Overall Study|Lost to Follow-up|45
5987398|NCT01004848|20703363|P1|Overall Study|Lost to Follow-up|55
5987399|NCT01004822|20703401|P8|Overall Study|Other|0
5987400|NCT01004822|20703402|P7|Overall Study|Other|0
5987401|NCT01004822|20703403|P6|Overall Study|Other|1
5987402|NCT01004822|20703404|P5|Overall Study|Other|0
5987403|NCT01004822|20703405|P4|Overall Study|Other|1
5987404|NCT01004822|20703406|P3|Overall Study|Other|4
5987405|NCT01004822|20703407|P2|Overall Study|Other|0
5987406|NCT01004822|20703408|P1|Overall Study|Other|0
5987407|NCT01004822|20703401|P8|Overall Study|Adverse Event|1
5987408|NCT01004822|20703402|P7|Overall Study|Adverse Event|1
5987409|NCT01004822|20703403|P6|Overall Study|Adverse Event|0
5987410|NCT01004822|20703404|P5|Overall Study|Adverse Event|0
5987411|NCT01004822|20703405|P4|Overall Study|Adverse Event|0
5987412|NCT01004822|20703406|P3|Overall Study|Adverse Event|0
5987413|NCT01004822|20703407|P2|Overall Study|Adverse Event|0
5987414|NCT01004822|20703408|P1|Overall Study|Adverse Event|0
5987415|NCT01004822|20703401|P8|Overall Study|No longer willing to continue|0
5987416|NCT01004822|20703402|P7|Overall Study|No longer willing to continue|1
5987417|NCT01004822|20703403|P6|Overall Study|No longer willing to continue|1
5987418|NCT01004822|20703404|P5|Overall Study|No longer willing to continue|2
5987419|NCT01004822|20703405|P4|Overall Study|No longer willing to continue|1
5987420|NCT01004822|20703406|P3|Overall Study|No longer willing to continue|0
5987421|NCT01004822|20703407|P2|Overall Study|No longer willing to continue|0
5987422|NCT01004822|20703408|P1|Overall Study|No longer willing to continue|0
5987423|NCT01004822|20703401|P8|Overall Study|Global deterioration of health status|0
5987424|NCT01004822|20703402|P7|Overall Study|Global deterioration of health status|1
5987425|NCT01004822|20703403|P6|Overall Study|Global deterioration of health status|0
5987426|NCT01004822|20703404|P5|Overall Study|Global deterioration of health status|0
5987427|NCT01004822|20703405|P4|Overall Study|Global deterioration of health status|1
5987428|NCT01004822|20703406|P3|Overall Study|Global deterioration of health status|0
5987429|NCT01004822|20703407|P2|Overall Study|Global deterioration of health status|0
5987430|NCT01004822|20703408|P1|Overall Study|Global deterioration of health status|0
5987431|NCT01004822|20703401|P8|Overall Study|Objective progression or relapse|4
5987432|NCT01004822|20703402|P7|Overall Study|Objective progression or relapse|1
5987433|NCT01004822|20703403|P6|Overall Study|Objective progression or relapse|2
5987434|NCT01004822|20703404|P5|Overall Study|Objective progression or relapse|2
5987435|NCT01004822|20703405|P4|Overall Study|Objective progression or relapse|1
5987436|NCT01004822|20703406|P3|Overall Study|Objective progression or relapse|0
5987437|NCT01004822|20703407|P2|Overall Study|Objective progression or relapse|3
5987438|NCT01004822|20703408|P1|Overall Study|Objective progression or relapse|3
5987439|NCT01004510|20703573|P1|Overall Study|Adverse Event|1
5987440|NCT01004432|20703577|P5|OL Study Extension (Week 52 - 76)|Lack of Efficacy|10
5987441|NCT01004432|20703578|P4|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0
5987442|NCT01004432|20703579|P3|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0
5987443|NCT01004432|20703580|P2|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0
5987444|NCT01004432|20703581|P1|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0
5987445|NCT01004432|20703577|P5|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|2
5987446|NCT01004432|20703578|P4|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0
5987447|NCT01004432|20703579|P3|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0
5987448|NCT01004432|20703580|P2|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0
5987449|NCT01004432|20703581|P1|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0
5987450|NCT01004432|20703577|P5|OL Study Extension (Week 52 - 76)|Protocol Violation|4
5987451|NCT01004432|20703578|P4|OL Study Extension (Week 52 - 76)|Protocol Violation|0
5987452|NCT01004432|20703579|P3|OL Study Extension (Week 52 - 76)|Protocol Violation|0
5987453|NCT01004432|20703580|P2|OL Study Extension (Week 52 - 76)|Protocol Violation|0
5987454|NCT01004432|20703581|P1|OL Study Extension (Week 52 - 76)|Protocol Violation|0
5987455|NCT01004432|20703577|P5|OL Study Extension (Week 52 - 76)|Adverse Event|2
5987456|NCT01004432|20703578|P4|OL Study Extension (Week 52 - 76)|Adverse Event|0
5987457|NCT01004432|20703579|P3|OL Study Extension (Week 52 - 76)|Adverse Event|0
5987458|NCT01004432|20703580|P2|OL Study Extension (Week 52 - 76)|Adverse Event|0
5987459|NCT01004432|20703581|P1|OL Study Extension (Week 52 - 76)|Adverse Event|0
5987460|NCT01004432|20703577|P5|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0
5987461|NCT01004432|20703578|P4|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3
5987462|NCT01004432|20703579|P3|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|1
5987463|NCT01004432|20703580|P2|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3
5987464|NCT01004432|20703581|P1|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0
5987465|NCT01004432|20703577|P5|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0
5987466|NCT01004432|20703578|P4|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|37
5987467|NCT01004432|20703579|P3|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|24
5987468|NCT01004432|20703580|P2|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|2
5987469|NCT01004432|20703581|P1|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0
5987470|NCT01004432|20703577|P5|OL/Double-Blind (DB) Period (Week 16-52)|Death|0
5987471|NCT01004432|20703578|P4|OL/Double-Blind (DB) Period (Week 16-52)|Death|1
5987472|NCT01004432|20703579|P3|OL/Double-Blind (DB) Period (Week 16-52)|Death|0
5987473|NCT01004432|20703580|P2|OL/Double-Blind (DB) Period (Week 16-52)|Death|0
5987474|NCT01004432|20703581|P1|OL/Double-Blind (DB) Period (Week 16-52)|Death|0
5987475|NCT01004432|20703577|P5|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0
5987476|NCT01004432|20703578|P4|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|7
5987477|NCT01004432|20703579|P3|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|4
5987478|NCT01004432|20703580|P2|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|1
5987479|NCT01004432|20703581|P1|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0
5987480|NCT01004432|20703577|P5|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0
5987481|NCT01004432|20703578|P4|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|4
5987482|NCT01004432|20703579|P3|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3
5987483|NCT01004432|20703580|P2|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3
5987484|NCT01004432|20703581|P1|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0
5987485|NCT01004432|20703577|P5|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0
5987486|NCT01004432|20703578|P4|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|6
5987487|NCT01004432|20703579|P3|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|5
5987657|NCT01003184|20703964|P1|Overall Study|Adverse Event|12
5987488|NCT01004432|20703580|P2|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|1
5987489|NCT01004432|20703581|P1|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0
5987490|NCT01004432|20703577|P5|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0
5987491|NCT01004432|20703578|P4|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0
5987492|NCT01004432|20703579|P3|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0
5987493|NCT01004432|20703580|P2|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0
5987494|NCT01004432|20703581|P1|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|2
5987495|NCT01004432|20703577|P5|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0
5987496|NCT01004432|20703578|P4|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0
5987497|NCT01004432|20703579|P3|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0
5987498|NCT01004432|20703580|P2|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0
5987499|NCT01004432|20703581|P1|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|15
5987500|NCT01004432|20703577|P5|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0
5987501|NCT01004432|20703578|P4|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0
5987502|NCT01004432|20703579|P3|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0
5987503|NCT01004432|20703580|P2|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0
5987504|NCT01004432|20703581|P1|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|17
5987505|NCT01004432|20703577|P5|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0
5987506|NCT01004432|20703578|P4|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0
5987507|NCT01004432|20703579|P3|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0
5987508|NCT01004432|20703580|P2|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0
5987509|NCT01004432|20703581|P1|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|29
5987510|NCT01004432|20703577|P5|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0
5987511|NCT01004432|20703578|P4|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0
5987512|NCT01004432|20703579|P3|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0
5987513|NCT01004432|20703580|P2|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0
5987514|NCT01004432|20703581|P1|Open-label (OL) Period (Week 0 - 16)|Adverse Event|20
5987515|NCT01004406|20703603|P2|Overall Study|Lost to Follow-up|0
5987516|NCT01004406|20703604|P1|Overall Study|Lost to Follow-up|1
5987517|NCT01004406|20703603|P2|Overall Study|Withdrawal by Subject|0
5987518|NCT01004406|20703604|P1|Overall Study|Withdrawal by Subject|2
5987519|NCT01004263|20703639|P1|Overall Study|Lack of Qualifying Event|2
5987520|NCT01004263|20703639|P1|Overall Study|Physician Decision|15
5987521|NCT01004263|20703639|P1|Overall Study|Pregnancy|2
5987522|NCT01004263|20703639|P1|Overall Study|Lack of Efficacy|13
5987523|NCT01004263|20703639|P1|Overall Study|Lost to Follow-up|64
5987524|NCT01004263|20703639|P1|Overall Study|Protocol Violation|10
5987525|NCT01004263|20703639|P1|Overall Study|Withdrawal by Subject|58
5987526|NCT01004263|20703639|P1|Overall Study|Adverse Event|15
5987527|NCT01004250|20703647|P1|Follow-Up (FU) Period|Lost to Follow-up|1
5987528|NCT01004250|20703647|P1|Maintenance Therapy Period|Physician Decision|4
5987529|NCT01004250|20703647|P1|Maintenance Therapy Period|Withdrawal by Subject|5
5987530|NCT01004250|20703647|P1|Maintenance Therapy Period|Protocol Violation|1
5987531|NCT01004250|20703647|P1|Maintenance Therapy Period|Lost to Follow-up|1
5987532|NCT01004250|20703647|P1|Maintenance Therapy Period|Adverse Event|15
5987533|NCT01004250|20703647|P1|Induction Therapy Period|Physician Decision|2
5987534|NCT01004250|20703647|P1|Induction Therapy Period|Withdrawal by Subject|2
5987535|NCT01004250|20703647|P1|Induction Therapy Period|Entry Criteria Not Met|1
5987536|NCT01004250|20703647|P1|Induction Therapy Period|Adverse Event|10
5987537|NCT01004185|20703659|P2|Overall Study|Withdrawal by Subject|1
5987538|NCT01004185|20703660|P1|Overall Study|Withdrawal by Subject|2
5987539|NCT01004185|20703659|P2|Overall Study|Sponsor Terminated Study|5
5987540|NCT01004185|20703660|P1|Overall Study|Sponsor Terminated Study|4
5987541|NCT01004185|20703659|P2|Overall Study|Lack of Efficacy|1
5987542|NCT01004185|20703660|P1|Overall Study|Lack of Efficacy|2
5987543|NCT01004185|20703659|P2|Overall Study|Lost to Follow-up|1
5987544|NCT01004185|20703660|P1|Overall Study|Lost to Follow-up|0
5987545|NCT01004185|20703659|P2|Overall Study|Adverse Event|1
5987546|NCT01004185|20703660|P1|Overall Study|Adverse Event|1
5987547|NCT01004172|20703668|P1|Overall Study|Symptomatic Deterioration|2
5987548|NCT01004172|20703668|P1|Overall Study|Physician Decision|1
5987549|NCT01004172|20703668|P1|Overall Study|Adverse Event|1
5987550|NCT01004172|20703668|P1|Overall Study|Progressive Disease in CNS and Non-CNS|2
5987551|NCT01004172|20703668|P1|Overall Study|Progressive Disease in Non-CNS Only|16
5987552|NCT01004172|20703668|P1|Overall Study|Progressive Disease in CNS Only|16
5987553|NCT01004159|20703676|P1|Overall Study|Disease Progression|18
5987554|NCT01004159|20703676|P1|Overall Study|Adverse Event|2
5987555|NCT01004146|20703683|P2|Overall Study|Withdrawal by Subject|5
5987556|NCT01004146|20703684|P1|Overall Study|Withdrawal by Subject|4
5987557|NCT01004003|20703795|P9|Overall Study|Other|0
5987558|NCT01004003|20703796|P8|Overall Study|Other|0
5987559|NCT01004003|20703797|P7|Overall Study|Other|0
5987560|NCT01004003|20703798|P6|Overall Study|Other|1
5987561|NCT01004003|20703799|P5|Overall Study|Other|0
5987562|NCT01004003|20703800|P4|Overall Study|Other|0
5987563|NCT01004003|20703801|P3|Overall Study|Other|0
5987564|NCT01004003|20703802|P2|Overall Study|Other|0
5987565|NCT01004003|20703803|P1|Overall Study|Other|0
5987566|NCT01004003|20703795|P9|Overall Study|Refused to continue taking trial med.|2
5987567|NCT01004003|20703796|P8|Overall Study|Refused to continue taking trial med.|0
5987568|NCT01004003|20703797|P7|Overall Study|Refused to continue taking trial med.|0
5987569|NCT01004003|20703798|P6|Overall Study|Refused to continue taking trial med.|0
5987570|NCT01004003|20703799|P5|Overall Study|Refused to continue taking trial med.|0
5987571|NCT01004003|20703800|P4|Overall Study|Refused to continue taking trial med.|0
5987572|NCT01004003|20703801|P3|Overall Study|Refused to continue taking trial med.|0
5987573|NCT01004003|20703802|P2|Overall Study|Refused to continue taking trial med.|0
5987574|NCT01004003|20703803|P1|Overall Study|Refused to continue taking trial med.|0
5987575|NCT01004003|20703795|P9|Overall Study|Adverse Event|6
5987576|NCT01004003|20703796|P8|Overall Study|Adverse Event|21
5987577|NCT01004003|20703797|P7|Overall Study|Adverse Event|7
5987578|NCT01004003|20703798|P6|Overall Study|Adverse Event|2
5987579|NCT01004003|20703799|P5|Overall Study|Adverse Event|2
5987580|NCT01004003|20703800|P4|Overall Study|Adverse Event|3
5987581|NCT01004003|20703801|P3|Overall Study|Adverse Event|3
5987582|NCT01004003|20703802|P2|Overall Study|Adverse Event|2
5987583|NCT01004003|20703803|P1|Overall Study|Adverse Event|4
5987584|NCT01004003|20703795|P9|Overall Study|Progressive disease|22
5987585|NCT01004003|20703796|P8|Overall Study|Progressive disease|39
5987586|NCT01004003|20703797|P7|Overall Study|Progressive disease|1
5987587|NCT01004003|20703798|P6|Overall Study|Progressive disease|1
5987588|NCT01004003|20703799|P5|Overall Study|Progressive disease|2
5987589|NCT01004003|20703800|P4|Overall Study|Progressive disease|0
5987590|NCT01004003|20703801|P3|Overall Study|Progressive disease|1
5987591|NCT01004003|20703802|P2|Overall Study|Progressive disease|1
5987592|NCT01004003|20703803|P1|Overall Study|Progressive disease|2
5987593|NCT01003990|20703834|P3|Overall Study|Subject Withdrew Consent|7
5987594|NCT01003990|20703835|P2|Overall Study|Subject Withdrew Consent|5
5987595|NCT01003990|20703836|P1|Overall Study|Subject Withdrew Consent|12
5987596|NCT01003990|20703834|P3|Overall Study|No Longer Met Study Criteria|0
5987597|NCT01003990|20703835|P2|Overall Study|No Longer Met Study Criteria|1
5987598|NCT01003990|20703836|P1|Overall Study|No Longer Met Study Criteria|4
5987599|NCT01003990|20703834|P3|Overall Study|Pregnancy|4
5987600|NCT01003990|20703835|P2|Overall Study|Pregnancy|2
5987601|NCT01003990|20703836|P1|Overall Study|Pregnancy|10
5987602|NCT01003990|20703834|P3|Overall Study|Poor/Non-compliance|2
5987603|NCT01003990|20703835|P2|Overall Study|Poor/Non-compliance|3
5987604|NCT01003990|20703836|P1|Overall Study|Poor/Non-compliance|4
5987605|NCT01003990|20703834|P3|Overall Study|Reasons Not Identified|8
5987606|NCT01003990|20703835|P2|Overall Study|Reasons Not Identified|13
5987607|NCT01003990|20703836|P1|Overall Study|Reasons Not Identified|14
5987608|NCT01003990|20703834|P3|Overall Study|Lost to Follow-up|7
5987609|NCT01003990|20703835|P2|Overall Study|Lost to Follow-up|12
5987610|NCT01003990|20703836|P1|Overall Study|Lost to Follow-up|30
5987611|NCT01003990|20703834|P3|Overall Study|Lack of Efficacy|3
5987612|NCT01003990|20703835|P2|Overall Study|Lack of Efficacy|2
5987613|NCT01003990|20703836|P1|Overall Study|Lack of Efficacy|10
5987614|NCT01003990|20703834|P3|Overall Study|Death|1
5987615|NCT01003990|20703835|P2|Overall Study|Death|8
5987616|NCT01003990|20703836|P1|Overall Study|Death|0
5987617|NCT01003990|20703834|P3|Overall Study|Adverse Event|11
5987618|NCT01003990|20703835|P2|Overall Study|Adverse Event|5
5987619|NCT01003990|20703836|P1|Overall Study|Adverse Event|8
5987620|NCT01003899|20703853|P1|Overall Study|Progressive disease|34
5987621|NCT01003899|20703853|P1|Overall Study|Not treated|1
5987622|NCT01003899|20703853|P1|Overall Study|Not entered|4
5987623|NCT01003899|20703853|P1|Overall Study|Other Adverse Event|8
5987624|NCT01003639|20703874|P2|Overall Study|Physician Decision|0
5987625|NCT01003639|20703875|P1|Overall Study|Physician Decision|1
5987626|NCT01003639|20703874|P2|Overall Study|Protocol Violation|1
5987627|NCT01003639|20703875|P1|Overall Study|Protocol Violation|0
5987628|NCT01003639|20703874|P2|Overall Study|Adverse Event|1
5987629|NCT01003639|20703875|P1|Overall Study|Adverse Event|0
5987630|NCT01003639|20703874|P2|Overall Study|Lack of Efficacy|6
5987631|NCT01003639|20703875|P1|Overall Study|Lack of Efficacy|1
5987632|NCT01003639|20703874|P2|Overall Study|Withdrawal by Subject|5
5987633|NCT01003639|20703875|P1|Overall Study|Withdrawal by Subject|9
5987634|NCT01003639|20703874|P2|Overall Study|Lost to Follow-up|9
5987635|NCT01003639|20703875|P1|Overall Study|Lost to Follow-up|6
5987636|NCT01003249|20703931|P2|Second Intervention (4 Weeks)|Adverse Event|0
5987637|NCT01003249|20703932|P1|Second Intervention (4 Weeks)|Adverse Event|1
5987638|NCT01003249|20703931|P2|Second Intervention (4 Weeks)|Withdrawal by Subject|1
5987639|NCT01003249|20703932|P1|Second Intervention (4 Weeks)|Withdrawal by Subject|0
5987640|NCT01003249|20703931|P2|First Intervention (4 Weeks)|Non-Serious Event|1
5987641|NCT01003249|20703932|P1|First Intervention (4 Weeks)|Non-Serious Event|1
5987642|NCT01003249|20703931|P2|First Intervention (4 Weeks)|Withdrawal by Subject|1
5987643|NCT01003249|20703932|P1|First Intervention (4 Weeks)|Withdrawal by Subject|1
5987644|NCT01003210|20703950|P2|Overall Study|Lost to Follow-up|3
5987645|NCT01003210|20703951|P1|Overall Study|Lost to Follow-up|1
5987646|NCT01003184|20703963|P2|Overall Study|Physician Decision|0
5987647|NCT01003184|20703964|P1|Overall Study|Physician Decision|1
5987648|NCT01003184|20703963|P2|Overall Study|Withdrawal by Subject|6
5987649|NCT01003184|20703964|P1|Overall Study|Withdrawal by Subject|1
5987650|NCT01003184|20703963|P2|Overall Study|Protocol Violation|0
5987651|NCT01003184|20703964|P1|Overall Study|Protocol Violation|3
5987652|NCT01003184|20703963|P2|Overall Study|Loss of glucose control|1
5987653|NCT01003184|20703964|P1|Overall Study|Loss of glucose control|1
5987654|NCT01003184|20703963|P2|Overall Study|Lost to Follow-up|0
5987655|NCT01003184|20703964|P1|Overall Study|Lost to Follow-up|1
5987656|NCT01003184|20703963|P2|Overall Study|Adverse Event|5
5987658|NCT01002989|20704047|P1|Overall Study|exclusion criteria, no consent|5
5987659|NCT01002742|20704062|P2|Overall Study|Determined to be ineligible|1
5987660|NCT01002742|20704063|P1|Overall Study|Determined to be ineligible|0
5987661|NCT01002573|20704099|P2|Overall Study|Subject did not receive at least 1 dose|7
5987662|NCT01002573|20704100|P1|Overall Study|Subject did not receive at least 1 dose|11
5987663|NCT01002547|20704121|P3|Overall Study|Adverse Event|0
5987664|NCT01002547|20704122|P2|Overall Study|Adverse Event|0
5987665|NCT01002547|20704123|P1|Overall Study|Adverse Event|1
5987666|NCT01002547|20704121|P3|Overall Study|Death|2
5987667|NCT01002547|20704122|P2|Overall Study|Death|2
5987668|NCT01002547|20704123|P1|Overall Study|Death|0
5987669|NCT01002547|20704121|P3|Overall Study|Physician Decision|0
5987670|NCT01002547|20704122|P2|Overall Study|Physician Decision|0
5987671|NCT01002547|20704123|P1|Overall Study|Physician Decision|1
5987672|NCT01002547|20704121|P3|Overall Study|Lost to Follow-up|1
5987673|NCT01002547|20704122|P2|Overall Study|Lost to Follow-up|1
5987674|NCT01002547|20704123|P1|Overall Study|Lost to Follow-up|2
5987675|NCT01002547|20704121|P3|Overall Study|Withdrawal by Subject|5
5987676|NCT01002547|20704122|P2|Overall Study|Withdrawal by Subject|0
5987677|NCT01002547|20704123|P1|Overall Study|Withdrawal by Subject|4
5987678|NCT01002482|20704181|P2|Overall Study|Included twice|0
5987679|NCT01002482|20704182|P1|Overall Study|Included twice|1
5987680|NCT01002482|20704181|P2|Overall Study|Withdrawal by Subject|21
5987681|NCT01002482|20704182|P1|Overall Study|Withdrawal by Subject|14
5987682|NCT01002339|20704216|P3|Overall Study|Randomized. Not transplanted|1
5987683|NCT01002339|20704217|P2|Overall Study|Randomized. Not transplanted|0
5987684|NCT01002339|20704218|P1|Overall Study|Randomized. Not transplanted|0
5987685|NCT01002339|20704216|P3|Overall Study|Lung cancer detected before transplant|1
5987686|NCT01002339|20704217|P2|Overall Study|Lung cancer detected before transplant|0
5987687|NCT01002339|20704218|P1|Overall Study|Lung cancer detected before transplant|0
5987688|NCT01002339|20704216|P3|Overall Study|Protocol Violation|2
5987689|NCT01002339|20704217|P2|Overall Study|Protocol Violation|0
5987690|NCT01002339|20704218|P1|Overall Study|Protocol Violation|0
5987691|NCT01002339|20704216|P3|Overall Study|Incorrect treatment assignment|1
5987692|NCT01002339|20704217|P2|Overall Study|Incorrect treatment assignment|0
5987693|NCT01002339|20704218|P1|Overall Study|Incorrect treatment assignment|0
5987694|NCT01002339|20704216|P3|Overall Study|Withdrawal by Subject|0
5987695|NCT01002339|20704217|P2|Overall Study|Withdrawal by Subject|1
5987696|NCT01002339|20704218|P1|Overall Study|Withdrawal by Subject|0
5987697|NCT01002105|20704294|P2|Overall Study|condition worsened|2
5987698|NCT01002105|20704295|P1|Overall Study|condition worsened|4
5987699|NCT01002105|20704294|P2|Overall Study|non compliance|3
5987700|NCT01002105|20704295|P1|Overall Study|non compliance|5
5987701|NCT01002105|20704294|P2|Overall Study|Lost to Follow-up|16
5987702|NCT01002105|20704295|P1|Overall Study|Lost to Follow-up|10
5987703|NCT01001988|20704311|P1|Overall Study|Lost to Follow-up|15
5987704|NCT01001988|20704311|P1|Overall Study|Withdrawal by Subject|18
5987705|NCT01001988|20704311|P1|Overall Study|Protocol Violation|84
5987706|NCT01001832|20704329|P2|Follow-up Period|Other|1
5987707|NCT01001832|20704330|P1|Follow-up Period|Other|2
5987708|NCT01001832|20704329|P2|Follow-up Period|Follow-up no longer required /protocol|20
5987709|NCT01001832|20704330|P1|Follow-up Period|Follow-up no longer required /protocol|15
5987710|NCT01001832|20704329|P2|Follow-up Period|Withdrawal by Subject|0
5987711|NCT01001832|20704330|P1|Follow-up Period|Withdrawal by Subject|1
5987712|NCT01001832|20704329|P2|Long-term Period|Other|2
5987713|NCT01001832|20704330|P1|Long-term Period|Other|1
5987714|NCT01001832|20704329|P2|Long-term Period|Lack of Efficacy|2
5987715|NCT01001832|20704330|P1|Long-term Period|Lack of Efficacy|0
5987716|NCT01001832|20704329|P2|Long-term Period|Withdrawal by Subject|0
5987717|NCT01001832|20704330|P1|Long-term Period|Withdrawal by Subject|1
5987718|NCT01001832|20704329|P2|Long-term Period|Adverse Event|1
5987719|NCT01001832|20704330|P1|Long-term Period|Adverse Event|2
5987720|NCT01001832|20704329|P2|Short-term Period|Adverse Event|3
5987721|NCT01001832|20704330|P1|Short-term Period|Adverse Event|2
5987722|NCT01001767|20704388|P2|Overall Study|Physician Decision|0
5987723|NCT01001767|20704389|P1|Overall Study|Physician Decision|1
5987724|NCT01001767|20704388|P2|Overall Study|Lost to Follow-up|0
5987725|NCT01001767|20704389|P1|Overall Study|Lost to Follow-up|1
5987726|NCT01001767|20704388|P2|Overall Study|Protocol Violation|0
5987727|NCT01001767|20704389|P1|Overall Study|Protocol Violation|1
5987728|NCT01001767|20704388|P2|Overall Study|no baseline study performed|0
5987729|NCT01001767|20704389|P1|Overall Study|no baseline study performed|1
5987730|NCT01001702|20704395|P1|Overall Study|Lack of Efficacy per Investigator|3
5987731|NCT01001702|20704395|P1|Overall Study|Withdrawal by Subject|19
5987732|NCT01001702|20704395|P1|Overall Study|Investigator withdrew Subject|10
5987733|NCT01001702|20704395|P1|Overall Study|Subject met Withdrawal Criteria|22
5987734|NCT01001702|20704395|P1|Overall Study|Sponsor Discontinued Study|4
5987735|NCT01001702|20704395|P1|Overall Study|Adverse Event|7
5987736|NCT01001702|20704395|P1|Overall Study|Lost to Follow-up|7
5987737|NCT01001598|20704406|P1|Overall Study|Adverse Event|1
5987738|NCT01001598|20704406|P1|Overall Study|Hematopoietic Stem Cell Transplant|1
5987739|NCT01001572|20704414|P3|Double-Blind Treatment Phase|Lost to Follow-up|1
5987740|NCT01001572|20704415|P2|Double-Blind Treatment Phase|Lost to Follow-up|0
5987741|NCT01001572|20704416|P1|Double-Blind Treatment Phase|Lost to Follow-up|0
5987742|NCT01001572|20704414|P3|Double-Blind Treatment Phase|Protocol deviation|1
5987743|NCT01001572|20704415|P2|Double-Blind Treatment Phase|Protocol deviation|0
5987744|NCT01001572|20704416|P1|Double-Blind Treatment Phase|Protocol deviation|0
5987745|NCT01001572|20704414|P3|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|1
5987746|NCT01001572|20704415|P2|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0
5987747|NCT01001572|20704416|P1|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0
5987748|NCT01001572|20704414|P3|Double-Blind Treatment Phase|Abnormal test procedure result(s)|1
5987749|NCT01001572|20704415|P2|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0
5987750|NCT01001572|20704416|P1|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0
5987751|NCT01001572|20704414|P3|Double-Blind Treatment Phase|Withdrawal by Subject|13
5987752|NCT01001572|20704415|P2|Double-Blind Treatment Phase|Withdrawal by Subject|8
5987753|NCT01001572|20704416|P1|Double-Blind Treatment Phase|Withdrawal by Subject|0
5987754|NCT01001572|20704414|P3|Double-Blind Treatment Phase|Adverse Event|2
5987755|NCT01001572|20704415|P2|Double-Blind Treatment Phase|Adverse Event|2
5987756|NCT01001572|20704416|P1|Double-Blind Treatment Phase|Adverse Event|0
5987757|NCT01001572|20704414|P3|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0
5987758|NCT01001572|20704415|P2|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0
5987759|NCT01001572|20704416|P1|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|45
5987760|NCT01001572|20704414|P3|Single-Blind Valsartan 160 mg|Administrative problems|0
5987761|NCT01001572|20704415|P2|Single-Blind Valsartan 160 mg|Administrative problems|0
5987762|NCT01001572|20704416|P1|Single-Blind Valsartan 160 mg|Administrative problems|82
5987763|NCT01001572|20704414|P3|Single-Blind Valsartan 160 mg|Lost to Follow-up|0
5987764|NCT01001572|20704415|P2|Single-Blind Valsartan 160 mg|Lost to Follow-up|0
5987765|NCT01001572|20704416|P1|Single-Blind Valsartan 160 mg|Lost to Follow-up|4
5987766|NCT01001572|20704414|P3|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0
5987767|NCT01001572|20704415|P2|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0
5987768|NCT01001572|20704416|P1|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|1
5987769|NCT01001572|20704414|P3|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0
5987770|NCT01001572|20704415|P2|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0
5987771|NCT01001572|20704416|P1|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|7
5987772|NCT01001572|20704414|P3|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0
5987773|NCT01001572|20704415|P2|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0
5987774|NCT01001572|20704416|P1|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|96
5987775|NCT01001572|20704414|P3|Single-Blind Valsartan 160 mg|Adverse Event|0
5987776|NCT01001572|20704415|P2|Single-Blind Valsartan 160 mg|Adverse Event|0
5987777|NCT01001572|20704416|P1|Single-Blind Valsartan 160 mg|Adverse Event|11
5987778|NCT01001572|20704414|P3|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0
5987779|NCT01001572|20704415|P2|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0
5987780|NCT01001572|20704416|P1|Single-Blind Valsartan 160 mg|Withdrawal by Subject|32
5987781|NCT01001520|20704454|P2|Medication Period 2|Withdrawal by Subject|3
5987782|NCT01001520|20704455|P1|Medication Period 2|Withdrawal by Subject|0
5987783|NCT01001520|20704454|P2|Washout Period|Withdrawal by Subject|1
5987784|NCT01001520|20704455|P1|Washout Period|Withdrawal by Subject|2
5987785|NCT01001520|20704454|P2|Medication Period 1|Ineligible: Claustrophobia in fMRI|0
5987786|NCT01001520|20704455|P1|Medication Period 1|Ineligible: Claustrophobia in fMRI|2
5987787|NCT01001520|20704454|P2|Medication Period 1|Ineligible: fMRI contraindicated metal|2
5987788|NCT01001520|20704455|P1|Medication Period 1|Ineligible: fMRI contraindicated metal|0
5987789|NCT01001520|20704454|P2|Medication Period 1|Ineligible: Positive Urine Drug Screen|3
5987790|NCT01001520|20704455|P1|Medication Period 1|Ineligible: Positive Urine Drug Screen|0
5987791|NCT01001520|20704454|P2|Medication Period 1|Withdrawal by Subject|2
5987792|NCT01001520|20704455|P1|Medication Period 1|Withdrawal by Subject|2
5987793|NCT01001494|20704482|P3|Overall Study|Other|3
5987794|NCT01001494|20704483|P2|Overall Study|Other|1
5987795|NCT01001494|20704484|P1|Overall Study|Other|0
5987796|NCT01001494|20704482|P3|Overall Study|Lack of Efficacy|8
5987797|NCT01001494|20704483|P2|Overall Study|Lack of Efficacy|0
5987798|NCT01001494|20704484|P1|Overall Study|Lack of Efficacy|2
5987799|NCT01001494|20704482|P3|Overall Study|COPD exacerbation|5
5987800|NCT01001494|20704483|P2|Overall Study|COPD exacerbation|4
5987801|NCT01001494|20704484|P1|Overall Study|COPD exacerbation|3
5987802|NCT01001494|20704482|P3|Overall Study|Withdrawal by Subject|17
5987803|NCT01001494|20704483|P2|Overall Study|Withdrawal by Subject|7
5987804|NCT01001494|20704484|P1|Overall Study|Withdrawal by Subject|9
5987805|NCT01001494|20704482|P3|Overall Study|Lost to Follow-up|1
5987806|NCT01001494|20704483|P2|Overall Study|Lost to Follow-up|0
5987807|NCT01001494|20704484|P1|Overall Study|Lost to Follow-up|2
5987808|NCT01001494|20704482|P3|Overall Study|Protocol Violation|1
5987809|NCT01001494|20704483|P2|Overall Study|Protocol Violation|1
5987810|NCT01001494|20704484|P1|Overall Study|Protocol Violation|0
5987811|NCT01001494|20704482|P3|Overall Study|Adverse Event|6
5987812|NCT01001494|20704483|P2|Overall Study|Adverse Event|4
5987813|NCT01001494|20704484|P1|Overall Study|Adverse Event|8
5987814|NCT01001429|20704569|P2|Overall Study|surgery cancelled|1
5987815|NCT01001429|20704570|P1|Overall Study|surgery cancelled|0
5987816|NCT01001390|20704609|P2|Overall Study|Failure to wear AFO device|0
5987817|NCT01001390|20704610|P1|Overall Study|Failure to wear AFO device|2
5987818|NCT01001377|20704618|P2|Overall Study|Death|384
5987819|NCT01001377|20704619|P1|Overall Study|Death|391
5987820|NCT01001377|20704618|P2|Overall Study|Lost to Follow-up|17
5987821|NCT01001377|20704619|P1|Overall Study|Lost to Follow-up|14
5987822|NCT01001377|20704618|P2|Overall Study|Withdrawal by Subject|20
5987823|NCT01001377|20704619|P1|Overall Study|Withdrawal by Subject|19
5987824|NCT01001377|20704618|P2|Overall Study|Ineligibility determined|0
5987825|NCT01001377|20704619|P1|Overall Study|Ineligibility determined|2
5987826|NCT01001325|20704649|P2|Overall Study|Protocol Violation|0
5987827|NCT01001325|20704650|P1|Overall Study|Protocol Violation|2
5987828|NCT01001325|20704649|P2|Overall Study|Lost to Follow-up|10
5987829|NCT01001325|20704650|P1|Overall Study|Lost to Follow-up|16
5987830|NCT01001299|20704656|P1|Overall Study|Withdrew Consent|1
5987831|NCT01001299|20704656|P1|Overall Study|Began Taking Commercially Available Drug|2
5987832|NCT01001299|20704656|P1|Overall Study|Death|1
5987833|NCT01001299|20704656|P1|Overall Study|Adverse event or Intercurrent Illness|1
5987834|NCT01001299|20704656|P1|Overall Study|Insufficient Therapeutic Response|20
5987835|NCT01001234|20704685|P5|Overall Study|Not Treated: Lack of Qualifying Event|0
5987836|NCT01001234|20704686|P4|Overall Study|Not Treated: Lack of Qualifying Event|0
5987837|NCT01001234|20704687|P3|Overall Study|Not Treated: Lack of Qualifying Event|0
5987838|NCT01001234|20704688|P2|Overall Study|Not Treated: Lack of Qualifying Event|13
5987839|NCT01001234|20704689|P1|Overall Study|Not Treated: Lack of Qualifying Event|248
5987840|NCT01001234|20704685|P5|Overall Study|Not Treated: Physician Decision|0
5987841|NCT01001234|20704686|P4|Overall Study|Not Treated: Physician Decision|0
5987842|NCT01001234|20704687|P3|Overall Study|Not Treated: Physician Decision|0
5987843|NCT01001234|20704688|P2|Overall Study|Not Treated: Physician Decision|4
5987844|NCT01001234|20704689|P1|Overall Study|Not Treated: Physician Decision|37
5987845|NCT01001234|20704685|P5|Overall Study|Not Treated: Pregnancy|0
5987846|NCT01001234|20704686|P4|Overall Study|Not Treated: Pregnancy|0
5987847|NCT01001234|20704687|P3|Overall Study|Not Treated: Pregnancy|0
5987848|NCT01001234|20704688|P2|Overall Study|Not Treated: Pregnancy|0
5987849|NCT01001234|20704689|P1|Overall Study|Not Treated: Pregnancy|3
5987850|NCT01001234|20704685|P5|Overall Study|Not Treated: Lost to Follow-up|0
5987851|NCT01001234|20704686|P4|Overall Study|Not Treated: Lost to Follow-up|5
5987852|NCT01001234|20704687|P3|Overall Study|Not Treated: Lost to Follow-up|7
5987853|NCT01001234|20704688|P2|Overall Study|Not Treated: Lost to Follow-up|4
5987854|NCT01001234|20704689|P1|Overall Study|Not Treated: Lost to Follow-up|53
5987855|NCT01001234|20704685|P5|Overall Study|Not Treated: Protocol Violation|0
5987856|NCT01001234|20704686|P4|Overall Study|Not Treated: Protocol Violation|0
5987857|NCT01001234|20704687|P3|Overall Study|Not Treated: Protocol Violation|0
5987858|NCT01001234|20704688|P2|Overall Study|Not Treated: Protocol Violation|0
5987859|NCT01001234|20704689|P1|Overall Study|Not Treated: Protocol Violation|3
5987860|NCT01001234|20704685|P5|Overall Study|Not Treated: Withdrawal by Subject|0
5987861|NCT01001234|20704686|P4|Overall Study|Not Treated: Withdrawal by Subject|0
5987862|NCT01001234|20704687|P3|Overall Study|Not Treated: Withdrawal by Subject|2
5987863|NCT01001234|20704688|P2|Overall Study|Not Treated: Withdrawal by Subject|2
5987864|NCT01001234|20704689|P1|Overall Study|Not Treated: Withdrawal by Subject|23
5987865|NCT01001234|20704685|P5|Overall Study|Not Treated: Adverse Event|0
5987866|NCT01001234|20704686|P4|Overall Study|Not Treated: Adverse Event|0
5987867|NCT01001234|20704687|P3|Overall Study|Not Treated: Adverse Event|0
5987868|NCT01001234|20704688|P2|Overall Study|Not Treated: Adverse Event|0
5987869|NCT01001234|20704689|P1|Overall Study|Not Treated: Adverse Event|1
5987870|NCT01001234|20704685|P5|Overall Study|Physician Decision|0
5987871|NCT01001234|20704686|P4|Overall Study|Physician Decision|0
5987872|NCT01001234|20704687|P3|Overall Study|Physician Decision|0
5987873|NCT01001234|20704688|P2|Overall Study|Physician Decision|0
5987874|NCT01001234|20704689|P1|Overall Study|Physician Decision|1
5987875|NCT01001234|20704685|P5|Overall Study|Lost to Follow-up|0
5987876|NCT01001234|20704686|P4|Overall Study|Lost to Follow-up|2
5987877|NCT01001234|20704687|P3|Overall Study|Lost to Follow-up|1
5987878|NCT01001234|20704688|P2|Overall Study|Lost to Follow-up|0
5987879|NCT01001234|20704689|P1|Overall Study|Lost to Follow-up|0
5987880|NCT01001234|20704685|P5|Overall Study|Protocol Violation|0
5987881|NCT01001234|20704686|P4|Overall Study|Protocol Violation|18
5987882|NCT01001234|20704687|P3|Overall Study|Protocol Violation|19
5987883|NCT01001234|20704688|P2|Overall Study|Protocol Violation|3
5987884|NCT01001234|20704689|P1|Overall Study|Protocol Violation|34
5987885|NCT01001234|20704685|P5|Overall Study|Withdrawal by Subject|0
5987886|NCT01001234|20704686|P4|Overall Study|Withdrawal by Subject|0
5987887|NCT01001234|20704687|P3|Overall Study|Withdrawal by Subject|3
5987888|NCT01001234|20704688|P2|Overall Study|Withdrawal by Subject|0
5987889|NCT01001234|20704689|P1|Overall Study|Withdrawal by Subject|2
5987890|NCT01001221|20704705|P5|Overall Study|Not treated; protocol exclusion|0
5987891|NCT01001221|20704706|P4|Overall Study|Not treated; protocol exclusion|0
5987892|NCT01001221|20704707|P3|Overall Study|Not treated; protocol exclusion|1
5987893|NCT01001221|20704708|P2|Overall Study|Not treated; protocol exclusion|0
5987894|NCT01001221|20704709|P1|Overall Study|Not treated; protocol exclusion|0
5987895|NCT01001221|20704705|P5|Overall Study|Other|0
5987896|NCT01001221|20704706|P4|Overall Study|Other|0
5987897|NCT01001221|20704707|P3|Overall Study|Other|0
5987898|NCT01001221|20704708|P2|Overall Study|Other|1
5987899|NCT01001221|20704709|P1|Overall Study|Other|1
5987900|NCT01001221|20704705|P5|Overall Study|Disease progression|0
5987901|NCT01001221|20704706|P4|Overall Study|Disease progression|4
5987902|NCT01001221|20704707|P3|Overall Study|Disease progression|2
5987903|NCT01001221|20704708|P2|Overall Study|Disease progression|2
5987904|NCT01001221|20704709|P1|Overall Study|Disease progression|3
5987905|NCT01001221|20704705|P5|Overall Study|Adverse Event|0
5987906|NCT01001221|20704706|P4|Overall Study|Adverse Event|2
5987907|NCT01001221|20704707|P3|Overall Study|Adverse Event|0
5987908|NCT01001221|20704708|P2|Overall Study|Adverse Event|2
5987909|NCT01001221|20704709|P1|Overall Study|Adverse Event|1
5987910|NCT01001208|20704884|P2|Overall Study|Other|2
5987911|NCT01001208|20704885|P1|Overall Study|Other|0
5987912|NCT01001208|20704884|P2|Overall Study|Disease Progression|3
5987913|NCT01001208|20704885|P1|Overall Study|Disease Progression|0
5987914|NCT01001208|20704884|P2|Overall Study|Noncompliance|7
5987915|NCT01001208|20704885|P1|Overall Study|Noncompliance|4
5987916|NCT01001208|20704884|P2|Overall Study|Ineligibility Determined|2
5987917|NCT01001208|20704885|P1|Overall Study|Ineligibility Determined|4
5987918|NCT01001208|20704884|P2|Overall Study|Withdrawal by Subject|5
5987919|NCT01001208|20704885|P1|Overall Study|Withdrawal by Subject|4
5987920|NCT01001208|20704884|P2|Overall Study|Physician Decision|0
5987921|NCT01001208|20704885|P1|Overall Study|Physician Decision|1
5987922|NCT01001208|20704884|P2|Overall Study|Lost to Follow-up|9
5987923|NCT01001208|20704885|P1|Overall Study|Lost to Follow-up|5
5987924|NCT01001208|20704884|P2|Overall Study|Adverse Event|5
5987925|NCT01001208|20704885|P1|Overall Study|Adverse Event|10
5987926|NCT01001169|20704928|P2|Overall Study|Withdrawal by Subject|1
5987927|NCT01001169|20704929|P1|Overall Study|Withdrawal by Subject|2
5987928|NCT01001104|20705037|P4|Overall Study|Withdrawal by Subject|2
5987929|NCT01001104|20705038|P3|Overall Study|Withdrawal by Subject|0
5987930|NCT01001104|20705039|P2|Overall Study|Withdrawal by Subject|0
5987931|NCT01001104|20705040|P1|Overall Study|Withdrawal by Subject|0
5987932|NCT01001104|20705037|P4|Overall Study|Entry Criteria Not Met|1
5987933|NCT01001104|20705038|P3|Overall Study|Entry Criteria Not Met|0
5987934|NCT01001104|20705039|P2|Overall Study|Entry Criteria Not Met|0
5987935|NCT01001104|20705040|P1|Overall Study|Entry Criteria Not Met|0
5987936|NCT01001104|20705037|P4|Overall Study|Lost to Follow-up|0
5987937|NCT01001104|20705038|P3|Overall Study|Lost to Follow-up|1
5987938|NCT01001104|20705039|P2|Overall Study|Lost to Follow-up|0
5987939|NCT01001104|20705040|P1|Overall Study|Lost to Follow-up|0
5987940|NCT01001104|20705037|P4|Overall Study|Adverse Event|0
5987941|NCT01001104|20705038|P3|Overall Study|Adverse Event|0
5987942|NCT01001104|20705039|P2|Overall Study|Adverse Event|1
5987943|NCT01001104|20705040|P1|Overall Study|Adverse Event|2
5987944|NCT01000974|20705131|P3|Booster Vaccination Phase|Other|4
5987945|NCT01000974|20705132|P2|Booster Vaccination Phase|Other|6
5987946|NCT01000974|20705133|P1|Booster Vaccination Phase|Other|24
5987947|NCT01000974|20705131|P3|Booster Vaccination Phase|Lost to Follow-up|7
5987948|NCT01000974|20705132|P2|Booster Vaccination Phase|Lost to Follow-up|5
5987949|NCT01000974|20705133|P1|Booster Vaccination Phase|Lost to Follow-up|40
5987950|NCT01000974|20705131|P3|Booster Vaccination Phase|Withdrawal by Subject|1
5987951|NCT01000974|20705132|P2|Booster Vaccination Phase|Withdrawal by Subject|1
5987952|NCT01000974|20705133|P1|Booster Vaccination Phase|Withdrawal by Subject|3
5987953|NCT01000974|20705131|P3|Booster Vaccination Phase|Protocol Violation|2
5987954|NCT01000974|20705132|P2|Booster Vaccination Phase|Protocol Violation|0
5987955|NCT01000974|20705133|P1|Booster Vaccination Phase|Protocol Violation|0
5987956|NCT01000974|20705131|P3|Primary Vaccination Phase|Other|12
5987957|NCT01000974|20705132|P2|Primary Vaccination Phase|Other|9
5987958|NCT01000974|20705133|P1|Primary Vaccination Phase|Other|4
5987959|NCT01000974|20705131|P3|Primary Vaccination Phase|Adverse Event|2
5987960|NCT01000974|20705132|P2|Primary Vaccination Phase|Adverse Event|2
5987961|NCT01000974|20705133|P1|Primary Vaccination Phase|Adverse Event|14
5987962|NCT01000974|20705131|P3|Primary Vaccination Phase|Protocol Violation|2
5987963|NCT01000974|20705132|P2|Primary Vaccination Phase|Protocol Violation|3
5987964|NCT01000974|20705133|P1|Primary Vaccination Phase|Protocol Violation|40
5987965|NCT01000974|20705131|P3|Primary Vaccination Phase|Lost to Follow-up|26
5987966|NCT01000974|20705132|P2|Primary Vaccination Phase|Lost to Follow-up|19
5987967|NCT01000974|20705133|P1|Primary Vaccination Phase|Lost to Follow-up|171
5987968|NCT01000974|20705131|P3|Primary Vaccination Phase|Withdrawal by Subject|21
5987969|NCT01000974|20705132|P2|Primary Vaccination Phase|Withdrawal by Subject|17
5987970|NCT01000974|20705133|P1|Primary Vaccination Phase|Withdrawal by Subject|109
5987971|NCT01000961|20705240|P2|First Intervention (3 Weeks)|Infection after pre-planned surgery|1
5987972|NCT01000961|20705241|P1|First Intervention (3 Weeks)|Infection after pre-planned surgery|0
5987973|NCT01000961|20705240|P2|First Intervention (3 Weeks)|Withdrawal by Subject|1
5987974|NCT01000961|20705241|P1|First Intervention (3 Weeks)|Withdrawal by Subject|0
5987975|NCT01000805|20705264|P2|Overall Study|Sponsor Decision|1
5987976|NCT01000805|20705265|P1|Overall Study|Sponsor Decision|0
5987977|NCT01000805|20705264|P2|Overall Study|Withdrawal by Subject|6
5987978|NCT01000805|20705265|P1|Overall Study|Withdrawal by Subject|16
5987979|NCT01000805|20705264|P2|Overall Study|Protocol Violation|8
5987980|NCT01000805|20705265|P1|Overall Study|Protocol Violation|12
5987981|NCT01000805|20705264|P2|Overall Study|Physician Decision|1
5987982|NCT01000805|20705265|P1|Overall Study|Physician Decision|0
5987983|NCT01000805|20705264|P2|Overall Study|Lost to Follow-up|21
5987984|NCT01000805|20705265|P1|Overall Study|Lost to Follow-up|16
5987985|NCT01000805|20705264|P2|Overall Study|Lack of Efficacy|16
5987986|NCT01000805|20705265|P1|Overall Study|Lack of Efficacy|5
5987987|NCT01000805|20705264|P2|Overall Study|Adverse Event|9
5987988|NCT01000805|20705265|P1|Overall Study|Adverse Event|21
5987989|NCT01000727|20705299|P2|Overall Study|Study closed/terminated|24
5987990|NCT01000727|20705300|P1|Overall Study|Study closed/terminated|23
5987991|NCT01000727|20705299|P2|Overall Study|Withdrawal by Subject|109
5987992|NCT01000727|20705300|P1|Overall Study|Withdrawal by Subject|111
5987993|NCT01000727|20705299|P2|Overall Study|Lost to Follow-up|43
5987994|NCT01000727|20705300|P1|Overall Study|Lost to Follow-up|41
5987995|NCT01000649|20705365|P4|Overall Study|Lost to Follow-up|2
5987996|NCT01000649|20705366|P3|Overall Study|Lost to Follow-up|0
5987997|NCT01000649|20705367|P2|Overall Study|Lost to Follow-up|2
5987998|NCT01000649|20705368|P1|Overall Study|Lost to Follow-up|0
5987999|NCT01000649|20705365|P4|Overall Study|Adverse Event|4
5988000|NCT01000649|20705366|P3|Overall Study|Adverse Event|2
5988001|NCT01000649|20705367|P2|Overall Study|Adverse Event|1
5988002|NCT01000649|20705368|P1|Overall Study|Adverse Event|5
5988003|NCT01000610|20705449|P1|Overall Study|Treatment failure|1
5988004|NCT01000610|20705449|P1|Overall Study|Lost to Follow-up|4
5988005|NCT01000610|20705449|P1|Overall Study|Adverse Event|1
5988006|NCT01000506|20705460|P4|Overall Study|Withdrawal by Subject|7
5988007|NCT01000506|20705461|P3|Overall Study|Withdrawal by Subject|2
5988008|NCT01000506|20705462|P2|Overall Study|Withdrawal by Subject|8
5988009|NCT01000506|20705463|P1|Overall Study|Withdrawal by Subject|11
5988010|NCT01000506|20705460|P4|Overall Study|Physician Decision|3
5988011|NCT01000506|20705461|P3|Overall Study|Physician Decision|3
5988012|NCT01000506|20705462|P2|Overall Study|Physician Decision|3
5988013|NCT01000506|20705463|P1|Overall Study|Physician Decision|1
5988014|NCT01000506|20705460|P4|Overall Study|Lost to Follow-up|0
5988015|NCT01000506|20705461|P3|Overall Study|Lost to Follow-up|4
5988016|NCT01000506|20705462|P2|Overall Study|Lost to Follow-up|1
5988017|NCT01000506|20705463|P1|Overall Study|Lost to Follow-up|1
5988018|NCT01000506|20705460|P4|Overall Study|Protocol Violation|0
5988019|NCT01000506|20705461|P3|Overall Study|Protocol Violation|0
5988020|NCT01000506|20705462|P2|Overall Study|Protocol Violation|1
5988021|NCT01000506|20705463|P1|Overall Study|Protocol Violation|1
5988022|NCT01000506|20705460|P4|Overall Study|Lack of Efficacy|4
5988023|NCT01000506|20705461|P3|Overall Study|Lack of Efficacy|4
5988024|NCT01000506|20705462|P2|Overall Study|Lack of Efficacy|6
5988025|NCT01000506|20705463|P1|Overall Study|Lack of Efficacy|8
5988026|NCT01000506|20705460|P4|Overall Study|Adverse Event|9
5988027|NCT01000506|20705461|P3|Overall Study|Adverse Event|8
5988028|NCT01000506|20705462|P2|Overall Study|Adverse Event|5
5988029|NCT01000506|20705463|P1|Overall Study|Adverse Event|6
5988030|NCT01000493|20705507|P2|Overall Study|Withdrawal by Subject|7
5988031|NCT01000493|20705508|P1|Overall Study|Withdrawal by Subject|3
5988032|NCT01000493|20705507|P2|Overall Study|Physician Decision|1
5988033|NCT01000493|20705508|P1|Overall Study|Physician Decision|1
5988034|NCT01000493|20705507|P2|Overall Study|Lost to Follow-up|9
5988035|NCT01000493|20705508|P1|Overall Study|Lost to Follow-up|5
5988036|NCT01000493|20705507|P2|Overall Study|Study closed/terminated|23
5988037|NCT01000493|20705508|P1|Overall Study|Study closed/terminated|25
5988038|NCT01000493|20705507|P2|Overall Study|Protocol Violation|8
5988039|NCT01000493|20705508|P1|Overall Study|Protocol Violation|1
5988040|NCT01000493|20705507|P2|Overall Study|Lack of Efficacy|1
5988041|NCT01000493|20705508|P1|Overall Study|Lack of Efficacy|1
5988042|NCT01000493|20705507|P2|Overall Study|Adverse Event|6
5988043|NCT01000493|20705508|P1|Overall Study|Adverse Event|3
5988044|NCT01000480|20705558|P1|Concurrent Therapy Phase|Physician Decision|1
5988045|NCT01000480|20705558|P1|Concurrent Therapy Phase|Withdrawal by Subject|3
5988046|NCT01000480|20705558|P1|Concurrent Therapy Phase|Protocol Violation|2
5988047|NCT01000480|20705558|P1|Concurrent Therapy Phase|Adverse Event|4
5988048|NCT01000480|20705558|P1|Induction Phase|Entry Criteria Not Met|3
5988049|NCT01000480|20705558|P1|Induction Phase|Physician Decision|1
5988050|NCT01000480|20705558|P1|Induction Phase|Lost to Follow-up|1
5988051|NCT01000480|20705558|P1|Induction Phase|Adverse Event|2
5988052|NCT01000376|20705566|P2|Cycle 1 Day 1|Progressive Disease|0
5988053|NCT01000376|20705567|P1|Cycle 1 Day 1|Progressive Disease|1
5988054|NCT01000376|20705566|P2|Cycle 1 Day 1|Adverse Event|0
5988055|NCT01000376|20705567|P1|Cycle 1 Day 1|Adverse Event|1
5988056|NCT01000337|20705577|P2|Overall Study|Lost to Follow-up|3
5988057|NCT01000337|20705578|P1|Overall Study|Lost to Follow-up|4
5988058|NCT01000311|20705596|P2|Overall Study|Administrative reason|15
5988059|NCT01000311|20705597|P1|Overall Study|Administrative reason|9
5988060|NCT01000311|20705596|P2|Overall Study|Inappropriate enrollment|0
5988061|NCT01000311|20705597|P1|Overall Study|Inappropriate enrollment|2
5988062|NCT01000311|20705596|P2|Overall Study|Protocol Violation|2
5988063|NCT01000311|20705597|P1|Overall Study|Protocol Violation|1
5988064|NCT01000311|20705596|P2|Overall Study|Lost to Follow-up|24
5988065|NCT01000311|20705597|P1|Overall Study|Lost to Follow-up|15
5988066|NCT01000311|20705596|P2|Overall Study|Withdrawal by Subject|24
5988067|NCT01000311|20705597|P1|Overall Study|Withdrawal by Subject|16
5988068|NCT01000311|20705596|P2|Overall Study|Adverse Event|5
5988069|NCT01000311|20705597|P1|Overall Study|Adverse Event|2
5988070|NCT01000155|20705647|P1|Overall Study|Adverse Event|1
5988071|NCT01000155|20705647|P1|Overall Study|Withdrawal by Subject|1
5988072|NCT01000064|20705653|P2|Overall Study|Withdrawal by Subject|1
5988073|NCT01000064|20705654|P1|Overall Study|Withdrawal by Subject|1
5988074|NCT01000051|20705677|P2|Overall Study|Serious noncompliance|0
5988075|NCT01000051|20705678|P1|Overall Study|Serious noncompliance|1
5988076|NCT01000051|20705677|P2|Overall Study|Disease Progression|0
5988077|NCT01000051|20705678|P1|Overall Study|Disease Progression|1
5988078|NCT01000051|20705677|P2|Overall Study|Withdrawal by Subject|1
5988079|NCT01000051|20705678|P1|Overall Study|Withdrawal by Subject|1
5988080|NCT01000025|20705686|P2|Overall Study|Intercurrent Illness|7
5988081|NCT01000025|20705687|P1|Overall Study|Intercurrent Illness|26
5988082|NCT01000025|20705686|P2|Overall Study|Lack of Efficacy|208
5988083|NCT01000025|20705687|P1|Overall Study|Lack of Efficacy|363
5988084|NCT01000025|20705686|P2|Overall Study|Death|13
5988085|NCT01000025|20705687|P1|Overall Study|Death|23
5988086|NCT01000025|20705686|P2|Overall Study|Withdrawal by Subject|8
5988087|NCT01000025|20705687|P1|Overall Study|Withdrawal by Subject|13
5988088|NCT01000025|20705686|P2|Overall Study|Adverse Event|2
5988089|NCT01000025|20705687|P1|Overall Study|Adverse Event|43
5988090|NCT00999921|20705705|P2|Overall Study|Lost to Follow-up|19
5988091|NCT00999921|20705706|P1|Overall Study|Lost to Follow-up|10
5988092|NCT00999908|20705716|P3|Treatment Period 2|Protocol Violation|0
5988093|NCT00999908|20705717|P2|Treatment Period 2|Protocol Violation|0
5988094|NCT00999908|20705718|P1|Treatment Period 2|Protocol Violation|1
5988095|NCT00999908|20705716|P3|Treatment Period 1|Subject withdrew consent|0
5988096|NCT00999908|20705717|P2|Treatment Period 1|Subject withdrew consent|0
5988097|NCT00999908|20705718|P1|Treatment Period 1|Subject withdrew consent|2
5988098|NCT00999804|20705747|P2|Overall Study|Ineligible|0
5988099|NCT00999804|20705748|P1|Overall Study|Ineligible|3
5988100|NCT00999804|20705747|P2|Overall Study|Death|0
5988101|NCT00999804|20705748|P1|Overall Study|Death|1
5988102|NCT00999804|20705747|P2|Overall Study|Withdrawal by Subject|0
5988103|NCT00999804|20705748|P1|Overall Study|Withdrawal by Subject|4
5988104|NCT00999804|20705747|P2|Overall Study|Adverse Event|3
5988105|NCT00999804|20705748|P1|Overall Study|Adverse Event|4
5988106|NCT00999804|20705747|P2|Overall Study|Lack of Efficacy|2
5988107|NCT00999804|20705748|P1|Overall Study|Lack of Efficacy|9
5988108|NCT00999713|20705762|P2|Overall Study|Physician Decision|0
5988109|NCT00999713|20705763|P1|Overall Study|Physician Decision|2
5988110|NCT00999687|20705777|P1|Second Intervention|Lack of Efficacy|1
5988111|NCT00999687|20705777|P1|Second Intervention|Withdrawal by Subject|2
5988112|NCT00999687|20705777|P1|First Intervention|Withdrawal by Subject|1
5988113|NCT00999661|20705784|P1|Overall Study|Not meeting eligibility criteria|9
5988114|NCT00999661|20705784|P1|Overall Study|Withdrawal by Subject|1
5988115|NCT00999661|20705784|P1|Overall Study|Adverse Event|1
5988116|NCT00999661|20705784|P1|Overall Study|Lost to Follow-up|59
5988117|NCT00999596|20705805|P1|Overall Study|Statistical population not required|101
5988118|NCT00999544|20705810|P1|Overall Study|Withdrawal by Subject|1
5988119|NCT00999466|20705846|P3|Main Part|Adverse Event|2
5988120|NCT00999466|20705847|P2|Main Part|Adverse Event|4
5988121|NCT00999466|20705848|P1|Main Part|Adverse Event|0
5988122|NCT00999466|20705846|P3|Main Part|Withdrawal by Subject|2
5988123|NCT00999466|20705847|P2|Main Part|Withdrawal by Subject|0
5988124|NCT00999466|20705848|P1|Main Part|Withdrawal by Subject|0
5988125|NCT00999167|20706125|P3|Part B: Randomized, Placebo Controlled|Physician stopped drug|0
5988126|NCT00999167|20706126|P2|Part B: Randomized, Placebo Controlled|Physician stopped drug|1
5988127|NCT00999167|20706127|P1|Part B: Randomized, Placebo Controlled|Physician stopped drug|0
5988128|NCT00999167|20706125|P3|Part B: Randomized, Placebo Controlled|Physician Decision|0
5988129|NCT00999167|20706126|P2|Part B: Randomized, Placebo Controlled|Physician Decision|1
5988130|NCT00999167|20706127|P1|Part B: Randomized, Placebo Controlled|Physician Decision|0
5988131|NCT00999167|20706125|P3|Part B: Randomized, Placebo Controlled|Noncompliance|0
5988132|NCT00999167|20706126|P2|Part B: Randomized, Placebo Controlled|Noncompliance|1
5988133|NCT00999167|20706127|P1|Part B: Randomized, Placebo Controlled|Noncompliance|0
5988134|NCT00999167|20706125|P3|Part B: Randomized, Placebo Controlled|Adverse Event|1
5988135|NCT00999167|20706126|P2|Part B: Randomized, Placebo Controlled|Adverse Event|6
5988136|NCT00999167|20706127|P1|Part B: Randomized, Placebo Controlled|Adverse Event|0
5988137|NCT00999167|20706125|P3|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|4
5988138|NCT00999167|20706126|P2|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|7
5988139|NCT00999167|20706127|P1|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|0
5988140|NCT00999167|20706125|P3|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|16
5988141|NCT00999167|20706126|P2|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|19
5988142|NCT00999167|20706127|P1|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|0
5988143|NCT00999167|20706125|P3|Part A: Open Label Safety run-in|Adverse Event|0
5988144|NCT00999167|20706126|P2|Part A: Open Label Safety run-in|Adverse Event|0
5988145|NCT00999167|20706127|P1|Part A: Open Label Safety run-in|Adverse Event|3
5988146|NCT00999167|20706125|P3|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0
5988147|NCT00999167|20706126|P2|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0
5988148|NCT00999167|20706127|P1|Part A: Open Label Safety run-in|Met protocol defined stopping rule|4
5988149|NCT00998985|20706265|P14|Overall Study|Protocol Violation|0
5988150|NCT00998985|20706266|P13|Overall Study|Protocol Violation|0
5988151|NCT00998985|20706267|P12|Overall Study|Protocol Violation|0
5988152|NCT00998985|20706268|P11|Overall Study|Protocol Violation|0
5988153|NCT00998985|20706269|P10|Overall Study|Protocol Violation|0
5988154|NCT00998985|20706270|P9|Overall Study|Protocol Violation|0
5988155|NCT00998985|20706271|P8|Overall Study|Protocol Violation|0
5988156|NCT00998985|20706272|P7|Overall Study|Protocol Violation|0
5988157|NCT00998985|20706273|P6|Overall Study|Protocol Violation|1
5988158|NCT00998985|20706274|P5|Overall Study|Protocol Violation|0
5988159|NCT00998985|20706275|P4|Overall Study|Protocol Violation|0
5988160|NCT00998985|20706276|P3|Overall Study|Protocol Violation|0
5988161|NCT00998985|20706277|P2|Overall Study|Protocol Violation|0
5988162|NCT00998985|20706278|P1|Overall Study|Protocol Violation|0
5988163|NCT00998985|20706265|P14|Overall Study|Withdrawal by Subject|0
5988164|NCT00998985|20706266|P13|Overall Study|Withdrawal by Subject|0
5988165|NCT00998985|20706267|P12|Overall Study|Withdrawal by Subject|0
5988166|NCT00998985|20706268|P11|Overall Study|Withdrawal by Subject|0
5988167|NCT00998985|20706269|P10|Overall Study|Withdrawal by Subject|0
5988168|NCT00998985|20706270|P9|Overall Study|Withdrawal by Subject|1
5988169|NCT00998985|20706271|P8|Overall Study|Withdrawal by Subject|0
5988170|NCT00998985|20706272|P7|Overall Study|Withdrawal by Subject|0
5988171|NCT00998985|20706273|P6|Overall Study|Withdrawal by Subject|0
5988172|NCT00998985|20706274|P5|Overall Study|Withdrawal by Subject|0
5988173|NCT00998985|20706275|P4|Overall Study|Withdrawal by Subject|0
5988174|NCT00998985|20706276|P3|Overall Study|Withdrawal by Subject|0
5988175|NCT00998985|20706277|P2|Overall Study|Withdrawal by Subject|0
5988176|NCT00998985|20706278|P1|Overall Study|Withdrawal by Subject|0
5988177|NCT00998881|20706346|P2|Overall Study|Personal matter|0
5988178|NCT00998881|20706347|P1|Overall Study|Personal matter|1
5988179|NCT00998881|20706346|P2|Overall Study|Withdrawal by Subject|0
5988180|NCT00998881|20706347|P1|Overall Study|Withdrawal by Subject|1
5988181|NCT00998881|20706346|P2|Overall Study|Physician Decision|0
5988182|NCT00998881|20706347|P1|Overall Study|Physician Decision|3
5988183|NCT00998881|20706346|P2|Overall Study|Lack of Efficacy|0
5988184|NCT00998881|20706347|P1|Overall Study|Lack of Efficacy|1
5988185|NCT00998881|20706346|P2|Overall Study|Adverse Event|2
5988186|NCT00998881|20706347|P1|Overall Study|Adverse Event|2
5988187|NCT00998790|20706366|P1|Overall Study|Withdrawal by Subject|21
5988188|NCT00998764|20706376|P2|Overall Study|Recurrent Episode of vasogenic edema|0
5988189|NCT00998764|20706377|P1|Overall Study|Recurrent Episode of vasogenic edema|1
5988190|NCT00998764|20706376|P2|Overall Study|Other|4
5988191|NCT00998764|20706377|P1|Overall Study|Other|4
5988192|NCT00998764|20706376|P2|Overall Study|Loss of Caregiver|3
5988193|NCT00998764|20706377|P1|Overall Study|Loss of Caregiver|0
5988194|NCT00998764|20706376|P2|Overall Study|Lost to Follow-up|1
5988195|NCT00998764|20706377|P1|Overall Study|Lost to Follow-up|1
5988196|NCT00998764|20706376|P2|Overall Study|Failed to Return|1
5988197|NCT00998764|20706377|P1|Overall Study|Failed to Return|1
5988198|NCT00998764|20706376|P2|Overall Study|Protocol Violation|1
5988199|NCT00998764|20706377|P1|Overall Study|Protocol Violation|0
5988200|NCT00998764|20706376|P2|Overall Study|Discontinuation of Study by Sponsor|217
5988201|NCT00998764|20706377|P1|Overall Study|Discontinuation of Study by Sponsor|164
5988202|NCT00998764|20706376|P2|Overall Study|Death|1
5988203|NCT00998764|20706377|P1|Overall Study|Death|3
5988204|NCT00998764|20706376|P2|Overall Study|Physician Decision|3
5988205|NCT00998764|20706377|P1|Overall Study|Physician Decision|3
5988206|NCT00998764|20706376|P2|Overall Study|Withdrawal by Subject|25
5988207|NCT00998764|20706377|P1|Overall Study|Withdrawal by Subject|19
5988208|NCT00998764|20706376|P2|Overall Study|Adverse Event|12
5988209|NCT00998764|20706377|P1|Overall Study|Adverse Event|17
5988210|NCT00998764|20706376|P2|Overall Study|Lack of Efficacy|6
5988211|NCT00998764|20706377|P1|Overall Study|Lack of Efficacy|3
5988212|NCT00998738|20706399|P1|Overall Study|Uknown|1
5988213|NCT00998400|20706467|P2|Overall Study|Logistical problems|0
5988214|NCT00998400|20706468|P1|Overall Study|Logistical problems|1
5988215|NCT00998400|20706467|P2|Overall Study|Lack of interest/motivation|2
5988216|NCT00998400|20706468|P1|Overall Study|Lack of interest/motivation|1
5988217|NCT00998335|20706513|P2|Randomized Period (Months 3 to 6)|Withdrawal by Subject|2
5988218|NCT00998335|20706514|P1|Randomized Period (Months 3 to 6)|Withdrawal by Subject|0
5988219|NCT00998309|20706542|P1|Overall Study|Protocol Violation|4
5988220|NCT00998296|20706609|P11|Overall Study|Reason other than those specified above|0
5988221|NCT00998296|20706610|P10|Overall Study|Reason other than those specified above|1
5988222|NCT00998296|20706611|P9|Overall Study|Reason other than those specified above|0
5988223|NCT00998296|20706612|P8|Overall Study|Reason other than those specified above|0
5988224|NCT00998296|20706613|P7|Overall Study|Reason other than those specified above|0
5988225|NCT00998296|20706614|P6|Overall Study|Reason other than those specified above|0
5988226|NCT00998296|20706615|P5|Overall Study|Reason other than those specified above|0
5988227|NCT00998296|20706616|P4|Overall Study|Reason other than those specified above|0
5988228|NCT00998296|20706617|P3|Overall Study|Reason other than those specified above|0
5988229|NCT00998296|20706618|P2|Overall Study|Reason other than those specified above|0
5988230|NCT00998296|20706619|P1|Overall Study|Reason other than those specified above|0
5988231|NCT00998296|20706609|P11|Overall Study|Refused to continue taking trial med.|0
5988232|NCT00998296|20706610|P10|Overall Study|Refused to continue taking trial med.|2
5988233|NCT00998296|20706611|P9|Overall Study|Refused to continue taking trial med.|0
5988234|NCT00998296|20706612|P8|Overall Study|Refused to continue taking trial med.|0
5988235|NCT00998296|20706613|P7|Overall Study|Refused to continue taking trial med.|0
5988236|NCT00998296|20706614|P6|Overall Study|Refused to continue taking trial med.|0
5988237|NCT00998296|20706615|P5|Overall Study|Refused to continue taking trial med.|0
5988238|NCT00998296|20706616|P4|Overall Study|Refused to continue taking trial med.|0
5988239|NCT00998296|20706617|P3|Overall Study|Refused to continue taking trial med.|0
5988240|NCT00998296|20706618|P2|Overall Study|Refused to continue taking trial med.|0
5988241|NCT00998296|20706619|P1|Overall Study|Refused to continue taking trial med.|0
5988242|NCT00998296|20706609|P11|Overall Study|Other adverse event|2
5988243|NCT00998296|20706610|P10|Overall Study|Other adverse event|1
5988244|NCT00998296|20706611|P9|Overall Study|Other adverse event|0
5988245|NCT00998296|20706612|P8|Overall Study|Other adverse event|0
5988246|NCT00998296|20706613|P7|Overall Study|Other adverse event|0
5988247|NCT00998296|20706614|P6|Overall Study|Other adverse event|0
5988248|NCT00998296|20706615|P5|Overall Study|Other adverse event|1
5988249|NCT00998296|20706616|P4|Overall Study|Other adverse event|0
5988250|NCT00998296|20706617|P3|Overall Study|Other adverse event|0
5988251|NCT00998296|20706618|P2|Overall Study|Other adverse event|0
5988252|NCT00998296|20706619|P1|Overall Study|Other adverse event|0
5988253|NCT00998296|20706609|P11|Overall Study|Dose limiting or dose reducing toxicity|0
5988254|NCT00998296|20706610|P10|Overall Study|Dose limiting or dose reducing toxicity|0
5988255|NCT00998296|20706611|P9|Overall Study|Dose limiting or dose reducing toxicity|2
5988256|NCT00998296|20706612|P8|Overall Study|Dose limiting or dose reducing toxicity|2
5988257|NCT00998296|20706613|P7|Overall Study|Dose limiting or dose reducing toxicity|0
5988258|NCT00998296|20706614|P6|Overall Study|Dose limiting or dose reducing toxicity|0
5988259|NCT00998296|20706615|P5|Overall Study|Dose limiting or dose reducing toxicity|1
5988260|NCT00998296|20706616|P4|Overall Study|Dose limiting or dose reducing toxicity|0
5988261|NCT00998296|20706617|P3|Overall Study|Dose limiting or dose reducing toxicity|0
5988262|NCT00998296|20706618|P2|Overall Study|Dose limiting or dose reducing toxicity|0
5988263|NCT00998296|20706619|P1|Overall Study|Dose limiting or dose reducing toxicity|0
5988264|NCT00998296|20706609|P11|Overall Study|Progressive disease|5
5988265|NCT00998296|20706610|P10|Overall Study|Progressive disease|14
5988266|NCT00998296|20706611|P9|Overall Study|Progressive disease|0
5988267|NCT00998296|20706612|P8|Overall Study|Progressive disease|0
5988268|NCT00998296|20706613|P7|Overall Study|Progressive disease|1
5988269|NCT00998296|20706614|P6|Overall Study|Progressive disease|0
5988270|NCT00998296|20706615|P5|Overall Study|Progressive disease|0
5988271|NCT00998296|20706616|P4|Overall Study|Progressive disease|0
5988272|NCT00998296|20706617|P3|Overall Study|Progressive disease|0
5988273|NCT00998296|20706618|P2|Overall Study|Progressive disease|1
5988274|NCT00998296|20706619|P1|Overall Study|Progressive disease|0
5988275|NCT00997984|20706722|P3|Overall Study|Work schedule|2
5988276|NCT00997984|20706723|P2|Overall Study|Work schedule|0
5988277|NCT00997984|20706724|P1|Overall Study|Work schedule|0
5988278|NCT00997984|20706722|P3|Overall Study|Suicidal ideation|1
5988279|NCT00997984|20706723|P2|Overall Study|Suicidal ideation|0
5988280|NCT00997984|20706724|P1|Overall Study|Suicidal ideation|0
5988281|NCT00997984|20706722|P3|Overall Study|Wrong medication dispensed|0
5988282|NCT00997984|20706723|P2|Overall Study|Wrong medication dispensed|1
5988283|NCT00997984|20706724|P1|Overall Study|Wrong medication dispensed|0
5988284|NCT00997984|20706722|P3|Overall Study|non-compliance|3
5988285|NCT00997984|20706723|P2|Overall Study|non-compliance|2
5988286|NCT00997984|20706724|P1|Overall Study|non-compliance|0
5988287|NCT00997984|20706722|P3|Overall Study|Met exclusion criteria|0
5988288|NCT00997984|20706723|P2|Overall Study|Met exclusion criteria|0
5988289|NCT00997984|20706724|P1|Overall Study|Met exclusion criteria|1
5988290|NCT00997984|20706722|P3|Overall Study|Lack of Efficacy|3
5988291|NCT00997984|20706723|P2|Overall Study|Lack of Efficacy|6
5988292|NCT00997984|20706724|P1|Overall Study|Lack of Efficacy|20
5988293|NCT00997984|20706722|P3|Overall Study|Lost to Follow-up|4
5988294|NCT00997984|20706723|P2|Overall Study|Lost to Follow-up|5
5988295|NCT00997984|20706724|P1|Overall Study|Lost to Follow-up|8
5988296|NCT00997984|20706722|P3|Overall Study|Withdrawal by Subject|5
5988297|NCT00997984|20706723|P2|Overall Study|Withdrawal by Subject|9
5988298|NCT00997984|20706724|P1|Overall Study|Withdrawal by Subject|6
5988299|NCT00997984|20706722|P3|Overall Study|Protocol Violation|0
5988300|NCT00997984|20706723|P2|Overall Study|Protocol Violation|3
5988301|NCT00997984|20706724|P1|Overall Study|Protocol Violation|1
5988302|NCT00997984|20706722|P3|Overall Study|Adverse Event|8
5988303|NCT00997984|20706723|P2|Overall Study|Adverse Event|8
5988304|NCT00997984|20706724|P1|Overall Study|Adverse Event|1
5988305|NCT00997893|20706798|P3|Overall Study|Pain/pain meds during Visit 4|0
5988306|NCT00997893|20706799|P2|Overall Study|Pain/pain meds during Visit 4|1
5988307|NCT00997893|20706800|P1|Overall Study|Pain/pain meds during Visit 4|0
5988308|NCT00997893|20706798|P3|Overall Study|Unable to meet study timelines|0
5988309|NCT00997893|20706799|P2|Overall Study|Unable to meet study timelines|0
5988310|NCT00997893|20706800|P1|Overall Study|Unable to meet study timelines|1
5988311|NCT00997893|20706798|P3|Overall Study|Adverse Event|0
5988312|NCT00997893|20706799|P2|Overall Study|Adverse Event|0
5988313|NCT00997893|20706800|P1|Overall Study|Adverse Event|1
5988314|NCT00997503|20706907|P1|Overall Study|Other reason|13
5988315|NCT00997503|20706907|P1|Overall Study|Missed 12-month follow-up|85
5988316|NCT00997503|20706907|P1|Overall Study|Physician Decision|10
5988317|NCT00997503|20706907|P1|Overall Study|Adverse Event|3
5988318|NCT00997503|20706907|P1|Overall Study|Lost to Follow-up|33
5988319|NCT00997503|20706907|P1|Overall Study|Withdrawal by Subject|76
5988320|NCT00997503|20706907|P1|Overall Study|Death|53
5988321|NCT00997438|20706950|P3|Overall Study|Exclusion criteria at visit 1|3
5988322|NCT00997438|20706951|P2|Overall Study|Exclusion criteria at visit 1|2
5988323|NCT00997438|20706952|P1|Overall Study|Exclusion criteria at visit 1|2
5988324|NCT00997438|20706950|P3|Overall Study|Withdrawal by Subject|0
5988325|NCT00997438|20706951|P2|Overall Study|Withdrawal by Subject|1
5988326|NCT00997438|20706952|P1|Overall Study|Withdrawal by Subject|1
5988327|NCT00997438|20706950|P3|Overall Study|Blood draw difficulty|1
5988328|NCT00997438|20706951|P2|Overall Study|Blood draw difficulty|0
5988329|NCT00997438|20706952|P1|Overall Study|Blood draw difficulty|2
5988330|NCT00997386|20706992|P1|Overall Study|Death|7
5988331|NCT00997373|20707001|P2|Overall Study|could not have hysterectomy|0
5988332|NCT00997373|20707002|P1|Overall Study|could not have hysterectomy|6
5988333|NCT00997373|20707001|P2|Overall Study|wrong tumor type|0
5988334|NCT00997373|20707002|P1|Overall Study|wrong tumor type|4
5988335|NCT00997373|20707001|P2|Overall Study|Withdrawal by Subject|0
5988336|NCT00997373|20707002|P1|Overall Study|Withdrawal by Subject|5
5988337|NCT00997334|20707008|P1|Overall Study|Ineligible|1
5988338|NCT00997334|20707008|P1|Overall Study|No lesion amenable|1
5988339|NCT00997334|20707008|P1|Overall Study|Urgent Palliative Care|2
5988340|NCT00997334|20707008|P1|Overall Study|Death|2
5988341|NCT00997334|20707008|P1|Overall Study|Withdrawal by Subject|3
5988342|NCT00997334|20707008|P1|Overall Study|Patient non-compliance|1
5988343|NCT00997334|20707008|P1|Overall Study|Adverse Event|3
5988344|NCT00997334|20707008|P1|Overall Study|still on therapy|12
5988345|NCT00997321|20707017|P2|Overall Study|did not undergo sedation after enrollmen|3
5988346|NCT00997321|20707018|P1|Overall Study|did not undergo sedation after enrollmen|0
5988347|NCT00997243|20707030|P1|Overall Study|Early termination of study by sponsor|7
5988348|NCT00997126|20707062|P2|Overall Study|Physician Decision|11
5988349|NCT00997126|20707063|P1|Overall Study|Physician Decision|7
5988350|NCT00997035|20707092|P2|3-month Follow-up Visit|Lost to Follow-up|6
5988351|NCT00997035|20707093|P1|3-month Follow-up Visit|Lost to Follow-up|12
5988352|NCT00997035|20707092|P2|3-week Followup Visit|Lost to Follow-up|6
5988353|NCT00997035|20707093|P1|3-week Followup Visit|Lost to Follow-up|9
5988354|NCT00996996|20707117|P1|Overall Study|Did Not Receive Study Medications|1
5988355|NCT00996996|20707117|P1|Overall Study|Death|5
5988356|NCT00996996|20707117|P1|Overall Study|Lost to Follow-up|9
5988357|NCT00996996|20707117|P1|Overall Study|Non-compliance|8
5988358|NCT00996996|20707117|P1|Overall Study|Progressive Disease|10
5988359|NCT00996944|20707151|P2|Long-term Treatment Period|Study Closed/Terminated|5
5988360|NCT00996944|20707152|P1|Long-term Treatment Period|Study Closed/Terminated|12
5988361|NCT00996944|20707151|P2|Double-blind Treatment Period|Withdrawal by Subject|1
5988362|NCT00996944|20707152|P1|Double-blind Treatment Period|Withdrawal by Subject|1
5988363|NCT00996944|20707151|P2|Double-blind Treatment Period|Study Closed/Terminated|5
5988364|NCT00996944|20707152|P1|Double-blind Treatment Period|Study Closed/Terminated|6
5988365|NCT00996944|20707151|P2|Double-blind Treatment Period|Protocol Violation|0
5988366|NCT00996944|20707152|P1|Double-blind Treatment Period|Protocol Violation|1
5988367|NCT00996944|20707151|P2|Double-blind Treatment Period|Adverse Event|1
5988368|NCT00996944|20707152|P1|Double-blind Treatment Period|Adverse Event|2
5988369|NCT00996918|20707204|P5|Overall Study|Other|0
5988370|NCT00996918|20707205|P4|Overall Study|Other|0
5988371|NCT00996918|20707206|P3|Overall Study|Other|0
5988372|NCT00996918|20707207|P2|Overall Study|Other|1
5988373|NCT00996918|20707208|P1|Overall Study|Other|3
5988374|NCT00996918|20707204|P5|Overall Study|Loss of Caregiver|0
5988375|NCT00996918|20707205|P4|Overall Study|Loss of Caregiver|0
5988376|NCT00996918|20707206|P3|Overall Study|Loss of Caregiver|0
5988377|NCT00996918|20707207|P2|Overall Study|Loss of Caregiver|1
5988378|NCT00996918|20707208|P1|Overall Study|Loss of Caregiver|0
5988379|NCT00996918|20707204|P5|Overall Study|Discontinuation of Study by Sponsor|2
5988380|NCT00996918|20707205|P4|Overall Study|Discontinuation of Study by Sponsor|45
5988381|NCT00996918|20707206|P3|Overall Study|Discontinuation of Study by Sponsor|30
5988382|NCT00996918|20707207|P2|Overall Study|Discontinuation of Study by Sponsor|54
5988383|NCT00996918|20707208|P1|Overall Study|Discontinuation of Study by Sponsor|31
5988384|NCT00996918|20707204|P5|Overall Study|Physician Decision|0
5988385|NCT00996918|20707205|P4|Overall Study|Physician Decision|0
5988386|NCT00996918|20707206|P3|Overall Study|Physician Decision|0
5988387|NCT00996918|20707207|P2|Overall Study|Physician Decision|0
5988388|NCT00996918|20707208|P1|Overall Study|Physician Decision|1
5988389|NCT00996918|20707204|P5|Overall Study|Withdrawal by Subject|2
5988390|NCT00996918|20707205|P4|Overall Study|Withdrawal by Subject|3
5988391|NCT00996918|20707206|P3|Overall Study|Withdrawal by Subject|3
5988392|NCT00996918|20707207|P2|Overall Study|Withdrawal by Subject|4
5988393|NCT00996918|20707208|P1|Overall Study|Withdrawal by Subject|1
5988394|NCT00996918|20707204|P5|Overall Study|Adverse Event|0
5988395|NCT00996918|20707205|P4|Overall Study|Adverse Event|6
5988396|NCT00996918|20707206|P3|Overall Study|Adverse Event|2
5988397|NCT00996918|20707207|P2|Overall Study|Adverse Event|5
5988398|NCT00996918|20707208|P1|Overall Study|Adverse Event|2
5988399|NCT00996918|20707204|P5|Overall Study|Lack of Efficacy|0
5988400|NCT00996918|20707205|P4|Overall Study|Lack of Efficacy|2
5988401|NCT00996918|20707206|P3|Overall Study|Lack of Efficacy|2
5988402|NCT00996918|20707207|P2|Overall Study|Lack of Efficacy|1
5988403|NCT00996918|20707208|P1|Overall Study|Lack of Efficacy|1
5988404|NCT00996892|20707252|P20|Expansion Stage 2A|Disease Progression|31
5988405|NCT00996892|20707253|P19|Expansion Stage 2A|Disease Progression|0
5988406|NCT00996892|20707254|P18|Expansion Stage 2A|Disease Progression|0
5988407|NCT00996892|20707255|P17|Expansion Stage 2A|Disease Progression|0
5988408|NCT00996892|20707256|P16|Expansion Stage 2A|Disease Progression|0
5988409|NCT00996892|20707257|P15|Expansion Stage 2A|Disease Progression|0
5988410|NCT00996892|20707258|P14|Expansion Stage 2A|Disease Progression|0
5988411|NCT00996892|20707259|P13|Expansion Stage 2A|Disease Progression|0
5988412|NCT00996892|20707260|P12|Expansion Stage 2A|Disease Progression|0
5988413|NCT00996892|20707261|P11|Expansion Stage 2A|Disease Progression|0
5988414|NCT00996892|20707262|P10|Expansion Stage 2A|Disease Progression|0
5988415|NCT00996892|20707263|P9|Expansion Stage 2A|Disease Progression|0
5988416|NCT00996892|20707264|P8|Expansion Stage 2A|Disease Progression|0
5988417|NCT00996892|20707265|P7|Expansion Stage 2A|Disease Progression|0
5988418|NCT00996892|20707266|P6|Expansion Stage 2A|Disease Progression|0
5988419|NCT00996892|20707267|P5|Expansion Stage 2A|Disease Progression|0
5988420|NCT00996892|20707268|P4|Expansion Stage 2A|Disease Progression|0
5988421|NCT00996892|20707269|P3|Expansion Stage 2A|Disease Progression|0
5988422|NCT00996892|20707270|P2|Expansion Stage 2A|Disease Progression|0
5988423|NCT00996892|20707271|P1|Expansion Stage 2A|Disease Progression|0
5988424|NCT00996892|20707252|P20|Expansion Stage 2A|Withdrawal by Subject|4
5988425|NCT00996892|20707253|P19|Expansion Stage 2A|Withdrawal by Subject|0
5988426|NCT00996892|20707254|P18|Expansion Stage 2A|Withdrawal by Subject|0
5988427|NCT00996892|20707255|P17|Expansion Stage 2A|Withdrawal by Subject|0
5988428|NCT00996892|20707256|P16|Expansion Stage 2A|Withdrawal by Subject|0
5988429|NCT00996892|20707257|P15|Expansion Stage 2A|Withdrawal by Subject|0
5988430|NCT00996892|20707258|P14|Expansion Stage 2A|Withdrawal by Subject|0
5988431|NCT00996892|20707259|P13|Expansion Stage 2A|Withdrawal by Subject|0
5988432|NCT00996892|20707260|P12|Expansion Stage 2A|Withdrawal by Subject|0
5988433|NCT00996892|20707261|P11|Expansion Stage 2A|Withdrawal by Subject|0
5988434|NCT00996892|20707262|P10|Expansion Stage 2A|Withdrawal by Subject|0
5988435|NCT00996892|20707263|P9|Expansion Stage 2A|Withdrawal by Subject|0
5988436|NCT00996892|20707264|P8|Expansion Stage 2A|Withdrawal by Subject|0
5988437|NCT00996892|20707265|P7|Expansion Stage 2A|Withdrawal by Subject|0
5988438|NCT00996892|20707266|P6|Expansion Stage 2A|Withdrawal by Subject|0
5988439|NCT00996892|20707267|P5|Expansion Stage 2A|Withdrawal by Subject|0
5988440|NCT00996892|20707268|P4|Expansion Stage 2A|Withdrawal by Subject|0
5988441|NCT00996892|20707269|P3|Expansion Stage 2A|Withdrawal by Subject|0
5988442|NCT00996892|20707270|P2|Expansion Stage 2A|Withdrawal by Subject|0
5988443|NCT00996892|20707271|P1|Expansion Stage 2A|Withdrawal by Subject|0
5988444|NCT00996892|20707252|P20|Expansion Stage 2A|Physician Decision|2
5988445|NCT00996892|20707253|P19|Expansion Stage 2A|Physician Decision|0
5988446|NCT00996892|20707254|P18|Expansion Stage 2A|Physician Decision|0
5988447|NCT00996892|20707255|P17|Expansion Stage 2A|Physician Decision|0
5988448|NCT00996892|20707256|P16|Expansion Stage 2A|Physician Decision|0
5988449|NCT00996892|20707257|P15|Expansion Stage 2A|Physician Decision|0
5988450|NCT00996892|20707258|P14|Expansion Stage 2A|Physician Decision|0
5988451|NCT00996892|20707259|P13|Expansion Stage 2A|Physician Decision|0
5988452|NCT00996892|20707260|P12|Expansion Stage 2A|Physician Decision|0
5988453|NCT00996892|20707261|P11|Expansion Stage 2A|Physician Decision|0
5988454|NCT00996892|20707262|P10|Expansion Stage 2A|Physician Decision|0
5988455|NCT00996892|20707263|P9|Expansion Stage 2A|Physician Decision|0
5988456|NCT00996892|20707264|P8|Expansion Stage 2A|Physician Decision|0
5988457|NCT00996892|20707265|P7|Expansion Stage 2A|Physician Decision|0
5988458|NCT00996892|20707266|P6|Expansion Stage 2A|Physician Decision|0
5988459|NCT00996892|20707267|P5|Expansion Stage 2A|Physician Decision|0
5988460|NCT00996892|20707268|P4|Expansion Stage 2A|Physician Decision|0
5988461|NCT00996892|20707269|P3|Expansion Stage 2A|Physician Decision|0
5988462|NCT00996892|20707270|P2|Expansion Stage 2A|Physician Decision|0
5988463|NCT00996892|20707271|P1|Expansion Stage 2A|Physician Decision|0
5988464|NCT00996892|20707252|P20|Expansion Stage 2A|Adverse Event|8
5988465|NCT00996892|20707253|P19|Expansion Stage 2A|Adverse Event|0
5988466|NCT00996892|20707254|P18|Expansion Stage 2A|Adverse Event|0
5988467|NCT00996892|20707255|P17|Expansion Stage 2A|Adverse Event|0
5988468|NCT00996892|20707256|P16|Expansion Stage 2A|Adverse Event|0
5988469|NCT00996892|20707257|P15|Expansion Stage 2A|Adverse Event|0
5988470|NCT00996892|20707258|P14|Expansion Stage 2A|Adverse Event|0
5988471|NCT00996892|20707259|P13|Expansion Stage 2A|Adverse Event|0
5988472|NCT00996892|20707260|P12|Expansion Stage 2A|Adverse Event|0
5988473|NCT00996892|20707261|P11|Expansion Stage 2A|Adverse Event|0
5988474|NCT00996892|20707262|P10|Expansion Stage 2A|Adverse Event|0
5988475|NCT00996892|20707263|P9|Expansion Stage 2A|Adverse Event|0
5988476|NCT00996892|20707264|P8|Expansion Stage 2A|Adverse Event|0
5988477|NCT00996892|20707265|P7|Expansion Stage 2A|Adverse Event|0
5988478|NCT00996892|20707266|P6|Expansion Stage 2A|Adverse Event|0
5988479|NCT00996892|20707267|P5|Expansion Stage 2A|Adverse Event|0
5988480|NCT00996892|20707268|P4|Expansion Stage 2A|Adverse Event|0
5988481|NCT00996892|20707269|P3|Expansion Stage 2A|Adverse Event|0
5988482|NCT00996892|20707270|P2|Expansion Stage 2A|Adverse Event|0
5988483|NCT00996892|20707271|P1|Expansion Stage 2A|Adverse Event|0
5988484|NCT00996892|20707252|P20|Expansion Stage 2|Disease Progression|0
5988485|NCT00996892|20707253|P19|Expansion Stage 2|Disease Progression|28
5988486|NCT00996892|20707254|P18|Expansion Stage 2|Disease Progression|0
5988487|NCT00996892|20707255|P17|Expansion Stage 2|Disease Progression|0
5988488|NCT00996892|20707256|P16|Expansion Stage 2|Disease Progression|0
5988489|NCT00996892|20707257|P15|Expansion Stage 2|Disease Progression|0
5988490|NCT00996892|20707258|P14|Expansion Stage 2|Disease Progression|0
5988491|NCT00996892|20707259|P13|Expansion Stage 2|Disease Progression|0
5988492|NCT00996892|20707260|P12|Expansion Stage 2|Disease Progression|0
5988493|NCT00996892|20707261|P11|Expansion Stage 2|Disease Progression|0
5988494|NCT00996892|20707262|P10|Expansion Stage 2|Disease Progression|0
5988495|NCT00996892|20707263|P9|Expansion Stage 2|Disease Progression|0
5988496|NCT00996892|20707264|P8|Expansion Stage 2|Disease Progression|0
5988497|NCT00996892|20707265|P7|Expansion Stage 2|Disease Progression|0
5988498|NCT00996892|20707266|P6|Expansion Stage 2|Disease Progression|0
5988499|NCT00996892|20707267|P5|Expansion Stage 2|Disease Progression|0
5988500|NCT00996892|20707268|P4|Expansion Stage 2|Disease Progression|0
5988501|NCT00996892|20707269|P3|Expansion Stage 2|Disease Progression|0
5988502|NCT00996892|20707270|P2|Expansion Stage 2|Disease Progression|0
5988503|NCT00996892|20707271|P1|Expansion Stage 2|Disease Progression|0
5988504|NCT00996892|20707252|P20|Expansion Stage 2|Withdrawal by Subject|0
5988505|NCT00996892|20707253|P19|Expansion Stage 2|Withdrawal by Subject|1
5988506|NCT00996892|20707254|P18|Expansion Stage 2|Withdrawal by Subject|0
5988507|NCT00996892|20707255|P17|Expansion Stage 2|Withdrawal by Subject|0
5988508|NCT00996892|20707256|P16|Expansion Stage 2|Withdrawal by Subject|0
5988509|NCT00996892|20707257|P15|Expansion Stage 2|Withdrawal by Subject|0
5988510|NCT00996892|20707258|P14|Expansion Stage 2|Withdrawal by Subject|0
5988511|NCT00996892|20707259|P13|Expansion Stage 2|Withdrawal by Subject|0
5988512|NCT00996892|20707260|P12|Expansion Stage 2|Withdrawal by Subject|0
5988513|NCT00996892|20707261|P11|Expansion Stage 2|Withdrawal by Subject|0
5988514|NCT00996892|20707262|P10|Expansion Stage 2|Withdrawal by Subject|0
5988515|NCT00996892|20707263|P9|Expansion Stage 2|Withdrawal by Subject|0
5988516|NCT00996892|20707264|P8|Expansion Stage 2|Withdrawal by Subject|0
5988517|NCT00996892|20707265|P7|Expansion Stage 2|Withdrawal by Subject|0
5988518|NCT00996892|20707266|P6|Expansion Stage 2|Withdrawal by Subject|0
5988519|NCT00996892|20707267|P5|Expansion Stage 2|Withdrawal by Subject|0
5988520|NCT00996892|20707268|P4|Expansion Stage 2|Withdrawal by Subject|0
5988521|NCT00996892|20707269|P3|Expansion Stage 2|Withdrawal by Subject|0
5988522|NCT00996892|20707270|P2|Expansion Stage 2|Withdrawal by Subject|0
5988523|NCT00996892|20707271|P1|Expansion Stage 2|Withdrawal by Subject|0
5988524|NCT00996892|20707252|P20|Expansion Stage 2|Physician Decision|0
5988525|NCT00996892|20707253|P19|Expansion Stage 2|Physician Decision|1
5988526|NCT00996892|20707254|P18|Expansion Stage 2|Physician Decision|0
5988527|NCT00996892|20707255|P17|Expansion Stage 2|Physician Decision|0
5988528|NCT00996892|20707256|P16|Expansion Stage 2|Physician Decision|0
5988529|NCT00996892|20707257|P15|Expansion Stage 2|Physician Decision|0
5988530|NCT00996892|20707258|P14|Expansion Stage 2|Physician Decision|0
5988531|NCT00996892|20707259|P13|Expansion Stage 2|Physician Decision|0
5988532|NCT00996892|20707260|P12|Expansion Stage 2|Physician Decision|0
5988533|NCT00996892|20707261|P11|Expansion Stage 2|Physician Decision|0
5988534|NCT00996892|20707262|P10|Expansion Stage 2|Physician Decision|0
5988535|NCT00996892|20707263|P9|Expansion Stage 2|Physician Decision|0
5988536|NCT00996892|20707264|P8|Expansion Stage 2|Physician Decision|0
5988537|NCT00996892|20707265|P7|Expansion Stage 2|Physician Decision|0
5988538|NCT00996892|20707266|P6|Expansion Stage 2|Physician Decision|0
5988539|NCT00996892|20707267|P5|Expansion Stage 2|Physician Decision|0
5988540|NCT00996892|20707268|P4|Expansion Stage 2|Physician Decision|0
5988541|NCT00996892|20707269|P3|Expansion Stage 2|Physician Decision|0
5988542|NCT00996892|20707270|P2|Expansion Stage 2|Physician Decision|0
5988543|NCT00996892|20707271|P1|Expansion Stage 2|Physician Decision|0
5988544|NCT00996892|20707252|P20|Expansion Stage 2|Death|0
5988545|NCT00996892|20707253|P19|Expansion Stage 2|Death|2
5988546|NCT00996892|20707254|P18|Expansion Stage 2|Death|0
5988547|NCT00996892|20707255|P17|Expansion Stage 2|Death|0
5988548|NCT00996892|20707256|P16|Expansion Stage 2|Death|0
5988549|NCT00996892|20707257|P15|Expansion Stage 2|Death|0
5988550|NCT00996892|20707258|P14|Expansion Stage 2|Death|0
5988551|NCT00996892|20707259|P13|Expansion Stage 2|Death|0
5988552|NCT00996892|20707260|P12|Expansion Stage 2|Death|0
5988553|NCT00996892|20707261|P11|Expansion Stage 2|Death|0
5988554|NCT00996892|20707262|P10|Expansion Stage 2|Death|0
5988555|NCT00996892|20707263|P9|Expansion Stage 2|Death|0
5988556|NCT00996892|20707264|P8|Expansion Stage 2|Death|0
5988557|NCT00996892|20707265|P7|Expansion Stage 2|Death|0
5988558|NCT00996892|20707266|P6|Expansion Stage 2|Death|0
5988559|NCT00996892|20707267|P5|Expansion Stage 2|Death|0
5988560|NCT00996892|20707268|P4|Expansion Stage 2|Death|0
5988561|NCT00996892|20707269|P3|Expansion Stage 2|Death|0
5988562|NCT00996892|20707270|P2|Expansion Stage 2|Death|0
5988563|NCT00996892|20707271|P1|Expansion Stage 2|Death|0
5988564|NCT00996892|20707252|P20|Expansion Stage 2|Adverse Event|0
5988565|NCT00996892|20707253|P19|Expansion Stage 2|Adverse Event|3
5988566|NCT00996892|20707254|P18|Expansion Stage 2|Adverse Event|0
5988567|NCT00996892|20707255|P17|Expansion Stage 2|Adverse Event|0
5988568|NCT00996892|20707256|P16|Expansion Stage 2|Adverse Event|0
5988569|NCT00996892|20707257|P15|Expansion Stage 2|Adverse Event|0
5988570|NCT00996892|20707258|P14|Expansion Stage 2|Adverse Event|0
5988571|NCT00996892|20707259|P13|Expansion Stage 2|Adverse Event|0
5988572|NCT00996892|20707260|P12|Expansion Stage 2|Adverse Event|0
5988573|NCT00996892|20707261|P11|Expansion Stage 2|Adverse Event|0
5988574|NCT00996892|20707262|P10|Expansion Stage 2|Adverse Event|0
5988575|NCT00996892|20707263|P9|Expansion Stage 2|Adverse Event|0
5988576|NCT00996892|20707264|P8|Expansion Stage 2|Adverse Event|0
5988577|NCT00996892|20707265|P7|Expansion Stage 2|Adverse Event|0
5988578|NCT00996892|20707266|P6|Expansion Stage 2|Adverse Event|0
5988579|NCT00996892|20707267|P5|Expansion Stage 2|Adverse Event|0
5988580|NCT00996892|20707268|P4|Expansion Stage 2|Adverse Event|0
5988581|NCT00996892|20707269|P3|Expansion Stage 2|Adverse Event|0
5988582|NCT00996892|20707270|P2|Expansion Stage 2|Adverse Event|0
5988583|NCT00996892|20707271|P1|Expansion Stage 2|Adverse Event|0
5988584|NCT00996892|20707252|P20|Dose-Escalation Stage 1B|Disease Progression|0
5988585|NCT00996892|20707253|P19|Dose-Escalation Stage 1B|Disease Progression|0
5988586|NCT00996892|20707254|P18|Dose-Escalation Stage 1B|Disease Progression|3
5988587|NCT00996892|20707255|P17|Dose-Escalation Stage 1B|Disease Progression|3
5988588|NCT00996892|20707256|P16|Dose-Escalation Stage 1B|Disease Progression|3
5988589|NCT00996892|20707257|P15|Dose-Escalation Stage 1B|Disease Progression|4
5988590|NCT00996892|20707258|P14|Dose-Escalation Stage 1B|Disease Progression|0
5988591|NCT00996892|20707259|P13|Dose-Escalation Stage 1B|Disease Progression|0
5988592|NCT00996892|20707260|P12|Dose-Escalation Stage 1B|Disease Progression|0
5988593|NCT00996892|20707261|P11|Dose-Escalation Stage 1B|Disease Progression|0
5988594|NCT00996892|20707262|P10|Dose-Escalation Stage 1B|Disease Progression|0
5988595|NCT00996892|20707263|P9|Dose-Escalation Stage 1B|Disease Progression|0
5988596|NCT00996892|20707264|P8|Dose-Escalation Stage 1B|Disease Progression|0
5988597|NCT00996892|20707265|P7|Dose-Escalation Stage 1B|Disease Progression|0
5988598|NCT00996892|20707266|P6|Dose-Escalation Stage 1B|Disease Progression|0
5988599|NCT00996892|20707267|P5|Dose-Escalation Stage 1B|Disease Progression|0
5988600|NCT00996892|20707268|P4|Dose-Escalation Stage 1B|Disease Progression|0
5988601|NCT00996892|20707269|P3|Dose-Escalation Stage 1B|Disease Progression|0
5988602|NCT00996892|20707270|P2|Dose-Escalation Stage 1B|Disease Progression|0
5988603|NCT00996892|20707271|P1|Dose-Escalation Stage 1B|Disease Progression|0
5988604|NCT00996892|20707252|P20|Dose-Escalation Stage 1B|Physician Decision|0
5988605|NCT00996892|20707253|P19|Dose-Escalation Stage 1B|Physician Decision|0
5988606|NCT00996892|20707254|P18|Dose-Escalation Stage 1B|Physician Decision|2
5988607|NCT00996892|20707255|P17|Dose-Escalation Stage 1B|Physician Decision|0
5988608|NCT00996892|20707256|P16|Dose-Escalation Stage 1B|Physician Decision|0
5988609|NCT00996892|20707257|P15|Dose-Escalation Stage 1B|Physician Decision|0
5988610|NCT00996892|20707258|P14|Dose-Escalation Stage 1B|Physician Decision|0
5988611|NCT00996892|20707259|P13|Dose-Escalation Stage 1B|Physician Decision|0
5988612|NCT00996892|20707260|P12|Dose-Escalation Stage 1B|Physician Decision|0
5988613|NCT00996892|20707261|P11|Dose-Escalation Stage 1B|Physician Decision|0
5988614|NCT00996892|20707262|P10|Dose-Escalation Stage 1B|Physician Decision|0
5988615|NCT00996892|20707263|P9|Dose-Escalation Stage 1B|Physician Decision|0
5988616|NCT00996892|20707264|P8|Dose-Escalation Stage 1B|Physician Decision|0
5988617|NCT00996892|20707265|P7|Dose-Escalation Stage 1B|Physician Decision|0
5988618|NCT00996892|20707266|P6|Dose-Escalation Stage 1B|Physician Decision|0
5988619|NCT00996892|20707267|P5|Dose-Escalation Stage 1B|Physician Decision|0
5988620|NCT00996892|20707268|P4|Dose-Escalation Stage 1B|Physician Decision|0
5988621|NCT00996892|20707269|P3|Dose-Escalation Stage 1B|Physician Decision|0
5988622|NCT00996892|20707270|P2|Dose-Escalation Stage 1B|Physician Decision|0
5988623|NCT00996892|20707271|P1|Dose-Escalation Stage 1B|Physician Decision|0
5988624|NCT00996892|20707252|P20|Dose-Escalation Stage 1A|Disease Progression|0
5988625|NCT00996892|20707253|P19|Dose-Escalation Stage 1A|Disease Progression|0
5988626|NCT00996892|20707254|P18|Dose-Escalation Stage 1A|Disease Progression|0
5988627|NCT00996892|20707255|P17|Dose-Escalation Stage 1A|Disease Progression|0
5988628|NCT00996892|20707256|P16|Dose-Escalation Stage 1A|Disease Progression|0
5988629|NCT00996892|20707257|P15|Dose-Escalation Stage 1A|Disease Progression|0
5988630|NCT00996892|20707258|P14|Dose-Escalation Stage 1A|Disease Progression|4
5988631|NCT00996892|20707259|P13|Dose-Escalation Stage 1A|Disease Progression|6
5988632|NCT00996892|20707260|P12|Dose-Escalation Stage 1A|Disease Progression|7
5988633|NCT00996892|20707261|P11|Dose-Escalation Stage 1A|Disease Progression|5
5988634|NCT00996892|20707262|P10|Dose-Escalation Stage 1A|Disease Progression|1
5988635|NCT00996892|20707263|P9|Dose-Escalation Stage 1A|Disease Progression|3
5988636|NCT00996892|20707264|P8|Dose-Escalation Stage 1A|Disease Progression|2
5988637|NCT00996892|20707265|P7|Dose-Escalation Stage 1A|Disease Progression|0
5988638|NCT00996892|20707266|P6|Dose-Escalation Stage 1A|Disease Progression|0
5988639|NCT00996892|20707267|P5|Dose-Escalation Stage 1A|Disease Progression|0
5988640|NCT00996892|20707268|P4|Dose-Escalation Stage 1A|Disease Progression|0
5988641|NCT00996892|20707269|P3|Dose-Escalation Stage 1A|Disease Progression|0
5988642|NCT00996892|20707270|P2|Dose-Escalation Stage 1A|Disease Progression|0
5988643|NCT00996892|20707271|P1|Dose-Escalation Stage 1A|Disease Progression|0
5988644|NCT00996892|20707252|P20|Dose-Escalation Stage 1A|Withdrawal by Subject|0
5988645|NCT00996892|20707253|P19|Dose-Escalation Stage 1A|Withdrawal by Subject|0
5988646|NCT00996892|20707254|P18|Dose-Escalation Stage 1A|Withdrawal by Subject|0
5988647|NCT00996892|20707255|P17|Dose-Escalation Stage 1A|Withdrawal by Subject|0
5988648|NCT00996892|20707256|P16|Dose-Escalation Stage 1A|Withdrawal by Subject|0
5988649|NCT00996892|20707257|P15|Dose-Escalation Stage 1A|Withdrawal by Subject|0
5988650|NCT00996892|20707258|P14|Dose-Escalation Stage 1A|Withdrawal by Subject|0
5988651|NCT00996892|20707259|P13|Dose-Escalation Stage 1A|Withdrawal by Subject|1
5988652|NCT00996892|20707260|P12|Dose-Escalation Stage 1A|Withdrawal by Subject|1
5988653|NCT00996892|20707261|P11|Dose-Escalation Stage 1A|Withdrawal by Subject|1
5988654|NCT00996892|20707262|P10|Dose-Escalation Stage 1A|Withdrawal by Subject|1
5988655|NCT00996892|20707263|P9|Dose-Escalation Stage 1A|Withdrawal by Subject|0
5988656|NCT00996892|20707264|P8|Dose-Escalation Stage 1A|Withdrawal by Subject|0
5988657|NCT00996892|20707265|P7|Dose-Escalation Stage 1A|Withdrawal by Subject|0
5988658|NCT00996892|20707266|P6|Dose-Escalation Stage 1A|Withdrawal by Subject|0
5988659|NCT00996892|20707267|P5|Dose-Escalation Stage 1A|Withdrawal by Subject|0
5988660|NCT00996892|20707268|P4|Dose-Escalation Stage 1A|Withdrawal by Subject|0
5988661|NCT00996892|20707269|P3|Dose-Escalation Stage 1A|Withdrawal by Subject|0
5988662|NCT00996892|20707270|P2|Dose-Escalation Stage 1A|Withdrawal by Subject|0
5988663|NCT00996892|20707271|P1|Dose-Escalation Stage 1A|Withdrawal by Subject|0
5988664|NCT00996892|20707252|P20|Dose-Escalation Stage 1A|Physician Decision|0
5988665|NCT00996892|20707253|P19|Dose-Escalation Stage 1A|Physician Decision|0
5988666|NCT00996892|20707254|P18|Dose-Escalation Stage 1A|Physician Decision|0
5988667|NCT00996892|20707255|P17|Dose-Escalation Stage 1A|Physician Decision|0
5988668|NCT00996892|20707256|P16|Dose-Escalation Stage 1A|Physician Decision|0
5988669|NCT00996892|20707257|P15|Dose-Escalation Stage 1A|Physician Decision|0
5988670|NCT00996892|20707258|P14|Dose-Escalation Stage 1A|Physician Decision|0
5988671|NCT00996892|20707259|P13|Dose-Escalation Stage 1A|Physician Decision|0
5988672|NCT00996892|20707260|P12|Dose-Escalation Stage 1A|Physician Decision|0
5988673|NCT00996892|20707261|P11|Dose-Escalation Stage 1A|Physician Decision|0
5988674|NCT00996892|20707262|P10|Dose-Escalation Stage 1A|Physician Decision|0
5988675|NCT00996892|20707263|P9|Dose-Escalation Stage 1A|Physician Decision|0
5988676|NCT00996892|20707264|P8|Dose-Escalation Stage 1A|Physician Decision|1
5988677|NCT00996892|20707265|P7|Dose-Escalation Stage 1A|Physician Decision|0
5988678|NCT00996892|20707266|P6|Dose-Escalation Stage 1A|Physician Decision|0
5988679|NCT00996892|20707267|P5|Dose-Escalation Stage 1A|Physician Decision|0
5988680|NCT00996892|20707268|P4|Dose-Escalation Stage 1A|Physician Decision|0
5988681|NCT00996892|20707269|P3|Dose-Escalation Stage 1A|Physician Decision|0
5988682|NCT00996892|20707270|P2|Dose-Escalation Stage 1A|Physician Decision|0
5988683|NCT00996892|20707271|P1|Dose-Escalation Stage 1A|Physician Decision|0
5988684|NCT00996892|20707252|P20|Dose-Escalation Stage 1A|Death|0
5988685|NCT00996892|20707253|P19|Dose-Escalation Stage 1A|Death|0
5988686|NCT00996892|20707254|P18|Dose-Escalation Stage 1A|Death|0
5988687|NCT00996892|20707255|P17|Dose-Escalation Stage 1A|Death|0
5988688|NCT00996892|20707256|P16|Dose-Escalation Stage 1A|Death|0
5988689|NCT00996892|20707257|P15|Dose-Escalation Stage 1A|Death|0
5988690|NCT00996892|20707258|P14|Dose-Escalation Stage 1A|Death|0
5988691|NCT00996892|20707259|P13|Dose-Escalation Stage 1A|Death|1
5988692|NCT00996892|20707260|P12|Dose-Escalation Stage 1A|Death|1
5988693|NCT00996892|20707261|P11|Dose-Escalation Stage 1A|Death|0
5988694|NCT00996892|20707262|P10|Dose-Escalation Stage 1A|Death|2
5988695|NCT00996892|20707263|P9|Dose-Escalation Stage 1A|Death|0
5988696|NCT00996892|20707264|P8|Dose-Escalation Stage 1A|Death|0
5988697|NCT00996892|20707265|P7|Dose-Escalation Stage 1A|Death|0
5988698|NCT00996892|20707266|P6|Dose-Escalation Stage 1A|Death|0
5988699|NCT00996892|20707267|P5|Dose-Escalation Stage 1A|Death|0
5988700|NCT00996892|20707268|P4|Dose-Escalation Stage 1A|Death|0
5988701|NCT00996892|20707269|P3|Dose-Escalation Stage 1A|Death|0
5988702|NCT00996892|20707270|P2|Dose-Escalation Stage 1A|Death|0
5988703|NCT00996892|20707271|P1|Dose-Escalation Stage 1A|Death|0
5988704|NCT00996892|20707252|P20|Dose-Escalation Stage 1A|Adverse Event|0
5988705|NCT00996892|20707253|P19|Dose-Escalation Stage 1A|Adverse Event|0
5988706|NCT00996892|20707254|P18|Dose-Escalation Stage 1A|Adverse Event|0
5988707|NCT00996892|20707255|P17|Dose-Escalation Stage 1A|Adverse Event|0
5988708|NCT00996892|20707256|P16|Dose-Escalation Stage 1A|Adverse Event|0
5988709|NCT00996892|20707257|P15|Dose-Escalation Stage 1A|Adverse Event|0
5988710|NCT00996892|20707258|P14|Dose-Escalation Stage 1A|Adverse Event|1
5988711|NCT00996892|20707259|P13|Dose-Escalation Stage 1A|Adverse Event|0
5988712|NCT00996892|20707260|P12|Dose-Escalation Stage 1A|Adverse Event|0
5988713|NCT00996892|20707261|P11|Dose-Escalation Stage 1A|Adverse Event|1
5988714|NCT00996892|20707262|P10|Dose-Escalation Stage 1A|Adverse Event|0
5988715|NCT00996892|20707263|P9|Dose-Escalation Stage 1A|Adverse Event|0
5988716|NCT00996892|20707264|P8|Dose-Escalation Stage 1A|Adverse Event|0
5988717|NCT00996892|20707265|P7|Dose-Escalation Stage 1A|Adverse Event|0
5988718|NCT00996892|20707266|P6|Dose-Escalation Stage 1A|Adverse Event|0
5988719|NCT00996892|20707267|P5|Dose-Escalation Stage 1A|Adverse Event|0
5988720|NCT00996892|20707268|P4|Dose-Escalation Stage 1A|Adverse Event|0
5988721|NCT00996892|20707269|P3|Dose-Escalation Stage 1A|Adverse Event|0
5988722|NCT00996892|20707270|P2|Dose-Escalation Stage 1A|Adverse Event|0
5988723|NCT00996892|20707271|P1|Dose-Escalation Stage 1A|Adverse Event|0
5988724|NCT00996892|20707252|P20|Dose-Escalation Stage 1|Disease Progression|0
5988725|NCT00996892|20707253|P19|Dose-Escalation Stage 1|Disease Progression|0
5988726|NCT00996892|20707254|P18|Dose-Escalation Stage 1|Disease Progression|0
5988727|NCT00996892|20707255|P17|Dose-Escalation Stage 1|Disease Progression|0
5988728|NCT00996892|20707256|P16|Dose-Escalation Stage 1|Disease Progression|0
5988729|NCT00996892|20707257|P15|Dose-Escalation Stage 1|Disease Progression|0
5988730|NCT00996892|20707258|P14|Dose-Escalation Stage 1|Disease Progression|0
5988731|NCT00996892|20707259|P13|Dose-Escalation Stage 1|Disease Progression|0
5988732|NCT00996892|20707260|P12|Dose-Escalation Stage 1|Disease Progression|0
5988733|NCT00996892|20707261|P11|Dose-Escalation Stage 1|Disease Progression|0
5988734|NCT00996892|20707262|P10|Dose-Escalation Stage 1|Disease Progression|0
5988735|NCT00996892|20707263|P9|Dose-Escalation Stage 1|Disease Progression|0
5988736|NCT00996892|20707264|P8|Dose-Escalation Stage 1|Disease Progression|0
5988737|NCT00996892|20707265|P7|Dose-Escalation Stage 1|Disease Progression|0
5988738|NCT00996892|20707266|P6|Dose-Escalation Stage 1|Disease Progression|7
5988739|NCT00996892|20707267|P5|Dose-Escalation Stage 1|Disease Progression|10
5988740|NCT00996892|20707268|P4|Dose-Escalation Stage 1|Disease Progression|4
5988741|NCT00996892|20707269|P3|Dose-Escalation Stage 1|Disease Progression|3
5988742|NCT00996892|20707270|P2|Dose-Escalation Stage 1|Disease Progression|2
5988743|NCT00996892|20707271|P1|Dose-Escalation Stage 1|Disease Progression|2
5988744|NCT00996892|20707252|P20|Dose-Escalation Stage 1|Withdrawal by Subject|0
5988745|NCT00996892|20707253|P19|Dose-Escalation Stage 1|Withdrawal by Subject|0
5988746|NCT00996892|20707254|P18|Dose-Escalation Stage 1|Withdrawal by Subject|0
5988747|NCT00996892|20707255|P17|Dose-Escalation Stage 1|Withdrawal by Subject|0
5988748|NCT00996892|20707256|P16|Dose-Escalation Stage 1|Withdrawal by Subject|0
5988749|NCT00996892|20707257|P15|Dose-Escalation Stage 1|Withdrawal by Subject|0
5988750|NCT00996892|20707258|P14|Dose-Escalation Stage 1|Withdrawal by Subject|0
5988751|NCT00996892|20707259|P13|Dose-Escalation Stage 1|Withdrawal by Subject|0
5988752|NCT00996892|20707260|P12|Dose-Escalation Stage 1|Withdrawal by Subject|0
5988753|NCT00996892|20707261|P11|Dose-Escalation Stage 1|Withdrawal by Subject|0
5988754|NCT00996892|20707262|P10|Dose-Escalation Stage 1|Withdrawal by Subject|0
5988755|NCT00996892|20707263|P9|Dose-Escalation Stage 1|Withdrawal by Subject|0
5988756|NCT00996892|20707264|P8|Dose-Escalation Stage 1|Withdrawal by Subject|0
5988757|NCT00996892|20707265|P7|Dose-Escalation Stage 1|Withdrawal by Subject|1
5988758|NCT00996892|20707266|P6|Dose-Escalation Stage 1|Withdrawal by Subject|1
5988759|NCT00996892|20707267|P5|Dose-Escalation Stage 1|Withdrawal by Subject|1
5988760|NCT00996892|20707268|P4|Dose-Escalation Stage 1|Withdrawal by Subject|2
5988761|NCT00996892|20707269|P3|Dose-Escalation Stage 1|Withdrawal by Subject|0
5988762|NCT00996892|20707270|P2|Dose-Escalation Stage 1|Withdrawal by Subject|1
5988763|NCT00996892|20707271|P1|Dose-Escalation Stage 1|Withdrawal by Subject|0
5988764|NCT00996892|20707252|P20|Dose-Escalation Stage 1|Physician Decision|0
5988765|NCT00996892|20707253|P19|Dose-Escalation Stage 1|Physician Decision|0
5988766|NCT00996892|20707254|P18|Dose-Escalation Stage 1|Physician Decision|0
5988767|NCT00996892|20707255|P17|Dose-Escalation Stage 1|Physician Decision|0
5988768|NCT00996892|20707256|P16|Dose-Escalation Stage 1|Physician Decision|0
5988769|NCT00996892|20707257|P15|Dose-Escalation Stage 1|Physician Decision|0
5988770|NCT00996892|20707258|P14|Dose-Escalation Stage 1|Physician Decision|0
5988771|NCT00996892|20707259|P13|Dose-Escalation Stage 1|Physician Decision|0
5988772|NCT00996892|20707260|P12|Dose-Escalation Stage 1|Physician Decision|0
5988773|NCT00996892|20707261|P11|Dose-Escalation Stage 1|Physician Decision|0
5988774|NCT00996892|20707262|P10|Dose-Escalation Stage 1|Physician Decision|0
5988775|NCT00996892|20707263|P9|Dose-Escalation Stage 1|Physician Decision|0
5988776|NCT00996892|20707264|P8|Dose-Escalation Stage 1|Physician Decision|0
5988777|NCT00996892|20707265|P7|Dose-Escalation Stage 1|Physician Decision|2
5988778|NCT00996892|20707266|P6|Dose-Escalation Stage 1|Physician Decision|1
5988779|NCT00996892|20707267|P5|Dose-Escalation Stage 1|Physician Decision|0
5988780|NCT00996892|20707268|P4|Dose-Escalation Stage 1|Physician Decision|1
5988781|NCT00996892|20707269|P3|Dose-Escalation Stage 1|Physician Decision|0
5988782|NCT00996892|20707270|P2|Dose-Escalation Stage 1|Physician Decision|0
5988783|NCT00996892|20707271|P1|Dose-Escalation Stage 1|Physician Decision|1
5988784|NCT00996892|20707252|P20|Dose-Escalation Stage 1|Death|0
5988785|NCT00996892|20707253|P19|Dose-Escalation Stage 1|Death|0
5988786|NCT00996892|20707254|P18|Dose-Escalation Stage 1|Death|0
5988787|NCT00996892|20707255|P17|Dose-Escalation Stage 1|Death|0
5988788|NCT00996892|20707256|P16|Dose-Escalation Stage 1|Death|0
5988789|NCT00996892|20707257|P15|Dose-Escalation Stage 1|Death|0
5988790|NCT00996892|20707258|P14|Dose-Escalation Stage 1|Death|0
5988791|NCT00996892|20707259|P13|Dose-Escalation Stage 1|Death|0
5988792|NCT00996892|20707260|P12|Dose-Escalation Stage 1|Death|0
5988793|NCT00996892|20707261|P11|Dose-Escalation Stage 1|Death|0
5988794|NCT00996892|20707262|P10|Dose-Escalation Stage 1|Death|0
5988795|NCT00996892|20707263|P9|Dose-Escalation Stage 1|Death|0
5988796|NCT00996892|20707264|P8|Dose-Escalation Stage 1|Death|0
5988797|NCT00996892|20707265|P7|Dose-Escalation Stage 1|Death|0
5988798|NCT00996892|20707266|P6|Dose-Escalation Stage 1|Death|1
5988799|NCT00996892|20707267|P5|Dose-Escalation Stage 1|Death|0
5988800|NCT00996892|20707268|P4|Dose-Escalation Stage 1|Death|0
5988801|NCT00996892|20707269|P3|Dose-Escalation Stage 1|Death|0
5988802|NCT00996892|20707270|P2|Dose-Escalation Stage 1|Death|0
5988803|NCT00996892|20707271|P1|Dose-Escalation Stage 1|Death|1
5988804|NCT00996892|20707252|P20|Dose-Escalation Stage 1|Adverse Event|0
5988805|NCT00996892|20707253|P19|Dose-Escalation Stage 1|Adverse Event|0
5988806|NCT00996892|20707254|P18|Dose-Escalation Stage 1|Adverse Event|0
5988807|NCT00996892|20707255|P17|Dose-Escalation Stage 1|Adverse Event|0
5988808|NCT00996892|20707256|P16|Dose-Escalation Stage 1|Adverse Event|0
5988809|NCT00996892|20707257|P15|Dose-Escalation Stage 1|Adverse Event|0
5988810|NCT00996892|20707258|P14|Dose-Escalation Stage 1|Adverse Event|0
5988811|NCT00996892|20707259|P13|Dose-Escalation Stage 1|Adverse Event|0
5988812|NCT00996892|20707260|P12|Dose-Escalation Stage 1|Adverse Event|0
5988813|NCT00996892|20707261|P11|Dose-Escalation Stage 1|Adverse Event|0
5988814|NCT00996892|20707262|P10|Dose-Escalation Stage 1|Adverse Event|0
5988815|NCT00996892|20707263|P9|Dose-Escalation Stage 1|Adverse Event|0
5988816|NCT00996892|20707264|P8|Dose-Escalation Stage 1|Adverse Event|0
5988817|NCT00996892|20707265|P7|Dose-Escalation Stage 1|Adverse Event|1
5988818|NCT00996892|20707266|P6|Dose-Escalation Stage 1|Adverse Event|0
5988819|NCT00996892|20707267|P5|Dose-Escalation Stage 1|Adverse Event|0
5988820|NCT00996892|20707268|P4|Dose-Escalation Stage 1|Adverse Event|2
5988821|NCT00996892|20707269|P3|Dose-Escalation Stage 1|Adverse Event|0
5988822|NCT00996892|20707270|P2|Dose-Escalation Stage 1|Adverse Event|0
5988823|NCT00996892|20707271|P1|Dose-Escalation Stage 1|Adverse Event|0
5988824|NCT00996840|20707865|P5|Overall Study|Withdrawal by Subject|0
5988825|NCT00996840|20707866|P4|Overall Study|Withdrawal by Subject|0
5988826|NCT00996840|20707867|P3|Overall Study|Withdrawal by Subject|0
5988827|NCT00996840|20707868|P2|Overall Study|Withdrawal by Subject|1
5988828|NCT00996840|20707869|P1|Overall Study|Withdrawal by Subject|1
5988829|NCT00996840|20707865|P5|Overall Study|Physician Decision|2
5988830|NCT00996840|20707866|P4|Overall Study|Physician Decision|1
5988831|NCT00996840|20707867|P3|Overall Study|Physician Decision|1
5988832|NCT00996840|20707868|P2|Overall Study|Physician Decision|0
5988833|NCT00996840|20707869|P1|Overall Study|Physician Decision|0
5988834|NCT00996840|20707865|P5|Overall Study|Adverse Event|0
5988835|NCT00996840|20707866|P4|Overall Study|Adverse Event|0
5988836|NCT00996840|20707867|P3|Overall Study|Adverse Event|0
5988837|NCT00996840|20707868|P2|Overall Study|Adverse Event|1
5988838|NCT00996840|20707869|P1|Overall Study|Adverse Event|0
5988839|NCT00996801|20708019|P6|Overall Study|Withdrawal by Subject|9
5988840|NCT00996801|20708020|P5|Overall Study|Withdrawal by Subject|5
5988841|NCT00996801|20708021|P4|Overall Study|Withdrawal by Subject|5
5988842|NCT00996801|20708022|P3|Overall Study|Withdrawal by Subject|9
5988843|NCT00996801|20708023|P2|Overall Study|Withdrawal by Subject|6
5988844|NCT00996801|20708024|P1|Overall Study|Withdrawal by Subject|8
5988845|NCT00996801|20708019|P6|Overall Study|Study Terminated by Sponsor|0
5988846|NCT00996801|20708020|P5|Overall Study|Study Terminated by Sponsor|46
5988847|NCT00996801|20708021|P4|Overall Study|Study Terminated by Sponsor|0
5988848|NCT00996801|20708022|P3|Overall Study|Study Terminated by Sponsor|0
5988849|NCT00996801|20708023|P2|Overall Study|Study Terminated by Sponsor|1
5988850|NCT00996801|20708024|P1|Overall Study|Study Terminated by Sponsor|0
5988851|NCT00996801|20708019|P6|Overall Study|Protocol Violation|4
5988852|NCT00996801|20708020|P5|Overall Study|Protocol Violation|3
5988853|NCT00996801|20708021|P4|Overall Study|Protocol Violation|2
5988854|NCT00996801|20708022|P3|Overall Study|Protocol Violation|1
5988855|NCT00996801|20708023|P2|Overall Study|Protocol Violation|4
5988856|NCT00996801|20708024|P1|Overall Study|Protocol Violation|3
5988857|NCT00996801|20708019|P6|Overall Study|Progressive Disease|0
5988858|NCT00996801|20708020|P5|Overall Study|Progressive Disease|0
5988859|NCT00996801|20708021|P4|Overall Study|Progressive Disease|0
5988860|NCT00996801|20708022|P3|Overall Study|Progressive Disease|0
5988861|NCT00996801|20708023|P2|Overall Study|Progressive Disease|1
5988862|NCT00996801|20708024|P1|Overall Study|Progressive Disease|0
5988863|NCT00996801|20708019|P6|Overall Study|Physician Decision|0
5988864|NCT00996801|20708020|P5|Overall Study|Physician Decision|0
5988865|NCT00996801|20708021|P4|Overall Study|Physician Decision|1
5988866|NCT00996801|20708022|P3|Overall Study|Physician Decision|0
5988867|NCT00996801|20708023|P2|Overall Study|Physician Decision|0
5988868|NCT00996801|20708024|P1|Overall Study|Physician Decision|0
5988869|NCT00996801|20708019|P6|Overall Study|Lost to Follow-up|2
5988870|NCT00996801|20708020|P5|Overall Study|Lost to Follow-up|3
5988871|NCT00996801|20708021|P4|Overall Study|Lost to Follow-up|3
5988872|NCT00996801|20708022|P3|Overall Study|Lost to Follow-up|0
5988873|NCT00996801|20708023|P2|Overall Study|Lost to Follow-up|0
5988874|NCT00996801|20708024|P1|Overall Study|Lost to Follow-up|0
5988875|NCT00996801|20708019|P6|Overall Study|Lack of Efficacy|1
5988876|NCT00996801|20708020|P5|Overall Study|Lack of Efficacy|0
5988877|NCT00996801|20708021|P4|Overall Study|Lack of Efficacy|3
5988878|NCT00996801|20708022|P3|Overall Study|Lack of Efficacy|1
5988879|NCT00996801|20708023|P2|Overall Study|Lack of Efficacy|0
5988880|NCT00996801|20708024|P1|Overall Study|Lack of Efficacy|3
5988881|NCT00996801|20708019|P6|Overall Study|Adverse Event|3
5988882|NCT00996801|20708020|P5|Overall Study|Adverse Event|31
5988883|NCT00996801|20708021|P4|Overall Study|Adverse Event|17
5988884|NCT00996801|20708022|P3|Overall Study|Adverse Event|12
5988885|NCT00996801|20708023|P2|Overall Study|Adverse Event|4
5988886|NCT00996801|20708024|P1|Overall Study|Adverse Event|6
5988887|NCT00996736|20708136|P2|Overall Study|Visit not within 3-month window|3
5988888|NCT00996736|20708137|P1|Overall Study|Visit not within 3-month window|5
5988889|NCT00996736|20708136|P2|Overall Study|Lost to Follow-up|14
5988890|NCT00996736|20708137|P1|Overall Study|Lost to Follow-up|15
5988891|NCT00996736|20708136|P2|Overall Study|Death|1
5988892|NCT00996736|20708137|P1|Overall Study|Death|1
5988893|NCT00996658|20708157|P2|Overall Study|Other|7
5988894|NCT00996658|20708158|P1|Overall Study|Other|9
5988895|NCT00996658|20708157|P2|Overall Study|Non-compliance issues|3
5988896|NCT00996658|20708158|P1|Overall Study|Non-compliance issues|3
5988897|NCT00996658|20708157|P2|Overall Study|Lost to Follow-up|5
5988898|NCT00996658|20708158|P1|Overall Study|Lost to Follow-up|2
5988899|NCT00996658|20708157|P2|Overall Study|Protocol Violation|1
5988900|NCT00996658|20708158|P1|Overall Study|Protocol Violation|0
5988901|NCT00996658|20708157|P2|Overall Study|Adverse Event|5
5988902|NCT00996658|20708158|P1|Overall Study|Adverse Event|2
5988903|NCT00996632|20708186|P2|Overall Study|Physician Decision|0
5988904|NCT00996632|20708187|P1|Overall Study|Physician Decision|0
5988905|NCT00996606|20708195|P1|Overall Study|Withdrawal by Subject|3
5988906|NCT00996606|20708195|P1|Overall Study|Protocol Violation|1
5988907|NCT00996606|20708195|P1|Overall Study|Insufficient Therapeutic Response|2
5988908|NCT00996606|20708195|P1|Overall Study|Adverse Event or Intercurrent Illness|2
5988909|NCT00996593|20708289|P1|Long-Term Follow-Up|Site Closed|1
5988910|NCT00996593|20708289|P1|Long-Term Follow-Up|Withdrawal by Subject|2
5988911|NCT00996593|20708289|P1|Dosimetric and Therapeutic Treatment|Non-compliance|1
5988912|NCT00996593|20708289|P1|Dosimetric and Therapeutic Treatment|Did Not Receive Any Study Drug|3
5988913|NCT00996593|20708289|P1|Dosimetric and Therapeutic Treatment|Enrolled in BEX104526|6
5988914|NCT00996593|20708289|P1|Dosimetric and Therapeutic Treatment|Death|1
5988915|NCT00996593|20708289|P1|Dosimetric and Therapeutic Treatment|Progressive Disease|22
5989006|NCT00995930|20708647|P2|Overall Study|Death|1
5988916|NCT00996593|20708289|P1|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|3
5988917|NCT00996593|20708289|P1|Dosimetric and Therapeutic Treatment|Lost to Follow-up|7
5988918|NCT00996580|20708317|P1|Overall Study|Other|29
5988919|NCT00996580|20708317|P1|Overall Study|Withdrawal by Subject|217
5988920|NCT00996580|20708317|P1|Overall Study|Sponsor requested participant withdrawal|35
5988921|NCT00996580|20708317|P1|Overall Study|Protocol Violation|16
5988922|NCT00996580|20708317|P1|Overall Study|Pregnancy|68
5988923|NCT00996580|20708317|P1|Overall Study|Physician Decision|5
5988924|NCT00996580|20708317|P1|Overall Study|Noncompliance with the protocol|137
5988925|NCT00996580|20708317|P1|Overall Study|Lost to Follow-up|480
5988926|NCT00996580|20708317|P1|Overall Study|Adverse Event|466
5988927|NCT00996489|20708352|P1|Overall Study|Discontinued|116
5988928|NCT00996489|20708352|P1|Overall Study|Device failure|45
5988929|NCT00996476|20708372|P5|Overall Study|Adverse Event|1
5988930|NCT00996476|20708373|P4|Overall Study|Adverse Event|0
5988931|NCT00996476|20708374|P3|Overall Study|Adverse Event|0
5988932|NCT00996476|20708375|P2|Overall Study|Adverse Event|1
5988933|NCT00996476|20708376|P1|Overall Study|Adverse Event|0
5988934|NCT00996476|20708372|P5|Overall Study|Withdrawal by Subject|1
5988935|NCT00996476|20708373|P4|Overall Study|Withdrawal by Subject|0
5988936|NCT00996476|20708374|P3|Overall Study|Withdrawal by Subject|1
5988937|NCT00996476|20708375|P2|Overall Study|Withdrawal by Subject|2
5988938|NCT00996476|20708376|P1|Overall Study|Withdrawal by Subject|1
5988939|NCT00996437|20708444|P2|Overall Study|Missed|5
5988940|NCT00996437|20708445|P1|Overall Study|Missed|2
5988941|NCT00996437|20708444|P2|Overall Study|Dropped|2
5988942|NCT00996437|20708445|P1|Overall Study|Dropped|2
5988943|NCT00996437|20708444|P2|Overall Study|Death|0
5988944|NCT00996437|20708445|P1|Overall Study|Death|1
5988945|NCT00996333|20708490|P1|Overall Study|Other|5
5988946|NCT00996333|20708490|P1|Overall Study|Physician Decision|1
5988947|NCT00996333|20708490|P1|Overall Study|Adverse Event|1
5988948|NCT00996333|20708490|P1|Overall Study|Death|4
5988949|NCT00996333|20708490|P1|Overall Study|Withdrawal by Subject|1
5988950|NCT00996333|20708490|P1|Overall Study|Screen failure|1
5988951|NCT00996307|20708500|P4|Overall Study|Unable to classify|1
5988952|NCT00996307|20708501|P3|Overall Study|Unable to classify|2
5988953|NCT00996307|20708502|P2|Overall Study|Unable to classify|0
5988954|NCT00996307|20708503|P1|Overall Study|Unable to classify|4
5988955|NCT00996307|20708500|P4|Overall Study|Administrative reason|0
5988956|NCT00996307|20708501|P3|Overall Study|Administrative reason|0
5988957|NCT00996307|20708502|P2|Overall Study|Administrative reason|1
5988958|NCT00996307|20708503|P1|Overall Study|Administrative reason|0
5988959|NCT00996307|20708500|P4|Overall Study|Lost to Follow-up|15
5988960|NCT00996307|20708501|P3|Overall Study|Lost to Follow-up|7
5988961|NCT00996307|20708502|P2|Overall Study|Lost to Follow-up|13
5988962|NCT00996307|20708503|P1|Overall Study|Lost to Follow-up|13
5988963|NCT00996307|20708500|P4|Overall Study|Withdrawal by Subject|5
5988964|NCT00996307|20708501|P3|Overall Study|Withdrawal by Subject|5
5988965|NCT00996307|20708502|P2|Overall Study|Withdrawal by Subject|2
5988966|NCT00996307|20708503|P1|Overall Study|Withdrawal by Subject|3
5988967|NCT00996307|20708500|P4|Overall Study|Adverse Event|0
5988968|NCT00996307|20708501|P3|Overall Study|Adverse Event|0
5988969|NCT00996307|20708502|P2|Overall Study|Adverse Event|1
5988970|NCT00996307|20708503|P1|Overall Study|Adverse Event|0
5988971|NCT00996281|20708563|P2|Overall Study|Other|7
5988972|NCT00996281|20708564|P1|Overall Study|Other|5
5988973|NCT00996281|20708563|P2|Overall Study|Lack of Efficacy|2
5988974|NCT00996281|20708564|P1|Overall Study|Lack of Efficacy|0
5988975|NCT00996281|20708563|P2|Overall Study|Withdrawal by Subject|20
5988976|NCT00996281|20708564|P1|Overall Study|Withdrawal by Subject|31
5988977|NCT00996281|20708563|P2|Overall Study|Lost to Follow-up|16
5988978|NCT00996281|20708564|P1|Overall Study|Lost to Follow-up|14
5988979|NCT00996281|20708563|P2|Overall Study|Major Protocol Deviation|7
5988980|NCT00996281|20708564|P1|Overall Study|Major Protocol Deviation|6
5988981|NCT00996281|20708563|P2|Overall Study|Adverse Event|37
5988982|NCT00996281|20708564|P1|Overall Study|Adverse Event|75
5988983|NCT00996216|20708572|P1|Part 2 (Antiviral Treatment Phase)|Withdrawal by Subject|1
5988984|NCT00996216|20708572|P1|Part 2 (Antiviral Treatment Phase)|Lost to Follow-up|3
5988985|NCT00996216|20708572|P1|Part 1 (Pre-Antiviral Treatment Phase)|Withdrawal by Subject|1
5988986|NCT00996203|20708588|P1|Overall Study|Protocol Violation|2
5988987|NCT00996203|20708588|P1|Overall Study|Lack of Efficacy|1
5988988|NCT00996203|20708588|P1|Overall Study|Lost to Follow-up|1
5988989|NCT00996203|20708588|P1|Overall Study|Adverse Event|3
5988990|NCT00996125|20708620|P2|Overall Study|Withdrawal by Subject|3
5988991|NCT00996125|20708621|P1|Overall Study|Withdrawal by Subject|4
5988992|NCT00996125|20708620|P2|Overall Study|Lost to Follow-up|6
5988993|NCT00996125|20708621|P1|Overall Study|Lost to Follow-up|1
5988994|NCT00996125|20708620|P2|Overall Study|Adverse Event|2
5988995|NCT00996125|20708621|P1|Overall Study|Adverse Event|0
5988996|NCT00996034|20708641|P1|Overall Study|withdrawn by PI|1
5988997|NCT00996034|20708641|P1|Overall Study|Lost to Follow-up|2
5988998|NCT00995930|20708647|P2|Overall Study|Adverse Event|14
5988999|NCT00995930|20708648|P1|Overall Study|Adverse Event|11
5989000|NCT00995930|20708647|P2|Overall Study|Withdrawal by Subject|4
5989001|NCT00995930|20708648|P1|Overall Study|Withdrawal by Subject|3
5989002|NCT00995930|20708647|P2|Overall Study|Lost to Follow-up|2
5989003|NCT00995930|20708648|P1|Overall Study|Lost to Follow-up|1
5989004|NCT00995930|20708647|P2|Overall Study|Administrative problems|2
5989005|NCT00995930|20708648|P1|Overall Study|Administrative problems|4
5989007|NCT00995930|20708648|P1|Overall Study|Death|0
5989008|NCT00995930|20708647|P2|Overall Study|Protocol deviation|5
5989009|NCT00995930|20708648|P1|Overall Study|Protocol deviation|2
5989010|NCT00995865|20708699|P3|Overall Study|Lost to Follow-up|1
5989011|NCT00995865|20708700|P2|Overall Study|Lost to Follow-up|0
5989012|NCT00995865|20708701|P1|Overall Study|Lost to Follow-up|0
5989013|NCT00995865|20708699|P3|Overall Study|Protocol Violation|0
5989014|NCT00995865|20708700|P2|Overall Study|Protocol Violation|0
5989015|NCT00995865|20708701|P1|Overall Study|Protocol Violation|2
5989016|NCT00995774|20708723|P2|Training Period 2|Withdrawal by Subject|0
5989017|NCT00995774|20708724|P1|Training Period 2|Withdrawal by Subject|2
5989018|NCT00995709|20708758|P3|Overall Study|Protocol Violation|0
5989019|NCT00995709|20708759|P2|Overall Study|Protocol Violation|1
5989020|NCT00995709|20708760|P1|Overall Study|Protocol Violation|2
5989021|NCT00995709|20708758|P3|Overall Study|Death|0
5989022|NCT00995709|20708759|P2|Overall Study|Death|1
5989023|NCT00995709|20708760|P1|Overall Study|Death|0
5989024|NCT00995709|20708758|P3|Overall Study|Lost to Follow-up|0
5989025|NCT00995709|20708759|P2|Overall Study|Lost to Follow-up|0
5989026|NCT00995709|20708760|P1|Overall Study|Lost to Follow-up|1
5989027|NCT00995709|20708758|P3|Overall Study|Withdrawal by Subject|1
5989028|NCT00995709|20708759|P2|Overall Study|Withdrawal by Subject|4
5989029|NCT00995709|20708760|P1|Overall Study|Withdrawal by Subject|0
5989030|NCT00995709|20708758|P3|Overall Study|Lack of Efficacy|4
5989031|NCT00995709|20708759|P2|Overall Study|Lack of Efficacy|1
5989032|NCT00995709|20708760|P1|Overall Study|Lack of Efficacy|0
5989033|NCT00995709|20708758|P3|Overall Study|Adverse Event|0
5989034|NCT00995709|20708759|P2|Overall Study|Adverse Event|2
5989035|NCT00995709|20708760|P1|Overall Study|Adverse Event|4
5989036|NCT00995670|20708786|P3|Overall Study|Failed arterial cannulation|3
5989037|NCT00995670|20708787|P2|Overall Study|Failed arterial cannulation|0
5989038|NCT00995670|20708788|P1|Overall Study|Failed arterial cannulation|1
5989039|NCT00995566|20708796|P1|Overall Study|Early study termination|52
5989040|NCT00995566|20708796|P1|Overall Study|Adverse Event|2
5989041|NCT00995553|20708810|P2|Overall Study|Withdrawal by Subject|6
5989042|NCT00995553|20708811|P1|Overall Study|Withdrawal by Subject|2
5989043|NCT00995488|20708860|P1|Overall Study|Withdrawal by Subject|1
5989044|NCT00995436|20708894|P3|Overall Study|Withdrawal by Subject|0
5989045|NCT00995436|20708895|P2|Overall Study|Withdrawal by Subject|5
5989046|NCT00995436|20708896|P1|Overall Study|Withdrawal by Subject|2
5989047|NCT00995410|20708904|P1|Overall Study|Misc|28
5989048|NCT00995410|20708904|P1|Overall Study|Lost to Follow-up|2
5989049|NCT00995410|20708904|P1|Overall Study|Withdrawal by Subject|7
5989050|NCT00995410|20708904|P1|Overall Study|Adverse Event|51
5989051|NCT00995371|20708911|P2|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5
5989052|NCT00995371|20708912|P1|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5
5989053|NCT00995345|20708930|P5|Overall Study|all other reasons combined|3
5989054|NCT00995345|20708931|P4|Overall Study|all other reasons combined|1
5989055|NCT00995345|20708932|P3|Overall Study|all other reasons combined|2
5989056|NCT00995345|20708933|P2|Overall Study|all other reasons combined|2
5989057|NCT00995345|20708934|P1|Overall Study|all other reasons combined|2
5989058|NCT00995345|20708930|P5|Overall Study|Lost to Follow-up|0
5989059|NCT00995345|20708931|P4|Overall Study|Lost to Follow-up|1
5989060|NCT00995345|20708932|P3|Overall Study|Lost to Follow-up|2
5989061|NCT00995345|20708933|P2|Overall Study|Lost to Follow-up|2
5989062|NCT00995345|20708934|P1|Overall Study|Lost to Follow-up|2
5989063|NCT00995345|20708930|P5|Overall Study|Adverse Event|1
5989064|NCT00995345|20708931|P4|Overall Study|Adverse Event|0
5989065|NCT00995345|20708932|P3|Overall Study|Adverse Event|2
5989066|NCT00995345|20708933|P2|Overall Study|Adverse Event|1
5989067|NCT00995345|20708934|P1|Overall Study|Adverse Event|3
5989068|NCT00995345|20708930|P5|Overall Study|Withdrawal by Subject|1
5989069|NCT00995345|20708931|P4|Overall Study|Withdrawal by Subject|3
5989070|NCT00995345|20708932|P3|Overall Study|Withdrawal by Subject|1
5989071|NCT00995345|20708933|P2|Overall Study|Withdrawal by Subject|2
5989072|NCT00995345|20708934|P1|Overall Study|Withdrawal by Subject|4
5989073|NCT00995085|20708966|P1|Overall Study|Withdrawal by Subject|5
5989074|NCT00995020|20708983|P2|Overall Study|specimen fragmentation, thermal damage|2
5989075|NCT00995020|20708984|P1|Overall Study|specimen fragmentation, thermal damage|1
5989076|NCT00995020|20708983|P2|Overall Study|margin analysis not performed|5
5989077|NCT00995020|20708984|P1|Overall Study|margin analysis not performed|2
5989078|NCT00995007|20708994|P2|Overall Study|Toxicity|0
5989079|NCT00995007|20708995|P1|Overall Study|Toxicity|8
5989080|NCT00995007|20708994|P2|Overall Study|Refused further treatment|2
5989081|NCT00995007|20708995|P1|Overall Study|Refused further treatment|8
5989082|NCT00995007|20708994|P2|Overall Study|Withdrew consent|0
5989083|NCT00995007|20708995|P1|Overall Study|Withdrew consent|1
5989084|NCT00994682|20709058|P2|Pioglitazone Open Label|Physician Decision|1
5989085|NCT00994682|20709059|P1|Pioglitazone Open Label|Physician Decision|6
5989086|NCT00994682|20709058|P2|Pioglitazone Open Label|Lost to Follow-up|2
5989087|NCT00994682|20709059|P1|Pioglitazone Open Label|Lost to Follow-up|3
5989088|NCT00994682|20709058|P2|Pioglitazone Open Label|Withdrawal by Subject|4
5989089|NCT00994682|20709059|P1|Pioglitazone Open Label|Withdrawal by Subject|4
5989090|NCT00994682|20709058|P2|Double Bilnd|Adverse Event|0
5989091|NCT00994682|20709059|P1|Double Bilnd|Adverse Event|1
5989092|NCT00994682|20709058|P2|Double Bilnd|Lost to Follow-up|3
5989093|NCT00994682|20709059|P1|Double Bilnd|Lost to Follow-up|3
5989094|NCT00994682|20709058|P2|Double Bilnd|Withdrawal by Subject|6
5989095|NCT00994682|20709059|P1|Double Bilnd|Withdrawal by Subject|5
5989096|NCT00994643|20709103|P1|Overall Study|Withdrawal by Subject|1
5989100|NCT00994448|20709147|P2|Overall Study|Physician Decision|0
5989101|NCT00994448|20709148|P1|Overall Study|Physician Decision|1
5989102|NCT00994448|20709147|P2|Overall Study|Withdrawal by Subject|1
5989103|NCT00994448|20709148|P1|Overall Study|Withdrawal by Subject|1
5989104|NCT00994448|20709147|P2|Overall Study|Lost to Follow-up|1
5989105|NCT00994448|20709148|P1|Overall Study|Lost to Follow-up|5
5989106|NCT00994448|20709147|P2|Overall Study|Adverse Event|0
5989107|NCT00994448|20709148|P1|Overall Study|Adverse Event|1
5989108|NCT00994422|20709156|P2|Overall Study|Lost to Follow-up|1
5989109|NCT00994422|20709157|P1|Overall Study|Lost to Follow-up|7
5989110|NCT00994279|20709182|P2|Overall Study|Multiple reasons|3
5989111|NCT00994279|20709183|P1|Overall Study|Multiple reasons|1
5989112|NCT00994279|20709182|P2|Overall Study|Toxicity|0
5989113|NCT00994279|20709183|P1|Overall Study|Toxicity|1
5989114|NCT00994279|20709182|P2|Overall Study|Withdrawal by Subject|2
5989115|NCT00994279|20709183|P1|Overall Study|Withdrawal by Subject|2
5989116|NCT00994240|20709193|P2|Overall Study|study termination|3
5989117|NCT00994240|20709194|P1|Overall Study|study termination|2
5989118|NCT00994240|20709193|P2|Overall Study|Withdrawal by Subject|0
5989119|NCT00994240|20709194|P1|Overall Study|Withdrawal by Subject|1
5989120|NCT00994240|20709193|P2|Overall Study|Lost to Follow-up|2
5989121|NCT00994240|20709194|P1|Overall Study|Lost to Follow-up|3
5989122|NCT00994214|20709204|P4|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2
5989123|NCT00994214|20709205|P3|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2
5989124|NCT00994214|20709206|P2|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|3
5989125|NCT00994214|20709207|P1|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|4
5989126|NCT00994214|20709204|P4|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|1
5989127|NCT00994214|20709205|P3|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0
5989128|NCT00994214|20709206|P2|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0
5989129|NCT00994214|20709207|P1|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0
5989130|NCT00994214|20709204|P4|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|14
5989131|NCT00994214|20709205|P3|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13
5989132|NCT00994214|20709206|P2|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|12
5989133|NCT00994214|20709207|P1|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13
5989134|NCT00994214|20709204|P4|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0
5989135|NCT00994214|20709205|P3|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0
5989136|NCT00994214|20709206|P2|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0
5989137|NCT00994214|20709207|P1|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|1
5989138|NCT00994214|20709204|P4|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|1
5989139|NCT00994214|20709205|P3|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0
5989140|NCT00994214|20709206|P2|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0
5989141|NCT00994214|20709207|P1|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0
5989142|NCT00994214|20709204|P4|ITT (Intention-to-Treat) - Part A|Adverse Event|0
5989143|NCT00994214|20709205|P3|ITT (Intention-to-Treat) - Part A|Adverse Event|0
5989144|NCT00994214|20709206|P2|ITT (Intention-to-Treat) - Part A|Adverse Event|1
5989145|NCT00994214|20709207|P1|ITT (Intention-to-Treat) - Part A|Adverse Event|0
5989146|NCT00994110|20709286|P2|Overall Study|Pt not eligible|5
5989147|NCT00994110|20709287|P1|Overall Study|Pt not eligible|10
5989148|NCT00994110|20709286|P2|Overall Study|Patient not resected|52
5989149|NCT00994110|20709287|P1|Overall Study|Patient not resected|41
5989150|NCT00994110|20709286|P2|Overall Study|Adverse Event|0
5989151|NCT00994110|20709287|P1|Overall Study|Adverse Event|1
5989152|NCT00994110|20709286|P2|Overall Study|Not Treated|8
5989153|NCT00994110|20709287|P1|Overall Study|Not Treated|4
5989154|NCT00994110|20709286|P2|Overall Study|Withdrawal by Subject|9
5989155|NCT00994110|20709287|P1|Overall Study|Withdrawal by Subject|9
5989156|NCT00993967|20709293|P1|Overall Study|Protocol Violation|2
5989157|NCT00993967|20709293|P1|Overall Study|Withdrawal by Subject|36
5989158|NCT00993967|20709293|P1|Overall Study|Lost to Follow-up|14
5989159|NCT00993967|20709293|P1|Overall Study|Death|1
5989160|NCT00993967|20709293|P1|Overall Study|Adverse Event|8
5989161|NCT00993954|20709300|P2|Overall Study|Protocol Violation|2
5989162|NCT00993954|20709301|P1|Overall Study|Protocol Violation|21
5989163|NCT00993928|20709314|P2|Overall Study|ineligible|0
5989164|NCT00993928|20709315|P1|Overall Study|ineligible|1
5989165|NCT00993928|20709314|P2|Overall Study|Withdrawal by Subject|7
5989166|NCT00993928|20709315|P1|Overall Study|Withdrawal by Subject|4
5989171|NCT00993668|20709355|P2|Open-Label Period|Lost to Follow-up|1
5989172|NCT00993668|20709356|P1|Open-Label Period|Lost to Follow-up|6
5989173|NCT00993668|20709355|P2|Open-Label Period|Withdrawal by Subject|3
5989174|NCT00993668|20709356|P1|Open-Label Period|Withdrawal by Subject|4
5989175|NCT00993668|20709355|P2|Open-Label Period|Lack of Efficacy|3
5989176|NCT00993668|20709356|P1|Open-Label Period|Lack of Efficacy|4
5989177|NCT00993668|20709355|P2|Open-Label Period|Adverse Event|8
5989178|NCT00993668|20709356|P1|Open-Label Period|Adverse Event|9
5989179|NCT00993668|20709355|P2|Single-Blind Period|Lost to Follow-up|1
5989180|NCT00993668|20709356|P1|Single-Blind Period|Lost to Follow-up|3
5989181|NCT00993668|20709355|P2|Single-Blind Period|Lack of Efficacy|1
5989182|NCT00993668|20709356|P1|Single-Blind Period|Lack of Efficacy|0
5989183|NCT00993668|20709355|P2|Single-Blind Period|Adverse Event|1
5989184|NCT00993668|20709356|P1|Single-Blind Period|Adverse Event|1
5989185|NCT00993616|20709400|P1|Overall Study|Never treated|1
5989186|NCT00993616|20709400|P1|Overall Study|No tumor at entry|1
5989187|NCT00993499|20709418|P6|Discontinued After Starting Course 3|Other adverse event|0
5989188|NCT00993499|20709419|P5|Discontinued After Starting Course 3|Other adverse event|0
5989189|NCT00993499|20709420|P4|Discontinued After Starting Course 3|Other adverse event|0
5989190|NCT00993499|20709421|P3|Discontinued After Starting Course 3|Other adverse event|1
5989191|NCT00993499|20709422|P2|Discontinued After Starting Course 3|Other adverse event|0
5989192|NCT00993499|20709423|P1|Discontinued After Starting Course 3|Other adverse event|1
5989193|NCT00993499|20709418|P6|Discontinued After Starting Course 3|DLT|0
5989194|NCT00993499|20709419|P5|Discontinued After Starting Course 3|DLT|0
5989195|NCT00993499|20709420|P4|Discontinued After Starting Course 3|DLT|1
5989196|NCT00993499|20709421|P3|Discontinued After Starting Course 3|DLT|2
5989197|NCT00993499|20709422|P2|Discontinued After Starting Course 3|DLT|0
5989198|NCT00993499|20709423|P1|Discontinued After Starting Course 3|DLT|1
5989199|NCT00993499|20709418|P6|Discontinued After Starting Course 3|Progressive Disease|3
5989200|NCT00993499|20709419|P5|Discontinued After Starting Course 3|Progressive Disease|3
5989201|NCT00993499|20709420|P4|Discontinued After Starting Course 3|Progressive Disease|1
5989202|NCT00993499|20709421|P3|Discontinued After Starting Course 3|Progressive Disease|3
5989203|NCT00993499|20709422|P2|Discontinued After Starting Course 3|Progressive Disease|4
5989204|NCT00993499|20709423|P1|Discontinued After Starting Course 3|Progressive Disease|6
5989205|NCT00993499|20709418|P6|Discontinued After Starting Course 3|Withdrawal by Subject|0
5989206|NCT00993499|20709419|P5|Discontinued After Starting Course 3|Withdrawal by Subject|0
5989207|NCT00993499|20709420|P4|Discontinued After Starting Course 3|Withdrawal by Subject|0
5989208|NCT00993499|20709421|P3|Discontinued After Starting Course 3|Withdrawal by Subject|0
5989209|NCT00993499|20709422|P2|Discontinued After Starting Course 3|Withdrawal by Subject|1
5989210|NCT00993499|20709423|P1|Discontinued After Starting Course 3|Withdrawal by Subject|0
5989211|NCT00993499|20709418|P6|Discontinued Before Starting Course 3|Non compliance with the protocol|0
5989212|NCT00993499|20709419|P5|Discontinued Before Starting Course 3|Non compliance with the protocol|0
5989213|NCT00993499|20709420|P4|Discontinued Before Starting Course 3|Non compliance with the protocol|0
5989214|NCT00993499|20709421|P3|Discontinued Before Starting Course 3|Non compliance with the protocol|2
5989215|NCT00993499|20709422|P2|Discontinued Before Starting Course 3|Non compliance with the protocol|0
5989216|NCT00993499|20709423|P1|Discontinued Before Starting Course 3|Non compliance with the protocol|0
5989217|NCT00993499|20709418|P6|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0
5989218|NCT00993499|20709419|P5|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0
5989219|NCT00993499|20709420|P4|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1
5989220|NCT00993499|20709421|P3|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1
5989221|NCT00993499|20709422|P2|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0
5989222|NCT00993499|20709423|P1|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0
5989223|NCT00993499|20709418|P6|Discontinued Before Starting Course 3|Withdrawal by Subject|0
5989224|NCT00993499|20709419|P5|Discontinued Before Starting Course 3|Withdrawal by Subject|0
5989225|NCT00993499|20709420|P4|Discontinued Before Starting Course 3|Withdrawal by Subject|0
5989226|NCT00993499|20709421|P3|Discontinued Before Starting Course 3|Withdrawal by Subject|0
5989227|NCT00993499|20709422|P2|Discontinued Before Starting Course 3|Withdrawal by Subject|2
5989228|NCT00993499|20709423|P1|Discontinued Before Starting Course 3|Withdrawal by Subject|2
5989229|NCT00993499|20709418|P6|Discontinued Before Starting Course 3|Progressive Disease|0
5989230|NCT00993499|20709419|P5|Discontinued Before Starting Course 3|Progressive Disease|0
5989231|NCT00993499|20709420|P4|Discontinued Before Starting Course 3|Progressive Disease|0
5989232|NCT00993499|20709421|P3|Discontinued Before Starting Course 3|Progressive Disease|0
5989233|NCT00993499|20709422|P2|Discontinued Before Starting Course 3|Progressive Disease|2
5989234|NCT00993499|20709423|P1|Discontinued Before Starting Course 3|Progressive Disease|2
5989235|NCT00993499|20709418|P6|Run-in Period (8 Days)|Progressive disease|0
5989236|NCT00993499|20709419|P5|Run-in Period (8 Days)|Progressive disease|0
5989237|NCT00993499|20709420|P4|Run-in Period (8 Days)|Progressive disease|0
5989238|NCT00993499|20709421|P3|Run-in Period (8 Days)|Progressive disease|1
5989239|NCT00993499|20709422|P2|Run-in Period (8 Days)|Progressive disease|1
5989240|NCT00993499|20709423|P1|Run-in Period (8 Days)|Progressive disease|0
5989241|NCT00993499|20709418|P6|Run-in Period (8 Days)|Consent withdrawn|0
5989242|NCT00993499|20709419|P5|Run-in Period (8 Days)|Consent withdrawn|0
5989243|NCT00993499|20709420|P4|Run-in Period (8 Days)|Consent withdrawn|0
5989244|NCT00993499|20709421|P3|Run-in Period (8 Days)|Consent withdrawn|0
5989245|NCT00993499|20709422|P2|Run-in Period (8 Days)|Consent withdrawn|1
5989246|NCT00993499|20709423|P1|Run-in Period (8 Days)|Consent withdrawn|0
5989247|NCT00993499|20709418|P6|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0
5989248|NCT00993499|20709419|P5|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0
5989249|NCT00993499|20709420|P4|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0
5989250|NCT00993499|20709421|P3|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0
5989251|NCT00993499|20709422|P2|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0
5989252|NCT00993499|20709423|P1|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|1
5989253|NCT00993499|20709418|P6|Run-in Period (8 Days)|Adverse Event|0
5989254|NCT00993499|20709419|P5|Run-in Period (8 Days)|Adverse Event|0
5989255|NCT00993499|20709420|P4|Run-in Period (8 Days)|Adverse Event|0
5989256|NCT00993499|20709421|P3|Run-in Period (8 Days)|Adverse Event|0
5989257|NCT00993499|20709422|P2|Run-in Period (8 Days)|Adverse Event|1
5989258|NCT00993499|20709423|P1|Run-in Period (8 Days)|Adverse Event|0
5989259|NCT00993473|20709505|P2|Overall Study|Family event|0
5989260|NCT00993473|20709506|P1|Overall Study|Family event|1
5989261|NCT00993473|20709505|P2|Overall Study|Technical problem with CGM device|1
5989262|NCT00993473|20709506|P1|Overall Study|Technical problem with CGM device|0
5989263|NCT00993473|20709505|P2|Overall Study|Withdrawal by Subject|5
5989264|NCT00993473|20709506|P1|Overall Study|Withdrawal by Subject|1
5989265|NCT00993473|20709505|P2|Overall Study|Lost to Follow-up|0
5989266|NCT00993473|20709506|P1|Overall Study|Lost to Follow-up|1
5989267|NCT00993473|20709505|P2|Overall Study|Protocol Violation|2
5989268|NCT00993473|20709506|P1|Overall Study|Protocol Violation|1
5989269|NCT00993473|20709505|P2|Overall Study|Adverse Event|2
5989270|NCT00993473|20709506|P1|Overall Study|Adverse Event|0
5989271|NCT00993447|20709544|P2|Overall Study|Adverse Event|0
5989272|NCT00993447|20709545|P1|Overall Study|Adverse Event|1
5989273|NCT00993447|20709544|P2|Overall Study|Lost to Follow-up|3
5989274|NCT00993447|20709545|P1|Overall Study|Lost to Follow-up|1
5989275|NCT00993447|20709544|P2|Overall Study|Protocol Violation|8
5989276|NCT00993447|20709545|P1|Overall Study|Protocol Violation|12
5989277|NCT00993447|20709544|P2|Overall Study|Withdrawal by Subject|8
5989278|NCT00993447|20709545|P1|Overall Study|Withdrawal by Subject|23
5989279|NCT00993421|20709582|P7|Overall Study|Protocol Violation|1
5989280|NCT00993421|20709583|P6|Overall Study|Protocol Violation|2
5989281|NCT00993421|20709584|P5|Overall Study|Protocol Violation|0
5989282|NCT00993421|20709585|P4|Overall Study|Protocol Violation|0
5989283|NCT00993421|20709586|P3|Overall Study|Protocol Violation|0
5989284|NCT00993421|20709587|P2|Overall Study|Protocol Violation|0
5989285|NCT00993421|20709588|P1|Overall Study|Protocol Violation|0
5989286|NCT00993421|20709582|P7|Overall Study|Physician Decision|1
5989287|NCT00993421|20709583|P6|Overall Study|Physician Decision|1
5989288|NCT00993421|20709584|P5|Overall Study|Physician Decision|0
5989289|NCT00993421|20709585|P4|Overall Study|Physician Decision|0
5989290|NCT00993421|20709586|P3|Overall Study|Physician Decision|0
5989291|NCT00993421|20709587|P2|Overall Study|Physician Decision|0
5989292|NCT00993421|20709588|P1|Overall Study|Physician Decision|0
5989293|NCT00993421|20709582|P7|Overall Study|Entry Criteria Exclusion|0
5989294|NCT00993421|20709583|P6|Overall Study|Entry Criteria Exclusion|1
5989295|NCT00993421|20709584|P5|Overall Study|Entry Criteria Exclusion|0
5989296|NCT00993421|20709585|P4|Overall Study|Entry Criteria Exclusion|3
5989297|NCT00993421|20709586|P3|Overall Study|Entry Criteria Exclusion|1
5989298|NCT00993421|20709587|P2|Overall Study|Entry Criteria Exclusion|0
5989299|NCT00993421|20709588|P1|Overall Study|Entry Criteria Exclusion|0
5989300|NCT00993421|20709582|P7|Overall Study|Death|1
5989301|NCT00993421|20709583|P6|Overall Study|Death|0
5989302|NCT00993421|20709584|P5|Overall Study|Death|0
5989303|NCT00993421|20709585|P4|Overall Study|Death|0
5989304|NCT00993421|20709586|P3|Overall Study|Death|0
5989305|NCT00993421|20709587|P2|Overall Study|Death|0
5989306|NCT00993421|20709588|P1|Overall Study|Death|0
5989307|NCT00993421|20709582|P7|Overall Study|Withdrawal by Subject|3
5989308|NCT00993421|20709583|P6|Overall Study|Withdrawal by Subject|5
5989309|NCT00993421|20709584|P5|Overall Study|Withdrawal by Subject|3
5989310|NCT00993421|20709585|P4|Overall Study|Withdrawal by Subject|3
5989311|NCT00993421|20709586|P3|Overall Study|Withdrawal by Subject|3
5989312|NCT00993421|20709587|P2|Overall Study|Withdrawal by Subject|2
5989313|NCT00993421|20709588|P1|Overall Study|Withdrawal by Subject|3
5989314|NCT00993421|20709582|P7|Overall Study|Lost to Follow-up|6
5989315|NCT00993421|20709583|P6|Overall Study|Lost to Follow-up|0
5989316|NCT00993421|20709584|P5|Overall Study|Lost to Follow-up|0
5989317|NCT00993421|20709585|P4|Overall Study|Lost to Follow-up|0
5989318|NCT00993421|20709586|P3|Overall Study|Lost to Follow-up|5
5989319|NCT00993421|20709587|P2|Overall Study|Lost to Follow-up|5
5989320|NCT00993421|20709588|P1|Overall Study|Lost to Follow-up|3
5989321|NCT00993421|20709582|P7|Overall Study|Sponsor Decision|29
5989322|NCT00993421|20709583|P6|Overall Study|Sponsor Decision|30
5989323|NCT00993421|20709584|P5|Overall Study|Sponsor Decision|38
5989324|NCT00993421|20709585|P4|Overall Study|Sponsor Decision|30
5989325|NCT00993421|20709586|P3|Overall Study|Sponsor Decision|28
5989326|NCT00993421|20709587|P2|Overall Study|Sponsor Decision|31
5989327|NCT00993421|20709588|P1|Overall Study|Sponsor Decision|36
5989328|NCT00993421|20709582|P7|Overall Study|Adverse Event|1
5989329|NCT00993421|20709583|P6|Overall Study|Adverse Event|7
5989330|NCT00993421|20709584|P5|Overall Study|Adverse Event|5
5989331|NCT00993421|20709585|P4|Overall Study|Adverse Event|9
5989332|NCT00993421|20709586|P3|Overall Study|Adverse Event|6
5989333|NCT00993421|20709587|P2|Overall Study|Adverse Event|7
5989334|NCT00993421|20709588|P1|Overall Study|Adverse Event|2
5989335|NCT00993317|20709739|P2|Overall Study|Early study termination at the site|0
5989336|NCT00993317|20709740|P1|Overall Study|Early study termination at the site|1
5989337|NCT00993317|20709739|P2|Overall Study|Investigator's opinion|1
5989338|NCT00993317|20709740|P1|Overall Study|Investigator's opinion|0
5989339|NCT00993317|20709739|P2|Overall Study|Withdrawal by Subject|2
5989340|NCT00993317|20709740|P1|Overall Study|Withdrawal by Subject|0
5989341|NCT00993317|20709739|P2|Overall Study|Lack of Efficacy|18
5989342|NCT00993317|20709740|P1|Overall Study|Lack of Efficacy|18
5989343|NCT00993317|20709739|P2|Overall Study|Adverse Event|4
5989344|NCT00993317|20709740|P1|Overall Study|Adverse Event|2
5989345|NCT00993291|20709758|P1|Overall Study|Withdrawal by Subject|1
5989346|NCT00993265|20709764|P2|Overall Study|Non-compliant with study medication|0
5989347|NCT00993265|20709765|P1|Overall Study|Non-compliant with study medication|1
5989348|NCT00993265|20709764|P2|Overall Study|Changed dose of concomitant drug|0
5989349|NCT00993265|20709765|P1|Overall Study|Changed dose of concomitant drug|2
5989350|NCT00993265|20709764|P2|Overall Study|Adverse Event|0
5989351|NCT00993265|20709765|P1|Overall Study|Adverse Event|1
5989352|NCT00993148|20709817|P1|Overall Study|never initiated treatment|1
5989353|NCT00993148|20709817|P1|Overall Study|Lost to Follow-up|2
5989354|NCT00993044|20709829|P1|Irinotecan 50 mg|Physician Decision|1
5989355|NCT00993031|20709836|P2|Overall Study|Lost to Follow-up|13
5989356|NCT00993031|20709837|P1|Overall Study|Lost to Follow-up|19
5989357|NCT00993031|20709836|P2|Overall Study|Withdrawal by Subject|3
5989358|NCT00993031|20709837|P1|Overall Study|Withdrawal by Subject|3
5989359|NCT00993031|20709836|P2|Overall Study|Physician Decision|2
5989360|NCT00993031|20709837|P1|Overall Study|Physician Decision|0
5989361|NCT00993031|20709836|P2|Overall Study|Death|1
5989362|NCT00993031|20709837|P1|Overall Study|Death|0
5989363|NCT00992992|20709869|P1|Overall Study|Sponsor Closed the Study|4
5989364|NCT00992992|20709869|P1|Overall Study|GlaxoSmithKline Closed the Study|2
5989365|NCT00992992|20709869|P1|Overall Study|Death|16
5989366|NCT00992992|20709869|P1|Overall Study|Lost to Follow-up|3
5989367|NCT00992836|20709900|P1|Overall Study|Protocol Violation|2
5989368|NCT00992836|20709900|P1|Overall Study|Withdrawal by Subject|2
5989369|NCT00992836|20709900|P1|Overall Study|Lost to Follow-up|1
5989370|NCT00992784|20709915|P3|Overall Study|Withdrawal by Subject|1
5989371|NCT00992784|20709916|P2|Overall Study|Withdrawal by Subject|1
5989372|NCT00992784|20709917|P1|Overall Study|Withdrawal by Subject|1
5989373|NCT00992784|20709915|P3|Overall Study|Adverse Event|0
5989374|NCT00992784|20709916|P2|Overall Study|Adverse Event|1
5989375|NCT00992784|20709917|P1|Overall Study|Adverse Event|2
5989376|NCT00992589|20710029|P4|Double-Blind Phase|Other|3
5989377|NCT00992589|20710030|P3|Double-Blind Phase|Other|6
5989378|NCT00992589|20710031|P2|Double-Blind Phase|Other|1
5989379|NCT00992589|20710032|P1|Double-Blind Phase|Other|0
5989380|NCT00992589|20710029|P4|Double-Blind Phase|Lost to Follow-up|2
5989381|NCT00992589|20710030|P3|Double-Blind Phase|Lost to Follow-up|0
5989382|NCT00992589|20710031|P2|Double-Blind Phase|Lost to Follow-up|0
5989383|NCT00992589|20710032|P1|Double-Blind Phase|Lost to Follow-up|0
5989384|NCT00992589|20710029|P4|Double-Blind Phase|Withdrawal by Subject|2
5989385|NCT00992589|20710030|P3|Double-Blind Phase|Withdrawal by Subject|5
5989386|NCT00992589|20710031|P2|Double-Blind Phase|Withdrawal by Subject|6
5989387|NCT00992589|20710032|P1|Double-Blind Phase|Withdrawal by Subject|0
5989388|NCT00992589|20710029|P4|Double-Blind Phase|Adverse Event|3
5989389|NCT00992589|20710030|P3|Double-Blind Phase|Adverse Event|2
5989390|NCT00992589|20710031|P2|Double-Blind Phase|Adverse Event|6
5989391|NCT00992589|20710032|P1|Double-Blind Phase|Adverse Event|0
5989392|NCT00992589|20710029|P4|Open-Label Phase|Other|0
5989393|NCT00992589|20710030|P3|Open-Label Phase|Other|0
5989394|NCT00992589|20710031|P2|Open-Label Phase|Other|0
5989395|NCT00992589|20710032|P1|Open-Label Phase|Other|45
5989396|NCT00992589|20710029|P4|Open-Label Phase|Physician Decision|0
5989397|NCT00992589|20710030|P3|Open-Label Phase|Physician Decision|0
5989398|NCT00992589|20710031|P2|Open-Label Phase|Physician Decision|0
5989399|NCT00992589|20710032|P1|Open-Label Phase|Physician Decision|4
5989400|NCT00992589|20710029|P4|Open-Label Phase|Protocol Violation|0
5989401|NCT00992589|20710030|P3|Open-Label Phase|Protocol Violation|0
5989402|NCT00992589|20710031|P2|Open-Label Phase|Protocol Violation|0
5989403|NCT00992589|20710032|P1|Open-Label Phase|Protocol Violation|3
5989404|NCT00992589|20710029|P4|Open-Label Phase|Lost to Follow-up|0
5989405|NCT00992589|20710030|P3|Open-Label Phase|Lost to Follow-up|0
5989406|NCT00992589|20710031|P2|Open-Label Phase|Lost to Follow-up|0
5989407|NCT00992589|20710032|P1|Open-Label Phase|Lost to Follow-up|1
5989408|NCT00992589|20710029|P4|Open-Label Phase|Withdrawal by Subject|0
5989409|NCT00992589|20710030|P3|Open-Label Phase|Withdrawal by Subject|0
5989410|NCT00992589|20710031|P2|Open-Label Phase|Withdrawal by Subject|0
5989411|NCT00992589|20710032|P1|Open-Label Phase|Withdrawal by Subject|20
5989412|NCT00992589|20710029|P4|Open-Label Phase|Adverse Event|0
5989413|NCT00992589|20710030|P3|Open-Label Phase|Adverse Event|0
5989414|NCT00992589|20710031|P2|Open-Label Phase|Adverse Event|0
5989415|NCT00992589|20710032|P1|Open-Label Phase|Adverse Event|4
5989416|NCT00992511|20710078|P4|Overall Study|Withdrawal by Subject|1
5989417|NCT00992511|20710079|P3|Overall Study|Withdrawal by Subject|1
5989418|NCT00992511|20710080|P2|Overall Study|Withdrawal by Subject|0
5989419|NCT00992511|20710081|P1|Overall Study|Withdrawal by Subject|0
5989420|NCT00992511|20710078|P4|Overall Study|Lost to Follow-up|2
5989421|NCT00992511|20710079|P3|Overall Study|Lost to Follow-up|0
5989422|NCT00992511|20710080|P2|Overall Study|Lost to Follow-up|0
5989423|NCT00992511|20710081|P1|Overall Study|Lost to Follow-up|1
5989424|NCT00992511|20710078|P4|Overall Study|Migrated/moved from study area|2
5989425|NCT00992511|20710079|P3|Overall Study|Migrated/moved from study area|1
5989426|NCT00992511|20710080|P2|Overall Study|Migrated/moved from study area|0
5989427|NCT00992511|20710081|P1|Overall Study|Migrated/moved from study area|1
5989428|NCT00992459|20710165|P2|Overall Study|Adverse Event|0
5989429|NCT00992459|20710166|P1|Overall Study|Adverse Event|1
5989430|NCT00992459|20710165|P2|Overall Study|Withdrawal by Subject|1
5989431|NCT00992459|20710166|P1|Overall Study|Withdrawal by Subject|0
5989432|NCT00992446|20710190|P1|Overall Study|Maintenance Therapy Screen Fail|5
5989433|NCT00992446|20710190|P1|Overall Study|Withdrawal by Subject|2
5989434|NCT00992446|20710190|P1|Overall Study|Disease Progression|1
5989435|NCT00992407|20710265|P2|Overall Study|Study medication not administered|13
5989436|NCT00992407|20710266|P1|Overall Study|Study medication not administered|17
5989437|NCT00992407|20710265|P2|Overall Study|Loss of follow-up & Adverse events|1
5989438|NCT00992407|20710266|P1|Overall Study|Loss of follow-up & Adverse events|2
5989439|NCT00992407|20710265|P2|Overall Study|Other|0
5989440|NCT00992407|20710266|P1|Overall Study|Other|2
5989441|NCT00992407|20710265|P2|Overall Study|protocol Violation & Adverse events|4
5989442|NCT00992407|20710266|P1|Overall Study|protocol Violation & Adverse events|2
5989443|NCT00992407|20710265|P2|Overall Study|Adverse Event|2
5989444|NCT00992407|20710266|P1|Overall Study|Adverse Event|3
5989445|NCT00992407|20710265|P2|Overall Study|Lost to Follow-up|3
5989446|NCT00992407|20710266|P1|Overall Study|Lost to Follow-up|3
5989447|NCT00992407|20710265|P2|Overall Study|Protocol Violation|1
5989448|NCT00992407|20710266|P1|Overall Study|Protocol Violation|2
5989449|NCT00992394|20710316|P2|Overall Study|Other event|0
5989450|NCT00992394|20710317|P1|Overall Study|Other event|1
5989451|NCT00992394|20710316|P2|Overall Study|Lost to Follow-up|0
5989452|NCT00992394|20710317|P1|Overall Study|Lost to Follow-up|2
5989453|NCT00992394|20710316|P2|Overall Study|Protocol Violation|4
5989454|NCT00992394|20710317|P1|Overall Study|Protocol Violation|2
5989455|NCT00992394|20710316|P2|Overall Study|Physician Decision|0
5989456|NCT00992394|20710317|P1|Overall Study|Physician Decision|1
5989457|NCT00992394|20710316|P2|Overall Study|Withdrawal by Subject|2
5989458|NCT00992394|20710317|P1|Overall Study|Withdrawal by Subject|8
5989459|NCT00992394|20710316|P2|Overall Study|Adverse Event|5
5989460|NCT00992394|20710317|P1|Overall Study|Adverse Event|4
5989461|NCT00992394|20710316|P2|Overall Study|Lack of Efficacy|3
5989462|NCT00992394|20710317|P1|Overall Study|Lack of Efficacy|6
5989463|NCT00992225|20710404|P1|Overall Study|Adverse Event|2
5989464|NCT00992225|20710404|P1|Overall Study|Entry Criteria Not Met|8
5989465|NCT00992186|20710414|P1|Overall Study|Refusal To Receive Study Agent|3
5989466|NCT00992186|20710414|P1|Overall Study|Progressive Disease|30
5989467|NCT00992186|20710414|P1|Overall Study|Adverse Event|9
5989468|NCT00992186|20710414|P1|Overall Study|Physician Decision|1
5989469|NCT00992186|20710414|P1|Overall Study|Protocol Violation|1
5989470|NCT00992186|20710414|P1|Overall Study|Withdrawal by Subject|2
5989471|NCT00992108|20710433|P2|Overall Study|Lost to Follow-up|1
5989472|NCT00992108|20710434|P1|Overall Study|Lost to Follow-up|0
5989473|NCT00992056|20710448|P2|Washout Period (2 Weeks)|Physician Decision|0
5989474|NCT00992056|20710449|P1|Washout Period (2 Weeks)|Physician Decision|1
5989475|NCT00992056|20710448|P2|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|2
5989476|NCT00992056|20710449|P1|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|1
5989477|NCT00992017|20710455|P1|Overall Study|Not adhere to study requirements|1
5989478|NCT00992017|20710455|P1|Overall Study|Unable to get to clinic|5
5989479|NCT00992017|20710455|P1|Overall Study|Withdrawal by Subject|2
5989480|NCT00992017|20710455|P1|Overall Study|Lost to Follow-up|2
5989481|NCT00991952|20710470|P2|Overall Study|Adverse Event|1
5989482|NCT00991952|20710471|P1|Overall Study|Adverse Event|0
5989483|NCT00991939|20710479|P2|Overall Study|Entire study terminated|1
5989484|NCT00991939|20710480|P1|Overall Study|Entire study terminated|4
5989485|NCT00991939|20710479|P2|Overall Study|Withdrawal by Subject|0
5989486|NCT00991939|20710480|P1|Overall Study|Withdrawal by Subject|1
5989487|NCT00991939|20710479|P2|Overall Study|Lost to Follow-up|1
5989488|NCT00991939|20710480|P1|Overall Study|Lost to Follow-up|0
5989489|NCT00991887|20710514|P2|Overall Study|Lost to Follow-up|1
5989490|NCT00991887|20710515|P1|Overall Study|Lost to Follow-up|2
5989491|NCT00991510|20710534|P2|Period III (Days 29-112)|Adverse Event|1
5989492|NCT00991510|20710535|P1|Period III (Days 29-112)|Adverse Event|1
5989493|NCT00991510|20710534|P2|Period I (Days 1-14)|Adverse Event|0
5989494|NCT00991510|20710535|P1|Period I (Days 1-14)|Adverse Event|1
5989495|NCT00991406|20710579|P1|Overall Study|One participant did not respond to FES.|1
5989496|NCT00991341|20710588|P2|Overall Study|Withdrawal by Subject|4
5989497|NCT00991341|20710589|P1|Overall Study|Withdrawal by Subject|3
5989498|NCT00991341|20710588|P2|Overall Study|Physician Decision|2
5989499|NCT00991341|20710589|P1|Overall Study|Physician Decision|1
5989500|NCT00991341|20710588|P2|Overall Study|no RBCs received 96hrs after randomized|155
5989501|NCT00991341|20710589|P1|Overall Study|no RBCs received 96hrs after randomized|186
5989502|NCT00991341|20710588|P2|Overall Study|Death|0
5989503|NCT00991341|20710589|P1|Overall Study|Death|3
5989504|NCT00991341|20710588|P2|Overall Study|no surgery w/in 30 days of randomization|18
5989505|NCT00991341|20710589|P1|Overall Study|no surgery w/in 30 days of randomization|11
5989506|NCT00991302|20710627|P2|Overall Study|Lost to Follow-up|12
5989507|NCT00991302|20710628|P1|Overall Study|Lost to Follow-up|14
5989508|NCT00991302|20710627|P2|Overall Study|Death|1
5989509|NCT00991302|20710628|P1|Overall Study|Death|0
5989510|NCT00991289|20710644|P1|Overall Study|Protocol Violation|2
5989511|NCT00991289|20710644|P1|Overall Study|Lost to Follow-up|4
5989512|NCT00991289|20710644|P1|Overall Study|Withdrawal by Subject|3
5989513|NCT00991289|20710644|P1|Overall Study|Physician Decision|2
5989514|NCT00991289|20710644|P1|Overall Study|Adverse Event|1
5989593|NCT00990821|20710884|P14|Overall Study|Withdrawal by Subject|1
5989594|NCT00990821|20710885|P13|Overall Study|Withdrawal by Subject|2
5989595|NCT00990821|20710886|P12|Overall Study|Withdrawal by Subject|5
5989596|NCT00990821|20710887|P11|Overall Study|Withdrawal by Subject|3
5989597|NCT00990821|20710888|P10|Overall Study|Withdrawal by Subject|1
5989598|NCT00990821|20710889|P9|Overall Study|Withdrawal by Subject|0
5989599|NCT00990821|20710890|P8|Overall Study|Withdrawal by Subject|0
5989600|NCT00990821|20710891|P7|Overall Study|Withdrawal by Subject|1
5989601|NCT00990821|20710892|P6|Overall Study|Withdrawal by Subject|3
5989602|NCT00990821|20710893|P5|Overall Study|Withdrawal by Subject|3
5989603|NCT00990821|20710894|P4|Overall Study|Withdrawal by Subject|0
5989604|NCT00990821|20710895|P3|Overall Study|Withdrawal by Subject|0
5989605|NCT00990821|20710896|P2|Overall Study|Withdrawal by Subject|2
5989606|NCT00990821|20710897|P1|Overall Study|Withdrawal by Subject|0
5989607|NCT00990704|20710934|P2|Overall Study|Physician Decision|1
5989608|NCT00990704|20710935|P1|Overall Study|Physician Decision|0
5989609|NCT00990704|20710934|P2|Overall Study|Adverse Event|1
5989610|NCT00990704|20710935|P1|Overall Study|Adverse Event|1
5989611|NCT00990665|20710955|P1|Overall Study|System Explant|3
5989612|NCT00990665|20710955|P1|Overall Study|Lost to Follow-up|1
5989613|NCT00990665|20710955|P1|Overall Study|Withdrawal by Subject|6
5989614|NCT00990665|20710955|P1|Overall Study|Heart Transplant|1
5989615|NCT00990665|20710955|P1|Overall Study|Death|29
5989616|NCT00990665|20710955|P1|Overall Study|Unsuccessful Implant|8
5989617|NCT00990652|20710962|P1|Post-sugery Bortezomib + Temozolomide|Withdrawal by Subject|1
5989618|NCT00990652|20710962|P1|Pre-surgical Bortezomib|Adverse Event|1
5989619|NCT00990340|20710996|P2|First 14-day Treatment|Protocol Violation|2
5989620|NCT00990340|20710997|P1|First 14-day Treatment|Protocol Violation|2
5989621|NCT00990340|20710996|P2|First 14-day Treatment|Lost to Follow-up|1
5989622|NCT00990340|20710997|P1|First 14-day Treatment|Lost to Follow-up|2
5989623|NCT00990340|20710996|P2|First 14-day Treatment|Not Compliant|1
5989624|NCT00990340|20710997|P1|First 14-day Treatment|Not Compliant|2
5989625|NCT00990314|20711011|P1|Overall Study|Lack of Efficacy|1
5989626|NCT00990314|20711011|P1|Overall Study|Physician Decision|3
5989627|NCT00990314|20711011|P1|Overall Study|Non-Compliance|1
5989628|NCT00990314|20711011|P1|Overall Study|Withdrawal by Subject|3
5989629|NCT00990314|20711011|P1|Overall Study|Adverse Event|2
5989630|NCT00990314|20711011|P1|Overall Study|Death|2
5989631|NCT00990249|20711053|P1|Overall Study|Not treated|2
5989632|NCT00990249|20711053|P1|Overall Study|Death|2
5989633|NCT00990249|20711053|P1|Overall Study|Non-Compliance|1
5989634|NCT00990249|20711053|P1|Overall Study|Disease Progression|8
5989635|NCT00990184|20711068|P1|Overall Study|Physician Decision|1
5989636|NCT00990106|20711076|P2|Overall Study|scheduling conflicts|2
5989637|NCT00990106|20711077|P1|Overall Study|scheduling conflicts|0
5989638|NCT00990106|20711076|P2|Overall Study|planned major surgery|1
5989639|NCT00990106|20711077|P1|Overall Study|planned major surgery|0
5989640|NCT00990106|20711076|P2|Overall Study|started exclusionary medication|1
5989641|NCT00990106|20711077|P1|Overall Study|started exclusionary medication|0
5989642|NCT00990106|20711076|P2|Overall Study|relocation/deployment|1
5989643|NCT00990106|20711077|P1|Overall Study|relocation/deployment|4
5989644|NCT00990106|20711076|P2|Overall Study|opted for open label prazosin|1
5989645|NCT00990106|20711077|P1|Overall Study|opted for open label prazosin|1
5989646|NCT00990106|20711076|P2|Overall Study|Withdrawal by Subject|1
5989647|NCT00990106|20711077|P1|Overall Study|Withdrawal by Subject|2
5989648|NCT00990106|20711076|P2|Overall Study|Lost to Follow-up|3
5989649|NCT00990106|20711077|P1|Overall Study|Lost to Follow-up|1
5989650|NCT00990106|20711076|P2|Overall Study|"too busy to continue"|2
5989651|NCT00990106|20711077|P1|Overall Study|"too busy to continue"|1
5989652|NCT00990093|20711087|P2|Test Period 2 (15-28 Days)|Other|1
5989653|NCT00990093|20711088|P1|Test Period 2 (15-28 Days)|Other|0
5989654|NCT00990093|20711087|P2|Test Period 2 (15-28 Days)|Lack of Efficacy|0
5989655|NCT00990093|20711088|P1|Test Period 2 (15-28 Days)|Lack of Efficacy|1
5989656|NCT00990093|20711087|P2|Test Period 2 (15-28 Days)|Adverse Event|0
5989657|NCT00990093|20711088|P1|Test Period 2 (15-28 Days)|Adverse Event|1
5989658|NCT00990093|20711087|P2|Test Period 1 (1-14 Days)|Lack of Efficacy|2
5989659|NCT00990093|20711088|P1|Test Period 1 (1-14 Days)|Lack of Efficacy|0
5989660|NCT00990093|20711087|P2|Test Period 1 (1-14 Days)|Other|0
5989661|NCT00990093|20711088|P1|Test Period 1 (1-14 Days)|Other|1
5989662|NCT00990093|20711087|P2|Test Period 1 (1-14 Days)|Withdrawal by Subject|0
5989663|NCT00990093|20711088|P1|Test Period 1 (1-14 Days)|Withdrawal by Subject|2
5989664|NCT00990093|20711087|P2|Test Period 1 (1-14 Days)|Adverse Event|0
5989665|NCT00990093|20711088|P1|Test Period 1 (1-14 Days)|Adverse Event|1
5989666|NCT00989963|20711140|P3|Overall Study|Adverse Event|1
5989667|NCT00989963|20711141|P2|Overall Study|Adverse Event|1
5989668|NCT00989963|20711142|P1|Overall Study|Adverse Event|1
5989669|NCT00989950|20711178|P4|Randomized Phase|Adverse Event|0
5989670|NCT00989950|20711179|P3|Randomized Phase|Adverse Event|0
5989671|NCT00989950|20711180|P2|Randomized Phase|Adverse Event|1
5989672|NCT00989950|20711181|P1|Randomized Phase|Adverse Event|0
5989673|NCT00989950|20711178|P4|Randomized Phase|Protocol Violation|0
5989674|NCT00989950|20711179|P3|Randomized Phase|Protocol Violation|0
5989675|NCT00989950|20711180|P2|Randomized Phase|Protocol Violation|0
5989676|NCT00989950|20711181|P1|Randomized Phase|Protocol Violation|1
5989677|NCT00989833|20711213|P3|Overall Study|Incorrectly randomized|0
5989678|NCT00989833|20711214|P2|Overall Study|Incorrectly randomized|0
5989679|NCT00989833|20711215|P1|Overall Study|Incorrectly randomized|1
5989680|NCT00989833|20711213|P3|Overall Study|Withdrawal by Subject|1
5989681|NCT00989833|20711214|P2|Overall Study|Withdrawal by Subject|0
5989682|NCT00989833|20711215|P1|Overall Study|Withdrawal by Subject|0
5989683|NCT00989833|20711213|P3|Overall Study|Protocol Violation|1
5989684|NCT00989833|20711214|P2|Overall Study|Protocol Violation|2
5989685|NCT00989833|20711215|P1|Overall Study|Protocol Violation|1
5989686|NCT00989833|20711213|P3|Overall Study|Lost to Follow-up|0
5989687|NCT00989833|20711214|P2|Overall Study|Lost to Follow-up|1
5989688|NCT00989833|20711215|P1|Overall Study|Lost to Follow-up|0
5989689|NCT00989781|20711246|P2|Ovarian Response to hCG|Lost to Follow-up|2
5989690|NCT00989781|20711247|P1|Ovarian Response to hCG|Lost to Follow-up|3
5989691|NCT00989664|20711277|P1|Long-Term Follow-Up|Death|3
5989692|NCT00989664|20711277|P1|Dosimetric and Therapeutic Treatment|Did Not Receive Study Drug|1
5989693|NCT00989664|20711277|P1|Dosimetric and Therapeutic Treatment|Enrolled into Study BEX104526|7
5989694|NCT00989664|20711277|P1|Dosimetric and Therapeutic Treatment|Death|1
5989695|NCT00989664|20711277|P1|Dosimetric and Therapeutic Treatment|Progressive Disease|49
5989696|NCT00989664|20711277|P1|Dosimetric and Therapeutic Treatment|Condition/Illness; Study Drug Unrelated|2
5989697|NCT00989664|20711277|P1|Dosimetric and Therapeutic Treatment|Non-compliant or Uncooperative|1
5989698|NCT00989287|20711362|P2|Overall Study|Lost to Follow-up|1
5989699|NCT00989287|20711363|P1|Overall Study|Lost to Follow-up|0
5989700|NCT00989287|20711362|P2|Overall Study|Adverse Event|0
5989701|NCT00989287|20711363|P1|Overall Study|Adverse Event|1
5989702|NCT00989261|20711465|P2|Overall Study|Lost to Follow-up|0
5989703|NCT00989261|20711466|P1|Overall Study|Lost to Follow-up|3
5989704|NCT00989261|20711465|P2|Overall Study|Withdrawal by Subject|1
5989705|NCT00989261|20711466|P1|Overall Study|Withdrawal by Subject|0
5989706|NCT00989261|20711465|P2|Overall Study|Still in follow up|21
5989707|NCT00989261|20711466|P1|Overall Study|Still in follow up|12
5989708|NCT00989235|20711496|P2|Overall Study|Lost to Follow-up|1
5989709|NCT00989235|20711497|P1|Overall Study|Lost to Follow-up|0
5989710|NCT00989235|20711496|P2|Overall Study|Randomized by Mistake|2
5989711|NCT00989235|20711497|P1|Overall Study|Randomized by Mistake|0
5989712|NCT00989235|20711496|P2|Overall Study|Desire to Become Pregnant|0
5989713|NCT00989235|20711497|P1|Overall Study|Desire to Become Pregnant|1
5989714|NCT00989235|20711496|P2|Overall Study|Withdrawal of Consent|1
5989715|NCT00989235|20711497|P1|Overall Study|Withdrawal of Consent|1
5989716|NCT00989235|20711496|P2|Overall Study|Lack of Efficacy|0
5989717|NCT00989235|20711497|P1|Overall Study|Lack of Efficacy|1
5989718|NCT00989235|20711496|P2|Overall Study|Adverse Event|1
5989719|NCT00989235|20711497|P1|Overall Study|Adverse Event|0
5989720|NCT00989235|20711496|P2|Overall Study|Death|1
5989721|NCT00989235|20711497|P1|Overall Study|Death|0
5989722|NCT00989196|20711542|P2|Treatment Period|Lost to Follow-up|0
5989723|NCT00989196|20711543|P1|Treatment Period|Lost to Follow-up|1
5989724|NCT00989092|20711581|P2|Overall Study|Did not receive study drug|0
5989725|NCT00989092|20711582|P1|Overall Study|Did not receive study drug|2
5989726|NCT00989092|20711581|P2|Overall Study|Erythropoietin therapy initiated|0
5989727|NCT00989092|20711582|P1|Overall Study|Erythropoietin therapy initiated|2
5989728|NCT00989092|20711581|P2|Overall Study|Protocol deviation|0
5989729|NCT00989092|20711582|P1|Overall Study|Protocol deviation|2
5989730|NCT00989092|20711581|P2|Overall Study|Other|1
5989731|NCT00989092|20711582|P1|Overall Study|Other|3
5989732|NCT00989092|20711581|P2|Overall Study|Lost to Follow-up|2
5989733|NCT00989092|20711582|P1|Overall Study|Lost to Follow-up|6
5989734|NCT00989092|20711581|P2|Overall Study|Ineligibility determined|3
5989735|NCT00989092|20711582|P1|Overall Study|Ineligibility determined|3
5989736|NCT00989092|20711581|P2|Overall Study|Death|2
5989737|NCT00989092|20711582|P1|Overall Study|Death|14
5989738|NCT00989092|20711581|P2|Overall Study|Withdrawal by Subject|9
5989739|NCT00989092|20711582|P1|Overall Study|Withdrawal by Subject|17
5989740|NCT00989092|20711581|P2|Overall Study|Chemotherapy initiated|4
5989741|NCT00989092|20711582|P1|Overall Study|Chemotherapy initiated|12
5989742|NCT00989092|20711581|P2|Overall Study|Adverse Event|1
5989743|NCT00989092|20711582|P1|Overall Study|Adverse Event|20
5989744|NCT00989092|20711581|P2|Overall Study|Physician Decision|6
5989745|NCT00989092|20711582|P1|Overall Study|Physician Decision|9
5989746|NCT00988884|20711634|P2|Overall Study|Withdrawal by Subject|18
5989747|NCT00988884|20711635|P1|Overall Study|Withdrawal by Subject|15
5989748|NCT00988884|20711634|P2|Overall Study|Protocol Violation|1
5989749|NCT00988884|20711635|P1|Overall Study|Protocol Violation|0
5989750|NCT00988884|20711634|P2|Overall Study|Lost to Follow-up|16
5989751|NCT00988884|20711635|P1|Overall Study|Lost to Follow-up|20
5989752|NCT00988884|20711634|P2|Overall Study|Adverse Event|1
5989753|NCT00988884|20711635|P1|Overall Study|Adverse Event|0
5989754|NCT00988858|20711657|P1|Overall Study|Sponsor Decision|1
5989755|NCT00988858|20711657|P1|Overall Study|Physician Decision|1
5989756|NCT00988858|20711657|P1|Overall Study|Death|1
5989757|NCT00988858|20711657|P1|Overall Study|Adverse Event|7
5989758|NCT00988637|20711706|P2|Overall Study|non-compliance with study drug|1
5989759|NCT00988637|20711707|P1|Overall Study|non-compliance with study drug|0
5989760|NCT00988637|20711706|P2|Overall Study|Withdrawal by Subject|1
5989761|NCT00988637|20711707|P1|Overall Study|Withdrawal by Subject|1
5989762|NCT00988637|20711706|P2|Overall Study|Lost to Follow-up|1
5989763|NCT00988637|20711707|P1|Overall Study|Lost to Follow-up|2
5989764|NCT00988598|20711739|P2|Overall Study|Withdrawal by Subject|0
5989765|NCT00988598|20711740|P1|Overall Study|Withdrawal by Subject|2
5989766|NCT00988559|20711768|P4|Overall Study|Lost to Follow-up|0
5989767|NCT00988559|20711769|P3|Overall Study|Lost to Follow-up|1
5989768|NCT00988559|20711770|P2|Overall Study|Lost to Follow-up|0
5989769|NCT00988559|20711771|P1|Overall Study|Lost to Follow-up|0
5989770|NCT00988559|20711768|P4|Overall Study|Pregnancy|0
5989771|NCT00988559|20711769|P3|Overall Study|Pregnancy|1
5989772|NCT00988559|20711770|P2|Overall Study|Pregnancy|1
5989773|NCT00988559|20711771|P1|Overall Study|Pregnancy|0
5989774|NCT00988559|20711768|P4|Overall Study|Withdrawal by Subject|1
5989775|NCT00988559|20711769|P3|Overall Study|Withdrawal by Subject|0
5989776|NCT00988559|20711770|P2|Overall Study|Withdrawal by Subject|1
5989777|NCT00988559|20711771|P1|Overall Study|Withdrawal by Subject|1
5989778|NCT00988533|20711785|P1|Overall Study|Lost to Follow-up|3
5989779|NCT00988442|20711799|P2|Overall Study|Early Study Closure|25
5989780|NCT00988442|20711800|P1|Overall Study|Early Study Closure|29
5989781|NCT00988442|20711799|P2|Overall Study|Lost to Follow-up|1
5989782|NCT00988442|20711800|P1|Overall Study|Lost to Follow-up|0
5989783|NCT00988442|20711799|P2|Overall Study|Death|2
5989784|NCT00988442|20711800|P1|Overall Study|Death|1
5989785|NCT00988429|20711863|P3|Overall Study|other reasons|1
5989786|NCT00988429|20711864|P2|Overall Study|other reasons|8
5989787|NCT00988429|20711865|P1|Overall Study|other reasons|8
5989788|NCT00988429|20711863|P3|Overall Study|Administrative Reasons|1
5989789|NCT00988429|20711864|P2|Overall Study|Administrative Reasons|2
5989790|NCT00988429|20711865|P1|Overall Study|Administrative Reasons|1
5989791|NCT00988429|20711863|P3|Overall Study|Withdrawal by Subject|12
5989792|NCT00988429|20711864|P2|Overall Study|Withdrawal by Subject|7
5989793|NCT00988429|20711865|P1|Overall Study|Withdrawal by Subject|7
5989794|NCT00988429|20711863|P3|Overall Study|Protocol Violation|3
5989795|NCT00988429|20711864|P2|Overall Study|Protocol Violation|3
5989796|NCT00988429|20711865|P1|Overall Study|Protocol Violation|4
5989797|NCT00988429|20711863|P3|Overall Study|Pregnancy|0
5989798|NCT00988429|20711864|P2|Overall Study|Pregnancy|1
5989799|NCT00988429|20711865|P1|Overall Study|Pregnancy|2
5989800|NCT00988429|20711863|P3|Overall Study|Physician Decision|3
5989801|NCT00988429|20711864|P2|Overall Study|Physician Decision|0
5989802|NCT00988429|20711865|P1|Overall Study|Physician Decision|1
5989803|NCT00988429|20711863|P3|Overall Study|Non-Compliance with Study Drug|3
5989804|NCT00988429|20711864|P2|Overall Study|Non-Compliance with Study Drug|1
5989805|NCT00988429|20711865|P1|Overall Study|Non-Compliance with Study Drug|5
5989806|NCT00988429|20711863|P3|Overall Study|Lack of Efficacy|1
5989807|NCT00988429|20711864|P2|Overall Study|Lack of Efficacy|0
5989808|NCT00988429|20711865|P1|Overall Study|Lack of Efficacy|0
5989809|NCT00988429|20711863|P3|Overall Study|Adverse Event|45
5989810|NCT00988429|20711864|P2|Overall Study|Adverse Event|21
5989811|NCT00988429|20711865|P1|Overall Study|Adverse Event|9
5989812|NCT00988351|20711878|P2|Overall Study|not using CPAP|3
5989813|NCT00988351|20711879|P1|Overall Study|not using CPAP|5
5989814|NCT00988351|20711878|P2|Overall Study|Lost to Follow-up|9
5989815|NCT00988351|20711879|P1|Overall Study|Lost to Follow-up|6
5989816|NCT00988351|20711878|P2|Overall Study|Withdrawal by Subject|0
5989817|NCT00988351|20711879|P1|Overall Study|Withdrawal by Subject|8
5989818|NCT00988247|20711956|P2|Overall Study|Other|0
5989819|NCT00988247|20711957|P1|Overall Study|Other|3
5989820|NCT00988247|20711956|P2|Overall Study|Sponsor requested withdrawal|1
5989821|NCT00988247|20711957|P1|Overall Study|Sponsor requested withdrawal|3
5989822|NCT00988247|20711956|P2|Overall Study|Protocol Violation|5
5989823|NCT00988247|20711957|P1|Overall Study|Protocol Violation|4
5989824|NCT00988247|20711956|P2|Overall Study|Lost to Follow-up|2
5989825|NCT00988247|20711957|P1|Overall Study|Lost to Follow-up|11
5989826|NCT00988247|20711956|P2|Overall Study|Pregnancy|2
5989827|NCT00988247|20711957|P1|Overall Study|Pregnancy|1
5989828|NCT00988247|20711956|P2|Overall Study|Withdrawal by Subject|13
5989829|NCT00988247|20711957|P1|Overall Study|Withdrawal by Subject|44
5989830|NCT00988247|20711956|P2|Overall Study|Adverse Event|3
5989831|NCT00988247|20711957|P1|Overall Study|Adverse Event|17
5989832|NCT00988221|20711976|P4|Part III|Refused Treatment|0
5989833|NCT00988221|20711977|P3|Part III|Refused Treatment|1
5989834|NCT00988221|20711978|P2|Part III|Refused Treatment|0
5989835|NCT00988221|20711979|P1|Part III|Refused Treatment|0
5989836|NCT00988221|20711976|P4|Part III|Insufficient Therapeutic Response|0
5989837|NCT00988221|20711977|P3|Part III|Insufficient Therapeutic Response|1
5989838|NCT00988221|20711978|P2|Part III|Insufficient Therapeutic Response|1
5989839|NCT00988221|20711979|P1|Part III|Insufficient Therapeutic Response|0
5989840|NCT00988221|20711976|P4|Part III|Adverse Event|0
5989841|NCT00988221|20711977|P3|Part III|Adverse Event|1
5989842|NCT00988221|20711978|P2|Part III|Adverse Event|0
5989843|NCT00988221|20711979|P1|Part III|Adverse Event|1
5989844|NCT00988221|20711976|P4|Part II|Reason not Specified|0
5989845|NCT00988221|20711977|P3|Part II|Reason not Specified|1
5989846|NCT00988221|20711978|P2|Part II|Reason not Specified|0
5989847|NCT00988221|20711979|P1|Part II|Reason not Specified|0
5989848|NCT00988221|20711976|P4|Part II|Withdrawal by Subject|2
5989849|NCT00988221|20711977|P3|Part II|Withdrawal by Subject|2
5989850|NCT00988221|20711978|P2|Part II|Withdrawal by Subject|0
5989851|NCT00988221|20711979|P1|Part II|Withdrawal by Subject|0
5989852|NCT00988221|20711976|P4|Part II|Adverse Event|1
5989853|NCT00988221|20711977|P3|Part II|Adverse Event|0
5989854|NCT00988221|20711978|P2|Part II|Adverse Event|0
5989855|NCT00988221|20711979|P1|Part II|Adverse Event|1
5989856|NCT00988221|20711976|P4|Part I|Lost to Follow-up|0
5989857|NCT00988221|20711977|P3|Part I|Lost to Follow-up|0
5989858|NCT00988221|20711978|P2|Part I|Lost to Follow-up|1
5989859|NCT00988221|20711979|P1|Part I|Lost to Follow-up|0
5989860|NCT00988221|20711976|P4|Part I|Refused Treatment|0
5989861|NCT00988221|20711977|P3|Part I|Refused Treatment|1
5989862|NCT00988221|20711978|P2|Part I|Refused Treatment|2
5989863|NCT00988221|20711979|P1|Part I|Refused Treatment|0
5989864|NCT00988221|20711976|P4|Part I|Insufficient Therapeutic Response|0
5989865|NCT00988221|20711977|P3|Part I|Insufficient Therapeutic Response|5
5989866|NCT00988221|20711978|P2|Part I|Insufficient Therapeutic Response|6
5989867|NCT00988221|20711979|P1|Part I|Insufficient Therapeutic Response|4
5989868|NCT00988221|20711976|P4|Part I|Adverse Event|0
5989869|NCT00988221|20711977|P3|Part I|Adverse Event|2
5989870|NCT00988221|20711978|P2|Part I|Adverse Event|1
5989871|NCT00988221|20711979|P1|Part I|Adverse Event|0
5989872|NCT00988208|20712152|P2|Overall Study|Other|3
5989873|NCT00988208|20712153|P1|Overall Study|Other|8
5989874|NCT00988208|20712152|P2|Overall Study|Subject Decision/Investigator Discretion|32
5989875|NCT00988208|20712153|P1|Overall Study|Subject Decision/Investigator Discretion|32
5989876|NCT00988208|20712152|P2|Overall Study|Clinical Deterioration|14
5989877|NCT00988208|20712153|P1|Overall Study|Clinical Deterioration|7
5989878|NCT00988208|20712152|P2|Overall Study|Biochemical Progression|7
5989879|NCT00988208|20712153|P1|Overall Study|Biochemical Progression|21
5989880|NCT00988208|20712152|P2|Overall Study|Clinical Progression|16
5989881|NCT00988208|20712153|P1|Overall Study|Clinical Progression|17
5989882|NCT00988208|20712152|P2|Overall Study|Sponsor Decision|78
5989883|NCT00988208|20712153|P1|Overall Study|Sponsor Decision|102
5989884|NCT00988208|20712152|P2|Overall Study|Protocol Violation|2
5989885|NCT00988208|20712153|P1|Overall Study|Protocol Violation|9
5989886|NCT00988208|20712152|P2|Overall Study|Lost to Follow-up|3
5989887|NCT00988208|20712153|P1|Overall Study|Lost to Follow-up|2
5989888|NCT00988208|20712152|P2|Overall Study|Death|15
5989889|NCT00988208|20712153|P1|Overall Study|Death|9
5989890|NCT00988208|20712152|P2|Overall Study|Withdrawal by Subject|57
5989891|NCT00988208|20712153|P1|Overall Study|Withdrawal by Subject|50
5989892|NCT00988208|20712152|P2|Overall Study|Disease Progression|89
5989893|NCT00988208|20712153|P1|Overall Study|Disease Progression|103
5989894|NCT00988208|20712152|P2|Overall Study|Adverse Event|122
5989895|NCT00988208|20712153|P1|Overall Study|Adverse Event|71
5989896|NCT00988169|20712171|P1|Overall Study|Withdrawal by Subject|1
5989897|NCT00988117|20712223|P1|9.5 mg/24 Hours From Week 4 to 12|Adverse Event|2
5989898|NCT00988117|20712223|P1|4.6 mg/24 Hours From Baseline to Week 4|Adverse Event|1
5989899|NCT00988091|20712232|P2|Open-label Period|Other|3
5989900|NCT00988091|20712233|P1|Open-label Period|Other|2
5989901|NCT00988091|20712232|P2|Open-label Period|Lost to Follow-up|5
5989902|NCT00988091|20712233|P1|Open-label Period|Lost to Follow-up|3
5989903|NCT00988091|20712232|P2|Open-label Period|Withdrawal by Subject|16
5989904|NCT00988091|20712233|P1|Open-label Period|Withdrawal by Subject|10
5989905|NCT00988091|20712232|P2|Open-label Period|Protocol Violation|1
5989906|NCT00988091|20712233|P1|Open-label Period|Protocol Violation|1
5989907|NCT00988091|20712232|P2|Open-label Period|Use of exclusionary medication|1
5989908|NCT00988091|20712233|P1|Open-label Period|Use of exclusionary medication|1
5989909|NCT00988091|20712232|P2|Open-label Period|Adverse Event|7
5989910|NCT00988091|20712233|P1|Open-label Period|Adverse Event|4
5989911|NCT00988091|20712232|P2|Double-blind Period|Use of exclusionary medication|3
5989912|NCT00988091|20712233|P1|Double-blind Period|Use of exclusionary medication|2
5989913|NCT00988091|20712232|P2|Double-blind Period|Adverse Event|9
5989914|NCT00988091|20712233|P1|Double-blind Period|Adverse Event|6
5989915|NCT00988091|20712232|P2|Double-blind Period|Other|8
5989916|NCT00988091|20712233|P1|Double-blind Period|Other|8
5989917|NCT00988091|20712232|P2|Double-blind Period|Lost to Follow-up|14
5989918|NCT00988091|20712233|P1|Double-blind Period|Lost to Follow-up|12
5989919|NCT00988091|20712232|P2|Double-blind Period|Withdrawal by Subject|13
5989920|NCT00988091|20712233|P1|Double-blind Period|Withdrawal by Subject|15
5989921|NCT00988065|20712255|P3|Overall Study|Noncompliance with protocol|9
5989922|NCT00988065|20712256|P2|Overall Study|Noncompliance with protocol|6
5989923|NCT00988065|20712257|P1|Overall Study|Noncompliance with protocol|5
5989924|NCT00988065|20712255|P3|Overall Study|Subject withdrew consent|2
5989925|NCT00988065|20712256|P2|Overall Study|Subject withdrew consent|5
5989926|NCT00988065|20712257|P1|Overall Study|Subject withdrew consent|3
5989927|NCT00988065|20712255|P3|Overall Study|Lost to Follow-up|2
5989928|NCT00988065|20712256|P2|Overall Study|Lost to Follow-up|2
5989929|NCT00988065|20712257|P1|Overall Study|Lost to Follow-up|1
5989930|NCT00988065|20712255|P3|Overall Study|Adverse Event|2
5989931|NCT00988065|20712256|P2|Overall Study|Adverse Event|10
5989932|NCT00988065|20712257|P1|Overall Study|Adverse Event|4
5989933|NCT00988052|20712279|P2|Overall Study|Study terminated by sponsor|236
5989934|NCT00988052|20712280|P1|Overall Study|Study terminated by sponsor|240
5989935|NCT00988052|20712279|P2|Overall Study|Withdrawal by Subject|91
5989936|NCT00988052|20712280|P1|Overall Study|Withdrawal by Subject|90
5989937|NCT00988052|20712279|P2|Overall Study|Adverse Event|28
5989938|NCT00988052|20712280|P1|Overall Study|Adverse Event|35
5989939|NCT00988052|20712279|P2|Overall Study|Physician Decision|28
5989940|NCT00988052|20712280|P1|Overall Study|Physician Decision|27
5989941|NCT00988052|20712279|P2|Overall Study|Lost to Follow-up|11
5989942|NCT00988052|20712280|P1|Overall Study|Lost to Follow-up|6
5989943|NCT00988052|20712279|P2|Overall Study|Lack of Efficacy|7
5989944|NCT00988052|20712280|P1|Overall Study|Lack of Efficacy|8
5989945|NCT00988052|20712279|P2|Overall Study|Pregnancy|6
5989946|NCT00988052|20712280|P1|Overall Study|Pregnancy|6
5989947|NCT00988052|20712279|P2|Overall Study|Protocol Violation|5
5989948|NCT00988052|20712280|P1|Overall Study|Protocol Violation|6
5989949|NCT00988052|20712279|P2|Overall Study|Death|3
5989950|NCT00988052|20712280|P1|Overall Study|Death|1
5989951|NCT00988052|20712279|P2|Overall Study|Teva requested subject withdrawal|1
5989952|NCT00988052|20712280|P1|Overall Study|Teva requested subject withdrawal|3
5989953|NCT00988052|20712279|P2|Overall Study|Missing|0
5989954|NCT00988052|20712280|P1|Overall Study|Missing|1
5989955|NCT00987935|20712324|P9|Overall Study|Reason other than those specified above|1
5989956|NCT00987935|20712325|P8|Overall Study|Reason other than those specified above|0
5989957|NCT00987935|20712326|P7|Overall Study|Reason other than those specified above|0
5989958|NCT00987935|20712327|P6|Overall Study|Reason other than those specified above|0
5989959|NCT00987935|20712328|P5|Overall Study|Reason other than those specified above|0
5989960|NCT00987935|20712329|P4|Overall Study|Reason other than those specified above|0
5989961|NCT00987935|20712330|P3|Overall Study|Reason other than those specified above|0
5989962|NCT00987935|20712331|P2|Overall Study|Reason other than those specified above|0
5989963|NCT00987935|20712332|P1|Overall Study|Reason other than those specified above|0
5989964|NCT00987935|20712324|P9|Overall Study|Refused to continue taking trial med.|2
5989965|NCT00987935|20712325|P8|Overall Study|Refused to continue taking trial med.|4
5989966|NCT00987935|20712326|P7|Overall Study|Refused to continue taking trial med.|4
5989967|NCT00987935|20712327|P6|Overall Study|Refused to continue taking trial med.|0
5989968|NCT00987935|20712328|P5|Overall Study|Refused to continue taking trial med.|1
5989969|NCT00987935|20712329|P4|Overall Study|Refused to continue taking trial med.|0
5989970|NCT00987935|20712330|P3|Overall Study|Refused to continue taking trial med.|0
5989971|NCT00987935|20712331|P2|Overall Study|Refused to continue taking trial med.|0
5989972|NCT00987935|20712332|P1|Overall Study|Refused to continue taking trial med.|1
5989973|NCT00987935|20712324|P9|Overall Study|Adverse Event|6
5989974|NCT00987935|20712325|P8|Overall Study|Adverse Event|10
5989975|NCT00987935|20712326|P7|Overall Study|Adverse Event|2
5989976|NCT00987935|20712327|P6|Overall Study|Adverse Event|0
5989977|NCT00987935|20712328|P5|Overall Study|Adverse Event|1
5989978|NCT00987935|20712329|P4|Overall Study|Adverse Event|1
5989979|NCT00987935|20712330|P3|Overall Study|Adverse Event|0
5989980|NCT00987935|20712331|P2|Overall Study|Adverse Event|1
5989981|NCT00987935|20712332|P1|Overall Study|Adverse Event|0
5989982|NCT00987935|20712324|P9|Overall Study|Progressive disease|23
5989983|NCT00987935|20712325|P8|Overall Study|Progressive disease|48
5989984|NCT00987935|20712326|P7|Overall Study|Progressive disease|9
5989985|NCT00987935|20712327|P6|Overall Study|Progressive disease|3
5989986|NCT00987935|20712328|P5|Overall Study|Progressive disease|5
5989987|NCT00987935|20712329|P4|Overall Study|Progressive disease|2
5989988|NCT00987935|20712330|P3|Overall Study|Progressive disease|3
5989989|NCT00987935|20712331|P2|Overall Study|Progressive disease|2
5989990|NCT00987935|20712332|P1|Overall Study|Progressive disease|3
5989991|NCT00987831|20712388|P3|Overall Study|Lost to Follow-up|0
5989992|NCT00987831|20712389|P2|Overall Study|Lost to Follow-up|3
5989993|NCT00987831|20712390|P1|Overall Study|Lost to Follow-up|0
5989994|NCT00987831|20712388|P3|Overall Study|Never flared in 12 months|0
5989995|NCT00987831|20712389|P2|Overall Study|Never flared in 12 months|0
5989996|NCT00987831|20712390|P1|Overall Study|Never flared in 12 months|1
5989997|NCT00987623|20712412|P2|Overall Study|Influenza|1
5989998|NCT00987623|20712413|P1|Overall Study|Influenza|0
5989999|NCT00987623|20712412|P2|Overall Study|Biomicroscopy|1
5990000|NCT00987623|20712413|P1|Overall Study|Biomicroscopy|0
5990001|NCT00987623|20712412|P2|Overall Study|Discomfort|0
5990002|NCT00987623|20712413|P1|Overall Study|Discomfort|1
5990003|NCT00987623|20712412|P2|Overall Study|Time/job conflict|0
5990004|NCT00987623|20712413|P1|Overall Study|Time/job conflict|2
5990005|NCT00987623|20712412|P2|Overall Study|Lost to Follow-up|1
5990006|NCT00987623|20712413|P1|Overall Study|Lost to Follow-up|2
5990007|NCT00987467|20712442|P1|Overall Study|Lost to Follow-up|2
5990008|NCT00987402|20712466|P2|Overall Study|Insufficient data entry|98
5990009|NCT00987402|20712467|P1|Overall Study|Insufficient data entry|86
5990010|NCT00987389|20712475|P4|Overall Study|Multiple different reasons|1
5990011|NCT00987389|20712476|P3|Overall Study|Multiple different reasons|3
5990012|NCT00987389|20712477|P2|Overall Study|Multiple different reasons|0
5990013|NCT00987389|20712478|P1|Overall Study|Multiple different reasons|1
5990014|NCT00987389|20712475|P4|Overall Study|Withdrawn from Treatment|0
5990015|NCT00987389|20712476|P3|Overall Study|Withdrawn from Treatment|0
5990016|NCT00987389|20712477|P2|Overall Study|Withdrawn from Treatment|1
5990017|NCT00987389|20712478|P1|Overall Study|Withdrawn from Treatment|0
5990018|NCT00987389|20712475|P4|Overall Study|Withdrawal by Subject|1
5990019|NCT00987389|20712476|P3|Overall Study|Withdrawal by Subject|2
5990020|NCT00987389|20712477|P2|Overall Study|Withdrawal by Subject|3
5990021|NCT00987389|20712478|P1|Overall Study|Withdrawal by Subject|4
5990022|NCT00987389|20712475|P4|Overall Study|Lost to Follow-up|1
5990023|NCT00987389|20712476|P3|Overall Study|Lost to Follow-up|3
5990024|NCT00987389|20712477|P2|Overall Study|Lost to Follow-up|1
5990025|NCT00987389|20712478|P1|Overall Study|Lost to Follow-up|4
5990026|NCT00987389|20712475|P4|Overall Study|Ineligible|0
5990027|NCT00987389|20712476|P3|Overall Study|Ineligible|0
5990028|NCT00987389|20712477|P2|Overall Study|Ineligible|3
5990029|NCT00987389|20712478|P1|Overall Study|Ineligible|0
5990030|NCT00987337|20712497|P3|Overall Study|Participant Relapsed|5
5990031|NCT00987337|20712498|P2|Overall Study|Participant Relapsed|20
5990032|NCT00987337|20712499|P1|Overall Study|Participant Relapsed|18
5990033|NCT00987337|20712497|P3|Overall Study|Protocol Violation|2
5990034|NCT00987337|20712498|P2|Overall Study|Protocol Violation|0
5990035|NCT00987337|20712499|P1|Overall Study|Protocol Violation|1
5990036|NCT00987337|20712497|P3|Overall Study|Other|5
5990037|NCT00987337|20712498|P2|Overall Study|Other|2
5990038|NCT00987337|20712499|P1|Overall Study|Other|0
5990039|NCT00987337|20712497|P3|Overall Study|Withdrawal by Subject|9
5990040|NCT00987337|20712498|P2|Overall Study|Withdrawal by Subject|9
5990041|NCT00987337|20712499|P1|Overall Study|Withdrawal by Subject|6
5990042|NCT00987337|20712497|P3|Overall Study|Lost to Follow-up|2
5990043|NCT00987337|20712498|P2|Overall Study|Lost to Follow-up|6
5990044|NCT00987337|20712499|P1|Overall Study|Lost to Follow-up|10
5990045|NCT00987337|20712497|P3|Overall Study|Virologic Breakthrough|8
5990046|NCT00987337|20712498|P2|Overall Study|Virologic Breakthrough|2
5990047|NCT00987337|20712499|P1|Overall Study|Virologic Breakthrough|2
5990048|NCT00987337|20712497|P3|Overall Study|Insufficient Virologic Response|12
5990049|NCT00987337|20712498|P2|Overall Study|Insufficient Virologic Response|7
5990050|NCT00987337|20712499|P1|Overall Study|Insufficient Virologic Response|10
5990051|NCT00987337|20712497|P3|Overall Study|Adverse Event|8
5990052|NCT00987337|20712498|P2|Overall Study|Adverse Event|9
5990053|NCT00987337|20712499|P1|Overall Study|Adverse Event|10
5990054|NCT00986986|20712554|P2|Overall Study|Lost to Follow-up|1
5990055|NCT00986986|20712555|P1|Overall Study|Lost to Follow-up|0
5990056|NCT00986973|20712565|P1|Overall Study|Withdrawn by study team|1
5990057|NCT00986921|20712582|P2|Overall Study|Physician Decision|0
5990058|NCT00986921|20712583|P1|Overall Study|Physician Decision|1
5990059|NCT00986830|20712616|P1|Overall Study|Unable to access sinus with device|5
5990060|NCT00986830|20712616|P1|Overall Study|Lack of Efficacy|1
5990061|NCT00986830|20712616|P1|Overall Study|Lost to Follow-up|1
5990062|NCT00986830|20712616|P1|Overall Study|Death|1
5990063|NCT00986674|20712631|P3|Overall Study|unknown/not specify|9
5990064|NCT00986674|20712632|P2|Overall Study|unknown/not specify|7
5990065|NCT00986674|20712633|P1|Overall Study|unknown/not specify|0
5990066|NCT00986674|20712631|P3|Overall Study|not start protocol therapy|1
5990067|NCT00986674|20712632|P2|Overall Study|not start protocol therapy|3
5990068|NCT00986674|20712633|P1|Overall Study|not start protocol therapy|4
5990069|NCT00986674|20712631|P3|Overall Study|alternative therapy|1
5990070|NCT00986674|20712632|P2|Overall Study|alternative therapy|0
5990071|NCT00986674|20712633|P1|Overall Study|alternative therapy|0
5990072|NCT00986674|20712631|P3|Overall Study|Withdrawal by Subject|1
5990073|NCT00986674|20712632|P2|Overall Study|Withdrawal by Subject|2
5990074|NCT00986674|20712633|P1|Overall Study|Withdrawal by Subject|6
5990075|NCT00986674|20712631|P3|Overall Study|Death|4
5990076|NCT00986674|20712632|P2|Overall Study|Death|0
5990077|NCT00986674|20712633|P1|Overall Study|Death|5
5990078|NCT00986674|20712631|P3|Overall Study|Adverse Event|9
5990079|NCT00986674|20712632|P2|Overall Study|Adverse Event|8
5990080|NCT00986674|20712633|P1|Overall Study|Adverse Event|4
5990081|NCT00986674|20712631|P3|Overall Study|Lack of Efficacy|23
5990082|NCT00986674|20712632|P2|Overall Study|Lack of Efficacy|25
5990083|NCT00986674|20712633|P1|Overall Study|Lack of Efficacy|28
5990084|NCT00986570|20712666|P1|Overall Study|Potential bias for objective assessment|1
5990085|NCT00986570|20712666|P1|Overall Study|Lost to Follow-up|6
5990086|NCT00986479|20712683|P2|Period 1|Administrative reasons|0
5990087|NCT00986479|20712684|P1|Period 1|Administrative reasons|1
5990088|NCT00986479|20712683|P2|Period 1|Improved mood|0
5990089|NCT00986479|20712684|P1|Period 1|Improved mood|1
5990090|NCT00986440|20712730|P2|Overall Study|Screen failure (not dosed)|2
5990091|NCT00986440|20712731|P1|Overall Study|Screen failure (not dosed)|4
5990092|NCT00986440|20712730|P2|Overall Study|Withdrawal by Subject|2
5990093|NCT00986440|20712731|P1|Overall Study|Withdrawal by Subject|1
5990094|NCT00986440|20712730|P2|Overall Study|Serious adverse event or adverse event|2
5990095|NCT00986440|20712731|P1|Overall Study|Serious adverse event or adverse event|9
5990096|NCT00986440|20712730|P2|Overall Study|Progressive disease|37
5990097|NCT00986440|20712731|P1|Overall Study|Progressive disease|27
5990098|NCT00986427|20712749|P2|Overall Study|Withdrawal by Subject|0
5990099|NCT00986427|20712750|P1|Overall Study|Withdrawal by Subject|1
5990100|NCT00986427|20712749|P2|Overall Study|Lack of Efficacy|0
5990101|NCT00986427|20712750|P1|Overall Study|Lack of Efficacy|1
5990102|NCT00986427|20712749|P2|Overall Study|Lost to Follow-up|0
5990103|NCT00986427|20712750|P1|Overall Study|Lost to Follow-up|2
5990104|NCT00986362|20712778|P2|Overall Study|Lost to Follow-up|1
5990105|NCT00986362|20712779|P1|Overall Study|Lost to Follow-up|0
5990106|NCT00986362|20712778|P2|Overall Study|Death|0
5990107|NCT00986362|20712779|P1|Overall Study|Death|2
5990108|NCT00986349|20712785|P1|Overall Study|device migration|1
5990109|NCT00986349|20712785|P1|Overall Study|Physician Decision|1
5990110|NCT00986349|20712785|P1|Overall Study|Adverse Event|2
5990111|NCT00986349|20712785|P1|Overall Study|Unsuccessful implant procedure|3
5990112|NCT00986258|20712809|P1|Maintenance Period|Withdrawal by Subject|2
5990113|NCT00986258|20712809|P1|Maintenance Period|Lack of Efficacy|2
5990114|NCT00986258|20712809|P1|Maintenance Period|Adverse Event|5
5990115|NCT00986258|20712809|P1|Titration and Optimal Dose Period|Other|1
5990116|NCT00986258|20712809|P1|Titration and Optimal Dose Period|Non-Compliance|1
5990117|NCT00986258|20712809|P1|Titration and Optimal Dose Period|Withdrawal by Subject|3
5990118|NCT00986258|20712809|P1|Titration and Optimal Dose Period|Lack of Efficacy|3
5990119|NCT00986258|20712809|P1|Titration and Optimal Dose Period|Adverse Event|15
5990120|NCT00986258|20712809|P1|Observation Period|Not eligible to be dosed|11
5990121|NCT00986245|20712837|P2|Second Intervention|Protocol Violation|1
5990122|NCT00986245|20712838|P1|Second Intervention|Protocol Violation|0
5990123|NCT00986245|20712837|P2|Second Intervention|Lost to Follow-up|0
5990124|NCT00986245|20712838|P1|Second Intervention|Lost to Follow-up|1
5990125|NCT00986245|20712837|P2|Second Intervention|Poor compliance|0
5990126|NCT00986245|20712838|P1|Second Intervention|Poor compliance|1
5990127|NCT00986245|20712837|P2|First Intervention|Out of indication|0
5990128|NCT00986245|20712838|P1|First Intervention|Out of indication|1
5990129|NCT00986245|20712837|P2|First Intervention|Protocol Violation|1
5990130|NCT00986245|20712838|P1|First Intervention|Protocol Violation|0
5990131|NCT00986245|20712837|P2|First Intervention|Withdrawal by Subject|1
5990132|NCT00986245|20712838|P1|First Intervention|Withdrawal by Subject|0
5990133|NCT00986245|20712837|P2|First Intervention|Lack of Efficacy|2
5990134|NCT00986245|20712838|P1|First Intervention|Lack of Efficacy|1
5990135|NCT00986245|20712837|P2|First Intervention|Poor compliance|4
5990136|NCT00986245|20712838|P1|First Intervention|Poor compliance|8
5990137|NCT00986232|20712875|P4|Overall Study|Incomplete safety follow-up|2
5990138|NCT00986232|20712876|P3|Overall Study|Incomplete safety follow-up|2
5990139|NCT00986232|20712877|P2|Overall Study|Incomplete safety follow-up|7
5990140|NCT00986232|20712878|P1|Overall Study|Incomplete safety follow-up|3
5990141|NCT00986232|20712875|P4|Overall Study|Missed one or more bleeds|7
5990142|NCT00986232|20712876|P3|Overall Study|Missed one or more bleeds|6
5990143|NCT00986232|20712877|P2|Overall Study|Missed one or more bleeds|10
5990144|NCT00986232|20712878|P1|Overall Study|Missed one or more bleeds|13
5990145|NCT00986232|20712875|P4|Overall Study|Withdrawal by Subject|3
5990146|NCT00986232|20712876|P3|Overall Study|Withdrawal by Subject|12
5990147|NCT00986232|20712877|P2|Overall Study|Withdrawal by Subject|16
5990148|NCT00986232|20712878|P1|Overall Study|Withdrawal by Subject|13
5990149|NCT00986232|20712875|P4|Overall Study|Protocol Violation|1
5990150|NCT00986232|20712876|P3|Overall Study|Protocol Violation|0
5990151|NCT00986232|20712877|P2|Overall Study|Protocol Violation|3
5990152|NCT00986232|20712878|P1|Overall Study|Protocol Violation|2
5990153|NCT00986232|20712875|P4|Overall Study|Lost to Follow-up|7
5990154|NCT00986232|20712876|P3|Overall Study|Lost to Follow-up|12
5990155|NCT00986232|20712877|P2|Overall Study|Lost to Follow-up|12
5990156|NCT00986232|20712878|P1|Overall Study|Lost to Follow-up|19
5990157|NCT00986232|20712875|P4|Overall Study|Adverse Event|0
5990158|NCT00986232|20712876|P3|Overall Study|Adverse Event|3
5990159|NCT00986232|20712877|P2|Overall Study|Adverse Event|2
5990160|NCT00986232|20712878|P1|Overall Study|Adverse Event|1
5990161|NCT00986180|20712952|P2|Overall Study|Miscellanies|11
5990162|NCT00986180|20712953|P1|Overall Study|Miscellanies|10
5990163|NCT00986180|20712952|P2|Overall Study|Withdrawal by Subject|9
5990164|NCT00986180|20712953|P1|Overall Study|Withdrawal by Subject|1
5990165|NCT00986180|20712952|P2|Overall Study|Protocol Violation|0
5990166|NCT00986180|20712953|P1|Overall Study|Protocol Violation|2
5990167|NCT00986180|20712952|P2|Overall Study|Physician Decision|3
5990168|NCT00986180|20712953|P1|Overall Study|Physician Decision|1
5990169|NCT00986180|20712952|P2|Overall Study|Lost to Follow-up|7
5990170|NCT00986180|20712953|P1|Overall Study|Lost to Follow-up|5
5990171|NCT00986180|20712952|P2|Overall Study|Lack of Efficacy|3
5990172|NCT00986180|20712953|P1|Overall Study|Lack of Efficacy|4
5990173|NCT00986180|20712952|P2|Overall Study|Adverse Event|23
5990174|NCT00986180|20712953|P1|Overall Study|Adverse Event|21
5990175|NCT00986154|20713031|P2|Overall Study|never received study drug|27
5990176|NCT00986154|20713032|P1|Overall Study|never received study drug|25
5990177|NCT00986154|20713031|P2|Overall Study|investigator/subject decide not continue|3
5990178|NCT00986154|20713032|P1|Overall Study|investigator/subject decide not continue|6
5990179|NCT00986154|20713031|P2|Overall Study|Withdrawal by Subject|33
5990180|NCT00986154|20713032|P1|Overall Study|Withdrawal by Subject|32
5990181|NCT00986154|20713031|P2|Overall Study|Lost to Follow-up|4
5990182|NCT00986154|20713032|P1|Overall Study|Lost to Follow-up|7
5990183|NCT00986154|20713031|P2|Overall Study|Death|127
5990184|NCT00986154|20713032|P1|Overall Study|Death|136
5990185|NCT00986102|20713046|P4|Overall Study|Withdrawal by Subject|0
5990186|NCT00986102|20713047|P3|Overall Study|Withdrawal by Subject|0
5990187|NCT00986102|20713048|P2|Overall Study|Withdrawal by Subject|1
5990188|NCT00986102|20713049|P1|Overall Study|Withdrawal by Subject|1
5990189|NCT00986102|20713046|P4|Overall Study|Lost to Follow-up|1
5990190|NCT00986102|20713047|P3|Overall Study|Lost to Follow-up|0
5990191|NCT00986102|20713048|P2|Overall Study|Lost to Follow-up|1
5990192|NCT00986102|20713049|P1|Overall Study|Lost to Follow-up|0
5990193|NCT00985985|20713099|P4|Overall Study|Other Reason|2
5990194|NCT00985985|20713100|P3|Overall Study|Other Reason|4
5990195|NCT00985985|20713101|P2|Overall Study|Other Reason|1
5990196|NCT00985985|20713102|P1|Overall Study|Other Reason|6
5990197|NCT00985985|20713099|P4|Overall Study|Withdrawal by Subject|2
5990198|NCT00985985|20713100|P3|Overall Study|Withdrawal by Subject|2
5990199|NCT00985985|20713101|P2|Overall Study|Withdrawal by Subject|2
5990200|NCT00985985|20713102|P1|Overall Study|Withdrawal by Subject|4
5990201|NCT00985985|20713099|P4|Overall Study|Lack of Efficacy|3
5990202|NCT00985985|20713100|P3|Overall Study|Lack of Efficacy|1
5990203|NCT00985985|20713101|P2|Overall Study|Lack of Efficacy|6
5990204|NCT00985985|20713102|P1|Overall Study|Lack of Efficacy|5
5990205|NCT00985985|20713099|P4|Overall Study|Protocol Violation|1
5990206|NCT00985985|20713100|P3|Overall Study|Protocol Violation|0
5990207|NCT00985985|20713101|P2|Overall Study|Protocol Violation|2
5990208|NCT00985985|20713102|P1|Overall Study|Protocol Violation|1
5990209|NCT00985985|20713099|P4|Overall Study|Lost to Follow-up|3
5990210|NCT00985985|20713100|P3|Overall Study|Lost to Follow-up|2
5990211|NCT00985985|20713101|P2|Overall Study|Lost to Follow-up|11
5990212|NCT00985985|20713102|P1|Overall Study|Lost to Follow-up|4
5990213|NCT00985985|20713099|P4|Overall Study|Adverse Event|2
5990214|NCT00985985|20713100|P3|Overall Study|Adverse Event|2
5990215|NCT00985985|20713101|P2|Overall Study|Adverse Event|2
5990216|NCT00985985|20713102|P1|Overall Study|Adverse Event|4
5990217|NCT00985959|20713143|P3|Overall Study|Other|11
5990218|NCT00985959|20713144|P2|Overall Study|Other|0
5990219|NCT00985959|20713145|P1|Overall Study|Other|0
5990220|NCT00985959|20713143|P3|Overall Study|Complete response observed over 2 cycles|4
5990221|NCT00985959|20713144|P2|Overall Study|Complete response observed over 2 cycles|1
5990222|NCT00985959|20713145|P1|Overall Study|Complete response observed over 2 cycles|0
5990223|NCT00985959|20713143|P3|Overall Study|Pneumonitis or pulmonary fibrosis|2
5990224|NCT00985959|20713144|P2|Overall Study|Pneumonitis or pulmonary fibrosis|0
5990225|NCT00985959|20713145|P1|Overall Study|Pneumonitis or pulmonary fibrosis|2
5990226|NCT00985959|20713143|P3|Overall Study|Unrecovered toxicity|7
5990227|NCT00985959|20713144|P2|Overall Study|Unrecovered toxicity|0
5990228|NCT00985959|20713145|P1|Overall Study|Unrecovered toxicity|0
5990229|NCT00985959|20713143|P3|Overall Study|Progressive disease|8
5990230|NCT00985959|20713144|P2|Overall Study|Progressive disease|2
5990231|NCT00985959|20713145|P1|Overall Study|Progressive disease|1
5990232|NCT00985959|20713143|P3|Overall Study|Withdrawal by Subject|8
5990233|NCT00985959|20713144|P2|Overall Study|Withdrawal by Subject|0
5990234|NCT00985959|20713145|P1|Overall Study|Withdrawal by Subject|0
5990235|NCT00985959|20713143|P3|Overall Study|Adverse Event|19
5990236|NCT00985959|20713144|P2|Overall Study|Adverse Event|0
5990237|NCT00985959|20713145|P1|Overall Study|Adverse Event|0
5990238|NCT00985946|20713168|P1|Overall Study|Withdrawal by Subject|1
5990239|NCT00985946|20713168|P1|Overall Study|Lost to Follow-up|6
5990240|NCT00985790|20713197|P2|Overall Study|Lost to Follow-up|7
5990241|NCT00985790|20713198|P1|Overall Study|Lost to Follow-up|6
5990242|NCT00985790|20713197|P2|Overall Study|Withdrawal by Subject|1
5990243|NCT00985790|20713198|P1|Overall Study|Withdrawal by Subject|1
5990244|NCT00985751|20713239|P5|Overall Study|Adverse Event|1
5990245|NCT00985751|20713240|P4|Overall Study|Adverse Event|0
5990246|NCT00985751|20713241|P3|Overall Study|Adverse Event|0
5990247|NCT00985751|20713242|P2|Overall Study|Adverse Event|0
5990248|NCT00985751|20713243|P1|Overall Study|Adverse Event|0
5990249|NCT00985738|20713306|P2|Overall Study|Study closed prematurely|8
5990250|NCT00985738|20713307|P1|Overall Study|Study closed prematurely|8
5990251|NCT00985725|20713315|P2|Overall Study|Out-of-window visits|1
5990252|NCT00985725|20713316|P1|Overall Study|Out-of-window visits|0
5990253|NCT00985725|20713315|P2|Overall Study|Non-compliance|2
5990254|NCT00985725|20713316|P1|Overall Study|Non-compliance|1
5990255|NCT00985725|20713315|P2|Overall Study|Lack of Efficacy|1
5990256|NCT00985725|20713316|P1|Overall Study|Lack of Efficacy|0
5990257|NCT00985725|20713315|P2|Overall Study|Lost to Follow-up|1
5990258|NCT00985725|20713316|P1|Overall Study|Lost to Follow-up|1
5990259|NCT00985725|20713315|P2|Overall Study|Withdrawal by Subject|4
5990260|NCT00985725|20713316|P1|Overall Study|Withdrawal by Subject|4
5990261|NCT00985725|20713315|P2|Overall Study|Protocol Violation|3
5990262|NCT00985725|20713316|P1|Overall Study|Protocol Violation|1
5990263|NCT00985725|20713315|P2|Overall Study|Adverse Event|1
5990264|NCT00985725|20713316|P1|Overall Study|Adverse Event|4
5990265|NCT00985712|20713352|P2|Overall Study|Sponsor decision|2
5990266|NCT00985712|20713353|P1|Overall Study|Sponsor decision|0
5990267|NCT00985712|20713352|P2|Overall Study|Withdrawal by Subject|1
5990268|NCT00985712|20713353|P1|Overall Study|Withdrawal by Subject|4
5990269|NCT00985712|20713352|P2|Overall Study|Protocol Violation|1
5990270|NCT00985712|20713353|P1|Overall Study|Protocol Violation|0
5990271|NCT00985712|20713352|P2|Overall Study|Lost to Follow-up|2
5990272|NCT00985712|20713353|P1|Overall Study|Lost to Follow-up|2
5990273|NCT00985712|20713352|P2|Overall Study|Adverse Event|1
5990274|NCT00985712|20713353|P1|Overall Study|Adverse Event|0
5990275|NCT00985686|20713371|P4|Overall Study|Lost to Follow-up|2
5990276|NCT00985686|20713372|P3|Overall Study|Lost to Follow-up|0
5990277|NCT00985686|20713373|P2|Overall Study|Lost to Follow-up|1
5990278|NCT00985686|20713374|P1|Overall Study|Lost to Follow-up|1
5990279|NCT00985673|20713388|P6|Overall Study|Other|0
5990280|NCT00985673|20713389|P5|Overall Study|Other|1
5990281|NCT00985673|20713390|P4|Overall Study|Other|0
5990282|NCT00985673|20713391|P3|Overall Study|Other|1
5990283|NCT00985673|20713392|P2|Overall Study|Other|0
5990284|NCT00985673|20713393|P1|Overall Study|Other|1
5990285|NCT00985673|20713388|P6|Overall Study|Withdrawal by Subject|3
5990286|NCT00985673|20713389|P5|Overall Study|Withdrawal by Subject|2
5990287|NCT00985673|20713390|P4|Overall Study|Withdrawal by Subject|2
5990288|NCT00985673|20713391|P3|Overall Study|Withdrawal by Subject|5
5990289|NCT00985673|20713392|P2|Overall Study|Withdrawal by Subject|4
5990290|NCT00985673|20713393|P1|Overall Study|Withdrawal by Subject|0
5990291|NCT00985673|20713388|P6|Overall Study|Lost to Follow-up|3
5990292|NCT00985673|20713389|P5|Overall Study|Lost to Follow-up|5
5990293|NCT00985673|20713390|P4|Overall Study|Lost to Follow-up|10
5990294|NCT00985673|20713391|P3|Overall Study|Lost to Follow-up|6
5990295|NCT00985673|20713392|P2|Overall Study|Lost to Follow-up|7
5990296|NCT00985673|20713393|P1|Overall Study|Lost to Follow-up|6
5990297|NCT00985504|20713676|P2|Optimization Period|Withdrawal by Subject|8
5990298|NCT00985504|20713677|P1|Optimization Period|Withdrawal by Subject|10
5990299|NCT00985504|20713676|P2|Optimization Period|Protocol Violation|1
5990300|NCT00985504|20713677|P1|Optimization Period|Protocol Violation|3
5990301|NCT00985504|20713676|P2|Optimization Period|Physician Decision|0
5990302|NCT00985504|20713677|P1|Optimization Period|Physician Decision|1
5990303|NCT00985504|20713676|P2|Optimization Period|Lost to Follow-up|1
5990304|NCT00985504|20713677|P1|Optimization Period|Lost to Follow-up|0
5990305|NCT00985504|20713676|P2|Optimization Period|Lack of Efficacy|3
5990306|NCT00985504|20713677|P1|Optimization Period|Lack of Efficacy|5
5990307|NCT00985504|20713676|P2|Optimization Period|Death|1
5990308|NCT00985504|20713677|P1|Optimization Period|Death|0
5990309|NCT00985504|20713676|P2|Optimization Period|Adverse Event|9
5990310|NCT00985504|20713677|P1|Optimization Period|Adverse Event|7
5990311|NCT00985504|20713676|P2|Acute Treatment Period|Withdrawal by Subject|5
5990312|NCT00985504|20713677|P1|Acute Treatment Period|Withdrawal by Subject|9
5990313|NCT00985504|20713676|P2|Acute Treatment Period|Sponsor Decision|1
5990314|NCT00985504|20713677|P1|Acute Treatment Period|Sponsor Decision|0
5990315|NCT00985504|20713676|P2|Acute Treatment Period|Protocol Violation|0
5990316|NCT00985504|20713677|P1|Acute Treatment Period|Protocol Violation|2
5990317|NCT00985504|20713676|P2|Acute Treatment Period|Entry Criteria Not Met|2
5990318|NCT00985504|20713677|P1|Acute Treatment Period|Entry Criteria Not Met|1
5990319|NCT00985504|20713676|P2|Acute Treatment Period|Adverse Event|4
5990320|NCT00985504|20713677|P1|Acute Treatment Period|Adverse Event|3
5990321|NCT00985491|20713703|P1|Overall Study|implant failure|3
5990322|NCT00985491|20713703|P1|Overall Study|Withdrawal by Subject|1
5990323|NCT00985491|20713703|P1|Overall Study|device migration|7
5990324|NCT00985491|20713703|P1|Overall Study|Adverse Event|8
5990325|NCT00985465|20713710|P2|Overall Study|Considered to be part of the other group|1
5990326|NCT00985465|20713711|P1|Overall Study|Considered to be part of the other group|0
5990327|NCT00985465|20713710|P2|Overall Study|Withdrawal by Subject|2
5990328|NCT00985465|20713711|P1|Overall Study|Withdrawal by Subject|1
5990329|NCT00985439|20713738|P4|Overall Study|Adverse Event|0
5990330|NCT00985439|20713739|P3|Overall Study|Adverse Event|1
5990331|NCT00985439|20713740|P2|Overall Study|Adverse Event|0
5990332|NCT00985439|20713741|P1|Overall Study|Adverse Event|0
5990333|NCT00985426|20713753|P2|Overall Study|Lack of seroprotection at protocol-specified timepoints|11
5990334|NCT00985426|20713754|P1|Overall Study|Lack of seroprotection at protocol-specified timepoints|11
5990335|NCT00985426|20713753|P2|Overall Study|Protocol Violation|0
5990336|NCT00985426|20713754|P1|Overall Study|Protocol Violation|2
5990337|NCT00985426|20713753|P2|Overall Study|Death|3
5990338|NCT00985426|20713754|P1|Overall Study|Death|7
5990339|NCT00985426|20713753|P2|Overall Study|Lost to Follow-up|10
5990340|NCT00985426|20713754|P1|Overall Study|Lost to Follow-up|8
5990341|NCT00985426|20713753|P2|Overall Study|Withdrawal by Subject|16
5990342|NCT00985426|20713754|P1|Overall Study|Withdrawal by Subject|12
5990343|NCT00985426|20713753|P2|Overall Study|Subject Non-Compliance|3
5990344|NCT00985426|20713754|P1|Overall Study|Subject Non-Compliance|3
5990345|NCT00985426|20713753|P2|Overall Study|Adverse Event|1
5990346|NCT00985426|20713754|P1|Overall Study|Adverse Event|0
5990347|NCT00985231|20713776|P2|Overall Study|Study related symptoms & complaints|2
5990348|NCT00985231|20713777|P1|Overall Study|Study related symptoms & complaints|0
5990349|NCT00985231|20713776|P2|Overall Study|Lost to Follow-up|1
5990350|NCT00985231|20713777|P1|Overall Study|Lost to Follow-up|0
5990351|NCT00985231|20713776|P2|Overall Study|Withdrawal by Subject|0
5990352|NCT00985231|20713777|P1|Overall Study|Withdrawal by Subject|1
5990353|NCT00985231|20713776|P2|Overall Study|Protocol Violation|0
5990354|NCT00985231|20713777|P1|Overall Study|Protocol Violation|1
5990355|NCT00985231|20713776|P2|Overall Study|ineligible|0
5990356|NCT00985231|20713777|P1|Overall Study|ineligible|1
5990357|NCT00985192|20713785|P1|Overall Study|Determined to be Ineligible During Trial|2
5990358|NCT00985192|20713785|P1|Overall Study|Disease Progression|1
5990359|NCT00985192|20713785|P1|Overall Study|Withdrawal by Subject|1
5990360|NCT00985166|20713797|P3|Overall Study|Other|1
5990361|NCT00985166|20713798|P2|Overall Study|Other|0
5990362|NCT00985166|20713799|P1|Overall Study|Other|1
5990363|NCT00985166|20713797|P3|Overall Study|Test not done|4
5990364|NCT00985166|20713798|P2|Overall Study|Test not done|0
5990365|NCT00985166|20713799|P1|Overall Study|Test not done|2
5990366|NCT00985166|20713797|P3|Overall Study|Withdrawal by Subject|0
5990367|NCT00985166|20713798|P2|Overall Study|Withdrawal by Subject|2
5990368|NCT00985166|20713799|P1|Overall Study|Withdrawal by Subject|3
5990369|NCT00985166|20713797|P3|Overall Study|Lost to Follow-up|2
5990370|NCT00985166|20713798|P2|Overall Study|Lost to Follow-up|2
5990371|NCT00985166|20713799|P1|Overall Study|Lost to Follow-up|3
5990372|NCT00985153|20713819|P4|Overall Study|Incomplete Safety Follow-up|4
5990373|NCT00985153|20713820|P3|Overall Study|Incomplete Safety Follow-up|4
5990374|NCT00985153|20713821|P2|Overall Study|Incomplete Safety Follow-up|5
5990375|NCT00985153|20713822|P1|Overall Study|Incomplete Safety Follow-up|3
5990376|NCT00985153|20713819|P4|Overall Study|Missed One or More Bleeds|10
5990377|NCT00985153|20713820|P3|Overall Study|Missed One or More Bleeds|8
5990378|NCT00985153|20713821|P2|Overall Study|Missed One or More Bleeds|7
5990379|NCT00985153|20713822|P1|Overall Study|Missed One or More Bleeds|7
5990380|NCT00985153|20713819|P4|Overall Study|Withdrawal by Subject|10
5990381|NCT00985153|20713820|P3|Overall Study|Withdrawal by Subject|11
5990382|NCT00985153|20713821|P2|Overall Study|Withdrawal by Subject|11
5990383|NCT00985153|20713822|P1|Overall Study|Withdrawal by Subject|6
5990384|NCT00985153|20713819|P4|Overall Study|Protocol Violation|3
5990385|NCT00985153|20713820|P3|Overall Study|Protocol Violation|4
5990386|NCT00985153|20713821|P2|Overall Study|Protocol Violation|2
5990387|NCT00985153|20713822|P1|Overall Study|Protocol Violation|3
5990388|NCT00985153|20713819|P4|Overall Study|Lost to Follow-up|20
5990389|NCT00985153|20713820|P3|Overall Study|Lost to Follow-up|17
5990390|NCT00985153|20713821|P2|Overall Study|Lost to Follow-up|19
5990391|NCT00985153|20713822|P1|Overall Study|Lost to Follow-up|16
5990392|NCT00985114|20713870|P2|Overall Study|Withdrawal by Subject|2
5990393|NCT00985114|20713871|P1|Overall Study|Withdrawal by Subject|0
5990394|NCT00985114|20713870|P2|Overall Study|Adverse Event|0
5990395|NCT00985114|20713871|P1|Overall Study|Adverse Event|1
5990396|NCT00985088|20713885|P8|Overall Study|Lost to Follow-up|2
5990397|NCT00985088|20713886|P7|Overall Study|Lost to Follow-up|3
5990398|NCT00985088|20713887|P6|Overall Study|Lost to Follow-up|5
5990399|NCT00985088|20713888|P5|Overall Study|Lost to Follow-up|6
5990400|NCT00985088|20713889|P4|Overall Study|Lost to Follow-up|6
5990401|NCT00985088|20713890|P3|Overall Study|Lost to Follow-up|2
5990402|NCT00985088|20713891|P2|Overall Study|Lost to Follow-up|1
5990403|NCT00985088|20713892|P1|Overall Study|Lost to Follow-up|6
5990404|NCT00985088|20713885|P8|Overall Study|Migrated/moved from study area|1
5990405|NCT00985088|20713886|P7|Overall Study|Migrated/moved from study area|0
5990406|NCT00985088|20713887|P6|Overall Study|Migrated/moved from study area|0
5990407|NCT00985088|20713888|P5|Overall Study|Migrated/moved from study area|0
5990408|NCT00985088|20713889|P4|Overall Study|Migrated/moved from study area|0
5990409|NCT00985088|20713890|P3|Overall Study|Migrated/moved from study area|1
5990410|NCT00985088|20713891|P2|Overall Study|Migrated/moved from study area|0
5990411|NCT00985088|20713892|P1|Overall Study|Migrated/moved from study area|0
5990412|NCT00985088|20713885|P8|Overall Study|Withdrawal by Subject|2
5990413|NCT00985088|20713886|P7|Overall Study|Withdrawal by Subject|1
5990414|NCT00985088|20713887|P6|Overall Study|Withdrawal by Subject|2
5990415|NCT00985088|20713888|P5|Overall Study|Withdrawal by Subject|3
5990416|NCT00985088|20713889|P4|Overall Study|Withdrawal by Subject|1
5990417|NCT00985088|20713890|P3|Overall Study|Withdrawal by Subject|0
5990418|NCT00985088|20713891|P2|Overall Study|Withdrawal by Subject|0
5990419|NCT00985088|20713892|P1|Overall Study|Withdrawal by Subject|4
5990420|NCT00985088|20713885|P8|Overall Study|Adverse Event|0
5990421|NCT00985088|20713886|P7|Overall Study|Adverse Event|0
5990422|NCT00985088|20713887|P6|Overall Study|Adverse Event|0
5990423|NCT00985088|20713888|P5|Overall Study|Adverse Event|0
5990424|NCT00985088|20713889|P4|Overall Study|Adverse Event|0
5990425|NCT00985088|20713890|P3|Overall Study|Adverse Event|1
5990426|NCT00985088|20713891|P2|Overall Study|Adverse Event|0
5990427|NCT00985088|20713892|P1|Overall Study|Adverse Event|0
5990428|NCT00985088|20713885|P8|Overall Study|Serious Adverse Event|1
5990429|NCT00985088|20713886|P7|Overall Study|Serious Adverse Event|0
5990430|NCT00985088|20713887|P6|Overall Study|Serious Adverse Event|0
5990431|NCT00985088|20713888|P5|Overall Study|Serious Adverse Event|0
5990432|NCT00985088|20713889|P4|Overall Study|Serious Adverse Event|0
5990433|NCT00985088|20713890|P3|Overall Study|Serious Adverse Event|0
5990434|NCT00985088|20713891|P2|Overall Study|Serious Adverse Event|1
5990435|NCT00985088|20713892|P1|Overall Study|Serious Adverse Event|1
5990436|NCT00984867|20714161|P2|Overall Study|lack of efficacy and subject compliance|0
5990437|NCT00984867|20714162|P1|Overall Study|lack of efficacy and subject compliance|1
5990438|NCT00984867|20714161|P2|Overall Study|site closing|0
5990439|NCT00984867|20714162|P1|Overall Study|site closing|1
5990440|NCT00984867|20714161|P2|Overall Study|Subject no longer meets study criteria|1
5990441|NCT00984867|20714162|P1|Overall Study|Subject no longer meets study criteria|1
5990442|NCT00984867|20714161|P2|Overall Study|Poor/non-compliance|1
5990443|NCT00984867|20714162|P1|Overall Study|Poor/non-compliance|0
5990444|NCT00984867|20714161|P2|Overall Study|Lost to Follow-up|4
5990445|NCT00984867|20714162|P1|Overall Study|Lost to Follow-up|3
5990446|NCT00984867|20714161|P2|Overall Study|Withdrawal by Subject|4
5990447|NCT00984867|20714162|P1|Overall Study|Withdrawal by Subject|13
5990448|NCT00984867|20714161|P2|Overall Study|Death|0
5990449|NCT00984867|20714162|P1|Overall Study|Death|1
5990450|NCT00984867|20714161|P2|Overall Study|Adverse Event|7
5990451|NCT00984867|20714162|P1|Overall Study|Adverse Event|3
5990452|NCT00984659|20714202|P4|6-week Double-blind Treatment Period|Withdrawal by Subject|1
5990453|NCT00984659|20714203|P3|6-week Double-blind Treatment Period|Withdrawal by Subject|7
5990454|NCT00984659|20714204|P2|6-week Double-blind Treatment Period|Withdrawal by Subject|1
5990455|NCT00984659|20714205|P1|6-week Double-blind Treatment Period|Withdrawal by Subject|0
5990456|NCT00984659|20714202|P4|6-week Double-blind Treatment Period|Study Closed/Terminated|0
5990457|NCT00984659|20714203|P3|6-week Double-blind Treatment Period|Study Closed/Terminated|1
5990458|NCT00984659|20714204|P2|6-week Double-blind Treatment Period|Study Closed/Terminated|0
5990459|NCT00984659|20714205|P1|6-week Double-blind Treatment Period|Study Closed/Terminated|0
5990460|NCT00984659|20714202|P4|6-week Double-blind Treatment Period|Protocol Violation|4
5990461|NCT00984659|20714203|P3|6-week Double-blind Treatment Period|Protocol Violation|0
5990462|NCT00984659|20714204|P2|6-week Double-blind Treatment Period|Protocol Violation|0
5990463|NCT00984659|20714205|P1|6-week Double-blind Treatment Period|Protocol Violation|0
5990464|NCT00984659|20714202|P4|6-week Double-blind Treatment Period|Lack of Efficacy|1
5990465|NCT00984659|20714203|P3|6-week Double-blind Treatment Period|Lack of Efficacy|0
5990466|NCT00984659|20714204|P2|6-week Double-blind Treatment Period|Lack of Efficacy|2
5990467|NCT00984659|20714205|P1|6-week Double-blind Treatment Period|Lack of Efficacy|0
5990468|NCT00984659|20714202|P4|6-week Double-blind Treatment Period|Adverse Event|7
5990469|NCT00984659|20714203|P3|6-week Double-blind Treatment Period|Adverse Event|3
5990470|NCT00984659|20714204|P2|6-week Double-blind Treatment Period|Adverse Event|3
5990471|NCT00984659|20714205|P1|6-week Double-blind Treatment Period|Adverse Event|0
5990472|NCT00984659|20714202|P4|2-week Run-in Period|Did Not Meet Continuation Criteria|0
5990473|NCT00984659|20714203|P3|2-week Run-in Period|Did Not Meet Continuation Criteria|0
5990474|NCT00984659|20714204|P2|2-week Run-in Period|Did Not Meet Continuation Criteria|0
5990475|NCT00984659|20714205|P1|2-week Run-in Period|Did Not Meet Continuation Criteria|14
5990476|NCT00984659|20714202|P4|2-week Run-in Period|Withdrawal by Subject|0
5990477|NCT00984659|20714203|P3|2-week Run-in Period|Withdrawal by Subject|0
5990478|NCT00984659|20714204|P2|2-week Run-in Period|Withdrawal by Subject|0
5990479|NCT00984659|20714205|P1|2-week Run-in Period|Withdrawal by Subject|10
5990480|NCT00984659|20714202|P4|2-week Run-in Period|Physician Decision|0
5990481|NCT00984659|20714203|P3|2-week Run-in Period|Physician Decision|0
5990482|NCT00984659|20714204|P2|2-week Run-in Period|Physician Decision|0
5990483|NCT00984659|20714205|P1|2-week Run-in Period|Physician Decision|10
5990484|NCT00984659|20714202|P4|2-week Run-in Period|Lost to Follow-up|0
5990485|NCT00984659|20714203|P3|2-week Run-in Period|Lost to Follow-up|0
5990486|NCT00984659|20714204|P2|2-week Run-in Period|Lost to Follow-up|0
5990487|NCT00984659|20714205|P1|2-week Run-in Period|Lost to Follow-up|3
5990488|NCT00984659|20714202|P4|2-week Run-in Period|Study Closed/Terminated|0
5990489|NCT00984659|20714203|P3|2-week Run-in Period|Study Closed/Terminated|0
5990490|NCT00984659|20714204|P2|2-week Run-in Period|Study Closed/Terminated|0
5990491|NCT00984659|20714205|P1|2-week Run-in Period|Study Closed/Terminated|2
5990492|NCT00984659|20714202|P4|2-week Run-in Period|Protocol Violation|0
5990493|NCT00984659|20714203|P3|2-week Run-in Period|Protocol Violation|0
5990494|NCT00984659|20714204|P2|2-week Run-in Period|Protocol Violation|0
5990495|NCT00984659|20714205|P1|2-week Run-in Period|Protocol Violation|5
5990496|NCT00984659|20714202|P4|2-week Run-in Period|Adverse Event|0
5990497|NCT00984659|20714203|P3|2-week Run-in Period|Adverse Event|0
5990498|NCT00984659|20714204|P2|2-week Run-in Period|Adverse Event|0
5990499|NCT00984659|20714205|P1|2-week Run-in Period|Adverse Event|8
5990500|NCT00984620|20714232|P2|Overall Study|reason other than listed above|4
5990501|NCT00984620|20714233|P1|Overall Study|reason other than listed above|0
5990502|NCT00984620|20714232|P2|Overall Study|Withdrawal by Subject|2
5990503|NCT00984620|20714233|P1|Overall Study|Withdrawal by Subject|0
5990504|NCT00984620|20714232|P2|Overall Study|Lost to Follow-up|1
5990505|NCT00984620|20714233|P1|Overall Study|Lost to Follow-up|1
5990506|NCT00984620|20714232|P2|Overall Study|Adverse Event|5
5990507|NCT00984620|20714233|P1|Overall Study|Adverse Event|5
5990508|NCT00984594|20714271|P2|Overall Study|Withdrawal by Subject|1
5990509|NCT00984594|20714272|P1|Overall Study|Withdrawal by Subject|0
5990510|NCT00984594|20714271|P2|Overall Study|Lost to Follow-up|0
5990511|NCT00984594|20714272|P1|Overall Study|Lost to Follow-up|1
5990512|NCT00984568|20714288|P2|Overall Study|Unknown Reason|3
5990513|NCT00984568|20714289|P1|Overall Study|Unknown Reason|1
5990514|NCT00984568|20714288|P2|Overall Study|Opportunistic Infection|0
5990515|NCT00984568|20714289|P1|Overall Study|Opportunistic Infection|1
5990516|NCT00984568|20714288|P2|Overall Study|Lost to Follow-up|1
5990517|NCT00984568|20714289|P1|Overall Study|Lost to Follow-up|0
5990518|NCT00984568|20714288|P2|Overall Study|Did Not Meet Randomization Criteria|0
5990519|NCT00984568|20714289|P1|Overall Study|Did Not Meet Randomization Criteria|1
5990520|NCT00984568|20714288|P2|Overall Study|Adverse Event|0
5990521|NCT00984568|20714289|P1|Overall Study|Adverse Event|2
5990522|NCT00984568|20714288|P2|Overall Study|Lack of Efficacy|0
5990523|NCT00984568|20714289|P1|Overall Study|Lack of Efficacy|2
5990524|NCT00984568|20714288|P2|Overall Study|Withdrawal by Subject|2
5990525|NCT00984568|20714289|P1|Overall Study|Withdrawal by Subject|1
5990526|NCT00984542|20714297|P1|Overall Study|clinical deterioration|2
5990527|NCT00984542|20714297|P1|Overall Study|Withdrawal by Subject|3
5990528|NCT00984542|20714297|P1|Overall Study|complicating disease|3
5990529|NCT00984542|20714297|P1|Overall Study|Death|7
5990530|NCT00984542|20714297|P1|Overall Study|toxicity|7
5990531|NCT00984542|20714297|P1|Overall Study|disease progression|19
5990532|NCT00984295|20714347|P3|Overall Study|Incomplete safety follow-up|3
5990533|NCT00984295|20714348|P2|Overall Study|Incomplete safety follow-up|2
5990534|NCT00984295|20714349|P1|Overall Study|Incomplete safety follow-up|11
5990535|NCT00984295|20714347|P3|Overall Study|Missed one or more blood samplings|2
5990536|NCT00984295|20714348|P2|Overall Study|Missed one or more blood samplings|7
5990537|NCT00984295|20714349|P1|Overall Study|Missed one or more blood samplings|3
5990538|NCT00984295|20714347|P3|Overall Study|CAE - discontinued test vaccine|3
5990539|NCT00984295|20714348|P2|Overall Study|CAE - discontinued test vaccine|1
5990540|NCT00984295|20714349|P1|Overall Study|CAE - discontinued test vaccine|0
5990541|NCT00984295|20714347|P3|Overall Study|Withdrawal by Subject|12
5990542|NCT00984295|20714348|P2|Overall Study|Withdrawal by Subject|9
5990543|NCT00984295|20714349|P1|Overall Study|Withdrawal by Subject|18
5990544|NCT00984295|20714347|P3|Overall Study|Protocol Violation|4
5990545|NCT00984295|20714348|P2|Overall Study|Protocol Violation|1
5990546|NCT00984295|20714349|P1|Overall Study|Protocol Violation|2
5990547|NCT00984295|20714347|P3|Overall Study|Lost to Follow-up|13
5990548|NCT00984295|20714348|P2|Overall Study|Lost to Follow-up|12
5990549|NCT00984295|20714349|P1|Overall Study|Lost to Follow-up|31
5990550|NCT00984282|20714416|P2|Long Term Follow-up|Disease prog., recurrence or relapse|1
5990551|NCT00984282|20714417|P1|Long Term Follow-up|Disease prog., recurrence or relapse|0
5990552|NCT00984282|20714416|P2|Long Term Follow-up|Switched to commercial drug|2
5990553|NCT00984282|20714417|P1|Long Term Follow-up|Switched to commercial drug|4
5990554|NCT00984282|20714416|P2|Long Term Follow-up|Transferred to treat. continuation study|3
5990555|NCT00984282|20714417|P1|Long Term Follow-up|Transferred to treat. continuation study|2
5990556|NCT00984282|20714416|P2|Long Term Follow-up|Protocol driven decision point|26
5990557|NCT00984282|20714417|P1|Long Term Follow-up|Protocol driven decision point|25
5990558|NCT00984282|20714416|P2|Long Term Follow-up|Lost to Follow-up|6
5990559|NCT00984282|20714417|P1|Long Term Follow-up|Lost to Follow-up|3
5990560|NCT00984282|20714416|P2|Long Term Follow-up|Death|68
5990561|NCT00984282|20714417|P1|Long Term Follow-up|Death|27
5990562|NCT00984282|20714416|P2|Long Term Follow-up|Withdrawal by Subject|14
5990563|NCT00984282|20714417|P1|Long Term Follow-up|Withdrawal by Subject|8
5990564|NCT00984282|20714416|P2|Open-label Treatment|Physician Decision|0
5990565|NCT00984282|20714417|P1|Open-label Treatment|Physician Decision|1
5990566|NCT00984282|20714416|P2|Open-label Treatment|Switched to commercial drug|7
5990567|NCT00984282|20714417|P1|Open-label Treatment|Switched to commercial drug|6
5990568|NCT00984282|20714416|P2|Open-label Treatment|Transferred to treat. continuation study|3
5990569|NCT00984282|20714417|P1|Open-label Treatment|Transferred to treat. continuation study|2
5990570|NCT00984282|20714416|P2|Open-label Treatment|Protocol driven decision point|1
5990571|NCT00984282|20714417|P1|Open-label Treatment|Protocol driven decision point|1
5990572|NCT00984282|20714416|P2|Open-label Treatment|Target lesion removed|1
5990573|NCT00984282|20714417|P1|Open-label Treatment|Target lesion removed|0
5990574|NCT00984282|20714416|P2|Open-label Treatment|Non-compliant with study medication|0
5990575|NCT00984282|20714417|P1|Open-label Treatment|Non-compliant with study medication|1
5990576|NCT00984282|20714416|P2|Open-label Treatment|Patient convenience|0
5990577|NCT00984282|20714417|P1|Open-label Treatment|Patient convenience|1
5990578|NCT00984282|20714416|P2|Open-label Treatment|Lost to Follow-up|1
5990579|NCT00984282|20714417|P1|Open-label Treatment|Lost to Follow-up|1
5990580|NCT00984282|20714416|P2|Open-label Treatment|Progression, recurrence or relapse|82
5990581|NCT00984282|20714417|P1|Open-label Treatment|Progression, recurrence or relapse|40
5990582|NCT00984282|20714416|P2|Open-label Treatment|Death|15
5990583|NCT00984282|20714417|P1|Open-label Treatment|Death|7
5990584|NCT00984282|20714416|P2|Open-label Treatment|Withdrawal by Subject|21
5990585|NCT00984282|20714417|P1|Open-label Treatment|Withdrawal by Subject|6
5990586|NCT00984282|20714416|P2|Open-label Treatment|Adverse Event|30
5990587|NCT00984282|20714417|P1|Open-label Treatment|Adverse Event|20
5990588|NCT00984282|20714416|P2|Double Blind Treatment|Transferred to treat. continuation study|1
5990589|NCT00984282|20714417|P1|Double Blind Treatment|Transferred to treat. continuation study|2
5990590|NCT00984282|20714416|P2|Double Blind Treatment|Radiological and clinical progression|1
5990591|NCT00984282|20714417|P1|Double Blind Treatment|Radiological and clinical progression|0
5990592|NCT00984282|20714416|P2|Double Blind Treatment|protocol driven decision point|1
5990593|NCT00984282|20714417|P1|Double Blind Treatment|protocol driven decision point|1
5990594|NCT00984282|20714416|P2|Double Blind Treatment|Switched to commercial drug|1
5990595|NCT00984282|20714417|P1|Double Blind Treatment|Switched to commercial drug|6
5990596|NCT00984282|20714416|P2|Double Blind Treatment|Not treated|1
5990597|NCT00984282|20714417|P1|Double Blind Treatment|Not treated|0
5990598|NCT00984282|20714416|P2|Double Blind Treatment|Death|4
5990599|NCT00984282|20714417|P1|Double Blind Treatment|Death|8
5990600|NCT00984282|20714416|P2|Double Blind Treatment|Lost to Follow-up|0
5990601|NCT00984282|20714417|P1|Double Blind Treatment|Lost to Follow-up|3
5990602|NCT00984282|20714416|P2|Double Blind Treatment|Withdrawal by Subject|18
5990603|NCT00984282|20714417|P1|Double Blind Treatment|Withdrawal by Subject|13
5990604|NCT00984282|20714416|P2|Double Blind Treatment|Progression by clinical judgment|0
5990605|NCT00984282|20714417|P1|Double Blind Treatment|Progression by clinical judgment|2
5990606|NCT00984282|20714416|P2|Double Blind Treatment|Noncompliance with study medication|0
5990607|NCT00984282|20714417|P1|Double Blind Treatment|Noncompliance with study medication|3
5990608|NCT00984282|20714416|P2|Double Blind Treatment|Physician Decision|2
5990609|NCT00984282|20714417|P1|Double Blind Treatment|Physician Decision|1
5990610|NCT00984282|20714416|P2|Double Blind Treatment|Progression, recurrence or relapse|3
5990611|NCT00984282|20714417|P1|Double Blind Treatment|Progression, recurrence or relapse|25
5990612|NCT00984282|20714416|P2|Double Blind Treatment|Adverse Event|6
5990613|NCT00984282|20714417|P1|Double Blind Treatment|Adverse Event|40
5990614|NCT00984256|20714440|P2|Overall Study|Withdrawal by Subject|1
5990615|NCT00984256|20714441|P1|Overall Study|Withdrawal by Subject|0
5990616|NCT00984204|20714461|P1|Overall Study|Lack of Efficacy|10
5990617|NCT00984204|20714461|P1|Overall Study|Lost to Follow-up|4
5990618|NCT00984204|20714461|P1|Overall Study|Death|1
5990619|NCT00984165|20714471|P4|Overall Study|removed with a pair recipient|1
5990620|NCT00984165|20714472|P3|Overall Study|removed with a pair recipient|0
5990621|NCT00984165|20714473|P2|Overall Study|removed with a pair recipient|0
5990622|NCT00984165|20714474|P1|Overall Study|removed with a pair recipient|0
5990623|NCT00984165|20714471|P4|Overall Study|P+/donor pair removed from protocol|1
5990624|NCT00984165|20714472|P3|Overall Study|P+/donor pair removed from protocol|0
5990625|NCT00984165|20714473|P2|Overall Study|P+/donor pair removed from protocol|0
5990626|NCT00984165|20714474|P1|Overall Study|P+/donor pair removed from protocol|0
5990627|NCT00984165|20714471|P4|Overall Study|New protocol|1
5990628|NCT00984165|20714472|P3|Overall Study|New protocol|0
5990629|NCT00984165|20714473|P2|Overall Study|New protocol|0
5990630|NCT00984165|20714474|P1|Overall Study|New protocol|0
5990631|NCT00984165|20714471|P4|Overall Study|Death of recipient|1
5990632|NCT00984165|20714472|P3|Overall Study|Death of recipient|0
5990633|NCT00984165|20714473|P2|Overall Study|Death of recipient|0
5990634|NCT00984165|20714474|P1|Overall Study|Death of recipient|0
5990635|NCT00984165|20714471|P4|Overall Study|Disease progression on study|0
5990636|NCT00984165|20714472|P3|Overall Study|Disease progression on study|0
5990637|NCT00984165|20714473|P2|Overall Study|Disease progression on study|1
5990638|NCT00984165|20714474|P1|Overall Study|Disease progression on study|5
5990639|NCT00984165|20714471|P4|Overall Study|Death on study|0
5990640|NCT00984165|20714472|P3|Overall Study|Death on study|0
5990641|NCT00984165|20714473|P2|Overall Study|Death on study|0
5990642|NCT00984165|20714474|P1|Overall Study|Death on study|2
5990643|NCT00984126|20714503|P4|Overall Study|Withdrawal criteria|9
5990644|NCT00984126|20714504|P3|Overall Study|Withdrawal criteria|3
5990645|NCT00984126|20714505|P2|Overall Study|Withdrawal criteria|1
5990646|NCT00984126|20714506|P1|Overall Study|Withdrawal criteria|0
5990647|NCT00984126|20714503|P4|Overall Study|Choose to join Pathfinder trial™ + other|46
5990648|NCT00984126|20714504|P3|Overall Study|Choose to join Pathfinder trial™ + other|3
5990649|NCT00984126|20714505|P2|Overall Study|Choose to join Pathfinder trial™ + other|7
5990650|NCT00984126|20714506|P1|Overall Study|Choose to join Pathfinder trial™ + other|7
5990651|NCT00984126|20714503|P4|Overall Study|Adverse Event|2
5990652|NCT00984126|20714504|P3|Overall Study|Adverse Event|0
5990653|NCT00984126|20714505|P2|Overall Study|Adverse Event|0
5990654|NCT00984126|20714506|P1|Overall Study|Adverse Event|0
5990655|NCT00984126|20714503|P4|Overall Study|Protocol Violation|2
5990656|NCT00984126|20714504|P3|Overall Study|Protocol Violation|1
5990657|NCT00984126|20714505|P2|Overall Study|Protocol Violation|0
5990658|NCT00984126|20714506|P1|Overall Study|Protocol Violation|0
5990659|NCT00984061|20714531|P1|Clarithromycin Alone|Protocol Violation|1
5990660|NCT00984022|20714544|P2|Overall Study|Lost to Follow-up|14
5990661|NCT00984022|20714545|P1|Overall Study|Lost to Follow-up|10
5990662|NCT00984009|20714555|P1|Grapefruit Juice Alone|missed serving of grapefruit juice|1
5990663|NCT00983957|20714588|P1|Overall Study|Personal Reasons|1
5990664|NCT00983957|20714588|P1|Overall Study|Adverse Event|1
5990665|NCT00983931|20714622|P1|14 Day Washout Period|Physician Decision|1
5990666|NCT00983918|20714636|P4|Overall Study|conversion to open cholecystectomy|2
5990667|NCT00983918|20714637|P3|Overall Study|conversion to open cholecystectomy|2
5990668|NCT00983918|20714638|P2|Overall Study|conversion to open cholecystectomy|2
5990669|NCT00983918|20714639|P1|Overall Study|conversion to open cholecystectomy|0
5990670|NCT00983905|20714649|P1|Colchicine Alone|Adverse Event|2
5990671|NCT00983905|20714649|P1|Theophylline Alone|Adverse Event|1
5990672|NCT00983892|20714662|P2|Overall Study|Withdrawal by Subject|12
5990673|NCT00983892|20714663|P1|Overall Study|Withdrawal by Subject|10
5990674|NCT00983853|20714675|P6|Overall Study|Unable to come to study follow-up visits|0
5990675|NCT00983853|20714676|P5|Overall Study|Unable to come to study follow-up visits|0
5990676|NCT00983853|20714677|P4|Overall Study|Unable to come to study follow-up visits|0
5990677|NCT00983853|20714678|P3|Overall Study|Unable to come to study follow-up visits|0
5990678|NCT00983853|20714679|P2|Overall Study|Unable to come to study follow-up visits|1
5990679|NCT00983853|20714680|P1|Overall Study|Unable to come to study follow-up visits|0
5990680|NCT00983853|20714675|P6|Overall Study|Withdrawal by Subject|0
5990681|NCT00983853|20714676|P5|Overall Study|Withdrawal by Subject|1
5990682|NCT00983853|20714677|P4|Overall Study|Withdrawal by Subject|0
5990683|NCT00983853|20714678|P3|Overall Study|Withdrawal by Subject|1
5990684|NCT00983853|20714679|P2|Overall Study|Withdrawal by Subject|0
5990685|NCT00983853|20714680|P1|Overall Study|Withdrawal by Subject|0
5990686|NCT00983853|20714675|P6|Overall Study|Lost to Follow-up|1
5990687|NCT00983853|20714676|P5|Overall Study|Lost to Follow-up|2
5990688|NCT00983853|20714677|P4|Overall Study|Lost to Follow-up|2
5990689|NCT00983853|20714678|P3|Overall Study|Lost to Follow-up|2
5990690|NCT00983853|20714679|P2|Overall Study|Lost to Follow-up|1
5990691|NCT00983853|20714680|P1|Overall Study|Lost to Follow-up|1
5990692|NCT00983827|20714708|P1|Overall Study|Withdrawal by Subject|1
5990693|NCT00983749|20714726|P2|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|3
5990694|NCT00983749|20714727|P1|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|1
5990695|NCT00983619|20714762|P12|Overall Study|Other|0
5990696|NCT00983619|20714763|P11|Overall Study|Other|1
5990697|NCT00983619|20714764|P10|Overall Study|Other|1
5990698|NCT00983619|20714765|P9|Overall Study|Other|0
5990699|NCT00983619|20714766|P8|Overall Study|Other|2
5990700|NCT00983619|20714767|P7|Overall Study|Other|2
5990701|NCT00983619|20714768|P6|Overall Study|Other|12
5990702|NCT00983619|20714769|P5|Overall Study|Other|0
5990703|NCT00983619|20714770|P4|Overall Study|Other|1
5990704|NCT00983619|20714771|P3|Overall Study|Other|0
5990705|NCT00983619|20714772|P2|Overall Study|Other|0
5990706|NCT00983619|20714773|P1|Overall Study|Other|1
5990707|NCT00983619|20714762|P12|Overall Study|Death|8
5990708|NCT00983619|20714763|P11|Overall Study|Death|9
5990709|NCT00983619|20714764|P10|Overall Study|Death|2
5990710|NCT00983619|20714765|P9|Overall Study|Death|1
5990711|NCT00983619|20714766|P8|Overall Study|Death|0
5990712|NCT00983619|20714767|P7|Overall Study|Death|1
5990713|NCT00983619|20714768|P6|Overall Study|Death|30
5990714|NCT00983619|20714769|P5|Overall Study|Death|2
5990715|NCT00983619|20714770|P4|Overall Study|Death|1
5990716|NCT00983619|20714771|P3|Overall Study|Death|2
5990717|NCT00983619|20714772|P2|Overall Study|Death|2
5990718|NCT00983619|20714773|P1|Overall Study|Death|0
5990719|NCT00983619|20714762|P12|Overall Study|Withdrawal by Subject|1
5990720|NCT00983619|20714763|P11|Overall Study|Withdrawal by Subject|1
5990721|NCT00983619|20714764|P10|Overall Study|Withdrawal by Subject|0
5990722|NCT00983619|20714765|P9|Overall Study|Withdrawal by Subject|0
5990723|NCT00983619|20714766|P8|Overall Study|Withdrawal by Subject|0
5990724|NCT00983619|20714767|P7|Overall Study|Withdrawal by Subject|0
5990725|NCT00983619|20714768|P6|Overall Study|Withdrawal by Subject|23
5990726|NCT00983619|20714769|P5|Overall Study|Withdrawal by Subject|1
5990727|NCT00983619|20714770|P4|Overall Study|Withdrawal by Subject|3
5990728|NCT00983619|20714771|P3|Overall Study|Withdrawal by Subject|1
5990729|NCT00983619|20714772|P2|Overall Study|Withdrawal by Subject|1
5990730|NCT00983619|20714773|P1|Overall Study|Withdrawal by Subject|2
5990731|NCT00983619|20714762|P12|Overall Study|Lost to Follow-up|2
5990732|NCT00983619|20714763|P11|Overall Study|Lost to Follow-up|0
5990733|NCT00983619|20714764|P10|Overall Study|Lost to Follow-up|0
5990734|NCT00983619|20714765|P9|Overall Study|Lost to Follow-up|0
5990735|NCT00983619|20714766|P8|Overall Study|Lost to Follow-up|0
5990736|NCT00983619|20714767|P7|Overall Study|Lost to Follow-up|0
5990737|NCT00983619|20714768|P6|Overall Study|Lost to Follow-up|2
5990738|NCT00983619|20714769|P5|Overall Study|Lost to Follow-up|0
5990739|NCT00983619|20714770|P4|Overall Study|Lost to Follow-up|0
5990740|NCT00983619|20714771|P3|Overall Study|Lost to Follow-up|0
5990741|NCT00983619|20714772|P2|Overall Study|Lost to Follow-up|1
5990742|NCT00983619|20714773|P1|Overall Study|Lost to Follow-up|0
5990743|NCT00983580|20715078|P2|Overall Study|Ineligible|0
5990744|NCT00983580|20715079|P1|Overall Study|Ineligible|3
5990745|NCT00983580|20715078|P2|Overall Study|Protocol Violation|1
5990746|NCT00983580|20715079|P1|Overall Study|Protocol Violation|1
5990747|NCT00983580|20715078|P2|Overall Study|Cancel Prior to treatment|3
5990748|NCT00983580|20715079|P1|Overall Study|Cancel Prior to treatment|1
5990749|NCT00983528|20715105|P1|Overall Study|Study Terminated|1
5990750|NCT00983528|20715105|P1|Overall Study|Lost to Follow-up|1
5990751|NCT00983528|20715105|P1|Overall Study|Death|4
5990752|NCT00983515|20715110|P1|Colchicine With Ritonavir|Lost to Follow-up|1
5990753|NCT00983515|20715110|P1|Ritonavir Alone|liver panel out of range|6
5990754|NCT00983476|20715137|P3|Overall Study|Did not receive intervention|0
5990755|NCT00983476|20715138|P2|Overall Study|Did not receive intervention|22
5990756|NCT00983476|20715139|P1|Overall Study|Did not receive intervention|17
5990757|NCT00983437|20715171|P1|Overall Study|Other Reason|26
5990758|NCT00983437|20715171|P1|Overall Study|Lost to Follow-up|2
5990759|NCT00983437|20715171|P1|Overall Study|Noncompliance to Study Procedures|1
5990760|NCT00983437|20715171|P1|Overall Study|Withdrawal by Subject|8
5990761|NCT00983437|20715171|P1|Overall Study|Lack of Efficacy|1
5990762|NCT00983437|20715171|P1|Overall Study|Adverse Event|9
5990763|NCT00983385|20715190|P1|Observation Period|Not Evaluable due to Non Compliance|12
5990764|NCT00983385|20715190|P1|Observation Period|Not eligible to be dosed|20
5990765|NCT00983372|20715235|P1|Diltiazem ER Alone|Adverse Event|1
5990766|NCT00983372|20715235|P1|Diltiazem ER Alone|missed diltiazem dose|2
5990767|NCT00983372|20715235|P1|14 Day Washout Period|Withdrawal by Subject|1
5990768|NCT00983294|20715262|P1|Colchicine With Azithromycin|Adverse Event|1
5990769|NCT00983294|20715262|P1|14 Day Washout Period|Withdrawal by Subject|2
5990770|NCT00983073|20715304|P1|Maintenance Period|Other Reason|7
5990771|NCT00983073|20715304|P1|Maintenance Period|Lack of Efficacy|2
5990772|NCT00983073|20715304|P1|Maintenance Period|Withdrawal by Subject|2
5990773|NCT00983073|20715304|P1|Maintenance Period|Adverse Event|5
5990774|NCT00983073|20715304|P1|Titration and Optimal Dose Period|Other reason|4
5990775|NCT00983073|20715304|P1|Titration and Optimal Dose Period|Non-Compliance|1
5990776|NCT00983073|20715304|P1|Titration and Optimal Dose Period|Lack of Efficacy|5
5990777|NCT00983073|20715304|P1|Titration and Optimal Dose Period|Withdrawal by Subject|11
5990778|NCT00983073|20715304|P1|Titration and Optimal Dose Period|Adverse Event|19
5990779|NCT00982878|20715330|P1|Overall Study|Physician Decision|1
5990780|NCT00982735|20715628|P1|Overall Study|Patient ineligible for trial|224
5990781|NCT00982735|20715628|P1|Overall Study|Lost to Follow-up|6
5990782|NCT00982657|20715638|P4|Overall Study|On going at date of cut-off|1
5990783|NCT00982657|20715639|P3|Overall Study|On going at date of cut-off|0
5990784|NCT00982657|20715640|P2|Overall Study|On going at date of cut-off|0
5990785|NCT00982657|20715641|P1|Overall Study|On going at date of cut-off|0
5990786|NCT00982657|20715638|P4|Overall Study|Other|4
5990787|NCT00982657|20715639|P3|Overall Study|Other|0
5990788|NCT00982657|20715640|P2|Overall Study|Other|0
5990789|NCT00982657|20715641|P1|Overall Study|Other|0
5990790|NCT00982657|20715638|P4|Overall Study|Withdrawal by Subject|3
5990791|NCT00982657|20715639|P3|Overall Study|Withdrawal by Subject|1
5990792|NCT00982657|20715640|P2|Overall Study|Withdrawal by Subject|0
5990793|NCT00982657|20715641|P1|Overall Study|Withdrawal by Subject|0
5990794|NCT00982657|20715638|P4|Overall Study|Death|1
5990795|NCT00982657|20715639|P3|Overall Study|Death|1
5990796|NCT00982657|20715640|P2|Overall Study|Death|0
5990797|NCT00982657|20715641|P1|Overall Study|Death|1
5990798|NCT00982644|20715682|P2|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|7
5990799|NCT00982644|20715683|P1|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|23
5990800|NCT00982644|20715682|P2|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|3
5990801|NCT00982644|20715683|P1|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|6
5990802|NCT00982644|20715682|P2|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|4
5990803|NCT00982644|20715683|P1|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|2
5990804|NCT00982644|20715682|P2|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|1
5990805|NCT00982644|20715683|P1|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|3
5990806|NCT00982644|20715682|P2|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|5
5990807|NCT00982644|20715683|P1|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|12
5990808|NCT00982644|20715682|P2|Main: Week 0 to 52 (NN1250-3579)|Unclassified|30
5990809|NCT00982644|20715683|P1|Main: Week 0 to 52 (NN1250-3579)|Unclassified|84
5990810|NCT00982644|20715682|P2|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|5
5990811|NCT00982644|20715683|P1|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|9
5990812|NCT00982644|20715682|P2|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|18
5990813|NCT00982644|20715683|P1|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|46
5990814|NCT00982644|20715682|P2|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|2
5990815|NCT00982644|20715683|P1|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|7
5990816|NCT00982644|20715682|P2|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|5
5990817|NCT00982644|20715683|P1|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|20
5990818|NCT00982488|20715738|P5|Overall Study|Withdrawal by Subject|0
5990819|NCT00982488|20715739|P4|Overall Study|Withdrawal by Subject|0
5990820|NCT00982488|20715740|P3|Overall Study|Withdrawal by Subject|1
5990821|NCT00982488|20715741|P2|Overall Study|Withdrawal by Subject|1
5990822|NCT00982488|20715742|P1|Overall Study|Withdrawal by Subject|5
5990823|NCT00982488|20715738|P5|Overall Study|Study drug toxicity|0
5990824|NCT00982488|20715739|P4|Overall Study|Study drug toxicity|0
5990825|NCT00982488|20715740|P3|Overall Study|Study drug toxicity|6
5990826|NCT00982488|20715741|P2|Overall Study|Study drug toxicity|1
5990827|NCT00982488|20715742|P1|Overall Study|Study drug toxicity|34
5990828|NCT00982488|20715738|P5|Overall Study|Stem cell transplant|0
5990829|NCT00982488|20715739|P4|Overall Study|Stem cell transplant|1
5990830|NCT00982488|20715740|P3|Overall Study|Stem cell transplant|0
5990831|NCT00982488|20715741|P2|Overall Study|Stem cell transplant|0
5990832|NCT00982488|20715742|P1|Overall Study|Stem cell transplant|2
5990833|NCT00982488|20715738|P5|Overall Study|Poor compliance/noncompliance|0
5990834|NCT00982488|20715739|P4|Overall Study|Poor compliance/noncompliance|0
5990835|NCT00982488|20715740|P3|Overall Study|Poor compliance/noncompliance|0
5990836|NCT00982488|20715741|P2|Overall Study|Poor compliance/noncompliance|1
5990837|NCT00982488|20715742|P1|Overall Study|Poor compliance/noncompliance|0
5990838|NCT00982488|20715738|P5|Overall Study|Other|0
5990839|NCT00982488|20715739|P4|Overall Study|Other|1
5990840|NCT00982488|20715740|P3|Overall Study|Other|3
5990841|NCT00982488|20715741|P2|Overall Study|Other|1
5990842|NCT00982488|20715742|P1|Overall Study|Other|15
5990843|NCT00982488|20715738|P5|Overall Study|Maximum clinical benefit|0
5990844|NCT00982488|20715739|P4|Overall Study|Maximum clinical benefit|0
5990845|NCT00982488|20715740|P3|Overall Study|Maximum clinical benefit|1
5990846|NCT00982488|20715741|P2|Overall Study|Maximum clinical benefit|1
5990847|NCT00982488|20715742|P1|Overall Study|Maximum clinical benefit|1
5990848|NCT00982488|20715738|P5|Overall Study|Lost to Follow-up|0
5990849|NCT00982488|20715739|P4|Overall Study|Lost to Follow-up|0
5990850|NCT00982488|20715740|P3|Overall Study|Lost to Follow-up|0
5990851|NCT00982488|20715741|P2|Overall Study|Lost to Follow-up|0
5990852|NCT00982488|20715742|P1|Overall Study|Lost to Follow-up|1
5990853|NCT00982488|20715738|P5|Overall Study|Disease progression|1
5990854|NCT00982488|20715739|P4|Overall Study|Disease progression|1
5990855|NCT00982488|20715740|P3|Overall Study|Disease progression|10
5990856|NCT00982488|20715741|P2|Overall Study|Disease progression|5
5990857|NCT00982488|20715742|P1|Overall Study|Disease progression|30
5990858|NCT00982488|20715738|P5|Overall Study|Death|0
5990859|NCT00982488|20715739|P4|Overall Study|Death|0
5990860|NCT00982488|20715740|P3|Overall Study|Death|2
5990861|NCT00982488|20715741|P2|Overall Study|Death|0
5990862|NCT00982488|20715742|P1|Overall Study|Death|11
5990863|NCT00982488|20715738|P5|Overall Study|Adverse event unrelated to study drug|0
5990864|NCT00982488|20715739|P4|Overall Study|Adverse event unrelated to study drug|0
5990865|NCT00982488|20715740|P3|Overall Study|Adverse event unrelated to study drug|0
5990866|NCT00982488|20715741|P2|Overall Study|Adverse event unrelated to study drug|1
5990867|NCT00982488|20715742|P1|Overall Study|Adverse event unrelated to study drug|5
5990868|NCT00982488|20715738|P5|Overall Study|Administrative reason by sponsor|0
5990869|NCT00982488|20715739|P4|Overall Study|Administrative reason by sponsor|0
5990870|NCT00982488|20715740|P3|Overall Study|Administrative reason by sponsor|11
5990871|NCT00982488|20715741|P2|Overall Study|Administrative reason by sponsor|3
5990872|NCT00982488|20715742|P1|Overall Study|Administrative reason by sponsor|81
5990873|NCT00982410|20715775|P2|12-month Follow-up Assessment|scheduled, no-show|0
5990874|NCT00982410|20715776|P1|12-month Follow-up Assessment|scheduled, no-show|1
5990875|NCT00982410|20715775|P2|12-month Follow-up Assessment|incarceration|1
5990876|NCT00982410|20715776|P1|12-month Follow-up Assessment|incarceration|2
5990877|NCT00982410|20715775|P2|12-month Follow-up Assessment|Withdrawal by Subject|1
5990878|NCT00982410|20715776|P1|12-month Follow-up Assessment|Withdrawal by Subject|0
5990879|NCT00982410|20715775|P2|12-month Follow-up Assessment|could not reach to schedule|5
5990880|NCT00982410|20715776|P1|12-month Follow-up Assessment|could not reach to schedule|6
5990881|NCT00982410|20715775|P2|12-month Follow-up Assessment|Death|2
5990882|NCT00982410|20715776|P1|12-month Follow-up Assessment|Death|0
5990883|NCT00982410|20715775|P2|6-month Follow-up Assessment|scheduled, no-show|1
5990884|NCT00982410|20715776|P1|6-month Follow-up Assessment|scheduled, no-show|0
5990885|NCT00982410|20715775|P2|6-month Follow-up Assessment|patent surgery|1
5990886|NCT00982410|20715776|P1|6-month Follow-up Assessment|patent surgery|0
5990887|NCT00982410|20715775|P2|6-month Follow-up Assessment|incarceration|2
5990888|NCT00982410|20715776|P1|6-month Follow-up Assessment|incarceration|0
5990889|NCT00982410|20715775|P2|6-month Follow-up Assessment|participant no transportation|0
5990890|NCT00982410|20715776|P1|6-month Follow-up Assessment|participant no transportation|1
5990891|NCT00982410|20715775|P2|6-month Follow-up Assessment|Could not reach to schedule|7
5990892|NCT00982410|20715776|P1|6-month Follow-up Assessment|Could not reach to schedule|5
5990893|NCT00982410|20715775|P2|3-month Follow-up Assessment|Withdrawal by Subject|2
5990894|NCT00982410|20715776|P1|3-month Follow-up Assessment|Withdrawal by Subject|0
5990895|NCT00982410|20715775|P2|3-month Follow-up Assessment|Scheduled, no-show|2
5990896|NCT00982410|20715776|P1|3-month Follow-up Assessment|Scheduled, no-show|1
5990897|NCT00982410|20715775|P2|3-month Follow-up Assessment|Could not reach to schedule|9
5990898|NCT00982410|20715776|P1|3-month Follow-up Assessment|Could not reach to schedule|8
5990899|NCT00982319|20715817|P2|Overall Study|Pregnancy|1
5990900|NCT00982319|20715818|P1|Overall Study|Pregnancy|0
5990901|NCT00982319|20715817|P2|Overall Study|Preop values out of acceptable range|1
5990902|NCT00982319|20715818|P1|Overall Study|Preop values out of acceptable range|1
5990903|NCT00982319|20715817|P2|Overall Study|Surgery date change|0
5990904|NCT00982319|20715818|P1|Overall Study|Surgery date change|1
5990905|NCT00982280|20715826|P1|Maintenance Period|Adverse Event|1
5990906|NCT00982280|20715826|P1|Titration and Optimal Dose Period|Withdrawal by Subject|1
5990907|NCT00982280|20715826|P1|Titration and Optimal Dose Period|Lack of Efficacy|2
5990908|NCT00982280|20715826|P1|Titration and Optimal Dose Period|Adverse Event|5
5990909|NCT00982280|20715826|P1|Observation Period|Not eligible to be dosed|19
5990910|NCT00982228|20715851|P2|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|1
5990911|NCT00982228|20715852|P1|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|11
5990912|NCT00982228|20715851|P2|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|0
5990913|NCT00982228|20715852|P1|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|5
5990914|NCT00982228|20715851|P2|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|2
5990915|NCT00982228|20715852|P1|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|1
5990916|NCT00982228|20715851|P2|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|0
5990917|NCT00982228|20715852|P1|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|1
5990918|NCT00982228|20715851|P2|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|2
5990919|NCT00982228|20715852|P1|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|3
5990920|NCT00982228|20715851|P2|Main: Week 0 to 52 (NN1250-3583)|Unclassified|13
5990921|NCT00982228|20715852|P1|Main: Week 0 to 52 (NN1250-3583)|Unclassified|28
5990922|NCT00982228|20715851|P2|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|3
5990923|NCT00982228|20715852|P1|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|15
5990924|NCT00982228|20715851|P2|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|2
5990925|NCT00982228|20715852|P1|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|11
5990926|NCT00982228|20715851|P2|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|0
5990927|NCT00982228|20715852|P1|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|2
5990928|NCT00982228|20715851|P2|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|2
5990929|NCT00982228|20715852|P1|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|12
5990930|NCT00982137|20715911|P4|Overall Study|Withdrawal by Subject|0
5990931|NCT00982137|20715912|P3|Overall Study|Withdrawal by Subject|0
5990932|NCT00982137|20715913|P2|Overall Study|Withdrawal by Subject|1
5990933|NCT00982137|20715914|P1|Overall Study|Withdrawal by Subject|0
5990934|NCT00982137|20715911|P4|Overall Study|Lost to Follow-up|1
5990935|NCT00982137|20715912|P3|Overall Study|Lost to Follow-up|0
5990936|NCT00982137|20715913|P2|Overall Study|Lost to Follow-up|0
5990937|NCT00982137|20715914|P1|Overall Study|Lost to Follow-up|0
5990938|NCT00982111|20715946|P2|Overall Study|Withdrawal by Subject|17
5990939|NCT00982111|20715947|P1|Overall Study|Withdrawal by Subject|16
5990940|NCT00982111|20715946|P2|Overall Study|On Study Treatment at Conclusion|0
5990941|NCT00982111|20715947|P1|Overall Study|On Study Treatment at Conclusion|7
5990942|NCT00982111|20715946|P2|Overall Study|New Anti-Cancer Therapy|5
5990943|NCT00982111|20715947|P1|Overall Study|New Anti-Cancer Therapy|5
5990944|NCT00982111|20715946|P2|Overall Study|Lost to Follow-up|6
5990945|NCT00982111|20715947|P1|Overall Study|Lost to Follow-up|9
5990946|NCT00982111|20715946|P2|Overall Study|Progressive Disease|37
5990947|NCT00982111|20715947|P1|Overall Study|Progressive Disease|37
5990948|NCT00982111|20715946|P2|Overall Study|Adverse Event|1
5990949|NCT00982111|20715947|P1|Overall Study|Adverse Event|1
5990950|NCT00982020|20715980|P2|Overall Study|Clinical Relapse|1
5990951|NCT00982020|20715981|P1|Overall Study|Clinical Relapse|0
5990952|NCT00982020|20715980|P2|Overall Study|Protocol Violation|2
5990953|NCT00982020|20715981|P1|Overall Study|Protocol Violation|0
5990954|NCT00982020|20715980|P2|Overall Study|Entry Criteria Not Met|1
5990955|NCT00982020|20715981|P1|Overall Study|Entry Criteria Not Met|2
5990956|NCT00982020|20715980|P2|Overall Study|Physician Decision|5
5990957|NCT00982020|20715981|P1|Overall Study|Physician Decision|2
5990958|NCT00982020|20715980|P2|Overall Study|Treatment Non-compliance|6
5990959|NCT00982020|20715981|P1|Overall Study|Treatment Non-compliance|3
5990960|NCT00982020|20715980|P2|Overall Study|Parent/Caregiver Decision|5
5990961|NCT00982020|20715981|P1|Overall Study|Parent/Caregiver Decision|5
5990962|NCT00982020|20715980|P2|Overall Study|Lack of Efficacy|4
5990963|NCT00982020|20715981|P1|Overall Study|Lack of Efficacy|10
5990964|NCT00982020|20715980|P2|Overall Study|Lost to Follow-up|11
5990965|NCT00982020|20715981|P1|Overall Study|Lost to Follow-up|5
5990966|NCT00982020|20715980|P2|Overall Study|Withdrawal by Subject|14
5990967|NCT00982020|20715981|P1|Overall Study|Withdrawal by Subject|11
5990968|NCT00982020|20715980|P2|Overall Study|Adverse Event|15
5990969|NCT00982020|20715981|P1|Overall Study|Adverse Event|19
5990970|NCT00981799|20716035|P4|Overall Study|Adverse Event|0
5990971|NCT00981799|20716036|P3|Overall Study|Adverse Event|0
5990972|NCT00981799|20716037|P2|Overall Study|Adverse Event|1
5990973|NCT00981799|20716038|P1|Overall Study|Adverse Event|1
5990974|NCT00981747|20716052|P1|Placebo Oral Tablet|Withdrawal by Subject|1
5990975|NCT00981747|20716052|P1|Losartan|Death|1
5990976|NCT00981747|20716052|P1|Losartan|Withdrawal by Subject|1
5990977|NCT00981682|20716070|P1|Overall Study|administrative|9
5990978|NCT00981682|20716070|P1|Overall Study|Protocol Violation|6
5990979|NCT00981682|20716070|P1|Overall Study|Lack of Efficacy|13
5990980|NCT00981682|20716070|P1|Overall Study|Lost to Follow-up|14
5990981|NCT00981682|20716070|P1|Overall Study|Withdrawal by Subject|52
5990982|NCT00981682|20716070|P1|Overall Study|Adverse Event|48
5990983|NCT00981578|20716122|P1|Overall Study|Withdrawal by Subject|2
5990984|NCT00981578|20716122|P1|Overall Study|Death|1
5990985|NCT00981526|20716130|P2|Overall Study|Physician Decision|4
5990986|NCT00981526|20716131|P1|Overall Study|Physician Decision|4
5990987|NCT00981526|20716130|P2|Overall Study|Withdrawal by Subject|2
5990988|NCT00981526|20716131|P1|Overall Study|Withdrawal by Subject|0
5990989|NCT00981461|20716149|P2|Overall Study|Lost to Follow-up|2
5990990|NCT00981461|20716150|P1|Overall Study|Lost to Follow-up|5
5990991|NCT00981409|20716174|P2|Overall Study|Prostate Cancer Treatment before Trial|0
5990992|NCT00981409|20716175|P1|Overall Study|Prostate Cancer Treatment before Trial|2
5990993|NCT00981409|20716174|P2|Overall Study|Protocol Violation|1
5990994|NCT00981409|20716175|P1|Overall Study|Protocol Violation|0
5990995|NCT00981409|20716174|P2|Overall Study|Adverse Event|0
5990996|NCT00981409|20716175|P1|Overall Study|Adverse Event|4
5990997|NCT00981292|20716214|P6|Day 3|Protocol Violation|1
5990998|NCT00981292|20716215|P5|Day 3|Protocol Violation|0
5990999|NCT00981292|20716216|P4|Day 3|Protocol Violation|0
5991000|NCT00981292|20716217|P3|Day 3|Protocol Violation|0
5991001|NCT00981292|20716218|P2|Day 3|Protocol Violation|0
5991002|NCT00981292|20716219|P1|Day 3|Protocol Violation|0
5991003|NCT00981292|20716214|P6|Day 2|Protocol Violation|0
5991004|NCT00981292|20716215|P5|Day 2|Protocol Violation|0
5991005|NCT00981292|20716216|P4|Day 2|Protocol Violation|0
5991006|NCT00981292|20716217|P3|Day 2|Protocol Violation|0
5991007|NCT00981292|20716218|P2|Day 2|Protocol Violation|0
5991008|NCT00981292|20716219|P1|Day 2|Protocol Violation|2
5991009|NCT00981292|20716214|P6|Day 1|Protocol Violation|2
5991010|NCT00981292|20716215|P5|Day 1|Protocol Violation|0
5991011|NCT00981292|20716216|P4|Day 1|Protocol Violation|0
5991012|NCT00981292|20716217|P3|Day 1|Protocol Violation|0
5991013|NCT00981292|20716218|P2|Day 1|Protocol Violation|0
5991014|NCT00981292|20716219|P1|Day 1|Protocol Violation|1
5991015|NCT00981175|20716303|P2|Booster Dose Vaccination|Lost to Follow-up|3
5991016|NCT00981175|20716304|P1|Booster Dose Vaccination|Lost to Follow-up|2
5991017|NCT00981175|20716303|P2|Primary Dose Vaccination|Lost to Follow-up|1
5991018|NCT00981175|20716304|P1|Primary Dose Vaccination|Lost to Follow-up|2
5991019|NCT00981175|20716303|P2|Primary Dose Vaccination|Protocol Violation|1
5991020|NCT00981175|20716304|P1|Primary Dose Vaccination|Protocol Violation|0
5991021|NCT00981175|20716303|P2|Primary Dose Vaccination|Adverse Event|0
5991022|NCT00981175|20716304|P1|Primary Dose Vaccination|Adverse Event|1
5991023|NCT00981149|20716329|P2|Overall Study|Withdrawal by Subject|1
5991024|NCT00981149|20716330|P1|Overall Study|Withdrawal by Subject|1
5991025|NCT00981149|20716329|P2|Overall Study|Lost to Follow-up|2
5991026|NCT00981149|20716330|P1|Overall Study|Lost to Follow-up|1
5991027|NCT00981084|20716340|P2|Post Intervention (Data Analysis)|imbalance in disease subtype|0
5991028|NCT00981084|20716341|P1|Post Intervention (Data Analysis)|imbalance in disease subtype|1
5991029|NCT00981084|20716340|P2|Post Intervention (Data Analysis)|poor effort|1
5991030|NCT00981084|20716341|P1|Post Intervention (Data Analysis)|poor effort|1
5991031|NCT00981058|20716357|P2|Overall Study|On study treatment at conclusion|0
5991032|NCT00981058|20716358|P1|Overall Study|On study treatment at conclusion|9
5991033|NCT00981058|20716357|P2|Overall Study|Withdrawal by Subject|23
5991034|NCT00981058|20716358|P1|Overall Study|Withdrawal by Subject|25
5991035|NCT00981058|20716357|P2|Overall Study|Randomization Error|2
5991036|NCT00981058|20716358|P1|Overall Study|Randomization Error|1
5991037|NCT00981058|20716357|P2|Overall Study|Radiologist Error|1
5991038|NCT00981058|20716358|P1|Overall Study|Radiologist Error|0
5991039|NCT00981058|20716357|P2|Overall Study|Noncompliance|0
5991040|NCT00981058|20716358|P1|Overall Study|Noncompliance|1
5991041|NCT00981058|20716357|P2|Overall Study|New Anticancer Therapy|6
5991042|NCT00981058|20716358|P1|Overall Study|New Anticancer Therapy|6
5991043|NCT00981058|20716357|P2|Overall Study|Lost to Follow-up|15
5991044|NCT00981058|20716358|P1|Overall Study|Lost to Follow-up|16
5991045|NCT00981058|20716357|P2|Overall Study|Progressive Disease|49
5991046|NCT00981058|20716358|P1|Overall Study|Progressive Disease|61
5991047|NCT00981058|20716357|P2|Overall Study|Adverse Event|1
5991048|NCT00981058|20716358|P1|Overall Study|Adverse Event|1
5991049|NCT00981019|20716389|P1|Overall Study|Hit the survey after closure|79
5991050|NCT00981019|20716389|P1|Overall Study|Inadvertent exclusion|239
5991051|NCT00981019|20716389|P1|Overall Study|Did not match target population|94
5991052|NCT00981019|20716389|P1|Overall Study|Did not respond|65
5991053|NCT00980980|20716396|P3|Overall Study|Withdrawal by Hospital|0
5991054|NCT00980980|20716397|P2|Overall Study|Withdrawal by Hospital|1
5991055|NCT00980980|20716398|P1|Overall Study|Withdrawal by Hospital|0
5991056|NCT00980798|20716429|P2|Overall Study|Other|1
5991057|NCT00980798|20716430|P1|Overall Study|Other|0
5991058|NCT00980798|20716429|P2|Overall Study|Withdrawal by Subject|11
5991059|NCT00980798|20716430|P1|Overall Study|Withdrawal by Subject|8
5991060|NCT00980798|20716429|P2|Overall Study|Physician Decision|1
5991061|NCT00980798|20716430|P1|Overall Study|Physician Decision|2
5991062|NCT00980798|20716429|P2|Overall Study|Lost to Follow-up|1
5991063|NCT00980798|20716430|P1|Overall Study|Lost to Follow-up|0
5991064|NCT00980798|20716429|P2|Overall Study|Lack of Efficacy|5
5991065|NCT00980798|20716430|P1|Overall Study|Lack of Efficacy|16
5991066|NCT00980798|20716429|P2|Overall Study|Adverse Event|36
5991067|NCT00980798|20716430|P1|Overall Study|Adverse Event|7
5991068|NCT00980655|20716486|P2|Overall Study|Other|1
5991069|NCT00980655|20716487|P1|Overall Study|Other|0
5991070|NCT00980655|20716486|P2|Overall Study|Parent/legal guardian request|0
5991071|NCT00980655|20716487|P1|Overall Study|Parent/legal guardian request|1
5991072|NCT00980655|20716486|P2|Overall Study|Lost to Follow-up|1
5991073|NCT00980655|20716487|P1|Overall Study|Lost to Follow-up|0
5991074|NCT00980655|20716486|P2|Overall Study|Withdrawal by Subject|4
5991075|NCT00980655|20716487|P1|Overall Study|Withdrawal by Subject|0
5991076|NCT00980655|20716486|P2|Overall Study|Protocol Violation|7
5991077|NCT00980655|20716487|P1|Overall Study|Protocol Violation|2
5991078|NCT00980655|20716486|P2|Overall Study|Death|7
5991079|NCT00980655|20716487|P1|Overall Study|Death|0
5991080|NCT00980655|20716486|P2|Overall Study|Adverse Event|31
5991081|NCT00980655|20716487|P1|Overall Study|Adverse Event|13
5991082|NCT00980343|20716570|P2|Overall Study|no tumor at surgery - treatment effect|3
5991083|NCT00980343|20716571|P1|Overall Study|no tumor at surgery - treatment effect|1
5991084|NCT00980330|20716595|P7|Overall Study|(not specified)|0
5991085|NCT00980330|20716596|P6|Overall Study|(not specified)|1
5991086|NCT00980330|20716597|P5|Overall Study|(not specified)|1
5991087|NCT00980330|20716598|P4|Overall Study|(not specified)|1
5991088|NCT00980330|20716599|P3|Overall Study|(not specified)|0
5991089|NCT00980330|20716600|P2|Overall Study|(not specified)|0
5991090|NCT00980330|20716601|P1|Overall Study|(not specified)|2
5991091|NCT00980330|20716595|P7|Overall Study|Withdrawal by Subject|5
5991092|NCT00980330|20716596|P6|Overall Study|Withdrawal by Subject|2
5991093|NCT00980330|20716597|P5|Overall Study|Withdrawal by Subject|3
5991094|NCT00980330|20716598|P4|Overall Study|Withdrawal by Subject|1
5991095|NCT00980330|20716599|P3|Overall Study|Withdrawal by Subject|4
5991096|NCT00980330|20716600|P2|Overall Study|Withdrawal by Subject|4
5991097|NCT00980330|20716601|P1|Overall Study|Withdrawal by Subject|2
5991098|NCT00980330|20716595|P7|Overall Study|Lost to Follow-up|2
5991099|NCT00980330|20716596|P6|Overall Study|Lost to Follow-up|1
5991100|NCT00980330|20716597|P5|Overall Study|Lost to Follow-up|1
5991101|NCT00980330|20716598|P4|Overall Study|Lost to Follow-up|2
5991102|NCT00980330|20716599|P3|Overall Study|Lost to Follow-up|4
5991103|NCT00980330|20716600|P2|Overall Study|Lost to Follow-up|1
5991104|NCT00980330|20716601|P1|Overall Study|Lost to Follow-up|1
5991105|NCT00980330|20716595|P7|Overall Study|Adverse Event|0
5991106|NCT00980330|20716596|P6|Overall Study|Adverse Event|0
5991107|NCT00980330|20716597|P5|Overall Study|Adverse Event|0
5991108|NCT00980330|20716598|P4|Overall Study|Adverse Event|1
5991109|NCT00980330|20716599|P3|Overall Study|Adverse Event|0
5991110|NCT00980330|20716600|P2|Overall Study|Adverse Event|0
5991111|NCT00980330|20716601|P1|Overall Study|Adverse Event|0
5991112|NCT00980200|20716716|P5|7-day Treatment Period 3|Lack of Efficacy|1
5991113|NCT00980200|20716717|P4|7-day Treatment Period 3|Lack of Efficacy|0
5991114|NCT00980200|20716718|P3|7-day Treatment Period 3|Lack of Efficacy|0
5991115|NCT00980200|20716719|P2|7-day Treatment Period 3|Lack of Efficacy|1
5991116|NCT00980200|20716720|P1|7-day Treatment Period 3|Lack of Efficacy|0
5991117|NCT00980200|20716716|P5|7-day Treatment Period 1|Withdrawal by Subject|0
5991118|NCT00980200|20716717|P4|7-day Treatment Period 1|Withdrawal by Subject|0
5991119|NCT00980200|20716718|P3|7-day Treatment Period 1|Withdrawal by Subject|0
5991120|NCT00980200|20716719|P2|7-day Treatment Period 1|Withdrawal by Subject|1
5991121|NCT00980200|20716720|P1|7-day Treatment Period 1|Withdrawal by Subject|0
5991122|NCT00980174|20716739|P2|Overall Study|Other|1
5991123|NCT00980174|20716740|P1|Overall Study|Other|0
5991124|NCT00980174|20716739|P2|Overall Study|Death|1
5991125|NCT00980174|20716740|P1|Overall Study|Death|1
5991126|NCT00980174|20716739|P2|Overall Study|Ineligibility determined|1
5991127|NCT00980174|20716740|P1|Overall Study|Ineligibility determined|2
5991128|NCT00980174|20716739|P2|Overall Study|Adverse Event|3
5991129|NCT00980174|20716740|P1|Overall Study|Adverse Event|0
5991130|NCT00980174|20716739|P2|Overall Study|Withdrawal by Subject|4
5991131|NCT00980174|20716740|P1|Overall Study|Withdrawal by Subject|1
5991132|NCT00980148|20716758|P2|Overall Study|Various other reasons|9
5991133|NCT00980148|20716759|P1|Overall Study|Various other reasons|8
5991134|NCT00980148|20716758|P2|Overall Study|Negative for chlamydia at enrollment|9
5991135|NCT00980148|20716759|P1|Overall Study|Negative for chlamydia at enrollment|12
5991136|NCT00980148|20716758|P2|Overall Study|Received other antichlamydia treatment|14
5991137|NCT00980148|20716759|P1|Overall Study|Received other antichlamydia treatment|20
5991138|NCT00980148|20716758|P2|Overall Study|Discharged from facility|96
5991139|NCT00980148|20716759|P1|Overall Study|Discharged from facility|89
5991140|NCT00980057|20716767|P2|Overall Study|Withdrawal by Subject|1
5991141|NCT00980057|20716768|P1|Overall Study|Withdrawal by Subject|1
5991142|NCT00980057|20716767|P2|Overall Study|Lost to Follow-up|0
5991143|NCT00980057|20716768|P1|Overall Study|Lost to Follow-up|1
5991144|NCT00980057|20716767|P2|Overall Study|Physician Decision|0
5991145|NCT00980057|20716768|P1|Overall Study|Physician Decision|4
5991146|NCT00980057|20716767|P2|Overall Study|Adverse Event|1
5991147|NCT00980057|20716768|P1|Overall Study|Adverse Event|0
5991148|NCT00980057|20716767|P2|Overall Study|Death|3
5991149|NCT00980057|20716768|P1|Overall Study|Death|13
5991150|NCT00980044|20716791|P3|Overall Study|Protocol Violation|2
5991151|NCT00980044|20716792|P2|Overall Study|Protocol Violation|0
5991152|NCT00980044|20716793|P1|Overall Study|Protocol Violation|0
5991153|NCT00980044|20716791|P3|Overall Study|Withdrawal by Subject|3
5991154|NCT00980044|20716792|P2|Overall Study|Withdrawal by Subject|7
5991155|NCT00980044|20716793|P1|Overall Study|Withdrawal by Subject|5
5991156|NCT00980005|20716812|P2|Overall Study|Other|3
5991157|NCT00980005|20716813|P1|Overall Study|Other|4
5991158|NCT00980005|20716812|P2|Overall Study|Lost to Follow-up|43
5991159|NCT00980005|20716813|P1|Overall Study|Lost to Follow-up|37
5991160|NCT00980005|20716812|P2|Overall Study|Withdrawal by Subject|17
5991161|NCT00980005|20716813|P1|Overall Study|Withdrawal by Subject|6
5991162|NCT00979992|20716853|P1|Overall Study|Refused - Never Treated|2
5991163|NCT00979992|20716853|P1|Overall Study|Ineligible - wrong cell type|2
5991164|NCT00979992|20716853|P1|Overall Study|Ineligible - inadequate pathology|1
5991165|NCT00979953|20716865|P4|Overall Study|Protocol Violation|2
5991166|NCT00979953|20716866|P3|Overall Study|Protocol Violation|2
5991167|NCT00979953|20716867|P2|Overall Study|Protocol Violation|0
5991168|NCT00979953|20716868|P1|Overall Study|Protocol Violation|1
5991169|NCT00979953|20716865|P4|Overall Study|Withdrawal by Subject|1
5991170|NCT00979953|20716866|P3|Overall Study|Withdrawal by Subject|2
5991171|NCT00979953|20716867|P2|Overall Study|Withdrawal by Subject|0
5991172|NCT00979953|20716868|P1|Overall Study|Withdrawal by Subject|0
5991173|NCT00979953|20716865|P4|Overall Study|Lost to Follow-up|0
5991174|NCT00979953|20716866|P3|Overall Study|Lost to Follow-up|1
5991175|NCT00979953|20716867|P2|Overall Study|Lost to Follow-up|1
5991176|NCT00979953|20716868|P1|Overall Study|Lost to Follow-up|1
5991177|NCT00979953|20716865|P4|Overall Study|Lack of Efficacy|0
5991178|NCT00979953|20716866|P3|Overall Study|Lack of Efficacy|0
5991179|NCT00979953|20716867|P2|Overall Study|Lack of Efficacy|2
5991180|NCT00979953|20716868|P1|Overall Study|Lack of Efficacy|1
5991181|NCT00979953|20716865|P4|Overall Study|Adverse Event|4
5991182|NCT00979953|20716866|P3|Overall Study|Adverse Event|17
5991183|NCT00979953|20716867|P2|Overall Study|Adverse Event|2
5991184|NCT00979953|20716868|P1|Overall Study|Adverse Event|5
5991185|NCT00979901|20716891|P4|Overall Study|Treatment Group Terminated by Sponsor|112
5991186|NCT00979901|20716892|P3|Overall Study|Treatment Group Terminated by Sponsor|0
5991187|NCT00979901|20716893|P2|Overall Study|Treatment Group Terminated by Sponsor|0
5991188|NCT00979901|20716894|P1|Overall Study|Treatment Group Terminated by Sponsor|0
5991189|NCT00979901|20716891|P4|Overall Study|Left Country|0
5991190|NCT00979901|20716892|P3|Overall Study|Left Country|1
5991191|NCT00979901|20716893|P2|Overall Study|Left Country|0
5991192|NCT00979901|20716894|P1|Overall Study|Left Country|0
5991193|NCT00979901|20716891|P4|Overall Study|Discontinued in Error|0
5991194|NCT00979901|20716892|P3|Overall Study|Discontinued in Error|0
5991195|NCT00979901|20716893|P2|Overall Study|Discontinued in Error|1
5991196|NCT00979901|20716894|P1|Overall Study|Discontinued in Error|0
5991197|NCT00979901|20716891|P4|Overall Study|elevated lab values pre-randomization|0
5991198|NCT00979901|20716892|P3|Overall Study|elevated lab values pre-randomization|0
5991199|NCT00979901|20716893|P2|Overall Study|elevated lab values pre-randomization|0
5991200|NCT00979901|20716894|P1|Overall Study|elevated lab values pre-randomization|1
5991201|NCT00979901|20716891|P4|Overall Study|vacation|0
5991202|NCT00979901|20716892|P3|Overall Study|vacation|0
5991203|NCT00979901|20716893|P2|Overall Study|vacation|0
5991204|NCT00979901|20716894|P1|Overall Study|vacation|1
5991205|NCT00979901|20716891|P4|Overall Study|out-of-state|0
5991206|NCT00979901|20716892|P3|Overall Study|out-of-state|0
5991207|NCT00979901|20716893|P2|Overall Study|out-of-state|0
5991208|NCT00979901|20716894|P1|Overall Study|out-of-state|1
5991209|NCT00979901|20716891|P4|Overall Study|Noncompliance|0
5991210|NCT00979901|20716892|P3|Overall Study|Noncompliance|0
5991211|NCT00979901|20716893|P2|Overall Study|Noncompliance|0
5991212|NCT00979901|20716894|P1|Overall Study|Noncompliance|1
5991213|NCT00979901|20716891|P4|Overall Study|Withdrawal by Subject|1
5991214|NCT00979901|20716892|P3|Overall Study|Withdrawal by Subject|1
5991215|NCT00979901|20716893|P2|Overall Study|Withdrawal by Subject|1
5991216|NCT00979901|20716894|P1|Overall Study|Withdrawal by Subject|2
5991217|NCT00979901|20716891|P4|Overall Study|Protocol Violation|1
5991218|NCT00979901|20716892|P3|Overall Study|Protocol Violation|7
5991219|NCT00979901|20716893|P2|Overall Study|Protocol Violation|2
5991220|NCT00979901|20716894|P1|Overall Study|Protocol Violation|2
5991221|NCT00979901|20716891|P4|Overall Study|Lost to Follow-up|0
5991222|NCT00979901|20716892|P3|Overall Study|Lost to Follow-up|2
5991223|NCT00979901|20716893|P2|Overall Study|Lost to Follow-up|1
5991224|NCT00979901|20716894|P1|Overall Study|Lost to Follow-up|1
5991225|NCT00979901|20716891|P4|Overall Study|Lack of Efficacy|0
5991226|NCT00979901|20716892|P3|Overall Study|Lack of Efficacy|9
5991227|NCT00979901|20716893|P2|Overall Study|Lack of Efficacy|4
5991228|NCT00979901|20716894|P1|Overall Study|Lack of Efficacy|8
5991229|NCT00979901|20716891|P4|Overall Study|Adverse Event|2
5991230|NCT00979901|20716892|P3|Overall Study|Adverse Event|9
5991231|NCT00979901|20716893|P2|Overall Study|Adverse Event|3
5991232|NCT00979901|20716894|P1|Overall Study|Adverse Event|1
5991233|NCT00979654|20716974|P1|Overall Study|Unfavorable Risk-Benefit Analysis|1
5991234|NCT00979654|20716974|P1|Overall Study|Serious Adverse Event|1
5991235|NCT00979654|20716974|P1|Overall Study|Patient Wanted to Pursue Other Treatment|1
5991236|NCT00979654|20716974|P1|Overall Study|Per Principal Investigator's Discretion|1
5991237|NCT00979654|20716974|P1|Overall Study|Adverse Event of Diverticulitis|1
5991238|NCT00979654|20716974|P1|Overall Study|Adverse Event|1
5991239|NCT00979654|20716974|P1|Overall Study|Lack of Efficacy|6
5991240|NCT00979654|20716974|P1|Overall Study|Death|1
5991241|NCT00979654|20716974|P1|Overall Study|Withdrawal by Subject|22
5991242|NCT00979654|20716974|P1|Overall Study|Lost to Follow-up|1
5991243|NCT00979628|20716989|P3|Overall Study|transferred to ICU|1
5991244|NCT00979628|20716990|P2|Overall Study|transferred to ICU|2
5991245|NCT00979628|20716991|P1|Overall Study|transferred to ICU|1
5991246|NCT00979628|20716989|P3|Overall Study|received steroids|0
5991247|NCT00979628|20716990|P2|Overall Study|received steroids|1
5991248|NCT00979628|20716991|P1|Overall Study|received steroids|1
5991249|NCT00979628|20716989|P3|Overall Study|received regimen < 24 hours|5
5991250|NCT00979628|20716990|P2|Overall Study|received regimen < 24 hours|6
5991251|NCT00979628|20716991|P1|Overall Study|received regimen < 24 hours|7
5991252|NCT00979602|20717021|P2|Overall Study|Others|3
5991253|NCT00979602|20717022|P1|Overall Study|Others|3
5991254|NCT00979602|20717021|P2|Overall Study|Migrated/moved from study area|6
5991255|NCT00979602|20717022|P1|Overall Study|Migrated/moved from study area|3
5991256|NCT00979602|20717021|P2|Overall Study|Lost to Follow-up|96
5991257|NCT00979602|20717022|P1|Overall Study|Lost to Follow-up|100
5991258|NCT00979602|20717021|P2|Overall Study|Withdrawal by Subject|25
5991259|NCT00979602|20717022|P1|Overall Study|Withdrawal by Subject|31
5991260|NCT00979602|20717021|P2|Overall Study|Protocol Violation|0
5991261|NCT00979602|20717022|P1|Overall Study|Protocol Violation|3
5991262|NCT00979602|20717021|P2|Overall Study|Serious Adverse Event|3
5991263|NCT00979602|20717022|P1|Overall Study|Serious Adverse Event|5
5991264|NCT00979576|20717193|P3|Combination Followed by Monotherapy|Progressive Disease|1
5991265|NCT00979576|20717194|P2|Combination Followed by Monotherapy|Progressive Disease|2
5991266|NCT00979576|20717195|P1|Combination Followed by Monotherapy|Progressive Disease|0
5991267|NCT00979576|20717193|P3|Combination Treatment Phase|Adverse Event|2
5991268|NCT00979576|20717194|P2|Combination Treatment Phase|Adverse Event|2
5991269|NCT00979576|20717195|P1|Combination Treatment Phase|Adverse Event|0
5991270|NCT00979576|20717193|P3|Combination Treatment Phase|Dose limiting toxicity|2
5991271|NCT00979576|20717194|P2|Combination Treatment Phase|Dose limiting toxicity|3
5991272|NCT00979576|20717195|P1|Combination Treatment Phase|Dose limiting toxicity|0
5991273|NCT00979576|20717193|P3|Combination Treatment Phase|Progressive disease|5
5991274|NCT00979576|20717194|P2|Combination Treatment Phase|Progressive disease|1
5991275|NCT00979576|20717195|P1|Combination Treatment Phase|Progressive disease|3
5991276|NCT00979420|20717252|P4|Overall Study|Other reasons not related to Viramune|1
5991277|NCT00979420|20717253|P3|Overall Study|Other reasons not related to Viramune|0
5991278|NCT00979420|20717254|P2|Overall Study|Other reasons not related to Viramune|0
5991279|NCT00979420|20717255|P1|Overall Study|Other reasons not related to Viramune|3
5991280|NCT00979420|20717252|P4|Overall Study|Lack of Efficacy|1
5991281|NCT00979420|20717253|P3|Overall Study|Lack of Efficacy|1
5991282|NCT00979420|20717254|P2|Overall Study|Lack of Efficacy|0
5991283|NCT00979420|20717255|P1|Overall Study|Lack of Efficacy|3
5991284|NCT00979420|20717252|P4|Overall Study|Adverse Event|0
5991285|NCT00979420|20717253|P3|Overall Study|Adverse Event|0
5991286|NCT00979420|20717254|P2|Overall Study|Adverse Event|0
5991287|NCT00979420|20717255|P1|Overall Study|Adverse Event|1
5991288|NCT00979407|20717325|P2|Overall Study|Lost to Follow-up|3
5991289|NCT00979407|20717326|P1|Overall Study|Lost to Follow-up|3
5991290|NCT00979407|20717325|P2|Overall Study|Withdrawal by Subject|4
5991291|NCT00979407|20717326|P1|Overall Study|Withdrawal by Subject|3
5991292|NCT00979212|20717379|P2|Overall Study|No protocol therapy received|0
5991293|NCT00979212|20717380|P1|Overall Study|No protocol therapy received|1
5991294|NCT00979212|20717379|P2|Overall Study|Protocol Violation|8
5991295|NCT00979212|20717380|P1|Overall Study|Protocol Violation|1
5991296|NCT00979134|20717417|P3|Overall Study|Other|5
5991297|NCT00979134|20717418|P2|Overall Study|Other|1
5991298|NCT00979134|20717419|P1|Overall Study|Other|8
5991299|NCT00979134|20717417|P3|Overall Study|Death|26
5991300|NCT00979134|20717418|P2|Overall Study|Death|0
5991301|NCT00979134|20717419|P1|Overall Study|Death|4
5991302|NCT00979134|20717417|P3|Overall Study|Lost to Follow-up|0
5991303|NCT00979134|20717418|P2|Overall Study|Lost to Follow-up|2
5991304|NCT00979134|20717419|P1|Overall Study|Lost to Follow-up|2
5991305|NCT00979134|20717417|P3|Overall Study|Withdrawal by Subject|2
5991306|NCT00979134|20717418|P2|Overall Study|Withdrawal by Subject|1
5991307|NCT00979134|20717419|P1|Overall Study|Withdrawal by Subject|1
5991308|NCT00979134|20717417|P3|Overall Study|Adverse Event|2
5991309|NCT00979134|20717418|P2|Overall Study|Adverse Event|0
5991310|NCT00979134|20717419|P1|Overall Study|Adverse Event|0
5991311|NCT00979134|20717417|P3|Overall Study|Disease progression|5
5991312|NCT00979134|20717418|P2|Overall Study|Disease progression|2
5991313|NCT00979134|20717419|P1|Overall Study|Disease progression|18
5991314|NCT00978757|20717507|P2|Overall Study|Physician Decision|3
5991315|NCT00978757|20717508|P1|Overall Study|Physician Decision|1
5991316|NCT00978731|20717518|P4|Overall Study|No response|0
5991317|NCT00978731|20717519|P3|Overall Study|No response|0
5991318|NCT00978731|20717520|P2|Overall Study|No response|0
5991319|NCT00978731|20717521|P1|Overall Study|No response|1
5991320|NCT00978731|20717518|P4|Overall Study|Study closure|1
5991321|NCT00978731|20717519|P3|Overall Study|Study closure|1
5991322|NCT00978731|20717520|P2|Overall Study|Study closure|4
5991323|NCT00978731|20717521|P1|Overall Study|Study closure|3
5991324|NCT00978731|20717518|P4|Overall Study|Disease progression/relapse|2
5991325|NCT00978731|20717519|P3|Overall Study|Disease progression/relapse|2
5991326|NCT00978731|20717520|P2|Overall Study|Disease progression/relapse|4
5991327|NCT00978731|20717521|P1|Overall Study|Disease progression/relapse|5
5991328|NCT00978731|20717518|P4|Overall Study|Deterioration without progression|0
5991329|NCT00978731|20717519|P3|Overall Study|Deterioration without progression|0
5991330|NCT00978731|20717520|P2|Overall Study|Deterioration without progression|1
5991331|NCT00978731|20717521|P1|Overall Study|Deterioration without progression|0
5991332|NCT00978731|20717518|P4|Overall Study|Administrative reason|0
5991333|NCT00978731|20717519|P3|Overall Study|Administrative reason|1
5991334|NCT00978731|20717520|P2|Overall Study|Administrative reason|3
5991335|NCT00978731|20717521|P1|Overall Study|Administrative reason|3
5991336|NCT00978731|20717518|P4|Overall Study|Participant's request|0
5991337|NCT00978731|20717519|P3|Overall Study|Participant's request|0
5991338|NCT00978731|20717520|P2|Overall Study|Participant's request|0
5991339|NCT00978731|20717521|P1|Overall Study|Participant's request|1
5991340|NCT00978731|20717518|P4|Overall Study|Adverse Event|0
5991341|NCT00978731|20717519|P3|Overall Study|Adverse Event|0
5991342|NCT00978731|20717520|P2|Overall Study|Adverse Event|2
5991343|NCT00978731|20717521|P1|Overall Study|Adverse Event|5
5991344|NCT00978731|20717518|P4|Overall Study|Lost to Follow-up|1
5991345|NCT00978731|20717519|P3|Overall Study|Lost to Follow-up|0
5991346|NCT00978731|20717520|P2|Overall Study|Lost to Follow-up|0
5991347|NCT00978731|20717521|P1|Overall Study|Lost to Follow-up|0
5991348|NCT00978731|20717518|P4|Overall Study|Death|0
5991349|NCT00978731|20717519|P3|Overall Study|Death|1
5991350|NCT00978731|20717520|P2|Overall Study|Death|1
5991351|NCT00978731|20717521|P1|Overall Study|Death|4
5991352|NCT00978627|20717561|P2|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|7
5991353|NCT00978627|20717562|P1|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|12
5991354|NCT00978627|20717561|P2|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|1
5991355|NCT00978627|20717562|P1|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|2
5991356|NCT00978627|20717561|P2|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|1
5991357|NCT00978627|20717562|P1|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|4
5991358|NCT00978627|20717561|P2|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|0
5991359|NCT00978627|20717562|P1|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|3
5991360|NCT00978627|20717561|P2|Main: Week 0 to 26 (NN5401-3594)|Unclassified|12
5991361|NCT00978627|20717562|P1|Main: Week 0 to 26 (NN5401-3594)|Unclassified|25
5991362|NCT00978627|20717561|P2|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|5
5991363|NCT00978627|20717562|P1|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|7
5991364|NCT00978627|20717561|P2|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|6
5991365|NCT00978627|20717562|P1|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|8
5991366|NCT00978627|20717561|P2|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|0
5991367|NCT00978627|20717562|P1|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|2
5991368|NCT00978627|20717561|P2|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|3
5991369|NCT00978627|20717562|P1|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|4
5991370|NCT00978432|20717600|P3|Overall Study|Adverse Event|1
5991371|NCT00978432|20717601|P2|Overall Study|Adverse Event|0
5991372|NCT00978432|20717602|P1|Overall Study|Adverse Event|2
5991373|NCT00978432|20717600|P3|Overall Study|Lack of Efficacy|3
5991374|NCT00978432|20717601|P2|Overall Study|Lack of Efficacy|1
5991375|NCT00978432|20717602|P1|Overall Study|Lack of Efficacy|1
5991376|NCT00978432|20717600|P3|Overall Study|Withdrawal by Subject|1
5991377|NCT00978432|20717601|P2|Overall Study|Withdrawal by Subject|0
5991378|NCT00978432|20717602|P1|Overall Study|Withdrawal by Subject|0
5991379|NCT00978380|20717653|P1|Overall Study|Unclassified|8
5991380|NCT00978380|20717653|P1|Overall Study|Withdrawal criteria|9
5991381|NCT00978380|20717653|P1|Overall Study|Protocol Violation|2
5991382|NCT00978341|20717659|P2|Washout Period of 2 Weeks|Adverse Event|0
5991383|NCT00978341|20717660|P1|Washout Period of 2 Weeks|Adverse Event|1
5991384|NCT00978250|20717682|P4|Overall Study|Late determination of ineligibility|1
5991385|NCT00978250|20717683|P3|Overall Study|Late determination of ineligibility|0
5991386|NCT00978250|20717684|P2|Overall Study|Late determination of ineligibility|1
5991387|NCT00978250|20717685|P1|Overall Study|Late determination of ineligibility|0
5991388|NCT00978120|20717701|P4|Overall Study|Moved out of state|1
5991389|NCT00978120|20717702|P3|Overall Study|Moved out of state|0
5991390|NCT00978120|20717703|P2|Overall Study|Moved out of state|0
5991391|NCT00978120|20717704|P1|Overall Study|Moved out of state|0
5991392|NCT00978120|20717701|P4|Overall Study|Withdrawal by Subject|0
5991393|NCT00978120|20717702|P3|Overall Study|Withdrawal by Subject|0
5991394|NCT00978120|20717703|P2|Overall Study|Withdrawal by Subject|0
5991395|NCT00978120|20717704|P1|Overall Study|Withdrawal by Subject|2
5991396|NCT00978120|20717701|P4|Overall Study|Lost to Follow-up|0
5991397|NCT00978120|20717702|P3|Overall Study|Lost to Follow-up|3
5991398|NCT00978120|20717703|P2|Overall Study|Lost to Follow-up|0
5991399|NCT00978120|20717704|P1|Overall Study|Lost to Follow-up|0
5991400|NCT00978120|20717701|P4|Overall Study|Death|1
5991401|NCT00978120|20717702|P3|Overall Study|Death|0
5991402|NCT00978120|20717703|P2|Overall Study|Death|0
5991403|NCT00978120|20717704|P1|Overall Study|Death|0
5991404|NCT00978068|20717756|P2|Overall Study|Unable to Comply with Study|2
5991405|NCT00978068|20717757|P1|Overall Study|Unable to Comply with Study|0
5991406|NCT00978068|20717756|P2|Overall Study|Physician Decision|1
5991407|NCT00978068|20717757|P1|Overall Study|Physician Decision|0
5991408|NCT00978068|20717756|P2|Overall Study|Lost to Follow-up|2
5991409|NCT00978068|20717757|P1|Overall Study|Lost to Follow-up|1
5991410|NCT00978068|20717756|P2|Overall Study|Death|2
5991411|NCT00978068|20717757|P1|Overall Study|Death|1
5991412|NCT00978068|20717756|P2|Overall Study|Were Awaiting Initiation of ART|2
5991413|NCT00978068|20717757|P1|Overall Study|Were Awaiting Initiation of ART|2
5991414|NCT00978042|20717775|P2|Initial Treatment Period|Other Miscellaneous Reasons|0
5991415|NCT00978042|20717776|P1|Initial Treatment Period|Other Miscellaneous Reasons|13
5991416|NCT00978042|20717775|P2|Initial Treatment Period|Consent withdrawn|9
5991417|NCT00978042|20717776|P1|Initial Treatment Period|Consent withdrawn|22
5991418|NCT00978042|20717775|P2|Initial Treatment Period|Discontinuation by Investigator/Sponsor|0
5991419|NCT00978042|20717776|P1|Initial Treatment Period|Discontinuation by Investigator/Sponsor|2
5991420|NCT00978042|20717775|P2|Initial Treatment Period|Adverse Event|0
5991421|NCT00978042|20717776|P1|Initial Treatment Period|Adverse Event|2
5991422|NCT00978042|20717775|P2|Initial Treatment Period|Lost to Follow-up|3
5991423|NCT00978042|20717776|P1|Initial Treatment Period|Lost to Follow-up|21
5991424|NCT00978042|20717775|P2|Initial Treatment Period|Ineligibility|0
5991425|NCT00978042|20717776|P1|Initial Treatment Period|Ineligibility|1
5991426|NCT00978042|20717775|P2|Initial Treatment Period|Treated in Error|3
5991427|NCT00978042|20717776|P1|Initial Treatment Period|Treated in Error|0
5991428|NCT00978029|20717789|P3|Overall Study|Protocol Violation|0
5991429|NCT00978029|20717790|P2|Overall Study|Protocol Violation|1
5991430|NCT00978029|20717791|P1|Overall Study|Protocol Violation|0
5991431|NCT00978029|20717789|P3|Overall Study|Withdrawal by Subject|1
5991432|NCT00978029|20717790|P2|Overall Study|Withdrawal by Subject|0
5991433|NCT00978029|20717791|P1|Overall Study|Withdrawal by Subject|0
5991434|NCT00978029|20717789|P3|Overall Study|Adverse Event|5
5991435|NCT00978029|20717790|P2|Overall Study|Adverse Event|2
5991436|NCT00978029|20717791|P1|Overall Study|Adverse Event|1
5991437|NCT00977938|20717818|P4|Observation (30-33 mo. Post Procedure)|Other|0
5991438|NCT00977938|20717819|P3|Observation (30-33 mo. Post Procedure)|Other|0
5991439|NCT00977938|20717820|P2|Observation (30-33 mo. Post Procedure)|Other|4
5991440|NCT00977938|20717821|P1|Observation (30-33 mo. Post Procedure)|Other|8
5991441|NCT00977938|20717818|P4|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|3
5991442|NCT00977938|20717819|P3|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|10
5991443|NCT00977938|20717820|P2|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|42
5991444|NCT00977938|20717821|P1|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|34
5991445|NCT00977938|20717818|P4|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|0
5991446|NCT00977938|20717819|P3|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|2
5991447|NCT00977938|20717820|P2|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|12
5991448|NCT00977938|20717821|P1|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|9
5991449|NCT00977938|20717818|P4|Treatment (12-30 mo. Post Procedure)|Other|4
5991450|NCT00977938|20717819|P3|Treatment (12-30 mo. Post Procedure)|Other|3
5991451|NCT00977938|20717820|P2|Treatment (12-30 mo. Post Procedure)|Other|18
5991452|NCT00977938|20717821|P1|Treatment (12-30 mo. Post Procedure)|Other|17
5991453|NCT00977938|20717818|P4|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|37
5991454|NCT00977938|20717819|P3|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|30
5991455|NCT00977938|20717820|P2|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|91
5991456|NCT00977938|20717821|P1|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|88
5991457|NCT00977938|20717818|P4|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|20
5991458|NCT00977938|20717819|P3|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|13
5991459|NCT00977938|20717820|P2|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|116
5991460|NCT00977938|20717821|P1|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|132
5991461|NCT00977665|20717898|P2|Overall Study|Treatment failure|1
5991462|NCT00977665|20717899|P1|Overall Study|Treatment failure|0
5991463|NCT00977665|20717898|P2|Overall Study|Adverse Event|7
5991464|NCT00977665|20717899|P1|Overall Study|Adverse Event|14
5991465|NCT00977665|20717898|P2|Overall Study|Death|2
5991466|NCT00977665|20717899|P1|Overall Study|Death|3
5991467|NCT00977665|20717898|P2|Overall Study|Lost to Follow-up|0
5991468|NCT00977665|20717899|P1|Overall Study|Lost to Follow-up|1
5991469|NCT00977665|20717898|P2|Overall Study|Sponsor requested withdrawal|1
5991470|NCT00977665|20717899|P1|Overall Study|Sponsor requested withdrawal|0
5991471|NCT00977665|20717898|P2|Overall Study|Physician Decision|1
5991472|NCT00977665|20717899|P1|Overall Study|Physician Decision|2
5991473|NCT00977665|20717898|P2|Overall Study|Withdrawal by Subject|3
5991474|NCT00977665|20717899|P1|Overall Study|Withdrawal by Subject|1
5991475|NCT00977613|20717931|P1|Overall Study|Lost to Follow-up|16
5991479|NCT00977561|20717959|P2|Overall Study|Other|0
5991480|NCT00977561|20717960|P1|Overall Study|Other|2
5991481|NCT00977561|20717959|P2|Overall Study|Study terminated|2
5991482|NCT00977561|20717960|P1|Overall Study|Study terminated|0
5991483|NCT00977561|20717959|P2|Overall Study|Death|2
5991484|NCT00977561|20717960|P1|Overall Study|Death|3
5991485|NCT00977548|20717987|P1|Overall Study|Withdrawal by Subject|1
5991486|NCT00977548|20717987|P1|Overall Study|Adverse Event|8
5991487|NCT00977548|20717987|P1|Overall Study|Ineligible|4
5991488|NCT00977470|20717996|P2|Overall Study|Still on-study|0
5991489|NCT00977470|20717997|P1|Overall Study|Still on-study|2
5991490|NCT00977470|20717996|P2|Overall Study|prolonged recovery post-surgery|1
5991491|NCT00977470|20717997|P1|Overall Study|prolonged recovery post-surgery|0
5991492|NCT00977470|20717996|P2|Overall Study|clinical decline|1
5991493|NCT00977470|20717997|P1|Overall Study|clinical decline|0
5991494|NCT00977470|20717996|P2|Overall Study|Death|2
5991495|NCT00977470|20717997|P1|Overall Study|Death|0
5991496|NCT00977470|20717996|P2|Overall Study|Withdrawal by Subject|2
5991497|NCT00977470|20717997|P1|Overall Study|Withdrawal by Subject|0
5991498|NCT00977470|20717996|P2|Overall Study|Protocol Violation|0
5991499|NCT00977470|20717997|P1|Overall Study|Protocol Violation|1
5991500|NCT00977470|20717996|P2|Overall Study|Adverse Event|2
5991501|NCT00977470|20717997|P1|Overall Study|Adverse Event|1
5991502|NCT00977470|20717996|P2|Overall Study|Physician Decision|0
5991503|NCT00977470|20717997|P1|Overall Study|Physician Decision|2
5991504|NCT00977470|20717996|P2|Overall Study|Lack of Efficacy|30
5991505|NCT00977470|20717997|P1|Overall Study|Lack of Efficacy|32
5991506|NCT00977431|20718020|P5|Overall Study|Progressive disease|5
5991507|NCT00977431|20718021|P4|Overall Study|Progressive disease|3
5991508|NCT00977431|20718022|P3|Overall Study|Progressive disease|1
5991509|NCT00977431|20718023|P2|Overall Study|Progressive disease|6
5991510|NCT00977431|20718024|P1|Overall Study|Progressive disease|2
5991511|NCT00977431|20718020|P5|Overall Study|Dose-limiting toxicity (DLT)|0
5991512|NCT00977431|20718021|P4|Overall Study|Dose-limiting toxicity (DLT)|0
5991513|NCT00977431|20718022|P3|Overall Study|Dose-limiting toxicity (DLT)|1
5991514|NCT00977431|20718023|P2|Overall Study|Dose-limiting toxicity (DLT)|0
5991515|NCT00977431|20718024|P1|Overall Study|Dose-limiting toxicity (DLT)|1
5991516|NCT00977431|20718020|P5|Overall Study|Adverse Event|6
5991517|NCT00977431|20718021|P4|Overall Study|Adverse Event|0
5991518|NCT00977431|20718022|P3|Overall Study|Adverse Event|4
5991519|NCT00977431|20718023|P2|Overall Study|Adverse Event|0
5991520|NCT00977431|20718024|P1|Overall Study|Adverse Event|3
5991521|NCT00977431|20718020|P5|Overall Study|Protocol Violation|0
5991522|NCT00977431|20718021|P4|Overall Study|Protocol Violation|0
5991523|NCT00977431|20718022|P3|Overall Study|Protocol Violation|1
5991524|NCT00977431|20718023|P2|Overall Study|Protocol Violation|0
5991525|NCT00977431|20718024|P1|Overall Study|Protocol Violation|0
5991526|NCT00977431|20718020|P5|Overall Study|Other than listed|2
5991527|NCT00977431|20718021|P4|Overall Study|Other than listed|0
5991528|NCT00977431|20718022|P3|Overall Study|Other than listed|0
5991529|NCT00977431|20718023|P2|Overall Study|Other than listed|0
5991530|NCT00977431|20718024|P1|Overall Study|Other than listed|1
5991531|NCT00977379|20718057|P2|Overall Study|Randomization Error|1
5991532|NCT00977379|20718058|P1|Overall Study|Randomization Error|0
5991533|NCT00977379|20718057|P2|Overall Study|Participant Moving House|1
5991534|NCT00977379|20718058|P1|Overall Study|Participant Moving House|0
5991535|NCT00977379|20718057|P2|Overall Study|Premature Study Termination|0
5991536|NCT00977379|20718058|P1|Overall Study|Premature Study Termination|4
5991537|NCT00977379|20718057|P2|Overall Study|Death|9
5991538|NCT00977379|20718058|P1|Overall Study|Death|7
5991539|NCT00977379|20718057|P2|Overall Study|Withdrawal by Subject|1
5991540|NCT00977379|20718058|P1|Overall Study|Withdrawal by Subject|1
5991541|NCT00977314|20718094|P2|Overall Study|Physician Decision|0
5991542|NCT00977314|20718095|P1|Overall Study|Physician Decision|1
5991543|NCT00977314|20718094|P2|Overall Study|Withdrawal by Subject|0
5991544|NCT00977314|20718095|P1|Overall Study|Withdrawal by Subject|1
5991545|NCT00977197|20718103|P2|Overall Study|Nonadherence|1
5991546|NCT00977197|20718104|P1|Overall Study|Nonadherence|1
5991547|NCT00977197|20718103|P2|Overall Study|Lost to Follow-up|3
5991548|NCT00977197|20718104|P1|Overall Study|Lost to Follow-up|1
5991549|NCT00977197|20718103|P2|Overall Study|Lack of Efficacy|0
5991550|NCT00977197|20718104|P1|Overall Study|Lack of Efficacy|1
5991551|NCT00977197|20718103|P2|Overall Study|Adverse Event|1
5991552|NCT00977197|20718104|P1|Overall Study|Adverse Event|3
5991553|NCT00977197|20718103|P2|Overall Study|Withdrawal by Subject|4
5991554|NCT00977197|20718104|P1|Overall Study|Withdrawal by Subject|3
5991555|NCT00977106|20718167|P2|Overall Study|Other|0
5991556|NCT00977106|20718168|P1|Overall Study|Other|1
5991557|NCT00977106|20718167|P2|Overall Study|Protocol Violation|1
5991558|NCT00977106|20718168|P1|Overall Study|Protocol Violation|0
5991559|NCT00977106|20718167|P2|Overall Study|Lack of Efficacy|2
5991560|NCT00977106|20718168|P1|Overall Study|Lack of Efficacy|2
5991561|NCT00977106|20718167|P2|Overall Study|Withdrawal by Subject|2
5991562|NCT00977106|20718168|P1|Overall Study|Withdrawal by Subject|2
5991563|NCT00977106|20718167|P2|Overall Study|Adverse Event|6
5991564|NCT00977106|20718168|P1|Overall Study|Adverse Event|5
5991565|NCT00977080|20718260|P4|Overall Study|Travel for family reasons|0
5991566|NCT00977080|20718261|P3|Overall Study|Travel for family reasons|0
5991567|NCT00977080|20718262|P2|Overall Study|Travel for family reasons|0
5991568|NCT00977080|20718263|P1|Overall Study|Travel for family reasons|1
5991569|NCT00977080|20718260|P4|Overall Study|Required kidney transplantation|1
5991570|NCT00977080|20718261|P3|Overall Study|Required kidney transplantation|3
5991571|NCT00977080|20718262|P2|Overall Study|Required kidney transplantation|3
5991572|NCT00977080|20718263|P1|Overall Study|Required kidney transplantation|1
5991573|NCT00977080|20718260|P4|Overall Study|Calcium < 7.5 mg/dL on 3 draws|1
5991574|NCT00977080|20718261|P3|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0
5991575|NCT00977080|20718262|P2|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0
5991576|NCT00977080|20718263|P1|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0
5991577|NCT00977080|20718260|P4|Overall Study|Noncompliance|0
5991578|NCT00977080|20718261|P3|Overall Study|Noncompliance|1
5991579|NCT00977080|20718262|P2|Overall Study|Noncompliance|2
5991580|NCT00977080|20718263|P1|Overall Study|Noncompliance|0
5991581|NCT00977080|20718260|P4|Overall Study|Protocol Violation|3
5991582|NCT00977080|20718261|P3|Overall Study|Protocol Violation|4
5991583|NCT00977080|20718262|P2|Overall Study|Protocol Violation|3
5991584|NCT00977080|20718263|P1|Overall Study|Protocol Violation|7
5991585|NCT00977080|20718260|P4|Overall Study|Withdrawal by Subject|5
5991586|NCT00977080|20718261|P3|Overall Study|Withdrawal by Subject|1
5991587|NCT00977080|20718262|P2|Overall Study|Withdrawal by Subject|5
5991588|NCT00977080|20718263|P1|Overall Study|Withdrawal by Subject|1
5991589|NCT00977080|20718260|P4|Overall Study|Adverse Event|7
5991590|NCT00977080|20718261|P3|Overall Study|Adverse Event|7
5991591|NCT00977080|20718262|P2|Overall Study|Adverse Event|7
5991592|NCT00977080|20718263|P1|Overall Study|Adverse Event|2
5991593|NCT00976989|20718296|P3|Overall Study|Other|1
5991594|NCT00976989|20718297|P2|Overall Study|Other|0
5991595|NCT00976989|20718298|P1|Overall Study|Other|1
5991596|NCT00976989|20718296|P3|Overall Study|Recurrence of Disease|0
5991597|NCT00976989|20718297|P2|Overall Study|Recurrence of Disease|1
5991598|NCT00976989|20718298|P1|Overall Study|Recurrence of Disease|0
5991599|NCT00976989|20718296|P3|Overall Study|Failure to Return|0
5991600|NCT00976989|20718297|P2|Overall Study|Failure to Return|1
5991601|NCT00976989|20718298|P1|Overall Study|Failure to Return|2
5991602|NCT00976989|20718296|P3|Overall Study|Refused Treatment|5
5991603|NCT00976989|20718297|P2|Overall Study|Refused Treatment|3
5991604|NCT00976989|20718298|P1|Overall Study|Refused Treatment|4
5991605|NCT00976989|20718296|P3|Overall Study|Death|10
5991606|NCT00976989|20718297|P2|Overall Study|Death|7
5991607|NCT00976989|20718298|P1|Overall Study|Death|5
5991608|NCT00976989|20718296|P3|Overall Study|Violation of Selection Criteria at Entry|1
5991609|NCT00976989|20718297|P2|Overall Study|Violation of Selection Criteria at Entry|0
5991610|NCT00976989|20718298|P1|Overall Study|Violation of Selection Criteria at Entry|1
5991611|NCT00976950|20718339|P1|Overall Study|Events with no relationship to Aptivus|3
5991612|NCT00976950|20718339|P1|Overall Study|Adverse Event|3
5991613|NCT00976937|20718347|P2|Overall Study|Personal and Familial Reason|2
5991614|NCT00976937|20718348|P1|Overall Study|Personal and Familial Reason|2
5991615|NCT00976937|20718347|P2|Overall Study|Poor compliance to protocol|0
5991616|NCT00976937|20718348|P1|Overall Study|Poor compliance to protocol|3
5991617|NCT00976937|20718347|P2|Overall Study|Withdrawal by Subject|3
5991618|NCT00976937|20718348|P1|Overall Study|Withdrawal by Subject|5
5991619|NCT00976937|20718347|P2|Overall Study|Lost to Follow-up|1
5991620|NCT00976937|20718348|P1|Overall Study|Lost to Follow-up|2
5991621|NCT00976937|20718347|P2|Overall Study|Adverse Event|5
5991622|NCT00976937|20718348|P1|Overall Study|Adverse Event|4
5991623|NCT00976911|20718390|P2|Overall Study|In Follow-Up as of 25 Jan 2013|37
5991624|NCT00976911|20718391|P1|Overall Study|In Follow-Up as of 25 Jan 2013|30
5991625|NCT00976911|20718390|P2|Overall Study|Other|9
5991626|NCT00976911|20718391|P1|Overall Study|Other|8
5991627|NCT00976911|20718390|P2|Overall Study|Protocol Violation|0
5991628|NCT00976911|20718391|P1|Overall Study|Protocol Violation|2
5991629|NCT00976911|20718390|P2|Overall Study|Adverse Event|1
5991630|NCT00976911|20718391|P1|Overall Study|Adverse Event|0
5991631|NCT00976911|20718390|P2|Overall Study|Death|126
5991632|NCT00976911|20718391|P1|Overall Study|Death|138
5991633|NCT00976911|20718390|P2|Overall Study|Withdrawal by Subject|6
5991634|NCT00976911|20718391|P1|Overall Study|Withdrawal by Subject|4
5991635|NCT00976898|20718409|P1|Overall Study|Progressive Disease|1
5991636|NCT00976898|20718409|P1|Overall Study|Liver Transplant|1
5991637|NCT00976898|20718409|P1|Overall Study|Physician Decision|1
5991638|NCT00976898|20718409|P1|Overall Study|Adverse Event|1
5991639|NCT00976898|20718409|P1|Overall Study|Protocol Violation|1
5991640|NCT00976820|20718420|P4|Overall Study|Withdrawal by Subject|4
5991641|NCT00976820|20718421|P3|Overall Study|Withdrawal by Subject|1
5991642|NCT00976820|20718422|P2|Overall Study|Withdrawal by Subject|4
5991643|NCT00976820|20718423|P1|Overall Study|Withdrawal by Subject|2
5991644|NCT00976820|20718420|P4|Overall Study|Poor Compliance. Numerous Visits Booked|0
5991645|NCT00976820|20718421|P3|Overall Study|Poor Compliance. Numerous Visits Booked|1
5991646|NCT00976820|20718422|P2|Overall Study|Poor Compliance. Numerous Visits Booked|0
5991647|NCT00976820|20718423|P1|Overall Study|Poor Compliance. Numerous Visits Booked|1
5991648|NCT00976820|20718420|P4|Overall Study|Lost to Follow-up|3
5991649|NCT00976820|20718421|P3|Overall Study|Lost to Follow-up|2
5991650|NCT00976820|20718422|P2|Overall Study|Lost to Follow-up|16
5991651|NCT00976820|20718423|P1|Overall Study|Lost to Follow-up|5
5991653|NCT00976703|20718777|P2|Overall Study|ineligible for study|2
5991654|NCT00976703|20718778|P1|Overall Study|ineligible for study|2
5991655|NCT00976703|20718777|P2|Overall Study|Physician Decision|1
5991656|NCT00976703|20718778|P1|Overall Study|Physician Decision|1
5991657|NCT00976677|20718792|P2|Overall Study|Unknown/Missing|0
5991658|NCT00976677|20718793|P1|Overall Study|Unknown/Missing|1
5991659|NCT00976677|20718792|P2|Overall Study|Trial unblinded|2
5991660|NCT00976677|20718793|P1|Overall Study|Trial unblinded|2
5991661|NCT00976677|20718792|P2|Overall Study|Disease progression|1
5991662|NCT00976677|20718793|P1|Overall Study|Disease progression|1
5991663|NCT00976677|20718792|P2|Overall Study|Withdrawal by Subject|2
5991664|NCT00976677|20718793|P1|Overall Study|Withdrawal by Subject|0
5991665|NCT00976677|20718792|P2|Overall Study|Adverse Event|0
5991666|NCT00976677|20718793|P1|Overall Study|Adverse Event|1
5991667|NCT00976573|20719001|P2|Overall Study|Cancel prior to receiving treatment|2
5991668|NCT00976573|20719002|P1|Overall Study|Cancel prior to receiving treatment|4
5991669|NCT00976573|20719001|P2|Overall Study|Ineligible|1
5991670|NCT00976573|20719002|P1|Overall Study|Ineligible|0
5991671|NCT00976560|20719016|P2|Overall Study|Withdrawal by Subject|3
5991672|NCT00976560|20719017|P1|Overall Study|Withdrawal by Subject|2
5991673|NCT00976560|20719016|P2|Overall Study|Physician Decision|0
5991674|NCT00976560|20719017|P1|Overall Study|Physician Decision|2
5991675|NCT00976560|20719016|P2|Overall Study|Lost to Follow-up|0
5991676|NCT00976560|20719017|P1|Overall Study|Lost to Follow-up|1
5991677|NCT00976560|20719016|P2|Overall Study|Protocol Violation|0
5991678|NCT00976560|20719017|P1|Overall Study|Protocol Violation|1
5991679|NCT00976560|20719016|P2|Overall Study|Lack of Efficacy|5
5991680|NCT00976560|20719017|P1|Overall Study|Lack of Efficacy|3
5991681|NCT00976560|20719016|P2|Overall Study|Adverse Event|5
5991682|NCT00976560|20719017|P1|Overall Study|Adverse Event|5
5991683|NCT00976508|20719086|P2|Overall Study|Terminated by the Sponsor|1
5991684|NCT00976508|20719087|P1|Overall Study|Terminated by the Sponsor|0
5991685|NCT00976508|20719086|P2|Overall Study|Subject Enrolled in Hospice|0
5991686|NCT00976508|20719087|P1|Overall Study|Subject Enrolled in Hospice|1
5991687|NCT00976508|20719086|P2|Overall Study|Disease Progression|4
5991688|NCT00976508|20719087|P1|Overall Study|Disease Progression|4
5991689|NCT00976508|20719086|P2|Overall Study|Withdrawal by Subject|0
5991690|NCT00976508|20719087|P1|Overall Study|Withdrawal by Subject|1
5991691|NCT00976508|20719086|P2|Overall Study|Lost to Follow-up|0
5991692|NCT00976508|20719087|P1|Overall Study|Lost to Follow-up|1
5991693|NCT00976508|20719086|P2|Overall Study|Death|1
5991694|NCT00976508|20719087|P1|Overall Study|Death|7
5991695|NCT00976495|20719120|P3|Overall Study|Withdrawal by Subject|0
5991696|NCT00976495|20719121|P2|Overall Study|Withdrawal by Subject|1
5991697|NCT00976495|20719122|P1|Overall Study|Withdrawal by Subject|0
5991698|NCT00976482|20719139|P1|Overall Study|Protocol Violation|5
5991699|NCT00976482|20719139|P1|Overall Study|Center terminated|1
5991700|NCT00976482|20719139|P1|Overall Study|Withdrawal by Subject|45
5991701|NCT00976482|20719139|P1|Overall Study|Death|208
5991702|NCT00976456|20719145|P2|Overall Study|screening failure, unknown|4
5991703|NCT00976456|20719146|P1|Overall Study|screening failure, unknown|11
5991704|NCT00976456|20719145|P2|Overall Study|Withdrawal by Subject|1
5991705|NCT00976456|20719146|P1|Overall Study|Withdrawal by Subject|3
5991706|NCT00976456|20719145|P2|Overall Study|Lack of Efficacy|2
5991707|NCT00976456|20719146|P1|Overall Study|Lack of Efficacy|5
5991708|NCT00976456|20719145|P2|Overall Study|Death|9
5991709|NCT00976456|20719146|P1|Overall Study|Death|7
5991710|NCT00976456|20719145|P2|Overall Study|Adverse Event|22
5991711|NCT00976456|20719146|P1|Overall Study|Adverse Event|17
5991712|NCT00976391|20719173|P2|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4
5991713|NCT00976391|20719174|P1|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0
5991714|NCT00976391|20719173|P2|Follow-up Period (8 Weeks)|Withdrawal by Subject|7
5991715|NCT00976391|20719174|P1|Follow-up Period (8 Weeks)|Withdrawal by Subject|4
5991716|NCT00976391|20719173|P2|Follow-up Period (8 Weeks)|Did not Entered Follow-up|8
5991717|NCT00976391|20719174|P1|Follow-up Period (8 Weeks)|Did not Entered Follow-up|6
5991718|NCT00976391|20719173|P2|Follow-up Period (8 Weeks)|Lost to Follow-up|12
5991719|NCT00976391|20719174|P1|Follow-up Period (8 Weeks)|Lost to Follow-up|14
5991720|NCT00976391|20719173|P2|Follow-up Period (8 Weeks)|Noncompliance|2
5991721|NCT00976391|20719174|P1|Follow-up Period (8 Weeks)|Noncompliance|2
5991722|NCT00976391|20719173|P2|Follow-up Period (8 Weeks)|Adverse Event|1
5991723|NCT00976391|20719174|P1|Follow-up Period (8 Weeks)|Adverse Event|3
5991724|NCT00976391|20719173|P2|Treatment Period (52 Weeks)|Pregnancy|0
5991725|NCT00976391|20719174|P1|Treatment Period (52 Weeks)|Pregnancy|1
5991726|NCT00976391|20719173|P2|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|4
5991727|NCT00976391|20719174|P1|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|0
5991728|NCT00976391|20719173|P2|Treatment Period (52 Weeks)|Physician Decision|1
5991729|NCT00976391|20719174|P1|Treatment Period (52 Weeks)|Physician Decision|1
5991730|NCT00976391|20719173|P2|Treatment Period (52 Weeks)|Withdrawal by Subject|19
5991731|NCT00976391|20719174|P1|Treatment Period (52 Weeks)|Withdrawal by Subject|9
5991732|NCT00976391|20719173|P2|Treatment Period (52 Weeks)|Lost to Follow-up|8
5991733|NCT00976391|20719174|P1|Treatment Period (52 Weeks)|Lost to Follow-up|10
5991734|NCT00976391|20719173|P2|Treatment Period (52 Weeks)|Noncompliance|4
5991735|NCT00976391|20719174|P1|Treatment Period (52 Weeks)|Noncompliance|4
5991736|NCT00976391|20719173|P2|Treatment Period (52 Weeks)|Protocol Violation|1
5991737|NCT00976391|20719174|P1|Treatment Period (52 Weeks)|Protocol Violation|1
5991738|NCT00976391|20719173|P2|Treatment Period (52 Weeks)|Adverse Event|2
5991739|NCT00976391|20719174|P1|Treatment Period (52 Weeks)|Adverse Event|16
5991740|NCT00976274|20719222|P2|Overall Study|Physician Decision|2
5991741|NCT00976274|20719223|P1|Overall Study|Physician Decision|1
5991742|NCT00976274|20719222|P2|Overall Study|Withdrawal by Subject|1
5991743|NCT00976274|20719223|P1|Overall Study|Withdrawal by Subject|1
5991744|NCT00976274|20719222|P2|Overall Study|Lost to Follow-up|5
5991745|NCT00976274|20719223|P1|Overall Study|Lost to Follow-up|5
5991746|NCT00976209|20719239|P2|Treatment Period 2|Lost to Follow-up|1
5991747|NCT00976209|20719240|P1|Treatment Period 2|Lost to Follow-up|0
5991748|NCT00976209|20719239|P2|Treatment Period 2|Withdrawal by Subject|1
5991749|NCT00976209|20719240|P1|Treatment Period 2|Withdrawal by Subject|0
5991750|NCT00976209|20719239|P2|Wash-out Period|Other|0
5991751|NCT00976209|20719240|P1|Wash-out Period|Other|1
5991752|NCT00976209|20719239|P2|Wash-out Period|Protocol Violation|0
5991753|NCT00976209|20719240|P1|Wash-out Period|Protocol Violation|1
5991754|NCT00976209|20719239|P2|Wash-out Period|Lost to Follow-up|0
5991755|NCT00976209|20719240|P1|Wash-out Period|Lost to Follow-up|1
5991756|NCT00976209|20719239|P2|Wash-out Period|Adverse Event|2
5991757|NCT00976209|20719240|P1|Wash-out Period|Adverse Event|1
5991758|NCT00976209|20719239|P2|Treatment Period 1|Other|1
5991759|NCT00976209|20719240|P1|Treatment Period 1|Other|0
5991760|NCT00976209|20719239|P2|Treatment Period 1|Lost to Follow-up|0
5991761|NCT00976209|20719240|P1|Treatment Period 1|Lost to Follow-up|2
5991762|NCT00976209|20719239|P2|Treatment Period 1|Protocol Violation|0
5991763|NCT00976209|20719240|P1|Treatment Period 1|Protocol Violation|1
5991764|NCT00976027|20719253|P2|Overall Study|Withdrawal by Subject|66
5991765|NCT00976027|20719254|P1|Overall Study|Withdrawal by Subject|107
5991766|NCT00976027|20719253|P2|Overall Study|Lost to Follow-up|103
5991767|NCT00976027|20719254|P1|Overall Study|Lost to Follow-up|208
5991768|NCT00976027|20719253|P2|Overall Study|Protocol Violation|27
5991769|NCT00976027|20719254|P1|Overall Study|Protocol Violation|60
5991770|NCT00976027|20719253|P2|Overall Study|Adverse Event|2
5991771|NCT00976027|20719254|P1|Overall Study|Adverse Event|0
5991772|NCT00976027|20719253|P2|Overall Study|Serious Adverse Event|17
5991773|NCT00976027|20719254|P1|Overall Study|Serious Adverse Event|36
5991774|NCT00975975|20719266|P1|Overall Study|Death|6
5991775|NCT00975923|20719274|P2|Overall Study|Withdrawal by Subject|1
5991776|NCT00975923|20719275|P1|Overall Study|Withdrawal by Subject|0
5991777|NCT00975884|20719285|P2|Overall Study|Other|3
5991778|NCT00975884|20719286|P1|Overall Study|Other|1
5991779|NCT00975884|20719285|P2|Overall Study|Withdrawal by Subject|9
5991780|NCT00975884|20719286|P1|Overall Study|Withdrawal by Subject|9
5991781|NCT00975884|20719285|P2|Overall Study|Lost to Follow-up|3
5991782|NCT00975884|20719286|P1|Overall Study|Lost to Follow-up|5
5991783|NCT00975884|20719285|P2|Overall Study|Adverse Event|0
5991784|NCT00975884|20719286|P1|Overall Study|Adverse Event|1
5991785|NCT00975806|20719443|P3|Overall Study|Physician decision and disease related|1
5991786|NCT00975806|20719444|P2|Overall Study|Physician decision and disease related|0
5991787|NCT00975806|20719445|P1|Overall Study|Physician decision and disease related|1
5991788|NCT00975806|20719443|P3|Overall Study|Death|0
5991789|NCT00975806|20719444|P2|Overall Study|Death|1
5991790|NCT00975806|20719445|P1|Overall Study|Death|0
5991791|NCT00975806|20719443|P3|Overall Study|Withdrawal by Subject|0
5991792|NCT00975806|20719444|P2|Overall Study|Withdrawal by Subject|0
5991793|NCT00975806|20719445|P1|Overall Study|Withdrawal by Subject|1
5991794|NCT00975806|20719443|P3|Overall Study|Disease Progression|1
5991795|NCT00975806|20719444|P2|Overall Study|Disease Progression|5
5991796|NCT00975806|20719445|P1|Overall Study|Disease Progression|1
5991797|NCT00975806|20719443|P3|Overall Study|Adverse Event|2
5991798|NCT00975806|20719444|P2|Overall Study|Adverse Event|1
5991799|NCT00975806|20719445|P1|Overall Study|Adverse Event|2
5991800|NCT00975780|20719469|P2|Follow Up|Discharged from Facility|12
5991801|NCT00975780|20719470|P1|Follow Up|Discharged from Facility|7
5991802|NCT00975780|20719469|P2|Follow Up|Facility Withdrawal|23
5991803|NCT00975780|20719470|P1|Follow Up|Facility Withdrawal|7
5991804|NCT00975780|20719469|P2|Follow Up|Death|122
5991805|NCT00975780|20719470|P1|Follow Up|Death|88
5991806|NCT00975715|20719480|P2|Maintenance Period|Adverse Event|1
5991807|NCT00975715|20719481|P1|Maintenance Period|Adverse Event|2
5991808|NCT00975715|20719480|P2|Titration Period|Protocol Violation|0
5991809|NCT00975715|20719481|P1|Titration Period|Protocol Violation|1
5991810|NCT00975715|20719480|P2|Titration Period|Adverse Event|0
5991811|NCT00975715|20719481|P1|Titration Period|Adverse Event|6
5991812|NCT00975689|20719497|P2|Overall Study|Physician Decision|0
5991813|NCT00975689|20719498|P1|Overall Study|Physician Decision|1
5991814|NCT00975689|20719497|P2|Overall Study|Withdrawal by Subject|0
5991815|NCT00975689|20719498|P1|Overall Study|Withdrawal by Subject|1
5991816|NCT00975689|20719497|P2|Overall Study|Adverse Event|3
5991817|NCT00975689|20719498|P1|Overall Study|Adverse Event|0
5991818|NCT00975611|20719567|P1|Overall Study|Physician Decision|1
5991819|NCT00975611|20719567|P1|Overall Study|Screen Fail|16
5991820|NCT00975585|20719573|P2|Overall Study|Lens issue|2
5991821|NCT00975585|20719574|P1|Overall Study|Lens issue|2
5991822|NCT00975585|20719573|P2|Overall Study|Withdrawal by Subject|1
5991823|NCT00975585|20719574|P1|Overall Study|Withdrawal by Subject|2
5991824|NCT00975585|20719573|P2|Overall Study|Lost to Follow-up|5
5991825|NCT00975585|20719574|P1|Overall Study|Lost to Follow-up|3
5991826|NCT00975585|20719573|P2|Overall Study|Adverse Event|4
5991827|NCT00975585|20719574|P1|Overall Study|Adverse Event|0
5991828|NCT00975507|20719594|P2|Overall Study|Withdrawal by Subject|3
5991829|NCT00975507|20719595|P1|Overall Study|Withdrawal by Subject|10
5991830|NCT00975507|20719594|P2|Overall Study|Protocol Violation|0
5991831|NCT00975507|20719595|P1|Overall Study|Protocol Violation|2
5991832|NCT00975507|20719594|P2|Overall Study|Lost to Follow-up|1
5991833|NCT00975507|20719595|P1|Overall Study|Lost to Follow-up|7
5991834|NCT00975507|20719594|P2|Overall Study|Adverse Event|0
5991835|NCT00975507|20719595|P1|Overall Study|Adverse Event|1
5991836|NCT00975481|20719615|P6|Fifth Intervention Period|Withdrawal by Subject|0
5991837|NCT00975481|20719616|P5|Fifth Intervention Period|Withdrawal by Subject|1
5991838|NCT00975481|20719617|P4|Fifth Intervention Period|Withdrawal by Subject|0
5991839|NCT00975481|20719618|P3|Fifth Intervention Period|Withdrawal by Subject|0
5991840|NCT00975481|20719619|P2|Fifth Intervention Period|Withdrawal by Subject|0
5991841|NCT00975481|20719620|P1|Fifth Intervention Period|Withdrawal by Subject|0
5991842|NCT00975481|20719615|P6|Fourth Intervention Period|Withdrawal by Subject|0
5991843|NCT00975481|20719616|P5|Fourth Intervention Period|Withdrawal by Subject|0
5991844|NCT00975481|20719617|P4|Fourth Intervention Period|Withdrawal by Subject|1
5991845|NCT00975481|20719618|P3|Fourth Intervention Period|Withdrawal by Subject|1
5991846|NCT00975481|20719619|P2|Fourth Intervention Period|Withdrawal by Subject|0
5991847|NCT00975481|20719620|P1|Fourth Intervention Period|Withdrawal by Subject|0
5991848|NCT00975481|20719615|P6|Second Intervention Period|Withdrawal by Subject|0
5991849|NCT00975481|20719616|P5|Second Intervention Period|Withdrawal by Subject|0
5991850|NCT00975481|20719617|P4|Second Intervention Period|Withdrawal by Subject|0
5991851|NCT00975481|20719618|P3|Second Intervention Period|Withdrawal by Subject|1
5991852|NCT00975481|20719619|P2|Second Intervention Period|Withdrawal by Subject|0
5991853|NCT00975481|20719620|P1|Second Intervention Period|Withdrawal by Subject|0
5991854|NCT00975481|20719615|P6|Second Intervention Period|Adverse Event|0
5991855|NCT00975481|20719616|P5|Second Intervention Period|Adverse Event|0
5991856|NCT00975481|20719617|P4|Second Intervention Period|Adverse Event|0
5991857|NCT00975481|20719618|P3|Second Intervention Period|Adverse Event|0
5991858|NCT00975481|20719619|P2|Second Intervention Period|Adverse Event|1
5991859|NCT00975481|20719620|P1|Second Intervention Period|Adverse Event|2
5991860|NCT00975416|20719720|P2|Overall Study|early discharge from tx|5
5991861|NCT00975416|20719721|P1|Overall Study|early discharge from tx|3
5991862|NCT00975286|20719730|P2|Overall Study|Sponsor Decision|2
5991863|NCT00975286|20719731|P1|Overall Study|Sponsor Decision|0
5991864|NCT00975286|20719730|P2|Overall Study|Poor Compliance to Protocol|2
5991865|NCT00975286|20719731|P1|Overall Study|Poor Compliance to Protocol|0
5991866|NCT00975286|20719730|P2|Overall Study|Familial and Personal Reasons|2
5991867|NCT00975286|20719731|P1|Overall Study|Familial and Personal Reasons|2
5991868|NCT00975286|20719730|P2|Overall Study|Withdrawal by Subject|2
5991869|NCT00975286|20719731|P1|Overall Study|Withdrawal by Subject|0
5991870|NCT00975286|20719730|P2|Overall Study|Protocol Violation|2
5991871|NCT00975286|20719731|P1|Overall Study|Protocol Violation|1
5991872|NCT00975286|20719730|P2|Overall Study|Adverse Event|19
5991873|NCT00975286|20719731|P1|Overall Study|Adverse Event|9
5991874|NCT00975221|20719763|P2|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|0
5991875|NCT00975221|20719764|P1|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|1
5991876|NCT00975221|20719763|P2|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1
5991877|NCT00975221|20719764|P1|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1
5991878|NCT00975221|20719763|P2|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|1
5991879|NCT00975221|20719764|P1|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|0
5991880|NCT00975221|20719763|P2|Titration Phase (Weeks 1-12)|Other|1
5991881|NCT00975221|20719764|P1|Titration Phase (Weeks 1-12)|Other|0
5991882|NCT00975221|20719763|P2|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|0
5991883|NCT00975221|20719764|P1|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|1
5991884|NCT00975221|20719763|P2|Titration Phase (Weeks 1-12)|Withdrawal by Subject|3
5991885|NCT00975221|20719764|P1|Titration Phase (Weeks 1-12)|Withdrawal by Subject|2
5991886|NCT00975195|20719780|P2|Overall Study|Not treated|2
5991887|NCT00975195|20719781|P1|Overall Study|Not treated|1
5991888|NCT00975195|20719780|P2|Overall Study|Other reason not defined above|33
5991889|NCT00975195|20719781|P1|Overall Study|Other reason not defined above|29
5991890|NCT00975195|20719780|P2|Overall Study|Withdrawal by Subject|61
5991891|NCT00975195|20719781|P1|Overall Study|Withdrawal by Subject|48
5991892|NCT00975195|20719780|P2|Overall Study|Lost to Follow-up|7
5991893|NCT00975195|20719781|P1|Overall Study|Lost to Follow-up|9
5991894|NCT00975195|20719780|P2|Overall Study|Protocol Violation|23
5991895|NCT00975195|20719781|P1|Overall Study|Protocol Violation|27
5991896|NCT00975195|20719780|P2|Overall Study|Lack of Efficacy|6
5991897|NCT00975195|20719781|P1|Overall Study|Lack of Efficacy|6
5991898|NCT00975195|20719780|P2|Overall Study|Adverse Event|101
5991899|NCT00975195|20719781|P1|Overall Study|Adverse Event|108
5991900|NCT00975156|20719841|P2|Overall Study|Protocol Violation|1
5991901|NCT00975156|20719842|P1|Overall Study|Protocol Violation|0
5991902|NCT00975143|20719854|P2|Overall Study|Details not available|4
5991903|NCT00975143|20719855|P1|Overall Study|Details not available|10
5991904|NCT00975143|20719854|P2|Overall Study|Physician Decision|2
5991905|NCT00975143|20719855|P1|Overall Study|Physician Decision|1
5991906|NCT00975143|20719854|P2|Overall Study|Non-compliance|8
5991907|NCT00975143|20719855|P1|Overall Study|Non-compliance|5
5991908|NCT00975143|20719854|P2|Overall Study|Lost to Follow-up|16
5991909|NCT00975143|20719855|P1|Overall Study|Lost to Follow-up|20
5991910|NCT00975143|20719854|P2|Overall Study|Withdrawal by Subject|15
5991911|NCT00975143|20719855|P1|Overall Study|Withdrawal by Subject|15
5991912|NCT00975143|20719854|P2|Overall Study|Adverse Event|15
5991913|NCT00975143|20719855|P1|Overall Study|Adverse Event|19
5991914|NCT00975130|20719865|P3|Study Part 2|Protocol Violation|1
5991915|NCT00975130|20719866|P2|Study Part 2|Protocol Violation|0
5991916|NCT00975130|20719867|P1|Study Part 2|Protocol Violation|0
5991917|NCT00975130|20719865|P3|Study Part 2|Administrative|0
5991918|NCT00975130|20719866|P2|Study Part 2|Administrative|1
5991919|NCT00975130|20719867|P1|Study Part 2|Administrative|0
5991920|NCT00975130|20719865|P3|Study Part 2|Did Not Meet Protocol Eligibility|1
5991921|NCT00975130|20719866|P2|Study Part 2|Did Not Meet Protocol Eligibility|4
5991922|NCT00975130|20719867|P1|Study Part 2|Did Not Meet Protocol Eligibility|0
5991923|NCT00975130|20719865|P3|Study Part 2|Withdrew Consent|2
5991924|NCT00975130|20719866|P2|Study Part 2|Withdrew Consent|6
5991925|NCT00975130|20719867|P1|Study Part 2|Withdrew Consent|0
5991926|NCT00975130|20719865|P3|Study Part 2|Withdrawal by Subject|5
5991927|NCT00975130|20719866|P2|Study Part 2|Withdrawal by Subject|13
5991928|NCT00975130|20719867|P1|Study Part 2|Withdrawal by Subject|0
5991929|NCT00975130|20719865|P3|Study Part 2|Lost to Follow-up|1
5991930|NCT00975130|20719866|P2|Study Part 2|Lost to Follow-up|0
5991931|NCT00975130|20719867|P1|Study Part 2|Lost to Follow-up|0
5991932|NCT00975130|20719865|P3|Study Part 2|Adverse Event|7
5991933|NCT00975130|20719866|P2|Study Part 2|Adverse Event|14
5991934|NCT00975130|20719867|P1|Study Part 2|Adverse Event|0
5991935|NCT00975130|20719865|P3|Study Part 1|Withdrew Consent|0
5991936|NCT00975130|20719866|P2|Study Part 1|Withdrew Consent|0
5991937|NCT00975130|20719867|P1|Study Part 1|Withdrew Consent|24
5991938|NCT00975130|20719865|P3|Study Part 1|Administrative|0
5991939|NCT00975130|20719866|P2|Study Part 1|Administrative|0
5991940|NCT00975130|20719867|P1|Study Part 1|Administrative|4
5991941|NCT00975130|20719865|P3|Study Part 1|Did Not Meet Protocol Eligibility|0
5991942|NCT00975130|20719866|P2|Study Part 1|Did Not Meet Protocol Eligibility|0
5991943|NCT00975130|20719867|P1|Study Part 1|Did Not Meet Protocol Eligibility|9
5991944|NCT00975130|20719865|P3|Study Part 1|Protocol Violation|0
5991945|NCT00975130|20719866|P2|Study Part 1|Protocol Violation|0
5991946|NCT00975130|20719867|P1|Study Part 1|Protocol Violation|13
5991947|NCT00975130|20719865|P3|Study Part 1|Withdrawal by Subject|0
5991948|NCT00975130|20719866|P2|Study Part 1|Withdrawal by Subject|0
5991949|NCT00975130|20719867|P1|Study Part 1|Withdrawal by Subject|61
5991950|NCT00975130|20719865|P3|Study Part 1|Lost to Follow-up|0
5991951|NCT00975130|20719866|P2|Study Part 1|Lost to Follow-up|0
5991952|NCT00975130|20719867|P1|Study Part 1|Lost to Follow-up|19
5991953|NCT00975130|20719865|P3|Study Part 1|Adverse Event|0
5991954|NCT00975130|20719866|P2|Study Part 1|Adverse Event|0
5991955|NCT00975130|20719867|P1|Study Part 1|Adverse Event|150
5991956|NCT00975000|20720051|P2|Overall Study|Non-compliance|1
5991957|NCT00975000|20720052|P1|Overall Study|Non-compliance|0
5991958|NCT00975000|20720051|P2|Overall Study|Protocol-specified Criteria|0
5991959|NCT00975000|20720052|P1|Overall Study|Protocol-specified Criteria|1
5991960|NCT00975000|20720051|P2|Overall Study|Lost to Follow-up|1
5991961|NCT00975000|20720052|P1|Overall Study|Lost to Follow-up|0
5991962|NCT00975000|20720051|P2|Overall Study|Withdrawal by Subject|2
5991963|NCT00975000|20720052|P1|Overall Study|Withdrawal by Subject|2
5991964|NCT00975000|20720051|P2|Overall Study|Adverse Event|1
5991965|NCT00975000|20720052|P1|Overall Study|Adverse Event|1
5991966|NCT00975000|20720051|P2|Overall Study|Other|0
5991967|NCT00975000|20720052|P1|Overall Study|Other|1
5991968|NCT00974974|20720076|P2|Maintenance - Double Blind Treatment|Various|0
5991969|NCT00974974|20720077|P1|Maintenance - Double Blind Treatment|Various|4
5991970|NCT00974974|20720076|P2|Maintenance - Double Blind Treatment|Withdrawal by Subject|2
5991971|NCT00974974|20720077|P1|Maintenance - Double Blind Treatment|Withdrawal by Subject|5
5991972|NCT00974974|20720076|P2|Maintenance - Double Blind Treatment|Lost to Follow-up|1
5991973|NCT00974974|20720077|P1|Maintenance - Double Blind Treatment|Lost to Follow-up|0
5991974|NCT00974974|20720076|P2|Maintenance - Double Blind Treatment|Lack of Efficacy|2
5991975|NCT00974974|20720077|P1|Maintenance - Double Blind Treatment|Lack of Efficacy|2
5991976|NCT00974974|20720076|P2|Maintenance - Double Blind Treatment|Noncompliance with study drug|1
5991977|NCT00974974|20720077|P1|Maintenance - Double Blind Treatment|Noncompliance with study drug|0
5991978|NCT00974974|20720076|P2|Maintenance - Double Blind Treatment|Protocol Violation|1
5991979|NCT00974974|20720077|P1|Maintenance - Double Blind Treatment|Protocol Violation|1
5991980|NCT00974974|20720076|P2|Maintenance - Double Blind Treatment|Adverse Event|3
5991981|NCT00974974|20720077|P1|Maintenance - Double Blind Treatment|Adverse Event|3
5991982|NCT00974974|20720076|P2|IPX066 Dose Conversion|Protocol Violation|0
5991983|NCT00974974|20720077|P1|IPX066 Dose Conversion|Protocol Violation|4
5991984|NCT00974974|20720076|P2|IPX066 Dose Conversion|Various|0
5991985|NCT00974974|20720077|P1|IPX066 Dose Conversion|Various|3
5991986|NCT00974974|20720076|P2|IPX066 Dose Conversion|Withdrawal by Subject|0
5991987|NCT00974974|20720077|P1|IPX066 Dose Conversion|Withdrawal by Subject|12
5991988|NCT00974974|20720076|P2|IPX066 Dose Conversion|Lack of Efficacy|0
5991989|NCT00974974|20720077|P1|IPX066 Dose Conversion|Lack of Efficacy|13
5991990|NCT00974974|20720076|P2|IPX066 Dose Conversion|Death|0
5991991|NCT00974974|20720077|P1|IPX066 Dose Conversion|Death|2
5991992|NCT00974974|20720076|P2|IPX066 Dose Conversion|Adverse Event|0
5991993|NCT00974974|20720077|P1|IPX066 Dose Conversion|Adverse Event|23
5991994|NCT00974974|20720076|P2|IR CD-LD Dose Adjustment|Various|9
5991995|NCT00974974|20720077|P1|IR CD-LD Dose Adjustment|Various|0
5991996|NCT00974974|20720076|P2|IR CD-LD Dose Adjustment|Withdrawal by Subject|7
5991997|NCT00974974|20720077|P1|IR CD-LD Dose Adjustment|Withdrawal by Subject|0
5991998|NCT00974974|20720076|P2|IR CD-LD Dose Adjustment|Noncompliance with study drug|1
5991999|NCT00974974|20720077|P1|IR CD-LD Dose Adjustment|Noncompliance with study drug|0
5992000|NCT00974974|20720076|P2|IR CD-LD Dose Adjustment|Protocol Violation|1
5992001|NCT00974974|20720077|P1|IR CD-LD Dose Adjustment|Protocol Violation|0
5992002|NCT00974974|20720076|P2|IR CD-LD Dose Adjustment|Adverse Event|3
5992003|NCT00974974|20720077|P1|IR CD-LD Dose Adjustment|Adverse Event|0
5992004|NCT00974922|20720087|P1|Overall Study|study terminated|24
5992005|NCT00974675|20720105|P4|Overall Study|Participant on holiday; unable to attend|1
5992006|NCT00974675|20720106|P3|Overall Study|Participant on holiday; unable to attend|0
5992007|NCT00974675|20720107|P2|Overall Study|Participant on holiday; unable to attend|0
5992008|NCT00974675|20720108|P1|Overall Study|Participant on holiday; unable to attend|0
5992009|NCT00974675|20720105|P4|Overall Study|Physician Decision|0
5992010|NCT00974675|20720106|P3|Overall Study|Physician Decision|1
5992011|NCT00974675|20720107|P2|Overall Study|Physician Decision|0
5992012|NCT00974675|20720108|P1|Overall Study|Physician Decision|0
5992013|NCT00974675|20720105|P4|Overall Study|Adverse Event|1
5992014|NCT00974675|20720106|P3|Overall Study|Adverse Event|1
5992015|NCT00974675|20720107|P2|Overall Study|Adverse Event|1
5992016|NCT00974675|20720108|P1|Overall Study|Adverse Event|2
5992017|NCT00974571|20720157|P3|Overall Study|Other|10
5992018|NCT00974571|20720158|P2|Overall Study|Other|0
5992019|NCT00974571|20720159|P1|Overall Study|Other|4
5992020|NCT00974571|20720157|P3|Overall Study|Patient Moved|1
5992021|NCT00974571|20720158|P2|Overall Study|Patient Moved|0
5992022|NCT00974571|20720159|P1|Overall Study|Patient Moved|1
5992023|NCT00974571|20720157|P3|Overall Study|Withdrawal by Subject|16
5992024|NCT00974571|20720158|P2|Overall Study|Withdrawal by Subject|5
5992025|NCT00974571|20720159|P1|Overall Study|Withdrawal by Subject|14
5992026|NCT00974571|20720157|P3|Overall Study|Protocol Violation|18
5992027|NCT00974571|20720158|P2|Overall Study|Protocol Violation|4
5992028|NCT00974571|20720159|P1|Overall Study|Protocol Violation|13
5992029|NCT00974571|20720157|P3|Overall Study|Lost to Follow-up|2
5992030|NCT00974571|20720158|P2|Overall Study|Lost to Follow-up|1
5992031|NCT00974571|20720159|P1|Overall Study|Lost to Follow-up|2
5992032|NCT00974571|20720157|P3|Overall Study|Lack of Efficacy|9
5992033|NCT00974571|20720158|P2|Overall Study|Lack of Efficacy|2
5992034|NCT00974571|20720159|P1|Overall Study|Lack of Efficacy|3
5992035|NCT00974571|20720157|P3|Overall Study|Adverse Event|27
5992036|NCT00974571|20720158|P2|Overall Study|Adverse Event|4
5992037|NCT00974571|20720159|P1|Overall Study|Adverse Event|31
5992038|NCT00974311|20720265|P2|OLE Phase (up to 77 Months)|Withdrawal by Subject|1
5992039|NCT00974311|20720266|P1|OLE Phase (up to 77 Months)|Withdrawal by Subject|2
5992040|NCT00974311|20720265|P2|OLE Phase (up to 77 Months)|Other|2
5992041|NCT00974311|20720266|P1|OLE Phase (up to 77 Months)|Other|15
5992042|NCT00974311|20720265|P2|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|26
5992043|NCT00974311|20720266|P1|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|78
5992044|NCT00974311|20720265|P2|OLE Phase (up to 77 Months)|Death|21
5992045|NCT00974311|20720266|P1|OLE Phase (up to 77 Months)|Death|14
5992046|NCT00974311|20720265|P2|DB Phase (up to 24 Months)|Other|0
5992047|NCT00974311|20720266|P1|DB Phase (up to 24 Months)|Other|1
5992048|NCT00974311|20720265|P2|DB Phase (up to 24 Months)|Study Terminated by Sponsor|42
5992049|NCT00974311|20720266|P1|DB Phase (up to 24 Months)|Study Terminated by Sponsor|108
5992050|NCT00974311|20720265|P2|DB Phase (up to 24 Months)|Withdrawal by Subject|7
5992051|NCT00974311|20720266|P1|DB Phase (up to 24 Months)|Withdrawal by Subject|16
5992052|NCT00974311|20720265|P2|DB Phase (up to 24 Months)|Death|298
5992053|NCT00974311|20720266|P1|DB Phase (up to 24 Months)|Death|561
5992054|NCT00974311|20720265|P2|DB Phase (up to 24 Months)|Lost to Follow-up|2
5992055|NCT00974311|20720266|P1|DB Phase (up to 24 Months)|Lost to Follow-up|5
5992056|NCT00974259|20720304|P2|Overall Study|Technically inadequate PbtO2 recordings|1
5992057|NCT00974259|20720305|P1|Overall Study|Technically inadequate PbtO2 recordings|2
5992058|NCT00974233|20720323|P1|Maintenance Lenalidomide|Adverse Event|8
5992059|NCT00974233|20720323|P1|Maintenance Lenalidomide|Lack of Efficacy|5
5992060|NCT00974233|20720323|P1|Induction Chemoimmunotherapy|Withdrawal by Subject|1
5992061|NCT00974233|20720323|P1|Induction Chemoimmunotherapy|Adverse Event|7
5992062|NCT00974233|20720323|P1|Induction Chemoimmunotherapy|Lack of Efficacy|5
5992063|NCT00974233|20720323|P1|Induction Chemoimmunotherapy|Death|2
5992064|NCT00974220|20720338|P2|Treatment Period 1|noncompliant subjects|1
5992065|NCT00974220|20720339|P1|Treatment Period 1|noncompliant subjects|0
5992066|NCT00974220|20720338|P2|Treatment Period 1|Adverse Event|1
5992067|NCT00974220|20720339|P1|Treatment Period 1|Adverse Event|2
5992068|NCT00974090|20720384|P2|Period 2: Open-label Period|Withdrawal by Subject|0
5992069|NCT00974090|20720385|P1|Period 2: Open-label Period|Withdrawal by Subject|1
5992070|NCT00974090|20720384|P2|Period 2: Open-label Period|Physician Decision|3
5992071|NCT00974090|20720385|P1|Period 2: Open-label Period|Physician Decision|0
5992072|NCT00974090|20720384|P2|Period 2: Open-label Period|Lack of Efficacy|1
5992073|NCT00974090|20720385|P1|Period 2: Open-label Period|Lack of Efficacy|3
5992074|NCT00974090|20720384|P2|Period 2: Open-label Period|Adverse Event|6
5992075|NCT00974090|20720385|P1|Period 2: Open-label Period|Adverse Event|4
5992076|NCT00974090|20720384|P2|Period 1: Double Blind Period|Physician Decision|0
5992077|NCT00974090|20720385|P1|Period 1: Double Blind Period|Physician Decision|1
5992078|NCT00974090|20720384|P2|Period 1: Double Blind Period|Adverse Event|1
5992079|NCT00974090|20720385|P1|Period 1: Double Blind Period|Adverse Event|2
5992080|NCT00973973|20720421|P2|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|0
5992081|NCT00973973|20720422|P1|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|1
5992082|NCT00973973|20720421|P2|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|0
5992083|NCT00973973|20720422|P1|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|1
5992084|NCT00973973|20720421|P2|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|3
5992085|NCT00973973|20720422|P1|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|1
5992086|NCT00973973|20720421|P2|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|0
5992087|NCT00973973|20720422|P1|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|1
5992088|NCT00973973|20720421|P2|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|0
5992089|NCT00973973|20720422|P1|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|1
5992090|NCT00973973|20720421|P2|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|2
5992091|NCT00973973|20720422|P1|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|1
5992092|NCT00973973|20720421|P2|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1
5992093|NCT00973973|20720422|P1|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1
5992094|NCT00973973|20720421|P2|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1
5992095|NCT00973973|20720422|P1|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1
5992096|NCT00973973|20720421|P2|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|0
5992097|NCT00973973|20720422|P1|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|1
5992098|NCT00973973|20720421|P2|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|3
5992099|NCT00973973|20720422|P1|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|1
5992100|NCT00973973|20720421|P2|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|0
5992101|NCT00973973|20720422|P1|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|1
5992102|NCT00973973|20720421|P2|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|3
5992103|NCT00973973|20720422|P1|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|1
5992104|NCT00973921|20720482|P1|Overall Study|IVUS results were not available|9
5992105|NCT00973765|20720499|P2|Overall Study|Lost to Follow-up|14
5992106|NCT00973765|20720500|P1|Overall Study|Lost to Follow-up|8
5992107|NCT00973700|20720522|P5|Overall Study|Unable to Classify|1
5992108|NCT00973700|20720523|P4|Overall Study|Unable to Classify|2
5992109|NCT00973700|20720524|P3|Overall Study|Unable to Classify|1
5992110|NCT00973700|20720525|P2|Overall Study|Unable to Classify|0
5992111|NCT00973700|20720526|P1|Overall Study|Unable to Classify|0
5992112|NCT00973700|20720522|P5|Overall Study|Inappropriate enrolment|0
5992113|NCT00973700|20720523|P4|Overall Study|Inappropriate enrolment|4
5992114|NCT00973700|20720524|P3|Overall Study|Inappropriate enrolment|0
5992115|NCT00973700|20720525|P2|Overall Study|Inappropriate enrolment|0
5992116|NCT00973700|20720526|P1|Overall Study|Inappropriate enrolment|0
5992117|NCT00973700|20720522|P5|Overall Study|Lost to Follow-up|5
5992118|NCT00973700|20720523|P4|Overall Study|Lost to Follow-up|8
5992119|NCT00973700|20720524|P3|Overall Study|Lost to Follow-up|1
5992120|NCT00973700|20720525|P2|Overall Study|Lost to Follow-up|0
5992121|NCT00973700|20720526|P1|Overall Study|Lost to Follow-up|5
5992122|NCT00973700|20720522|P5|Overall Study|Withdrawal by Subject|4
5992123|NCT00973700|20720523|P4|Overall Study|Withdrawal by Subject|4
5992124|NCT00973700|20720524|P3|Overall Study|Withdrawal by Subject|8
5992125|NCT00973700|20720525|P2|Overall Study|Withdrawal by Subject|2
5992126|NCT00973700|20720526|P1|Overall Study|Withdrawal by Subject|2
5992127|NCT00973674|20720575|P2|Overall Study|Protocol Violation|0
5992128|NCT00973674|20720576|P1|Overall Study|Protocol Violation|2
5992129|NCT00973622|20720590|P2|Overall Study|did not complete rTMS sessions|2
5992130|NCT00973622|20720591|P1|Overall Study|did not complete rTMS sessions|11
5992131|NCT00973622|20720590|P2|Overall Study|did not pass MRI screen|0
5992132|NCT00973622|20720591|P1|Overall Study|did not pass MRI screen|6
5992133|NCT00973622|20720590|P2|Overall Study|did not attend MRI|3
5992134|NCT00973622|20720591|P1|Overall Study|did not attend MRI|14
5992135|NCT00973479|20720599|P2|Overall Study|Other|7
5992136|NCT00973479|20720600|P1|Overall Study|Other|1
5992137|NCT00973479|20720599|P2|Overall Study|Protocol Violation|2
5992138|NCT00973479|20720600|P1|Overall Study|Protocol Violation|2
5992139|NCT00973479|20720599|P2|Overall Study|Adverse Event|32
5992140|NCT00973479|20720600|P1|Overall Study|Adverse Event|12
5992141|NCT00973479|20720599|P2|Overall Study|Lack of Efficacy|7
5992142|NCT00973479|20720600|P1|Overall Study|Lack of Efficacy|5
5992143|NCT00973479|20720599|P2|Overall Study|Withdrawal by Subject|16
5992144|NCT00973479|20720600|P1|Overall Study|Withdrawal by Subject|15
5992145|NCT00973479|20720599|P2|Overall Study|Death|2
5992146|NCT00973479|20720600|P1|Overall Study|Death|2
5992147|NCT00973479|20720599|P2|Overall Study|Lost to Follow-up|3
5992148|NCT00973479|20720600|P1|Overall Study|Lost to Follow-up|0
5992149|NCT00973362|20720618|P2|3-Year Follow-up|Lost to Follow-up|0
5992150|NCT00973362|20720619|P1|3-Year Follow-up|Lost to Follow-up|17
5992151|NCT00973362|20720618|P2|Baseline Evaluation|Inevaluable|223
5992152|NCT00973362|20720619|P1|Baseline Evaluation|Inevaluable|686
5992153|NCT00973362|20720618|P2|Baseline Evaluation|No colposcopy visit|0
5992154|NCT00973362|20720619|P1|Baseline Evaluation|No colposcopy visit|62
5992155|NCT00973362|20720618|P2|Baseline Evaluation|W/D, later determined to be ineligible|0
5992156|NCT00973362|20720619|P1|Baseline Evaluation|W/D, later determined to be ineligible|25
5992157|NCT00973349|20720644|P16|Overall Study|Unable to classify|0
5992158|NCT00973349|20720645|P15|Overall Study|Unable to classify|0
5992159|NCT00973349|20720646|P14|Overall Study|Unable to classify|0
5992160|NCT00973349|20720647|P13|Overall Study|Unable to classify|0
5992161|NCT00973349|20720648|P12|Overall Study|Unable to classify|0
5992162|NCT00973349|20720649|P11|Overall Study|Unable to classify|0
5992163|NCT00973349|20720650|P10|Overall Study|Unable to classify|1
5992164|NCT00973349|20720651|P9|Overall Study|Unable to classify|0
5992165|NCT00973349|20720652|P8|Overall Study|Unable to classify|0
5992166|NCT00973349|20720653|P7|Overall Study|Unable to classify|0
5992167|NCT00973349|20720654|P6|Overall Study|Unable to classify|1
5992168|NCT00973349|20720655|P5|Overall Study|Unable to classify|1
5992169|NCT00973349|20720656|P4|Overall Study|Unable to classify|0
5992170|NCT00973349|20720657|P3|Overall Study|Unable to classify|0
5992171|NCT00973349|20720658|P2|Overall Study|Unable to classify|0
5992172|NCT00973349|20720659|P1|Overall Study|Unable to classify|0
5992173|NCT00973349|20720644|P16|Overall Study|Protocol Violation|0
5992174|NCT00973349|20720645|P15|Overall Study|Protocol Violation|0
5992175|NCT00973349|20720646|P14|Overall Study|Protocol Violation|0
5992176|NCT00973349|20720647|P13|Overall Study|Protocol Violation|0
5992177|NCT00973349|20720648|P12|Overall Study|Protocol Violation|0
5992178|NCT00973349|20720649|P11|Overall Study|Protocol Violation|0
5992179|NCT00973349|20720650|P10|Overall Study|Protocol Violation|0
5992180|NCT00973349|20720651|P9|Overall Study|Protocol Violation|1
5992181|NCT00973349|20720652|P8|Overall Study|Protocol Violation|0
5992182|NCT00973349|20720653|P7|Overall Study|Protocol Violation|0
5992183|NCT00973349|20720654|P6|Overall Study|Protocol Violation|0
5992184|NCT00973349|20720655|P5|Overall Study|Protocol Violation|0
5992185|NCT00973349|20720656|P4|Overall Study|Protocol Violation|0
5992186|NCT00973349|20720657|P3|Overall Study|Protocol Violation|0
5992187|NCT00973349|20720658|P2|Overall Study|Protocol Violation|0
5992188|NCT00973349|20720659|P1|Overall Study|Protocol Violation|0
5992189|NCT00973349|20720644|P16|Overall Study|Inappropriate enrolment|1
5992190|NCT00973349|20720645|P15|Overall Study|Inappropriate enrolment|1
5992191|NCT00973349|20720646|P14|Overall Study|Inappropriate enrolment|0
5992192|NCT00973349|20720647|P13|Overall Study|Inappropriate enrolment|1
5992193|NCT00973349|20720648|P12|Overall Study|Inappropriate enrolment|0
5992194|NCT00973349|20720649|P11|Overall Study|Inappropriate enrolment|0
5992195|NCT00973349|20720650|P10|Overall Study|Inappropriate enrolment|2
5992196|NCT00973349|20720651|P9|Overall Study|Inappropriate enrolment|0
5992197|NCT00973349|20720652|P8|Overall Study|Inappropriate enrolment|0
5992198|NCT00973349|20720653|P7|Overall Study|Inappropriate enrolment|0
5992199|NCT00973349|20720654|P6|Overall Study|Inappropriate enrolment|0
5992200|NCT00973349|20720655|P5|Overall Study|Inappropriate enrolment|0
5992201|NCT00973349|20720656|P4|Overall Study|Inappropriate enrolment|0
5992202|NCT00973349|20720657|P3|Overall Study|Inappropriate enrolment|1
5992203|NCT00973349|20720658|P2|Overall Study|Inappropriate enrolment|0
5992204|NCT00973349|20720659|P1|Overall Study|Inappropriate enrolment|0
5992205|NCT00973349|20720644|P16|Overall Study|Lost to Follow-up|1
5992206|NCT00973349|20720645|P15|Overall Study|Lost to Follow-up|0
5992207|NCT00973349|20720646|P14|Overall Study|Lost to Follow-up|0
5992208|NCT00973349|20720647|P13|Overall Study|Lost to Follow-up|0
5992209|NCT00973349|20720648|P12|Overall Study|Lost to Follow-up|1
5992210|NCT00973349|20720649|P11|Overall Study|Lost to Follow-up|0
5992211|NCT00973349|20720650|P10|Overall Study|Lost to Follow-up|1
5992212|NCT00973349|20720651|P9|Overall Study|Lost to Follow-up|2
5992213|NCT00973349|20720652|P8|Overall Study|Lost to Follow-up|1
5992214|NCT00973349|20720653|P7|Overall Study|Lost to Follow-up|0
5992215|NCT00973349|20720654|P6|Overall Study|Lost to Follow-up|3
5992216|NCT00973349|20720655|P5|Overall Study|Lost to Follow-up|1
5992217|NCT00973349|20720656|P4|Overall Study|Lost to Follow-up|2
5992218|NCT00973349|20720657|P3|Overall Study|Lost to Follow-up|2
5992219|NCT00973349|20720658|P2|Overall Study|Lost to Follow-up|1
5992220|NCT00973349|20720659|P1|Overall Study|Lost to Follow-up|3
5992221|NCT00973349|20720644|P16|Overall Study|Withdrawal by Subject|0
5992222|NCT00973349|20720645|P15|Overall Study|Withdrawal by Subject|0
5992223|NCT00973349|20720646|P14|Overall Study|Withdrawal by Subject|0
5992224|NCT00973349|20720647|P13|Overall Study|Withdrawal by Subject|0
5992225|NCT00973349|20720648|P12|Overall Study|Withdrawal by Subject|1
5992226|NCT00973349|20720649|P11|Overall Study|Withdrawal by Subject|0
5992227|NCT00973349|20720650|P10|Overall Study|Withdrawal by Subject|2
5992228|NCT00973349|20720651|P9|Overall Study|Withdrawal by Subject|0
5992229|NCT00973349|20720652|P8|Overall Study|Withdrawal by Subject|2
5992230|NCT00973349|20720653|P7|Overall Study|Withdrawal by Subject|2
5992231|NCT00973349|20720654|P6|Overall Study|Withdrawal by Subject|0
5992232|NCT00973349|20720655|P5|Overall Study|Withdrawal by Subject|2
5992233|NCT00973349|20720656|P4|Overall Study|Withdrawal by Subject|3
5992234|NCT00973349|20720657|P3|Overall Study|Withdrawal by Subject|2
5992235|NCT00973349|20720658|P2|Overall Study|Withdrawal by Subject|2
5992236|NCT00973349|20720659|P1|Overall Study|Withdrawal by Subject|1
5992237|NCT00973349|20720644|P16|Overall Study|Adverse Event|0
5992238|NCT00973349|20720645|P15|Overall Study|Adverse Event|1
5992239|NCT00973349|20720646|P14|Overall Study|Adverse Event|0
5992240|NCT00973349|20720647|P13|Overall Study|Adverse Event|0
5992241|NCT00973349|20720648|P12|Overall Study|Adverse Event|0
5992242|NCT00973349|20720649|P11|Overall Study|Adverse Event|0
5992243|NCT00973349|20720650|P10|Overall Study|Adverse Event|0
5992244|NCT00973349|20720651|P9|Overall Study|Adverse Event|1
5992245|NCT00973349|20720652|P8|Overall Study|Adverse Event|0
5992246|NCT00973349|20720653|P7|Overall Study|Adverse Event|0
5992247|NCT00973349|20720654|P6|Overall Study|Adverse Event|0
5992248|NCT00973349|20720655|P5|Overall Study|Adverse Event|1
5992249|NCT00973349|20720656|P4|Overall Study|Adverse Event|0
5992250|NCT00973349|20720657|P3|Overall Study|Adverse Event|0
5992251|NCT00973349|20720658|P2|Overall Study|Adverse Event|0
5992252|NCT00973349|20720659|P1|Overall Study|Adverse Event|0
5992253|NCT00973102|20720759|P2|Overall Study|Prisoner|1
5992254|NCT00973102|20720760|P1|Overall Study|Prisoner|0
5992255|NCT00973102|20720759|P2|Overall Study|Protocol Violation|0
5992256|NCT00973102|20720760|P1|Overall Study|Protocol Violation|1
5992257|NCT00972816|20720791|P8|Overall Study|Unable to classify|0
5992258|NCT00972816|20720792|P7|Overall Study|Unable to classify|0
5992259|NCT00972816|20720793|P6|Overall Study|Unable to classify|0
5992260|NCT00972816|20720794|P5|Overall Study|Unable to classify|1
5992261|NCT00972816|20720795|P4|Overall Study|Unable to classify|0
5992262|NCT00972816|20720796|P3|Overall Study|Unable to classify|0
5992263|NCT00972816|20720797|P2|Overall Study|Unable to classify|0
5992264|NCT00972816|20720798|P1|Overall Study|Unable to classify|2
5992265|NCT00972816|20720791|P8|Overall Study|Inappropriate enrolment|0
5992266|NCT00972816|20720792|P7|Overall Study|Inappropriate enrolment|2
5992267|NCT00972816|20720793|P6|Overall Study|Inappropriate enrolment|0
5992268|NCT00972816|20720794|P5|Overall Study|Inappropriate enrolment|0
5992269|NCT00972816|20720795|P4|Overall Study|Inappropriate enrolment|0
5992270|NCT00972816|20720796|P3|Overall Study|Inappropriate enrolment|0
5992271|NCT00972816|20720797|P2|Overall Study|Inappropriate enrolment|0
5992272|NCT00972816|20720798|P1|Overall Study|Inappropriate enrolment|0
5992273|NCT00972816|20720791|P8|Overall Study|Lost to Follow-up|7
5992274|NCT00972816|20720792|P7|Overall Study|Lost to Follow-up|7
5992275|NCT00972816|20720793|P6|Overall Study|Lost to Follow-up|10
5992276|NCT00972816|20720794|P5|Overall Study|Lost to Follow-up|11
5992277|NCT00972816|20720795|P4|Overall Study|Lost to Follow-up|5
5992278|NCT00972816|20720796|P3|Overall Study|Lost to Follow-up|7
5992279|NCT00972816|20720797|P2|Overall Study|Lost to Follow-up|9
5992280|NCT00972816|20720798|P1|Overall Study|Lost to Follow-up|11
5992281|NCT00972816|20720791|P8|Overall Study|Withdrawal by Subject|2
5992282|NCT00972816|20720792|P7|Overall Study|Withdrawal by Subject|1
5992283|NCT00972816|20720793|P6|Overall Study|Withdrawal by Subject|1
5992284|NCT00972816|20720794|P5|Overall Study|Withdrawal by Subject|0
5992285|NCT00972816|20720795|P4|Overall Study|Withdrawal by Subject|3
5992286|NCT00972816|20720796|P3|Overall Study|Withdrawal by Subject|1
5992287|NCT00972816|20720797|P2|Overall Study|Withdrawal by Subject|2
5992288|NCT00972816|20720798|P1|Overall Study|Withdrawal by Subject|4
5992289|NCT00972816|20720791|P8|Overall Study|Adverse Event|0
5992290|NCT00972816|20720792|P7|Overall Study|Adverse Event|0
5992291|NCT00972816|20720793|P6|Overall Study|Adverse Event|0
5992292|NCT00972816|20720794|P5|Overall Study|Adverse Event|0
5992293|NCT00972816|20720795|P4|Overall Study|Adverse Event|0
5992294|NCT00972816|20720796|P3|Overall Study|Adverse Event|1
5992295|NCT00972816|20720797|P2|Overall Study|Adverse Event|0
5992296|NCT00972816|20720798|P1|Overall Study|Adverse Event|0
5992297|NCT00972777|20720882|P2|Overall Study|Missed visit|0
5992298|NCT00972777|20720883|P1|Overall Study|Missed visit|1
5992299|NCT00972777|20720882|P2|Overall Study|Screening Failure|1
5992300|NCT00972777|20720883|P1|Overall Study|Screening Failure|2
5992301|NCT00972777|20720882|P2|Overall Study|Protocol Violation|2
5992302|NCT00972777|20720883|P1|Overall Study|Protocol Violation|0
5992303|NCT00972777|20720882|P2|Overall Study|Physician Decision|0
5992304|NCT00972777|20720883|P1|Overall Study|Physician Decision|4
5992305|NCT00972777|20720882|P2|Overall Study|Withdrawal by Subject|5
5992306|NCT00972777|20720883|P1|Overall Study|Withdrawal by Subject|4
5992307|NCT00972777|20720882|P2|Overall Study|Lost to Follow-up|4
5992308|NCT00972777|20720883|P1|Overall Study|Lost to Follow-up|0
5992309|NCT00972777|20720882|P2|Overall Study|Adverse Event|2
5992310|NCT00972777|20720883|P1|Overall Study|Adverse Event|3
5992311|NCT00972738|20720898|P3|Overall Study|Other|1
5992312|NCT00972738|20720899|P2|Overall Study|Other|2
5992313|NCT00972738|20720900|P1|Overall Study|Other|1
5992314|NCT00972738|20720898|P3|Overall Study|Moved|1
5992315|NCT00972738|20720899|P2|Overall Study|Moved|0
5992316|NCT00972738|20720900|P1|Overall Study|Moved|0
5992317|NCT00972738|20720898|P3|Overall Study|Withdrawal by Subject|4
5992318|NCT00972738|20720899|P2|Overall Study|Withdrawal by Subject|1
5992319|NCT00972738|20720900|P1|Overall Study|Withdrawal by Subject|5
5992320|NCT00972738|20720898|P3|Overall Study|Lack of Efficacy|11
5992321|NCT00972738|20720899|P2|Overall Study|Lack of Efficacy|1
5992322|NCT00972738|20720900|P1|Overall Study|Lack of Efficacy|5
5992323|NCT00972738|20720898|P3|Overall Study|Lost to Follow-up|1
5992324|NCT00972738|20720899|P2|Overall Study|Lost to Follow-up|0
5992325|NCT00972738|20720900|P1|Overall Study|Lost to Follow-up|1
5992326|NCT00972738|20720898|P3|Overall Study|Protocol Violation|3
5992327|NCT00972738|20720899|P2|Overall Study|Protocol Violation|1
5992328|NCT00972738|20720900|P1|Overall Study|Protocol Violation|2
5992329|NCT00972738|20720898|P3|Overall Study|Adverse Event|8
5992330|NCT00972738|20720899|P2|Overall Study|Adverse Event|1
5992331|NCT00972738|20720900|P1|Overall Study|Adverse Event|7
5992332|NCT00972595|20721017|P2|Period 1|Adverse Event|0
5992333|NCT00972595|20721018|P1|Period 1|Adverse Event|1
5992334|NCT00972543|20721028|P2|Overall Study|Early study termination by sponsor|1
5992335|NCT00972543|20721029|P1|Overall Study|Early study termination by sponsor|4
5992336|NCT00972543|20721028|P2|Overall Study|Adverse Event|0
5992337|NCT00972543|20721029|P1|Overall Study|Adverse Event|1
5992338|NCT00972517|20721112|P6|Overall Study|Withdrawal by Subject|0
5992339|NCT00972517|20721113|P5|Overall Study|Withdrawal by Subject|1
5992340|NCT00972517|20721114|P4|Overall Study|Withdrawal by Subject|2
5992341|NCT00972517|20721115|P3|Overall Study|Withdrawal by Subject|0
5992342|NCT00972517|20721116|P2|Overall Study|Withdrawal by Subject|1
5992343|NCT00972517|20721117|P1|Overall Study|Withdrawal by Subject|0
5992344|NCT00972517|20721112|P6|Overall Study|Adverse Event|0
5992345|NCT00972517|20721113|P5|Overall Study|Adverse Event|0
5992346|NCT00972517|20721114|P4|Overall Study|Adverse Event|1
5992347|NCT00972517|20721115|P3|Overall Study|Adverse Event|0
5992348|NCT00972517|20721116|P2|Overall Study|Adverse Event|0
5992349|NCT00972517|20721117|P1|Overall Study|Adverse Event|0
5992350|NCT00972504|20721212|P1|Overall Study|Investigator discretion|1
5992351|NCT00972504|20721212|P1|Overall Study|Adverse Event|2
5992352|NCT00972478|20721244|P2|Overall Study|Not start protocol treatment|2
5992353|NCT00972478|20721245|P1|Overall Study|Not start protocol treatment|1
5992354|NCT00972478|20721244|P2|Overall Study|Ineligible|7
5992355|NCT00972478|20721245|P1|Overall Study|Ineligible|1
5992356|NCT00972478|20721244|P2|Overall Study|Not protocol specified|1
5992357|NCT00972478|20721245|P1|Overall Study|Not protocol specified|1
5992358|NCT00972478|20721244|P2|Overall Study|Death|2
5992359|NCT00972478|20721245|P1|Overall Study|Death|0
5992360|NCT00972478|20721244|P2|Overall Study|Progression/Relapse|2
5992361|NCT00972478|20721245|P1|Overall Study|Progression/Relapse|0
5992362|NCT00972478|20721244|P2|Overall Study|Withdrawal by Subject|8
5992363|NCT00972478|20721245|P1|Overall Study|Withdrawal by Subject|1
5992364|NCT00972478|20721244|P2|Overall Study|Adverse Event|16
5992365|NCT00972478|20721245|P1|Overall Study|Adverse Event|3
5992366|NCT00972322|20721290|P2|Overall Study|Consistently high glucose values|0
5992367|NCT00972322|20721291|P1|Overall Study|Consistently high glucose values|1
5992368|NCT00972322|20721290|P2|Overall Study|Lost to Follow-up|1
5992369|NCT00972322|20721291|P1|Overall Study|Lost to Follow-up|0
5992370|NCT00972322|20721290|P2|Overall Study|Positive drug screen|1
5992371|NCT00972322|20721291|P1|Overall Study|Positive drug screen|0
5992372|NCT00972322|20721290|P2|Overall Study|Adverse Event|1
5992373|NCT00972322|20721291|P1|Overall Study|Adverse Event|2
5992374|NCT00972283|20721303|P2|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|5
5992375|NCT00972283|20721304|P1|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|11
5992376|NCT00972283|20721303|P2|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|2
5992377|NCT00972283|20721304|P1|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|6
5992378|NCT00972283|20721303|P2|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|0
5992379|NCT00972283|20721304|P1|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|5
5992380|NCT00972283|20721303|P2|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1
5992381|NCT00972283|20721304|P1|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1
5992382|NCT00972283|20721303|P2|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|0
5992383|NCT00972283|20721304|P1|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|4
5992384|NCT00972283|20721303|P2|Main: Week 0 to 52 (NN1250-3582)|Unclassified|17
5992385|NCT00972283|20721304|P1|Main: Week 0 to 52 (NN1250-3582)|Unclassified|72
5992386|NCT00972283|20721303|P2|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|2
5992387|NCT00972283|20721304|P1|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|8
5992388|NCT00972283|20721303|P2|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|12
5992389|NCT00972283|20721304|P1|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|23
5992390|NCT00972283|20721303|P2|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|0
5992391|NCT00972283|20721304|P1|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|3
5992392|NCT00972283|20721303|P2|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|9
5992393|NCT00972283|20721304|P1|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|31
5992394|NCT00972244|20721331|P5|Overall Study|Various|2
5992395|NCT00972244|20721332|P4|Overall Study|Various|0
5992396|NCT00972244|20721333|P3|Overall Study|Various|0
5992397|NCT00972244|20721334|P2|Overall Study|Various|0
5992398|NCT00972244|20721335|P1|Overall Study|Various|0
5992399|NCT00972244|20721331|P5|Overall Study|Death|0
5992400|NCT00972244|20721332|P4|Overall Study|Death|0
5992401|NCT00972244|20721333|P3|Overall Study|Death|0
5992402|NCT00972244|20721334|P2|Overall Study|Death|0
5992403|NCT00972244|20721335|P1|Overall Study|Death|1
5992404|NCT00972244|20721331|P5|Overall Study|Safety|1
5992405|NCT00972244|20721332|P4|Overall Study|Safety|0
5992406|NCT00972244|20721333|P3|Overall Study|Safety|0
5992407|NCT00972244|20721334|P2|Overall Study|Safety|0
5992408|NCT00972244|20721335|P1|Overall Study|Safety|0
5992409|NCT00972244|20721331|P5|Overall Study|Withdrawal by Subject|1
5992410|NCT00972244|20721332|P4|Overall Study|Withdrawal by Subject|0
5992411|NCT00972244|20721333|P3|Overall Study|Withdrawal by Subject|1
5992412|NCT00972244|20721334|P2|Overall Study|Withdrawal by Subject|2
5992413|NCT00972244|20721335|P1|Overall Study|Withdrawal by Subject|1
5992414|NCT00972244|20721331|P5|Overall Study|Subject No Longer Meets Study Criteria|5
5992415|NCT00972244|20721332|P4|Overall Study|Subject No Longer Meets Study Criteria|0
5992416|NCT00972244|20721333|P3|Overall Study|Subject No Longer Meets Study Criteria|0
5992417|NCT00972244|20721334|P2|Overall Study|Subject No Longer Meets Study Criteria|2
5992418|NCT00972244|20721335|P1|Overall Study|Subject No Longer Meets Study Criteria|2
5992419|NCT00972244|20721331|P5|Overall Study|Adverse Event|0
5992420|NCT00972244|20721332|P4|Overall Study|Adverse Event|0
5992421|NCT00972244|20721333|P3|Overall Study|Adverse Event|1
5992422|NCT00972244|20721334|P2|Overall Study|Adverse Event|1
5992423|NCT00972244|20721335|P1|Overall Study|Adverse Event|0
5992424|NCT00972244|20721331|P5|Overall Study|Incorrect Enrolment|0
5992425|NCT00972244|20721332|P4|Overall Study|Incorrect Enrolment|0
5992426|NCT00972244|20721333|P3|Overall Study|Incorrect Enrolment|0
5992427|NCT00972244|20721334|P2|Overall Study|Incorrect Enrolment|0
5992428|NCT00972244|20721335|P1|Overall Study|Incorrect Enrolment|1
5992429|NCT00972153|20721367|P3|Overall Study|Equipment malfunction during case|0
5992430|NCT00972153|20721368|P2|Overall Study|Equipment malfunction during case|1
5992431|NCT00972153|20721369|P1|Overall Study|Equipment malfunction during case|0
5992432|NCT00972023|20721384|P1|Overall Study|Withdrawal by Subject|1
5992433|NCT00971997|20721391|P1|Overall Study|Physician Decision|7
5992434|NCT00971997|20721391|P1|Overall Study|Withdrawal by Subject|5
5992435|NCT00971997|20721391|P1|Overall Study|Protocol Violation|4
5992436|NCT00971997|20721391|P1|Overall Study|Death|1
5992437|NCT00971997|20721391|P1|Overall Study|Adverse Event|2
5992438|NCT00971932|20721409|P1|Overall Study|Ongoing|4
5992439|NCT00971932|20721409|P1|Overall Study|Investigator's decision|2
5992440|NCT00971932|20721409|P1|Overall Study|Withdrawal by Subject|1
5992441|NCT00971425|20721510|P2|Overall Study|Withdrawal by Subject|1
5992442|NCT00971425|20721511|P1|Overall Study|Withdrawal by Subject|0
5992443|NCT00971425|20721510|P2|Overall Study|Adverse Event|1
5992444|NCT00971425|20721511|P1|Overall Study|Adverse Event|1
5992445|NCT00971321|20721547|P2|Up to Month 11-12|Lost to Follow-up|0
5992446|NCT00971321|20721548|P1|Up to Month 11-12|Lost to Follow-up|1
5992447|NCT00971321|20721547|P2|Up to Month 11-12|Migrated/moved from study area|2
5992448|NCT00971321|20721548|P1|Up to Month 11-12|Migrated/moved from study area|2
5992449|NCT00971321|20721547|P2|Up to Month 11-12|Withdrawal by Subject|1
5992450|NCT00971321|20721548|P1|Up to Month 11-12|Withdrawal by Subject|2
5992451|NCT00971321|20721547|P2|Up to Month 7|Migrated/moved from study area|2
5992452|NCT00971321|20721548|P1|Up to Month 7|Migrated/moved from study area|3
5992453|NCT00971321|20721547|P2|Up to Month 7|Withdrawal by Subject|0
5992454|NCT00971321|20721548|P1|Up to Month 7|Withdrawal by Subject|1
5992455|NCT00971243|20721628|P5|Open-label Period|Other reason|2
5992456|NCT00971243|20721629|P4|Open-label Period|Other reason|0
5992457|NCT00971243|20721630|P3|Open-label Period|Other reason|0
5992458|NCT00971243|20721631|P2|Open-label Period|Other reason|0
5992459|NCT00971243|20721632|P1|Open-label Period|Other reason|0
5992460|NCT00971243|20721628|P5|Open-label Period|Withdrawal by Subject|1
5992461|NCT00971243|20721629|P4|Open-label Period|Withdrawal by Subject|2
5992462|NCT00971243|20721630|P3|Open-label Period|Withdrawal by Subject|0
5992463|NCT00971243|20721631|P2|Open-label Period|Withdrawal by Subject|0
5992464|NCT00971243|20721632|P1|Open-label Period|Withdrawal by Subject|1
5992465|NCT00971243|20721628|P5|Open-label Period|Protocol Violation|1
5992466|NCT00971243|20721629|P4|Open-label Period|Protocol Violation|0
5992467|NCT00971243|20721630|P3|Open-label Period|Protocol Violation|1
5992468|NCT00971243|20721631|P2|Open-label Period|Protocol Violation|1
5992469|NCT00971243|20721632|P1|Open-label Period|Protocol Violation|1
5992470|NCT00971243|20721628|P5|Open-label Period|Physician Decision|2
5992471|NCT00971243|20721629|P4|Open-label Period|Physician Decision|7
5992472|NCT00971243|20721630|P3|Open-label Period|Physician Decision|3
5992473|NCT00971243|20721631|P2|Open-label Period|Physician Decision|9
5992474|NCT00971243|20721632|P1|Open-label Period|Physician Decision|5
5992475|NCT00971243|20721628|P5|Open-label Period|Adverse Event|0
5992476|NCT00971243|20721629|P4|Open-label Period|Adverse Event|1
5992477|NCT00971243|20721630|P3|Open-label Period|Adverse Event|1
5992478|NCT00971243|20721631|P2|Open-label Period|Adverse Event|0
5992479|NCT00971243|20721632|P1|Open-label Period|Adverse Event|1
5992480|NCT00971243|20721628|P5|Double Blind Period|Other reasons|1
5992481|NCT00971243|20721629|P4|Double Blind Period|Other reasons|0
5992482|NCT00971243|20721630|P3|Double Blind Period|Other reasons|2
5992483|NCT00971243|20721631|P2|Double Blind Period|Other reasons|0
5992484|NCT00971243|20721632|P1|Double Blind Period|Other reasons|1
5992485|NCT00971243|20721628|P5|Double Blind Period|Withdrawal by Subject|4
5992486|NCT00971243|20721629|P4|Double Blind Period|Withdrawal by Subject|4
5992487|NCT00971243|20721630|P3|Double Blind Period|Withdrawal by Subject|4
5992488|NCT00971243|20721631|P2|Double Blind Period|Withdrawal by Subject|1
5992489|NCT00971243|20721632|P1|Double Blind Period|Withdrawal by Subject|4
5992490|NCT00971243|20721628|P5|Double Blind Period|Protocol Violation|2
5992491|NCT00971243|20721629|P4|Double Blind Period|Protocol Violation|2
5992492|NCT00971243|20721630|P3|Double Blind Period|Protocol Violation|3
5992493|NCT00971243|20721631|P2|Double Blind Period|Protocol Violation|0
5992494|NCT00971243|20721632|P1|Double Blind Period|Protocol Violation|2
5992495|NCT00971243|20721628|P5|Double Blind Period|Physician Decision|7
5992496|NCT00971243|20721629|P4|Double Blind Period|Physician Decision|6
5992497|NCT00971243|20721630|P3|Double Blind Period|Physician Decision|7
5992498|NCT00971243|20721631|P2|Double Blind Period|Physician Decision|6
5992499|NCT00971243|20721632|P1|Double Blind Period|Physician Decision|10
5992500|NCT00971243|20721628|P5|Double Blind Period|Lost to Follow-up|1
5992501|NCT00971243|20721629|P4|Double Blind Period|Lost to Follow-up|0
5992502|NCT00971243|20721630|P3|Double Blind Period|Lost to Follow-up|1
5992503|NCT00971243|20721631|P2|Double Blind Period|Lost to Follow-up|1
5992504|NCT00971243|20721632|P1|Double Blind Period|Lost to Follow-up|0
5992505|NCT00971243|20721628|P5|Double Blind Period|Adverse Event|3
5992506|NCT00971243|20721629|P4|Double Blind Period|Adverse Event|2
5992507|NCT00971243|20721630|P3|Double Blind Period|Adverse Event|2
5992508|NCT00971243|20721631|P2|Double Blind Period|Adverse Event|3
5992509|NCT00971243|20721632|P1|Double Blind Period|Adverse Event|2
5992510|NCT00971204|20721649|P1|Overall Study|Lost to Follow-up|10
5992511|NCT00971204|20721649|P1|Overall Study|Did not meet all criteria-not treated|14
5992512|NCT00971178|20721656|P3|Overall Study|Lost to Follow-up|2
5992513|NCT00971178|20721657|P2|Overall Study|Lost to Follow-up|2
5992514|NCT00971178|20721658|P1|Overall Study|Lost to Follow-up|2
5992515|NCT00971048|20721670|P4|Overall Study|Physician Decision|1
5992516|NCT00971048|20721671|P3|Overall Study|Physician Decision|0
5992517|NCT00971048|20721672|P2|Overall Study|Physician Decision|0
5992518|NCT00971048|20721673|P1|Overall Study|Physician Decision|0
5992519|NCT00971048|20721670|P4|Overall Study|Adverse Event|0
5992520|NCT00971048|20721671|P3|Overall Study|Adverse Event|1
5992521|NCT00971048|20721672|P2|Overall Study|Adverse Event|0
5992522|NCT00971048|20721673|P1|Overall Study|Adverse Event|0
5992523|NCT00971048|20721670|P4|Overall Study|Protocol Violation|1
5992524|NCT00971048|20721671|P3|Overall Study|Protocol Violation|0
5992525|NCT00971048|20721672|P2|Overall Study|Protocol Violation|2
5992526|NCT00971048|20721673|P1|Overall Study|Protocol Violation|1
5992527|NCT00970944|20721697|P2|Overall Study|Physician Decision|2
5992528|NCT00970944|20721698|P1|Overall Study|Physician Decision|0
5992529|NCT00970944|20721697|P2|Overall Study|Death|0
5992530|NCT00970944|20721698|P1|Overall Study|Death|1
5992531|NCT00970684|20721750|P1|Overall Study|Withdrawal by Subject|1
5992532|NCT00970684|20721750|P1|Overall Study|Adverse Event|4
5992533|NCT00970684|20721750|P1|Overall Study|Lack of Efficacy|5
5992534|NCT00970632|20721759|P3|Overall Study|Sponsor decision|1
5992535|NCT00970632|20721760|P2|Overall Study|Sponsor decision|0
5992536|NCT00970632|20721761|P1|Overall Study|Sponsor decision|1
5992537|NCT00970632|20721759|P3|Overall Study|Entry criteria not met|2
5992538|NCT00970632|20721760|P2|Overall Study|Entry criteria not met|2
5992539|NCT00970632|20721761|P1|Overall Study|Entry criteria not met|0
5992540|NCT00970632|20721759|P3|Overall Study|Withdrawal by Subject|4
5992541|NCT00970632|20721760|P2|Overall Study|Withdrawal by Subject|6
5992542|NCT00970632|20721761|P1|Overall Study|Withdrawal by Subject|7
5992543|NCT00970632|20721759|P3|Overall Study|Protocol Violation|8
5992544|NCT00970632|20721760|P2|Overall Study|Protocol Violation|5
5992545|NCT00970632|20721761|P1|Overall Study|Protocol Violation|8
5992546|NCT00970632|20721759|P3|Overall Study|Lost to Follow-up|2
5992547|NCT00970632|20721760|P2|Overall Study|Lost to Follow-up|0
5992548|NCT00970632|20721761|P1|Overall Study|Lost to Follow-up|3
5992549|NCT00970632|20721759|P3|Overall Study|Lack of Efficacy|0
5992550|NCT00970632|20721760|P2|Overall Study|Lack of Efficacy|0
5992551|NCT00970632|20721761|P1|Overall Study|Lack of Efficacy|3
5992552|NCT00970632|20721759|P3|Overall Study|Adverse Event|1
5992553|NCT00970632|20721760|P2|Overall Study|Adverse Event|2
5992554|NCT00970632|20721761|P1|Overall Study|Adverse Event|2
5992555|NCT00970593|20721833|P7|Overall Study|Withdrawal by Subject|0
5992556|NCT00970593|20721834|P6|Overall Study|Withdrawal by Subject|0
5992557|NCT00970593|20721835|P5|Overall Study|Withdrawal by Subject|0
5992558|NCT00970593|20721836|P4|Overall Study|Withdrawal by Subject|0
5992559|NCT00970593|20721837|P3|Overall Study|Withdrawal by Subject|1
5992560|NCT00970593|20721838|P2|Overall Study|Withdrawal by Subject|0
5992561|NCT00970593|20721839|P1|Overall Study|Withdrawal by Subject|0
5992562|NCT00970593|20721833|P7|Overall Study|Discontinuation of study by sponsor|2
5992563|NCT00970593|20721834|P6|Overall Study|Discontinuation of study by sponsor|0
5992564|NCT00970593|20721835|P5|Overall Study|Discontinuation of study by sponsor|0
5992565|NCT00970593|20721836|P4|Overall Study|Discontinuation of study by sponsor|0
5992566|NCT00970593|20721837|P3|Overall Study|Discontinuation of study by sponsor|5
5992567|NCT00970593|20721838|P2|Overall Study|Discontinuation of study by sponsor|0
5992568|NCT00970593|20721839|P1|Overall Study|Discontinuation of study by sponsor|0
5992569|NCT00970593|20721833|P7|Overall Study|Adverse Event|0
5992570|NCT00970593|20721834|P6|Overall Study|Adverse Event|0
5992571|NCT00970593|20721835|P5|Overall Study|Adverse Event|0
5992572|NCT00970593|20721836|P4|Overall Study|Adverse Event|0
5992573|NCT00970593|20721837|P3|Overall Study|Adverse Event|0
5992574|NCT00970593|20721838|P2|Overall Study|Adverse Event|1
5992575|NCT00970593|20721839|P1|Overall Study|Adverse Event|1
5992576|NCT00970502|20721921|P1|Overall Study|Withdrawal by Subject|1
5992577|NCT00970489|20721932|P2|Overall Study|Death/Withdrew/Criteria Violation|41
5992578|NCT00970489|20721933|P1|Overall Study|Death/Withdrew/Criteria Violation|54
5992579|NCT00970359|20721945|P1|Overall Study|Not Treated|4
5992580|NCT00970307|20721975|P3|Overall Study|Withdrawal by Subject|2
5992581|NCT00970307|20721976|P2|Overall Study|Withdrawal by Subject|3
5992582|NCT00970307|20721977|P1|Overall Study|Withdrawal by Subject|2
5992583|NCT00970307|20721975|P3|Overall Study|Serious Adverse Event|0
5992584|NCT00970307|20721976|P2|Overall Study|Serious Adverse Event|0
5992585|NCT00970307|20721977|P1|Overall Study|Serious Adverse Event|1
5992586|NCT00970294|20722051|P1|Overall Study|Withdrawal by Subject|1
5992587|NCT00970294|20722051|P1|Overall Study|Physician Decision|4
5992588|NCT00970281|20722059|P2|Overall Study|Physician Decision|1
5992589|NCT00970281|20722060|P1|Overall Study|Physician Decision|1
5992590|NCT00970281|20722059|P2|Overall Study|Withdrawal by Subject|1
5992591|NCT00970281|20722060|P1|Overall Study|Withdrawal by Subject|0
5992592|NCT00970281|20722059|P2|Overall Study|Lack of Efficacy|14
5992593|NCT00970281|20722060|P1|Overall Study|Lack of Efficacy|1
5992594|NCT00970268|20722078|P2|Overall Study|Inclusion/Exclusion Criteria|0
5992595|NCT00970268|20722079|P1|Overall Study|Inclusion/Exclusion Criteria|1
5992596|NCT00970268|20722078|P2|Overall Study|Lost to Follow-up|2
5992597|NCT00970268|20722079|P1|Overall Study|Lost to Follow-up|1
5992598|NCT00970268|20722078|P2|Overall Study|COPD Exacerbation|2
5992599|NCT00970268|20722079|P1|Overall Study|COPD Exacerbation|4
5992600|NCT00970268|20722078|P2|Overall Study|Other Reason|1
5992601|NCT00970268|20722079|P1|Overall Study|Other Reason|3
5992602|NCT00970268|20722078|P2|Overall Study|Protocol Violation|7
5992603|NCT00970268|20722079|P1|Overall Study|Protocol Violation|4
5992604|NCT00970268|20722078|P2|Overall Study|Lack of Efficacy|6
5992605|NCT00970268|20722079|P1|Overall Study|Lack of Efficacy|3
5992606|NCT00970268|20722078|P2|Overall Study|Adverse Event|12
5992607|NCT00970268|20722079|P1|Overall Study|Adverse Event|15
5992608|NCT00970268|20722078|P2|Overall Study|Withdrawal by Subject|19
5992609|NCT00970268|20722079|P1|Overall Study|Withdrawal by Subject|12
5992610|NCT00969761|20722165|P12|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
5992611|NCT00969761|20722166|P11|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
5992612|NCT00969761|20722167|P10|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
5992613|NCT00969761|20722168|P9|Treated in and Beyond Treat. Cycle 2|Other adverse events|2
5992614|NCT00969761|20722169|P8|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
5992615|NCT00969761|20722170|P7|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
5992616|NCT00969761|20722171|P6|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
5992617|NCT00969761|20722172|P5|Treated in and Beyond Treat. Cycle 2|Other adverse events|1
5992618|NCT00969761|20722173|P4|Treated in and Beyond Treat. Cycle 2|Other adverse events|2
5992619|NCT00969761|20722174|P3|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
5992620|NCT00969761|20722175|P2|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
5992621|NCT00969761|20722176|P1|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
5992622|NCT00969761|20722165|P12|Treated in and Beyond Treat. Cycle 2|Progressive disease|3
5992623|NCT00969761|20722166|P11|Treated in and Beyond Treat. Cycle 2|Progressive disease|3
5992624|NCT00969761|20722167|P10|Treated in and Beyond Treat. Cycle 2|Progressive disease|2
5992625|NCT00969761|20722168|P9|Treated in and Beyond Treat. Cycle 2|Progressive disease|9
5992626|NCT00969761|20722169|P8|Treated in and Beyond Treat. Cycle 2|Progressive disease|6
5992627|NCT00969761|20722170|P7|Treated in and Beyond Treat. Cycle 2|Progressive disease|3
5992628|NCT00969761|20722171|P6|Treated in and Beyond Treat. Cycle 2|Progressive disease|3
5992629|NCT00969761|20722172|P5|Treated in and Beyond Treat. Cycle 2|Progressive disease|2
5992630|NCT00969761|20722173|P4|Treated in and Beyond Treat. Cycle 2|Progressive disease|3
5992631|NCT00969761|20722174|P3|Treated in and Beyond Treat. Cycle 2|Progressive disease|10
5992632|NCT00969761|20722175|P2|Treated in and Beyond Treat. Cycle 2|Progressive disease|3
5992633|NCT00969761|20722176|P1|Treated in and Beyond Treat. Cycle 2|Progressive disease|2
5992634|NCT00969761|20722165|P12|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
5992635|NCT00969761|20722166|P11|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
5992636|NCT00969761|20722167|P10|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
5992637|NCT00969761|20722168|P9|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|1
5992638|NCT00969761|20722169|P8|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
5992639|NCT00969761|20722170|P7|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
5992640|NCT00969761|20722171|P6|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
5992641|NCT00969761|20722172|P5|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
5992642|NCT00969761|20722173|P4|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
5992643|NCT00969761|20722174|P3|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
5992644|NCT00969761|20722175|P2|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
5992645|NCT00969761|20722176|P1|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
5992646|NCT00969761|20722165|P12|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
5992647|NCT00969761|20722166|P11|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
5992648|NCT00969761|20722167|P10|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
5992649|NCT00969761|20722168|P9|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
5992650|NCT00969761|20722169|P8|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
5992651|NCT00969761|20722170|P7|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
5992652|NCT00969761|20722171|P6|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
5992653|NCT00969761|20722172|P5|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
5992654|NCT00969761|20722173|P4|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
5992655|NCT00969761|20722174|P3|Discont. Before Start of Treat. Cycle 2|Other adverse events|1
5992656|NCT00969761|20722175|P2|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
5992657|NCT00969761|20722176|P1|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
5992658|NCT00969761|20722165|P12|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
5992659|NCT00969761|20722166|P11|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
5992660|NCT00969761|20722167|P10|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
5992661|NCT00969761|20722168|P9|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
5992662|NCT00969761|20722169|P8|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
5992663|NCT00969761|20722170|P7|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
5992664|NCT00969761|20722171|P6|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
5992665|NCT00969761|20722172|P5|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
5992666|NCT00969761|20722173|P4|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
5992667|NCT00969761|20722174|P3|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|1
5992668|NCT00969761|20722175|P2|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
5992669|NCT00969761|20722176|P1|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
5992670|NCT00969761|20722165|P12|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0
5992671|NCT00969761|20722166|P11|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0
5992672|NCT00969761|20722167|P10|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1
5992673|NCT00969761|20722168|P9|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1
5992674|NCT00969761|20722169|P8|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0
5992675|NCT00969761|20722170|P7|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0
5992676|NCT00969761|20722171|P6|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0
5992677|NCT00969761|20722172|P5|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0
5992678|NCT00969761|20722173|P4|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1
5992679|NCT00969761|20722174|P3|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0
5992680|NCT00969761|20722175|P2|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0
5992681|NCT00969761|20722176|P1|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1
5992682|NCT00969709|20722482|P4|Overall Study|Other reasons|0
5992683|NCT00969709|20722483|P3|Overall Study|Other reasons|3
5992684|NCT00969709|20722484|P2|Overall Study|Other reasons|0
5992685|NCT00969709|20722485|P1|Overall Study|Other reasons|0
5992686|NCT00969709|20722482|P4|Overall Study|Lost to Follow-up|15
5992687|NCT00969709|20722483|P3|Overall Study|Lost to Follow-up|8
5992688|NCT00969709|20722484|P2|Overall Study|Lost to Follow-up|14
5992689|NCT00969709|20722485|P1|Overall Study|Lost to Follow-up|10
5992690|NCT00969709|20722482|P4|Overall Study|Withdrawal by Subject|23
5992691|NCT00969709|20722483|P3|Overall Study|Withdrawal by Subject|11
5992692|NCT00969709|20722484|P2|Overall Study|Withdrawal by Subject|12
5992693|NCT00969709|20722485|P1|Overall Study|Withdrawal by Subject|9
5992694|NCT00969709|20722482|P4|Overall Study|Protocol Violation|10
5992695|NCT00969709|20722483|P3|Overall Study|Protocol Violation|9
5992696|NCT00969709|20722484|P2|Overall Study|Protocol Violation|5
5992697|NCT00969709|20722485|P1|Overall Study|Protocol Violation|9
5992698|NCT00969709|20722482|P4|Overall Study|Lack of Efficacy|3
5992699|NCT00969709|20722483|P3|Overall Study|Lack of Efficacy|1
5992700|NCT00969709|20722484|P2|Overall Study|Lack of Efficacy|4
5992701|NCT00969709|20722485|P1|Overall Study|Lack of Efficacy|7
5992702|NCT00969709|20722482|P4|Overall Study|Adverse Event|12
5992703|NCT00969709|20722483|P3|Overall Study|Adverse Event|26
5992704|NCT00969709|20722484|P2|Overall Study|Adverse Event|13
5992705|NCT00969709|20722485|P1|Overall Study|Adverse Event|3
5992706|NCT00969618|20722499|P1|Overall Study|Withdrawal by Subject|27
5992707|NCT00969618|20722499|P1|Overall Study|Protocol Violation|9
5992708|NCT00969618|20722499|P1|Overall Study|Physician Decision|1
5992709|NCT00969618|20722499|P1|Overall Study|Lost to Follow-up|7
5992710|NCT00969618|20722499|P1|Overall Study|Lack of Efficacy|2
5992711|NCT00969618|20722499|P1|Overall Study|Entry Criteria Not Met|3
5992712|NCT00969618|20722499|P1|Overall Study|Adverse Event|29
5992713|NCT00969553|20722519|P9|Overall Study|Not specified above|0
5992714|NCT00969553|20722520|P8|Overall Study|Not specified above|1
5992715|NCT00969553|20722521|P7|Overall Study|Not specified above|1
5992716|NCT00969553|20722522|P6|Overall Study|Not specified above|0
5992717|NCT00969553|20722523|P5|Overall Study|Not specified above|0
5992718|NCT00969553|20722524|P4|Overall Study|Not specified above|4
5992719|NCT00969553|20722525|P3|Overall Study|Not specified above|0
5992720|NCT00969553|20722526|P2|Overall Study|Not specified above|0
5992721|NCT00969553|20722527|P1|Overall Study|Not specified above|0
5992722|NCT00969553|20722519|P9|Overall Study|Refused cont. medication|0
5992723|NCT00969553|20722520|P8|Overall Study|Refused cont. medication|1
5992724|NCT00969553|20722521|P7|Overall Study|Refused cont. medication|0
5992725|NCT00969553|20722522|P6|Overall Study|Refused cont. medication|0
5992726|NCT00969553|20722523|P5|Overall Study|Refused cont. medication|0
5992727|NCT00969553|20722524|P4|Overall Study|Refused cont. medication|2
5992728|NCT00969553|20722525|P3|Overall Study|Refused cont. medication|0
5992729|NCT00969553|20722526|P2|Overall Study|Refused cont. medication|1
5992730|NCT00969553|20722527|P1|Overall Study|Refused cont. medication|1
5992731|NCT00969553|20722519|P9|Overall Study|Other Adverse Event|0
5992732|NCT00969553|20722520|P8|Overall Study|Other Adverse Event|0
5992733|NCT00969553|20722521|P7|Overall Study|Other Adverse Event|1
5992734|NCT00969553|20722522|P6|Overall Study|Other Adverse Event|0
5992735|NCT00969553|20722523|P5|Overall Study|Other Adverse Event|0
5992736|NCT00969553|20722524|P4|Overall Study|Other Adverse Event|1
5992737|NCT00969553|20722525|P3|Overall Study|Other Adverse Event|0
5992738|NCT00969553|20722526|P2|Overall Study|Other Adverse Event|0
5992739|NCT00969553|20722527|P1|Overall Study|Other Adverse Event|0
5992740|NCT00969553|20722519|P9|Overall Study|Dose limiting Toxicity (DLT)|0
5992741|NCT00969553|20722520|P8|Overall Study|Dose limiting Toxicity (DLT)|0
5992742|NCT00969553|20722521|P7|Overall Study|Dose limiting Toxicity (DLT)|0
5992743|NCT00969553|20722522|P6|Overall Study|Dose limiting Toxicity (DLT)|0
5992744|NCT00969553|20722523|P5|Overall Study|Dose limiting Toxicity (DLT)|1
5992745|NCT00969553|20722524|P4|Overall Study|Dose limiting Toxicity (DLT)|0
5992746|NCT00969553|20722525|P3|Overall Study|Dose limiting Toxicity (DLT)|0
5992747|NCT00969553|20722526|P2|Overall Study|Dose limiting Toxicity (DLT)|0
5992748|NCT00969553|20722527|P1|Overall Study|Dose limiting Toxicity (DLT)|0
5992749|NCT00969553|20722519|P9|Overall Study|Progressive disease (PD)|3
5992750|NCT00969553|20722520|P8|Overall Study|Progressive disease (PD)|12
5992751|NCT00969553|20722521|P7|Overall Study|Progressive disease (PD)|2
5992752|NCT00969553|20722522|P6|Overall Study|Progressive disease (PD)|4
5992753|NCT00969553|20722523|P5|Overall Study|Progressive disease (PD)|2
5992754|NCT00969553|20722524|P4|Overall Study|Progressive disease (PD)|9
5992755|NCT00969553|20722525|P3|Overall Study|Progressive disease (PD)|6
5992756|NCT00969553|20722526|P2|Overall Study|Progressive disease (PD)|2
5992757|NCT00969553|20722527|P1|Overall Study|Progressive disease (PD)|2
5992758|NCT00969540|20722670|P2|Overall Study|Lost to Follow-up|1
5992759|NCT00969540|20722671|P1|Overall Study|Lost to Follow-up|1
5992760|NCT00969436|20722696|P3|Overall Study|Lost to Follow-up|5
5992761|NCT00969436|20722697|P2|Overall Study|Lost to Follow-up|8
5992762|NCT00969436|20722698|P1|Overall Study|Lost to Follow-up|8
5992763|NCT00969436|20722696|P3|Overall Study|Withdrawal by Subject|2
5992764|NCT00969436|20722697|P2|Overall Study|Withdrawal by Subject|0
5992765|NCT00969436|20722698|P1|Overall Study|Withdrawal by Subject|3
5992766|NCT00969436|20722696|P3|Overall Study|Subject eliminated (other vaccine)|0
5992767|NCT00969436|20722697|P2|Overall Study|Subject eliminated (other vaccine)|0
5992768|NCT00969436|20722698|P1|Overall Study|Subject eliminated (other vaccine)|1
5992769|NCT00969436|20722696|P3|Overall Study|Parents personal problem|1
5992770|NCT00969436|20722697|P2|Overall Study|Parents personal problem|0
5992771|NCT00969436|20722698|P1|Overall Study|Parents personal problem|0
5992772|NCT00969436|20722696|P3|Overall Study|Father - serious health problem|1
5992773|NCT00969436|20722697|P2|Overall Study|Father - serious health problem|0
5992774|NCT00969436|20722698|P1|Overall Study|Father - serious health problem|0
5992775|NCT00969436|20722696|P3|Overall Study|Migrated/moved from study area|2
5992776|NCT00969436|20722697|P2|Overall Study|Migrated/moved from study area|10
5992777|NCT00969436|20722698|P1|Overall Study|Migrated/moved from study area|12
5992778|NCT00969436|20722696|P3|Overall Study|Protocol Violation|0
5992779|NCT00969436|20722697|P2|Overall Study|Protocol Violation|3
5992780|NCT00969436|20722698|P1|Overall Study|Protocol Violation|1
5992781|NCT00969332|20722730|P1|Overall Study|Withdrawal by Subject|3
5992782|NCT00969332|20722730|P1|Overall Study|Physician Decision|8
5992783|NCT00969280|20722746|P2|Overall Study|infection of influenza A(H1N1)|1
5992784|NCT00969280|20722747|P1|Overall Study|infection of influenza A(H1N1)|0
5992785|NCT00969280|20722746|P2|Overall Study|Withdrawal by Subject|1
5992786|NCT00969280|20722747|P1|Overall Study|Withdrawal by Subject|0
5992787|NCT00969280|20722746|P2|Overall Study|Protocol Violation|1
5992788|NCT00969280|20722747|P1|Overall Study|Protocol Violation|2
5992789|NCT00969228|20722755|P2|Overall Study|Porcine circovirus detection in vaccine|14
5992790|NCT00969228|20722756|P1|Overall Study|Porcine circovirus detection in vaccine|38
5992791|NCT00969228|20722755|P2|Overall Study|Withdrawal by Subject|0
5992792|NCT00969228|20722756|P1|Overall Study|Withdrawal by Subject|4
5992793|NCT00969228|20722755|P2|Overall Study|Adverse Event|0
5992794|NCT00969228|20722756|P1|Overall Study|Adverse Event|1
5992795|NCT00969150|20722774|P2|Overall Study|Other reasons|0
5992796|NCT00969150|20722775|P1|Overall Study|Other reasons|1
5992797|NCT00969150|20722774|P2|Overall Study|Lost to Follow-up|4
5992798|NCT00969150|20722775|P1|Overall Study|Lost to Follow-up|5
5992799|NCT00969150|20722774|P2|Overall Study|Withdrawal by Subject|9
5992800|NCT00969150|20722775|P1|Overall Study|Withdrawal by Subject|13
5992801|NCT00969150|20722774|P2|Overall Study|Protocol Violation|12
5992802|NCT00969150|20722775|P1|Overall Study|Protocol Violation|9
5992803|NCT00969150|20722774|P2|Overall Study|Lack of Efficacy|1
5992804|NCT00969150|20722775|P1|Overall Study|Lack of Efficacy|1
5992805|NCT00969150|20722774|P2|Overall Study|Adverse Event|14
5992806|NCT00969150|20722775|P1|Overall Study|Adverse Event|4
5992807|NCT00969124|20722783|P1|Overall Study|Technical error|1
5992808|NCT00969124|20722783|P1|Overall Study|Previously unrecognized disease|3
5992809|NCT00969124|20722783|P1|Overall Study|Inability to reach cecum|9
5992810|NCT00969124|20722783|P1|Overall Study|Inadequate bowel preparation|15
5992811|NCT00969124|20722783|P1|Overall Study|Protocol Violation|2
5992812|NCT00968981|20722792|P3|Overall Study|Withdrawal by Subject|3
5992813|NCT00968981|20722793|P2|Overall Study|Withdrawal by Subject|3
5992814|NCT00968981|20722794|P1|Overall Study|Withdrawal by Subject|1
5992815|NCT00968981|20722792|P3|Overall Study|Physician Decision|5
5992816|NCT00968981|20722793|P2|Overall Study|Physician Decision|3
5992817|NCT00968981|20722794|P1|Overall Study|Physician Decision|5
5992818|NCT00968981|20722792|P3|Overall Study|Lost to Follow-up|1
5992819|NCT00968981|20722793|P2|Overall Study|Lost to Follow-up|0
5992820|NCT00968981|20722794|P1|Overall Study|Lost to Follow-up|0
5992821|NCT00968981|20722792|P3|Overall Study|Disease Progression|13
5992822|NCT00968981|20722793|P2|Overall Study|Disease Progression|16
5992823|NCT00968981|20722794|P1|Overall Study|Disease Progression|14
5992824|NCT00968981|20722792|P3|Overall Study|Adverse Event|0
5992825|NCT00968981|20722793|P2|Overall Study|Adverse Event|0
5992826|NCT00968981|20722794|P1|Overall Study|Adverse Event|2
5992827|NCT00968968|20722832|P2|Overall Study|Lost to Follow-up|1
5992828|NCT00968968|20722833|P1|Overall Study|Lost to Follow-up|0
5992829|NCT00968968|20722832|P2|Overall Study|Physician Decision|2
5992830|NCT00968968|20722833|P1|Overall Study|Physician Decision|1
5992831|NCT00968968|20722832|P2|Overall Study|Withdrawal by Subject|0
5992832|NCT00968968|20722833|P1|Overall Study|Withdrawal by Subject|2
5992833|NCT00968968|20722832|P2|Overall Study|Protocol defined stopping criteria|1
5992834|NCT00968968|20722833|P1|Overall Study|Protocol defined stopping criteria|3
5992835|NCT00968968|20722832|P2|Overall Study|Study closed/terminated|10
5992836|NCT00968968|20722833|P1|Overall Study|Study closed/terminated|10
5992837|NCT00968864|20722879|P1|Overall Study|Protocol exception/ not evaluable|1
5992838|NCT00968812|20722907|P3|Overall Study|Other|40
5992839|NCT00968812|20722908|P2|Overall Study|Other|37
5992840|NCT00968812|20722909|P1|Overall Study|Other|25
5992841|NCT00968812|20722907|P3|Overall Study|Unable to take rescue therapy|17
5992842|NCT00968812|20722908|P2|Overall Study|Unable to take rescue therapy|12
5992843|NCT00968812|20722909|P1|Overall Study|Unable to take rescue therapy|12
5992844|NCT00968812|20722907|P3|Overall Study|Noncompliance with study drug|6
5992845|NCT00968812|20722908|P2|Overall Study|Noncompliance with study drug|1
5992846|NCT00968812|20722909|P1|Overall Study|Noncompliance with study drug|4
5992847|NCT00968812|20722907|P3|Overall Study|Creatinine or eGFR withdrawal criteria|7
5992848|NCT00968812|20722908|P2|Overall Study|Creatinine or eGFR withdrawal criteria|13
5992849|NCT00968812|20722909|P1|Overall Study|Creatinine or eGFR withdrawal criteria|9
5992850|NCT00968812|20722907|P3|Overall Study|Withdrawal by Subject|25
5992851|NCT00968812|20722908|P2|Overall Study|Withdrawal by Subject|23
5992852|NCT00968812|20722909|P1|Overall Study|Withdrawal by Subject|17
5992853|NCT00968812|20722907|P3|Overall Study|Protocol Violation|3
5992854|NCT00968812|20722908|P2|Overall Study|Protocol Violation|4
5992855|NCT00968812|20722909|P1|Overall Study|Protocol Violation|7
5992856|NCT00968812|20722907|P3|Overall Study|Physician Decision|9
5992857|NCT00968812|20722908|P2|Overall Study|Physician Decision|5
5992858|NCT00968812|20722909|P1|Overall Study|Physician Decision|8
5992859|NCT00968812|20722907|P3|Overall Study|Lost to Follow-up|11
5992860|NCT00968812|20722908|P2|Overall Study|Lost to Follow-up|12
5992861|NCT00968812|20722909|P1|Overall Study|Lost to Follow-up|17
5992862|NCT00968812|20722907|P3|Overall Study|Lack of Efficacy|16
5992863|NCT00968812|20722908|P2|Overall Study|Lack of Efficacy|7
5992864|NCT00968812|20722909|P1|Overall Study|Lack of Efficacy|9
5992865|NCT00968812|20722907|P3|Overall Study|Death|1
5992866|NCT00968812|20722908|P2|Overall Study|Death|2
5992867|NCT00968812|20722909|P1|Overall Study|Death|2
5992868|NCT00968812|20722907|P3|Overall Study|Adverse Event|33
5992869|NCT00968812|20722908|P2|Overall Study|Adverse Event|46
5992870|NCT00968812|20722909|P1|Overall Study|Adverse Event|30
5992871|NCT00968799|20722929|P1|Overall Study|Advanced disease, HIPEC not applicable|2
5992872|NCT00968708|20722939|P2|Overall Study|Other|34
5992873|NCT00968708|20722940|P1|Overall Study|Other|26
5992874|NCT00968708|20722939|P2|Overall Study|Investigator Discretion|1
5992875|NCT00968708|20722940|P1|Overall Study|Investigator Discretion|0
5992876|NCT00968708|20722939|P2|Overall Study|Voluntary Withdrawal|101
5992877|NCT00968708|20722940|P1|Overall Study|Voluntary Withdrawal|104
5992878|NCT00968708|20722939|P2|Overall Study|Lost to Follow-up|11
5992879|NCT00968708|20722940|P1|Overall Study|Lost to Follow-up|19
5992880|NCT00968708|20722939|P2|Overall Study|Major Protocol Deviation|1
5992881|NCT00968708|20722940|P1|Overall Study|Major Protocol Deviation|0
5992882|NCT00968708|20722939|P2|Overall Study|Adverse Event|150
5992883|NCT00968708|20722940|P1|Overall Study|Adverse Event|169
5992884|NCT00968669|20722952|P4|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|1
5992885|NCT00968669|20722953|P3|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0
5992886|NCT00968669|20722954|P2|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0
5992887|NCT00968669|20722955|P1|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0
5992888|NCT00968669|20722952|P4|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0
5992889|NCT00968669|20722953|P3|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0
5992890|NCT00968669|20722954|P2|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|1
5992891|NCT00968669|20722955|P1|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0
5992892|NCT00968669|20722952|P4|Overall Study|SUBJECT INCARCERATED|0
5992893|NCT00968669|20722953|P3|Overall Study|SUBJECT INCARCERATED|0
5992894|NCT00968669|20722954|P2|Overall Study|SUBJECT INCARCERATED|1
5992895|NCT00968669|20722955|P1|Overall Study|SUBJECT INCARCERATED|0
5992896|NCT00968669|20722952|P4|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0
5992897|NCT00968669|20722953|P3|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0
5992898|NCT00968669|20722954|P2|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|1
5992899|NCT00968669|20722955|P1|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0
5992900|NCT00968669|20722952|P4|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0
5992901|NCT00968669|20722953|P3|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|1
5992902|NCT00968669|20722954|P2|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0
5992903|NCT00968669|20722955|P1|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0
5992904|NCT00968669|20722952|P4|Overall Study|SPONSOR DECISION|0
5992905|NCT00968669|20722953|P3|Overall Study|SPONSOR DECISION|0
5992906|NCT00968669|20722954|P2|Overall Study|SPONSOR DECISION|1
5992907|NCT00968669|20722955|P1|Overall Study|SPONSOR DECISION|0
5992908|NCT00968669|20722952|P4|Overall Study|PATIENT WILL BE WORKING ABROAD|0
5992909|NCT00968669|20722953|P3|Overall Study|PATIENT WILL BE WORKING ABROAD|0
5992910|NCT00968669|20722954|P2|Overall Study|PATIENT WILL BE WORKING ABROAD|1
5992911|NCT00968669|20722955|P1|Overall Study|PATIENT WILL BE WORKING ABROAD|0
5992912|NCT00968669|20722952|P4|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0
5992913|NCT00968669|20722953|P3|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0
5992914|NCT00968669|20722954|P2|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|1
5992915|NCT00968669|20722955|P1|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0
5992916|NCT00968669|20722952|P4|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0
5992917|NCT00968669|20722953|P3|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0
5992918|NCT00968669|20722954|P2|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|1
5992919|NCT00968669|20722955|P1|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0
5992920|NCT00968669|20722952|P4|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0
5992921|NCT00968669|20722953|P3|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0
5992922|NCT00968669|20722954|P2|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|1
5992923|NCT00968669|20722955|P1|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0
5992924|NCT00968669|20722952|P4|Overall Study|INEGIBILITY TO PERFORM VISIT|0
5992925|NCT00968669|20722953|P3|Overall Study|INEGIBILITY TO PERFORM VISIT|0
5992926|NCT00968669|20722954|P2|Overall Study|INEGIBILITY TO PERFORM VISIT|0
5992927|NCT00968669|20722955|P1|Overall Study|INEGIBILITY TO PERFORM VISIT|1
5992928|NCT00968669|20722952|P4|Overall Study|ERROR IN HADS ADMINISTRATION|0
5992929|NCT00968669|20722953|P3|Overall Study|ERROR IN HADS ADMINISTRATION|1
5992930|NCT00968669|20722954|P2|Overall Study|ERROR IN HADS ADMINISTRATION|0
5992931|NCT00968669|20722955|P1|Overall Study|ERROR IN HADS ADMINISTRATION|0
5992932|NCT00968669|20722952|P4|Overall Study|EARLY WITHDRAWAL|0
5992933|NCT00968669|20722953|P3|Overall Study|EARLY WITHDRAWAL|0
5992934|NCT00968669|20722954|P2|Overall Study|EARLY WITHDRAWAL|1
5992935|NCT00968669|20722955|P1|Overall Study|EARLY WITHDRAWAL|0
5992936|NCT00968669|20722952|P4|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0
5992937|NCT00968669|20722953|P3|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|1
5992938|NCT00968669|20722954|P2|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0
5992939|NCT00968669|20722955|P1|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0
5992940|NCT00968669|20722952|P4|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0
5992941|NCT00968669|20722953|P3|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0
5992942|NCT00968669|20722954|P2|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0
5992943|NCT00968669|20722955|P1|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|1
5992944|NCT00968669|20722952|P4|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0
5992945|NCT00968669|20722953|P3|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0
5992946|NCT00968669|20722954|P2|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0
5992947|NCT00968669|20722955|P1|Overall Study|DID NOT MEET EXCLUSION CRITERIA|1
5992948|NCT00968669|20722952|P4|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|1
5992949|NCT00968669|20722953|P3|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0
5992950|NCT00968669|20722954|P2|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0
5992951|NCT00968669|20722955|P1|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0
5992952|NCT00968669|20722952|P4|Overall Study|AE|0
5992953|NCT00968669|20722953|P3|Overall Study|AE|0
5992954|NCT00968669|20722954|P2|Overall Study|AE|0
5992955|NCT00968669|20722955|P1|Overall Study|AE|1
5992956|NCT00968669|20722952|P4|Overall Study|Pregnancy|0
5992957|NCT00968669|20722953|P3|Overall Study|Pregnancy|2
5992958|NCT00968669|20722954|P2|Overall Study|Pregnancy|0
5992959|NCT00968669|20722955|P1|Overall Study|Pregnancy|0
5992960|NCT00968669|20722952|P4|Overall Study|Withdrawal by Subject|3
5992961|NCT00968669|20722953|P3|Overall Study|Withdrawal by Subject|5
5992962|NCT00968669|20722954|P2|Overall Study|Withdrawal by Subject|7
5992963|NCT00968669|20722955|P1|Overall Study|Withdrawal by Subject|9
5992964|NCT00968669|20722952|P4|Overall Study|Lost to Follow-up|4
5992965|NCT00968669|20722953|P3|Overall Study|Lost to Follow-up|1
5992966|NCT00968669|20722954|P2|Overall Study|Lost to Follow-up|2
5992967|NCT00968669|20722955|P1|Overall Study|Lost to Follow-up|5
5992968|NCT00968617|20723045|P1|Overall Study|Study terminated by sponsor|6
5992969|NCT00968539|20723059|P2|Overall Study|Lost to follow-up (incompl. vaccination)|0
5992970|NCT00968539|20723060|P1|Overall Study|Lost to follow-up (incompl. vaccination)|1
5992971|NCT00968526|20723120|P2|Overall Study|Migrated/moved from study area|0
5992972|NCT00968526|20723121|P1|Overall Study|Migrated/moved from study area|1
5992973|NCT00968526|20723120|P2|Overall Study|Adverse Event|0
5992974|NCT00968526|20723121|P1|Overall Study|Adverse Event|2
5992975|NCT00968253|20723223|P3|Overall Study|Adverse Event|1
5992976|NCT00968253|20723224|P2|Overall Study|Adverse Event|0
5992977|NCT00968253|20723225|P1|Overall Study|Adverse Event|0
5992978|NCT00968253|20723223|P3|Overall Study|Disease Progression|3
5992979|NCT00968253|20723224|P2|Overall Study|Disease Progression|3
5992980|NCT00968253|20723225|P1|Overall Study|Disease Progression|0
5992981|NCT00968253|20723223|P3|Overall Study|Withdrawal by Subject|1
5992982|NCT00968253|20723224|P2|Overall Study|Withdrawal by Subject|0
5992983|NCT00968253|20723225|P1|Overall Study|Withdrawal by Subject|0
5992984|NCT00968253|20723223|P3|Overall Study|Death|2
5992985|NCT00968253|20723224|P2|Overall Study|Death|0
5992986|NCT00968253|20723225|P1|Overall Study|Death|0
5992987|NCT00968201|20723246|P3|Extension Study - (Period III)|Study Terminated for Admin Reasons|185
5992988|NCT00968201|20723247|P2|Extension Study - (Period III)|Study Terminated for Admin Reasons|74
5992989|NCT00968201|20723248|P1|Extension Study - (Period III)|Study Terminated for Admin Reasons|0
5992990|NCT00968201|20723246|P3|Extension Study - (Period III)|Other|2
5992991|NCT00968201|20723247|P2|Extension Study - (Period III)|Other|0
5992992|NCT00968201|20723248|P1|Extension Study - (Period III)|Other|0
5992993|NCT00968201|20723246|P3|Extension Study - (Period III)|Noncompliance|3
5992994|NCT00968201|20723247|P2|Extension Study - (Period III)|Noncompliance|0
5992995|NCT00968201|20723248|P1|Extension Study - (Period III)|Noncompliance|0
5992996|NCT00968201|20723246|P3|Extension Study - (Period III)|Patient Relocated|1
5992997|NCT00968201|20723247|P2|Extension Study - (Period III)|Patient Relocated|1
5992998|NCT00968201|20723248|P1|Extension Study - (Period III)|Patient Relocated|0
5992999|NCT00968201|20723246|P3|Extension Study - (Period III)|Withdrawal by Subject|40
5993000|NCT00968201|20723247|P2|Extension Study - (Period III)|Withdrawal by Subject|20
5993001|NCT00968201|20723248|P1|Extension Study - (Period III)|Withdrawal by Subject|0
5993002|NCT00968201|20723246|P3|Extension Study - (Period III)|Protocol Violation|14
5993003|NCT00968201|20723247|P2|Extension Study - (Period III)|Protocol Violation|17
5993004|NCT00968201|20723248|P1|Extension Study - (Period III)|Protocol Violation|0
5993005|NCT00968201|20723246|P3|Extension Study - (Period III)|Lost to Follow-up|13
5993006|NCT00968201|20723247|P2|Extension Study - (Period III)|Lost to Follow-up|7
5993007|NCT00968201|20723248|P1|Extension Study - (Period III)|Lost to Follow-up|0
5993008|NCT00968201|20723246|P3|Extension Study - (Period III)|Adverse Event|22
5993009|NCT00968201|20723247|P2|Extension Study - (Period III)|Adverse Event|5
5993010|NCT00968201|20723248|P1|Extension Study - (Period III)|Adverse Event|0
5993011|NCT00968201|20723246|P3|Base Study - (Period II)|Site Error|1
5993012|NCT00968201|20723247|P2|Base Study - (Period II)|Site Error|0
5993013|NCT00968201|20723248|P1|Base Study - (Period II)|Site Error|0
5993014|NCT00968201|20723246|P3|Base Study - (Period II)|Withdrawal by Subject|8
5993015|NCT00968201|20723247|P2|Base Study - (Period II)|Withdrawal by Subject|0
5993016|NCT00968201|20723248|P1|Base Study - (Period II)|Withdrawal by Subject|4
5993017|NCT00968201|20723246|P3|Base Study - (Period II)|Protocol Violation|12
5993018|NCT00968201|20723247|P2|Base Study - (Period II)|Protocol Violation|0
5993019|NCT00968201|20723248|P1|Base Study - (Period II)|Protocol Violation|12
5993020|NCT00968201|20723246|P3|Base Study - (Period II)|Lost to Follow-up|7
5993021|NCT00968201|20723247|P2|Base Study - (Period II)|Lost to Follow-up|0
5993022|NCT00968201|20723248|P1|Base Study - (Period II)|Lost to Follow-up|2
5993023|NCT00968201|20723246|P3|Base Study - (Period II)|Lack of Efficacy|1
5993024|NCT00968201|20723247|P2|Base Study - (Period II)|Lack of Efficacy|0
5993025|NCT00968201|20723248|P1|Base Study - (Period II)|Lack of Efficacy|0
5993026|NCT00968201|20723246|P3|Base Study - (Period II)|Adverse Event|16
5993027|NCT00968201|20723247|P2|Base Study - (Period II)|Adverse Event|0
5993028|NCT00968201|20723248|P1|Base Study - (Period II)|Adverse Event|8
5993029|NCT00968149|20723309|P2|Overall Study|Withdrawal by Subject|0
5993030|NCT00968149|20723310|P1|Overall Study|Withdrawal by Subject|2
5993031|NCT00968149|20723309|P2|Overall Study|Protocol Violation|0
5993032|NCT00968149|20723310|P1|Overall Study|Protocol Violation|4
5993033|NCT00968149|20723309|P2|Overall Study|Lost to Follow-up|1
5993034|NCT00968149|20723310|P1|Overall Study|Lost to Follow-up|0
5993035|NCT00968149|20723309|P2|Overall Study|Lack of Efficacy|4
5993036|NCT00968149|20723310|P1|Overall Study|Lack of Efficacy|0
5993037|NCT00968149|20723309|P2|Overall Study|Adverse Event|1
5993038|NCT00968149|20723310|P1|Overall Study|Adverse Event|5
5993039|NCT00967798|20723378|P2|Overall Study|Lost to Follow-up|1
5993040|NCT00967798|20723379|P1|Overall Study|Lost to Follow-up|4
5993041|NCT00967798|20723378|P2|Overall Study|Withdrawal by Subject|2
5993042|NCT00967798|20723379|P1|Overall Study|Withdrawal by Subject|5
5993043|NCT00967694|20723393|P1|Overall Study|Withdrawal by Subject|6
5993044|NCT00967668|20723400|P3|Overall Study|Pregnancy|0
5993045|NCT00967668|20723401|P2|Overall Study|Pregnancy|0
5993046|NCT00967668|20723402|P1|Overall Study|Pregnancy|1
5993047|NCT00967668|20723400|P3|Overall Study|Refused 12-mo assessment|9
5993048|NCT00967668|20723401|P2|Overall Study|Refused 12-mo assessment|1
5993049|NCT00967668|20723402|P1|Overall Study|Refused 12-mo assessment|3
5993050|NCT00967668|20723400|P3|Overall Study|Lost to Follow-up|16
5993051|NCT00967668|20723401|P2|Overall Study|Lost to Follow-up|9
5993052|NCT00967668|20723402|P1|Overall Study|Lost to Follow-up|15
5993053|NCT00967668|20723400|P3|Overall Study|Lost to follow-up at 12-mo|26
5993054|NCT00967668|20723401|P2|Overall Study|Lost to follow-up at 12-mo|29
5993055|NCT00967668|20723402|P1|Overall Study|Lost to follow-up at 12-mo|27
5993056|NCT00967668|20723400|P3|Overall Study|Refused Year 2|4
5993057|NCT00967668|20723401|P2|Overall Study|Refused Year 2|6
5993058|NCT00967668|20723402|P1|Overall Study|Refused Year 2|11
5993059|NCT00967668|20723400|P3|Overall Study|Removed due to behavior|2
5993060|NCT00967668|20723401|P2|Overall Study|Removed due to behavior|1
5993061|NCT00967668|20723402|P1|Overall Study|Removed due to behavior|1
5993062|NCT00967668|20723400|P3|Overall Study|Death|4
5993063|NCT00967668|20723401|P2|Overall Study|Death|2
5993064|NCT00967668|20723402|P1|Overall Study|Death|0
5993065|NCT00967668|20723400|P3|Overall Study|Withdrawal by Subject|8
5993066|NCT00967668|20723401|P2|Overall Study|Withdrawal by Subject|8
5993067|NCT00967668|20723402|P1|Overall Study|Withdrawal by Subject|13
5993068|NCT00967616|20723415|P2|Overall Study|Protocol Violation|0
5993069|NCT00967616|20723416|P1|Overall Study|Protocol Violation|1
5993070|NCT00967616|20723415|P2|Overall Study|Other|8
5993071|NCT00967616|20723416|P1|Overall Study|Other|8
5993072|NCT00967616|20723415|P2|Overall Study|Progressive Disease|18
5993073|NCT00967616|20723416|P1|Overall Study|Progressive Disease|31
5993074|NCT00967616|20723415|P2|Overall Study|Withdrawal by Subject|4
5993075|NCT00967616|20723416|P1|Overall Study|Withdrawal by Subject|8
5993076|NCT00967616|20723415|P2|Overall Study|Death|3
5993077|NCT00967616|20723416|P1|Overall Study|Death|0
5993078|NCT00967616|20723415|P2|Overall Study|Adverse Event or Serious Adverse Event|17
5993079|NCT00967616|20723416|P1|Overall Study|Adverse Event or Serious Adverse Event|2
5993080|NCT00967499|20723443|P2|Overall Study|Randomized but not treated|59
5993081|NCT00967499|20723444|P1|Overall Study|Randomized but not treated|63
5993082|NCT00967499|20723443|P2|Overall Study|Sponsor Decision|0
5993083|NCT00967499|20723444|P1|Overall Study|Sponsor Decision|1
5993084|NCT00967499|20723443|P2|Overall Study|Protocol Violation|0
5993085|NCT00967499|20723444|P1|Overall Study|Protocol Violation|1
5993086|NCT00967499|20723443|P2|Overall Study|Adverse Event|1
5993087|NCT00967499|20723444|P1|Overall Study|Adverse Event|0
5993088|NCT00967343|20723501|P1|Overall Study|Lost to Follow-up|1
5993089|NCT00967343|20723501|P1|Overall Study|Relapse|1
5993090|NCT00967343|20723501|P1|Overall Study|Death|24
5993091|NCT00967343|20723501|P1|Overall Study|Study termination by sponsor|12
5993092|NCT00967330|20723507|P2|Overall Study|Severe protocol deviation|1
5993093|NCT00967330|20723508|P1|Overall Study|Severe protocol deviation|0
5993094|NCT00967330|20723507|P2|Overall Study|Death|51
5993095|NCT00967330|20723508|P1|Overall Study|Death|102
5993096|NCT00967330|20723507|P2|Overall Study|Lost to Follow-up|1
5993097|NCT00967330|20723508|P1|Overall Study|Lost to Follow-up|1
5993098|NCT00967330|20723507|P2|Overall Study|Withdrawal by Subject|0
5993099|NCT00967330|20723508|P1|Overall Study|Withdrawal by Subject|6
5993100|NCT00967330|20723507|P2|Overall Study|Regular|3
5993101|NCT00967330|20723508|P1|Overall Study|Regular|10
5993102|NCT00967330|20723507|P2|Overall Study|Protocol Violation|4
5993103|NCT00967330|20723508|P1|Overall Study|Protocol Violation|3
5993104|NCT00967226|20723538|P2|Overall Study|Physician Decision|1
5993105|NCT00967226|20723539|P1|Overall Study|Physician Decision|0
5993106|NCT00967226|20723538|P2|Overall Study|Protocol Violation|0
5993107|NCT00967226|20723539|P1|Overall Study|Protocol Violation|2
5993108|NCT00967226|20723538|P2|Overall Study|Adverse Event|5
5993109|NCT00967226|20723539|P1|Overall Study|Adverse Event|0
5993110|NCT00967018|20723573|P1|Overall Study|Miscellaneous Reasons|9
5993111|NCT00967018|20723573|P1|Overall Study|Withdrawal by Subject|1
5993112|NCT00967018|20723573|P1|Overall Study|Lost to Follow-up|2
5993113|NCT00967018|20723573|P1|Overall Study|Physician Decision|7
5993114|NCT00967018|20723573|P1|Overall Study|Adverse Event|2
5993115|NCT00967005|20723582|P2|Overall Study|Lost to Follow-up|10
5993116|NCT00967005|20723583|P1|Overall Study|Lost to Follow-up|7
5993117|NCT00966940|20723669|P2|Period 1, First 6 Weeks|Protocol Violation|0
5993118|NCT00966940|20723670|P1|Period 1, First 6 Weeks|Protocol Violation|1
5993119|NCT00966940|20723669|P2|Period 1, First 6 Weeks|Withdrawal by Subject|0
5993120|NCT00966940|20723670|P1|Period 1, First 6 Weeks|Withdrawal by Subject|2
5993121|NCT00966875|20723697|P9|Part B|Entry Criteria|1
5993122|NCT00966875|20723698|P8|Part B|Entry Criteria|0
5993123|NCT00966875|20723699|P7|Part B|Entry Criteria|1
5993124|NCT00966875|20723700|P6|Part B|Entry Criteria|0
5993125|NCT00966875|20723701|P5|Part B|Entry Criteria|0
5993126|NCT00966875|20723702|P4|Part B|Entry Criteria|0
5993127|NCT00966875|20723703|P3|Part B|Entry Criteria|0
5993128|NCT00966875|20723704|P2|Part B|Entry Criteria|0
5993129|NCT00966875|20723705|P1|Part B|Entry Criteria|0
5993130|NCT00966875|20723697|P9|Part B|Withdrawal by Subject|5
5993131|NCT00966875|20723698|P8|Part B|Withdrawal by Subject|5
5993132|NCT00966875|20723699|P7|Part B|Withdrawal by Subject|4
5993133|NCT00966875|20723700|P6|Part B|Withdrawal by Subject|1
5993134|NCT00966875|20723701|P5|Part B|Withdrawal by Subject|2
5993135|NCT00966875|20723702|P4|Part B|Withdrawal by Subject|1
5993136|NCT00966875|20723703|P3|Part B|Withdrawal by Subject|2
5993137|NCT00966875|20723704|P2|Part B|Withdrawal by Subject|1
5993138|NCT00966875|20723705|P1|Part B|Withdrawal by Subject|2
5993139|NCT00966875|20723697|P9|Part B|Sponsor Decision|1
5993140|NCT00966875|20723698|P8|Part B|Sponsor Decision|2
5993141|NCT00966875|20723699|P7|Part B|Sponsor Decision|0
5993142|NCT00966875|20723700|P6|Part B|Sponsor Decision|1
5993143|NCT00966875|20723701|P5|Part B|Sponsor Decision|0
5993144|NCT00966875|20723702|P4|Part B|Sponsor Decision|0
5993145|NCT00966875|20723703|P3|Part B|Sponsor Decision|0
5993146|NCT00966875|20723704|P2|Part B|Sponsor Decision|0
5993147|NCT00966875|20723705|P1|Part B|Sponsor Decision|1
5993148|NCT00966875|20723697|P9|Part B|Physician Decision|2
5993149|NCT00966875|20723698|P8|Part B|Physician Decision|0
5993150|NCT00966875|20723699|P7|Part B|Physician Decision|0
5993151|NCT00966875|20723700|P6|Part B|Physician Decision|1
5993152|NCT00966875|20723701|P5|Part B|Physician Decision|2
5993153|NCT00966875|20723702|P4|Part B|Physician Decision|0
5993154|NCT00966875|20723703|P3|Part B|Physician Decision|1
5993155|NCT00966875|20723704|P2|Part B|Physician Decision|0
5993156|NCT00966875|20723705|P1|Part B|Physician Decision|0
5993157|NCT00966875|20723697|P9|Part B|Lost to Follow-up|1
5993158|NCT00966875|20723698|P8|Part B|Lost to Follow-up|0
5993159|NCT00966875|20723699|P7|Part B|Lost to Follow-up|0
5993160|NCT00966875|20723700|P6|Part B|Lost to Follow-up|0
5993161|NCT00966875|20723701|P5|Part B|Lost to Follow-up|0
5993162|NCT00966875|20723702|P4|Part B|Lost to Follow-up|1
5993163|NCT00966875|20723703|P3|Part B|Lost to Follow-up|0
5993164|NCT00966875|20723704|P2|Part B|Lost to Follow-up|0
5993165|NCT00966875|20723705|P1|Part B|Lost to Follow-up|0
5993166|NCT00966875|20723697|P9|Part B|Lack of Efficacy|6
5993167|NCT00966875|20723698|P8|Part B|Lack of Efficacy|9
5993168|NCT00966875|20723699|P7|Part B|Lack of Efficacy|12
5993169|NCT00966875|20723700|P6|Part B|Lack of Efficacy|3
5993170|NCT00966875|20723701|P5|Part B|Lack of Efficacy|2
5993171|NCT00966875|20723702|P4|Part B|Lack of Efficacy|1
5993172|NCT00966875|20723703|P3|Part B|Lack of Efficacy|1
5993173|NCT00966875|20723704|P2|Part B|Lack of Efficacy|1
5993174|NCT00966875|20723705|P1|Part B|Lack of Efficacy|2
5993175|NCT00966875|20723697|P9|Part B|Death|0
5993176|NCT00966875|20723698|P8|Part B|Death|1
5993177|NCT00966875|20723699|P7|Part B|Death|0
5993178|NCT00966875|20723700|P6|Part B|Death|0
5993179|NCT00966875|20723701|P5|Part B|Death|0
5993180|NCT00966875|20723702|P4|Part B|Death|0
5993181|NCT00966875|20723703|P3|Part B|Death|1
5993182|NCT00966875|20723704|P2|Part B|Death|0
5993183|NCT00966875|20723705|P1|Part B|Death|0
5993184|NCT00966875|20723697|P9|Part B|Adverse Event|2
5993185|NCT00966875|20723698|P8|Part B|Adverse Event|2
5993186|NCT00966875|20723699|P7|Part B|Adverse Event|5
5993187|NCT00966875|20723700|P6|Part B|Adverse Event|0
5993188|NCT00966875|20723701|P5|Part B|Adverse Event|1
5993189|NCT00966875|20723702|P4|Part B|Adverse Event|0
5993190|NCT00966875|20723703|P3|Part B|Adverse Event|1
5993191|NCT00966875|20723704|P2|Part B|Adverse Event|1
5993192|NCT00966875|20723705|P1|Part B|Adverse Event|0
5993193|NCT00966875|20723697|P9|Part A|Protocol Violation|1
5993194|NCT00966875|20723698|P8|Part A|Protocol Violation|1
5993195|NCT00966875|20723699|P7|Part A|Protocol Violation|2
5993196|NCT00966875|20723700|P6|Part A|Protocol Violation|0
5993197|NCT00966875|20723701|P5|Part A|Protocol Violation|0
5993198|NCT00966875|20723702|P4|Part A|Protocol Violation|0
5993199|NCT00966875|20723703|P3|Part A|Protocol Violation|0
5993200|NCT00966875|20723704|P2|Part A|Protocol Violation|0
5993201|NCT00966875|20723705|P1|Part A|Protocol Violation|0
5993202|NCT00966875|20723697|P9|Part A|Withdrawal by Subject|1
5993203|NCT00966875|20723698|P8|Part A|Withdrawal by Subject|1
5993204|NCT00966875|20723699|P7|Part A|Withdrawal by Subject|5
5993205|NCT00966875|20723700|P6|Part A|Withdrawal by Subject|0
5993206|NCT00966875|20723701|P5|Part A|Withdrawal by Subject|3
5993207|NCT00966875|20723702|P4|Part A|Withdrawal by Subject|1
5993208|NCT00966875|20723703|P3|Part A|Withdrawal by Subject|1
5993209|NCT00966875|20723704|P2|Part A|Withdrawal by Subject|2
5993210|NCT00966875|20723705|P1|Part A|Withdrawal by Subject|2
5993211|NCT00966875|20723697|P9|Part A|Sponsor Decision|1
5993212|NCT00966875|20723698|P8|Part A|Sponsor Decision|2
5993213|NCT00966875|20723699|P7|Part A|Sponsor Decision|0
5993214|NCT00966875|20723700|P6|Part A|Sponsor Decision|0
5993215|NCT00966875|20723701|P5|Part A|Sponsor Decision|1
5993216|NCT00966875|20723702|P4|Part A|Sponsor Decision|0
5993217|NCT00966875|20723703|P3|Part A|Sponsor Decision|1
5993218|NCT00966875|20723704|P2|Part A|Sponsor Decision|0
5993219|NCT00966875|20723705|P1|Part A|Sponsor Decision|0
5993220|NCT00966875|20723697|P9|Part A|Physician Decision|2
5993221|NCT00966875|20723698|P8|Part A|Physician Decision|0
5993222|NCT00966875|20723699|P7|Part A|Physician Decision|1
5993223|NCT00966875|20723700|P6|Part A|Physician Decision|0
5993224|NCT00966875|20723701|P5|Part A|Physician Decision|1
5993225|NCT00966875|20723702|P4|Part A|Physician Decision|0
5993226|NCT00966875|20723703|P3|Part A|Physician Decision|0
5993227|NCT00966875|20723704|P2|Part A|Physician Decision|0
5993228|NCT00966875|20723705|P1|Part A|Physician Decision|0
5993229|NCT00966875|20723697|P9|Part A|Parent/Caregiver Decision|0
5993230|NCT00966875|20723698|P8|Part A|Parent/Caregiver Decision|0
5993231|NCT00966875|20723699|P7|Part A|Parent/Caregiver Decision|0
5993232|NCT00966875|20723700|P6|Part A|Parent/Caregiver Decision|0
5993233|NCT00966875|20723701|P5|Part A|Parent/Caregiver Decision|0
5993234|NCT00966875|20723702|P4|Part A|Parent/Caregiver Decision|1
5993235|NCT00966875|20723703|P3|Part A|Parent/Caregiver Decision|0
5993236|NCT00966875|20723704|P2|Part A|Parent/Caregiver Decision|0
5993237|NCT00966875|20723705|P1|Part A|Parent/Caregiver Decision|0
5993238|NCT00966875|20723697|P9|Part A|Lost to Follow-up|0
5993239|NCT00966875|20723698|P8|Part A|Lost to Follow-up|0
5993240|NCT00966875|20723699|P7|Part A|Lost to Follow-up|0
5993241|NCT00966875|20723700|P6|Part A|Lost to Follow-up|1
5993242|NCT00966875|20723701|P5|Part A|Lost to Follow-up|0
5993243|NCT00966875|20723702|P4|Part A|Lost to Follow-up|0
5993244|NCT00966875|20723703|P3|Part A|Lost to Follow-up|0
5993245|NCT00966875|20723704|P2|Part A|Lost to Follow-up|0
5993246|NCT00966875|20723705|P1|Part A|Lost to Follow-up|2
5993247|NCT00966875|20723697|P9|Part A|Lack of Efficacy|0
5993248|NCT00966875|20723698|P8|Part A|Lack of Efficacy|0
5993249|NCT00966875|20723699|P7|Part A|Lack of Efficacy|4
5993250|NCT00966875|20723700|P6|Part A|Lack of Efficacy|0
5993251|NCT00966875|20723701|P5|Part A|Lack of Efficacy|0
5993252|NCT00966875|20723702|P4|Part A|Lack of Efficacy|0
5993253|NCT00966875|20723703|P3|Part A|Lack of Efficacy|0
5993254|NCT00966875|20723704|P2|Part A|Lack of Efficacy|1
5993255|NCT00966875|20723705|P1|Part A|Lack of Efficacy|0
5993256|NCT00966875|20723697|P9|Part A|Entry Criteria|0
5993257|NCT00966875|20723698|P8|Part A|Entry Criteria|0
5993258|NCT00966875|20723699|P7|Part A|Entry Criteria|0
5993259|NCT00966875|20723700|P6|Part A|Entry Criteria|2
5993260|NCT00966875|20723701|P5|Part A|Entry Criteria|0
5993261|NCT00966875|20723702|P4|Part A|Entry Criteria|0
5993262|NCT00966875|20723703|P3|Part A|Entry Criteria|0
5993263|NCT00966875|20723704|P2|Part A|Entry Criteria|0
5993264|NCT00966875|20723705|P1|Part A|Entry Criteria|0
5993265|NCT00966875|20723697|P9|Part A|Adverse Event|3
5993266|NCT00966875|20723698|P8|Part A|Adverse Event|3
5993267|NCT00966875|20723699|P7|Part A|Adverse Event|0
5993268|NCT00966875|20723700|P6|Part A|Adverse Event|1
5993269|NCT00966875|20723701|P5|Part A|Adverse Event|0
5993270|NCT00966875|20723702|P4|Part A|Adverse Event|1
5993271|NCT00966875|20723703|P3|Part A|Adverse Event|0
5993272|NCT00966875|20723704|P2|Part A|Adverse Event|1
5993273|NCT00966875|20723705|P1|Part A|Adverse Event|2
5993274|NCT00966719|20724056|P2|Overall Study|Lost to Follow-up|11
5993275|NCT00966719|20724057|P1|Overall Study|Lost to Follow-up|6
5993276|NCT00966693|20724081|P4|Overall Study|Disease Progression|16
5993277|NCT00966693|20724082|P3|Overall Study|Disease Progression|1
5993278|NCT00966693|20724083|P2|Overall Study|Disease Progression|0
5993279|NCT00966693|20724084|P1|Overall Study|Disease Progression|0
5993280|NCT00966693|20724081|P4|Overall Study|Withdrawal by Subject|5
5993281|NCT00966693|20724082|P3|Overall Study|Withdrawal by Subject|0
5993282|NCT00966693|20724083|P2|Overall Study|Withdrawal by Subject|0
5993283|NCT00966693|20724084|P1|Overall Study|Withdrawal by Subject|1
5993284|NCT00966693|20724081|P4|Overall Study|Death|0
5993285|NCT00966693|20724082|P3|Overall Study|Death|1
5993286|NCT00966693|20724083|P2|Overall Study|Death|0
5993287|NCT00966693|20724084|P1|Overall Study|Death|0
5993288|NCT00966693|20724081|P4|Overall Study|Adverse Event|2
5993289|NCT00966693|20724082|P3|Overall Study|Adverse Event|1
5993290|NCT00966693|20724083|P2|Overall Study|Adverse Event|0
5993291|NCT00966693|20724084|P1|Overall Study|Adverse Event|0
5993292|NCT00966654|20724118|P1|Overall Study|Study was terminated,PI left institution|12
5993293|NCT00966355|20724192|P3|Overall Study|Lost to Follow-up|3
5993294|NCT00966355|20724193|P2|Overall Study|Lost to Follow-up|4
5993295|NCT00966355|20724194|P1|Overall Study|Lost to Follow-up|5
5993296|NCT00966355|20724192|P3|Overall Study|newly diagnosed advanced HCC|10
5993297|NCT00966355|20724193|P2|Overall Study|newly diagnosed advanced HCC|12
5993298|NCT00966355|20724194|P1|Overall Study|newly diagnosed advanced HCC|11
5993299|NCT00966355|20724192|P3|Overall Study|non-variceal bleeding on endoscopy|71
5993300|NCT00966355|20724193|P2|Overall Study|non-variceal bleeding on endoscopy|70
5993301|NCT00966355|20724194|P1|Overall Study|non-variceal bleeding on endoscopy|68
5993302|NCT00966277|20724207|P2|Overall Study|Treatment Plan Changed|1
5993303|NCT00966277|20724208|P1|Overall Study|Treatment Plan Changed|0
5993304|NCT00966277|20724207|P2|Overall Study|Ineligible|3
5993305|NCT00966277|20724208|P1|Overall Study|Ineligible|1
5993306|NCT00966277|20724207|P2|Overall Study|Withdrawal by Subject|0
5993307|NCT00966277|20724208|P1|Overall Study|Withdrawal by Subject|3
5993308|NCT00966264|20724216|P2|Overall Study|Lost to Follow-up|3
5993309|NCT00966264|20724217|P1|Overall Study|Lost to Follow-up|4
5993310|NCT00965848|20724263|P3|Overall Study|Other|1
5993311|NCT00965848|20724264|P2|Overall Study|Other|0
5993312|NCT00965848|20724265|P1|Overall Study|Other|5
5993313|NCT00965848|20724263|P3|Overall Study|Not Clinically Evaluable|1
5993314|NCT00965848|20724264|P2|Overall Study|Not Clinically Evaluable|1
5993315|NCT00965848|20724265|P1|Overall Study|Not Clinically Evaluable|7
5993316|NCT00965848|20724263|P3|Overall Study|Indeterminate Clinical Outcome|1
5993317|NCT00965848|20724264|P2|Overall Study|Indeterminate Clinical Outcome|0
5993318|NCT00965848|20724265|P1|Overall Study|Indeterminate Clinical Outcome|2
5993319|NCT00965848|20724263|P3|Overall Study|Withdrawal by Subject|0
5993320|NCT00965848|20724264|P2|Overall Study|Withdrawal by Subject|0
5993321|NCT00965848|20724265|P1|Overall Study|Withdrawal by Subject|1
5993322|NCT00965848|20724263|P3|Overall Study|Lost to Follow-up|1
5993323|NCT00965848|20724264|P2|Overall Study|Lost to Follow-up|0
5993324|NCT00965848|20724265|P1|Overall Study|Lost to Follow-up|0
5993325|NCT00965848|20724263|P3|Overall Study|Death|5
5993326|NCT00965848|20724264|P2|Overall Study|Death|1
5993327|NCT00965848|20724265|P1|Overall Study|Death|11
5993328|NCT00965848|20724263|P3|Overall Study|Protocol Violation|1
5993329|NCT00965848|20724264|P2|Overall Study|Protocol Violation|0
5993330|NCT00965848|20724265|P1|Overall Study|Protocol Violation|3
5993331|NCT00965757|20724284|P4|Extension Phase|Other|1
5993332|NCT00965757|20724285|P3|Extension Phase|Other|2
5993333|NCT00965757|20724286|P2|Extension Phase|Other|0
5993334|NCT00965757|20724287|P1|Extension Phase|Other|0
5993335|NCT00965757|20724284|P4|Extension Phase|Protocol Violation|1
5993336|NCT00965757|20724285|P3|Extension Phase|Protocol Violation|0
5993337|NCT00965757|20724286|P2|Extension Phase|Protocol Violation|0
5993338|NCT00965757|20724287|P1|Extension Phase|Protocol Violation|0
5993339|NCT00965757|20724284|P4|Extension Phase|Ineligible after Taking Study Drug|3
5993340|NCT00965757|20724285|P3|Extension Phase|Ineligible after Taking Study Drug|3
5993341|NCT00965757|20724286|P2|Extension Phase|Ineligible after Taking Study Drug|0
5993342|NCT00965757|20724287|P1|Extension Phase|Ineligible after Taking Study Drug|0
5993343|NCT00965757|20724284|P4|Extension Phase|Lost to Follow-up|1
5993344|NCT00965757|20724285|P3|Extension Phase|Lost to Follow-up|0
5993345|NCT00965757|20724286|P2|Extension Phase|Lost to Follow-up|0
5993346|NCT00965757|20724287|P1|Extension Phase|Lost to Follow-up|0
5993347|NCT00965757|20724284|P4|Extension Phase|Drug Refusal Due to Adverse Event|0
5993348|NCT00965757|20724285|P3|Extension Phase|Drug Refusal Due to Adverse Event|4
5993349|NCT00965757|20724286|P2|Extension Phase|Drug Refusal Due to Adverse Event|0
5993350|NCT00965757|20724287|P1|Extension Phase|Drug Refusal Due to Adverse Event|0
5993351|NCT00965757|20724284|P4|Extension Phase|Lack of Efficacy|12
5993352|NCT00965757|20724285|P3|Extension Phase|Lack of Efficacy|8
5993353|NCT00965757|20724286|P2|Extension Phase|Lack of Efficacy|0
5993354|NCT00965757|20724287|P1|Extension Phase|Lack of Efficacy|0
5993355|NCT00965757|20724284|P4|Extension Phase|Abnormal Laboratory Value|1
5993356|NCT00965757|20724285|P3|Extension Phase|Abnormal Laboratory Value|6
5993357|NCT00965757|20724286|P2|Extension Phase|Abnormal Laboratory Value|0
5993358|NCT00965757|20724287|P1|Extension Phase|Abnormal Laboratory Value|0
5993359|NCT00965757|20724284|P4|Extension Phase|Adverse drug reaction|3
5993360|NCT00965757|20724285|P3|Extension Phase|Adverse drug reaction|6
5993361|NCT00965757|20724286|P2|Extension Phase|Adverse drug reaction|0
5993362|NCT00965757|20724287|P1|Extension Phase|Adverse drug reaction|0
5993363|NCT00965757|20724284|P4|Extension Phase|Progression of concomitant disease|2
5993364|NCT00965757|20724285|P3|Extension Phase|Progression of concomitant disease|4
5993365|NCT00965757|20724286|P2|Extension Phase|Progression of concomitant disease|0
5993366|NCT00965757|20724287|P1|Extension Phase|Progression of concomitant disease|0
5993367|NCT00965757|20724284|P4|Double-blind Phase|Other|0
5993368|NCT00965757|20724285|P3|Double-blind Phase|Other|0
5993369|NCT00965757|20724286|P2|Double-blind Phase|Other|0
5993370|NCT00965757|20724287|P1|Double-blind Phase|Other|1
5993371|NCT00965757|20724284|P4|Double-blind Phase|Ineligible after Taking Study Drug|0
5993372|NCT00965757|20724285|P3|Double-blind Phase|Ineligible after Taking Study Drug|0
5993373|NCT00965757|20724286|P2|Double-blind Phase|Ineligible after Taking Study Drug|3
5993374|NCT00965757|20724287|P1|Double-blind Phase|Ineligible after Taking Study Drug|2
5993375|NCT00965757|20724284|P4|Double-blind Phase|Lost to Follow-up|0
5993376|NCT00965757|20724285|P3|Double-blind Phase|Lost to Follow-up|0
5993377|NCT00965757|20724286|P2|Double-blind Phase|Lost to Follow-up|1
5993378|NCT00965757|20724287|P1|Double-blind Phase|Lost to Follow-up|0
5993379|NCT00965757|20724284|P4|Double-blind Phase|Drug Refusal Due to Adverse Event|0
5993380|NCT00965757|20724285|P3|Double-blind Phase|Drug Refusal Due to Adverse Event|0
5993381|NCT00965757|20724286|P2|Double-blind Phase|Drug Refusal Due to Adverse Event|0
5993382|NCT00965757|20724287|P1|Double-blind Phase|Drug Refusal Due to Adverse Event|2
5993383|NCT00965757|20724284|P4|Double-blind Phase|Lack of Efficacy|0
5993384|NCT00965757|20724285|P3|Double-blind Phase|Lack of Efficacy|0
5993385|NCT00965757|20724286|P2|Double-blind Phase|Lack of Efficacy|11
5993386|NCT00965757|20724287|P1|Double-blind Phase|Lack of Efficacy|7
5993387|NCT00965757|20724284|P4|Double-blind Phase|Abnormal Laboratory Value|0
5993388|NCT00965757|20724285|P3|Double-blind Phase|Abnormal Laboratory Value|0
5993389|NCT00965757|20724286|P2|Double-blind Phase|Abnormal Laboratory Value|0
5993390|NCT00965757|20724287|P1|Double-blind Phase|Abnormal Laboratory Value|2
5993391|NCT00965757|20724284|P4|Double-blind Phase|Adverse drug reaction|0
5993392|NCT00965757|20724285|P3|Double-blind Phase|Adverse drug reaction|0
5993393|NCT00965757|20724286|P2|Double-blind Phase|Adverse drug reaction|1
5993394|NCT00965757|20724287|P1|Double-blind Phase|Adverse drug reaction|2
5993395|NCT00965757|20724284|P4|Double-blind Phase|Progression of concomitant disease|0
5993396|NCT00965757|20724285|P3|Double-blind Phase|Progression of concomitant disease|0
5993397|NCT00965757|20724286|P2|Double-blind Phase|Progression of concomitant disease|2
5993398|NCT00965757|20724287|P1|Double-blind Phase|Progression of concomitant disease|1
5993399|NCT00965731|20724321|P2|Overall Study|Other|15
5993400|NCT00965731|20724322|P1|Overall Study|Other|7
5993401|NCT00965731|20724321|P2|Overall Study|Withdrawal by Subject|1
5993402|NCT00965731|20724322|P1|Overall Study|Withdrawal by Subject|0
5993403|NCT00965731|20724321|P2|Overall Study|Death|4
5993404|NCT00965731|20724322|P1|Overall Study|Death|0
5993405|NCT00965718|20724386|P1|Overall Study|Withdrawal by Subject|4
5993406|NCT00965575|20724398|P2|Overall Study|subject unwillingness to swallow study c|0
5993407|NCT00965575|20724399|P1|Overall Study|subject unwillingness to swallow study c|1
5993408|NCT00965562|20724410|P3|Overall Study|Withdrawal by Subject|0
5993409|NCT00965562|20724411|P2|Overall Study|Withdrawal by Subject|2
5993410|NCT00965562|20724412|P1|Overall Study|Withdrawal by Subject|2
5993411|NCT00965562|20724410|P3|Overall Study|Lost to Follow-up|3
5993412|NCT00965562|20724411|P2|Overall Study|Lost to Follow-up|2
5993413|NCT00965562|20724412|P1|Overall Study|Lost to Follow-up|1
5993414|NCT00965523|20724450|P1|Study 224|Physician Decision|1
5993415|NCT00965523|20724450|P1|Study 224|Progressive Disease|5
5993416|NCT00965523|20724450|P1|Study 221|Physician Decision|3
5993417|NCT00965523|20724450|P1|Study 221|Progressive Disease|4
5993418|NCT00965497|20724455|P1|Overall Study|Physician Decision|1
5993419|NCT00965484|20724460|P1|Overall Study|Withdrawal by Subject|1
5993420|NCT00965484|20724460|P1|Overall Study|Protocol Violation|1
5993421|NCT00965458|20724469|P2|Overall Study|Withdrawal by Subject|1
5993422|NCT00965458|20724470|P1|Overall Study|Withdrawal by Subject|0
5993423|NCT00965458|20724469|P2|Overall Study|Lost to Follow-up|3
5993424|NCT00965458|20724470|P1|Overall Study|Lost to Follow-up|1
5993425|NCT00965458|20724469|P2|Overall Study|Adverse Event|0
5993426|NCT00965458|20724470|P1|Overall Study|Adverse Event|1
5993427|NCT00965419|20724486|P1|Follow-up Phase|Lack of Efficacy|28
5993428|NCT00965419|20724486|P1|Follow-up Phase|Parent/Caregiver Decision|9
5993429|NCT00965419|20724486|P1|Follow-up Phase|Physician Decision|4
5993430|NCT00965419|20724486|P1|Follow-up Phase|Withdrawal by Subject|8
5993431|NCT00965419|20724486|P1|Follow-up Phase|Protocol Violation|4
5993432|NCT00965419|20724486|P1|Follow-up Phase|Adverse Event|9
5993433|NCT00965419|20724486|P1|Open Label Treatment for Responders|Lost to Follow-up|46
5993434|NCT00965419|20724486|P1|Open Label Treatment for Responders|Lack of Efficacy|67
5993435|NCT00965419|20724486|P1|Open Label Treatment for Responders|Parent/Caregiver Decision|41
5993436|NCT00965419|20724486|P1|Open Label Treatment for Responders|Sponsor Decision|5
5993437|NCT00965419|20724486|P1|Open Label Treatment for Responders|Physician Decision|6
5993438|NCT00965419|20724486|P1|Open Label Treatment for Responders|Withdrawal by Subject|27
5993439|NCT00965419|20724486|P1|Open Label Treatment for Responders|Protocol Violation|21
5993440|NCT00965419|20724486|P1|Open Label Treatment for Responders|Entry Criteria Not Met|1
5993441|NCT00965419|20724486|P1|Open Label Treatment for Responders|Adverse Event|33
5993442|NCT00965341|20724532|P2|Overall Study|Transportation issues|3
5993443|NCT00965341|20724533|P1|Overall Study|Transportation issues|4
5993444|NCT00965341|20724532|P2|Overall Study|Lost to Follow-up|0
5993445|NCT00965341|20724533|P1|Overall Study|Lost to Follow-up|1
5993446|NCT00965341|20724532|P2|Overall Study|Withdrew consent|5
5993447|NCT00965341|20724533|P1|Overall Study|Withdrew consent|1
5993448|NCT00965263|20724543|P2|Overall Study|Protocol Violation|2
5993449|NCT00965263|20724544|P1|Overall Study|Protocol Violation|0
5993450|NCT00965263|20724543|P2|Overall Study|Family emergency|1
5993451|NCT00965263|20724544|P1|Overall Study|Family emergency|0
5993452|NCT00965263|20724543|P2|Overall Study|Physician Decision|0
5993453|NCT00965263|20724544|P1|Overall Study|Physician Decision|2
5993454|NCT00965185|20724604|P2|Overall Study|Withdrawal by Subject|1
5993455|NCT00965185|20724605|P1|Overall Study|Withdrawal by Subject|0
5993456|NCT00965185|20724604|P2|Overall Study|Lost to Follow-up|0
5993457|NCT00965185|20724605|P1|Overall Study|Lost to Follow-up|2
5993458|NCT00965146|20724625|P1|Overall Study|Overall Study Termination|145
5993459|NCT00965146|20724625|P1|Overall Study|Revision / Removal of Study Implant|6
5993460|NCT00965146|20724625|P1|Overall Study|Intercurrent illness|1
5993461|NCT00965146|20724625|P1|Overall Study|Unwilling to return|11
5993462|NCT00965146|20724625|P1|Overall Study|Unable to return|1
5993463|NCT00965146|20724625|P1|Overall Study|Withdrawal by Subject|17
5993464|NCT00965146|20724625|P1|Overall Study|Lost to Follow-up|22
5993465|NCT00965146|20724625|P1|Overall Study|Death|7
5993466|NCT00965094|20724632|P2|Overall Study|Lost to Follow-up|1
5993467|NCT00965094|20724633|P1|Overall Study|Lost to Follow-up|0
5993468|NCT00965094|20724632|P2|Overall Study|Adverse Event|0
5993469|NCT00965094|20724633|P1|Overall Study|Adverse Event|5
5993470|NCT00965081|20724649|P2|Overall Study|Switched to Rescue Arm|12
5993471|NCT00965081|20724650|P1|Overall Study|Switched to Rescue Arm|5
5993472|NCT00965081|20724649|P2|Overall Study|Withdrawal by Subject|7
5993473|NCT00965081|20724650|P1|Overall Study|Withdrawal by Subject|4
5993474|NCT00965081|20724649|P2|Overall Study|Sponsor Decision|0
5993475|NCT00965081|20724650|P1|Overall Study|Sponsor Decision|1
5993476|NCT00965081|20724649|P2|Overall Study|Protocol Violation|5
5993477|NCT00965081|20724650|P1|Overall Study|Protocol Violation|2
5993478|NCT00965081|20724649|P2|Overall Study|Physician Decision|0
5993479|NCT00965081|20724650|P1|Overall Study|Physician Decision|2
5993480|NCT00965081|20724649|P2|Overall Study|Lost to Follow-up|5
5993481|NCT00965081|20724650|P1|Overall Study|Lost to Follow-up|4
5993482|NCT00965081|20724649|P2|Overall Study|Lack of Efficacy|5
5993483|NCT00965081|20724650|P1|Overall Study|Lack of Efficacy|2
5993484|NCT00965081|20724649|P2|Overall Study|Adverse Event|9
5993485|NCT00965081|20724650|P1|Overall Study|Adverse Event|14
5993486|NCT00964886|20724682|P4|Overall Study|Protocol Violation|0
5993487|NCT00964886|20724683|P3|Overall Study|Protocol Violation|0
5993488|NCT00964886|20724684|P2|Overall Study|Protocol Violation|2
5993489|NCT00964886|20724685|P1|Overall Study|Protocol Violation|0
5993490|NCT00964886|20724682|P4|Overall Study|Adverse Event|2
5993491|NCT00964886|20724683|P3|Overall Study|Adverse Event|5
5993492|NCT00964886|20724684|P2|Overall Study|Adverse Event|1
5993493|NCT00964886|20724685|P1|Overall Study|Adverse Event|3
5993494|NCT00964886|20724682|P4|Overall Study|Withdrawal by Subject|3
5993495|NCT00964886|20724683|P3|Overall Study|Withdrawal by Subject|5
5993496|NCT00964886|20724684|P2|Overall Study|Withdrawal by Subject|2
5993497|NCT00964886|20724685|P1|Overall Study|Withdrawal by Subject|6
5993498|NCT00964886|20724682|P4|Overall Study|Lost to Follow-up|4
5993499|NCT00964886|20724683|P3|Overall Study|Lost to Follow-up|6
5993500|NCT00964886|20724684|P2|Overall Study|Lost to Follow-up|2
5993501|NCT00964886|20724685|P1|Overall Study|Lost to Follow-up|2
5993502|NCT00964860|20724701|P2|Overall Study|Withdrawal by Subject|1
5993503|NCT00964860|20724702|P1|Overall Study|Withdrawal by Subject|0
5993504|NCT00964795|20724710|P1|Overall Study|Other|23
5993505|NCT00964795|20724710|P1|Overall Study|Unwilling to sign ICF for amendment 4|3
5993506|NCT00964795|20724710|P1|Overall Study|Termination of Study by Sponsor|169
5993507|NCT00964795|20724710|P1|Overall Study|Lost to Follow-up|7
5993508|NCT00964795|20724710|P1|Overall Study|Death|14
5993509|NCT00964795|20724710|P1|Overall Study|Adverse Event|12
5993510|NCT00964795|20724710|P1|Overall Study|Withdrawal by Subject|79
5993511|NCT00964782|20724719|P2|Overall Study|Lost to Follow-up|0
5993512|NCT00964782|20724720|P1|Overall Study|Lost to Follow-up|1
5993513|NCT00964743|20724734|P1|Overall Study|Neither patient completed 8 weeks of tre|2
5993514|NCT00964678|20724742|P1|Overall Study|Physician Decision|4
5993515|NCT00964392|20724806|P2|Overall Study|Not completed|168
5993516|NCT00964392|20724807|P1|Overall Study|Not completed|44
5993517|NCT00964392|20724806|P2|Overall Study|Early Termination, non-study arrhythmia|6
5993518|NCT00964392|20724807|P1|Overall Study|Early Termination, non-study arrhythmia|1
5993519|NCT00964392|20724806|P2|Overall Study|Lost to Follow-up|10
5993520|NCT00964392|20724807|P1|Overall Study|Lost to Follow-up|4
5993521|NCT00964392|20724806|P2|Overall Study|Withdrawal by Subject|6
5993522|NCT00964392|20724807|P1|Overall Study|Withdrawal by Subject|4
5993523|NCT00964366|20724817|P2|Overall Study|Withdrawal by Subject|1
5993524|NCT00964366|20724818|P1|Overall Study|Withdrawal by Subject|0
5993525|NCT00964366|20724817|P2|Overall Study|Did not qualify at Day 1|0
5993526|NCT00964366|20724818|P1|Overall Study|Did not qualify at Day 1|1
5993527|NCT00964223|20724843|P1|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1
5993528|NCT00964158|20724911|P3|Overall Study|Withdrawal by Subject|6
5993529|NCT00964158|20724912|P2|Overall Study|Withdrawal by Subject|0
5993530|NCT00964158|20724913|P1|Overall Study|Withdrawal by Subject|0
5993531|NCT00964158|20724911|P3|Overall Study|Lost to Follow-up|2
5993532|NCT00964158|20724912|P2|Overall Study|Lost to Follow-up|1
5993533|NCT00964158|20724913|P1|Overall Study|Lost to Follow-up|0
5993534|NCT00964028|20724988|P2|Overall Study|Withdrawal by Subject|1
5993535|NCT00964028|20724989|P1|Overall Study|Withdrawal by Subject|0
5993536|NCT00963937|20725004|P3|Overall Study|Physician Decision|4
5993537|NCT00963937|20725005|P2|Overall Study|Physician Decision|10
5993538|NCT00963937|20725006|P1|Overall Study|Physician Decision|18
5993539|NCT00963937|20725004|P3|Overall Study|Protocol Violation|0
5993540|NCT00963937|20725005|P2|Overall Study|Protocol Violation|1
5993541|NCT00963937|20725006|P1|Overall Study|Protocol Violation|1
5993542|NCT00963924|20725044|P2|Overall Study|Lost to Follow-up|1
5993543|NCT00963924|20725045|P1|Overall Study|Lost to Follow-up|0
5993544|NCT00963924|20725044|P2|Overall Study|Changed antipsychotic|1
5993545|NCT00963924|20725045|P1|Overall Study|Changed antipsychotic|0
5993546|NCT00963924|20725044|P2|Overall Study|Withdrawal by Subject|1
5993547|NCT00963924|20725045|P1|Overall Study|Withdrawal by Subject|0
5993548|NCT00963924|20725044|P2|Overall Study|Adverse Event|0
5993549|NCT00963924|20725045|P1|Overall Study|Adverse Event|1
5993550|NCT00963820|20725128|P12|Expansion Phase|Unsatisfactory Therapeutic Response|1
5993551|NCT00963820|20725129|P11|Expansion Phase|Unsatisfactory Therapeutic Response|0
5993552|NCT00963820|20725130|P10|Expansion Phase|Unsatisfactory Therapeutic Response|0
5993553|NCT00963820|20725131|P9|Expansion Phase|Unsatisfactory Therapeutic Response|0
5993554|NCT00963820|20725132|P8|Expansion Phase|Unsatisfactory Therapeutic Response|0
5993555|NCT00963820|20725133|P7|Expansion Phase|Unsatisfactory Therapeutic Response|0
5993556|NCT00963820|20725134|P6|Expansion Phase|Unsatisfactory Therapeutic Response|0
5993557|NCT00963820|20725135|P5|Expansion Phase|Unsatisfactory Therapeutic Response|0
5993558|NCT00963820|20725136|P4|Expansion Phase|Unsatisfactory Therapeutic Response|0
5993559|NCT00963820|20725137|P3|Expansion Phase|Unsatisfactory Therapeutic Response|0
5993560|NCT00963820|20725138|P2|Expansion Phase|Unsatisfactory Therapeutic Response|0
5993561|NCT00963820|20725139|P1|Expansion Phase|Unsatisfactory Therapeutic Response|0
5993562|NCT00963820|20725128|P12|Expansion Phase|Withdrawal by Subject|1
5993563|NCT00963820|20725129|P11|Expansion Phase|Withdrawal by Subject|1
5993564|NCT00963820|20725130|P10|Expansion Phase|Withdrawal by Subject|0
5993565|NCT00963820|20725131|P9|Expansion Phase|Withdrawal by Subject|1
5993566|NCT00963820|20725132|P8|Expansion Phase|Withdrawal by Subject|0
5993567|NCT00963820|20725133|P7|Expansion Phase|Withdrawal by Subject|0
5993568|NCT00963820|20725134|P6|Expansion Phase|Withdrawal by Subject|0
5993569|NCT00963820|20725135|P5|Expansion Phase|Withdrawal by Subject|0
5993570|NCT00963820|20725136|P4|Expansion Phase|Withdrawal by Subject|0
5993571|NCT00963820|20725137|P3|Expansion Phase|Withdrawal by Subject|0
5993572|NCT00963820|20725138|P2|Expansion Phase|Withdrawal by Subject|0
5993573|NCT00963820|20725139|P1|Expansion Phase|Withdrawal by Subject|0
5993574|NCT00963820|20725128|P12|Expansion Phase|Adverse Event|0
5993575|NCT00963820|20725129|P11|Expansion Phase|Adverse Event|0
5993576|NCT00963820|20725130|P10|Expansion Phase|Adverse Event|3
5993577|NCT00963820|20725131|P9|Expansion Phase|Adverse Event|1
5993578|NCT00963820|20725132|P8|Expansion Phase|Adverse Event|0
5993579|NCT00963820|20725133|P7|Expansion Phase|Adverse Event|0
5993580|NCT00963820|20725134|P6|Expansion Phase|Adverse Event|0
5993581|NCT00963820|20725135|P5|Expansion Phase|Adverse Event|0
5993582|NCT00963820|20725136|P4|Expansion Phase|Adverse Event|0
5993583|NCT00963820|20725137|P3|Expansion Phase|Adverse Event|0
5993584|NCT00963820|20725138|P2|Expansion Phase|Adverse Event|0
5993585|NCT00963820|20725139|P1|Expansion Phase|Adverse Event|0
5993586|NCT00963820|20725128|P12|Expansion Phase|Progressive Disease|2
5993587|NCT00963820|20725129|P11|Expansion Phase|Progressive Disease|4
5993588|NCT00963820|20725130|P10|Expansion Phase|Progressive Disease|6
5993589|NCT00963820|20725131|P9|Expansion Phase|Progressive Disease|8
5993590|NCT00963820|20725132|P8|Expansion Phase|Progressive Disease|0
5993591|NCT00963820|20725133|P7|Expansion Phase|Progressive Disease|0
5993592|NCT00963820|20725134|P6|Expansion Phase|Progressive Disease|0
5993593|NCT00963820|20725135|P5|Expansion Phase|Progressive Disease|0
5993594|NCT00963820|20725136|P4|Expansion Phase|Progressive Disease|0
5993595|NCT00963820|20725137|P3|Expansion Phase|Progressive Disease|0
5993596|NCT00963820|20725138|P2|Expansion Phase|Progressive Disease|0
5993597|NCT00963820|20725139|P1|Expansion Phase|Progressive Disease|0
5993598|NCT00963820|20725128|P12|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
5993599|NCT00963820|20725129|P11|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
5993600|NCT00963820|20725130|P10|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
5993601|NCT00963820|20725131|P9|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
5993602|NCT00963820|20725132|P8|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
5993603|NCT00963820|20725133|P7|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1
5993604|NCT00963820|20725134|P6|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
5993605|NCT00963820|20725135|P5|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
5993606|NCT00963820|20725136|P4|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
5993607|NCT00963820|20725137|P3|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
5993608|NCT00963820|20725138|P2|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
5993609|NCT00963820|20725139|P1|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
5993610|NCT00963820|20725128|P12|Dose Escalation Phase|Withdrawal by Subject|0
5993611|NCT00963820|20725129|P11|Dose Escalation Phase|Withdrawal by Subject|0
5993612|NCT00963820|20725130|P10|Dose Escalation Phase|Withdrawal by Subject|0
5993613|NCT00963820|20725131|P9|Dose Escalation Phase|Withdrawal by Subject|0
5993614|NCT00963820|20725132|P8|Dose Escalation Phase|Withdrawal by Subject|2
5993615|NCT00963820|20725133|P7|Dose Escalation Phase|Withdrawal by Subject|1
5993616|NCT00963820|20725134|P6|Dose Escalation Phase|Withdrawal by Subject|0
5993617|NCT00963820|20725135|P5|Dose Escalation Phase|Withdrawal by Subject|0
5993618|NCT00963820|20725136|P4|Dose Escalation Phase|Withdrawal by Subject|0
5993619|NCT00963820|20725137|P3|Dose Escalation Phase|Withdrawal by Subject|0
5993620|NCT00963820|20725138|P2|Dose Escalation Phase|Withdrawal by Subject|0
5993621|NCT00963820|20725139|P1|Dose Escalation Phase|Withdrawal by Subject|0
5993622|NCT00963820|20725128|P12|Dose Escalation Phase|Adverse Event|0
5993623|NCT00963820|20725129|P11|Dose Escalation Phase|Adverse Event|0
5993624|NCT00963820|20725130|P10|Dose Escalation Phase|Adverse Event|0
5993625|NCT00963820|20725131|P9|Dose Escalation Phase|Adverse Event|0
5993626|NCT00963820|20725132|P8|Dose Escalation Phase|Adverse Event|1
5993627|NCT00963820|20725133|P7|Dose Escalation Phase|Adverse Event|3
5993628|NCT00963820|20725134|P6|Dose Escalation Phase|Adverse Event|0
5993629|NCT00963820|20725135|P5|Dose Escalation Phase|Adverse Event|0
5993630|NCT00963820|20725136|P4|Dose Escalation Phase|Adverse Event|0
5993631|NCT00963820|20725137|P3|Dose Escalation Phase|Adverse Event|0
5993632|NCT00963820|20725138|P2|Dose Escalation Phase|Adverse Event|0
5993633|NCT00963820|20725139|P1|Dose Escalation Phase|Adverse Event|0
5993634|NCT00963820|20725128|P12|Dose Escalation Phase|Progressive Disease|0
5993635|NCT00963820|20725129|P11|Dose Escalation Phase|Progressive Disease|0
5993636|NCT00963820|20725130|P10|Dose Escalation Phase|Progressive Disease|0
5993637|NCT00963820|20725131|P9|Dose Escalation Phase|Progressive Disease|0
5993638|NCT00963820|20725132|P8|Dose Escalation Phase|Progressive Disease|2
5993639|NCT00963820|20725133|P7|Dose Escalation Phase|Progressive Disease|3
5993640|NCT00963820|20725134|P6|Dose Escalation Phase|Progressive Disease|3
5993641|NCT00963820|20725135|P5|Dose Escalation Phase|Progressive Disease|4
5993642|NCT00963820|20725136|P4|Dose Escalation Phase|Progressive Disease|3
5993643|NCT00963820|20725137|P3|Dose Escalation Phase|Progressive Disease|3
5993644|NCT00963820|20725138|P2|Dose Escalation Phase|Progressive Disease|3
5993645|NCT00963820|20725139|P1|Dose Escalation Phase|Progressive Disease|3
5993646|NCT00963807|20725275|P1|Overall Study|Disease progression|15
5993647|NCT00963807|20725275|P1|Overall Study|Reaction to study chemotherapy regimen|1
5993648|NCT00963807|20725275|P1|Overall Study|Physician Decision|2
5993649|NCT00963599|20725308|P4|Overall Study|Withdrawal by Subject|3
5993650|NCT00963599|20725309|P3|Overall Study|Withdrawal by Subject|3
5993651|NCT00963599|20725310|P2|Overall Study|Withdrawal by Subject|1
5993652|NCT00963599|20725311|P1|Overall Study|Withdrawal by Subject|2
5993653|NCT00963599|20725308|P4|Overall Study|Protocol Violation|4
5993654|NCT00963599|20725309|P3|Overall Study|Protocol Violation|3
5993655|NCT00963599|20725310|P2|Overall Study|Protocol Violation|2
5993656|NCT00963599|20725311|P1|Overall Study|Protocol Violation|2
5993657|NCT00963599|20725308|P4|Overall Study|Lost to Follow-up|1
5993658|NCT00963599|20725309|P3|Overall Study|Lost to Follow-up|1
5993659|NCT00963599|20725310|P2|Overall Study|Lost to Follow-up|1
5993660|NCT00963599|20725311|P1|Overall Study|Lost to Follow-up|0
5993661|NCT00963599|20725308|P4|Overall Study|Lack of Efficacy|4
5993662|NCT00963599|20725309|P3|Overall Study|Lack of Efficacy|1
5993663|NCT00963599|20725310|P2|Overall Study|Lack of Efficacy|2
5993664|NCT00963599|20725311|P1|Overall Study|Lack of Efficacy|0
5993665|NCT00963599|20725308|P4|Overall Study|Adverse Event|2
5993666|NCT00963599|20725309|P3|Overall Study|Adverse Event|1
5993667|NCT00963599|20725310|P2|Overall Study|Adverse Event|0
5993668|NCT00963599|20725311|P1|Overall Study|Adverse Event|2
5993669|NCT00963547|20725382|P7|Overall Study|Reason Unknown|0
5993670|NCT00963547|20725383|P6|Overall Study|Reason Unknown|0
5993671|NCT00963547|20725384|P5|Overall Study|Reason Unknown|0
5993672|NCT00963547|20725385|P4|Overall Study|Reason Unknown|0
5993673|NCT00963547|20725386|P3|Overall Study|Reason Unknown|0
5993674|NCT00963547|20725387|P2|Overall Study|Reason Unknown|1
5993675|NCT00963547|20725388|P1|Overall Study|Reason Unknown|0
5993676|NCT00963547|20725382|P7|Overall Study|Withdrawal by Subject|0
5993677|NCT00963547|20725383|P6|Overall Study|Withdrawal by Subject|0
5993678|NCT00963547|20725384|P5|Overall Study|Withdrawal by Subject|0
5993679|NCT00963547|20725385|P4|Overall Study|Withdrawal by Subject|0
5993680|NCT00963547|20725386|P3|Overall Study|Withdrawal by Subject|3
5993681|NCT00963547|20725387|P2|Overall Study|Withdrawal by Subject|0
5993682|NCT00963547|20725388|P1|Overall Study|Withdrawal by Subject|0
5993683|NCT00963547|20725382|P7|Overall Study|Progressive Disease|0
5993684|NCT00963547|20725383|P6|Overall Study|Progressive Disease|0
5993685|NCT00963547|20725384|P5|Overall Study|Progressive Disease|0
5993686|NCT00963547|20725385|P4|Overall Study|Progressive Disease|5
5993687|NCT00963547|20725386|P3|Overall Study|Progressive Disease|9
5993688|NCT00963547|20725387|P2|Overall Study|Progressive Disease|8
5993689|NCT00963547|20725388|P1|Overall Study|Progressive Disease|3
5993690|NCT00963547|20725382|P7|Overall Study|Physician Decision|0
5993691|NCT00963547|20725383|P6|Overall Study|Physician Decision|0
5993692|NCT00963547|20725384|P5|Overall Study|Physician Decision|0
5993693|NCT00963547|20725385|P4|Overall Study|Physician Decision|0
5993694|NCT00963547|20725386|P3|Overall Study|Physician Decision|0
5993695|NCT00963547|20725387|P2|Overall Study|Physician Decision|1
5993696|NCT00963547|20725388|P1|Overall Study|Physician Decision|1
5993697|NCT00963547|20725382|P7|Overall Study|Adverse Event|0
5993698|NCT00963547|20725383|P6|Overall Study|Adverse Event|0
5993699|NCT00963547|20725384|P5|Overall Study|Adverse Event|0
5993700|NCT00963547|20725385|P4|Overall Study|Adverse Event|1
5993701|NCT00963547|20725386|P3|Overall Study|Adverse Event|0
5993702|NCT00963547|20725387|P2|Overall Study|Adverse Event|1
5993703|NCT00963547|20725388|P1|Overall Study|Adverse Event|0
5993704|NCT00963469|20725435|P3|Overall Study|Site closed (local pollen Season ended)|3
5993705|NCT00963469|20725436|P2|Overall Study|Site closed (local pollen Season ended)|1
5993706|NCT00963469|20725437|P1|Overall Study|Site closed (local pollen Season ended)|4
5993707|NCT00963469|20725435|P3|Overall Study|Moved|0
5993708|NCT00963469|20725436|P2|Overall Study|Moved|0
5993709|NCT00963469|20725437|P1|Overall Study|Moved|1
5993710|NCT00963469|20725435|P3|Overall Study|Pre-randomization Adverse Event|0
5993711|NCT00963469|20725436|P2|Overall Study|Pre-randomization Adverse Event|2
5993712|NCT00963469|20725437|P1|Overall Study|Pre-randomization Adverse Event|1
5993713|NCT00963469|20725435|P3|Overall Study|Withdrawal by Subject|1
5993714|NCT00963469|20725436|P2|Overall Study|Withdrawal by Subject|1
5993715|NCT00963469|20725437|P1|Overall Study|Withdrawal by Subject|4
5993716|NCT00963469|20725435|P3|Overall Study|Protocol Violation|3
5993717|NCT00963469|20725436|P2|Overall Study|Protocol Violation|5
5993718|NCT00963469|20725437|P1|Overall Study|Protocol Violation|5
5993719|NCT00963469|20725435|P3|Overall Study|Lost to Follow-up|0
5993720|NCT00963469|20725436|P2|Overall Study|Lost to Follow-up|1
5993721|NCT00963469|20725437|P1|Overall Study|Lost to Follow-up|1
5993722|NCT00963469|20725435|P3|Overall Study|Lack of Efficacy|2
5993723|NCT00963469|20725436|P2|Overall Study|Lack of Efficacy|7
5993724|NCT00963469|20725437|P1|Overall Study|Lack of Efficacy|10
5993725|NCT00963469|20725435|P3|Overall Study|Adverse Event|1
5993726|NCT00963469|20725436|P2|Overall Study|Adverse Event|11
5993727|NCT00963469|20725437|P1|Overall Study|Adverse Event|15
5993728|NCT00963235|20725504|P1|Overall Study|Other|1
5993729|NCT00963235|20725504|P1|Overall Study|Physician Decision|2
5993730|NCT00963235|20725504|P1|Overall Study|Adverse Event|5
5993731|NCT00963235|20725504|P1|Overall Study|Protocol Violation|7
5993732|NCT00963235|20725504|P1|Overall Study|Failed to return|9
5993733|NCT00963235|20725504|P1|Overall Study|Lost to Follow-up|14
5993734|NCT00963235|20725504|P1|Overall Study|Withdrawal by Subject|22
5993735|NCT00962780|20725796|P2|Overall Study|Other|1
5993736|NCT00962780|20725797|P1|Overall Study|Other|0
5993737|NCT00962780|20725796|P2|Overall Study|Withdrawal by Subject|8
5993738|NCT00962780|20725797|P1|Overall Study|Withdrawal by Subject|1
5993739|NCT00962780|20725796|P2|Overall Study|Protocol Violation|4
5993740|NCT00962780|20725797|P1|Overall Study|Protocol Violation|9
5993741|NCT00962780|20725796|P2|Overall Study|Death|1
5993742|NCT00962780|20725797|P1|Overall Study|Death|0
5993743|NCT00962741|20725872|P1|Overall Study|drug ineffective+prohibited drug taken|1
5993744|NCT00962741|20725872|P1|Overall Study|Lack of Efficacy|1
5993745|NCT00962741|20725872|P1|Overall Study|Withdrawal by Subject|1
5993746|NCT00962741|20725872|P1|Overall Study|Lost to Follow-up|2
5993747|NCT00962741|20725872|P1|Overall Study|Failed to return|3
5993748|NCT00962650|20725963|P1|Overall Study|Transgastric DP was not completed|2
5993749|NCT00962585|20725982|P4|Overall Study|Withdrew Consent|0
5993750|NCT00962585|20725983|P3|Overall Study|Withdrew Consent|0
5993751|NCT00962585|20725984|P2|Overall Study|Withdrew Consent|0
5993752|NCT00962585|20725985|P1|Overall Study|Withdrew Consent|2
5993753|NCT00962585|20725982|P4|Overall Study|Withdrawal by Subject|0
5993754|NCT00962585|20725983|P3|Overall Study|Withdrawal by Subject|0
5993755|NCT00962585|20725984|P2|Overall Study|Withdrawal by Subject|0
5993756|NCT00962585|20725985|P1|Overall Study|Withdrawal by Subject|1
5993757|NCT00962585|20725982|P4|Overall Study|Protocol Violation|0
5993758|NCT00962585|20725983|P3|Overall Study|Protocol Violation|1
5993759|NCT00962585|20725984|P2|Overall Study|Protocol Violation|0
5993760|NCT00962585|20725985|P1|Overall Study|Protocol Violation|0
5993761|NCT00962585|20725982|P4|Overall Study|Lost to Follow-up|0
5993762|NCT00962585|20725983|P3|Overall Study|Lost to Follow-up|1
5993763|NCT00962585|20725984|P2|Overall Study|Lost to Follow-up|0
5993764|NCT00962585|20725985|P1|Overall Study|Lost to Follow-up|3
5993765|NCT00962585|20725982|P4|Overall Study|Adverse Event|0
5993766|NCT00962585|20725983|P3|Overall Study|Adverse Event|1
5993767|NCT00962585|20725984|P2|Overall Study|Adverse Event|2
5993768|NCT00962585|20725985|P1|Overall Study|Adverse Event|0
5993769|NCT00962390|20726062|P4|Overall Study|Withdrawal by Subject|0
5993770|NCT00962390|20726063|P3|Overall Study|Withdrawal by Subject|1
5993771|NCT00962390|20726064|P2|Overall Study|Withdrawal by Subject|1
5993772|NCT00962390|20726065|P1|Overall Study|Withdrawal by Subject|1
5993773|NCT00962390|20726062|P4|Overall Study|Protocol Violation|0
5993774|NCT00962390|20726063|P3|Overall Study|Protocol Violation|0
5993775|NCT00962390|20726064|P2|Overall Study|Protocol Violation|0
5993776|NCT00962390|20726065|P1|Overall Study|Protocol Violation|1
5993777|NCT00962390|20726062|P4|Overall Study|Lost to Follow-up|0
5993778|NCT00962390|20726063|P3|Overall Study|Lost to Follow-up|0
5993779|NCT00962390|20726064|P2|Overall Study|Lost to Follow-up|2
5993780|NCT00962390|20726065|P1|Overall Study|Lost to Follow-up|2
5993781|NCT00962390|20726062|P4|Overall Study|Adverse Event|1
5993782|NCT00962390|20726063|P3|Overall Study|Adverse Event|3
5993783|NCT00962390|20726064|P2|Overall Study|Adverse Event|0
5993784|NCT00962390|20726065|P1|Overall Study|Adverse Event|0
5993785|NCT00962247|20726127|P1|25% Reduction of Sedentary Activity|Withdrawal by Subject|1
5993786|NCT00962247|20726127|P1|25% Reduction of Sedentary Activity|Protocol Violation|4
5993787|NCT00962208|20726138|P2|Overall Study|Lost to Follow-up|9
5993788|NCT00962208|20726139|P1|Overall Study|Lost to Follow-up|0
5993789|NCT00962208|20726138|P2|Overall Study|Contraindicated to continue study|1
5993790|NCT00962208|20726139|P1|Overall Study|Contraindicated to continue study|5
5993791|NCT00962208|20726138|P2|Overall Study|Could not achieve good vision|0
5993792|NCT00962208|20726139|P1|Overall Study|Could not achieve good vision|9
5993793|NCT00962104|20726147|P2|Overall Study|Other|0
5993794|NCT00962104|20726148|P1|Overall Study|Other|2
5993795|NCT00962104|20726147|P2|Overall Study|Withdrawal by Subject|6
5993796|NCT00962104|20726148|P1|Overall Study|Withdrawal by Subject|10
5993797|NCT00962104|20726147|P2|Overall Study|Sponsor Decision|1
5993798|NCT00962104|20726148|P1|Overall Study|Sponsor Decision|0
5993799|NCT00962104|20726147|P2|Overall Study|Protocol Violation|8
5993800|NCT00962104|20726148|P1|Overall Study|Protocol Violation|6
5993801|NCT00962104|20726147|P2|Overall Study|Physician Decision|0
5993802|NCT00962104|20726148|P1|Overall Study|Physician Decision|1
5993803|NCT00962104|20726147|P2|Overall Study|Lost to Follow-up|4
5993804|NCT00962104|20726148|P1|Overall Study|Lost to Follow-up|10
5993805|NCT00962104|20726147|P2|Overall Study|Lack of Efficacy|1
5993806|NCT00962104|20726148|P1|Overall Study|Lack of Efficacy|0
5993807|NCT00962104|20726147|P2|Overall Study|Entry Criteria Not Met|2
5993808|NCT00962104|20726148|P1|Overall Study|Entry Criteria Not Met|1
5993809|NCT00962104|20726147|P2|Overall Study|Adverse Event|3
5993810|NCT00962104|20726148|P1|Overall Study|Adverse Event|10
5993811|NCT00962091|20726181|P7|Overall Study|Adverse Event|1
5993812|NCT00962091|20726182|P6|Overall Study|Adverse Event|0
5993813|NCT00962091|20726183|P5|Overall Study|Adverse Event|0
5993814|NCT00962091|20726184|P4|Overall Study|Adverse Event|0
5993815|NCT00962091|20726185|P3|Overall Study|Adverse Event|0
5993816|NCT00962091|20726186|P2|Overall Study|Adverse Event|0
5993817|NCT00962091|20726187|P1|Overall Study|Adverse Event|0
5993818|NCT00962091|20726181|P7|Overall Study|Withdrawal by Subject|0
5993819|NCT00962091|20726182|P6|Overall Study|Withdrawal by Subject|1
5993820|NCT00962091|20726183|P5|Overall Study|Withdrawal by Subject|0
5993821|NCT00962091|20726184|P4|Overall Study|Withdrawal by Subject|1
5993822|NCT00962091|20726185|P3|Overall Study|Withdrawal by Subject|1
5993823|NCT00962091|20726186|P2|Overall Study|Withdrawal by Subject|2
5993824|NCT00962091|20726187|P1|Overall Study|Withdrawal by Subject|1
5993825|NCT00962013|20726290|P1|Overall Study|No 5 year evaluation|6
5993826|NCT00962013|20726290|P1|Overall Study|Site Termination|24
5993827|NCT00962013|20726290|P1|Overall Study|Removal of study device|3
5993828|NCT00962013|20726290|P1|Overall Study|Withdrawal by Subject|8
5993829|NCT00962013|20726290|P1|Overall Study|Unable/Unwilling to return|6
5993830|NCT00962013|20726290|P1|Overall Study|Lost to Follow-up|12
5993831|NCT00962013|20726290|P1|Overall Study|Death|8
5993832|NCT00962013|20726290|P1|Overall Study|Did not have surgery|1
5993833|NCT00961961|20726314|P4|Phase II|Withdrawal by Subject|0
5993834|NCT00961961|20726315|P3|Phase II|Withdrawal by Subject|1
5993835|NCT00961961|20726316|P2|Phase II|Withdrawal by Subject|0
5993836|NCT00961961|20726317|P1|Phase II|Withdrawal by Subject|0
5993837|NCT00961961|20726314|P4|Phase II|Physician Decision|0
5993838|NCT00961961|20726315|P3|Phase II|Physician Decision|1
5993839|NCT00961961|20726316|P2|Phase II|Physician Decision|0
5993840|NCT00961961|20726317|P1|Phase II|Physician Decision|0
5993841|NCT00961961|20726314|P4|Phase II|Adverse Event|1
5993842|NCT00961961|20726315|P3|Phase II|Adverse Event|0
5993843|NCT00961961|20726316|P2|Phase II|Adverse Event|0
5993844|NCT00961961|20726317|P1|Phase II|Adverse Event|0
5993845|NCT00961961|20726314|P4|Phase II|Lost to Follow-up|7
5993846|NCT00961961|20726315|P3|Phase II|Lost to Follow-up|10
5993847|NCT00961961|20726316|P2|Phase II|Lost to Follow-up|0
5993848|NCT00961961|20726317|P1|Phase II|Lost to Follow-up|0
5993849|NCT00961961|20726314|P4|Phase I|Physician Decision|0
5993850|NCT00961961|20726315|P3|Phase I|Physician Decision|0
5993851|NCT00961961|20726316|P2|Phase I|Physician Decision|0
5993852|NCT00961961|20726317|P1|Phase I|Physician Decision|8
5993853|NCT00961961|20726314|P4|Phase I|Adverse Event|0
5993854|NCT00961961|20726315|P3|Phase I|Adverse Event|0
5993855|NCT00961961|20726316|P2|Phase I|Adverse Event|0
5993856|NCT00961961|20726317|P1|Phase I|Adverse Event|7
5993857|NCT00961961|20726314|P4|Phase I|Lack of Efficacy|0
5993858|NCT00961961|20726315|P3|Phase I|Lack of Efficacy|0
5993859|NCT00961961|20726316|P2|Phase I|Lack of Efficacy|0
5993860|NCT00961961|20726317|P1|Phase I|Lack of Efficacy|94
5993861|NCT00961961|20726314|P4|Phase I|Lost to Follow-up|0
5993862|NCT00961961|20726315|P3|Phase I|Lost to Follow-up|0
5993863|NCT00961961|20726316|P2|Phase I|Lost to Follow-up|0
5993864|NCT00961961|20726317|P1|Phase I|Lost to Follow-up|10
5993865|NCT00961961|20726314|P4|Phase I|Withdrawal by Subject|0
5993866|NCT00961961|20726315|P3|Phase I|Withdrawal by Subject|0
5993867|NCT00961961|20726316|P2|Phase I|Withdrawal by Subject|0
5993868|NCT00961961|20726317|P1|Phase I|Withdrawal by Subject|7
5993869|NCT00961896|20726342|P3|Overall Study|Abnormal laboratory value|1
5993870|NCT00961896|20726343|P2|Overall Study|Abnormal laboratory value|0
5993871|NCT00961896|20726344|P1|Overall Study|Abnormal laboratory value|0
5993872|NCT00961649|20726411|P4|Overall Study|Study terminated by sponsor|1
5993873|NCT00961649|20726412|P3|Overall Study|Study terminated by sponsor|4
5993874|NCT00961649|20726413|P2|Overall Study|Study terminated by sponsor|4
5993875|NCT00961649|20726414|P1|Overall Study|Study terminated by sponsor|4
5993876|NCT00961649|20726411|P4|Overall Study|Patient left to Mexico-family emergency|0
5993877|NCT00961649|20726412|P3|Overall Study|Patient left to Mexico-family emergency|0
5993878|NCT00961649|20726413|P2|Overall Study|Patient left to Mexico-family emergency|0
5993879|NCT00961649|20726414|P1|Overall Study|Patient left to Mexico-family emergency|1
5993880|NCT00961649|20726411|P4|Overall Study|Patient has travel plans during holidays|0
5993881|NCT00961649|20726412|P3|Overall Study|Patient has travel plans during holidays|1
5993882|NCT00961649|20726413|P2|Overall Study|Patient has travel plans during holidays|0
5993883|NCT00961649|20726414|P1|Overall Study|Patient has travel plans during holidays|0
5993884|NCT00961649|20726411|P4|Overall Study|Inadequate control of IOP|1
5993885|NCT00961649|20726412|P3|Overall Study|Inadequate control of IOP|0
5993886|NCT00961649|20726413|P2|Overall Study|Inadequate control of IOP|0
5993887|NCT00961649|20726414|P1|Overall Study|Inadequate control of IOP|0
5993888|NCT00961649|20726411|P4|Overall Study|Adverse Event|2
5993889|NCT00961649|20726412|P3|Overall Study|Adverse Event|0
5993890|NCT00961649|20726413|P2|Overall Study|Adverse Event|0
5993891|NCT00961649|20726414|P1|Overall Study|Adverse Event|4
5993892|NCT00961636|20726428|P3|Overall Study|Withdrawal by Subject|13
5993893|NCT00961636|20726429|P2|Overall Study|Withdrawal by Subject|22
5993894|NCT00961636|20726430|P1|Overall Study|Withdrawal by Subject|29
5993895|NCT00961636|20726428|P3|Overall Study|Protocol Violation|1
5993896|NCT00961636|20726429|P2|Overall Study|Protocol Violation|5
5993897|NCT00961636|20726430|P1|Overall Study|Protocol Violation|9
5993898|NCT00961636|20726428|P3|Overall Study|Physician Decision|1
5993899|NCT00961636|20726429|P2|Overall Study|Physician Decision|1
5993900|NCT00961636|20726430|P1|Overall Study|Physician Decision|3
5993901|NCT00961636|20726428|P3|Overall Study|Lost to Follow-up|1
5993902|NCT00961636|20726429|P2|Overall Study|Lost to Follow-up|3
5993903|NCT00961636|20726430|P1|Overall Study|Lost to Follow-up|2
5993904|NCT00961636|20726428|P3|Overall Study|Flushing Symptoms|3
5993905|NCT00961636|20726429|P2|Overall Study|Flushing Symptoms|46
5993906|NCT00961636|20726430|P1|Overall Study|Flushing Symptoms|29
5993907|NCT00961636|20726428|P3|Overall Study|Adverse Event|13
5993908|NCT00961636|20726429|P2|Overall Study|Adverse Event|54
5993909|NCT00961636|20726430|P1|Overall Study|Adverse Event|35
5993910|NCT00961571|20726441|P1|Overall Study|Physician Decision|39
5993911|NCT00961415|20726469|P3|Maintenance Treatment Phase|Other reason|3
5993912|NCT00961415|20726470|P2|Maintenance Treatment Phase|Other reason|1
5993913|NCT00961415|20726471|P1|Maintenance Treatment Phase|Other reason|0
5993914|NCT00961415|20726469|P3|Maintenance Treatment Phase|Withdrawal by Subject|8
5993915|NCT00961415|20726470|P2|Maintenance Treatment Phase|Withdrawal by Subject|3
5993916|NCT00961415|20726471|P1|Maintenance Treatment Phase|Withdrawal by Subject|0
5993917|NCT00961415|20726469|P3|Maintenance Treatment Phase|Investigators decision|0
5993918|NCT00961415|20726470|P2|Maintenance Treatment Phase|Investigators decision|2
5993919|NCT00961415|20726471|P1|Maintenance Treatment Phase|Investigators decision|0
5993920|NCT00961415|20726469|P3|Maintenance Treatment Phase|Death|34
5993921|NCT00961415|20726470|P2|Maintenance Treatment Phase|Death|42
5993922|NCT00961415|20726471|P1|Maintenance Treatment Phase|Death|0
5993923|NCT00961415|20726469|P3|Induction Treatment Phase|Other Reason|0
5993924|NCT00961415|20726470|P2|Induction Treatment Phase|Other Reason|0
5993925|NCT00961415|20726471|P1|Induction Treatment Phase|Other Reason|5
5993926|NCT00961415|20726469|P3|Induction Treatment Phase|Didn't meet maintenance phase criteria|0
5993927|NCT00961415|20726470|P2|Induction Treatment Phase|Didn't meet maintenance phase criteria|0
5993928|NCT00961415|20726471|P1|Induction Treatment Phase|Didn't meet maintenance phase criteria|27
5993929|NCT00961415|20726469|P3|Induction Treatment Phase|Physician Decision|0
5993930|NCT00961415|20726470|P2|Induction Treatment Phase|Physician Decision|0
5993931|NCT00961415|20726471|P1|Induction Treatment Phase|Physician Decision|2
5993932|NCT00961415|20726469|P3|Induction Treatment Phase|Protocol Violation|0
5993933|NCT00961415|20726470|P2|Induction Treatment Phase|Protocol Violation|0
5993934|NCT00961415|20726471|P1|Induction Treatment Phase|Protocol Violation|1
5993935|NCT00961415|20726469|P3|Induction Treatment Phase|Death|0
5993936|NCT00961415|20726470|P2|Induction Treatment Phase|Death|0
5993937|NCT00961415|20726471|P1|Induction Treatment Phase|Death|77
5993938|NCT00961415|20726469|P3|Induction Treatment Phase|Withdrawal by Subject|0
5993939|NCT00961415|20726470|P2|Induction Treatment Phase|Withdrawal by Subject|0
5993940|NCT00961415|20726471|P1|Induction Treatment Phase|Withdrawal by Subject|11
5993941|NCT00961350|20726511|P2|Overall Study|Misc|21
5993942|NCT00961350|20726512|P1|Overall Study|Misc|16
5993943|NCT00961350|20726511|P2|Overall Study|Lost to Follow-up|3
5993944|NCT00961350|20726512|P1|Overall Study|Lost to Follow-up|3
5993945|NCT00961350|20726511|P2|Overall Study|Withdrawal by Subject|10
5993946|NCT00961350|20726512|P1|Overall Study|Withdrawal by Subject|10
5993947|NCT00961350|20726511|P2|Overall Study|Adverse Event|33
5993948|NCT00961350|20726512|P1|Overall Study|Adverse Event|18
5993949|NCT00961298|20726533|P1|12 Weeks Duloxetine Treatment Phase|Protocol Violation|1
5993950|NCT00961298|20726533|P1|12 Weeks Duloxetine Treatment Phase|Withdrawal by Subject|2
5993951|NCT00961298|20726533|P1|Two Week Placebo Run in|Withdrawal by Subject|1
5993952|NCT00961259|20726540|P3|Washout Period of 7 Days|due to concomitant medication used|0
5993953|NCT00961259|20726541|P2|Washout Period of 7 Days|due to concomitant medication used|1
5993954|NCT00961259|20726542|P1|Washout Period of 7 Days|due to concomitant medication used|0
5993955|NCT00961220|20726570|P1|Overall Study|Complete Response prior to 12 courses|1
5993956|NCT00961220|20726570|P1|Overall Study|O6BG no longer supplied|1
5993957|NCT00961220|20726570|P1|Overall Study|No IV access for O6BG|1
5993958|NCT00961220|20726570|P1|Overall Study|Lack of Efficacy|1
5993959|NCT00961220|20726570|P1|Overall Study|Adverse Event|3
5993960|NCT00961181|20726586|P1|Overall Study|Lost to Follow-up|1
5993961|NCT00961181|20726586|P1|Overall Study|Withdrawal by Subject|2
5993962|NCT00961181|20726586|P1|Overall Study|Death|2
5993963|NCT00961116|20726599|P2|Washout Period of 7 Days|Protocol Violation|1
5993964|NCT00961116|20726600|P1|Washout Period of 7 Days|Protocol Violation|0
5993965|NCT00961116|20726599|P2|Washout Period of 7 Days|Withdrawal by Subject|1
5993966|NCT00961116|20726600|P1|Washout Period of 7 Days|Withdrawal by Subject|1
5993967|NCT00961116|20726599|P2|Washout Period of 7 Days|Adverse Event|1
5993968|NCT00961116|20726600|P1|Washout Period of 7 Days|Adverse Event|1
5993969|NCT00960999|20726627|P2|Overall Study|RT dose constraints not met|0
5993970|NCT00960999|20726628|P1|Overall Study|RT dose constraints not met|2
5993971|NCT00960999|20726627|P2|Overall Study|Protocol Violation|2
5993972|NCT00960999|20726628|P1|Overall Study|Protocol Violation|5
5993973|NCT00960999|20726627|P2|Overall Study|Withdrawal by Subject|0
5993974|NCT00960999|20726628|P1|Overall Study|Withdrawal by Subject|1
5993975|NCT00960986|20726660|P4|Period 3 (7-week Therapy Period)|Lack of Efficacy|0
5993976|NCT00960986|20726661|P3|Period 3 (7-week Therapy Period)|Lack of Efficacy|1
5993977|NCT00960986|20726662|P2|Period 3 (7-week Therapy Period)|Lack of Efficacy|2
5993978|NCT00960986|20726663|P1|Period 3 (7-week Therapy Period)|Lack of Efficacy|1
5993979|NCT00960986|20726660|P4|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2
5993980|NCT00960986|20726661|P3|Period 3 (7-week Therapy Period)|Withdrawal by Subject|4
5993981|NCT00960986|20726662|P2|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2
5993982|NCT00960986|20726663|P1|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2
5993983|NCT00960986|20726660|P4|Period 3 (7-week Therapy Period)|Protocol Violation|11
5993984|NCT00960986|20726661|P3|Period 3 (7-week Therapy Period)|Protocol Violation|3
5993985|NCT00960986|20726662|P2|Period 3 (7-week Therapy Period)|Protocol Violation|4
5993986|NCT00960986|20726663|P1|Period 3 (7-week Therapy Period)|Protocol Violation|10
5993987|NCT00960986|20726660|P4|Period 3 (7-week Therapy Period)|Lost to Follow-up|0
5993988|NCT00960986|20726661|P3|Period 3 (7-week Therapy Period)|Lost to Follow-up|1
5993989|NCT00960986|20726662|P2|Period 3 (7-week Therapy Period)|Lost to Follow-up|0
5993990|NCT00960986|20726663|P1|Period 3 (7-week Therapy Period)|Lost to Follow-up|0
5993991|NCT00960986|20726660|P4|Period 3 (7-week Therapy Period)|Death|0
5993992|NCT00960986|20726661|P3|Period 3 (7-week Therapy Period)|Death|1
5993993|NCT00960986|20726662|P2|Period 3 (7-week Therapy Period)|Death|0
5993994|NCT00960986|20726663|P1|Period 3 (7-week Therapy Period)|Death|0
5993995|NCT00960986|20726660|P4|Period 3 (7-week Therapy Period)|Adverse Event|12
5993996|NCT00960986|20726661|P3|Period 3 (7-week Therapy Period)|Adverse Event|10
5993997|NCT00960986|20726662|P2|Period 3 (7-week Therapy Period)|Adverse Event|15
5993998|NCT00960986|20726663|P1|Period 3 (7-week Therapy Period)|Adverse Event|17
5993999|NCT00960986|20726660|P4|Period 1 (Screening and Washout)|Withdrawal by Subject|1
5994000|NCT00960986|20726661|P3|Period 1 (Screening and Washout)|Withdrawal by Subject|1
5994001|NCT00960986|20726662|P2|Period 1 (Screening and Washout)|Withdrawal by Subject|2
5994002|NCT00960986|20726663|P1|Period 1 (Screening and Washout)|Withdrawal by Subject|1
5994003|NCT00960986|20726660|P4|Period 1 (Screening and Washout)|Protocol Violation|0
5994004|NCT00960986|20726661|P3|Period 1 (Screening and Washout)|Protocol Violation|0
5994005|NCT00960986|20726662|P2|Period 1 (Screening and Washout)|Protocol Violation|0
5994006|NCT00960986|20726663|P1|Period 1 (Screening and Washout)|Protocol Violation|1
5994007|NCT00960986|20726660|P4|Period 1 (Screening and Washout)|Lost to Follow-up|1
5994008|NCT00960986|20726661|P3|Period 1 (Screening and Washout)|Lost to Follow-up|2
5994009|NCT00960986|20726662|P2|Period 1 (Screening and Washout)|Lost to Follow-up|0
5994010|NCT00960986|20726663|P1|Period 1 (Screening and Washout)|Lost to Follow-up|0
5994011|NCT00960986|20726660|P4|Period 1 (Screening and Washout)|Adverse Event|1
5994012|NCT00960986|20726661|P3|Period 1 (Screening and Washout)|Adverse Event|1
5994013|NCT00960986|20726662|P2|Period 1 (Screening and Washout)|Adverse Event|2
5994014|NCT00960986|20726663|P1|Period 1 (Screening and Washout)|Adverse Event|1
5994015|NCT00960934|20726739|P6|Overall Study|Study Terminated by Sponsor|49
5994016|NCT00960934|20726740|P5|Overall Study|Study Terminated by Sponsor|49
5994017|NCT00960934|20726741|P4|Overall Study|Study Terminated by Sponsor|50
5994018|NCT00960934|20726742|P3|Overall Study|Study Terminated by Sponsor|52
5994019|NCT00960934|20726743|P2|Overall Study|Study Terminated by Sponsor|46
5994020|NCT00960934|20726744|P1|Overall Study|Study Terminated by Sponsor|50
5994021|NCT00960934|20726739|P6|Overall Study|Withdrawal by Subject|7
5994022|NCT00960934|20726740|P5|Overall Study|Withdrawal by Subject|5
5994023|NCT00960934|20726741|P4|Overall Study|Withdrawal by Subject|5
5994024|NCT00960934|20726742|P3|Overall Study|Withdrawal by Subject|4
5994025|NCT00960934|20726743|P2|Overall Study|Withdrawal by Subject|6
5994026|NCT00960934|20726744|P1|Overall Study|Withdrawal by Subject|5
5994027|NCT00960934|20726739|P6|Overall Study|Protocol Violation|2
5994028|NCT00960934|20726740|P5|Overall Study|Protocol Violation|3
5994029|NCT00960934|20726741|P4|Overall Study|Protocol Violation|3
5994030|NCT00960934|20726742|P3|Overall Study|Protocol Violation|0
5994031|NCT00960934|20726743|P2|Overall Study|Protocol Violation|4
5994032|NCT00960934|20726744|P1|Overall Study|Protocol Violation|3
5994033|NCT00960934|20726739|P6|Overall Study|Progressive Disease|1
5994034|NCT00960934|20726740|P5|Overall Study|Progressive Disease|1
5994035|NCT00960934|20726741|P4|Overall Study|Progressive Disease|0
5994036|NCT00960934|20726742|P3|Overall Study|Progressive Disease|0
5994037|NCT00960934|20726743|P2|Overall Study|Progressive Disease|1
5994038|NCT00960934|20726744|P1|Overall Study|Progressive Disease|1
5994039|NCT00960934|20726739|P6|Overall Study|Physician Decision|0
5994040|NCT00960934|20726740|P5|Overall Study|Physician Decision|0
5994041|NCT00960934|20726741|P4|Overall Study|Physician Decision|0
5994042|NCT00960934|20726742|P3|Overall Study|Physician Decision|0
5994043|NCT00960934|20726743|P2|Overall Study|Physician Decision|1
5994044|NCT00960934|20726744|P1|Overall Study|Physician Decision|0
5994045|NCT00960934|20726739|P6|Overall Study|Other|2
5994046|NCT00960934|20726740|P5|Overall Study|Other|2
5994047|NCT00960934|20726741|P4|Overall Study|Other|4
5994048|NCT00960934|20726742|P3|Overall Study|Other|5
5994049|NCT00960934|20726743|P2|Overall Study|Other|1
5994050|NCT00960934|20726744|P1|Overall Study|Other|2
5994051|NCT00960934|20726739|P6|Overall Study|Lost to Follow-up|0
5994052|NCT00960934|20726740|P5|Overall Study|Lost to Follow-up|0
5994053|NCT00960934|20726741|P4|Overall Study|Lost to Follow-up|0
5994054|NCT00960934|20726742|P3|Overall Study|Lost to Follow-up|0
5994055|NCT00960934|20726743|P2|Overall Study|Lost to Follow-up|1
5994056|NCT00960934|20726744|P1|Overall Study|Lost to Follow-up|0
5994057|NCT00960934|20726739|P6|Overall Study|Lack of Efficacy|0
5994058|NCT00960934|20726740|P5|Overall Study|Lack of Efficacy|0
5994059|NCT00960934|20726741|P4|Overall Study|Lack of Efficacy|0
5994060|NCT00960934|20726742|P3|Overall Study|Lack of Efficacy|0
5994061|NCT00960934|20726743|P2|Overall Study|Lack of Efficacy|0
5994062|NCT00960934|20726744|P1|Overall Study|Lack of Efficacy|1
5994063|NCT00960934|20726739|P6|Overall Study|Adverse Event|3
5994064|NCT00960934|20726740|P5|Overall Study|Adverse Event|4
5994065|NCT00960934|20726741|P4|Overall Study|Adverse Event|2
5994066|NCT00960934|20726742|P3|Overall Study|Adverse Event|3
5994067|NCT00960934|20726743|P2|Overall Study|Adverse Event|3
5994068|NCT00960934|20726744|P1|Overall Study|Adverse Event|2
5994069|NCT00960869|20726856|P2|Overall Study|Misc|18
5994070|NCT00960869|20726857|P1|Overall Study|Misc|19
5994071|NCT00960869|20726856|P2|Overall Study|Lost to Follow-up|4
5994072|NCT00960869|20726857|P1|Overall Study|Lost to Follow-up|1
5994073|NCT00960869|20726856|P2|Overall Study|Withdrawal by Subject|14
5994074|NCT00960869|20726857|P1|Overall Study|Withdrawal by Subject|16
5994075|NCT00960869|20726856|P2|Overall Study|Adverse Event|26
5994076|NCT00960869|20726857|P1|Overall Study|Adverse Event|17
5994077|NCT00960856|20726871|P4|Washout Period of 7 Days|Adverse Event|0
5994078|NCT00960856|20726872|P3|Washout Period of 7 Days|Adverse Event|1
5994079|NCT00960856|20726873|P2|Washout Period of 7 Days|Adverse Event|0
5994080|NCT00960856|20726874|P1|Washout Period of 7 Days|Adverse Event|0
5994081|NCT00960856|20726871|P4|Washout Period of 7 Days|Withdrawal by Subject|0
5994082|NCT00960856|20726872|P3|Washout Period of 7 Days|Withdrawal by Subject|0
5994083|NCT00960856|20726873|P2|Washout Period of 7 Days|Withdrawal by Subject|2
5994084|NCT00960856|20726874|P1|Washout Period of 7 Days|Withdrawal by Subject|0
5994085|NCT00960843|20726894|P2|Overall Study|Repeated needle dislodgment|1
5994086|NCT00960843|20726895|P1|Overall Study|Repeated needle dislodgment|0
5994087|NCT00960843|20726894|P2|Overall Study|Protocol Violation|4
5994088|NCT00960843|20726895|P1|Overall Study|Protocol Violation|0
5994089|NCT00960843|20726894|P2|Overall Study|Lost to Follow-up|0
5994090|NCT00960843|20726895|P1|Overall Study|Lost to Follow-up|2
5994091|NCT00960687|20726916|P2|Washout Period of 7 Days|Withdrawal by Subject|1
5994092|NCT00960687|20726917|P1|Washout Period of 7 Days|Withdrawal by Subject|1
5994093|NCT00960687|20726916|P2|Washout Period of 7 Days|Adverse Event|2
5994094|NCT00960687|20726917|P1|Washout Period of 7 Days|Adverse Event|3
5994095|NCT00960661|20726929|P3|Interventional Phase|Lack of Efficacy|0
5994096|NCT00960661|20726930|P2|Interventional Phase|Lack of Efficacy|2
5994097|NCT00960661|20726931|P1|Interventional Phase|Lack of Efficacy|0
5994098|NCT00960661|20726929|P3|Interventional Phase|sponsor decision|0
5994099|NCT00960661|20726930|P2|Interventional Phase|sponsor decision|1
5994100|NCT00960661|20726931|P1|Interventional Phase|sponsor decision|0
5994101|NCT00960661|20726929|P3|Interventional Phase|Physician Decision|5
5994102|NCT00960661|20726930|P2|Interventional Phase|Physician Decision|3
5994103|NCT00960661|20726931|P1|Interventional Phase|Physician Decision|0
5994104|NCT00960661|20726929|P3|Interventional Phase|Withdrawal by Subject|29
5994105|NCT00960661|20726930|P2|Interventional Phase|Withdrawal by Subject|18
5994106|NCT00960661|20726931|P1|Interventional Phase|Withdrawal by Subject|0
5994107|NCT00960661|20726929|P3|Interventional Phase|Protocol Violation|2
5994108|NCT00960661|20726930|P2|Interventional Phase|Protocol Violation|7
5994109|NCT00960661|20726931|P1|Interventional Phase|Protocol Violation|0
5994110|NCT00960661|20726929|P3|Interventional Phase|entry criteria not met|0
5994111|NCT00960661|20726930|P2|Interventional Phase|entry criteria not met|3
5994112|NCT00960661|20726931|P1|Interventional Phase|entry criteria not met|0
5994113|NCT00960661|20726929|P3|Interventional Phase|Lost to Follow-up|2
5994114|NCT00960661|20726930|P2|Interventional Phase|Lost to Follow-up|0
5994115|NCT00960661|20726931|P1|Interventional Phase|Lost to Follow-up|0
5994116|NCT00960661|20726929|P3|Interventional Phase|Death|0
5994117|NCT00960661|20726930|P2|Interventional Phase|Death|1
5994118|NCT00960661|20726931|P1|Interventional Phase|Death|0
5994119|NCT00960661|20726929|P3|Interventional Phase|Adverse Event|8
5994120|NCT00960661|20726930|P2|Interventional Phase|Adverse Event|17
5994121|NCT00960661|20726931|P1|Interventional Phase|Adverse Event|0
5994122|NCT00960661|20726929|P3|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0
5994123|NCT00960661|20726930|P2|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0
5994124|NCT00960661|20726931|P1|Basal Insulin Optimization Phase (BIO)|Sponsor decision|3
5994125|NCT00960661|20726929|P3|Basal Insulin Optimization Phase (BIO)|Physician Decision|0
5994126|NCT00960661|20726930|P2|Basal Insulin Optimization Phase (BIO)|Physician Decision|0
5994127|NCT00960661|20726931|P1|Basal Insulin Optimization Phase (BIO)|Physician Decision|8
5994128|NCT00960661|20726929|P3|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0
5994129|NCT00960661|20726930|P2|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0
5994130|NCT00960661|20726931|P1|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|47
5994131|NCT00960661|20726929|P3|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0
5994132|NCT00960661|20726930|P2|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0
5994133|NCT00960661|20726931|P1|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|331
5994134|NCT00960661|20726929|P3|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0
5994135|NCT00960661|20726930|P2|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0
5994136|NCT00960661|20726931|P1|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|4
5994137|NCT00960661|20726929|P3|Basal Insulin Optimization Phase (BIO)|Adverse Event|0
5994138|NCT00960661|20726930|P2|Basal Insulin Optimization Phase (BIO)|Adverse Event|0
5994139|NCT00960661|20726931|P1|Basal Insulin Optimization Phase (BIO)|Adverse Event|6
5994140|NCT00960570|20726970|P1|1 Day Period Between Dosing|Withdrawal by Subject|1
5994141|NCT00960570|20726970|P1|1 Day Period Between Dosing|Adverse Event|2
5994142|NCT00960570|20726970|P1|21 Day Washout Period|Withdrawal by Subject|1
5994143|NCT00960570|20726970|P1|21 Day Washout Period|Adverse Event|1
5994144|NCT00960531|20726991|P10|Overall Study|Reason not Specified|1
5994145|NCT00960531|20726992|P9|Overall Study|Reason not Specified|8
5994146|NCT00960531|20726993|P8|Overall Study|Reason not Specified|0
5994147|NCT00960531|20726994|P7|Overall Study|Reason not Specified|16
5994148|NCT00960531|20726995|P6|Overall Study|Reason not Specified|0
5994149|NCT00960531|20726996|P5|Overall Study|Reason not Specified|2
5994150|NCT00960531|20726997|P4|Overall Study|Reason not Specified|1
5994151|NCT00960531|20726998|P3|Overall Study|Reason not Specified|13
5994152|NCT00960531|20726999|P2|Overall Study|Reason not Specified|1
5994153|NCT00960531|20727000|P1|Overall Study|Reason not Specified|2
5994154|NCT00960531|20726991|P10|Overall Study|Adverse Event (AE)|0
5994155|NCT00960531|20726992|P9|Overall Study|Adverse Event (AE)|2
5994156|NCT00960531|20726993|P8|Overall Study|Adverse Event (AE)|0
5994157|NCT00960531|20726994|P7|Overall Study|Adverse Event (AE)|2
5994158|NCT00960531|20726995|P6|Overall Study|Adverse Event (AE)|1
5994159|NCT00960531|20726996|P5|Overall Study|Adverse Event (AE)|0
5994160|NCT00960531|20726997|P4|Overall Study|Adverse Event (AE)|0
5994161|NCT00960531|20726998|P3|Overall Study|Adverse Event (AE)|0
5994162|NCT00960531|20726999|P2|Overall Study|Adverse Event (AE)|0
5994163|NCT00960531|20727000|P1|Overall Study|Adverse Event (AE)|2
5994164|NCT00960531|20726991|P10|Overall Study|Failed to Return|0
5994165|NCT00960531|20726992|P9|Overall Study|Failed to Return|0
5994166|NCT00960531|20726993|P8|Overall Study|Failed to Return|2
5994167|NCT00960531|20726994|P7|Overall Study|Failed to Return|0
5994168|NCT00960531|20726995|P6|Overall Study|Failed to Return|0
5994169|NCT00960531|20726996|P5|Overall Study|Failed to Return|0
5994170|NCT00960531|20726997|P4|Overall Study|Failed to Return|0
5994171|NCT00960531|20726998|P3|Overall Study|Failed to Return|0
5994172|NCT00960531|20726999|P2|Overall Study|Failed to Return|0
5994173|NCT00960531|20727000|P1|Overall Study|Failed to Return|2
5994174|NCT00960531|20726991|P10|Overall Study|Lost to Follow-up|0
5994175|NCT00960531|20726992|P9|Overall Study|Lost to Follow-up|0
5994176|NCT00960531|20726993|P8|Overall Study|Lost to Follow-up|0
5994177|NCT00960531|20726994|P7|Overall Study|Lost to Follow-up|1
5994178|NCT00960531|20726995|P6|Overall Study|Lost to Follow-up|0
5994179|NCT00960531|20726996|P5|Overall Study|Lost to Follow-up|0
5994180|NCT00960531|20726997|P4|Overall Study|Lost to Follow-up|0
5994181|NCT00960531|20726998|P3|Overall Study|Lost to Follow-up|1
5994182|NCT00960531|20726999|P2|Overall Study|Lost to Follow-up|0
5994183|NCT00960531|20727000|P1|Overall Study|Lost to Follow-up|0
5994184|NCT00960531|20726991|P10|Overall Study|Discontinuation of Study by Sponsor|0
5994185|NCT00960531|20726992|P9|Overall Study|Discontinuation of Study by Sponsor|0
5994186|NCT00960531|20726993|P8|Overall Study|Discontinuation of Study by Sponsor|1
5994187|NCT00960531|20726994|P7|Overall Study|Discontinuation of Study by Sponsor|0
5994188|NCT00960531|20726995|P6|Overall Study|Discontinuation of Study by Sponsor|0
5994189|NCT00960531|20726996|P5|Overall Study|Discontinuation of Study by Sponsor|0
5994190|NCT00960531|20726997|P4|Overall Study|Discontinuation of Study by Sponsor|0
5994191|NCT00960531|20726998|P3|Overall Study|Discontinuation of Study by Sponsor|0
5994192|NCT00960531|20726999|P2|Overall Study|Discontinuation of Study by Sponsor|0
5994193|NCT00960531|20727000|P1|Overall Study|Discontinuation of Study by Sponsor|0
5994194|NCT00960531|20726991|P10|Overall Study|Investigator Request|0
5994195|NCT00960531|20726992|P9|Overall Study|Investigator Request|0
5994196|NCT00960531|20726993|P8|Overall Study|Investigator Request|0
5994197|NCT00960531|20726994|P7|Overall Study|Investigator Request|0
5994198|NCT00960531|20726995|P6|Overall Study|Investigator Request|0
5994199|NCT00960531|20726996|P5|Overall Study|Investigator Request|0
5994200|NCT00960531|20726997|P4|Overall Study|Investigator Request|0
5994201|NCT00960531|20726998|P3|Overall Study|Investigator Request|1
5994202|NCT00960531|20726999|P2|Overall Study|Investigator Request|0
5994203|NCT00960531|20727000|P1|Overall Study|Investigator Request|0
5994204|NCT00960531|20726991|P10|Overall Study|Caregiver Request|0
5994205|NCT00960531|20726992|P9|Overall Study|Caregiver Request|3
5994206|NCT00960531|20726993|P8|Overall Study|Caregiver Request|1
5994207|NCT00960531|20726994|P7|Overall Study|Caregiver Request|3
5994208|NCT00960531|20726995|P6|Overall Study|Caregiver Request|2
5994209|NCT00960531|20726996|P5|Overall Study|Caregiver Request|0
5994210|NCT00960531|20726997|P4|Overall Study|Caregiver Request|5
5994211|NCT00960531|20726998|P3|Overall Study|Caregiver Request|6
5994212|NCT00960531|20726999|P2|Overall Study|Caregiver Request|0
5994213|NCT00960531|20727000|P1|Overall Study|Caregiver Request|2
5994214|NCT00960531|20726991|P10|Overall Study|Withdrawal by Subject|0
5994215|NCT00960531|20726992|P9|Overall Study|Withdrawal by Subject|1
5994216|NCT00960531|20726993|P8|Overall Study|Withdrawal by Subject|0
5994217|NCT00960531|20726994|P7|Overall Study|Withdrawal by Subject|2
5994218|NCT00960531|20726995|P6|Overall Study|Withdrawal by Subject|0
5994219|NCT00960531|20726996|P5|Overall Study|Withdrawal by Subject|0
5994220|NCT00960531|20726997|P4|Overall Study|Withdrawal by Subject|2
5994221|NCT00960531|20726998|P3|Overall Study|Withdrawal by Subject|5
5994222|NCT00960531|20726999|P2|Overall Study|Withdrawal by Subject|0
5994223|NCT00960531|20727000|P1|Overall Study|Withdrawal by Subject|1
5994224|NCT00960531|20726991|P10|Overall Study|Lack of Efficacy|0
5994225|NCT00960531|20726992|P9|Overall Study|Lack of Efficacy|0
5994226|NCT00960531|20726993|P8|Overall Study|Lack of Efficacy|0
5994227|NCT00960531|20726994|P7|Overall Study|Lack of Efficacy|0
5994228|NCT00960531|20726995|P6|Overall Study|Lack of Efficacy|0
5994229|NCT00960531|20726996|P5|Overall Study|Lack of Efficacy|0
5994230|NCT00960531|20726997|P4|Overall Study|Lack of Efficacy|0
5994231|NCT00960531|20726998|P3|Overall Study|Lack of Efficacy|0
5994232|NCT00960531|20726999|P2|Overall Study|Lack of Efficacy|0
5994233|NCT00960531|20727000|P1|Overall Study|Lack of Efficacy|1
5994234|NCT00960440|20727082|P4|Overall Study|Other|0
5994235|NCT00960440|20727083|P3|Overall Study|Other|1
5994236|NCT00960440|20727084|P2|Overall Study|Other|1
5994237|NCT00960440|20727085|P1|Overall Study|Other|1
5994238|NCT00960440|20727082|P4|Overall Study|Withdrawal by Subject|1
5994239|NCT00960440|20727083|P3|Overall Study|Withdrawal by Subject|2
5994240|NCT00960440|20727084|P2|Overall Study|Withdrawal by Subject|5
5994241|NCT00960440|20727085|P1|Overall Study|Withdrawal by Subject|9
5994242|NCT00960440|20727082|P4|Overall Study|Protocol Violation|4
5994243|NCT00960440|20727083|P3|Overall Study|Protocol Violation|3
5994244|NCT00960440|20727084|P2|Overall Study|Protocol Violation|8
5994245|NCT00960440|20727085|P1|Overall Study|Protocol Violation|2
5994246|NCT00960440|20727082|P4|Overall Study|Lack of Efficacy|8
5994247|NCT00960440|20727083|P3|Overall Study|Lack of Efficacy|3
5994248|NCT00960440|20727084|P2|Overall Study|Lack of Efficacy|5
5994249|NCT00960440|20727085|P1|Overall Study|Lack of Efficacy|2
5994250|NCT00960440|20727082|P4|Overall Study|Adverse Event|4
5994251|NCT00960440|20727083|P3|Overall Study|Adverse Event|4
5994252|NCT00960440|20727084|P2|Overall Study|Adverse Event|12
5994253|NCT00960440|20727085|P1|Overall Study|Adverse Event|12
5994254|NCT00960440|20727082|P4|Overall Study|Death|1
5994255|NCT00960440|20727083|P3|Overall Study|Death|0
5994256|NCT00960440|20727084|P2|Overall Study|Death|0
5994257|NCT00960440|20727085|P1|Overall Study|Death|0
5994258|NCT00960375|20727257|P2|Overall Study|Lost to Follow-up|22
5994259|NCT00960375|20727258|P1|Overall Study|Lost to Follow-up|20
5994260|NCT00960323|20727266|P1|Atorvastatin Alone|Withdrawal by Subject|1
5994261|NCT00960297|20727277|P1|Overall Study|Disease progression|1
5994262|NCT00960297|20727277|P1|Overall Study|Venous port infection|1
5994263|NCT00960297|20727277|P1|Overall Study|Physician Decision|1
5994264|NCT00960206|20727284|P3|Overall Study|Missing 10 year data|1
5994265|NCT00960206|20727285|P2|Overall Study|Missing 10 year data|1
5994266|NCT00960206|20727286|P1|Overall Study|Missing 10 year data|20
5994267|NCT00960206|20727284|P3|Overall Study|Revision of study component|2
5994268|NCT00960206|20727285|P2|Overall Study|Revision of study component|2
5994269|NCT00960206|20727286|P1|Overall Study|Revision of study component|2
5994270|NCT00960206|20727284|P3|Overall Study|Withdrawal by Subject|0
5994271|NCT00960206|20727285|P2|Overall Study|Withdrawal by Subject|4
5994272|NCT00960206|20727286|P1|Overall Study|Withdrawal by Subject|2
5994273|NCT00960206|20727284|P3|Overall Study|Lost to Follow-up|8
5994274|NCT00960206|20727285|P2|Overall Study|Lost to Follow-up|14
5994275|NCT00960206|20727286|P1|Overall Study|Lost to Follow-up|8
5994276|NCT00960206|20727284|P3|Overall Study|Unwilling/Unable to return|0
5994277|NCT00960206|20727285|P2|Overall Study|Unwilling/Unable to return|2
5994278|NCT00960206|20727286|P1|Overall Study|Unwilling/Unable to return|1
5994279|NCT00960206|20727284|P3|Overall Study|Death|1
5994280|NCT00960206|20727285|P2|Overall Study|Death|4
5994281|NCT00960206|20727286|P1|Overall Study|Death|7
5994282|NCT00960193|20727304|P1|14 Day Washout Period|Withdrawal by Subject|1
5994283|NCT00960154|20727317|P2|Overall Study|Study termination|25
5994284|NCT00960154|20727318|P1|Overall Study|Study termination|25
5994285|NCT00960141|20727329|P3|Overall Study|Withdrawal by Subject|1
5994286|NCT00960141|20727330|P2|Overall Study|Withdrawal by Subject|2
5994287|NCT00960141|20727331|P1|Overall Study|Withdrawal by Subject|1
5994288|NCT00960141|20727329|P3|Overall Study|Protocol Violation|2
5994289|NCT00960141|20727330|P2|Overall Study|Protocol Violation|3
5994290|NCT00960141|20727331|P1|Overall Study|Protocol Violation|1
5994291|NCT00960141|20727329|P3|Overall Study|Lost to Follow-up|0
5994292|NCT00960141|20727330|P2|Overall Study|Lost to Follow-up|0
5994293|NCT00960141|20727331|P1|Overall Study|Lost to Follow-up|1
5994294|NCT00960141|20727329|P3|Overall Study|Lack of Efficacy|2
5994295|NCT00960141|20727330|P2|Overall Study|Lack of Efficacy|4
5994296|NCT00960141|20727331|P1|Overall Study|Lack of Efficacy|3
5994297|NCT00960141|20727329|P3|Overall Study|Adverse Event|2
5994298|NCT00960141|20727330|P2|Overall Study|Adverse Event|8
5994299|NCT00960141|20727331|P1|Overall Study|Adverse Event|4
5994300|NCT00960115|20727356|P2|Overall Study|Ongoing treatment at data cut-off date|15
5994301|NCT00960115|20727357|P1|Overall Study|Ongoing treatment at data cut-off date|19
5994302|NCT00960076|20727371|P2|Overall Study|Did not attend the termination visit|1
5994303|NCT00960076|20727372|P1|Overall Study|Did not attend the termination visit|0
5994304|NCT00960076|20727371|P2|Overall Study|Hyperglycemia|5
5994305|NCT00960076|20727372|P1|Overall Study|Hyperglycemia|1
5994306|NCT00960076|20727371|P2|Overall Study|Severe non-compliance to protocol|2
5994307|NCT00960076|20727372|P1|Overall Study|Severe non-compliance to protocol|1
5994308|NCT00960076|20727371|P2|Overall Study|Lost to Follow-up|3
5994309|NCT00960076|20727372|P1|Overall Study|Lost to Follow-up|3
5994310|NCT00960076|20727371|P2|Overall Study|Withdrawal by Subject|2
5994311|NCT00960076|20727372|P1|Overall Study|Withdrawal by Subject|1
5994312|NCT00960076|20727371|P2|Overall Study|No longer met study criteria|5
5994313|NCT00960076|20727372|P1|Overall Study|No longer met study criteria|1
5994314|NCT00960076|20727371|P2|Overall Study|Adverse Event|7
5994315|NCT00960076|20727372|P1|Overall Study|Adverse Event|1
5994316|NCT00960063|20727387|P3|Overall Study|Progression of Disease|3
5994317|NCT00960063|20727388|P2|Overall Study|Progression of Disease|0
5994318|NCT00960063|20727389|P1|Overall Study|Progression of Disease|0
5994319|NCT00960063|20727387|P3|Overall Study|Adverse Event|0
5994320|NCT00960063|20727388|P2|Overall Study|Adverse Event|0
5994321|NCT00960063|20727389|P1|Overall Study|Adverse Event|1
5994322|NCT00960011|20727429|P2|Overall Study|Lost to Follow-up|2
5994323|NCT00960011|20727430|P1|Overall Study|Lost to Follow-up|6
5994324|NCT00960011|20727429|P2|Overall Study|Death|0
5994325|NCT00960011|20727430|P1|Overall Study|Death|5
5994326|NCT00959946|20727523|P8|Overall Study|Withdrawal by Subject|0
5994327|NCT00959946|20727524|P7|Overall Study|Withdrawal by Subject|0
5994328|NCT00959946|20727525|P6|Overall Study|Withdrawal by Subject|1
5994329|NCT00959946|20727526|P5|Overall Study|Withdrawal by Subject|0
5994330|NCT00959946|20727527|P4|Overall Study|Withdrawal by Subject|0
5994331|NCT00959946|20727528|P3|Overall Study|Withdrawal by Subject|0
5994332|NCT00959946|20727529|P2|Overall Study|Withdrawal by Subject|0
5994333|NCT00959946|20727530|P1|Overall Study|Withdrawal by Subject|0
5994334|NCT00959946|20727523|P8|Overall Study|Disease Progression|2
5994335|NCT00959946|20727524|P7|Overall Study|Disease Progression|2
5994336|NCT00959946|20727525|P6|Overall Study|Disease Progression|6
5994337|NCT00959946|20727526|P5|Overall Study|Disease Progression|4
5994338|NCT00959946|20727527|P4|Overall Study|Disease Progression|4
5994339|NCT00959946|20727528|P3|Overall Study|Disease Progression|2
5994340|NCT00959946|20727529|P2|Overall Study|Disease Progression|4
5994341|NCT00959946|20727530|P1|Overall Study|Disease Progression|2
5994342|NCT00959946|20727523|P8|Overall Study|Death|0
5994343|NCT00959946|20727524|P7|Overall Study|Death|0
5994344|NCT00959946|20727525|P6|Overall Study|Death|1
5994345|NCT00959946|20727526|P5|Overall Study|Death|0
5994346|NCT00959946|20727527|P4|Overall Study|Death|0
5994347|NCT00959946|20727528|P3|Overall Study|Death|0
5994348|NCT00959946|20727529|P2|Overall Study|Death|0
5994349|NCT00959946|20727530|P1|Overall Study|Death|0
5994350|NCT00959946|20727523|P8|Overall Study|Adverse Event|0
5994351|NCT00959946|20727524|P7|Overall Study|Adverse Event|0
5994352|NCT00959946|20727525|P6|Overall Study|Adverse Event|1
5994353|NCT00959946|20727526|P5|Overall Study|Adverse Event|0
5994354|NCT00959946|20727527|P4|Overall Study|Adverse Event|1
5994355|NCT00959946|20727528|P3|Overall Study|Adverse Event|2
5994356|NCT00959946|20727529|P2|Overall Study|Adverse Event|0
5994357|NCT00959946|20727530|P1|Overall Study|Adverse Event|0
5994358|NCT00959907|20727594|P2|Overall Study|Withdrawal by Subject|0
5994359|NCT00959907|20727595|P1|Overall Study|Withdrawal by Subject|2
5994360|NCT00959907|20727594|P2|Overall Study|Adverse Event|0
5994361|NCT00959907|20727595|P1|Overall Study|Adverse Event|1
5994362|NCT00959907|20727594|P2|Overall Study|Protocol Violation|1
5994363|NCT00959907|20727595|P1|Overall Study|Protocol Violation|0
5994364|NCT00959894|20727605|P1|Overall Study|Subject moved out of town|1
5994365|NCT00959894|20727605|P1|Overall Study|Need for contraindicated medication|1
5994366|NCT00959894|20727605|P1|Overall Study|Withdrawal by Subject|1
5994367|NCT00959894|20727605|P1|Overall Study|Adverse Event|3
5994368|NCT00959894|20727605|P1|Overall Study|Lost to Follow-up|10
5994369|NCT00959751|20727654|P2|Overall Study|No migraine headache without aura|7
5994370|NCT00959751|20727655|P1|Overall Study|No migraine headache without aura|7
5994371|NCT00959751|20727654|P2|Overall Study|Non-compliance to Study Procedures|1
5994372|NCT00959751|20727655|P1|Overall Study|Non-compliance to Study Procedures|0
5994373|NCT00959751|20727654|P2|Overall Study|Consent Withdrawn|1
5994374|NCT00959751|20727655|P1|Overall Study|Consent Withdrawn|0
5994375|NCT00959751|20727654|P2|Overall Study|Lost to Follow-up|3
5994376|NCT00959751|20727655|P1|Overall Study|Lost to Follow-up|2
5994377|NCT00959699|20727677|P2|Follow-up Period|Withdrawal by Subject|4
5994378|NCT00959699|20727678|P1|Follow-up Period|Withdrawal by Subject|3
5994379|NCT00959699|20727677|P2|Follow-up Period|Lost to Follow-up|2
5994380|NCT00959699|20727678|P1|Follow-up Period|Lost to Follow-up|3
5994381|NCT00959699|20727677|P2|Treatment Period|Futility/crossover to boceprevir|0
5994382|NCT00959699|20727678|P1|Treatment Period|Futility/crossover to boceprevir|4
5994383|NCT00959699|20727677|P2|Treatment Period|Did not receive treatment|1
5994384|NCT00959699|20727678|P1|Treatment Period|Did not receive treatment|0
5994385|NCT00959699|20727677|P2|Treatment Period|Non-Compliance with Protocol|1
5994386|NCT00959699|20727678|P1|Treatment Period|Non-Compliance with Protocol|0
5994387|NCT00959699|20727677|P2|Treatment Period|Withdrawal by Subject|3
5994388|NCT00959699|20727678|P1|Treatment Period|Withdrawal by Subject|1
5994389|NCT00959699|20727677|P2|Treatment Period|Lost to Follow-up|1
5994390|NCT00959699|20727678|P1|Treatment Period|Lost to Follow-up|0
5994391|NCT00959699|20727677|P2|Treatment Period|Lack of Efficacy|6
5994392|NCT00959699|20727678|P1|Treatment Period|Lack of Efficacy|15
5994393|NCT00959699|20727677|P2|Treatment Period|Adverse Event|13
5994394|NCT00959699|20727678|P1|Treatment Period|Adverse Event|3
5994395|NCT00959647|20727724|P1|Overall Study|Withdrawal by Subject|7
5994396|NCT00959647|20727724|P1|Overall Study|Study terminated by sponsor|4
5994397|NCT00959647|20727724|P1|Overall Study|Progressive disease|6
5994398|NCT00959647|20727724|P1|Overall Study|Adverse Event|2
5994399|NCT00959374|20727729|P1|Overall Study|Physician Decision|1
5994400|NCT00959374|20727729|P1|Overall Study|Implant Removed/Not Replaced|4
5994401|NCT00959374|20727729|P1|Overall Study|Protocol Violation|1
5994402|NCT00959374|20727729|P1|Overall Study|Death|1
5994403|NCT00959374|20727729|P1|Overall Study|Lost to Follow-up|14
5994404|NCT00959374|20727729|P1|Overall Study|Withdrawal by Subject|2
5994405|NCT00959192|20727743|P4|Overall Study|Caregiver Request|1
5994406|NCT00959192|20727744|P3|Overall Study|Caregiver Request|2
5994407|NCT00959192|20727745|P2|Overall Study|Caregiver Request|0
5994408|NCT00959192|20727746|P1|Overall Study|Caregiver Request|0
5994409|NCT00959192|20727743|P4|Overall Study|Investigator Request|0
5994410|NCT00959192|20727744|P3|Overall Study|Investigator Request|0
5994411|NCT00959192|20727745|P2|Overall Study|Investigator Request|0
5994412|NCT00959192|20727746|P1|Overall Study|Investigator Request|1
5994413|NCT00959192|20727743|P4|Overall Study|Adverse Event|0
5994414|NCT00959192|20727744|P3|Overall Study|Adverse Event|1
5994415|NCT00959192|20727745|P2|Overall Study|Adverse Event|1
5994416|NCT00959192|20727746|P1|Overall Study|Adverse Event|1
5994417|NCT00959049|20727805|P6|Overall Study|Withdrawal by Subject|0
5994418|NCT00959049|20727806|P5|Overall Study|Withdrawal by Subject|0
5994419|NCT00959049|20727807|P4|Overall Study|Withdrawal by Subject|0
5994420|NCT00959049|20727808|P3|Overall Study|Withdrawal by Subject|0
5994421|NCT00959049|20727809|P2|Overall Study|Withdrawal by Subject|2
5994422|NCT00959049|20727810|P1|Overall Study|Withdrawal by Subject|0
5994423|NCT00959049|20727805|P6|Overall Study|Contraindicated medication|0
5994424|NCT00959049|20727806|P5|Overall Study|Contraindicated medication|0
5994425|NCT00959049|20727807|P4|Overall Study|Contraindicated medication|1
5994426|NCT00959049|20727808|P3|Overall Study|Contraindicated medication|0
5994427|NCT00959049|20727809|P2|Overall Study|Contraindicated medication|0
5994428|NCT00959049|20727810|P1|Overall Study|Contraindicated medication|0
5994429|NCT00959049|20727805|P6|Overall Study|Lost to Follow-up|1
5994430|NCT00959049|20727806|P5|Overall Study|Lost to Follow-up|9
5994431|NCT00959049|20727807|P4|Overall Study|Lost to Follow-up|10
5994432|NCT00959049|20727808|P3|Overall Study|Lost to Follow-up|1
5994433|NCT00959049|20727809|P2|Overall Study|Lost to Follow-up|5
5994434|NCT00959049|20727810|P1|Overall Study|Lost to Follow-up|17
5994435|NCT00959049|20727805|P6|Overall Study|Adverse Event|0
5994436|NCT00959049|20727806|P5|Overall Study|Adverse Event|0
5994437|NCT00959049|20727807|P4|Overall Study|Adverse Event|0
5994438|NCT00959049|20727808|P3|Overall Study|Adverse Event|0
5994439|NCT00959049|20727809|P2|Overall Study|Adverse Event|0
5994440|NCT00959049|20727810|P1|Overall Study|Adverse Event|1
5994441|NCT00958893|20727875|P1|Overall Study|Study prematurely terminated|4
5994442|NCT00958880|20727881|P2|Overall Study|Lost to Follow-up|2
5994443|NCT00958880|20727882|P1|Overall Study|Lost to Follow-up|2
5994444|NCT00958841|20727890|P1|Overall Study|Discontinued prior to M*|28
5994445|NCT00958841|20727890|P1|Overall Study|Completed M6/did not enter extension|27
5994446|NCT00958841|20727890|P1|Overall Study|Unsatisfactory therapeutic effect|22
5994447|NCT00958841|20727890|P1|Overall Study|Withdrawal by Subject|1
5994448|NCT00958841|20727890|P1|Overall Study|New cancer therapy|5
5994449|NCT00958841|20727890|P1|Overall Study|Adverse Event|8
5994450|NCT00958841|20727890|P1|Overall Study|Administrative problems|1
5994451|NCT00958841|20727890|P1|Overall Study|Abnormal test procedure result(s)|3
5994452|NCT00958841|20727890|P1|Overall Study|Abnormal laboratory value(s)|1
5994453|NCT00958828|20727908|P2|Period 2, 1 Week of Wear|Unacceptable lens fit|1
5994454|NCT00958828|20727909|P1|Period 2, 1 Week of Wear|Unacceptable lens fit|0
5994455|NCT00958828|20727908|P2|Period 1, 1 Week of Wear|Randomization break|1
5994456|NCT00958828|20727909|P1|Period 1, 1 Week of Wear|Randomization break|0
5994457|NCT00958789|20727915|P1|Overall Study|Revision|7
5994458|NCT00958789|20727915|P1|Overall Study|Subject terminated|2
5994459|NCT00958789|20727915|P1|Overall Study|2 yr. Knee Society Score not calculable|1
5994460|NCT00958789|20727915|P1|Overall Study|No 2 yr. Knee Society Score data|4
5994461|NCT00958789|20727915|P1|Overall Study|Withdrawal by Subject|17
5994462|NCT00958789|20727915|P1|Overall Study|Lost to Follow-up|14
5994463|NCT00958789|20727915|P1|Overall Study|Death|5
5994464|NCT00958776|20727935|P2|Overall Study|Missing|1
5994465|NCT00958776|20727936|P1|Overall Study|Missing|1
5994466|NCT00958776|20727935|P2|Overall Study|Noncompliance; Protocol Deviations|3
5994467|NCT00958776|20727936|P1|Overall Study|Noncompliance; Protocol Deviations|2
5994468|NCT00958776|20727935|P2|Overall Study|Death|1
5994469|NCT00958776|20727936|P1|Overall Study|Death|2
5994470|NCT00958776|20727935|P2|Overall Study|Protocol Violation|1
5994471|NCT00958776|20727936|P1|Overall Study|Protocol Violation|1
5994472|NCT00958776|20727935|P2|Overall Study|Withdrawal by Subject|16
5994473|NCT00958776|20727936|P1|Overall Study|Withdrawal by Subject|7
5994474|NCT00958776|20727935|P2|Overall Study|Lost to Follow-up|6
5994475|NCT00958776|20727936|P1|Overall Study|Lost to Follow-up|2
5994476|NCT00958776|20727935|P2|Overall Study|Physician Decision|0
5994477|NCT00958776|20727936|P1|Overall Study|Physician Decision|1
5994478|NCT00958776|20727935|P2|Overall Study|Adverse Event|1
5994479|NCT00958776|20727936|P1|Overall Study|Adverse Event|0
5994480|NCT00958724|20727966|P1|Overall Study|Disease Progression|6
5994481|NCT00958711|20727978|P2|Overall Study|Adverse Event|2
5994482|NCT00958711|20727979|P1|Overall Study|Adverse Event|1
5994483|NCT00958711|20727978|P2|Overall Study|Death|2
5994484|NCT00958711|20727979|P1|Overall Study|Death|1
5994485|NCT00958711|20727978|P2|Overall Study|Other|5
5994486|NCT00958711|20727979|P1|Overall Study|Other|2
5994487|NCT00958711|20727978|P2|Overall Study|Lost to Follow-up|1
5994488|NCT00958711|20727979|P1|Overall Study|Lost to Follow-up|4
5994489|NCT00958711|20727978|P2|Overall Study|Physician Decision|7
5994490|NCT00958711|20727979|P1|Overall Study|Physician Decision|5
5994491|NCT00958711|20727978|P2|Overall Study|Withdrawal by Subject|4
5994492|NCT00958711|20727979|P1|Overall Study|Withdrawal by Subject|0
5994493|NCT00958568|20728024|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0
5994494|NCT00958568|20728025|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|1
5994495|NCT00958568|20728026|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0
5994496|NCT00958568|20728027|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0
5994497|NCT00958568|20728024|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0
5994498|NCT00958568|20728025|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Death|1
5994499|NCT00958568|20728026|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0
5994500|NCT00958568|20728027|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0
5994501|NCT00958568|20728024|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|1
5994502|NCT00958568|20728025|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|2
5994503|NCT00958568|20728026|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0
5994504|NCT00958568|20728027|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0
5994505|NCT00958568|20728024|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|4
5994506|NCT00958568|20728025|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|5
5994507|NCT00958568|20728026|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0
5994508|NCT00958568|20728027|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0
5994509|NCT00958568|20728024|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|8
5994510|NCT00958568|20728025|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|3
5994511|NCT00958568|20728026|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0
5994512|NCT00958568|20728027|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0
5994513|NCT00958568|20728024|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|5
5994514|NCT00958568|20728025|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|11
5994515|NCT00958568|20728026|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0
5994516|NCT00958568|20728027|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0
5994517|NCT00958568|20728024|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|15
5994518|NCT00958568|20728025|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|16
5994519|NCT00958568|20728026|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0
5994520|NCT00958568|20728027|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0
5994521|NCT00958568|20728024|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|10
5994522|NCT00958568|20728025|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|19
5994523|NCT00958568|20728026|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0
5994524|NCT00958568|20728027|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0
5994525|NCT00958568|20728024|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|63
5994526|NCT00958568|20728025|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|24
5994527|NCT00958568|20728026|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0
5994528|NCT00958568|20728027|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0
5994529|NCT00958568|20728024|P4|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0
5994530|NCT00958568|20728025|P3|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0
5994531|NCT00958568|20728026|P2|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|1
5994532|NCT00958568|20728027|P1|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0
5994533|NCT00958568|20728024|P4|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0
5994534|NCT00958568|20728025|P3|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0
5994535|NCT00958568|20728026|P2|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|1
5994536|NCT00958568|20728027|P1|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0
5994537|NCT00958568|20728024|P4|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0
5994538|NCT00958568|20728025|P3|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0
5994539|NCT00958568|20728026|P2|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|4
5994540|NCT00958568|20728027|P1|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0
5994541|NCT00958568|20728024|P4|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0
5994542|NCT00958568|20728025|P3|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0
5994543|NCT00958568|20728026|P2|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|5
5994544|NCT00958568|20728027|P1|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0
5994545|NCT00958568|20728024|P4|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0
5994546|NCT00958568|20728025|P3|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0
5994547|NCT00958568|20728026|P2|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|6
5994548|NCT00958568|20728027|P1|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0
5994549|NCT00958568|20728024|P4|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0
5994550|NCT00958568|20728025|P3|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0
5994551|NCT00958568|20728026|P2|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|9
5994552|NCT00958568|20728027|P1|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0
5994553|NCT00958568|20728024|P4|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0
5994554|NCT00958568|20728025|P3|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0
5994555|NCT00958568|20728026|P2|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|24
5994556|NCT00958568|20728027|P1|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0
5994557|NCT00958568|20728024|P4|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0
5994558|NCT00958568|20728025|P3|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0
5994559|NCT00958568|20728026|P2|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|41
5994560|NCT00958568|20728027|P1|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0
5994561|NCT00958568|20728024|P4|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0
5994562|NCT00958568|20728025|P3|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0
5994563|NCT00958568|20728026|P2|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|28
5994564|NCT00958568|20728027|P1|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0
5994565|NCT00958568|20728024|P4|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0
5994566|NCT00958568|20728025|P3|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0
5994645|NCT00958243|20728364|P6|Overall Study|Withdrawal by Subject|5
5994567|NCT00958568|20728026|P2|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|30
5994568|NCT00958568|20728027|P1|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0
5994569|NCT00958568|20728024|P4|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0
5994570|NCT00958568|20728025|P3|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0
5994571|NCT00958568|20728026|P2|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|62
5994572|NCT00958568|20728027|P1|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0
5994573|NCT00958568|20728024|P4|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0
5994574|NCT00958568|20728025|P3|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0
5994575|NCT00958568|20728026|P2|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0
5994576|NCT00958568|20728027|P1|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|1
5994577|NCT00958568|20728024|P4|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0
5994578|NCT00958568|20728025|P3|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0
5994579|NCT00958568|20728026|P2|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0
5994580|NCT00958568|20728027|P1|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|8
5994581|NCT00958568|20728024|P4|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0
5994582|NCT00958568|20728025|P3|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0
5994583|NCT00958568|20728026|P2|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0
5994584|NCT00958568|20728027|P1|SPII (Wk 0-8, Acute Open-label)|Physician Decision|4
5994585|NCT00958568|20728024|P4|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0
5994586|NCT00958568|20728025|P3|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0
5994587|NCT00958568|20728026|P2|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0
5994588|NCT00958568|20728027|P1|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|13
5994589|NCT00958568|20728024|P4|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0
5994590|NCT00958568|20728025|P3|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0
5994591|NCT00958568|20728026|P2|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0
5994592|NCT00958568|20728027|P1|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|14
5994593|NCT00958568|20728024|P4|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0
5994594|NCT00958568|20728025|P3|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0
5994595|NCT00958568|20728026|P2|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0
5994596|NCT00958568|20728027|P1|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|39
5994597|NCT00958568|20728024|P4|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0
5994598|NCT00958568|20728025|P3|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0
5994599|NCT00958568|20728026|P2|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0
5994600|NCT00958568|20728027|P1|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|34
5994601|NCT00958568|20728024|P4|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0
5994602|NCT00958568|20728025|P3|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0
5994603|NCT00958568|20728026|P2|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0
5994604|NCT00958568|20728027|P1|SPII (Wk 0-8, Acute Open-label)|Adverse Event|44
5994605|NCT00958568|20728024|P4|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0
5994606|NCT00958568|20728025|P3|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0
5994607|NCT00958568|20728026|P2|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0
5994608|NCT00958568|20728027|P1|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|80
5994609|NCT00958438|20728264|P3|Overall Study|Other than specified above|2
5994610|NCT00958438|20728265|P2|Overall Study|Other than specified above|3
5994611|NCT00958438|20728266|P1|Overall Study|Other than specified above|2
5994612|NCT00958438|20728264|P3|Overall Study|Physician Decision|1
5994613|NCT00958438|20728265|P2|Overall Study|Physician Decision|0
5994614|NCT00958438|20728266|P1|Overall Study|Physician Decision|1
5994615|NCT00958438|20728264|P3|Overall Study|Adverse Event|0
5994616|NCT00958438|20728265|P2|Overall Study|Adverse Event|3
5994617|NCT00958438|20728266|P1|Overall Study|Adverse Event|0
5994618|NCT00958438|20728264|P3|Overall Study|Withdrawal by Subject|1
5994619|NCT00958438|20728265|P2|Overall Study|Withdrawal by Subject|2
5994620|NCT00958438|20728266|P1|Overall Study|Withdrawal by Subject|4
5994621|NCT00958438|20728264|P3|Overall Study|Protocol Violation|2
5994622|NCT00958438|20728265|P2|Overall Study|Protocol Violation|2
5994623|NCT00958438|20728266|P1|Overall Study|Protocol Violation|3
5994624|NCT00958412|20728289|P1|Overall Study|Study prematurely terminated|18
5994625|NCT00958360|20728295|P2|Overall Study|Lost to Follow-up|1
5994626|NCT00958360|20728296|P1|Overall Study|Lost to Follow-up|0
5994627|NCT00958360|20728295|P2|Overall Study|Physician Decision|1
5994628|NCT00958360|20728296|P1|Overall Study|Physician Decision|2
5994629|NCT00958360|20728295|P2|Overall Study|Death|7
5994630|NCT00958360|20728296|P1|Overall Study|Death|6
5994631|NCT00958360|20728295|P2|Overall Study|Withdrawal by Subject|1
5994632|NCT00958360|20728296|P1|Overall Study|Withdrawal by Subject|3
5994633|NCT00958347|20728310|P1|Overall Study|study termination|135
5994634|NCT00958347|20728310|P1|Overall Study|revision/removal|10
5994635|NCT00958347|20728310|P1|Overall Study|Lost to Follow-up|15
5994636|NCT00958347|20728310|P1|Overall Study|Withdrawal by Subject|23
5994637|NCT00958347|20728310|P1|Overall Study|Death|43
5994638|NCT00958256|20728354|P1|Overall Study|Adverse Event|3
5994639|NCT00958243|20728364|P6|Overall Study|Lost to Follow-up|5
5994640|NCT00958243|20728365|P5|Overall Study|Lost to Follow-up|8
5994641|NCT00958243|20728366|P4|Overall Study|Lost to Follow-up|2
5994642|NCT00958243|20728367|P3|Overall Study|Lost to Follow-up|11
5994643|NCT00958243|20728368|P2|Overall Study|Lost to Follow-up|5
5994644|NCT00958243|20728369|P1|Overall Study|Lost to Follow-up|2
5994646|NCT00958243|20728365|P5|Overall Study|Withdrawal by Subject|1
5994647|NCT00958243|20728366|P4|Overall Study|Withdrawal by Subject|1
5994648|NCT00958243|20728367|P3|Overall Study|Withdrawal by Subject|3
5994649|NCT00958243|20728368|P2|Overall Study|Withdrawal by Subject|1
5994650|NCT00958243|20728369|P1|Overall Study|Withdrawal by Subject|0
5994651|NCT00958217|20728427|P2|Overall Study|Inpatient hospitalization|1
5994652|NCT00958217|20728428|P1|Overall Study|Inpatient hospitalization|0
5994653|NCT00958217|20728427|P2|Overall Study|Moved out of area|1
5994654|NCT00958217|20728428|P1|Overall Study|Moved out of area|1
5994655|NCT00958217|20728427|P2|Overall Study|Lost to Follow-up|19
5994656|NCT00958217|20728428|P1|Overall Study|Lost to Follow-up|17
5994657|NCT00958217|20728427|P2|Overall Study|Withdrawal by Subject|3
5994658|NCT00958217|20728428|P1|Overall Study|Withdrawal by Subject|4
5994659|NCT00958217|20728427|P2|Overall Study|Death|1
5994660|NCT00958217|20728428|P1|Overall Study|Death|2
5994661|NCT00958191|20728439|P1|Overall Study|No 5 yr x-rays|56
5994662|NCT00958191|20728439|P1|Overall Study|Site termination|11
5994663|NCT00958191|20728439|P1|Overall Study|Revision of study device|4
5994664|NCT00958191|20728439|P1|Overall Study|Unable/Unwilling to Return/Withdrawal|21
5994665|NCT00958191|20728439|P1|Overall Study|Inadequate 5 yr x-ray quality|10
5994666|NCT00958191|20728439|P1|Overall Study|Lost to Follow-up|5
5994667|NCT00958191|20728439|P1|Overall Study|Death|4
5994668|NCT00958165|20728454|P1|Overall Study|Not eligible|9
5994669|NCT00958165|20728454|P1|Overall Study|Lost to Follow-up|5
5994670|NCT00958126|20728466|P8|Overall Study|Other Reason|0
5994671|NCT00958126|20728467|P7|Overall Study|Other Reason|0
5994672|NCT00958126|20728468|P6|Overall Study|Other Reason|1
5994673|NCT00958126|20728469|P5|Overall Study|Other Reason|0
5994674|NCT00958126|20728470|P4|Overall Study|Other Reason|1
5994675|NCT00958126|20728471|P3|Overall Study|Other Reason|0
5994676|NCT00958126|20728472|P2|Overall Study|Other Reason|0
5994677|NCT00958126|20728473|P1|Overall Study|Other Reason|0
5994678|NCT00958126|20728466|P8|Overall Study|Sponsor/Investigator decision|0
5994679|NCT00958126|20728467|P7|Overall Study|Sponsor/Investigator decision|0
5994680|NCT00958126|20728468|P6|Overall Study|Sponsor/Investigator decision|0
5994681|NCT00958126|20728469|P5|Overall Study|Sponsor/Investigator decision|0
5994682|NCT00958126|20728470|P4|Overall Study|Sponsor/Investigator decision|1
5994683|NCT00958126|20728471|P3|Overall Study|Sponsor/Investigator decision|0
5994684|NCT00958126|20728472|P2|Overall Study|Sponsor/Investigator decision|0
5994685|NCT00958126|20728473|P1|Overall Study|Sponsor/Investigator decision|0
5994686|NCT00958126|20728466|P8|Overall Study|Lost to Follow-up|0
5994687|NCT00958126|20728467|P7|Overall Study|Lost to Follow-up|0
5994688|NCT00958126|20728468|P6|Overall Study|Lost to Follow-up|0
5994689|NCT00958126|20728469|P5|Overall Study|Lost to Follow-up|0
5994690|NCT00958126|20728470|P4|Overall Study|Lost to Follow-up|8
5994691|NCT00958126|20728471|P3|Overall Study|Lost to Follow-up|9
5994692|NCT00958126|20728472|P2|Overall Study|Lost to Follow-up|5
5994693|NCT00958126|20728473|P1|Overall Study|Lost to Follow-up|1
5994694|NCT00958126|20728466|P8|Overall Study|Moved away from study area|0
5994695|NCT00958126|20728467|P7|Overall Study|Moved away from study area|0
5994696|NCT00958126|20728468|P6|Overall Study|Moved away from study area|0
5994697|NCT00958126|20728469|P5|Overall Study|Moved away from study area|0
5994698|NCT00958126|20728470|P4|Overall Study|Moved away from study area|1
5994699|NCT00958126|20728471|P3|Overall Study|Moved away from study area|1
5994700|NCT00958126|20728472|P2|Overall Study|Moved away from study area|0
5994701|NCT00958126|20728473|P1|Overall Study|Moved away from study area|0
5994702|NCT00958126|20728466|P8|Overall Study|Withdrawal by Subject|0
5994703|NCT00958126|20728467|P7|Overall Study|Withdrawal by Subject|0
5994704|NCT00958126|20728468|P6|Overall Study|Withdrawal by Subject|0
5994705|NCT00958126|20728469|P5|Overall Study|Withdrawal by Subject|0
5994706|NCT00958126|20728470|P4|Overall Study|Withdrawal by Subject|0
5994707|NCT00958126|20728471|P3|Overall Study|Withdrawal by Subject|0
5994708|NCT00958126|20728472|P2|Overall Study|Withdrawal by Subject|2
5994709|NCT00958126|20728473|P1|Overall Study|Withdrawal by Subject|0
5994710|NCT00958126|20728466|P8|Overall Study|Serious Adverse Event|0
5994711|NCT00958126|20728467|P7|Overall Study|Serious Adverse Event|1
5994712|NCT00958126|20728468|P6|Overall Study|Serious Adverse Event|0
5994713|NCT00958126|20728469|P5|Overall Study|Serious Adverse Event|0
5994714|NCT00958126|20728470|P4|Overall Study|Serious Adverse Event|0
5994715|NCT00958126|20728471|P3|Overall Study|Serious Adverse Event|0
5994716|NCT00958126|20728472|P2|Overall Study|Serious Adverse Event|2
5994717|NCT00958126|20728473|P1|Overall Study|Serious Adverse Event|0
5994718|NCT00958074|20728545|P2|Overall Study|Withdrawal by Subject|1
5994719|NCT00958074|20728546|P1|Overall Study|Withdrawal by Subject|0
5994720|NCT00958009|20728569|P1|Overall Study|Subject found device difficult to use|1
5994721|NCT00958009|20728569|P1|Overall Study|Adverse Event|1
5994722|NCT00957996|20728576|P2|Overall Study|Noncompliance; Protocol Deviations|6
5994723|NCT00957996|20728577|P1|Overall Study|Noncompliance; Protocol Deviations|5
5994724|NCT00957996|20728576|P2|Overall Study|Missing|0
5994725|NCT00957996|20728577|P1|Overall Study|Missing|1
5994726|NCT00957996|20728576|P2|Overall Study|Influenza-related complication|1
5994727|NCT00957996|20728577|P1|Overall Study|Influenza-related complication|0
5994728|NCT00957996|20728576|P2|Overall Study|Physician Decision|1
5994729|NCT00957996|20728577|P1|Overall Study|Physician Decision|1
5994730|NCT00957996|20728576|P2|Overall Study|Adverse Event|1
5994731|NCT00957996|20728577|P1|Overall Study|Adverse Event|2
5994732|NCT00957996|20728576|P2|Overall Study|Withdrawal by Subject|2
5994733|NCT00957996|20728577|P1|Overall Study|Withdrawal by Subject|9
5994734|NCT00957996|20728576|P2|Overall Study|Lost to Follow-up|7
5994735|NCT00957996|20728577|P1|Overall Study|Lost to Follow-up|4
5994736|NCT00957996|20728576|P2|Overall Study|Death|10
5994737|NCT00957996|20728577|P1|Overall Study|Death|4
5994738|NCT00957944|20728609|P2|First Intervention- 24 Hours|Withdrawal by Subject|1
5994739|NCT00957944|20728610|P1|First Intervention- 24 Hours|Withdrawal by Subject|0
5994740|NCT00957931|20728644|P1|Overall Study|Death|4
5994741|NCT00957905|20728654|P2|Part B|Protocol Violation|1
5994742|NCT00957905|20728655|P1|Part B|Protocol Violation|0
5994743|NCT00957905|20728654|P2|Part B|Death|1
5994744|NCT00957905|20728655|P1|Part B|Death|0
5994745|NCT00957905|20728654|P2|Part B|Physician Decision|1
5994746|NCT00957905|20728655|P1|Part B|Physician Decision|0
5994747|NCT00957905|20728654|P2|Part B|Not Treated|1
5994748|NCT00957905|20728655|P1|Part B|Not Treated|0
5994749|NCT00957853|20728664|P3|Overall Study|Withdrawal by Subject|0
5994750|NCT00957853|20728665|P2|Overall Study|Withdrawal by Subject|0
5994751|NCT00957853|20728666|P1|Overall Study|Withdrawal by Subject|1
5994752|NCT00957801|20728690|P4|Overall Study|Withdrawal by Subject|1
5994753|NCT00957801|20728691|P3|Overall Study|Withdrawal by Subject|0
5994754|NCT00957801|20728692|P2|Overall Study|Withdrawal by Subject|0
5994755|NCT00957801|20728693|P1|Overall Study|Withdrawal by Subject|0
5994756|NCT00957723|20728859|P1|Overall Study|2yr ROM Data Not Evaluable|12
5994757|NCT00957723|20728859|P1|Overall Study|Intercurrent Illness|2
5994758|NCT00957723|20728859|P1|Overall Study|Investigative Site Terminated|61
5994759|NCT00957723|20728859|P1|Overall Study|Withdrawal by Subject|24
5994760|NCT00957723|20728859|P1|Overall Study|Lost to Follow-up|8
5994761|NCT00957723|20728859|P1|Overall Study|Revision/ Removal of Study Implant|3
5994762|NCT00957723|20728859|P1|Overall Study|Death|3
5994763|NCT00957658|20728948|P1|Overall Study|Protocol Violation|5
5994764|NCT00957658|20728948|P1|Overall Study|surgery cancelled|2
5994765|NCT00957658|20728948|P1|Overall Study|unwilling/unable to return|2
5994766|NCT00957658|20728948|P1|Overall Study|Site termination|10
5994767|NCT00957658|20728948|P1|Overall Study|Incomplete 2 yr data|28
5994768|NCT00957658|20728948|P1|Overall Study|Revision|1
5994769|NCT00957658|20728948|P1|Overall Study|Withdrawal by Subject|12
5994770|NCT00957658|20728948|P1|Overall Study|Lost to Follow-up|4
5994771|NCT00957658|20728948|P1|Overall Study|Death|1
5994772|NCT00957580|20728975|P3|Overall Study|Enrolled but not treated|0
5994773|NCT00957580|20728976|P2|Overall Study|Enrolled but not treated|1
5994774|NCT00957580|20728977|P1|Overall Study|Enrolled but not treated|0
5994775|NCT00957580|20728975|P3|Overall Study|Ongoing at data cut-off|0
5994776|NCT00957580|20728976|P2|Overall Study|Ongoing at data cut-off|1
5994777|NCT00957580|20728977|P1|Overall Study|Ongoing at data cut-off|0
5994778|NCT00957528|20729124|P3|Overall Study|Withdrawal by Subject|1
5994779|NCT00957528|20729125|P2|Overall Study|Withdrawal by Subject|0
5994780|NCT00957528|20729126|P1|Overall Study|Withdrawal by Subject|0
5994781|NCT00957528|20729124|P3|Overall Study|Protocol Violation|0
5994782|NCT00957528|20729125|P2|Overall Study|Protocol Violation|1
5994783|NCT00957528|20729126|P1|Overall Study|Protocol Violation|0
5994784|NCT00957424|20729149|P1|Overall Study|Withdrawal by Subject|1
5994785|NCT00957424|20729149|P1|Overall Study|Protocol Violation|3
5994786|NCT00957424|20729149|P1|Overall Study|Lost to Follow-up|19
5994787|NCT00957372|20729159|P4|PART II|Patient non-compliance|4
5994788|NCT00957372|20729160|P3|PART II|Patient non-compliance|0
5994789|NCT00957372|20729161|P2|PART II|Patient non-compliance|0
5994790|NCT00957372|20729162|P1|PART II|Patient non-compliance|0
5994791|NCT00957372|20729159|P4|PART II|Adverse Event|10
5994792|NCT00957372|20729160|P3|PART II|Adverse Event|0
5994793|NCT00957372|20729161|P2|PART II|Adverse Event|0
5994794|NCT00957372|20729162|P1|PART II|Adverse Event|0
5994795|NCT00957372|20729159|P4|PART II|Not Know|20
5994796|NCT00957372|20729160|P3|PART II|Not Know|0
5994797|NCT00957372|20729161|P2|PART II|Not Know|0
5994798|NCT00957372|20729162|P1|PART II|Not Know|0
5994799|NCT00957372|20729159|P4|PART II|Pregnancy|1
5994800|NCT00957372|20729160|P3|PART II|Pregnancy|0
5994801|NCT00957372|20729161|P2|PART II|Pregnancy|0
5994802|NCT00957372|20729162|P1|PART II|Pregnancy|0
5994803|NCT00957372|20729159|P4|PART II|Physician Decision|1
5994804|NCT00957372|20729160|P3|PART II|Physician Decision|0
5994805|NCT00957372|20729161|P2|PART II|Physician Decision|0
5994806|NCT00957372|20729162|P1|PART II|Physician Decision|0
5994807|NCT00957372|20729159|P4|PART II|Withdrawal by Subject|8
5994808|NCT00957372|20729160|P3|PART II|Withdrawal by Subject|0
5994809|NCT00957372|20729161|P2|PART II|Withdrawal by Subject|0
5994810|NCT00957372|20729162|P1|PART II|Withdrawal by Subject|0
5994811|NCT00957372|20729159|P4|PART I|Lost to Follow-up|0
5994812|NCT00957372|20729160|P3|PART I|Lost to Follow-up|1
5994813|NCT00957372|20729161|P2|PART I|Lost to Follow-up|0
5994814|NCT00957372|20729162|P1|PART I|Lost to Follow-up|0
5994815|NCT00957268|20729302|P5|Overall Study|Voluntary Withdrawal|0
5994816|NCT00957268|20729303|P4|Overall Study|Voluntary Withdrawal|0
5994817|NCT00957268|20729304|P3|Overall Study|Voluntary Withdrawal|1
5994818|NCT00957268|20729305|P2|Overall Study|Voluntary Withdrawal|0
5994819|NCT00957268|20729306|P1|Overall Study|Voluntary Withdrawal|0
5994820|NCT00957229|20729401|P2|Reallocated to or Continued Vismodegib|Adverse Event|1
5994821|NCT00957229|20729402|P1|Reallocated to or Continued Vismodegib|Adverse Event|2
5994822|NCT00957229|20729401|P2|Reallocated to or Continued Vismodegib|Death|1
5994823|NCT00957229|20729402|P1|Reallocated to or Continued Vismodegib|Death|1
5994824|NCT00957229|20729401|P2|Study Start|Disease Progression|0
5994825|NCT00957229|20729402|P1|Study Start|Disease Progression|1
5994826|NCT00957229|20729401|P2|Study Start|Adverse Event|3
5994827|NCT00957229|20729402|P1|Study Start|Adverse Event|0
5994828|NCT00957034|20729441|P3|Overall Study|Withdrawal by Subject|0
5994829|NCT00957034|20729442|P2|Overall Study|Withdrawal by Subject|2
5994830|NCT00957034|20729443|P1|Overall Study|Withdrawal by Subject|0
5994831|NCT00957034|20729441|P3|Overall Study|Sponsor Terminated Study|5
5994832|NCT00957034|20729442|P2|Overall Study|Sponsor Terminated Study|1
5994833|NCT00957034|20729443|P1|Overall Study|Sponsor Terminated Study|6
5994834|NCT00957034|20729441|P3|Overall Study|Adverse Event|1
5994835|NCT00957034|20729442|P2|Overall Study|Adverse Event|1
5994836|NCT00957034|20729443|P1|Overall Study|Adverse Event|0
5994837|NCT00957021|20729466|P1|Overall Study|Termination due to language issue|2
5994838|NCT00957021|20729466|P1|Overall Study|Surgery Cancelled|9
5994839|NCT00957021|20729466|P1|Overall Study|Site Termination by the 2 yr visit|16
5994840|NCT00957021|20729466|P1|Overall Study|Revised study component by 2 yr visit|8
5994841|NCT00957021|20729466|P1|Overall Study|No 2 yr ROM data|35
5994842|NCT00957021|20729466|P1|Overall Study|Withdrawal by Subject|34
5994843|NCT00957021|20729466|P1|Overall Study|Lost to Follow-up|8
5994844|NCT00957021|20729466|P1|Overall Study|Death|5
5994845|NCT00957008|20729479|P4|Overall Study|Relocated; Family conflict|3
5994846|NCT00957008|20729480|P3|Overall Study|Relocated; Family conflict|1
5994847|NCT00957008|20729481|P2|Overall Study|Relocated; Family conflict|1
5994848|NCT00957008|20729482|P1|Overall Study|Relocated; Family conflict|4
5994849|NCT00957008|20729479|P4|Overall Study|Physician Decision|1
5994850|NCT00957008|20729480|P3|Overall Study|Physician Decision|1
5994851|NCT00957008|20729481|P2|Overall Study|Physician Decision|0
5994852|NCT00957008|20729482|P1|Overall Study|Physician Decision|1
5994853|NCT00957008|20729479|P4|Overall Study|Lost to Follow-up|4
5994854|NCT00957008|20729480|P3|Overall Study|Lost to Follow-up|3
5994855|NCT00957008|20729481|P2|Overall Study|Lost to Follow-up|1
5994856|NCT00957008|20729482|P1|Overall Study|Lost to Follow-up|3
5994857|NCT00957008|20729479|P4|Overall Study|Withdrawal by Subject|16
5994858|NCT00957008|20729480|P3|Overall Study|Withdrawal by Subject|12
5994859|NCT00957008|20729481|P2|Overall Study|Withdrawal by Subject|10
5994860|NCT00957008|20729482|P1|Overall Study|Withdrawal by Subject|13
5994861|NCT00956943|20729510|P2|Overall Study|Lost to Follow-up|10
5994862|NCT00956943|20729511|P1|Overall Study|Lost to Follow-up|9
5994863|NCT00956839|20729535|P3|Overall Study|Lost to Follow-up|3
5994864|NCT00956839|20729536|P2|Overall Study|Lost to Follow-up|0
5994865|NCT00956839|20729537|P1|Overall Study|Lost to Follow-up|3
5994866|NCT00956813|20729550|P2|Flaxseed and Placebo|Ineligible|1
5994867|NCT00956813|20729551|P1|Flaxseed and Placebo|Ineligible|3
5994868|NCT00956813|20729550|P2|Flaxseed and Placebo|Withdrawal by Subject|4
5994869|NCT00956813|20729551|P1|Flaxseed and Placebo|Withdrawal by Subject|5
5994870|NCT00956592|20729603|P2|Overall Study|Protocol Violation|3
5994871|NCT00956592|20729604|P1|Overall Study|Protocol Violation|1
5994872|NCT00956293|20729639|P3|Follow-up Period|Follow-up period was terminated.|0
5994873|NCT00956293|20729640|P2|Follow-up Period|Follow-up period was terminated.|32
5994874|NCT00956293|20729641|P1|Follow-up Period|Follow-up period was terminated.|20
5994875|NCT00956293|20729639|P3|Main Period (Randomization)|Adverse Event|0
5994876|NCT00956293|20729640|P2|Main Period (Randomization)|Adverse Event|15
5994877|NCT00956293|20729641|P1|Main Period (Randomization)|Adverse Event|0
5994878|NCT00956293|20729639|P3|Main Period (Randomization)|Lack of Efficacy|0
5994879|NCT00956293|20729640|P2|Main Period (Randomization)|Lack of Efficacy|10
5994880|NCT00956293|20729641|P1|Main Period (Randomization)|Lack of Efficacy|1
5994881|NCT00956293|20729639|P3|Main Period (Randomization)|Abnormal laboratory value|0
5994882|NCT00956293|20729640|P2|Main Period (Randomization)|Abnormal laboratory value|2
5994883|NCT00956293|20729641|P1|Main Period (Randomization)|Abnormal laboratory value|0
5994884|NCT00956293|20729639|P3|Main Period (Pre-randomization)|Abnormal laboratory value|44
5994885|NCT00956293|20729640|P2|Main Period (Pre-randomization)|Abnormal laboratory value|0
5994886|NCT00956293|20729641|P1|Main Period (Pre-randomization)|Abnormal laboratory value|0
5994887|NCT00956293|20729639|P3|Main Period (Pre-randomization)|Adverse Event|36
5994888|NCT00956293|20729640|P2|Main Period (Pre-randomization)|Adverse Event|0
5994889|NCT00956293|20729641|P1|Main Period (Pre-randomization)|Adverse Event|0
5994890|NCT00956293|20729639|P3|Main Period (Pre-randomization)|Lack of Efficacy|20
5994891|NCT00956293|20729640|P2|Main Period (Pre-randomization)|Lack of Efficacy|0
5994892|NCT00956293|20729641|P1|Main Period (Pre-randomization)|Lack of Efficacy|0
5994893|NCT00956293|20729639|P3|Main Period (Pre-randomization)|Withdrawal by Subject|12
5994894|NCT00956293|20729640|P2|Main Period (Pre-randomization)|Withdrawal by Subject|0
5994895|NCT00956293|20729641|P1|Main Period (Pre-randomization)|Withdrawal by Subject|0
5994896|NCT00956293|20729639|P3|Main Period (Pre-randomization)|Graft loss|7
5994897|NCT00956293|20729640|P2|Main Period (Pre-randomization)|Graft loss|0
5994898|NCT00956293|20729641|P1|Main Period (Pre-randomization)|Graft loss|0
5994899|NCT00956293|20729639|P3|Main Period (Pre-randomization)|Administrative problems|6
5994900|NCT00956293|20729640|P2|Main Period (Pre-randomization)|Administrative problems|0
5994901|NCT00956293|20729641|P1|Main Period (Pre-randomization)|Administrative problems|0
5994902|NCT00956293|20729639|P3|Main Period (Pre-randomization)|Abnormal test procedure result|2
5994903|NCT00956293|20729640|P2|Main Period (Pre-randomization)|Abnormal test procedure result|0
5994904|NCT00956293|20729641|P1|Main Period (Pre-randomization)|Abnormal test procedure result|0
5994905|NCT00956293|20729639|P3|Main Period (Pre-randomization)|Protocol Violation|1
5994906|NCT00956293|20729640|P2|Main Period (Pre-randomization)|Protocol Violation|0
5994907|NCT00956293|20729641|P1|Main Period (Pre-randomization)|Protocol Violation|0
5994908|NCT00956293|20729639|P3|Main Period (Pre-randomization)|Death|1
5994909|NCT00956293|20729640|P2|Main Period (Pre-randomization)|Death|0
5994910|NCT00956293|20729641|P1|Main Period (Pre-randomization)|Death|0
5994911|NCT00956293|20729639|P3|Main Period (Pre-randomization)|Not specified (data missing)|1
5994912|NCT00956293|20729640|P2|Main Period (Pre-randomization)|Not specified (data missing)|0
5994913|NCT00956293|20729641|P1|Main Period (Pre-randomization)|Not specified (data missing)|0
5994914|NCT00955968|20729696|P2|Overall Study|Site closed|52
5994915|NCT00955968|20729697|P1|Overall Study|Site closed|55
5994916|NCT00955968|20729696|P2|Overall Study|Lost to Follow-up|39
5994917|NCT00955968|20729697|P1|Overall Study|Lost to Follow-up|45
5994918|NCT00955968|20729696|P2|Overall Study|Withdrawal by Subject|31
5994919|NCT00955968|20729697|P1|Overall Study|Withdrawal by Subject|35
5994920|NCT00955968|20729696|P2|Overall Study|Death|4
5994921|NCT00955968|20729697|P1|Overall Study|Death|2
5994922|NCT00955955|20729739|P3|Overall Study|Lost to Follow-up|0
5994923|NCT00955955|20729740|P2|Overall Study|Lost to Follow-up|0
5994924|NCT00955955|20729741|P1|Overall Study|Lost to Follow-up|2
5994925|NCT00955825|20729825|P2|Overall Study|Any other reason not above-mentioned|9
5994926|NCT00955825|20729826|P1|Overall Study|Any other reason not above-mentioned|7
5994927|NCT00955825|20729825|P2|Overall Study|Withdrawal by Subject|6
5994928|NCT00955825|20729826|P1|Overall Study|Withdrawal by Subject|4
5994929|NCT00955825|20729825|P2|Overall Study|Adverse Event|2
5994930|NCT00955825|20729826|P1|Overall Study|Adverse Event|15
5994931|NCT00955721|20729843|P2|Overall Study|Withdrawal by Subject|0
5994932|NCT00955721|20729844|P1|Overall Study|Withdrawal by Subject|1
5994933|NCT00955721|20729843|P2|Overall Study|Death|0
5994934|NCT00955721|20729844|P1|Overall Study|Death|1
5994935|NCT00955721|20729843|P2|Overall Study|Physician Decision|0
5994936|NCT00955721|20729844|P1|Overall Study|Physician Decision|1
5994937|NCT00955708|20729854|P1|Overall Study|Patient changed care provider/moved|91
5994938|NCT00955708|20729854|P1|Overall Study|Closure of study location|60
5994939|NCT00955708|20729854|P1|Overall Study|Patient Refused to participate further|116
5994940|NCT00955708|20729854|P1|Overall Study|Product removed from service|94
5994941|NCT00955708|20729854|P1|Overall Study|Registry Conclusion|186
5994942|NCT00955708|20729854|P1|Overall Study|Protocol Violation|134
5994943|NCT00955708|20729854|P1|Overall Study|Physician Decision|36
5994944|NCT00955708|20729854|P1|Overall Study|Lost to Follow-up|72
5994945|NCT00955708|20729854|P1|Overall Study|Death|269
5994948|NCT00955617|20729971|P2|Second MRA (Between Day 1 and Day 51)|conventional angiography|0
5994949|NCT00955617|20729972|P1|Second MRA (Between Day 1 and Day 51)|conventional angiography|1
5994950|NCT00955617|20729971|P2|Second MRA (Between Day 1 and Day 51)|technical incident|1
5994951|NCT00955617|20729972|P1|Second MRA (Between Day 1 and Day 51)|technical incident|0
5994952|NCT00955617|20729971|P2|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|1
5994953|NCT00955617|20729972|P1|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|0
5994954|NCT00955617|20729971|P2|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|1
5994955|NCT00955617|20729972|P1|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|2
5994956|NCT00955474|20730036|P2|Overall Study|Physician Decision|5
5994957|NCT00955474|20730037|P1|Overall Study|Physician Decision|7
5994958|NCT00955357|20730073|P2|Maintenance Phase|Non compliance to study procedures|0
5994959|NCT00955357|20730074|P1|Maintenance Phase|Non compliance to study procedures|1
5994960|NCT00955357|20730073|P2|Maintenance Phase|Patient moving out of area|1
5994961|NCT00955357|20730074|P1|Maintenance Phase|Patient moving out of area|0
5994962|NCT00955357|20730073|P2|Maintenance Phase|Withdrawal by Subject|4
5994963|NCT00955357|20730074|P1|Maintenance Phase|Withdrawal by Subject|4
5994964|NCT00955357|20730073|P2|Maintenance Phase|Lost to Follow-up|7
5994965|NCT00955357|20730074|P1|Maintenance Phase|Lost to Follow-up|2
5994966|NCT00955357|20730073|P2|Maintenance Phase|Protocol Violation|6
5994967|NCT00955357|20730074|P1|Maintenance Phase|Protocol Violation|2
5994968|NCT00955357|20730073|P2|Maintenance Phase|Lack of Efficacy|4
5994969|NCT00955357|20730074|P1|Maintenance Phase|Lack of Efficacy|0
5994970|NCT00955357|20730073|P2|Maintenance Phase|Adverse Event|23
5994971|NCT00955357|20730074|P1|Maintenance Phase|Adverse Event|3
5994972|NCT00955357|20730073|P2|Titration Phase|Non compliance to study procedures|1
5994973|NCT00955357|20730074|P1|Titration Phase|Non compliance to study procedures|0
5994974|NCT00955357|20730073|P2|Titration Phase|Study medication not tolerated|1
5994975|NCT00955357|20730074|P1|Titration Phase|Study medication not tolerated|0
5994976|NCT00955357|20730073|P2|Titration Phase|Prohibited Antiepileptic Drug change|1
5994977|NCT00955357|20730074|P1|Titration Phase|Prohibited Antiepileptic Drug change|0
5994978|NCT00955357|20730073|P2|Titration Phase|Withdrawal by Subject|5
5994979|NCT00955357|20730074|P1|Titration Phase|Withdrawal by Subject|3
5994980|NCT00955357|20730073|P2|Titration Phase|Lost to Follow-up|3
5994981|NCT00955357|20730074|P1|Titration Phase|Lost to Follow-up|1
5994982|NCT00955357|20730073|P2|Titration Phase|Protocol Violation|7
5994983|NCT00955357|20730074|P1|Titration Phase|Protocol Violation|3
5994984|NCT00955357|20730073|P2|Titration Phase|Lack of Efficacy|2
5994985|NCT00955357|20730074|P1|Titration Phase|Lack of Efficacy|0
5994986|NCT00955357|20730073|P2|Titration Phase|Adverse Event|46
5994987|NCT00955357|20730074|P1|Titration Phase|Adverse Event|9
5994988|NCT00955305|20730082|P2|Overall Study|Ineligible|7
5994989|NCT00955305|20730083|P1|Overall Study|Ineligible|5
5994990|NCT00955305|20730082|P2|Overall Study|Never started protocol treatment|5
5994991|NCT00955305|20730083|P1|Overall Study|Never started protocol treatment|5
5994992|NCT00955305|20730082|P2|Overall Study|No off-treatment reason submitted|0
5994993|NCT00955305|20730083|P1|Overall Study|No off-treatment reason submitted|1
5994994|NCT00955305|20730082|P2|Overall Study|Lost to Follow-up|1
5994995|NCT00955305|20730083|P1|Overall Study|Lost to Follow-up|0
5994996|NCT00955305|20730082|P2|Overall Study|Maximum response achieved|1
5994997|NCT00955305|20730083|P1|Overall Study|Maximum response achieved|0
5994998|NCT00955305|20730082|P2|Overall Study|Functional decline|0
5994999|NCT00955305|20730083|P1|Overall Study|Functional decline|2
5995000|NCT00955305|20730082|P2|Overall Study|Continued presence of residual disease|1
5995001|NCT00955305|20730083|P1|Overall Study|Continued presence of residual disease|0
5995002|NCT00955305|20730082|P2|Overall Study|Physician Decision|0
5995003|NCT00955305|20730083|P1|Overall Study|Physician Decision|1
5995004|NCT00955305|20730082|P2|Overall Study|Other complicating disease|4
5995005|NCT00955305|20730083|P1|Overall Study|Other complicating disease|2
5995006|NCT00955305|20730082|P2|Overall Study|Alternative therapy|0
5995007|NCT00955305|20730083|P1|Overall Study|Alternative therapy|4
5995008|NCT00955305|20730082|P2|Overall Study|Withdrawal by Subject|4
5995009|NCT00955305|20730083|P1|Overall Study|Withdrawal by Subject|5
5995010|NCT00955305|20730082|P2|Overall Study|Death|1
5995011|NCT00955305|20730083|P1|Overall Study|Death|2
5995012|NCT00955305|20730082|P2|Overall Study|Adverse Event|22
5995013|NCT00955305|20730083|P1|Overall Study|Adverse Event|22
5995014|NCT00955305|20730082|P2|Overall Study|Disease progression|41
5995015|NCT00955305|20730083|P1|Overall Study|Disease progression|39
5995016|NCT00955279|20730096|P3|Overall Study|Withdrawal by Subject|3
5995017|NCT00955279|20730097|P2|Overall Study|Withdrawal by Subject|0
5995018|NCT00955279|20730098|P1|Overall Study|Withdrawal by Subject|2
5995019|NCT00955279|20730096|P3|Overall Study|Lost to Follow-up|1
5995020|NCT00955279|20730097|P2|Overall Study|Lost to Follow-up|3
5995021|NCT00955279|20730098|P1|Overall Study|Lost to Follow-up|0
5995022|NCT00955279|20730096|P3|Overall Study|Death|1
5995023|NCT00955279|20730097|P2|Overall Study|Death|1
5995024|NCT00955279|20730098|P1|Overall Study|Death|1
5995025|NCT00955279|20730096|P3|Overall Study|Other|3
5995026|NCT00955279|20730097|P2|Overall Study|Other|0
5995027|NCT00955279|20730098|P1|Overall Study|Other|0
5995028|NCT00955110|20730306|P1|Treatment Phase|Withdrawn by physician pre-treatment|1
5995029|NCT00955110|20730306|P1|Treatment Phase|Non-compliance with study restrictions|1
5995030|NCT00955110|20730306|P1|Treatment Phase|Administrative reasons|2
5995031|NCT00955110|20730306|P1|Treatment Phase|Adverse Event|2
5995032|NCT00955110|20730306|P1|Qualification Phase|Did not meet eligibility criteria|24
5995033|NCT00954941|20730353|P2|Overall Study|Adverse Event|1
5995034|NCT00954941|20730354|P1|Overall Study|Adverse Event|0
5995035|NCT00954941|20730353|P2|Overall Study|Ineligible|2
5995036|NCT00954941|20730354|P1|Overall Study|Ineligible|2
5995037|NCT00954941|20730353|P2|Overall Study|Physician Decision|2
5995038|NCT00954941|20730354|P1|Overall Study|Physician Decision|2
5995039|NCT00954941|20730353|P2|Overall Study|Insurance Denial|2
5995040|NCT00954941|20730354|P1|Overall Study|Insurance Denial|2
5995041|NCT00954941|20730353|P2|Overall Study|Withdrawal by Subject|0
5995042|NCT00954941|20730354|P1|Overall Study|Withdrawal by Subject|1
5995043|NCT00954941|20730353|P2|Overall Study|Received treatment at home|0
5995044|NCT00954941|20730354|P1|Overall Study|Received treatment at home|1
5995045|NCT00954733|20730370|P1|Overall Study|blood gas machine did not work|1
5995046|NCT00954707|20730374|P1|Overall Study|Lost to Follow-up|33
5995047|NCT00954707|20730374|P1|Overall Study|Withdrawal by Subject|100
5995048|NCT00954707|20730374|P1|Overall Study|Death|34
5995049|NCT00954538|20730396|P6|Part III|Withdrawal by Subject|0
5995050|NCT00954538|20730397|P5|Part III|Withdrawal by Subject|1
5995051|NCT00954538|20730398|P4|Part III|Withdrawal by Subject|0
5995052|NCT00954538|20730399|P3|Part III|Withdrawal by Subject|0
5995053|NCT00954538|20730400|P2|Part III|Withdrawal by Subject|0
5995054|NCT00954538|20730401|P1|Part III|Withdrawal by Subject|0
5995055|NCT00954512|20730418|P6|Overall Study|Progression of Disease|1
5995056|NCT00954512|20730419|P5|Overall Study|Progression of Disease|1
5995057|NCT00954512|20730420|P4|Overall Study|Progression of Disease|1
5995058|NCT00954512|20730421|P3|Overall Study|Progression of Disease|0
5995059|NCT00954512|20730422|P2|Overall Study|Progression of Disease|1
5995060|NCT00954512|20730423|P1|Overall Study|Progression of Disease|2
5995061|NCT00954512|20730418|P6|Overall Study|Symptomatic Deterioration|0
5995062|NCT00954512|20730419|P5|Overall Study|Symptomatic Deterioration|2
5995063|NCT00954512|20730420|P4|Overall Study|Symptomatic Deterioration|0
5995064|NCT00954512|20730421|P3|Overall Study|Symptomatic Deterioration|0
5995065|NCT00954512|20730422|P2|Overall Study|Symptomatic Deterioration|1
5995066|NCT00954512|20730423|P1|Overall Study|Symptomatic Deterioration|0
5995067|NCT00954512|20730418|P6|Overall Study|Physician Decision|0
5995068|NCT00954512|20730419|P5|Overall Study|Physician Decision|0
5995069|NCT00954512|20730420|P4|Overall Study|Physician Decision|1
5995070|NCT00954512|20730421|P3|Overall Study|Physician Decision|0
5995071|NCT00954512|20730422|P2|Overall Study|Physician Decision|1
5995072|NCT00954512|20730423|P1|Overall Study|Physician Decision|0
5995073|NCT00954512|20730418|P6|Overall Study|Adverse Event|2
5995074|NCT00954512|20730419|P5|Overall Study|Adverse Event|1
5995075|NCT00954512|20730420|P4|Overall Study|Adverse Event|0
5995076|NCT00954512|20730421|P3|Overall Study|Adverse Event|0
5995077|NCT00954512|20730422|P2|Overall Study|Adverse Event|0
5995078|NCT00954512|20730423|P1|Overall Study|Adverse Event|0
5995079|NCT00954512|20730418|P6|Overall Study|Withdrawal by Subject|1
5995080|NCT00954512|20730419|P5|Overall Study|Withdrawal by Subject|0
5995081|NCT00954512|20730420|P4|Overall Study|Withdrawal by Subject|0
5995082|NCT00954512|20730421|P3|Overall Study|Withdrawal by Subject|0
5995083|NCT00954512|20730422|P2|Overall Study|Withdrawal by Subject|0
5995084|NCT00954512|20730423|P1|Overall Study|Withdrawal by Subject|0
5995085|NCT00954447|20730444|P2|Overall Study|Other|18
5995086|NCT00954447|20730445|P1|Overall Study|Other|21
5995087|NCT00954447|20730444|P2|Overall Study|Withdrawal by Subject|21
5995088|NCT00954447|20730445|P1|Overall Study|Withdrawal by Subject|26
5995089|NCT00954447|20730444|P2|Overall Study|Lost to Follow-up|14
5995090|NCT00954447|20730445|P1|Overall Study|Lost to Follow-up|8
5995091|NCT00954447|20730444|P2|Overall Study|Protocol Violation|7
5995092|NCT00954447|20730445|P1|Overall Study|Protocol Violation|5
5995093|NCT00954447|20730444|P2|Overall Study|Lack of Efficacy|3
5995094|NCT00954447|20730445|P1|Overall Study|Lack of Efficacy|17
5995095|NCT00954447|20730444|P2|Overall Study|Adverse Event|25
5995096|NCT00954447|20730445|P1|Overall Study|Adverse Event|33
5995097|NCT00954421|20730481|P1|VIM=ON VO=OFF at 6 Months|Withdrawal by Subject|1
5995098|NCT00954421|20730481|P1|6 Months of DBS|Withdrawal by Subject|1
5995099|NCT00954421|20730481|P1|Screening|screen failures|3
5995100|NCT00954174|20730531|P4|Overall Study|Never Treated|3
5995101|NCT00954174|20730532|P3|Overall Study|Never Treated|0
5995102|NCT00954174|20730533|P2|Overall Study|Never Treated|17
5995103|NCT00954174|20730534|P1|Overall Study|Never Treated|4
5995104|NCT00954174|20730531|P4|Overall Study|Ineligible|4
5995105|NCT00954174|20730532|P3|Overall Study|Ineligible|7
5995106|NCT00954174|20730533|P2|Overall Study|Ineligible|47
5995107|NCT00954174|20730534|P1|Overall Study|Ineligible|40
5995108|NCT00954174|20730531|P4|Overall Study|Medical Reason|0
5995109|NCT00954174|20730532|P3|Overall Study|Medical Reason|1
5995110|NCT00954174|20730533|P2|Overall Study|Medical Reason|2
5995111|NCT00954174|20730534|P1|Overall Study|Medical Reason|4
5995112|NCT00954174|20730531|P4|Overall Study|Withdrawal by Subject|3
5995113|NCT00954174|20730532|P3|Overall Study|Withdrawal by Subject|4
5995114|NCT00954174|20730533|P2|Overall Study|Withdrawal by Subject|10
5995115|NCT00954174|20730534|P1|Overall Study|Withdrawal by Subject|14
5995116|NCT00954174|20730531|P4|Overall Study|Lack of Efficacy|6
5995117|NCT00954174|20730532|P3|Overall Study|Lack of Efficacy|8
5995118|NCT00954174|20730533|P2|Overall Study|Lack of Efficacy|22
5995119|NCT00954174|20730534|P1|Overall Study|Lack of Efficacy|32
5995120|NCT00954174|20730531|P4|Overall Study|Death|0
5995121|NCT00954174|20730532|P3|Overall Study|Death|0
5995122|NCT00954174|20730533|P2|Overall Study|Death|2
5995123|NCT00954174|20730534|P1|Overall Study|Death|4
5995124|NCT00954174|20730531|P4|Overall Study|Adverse Event|9
5995125|NCT00954174|20730532|P3|Overall Study|Adverse Event|4
5995126|NCT00954174|20730533|P2|Overall Study|Adverse Event|23
5995127|NCT00954174|20730534|P1|Overall Study|Adverse Event|28
5995128|NCT00954122|20730554|P1|Overall Study|Safety Reason|1
5995129|NCT00954122|20730554|P1|Overall Study|Adverse Event|1
5995130|NCT00954122|20730554|P1|Overall Study|Withdrawal by Subject|5
5995131|NCT00953927|20730571|P2|Overall Study|Other study discontinuation|1
5995132|NCT00953927|20730572|P1|Overall Study|Other study discontinuation|1
5995133|NCT00953927|20730571|P2|Overall Study|Death|4
5995134|NCT00953927|20730572|P1|Overall Study|Death|7
5995135|NCT00953927|20730571|P2|Overall Study|Withdrawal by Subject|25
5995136|NCT00953927|20730572|P1|Overall Study|Withdrawal by Subject|36
5995137|NCT00953927|20730571|P2|Overall Study|Lost to Follow-up|65
5995138|NCT00953927|20730572|P1|Overall Study|Lost to Follow-up|61
5995139|NCT00953745|20730627|P2|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|0
5995140|NCT00953745|20730628|P1|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|1
5995141|NCT00953745|20730627|P2|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|0
5995142|NCT00953745|20730628|P1|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|6
5995143|NCT00953745|20730627|P2|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|0
5995144|NCT00953745|20730628|P1|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|1
5995145|NCT00953745|20730627|P2|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|0
5995146|NCT00953745|20730628|P1|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|3
5995147|NCT00953745|20730627|P2|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|0
5995148|NCT00953745|20730628|P1|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|2
5995149|NCT00953745|20730627|P2|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|0
5995150|NCT00953745|20730628|P1|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|1
5995151|NCT00953706|20730661|P4|Part B (96-Week Open-Label Extension)|Other|2
5995152|NCT00953706|20730662|P3|Part B (96-Week Open-Label Extension)|Other|0
5995153|NCT00953706|20730663|P2|Part B (96-Week Open-Label Extension)|Other|0
5995154|NCT00953706|20730664|P1|Part B (96-Week Open-Label Extension)|Other|0
5995155|NCT00953706|20730661|P4|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|2
5995156|NCT00953706|20730662|P3|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|1
5995157|NCT00953706|20730663|P2|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0
5995158|NCT00953706|20730664|P1|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0
5995159|NCT00953706|20730661|P4|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|25
5995160|NCT00953706|20730662|P3|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|4
5995161|NCT00953706|20730663|P2|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0
5995162|NCT00953706|20730664|P1|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0
5995163|NCT00953706|20730661|P4|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|1
5995164|NCT00953706|20730662|P3|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0
5995165|NCT00953706|20730663|P2|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0
5995166|NCT00953706|20730664|P1|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0
5995167|NCT00953706|20730661|P4|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|1
5995168|NCT00953706|20730662|P3|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0
5995169|NCT00953706|20730663|P2|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0
5995170|NCT00953706|20730664|P1|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0
5995171|NCT00953706|20730661|P4|Part B (96-Week Open-Label Extension)|Adverse Event|2
5995172|NCT00953706|20730662|P3|Part B (96-Week Open-Label Extension)|Adverse Event|0
5995173|NCT00953706|20730663|P2|Part B (96-Week Open-Label Extension)|Adverse Event|0
5995174|NCT00953706|20730664|P1|Part B (96-Week Open-Label Extension)|Adverse Event|0
5995175|NCT00953706|20730661|P4|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0
5995176|NCT00953706|20730662|P3|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0
5995177|NCT00953706|20730663|P2|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|1
5995178|NCT00953706|20730664|P1|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0
5995179|NCT00953706|20730661|P4|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0
5995180|NCT00953706|20730662|P3|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0
5995181|NCT00953706|20730663|P2|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|1
5995182|NCT00953706|20730664|P1|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0
5995183|NCT00953706|20730661|P4|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0
5995184|NCT00953706|20730662|P3|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0
5995185|NCT00953706|20730663|P2|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|2
5995186|NCT00953706|20730664|P1|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0
5995187|NCT00953706|20730661|P4|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0
5995188|NCT00953706|20730662|P3|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0
5995189|NCT00953706|20730663|P2|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|1
5995190|NCT00953706|20730664|P1|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0
5995191|NCT00953706|20730661|P4|Part A (16-Week Double-Blind Treatment)|Adverse Event|0
5995192|NCT00953706|20730662|P3|Part A (16-Week Double-Blind Treatment)|Adverse Event|0
5995193|NCT00953706|20730663|P2|Part A (16-Week Double-Blind Treatment)|Adverse Event|3
5995194|NCT00953706|20730664|P1|Part A (16-Week Double-Blind Treatment)|Adverse Event|2
5995195|NCT00953680|20730696|P2|Period 1|Withdrawal by Subject|1
5995196|NCT00953680|20730697|P1|Period 1|Withdrawal by Subject|0
5995197|NCT00953667|20730709|P1|Overall Study|poor venous access,unable to draw blood|4
5995198|NCT00953667|20730709|P1|Overall Study|Adverse Event|10
5995199|NCT00953667|20730709|P1|Overall Study|Withdrawal by Subject|63
5995200|NCT00953667|20730709|P1|Overall Study|Physician Decision|35
5995201|NCT00953667|20730709|P1|Overall Study|Lost to Follow-up|11
5995202|NCT00953615|20730730|P1|Overall Study|Adverse Event|1
5995203|NCT00953576|20730739|P2|Overall Study|Ineligible after Consent|0
5995204|NCT00953576|20730740|P1|Overall Study|Ineligible after Consent|2
5995205|NCT00953576|20730739|P2|Overall Study|Adverse Event|1
5995206|NCT00953576|20730740|P1|Overall Study|Adverse Event|0
5995207|NCT00953524|20730755|P4|Overall Study|Withdrawal by Subject|0
5995208|NCT00953524|20730756|P3|Overall Study|Withdrawal by Subject|1
5995209|NCT00953524|20730757|P2|Overall Study|Withdrawal by Subject|4
5995210|NCT00953524|20730758|P1|Overall Study|Withdrawal by Subject|2
5995211|NCT00953524|20730755|P4|Overall Study|Lost to Follow-up|0
5995212|NCT00953524|20730756|P3|Overall Study|Lost to Follow-up|1
5995213|NCT00953524|20730757|P2|Overall Study|Lost to Follow-up|1
5995214|NCT00953524|20730758|P1|Overall Study|Lost to Follow-up|0
5995215|NCT00953524|20730755|P4|Overall Study|Protocol Violation|6
5995216|NCT00953524|20730756|P3|Overall Study|Protocol Violation|11
5995217|NCT00953524|20730757|P2|Overall Study|Protocol Violation|10
5995218|NCT00953524|20730758|P1|Overall Study|Protocol Violation|18
5995219|NCT00953524|20730755|P4|Overall Study|Adverse Event|2
5995220|NCT00953524|20730756|P3|Overall Study|Adverse Event|1
5995221|NCT00953524|20730757|P2|Overall Study|Adverse Event|0
5995222|NCT00953524|20730758|P1|Overall Study|Adverse Event|2
5995223|NCT00953407|20730801|P5|Overall Study|Lost to Follow-up|0
5995224|NCT00953407|20730802|P4|Overall Study|Lost to Follow-up|1
5995225|NCT00953407|20730803|P3|Overall Study|Lost to Follow-up|0
5995226|NCT00953407|20730804|P2|Overall Study|Lost to Follow-up|0
5995227|NCT00953407|20730805|P1|Overall Study|Lost to Follow-up|0
5995228|NCT00953407|20730801|P5|Overall Study|Failed inclusion criteria|1
5995229|NCT00953407|20730802|P4|Overall Study|Failed inclusion criteria|1
5995230|NCT00953407|20730803|P3|Overall Study|Failed inclusion criteria|1
5995231|NCT00953407|20730804|P2|Overall Study|Failed inclusion criteria|1
5995232|NCT00953407|20730805|P1|Overall Study|Failed inclusion criteria|1
5995233|NCT00953329|20730817|P1|Overall Study|Lack of Efficacy|1
5995234|NCT00953225|20730830|P2|Overall Study|Withdrawal by Subject|0
5995235|NCT00953225|20730831|P1|Overall Study|Withdrawal by Subject|2
5995236|NCT00953160|20730915|P1|Overall Study|Withdrawal by Subject|4
5995237|NCT00953160|20730915|P1|Overall Study|Lost to Follow-up|23
5995238|NCT00953147|20730924|P3|Overall Study|Other|13
5995239|NCT00953147|20730925|P2|Overall Study|Other|11
5995240|NCT00953147|20730926|P1|Overall Study|Other|4
5995241|NCT00953147|20730924|P3|Overall Study|Physician Decision|3
5995242|NCT00953147|20730925|P2|Overall Study|Physician Decision|7
5995243|NCT00953147|20730926|P1|Overall Study|Physician Decision|2
5995244|NCT00953147|20730924|P3|Overall Study|Lost to Follow-up|4
5995245|NCT00953147|20730925|P2|Overall Study|Lost to Follow-up|9
5995246|NCT00953147|20730926|P1|Overall Study|Lost to Follow-up|8
5995247|NCT00953147|20730924|P3|Overall Study|Withdrawal by Subject|12
5995248|NCT00953147|20730925|P2|Overall Study|Withdrawal by Subject|15
5995249|NCT00953147|20730926|P1|Overall Study|Withdrawal by Subject|13
5995250|NCT00953147|20730924|P3|Overall Study|Protocol Violation|4
5995251|NCT00953147|20730925|P2|Overall Study|Protocol Violation|8
5995252|NCT00953147|20730926|P1|Overall Study|Protocol Violation|2
5995253|NCT00953147|20730924|P3|Overall Study|Adverse Event|6
5995254|NCT00953147|20730925|P2|Overall Study|Adverse Event|16
5995255|NCT00953147|20730926|P1|Overall Study|Adverse Event|8
5995256|NCT00953056|20731004|P6|Overall Study|Serious Adverse Event|1
5995257|NCT00953056|20731005|P5|Overall Study|Serious Adverse Event|0
5995258|NCT00953056|20731006|P4|Overall Study|Serious Adverse Event|0
5995259|NCT00953056|20731007|P3|Overall Study|Serious Adverse Event|0
5995260|NCT00953056|20731008|P2|Overall Study|Serious Adverse Event|0
5995261|NCT00953056|20731009|P1|Overall Study|Serious Adverse Event|0
5995262|NCT00953056|20731004|P6|Overall Study|Withdrew Consent|3
5995263|NCT00953056|20731005|P5|Overall Study|Withdrew Consent|2
5995264|NCT00953056|20731006|P4|Overall Study|Withdrew Consent|0
5995265|NCT00953056|20731007|P3|Overall Study|Withdrew Consent|0
5995266|NCT00953056|20731008|P2|Overall Study|Withdrew Consent|0
5995267|NCT00953056|20731009|P1|Overall Study|Withdrew Consent|0
5995268|NCT00953043|20731033|P2|Overall Study|Physician Decision|2
5995269|NCT00953043|20731034|P1|Overall Study|Physician Decision|0
5995270|NCT00953043|20731033|P2|Overall Study|Withdrawal by Subject|0
5995271|NCT00953043|20731034|P1|Overall Study|Withdrawal by Subject|4
5995272|NCT00953017|20731058|P4|Overall Study|Brown stool prior to procedure|0
5995273|NCT00953017|20731059|P3|Overall Study|Brown stool prior to procedure|1
5995274|NCT00953017|20731060|P2|Overall Study|Brown stool prior to procedure|0
5995275|NCT00953017|20731061|P1|Overall Study|Brown stool prior to procedure|0
5995276|NCT00953017|20731058|P4|Overall Study|Procedure incomplete due to pain/looping|1
5995277|NCT00953017|20731059|P3|Overall Study|Procedure incomplete due to pain/looping|0
5995278|NCT00953017|20731060|P2|Overall Study|Procedure incomplete due to pain/looping|1
5995279|NCT00953017|20731061|P1|Overall Study|Procedure incomplete due to pain/looping|0
5995280|NCT00953017|20731058|P4|Overall Study|Incomplete data|0
5995281|NCT00953017|20731059|P3|Overall Study|Incomplete data|0
5995282|NCT00953017|20731060|P2|Overall Study|Incomplete data|1
5995283|NCT00953017|20731061|P1|Overall Study|Incomplete data|1
5995284|NCT00953017|20731058|P4|Overall Study|DId not show up for colonoscopy|4
5995285|NCT00953017|20731059|P3|Overall Study|DId not show up for colonoscopy|5
5995286|NCT00953017|20731060|P2|Overall Study|DId not show up for colonoscopy|4
5995287|NCT00953017|20731061|P1|Overall Study|DId not show up for colonoscopy|4
5995288|NCT00952848|20731083|P1|Overall Study|Withdrawal by Subject|4
5995289|NCT00952822|20731090|P4|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0
5995290|NCT00952822|20731091|P3|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|1
5995291|NCT00952822|20731092|P2|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0
5995292|NCT00952822|20731093|P1|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0
5995293|NCT00952822|20731090|P4|1st Pharmacokinetic Evaluation|Lost to Follow-up|0
5995294|NCT00952822|20731091|P3|1st Pharmacokinetic Evaluation|Lost to Follow-up|0
5995295|NCT00952822|20731092|P2|1st Pharmacokinetic Evaluation|Lost to Follow-up|1
5995296|NCT00952822|20731093|P1|1st Pharmacokinetic Evaluation|Lost to Follow-up|0
5995297|NCT00952731|20731125|P2|Overall Study|Drug supply expired|0
5995298|NCT00952731|20731126|P1|Overall Study|Drug supply expired|1
5995299|NCT00952705|20731158|P3|Overall Study|Exclusion criteria not met pre dose|0
5995300|NCT00952705|20731159|P2|Overall Study|Exclusion criteria not met pre dose|1
5995301|NCT00952705|20731160|P1|Overall Study|Exclusion criteria not met pre dose|0
5995302|NCT00952705|20731158|P3|Overall Study|Incarcerated post dose|0
5995303|NCT00952705|20731159|P2|Overall Study|Incarcerated post dose|0
5995304|NCT00952705|20731160|P1|Overall Study|Incarcerated post dose|5
5995305|NCT00952705|20731158|P3|Overall Study|Death|0
5995306|NCT00952705|20731159|P2|Overall Study|Death|0
5995307|NCT00952705|20731160|P1|Overall Study|Death|2
5995308|NCT00952705|20731158|P3|Overall Study|Withdrawal by Subject|1
5995309|NCT00952705|20731159|P2|Overall Study|Withdrawal by Subject|1
5995310|NCT00952705|20731160|P1|Overall Study|Withdrawal by Subject|2
5995311|NCT00952705|20731158|P3|Overall Study|Lost to Follow-up|9
5995312|NCT00952705|20731159|P2|Overall Study|Lost to Follow-up|8
5995313|NCT00952705|20731160|P1|Overall Study|Lost to Follow-up|24
5995314|NCT00952614|20731247|P1|Overall Study|other reason|1
5995315|NCT00952614|20731247|P1|Overall Study|Lost to Follow-up|3
5995316|NCT00952614|20731247|P1|Overall Study|Death|3
5995317|NCT00952588|20731254|P2|Overall Study|Lack of Efficacy|2
5995318|NCT00952588|20731255|P1|Overall Study|Lack of Efficacy|2
5995319|NCT00952588|20731254|P2|Overall Study|Physician Decision|1
5995320|NCT00952588|20731255|P1|Overall Study|Physician Decision|0
5995321|NCT00952588|20731254|P2|Overall Study|Lost to Follow-up|0
5995322|NCT00952588|20731255|P1|Overall Study|Lost to Follow-up|2
5995323|NCT00952588|20731254|P2|Overall Study|Adverse Event|3
5995324|NCT00952588|20731255|P1|Overall Study|Adverse Event|2
5995325|NCT00952588|20731254|P2|Overall Study|Withdrawal by Subject|5
5995326|NCT00952588|20731255|P1|Overall Study|Withdrawal by Subject|2
5995327|NCT00952588|20731254|P2|Overall Study|Death|13
5995328|NCT00952588|20731255|P1|Overall Study|Death|28
5995329|NCT00952523|20731273|P1|Overall Study|Withdrawal by Subject|7
5995330|NCT00952484|20731282|P3|Overall Study|Withdrawal by Subject|0
5995331|NCT00952484|20731283|P2|Overall Study|Withdrawal by Subject|1
5995332|NCT00952484|20731284|P1|Overall Study|Withdrawal by Subject|0
5995333|NCT00952419|20731311|P3|Overall Study|Withdrawal by Subject|0
5995334|NCT00952419|20731312|P2|Overall Study|Withdrawal by Subject|3
5995335|NCT00952419|20731313|P1|Overall Study|Withdrawal by Subject|1
5995336|NCT00952419|20731311|P3|Overall Study|Protocol Violation|0
5995337|NCT00952419|20731312|P2|Overall Study|Protocol Violation|7
5995338|NCT00952419|20731313|P1|Overall Study|Protocol Violation|3
5995339|NCT00952419|20731311|P3|Overall Study|Adverse Event|0
5995340|NCT00952419|20731312|P2|Overall Study|Adverse Event|0
5995341|NCT00952419|20731313|P1|Overall Study|Adverse Event|2
5995342|NCT00952380|20731354|P5|Overall Study|Non-compliant to protocol|0
5995343|NCT00952380|20731355|P4|Overall Study|Non-compliant to protocol|1
5995344|NCT00952380|20731356|P3|Overall Study|Non-compliant to protocol|0
5995345|NCT00952380|20731357|P2|Overall Study|Non-compliant to protocol|0
5995346|NCT00952380|20731358|P1|Overall Study|Non-compliant to protocol|0
5995347|NCT00952380|20731354|P5|Overall Study|Physician Decision|0
5995348|NCT00952380|20731355|P4|Overall Study|Physician Decision|2
5995349|NCT00952380|20731356|P3|Overall Study|Physician Decision|1
5995350|NCT00952380|20731357|P2|Overall Study|Physician Decision|0
5995351|NCT00952380|20731358|P1|Overall Study|Physician Decision|0
5995352|NCT00952380|20731354|P5|Overall Study|Adverse Event|3
5995353|NCT00952380|20731355|P4|Overall Study|Adverse Event|0
5995354|NCT00952380|20731356|P3|Overall Study|Adverse Event|0
5995355|NCT00952380|20731357|P2|Overall Study|Adverse Event|1
5995356|NCT00952380|20731358|P1|Overall Study|Adverse Event|0
5995357|NCT00952380|20731354|P5|Overall Study|Withdrawal by Subject|2
5995358|NCT00952380|20731355|P4|Overall Study|Withdrawal by Subject|0
5995359|NCT00952380|20731356|P3|Overall Study|Withdrawal by Subject|1
5995360|NCT00952380|20731357|P2|Overall Study|Withdrawal by Subject|0
5995361|NCT00952380|20731358|P1|Overall Study|Withdrawal by Subject|0
5995362|NCT00952380|20731354|P5|Overall Study|Other|1
5995363|NCT00952380|20731355|P4|Overall Study|Other|0
5995364|NCT00952380|20731356|P3|Overall Study|Other|0
5995365|NCT00952380|20731357|P2|Overall Study|Other|0
5995366|NCT00952380|20731358|P1|Overall Study|Other|0
5995367|NCT00952367|20731459|P1|Overall Study|Protocol Violation|3
5995368|NCT00952367|20731459|P1|Overall Study|Noncoordination|1
5995369|NCT00952367|20731459|P1|Overall Study|Withdrawal by Subject|2
5995370|NCT00952341|20731474|P2|Cycle 2|Progressive Disease|1
5995371|NCT00952341|20731475|P1|Cycle 2|Progressive Disease|0
5995372|NCT00952341|20731474|P2|Cycle 2|Physician Decision|1
5995373|NCT00952341|20731475|P1|Cycle 2|Physician Decision|1
5995374|NCT00952341|20731474|P2|Cycle 2|Lost to Follow-up|9
5995375|NCT00952341|20731475|P1|Cycle 2|Lost to Follow-up|6
5995376|NCT00952341|20731474|P2|Cycle 2|Protocol Violation|0
5995377|NCT00952341|20731475|P1|Cycle 2|Protocol Violation|1
5995378|NCT00952341|20731474|P2|Cycle 2|Withdrawal by Subject|1
5995379|NCT00952341|20731475|P1|Cycle 2|Withdrawal by Subject|1
5995380|NCT00952341|20731474|P2|Cycle 1|Physician Decision|1
5995381|NCT00952341|20731475|P1|Cycle 1|Physician Decision|0
5995382|NCT00952341|20731474|P2|Cycle 1|Lost to Follow-up|2
5995383|NCT00952341|20731475|P1|Cycle 1|Lost to Follow-up|11
5995384|NCT00952341|20731474|P2|Cycle 1|Protocol Violation|1
5995385|NCT00952341|20731475|P1|Cycle 1|Protocol Violation|2
5995386|NCT00952341|20731474|P2|Cycle 1|Withdrawal by Subject|8
5995387|NCT00952341|20731475|P1|Cycle 1|Withdrawal by Subject|3
5995388|NCT00952341|20731474|P2|Cycle 1|Adverse Event|1
5995389|NCT00952341|20731475|P1|Cycle 1|Adverse Event|4
5995390|NCT00952289|20731537|P2|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|7
5995391|NCT00952289|20731538|P1|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|0
5995392|NCT00952289|20731537|P2|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|2
5995393|NCT00952289|20731538|P1|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|0
5995394|NCT00952289|20731537|P2|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|11
5995395|NCT00952289|20731538|P1|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|0
5995396|NCT00952289|20731537|P2|Patients Who Crossed Over to Ruxolitinib|Disease progression|15
5995397|NCT00952289|20731538|P1|Patients Who Crossed Over to Ruxolitinib|Disease progression|0
5995398|NCT00952289|20731537|P2|Patients Who Crossed Over to Ruxolitinib|Adverse Event|19
5995399|NCT00952289|20731538|P1|Patients Who Crossed Over to Ruxolitinib|Adverse Event|0
5995400|NCT00952289|20731537|P2|All Participants|Data lost during site relocation|1
5995401|NCT00952289|20731538|P1|All Participants|Data lost during site relocation|0
5995402|NCT00952289|20731537|P2|All Participants|Withdrawal by Subject|10
5995403|NCT00952289|20731538|P1|All Participants|Withdrawal by Subject|1
5995404|NCT00952289|20731537|P2|All Participants|Disease progression|12
5995405|NCT00952289|20731538|P1|All Participants|Disease progression|3
5995406|NCT00952289|20731537|P2|All Participants|Adverse Event|8
5995407|NCT00952289|20731538|P1|All Participants|Adverse Event|8
5995408|NCT00952289|20731537|P2|All Participants|Death|9
5995409|NCT00952289|20731538|P1|All Participants|Death|9
5995410|NCT00952276|20731567|P5|Overall Study|Withdrawal by Subject|0
5995411|NCT00952276|20731568|P4|Overall Study|Withdrawal by Subject|1
5995412|NCT00952276|20731569|P3|Overall Study|Withdrawal by Subject|0
5995413|NCT00952276|20731570|P2|Overall Study|Withdrawal by Subject|0
5995414|NCT00952276|20731571|P1|Overall Study|Withdrawal by Subject|1
5995415|NCT00952068|20731657|P1|Overall Study|Withdrawal by Subject|4
5995416|NCT00952068|20731657|P1|Overall Study|Adverse Event|3
5995417|NCT00951912|20731668|P3|Overall Study|Other: Stroke|0
5995418|NCT00951912|20731669|P2|Overall Study|Other: Stroke|1
5995419|NCT00951912|20731670|P1|Overall Study|Other: Stroke|0
5995420|NCT00951912|20731668|P3|Overall Study|Other: Colon cancer|0
5995421|NCT00951912|20731669|P2|Overall Study|Other: Colon cancer|0
5995422|NCT00951912|20731670|P1|Overall Study|Other: Colon cancer|1
5995423|NCT00951912|20731668|P3|Overall Study|Other:Depression|0
5995424|NCT00951912|20731669|P2|Overall Study|Other:Depression|0
5995425|NCT00951912|20731670|P1|Overall Study|Other:Depression|1
5995426|NCT00951912|20731668|P3|Overall Study|Withdrawal by Subject|0
5995427|NCT00951912|20731669|P2|Overall Study|Withdrawal by Subject|1
5995428|NCT00951912|20731670|P1|Overall Study|Withdrawal by Subject|1
5995429|NCT00951912|20731668|P3|Overall Study|Physician Decision|1
5995430|NCT00951912|20731669|P2|Overall Study|Physician Decision|0
5995431|NCT00951912|20731670|P1|Overall Study|Physician Decision|1
5995432|NCT00951912|20731668|P3|Overall Study|Lost to Follow-up|0
5995433|NCT00951912|20731669|P2|Overall Study|Lost to Follow-up|2
5995434|NCT00951912|20731670|P1|Overall Study|Lost to Follow-up|2
5995435|NCT00951912|20731668|P3|Overall Study|Adverse Event|1
5995436|NCT00951912|20731669|P2|Overall Study|Adverse Event|1
5995437|NCT00951912|20731670|P1|Overall Study|Adverse Event|0
5995438|NCT00951912|20731668|P3|Overall Study|Lack of Efficacy|0
5995439|NCT00951912|20731669|P2|Overall Study|Lack of Efficacy|0
5995440|NCT00951912|20731670|P1|Overall Study|Lack of Efficacy|1
5995441|NCT00951665|20731770|P6|Phase 2a|Disease Progression|5
5995442|NCT00951665|20731771|P5|Phase 2a|Disease Progression|6
5995443|NCT00951665|20731772|P4|Phase 2a|Disease Progression|0
5995444|NCT00951665|20731773|P3|Phase 2a|Disease Progression|0
5995445|NCT00951665|20731774|P2|Phase 2a|Disease Progression|0
5995446|NCT00951665|20731775|P1|Phase 2a|Disease Progression|0
5995447|NCT00951665|20731770|P6|Phase 2a|Withdrawal by Subject|0
5995448|NCT00951665|20731771|P5|Phase 2a|Withdrawal by Subject|2
5995449|NCT00951665|20731772|P4|Phase 2a|Withdrawal by Subject|0
5995450|NCT00951665|20731773|P3|Phase 2a|Withdrawal by Subject|0
5995451|NCT00951665|20731774|P2|Phase 2a|Withdrawal by Subject|0
5995452|NCT00951665|20731775|P1|Phase 2a|Withdrawal by Subject|0
5995453|NCT00951665|20731770|P6|Phase 2a|Physician Decision|1
5995454|NCT00951665|20731771|P5|Phase 2a|Physician Decision|0
5995455|NCT00951665|20731772|P4|Phase 2a|Physician Decision|0
5995456|NCT00951665|20731773|P3|Phase 2a|Physician Decision|0
5995457|NCT00951665|20731774|P2|Phase 2a|Physician Decision|0
5995458|NCT00951665|20731775|P1|Phase 2a|Physician Decision|0
5995459|NCT00951665|20731770|P6|Phase 2a|Lost to Follow-up|0
5995460|NCT00951665|20731771|P5|Phase 2a|Lost to Follow-up|1
5995461|NCT00951665|20731772|P4|Phase 2a|Lost to Follow-up|0
5995462|NCT00951665|20731773|P3|Phase 2a|Lost to Follow-up|0
5995463|NCT00951665|20731774|P2|Phase 2a|Lost to Follow-up|0
5995464|NCT00951665|20731775|P1|Phase 2a|Lost to Follow-up|0
5995465|NCT00951665|20731770|P6|Phase 2a|Death|1
5995466|NCT00951665|20731771|P5|Phase 2a|Death|1
5995467|NCT00951665|20731772|P4|Phase 2a|Death|0
5995468|NCT00951665|20731773|P3|Phase 2a|Death|0
5995469|NCT00951665|20731774|P2|Phase 2a|Death|0
5995470|NCT00951665|20731775|P1|Phase 2a|Death|0
5995471|NCT00951665|20731770|P6|Phase 2a|Adverse Event|0
5995472|NCT00951665|20731771|P5|Phase 2a|Adverse Event|2
5995473|NCT00951665|20731772|P4|Phase 2a|Adverse Event|0
5995474|NCT00951665|20731773|P3|Phase 2a|Adverse Event|0
5995475|NCT00951665|20731774|P2|Phase 2a|Adverse Event|0
5995476|NCT00951665|20731775|P1|Phase 2a|Adverse Event|0
5995477|NCT00951665|20731770|P6|Phase 1b|Protocol Violation|0
5995478|NCT00951665|20731771|P5|Phase 1b|Protocol Violation|0
5995479|NCT00951665|20731772|P4|Phase 1b|Protocol Violation|0
5995480|NCT00951665|20731773|P3|Phase 1b|Protocol Violation|0
5995481|NCT00951665|20731774|P2|Phase 1b|Protocol Violation|0
5995482|NCT00951665|20731775|P1|Phase 1b|Protocol Violation|2
5995483|NCT00951665|20731770|P6|Phase 1b|Disease Progression|0
5995484|NCT00951665|20731771|P5|Phase 1b|Disease Progression|0
5995485|NCT00951665|20731772|P4|Phase 1b|Disease Progression|0
5995486|NCT00951665|20731773|P3|Phase 1b|Disease Progression|14
5995487|NCT00951665|20731774|P2|Phase 1b|Disease Progression|2
5995488|NCT00951665|20731775|P1|Phase 1b|Disease Progression|13
5995489|NCT00951665|20731770|P6|Phase 1b|Withdrawal by Subject|0
5995490|NCT00951665|20731771|P5|Phase 1b|Withdrawal by Subject|0
5995491|NCT00951665|20731772|P4|Phase 1b|Withdrawal by Subject|0
5995492|NCT00951665|20731773|P3|Phase 1b|Withdrawal by Subject|0
5995493|NCT00951665|20731774|P2|Phase 1b|Withdrawal by Subject|1
5995494|NCT00951665|20731775|P1|Phase 1b|Withdrawal by Subject|0
5995495|NCT00951665|20731770|P6|Phase 1b|Physician Decision|0
5995496|NCT00951665|20731771|P5|Phase 1b|Physician Decision|0
5995497|NCT00951665|20731772|P4|Phase 1b|Physician Decision|0
5995498|NCT00951665|20731773|P3|Phase 1b|Physician Decision|1
5995499|NCT00951665|20731774|P2|Phase 1b|Physician Decision|0
5995500|NCT00951665|20731775|P1|Phase 1b|Physician Decision|4
5995501|NCT00951665|20731770|P6|Phase 1b|Death|0
5995502|NCT00951665|20731771|P5|Phase 1b|Death|0
5995503|NCT00951665|20731772|P4|Phase 1b|Death|0
5995504|NCT00951665|20731773|P3|Phase 1b|Death|2
5995505|NCT00951665|20731774|P2|Phase 1b|Death|0
5995506|NCT00951665|20731775|P1|Phase 1b|Death|1
5995507|NCT00951665|20731770|P6|Phase 1b|Adverse Event|0
5995508|NCT00951665|20731771|P5|Phase 1b|Adverse Event|0
5995509|NCT00951665|20731772|P4|Phase 1b|Adverse Event|1
5995510|NCT00951665|20731773|P3|Phase 1b|Adverse Event|0
5995511|NCT00951665|20731774|P2|Phase 1b|Adverse Event|1
5995512|NCT00951665|20731775|P1|Phase 1b|Adverse Event|2
5995513|NCT00951509|20731884|P1|Overall Study|Withdrawal by Subject|2
5995517|NCT00951483|20731925|P2|Overall Study|Withdrawal by Subject|0
5995518|NCT00951483|20731926|P1|Overall Study|Withdrawal by Subject|15
5995519|NCT00951483|20731925|P2|Overall Study|Physician Decision|0
5995520|NCT00951483|20731926|P1|Overall Study|Physician Decision|4
5995521|NCT00951379|20731946|P2|Overall Study|Disease Progression|1
5995522|NCT00951379|20731947|P1|Overall Study|Disease Progression|0
5995523|NCT00951379|20731946|P2|Overall Study|Noncompliance|0
5995524|NCT00951379|20731947|P1|Overall Study|Noncompliance|1
5995525|NCT00951379|20731946|P2|Overall Study|Withdrawal by Subject|0
5995526|NCT00951379|20731947|P1|Overall Study|Withdrawal by Subject|1
5995527|NCT00951379|20731946|P2|Overall Study|Adverse Event|1
5995528|NCT00951379|20731947|P1|Overall Study|Adverse Event|4
5995529|NCT00951275|20731989|P1|Overall Study|Protocol Violation|1
5995530|NCT00951275|20731989|P1|Overall Study|Withdrawal by Subject|4
5995531|NCT00951275|20731989|P1|Overall Study|Adverse Event|7
5995532|NCT00951275|20731989|P1|Overall Study|Administrative Reason|1
5995533|NCT00951171|20732021|P2|Overall Study|Adverse Event|0
5995534|NCT00951171|20732022|P1|Overall Study|Adverse Event|2
5995535|NCT00951080|20732054|P2|Overall Study|Other|22
5995536|NCT00951080|20732055|P1|Overall Study|Other|19
5995537|NCT00951080|20732054|P2|Overall Study|Physician Decision|1
5995538|NCT00951080|20732055|P1|Overall Study|Physician Decision|4
5995539|NCT00951080|20732054|P2|Overall Study|Lost to Follow-up|1
5995540|NCT00951080|20732055|P1|Overall Study|Lost to Follow-up|0
5995541|NCT00951080|20732054|P2|Overall Study|Adverse Event|3
5995542|NCT00951080|20732055|P1|Overall Study|Adverse Event|3
5995543|NCT00951041|20732063|P2|Overall Study|Other|0
5995544|NCT00951041|20732064|P1|Overall Study|Other|3
5995545|NCT00951041|20732063|P2|Overall Study|Lost to Follow-up|0
5995546|NCT00951041|20732064|P1|Overall Study|Lost to Follow-up|1
5995547|NCT00951041|20732063|P2|Overall Study|Withdrawal by Subject|1
5995548|NCT00951041|20732064|P1|Overall Study|Withdrawal by Subject|1
5995549|NCT00951015|20732119|P5|Open-label Phase|Physician Decision|8
5995550|NCT00951015|20732120|P4|Open-label Phase|Physician Decision|0
5995551|NCT00951015|20732121|P3|Open-label Phase|Physician Decision|0
5995552|NCT00951015|20732122|P2|Open-label Phase|Physician Decision|0
5995553|NCT00951015|20732123|P1|Open-label Phase|Physician Decision|0
5995554|NCT00951015|20732119|P5|Open-label Phase|Withdrawal by Subject|14
5995555|NCT00951015|20732120|P4|Open-label Phase|Withdrawal by Subject|0
5995556|NCT00951015|20732121|P3|Open-label Phase|Withdrawal by Subject|0
5995557|NCT00951015|20732122|P2|Open-label Phase|Withdrawal by Subject|0
5995558|NCT00951015|20732123|P1|Open-label Phase|Withdrawal by Subject|0
5995559|NCT00951015|20732119|P5|Open-label Phase|Lost to Follow-up|12
5995560|NCT00951015|20732120|P4|Open-label Phase|Lost to Follow-up|0
5995561|NCT00951015|20732121|P3|Open-label Phase|Lost to Follow-up|0
5995562|NCT00951015|20732122|P2|Open-label Phase|Lost to Follow-up|0
5995563|NCT00951015|20732123|P1|Open-label Phase|Lost to Follow-up|0
5995564|NCT00951015|20732119|P5|Open-label Phase|Protocol Violation|12
5995565|NCT00951015|20732120|P4|Open-label Phase|Protocol Violation|0
5995566|NCT00951015|20732121|P3|Open-label Phase|Protocol Violation|0
5995567|NCT00951015|20732122|P2|Open-label Phase|Protocol Violation|0
5995568|NCT00951015|20732123|P1|Open-label Phase|Protocol Violation|0
5995569|NCT00951015|20732119|P5|Open-label Phase|Lack of Efficacy|1
5995570|NCT00951015|20732120|P4|Open-label Phase|Lack of Efficacy|0
5995571|NCT00951015|20732121|P3|Open-label Phase|Lack of Efficacy|0
5995572|NCT00951015|20732122|P2|Open-label Phase|Lack of Efficacy|0
5995573|NCT00951015|20732123|P1|Open-label Phase|Lack of Efficacy|0
5995574|NCT00951015|20732119|P5|Open-label Phase|Adverse Event|3
5995575|NCT00951015|20732120|P4|Open-label Phase|Adverse Event|0
5995576|NCT00951015|20732121|P3|Open-label Phase|Adverse Event|0
5995577|NCT00951015|20732122|P2|Open-label Phase|Adverse Event|0
5995578|NCT00951015|20732123|P1|Open-label Phase|Adverse Event|0
5995579|NCT00951015|20732119|P5|Randomization Phase 96 Week|Withdrawal by Subject|0
5995580|NCT00951015|20732120|P4|Randomization Phase 96 Week|Withdrawal by Subject|2
5995581|NCT00951015|20732121|P3|Randomization Phase 96 Week|Withdrawal by Subject|1
5995582|NCT00951015|20732122|P2|Randomization Phase 96 Week|Withdrawal by Subject|1
5995583|NCT00951015|20732123|P1|Randomization Phase 96 Week|Withdrawal by Subject|2
5995584|NCT00951015|20732119|P5|Randomization Phase 96 Week|Lost to Follow-up|0
5995585|NCT00951015|20732120|P4|Randomization Phase 96 Week|Lost to Follow-up|2
5995586|NCT00951015|20732121|P3|Randomization Phase 96 Week|Lost to Follow-up|1
5995587|NCT00951015|20732122|P2|Randomization Phase 96 Week|Lost to Follow-up|3
5995588|NCT00951015|20732123|P1|Randomization Phase 96 Week|Lost to Follow-up|0
5995589|NCT00951015|20732119|P5|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0
5995590|NCT00951015|20732120|P4|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|1
5995591|NCT00951015|20732121|P3|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0
5995592|NCT00951015|20732122|P2|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0
5995593|NCT00951015|20732123|P1|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0
5995594|NCT00951015|20732119|P5|Randomization Phase 96 Week|Protocol Violation|0
5995595|NCT00951015|20732120|P4|Randomization Phase 96 Week|Protocol Violation|0
5995596|NCT00951015|20732121|P3|Randomization Phase 96 Week|Protocol Violation|1
5995597|NCT00951015|20732122|P2|Randomization Phase 96 Week|Protocol Violation|1
5995598|NCT00951015|20732123|P1|Randomization Phase 96 Week|Protocol Violation|1
5995599|NCT00951015|20732119|P5|Randomization Phase 96 Week|Lack of Efficacy|0
5995600|NCT00951015|20732120|P4|Randomization Phase 96 Week|Lack of Efficacy|0
5995601|NCT00951015|20732121|P3|Randomization Phase 96 Week|Lack of Efficacy|0
5995602|NCT00951015|20732122|P2|Randomization Phase 96 Week|Lack of Efficacy|1
5995603|NCT00951015|20732123|P1|Randomization Phase 96 Week|Lack of Efficacy|1
5995604|NCT00951015|20732119|P5|Randomization Phase 96 Week|Adverse Event|0
5995605|NCT00951015|20732120|P4|Randomization Phase 96 Week|Adverse Event|5
5995606|NCT00951015|20732121|P3|Randomization Phase 96 Week|Adverse Event|2
5995607|NCT00951015|20732122|P2|Randomization Phase 96 Week|Adverse Event|1
5995608|NCT00951015|20732123|P1|Randomization Phase 96 Week|Adverse Event|1
5995609|NCT00950963|20732220|P2|Overall Study|Lost to Follow-up|24
5995610|NCT00950963|20732221|P1|Overall Study|Lost to Follow-up|29
5995611|NCT00950950|20732237|P2|Overall Study|Withdrawal by Subject|1
5995612|NCT00950950|20732238|P1|Overall Study|Withdrawal by Subject|0
5995613|NCT00950950|20732237|P2|Overall Study|Adverse Event|0
5995614|NCT00950950|20732238|P1|Overall Study|Adverse Event|1
5995615|NCT00950911|20732320|P2|Overall Study|Poor performance status|1
5995616|NCT00950911|20732321|P1|Overall Study|Poor performance status|0
5995617|NCT00950911|20732320|P2|Overall Study|Noncompliance|0
5995618|NCT00950911|20732321|P1|Overall Study|Noncompliance|1
5995619|NCT00950911|20732320|P2|Overall Study|Ineligibility determined|0
5995620|NCT00950911|20732321|P1|Overall Study|Ineligibility determined|1
5995621|NCT00950911|20732320|P2|Overall Study|Administrative decision|1
5995622|NCT00950911|20732321|P1|Overall Study|Administrative decision|3
5995623|NCT00950911|20732320|P2|Overall Study|Consent withdrawn|3
5995624|NCT00950911|20732321|P1|Overall Study|Consent withdrawn|1
5995625|NCT00950911|20732320|P2|Overall Study|Disease progression|2
5995626|NCT00950911|20732321|P1|Overall Study|Disease progression|2
5995627|NCT00950911|20732320|P2|Overall Study|Death|6
5995628|NCT00950911|20732321|P1|Overall Study|Death|4
5995629|NCT00950911|20732320|P2|Overall Study|Adverse Event|2
5995630|NCT00950911|20732321|P1|Overall Study|Adverse Event|0
5995631|NCT00950872|20732327|P1|Overall Study|Did not have surgery|2
5995632|NCT00950872|20732327|P1|Overall Study|Withdrawal by Subject|1
5995633|NCT00950859|20732336|P2|Overall Study|Lost to Follow-up|3
5995634|NCT00950859|20732337|P1|Overall Study|Lost to Follow-up|0
5995635|NCT00950859|20732336|P2|Overall Study|Protocol Violation|1
5995636|NCT00950859|20732337|P1|Overall Study|Protocol Violation|1
5995637|NCT00950859|20732336|P2|Overall Study|Insufficient Viral Load Response|3
5995638|NCT00950859|20732337|P1|Overall Study|Insufficient Viral Load Response|12
5995639|NCT00950859|20732336|P2|Overall Study|Adverse Event|3
5995640|NCT00950859|20732337|P1|Overall Study|Adverse Event|3
5995641|NCT00950807|20732436|P10|Treatment Period 3|Adverse Event|0
5995642|NCT00950807|20732437|P9|Treatment Period 3|Adverse Event|0
5995643|NCT00950807|20732438|P8|Treatment Period 3|Adverse Event|0
5995644|NCT00950807|20732439|P7|Treatment Period 3|Adverse Event|1
5995645|NCT00950807|20732440|P6|Treatment Period 3|Adverse Event|0
5995646|NCT00950807|20732441|P5|Treatment Period 3|Adverse Event|0
5995647|NCT00950807|20732442|P4|Treatment Period 3|Adverse Event|0
5995648|NCT00950807|20732443|P3|Treatment Period 3|Adverse Event|0
5995649|NCT00950807|20732444|P2|Treatment Period 3|Adverse Event|0
5995650|NCT00950807|20732445|P1|Treatment Period 3|Adverse Event|0
5995651|NCT00950807|20732436|P10|Treatment Period 3|Protocol-defined Stopping Criteria|0
5995652|NCT00950807|20732437|P9|Treatment Period 3|Protocol-defined Stopping Criteria|0
5995653|NCT00950807|20732438|P8|Treatment Period 3|Protocol-defined Stopping Criteria|1
5995654|NCT00950807|20732439|P7|Treatment Period 3|Protocol-defined Stopping Criteria|0
5995655|NCT00950807|20732440|P6|Treatment Period 3|Protocol-defined Stopping Criteria|0
5995656|NCT00950807|20732441|P5|Treatment Period 3|Protocol-defined Stopping Criteria|0
5995657|NCT00950807|20732442|P4|Treatment Period 3|Protocol-defined Stopping Criteria|0
5995658|NCT00950807|20732443|P3|Treatment Period 3|Protocol-defined Stopping Criteria|0
5995659|NCT00950807|20732444|P2|Treatment Period 3|Protocol-defined Stopping Criteria|0
5995660|NCT00950807|20732445|P1|Treatment Period 3|Protocol-defined Stopping Criteria|1
5995661|NCT00950807|20732436|P10|Treatment Period 3|Withdrawal by Subject|1
5995662|NCT00950807|20732437|P9|Treatment Period 3|Withdrawal by Subject|0
5995663|NCT00950807|20732438|P8|Treatment Period 3|Withdrawal by Subject|0
5995664|NCT00950807|20732439|P7|Treatment Period 3|Withdrawal by Subject|0
5995665|NCT00950807|20732440|P6|Treatment Period 3|Withdrawal by Subject|0
5995666|NCT00950807|20732441|P5|Treatment Period 3|Withdrawal by Subject|0
5995667|NCT00950807|20732442|P4|Treatment Period 3|Withdrawal by Subject|0
5995668|NCT00950807|20732443|P3|Treatment Period 3|Withdrawal by Subject|0
5995669|NCT00950807|20732444|P2|Treatment Period 3|Withdrawal by Subject|0
5995670|NCT00950807|20732445|P1|Treatment Period 3|Withdrawal by Subject|0
5995671|NCT00950807|20732436|P10|Washout Period 2|Adverse Event|0
5995672|NCT00950807|20732437|P9|Washout Period 2|Adverse Event|0
5995673|NCT00950807|20732438|P8|Washout Period 2|Adverse Event|0
5995674|NCT00950807|20732439|P7|Washout Period 2|Adverse Event|0
5995675|NCT00950807|20732440|P6|Washout Period 2|Adverse Event|0
5995676|NCT00950807|20732441|P5|Washout Period 2|Adverse Event|0
5995677|NCT00950807|20732442|P4|Washout Period 2|Adverse Event|1
5995678|NCT00950807|20732443|P3|Washout Period 2|Adverse Event|0
5995679|NCT00950807|20732444|P2|Washout Period 2|Adverse Event|0
5995680|NCT00950807|20732445|P1|Washout Period 2|Adverse Event|3
5995681|NCT00950807|20732436|P10|Washout Period 2|Protocol-defined Stopping Criteria|0
5995682|NCT00950807|20732437|P9|Washout Period 2|Protocol-defined Stopping Criteria|0
5995683|NCT00950807|20732438|P8|Washout Period 2|Protocol-defined Stopping Criteria|1
5995684|NCT00950807|20732439|P7|Washout Period 2|Protocol-defined Stopping Criteria|1
5995685|NCT00950807|20732440|P6|Washout Period 2|Protocol-defined Stopping Criteria|0
5995686|NCT00950807|20732441|P5|Washout Period 2|Protocol-defined Stopping Criteria|1
5995687|NCT00950807|20732442|P4|Washout Period 2|Protocol-defined Stopping Criteria|0
5995688|NCT00950807|20732443|P3|Washout Period 2|Protocol-defined Stopping Criteria|0
5995689|NCT00950807|20732444|P2|Washout Period 2|Protocol-defined Stopping Criteria|1
5995690|NCT00950807|20732445|P1|Washout Period 2|Protocol-defined Stopping Criteria|0
5995691|NCT00950807|20732436|P10|Washout Period 2|Lack of Efficacy|0
5995692|NCT00950807|20732437|P9|Washout Period 2|Lack of Efficacy|0
5995693|NCT00950807|20732438|P8|Washout Period 2|Lack of Efficacy|0
5995694|NCT00950807|20732439|P7|Washout Period 2|Lack of Efficacy|0
5995695|NCT00950807|20732440|P6|Washout Period 2|Lack of Efficacy|0
5995696|NCT00950807|20732441|P5|Washout Period 2|Lack of Efficacy|0
5995697|NCT00950807|20732442|P4|Washout Period 2|Lack of Efficacy|0
5995698|NCT00950807|20732443|P3|Washout Period 2|Lack of Efficacy|0
5995699|NCT00950807|20732444|P2|Washout Period 2|Lack of Efficacy|0
5995700|NCT00950807|20732445|P1|Washout Period 2|Lack of Efficacy|1
5995701|NCT00950807|20732436|P10|Treatment Period 2|Adverse Event|0
5995702|NCT00950807|20732437|P9|Treatment Period 2|Adverse Event|0
5995703|NCT00950807|20732438|P8|Treatment Period 2|Adverse Event|1
5995704|NCT00950807|20732439|P7|Treatment Period 2|Adverse Event|0
5995705|NCT00950807|20732440|P6|Treatment Period 2|Adverse Event|1
5995706|NCT00950807|20732441|P5|Treatment Period 2|Adverse Event|0
5995707|NCT00950807|20732442|P4|Treatment Period 2|Adverse Event|1
5995708|NCT00950807|20732443|P3|Treatment Period 2|Adverse Event|0
5995709|NCT00950807|20732444|P2|Treatment Period 2|Adverse Event|1
5995710|NCT00950807|20732445|P1|Treatment Period 2|Adverse Event|0
5995711|NCT00950807|20732436|P10|Treatment Period 2|Protocol-defined Stopping Criteria|0
5995712|NCT00950807|20732437|P9|Treatment Period 2|Protocol-defined Stopping Criteria|0
5995713|NCT00950807|20732438|P8|Treatment Period 2|Protocol-defined Stopping Criteria|0
5995714|NCT00950807|20732439|P7|Treatment Period 2|Protocol-defined Stopping Criteria|0
5995715|NCT00950807|20732440|P6|Treatment Period 2|Protocol-defined Stopping Criteria|0
5995716|NCT00950807|20732441|P5|Treatment Period 2|Protocol-defined Stopping Criteria|0
5995717|NCT00950807|20732442|P4|Treatment Period 2|Protocol-defined Stopping Criteria|0
5995718|NCT00950807|20732443|P3|Treatment Period 2|Protocol-defined Stopping Criteria|0
5995719|NCT00950807|20732444|P2|Treatment Period 2|Protocol-defined Stopping Criteria|0
5995720|NCT00950807|20732445|P1|Treatment Period 2|Protocol-defined Stopping Criteria|1
5995721|NCT00950807|20732436|P10|Treatment Period 2|Withdrawal by Subject|0
5995722|NCT00950807|20732437|P9|Treatment Period 2|Withdrawal by Subject|0
5995723|NCT00950807|20732438|P8|Treatment Period 2|Withdrawal by Subject|2
5995724|NCT00950807|20732439|P7|Treatment Period 2|Withdrawal by Subject|1
5995725|NCT00950807|20732440|P6|Treatment Period 2|Withdrawal by Subject|0
5995726|NCT00950807|20732441|P5|Treatment Period 2|Withdrawal by Subject|0
5995727|NCT00950807|20732442|P4|Treatment Period 2|Withdrawal by Subject|0
5995728|NCT00950807|20732443|P3|Treatment Period 2|Withdrawal by Subject|0
5995729|NCT00950807|20732444|P2|Treatment Period 2|Withdrawal by Subject|0
5995730|NCT00950807|20732445|P1|Treatment Period 2|Withdrawal by Subject|0
5995731|NCT00950807|20732436|P10|Treatment Period 2|Lack of Efficacy|0
5995732|NCT00950807|20732437|P9|Treatment Period 2|Lack of Efficacy|0
5995733|NCT00950807|20732438|P8|Treatment Period 2|Lack of Efficacy|0
5995734|NCT00950807|20732439|P7|Treatment Period 2|Lack of Efficacy|0
5995735|NCT00950807|20732440|P6|Treatment Period 2|Lack of Efficacy|0
5995736|NCT00950807|20732441|P5|Treatment Period 2|Lack of Efficacy|0
5995737|NCT00950807|20732442|P4|Treatment Period 2|Lack of Efficacy|0
5995738|NCT00950807|20732443|P3|Treatment Period 2|Lack of Efficacy|0
5995739|NCT00950807|20732444|P2|Treatment Period 2|Lack of Efficacy|0
5995740|NCT00950807|20732445|P1|Treatment Period 2|Lack of Efficacy|1
5995741|NCT00950807|20732436|P10|Washout Period 1|Adverse Event|0
5995742|NCT00950807|20732437|P9|Washout Period 1|Adverse Event|0
5995743|NCT00950807|20732438|P8|Washout Period 1|Adverse Event|0
5995744|NCT00950807|20732439|P7|Washout Period 1|Adverse Event|0
5995745|NCT00950807|20732440|P6|Washout Period 1|Adverse Event|0
5995746|NCT00950807|20732441|P5|Washout Period 1|Adverse Event|1
5995747|NCT00950807|20732442|P4|Washout Period 1|Adverse Event|1
5995748|NCT00950807|20732443|P3|Washout Period 1|Adverse Event|0
5995749|NCT00950807|20732444|P2|Washout Period 1|Adverse Event|0
5995750|NCT00950807|20732445|P1|Washout Period 1|Adverse Event|2
5995751|NCT00950807|20732436|P10|Washout Period 1|Protocol-defined Stopping Criteria|0
5995752|NCT00950807|20732437|P9|Washout Period 1|Protocol-defined Stopping Criteria|0
5995753|NCT00950807|20732438|P8|Washout Period 1|Protocol-defined Stopping Criteria|1
5995754|NCT00950807|20732439|P7|Washout Period 1|Protocol-defined Stopping Criteria|1
5995755|NCT00950807|20732440|P6|Washout Period 1|Protocol-defined Stopping Criteria|0
5995756|NCT00950807|20732441|P5|Washout Period 1|Protocol-defined Stopping Criteria|0
5995757|NCT00950807|20732442|P4|Washout Period 1|Protocol-defined Stopping Criteria|0
5995758|NCT00950807|20732443|P3|Washout Period 1|Protocol-defined Stopping Criteria|0
5995759|NCT00950807|20732444|P2|Washout Period 1|Protocol-defined Stopping Criteria|0
5995760|NCT00950807|20732445|P1|Washout Period 1|Protocol-defined Stopping Criteria|3
5995761|NCT00950807|20732436|P10|Washout Period 1|Withdrawal by Subject|0
5995762|NCT00950807|20732437|P9|Washout Period 1|Withdrawal by Subject|1
5995763|NCT00950807|20732438|P8|Washout Period 1|Withdrawal by Subject|0
5995764|NCT00950807|20732439|P7|Washout Period 1|Withdrawal by Subject|0
5995765|NCT00950807|20732440|P6|Washout Period 1|Withdrawal by Subject|0
5995766|NCT00950807|20732441|P5|Washout Period 1|Withdrawal by Subject|0
5995767|NCT00950807|20732442|P4|Washout Period 1|Withdrawal by Subject|0
5995768|NCT00950807|20732443|P3|Washout Period 1|Withdrawal by Subject|0
5995769|NCT00950807|20732444|P2|Washout Period 1|Withdrawal by Subject|0
5995770|NCT00950807|20732445|P1|Washout Period 1|Withdrawal by Subject|0
5995771|NCT00950807|20732436|P10|Washout Period 1|Lack of Efficacy|0
5995772|NCT00950807|20732437|P9|Washout Period 1|Lack of Efficacy|0
5995773|NCT00950807|20732438|P8|Washout Period 1|Lack of Efficacy|0
5995774|NCT00950807|20732439|P7|Washout Period 1|Lack of Efficacy|1
5995775|NCT00950807|20732440|P6|Washout Period 1|Lack of Efficacy|0
5995776|NCT00950807|20732441|P5|Washout Period 1|Lack of Efficacy|0
5995777|NCT00950807|20732442|P4|Washout Period 1|Lack of Efficacy|0
5995778|NCT00950807|20732443|P3|Washout Period 1|Lack of Efficacy|0
5995779|NCT00950807|20732444|P2|Washout Period 1|Lack of Efficacy|0
5995780|NCT00950807|20732445|P1|Washout Period 1|Lack of Efficacy|0
5995781|NCT00950807|20732436|P10|Treatment Period 1|Adverse Event|0
5995782|NCT00950807|20732437|P9|Treatment Period 1|Adverse Event|0
5995783|NCT00950807|20732438|P8|Treatment Period 1|Adverse Event|0
5995784|NCT00950807|20732439|P7|Treatment Period 1|Adverse Event|0
5995785|NCT00950807|20732440|P6|Treatment Period 1|Adverse Event|1
5995786|NCT00950807|20732441|P5|Treatment Period 1|Adverse Event|0
5995787|NCT00950807|20732442|P4|Treatment Period 1|Adverse Event|0
5995788|NCT00950807|20732443|P3|Treatment Period 1|Adverse Event|0
5995789|NCT00950807|20732444|P2|Treatment Period 1|Adverse Event|0
5995790|NCT00950807|20732445|P1|Treatment Period 1|Adverse Event|0
5995791|NCT00950807|20732436|P10|Treatment Period 1|Withdrawal by Subject|0
5995792|NCT00950807|20732437|P9|Treatment Period 1|Withdrawal by Subject|1
5995793|NCT00950807|20732438|P8|Treatment Period 1|Withdrawal by Subject|0
5995794|NCT00950807|20732439|P7|Treatment Period 1|Withdrawal by Subject|0
5995795|NCT00950807|20732440|P6|Treatment Period 1|Withdrawal by Subject|0
5995796|NCT00950807|20732441|P5|Treatment Period 1|Withdrawal by Subject|1
5995797|NCT00950807|20732442|P4|Treatment Period 1|Withdrawal by Subject|0
5995798|NCT00950807|20732443|P3|Treatment Period 1|Withdrawal by Subject|0
5995799|NCT00950807|20732444|P2|Treatment Period 1|Withdrawal by Subject|0
5995800|NCT00950807|20732445|P1|Treatment Period 1|Withdrawal by Subject|1
5995801|NCT00950807|20732436|P10|Treatment Period 1|Lost to Follow-up|0
5995802|NCT00950807|20732437|P9|Treatment Period 1|Lost to Follow-up|0
5995803|NCT00950807|20732438|P8|Treatment Period 1|Lost to Follow-up|0
5995804|NCT00950807|20732439|P7|Treatment Period 1|Lost to Follow-up|0
5995805|NCT00950807|20732440|P6|Treatment Period 1|Lost to Follow-up|0
5995806|NCT00950807|20732441|P5|Treatment Period 1|Lost to Follow-up|0
5995807|NCT00950807|20732442|P4|Treatment Period 1|Lost to Follow-up|0
5995808|NCT00950807|20732443|P3|Treatment Period 1|Lost to Follow-up|1
5995809|NCT00950807|20732444|P2|Treatment Period 1|Lost to Follow-up|0
5995810|NCT00950807|20732445|P1|Treatment Period 1|Lost to Follow-up|0
5995811|NCT00950807|20732436|P10|Treatment Period 1|Protocol Violation|0
5995812|NCT00950807|20732437|P9|Treatment Period 1|Protocol Violation|0
5995813|NCT00950807|20732438|P8|Treatment Period 1|Protocol Violation|0
5995814|NCT00950807|20732439|P7|Treatment Period 1|Protocol Violation|0
5995815|NCT00950807|20732440|P6|Treatment Period 1|Protocol Violation|0
5995816|NCT00950807|20732441|P5|Treatment Period 1|Protocol Violation|0
5995817|NCT00950807|20732442|P4|Treatment Period 1|Protocol Violation|0
5995818|NCT00950807|20732443|P3|Treatment Period 1|Protocol Violation|0
5995819|NCT00950807|20732444|P2|Treatment Period 1|Protocol Violation|0
5995820|NCT00950807|20732445|P1|Treatment Period 1|Protocol Violation|1
5995821|NCT00950807|20732436|P10|Treatment Period 1|Lack of Efficacy|0
5995822|NCT00950807|20732437|P9|Treatment Period 1|Lack of Efficacy|0
5995823|NCT00950807|20732438|P8|Treatment Period 1|Lack of Efficacy|0
5995824|NCT00950807|20732439|P7|Treatment Period 1|Lack of Efficacy|0
5995825|NCT00950807|20732440|P6|Treatment Period 1|Lack of Efficacy|1
5995826|NCT00950807|20732441|P5|Treatment Period 1|Lack of Efficacy|0
5995827|NCT00950807|20732442|P4|Treatment Period 1|Lack of Efficacy|0
5995828|NCT00950807|20732443|P3|Treatment Period 1|Lack of Efficacy|0
5995829|NCT00950807|20732444|P2|Treatment Period 1|Lack of Efficacy|0
5995830|NCT00950807|20732445|P1|Treatment Period 1|Lack of Efficacy|1
5995831|NCT00950755|20732487|P1|Long-Term Follow-Up|Death|8
5995832|NCT00950755|20732487|P1|Long-Term Follow-Up|Lost to Follow-up|1
5995833|NCT00950755|20732487|P1|Dosimetric and Therapeutic Treatment|Investigator Discretion|1
5995834|NCT00950755|20732487|P1|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|6
5995835|NCT00950755|20732487|P1|Dosimetric and Therapeutic Treatment|Participant Moved; Unable to Follow Up|1
5995836|NCT00950755|20732487|P1|Dosimetric and Therapeutic Treatment|Stroke; Difficult to Attend Study Visits|1
5995837|NCT00950755|20732487|P1|Dosimetric and Therapeutic Treatment|Death|1
5995838|NCT00950755|20732487|P1|Dosimetric and Therapeutic Treatment|Progressive Disease|27
5995839|NCT00950755|20732487|P1|Dosimetric and Therapeutic Treatment|Received Alternative Therapy|1
5995840|NCT00950755|20732487|P1|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3
5995841|NCT00950742|20732513|P2|Overall Study|Dose limiting toxicity|0
5995842|NCT00950742|20732514|P1|Overall Study|Dose limiting toxicity|6
5995843|NCT00950742|20732513|P2|Overall Study|Progressive Disease|2
5995844|NCT00950742|20732514|P1|Overall Study|Progressive Disease|6
5995845|NCT00950742|20732513|P2|Overall Study|Withdrawal by Subject|0
5995846|NCT00950742|20732514|P1|Overall Study|Withdrawal by Subject|3
5995847|NCT00950742|20732513|P2|Overall Study|Other Adverse Event|0
5995848|NCT00950742|20732514|P1|Overall Study|Other Adverse Event|1
5995854|NCT00950664|20732542|P2|First Intervention|Withdrawal by Subject|2
5995855|NCT00950664|20732543|P1|First Intervention|Withdrawal by Subject|2
5995856|NCT00950664|20732542|P2|First Intervention|Lost to Follow-up|3
5995857|NCT00950664|20732543|P1|First Intervention|Lost to Follow-up|1
5995858|NCT00950651|20732563|P2|Overall Study|Withdrawal by Subject|9
5995859|NCT00950651|20732564|P1|Overall Study|Withdrawal by Subject|8
5995860|NCT00950651|20732563|P2|Overall Study|Protocol Violation|4
5995861|NCT00950651|20732564|P1|Overall Study|Protocol Violation|3
5995862|NCT00950651|20732563|P2|Overall Study|Lack of Efficacy|2
5995863|NCT00950651|20732564|P1|Overall Study|Lack of Efficacy|2
5995864|NCT00950651|20732563|P2|Overall Study|Death|0
5995865|NCT00950651|20732564|P1|Overall Study|Death|1
5995866|NCT00950651|20732563|P2|Overall Study|Adverse Event|20
5995867|NCT00950651|20732564|P1|Overall Study|Adverse Event|17
5995868|NCT00950599|20732657|P10|Follow-Up Period|Subject withdrew Consent|1
5995869|NCT00950599|20732658|P9|Follow-Up Period|Subject withdrew Consent|2
5995870|NCT00950599|20732659|P8|Follow-Up Period|Subject withdrew Consent|0
5995871|NCT00950599|20732660|P7|Follow-Up Period|Subject withdrew Consent|0
5995872|NCT00950599|20732661|P6|Follow-Up Period|Subject withdrew Consent|0
5995873|NCT00950599|20732662|P5|Follow-Up Period|Subject withdrew Consent|0
5995874|NCT00950599|20732663|P4|Follow-Up Period|Subject withdrew Consent|0
5995875|NCT00950599|20732664|P3|Follow-Up Period|Subject withdrew Consent|0
5995876|NCT00950599|20732665|P2|Follow-Up Period|Subject withdrew Consent|0
5995877|NCT00950599|20732666|P1|Follow-Up Period|Subject withdrew Consent|0
5995878|NCT00950599|20732657|P10|Follow-Up Period|Poor/Noncompliance|0
5995879|NCT00950599|20732658|P9|Follow-Up Period|Poor/Noncompliance|1
5995880|NCT00950599|20732659|P8|Follow-Up Period|Poor/Noncompliance|0
5995881|NCT00950599|20732660|P7|Follow-Up Period|Poor/Noncompliance|0
5995882|NCT00950599|20732661|P6|Follow-Up Period|Poor/Noncompliance|0
5995883|NCT00950599|20732662|P5|Follow-Up Period|Poor/Noncompliance|0
5995884|NCT00950599|20732663|P4|Follow-Up Period|Poor/Noncompliance|0
5995885|NCT00950599|20732664|P3|Follow-Up Period|Poor/Noncompliance|0
5995886|NCT00950599|20732665|P2|Follow-Up Period|Poor/Noncompliance|0
5995887|NCT00950599|20732666|P1|Follow-Up Period|Poor/Noncompliance|0
5995888|NCT00950599|20732657|P10|Follow-Up Period|Physician Decision|0
5995889|NCT00950599|20732658|P9|Follow-Up Period|Physician Decision|1
5995890|NCT00950599|20732659|P8|Follow-Up Period|Physician Decision|0
5995891|NCT00950599|20732660|P7|Follow-Up Period|Physician Decision|0
5995892|NCT00950599|20732661|P6|Follow-Up Period|Physician Decision|0
5995893|NCT00950599|20732662|P5|Follow-Up Period|Physician Decision|0
5995894|NCT00950599|20732663|P4|Follow-Up Period|Physician Decision|0
5995895|NCT00950599|20732664|P3|Follow-Up Period|Physician Decision|0
5995896|NCT00950599|20732665|P2|Follow-Up Period|Physician Decision|0
5995897|NCT00950599|20732666|P1|Follow-Up Period|Physician Decision|0
5995898|NCT00950599|20732657|P10|Follow-Up Period|Lost to Follow-up|1
5995899|NCT00950599|20732658|P9|Follow-Up Period|Lost to Follow-up|5
5995900|NCT00950599|20732659|P8|Follow-Up Period|Lost to Follow-up|0
5995901|NCT00950599|20732660|P7|Follow-Up Period|Lost to Follow-up|0
5995902|NCT00950599|20732661|P6|Follow-Up Period|Lost to Follow-up|0
5995903|NCT00950599|20732662|P5|Follow-Up Period|Lost to Follow-up|0
5995904|NCT00950599|20732663|P4|Follow-Up Period|Lost to Follow-up|0
5995905|NCT00950599|20732664|P3|Follow-Up Period|Lost to Follow-up|0
5995906|NCT00950599|20732665|P2|Follow-Up Period|Lost to Follow-up|0
5995907|NCT00950599|20732666|P1|Follow-Up Period|Lost to Follow-up|0
5995908|NCT00950599|20732657|P10|Follow-Up Period|Lack of Efficacy|0
5995909|NCT00950599|20732658|P9|Follow-Up Period|Lack of Efficacy|3
5995910|NCT00950599|20732659|P8|Follow-Up Period|Lack of Efficacy|0
5995911|NCT00950599|20732660|P7|Follow-Up Period|Lack of Efficacy|0
5995912|NCT00950599|20732661|P6|Follow-Up Period|Lack of Efficacy|0
5995913|NCT00950599|20732662|P5|Follow-Up Period|Lack of Efficacy|0
5995914|NCT00950599|20732663|P4|Follow-Up Period|Lack of Efficacy|0
5995915|NCT00950599|20732664|P3|Follow-Up Period|Lack of Efficacy|0
5995916|NCT00950599|20732665|P2|Follow-Up Period|Lack of Efficacy|0
5995917|NCT00950599|20732666|P1|Follow-Up Period|Lack of Efficacy|0
5995918|NCT00950599|20732657|P10|Follow-Up Period|Adverse Event|0
5995919|NCT00950599|20732658|P9|Follow-Up Period|Adverse Event|1
5995920|NCT00950599|20732659|P8|Follow-Up Period|Adverse Event|0
5995921|NCT00950599|20732660|P7|Follow-Up Period|Adverse Event|0
5995922|NCT00950599|20732661|P6|Follow-Up Period|Adverse Event|0
5995923|NCT00950599|20732662|P5|Follow-Up Period|Adverse Event|0
5995924|NCT00950599|20732663|P4|Follow-Up Period|Adverse Event|0
5995925|NCT00950599|20732664|P3|Follow-Up Period|Adverse Event|0
5995926|NCT00950599|20732665|P2|Follow-Up Period|Adverse Event|0
5995927|NCT00950599|20732666|P1|Follow-Up Period|Adverse Event|0
5995928|NCT00950599|20732657|P10|Double-Blind Treatment Period|Subject Withdrew consent|0
5995929|NCT00950599|20732658|P9|Double-Blind Treatment Period|Subject Withdrew consent|0
5996004|NCT00950300|20733252|P2|TFFU Period|Other|3
5995930|NCT00950599|20732659|P8|Double-Blind Treatment Period|Subject Withdrew consent|3
5995931|NCT00950599|20732660|P7|Double-Blind Treatment Period|Subject Withdrew consent|0
5995932|NCT00950599|20732661|P6|Double-Blind Treatment Period|Subject Withdrew consent|2
5995933|NCT00950599|20732662|P5|Double-Blind Treatment Period|Subject Withdrew consent|1
5995934|NCT00950599|20732663|P4|Double-Blind Treatment Period|Subject Withdrew consent|1
5995935|NCT00950599|20732664|P3|Double-Blind Treatment Period|Subject Withdrew consent|3
5995936|NCT00950599|20732665|P2|Double-Blind Treatment Period|Subject Withdrew consent|3
5995937|NCT00950599|20732666|P1|Double-Blind Treatment Period|Subject Withdrew consent|4
5995938|NCT00950599|20732657|P10|Double-Blind Treatment Period|Subject no longer meets study criteria|0
5995939|NCT00950599|20732658|P9|Double-Blind Treatment Period|Subject no longer meets study criteria|0
5995940|NCT00950599|20732659|P8|Double-Blind Treatment Period|Subject no longer meets study criteria|0
5995941|NCT00950599|20732660|P7|Double-Blind Treatment Period|Subject no longer meets study criteria|0
5995942|NCT00950599|20732661|P6|Double-Blind Treatment Period|Subject no longer meets study criteria|1
5995943|NCT00950599|20732662|P5|Double-Blind Treatment Period|Subject no longer meets study criteria|1
5995944|NCT00950599|20732663|P4|Double-Blind Treatment Period|Subject no longer meets study criteria|0
5995945|NCT00950599|20732664|P3|Double-Blind Treatment Period|Subject no longer meets study criteria|0
5995946|NCT00950599|20732665|P2|Double-Blind Treatment Period|Subject no longer meets study criteria|0
5995947|NCT00950599|20732666|P1|Double-Blind Treatment Period|Subject no longer meets study criteria|0
5995948|NCT00950599|20732657|P10|Double-Blind Treatment Period|Poor/Noncompliance|0
5995949|NCT00950599|20732658|P9|Double-Blind Treatment Period|Poor/Noncompliance|0
5995950|NCT00950599|20732659|P8|Double-Blind Treatment Period|Poor/Noncompliance|1
5995951|NCT00950599|20732660|P7|Double-Blind Treatment Period|Poor/Noncompliance|0
5995952|NCT00950599|20732661|P6|Double-Blind Treatment Period|Poor/Noncompliance|0
5995953|NCT00950599|20732662|P5|Double-Blind Treatment Period|Poor/Noncompliance|0
5995954|NCT00950599|20732663|P4|Double-Blind Treatment Period|Poor/Noncompliance|0
5995955|NCT00950599|20732664|P3|Double-Blind Treatment Period|Poor/Noncompliance|0
5995956|NCT00950599|20732665|P2|Double-Blind Treatment Period|Poor/Noncompliance|1
5995957|NCT00950599|20732666|P1|Double-Blind Treatment Period|Poor/Noncompliance|1
5995958|NCT00950599|20732657|P10|Double-Blind Treatment Period|Lost to Follow-up|0
5995959|NCT00950599|20732658|P9|Double-Blind Treatment Period|Lost to Follow-up|0
5995960|NCT00950599|20732659|P8|Double-Blind Treatment Period|Lost to Follow-up|1
5995961|NCT00950599|20732660|P7|Double-Blind Treatment Period|Lost to Follow-up|0
5995962|NCT00950599|20732661|P6|Double-Blind Treatment Period|Lost to Follow-up|2
5995963|NCT00950599|20732662|P5|Double-Blind Treatment Period|Lost to Follow-up|1
5995964|NCT00950599|20732663|P4|Double-Blind Treatment Period|Lost to Follow-up|1
5995965|NCT00950599|20732664|P3|Double-Blind Treatment Period|Lost to Follow-up|0
5995966|NCT00950599|20732665|P2|Double-Blind Treatment Period|Lost to Follow-up|0
5995967|NCT00950599|20732666|P1|Double-Blind Treatment Period|Lost to Follow-up|0
5995968|NCT00950599|20732657|P10|Double-Blind Treatment Period|Lack of Efficacy|0
5995969|NCT00950599|20732658|P9|Double-Blind Treatment Period|Lack of Efficacy|0
5995970|NCT00950599|20732659|P8|Double-Blind Treatment Period|Lack of Efficacy|1
5995971|NCT00950599|20732660|P7|Double-Blind Treatment Period|Lack of Efficacy|0
5995972|NCT00950599|20732661|P6|Double-Blind Treatment Period|Lack of Efficacy|6
5995973|NCT00950599|20732662|P5|Double-Blind Treatment Period|Lack of Efficacy|3
5995974|NCT00950599|20732663|P4|Double-Blind Treatment Period|Lack of Efficacy|7
5995975|NCT00950599|20732664|P3|Double-Blind Treatment Period|Lack of Efficacy|5
5995976|NCT00950599|20732665|P2|Double-Blind Treatment Period|Lack of Efficacy|5
5995977|NCT00950599|20732666|P1|Double-Blind Treatment Period|Lack of Efficacy|2
5995978|NCT00950599|20732657|P10|Double-Blind Treatment Period|Adverse Event|0
5995979|NCT00950599|20732658|P9|Double-Blind Treatment Period|Adverse Event|0
5995980|NCT00950599|20732659|P8|Double-Blind Treatment Period|Adverse Event|0
5995981|NCT00950599|20732660|P7|Double-Blind Treatment Period|Adverse Event|0
5995982|NCT00950599|20732661|P6|Double-Blind Treatment Period|Adverse Event|1
5995983|NCT00950599|20732662|P5|Double-Blind Treatment Period|Adverse Event|1
5995984|NCT00950599|20732663|P4|Double-Blind Treatment Period|Adverse Event|1
5995985|NCT00950599|20732664|P3|Double-Blind Treatment Period|Adverse Event|1
5995986|NCT00950599|20732665|P2|Double-Blind Treatment Period|Adverse Event|1
5995987|NCT00950599|20732666|P1|Double-Blind Treatment Period|Adverse Event|0
5995988|NCT00950599|20732657|P10|Double-Blind Treatment Period|Administrative reason by sponsor|0
5995989|NCT00950599|20732658|P9|Double-Blind Treatment Period|Administrative reason by sponsor|0
5995990|NCT00950599|20732659|P8|Double-Blind Treatment Period|Administrative reason by sponsor|0
5995991|NCT00950599|20732660|P7|Double-Blind Treatment Period|Administrative reason by sponsor|0
5995992|NCT00950599|20732661|P6|Double-Blind Treatment Period|Administrative reason by sponsor|0
5995993|NCT00950599|20732662|P5|Double-Blind Treatment Period|Administrative reason by sponsor|0
5995994|NCT00950599|20732663|P4|Double-Blind Treatment Period|Administrative reason by sponsor|1
5995995|NCT00950599|20732664|P3|Double-Blind Treatment Period|Administrative reason by sponsor|0
5995996|NCT00950599|20732665|P2|Double-Blind Treatment Period|Administrative reason by sponsor|0
5995997|NCT00950599|20732666|P1|Double-Blind Treatment Period|Administrative reason by sponsor|0
5995998|NCT00950300|20733252|P2|SFU Period|Withdrawal by Subject|8
5995999|NCT00950300|20733253|P1|SFU Period|Withdrawal by Subject|4
5996000|NCT00950300|20733252|P2|SFU Period|Lost to Follow-up|28
5996001|NCT00950300|20733253|P1|SFU Period|Lost to Follow-up|30
5996002|NCT00950300|20733252|P2|SFU Period|Death|42
5996003|NCT00950300|20733253|P1|SFU Period|Death|44
5996005|NCT00950300|20733253|P1|TFFU Period|Other|4
5996006|NCT00950300|20733252|P2|TFFU Period|Recurrence of Disease|72
5996007|NCT00950300|20733253|P1|TFFU Period|Recurrence of Disease|63
5996008|NCT00950300|20733252|P2|TFFU Period|Failure to Return|16
5996009|NCT00950300|20733253|P1|TFFU Period|Failure to Return|16
5996010|NCT00950300|20733252|P2|TFFU Period|Refused Treatment|11
5996011|NCT00950300|20733253|P1|TFFU Period|Refused Treatment|10
5996012|NCT00950300|20733252|P2|TFFU Period|Death|1
5996013|NCT00950300|20733253|P1|TFFU Period|Death|4
5996014|NCT00950300|20733252|P2|TFFU Period|Adverse Event or Intercurrent Illness|4
5996015|NCT00950300|20733253|P1|TFFU Period|Adverse Event or Intercurrent Illness|3
5996016|NCT00950300|20733252|P2|Neoadjuvant/Adjuvant Treatment Periods|Other|1
5996017|NCT00950300|20733253|P1|Neoadjuvant/Adjuvant Treatment Periods|Other|1
5996018|NCT00950300|20733252|P2|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|5
5996019|NCT00950300|20733253|P1|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|10
5996020|NCT00950300|20733252|P2|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|11
5996021|NCT00950300|20733253|P1|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|12
5996022|NCT00950300|20733252|P2|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|1
5996023|NCT00950300|20733253|P1|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|2
5996024|NCT00950300|20733252|P2|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|5
5996025|NCT00950300|20733253|P1|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|4
5996026|NCT00950300|20733252|P2|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|0
5996027|NCT00950300|20733253|P1|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|1
5996028|NCT00950300|20733252|P2|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|1
5996029|NCT00950300|20733253|P1|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|2
5996030|NCT00950300|20733252|P2|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|0
5996031|NCT00950300|20733253|P1|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|3
5996032|NCT00950300|20733252|P2|Neoadjuvant/Adjuvant Treatment Periods|Death|3
5996033|NCT00950300|20733253|P1|Neoadjuvant/Adjuvant Treatment Periods|Death|1
5996034|NCT00950300|20733252|P2|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|15
5996035|NCT00950300|20733253|P1|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|6
5996036|NCT00950248|20733302|P3|Year 2&3 Treatment Randomization|MRI contraindication|0
5996037|NCT00950248|20733303|P2|Year 2&3 Treatment Randomization|MRI contraindication|1
5996038|NCT00950248|20733304|P1|Year 2&3 Treatment Randomization|MRI contraindication|0
5996039|NCT00950248|20733302|P3|Year 2&3 Treatment Randomization|Death|1
5996040|NCT00950248|20733303|P2|Year 2&3 Treatment Randomization|Death|0
5996041|NCT00950248|20733304|P1|Year 2&3 Treatment Randomization|Death|0
5996042|NCT00950248|20733302|P3|Year 2&3 Treatment Randomization|Withdrawal by Subject|0
5996043|NCT00950248|20733303|P2|Year 2&3 Treatment Randomization|Withdrawal by Subject|3
5996044|NCT00950248|20733304|P1|Year 2&3 Treatment Randomization|Withdrawal by Subject|0
5996045|NCT00950248|20733302|P3|Year 2&3 Treatment Randomization|worsening of symptoms|4
5996046|NCT00950248|20733303|P2|Year 2&3 Treatment Randomization|worsening of symptoms|2
5996047|NCT00950248|20733304|P1|Year 2&3 Treatment Randomization|worsening of symptoms|0
5996048|NCT00950248|20733302|P3|Year 1: Baseline|worsening of symptoms|0
5996049|NCT00950248|20733303|P2|Year 1: Baseline|worsening of symptoms|0
5996050|NCT00950248|20733304|P1|Year 1: Baseline|worsening of symptoms|2
5996051|NCT00950248|20733302|P3|Year 1: Baseline|Withdrawal by Subject|0
5996052|NCT00950248|20733303|P2|Year 1: Baseline|Withdrawal by Subject|0
5996053|NCT00950248|20733304|P1|Year 1: Baseline|Withdrawal by Subject|6
5996054|NCT00950170|20733344|P1|Overall Study|Discontinuation of Study by Sponsor|1
5996055|NCT00950170|20733344|P1|Overall Study|Adverse Event|2
5996056|NCT00950170|20733344|P1|Overall Study|Parent/Legal Guardian Request|1
5996057|NCT00949988|20733395|P1|Overall Study|Withdrawal by Subject|3
5996058|NCT00949975|20733410|P4|Overall Study|Other|0
5996059|NCT00949975|20733411|P3|Overall Study|Other|0
5996060|NCT00949975|20733412|P2|Overall Study|Other|0
5996061|NCT00949975|20733413|P1|Overall Study|Other|1
5996062|NCT00949975|20733410|P4|Overall Study|Lost to Follow-up|3
5996063|NCT00949975|20733411|P3|Overall Study|Lost to Follow-up|1
5996064|NCT00949975|20733412|P2|Overall Study|Lost to Follow-up|0
5996065|NCT00949975|20733413|P1|Overall Study|Lost to Follow-up|1
5996066|NCT00949975|20733410|P4|Overall Study|Severe non-compliance|2
5996067|NCT00949975|20733411|P3|Overall Study|Severe non-compliance|0
5996068|NCT00949975|20733412|P2|Overall Study|Severe non-compliance|1
5996069|NCT00949975|20733413|P1|Overall Study|Severe non-compliance|3
5996070|NCT00949975|20733410|P4|Overall Study|Incorrect enrolment|7
5996071|NCT00949975|20733411|P3|Overall Study|Incorrect enrolment|4
5996072|NCT00949975|20733412|P2|Overall Study|Incorrect enrolment|10
5996073|NCT00949975|20733413|P1|Overall Study|Incorrect enrolment|5
5996074|NCT00949975|20733410|P4|Overall Study|Study-specific criteria|0
5996075|NCT00949975|20733411|P3|Overall Study|Study-specific criteria|1
5996076|NCT00949975|20733412|P2|Overall Study|Study-specific criteria|1
5996077|NCT00949975|20733413|P1|Overall Study|Study-specific criteria|0
5996078|NCT00949975|20733410|P4|Overall Study|Safety reason|0
5996079|NCT00949975|20733411|P3|Overall Study|Safety reason|0
5996080|NCT00949975|20733412|P2|Overall Study|Safety reason|1
5996081|NCT00949975|20733413|P1|Overall Study|Safety reason|0
5996082|NCT00949975|20733410|P4|Overall Study|Adverse Event|10
5996083|NCT00949975|20733411|P3|Overall Study|Adverse Event|10
5996084|NCT00949975|20733412|P2|Overall Study|Adverse Event|11
5996085|NCT00949975|20733413|P1|Overall Study|Adverse Event|11
5996086|NCT00949975|20733410|P4|Overall Study|Voluntary discontinuation|6
5996087|NCT00949975|20733411|P3|Overall Study|Voluntary discontinuation|3
5996088|NCT00949975|20733412|P2|Overall Study|Voluntary discontinuation|5
5996089|NCT00949975|20733413|P1|Overall Study|Voluntary discontinuation|6
5996090|NCT00949910|20733531|P1|Overall Study|No Data|9
5996091|NCT00949910|20733531|P1|Overall Study|Other|4
5996092|NCT00949910|20733531|P1|Overall Study|Physician/Participant Decision|7
5996093|NCT00949910|20733531|P1|Overall Study|Serious Adverse Event|6
5996094|NCT00949910|20733531|P1|Overall Study|Adverse Event|83
5996095|NCT00949910|20733531|P1|Overall Study|Prolonged Dosing Interruption|4
5996096|NCT00949910|20733531|P1|Overall Study|Non-Compliance|10
5996097|NCT00949910|20733531|P1|Overall Study|Logistical Reasons|13
5996098|NCT00949910|20733531|P1|Overall Study|Violation of Eligibility|23
5996099|NCT00949910|20733531|P1|Overall Study|Switched to Commercial Treatment|4
5996100|NCT00949910|20733531|P1|Overall Study|Switched to Compassionate/Other Use|174
5996101|NCT00949910|20733531|P1|Overall Study|Unspecified Progression/Deterioration|13
5996102|NCT00949910|20733531|P1|Overall Study|Death from Unknown Cause|5
5996103|NCT00949910|20733531|P1|Overall Study|Death Due to Toxicity|3
5996104|NCT00949910|20733531|P1|Overall Study|Death Due to Adverse Event|115
5996105|NCT00949910|20733531|P1|Overall Study|Death Due to Progression/Deterioration|4
5996106|NCT00949910|20733531|P1|Overall Study|Death Due to Malignant Disease|456
5996107|NCT00949910|20733531|P1|Overall Study|Participant Refusal|390
5996108|NCT00949910|20733531|P1|Overall Study|Study Drug-Related Adverse Event|315
5996109|NCT00949910|20733531|P1|Overall Study|Lost to Follow-up|100
5996110|NCT00949910|20733531|P1|Overall Study|Symptomatic Deterioration|1088
5996111|NCT00949910|20733531|P1|Overall Study|Progressive Disease|3750
5996112|NCT00949884|20733544|P3|Overall Study|Study terminated by sponsor|1
5996113|NCT00949884|20733545|P2|Overall Study|Study terminated by sponsor|0
5996114|NCT00949884|20733546|P1|Overall Study|Study terminated by sponsor|0
5996115|NCT00949884|20733544|P3|Overall Study|Lack of Efficacy|7
5996116|NCT00949884|20733545|P2|Overall Study|Lack of Efficacy|2
5996117|NCT00949884|20733546|P1|Overall Study|Lack of Efficacy|4
5996118|NCT00949884|20733544|P3|Overall Study|Withdrawal by Subject|16
5996119|NCT00949884|20733545|P2|Overall Study|Withdrawal by Subject|4
5996120|NCT00949884|20733546|P1|Overall Study|Withdrawal by Subject|13
5996121|NCT00949884|20733544|P3|Overall Study|Treatment non-compliance|8
5996122|NCT00949884|20733545|P2|Overall Study|Treatment non-compliance|0
5996123|NCT00949884|20733546|P1|Overall Study|Treatment non-compliance|5
5996124|NCT00949884|20733544|P3|Overall Study|Physician Decision|6
5996125|NCT00949884|20733545|P2|Overall Study|Physician Decision|0
5996126|NCT00949884|20733546|P1|Overall Study|Physician Decision|5
5996127|NCT00949884|20733544|P3|Overall Study|Lost to Follow-up|5
5996128|NCT00949884|20733545|P2|Overall Study|Lost to Follow-up|5
5996129|NCT00949884|20733546|P1|Overall Study|Lost to Follow-up|7
5996130|NCT00949884|20733544|P3|Overall Study|Did not meet inclusion/exclusion|3
5996131|NCT00949884|20733545|P2|Overall Study|Did not meet inclusion/exclusion|1
5996132|NCT00949884|20733546|P1|Overall Study|Did not meet inclusion/exclusion|2
5996133|NCT00949884|20733544|P3|Overall Study|Adverse Event|12
5996134|NCT00949884|20733545|P2|Overall Study|Adverse Event|3
5996135|NCT00949884|20733546|P1|Overall Study|Adverse Event|14
5996136|NCT00949715|20733601|P2|Overall Study|Missing 24 month LVEF measurement|0
5996137|NCT00949715|20733602|P1|Overall Study|Missing 24 month LVEF measurement|2
5996138|NCT00949715|20733601|P2|Overall Study|Lost to Follow-up|0
5996139|NCT00949715|20733602|P1|Overall Study|Lost to Follow-up|1
5996140|NCT00949715|20733601|P2|Overall Study|Physician Decision|0
5996141|NCT00949715|20733602|P1|Overall Study|Physician Decision|1
5996142|NCT00949702|20733613|P1|Overall Study|Withdrawal of consent|1
5996143|NCT00949702|20733613|P1|Overall Study|Disease progression|7
5996144|NCT00949702|20733613|P1|Overall Study|Death|40
5996145|NCT00949650|20733630|P2|Overall Study|Other not specified above|0
5996146|NCT00949650|20733631|P1|Overall Study|Other not specified above|5
5996147|NCT00949650|20733630|P2|Overall Study|Not treated|4
5996148|NCT00949650|20733631|P1|Overall Study|Not treated|1
5996149|NCT00949650|20733630|P2|Overall Study|Refusal to continue medication|11
5996150|NCT00949650|20733631|P1|Overall Study|Refusal to continue medication|7
5996151|NCT00949650|20733630|P2|Overall Study|Protocol Violation|4
5996152|NCT00949650|20733631|P1|Overall Study|Protocol Violation|1
5996153|NCT00949650|20733630|P2|Overall Study|Other Adverse Event (AE)|17
5996154|NCT00949650|20733631|P1|Overall Study|Other Adverse Event (AE)|28
5996155|NCT00949650|20733630|P2|Overall Study|Completed 6 courses of chemotherapy|60
5996156|NCT00949650|20733631|P1|Overall Study|Completed 6 courses of chemotherapy|0
5996157|NCT00949650|20733630|P2|Overall Study|Progressive disease|19
5996158|NCT00949650|20733631|P1|Overall Study|Progressive disease|188
5996159|NCT00949533|20733669|P2|Overall Study|Lost to Follow-up|1
5996160|NCT00949533|20733670|P1|Overall Study|Lost to Follow-up|0
5996161|NCT00949325|20733686|P3|Overall Study|Adverse Event|0
5996162|NCT00949325|20733687|P2|Overall Study|Adverse Event|2
5996163|NCT00949325|20733688|P1|Overall Study|Adverse Event|0
5996164|NCT00949117|20733712|P2|Overall Study|Adverse Event|1
5996165|NCT00949117|20733713|P1|Overall Study|Adverse Event|0
5996166|NCT00949117|20733712|P2|Overall Study|Protocol Violation|1
5996167|NCT00949117|20733713|P1|Overall Study|Protocol Violation|1
5996168|NCT00949117|20733712|P2|Overall Study|Lack of Efficacy|3
5996169|NCT00949117|20733713|P1|Overall Study|Lack of Efficacy|2
5996170|NCT00948974|20733754|P2|Overall Study|Lost to Follow-up|20
5996171|NCT00948974|20733755|P1|Overall Study|Lost to Follow-up|23
5996172|NCT00948922|20733773|P3|Overall Study|Not evaluable at time of analysis|0
5996173|NCT00948922|20733774|P2|Overall Study|Not evaluable at time of analysis|3
5996174|NCT00948922|20733775|P1|Overall Study|Not evaluable at time of analysis|0
5996175|NCT00948922|20733773|P3|Overall Study|Transplant eligibility issues|0
5996176|NCT00948922|20733774|P2|Overall Study|Transplant eligibility issues|3
5996177|NCT00948922|20733775|P1|Overall Study|Transplant eligibility issues|2
5996178|NCT00948922|20733773|P3|Overall Study|Insurance issues|0
5996179|NCT00948922|20733774|P2|Overall Study|Insurance issues|0
5996180|NCT00948922|20733775|P1|Overall Study|Insurance issues|1
5996181|NCT00948922|20733773|P3|Overall Study|Disease progression|0
5996182|NCT00948922|20733774|P2|Overall Study|Disease progression|1
5996183|NCT00948922|20733775|P1|Overall Study|Disease progression|0
5996184|NCT00948922|20733773|P3|Overall Study|Death|0
5996185|NCT00948922|20733774|P2|Overall Study|Death|0
5996186|NCT00948922|20733775|P1|Overall Study|Death|3
5996187|NCT00948922|20733773|P3|Overall Study|Withdrawal by Subject|1
5996188|NCT00948922|20733774|P2|Overall Study|Withdrawal by Subject|2
5996189|NCT00948922|20733775|P1|Overall Study|Withdrawal by Subject|0
5996190|NCT00948922|20733773|P3|Overall Study|Did not start study treatment|0
5996191|NCT00948922|20733774|P2|Overall Study|Did not start study treatment|5
5996192|NCT00948922|20733775|P1|Overall Study|Did not start study treatment|2
5996193|NCT00948896|20733798|P8|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
5996194|NCT00948896|20733799|P7|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
5996195|NCT00948896|20733800|P6|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
5996196|NCT00948896|20733801|P5|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
5996197|NCT00948896|20733802|P4|24 Months of Age to 36 Months of Age|Moved out of Study Area|1
5996198|NCT00948896|20733803|P3|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
5996199|NCT00948896|20733804|P2|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
5996200|NCT00948896|20733805|P1|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
5996201|NCT00948896|20733798|P8|24 Months of Age to 36 Months of Age|Protocol Violation|0
5996202|NCT00948896|20733799|P7|24 Months of Age to 36 Months of Age|Protocol Violation|0
5996203|NCT00948896|20733800|P6|24 Months of Age to 36 Months of Age|Protocol Violation|1
5996204|NCT00948896|20733801|P5|24 Months of Age to 36 Months of Age|Protocol Violation|0
5996205|NCT00948896|20733802|P4|24 Months of Age to 36 Months of Age|Protocol Violation|0
5996206|NCT00948896|20733803|P3|24 Months of Age to 36 Months of Age|Protocol Violation|1
5996207|NCT00948896|20733804|P2|24 Months of Age to 36 Months of Age|Protocol Violation|0
5996208|NCT00948896|20733805|P1|24 Months of Age to 36 Months of Age|Protocol Violation|0
5996209|NCT00948896|20733798|P8|24 Months of Age to 36 Months of Age|Lost to Follow-up|0
5996210|NCT00948896|20733799|P7|24 Months of Age to 36 Months of Age|Lost to Follow-up|0
5996211|NCT00948896|20733800|P6|24 Months of Age to 36 Months of Age|Lost to Follow-up|0
5996212|NCT00948896|20733801|P5|24 Months of Age to 36 Months of Age|Lost to Follow-up|1
5996213|NCT00948896|20733802|P4|24 Months of Age to 36 Months of Age|Lost to Follow-up|0
5996214|NCT00948896|20733803|P3|24 Months of Age to 36 Months of Age|Lost to Follow-up|1
5996215|NCT00948896|20733804|P2|24 Months of Age to 36 Months of Age|Lost to Follow-up|0
5996216|NCT00948896|20733805|P1|24 Months of Age to 36 Months of Age|Lost to Follow-up|2
5996217|NCT00948896|20733798|P8|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0
5996218|NCT00948896|20733799|P7|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0
5996219|NCT00948896|20733800|P6|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0
5996220|NCT00948896|20733801|P5|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0
5996221|NCT00948896|20733802|P4|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1
5996222|NCT00948896|20733803|P3|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1
5996223|NCT00948896|20733804|P2|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0
5996224|NCT00948896|20733805|P1|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1
5996225|NCT00948896|20733798|P8|24 Months of Age to 36 Months of Age|Death|0
5996226|NCT00948896|20733799|P7|24 Months of Age to 36 Months of Age|Death|0
5996227|NCT00948896|20733800|P6|24 Months of Age to 36 Months of Age|Death|1
5996228|NCT00948896|20733801|P5|24 Months of Age to 36 Months of Age|Death|0
5996229|NCT00948896|20733802|P4|24 Months of Age to 36 Months of Age|Death|0
5996230|NCT00948896|20733803|P3|24 Months of Age to 36 Months of Age|Death|2
5996231|NCT00948896|20733804|P2|24 Months of Age to 36 Months of Age|Death|2
5996232|NCT00948896|20733805|P1|24 Months of Age to 36 Months of Age|Death|0
5996233|NCT00948896|20733798|P8|Randomization to 24 Months of Age|Moved out of Study Area|0
5996234|NCT00948896|20733799|P7|Randomization to 24 Months of Age|Moved out of Study Area|0
5996235|NCT00948896|20733800|P6|Randomization to 24 Months of Age|Moved out of Study Area|2
5996236|NCT00948896|20733801|P5|Randomization to 24 Months of Age|Moved out of Study Area|0
5996237|NCT00948896|20733802|P4|Randomization to 24 Months of Age|Moved out of Study Area|1
5996238|NCT00948896|20733803|P3|Randomization to 24 Months of Age|Moved out of Study Area|3
5996239|NCT00948896|20733804|P2|Randomization to 24 Months of Age|Moved out of Study Area|3
5996240|NCT00948896|20733805|P1|Randomization to 24 Months of Age|Moved out of Study Area|0
5996241|NCT00948896|20733798|P8|Randomization to 24 Months of Age|Protocol Violation|1
5996242|NCT00948896|20733799|P7|Randomization to 24 Months of Age|Protocol Violation|1
5996243|NCT00948896|20733800|P6|Randomization to 24 Months of Age|Protocol Violation|0
5996244|NCT00948896|20733801|P5|Randomization to 24 Months of Age|Protocol Violation|0
5996245|NCT00948896|20733802|P4|Randomization to 24 Months of Age|Protocol Violation|1
5996246|NCT00948896|20733803|P3|Randomization to 24 Months of Age|Protocol Violation|0
5996247|NCT00948896|20733804|P2|Randomization to 24 Months of Age|Protocol Violation|1
5996248|NCT00948896|20733805|P1|Randomization to 24 Months of Age|Protocol Violation|0
5996249|NCT00948896|20733798|P8|Randomization to 24 Months of Age|Lost to Follow-up|0
5996250|NCT00948896|20733799|P7|Randomization to 24 Months of Age|Lost to Follow-up|1
5996251|NCT00948896|20733800|P6|Randomization to 24 Months of Age|Lost to Follow-up|0
5996252|NCT00948896|20733801|P5|Randomization to 24 Months of Age|Lost to Follow-up|0
5996253|NCT00948896|20733802|P4|Randomization to 24 Months of Age|Lost to Follow-up|5
5996254|NCT00948896|20733803|P3|Randomization to 24 Months of Age|Lost to Follow-up|2
5996255|NCT00948896|20733804|P2|Randomization to 24 Months of Age|Lost to Follow-up|4
5996256|NCT00948896|20733805|P1|Randomization to 24 Months of Age|Lost to Follow-up|4
5996257|NCT00948896|20733798|P8|Randomization to 24 Months of Age|Withdrawal by Subject|0
5996258|NCT00948896|20733799|P7|Randomization to 24 Months of Age|Withdrawal by Subject|0
5996259|NCT00948896|20733800|P6|Randomization to 24 Months of Age|Withdrawal by Subject|1
5996260|NCT00948896|20733801|P5|Randomization to 24 Months of Age|Withdrawal by Subject|0
5996261|NCT00948896|20733802|P4|Randomization to 24 Months of Age|Withdrawal by Subject|4
5996262|NCT00948896|20733803|P3|Randomization to 24 Months of Age|Withdrawal by Subject|4
5996263|NCT00948896|20733804|P2|Randomization to 24 Months of Age|Withdrawal by Subject|5
5996264|NCT00948896|20733805|P1|Randomization to 24 Months of Age|Withdrawal by Subject|3
5996265|NCT00948896|20733798|P8|Randomization to 24 Months of Age|Death|1
5996266|NCT00948896|20733799|P7|Randomization to 24 Months of Age|Death|2
5996267|NCT00948896|20733800|P6|Randomization to 24 Months of Age|Death|1
5996268|NCT00948896|20733801|P5|Randomization to 24 Months of Age|Death|2
5996269|NCT00948896|20733802|P4|Randomization to 24 Months of Age|Death|0
5996270|NCT00948896|20733803|P3|Randomization to 24 Months of Age|Death|0
5996271|NCT00948896|20733804|P2|Randomization to 24 Months of Age|Death|0
5996272|NCT00948896|20733805|P1|Randomization to 24 Months of Age|Death|1
5996273|NCT00948857|20733841|P2|Overall Study|Lost to Follow-up|0
5996274|NCT00948857|20733842|P1|Overall Study|Lost to Follow-up|1
5996275|NCT00948818|20733850|P2|Overall Study|Other Reason|5
5996276|NCT00948818|20733851|P1|Overall Study|Other Reason|4
5996277|NCT00948818|20733850|P2|Overall Study|Lack of Efficacy|5
5996278|NCT00948818|20733851|P1|Overall Study|Lack of Efficacy|4
5996279|NCT00948818|20733850|P2|Overall Study|Lost to Follow-up|17
5996280|NCT00948818|20733851|P1|Overall Study|Lost to Follow-up|10
5996281|NCT00948818|20733850|P2|Overall Study|Withdrawal by Subject|25
5996282|NCT00948818|20733851|P1|Overall Study|Withdrawal by Subject|25
5996283|NCT00948818|20733850|P2|Overall Study|Protocol Violation|10
5996284|NCT00948818|20733851|P1|Overall Study|Protocol Violation|9
5996285|NCT00948818|20733850|P2|Overall Study|Adverse Event|32
5996286|NCT00948818|20733851|P1|Overall Study|Adverse Event|10
5996287|NCT00948766|20733898|P2|Extension Study|Death|0
5996288|NCT00948766|20733899|P1|Extension Study|Death|4
5996289|NCT00948766|20733898|P2|Extension Study|Administrative Problems|0
5996290|NCT00948766|20733899|P1|Extension Study|Administrative Problems|1
5996291|NCT00948766|20733898|P2|Extension Study|Lost to Follow-up|0
5996292|NCT00948766|20733899|P1|Extension Study|Lost to Follow-up|8
5996293|NCT00948766|20733898|P2|Extension Study|Patient Withdrew Consent|0
5996294|NCT00948766|20733899|P1|Extension Study|Patient Withdrew Consent|32
5996295|NCT00948766|20733898|P2|Extension Study|Study Drug No Longer Required|0
5996296|NCT00948766|20733899|P1|Extension Study|Study Drug No Longer Required|1
5996297|NCT00948766|20733898|P2|Extension Study|Unsatisfactory Therapeutic Effect|0
5996298|NCT00948766|20733899|P1|Extension Study|Unsatisfactory Therapeutic Effect|2
5996299|NCT00948766|20733898|P2|Extension Study|Adverse Event|0
5996300|NCT00948766|20733899|P1|Extension Study|Adverse Event|43
5996301|NCT00948766|20733898|P2|Core Study|Protocol Deviation|10
5996302|NCT00948766|20733899|P1|Core Study|Protocol Deviation|8
5996303|NCT00948766|20733898|P2|Core Study|Death|1
5996304|NCT00948766|20733899|P1|Core Study|Death|1
5996305|NCT00948766|20733898|P2|Core Study|Administrative Problems|2
5996306|NCT00948766|20733899|P1|Core Study|Administrative Problems|2
5996307|NCT00948766|20733898|P2|Core Study|Lost to Follow-up|2
5996308|NCT00948766|20733899|P1|Core Study|Lost to Follow-up|3
5996309|NCT00948766|20733898|P2|Core Study|Patient Withdrew Consent|46
5996310|NCT00948766|20733899|P1|Core Study|Patient Withdrew Consent|27
5996311|NCT00948766|20733898|P2|Core Study|Unsatisfactory Therapeutic Effect|14
5996312|NCT00948766|20733899|P1|Core Study|Unsatisfactory Therapeutic Effect|13
5996313|NCT00948766|20733898|P2|Core Study|Adverse Event|51
5996314|NCT00948766|20733899|P1|Core Study|Adverse Event|73
5996315|NCT00948688|20733915|P2|Period 2: 100 mg Vorinostat|Adverse Event|1
5996316|NCT00948688|20733916|P1|Period 2: 100 mg Vorinostat|Adverse Event|0
5996317|NCT00948688|20733915|P2|Period 1: 200 mg Vorinostat|Protocol Violation|0
5996318|NCT00948688|20733916|P1|Period 1: 200 mg Vorinostat|Protocol Violation|1
5996319|NCT00948688|20733915|P2|Period 1: 200 mg Vorinostat|Adverse Event|0
5996320|NCT00948688|20733916|P1|Period 1: 200 mg Vorinostat|Adverse Event|1
5996325|NCT00948506|20733958|P2|Overall Study|Withdrawal by Subject|1
5996326|NCT00948506|20733959|P1|Overall Study|Withdrawal by Subject|3
5996327|NCT00948441|20733970|P2|Overall Study|no longer meet inclusion criteria|4
5996328|NCT00948441|20733971|P1|Overall Study|no longer meet inclusion criteria|1
5996329|NCT00948428|20733982|P3|Overall Study|Non-compliance|0
5996330|NCT00948428|20733983|P2|Overall Study|Non-compliance|2
5996331|NCT00948428|20733984|P1|Overall Study|Non-compliance|1
5996332|NCT00948428|20733982|P3|Overall Study|Intercurrent Illness|0
5996333|NCT00948428|20733983|P2|Overall Study|Intercurrent Illness|0
5996334|NCT00948428|20733984|P1|Overall Study|Intercurrent Illness|1
5996335|NCT00948428|20733982|P3|Overall Study|Death|0
5996336|NCT00948428|20733983|P2|Overall Study|Death|0
5996337|NCT00948428|20733984|P1|Overall Study|Death|2
5996338|NCT00948428|20733982|P3|Overall Study|Lost to Follow-up|1
5996339|NCT00948428|20733983|P2|Overall Study|Lost to Follow-up|1
5996340|NCT00948428|20733984|P1|Overall Study|Lost to Follow-up|2
5996341|NCT00948428|20733982|P3|Overall Study|Adverse Event|0
5996342|NCT00948428|20733983|P2|Overall Study|Adverse Event|3
5996343|NCT00948428|20733984|P1|Overall Study|Adverse Event|6
5996344|NCT00948428|20733982|P3|Overall Study|Withdrawal by Subject|7
5996345|NCT00948428|20733983|P2|Overall Study|Withdrawal by Subject|12
5996346|NCT00948428|20733984|P1|Overall Study|Withdrawal by Subject|6
5996347|NCT00948389|20734003|P5|Overall Study|Both Progression and Toxicity|0
5996348|NCT00948389|20734004|P4|Overall Study|Both Progression and Toxicity|0
5996349|NCT00948389|20734005|P3|Overall Study|Both Progression and Toxicity|0
5996350|NCT00948389|20734006|P2|Overall Study|Both Progression and Toxicity|0
5996351|NCT00948389|20734007|P1|Overall Study|Both Progression and Toxicity|1
5996352|NCT00948389|20734003|P5|Overall Study|Thrombocytopenia, Grade 4|0
5996353|NCT00948389|20734004|P4|Overall Study|Thrombocytopenia, Grade 4|1
5996354|NCT00948389|20734005|P3|Overall Study|Thrombocytopenia, Grade 4|0
5996355|NCT00948389|20734006|P2|Overall Study|Thrombocytopenia, Grade 4|0
5996356|NCT00948389|20734007|P1|Overall Study|Thrombocytopenia, Grade 4|2
5996357|NCT00948389|20734003|P5|Overall Study|Disease Progression/Relapse/Death|1
5996358|NCT00948389|20734004|P4|Overall Study|Disease Progression/Relapse/Death|8
5996359|NCT00948389|20734005|P3|Overall Study|Disease Progression/Relapse/Death|7
5996360|NCT00948389|20734006|P2|Overall Study|Disease Progression/Relapse/Death|3
5996361|NCT00948389|20734007|P1|Overall Study|Disease Progression/Relapse/Death|3
5996362|NCT00948246|20734055|P1|Overall Study|Withdrawal by Subject|1
5996363|NCT00948246|20734055|P1|Overall Study|Death|1
5996364|NCT00948246|20734055|P1|Overall Study|Adverse Event|11
5996365|NCT00948246|20734055|P1|Overall Study|Lost to Follow-up|11
5996366|NCT00948155|20734064|P2|Washout 14 Days|Lost to Follow-up|2
5996367|NCT00948155|20734065|P1|Washout 14 Days|Lost to Follow-up|1
5996368|NCT00948155|20734064|P2|First Intervention 21 Days|Lost to Follow-up|2
5996369|NCT00948155|20734065|P1|First Intervention 21 Days|Lost to Follow-up|2
5996370|NCT00948064|20734112|P3|Phase II|Withdrawal by Subject|0
5996371|NCT00948064|20734113|P2|Phase II|Withdrawal by Subject|1
5996372|NCT00948064|20734114|P1|Phase II|Withdrawal by Subject|0
5996373|NCT00948064|20734112|P3|Phase II|Physician Decision|1
5996374|NCT00948064|20734113|P2|Phase II|Physician Decision|0
5996375|NCT00948064|20734114|P1|Phase II|Physician Decision|0
5996376|NCT00948064|20734112|P3|Phase I|No treatment received|0
5996377|NCT00948064|20734113|P2|Phase I|No treatment received|0
5996378|NCT00948064|20734114|P1|Phase I|No treatment received|1
5996379|NCT00948025|20734127|P2|Phase 1 (Pilot Phase)|Withdrawal by Subject|1
5996380|NCT00948025|20734128|P1|Phase 1 (Pilot Phase)|Withdrawal by Subject|1
5996381|NCT00948025|20734127|P2|Phase 1 (Pilot Phase)|Lost to Follow-up|1
5996382|NCT00948025|20734128|P1|Phase 1 (Pilot Phase)|Lost to Follow-up|7
5996383|NCT00948025|20734127|P2|Phase 1 (Pilot Phase)|Adverse Event|1
5996384|NCT00948025|20734128|P1|Phase 1 (Pilot Phase)|Adverse Event|1
5996385|NCT00947882|20734156|P4|Overall Study|Trial Terminated by Sponsor|70
5996386|NCT00947882|20734157|P3|Overall Study|Trial Terminated by Sponsor|62
5996387|NCT00947882|20734158|P2|Overall Study|Trial Terminated by Sponsor|61
5996388|NCT00947882|20734159|P1|Overall Study|Trial Terminated by Sponsor|62
5996389|NCT00947882|20734156|P4|Overall Study|Other/Unknown|6
5996390|NCT00947882|20734157|P3|Overall Study|Other/Unknown|3
5996391|NCT00947882|20734158|P2|Overall Study|Other/Unknown|13
5996392|NCT00947882|20734159|P1|Overall Study|Other/Unknown|10
5996393|NCT00947882|20734156|P4|Overall Study|Lost to Follow-up|0
5996394|NCT00947882|20734157|P3|Overall Study|Lost to Follow-up|1
5996395|NCT00947882|20734158|P2|Overall Study|Lost to Follow-up|2
5996396|NCT00947882|20734159|P1|Overall Study|Lost to Follow-up|0
5996397|NCT00947882|20734156|P4|Overall Study|Protocol Violation|0
5996398|NCT00947882|20734157|P3|Overall Study|Protocol Violation|1
5996399|NCT00947882|20734158|P2|Overall Study|Protocol Violation|0
5996400|NCT00947882|20734159|P1|Overall Study|Protocol Violation|0
5996401|NCT00947882|20734156|P4|Overall Study|Withdrawal by Subject|2
5996402|NCT00947882|20734157|P3|Overall Study|Withdrawal by Subject|8
5996403|NCT00947882|20734158|P2|Overall Study|Withdrawal by Subject|0
5996404|NCT00947882|20734159|P1|Overall Study|Withdrawal by Subject|2
5996405|NCT00947882|20734156|P4|Overall Study|Adverse Event|4
5996406|NCT00947882|20734157|P3|Overall Study|Adverse Event|4
5996407|NCT00947882|20734158|P2|Overall Study|Adverse Event|1
5996408|NCT00947882|20734159|P1|Overall Study|Adverse Event|0
5996409|NCT00947856|20734187|P2|Follow-up Period|Withdrawal by Subject|0
5996410|NCT00947856|20734188|P1|Follow-up Period|Withdrawal by Subject|1
5996411|NCT00947856|20734187|P2|Follow-up Period|Patient unavailable for site visits|0
5996412|NCT00947856|20734188|P1|Follow-up Period|Patient unavailable for site visits|1
5996413|NCT00947856|20734187|P2|Follow-up Period|Lost to Follow-up|0
5996414|NCT00947856|20734188|P1|Follow-up Period|Lost to Follow-up|7
5996415|NCT00947856|20734187|P2|Follow-up Period|Re-enrolled for Retreatment|3
5996416|NCT00947856|20734188|P1|Follow-up Period|Re-enrolled for Retreatment|2
5996417|NCT00947856|20734187|P2|Follow-up Period|Study Stopped by Sponsor|20
5996418|NCT00947856|20734188|P1|Follow-up Period|Study Stopped by Sponsor|40
5996419|NCT00947856|20734187|P2|Treatment Period|Withdrawal by Subject|1
5996420|NCT00947856|20734188|P1|Treatment Period|Withdrawal by Subject|12
5996421|NCT00947856|20734187|P2|Treatment Period|Study Stopped by Sponsor|4
5996422|NCT00947856|20734188|P1|Treatment Period|Study Stopped by Sponsor|4
5996423|NCT00947856|20734187|P2|Treatment Period|Physician Decision|6
5996424|NCT00947856|20734188|P1|Treatment Period|Physician Decision|14
5996425|NCT00947856|20734187|P2|Treatment Period|Adverse Event|9
5996426|NCT00947856|20734188|P1|Treatment Period|Adverse Event|15
5996427|NCT00947856|20734187|P2|Treatment Period|Progressive Disease|12
5996428|NCT00947856|20734188|P1|Treatment Period|Progressive Disease|33
5996429|NCT00947544|20734277|P2|Safety-Extension Period (12 Months)|Withdrawal by Subject|0
5996430|NCT00947544|20734278|P1|Safety-Extension Period (12 Months)|Withdrawal by Subject|1
5996431|NCT00947531|20734304|P2|Overall Study|Other|1
5996432|NCT00947531|20734305|P1|Overall Study|Other|1
5996433|NCT00947531|20734304|P2|Overall Study|Lack of Efficacy|0
5996434|NCT00947531|20734305|P1|Overall Study|Lack of Efficacy|1
5996435|NCT00947531|20734304|P2|Overall Study|Adverse Event|2
5996436|NCT00947531|20734305|P1|Overall Study|Adverse Event|2
5996437|NCT00947531|20734304|P2|Overall Study|Administrative Reason|1
5996438|NCT00947531|20734305|P1|Overall Study|Administrative Reason|0
5996439|NCT00947531|20734304|P2|Overall Study|Withdrawal by Subject|7
5996440|NCT00947531|20734305|P1|Overall Study|Withdrawal by Subject|10
5996441|NCT00947427|20734343|P2|Overall Study|Protocol Violation|1
5996442|NCT00947427|20734344|P1|Overall Study|Protocol Violation|0
5996443|NCT00947427|20734343|P2|Overall Study|Withdrawal by Subject|3
5996444|NCT00947427|20734344|P1|Overall Study|Withdrawal by Subject|1
5996445|NCT00947349|20734354|P4|Overall Study Standard of Care|Other|1
5996446|NCT00947349|20734355|P3|Overall Study Standard of Care|Other|0
5996447|NCT00947349|20734356|P2|Overall Study Standard of Care|Other|0
5996448|NCT00947349|20734357|P1|Overall Study Standard of Care|Other|0
5996449|NCT00947349|20734354|P4|Overall Study Standard of Care|Withdrawal by Subject|0
5996450|NCT00947349|20734355|P3|Overall Study Standard of Care|Withdrawal by Subject|1
5996451|NCT00947349|20734356|P2|Overall Study Standard of Care|Withdrawal by Subject|0
5996452|NCT00947349|20734357|P1|Overall Study Standard of Care|Withdrawal by Subject|0
5996453|NCT00947349|20734354|P4|Overall Study Standard of Care|Lack of Efficacy|1
5996454|NCT00947349|20734355|P3|Overall Study Standard of Care|Lack of Efficacy|1
5996455|NCT00947349|20734356|P2|Overall Study Standard of Care|Lack of Efficacy|0
5996456|NCT00947349|20734357|P1|Overall Study Standard of Care|Lack of Efficacy|0
5996457|NCT00947349|20734354|P4|Triple Treatment Combination Period|Adverse Event|0
5996458|NCT00947349|20734355|P3|Triple Treatment Combination Period|Adverse Event|0
5996459|NCT00947349|20734356|P2|Triple Treatment Combination Period|Adverse Event|1
5996460|NCT00947349|20734357|P1|Triple Treatment Combination Period|Adverse Event|0
5996461|NCT00947193|20734566|P2|Overall Study|Factor VIII >1%|0
5996462|NCT00947193|20734567|P1|Overall Study|Factor VIII >1%|1
5996463|NCT00947193|20734566|P2|Overall Study|Withdrawal by Subject|0
5996464|NCT00947193|20734567|P1|Overall Study|Withdrawal by Subject|1
5996465|NCT00947193|20734566|P2|Overall Study|Lost to Follow-up|0
5996466|NCT00947193|20734567|P1|Overall Study|Lost to Follow-up|1
5996467|NCT00947154|20734582|P1|Overall Study|Lost to Follow-up|1
5996468|NCT00947115|20734592|P3|Overall Study|Lost to Follow-up|8
5996469|NCT00947115|20734593|P2|Overall Study|Lost to Follow-up|12
5996470|NCT00947115|20734594|P1|Overall Study|Lost to Follow-up|11
5996471|NCT00947115|20734592|P3|Overall Study|Withdrawal by Subject|4
5996472|NCT00947115|20734593|P2|Overall Study|Withdrawal by Subject|3
5996473|NCT00947115|20734594|P1|Overall Study|Withdrawal by Subject|1
5996474|NCT00947115|20734592|P3|Overall Study|Migrated from study area|0
5996475|NCT00947115|20734593|P2|Overall Study|Migrated from study area|0
5996476|NCT00947115|20734594|P1|Overall Study|Migrated from study area|2
5996477|NCT00947115|20734592|P3|Overall Study|Death|1
5996478|NCT00947115|20734593|P2|Overall Study|Death|1
5996479|NCT00947115|20734594|P1|Overall Study|Death|0
5996480|NCT00947115|20734592|P3|Overall Study|Physician Decision|0
5996481|NCT00947115|20734593|P2|Overall Study|Physician Decision|2
5996482|NCT00947115|20734594|P1|Overall Study|Physician Decision|0
5996483|NCT00947115|20734592|P3|Overall Study|Missed reporting interval|2
5996484|NCT00947115|20734593|P2|Overall Study|Missed reporting interval|4
5996485|NCT00947115|20734594|P1|Overall Study|Missed reporting interval|3
5996486|NCT00947011|20734656|P1|Overall Study|Study was terminated,PI left institution|12
5996487|NCT00946998|20734666|P2|Overall Study|Exited prior to first outcome assessment|3
5996488|NCT00946998|20734667|P1|Overall Study|Exited prior to first outcome assessment|5
5996489|NCT00946985|20734681|P1|Relapse Prevention Phase (24 Months)|Study Closed by Sponsor|2
5996490|NCT00946985|20734681|P1|Stabilization Phase (25 Weeks)|Patient Moved Away|2
5996491|NCT00946985|20734681|P1|Stabilization Phase (25 Weeks)|Prohibited Medication During Study|1
5996492|NCT00946985|20734681|P1|Stabilization Phase (25 Weeks)|Failed to Meet Stability Criteria|2
5996493|NCT00946985|20734681|P1|Stabilization Phase (25 Weeks)|Study Closed by Sponsor|139
5996494|NCT00946985|20734681|P1|Stabilization Phase (25 Weeks)|Withdrawal by Subject|4
5996495|NCT00946985|20734681|P1|Stabilization Phase (25 Weeks)|Lost to Follow-up|5
5996496|NCT00946985|20734681|P1|Stabilization Phase (25 Weeks)|Lack of Efficacy|3
5996497|NCT00946985|20734681|P1|Stabilization Phase (25 Weeks)|Adverse Event|4
5996498|NCT00946920|20734687|P2|Overall Study|Miscellaneous reasons|3
5996499|NCT00946920|20734688|P1|Overall Study|Miscellaneous reasons|18
5996500|NCT00946920|20734687|P2|Overall Study|Protocol Violation|8
5996501|NCT00946920|20734688|P1|Overall Study|Protocol Violation|16
5996502|NCT00946920|20734687|P2|Overall Study|Adverse Event|14
5996503|NCT00946920|20734688|P1|Overall Study|Adverse Event|41
5996504|NCT00946920|20734687|P2|Overall Study|Physician Decision|2
5996505|NCT00946920|20734688|P1|Overall Study|Physician Decision|5
5996506|NCT00946920|20734687|P2|Overall Study|Lost to Follow-up|2
5996507|NCT00946920|20734688|P1|Overall Study|Lost to Follow-up|2
5996508|NCT00946920|20734687|P2|Overall Study|Withdrawal by Subject|15
5996509|NCT00946920|20734688|P1|Overall Study|Withdrawal by Subject|28
5996510|NCT00946881|20734703|P1|Retreatment|Withdrawal by Subject|1
5996511|NCT00946881|20734703|P1|First Treatment|Patient relocated to another state|1
5996512|NCT00946881|20734703|P1|First Treatment|Withdrawal by Subject|1
5996513|NCT00946712|20734734|P2|Overall Study|Ineligible|6
5996514|NCT00946712|20734735|P1|Overall Study|Ineligible|14
5996515|NCT00946712|20734734|P2|Overall Study|On Treatment|4
5996516|NCT00946712|20734735|P1|Overall Study|On Treatment|0
5996517|NCT00946712|20734734|P2|Overall Study|Other reasons|73
5996518|NCT00946712|20734735|P1|Overall Study|Other reasons|61
5996519|NCT00946712|20734734|P2|Overall Study|No treatment given|29
5996520|NCT00946712|20734735|P1|Overall Study|No treatment given|25
5996521|NCT00946712|20734734|P2|Overall Study|Death|22
5996522|NCT00946712|20734735|P1|Overall Study|Death|21
5996523|NCT00946712|20734734|P2|Overall Study|Disease progression|404
5996524|NCT00946712|20734735|P1|Overall Study|Disease progression|308
5996525|NCT00946712|20734734|P2|Overall Study|Adverse Event|124
5996526|NCT00946712|20734735|P1|Overall Study|Adverse Event|118
5996527|NCT00946647|20734754|P5|Phase ll Part|Subj cond no longer required study drug|0
5996528|NCT00946647|20734755|P4|Phase ll Part|Subj cond no longer required study drug|2
5996529|NCT00946647|20734756|P3|Phase ll Part|Subj cond no longer required study drug|0
5996530|NCT00946647|20734757|P2|Phase ll Part|Subj cond no longer required study drug|0
5996531|NCT00946647|20734758|P1|Phase ll Part|Subj cond no longer required study drug|0
5996532|NCT00946647|20734754|P5|Phase ll Part|Protocol Violation|2
5996533|NCT00946647|20734755|P4|Phase ll Part|Protocol Violation|4
5996534|NCT00946647|20734756|P3|Phase ll Part|Protocol Violation|0
5996535|NCT00946647|20734757|P2|Phase ll Part|Protocol Violation|0
5996536|NCT00946647|20734758|P1|Phase ll Part|Protocol Violation|0
5996537|NCT00946647|20734754|P5|Phase ll Part|Disease progression|14
5996538|NCT00946647|20734755|P4|Phase ll Part|Disease progression|6
5996539|NCT00946647|20734756|P3|Phase ll Part|Disease progression|0
5996540|NCT00946647|20734757|P2|Phase ll Part|Disease progression|0
5996541|NCT00946647|20734758|P1|Phase ll Part|Disease progression|0
5996542|NCT00946647|20734754|P5|Phase ll Part|Death|4
5996543|NCT00946647|20734755|P4|Phase ll Part|Death|7
5996544|NCT00946647|20734756|P3|Phase ll Part|Death|0
5996545|NCT00946647|20734757|P2|Phase ll Part|Death|0
5996546|NCT00946647|20734758|P1|Phase ll Part|Death|0
5996547|NCT00946647|20734754|P5|Phase ll Part|Administrative problems|8
5996548|NCT00946647|20734755|P4|Phase ll Part|Administrative problems|3
5996549|NCT00946647|20734756|P3|Phase ll Part|Administrative problems|0
5996550|NCT00946647|20734757|P2|Phase ll Part|Administrative problems|0
5996551|NCT00946647|20734758|P1|Phase ll Part|Administrative problems|0
5996552|NCT00946647|20734754|P5|Phase ll Part|Withdrawal by Subject|6
5996553|NCT00946647|20734755|P4|Phase ll Part|Withdrawal by Subject|8
5996554|NCT00946647|20734756|P3|Phase ll Part|Withdrawal by Subject|0
5996555|NCT00946647|20734757|P2|Phase ll Part|Withdrawal by Subject|0
5996556|NCT00946647|20734758|P1|Phase ll Part|Withdrawal by Subject|0
5996557|NCT00946647|20734754|P5|Phase ll Part|Adverse Event|6
5996558|NCT00946647|20734755|P4|Phase ll Part|Adverse Event|10
5996559|NCT00946647|20734756|P3|Phase ll Part|Adverse Event|0
5996560|NCT00946647|20734757|P2|Phase ll Part|Adverse Event|0
5996561|NCT00946647|20734758|P1|Phase ll Part|Adverse Event|0
5996562|NCT00946647|20734754|P5|Phase ll Part|Untreated|2
5996563|NCT00946647|20734755|P4|Phase ll Part|Untreated|0
5996564|NCT00946647|20734756|P3|Phase ll Part|Untreated|0
5996565|NCT00946647|20734757|P2|Phase ll Part|Untreated|0
5996566|NCT00946647|20734758|P1|Phase ll Part|Untreated|0
5996567|NCT00946647|20734754|P5|Phase 1 Part|Reason missing|0
5996568|NCT00946647|20734755|P4|Phase 1 Part|Reason missing|0
5996569|NCT00946647|20734756|P3|Phase 1 Part|Reason missing|0
5996570|NCT00946647|20734757|P2|Phase 1 Part|Reason missing|1
5996571|NCT00946647|20734758|P1|Phase 1 Part|Reason missing|0
5996572|NCT00946647|20734754|P5|Phase 1 Part|Abnormal values|0
5996573|NCT00946647|20734755|P4|Phase 1 Part|Abnormal values|0
5996574|NCT00946647|20734756|P3|Phase 1 Part|Abnormal values|0
5996575|NCT00946647|20734757|P2|Phase 1 Part|Abnormal values|2
5996576|NCT00946647|20734758|P1|Phase 1 Part|Abnormal values|0
5996577|NCT00946647|20734754|P5|Phase 1 Part|Withdrawal by Subject|0
5996578|NCT00946647|20734755|P4|Phase 1 Part|Withdrawal by Subject|0
5996579|NCT00946647|20734756|P3|Phase 1 Part|Withdrawal by Subject|3
5996580|NCT00946647|20734757|P2|Phase 1 Part|Withdrawal by Subject|4
5996581|NCT00946647|20734758|P1|Phase 1 Part|Withdrawal by Subject|1
5996582|NCT00946647|20734754|P5|Phase 1 Part|Disease progression|0
5996583|NCT00946647|20734755|P4|Phase 1 Part|Disease progression|0
5996584|NCT00946647|20734756|P3|Phase 1 Part|Disease progression|1
5996585|NCT00946647|20734757|P2|Phase 1 Part|Disease progression|6
5996586|NCT00946647|20734758|P1|Phase 1 Part|Disease progression|3
5996587|NCT00946647|20734754|P5|Phase 1 Part|Adverse Event|0
5996588|NCT00946647|20734755|P4|Phase 1 Part|Adverse Event|0
5996589|NCT00946647|20734756|P3|Phase 1 Part|Adverse Event|3
5996590|NCT00946647|20734757|P2|Phase 1 Part|Adverse Event|5
5996591|NCT00946647|20734758|P1|Phase 1 Part|Adverse Event|2
5996592|NCT00946530|20734792|P4|Overall Study|Physician Decision|1
5996593|NCT00946530|20734793|P3|Overall Study|Physician Decision|1
5996594|NCT00946530|20734794|P2|Overall Study|Physician Decision|1
5996595|NCT00946530|20734795|P1|Overall Study|Physician Decision|1
5996596|NCT00946530|20734792|P4|Overall Study|Withdrawal by Subject|3
5996597|NCT00946530|20734793|P3|Overall Study|Withdrawal by Subject|0
5996598|NCT00946530|20734794|P2|Overall Study|Withdrawal by Subject|3
5996599|NCT00946530|20734795|P1|Overall Study|Withdrawal by Subject|0
5996600|NCT00946322|20734827|P1|Post-treatment|participant failure to follow up|2
5996601|NCT00946322|20734827|P1|Pre-treatment|participant failure to follow up|1
5996602|NCT00946309|20734840|P2|Overall Study|Procedure cancelled/discontinued|3
5996603|NCT00946309|20734841|P1|Overall Study|Procedure cancelled/discontinued|0
5996604|NCT00946309|20734840|P2|Overall Study|Lost to Follow-up|1
5996605|NCT00946309|20734841|P1|Overall Study|Lost to Follow-up|0
5996606|NCT00946309|20734840|P2|Overall Study|Protocol Violation|0
5996607|NCT00946309|20734841|P1|Overall Study|Protocol Violation|1
5996608|NCT00946296|20734859|P2|Overall Study|Physician Decision|0
5996609|NCT00946296|20734860|P1|Overall Study|Physician Decision|3
5996610|NCT00946192|20734882|P3|Overall Study|Did not start medication|0
5996611|NCT00946192|20734883|P2|Overall Study|Did not start medication|0
5996612|NCT00946192|20734884|P1|Overall Study|Did not start medication|2
5996613|NCT00946192|20734882|P3|Overall Study|Withdrawal by Subject|3
5996614|NCT00946192|20734883|P2|Overall Study|Withdrawal by Subject|7
5996615|NCT00946192|20734884|P1|Overall Study|Withdrawal by Subject|10
5996616|NCT00946192|20734882|P3|Overall Study|Lost to Follow-up|9
5996617|NCT00946192|20734883|P2|Overall Study|Lost to Follow-up|11
5996618|NCT00946192|20734884|P1|Overall Study|Lost to Follow-up|6
5996619|NCT00946153|20734900|P5|Phase 2|14 days washout for recovery due to AE|4
5996620|NCT00946153|20734901|P4|Phase 2|14 days washout for recovery due to AE|0
5996621|NCT00946153|20734902|P3|Phase 2|14 days washout for recovery due to AE|0
5996622|NCT00946153|20734903|P2|Phase 2|14 days washout for recovery due to AE|0
5996623|NCT00946153|20734904|P1|Phase 2|14 days washout for recovery due to AE|0
5996624|NCT00946153|20734900|P5|Phase 2|Physician Decision|1
5996625|NCT00946153|20734901|P4|Phase 2|Physician Decision|0
5996626|NCT00946153|20734902|P3|Phase 2|Physician Decision|0
5996627|NCT00946153|20734903|P2|Phase 2|Physician Decision|0
5996628|NCT00946153|20734904|P1|Phase 2|Physician Decision|0
5996629|NCT00946153|20734900|P5|Phase 2|Need more reduction of dose|2
5996630|NCT00946153|20734901|P4|Phase 2|Need more reduction of dose|0
5996631|NCT00946153|20734902|P3|Phase 2|Need more reduction of dose|0
5996632|NCT00946153|20734903|P2|Phase 2|Need more reduction of dose|0
5996633|NCT00946153|20734904|P1|Phase 2|Need more reduction of dose|0
5996634|NCT00946153|20734900|P5|Phase 2|Adverse Event|6
5996635|NCT00946153|20734901|P4|Phase 2|Adverse Event|0
5996636|NCT00946153|20734902|P3|Phase 2|Adverse Event|0
5996637|NCT00946153|20734903|P2|Phase 2|Adverse Event|0
5996638|NCT00946153|20734904|P1|Phase 2|Adverse Event|0
5996645|NCT00946101|20734941|P2|Overall Study|Physician Decision|1
5996646|NCT00946101|20734942|P1|Overall Study|Physician Decision|0
5996647|NCT00946101|20734941|P2|Overall Study|Withdrawal of consent|0
5996648|NCT00946101|20734942|P1|Overall Study|Withdrawal of consent|2
5996649|NCT00946101|20734941|P2|Overall Study|Lost to Follow-up|1
5996650|NCT00946101|20734942|P1|Overall Study|Lost to Follow-up|2
5996651|NCT00946088|20735008|P2|Overall Study|Withdrawal by Subject|1
5996652|NCT00946088|20735009|P1|Overall Study|Withdrawal by Subject|0
5996653|NCT00945945|20735053|P2|Overall Study|Entry Criteria Not Met|1
5996654|NCT00945945|20735054|P1|Overall Study|Entry Criteria Not Met|0
5996655|NCT00945945|20735053|P2|Overall Study|Protocol Violation|2
5996656|NCT00945945|20735054|P1|Overall Study|Protocol Violation|4
5996657|NCT00945945|20735053|P2|Overall Study|Lack of Efficacy|2
5996658|NCT00945945|20735054|P1|Overall Study|Lack of Efficacy|6
5996659|NCT00945945|20735053|P2|Overall Study|Lost to Follow-up|5
5996660|NCT00945945|20735054|P1|Overall Study|Lost to Follow-up|4
5996661|NCT00945945|20735053|P2|Overall Study|Withdrawal by Subject|10
5996662|NCT00945945|20735054|P1|Overall Study|Withdrawal by Subject|7
5996663|NCT00945945|20735053|P2|Overall Study|Adverse Event|35
5996664|NCT00945945|20735054|P1|Overall Study|Adverse Event|15
5996665|NCT00945906|20735080|P1|Overall Study|Moved to another country|2
5996666|NCT00945906|20735080|P1|Overall Study|Unable to return for last visit|2
5996667|NCT00945906|20735080|P1|Overall Study|Did not want to return for last visit|2
5996668|NCT00945906|20735080|P1|Overall Study|Withdrawal by Subject|1
5996669|NCT00945893|20735091|P2|Overall Study|Withdrawal of consent|2
5996670|NCT00945893|20735092|P1|Overall Study|Withdrawal of consent|1
5996671|NCT00945893|20735091|P2|Overall Study|Lost to Follow-up|8
5996672|NCT00945893|20735092|P1|Overall Study|Lost to Follow-up|2
5996673|NCT00945815|20735169|P1|Overall Study|Did not begin protocol therapy|1
5996674|NCT00945815|20735169|P1|Overall Study|Ineligible|3
5996675|NCT00945815|20735169|P1|Overall Study|Not protocol specified|1
5996676|NCT00945815|20735169|P1|Overall Study|Death|3
5996677|NCT00945659|20735201|P3|Overall Study|Lost to Follow-up|17
5996678|NCT00945659|20735202|P2|Overall Study|Lost to Follow-up|20
5996679|NCT00945659|20735203|P1|Overall Study|Lost to Follow-up|7
5996680|NCT00945555|20735260|P1|Overall Study|Other|1
5996681|NCT00945555|20735260|P1|Overall Study|Death|18
5996682|NCT00945555|20735260|P1|Overall Study|Participant continued treatment at home|1
5996683|NCT00945555|20735260|P1|Overall Study|Withdrawal by Subject|2
5996684|NCT00945555|20735260|P1|Overall Study|Worsening condition, intensive care unit|1
5996685|NCT00945555|20735260|P1|Overall Study|Referred to another hospital|5
5996686|NCT00945477|20735271|P1|Overall Study|Withdrawal by Subject|1
5996687|NCT00945477|20735271|P1|Overall Study|Lack of Efficacy|2
5996688|NCT00945477|20735271|P1|Overall Study|Adverse Event|3
5996689|NCT00945321|20735287|P6|Period 4|Lost to Follow-up|1
5996690|NCT00945321|20735288|P5|Period 4|Lost to Follow-up|0
5996691|NCT00945321|20735289|P4|Period 4|Lost to Follow-up|0
5996692|NCT00945321|20735290|P3|Period 4|Lost to Follow-up|0
5996693|NCT00945321|20735291|P2|Period 4|Lost to Follow-up|0
5996694|NCT00945321|20735292|P1|Period 4|Lost to Follow-up|0
5996695|NCT00945321|20735287|P6|Period 1|Adverse Event|0
5996696|NCT00945321|20735288|P5|Period 1|Adverse Event|1
5996697|NCT00945321|20735289|P4|Period 1|Adverse Event|0
5996698|NCT00945321|20735290|P3|Period 1|Adverse Event|0
5996699|NCT00945321|20735291|P2|Period 1|Adverse Event|0
5996700|NCT00945321|20735292|P1|Period 1|Adverse Event|0
5996701|NCT00945243|20735425|P1|Overall Study|Study Terminated: Subjects Dispositioned|3
5996702|NCT00945191|20735431|P1|Overall Study|Investigator's discretion|1
5996703|NCT00945191|20735431|P1|Overall Study|Serious adverse event or adverse event|1
5996704|NCT00945191|20735431|P1|Overall Study|Disease progression|3
5996705|NCT00945191|20735431|P1|Overall Study|Participant relocated to another state|1
5996706|NCT00945191|20735431|P1|Overall Study|Did not achieve a complete response|18
5996707|NCT00945009|20735627|P3|Overall Study|Refusal of further protocol|0
5996708|NCT00945009|20735628|P2|Overall Study|Refusal of further protocol|0
5996709|NCT00945009|20735629|P1|Overall Study|Refusal of further protocol|1
5996710|NCT00945009|20735627|P3|Overall Study|Inevaluable|0
5996711|NCT00945009|20735628|P2|Overall Study|Inevaluable|1
5996712|NCT00945009|20735629|P1|Overall Study|Inevaluable|0
5996713|NCT00945009|20735627|P3|Overall Study|Ineligible|0
5996714|NCT00945009|20735628|P2|Overall Study|Ineligible|1
5996715|NCT00945009|20735629|P1|Overall Study|Ineligible|6
5996716|NCT00945009|20735627|P3|Overall Study|Withdrawal by Subject|0
5996717|NCT00945009|20735628|P2|Overall Study|Withdrawal by Subject|0
5996718|NCT00945009|20735629|P1|Overall Study|Withdrawal by Subject|1
5996719|NCT00945009|20735627|P3|Overall Study|Protocol Violation|0
5996720|NCT00945009|20735628|P2|Overall Study|Protocol Violation|1
5996721|NCT00945009|20735629|P1|Overall Study|Protocol Violation|6
5996722|NCT00945009|20735627|P3|Overall Study|Physician Decision|3
5996723|NCT00945009|20735628|P2|Overall Study|Physician Decision|4
5996724|NCT00945009|20735629|P1|Overall Study|Physician Decision|21
5996725|NCT00945009|20735627|P3|Overall Study|Lack of Efficacy|0
5996726|NCT00945009|20735628|P2|Overall Study|Lack of Efficacy|0
5996727|NCT00945009|20735629|P1|Overall Study|Lack of Efficacy|10
5996728|NCT00944697|20735705|P2|Overall Study|Administrative|1
5996729|NCT00944697|20735706|P1|Overall Study|Administrative|1
5996730|NCT00944697|20735705|P2|Overall Study|Adverse Event|3
5996731|NCT00944697|20735706|P1|Overall Study|Adverse Event|0
5996732|NCT00944697|20735705|P2|Overall Study|Withdrawal by Subject|1
5996733|NCT00944697|20735706|P1|Overall Study|Withdrawal by Subject|1
5996734|NCT00944658|20735738|P2|Treatment 12 Weeks|Adverse Event|2
5996735|NCT00944658|20735739|P1|Treatment 12 Weeks|Adverse Event|0
5996736|NCT00944645|20735751|P2|Period 2|Withdrawal by Subject|6
5996737|NCT00944645|20735752|P1|Period 2|Withdrawal by Subject|7
5996738|NCT00944645|20735751|P2|Period 2|Lost to Follow-up|3
5996739|NCT00944645|20735752|P1|Period 2|Lost to Follow-up|0
5996740|NCT00944645|20735751|P2|Period 2|Adverse Event|0
5996741|NCT00944645|20735752|P1|Period 2|Adverse Event|1
5996742|NCT00944229|20735799|P1|Overall Study|Physician Decision|14
5996743|NCT00944229|20735799|P1|Overall Study|Withdrawal by Subject|11
5996744|NCT00944125|20735805|P2|6 Months to Study Completion|Withdrawal by Subject|2
5996745|NCT00944125|20735806|P1|6 Months to Study Completion|Withdrawal by Subject|0
5996746|NCT00944125|20735805|P2|3 to 6 Months|Withdrawal by Subject|2
5996747|NCT00944125|20735806|P1|3 to 6 Months|Withdrawal by Subject|0
5996748|NCT00944034|20735909|P12|Overall Study|Administrative reason|0
5996749|NCT00944034|20735910|P11|Overall Study|Administrative reason|0
5996750|NCT00944034|20735911|P10|Overall Study|Administrative reason|0
5996751|NCT00944034|20735912|P9|Overall Study|Administrative reason|0
5996752|NCT00944034|20735913|P8|Overall Study|Administrative reason|0
5996753|NCT00944034|20735914|P7|Overall Study|Administrative reason|1
5996754|NCT00944034|20735915|P6|Overall Study|Administrative reason|0
5996755|NCT00944034|20735916|P5|Overall Study|Administrative reason|0
5996756|NCT00944034|20735917|P4|Overall Study|Administrative reason|0
5996757|NCT00944034|20735918|P3|Overall Study|Administrative reason|0
5996758|NCT00944034|20735919|P2|Overall Study|Administrative reason|0
5996759|NCT00944034|20735920|P1|Overall Study|Administrative reason|0
5996760|NCT00944034|20735909|P12|Overall Study|Unable to classify|0
5996761|NCT00944034|20735910|P11|Overall Study|Unable to classify|0
5996762|NCT00944034|20735911|P10|Overall Study|Unable to classify|0
5996763|NCT00944034|20735912|P9|Overall Study|Unable to classify|0
5996764|NCT00944034|20735913|P8|Overall Study|Unable to classify|1
5996765|NCT00944034|20735914|P7|Overall Study|Unable to classify|1
5996766|NCT00944034|20735915|P6|Overall Study|Unable to classify|1
5996767|NCT00944034|20735916|P5|Overall Study|Unable to classify|0
5996768|NCT00944034|20735917|P4|Overall Study|Unable to classify|0
5996769|NCT00944034|20735918|P3|Overall Study|Unable to classify|0
5996770|NCT00944034|20735919|P2|Overall Study|Unable to classify|0
5996771|NCT00944034|20735920|P1|Overall Study|Unable to classify|0
5996772|NCT00944034|20735909|P12|Overall Study|Protocol Violation|0
5996773|NCT00944034|20735910|P11|Overall Study|Protocol Violation|0
5996774|NCT00944034|20735911|P10|Overall Study|Protocol Violation|4
5996775|NCT00944034|20735912|P9|Overall Study|Protocol Violation|1
5996776|NCT00944034|20735913|P8|Overall Study|Protocol Violation|1
5996777|NCT00944034|20735914|P7|Overall Study|Protocol Violation|0
5996778|NCT00944034|20735915|P6|Overall Study|Protocol Violation|3
5996779|NCT00944034|20735916|P5|Overall Study|Protocol Violation|2
5996780|NCT00944034|20735917|P4|Overall Study|Protocol Violation|1
5996781|NCT00944034|20735918|P3|Overall Study|Protocol Violation|0
5996782|NCT00944034|20735919|P2|Overall Study|Protocol Violation|0
5996783|NCT00944034|20735920|P1|Overall Study|Protocol Violation|2
5996784|NCT00944034|20735909|P12|Overall Study|Death|0
5996785|NCT00944034|20735910|P11|Overall Study|Death|0
5996786|NCT00944034|20735911|P10|Overall Study|Death|0
5996787|NCT00944034|20735912|P9|Overall Study|Death|0
5996788|NCT00944034|20735913|P8|Overall Study|Death|0
5996789|NCT00944034|20735914|P7|Overall Study|Death|0
5996790|NCT00944034|20735915|P6|Overall Study|Death|0
5996791|NCT00944034|20735916|P5|Overall Study|Death|0
5996792|NCT00944034|20735917|P4|Overall Study|Death|0
5996793|NCT00944034|20735918|P3|Overall Study|Death|1
5996794|NCT00944034|20735919|P2|Overall Study|Death|0
5996795|NCT00944034|20735920|P1|Overall Study|Death|0
5996796|NCT00944034|20735909|P12|Overall Study|Lost to Follow-up|0
5996797|NCT00944034|20735910|P11|Overall Study|Lost to Follow-up|1
5996798|NCT00944034|20735911|P10|Overall Study|Lost to Follow-up|1
5996799|NCT00944034|20735912|P9|Overall Study|Lost to Follow-up|5
5996800|NCT00944034|20735913|P8|Overall Study|Lost to Follow-up|1
5996801|NCT00944034|20735914|P7|Overall Study|Lost to Follow-up|0
5996802|NCT00944034|20735915|P6|Overall Study|Lost to Follow-up|7
5996803|NCT00944034|20735916|P5|Overall Study|Lost to Follow-up|5
5996804|NCT00944034|20735917|P4|Overall Study|Lost to Follow-up|0
5996805|NCT00944034|20735918|P3|Overall Study|Lost to Follow-up|2
5996806|NCT00944034|20735919|P2|Overall Study|Lost to Follow-up|4
5996807|NCT00944034|20735920|P1|Overall Study|Lost to Follow-up|0
5996808|NCT00944034|20735909|P12|Overall Study|Withdrawal by Subject|4
5996809|NCT00944034|20735910|P11|Overall Study|Withdrawal by Subject|0
5996810|NCT00944034|20735911|P10|Overall Study|Withdrawal by Subject|4
5996811|NCT00944034|20735912|P9|Overall Study|Withdrawal by Subject|3
5996812|NCT00944034|20735913|P8|Overall Study|Withdrawal by Subject|2
5996813|NCT00944034|20735914|P7|Overall Study|Withdrawal by Subject|2
5996814|NCT00944034|20735915|P6|Overall Study|Withdrawal by Subject|8
5996815|NCT00944034|20735916|P5|Overall Study|Withdrawal by Subject|5
5996816|NCT00944034|20735917|P4|Overall Study|Withdrawal by Subject|2
5996817|NCT00944034|20735918|P3|Overall Study|Withdrawal by Subject|6
5996818|NCT00944034|20735919|P2|Overall Study|Withdrawal by Subject|2
5996819|NCT00944034|20735920|P1|Overall Study|Withdrawal by Subject|3
5996820|NCT00944034|20735909|P12|Overall Study|Inappropriate enrollment|0
5996821|NCT00944034|20735910|P11|Overall Study|Inappropriate enrollment|0
5996822|NCT00944034|20735911|P10|Overall Study|Inappropriate enrollment|1
5996823|NCT00944034|20735912|P9|Overall Study|Inappropriate enrollment|1
5996824|NCT00944034|20735913|P8|Overall Study|Inappropriate enrollment|0
5996825|NCT00944034|20735914|P7|Overall Study|Inappropriate enrollment|0
5996826|NCT00944034|20735915|P6|Overall Study|Inappropriate enrollment|1
5996827|NCT00944034|20735916|P5|Overall Study|Inappropriate enrollment|2
5996828|NCT00944034|20735917|P4|Overall Study|Inappropriate enrollment|1
5996829|NCT00944034|20735918|P3|Overall Study|Inappropriate enrollment|0
5996830|NCT00944034|20735919|P2|Overall Study|Inappropriate enrollment|1
5996831|NCT00944034|20735920|P1|Overall Study|Inappropriate enrollment|0
5996832|NCT00943917|20736066|P15|Stage II Continuation|A1C elevation|0
5996833|NCT00943917|20736067|P14|Stage II Continuation|A1C elevation|1
5996834|NCT00943917|20736068|P13|Stage II Continuation|A1C elevation|0
5996835|NCT00943917|20736069|P12|Stage II Continuation|A1C elevation|0
5996836|NCT00943917|20736070|P11|Stage II Continuation|A1C elevation|0
5996837|NCT00943917|20736071|P10|Stage II Continuation|A1C elevation|0
5996838|NCT00943917|20736072|P9|Stage II Continuation|A1C elevation|0
5996839|NCT00943917|20736073|P8|Stage II Continuation|A1C elevation|0
5996840|NCT00943917|20736074|P7|Stage II Continuation|A1C elevation|0
5996841|NCT00943917|20736075|P6|Stage II Continuation|A1C elevation|0
5996842|NCT00943917|20736076|P5|Stage II Continuation|A1C elevation|0
5996843|NCT00943917|20736077|P4|Stage II Continuation|A1C elevation|0
5996844|NCT00943917|20736078|P3|Stage II Continuation|A1C elevation|0
5996845|NCT00943917|20736079|P2|Stage II Continuation|A1C elevation|0
5996846|NCT00943917|20736080|P1|Stage II Continuation|A1C elevation|0
5996847|NCT00943917|20736066|P15|Stage II Continuation|hypoglycemia|0
5996848|NCT00943917|20736067|P14|Stage II Continuation|hypoglycemia|0
5996849|NCT00943917|20736068|P13|Stage II Continuation|hypoglycemia|1
5996850|NCT00943917|20736069|P12|Stage II Continuation|hypoglycemia|0
5996851|NCT00943917|20736070|P11|Stage II Continuation|hypoglycemia|0
5996852|NCT00943917|20736071|P10|Stage II Continuation|hypoglycemia|0
5996853|NCT00943917|20736072|P9|Stage II Continuation|hypoglycemia|0
5996854|NCT00943917|20736073|P8|Stage II Continuation|hypoglycemia|0
5996855|NCT00943917|20736074|P7|Stage II Continuation|hypoglycemia|0
5996856|NCT00943917|20736075|P6|Stage II Continuation|hypoglycemia|0
5996857|NCT00943917|20736076|P5|Stage II Continuation|hypoglycemia|0
5996858|NCT00943917|20736077|P4|Stage II Continuation|hypoglycemia|0
5996859|NCT00943917|20736078|P3|Stage II Continuation|hypoglycemia|0
5996860|NCT00943917|20736079|P2|Stage II Continuation|hypoglycemia|0
5996861|NCT00943917|20736080|P1|Stage II Continuation|hypoglycemia|0
5996862|NCT00943917|20736066|P15|Stage II Continuation|Protocol Violation|0
5996863|NCT00943917|20736067|P14|Stage II Continuation|Protocol Violation|0
5996864|NCT00943917|20736068|P13|Stage II Continuation|Protocol Violation|0
5996865|NCT00943917|20736069|P12|Stage II Continuation|Protocol Violation|1
5996866|NCT00943917|20736070|P11|Stage II Continuation|Protocol Violation|0
5996867|NCT00943917|20736071|P10|Stage II Continuation|Protocol Violation|1
5996868|NCT00943917|20736072|P9|Stage II Continuation|Protocol Violation|0
5996869|NCT00943917|20736073|P8|Stage II Continuation|Protocol Violation|0
5996870|NCT00943917|20736074|P7|Stage II Continuation|Protocol Violation|0
5996871|NCT00943917|20736075|P6|Stage II Continuation|Protocol Violation|0
5996872|NCT00943917|20736076|P5|Stage II Continuation|Protocol Violation|0
5996873|NCT00943917|20736077|P4|Stage II Continuation|Protocol Violation|0
5996874|NCT00943917|20736078|P3|Stage II Continuation|Protocol Violation|0
5996875|NCT00943917|20736079|P2|Stage II Continuation|Protocol Violation|0
5996876|NCT00943917|20736080|P1|Stage II Continuation|Protocol Violation|0
5996877|NCT00943917|20736066|P15|Stage II Continuation|Withdrawal by Subject|3
5996878|NCT00943917|20736067|P14|Stage II Continuation|Withdrawal by Subject|1
5996879|NCT00943917|20736068|P13|Stage II Continuation|Withdrawal by Subject|0
5996880|NCT00943917|20736069|P12|Stage II Continuation|Withdrawal by Subject|0
5996881|NCT00943917|20736070|P11|Stage II Continuation|Withdrawal by Subject|0
5996882|NCT00943917|20736071|P10|Stage II Continuation|Withdrawal by Subject|0
5996883|NCT00943917|20736072|P9|Stage II Continuation|Withdrawal by Subject|0
5996884|NCT00943917|20736073|P8|Stage II Continuation|Withdrawal by Subject|0
5996885|NCT00943917|20736074|P7|Stage II Continuation|Withdrawal by Subject|0
5996886|NCT00943917|20736075|P6|Stage II Continuation|Withdrawal by Subject|0
5996887|NCT00943917|20736076|P5|Stage II Continuation|Withdrawal by Subject|0
5996888|NCT00943917|20736077|P4|Stage II Continuation|Withdrawal by Subject|0
5996889|NCT00943917|20736078|P3|Stage II Continuation|Withdrawal by Subject|0
5996890|NCT00943917|20736079|P2|Stage II Continuation|Withdrawal by Subject|0
5996891|NCT00943917|20736080|P1|Stage II Continuation|Withdrawal by Subject|0
5996892|NCT00943917|20736066|P15|Stage II Continuation|Adverse Event|1
5996893|NCT00943917|20736067|P14|Stage II Continuation|Adverse Event|1
5996894|NCT00943917|20736068|P13|Stage II Continuation|Adverse Event|2
5996895|NCT00943917|20736069|P12|Stage II Continuation|Adverse Event|1
5996896|NCT00943917|20736070|P11|Stage II Continuation|Adverse Event|0
5996897|NCT00943917|20736071|P10|Stage II Continuation|Adverse Event|0
5996898|NCT00943917|20736072|P9|Stage II Continuation|Adverse Event|0
5996899|NCT00943917|20736073|P8|Stage II Continuation|Adverse Event|0
5996900|NCT00943917|20736074|P7|Stage II Continuation|Adverse Event|0
5996901|NCT00943917|20736075|P6|Stage II Continuation|Adverse Event|0
5996902|NCT00943917|20736076|P5|Stage II Continuation|Adverse Event|0
5996903|NCT00943917|20736077|P4|Stage II Continuation|Adverse Event|0
5996904|NCT00943917|20736078|P3|Stage II Continuation|Adverse Event|0
5996905|NCT00943917|20736079|P2|Stage II Continuation|Adverse Event|0
5996906|NCT00943917|20736080|P1|Stage II Continuation|Adverse Event|0
5996907|NCT00943917|20736066|P15|Stage II|Pregnancy|0
5996908|NCT00943917|20736067|P14|Stage II|Pregnancy|0
5996909|NCT00943917|20736068|P13|Stage II|Pregnancy|0
5996910|NCT00943917|20736069|P12|Stage II|Pregnancy|0
5996911|NCT00943917|20736070|P11|Stage II|Pregnancy|0
5996912|NCT00943917|20736071|P10|Stage II|Pregnancy|0
5996913|NCT00943917|20736072|P9|Stage II|Pregnancy|0
5996914|NCT00943917|20736073|P8|Stage II|Pregnancy|0
5996915|NCT00943917|20736074|P7|Stage II|Pregnancy|0
5996916|NCT00943917|20736075|P6|Stage II|Pregnancy|1
5996917|NCT00943917|20736076|P5|Stage II|Pregnancy|0
5996918|NCT00943917|20736077|P4|Stage II|Pregnancy|0
5996919|NCT00943917|20736078|P3|Stage II|Pregnancy|0
5996920|NCT00943917|20736079|P2|Stage II|Pregnancy|0
5996921|NCT00943917|20736080|P1|Stage II|Pregnancy|0
5996922|NCT00943917|20736066|P15|Stage II|Withdrawal by Subject|0
5996923|NCT00943917|20736067|P14|Stage II|Withdrawal by Subject|0
5996924|NCT00943917|20736068|P13|Stage II|Withdrawal by Subject|0
5996925|NCT00943917|20736069|P12|Stage II|Withdrawal by Subject|0
5996926|NCT00943917|20736070|P11|Stage II|Withdrawal by Subject|0
5996927|NCT00943917|20736071|P10|Stage II|Withdrawal by Subject|0
5996928|NCT00943917|20736072|P9|Stage II|Withdrawal by Subject|0
5996929|NCT00943917|20736073|P8|Stage II|Withdrawal by Subject|0
5996930|NCT00943917|20736074|P7|Stage II|Withdrawal by Subject|0
5996931|NCT00943917|20736075|P6|Stage II|Withdrawal by Subject|1
5996932|NCT00943917|20736076|P5|Stage II|Withdrawal by Subject|0
5996933|NCT00943917|20736077|P4|Stage II|Withdrawal by Subject|0
5996934|NCT00943917|20736078|P3|Stage II|Withdrawal by Subject|0
5996935|NCT00943917|20736079|P2|Stage II|Withdrawal by Subject|0
5996936|NCT00943917|20736080|P1|Stage II|Withdrawal by Subject|0
5996937|NCT00943917|20736066|P15|Stage II|Adverse Event|0
5996938|NCT00943917|20736067|P14|Stage II|Adverse Event|0
5996939|NCT00943917|20736068|P13|Stage II|Adverse Event|0
5996940|NCT00943917|20736069|P12|Stage II|Adverse Event|0
5996941|NCT00943917|20736070|P11|Stage II|Adverse Event|0
5996942|NCT00943917|20736071|P10|Stage II|Adverse Event|0
5996943|NCT00943917|20736072|P9|Stage II|Adverse Event|1
5996944|NCT00943917|20736073|P8|Stage II|Adverse Event|0
5996945|NCT00943917|20736074|P7|Stage II|Adverse Event|3
5996946|NCT00943917|20736075|P6|Stage II|Adverse Event|1
5996947|NCT00943917|20736076|P5|Stage II|Adverse Event|0
5996948|NCT00943917|20736077|P4|Stage II|Adverse Event|0
5996949|NCT00943917|20736078|P3|Stage II|Adverse Event|0
5996950|NCT00943917|20736079|P2|Stage II|Adverse Event|0
5996951|NCT00943917|20736080|P1|Stage II|Adverse Event|0
5996952|NCT00943917|20736066|P15|Stage I|Withdrawal by Subject|0
5996953|NCT00943917|20736067|P14|Stage I|Withdrawal by Subject|0
5996954|NCT00943917|20736068|P13|Stage I|Withdrawal by Subject|0
5996955|NCT00943917|20736069|P12|Stage I|Withdrawal by Subject|0
5996956|NCT00943917|20736070|P11|Stage I|Withdrawal by Subject|0
5996957|NCT00943917|20736071|P10|Stage I|Withdrawal by Subject|0
5996958|NCT00943917|20736072|P9|Stage I|Withdrawal by Subject|0
5996959|NCT00943917|20736073|P8|Stage I|Withdrawal by Subject|0
5996960|NCT00943917|20736074|P7|Stage I|Withdrawal by Subject|0
5996961|NCT00943917|20736075|P6|Stage I|Withdrawal by Subject|0
5996962|NCT00943917|20736076|P5|Stage I|Withdrawal by Subject|0
5996963|NCT00943917|20736077|P4|Stage I|Withdrawal by Subject|0
5996964|NCT00943917|20736078|P3|Stage I|Withdrawal by Subject|2
5996965|NCT00943917|20736079|P2|Stage I|Withdrawal by Subject|1
5996966|NCT00943917|20736080|P1|Stage I|Withdrawal by Subject|2
5996967|NCT00943917|20736066|P15|Stage I|A1C elevation|0
5996968|NCT00943917|20736067|P14|Stage I|A1C elevation|0
5996969|NCT00943917|20736068|P13|Stage I|A1C elevation|0
5996970|NCT00943917|20736069|P12|Stage I|A1C elevation|0
5996971|NCT00943917|20736070|P11|Stage I|A1C elevation|0
5996972|NCT00943917|20736071|P10|Stage I|A1C elevation|0
5996973|NCT00943917|20736072|P9|Stage I|A1C elevation|0
5996974|NCT00943917|20736073|P8|Stage I|A1C elevation|0
5996975|NCT00943917|20736074|P7|Stage I|A1C elevation|0
5996976|NCT00943917|20736075|P6|Stage I|A1C elevation|0
5996977|NCT00943917|20736076|P5|Stage I|A1C elevation|0
5996978|NCT00943917|20736077|P4|Stage I|A1C elevation|0
5996979|NCT00943917|20736078|P3|Stage I|A1C elevation|0
5996980|NCT00943917|20736079|P2|Stage I|A1C elevation|0
5996981|NCT00943917|20736080|P1|Stage I|A1C elevation|1
5996982|NCT00943917|20736066|P15|Stage I|hyperglycemia|0
5996983|NCT00943917|20736067|P14|Stage I|hyperglycemia|0
5996984|NCT00943917|20736068|P13|Stage I|hyperglycemia|0
5996985|NCT00943917|20736069|P12|Stage I|hyperglycemia|0
5996986|NCT00943917|20736070|P11|Stage I|hyperglycemia|0
5996987|NCT00943917|20736071|P10|Stage I|hyperglycemia|0
5996988|NCT00943917|20736072|P9|Stage I|hyperglycemia|0
5996989|NCT00943917|20736073|P8|Stage I|hyperglycemia|0
5996990|NCT00943917|20736074|P7|Stage I|hyperglycemia|0
5996991|NCT00943917|20736075|P6|Stage I|hyperglycemia|0
5996992|NCT00943917|20736076|P5|Stage I|hyperglycemia|0
5996993|NCT00943917|20736077|P4|Stage I|hyperglycemia|0
5996994|NCT00943917|20736078|P3|Stage I|hyperglycemia|1
5996995|NCT00943917|20736079|P2|Stage I|hyperglycemia|0
5996996|NCT00943917|20736080|P1|Stage I|hyperglycemia|0
5996997|NCT00943917|20736066|P15|Stage I|Lost to Follow-up|0
5996998|NCT00943917|20736067|P14|Stage I|Lost to Follow-up|0
5996999|NCT00943917|20736068|P13|Stage I|Lost to Follow-up|0
5997000|NCT00943917|20736069|P12|Stage I|Lost to Follow-up|0
5997001|NCT00943917|20736070|P11|Stage I|Lost to Follow-up|0
5997002|NCT00943917|20736071|P10|Stage I|Lost to Follow-up|0
5997003|NCT00943917|20736072|P9|Stage I|Lost to Follow-up|0
5997004|NCT00943917|20736073|P8|Stage I|Lost to Follow-up|0
5997005|NCT00943917|20736074|P7|Stage I|Lost to Follow-up|0
5997006|NCT00943917|20736075|P6|Stage I|Lost to Follow-up|0
5997007|NCT00943917|20736076|P5|Stage I|Lost to Follow-up|0
5997008|NCT00943917|20736077|P4|Stage I|Lost to Follow-up|0
5997009|NCT00943917|20736078|P3|Stage I|Lost to Follow-up|1
5997010|NCT00943917|20736079|P2|Stage I|Lost to Follow-up|0
5997011|NCT00943917|20736080|P1|Stage I|Lost to Follow-up|0
5997012|NCT00943917|20736066|P15|Stage I|Adverse Event|0
5997013|NCT00943917|20736067|P14|Stage I|Adverse Event|0
5997014|NCT00943917|20736068|P13|Stage I|Adverse Event|0
5997015|NCT00943917|20736069|P12|Stage I|Adverse Event|0
5997016|NCT00943917|20736070|P11|Stage I|Adverse Event|0
5997017|NCT00943917|20736071|P10|Stage I|Adverse Event|0
5997018|NCT00943917|20736072|P9|Stage I|Adverse Event|0
5997019|NCT00943917|20736073|P8|Stage I|Adverse Event|0
5997020|NCT00943917|20736074|P7|Stage I|Adverse Event|0
5997021|NCT00943917|20736075|P6|Stage I|Adverse Event|0
5997022|NCT00943917|20736076|P5|Stage I|Adverse Event|0
5997023|NCT00943917|20736077|P4|Stage I|Adverse Event|0
5997024|NCT00943917|20736078|P3|Stage I|Adverse Event|2
5997025|NCT00943917|20736079|P2|Stage I|Adverse Event|2
5997026|NCT00943917|20736080|P1|Stage I|Adverse Event|1
5997027|NCT00943852|20736256|P10|Washout Period After Period 4 Treatment|Trial stopped early|0
5997028|NCT00943852|20736257|P9|Washout Period After Period 4 Treatment|Trial stopped early|0
5997029|NCT00943852|20736258|P8|Washout Period After Period 4 Treatment|Trial stopped early|0
5997030|NCT00943852|20736259|P7|Washout Period After Period 4 Treatment|Trial stopped early|1
5997031|NCT00943852|20736260|P6|Washout Period After Period 4 Treatment|Trial stopped early|0
5997032|NCT00943852|20736261|P5|Washout Period After Period 4 Treatment|Trial stopped early|0
5997033|NCT00943852|20736262|P4|Washout Period After Period 4 Treatment|Trial stopped early|1
5997034|NCT00943852|20736263|P3|Washout Period After Period 4 Treatment|Trial stopped early|1
5997035|NCT00943852|20736264|P2|Washout Period After Period 4 Treatment|Trial stopped early|0
5997036|NCT00943852|20736265|P1|Washout Period After Period 4 Treatment|Trial stopped early|1
5997037|NCT00943852|20736256|P10|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
5997038|NCT00943852|20736257|P9|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
5997039|NCT00943852|20736258|P8|Washout Period After Period 4 Treatment|Not taking medication per protocol|1
5997040|NCT00943852|20736259|P7|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
5997041|NCT00943852|20736260|P6|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
5997042|NCT00943852|20736261|P5|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
5997043|NCT00943852|20736262|P4|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
5997044|NCT00943852|20736263|P3|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
5997045|NCT00943852|20736264|P2|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
5997046|NCT00943852|20736265|P1|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
5997047|NCT00943852|20736256|P10|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
5997048|NCT00943852|20736257|P9|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
5997049|NCT00943852|20736258|P8|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
5997050|NCT00943852|20736259|P7|Washout Period After Period 3 Treatment|Did not meet criteria for next period|1
5997051|NCT00943852|20736260|P6|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
5997052|NCT00943852|20736261|P5|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
5997053|NCT00943852|20736262|P4|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
5997054|NCT00943852|20736263|P3|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
5997055|NCT00943852|20736264|P2|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
5997056|NCT00943852|20736265|P1|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
5997057|NCT00943852|20736256|P10|Washout Period After Period 2 Treatment|Trial stopped early|0
5997058|NCT00943852|20736257|P9|Washout Period After Period 2 Treatment|Trial stopped early|0
5997059|NCT00943852|20736258|P8|Washout Period After Period 2 Treatment|Trial stopped early|0
5997060|NCT00943852|20736259|P7|Washout Period After Period 2 Treatment|Trial stopped early|0
5997061|NCT00943852|20736260|P6|Washout Period After Period 2 Treatment|Trial stopped early|1
5997062|NCT00943852|20736261|P5|Washout Period After Period 2 Treatment|Trial stopped early|0
5997063|NCT00943852|20736262|P4|Washout Period After Period 2 Treatment|Trial stopped early|0
5997064|NCT00943852|20736263|P3|Washout Period After Period 2 Treatment|Trial stopped early|0
5997065|NCT00943852|20736264|P2|Washout Period After Period 2 Treatment|Trial stopped early|0
5997066|NCT00943852|20736265|P1|Washout Period After Period 2 Treatment|Trial stopped early|0
5997067|NCT00943852|20736256|P10|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
5997068|NCT00943852|20736257|P9|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
5997069|NCT00943852|20736258|P8|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
5997070|NCT00943852|20736259|P7|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
5997071|NCT00943852|20736260|P6|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
5997072|NCT00943852|20736261|P5|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
5997073|NCT00943852|20736262|P4|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|1
5997074|NCT00943852|20736263|P3|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
5997075|NCT00943852|20736264|P2|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
5997076|NCT00943852|20736265|P1|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
5997077|NCT00943826|20736278|P2|After Primary Overall Survival Analysis|Withdrew Consent|0
5997078|NCT00943826|20736279|P1|After Primary Overall Survival Analysis|Withdrew Consent|4
5997079|NCT00943826|20736278|P2|After Primary Overall Survival Analysis|Progression of Disease|4
5997080|NCT00943826|20736279|P1|After Primary Overall Survival Analysis|Progression of Disease|2
5997081|NCT00943826|20736278|P2|After Primary Overall Survival Analysis|Administrative reasons|16
5997082|NCT00943826|20736279|P1|After Primary Overall Survival Analysis|Administrative reasons|10
5997083|NCT00943826|20736278|P2|After Primary Overall Survival Analysis|Adverse Event|0
5997084|NCT00943826|20736279|P1|After Primary Overall Survival Analysis|Adverse Event|11
5997085|NCT00943826|20736278|P2|Monotherapy Phase|Failure to return|1
5997086|NCT00943826|20736279|P1|Monotherapy Phase|Failure to return|2
5997087|NCT00943826|20736278|P2|Monotherapy Phase|Withdrew Consent|3
5997088|NCT00943826|20736279|P1|Monotherapy Phase|Withdrew Consent|2
5997089|NCT00943826|20736278|P2|Monotherapy Phase|Refused treatment/ Did not cooperate|2
5997090|NCT00943826|20736279|P1|Monotherapy Phase|Refused treatment/ Did not cooperate|8
5997091|NCT00943826|20736278|P2|Monotherapy Phase|Administrative reasons|5
5997092|NCT00943826|20736279|P1|Monotherapy Phase|Administrative reasons|11
5997093|NCT00943826|20736278|P2|Monotherapy Phase|Adverse Event|5
5997094|NCT00943826|20736279|P1|Monotherapy Phase|Adverse Event|42
5997095|NCT00943826|20736278|P2|Maintenance Phase|Failure to return|1
5997096|NCT00943826|20736279|P1|Maintenance Phase|Failure to return|0
5997097|NCT00943826|20736278|P2|Maintenance Phase|Administrative reasons|1
5997098|NCT00943826|20736279|P1|Maintenance Phase|Administrative reasons|4
5997099|NCT00943826|20736278|P2|Maintenance Phase|Refused treatment/Did not cooperate|3
5997100|NCT00943826|20736279|P1|Maintenance Phase|Refused treatment/Did not cooperate|6
5997101|NCT00943826|20736278|P2|Maintenance Phase|Withdrew consent|4
5997102|NCT00943826|20736279|P1|Maintenance Phase|Withdrew consent|2
5997103|NCT00943826|20736278|P2|Maintenance Phase|Adverse Event|30
5997104|NCT00943826|20736279|P1|Maintenance Phase|Adverse Event|31
5997105|NCT00943826|20736278|P2|Concurrent Phase|Protocol Violation|0
5997106|NCT00943826|20736279|P1|Concurrent Phase|Protocol Violation|1
5997107|NCT00943826|20736278|P2|Concurrent Phase|Administrative reasons|1
5997108|NCT00943826|20736279|P1|Concurrent Phase|Administrative reasons|2
5997109|NCT00943826|20736278|P2|Concurrent Phase|Refused treatment/Did not cooperate|7
5997110|NCT00943826|20736279|P1|Concurrent Phase|Refused treatment/Did not cooperate|5
5997111|NCT00943826|20736278|P2|Concurrent Phase|Withdrew consent|7
5997112|NCT00943826|20736279|P1|Concurrent Phase|Withdrew consent|3
5997113|NCT00943826|20736278|P2|Concurrent Phase|Adverse Event|27
5997114|NCT00943826|20736279|P1|Concurrent Phase|Adverse Event|50
5997115|NCT00943787|20736303|P1|Overall Study|Withdrawal by Subject|3
5997116|NCT00943787|20736303|P1|Overall Study|Physician Decision|4
5997121|NCT00943735|20736323|P1|Overall Study|Other|3
5997122|NCT00943735|20736323|P1|Overall Study|Other|8
5997123|NCT00943735|20736323|P1|Overall Study|Death|1
5997124|NCT00943735|20736323|P1|Overall Study|Withdrawal by Subject|8
5997125|NCT00943735|20736323|P1|Overall Study|Adverse Event|12
5997156|NCT00943683|20736395|P2|Overall Study|Patient Moved|0
5997157|NCT00943683|20736396|P1|Overall Study|Patient Moved|1
5997158|NCT00943683|20736395|P2|Overall Study|Withdrawal by Subject|0
5997159|NCT00943683|20736396|P1|Overall Study|Withdrawal by Subject|1
5997160|NCT00943683|20736395|P2|Overall Study|Protocol Violation|2
5997161|NCT00943683|20736396|P1|Overall Study|Protocol Violation|1
5997162|NCT00943683|20736395|P2|Overall Study|Lost to Follow-up|1
5997163|NCT00943683|20736396|P1|Overall Study|Lost to Follow-up|1
5997164|NCT00943683|20736395|P2|Overall Study|Adverse Event|3
5997165|NCT00943683|20736396|P1|Overall Study|Adverse Event|3
5997166|NCT00943670|20736402|P1|Trastuzumab Emtansine + Pertuzumab|Adverse Event|5
5997167|NCT00943670|20736402|P1|Trastuzumab Emtansine + Pertuzumab|Progression of brain metastases|2
5997168|NCT00943670|20736402|P1|Trastuzumab Emtansine + Pertuzumab|Systemic progression|6
5997169|NCT00943670|20736402|P1|Trastuzumab Emtansine + Pertuzumab|Withdrawal by Subject|4
5997170|NCT00943670|20736402|P1|Trastuzumab Emtansine + Pertuzumab|Physician Decision|1
5997171|NCT00943670|20736402|P1|Single-agent Trastuzumab Emtansine|Early progressive disease|20
5997172|NCT00943670|20736402|P1|Single-agent Trastuzumab Emtansine|Adverse Event|2
5997173|NCT00943670|20736402|P1|Single-agent Trastuzumab Emtansine|Systemic progression|15
5997174|NCT00943670|20736402|P1|Single-agent Trastuzumab Emtansine|Withdrawal by Subject|3
5997175|NCT00943670|20736402|P1|Single-agent Trastuzumab Emtansine|Physician Decision|2
5997176|NCT00943605|20736491|P2|Overall Study|Study termination|30
5997177|NCT00943605|20736492|P1|Overall Study|Study termination|30
5997178|NCT00943592|20736502|P1|Overall Study|Death|3
5997179|NCT00943579|20736515|P2|Overall Study|Lack of Efficacy|2
5997180|NCT00943579|20736516|P1|Overall Study|Lack of Efficacy|2
5997181|NCT00943579|20736515|P2|Overall Study|Adverse Event|3
5997182|NCT00943579|20736516|P1|Overall Study|Adverse Event|4
5997183|NCT00943397|20736617|P2|Overall Study|Site terminated and other|56
5997184|NCT00943397|20736618|P1|Overall Study|Site terminated and other|12
5997185|NCT00943397|20736617|P2|Overall Study|Withdrawal by Subject|1
5997186|NCT00943397|20736618|P1|Overall Study|Withdrawal by Subject|1
5997187|NCT00943397|20736617|P2|Overall Study|Protocol Violation|5
5997188|NCT00943397|20736618|P1|Overall Study|Protocol Violation|2
5997189|NCT00943397|20736617|P2|Overall Study|Lost to Follow-up|4
5997190|NCT00943397|20736618|P1|Overall Study|Lost to Follow-up|0
5997191|NCT00943397|20736617|P2|Overall Study|Adverse Event|6
5997192|NCT00943397|20736618|P1|Overall Study|Adverse Event|0
5997193|NCT00943384|20736624|P1|Overall Study|Withdrawal by Subject|5
5997194|NCT00943384|20736624|P1|Overall Study|Lost to Follow-up|16
5997195|NCT00943384|20736624|P1|Overall Study|Treated off protocol-protocol violation|5
5997196|NCT00943384|20736624|P1|Overall Study|Dispositioned prior to treatment|23
5997197|NCT00943319|20736638|P1|Overall Study|Death|1
5997198|NCT00943306|20736644|P1|Overall Study|Sponsor decision due to non-compliance|1
5997199|NCT00943306|20736644|P1|Overall Study|Death|1
5997200|NCT00943306|20736644|P1|Overall Study|Physician Decision|1
5997201|NCT00943124|20736946|P2|Period 1|Personal Reasons|1
5997202|NCT00943124|20736947|P1|Period 1|Personal Reasons|0
5997203|NCT00943124|20736946|P2|Period 1|Did Not Follow Study Procedures|0
5997204|NCT00943124|20736947|P1|Period 1|Did Not Follow Study Procedures|1
5997205|NCT00943124|20736946|P2|Period 1|Withdrawal by Subject|1
5997206|NCT00943124|20736947|P1|Period 1|Withdrawal by Subject|1
5997207|NCT00943111|20736969|P3|5 Years Long-term Treatment Period|Other than specified above|2
5997208|NCT00943111|20736970|P2|5 Years Long-term Treatment Period|Other than specified above|0
5997209|NCT00943111|20736971|P1|5 Years Long-term Treatment Period|Other than specified above|0
5997210|NCT00943111|20736969|P3|5 Years Long-term Treatment Period|Lost to Follow-up|1
5997211|NCT00943111|20736970|P2|5 Years Long-term Treatment Period|Lost to Follow-up|0
5997212|NCT00943111|20736971|P1|5 Years Long-term Treatment Period|Lost to Follow-up|0
5997213|NCT00943111|20736969|P3|5 Years Long-term Treatment Period|Pregnancy|4
5997214|NCT00943111|20736970|P2|5 Years Long-term Treatment Period|Pregnancy|0
5997215|NCT00943111|20736971|P1|5 Years Long-term Treatment Period|Pregnancy|0
5997216|NCT00943111|20736969|P3|5 Years Long-term Treatment Period|Withdrawal by Subject|8
5997217|NCT00943111|20736970|P2|5 Years Long-term Treatment Period|Withdrawal by Subject|0
5997218|NCT00943111|20736971|P1|5 Years Long-term Treatment Period|Withdrawal by Subject|0
5997219|NCT00943111|20736969|P3|5 Years Long-term Treatment Period|Adverse Event|9
5997220|NCT00943111|20736970|P2|5 Years Long-term Treatment Period|Adverse Event|0
5997221|NCT00943111|20736971|P1|5 Years Long-term Treatment Period|Adverse Event|0
5997222|NCT00943111|20736969|P3|5 Years Long-term Treatment Period|Transition to commercial eliglustat|51
5997223|NCT00943111|20736970|P2|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0
5997224|NCT00943111|20736971|P1|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0
5997225|NCT00943111|20736969|P3|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0
5997226|NCT00943111|20736970|P2|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|1
5997227|NCT00943111|20736971|P1|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0
5997228|NCT00943111|20736969|P3|52-Weeks Primary Analysis Period|Adverse Event|0
5997229|NCT00943111|20736970|P2|52-Weeks Primary Analysis Period|Adverse Event|1
5997230|NCT00943111|20736971|P1|52-Weeks Primary Analysis Period|Adverse Event|2
5997231|NCT00943072|20737039|P2|Overall Study|Other|1
5997232|NCT00943072|20737040|P1|Overall Study|Other|1
5997233|NCT00943072|20737039|P2|Overall Study|Lack of Efficacy|4
5997234|NCT00943072|20737040|P1|Overall Study|Lack of Efficacy|0
5997235|NCT00943072|20737039|P2|Overall Study|Lost to Follow-up|2
5997236|NCT00943072|20737040|P1|Overall Study|Lost to Follow-up|1
5997237|NCT00943072|20737039|P2|Overall Study|Protocol Violation|1
5997238|NCT00943072|20737040|P1|Overall Study|Protocol Violation|0
5997239|NCT00943072|20737039|P2|Overall Study|Withdrawal by Subject|1
5997240|NCT00943072|20737040|P1|Overall Study|Withdrawal by Subject|3
5997241|NCT00943072|20737039|P2|Overall Study|Death|2
5997242|NCT00943072|20737040|P1|Overall Study|Death|0
5997243|NCT00943072|20737039|P2|Overall Study|Adverse Event|3
5997244|NCT00943072|20737040|P1|Overall Study|Adverse Event|0
5997245|NCT00942994|20737058|P2|Overall Study|Protocol deviation|2
5997246|NCT00942994|20737059|P1|Overall Study|Protocol deviation|1
5997247|NCT00942994|20737058|P2|Overall Study|Lost to Follow-up|4
5997248|NCT00942994|20737059|P1|Overall Study|Lost to Follow-up|1
5997249|NCT00942994|20737058|P2|Overall Study|Patient withdrew consent|8
5997250|NCT00942994|20737059|P1|Overall Study|Patient withdrew consent|5
5997251|NCT00942994|20737058|P2|Overall Study|Unsatisfactory therapeutic effect|1
5997252|NCT00942994|20737059|P1|Overall Study|Unsatisfactory therapeutic effect|1
5997253|NCT00942994|20737058|P2|Overall Study|Abnormal laboratory value(s)|0
5997254|NCT00942994|20737059|P1|Overall Study|Abnormal laboratory value(s)|1
5997255|NCT00942994|20737058|P2|Overall Study|Adverse Event|4
5997256|NCT00942994|20737059|P1|Overall Study|Adverse Event|7
5997257|NCT00942968|20737075|P1|Overall Study|Deep vein thrombosis (DVT)|2
5997258|NCT00942968|20737075|P1|Overall Study|Participant required pancreatic biopsy|1
5997259|NCT00942968|20737075|P1|Overall Study|Pulmonary embolism (PE)|1
5997260|NCT00942968|20737075|P1|Overall Study|Inferior vena cava filter placement|4
5997261|NCT00942968|20737075|P1|Overall Study|Progression of disease|12
5997262|NCT00942968|20737075|P1|Overall Study|Physician Decision|11
5997263|NCT00942968|20737075|P1|Overall Study|Sponsor request|5
5997264|NCT00942968|20737075|P1|Overall Study|Withdrawal by Subject|44
5997265|NCT00942968|20737075|P1|Overall Study|Lost to Follow-up|4
5997266|NCT00942968|20737075|P1|Overall Study|Protocol Violation|9
5997267|NCT00942968|20737075|P1|Overall Study|Death|76
5997268|NCT00942968|20737075|P1|Overall Study|Adverse Event|60
5997269|NCT00942734|20737153|P1|Overall Study|Physician Decision|1
5997270|NCT00942734|20737153|P1|Overall Study|Disease Progression|2
5997271|NCT00942734|20737153|P1|Overall Study|Protocol Violation|3
5997272|NCT00942734|20737153|P1|Overall Study|Adverse Event|2
5997273|NCT00942708|20737157|P1|Overall Study|Withdrawal by Subject|1
5997274|NCT00942604|20737165|P2|Overall Study|Patient relocation|1
5997275|NCT00942604|20737166|P1|Overall Study|Patient relocation|1
5997276|NCT00942604|20737165|P2|Overall Study|Withdrawal by Subject|1
5997277|NCT00942604|20737166|P1|Overall Study|Withdrawal by Subject|0
5997278|NCT00942604|20737165|P2|Overall Study|Adverse Event|1
5997279|NCT00942604|20737166|P1|Overall Study|Adverse Event|0
5997280|NCT00942604|20737165|P2|Overall Study|Protocol Violation|1
5997281|NCT00942604|20737166|P1|Overall Study|Protocol Violation|1
5997282|NCT00942422|20737274|P1|Overall Study|Progressive diease|1
5997283|NCT00942422|20737274|P1|Overall Study|Death|1
5997284|NCT00942422|20737274|P1|Overall Study|Withdrawal by Subject|1
5997285|NCT00942409|20737278|P1|Overall Study|study drug unavailable|2
5997286|NCT00942409|20737278|P1|Overall Study|Lack of Efficacy|1
5997287|NCT00942357|20737284|P2|Overall Study|Ineligible|40
5997288|NCT00942357|20737285|P1|Overall Study|Ineligible|37
5997291|NCT00942266|20737314|P2|Overall Study|medical deterioration (pneumonia)|1
5997292|NCT00942266|20737315|P1|Overall Study|medical deterioration (pneumonia)|0
5997293|NCT00942266|20737314|P2|Overall Study|Physician Decision|0
5997294|NCT00942266|20737315|P1|Overall Study|Physician Decision|2
5997295|NCT00942266|20737314|P2|Overall Study|Intercurrent illness|1
5997296|NCT00942266|20737315|P1|Overall Study|Intercurrent illness|0
5997297|NCT00942266|20737314|P2|Overall Study|Failure to thrive and pt withdrawal|1
5997298|NCT00942266|20737315|P1|Overall Study|Failure to thrive and pt withdrawal|0
5997299|NCT00942266|20737314|P2|Overall Study|Disease Progression|11
5997300|NCT00942266|20737315|P1|Overall Study|Disease Progression|38
5997301|NCT00942266|20737314|P2|Overall Study|Adverse Event|1
5997302|NCT00942266|20737315|P1|Overall Study|Adverse Event|2
5997303|NCT00942266|20737314|P2|Overall Study|Withdrawal by Subject|0
5997304|NCT00942266|20737315|P1|Overall Study|Withdrawal by Subject|1
5997305|NCT00942188|20737337|P4|Overall Study|Sponsor Decision|1
5997306|NCT00942188|20737338|P3|Overall Study|Sponsor Decision|0
5997307|NCT00942188|20737339|P2|Overall Study|Sponsor Decision|2
5997308|NCT00942188|20737340|P1|Overall Study|Sponsor Decision|0
5997309|NCT00942188|20737337|P4|Overall Study|Physician Decision|0
5997310|NCT00942188|20737338|P3|Overall Study|Physician Decision|1
5997311|NCT00942188|20737339|P2|Overall Study|Physician Decision|0
5997312|NCT00942188|20737340|P1|Overall Study|Physician Decision|0
5997313|NCT00942188|20737337|P4|Overall Study|Withdrawal by Subject|2
5997314|NCT00942188|20737338|P3|Overall Study|Withdrawal by Subject|4
5997315|NCT00942188|20737339|P2|Overall Study|Withdrawal by Subject|3
5997316|NCT00942188|20737340|P1|Overall Study|Withdrawal by Subject|1
5997317|NCT00942188|20737337|P4|Overall Study|Lost to Follow-up|0
5997318|NCT00942188|20737338|P3|Overall Study|Lost to Follow-up|2
5997319|NCT00942188|20737339|P2|Overall Study|Lost to Follow-up|1
5997320|NCT00942188|20737340|P1|Overall Study|Lost to Follow-up|2
5997321|NCT00942188|20737337|P4|Overall Study|Protocol Violation|0
5997322|NCT00942188|20737338|P3|Overall Study|Protocol Violation|0
5997323|NCT00942188|20737339|P2|Overall Study|Protocol Violation|1
5997324|NCT00942188|20737340|P1|Overall Study|Protocol Violation|1
5997325|NCT00942188|20737337|P4|Overall Study|Lack of Efficacy|1
5997326|NCT00942188|20737338|P3|Overall Study|Lack of Efficacy|0
5997327|NCT00942188|20737339|P2|Overall Study|Lack of Efficacy|0
5997328|NCT00942188|20737340|P1|Overall Study|Lack of Efficacy|0
5997329|NCT00942188|20737337|P4|Overall Study|Adverse Event|0
5997330|NCT00942188|20737338|P3|Overall Study|Adverse Event|2
5997331|NCT00942188|20737339|P2|Overall Study|Adverse Event|3
5997332|NCT00942188|20737340|P1|Overall Study|Adverse Event|0
5997333|NCT00942175|20737379|P4|Overall Study|Low Platelet Count|0
5997334|NCT00942175|20737380|P3|Overall Study|Low Platelet Count|0
5997335|NCT00942175|20737381|P2|Overall Study|Low Platelet Count|2
5997336|NCT00942175|20737382|P1|Overall Study|Low Platelet Count|0
5997337|NCT00942175|20737379|P4|Overall Study|Elevated Alanine Amino Transferase|1
5997338|NCT00942175|20737380|P3|Overall Study|Elevated Alanine Amino Transferase|0
5997339|NCT00942175|20737381|P2|Overall Study|Elevated Alanine Amino Transferase|0
5997340|NCT00942175|20737382|P1|Overall Study|Elevated Alanine Amino Transferase|0
5997341|NCT00942175|20737379|P4|Overall Study|Pregnancy|1
5997342|NCT00942175|20737380|P3|Overall Study|Pregnancy|0
5997343|NCT00942175|20737381|P2|Overall Study|Pregnancy|0
5997344|NCT00942175|20737382|P1|Overall Study|Pregnancy|0
5997345|NCT00942175|20737379|P4|Overall Study|Protocol Violation|0
5997346|NCT00942175|20737380|P3|Overall Study|Protocol Violation|2
5997347|NCT00942175|20737381|P2|Overall Study|Protocol Violation|1
5997348|NCT00942175|20737382|P1|Overall Study|Protocol Violation|0
5997349|NCT00942175|20737379|P4|Overall Study|Adverse Event|0
5997350|NCT00942175|20737380|P3|Overall Study|Adverse Event|0
5997351|NCT00942175|20737381|P2|Overall Study|Adverse Event|1
5997352|NCT00942175|20737382|P1|Overall Study|Adverse Event|2
5997353|NCT00942162|20737435|P3|Overall Study|Other|2
5997354|NCT00942162|20737436|P2|Overall Study|Other|13
5997355|NCT00942162|20737437|P1|Overall Study|Other|14
5997356|NCT00942162|20737435|P3|Overall Study|Lost to Follow-up|0
5997357|NCT00942162|20737436|P2|Overall Study|Lost to Follow-up|0
5997358|NCT00942162|20737437|P1|Overall Study|Lost to Follow-up|4
5997359|NCT00942162|20737435|P3|Overall Study|Withdrawal by Subject|0
5997360|NCT00942162|20737436|P2|Overall Study|Withdrawal by Subject|2
5997361|NCT00942162|20737437|P1|Overall Study|Withdrawal by Subject|7
5997362|NCT00942162|20737435|P3|Overall Study|Death|0
5997363|NCT00942162|20737436|P2|Overall Study|Death|35
5997364|NCT00942162|20737437|P1|Overall Study|Death|45
5997365|NCT00942084|20737508|P1|Overall Study|Death|2
5997366|NCT00941928|20737525|P1|Overall Study|Disease Progression|1
5997367|NCT00941928|20737525|P1|Overall Study|Withdrawal by Subject|1
5997368|NCT00941863|20737543|P5|Continued After PCD|Disease progression, recurrence, relapse|18
5997369|NCT00941863|20737544|P4|Continued After PCD|Disease progression, recurrence, relapse|0
5997370|NCT00941863|20737545|P3|Continued After PCD|Disease progression, recurrence, relapse|0
5997371|NCT00941863|20737546|P2|Continued After PCD|Disease progression, recurrence, relapse|0
5997372|NCT00941863|20737547|P1|Continued After PCD|Disease progression, recurrence, relapse|0
5997373|NCT00941863|20737543|P5|Continued After PCD|Withdrawal by Subject|1
5997374|NCT00941863|20737544|P4|Continued After PCD|Withdrawal by Subject|0
5997375|NCT00941863|20737545|P3|Continued After PCD|Withdrawal by Subject|0
5997376|NCT00941863|20737546|P2|Continued After PCD|Withdrawal by Subject|0
5997377|NCT00941863|20737547|P1|Continued After PCD|Withdrawal by Subject|0
5997378|NCT00941863|20737543|P5|Until Primary Completion Date (PCD)|Disease progression|73
5997379|NCT00941863|20737544|P4|Until Primary Completion Date (PCD)|Disease progression|14
5997380|NCT00941863|20737545|P3|Until Primary Completion Date (PCD)|Disease progression|8
5997381|NCT00941863|20737546|P2|Until Primary Completion Date (PCD)|Disease progression|1
5997382|NCT00941863|20737547|P1|Until Primary Completion Date (PCD)|Disease progression|6
5997383|NCT00941863|20737543|P5|Until Primary Completion Date (PCD)|Death|7
5997384|NCT00941863|20737544|P4|Until Primary Completion Date (PCD)|Death|2
5997385|NCT00941863|20737545|P3|Until Primary Completion Date (PCD)|Death|1
5997386|NCT00941863|20737546|P2|Until Primary Completion Date (PCD)|Death|0
5997387|NCT00941863|20737547|P1|Until Primary Completion Date (PCD)|Death|0
5997388|NCT00941863|20737543|P5|Until Primary Completion Date (PCD)|Withdrawal by Subject|8
5997389|NCT00941863|20737544|P4|Until Primary Completion Date (PCD)|Withdrawal by Subject|0
5997390|NCT00941863|20737545|P3|Until Primary Completion Date (PCD)|Withdrawal by Subject|1
5997391|NCT00941863|20737546|P2|Until Primary Completion Date (PCD)|Withdrawal by Subject|0
5997392|NCT00941863|20737547|P1|Until Primary Completion Date (PCD)|Withdrawal by Subject|0
5997393|NCT00941863|20737543|P5|Until Primary Completion Date (PCD)|Physician Decision|1
5997394|NCT00941863|20737544|P4|Until Primary Completion Date (PCD)|Physician Decision|0
5997395|NCT00941863|20737545|P3|Until Primary Completion Date (PCD)|Physician Decision|0
5997396|NCT00941863|20737546|P2|Until Primary Completion Date (PCD)|Physician Decision|0
5997397|NCT00941863|20737547|P1|Until Primary Completion Date (PCD)|Physician Decision|0
5997398|NCT00941863|20737543|P5|Until Primary Completion Date (PCD)|Adverse Event|5
5997399|NCT00941863|20737544|P4|Until Primary Completion Date (PCD)|Adverse Event|1
5997400|NCT00941863|20737545|P3|Until Primary Completion Date (PCD)|Adverse Event|2
5997401|NCT00941863|20737546|P2|Until Primary Completion Date (PCD)|Adverse Event|2
5997402|NCT00941863|20737547|P1|Until Primary Completion Date (PCD)|Adverse Event|1
5997403|NCT00941798|20737574|P2|Overall Study|Death|1
5997404|NCT00941798|20737575|P1|Overall Study|Death|0
5997405|NCT00941798|20737574|P2|Overall Study|Abnormal laboratory values|2
5997406|NCT00941798|20737575|P1|Overall Study|Abnormal laboratory values|1
5997407|NCT00941798|20737574|P2|Overall Study|Abnormal test procedure results|1
5997408|NCT00941798|20737575|P1|Overall Study|Abnormal test procedure results|3
5997409|NCT00941798|20737574|P2|Overall Study|Patient's inability to use device|1
5997410|NCT00941798|20737575|P1|Overall Study|Patient's inability to use device|6
5997411|NCT00941798|20737574|P2|Overall Study|Lack of Efficacy|17
5997412|NCT00941798|20737575|P1|Overall Study|Lack of Efficacy|10
5997413|NCT00941798|20737574|P2|Overall Study|Administrative problems|23
5997414|NCT00941798|20737575|P1|Overall Study|Administrative problems|13
5997415|NCT00941798|20737574|P2|Overall Study|Protocol Violation|20
5997416|NCT00941798|20737575|P1|Overall Study|Protocol Violation|17
5997417|NCT00941798|20737574|P2|Overall Study|Lost to Follow-up|23
5997418|NCT00941798|20737575|P1|Overall Study|Lost to Follow-up|29
5997419|NCT00941798|20737574|P2|Overall Study|Adverse Event|23
5997420|NCT00941798|20737575|P1|Overall Study|Adverse Event|43
5997421|NCT00941798|20737574|P2|Overall Study|Withdrawal by Subject|74
5997422|NCT00941798|20737575|P1|Overall Study|Withdrawal by Subject|72
5997423|NCT00941733|20737605|P2|Overall Study|Protocol Violation|6
5997424|NCT00941733|20737606|P1|Overall Study|Protocol Violation|15
5997425|NCT00941733|20737605|P2|Overall Study|Lost to Follow-up|2
5997426|NCT00941733|20737606|P1|Overall Study|Lost to Follow-up|1
5997427|NCT00941733|20737605|P2|Overall Study|Adverse Event|4
5997428|NCT00941733|20737606|P1|Overall Study|Adverse Event|20
5997429|NCT00941733|20737605|P2|Overall Study|Withdrawal by Subject|6
5997430|NCT00941733|20737606|P1|Overall Study|Withdrawal by Subject|14
5997431|NCT00941733|20737605|P2|Overall Study|Death|10
5997432|NCT00941733|20737606|P1|Overall Study|Death|24
5997433|NCT00941720|20737646|P1|Overall Study|ineligible|2
5997434|NCT00941720|20737646|P1|Overall Study|Insurance denied participation|11
5997435|NCT00941720|20737646|P1|Overall Study|Withdrawal by Subject|1
5997436|NCT00941655|20737693|P2|Overall Study|non-compliant|1
5997437|NCT00941655|20737694|P1|Overall Study|non-compliant|0
5997438|NCT00941655|20737693|P2|Overall Study|withdrew consent|1
5997439|NCT00941655|20737694|P1|Overall Study|withdrew consent|0
5997440|NCT00941655|20737693|P2|Overall Study|refused further treatment|1
5997441|NCT00941655|20737694|P1|Overall Study|refused further treatment|0
5997442|NCT00941655|20737693|P2|Overall Study|progressed while on chemo|2
5997443|NCT00941655|20737694|P1|Overall Study|progressed while on chemo|0
5997444|NCT00941655|20737693|P2|Overall Study|not meet criteria for chemo foll surgery|0
5997445|NCT00941655|20737694|P1|Overall Study|not meet criteria for chemo foll surgery|4
5997446|NCT00941655|20737693|P2|Overall Study|received some chemo, 4 and 9 cycles|0
5997447|NCT00941655|20737694|P1|Overall Study|received some chemo, 4 and 9 cycles|1
5997448|NCT00941603|20737719|P6|Overall Study|Did not meet protocol eligibility|0
5997449|NCT00941603|20737720|P5|Overall Study|Did not meet protocol eligibility|0
5997450|NCT00941603|20737721|P4|Overall Study|Did not meet protocol eligibility|0
5997451|NCT00941603|20737722|P3|Overall Study|Did not meet protocol eligibility|0
5997452|NCT00941603|20737723|P2|Overall Study|Did not meet protocol eligibility|0
5997453|NCT00941603|20737724|P1|Overall Study|Did not meet protocol eligibility|1
5997454|NCT00941603|20737719|P6|Overall Study|Protocol Violation|0
5997455|NCT00941603|20737720|P5|Overall Study|Protocol Violation|0
5997456|NCT00941603|20737721|P4|Overall Study|Protocol Violation|0
5997457|NCT00941603|20737722|P3|Overall Study|Protocol Violation|0
5997458|NCT00941603|20737723|P2|Overall Study|Protocol Violation|1
5997459|NCT00941603|20737724|P1|Overall Study|Protocol Violation|0
5997460|NCT00941603|20737719|P6|Overall Study|Withdrawal by Subject|1
5997461|NCT00941603|20737720|P5|Overall Study|Withdrawal by Subject|0
5997462|NCT00941603|20737721|P4|Overall Study|Withdrawal by Subject|2
5997463|NCT00941603|20737722|P3|Overall Study|Withdrawal by Subject|0
5997464|NCT00941603|20737723|P2|Overall Study|Withdrawal by Subject|0
5997465|NCT00941603|20737724|P1|Overall Study|Withdrawal by Subject|0
5997466|NCT00941603|20737719|P6|Overall Study|Lost to Follow-up|2
5997467|NCT00941603|20737720|P5|Overall Study|Lost to Follow-up|0
5997468|NCT00941603|20737721|P4|Overall Study|Lost to Follow-up|1
5997469|NCT00941603|20737722|P3|Overall Study|Lost to Follow-up|0
5997470|NCT00941603|20737723|P2|Overall Study|Lost to Follow-up|0
5997471|NCT00941603|20737724|P1|Overall Study|Lost to Follow-up|0
5997472|NCT00941603|20737719|P6|Overall Study|Adverse Event|0
5997473|NCT00941603|20737720|P5|Overall Study|Adverse Event|4
5997474|NCT00941603|20737721|P4|Overall Study|Adverse Event|1
5997475|NCT00941603|20737722|P3|Overall Study|Adverse Event|5
5997476|NCT00941603|20737723|P2|Overall Study|Adverse Event|15
5997477|NCT00941603|20737724|P1|Overall Study|Adverse Event|10
5997478|NCT00941330|20737746|P2|Overall Study|Physician Decision|2
5997479|NCT00941330|20737747|P1|Overall Study|Physician Decision|0
5997480|NCT00941330|20737746|P2|Overall Study|Other|0
5997481|NCT00941330|20737747|P1|Overall Study|Other|1
5997482|NCT00941304|20737760|P5|Overall Study|Lost to Follow-up|0
5997483|NCT00941304|20737761|P4|Overall Study|Lost to Follow-up|0
5997484|NCT00941304|20737762|P3|Overall Study|Lost to Follow-up|0
5997485|NCT00941304|20737763|P2|Overall Study|Lost to Follow-up|0
5997486|NCT00941304|20737764|P1|Overall Study|Lost to Follow-up|1
5997487|NCT00941070|20737826|P1|Overall Study|Patient non-compliant|1
5997488|NCT00941031|20737846|P7|Maintenance Period|Lack of Efficacy|13
5997489|NCT00941031|20737847|P6|Maintenance Period|Lack of Efficacy|0
5997490|NCT00941031|20737848|P5|Maintenance Period|Lack of Efficacy|0
5997491|NCT00941031|20737849|P4|Maintenance Period|Lack of Efficacy|0
5997492|NCT00941031|20737850|P3|Maintenance Period|Lack of Efficacy|0
5997493|NCT00941031|20737851|P2|Maintenance Period|Lack of Efficacy|0
5997494|NCT00941031|20737852|P1|Maintenance Period|Lack of Efficacy|0
5997495|NCT00941031|20737846|P7|Maintenance Period|Lost to Follow-up|7
5997496|NCT00941031|20737847|P6|Maintenance Period|Lost to Follow-up|2
5997497|NCT00941031|20737848|P5|Maintenance Period|Lost to Follow-up|2
5997498|NCT00941031|20737849|P4|Maintenance Period|Lost to Follow-up|0
5997499|NCT00941031|20737850|P3|Maintenance Period|Lost to Follow-up|0
5997500|NCT00941031|20737851|P2|Maintenance Period|Lost to Follow-up|0
5997501|NCT00941031|20737852|P1|Maintenance Period|Lost to Follow-up|0
5997502|NCT00941031|20737846|P7|Maintenance Period|Adverse Event|8
5997503|NCT00941031|20737847|P6|Maintenance Period|Adverse Event|2
5997504|NCT00941031|20737848|P5|Maintenance Period|Adverse Event|0
5997505|NCT00941031|20737849|P4|Maintenance Period|Adverse Event|0
5997506|NCT00941031|20737850|P3|Maintenance Period|Adverse Event|0
5997507|NCT00941031|20737851|P2|Maintenance Period|Adverse Event|0
5997508|NCT00941031|20737852|P1|Maintenance Period|Adverse Event|0
5997509|NCT00941031|20737846|P7|Maintenance Period|Protocol Violation|1
5997510|NCT00941031|20737847|P6|Maintenance Period|Protocol Violation|0
5997511|NCT00941031|20737848|P5|Maintenance Period|Protocol Violation|0
5997512|NCT00941031|20737849|P4|Maintenance Period|Protocol Violation|0
5997513|NCT00941031|20737850|P3|Maintenance Period|Protocol Violation|0
5997514|NCT00941031|20737851|P2|Maintenance Period|Protocol Violation|0
5997515|NCT00941031|20737852|P1|Maintenance Period|Protocol Violation|0
5997516|NCT00941031|20737846|P7|Maintenance Period|Administrative Problems|1
5997517|NCT00941031|20737847|P6|Maintenance Period|Administrative Problems|0
5997518|NCT00941031|20737848|P5|Maintenance Period|Administrative Problems|1
5997519|NCT00941031|20737849|P4|Maintenance Period|Administrative Problems|0
5997520|NCT00941031|20737850|P3|Maintenance Period|Administrative Problems|0
5997521|NCT00941031|20737851|P2|Maintenance Period|Administrative Problems|0
5997522|NCT00941031|20737852|P1|Maintenance Period|Administrative Problems|0
5997523|NCT00941031|20737846|P7|Maintenance Period|Withdrawal by Subject|13
5997524|NCT00941031|20737847|P6|Maintenance Period|Withdrawal by Subject|2
5997525|NCT00941031|20737848|P5|Maintenance Period|Withdrawal by Subject|6
5997526|NCT00941031|20737849|P4|Maintenance Period|Withdrawal by Subject|0
5997527|NCT00941031|20737850|P3|Maintenance Period|Withdrawal by Subject|0
5997528|NCT00941031|20737851|P2|Maintenance Period|Withdrawal by Subject|0
5997529|NCT00941031|20737852|P1|Maintenance Period|Withdrawal by Subject|0
5997530|NCT00941031|20737846|P7|Induction Period|Adverse Event|0
5997531|NCT00941031|20737847|P6|Induction Period|Adverse Event|0
5997532|NCT00941031|20737848|P5|Induction Period|Adverse Event|0
5997533|NCT00941031|20737849|P4|Induction Period|Adverse Event|2
5997534|NCT00941031|20737850|P3|Induction Period|Adverse Event|3
5997535|NCT00941031|20737851|P2|Induction Period|Adverse Event|0
5997536|NCT00941031|20737852|P1|Induction Period|Adverse Event|1
5997537|NCT00941031|20737846|P7|Induction Period|Adminstative Problems|0
5997538|NCT00941031|20737847|P6|Induction Period|Adminstative Problems|0
5997539|NCT00941031|20737848|P5|Induction Period|Adminstative Problems|0
5997540|NCT00941031|20737849|P4|Induction Period|Adminstative Problems|0
5997541|NCT00941031|20737850|P3|Induction Period|Adminstative Problems|1
5997542|NCT00941031|20737851|P2|Induction Period|Adminstative Problems|1
5997543|NCT00941031|20737852|P1|Induction Period|Adminstative Problems|1
5997544|NCT00941031|20737846|P7|Induction Period|Withdrawal by Subject|0
5997545|NCT00941031|20737847|P6|Induction Period|Withdrawal by Subject|0
5997546|NCT00941031|20737848|P5|Induction Period|Withdrawal by Subject|0
5997547|NCT00941031|20737849|P4|Induction Period|Withdrawal by Subject|2
5997548|NCT00941031|20737850|P3|Induction Period|Withdrawal by Subject|2
5997549|NCT00941031|20737851|P2|Induction Period|Withdrawal by Subject|2
5997550|NCT00941031|20737852|P1|Induction Period|Withdrawal by Subject|1
5997551|NCT00941031|20737846|P7|Induction Period|Lack of Efficacy|0
5997552|NCT00941031|20737847|P6|Induction Period|Lack of Efficacy|0
5997553|NCT00941031|20737848|P5|Induction Period|Lack of Efficacy|0
5997554|NCT00941031|20737849|P4|Induction Period|Lack of Efficacy|5
5997555|NCT00941031|20737850|P3|Induction Period|Lack of Efficacy|0
5997556|NCT00941031|20737851|P2|Induction Period|Lack of Efficacy|1
5997557|NCT00941031|20737852|P1|Induction Period|Lack of Efficacy|2
5997558|NCT00940992|20737899|P3|Overall Study|Lost to Follow-up|1
5997559|NCT00940992|20737900|P2|Overall Study|Lost to Follow-up|1
5997560|NCT00940992|20737901|P1|Overall Study|Lost to Follow-up|0
5997561|NCT00940992|20737899|P3|Overall Study|subject request|0
5997562|NCT00940992|20737900|P2|Overall Study|subject request|1
5997563|NCT00940992|20737901|P1|Overall Study|subject request|2
5997564|NCT00940992|20737899|P3|Overall Study|Adverse Event|1
5997565|NCT00940992|20737900|P2|Overall Study|Adverse Event|0
5997566|NCT00940992|20737901|P1|Overall Study|Adverse Event|2
5997567|NCT00940888|20737930|P1|Overall Study|Lost to Follow-up|6
5997568|NCT00940888|20737930|P1|Overall Study|Withdrawn - Non-Death|364
5997569|NCT00940888|20737930|P1|Overall Study|Death|461
5997570|NCT00940888|20737930|P1|Overall Study|Unsuccessful Implant|4
5997571|NCT00940875|20737937|P2|Post-Study Treatment|Disease Progression|2
5997572|NCT00940875|20737938|P1|Post-Study Treatment|Disease Progression|0
5997573|NCT00940875|20737937|P2|Post-Study Treatment|Death|1
5997574|NCT00940875|20737938|P1|Post-Study Treatment|Death|0
5997575|NCT00940875|20737937|P2|Treatment Phase|Physician Decision|0
5997576|NCT00940875|20737938|P1|Treatment Phase|Physician Decision|1
5997577|NCT00940875|20737937|P2|Treatment Phase|Disease progression|11
5997578|NCT00940875|20737938|P1|Treatment Phase|Disease progression|9
5997579|NCT00940875|20737937|P2|Treatment Phase|Withdrawal by Subject|0
5997580|NCT00940875|20737938|P1|Treatment Phase|Withdrawal by Subject|3
5997581|NCT00940875|20737937|P2|Treatment Phase|Lack of Efficacy|0
5997582|NCT00940875|20737938|P1|Treatment Phase|Lack of Efficacy|1
5997583|NCT00940875|20737937|P2|Treatment Phase|Death|5
5997584|NCT00940875|20737938|P1|Treatment Phase|Death|3
5997585|NCT00940875|20737937|P2|Treatment Phase|Adverse Event|3
5997586|NCT00940875|20737938|P1|Treatment Phase|Adverse Event|9
5997587|NCT00940823|20737958|P2|Overall Study|Lost to Follow-up|20
5997588|NCT00940823|20737959|P1|Overall Study|Lost to Follow-up|27
5997589|NCT00940823|20737958|P2|Overall Study|Death|12
5997590|NCT00940823|20737959|P1|Overall Study|Death|8
5997591|NCT00940602|20737984|P2|Overall Study|Study terminated by Sponsor = trial was to continue for 3 years from date the last patient enrolled|5
5997592|NCT00940602|20737985|P1|Overall Study|Study terminated by Sponsor = trial was to continue for 3 years from date the last patient enrolled|43
5997593|NCT00940602|20737984|P2|Overall Study|Adverse Event|2
5997594|NCT00940602|20737985|P1|Overall Study|Adverse Event|7
5997595|NCT00940602|20737984|P2|Overall Study|Patient withdrew consent|13
5997596|NCT00940602|20737985|P1|Overall Study|Patient withdrew consent|26
5997597|NCT00940602|20737984|P2|Overall Study|Lost to Follow-up|1
5997598|NCT00940602|20737985|P1|Overall Study|Lost to Follow-up|3
5997599|NCT00940602|20737984|P2|Overall Study|Death|19
5997600|NCT00940602|20737985|P1|Overall Study|Death|38
5997601|NCT00940602|20737984|P2|Overall Study|Disease progression|2
5997602|NCT00940602|20737985|P1|Overall Study|Disease progression|8
5997603|NCT00940602|20737984|P2|Overall Study|Protocol Deviation (untreated)|0
5997604|NCT00940602|20737985|P1|Overall Study|Protocol Deviation (untreated)|1
5997605|NCT00940602|20737984|P2|Overall Study|Pregnancy|0
5997606|NCT00940602|20737985|P1|Overall Study|Pregnancy|1
5997607|NCT00940602|20737984|P2|Overall Study|Physician Decision|5
5997608|NCT00940602|20737985|P1|Overall Study|Physician Decision|8
5997609|NCT00940602|20737984|P2|Overall Study|Patient/guardian decision|28
5997610|NCT00940602|20737985|P1|Overall Study|Patient/guardian decision|13
5997611|NCT00940602|20737984|P2|Overall Study|Administrative problems|1
5997612|NCT00940602|20737985|P1|Overall Study|Administrative problems|1
5997613|NCT00940498|20738063|P8|Overall Study|Not treated due to disease related pain|0
5997614|NCT00940498|20738064|P7|Overall Study|Not treated due to disease related pain|0
5997615|NCT00940498|20738065|P6|Overall Study|Not treated due to disease related pain|0
5997616|NCT00940498|20738066|P5|Overall Study|Not treated due to disease related pain|1
5997617|NCT00940498|20738067|P4|Overall Study|Not treated due to disease related pain|0
5997618|NCT00940498|20738068|P3|Overall Study|Not treated due to disease related pain|0
5997619|NCT00940498|20738069|P2|Overall Study|Not treated due to disease related pain|0
5997620|NCT00940498|20738070|P1|Overall Study|Not treated due to disease related pain|0
5997621|NCT00940498|20738063|P8|Overall Study|Physician Decision|0
5997622|NCT00940498|20738064|P7|Overall Study|Physician Decision|0
5997623|NCT00940498|20738065|P6|Overall Study|Physician Decision|0
5997624|NCT00940498|20738066|P5|Overall Study|Physician Decision|2
5997625|NCT00940498|20738067|P4|Overall Study|Physician Decision|0
5997626|NCT00940498|20738068|P3|Overall Study|Physician Decision|0
5997627|NCT00940498|20738069|P2|Overall Study|Physician Decision|0
5997628|NCT00940498|20738070|P1|Overall Study|Physician Decision|0
5997629|NCT00940498|20738063|P8|Overall Study|Disease Progression|0
5997630|NCT00940498|20738064|P7|Overall Study|Disease Progression|0
5997631|NCT00940498|20738065|P6|Overall Study|Disease Progression|1
5997632|NCT00940498|20738066|P5|Overall Study|Disease Progression|0
5997633|NCT00940498|20738067|P4|Overall Study|Disease Progression|1
5997634|NCT00940498|20738068|P3|Overall Study|Disease Progression|1
5997635|NCT00940498|20738069|P2|Overall Study|Disease Progression|0
5997636|NCT00940498|20738070|P1|Overall Study|Disease Progression|0
5997637|NCT00940498|20738063|P8|Overall Study|Lost to Follow-up|1
5997638|NCT00940498|20738064|P7|Overall Study|Lost to Follow-up|0
5997639|NCT00940498|20738065|P6|Overall Study|Lost to Follow-up|0
5997640|NCT00940498|20738066|P5|Overall Study|Lost to Follow-up|1
5997641|NCT00940498|20738067|P4|Overall Study|Lost to Follow-up|0
5997642|NCT00940498|20738068|P3|Overall Study|Lost to Follow-up|2
5997643|NCT00940498|20738069|P2|Overall Study|Lost to Follow-up|1
5997644|NCT00940498|20738070|P1|Overall Study|Lost to Follow-up|1
5997645|NCT00940498|20738063|P8|Overall Study|Death|0
5997646|NCT00940498|20738064|P7|Overall Study|Death|1
5997647|NCT00940498|20738065|P6|Overall Study|Death|0
5997648|NCT00940498|20738066|P5|Overall Study|Death|5
5997649|NCT00940498|20738067|P4|Overall Study|Death|1
5997650|NCT00940498|20738068|P3|Overall Study|Death|0
5997651|NCT00940498|20738069|P2|Overall Study|Death|0
5997652|NCT00940498|20738070|P1|Overall Study|Death|2
5997653|NCT00940485|20738188|P2|Overall Study|Others|1
5997654|NCT00940485|20738189|P1|Overall Study|Others|1
5997655|NCT00940485|20738188|P2|Overall Study|Withdrawal by Subject|1
5997656|NCT00940485|20738189|P1|Overall Study|Withdrawal by Subject|1
5997657|NCT00940485|20738188|P2|Overall Study|Adverse Event|0
5997658|NCT00940485|20738189|P1|Overall Study|Adverse Event|8
5997659|NCT00940485|20738188|P2|Overall Study|Lost to Follow-up|3
5997660|NCT00940485|20738189|P1|Overall Study|Lost to Follow-up|2
5997661|NCT00940485|20738188|P2|Overall Study|HBeAb positive at Baseline|2
5997662|NCT00940485|20738189|P1|Overall Study|HBeAb positive at Baseline|3
5997663|NCT00940342|20738227|P3|Overall Study|Adverse Event|1
5997664|NCT00940342|20738228|P2|Overall Study|Adverse Event|2
5997665|NCT00940342|20738229|P1|Overall Study|Adverse Event|0
5997666|NCT00940316|20738240|P3|Treated After Cycle 5|Progressive disease|0
5997667|NCT00940316|20738241|P2|Treated After Cycle 5|Progressive disease|1
5997668|NCT00940316|20738242|P1|Treated After Cycle 5|Progressive disease|0
5997669|NCT00940316|20738240|P3|Treated After Cycle 5|Adverse Event|1
5997670|NCT00940316|20738241|P2|Treated After Cycle 5|Adverse Event|0
5997671|NCT00940316|20738242|P1|Treated After Cycle 5|Adverse Event|0
5997672|NCT00940316|20738240|P3|Moved on to be Treated Cycle 5|Adverse Event|0
5997673|NCT00940316|20738241|P2|Moved on to be Treated Cycle 5|Adverse Event|0
5997674|NCT00940316|20738242|P1|Moved on to be Treated Cycle 5|Adverse Event|2
5997675|NCT00940316|20738240|P3|Reached First Response at 8 Weeks|Progressive disease|0
5997676|NCT00940316|20738241|P2|Reached First Response at 8 Weeks|Progressive disease|3
5997677|NCT00940316|20738242|P1|Reached First Response at 8 Weeks|Progressive disease|1
5997678|NCT00940316|20738240|P3|Reached First Response at 8 Weeks|Adverse Event|0
5997679|NCT00940316|20738241|P2|Reached First Response at 8 Weeks|Adverse Event|1
5997680|NCT00940316|20738242|P1|Reached First Response at 8 Weeks|Adverse Event|2
5997681|NCT00940108|20738285|P4|Overall Study|Diagnosed with H1N1|1
5997682|NCT00940108|20738286|P3|Overall Study|Diagnosed with H1N1|0
5997683|NCT00940108|20738287|P2|Overall Study|Diagnosed with H1N1|0
5997684|NCT00940108|20738288|P1|Overall Study|Diagnosed with H1N1|0
5997685|NCT00940108|20738285|P4|Overall Study|Viral illness after Dose 1|0
5997686|NCT00940108|20738286|P3|Overall Study|Viral illness after Dose 1|0
5997687|NCT00940108|20738287|P2|Overall Study|Viral illness after Dose 1|1
5997688|NCT00940108|20738288|P1|Overall Study|Viral illness after Dose 1|0
5997689|NCT00940108|20738285|P4|Overall Study|Refused - pyrexia after Dose 1|0
5997690|NCT00940108|20738286|P3|Overall Study|Refused - pyrexia after Dose 1|0
5997691|NCT00940108|20738287|P2|Overall Study|Refused - pyrexia after Dose 1|1
5997692|NCT00940108|20738288|P1|Overall Study|Refused - pyrexia after Dose 1|0
5997693|NCT00940108|20738285|P4|Overall Study|Declined further vaccination|0
5997694|NCT00940108|20738286|P3|Overall Study|Declined further vaccination|3
5997695|NCT00940108|20738287|P2|Overall Study|Declined further vaccination|1
5997696|NCT00940108|20738288|P1|Overall Study|Declined further vaccination|0
5997697|NCT00940108|20738285|P4|Overall Study|Dose 2 contraindicated|1
5997698|NCT00940108|20738286|P3|Overall Study|Dose 2 contraindicated|0
5997699|NCT00940108|20738287|P2|Overall Study|Dose 2 contraindicated|1
5997700|NCT00940108|20738288|P1|Overall Study|Dose 2 contraindicated|1
5997701|NCT00940108|20738285|P4|Overall Study|Withdrew Consent|1
5997702|NCT00940108|20738286|P3|Overall Study|Withdrew Consent|0
5997703|NCT00940108|20738287|P2|Overall Study|Withdrew Consent|1
5997704|NCT00940108|20738288|P1|Overall Study|Withdrew Consent|2
5997705|NCT00940108|20738285|P4|Overall Study|Adverse Event|2
5997706|NCT00940108|20738286|P3|Overall Study|Adverse Event|0
5997707|NCT00940108|20738287|P2|Overall Study|Adverse Event|4
5997708|NCT00940108|20738288|P1|Overall Study|Adverse Event|2
5997709|NCT00940017|20738338|P1|Overall Study|Adverse Event|1
5997710|NCT00940017|20738338|P1|Overall Study|did not meet entrance criteria|3
5997711|NCT00939822|20738396|P2|Overall Study|Mental health issues|2
5997712|NCT00939822|20738397|P1|Overall Study|Mental health issues|0
5997713|NCT00939822|20738396|P2|Overall Study|withdrew from study due to busy schedule|1
5997714|NCT00939822|20738397|P1|Overall Study|withdrew from study due to busy schedule|1
5997715|NCT00939822|20738396|P2|Overall Study|Lost to Follow-up|0
5997716|NCT00939822|20738397|P1|Overall Study|Lost to Follow-up|1
5997717|NCT00939809|20738409|P1|Overall Study|Death|1
5997718|NCT00939809|20738409|P1|Overall Study|Adverse Event|2
5997719|NCT00939783|20738424|P1|Overall Study|Enrolled but not treated|1
5997720|NCT00939783|20738424|P1|Overall Study|Protocol Violation|3
5997721|NCT00939783|20738424|P1|Overall Study|Lost to Follow-up|8
5997722|NCT00939783|20738424|P1|Overall Study|Other|16
5997723|NCT00939783|20738424|P1|Overall Study|Withdrawal by Subject|78
5997724|NCT00939783|20738424|P1|Overall Study|Study Terminated by Sponsor|498
5997725|NCT00939783|20738424|P1|Overall Study|Adverse Event|39
5997726|NCT00939783|20738424|P1|Overall Study|Death|6
5997727|NCT00939770|20738439|P8|Overall Study|Withdrawal by Subject|2
5997728|NCT00939770|20738440|P7|Overall Study|Withdrawal by Subject|2
5997729|NCT00939770|20738441|P6|Overall Study|Withdrawal by Subject|0
5997730|NCT00939770|20738442|P5|Overall Study|Withdrawal by Subject|6
5997731|NCT00939770|20738443|P4|Overall Study|Withdrawal by Subject|2
5997732|NCT00939770|20738444|P3|Overall Study|Withdrawal by Subject|5
5997733|NCT00939770|20738445|P2|Overall Study|Withdrawal by Subject|1
5997734|NCT00939770|20738446|P1|Overall Study|Withdrawal by Subject|0
5997735|NCT00939770|20738439|P8|Overall Study|Protocol Violation|0
5997736|NCT00939770|20738440|P7|Overall Study|Protocol Violation|0
5997737|NCT00939770|20738441|P6|Overall Study|Protocol Violation|0
5997738|NCT00939770|20738442|P5|Overall Study|Protocol Violation|1
5997739|NCT00939770|20738443|P4|Overall Study|Protocol Violation|0
5997740|NCT00939770|20738444|P3|Overall Study|Protocol Violation|0
5997741|NCT00939770|20738445|P2|Overall Study|Protocol Violation|0
5997742|NCT00939770|20738446|P1|Overall Study|Protocol Violation|0
5997743|NCT00939770|20738439|P8|Overall Study|Physician Decision|6
5997744|NCT00939770|20738440|P7|Overall Study|Physician Decision|0
5997745|NCT00939770|20738441|P6|Overall Study|Physician Decision|1
5997746|NCT00939770|20738442|P5|Overall Study|Physician Decision|7
5997747|NCT00939770|20738443|P4|Overall Study|Physician Decision|0
5997748|NCT00939770|20738444|P3|Overall Study|Physician Decision|2
5997749|NCT00939770|20738445|P2|Overall Study|Physician Decision|0
5997750|NCT00939770|20738446|P1|Overall Study|Physician Decision|0
5997751|NCT00939770|20738439|P8|Overall Study|Lost to Follow-up|0
5997752|NCT00939770|20738440|P7|Overall Study|Lost to Follow-up|0
5997753|NCT00939770|20738441|P6|Overall Study|Lost to Follow-up|0
5997754|NCT00939770|20738442|P5|Overall Study|Lost to Follow-up|1
5997755|NCT00939770|20738443|P4|Overall Study|Lost to Follow-up|0
5997756|NCT00939770|20738444|P3|Overall Study|Lost to Follow-up|0
5997757|NCT00939770|20738445|P2|Overall Study|Lost to Follow-up|0
5997758|NCT00939770|20738446|P1|Overall Study|Lost to Follow-up|0
5997759|NCT00939770|20738439|P8|Overall Study|Lack of Efficacy|1
5997760|NCT00939770|20738440|P7|Overall Study|Lack of Efficacy|11
5997761|NCT00939770|20738441|P6|Overall Study|Lack of Efficacy|8
5997762|NCT00939770|20738442|P5|Overall Study|Lack of Efficacy|16
5997763|NCT00939770|20738443|P4|Overall Study|Lack of Efficacy|9
5997764|NCT00939770|20738444|P3|Overall Study|Lack of Efficacy|13
5997765|NCT00939770|20738445|P2|Overall Study|Lack of Efficacy|6
5997766|NCT00939770|20738446|P1|Overall Study|Lack of Efficacy|4
5997767|NCT00939770|20738439|P8|Overall Study|Adverse Event|1
5997768|NCT00939770|20738440|P7|Overall Study|Adverse Event|1
5997769|NCT00939770|20738441|P6|Overall Study|Adverse Event|2
5997770|NCT00939770|20738442|P5|Overall Study|Adverse Event|6
5997771|NCT00939770|20738443|P4|Overall Study|Adverse Event|0
5997772|NCT00939770|20738444|P3|Overall Study|Adverse Event|0
5997773|NCT00939770|20738445|P2|Overall Study|Adverse Event|1
5997774|NCT00939770|20738446|P1|Overall Study|Adverse Event|1
5997775|NCT00939692|20738531|P2|Period 2 - Second Intervent - 5 Days|Protocol Violation|1
5997776|NCT00939692|20738532|P1|Period 2 - Second Intervent - 5 Days|Protocol Violation|0
5997777|NCT00939692|20738531|P2|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|0
5997778|NCT00939692|20738532|P1|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|1
5997779|NCT00939640|20738547|P1|Overall Study|Physician Decision|1
5997780|NCT00939627|20738568|P3|Overall Study|No off-tx reason given|0
5997781|NCT00939627|20738569|P2|Overall Study|No off-tx reason given|2
5997782|NCT00939627|20738570|P1|Overall Study|No off-tx reason given|0
5997783|NCT00939627|20738568|P3|Overall Study|Not compliant|0
5997784|NCT00939627|20738569|P2|Overall Study|Not compliant|0
5997785|NCT00939627|20738570|P1|Overall Study|Not compliant|2
5997786|NCT00939627|20738568|P3|Overall Study|Other complicating disease|0
5997787|NCT00939627|20738569|P2|Overall Study|Other complicating disease|1
5997788|NCT00939627|20738570|P1|Overall Study|Other complicating disease|1
5997789|NCT00939627|20738568|P3|Overall Study|Withdrawal by Subject|0
5997790|NCT00939627|20738569|P2|Overall Study|Withdrawal by Subject|4
5997791|NCT00939627|20738570|P1|Overall Study|Withdrawal by Subject|2
5997792|NCT00939627|20738568|P3|Overall Study|Death|0
5997793|NCT00939627|20738569|P2|Overall Study|Death|2
5997794|NCT00939627|20738570|P1|Overall Study|Death|0
5997795|NCT00939627|20738568|P3|Overall Study|Adverse Event|0
5997796|NCT00939627|20738569|P2|Overall Study|Adverse Event|7
5997797|NCT00939627|20738570|P1|Overall Study|Adverse Event|6
5997798|NCT00939627|20738568|P3|Overall Study|Disease Progression|0
5997799|NCT00939627|20738569|P2|Overall Study|Disease Progression|12
5997800|NCT00939627|20738570|P1|Overall Study|Disease Progression|16
5997801|NCT00939523|20738610|P1|Overall Study|Physician Decision|2
5997802|NCT00939523|20738610|P1|Overall Study|Lack of Efficacy|1
5997803|NCT00939510|20738617|P1|Overall Study|Withdrawal by Subject|1
5997804|NCT00939484|20738626|P3|Overall Study|Progression/Relapse|3
5997805|NCT00939484|20738627|P2|Overall Study|Progression/Relapse|20
5997806|NCT00939484|20738628|P1|Overall Study|Progression/Relapse|8
5997807|NCT00939393|20738654|P2|Overall Study|Lost to Follow-up|0
5997808|NCT00939393|20738655|P1|Overall Study|Lost to Follow-up|3
5997809|NCT00939393|20738654|P2|Overall Study|Withdrawal by Subject|0
5997810|NCT00939393|20738655|P1|Overall Study|Withdrawal by Subject|1
5997811|NCT00939341|20738686|P1|Overall Study|Incorrect enrolment|8
5997812|NCT00939341|20738686|P1|Overall Study|Protocol Violation|6
5997813|NCT00939341|20738686|P1|Overall Study|Withdrawal by Subject|13
5997814|NCT00939341|20738686|P1|Overall Study|Lost to Follow-up|23
5997815|NCT00939341|20738686|P1|Overall Study|Pregnancy|1
5997816|NCT00939341|20738686|P1|Overall Study|Adverse Event|15
5997817|NCT00939185|20738773|P1|Overall Study|Randomized But Did Not Receive Treatment|10
5997818|NCT00939185|20738773|P1|Overall Study|Withdrawal by Subject|2
5997819|NCT00939185|20738773|P1|Overall Study|Other|3
5997820|NCT00939185|20738773|P1|Overall Study|Lost to Follow-up|6
5997821|NCT00939185|20738773|P1|Overall Study|Lack of Efficacy|1
5997822|NCT00939185|20738773|P1|Overall Study|Adverse Event|3
5997823|NCT00939107|20738811|P2|Overall Study|Lost to Follow-up|12
5997824|NCT00939107|20738812|P1|Overall Study|Lost to Follow-up|14
5997825|NCT00939094|20738826|P2|Overall Study|Abnormal ECG findings|0
5997826|NCT00939094|20738827|P1|Overall Study|Abnormal ECG findings|1
5997827|NCT00939094|20738826|P2|Overall Study|Study stopped by sponsor|2
5997828|NCT00939094|20738827|P1|Overall Study|Study stopped by sponsor|0
5997829|NCT00939094|20738826|P2|Overall Study|Severe non-compliance to protocol|1
5997830|NCT00939094|20738827|P1|Overall Study|Severe non-compliance to protocol|0
5997831|NCT00939094|20738826|P2|Overall Study|Eligibility criteria not fulfilled|0
5997832|NCT00939094|20738827|P1|Overall Study|Eligibility criteria not fulfilled|2
5997833|NCT00939094|20738826|P2|Overall Study|Lost to Follow-up|1
5997834|NCT00939094|20738827|P1|Overall Study|Lost to Follow-up|1
5997835|NCT00939094|20738826|P2|Overall Study|Withdrawal by Subject|6
5997836|NCT00939094|20738827|P1|Overall Study|Withdrawal by Subject|1
5997837|NCT00939094|20738826|P2|Overall Study|Adverse Event|0
5997838|NCT00939094|20738827|P1|Overall Study|Adverse Event|9
5997839|NCT00939055|20738849|P2|Overall Study|Discontinuation prior to procedure|0
5997840|NCT00939055|20738850|P1|Overall Study|Discontinuation prior to procedure|4
5997841|NCT00939029|20738860|P2|Overall Study|Adverse Event|1
5997842|NCT00939029|20738861|P1|Overall Study|Adverse Event|0
5997843|NCT00939029|20738860|P2|Overall Study|Lost to Follow-up|4
5997844|NCT00939029|20738861|P1|Overall Study|Lost to Follow-up|3
5997845|NCT00939029|20738860|P2|Overall Study|Withdrawal by Subject|7
5997846|NCT00939029|20738861|P1|Overall Study|Withdrawal by Subject|3
5997847|NCT00939003|20738873|P2|Open-label Treatment Period|Site Closure|4
5997848|NCT00939003|20738874|P1|Open-label Treatment Period|Site Closure|3
5997849|NCT00939003|20738873|P2|Open-label Treatment Period|Exclusion Criteria|0
5997850|NCT00939003|20738874|P1|Open-label Treatment Period|Exclusion Criteria|1
5997851|NCT00939003|20738873|P2|Open-label Treatment Period|Pregnancy|1
5997852|NCT00939003|20738874|P1|Open-label Treatment Period|Pregnancy|1
5997853|NCT00939003|20738873|P2|Open-label Treatment Period|Lack of Efficacy|9
5997854|NCT00939003|20738874|P1|Open-label Treatment Period|Lack of Efficacy|6
5997855|NCT00939003|20738873|P2|Open-label Treatment Period|Withdrawal by Subject|7
5997856|NCT00939003|20738874|P1|Open-label Treatment Period|Withdrawal by Subject|14
5997857|NCT00939003|20738873|P2|Open-label Treatment Period|Adverse Event|8
5997858|NCT00939003|20738874|P1|Open-label Treatment Period|Adverse Event|4
5997859|NCT00939003|20738873|P2|Double-blind Treatment Period|MRI Not Diagnostic|1
5997860|NCT00939003|20738874|P1|Double-blind Treatment Period|MRI Not Diagnostic|1
5997861|NCT00939003|20738873|P2|Double-blind Treatment Period|Pregnancy|1
5997862|NCT00939003|20738874|P1|Double-blind Treatment Period|Pregnancy|0
5997863|NCT00939003|20738873|P2|Double-blind Treatment Period|Lack of Efficacy|1
5997864|NCT00939003|20738874|P1|Double-blind Treatment Period|Lack of Efficacy|0
5997865|NCT00939003|20738873|P2|Double-blind Treatment Period|Adverse Event|1
5997866|NCT00939003|20738874|P1|Double-blind Treatment Period|Adverse Event|1
5997867|NCT00938964|20738911|P2|Overall Study|Found to Meet Exclusion Criteria|4
5997868|NCT00938964|20738912|P1|Overall Study|Found to Meet Exclusion Criteria|3
5997869|NCT00938964|20738911|P2|Overall Study|Withdrawal by Subject|18
5997870|NCT00938964|20738912|P1|Overall Study|Withdrawal by Subject|22
5997871|NCT00938964|20738911|P2|Overall Study|Lost to Follow-up|3
5997872|NCT00938964|20738912|P1|Overall Study|Lost to Follow-up|2
5997873|NCT00938964|20738911|P2|Overall Study|Death|3
5997874|NCT00938964|20738912|P1|Overall Study|Death|3
5997875|NCT00938886|20738976|P2|Overall Study|Lost to Follow-up|2
5997876|NCT00938886|20738977|P1|Overall Study|Lost to Follow-up|3
5997877|NCT00938886|20738976|P2|Overall Study|Withdrawal by Subject|7
5997878|NCT00938886|20738977|P1|Overall Study|Withdrawal by Subject|4
5997879|NCT00938886|20738976|P2|Overall Study|Death|1
5997880|NCT00938886|20738977|P1|Overall Study|Death|0
5997881|NCT00938860|20738987|P2|Overall Study|Protocol Violation|1
5997882|NCT00938860|20738988|P1|Overall Study|Protocol Violation|3
5997883|NCT00938860|20738987|P2|Overall Study|Death|1
5997884|NCT00938860|20738988|P1|Overall Study|Death|1
5997885|NCT00938860|20738987|P2|Overall Study|Administration problems|0
5997886|NCT00938860|20738988|P1|Overall Study|Administration problems|2
5997887|NCT00938860|20738987|P2|Overall Study|Lost to Follow-up|4
5997888|NCT00938860|20738988|P1|Overall Study|Lost to Follow-up|4
5997889|NCT00938860|20738987|P2|Overall Study|Withdrawal by Subject|8
5997890|NCT00938860|20738988|P1|Overall Study|Withdrawal by Subject|11
5997891|NCT00938860|20738987|P2|Overall Study|Abnormal laboratory values|2
5997892|NCT00938860|20738988|P1|Overall Study|Abnormal laboratory values|2
5997893|NCT00938860|20738987|P2|Overall Study|Adverse Event|1
5997894|NCT00938860|20738988|P1|Overall Study|Adverse Event|2
5997895|NCT00938717|20739021|P2|Overall Study|Other reason|2
5997896|NCT00938717|20739022|P1|Overall Study|Other reason|5
5997897|NCT00938717|20739021|P2|Overall Study|Lack of Efficacy|15
5997898|NCT00938717|20739022|P1|Overall Study|Lack of Efficacy|33
5997899|NCT00938717|20739021|P2|Overall Study|Lost to Follow-up|18
5997900|NCT00938717|20739022|P1|Overall Study|Lost to Follow-up|13
5997901|NCT00938717|20739021|P2|Overall Study|Withdrawal by Subject|24
5997902|NCT00938717|20739022|P1|Overall Study|Withdrawal by Subject|26
5997903|NCT00938717|20739021|P2|Overall Study|Protocol Violation|8
5997904|NCT00938717|20739022|P1|Overall Study|Protocol Violation|11
5997905|NCT00938717|20739021|P2|Overall Study|Adverse Event|41
5997906|NCT00938717|20739022|P1|Overall Study|Adverse Event|10
5997907|NCT00938639|20739073|P2|Overall Study|Participant noncompliance|0
5997908|NCT00938639|20739074|P1|Overall Study|Participant noncompliance|1
5997909|NCT00938639|20739073|P2|Overall Study|Family issues|1
5997910|NCT00938639|20739074|P1|Overall Study|Family issues|1
5997911|NCT00938639|20739073|P2|Overall Study|Lost to Follow-up|2
5997912|NCT00938639|20739074|P1|Overall Study|Lost to Follow-up|1
5997913|NCT00938639|20739073|P2|Overall Study|Moved away from study area|1
5997914|NCT00938639|20739074|P1|Overall Study|Moved away from study area|0
5997915|NCT00938470|20739157|P2|Overall Study|Other Reason|1
5997916|NCT00938470|20739158|P1|Overall Study|Other Reason|0
5997917|NCT00938470|20739157|P2|Overall Study|Death|2
5997918|NCT00938470|20739158|P1|Overall Study|Death|3
5997919|NCT00938470|20739157|P2|Overall Study|Alternate Treatment|0
5997920|NCT00938470|20739158|P1|Overall Study|Alternate Treatment|1
5997921|NCT00938470|20739157|P2|Overall Study|Disease Progression|0
5997922|NCT00938470|20739158|P1|Overall Study|Disease Progression|3
5997923|NCT00938431|20739188|P3|Overall Study|Reached maximum dose early|1
5997924|NCT00938431|20739189|P2|Overall Study|Reached maximum dose early|0
5997925|NCT00938431|20739190|P1|Overall Study|Reached maximum dose early|0
5997926|NCT00938431|20739188|P3|Overall Study|Dosing compliance issue|1
5997927|NCT00938431|20739189|P2|Overall Study|Dosing compliance issue|0
5997928|NCT00938431|20739190|P1|Overall Study|Dosing compliance issue|0
5997929|NCT00938431|20739188|P3|Overall Study|Did not up titrate to 12 mg kg/day|0
5997930|NCT00938431|20739189|P2|Overall Study|Did not up titrate to 12 mg kg/day|0
5997931|NCT00938431|20739190|P1|Overall Study|Did not up titrate to 12 mg kg/day|1
5997932|NCT00938431|20739188|P3|Overall Study|Lack of Efficacy|0
5997933|NCT00938431|20739189|P2|Overall Study|Lack of Efficacy|1
5997934|NCT00938431|20739190|P1|Overall Study|Lack of Efficacy|0
5997935|NCT00938431|20739188|P3|Overall Study|Adverse Event|6
5997936|NCT00938431|20739189|P2|Overall Study|Adverse Event|8
5997937|NCT00938431|20739190|P1|Overall Study|Adverse Event|5
5997938|NCT00938392|20739217|P2|Overall Study|Lost to Follow-up|2
5997939|NCT00938392|20739218|P1|Overall Study|Lost to Follow-up|2
5997940|NCT00938392|20739217|P2|Overall Study|Withdrawal by Subject|1
5997941|NCT00938392|20739218|P1|Overall Study|Withdrawal by Subject|0
5997942|NCT00938392|20739217|P2|Overall Study|Adverse Event|1
5997943|NCT00938392|20739218|P1|Overall Study|Adverse Event|0
5997944|NCT00938366|20739244|P2|Overall Study|Withdrawal by Subject|0
5997945|NCT00938366|20739245|P1|Overall Study|Withdrawal by Subject|1
5997946|NCT00938340|20739265|P1|Overall Study|Adverse Event|1
5997947|NCT00938340|20739265|P1|Overall Study|Protocol Violation|1
5997948|NCT00938340|20739265|P1|Overall Study|Withdrawal by Subject|3
5997949|NCT00938327|20739395|P1|Overall Study|Vaccine not received as out of stock|9
5997950|NCT00938327|20739395|P1|Overall Study|2nd dose received outside of the study|7
5997951|NCT00938327|20739395|P1|Overall Study|Lost to Follow-up|37
5997952|NCT00938327|20739395|P1|Overall Study|Withdrawal by Subject|4
5997953|NCT00938327|20739395|P1|Overall Study|Protocol Violation|1
5997954|NCT00938327|20739395|P1|Overall Study|Adverse Event|2
5997955|NCT00938041|20739463|P1|Overall Study|Adrenal Insufficiency|3
5997956|NCT00938041|20739463|P1|Overall Study|Death|12
5997957|NCT00938041|20739463|P1|Overall Study|Progressive Disease|5
5997958|NCT00938041|20739463|P1|Overall Study|Received Alternative Therapy|1
5997959|NCT00938041|20739463|P1|Overall Study|Lost to Follow-up|6
5997960|NCT00938015|20739472|P1|Overall Study|Reason not related to Etanercept|29
5997961|NCT00938015|20739472|P1|Overall Study|Non-responder|52
5997962|NCT00938015|20739472|P1|Overall Study|Adverse Event|32
5997963|NCT00938015|20739472|P1|Overall Study|Lost to Follow-up|32
5997964|NCT00938015|20739472|P1|Overall Study|Death|2
5997965|NCT00937950|20739488|P1|Overall Study|Other|18
5997966|NCT00937950|20739488|P1|Overall Study|Missing confirmed|4
5997967|NCT00937950|20739488|P1|Overall Study|Lost to Follow-up|144
5997968|NCT00937950|20739488|P1|Overall Study|Migrated/moved from study area|27
5997969|NCT00937950|20739488|P1|Overall Study|Withdrawal by Subject|23
5997970|NCT00937937|20739504|P1|Overall Study|Other|2
5997971|NCT00937937|20739504|P1|Overall Study|Death|1
5997972|NCT00937937|20739504|P1|Overall Study|Progression/relapse|61
5997973|NCT00937937|20739504|P1|Overall Study|Withdrawal by Subject|2
5997974|NCT00937937|20739504|P1|Overall Study|Adverse Event|6
5997975|NCT00937833|20739524|P2|Overall Study|Withdrawal by Subject|6
5997976|NCT00937833|20739525|P1|Overall Study|Withdrawal by Subject|4
5997977|NCT00937833|20739524|P2|Overall Study|Lost to Follow-up|8
5997978|NCT00937833|20739525|P1|Overall Study|Lost to Follow-up|10
5997979|NCT00937833|20739524|P2|Overall Study|Procedure delayed; enrollment closed|1
5997980|NCT00937833|20739525|P1|Overall Study|Procedure delayed; enrollment closed|0
5997981|NCT00937833|20739524|P2|Overall Study|Protocol Violation|2
5997982|NCT00937833|20739525|P1|Overall Study|Protocol Violation|1
5997983|NCT00937768|20739538|P2|Overall Study|No Further Funding|4
5997984|NCT00937768|20739539|P1|Overall Study|No Further Funding|4
5997985|NCT00937768|20739538|P2|Overall Study|Alternate Treatment|1
5997986|NCT00937768|20739539|P1|Overall Study|Alternate Treatment|0
5997987|NCT00937768|20739538|P2|Overall Study|Disease Progression|1
5997988|NCT00937768|20739539|P1|Overall Study|Disease Progression|1
5997989|NCT00937768|20739538|P2|Overall Study|Refused Further Treatment|2
5997990|NCT00937768|20739539|P1|Overall Study|Refused Further Treatment|3
5997991|NCT00937560|20739559|P1|Maintenance Treatment|According to protocol|1
5997992|NCT00937560|20739559|P1|Maintenance Treatment|Withdraw consent|5
5997993|NCT00937560|20739559|P1|Maintenance Treatment|Death|12
5997994|NCT00937560|20739559|P1|Initial Treatment|No end of study page|10
5997995|NCT00937560|20739559|P1|Initial Treatment|Lost to Follow-up|1
5997996|NCT00937560|20739559|P1|Initial Treatment|Adverse Event|1
5997997|NCT00937560|20739559|P1|Initial Treatment|Withdraw consent|3
5997998|NCT00937560|20739559|P1|Initial Treatment|Death|6
5997999|NCT00937547|20739570|P3|Overall Study|misdiagnosis|7
5998000|NCT00937547|20739571|P2|Overall Study|misdiagnosis|6
5998001|NCT00937547|20739572|P1|Overall Study|misdiagnosis|1
5998002|NCT00937521|20739609|P8|Booster Phase|Protocol Deviation|0
5998003|NCT00937521|20739610|P7|Booster Phase|Protocol Deviation|1
5998004|NCT00937521|20739611|P6|Booster Phase|Protocol Deviation|0
5998005|NCT00937521|20739612|P5|Booster Phase|Protocol Deviation|0
5998006|NCT00937521|20739613|P4|Booster Phase|Protocol Deviation|0
5998007|NCT00937521|20739614|P3|Booster Phase|Protocol Deviation|0
5998008|NCT00937521|20739615|P2|Booster Phase|Protocol Deviation|0
5998009|NCT00937521|20739616|P1|Booster Phase|Protocol Deviation|0
5998010|NCT00937521|20739609|P8|Booster Phase|Administrative Reason|0
5998011|NCT00937521|20739610|P7|Booster Phase|Administrative Reason|0
5998012|NCT00937521|20739611|P6|Booster Phase|Administrative Reason|1
5998013|NCT00937521|20739612|P5|Booster Phase|Administrative Reason|1
5998014|NCT00937521|20739613|P4|Booster Phase|Administrative Reason|0
5998015|NCT00937521|20739614|P3|Booster Phase|Administrative Reason|1
5998016|NCT00937521|20739615|P2|Booster Phase|Administrative Reason|0
5998017|NCT00937521|20739616|P1|Booster Phase|Administrative Reason|0
5998018|NCT00937521|20739609|P8|Booster Phase|Lost to Follow-up|0
5998019|NCT00937521|20739610|P7|Booster Phase|Lost to Follow-up|3
5998020|NCT00937521|20739611|P6|Booster Phase|Lost to Follow-up|4
5998021|NCT00937521|20739612|P5|Booster Phase|Lost to Follow-up|4
5998022|NCT00937521|20739613|P4|Booster Phase|Lost to Follow-up|2
5998023|NCT00937521|20739614|P3|Booster Phase|Lost to Follow-up|4
5998024|NCT00937521|20739615|P2|Booster Phase|Lost to Follow-up|2
5998025|NCT00937521|20739616|P1|Booster Phase|Lost to Follow-up|2
5998026|NCT00937521|20739609|P8|Booster Phase|Withdrawal by Subject|2
5998027|NCT00937521|20739610|P7|Booster Phase|Withdrawal by Subject|0
5998028|NCT00937521|20739611|P6|Booster Phase|Withdrawal by Subject|0
5998029|NCT00937521|20739612|P5|Booster Phase|Withdrawal by Subject|0
5998030|NCT00937521|20739613|P4|Booster Phase|Withdrawal by Subject|1
5998031|NCT00937521|20739614|P3|Booster Phase|Withdrawal by Subject|0
5998032|NCT00937521|20739615|P2|Booster Phase|Withdrawal by Subject|0
5998033|NCT00937521|20739616|P1|Booster Phase|Withdrawal by Subject|1
5998034|NCT00937521|20739609|P8|Booster Phase|Adverse Event|0
5998035|NCT00937521|20739610|P7|Booster Phase|Adverse Event|1
5998036|NCT00937521|20739611|P6|Booster Phase|Adverse Event|0
5998037|NCT00937521|20739612|P5|Booster Phase|Adverse Event|0
5998038|NCT00937521|20739613|P4|Booster Phase|Adverse Event|0
5998039|NCT00937521|20739614|P3|Booster Phase|Adverse Event|0
5998040|NCT00937521|20739615|P2|Booster Phase|Adverse Event|0
5998041|NCT00937521|20739616|P1|Booster Phase|Adverse Event|0
5998042|NCT00937521|20739609|P8|Overall Study - Prior to Booster Dose|Protocol Deviation|0
5998043|NCT00937521|20739610|P7|Overall Study - Prior to Booster Dose|Protocol Deviation|1
5998044|NCT00937521|20739611|P6|Overall Study - Prior to Booster Dose|Protocol Deviation|0
5998045|NCT00937521|20739612|P5|Overall Study - Prior to Booster Dose|Protocol Deviation|0
5998046|NCT00937521|20739613|P4|Overall Study - Prior to Booster Dose|Protocol Deviation|0
5998047|NCT00937521|20739614|P3|Overall Study - Prior to Booster Dose|Protocol Deviation|0
5998048|NCT00937521|20739615|P2|Overall Study - Prior to Booster Dose|Protocol Deviation|0
5998049|NCT00937521|20739616|P1|Overall Study - Prior to Booster Dose|Protocol Deviation|1
5998050|NCT00937521|20739609|P8|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0
5998051|NCT00937521|20739610|P7|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1
5998052|NCT00937521|20739611|P6|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1
5998053|NCT00937521|20739612|P5|Overall Study - Prior to Booster Dose|Inappropriate enrollment|2
5998054|NCT00937521|20739613|P4|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0
5998055|NCT00937521|20739614|P3|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0
5998056|NCT00937521|20739615|P2|Overall Study - Prior to Booster Dose|Inappropriate enrollment|4
5998057|NCT00937521|20739616|P1|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0
5998058|NCT00937521|20739609|P8|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
5998059|NCT00937521|20739610|P7|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
5998060|NCT00937521|20739611|P6|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
5998061|NCT00937521|20739612|P5|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
5998062|NCT00937521|20739613|P4|Overall Study - Prior to Booster Dose|Lost to Follow-up|1
5998063|NCT00937521|20739614|P3|Overall Study - Prior to Booster Dose|Lost to Follow-up|1
5998064|NCT00937521|20739615|P2|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
5998065|NCT00937521|20739616|P1|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
5998066|NCT00937521|20739609|P8|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1
5998067|NCT00937521|20739610|P7|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2
5998068|NCT00937521|20739611|P6|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0
5998069|NCT00937521|20739612|P5|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1
5998070|NCT00937521|20739613|P4|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0
5998071|NCT00937521|20739614|P3|Overall Study - Prior to Booster Dose|Withdrawal by Subject|3
5998072|NCT00937521|20739615|P2|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1
5998073|NCT00937521|20739616|P1|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2
5998074|NCT00937521|20739609|P8|Overall Study - Prior to Booster Dose|Adverse Event|0
5998075|NCT00937521|20739610|P7|Overall Study - Prior to Booster Dose|Adverse Event|1
5998076|NCT00937521|20739611|P6|Overall Study - Prior to Booster Dose|Adverse Event|0
5998077|NCT00937521|20739612|P5|Overall Study - Prior to Booster Dose|Adverse Event|0
5998078|NCT00937521|20739613|P4|Overall Study - Prior to Booster Dose|Adverse Event|0
5998079|NCT00937521|20739614|P3|Overall Study - Prior to Booster Dose|Adverse Event|2
5998080|NCT00937521|20739615|P2|Overall Study - Prior to Booster Dose|Adverse Event|0
5998081|NCT00937521|20739616|P1|Overall Study - Prior to Booster Dose|Adverse Event|0
5998082|NCT00937495|20739722|P1|Overall Study|Protocol Violation|2
5998083|NCT00937404|20739728|P1|Overall Study|Withdrawal by Subject|1
5998084|NCT00937404|20739728|P1|Overall Study|Protocol Violation|1
5998085|NCT00937391|20739737|P1|Stage 2|Withdrawal by Subject|1
5998086|NCT00937326|20739804|P5|Overall Study|Chest X-ray showed a suspicious shadow|0
5998087|NCT00937326|20739805|P4|Overall Study|Chest X-ray showed a suspicious shadow|0
5998088|NCT00937326|20739806|P3|Overall Study|Chest X-ray showed a suspicious shadow|1
5998089|NCT00937326|20739807|P2|Overall Study|Chest X-ray showed a suspicious shadow|0
5998090|NCT00937326|20739808|P1|Overall Study|Chest X-ray showed a suspicious shadow|0
5998091|NCT00937326|20739804|P5|Overall Study|Withdrawal by Subject|3
5998092|NCT00937326|20739805|P4|Overall Study|Withdrawal by Subject|4
5998093|NCT00937326|20739806|P3|Overall Study|Withdrawal by Subject|1
5998094|NCT00937326|20739807|P2|Overall Study|Withdrawal by Subject|4
5998095|NCT00937326|20739808|P1|Overall Study|Withdrawal by Subject|3
5998096|NCT00937326|20739804|P5|Overall Study|Death|0
5998097|NCT00937326|20739805|P4|Overall Study|Death|0
5998098|NCT00937326|20739806|P3|Overall Study|Death|1
5998099|NCT00937326|20739807|P2|Overall Study|Death|0
5998100|NCT00937326|20739808|P1|Overall Study|Death|0
5998101|NCT00937326|20739804|P5|Overall Study|Adverse Event|2
5998102|NCT00937326|20739805|P4|Overall Study|Adverse Event|1
5998103|NCT00937326|20739806|P3|Overall Study|Adverse Event|1
5998104|NCT00937326|20739807|P2|Overall Study|Adverse Event|3
5998105|NCT00937326|20739808|P1|Overall Study|Adverse Event|0
5998106|NCT00937157|20740057|P1|Overall Study|Lost to Follow-up|3
5998107|NCT00937157|20740057|P1|Overall Study|Pregnancy|1
5998108|NCT00937040|20740088|P2|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|8
5998109|NCT00937040|20740089|P1|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|5
5998110|NCT00937040|20740088|P2|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|2
5998111|NCT00937040|20740089|P1|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|3
5998112|NCT00937040|20740088|P2|Overall Study|Withdrawal by Subject|7
5998113|NCT00937040|20740089|P1|Overall Study|Withdrawal by Subject|13
5998114|NCT00937040|20740088|P2|Overall Study|Protocol Violation|0
5998115|NCT00937040|20740089|P1|Overall Study|Protocol Violation|3
5998116|NCT00937040|20740088|P2|Overall Study|Lost to Follow-up|12
5998117|NCT00937040|20740089|P1|Overall Study|Lost to Follow-up|12
5998118|NCT00937040|20740088|P2|Overall Study|Adverse Event|8
5998119|NCT00937040|20740089|P1|Overall Study|Adverse Event|5
5998120|NCT00936975|20740131|P1|Overall Study|Post-Tx scan uninterpretable|2
5998121|NCT00936975|20740131|P1|Overall Study|Disease progression|3
5998122|NCT00936975|20740131|P1|Overall Study|Withdrawal by Subject|1
5998123|NCT00936910|20740140|P1|Overall Study|Lack of Efficacy|3
5998124|NCT00936897|20740149|P2|Overall Study|Death|1
5998125|NCT00936897|20740150|P1|Overall Study|Death|0
5998126|NCT00936897|20740149|P2|Overall Study|Noncompliance|2
5998127|NCT00936897|20740150|P1|Overall Study|Noncompliance|0
5998128|NCT00936897|20740149|P2|Overall Study|Ineligibility Determined|3
5998129|NCT00936897|20740150|P1|Overall Study|Ineligibility Determined|0
5998130|NCT00936897|20740149|P2|Overall Study|Protocol Violation|1
5998131|NCT00936897|20740150|P1|Overall Study|Protocol Violation|1
5998132|NCT00936897|20740149|P2|Overall Study|Administrative Decision|2
5998133|NCT00936897|20740150|P1|Overall Study|Administrative Decision|1
5998134|NCT00936897|20740149|P2|Overall Study|Lost to Follow-up|10
5998135|NCT00936897|20740150|P1|Overall Study|Lost to Follow-up|1
5998136|NCT00936897|20740149|P2|Overall Study|Other|9
5998137|NCT00936897|20740150|P1|Overall Study|Other|3
5998138|NCT00936897|20740149|P2|Overall Study|Adverse Event|13
5998139|NCT00936897|20740150|P1|Overall Study|Adverse Event|4
5998140|NCT00936897|20740149|P2|Overall Study|Withdrawal by Subject|19
5998141|NCT00936897|20740150|P1|Overall Study|Withdrawal by Subject|9
5998142|NCT00936884|20740164|P3|Double-blind|Did not receive study drug|0
5998143|NCT00936884|20740165|P2|Double-blind|Did not receive study drug|1
5998144|NCT00936884|20740166|P1|Double-blind|Did not receive study drug|0
5998145|NCT00936884|20740164|P3|Double-blind|No post baseline diary entry|0
5998146|NCT00936884|20740165|P2|Double-blind|No post baseline diary entry|0
5998147|NCT00936884|20740166|P1|Double-blind|No post baseline diary entry|1
5998148|NCT00936884|20740164|P3|Double-blind|Physician Decision|0
5998149|NCT00936884|20740165|P2|Double-blind|Physician Decision|0
5998150|NCT00936884|20740166|P1|Double-blind|Physician Decision|1
5998151|NCT00936884|20740164|P3|Double-blind|Adverse Event|0
5998152|NCT00936884|20740165|P2|Double-blind|Adverse Event|0
5998153|NCT00936884|20740166|P1|Double-blind|Adverse Event|1
5998154|NCT00936884|20740164|P3|Double-blind|Lack of Efficacy|0
5998155|NCT00936884|20740165|P2|Double-blind|Lack of Efficacy|1
5998156|NCT00936884|20740166|P1|Double-blind|Lack of Efficacy|1
5998157|NCT00936884|20740164|P3|Double-blind|Death|0
5998158|NCT00936884|20740165|P2|Double-blind|Death|1
5998159|NCT00936884|20740166|P1|Double-blind|Death|2
5998160|NCT00936884|20740164|P3|Double-blind|Withdrawal by Subject|0
5998161|NCT00936884|20740165|P2|Double-blind|Withdrawal by Subject|4
5998162|NCT00936884|20740166|P1|Double-blind|Withdrawal by Subject|6
5998163|NCT00936715|20740182|P1|Overall Study|Safety or Tolerability Reasons|4
5998164|NCT00936715|20740182|P1|Overall Study|Protocol Violation|1
5998165|NCT00936715|20740182|P1|Overall Study|Investigators Discretion|1
5998166|NCT00936702|20740186|P1|Overall Study|Other|1
5998167|NCT00936702|20740186|P1|Overall Study|Alternative Treatment|1
5998168|NCT00936702|20740186|P1|Overall Study|Withdrawal by Subject|2
5998169|NCT00936702|20740186|P1|Overall Study|Adverse Event|8
5998170|NCT00936702|20740186|P1|Overall Study|Disease progression|34
5998171|NCT00936598|20740219|P2|Overall Study|Ineligible after consent|0
5998172|NCT00936598|20740220|P1|Overall Study|Ineligible after consent|1
5998173|NCT00936598|20740219|P2|Overall Study|Withdrawal by Subject|0
5998174|NCT00936598|20740220|P1|Overall Study|Withdrawal by Subject|1
5998175|NCT00936221|20740322|P2|Overall Study|Withdrawal by Subject|1
5998176|NCT00936221|20740323|P1|Overall Study|Withdrawal by Subject|1
5998177|NCT00936208|20740337|P2|Overall Study|Protocol Violation|22
5998178|NCT00936208|20740338|P1|Overall Study|Protocol Violation|37
5998179|NCT00936117|20740356|P1|Overall Study|Unable to continue oral medication|3
5998180|NCT00936117|20740356|P1|Overall Study|Adverse Event|7
5998181|NCT00936065|20740364|P3|Overall Study|Withdrawal by Subject|4
5998182|NCT00936065|20740365|P2|Overall Study|Withdrawal by Subject|2
5998183|NCT00936065|20740366|P1|Overall Study|Withdrawal by Subject|0
5998184|NCT00936065|20740364|P3|Overall Study|Protocol Violation|1
5998185|NCT00936065|20740365|P2|Overall Study|Protocol Violation|2
5998186|NCT00936065|20740366|P1|Overall Study|Protocol Violation|1
5998187|NCT00936065|20740364|P3|Overall Study|Lost to Follow-up|0
5998188|NCT00936065|20740365|P2|Overall Study|Lost to Follow-up|0
5998189|NCT00936065|20740366|P1|Overall Study|Lost to Follow-up|1
5998190|NCT00936065|20740364|P3|Overall Study|Lack of Efficacy|1
5998191|NCT00936065|20740365|P2|Overall Study|Lack of Efficacy|0
5998192|NCT00936065|20740366|P1|Overall Study|Lack of Efficacy|1
5998193|NCT00936065|20740364|P3|Overall Study|Adverse Event|1
5998194|NCT00936065|20740365|P2|Overall Study|Adverse Event|0
5998195|NCT00936065|20740366|P1|Overall Study|Adverse Event|1
5998196|NCT00935883|20740472|P2|Treatment Period|Withdrawal by Subject|2
5998197|NCT00935883|20740473|P1|Treatment Period|Withdrawal by Subject|0
5998198|NCT00935883|20740472|P2|Treatment Period|Physician Decision|0
5998199|NCT00935883|20740473|P1|Treatment Period|Physician Decision|1
5998200|NCT00935818|20740500|P2|Overall Study|Physician Decision|1
5998201|NCT00935818|20740501|P1|Overall Study|Physician Decision|0
5998202|NCT00935818|20740500|P2|Overall Study|Adverse Event|7
5998203|NCT00935818|20740501|P1|Overall Study|Adverse Event|6
5998204|NCT00935818|20740500|P2|Overall Study|Lost to Follow-up|42
5998205|NCT00935818|20740501|P1|Overall Study|Lost to Follow-up|40
5998206|NCT00935818|20740500|P2|Overall Study|Withdrawal by Subject|50
5998207|NCT00935818|20740501|P1|Overall Study|Withdrawal by Subject|45
5998208|NCT00935701|20740552|P1|Overall Study|Failure to Transition to Acupuncture|1
5998209|NCT00935584|20740569|P2|Overall Study|Provider dropped out of study|4
5998210|NCT00935584|20740570|P1|Overall Study|Provider dropped out of study|14
5998211|NCT00935584|20740569|P2|Overall Study|Patient changed provider|0
5998212|NCT00935584|20740570|P1|Overall Study|Patient changed provider|3
5998213|NCT00935584|20740569|P2|Overall Study|Relocated|0
5998214|NCT00935584|20740570|P1|Overall Study|Relocated|3
5998215|NCT00935584|20740569|P2|Overall Study|No show|0
5998216|NCT00935584|20740570|P1|Overall Study|No show|9
5998217|NCT00935584|20740569|P2|Overall Study|Lost to Follow-up|0
5998218|NCT00935584|20740570|P1|Overall Study|Lost to Follow-up|8
5998219|NCT00935584|20740569|P2|Overall Study|Death|0
5998220|NCT00935584|20740570|P1|Overall Study|Death|3
5998221|NCT00935584|20740569|P2|Overall Study|Withdrawal by Subject|0
5998222|NCT00935584|20740570|P1|Overall Study|Withdrawal by Subject|9
5998223|NCT00935532|20740582|P2|Overall Study|Loss Glucose Control|0
5998224|NCT00935532|20740583|P1|Overall Study|Loss Glucose Control|4
5998225|NCT00935532|20740582|P2|Overall Study|Sponsor Decision|1
5998226|NCT00935532|20740583|P1|Overall Study|Sponsor Decision|0
5998227|NCT00935532|20740582|P2|Overall Study|Subject Decision|1
5998228|NCT00935532|20740583|P1|Overall Study|Subject Decision|2
5998229|NCT00935532|20740582|P2|Overall Study|Protocol Violation|1
5998230|NCT00935532|20740583|P1|Overall Study|Protocol Violation|2
5998231|NCT00935532|20740582|P2|Overall Study|Physician Decision|2
5998232|NCT00935532|20740583|P1|Overall Study|Physician Decision|1
5998233|NCT00935532|20740582|P2|Overall Study|Lost to Follow-up|0
5998234|NCT00935532|20740583|P1|Overall Study|Lost to Follow-up|1
5998235|NCT00935532|20740582|P2|Overall Study|Death|0
5998236|NCT00935532|20740583|P1|Overall Study|Death|1
5998237|NCT00935532|20740582|P2|Overall Study|Adverse Event|6
5998238|NCT00935532|20740583|P1|Overall Study|Adverse Event|11
5998239|NCT00935493|20740612|P3|Overall Study|Treatment Discontinued|0
5998240|NCT00935493|20740613|P2|Overall Study|Treatment Discontinued|1
5998241|NCT00935493|20740614|P1|Overall Study|Treatment Discontinued|0
5998242|NCT00935493|20740612|P3|Overall Study|Lost to Follow-up|1
5998243|NCT00935493|20740613|P2|Overall Study|Lost to Follow-up|1
5998244|NCT00935493|20740614|P1|Overall Study|Lost to Follow-up|1
5998245|NCT00935272|20740663|P2|Overall Study|Protocol Violation|1
5998246|NCT00935272|20740664|P1|Overall Study|Protocol Violation|0
5998247|NCT00935272|20740663|P2|Overall Study|Physician Decision|0
5998248|NCT00935272|20740664|P1|Overall Study|Physician Decision|1
5998249|NCT00935272|20740663|P2|Overall Study|Withdrawal by Subject|2
5998250|NCT00935272|20740664|P1|Overall Study|Withdrawal by Subject|8
5998251|NCT00935272|20740663|P2|Overall Study|Lost to Follow-up|3
5998252|NCT00935272|20740664|P1|Overall Study|Lost to Follow-up|10
5998253|NCT00935259|20740673|P2|Period 1|Administrative (scheduling conflict)|1
5998254|NCT00935259|20740674|P1|Period 1|Administrative (scheduling conflict)|1
5998255|NCT00935220|20740688|P1|Overall Study|Other reason (not specified)|1
5998256|NCT00935220|20740688|P1|Overall Study|Adverse Event|1
5998257|NCT00935012|20740717|P1|Overall Study|Adverse Event|2
5998258|NCT00935012|20740717|P1|Overall Study|Other|5
5998259|NCT00935012|20740717|P1|Overall Study|Withdrawal by Subject|3
5998260|NCT00935012|20740717|P1|Overall Study|Death|19
5998261|NCT00934947|20740759|P2|Overall Study|Adverse Event|2
5998262|NCT00934947|20740760|P1|Overall Study|Adverse Event|0
5998263|NCT00934856|20740789|P6|Extension Part|Non-compliance with drug|1
5998264|NCT00934856|20740790|P5|Extension Part|Non-compliance with drug|0
5998265|NCT00934856|20740791|P4|Extension Part|Non-compliance with drug|0
5998266|NCT00934856|20740792|P3|Extension Part|Non-compliance with drug|0
5998267|NCT00934856|20740793|P2|Extension Part|Non-compliance with drug|0
5998268|NCT00934856|20740794|P1|Extension Part|Non-compliance with drug|0
5998269|NCT00934856|20740789|P6|Extension Part|Progressive disease|0
5998270|NCT00934856|20740790|P5|Extension Part|Progressive disease|0
5998271|NCT00934856|20740791|P4|Extension Part|Progressive disease|1
5998272|NCT00934856|20740792|P3|Extension Part|Progressive disease|0
5998273|NCT00934856|20740793|P2|Extension Part|Progressive disease|0
5998274|NCT00934856|20740794|P1|Extension Part|Progressive disease|0
5998275|NCT00934856|20740789|P6|Extension Part|Adverse Event|4
5998276|NCT00934856|20740790|P5|Extension Part|Adverse Event|4
5998277|NCT00934856|20740791|P4|Extension Part|Adverse Event|1
5998278|NCT00934856|20740792|P3|Extension Part|Adverse Event|0
5998279|NCT00934856|20740793|P2|Extension Part|Adverse Event|0
5998280|NCT00934856|20740794|P1|Extension Part|Adverse Event|0
5998281|NCT00934856|20740789|P6|Feasibility Part|Withdrawal by Subject|1
5998282|NCT00934856|20740790|P5|Feasibility Part|Withdrawal by Subject|0
5998283|NCT00934856|20740791|P4|Feasibility Part|Withdrawal by Subject|1
5998284|NCT00934856|20740792|P3|Feasibility Part|Withdrawal by Subject|0
5998285|NCT00934856|20740793|P2|Feasibility Part|Withdrawal by Subject|0
5998286|NCT00934856|20740794|P1|Feasibility Part|Withdrawal by Subject|0
5998287|NCT00934856|20740789|P6|Feasibility Part|Adverse Event|2
5998288|NCT00934856|20740790|P5|Feasibility Part|Adverse Event|0
5998289|NCT00934856|20740791|P4|Feasibility Part|Adverse Event|1
5998290|NCT00934856|20740792|P3|Feasibility Part|Adverse Event|0
5998291|NCT00934856|20740793|P2|Feasibility Part|Adverse Event|1
5998292|NCT00934856|20740794|P1|Feasibility Part|Adverse Event|1
5998293|NCT00934856|20740789|P6|Feasibility Part|Physician Decision|0
5998294|NCT00934856|20740790|P5|Feasibility Part|Physician Decision|0
5998295|NCT00934856|20740791|P4|Feasibility Part|Physician Decision|0
5998296|NCT00934856|20740792|P3|Feasibility Part|Physician Decision|1
5998297|NCT00934856|20740793|P2|Feasibility Part|Physician Decision|0
5998298|NCT00934856|20740794|P1|Feasibility Part|Physician Decision|0
5998299|NCT00934856|20740789|P6|Feasibility Part|Progressive disease|0
5998300|NCT00934856|20740790|P5|Feasibility Part|Progressive disease|0
5998301|NCT00934856|20740791|P4|Feasibility Part|Progressive disease|3
5998302|NCT00934856|20740792|P3|Feasibility Part|Progressive disease|2
5998303|NCT00934856|20740793|P2|Feasibility Part|Progressive disease|4
5998304|NCT00934856|20740794|P1|Feasibility Part|Progressive disease|4
5998305|NCT00934843|20740892|P2|Overall Study|Protocol Violation|1
5998306|NCT00934843|20740893|P1|Overall Study|Protocol Violation|0
5998307|NCT00934791|20740909|P2|Overall Study|Withdrawal by Subject|0
5998308|NCT00934791|20740910|P1|Overall Study|Withdrawal by Subject|1
5998309|NCT00934661|20740918|P2|Overall Study|Failure of Combined/Spinal Epidural|0
5998310|NCT00934661|20740919|P1|Overall Study|Failure of Combined/Spinal Epidural|1
5998311|NCT00934648|20740939|P1|Overall Study|Withdrawal by Subject|1
5998312|NCT00934648|20740939|P1|Overall Study|Failure to return|8
5998313|NCT00934622|20740983|P1|Overall Study|2nd Intraoperative exclusion criteria|1
5998314|NCT00934622|20740983|P1|Overall Study|Lost to Follow-up|7
5998315|NCT00934544|20741021|P3|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|5
5998316|NCT00934544|20741022|P2|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|0
5998317|NCT00934544|20741023|P1|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|8
5998318|NCT00934544|20741021|P3|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0
5998319|NCT00934544|20741022|P2|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|1
5998320|NCT00934544|20741023|P1|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0
5998321|NCT00934544|20741021|P3|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|1
5998322|NCT00934544|20741022|P2|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|0
5998323|NCT00934544|20741023|P1|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|4
5998324|NCT00934544|20741021|P3|Overall Disposition at 5 Year Follow-up|Disease progression|7
5998325|NCT00934544|20741022|P2|Overall Disposition at 5 Year Follow-up|Disease progression|4
5998326|NCT00934544|20741023|P1|Overall Disposition at 5 Year Follow-up|Disease progression|32
5998327|NCT00934544|20741021|P3|Overall Disposition at 5 Year Follow-up|Protocol Violation|5
5998328|NCT00934544|20741022|P2|Overall Disposition at 5 Year Follow-up|Protocol Violation|0
5998329|NCT00934544|20741023|P1|Overall Disposition at 5 Year Follow-up|Protocol Violation|2
5998330|NCT00934544|20741021|P3|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|0
5998331|NCT00934544|20741022|P2|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|9
5998332|NCT00934544|20741023|P1|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|10
5998333|NCT00934544|20741021|P3|Overall Disposition at 5 Year Follow-up|Adverse Event|10
5998334|NCT00934544|20741022|P2|Overall Disposition at 5 Year Follow-up|Adverse Event|5
5998335|NCT00934544|20741023|P1|Overall Disposition at 5 Year Follow-up|Adverse Event|35
5998336|NCT00934544|20741021|P3|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|6
5998337|NCT00934544|20741022|P2|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|9
5998338|NCT00934544|20741023|P1|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|16
5998339|NCT00934544|20741021|P3|Primary Endpoint Analysis (Interim)|Entered extension phase|0
5998340|NCT00934544|20741022|P2|Primary Endpoint Analysis (Interim)|Entered extension phase|18
5998341|NCT00934544|20741023|P1|Primary Endpoint Analysis (Interim)|Entered extension phase|29
5998342|NCT00934544|20741021|P3|Primary Endpoint Analysis (Interim)|Other reasons|0
5998343|NCT00934544|20741022|P2|Primary Endpoint Analysis (Interim)|Other reasons|7
5998344|NCT00934544|20741023|P1|Primary Endpoint Analysis (Interim)|Other reasons|7
5998345|NCT00934544|20741021|P3|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0
5998346|NCT00934544|20741022|P2|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|1
5998347|NCT00934544|20741023|P1|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0
5998348|NCT00934544|20741021|P3|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0
5998349|NCT00934544|20741022|P2|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0
5998350|NCT00934544|20741023|P1|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|2
5998351|NCT00934544|20741021|P3|Primary Endpoint Analysis (Interim)|Disease Progression|0
5998352|NCT00934544|20741022|P2|Primary Endpoint Analysis (Interim)|Disease Progression|3
5998353|NCT00934544|20741023|P1|Primary Endpoint Analysis (Interim)|Disease Progression|1
5998354|NCT00934544|20741021|P3|Primary Endpoint Analysis (Interim)|Protocol Violation|0
5998355|NCT00934544|20741022|P2|Primary Endpoint Analysis (Interim)|Protocol Violation|0
5998356|NCT00934544|20741023|P1|Primary Endpoint Analysis (Interim)|Protocol Violation|2
5998357|NCT00934544|20741021|P3|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|0
5998358|NCT00934544|20741022|P2|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|9
5998359|NCT00934544|20741023|P1|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|2
5998360|NCT00934544|20741021|P3|Primary Endpoint Analysis (Interim)|Adverse Event|0
5998361|NCT00934544|20741022|P2|Primary Endpoint Analysis (Interim)|Adverse Event|4
5998362|NCT00934544|20741023|P1|Primary Endpoint Analysis (Interim)|Adverse Event|12
5998363|NCT00934440|20741059|P1|Overall Study|Lost to Follow-up|1
5998364|NCT00934362|20741075|P2|Overall Study|Adverse Event|0
5998365|NCT00934362|20741076|P1|Overall Study|Adverse Event|1
5998366|NCT00934128|20741126|P2|Second Intervention (2 Hours)|Claustrophobia/anxiety|3
5998367|NCT00934128|20741127|P1|Second Intervention (2 Hours)|Claustrophobia/anxiety|0
5998368|NCT00934128|20741126|P2|Washout Period (1 Hour)|Dyspnea too low to continue|2
5998369|NCT00934128|20741127|P1|Washout Period (1 Hour)|Dyspnea too low to continue|4
5998370|NCT00934128|20741126|P2|Washout Period (1 Hour)|Too tired|0
5998371|NCT00934128|20741127|P1|Washout Period (1 Hour)|Too tired|1
5998372|NCT00934128|20741126|P2|Washout Period (1 Hour)|Pain|0
5998373|NCT00934128|20741127|P1|Washout Period (1 Hour)|Pain|1
5998374|NCT00934128|20741126|P2|Washout Period (1 Hour)|Patient preference|3
5998375|NCT00934128|20741127|P1|Washout Period (1 Hour)|Patient preference|1
5998376|NCT00934128|20741126|P2|First Intervention (2 Hours)|Treatment Delivery Order Switched|0
5998377|NCT00934128|20741127|P1|First Intervention (2 Hours)|Treatment Delivery Order Switched|1
5998378|NCT00934128|20741126|P2|First Intervention (2 Hours)|Adverse Event|1
5998379|NCT00934128|20741127|P1|First Intervention (2 Hours)|Adverse Event|4
5998380|NCT00934128|20741126|P2|First Intervention (2 Hours)|Withdrawal by Subject|1
5998381|NCT00934128|20741127|P1|First Intervention (2 Hours)|Withdrawal by Subject|0
5998382|NCT00934102|20741135|P3|Period 1, One Night of Wear|Personal Reasons|0
5998383|NCT00934102|20741136|P2|Period 1, One Night of Wear|Personal Reasons|0
5998384|NCT00934102|20741137|P1|Period 1, One Night of Wear|Personal Reasons|1
5998385|NCT00934050|20741151|P6|Enrolled After 15 Dec 2009|Withdrawal by Subject|2
5998386|NCT00934050|20741152|P5|Enrolled After 15 Dec 2009|Withdrawal by Subject|4
5998387|NCT00934050|20741153|P4|Enrolled After 15 Dec 2009|Withdrawal by Subject|0
5998388|NCT00934050|20741154|P3|Enrolled After 15 Dec 2009|Withdrawal by Subject|0
5998389|NCT00934050|20741155|P2|Enrolled After 15 Dec 2009|Withdrawal by Subject|0
5998390|NCT00934050|20741156|P1|Enrolled After 15 Dec 2009|Withdrawal by Subject|0
5998391|NCT00934050|20741151|P6|Enrolled After 15 Dec 2009|Lost to Follow-up|1
5998392|NCT00934050|20741152|P5|Enrolled After 15 Dec 2009|Lost to Follow-up|0
5998393|NCT00934050|20741153|P4|Enrolled After 15 Dec 2009|Lost to Follow-up|0
5998394|NCT00934050|20741154|P3|Enrolled After 15 Dec 2009|Lost to Follow-up|0
5998395|NCT00934050|20741155|P2|Enrolled After 15 Dec 2009|Lost to Follow-up|0
5998396|NCT00934050|20741156|P1|Enrolled After 15 Dec 2009|Lost to Follow-up|0
5998397|NCT00934050|20741151|P6|Enrolled After 15 Dec 2009|Death|1
5998398|NCT00934050|20741152|P5|Enrolled After 15 Dec 2009|Death|0
5998399|NCT00934050|20741153|P4|Enrolled After 15 Dec 2009|Death|0
5998400|NCT00934050|20741154|P3|Enrolled After 15 Dec 2009|Death|0
5998401|NCT00934050|20741155|P2|Enrolled After 15 Dec 2009|Death|0
5998402|NCT00934050|20741156|P1|Enrolled After 15 Dec 2009|Death|0
5998403|NCT00934050|20741151|P6|Enrolled After 15 Dec 2009|Adverse Event|0
5998404|NCT00934050|20741152|P5|Enrolled After 15 Dec 2009|Adverse Event|3
5998405|NCT00934050|20741153|P4|Enrolled After 15 Dec 2009|Adverse Event|0
5998406|NCT00934050|20741154|P3|Enrolled After 15 Dec 2009|Adverse Event|0
5998407|NCT00934050|20741155|P2|Enrolled After 15 Dec 2009|Adverse Event|0
5998408|NCT00934050|20741156|P1|Enrolled After 15 Dec 2009|Adverse Event|0
5998409|NCT00934050|20741151|P6|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0
5998410|NCT00934050|20741152|P5|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0
5998411|NCT00934050|20741153|P4|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0
5998412|NCT00934050|20741154|P3|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|1
5998413|NCT00934050|20741155|P2|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0
5998414|NCT00934050|20741156|P1|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0
5998415|NCT00934050|20741151|P6|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0
5998416|NCT00934050|20741152|P5|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0
5998417|NCT00934050|20741153|P4|Enrolled Prior to 15 Dec 2009|Sponsor Decision|13
5998418|NCT00934050|20741154|P3|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11
5998419|NCT00934050|20741155|P2|Enrolled Prior to 15 Dec 2009|Sponsor Decision|12
5998420|NCT00934050|20741156|P1|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11
5998421|NCT00934050|20741151|P6|Enrolled Prior to 15 Dec 2009|Adverse Event|0
5998422|NCT00934050|20741152|P5|Enrolled Prior to 15 Dec 2009|Adverse Event|0
5998423|NCT00934050|20741153|P4|Enrolled Prior to 15 Dec 2009|Adverse Event|1
5998424|NCT00934050|20741154|P3|Enrolled Prior to 15 Dec 2009|Adverse Event|0
5998425|NCT00934050|20741155|P2|Enrolled Prior to 15 Dec 2009|Adverse Event|0
5998426|NCT00934050|20741156|P1|Enrolled Prior to 15 Dec 2009|Adverse Event|1
5998427|NCT00933933|20741179|P3|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0
5998428|NCT00933933|20741180|P2|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|2
5998429|NCT00933933|20741181|P1|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0
5998430|NCT00933933|20741179|P3|General Population From 16 to 89 Years|Did not meet criteria for analysis|0
5998431|NCT00933933|20741180|P2|General Population From 16 to 89 Years|Did not meet criteria for analysis|20
5998432|NCT00933933|20741181|P1|General Population From 16 to 89 Years|Did not meet criteria for analysis|0
5998433|NCT00933686|20741199|P2|Overall Study|Failure to show up at endpoint visits|2
5998434|NCT00933686|20741200|P1|Overall Study|Failure to show up at endpoint visits|0
5998435|NCT00933686|20741199|P2|Overall Study|Physician Decision|0
5998436|NCT00933686|20741200|P1|Overall Study|Physician Decision|1
5998437|NCT00933686|20741199|P2|Overall Study|Adverse Event|1
5998438|NCT00933686|20741200|P1|Overall Study|Adverse Event|1
5998439|NCT00933686|20741199|P2|Overall Study|Withdrawal by Subject|5
5998440|NCT00933686|20741200|P1|Overall Study|Withdrawal by Subject|6
5998441|NCT00933686|20741199|P2|Overall Study|Lost to Follow-up|2
5998442|NCT00933686|20741200|P1|Overall Study|Lost to Follow-up|2
5998443|NCT00933686|20741199|P2|Overall Study|Protocol Violation|1
5998444|NCT00933686|20741200|P1|Overall Study|Protocol Violation|0
5998445|NCT00933608|20741220|P2|Overall Study|Physician Decision|0
5998446|NCT00933608|20741221|P1|Overall Study|Physician Decision|1
5998447|NCT00933608|20741220|P2|Overall Study|Adverse Event|2
5998448|NCT00933608|20741221|P1|Overall Study|Adverse Event|4
5998449|NCT00933543|20741229|P2|Overall Study|Other|1
5998450|NCT00933543|20741230|P1|Overall Study|Other|1
5998451|NCT00933543|20741229|P2|Overall Study|Lack of Efficacy|3
5998452|NCT00933543|20741230|P1|Overall Study|Lack of Efficacy|0
5998453|NCT00933543|20741229|P2|Overall Study|Withdrawal by Subject|1
5998454|NCT00933543|20741230|P1|Overall Study|Withdrawal by Subject|0
5998455|NCT00933543|20741229|P2|Overall Study|Lost to Follow-up|1
5998456|NCT00933543|20741230|P1|Overall Study|Lost to Follow-up|0
5998457|NCT00933543|20741229|P2|Overall Study|Adverse Event|1
5998458|NCT00933543|20741230|P1|Overall Study|Adverse Event|2
5998459|NCT00933335|20741299|P2|Overall Study|Co-morbid Illness|0
5998460|NCT00933335|20741300|P1|Overall Study|Co-morbid Illness|1
5998461|NCT00933335|20741299|P2|Overall Study|Didn't Meet Criteria for TST/I 131 TST|1
5998462|NCT00933335|20741300|P1|Overall Study|Didn't Meet Criteria for TST/I 131 TST|0
5998463|NCT00933335|20741299|P2|Overall Study|Progressive Disease|11
5998464|NCT00933335|20741300|P1|Overall Study|Progressive Disease|0
5998465|NCT00933335|20741299|P2|Overall Study|Withdrawal by Subject|1
5998466|NCT00933335|20741300|P1|Overall Study|Withdrawal by Subject|0
5998467|NCT00933335|20741299|P2|Overall Study|Lost to Follow-up|3
5998468|NCT00933335|20741300|P1|Overall Study|Lost to Follow-up|1
5998469|NCT00933270|20741370|P1|Overall Study|Moved or would not return|10
5998470|NCT00933270|20741370|P1|Overall Study|Death|24
5998471|NCT00933270|20741370|P1|Overall Study|Missed Visit|2
5998472|NCT00933270|20741370|P1|Overall Study|Adverse Event|1
5998473|NCT00933270|20741370|P1|Overall Study|Lost to Follow-up|14
5998474|NCT00933270|20741370|P1|Overall Study|Insufficient Follow-up|10
5998475|NCT00933270|20741370|P1|Overall Study|Withdrawal by Subject|26
5998476|NCT00933244|20741464|P3|Overall Study|Withdrawal by Subject|3
5998477|NCT00933244|20741465|P2|Overall Study|Withdrawal by Subject|1
5998478|NCT00933244|20741466|P1|Overall Study|Withdrawal by Subject|5
5998479|NCT00933166|20741483|P1|Overall Study|Withdrawal by Subject|1
5998480|NCT00933166|20741483|P1|Overall Study|Unavailable|4
5998481|NCT00933166|20741483|P1|Overall Study|Lack of Efficacy|9
5998482|NCT00933166|20741483|P1|Overall Study|Lost to Follow-up|4
5998483|NCT00932893|20741489|P2|Overall Study|Other|144
5998484|NCT00932893|20741490|P1|Overall Study|Other|5
5998485|NCT00932893|20741489|P2|Overall Study|Withdrawal by Subject|2
5998486|NCT00932893|20741490|P1|Overall Study|Withdrawal by Subject|5
5998487|NCT00932893|20741489|P2|Overall Study|Lost to Follow-up|0
5998488|NCT00932893|20741490|P1|Overall Study|Lost to Follow-up|8
5998489|NCT00932893|20741489|P2|Overall Study|Death|24
5998490|NCT00932893|20741490|P1|Overall Study|Death|115
5998491|NCT00932698|20741538|P11|Part 2 (Dose Expansion)|Adverse Event|0
5998492|NCT00932698|20741539|P10|Part 2 (Dose Expansion)|Adverse Event|1
5998493|NCT00932698|20741540|P9|Part 2 (Dose Expansion)|Adverse Event|1
5998494|NCT00932698|20741541|P8|Part 2 (Dose Expansion)|Adverse Event|5
5998495|NCT00932698|20741542|P7|Part 2 (Dose Expansion)|Adverse Event|0
5998496|NCT00932698|20741543|P6|Part 2 (Dose Expansion)|Adverse Event|0
5998497|NCT00932698|20741544|P5|Part 2 (Dose Expansion)|Adverse Event|0
5998498|NCT00932698|20741545|P4|Part 2 (Dose Expansion)|Adverse Event|0
5998499|NCT00932698|20741546|P3|Part 2 (Dose Expansion)|Adverse Event|0
5998500|NCT00932698|20741547|P2|Part 2 (Dose Expansion)|Adverse Event|0
5998501|NCT00932698|20741548|P1|Part 2 (Dose Expansion)|Adverse Event|0
5998502|NCT00932698|20741538|P11|Part 2 (Dose Expansion)|Withdrawal by Subject|0
5998503|NCT00932698|20741539|P10|Part 2 (Dose Expansion)|Withdrawal by Subject|2
5998504|NCT00932698|20741540|P9|Part 2 (Dose Expansion)|Withdrawal by Subject|3
5998505|NCT00932698|20741541|P8|Part 2 (Dose Expansion)|Withdrawal by Subject|1
5998506|NCT00932698|20741542|P7|Part 2 (Dose Expansion)|Withdrawal by Subject|0
5998507|NCT00932698|20741543|P6|Part 2 (Dose Expansion)|Withdrawal by Subject|0
5998508|NCT00932698|20741544|P5|Part 2 (Dose Expansion)|Withdrawal by Subject|0
5998509|NCT00932698|20741545|P4|Part 2 (Dose Expansion)|Withdrawal by Subject|0
5998510|NCT00932698|20741546|P3|Part 2 (Dose Expansion)|Withdrawal by Subject|0
5998511|NCT00932698|20741547|P2|Part 2 (Dose Expansion)|Withdrawal by Subject|0
5998512|NCT00932698|20741548|P1|Part 2 (Dose Expansion)|Withdrawal by Subject|0
5998513|NCT00932698|20741538|P11|Part 2 (Dose Expansion)|Progressive Disease|2
5998514|NCT00932698|20741539|P10|Part 2 (Dose Expansion)|Progressive Disease|3
5998515|NCT00932698|20741540|P9|Part 2 (Dose Expansion)|Progressive Disease|8
5998516|NCT00932698|20741541|P8|Part 2 (Dose Expansion)|Progressive Disease|14
5998517|NCT00932698|20741542|P7|Part 2 (Dose Expansion)|Progressive Disease|0
5998518|NCT00932698|20741543|P6|Part 2 (Dose Expansion)|Progressive Disease|0
5998519|NCT00932698|20741544|P5|Part 2 (Dose Expansion)|Progressive Disease|0
5998520|NCT00932698|20741545|P4|Part 2 (Dose Expansion)|Progressive Disease|0
5998521|NCT00932698|20741546|P3|Part 2 (Dose Expansion)|Progressive Disease|0
5998522|NCT00932698|20741547|P2|Part 2 (Dose Expansion)|Progressive Disease|0
5998523|NCT00932698|20741548|P1|Part 2 (Dose Expansion)|Progressive Disease|0
5998524|NCT00932698|20741538|P11|Part 1 (Dose Escalation)|Other|0
5998525|NCT00932698|20741539|P10|Part 1 (Dose Escalation)|Other|0
5998526|NCT00932698|20741540|P9|Part 1 (Dose Escalation)|Other|0
5998527|NCT00932698|20741541|P8|Part 1 (Dose Escalation)|Other|0
5998528|NCT00932698|20741542|P7|Part 1 (Dose Escalation)|Other|1
5998529|NCT00932698|20741543|P6|Part 1 (Dose Escalation)|Other|0
5998530|NCT00932698|20741544|P5|Part 1 (Dose Escalation)|Other|0
5998531|NCT00932698|20741545|P4|Part 1 (Dose Escalation)|Other|0
5998532|NCT00932698|20741546|P3|Part 1 (Dose Escalation)|Other|1
5998533|NCT00932698|20741547|P2|Part 1 (Dose Escalation)|Other|0
5998534|NCT00932698|20741548|P1|Part 1 (Dose Escalation)|Other|0
5998535|NCT00932698|20741538|P11|Part 1 (Dose Escalation)|Adverse Event|0
5998536|NCT00932698|20741539|P10|Part 1 (Dose Escalation)|Adverse Event|0
5998537|NCT00932698|20741540|P9|Part 1 (Dose Escalation)|Adverse Event|0
5998538|NCT00932698|20741541|P8|Part 1 (Dose Escalation)|Adverse Event|0
5998539|NCT00932698|20741542|P7|Part 1 (Dose Escalation)|Adverse Event|0
5998540|NCT00932698|20741543|P6|Part 1 (Dose Escalation)|Adverse Event|1
5998541|NCT00932698|20741544|P5|Part 1 (Dose Escalation)|Adverse Event|0
5998542|NCT00932698|20741545|P4|Part 1 (Dose Escalation)|Adverse Event|0
5998543|NCT00932698|20741546|P3|Part 1 (Dose Escalation)|Adverse Event|0
5998544|NCT00932698|20741547|P2|Part 1 (Dose Escalation)|Adverse Event|0
5998545|NCT00932698|20741548|P1|Part 1 (Dose Escalation)|Adverse Event|0
5998546|NCT00932698|20741538|P11|Part 1 (Dose Escalation)|Withdrawal by Participant|0
5998547|NCT00932698|20741539|P10|Part 1 (Dose Escalation)|Withdrawal by Participant|0
5998548|NCT00932698|20741540|P9|Part 1 (Dose Escalation)|Withdrawal by Participant|0
5998549|NCT00932698|20741541|P8|Part 1 (Dose Escalation)|Withdrawal by Participant|0
5998550|NCT00932698|20741542|P7|Part 1 (Dose Escalation)|Withdrawal by Participant|1
5998551|NCT00932698|20741543|P6|Part 1 (Dose Escalation)|Withdrawal by Participant|1
5998552|NCT00932698|20741544|P5|Part 1 (Dose Escalation)|Withdrawal by Participant|0
5998553|NCT00932698|20741545|P4|Part 1 (Dose Escalation)|Withdrawal by Participant|1
5998554|NCT00932698|20741546|P3|Part 1 (Dose Escalation)|Withdrawal by Participant|0
5998555|NCT00932698|20741547|P2|Part 1 (Dose Escalation)|Withdrawal by Participant|1
5998556|NCT00932698|20741548|P1|Part 1 (Dose Escalation)|Withdrawal by Participant|0
5998557|NCT00932698|20741538|P11|Part 1 (Dose Escalation)|Progressive Disease|0
5998558|NCT00932698|20741539|P10|Part 1 (Dose Escalation)|Progressive Disease|0
5998559|NCT00932698|20741540|P9|Part 1 (Dose Escalation)|Progressive Disease|0
5998560|NCT00932698|20741541|P8|Part 1 (Dose Escalation)|Progressive Disease|0
5998561|NCT00932698|20741542|P7|Part 1 (Dose Escalation)|Progressive Disease|2
5998562|NCT00932698|20741543|P6|Part 1 (Dose Escalation)|Progressive Disease|5
5998563|NCT00932698|20741544|P5|Part 1 (Dose Escalation)|Progressive Disease|3
5998564|NCT00932698|20741545|P4|Part 1 (Dose Escalation)|Progressive Disease|2
5998565|NCT00932698|20741546|P3|Part 1 (Dose Escalation)|Progressive Disease|2
5998566|NCT00932698|20741547|P2|Part 1 (Dose Escalation)|Progressive Disease|2
5998567|NCT00932698|20741548|P1|Part 1 (Dose Escalation)|Progressive Disease|3
5998568|NCT00932646|20741722|P4|Overall Study|Withdrawal by Subject|0
5998569|NCT00932646|20741723|P3|Overall Study|Withdrawal by Subject|3
5998570|NCT00932646|20741724|P2|Overall Study|Withdrawal by Subject|1
5998571|NCT00932646|20741725|P1|Overall Study|Withdrawal by Subject|1
5998572|NCT00932646|20741722|P4|Overall Study|Lost to Follow-up|0
5998573|NCT00932646|20741723|P3|Overall Study|Lost to Follow-up|0
5998574|NCT00932646|20741724|P2|Overall Study|Lost to Follow-up|1
5998575|NCT00932646|20741725|P1|Overall Study|Lost to Follow-up|2
5998576|NCT00932646|20741722|P4|Overall Study|Adverse Event|1
5998577|NCT00932646|20741723|P3|Overall Study|Adverse Event|1
5998578|NCT00932646|20741724|P2|Overall Study|Adverse Event|1
5998579|NCT00932646|20741725|P1|Overall Study|Adverse Event|2
5998580|NCT00932451|20741812|P1|Overall Study|Other reasons|5
5998581|NCT00932451|20741812|P1|Overall Study|Death|726
5998582|NCT00932451|20741812|P1|Overall Study|Lost to Follow-up|22
5998583|NCT00932451|20741812|P1|Overall Study|Withdrawal by Subject|69
5998584|NCT00932425|20741836|P2|Overall Study|Withdrawal by Subject|1
5998585|NCT00932425|20741837|P1|Overall Study|Withdrawal by Subject|0
5998586|NCT00932425|20741836|P2|Overall Study|Lost to Follow-up|1
5998587|NCT00932425|20741837|P1|Overall Study|Lost to Follow-up|0
5998588|NCT00932373|20741870|P11|Overall Study|Lack of Efficacy|0
5998589|NCT00932373|20741871|P10|Overall Study|Lack of Efficacy|1
5998590|NCT00932373|20741872|P9|Overall Study|Lack of Efficacy|0
5998591|NCT00932373|20741873|P8|Overall Study|Lack of Efficacy|0
5998592|NCT00932373|20741874|P7|Overall Study|Lack of Efficacy|0
5998593|NCT00932373|20741875|P6|Overall Study|Lack of Efficacy|0
5998594|NCT00932373|20741876|P5|Overall Study|Lack of Efficacy|0
5998595|NCT00932373|20741877|P4|Overall Study|Lack of Efficacy|0
5998596|NCT00932373|20741878|P3|Overall Study|Lack of Efficacy|0
5998597|NCT00932373|20741879|P2|Overall Study|Lack of Efficacy|0
5998598|NCT00932373|20741880|P1|Overall Study|Lack of Efficacy|0
5998599|NCT00932373|20741870|P11|Overall Study|Clinical progression|0
5998600|NCT00932373|20741871|P10|Overall Study|Clinical progression|0
5998601|NCT00932373|20741872|P9|Overall Study|Clinical progression|0
5998602|NCT00932373|20741873|P8|Overall Study|Clinical progression|0
5998603|NCT00932373|20741874|P7|Overall Study|Clinical progression|1
5998604|NCT00932373|20741875|P6|Overall Study|Clinical progression|0
5998605|NCT00932373|20741876|P5|Overall Study|Clinical progression|0
5998606|NCT00932373|20741877|P4|Overall Study|Clinical progression|0
5998607|NCT00932373|20741878|P3|Overall Study|Clinical progression|0
5998608|NCT00932373|20741879|P2|Overall Study|Clinical progression|0
5998609|NCT00932373|20741880|P1|Overall Study|Clinical progression|0
5998610|NCT00932373|20741870|P11|Overall Study|Withdrawal by Subject|0
5998611|NCT00932373|20741871|P10|Overall Study|Withdrawal by Subject|0
5998612|NCT00932373|20741872|P9|Overall Study|Withdrawal by Subject|1
5998613|NCT00932373|20741873|P8|Overall Study|Withdrawal by Subject|0
5998614|NCT00932373|20741874|P7|Overall Study|Withdrawal by Subject|0
5998615|NCT00932373|20741875|P6|Overall Study|Withdrawal by Subject|0
5998616|NCT00932373|20741876|P5|Overall Study|Withdrawal by Subject|0
5998617|NCT00932373|20741877|P4|Overall Study|Withdrawal by Subject|0
5998618|NCT00932373|20741878|P3|Overall Study|Withdrawal by Subject|0
5998619|NCT00932373|20741879|P2|Overall Study|Withdrawal by Subject|0
5998620|NCT00932373|20741880|P1|Overall Study|Withdrawal by Subject|0
5998621|NCT00932373|20741870|P11|Overall Study|Dose limiting toxicity|0
5998622|NCT00932373|20741871|P10|Overall Study|Dose limiting toxicity|0
5998623|NCT00932373|20741872|P9|Overall Study|Dose limiting toxicity|0
5998624|NCT00932373|20741873|P8|Overall Study|Dose limiting toxicity|0
5998625|NCT00932373|20741874|P7|Overall Study|Dose limiting toxicity|0
5998626|NCT00932373|20741875|P6|Overall Study|Dose limiting toxicity|1
5998627|NCT00932373|20741876|P5|Overall Study|Dose limiting toxicity|0
5998628|NCT00932373|20741877|P4|Overall Study|Dose limiting toxicity|0
5998629|NCT00932373|20741878|P3|Overall Study|Dose limiting toxicity|0
5998630|NCT00932373|20741879|P2|Overall Study|Dose limiting toxicity|0
5998631|NCT00932373|20741880|P1|Overall Study|Dose limiting toxicity|0
5998632|NCT00932373|20741870|P11|Overall Study|Physician Decision|0
5998633|NCT00932373|20741871|P10|Overall Study|Physician Decision|1
5998634|NCT00932373|20741872|P9|Overall Study|Physician Decision|0
5998635|NCT00932373|20741873|P8|Overall Study|Physician Decision|0
5998636|NCT00932373|20741874|P7|Overall Study|Physician Decision|0
5998637|NCT00932373|20741875|P6|Overall Study|Physician Decision|0
5998638|NCT00932373|20741876|P5|Overall Study|Physician Decision|2
5998639|NCT00932373|20741877|P4|Overall Study|Physician Decision|0
5998640|NCT00932373|20741878|P3|Overall Study|Physician Decision|1
5998641|NCT00932373|20741879|P2|Overall Study|Physician Decision|0
5998642|NCT00932373|20741880|P1|Overall Study|Physician Decision|0
5998643|NCT00932373|20741870|P11|Overall Study|Adverse Event|1
5998644|NCT00932373|20741871|P10|Overall Study|Adverse Event|2
5998645|NCT00932373|20741872|P9|Overall Study|Adverse Event|0
5998646|NCT00932373|20741873|P8|Overall Study|Adverse Event|1
5998647|NCT00932373|20741874|P7|Overall Study|Adverse Event|0
5998648|NCT00932373|20741875|P6|Overall Study|Adverse Event|1
5998649|NCT00932373|20741876|P5|Overall Study|Adverse Event|2
5998650|NCT00932373|20741877|P4|Overall Study|Adverse Event|0
5998651|NCT00932373|20741878|P3|Overall Study|Adverse Event|0
5998652|NCT00932373|20741879|P2|Overall Study|Adverse Event|0
5998653|NCT00932373|20741880|P1|Overall Study|Adverse Event|0
5998654|NCT00932373|20741870|P11|Overall Study|Progressive disease|2
5998655|NCT00932373|20741871|P10|Overall Study|Progressive disease|9
5998656|NCT00932373|20741872|P9|Overall Study|Progressive disease|1
5998657|NCT00932373|20741873|P8|Overall Study|Progressive disease|2
5998658|NCT00932373|20741874|P7|Overall Study|Progressive disease|0
5998659|NCT00932373|20741875|P6|Overall Study|Progressive disease|1
5998660|NCT00932373|20741876|P5|Overall Study|Progressive disease|10
5998661|NCT00932373|20741877|P4|Overall Study|Progressive disease|0
5998662|NCT00932373|20741878|P3|Overall Study|Progressive disease|0
5998663|NCT00932373|20741879|P2|Overall Study|Progressive disease|1
5998664|NCT00932373|20741880|P1|Overall Study|Progressive disease|3
5998665|NCT00932360|20741980|P6|Washout (One Week)|Withdrawal by Subject|0
5998666|NCT00932360|20741981|P5|Washout (One Week)|Withdrawal by Subject|2
5998667|NCT00932360|20741982|P4|Washout (One Week)|Withdrawal by Subject|0
5998668|NCT00932360|20741983|P3|Washout (One Week)|Withdrawal by Subject|0
5998669|NCT00932360|20741984|P2|Washout (One Week)|Withdrawal by Subject|0
5998670|NCT00932360|20741985|P1|Washout (One Week)|Withdrawal by Subject|0
5998671|NCT00932165|20742042|P1|Overall Study|Lost to Follow-up|1
5998672|NCT00932126|20742066|P8|Overall Study|Other|2
5998673|NCT00932126|20742067|P7|Overall Study|Other|1
5998674|NCT00932126|20742068|P6|Overall Study|Other|0
5998675|NCT00932126|20742069|P5|Overall Study|Other|1
5998676|NCT00932126|20742070|P4|Overall Study|Other|0
5998677|NCT00932126|20742071|P3|Overall Study|Other|0
5998678|NCT00932126|20742072|P2|Overall Study|Other|0
5998679|NCT00932126|20742073|P1|Overall Study|Other|0
5998680|NCT00932126|20742066|P8|Overall Study|Objective progression or relapse|5
5998681|NCT00932126|20742067|P7|Overall Study|Objective progression or relapse|3
5998682|NCT00932126|20742068|P6|Overall Study|Objective progression or relapse|3
5998683|NCT00932126|20742069|P5|Overall Study|Objective progression or relapse|3
5998684|NCT00932126|20742070|P4|Overall Study|Objective progression or relapse|3
5998685|NCT00932126|20742071|P3|Overall Study|Objective progression or relapse|2
5998686|NCT00932126|20742072|P2|Overall Study|Objective progression or relapse|3
5998687|NCT00932126|20742073|P1|Overall Study|Objective progression or relapse|3
5998688|NCT00932126|20742066|P8|Overall Study|Withdrawal by Subject|1
5998689|NCT00932126|20742067|P7|Overall Study|Withdrawal by Subject|0
5998690|NCT00932126|20742068|P6|Overall Study|Withdrawal by Subject|0
5998691|NCT00932126|20742069|P5|Overall Study|Withdrawal by Subject|0
5998692|NCT00932126|20742070|P4|Overall Study|Withdrawal by Subject|0
5998693|NCT00932126|20742071|P3|Overall Study|Withdrawal by Subject|1
5998694|NCT00932126|20742072|P2|Overall Study|Withdrawal by Subject|0
5998695|NCT00932126|20742073|P1|Overall Study|Withdrawal by Subject|0
5998696|NCT00932126|20742066|P8|Overall Study|Protocol Violation|0
5998697|NCT00932126|20742067|P7|Overall Study|Protocol Violation|0
5998698|NCT00932126|20742068|P6|Overall Study|Protocol Violation|0
5998699|NCT00932126|20742069|P5|Overall Study|Protocol Violation|1
5998700|NCT00932126|20742070|P4|Overall Study|Protocol Violation|0
5998701|NCT00932126|20742071|P3|Overall Study|Protocol Violation|0
5998702|NCT00932126|20742072|P2|Overall Study|Protocol Violation|0
5998703|NCT00932126|20742073|P1|Overall Study|Protocol Violation|0
5998704|NCT00932126|20742066|P8|Overall Study|Adverse Event|2
5998705|NCT00932126|20742067|P7|Overall Study|Adverse Event|1
5998706|NCT00932126|20742068|P6|Overall Study|Adverse Event|0
5998707|NCT00932126|20742069|P5|Overall Study|Adverse Event|0
5998708|NCT00932126|20742070|P4|Overall Study|Adverse Event|0
5998709|NCT00932126|20742071|P3|Overall Study|Adverse Event|0
5998710|NCT00932126|20742072|P2|Overall Study|Adverse Event|0
5998711|NCT00932126|20742073|P1|Overall Study|Adverse Event|0
5998712|NCT00932113|20742111|P2|Overall Study|Lost to Follow-up|0
5998713|NCT00932113|20742112|P1|Overall Study|Lost to Follow-up|1
5998714|NCT00931918|20742164|P2|Overall Study|Did not receive study drug|2
5998715|NCT00931918|20742165|P1|Overall Study|Did not receive study drug|3
5998716|NCT00931918|20742164|P2|Overall Study|Other Reason not Specified|4
5998717|NCT00931918|20742165|P1|Overall Study|Other Reason not Specified|4
5998718|NCT00931918|20742164|P2|Overall Study|Withdrawal by Patient|4
5998719|NCT00931918|20742165|P1|Overall Study|Withdrawal by Patient|3
5998720|NCT00931918|20742164|P2|Overall Study|Symptomatic Deterioration|0
5998721|NCT00931918|20742165|P1|Overall Study|Symptomatic Deterioration|1
5998722|NCT00931918|20742164|P2|Overall Study|Progressive Disease|1
5998723|NCT00931918|20742165|P1|Overall Study|Progressive Disease|2
5998724|NCT00931918|20742164|P2|Overall Study|Adverse Event|6
5998725|NCT00931918|20742165|P1|Overall Study|Adverse Event|4
5998726|NCT00931801|20742217|P3|Overall Study|Confirmed Virologic Failure|3
5998727|NCT00931801|20742218|P2|Overall Study|Confirmed Virologic Failure|0
5998728|NCT00931801|20742219|P1|Overall Study|Confirmed Virologic Failure|0
5998729|NCT00931801|20742217|P3|Overall Study|Withdrawal by Subject|0
5998730|NCT00931801|20742218|P2|Overall Study|Withdrawal by Subject|0
5998731|NCT00931801|20742219|P1|Overall Study|Withdrawal by Subject|1
5998732|NCT00931801|20742217|P3|Overall Study|Lost to Follow-up|0
5998733|NCT00931801|20742218|P2|Overall Study|Lost to Follow-up|1
5998734|NCT00931801|20742219|P1|Overall Study|Lost to Follow-up|0
5998735|NCT00931801|20742217|P3|Overall Study|Adverse Event|1
5998736|NCT00931801|20742218|P2|Overall Study|Adverse Event|0
5998737|NCT00931801|20742219|P1|Overall Study|Adverse Event|0
5998738|NCT00931723|20742242|P2|Overall Study|Late hospital discharge|0
5998739|NCT00931723|20742243|P1|Overall Study|Late hospital discharge|1
5998740|NCT00931723|20742242|P2|Overall Study|Sponsor decision|0
5998741|NCT00931723|20742243|P1|Overall Study|Sponsor decision|1
5998742|NCT00931723|20742242|P2|Overall Study|Lack or insufficient theraputic response|5
5998743|NCT00931723|20742243|P1|Overall Study|Lack or insufficient theraputic response|2
5998744|NCT00931723|20742242|P2|Overall Study|Took prohibited concomitant medication|1
5998745|NCT00931723|20742243|P1|Overall Study|Took prohibited concomitant medication|0
5998746|NCT00931723|20742242|P2|Overall Study|Safety reasons|1
5998747|NCT00931723|20742243|P1|Overall Study|Safety reasons|0
5998748|NCT00931723|20742242|P2|Overall Study|Severe non-compliance to protocol|0
5998749|NCT00931723|20742243|P1|Overall Study|Severe non-compliance to protocol|2
5998750|NCT00931723|20742242|P2|Overall Study|Study-specific discontinuation criteria|1
5998751|NCT00931723|20742243|P1|Overall Study|Study-specific discontinuation criteria|1
5998752|NCT00931723|20742242|P2|Overall Study|Lost to Follow-up|2
5998753|NCT00931723|20742243|P1|Overall Study|Lost to Follow-up|1
5998754|NCT00931723|20742242|P2|Overall Study|Condition under investigation worsened|2
5998755|NCT00931723|20742243|P1|Overall Study|Condition under investigation worsened|1
5998756|NCT00931723|20742242|P2|Overall Study|Lithium found in blood|1
5998757|NCT00931723|20742243|P1|Overall Study|Lithium found in blood|0
5998758|NCT00931723|20742242|P2|Overall Study|Adverse Event|13
5998759|NCT00931723|20742243|P1|Overall Study|Adverse Event|6
5998760|NCT00931723|20742242|P2|Overall Study|Withdrawal by Subject|13
5998761|NCT00931723|20742243|P1|Overall Study|Withdrawal by Subject|11
5998762|NCT00931710|20742291|P2|Overall Study|Protocol deviation|2
5998763|NCT00931710|20742292|P1|Overall Study|Protocol deviation|1
5998764|NCT00931710|20742291|P2|Overall Study|Lost to Follow-up|5
5998765|NCT00931710|20742292|P1|Overall Study|Lost to Follow-up|6
5998766|NCT00931710|20742291|P2|Overall Study|Patient withdrew consent|9
5998767|NCT00931710|20742292|P1|Overall Study|Patient withdrew consent|4
5998768|NCT00931710|20742291|P2|Overall Study|Unsatisfactory therapeutic effects|12
5998769|NCT00931710|20742292|P1|Overall Study|Unsatisfactory therapeutic effects|5
5998770|NCT00931710|20742291|P2|Overall Study|Abnormal test procedure results|0
5998771|NCT00931710|20742292|P1|Overall Study|Abnormal test procedure results|2
5998772|NCT00931710|20742291|P2|Overall Study|Adverse Event|10
5998773|NCT00931710|20742292|P1|Overall Study|Adverse Event|16
5998774|NCT00931632|20742310|P2|Overall Study|Adverse Event|15
5998775|NCT00931632|20742311|P1|Overall Study|Adverse Event|19
5998776|NCT00931632|20742310|P2|Overall Study|Withdrawal by Subject|3
5998777|NCT00931632|20742311|P1|Overall Study|Withdrawal by Subject|2
5998778|NCT00931528|20742333|P2|Overall Study|Assessment outside of Time Frame|23
5998779|NCT00931528|20742334|P1|Overall Study|Assessment outside of Time Frame|22
5998780|NCT00931528|20742333|P2|Overall Study|Lost to Follow-up|13
5998781|NCT00931528|20742334|P1|Overall Study|Lost to Follow-up|6
5998782|NCT00931528|20742333|P2|Overall Study|Withdrawal by Subject|12
5998783|NCT00931528|20742334|P1|Overall Study|Withdrawal by Subject|4
5998784|NCT00931528|20742333|P2|Overall Study|Protocol Violation|12
5998785|NCT00931528|20742334|P1|Overall Study|Protocol Violation|9
5998786|NCT00931515|20742354|P2|Overall Study|Lost to Follow-up|5
5998787|NCT00931515|20742355|P1|Overall Study|Lost to Follow-up|2
5998788|NCT00931463|20742385|P2|Overall Study|Lost to Follow-up|1
5998789|NCT00931463|20742386|P1|Overall Study|Lost to Follow-up|4
5998790|NCT00931463|20742385|P2|Overall Study|Withdrawal by Subject|0
5998791|NCT00931463|20742386|P1|Overall Study|Withdrawal by Subject|5
5998792|NCT00931463|20742385|P2|Overall Study|Death|4
5998793|NCT00931463|20742386|P1|Overall Study|Death|8
5998794|NCT00931411|20742402|P2|After Crossover - 14 Days (up to Day 56)|Adverse Event|1
5998795|NCT00931411|20742403|P1|After Crossover - 14 Days (up to Day 56)|Adverse Event|0
5998796|NCT00931411|20742402|P2|First Intervention - 42 Days|Lost to Follow-up|0
5998797|NCT00931411|20742403|P1|First Intervention - 42 Days|Lost to Follow-up|2
5998798|NCT00931411|20742402|P2|First Intervention - 42 Days|Adverse Event|3
5998799|NCT00931411|20742403|P1|First Intervention - 42 Days|Adverse Event|2
5998800|NCT00931385|20742424|P4|Overall Study|Lost to Follow-up|1
5998801|NCT00931385|20742425|P3|Overall Study|Lost to Follow-up|0
5998802|NCT00931385|20742426|P2|Overall Study|Lost to Follow-up|0
5998803|NCT00931385|20742427|P1|Overall Study|Lost to Follow-up|0
5998804|NCT00931385|20742424|P4|Overall Study|Withdrawal by Subject|1
5998805|NCT00931385|20742425|P3|Overall Study|Withdrawal by Subject|0
5998806|NCT00931385|20742426|P2|Overall Study|Withdrawal by Subject|1
5998807|NCT00931385|20742427|P1|Overall Study|Withdrawal by Subject|0
5998808|NCT00931385|20742424|P4|Overall Study|Protocol Violation|0
5998809|NCT00931385|20742425|P3|Overall Study|Protocol Violation|1
5998810|NCT00931385|20742426|P2|Overall Study|Protocol Violation|0
5998811|NCT00931385|20742427|P1|Overall Study|Protocol Violation|0
5998812|NCT00931385|20742424|P4|Overall Study|Adverse Event|3
5998813|NCT00931385|20742425|P3|Overall Study|Adverse Event|0
5998814|NCT00931385|20742426|P2|Overall Study|Adverse Event|1
5998815|NCT00931385|20742427|P1|Overall Study|Adverse Event|2
5998816|NCT00931307|20742496|P1|Overall Study|Biomicroscopy|1
5998817|NCT00931307|20742496|P1|Overall Study|Lack of Efficacy|12
5998818|NCT00931268|20742500|P1|Overall Study|Lost to Follow-up|6
5998819|NCT00931255|20742512|P2|Overall Study|Follow up biopsy not done|3
5998820|NCT00931255|20742513|P1|Overall Study|Follow up biopsy not done|2
5998821|NCT00930982|20742550|P2|Overall Study|Withdrawal by Subject|1
5998822|NCT00930982|20742551|P1|Overall Study|Withdrawal by Subject|1
5998823|NCT00930982|20742550|P2|Overall Study|Protocol Violation|5
5998824|NCT00930982|20742551|P1|Overall Study|Protocol Violation|1
5998825|NCT00930982|20742550|P2|Overall Study|Adverse Event|23
5998826|NCT00930982|20742551|P1|Overall Study|Adverse Event|19
5998827|NCT00930969|20742585|P1|Overall Study|Withdrawal by Subject|19
5998828|NCT00930969|20742585|P1|Overall Study|Physician Decision|13
5998829|NCT00930969|20742585|P1|Overall Study|Lost to Follow-up|1
5998830|NCT00930969|20742585|P1|Overall Study|Death|5
5998831|NCT00930930|20742595|P2|Overall Study|patients not compliant|1
5998832|NCT00930930|20742596|P1|Overall Study|patients not compliant|1
5998833|NCT00930930|20742595|P2|Overall Study|excessive lapse btw txs, not eligible|1
5998834|NCT00930930|20742596|P1|Overall Study|excessive lapse btw txs, not eligible|0
5998835|NCT00930930|20742595|P2|Overall Study|Disease progression|3
5998836|NCT00930930|20742596|P1|Overall Study|Disease progression|2
5998837|NCT00930930|20742595|P2|Overall Study|Withdrawal by Subject|1
5998838|NCT00930930|20742596|P1|Overall Study|Withdrawal by Subject|3
5998839|NCT00930930|20742595|P2|Overall Study|Adverse Event|3
5998840|NCT00930930|20742596|P1|Overall Study|Adverse Event|13
5998841|NCT00930930|20742595|P2|Overall Study|Physician Decision|0
5998842|NCT00930930|20742596|P1|Overall Study|Physician Decision|1
5998843|NCT00930930|20742595|P2|Overall Study|Death|0
5998844|NCT00930930|20742596|P1|Overall Study|Death|1
5998845|NCT00930813|20742610|P2|Overall Study|Lost to Follow-up|4
5998846|NCT00930813|20742611|P1|Overall Study|Lost to Follow-up|2
5998847|NCT00930813|20742610|P2|Overall Study|Withdrawal by Subject|5
5998848|NCT00930813|20742611|P1|Overall Study|Withdrawal by Subject|2
5998849|NCT00930813|20742610|P2|Overall Study|Death|5
5998850|NCT00930813|20742611|P1|Overall Study|Death|4
5998851|NCT00930774|20742632|P4|Overall Study|Withdrawal by Subject|0
5998852|NCT00930774|20742633|P3|Overall Study|Withdrawal by Subject|2
5998853|NCT00930774|20742634|P2|Overall Study|Withdrawal by Subject|9
5998854|NCT00930774|20742635|P1|Overall Study|Withdrawal by Subject|1
5998855|NCT00930761|20742675|P2|Overall Study|less than 3 music therapy sessions|3
5998856|NCT00930761|20742676|P1|Overall Study|less than 3 music therapy sessions|0
5998857|NCT00930761|20742675|P2|Overall Study|3 newborns died; 1 mother quit the study|0
5998858|NCT00930761|20742676|P1|Overall Study|3 newborns died; 1 mother quit the study|4
5998859|NCT00930722|20742688|P1|Overall Study|Study terminated by sponsor|2
5998860|NCT00930722|20742688|P1|Overall Study|No longer willing to participate|9
5998861|NCT00930722|20742688|P1|Overall Study|Lost to Follow-up|16
5998862|NCT00930644|20742703|P1|Overall Study|Adverse Event|16
5998863|NCT00930644|20742703|P1|Overall Study|Death|1
5998864|NCT00930644|20742703|P1|Overall Study|Physician Decision|2
5998865|NCT00930644|20742703|P1|Overall Study|Withdrawal by Subject|4
5998866|NCT00930553|20742716|P1|Overall Study|Other than specified above|28
5998867|NCT00930553|20742716|P1|Overall Study|Study terminated by sponsor|24
5998868|NCT00930553|20742716|P1|Overall Study|Death|9
5998869|NCT00930553|20742716|P1|Overall Study|Lost to Follow-up|25
5998870|NCT00930553|20742716|P1|Overall Study|Withdrawal by Subject|88
5998871|NCT00930553|20742716|P1|Overall Study|Pregnancy|1
5998872|NCT00930553|20742716|P1|Overall Study|Protocol Violation|1
5998873|NCT00930553|20742716|P1|Overall Study|Physician Decision|39
5998874|NCT00930553|20742716|P1|Overall Study|Lack of Efficacy|7
5998875|NCT00930553|20742716|P1|Overall Study|Adverse Event|1
5998876|NCT00930176|20742793|P1|Overall Study|Death|1
5998877|NCT00930059|20742800|P2|Overall Study|Adverse Event|6
5998878|NCT00930059|20742801|P1|Overall Study|Adverse Event|1
5998879|NCT00930059|20742800|P2|Overall Study|1 site terminated by sponsor|1
5998880|NCT00930059|20742801|P1|Overall Study|1 site terminated by sponsor|1
5998881|NCT00930059|20742800|P2|Overall Study|Other|0
5998882|NCT00930059|20742801|P1|Overall Study|Other|1
5998883|NCT00930059|20742800|P2|Overall Study|Withdrawal by Subject|4
5998884|NCT00930059|20742801|P1|Overall Study|Withdrawal by Subject|3
5998885|NCT00930059|20742800|P2|Overall Study|Did not meet entrance criteria|1
5998886|NCT00930059|20742801|P1|Overall Study|Did not meet entrance criteria|1
5998887|NCT00930059|20742800|P2|Overall Study|Death|0
5998888|NCT00930059|20742801|P1|Overall Study|Death|1
5998889|NCT00930046|20742831|P2|Overall Study|Wound catheter malfunctioned|2
5998890|NCT00930046|20742832|P1|Overall Study|Wound catheter malfunctioned|1
5998891|NCT00929994|20742840|P1|Overall Study|employment|1
5998892|NCT00929994|20742840|P1|Overall Study|medical issue unrelated to intervention|4
5998893|NCT00929994|20742840|P1|Overall Study|Withdrawal by Subject|1
5998894|NCT00929864|20742859|P2|Overall Study|Non-specified|7
5998895|NCT00929864|20742860|P1|Overall Study|Non-specified|2
5998896|NCT00929864|20742859|P2|Overall Study|Administrative reason by Sponsor|1
5998897|NCT00929864|20742860|P1|Overall Study|Administrative reason by Sponsor|1
5998898|NCT00929864|20742859|P2|Overall Study|Pregnancy|3
5998899|NCT00929864|20742860|P1|Overall Study|Pregnancy|0
5998900|NCT00929864|20742859|P2|Overall Study|Poor or non-compliance|3
5998901|NCT00929864|20742860|P1|Overall Study|Poor or non-compliance|3
5998902|NCT00929864|20742859|P2|Overall Study|No longer met criteria|1
5998903|NCT00929864|20742860|P1|Overall Study|No longer met criteria|2
5998904|NCT00929864|20742859|P2|Overall Study|Withdrawal by Subject|9
5998905|NCT00929864|20742860|P1|Overall Study|Withdrawal by Subject|20
5998906|NCT00929864|20742859|P2|Overall Study|Lost to Follow-up|12
5998907|NCT00929864|20742860|P1|Overall Study|Lost to Follow-up|7
5998908|NCT00929864|20742859|P2|Overall Study|Lack of Efficacy|16
5998909|NCT00929864|20742860|P1|Overall Study|Lack of Efficacy|19
5998910|NCT00929864|20742859|P2|Overall Study|Adverse Event|30
5998911|NCT00929864|20742860|P1|Overall Study|Adverse Event|11
5998912|NCT00929864|20742859|P2|Overall Study|Death|1
5998913|NCT00929864|20742860|P1|Overall Study|Death|1
5998914|NCT00929734|20742916|P2|Overall Study|Withdrawal by Subject|2
5998915|NCT00929734|20742917|P1|Overall Study|Withdrawal by Subject|0
5998916|NCT00929734|20742916|P2|Overall Study|Lost to Follow-up|1
5998917|NCT00929734|20742917|P1|Overall Study|Lost to Follow-up|2
5998918|NCT00929708|20742934|P5|Overall Study|Lost to Follow-up|0
5998919|NCT00929708|20742935|P4|Overall Study|Lost to Follow-up|1
5998920|NCT00929708|20742936|P3|Overall Study|Lost to Follow-up|0
5998921|NCT00929708|20742937|P2|Overall Study|Lost to Follow-up|0
5998922|NCT00929708|20742938|P1|Overall Study|Lost to Follow-up|0
5998923|NCT00929708|20742934|P5|Overall Study|Physician Decision|1
5998924|NCT00929708|20742935|P4|Overall Study|Physician Decision|2
5998925|NCT00929708|20742936|P3|Overall Study|Physician Decision|2
5998926|NCT00929708|20742937|P2|Overall Study|Physician Decision|2
5998927|NCT00929708|20742938|P1|Overall Study|Physician Decision|0
5998928|NCT00929708|20742934|P5|Overall Study|Adverse Event|3
5998929|NCT00929708|20742935|P4|Overall Study|Adverse Event|0
5998930|NCT00929708|20742936|P3|Overall Study|Adverse Event|0
5998931|NCT00929708|20742937|P2|Overall Study|Adverse Event|0
5998932|NCT00929708|20742938|P1|Overall Study|Adverse Event|0
5998933|NCT00929708|20742934|P5|Overall Study|Withdrawal by Subject|1
5998934|NCT00929708|20742935|P4|Overall Study|Withdrawal by Subject|2
5998935|NCT00929708|20742936|P3|Overall Study|Withdrawal by Subject|0
5998936|NCT00929708|20742937|P2|Overall Study|Withdrawal by Subject|0
5998937|NCT00929708|20742938|P1|Overall Study|Withdrawal by Subject|2
5998938|NCT00929708|20742934|P5|Overall Study|Protocol Violation|1
5998939|NCT00929708|20742935|P4|Overall Study|Protocol Violation|1
5998940|NCT00929708|20742936|P3|Overall Study|Protocol Violation|1
5998941|NCT00929708|20742937|P2|Overall Study|Protocol Violation|1
5998942|NCT00929708|20742938|P1|Overall Study|Protocol Violation|2
5998943|NCT00929695|20742992|P2|Overall Study|incorrect stratification|0
5998944|NCT00929695|20742993|P1|Overall Study|incorrect stratification|2
5998945|NCT00929695|20742992|P2|Overall Study|discharge home|3
5998946|NCT00929695|20742993|P1|Overall Study|discharge home|4
5998947|NCT00929695|20742992|P2|Overall Study|Withdrawal by Subject|2
5998948|NCT00929695|20742993|P1|Overall Study|Withdrawal by Subject|0
5998949|NCT00929695|20742992|P2|Overall Study|Death|1
5998950|NCT00929695|20742993|P1|Overall Study|Death|2
5998951|NCT00929669|20743023|P1|Overall Study|elevated glucose levels|1
5998952|NCT00929656|20743030|P2|Overall Study|Lost to Follow-up|1
5998953|NCT00929656|20743031|P1|Overall Study|Lost to Follow-up|0
5998954|NCT00929643|20743045|P1|Overall Study|Protocol Violation|2
5998955|NCT00929526|20743067|P2|Overall Study|Other|6
5998956|NCT00929526|20743068|P1|Overall Study|Other|8
5998957|NCT00929526|20743067|P2|Overall Study|Lost to Follow-up|12
5998958|NCT00929526|20743068|P1|Overall Study|Lost to Follow-up|8
5998959|NCT00929526|20743067|P2|Overall Study|Withdrawal by Subject|11
5998960|NCT00929526|20743068|P1|Overall Study|Withdrawal by Subject|1
5998961|NCT00929240|20743222|P3|Maintenance Phase|Participant not treated|0
5998962|NCT00929240|20743223|P2|Maintenance Phase|Participant not treated|2
5998963|NCT00929240|20743224|P1|Maintenance Phase|Participant not treated|0
5998964|NCT00929240|20743222|P3|Maintenance Phase|Treatment ongoing at study closure|10
5998965|NCT00929240|20743223|P2|Maintenance Phase|Treatment ongoing at study closure|0
5998966|NCT00929240|20743224|P1|Maintenance Phase|Treatment ongoing at study closure|0
5998967|NCT00929240|20743222|P3|Maintenance Phase|Change of treatment|0
5998968|NCT00929240|20743223|P2|Maintenance Phase|Change of treatment|4
5998969|NCT00929240|20743224|P1|Maintenance Phase|Change of treatment|0
5998970|NCT00929240|20743222|P3|Maintenance Phase|Physician Decision|1
5998971|NCT00929240|20743223|P2|Maintenance Phase|Physician Decision|2
5998972|NCT00929240|20743224|P1|Maintenance Phase|Physician Decision|0
5998973|NCT00929240|20743222|P3|Maintenance Phase|Health authority/Study termination|2
5998974|NCT00929240|20743223|P2|Maintenance Phase|Health authority/Study termination|1
5998975|NCT00929240|20743224|P1|Maintenance Phase|Health authority/Study termination|0
5998976|NCT00929240|20743222|P3|Maintenance Phase|Protocol Violation|0
5998977|NCT00929240|20743223|P2|Maintenance Phase|Protocol Violation|1
5998978|NCT00929240|20743224|P1|Maintenance Phase|Protocol Violation|0
5998979|NCT00929240|20743222|P3|Maintenance Phase|Withdrawal by Subject|6
5998980|NCT00929240|20743223|P2|Maintenance Phase|Withdrawal by Subject|2
5998981|NCT00929240|20743224|P1|Maintenance Phase|Withdrawal by Subject|0
5998982|NCT00929240|20743222|P3|Maintenance Phase|Adverse Event|12
5998983|NCT00929240|20743223|P2|Maintenance Phase|Adverse Event|9
5998984|NCT00929240|20743224|P1|Maintenance Phase|Adverse Event|0
5998985|NCT00929240|20743222|P3|Maintenance Phase|Disease progression|60
5998986|NCT00929240|20743223|P2|Maintenance Phase|Disease progression|73
5998987|NCT00929240|20743224|P1|Maintenance Phase|Disease progression|0
5998988|NCT00929240|20743222|P3|Initial Treatment Phase|Physician Decision|0
5998989|NCT00929240|20743223|P2|Initial Treatment Phase|Physician Decision|0
5998990|NCT00929240|20743224|P1|Initial Treatment Phase|Physician Decision|4
5998991|NCT00929240|20743222|P3|Initial Treatment Phase|Health authority/Study termination|0
5998992|NCT00929240|20743223|P2|Initial Treatment Phase|Health authority/Study termination|0
5998993|NCT00929240|20743224|P1|Initial Treatment Phase|Health authority/Study termination|3
5998994|NCT00929240|20743222|P3|Initial Treatment Phase|Death|0
5998995|NCT00929240|20743223|P2|Initial Treatment Phase|Death|0
5998996|NCT00929240|20743224|P1|Initial Treatment Phase|Death|2
5998997|NCT00929240|20743222|P3|Initial Treatment Phase|Protocol Violation|0
5998998|NCT00929240|20743223|P2|Initial Treatment Phase|Protocol Violation|0
5998999|NCT00929240|20743224|P1|Initial Treatment Phase|Protocol Violation|5
5999000|NCT00929240|20743222|P3|Initial Treatment Phase|Withdrawal by Subject|0
5999001|NCT00929240|20743223|P2|Initial Treatment Phase|Withdrawal by Subject|0
5999002|NCT00929240|20743224|P1|Initial Treatment Phase|Withdrawal by Subject|13
5999003|NCT00929240|20743222|P3|Initial Treatment Phase|Disease progression|0
5999004|NCT00929240|20743223|P2|Initial Treatment Phase|Disease progression|0
5999005|NCT00929240|20743224|P1|Initial Treatment Phase|Disease progression|41
5999006|NCT00929240|20743222|P3|Initial Treatment Phase|Adverse Event|0
5999007|NCT00929240|20743223|P2|Initial Treatment Phase|Adverse Event|0
5999008|NCT00929240|20743224|P1|Initial Treatment Phase|Adverse Event|31
5999009|NCT00929201|20743251|P2|Period 1|Withdrawal by Subject|1
5999010|NCT00929201|20743252|P1|Period 1|Withdrawal by Subject|0
5999011|NCT00929162|20743262|P2|Overall Study|Other termination reason|6
5999012|NCT00929162|20743263|P1|Overall Study|Other termination reason|5
5999013|NCT00929162|20743262|P2|Overall Study|Protocol Violation|30
5999014|NCT00929162|20743263|P1|Overall Study|Protocol Violation|32
5999015|NCT00929162|20743262|P2|Overall Study|Withdrawal by Subject|1
5999016|NCT00929162|20743263|P1|Overall Study|Withdrawal by Subject|3
5999017|NCT00929162|20743262|P2|Overall Study|Adverse Event|5
5999018|NCT00929162|20743263|P1|Overall Study|Adverse Event|8
5999019|NCT00929110|20743276|P3|Overall Study|Patient inability to use the device|0
5999020|NCT00929110|20743277|P2|Overall Study|Patient inability to use the device|1
5999021|NCT00929110|20743278|P1|Overall Study|Patient inability to use the device|0
5999022|NCT00929110|20743276|P3|Overall Study|Abnormal test procedure result(s)|1
5999023|NCT00929110|20743277|P2|Overall Study|Abnormal test procedure result(s)|1
5999024|NCT00929110|20743278|P1|Overall Study|Abnormal test procedure result(s)|0
5999025|NCT00929110|20743276|P3|Overall Study|Abnormal laboratory value(s)|0
5999026|NCT00929110|20743277|P2|Overall Study|Abnormal laboratory value(s)|1
5999027|NCT00929110|20743278|P1|Overall Study|Abnormal laboratory value(s)|0
5999028|NCT00929110|20743276|P3|Overall Study|Death|2
5999029|NCT00929110|20743277|P2|Overall Study|Death|2
5999030|NCT00929110|20743278|P1|Overall Study|Death|2
5999031|NCT00929110|20743276|P3|Overall Study|Administrative problems|2
5999032|NCT00929110|20743277|P2|Overall Study|Administrative problems|1
5999033|NCT00929110|20743278|P1|Overall Study|Administrative problems|4
5999034|NCT00929110|20743276|P3|Overall Study|Protocol deviation|4
5999035|NCT00929110|20743277|P2|Overall Study|Protocol deviation|2
5999036|NCT00929110|20743278|P1|Overall Study|Protocol deviation|5
5999037|NCT00929110|20743276|P3|Overall Study|Lost to Follow-up|3
5999038|NCT00929110|20743277|P2|Overall Study|Lost to Follow-up|7
5999039|NCT00929110|20743278|P1|Overall Study|Lost to Follow-up|7
5999040|NCT00929110|20743276|P3|Overall Study|Unsatisfactory therapeutic effect|6
5999041|NCT00929110|20743277|P2|Overall Study|Unsatisfactory therapeutic effect|9
5999042|NCT00929110|20743278|P1|Overall Study|Unsatisfactory therapeutic effect|20
5999043|NCT00929110|20743276|P3|Overall Study|Subject withdrew consent|26
5999044|NCT00929110|20743277|P2|Overall Study|Subject withdrew consent|23
5999045|NCT00929110|20743278|P1|Overall Study|Subject withdrew consent|40
5999046|NCT00929110|20743276|P3|Overall Study|Adverse Event|18
5999047|NCT00929110|20743277|P2|Overall Study|Adverse Event|29
5999048|NCT00929110|20743278|P1|Overall Study|Adverse Event|40
5999049|NCT00928889|20743361|P2|Overall Study|Other|0
5999050|NCT00928889|20743362|P1|Overall Study|Other|1
5999051|NCT00928889|20743361|P2|Overall Study|Adverse Event|0
5999052|NCT00928889|20743362|P1|Overall Study|Adverse Event|1
5999053|NCT00928889|20743361|P2|Overall Study|Protocol Violation|1
5999054|NCT00928889|20743362|P1|Overall Study|Protocol Violation|0
5999055|NCT00928889|20743361|P2|Overall Study|Lost to Follow-up|1
5999056|NCT00928889|20743362|P1|Overall Study|Lost to Follow-up|3
5999057|NCT00928746|20743408|P1|Overall Study|Other|2
5999058|NCT00928746|20743408|P1|Overall Study|Withdrawal by Subject|1
5999059|NCT00928746|20743408|P1|Overall Study|Protocol Violation|1
5999060|NCT00928746|20743408|P1|Overall Study|Adverse Event|2
5999061|NCT00928707|20743458|P2|Overall Study|Protocol Violation|0
5999062|NCT00928707|20743459|P1|Overall Study|Protocol Violation|1
5999063|NCT00928668|20743480|P5|Overall Study|Other reasons not listed above|0
5999064|NCT00928668|20743481|P4|Overall Study|Other reasons not listed above|1
5999065|NCT00928668|20743482|P3|Overall Study|Other reasons not listed above|0
5999066|NCT00928668|20743483|P2|Overall Study|Other reasons not listed above|0
5999067|NCT00928668|20743484|P1|Overall Study|Other reasons not listed above|0
5999068|NCT00928668|20743480|P5|Overall Study|Withdrawal by Subject|0
5999069|NCT00928668|20743481|P4|Overall Study|Withdrawal by Subject|0
5999070|NCT00928668|20743482|P3|Overall Study|Withdrawal by Subject|1
5999071|NCT00928668|20743483|P2|Overall Study|Withdrawal by Subject|1
5999072|NCT00928668|20743484|P1|Overall Study|Withdrawal by Subject|0
5999073|NCT00928668|20743480|P5|Overall Study|Protocol Violation|1
5999074|NCT00928668|20743481|P4|Overall Study|Protocol Violation|0
5999075|NCT00928668|20743482|P3|Overall Study|Protocol Violation|0
5999076|NCT00928668|20743483|P2|Overall Study|Protocol Violation|0
5999077|NCT00928668|20743484|P1|Overall Study|Protocol Violation|0
5999078|NCT00928668|20743480|P5|Overall Study|Adverse Event|0
5999079|NCT00928668|20743481|P4|Overall Study|Adverse Event|0
5999080|NCT00928668|20743482|P3|Overall Study|Adverse Event|0
5999081|NCT00928668|20743483|P2|Overall Study|Adverse Event|0
5999082|NCT00928668|20743484|P1|Overall Study|Adverse Event|1
5999083|NCT00928512|20743540|P5|Overall Study|Administrative Problems|0
5999084|NCT00928512|20743541|P4|Overall Study|Administrative Problems|0
5999085|NCT00928512|20743542|P3|Overall Study|Administrative Problems|0
5999086|NCT00928512|20743543|P2|Overall Study|Administrative Problems|1
5999087|NCT00928512|20743544|P1|Overall Study|Administrative Problems|0
5999088|NCT00928512|20743540|P5|Overall Study|Lost to Follow-up|3
5999089|NCT00928512|20743541|P4|Overall Study|Lost to Follow-up|1
5999090|NCT00928512|20743542|P3|Overall Study|Lost to Follow-up|2
5999091|NCT00928512|20743543|P2|Overall Study|Lost to Follow-up|1
5999092|NCT00928512|20743544|P1|Overall Study|Lost to Follow-up|1
5999093|NCT00928512|20743540|P5|Overall Study|Withdrawal by Subject|0
5999094|NCT00928512|20743541|P4|Overall Study|Withdrawal by Subject|4
5999095|NCT00928512|20743542|P3|Overall Study|Withdrawal by Subject|3
5999096|NCT00928512|20743543|P2|Overall Study|Withdrawal by Subject|0
5999097|NCT00928512|20743544|P1|Overall Study|Withdrawal by Subject|3
5999098|NCT00928512|20743540|P5|Overall Study|Protocol Violation|3
5999099|NCT00928512|20743541|P4|Overall Study|Protocol Violation|1
5999100|NCT00928512|20743542|P3|Overall Study|Protocol Violation|0
5999101|NCT00928512|20743543|P2|Overall Study|Protocol Violation|1
5999102|NCT00928512|20743544|P1|Overall Study|Protocol Violation|0
5999103|NCT00928512|20743540|P5|Overall Study|Lack of Efficacy|3
5999104|NCT00928512|20743541|P4|Overall Study|Lack of Efficacy|7
5999105|NCT00928512|20743542|P3|Overall Study|Lack of Efficacy|4
5999106|NCT00928512|20743543|P2|Overall Study|Lack of Efficacy|0
5999107|NCT00928512|20743544|P1|Overall Study|Lack of Efficacy|2
5999108|NCT00928512|20743540|P5|Overall Study|Adverse Event|6
5999109|NCT00928512|20743541|P4|Overall Study|Adverse Event|8
5999110|NCT00928512|20743542|P3|Overall Study|Adverse Event|2
5999111|NCT00928512|20743543|P2|Overall Study|Adverse Event|3
5999112|NCT00928512|20743544|P1|Overall Study|Adverse Event|4
5999113|NCT00928486|20743645|P1|Overall Study|Withdrawal by Subject|1
5999114|NCT00928486|20743645|P1|Overall Study|Disease Progression|7
5999115|NCT00928486|20743645|P1|Overall Study|Adverse Event|2
5999116|NCT00928434|20743654|P3|Overall Study|Other (not meeting above criteria)|2
5999117|NCT00928434|20743655|P2|Overall Study|Other (not meeting above criteria)|1
5999118|NCT00928434|20743656|P1|Overall Study|Other (not meeting above criteria)|5
5999119|NCT00928434|20743654|P3|Overall Study|PSA failure (>2 ng/mL) on other visit|1
5999120|NCT00928434|20743655|P2|Overall Study|PSA failure (>2 ng/mL) on other visit|1
5999121|NCT00928434|20743656|P1|Overall Study|PSA failure (>2 ng/mL) on other visit|2
5999122|NCT00928434|20743654|P3|Overall Study|PSA failure (>2 ng/mL) at Visit 8|7
5999123|NCT00928434|20743655|P2|Overall Study|PSA failure (>2 ng/mL) at Visit 8|4
5999124|NCT00928434|20743656|P1|Overall Study|PSA failure (>2 ng/mL) at Visit 8|10
5999125|NCT00928434|20743654|P3|Overall Study|Withdrawal by Subject|2
5999126|NCT00928434|20743655|P2|Overall Study|Withdrawal by Subject|3
5999127|NCT00928434|20743656|P1|Overall Study|Withdrawal by Subject|5
5999128|NCT00928434|20743654|P3|Overall Study|Lost to Follow-up|3
5999129|NCT00928434|20743655|P2|Overall Study|Lost to Follow-up|0
5999130|NCT00928434|20743656|P1|Overall Study|Lost to Follow-up|1
5999131|NCT00928434|20743654|P3|Overall Study|Physician Decision|3
5999132|NCT00928434|20743655|P2|Overall Study|Physician Decision|0
5999133|NCT00928434|20743656|P1|Overall Study|Physician Decision|2
5999134|NCT00928434|20743654|P3|Overall Study|Protocol Violation|8
5999135|NCT00928434|20743655|P2|Overall Study|Protocol Violation|0
5999136|NCT00928434|20743656|P1|Overall Study|Protocol Violation|5
5999137|NCT00928434|20743654|P3|Overall Study|Adverse Event|18
5999138|NCT00928434|20743655|P2|Overall Study|Adverse Event|5
5999139|NCT00928434|20743656|P1|Overall Study|Adverse Event|14
5999140|NCT00928408|20743732|P1|Overall Study|Lost to Follow-up|12
5999141|NCT00928408|20743732|P1|Overall Study|Death|5
5999142|NCT00928408|20743732|P1|Overall Study|Withdrawal by Subject|4
5999143|NCT00928408|20743732|P1|Overall Study|Other|2
5999144|NCT00928252|20743778|P1|Overall Study|Physician Decision|3
5999145|NCT00928187|20743838|P3|Overall Study|Protocol Violation|0
5999146|NCT00928187|20743839|P2|Overall Study|Protocol Violation|1
5999147|NCT00928187|20743840|P1|Overall Study|Protocol Violation|0
5999148|NCT00928187|20743838|P3|Overall Study|Withdrawal by Subject|1
5999149|NCT00928187|20743839|P2|Overall Study|Withdrawal by Subject|1
5999150|NCT00928187|20743840|P1|Overall Study|Withdrawal by Subject|0
5999151|NCT00928187|20743838|P3|Overall Study|Lost to Follow-up|1
5999152|NCT00928187|20743839|P2|Overall Study|Lost to Follow-up|2
5999153|NCT00928187|20743840|P1|Overall Study|Lost to Follow-up|1
5999154|NCT00928187|20743838|P3|Overall Study|Death|3
5999155|NCT00928187|20743839|P2|Overall Study|Death|2
5999156|NCT00928187|20743840|P1|Overall Study|Death|1
5999157|NCT00928070|20744010|P2|Overall Study|Other|5
5999158|NCT00928070|20744011|P1|Overall Study|Other|5
5999159|NCT00928070|20744010|P2|Overall Study|Randomized but not treated|2
5999160|NCT00928070|20744011|P1|Overall Study|Randomized but not treated|2
5999161|NCT00928070|20744010|P2|Overall Study|Protocol Violation|5
5999162|NCT00928070|20744011|P1|Overall Study|Protocol Violation|6
5999163|NCT00928070|20744010|P2|Overall Study|Did not meet entrance criteria|9
5999164|NCT00928070|20744011|P1|Overall Study|Did not meet entrance criteria|16
5999165|NCT00928070|20744010|P2|Overall Study|Lack of Efficacy|5
5999166|NCT00928070|20744011|P1|Overall Study|Lack of Efficacy|9
5999167|NCT00928070|20744010|P2|Overall Study|Adverse Event|26
5999168|NCT00928070|20744011|P1|Overall Study|Adverse Event|14
5999169|NCT00928070|20744010|P2|Overall Study|Withdrawal by Subject|3
5999170|NCT00928070|20744011|P1|Overall Study|Withdrawal by Subject|10
5999171|NCT00928070|20744010|P2|Overall Study|Lost to Follow-up|2
5999172|NCT00928070|20744011|P1|Overall Study|Lost to Follow-up|1
5999173|NCT00928057|20744069|P2|Overall Study|Protocol Violation|1
5999174|NCT00928057|20744070|P1|Overall Study|Protocol Violation|0
5999175|NCT00928057|20744069|P2|Overall Study|Lost to Follow-up|1
5999176|NCT00928057|20744070|P1|Overall Study|Lost to Follow-up|0
5999177|NCT00928057|20744069|P2|Overall Study|Withdrawal by Subject|0
5999178|NCT00928057|20744070|P1|Overall Study|Withdrawal by Subject|1
5999179|NCT00928057|20744069|P2|Overall Study|Adverse Event|2
5999180|NCT00928057|20744070|P1|Overall Study|Adverse Event|1
5999181|NCT00928018|20744095|P2|Overall Study|Withdrawal by Subject|0
5999182|NCT00928018|20744096|P1|Overall Study|Withdrawal by Subject|1
5999183|NCT00927953|20744126|P2|Overall Study|Death|1
5999184|NCT00927953|20744127|P1|Overall Study|Death|2
5999185|NCT00927940|20744141|P1|Overall Study|Death|1
5999186|NCT00927927|20744161|P15|Overall Study|Withdrawal by Subject|0
5999187|NCT00927927|20744162|P14|Overall Study|Withdrawal by Subject|0
5999188|NCT00927927|20744163|P13|Overall Study|Withdrawal by Subject|0
5999189|NCT00927927|20744164|P12|Overall Study|Withdrawal by Subject|2
5999190|NCT00927927|20744165|P11|Overall Study|Withdrawal by Subject|0
5999191|NCT00927927|20744166|P10|Overall Study|Withdrawal by Subject|0
5999192|NCT00927927|20744167|P9|Overall Study|Withdrawal by Subject|0
5999193|NCT00927927|20744168|P8|Overall Study|Withdrawal by Subject|2
5999194|NCT00927927|20744169|P7|Overall Study|Withdrawal by Subject|0
5999195|NCT00927927|20744170|P6|Overall Study|Withdrawal by Subject|0
5999196|NCT00927927|20744171|P5|Overall Study|Withdrawal by Subject|0
5999197|NCT00927927|20744172|P4|Overall Study|Withdrawal by Subject|0
5999198|NCT00927927|20744173|P3|Overall Study|Withdrawal by Subject|0
5999199|NCT00927927|20744174|P2|Overall Study|Withdrawal by Subject|0
5999200|NCT00927927|20744175|P1|Overall Study|Withdrawal by Subject|0
5999201|NCT00927901|20744222|P4|Treatment Period 4|Subject withdrew consent|0
5999202|NCT00927901|20744223|P3|Treatment Period 4|Subject withdrew consent|1
5999203|NCT00927901|20744224|P2|Treatment Period 4|Subject withdrew consent|0
5999204|NCT00927901|20744225|P1|Treatment Period 4|Subject withdrew consent|0
5999205|NCT00927901|20744222|P4|Treatment Period 4|Adverse Event|1
5999206|NCT00927901|20744223|P3|Treatment Period 4|Adverse Event|0
5999207|NCT00927901|20744224|P2|Treatment Period 4|Adverse Event|0
5999208|NCT00927901|20744225|P1|Treatment Period 4|Adverse Event|0
5999209|NCT00927901|20744222|P4|Treatment Period 1|Subject withdrew consent|0
5999210|NCT00927901|20744223|P3|Treatment Period 1|Subject withdrew consent|1
5999211|NCT00927901|20744224|P2|Treatment Period 1|Subject withdrew consent|0
5999212|NCT00927901|20744225|P1|Treatment Period 1|Subject withdrew consent|0
5999213|NCT00927862|20744266|P2|Overall Study|Missing data needed for endpt analyses|45
5999214|NCT00927862|20744267|P1|Overall Study|Missing data needed for endpt analyses|27
5999215|NCT00927823|20744302|P4|Continuous Dosing Period|Other|3
5999216|NCT00927823|20744303|P3|Continuous Dosing Period|Other|9
5999217|NCT00927823|20744304|P2|Continuous Dosing Period|Other|2
5999218|NCT00927823|20744305|P1|Continuous Dosing Period|Other|1
5999219|NCT00927823|20744302|P4|Continuous Dosing Period|Withdrawal by Subject|2
5999220|NCT00927823|20744303|P3|Continuous Dosing Period|Withdrawal by Subject|2
5999221|NCT00927823|20744304|P2|Continuous Dosing Period|Withdrawal by Subject|0
5999222|NCT00927823|20744305|P1|Continuous Dosing Period|Withdrawal by Subject|1
5999223|NCT00927823|20744302|P4|Continuous Dosing Period|Lost to Follow-up|0
5999224|NCT00927823|20744303|P3|Continuous Dosing Period|Lost to Follow-up|9
5999225|NCT00927823|20744304|P2|Continuous Dosing Period|Lost to Follow-up|1
5999226|NCT00927823|20744305|P1|Continuous Dosing Period|Lost to Follow-up|1
5999227|NCT00927823|20744302|P4|Continuous Dosing Period|Death|0
5999228|NCT00927823|20744303|P3|Continuous Dosing Period|Death|6
5999229|NCT00927823|20744304|P2|Continuous Dosing Period|Death|0
5999230|NCT00927823|20744305|P1|Continuous Dosing Period|Death|0
5999231|NCT00927784|20744371|P2|Overall Study|Withdrawal by Subject|0
5999232|NCT00927784|20744372|P1|Overall Study|Withdrawal by Subject|1
5999233|NCT00927784|20744371|P2|Overall Study|Death|0
5999234|NCT00927784|20744372|P1|Overall Study|Death|1
5999235|NCT00927758|20744402|P6|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1
5999236|NCT00927758|20744403|P5|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0
5999237|NCT00927758|20744404|P4|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1
5999238|NCT00927758|20744405|P3|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1
5999239|NCT00927758|20744406|P2|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0
5999240|NCT00927758|20744407|P1|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0
5999241|NCT00927758|20744402|P6|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1
5999242|NCT00927758|20744403|P5|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0
5999243|NCT00927758|20744404|P4|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1
5999244|NCT00927758|20744405|P3|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0
5999245|NCT00927758|20744406|P2|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0
5999246|NCT00927758|20744407|P1|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0
5999247|NCT00927589|20744415|P1|Overall Study|Non-compliance|1
5999248|NCT00927589|20744415|P1|Overall Study|Disease Progression|8
5999249|NCT00927589|20744415|P1|Overall Study|Adverse Event|2
5999250|NCT00927589|20744415|P1|Overall Study|Withdrawal by Subject|3
5999251|NCT00927589|20744415|P1|Overall Study|Physician Decision|1
5999252|NCT00927589|20744415|P1|Overall Study|Death|1
5999253|NCT00927563|20744445|P1|Overall Study|Withdrawal by Subject|1
5999254|NCT00927563|20744445|P1|Overall Study|Lost to Follow-up|1
5999255|NCT00927485|20744453|P2|Overall Study|noncompliance, prophylactic surgery, inc|2
5999256|NCT00927485|20744454|P1|Overall Study|noncompliance, prophylactic surgery, inc|2
5999257|NCT00927485|20744453|P2|Overall Study|Adverse Event|2
5999258|NCT00927485|20744454|P1|Overall Study|Adverse Event|4
5999259|NCT00927472|20744464|P2|Overall Study|Post treatment Assessment out of window|4
5999260|NCT00927472|20744465|P1|Overall Study|Post treatment Assessment out of window|0
5999261|NCT00927472|20744464|P2|Overall Study|Protocol Violation|1
5999262|NCT00927472|20744465|P1|Overall Study|Protocol Violation|0
5999263|NCT00927472|20744464|P2|Overall Study|Lost to Follow-up|6
5999264|NCT00927472|20744465|P1|Overall Study|Lost to Follow-up|1
5999265|NCT00927472|20744464|P2|Overall Study|Withdrawal by Subject|11
5999266|NCT00927472|20744465|P1|Overall Study|Withdrawal by Subject|10
5999267|NCT00927394|20744491|P2|Overall Study|Randomized in error|1
5999268|NCT00927394|20744492|P1|Overall Study|Randomized in error|0
5999269|NCT00927394|20744491|P2|Overall Study|Protocol deviation|13
5999270|NCT00927394|20744492|P1|Overall Study|Protocol deviation|16
5999271|NCT00927394|20744491|P2|Overall Study|Death|1
5999272|NCT00927394|20744492|P1|Overall Study|Death|1
5999273|NCT00927394|20744491|P2|Overall Study|Administrative Problem|0
5999274|NCT00927394|20744492|P1|Overall Study|Administrative Problem|1
5999275|NCT00927394|20744491|P2|Overall Study|Lost to Follow-up|14
5999276|NCT00927394|20744492|P1|Overall Study|Lost to Follow-up|8
5999277|NCT00927394|20744491|P2|Overall Study|Withdrawal by Subject|24
5999278|NCT00927394|20744492|P1|Overall Study|Withdrawal by Subject|20
5999279|NCT00927394|20744491|P2|Overall Study|Unsatisfactory therapeutic effect|23
5999280|NCT00927394|20744492|P1|Overall Study|Unsatisfactory therapeutic effect|17
5999281|NCT00927394|20744491|P2|Overall Study|Adverse Event|9
5999282|NCT00927394|20744492|P1|Overall Study|Adverse Event|14
5999283|NCT00927368|20744523|P3|Overall Study|cancellation of surgery|2
5999284|NCT00927368|20744524|P2|Overall Study|cancellation of surgery|1
5999285|NCT00927368|20744525|P1|Overall Study|cancellation of surgery|0
5999286|NCT00927368|20744523|P3|Overall Study|ineligible post randomization|1
5999287|NCT00927368|20744524|P2|Overall Study|ineligible post randomization|3
5999288|NCT00927368|20744525|P1|Overall Study|ineligible post randomization|0
5999289|NCT00927368|20744523|P3|Overall Study|equipment failure|0
5999290|NCT00927368|20744524|P2|Overall Study|equipment failure|0
5999291|NCT00927368|20744525|P1|Overall Study|equipment failure|1
5999292|NCT00927368|20744523|P3|Overall Study|Lost to Follow-up|0
5999293|NCT00927368|20744524|P2|Overall Study|Lost to Follow-up|0
5999294|NCT00927368|20744525|P1|Overall Study|Lost to Follow-up|4
5999295|NCT00927368|20744523|P3|Overall Study|enrollment in another study|2
5999296|NCT00927368|20744524|P2|Overall Study|enrollment in another study|1
5999297|NCT00927368|20744525|P1|Overall Study|enrollment in another study|1
5999298|NCT00927355|20744544|P2|Overall Study|Adverse Event|1
5999299|NCT00927355|20744545|P1|Overall Study|Adverse Event|1
5999300|NCT00927251|20744580|P1|Overall Study|Patients not implanted with 4296 lead|8
5999301|NCT00927186|20744586|P2|12 Months Primary Study|Withdrawal by Subject|1
5999302|NCT00927186|20744587|P1|12 Months Primary Study|Withdrawal by Subject|1
5999303|NCT00927186|20744586|P2|12 Months Primary Study|Protocol Violation|1
5999304|NCT00927186|20744587|P1|12 Months Primary Study|Protocol Violation|0
5999305|NCT00927186|20744586|P2|12 Months Primary Study|Lost to Follow-up|0
5999306|NCT00927186|20744587|P1|12 Months Primary Study|Lost to Follow-up|1
5999307|NCT00927186|20744586|P2|12 Months Primary Study|Adverse Event|2
5999308|NCT00927186|20744587|P1|12 Months Primary Study|Adverse Event|5
5999309|NCT00927095|20744717|P3|Overall Study|Physician Decision|1
5999310|NCT00927095|20744718|P2|Overall Study|Physician Decision|2
5999311|NCT00927095|20744719|P1|Overall Study|Physician Decision|1
5999312|NCT00927095|20744717|P3|Overall Study|Withdrawal by Subject|1
5999313|NCT00927095|20744718|P2|Overall Study|Withdrawal by Subject|1
5999314|NCT00927095|20744719|P1|Overall Study|Withdrawal by Subject|2
5999315|NCT00927095|20744717|P3|Overall Study|Adverse Event|0
5999316|NCT00927095|20744718|P2|Overall Study|Adverse Event|1
5999317|NCT00927095|20744719|P1|Overall Study|Adverse Event|3
5999318|NCT00927082|20744731|P4|Overall Study|Screen fail,Participant migrated,Unknown|1
5999319|NCT00927082|20744732|P3|Overall Study|Screen fail,Participant migrated,Unknown|2
5999320|NCT00927082|20744733|P2|Overall Study|Screen fail,Participant migrated,Unknown|0
5999321|NCT00927082|20744734|P1|Overall Study|Screen fail,Participant migrated,Unknown|0
5999322|NCT00927082|20744731|P4|Overall Study|Death|0
5999323|NCT00927082|20744732|P3|Overall Study|Death|1
5999324|NCT00927082|20744733|P2|Overall Study|Death|0
5999325|NCT00927082|20744734|P1|Overall Study|Death|0
5999326|NCT00927082|20744731|P4|Overall Study|Withdrawal by Subject|2
5999327|NCT00927082|20744732|P3|Overall Study|Withdrawal by Subject|7
5999328|NCT00927082|20744733|P2|Overall Study|Withdrawal by Subject|2
5999329|NCT00927082|20744734|P1|Overall Study|Withdrawal by Subject|3
5999330|NCT00927082|20744731|P4|Overall Study|Lost to Follow-up|16
5999331|NCT00927082|20744732|P3|Overall Study|Lost to Follow-up|12
5999332|NCT00927082|20744733|P2|Overall Study|Lost to Follow-up|8
5999333|NCT00927082|20744734|P1|Overall Study|Lost to Follow-up|9
5999334|NCT00927069|20744798|P4|Week 12 to Week 24|Had a vaccination, removed from study|0
5999335|NCT00927069|20744799|P3|Week 12 to Week 24|Had a vaccination, removed from study|0
5999336|NCT00927069|20744800|P2|Week 12 to Week 24|Had a vaccination, removed from study|0
5999337|NCT00927069|20744801|P1|Week 12 to Week 24|Had a vaccination, removed from study|1
5999338|NCT00927069|20744798|P4|Week 12 to Week 24|Withdrawal by Subject|0
5999339|NCT00927069|20744799|P3|Week 12 to Week 24|Withdrawal by Subject|0
5999340|NCT00927069|20744800|P2|Week 12 to Week 24|Withdrawal by Subject|0
5999341|NCT00927069|20744801|P1|Week 12 to Week 24|Withdrawal by Subject|1
5999342|NCT00927069|20744798|P4|Week 12 to Week 24|Lost to Follow-up|0
5999343|NCT00927069|20744799|P3|Week 12 to Week 24|Lost to Follow-up|1
5999344|NCT00927069|20744800|P2|Week 12 to Week 24|Lost to Follow-up|0
5999345|NCT00927069|20744801|P1|Week 12 to Week 24|Lost to Follow-up|0
5999346|NCT00927069|20744798|P4|Week 12 to Week 24|Lack of Efficacy|3
5999347|NCT00927069|20744799|P3|Week 12 to Week 24|Lack of Efficacy|2
5999348|NCT00927069|20744800|P2|Week 12 to Week 24|Lack of Efficacy|0
5999349|NCT00927069|20744801|P1|Week 12 to Week 24|Lack of Efficacy|0
5999350|NCT00927069|20744798|P4|Week 0 to Week 12|Worsening of psoriasis|0
5999351|NCT00927069|20744799|P3|Week 0 to Week 12|Worsening of psoriasis|0
5999352|NCT00927069|20744800|P2|Week 0 to Week 12|Worsening of psoriasis|1
5999353|NCT00927069|20744801|P1|Week 0 to Week 12|Worsening of psoriasis|1
5999354|NCT00926796|20744857|P2|Overall Study|Withdrawal by Subject|0
5999355|NCT00926796|20744858|P1|Overall Study|Withdrawal by Subject|1
5999356|NCT00926796|20744857|P2|Overall Study|Protocol Violation|11
5999357|NCT00926796|20744858|P1|Overall Study|Protocol Violation|15
5999358|NCT00926796|20744857|P2|Overall Study|Lost to Follow-up|13
5999359|NCT00926796|20744858|P1|Overall Study|Lost to Follow-up|22
5999360|NCT00926796|20744857|P2|Overall Study|Adverse Event|14
5999361|NCT00926796|20744858|P1|Overall Study|Adverse Event|7
5999362|NCT00926796|20744857|P2|Overall Study|Ineligible, but positive for gonorrhea|1
5999363|NCT00926796|20744858|P1|Overall Study|Ineligible, but positive for gonorrhea|1
5999364|NCT00926796|20744857|P2|Overall Study|Ineligible, negative for gonorrhea|60
5999365|NCT00926796|20744858|P1|Overall Study|Ineligible, negative for gonorrhea|57
5999366|NCT00926796|20744857|P2|Overall Study|Did not receive randomized treatment|7
5999367|NCT00926796|20744858|P1|Overall Study|Did not receive randomized treatment|4
5999368|NCT00926783|20744879|P2|Overall Study|Incomplete CFAE Procedures|3
5999369|NCT00926783|20744880|P1|Overall Study|Incomplete CFAE Procedures|3
5999370|NCT00926575|20744907|P2|Overall Study|Withdrawal by Subject|9
5999371|NCT00926575|20744908|P1|Overall Study|Withdrawal by Subject|8
5999372|NCT00926575|20744907|P2|Overall Study|Protocol Violation|0
5999373|NCT00926575|20744908|P1|Overall Study|Protocol Violation|1
5999374|NCT00926575|20744907|P2|Overall Study|Physician Decision|2
5999375|NCT00926575|20744908|P1|Overall Study|Physician Decision|1
5999376|NCT00926575|20744907|P2|Overall Study|Lost to Follow-up|1
5999377|NCT00926575|20744908|P1|Overall Study|Lost to Follow-up|1
5999378|NCT00926575|20744907|P2|Overall Study|Death|4
5999379|NCT00926575|20744908|P1|Overall Study|Death|4
5999380|NCT00926575|20744907|P2|Overall Study|Adverse Event|1
5999381|NCT00926575|20744908|P1|Overall Study|Adverse Event|1
5999382|NCT00926536|20744920|P2|Overall Study|Physician Decision|2
5999383|NCT00926536|20744921|P1|Overall Study|Physician Decision|1
5999384|NCT00926393|20744942|P2|Overall Study|Adverse Event|1
5999385|NCT00926393|20744943|P1|Overall Study|Adverse Event|1
5999386|NCT00926393|20744942|P2|Overall Study|Withdrawal by Subject|2
5999387|NCT00926393|20744943|P1|Overall Study|Withdrawal by Subject|1
5999388|NCT00926367|20744988|P2|Overall Study|Skin Irritation|2
5999389|NCT00926367|20744989|P1|Overall Study|Skin Irritation|1
5999390|NCT00926367|20744988|P2|Overall Study|Lost to Follow-up|0
5999391|NCT00926367|20744989|P1|Overall Study|Lost to Follow-up|1
5999392|NCT00926367|20744988|P2|Overall Study|Withdrawal by Subject|1
5999393|NCT00926367|20744989|P1|Overall Study|Withdrawal by Subject|0
5999394|NCT00926328|20745031|P2|Overall Study|Lost to Follow-up|14
5999395|NCT00926328|20745032|P1|Overall Study|Lost to Follow-up|12
5999396|NCT00926289|20745042|P2|Overall Study|Other|3
5999397|NCT00926289|20745043|P1|Overall Study|Other|1
5999398|NCT00926289|20745042|P2|Overall Study|Withdrawal by Subject|4
5999399|NCT00926289|20745043|P1|Overall Study|Withdrawal by Subject|4
5999400|NCT00926289|20745042|P2|Overall Study|Lost to Follow-up|6
5999401|NCT00926289|20745043|P1|Overall Study|Lost to Follow-up|3
5999402|NCT00926289|20745042|P2|Overall Study|Protocol Violation|12
5999403|NCT00926289|20745043|P1|Overall Study|Protocol Violation|8
5999404|NCT00926289|20745042|P2|Overall Study|Adverse Event|11
5999405|NCT00926289|20745043|P1|Overall Study|Adverse Event|9
5999406|NCT00926237|20745111|P2|Overall Study|Withdrawal by Subject|1
5999407|NCT00926237|20745112|P1|Overall Study|Withdrawal by Subject|2
5999408|NCT00926211|20745122|P1|Overall Study|Lost to Follow-up|1
5999409|NCT00926029|20745153|P3|Overall Study|Lost to Follow-up|1
5999410|NCT00926029|20745154|P2|Overall Study|Lost to Follow-up|1
5999411|NCT00926029|20745155|P1|Overall Study|Lost to Follow-up|2
5999412|NCT00926003|20745169|P3|Post-Training 3-month Follow-up|Lost to Follow-up|0
5999413|NCT00926003|20745170|P2|Post-Training 3-month Follow-up|Lost to Follow-up|0
5999414|NCT00926003|20745171|P1|Post-Training 3-month Follow-up|Lost to Follow-up|1
5999415|NCT00926003|20745169|P3|Post-Training Evaluation|Withdrawal by Subject|0
5999416|NCT00926003|20745170|P2|Post-Training Evaluation|Withdrawal by Subject|0
5999417|NCT00926003|20745171|P1|Post-Training Evaluation|Withdrawal by Subject|1
5999418|NCT00925990|20745184|P2|Overall Study|moved out of state, missed medication|2
5999419|NCT00925990|20745185|P1|Overall Study|moved out of state, missed medication|0
5999420|NCT00925990|20745184|P2|Overall Study|Physician Decision|1
5999421|NCT00925990|20745185|P1|Overall Study|Physician Decision|1
5999422|NCT00925990|20745184|P2|Overall Study|Lost to Follow-up|3
5999423|NCT00925990|20745185|P1|Overall Study|Lost to Follow-up|1
5999424|NCT00925990|20745184|P2|Overall Study|Withdrawal by Subject|2
5999425|NCT00925990|20745185|P1|Overall Study|Withdrawal by Subject|2
5999426|NCT00925990|20745184|P2|Overall Study|Adverse Event|3
5999427|NCT00925990|20745185|P1|Overall Study|Adverse Event|1
5999428|NCT00925899|20745220|P2|Part 1|Withdrawal by Subject|9
5999429|NCT00925899|20745221|P1|Part 1|Withdrawal by Subject|10
5999430|NCT00925899|20745220|P2|Part 1|Death|2
5999431|NCT00925899|20745221|P1|Part 1|Death|1
5999432|NCT00925769|20745249|P6|Overall Study|Adverse Event|0
5999433|NCT00925769|20745250|P5|Overall Study|Adverse Event|1
5999434|NCT00925769|20745251|P4|Overall Study|Adverse Event|0
5999435|NCT00925769|20745252|P3|Overall Study|Adverse Event|0
5999436|NCT00925769|20745253|P2|Overall Study|Adverse Event|0
5999437|NCT00925769|20745254|P1|Overall Study|Adverse Event|0
5999438|NCT00925769|20745249|P6|Overall Study|Participant is unable to swallow drug|0
5999439|NCT00925769|20745250|P5|Overall Study|Participant is unable to swallow drug|0
5999440|NCT00925769|20745251|P4|Overall Study|Participant is unable to swallow drug|1
5999441|NCT00925769|20745252|P3|Overall Study|Participant is unable to swallow drug|0
5999442|NCT00925769|20745253|P2|Overall Study|Participant is unable to swallow drug|0
5999443|NCT00925769|20745254|P1|Overall Study|Participant is unable to swallow drug|0
5999444|NCT00925769|20745249|P6|Overall Study|End of study visit not done|0
5999445|NCT00925769|20745250|P5|Overall Study|End of study visit not done|0
5999446|NCT00925769|20745251|P4|Overall Study|End of study visit not done|0
5999447|NCT00925769|20745252|P3|Overall Study|End of study visit not done|1
5999448|NCT00925769|20745253|P2|Overall Study|End of study visit not done|0
5999449|NCT00925769|20745254|P1|Overall Study|End of study visit not done|0
5999450|NCT00925769|20745249|P6|Overall Study|Missing documentation|0
5999451|NCT00925769|20745250|P5|Overall Study|Missing documentation|0
5999452|NCT00925769|20745251|P4|Overall Study|Missing documentation|0
5999453|NCT00925769|20745252|P3|Overall Study|Missing documentation|0
5999454|NCT00925769|20745253|P2|Overall Study|Missing documentation|1
5999455|NCT00925769|20745254|P1|Overall Study|Missing documentation|0
5999456|NCT00925769|20745249|P6|Overall Study|Physician Decision|0
5999457|NCT00925769|20745250|P5|Overall Study|Physician Decision|0
5999458|NCT00925769|20745251|P4|Overall Study|Physician Decision|0
5999459|NCT00925769|20745252|P3|Overall Study|Physician Decision|0
5999460|NCT00925769|20745253|P2|Overall Study|Physician Decision|0
5999461|NCT00925769|20745254|P1|Overall Study|Physician Decision|1
5999462|NCT00925769|20745249|P6|Overall Study|Death|0
5999463|NCT00925769|20745250|P5|Overall Study|Death|0
5999464|NCT00925769|20745251|P4|Overall Study|Death|0
5999465|NCT00925769|20745252|P3|Overall Study|Death|1
5999466|NCT00925769|20745253|P2|Overall Study|Death|0
5999467|NCT00925769|20745254|P1|Overall Study|Death|0
5999468|NCT00925769|20745249|P6|Overall Study|Disease progression|3
5999469|NCT00925769|20745250|P5|Overall Study|Disease progression|2
5999470|NCT00925769|20745251|P4|Overall Study|Disease progression|4
5999471|NCT00925769|20745252|P3|Overall Study|Disease progression|3
5999472|NCT00925769|20745253|P2|Overall Study|Disease progression|5
5999473|NCT00925769|20745254|P1|Overall Study|Disease progression|4
5999474|NCT00925769|20745249|P6|Overall Study|Major toxicity|0
5999475|NCT00925769|20745250|P5|Overall Study|Major toxicity|0
5999476|NCT00925769|20745251|P4|Overall Study|Major toxicity|1
5999477|NCT00925769|20745252|P3|Overall Study|Major toxicity|1
5999478|NCT00925769|20745253|P2|Overall Study|Major toxicity|0
5999479|NCT00925769|20745254|P1|Overall Study|Major toxicity|1
5999480|NCT00925704|20745328|P6|Third Intervention|Withdrew consent|1
5999481|NCT00925704|20745329|P5|Third Intervention|Withdrew consent|0
5999482|NCT00925704|20745330|P4|Third Intervention|Withdrew consent|0
5999483|NCT00925704|20745331|P3|Third Intervention|Withdrew consent|0
5999484|NCT00925704|20745332|P2|Third Intervention|Withdrew consent|0
5999485|NCT00925704|20745333|P1|Third Intervention|Withdrew consent|0
5999486|NCT00925704|20745328|P6|Second Intervention|Withdrawal by Subject|0
5999487|NCT00925704|20745329|P5|Second Intervention|Withdrawal by Subject|1
5999488|NCT00925704|20745330|P4|Second Intervention|Withdrawal by Subject|0
5999489|NCT00925704|20745331|P3|Second Intervention|Withdrawal by Subject|0
5999490|NCT00925704|20745332|P2|Second Intervention|Withdrawal by Subject|0
5999491|NCT00925704|20745333|P1|Second Intervention|Withdrawal by Subject|1
5999492|NCT00925704|20745328|P6|First Intervention|Withdrew consent|0
5999493|NCT00925704|20745329|P5|First Intervention|Withdrew consent|1
5999494|NCT00925704|20745330|P4|First Intervention|Withdrew consent|1
5999495|NCT00925704|20745331|P3|First Intervention|Withdrew consent|0
5999496|NCT00925704|20745332|P2|First Intervention|Withdrew consent|0
5999497|NCT00925704|20745333|P1|First Intervention|Withdrew consent|0
5999498|NCT00925600|20745346|P2|Overall Study|Adverse Event|2
5999499|NCT00925600|20745347|P1|Overall Study|Adverse Event|1
5999500|NCT00925600|20745346|P2|Overall Study|Other|1
5999501|NCT00925600|20745347|P1|Overall Study|Other|3
5999502|NCT00925600|20745346|P2|Overall Study|Requirement for Alternative Therapy|1
5999503|NCT00925600|20745347|P1|Overall Study|Requirement for Alternative Therapy|0
5999504|NCT00925600|20745346|P2|Overall Study|Protocol Deviation|1
5999505|NCT00925600|20745347|P1|Overall Study|Protocol Deviation|0
5999506|NCT00925600|20745346|P2|Overall Study|Ineligibility Determined|0
5999507|NCT00925600|20745347|P1|Overall Study|Ineligibility Determined|2
5999508|NCT00925600|20745346|P2|Overall Study|Noncompliance|0
5999509|NCT00925600|20745347|P1|Overall Study|Noncompliance|2
5999510|NCT00925600|20745346|P2|Overall Study|Administrative Decision|1
5999511|NCT00925600|20745347|P1|Overall Study|Administrative Decision|1
5999512|NCT00925600|20745346|P2|Overall Study|Disease Progression|3
5999513|NCT00925600|20745347|P1|Overall Study|Disease Progression|1
5999514|NCT00925600|20745346|P2|Overall Study|Lost to Follow-up|2
5999515|NCT00925600|20745347|P1|Overall Study|Lost to Follow-up|2
5999516|NCT00925600|20745346|P2|Overall Study|Death|3
5999517|NCT00925600|20745347|P1|Overall Study|Death|4
5999518|NCT00925600|20745346|P2|Overall Study|Withdrawal by Subject|14
5999519|NCT00925600|20745347|P1|Overall Study|Withdrawal by Subject|16
5999520|NCT00925587|20745369|P2|Overall Study|Lost to Follow-up|1
5999521|NCT00925587|20745370|P1|Overall Study|Lost to Follow-up|0
5999522|NCT00925587|20745369|P2|Overall Study|Adverse Event|2
5999523|NCT00925587|20745370|P1|Overall Study|Adverse Event|6
5999524|NCT00925587|20745369|P2|Overall Study|Death|5
5999525|NCT00925587|20745370|P1|Overall Study|Death|5
5999526|NCT00925587|20745369|P2|Overall Study|Withdrawal by Subject|6
5999527|NCT00925587|20745370|P1|Overall Study|Withdrawal by Subject|9
5999528|NCT00925587|20745369|P2|Overall Study|Protocol Violation|4
5999529|NCT00925587|20745370|P1|Overall Study|Protocol Violation|6
5999530|NCT00925587|20745369|P2|Overall Study|Physician Decision|1
5999531|NCT00925587|20745370|P1|Overall Study|Physician Decision|4
5999532|NCT00925587|20745369|P2|Overall Study|Protocol Specified Criteria|6
5999533|NCT00925587|20745370|P1|Overall Study|Protocol Specified Criteria|6
5999534|NCT00925548|20745484|P2|Overall Study|Discontinuation of trial by sponsor|5
5999535|NCT00925548|20745485|P1|Overall Study|Discontinuation of trial by sponsor|10
5999536|NCT00925522|20745511|P1|Overall Study|study closed -- business decision|20
5999537|NCT00925353|20745515|P1|Overall Study|Failed preliminary EKG or lab criteria.|3
5999538|NCT00925301|20745521|P4|12-Month Open-label Extension (Optional)|Lost to Follow-up|1
5999539|NCT00925301|20745522|P3|12-Month Open-label Extension (Optional)|Lost to Follow-up|0
5999540|NCT00925301|20745523|P2|12-Month Open-label Extension (Optional)|Lost to Follow-up|0
5999541|NCT00925301|20745524|P1|12-Month Open-label Extension (Optional)|Lost to Follow-up|0
5999542|NCT00925301|20745521|P4|12-Month Open-label Extension (Optional)|Pregnancy|1
5999543|NCT00925301|20745522|P3|12-Month Open-label Extension (Optional)|Pregnancy|0
5999544|NCT00925301|20745523|P2|12-Month Open-label Extension (Optional)|Pregnancy|0
5999545|NCT00925301|20745524|P1|12-Month Open-label Extension (Optional)|Pregnancy|0
5999546|NCT00925301|20745521|P4|12-Month Open-label Extension (Optional)|Withdrawal by Subject|1
5999547|NCT00925301|20745522|P3|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0
5999548|NCT00925301|20745523|P2|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0
5999549|NCT00925301|20745524|P1|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0
5999550|NCT00925301|20745521|P4|6-Month Open-label (Stage 2)|Adverse Event|0
5999551|NCT00925301|20745522|P3|6-Month Open-label (Stage 2)|Adverse Event|2
5999552|NCT00925301|20745523|P2|6-Month Open-label (Stage 2)|Adverse Event|0
5999553|NCT00925301|20745524|P1|6-Month Open-label (Stage 2)|Adverse Event|0
5999554|NCT00925301|20745521|P4|6-Month Open-label (Stage 2)|Withdrawal by Subject|0
5999555|NCT00925301|20745522|P3|6-Month Open-label (Stage 2)|Withdrawal by Subject|1
5999556|NCT00925301|20745523|P2|6-Month Open-label (Stage 2)|Withdrawal by Subject|0
5999557|NCT00925301|20745524|P1|6-Month Open-label (Stage 2)|Withdrawal by Subject|0
5999558|NCT00925301|20745521|P4|6-Month Double-blind (Stage 1)|Pregnancy|0
5999559|NCT00925301|20745522|P3|6-Month Double-blind (Stage 1)|Pregnancy|0
5999560|NCT00925301|20745523|P2|6-Month Double-blind (Stage 1)|Pregnancy|1
5999561|NCT00925301|20745524|P1|6-Month Double-blind (Stage 1)|Pregnancy|0
5999562|NCT00925301|20745521|P4|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0
5999563|NCT00925301|20745522|P3|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0
5999564|NCT00925301|20745523|P2|6-Month Double-blind (Stage 1)|Withdrawal by Subject|2
5999565|NCT00925301|20745524|P1|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0
5999566|NCT00925288|20745540|P2|Overall Study|Lost to Follow-up|7
5999567|NCT00925288|20745541|P1|Overall Study|Lost to Follow-up|9
5999568|NCT00925132|20745553|P5|Overall Study|Removed due to disease progression|4
5999569|NCT00925132|20745554|P4|Overall Study|Removed due to disease progression|0
5999570|NCT00925132|20745555|P3|Overall Study|Removed due to disease progression|0
5999571|NCT00925132|20745556|P2|Overall Study|Removed due to disease progression|0
5999572|NCT00925132|20745557|P1|Overall Study|Removed due to disease progression|0
5999573|NCT00925132|20745553|P5|Overall Study|Withdrawal by Subject|1
5999574|NCT00925132|20745554|P4|Overall Study|Withdrawal by Subject|0
5999575|NCT00925132|20745555|P3|Overall Study|Withdrawal by Subject|0
5999576|NCT00925132|20745556|P2|Overall Study|Withdrawal by Subject|0
5999577|NCT00925132|20745557|P1|Overall Study|Withdrawal by Subject|2
5999578|NCT00925015|20745652|P3|Overall Study|Withdrawal by Subject|1
5999579|NCT00925015|20745653|P2|Overall Study|Withdrawal by Subject|0
5999580|NCT00925015|20745654|P1|Overall Study|Withdrawal by Subject|0
5999581|NCT00925015|20745652|P3|Overall Study|Progressive Disease|4
5999582|NCT00925015|20745653|P2|Overall Study|Progressive Disease|3
5999583|NCT00925015|20745654|P1|Overall Study|Progressive Disease|7
5999584|NCT00925015|20745652|P3|Overall Study|Physician Decision|0
5999585|NCT00925015|20745653|P2|Overall Study|Physician Decision|1
5999586|NCT00925015|20745654|P1|Overall Study|Physician Decision|0
5999587|NCT00925015|20745652|P3|Overall Study|Adverse Event|1
5999588|NCT00925015|20745653|P2|Overall Study|Adverse Event|2
5999589|NCT00925015|20745654|P1|Overall Study|Adverse Event|1
5999590|NCT00924950|20745710|P1|Overall Study|Lost to Follow-up|2
5999591|NCT00924898|20745717|P1|Overall Study|Withdrawal by Subject|2
5999592|NCT00924820|20745756|P1|Overall Study|Ineligible, Screen Failure|5
5999593|NCT00924820|20745756|P1|Overall Study|Death|2
5999594|NCT00924781|20745771|P2|Overall Study|Study terminated by sponsor|10
5999595|NCT00924781|20745772|P1|Overall Study|Study terminated by sponsor|12
5999596|NCT00924729|20745806|P2|Overall Study|Protocol Violation|0
5999597|NCT00924729|20745807|P1|Overall Study|Protocol Violation|1
5999598|NCT00924729|20745806|P2|Overall Study|insufficient volume for analysis|0
5999599|NCT00924729|20745807|P1|Overall Study|insufficient volume for analysis|1
5999600|NCT00924651|20745817|P2|Overall Study|Incomplete Form|1
5999601|NCT00924651|20745818|P1|Overall Study|Incomplete Form|2
5999602|NCT00924651|20745817|P2|Overall Study|Changed Mind|1
5999603|NCT00924651|20745818|P1|Overall Study|Changed Mind|10
5999604|NCT00924651|20745817|P2|Overall Study|Medical|3
5999605|NCT00924651|20745818|P1|Overall Study|Medical|1
5999606|NCT00924651|20745817|P2|Overall Study|Noncompliant|4
5999607|NCT00924651|20745818|P1|Overall Study|Noncompliant|1
5999608|NCT00924651|20745817|P2|Overall Study|Overwhelmed|6
5999609|NCT00924651|20745818|P1|Overall Study|Overwhelmed|6
5999610|NCT00924651|20745817|P2|Overall Study|No Reason|7
5999611|NCT00924651|20745818|P1|Overall Study|No Reason|3
5999612|NCT00924651|20745817|P2|Overall Study|Chemo started too soon|3
5999613|NCT00924651|20745818|P1|Overall Study|Chemo started too soon|2
5999614|NCT00924638|20745826|P2|Overall Study|Physician Decision|3
5999615|NCT00924638|20745827|P1|Overall Study|Physician Decision|3
5999616|NCT00924638|20745826|P2|Overall Study|Withdrawal by Subject|7
5999617|NCT00924638|20745827|P1|Overall Study|Withdrawal by Subject|5
5999618|NCT00924638|20745826|P2|Overall Study|Lost to Follow-up|1
5999619|NCT00924638|20745827|P1|Overall Study|Lost to Follow-up|1
5999620|NCT00924638|20745826|P2|Overall Study|Death|2
5999621|NCT00924638|20745827|P1|Overall Study|Death|3
5999622|NCT00924560|20745864|P3|Overall Study|Miscellaneous Reasons|10
5999623|NCT00924560|20745865|P2|Overall Study|Miscellaneous Reasons|10
5999624|NCT00924560|20745866|P1|Overall Study|Miscellaneous Reasons|13
5999625|NCT00924560|20745864|P3|Overall Study|Lost to Follow-up|45
5999626|NCT00924560|20745865|P2|Overall Study|Lost to Follow-up|94
5999627|NCT00924560|20745866|P1|Overall Study|Lost to Follow-up|78
5999628|NCT00924560|20745864|P3|Overall Study|Pregnancy|1
5999629|NCT00924560|20745865|P2|Overall Study|Pregnancy|7
5999630|NCT00924560|20745866|P1|Overall Study|Pregnancy|5
5999631|NCT00924560|20745864|P3|Overall Study|Adverse Event|0
5999632|NCT00924560|20745865|P2|Overall Study|Adverse Event|33
5999633|NCT00924560|20745866|P1|Overall Study|Adverse Event|39
5999634|NCT00924560|20745864|P3|Overall Study|Withdrawal by Subject|18
5999635|NCT00924560|20745865|P2|Overall Study|Withdrawal by Subject|44
5999636|NCT00924560|20745866|P1|Overall Study|Withdrawal by Subject|50
5999637|NCT00924560|20745864|P3|Overall Study|Physician Decision|4
5999638|NCT00924560|20745865|P2|Overall Study|Physician Decision|3
5999639|NCT00924560|20745866|P1|Overall Study|Physician Decision|2
5999640|NCT00924560|20745864|P3|Overall Study|Non Compliance with the Protocol|4
5999641|NCT00924560|20745865|P2|Overall Study|Non Compliance with the Protocol|15
5999642|NCT00924560|20745866|P1|Overall Study|Non Compliance with the Protocol|20
5999643|NCT00924560|20745864|P3|Overall Study|Did Not Meet Protocol Requirements|1
5999644|NCT00924560|20745865|P2|Overall Study|Did Not Meet Protocol Requirements|2
5999645|NCT00924560|20745866|P1|Overall Study|Did Not Meet Protocol Requirements|4
5999646|NCT00924508|20745910|P1|Overall Study|Withdrawal by Subject|3
5999647|NCT00924469|20745924|P2|Overall Study|Lost to Follow-up|1
5999648|NCT00924469|20745925|P1|Overall Study|Lost to Follow-up|0
5999649|NCT00924469|20745924|P2|Overall Study|Withdrawal by Subject|1
5999650|NCT00924469|20745925|P1|Overall Study|Withdrawal by Subject|0
5999651|NCT00924469|20745924|P2|Overall Study|Adverse Event|0
5999652|NCT00924469|20745925|P1|Overall Study|Adverse Event|2
5999653|NCT00924443|20745947|P1|Overall Study|Protocol Violation|1
5999654|NCT00924443|20745947|P1|Overall Study|Physician Decision|2
5999655|NCT00924404|20745957|P2|Overall Study|Lost to Follow-up|4
5999656|NCT00924404|20745958|P1|Overall Study|Lost to Follow-up|6
5999657|NCT00924313|20746029|P1|Overall Study|not imaged due to failed tracer imaging|1
5999658|NCT00924287|20746041|P1|Overall Study|Death|1
5999669|NCT00923975|20746183|P1|Overall Study|Did not meet inclusion criteria|1
5999670|NCT00923936|20746202|P2|Overall Study|Continuing in follow up period|1
5999671|NCT00923936|20746203|P1|Overall Study|Continuing in follow up period|2
5999672|NCT00923936|20746202|P2|Overall Study|Lost to follow up|0
5999673|NCT00923936|20746203|P1|Overall Study|Lost to follow up|2
5999674|NCT00923936|20746202|P2|Overall Study|Adverse Event|1
5999675|NCT00923936|20746203|P1|Overall Study|Adverse Event|2
5999676|NCT00923936|20746202|P2|Overall Study|progressive disease on study|1
5999677|NCT00923936|20746203|P1|Overall Study|progressive disease on study|2
5999678|NCT00923845|20746232|P2|Induction Therapy|Poor performance status|2
5999679|NCT00923845|20746233|P1|Induction Therapy|Poor performance status|0
5999680|NCT00923364|20746268|P2|Overall Study|Did not go to transplant|0
5999681|NCT00923364|20746269|P1|Overall Study|Did not go to transplant|1
5999682|NCT00923364|20746268|P2|Overall Study|Death|0
5999683|NCT00923364|20746269|P1|Overall Study|Death|3
5999684|NCT00923351|20746281|P3|Overall Study|no apheresis/adequate tumor sample|12
5999685|NCT00923351|20746282|P2|Overall Study|no apheresis/adequate tumor sample|0
5999686|NCT00923351|20746283|P1|Overall Study|no apheresis/adequate tumor sample|0
5999687|NCT00923273|20746298|P5|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0
5999688|NCT00923273|20746299|P4|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|6
5999689|NCT00923273|20746300|P3|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0
5999690|NCT00923273|20746301|P2|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0
5999691|NCT00923273|20746302|P1|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0
5999692|NCT00923273|20746298|P5|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0
5999693|NCT00923273|20746299|P4|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|1
5999694|NCT00923273|20746300|P3|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0
5999695|NCT00923273|20746301|P2|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0
5999696|NCT00923273|20746302|P1|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0
5999697|NCT00923260|20746327|P2|Overall Study|Lost to Follow-up|1
5999698|NCT00923260|20746328|P1|Overall Study|Lost to Follow-up|1
5999699|NCT00923195|20746491|P2|Overall Study|Death|1
5999700|NCT00923195|20746492|P1|Overall Study|Death|0
5999701|NCT00923156|20746503|P3|Overall Study|Lack of Efficacy|1
5999702|NCT00923156|20746504|P2|Overall Study|Lack of Efficacy|0
5999703|NCT00923156|20746505|P1|Overall Study|Lack of Efficacy|0
5999704|NCT00923156|20746503|P3|Overall Study|Death|0
5999705|NCT00923156|20746504|P2|Overall Study|Death|1
5999706|NCT00923156|20746505|P1|Overall Study|Death|0
5999707|NCT00923156|20746503|P3|Overall Study|Withdrawal by Subject|0
5999708|NCT00923156|20746504|P2|Overall Study|Withdrawal by Subject|1
5999709|NCT00923156|20746505|P1|Overall Study|Withdrawal by Subject|0
5999710|NCT00923156|20746503|P3|Overall Study|Abnormal laboratory values|1
5999711|NCT00923156|20746504|P2|Overall Study|Abnormal laboratory values|0
5999712|NCT00923156|20746505|P1|Overall Study|Abnormal laboratory values|0
5999713|NCT00923156|20746503|P3|Overall Study|Adverse Event|1
5999714|NCT00923156|20746504|P2|Overall Study|Adverse Event|2
5999715|NCT00923156|20746505|P1|Overall Study|Adverse Event|0
5999716|NCT00923130|20746531|P1|Overall Study|Refused further treatment|2
5999717|NCT00923130|20746531|P1|Overall Study|Switched to alternative treatment|2
5999718|NCT00923130|20746531|P1|Overall Study|Discontinued treatment due to toxicities|3
5999719|NCT00923130|20746531|P1|Overall Study|Death|1
5999720|NCT00923130|20746531|P1|Overall Study|Stopped treatment due to progression|17
5999721|NCT00923091|20746566|P13|Period VI (Open-Label)|Other Reason|0
5999722|NCT00923091|20746567|P12|Period VI (Open-Label)|Other Reason|0
5999723|NCT00923091|20746568|P11|Period VI (Open-Label)|Other Reason|0
5999724|NCT00923091|20746569|P10|Period VI (Open-Label)|Other Reason|0
5999725|NCT00923091|20746570|P9|Period VI (Open-Label)|Other Reason|0
5999726|NCT00923091|20746571|P8|Period VI (Open-Label)|Other Reason|0
5999727|NCT00923091|20746572|P7|Period VI (Open-Label)|Other Reason|0
5999728|NCT00923091|20746573|P6|Period VI (Open-Label)|Other Reason|0
5999729|NCT00923091|20746574|P5|Period VI (Open-Label)|Other Reason|1
5999730|NCT00923091|20746575|P4|Period VI (Open-Label)|Other Reason|1
5999731|NCT00923091|20746576|P3|Period VI (Open-Label)|Other Reason|0
5999732|NCT00923091|20746577|P2|Period VI (Open-Label)|Other Reason|0
5999733|NCT00923091|20746578|P1|Period VI (Open-Label)|Other Reason|0
5999734|NCT00923091|20746566|P13|Period VI (Open-Label)|Lost to Follow-up|0
5999735|NCT00923091|20746567|P12|Period VI (Open-Label)|Lost to Follow-up|0
5999736|NCT00923091|20746568|P11|Period VI (Open-Label)|Lost to Follow-up|0
5999737|NCT00923091|20746569|P10|Period VI (Open-Label)|Lost to Follow-up|0
5999738|NCT00923091|20746570|P9|Period VI (Open-Label)|Lost to Follow-up|0
5999739|NCT00923091|20746571|P8|Period VI (Open-Label)|Lost to Follow-up|0
5999740|NCT00923091|20746572|P7|Period VI (Open-Label)|Lost to Follow-up|0
5999741|NCT00923091|20746573|P6|Period VI (Open-Label)|Lost to Follow-up|0
5999742|NCT00923091|20746574|P5|Period VI (Open-Label)|Lost to Follow-up|0
5999743|NCT00923091|20746575|P4|Period VI (Open-Label)|Lost to Follow-up|0
5999744|NCT00923091|20746576|P3|Period VI (Open-Label)|Lost to Follow-up|1
5999745|NCT00923091|20746577|P2|Period VI (Open-Label)|Lost to Follow-up|0
5999746|NCT00923091|20746578|P1|Period VI (Open-Label)|Lost to Follow-up|1
5999747|NCT00923091|20746566|P13|Period VI (Open-Label)|Protocol Violation|0
5999748|NCT00923091|20746567|P12|Period VI (Open-Label)|Protocol Violation|0
5999749|NCT00923091|20746568|P11|Period VI (Open-Label)|Protocol Violation|0
5999750|NCT00923091|20746569|P10|Period VI (Open-Label)|Protocol Violation|0
5999751|NCT00923091|20746570|P9|Period VI (Open-Label)|Protocol Violation|0
5999752|NCT00923091|20746571|P8|Period VI (Open-Label)|Protocol Violation|0
5999753|NCT00923091|20746572|P7|Period VI (Open-Label)|Protocol Violation|0
5999754|NCT00923091|20746573|P6|Period VI (Open-Label)|Protocol Violation|0
5999755|NCT00923091|20746574|P5|Period VI (Open-Label)|Protocol Violation|4
5999756|NCT00923091|20746575|P4|Period VI (Open-Label)|Protocol Violation|1
5999757|NCT00923091|20746576|P3|Period VI (Open-Label)|Protocol Violation|3
5999758|NCT00923091|20746577|P2|Period VI (Open-Label)|Protocol Violation|1
5999759|NCT00923091|20746578|P1|Period VI (Open-Label)|Protocol Violation|6
5999760|NCT00923091|20746566|P13|Period VI (Open-Label)|Withdrawal by Subject|0
5999761|NCT00923091|20746567|P12|Period VI (Open-Label)|Withdrawal by Subject|0
5999762|NCT00923091|20746568|P11|Period VI (Open-Label)|Withdrawal by Subject|0
5999763|NCT00923091|20746569|P10|Period VI (Open-Label)|Withdrawal by Subject|0
5999764|NCT00923091|20746570|P9|Period VI (Open-Label)|Withdrawal by Subject|0
5999765|NCT00923091|20746571|P8|Period VI (Open-Label)|Withdrawal by Subject|0
5999766|NCT00923091|20746572|P7|Period VI (Open-Label)|Withdrawal by Subject|0
5999767|NCT00923091|20746573|P6|Period VI (Open-Label)|Withdrawal by Subject|0
5999768|NCT00923091|20746574|P5|Period VI (Open-Label)|Withdrawal by Subject|1
5999769|NCT00923091|20746575|P4|Period VI (Open-Label)|Withdrawal by Subject|0
5999770|NCT00923091|20746576|P3|Period VI (Open-Label)|Withdrawal by Subject|5
5999771|NCT00923091|20746577|P2|Period VI (Open-Label)|Withdrawal by Subject|7
5999772|NCT00923091|20746578|P1|Period VI (Open-Label)|Withdrawal by Subject|15
5999773|NCT00923091|20746566|P13|Period VI (Open-Label)|Adverse Event|0
5999774|NCT00923091|20746567|P12|Period VI (Open-Label)|Adverse Event|0
5999775|NCT00923091|20746568|P11|Period VI (Open-Label)|Adverse Event|0
5999776|NCT00923091|20746569|P10|Period VI (Open-Label)|Adverse Event|0
5999777|NCT00923091|20746570|P9|Period VI (Open-Label)|Adverse Event|0
5999778|NCT00923091|20746571|P8|Period VI (Open-Label)|Adverse Event|0
5999779|NCT00923091|20746572|P7|Period VI (Open-Label)|Adverse Event|0
5999780|NCT00923091|20746573|P6|Period VI (Open-Label)|Adverse Event|0
5999781|NCT00923091|20746574|P5|Period VI (Open-Label)|Adverse Event|1
5999782|NCT00923091|20746575|P4|Period VI (Open-Label)|Adverse Event|1
5999783|NCT00923091|20746576|P3|Period VI (Open-Label)|Adverse Event|4
5999784|NCT00923091|20746577|P2|Period VI (Open-Label)|Adverse Event|0
5999785|NCT00923091|20746578|P1|Period VI (Open-Label)|Adverse Event|17
5999786|NCT00923091|20746566|P13|Period V (Double -Blind)|Lost to Follow-up|0
5999787|NCT00923091|20746567|P12|Period V (Double -Blind)|Lost to Follow-up|0
5999788|NCT00923091|20746568|P11|Period V (Double -Blind)|Lost to Follow-up|1
5999789|NCT00923091|20746569|P10|Period V (Double -Blind)|Lost to Follow-up|0
5999790|NCT00923091|20746570|P9|Period V (Double -Blind)|Lost to Follow-up|0
5999791|NCT00923091|20746571|P8|Period V (Double -Blind)|Lost to Follow-up|0
5999792|NCT00923091|20746572|P7|Period V (Double -Blind)|Lost to Follow-up|0
5999793|NCT00923091|20746573|P6|Period V (Double -Blind)|Lost to Follow-up|0
5999794|NCT00923091|20746574|P5|Period V (Double -Blind)|Lost to Follow-up|0
5999795|NCT00923091|20746575|P4|Period V (Double -Blind)|Lost to Follow-up|0
5999796|NCT00923091|20746576|P3|Period V (Double -Blind)|Lost to Follow-up|0
5999797|NCT00923091|20746577|P2|Period V (Double -Blind)|Lost to Follow-up|0
5999798|NCT00923091|20746578|P1|Period V (Double -Blind)|Lost to Follow-up|0
5999799|NCT00923091|20746566|P13|Period V (Double -Blind)|Protocol Violation|1
5999800|NCT00923091|20746567|P12|Period V (Double -Blind)|Protocol Violation|0
5999801|NCT00923091|20746568|P11|Period V (Double -Blind)|Protocol Violation|0
5999802|NCT00923091|20746569|P10|Period V (Double -Blind)|Protocol Violation|0
5999803|NCT00923091|20746570|P9|Period V (Double -Blind)|Protocol Violation|0
5999804|NCT00923091|20746571|P8|Period V (Double -Blind)|Protocol Violation|0
5999805|NCT00923091|20746572|P7|Period V (Double -Blind)|Protocol Violation|0
5999806|NCT00923091|20746573|P6|Period V (Double -Blind)|Protocol Violation|0
5999807|NCT00923091|20746574|P5|Period V (Double -Blind)|Protocol Violation|0
5999808|NCT00923091|20746575|P4|Period V (Double -Blind)|Protocol Violation|0
5999809|NCT00923091|20746576|P3|Period V (Double -Blind)|Protocol Violation|0
5999810|NCT00923091|20746577|P2|Period V (Double -Blind)|Protocol Violation|0
5999811|NCT00923091|20746578|P1|Period V (Double -Blind)|Protocol Violation|0
5999812|NCT00923091|20746566|P13|Period V (Double -Blind)|Withdrawal by Subject|1
5999813|NCT00923091|20746567|P12|Period V (Double -Blind)|Withdrawal by Subject|0
5999814|NCT00923091|20746568|P11|Period V (Double -Blind)|Withdrawal by Subject|0
5999815|NCT00923091|20746569|P10|Period V (Double -Blind)|Withdrawal by Subject|0
5999816|NCT00923091|20746570|P9|Period V (Double -Blind)|Withdrawal by Subject|1
5999817|NCT00923091|20746571|P8|Period V (Double -Blind)|Withdrawal by Subject|0
5999818|NCT00923091|20746572|P7|Period V (Double -Blind)|Withdrawal by Subject|0
5999819|NCT00923091|20746573|P6|Period V (Double -Blind)|Withdrawal by Subject|0
5999820|NCT00923091|20746574|P5|Period V (Double -Blind)|Withdrawal by Subject|0
5999821|NCT00923091|20746575|P4|Period V (Double -Blind)|Withdrawal by Subject|0
5999822|NCT00923091|20746576|P3|Period V (Double -Blind)|Withdrawal by Subject|0
5999823|NCT00923091|20746577|P2|Period V (Double -Blind)|Withdrawal by Subject|0
5999824|NCT00923091|20746578|P1|Period V (Double -Blind)|Withdrawal by Subject|0
5999825|NCT00923091|20746566|P13|Period IV (Double-Blind)|Protocol Violation|0
5999826|NCT00923091|20746567|P12|Period IV (Double-Blind)|Protocol Violation|0
5999827|NCT00923091|20746568|P11|Period IV (Double-Blind)|Protocol Violation|0
5999828|NCT00923091|20746569|P10|Period IV (Double-Blind)|Protocol Violation|0
5999829|NCT00923091|20746570|P9|Period IV (Double-Blind)|Protocol Violation|0
5999830|NCT00923091|20746571|P8|Period IV (Double-Blind)|Protocol Violation|0
5999831|NCT00923091|20746572|P7|Period IV (Double-Blind)|Protocol Violation|0
5999832|NCT00923091|20746573|P6|Period IV (Double-Blind)|Protocol Violation|0
5999833|NCT00923091|20746574|P5|Period IV (Double-Blind)|Protocol Violation|0
5999834|NCT00923091|20746575|P4|Period IV (Double-Blind)|Protocol Violation|0
5999835|NCT00923091|20746576|P3|Period IV (Double-Blind)|Protocol Violation|0
5999836|NCT00923091|20746577|P2|Period IV (Double-Blind)|Protocol Violation|1
5999837|NCT00923091|20746578|P1|Period IV (Double-Blind)|Protocol Violation|0
5999838|NCT00923091|20746566|P13|Period IV (Double-Blind)|Withdrawal by Subject|0
5999839|NCT00923091|20746567|P12|Period IV (Double-Blind)|Withdrawal by Subject|0
5999840|NCT00923091|20746568|P11|Period IV (Double-Blind)|Withdrawal by Subject|0
5999841|NCT00923091|20746569|P10|Period IV (Double-Blind)|Withdrawal by Subject|0
5999842|NCT00923091|20746570|P9|Period IV (Double-Blind)|Withdrawal by Subject|0
5999843|NCT00923091|20746571|P8|Period IV (Double-Blind)|Withdrawal by Subject|0
5999844|NCT00923091|20746572|P7|Period IV (Double-Blind)|Withdrawal by Subject|0
5999845|NCT00923091|20746573|P6|Period IV (Double-Blind)|Withdrawal by Subject|0
5999846|NCT00923091|20746574|P5|Period IV (Double-Blind)|Withdrawal by Subject|0
5999847|NCT00923091|20746575|P4|Period IV (Double-Blind)|Withdrawal by Subject|0
5999848|NCT00923091|20746576|P3|Period IV (Double-Blind)|Withdrawal by Subject|0
5999849|NCT00923091|20746577|P2|Period IV (Double-Blind)|Withdrawal by Subject|1
5999850|NCT00923091|20746578|P1|Period IV (Double-Blind)|Withdrawal by Subject|0
5999851|NCT00923091|20746566|P13|Period IV (Double-Blind)|Adverse Event|0
5999852|NCT00923091|20746567|P12|Period IV (Double-Blind)|Adverse Event|0
5999853|NCT00923091|20746568|P11|Period IV (Double-Blind)|Adverse Event|0
5999854|NCT00923091|20746569|P10|Period IV (Double-Blind)|Adverse Event|0
5999855|NCT00923091|20746570|P9|Period IV (Double-Blind)|Adverse Event|0
5999856|NCT00923091|20746571|P8|Period IV (Double-Blind)|Adverse Event|0
5999857|NCT00923091|20746572|P7|Period IV (Double-Blind)|Adverse Event|0
5999858|NCT00923091|20746573|P6|Period IV (Double-Blind)|Adverse Event|0
5999859|NCT00923091|20746574|P5|Period IV (Double-Blind)|Adverse Event|0
5999860|NCT00923091|20746575|P4|Period IV (Double-Blind)|Adverse Event|0
5999861|NCT00923091|20746576|P3|Period IV (Double-Blind)|Adverse Event|0
5999862|NCT00923091|20746577|P2|Period IV (Double-Blind)|Adverse Event|0
5999863|NCT00923091|20746578|P1|Period IV (Double-Blind)|Adverse Event|2
5999864|NCT00923091|20746566|P13|Period III (Single-Blind)|Lost to Follow-up|0
5999865|NCT00923091|20746567|P12|Period III (Single-Blind)|Lost to Follow-up|0
5999866|NCT00923091|20746568|P11|Period III (Single-Blind)|Lost to Follow-up|0
5999867|NCT00923091|20746569|P10|Period III (Single-Blind)|Lost to Follow-up|0
5999868|NCT00923091|20746570|P9|Period III (Single-Blind)|Lost to Follow-up|0
5999869|NCT00923091|20746571|P8|Period III (Single-Blind)|Lost to Follow-up|0
5999870|NCT00923091|20746572|P7|Period III (Single-Blind)|Lost to Follow-up|0
5999871|NCT00923091|20746573|P6|Period III (Single-Blind)|Lost to Follow-up|0
5999872|NCT00923091|20746574|P5|Period III (Single-Blind)|Lost to Follow-up|0
5999873|NCT00923091|20746575|P4|Period III (Single-Blind)|Lost to Follow-up|0
5999874|NCT00923091|20746576|P3|Period III (Single-Blind)|Lost to Follow-up|0
5999875|NCT00923091|20746577|P2|Period III (Single-Blind)|Lost to Follow-up|0
5999876|NCT00923091|20746578|P1|Period III (Single-Blind)|Lost to Follow-up|2
5999877|NCT00923091|20746566|P13|Period III (Single-Blind)|Protocol Violation|0
5999878|NCT00923091|20746567|P12|Period III (Single-Blind)|Protocol Violation|0
5999879|NCT00923091|20746568|P11|Period III (Single-Blind)|Protocol Violation|0
5999880|NCT00923091|20746569|P10|Period III (Single-Blind)|Protocol Violation|0
5999881|NCT00923091|20746570|P9|Period III (Single-Blind)|Protocol Violation|0
5999882|NCT00923091|20746571|P8|Period III (Single-Blind)|Protocol Violation|0
5999883|NCT00923091|20746572|P7|Period III (Single-Blind)|Protocol Violation|0
5999884|NCT00923091|20746573|P6|Period III (Single-Blind)|Protocol Violation|0
5999885|NCT00923091|20746574|P5|Period III (Single-Blind)|Protocol Violation|0
5999886|NCT00923091|20746575|P4|Period III (Single-Blind)|Protocol Violation|0
5999887|NCT00923091|20746576|P3|Period III (Single-Blind)|Protocol Violation|0
5999888|NCT00923091|20746577|P2|Period III (Single-Blind)|Protocol Violation|0
5999889|NCT00923091|20746578|P1|Period III (Single-Blind)|Protocol Violation|3
5999890|NCT00923091|20746566|P13|Period III (Single-Blind)|Withdrawal by Subject|0
5999891|NCT00923091|20746567|P12|Period III (Single-Blind)|Withdrawal by Subject|0
5999892|NCT00923091|20746568|P11|Period III (Single-Blind)|Withdrawal by Subject|0
5999893|NCT00923091|20746569|P10|Period III (Single-Blind)|Withdrawal by Subject|0
5999894|NCT00923091|20746570|P9|Period III (Single-Blind)|Withdrawal by Subject|0
5999895|NCT00923091|20746571|P8|Period III (Single-Blind)|Withdrawal by Subject|0
5999896|NCT00923091|20746572|P7|Period III (Single-Blind)|Withdrawal by Subject|0
5999897|NCT00923091|20746573|P6|Period III (Single-Blind)|Withdrawal by Subject|0
5999898|NCT00923091|20746574|P5|Period III (Single-Blind)|Withdrawal by Subject|0
5999899|NCT00923091|20746575|P4|Period III (Single-Blind)|Withdrawal by Subject|0
5999900|NCT00923091|20746576|P3|Period III (Single-Blind)|Withdrawal by Subject|0
5999901|NCT00923091|20746577|P2|Period III (Single-Blind)|Withdrawal by Subject|0
5999902|NCT00923091|20746578|P1|Period III (Single-Blind)|Withdrawal by Subject|10
5999903|NCT00923091|20746566|P13|Period III (Single-Blind)|Adverse Event|0
5999904|NCT00923091|20746567|P12|Period III (Single-Blind)|Adverse Event|0
5999905|NCT00923091|20746568|P11|Period III (Single-Blind)|Adverse Event|0
5999906|NCT00923091|20746569|P10|Period III (Single-Blind)|Adverse Event|0
5999907|NCT00923091|20746570|P9|Period III (Single-Blind)|Adverse Event|0
5999908|NCT00923091|20746571|P8|Period III (Single-Blind)|Adverse Event|0
5999909|NCT00923091|20746572|P7|Period III (Single-Blind)|Adverse Event|0
5999910|NCT00923091|20746573|P6|Period III (Single-Blind)|Adverse Event|0
5999911|NCT00923091|20746574|P5|Period III (Single-Blind)|Adverse Event|0
5999912|NCT00923091|20746575|P4|Period III (Single-Blind)|Adverse Event|0
5999913|NCT00923091|20746576|P3|Period III (Single-Blind)|Adverse Event|0
5999914|NCT00923091|20746577|P2|Period III (Single-Blind)|Adverse Event|0
5999915|NCT00923091|20746578|P1|Period III (Single-Blind)|Adverse Event|5
5999916|NCT00923091|20746566|P13|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
5999917|NCT00923091|20746567|P12|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
5999918|NCT00923091|20746568|P11|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
5999919|NCT00923091|20746569|P10|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
5999920|NCT00923091|20746570|P9|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
5999921|NCT00923091|20746571|P8|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
5999922|NCT00923091|20746572|P7|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
5999923|NCT00923091|20746573|P6|PeriodI-II (Randomized, Double-Blind)|Other Reason|1
5999924|NCT00923091|20746574|P5|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
5999925|NCT00923091|20746575|P4|PeriodI-II (Randomized, Double-Blind)|Other Reason|1
5999926|NCT00923091|20746576|P3|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
5999927|NCT00923091|20746577|P2|PeriodI-II (Randomized, Double-Blind)|Other Reason|1
5999928|NCT00923091|20746578|P1|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
5999929|NCT00923091|20746566|P13|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
5999930|NCT00923091|20746567|P12|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
5999931|NCT00923091|20746568|P11|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
5999932|NCT00923091|20746569|P10|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
5999933|NCT00923091|20746570|P9|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
5999934|NCT00923091|20746571|P8|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
5999935|NCT00923091|20746572|P7|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
5999936|NCT00923091|20746573|P6|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|1
5999937|NCT00923091|20746574|P5|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
5999938|NCT00923091|20746575|P4|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
5999939|NCT00923091|20746576|P3|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
5999940|NCT00923091|20746577|P2|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
5999941|NCT00923091|20746578|P1|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
5999942|NCT00923091|20746566|P13|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0
5999943|NCT00923091|20746567|P12|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0
5999944|NCT00923091|20746568|P11|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0
5999945|NCT00923091|20746569|P10|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0
5999946|NCT00923091|20746570|P9|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0
5999947|NCT00923091|20746571|P8|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|3
5999948|NCT00923091|20746572|P7|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4
5999949|NCT00923091|20746573|P6|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|2
5999950|NCT00923091|20746574|P5|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4
5999951|NCT00923091|20746575|P4|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|5
5999952|NCT00923091|20746576|P3|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1
5999953|NCT00923091|20746577|P2|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1
5999954|NCT00923091|20746578|P1|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1
5999955|NCT00923091|20746566|P13|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0
5999956|NCT00923091|20746567|P12|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0
5999957|NCT00923091|20746568|P11|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0
5999958|NCT00923091|20746569|P10|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0
5999959|NCT00923091|20746570|P9|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0
5999960|NCT00923091|20746571|P8|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5
5999961|NCT00923091|20746572|P7|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5
5999962|NCT00923091|20746573|P6|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6
5999963|NCT00923091|20746574|P5|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|7
5999964|NCT00923091|20746575|P4|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|8
5999965|NCT00923091|20746576|P3|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5
5999966|NCT00923091|20746577|P2|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6
5999967|NCT00923091|20746578|P1|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|4
5999968|NCT00923091|20746566|P13|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0
5999969|NCT00923091|20746567|P12|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0
5999970|NCT00923091|20746568|P11|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0
5999971|NCT00923091|20746569|P10|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0
5999972|NCT00923091|20746570|P9|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0
5999973|NCT00923091|20746571|P8|PeriodI-II (Randomized, Double-Blind)|Adverse Event|17
5999974|NCT00923091|20746572|P7|PeriodI-II (Randomized, Double-Blind)|Adverse Event|9
5999975|NCT00923091|20746573|P6|PeriodI-II (Randomized, Double-Blind)|Adverse Event|5
5999976|NCT00923091|20746574|P5|PeriodI-II (Randomized, Double-Blind)|Adverse Event|10
5999977|NCT00923091|20746575|P4|PeriodI-II (Randomized, Double-Blind)|Adverse Event|13
5999978|NCT00923091|20746576|P3|PeriodI-II (Randomized, Double-Blind)|Adverse Event|7
5999979|NCT00923091|20746577|P2|PeriodI-II (Randomized, Double-Blind)|Adverse Event|3
5999980|NCT00923091|20746578|P1|PeriodI-II (Randomized, Double-Blind)|Adverse Event|11
5999981|NCT00923078|20746628|P3|First Intervention (Weeks 1-4)|No intervention per protocol|20
5999982|NCT00923078|20746629|P2|First Intervention (Weeks 1-4)|No intervention per protocol|0
5999983|NCT00923078|20746630|P1|First Intervention (Weeks 1-4)|No intervention per protocol|0
5999984|NCT00923078|20746628|P3|First Intervention (Weeks 1-4)|Withdrawal by Subject|0
5999985|NCT00923078|20746629|P2|First Intervention (Weeks 1-4)|Withdrawal by Subject|1
5999986|NCT00923078|20746630|P1|First Intervention (Weeks 1-4)|Withdrawal by Subject|1
5999987|NCT00922987|20746649|P1|Overall Study|Adverse Event|1
5999988|NCT00922987|20746649|P1|Overall Study|Protocol Violation|2
5999989|NCT00922987|20746649|P1|Overall Study|Insufficient clinical response|1
5999990|NCT00922974|20746664|P2|Phase III Component|Protocol Violation|6
5999991|NCT00922974|20746665|P1|Phase III Component|Protocol Violation|8
5999992|NCT00922974|20746664|P2|Phase II Component|Not evaluable for treatment review|0
5999993|NCT00922974|20746665|P1|Phase II Component|Not evaluable for treatment review|5
5999994|NCT00922974|20746664|P2|Phase II Component|Protocol Violation|0
5999995|NCT00922974|20746665|P1|Phase II Component|Protocol Violation|2
5999996|NCT00922935|20746680|P3|Overall Study|Lost to Follow-up|0
5999997|NCT00922935|20746681|P2|Overall Study|Lost to Follow-up|1
5999998|NCT00922935|20746682|P1|Overall Study|Lost to Follow-up|0
5999999|NCT00922935|20746680|P3|Overall Study|Physician Decision|0
6000000|NCT00922935|20746681|P2|Overall Study|Physician Decision|1
6000001|NCT00922935|20746682|P1|Overall Study|Physician Decision|1
6000002|NCT00922935|20746680|P3|Overall Study|Protocol Violation|0
6000003|NCT00922935|20746681|P2|Overall Study|Protocol Violation|3
6000004|NCT00922935|20746682|P1|Overall Study|Protocol Violation|0
6000005|NCT00922779|20746694|P1|Overall Study|Missing|1874
6000006|NCT00922779|20746694|P1|Overall Study|Other|27
6000007|NCT00922779|20746694|P1|Overall Study|Lost to Follow-up|44
6000008|NCT00922779|20746694|P1|Overall Study|Withdrawal by Subject|308
6000009|NCT00922779|20746694|P1|Overall Study|Pregnancy|7
6000010|NCT00922779|20746694|P1|Overall Study|Adverse Event|67
6000011|NCT00922766|20746701|P1|Overall Study|Adverse Event|1
6000012|NCT00922766|20746701|P1|Overall Study|Other|1
6000013|NCT00922766|20746701|P1|Overall Study|Withdrawal by Subject|2
6000014|NCT00922766|20746701|P1|Overall Study|Death|3
6000015|NCT00922636|20746719|P5|Overall Study|Lost to Follow-up|4
6000016|NCT00922636|20746720|P4|Overall Study|Lost to Follow-up|2
6000017|NCT00922636|20746721|P3|Overall Study|Lost to Follow-up|2
6000018|NCT00922636|20746722|P2|Overall Study|Lost to Follow-up|2
6000019|NCT00922636|20746723|P1|Overall Study|Lost to Follow-up|1
6000020|NCT00922636|20746719|P5|Overall Study|Parent/Caregiver Decision|2
6000021|NCT00922636|20746720|P4|Overall Study|Parent/Caregiver Decision|5
6000022|NCT00922636|20746721|P3|Overall Study|Parent/Caregiver Decision|3
6000023|NCT00922636|20746722|P2|Overall Study|Parent/Caregiver Decision|4
6000024|NCT00922636|20746723|P1|Overall Study|Parent/Caregiver Decision|2
6000025|NCT00922636|20746719|P5|Overall Study|Entry Criteria Not Met|0
6000026|NCT00922636|20746720|P4|Overall Study|Entry Criteria Not Met|1
6000027|NCT00922636|20746721|P3|Overall Study|Entry Criteria Not Met|1
6000028|NCT00922636|20746722|P2|Overall Study|Entry Criteria Not Met|0
6000029|NCT00922636|20746723|P1|Overall Study|Entry Criteria Not Met|0
6000030|NCT00922636|20746719|P5|Overall Study|Protocol Violation|0
6000031|NCT00922636|20746720|P4|Overall Study|Protocol Violation|2
6000032|NCT00922636|20746721|P3|Overall Study|Protocol Violation|2
6000033|NCT00922636|20746722|P2|Overall Study|Protocol Violation|0
6000034|NCT00922636|20746723|P1|Overall Study|Protocol Violation|0
6000035|NCT00922636|20746719|P5|Overall Study|Withdrawal by Subject|4
6000036|NCT00922636|20746720|P4|Overall Study|Withdrawal by Subject|2
6000037|NCT00922636|20746721|P3|Overall Study|Withdrawal by Subject|5
6000038|NCT00922636|20746722|P2|Overall Study|Withdrawal by Subject|0
6000039|NCT00922636|20746723|P1|Overall Study|Withdrawal by Subject|0
6000040|NCT00922636|20746719|P5|Overall Study|Sponsor Decision|0
6000041|NCT00922636|20746720|P4|Overall Study|Sponsor Decision|0
6000042|NCT00922636|20746721|P3|Overall Study|Sponsor Decision|2
6000043|NCT00922636|20746722|P2|Overall Study|Sponsor Decision|0
6000044|NCT00922636|20746723|P1|Overall Study|Sponsor Decision|0
6000045|NCT00922636|20746719|P5|Overall Study|Lack of Efficacy|4
6000046|NCT00922636|20746720|P4|Overall Study|Lack of Efficacy|2
6000047|NCT00922636|20746721|P3|Overall Study|Lack of Efficacy|3
6000048|NCT00922636|20746722|P2|Overall Study|Lack of Efficacy|7
6000049|NCT00922636|20746723|P1|Overall Study|Lack of Efficacy|1
6000050|NCT00922636|20746719|P5|Overall Study|Adverse Event|2
6000051|NCT00922636|20746720|P4|Overall Study|Adverse Event|3
6000052|NCT00922636|20746721|P3|Overall Study|Adverse Event|2
6000053|NCT00922636|20746722|P2|Overall Study|Adverse Event|3
6000054|NCT00922636|20746723|P1|Overall Study|Adverse Event|3
6000055|NCT00922623|20746870|P1|Overall Study|Lost to Follow-up|1
6000056|NCT00922623|20746870|P1|Overall Study|Other|4
6000057|NCT00922480|20746878|P2|Extension Study|Others|1
6000058|NCT00922480|20746879|P1|Extension Study|Others|0
6000059|NCT00922480|20746878|P2|Extension Study|Withdrawal by Subject|1
6000060|NCT00922480|20746879|P1|Extension Study|Withdrawal by Subject|1
6000061|NCT00922480|20746878|P2|Extension Study|Adverse Event|1
6000062|NCT00922480|20746879|P1|Extension Study|Adverse Event|1
6000063|NCT00922480|20746878|P2|Extension Study|Protocol Violation|0
6000064|NCT00922480|20746879|P1|Extension Study|Protocol Violation|3
6000065|NCT00922480|20746878|P2|Main Study|Physician Decision|1
6000066|NCT00922480|20746879|P1|Main Study|Physician Decision|0
6000067|NCT00922480|20746878|P2|Main Study|Lost to Follow-up|0
6000068|NCT00922480|20746879|P1|Main Study|Lost to Follow-up|5
6000069|NCT00922480|20746878|P2|Main Study|Withdrawal by Subject|15
6000070|NCT00922480|20746879|P1|Main Study|Withdrawal by Subject|20
6000071|NCT00922480|20746878|P2|Main Study|Lack of Efficacy|0
6000072|NCT00922480|20746879|P1|Main Study|Lack of Efficacy|3
6000073|NCT00922480|20746878|P2|Main Study|Adverse Event|7
6000074|NCT00922480|20746879|P1|Main Study|Adverse Event|6
6000075|NCT00922480|20746878|P2|Main Study|Protocol Violation|6
6000076|NCT00922480|20746879|P1|Main Study|Protocol Violation|3
6000077|NCT00922441|20746890|P3|Overall Study|Withdrawal by Subject|1
6000078|NCT00922441|20746891|P2|Overall Study|Withdrawal by Subject|0
6000079|NCT00922441|20746892|P1|Overall Study|Withdrawal by Subject|0
6000080|NCT00922441|20746890|P3|Overall Study|Protocol Violation|2
6000081|NCT00922441|20746891|P2|Overall Study|Protocol Violation|0
6000082|NCT00922441|20746892|P1|Overall Study|Protocol Violation|0
6000083|NCT00922428|20746900|P1|Overall Study|no medication use or questionable use|13
6000084|NCT00922428|20746900|P1|Overall Study|retrospective/extremely implausible data|2
6000085|NCT00922272|20746929|P2|Double-blind Phase|Positive urine drug screen|1
6000086|NCT00922272|20746930|P1|Double-blind Phase|Positive urine drug screen|1
6000087|NCT00922272|20746929|P2|Double-blind Phase|Noncompliance|1
6000088|NCT00922272|20746930|P1|Double-blind Phase|Noncompliance|1
6000089|NCT00922272|20746929|P2|Double-blind Phase|Withdrawal criteria met|1
6000090|NCT00922272|20746930|P1|Double-blind Phase|Withdrawal criteria met|1
6000091|NCT00922272|20746929|P2|Double-blind Phase|Lost to Follow-up|1
6000092|NCT00922272|20746930|P1|Double-blind Phase|Lost to Follow-up|2
6000093|NCT00922272|20746929|P2|Double-blind Phase|Withdrawal by Subject|1
6000094|NCT00922272|20746930|P1|Double-blind Phase|Withdrawal by Subject|1
6000095|NCT00922272|20746929|P2|Double-blind Phase|Adverse Event|1
6000096|NCT00922272|20746930|P1|Double-blind Phase|Adverse Event|1
6000097|NCT00922272|20746929|P2|Open-label Phase|Withdrawal criteria met|0
6000098|NCT00922272|20746930|P1|Open-label Phase|Withdrawal criteria met|5
6000099|NCT00922272|20746929|P2|Open-label Phase|Failure to meet randomization criteria|0
6000100|NCT00922272|20746930|P1|Open-label Phase|Failure to meet randomization criteria|1
6000101|NCT00922272|20746929|P2|Open-label Phase|Withdrawal by Subject|0
6000102|NCT00922272|20746930|P1|Open-label Phase|Withdrawal by Subject|11
6000103|NCT00922272|20746929|P2|Open-label Phase|Protocol Violation|0
6000104|NCT00922272|20746930|P1|Open-label Phase|Protocol Violation|1
6000105|NCT00922272|20746929|P2|Open-label Phase|Adverse Event|0
6000106|NCT00922272|20746930|P1|Open-label Phase|Adverse Event|5
6000107|NCT00922207|20746995|P3|Overall Study|Abnormality of Laboratory Test|1
6000108|NCT00922207|20746996|P2|Overall Study|Abnormality of Laboratory Test|1
6000109|NCT00922207|20746997|P1|Overall Study|Abnormality of Laboratory Test|0
6000110|NCT00922207|20746995|P3|Overall Study|Withdrew Consent|2
6000111|NCT00922207|20746996|P2|Overall Study|Withdrew Consent|5
6000112|NCT00922207|20746997|P1|Overall Study|Withdrew Consent|2
6000113|NCT00922207|20746995|P3|Overall Study|Refused Treatment/Did Not Cooperate|0
6000114|NCT00922207|20746996|P2|Overall Study|Refused Treatment/Did Not Cooperate|0
6000115|NCT00922207|20746997|P1|Overall Study|Refused Treatment/Did Not Cooperate|1
6000116|NCT00922207|20746995|P3|Overall Study|Violation of Selection Criteria at Entry|0
6000117|NCT00922207|20746996|P2|Overall Study|Violation of Selection Criteria at Entry|1
6000118|NCT00922207|20746997|P1|Overall Study|Violation of Selection Criteria at Entry|0
6000119|NCT00922207|20746995|P3|Overall Study|Insufficient Therapeutic Response|1
6000120|NCT00922207|20746996|P2|Overall Study|Insufficient Therapeutic Response|0
6000121|NCT00922207|20746997|P1|Overall Study|Insufficient Therapeutic Response|0
6000122|NCT00922207|20746995|P3|Overall Study|Adverse Event/Intercurrent Illness|0
6000123|NCT00922207|20746996|P2|Overall Study|Adverse Event/Intercurrent Illness|0
6000124|NCT00922207|20746997|P1|Overall Study|Adverse Event/Intercurrent Illness|3
6000125|NCT00922116|20747033|P1|Overall Study|Other|5
6000126|NCT00922116|20747033|P1|Overall Study|Withdrawal by Subject|4
6000127|NCT00922116|20747033|P1|Overall Study|Lost to Follow-up|1
6000128|NCT00922116|20747033|P1|Overall Study|Death|1
6000129|NCT00922116|20747033|P1|Overall Study|Adverse Event|4
6000130|NCT00921557|20747095|P3|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1
6000131|NCT00921557|20747096|P2|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1
6000132|NCT00921557|20747097|P1|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|2
6000133|NCT00921557|20747095|P3|Weeks 96-144 (Off Study Treatment)|Site closure|0
6000134|NCT00921557|20747096|P2|Weeks 96-144 (Off Study Treatment)|Site closure|0
6000135|NCT00921557|20747097|P1|Weeks 96-144 (Off Study Treatment)|Site closure|1
6000136|NCT00921557|20747095|P3|Weeks 48-96 (on Study Treatment)|Became a ward of the state|1
6000137|NCT00921557|20747096|P2|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0
6000138|NCT00921557|20747097|P1|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0
6000139|NCT00921557|20747095|P3|Weeks 48-96 (on Study Treatment)|Site Closure|0
6000140|NCT00921557|20747096|P2|Weeks 48-96 (on Study Treatment)|Site Closure|1
6000141|NCT00921557|20747097|P1|Weeks 48-96 (on Study Treatment)|Site Closure|0
6000142|NCT00921557|20747095|P3|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0
6000143|NCT00921557|20747096|P2|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0
6000144|NCT00921557|20747097|P1|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|2
6000145|NCT00921024|20747199|P2|Overall Study|Withdrawal by Subject|3
6000146|NCT00921024|20747200|P1|Overall Study|Withdrawal by Subject|0
6000147|NCT00921024|20747199|P2|Overall Study|Received concomittant therapy|0
6000148|NCT00921024|20747200|P1|Overall Study|Received concomittant therapy|2
6000149|NCT00921024|20747199|P2|Overall Study|Lost to Follow-up|0
6000150|NCT00921024|20747200|P1|Overall Study|Lost to Follow-up|2
6000151|NCT00920907|20747210|P2|Maintenance Period|Adverse Event|1
6000152|NCT00920907|20747211|P1|Maintenance Period|Adverse Event|0
6000153|NCT00920907|20747210|P2|Maintenance Period|Withdrawal by Subject|0
6000154|NCT00920907|20747211|P1|Maintenance Period|Withdrawal by Subject|1
6000155|NCT00920907|20747210|P2|Maintenance Period|Death|1
6000156|NCT00920907|20747211|P1|Maintenance Period|Death|1
6000157|NCT00920907|20747210|P2|Maintenance Period|Study Drug Toxicity|2
6000158|NCT00920907|20747211|P1|Maintenance Period|Study Drug Toxicity|0
6000159|NCT00920907|20747210|P2|Maintenance Period|Administrative (study closure)|2
6000160|NCT00920907|20747211|P1|Maintenance Period|Administrative (study closure)|7
6000161|NCT00920907|20747210|P2|Maintenance Period|Disease Progression|7
6000162|NCT00920907|20747211|P1|Maintenance Period|Disease Progression|3
6000163|NCT00920907|20747210|P2|Induction Period|Withdrawal by Subject|1
6000164|NCT00920907|20747211|P1|Induction Period|Withdrawal by Subject|1
6000165|NCT00920907|20747210|P2|Induction Period|No longer meets study criteria|1
6000166|NCT00920907|20747211|P1|Induction Period|No longer meets study criteria|0
6000167|NCT00920907|20747210|P2|Induction Period|Study Drug Toxicity|6
6000168|NCT00920907|20747211|P1|Induction Period|Study Drug Toxicity|8
6000169|NCT00920907|20747210|P2|Induction Period|Disease Progression|11
6000170|NCT00920907|20747211|P1|Induction Period|Disease Progression|12
6000171|NCT00920907|20747210|P2|Induction Period|Death|1
6000172|NCT00920907|20747211|P1|Induction Period|Death|1
6000173|NCT00920907|20747210|P2|Induction Period|Adverse Event|2
6000174|NCT00920907|20747211|P1|Induction Period|Adverse Event|0
6000175|NCT00920855|20747252|P3|Overall Study|Response plateau; started maintenance|1
6000176|NCT00920855|20747253|P2|Overall Study|Response plateau; started maintenance|0
6000177|NCT00920855|20747254|P1|Overall Study|Response plateau; started maintenance|0
6000178|NCT00920855|20747252|P3|Overall Study|Noncompliance to study medication|1
6000179|NCT00920855|20747253|P2|Overall Study|Noncompliance to study medication|0
6000180|NCT00920855|20747254|P1|Overall Study|Noncompliance to study medication|0
6000181|NCT00920855|20747252|P3|Overall Study|Disease progression|10
6000182|NCT00920855|20747253|P2|Overall Study|Disease progression|1
6000183|NCT00920855|20747254|P1|Overall Study|Disease progression|2
6000184|NCT00920855|20747252|P3|Overall Study|Withdrawal by Subject|6
6000185|NCT00920855|20747253|P2|Overall Study|Withdrawal by Subject|1
6000186|NCT00920855|20747254|P1|Overall Study|Withdrawal by Subject|2
6000187|NCT00920855|20747252|P3|Overall Study|Adverse Event|4
6000188|NCT00920855|20747253|P2|Overall Study|Adverse Event|1
6000189|NCT00920855|20747254|P1|Overall Study|Adverse Event|1
6000190|NCT00920829|20747280|P4|Available for Analysis|Required more treatment|1
6000191|NCT00920829|20747281|P3|Available for Analysis|Required more treatment|0
6000192|NCT00920829|20747282|P2|Available for Analysis|Required more treatment|2
6000193|NCT00920829|20747283|P1|Available for Analysis|Required more treatment|0
6000194|NCT00920829|20747280|P4|Available for Analysis|Protocol Violation|0
6000195|NCT00920829|20747281|P3|Available for Analysis|Protocol Violation|1
6000196|NCT00920829|20747282|P2|Available for Analysis|Protocol Violation|0
6000197|NCT00920829|20747283|P1|Available for Analysis|Protocol Violation|0
6000198|NCT00920829|20747280|P4|Available for Analysis|Death|0
6000199|NCT00920829|20747281|P3|Available for Analysis|Death|0
6000200|NCT00920829|20747282|P2|Available for Analysis|Death|0
6000201|NCT00920829|20747283|P1|Available for Analysis|Death|1
6000202|NCT00920829|20747280|P4|Available for Analysis|Adverse Event|0
6000203|NCT00920829|20747281|P3|Available for Analysis|Adverse Event|1
6000204|NCT00920829|20747282|P2|Available for Analysis|Adverse Event|2
6000205|NCT00920829|20747283|P1|Available for Analysis|Adverse Event|1
6000206|NCT00920829|20747280|P4|Available for Analysis|Required Medical Treatment|0
6000207|NCT00920829|20747281|P3|Available for Analysis|Required Medical Treatment|2
6000208|NCT00920829|20747282|P2|Available for Analysis|Required Medical Treatment|1
6000209|NCT00920829|20747283|P1|Available for Analysis|Required Medical Treatment|0
6000210|NCT00920829|20747280|P4|Available for Analysis|Withdrawal by Subject|10
6000211|NCT00920829|20747281|P3|Available for Analysis|Withdrawal by Subject|6
6000212|NCT00920829|20747282|P2|Available for Analysis|Withdrawal by Subject|6
6000213|NCT00920829|20747283|P1|Available for Analysis|Withdrawal by Subject|6
6000214|NCT00920829|20747280|P4|Allocation|No post randomization data|2
6000215|NCT00920829|20747281|P3|Allocation|No post randomization data|0
6000216|NCT00920829|20747282|P2|Allocation|No post randomization data|1
6000217|NCT00920829|20747283|P1|Allocation|No post randomization data|3
6000218|NCT00920816|20747297|P4|Overall Study|Ongoing|36
6000219|NCT00920816|20747298|P3|Overall Study|Ongoing|70
6000220|NCT00920816|20747299|P2|Overall Study|Ongoing|56
6000221|NCT00920816|20747300|P1|Overall Study|Ongoing|106
6000222|NCT00920816|20747297|P4|Overall Study|Withdrawal by Subject|1
6000223|NCT00920816|20747298|P3|Overall Study|Withdrawal by Subject|1
6000224|NCT00920816|20747299|P2|Overall Study|Withdrawal by Subject|2
6000225|NCT00920816|20747300|P1|Overall Study|Withdrawal by Subject|7
6000226|NCT00920816|20747297|P4|Overall Study|Objective progression or relapse|0
6000227|NCT00920816|20747298|P3|Overall Study|Objective progression or relapse|2
6000228|NCT00920816|20747299|P2|Overall Study|Objective progression or relapse|0
6000229|NCT00920816|20747300|P1|Overall Study|Objective progression or relapse|0
6000230|NCT00920816|20747297|P4|Overall Study|Lost to Follow-up|4
6000231|NCT00920816|20747298|P3|Overall Study|Lost to Follow-up|3
6000232|NCT00920816|20747299|P2|Overall Study|Lost to Follow-up|2
6000233|NCT00920816|20747300|P1|Overall Study|Lost to Follow-up|1
6000234|NCT00920816|20747297|P4|Overall Study|Adverse Event|0
6000235|NCT00920816|20747298|P3|Overall Study|Adverse Event|1
6000236|NCT00920816|20747299|P2|Overall Study|Adverse Event|0
6000237|NCT00920816|20747300|P1|Overall Study|Adverse Event|1
6000238|NCT00920816|20747297|P4|Overall Study|Death|28
6000239|NCT00920816|20747298|P3|Overall Study|Death|58
6000240|NCT00920816|20747299|P2|Overall Study|Death|36
6000241|NCT00920816|20747300|P1|Overall Study|Death|77
6000242|NCT00920790|20747338|P1|Overall Study|aggravation of general condition|14
6000243|NCT00920699|20747350|P3|Overall Study|Lost to Follow-up|2
6000244|NCT00920699|20747351|P2|Overall Study|Lost to Follow-up|0
6000245|NCT00920699|20747352|P1|Overall Study|Lost to Follow-up|0
6000246|NCT00920699|20747350|P3|Overall Study|no longer met eligibility|0
6000247|NCT00920699|20747351|P2|Overall Study|no longer met eligibility|1
6000248|NCT00920699|20747352|P1|Overall Study|no longer met eligibility|0
6000249|NCT00920699|20747350|P3|Overall Study|Withdrawal by Subject|2
6000250|NCT00920699|20747351|P2|Overall Study|Withdrawal by Subject|0
6000251|NCT00920699|20747352|P1|Overall Study|Withdrawal by Subject|2
6000252|NCT00920686|20747369|P3|Overall Study|Study drug dosing criteria not met|12
6000253|NCT00920686|20747370|P2|Overall Study|Study drug dosing criteria not met|19
6000254|NCT00920686|20747371|P1|Overall Study|Study drug dosing criteria not met|17
6000255|NCT00920686|20747369|P3|Overall Study|Lost to Follow-up|1
6000256|NCT00920686|20747370|P2|Overall Study|Lost to Follow-up|3
6000257|NCT00920686|20747371|P1|Overall Study|Lost to Follow-up|2
6000258|NCT00920556|20747446|P1|Overall Study|Withdrawal by Subject|1
6000259|NCT00920556|20747446|P1|Overall Study|Physician Decision|7
6000260|NCT00920556|20747446|P1|Overall Study|Adverse Event|16
6000261|NCT00920426|20747495|P4|ITZ111451|Adverse Event|0
6000262|NCT00920426|20747496|P3|ITZ111451|Adverse Event|0
6000263|NCT00920426|20747497|P2|ITZ111451|Adverse Event|0
6000264|NCT00920426|20747498|P1|ITZ111451|Adverse Event|1
6000265|NCT00920218|20747618|P4|Overall Study|Other|0
6000266|NCT00920218|20747619|P3|Overall Study|Other|1
6000267|NCT00920218|20747620|P2|Overall Study|Other|0
6000268|NCT00920218|20747621|P1|Overall Study|Other|0
6000269|NCT00920218|20747618|P4|Overall Study|Transplant failed/malignancy recurrence|3
6000270|NCT00920218|20747619|P3|Overall Study|Transplant failed/malignancy recurrence|2
6000271|NCT00920218|20747620|P2|Overall Study|Transplant failed/malignancy recurrence|1
6000272|NCT00920218|20747621|P1|Overall Study|Transplant failed/malignancy recurrence|0
6000273|NCT00920218|20747618|P4|Overall Study|Lost to Follow-up|3
6000274|NCT00920218|20747619|P3|Overall Study|Lost to Follow-up|0
6000275|NCT00920218|20747620|P2|Overall Study|Lost to Follow-up|1
6000276|NCT00920218|20747621|P1|Overall Study|Lost to Follow-up|0
6000277|NCT00920218|20747618|P4|Overall Study|Migrated/moved from study area|0
6000278|NCT00920218|20747619|P3|Overall Study|Migrated/moved from study area|1
6000279|NCT00920218|20747620|P2|Overall Study|Migrated/moved from study area|0
6000280|NCT00920218|20747621|P1|Overall Study|Migrated/moved from study area|0
6000281|NCT00920218|20747618|P4|Overall Study|Withdrawal by Subject|0
6000282|NCT00920218|20747619|P3|Overall Study|Withdrawal by Subject|2
6000283|NCT00920218|20747620|P2|Overall Study|Withdrawal by Subject|3
6000284|NCT00920218|20747621|P1|Overall Study|Withdrawal by Subject|0
6000285|NCT00920218|20747618|P4|Overall Study|Serious Adverse Event|1
6000286|NCT00920218|20747619|P3|Overall Study|Serious Adverse Event|2
6000287|NCT00920218|20747620|P2|Overall Study|Serious Adverse Event|0
6000288|NCT00920218|20747621|P1|Overall Study|Serious Adverse Event|2
6000289|NCT00920140|20747724|P5|Phase 2|Withdrawal by Subject|1
6000290|NCT00920140|20747725|P4|Phase 2|Withdrawal by Subject|2
6000291|NCT00920140|20747726|P3|Phase 2|Withdrawal by Subject|4
6000292|NCT00920140|20747727|P2|Phase 2|Withdrawal by Subject|0
6000293|NCT00920140|20747728|P1|Phase 2|Withdrawal by Subject|0
6000294|NCT00920140|20747724|P5|Phase 2|Physician Decision|2
6000295|NCT00920140|20747725|P4|Phase 2|Physician Decision|3
6000296|NCT00920140|20747726|P3|Phase 2|Physician Decision|3
6000297|NCT00920140|20747727|P2|Phase 2|Physician Decision|0
6000298|NCT00920140|20747728|P1|Phase 2|Physician Decision|0
6000299|NCT00920140|20747724|P5|Phase 2|Lost to Follow-up|0
6000300|NCT00920140|20747725|P4|Phase 2|Lost to Follow-up|1
6000301|NCT00920140|20747726|P3|Phase 2|Lost to Follow-up|0
6000302|NCT00920140|20747727|P2|Phase 2|Lost to Follow-up|0
6000303|NCT00920140|20747728|P1|Phase 2|Lost to Follow-up|0
6000304|NCT00920140|20747724|P5|Phase 2|Lack of Efficacy|5
6000305|NCT00920140|20747725|P4|Phase 2|Lack of Efficacy|14
6000306|NCT00920140|20747726|P3|Phase 2|Lack of Efficacy|29
6000307|NCT00920140|20747727|P2|Phase 2|Lack of Efficacy|0
6000308|NCT00920140|20747728|P1|Phase 2|Lack of Efficacy|0
6000309|NCT00920140|20747724|P5|Phase 2|Adverse Event|3
6000310|NCT00920140|20747725|P4|Phase 2|Adverse Event|2
6000311|NCT00920140|20747726|P3|Phase 2|Adverse Event|14
6000312|NCT00920140|20747727|P2|Phase 2|Adverse Event|0
6000313|NCT00920140|20747728|P1|Phase 2|Adverse Event|0
6000314|NCT00920140|20747724|P5|Phase 1 (Dose Escalation)|Withdrawal by Subject|0
6000315|NCT00920140|20747725|P4|Phase 1 (Dose Escalation)|Withdrawal by Subject|0
6000316|NCT00920140|20747726|P3|Phase 1 (Dose Escalation)|Withdrawal by Subject|0
6000317|NCT00920140|20747727|P2|Phase 1 (Dose Escalation)|Withdrawal by Subject|2
6000318|NCT00920140|20747728|P1|Phase 1 (Dose Escalation)|Withdrawal by Subject|0
6000319|NCT00920140|20747724|P5|Phase 1 (Dose Escalation)|Lack of Efficacy|0
6000320|NCT00920140|20747725|P4|Phase 1 (Dose Escalation)|Lack of Efficacy|0
6000321|NCT00920140|20747726|P3|Phase 1 (Dose Escalation)|Lack of Efficacy|0
6000322|NCT00920140|20747727|P2|Phase 1 (Dose Escalation)|Lack of Efficacy|4
6000323|NCT00920140|20747728|P1|Phase 1 (Dose Escalation)|Lack of Efficacy|2
6000324|NCT00920140|20747724|P5|Phase 1 (Dose Escalation)|Adverse Event|0
6000325|NCT00920140|20747725|P4|Phase 1 (Dose Escalation)|Adverse Event|0
6000326|NCT00920140|20747726|P3|Phase 1 (Dose Escalation)|Adverse Event|0
6000327|NCT00920140|20747727|P2|Phase 1 (Dose Escalation)|Adverse Event|3
6000328|NCT00920140|20747728|P1|Phase 1 (Dose Escalation)|Adverse Event|3
6000329|NCT00919893|20747790|P2|Overall Study|Protocol Violation|9
6000330|NCT00919893|20747791|P1|Overall Study|Protocol Violation|19
6000331|NCT00919867|20747803|P6|First Intervention|Physician Decision|1
6000332|NCT00919867|20747804|P5|First Intervention|Physician Decision|0
6000333|NCT00919867|20747805|P4|First Intervention|Physician Decision|0
6000334|NCT00919867|20747806|P3|First Intervention|Physician Decision|0
6000335|NCT00919867|20747807|P2|First Intervention|Physician Decision|0
6000336|NCT00919867|20747808|P1|First Intervention|Physician Decision|0
6000337|NCT00919867|20747803|P6|First Intervention|Withdrawal by Subject|0
6000338|NCT00919867|20747804|P5|First Intervention|Withdrawal by Subject|0
6000339|NCT00919867|20747805|P4|First Intervention|Withdrawal by Subject|0
6000340|NCT00919867|20747806|P3|First Intervention|Withdrawal by Subject|1
6000341|NCT00919867|20747807|P2|First Intervention|Withdrawal by Subject|0
6000342|NCT00919867|20747808|P1|First Intervention|Withdrawal by Subject|0
6000343|NCT00919854|20747829|P1|Overall Study|Adverse Event|1
6000344|NCT00919711|20747867|P2|Overall Study|Noncompliance|0
6000345|NCT00919711|20747868|P1|Overall Study|Noncompliance|1
6000346|NCT00919711|20747867|P2|Overall Study|Death|0
6000347|NCT00919711|20747868|P1|Overall Study|Death|1
6000348|NCT00919711|20747867|P2|Overall Study|Lost to Follow-up|0
6000349|NCT00919711|20747868|P1|Overall Study|Lost to Follow-up|2
6000350|NCT00919711|20747867|P2|Overall Study|Administrative Decision|1
6000351|NCT00919711|20747868|P1|Overall Study|Administrative Decision|0
6000352|NCT00919711|20747867|P2|Overall Study|Other|2
6000353|NCT00919711|20747868|P1|Overall Study|Other|1
6000354|NCT00919711|20747867|P2|Overall Study|Adverse Event|3
6000355|NCT00919711|20747868|P1|Overall Study|Adverse Event|13
6000356|NCT00919711|20747867|P2|Overall Study|Withdrawal by Subject|7
6000357|NCT00919711|20747868|P1|Overall Study|Withdrawal by Subject|15
6000358|NCT00919633|20747884|P4|Overall Study|Viral rebound outside protocol timepoint|0
6000359|NCT00919633|20747885|P3|Overall Study|Viral rebound outside protocol timepoint|1
6000360|NCT00919633|20747886|P2|Overall Study|Viral rebound outside protocol timepoint|0
6000361|NCT00919633|20747887|P1|Overall Study|Viral rebound outside protocol timepoint|0
6000362|NCT00919633|20747884|P4|Overall Study|Request of withdrawal w/o future contact|0
6000363|NCT00919633|20747885|P3|Overall Study|Request of withdrawal w/o future contact|1
6000364|NCT00919633|20747886|P2|Overall Study|Request of withdrawal w/o future contact|0
6000365|NCT00919633|20747887|P1|Overall Study|Request of withdrawal w/o future contact|0
6000366|NCT00919633|20747884|P4|Overall Study|Physician Decision|1
6000367|NCT00919633|20747885|P3|Overall Study|Physician Decision|0
6000368|NCT00919633|20747886|P2|Overall Study|Physician Decision|0
6000369|NCT00919633|20747887|P1|Overall Study|Physician Decision|0
6000370|NCT00919633|20747884|P4|Overall Study|Protocol Violation|1
6000371|NCT00919633|20747885|P3|Overall Study|Protocol Violation|0
6000372|NCT00919633|20747886|P2|Overall Study|Protocol Violation|0
6000373|NCT00919633|20747887|P1|Overall Study|Protocol Violation|0
6000374|NCT00919633|20747884|P4|Overall Study|Withdraw consent post transition to SOC|1
6000375|NCT00919633|20747885|P3|Overall Study|Withdraw consent post transition to SOC|1
6000376|NCT00919633|20747886|P2|Overall Study|Withdraw consent post transition to SOC|0
6000377|NCT00919633|20747887|P1|Overall Study|Withdraw consent post transition to SOC|0
6000378|NCT00919633|20747884|P4|Overall Study|Lost to Follow-up|2
6000379|NCT00919633|20747885|P3|Overall Study|Lost to Follow-up|0
6000380|NCT00919633|20747886|P2|Overall Study|Lost to Follow-up|1
6000381|NCT00919633|20747887|P1|Overall Study|Lost to Follow-up|3
6000382|NCT00919633|20747884|P4|Overall Study|Withdrawal by Subject|3
6000383|NCT00919633|20747885|P3|Overall Study|Withdrawal by Subject|4
6000384|NCT00919633|20747886|P2|Overall Study|Withdrawal by Subject|2
6000385|NCT00919633|20747887|P1|Overall Study|Withdrawal by Subject|1
6000386|NCT00919633|20747884|P4|Overall Study|Lack of Efficacy|3
6000387|NCT00919633|20747885|P3|Overall Study|Lack of Efficacy|2
6000388|NCT00919633|20747886|P2|Overall Study|Lack of Efficacy|3
6000389|NCT00919633|20747887|P1|Overall Study|Lack of Efficacy|17
6000390|NCT00919633|20747884|P4|Overall Study|Death|0
6000391|NCT00919633|20747885|P3|Overall Study|Death|2
6000392|NCT00919633|20747886|P2|Overall Study|Death|0
6000393|NCT00919633|20747887|P1|Overall Study|Death|0
6000394|NCT00919633|20747884|P4|Overall Study|Adverse Event|10
6000395|NCT00919633|20747885|P3|Overall Study|Adverse Event|12
6000396|NCT00919633|20747886|P2|Overall Study|Adverse Event|9
6000397|NCT00919633|20747887|P1|Overall Study|Adverse Event|1
6000398|NCT00919061|20747985|P1|Overall Study|Withdrawal by Subject|1
6000399|NCT00919061|20747985|P1|Overall Study|Adverse Event|1
6000400|NCT00918957|20747998|P2|Overall Study|Withdrawal by Subject|0
6000401|NCT00918957|20747999|P1|Overall Study|Withdrawal by Subject|1
6000402|NCT00918957|20747998|P2|Overall Study|Adverse Event|0
6000403|NCT00918957|20747999|P1|Overall Study|Adverse Event|2
6000404|NCT00918879|20748032|P2|Overall Study|Severe non-compliance to protocol|1
6000405|NCT00918879|20748033|P1|Overall Study|Severe non-compliance to protocol|1
6000406|NCT00918879|20748032|P2|Overall Study|Lost to Follow-up|1
6000407|NCT00918879|20748033|P1|Overall Study|Lost to Follow-up|1
6000408|NCT00918879|20748032|P2|Overall Study|Withdrawal by Subject|4
6000409|NCT00918879|20748033|P1|Overall Study|Withdrawal by Subject|4
6000410|NCT00918749|20748065|P3|Overall Study|No Study Medication Taken|0
6000411|NCT00918749|20748066|P2|Overall Study|No Study Medication Taken|0
6000412|NCT00918749|20748067|P1|Overall Study|No Study Medication Taken|1
6000413|NCT00918749|20748065|P3|Overall Study|Withdrawal by Subject|5
6000414|NCT00918749|20748066|P2|Overall Study|Withdrawal by Subject|3
6000415|NCT00918749|20748067|P1|Overall Study|Withdrawal by Subject|5
6000416|NCT00918749|20748065|P3|Overall Study|Lost to Follow-up|1
6000417|NCT00918749|20748066|P2|Overall Study|Lost to Follow-up|0
6000418|NCT00918749|20748067|P1|Overall Study|Lost to Follow-up|0
6000419|NCT00918749|20748065|P3|Overall Study|Adverse Event|1
6000420|NCT00918749|20748066|P2|Overall Study|Adverse Event|0
6000421|NCT00918749|20748067|P1|Overall Study|Adverse Event|1
6000422|NCT00918736|20748099|P1|Overall Study|Withdrawal by Subject|4
6000423|NCT00918684|20748112|P1|Treatment Phase|Withdrawal by Subject|8
6000424|NCT00918684|20748112|P1|Treatment Phase|Protocol Violation|1
6000425|NCT00918684|20748112|P1|Treatment Phase|Physician Decision|8
6000426|NCT00918684|20748112|P1|Treatment Phase|Lost to Follow-up|2
6000427|NCT00918684|20748112|P1|Treatment Phase|Lack of Efficacy|6
6000428|NCT00918684|20748112|P1|Two Week Drug Washout and Placebo Phase|Placebo Reponder|16
6000429|NCT00918645|20748123|P1|Overall Study|Withdrawal by Subject|1
6000430|NCT00918580|20748129|P1|After 6-month FU to 1-year FU|Failed to Return|2
6000431|NCT00918580|20748129|P1|After 6-month FU to 1-year FU|Did Not Continue After 6-Month FU|58
6000432|NCT00918580|20748129|P1|Up to 6-month Follow-up(FU)|Failed to Return|1
6000433|NCT00918580|20748129|P1|Up to 6-month Follow-up(FU)|Parent/Legal Guardian Request|2
6000434|NCT00918580|20748129|P1|Up to 6-month Follow-up(FU)|Withdrawal by Subject|2
6000435|NCT00918580|20748129|P1|Up to 6-month Follow-up(FU)|Lost to Follow-up|5
6000436|NCT00918580|20748129|P1|Up to 6-month Follow-up(FU)|Adverse Event|1
6000437|NCT00918567|20748149|P2|Overall Study|Adverse Event|0
6000438|NCT00918567|20748150|P1|Overall Study|Adverse Event|1
6000439|NCT00918567|20748149|P2|Overall Study|Withdrawal by Subject|1
6000440|NCT00918567|20748150|P1|Overall Study|Withdrawal by Subject|1
6000441|NCT00918567|20748149|P2|Overall Study|Lack of Efficacy|1
6000442|NCT00918567|20748150|P1|Overall Study|Lack of Efficacy|3
6000443|NCT00918463|20748176|P1|Overall Study|Lack of Efficacy|1
6000444|NCT00918463|20748176|P1|Overall Study|Death|1
6000445|NCT00918385|20748184|P2|Combination Nilutamide and Dasatinib|Withdrawal by Subject|7
6000446|NCT00918385|20748185|P1|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2
6000447|NCT00918385|20748184|P2|Combination Nilutamide and Dasatinib|Complicating illness|0
6000448|NCT00918385|20748185|P1|Combination Nilutamide and Dasatinib|Complicating illness|1
6000449|NCT00918385|20748184|P2|Combination Nilutamide and Dasatinib|Withdrawal by Subject|0
6000450|NCT00918385|20748185|P1|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2
6000451|NCT00918385|20748184|P2|Combination Nilutamide and Dasatinib|Adverse Event|1
6000452|NCT00918385|20748185|P1|Combination Nilutamide and Dasatinib|Adverse Event|1
6000453|NCT00918385|20748184|P2|Monotherapy|Complicating illness|0
6000454|NCT00918385|20748185|P1|Monotherapy|Complicating illness|1
6000455|NCT00918385|20748184|P2|Monotherapy|Adverse Event|6
6000456|NCT00918385|20748185|P1|Monotherapy|Adverse Event|1
6000457|NCT00918346|20748194|P2|First Treatment Period (4 Weeks)|Lack of Efficacy|1
6000458|NCT00918346|20748195|P1|First Treatment Period (4 Weeks)|Lack of Efficacy|0
6000459|NCT00918333|20748211|P2|Overall Study|Withdrawal by Subject|1
6000460|NCT00918333|20748212|P1|Overall Study|Withdrawal by Subject|0
6000461|NCT00918333|20748211|P2|Overall Study|Ineligible|0
6000462|NCT00918333|20748212|P1|Overall Study|Ineligible|1
6000463|NCT00918333|20748211|P2|Overall Study|Inadequate amount of drugs provided|4
6000464|NCT00918333|20748212|P1|Overall Study|Inadequate amount of drugs provided|1
6000465|NCT00918333|20748211|P2|Overall Study|Drug not taken per protocol|0
6000466|NCT00918333|20748212|P1|Overall Study|Drug not taken per protocol|1
6000467|NCT00918281|20748232|P1|Overall Study|Physician Decision|29
6000468|NCT00918255|20748242|P3|Overall Study|Investigator discretion|0
6000469|NCT00918255|20748243|P2|Overall Study|Investigator discretion|0
6000470|NCT00918255|20748244|P1|Overall Study|Investigator discretion|1
6000471|NCT00918255|20748242|P3|Overall Study|Non-compliance|0
6000472|NCT00918255|20748243|P2|Overall Study|Non-compliance|0
6000473|NCT00918255|20748244|P1|Overall Study|Non-compliance|1
6000474|NCT00918255|20748242|P3|Overall Study|Exceeded allowed number of interventions|1
6000475|NCT00918255|20748243|P2|Overall Study|Exceeded allowed number of interventions|0
6000476|NCT00918255|20748244|P1|Overall Study|Exceeded allowed number of interventions|0
6000477|NCT00918255|20748242|P3|Overall Study|Lost to Follow-up|2
6000478|NCT00918255|20748243|P2|Overall Study|Lost to Follow-up|0
6000479|NCT00918255|20748244|P1|Overall Study|Lost to Follow-up|1
6000480|NCT00918255|20748242|P3|Overall Study|Lack of Efficacy|0
6000481|NCT00918255|20748243|P2|Overall Study|Lack of Efficacy|0
6000482|NCT00918255|20748244|P1|Overall Study|Lack of Efficacy|1
6000483|NCT00918255|20748242|P3|Overall Study|Withdrawal by Subject|2
6000484|NCT00918255|20748243|P2|Overall Study|Withdrawal by Subject|0
6000485|NCT00918255|20748244|P1|Overall Study|Withdrawal by Subject|1
6000486|NCT00918255|20748242|P3|Overall Study|Adverse Event|0
6000487|NCT00918255|20748243|P2|Overall Study|Adverse Event|0
6000488|NCT00918255|20748244|P1|Overall Study|Adverse Event|1
6000489|NCT00918203|20748277|P3|Treatment With or Without Olaratumab|Never Treated/Death|0
6000490|NCT00918203|20748278|P2|Treatment With or Without Olaratumab|Never Treated/Death|0
6000491|NCT00918203|20748279|P1|Treatment With or Without Olaratumab|Never Treated/Death|1
6000492|NCT00918203|20748277|P3|Treatment With or Without Olaratumab|Other Therapy Started|0
6000493|NCT00918203|20748278|P2|Treatment With or Without Olaratumab|Other Therapy Started|1
6000494|NCT00918203|20748279|P1|Treatment With or Without Olaratumab|Other Therapy Started|2
6000495|NCT00918203|20748277|P3|Treatment With or Without Olaratumab|Withdrawal by Subject|0
6000496|NCT00918203|20748278|P2|Treatment With or Without Olaratumab|Withdrawal by Subject|8
6000497|NCT00918203|20748279|P1|Treatment With or Without Olaratumab|Withdrawal by Subject|2
6000498|NCT00918203|20748277|P3|Treatment With or Without Olaratumab|Lost to Follow-up|0
6000499|NCT00918203|20748278|P2|Treatment With or Without Olaratumab|Lost to Follow-up|1
6000500|NCT00918203|20748279|P1|Treatment With or Without Olaratumab|Lost to Follow-up|1
6000501|NCT00918138|20748310|P2|Overall Study|Death|0
6000502|NCT00918138|20748311|P1|Overall Study|Death|1
6000503|NCT00918138|20748310|P2|Overall Study|Subject withdrew consent|1
6000504|NCT00918138|20748311|P1|Overall Study|Subject withdrew consent|1
6000505|NCT00917852|20748350|P1|Overall Study|Death|6
6000512|NCT00917579|20748383|P2|Washout >= 2 Weeks|Withdrawal by Subject|0
6000513|NCT00917579|20748384|P1|Washout >= 2 Weeks|Withdrawal by Subject|1
6000514|NCT00917579|20748383|P2|Washout >= 2 Weeks|Adverse Event|0
6000515|NCT00917579|20748384|P1|Washout >= 2 Weeks|Adverse Event|1
6000516|NCT00917553|20748400|P2|Overall Study|Lost to Follow-up|1
6000517|NCT00917553|20748401|P1|Overall Study|Lost to Follow-up|2
6000518|NCT00917501|20748417|P2|Overall Study|trouble swollowing capsules|1
6000519|NCT00917501|20748418|P1|Overall Study|trouble swollowing capsules|0
6000520|NCT00917501|20748417|P2|Overall Study|Lack of Efficacy|2
6000521|NCT00917501|20748418|P1|Overall Study|Lack of Efficacy|1
6000522|NCT00917501|20748417|P2|Overall Study|Withdrawal by Subject|1
6000523|NCT00917501|20748418|P1|Overall Study|Withdrawal by Subject|3
6000524|NCT00917501|20748417|P2|Overall Study|Lost to Follow-up|1
6000525|NCT00917501|20748418|P1|Overall Study|Lost to Follow-up|4
6000526|NCT00917462|20748424|P1|Overall Study|Clinical Deterioration|1
6000527|NCT00917384|20748434|P2|Overall Study|Withdrawal by Subject|2
6000528|NCT00917384|20748435|P1|Overall Study|Withdrawal by Subject|10
6000529|NCT00917384|20748434|P2|Overall Study|Lost to Follow-up|2
6000530|NCT00917384|20748435|P1|Overall Study|Lost to Follow-up|4
6000531|NCT00917267|20748459|P2|Overall Study|Lack of Efficacy-Loss of Glucose Control|2
6000532|NCT00917267|20748460|P1|Overall Study|Lack of Efficacy-Loss of Glucose Control|2
6000533|NCT00917267|20748459|P2|Overall Study|Sponsor Decision|5
6000534|NCT00917267|20748460|P1|Overall Study|Sponsor Decision|5
6000535|NCT00917267|20748459|P2|Overall Study|Entry Criteria Not Met|0
6000536|NCT00917267|20748460|P1|Overall Study|Entry Criteria Not Met|1
6000537|NCT00917267|20748459|P2|Overall Study|Lost to follow up|2
6000538|NCT00917267|20748460|P1|Overall Study|Lost to follow up|0
6000539|NCT00917267|20748459|P2|Overall Study|Withdrawal by Subject|12
6000540|NCT00917267|20748460|P1|Overall Study|Withdrawal by Subject|5
6000541|NCT00917267|20748459|P2|Overall Study|Protocol Violation|18
6000542|NCT00917267|20748460|P1|Overall Study|Protocol Violation|9
6000543|NCT00917267|20748459|P2|Overall Study|Physician Decision|4
6000544|NCT00917267|20748460|P1|Overall Study|Physician Decision|2
6000545|NCT00917267|20748459|P2|Overall Study|Adverse Event|36
6000546|NCT00917267|20748460|P1|Overall Study|Adverse Event|15
6000547|NCT00917124|20748488|P2|Overall Study|Protocol Violation|6
6000548|NCT00917124|20748489|P1|Overall Study|Protocol Violation|4
6000549|NCT00916929|20748499|P2|Overall Study|Device unable to process impedance data|7
6000550|NCT00916929|20748500|P1|Overall Study|Device unable to process impedance data|0
6000551|NCT00916929|20748499|P2|Overall Study|Moved to another state|1
6000552|NCT00916929|20748500|P1|Overall Study|Moved to another state|0
6000553|NCT00916929|20748499|P2|Overall Study|System explant|0
6000554|NCT00916929|20748500|P1|Overall Study|System explant|1
6000555|NCT00916929|20748499|P2|Overall Study|Transferred to hospice care|1
6000556|NCT00916929|20748500|P1|Overall Study|Transferred to hospice care|1
6000557|NCT00916929|20748499|P2|Overall Study|Left ventricular epicardial lead|2
6000558|NCT00916929|20748500|P1|Overall Study|Left ventricular epicardial lead|1
6000559|NCT00916929|20748499|P2|Overall Study|Withdrawal by Subject|5
6000560|NCT00916929|20748500|P1|Overall Study|Withdrawal by Subject|1
6000561|NCT00916929|20748499|P2|Overall Study|Death|10
6000562|NCT00916929|20748500|P1|Overall Study|Death|5
6000563|NCT00916929|20748499|P2|Overall Study|Lost to Follow-up|3
6000564|NCT00916929|20748500|P1|Overall Study|Lost to Follow-up|1
6000565|NCT00916721|20748510|P2|Overall Study|Protocol Violation|4
6000566|NCT00916721|20748511|P1|Overall Study|Protocol Violation|2
6000567|NCT00916721|20748510|P2|Overall Study|Withdrawal by Subject|2
6000568|NCT00916721|20748511|P1|Overall Study|Withdrawal by Subject|2
6000569|NCT00916721|20748510|P2|Overall Study|Adverse Event|3
6000570|NCT00916721|20748511|P1|Overall Study|Adverse Event|6
6000571|NCT00916721|20748510|P2|Overall Study|Lost to Follow-up|1
6000572|NCT00916721|20748511|P1|Overall Study|Lost to Follow-up|0
6000573|NCT00916617|20748534|P4|Overall Study|Other|2
6000574|NCT00916617|20748535|P3|Overall Study|Other|0
6000575|NCT00916617|20748536|P2|Overall Study|Other|0
6000576|NCT00916617|20748537|P1|Overall Study|Other|2
6000577|NCT00916617|20748534|P4|Overall Study|Lack of Efficacy|0
6000578|NCT00916617|20748535|P3|Overall Study|Lack of Efficacy|0
6000579|NCT00916617|20748536|P2|Overall Study|Lack of Efficacy|0
6000580|NCT00916617|20748537|P1|Overall Study|Lack of Efficacy|1
6000581|NCT00916617|20748534|P4|Overall Study|Lost to Follow-up|0
6000582|NCT00916617|20748535|P3|Overall Study|Lost to Follow-up|0
6000583|NCT00916617|20748536|P2|Overall Study|Lost to Follow-up|1
6000584|NCT00916617|20748537|P1|Overall Study|Lost to Follow-up|2
6000585|NCT00916617|20748534|P4|Overall Study|Discontinuation of Study by Sponsor|1
6000586|NCT00916617|20748535|P3|Overall Study|Discontinuation of Study by Sponsor|3
6000587|NCT00916617|20748536|P2|Overall Study|Discontinuation of Study by Sponsor|13
6000588|NCT00916617|20748537|P1|Overall Study|Discontinuation of Study by Sponsor|8
6000589|NCT00916617|20748534|P4|Overall Study|Physician Decision|0
6000590|NCT00916617|20748535|P3|Overall Study|Physician Decision|0
6000591|NCT00916617|20748536|P2|Overall Study|Physician Decision|1
6000592|NCT00916617|20748537|P1|Overall Study|Physician Decision|1
6000593|NCT00916617|20748534|P4|Overall Study|Caregiver Request|0
6000594|NCT00916617|20748535|P3|Overall Study|Caregiver Request|1
6000595|NCT00916617|20748536|P2|Overall Study|Caregiver Request|2
6000596|NCT00916617|20748537|P1|Overall Study|Caregiver Request|3
6000597|NCT00916617|20748534|P4|Overall Study|Withdrawal by Subject|1
6000598|NCT00916617|20748535|P3|Overall Study|Withdrawal by Subject|0
6000599|NCT00916617|20748536|P2|Overall Study|Withdrawal by Subject|2
6000600|NCT00916617|20748537|P1|Overall Study|Withdrawal by Subject|3
6000601|NCT00916617|20748534|P4|Overall Study|Adverse Event|3
6000602|NCT00916617|20748535|P3|Overall Study|Adverse Event|6
6000603|NCT00916617|20748536|P2|Overall Study|Adverse Event|2
6000604|NCT00916617|20748537|P1|Overall Study|Adverse Event|3
6000605|NCT00916578|20748551|P1|Overall Study|Insurance Denial|2
6000606|NCT00916578|20748551|P1|Overall Study|Withdrawal by Subject|3
6000607|NCT00916578|20748551|P1|Overall Study|Physician Decision|2
6000608|NCT00916383|20748580|P1|Overall Study|Protocol Violation|1
6000609|NCT00916383|20748580|P1|Overall Study|Death|1
6000610|NCT00916383|20748580|P1|Overall Study|Adverse Event|1
6000611|NCT00916370|20748608|P2|Overall Study|Physician Decision|1
6000612|NCT00916370|20748609|P1|Overall Study|Physician Decision|0
6000613|NCT00916370|20748608|P2|Overall Study|Withdrawal by Subject|0
6000614|NCT00916370|20748609|P1|Overall Study|Withdrawal by Subject|2
6000615|NCT00916370|20748608|P2|Overall Study|Death|1
6000616|NCT00916370|20748609|P1|Overall Study|Death|3
6000617|NCT00916357|20748783|P6|Period 2|Weight loss > 3 kilograms (kg)|0
6000618|NCT00916357|20748784|P5|Period 2|Weight loss > 3 kilograms (kg)|0
6000619|NCT00916357|20748785|P4|Period 2|Weight loss > 3 kilograms (kg)|1
6000620|NCT00916357|20748786|P3|Period 2|Weight loss > 3 kilograms (kg)|0
6000621|NCT00916357|20748787|P2|Period 2|Weight loss > 3 kilograms (kg)|0
6000622|NCT00916357|20748788|P1|Period 2|Weight loss > 3 kilograms (kg)|0
6000623|NCT00916357|20748783|P6|Period 1|Withdrawal by Subject|0
6000624|NCT00916357|20748784|P5|Period 1|Withdrawal by Subject|0
6000625|NCT00916357|20748785|P4|Period 1|Withdrawal by Subject|0
6000626|NCT00916357|20748786|P3|Period 1|Withdrawal by Subject|0
6000627|NCT00916357|20748787|P2|Period 1|Withdrawal by Subject|0
6000628|NCT00916357|20748788|P1|Period 1|Withdrawal by Subject|1
6000629|NCT00916344|20748826|P1|Overall Study|Drop-out|5
6000630|NCT00916344|20748826|P1|Overall Study|ICD upgrade|1
6000631|NCT00916344|20748826|P1|Overall Study|Death|2
6000632|NCT00916305|20748833|P2|Overall Study|Withdrawal by Subject|1
6000633|NCT00916305|20748834|P1|Overall Study|Withdrawal by Subject|0
6000634|NCT00916305|20748833|P2|Overall Study|Lost to Follow-up|27
6000635|NCT00916305|20748834|P1|Overall Study|Lost to Follow-up|21
6000636|NCT00916279|20748842|P1|Overall Study|Lost to Follow-up|2
6000637|NCT00916279|20748842|P1|Overall Study|Death|2
6000638|NCT00916149|20748853|P3|Overall Study|Unable to place scalp EEG leads|0
6000639|NCT00916149|20748854|P2|Overall Study|Unable to place scalp EEG leads|0
6000640|NCT00916149|20748855|P1|Overall Study|Unable to place scalp EEG leads|1
6000641|NCT00916149|20748853|P3|Overall Study|Lost to Follow-up|0
6000642|NCT00916149|20748854|P2|Overall Study|Lost to Follow-up|2
6000643|NCT00916149|20748855|P1|Overall Study|Lost to Follow-up|3
6000644|NCT00916058|20748942|P7|Phase 2|Screen Failure|3
6000645|NCT00916058|20748943|P6|Phase 2|Screen Failure|0
6000646|NCT00916058|20748944|P5|Phase 2|Screen Failure|0
6000647|NCT00916058|20748945|P4|Phase 2|Screen Failure|0
6000648|NCT00916058|20748946|P3|Phase 2|Screen Failure|0
6000649|NCT00916058|20748947|P2|Phase 2|Screen Failure|0
6000650|NCT00916058|20748948|P1|Phase 2|Screen Failure|0
6000651|NCT00916058|20748942|P7|Phase 1|Screen Failure|0
6000652|NCT00916058|20748943|P6|Phase 1|Screen Failure|1
6000653|NCT00916058|20748944|P5|Phase 1|Screen Failure|0
6000654|NCT00916058|20748945|P4|Phase 1|Screen Failure|0
6000655|NCT00916058|20748946|P3|Phase 1|Screen Failure|0
6000656|NCT00916058|20748947|P2|Phase 1|Screen Failure|0
6000657|NCT00916058|20748948|P1|Phase 1|Screen Failure|0
6000658|NCT00916006|20749011|P2|Overall Study|Protocol Violation|1
6000659|NCT00916006|20749012|P1|Overall Study|Protocol Violation|0
6000660|NCT00916006|20749011|P2|Overall Study|Withdrawal by Subject|5
6000661|NCT00916006|20749012|P1|Overall Study|Withdrawal by Subject|2
6000662|NCT00916006|20749011|P2|Overall Study|Adverse Event|1
6000663|NCT00916006|20749012|P1|Overall Study|Adverse Event|1
6000664|NCT00915876|20749074|P2|Overall Study|Adverse Event|1
6000665|NCT00915876|20749075|P1|Overall Study|Adverse Event|0
6000666|NCT00915772|20749111|P3|Overall Study|Any other reason|7
6000667|NCT00915772|20749112|P2|Overall Study|Any other reason|7
6000668|NCT00915772|20749113|P1|Overall Study|Any other reason|4
6000669|NCT00915772|20749111|P3|Overall Study|Refused to continue trial medication|4
6000670|NCT00915772|20749112|P2|Overall Study|Refused to continue trial medication|8
6000671|NCT00915772|20749113|P1|Overall Study|Refused to continue trial medication|6
6000672|NCT00915772|20749111|P3|Overall Study|Lack of Efficacy|3
6000673|NCT00915772|20749112|P2|Overall Study|Lack of Efficacy|15
6000674|NCT00915772|20749113|P1|Overall Study|Lack of Efficacy|9
6000675|NCT00915772|20749111|P3|Overall Study|Lost to Follow-up|2
6000676|NCT00915772|20749112|P2|Overall Study|Lost to Follow-up|2
6000677|NCT00915772|20749113|P1|Overall Study|Lost to Follow-up|1
6000678|NCT00915772|20749111|P3|Overall Study|Protocol Violation|2
6000679|NCT00915772|20749112|P2|Overall Study|Protocol Violation|1
6000680|NCT00915772|20749113|P1|Overall Study|Protocol Violation|4
6000681|NCT00915772|20749111|P3|Overall Study|Adverse Event|11
6000682|NCT00915772|20749112|P2|Overall Study|Adverse Event|13
6000683|NCT00915772|20749113|P1|Overall Study|Adverse Event|12
6000684|NCT00915551|20749212|P2|Overall Study|Withdrawal by Subject|1
6000685|NCT00915551|20749213|P1|Overall Study|Withdrawal by Subject|0
6000686|NCT00915525|20749234|P2|Overall Study|Patient Moved|9
6000687|NCT00915525|20749235|P1|Overall Study|Patient Moved|15
6000688|NCT00915525|20749234|P2|Overall Study|Non-Compliance|1
6000689|NCT00915525|20749235|P1|Overall Study|Non-Compliance|3
6000690|NCT00915525|20749234|P2|Overall Study|Study Burden|12
6000691|NCT00915525|20749235|P1|Overall Study|Study Burden|28
6000692|NCT00915525|20749234|P2|Overall Study|Retreat Request >Wk 144 (exclusionary)|5
6000693|NCT00915525|20749235|P1|Overall Study|Retreat Request >Wk 144 (exclusionary)|4
6000694|NCT00915525|20749234|P2|Overall Study|Site Closed|9
6000695|NCT00915525|20749235|P1|Overall Study|Site Closed|27
6000696|NCT00915525|20749234|P2|Overall Study|Other Reason|12
6000697|NCT00915525|20749235|P1|Overall Study|Other Reason|35
6000698|NCT00915525|20749234|P2|Overall Study|Missing|1
6000699|NCT00915525|20749235|P1|Overall Study|Missing|12
6000700|NCT00915525|20749234|P2|Overall Study|Adverse Event|13
6000701|NCT00915525|20749235|P1|Overall Study|Adverse Event|29
6000702|NCT00915525|20749234|P2|Overall Study|Lack of Efficacy|32
6000703|NCT00915525|20749235|P1|Overall Study|Lack of Efficacy|15
6000704|NCT00915525|20749234|P2|Overall Study|Pregnancy|0
6000705|NCT00915525|20749235|P1|Overall Study|Pregnancy|2
6000706|NCT00915525|20749234|P2|Overall Study|Lost to Follow-up|16
6000707|NCT00915525|20749235|P1|Overall Study|Lost to Follow-up|27
6000708|NCT00915525|20749234|P2|Overall Study|Withdrawal by Subject|21
6000709|NCT00915525|20749235|P1|Overall Study|Withdrawal by Subject|59
6000710|NCT00915525|20749234|P2|Overall Study|Protocol Violation|4
6000711|NCT00915525|20749235|P1|Overall Study|Protocol Violation|9
6000712|NCT00915473|20749349|P2|4-week Follow Up|Lost to Follow-up|5
6000713|NCT00915473|20749350|P1|4-week Follow Up|Lost to Follow-up|1
6000714|NCT00915473|20749349|P2|Screening|Withdrawal by Subject|0
6000715|NCT00915473|20749350|P1|Screening|Withdrawal by Subject|1
6000716|NCT00915356|20749367|P5|Overall Study|Withdrawal by Subject|0
6000717|NCT00915356|20749368|P4|Overall Study|Withdrawal by Subject|0
6000718|NCT00915356|20749369|P3|Overall Study|Withdrawal by Subject|0
6000719|NCT00915356|20749370|P2|Overall Study|Withdrawal by Subject|0
6000720|NCT00915356|20749371|P1|Overall Study|Withdrawal by Subject|1
6000721|NCT00915343|20749433|P3|Part B - Open Label Period|Did not attend the last visit|1
6000722|NCT00915343|20749434|P2|Part B - Open Label Period|Did not attend the last visit|0
6000723|NCT00915343|20749435|P1|Part B - Open Label Period|Did not attend the last visit|0
6000724|NCT00915343|20749433|P3|Part B - Open Label Period|Treatment switch|1
6000725|NCT00915343|20749434|P2|Part B - Open Label Period|Treatment switch|0
6000726|NCT00915343|20749435|P1|Part B - Open Label Period|Treatment switch|0
6000727|NCT00915278|20749520|P6|Overall Study|Admission to hospice|0
6000728|NCT00915278|20749521|P5|Overall Study|Admission to hospice|0
6000729|NCT00915278|20749522|P4|Overall Study|Admission to hospice|0
6000730|NCT00915278|20749523|P3|Overall Study|Admission to hospice|1
6000731|NCT00915278|20749524|P2|Overall Study|Admission to hospice|0
6000732|NCT00915278|20749525|P1|Overall Study|Admission to hospice|0
6000733|NCT00915278|20749520|P6|Overall Study|Infusion related AEs|2
6000734|NCT00915278|20749521|P5|Overall Study|Infusion related AEs|0
6000735|NCT00915278|20749522|P4|Overall Study|Infusion related AEs|0
6000736|NCT00915278|20749523|P3|Overall Study|Infusion related AEs|0
6000737|NCT00915278|20749524|P2|Overall Study|Infusion related AEs|0
6000738|NCT00915278|20749525|P1|Overall Study|Infusion related AEs|0
6000739|NCT00915278|20749520|P6|Overall Study|Progressive disease/clinical progression|2
6000740|NCT00915278|20749521|P5|Overall Study|Progressive disease/clinical progression|1
6000741|NCT00915278|20749522|P4|Overall Study|Progressive disease/clinical progression|3
6000742|NCT00915278|20749523|P3|Overall Study|Progressive disease/clinical progression|0
6000743|NCT00915278|20749524|P2|Overall Study|Progressive disease/clinical progression|0
6000744|NCT00915278|20749525|P1|Overall Study|Progressive disease/clinical progression|0
6000745|NCT00915278|20749520|P6|Overall Study|Adverse Event|0
6000746|NCT00915278|20749521|P5|Overall Study|Adverse Event|0
6000747|NCT00915278|20749522|P4|Overall Study|Adverse Event|0
6000748|NCT00915278|20749523|P3|Overall Study|Adverse Event|0
6000749|NCT00915278|20749524|P2|Overall Study|Adverse Event|1
6000750|NCT00915278|20749525|P1|Overall Study|Adverse Event|4
6000751|NCT00915278|20749520|P6|Overall Study|Withdrawal by Subject|4
6000752|NCT00915278|20749521|P5|Overall Study|Withdrawal by Subject|1
6000753|NCT00915278|20749522|P4|Overall Study|Withdrawal by Subject|0
6000754|NCT00915278|20749523|P3|Overall Study|Withdrawal by Subject|0
6000755|NCT00915278|20749524|P2|Overall Study|Withdrawal by Subject|1
6000756|NCT00915278|20749525|P1|Overall Study|Withdrawal by Subject|0
6000757|NCT00915278|20749520|P6|Overall Study|Lost to Follow-up|0
6000758|NCT00915278|20749521|P5|Overall Study|Lost to Follow-up|0
6000759|NCT00915278|20749522|P4|Overall Study|Lost to Follow-up|0
6000760|NCT00915278|20749523|P3|Overall Study|Lost to Follow-up|0
6000761|NCT00915278|20749524|P2|Overall Study|Lost to Follow-up|1
6000762|NCT00915278|20749525|P1|Overall Study|Lost to Follow-up|0
6000763|NCT00915278|20749520|P6|Overall Study|Death|0
6000764|NCT00915278|20749521|P5|Overall Study|Death|0
6000765|NCT00915278|20749522|P4|Overall Study|Death|0
6000766|NCT00915278|20749523|P3|Overall Study|Death|0
6000767|NCT00915278|20749524|P2|Overall Study|Death|0
6000768|NCT00915278|20749525|P1|Overall Study|Death|1
6000769|NCT00915018|20749686|P2|Overall Study|By Sponsor due to Protocol Amendment|105
6000770|NCT00915018|20749687|P1|Overall Study|By Sponsor due to Protocol Amendment|92
6000771|NCT00915018|20749686|P2|Overall Study|Withdrawal by Subject|27
6000772|NCT00915018|20749687|P1|Overall Study|Withdrawal by Subject|38
6000773|NCT00915018|20749686|P2|Overall Study|Lost to Follow-up|5
6000774|NCT00915018|20749687|P1|Overall Study|Lost to Follow-up|10
6000775|NCT00915018|20749686|P2|Overall Study|Death|70
6000776|NCT00915018|20749687|P1|Overall Study|Death|75
6000777|NCT00915005|20749703|P2|Overall Study|Insurance denial|15
6000778|NCT00915005|20749704|P1|Overall Study|Insurance denial|3
6000779|NCT00915005|20749703|P2|Overall Study|Patient preferred protons therapy|0
6000780|NCT00915005|20749704|P1|Overall Study|Patient preferred protons therapy|6
6000781|NCT00915005|20749703|P2|Overall Study|Withdrawal by Subject|4
6000782|NCT00915005|20749704|P1|Overall Study|Withdrawal by Subject|4
6000783|NCT00914966|20749712|P1|Step 2: 2000 Units|Withdrawal by Subject|1
6000784|NCT00914966|20749712|P1|Step 1: 1500 Units|Physician Decision|1
6000785|NCT00914966|20749712|P1|Step 1: 1500 Units|Withdrawal by Subject|1
6000786|NCT00914940|20749724|P1|2 Years to 5 Years Post-transplant|Death|3
6000787|NCT00914940|20749724|P1|D101 to 2 Years Post-transplant|Death|8
6000788|NCT00914940|20749724|P1|D0 to D100 Post-transplant|Death|2
6000789|NCT00914927|20749739|P7|Overall Study|Administrative/Other|0
6000790|NCT00914927|20749740|P6|Overall Study|Administrative/Other|0
6000791|NCT00914927|20749741|P5|Overall Study|Administrative/Other|1
6000792|NCT00914927|20749742|P4|Overall Study|Administrative/Other|0
6000793|NCT00914927|20749743|P3|Overall Study|Administrative/Other|0
6000794|NCT00914927|20749744|P2|Overall Study|Administrative/Other|1
6000795|NCT00914927|20749745|P1|Overall Study|Administrative/Other|2
6000796|NCT00914927|20749739|P7|Overall Study|Lost to Follow-up|0
6000797|NCT00914927|20749740|P6|Overall Study|Lost to Follow-up|0
6000798|NCT00914927|20749741|P5|Overall Study|Lost to Follow-up|0
6000799|NCT00914927|20749742|P4|Overall Study|Lost to Follow-up|1
6000800|NCT00914927|20749743|P3|Overall Study|Lost to Follow-up|0
6000801|NCT00914927|20749744|P2|Overall Study|Lost to Follow-up|0
6000802|NCT00914927|20749745|P1|Overall Study|Lost to Follow-up|0
6000803|NCT00914927|20749739|P7|Overall Study|Withdrawal by Subject|0
6000804|NCT00914927|20749740|P6|Overall Study|Withdrawal by Subject|0
6000805|NCT00914927|20749741|P5|Overall Study|Withdrawal by Subject|0
6000806|NCT00914927|20749742|P4|Overall Study|Withdrawal by Subject|1
6000807|NCT00914927|20749743|P3|Overall Study|Withdrawal by Subject|0
6000808|NCT00914927|20749744|P2|Overall Study|Withdrawal by Subject|1
6000809|NCT00914927|20749745|P1|Overall Study|Withdrawal by Subject|0
6000810|NCT00914927|20749739|P7|Overall Study|Adverse Event|0
6000811|NCT00914927|20749740|P6|Overall Study|Adverse Event|0
6000812|NCT00914927|20749741|P5|Overall Study|Adverse Event|1
6000813|NCT00914927|20749742|P4|Overall Study|Adverse Event|0
6000814|NCT00914927|20749743|P3|Overall Study|Adverse Event|0
6000815|NCT00914927|20749744|P2|Overall Study|Adverse Event|0
6000816|NCT00914927|20749745|P1|Overall Study|Adverse Event|0
6000817|NCT00914849|20749872|P2|Overall Study|Not eligible|1
6000818|NCT00914849|20749873|P1|Overall Study|Not eligible|0
6000819|NCT00914849|20749872|P2|Overall Study|Withdrawal by Subject|0
6000820|NCT00914849|20749873|P1|Overall Study|Withdrawal by Subject|1
6000821|NCT00914810|20749907|P2|Overall Study|Hospitalized and unable to follow up.|1
6000822|NCT00914810|20749908|P1|Overall Study|Hospitalized and unable to follow up.|0
6000823|NCT00914810|20749907|P2|Overall Study|Relocated out of state|0
6000824|NCT00914810|20749908|P1|Overall Study|Relocated out of state|1
6000825|NCT00914810|20749907|P2|Overall Study|Withdrawal by Subject|0
6000826|NCT00914810|20749908|P1|Overall Study|Withdrawal by Subject|1
6000836|NCT00914589|20749951|P3|Overall Study|Death|1
6000837|NCT00914589|20749952|P2|Overall Study|Death|1
6000838|NCT00914589|20749953|P1|Overall Study|Death|0
6000839|NCT00914589|20749951|P3|Overall Study|unclassified|7
6000840|NCT00914589|20749952|P2|Overall Study|unclassified|9
6000841|NCT00914589|20749953|P1|Overall Study|unclassified|16
6000842|NCT00914589|20749951|P3|Overall Study|Protocol Violation|3
6000843|NCT00914589|20749952|P2|Overall Study|Protocol Violation|6
6000844|NCT00914589|20749953|P1|Overall Study|Protocol Violation|8
6000845|NCT00914589|20749951|P3|Overall Study|Adverse Event|1
6000846|NCT00914589|20749952|P2|Overall Study|Adverse Event|0
6000847|NCT00914589|20749953|P1|Overall Study|Adverse Event|1
6000848|NCT00914459|20749979|P2|Overall Study|Parent/Legal guardian request|0
6000849|NCT00914459|20749980|P1|Overall Study|Parent/Legal guardian request|1
6000850|NCT00914459|20749979|P2|Overall Study|Protocol Violation|1
6000851|NCT00914459|20749980|P1|Overall Study|Protocol Violation|0
6000852|NCT00914316|20750010|P4|Phase 2|Withdrawal by Subject|0
6000853|NCT00914316|20750011|P3|Phase 2|Withdrawal by Subject|1
6000854|NCT00914316|20750012|P2|Phase 2|Withdrawal by Subject|0
6000855|NCT00914316|20750013|P1|Phase 2|Withdrawal by Subject|1
6000856|NCT00914316|20750010|P4|Phase 1|Adverse Event|0
6000857|NCT00914316|20750011|P3|Phase 1|Adverse Event|0
6000858|NCT00914316|20750012|P2|Phase 1|Adverse Event|0
6000859|NCT00914316|20750013|P1|Phase 1|Adverse Event|1
6000860|NCT00914316|20750010|P4|Phase 1|Withdrawal by Subject|0
6000861|NCT00914316|20750011|P3|Phase 1|Withdrawal by Subject|4
6000862|NCT00914316|20750012|P2|Phase 1|Withdrawal by Subject|2
6000863|NCT00914316|20750013|P1|Phase 1|Withdrawal by Subject|0
6000864|NCT00914316|20750010|P4|Phase 1|Physician Decision|2
6000865|NCT00914316|20750011|P3|Phase 1|Physician Decision|1
6000866|NCT00914316|20750012|P2|Phase 1|Physician Decision|0
6000867|NCT00914316|20750013|P1|Phase 1|Physician Decision|4
6000868|NCT00913978|20750085|P2|Overall Study|Surgeon choice|3
6000869|NCT00913978|20750086|P1|Overall Study|Surgeon choice|1
6000870|NCT00913835|20750103|P2|Lip Dox: Olaratumab Monotherapy|Other|3
6000871|NCT00913835|20750104|P1|Lip Dox: Olaratumab Monotherapy|Other|0
6000872|NCT00913835|20750103|P2|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1
6000873|NCT00913835|20750104|P1|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1
6000874|NCT00913835|20750103|P2|Olara+Lip Dox and Lip Dox Monotherapy|Other|3
6000875|NCT00913835|20750104|P1|Olara+Lip Dox and Lip Dox Monotherapy|Other|4
6000876|NCT00913835|20750103|P2|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|0
6000877|NCT00913835|20750104|P1|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|1
6000878|NCT00913835|20750103|P2|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|3
6000879|NCT00913835|20750104|P1|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|2
6000880|NCT00913770|20750143|P3|Overall Study|Refused|8
6000881|NCT00913770|20750144|P2|Overall Study|Refused|10
6000882|NCT00913770|20750145|P1|Overall Study|Refused|11
6000883|NCT00913770|20750143|P3|Overall Study|Unable to contact|13
6000884|NCT00913770|20750144|P2|Overall Study|Unable to contact|19
6000885|NCT00913770|20750145|P1|Overall Study|Unable to contact|24
6000886|NCT00913744|20750158|P2|Overall Study|Death|0
6000887|NCT00913744|20750159|P1|Overall Study|Death|1
6000888|NCT00913744|20750158|P2|Overall Study|Withdrawal by Subject|1
6000889|NCT00913744|20750159|P1|Overall Study|Withdrawal by Subject|2
6000890|NCT00913744|20750158|P2|Overall Study|Adverse Event|0
6000891|NCT00913744|20750159|P1|Overall Study|Adverse Event|2
6000892|NCT00913692|20750165|P1|Treatment Phase 1 (5 Months)|Physician Decision|1
6000893|NCT00913692|20750165|P1|Screening (4 Months)|Not eligible after screening phase.|6
6000894|NCT00913692|20750165|P1|Screening (4 Months)|Physician Decision|3
6000895|NCT00913523|20750259|P3|Overall Study|Inadequate Number of Tampons Used|3
6000896|NCT00913523|20750260|P2|Overall Study|Inadequate Number of Tampons Used|2
6000897|NCT00913523|20750261|P1|Overall Study|Inadequate Number of Tampons Used|7
6000898|NCT00913523|20750259|P3|Overall Study|Pregnancy|0
6000899|NCT00913523|20750260|P2|Overall Study|Pregnancy|3
6000900|NCT00913523|20750261|P1|Overall Study|Pregnancy|1
6000901|NCT00913523|20750259|P3|Overall Study|Protocol Violation|8
6000902|NCT00913523|20750260|P2|Overall Study|Protocol Violation|8
6000903|NCT00913523|20750261|P1|Overall Study|Protocol Violation|5
6000904|NCT00913523|20750259|P3|Overall Study|Adverse Event|0
6000905|NCT00913523|20750260|P2|Overall Study|Adverse Event|0
6000906|NCT00913523|20750261|P1|Overall Study|Adverse Event|1
6000907|NCT00913523|20750259|P3|Overall Study|Lost to Follow-up|1
6000908|NCT00913523|20750260|P2|Overall Study|Lost to Follow-up|1
6000909|NCT00913523|20750261|P1|Overall Study|Lost to Follow-up|1
6000910|NCT00913523|20750259|P3|Overall Study|Withdrawal by Subject|2
6000911|NCT00913523|20750260|P2|Overall Study|Withdrawal by Subject|2
6000912|NCT00913523|20750261|P1|Overall Study|Withdrawal by Subject|3
6000913|NCT00913458|20750293|P7|Phase 3|Unsatisfactory Response per Investigator|4
6000914|NCT00913458|20750294|P6|Phase 3|Unsatisfactory Response per Investigator|11
6000915|NCT00913458|20750295|P5|Phase 3|Unsatisfactory Response per Investigator|14
6000916|NCT00913458|20750296|P4|Phase 3|Unsatisfactory Response per Investigator|0
6000917|NCT00913458|20750297|P3|Phase 3|Unsatisfactory Response per Investigator|0
6000918|NCT00913458|20750298|P2|Phase 3|Unsatisfactory Response per Investigator|0
6000919|NCT00913458|20750299|P1|Phase 3|Unsatisfactory Response per Investigator|0
6000920|NCT00913458|20750293|P7|Phase 3|Withdrawal by Subject|0
6000921|NCT00913458|20750294|P6|Phase 3|Withdrawal by Subject|2
6000922|NCT00913458|20750295|P5|Phase 3|Withdrawal by Subject|1
6000923|NCT00913458|20750296|P4|Phase 3|Withdrawal by Subject|0
6000924|NCT00913458|20750297|P3|Phase 3|Withdrawal by Subject|0
6000925|NCT00913458|20750298|P2|Phase 3|Withdrawal by Subject|0
6000926|NCT00913458|20750299|P1|Phase 3|Withdrawal by Subject|0
6000927|NCT00913458|20750293|P7|Phase 3|Non-Responder|3
6000928|NCT00913458|20750294|P6|Phase 3|Non-Responder|1
6000929|NCT00913458|20750295|P5|Phase 3|Non-Responder|0
6000930|NCT00913458|20750296|P4|Phase 3|Non-Responder|0
6000931|NCT00913458|20750297|P3|Phase 3|Non-Responder|0
6000932|NCT00913458|20750298|P2|Phase 3|Non-Responder|0
6000933|NCT00913458|20750299|P1|Phase 3|Non-Responder|0
6000934|NCT00913458|20750293|P7|Phase 3|Lost to Follow-up|0
6000935|NCT00913458|20750294|P6|Phase 3|Lost to Follow-up|0
6000936|NCT00913458|20750295|P5|Phase 3|Lost to Follow-up|2
6000937|NCT00913458|20750296|P4|Phase 3|Lost to Follow-up|0
6000938|NCT00913458|20750297|P3|Phase 3|Lost to Follow-up|0
6000939|NCT00913458|20750298|P2|Phase 3|Lost to Follow-up|0
6000940|NCT00913458|20750299|P1|Phase 3|Lost to Follow-up|0
6000941|NCT00913458|20750293|P7|Phase 3|Adverse Event|1
6000942|NCT00913458|20750294|P6|Phase 3|Adverse Event|4
6000943|NCT00913458|20750295|P5|Phase 3|Adverse Event|5
6000944|NCT00913458|20750296|P4|Phase 3|Adverse Event|0
6000945|NCT00913458|20750297|P3|Phase 3|Adverse Event|0
6000946|NCT00913458|20750298|P2|Phase 3|Adverse Event|0
6000947|NCT00913458|20750299|P1|Phase 3|Adverse Event|0
6000948|NCT00913458|20750293|P7|Phase 2|Unsatisfactory Response per Investigator|0
6000949|NCT00913458|20750294|P6|Phase 2|Unsatisfactory Response per Investigator|0
6000950|NCT00913458|20750295|P5|Phase 2|Unsatisfactory Response per Investigator|0
6000951|NCT00913458|20750296|P4|Phase 2|Unsatisfactory Response per Investigator|17
6000952|NCT00913458|20750297|P3|Phase 2|Unsatisfactory Response per Investigator|11
6000953|NCT00913458|20750298|P2|Phase 2|Unsatisfactory Response per Investigator|0
6000954|NCT00913458|20750299|P1|Phase 2|Unsatisfactory Response per Investigator|0
6000955|NCT00913458|20750293|P7|Phase 2|Protocol Violation|0
6000956|NCT00913458|20750294|P6|Phase 2|Protocol Violation|0
6000957|NCT00913458|20750295|P5|Phase 2|Protocol Violation|0
6000958|NCT00913458|20750296|P4|Phase 2|Protocol Violation|0
6000959|NCT00913458|20750297|P3|Phase 2|Protocol Violation|0
6000960|NCT00913458|20750298|P2|Phase 2|Protocol Violation|2
6000961|NCT00913458|20750299|P1|Phase 2|Protocol Violation|0
6000962|NCT00913458|20750293|P7|Phase 2|Lost to Follow-up|0
6000963|NCT00913458|20750294|P6|Phase 2|Lost to Follow-up|0
6000964|NCT00913458|20750295|P5|Phase 2|Lost to Follow-up|0
6000965|NCT00913458|20750296|P4|Phase 2|Lost to Follow-up|1
6000966|NCT00913458|20750297|P3|Phase 2|Lost to Follow-up|0
6000967|NCT00913458|20750298|P2|Phase 2|Lost to Follow-up|0
6000968|NCT00913458|20750299|P1|Phase 2|Lost to Follow-up|0
6000969|NCT00913458|20750293|P7|Phase 2|Adverse Event|0
6000970|NCT00913458|20750294|P6|Phase 2|Adverse Event|0
6000971|NCT00913458|20750295|P5|Phase 2|Adverse Event|0
6000972|NCT00913458|20750296|P4|Phase 2|Adverse Event|1
6000973|NCT00913458|20750297|P3|Phase 2|Adverse Event|0
6000974|NCT00913458|20750298|P2|Phase 2|Adverse Event|3
6000975|NCT00913458|20750299|P1|Phase 2|Adverse Event|0
6000976|NCT00913458|20750293|P7|Phase 2|Subject Request|0
6000977|NCT00913458|20750294|P6|Phase 2|Subject Request|0
6000978|NCT00913458|20750295|P5|Phase 2|Subject Request|0
6000979|NCT00913458|20750296|P4|Phase 2|Subject Request|2
6000980|NCT00913458|20750297|P3|Phase 2|Subject Request|1
6000981|NCT00913458|20750298|P2|Phase 2|Subject Request|0
6000982|NCT00913458|20750299|P1|Phase 2|Subject Request|0
6000983|NCT00913458|20750293|P7|Phase 2|Non-Responder|0
6000984|NCT00913458|20750294|P6|Phase 2|Non-Responder|0
6000985|NCT00913458|20750295|P5|Phase 2|Non-Responder|0
6000986|NCT00913458|20750296|P4|Phase 2|Non-Responder|12
6000987|NCT00913458|20750297|P3|Phase 2|Non-Responder|7
6000988|NCT00913458|20750298|P2|Phase 2|Non-Responder|5
6000989|NCT00913458|20750299|P1|Phase 2|Non-Responder|0
6000990|NCT00913458|20750293|P7|Phase 1|Unsatisfactory Response per Investigator|0
6000991|NCT00913458|20750294|P6|Phase 1|Unsatisfactory Response per Investigator|0
6000992|NCT00913458|20750295|P5|Phase 1|Unsatisfactory Response per Investigator|0
6000993|NCT00913458|20750296|P4|Phase 1|Unsatisfactory Response per Investigator|0
6000994|NCT00913458|20750297|P3|Phase 1|Unsatisfactory Response per Investigator|0
6000995|NCT00913458|20750298|P2|Phase 1|Unsatisfactory Response per Investigator|0
6000996|NCT00913458|20750299|P1|Phase 1|Unsatisfactory Response per Investigator|7
6000997|NCT00913458|20750293|P7|Phase 1|Sponsor|0
6000998|NCT00913458|20750294|P6|Phase 1|Sponsor|0
6000999|NCT00913458|20750295|P5|Phase 1|Sponsor|0
6001000|NCT00913458|20750296|P4|Phase 1|Sponsor|0
6001001|NCT00913458|20750297|P3|Phase 1|Sponsor|0
6001002|NCT00913458|20750298|P2|Phase 1|Sponsor|0
6001003|NCT00913458|20750299|P1|Phase 1|Sponsor|2
6001004|NCT00913458|20750293|P7|Phase 1|Protocol Violation|0
6001005|NCT00913458|20750294|P6|Phase 1|Protocol Violation|0
6001006|NCT00913458|20750295|P5|Phase 1|Protocol Violation|0
6001007|NCT00913458|20750296|P4|Phase 1|Protocol Violation|0
6001008|NCT00913458|20750297|P3|Phase 1|Protocol Violation|0
6001009|NCT00913458|20750298|P2|Phase 1|Protocol Violation|0
6001010|NCT00913458|20750299|P1|Phase 1|Protocol Violation|10
6001011|NCT00913458|20750293|P7|Phase 1|Lost to Follow-up|0
6001012|NCT00913458|20750294|P6|Phase 1|Lost to Follow-up|0
6001013|NCT00913458|20750295|P5|Phase 1|Lost to Follow-up|0
6001014|NCT00913458|20750296|P4|Phase 1|Lost to Follow-up|0
6001015|NCT00913458|20750297|P3|Phase 1|Lost to Follow-up|0
6001016|NCT00913458|20750298|P2|Phase 1|Lost to Follow-up|0
6001017|NCT00913458|20750299|P1|Phase 1|Lost to Follow-up|2
6001018|NCT00913458|20750293|P7|Phase 1|Adverse Event|0
6001019|NCT00913458|20750294|P6|Phase 1|Adverse Event|0
6001020|NCT00913458|20750295|P5|Phase 1|Adverse Event|0
6001021|NCT00913458|20750296|P4|Phase 1|Adverse Event|0
6001022|NCT00913458|20750297|P3|Phase 1|Adverse Event|0
6001023|NCT00913458|20750298|P2|Phase 1|Adverse Event|0
6001024|NCT00913458|20750299|P1|Phase 1|Adverse Event|20
6001025|NCT00913458|20750293|P7|Phase 1|Subject Request|0
6001026|NCT00913458|20750294|P6|Phase 1|Subject Request|0
6001027|NCT00913458|20750295|P5|Phase 1|Subject Request|0
6001028|NCT00913458|20750296|P4|Phase 1|Subject Request|0
6001029|NCT00913458|20750297|P3|Phase 1|Subject Request|0
6001030|NCT00913458|20750298|P2|Phase 1|Subject Request|0
6001031|NCT00913458|20750299|P1|Phase 1|Subject Request|17
6001032|NCT00913458|20750293|P7|Phase 1|Non-Responder|0
6001033|NCT00913458|20750294|P6|Phase 1|Non-Responder|0
6001034|NCT00913458|20750295|P5|Phase 1|Non-Responder|0
6001035|NCT00913458|20750296|P4|Phase 1|Non-Responder|0
6001036|NCT00913458|20750297|P3|Phase 1|Non-Responder|0
6001037|NCT00913458|20750298|P2|Phase 1|Non-Responder|0
6001038|NCT00913458|20750299|P1|Phase 1|Non-Responder|54
6001039|NCT00913380|20750392|P2|Clinical Outcomes|Lost to Follow-up|6
6001040|NCT00913380|20750393|P1|Clinical Outcomes|Lost to Follow-up|6
6001041|NCT00912964|20750472|P3|Overall Study|Randomized but never received study drug|0
6001042|NCT00912964|20750473|P2|Overall Study|Randomized but never received study drug|1
6001043|NCT00912964|20750474|P1|Overall Study|Randomized but never received study drug|0
6001044|NCT00912964|20750472|P3|Overall Study|Violation of exclusion criterion|2
6001045|NCT00912964|20750473|P2|Overall Study|Violation of exclusion criterion|0
6001046|NCT00912964|20750474|P1|Overall Study|Violation of exclusion criterion|0
6001047|NCT00912964|20750472|P3|Overall Study|Non-compliance with study procedures|0
6001048|NCT00912964|20750473|P2|Overall Study|Non-compliance with study procedures|0
6001049|NCT00912964|20750474|P1|Overall Study|Non-compliance with study procedures|2
6001050|NCT00912964|20750472|P3|Overall Study|Medical History|0
6001051|NCT00912964|20750473|P2|Overall Study|Medical History|0
6001052|NCT00912964|20750474|P1|Overall Study|Medical History|1
6001053|NCT00912964|20750472|P3|Overall Study|Taking exclusionary medications|8
6001054|NCT00912964|20750473|P2|Overall Study|Taking exclusionary medications|4
6001055|NCT00912964|20750474|P1|Overall Study|Taking exclusionary medications|7
6001056|NCT00912964|20750472|P3|Overall Study|Protocol Violation|8
6001057|NCT00912964|20750473|P2|Overall Study|Protocol Violation|3
6001058|NCT00912964|20750474|P1|Overall Study|Protocol Violation|5
6001059|NCT00912964|20750472|P3|Overall Study|Lost to Follow-up|3
6001060|NCT00912964|20750473|P2|Overall Study|Lost to Follow-up|3
6001061|NCT00912964|20750474|P1|Overall Study|Lost to Follow-up|4
6001062|NCT00912964|20750472|P3|Overall Study|Withdrawal by Subject|18
6001063|NCT00912964|20750473|P2|Overall Study|Withdrawal by Subject|12
6001064|NCT00912964|20750474|P1|Overall Study|Withdrawal by Subject|20
6001065|NCT00912964|20750472|P3|Overall Study|Lack of Efficacy|3
6001066|NCT00912964|20750473|P2|Overall Study|Lack of Efficacy|4
6001067|NCT00912964|20750474|P1|Overall Study|Lack of Efficacy|11
6001068|NCT00912964|20750472|P3|Overall Study|Adverse Event|12
6001069|NCT00912964|20750473|P2|Overall Study|Adverse Event|18
6001070|NCT00912964|20750474|P1|Overall Study|Adverse Event|15
6001071|NCT00912964|20750472|P3|Overall Study|Eligibility criterion not met|0
6001072|NCT00912964|20750473|P2|Overall Study|Eligibility criterion not met|1
6001073|NCT00912964|20750474|P1|Overall Study|Eligibility criterion not met|1
6001074|NCT00912912|20750617|P1|Overall Study|Disease Progression|3
6001075|NCT00912912|20750617|P1|Overall Study|Withdrawal by Subject|1
6001076|NCT00912808|20750623|P2|Second Intervention (6 Weeks)|Withdrawal by Subject|0
6001077|NCT00912808|20750624|P1|Second Intervention (6 Weeks)|Withdrawal by Subject|1
6001078|NCT00912808|20750623|P2|Second Intervention (6 Weeks)|Adverse Event|1
6001079|NCT00912808|20750624|P1|Second Intervention (6 Weeks)|Adverse Event|0
6001080|NCT00912808|20750623|P2|Washout|Withdrawal by Subject|1
6001081|NCT00912808|20750624|P1|Washout|Withdrawal by Subject|0
6001082|NCT00912808|20750623|P2|First Intervention (6 Weeks)|Adverse Event|1
6001083|NCT00912808|20750624|P1|First Intervention (6 Weeks)|Adverse Event|2
6001084|NCT00912782|20750649|P2|Overall Study|Relocated before study completion|1
6001085|NCT00912782|20750650|P1|Overall Study|Relocated before study completion|0
6001086|NCT00912782|20750649|P2|Overall Study|Did not receive vascular access type|2
6001087|NCT00912782|20750650|P1|Overall Study|Did not receive vascular access type|1
6001088|NCT00912782|20750649|P2|Overall Study|Lost to Follow-up|1
6001089|NCT00912782|20750650|P1|Overall Study|Lost to Follow-up|0
6001090|NCT00912782|20750649|P2|Overall Study|Death|1
6001091|NCT00912782|20750650|P1|Overall Study|Death|2
6001092|NCT00912743|20750660|P2|Overall Study|End of treatment form was not collected|0
6001093|NCT00912743|20750661|P1|Overall Study|End of treatment form was not collected|1
6001094|NCT00912743|20750660|P2|Overall Study|Toxicity|1
6001095|NCT00912743|20750661|P1|Overall Study|Toxicity|0
6001096|NCT00912743|20750660|P2|Overall Study|Lack of Efficacy|18
6001097|NCT00912743|20750661|P1|Overall Study|Lack of Efficacy|9
6001098|NCT00912743|20750660|P2|Overall Study|Adverse Event|1
6001099|NCT00912743|20750661|P1|Overall Study|Adverse Event|3
6001100|NCT00912509|20750673|P2|Overall Study|Lack of Efficacy|3
6001101|NCT00912509|20750674|P1|Overall Study|Lack of Efficacy|4
6001102|NCT00912509|20750673|P2|Overall Study|Lost to Follow-up|0
6001103|NCT00912509|20750674|P1|Overall Study|Lost to Follow-up|1
6001104|NCT00912405|20750682|P1|Overall Study|Lost to Follow-up|5
6001105|NCT00912340|20750692|P3|Overall Study|Protocol revised to remove arm|4
6001106|NCT00912340|20750693|P2|Overall Study|Protocol revised to remove arm|0
6001107|NCT00912340|20750694|P1|Overall Study|Protocol revised to remove arm|0
6001108|NCT00912340|20750692|P3|Overall Study|Adverse Event|0
6001109|NCT00912340|20750693|P2|Overall Study|Adverse Event|4
6001110|NCT00912340|20750694|P1|Overall Study|Adverse Event|2
6001111|NCT00912288|20750732|P2|Overall Study|Other|0
6001112|NCT00912288|20750733|P1|Overall Study|Other|1
6001113|NCT00912288|20750732|P2|Overall Study|Study terminated by sponsor|35
6001114|NCT00912288|20750733|P1|Overall Study|Study terminated by sponsor|34
6001115|NCT00912288|20750732|P2|Overall Study|Withdrawal by Subject|3
6001116|NCT00912288|20750733|P1|Overall Study|Withdrawal by Subject|3
6001117|NCT00912288|20750732|P2|Overall Study|Protocol Violation|0
6001118|NCT00912288|20750733|P1|Overall Study|Protocol Violation|1
6001119|NCT00912288|20750732|P2|Overall Study|Lost to Follow-up|0
6001120|NCT00912288|20750733|P1|Overall Study|Lost to Follow-up|1
6001121|NCT00912288|20750732|P2|Overall Study|Adverse Event|1
6001122|NCT00912288|20750733|P1|Overall Study|Adverse Event|1
6001123|NCT00912288|20750732|P2|Overall Study|Death|1
6001124|NCT00912288|20750733|P1|Overall Study|Death|0
6001125|NCT00912223|20750755|P1|Overall Study|Transformed disease|1
6001126|NCT00912223|20750755|P1|Overall Study|Not transplanted|1
6001127|NCT00912223|20750755|P1|Overall Study|Withdrawal by Subject|1
6001128|NCT00912197|20750773|P2|Overall Study|Withdrawal by Subject|3
6001129|NCT00912197|20750774|P1|Overall Study|Withdrawal by Subject|3
6001130|NCT00912093|20750817|P5|The Controlled Phase|Lost to Follow-up|1
6001131|NCT00912093|20750818|P4|The Controlled Phase|Lost to Follow-up|0
6001132|NCT00912093|20750819|P3|The Controlled Phase|Lost to Follow-up|0
6001133|NCT00912093|20750820|P2|The Controlled Phase|Lost to Follow-up|0
6001134|NCT00912093|20750821|P1|The Controlled Phase|Lost to Follow-up|0
6001135|NCT00912093|20750817|P5|The Controlled Phase|Medical Condition|0
6001136|NCT00912093|20750818|P4|The Controlled Phase|Medical Condition|0
6001137|NCT00912093|20750819|P3|The Controlled Phase|Medical Condition|0
6001138|NCT00912093|20750820|P2|The Controlled Phase|Medical Condition|1
6001139|NCT00912093|20750821|P1|The Controlled Phase|Medical Condition|0
6001140|NCT00912093|20750817|P5|The Controlled Phase|Death|0
6001141|NCT00912093|20750818|P4|The Controlled Phase|Death|0
6001142|NCT00912093|20750819|P3|The Controlled Phase|Death|0
6001143|NCT00912093|20750820|P2|The Controlled Phase|Death|1
6001144|NCT00912093|20750821|P1|The Controlled Phase|Death|0
6001145|NCT00912028|20750840|P5|Overall Study|Withdrawal by Subject|0
6001146|NCT00912028|20750841|P4|Overall Study|Withdrawal by Subject|0
6001147|NCT00912028|20750842|P3|Overall Study|Withdrawal by Subject|0
6001148|NCT00912028|20750843|P2|Overall Study|Withdrawal by Subject|0
6001149|NCT00912028|20750844|P1|Overall Study|Withdrawal by Subject|3
6001150|NCT00912028|20750840|P5|Overall Study|Lost to Follow-up|3
6001151|NCT00912028|20750841|P4|Overall Study|Lost to Follow-up|1
6001152|NCT00912028|20750842|P3|Overall Study|Lost to Follow-up|0
6001153|NCT00912028|20750843|P2|Overall Study|Lost to Follow-up|3
6001154|NCT00912028|20750844|P1|Overall Study|Lost to Follow-up|2
6001155|NCT00912015|20750873|P4|Overall Study|Adverse Event|1
6001156|NCT00912015|20750874|P3|Overall Study|Adverse Event|0
6001157|NCT00912015|20750875|P2|Overall Study|Adverse Event|0
6001158|NCT00912015|20750876|P1|Overall Study|Adverse Event|6
6001159|NCT00912015|20750873|P4|Overall Study|Protocol Violation|1
6001160|NCT00912015|20750874|P3|Overall Study|Protocol Violation|0
6001161|NCT00912015|20750875|P2|Overall Study|Protocol Violation|0
6001162|NCT00912015|20750876|P1|Overall Study|Protocol Violation|1
6001163|NCT00912015|20750873|P4|Overall Study|Withdrawal by Subject|0
6001164|NCT00912015|20750874|P3|Overall Study|Withdrawal by Subject|3
6001165|NCT00912015|20750875|P2|Overall Study|Withdrawal by Subject|8
6001166|NCT00912015|20750876|P1|Overall Study|Withdrawal by Subject|8
6001167|NCT00912015|20750873|P4|Overall Study|Lack of Efficacy|0
6001168|NCT00912015|20750874|P3|Overall Study|Lack of Efficacy|0
6001169|NCT00912015|20750875|P2|Overall Study|Lack of Efficacy|0
6001170|NCT00912015|20750876|P1|Overall Study|Lack of Efficacy|1
6001171|NCT00911989|20750892|P1|Overall Study|Adverse Event|1
6001172|NCT00911937|20750898|P2|Overall Study|Other|5
6001173|NCT00911937|20750899|P1|Overall Study|Other|9
6001174|NCT00911937|20750898|P2|Overall Study|Randomized but not treated|13
6001175|NCT00911937|20750899|P1|Overall Study|Randomized but not treated|13
6001176|NCT00911937|20750898|P2|Overall Study|Protocol Violation|23
6001177|NCT00911937|20750899|P1|Overall Study|Protocol Violation|14
6001178|NCT00911937|20750898|P2|Overall Study|Did not meet inclusion criteria|11
6001179|NCT00911937|20750899|P1|Overall Study|Did not meet inclusion criteria|9
6001180|NCT00911937|20750898|P2|Overall Study|Lack of Efficacy|6
6001181|NCT00911937|20750899|P1|Overall Study|Lack of Efficacy|11
6001182|NCT00911937|20750898|P2|Overall Study|Adverse Event|25
6001183|NCT00911937|20750899|P1|Overall Study|Adverse Event|11
6001184|NCT00911937|20750898|P2|Overall Study|Withdrawn due to pregnancy|0
6001185|NCT00911937|20750899|P1|Overall Study|Withdrawn due to pregnancy|1
6001186|NCT00911937|20750898|P2|Overall Study|Withdrawal by Subject|7
6001187|NCT00911937|20750899|P1|Overall Study|Withdrawal by Subject|10
6001188|NCT00911937|20750898|P2|Overall Study|Lost to Follow-up|5
6001189|NCT00911937|20750899|P1|Overall Study|Lost to Follow-up|8
6001190|NCT00911937|20750898|P2|Overall Study|Death|0
6001191|NCT00911937|20750899|P1|Overall Study|Death|1
6001192|NCT00911859|20750966|P3|Follow-up Period|Study terminated by sponsor|27
6001193|NCT00911859|20750967|P2|Follow-up Period|Study terminated by sponsor|33
6001194|NCT00911859|20750968|P1|Follow-up Period|Study terminated by sponsor|5
6001195|NCT00911859|20750966|P3|Follow-up Period|Withdrawal by Subject|4
6001196|NCT00911859|20750967|P2|Follow-up Period|Withdrawal by Subject|4
6001197|NCT00911859|20750968|P1|Follow-up Period|Withdrawal by Subject|0
6001198|NCT00911859|20750966|P3|Follow-up Period|Lost to Follow-up|0
6001199|NCT00911859|20750967|P2|Follow-up Period|Lost to Follow-up|1
6001200|NCT00911859|20750968|P1|Follow-up Period|Lost to Follow-up|1
6001201|NCT00911859|20750966|P3|Follow-up Period|Death|10
6001202|NCT00911859|20750967|P2|Follow-up Period|Death|8
6001203|NCT00911859|20750968|P1|Follow-up Period|Death|5
6001204|NCT00911859|20750966|P3|Maintainance Period|Withdrawal by Subject|3
6001205|NCT00911859|20750967|P2|Maintainance Period|Withdrawal by Subject|0
6001206|NCT00911859|20750968|P1|Maintainance Period|Withdrawal by Subject|0
6001207|NCT00911859|20750966|P3|Maintainance Period|Physician Decision|9
6001208|NCT00911859|20750967|P2|Maintainance Period|Physician Decision|0
6001209|NCT00911859|20750968|P1|Maintainance Period|Physician Decision|0
6001210|NCT00911859|20750966|P3|Maintainance Period|Lack of Efficacy|9
6001211|NCT00911859|20750967|P2|Maintainance Period|Lack of Efficacy|0
6001212|NCT00911859|20750968|P1|Maintainance Period|Lack of Efficacy|0
6001213|NCT00911859|20750966|P3|Treatment Period|Did not receive study treatment|0
6001214|NCT00911859|20750967|P2|Treatment Period|Did not receive study treatment|1
6001215|NCT00911859|20750968|P1|Treatment Period|Did not receive study treatment|0
6001216|NCT00911859|20750966|P3|Treatment Period|Withdrawal by Subject|5
6001217|NCT00911859|20750967|P2|Treatment Period|Withdrawal by Subject|4
6001218|NCT00911859|20750968|P1|Treatment Period|Withdrawal by Subject|0
6001219|NCT00911859|20750966|P3|Treatment Period|Physician Decision|3
6001220|NCT00911859|20750967|P2|Treatment Period|Physician Decision|3
6001221|NCT00911859|20750968|P1|Treatment Period|Physician Decision|3
6001222|NCT00911859|20750966|P3|Treatment Period|Lack of Efficacy|5
6001223|NCT00911859|20750967|P2|Treatment Period|Lack of Efficacy|7
6001224|NCT00911859|20750968|P1|Treatment Period|Lack of Efficacy|1
6001225|NCT00911859|20750966|P3|Treatment Period|Death|5
6001226|NCT00911859|20750967|P2|Treatment Period|Death|3
6001227|NCT00911859|20750968|P1|Treatment Period|Death|1
6001228|NCT00911859|20750966|P3|Treatment Period|Adverse Event|7
6001229|NCT00911859|20750967|P2|Treatment Period|Adverse Event|3
6001230|NCT00911859|20750968|P1|Treatment Period|Adverse Event|3
6001231|NCT00911820|20750994|P2|Overall Study|Withdraw before Receive Treatment|2
6001232|NCT00911820|20750995|P1|Overall Study|Withdraw before Receive Treatment|0
6001233|NCT00911820|20750994|P2|Overall Study|Pathology Not Confirmed|0
6001234|NCT00911820|20750995|P1|Overall Study|Pathology Not Confirmed|1
6001235|NCT00911820|20750994|P2|Overall Study|Still on Therapy|2
6001236|NCT00911820|20750995|P1|Overall Study|Still on Therapy|2
6001237|NCT00911820|20750994|P2|Overall Study|Pursue Radiation|0
6001238|NCT00911820|20750995|P1|Overall Study|Pursue Radiation|1
6001239|NCT00911820|20750994|P2|Overall Study|Pursue surgery|1
6001240|NCT00911820|20750995|P1|Overall Study|Pursue surgery|1
6001241|NCT00911820|20750994|P2|Overall Study|Death|2
6001242|NCT00911820|20750995|P1|Overall Study|Death|1
6001243|NCT00911820|20750994|P2|Overall Study|Withdrawal by Subject|4
6001244|NCT00911820|20750995|P1|Overall Study|Withdrawal by Subject|3
6001245|NCT00911820|20750994|P2|Overall Study|Decline in Performance Status|2
6001246|NCT00911820|20750995|P1|Overall Study|Decline in Performance Status|4
6001247|NCT00911820|20750994|P2|Overall Study|Physician Decision|9
6001248|NCT00911820|20750995|P1|Overall Study|Physician Decision|5
6001249|NCT00911820|20750994|P2|Overall Study|Clinical Progression|5
6001250|NCT00911820|20750995|P1|Overall Study|Clinical Progression|7
6001251|NCT00911820|20750994|P2|Overall Study|Adverse Event|8
6001252|NCT00911820|20750995|P1|Overall Study|Adverse Event|8
6001253|NCT00911820|20750994|P2|Overall Study|RECIST progression|8
6001254|NCT00911820|20750995|P1|Overall Study|RECIST progression|12
6001255|NCT00911807|20751012|P3|Overall Study|Organizational reasons|1
6001256|NCT00911807|20751013|P2|Overall Study|Organizational reasons|3
6001257|NCT00911807|20751014|P1|Overall Study|Organizational reasons|1
6001258|NCT00911807|20751012|P3|Overall Study|Withdrawal by Subject|7
6001259|NCT00911807|20751013|P2|Overall Study|Withdrawal by Subject|10
6001260|NCT00911807|20751014|P1|Overall Study|Withdrawal by Subject|8
6001261|NCT00911807|20751012|P3|Overall Study|Protocol Violation|9
6001262|NCT00911807|20751013|P2|Overall Study|Protocol Violation|4
6001263|NCT00911807|20751014|P1|Overall Study|Protocol Violation|6
6001264|NCT00911807|20751012|P3|Overall Study|Death|1
6001265|NCT00911807|20751013|P2|Overall Study|Death|0
6001266|NCT00911807|20751014|P1|Overall Study|Death|0
6001267|NCT00911807|20751012|P3|Overall Study|Adverse Event|5
6001268|NCT00911807|20751013|P2|Overall Study|Adverse Event|1
6001269|NCT00911807|20751014|P1|Overall Study|Adverse Event|2
6001270|NCT00911768|20751024|P2|Overall Study|Withdrawal by Subject|0
6001271|NCT00911768|20751025|P1|Overall Study|Withdrawal by Subject|1
6001272|NCT00911768|20751024|P2|Overall Study|Protocol Violation|4
6001273|NCT00911768|20751025|P1|Overall Study|Protocol Violation|5
6001274|NCT00911625|20751054|P2|Overall Study|Lost to Follow-up|0
6001275|NCT00911625|20751055|P1|Overall Study|Lost to Follow-up|7
6001276|NCT00911547|20751089|P4|Overall Study|Withdrawal by Subject|8
6001277|NCT00911547|20751090|P3|Overall Study|Withdrawal by Subject|4
6001278|NCT00911547|20751091|P2|Overall Study|Withdrawal by Subject|10
6001279|NCT00911547|20751092|P1|Overall Study|Withdrawal by Subject|3
6001280|NCT00911547|20751089|P4|Overall Study|Protocol Violation|1
6001281|NCT00911547|20751090|P3|Overall Study|Protocol Violation|5
6001282|NCT00911547|20751091|P2|Overall Study|Protocol Violation|5
6001283|NCT00911547|20751092|P1|Overall Study|Protocol Violation|0
6001284|NCT00911547|20751089|P4|Overall Study|Lost to Follow-up|1
6001285|NCT00911547|20751090|P3|Overall Study|Lost to Follow-up|2
6001286|NCT00911547|20751091|P2|Overall Study|Lost to Follow-up|0
6001287|NCT00911547|20751092|P1|Overall Study|Lost to Follow-up|0
6001288|NCT00911547|20751089|P4|Overall Study|Adverse Event|6
6001289|NCT00911547|20751090|P3|Overall Study|Adverse Event|11
6001290|NCT00911547|20751091|P2|Overall Study|Adverse Event|27
6001291|NCT00911547|20751092|P1|Overall Study|Adverse Event|8
6001292|NCT00911534|20751120|P2|Overall Study|Other|2
6001293|NCT00911534|20751121|P1|Overall Study|Other|2
6001294|NCT00911534|20751120|P2|Overall Study|Withdrawal of consent|4
6001295|NCT00911534|20751121|P1|Overall Study|Withdrawal of consent|1
6001296|NCT00911534|20751120|P2|Overall Study|Lack of Efficacy|1
6001297|NCT00911534|20751121|P1|Overall Study|Lack of Efficacy|4
6001298|NCT00911534|20751120|P2|Overall Study|Withdrawal by Subject|1
6001299|NCT00911534|20751121|P1|Overall Study|Withdrawal by Subject|2
6001300|NCT00911534|20751120|P2|Overall Study|Lost to Follow-up|4
6001301|NCT00911534|20751121|P1|Overall Study|Lost to Follow-up|2
6001302|NCT00911534|20751120|P2|Overall Study|Adverse Event|4
6001303|NCT00911534|20751121|P1|Overall Study|Adverse Event|4
6001304|NCT00911508|20751135|P2|Overall Study|Withdrawal by Subject|112
6001305|NCT00911508|20751136|P1|Overall Study|Withdrawal by Subject|79
6001306|NCT00911508|20751135|P2|Overall Study|Lost to Follow-up|18
6001307|NCT00911508|20751136|P1|Overall Study|Lost to Follow-up|27
6001308|NCT00911300|20751211|P2|Overall Study|Randomized; No Study Medication Received|2
6001309|NCT00911300|20751212|P1|Overall Study|Randomized; No Study Medication Received|0
6001310|NCT00911300|20751211|P2|Overall Study|Treatment Stopped by Mistake|1
6001311|NCT00911300|20751212|P1|Overall Study|Treatment Stopped by Mistake|0
6001312|NCT00911300|20751211|P2|Overall Study|Physician Decision|1
6001313|NCT00911300|20751212|P1|Overall Study|Physician Decision|0
6001314|NCT00911300|20751211|P2|Overall Study|Underlying Disease (Myocarditis)|1
6001315|NCT00911300|20751212|P1|Overall Study|Underlying Disease (Myocarditis)|0
6001316|NCT00911300|20751211|P2|Overall Study|Participant Refused Hospital Consulation|1
6001317|NCT00911300|20751212|P1|Overall Study|Participant Refused Hospital Consulation|0
6001318|NCT00911300|20751211|P2|Overall Study|International Normalized Ratio Too High|1
6001319|NCT00911300|20751212|P1|Overall Study|International Normalized Ratio Too High|0
6001320|NCT00911300|20751211|P2|Overall Study|Investigator's Decision; New AF Episode|1
6001321|NCT00911300|20751212|P1|Overall Study|Investigator's Decision; New AF Episode|0
6001322|NCT00911300|20751211|P2|Overall Study|Participant Could Not Stay in Hospital|1
6001323|NCT00911300|20751212|P1|Overall Study|Participant Could Not Stay in Hospital|0
6001324|NCT00911300|20751211|P2|Overall Study|CV Unsuccessful; Phenprocoumon Received|0
6001325|NCT00911300|20751212|P1|Overall Study|CV Unsuccessful; Phenprocoumon Received|1
6001326|NCT00911300|20751211|P2|Overall Study|Nurse Unavailable in Participant's City|0
6001327|NCT00911300|20751212|P1|Overall Study|Nurse Unavailable in Participant's City|1
6001328|NCT00911300|20751211|P2|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1
6001329|NCT00911300|20751212|P1|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1
6001330|NCT00911300|20751211|P2|Overall Study|Recurrent Tachyarrhythmia|1
6001331|NCT00911300|20751212|P1|Overall Study|Recurrent Tachyarrhythmia|1
6001332|NCT00911300|20751211|P2|Overall Study|Received Commercial Treatment|0
6001333|NCT00911300|20751212|P1|Overall Study|Received Commercial Treatment|1
6001334|NCT00911300|20751211|P2|Overall Study|Atrial Fibrillation (AF) Recurrence|3
6001335|NCT00911300|20751212|P1|Overall Study|Atrial Fibrillation (AF) Recurrence|3
6001336|NCT00911300|20751211|P2|Overall Study|Coronary Angiography Performed|0
6001337|NCT00911300|20751212|P1|Overall Study|Coronary Angiography Performed|1
6001338|NCT00911300|20751211|P2|Overall Study|Consent Withdrawn|12
6001339|NCT00911300|20751212|P1|Overall Study|Consent Withdrawn|4
6001340|NCT00911300|20751211|P2|Overall Study|Protocol Violation|2
6001341|NCT00911300|20751212|P1|Overall Study|Protocol Violation|3
6001342|NCT00911300|20751211|P2|Overall Study|Adverse Event|6
6001343|NCT00911300|20751212|P1|Overall Study|Adverse Event|14
6001344|NCT00911300|20751211|P2|Overall Study|Thrombus Persistant in Second TEE|7
6001345|NCT00911300|20751212|P1|Overall Study|Thrombus Persistant in Second TEE|3
6001346|NCT00911300|20751211|P2|Overall Study|Death|0
6001347|NCT00911300|20751212|P1|Overall Study|Death|1
6001348|NCT00911300|20751211|P2|Overall Study|Primary Endpoint Component Occurred|2
6001349|NCT00911300|20751212|P1|Overall Study|Primary Endpoint Component Occurred|1
6001350|NCT00911170|20751249|P2|Long Term Follow-Up|Death|121
6001351|NCT00911170|20751250|P1|Long Term Follow-Up|Death|116
6001352|NCT00911170|20751249|P2|Long Term Follow-Up|Lost to Follow-up|7
6001353|NCT00911170|20751250|P1|Long Term Follow-Up|Lost to Follow-up|8
6001354|NCT00911170|20751249|P2|Long Term Follow-Up|Physician Decision|4
6001355|NCT00911170|20751250|P1|Long Term Follow-Up|Physician Decision|5
6001356|NCT00911170|20751249|P2|Long Term Follow-Up|Withdrawal by Subject|21
6001357|NCT00911170|20751250|P1|Long Term Follow-Up|Withdrawal by Subject|20
6001358|NCT00911170|20751249|P2|Long Term Follow-Up|Continuing in study|269
6001359|NCT00911170|20751250|P1|Long Term Follow-Up|Continuing in study|274
6001360|NCT00911170|20751249|P2|Treatment Period|Death|9
6001361|NCT00911170|20751250|P1|Treatment Period|Death|6
6001362|NCT00911170|20751249|P2|Treatment Period|Lost to Follow-up|1
6001363|NCT00911170|20751250|P1|Treatment Period|Lost to Follow-up|0
6001364|NCT00911170|20751249|P2|Treatment Period|Physician Decision|5
6001365|NCT00911170|20751250|P1|Treatment Period|Physician Decision|5
6001366|NCT00911170|20751249|P2|Treatment Period|Disease progression|2
6001367|NCT00911170|20751250|P1|Treatment Period|Disease progression|0
6001368|NCT00911170|20751249|P2|Treatment Period|Withdrawal by Subject|4
6001369|NCT00911170|20751250|P1|Treatment Period|Withdrawal by Subject|4
6001370|NCT00911170|20751249|P2|Treatment Period|Adverse Event|10
6001371|NCT00911170|20751250|P1|Treatment Period|Adverse Event|9
6001372|NCT00911170|20751249|P2|Treatment Period|Protocol deviation|2
6001373|NCT00911170|20751250|P1|Treatment Period|Protocol deviation|1
6001374|NCT00911170|20751249|P2|Treatment Period|Ineligibility determined|3
6001375|NCT00911170|20751250|P1|Treatment Period|Ineligibility determined|1
6001376|NCT00911170|20751249|P2|Treatment Period|Randomized in error|1
6001377|NCT00911170|20751250|P1|Treatment Period|Randomized in error|1
6001378|NCT00911157|20751274|P2|Overall Study|Need to treat for lung cancer|0
6001379|NCT00911157|20751275|P1|Overall Study|Need to treat for lung cancer|1
6001380|NCT00911157|20751274|P2|Overall Study|Need for prohibited drug (heparin)|0
6001381|NCT00911157|20751275|P1|Overall Study|Need for prohibited drug (heparin)|1
6001382|NCT00911157|20751274|P2|Overall Study|Withdrawal by Subject|1
6001383|NCT00911157|20751275|P1|Overall Study|Withdrawal by Subject|1
6001384|NCT00911157|20751274|P2|Overall Study|Adverse Event|1
6001385|NCT00911157|20751275|P1|Overall Study|Adverse Event|4
6001386|NCT00911144|20751291|P2|Overall Study|Withdrawal by Subject|5
6001387|NCT00911144|20751292|P1|Overall Study|Withdrawal by Subject|16
6001388|NCT00910988|20751346|P4|Overall Study|Lost to Follow-up|0
6001389|NCT00910988|20751347|P3|Overall Study|Lost to Follow-up|3
6001390|NCT00910988|20751348|P2|Overall Study|Lost to Follow-up|4
6001391|NCT00910988|20751349|P1|Overall Study|Lost to Follow-up|2
6001392|NCT00910962|20751394|P3|Overall Study|Reached defined stopping criteria|17
6001393|NCT00910962|20751395|P2|Overall Study|Reached defined stopping criteria|14
6001394|NCT00910962|20751396|P1|Overall Study|Reached defined stopping criteria|12
6001395|NCT00910962|20751394|P3|Overall Study|Withdrawal by Subject|32
6001396|NCT00910962|20751395|P2|Overall Study|Withdrawal by Subject|32
6001397|NCT00910962|20751396|P1|Overall Study|Withdrawal by Subject|25
6001398|NCT00910962|20751394|P3|Overall Study|Physician Decision|6
6001399|NCT00910962|20751395|P2|Overall Study|Physician Decision|6
6001400|NCT00910962|20751396|P1|Overall Study|Physician Decision|0
6001401|NCT00910962|20751394|P3|Overall Study|Lost to Follow-up|1
6001402|NCT00910962|20751395|P2|Overall Study|Lost to Follow-up|3
6001403|NCT00910962|20751396|P1|Overall Study|Lost to Follow-up|0
6001404|NCT00910962|20751394|P3|Overall Study|Protocol Violation|3
6001405|NCT00910962|20751395|P2|Overall Study|Protocol Violation|3
6001406|NCT00910962|20751396|P1|Overall Study|Protocol Violation|1
6001407|NCT00910962|20751394|P3|Overall Study|Adverse Event|17
6001408|NCT00910962|20751395|P2|Overall Study|Adverse Event|20
6001409|NCT00910962|20751396|P1|Overall Study|Adverse Event|5
6001410|NCT00910910|20751488|P2|Overall Study|Untreated before cycle 1|2
6001411|NCT00910910|20751489|P1|Overall Study|Untreated before cycle 1|1
6001412|NCT00910910|20751488|P2|Overall Study|Other|32
6001413|NCT00910910|20751489|P1|Overall Study|Other|114
6001414|NCT00910910|20751488|P2|Overall Study|Completed 13 cycles of treatment|118
6001415|NCT00910910|20751489|P1|Overall Study|Completed 13 cycles of treatment|0
6001416|NCT00910910|20751488|P2|Overall Study|Protocol Violation|2
6001417|NCT00910910|20751489|P1|Overall Study|Protocol Violation|2
6001418|NCT00910910|20751488|P2|Overall Study|Death|3
6001419|NCT00910910|20751489|P1|Overall Study|Death|9
6001420|NCT00910910|20751488|P2|Overall Study|Lost to Follow-up|2
6001421|NCT00910910|20751489|P1|Overall Study|Lost to Follow-up|2
6001422|NCT00910910|20751488|P2|Overall Study|Withdrawal by Subject|5
6001423|NCT00910910|20751489|P1|Overall Study|Withdrawal by Subject|7
6001424|NCT00910910|20751488|P2|Overall Study|PD with histologic change|2
6001425|NCT00910910|20751489|P1|Overall Study|PD with histologic change|0
6001426|NCT00910910|20751488|P2|Overall Study|PD without histologic change|23
6001427|NCT00910910|20751489|P1|Overall Study|PD without histologic change|27
6001428|NCT00910910|20751488|P2|Overall Study|Adverse Event|35
6001429|NCT00910910|20751489|P1|Overall Study|Adverse Event|63
6001430|NCT00910871|20751525|P1|Overall Study|Undefined|1
6001431|NCT00910871|20751525|P1|Overall Study|Subject didn't meet eligibility criteria|5
6001432|NCT00910871|20751525|P1|Overall Study|Withdrawal by Subject|12
6001433|NCT00910871|20751525|P1|Overall Study|Protocol Violation|11
6001434|NCT00910871|20751525|P1|Overall Study|Lost to Follow-up|8
6001435|NCT00910871|20751525|P1|Overall Study|Death|12
6001436|NCT00910871|20751525|P1|Overall Study|Adverse Event|5
6001437|NCT00910858|20751533|P3|Combined Treatment Phase|Other|1
6001438|NCT00910858|20751534|P2|Combined Treatment Phase|Other|2
6001439|NCT00910858|20751535|P1|Combined Treatment Phase|Other|0
6001440|NCT00910858|20751533|P3|Combined Treatment Phase|Protocol Violation|0
6001441|NCT00910858|20751534|P2|Combined Treatment Phase|Protocol Violation|0
6001442|NCT00910858|20751535|P1|Combined Treatment Phase|Protocol Violation|1
6001443|NCT00910858|20751533|P3|Combined Treatment Phase|Withdrawal by Subject|0
6001444|NCT00910858|20751534|P2|Combined Treatment Phase|Withdrawal by Subject|2
6001445|NCT00910858|20751535|P1|Combined Treatment Phase|Withdrawal by Subject|0
6001446|NCT00910858|20751533|P3|Combined Treatment Phase|Lack of therapeutic effect|3
6001447|NCT00910858|20751534|P2|Combined Treatment Phase|Lack of therapeutic effect|6
6001448|NCT00910858|20751535|P1|Combined Treatment Phase|Lack of therapeutic effect|8
6001449|NCT00910858|20751533|P3|Monotherapy Phase|Other|2
6001450|NCT00910858|20751534|P2|Monotherapy Phase|Other|4
6001451|NCT00910858|20751535|P1|Monotherapy Phase|Other|3
6001452|NCT00910858|20751533|P3|Monotherapy Phase|Protocol Violation|0
6001453|NCT00910858|20751534|P2|Monotherapy Phase|Protocol Violation|0
6001454|NCT00910858|20751535|P1|Monotherapy Phase|Protocol Violation|1
6001455|NCT00910858|20751533|P3|Monotherapy Phase|Withdrawal by Subject|1
6001456|NCT00910858|20751534|P2|Monotherapy Phase|Withdrawal by Subject|3
6001457|NCT00910858|20751535|P1|Monotherapy Phase|Withdrawal by Subject|1
6001458|NCT00910858|20751533|P3|Monotherapy Phase|Lack of therapeutic effect|4
6001459|NCT00910858|20751534|P2|Monotherapy Phase|Lack of therapeutic effect|6
6001460|NCT00910858|20751535|P1|Monotherapy Phase|Lack of therapeutic effect|9
6001461|NCT00910858|20751533|P3|Monotherapy Phase|Adverse Event|0
6001462|NCT00910858|20751534|P2|Monotherapy Phase|Adverse Event|2
6001463|NCT00910858|20751535|P1|Monotherapy Phase|Adverse Event|3
6001464|NCT00910858|20751533|P3|Pharmacokinetic Phase|Adverse Event|0
6001465|NCT00910858|20751534|P2|Pharmacokinetic Phase|Adverse Event|0
6001466|NCT00910858|20751535|P1|Pharmacokinetic Phase|Adverse Event|1
6001467|NCT00910728|20751580|P9|Overall Study|Adverse Event|1
6001468|NCT00910728|20751581|P8|Overall Study|Adverse Event|1
6001469|NCT00910728|20751582|P7|Overall Study|Adverse Event|2
6001470|NCT00910728|20751583|P6|Overall Study|Adverse Event|0
6001471|NCT00910728|20751584|P5|Overall Study|Adverse Event|0
6001472|NCT00910728|20751585|P4|Overall Study|Adverse Event|1
6001473|NCT00910728|20751586|P3|Overall Study|Adverse Event|1
6001474|NCT00910728|20751587|P2|Overall Study|Adverse Event|0
6001475|NCT00910728|20751588|P1|Overall Study|Adverse Event|2
6001476|NCT00910728|20751580|P9|Overall Study|(not specified)|0
6001477|NCT00910728|20751581|P8|Overall Study|(not specified)|0
6001478|NCT00910728|20751582|P7|Overall Study|(not specified)|0
6001479|NCT00910728|20751583|P6|Overall Study|(not specified)|0
6001480|NCT00910728|20751584|P5|Overall Study|(not specified)|1
6001481|NCT00910728|20751585|P4|Overall Study|(not specified)|0
6001482|NCT00910728|20751586|P3|Overall Study|(not specified)|1
6001483|NCT00910728|20751587|P2|Overall Study|(not specified)|0
6001484|NCT00910728|20751588|P1|Overall Study|(not specified)|2
6001485|NCT00910728|20751580|P9|Overall Study|Withdrawal by Subject|0
6001486|NCT00910728|20751581|P8|Overall Study|Withdrawal by Subject|0
6001487|NCT00910728|20751582|P7|Overall Study|Withdrawal by Subject|2
6001488|NCT00910728|20751583|P6|Overall Study|Withdrawal by Subject|1
6001489|NCT00910728|20751584|P5|Overall Study|Withdrawal by Subject|3
6001490|NCT00910728|20751585|P4|Overall Study|Withdrawal by Subject|0
6001491|NCT00910728|20751586|P3|Overall Study|Withdrawal by Subject|0
6001492|NCT00910728|20751587|P2|Overall Study|Withdrawal by Subject|0
6001493|NCT00910728|20751588|P1|Overall Study|Withdrawal by Subject|0
6001494|NCT00910728|20751580|P9|Overall Study|Lack of Efficacy|2
6001495|NCT00910728|20751581|P8|Overall Study|Lack of Efficacy|2
6001496|NCT00910728|20751582|P7|Overall Study|Lack of Efficacy|2
6001497|NCT00910728|20751583|P6|Overall Study|Lack of Efficacy|0
6001498|NCT00910728|20751584|P5|Overall Study|Lack of Efficacy|1
6001499|NCT00910728|20751585|P4|Overall Study|Lack of Efficacy|2
6001500|NCT00910728|20751586|P3|Overall Study|Lack of Efficacy|1
6001501|NCT00910728|20751587|P2|Overall Study|Lack of Efficacy|3
6001502|NCT00910728|20751588|P1|Overall Study|Lack of Efficacy|2
6001503|NCT00910715|20751710|P3|Overall Study|Lost to Follow-up|0
6001504|NCT00910715|20751711|P2|Overall Study|Lost to Follow-up|26
6001505|NCT00910715|20751712|P1|Overall Study|Lost to Follow-up|22
6001506|NCT00910689|20751726|P4|Months 11- 16: Evaluation Period II|Physician Decision|0
6001507|NCT00910689|20751727|P3|Months 11- 16: Evaluation Period II|Physician Decision|1
6001508|NCT00910689|20751728|P2|Months 11- 16: Evaluation Period II|Physician Decision|2
6001509|NCT00910689|20751729|P1|Months 11- 16: Evaluation Period II|Physician Decision|0
6001510|NCT00910689|20751726|P4|Months 11- 16: Evaluation Period II|Perceived Improvement|1
6001511|NCT00910689|20751727|P3|Months 11- 16: Evaluation Period II|Perceived Improvement|0
6001512|NCT00910689|20751728|P2|Months 11- 16: Evaluation Period II|Perceived Improvement|0
6001513|NCT00910689|20751729|P1|Months 11- 16: Evaluation Period II|Perceived Improvement|0
6001514|NCT00910689|20751726|P4|Months 11- 16: Evaluation Period II|Time Demands|0
6001515|NCT00910689|20751727|P3|Months 11- 16: Evaluation Period II|Time Demands|0
6001516|NCT00910689|20751728|P2|Months 11- 16: Evaluation Period II|Time Demands|1
6001517|NCT00910689|20751729|P1|Months 11- 16: Evaluation Period II|Time Demands|2
6001518|NCT00910689|20751726|P4|Months 11- 16: Evaluation Period II|Lack of Efficacy|1
6001519|NCT00910689|20751727|P3|Months 11- 16: Evaluation Period II|Lack of Efficacy|3
6001520|NCT00910689|20751728|P2|Months 11- 16: Evaluation Period II|Lack of Efficacy|3
6001521|NCT00910689|20751729|P1|Months 11- 16: Evaluation Period II|Lack of Efficacy|2
6001522|NCT00910689|20751726|P4|Months 11- 16: Evaluation Period II|Pregnancy|0
6001523|NCT00910689|20751727|P3|Months 11- 16: Evaluation Period II|Pregnancy|0
6001524|NCT00910689|20751728|P2|Months 11- 16: Evaluation Period II|Pregnancy|0
6001525|NCT00910689|20751729|P1|Months 11- 16: Evaluation Period II|Pregnancy|1
6001526|NCT00910689|20751726|P4|Months 11- 16: Evaluation Period II|Adverse Event|2
6001527|NCT00910689|20751727|P3|Months 11- 16: Evaluation Period II|Adverse Event|2
6001528|NCT00910689|20751728|P2|Months 11- 16: Evaluation Period II|Adverse Event|4
6001529|NCT00910689|20751729|P1|Months 11- 16: Evaluation Period II|Adverse Event|2
6001530|NCT00910689|20751726|P4|Months 11- 16: Evaluation Period II|Lost to Follow-up|2
6001531|NCT00910689|20751727|P3|Months 11- 16: Evaluation Period II|Lost to Follow-up|1
6001532|NCT00910689|20751728|P2|Months 11- 16: Evaluation Period II|Lost to Follow-up|0
6001533|NCT00910689|20751729|P1|Months 11- 16: Evaluation Period II|Lost to Follow-up|3
6001534|NCT00910689|20751726|P4|Months 5 - 10: Evaluation Period I|Time Demands|1
6001535|NCT00910689|20751727|P3|Months 5 - 10: Evaluation Period I|Time Demands|1
6001536|NCT00910689|20751728|P2|Months 5 - 10: Evaluation Period I|Time Demands|0
6001537|NCT00910689|20751729|P1|Months 5 - 10: Evaluation Period I|Time Demands|0
6001538|NCT00910689|20751726|P4|Months 5 - 10: Evaluation Period I|Pregnancy|0
6001539|NCT00910689|20751727|P3|Months 5 - 10: Evaluation Period I|Pregnancy|2
6001540|NCT00910689|20751728|P2|Months 5 - 10: Evaluation Period I|Pregnancy|0
6001541|NCT00910689|20751729|P1|Months 5 - 10: Evaluation Period I|Pregnancy|0
6001542|NCT00910689|20751726|P4|Months 5 - 10: Evaluation Period I|Protocol Violation|0
6001543|NCT00910689|20751727|P3|Months 5 - 10: Evaluation Period I|Protocol Violation|0
6001544|NCT00910689|20751728|P2|Months 5 - 10: Evaluation Period I|Protocol Violation|1
6001545|NCT00910689|20751729|P1|Months 5 - 10: Evaluation Period I|Protocol Violation|1
6001546|NCT00910689|20751726|P4|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1
6001547|NCT00910689|20751727|P3|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1
6001548|NCT00910689|20751728|P2|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1
6001549|NCT00910689|20751729|P1|Months 5 - 10: Evaluation Period I|Lack of Efficacy|0
6001550|NCT00910689|20751726|P4|Months 5 - 10: Evaluation Period I|Adverse Event|4
6001551|NCT00910689|20751727|P3|Months 5 - 10: Evaluation Period I|Adverse Event|2
6001552|NCT00910689|20751728|P2|Months 5 - 10: Evaluation Period I|Adverse Event|0
6001553|NCT00910689|20751729|P1|Months 5 - 10: Evaluation Period I|Adverse Event|1
6001554|NCT00910689|20751726|P4|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1
6001555|NCT00910689|20751727|P3|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1
6001556|NCT00910689|20751728|P2|Months 5 - 10: Evaluation Period I|Lost to Follow-up|5
6001557|NCT00910689|20751729|P1|Months 5 - 10: Evaluation Period I|Lost to Follow-up|2
6001558|NCT00910689|20751726|P4|Month 2- 4: Treatment Period|Protocol Violation|0
6001559|NCT00910689|20751727|P3|Month 2- 4: Treatment Period|Protocol Violation|0
6001560|NCT00910689|20751728|P2|Month 2- 4: Treatment Period|Protocol Violation|0
6001561|NCT00910689|20751729|P1|Month 2- 4: Treatment Period|Protocol Violation|1
6001562|NCT00910689|20751726|P4|Month 2- 4: Treatment Period|Pregnancy|0
6001563|NCT00910689|20751727|P3|Month 2- 4: Treatment Period|Pregnancy|0
6001564|NCT00910689|20751728|P2|Month 2- 4: Treatment Period|Pregnancy|2
6001565|NCT00910689|20751729|P1|Month 2- 4: Treatment Period|Pregnancy|0
6001566|NCT00910689|20751726|P4|Month 2- 4: Treatment Period|Perceived Improvement|0
6001567|NCT00910689|20751727|P3|Month 2- 4: Treatment Period|Perceived Improvement|1
6001568|NCT00910689|20751728|P2|Month 2- 4: Treatment Period|Perceived Improvement|0
6001569|NCT00910689|20751729|P1|Month 2- 4: Treatment Period|Perceived Improvement|0
6001570|NCT00910689|20751726|P4|Month 2- 4: Treatment Period|Lack of Efficacy|0
6001571|NCT00910689|20751727|P3|Month 2- 4: Treatment Period|Lack of Efficacy|0
6001572|NCT00910689|20751728|P2|Month 2- 4: Treatment Period|Lack of Efficacy|1
6001573|NCT00910689|20751729|P1|Month 2- 4: Treatment Period|Lack of Efficacy|2
6001574|NCT00910689|20751726|P4|Month 2- 4: Treatment Period|Time Demands|8
6001575|NCT00910689|20751727|P3|Month 2- 4: Treatment Period|Time Demands|4
6001576|NCT00910689|20751728|P2|Month 2- 4: Treatment Period|Time Demands|0
6001577|NCT00910689|20751729|P1|Month 2- 4: Treatment Period|Time Demands|1
6001578|NCT00910689|20751726|P4|Month 2- 4: Treatment Period|Adverse Event|0
6001579|NCT00910689|20751727|P3|Month 2- 4: Treatment Period|Adverse Event|2
6001580|NCT00910689|20751728|P2|Month 2- 4: Treatment Period|Adverse Event|3
6001581|NCT00910689|20751729|P1|Month 2- 4: Treatment Period|Adverse Event|2
6001582|NCT00910689|20751726|P4|Month 2- 4: Treatment Period|Lost to Follow-up|3
6001583|NCT00910689|20751727|P3|Month 2- 4: Treatment Period|Lost to Follow-up|1
6001584|NCT00910689|20751728|P2|Month 2- 4: Treatment Period|Lost to Follow-up|4
6001585|NCT00910689|20751729|P1|Month 2- 4: Treatment Period|Lost to Follow-up|3
6001586|NCT00910689|20751726|P4|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|10
6001587|NCT00910689|20751727|P3|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|5
6001588|NCT00910689|20751728|P2|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|1
6001589|NCT00910689|20751729|P1|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|2
6001590|NCT00910663|20751761|P2|Period 1|Withdrawal by Subject|1
6001591|NCT00910663|20751762|P1|Period 1|Withdrawal by Subject|0
6001640|NCT00910429|20751806|P2|Overall Study|Lack of Efficacy|1
6001641|NCT00910429|20751807|P1|Overall Study|Lack of Efficacy|4
6001642|NCT00910429|20751806|P2|Overall Study|Drug non-compliance|0
6001643|NCT00910429|20751807|P1|Overall Study|Drug non-compliance|1
6001644|NCT00910429|20751806|P2|Overall Study|Adverse Event|5
6001645|NCT00910429|20751807|P1|Overall Study|Adverse Event|10
6001646|NCT00910429|20751806|P2|Overall Study|Lost to Follow-up|1
6001647|NCT00910429|20751807|P1|Overall Study|Lost to Follow-up|2
6001648|NCT00910429|20751806|P2|Overall Study|Protocol Violation|0
6001649|NCT00910429|20751807|P1|Overall Study|Protocol Violation|1
6001650|NCT00910429|20751806|P2|Overall Study|Withdrawal by Subject|2
6001651|NCT00910429|20751807|P1|Overall Study|Withdrawal by Subject|3
6001652|NCT00910429|20751806|P2|Overall Study|Death|12
6001653|NCT00910429|20751807|P1|Overall Study|Death|18
6001654|NCT00910299|20751869|P2|Overall Study|Didn't receive any study drug|1
6001655|NCT00910299|20751870|P1|Overall Study|Didn't receive any study drug|2
6001656|NCT00910299|20751869|P2|Overall Study|Sponsor Decision|60
6001657|NCT00910299|20751870|P1|Overall Study|Sponsor Decision|58
6001658|NCT00910299|20751869|P2|Overall Study|Withdrawal by Subject|13
6001659|NCT00910299|20751870|P1|Overall Study|Withdrawal by Subject|16
6001660|NCT00910273|20751882|P2|Overall Study|Lost to Follow-up|1
6001661|NCT00910273|20751883|P1|Overall Study|Lost to Follow-up|1
6001662|NCT00910273|20751882|P2|Overall Study|Protocol Violation|0
6001663|NCT00910273|20751883|P1|Overall Study|Protocol Violation|1
6001664|NCT00910273|20751882|P2|Overall Study|Discontinuation of study by sponsor|2
6001665|NCT00910273|20751883|P1|Overall Study|Discontinuation of study by sponsor|8
6001666|NCT00910273|20751882|P2|Overall Study|Withdrawal by Subject|0
6001667|NCT00910273|20751883|P1|Overall Study|Withdrawal by Subject|1
6001668|NCT00910273|20751882|P2|Overall Study|Adverse Event|1
6001669|NCT00910273|20751883|P1|Overall Study|Adverse Event|1
6001670|NCT00910273|20751882|P2|Overall Study|Lack of Efficacy|9
6001671|NCT00910273|20751883|P1|Overall Study|Lack of Efficacy|6
6001672|NCT00910247|20751933|P1|Overall Study|Not collected|4
6001673|NCT00910247|20751933|P1|Overall Study|Withdrawal by Subject|25
6001674|NCT00910247|20751933|P1|Overall Study|Protocol Violation|10
6001675|NCT00910247|20751933|P1|Overall Study|Physician Decision|3
6001676|NCT00910247|20751933|P1|Overall Study|Lost to Follow-up|10
6001677|NCT00910247|20751933|P1|Overall Study|Death|2
6001678|NCT00910247|20751933|P1|Overall Study|Adverse Event|15
6001679|NCT00910091|20751983|P2|Treatment and Survival|Adverse Event|0
6001680|NCT00910091|20751984|P1|Treatment and Survival|Adverse Event|1
6001681|NCT00910091|20751983|P2|Treatment and Survival|Withdrawal by Subject|4
6001682|NCT00910091|20751984|P1|Treatment and Survival|Withdrawal by Subject|3
6001683|NCT00910091|20751983|P2|Pre-assignment|Withdrawal by Subject|2
6001684|NCT00910091|20751984|P1|Pre-assignment|Withdrawal by Subject|0
6001685|NCT00910039|20752012|P1|Overall Study|Physician Decision|1
6001686|NCT00910000|20752029|P6|Overall Study|Withdrawal by Subject|0
6001687|NCT00910000|20752030|P5|Overall Study|Withdrawal by Subject|1
6001688|NCT00910000|20752031|P4|Overall Study|Withdrawal by Subject|0
6001689|NCT00910000|20752032|P3|Overall Study|Withdrawal by Subject|1
6001690|NCT00910000|20752033|P2|Overall Study|Withdrawal by Subject|0
6001691|NCT00910000|20752034|P1|Overall Study|Withdrawal by Subject|0
6001692|NCT00910000|20752029|P6|Overall Study|Adverse Event|1
6001693|NCT00910000|20752030|P5|Overall Study|Adverse Event|0
6001694|NCT00910000|20752031|P4|Overall Study|Adverse Event|2
6001695|NCT00910000|20752032|P3|Overall Study|Adverse Event|2
6001696|NCT00910000|20752033|P2|Overall Study|Adverse Event|3
6001697|NCT00910000|20752034|P1|Overall Study|Adverse Event|0
6001698|NCT00909870|20752052|P2|Overall Study|Other|5
6001699|NCT00909870|20752053|P1|Overall Study|Other|1
6001700|NCT00909870|20752052|P2|Overall Study|Physician Decision|2
6001701|NCT00909870|20752053|P1|Overall Study|Physician Decision|0
6001702|NCT00909870|20752052|P2|Overall Study|Lost to Follow-up|3
6001703|NCT00909870|20752053|P1|Overall Study|Lost to Follow-up|3
6001704|NCT00909870|20752052|P2|Overall Study|Withdrawal by Subject|8
6001705|NCT00909870|20752053|P1|Overall Study|Withdrawal by Subject|5
6001706|NCT00909870|20752052|P2|Overall Study|Protocol Violation|2
6001707|NCT00909870|20752053|P1|Overall Study|Protocol Violation|1
6001708|NCT00909870|20752052|P2|Overall Study|Adverse Event|7
6001709|NCT00909870|20752053|P1|Overall Study|Adverse Event|13
6001710|NCT00909857|20752065|P2|Overall Study|Did not receive study medication|24
6001711|NCT00909857|20752066|P1|Overall Study|Did not receive study medication|19
6001712|NCT00909857|20752065|P2|Overall Study|Other|0
6001713|NCT00909857|20752066|P1|Overall Study|Other|1
6001714|NCT00909857|20752065|P2|Overall Study|Pregnancy|0
6001715|NCT00909857|20752066|P1|Overall Study|Pregnancy|1
6001716|NCT00909857|20752065|P2|Overall Study|Protocol Violation|1
6001717|NCT00909857|20752066|P1|Overall Study|Protocol Violation|2
6001718|NCT00909857|20752065|P2|Overall Study|Lost to Follow-up|5
6001719|NCT00909857|20752066|P1|Overall Study|Lost to Follow-up|2
6001720|NCT00909857|20752065|P2|Overall Study|Adverse Event|5
6001721|NCT00909857|20752066|P1|Overall Study|Adverse Event|5
6001722|NCT00909857|20752065|P2|Overall Study|Withdrawal by Subject|10
6001723|NCT00909857|20752066|P1|Overall Study|Withdrawal by Subject|6
6001724|NCT00909844|20752206|P1|Overall Study|Lost to Follow-up|2
6001725|NCT00909844|20752206|P1|Overall Study|Withdrawal by Subject|1
6001726|NCT00909844|20752206|P1|Overall Study|Adverse Event|1
6001727|NCT00909792|20752224|P2|Period 2|Lost to Follow-up|1
6001728|NCT00909792|20752225|P1|Period 2|Lost to Follow-up|0
6001729|NCT00909792|20752224|P2|Period 2|Biomicroscopy|0
6001730|NCT00909792|20752225|P1|Period 2|Biomicroscopy|1
6001731|NCT00909792|20752224|P2|Period 1|Did not meet inclusion criteria|1
6001732|NCT00909792|20752225|P1|Period 1|Did not meet inclusion criteria|0
6001733|NCT00909779|20752233|P2|Overall Study|Randomized in error|1
6001734|NCT00909779|20752234|P1|Overall Study|Randomized in error|1
6001735|NCT00909779|20752233|P2|Overall Study|Noncompliance|1
6001736|NCT00909779|20752234|P1|Overall Study|Noncompliance|1
6001737|NCT00909779|20752233|P2|Overall Study|Medical Monitor Decision|0
6001738|NCT00909779|20752234|P1|Overall Study|Medical Monitor Decision|1
6001739|NCT00909779|20752233|P2|Overall Study|Site Ceasing Operation|2
6001740|NCT00909779|20752234|P1|Overall Study|Site Ceasing Operation|2
6001741|NCT00909779|20752233|P2|Overall Study|Withdrawal by Subject|80
6001742|NCT00909779|20752234|P1|Overall Study|Withdrawal by Subject|116
6001743|NCT00909779|20752233|P2|Overall Study|Protocol Violation|5
6001744|NCT00909779|20752234|P1|Overall Study|Protocol Violation|2
6001745|NCT00909779|20752233|P2|Overall Study|Physician Decision|2
6001746|NCT00909779|20752234|P1|Overall Study|Physician Decision|8
6001747|NCT00909779|20752233|P2|Overall Study|Lost to Follow-up|15
6001748|NCT00909779|20752234|P1|Overall Study|Lost to Follow-up|19
6001749|NCT00909779|20752233|P2|Overall Study|Lack of Efficacy|4
6001750|NCT00909779|20752234|P1|Overall Study|Lack of Efficacy|7
6001751|NCT00909779|20752233|P2|Overall Study|Adverse Event|55
6001752|NCT00909779|20752234|P1|Overall Study|Adverse Event|53
6001753|NCT00909753|20752258|P2|Period: Second Intervention|Protocol Violation|0
6001754|NCT00909753|20752259|P1|Period: Second Intervention|Protocol Violation|1
6001755|NCT00909753|20752258|P2|Period: Washout of 28 Days|Protocol Violation|3
6001756|NCT00909753|20752259|P1|Period: Washout of 28 Days|Protocol Violation|2
6001757|NCT00909727|20752279|P2|Overall Study|Prohibited Medication|0
6001758|NCT00909727|20752280|P1|Overall Study|Prohibited Medication|1
6001759|NCT00909727|20752279|P2|Overall Study|Withdrawal of Consent|0
6001760|NCT00909727|20752280|P1|Overall Study|Withdrawal of Consent|1
6001761|NCT00909727|20752279|P2|Overall Study|Wrong Genotype|0
6001762|NCT00909727|20752280|P1|Overall Study|Wrong Genotype|1
6001763|NCT00909727|20752279|P2|Overall Study|Adverse Event|0
6001764|NCT00909727|20752280|P1|Overall Study|Adverse Event|1
6001765|NCT00909610|20752303|P2|Period: Second Intervention|Adverse Event|0
6001766|NCT00909610|20752304|P1|Period: Second Intervention|Adverse Event|1
6001767|NCT00909610|20752303|P2|Period: Washout of 28 Days|Withdrawal by Subject|6
6001768|NCT00909610|20752304|P1|Period: Washout of 28 Days|Withdrawal by Subject|3
6001769|NCT00909610|20752303|P2|Period: First Intervention|Adverse Event|1
6001770|NCT00909610|20752304|P1|Period: First Intervention|Adverse Event|0
6001771|NCT00909532|20752465|P2|Overall Study|Increased Lab Draws, Difficult Lab Stick|0
6001772|NCT00909532|20752466|P1|Overall Study|Increased Lab Draws, Difficult Lab Stick|1
6001773|NCT00909532|20752465|P2|Overall Study|Wrong Genotype|0
6001774|NCT00909532|20752466|P1|Overall Study|Wrong Genotype|1
6001775|NCT00909532|20752465|P2|Overall Study|Physician Decision|0
6001776|NCT00909532|20752466|P1|Overall Study|Physician Decision|1
6001777|NCT00909532|20752465|P2|Overall Study|Noncompliance with Study Requirements|2
6001778|NCT00909532|20752466|P1|Overall Study|Noncompliance with Study Requirements|0
6001779|NCT00909532|20752465|P2|Overall Study|Withdrawal of Consent|1
6001780|NCT00909532|20752466|P1|Overall Study|Withdrawal of Consent|1
6001781|NCT00909532|20752465|P2|Overall Study|Prohibited Medication|1
6001782|NCT00909532|20752466|P1|Overall Study|Prohibited Medication|2
6001783|NCT00909532|20752465|P2|Overall Study|Pregnancy|1
6001784|NCT00909532|20752466|P1|Overall Study|Pregnancy|0
6001785|NCT00909532|20752465|P2|Overall Study|Adverse Event|1
6001786|NCT00909532|20752466|P1|Overall Study|Adverse Event|4
6001787|NCT00909480|20752484|P2|Overall Study|Unclassified|19
6001788|NCT00909480|20752485|P1|Overall Study|Unclassified|18
6001789|NCT00909480|20752484|P2|Overall Study|Withdrawal criteria|11
6001790|NCT00909480|20752485|P1|Overall Study|Withdrawal criteria|9
6001791|NCT00909480|20752484|P2|Overall Study|Protocol Violation|8
6001792|NCT00909480|20752485|P1|Overall Study|Protocol Violation|6
6001793|NCT00909480|20752484|P2|Overall Study|Adverse Event|3
6001794|NCT00909480|20752485|P1|Overall Study|Adverse Event|5
6001795|NCT00909428|20752520|P3|Overall Study|Lost to Follow-up|9
6001796|NCT00909428|20752521|P2|Overall Study|Lost to Follow-up|10
6001797|NCT00909428|20752522|P1|Overall Study|Lost to Follow-up|13
6001798|NCT00909389|20752529|P1|Overall Study|No Information|103
6001799|NCT00909389|20752529|P1|Overall Study|Lost to Follow-up|4
6001800|NCT00909389|20752529|P1|Overall Study|Poor Compliance|16
6001801|NCT00909389|20752529|P1|Overall Study|Death|4
6001802|NCT00909389|20752529|P1|Overall Study|Adverse Event|6
6001803|NCT00909363|20752536|P3|Overall Study|Lack of Efficacy|0
6001804|NCT00909363|20752537|P2|Overall Study|Lack of Efficacy|0
6001805|NCT00909363|20752538|P1|Overall Study|Lack of Efficacy|1
6001806|NCT00909363|20752536|P3|Overall Study|Withdrawal by Subject|0
6001807|NCT00909363|20752537|P2|Overall Study|Withdrawal by Subject|0
6001808|NCT00909363|20752538|P1|Overall Study|Withdrawal by Subject|1
6001809|NCT00909181|20752585|P3|Overall Study|Lost to Follow-up|33
6001810|NCT00909181|20752586|P2|Overall Study|Lost to Follow-up|18
6001811|NCT00909181|20752587|P1|Overall Study|Lost to Follow-up|39
6001812|NCT00909090|20752613|P2|Overall Study|Lost to Follow-up|17
6001813|NCT00909090|20752614|P1|Overall Study|Lost to Follow-up|17
6001814|NCT00909038|20752632|P1|Overall Study|Non-evaluable Subjects|230
6001815|NCT00909038|20752632|P1|Overall Study|Protocol Violation|187
6001816|NCT00908960|20752644|P3|Overall Study|Presence VTE dx or Absent VTE eval|2
6001817|NCT00908960|20752645|P2|Overall Study|Presence VTE dx or Absent VTE eval|1
6001818|NCT00908960|20752646|P1|Overall Study|Presence VTE dx or Absent VTE eval|1
6001819|NCT00908895|20752690|P2|Overall Study|Adverse Event|1
6001820|NCT00908895|20752691|P1|Overall Study|Adverse Event|1
6001821|NCT00908895|20752690|P2|Overall Study|algodystrophy|2
6001822|NCT00908895|20752691|P1|Overall Study|algodystrophy|2
6001823|NCT00908895|20752690|P2|Overall Study|Lost to Follow-up|3
6001824|NCT00908895|20752691|P1|Overall Study|Lost to Follow-up|1
6001825|NCT00908596|20752792|P4|Overall Study|Withdrawal by Subject|1
6001826|NCT00908596|20752793|P3|Overall Study|Withdrawal by Subject|3
6001827|NCT00908596|20752794|P2|Overall Study|Withdrawal by Subject|1
6001828|NCT00908596|20752795|P1|Overall Study|Withdrawal by Subject|0
6001829|NCT00908596|20752792|P4|Overall Study|Protocol Violation|0
6001830|NCT00908596|20752793|P3|Overall Study|Protocol Violation|0
6001831|NCT00908596|20752794|P2|Overall Study|Protocol Violation|0
6001832|NCT00908596|20752795|P1|Overall Study|Protocol Violation|1
6001833|NCT00908596|20752792|P4|Overall Study|Death|32
6001834|NCT00908596|20752793|P3|Overall Study|Death|57
6001835|NCT00908596|20752794|P2|Overall Study|Death|5
6001836|NCT00908596|20752795|P1|Overall Study|Death|0
6001837|NCT00908596|20752792|P4|Overall Study|Lost to Follow-up|4
6001838|NCT00908596|20752793|P3|Overall Study|Lost to Follow-up|12
6001839|NCT00908596|20752794|P2|Overall Study|Lost to Follow-up|1
6001840|NCT00908596|20752795|P1|Overall Study|Lost to Follow-up|0
6001841|NCT00908596|20752792|P4|Overall Study|Other reasons|0
6001842|NCT00908596|20752793|P3|Overall Study|Other reasons|2
6001843|NCT00908596|20752794|P2|Overall Study|Other reasons|6
6001844|NCT00908596|20752795|P1|Overall Study|Other reasons|46
6001845|NCT00908583|20752825|P1|Phase 5|Adverse Event|3
6001846|NCT00908583|20752825|P1|Phase 4|Physician Decision|1
6001847|NCT00908583|20752825|P1|Phase 4|Adverse Event|1
6001848|NCT00908583|20752825|P1|Phase 3|Adverse Event|2
6001849|NCT00908583|20752825|P1|Phase 2|Adverse Event|1
6001850|NCT00908583|20752825|P1|Phase 2|Physician Decision|1
6001851|NCT00908583|20752825|P1|Phase 1|Adverse Event|4
6001852|NCT00908583|20752825|P1|Phase 1|Withdrawal by Subject|1
6001853|NCT00908544|20752845|P2|Overall Study|Unable to visit sutdy center|0
6001854|NCT00908544|20752846|P1|Overall Study|Unable to visit sutdy center|1
6001855|NCT00908544|20752845|P2|Overall Study|Relocation abroad|1
6001856|NCT00908544|20752846|P1|Overall Study|Relocation abroad|1
6001857|NCT00908544|20752845|P2|Overall Study|Pregnancy|0
6001858|NCT00908544|20752846|P1|Overall Study|Pregnancy|1
6001859|NCT00908544|20752845|P2|Overall Study|Lack of Efficacy|1
6001860|NCT00908544|20752846|P1|Overall Study|Lack of Efficacy|0
6001861|NCT00908544|20752845|P2|Overall Study|Withdrawal by Subject|4
6001862|NCT00908544|20752846|P1|Overall Study|Withdrawal by Subject|2
6001863|NCT00908375|20752905|P2|Overall Study|Lost to Follow-up|6
6001864|NCT00908375|20752906|P1|Overall Study|Lost to Follow-up|8
6001865|NCT00908375|20752905|P2|Overall Study|Withdrawal by Subject|4
6001866|NCT00908375|20752906|P1|Overall Study|Withdrawal by Subject|2
6001867|NCT00908349|20752916|P1|Overall Study|Various|6
6001868|NCT00908349|20752916|P1|Overall Study|Lost to Follow-up|5
6001869|NCT00908349|20752916|P1|Overall Study|Physician Decision|5
6001870|NCT00908349|20752916|P1|Overall Study|Withdrawal by Subject|9
6001871|NCT00908349|20752916|P1|Overall Study|Adverse Event|10
6001872|NCT00908310|20752920|P1|Overall Study|Other reasons|4
6001873|NCT00908310|20752920|P1|Overall Study|Screening failure|5
6001874|NCT00908310|20752920|P1|Overall Study|Lost to Follow-up|7
6001875|NCT00908310|20752920|P1|Overall Study|Withdrawal by Subject|7
6001876|NCT00908310|20752920|P1|Overall Study|Death|37
6001877|NCT00908232|20752924|P4|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0
6001878|NCT00908232|20752925|P3|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0
6001879|NCT00908232|20752926|P2|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0
6001880|NCT00908232|20752927|P1|Randomization (Cycle 5) to Cycle 8|Protocol Violation|1
6001881|NCT00908232|20752924|P4|Randomization (Cycle 5) to Cycle 8|Other|0
6001882|NCT00908232|20752925|P3|Randomization (Cycle 5) to Cycle 8|Other|0
6001883|NCT00908232|20752926|P2|Randomization (Cycle 5) to Cycle 8|Other|1
6001884|NCT00908232|20752927|P1|Randomization (Cycle 5) to Cycle 8|Other|3
6001885|NCT00908232|20752924|P4|Randomization (Cycle 5) to Cycle 8|Physician Decision|0
6001886|NCT00908232|20752925|P3|Randomization (Cycle 5) to Cycle 8|Physician Decision|0
6001887|NCT00908232|20752926|P2|Randomization (Cycle 5) to Cycle 8|Physician Decision|0
6001888|NCT00908232|20752927|P1|Randomization (Cycle 5) to Cycle 8|Physician Decision|2
6001889|NCT00908232|20752924|P4|Randomization (Cycle 5) to Cycle 8|Adverse Event|0
6001890|NCT00908232|20752925|P3|Randomization (Cycle 5) to Cycle 8|Adverse Event|0
6001891|NCT00908232|20752926|P2|Randomization (Cycle 5) to Cycle 8|Adverse Event|2
6001892|NCT00908232|20752927|P1|Randomization (Cycle 5) to Cycle 8|Adverse Event|17
6001893|NCT00908232|20752924|P4|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0
6001894|NCT00908232|20752925|P3|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|1
6001895|NCT00908232|20752926|P2|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0
6001896|NCT00908232|20752927|P1|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|4
6001897|NCT00908232|20752924|P4|Randomization (Cycle 5) to Cycle 8|Death|0
6001898|NCT00908232|20752925|P3|Randomization (Cycle 5) to Cycle 8|Death|0
6001899|NCT00908232|20752926|P2|Randomization (Cycle 5) to Cycle 8|Death|0
6001900|NCT00908232|20752927|P1|Randomization (Cycle 5) to Cycle 8|Death|2
6001901|NCT00908232|20752924|P4|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0
6001902|NCT00908232|20752925|P3|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0
6001903|NCT00908232|20752926|P2|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0
6001904|NCT00908232|20752927|P1|Randomization (Cycle 5) to Cycle 8|Progressive Disease|5
6001905|NCT00908232|20752924|P4|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0
6001906|NCT00908232|20752925|P3|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0
6001907|NCT00908232|20752926|P2|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0
6001908|NCT00908232|20752927|P1|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|1
6001909|NCT00908232|20752924|P4|Cycle 1 to 4|Other|0
6001910|NCT00908232|20752925|P3|Cycle 1 to 4|Other|0
6001911|NCT00908232|20752926|P2|Cycle 1 to 4|Other|0
6001912|NCT00908232|20752927|P1|Cycle 1 to 4|Other|1
6001913|NCT00908232|20752924|P4|Cycle 1 to 4|Adverse Event|0
6001914|NCT00908232|20752925|P3|Cycle 1 to 4|Adverse Event|0
6001915|NCT00908232|20752926|P2|Cycle 1 to 4|Adverse Event|0
6001916|NCT00908232|20752927|P1|Cycle 1 to 4|Adverse Event|12
6001917|NCT00908232|20752924|P4|Cycle 1 to 4|Progressive Disease|0
6001918|NCT00908232|20752925|P3|Cycle 1 to 4|Progressive Disease|0
6001919|NCT00908232|20752926|P2|Cycle 1 to 4|Progressive Disease|0
6001920|NCT00908232|20752927|P1|Cycle 1 to 4|Progressive Disease|6
6001921|NCT00908232|20752924|P4|Cycle 1 to 4|Withdrawal by Subject|0
6001922|NCT00908232|20752925|P3|Cycle 1 to 4|Withdrawal by Subject|0
6001923|NCT00908232|20752926|P2|Cycle 1 to 4|Withdrawal by Subject|0
6001924|NCT00908232|20752927|P1|Cycle 1 to 4|Withdrawal by Subject|4
6001925|NCT00908232|20752924|P4|Cycle 1 to 4|Death|0
6001926|NCT00908232|20752925|P3|Cycle 1 to 4|Death|0
6001927|NCT00908232|20752926|P2|Cycle 1 to 4|Death|0
6001928|NCT00908232|20752927|P1|Cycle 1 to 4|Death|5
6001929|NCT00908141|20752945|P2|Overall Study|Withdrawal by Subject|1
6001930|NCT00908141|20752946|P1|Overall Study|Withdrawal by Subject|0
6001931|NCT00908115|20752963|P1|Overall Study|Other|14
6001932|NCT00908076|20752971|P2|Overall Study|Lack of Efficacy|1
6001933|NCT00908076|20752972|P1|Overall Study|Lack of Efficacy|1
6001934|NCT00908037|20752985|P12|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
6001935|NCT00908037|20752986|P11|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|2
6001936|NCT00908037|20752987|P10|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
6001937|NCT00908037|20752988|P9|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
6001938|NCT00908037|20752989|P8|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
6001939|NCT00908037|20752990|P7|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
6001940|NCT00908037|20752991|P6|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
6001941|NCT00908037|20752992|P5|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
6001942|NCT00908037|20752993|P4|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
6001943|NCT00908037|20752994|P3|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
6001944|NCT00908037|20752995|P2|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
6001945|NCT00908037|20752996|P1|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
6001946|NCT00908037|20752985|P12|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
6001947|NCT00908037|20752986|P11|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
6001948|NCT00908037|20752987|P10|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|1
6001949|NCT00908037|20752988|P9|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
6001950|NCT00908037|20752989|P8|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
6001951|NCT00908037|20752990|P7|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
6001952|NCT00908037|20752991|P6|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
6001953|NCT00908037|20752992|P5|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
6001954|NCT00908037|20752993|P4|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
6001955|NCT00908037|20752994|P3|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
6001956|NCT00908037|20752995|P2|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
6001957|NCT00908037|20752996|P1|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
6001958|NCT00908037|20752985|P12|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
6001959|NCT00908037|20752986|P11|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|2
6001960|NCT00908037|20752987|P10|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
6001961|NCT00908037|20752988|P9|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
6001962|NCT00908037|20752989|P8|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
6001963|NCT00908037|20752990|P7|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
6001964|NCT00908037|20752991|P6|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
6001965|NCT00908037|20752992|P5|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
6001966|NCT00908037|20752993|P4|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
6001967|NCT00908037|20752994|P3|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
6001968|NCT00908037|20752995|P2|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
6001969|NCT00908037|20752996|P1|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
6001970|NCT00908037|20752985|P12|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
6001971|NCT00908037|20752986|P11|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
6001972|NCT00908037|20752987|P10|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|1
6001973|NCT00908037|20752988|P9|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
6001974|NCT00908037|20752989|P8|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
6001975|NCT00908037|20752990|P7|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
6001976|NCT00908037|20752991|P6|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
6001977|NCT00908037|20752992|P5|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
6001978|NCT00908037|20752993|P4|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
6001979|NCT00908037|20752994|P3|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
6001980|NCT00908037|20752995|P2|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
6001981|NCT00908037|20752996|P1|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
6001982|NCT00908037|20752985|P12|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|2
6001983|NCT00908037|20752986|P11|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
6001984|NCT00908037|20752987|P10|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|1
6001985|NCT00908037|20752988|P9|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
6001986|NCT00908037|20752989|P8|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
6001987|NCT00908037|20752990|P7|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
6001988|NCT00908037|20752991|P6|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
6001989|NCT00908037|20752992|P5|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
6001990|NCT00908037|20752993|P4|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
6001991|NCT00908037|20752994|P3|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
6001992|NCT00908037|20752995|P2|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
6001993|NCT00908037|20752996|P1|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
6001994|NCT00908037|20752985|P12|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|1
6001995|NCT00908037|20752986|P11|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
6001996|NCT00908037|20752987|P10|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
6001997|NCT00908037|20752988|P9|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
6001998|NCT00908037|20752989|P8|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
6001999|NCT00908037|20752990|P7|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
6002000|NCT00908037|20752991|P6|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
6002001|NCT00908037|20752992|P5|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
6002002|NCT00908037|20752993|P4|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
6002003|NCT00908037|20752994|P3|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
6002004|NCT00908037|20752995|P2|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
6002005|NCT00908037|20752996|P1|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
6002006|NCT00908037|20752985|P12|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
6002007|NCT00908037|20752986|P11|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
6002008|NCT00908037|20752987|P10|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
6002009|NCT00908037|20752988|P9|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
6002010|NCT00908037|20752989|P8|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
6002011|NCT00908037|20752990|P7|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1
6002012|NCT00908037|20752991|P6|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
6002013|NCT00908037|20752992|P5|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
6002014|NCT00908037|20752993|P4|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1
6002015|NCT00908037|20752994|P3|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
6002016|NCT00908037|20752995|P2|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
6002017|NCT00908037|20752996|P1|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
6002018|NCT00908037|20752985|P12|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
6002019|NCT00908037|20752986|P11|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
6002020|NCT00908037|20752987|P10|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
6002021|NCT00908037|20752988|P9|Part 2 (7 Week Randomized Period)|Lost to Follow-up|4
6002022|NCT00908037|20752989|P8|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
6002023|NCT00908037|20752990|P7|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
6002024|NCT00908037|20752991|P6|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
6002025|NCT00908037|20752992|P5|Part 2 (7 Week Randomized Period)|Lost to Follow-up|2
6002026|NCT00908037|20752993|P4|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
6002027|NCT00908037|20752994|P3|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
6002028|NCT00908037|20752995|P2|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
6002029|NCT00908037|20752996|P1|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
6002030|NCT00908037|20752985|P12|Part 2 (7 Week Randomized Period)|Protocol Violation|0
6002031|NCT00908037|20752986|P11|Part 2 (7 Week Randomized Period)|Protocol Violation|0
6002032|NCT00908037|20752987|P10|Part 2 (7 Week Randomized Period)|Protocol Violation|0
6002033|NCT00908037|20752988|P9|Part 2 (7 Week Randomized Period)|Protocol Violation|1
6002034|NCT00908037|20752989|P8|Part 2 (7 Week Randomized Period)|Protocol Violation|0
6002035|NCT00908037|20752990|P7|Part 2 (7 Week Randomized Period)|Protocol Violation|3
6002036|NCT00908037|20752991|P6|Part 2 (7 Week Randomized Period)|Protocol Violation|0
6002037|NCT00908037|20752992|P5|Part 2 (7 Week Randomized Period)|Protocol Violation|1
6002038|NCT00908037|20752993|P4|Part 2 (7 Week Randomized Period)|Protocol Violation|0
6002039|NCT00908037|20752994|P3|Part 2 (7 Week Randomized Period)|Protocol Violation|0
6002040|NCT00908037|20752995|P2|Part 2 (7 Week Randomized Period)|Protocol Violation|0
6002041|NCT00908037|20752996|P1|Part 2 (7 Week Randomized Period)|Protocol Violation|0
6002042|NCT00908011|20753145|P2|Overall Study|Withdrawal by Subject|2
6002043|NCT00908011|20753146|P1|Overall Study|Withdrawal by Subject|2
6002044|NCT00907881|20753163|P1|Overall Study|Missing discontinuation information|15
6002045|NCT00907881|20753163|P1|Overall Study|Protocol Violation|1
6002046|NCT00907881|20753163|P1|Overall Study|Withdrawal by Subject|5
6002047|NCT00907881|20753163|P1|Overall Study|Noncompliance|5
6002048|NCT00907881|20753163|P1|Overall Study|Lost to Follow-up|59
6002049|NCT00907803|20753173|P3|Overall Study|Protocol Violation|0
6002050|NCT00907803|20753174|P2|Overall Study|Protocol Violation|1
6002051|NCT00907803|20753175|P1|Overall Study|Protocol Violation|0
6002052|NCT00907803|20753173|P3|Overall Study|Lost to Follow-up|0
6002053|NCT00907803|20753174|P2|Overall Study|Lost to Follow-up|1
6002054|NCT00907803|20753175|P1|Overall Study|Lost to Follow-up|0
6002055|NCT00907803|20753173|P3|Overall Study|Withdrawal by Subject|0
6002056|NCT00907803|20753174|P2|Overall Study|Withdrawal by Subject|1
6002057|NCT00907803|20753175|P1|Overall Study|Withdrawal by Subject|0
6002058|NCT00907803|20753173|P3|Overall Study|Adverse Event|0
6002059|NCT00907803|20753174|P2|Overall Study|Adverse Event|0
6002060|NCT00907803|20753175|P1|Overall Study|Adverse Event|2
6002061|NCT00907803|20753173|P3|Overall Study|Withdrawal of consent - long commute|0
6002062|NCT00907803|20753174|P2|Overall Study|Withdrawal of consent - long commute|0
6002063|NCT00907803|20753175|P1|Overall Study|Withdrawal of consent - long commute|1
6002064|NCT00907777|20753206|P2|Overall Study|Withdrawal by Subject|1
6002065|NCT00907777|20753207|P1|Overall Study|Withdrawal by Subject|0
6002066|NCT00907738|20753234|P5|Overall Study|Disease progression|2
6002067|NCT00907738|20753235|P4|Overall Study|Disease progression|4
6002068|NCT00907738|20753236|P3|Overall Study|Disease progression|6
6002069|NCT00907738|20753237|P2|Overall Study|Disease progression|1
6002070|NCT00907738|20753238|P1|Overall Study|Disease progression|8
6002071|NCT00907738|20753234|P5|Overall Study|not specified or withdrew consent|0
6002072|NCT00907738|20753235|P4|Overall Study|not specified or withdrew consent|0
6002073|NCT00907738|20753236|P3|Overall Study|not specified or withdrew consent|0
6002074|NCT00907738|20753237|P2|Overall Study|not specified or withdrew consent|0
6002075|NCT00907738|20753238|P1|Overall Study|not specified or withdrew consent|3
6002076|NCT00907738|20753234|P5|Overall Study|Adverse Event|0
6002077|NCT00907738|20753235|P4|Overall Study|Adverse Event|0
6002078|NCT00907738|20753236|P3|Overall Study|Adverse Event|1
6002079|NCT00907738|20753237|P2|Overall Study|Adverse Event|0
6002080|NCT00907738|20753238|P1|Overall Study|Adverse Event|2
6002081|NCT00907621|20753256|P2|Overall Study|intercurrent febrile illness|1
6002082|NCT00907621|20753257|P1|Overall Study|intercurrent febrile illness|1
6002083|NCT00907621|20753256|P2|Overall Study|Lost to Follow-up|3
6002084|NCT00907621|20753257|P1|Overall Study|Lost to Follow-up|6
6002085|NCT00907517|20753270|P5|Overall Study|Symptomatic Deterioration|1
6002086|NCT00907517|20753271|P4|Overall Study|Symptomatic Deterioration|0
6002087|NCT00907517|20753272|P3|Overall Study|Symptomatic Deterioration|0
6002088|NCT00907517|20753273|P2|Overall Study|Symptomatic Deterioration|0
6002089|NCT00907517|20753274|P1|Overall Study|Symptomatic Deterioration|0
6002090|NCT00907517|20753270|P5|Overall Study|Progressive Disease|4
6002091|NCT00907517|20753271|P4|Overall Study|Progressive Disease|4
6002092|NCT00907517|20753272|P3|Overall Study|Progressive Disease|4
6002093|NCT00907517|20753273|P2|Overall Study|Progressive Disease|3
6002094|NCT00907517|20753274|P1|Overall Study|Progressive Disease|3
6002095|NCT00907478|20753299|P3|Overall Study|Other|1
6002096|NCT00907478|20753300|P2|Overall Study|Other|0
6002097|NCT00907478|20753301|P1|Overall Study|Other|3
6002098|NCT00907478|20753299|P3|Overall Study|Lost to Follow-up|0
6002099|NCT00907478|20753300|P2|Overall Study|Lost to Follow-up|0
6002100|NCT00907478|20753301|P1|Overall Study|Lost to Follow-up|1
6002101|NCT00907478|20753299|P3|Overall Study|Pregnancy|1
6002102|NCT00907478|20753300|P2|Overall Study|Pregnancy|1
6002103|NCT00907478|20753301|P1|Overall Study|Pregnancy|0
6002104|NCT00907478|20753299|P3|Overall Study|Protocol-specified criteria|3
6002105|NCT00907478|20753300|P2|Overall Study|Protocol-specified criteria|2
6002106|NCT00907478|20753301|P1|Overall Study|Protocol-specified criteria|5
6002107|NCT00907478|20753299|P3|Overall Study|Death|1
6002108|NCT00907478|20753300|P2|Overall Study|Death|2
6002109|NCT00907478|20753301|P1|Overall Study|Death|4
6002110|NCT00907478|20753299|P3|Overall Study|Physician Decision|3
6002111|NCT00907478|20753300|P2|Overall Study|Physician Decision|0
6002112|NCT00907478|20753301|P1|Overall Study|Physician Decision|2
6002113|NCT00907478|20753299|P3|Overall Study|Requirement for alternative therapy|3
6002114|NCT00907478|20753300|P2|Overall Study|Requirement for alternative therapy|2
6002115|NCT00907478|20753301|P1|Overall Study|Requirement for alternative therapy|1
6002116|NCT00907478|20753299|P3|Overall Study|Withdrawal by Subject|6
6002117|NCT00907478|20753300|P2|Overall Study|Withdrawal by Subject|9
6002118|NCT00907478|20753301|P1|Overall Study|Withdrawal by Subject|8
6002119|NCT00907478|20753299|P3|Overall Study|Adverse Event|2
6002120|NCT00907478|20753300|P2|Overall Study|Adverse Event|1
6002121|NCT00907478|20753301|P1|Overall Study|Adverse Event|3
6002122|NCT00907478|20753299|P3|Overall Study|Noncompliance|1
6002123|NCT00907478|20753300|P2|Overall Study|Noncompliance|0
6002124|NCT00907478|20753301|P1|Overall Study|Noncompliance|0
6002125|NCT00907478|20753299|P3|Overall Study|Ineligibility determined|1
6002126|NCT00907478|20753300|P2|Overall Study|Ineligibility determined|0
6002127|NCT00907478|20753301|P1|Overall Study|Ineligibility determined|0
6002128|NCT00907374|20753351|P2|Overall Study|Noncompliant w/study protocol at <3 mos|2
6002129|NCT00907374|20753352|P1|Overall Study|Noncompliant w/study protocol at <3 mos|2
6002130|NCT00907335|20753366|P2|Overall Study|Lost to Follow-up|0
6002131|NCT00907335|20753367|P1|Overall Study|Lost to Follow-up|2
6002132|NCT00907335|20753366|P2|Overall Study|Adverse Event|1
6002133|NCT00907335|20753367|P1|Overall Study|Adverse Event|4
6002134|NCT00907335|20753366|P2|Overall Study|Withdrawal by Subject|0
6002135|NCT00907335|20753367|P1|Overall Study|Withdrawal by Subject|2
6002136|NCT00907296|20753393|P10|Overall Study|Lost to Follow-up|4
6002137|NCT00907296|20753394|P9|Overall Study|Lost to Follow-up|0
6002138|NCT00907296|20753395|P8|Overall Study|Lost to Follow-up|2
6002139|NCT00907296|20753396|P7|Overall Study|Lost to Follow-up|2
6002140|NCT00907296|20753397|P6|Overall Study|Lost to Follow-up|3
6002141|NCT00907296|20753398|P5|Overall Study|Lost to Follow-up|0
6002142|NCT00907296|20753399|P4|Overall Study|Lost to Follow-up|2
6002143|NCT00907296|20753400|P3|Overall Study|Lost to Follow-up|0
6002144|NCT00907296|20753401|P2|Overall Study|Lost to Follow-up|1
6002145|NCT00907296|20753402|P1|Overall Study|Lost to Follow-up|9
6002146|NCT00907296|20753393|P10|Overall Study|Withdrawal by Subject|2
6002147|NCT00907296|20753394|P9|Overall Study|Withdrawal by Subject|4
6002148|NCT00907296|20753395|P8|Overall Study|Withdrawal by Subject|2
6002149|NCT00907296|20753396|P7|Overall Study|Withdrawal by Subject|3
6002150|NCT00907296|20753397|P6|Overall Study|Withdrawal by Subject|5
6002151|NCT00907296|20753398|P5|Overall Study|Withdrawal by Subject|1
6002152|NCT00907296|20753399|P4|Overall Study|Withdrawal by Subject|1
6002153|NCT00907296|20753400|P3|Overall Study|Withdrawal by Subject|1
6002154|NCT00907296|20753401|P2|Overall Study|Withdrawal by Subject|2
6002155|NCT00907296|20753402|P1|Overall Study|Withdrawal by Subject|7
6002156|NCT00907296|20753393|P10|Overall Study|Adverse Event|1
6002157|NCT00907296|20753394|P9|Overall Study|Adverse Event|0
6002158|NCT00907296|20753395|P8|Overall Study|Adverse Event|0
6002159|NCT00907296|20753396|P7|Overall Study|Adverse Event|1
6002160|NCT00907296|20753397|P6|Overall Study|Adverse Event|0
6002161|NCT00907296|20753398|P5|Overall Study|Adverse Event|0
6002162|NCT00907296|20753399|P4|Overall Study|Adverse Event|0
6002163|NCT00907296|20753400|P3|Overall Study|Adverse Event|0
6002164|NCT00907296|20753401|P2|Overall Study|Adverse Event|0
6002165|NCT00907296|20753402|P1|Overall Study|Adverse Event|2
6002166|NCT00907296|20753393|P10|Overall Study|Noncompliance|0
6002167|NCT00907296|20753394|P9|Overall Study|Noncompliance|0
6002168|NCT00907296|20753395|P8|Overall Study|Noncompliance|2
6002169|NCT00907296|20753396|P7|Overall Study|Noncompliance|0
6002170|NCT00907296|20753397|P6|Overall Study|Noncompliance|1
6002171|NCT00907296|20753398|P5|Overall Study|Noncompliance|0
6002172|NCT00907296|20753399|P4|Overall Study|Noncompliance|0
6002173|NCT00907296|20753400|P3|Overall Study|Noncompliance|1
6002174|NCT00907296|20753401|P2|Overall Study|Noncompliance|1
6002175|NCT00907296|20753402|P1|Overall Study|Noncompliance|1
6002176|NCT00907296|20753393|P10|Overall Study|Protocol Deviation|0
6002177|NCT00907296|20753394|P9|Overall Study|Protocol Deviation|0
6002178|NCT00907296|20753395|P8|Overall Study|Protocol Deviation|0
6002179|NCT00907296|20753396|P7|Overall Study|Protocol Deviation|0
6002180|NCT00907296|20753397|P6|Overall Study|Protocol Deviation|0
6002181|NCT00907296|20753398|P5|Overall Study|Protocol Deviation|0
6002182|NCT00907296|20753399|P4|Overall Study|Protocol Deviation|0
6002183|NCT00907296|20753400|P3|Overall Study|Protocol Deviation|0
6002184|NCT00907296|20753401|P2|Overall Study|Protocol Deviation|1
6002185|NCT00907296|20753402|P1|Overall Study|Protocol Deviation|0
6002186|NCT00907296|20753393|P10|Overall Study|Ineligibility Determined|0
6002187|NCT00907296|20753394|P9|Overall Study|Ineligibility Determined|0
6002188|NCT00907296|20753395|P8|Overall Study|Ineligibility Determined|1
6002189|NCT00907296|20753396|P7|Overall Study|Ineligibility Determined|0
6002190|NCT00907296|20753397|P6|Overall Study|Ineligibility Determined|0
6002191|NCT00907296|20753398|P5|Overall Study|Ineligibility Determined|0
6002192|NCT00907296|20753399|P4|Overall Study|Ineligibility Determined|1
6002193|NCT00907296|20753400|P3|Overall Study|Ineligibility Determined|0
6002194|NCT00907296|20753401|P2|Overall Study|Ineligibility Determined|0
6002195|NCT00907296|20753402|P1|Overall Study|Ineligibility Determined|1
6002196|NCT00907257|20753456|P2|Overall Study|Personal Reasons|1
6002197|NCT00907257|20753457|P1|Overall Study|Personal Reasons|6
6002198|NCT00907257|20753456|P2|Overall Study|Moved|0
6002199|NCT00907257|20753457|P1|Overall Study|Moved|1
6002200|NCT00907257|20753456|P2|Overall Study|Per IRB-Subject became vulnerable|0
6002201|NCT00907257|20753457|P1|Overall Study|Per IRB-Subject became vulnerable|1
6002202|NCT00907257|20753456|P2|Overall Study|Withdrawal by Subject|2
6002203|NCT00907257|20753457|P1|Overall Study|Withdrawal by Subject|1
6002204|NCT00907257|20753456|P2|Overall Study|Lost to Follow-up|3
6002205|NCT00907257|20753457|P1|Overall Study|Lost to Follow-up|3
6002206|NCT00907257|20753456|P2|Overall Study|Protocol Violation|2
6002207|NCT00907257|20753457|P1|Overall Study|Protocol Violation|1
6002208|NCT00907257|20753456|P2|Overall Study|Adverse Event|4
6002209|NCT00907257|20753457|P1|Overall Study|Adverse Event|0
6002210|NCT00907153|20753479|P2|Overall Study|Withdrawal by Subject|3
6002211|NCT00907153|20753480|P1|Overall Study|Withdrawal by Subject|1
6002212|NCT00907153|20753479|P2|Overall Study|Lost to Follow-up|1
6002213|NCT00907153|20753480|P1|Overall Study|Lost to Follow-up|1
6002214|NCT00906971|20753541|P2|Overall Study|Lost to Follow-up|1
6002215|NCT00906971|20753542|P1|Overall Study|Lost to Follow-up|0
6002216|NCT00906971|20753541|P2|Overall Study|Withdrawal by Subject|2
6002217|NCT00906971|20753542|P1|Overall Study|Withdrawal by Subject|8
6002218|NCT00906945|20753555|P6|Overall Study|Physician Decision|1
6002219|NCT00906945|20753556|P5|Overall Study|Physician Decision|0
6002220|NCT00906945|20753557|P4|Overall Study|Physician Decision|0
6002221|NCT00906945|20753558|P3|Overall Study|Physician Decision|0
6002222|NCT00906945|20753559|P2|Overall Study|Physician Decision|0
6002223|NCT00906945|20753560|P1|Overall Study|Physician Decision|0
6002224|NCT00906945|20753555|P6|Overall Study|Found to be not eligible|1
6002225|NCT00906945|20753556|P5|Overall Study|Found to be not eligible|1
6002226|NCT00906945|20753557|P4|Overall Study|Found to be not eligible|1
6002227|NCT00906945|20753558|P3|Overall Study|Found to be not eligible|0
6002228|NCT00906945|20753559|P2|Overall Study|Found to be not eligible|0
6002229|NCT00906945|20753560|P1|Overall Study|Found to be not eligible|0
6002230|NCT00906698|20753620|P6|Overall Study|incl. non compliance, lost to follow-up|0
6002231|NCT00906698|20753621|P5|Overall Study|incl. non compliance, lost to follow-up|0
6002232|NCT00906698|20753622|P4|Overall Study|incl. non compliance, lost to follow-up|0
6002233|NCT00906698|20753623|P3|Overall Study|incl. non compliance, lost to follow-up|0
6002234|NCT00906698|20753624|P2|Overall Study|incl. non compliance, lost to follow-up|1
6002235|NCT00906698|20753625|P1|Overall Study|incl. non compliance, lost to follow-up|0
6002236|NCT00906698|20753620|P6|Overall Study|Withdrawal by Subject|0
6002237|NCT00906698|20753621|P5|Overall Study|Withdrawal by Subject|1
6002238|NCT00906698|20753622|P4|Overall Study|Withdrawal by Subject|0
6002239|NCT00906698|20753623|P3|Overall Study|Withdrawal by Subject|0
6002240|NCT00906698|20753624|P2|Overall Study|Withdrawal by Subject|0
6002241|NCT00906698|20753625|P1|Overall Study|Withdrawal by Subject|0
6002242|NCT00906698|20753620|P6|Overall Study|Disease progression|4
6002243|NCT00906698|20753621|P5|Overall Study|Disease progression|12
6002244|NCT00906698|20753622|P4|Overall Study|Disease progression|4
6002245|NCT00906698|20753623|P3|Overall Study|Disease progression|4
6002246|NCT00906698|20753624|P2|Overall Study|Disease progression|12
6002247|NCT00906698|20753625|P1|Overall Study|Disease progression|3
6002248|NCT00906698|20753620|P6|Overall Study|Adverse Event|1
6002249|NCT00906698|20753621|P5|Overall Study|Adverse Event|4
6002250|NCT00906698|20753622|P4|Overall Study|Adverse Event|0
6002251|NCT00906698|20753623|P3|Overall Study|Adverse Event|2
6002252|NCT00906698|20753624|P2|Overall Study|Adverse Event|0
6002253|NCT00906698|20753625|P1|Overall Study|Adverse Event|0
6002254|NCT00906698|20753620|P6|Overall Study|Dose-limiting toxicity (DLT)|0
6002255|NCT00906698|20753621|P5|Overall Study|Dose-limiting toxicity (DLT)|1
6002256|NCT00906698|20753622|P4|Overall Study|Dose-limiting toxicity (DLT)|0
6002257|NCT00906698|20753623|P3|Overall Study|Dose-limiting toxicity (DLT)|0
6002258|NCT00906698|20753624|P2|Overall Study|Dose-limiting toxicity (DLT)|6
6002259|NCT00906698|20753625|P1|Overall Study|Dose-limiting toxicity (DLT)|0
6002260|NCT00906399|20753727|P7|Year 2|Other|0
6002261|NCT00906399|20753728|P6|Year 2|Other|1
6002262|NCT00906399|20753729|P5|Year 2|Other|3
6002263|NCT00906399|20753730|P4|Year 2|Other|2
6002264|NCT00906399|20753731|P3|Year 2|Other|0
6002265|NCT00906399|20753732|P2|Year 2|Other|0
6002266|NCT00906399|20753733|P1|Year 2|Other|0
6002267|NCT00906399|20753727|P7|Year 2|Death|3
6002268|NCT00906399|20753728|P6|Year 2|Death|0
6002269|NCT00906399|20753729|P5|Year 2|Death|0
6002270|NCT00906399|20753730|P4|Year 2|Death|1
6002271|NCT00906399|20753731|P3|Year 2|Death|0
6002272|NCT00906399|20753732|P2|Year 2|Death|0
6002273|NCT00906399|20753733|P1|Year 2|Death|0
6002274|NCT00906399|20753727|P7|Year 2|Physician Decision|3
6002275|NCT00906399|20753728|P6|Year 2|Physician Decision|6
6002276|NCT00906399|20753729|P5|Year 2|Physician Decision|2
6002277|NCT00906399|20753730|P4|Year 2|Physician Decision|0
6002278|NCT00906399|20753731|P3|Year 2|Physician Decision|0
6002279|NCT00906399|20753732|P2|Year 2|Physician Decision|0
6002280|NCT00906399|20753733|P1|Year 2|Physician Decision|0
6002281|NCT00906399|20753727|P7|Year 2|Withdrawal by Subject|13
6002282|NCT00906399|20753728|P6|Year 2|Withdrawal by Subject|27
6002283|NCT00906399|20753729|P5|Year 2|Withdrawal by Subject|18
6002284|NCT00906399|20753730|P4|Year 2|Withdrawal by Subject|17
6002285|NCT00906399|20753731|P3|Year 2|Withdrawal by Subject|0
6002286|NCT00906399|20753732|P2|Year 2|Withdrawal by Subject|0
6002287|NCT00906399|20753733|P1|Year 2|Withdrawal by Subject|0
6002288|NCT00906399|20753727|P7|Year 2|Lost to Follow-up|4
6002289|NCT00906399|20753728|P6|Year 2|Lost to Follow-up|2
6002290|NCT00906399|20753729|P5|Year 2|Lost to Follow-up|4
6002291|NCT00906399|20753730|P4|Year 2|Lost to Follow-up|1
6002292|NCT00906399|20753731|P3|Year 2|Lost to Follow-up|0
6002293|NCT00906399|20753732|P2|Year 2|Lost to Follow-up|0
6002294|NCT00906399|20753733|P1|Year 2|Lost to Follow-up|0
6002295|NCT00906399|20753727|P7|Year 2|Adverse Event|6
6002296|NCT00906399|20753728|P6|Year 2|Adverse Event|11
6002297|NCT00906399|20753729|P5|Year 2|Adverse Event|8
6002298|NCT00906399|20753730|P4|Year 2|Adverse Event|9
6002299|NCT00906399|20753731|P3|Year 2|Adverse Event|0
6002300|NCT00906399|20753732|P2|Year 2|Adverse Event|0
6002301|NCT00906399|20753733|P1|Year 2|Adverse Event|0
6002302|NCT00906399|20753727|P7|Year 1|Other|0
6002303|NCT00906399|20753728|P6|Year 1|Other|0
6002304|NCT00906399|20753729|P5|Year 1|Other|0
6002305|NCT00906399|20753730|P4|Year 1|Other|0
6002306|NCT00906399|20753731|P3|Year 1|Other|7
6002307|NCT00906399|20753732|P2|Year 1|Other|2
6002308|NCT00906399|20753733|P1|Year 1|Other|4
6002309|NCT00906399|20753727|P7|Year 1|Death|0
6002310|NCT00906399|20753728|P6|Year 1|Death|0
6002311|NCT00906399|20753729|P5|Year 1|Death|0
6002312|NCT00906399|20753730|P4|Year 1|Death|0
6002313|NCT00906399|20753731|P3|Year 1|Death|1
6002314|NCT00906399|20753732|P2|Year 1|Death|1
6002315|NCT00906399|20753733|P1|Year 1|Death|2
6002316|NCT00906399|20753727|P7|Year 1|Physician Decision|0
6002317|NCT00906399|20753728|P6|Year 1|Physician Decision|0
6002318|NCT00906399|20753729|P5|Year 1|Physician Decision|0
6002319|NCT00906399|20753730|P4|Year 1|Physician Decision|0
6002320|NCT00906399|20753731|P3|Year 1|Physician Decision|3
6002321|NCT00906399|20753732|P2|Year 1|Physician Decision|1
6002322|NCT00906399|20753733|P1|Year 1|Physician Decision|0
6002323|NCT00906399|20753727|P7|Year 1|Withdrawal by Subject|0
6002324|NCT00906399|20753728|P6|Year 1|Withdrawal by Subject|0
6002325|NCT00906399|20753729|P5|Year 1|Withdrawal by Subject|0
6002326|NCT00906399|20753730|P4|Year 1|Withdrawal by Subject|0
6002327|NCT00906399|20753731|P3|Year 1|Withdrawal by Subject|36
6002328|NCT00906399|20753732|P2|Year 1|Withdrawal by Subject|32
6002329|NCT00906399|20753733|P1|Year 1|Withdrawal by Subject|30
6002330|NCT00906399|20753727|P7|Year 1|Lost to Follow-up|0
6002331|NCT00906399|20753728|P6|Year 1|Lost to Follow-up|0
6002332|NCT00906399|20753729|P5|Year 1|Lost to Follow-up|0
6002333|NCT00906399|20753730|P4|Year 1|Lost to Follow-up|0
6002334|NCT00906399|20753731|P3|Year 1|Lost to Follow-up|2
6002335|NCT00906399|20753732|P2|Year 1|Lost to Follow-up|4
6002336|NCT00906399|20753733|P1|Year 1|Lost to Follow-up|4
6002337|NCT00906399|20753727|P7|Year 1|Adverse Event|0
6002338|NCT00906399|20753728|P6|Year 1|Adverse Event|0
6002339|NCT00906399|20753729|P5|Year 1|Adverse Event|0
6002340|NCT00906399|20753730|P4|Year 1|Adverse Event|0
6002341|NCT00906399|20753731|P3|Year 1|Adverse Event|24
6002342|NCT00906399|20753732|P2|Year 1|Adverse Event|22
6002343|NCT00906399|20753733|P1|Year 1|Adverse Event|4
6002344|NCT00906399|20753727|P7|Year 1|Randomized But Not Treated|0
6002345|NCT00906399|20753728|P6|Year 1|Randomized But Not Treated|0
6002346|NCT00906399|20753729|P5|Year 1|Randomized But Not Treated|0
6002347|NCT00906399|20753730|P4|Year 1|Randomized But Not Treated|0
6002348|NCT00906399|20753731|P3|Year 1|Randomized But Not Treated|3
6002349|NCT00906399|20753732|P2|Year 1|Randomized But Not Treated|1
6002350|NCT00906399|20753733|P1|Year 1|Randomized But Not Treated|0
6002351|NCT00906373|20753756|P2|Overall Study|Still on treatment at cutoff date|2
6002352|NCT00906373|20753757|P1|Overall Study|Still on treatment at cutoff date|0
6002353|NCT00906373|20753756|P2|Overall Study|Other|1
6002354|NCT00906373|20753757|P1|Overall Study|Other|0
6002355|NCT00906373|20753756|P2|Overall Study|Withdrawal by Subject|5
6002356|NCT00906373|20753757|P1|Overall Study|Withdrawal by Subject|0
6002357|NCT00906347|20753796|P2|Received Study Drug|Uterine tachysystole or hypertonus|0
6002358|NCT00906347|20753797|P1|Received Study Drug|Uterine tachysystole or hypertonus|8
6002359|NCT00906347|20753796|P2|Received Study Drug|Refused study drug|0
6002360|NCT00906347|20753797|P1|Received Study Drug|Refused study drug|1
6002361|NCT00906347|20753796|P2|Received Study Drug|Nonreassuring fetal heart rate|1
6002362|NCT00906347|20753797|P1|Received Study Drug|Nonreassuring fetal heart rate|13
6002363|NCT00906347|20753796|P2|Received Study Drug|8 cm prior to initiation of study drug|30
6002364|NCT00906347|20753797|P1|Received Study Drug|8 cm prior to initiation of study drug|18
6002365|NCT00906282|20753817|P1|Preoperative Chemotherapy|Toxicity|1
6002366|NCT00906282|20753817|P1|Preoperative Chemotherapy|Progressive disease|6
6002367|NCT00906282|20753817|P1|Preoperative Chemotherapy|Not surgical candidates, off study|10
6002368|NCT00906282|20753817|P1|Preoperative Chemotherapy|Withdrawal by Subject|2
6002369|NCT00906204|20753831|P2|Secondary Endpoints (Long-term Safety)|Death|1
6002370|NCT00906204|20753832|P1|Secondary Endpoints (Long-term Safety)|Death|0
6002371|NCT00906204|20753831|P2|Secondary Endpoints (Long-term Safety)|Adverse Event|2
6002372|NCT00906204|20753832|P1|Secondary Endpoints (Long-term Safety)|Adverse Event|2
6002373|NCT00906204|20753831|P2|Primary Endpoint (Early Safety)|Withdrawal by Subject|0
6002374|NCT00906204|20753832|P1|Primary Endpoint (Early Safety)|Withdrawal by Subject|1
6002375|NCT00906204|20753831|P2|Primary Endpoint (Early Safety)|Untransplantable donor kidney|1
6002376|NCT00906204|20753832|P1|Primary Endpoint (Early Safety)|Untransplantable donor kidney|0
6002377|NCT00906204|20753831|P2|Primary Endpoint (Early Safety)|Physician Decision|0
6002378|NCT00906204|20753832|P1|Primary Endpoint (Early Safety)|Physician Decision|1
6002379|NCT00906087|20753886|P1|Initial Washout|Physician Decision|1
6002380|NCT00906087|20753886|P1|Initial Washout|Withdrawal by Subject|1
6002381|NCT00906035|20753923|P3|Overall Study|Withdrawal by Subject|0
6002382|NCT00906035|20753924|P2|Overall Study|Withdrawal by Subject|3
6002383|NCT00906035|20753925|P1|Overall Study|Withdrawal by Subject|2
6002384|NCT00905840|20753939|P1|Overall Study|Adverse Event|1
6002385|NCT00905840|20753939|P1|Overall Study|Withdrawal by Subject|1
6002386|NCT00905840|20753939|P1|Overall Study|Death|3
6002387|NCT00905840|20753939|P1|Overall Study|Lost to Follow-up|11
6002388|NCT00905632|20753970|P7|Overall Study|Adverse Event|4
6002389|NCT00905632|20753971|P6|Overall Study|Adverse Event|1
6002390|NCT00905632|20753972|P5|Overall Study|Adverse Event|0
6002391|NCT00905632|20753973|P4|Overall Study|Adverse Event|0
6002392|NCT00905632|20753974|P3|Overall Study|Adverse Event|0
6002393|NCT00905632|20753975|P2|Overall Study|Adverse Event|0
6002394|NCT00905632|20753976|P1|Overall Study|Adverse Event|0
6002395|NCT00905606|20754114|P2|Washout|Withdrawal by Subject|0
6002396|NCT00905606|20754115|P1|Washout|Withdrawal by Subject|1
6002397|NCT00905606|20754114|P2|Period 1|Adverse Event|1
6002398|NCT00905606|20754115|P1|Period 1|Adverse Event|0
6002399|NCT00905567|20754140|P2|Washout|Withdrawal by Subject|1
6002400|NCT00905567|20754141|P1|Washout|Withdrawal by Subject|0
6002401|NCT00905489|20754173|P1|Optional Extension Phase (OEP)|Adverse Event|1
6002402|NCT00905489|20754173|P1|Pharmaco-kinetic (PK) Phase|Other reason not defined above|3
6002403|NCT00905489|20754173|P1|Pharmaco-kinetic (PK) Phase|Protocol Violation|2
6002404|NCT00905424|20754263|P2|Overall Study|Non-adherence to visit schedule|1
6002405|NCT00905424|20754264|P1|Overall Study|Non-adherence to visit schedule|0
6002406|NCT00905424|20754263|P2|Overall Study|Positive urine drug screen|1
6002407|NCT00905424|20754264|P1|Overall Study|Positive urine drug screen|0
6002408|NCT00905424|20754263|P2|Overall Study|Sponsor decision|0
6002409|NCT00905424|20754264|P1|Overall Study|Sponsor decision|1
6002410|NCT00905424|20754263|P2|Overall Study|Non-compliance with study medication|0
6002411|NCT00905424|20754264|P1|Overall Study|Non-compliance with study medication|2
6002412|NCT00905424|20754263|P2|Overall Study|Adverse Event|2
6002413|NCT00905424|20754264|P1|Overall Study|Adverse Event|4
6002414|NCT00905424|20754263|P2|Overall Study|Withdrawal by Subject|2
6002415|NCT00905424|20754264|P1|Overall Study|Withdrawal by Subject|1
6002416|NCT00905424|20754263|P2|Overall Study|Lost to Follow-up|3
6002417|NCT00905424|20754264|P1|Overall Study|Lost to Follow-up|3
6002418|NCT00905359|20754306|P2|Overall Study|Withdrawal consent|6
6002419|NCT00905359|20754307|P1|Overall Study|Withdrawal consent|5
6002420|NCT00905359|20754306|P2|Overall Study|Death|0
6002421|NCT00905359|20754307|P1|Overall Study|Death|2
6002422|NCT00905359|20754306|P2|Overall Study|Lost to Follow-up|10
6002423|NCT00905359|20754307|P1|Overall Study|Lost to Follow-up|17
6002424|NCT00905346|20754343|P2|Period 1|Withdrawal by Subject|0
6002425|NCT00905346|20754344|P1|Period 1|Withdrawal by Subject|1
6002426|NCT00905307|20754358|P6|Overall Study|Lack of Efficacy|8
6002427|NCT00905307|20754359|P5|Overall Study|Lack of Efficacy|4
6002428|NCT00905307|20754360|P4|Overall Study|Lack of Efficacy|4
6002429|NCT00905307|20754361|P3|Overall Study|Lack of Efficacy|5
6002430|NCT00905307|20754362|P2|Overall Study|Lack of Efficacy|3
6002431|NCT00905307|20754363|P1|Overall Study|Lack of Efficacy|6
6002432|NCT00905307|20754358|P6|Overall Study|Protocol Violation|0
6002433|NCT00905307|20754359|P5|Overall Study|Protocol Violation|0
6002434|NCT00905307|20754360|P4|Overall Study|Protocol Violation|0
6002435|NCT00905307|20754361|P3|Overall Study|Protocol Violation|1
6002436|NCT00905307|20754362|P2|Overall Study|Protocol Violation|0
6002437|NCT00905307|20754363|P1|Overall Study|Protocol Violation|1
6002438|NCT00905307|20754358|P6|Overall Study|Withdrawal by Subject|13
6002439|NCT00905307|20754359|P5|Overall Study|Withdrawal by Subject|4
6002440|NCT00905307|20754360|P4|Overall Study|Withdrawal by Subject|11
6002441|NCT00905307|20754361|P3|Overall Study|Withdrawal by Subject|15
6002442|NCT00905307|20754362|P2|Overall Study|Withdrawal by Subject|13
6002443|NCT00905307|20754363|P1|Overall Study|Withdrawal by Subject|5
6002444|NCT00905307|20754358|P6|Overall Study|Adverse Event|5
6002445|NCT00905307|20754359|P5|Overall Study|Adverse Event|3
6002446|NCT00905307|20754360|P4|Overall Study|Adverse Event|11
6002447|NCT00905307|20754361|P3|Overall Study|Adverse Event|5
6002448|NCT00905307|20754362|P2|Overall Study|Adverse Event|4
6002449|NCT00905307|20754363|P1|Overall Study|Adverse Event|3
6002450|NCT00905307|20754358|P6|Overall Study|Lost to Follow-up|1
6002451|NCT00905307|20754359|P5|Overall Study|Lost to Follow-up|1
6002452|NCT00905307|20754360|P4|Overall Study|Lost to Follow-up|0
6002453|NCT00905307|20754361|P3|Overall Study|Lost to Follow-up|0
6002454|NCT00905307|20754362|P2|Overall Study|Lost to Follow-up|0
6002455|NCT00905307|20754363|P1|Overall Study|Lost to Follow-up|0
6002456|NCT00905307|20754358|P6|Overall Study|Switched to Open Label Rescue|15
6002457|NCT00905307|20754359|P5|Overall Study|Switched to Open Label Rescue|4
6002458|NCT00905307|20754360|P4|Overall Study|Switched to Open Label Rescue|11
6002459|NCT00905307|20754361|P3|Overall Study|Switched to Open Label Rescue|11
6002460|NCT00905307|20754362|P2|Overall Study|Switched to Open Label Rescue|17
6002461|NCT00905307|20754363|P1|Overall Study|Switched to Open Label Rescue|7
6002462|NCT00905255|20754458|P2|Overall Study|Familial and Personal Reasons|0
6002463|NCT00905255|20754459|P1|Overall Study|Familial and Personal Reasons|1
6002464|NCT00905255|20754458|P2|Overall Study|Withdrawal by Subject|4
6002465|NCT00905255|20754459|P1|Overall Study|Withdrawal by Subject|5
6002466|NCT00905255|20754458|P2|Overall Study|Adverse Event|5
6002467|NCT00905255|20754459|P1|Overall Study|Adverse Event|7
6002468|NCT00905164|20754477|P2|Period 1|Protocol Violation|1
6002469|NCT00905164|20754478|P1|Period 1|Protocol Violation|0
6002470|NCT00905034|20754525|P1|Overall Study|Withdrawal by Subject|1
6002471|NCT00905021|20754529|P1|Overall Study|Adverse Event|2
6002472|NCT00904982|20754549|P4|Overall Study|Withdrawal by Subject|0
6002473|NCT00904982|20754550|P3|Overall Study|Withdrawal by Subject|0
6002474|NCT00904982|20754551|P2|Overall Study|Withdrawal by Subject|0
6002475|NCT00904982|20754552|P1|Overall Study|Withdrawal by Subject|2
6002476|NCT00904969|20754562|P1|Overall Study|Case Aborted; Subject Exited|1
6002477|NCT00904969|20754562|P1|Overall Study|Additional Treatments|11
6002478|NCT00904969|20754562|P1|Overall Study|Withdrawal by Subject|3
6002479|NCT00904969|20754562|P1|Overall Study|Lost to Follow-up|4
6002480|NCT00904917|20754627|P4|Overall Study|Lost to Follow-up|2
6002481|NCT00904917|20754628|P3|Overall Study|Lost to Follow-up|2
6002482|NCT00904917|20754629|P2|Overall Study|Lost to Follow-up|2
6002483|NCT00904917|20754630|P1|Overall Study|Lost to Follow-up|2
6002484|NCT00904839|20754648|P3|Overall Study|Other than above|7
6002485|NCT00904839|20754649|P2|Overall Study|Other than above|9
6002486|NCT00904839|20754650|P1|Overall Study|Other than above|0
6002487|NCT00904839|20754648|P3|Overall Study|Not treated|1
6002488|NCT00904839|20754649|P2|Overall Study|Not treated|0
6002489|NCT00904839|20754650|P1|Overall Study|Not treated|1
6002490|NCT00904839|20754648|P3|Overall Study|Withdrawal by Subject|0
6002491|NCT00904839|20754649|P2|Overall Study|Withdrawal by Subject|2
6002492|NCT00904839|20754650|P1|Overall Study|Withdrawal by Subject|0
6002493|NCT00904839|20754648|P3|Overall Study|Lost to Follow-up|2
6002494|NCT00904839|20754649|P2|Overall Study|Lost to Follow-up|1
6002495|NCT00904839|20754650|P1|Overall Study|Lost to Follow-up|0
6002496|NCT00904839|20754648|P3|Overall Study|Protocol Violation|1
6002497|NCT00904839|20754649|P2|Overall Study|Protocol Violation|1
6002498|NCT00904839|20754650|P1|Overall Study|Protocol Violation|0
6002499|NCT00904839|20754648|P3|Overall Study|Adverse Event|4
6002500|NCT00904839|20754649|P2|Overall Study|Adverse Event|5
6002501|NCT00904839|20754650|P1|Overall Study|Adverse Event|0
6002514|NCT00904722|20754725|P1|Overall Study|Physician Decision|1
6002515|NCT00904670|20754730|P2|Open Label Phase|Lost to Follow-up|0
6002516|NCT00904670|20754731|P1|Open Label Phase|Lost to Follow-up|1
6002517|NCT00904670|20754730|P2|Open Label Phase|Lack of Efficacy|0
6002518|NCT00904670|20754731|P1|Open Label Phase|Lack of Efficacy|1
6002519|NCT00904670|20754730|P2|Open Label Phase|Adverse Event|0
6002520|NCT00904670|20754731|P1|Open Label Phase|Adverse Event|2
6002521|NCT00904670|20754730|P2|Open Label Phase|Withdrawal by Subject|0
6002522|NCT00904670|20754731|P1|Open Label Phase|Withdrawal by Subject|2
6002523|NCT00904371|20754801|P1|Overall Study|Continued with Tritace|1
6002524|NCT00904371|20754801|P1|Overall Study|Discontinued at target blood pressure|2
6002525|NCT00904371|20754801|P1|Overall Study|Lost to Follow-up|4
6002526|NCT00904371|20754801|P1|Overall Study|Adverse Event|2
6002527|NCT00904215|20754826|P1|Overall Study|Other|28
6002528|NCT00904215|20754826|P1|Overall Study|Withdrawal by Subject|9
6002529|NCT00904215|20754826|P1|Overall Study|Lost to Follow-up|63
6002530|NCT00904215|20754826|P1|Overall Study|Protocol Violation|10
6002531|NCT00904215|20754826|P1|Overall Study|Adverse Event|25
6002532|NCT00904150|20754840|P2|Saliva Samples (DNA)|Australian samples of different genotype|145
6002533|NCT00904150|20754841|P1|Saliva Samples (DNA)|Australian samples of different genotype|0
6002534|NCT00904150|20754840|P2|Saliva Samples (DNA)|saliva samples not suitable for assay|0
6002535|NCT00904150|20754841|P1|Saliva Samples (DNA)|saliva samples not suitable for assay|3
6002536|NCT00904033|20754863|P4|Overall Study|Unable to obtain final blood draw|2
6002537|NCT00904033|20754864|P3|Overall Study|Unable to obtain final blood draw|0
6002538|NCT00904033|20754865|P2|Overall Study|Unable to obtain final blood draw|0
6002539|NCT00904033|20754866|P1|Overall Study|Unable to obtain final blood draw|0
6002540|NCT00904033|20754863|P4|Overall Study|Physician Decision|0
6002541|NCT00904033|20754864|P3|Overall Study|Physician Decision|1
6002542|NCT00904033|20754865|P2|Overall Study|Physician Decision|0
6002543|NCT00904033|20754866|P1|Overall Study|Physician Decision|0
6002544|NCT00904033|20754863|P4|Overall Study|Withdrawal by Subject|0
6002545|NCT00904033|20754864|P3|Overall Study|Withdrawal by Subject|0
6002546|NCT00904033|20754865|P2|Overall Study|Withdrawal by Subject|1
6002547|NCT00904033|20754866|P1|Overall Study|Withdrawal by Subject|1
6002548|NCT00903968|20754931|P8|Overall Study|Lack of Efficacy|3
6002549|NCT00903968|20754932|P7|Overall Study|Lack of Efficacy|0
6002550|NCT00903968|20754933|P6|Overall Study|Lack of Efficacy|0
6002551|NCT00903968|20754934|P5|Overall Study|Lack of Efficacy|0
6002552|NCT00903968|20754935|P4|Overall Study|Lack of Efficacy|0
6002553|NCT00903968|20754936|P3|Overall Study|Lack of Efficacy|0
6002554|NCT00903968|20754937|P2|Overall Study|Lack of Efficacy|0
6002555|NCT00903968|20754938|P1|Overall Study|Lack of Efficacy|0
6002556|NCT00903968|20754931|P8|Overall Study|Progressive Disease|18
6002557|NCT00903968|20754932|P7|Overall Study|Progressive Disease|0
6002558|NCT00903968|20754933|P6|Overall Study|Progressive Disease|3
6002559|NCT00903968|20754934|P5|Overall Study|Progressive Disease|3
6002560|NCT00903968|20754935|P4|Overall Study|Progressive Disease|3
6002561|NCT00903968|20754936|P3|Overall Study|Progressive Disease|2
6002562|NCT00903968|20754937|P2|Overall Study|Progressive Disease|3
6002563|NCT00903968|20754938|P1|Overall Study|Progressive Disease|2
6002564|NCT00903968|20754931|P8|Overall Study|Physician Decision|0
6002565|NCT00903968|20754932|P7|Overall Study|Physician Decision|0
6002566|NCT00903968|20754933|P6|Overall Study|Physician Decision|1
6002567|NCT00903968|20754934|P5|Overall Study|Physician Decision|0
6002568|NCT00903968|20754935|P4|Overall Study|Physician Decision|0
6002569|NCT00903968|20754936|P3|Overall Study|Physician Decision|0
6002570|NCT00903968|20754937|P2|Overall Study|Physician Decision|0
6002571|NCT00903968|20754938|P1|Overall Study|Physician Decision|0
6002572|NCT00903968|20754931|P8|Overall Study|Non-Compliance|0
6002573|NCT00903968|20754932|P7|Overall Study|Non-Compliance|0
6002574|NCT00903968|20754933|P6|Overall Study|Non-Compliance|1
6002575|NCT00903968|20754934|P5|Overall Study|Non-Compliance|0
6002576|NCT00903968|20754935|P4|Overall Study|Non-Compliance|0
6002577|NCT00903968|20754936|P3|Overall Study|Non-Compliance|0
6002578|NCT00903968|20754937|P2|Overall Study|Non-Compliance|0
6002579|NCT00903968|20754938|P1|Overall Study|Non-Compliance|0
6002580|NCT00903968|20754931|P8|Overall Study|Withdrawal by Subject|4
6002581|NCT00903968|20754932|P7|Overall Study|Withdrawal by Subject|0
6002582|NCT00903968|20754933|P6|Overall Study|Withdrawal by Subject|1
6002583|NCT00903968|20754934|P5|Overall Study|Withdrawal by Subject|1
6002584|NCT00903968|20754935|P4|Overall Study|Withdrawal by Subject|0
6002585|NCT00903968|20754936|P3|Overall Study|Withdrawal by Subject|1
6002586|NCT00903968|20754937|P2|Overall Study|Withdrawal by Subject|0
6002587|NCT00903968|20754938|P1|Overall Study|Withdrawal by Subject|1
6002588|NCT00903968|20754931|P8|Overall Study|DLT|0
6002589|NCT00903968|20754932|P7|Overall Study|DLT|2
6002590|NCT00903968|20754933|P6|Overall Study|DLT|0
6002591|NCT00903968|20754934|P5|Overall Study|DLT|0
6002592|NCT00903968|20754935|P4|Overall Study|DLT|0
6002593|NCT00903968|20754936|P3|Overall Study|DLT|0
6002594|NCT00903968|20754937|P2|Overall Study|DLT|0
6002595|NCT00903968|20754938|P1|Overall Study|DLT|0
6002596|NCT00903968|20754931|P8|Overall Study|Adverse Event|8
6002597|NCT00903968|20754932|P7|Overall Study|Adverse Event|1
6002598|NCT00903968|20754933|P6|Overall Study|Adverse Event|0
6002599|NCT00903968|20754934|P5|Overall Study|Adverse Event|0
6002600|NCT00903968|20754935|P4|Overall Study|Adverse Event|0
6002601|NCT00903968|20754936|P3|Overall Study|Adverse Event|0
6002602|NCT00903968|20754937|P2|Overall Study|Adverse Event|0
6002603|NCT00903968|20754938|P1|Overall Study|Adverse Event|0
6002604|NCT00903929|20754968|P4|Overall Study|Adverse Event|1
6002605|NCT00903929|20754969|P3|Overall Study|Adverse Event|0
6002606|NCT00903929|20754970|P2|Overall Study|Adverse Event|0
6002607|NCT00903929|20754971|P1|Overall Study|Adverse Event|0
6002608|NCT00903929|20754968|P4|Overall Study|Withdrawal by Subject|2
6002609|NCT00903929|20754969|P3|Overall Study|Withdrawal by Subject|1
6002610|NCT00903929|20754970|P2|Overall Study|Withdrawal by Subject|0
6002611|NCT00903929|20754971|P1|Overall Study|Withdrawal by Subject|0
6002612|NCT00903877|20754977|P1|Overall Study|Participation put on hold|4
6002613|NCT00903877|20754977|P1|Overall Study|Lost to Follow-up|1
6002614|NCT00903877|20754977|P1|Overall Study|Adverse Event|2
6002615|NCT00903877|20754977|P1|Overall Study|Withdrawal by Subject|3
6002616|NCT00903877|20754977|P1|Overall Study|Did not meet study criteria|33
6002617|NCT00903786|20754981|P1|Overall Study|Reason other than lack of efficacy|4
6002618|NCT00903786|20754981|P1|Overall Study|Lack of Efficacy|5
6002619|NCT00903786|20754981|P1|Overall Study|Physician Decision|6
6002620|NCT00903760|20754991|P2|Overall Study|Off treatment for long period|1
6002621|NCT00903760|20754992|P1|Overall Study|Off treatment for long period|0
6002622|NCT00903760|20754991|P2|Overall Study|Withdrawal by Subject|2
6002623|NCT00903760|20754992|P1|Overall Study|Withdrawal by Subject|1
6002624|NCT00903760|20754991|P2|Overall Study|Lost to Follow-up|0
6002625|NCT00903760|20754992|P1|Overall Study|Lost to Follow-up|1
6002626|NCT00903760|20754991|P2|Overall Study|Death|1
6002627|NCT00903760|20754992|P1|Overall Study|Death|0
6002628|NCT00903760|20754991|P2|Overall Study|Physician Decision|2
6002629|NCT00903760|20754992|P1|Overall Study|Physician Decision|1
6002630|NCT00903760|20754991|P2|Overall Study|Stem Cell Transplant|4
6002631|NCT00903760|20754992|P1|Overall Study|Stem Cell Transplant|8
6002632|NCT00903760|20754991|P2|Overall Study|Disease Progression/Death|6
6002633|NCT00903760|20754992|P1|Overall Study|Disease Progression/Death|8
6002634|NCT00903695|20755002|P2|Overall Study|lung cancer|0
6002635|NCT00903695|20755003|P1|Overall Study|lung cancer|1
6002636|NCT00903695|20755002|P2|Overall Study|medical exclusion after 1st testing|0
6002637|NCT00903695|20755003|P1|Overall Study|medical exclusion after 1st testing|1
6002638|NCT00903682|20755025|P2|Overall Study|For Resistent Profile (Excl Crit 2 Met)|0
6002639|NCT00903682|20755026|P1|Overall Study|For Resistent Profile (Excl Crit 2 Met)|1
6002640|NCT00903682|20755025|P2|Overall Study|Patient Couldn't Come For The Visit Due|0
6002641|NCT00903682|20755026|P1|Overall Study|Patient Couldn't Come For The Visit Due|1
6002642|NCT00903682|20755025|P2|Overall Study|Subject Non-Compliant|0
6002643|NCT00903682|20755026|P1|Overall Study|Subject Non-Compliant|1
6002644|NCT00903682|20755025|P2|Overall Study|Subject Reached A Virologic Endpoint|1
6002645|NCT00903682|20755026|P1|Overall Study|Subject Reached A Virologic Endpoint|1
6002646|NCT00903682|20755025|P2|Overall Study|Pregnancy|1
6002647|NCT00903682|20755026|P1|Overall Study|Pregnancy|0
6002648|NCT00903682|20755025|P2|Overall Study|Withdrawal by Subject|0
6002649|NCT00903682|20755026|P1|Overall Study|Withdrawal by Subject|5
6002650|NCT00903682|20755025|P2|Overall Study|Lost to Follow-up|0
6002651|NCT00903682|20755026|P1|Overall Study|Lost to Follow-up|1
6002652|NCT00903682|20755025|P2|Overall Study|Adverse Event|13
6002653|NCT00903682|20755026|P1|Overall Study|Adverse Event|6
6002654|NCT00903630|20755047|P3|Phase 2|Adverse Event|1
6002655|NCT00903630|20755048|P2|Phase 2|Adverse Event|0
6002656|NCT00903630|20755049|P1|Phase 2|Adverse Event|0
6002657|NCT00903617|20755067|P4|Overall Study|Withdrawal by Subject|0
6002658|NCT00903617|20755068|P3|Overall Study|Withdrawal by Subject|3
6002659|NCT00903617|20755069|P2|Overall Study|Withdrawal by Subject|2
6002660|NCT00903617|20755070|P1|Overall Study|Withdrawal by Subject|1
6002661|NCT00903617|20755067|P4|Overall Study|Lost to Follow-up|1
6002662|NCT00903617|20755068|P3|Overall Study|Lost to Follow-up|1
6002663|NCT00903617|20755069|P2|Overall Study|Lost to Follow-up|0
6002664|NCT00903617|20755070|P1|Overall Study|Lost to Follow-up|2
6002665|NCT00903617|20755067|P4|Overall Study|Protocol-defined stopping criteria|0
6002666|NCT00903617|20755068|P3|Overall Study|Protocol-defined stopping criteria|0
6002667|NCT00903617|20755069|P2|Overall Study|Protocol-defined stopping criteria|2
6002668|NCT00903617|20755070|P1|Overall Study|Protocol-defined stopping criteria|0
6002669|NCT00903617|20755067|P4|Overall Study|Adverse Event|0
6002670|NCT00903617|20755068|P3|Overall Study|Adverse Event|1
6002671|NCT00903617|20755069|P2|Overall Study|Adverse Event|1
6002672|NCT00903617|20755070|P1|Overall Study|Adverse Event|0
6002673|NCT00903409|20755173|P2|Overall Study|Lost to Follow-up|6
6002674|NCT00903409|20755174|P1|Overall Study|Lost to Follow-up|2
6002675|NCT00903409|20755173|P2|Overall Study|Other|3
6002676|NCT00903409|20755174|P1|Overall Study|Other|2
6002677|NCT00903409|20755173|P2|Overall Study|Withdrawal by Subject|8
6002678|NCT00903409|20755174|P1|Overall Study|Withdrawal by Subject|8
6002679|NCT00903409|20755173|P2|Overall Study|Laboratory Abnormality|0
6002680|NCT00903409|20755174|P1|Overall Study|Laboratory Abnormality|2
6002681|NCT00903409|20755173|P2|Overall Study|Non-compliance with Protocol|1
6002682|NCT00903409|20755174|P1|Overall Study|Non-compliance with Protocol|1
6002683|NCT00903409|20755173|P2|Overall Study|Adverse Event|9
6002684|NCT00903409|20755174|P1|Overall Study|Adverse Event|11
6002685|NCT00903383|20755225|P4|Overall Study|Patient Decision|1
6002686|NCT00903383|20755226|P3|Overall Study|Patient Decision|0
6002687|NCT00903383|20755227|P2|Overall Study|Patient Decision|0
6002688|NCT00903383|20755228|P1|Overall Study|Patient Decision|0
6002689|NCT00903383|20755225|P4|Overall Study|Patient Decision - Lack of Efficacy|0
6002690|NCT00903383|20755226|P3|Overall Study|Patient Decision - Lack of Efficacy|0
6002691|NCT00903383|20755227|P2|Overall Study|Patient Decision - Lack of Efficacy|1
6002692|NCT00903383|20755228|P1|Overall Study|Patient Decision - Lack of Efficacy|0
6002693|NCT00903383|20755225|P4|Overall Study|Withdrawal by Subject|2
6002694|NCT00903383|20755226|P3|Overall Study|Withdrawal by Subject|0
6002695|NCT00903383|20755227|P2|Overall Study|Withdrawal by Subject|1
6002696|NCT00903383|20755228|P1|Overall Study|Withdrawal by Subject|4
6002697|NCT00903383|20755225|P4|Overall Study|Decision of Sponsor|0
6002698|NCT00903383|20755226|P3|Overall Study|Decision of Sponsor|0
6002699|NCT00903383|20755227|P2|Overall Study|Decision of Sponsor|0
6002700|NCT00903383|20755228|P1|Overall Study|Decision of Sponsor|1
6002701|NCT00903383|20755225|P4|Overall Study|Lost to Follow-up|1
6002702|NCT00903383|20755226|P3|Overall Study|Lost to Follow-up|0
6002703|NCT00903383|20755227|P2|Overall Study|Lost to Follow-up|0
6002704|NCT00903383|20755228|P1|Overall Study|Lost to Follow-up|0
6002705|NCT00903383|20755225|P4|Overall Study|Physician Decision|0
6002706|NCT00903383|20755226|P3|Overall Study|Physician Decision|0
6002707|NCT00903383|20755227|P2|Overall Study|Physician Decision|2
6002708|NCT00903383|20755228|P1|Overall Study|Physician Decision|1
6002709|NCT00903383|20755225|P4|Overall Study|Adverse Event|1
6002710|NCT00903383|20755226|P3|Overall Study|Adverse Event|3
6002711|NCT00903383|20755227|P2|Overall Study|Adverse Event|2
6002712|NCT00903383|20755228|P1|Overall Study|Adverse Event|1
6002713|NCT00903370|20755260|P2|Overall Study|Lost to Follow-up|8
6002714|NCT00903370|20755261|P1|Overall Study|Lost to Follow-up|6
6002715|NCT00903370|20755260|P2|Overall Study|Withdrawal by Subject|6
6002716|NCT00903370|20755261|P1|Overall Study|Withdrawal by Subject|9
6002717|NCT00903370|20755260|P2|Overall Study|Death|10
6002718|NCT00903370|20755261|P1|Overall Study|Death|13
6002719|NCT00903357|20755269|P2|Second Intervention|Lost to Follow-up|0
6002720|NCT00903357|20755270|P1|Second Intervention|Lost to Follow-up|1
6002721|NCT00903357|20755269|P2|Wash Out Period of 2 Weeks|Flu|1
6002722|NCT00903357|20755270|P1|Wash Out Period of 2 Weeks|Flu|0
6002723|NCT00903357|20755269|P2|First Intervention|Flu|1
6002724|NCT00903357|20755270|P1|First Intervention|Flu|0
6002725|NCT00903357|20755269|P2|First Intervention|Withdrawal by Subject|3
6002726|NCT00903357|20755270|P1|First Intervention|Withdrawal by Subject|5
6002727|NCT00903344|20755282|P2|Overall Study|Lost to Follow-up|0
6002728|NCT00903344|20755283|P1|Overall Study|Lost to Follow-up|3
6002729|NCT00903344|20755282|P2|Overall Study|Pregnancy|3
6002730|NCT00903344|20755283|P1|Overall Study|Pregnancy|2
6002731|NCT00903331|20755301|P2|Overall Study|Lung transplant|2
6002732|NCT00903331|20755302|P1|Overall Study|Lung transplant|0
6002733|NCT00903331|20755301|P2|Overall Study|Withdrawal of consent|8
6002734|NCT00903331|20755302|P1|Overall Study|Withdrawal of consent|1
6002735|NCT00903331|20755301|P2|Overall Study|Death|8
6002736|NCT00903331|20755302|P1|Overall Study|Death|4
6002737|NCT00903201|20755313|P3|Overall Study|Withdrawal by Subject|1
6002738|NCT00903201|20755314|P2|Overall Study|Withdrawal by Subject|0
6002739|NCT00903201|20755315|P1|Overall Study|Withdrawal by Subject|1
6002740|NCT00903201|20755313|P3|Overall Study|Physician Decision|1
6002741|NCT00903201|20755314|P2|Overall Study|Physician Decision|0
6002742|NCT00903201|20755315|P1|Overall Study|Physician Decision|1
6002743|NCT00903201|20755313|P3|Overall Study|Lost to Follow-up|0
6002744|NCT00903201|20755314|P2|Overall Study|Lost to Follow-up|1
6002745|NCT00903201|20755315|P1|Overall Study|Lost to Follow-up|0
6002746|NCT00903201|20755313|P3|Overall Study|Protocol Violation|0
6002747|NCT00903201|20755314|P2|Overall Study|Protocol Violation|1
6002748|NCT00903201|20755315|P1|Overall Study|Protocol Violation|2
6002749|NCT00903201|20755313|P3|Overall Study|Adverse Event|0
6002750|NCT00903201|20755314|P2|Overall Study|Adverse Event|4
6002751|NCT00903201|20755315|P1|Overall Study|Adverse Event|1
6002752|NCT00903175|20755373|P2|Period 2 - Second Line|Death|2
6002753|NCT00903175|20755374|P1|Period 2 - Second Line|Death|5
6002754|NCT00903175|20755373|P2|Period 2 - Second Line|Administrative problems|9
6002755|NCT00903175|20755374|P1|Period 2 - Second Line|Administrative problems|19
6002756|NCT00903175|20755373|P2|Period 2 - Second Line|Lost to Follow-up|0
6002757|NCT00903175|20755374|P1|Period 2 - Second Line|Lost to Follow-up|1
6002758|NCT00903175|20755373|P2|Period 2 - Second Line|Withdrawal by Subject|5
6002759|NCT00903175|20755374|P1|Period 2 - Second Line|Withdrawal by Subject|7
6002760|NCT00903175|20755373|P2|Period 2 - Second Line|Adverse Event|20
6002761|NCT00903175|20755374|P1|Period 2 - Second Line|Adverse Event|16
6002762|NCT00903175|20755373|P2|Period 2 - Second Line|Missing|0
6002763|NCT00903175|20755374|P1|Period 2 - Second Line|Missing|1
6002764|NCT00903175|20755373|P2|Period 1 - First Line|Death|10
6002765|NCT00903175|20755374|P1|Period 1 - First Line|Death|17
6002766|NCT00903175|20755373|P2|Period 1 - First Line|Administrative problems|13
6002767|NCT00903175|20755374|P1|Period 1 - First Line|Administrative problems|12
6002768|NCT00903175|20755373|P2|Period 1 - First Line|Withdrawal by Subject|12
6002769|NCT00903175|20755374|P1|Period 1 - First Line|Withdrawal by Subject|8
6002770|NCT00903175|20755373|P2|Period 1 - First Line|Protocol Violation|3
6002771|NCT00903175|20755374|P1|Period 1 - First Line|Protocol Violation|3
6002772|NCT00903175|20755373|P2|Period 1 - First Line|Abnormal test procedure result(s)|0
6002773|NCT00903175|20755374|P1|Period 1 - First Line|Abnormal test procedure result(s)|1
6002774|NCT00903175|20755373|P2|Period 1 - First Line|Abnormal lab value(s)|1
6002775|NCT00903175|20755374|P1|Period 1 - First Line|Abnormal lab value(s)|0
6002776|NCT00903175|20755373|P2|Period 1 - First Line|Adverse Event|50
6002777|NCT00903175|20755374|P1|Period 1 - First Line|Adverse Event|36
6002778|NCT00903032|20755412|P2|Overall Study|Lost to Follow-up|2
6002779|NCT00903032|20755413|P1|Overall Study|Lost to Follow-up|2
6002780|NCT00903032|20755412|P2|Overall Study|Withdrawal by Subject|3
6002781|NCT00903032|20755413|P1|Overall Study|Withdrawal by Subject|5
6002782|NCT00903006|20755423|P4|Overall Study|Progressive Disease|0
6002783|NCT00903006|20755424|P3|Overall Study|Progressive Disease|1
6002784|NCT00903006|20755425|P2|Overall Study|Progressive Disease|3
6002785|NCT00903006|20755426|P1|Overall Study|Progressive Disease|0
6002786|NCT00903006|20755423|P4|Overall Study|Withdrawal by Subject|0
6002787|NCT00903006|20755424|P3|Overall Study|Withdrawal by Subject|0
6002788|NCT00903006|20755425|P2|Overall Study|Withdrawal by Subject|0
6002789|NCT00903006|20755426|P1|Overall Study|Withdrawal by Subject|2
6002790|NCT00902850|20755438|P2|Overall Study|Physician Decision|2
6002791|NCT00902850|20755439|P1|Overall Study|Physician Decision|2
6002792|NCT00902746|20755445|P1|Overall Study|Physician Decision|2
6002793|NCT00902746|20755445|P1|Overall Study|Lost to Follow-up|3
6002794|NCT00902746|20755445|P1|Overall Study|Adverse Event|8
6002795|NCT00902746|20755445|P1|Overall Study|Withdrawal by Subject|16
6002796|NCT00902746|20755445|P1|Overall Study|Protocol Violation|7
6002797|NCT00902668|20755450|P1|Overall Study|Protocol stopped due to slow accrual.|3
6002798|NCT00902577|20755454|P1|Overall Study|FMISO production failure|2
6002799|NCT00902577|20755454|P1|Overall Study|Withdrawal by Subject|6
6002800|NCT00902564|20755483|P1|Overall Study|Withdrawal by Subject|2
6002801|NCT00902538|20755498|P6|4-Randomized Double-blind 2 Treatments|Protocol Violation|0
6002802|NCT00902538|20755499|P5|4-Randomized Double-blind 2 Treatments|Protocol Violation|0
6002803|NCT00902538|20755500|P4|4-Randomized Double-blind 2 Treatments|Protocol Violation|3
6002804|NCT00902538|20755501|P3|4-Randomized Double-blind 2 Treatments|Protocol Violation|0
6002805|NCT00902538|20755502|P2|4-Randomized Double-blind 2 Treatments|Protocol Violation|0
6002806|NCT00902538|20755503|P1|4-Randomized Double-blind 2 Treatments|Protocol Violation|0
6002807|NCT00902538|20755498|P6|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0
6002808|NCT00902538|20755499|P5|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|1
6002809|NCT00902538|20755500|P4|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|3
6002810|NCT00902538|20755501|P3|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0
6002811|NCT00902538|20755502|P2|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0
6002812|NCT00902538|20755503|P1|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0
6002813|NCT00902538|20755498|P6|4-Randomized Double-blind 2 Treatments|Adverse Event|1
6002814|NCT00902538|20755499|P5|4-Randomized Double-blind 2 Treatments|Adverse Event|1
6002815|NCT00902538|20755500|P4|4-Randomized Double-blind 2 Treatments|Adverse Event|3
6002816|NCT00902538|20755501|P3|4-Randomized Double-blind 2 Treatments|Adverse Event|0
6002817|NCT00902538|20755502|P2|4-Randomized Double-blind 2 Treatments|Adverse Event|0
6002818|NCT00902538|20755503|P1|4-Randomized Double-blind 2 Treatments|Adverse Event|0
6002819|NCT00902538|20755498|P6|3-Single-blind, Single Treatment|Lost to Follow-up|0
6002820|NCT00902538|20755499|P5|3-Single-blind, Single Treatment|Lost to Follow-up|0
6002821|NCT00902538|20755500|P4|3-Single-blind, Single Treatment|Lost to Follow-up|0
6002822|NCT00902538|20755501|P3|3-Single-blind, Single Treatment|Lost to Follow-up|0
6002823|NCT00902538|20755502|P2|3-Single-blind, Single Treatment|Lost to Follow-up|1
6002824|NCT00902538|20755503|P1|3-Single-blind, Single Treatment|Lost to Follow-up|0
6002825|NCT00902538|20755498|P6|3-Single-blind, Single Treatment|Withdrawal by Subject|0
6002826|NCT00902538|20755499|P5|3-Single-blind, Single Treatment|Withdrawal by Subject|0
6002827|NCT00902538|20755500|P4|3-Single-blind, Single Treatment|Withdrawal by Subject|0
6002828|NCT00902538|20755501|P3|3-Single-blind, Single Treatment|Withdrawal by Subject|0
6002829|NCT00902538|20755502|P2|3-Single-blind, Single Treatment|Withdrawal by Subject|4
6002830|NCT00902538|20755503|P1|3-Single-blind, Single Treatment|Withdrawal by Subject|0
6002831|NCT00902538|20755498|P6|3-Single-blind, Single Treatment|Protocol Violation|0
6002832|NCT00902538|20755499|P5|3-Single-blind, Single Treatment|Protocol Violation|0
6002833|NCT00902538|20755500|P4|3-Single-blind, Single Treatment|Protocol Violation|0
6002834|NCT00902538|20755501|P3|3-Single-blind, Single Treatment|Protocol Violation|0
6002835|NCT00902538|20755502|P2|3-Single-blind, Single Treatment|Protocol Violation|5
6002836|NCT00902538|20755503|P1|3-Single-blind, Single Treatment|Protocol Violation|0
6002837|NCT00902538|20755498|P6|3-Single-blind, Single Treatment|Adverse Event|0
6002838|NCT00902538|20755499|P5|3-Single-blind, Single Treatment|Adverse Event|0
6002839|NCT00902538|20755500|P4|3-Single-blind, Single Treatment|Adverse Event|0
6002840|NCT00902538|20755501|P3|3-Single-blind, Single Treatment|Adverse Event|0
6002841|NCT00902538|20755502|P2|3-Single-blind, Single Treatment|Adverse Event|5
6002842|NCT00902538|20755503|P1|3-Single-blind, Single Treatment|Adverse Event|0
6002843|NCT00902538|20755498|P6|2-Randomized Double-blind 3 Treatments|Protocol Violation|0
6002844|NCT00902538|20755499|P5|2-Randomized Double-blind 3 Treatments|Protocol Violation|0
6002845|NCT00902538|20755500|P4|2-Randomized Double-blind 3 Treatments|Protocol Violation|0
6002846|NCT00902538|20755501|P3|2-Randomized Double-blind 3 Treatments|Protocol Violation|2
6002847|NCT00902538|20755502|P2|2-Randomized Double-blind 3 Treatments|Protocol Violation|1
6002848|NCT00902538|20755503|P1|2-Randomized Double-blind 3 Treatments|Protocol Violation|1
6002849|NCT00902538|20755498|P6|2-Randomized Double-blind 3 Treatments|Other|0
6002850|NCT00902538|20755499|P5|2-Randomized Double-blind 3 Treatments|Other|0
6002851|NCT00902538|20755500|P4|2-Randomized Double-blind 3 Treatments|Other|0
6002852|NCT00902538|20755501|P3|2-Randomized Double-blind 3 Treatments|Other|0
6002853|NCT00902538|20755502|P2|2-Randomized Double-blind 3 Treatments|Other|1
6002854|NCT00902538|20755503|P1|2-Randomized Double-blind 3 Treatments|Other|2
6002855|NCT00902538|20755498|P6|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0
6002856|NCT00902538|20755499|P5|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0
6002857|NCT00902538|20755500|P4|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0
6002858|NCT00902538|20755501|P3|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|2
6002859|NCT00902538|20755502|P2|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0
6002860|NCT00902538|20755503|P1|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|1
6002861|NCT00902538|20755498|P6|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0
6002862|NCT00902538|20755499|P5|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0
6002863|NCT00902538|20755500|P4|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0
6002864|NCT00902538|20755501|P3|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1
6002865|NCT00902538|20755502|P2|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|2
6002866|NCT00902538|20755503|P1|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1
6002867|NCT00902538|20755498|P6|2-Randomized Double-blind 3 Treatments|Adverse Event|0
6002868|NCT00902538|20755499|P5|2-Randomized Double-blind 3 Treatments|Adverse Event|0
6002869|NCT00902538|20755500|P4|2-Randomized Double-blind 3 Treatments|Adverse Event|0
6002870|NCT00902538|20755501|P3|2-Randomized Double-blind 3 Treatments|Adverse Event|3
6002871|NCT00902538|20755502|P2|2-Randomized Double-blind 3 Treatments|Adverse Event|2
6002872|NCT00902538|20755503|P1|2-Randomized Double-blind 3 Treatments|Adverse Event|4
6002873|NCT00902538|20755498|P6|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0
6002874|NCT00902538|20755499|P5|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0
6002875|NCT00902538|20755500|P4|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0
6002876|NCT00902538|20755501|P3|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0
6002877|NCT00902538|20755502|P2|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0
6002878|NCT00902538|20755503|P1|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|4
6002879|NCT00902538|20755498|P6|1-Single-blind, Run-in, Single-Treatment|Other Reason|0
6002880|NCT00902538|20755499|P5|1-Single-blind, Run-in, Single-Treatment|Other Reason|0
6002881|NCT00902538|20755500|P4|1-Single-blind, Run-in, Single-Treatment|Other Reason|0
6002882|NCT00902538|20755501|P3|1-Single-blind, Run-in, Single-Treatment|Other Reason|0
6002883|NCT00902538|20755502|P2|1-Single-blind, Run-in, Single-Treatment|Other Reason|0
6002884|NCT00902538|20755503|P1|1-Single-blind, Run-in, Single-Treatment|Other Reason|13
6002885|NCT00902538|20755498|P6|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0
6002886|NCT00902538|20755499|P5|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0
6002887|NCT00902538|20755500|P4|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0
6002888|NCT00902538|20755501|P3|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0
6002889|NCT00902538|20755502|P2|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0
6002890|NCT00902538|20755503|P1|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|22
6002891|NCT00902538|20755498|P6|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0
6002892|NCT00902538|20755499|P5|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0
6002893|NCT00902538|20755500|P4|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0
6002894|NCT00902538|20755501|P3|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0
6002895|NCT00902538|20755502|P2|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0
6002896|NCT00902538|20755503|P1|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|30
6002897|NCT00902538|20755498|P6|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0
6002898|NCT00902538|20755499|P5|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0
6002899|NCT00902538|20755500|P4|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0
6002900|NCT00902538|20755501|P3|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0
6002901|NCT00902538|20755502|P2|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0
6002902|NCT00902538|20755503|P1|1-Single-blind, Run-in, Single-Treatment|Adverse Event|49
6002903|NCT00902486|20755537|P6|Follow-up (After Week 24)|Lost to Follow-up|0
6002904|NCT00902486|20755538|P5|Follow-up (After Week 24)|Lost to Follow-up|0
6002905|NCT00902486|20755539|P4|Follow-up (After Week 24)|Lost to Follow-up|1
6002906|NCT00902486|20755540|P3|Follow-up (After Week 24)|Lost to Follow-up|0
6002907|NCT00902486|20755541|P2|Follow-up (After Week 24)|Lost to Follow-up|0
6002908|NCT00902486|20755542|P1|Follow-up (After Week 24)|Lost to Follow-up|0
6002909|NCT00902486|20755537|P6|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0
6002910|NCT00902486|20755538|P5|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0
6002911|NCT00902486|20755539|P4|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0
6002912|NCT00902486|20755540|P3|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|1
6002913|NCT00902486|20755541|P2|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0
6002914|NCT00902486|20755542|P1|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0
6002915|NCT00902486|20755537|P6|Extension Period (Weeks 12 Through 24)|Disease Progression|0
6002916|NCT00902486|20755538|P5|Extension Period (Weeks 12 Through 24)|Disease Progression|0
6002917|NCT00902486|20755539|P4|Extension Period (Weeks 12 Through 24)|Disease Progression|1
6002918|NCT00902486|20755540|P3|Extension Period (Weeks 12 Through 24)|Disease Progression|0
6002919|NCT00902486|20755541|P2|Extension Period (Weeks 12 Through 24)|Disease Progression|0
6002920|NCT00902486|20755542|P1|Extension Period (Weeks 12 Through 24)|Disease Progression|0
6002921|NCT00902486|20755537|P6|Extension Period (Weeks 12 Through 24)|Protocol Deviation|1
6002922|NCT00902486|20755538|P5|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0
6002923|NCT00902486|20755539|P4|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0
6002924|NCT00902486|20755540|P3|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0
6002925|NCT00902486|20755541|P2|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0
6002926|NCT00902486|20755542|P1|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0
6002927|NCT00902486|20755537|P6|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0
6002928|NCT00902486|20755538|P5|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0
6002929|NCT00902486|20755539|P4|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1
6002930|NCT00902486|20755540|P3|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1
6002931|NCT00902486|20755541|P2|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0
6002932|NCT00902486|20755542|P1|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0
6002933|NCT00902486|20755537|P6|Extension Period (Weeks 12 Through 24)|Adverse Event|2
6002934|NCT00902486|20755538|P5|Extension Period (Weeks 12 Through 24)|Adverse Event|1
6002935|NCT00902486|20755539|P4|Extension Period (Weeks 12 Through 24)|Adverse Event|0
6002936|NCT00902486|20755540|P3|Extension Period (Weeks 12 Through 24)|Adverse Event|0
6002937|NCT00902486|20755541|P2|Extension Period (Weeks 12 Through 24)|Adverse Event|0
6002938|NCT00902486|20755542|P1|Extension Period (Weeks 12 Through 24)|Adverse Event|0
6002939|NCT00902486|20755537|P6|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0
6002940|NCT00902486|20755538|P5|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0
6002941|NCT00902486|20755539|P4|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|1
6002942|NCT00902486|20755540|P3|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0
6002943|NCT00902486|20755541|P2|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0
6002944|NCT00902486|20755542|P1|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0
6002945|NCT00902486|20755537|P6|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0
6002946|NCT00902486|20755538|P5|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0
6002947|NCT00902486|20755539|P4|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|1
6002948|NCT00902486|20755540|P3|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0
6002949|NCT00902486|20755541|P2|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0
6002950|NCT00902486|20755542|P1|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0
6002951|NCT00902486|20755537|P6|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1
6002952|NCT00902486|20755538|P5|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1
6002953|NCT00902486|20755539|P4|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0
6002954|NCT00902486|20755540|P3|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0
6002955|NCT00902486|20755541|P2|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0
6002956|NCT00902486|20755542|P1|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0
6002957|NCT00902486|20755537|P6|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|2
6002958|NCT00902486|20755538|P5|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0
6002959|NCT00902486|20755539|P4|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0
6002960|NCT00902486|20755540|P3|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0
6002961|NCT00902486|20755541|P2|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0
6002962|NCT00902486|20755542|P1|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|1
6002963|NCT00902486|20755537|P6|Treatment Period (Weeks 0 Through 12)|Adverse Event|2
6002964|NCT00902486|20755538|P5|Treatment Period (Weeks 0 Through 12)|Adverse Event|1
6002965|NCT00902486|20755539|P4|Treatment Period (Weeks 0 Through 12)|Adverse Event|1
6002966|NCT00902486|20755540|P3|Treatment Period (Weeks 0 Through 12)|Adverse Event|0
6002967|NCT00902486|20755541|P2|Treatment Period (Weeks 0 Through 12)|Adverse Event|0
6002968|NCT00902486|20755542|P1|Treatment Period (Weeks 0 Through 12)|Adverse Event|1
6002969|NCT00902330|20755680|P2|Overall Study|No post baseline data|0
6002970|NCT00902330|20755681|P1|Overall Study|No post baseline data|1
6002971|NCT00902330|20755680|P2|Overall Study|Adverse Event|0
6002972|NCT00902330|20755681|P1|Overall Study|Adverse Event|1
6002973|NCT00902330|20755680|P2|Overall Study|Too overwhelmed by treatment|5
6002974|NCT00902330|20755681|P1|Overall Study|Too overwhelmed by treatment|2
6002975|NCT00902304|20755718|P3|Overall Study|includes pregnancy|2
6002976|NCT00902304|20755719|P2|Overall Study|includes pregnancy|9
6002977|NCT00902304|20755720|P1|Overall Study|includes pregnancy|3
6002978|NCT00902304|20755718|P3|Overall Study|Withdrawal by Subject|43
6002979|NCT00902304|20755719|P2|Overall Study|Withdrawal by Subject|22
6002980|NCT00902304|20755720|P1|Overall Study|Withdrawal by Subject|32
6002981|NCT00902304|20755718|P3|Overall Study|Protocol Violation|20
6002982|NCT00902304|20755719|P2|Overall Study|Protocol Violation|18
6002983|NCT00902304|20755720|P1|Overall Study|Protocol Violation|9
6002984|NCT00902304|20755718|P3|Overall Study|Lost to Follow-up|7
6002985|NCT00902304|20755719|P2|Overall Study|Lost to Follow-up|7
6002986|NCT00902304|20755720|P1|Overall Study|Lost to Follow-up|7
6002987|NCT00902304|20755718|P3|Overall Study|Investigator discretion|13
6002988|NCT00902304|20755719|P2|Overall Study|Investigator discretion|5
6002989|NCT00902304|20755720|P1|Overall Study|Investigator discretion|3
6002990|NCT00902304|20755718|P3|Overall Study|Adverse Event|25
6002991|NCT00902304|20755719|P2|Overall Study|Adverse Event|10
6002992|NCT00902304|20755720|P1|Overall Study|Adverse Event|4
6002993|NCT00902278|20755770|P5|Overall Study|Lost to Follow-up|1
6002994|NCT00902278|20755771|P4|Overall Study|Lost to Follow-up|0
6002995|NCT00902278|20755772|P3|Overall Study|Lost to Follow-up|3
6002996|NCT00902278|20755773|P2|Overall Study|Lost to Follow-up|2
6002997|NCT00902278|20755774|P1|Overall Study|Lost to Follow-up|3
6002998|NCT00902278|20755770|P5|Overall Study|Physician Decision|1
6002999|NCT00902278|20755771|P4|Overall Study|Physician Decision|0
6003000|NCT00902278|20755772|P3|Overall Study|Physician Decision|2
6003001|NCT00902278|20755773|P2|Overall Study|Physician Decision|0
6003002|NCT00902278|20755774|P1|Overall Study|Physician Decision|1
6003003|NCT00902265|20755791|P1|Overall Study|Protocol Violation|1
6003004|NCT00902265|20755791|P1|Overall Study|Lack of Efficacy|2
6003005|NCT00902265|20755791|P1|Overall Study|Adverse Event|2
6003006|NCT00902265|20755791|P1|Overall Study|Lost to Follow-up Prior to First Visit|1
6003007|NCT00902174|20755815|P2|Overall Study|Administration problem|1
6003008|NCT00902174|20755816|P1|Overall Study|Administration problem|0
6003009|NCT00902174|20755815|P2|Overall Study|Protocol Violation|1
6003010|NCT00902174|20755816|P1|Overall Study|Protocol Violation|1
6003011|NCT00902174|20755815|P2|Overall Study|Abnormal labs|1
6003012|NCT00902174|20755816|P1|Overall Study|Abnormal labs|1
6003013|NCT00902174|20755815|P2|Overall Study|Withdrawal by Subject|1
6003014|NCT00902174|20755816|P1|Overall Study|Withdrawal by Subject|2
6003015|NCT00902174|20755815|P2|Overall Study|Death|2
6003016|NCT00902174|20755816|P1|Overall Study|Death|2
6003017|NCT00902174|20755815|P2|Overall Study|Lack of Efficacy|5
6003018|NCT00902174|20755816|P1|Overall Study|Lack of Efficacy|1
6003019|NCT00902174|20755815|P2|Overall Study|Adverse Event|7
6003020|NCT00902174|20755816|P1|Overall Study|Adverse Event|27
6003021|NCT00901927|20755891|P1|Overall Study|Withdrawal by Subject|2
6003022|NCT00901927|20755891|P1|Overall Study|Protocol Violation|3
6003023|NCT00901927|20755891|P1|Overall Study|Lack of Efficacy|1
6003024|NCT00901901|20755899|P2|Follow-up Period|Missing|80
6003025|NCT00901901|20755900|P1|Follow-up Period|Missing|94
6003026|NCT00901901|20755899|P2|Follow-up Period|Lost to Follow-up|8
6003027|NCT00901901|20755900|P1|Follow-up Period|Lost to Follow-up|12
6003028|NCT00901901|20755899|P2|Follow-up Period|Withdrawal by Subject|9
6003029|NCT00901901|20755900|P1|Follow-up Period|Withdrawal by Subject|6
6003030|NCT00901901|20755899|P2|Follow-up Period|Protocol driven decision point|36
6003031|NCT00901901|20755900|P1|Follow-up Period|Protocol driven decision point|47
6003032|NCT00901901|20755899|P2|Follow-up Period|Death|208
6003033|NCT00901901|20755900|P1|Follow-up Period|Death|181
6003034|NCT00901901|20755899|P2|Treatment Period|Transfer to treatment continuation study|2
6003035|NCT00901901|20755900|P1|Treatment Period|Transfer to treatment continuation study|5
6003036|NCT00901901|20755899|P2|Treatment Period|Switch to commercial drug|1
6003037|NCT00901901|20755900|P1|Treatment Period|Switch to commercial drug|1
6003038|NCT00901901|20755899|P2|Treatment Period|Protocol Violation|9
6003039|NCT00901901|20755900|P1|Treatment Period|Protocol Violation|5
6003040|NCT00901901|20755899|P2|Treatment Period|Study terminated by sponsor|0
6003041|NCT00901901|20755900|P1|Treatment Period|Study terminated by sponsor|2
6003042|NCT00901901|20755899|P2|Treatment Period|Protocol driven decision point|2
6003043|NCT00901901|20755900|P1|Treatment Period|Protocol driven decision point|0
6003044|NCT00901901|20755899|P2|Treatment Period|Never treated|3
6003045|NCT00901901|20755900|P1|Treatment Period|Never treated|0
6003046|NCT00901901|20755899|P2|Treatment Period|Missing|0
6003047|NCT00901901|20755900|P1|Treatment Period|Missing|1
6003048|NCT00901901|20755899|P2|Treatment Period|Noncompliance with study medication|1
6003049|NCT00901901|20755900|P1|Treatment Period|Noncompliance with study medication|4
6003050|NCT00901901|20755899|P2|Treatment Period|Lost to Follow-up|5
6003051|NCT00901901|20755900|P1|Treatment Period|Lost to Follow-up|3
6003052|NCT00901901|20755899|P2|Treatment Period|Physician Decision|2
6003053|NCT00901901|20755900|P1|Treatment Period|Physician Decision|2
6003054|NCT00901901|20755899|P2|Treatment Period|Withdrawal by Subject|24
6003055|NCT00901901|20755900|P1|Treatment Period|Withdrawal by Subject|26
6003056|NCT00901901|20755899|P2|Treatment Period|Adverse Event|128
6003057|NCT00901901|20755900|P1|Treatment Period|Adverse Event|120
6003058|NCT00901628|20755922|P2|Overall Study|peroneal nerve palsy|1
6003059|NCT00901628|20755923|P1|Overall Study|peroneal nerve palsy|0
6003060|NCT00901628|20755922|P2|Overall Study|disconnection of drain|1
6003061|NCT00901628|20755923|P1|Overall Study|disconnection of drain|0
6003062|NCT00901628|20755922|P2|Overall Study|disconnection of catheter|8
6003063|NCT00901628|20755923|P1|Overall Study|disconnection of catheter|4
6003064|NCT00901576|20755945|P6|Second Intervention|Physician Decision|0
6003065|NCT00901576|20755946|P5|Second Intervention|Physician Decision|0
6003066|NCT00901576|20755947|P4|Second Intervention|Physician Decision|0
6003067|NCT00901576|20755948|P3|Second Intervention|Physician Decision|0
6003068|NCT00901576|20755949|P2|Second Intervention|Physician Decision|0
6003069|NCT00901576|20755950|P1|Second Intervention|Physician Decision|1
6003070|NCT00901576|20755945|P6|Second Intervention|Withdrawal by Subject|1
6003071|NCT00901576|20755946|P5|Second Intervention|Withdrawal by Subject|0
6003072|NCT00901576|20755947|P4|Second Intervention|Withdrawal by Subject|1
6003073|NCT00901576|20755948|P3|Second Intervention|Withdrawal by Subject|0
6003074|NCT00901576|20755949|P2|Second Intervention|Withdrawal by Subject|0
6003075|NCT00901576|20755950|P1|Second Intervention|Withdrawal by Subject|0
6003076|NCT00901459|20755971|P1|Overall Study|Withdrawal by Subject|6
6003077|NCT00901394|20755985|P3|Overall Study|Physician Decision|2
6003078|NCT00901394|20755986|P2|Overall Study|Physician Decision|1
6003079|NCT00901394|20755987|P1|Overall Study|Physician Decision|1
6003080|NCT00901342|20755995|P1|Overall Study|Withdrawal by Subject|9
6003081|NCT00901342|20755995|P1|Overall Study|Disease progression|1
6003082|NCT00901342|20755995|P1|Overall Study|Death|4
6003083|NCT00901342|20755995|P1|Overall Study|Adverse Event|1
6003084|NCT00901186|20756028|P2|Overall Study|Protocol deviations|4
6003085|NCT00901186|20756029|P1|Overall Study|Protocol deviations|5
6003086|NCT00901186|20756028|P2|Overall Study|Administration problems|1
6003087|NCT00901186|20756029|P1|Overall Study|Administration problems|0
6003088|NCT00901186|20756028|P2|Overall Study|Adverse Event|4
6003089|NCT00901186|20756029|P1|Overall Study|Adverse Event|2
6003090|NCT00901186|20756028|P2|Overall Study|Lost to Follow-up|0
6003091|NCT00901186|20756029|P1|Overall Study|Lost to Follow-up|2
6003092|NCT00901186|20756028|P2|Overall Study|Abnormal laboratory values|1
6003093|NCT00901186|20756029|P1|Overall Study|Abnormal laboratory values|0
6003094|NCT00901186|20756028|P2|Overall Study|Lack of Efficacy|1
6003095|NCT00901186|20756029|P1|Overall Study|Lack of Efficacy|0
6003096|NCT00900796|20756069|P1|Phase 2|Lost to Follow-up|5
6003097|NCT00900796|20756069|P1|Between Phase 1 and Phase 2|Responded to therapy- ineligible for Ph2|110
6003098|NCT00900796|20756069|P1|Phase 1|Missing information at Week 16|7
6003099|NCT00900796|20756069|P1|Phase 1|Lacked sufficient information|4
6003100|NCT00900757|20756079|P1|Overall Study|screen failure|19
6003101|NCT00900731|20756089|P2|Overall Study|Death|2
6003102|NCT00900731|20756090|P1|Overall Study|Death|0
6003103|NCT00900731|20756089|P2|Overall Study|Lack of Efficacy|3
6003104|NCT00900731|20756090|P1|Overall Study|Lack of Efficacy|1
6003105|NCT00900731|20756089|P2|Overall Study|Lost to Follow-up|3
6003106|NCT00900731|20756090|P1|Overall Study|Lost to Follow-up|2
6003107|NCT00900731|20756089|P2|Overall Study|Abnormal Laboratory Value(s)|4
6003108|NCT00900731|20756090|P1|Overall Study|Abnormal Laboratory Value(s)|2
6003109|NCT00900731|20756089|P2|Overall Study|Abnormal Test Procedure Result(s)|0
6003110|NCT00900731|20756090|P1|Overall Study|Abnormal Test Procedure Result(s)|3
6003111|NCT00900731|20756089|P2|Overall Study|Administrative Problems|4
6003112|NCT00900731|20756090|P1|Overall Study|Administrative Problems|5
6003113|NCT00900731|20756089|P2|Overall Study|Protocol Deviation|11
6003114|NCT00900731|20756090|P1|Overall Study|Protocol Deviation|8
6003115|NCT00900731|20756089|P2|Overall Study|Withdrawal by Subject|7
6003116|NCT00900731|20756090|P1|Overall Study|Withdrawal by Subject|8
6003117|NCT00900731|20756089|P2|Overall Study|Adverse Event|27
6003118|NCT00900731|20756090|P1|Overall Study|Adverse Event|31
6003119|NCT00900627|20756127|P6|Overall Study|Death|24
6003120|NCT00900627|20756128|P5|Overall Study|Death|28
6003121|NCT00900627|20756129|P4|Overall Study|Death|0
6003122|NCT00900627|20756130|P3|Overall Study|Death|0
6003123|NCT00900627|20756131|P2|Overall Study|Death|0
6003124|NCT00900627|20756132|P1|Overall Study|Death|0
6003125|NCT00900627|20756127|P6|Overall Study|Adverse Event|0
6003126|NCT00900627|20756128|P5|Overall Study|Adverse Event|0
6003127|NCT00900627|20756129|P4|Overall Study|Adverse Event|3
6003128|NCT00900627|20756130|P3|Overall Study|Adverse Event|0
6003129|NCT00900627|20756131|P2|Overall Study|Adverse Event|2
6003130|NCT00900627|20756132|P1|Overall Study|Adverse Event|1
6003131|NCT00900627|20756127|P6|Overall Study|Withdrawal by Subject|2
6003132|NCT00900627|20756128|P5|Overall Study|Withdrawal by Subject|1
6003133|NCT00900627|20756129|P4|Overall Study|Withdrawal by Subject|0
6003134|NCT00900627|20756130|P3|Overall Study|Withdrawal by Subject|1
6003135|NCT00900627|20756131|P2|Overall Study|Withdrawal by Subject|0
6003136|NCT00900627|20756132|P1|Overall Study|Withdrawal by Subject|1
6003137|NCT00900627|20756127|P6|Overall Study|Condition under investigation worsened|0
6003138|NCT00900627|20756128|P5|Overall Study|Condition under investigation worsened|0
6003139|NCT00900627|20756129|P4|Overall Study|Condition under investigation worsened|3
6003140|NCT00900627|20756130|P3|Overall Study|Condition under investigation worsened|5
6003141|NCT00900627|20756131|P2|Overall Study|Condition under investigation worsened|0
6003142|NCT00900627|20756132|P1|Overall Study|Condition under investigation worsened|4
6003143|NCT00900601|20756150|P1|Overall Study|Physician Decision|1
6003144|NCT00900159|20756169|P2|Second Intervention|disempanelled for inappropriate behavior|0
6003145|NCT00900159|20756170|P1|Second Intervention|disempanelled for inappropriate behavior|1
6003146|NCT00900146|20756189|P5|Intermediate: Period III|Administrative problems|163
6003147|NCT00900146|20756190|P4|Intermediate: Period III|Administrative problems|90
6003148|NCT00900146|20756191|P3|Intermediate: Period III|Administrative problems|84
6003149|NCT00900146|20756192|P2|Intermediate: Period III|Administrative problems|92
6003150|NCT00900146|20756193|P1|Intermediate: Period III|Administrative problems|85
6003151|NCT00900146|20756189|P5|Intermediate: Period III|Lost to Follow-up|1
6003152|NCT00900146|20756190|P4|Intermediate: Period III|Lost to Follow-up|0
6003153|NCT00900146|20756191|P3|Intermediate: Period III|Lost to Follow-up|0
6003154|NCT00900146|20756192|P2|Intermediate: Period III|Lost to Follow-up|0
6003155|NCT00900146|20756193|P1|Intermediate: Period III|Lost to Follow-up|2
6003156|NCT00900146|20756189|P5|Intermediate: Period III|Withdrawal by Subject|3
6003157|NCT00900146|20756190|P4|Intermediate: Period III|Withdrawal by Subject|0
6003158|NCT00900146|20756191|P3|Intermediate: Period III|Withdrawal by Subject|0
6003159|NCT00900146|20756192|P2|Intermediate: Period III|Withdrawal by Subject|1
6003160|NCT00900146|20756193|P1|Intermediate: Period III|Withdrawal by Subject|0
6003161|NCT00900146|20756189|P5|Dose Finding: Period II (4 Months)|Administrative problems|0
6003162|NCT00900146|20756190|P4|Dose Finding: Period II (4 Months)|Administrative problems|0
6003163|NCT00900146|20756191|P3|Dose Finding: Period II (4 Months)|Administrative problems|0
6003164|NCT00900146|20756192|P2|Dose Finding: Period II (4 Months)|Administrative problems|0
6003165|NCT00900146|20756193|P1|Dose Finding: Period II (4 Months)|Administrative problems|1
6003166|NCT00900146|20756189|P5|Dose Finding: Period II (4 Months)|Lost to Follow-up|3
6003167|NCT00900146|20756190|P4|Dose Finding: Period II (4 Months)|Lost to Follow-up|1
6003168|NCT00900146|20756191|P3|Dose Finding: Period II (4 Months)|Lost to Follow-up|0
6003169|NCT00900146|20756192|P2|Dose Finding: Period II (4 Months)|Lost to Follow-up|0
6003170|NCT00900146|20756193|P1|Dose Finding: Period II (4 Months)|Lost to Follow-up|2
6003171|NCT00900146|20756189|P5|Dose Finding: Period II (4 Months)|Withdrawal by Subject|9
6003172|NCT00900146|20756190|P4|Dose Finding: Period II (4 Months)|Withdrawal by Subject|1
6003173|NCT00900146|20756191|P3|Dose Finding: Period II (4 Months)|Withdrawal by Subject|5
6003174|NCT00900146|20756192|P2|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2
6003175|NCT00900146|20756193|P1|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2
6003176|NCT00900029|20756310|P5|Overall Study|Death|0
6003177|NCT00900029|20756311|P4|Overall Study|Death|1
6003178|NCT00900029|20756312|P3|Overall Study|Death|0
6003179|NCT00900029|20756313|P2|Overall Study|Death|0
6003180|NCT00900029|20756314|P1|Overall Study|Death|1
6003181|NCT00900029|20756310|P5|Overall Study|Adverse Event|1
6003182|NCT00900029|20756311|P4|Overall Study|Adverse Event|1
6003183|NCT00900029|20756312|P3|Overall Study|Adverse Event|1
6003184|NCT00900029|20756313|P2|Overall Study|Adverse Event|0
6003185|NCT00900029|20756314|P1|Overall Study|Adverse Event|0
6003186|NCT00900029|20756310|P5|Overall Study|Withdrawal by Subject|1
6003187|NCT00900029|20756311|P4|Overall Study|Withdrawal by Subject|1
6003188|NCT00900029|20756312|P3|Overall Study|Withdrawal by Subject|1
6003189|NCT00900029|20756313|P2|Overall Study|Withdrawal by Subject|2
6003190|NCT00900029|20756314|P1|Overall Study|Withdrawal by Subject|2
6003191|NCT00900029|20756310|P5|Overall Study|Lost to Follow-up|4
6003192|NCT00900029|20756311|P4|Overall Study|Lost to Follow-up|4
6003193|NCT00900029|20756312|P3|Overall Study|Lost to Follow-up|1
6003194|NCT00900029|20756313|P2|Overall Study|Lost to Follow-up|2
6003195|NCT00900029|20756314|P1|Overall Study|Lost to Follow-up|0
6003196|NCT00899847|20756331|P1|Overall Study|Lack of suitable allogeneic donor|2
6003197|NCT00899678|20756362|P3|Maintenance Period (Weeks 8 to 62)|Other reason|2
6003198|NCT00899678|20756363|P2|Maintenance Period (Weeks 8 to 62)|Other reason|2
6003199|NCT00899678|20756364|P1|Maintenance Period (Weeks 8 to 62)|Other reason|0
6003200|NCT00899678|20756362|P3|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|2
6003201|NCT00899678|20756363|P2|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|1
6003202|NCT00899678|20756364|P1|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|0
6003203|NCT00899678|20756362|P3|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1
6003204|NCT00899678|20756363|P2|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1
6003205|NCT00899678|20756364|P1|Maintenance Period (Weeks 8 to 62)|Protocol Violation|0
6003206|NCT00899678|20756362|P3|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|18
6003207|NCT00899678|20756363|P2|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|11
6003208|NCT00899678|20756364|P1|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|0
6003209|NCT00899678|20756362|P3|Maintenance Period (Weeks 8 to 62)|Adverse Event|5
6003210|NCT00899678|20756363|P2|Maintenance Period (Weeks 8 to 62)|Adverse Event|10
6003211|NCT00899678|20756364|P1|Maintenance Period (Weeks 8 to 62)|Adverse Event|0
6003212|NCT00899678|20756362|P3|Induction Period (Weeks 0 to 6)|Other reason|0
6003213|NCT00899678|20756363|P2|Induction Period (Weeks 0 to 6)|Other reason|0
6003214|NCT00899678|20756364|P1|Induction Period (Weeks 0 to 6)|Other reason|1
6003215|NCT00899678|20756362|P3|Induction Period (Weeks 0 to 6)|Protocol Violation|0
6003216|NCT00899678|20756363|P2|Induction Period (Weeks 0 to 6)|Protocol Violation|0
6003217|NCT00899678|20756364|P1|Induction Period (Weeks 0 to 6)|Protocol Violation|1
6003218|NCT00899678|20756362|P3|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0
6003219|NCT00899678|20756363|P2|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0
6003220|NCT00899678|20756364|P1|Induction Period (Weeks 0 to 6)|Lack of Efficacy|17
6003221|NCT00899678|20756362|P3|Induction Period (Weeks 0 to 6)|Adverse Event|0
6003222|NCT00899678|20756363|P2|Induction Period (Weeks 0 to 6)|Adverse Event|0
6003223|NCT00899678|20756364|P1|Induction Period (Weeks 0 to 6)|Adverse Event|6
6003224|NCT00899548|20756414|P1|Overall Study|Physician Decision|3
6003225|NCT00899431|20756508|P3|Overall Study|Physician Decision|0
6003226|NCT00899431|20756509|P2|Overall Study|Physician Decision|0
6003227|NCT00899431|20756510|P1|Overall Study|Physician Decision|1
6003228|NCT00899392|20756523|P2|Overall Study|Subject didn't finish/partial pilot data|24
6003229|NCT00899392|20756524|P1|Overall Study|Subject didn't finish/partial pilot data|21
6003230|NCT00899379|20756541|P5|Overall Study|Inc/Exc Criteria Not Met|0
6003231|NCT00899379|20756542|P4|Overall Study|Inc/Exc Criteria Not Met|0
6003232|NCT00899379|20756543|P3|Overall Study|Inc/Exc Criteria Not Met|1
6003233|NCT00899379|20756544|P2|Overall Study|Inc/Exc Criteria Not Met|0
6003234|NCT00899379|20756545|P1|Overall Study|Inc/Exc Criteria Not Met|0
6003235|NCT00899379|20756541|P5|Overall Study|No Longer Met Inc/Exc Criteria|0
6003236|NCT00899379|20756542|P4|Overall Study|No Longer Met Inc/Exc Criteria|0
6003237|NCT00899379|20756543|P3|Overall Study|No Longer Met Inc/Exc Criteria|0
6003238|NCT00899379|20756544|P2|Overall Study|No Longer Met Inc/Exc Criteria|0
6003239|NCT00899379|20756545|P1|Overall Study|No Longer Met Inc/Exc Criteria|1
6003240|NCT00899379|20756541|P5|Overall Study|No Attack Pretreatment|4
6003241|NCT00899379|20756542|P4|Overall Study|No Attack Pretreatment|6
6003242|NCT00899379|20756543|P3|Overall Study|No Attack Pretreatment|5
6003243|NCT00899379|20756544|P2|Overall Study|No Attack Pretreatment|5
6003244|NCT00899379|20756545|P1|Overall Study|No Attack Pretreatment|3
6003245|NCT00899379|20756541|P5|Overall Study|Abnormal Baseline ECG|0
6003246|NCT00899379|20756542|P4|Overall Study|Abnormal Baseline ECG|1
6003247|NCT00899379|20756543|P3|Overall Study|Abnormal Baseline ECG|1
6003248|NCT00899379|20756544|P2|Overall Study|Abnormal Baseline ECG|0
6003249|NCT00899379|20756545|P1|Overall Study|Abnormal Baseline ECG|0
6003250|NCT00899379|20756541|P5|Overall Study|Abnormal Prestudy Labs|2
6003251|NCT00899379|20756542|P4|Overall Study|Abnormal Prestudy Labs|0
6003252|NCT00899379|20756543|P3|Overall Study|Abnormal Prestudy Labs|0
6003253|NCT00899379|20756544|P2|Overall Study|Abnormal Prestudy Labs|0
6003254|NCT00899379|20756545|P1|Overall Study|Abnormal Prestudy Labs|0
6003255|NCT00899379|20756541|P5|Overall Study|Patient Uncooperative|0
6003256|NCT00899379|20756542|P4|Overall Study|Patient Uncooperative|1
6003257|NCT00899379|20756543|P3|Overall Study|Patient Uncooperative|0
6003258|NCT00899379|20756544|P2|Overall Study|Patient Uncooperative|0
6003259|NCT00899379|20756545|P1|Overall Study|Patient Uncooperative|0
6003260|NCT00899379|20756541|P5|Overall Study|Pregnancy|0
6003261|NCT00899379|20756542|P4|Overall Study|Pregnancy|0
6003262|NCT00899379|20756543|P3|Overall Study|Pregnancy|0
6003263|NCT00899379|20756544|P2|Overall Study|Pregnancy|0
6003264|NCT00899379|20756545|P1|Overall Study|Pregnancy|1
6003265|NCT00899379|20756541|P5|Overall Study|Withdrawal by Subject|2
6003266|NCT00899379|20756542|P4|Overall Study|Withdrawal by Subject|7
6003267|NCT00899379|20756543|P3|Overall Study|Withdrawal by Subject|4
6003268|NCT00899379|20756544|P2|Overall Study|Withdrawal by Subject|7
6003269|NCT00899379|20756545|P1|Overall Study|Withdrawal by Subject|4
6003270|NCT00899379|20756541|P5|Overall Study|Lost to Follow-up|5
6003271|NCT00899379|20756542|P4|Overall Study|Lost to Follow-up|2
6003272|NCT00899379|20756543|P3|Overall Study|Lost to Follow-up|0
6003273|NCT00899379|20756544|P2|Overall Study|Lost to Follow-up|1
6003274|NCT00899379|20756545|P1|Overall Study|Lost to Follow-up|3
6003275|NCT00899379|20756541|P5|Overall Study|Study Terminated|1
6003276|NCT00899379|20756542|P4|Overall Study|Study Terminated|3
6003277|NCT00899379|20756543|P3|Overall Study|Study Terminated|3
6003278|NCT00899379|20756544|P2|Overall Study|Study Terminated|0
6003279|NCT00899379|20756545|P1|Overall Study|Study Terminated|3
6003280|NCT00899379|20756541|P5|Overall Study|Not Completed/Entered Extn|3
6003281|NCT00899379|20756542|P4|Overall Study|Not Completed/Entered Extn|4
6003282|NCT00899379|20756543|P3|Overall Study|Not Completed/Entered Extn|6
6003283|NCT00899379|20756544|P2|Overall Study|Not Completed/Entered Extn|1
6003284|NCT00899379|20756545|P1|Overall Study|Not Completed/Entered Extn|5
6003285|NCT00899379|20756541|P5|Overall Study|No Longer Met Inc/Exc Criteria|0
6003286|NCT00899379|20756542|P4|Overall Study|No Longer Met Inc/Exc Criteria|0
6003287|NCT00899379|20756543|P3|Overall Study|No Longer Met Inc/Exc Criteria|1
6003288|NCT00899379|20756544|P2|Overall Study|No Longer Met Inc/Exc Criteria|1
6003289|NCT00899379|20756545|P1|Overall Study|No Longer Met Inc/Exc Criteria|1
6003290|NCT00899379|20756541|P5|Overall Study|Abnormal Baseline ECG|0
6003291|NCT00899379|20756542|P4|Overall Study|Abnormal Baseline ECG|1
6003292|NCT00899379|20756543|P3|Overall Study|Abnormal Baseline ECG|0
6003293|NCT00899379|20756544|P2|Overall Study|Abnormal Baseline ECG|0
6003294|NCT00899379|20756545|P1|Overall Study|Abnormal Baseline ECG|0
6003295|NCT00899379|20756541|P5|Overall Study|Patient Uncooperative|2
6003296|NCT00899379|20756542|P4|Overall Study|Patient Uncooperative|1
6003297|NCT00899379|20756543|P3|Overall Study|Patient Uncooperative|0
6003298|NCT00899379|20756544|P2|Overall Study|Patient Uncooperative|1
6003299|NCT00899379|20756545|P1|Overall Study|Patient Uncooperative|0
6003300|NCT00899379|20756541|P5|Overall Study|Pregnancy|1
6003301|NCT00899379|20756542|P4|Overall Study|Pregnancy|0
6003302|NCT00899379|20756543|P3|Overall Study|Pregnancy|1
6003303|NCT00899379|20756544|P2|Overall Study|Pregnancy|0
6003304|NCT00899379|20756545|P1|Overall Study|Pregnancy|0
6003305|NCT00899379|20756541|P5|Overall Study|Withdrawal by Subject|6
6003306|NCT00899379|20756542|P4|Overall Study|Withdrawal by Subject|3
6003307|NCT00899379|20756543|P3|Overall Study|Withdrawal by Subject|2
6003308|NCT00899379|20756544|P2|Overall Study|Withdrawal by Subject|4
6003309|NCT00899379|20756545|P1|Overall Study|Withdrawal by Subject|2
6003310|NCT00899379|20756541|P5|Overall Study|Protocol Violation|0
6003311|NCT00899379|20756542|P4|Overall Study|Protocol Violation|1
6003312|NCT00899379|20756543|P3|Overall Study|Protocol Violation|1
6003313|NCT00899379|20756544|P2|Overall Study|Protocol Violation|0
6003314|NCT00899379|20756545|P1|Overall Study|Protocol Violation|0
6003315|NCT00899379|20756541|P5|Overall Study|Lost to Follow-up|2
6003316|NCT00899379|20756542|P4|Overall Study|Lost to Follow-up|6
6003317|NCT00899379|20756543|P3|Overall Study|Lost to Follow-up|0
6003318|NCT00899379|20756544|P2|Overall Study|Lost to Follow-up|3
6003319|NCT00899379|20756545|P1|Overall Study|Lost to Follow-up|9
6003320|NCT00899379|20756541|P5|Overall Study|Lack of Efficacy|1
6003321|NCT00899379|20756542|P4|Overall Study|Lack of Efficacy|0
6003322|NCT00899379|20756543|P3|Overall Study|Lack of Efficacy|3
6003323|NCT00899379|20756544|P2|Overall Study|Lack of Efficacy|4
6003324|NCT00899379|20756545|P1|Overall Study|Lack of Efficacy|0
6003325|NCT00899379|20756541|P5|Overall Study|Adverse Event|2
6003326|NCT00899379|20756542|P4|Overall Study|Adverse Event|1
6003327|NCT00899379|20756543|P3|Overall Study|Adverse Event|1
6003328|NCT00899379|20756544|P2|Overall Study|Adverse Event|2
6003329|NCT00899379|20756545|P1|Overall Study|Adverse Event|2
6003330|NCT00899353|20756557|P1|Overall Study|Withdrawal by Subject|2
6003331|NCT00899353|20756557|P1|Overall Study|Lost to Follow-up|1
6003332|NCT00899353|20756557|P1|Overall Study|Adverse Event|2
6003333|NCT00898807|20756593|P2|Overall Study|Death|1
6003334|NCT00898807|20756594|P1|Overall Study|Death|0
6003335|NCT00898807|20756593|P2|Overall Study|Lost to Follow-up|3
6003336|NCT00898807|20756594|P1|Overall Study|Lost to Follow-up|1
6003337|NCT00898807|20756593|P2|Overall Study|Family pressure to discontinue|2
6003338|NCT00898807|20756594|P1|Overall Study|Family pressure to discontinue|2
6003339|NCT00898807|20756593|P2|Overall Study|Withdrawal by Subject|3
6003340|NCT00898807|20756594|P1|Overall Study|Withdrawal by Subject|5
6003341|NCT00898677|20756610|P4|Overall Study|Not Treated: Other (Not Specified)|0
6003342|NCT00898677|20756611|P3|Overall Study|Not Treated: Other (Not Specified)|2
6003343|NCT00898677|20756612|P2|Overall Study|Not Treated: Other (Not Specified)|0
6003344|NCT00898677|20756613|P1|Overall Study|Not Treated: Other (Not Specified)|0
6003345|NCT00898677|20756610|P4|Overall Study|Not Treated: Lack of Migraine Attack|12
6003346|NCT00898677|20756611|P3|Overall Study|Not Treated: Lack of Migraine Attack|43
6003347|NCT00898677|20756612|P2|Overall Study|Not Treated: Lack of Migraine Attack|39
6003348|NCT00898677|20756613|P1|Overall Study|Not Treated: Lack of Migraine Attack|9
6003349|NCT00898677|20756610|P4|Overall Study|Not Treated: No Longer Met Inc Criteria|0
6003350|NCT00898677|20756611|P3|Overall Study|Not Treated: No Longer Met Inc Criteria|1
6003351|NCT00898677|20756612|P2|Overall Study|Not Treated: No Longer Met Inc Criteria|3
6003352|NCT00898677|20756613|P1|Overall Study|Not Treated: No Longer Met Inc Criteria|0
6003353|NCT00898677|20756610|P4|Overall Study|Not Treated: Abnormal Baseline ECG|0
6003354|NCT00898677|20756611|P3|Overall Study|Not Treated: Abnormal Baseline ECG|0
6003355|NCT00898677|20756612|P2|Overall Study|Not Treated: Abnormal Baseline ECG|0
6003356|NCT00898677|20756613|P1|Overall Study|Not Treated: Abnormal Baseline ECG|1
6003357|NCT00898677|20756610|P4|Overall Study|Not Treated: Abnormal Prestudy Labs|1
6003358|NCT00898677|20756611|P3|Overall Study|Not Treated: Abnormal Prestudy Labs|0
6003359|NCT00898677|20756612|P2|Overall Study|Not Treated: Abnormal Prestudy Labs|0
6003360|NCT00898677|20756613|P1|Overall Study|Not Treated: Abnormal Prestudy Labs|0
6003361|NCT00898677|20756610|P4|Overall Study|Not Treated: Patient uncooperative|0
6003362|NCT00898677|20756611|P3|Overall Study|Not Treated: Patient uncooperative|1
6003363|NCT00898677|20756612|P2|Overall Study|Not Treated: Patient uncooperative|3
6003364|NCT00898677|20756613|P1|Overall Study|Not Treated: Patient uncooperative|2
6003365|NCT00898677|20756610|P4|Overall Study|Not Treated: Withdraw by Subject|3
6003366|NCT00898677|20756611|P3|Overall Study|Not Treated: Withdraw by Subject|11
6003367|NCT00898677|20756612|P2|Overall Study|Not Treated: Withdraw by Subject|16
6003368|NCT00898677|20756613|P1|Overall Study|Not Treated: Withdraw by Subject|2
6003369|NCT00898677|20756610|P4|Overall Study|Not Treated: Protocol Violation|0
6003370|NCT00898677|20756611|P3|Overall Study|Not Treated: Protocol Violation|2
6003371|NCT00898677|20756612|P2|Overall Study|Not Treated: Protocol Violation|0
6003372|NCT00898677|20756613|P1|Overall Study|Not Treated: Protocol Violation|2
6003373|NCT00898677|20756610|P4|Overall Study|Not Treated: Pregnancy|0
6003374|NCT00898677|20756611|P3|Overall Study|Not Treated: Pregnancy|1
6003375|NCT00898677|20756612|P2|Overall Study|Not Treated: Pregnancy|0
6003376|NCT00898677|20756613|P1|Overall Study|Not Treated: Pregnancy|0
6003377|NCT00898677|20756610|P4|Overall Study|Not Treated: Lost to Follow-Up|2
6003378|NCT00898677|20756611|P3|Overall Study|Not Treated: Lost to Follow-Up|5
6003379|NCT00898677|20756612|P2|Overall Study|Not Treated: Lost to Follow-Up|5
6003380|NCT00898677|20756613|P1|Overall Study|Not Treated: Lost to Follow-Up|0
6003381|NCT00898677|20756610|P4|Overall Study|Not Treated: Adverse Event|0
6003382|NCT00898677|20756611|P3|Overall Study|Not Treated: Adverse Event|1
6003383|NCT00898677|20756612|P2|Overall Study|Not Treated: Adverse Event|2
6003384|NCT00898677|20756613|P1|Overall Study|Not Treated: Adverse Event|0
6003385|NCT00898677|20756610|P4|Overall Study|Withdrawal by Subject|1
6003386|NCT00898677|20756611|P3|Overall Study|Withdrawal by Subject|0
6003387|NCT00898677|20756612|P2|Overall Study|Withdrawal by Subject|0
6003388|NCT00898677|20756613|P1|Overall Study|Withdrawal by Subject|0
6003389|NCT00898677|20756610|P4|Overall Study|Protocol Violation|0
6003390|NCT00898677|20756611|P3|Overall Study|Protocol Violation|2
6003391|NCT00898677|20756612|P2|Overall Study|Protocol Violation|1
6003392|NCT00898677|20756613|P1|Overall Study|Protocol Violation|1
6003393|NCT00898677|20756610|P4|Overall Study|Lost to Follow-up|0
6003394|NCT00898677|20756611|P3|Overall Study|Lost to Follow-up|2
6003395|NCT00898677|20756612|P2|Overall Study|Lost to Follow-up|0
6003396|NCT00898677|20756613|P1|Overall Study|Lost to Follow-up|0
6003397|NCT00898677|20756610|P4|Overall Study|Adverse Event|0
6003398|NCT00898677|20756611|P3|Overall Study|Adverse Event|1
6003399|NCT00898677|20756612|P2|Overall Study|Adverse Event|0
6003400|NCT00898677|20756613|P1|Overall Study|Adverse Event|0
6003401|NCT00898443|20756651|P2|Overall Study|Withdrawal by Subject|0
6003402|NCT00898443|20756652|P1|Overall Study|Withdrawal by Subject|1
6003403|NCT00897949|20756667|P3|Overall Study|Did not take study drug|4
6003404|NCT00897949|20756668|P2|Overall Study|Did not take study drug|3
6003405|NCT00897949|20756669|P1|Overall Study|Did not take study drug|9
6003406|NCT00897949|20756667|P3|Overall Study|Lack of Migraine Attack|19
6003407|NCT00897949|20756668|P2|Overall Study|Lack of Migraine Attack|30
6003408|NCT00897949|20756669|P1|Overall Study|Lack of Migraine Attack|29
6003409|NCT00897949|20756667|P3|Overall Study|Need for Concom. Med.|1
6003410|NCT00897949|20756668|P2|Overall Study|Need for Concom. Med.|1
6003411|NCT00897949|20756669|P1|Overall Study|Need for Concom. Med.|0
6003412|NCT00897949|20756667|P3|Overall Study|Abnormal Baseline ECG|4
6003413|NCT00897949|20756668|P2|Overall Study|Abnormal Baseline ECG|2
6003414|NCT00897949|20756669|P1|Overall Study|Abnormal Baseline ECG|2
6003415|NCT00897949|20756667|P3|Overall Study|Abnormal Prestudy Labs|4
6003416|NCT00897949|20756668|P2|Overall Study|Abnormal Prestudy Labs|3
6003417|NCT00897949|20756669|P1|Overall Study|Abnormal Prestudy Labs|2
6003418|NCT00897949|20756667|P3|Overall Study|Withdrawal by Subject|17
6003419|NCT00897949|20756668|P2|Overall Study|Withdrawal by Subject|31
6003420|NCT00897949|20756669|P1|Overall Study|Withdrawal by Subject|24
6003421|NCT00897949|20756667|P3|Overall Study|Lost to Follow-up|17
6003422|NCT00897949|20756668|P2|Overall Study|Lost to Follow-up|23
6003423|NCT00897949|20756669|P1|Overall Study|Lost to Follow-up|30
6003424|NCT00897949|20756667|P3|Overall Study|Patient Uncoorperative|1
6003425|NCT00897949|20756668|P2|Overall Study|Patient Uncoorperative|2
6003426|NCT00897949|20756669|P1|Overall Study|Patient Uncoorperative|0
6003427|NCT00897949|20756667|P3|Overall Study|Withdrawal by Subject|0
6003428|NCT00897949|20756668|P2|Overall Study|Withdrawal by Subject|2
6003429|NCT00897949|20756669|P1|Overall Study|Withdrawal by Subject|1
6003430|NCT00897949|20756667|P3|Overall Study|Protocol Violation|1
6003431|NCT00897949|20756668|P2|Overall Study|Protocol Violation|3
6003432|NCT00897949|20756669|P1|Overall Study|Protocol Violation|6
6003433|NCT00897949|20756667|P3|Overall Study|Lost to Follow-up|1
6003434|NCT00897949|20756668|P2|Overall Study|Lost to Follow-up|2
6003435|NCT00897949|20756669|P1|Overall Study|Lost to Follow-up|0
6003436|NCT00897949|20756667|P3|Overall Study|Adverse Event|0
6003437|NCT00897949|20756668|P2|Overall Study|Adverse Event|1
6003438|NCT00897949|20756669|P1|Overall Study|Adverse Event|1
6003439|NCT00897715|20756703|P2|Overall Study|increased risk of infection|0
6003440|NCT00897715|20756704|P1|Overall Study|increased risk of infection|1
6003441|NCT00897715|20756703|P2|Overall Study|Physician Decision|0
6003442|NCT00897715|20756704|P1|Overall Study|Physician Decision|1
6003443|NCT00897715|20756703|P2|Overall Study|Lost to Follow-up|1
6003444|NCT00897715|20756704|P1|Overall Study|Lost to Follow-up|0
6003445|NCT00897390|20756729|P1|Overall Study|Did not Return for the Clinic Visit|2
6003446|NCT00897390|20756729|P1|Overall Study|Personal Reasons|1
6003447|NCT00897390|20756729|P1|Overall Study|No Longer Met Study Criteria|1
6003448|NCT00897390|20756729|P1|Overall Study|Adverse Event|2
6003449|NCT00897104|20756819|P3|Overall Study|Withdrawal by Subject|1
6003450|NCT00897104|20756820|P2|Overall Study|Withdrawal by Subject|0
6003451|NCT00897104|20756821|P1|Overall Study|Withdrawal by Subject|0
6003452|NCT00897104|20756819|P3|Overall Study|Protocol Violation|0
6003453|NCT00897104|20756820|P2|Overall Study|Protocol Violation|0
6003454|NCT00897104|20756821|P1|Overall Study|Protocol Violation|1
6003455|NCT00897104|20756819|P3|Overall Study|Other|0
6003456|NCT00897104|20756820|P2|Overall Study|Other|0
6003457|NCT00897104|20756821|P1|Overall Study|Other|3
6003458|NCT00897104|20756819|P3|Overall Study|No Longer Met Inc/Exc Criteria|0
6003459|NCT00897104|20756820|P2|Overall Study|No Longer Met Inc/Exc Criteria|0
6003460|NCT00897104|20756821|P1|Overall Study|No Longer Met Inc/Exc Criteria|1
6003461|NCT00897104|20756819|P3|Overall Study|Lack of Migraine Attack|1
6003462|NCT00897104|20756820|P2|Overall Study|Lack of Migraine Attack|22
6003463|NCT00897104|20756821|P1|Overall Study|Lack of Migraine Attack|20
6003464|NCT00897104|20756819|P3|Overall Study|Need for Concom. Med.|1
6003465|NCT00897104|20756820|P2|Overall Study|Need for Concom. Med.|1
6003466|NCT00897104|20756821|P1|Overall Study|Need for Concom. Med.|0
6003467|NCT00897104|20756819|P3|Overall Study|Abnormal Baseline ECG|0
6003468|NCT00897104|20756820|P2|Overall Study|Abnormal Baseline ECG|2
6003469|NCT00897104|20756821|P1|Overall Study|Abnormal Baseline ECG|2
6003470|NCT00897104|20756819|P3|Overall Study|Abnormal Prestudy Labs|0
6003471|NCT00897104|20756820|P2|Overall Study|Abnormal Prestudy Labs|0
6003472|NCT00897104|20756821|P1|Overall Study|Abnormal Prestudy Labs|2
6003473|NCT00897104|20756819|P3|Overall Study|Withdrawal by Subject|3
6003474|NCT00897104|20756820|P2|Overall Study|Withdrawal by Subject|27
6003475|NCT00897104|20756821|P1|Overall Study|Withdrawal by Subject|23
6003476|NCT00897104|20756819|P3|Overall Study|Protocol Violation|0
6003477|NCT00897104|20756820|P2|Overall Study|Protocol Violation|1
6003478|NCT00897104|20756821|P1|Overall Study|Protocol Violation|0
6003479|NCT00897104|20756819|P3|Overall Study|Pregnancy|0
6003480|NCT00897104|20756820|P2|Overall Study|Pregnancy|1
6003481|NCT00897104|20756821|P1|Overall Study|Pregnancy|0
6003482|NCT00897104|20756819|P3|Overall Study|Lost to Follow-up|2
6003483|NCT00897104|20756820|P2|Overall Study|Lost to Follow-up|17
6003484|NCT00897104|20756821|P1|Overall Study|Lost to Follow-up|12
6003485|NCT00896649|20756856|P1|Overall Study|technical difficulties|2
6003486|NCT00896649|20756856|P1|Overall Study|missing documentation|1
6003487|NCT00896649|20756856|P1|Overall Study|Pregnancy|1
6003488|NCT00896649|20756856|P1|Overall Study|Physician Decision|1
6003489|NCT00896532|20756869|P23|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
6003490|NCT00896532|20756870|P22|Months 48-72: Follow-on Phase|Withdrawal by Subject|1
6003491|NCT00896532|20756871|P21|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
6003492|NCT00896532|20756872|P20|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
6003493|NCT00896532|20756873|P19|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
6003494|NCT00896532|20756874|P18|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
6003495|NCT00896532|20756875|P17|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
6003496|NCT00896532|20756876|P16|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
6003497|NCT00896532|20756877|P15|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
6003498|NCT00896532|20756878|P14|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
6003499|NCT00896532|20756879|P13|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
6003500|NCT00896532|20756880|P12|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
6003501|NCT00896532|20756881|P11|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
6003502|NCT00896532|20756882|P10|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
6003503|NCT00896532|20756883|P9|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
6003504|NCT00896532|20756884|P8|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
6003505|NCT00896532|20756885|P7|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
6003506|NCT00896532|20756886|P6|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
6003507|NCT00896532|20756887|P5|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
6003508|NCT00896532|20756888|P4|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
6003509|NCT00896532|20756889|P3|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
6003510|NCT00896532|20756890|P2|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
6003511|NCT00896532|20756891|P1|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
6003512|NCT00896532|20756869|P23|Months 48-72: Follow-on Phase|Ineligibility Determined|0
6003513|NCT00896532|20756870|P22|Months 48-72: Follow-on Phase|Ineligibility Determined|1
6003514|NCT00896532|20756871|P21|Months 48-72: Follow-on Phase|Ineligibility Determined|0
6003515|NCT00896532|20756872|P20|Months 48-72: Follow-on Phase|Ineligibility Determined|0
6003516|NCT00896532|20756873|P19|Months 48-72: Follow-on Phase|Ineligibility Determined|0
6003517|NCT00896532|20756874|P18|Months 48-72: Follow-on Phase|Ineligibility Determined|0
6003518|NCT00896532|20756875|P17|Months 48-72: Follow-on Phase|Ineligibility Determined|0
6003519|NCT00896532|20756876|P16|Months 48-72: Follow-on Phase|Ineligibility Determined|0
6003520|NCT00896532|20756877|P15|Months 48-72: Follow-on Phase|Ineligibility Determined|0
6003521|NCT00896532|20756878|P14|Months 48-72: Follow-on Phase|Ineligibility Determined|0
6003522|NCT00896532|20756879|P13|Months 48-72: Follow-on Phase|Ineligibility Determined|0
6003523|NCT00896532|20756880|P12|Months 48-72: Follow-on Phase|Ineligibility Determined|0
6003524|NCT00896532|20756881|P11|Months 48-72: Follow-on Phase|Ineligibility Determined|0
6003525|NCT00896532|20756882|P10|Months 48-72: Follow-on Phase|Ineligibility Determined|0
6003526|NCT00896532|20756883|P9|Months 48-72: Follow-on Phase|Ineligibility Determined|0
6003527|NCT00896532|20756884|P8|Months 48-72: Follow-on Phase|Ineligibility Determined|0
6003528|NCT00896532|20756885|P7|Months 48-72: Follow-on Phase|Ineligibility Determined|0
6003529|NCT00896532|20756886|P6|Months 48-72: Follow-on Phase|Ineligibility Determined|0
6003530|NCT00896532|20756887|P5|Months 48-72: Follow-on Phase|Ineligibility Determined|0
6003531|NCT00896532|20756888|P4|Months 48-72: Follow-on Phase|Ineligibility Determined|0
6003532|NCT00896532|20756889|P3|Months 48-72: Follow-on Phase|Ineligibility Determined|0
6003533|NCT00896532|20756890|P2|Months 48-72: Follow-on Phase|Ineligibility Determined|0
6003534|NCT00896532|20756891|P1|Months 48-72: Follow-on Phase|Ineligibility Determined|0
6003535|NCT00896532|20756869|P23|Months 48-72: Follow-on Phase|Death|0
6003536|NCT00896532|20756870|P22|Months 48-72: Follow-on Phase|Death|0
6003537|NCT00896532|20756871|P21|Months 48-72: Follow-on Phase|Death|0
6003538|NCT00896532|20756872|P20|Months 48-72: Follow-on Phase|Death|0
6003539|NCT00896532|20756873|P19|Months 48-72: Follow-on Phase|Death|1
6003540|NCT00896532|20756874|P18|Months 48-72: Follow-on Phase|Death|0
6003541|NCT00896532|20756875|P17|Months 48-72: Follow-on Phase|Death|0
6003542|NCT00896532|20756876|P16|Months 48-72: Follow-on Phase|Death|0
6003543|NCT00896532|20756877|P15|Months 48-72: Follow-on Phase|Death|0
6003544|NCT00896532|20756878|P14|Months 48-72: Follow-on Phase|Death|0
6003545|NCT00896532|20756879|P13|Months 48-72: Follow-on Phase|Death|0
6003546|NCT00896532|20756880|P12|Months 48-72: Follow-on Phase|Death|0
6003547|NCT00896532|20756881|P11|Months 48-72: Follow-on Phase|Death|0
6003548|NCT00896532|20756882|P10|Months 48-72: Follow-on Phase|Death|0
6003549|NCT00896532|20756883|P9|Months 48-72: Follow-on Phase|Death|0
6003550|NCT00896532|20756884|P8|Months 48-72: Follow-on Phase|Death|0
6003551|NCT00896532|20756885|P7|Months 48-72: Follow-on Phase|Death|0
6003552|NCT00896532|20756886|P6|Months 48-72: Follow-on Phase|Death|0
6003553|NCT00896532|20756887|P5|Months 48-72: Follow-on Phase|Death|0
6003554|NCT00896532|20756888|P4|Months 48-72: Follow-on Phase|Death|0
6003555|NCT00896532|20756889|P3|Months 48-72: Follow-on Phase|Death|0
6003556|NCT00896532|20756890|P2|Months 48-72: Follow-on Phase|Death|0
6003557|NCT00896532|20756891|P1|Months 48-72: Follow-on Phase|Death|0
6003558|NCT00896532|20756869|P23|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
6003559|NCT00896532|20756870|P22|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
6003560|NCT00896532|20756871|P21|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
6003561|NCT00896532|20756872|P20|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
6003562|NCT00896532|20756873|P19|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
6003563|NCT00896532|20756874|P18|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
6003564|NCT00896532|20756875|P17|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|1
6003565|NCT00896532|20756876|P16|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
6003566|NCT00896532|20756877|P15|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
6003567|NCT00896532|20756878|P14|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
6003568|NCT00896532|20756879|P13|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
6003569|NCT00896532|20756880|P12|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
6003570|NCT00896532|20756881|P11|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
6003571|NCT00896532|20756882|P10|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
6003572|NCT00896532|20756883|P9|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
6003573|NCT00896532|20756884|P8|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
6003574|NCT00896532|20756885|P7|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
6003575|NCT00896532|20756886|P6|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
6003576|NCT00896532|20756887|P5|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
6003577|NCT00896532|20756888|P4|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
6003578|NCT00896532|20756889|P3|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
6003579|NCT00896532|20756890|P2|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
6003580|NCT00896532|20756891|P1|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
6003581|NCT00896532|20756869|P23|Months 36-48: Romosozumab Retreatment|Other|0
6003582|NCT00896532|20756870|P22|Months 36-48: Romosozumab Retreatment|Other|0
6003583|NCT00896532|20756871|P21|Months 36-48: Romosozumab Retreatment|Other|0
6003584|NCT00896532|20756872|P20|Months 36-48: Romosozumab Retreatment|Other|0
6003585|NCT00896532|20756873|P19|Months 36-48: Romosozumab Retreatment|Other|0
6003586|NCT00896532|20756874|P18|Months 36-48: Romosozumab Retreatment|Other|1
6003587|NCT00896532|20756875|P17|Months 36-48: Romosozumab Retreatment|Other|0
6003588|NCT00896532|20756876|P16|Months 36-48: Romosozumab Retreatment|Other|0
6003589|NCT00896532|20756877|P15|Months 36-48: Romosozumab Retreatment|Other|0
6003590|NCT00896532|20756878|P14|Months 36-48: Romosozumab Retreatment|Other|0
6003591|NCT00896532|20756879|P13|Months 36-48: Romosozumab Retreatment|Other|0
6003592|NCT00896532|20756880|P12|Months 36-48: Romosozumab Retreatment|Other|0
6003593|NCT00896532|20756881|P11|Months 36-48: Romosozumab Retreatment|Other|0
6003594|NCT00896532|20756882|P10|Months 36-48: Romosozumab Retreatment|Other|0
6003595|NCT00896532|20756883|P9|Months 36-48: Romosozumab Retreatment|Other|0
6003596|NCT00896532|20756884|P8|Months 36-48: Romosozumab Retreatment|Other|0
6003597|NCT00896532|20756885|P7|Months 36-48: Romosozumab Retreatment|Other|0
6003598|NCT00896532|20756886|P6|Months 36-48: Romosozumab Retreatment|Other|0
6003599|NCT00896532|20756887|P5|Months 36-48: Romosozumab Retreatment|Other|0
6003600|NCT00896532|20756888|P4|Months 36-48: Romosozumab Retreatment|Other|0
6003601|NCT00896532|20756889|P3|Months 36-48: Romosozumab Retreatment|Other|0
6003602|NCT00896532|20756890|P2|Months 36-48: Romosozumab Retreatment|Other|0
6003603|NCT00896532|20756891|P1|Months 36-48: Romosozumab Retreatment|Other|0
6003604|NCT00896532|20756869|P23|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
6003605|NCT00896532|20756870|P22|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
6003606|NCT00896532|20756871|P21|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
6003607|NCT00896532|20756872|P20|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
6003608|NCT00896532|20756873|P19|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
6003609|NCT00896532|20756874|P18|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
6003610|NCT00896532|20756875|P17|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|1
6003611|NCT00896532|20756876|P16|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
6003612|NCT00896532|20756877|P15|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
6003613|NCT00896532|20756878|P14|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
6003614|NCT00896532|20756879|P13|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
6003615|NCT00896532|20756880|P12|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
6003616|NCT00896532|20756881|P11|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
6003617|NCT00896532|20756882|P10|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
6003618|NCT00896532|20756883|P9|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
6003619|NCT00896532|20756884|P8|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
6003620|NCT00896532|20756885|P7|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
6003621|NCT00896532|20756886|P6|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
6003622|NCT00896532|20756887|P5|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
6003623|NCT00896532|20756888|P4|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
6003624|NCT00896532|20756889|P3|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
6003625|NCT00896532|20756890|P2|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
6003626|NCT00896532|20756891|P1|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
6003627|NCT00896532|20756869|P23|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
6003628|NCT00896532|20756870|P22|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
6003629|NCT00896532|20756871|P21|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
6003630|NCT00896532|20756872|P20|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
6003631|NCT00896532|20756873|P19|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
6003632|NCT00896532|20756874|P18|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2
6003633|NCT00896532|20756875|P17|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2
6003634|NCT00896532|20756876|P16|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|1
6003635|NCT00896532|20756877|P15|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
6003636|NCT00896532|20756878|P14|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
6003637|NCT00896532|20756879|P13|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
6003638|NCT00896532|20756880|P12|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
6003639|NCT00896532|20756881|P11|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
6003640|NCT00896532|20756882|P10|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
6003641|NCT00896532|20756883|P9|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
6003642|NCT00896532|20756884|P8|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
6003643|NCT00896532|20756885|P7|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
6003644|NCT00896532|20756886|P6|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
6003645|NCT00896532|20756887|P5|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
6003646|NCT00896532|20756888|P4|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
6003647|NCT00896532|20756889|P3|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
6003648|NCT00896532|20756890|P2|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
6003649|NCT00896532|20756891|P1|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
6003650|NCT00896532|20756869|P23|Months 36-48: Romosozumab Retreatment|Adverse Event|0
6003651|NCT00896532|20756870|P22|Months 36-48: Romosozumab Retreatment|Adverse Event|0
6003652|NCT00896532|20756871|P21|Months 36-48: Romosozumab Retreatment|Adverse Event|0
6003653|NCT00896532|20756872|P20|Months 36-48: Romosozumab Retreatment|Adverse Event|0
6003654|NCT00896532|20756873|P19|Months 36-48: Romosozumab Retreatment|Adverse Event|0
6003655|NCT00896532|20756874|P18|Months 36-48: Romosozumab Retreatment|Adverse Event|0
6003656|NCT00896532|20756875|P17|Months 36-48: Romosozumab Retreatment|Adverse Event|3
6003657|NCT00896532|20756876|P16|Months 36-48: Romosozumab Retreatment|Adverse Event|1
6003658|NCT00896532|20756877|P15|Months 36-48: Romosozumab Retreatment|Adverse Event|0
6003659|NCT00896532|20756878|P14|Months 36-48: Romosozumab Retreatment|Adverse Event|0
6003660|NCT00896532|20756879|P13|Months 36-48: Romosozumab Retreatment|Adverse Event|0
6003661|NCT00896532|20756880|P12|Months 36-48: Romosozumab Retreatment|Adverse Event|0
6003662|NCT00896532|20756881|P11|Months 36-48: Romosozumab Retreatment|Adverse Event|0
6003663|NCT00896532|20756882|P10|Months 36-48: Romosozumab Retreatment|Adverse Event|0
6003664|NCT00896532|20756883|P9|Months 36-48: Romosozumab Retreatment|Adverse Event|0
6003665|NCT00896532|20756884|P8|Months 36-48: Romosozumab Retreatment|Adverse Event|0
6003666|NCT00896532|20756885|P7|Months 36-48: Romosozumab Retreatment|Adverse Event|0
6003667|NCT00896532|20756886|P6|Months 36-48: Romosozumab Retreatment|Adverse Event|0
6003668|NCT00896532|20756887|P5|Months 36-48: Romosozumab Retreatment|Adverse Event|0
6003669|NCT00896532|20756888|P4|Months 36-48: Romosozumab Retreatment|Adverse Event|0
6003670|NCT00896532|20756889|P3|Months 36-48: Romosozumab Retreatment|Adverse Event|0
6003671|NCT00896532|20756890|P2|Months 36-48: Romosozumab Retreatment|Adverse Event|0
6003672|NCT00896532|20756891|P1|Months 36-48: Romosozumab Retreatment|Adverse Event|0
6003673|NCT00896532|20756869|P23|Months 24-36: Denosumab Extension Phase|Other|0
6003674|NCT00896532|20756870|P22|Months 24-36: Denosumab Extension Phase|Other|0
6003675|NCT00896532|20756871|P21|Months 24-36: Denosumab Extension Phase|Other|0
6003676|NCT00896532|20756872|P20|Months 24-36: Denosumab Extension Phase|Other|0
6003677|NCT00896532|20756873|P19|Months 24-36: Denosumab Extension Phase|Other|0
6003678|NCT00896532|20756874|P18|Months 24-36: Denosumab Extension Phase|Other|0
6003679|NCT00896532|20756875|P17|Months 24-36: Denosumab Extension Phase|Other|0
6003680|NCT00896532|20756876|P16|Months 24-36: Denosumab Extension Phase|Other|0
6003681|NCT00896532|20756877|P15|Months 24-36: Denosumab Extension Phase|Other|0
6003682|NCT00896532|20756878|P14|Months 24-36: Denosumab Extension Phase|Other|1
6003683|NCT00896532|20756879|P13|Months 24-36: Denosumab Extension Phase|Other|2
6003684|NCT00896532|20756880|P12|Months 24-36: Denosumab Extension Phase|Other|2
6003685|NCT00896532|20756881|P11|Months 24-36: Denosumab Extension Phase|Other|1
6003686|NCT00896532|20756882|P10|Months 24-36: Denosumab Extension Phase|Other|0
6003687|NCT00896532|20756883|P9|Months 24-36: Denosumab Extension Phase|Other|0
6003688|NCT00896532|20756884|P8|Months 24-36: Denosumab Extension Phase|Other|0
6003689|NCT00896532|20756885|P7|Months 24-36: Denosumab Extension Phase|Other|0
6003690|NCT00896532|20756886|P6|Months 24-36: Denosumab Extension Phase|Other|0
6003691|NCT00896532|20756887|P5|Months 24-36: Denosumab Extension Phase|Other|0
6003692|NCT00896532|20756888|P4|Months 24-36: Denosumab Extension Phase|Other|0
6003693|NCT00896532|20756889|P3|Months 24-36: Denosumab Extension Phase|Other|0
6003694|NCT00896532|20756890|P2|Months 24-36: Denosumab Extension Phase|Other|0
6003695|NCT00896532|20756891|P1|Months 24-36: Denosumab Extension Phase|Other|0
6003696|NCT00896532|20756869|P23|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
6003697|NCT00896532|20756870|P22|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
6003698|NCT00896532|20756871|P21|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
6003699|NCT00896532|20756872|P20|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
6003700|NCT00896532|20756873|P19|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
6003701|NCT00896532|20756874|P18|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
6003702|NCT00896532|20756875|P17|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
6003703|NCT00896532|20756876|P16|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
6003704|NCT00896532|20756877|P15|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
6003705|NCT00896532|20756878|P14|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1
6003706|NCT00896532|20756879|P13|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1
6003707|NCT00896532|20756880|P12|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
6003708|NCT00896532|20756881|P11|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
6003709|NCT00896532|20756882|P10|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
6003710|NCT00896532|20756883|P9|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
6003711|NCT00896532|20756884|P8|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
6003712|NCT00896532|20756885|P7|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
6003713|NCT00896532|20756886|P6|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
6003714|NCT00896532|20756887|P5|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
6003715|NCT00896532|20756888|P4|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
6003716|NCT00896532|20756889|P3|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
6003717|NCT00896532|20756890|P2|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
6003718|NCT00896532|20756891|P1|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
6003719|NCT00896532|20756869|P23|Months 24-36: Denosumab Extension Phase|Adverse Event|0
6003720|NCT00896532|20756870|P22|Months 24-36: Denosumab Extension Phase|Adverse Event|0
6003721|NCT00896532|20756871|P21|Months 24-36: Denosumab Extension Phase|Adverse Event|0
6003722|NCT00896532|20756872|P20|Months 24-36: Denosumab Extension Phase|Adverse Event|0
6003723|NCT00896532|20756873|P19|Months 24-36: Denosumab Extension Phase|Adverse Event|0
6003724|NCT00896532|20756874|P18|Months 24-36: Denosumab Extension Phase|Adverse Event|0
6003725|NCT00896532|20756875|P17|Months 24-36: Denosumab Extension Phase|Adverse Event|0
6003726|NCT00896532|20756876|P16|Months 24-36: Denosumab Extension Phase|Adverse Event|0
6003727|NCT00896532|20756877|P15|Months 24-36: Denosumab Extension Phase|Adverse Event|0
6003728|NCT00896532|20756878|P14|Months 24-36: Denosumab Extension Phase|Adverse Event|0
6003729|NCT00896532|20756879|P13|Months 24-36: Denosumab Extension Phase|Adverse Event|1
6003730|NCT00896532|20756880|P12|Months 24-36: Denosumab Extension Phase|Adverse Event|0
6003731|NCT00896532|20756881|P11|Months 24-36: Denosumab Extension Phase|Adverse Event|1
6003732|NCT00896532|20756882|P10|Months 24-36: Denosumab Extension Phase|Adverse Event|0
6003733|NCT00896532|20756883|P9|Months 24-36: Denosumab Extension Phase|Adverse Event|0
6003734|NCT00896532|20756884|P8|Months 24-36: Denosumab Extension Phase|Adverse Event|0
6003735|NCT00896532|20756885|P7|Months 24-36: Denosumab Extension Phase|Adverse Event|0
6003736|NCT00896532|20756886|P6|Months 24-36: Denosumab Extension Phase|Adverse Event|0
6003737|NCT00896532|20756887|P5|Months 24-36: Denosumab Extension Phase|Adverse Event|0
6003738|NCT00896532|20756888|P4|Months 24-36: Denosumab Extension Phase|Adverse Event|0
6003739|NCT00896532|20756889|P3|Months 24-36: Denosumab Extension Phase|Adverse Event|0
6003740|NCT00896532|20756890|P2|Months 24-36: Denosumab Extension Phase|Adverse Event|0
6003741|NCT00896532|20756891|P1|Months 24-36: Denosumab Extension Phase|Adverse Event|0
6003742|NCT00896532|20756869|P23|Months 24-36: Denosumab Extension Phase|Noncompliance|0
6003743|NCT00896532|20756870|P22|Months 24-36: Denosumab Extension Phase|Noncompliance|0
6003744|NCT00896532|20756871|P21|Months 24-36: Denosumab Extension Phase|Noncompliance|0
6003745|NCT00896532|20756872|P20|Months 24-36: Denosumab Extension Phase|Noncompliance|0
6003746|NCT00896532|20756873|P19|Months 24-36: Denosumab Extension Phase|Noncompliance|0
6003747|NCT00896532|20756874|P18|Months 24-36: Denosumab Extension Phase|Noncompliance|0
6003748|NCT00896532|20756875|P17|Months 24-36: Denosumab Extension Phase|Noncompliance|0
6003749|NCT00896532|20756876|P16|Months 24-36: Denosumab Extension Phase|Noncompliance|0
6003750|NCT00896532|20756877|P15|Months 24-36: Denosumab Extension Phase|Noncompliance|0
6003751|NCT00896532|20756878|P14|Months 24-36: Denosumab Extension Phase|Noncompliance|0
6003752|NCT00896532|20756879|P13|Months 24-36: Denosumab Extension Phase|Noncompliance|1
6003753|NCT00896532|20756880|P12|Months 24-36: Denosumab Extension Phase|Noncompliance|0
6003754|NCT00896532|20756881|P11|Months 24-36: Denosumab Extension Phase|Noncompliance|0
6003755|NCT00896532|20756882|P10|Months 24-36: Denosumab Extension Phase|Noncompliance|0
6003756|NCT00896532|20756883|P9|Months 24-36: Denosumab Extension Phase|Noncompliance|0
6003757|NCT00896532|20756884|P8|Months 24-36: Denosumab Extension Phase|Noncompliance|0
6003758|NCT00896532|20756885|P7|Months 24-36: Denosumab Extension Phase|Noncompliance|0
6003759|NCT00896532|20756886|P6|Months 24-36: Denosumab Extension Phase|Noncompliance|0
6003760|NCT00896532|20756887|P5|Months 24-36: Denosumab Extension Phase|Noncompliance|0
6003761|NCT00896532|20756888|P4|Months 24-36: Denosumab Extension Phase|Noncompliance|0
6003762|NCT00896532|20756889|P3|Months 24-36: Denosumab Extension Phase|Noncompliance|0
6003763|NCT00896532|20756890|P2|Months 24-36: Denosumab Extension Phase|Noncompliance|0
6003764|NCT00896532|20756891|P1|Months 24-36: Denosumab Extension Phase|Noncompliance|0
6004055|NCT00895895|20757480|P2|Period 2|Protocol Violation|0
6003765|NCT00896532|20756869|P23|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
6003766|NCT00896532|20756870|P22|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
6003767|NCT00896532|20756871|P21|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
6003768|NCT00896532|20756872|P20|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
6003769|NCT00896532|20756873|P19|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
6003770|NCT00896532|20756874|P18|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
6003771|NCT00896532|20756875|P17|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
6003772|NCT00896532|20756876|P16|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
6003773|NCT00896532|20756877|P15|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
6003774|NCT00896532|20756878|P14|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
6003775|NCT00896532|20756879|P13|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
6003776|NCT00896532|20756880|P12|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
6003777|NCT00896532|20756881|P11|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
6003778|NCT00896532|20756882|P10|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
6003779|NCT00896532|20756883|P9|Months 24-36: Denosumab Extension Phase|Protocol Deviation|1
6003780|NCT00896532|20756884|P8|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
6003781|NCT00896532|20756885|P7|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
6003782|NCT00896532|20756886|P6|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
6003783|NCT00896532|20756887|P5|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
6003784|NCT00896532|20756888|P4|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
6003785|NCT00896532|20756889|P3|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
6003786|NCT00896532|20756890|P2|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
6003787|NCT00896532|20756891|P1|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
6003788|NCT00896532|20756869|P23|Months 1-24: Romosozumab Treatment Phase|Other|0
6003789|NCT00896532|20756870|P22|Months 1-24: Romosozumab Treatment Phase|Other|0
6003790|NCT00896532|20756871|P21|Months 1-24: Romosozumab Treatment Phase|Other|0
6003791|NCT00896532|20756872|P20|Months 1-24: Romosozumab Treatment Phase|Other|0
6003792|NCT00896532|20756873|P19|Months 1-24: Romosozumab Treatment Phase|Other|0
6003793|NCT00896532|20756874|P18|Months 1-24: Romosozumab Treatment Phase|Other|0
6003794|NCT00896532|20756875|P17|Months 1-24: Romosozumab Treatment Phase|Other|0
6003795|NCT00896532|20756876|P16|Months 1-24: Romosozumab Treatment Phase|Other|0
6003796|NCT00896532|20756877|P15|Months 1-24: Romosozumab Treatment Phase|Other|0
6003797|NCT00896532|20756878|P14|Months 1-24: Romosozumab Treatment Phase|Other|0
6003798|NCT00896532|20756879|P13|Months 1-24: Romosozumab Treatment Phase|Other|0
6003799|NCT00896532|20756880|P12|Months 1-24: Romosozumab Treatment Phase|Other|0
6003800|NCT00896532|20756881|P11|Months 1-24: Romosozumab Treatment Phase|Other|0
6003801|NCT00896532|20756882|P10|Months 1-24: Romosozumab Treatment Phase|Other|0
6003802|NCT00896532|20756883|P9|Months 1-24: Romosozumab Treatment Phase|Other|0
6003803|NCT00896532|20756884|P8|Months 1-24: Romosozumab Treatment Phase|Other|0
6003804|NCT00896532|20756885|P7|Months 1-24: Romosozumab Treatment Phase|Other|0
6003805|NCT00896532|20756886|P6|Months 1-24: Romosozumab Treatment Phase|Other|0
6003806|NCT00896532|20756887|P5|Months 1-24: Romosozumab Treatment Phase|Other|1
6003807|NCT00896532|20756888|P4|Months 1-24: Romosozumab Treatment Phase|Other|1
6003808|NCT00896532|20756889|P3|Months 1-24: Romosozumab Treatment Phase|Other|0
6003809|NCT00896532|20756890|P2|Months 1-24: Romosozumab Treatment Phase|Other|1
6003810|NCT00896532|20756891|P1|Months 1-24: Romosozumab Treatment Phase|Other|0
6003811|NCT00896532|20756869|P23|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
6003812|NCT00896532|20756870|P22|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
6003813|NCT00896532|20756871|P21|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
6003814|NCT00896532|20756872|P20|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
6003815|NCT00896532|20756873|P19|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
6003816|NCT00896532|20756874|P18|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
6003817|NCT00896532|20756875|P17|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
6003818|NCT00896532|20756876|P16|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
6003819|NCT00896532|20756877|P15|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
6003820|NCT00896532|20756878|P14|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
6003821|NCT00896532|20756879|P13|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
6003822|NCT00896532|20756880|P12|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
6003823|NCT00896532|20756881|P11|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
6003824|NCT00896532|20756882|P10|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
6003825|NCT00896532|20756883|P9|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
6003826|NCT00896532|20756884|P8|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
6003827|NCT00896532|20756885|P7|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
6003828|NCT00896532|20756886|P6|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
6003829|NCT00896532|20756887|P5|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
6003830|NCT00896532|20756888|P4|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|1
6003831|NCT00896532|20756889|P3|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
6003832|NCT00896532|20756890|P2|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
6004056|NCT00895895|20757481|P1|Period 2|Protocol Violation|1
6003833|NCT00896532|20756891|P1|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
6003834|NCT00896532|20756869|P23|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
6003835|NCT00896532|20756870|P22|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
6003836|NCT00896532|20756871|P21|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
6003837|NCT00896532|20756872|P20|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
6003838|NCT00896532|20756873|P19|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
6003839|NCT00896532|20756874|P18|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
6003840|NCT00896532|20756875|P17|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
6003841|NCT00896532|20756876|P16|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
6003842|NCT00896532|20756877|P15|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
6003843|NCT00896532|20756878|P14|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
6003844|NCT00896532|20756879|P13|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
6003845|NCT00896532|20756880|P12|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
6003846|NCT00896532|20756881|P11|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
6003847|NCT00896532|20756882|P10|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
6003848|NCT00896532|20756883|P9|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
6003849|NCT00896532|20756884|P8|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
6003850|NCT00896532|20756885|P7|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
6003851|NCT00896532|20756886|P6|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
6003852|NCT00896532|20756887|P5|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
6003853|NCT00896532|20756888|P4|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
6003854|NCT00896532|20756889|P3|Months 1-24: Romosozumab Treatment Phase|Noncompliance|1
6003855|NCT00896532|20756890|P2|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
6003856|NCT00896532|20756891|P1|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
6003857|NCT00896532|20756869|P23|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
6003858|NCT00896532|20756870|P22|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
6003859|NCT00896532|20756871|P21|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
6003860|NCT00896532|20756872|P20|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
6003861|NCT00896532|20756873|P19|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
6003862|NCT00896532|20756874|P18|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
6003863|NCT00896532|20756875|P17|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
6003864|NCT00896532|20756876|P16|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
6003865|NCT00896532|20756877|P15|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
6003866|NCT00896532|20756878|P14|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
6003867|NCT00896532|20756879|P13|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
6003868|NCT00896532|20756880|P12|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
6003869|NCT00896532|20756881|P11|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
6003870|NCT00896532|20756882|P10|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
6003871|NCT00896532|20756883|P9|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
6003872|NCT00896532|20756884|P8|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
6003873|NCT00896532|20756885|P7|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
6003874|NCT00896532|20756886|P6|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
6003875|NCT00896532|20756887|P5|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
6003876|NCT00896532|20756888|P4|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
6003877|NCT00896532|20756889|P3|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|1
6003878|NCT00896532|20756890|P2|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
6003879|NCT00896532|20756891|P1|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
6003880|NCT00896532|20756869|P23|Months 1-24: Romosozumab Treatment Phase|Death|0
6003881|NCT00896532|20756870|P22|Months 1-24: Romosozumab Treatment Phase|Death|0
6003882|NCT00896532|20756871|P21|Months 1-24: Romosozumab Treatment Phase|Death|0
6003883|NCT00896532|20756872|P20|Months 1-24: Romosozumab Treatment Phase|Death|0
6003884|NCT00896532|20756873|P19|Months 1-24: Romosozumab Treatment Phase|Death|0
6003885|NCT00896532|20756874|P18|Months 1-24: Romosozumab Treatment Phase|Death|0
6003886|NCT00896532|20756875|P17|Months 1-24: Romosozumab Treatment Phase|Death|0
6003887|NCT00896532|20756876|P16|Months 1-24: Romosozumab Treatment Phase|Death|0
6003888|NCT00896532|20756877|P15|Months 1-24: Romosozumab Treatment Phase|Death|0
6003889|NCT00896532|20756878|P14|Months 1-24: Romosozumab Treatment Phase|Death|0
6003890|NCT00896532|20756879|P13|Months 1-24: Romosozumab Treatment Phase|Death|0
6003891|NCT00896532|20756880|P12|Months 1-24: Romosozumab Treatment Phase|Death|0
6003892|NCT00896532|20756881|P11|Months 1-24: Romosozumab Treatment Phase|Death|0
6003893|NCT00896532|20756882|P10|Months 1-24: Romosozumab Treatment Phase|Death|0
6003894|NCT00896532|20756883|P9|Months 1-24: Romosozumab Treatment Phase|Death|0
6003895|NCT00896532|20756884|P8|Months 1-24: Romosozumab Treatment Phase|Death|0
6003896|NCT00896532|20756885|P7|Months 1-24: Romosozumab Treatment Phase|Death|0
6003897|NCT00896532|20756886|P6|Months 1-24: Romosozumab Treatment Phase|Death|0
6003898|NCT00896532|20756887|P5|Months 1-24: Romosozumab Treatment Phase|Death|0
6003899|NCT00896532|20756888|P4|Months 1-24: Romosozumab Treatment Phase|Death|1
6003900|NCT00896532|20756889|P3|Months 1-24: Romosozumab Treatment Phase|Death|0
6003901|NCT00896532|20756890|P2|Months 1-24: Romosozumab Treatment Phase|Death|0
6003902|NCT00896532|20756891|P1|Months 1-24: Romosozumab Treatment Phase|Death|1
6003903|NCT00896532|20756869|P23|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
6003904|NCT00896532|20756870|P22|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
6003905|NCT00896532|20756871|P21|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
6003906|NCT00896532|20756872|P20|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
6003907|NCT00896532|20756873|P19|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
6003908|NCT00896532|20756874|P18|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
6003909|NCT00896532|20756875|P17|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
6003910|NCT00896532|20756876|P16|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
6003911|NCT00896532|20756877|P15|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
6003912|NCT00896532|20756878|P14|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
6003913|NCT00896532|20756879|P13|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
6003914|NCT00896532|20756880|P12|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
6003915|NCT00896532|20756881|P11|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
6003916|NCT00896532|20756882|P10|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
6003917|NCT00896532|20756883|P9|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
6003918|NCT00896532|20756884|P8|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
6003919|NCT00896532|20756885|P7|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
6003920|NCT00896532|20756886|P6|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
6003921|NCT00896532|20756887|P5|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|1
6003922|NCT00896532|20756888|P4|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
6003923|NCT00896532|20756889|P3|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|2
6003924|NCT00896532|20756890|P2|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
6003925|NCT00896532|20756891|P1|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
6003926|NCT00896532|20756869|P23|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
6003927|NCT00896532|20756870|P22|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
6003928|NCT00896532|20756871|P21|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
6003929|NCT00896532|20756872|P20|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
6003930|NCT00896532|20756873|P19|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
6003931|NCT00896532|20756874|P18|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
6003932|NCT00896532|20756875|P17|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
6003933|NCT00896532|20756876|P16|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
6003934|NCT00896532|20756877|P15|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
6003935|NCT00896532|20756878|P14|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
6003936|NCT00896532|20756879|P13|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
6003937|NCT00896532|20756880|P12|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
6003938|NCT00896532|20756881|P11|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
6003939|NCT00896532|20756882|P10|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
6003940|NCT00896532|20756883|P9|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
6003941|NCT00896532|20756884|P8|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4
6003942|NCT00896532|20756885|P7|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4
6003943|NCT00896532|20756886|P6|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6
6003944|NCT00896532|20756887|P5|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|5
6003945|NCT00896532|20756888|P4|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6
6003946|NCT00896532|20756889|P3|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4
6003947|NCT00896532|20756890|P2|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|3
6003948|NCT00896532|20756891|P1|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4
6003949|NCT00896532|20756869|P23|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
6003950|NCT00896532|20756870|P22|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
6003951|NCT00896532|20756871|P21|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
6003952|NCT00896532|20756872|P20|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
6003953|NCT00896532|20756873|P19|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
6003954|NCT00896532|20756874|P18|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
6003955|NCT00896532|20756875|P17|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
6003956|NCT00896532|20756876|P16|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
6003957|NCT00896532|20756877|P15|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
6003958|NCT00896532|20756878|P14|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
6003959|NCT00896532|20756879|P13|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
6003960|NCT00896532|20756880|P12|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
6003961|NCT00896532|20756881|P11|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
6003962|NCT00896532|20756882|P10|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
6003963|NCT00896532|20756883|P9|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
6003964|NCT00896532|20756884|P8|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
6003965|NCT00896532|20756885|P7|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1
6003966|NCT00896532|20756886|P6|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1
6003967|NCT00896532|20756887|P5|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1
6003968|NCT00896532|20756888|P4|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2
6003969|NCT00896532|20756889|P3|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1
6003970|NCT00896532|20756890|P2|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2
6003971|NCT00896532|20756891|P1|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1
6003972|NCT00896532|20756869|P23|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
6003973|NCT00896532|20756870|P22|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
6003974|NCT00896532|20756871|P21|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
6003975|NCT00896532|20756872|P20|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
6003976|NCT00896532|20756873|P19|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
6003977|NCT00896532|20756874|P18|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
6003978|NCT00896532|20756875|P17|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
6003979|NCT00896532|20756876|P16|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
6003980|NCT00896532|20756877|P15|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
6003981|NCT00896532|20756878|P14|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
6003982|NCT00896532|20756879|P13|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
6003983|NCT00896532|20756880|P12|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
6003984|NCT00896532|20756881|P11|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
6003985|NCT00896532|20756882|P10|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
6003986|NCT00896532|20756883|P9|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
6003987|NCT00896532|20756884|P8|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
6003988|NCT00896532|20756885|P7|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
6003989|NCT00896532|20756886|P6|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1
6003990|NCT00896532|20756887|P5|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
6003991|NCT00896532|20756888|P4|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1
6003992|NCT00896532|20756889|P3|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
6003993|NCT00896532|20756890|P2|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
6003994|NCT00896532|20756891|P1|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
6003995|NCT00896480|20757018|P1|Overall Study|Disease progression/recurrence|21
6003996|NCT00896454|20757066|P1|Overall Study|Withdrawal by Subject|1
6003997|NCT00896454|20757066|P1|Overall Study|Ongoing in study|2
6003998|NCT00896454|20757066|P1|Overall Study|Requirement for alternative therapy|3
6003999|NCT00896454|20757066|P1|Overall Study|Other|4
6004000|NCT00896454|20757066|P1|Overall Study|Disease Progression|5
6004001|NCT00896454|20757066|P1|Overall Study|Adverse Event|8
6004002|NCT00896454|20757066|P1|Overall Study|Death|10
6004003|NCT00896363|20757105|P3|Overall Study|Withdrawal by Subject|5
6004004|NCT00896363|20757106|P2|Overall Study|Withdrawal by Subject|5
6004005|NCT00896363|20757107|P1|Overall Study|Withdrawal by Subject|3
6004006|NCT00896363|20757105|P3|Overall Study|Lack of Efficacy|1
6004007|NCT00896363|20757106|P2|Overall Study|Lack of Efficacy|2
6004008|NCT00896363|20757107|P1|Overall Study|Lack of Efficacy|0
6004009|NCT00896363|20757105|P3|Overall Study|Adverse Event|2
6004010|NCT00896363|20757106|P2|Overall Study|Adverse Event|4
6004011|NCT00896363|20757107|P1|Overall Study|Adverse Event|3
6004012|NCT00896337|20757159|P1|Overall Study|Lost to Follow-up|11
6004013|NCT00896337|20757159|P1|Overall Study|Withdrawal by Subject|7
6004014|NCT00896337|20757159|P1|Overall Study|Death|7
6004015|NCT00896233|20757241|P1|Overall Study|Claustrophobia during MRI|1
6004016|NCT00896168|20757254|P2|Overall Study|Other|1
6004017|NCT00896168|20757255|P1|Overall Study|Other|1
6004018|NCT00896168|20757254|P2|Overall Study|Lost to Follow-up|1
6004019|NCT00896168|20757255|P1|Overall Study|Lost to Follow-up|1
6004020|NCT00896168|20757254|P2|Overall Study|Treatment failure|10
6004021|NCT00896168|20757255|P1|Overall Study|Treatment failure|8
6004022|NCT00896168|20757254|P2|Overall Study|Adverse Event|7
6004023|NCT00896168|20757255|P1|Overall Study|Adverse Event|4
6004024|NCT00896051|20757316|P2|Overall Study|Other|1
6004025|NCT00896051|20757317|P1|Overall Study|Other|1
6004026|NCT00896051|20757316|P2|Overall Study|Subject noncompliant|3
6004027|NCT00896051|20757317|P1|Overall Study|Subject noncompliant|1
6004028|NCT00896051|20757316|P2|Overall Study|Withdrawal by Subject|2
6004029|NCT00896051|20757317|P1|Overall Study|Withdrawal by Subject|3
6004030|NCT00896051|20757316|P2|Overall Study|Lost to Follow-up|2
6004031|NCT00896051|20757317|P1|Overall Study|Lost to Follow-up|3
6004032|NCT00896051|20757316|P2|Overall Study|Adverse Event|1
6004033|NCT00896051|20757317|P1|Overall Study|Adverse Event|2
6004034|NCT00895947|20757425|P2|Overall Study|Withdrawal by Subject|0
6004035|NCT00895947|20757426|P1|Overall Study|Withdrawal by Subject|2
6004036|NCT00895947|20757425|P2|Overall Study|Protocol Violation|2
6004037|NCT00895947|20757426|P1|Overall Study|Protocol Violation|4
6004038|NCT00895947|20757425|P2|Overall Study|Lost to Follow-up|4
6004039|NCT00895947|20757426|P1|Overall Study|Lost to Follow-up|3
6004040|NCT00895947|20757425|P2|Overall Study|Adverse Event|4
6004041|NCT00895947|20757426|P1|Overall Study|Adverse Event|3
6004042|NCT00895895|20757477|P5|Period 2|unsatisfactory response-efficacy|0
6004043|NCT00895895|20757478|P4|Period 2|unsatisfactory response-efficacy|0
6004044|NCT00895895|20757479|P3|Period 2|unsatisfactory response-efficacy|0
6004045|NCT00895895|20757480|P2|Period 2|unsatisfactory response-efficacy|1
6004046|NCT00895895|20757481|P1|Period 2|unsatisfactory response-efficacy|2
6004047|NCT00895895|20757477|P5|Period 2|Withdrawal by Subject|5
6004048|NCT00895895|20757478|P4|Period 2|Withdrawal by Subject|3
6004049|NCT00895895|20757479|P3|Period 2|Withdrawal by Subject|0
6004050|NCT00895895|20757480|P2|Period 2|Withdrawal by Subject|2
6004051|NCT00895895|20757481|P1|Period 2|Withdrawal by Subject|0
6004052|NCT00895895|20757477|P5|Period 2|Protocol Violation|1
6004053|NCT00895895|20757478|P4|Period 2|Protocol Violation|1
6004054|NCT00895895|20757479|P3|Period 2|Protocol Violation|1
6004057|NCT00895895|20757477|P5|Period 2|Other|1
6004058|NCT00895895|20757478|P4|Period 2|Other|1
6004059|NCT00895895|20757479|P3|Period 2|Other|3
6004060|NCT00895895|20757480|P2|Period 2|Other|1
6004061|NCT00895895|20757481|P1|Period 2|Other|1
6004062|NCT00895895|20757477|P5|Period 2|Lost to Follow-up|0
6004063|NCT00895895|20757478|P4|Period 2|Lost to Follow-up|1
6004064|NCT00895895|20757479|P3|Period 2|Lost to Follow-up|1
6004065|NCT00895895|20757480|P2|Period 2|Lost to Follow-up|2
6004066|NCT00895895|20757481|P1|Period 2|Lost to Follow-up|1
6004067|NCT00895895|20757477|P5|Period 2|investigator request|0
6004068|NCT00895895|20757478|P4|Period 2|investigator request|0
6004069|NCT00895895|20757479|P3|Period 2|investigator request|0
6004070|NCT00895895|20757480|P2|Period 2|investigator request|0
6004071|NCT00895895|20757481|P1|Period 2|investigator request|2
6004072|NCT00895895|20757477|P5|Period 2|failed to return|0
6004073|NCT00895895|20757478|P4|Period 2|failed to return|0
6004074|NCT00895895|20757479|P3|Period 2|failed to return|0
6004075|NCT00895895|20757480|P2|Period 2|failed to return|0
6004076|NCT00895895|20757481|P1|Period 2|failed to return|2
6004077|NCT00895895|20757477|P5|Period 2|discontinued by sponsor|37
6004078|NCT00895895|20757478|P4|Period 2|discontinued by sponsor|46
6004079|NCT00895895|20757479|P3|Period 2|discontinued by sponsor|38
6004080|NCT00895895|20757480|P2|Period 2|discontinued by sponsor|44
6004081|NCT00895895|20757481|P1|Period 2|discontinued by sponsor|44
6004082|NCT00895895|20757477|P5|Period 2|Death|0
6004083|NCT00895895|20757478|P4|Period 2|Death|0
6004084|NCT00895895|20757479|P3|Period 2|Death|1
6004085|NCT00895895|20757480|P2|Period 2|Death|0
6004086|NCT00895895|20757481|P1|Period 2|Death|0
6004087|NCT00895895|20757477|P5|Period 2|Adverse Event|5
6004088|NCT00895895|20757478|P4|Period 2|Adverse Event|2
6004089|NCT00895895|20757479|P3|Period 2|Adverse Event|5
6004090|NCT00895895|20757480|P2|Period 2|Adverse Event|3
6004091|NCT00895895|20757481|P1|Period 2|Adverse Event|3
6004092|NCT00895895|20757477|P5|After Period 1, Prior to Period 2|Withdrawal by Subject|1
6004093|NCT00895895|20757478|P4|After Period 1, Prior to Period 2|Withdrawal by Subject|0
6004094|NCT00895895|20757479|P3|After Period 1, Prior to Period 2|Withdrawal by Subject|0
6004095|NCT00895895|20757480|P2|After Period 1, Prior to Period 2|Withdrawal by Subject|0
6004096|NCT00895895|20757481|P1|After Period 1, Prior to Period 2|Withdrawal by Subject|0
6004097|NCT00895895|20757477|P5|After Period 1, Prior to Period 2|Protocol Violation|1
6004098|NCT00895895|20757478|P4|After Period 1, Prior to Period 2|Protocol Violation|0
6004099|NCT00895895|20757479|P3|After Period 1, Prior to Period 2|Protocol Violation|0
6004100|NCT00895895|20757480|P2|After Period 1, Prior to Period 2|Protocol Violation|0
6004101|NCT00895895|20757481|P1|After Period 1, Prior to Period 2|Protocol Violation|0
6004102|NCT00895895|20757477|P5|After Period 1, Prior to Period 2|Other|0
6004103|NCT00895895|20757478|P4|After Period 1, Prior to Period 2|Other|0
6004104|NCT00895895|20757479|P3|After Period 1, Prior to Period 2|Other|1
6004105|NCT00895895|20757480|P2|After Period 1, Prior to Period 2|Other|0
6004106|NCT00895895|20757481|P1|After Period 1, Prior to Period 2|Other|0
6004107|NCT00895895|20757477|P5|After Period 1, Prior to Period 2|Adverse Event|0
6004108|NCT00895895|20757478|P4|After Period 1, Prior to Period 2|Adverse Event|0
6004109|NCT00895895|20757479|P3|After Period 1, Prior to Period 2|Adverse Event|1
6004110|NCT00895895|20757480|P2|After Period 1, Prior to Period 2|Adverse Event|0
6004111|NCT00895895|20757481|P1|After Period 1, Prior to Period 2|Adverse Event|0
6004112|NCT00895895|20757477|P5|Period 1|randomized and not treated|2
6004113|NCT00895895|20757478|P4|Period 1|randomized and not treated|1
6004114|NCT00895895|20757479|P3|Period 1|randomized and not treated|1
6004115|NCT00895895|20757480|P2|Period 1|randomized and not treated|3
6004116|NCT00895895|20757481|P1|Period 1|randomized and not treated|1
6004117|NCT00895895|20757477|P5|Period 1|unsatisfactory response-efficacy|0
6004118|NCT00895895|20757478|P4|Period 1|unsatisfactory response-efficacy|0
6004119|NCT00895895|20757479|P3|Period 1|unsatisfactory response-efficacy|0
6004120|NCT00895895|20757480|P2|Period 1|unsatisfactory response-efficacy|0
6004121|NCT00895895|20757481|P1|Period 1|unsatisfactory response-efficacy|2
6004122|NCT00895895|20757477|P5|Period 1|Withdrawal by Subject|4
6004123|NCT00895895|20757478|P4|Period 1|Withdrawal by Subject|2
6004124|NCT00895895|20757479|P3|Period 1|Withdrawal by Subject|8
6004125|NCT00895895|20757480|P2|Period 1|Withdrawal by Subject|6
6004126|NCT00895895|20757481|P1|Period 1|Withdrawal by Subject|6
6004127|NCT00895895|20757477|P5|Period 1|Protocol Violation|0
6004128|NCT00895895|20757478|P4|Period 1|Protocol Violation|0
6004129|NCT00895895|20757479|P3|Period 1|Protocol Violation|0
6004130|NCT00895895|20757480|P2|Period 1|Protocol Violation|1
6004131|NCT00895895|20757481|P1|Period 1|Protocol Violation|0
6004132|NCT00895895|20757477|P5|Period 1|Other|1
6004133|NCT00895895|20757478|P4|Period 1|Other|1
6004134|NCT00895895|20757479|P3|Period 1|Other|1
6004135|NCT00895895|20757480|P2|Period 1|Other|2
6004136|NCT00895895|20757481|P1|Period 1|Other|1
6004137|NCT00895895|20757477|P5|Period 1|Lost to Follow-up|3
6004138|NCT00895895|20757478|P4|Period 1|Lost to Follow-up|2
6004139|NCT00895895|20757479|P3|Period 1|Lost to Follow-up|3
6004140|NCT00895895|20757480|P2|Period 1|Lost to Follow-up|1
6004141|NCT00895895|20757481|P1|Period 1|Lost to Follow-up|2
6004142|NCT00895895|20757477|P5|Period 1|investigator request|0
6004143|NCT00895895|20757478|P4|Period 1|investigator request|0
6004144|NCT00895895|20757479|P3|Period 1|investigator request|0
6004145|NCT00895895|20757480|P2|Period 1|investigator request|1
6004146|NCT00895895|20757481|P1|Period 1|investigator request|0
6004147|NCT00895895|20757477|P5|Period 1|failed to return|1
6004148|NCT00895895|20757478|P4|Period 1|failed to return|0
6004149|NCT00895895|20757479|P3|Period 1|failed to return|1
6004150|NCT00895895|20757480|P2|Period 1|failed to return|0
6004151|NCT00895895|20757481|P1|Period 1|failed to return|0
6004152|NCT00895895|20757477|P5|Period 1|discontinued by sponsor|1
6004153|NCT00895895|20757478|P4|Period 1|discontinued by sponsor|1
6004154|NCT00895895|20757479|P3|Period 1|discontinued by sponsor|2
6004155|NCT00895895|20757480|P2|Period 1|discontinued by sponsor|1
6004156|NCT00895895|20757481|P1|Period 1|discontinued by sponsor|2
6004157|NCT00895895|20757477|P5|Period 1|Death|1
6004158|NCT00895895|20757478|P4|Period 1|Death|0
6004159|NCT00895895|20757479|P3|Period 1|Death|0
6004160|NCT00895895|20757480|P2|Period 1|Death|0
6004161|NCT00895895|20757481|P1|Period 1|Death|0
6004162|NCT00895895|20757477|P5|Period 1|Adverse Event|7
6004163|NCT00895895|20757478|P4|Period 1|Adverse Event|6
6004164|NCT00895895|20757479|P3|Period 1|Adverse Event|4
6004165|NCT00895895|20757480|P2|Period 1|Adverse Event|6
6004166|NCT00895895|20757481|P1|Period 1|Adverse Event|7
6004167|NCT00895843|20757595|P2|Overall Study|Protocol Violation|12
6004168|NCT00895843|20757596|P1|Overall Study|Protocol Violation|12
6004169|NCT00895661|20757643|P1|Overall Study|reason unknown|2
6004170|NCT00895661|20757643|P1|Overall Study|Death|1
6004171|NCT00895622|20757653|P3|Overall Study|Protocol Violation|4
6004172|NCT00895622|20757654|P2|Overall Study|Protocol Violation|4
6004173|NCT00895622|20757655|P1|Overall Study|Protocol Violation|5
6004174|NCT00895583|20757682|P2|Overall Study|Other|1
6004175|NCT00895583|20757683|P1|Overall Study|Other|0
6004176|NCT00895583|20757682|P2|Overall Study|Lack of Efficacy|0
6004177|NCT00895583|20757683|P1|Overall Study|Lack of Efficacy|5
6004178|NCT00895583|20757682|P2|Overall Study|Withdrawal by Subject|2
6004179|NCT00895583|20757683|P1|Overall Study|Withdrawal by Subject|4
6004180|NCT00895583|20757682|P2|Overall Study|Protocol Violation|0
6004181|NCT00895583|20757683|P1|Overall Study|Protocol Violation|1
6004182|NCT00895583|20757682|P2|Overall Study|Lost to Follow-up|3
6004183|NCT00895583|20757683|P1|Overall Study|Lost to Follow-up|1
6004184|NCT00895583|20757682|P2|Overall Study|Physician Decision|1
6004185|NCT00895583|20757683|P1|Overall Study|Physician Decision|3
6004186|NCT00895583|20757682|P2|Overall Study|Death|1
6004187|NCT00895583|20757683|P1|Overall Study|Death|2
6004188|NCT00895583|20757682|P2|Overall Study|Adverse Event|4
6004189|NCT00895583|20757683|P1|Overall Study|Adverse Event|28
6004190|NCT00895453|20757773|P3|Overall Study|Lost to Follow-up|23
6004191|NCT00895453|20757774|P2|Overall Study|Lost to Follow-up|25
6004192|NCT00895453|20757775|P1|Overall Study|Lost to Follow-up|25
6004193|NCT00895414|20757783|P2|First Intervention (14 Days)|Physician Decision|1
6004194|NCT00895414|20757784|P1|First Intervention (14 Days)|Physician Decision|0
6004195|NCT00895414|20757783|P2|First Intervention (14 Days)|Withdrawal by Subject|0
6004196|NCT00895414|20757784|P1|First Intervention (14 Days)|Withdrawal by Subject|1
6004197|NCT00895310|20757794|P1|Overall Study|Withdrawal by Subject|1
6004198|NCT00895245|20757810|P1|Overall Study|Lack of Efficacy|6
6004199|NCT00895154|20757888|P2|Overall Study|Withdrawal by Subject|1
6004200|NCT00895154|20757889|P1|Overall Study|Withdrawal by Subject|0
6004201|NCT00895154|20757888|P2|Overall Study|Lost to Follow-up|1
6004202|NCT00895154|20757889|P1|Overall Study|Lost to Follow-up|1
6004203|NCT00895037|20757924|P3|Overall Study|Death|1
6004204|NCT00895037|20757925|P2|Overall Study|Death|2
6004205|NCT00895037|20757926|P1|Overall Study|Death|0
6004206|NCT00895011|20757957|P3|Overall Study|schedule conflict|0
6004207|NCT00895011|20757958|P2|Overall Study|schedule conflict|0
6004208|NCT00895011|20757959|P1|Overall Study|schedule conflict|1
6004209|NCT00895011|20757957|P3|Overall Study|Adverse Event|2
6004210|NCT00895011|20757958|P2|Overall Study|Adverse Event|2
6004211|NCT00895011|20757959|P1|Overall Study|Adverse Event|1
6004212|NCT00895011|20757957|P3|Overall Study|Protocol Violation|3
6004213|NCT00895011|20757958|P2|Overall Study|Protocol Violation|1
6004214|NCT00895011|20757959|P1|Overall Study|Protocol Violation|3
6004215|NCT00895011|20757957|P3|Overall Study|Lost to Follow-up|1
6004216|NCT00895011|20757958|P2|Overall Study|Lost to Follow-up|4
6004217|NCT00895011|20757959|P1|Overall Study|Lost to Follow-up|5
6004218|NCT00895011|20757957|P3|Overall Study|Withdrawal by Subject|2
6004219|NCT00895011|20757958|P2|Overall Study|Withdrawal by Subject|7
6004220|NCT00895011|20757959|P1|Overall Study|Withdrawal by Subject|14
6004221|NCT00894933|20757973|P1|Overall Study|Did not meeting incl/excl criteria|1
6004222|NCT00894933|20757973|P1|Overall Study|Cancelled Procedure|1
6004223|NCT00894933|20757973|P1|Overall Study|Lost to Follow-up|2
6004224|NCT00894803|20757991|P2|Overall Study|Lost to Follow-up|1
6004225|NCT00894803|20757992|P1|Overall Study|Lost to Follow-up|0
6004226|NCT00894803|20757991|P2|Overall Study|Death|4
6004227|NCT00894803|20757992|P1|Overall Study|Death|20
6004234|NCT00894686|20758071|P1|Overall Study|Other|5
6004235|NCT00894686|20758071|P1|Overall Study|Physician Decision|1
6004236|NCT00894686|20758071|P1|Overall Study|Withdrawal by Subject|50
6004237|NCT00894647|20758095|P2|Overall Study|Other, not due to AE|2
6004238|NCT00894647|20758096|P1|Overall Study|Other, not due to AE|1
6004239|NCT00894647|20758095|P2|Overall Study|Non-compliance with study procedures|2
6004240|NCT00894647|20758096|P1|Overall Study|Non-compliance with study procedures|0
6004241|NCT00894647|20758095|P2|Overall Study|Lost to Follow-up|2
6004242|NCT00894647|20758096|P1|Overall Study|Lost to Follow-up|0
6004243|NCT00894647|20758095|P2|Overall Study|Withdrawal by Subject|4
6004244|NCT00894647|20758096|P1|Overall Study|Withdrawal by Subject|4
6004245|NCT00894647|20758095|P2|Overall Study|Adverse Event|4
6004246|NCT00894647|20758096|P1|Overall Study|Adverse Event|5
6004247|NCT00894556|20758109|P4|Treatment Phase|Lack of Qualifying Event|0
6004248|NCT00894556|20758110|P3|Treatment Phase|Lack of Qualifying Event|0
6004249|NCT00894556|20758111|P2|Treatment Phase|Lack of Qualifying Event|1
6004250|NCT00894556|20758112|P1|Treatment Phase|Lack of Qualifying Event|2
6004251|NCT00894556|20758109|P4|Treatment Phase|Lost to Follow-up|0
6004252|NCT00894556|20758110|P3|Treatment Phase|Lost to Follow-up|1
6004253|NCT00894556|20758111|P2|Treatment Phase|Lost to Follow-up|3
6004254|NCT00894556|20758112|P1|Treatment Phase|Lost to Follow-up|2
6004255|NCT00894556|20758109|P4|Baseline Phase|Did not meet Randomization Criteria|85
6004256|NCT00894556|20758110|P3|Baseline Phase|Did not meet Randomization Criteria|0
6004257|NCT00894556|20758111|P2|Baseline Phase|Did not meet Randomization Criteria|0
6004258|NCT00894556|20758112|P1|Baseline Phase|Did not meet Randomization Criteria|0
6004259|NCT00894543|20758123|P2|Week 4 to Week 8|No diary or lost or withdrew|2
6004260|NCT00894543|20758124|P1|Week 4 to Week 8|No diary or lost or withdrew|4
6004261|NCT00894543|20758123|P2|Baseline to Week 4|No diary or lost or withdrew|2
6004262|NCT00894543|20758124|P1|Baseline to Week 4|No diary or lost or withdrew|3
6004263|NCT00894413|20758190|P2|Overall Study|Withdrawal by Subject|4
6004264|NCT00894413|20758191|P1|Overall Study|Withdrawal by Subject|0
6004265|NCT00894413|20758190|P2|Overall Study|Adverse Event|2
6004266|NCT00894413|20758191|P1|Overall Study|Adverse Event|0
6004267|NCT00894413|20758190|P2|Overall Study|Physician Decision|2
6004268|NCT00894413|20758191|P1|Overall Study|Physician Decision|0
6004269|NCT00894387|20758199|P2|Overall Study|GCP non-compliance|2
6004270|NCT00894387|20758200|P1|Overall Study|GCP non-compliance|0
6004271|NCT00894387|20758199|P2|Overall Study|Mis-randomized|9
6004272|NCT00894387|20758200|P1|Overall Study|Mis-randomized|13
6004273|NCT00894387|20758199|P2|Overall Study|Other (Missing)|3
6004274|NCT00894387|20758200|P1|Overall Study|Other (Missing)|5
6004275|NCT00894387|20758199|P2|Overall Study|Patient's request|30
6004276|NCT00894387|20758200|P1|Overall Study|Patient's request|25
6004277|NCT00894387|20758199|P2|Overall Study|Protocol Deviation|0
6004278|NCT00894387|20758200|P1|Overall Study|Protocol Deviation|4
6004279|NCT00894387|20758199|P2|Overall Study|Death|76
6004280|NCT00894387|20758200|P1|Overall Study|Death|77
6004281|NCT00894387|20758199|P2|Overall Study|Administrative problems|2
6004282|NCT00894387|20758200|P1|Overall Study|Administrative problems|2
6004283|NCT00894387|20758199|P2|Overall Study|Lost to Follow-up|5
6004284|NCT00894387|20758200|P1|Overall Study|Lost to Follow-up|3
6004285|NCT00894387|20758199|P2|Overall Study|Unsatisfactory therapeutic effect|1
6004286|NCT00894387|20758200|P1|Overall Study|Unsatisfactory therapeutic effect|0
6004287|NCT00894387|20758199|P2|Overall Study|Abnormal Laboratory values|2
6004288|NCT00894387|20758200|P1|Overall Study|Abnormal Laboratory values|2
6004289|NCT00894387|20758199|P2|Overall Study|Adverse Event|45
6004290|NCT00894387|20758200|P1|Overall Study|Adverse Event|44
6004291|NCT00894361|20758220|P2|Overall Study|deaths and less than 2 years followup|64
6004292|NCT00894361|20758221|P1|Overall Study|deaths and less than 2 years followup|24
6004293|NCT00894322|20758232|P3|Overall Study|Withdrawal by Subject|0
6004294|NCT00894322|20758233|P2|Overall Study|Withdrawal by Subject|0
6004295|NCT00894322|20758234|P1|Overall Study|Withdrawal by Subject|1
6004296|NCT00894166|20758285|P8|Overall Study|Death|0
6004297|NCT00894166|20758286|P7|Overall Study|Death|0
6004298|NCT00894166|20758287|P6|Overall Study|Death|0
6004299|NCT00894166|20758288|P5|Overall Study|Death|0
6004300|NCT00894166|20758289|P4|Overall Study|Death|1
6004301|NCT00894166|20758290|P3|Overall Study|Death|0
6004302|NCT00894166|20758291|P2|Overall Study|Death|0
6004303|NCT00894166|20758292|P1|Overall Study|Death|0
6004304|NCT00894166|20758285|P8|Overall Study|Withdrew or Lost to Follow-Up|34
6004305|NCT00894166|20758286|P7|Overall Study|Withdrew or Lost to Follow-Up|16
6004306|NCT00894166|20758287|P6|Overall Study|Withdrew or Lost to Follow-Up|16
6004307|NCT00894166|20758288|P5|Overall Study|Withdrew or Lost to Follow-Up|24
6004308|NCT00894166|20758289|P4|Overall Study|Withdrew or Lost to Follow-Up|68
6004309|NCT00894166|20758290|P3|Overall Study|Withdrew or Lost to Follow-Up|62
6004310|NCT00894166|20758291|P2|Overall Study|Withdrew or Lost to Follow-Up|63
6004311|NCT00894166|20758292|P1|Overall Study|Withdrew or Lost to Follow-Up|61
6004312|NCT00893971|20758338|P1|Overall Study|Physician Decision|3
6004313|NCT00893789|20758456|P4|Overall Study|Lost to Follow-up|1
6004314|NCT00893789|20758457|P3|Overall Study|Lost to Follow-up|0
6004315|NCT00893789|20758458|P2|Overall Study|Lost to Follow-up|0
6004316|NCT00893789|20758459|P1|Overall Study|Lost to Follow-up|0
6004317|NCT00893789|20758456|P4|Overall Study|Protocol Violation|4
6004318|NCT00893789|20758457|P3|Overall Study|Protocol Violation|1
6004319|NCT00893789|20758458|P2|Overall Study|Protocol Violation|1
6004320|NCT00893789|20758459|P1|Overall Study|Protocol Violation|0
6004321|NCT00893789|20758456|P4|Overall Study|Adverse Event|5
6004322|NCT00893789|20758457|P3|Overall Study|Adverse Event|1
6004323|NCT00893789|20758458|P2|Overall Study|Adverse Event|2
6004324|NCT00893789|20758459|P1|Overall Study|Adverse Event|0
6004325|NCT00893789|20758456|P4|Overall Study|Taking Excluded Concomitant Medication|0
6004326|NCT00893789|20758457|P3|Overall Study|Taking Excluded Concomitant Medication|1
6004327|NCT00893789|20758458|P2|Overall Study|Taking Excluded Concomitant Medication|0
6004328|NCT00893789|20758459|P1|Overall Study|Taking Excluded Concomitant Medication|1
6004329|NCT00893789|20758456|P4|Overall Study|Noncompliance With Study Procedures|0
6004330|NCT00893789|20758457|P3|Overall Study|Noncompliance With Study Procedures|0
6004331|NCT00893789|20758458|P2|Overall Study|Noncompliance With Study Procedures|0
6004332|NCT00893789|20758459|P1|Overall Study|Noncompliance With Study Procedures|1
6004333|NCT00893789|20758456|P4|Overall Study|Noncompliance With Study Drug|2
6004334|NCT00893789|20758457|P3|Overall Study|Noncompliance With Study Drug|1
6004335|NCT00893789|20758458|P2|Overall Study|Noncompliance With Study Drug|0
6004336|NCT00893789|20758459|P1|Overall Study|Noncompliance With Study Drug|1
6004337|NCT00893789|20758456|P4|Overall Study|Withdrawal by Subject|1
6004338|NCT00893789|20758457|P3|Overall Study|Withdrawal by Subject|3
6004339|NCT00893789|20758458|P2|Overall Study|Withdrawal by Subject|1
6004340|NCT00893789|20758459|P1|Overall Study|Withdrawal by Subject|3
6004341|NCT00893763|20758543|P2|Overall Study|extubated|110
6004342|NCT00893763|20758544|P1|Overall Study|extubated|110
6004343|NCT00893737|20758552|P1|Overall Study|Lost to Follow-up|6
6004344|NCT00893737|20758552|P1|Overall Study|Withdrawal by Subject|2
6004345|NCT00893737|20758552|P1|Overall Study|Adverse Event|4
6004346|NCT00893464|20758566|P8|Overall Study|Did not complete therapy/experience PD|2
6004347|NCT00893464|20758567|P7|Overall Study|Did not complete therapy/experience PD|2
6004348|NCT00893464|20758568|P6|Overall Study|Did not complete therapy/experience PD|0
6004349|NCT00893464|20758569|P5|Overall Study|Did not complete therapy/experience PD|0
6004350|NCT00893464|20758570|P4|Overall Study|Did not complete therapy/experience PD|0
6004351|NCT00893464|20758571|P3|Overall Study|Did not complete therapy/experience PD|0
6004352|NCT00893464|20758572|P2|Overall Study|Did not complete therapy/experience PD|0
6004353|NCT00893464|20758573|P1|Overall Study|Did not complete therapy/experience PD|0
6004354|NCT00893113|20758700|P2|Overall Study|Withdrew Consent|7
6004355|NCT00893113|20758701|P1|Overall Study|Withdrew Consent|8
6004356|NCT00893113|20758700|P2|Overall Study|Early Termination|1
6004357|NCT00893113|20758701|P1|Overall Study|Early Termination|1
6004358|NCT00893113|20758700|P2|Overall Study|Lost to Follow-up|8
6004359|NCT00893113|20758701|P1|Overall Study|Lost to Follow-up|4
6004360|NCT00892957|20758731|P2|Between Postoperative Day 1 and Day 14|Lost to Follow-up|2
6004361|NCT00892957|20758732|P1|Between Postoperative Day 1 and Day 14|Lost to Follow-up|0
6004362|NCT00892957|20758731|P2|Between Postoperative Day 1 and Day 14|Death|2
6004363|NCT00892957|20758732|P1|Between Postoperative Day 1 and Day 14|Death|0
6004364|NCT00892775|20758820|P2|Overall Study|Lost to Follow-up|0
6004365|NCT00892775|20758821|P1|Overall Study|Lost to Follow-up|1
6004366|NCT00892775|20758820|P2|Overall Study|Withdrawal by Subject|1
6004367|NCT00892775|20758821|P1|Overall Study|Withdrawal by Subject|0
6004368|NCT00892775|20758820|P2|Overall Study|Migrated/ moved from study area|0
6004369|NCT00892775|20758821|P1|Overall Study|Migrated/ moved from study area|1
6004370|NCT00892775|20758820|P2|Overall Study|Disclaimer/ Withdrawal caused by H1N1|0
6004371|NCT00892775|20758821|P1|Overall Study|Disclaimer/ Withdrawal caused by H1N1|1
6004372|NCT00892775|20758820|P2|Overall Study|Subject difficulties with blood drawing|0
6004373|NCT00892775|20758821|P1|Overall Study|Subject difficulties with blood drawing|1
6004374|NCT00892775|20758820|P2|Overall Study|Protocol Violation|0
6004375|NCT00892775|20758821|P1|Overall Study|Protocol Violation|1
6004376|NCT00892723|20758848|P3|Overall Study|Withdrawal by Subject|1
6004377|NCT00892723|20758849|P2|Overall Study|Withdrawal by Subject|1
6004378|NCT00892723|20758850|P1|Overall Study|Withdrawal by Subject|1
6004379|NCT00892723|20758848|P3|Overall Study|Lost to Follow-up|1
6004380|NCT00892723|20758849|P2|Overall Study|Lost to Follow-up|3
6004381|NCT00892723|20758850|P1|Overall Study|Lost to Follow-up|1
6004382|NCT00892437|20758939|P2|Open-Label Extension Phase|Withdrew Consent|1
6004383|NCT00892437|20758940|P1|Open-Label Extension Phase|Withdrew Consent|3
6004384|NCT00892437|20758939|P2|Open-Label Extension Phase|Investigator's Discretion|0
6004385|NCT00892437|20758940|P1|Open-Label Extension Phase|Investigator's Discretion|1
6004386|NCT00892437|20758939|P2|Open-Label Extension Phase|Lost to Follow-up|1
6004387|NCT00892437|20758940|P1|Open-Label Extension Phase|Lost to Follow-up|3
6004388|NCT00892437|20758939|P2|Open-Label Extension Phase|Lack of Efficacy|0
6004389|NCT00892437|20758940|P1|Open-Label Extension Phase|Lack of Efficacy|1
6004390|NCT00892437|20758939|P2|Open-Label Extension Phase|Adverse Event|2
6004391|NCT00892437|20758940|P1|Open-Label Extension Phase|Adverse Event|4
6004392|NCT00892437|20758939|P2|Randomized Phase|Withdrew Consent|0
6004393|NCT00892437|20758940|P1|Randomized Phase|Withdrew Consent|1
6004394|NCT00892437|20758939|P2|Randomized Phase|Investigator's Discretion|0
6004395|NCT00892437|20758940|P1|Randomized Phase|Investigator's Discretion|1
6004396|NCT00892437|20758939|P2|Randomized Phase|Lost to Follow-up|3
6004397|NCT00892437|20758940|P1|Randomized Phase|Lost to Follow-up|1
6004398|NCT00892437|20758939|P2|Randomized Phase|Adverse Event|2
6004399|NCT00892437|20758940|P1|Randomized Phase|Adverse Event|2
6004400|NCT00892437|20758939|P2|Randomized Phase|Randomized but not treated|0
6004401|NCT00892437|20758940|P1|Randomized Phase|Randomized but not treated|6
6004402|NCT00892281|20758959|P2|Overall Study|Visit 4 date out of window|0
6004403|NCT00892281|20758960|P1|Overall Study|Visit 4 date out of window|1
6004404|NCT00892281|20758959|P2|Overall Study|Rash on hand|0
6004405|NCT00892281|20758960|P1|Overall Study|Rash on hand|1
6004406|NCT00892281|20758959|P2|Overall Study|Subject had history of drug abuse|0
6004407|NCT00892281|20758960|P1|Overall Study|Subject had history of drug abuse|1
6004408|NCT00892281|20758959|P2|Overall Study|Non-compliant with visits as scheduled|0
6004409|NCT00892281|20758960|P1|Overall Study|Non-compliant with visits as scheduled|1
6004410|NCT00892281|20758959|P2|Overall Study|Missed visits rescheduled out of window|0
6004411|NCT00892281|20758960|P1|Overall Study|Missed visits rescheduled out of window|1
6004412|NCT00892281|20758959|P2|Overall Study|Missed multiple visits|0
6004413|NCT00892281|20758960|P1|Overall Study|Missed multiple visits|1
6004414|NCT00892281|20758959|P2|Overall Study|No show Visit 2; prescription not filled|0
6004415|NCT00892281|20758960|P1|Overall Study|No show Visit 2; prescription not filled|1
6004416|NCT00892281|20758959|P2|Overall Study|Subject not seen by PI at final visit|0
6004417|NCT00892281|20758960|P1|Overall Study|Subject not seen by PI at final visit|1
6004418|NCT00892281|20758959|P2|Overall Study|Lack of efficacy of study product|0
6004419|NCT00892281|20758960|P1|Overall Study|Lack of efficacy of study product|2
6004420|NCT00892281|20758959|P2|Overall Study|Death in family|0
6004421|NCT00892281|20758960|P1|Overall Study|Death in family|1
6004422|NCT00892281|20758959|P2|Overall Study|Bad taste in mouth after taking Oracea®|1
6004423|NCT00892281|20758960|P1|Overall Study|Bad taste in mouth after taking Oracea®|0
6004424|NCT00892281|20758959|P2|Overall Study|Subject lost interest in program|1
6004425|NCT00892281|20758960|P1|Overall Study|Subject lost interest in program|0
6004426|NCT00892281|20758959|P2|Overall Study|PI complained of inadequate compensation|0
6004427|NCT00892281|20758960|P1|Overall Study|PI complained of inadequate compensation|3
6004428|NCT00892281|20758959|P2|Overall Study|Scheduled for knee replacement|1
6004429|NCT00892281|20758960|P1|Overall Study|Scheduled for knee replacement|0
6004430|NCT00892281|20758959|P2|Overall Study|Missed Visit 4 and off meds for 65 days|1
6004431|NCT00892281|20758960|P1|Overall Study|Missed Visit 4 and off meds for 65 days|1
6004432|NCT00892281|20758959|P2|Overall Study|Subject missed several visits/lost meds|0
6004433|NCT00892281|20758960|P1|Overall Study|Subject missed several visits/lost meds|1
6004434|NCT00892281|20758959|P2|Overall Study|Subject did not return for any visits|0
6004435|NCT00892281|20758960|P1|Overall Study|Subject did not return for any visits|1
6004436|NCT00892281|20758959|P2|Overall Study|Subject not good candidate for study|0
6004437|NCT00892281|20758960|P1|Overall Study|Subject not good candidate for study|1
6004438|NCT00892281|20758959|P2|Overall Study|Unable to redeem the drug voucher|0
6004439|NCT00892281|20758960|P1|Overall Study|Unable to redeem the drug voucher|1
6004440|NCT00892281|20758959|P2|Overall Study|Rosacea cleared; subject D/C'd self|0
6004441|NCT00892281|20758960|P1|Overall Study|Rosacea cleared; subject D/C'd self|1
6004442|NCT00892281|20758959|P2|Overall Study|Did not meet incl/excl criteria|0
6004443|NCT00892281|20758960|P1|Overall Study|Did not meet incl/excl criteria|1
6004444|NCT00892281|20758959|P2|Overall Study|Last visit not done - death in family|0
6004445|NCT00892281|20758960|P1|Overall Study|Last visit not done - death in family|1
6004446|NCT00892281|20758959|P2|Overall Study|Family emergency|0
6004447|NCT00892281|20758960|P1|Overall Study|Family emergency|1
6004448|NCT00892281|20758959|P2|Overall Study|Subject completed day after study closed|0
6004449|NCT00892281|20758960|P1|Overall Study|Subject completed day after study closed|1
6004450|NCT00892281|20758959|P2|Overall Study|Final visit completed 4 weeks late|1
6004451|NCT00892281|20758960|P1|Overall Study|Final visit completed 4 weeks late|0
6004452|NCT00892281|20758959|P2|Overall Study|Subject unable to keep follow-up visits|0
6004453|NCT00892281|20758960|P1|Overall Study|Subject unable to keep follow-up visits|1
6004454|NCT00892281|20758959|P2|Overall Study|Subject failed to return for final visit|0
6004455|NCT00892281|20758960|P1|Overall Study|Subject failed to return for final visit|2
6004456|NCT00892281|20758959|P2|Overall Study|Withdrawal by Subject|14
6004457|NCT00892281|20758960|P1|Overall Study|Withdrawal by Subject|86
6004458|NCT00892281|20758959|P2|Overall Study|Protocol Violation|2
6004459|NCT00892281|20758960|P1|Overall Study|Protocol Violation|7
6004460|NCT00892281|20758959|P2|Overall Study|Pregnancy|0
6004461|NCT00892281|20758960|P1|Overall Study|Pregnancy|1
6004462|NCT00892281|20758959|P2|Overall Study|Lost to Follow-up|8
6004463|NCT00892281|20758960|P1|Overall Study|Lost to Follow-up|81
6004464|NCT00892281|20758959|P2|Overall Study|Adverse Event|8
6004465|NCT00892281|20758960|P1|Overall Study|Adverse Event|65
6004466|NCT00892177|20758973|P6|Phase II|Withdrawal by Subject|1
6004467|NCT00892177|20758974|P5|Phase II|Withdrawal by Subject|4
6004468|NCT00892177|20758975|P4|Phase II|Withdrawal by Subject|0
6004469|NCT00892177|20758976|P3|Phase II|Withdrawal by Subject|0
6004470|NCT00892177|20758977|P2|Phase II|Withdrawal by Subject|0
6004471|NCT00892177|20758978|P1|Phase II|Withdrawal by Subject|0
6004472|NCT00892177|20758973|P6|Phase II|Ineligible|1
6004473|NCT00892177|20758974|P5|Phase II|Ineligible|1
6004474|NCT00892177|20758975|P4|Phase II|Ineligible|0
6004475|NCT00892177|20758976|P3|Phase II|Ineligible|0
6004476|NCT00892177|20758977|P2|Phase II|Ineligible|0
6004477|NCT00892177|20758978|P1|Phase II|Ineligible|0
6004478|NCT00892151|20759003|P1|Overall Study|Protocol Violation|1
6004479|NCT00892099|20759012|P3|Overall Study|Lost to Follow-up|1
6004480|NCT00892099|20759013|P2|Overall Study|Lost to Follow-up|0
6004481|NCT00892099|20759014|P1|Overall Study|Lost to Follow-up|0
6004482|NCT00892099|20759012|P3|Overall Study|investigator decision|1
6004483|NCT00892099|20759013|P2|Overall Study|investigator decision|0
6004484|NCT00892099|20759014|P1|Overall Study|investigator decision|0
6004485|NCT00892099|20759012|P3|Overall Study|kidney function recovered|0
6004486|NCT00892099|20759013|P2|Overall Study|kidney function recovered|1
6004487|NCT00892099|20759014|P1|Overall Study|kidney function recovered|0
6004488|NCT00892099|20759012|P3|Overall Study|no further details|1
6004489|NCT00892099|20759013|P2|Overall Study|no further details|0
6004490|NCT00892099|20759014|P1|Overall Study|no further details|1
6004491|NCT00892099|20759012|P3|Overall Study|Prolonged hospitalization|1
6004492|NCT00892099|20759013|P2|Overall Study|Prolonged hospitalization|0
6004493|NCT00892099|20759014|P1|Overall Study|Prolonged hospitalization|1
6004494|NCT00892099|20759012|P3|Overall Study|replocated|2
6004495|NCT00892099|20759013|P2|Overall Study|replocated|0
6004496|NCT00892099|20759014|P1|Overall Study|replocated|1
6004497|NCT00892099|20759012|P3|Overall Study|Adverse Event|0
6004498|NCT00892099|20759013|P2|Overall Study|Adverse Event|0
6004499|NCT00892099|20759014|P1|Overall Study|Adverse Event|1
6004500|NCT00892099|20759012|P3|Overall Study|Death|1
6004501|NCT00892099|20759013|P2|Overall Study|Death|0
6004502|NCT00892099|20759014|P1|Overall Study|Death|1
6004503|NCT00892047|20759039|P2|Overall Study|Lack of Efficacy|2
6004504|NCT00892047|20759040|P1|Overall Study|Lack of Efficacy|0
6004505|NCT00892047|20759039|P2|Overall Study|subject burden|3
6004506|NCT00892047|20759040|P1|Overall Study|subject burden|2
6004507|NCT00892047|20759039|P2|Overall Study|Adverse Event|2
6004508|NCT00892047|20759040|P1|Overall Study|Adverse Event|2
6004509|NCT00892008|20759056|P1|Overall Study|Adverse Event|37
6004510|NCT00892008|20759056|P1|Overall Study|Other|378
6004511|NCT00892008|20759056|P1|Overall Study|Lost to Follow-up|142
6004512|NCT00892008|20759056|P1|Overall Study|Lack of Efficacy|3
6004513|NCT00892008|20759056|P1|Overall Study|Death|5
6004514|NCT00891930|20759142|P1|Part 2: Panitumumab + Ganitumab|Withdrawal by Subject|1
6004515|NCT00891930|20759142|P1|Part 2: Panitumumab + Ganitumab|Death|30
6004516|NCT00891930|20759142|P1|Part 1: Panitumumab +Irinotecan|Lost to Follow-up|1
6004517|NCT00891930|20759142|P1|Part 1: Panitumumab +Irinotecan|Withdrawal by Subject|1
6004518|NCT00891930|20759142|P1|Part 1: Panitumumab +Irinotecan|Death|38
6004519|NCT00891904|20759163|P1|Overall Study|Adverse Event|1
6004520|NCT00891904|20759163|P1|Overall Study|Death|1
6004521|NCT00891839|20759189|P1|Overall Study|Disease progression|3
6004522|NCT00891839|20759189|P1|Overall Study|Withdrawal by Subject|2
6004523|NCT00891839|20759189|P1|Overall Study|Adverse Event|2
6004524|NCT00891813|20759198|P1|Overall Study|Protocol Violation|2
6004525|NCT00891813|20759198|P1|Overall Study|Patient Noncompliance|6
6004526|NCT00891813|20759198|P1|Overall Study|Withdrawal by Subject|1
6004527|NCT00891813|20759198|P1|Overall Study|Adverse Event|3
6004528|NCT00891774|20759204|P1|Overall Study|Protocol Violation|4
6004529|NCT00891774|20759204|P1|Overall Study|Withdrawal by Subject|2
6004530|NCT00891774|20759204|P1|Overall Study|Illness (Self/Mother)|3
6004531|NCT00891774|20759204|P1|Overall Study|Lost to Follow-up|5
6004532|NCT00891735|20759215|P4|Overall Study|Patient's decision to withdraw|8
6004533|NCT00891735|20759216|P3|Overall Study|Patient's decision to withdraw|4
6004534|NCT00891735|20759217|P2|Overall Study|Patient's decision to withdraw|9
6004535|NCT00891735|20759218|P1|Overall Study|Patient's decision to withdraw|4
6004536|NCT00891735|20759215|P4|Overall Study|Physician's decision to withdraw patient|0
6004537|NCT00891735|20759216|P3|Overall Study|Physician's decision to withdraw patient|0
6004538|NCT00891735|20759217|P2|Overall Study|Physician's decision to withdraw patient|0
6004539|NCT00891735|20759218|P1|Overall Study|Physician's decision to withdraw patient|1
6004540|NCT00891735|20759215|P4|Overall Study|Lost to Follow-up|2
6004541|NCT00891735|20759216|P3|Overall Study|Lost to Follow-up|2
6004542|NCT00891735|20759217|P2|Overall Study|Lost to Follow-up|2
6004543|NCT00891735|20759218|P1|Overall Study|Lost to Follow-up|2
6004544|NCT00891735|20759215|P4|Overall Study|Death|5
6004545|NCT00891735|20759216|P3|Overall Study|Death|4
6004546|NCT00891735|20759217|P2|Overall Study|Death|5
6004547|NCT00891735|20759218|P1|Overall Study|Death|8
6004548|NCT00891735|20759215|P4|Overall Study|Adverse Event|0
6004549|NCT00891735|20759216|P3|Overall Study|Adverse Event|2
6004550|NCT00891735|20759217|P2|Overall Study|Adverse Event|0
6004551|NCT00891735|20759218|P1|Overall Study|Adverse Event|2
6004552|NCT00891657|20759258|P2|Overall Study|Withdrawal by Subject|1
6004553|NCT00891657|20759259|P1|Overall Study|Withdrawal by Subject|1
6004554|NCT00891618|20759271|P1|Overall Study|Withdrawal by Subject|1
6004555|NCT00891527|20759275|P1|Overall Study|Withdrawal by Subject|2
6004556|NCT00891462|20759284|P3|Overall Study|Lost to Follow-up|0
6004557|NCT00891462|20759285|P2|Overall Study|Lost to Follow-up|2
6004558|NCT00891462|20759286|P1|Overall Study|Lost to Follow-up|0
6004559|NCT00891462|20759284|P3|Overall Study|Inclusion/exclusion criteria|2
6004560|NCT00891462|20759285|P2|Overall Study|Inclusion/exclusion criteria|2
6004561|NCT00891462|20759286|P1|Overall Study|Inclusion/exclusion criteria|0
6004562|NCT00891462|20759284|P3|Overall Study|Protocol Violation|3
6004563|NCT00891462|20759285|P2|Overall Study|Protocol Violation|1
6004564|NCT00891462|20759286|P1|Overall Study|Protocol Violation|2
6004565|NCT00891462|20759284|P3|Overall Study|Other Reason|3
6004566|NCT00891462|20759285|P2|Overall Study|Other Reason|5
6004567|NCT00891462|20759286|P1|Overall Study|Other Reason|2
6004568|NCT00891462|20759284|P3|Overall Study|COPD exacerbation|1
6004569|NCT00891462|20759285|P2|Overall Study|COPD exacerbation|4
6004570|NCT00891462|20759286|P1|Overall Study|COPD exacerbation|7
6004571|NCT00891462|20759284|P3|Overall Study|Lack of Efficacy|1
6004572|NCT00891462|20759285|P2|Overall Study|Lack of Efficacy|5
6004573|NCT00891462|20759286|P1|Overall Study|Lack of Efficacy|10
6004574|NCT00891462|20759284|P3|Overall Study|Adverse Event|7
6004575|NCT00891462|20759285|P2|Overall Study|Adverse Event|8
6004576|NCT00891462|20759286|P1|Overall Study|Adverse Event|7
6004577|NCT00891462|20759284|P3|Overall Study|Withdrawal by Subject|7
6004578|NCT00891462|20759285|P2|Overall Study|Withdrawal by Subject|6
6004579|NCT00891462|20759286|P1|Overall Study|Withdrawal by Subject|9
6004580|NCT00891371|20759308|P1|Treatment|Lost to Follow-up|1
6004581|NCT00891371|20759308|P1|Treatment|Death|1
6004582|NCT00891371|20759308|P1|Treatment|Adverse Event|2
6004583|NCT00891371|20759308|P1|Treatment|Lack of Efficacy|5
6004584|NCT00891371|20759308|P1|Pre-assignment|Consent withdrawal|1
6004585|NCT00891371|20759308|P1|Pre-assignment|Inclusion/exclusion|5
6004586|NCT00891293|20759330|P1|Overall Study|Sponsor termination|62
6004587|NCT00891293|20759330|P1|Overall Study|Subject withdrew consent|7
6004588|NCT00891293|20759330|P1|Overall Study|Lost to Follow-up|7
6004589|NCT00891293|20759330|P1|Overall Study|Laboratory abnormality|4
6004590|NCT00891293|20759330|P1|Overall Study|Protocol Violation|2
6004591|NCT00891293|20759330|P1|Overall Study|Adverse Event|2
6004592|NCT00891228|20759345|P3|Overall Study|Pregnancy|0
6004593|NCT00891228|20759346|P2|Overall Study|Pregnancy|1
6004594|NCT00891228|20759347|P1|Overall Study|Pregnancy|0
6004595|NCT00891228|20759345|P3|Overall Study|Lost to Follow-up|5
6004596|NCT00891228|20759346|P2|Overall Study|Lost to Follow-up|4
6004597|NCT00891228|20759347|P1|Overall Study|Lost to Follow-up|4
6004598|NCT00891228|20759345|P3|Overall Study|Physician Decision|0
6004599|NCT00891228|20759346|P2|Overall Study|Physician Decision|1
6004600|NCT00891228|20759347|P1|Overall Study|Physician Decision|2
6004601|NCT00891228|20759345|P3|Overall Study|Protocol Violation|2
6004602|NCT00891228|20759346|P2|Overall Study|Protocol Violation|1
6004603|NCT00891228|20759347|P1|Overall Study|Protocol Violation|3
6004604|NCT00891228|20759345|P3|Overall Study|Withdrawal by Subject|5
6004605|NCT00891228|20759346|P2|Overall Study|Withdrawal by Subject|4
6004606|NCT00891228|20759347|P1|Overall Study|Withdrawal by Subject|2
6004607|NCT00891228|20759345|P3|Overall Study|Adverse Event|3
6004608|NCT00891228|20759346|P2|Overall Study|Adverse Event|2
6004609|NCT00891228|20759347|P1|Overall Study|Adverse Event|0
6004610|NCT00891202|20759369|P4|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|5
6004611|NCT00891202|20759370|P3|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|2
6004612|NCT00891202|20759371|P2|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0
6004613|NCT00891202|20759372|P1|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0
6004614|NCT00891202|20759369|P4|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0
6004615|NCT00891202|20759370|P3|LTTP (Post-Week 39 up to Week 312)|Pregnancy|1
6004616|NCT00891202|20759371|P2|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0
6004617|NCT00891202|20759372|P1|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0
6004618|NCT00891202|20759369|P4|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0
6004619|NCT00891202|20759370|P3|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|4
6004620|NCT00891202|20759371|P2|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0
6004621|NCT00891202|20759372|P1|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0
6004622|NCT00891202|20759369|P4|PAP (Up To Week 39)|Withdrawal by Subject|0
6004623|NCT00891202|20759370|P3|PAP (Up To Week 39)|Withdrawal by Subject|0
6004624|NCT00891202|20759371|P2|PAP (Up To Week 39)|Withdrawal by Subject|0
6004625|NCT00891202|20759372|P1|PAP (Up To Week 39)|Withdrawal by Subject|1
6004626|NCT00891046|20759548|P5|Overall Study|Lost to Follow-up|1
6004627|NCT00891046|20759549|P4|Overall Study|Lost to Follow-up|0
6004628|NCT00891046|20759550|P3|Overall Study|Lost to Follow-up|0
6004629|NCT00891046|20759551|P2|Overall Study|Lost to Follow-up|0
6004630|NCT00891046|20759552|P1|Overall Study|Lost to Follow-up|0
6004631|NCT00891046|20759548|P5|Overall Study|Withdrawal by Subject|1
6004632|NCT00891046|20759549|P4|Overall Study|Withdrawal by Subject|1
6004633|NCT00891046|20759550|P3|Overall Study|Withdrawal by Subject|2
6004634|NCT00891046|20759551|P2|Overall Study|Withdrawal by Subject|1
6004635|NCT00891046|20759552|P1|Overall Study|Withdrawal by Subject|2
6004636|NCT00891046|20759548|P5|Overall Study|Adverse Event|14
6004637|NCT00891046|20759549|P4|Overall Study|Adverse Event|0
6004638|NCT00891046|20759550|P3|Overall Study|Adverse Event|2
6004639|NCT00891046|20759551|P2|Overall Study|Adverse Event|3
6004640|NCT00891046|20759552|P1|Overall Study|Adverse Event|4
6004641|NCT00891046|20759548|P5|Overall Study|Participant no longer required drug|1
6004642|NCT00891046|20759549|P4|Overall Study|Participant no longer required drug|0
6004643|NCT00891046|20759550|P3|Overall Study|Participant no longer required drug|0
6004644|NCT00891046|20759551|P2|Overall Study|Participant no longer required drug|2
6004645|NCT00891046|20759552|P1|Overall Study|Participant no longer required drug|0
6004646|NCT00891046|20759548|P5|Overall Study|Administrative problems|1
6004647|NCT00891046|20759549|P4|Overall Study|Administrative problems|0
6004648|NCT00891046|20759550|P3|Overall Study|Administrative problems|0
6004649|NCT00891046|20759551|P2|Overall Study|Administrative problems|0
6004650|NCT00891046|20759552|P1|Overall Study|Administrative problems|0
6004651|NCT00891046|20759548|P5|Overall Study|Unsatisfactory therapeutic effect|20
6004652|NCT00891046|20759549|P4|Overall Study|Unsatisfactory therapeutic effect|2
6004653|NCT00891046|20759550|P3|Overall Study|Unsatisfactory therapeutic effect|19
6004654|NCT00891046|20759551|P2|Overall Study|Unsatisfactory therapeutic effect|2
6004655|NCT00891046|20759552|P1|Overall Study|Unsatisfactory therapeutic effect|5
6004656|NCT00891046|20759548|P5|Overall Study|Protocol Violation|1
6004657|NCT00891046|20759549|P4|Overall Study|Protocol Violation|0
6004658|NCT00891046|20759550|P3|Overall Study|Protocol Violation|0
6004659|NCT00891046|20759551|P2|Overall Study|Protocol Violation|1
6004660|NCT00891046|20759552|P1|Overall Study|Protocol Violation|1
6004661|NCT00891020|20759628|P3|Long-term Extension Period|Administrative|2
6004662|NCT00891020|20759629|P2|Long-term Extension Period|Administrative|2
6004663|NCT00891020|20759630|P1|Long-term Extension Period|Administrative|1
6004664|NCT00891020|20759628|P3|Long-term Extension Period|Failure to return|3
6004665|NCT00891020|20759629|P2|Long-term Extension Period|Failure to return|2
6004666|NCT00891020|20759630|P1|Long-term Extension Period|Failure to return|0
6004667|NCT00891020|20759628|P3|Long-term Extension Period|Refused treatment/did not cooperate|4
6004668|NCT00891020|20759629|P2|Long-term Extension Period|Refused treatment/did not cooperate|6
6004669|NCT00891020|20759630|P1|Long-term Extension Period|Refused treatment/did not cooperate|1
6004670|NCT00891020|20759628|P3|Long-term Extension Period|Protocol Violation|1
6004671|NCT00891020|20759629|P2|Long-term Extension Period|Protocol Violation|1
6004672|NCT00891020|20759630|P1|Long-term Extension Period|Protocol Violation|0
6004673|NCT00891020|20759628|P3|Long-term Extension Period|Insufficient therapeutic response|2
6004674|NCT00891020|20759629|P2|Long-term Extension Period|Insufficient therapeutic response|2
6004675|NCT00891020|20759630|P1|Long-term Extension Period|Insufficient therapeutic response|3
6004676|NCT00891020|20759628|P3|Long-term Extension Period|Death|1
6004677|NCT00891020|20759629|P2|Long-term Extension Period|Death|0
6004678|NCT00891020|20759630|P1|Long-term Extension Period|Death|0
6004679|NCT00891020|20759628|P3|Long-term Extension Period|Adverse Event|10
6004680|NCT00891020|20759629|P2|Long-term Extension Period|Adverse Event|11
6004681|NCT00891020|20759630|P1|Long-term Extension Period|Adverse Event|1
6004682|NCT00891020|20759628|P3|24 Week Treatment Period|Administrative/Other|1
6004683|NCT00891020|20759629|P2|24 Week Treatment Period|Administrative/Other|6
6004684|NCT00891020|20759630|P1|24 Week Treatment Period|Administrative/Other|5
6004685|NCT00891020|20759628|P3|24 Week Treatment Period|Withdrew consent|15
6004686|NCT00891020|20759629|P2|24 Week Treatment Period|Withdrew consent|3
6004687|NCT00891020|20759630|P1|24 Week Treatment Period|Withdrew consent|6
6004688|NCT00891020|20759628|P3|24 Week Treatment Period|Refused treatment/did not cooperate|1
6004689|NCT00891020|20759629|P2|24 Week Treatment Period|Refused treatment/did not cooperate|2
6004690|NCT00891020|20759630|P1|24 Week Treatment Period|Refused treatment/did not cooperate|3
6004691|NCT00891020|20759628|P3|24 Week Treatment Period|Other protocol violation|2
6004692|NCT00891020|20759629|P2|24 Week Treatment Period|Other protocol violation|1
6004693|NCT00891020|20759630|P1|24 Week Treatment Period|Other protocol violation|1
6004694|NCT00891020|20759628|P3|24 Week Treatment Period|Violation of selection criteria at entry|2
6004695|NCT00891020|20759629|P2|24 Week Treatment Period|Violation of selection criteria at entry|0
6004696|NCT00891020|20759630|P1|24 Week Treatment Period|Violation of selection criteria at entry|1
6004697|NCT00891020|20759628|P3|24 Week Treatment Period|Failure to return|5
6004698|NCT00891020|20759629|P2|24 Week Treatment Period|Failure to return|5
6004699|NCT00891020|20759630|P1|24 Week Treatment Period|Failure to return|4
6004700|NCT00891020|20759628|P3|24 Week Treatment Period|Insufficient therapeutic response|15
6004701|NCT00891020|20759629|P2|24 Week Treatment Period|Insufficient therapeutic response|9
6004702|NCT00891020|20759630|P1|24 Week Treatment Period|Insufficient therapeutic response|6
6004703|NCT00891020|20759628|P3|24 Week Treatment Period|Death|0
6004704|NCT00891020|20759629|P2|24 Week Treatment Period|Death|2
6004705|NCT00891020|20759630|P1|24 Week Treatment Period|Death|0
6004706|NCT00891020|20759628|P3|24 Week Treatment Period|Adverse event or intercurrent illness|17
6004707|NCT00891020|20759629|P2|24 Week Treatment Period|Adverse event or intercurrent illness|32
6004708|NCT00891020|20759630|P1|24 Week Treatment Period|Adverse event or intercurrent illness|11
6004709|NCT00890929|20759694|P1|Overall Study|Physician Decision|1
6004710|NCT00890929|20759694|P1|Overall Study|Withdrawal by Subject|3
6004711|NCT00890929|20759694|P1|Overall Study|Death before treatment|2
6004712|NCT00890825|20759712|P2|Overall Study|Alive at data cut off (DCO)|14
6004713|NCT00890825|20759713|P1|Overall Study|Alive at data cut off (DCO)|13
6004714|NCT00890825|20759712|P2|Overall Study|Withdrawal by Subject|0
6004715|NCT00890825|20759713|P1|Overall Study|Withdrawal by Subject|1
6004716|NCT00890695|20759742|P2|Overall Study|Protocol Violation|0
6004717|NCT00890695|20759743|P1|Overall Study|Protocol Violation|1
6004718|NCT00890591|20759777|P1|Overall Study|Lack of Efficacy|20
6004719|NCT00890552|20759783|P1|On-treatment|Early prog disease/ death|10
6004720|NCT00890552|20759783|P1|Enrollment and Pre-treatment|Death/ lost to follow up|1
6004721|NCT00890409|20759792|P2|Overall Study|Lost to Follow-up|21
6004722|NCT00890409|20759793|P1|Overall Study|Lost to Follow-up|20
6004723|NCT00890201|20759830|P2|Overall Study|Protocol Violation|56
6004724|NCT00890201|20759831|P1|Overall Study|Protocol Violation|5
6004725|NCT00890097|20759849|P3|Overall Study|Protocol Deviation|1
6004726|NCT00890097|20759850|P2|Overall Study|Protocol Deviation|1
6004727|NCT00890097|20759851|P1|Overall Study|Protocol Deviation|1
6004728|NCT00890097|20759849|P3|Overall Study|Subject Moved|0
6004729|NCT00890097|20759850|P2|Overall Study|Subject Moved|4
6004730|NCT00890097|20759851|P1|Overall Study|Subject Moved|0
6004731|NCT00890097|20759849|P3|Overall Study|Transportation|0
6004732|NCT00890097|20759850|P2|Overall Study|Transportation|2
6004733|NCT00890097|20759851|P1|Overall Study|Transportation|0
6004734|NCT00890097|20759849|P3|Overall Study|Failed inclusion criteria|0
6004735|NCT00890097|20759850|P2|Overall Study|Failed inclusion criteria|4
6004736|NCT00890097|20759851|P1|Overall Study|Failed inclusion criteria|3
6004737|NCT00890097|20759849|P3|Overall Study|Randomization Error|0
6004738|NCT00890097|20759850|P2|Overall Study|Randomization Error|0
6004739|NCT00890097|20759851|P1|Overall Study|Randomization Error|2
6004740|NCT00890097|20759849|P3|Overall Study|Subject Decision|6
6004741|NCT00890097|20759850|P2|Overall Study|Subject Decision|2
6004742|NCT00890097|20759851|P1|Overall Study|Subject Decision|3
6004743|NCT00890097|20759849|P3|Overall Study|Did not attend final visit|0
6004744|NCT00890097|20759850|P2|Overall Study|Did not attend final visit|3
6004745|NCT00890097|20759851|P1|Overall Study|Did not attend final visit|2
6004746|NCT00890097|20759849|P3|Overall Study|Sponsor Decision|7
6004747|NCT00890097|20759850|P2|Overall Study|Sponsor Decision|11
6004748|NCT00890097|20759851|P1|Overall Study|Sponsor Decision|7
6004749|NCT00890097|20759849|P3|Overall Study|Noncompliance|4
6004750|NCT00890097|20759850|P2|Overall Study|Noncompliance|4
6004751|NCT00890097|20759851|P1|Overall Study|Noncompliance|0
6004752|NCT00890097|20759849|P3|Overall Study|Lost to Follow-up|5
6004753|NCT00890097|20759850|P2|Overall Study|Lost to Follow-up|5
6004754|NCT00890097|20759851|P1|Overall Study|Lost to Follow-up|5
6004755|NCT00890097|20759849|P3|Overall Study|Withdrew Consent|9
6004756|NCT00890097|20759850|P2|Overall Study|Withdrew Consent|6
6004757|NCT00890097|20759851|P1|Overall Study|Withdrew Consent|9
6004758|NCT00890097|20759849|P3|Overall Study|Decision Unrelated to an Adverse Event|17
6004759|NCT00890097|20759850|P2|Overall Study|Decision Unrelated to an Adverse Event|12
6004760|NCT00890097|20759851|P1|Overall Study|Decision Unrelated to an Adverse Event|15
6004761|NCT00890097|20759849|P3|Overall Study|Adverse Event|28
6004762|NCT00890097|20759850|P2|Overall Study|Adverse Event|32
6004763|NCT00890097|20759851|P1|Overall Study|Adverse Event|21
6004764|NCT00890084|20759859|P1|Overall Study|Lost to Follow-up|126
6004765|NCT00890084|20759859|P1|Overall Study|Adverse Event|16
6004766|NCT00889863|20759899|P2|Part II: Randomized Double Blind|Protocol deviation|1
6004767|NCT00889863|20759900|P1|Part II: Randomized Double Blind|Protocol deviation|0
6004768|NCT00889863|20759899|P2|Part II: Randomized Double Blind|Withdrawal by Subject|1
6004769|NCT00889863|20759900|P1|Part II: Randomized Double Blind|Withdrawal by Subject|0
6004770|NCT00889863|20759899|P2|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|20
6004771|NCT00889863|20759900|P1|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|11
6004772|NCT00889863|20759899|P2|Part II: Randomized Double Blind|Adverse Event|4
6004773|NCT00889863|20759900|P1|Part II: Randomized Double Blind|Adverse Event|0
6004774|NCT00889863|20759899|P2|Part I: Open Label|Unsatisfactory therapeutic effect|0
6004775|NCT00889863|20759900|P1|Part I: Open Label|Unsatisfactory therapeutic effect|72
6004776|NCT00889863|20759899|P2|Part I: Open Label|Adverse Event|0
6004777|NCT00889863|20759900|P1|Part I: Open Label|Adverse Event|4
6004778|NCT00889863|20759899|P2|Part I: Open Label|Death|0
6004779|NCT00889863|20759900|P1|Part I: Open Label|Death|1
6004780|NCT00889720|20759926|P1|Overall Study|Other|4
6004781|NCT00889720|20759926|P1|Overall Study|Withdrawal by Subject|4
6004782|NCT00889707|20759953|P2|Overall Study|Lack of Efficacy|5
6004783|NCT00889707|20759954|P1|Overall Study|Lack of Efficacy|2
6004784|NCT00889707|20759953|P2|Overall Study|Lost to Follow-up|2
6004785|NCT00889707|20759954|P1|Overall Study|Lost to Follow-up|0
6004786|NCT00889707|20759953|P2|Overall Study|Withdrawal by Subject|3
6004787|NCT00889707|20759954|P1|Overall Study|Withdrawal by Subject|4
6004788|NCT00889707|20759953|P2|Overall Study|Adverse Event|0
6004789|NCT00889707|20759954|P1|Overall Study|Adverse Event|1
6004790|NCT00889681|20759962|P1|Overall Study|Insurance disapproval|1
6004791|NCT00889681|20759962|P1|Overall Study|Not meeting qualification Criteria|2
6004792|NCT00889603|20759969|P1|Overall Study|Other|4
6004793|NCT00889603|20759969|P1|Overall Study|No longer willing to participant in stud|4
6004794|NCT00889603|20759969|P1|Overall Study|Lost to Follow-up|19
6004795|NCT00889603|20759969|P1|Overall Study|Death|3
6004796|NCT00889603|20759969|P1|Overall Study|Adverse Event|7
6004797|NCT00889421|20759991|P1|Overall Study|Lack of Efficacy|3
6004798|NCT00889265|20760032|P1|Overall Study|Protocol Violation|1
6004799|NCT00889265|20760032|P1|Overall Study|Lost to Follow-up|5
6004800|NCT00889265|20760032|P1|Overall Study|Adverse Event|1
6004801|NCT00889252|20760039|P2|Overall Study|Protocol Violation|0
6004802|NCT00889252|20760040|P1|Overall Study|Protocol Violation|2
6004803|NCT00889252|20760039|P2|Overall Study|Withdrawal by Subject|0
6004804|NCT00889252|20760040|P1|Overall Study|Withdrawal by Subject|3
6004805|NCT00889252|20760039|P2|Overall Study|Adverse Event|4
6004806|NCT00889252|20760040|P1|Overall Study|Adverse Event|2
6004807|NCT00889005|20760117|P2|Overall Study|Withdrawal by Subject|0
6004808|NCT00889005|20760118|P1|Overall Study|Withdrawal by Subject|4
6004809|NCT00889005|20760117|P2|Overall Study|Lost to Follow-up|2
6004810|NCT00889005|20760118|P1|Overall Study|Lost to Follow-up|4
6004811|NCT00888940|20760132|P2|Overall Study|Randomized Not Treated|13
6004812|NCT00888940|20760133|P1|Overall Study|Randomized Not Treated|11
6004813|NCT00888940|20760132|P2|Overall Study|Lost to Follow-up|5
6004814|NCT00888940|20760133|P1|Overall Study|Lost to Follow-up|5
6004815|NCT00888940|20760132|P2|Overall Study|Adverse Event|3
6004816|NCT00888940|20760133|P1|Overall Study|Adverse Event|12
6004817|NCT00888927|20760145|P4|Overall Study|Withdrawal of consent|1
6004818|NCT00888927|20760146|P3|Overall Study|Withdrawal of consent|0
6004819|NCT00888927|20760147|P2|Overall Study|Withdrawal of consent|0
6004820|NCT00888927|20760148|P1|Overall Study|Withdrawal of consent|0
6004821|NCT00888927|20760145|P4|Overall Study|Adverse Event|1
6004822|NCT00888927|20760146|P3|Overall Study|Adverse Event|0
6004823|NCT00888927|20760147|P2|Overall Study|Adverse Event|0
6004824|NCT00888927|20760148|P1|Overall Study|Adverse Event|0
6004825|NCT00888849|20760164|P2|Overall Study|Lost to Follow-up|2
6004826|NCT00888849|20760165|P1|Overall Study|Lost to Follow-up|1
6004827|NCT00888849|20760164|P2|Overall Study|Death|7
6004828|NCT00888849|20760165|P1|Overall Study|Death|4
6004829|NCT00888654|20760175|P1|Overall Study|Stopped meds due to headaches|1
6004830|NCT00888654|20760175|P1|Overall Study|Change in surg date|1
6004831|NCT00888654|20760175|P1|Overall Study|Inelig. due to contraindication of med|1
6004832|NCT00888654|20760175|P1|Overall Study|Withdrawal by Subject|1
6004833|NCT00888654|20760175|P1|Overall Study|Surgery aborted|2
6004834|NCT00888654|20760175|P1|Overall Study|Not enough oral meds before surgery|3
6004835|NCT00888654|20760175|P1|Overall Study|Problems swallowing oral meds.|1
6004836|NCT00888615|20760193|P1|Overall Study|No treatment|2
6004837|NCT00888433|20760217|P2|Overall Study|Missed Visit|1
6004838|NCT00888433|20760218|P1|Overall Study|Missed Visit|2
6004839|NCT00888433|20760217|P2|Overall Study|Withdrawal by Subject|2
6004840|NCT00888433|20760218|P1|Overall Study|Withdrawal by Subject|1
6004841|NCT00888381|20760226|P2|Overall Study|Lost to Follow-up|1
6004842|NCT00888381|20760227|P1|Overall Study|Lost to Follow-up|0
6004843|NCT00888355|20760247|P4|Overall Study|Withdrawal by Subject|3
6004844|NCT00888355|20760248|P3|Overall Study|Withdrawal by Subject|1
6004845|NCT00888355|20760249|P2|Overall Study|Withdrawal by Subject|3
6004846|NCT00888355|20760250|P1|Overall Study|Withdrawal by Subject|0
6004847|NCT00888355|20760247|P4|Overall Study|Protocol Violation|2
6004848|NCT00888355|20760248|P3|Overall Study|Protocol Violation|1
6004849|NCT00888355|20760249|P2|Overall Study|Protocol Violation|2
6004850|NCT00888355|20760250|P1|Overall Study|Protocol Violation|3
6004851|NCT00888355|20760247|P4|Overall Study|Lost to Follow-up|0
6004852|NCT00888355|20760248|P3|Overall Study|Lost to Follow-up|2
6004853|NCT00888355|20760249|P2|Overall Study|Lost to Follow-up|2
6004854|NCT00888355|20760250|P1|Overall Study|Lost to Follow-up|0
6004855|NCT00888355|20760247|P4|Overall Study|Lack of Efficacy|2
6004856|NCT00888355|20760248|P3|Overall Study|Lack of Efficacy|5
6004857|NCT00888355|20760249|P2|Overall Study|Lack of Efficacy|2
6004858|NCT00888355|20760250|P1|Overall Study|Lack of Efficacy|9
6004859|NCT00888355|20760247|P4|Overall Study|Adverse Event|3
6004860|NCT00888355|20760248|P3|Overall Study|Adverse Event|3
6004861|NCT00888355|20760249|P2|Overall Study|Adverse Event|0
6004862|NCT00888355|20760250|P1|Overall Study|Adverse Event|10
6004863|NCT00888329|20760306|P2|Overall Study|Physician Decision|9
6004864|NCT00888329|20760307|P1|Overall Study|Physician Decision|6
6004865|NCT00888238|20760313|P3|Washout Period After Period 2|Adverse Event|1
6004866|NCT00888238|20760314|P2|Washout Period After Period 2|Adverse Event|0
6004867|NCT00888238|20760315|P1|Washout Period After Period 2|Adverse Event|0
6004868|NCT00888173|20760323|P1|Overall Study|Ineligible: required test not done|1
6004869|NCT00888173|20760323|P1|Overall Study|Wrong Primary|1
6004870|NCT00888134|20760331|P1|Follow-up|being followed for long-term survival|1
6004871|NCT00888134|20760331|P1|Treatment With Study Drug|Withdrawal by Subject|1
6004872|NCT00887978|20760341|P2|Overall Study|Lost to Follow-up|1
6004873|NCT00887978|20760342|P1|Overall Study|Lost to Follow-up|0
6004874|NCT00887978|20760341|P2|Overall Study|Withdrawal by Subject|2
6004875|NCT00887978|20760342|P1|Overall Study|Withdrawal by Subject|1
6004876|NCT00887978|20760341|P2|Overall Study|Death|3
6004877|NCT00887978|20760342|P1|Overall Study|Death|2
6004878|NCT00887978|20760341|P2|Overall Study|Clinical Worsening|4
6004879|NCT00887978|20760342|P1|Overall Study|Clinical Worsening|4
6004880|NCT00887978|20760341|P2|Overall Study|Adverse Event|5
6004881|NCT00887978|20760342|P1|Overall Study|Adverse Event|18
6004882|NCT00887926|20760412|P4|Overall Study|Withdrawal by Subject|0
6004883|NCT00887926|20760413|P3|Overall Study|Withdrawal by Subject|0
6004884|NCT00887926|20760414|P2|Overall Study|Withdrawal by Subject|1
6004885|NCT00887926|20760415|P1|Overall Study|Withdrawal by Subject|0
6004886|NCT00887913|20760450|P1|Overall Study|Withdrawal by Subject|6
6004887|NCT00887822|20760458|P2|Overall Study|Randomized but not treated|1
6004888|NCT00887822|20760459|P1|Overall Study|Randomized but not treated|0
6004889|NCT00887822|20760458|P2|Overall Study|Protocol Violation|1
6004890|NCT00887822|20760459|P1|Overall Study|Protocol Violation|0
6004891|NCT00887822|20760458|P2|Overall Study|Death|3
6004892|NCT00887822|20760459|P1|Overall Study|Death|2
6004893|NCT00887822|20760458|P2|Overall Study|Administrative/Other than specified|4
6004894|NCT00887822|20760459|P1|Overall Study|Administrative/Other than specified|5
6004895|NCT00887822|20760458|P2|Overall Study|Refused treatment/Did not cooperate|10
6004896|NCT00887822|20760459|P1|Overall Study|Refused treatment/Did not cooperate|12
6004897|NCT00887822|20760458|P2|Overall Study|Failure to return|11
6004898|NCT00887822|20760459|P1|Overall Study|Failure to return|11
6004899|NCT00887822|20760458|P2|Overall Study|Adverse Event|17
6004900|NCT00887822|20760459|P1|Overall Study|Adverse Event|14
6004901|NCT00887822|20760458|P2|Overall Study|Insufficient therapeutic response|55
6004902|NCT00887822|20760459|P1|Overall Study|Insufficient therapeutic response|53
6004903|NCT00887809|20760491|P2|Overall Study|Death|0
6004904|NCT00887809|20760492|P1|Overall Study|Death|1
6004905|NCT00887809|20760491|P2|Overall Study|Patient Not Treated|0
6004906|NCT00887809|20760492|P1|Overall Study|Patient Not Treated|3
6004907|NCT00887744|20760513|P1|Overall Study|Various reasons|9
6004908|NCT00887744|20760513|P1|Overall Study|Withdrawal by Subject|18
6004909|NCT00887744|20760513|P1|Overall Study|Lost to Follow-up|3
6004910|NCT00887744|20760513|P1|Overall Study|Death|1
6004911|NCT00887744|20760513|P1|Overall Study|Adverse Event|3
6004912|NCT00887679|20760522|P1|Overall Study|Physician Decision|5
6004913|NCT00887679|20760522|P1|Overall Study|Lost to Follow-up|4
6004914|NCT00887679|20760522|P1|Overall Study|Withdrawal by Subject|1
6004915|NCT00887588|20760552|P2|Extension Period|Lost to Follow-up|0
6004916|NCT00887588|20760553|P1|Extension Period|Lost to Follow-up|1
6004917|NCT00887588|20760552|P2|Extension Period|Protocol deviation|0
6004918|NCT00887588|20760553|P1|Extension Period|Protocol deviation|1
6004919|NCT00887588|20760552|P2|Extension Period|Death|1
6004920|NCT00887588|20760553|P1|Extension Period|Death|0
6004921|NCT00887588|20760552|P2|Extension Period|Adverse Event|4
6004922|NCT00887588|20760553|P1|Extension Period|Adverse Event|4
6004923|NCT00887588|20760552|P2|Core Period|Adverse Event|11
6004924|NCT00887588|20760553|P1|Core Period|Adverse Event|9
6004925|NCT00887588|20760552|P2|Core Period|Withdrawal by Subject|8
6004926|NCT00887588|20760553|P1|Core Period|Withdrawal by Subject|6
6004927|NCT00887588|20760552|P2|Core Period|Lost to Follow-up|1
6004928|NCT00887588|20760553|P1|Core Period|Lost to Follow-up|3
6004929|NCT00887588|20760552|P2|Core Period|Death|1
6004930|NCT00887588|20760553|P1|Core Period|Death|1
6004931|NCT00887549|20760634|P1|Maintenance Therapy|Death due to adverse event|1
6004932|NCT00887549|20760634|P1|Maintenance Therapy|Progressive Disease|25
6004933|NCT00887549|20760634|P1|Maintenance Therapy|Physician Decision|1
6004934|NCT00887549|20760634|P1|Maintenance Therapy|Adverse Event|16
6004935|NCT00887549|20760634|P1|Induction Therapy|Death due to Study Drug Toxicity|1
6004936|NCT00887549|20760634|P1|Induction Therapy|Death due to Study Disease|4
6004937|NCT00887549|20760634|P1|Induction Therapy|Progressive Disease|13
6004938|NCT00887549|20760634|P1|Induction Therapy|Physician Decision|1
6004939|NCT00887549|20760634|P1|Induction Therapy|Adverse Event|8
6004940|NCT00887484|20760652|P1|Full Face Treatment (Weeks 5 and 8)|Pregnancy|1
6004941|NCT00887484|20760652|P1|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1
6004942|NCT00887484|20760652|P1|Full Face Treatment (Weeks 5 and 8)|Adverse Event|1
6004943|NCT00887354|20760740|P2|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1
6004944|NCT00887354|20760741|P1|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1
6004945|NCT00887354|20760740|P2|Open Label Phase (Week 26 to Week 78)|Adverse Event|0
6004946|NCT00887354|20760741|P1|Open Label Phase (Week 26 to Week 78)|Adverse Event|1
6004947|NCT00887354|20760740|P2|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|2
6004948|NCT00887354|20760741|P1|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|1
6004949|NCT00887354|20760740|P2|Open Label Phase (Week 26 to Week 78)|Physician Decision|1
6004950|NCT00887354|20760741|P1|Open Label Phase (Week 26 to Week 78)|Physician Decision|0
6004951|NCT00887354|20760740|P2|Open Label Phase (Week 26 to Week 78)|Death|2
6004952|NCT00887354|20760741|P1|Open Label Phase (Week 26 to Week 78)|Death|0
6004953|NCT00887354|20760740|P2|Treatment Phase (Week 0 to Week 26)|Not Treated|3
6004954|NCT00887354|20760741|P1|Treatment Phase (Week 0 to Week 26)|Not Treated|5
6004955|NCT00887354|20760740|P2|Treatment Phase (Week 0 to Week 26)|No efficacy data|25
6004956|NCT00887354|20760741|P1|Treatment Phase (Week 0 to Week 26)|No efficacy data|20
6004957|NCT00887354|20760740|P2|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|2
6004958|NCT00887354|20760741|P1|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|1
6004959|NCT00887354|20760740|P2|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3
6004960|NCT00887354|20760741|P1|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3
6004961|NCT00887354|20760740|P2|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|1
6004962|NCT00887354|20760741|P1|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|2
6004963|NCT00887354|20760740|P2|Treatment Phase (Week 0 to Week 26)|Adverse Event|3
6004964|NCT00887354|20760741|P1|Treatment Phase (Week 0 to Week 26)|Adverse Event|3
6004965|NCT00887354|20760740|P2|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|8
6004966|NCT00887354|20760741|P1|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|14
6004967|NCT00887354|20760740|P2|Treatment Phase (Week 0 to Week 26)|Physician Decision|1
6004968|NCT00887354|20760741|P1|Treatment Phase (Week 0 to Week 26)|Physician Decision|2
6004969|NCT00887354|20760740|P2|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1
6004970|NCT00887354|20760741|P1|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1
6004971|NCT00887354|20760740|P2|Treatment Phase (Week 0 to Week 26)|Death|1
6004972|NCT00887354|20760741|P1|Treatment Phase (Week 0 to Week 26)|Death|0
6004973|NCT00887341|20760761|P2|Overall Study|Lost to Follow-up|1
6004974|NCT00887341|20760762|P1|Overall Study|Lost to Follow-up|0
6004975|NCT00887341|20760761|P2|Overall Study|Adverse Event|1
6004976|NCT00887341|20760762|P1|Overall Study|Adverse Event|0
6004977|NCT00887341|20760761|P2|Overall Study|Withdrawal by Subject|1
6004978|NCT00887341|20760762|P1|Overall Study|Withdrawal by Subject|1
6004979|NCT00887341|20760761|P2|Overall Study|Refused treatment|0
6004980|NCT00887341|20760762|P1|Overall Study|Refused treatment|1
6004981|NCT00887315|20760798|P2|Overall Study|Study termination|4
6004982|NCT00887315|20760799|P1|Overall Study|Study termination|7
6004983|NCT00887289|20760807|P1|Overall Study|Other|20
6004984|NCT00887289|20760807|P1|Overall Study|Lost to Follow-up|8
6004985|NCT00887289|20760807|P1|Overall Study|Withdrawal by Subject|26
6004986|NCT00887289|20760807|P1|Overall Study|Adverse Event|27
6004987|NCT00887289|20760807|P1|Overall Study|Lack of Efficacy|14
6004988|NCT00887250|20760819|P3|Overall Study|Patient uncooperative|1
6004989|NCT00887250|20760820|P2|Overall Study|Patient uncooperative|0
6004990|NCT00887250|20760821|P1|Overall Study|Patient uncooperative|0
6004991|NCT00887250|20760819|P3|Overall Study|Withdrawal by Subject|2
6004992|NCT00887250|20760820|P2|Overall Study|Withdrawal by Subject|1
6004993|NCT00887250|20760821|P1|Overall Study|Withdrawal by Subject|2
6004994|NCT00887250|20760819|P3|Overall Study|Protocol Violation|1
6004995|NCT00887250|20760820|P2|Overall Study|Protocol Violation|2
6004996|NCT00887250|20760821|P1|Overall Study|Protocol Violation|2
6004997|NCT00887250|20760819|P3|Overall Study|Lost to Follow-up|1
6004998|NCT00887250|20760820|P2|Overall Study|Lost to Follow-up|3
6004999|NCT00887250|20760821|P1|Overall Study|Lost to Follow-up|2
6005000|NCT00887250|20760819|P3|Overall Study|Lack of Efficacy|1
6005001|NCT00887250|20760820|P2|Overall Study|Lack of Efficacy|6
6005002|NCT00887250|20760821|P1|Overall Study|Lack of Efficacy|9
6005003|NCT00887250|20760819|P3|Overall Study|Adverse Event|7
6005004|NCT00887250|20760820|P2|Overall Study|Adverse Event|0
6005005|NCT00887250|20760821|P1|Overall Study|Adverse Event|3
6005006|NCT00887224|20760844|P3|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|11
6005007|NCT00887224|20760845|P2|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|8
6005008|NCT00887224|20760846|P1|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|0
6005009|NCT00887224|20760844|P3|DB Taper Phase / Post Study Follow Up|Protocol Violation|1
6005010|NCT00887224|20760845|P2|DB Taper Phase / Post Study Follow Up|Protocol Violation|4
6005011|NCT00887224|20760846|P1|DB Taper Phase / Post Study Follow Up|Protocol Violation|0
6005012|NCT00887224|20760844|P3|DB Taper Phase / Post Study Follow Up|Other|12
6005013|NCT00887224|20760845|P2|DB Taper Phase / Post Study Follow Up|Other|11
6005014|NCT00887224|20760846|P1|DB Taper Phase / Post Study Follow Up|Other|0
6005015|NCT00887224|20760844|P3|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2
6005016|NCT00887224|20760845|P2|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2
6005017|NCT00887224|20760846|P1|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|0
6005018|NCT00887224|20760844|P3|DB Taper Phase / Post Study Follow Up|Physician Decision|0
6005019|NCT00887224|20760845|P2|DB Taper Phase / Post Study Follow Up|Physician Decision|6
6005020|NCT00887224|20760846|P1|DB Taper Phase / Post Study Follow Up|Physician Decision|0
6005021|NCT00887224|20760844|P3|DB Taper Phase / Post Study Follow Up|Failed to return|4
6005022|NCT00887224|20760845|P2|DB Taper Phase / Post Study Follow Up|Failed to return|5
6005023|NCT00887224|20760846|P1|DB Taper Phase / Post Study Follow Up|Failed to return|0
6005024|NCT00887224|20760844|P3|DB Taper Phase / Post Study Follow Up|Adverse Event|0
6005025|NCT00887224|20760845|P2|DB Taper Phase / Post Study Follow Up|Adverse Event|5
6005026|NCT00887224|20760846|P1|DB Taper Phase / Post Study Follow Up|Adverse Event|0
6005027|NCT00887224|20760844|P3|Double-blind (DB) Phase|Withdrawal by Subject|12
6005028|NCT00887224|20760845|P2|Double-blind (DB) Phase|Withdrawal by Subject|6
6005029|NCT00887224|20760846|P1|Double-blind (DB) Phase|Withdrawal by Subject|0
6005030|NCT00887224|20760844|P3|Double-blind (DB) Phase|Protocol Violation|5
6005031|NCT00887224|20760845|P2|Double-blind (DB) Phase|Protocol Violation|8
6005032|NCT00887224|20760846|P1|Double-blind (DB) Phase|Protocol Violation|0
6005033|NCT00887224|20760844|P3|Double-blind (DB) Phase|Other|0
6005034|NCT00887224|20760845|P2|Double-blind (DB) Phase|Other|2
6005035|NCT00887224|20760846|P1|Double-blind (DB) Phase|Other|0
6005036|NCT00887224|20760844|P3|Double-blind (DB) Phase|Lost to Follow-up|8
6005037|NCT00887224|20760845|P2|Double-blind (DB) Phase|Lost to Follow-up|8
6005038|NCT00887224|20760846|P1|Double-blind (DB) Phase|Lost to Follow-up|0
6005039|NCT00887224|20760844|P3|Double-blind (DB) Phase|Lack of Efficacy|33
6005040|NCT00887224|20760845|P2|Double-blind (DB) Phase|Lack of Efficacy|67
6005041|NCT00887224|20760846|P1|Double-blind (DB) Phase|Lack of Efficacy|0
6005042|NCT00887224|20760844|P3|Double-blind (DB) Phase|Failed to return|2
6005043|NCT00887224|20760845|P2|Double-blind (DB) Phase|Failed to return|2
6005044|NCT00887224|20760846|P1|Double-blind (DB) Phase|Failed to return|0
6005045|NCT00887224|20760844|P3|Double-blind (DB) Phase|Adverse Event|2
6005046|NCT00887224|20760845|P2|Double-blind (DB) Phase|Adverse Event|7
6005047|NCT00887224|20760846|P1|Double-blind (DB) Phase|Adverse Event|0
6005048|NCT00887224|20760844|P3|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0
6005049|NCT00887224|20760845|P2|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0
6005050|NCT00887224|20760846|P1|OL Taper Phase / OL Follow Up|Withdrawal by Subject|48
6005051|NCT00887224|20760844|P3|OL Taper Phase / OL Follow Up|Protocol Violation|0
6005052|NCT00887224|20760845|P2|OL Taper Phase / OL Follow Up|Protocol Violation|0
6005053|NCT00887224|20760846|P1|OL Taper Phase / OL Follow Up|Protocol Violation|3
6005054|NCT00887224|20760844|P3|OL Taper Phase / OL Follow Up|Other|0
6005055|NCT00887224|20760845|P2|OL Taper Phase / OL Follow Up|Other|0
6005056|NCT00887224|20760846|P1|OL Taper Phase / OL Follow Up|Other|30
6005057|NCT00887224|20760844|P3|OL Taper Phase / OL Follow Up|Lost to Follow-up|0
6005058|NCT00887224|20760845|P2|OL Taper Phase / OL Follow Up|Lost to Follow-up|0
6005059|NCT00887224|20760846|P1|OL Taper Phase / OL Follow Up|Lost to Follow-up|8
6005060|NCT00887224|20760844|P3|OL Taper Phase / OL Follow Up|Physician Decision|0
6005061|NCT00887224|20760845|P2|OL Taper Phase / OL Follow Up|Physician Decision|0
6005062|NCT00887224|20760846|P1|OL Taper Phase / OL Follow Up|Physician Decision|10
6005063|NCT00887224|20760844|P3|OL Taper Phase / OL Follow Up|Failed to return|0
6005064|NCT00887224|20760845|P2|OL Taper Phase / OL Follow Up|Failed to return|0
6005065|NCT00887224|20760846|P1|OL Taper Phase / OL Follow Up|Failed to return|17
6005066|NCT00887224|20760844|P3|OL Taper Phase / OL Follow Up|Adverse Event|0
6005067|NCT00887224|20760845|P2|OL Taper Phase / OL Follow Up|Adverse Event|0
6005068|NCT00887224|20760846|P1|OL Taper Phase / OL Follow Up|Adverse Event|28
6005069|NCT00887224|20760844|P3|Open-label Stability (OLS) Phase|Withdrawal by Subject|0
6005070|NCT00887224|20760845|P2|Open-label Stability (OLS) Phase|Withdrawal by Subject|0
6005071|NCT00887224|20760846|P1|Open-label Stability (OLS) Phase|Withdrawal by Subject|19
6005072|NCT00887224|20760844|P3|Open-label Stability (OLS) Phase|Protocol Violation|0
6005073|NCT00887224|20760845|P2|Open-label Stability (OLS) Phase|Protocol Violation|0
6005074|NCT00887224|20760846|P1|Open-label Stability (OLS) Phase|Protocol Violation|13
6005075|NCT00887224|20760844|P3|Open-label Stability (OLS) Phase|Other|0
6005076|NCT00887224|20760845|P2|Open-label Stability (OLS) Phase|Other|0
6005077|NCT00887224|20760846|P1|Open-label Stability (OLS) Phase|Other|1
6005078|NCT00887224|20760844|P3|Open-label Stability (OLS) Phase|Lost to Follow-up|0
6005079|NCT00887224|20760845|P2|Open-label Stability (OLS) Phase|Lost to Follow-up|0
6005080|NCT00887224|20760846|P1|Open-label Stability (OLS) Phase|Lost to Follow-up|9
6005081|NCT00887224|20760844|P3|Open-label Stability (OLS) Phase|Lack of Efficacy|0
6005082|NCT00887224|20760845|P2|Open-label Stability (OLS) Phase|Lack of Efficacy|0
6005083|NCT00887224|20760846|P1|Open-label Stability (OLS) Phase|Lack of Efficacy|16
6005084|NCT00887224|20760844|P3|Open-label Stability (OLS) Phase|Failed to return|0
6005085|NCT00887224|20760845|P2|Open-label Stability (OLS) Phase|Failed to return|0
6005086|NCT00887224|20760846|P1|Open-label Stability (OLS) Phase|Failed to return|3
6005087|NCT00887224|20760844|P3|Open-label Stability (OLS) Phase|Adverse Event|0
6005088|NCT00887224|20760845|P2|Open-label Stability (OLS) Phase|Adverse Event|0
6005089|NCT00887224|20760846|P1|Open-label Stability (OLS) Phase|Adverse Event|22
6005090|NCT00887224|20760844|P3|Open-label Response (OLR) Phase|Withdrawal by Subject|0
6005091|NCT00887224|20760845|P2|Open-label Response (OLR) Phase|Withdrawal by Subject|0
6005092|NCT00887224|20760846|P1|Open-label Response (OLR) Phase|Withdrawal by Subject|15
6005093|NCT00887224|20760844|P3|Open-label Response (OLR) Phase|Protocol Violation|0
6005094|NCT00887224|20760845|P2|Open-label Response (OLR) Phase|Protocol Violation|0
6005095|NCT00887224|20760846|P1|Open-label Response (OLR) Phase|Protocol Violation|12
6005096|NCT00887224|20760844|P3|Open-label Response (OLR) Phase|Other|0
6005097|NCT00887224|20760845|P2|Open-label Response (OLR) Phase|Other|0
6005098|NCT00887224|20760846|P1|Open-label Response (OLR) Phase|Other|1
6005099|NCT00887224|20760844|P3|Open-label Response (OLR) Phase|Lost to Follow-up|0
6005100|NCT00887224|20760845|P2|Open-label Response (OLR) Phase|Lost to Follow-up|0
6005101|NCT00887224|20760846|P1|Open-label Response (OLR) Phase|Lost to Follow-up|16
6005102|NCT00887224|20760844|P3|Open-label Response (OLR) Phase|Lack of Efficacy|0
6005103|NCT00887224|20760845|P2|Open-label Response (OLR) Phase|Lack of Efficacy|0
6005104|NCT00887224|20760846|P1|Open-label Response (OLR) Phase|Lack of Efficacy|26
6005105|NCT00887224|20760844|P3|Open-label Response (OLR) Phase|Failed to return|0
6005106|NCT00887224|20760845|P2|Open-label Response (OLR) Phase|Failed to return|0
6005107|NCT00887224|20760846|P1|Open-label Response (OLR) Phase|Failed to return|6
6005108|NCT00887224|20760844|P3|Open-label Response (OLR) Phase|Adverse Event|0
6005109|NCT00887224|20760845|P2|Open-label Response (OLR) Phase|Adverse Event|0
6005110|NCT00887224|20760846|P1|Open-label Response (OLR) Phase|Adverse Event|46
6005111|NCT00887198|20760873|P3|Cross Over (Placebo to AA)|Other|19
6005112|NCT00887198|20760874|P2|Cross Over (Placebo to AA)|Other|0
6005113|NCT00887198|20760875|P1|Cross Over (Placebo to AA)|Other|0
6005114|NCT00887198|20760873|P3|Cross Over (Placebo to AA)|Progressive disease|20
6005115|NCT00887198|20760874|P2|Cross Over (Placebo to AA)|Progressive disease|0
6005116|NCT00887198|20760875|P1|Cross Over (Placebo to AA)|Progressive disease|0
6005117|NCT00887198|20760873|P3|Cross Over (Placebo to AA)|Withdrawal by Subject|2
6005118|NCT00887198|20760874|P2|Cross Over (Placebo to AA)|Withdrawal by Subject|0
6005119|NCT00887198|20760875|P1|Cross Over (Placebo to AA)|Withdrawal by Subject|0
6005120|NCT00887198|20760873|P3|Cross Over (Placebo to AA)|Adverse Event|9
6005121|NCT00887198|20760874|P2|Cross Over (Placebo to AA)|Adverse Event|0
6005122|NCT00887198|20760875|P1|Cross Over (Placebo to AA)|Adverse Event|0
6005123|NCT00887198|20760873|P3|Cross Over (Placebo to AA)|Ongoing|35
6005124|NCT00887198|20760874|P2|Cross Over (Placebo to AA)|Ongoing|0
6005125|NCT00887198|20760875|P1|Cross Over (Placebo to AA)|Ongoing|0
6005126|NCT00887198|20760873|P3|Cross Over (Placebo to AA)|Started other prostate cancer treatment|8
6005127|NCT00887198|20760874|P2|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0
6005128|NCT00887198|20760875|P1|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0
6005129|NCT00887198|20760873|P3|Randomized Period|Randomized, Not treated|0
6005130|NCT00887198|20760874|P2|Randomized Period|Randomized, Not treated|2
6005131|NCT00887198|20760875|P1|Randomized Period|Randomized, Not treated|4
6005132|NCT00887198|20760873|P3|Randomized Period|Other|0
6005133|NCT00887198|20760874|P2|Randomized Period|Other|30
6005134|NCT00887198|20760875|P1|Randomized Period|Other|42
6005135|NCT00887198|20760873|P3|Randomized Period|Progressive disease|0
6005136|NCT00887198|20760874|P2|Randomized Period|Progressive disease|370
6005137|NCT00887198|20760875|P1|Randomized Period|Progressive disease|366
6005138|NCT00887198|20760873|P3|Randomized Period|Withdrawal by Subject|0
6005139|NCT00887198|20760874|P2|Randomized Period|Withdrawal by Subject|56
6005140|NCT00887198|20760875|P1|Randomized Period|Withdrawal by Subject|41
6005141|NCT00887198|20760873|P3|Randomized Period|Cross-over to AA (under amendment 3)|0
6005142|NCT00887198|20760874|P2|Randomized Period|Cross-over to AA (under amendment 3)|51
6005143|NCT00887198|20760875|P1|Randomized Period|Cross-over to AA (under amendment 3)|0
6005144|NCT00887198|20760873|P3|Randomized Period|Lost to Follow-up|0
6005145|NCT00887198|20760874|P2|Randomized Period|Lost to Follow-up|0
6005146|NCT00887198|20760875|P1|Randomized Period|Lost to Follow-up|1
6005147|NCT00887198|20760873|P3|Randomized Period|Adverse Event|0
6005148|NCT00887198|20760874|P2|Randomized Period|Adverse Event|33
6005149|NCT00887198|20760875|P1|Randomized Period|Adverse Event|50
6005150|NCT00887198|20760873|P3|Randomized Period|Ongoing|0
6005151|NCT00887198|20760874|P2|Randomized Period|Ongoing|0
6005152|NCT00887198|20760875|P1|Randomized Period|Ongoing|42
6005153|NCT00887159|20760906|P3|Overall Study|Never started assigned therapy|4
6005154|NCT00887159|20760907|P2|Overall Study|Never started assigned therapy|3
6005155|NCT00887159|20760908|P1|Overall Study|Never started assigned therapy|3
6005156|NCT00887159|20760906|P3|Overall Study|Ineligible|0
6005157|NCT00887159|20760907|P2|Overall Study|Ineligible|1
6005158|NCT00887159|20760908|P1|Overall Study|Ineligible|5
6005159|NCT00887159|20760906|P3|Overall Study|Received more tx instead of observation|0
6005160|NCT00887159|20760907|P2|Overall Study|Received more tx instead of observation|0
6005161|NCT00887159|20760908|P1|Overall Study|Received more tx instead of observation|1
6005162|NCT00887159|20760906|P3|Overall Study|Pt had PD but was SD when re-measured|0
6005163|NCT00887159|20760907|P2|Overall Study|Pt had PD but was SD when re-measured|1
6005164|NCT00887159|20760908|P1|Overall Study|Pt had PD but was SD when re-measured|0
6005165|NCT00887159|20760906|P3|Overall Study|Treatment delayed|0
6005166|NCT00887159|20760907|P2|Overall Study|Treatment delayed|1
6005167|NCT00887159|20760908|P1|Overall Study|Treatment delayed|1
6005168|NCT00887159|20760906|P3|Overall Study|Sympomatic deterioration|0
6005169|NCT00887159|20760907|P2|Overall Study|Sympomatic deterioration|0
6005170|NCT00887159|20760908|P1|Overall Study|Sympomatic deterioration|1
6005171|NCT00887159|20760906|P3|Overall Study|Physician Decision|0
6005172|NCT00887159|20760907|P2|Overall Study|Physician Decision|1
6005173|NCT00887159|20760908|P1|Overall Study|Physician Decision|1
6005174|NCT00887159|20760906|P3|Overall Study|Alternative therapy|0
6005175|NCT00887159|20760907|P2|Overall Study|Alternative therapy|0
6005176|NCT00887159|20760908|P1|Overall Study|Alternative therapy|2
6005177|NCT00887159|20760906|P3|Overall Study|Withdrawal by Subject|2
6005178|NCT00887159|20760907|P2|Overall Study|Withdrawal by Subject|4
6005179|NCT00887159|20760908|P1|Overall Study|Withdrawal by Subject|4
6005180|NCT00887159|20760906|P3|Overall Study|Death|0
6005181|NCT00887159|20760907|P2|Overall Study|Death|2
6005182|NCT00887159|20760908|P1|Overall Study|Death|2
6005183|NCT00887159|20760906|P3|Overall Study|Adverse Event|17
6005184|NCT00887159|20760907|P2|Overall Study|Adverse Event|4
6005185|NCT00887159|20760908|P1|Overall Study|Adverse Event|3
6005186|NCT00887159|20760906|P3|Overall Study|Disease progression|33
6005187|NCT00887159|20760907|P2|Overall Study|Disease progression|39
6005188|NCT00887159|20760908|P1|Overall Study|Disease progression|6
6005189|NCT00887068|20760926|P2|Overall Study|Didn't meet eligibility to start cycle 1|0
6005190|NCT00887068|20760927|P1|Overall Study|Didn't meet eligibility to start cycle 1|4
6005191|NCT00887068|20760926|P2|Overall Study|Withdrawal by Subject|0
6005192|NCT00887068|20760927|P1|Overall Study|Withdrawal by Subject|2
6005193|NCT00886938|20760935|P1|Overall Study|Withdrawal by Subject|1
6005194|NCT00886938|20760935|P1|Overall Study|Adverse Event|1
6005195|NCT00886834|20760948|P2|Overall Study|Protocol Violation|3
6005196|NCT00886834|20760949|P1|Overall Study|Protocol Violation|0
6005197|NCT00886821|20760971|P14|Stage 2|Lost to Follow-up|1
6005198|NCT00886821|20760972|P13|Stage 2|Lost to Follow-up|2
6005199|NCT00886821|20760973|P12|Stage 2|Lost to Follow-up|0
6005200|NCT00886821|20760974|P11|Stage 2|Lost to Follow-up|0
6005201|NCT00886821|20760975|P10|Stage 2|Lost to Follow-up|0
6005202|NCT00886821|20760976|P9|Stage 2|Lost to Follow-up|0
6005203|NCT00886821|20760977|P8|Stage 2|Lost to Follow-up|0
6005204|NCT00886821|20760978|P7|Stage 2|Lost to Follow-up|0
6005205|NCT00886821|20760979|P6|Stage 2|Lost to Follow-up|0
6005206|NCT00886821|20760980|P5|Stage 2|Lost to Follow-up|0
6005207|NCT00886821|20760981|P4|Stage 2|Lost to Follow-up|0
6005208|NCT00886821|20760982|P3|Stage 2|Lost to Follow-up|0
6005209|NCT00886821|20760983|P2|Stage 2|Lost to Follow-up|0
6005210|NCT00886821|20760984|P1|Stage 2|Lost to Follow-up|0
6005211|NCT00886821|20760971|P14|Stage 2|Adverse Event|0
6005212|NCT00886821|20760972|P13|Stage 2|Adverse Event|3
6005213|NCT00886821|20760973|P12|Stage 2|Adverse Event|1
6005214|NCT00886821|20760974|P11|Stage 2|Adverse Event|0
6005215|NCT00886821|20760975|P10|Stage 2|Adverse Event|0
6005216|NCT00886821|20760976|P9|Stage 2|Adverse Event|0
6005217|NCT00886821|20760977|P8|Stage 2|Adverse Event|0
6005218|NCT00886821|20760978|P7|Stage 2|Adverse Event|0
6005219|NCT00886821|20760979|P6|Stage 2|Adverse Event|0
6005220|NCT00886821|20760980|P5|Stage 2|Adverse Event|0
6005221|NCT00886821|20760981|P4|Stage 2|Adverse Event|0
6005222|NCT00886821|20760982|P3|Stage 2|Adverse Event|0
6005223|NCT00886821|20760983|P2|Stage 2|Adverse Event|0
6005224|NCT00886821|20760984|P1|Stage 2|Adverse Event|0
6005225|NCT00886795|20761209|P1|Overall Study|Lack of Efficacy|1
6005226|NCT00886769|20761216|P2|Overall Study|Unsatisfactory therapeutic effect|37
6005227|NCT00886769|20761217|P1|Overall Study|Unsatisfactory therapeutic effect|6
6005228|NCT00886743|20761241|P1|Overall Study|Other|1
6005229|NCT00886743|20761241|P1|Overall Study|Adverse Event|3
6005230|NCT00886639|20761279|P1|Overall Study|non-compliance|2
6005231|NCT00886639|20761279|P1|Overall Study|acute exacerbation|14
6005232|NCT00886613|20761293|P3|Overall Study|Subject withdrew consent (Part A)|2
6005233|NCT00886613|20761294|P2|Overall Study|Subject withdrew consent (Part A)|0
6005234|NCT00886613|20761295|P1|Overall Study|Subject withdrew consent (Part A)|0
6005235|NCT00886613|20761293|P3|Overall Study|Lost to follow-up (Part B)|1
6005236|NCT00886613|20761294|P2|Overall Study|Lost to follow-up (Part B)|0
6005237|NCT00886613|20761295|P1|Overall Study|Lost to follow-up (Part B)|1
6005238|NCT00886613|20761293|P3|Overall Study|Protocol deviation (Part B)|0
6005239|NCT00886613|20761294|P2|Overall Study|Protocol deviation (Part B)|0
6005240|NCT00886613|20761295|P1|Overall Study|Protocol deviation (Part B)|1
6005241|NCT00886600|20761317|P4|Combination Therapy Period|Protocol Violation|0
6005242|NCT00886600|20761318|P3|Combination Therapy Period|Protocol Violation|1
6005243|NCT00886600|20761319|P2|Combination Therapy Period|Protocol Violation|0
6005244|NCT00886600|20761320|P1|Combination Therapy Period|Protocol Violation|0
6005245|NCT00886600|20761317|P4|Combination Therapy Period|Adverse Event|0
6005246|NCT00886600|20761318|P3|Combination Therapy Period|Adverse Event|1
6005247|NCT00886600|20761319|P2|Combination Therapy Period|Adverse Event|0
6005248|NCT00886600|20761320|P1|Combination Therapy Period|Adverse Event|0
6005249|NCT00886600|20761317|P4|Double-blind Monotherapy|Withdrawal by Subject|0
6005250|NCT00886600|20761318|P3|Double-blind Monotherapy|Withdrawal by Subject|0
6005251|NCT00886600|20761319|P2|Double-blind Monotherapy|Withdrawal by Subject|0
6005252|NCT00886600|20761320|P1|Double-blind Monotherapy|Withdrawal by Subject|1
6005253|NCT00886600|20761317|P4|Double-blind Monotherapy|Protocol Violation|1
6005254|NCT00886600|20761318|P3|Double-blind Monotherapy|Protocol Violation|0
6005255|NCT00886600|20761319|P2|Double-blind Monotherapy|Protocol Violation|0
6005256|NCT00886600|20761320|P1|Double-blind Monotherapy|Protocol Violation|0
6005257|NCT00886600|20761317|P4|Double-blind Monotherapy|Adverse Event|1
6005258|NCT00886600|20761318|P3|Double-blind Monotherapy|Adverse Event|1
6005259|NCT00886600|20761319|P2|Double-blind Monotherapy|Adverse Event|1
6005260|NCT00886600|20761320|P1|Double-blind Monotherapy|Adverse Event|1
6005261|NCT00886587|20761344|P2|Overall Study|Withdrawal by Subject|1
6005262|NCT00886587|20761345|P1|Overall Study|Withdrawal by Subject|0
6005263|NCT00886587|20761344|P2|Overall Study|Protocol Violation|0
6005264|NCT00886587|20761345|P1|Overall Study|Protocol Violation|2
6005265|NCT00886587|20761344|P2|Overall Study|Adverse Event|1
6005266|NCT00886587|20761345|P1|Overall Study|Adverse Event|2
6005267|NCT00886483|20761359|P2|Overall Study|Distance to center, poor grades|0
6005268|NCT00886483|20761360|P1|Overall Study|Distance to center, poor grades|1
6005269|NCT00886483|20761359|P2|Overall Study|Pursue medications|2
6005270|NCT00886483|20761360|P1|Overall Study|Pursue medications|1
6005271|NCT00886483|20761359|P2|Overall Study|Lost to Follow-up|1
6005272|NCT00886483|20761360|P1|Overall Study|Lost to Follow-up|0
6005273|NCT00886340|20761378|P2|Overall Study|Withdrawal by Subject|7
6005274|NCT00886340|20761379|P1|Overall Study|Withdrawal by Subject|0
6005275|NCT00886288|20761387|P2|Overall Study|Lost to Follow-up|0
6005276|NCT00886288|20761388|P1|Overall Study|Lost to Follow-up|86
6005277|NCT00886288|20761387|P2|Overall Study|no respect of the 12 weeks period|227
6005278|NCT00886288|20761388|P1|Overall Study|no respect of the 12 weeks period|657
6005279|NCT00886119|20761444|P2|Period 1|Did not meet inclusion criteria|0
6005280|NCT00886119|20761445|P1|Period 1|Did not meet inclusion criteria|1
6005281|NCT00886015|20761453|P2|Overall Study|Death|2
6005282|NCT00886015|20761454|P1|Overall Study|Death|0
6005283|NCT00885846|20761473|P3|Overall Study|Withdrawal by Subject|2
6005284|NCT00885846|20761474|P2|Overall Study|Withdrawal by Subject|5
6005285|NCT00885846|20761475|P1|Overall Study|Withdrawal by Subject|2
6005286|NCT00885755|20761490|P3|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0
6005287|NCT00885755|20761491|P2|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0
6005288|NCT00885755|20761492|P1|Part II: Trastuzumab + Capecitabine.|Unknown Reason|5
6005289|NCT00885755|20761490|P3|Part I: Trastuzumab+Taxane|Death|1
6005290|NCT00885755|20761491|P2|Part I: Trastuzumab+Taxane|Death|0
6005291|NCT00885755|20761492|P1|Part I: Trastuzumab+Taxane|Death|0
6005292|NCT00885755|20761490|P3|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0
6005293|NCT00885755|20761491|P2|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0
6005294|NCT00885755|20761492|P1|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|1
6005295|NCT00885755|20761490|P3|Part I: Trastuzumab+Taxane|Unknown Reason|0
6005296|NCT00885755|20761491|P2|Part I: Trastuzumab+Taxane|Unknown Reason|0
6005297|NCT00885755|20761492|P1|Part I: Trastuzumab+Taxane|Unknown Reason|16
6005298|NCT00885755|20761490|P3|Part I: Trastuzumab+Taxane|Adverse Event|0
6005299|NCT00885755|20761491|P2|Part I: Trastuzumab+Taxane|Adverse Event|0
6005300|NCT00885755|20761492|P1|Part I: Trastuzumab+Taxane|Adverse Event|1
6005301|NCT00885703|20761535|P7|Overall Study|Ineligible (no CM)|1
6005302|NCT00885703|20761536|P6|Overall Study|Ineligible (no CM)|3
6005303|NCT00885703|20761537|P5|Overall Study|Ineligible (no CM)|2
6005304|NCT00885703|20761538|P4|Overall Study|Ineligible (no CM)|1
6005305|NCT00885703|20761539|P3|Overall Study|Ineligible (no CM)|2
6005306|NCT00885703|20761540|P2|Overall Study|Ineligible (no CM)|3
6005307|NCT00885703|20761541|P1|Overall Study|Ineligible (no CM)|1
6005308|NCT00885703|20761535|P7|Overall Study|Withdrawal by Subject|1
6005309|NCT00885703|20761536|P6|Overall Study|Withdrawal by Subject|1
6005310|NCT00885703|20761537|P5|Overall Study|Withdrawal by Subject|3
6005311|NCT00885703|20761538|P4|Overall Study|Withdrawal by Subject|1
6005312|NCT00885703|20761539|P3|Overall Study|Withdrawal by Subject|0
6005313|NCT00885703|20761540|P2|Overall Study|Withdrawal by Subject|0
6005314|NCT00885703|20761541|P1|Overall Study|Withdrawal by Subject|0
6005315|NCT00885703|20761535|P7|Overall Study|Lost to Follow-up|0
6005316|NCT00885703|20761536|P6|Overall Study|Lost to Follow-up|1
6005317|NCT00885703|20761537|P5|Overall Study|Lost to Follow-up|0
6005318|NCT00885703|20761538|P4|Overall Study|Lost to Follow-up|0
6005319|NCT00885703|20761539|P3|Overall Study|Lost to Follow-up|1
6005320|NCT00885703|20761540|P2|Overall Study|Lost to Follow-up|0
6005321|NCT00885703|20761541|P1|Overall Study|Lost to Follow-up|0
6005322|NCT00885703|20761535|P7|Overall Study|Death|4
6005323|NCT00885703|20761536|P6|Overall Study|Death|8
6005324|NCT00885703|20761537|P5|Overall Study|Death|7
6005325|NCT00885703|20761538|P4|Overall Study|Death|7
6005326|NCT00885703|20761539|P3|Overall Study|Death|8
6005327|NCT00885703|20761540|P2|Overall Study|Death|7
6005328|NCT00885703|20761541|P1|Overall Study|Death|9
6005329|NCT00885677|20761599|P2|Overall Study|Inclusion/exclusion not met|27
6005330|NCT00885677|20761600|P1|Overall Study|Inclusion/exclusion not met|25
6005331|NCT00885677|20761599|P2|Overall Study|Heart transplantation|0
6005332|NCT00885677|20761600|P1|Overall Study|Heart transplantation|1
6005333|NCT00885677|20761599|P2|Overall Study|device/lead revision or replacement|6
6005334|NCT00885677|20761600|P1|Overall Study|device/lead revision or replacement|7
6005335|NCT00885677|20761599|P2|Overall Study|premature study closure|44
6005336|NCT00885677|20761600|P1|Overall Study|premature study closure|41
6005337|NCT00885677|20761599|P2|Overall Study|Protocol Violation|54
6005338|NCT00885677|20761600|P1|Overall Study|Protocol Violation|54
6005339|NCT00885677|20761599|P2|Overall Study|Lost to Follow-up|13
6005340|NCT00885677|20761600|P1|Overall Study|Lost to Follow-up|15
6005341|NCT00885677|20761599|P2|Overall Study|Death|34
6005342|NCT00885677|20761600|P1|Overall Study|Death|40
6005343|NCT00885534|20761616|P1|Overall Study|Patient deemed ineligible|1
6005344|NCT00885482|20761620|P1|Overall Study|low Therapeutic drug monitoring (TDM)|1
6005345|NCT00885482|20761620|P1|Overall Study|Death|1
6005346|NCT00885482|20761620|P1|Overall Study|Lack of Efficacy|1
6005347|NCT00885482|20761620|P1|Overall Study|Pregnancy|1
6005348|NCT00885378|20761626|P2|Overall Study|Protocol Violation|0
6005349|NCT00885378|20761627|P1|Overall Study|Protocol Violation|2
6005350|NCT00885378|20761626|P2|Overall Study|Poor/Noncompliance|2
6005351|NCT00885378|20761627|P1|Overall Study|Poor/Noncompliance|2
6005352|NCT00885378|20761626|P2|Overall Study|Lost to Follow-up|2
6005353|NCT00885378|20761627|P1|Overall Study|Lost to Follow-up|1
6005354|NCT00885378|20761626|P2|Overall Study|Withdrawal by Subject|2
6005355|NCT00885378|20761627|P1|Overall Study|Withdrawal by Subject|1
6005356|NCT00885378|20761626|P2|Overall Study|Lack of Efficacy|2
6005357|NCT00885378|20761627|P1|Overall Study|Lack of Efficacy|2
6005358|NCT00885365|20761657|P2|4 Weeks ON Treatment|Withdrawal by Subject|0
6005359|NCT00885365|20761658|P1|4 Weeks ON Treatment|Withdrawal by Subject|1
6005360|NCT00885365|20761657|P2|4 Weeks ON Treatment|Protocol Violation|2
6005361|NCT00885365|20761658|P1|4 Weeks ON Treatment|Protocol Violation|1
6005362|NCT00885365|20761657|P2|4 Weeks ON Treatment|Adverse Event|4
6005363|NCT00885365|20761658|P1|4 Weeks ON Treatment|Adverse Event|2
6005364|NCT00885352|20761694|P2|Overall Study|Lab abnormalities|1
6005365|NCT00885352|20761695|P1|Overall Study|Lab abnormalities|1
6005366|NCT00885352|20761694|P2|Overall Study|Excluded medication|2
6005367|NCT00885352|20761695|P1|Overall Study|Excluded medication|2
6005368|NCT00885352|20761694|P2|Overall Study|Contradiction to study medication|2
6005369|NCT00885352|20761695|P1|Overall Study|Contradiction to study medication|0
6005370|NCT00885352|20761694|P2|Overall Study|Withdrawal by Subject|5
6005371|NCT00885352|20761695|P1|Overall Study|Withdrawal by Subject|1
6005372|NCT00885352|20761694|P2|Overall Study|Protocol Violation|2
6005373|NCT00885352|20761695|P1|Overall Study|Protocol Violation|0
6005374|NCT00885352|20761694|P2|Overall Study|Physician Decision|3
6005375|NCT00885352|20761695|P1|Overall Study|Physician Decision|0
6005376|NCT00885352|20761694|P2|Overall Study|Lost to Follow-up|2
6005377|NCT00885352|20761695|P1|Overall Study|Lost to Follow-up|2
6005378|NCT00885352|20761694|P2|Overall Study|Adverse Event|3
6005379|NCT00885352|20761695|P1|Overall Study|Adverse Event|2
6005380|NCT00885170|20761707|P2|Overall Study|Withdrawal by Subject|13
6005381|NCT00885170|20761708|P1|Overall Study|Withdrawal by Subject|13
6005382|NCT00885170|20761707|P2|Overall Study|Protocol Violation|1
6005383|NCT00885170|20761708|P1|Overall Study|Protocol Violation|3
6005384|NCT00885170|20761707|P2|Overall Study|Physician Decision|1
6005385|NCT00885170|20761708|P1|Overall Study|Physician Decision|2
6005386|NCT00885170|20761707|P2|Overall Study|Lost to Follow-up|1
6005387|NCT00885170|20761708|P1|Overall Study|Lost to Follow-up|2
6005388|NCT00885170|20761707|P2|Overall Study|Excessive bone loss|3
6005389|NCT00885170|20761708|P1|Overall Study|Excessive bone loss|6
6005390|NCT00885170|20761707|P2|Overall Study|Adverse Event|4
6005391|NCT00885170|20761708|P1|Overall Study|Adverse Event|12
6005392|NCT00885118|20761767|P5|Overall Study|Other reason not defined above|0
6005393|NCT00885118|20761768|P4|Overall Study|Other reason not defined above|0
6005394|NCT00885118|20761769|P3|Overall Study|Other reason not defined above|1
6005395|NCT00885118|20761770|P2|Overall Study|Other reason not defined above|0
6005396|NCT00885118|20761771|P1|Overall Study|Other reason not defined above|0
6005397|NCT00885118|20761767|P5|Overall Study|Withdrawal by Subject|1
6005398|NCT00885118|20761768|P4|Overall Study|Withdrawal by Subject|0
6005399|NCT00885118|20761769|P3|Overall Study|Withdrawal by Subject|0
6005400|NCT00885118|20761770|P2|Overall Study|Withdrawal by Subject|0
6005401|NCT00885118|20761771|P1|Overall Study|Withdrawal by Subject|0
6005402|NCT00885118|20761767|P5|Overall Study|Adverse Event|0
6005403|NCT00885118|20761768|P4|Overall Study|Adverse Event|0
6005404|NCT00885118|20761769|P3|Overall Study|Adverse Event|0
6005405|NCT00885118|20761770|P2|Overall Study|Adverse Event|0
6005406|NCT00885118|20761771|P1|Overall Study|Adverse Event|1
6005407|NCT00885105|20761910|P2|Overall Study|Protocol Violation|2
6005408|NCT00885105|20761911|P1|Overall Study|Protocol Violation|0
6005409|NCT00885105|20761910|P2|Overall Study|Adverse Event|0
6005410|NCT00885105|20761911|P1|Overall Study|Adverse Event|1
6005411|NCT00885105|20761910|P2|Overall Study|Withdrawal by Subject|8
6005412|NCT00885105|20761911|P1|Overall Study|Withdrawal by Subject|0
6005413|NCT00884949|20761951|P1|Weeks 1-12: 0.1 mg/kg/Week|Withdrawal by Subject|1
6005414|NCT00884949|20761951|P1|Weeks 1-12: 0.1 mg/kg/Week|Adverse Event|1
6005415|NCT00884832|20761986|P2|Overall Study|Withdrawal by Subject|1
6005416|NCT00884832|20761987|P1|Overall Study|Withdrawal by Subject|0
6005417|NCT00884793|20762022|P1|Overall Study|Withdrawal by Subject|1
6005418|NCT00884741|20762041|P4|Randomization|Protocol Violation|8
6005419|NCT00884741|20762042|P3|Randomization|Protocol Violation|8
6005420|NCT00884741|20762043|P2|Randomization|Protocol Violation|0
6005421|NCT00884741|20762044|P1|Randomization|Protocol Violation|0
6005422|NCT00884741|20762041|P4|Step 2 Registration: Tissue Analysis|Disease Progression|0
6005423|NCT00884741|20762042|P3|Step 2 Registration: Tissue Analysis|Disease Progression|0
6005424|NCT00884741|20762043|P2|Step 2 Registration: Tissue Analysis|Disease Progression|4
6005425|NCT00884741|20762044|P1|Step 2 Registration: Tissue Analysis|Disease Progression|0
6005426|NCT00884741|20762041|P4|Step 2 Registration: Tissue Analysis|Patient refusal|0
6005427|NCT00884741|20762042|P3|Step 2 Registration: Tissue Analysis|Patient refusal|0
6005428|NCT00884741|20762043|P2|Step 2 Registration: Tissue Analysis|Patient refusal|7
6005429|NCT00884741|20762044|P1|Step 2 Registration: Tissue Analysis|Patient refusal|0
6005430|NCT00884741|20762041|P4|Step 2 Registration: Tissue Analysis|Adverse Event|0
6005431|NCT00884741|20762042|P3|Step 2 Registration: Tissue Analysis|Adverse Event|0
6005432|NCT00884741|20762043|P2|Step 2 Registration: Tissue Analysis|Adverse Event|2
6005433|NCT00884741|20762044|P1|Step 2 Registration: Tissue Analysis|Adverse Event|0
6005434|NCT00884741|20762041|P4|Step 2 Registration: Tissue Analysis|Death|0
6005435|NCT00884741|20762042|P3|Step 2 Registration: Tissue Analysis|Death|0
6005436|NCT00884741|20762043|P2|Step 2 Registration: Tissue Analysis|Death|1
6005437|NCT00884741|20762044|P1|Step 2 Registration: Tissue Analysis|Death|0
6005438|NCT00884741|20762041|P4|Step 2 Registration: Tissue Analysis|Protocol Violation|0
6005439|NCT00884741|20762042|P3|Step 2 Registration: Tissue Analysis|Protocol Violation|0
6005440|NCT00884741|20762043|P2|Step 2 Registration: Tissue Analysis|Protocol Violation|15
6005441|NCT00884741|20762044|P1|Step 2 Registration: Tissue Analysis|Protocol Violation|0
6005442|NCT00884741|20762041|P4|Step 1 Registration: Tissue Screening|Patient refusal|0
6005443|NCT00884741|20762042|P3|Step 1 Registration: Tissue Screening|Patient refusal|0
6005444|NCT00884741|20762043|P2|Step 1 Registration: Tissue Screening|Patient refusal|0
6005445|NCT00884741|20762044|P1|Step 1 Registration: Tissue Screening|Patient refusal|32
6005446|NCT00884741|20762041|P4|Step 1 Registration: Tissue Screening|Disease progression|0
6005447|NCT00884741|20762042|P3|Step 1 Registration: Tissue Screening|Disease progression|0
6005448|NCT00884741|20762043|P2|Step 1 Registration: Tissue Screening|Disease progression|0
6005449|NCT00884741|20762044|P1|Step 1 Registration: Tissue Screening|Disease progression|12
6005450|NCT00884741|20762041|P4|Step 1 Registration: Tissue Screening|Insufficient tissue|0
6005451|NCT00884741|20762042|P3|Step 1 Registration: Tissue Screening|Insufficient tissue|0
6005452|NCT00884741|20762043|P2|Step 1 Registration: Tissue Screening|Insufficient tissue|0
6005453|NCT00884741|20762044|P1|Step 1 Registration: Tissue Screening|Insufficient tissue|105
6005454|NCT00884741|20762041|P4|Step 1 Registration: Tissue Screening|Physician Decision|0
6005455|NCT00884741|20762042|P3|Step 1 Registration: Tissue Screening|Physician Decision|0
6005456|NCT00884741|20762043|P2|Step 1 Registration: Tissue Screening|Physician Decision|0
6005457|NCT00884741|20762044|P1|Step 1 Registration: Tissue Screening|Physician Decision|3
6005458|NCT00884741|20762041|P4|Step 1 Registration: Tissue Screening|Death|0
6005459|NCT00884741|20762042|P3|Step 1 Registration: Tissue Screening|Death|0
6005460|NCT00884741|20762043|P2|Step 1 Registration: Tissue Screening|Death|0
6005461|NCT00884741|20762044|P1|Step 1 Registration: Tissue Screening|Death|3
6005462|NCT00884741|20762041|P4|Step 1 Registration: Tissue Screening|Protocol Violation|0
6005463|NCT00884741|20762042|P3|Step 1 Registration: Tissue Screening|Protocol Violation|0
6005464|NCT00884741|20762043|P2|Step 1 Registration: Tissue Screening|Protocol Violation|0
6005465|NCT00884741|20762044|P1|Step 1 Registration: Tissue Screening|Protocol Violation|157
6005466|NCT00884390|20762094|P2|Overall Study|Other|1
6005467|NCT00884390|20762095|P1|Overall Study|Other|11
6005468|NCT00884390|20762094|P2|Overall Study|Discontinuation of Study by Sponsor|2
6005469|NCT00884390|20762095|P1|Overall Study|Discontinuation of Study by Sponsor|2
6005470|NCT00884390|20762094|P2|Overall Study|Withdrawal by Subject|1
6005471|NCT00884390|20762095|P1|Overall Study|Withdrawal by Subject|4
6005472|NCT00884390|20762094|P2|Overall Study|Protocol Violation|1
6005473|NCT00884390|20762095|P1|Overall Study|Protocol Violation|4
6005474|NCT00884390|20762094|P2|Overall Study|Physician Decision|1
6005475|NCT00884390|20762095|P1|Overall Study|Physician Decision|2
6005476|NCT00884390|20762094|P2|Overall Study|Lost to Follow-up|1
6005477|NCT00884390|20762095|P1|Overall Study|Lost to Follow-up|0
6005478|NCT00884390|20762094|P2|Overall Study|Adverse Event|1
6005479|NCT00884390|20762095|P1|Overall Study|Adverse Event|0
6005480|NCT00884377|20762113|P2|Overall Study|Physician Decision|1
6005481|NCT00884377|20762114|P1|Overall Study|Physician Decision|0
6005482|NCT00884377|20762113|P2|Overall Study|Could not confirm diagnosis|0
6005483|NCT00884377|20762114|P1|Overall Study|Could not confirm diagnosis|1
6005484|NCT00884377|20762113|P2|Overall Study|Withdrawal by Subject|0
6005485|NCT00884377|20762114|P1|Overall Study|Withdrawal by Subject|1
6005486|NCT00884325|20762136|P2|Overall Study|Not provided|0
6005487|NCT00884325|20762137|P1|Overall Study|Not provided|1
6005488|NCT00884325|20762136|P2|Overall Study|Withdrawal by Subject|1
6005489|NCT00884325|20762137|P1|Overall Study|Withdrawal by Subject|1
6005490|NCT00884325|20762136|P2|Overall Study|Lack of Efficacy|1
6005491|NCT00884325|20762137|P1|Overall Study|Lack of Efficacy|0
6005492|NCT00884325|20762136|P2|Overall Study|Lost to Follow-up|2
6005493|NCT00884325|20762137|P1|Overall Study|Lost to Follow-up|1
6005494|NCT00884312|20762147|P2|Overall Study|Did Not Receive Study Drug|1
6005495|NCT00884312|20762148|P1|Overall Study|Did Not Receive Study Drug|0
6005496|NCT00884312|20762147|P2|Overall Study|Other|4
6005497|NCT00884312|20762148|P1|Overall Study|Other|0
6005498|NCT00884312|20762147|P2|Overall Study|Physician Decision|1
6005499|NCT00884312|20762148|P1|Overall Study|Physician Decision|0
6005500|NCT00884312|20762147|P2|Overall Study|Withdrawal by Subject|6
6005501|NCT00884312|20762148|P1|Overall Study|Withdrawal by Subject|0
6005502|NCT00884312|20762147|P2|Overall Study|Fatal Adverse Event|4
6005503|NCT00884312|20762148|P1|Overall Study|Fatal Adverse Event|1
6005504|NCT00884312|20762147|P2|Overall Study|Non-fatal Adverse Event|0
6005505|NCT00884312|20762148|P1|Overall Study|Non-fatal Adverse Event|1
6005506|NCT00884312|20762147|P2|Overall Study|Fatal Progressive Disease|1
6005507|NCT00884312|20762148|P1|Overall Study|Fatal Progressive Disease|0
6005508|NCT00884312|20762147|P2|Overall Study|Non-fatal Progressive Disease|8
6005509|NCT00884312|20762148|P1|Overall Study|Non-fatal Progressive Disease|0
6005510|NCT00884286|20762164|P2|Overall Study|Comprised lung carcinoma|1
6005511|NCT00884286|20762165|P1|Overall Study|Comprised lung carcinoma|0
6005512|NCT00884286|20762164|P2|Overall Study|Not treated|1
6005513|NCT00884286|20762165|P1|Overall Study|Not treated|2
6005514|NCT00884286|20762164|P2|Overall Study|Thrombus in right auricle|0
6005515|NCT00884286|20762165|P1|Overall Study|Thrombus in right auricle|1
6005516|NCT00884286|20762164|P2|Overall Study|Septic shock|0
6005517|NCT00884286|20762165|P1|Overall Study|Septic shock|1
6005518|NCT00884286|20762164|P2|Overall Study|Physician Decision|0
6005519|NCT00884286|20762165|P1|Overall Study|Physician Decision|1
6005520|NCT00884286|20762164|P2|Overall Study|Death|2
6005521|NCT00884286|20762165|P1|Overall Study|Death|2
6005522|NCT00884286|20762164|P2|Overall Study|Toxicity|1
6005523|NCT00884286|20762165|P1|Overall Study|Toxicity|4
6005524|NCT00884286|20762164|P2|Overall Study|Progressive disease|28
6005525|NCT00884286|20762165|P1|Overall Study|Progressive disease|21
6005526|NCT00884273|20762179|P2|Overall Study|Practical reasons|0
6005527|NCT00884273|20762180|P1|Overall Study|Practical reasons|1
6005528|NCT00884273|20762179|P2|Overall Study|Protocol Violation|3
6005529|NCT00884273|20762180|P1|Overall Study|Protocol Violation|1
6005530|NCT00884273|20762179|P2|Overall Study|Adverse Event|2
6005531|NCT00884273|20762180|P1|Overall Study|Adverse Event|0
6005532|NCT00884221|20762206|P2|Overall Study|Cancellation of Cycle and Other Reason|13
6005533|NCT00884221|20762207|P1|Overall Study|Cancellation of Cycle and Other Reason|12
6005534|NCT00884221|20762206|P2|Overall Study|Protocol Violation|13
6005535|NCT00884221|20762207|P1|Overall Study|Protocol Violation|16
6005536|NCT00884221|20762206|P2|Overall Study|Adverse Event|3
6005537|NCT00884221|20762207|P1|Overall Study|Adverse Event|6
6005538|NCT00884221|20762206|P2|Overall Study|Withdrawal by Subject|3
6005539|NCT00884221|20762207|P1|Overall Study|Withdrawal by Subject|0
6005540|NCT00884117|20762243|P1|Overall Study|Other|12
6005541|NCT00884117|20762243|P1|Overall Study|Lost to Follow-up|143
6005542|NCT00884117|20762243|P1|Overall Study|Death|3
6005543|NCT00884117|20762243|P1|Overall Study|Withdrawal by Subject|89
6005544|NCT00884117|20762243|P1|Overall Study|Adverse Event|2
6005545|NCT00884039|20762314|P2|Overall Study|Lack of Efficacy|0
6005546|NCT00884039|20762315|P1|Overall Study|Lack of Efficacy|2
6005547|NCT00884039|20762314|P2|Overall Study|Withdrawal by Subject|1
6005548|NCT00884039|20762315|P1|Overall Study|Withdrawal by Subject|0
6005549|NCT00883779|20762323|P2|Off-study Phase|Other|21
6005550|NCT00883779|20762324|P1|Off-study Phase|Other|18
6005551|NCT00883779|20762323|P2|Off-study Phase|Failure to return|6
6005552|NCT00883779|20762324|P1|Off-study Phase|Failure to return|5
6005553|NCT00883779|20762323|P2|Off-study Phase|Refused treatment|1
6005554|NCT00883779|20762324|P1|Off-study Phase|Refused treatment|1
6005555|NCT00883779|20762323|P2|Off-study Phase|Death|174
6005556|NCT00883779|20762324|P1|Off-study Phase|Death|185
6005557|NCT00883779|20762323|P2|Post-Study Treatment Phase|Ongoing in the study|6
6005558|NCT00883779|20762324|P1|Post-Study Treatment Phase|Ongoing in the study|0
6005559|NCT00883779|20762323|P2|Post-Study Treatment Phase|Other|0
6005560|NCT00883779|20762324|P1|Post-Study Treatment Phase|Other|3
6005561|NCT00883779|20762323|P2|Post-Study Treatment Phase|Disease progression|122
6005562|NCT00883779|20762324|P1|Post-Study Treatment Phase|Disease progression|103
6005563|NCT00883779|20762323|P2|Post-Study Treatment Phase|Refused Treatment|0
6005564|NCT00883779|20762324|P1|Post-Study Treatment Phase|Refused Treatment|3
6005565|NCT00883779|20762323|P2|Post-Study Treatment Phase|Protocol Violation|1
6005566|NCT00883779|20762324|P1|Post-Study Treatment Phase|Protocol Violation|0
6005567|NCT00883779|20762323|P2|Post-Study Treatment Phase|Death|3
6005568|NCT00883779|20762324|P1|Post-Study Treatment Phase|Death|1
6005569|NCT00883779|20762323|P2|Post-Study Treatment Phase|Adverse Event|3
6005570|NCT00883779|20762324|P1|Post-Study Treatment Phase|Adverse Event|2
6005571|NCT00883779|20762323|P2|Primary Study Treatment Phase|Other|0
6005572|NCT00883779|20762324|P1|Primary Study Treatment Phase|Other|3
6005573|NCT00883779|20762323|P2|Primary Study Treatment Phase|Refused Treatment|4
6005574|NCT00883779|20762324|P1|Primary Study Treatment Phase|Refused Treatment|5
6005575|NCT00883779|20762323|P2|Primary Study Treatment Phase|Death|3
6005576|NCT00883779|20762324|P1|Primary Study Treatment Phase|Death|2
6005577|NCT00883779|20762323|P2|Primary Study Treatment Phase|Adverse Event|16
6005578|NCT00883779|20762324|P1|Primary Study Treatment Phase|Adverse Event|16
6005579|NCT00883779|20762323|P2|Primary Study Treatment Phase|Disease progression|59
6005580|NCT00883779|20762324|P1|Primary Study Treatment Phase|Disease progression|75
6005581|NCT00883779|20762323|P2|Primary Study Treatment Phase|Did not receive allocated intervention|4
6005582|NCT00883779|20762324|P1|Primary Study Treatment Phase|Did not receive allocated intervention|4
6005583|NCT00883753|20762360|P1|Overall Study|Administrative/Other|8
6005584|NCT00883753|20762360|P1|Overall Study|Investigator's decision|17
6005585|NCT00883753|20762360|P1|Overall Study|Withdrew consent|10
6005586|NCT00883753|20762360|P1|Overall Study|Refused treatment|4
6005587|NCT00883753|20762360|P1|Overall Study|Protocol Violation|2
6005588|NCT00883753|20762360|P1|Overall Study|Violation of selection criteria at entry|7
6005589|NCT00883753|20762360|P1|Overall Study|Lost to Follow-up|4
6005590|NCT00883753|20762360|P1|Overall Study|Insufficient therapeutic response|16
6005591|NCT00883753|20762360|P1|Overall Study|Death|2
6005592|NCT00883753|20762360|P1|Overall Study|Adverse Event|37
6005593|NCT00883740|20762400|P2|Second Intervention|No longer willing to participate|1
6005594|NCT00883740|20762401|P1|Second Intervention|No longer willing to participate|0
6005595|NCT00883740|20762400|P2|Second Intervention|Protocol Violation|0
6005596|NCT00883740|20762401|P1|Second Intervention|Protocol Violation|1
6005597|NCT00883740|20762400|P2|First Intervention|Adverse Event|2
6005598|NCT00883740|20762401|P1|First Intervention|Adverse Event|1
6005599|NCT00883740|20762400|P2|First Intervention|Protocol Violation|6
6005600|NCT00883740|20762401|P1|First Intervention|Protocol Violation|3
6005601|NCT00883740|20762400|P2|First Intervention|No longer willing to participate|0
6005602|NCT00883740|20762401|P1|First Intervention|No longer willing to participate|2
6005603|NCT00883740|20762400|P2|First Intervention|Lost to Follow-up|0
6005604|NCT00883740|20762401|P1|First Intervention|Lost to Follow-up|1
6005605|NCT00883688|20762441|P1|Overall Study|Ineligible|2
6005606|NCT00883558|20762449|P3|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|1
6005607|NCT00883558|20762450|P2|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0
6005608|NCT00883558|20762451|P1|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0
6005609|NCT00883558|20762449|P3|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0
6005610|NCT00883558|20762450|P2|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|1
6005611|NCT00883558|20762451|P1|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0
6005612|NCT00883558|20762449|P3|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1
6005613|NCT00883558|20762450|P2|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1
6005614|NCT00883558|20762451|P1|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|0
6005615|NCT00883558|20762449|P3|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0
6005616|NCT00883558|20762450|P2|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|1
6005617|NCT00883558|20762451|P1|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0
6005618|NCT00883558|20762449|P3|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0
6005619|NCT00883558|20762450|P2|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0
6005620|NCT00883558|20762451|P1|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|2
6005621|NCT00883493|20762463|P2|Overall Study|Other|3
6005622|NCT00883493|20762464|P1|Overall Study|Other|5
6005623|NCT00883493|20762463|P2|Overall Study|Study specific disc. criteria|0
6005624|NCT00883493|20762464|P1|Overall Study|Study specific disc. criteria|2
6005625|NCT00883493|20762463|P2|Overall Study|Eligibility Criteria not fullfilled|6
6005626|NCT00883493|20762464|P1|Overall Study|Eligibility Criteria not fullfilled|6
6005627|NCT00883493|20762463|P2|Overall Study|Withdrawal by Subject|20
6005628|NCT00883493|20762464|P1|Overall Study|Withdrawal by Subject|11
6005629|NCT00883493|20762463|P2|Overall Study|Lost to Follow-up|6
6005630|NCT00883493|20762464|P1|Overall Study|Lost to Follow-up|7
6005631|NCT00883493|20762463|P2|Overall Study|Lack of Efficacy|3
6005632|NCT00883493|20762464|P1|Overall Study|Lack of Efficacy|4
6005633|NCT00883493|20762463|P2|Overall Study|Adverse Event|12
6005634|NCT00883493|20762464|P1|Overall Study|Adverse Event|11
6005635|NCT00883337|20762499|P3|Extension Treatment Period|Other than above|5
6005636|NCT00883337|20762500|P2|Extension Treatment Period|Other than above|9
6005637|NCT00883337|20762501|P1|Extension Treatment Period|Other than above|10
6005638|NCT00883337|20762499|P3|Extension Treatment Period|Lost to Follow-up|0
6005639|NCT00883337|20762500|P2|Extension Treatment Period|Lost to Follow-up|0
6005640|NCT00883337|20762501|P1|Extension Treatment Period|Lost to Follow-up|1
6005641|NCT00883337|20762499|P3|Extension Treatment Period|Poor compliance to protocol|1
6005642|NCT00883337|20762500|P2|Extension Treatment Period|Poor compliance to protocol|1
6005643|NCT00883337|20762501|P1|Extension Treatment Period|Poor compliance to protocol|1
6005644|NCT00883337|20762499|P3|Extension Treatment Period|Lack of Efficacy|8
6005645|NCT00883337|20762500|P2|Extension Treatment Period|Lack of Efficacy|8
6005646|NCT00883337|20762501|P1|Extension Treatment Period|Lack of Efficacy|8
6005647|NCT00883337|20762499|P3|Extension Treatment Period|Adverse Event|5
6005648|NCT00883337|20762500|P2|Extension Treatment Period|Adverse Event|5
6005649|NCT00883337|20762501|P1|Extension Treatment Period|Adverse Event|8
6005650|NCT00883337|20762499|P3|Core Treatment Period|Other than above|1
6005651|NCT00883337|20762500|P2|Core Treatment Period|Other than above|1
6005652|NCT00883337|20762501|P1|Core Treatment Period|Other than above|0
6005653|NCT00883337|20762499|P3|Core Treatment Period|Poor compliance to protocol|1
6005654|NCT00883337|20762500|P2|Core Treatment Period|Poor compliance to protocol|0
6005655|NCT00883337|20762501|P1|Core Treatment Period|Poor compliance to protocol|0
6005656|NCT00883337|20762499|P3|Core Treatment Period|Wish to be pregnant|1
6005657|NCT00883337|20762500|P2|Core Treatment Period|Wish to be pregnant|2
6005658|NCT00883337|20762501|P1|Core Treatment Period|Wish to be pregnant|1
6005659|NCT00883337|20762499|P3|Core Treatment Period|Withdrawal by Subject|6
6005660|NCT00883337|20762500|P2|Core Treatment Period|Withdrawal by Subject|2
6005661|NCT00883337|20762501|P1|Core Treatment Period|Withdrawal by Subject|2
6005662|NCT00883337|20762499|P3|Core Treatment Period|Lost to Follow-up|0
6005663|NCT00883337|20762500|P2|Core Treatment Period|Lost to Follow-up|1
6005664|NCT00883337|20762501|P1|Core Treatment Period|Lost to Follow-up|1
6005665|NCT00883337|20762499|P3|Core Treatment Period|Lack of Efficacy|2
6005666|NCT00883337|20762500|P2|Core Treatment Period|Lack of Efficacy|4
6005667|NCT00883337|20762501|P1|Core Treatment Period|Lack of Efficacy|7
6005668|NCT00883337|20762499|P3|Core Treatment Period|Adverse Event|22
6005669|NCT00883337|20762500|P2|Core Treatment Period|Adverse Event|12
6005670|NCT00883337|20762501|P1|Core Treatment Period|Adverse Event|9
6005671|NCT00883181|20762568|P1|Overall Study|Noncompliance|3
6005672|NCT00883181|20762568|P1|Overall Study|Protocol Deviation|3
6005673|NCT00883181|20762568|P1|Overall Study|Other|38
6005674|NCT00883181|20762568|P1|Overall Study|Death|31
6005675|NCT00883181|20762568|P1|Overall Study|Withdrawal by Subject|4
6005676|NCT00883181|20762568|P1|Overall Study|Administrative Reason|24
6005677|NCT00883181|20762568|P1|Overall Study|Disease Progression|94
6005678|NCT00883181|20762568|P1|Overall Study|Non-hematological Adverse Event|55
6005679|NCT00883181|20762568|P1|Overall Study|Hematological Adverse Event|26
6005680|NCT00883129|20762804|P2|Overall Study|Defined Treatment Failure|2
6005681|NCT00883129|20762805|P1|Overall Study|Defined Treatment Failure|0
6005682|NCT00883129|20762804|P2|Overall Study|Death|2
6005683|NCT00883129|20762805|P1|Overall Study|Death|1
6005684|NCT00883129|20762804|P2|Overall Study|Lost to Follow-up|2
6005685|NCT00883129|20762805|P1|Overall Study|Lost to Follow-up|1
6005686|NCT00883129|20762804|P2|Overall Study|Non-compliance|6
6005687|NCT00883129|20762805|P1|Overall Study|Non-compliance|3
6005688|NCT00883129|20762804|P2|Overall Study|Withdrawal by Subject|9
6005689|NCT00883129|20762805|P1|Overall Study|Withdrawal by Subject|8
6005690|NCT00883129|20762804|P2|Overall Study|Adverse Event|15
6005691|NCT00883129|20762805|P1|Overall Study|Adverse Event|7
6005692|NCT00883116|20762829|P2|Overall Study|No longer meets study criteria|2
6005693|NCT00883116|20762830|P1|Overall Study|No longer meets study criteria|2
6005694|NCT00883116|20762829|P2|Overall Study|Withdrawal by Subject|8
6005695|NCT00883116|20762830|P1|Overall Study|Withdrawal by Subject|14
6005696|NCT00883116|20762829|P2|Overall Study|Study drug toxicity|16
6005697|NCT00883116|20762830|P1|Overall Study|Study drug toxicity|36
6005698|NCT00883116|20762829|P2|Overall Study|Not identified|6
6005699|NCT00883116|20762830|P1|Overall Study|Not identified|3
6005700|NCT00883116|20762829|P2|Overall Study|Maximum clinical benefit|46
6005701|NCT00883116|20762830|P1|Overall Study|Maximum clinical benefit|13
6005702|NCT00883116|20762829|P2|Overall Study|Lost to Follow-up|1
6005703|NCT00883116|20762830|P1|Overall Study|Lost to Follow-up|0
6005704|NCT00883116|20762829|P2|Overall Study|Disease progression|128
6005705|NCT00883116|20762830|P1|Overall Study|Disease progression|130
6005706|NCT00883116|20762829|P2|Overall Study|Death|2
6005707|NCT00883116|20762830|P1|Overall Study|Death|6
6005708|NCT00883116|20762829|P2|Overall Study|Adverse event unrelated to study drug|10
6005709|NCT00883116|20762830|P1|Overall Study|Adverse event unrelated to study drug|5
6005710|NCT00883090|20762852|P1|Overall Study|Withdrawal by Subject|1
6005711|NCT00883090|20762852|P1|Overall Study|Sponsor's decision|1
6005712|NCT00883051|20762872|P5|Overall Study|Did not use study medication|17
6005713|NCT00883051|20762873|P4|Overall Study|Did not use study medication|29
6005714|NCT00883051|20762874|P3|Overall Study|Did not use study medication|29
6005715|NCT00883051|20762875|P2|Overall Study|Did not use study medication|22
6005716|NCT00883051|20762876|P1|Overall Study|Did not use study medication|24
6005717|NCT00883051|20762872|P5|Overall Study|Lost to Follow-up|1
6005718|NCT00883051|20762873|P4|Overall Study|Lost to Follow-up|0
6005719|NCT00883051|20762874|P3|Overall Study|Lost to Follow-up|0
6005720|NCT00883051|20762875|P2|Overall Study|Lost to Follow-up|0
6005721|NCT00883051|20762876|P1|Overall Study|Lost to Follow-up|0
6005722|NCT00882999|20762980|P7|Overall Study|Physician Decision|1
6005723|NCT00882999|20762981|P6|Overall Study|Physician Decision|1
6005724|NCT00882999|20762982|P5|Overall Study|Physician Decision|0
6005725|NCT00882999|20762983|P4|Overall Study|Physician Decision|0
6005726|NCT00882999|20762984|P3|Overall Study|Physician Decision|0
6005727|NCT00882999|20762985|P2|Overall Study|Physician Decision|0
6005728|NCT00882999|20762986|P1|Overall Study|Physician Decision|1
6005729|NCT00882999|20762980|P7|Overall Study|Lost to Follow-up|2
6005730|NCT00882999|20762981|P6|Overall Study|Lost to Follow-up|1
6005731|NCT00882999|20762982|P5|Overall Study|Lost to Follow-up|1
6005732|NCT00882999|20762983|P4|Overall Study|Lost to Follow-up|2
6005733|NCT00882999|20762984|P3|Overall Study|Lost to Follow-up|1
6005734|NCT00882999|20762985|P2|Overall Study|Lost to Follow-up|1
6005735|NCT00882999|20762986|P1|Overall Study|Lost to Follow-up|0
6005736|NCT00882999|20762980|P7|Overall Study|Withdrawal by Subject|5
6005737|NCT00882999|20762981|P6|Overall Study|Withdrawal by Subject|5
6005738|NCT00882999|20762982|P5|Overall Study|Withdrawal by Subject|6
6005739|NCT00882999|20762983|P4|Overall Study|Withdrawal by Subject|3
6005740|NCT00882999|20762984|P3|Overall Study|Withdrawal by Subject|3
6005741|NCT00882999|20762985|P2|Overall Study|Withdrawal by Subject|6
6005742|NCT00882999|20762986|P1|Overall Study|Withdrawal by Subject|7
6005743|NCT00882999|20762980|P7|Overall Study|Death|0
6005744|NCT00882999|20762981|P6|Overall Study|Death|0
6005745|NCT00882999|20762982|P5|Overall Study|Death|0
6005746|NCT00882999|20762983|P4|Overall Study|Death|0
6005747|NCT00882999|20762984|P3|Overall Study|Death|0
6005748|NCT00882999|20762985|P2|Overall Study|Death|1
6005749|NCT00882999|20762986|P1|Overall Study|Death|0
6005750|NCT00882999|20762980|P7|Overall Study|Adverse Event|0
6005751|NCT00882999|20762981|P6|Overall Study|Adverse Event|0
6005752|NCT00882999|20762982|P5|Overall Study|Adverse Event|1
6005753|NCT00882999|20762983|P4|Overall Study|Adverse Event|0
6005754|NCT00882999|20762984|P3|Overall Study|Adverse Event|0
6005755|NCT00882999|20762985|P2|Overall Study|Adverse Event|0
6005756|NCT00882999|20762986|P1|Overall Study|Adverse Event|0
6005757|NCT00882921|20763113|P1|Overall Study|Withdrawal Of Consent|1
6005758|NCT00882921|20763113|P1|Overall Study|Termination By Investigator|3
6005759|NCT00882921|20763113|P1|Overall Study|Lost to Follow-up|2
6005760|NCT00882921|20763113|P1|Overall Study|Other|3
6005761|NCT00882921|20763113|P1|Overall Study|Death|2
6005762|NCT00882908|20763123|P5|Overall Study|Study terminated in error|0
6005763|NCT00882908|20763124|P4|Overall Study|Study terminated in error|1
6005764|NCT00882908|20763125|P3|Overall Study|Study terminated in error|0
6005765|NCT00882908|20763126|P2|Overall Study|Study terminated in error|0
6005766|NCT00882908|20763127|P1|Overall Study|Study terminated in error|0
6005767|NCT00882908|20763123|P5|Overall Study|Subject reached a virologic endpoint|1
6005768|NCT00882908|20763124|P4|Overall Study|Subject reached a virologic endpoint|0
6005769|NCT00882908|20763125|P3|Overall Study|Subject reached a virologic endpoint|0
6005770|NCT00882908|20763126|P2|Overall Study|Subject reached a virologic endpoint|0
6005771|NCT00882908|20763127|P1|Overall Study|Subject reached a virologic endpoint|0
6005772|NCT00882908|20763123|P5|Overall Study|Withdrawal by Subject|2
6005773|NCT00882908|20763124|P4|Overall Study|Withdrawal by Subject|5
6005774|NCT00882908|20763125|P3|Overall Study|Withdrawal by Subject|3
6005775|NCT00882908|20763126|P2|Overall Study|Withdrawal by Subject|0
6005776|NCT00882908|20763127|P1|Overall Study|Withdrawal by Subject|0
6005777|NCT00882908|20763123|P5|Overall Study|Protocol Violation|0
6005778|NCT00882908|20763124|P4|Overall Study|Protocol Violation|0
6005779|NCT00882908|20763125|P3|Overall Study|Protocol Violation|0
6005780|NCT00882908|20763126|P2|Overall Study|Protocol Violation|1
6005781|NCT00882908|20763127|P1|Overall Study|Protocol Violation|0
6005782|NCT00882908|20763123|P5|Overall Study|Lost to Follow-up|2
6005783|NCT00882908|20763124|P4|Overall Study|Lost to Follow-up|1
6005784|NCT00882908|20763125|P3|Overall Study|Lost to Follow-up|3
6005785|NCT00882908|20763126|P2|Overall Study|Lost to Follow-up|5
6005786|NCT00882908|20763127|P1|Overall Study|Lost to Follow-up|3
6005787|NCT00882908|20763123|P5|Overall Study|Adverse Event|1
6005788|NCT00882908|20763124|P4|Overall Study|Adverse Event|0
6005789|NCT00882908|20763125|P3|Overall Study|Adverse Event|1
6005790|NCT00882908|20763126|P2|Overall Study|Adverse Event|0
6005791|NCT00882908|20763127|P1|Overall Study|Adverse Event|0
6005792|NCT00882713|20763233|P1|Overall Study|Other - Reasons|2
6005793|NCT00882713|20763233|P1|Overall Study|Failure to return|2
6005794|NCT00882713|20763233|P1|Overall Study|Insufficient therapeutic response|3
6005795|NCT00882713|20763233|P1|Overall Study|Blood transfusion|2
6005796|NCT00882713|20763233|P1|Overall Study|refused treatment/withdrew consent|4
6005797|NCT00882713|20763233|P1|Overall Study|Administrative reasons|4
6005798|NCT00882713|20763233|P1|Overall Study|Death|3
6005799|NCT00882713|20763233|P1|Overall Study|Adverse Event|2
6005800|NCT00882583|20763326|P2|Overall Study|Adverse Event|1
6005801|NCT00882583|20763327|P1|Overall Study|Adverse Event|0
6005802|NCT00882583|20763326|P2|Overall Study|Physician Decision|0
6005803|NCT00882583|20763327|P1|Overall Study|Physician Decision|1
6005804|NCT00882557|20763335|P2|Overall Study|Randomized Not Treated|1
6005805|NCT00882557|20763336|P1|Overall Study|Randomized Not Treated|0
6005806|NCT00882557|20763335|P2|Overall Study|Trouble with Vein Access|0
6005807|NCT00882557|20763336|P1|Overall Study|Trouble with Vein Access|1
6005808|NCT00882557|20763335|P2|Overall Study|Withdrawal by Subject|0
6005809|NCT00882557|20763336|P1|Overall Study|Withdrawal by Subject|1
6005810|NCT00882518|20763356|P2|Overall Study|Allocating random number by mistake|1
6005811|NCT00882518|20763357|P1|Overall Study|Allocating random number by mistake|0
6005812|NCT00882518|20763356|P2|Overall Study|Central lab closure for National day|0
6005813|NCT00882518|20763357|P1|Overall Study|Central lab closure for National day|1
6005814|NCT00882518|20763356|P2|Overall Study|Incorrect enrolment|2
6005815|NCT00882518|20763357|P1|Overall Study|Incorrect enrolment|4
6005816|NCT00882518|20763356|P2|Overall Study|Severe non-compliance to protocol|1
6005817|NCT00882518|20763357|P1|Overall Study|Severe non-compliance to protocol|3
6005818|NCT00882518|20763356|P2|Overall Study|Lack of Efficacy|9
6005819|NCT00882518|20763357|P1|Overall Study|Lack of Efficacy|12
6005820|NCT00882518|20763356|P2|Overall Study|Withdrawal by Subject|13
6005821|NCT00882518|20763357|P1|Overall Study|Withdrawal by Subject|9
6005822|NCT00882518|20763356|P2|Overall Study|Adverse Event|18
6005823|NCT00882518|20763357|P1|Overall Study|Adverse Event|9
6005824|NCT00882440|20763386|P7|Overall Study|Patient Uncooperative|0
6005825|NCT00882440|20763387|P6|Overall Study|Patient Uncooperative|0
6005826|NCT00882440|20763388|P5|Overall Study|Patient Uncooperative|1
6005827|NCT00882440|20763389|P4|Overall Study|Patient Uncooperative|0
6005828|NCT00882440|20763390|P3|Overall Study|Patient Uncooperative|0
6005829|NCT00882440|20763391|P2|Overall Study|Patient Uncooperative|0
6005830|NCT00882440|20763392|P1|Overall Study|Patient Uncooperative|2
6005831|NCT00882440|20763386|P7|Overall Study|Withdrawal by Subject|1
6005832|NCT00882440|20763387|P6|Overall Study|Withdrawal by Subject|0
6005833|NCT00882440|20763388|P5|Overall Study|Withdrawal by Subject|6
6005834|NCT00882440|20763389|P4|Overall Study|Withdrawal by Subject|0
6005835|NCT00882440|20763390|P3|Overall Study|Withdrawal by Subject|1
6005836|NCT00882440|20763391|P2|Overall Study|Withdrawal by Subject|1
6005837|NCT00882440|20763392|P1|Overall Study|Withdrawal by Subject|2
6005838|NCT00882440|20763386|P7|Overall Study|Protocol Violation|0
6005839|NCT00882440|20763387|P6|Overall Study|Protocol Violation|0
6005840|NCT00882440|20763388|P5|Overall Study|Protocol Violation|1
6005841|NCT00882440|20763389|P4|Overall Study|Protocol Violation|1
6005842|NCT00882440|20763390|P3|Overall Study|Protocol Violation|1
6005843|NCT00882440|20763391|P2|Overall Study|Protocol Violation|0
6005844|NCT00882440|20763392|P1|Overall Study|Protocol Violation|0
6005845|NCT00882440|20763386|P7|Overall Study|Lost to Follow-up|1
6005846|NCT00882440|20763387|P6|Overall Study|Lost to Follow-up|0
6005847|NCT00882440|20763388|P5|Overall Study|Lost to Follow-up|1
6005848|NCT00882440|20763389|P4|Overall Study|Lost to Follow-up|1
6005849|NCT00882440|20763390|P3|Overall Study|Lost to Follow-up|1
6005850|NCT00882440|20763391|P2|Overall Study|Lost to Follow-up|0
6005851|NCT00882440|20763392|P1|Overall Study|Lost to Follow-up|2
6005852|NCT00882440|20763386|P7|Overall Study|Lack of Efficacy|0
6005853|NCT00882440|20763387|P6|Overall Study|Lack of Efficacy|3
6005854|NCT00882440|20763388|P5|Overall Study|Lack of Efficacy|0
6005855|NCT00882440|20763389|P4|Overall Study|Lack of Efficacy|0
6005856|NCT00882440|20763390|P3|Overall Study|Lack of Efficacy|2
6005857|NCT00882440|20763391|P2|Overall Study|Lack of Efficacy|5
6005858|NCT00882440|20763392|P1|Overall Study|Lack of Efficacy|3
6005859|NCT00882440|20763386|P7|Overall Study|Adverse Event|2
6005860|NCT00882440|20763387|P6|Overall Study|Adverse Event|4
6005861|NCT00882440|20763388|P5|Overall Study|Adverse Event|1
6005862|NCT00882440|20763389|P4|Overall Study|Adverse Event|1
6005863|NCT00882440|20763390|P3|Overall Study|Adverse Event|2
6005864|NCT00882440|20763391|P2|Overall Study|Adverse Event|2
6005865|NCT00882440|20763392|P1|Overall Study|Adverse Event|2
6005866|NCT00882362|20763417|P2|Overall Study|change of residence or other commitments|0
6005867|NCT00882362|20763418|P1|Overall Study|change of residence or other commitments|5
6005868|NCT00882362|20763417|P2|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0
6005869|NCT00882362|20763418|P1|Overall Study|Diabetic glucose level or HbA1C>=6.5%|2
6005870|NCT00882362|20763417|P2|Overall Study|Physician Decision|1
6005871|NCT00882362|20763418|P1|Overall Study|Physician Decision|5
6005872|NCT00882362|20763417|P2|Overall Study|Pregnancy|0
6005873|NCT00882362|20763418|P1|Overall Study|Pregnancy|1
6005874|NCT00882362|20763417|P2|Overall Study|Protocol Violation|2
6005875|NCT00882362|20763418|P1|Overall Study|Protocol Violation|7
6005876|NCT00882362|20763417|P2|Overall Study|Lack of Efficacy|0
6005877|NCT00882362|20763418|P1|Overall Study|Lack of Efficacy|3
6005878|NCT00882362|20763417|P2|Overall Study|Withdrawal by Subject|10
6005879|NCT00882362|20763418|P1|Overall Study|Withdrawal by Subject|13
6005880|NCT00882362|20763417|P2|Overall Study|Adverse Event|10
6005881|NCT00882362|20763418|P1|Overall Study|Adverse Event|13
6005882|NCT00882310|20763424|P1|Overall Study|Adverse Event|1
6005883|NCT00882310|20763424|P1|Overall Study|Progression of disease|4
6005884|NCT00882310|20763424|P1|Overall Study|Death|6
6005885|NCT00882310|20763424|P1|Overall Study|Never received treatment|1
6005886|NCT00882310|20763424|P1|Overall Study|Screen Failure|10
6005887|NCT00882115|20763437|P1|Overall Study|did not respond to DEP challe|6
6005888|NCT00882115|20763437|P1|Overall Study|Withdrawal by Subject|3
6005889|NCT00881959|20763447|P2|Overall Study|Lost to Follow-up|4
6005890|NCT00881959|20763448|P1|Overall Study|Lost to Follow-up|2
6005891|NCT00881894|20763456|P2|Overall Study|Other reasons for premature termination|2
6005892|NCT00881894|20763457|P1|Overall Study|Other reasons for premature termination|1
6005893|NCT00881894|20763456|P2|Overall Study|Consent withdrawn|1
6005894|NCT00881894|20763457|P1|Overall Study|Consent withdrawn|0
6005895|NCT00881868|20763489|P2|Overall Study|Protocol Violation|0
6005896|NCT00881868|20763490|P1|Overall Study|Protocol Violation|2
6005897|NCT00881868|20763489|P2|Overall Study|Physician Decision|0
6005898|NCT00881868|20763490|P1|Overall Study|Physician Decision|4
6005899|NCT00881868|20763489|P2|Overall Study|Lost to Follow-up|1
6005900|NCT00881868|20763490|P1|Overall Study|Lost to Follow-up|2
6005901|NCT00881868|20763489|P2|Overall Study|Adverse Event|1
6005902|NCT00881868|20763490|P1|Overall Study|Adverse Event|0
6005903|NCT00881751|20763504|P2|Overall Study|Withdrawal by Subject|2
6005904|NCT00881751|20763505|P1|Overall Study|Withdrawal by Subject|0
6005905|NCT00881751|20763504|P2|Overall Study|Adverse Event|2
6005906|NCT00881751|20763505|P1|Overall Study|Adverse Event|0
6005907|NCT00881751|20763504|P2|Overall Study|Physician Decision|1
6005908|NCT00881751|20763505|P1|Overall Study|Physician Decision|0
6005909|NCT00881712|20763520|P3|Overall Study|Withdrawal by Subject|0
6005910|NCT00881712|20763521|P2|Overall Study|Withdrawal by Subject|0
6005911|NCT00881712|20763522|P1|Overall Study|Withdrawal by Subject|1
6005912|NCT00881712|20763520|P3|Overall Study|Death|0
6005913|NCT00881712|20763521|P2|Overall Study|Death|0
6005914|NCT00881712|20763522|P1|Overall Study|Death|1
6005915|NCT00881621|20763555|P1|Overall Study|Physician Decision|34
6005916|NCT00881608|20763567|P1|Overall Study|Study prematurely terminated|11
6005917|NCT00881569|20763586|P2|Overall Study|Disease progression|1
6005918|NCT00881569|20763587|P1|Overall Study|Disease progression|1
6005919|NCT00881530|20763603|P6|Overall Study|Other reason not defined above|2
6005920|NCT00881530|20763604|P5|Overall Study|Other reason not defined above|0
6005921|NCT00881530|20763605|P4|Overall Study|Other reason not defined above|0
6005922|NCT00881530|20763606|P3|Overall Study|Other reason not defined above|2
6005923|NCT00881530|20763607|P2|Overall Study|Other reason not defined above|1
6005924|NCT00881530|20763608|P1|Overall Study|Other reason not defined above|1
6005925|NCT00881530|20763603|P6|Overall Study|Refused to continue medication|0
6005926|NCT00881530|20763604|P5|Overall Study|Refused to continue medication|0
6005927|NCT00881530|20763605|P4|Overall Study|Refused to continue medication|2
6005928|NCT00881530|20763606|P3|Overall Study|Refused to continue medication|1
6005929|NCT00881530|20763607|P2|Overall Study|Refused to continue medication|2
6005930|NCT00881530|20763608|P1|Overall Study|Refused to continue medication|7
6005931|NCT00881530|20763603|P6|Overall Study|Lost to Follow-up|0
6005932|NCT00881530|20763604|P5|Overall Study|Lost to Follow-up|1
6005933|NCT00881530|20763605|P4|Overall Study|Lost to Follow-up|3
6005934|NCT00881530|20763606|P3|Overall Study|Lost to Follow-up|1
6005935|NCT00881530|20763607|P2|Overall Study|Lost to Follow-up|1
6005936|NCT00881530|20763608|P1|Overall Study|Lost to Follow-up|0
6005937|NCT00881530|20763603|P6|Overall Study|Not compliant with the protocol|0
6005938|NCT00881530|20763604|P5|Overall Study|Not compliant with the protocol|2
6005939|NCT00881530|20763605|P4|Overall Study|Not compliant with the protocol|0
6005940|NCT00881530|20763606|P3|Overall Study|Not compliant with the protocol|0
6005941|NCT00881530|20763607|P2|Overall Study|Not compliant with the protocol|0
6005942|NCT00881530|20763608|P1|Overall Study|Not compliant with the protocol|0
6005943|NCT00881530|20763603|P6|Overall Study|Lack of Efficacy|1
6005944|NCT00881530|20763604|P5|Overall Study|Lack of Efficacy|1
6005945|NCT00881530|20763605|P4|Overall Study|Lack of Efficacy|0
6005946|NCT00881530|20763606|P3|Overall Study|Lack of Efficacy|0
6005947|NCT00881530|20763607|P2|Overall Study|Lack of Efficacy|0
6005948|NCT00881530|20763608|P1|Overall Study|Lack of Efficacy|1
6005949|NCT00881530|20763603|P6|Overall Study|Adverse Event|2
6005950|NCT00881530|20763604|P5|Overall Study|Adverse Event|10
6005951|NCT00881530|20763605|P4|Overall Study|Adverse Event|4
6005952|NCT00881530|20763606|P3|Overall Study|Adverse Event|1
6005953|NCT00881530|20763607|P2|Overall Study|Adverse Event|1
6005954|NCT00881530|20763608|P1|Overall Study|Adverse Event|5
6005955|NCT00881504|20763664|P1|Overall Study|Withdrawal by Subject|1
6005956|NCT00881361|20763684|P3|Overall Study|Ineligible|2
6005957|NCT00881361|20763685|P2|Overall Study|Ineligible|2
6005958|NCT00881361|20763686|P1|Overall Study|Ineligible|17
6005959|NCT00881361|20763684|P3|Overall Study|Terminated prior to surgery|0
6005960|NCT00881361|20763685|P2|Overall Study|Terminated prior to surgery|7
6005961|NCT00881361|20763686|P1|Overall Study|Terminated prior to surgery|27
6005962|NCT00881335|20763701|P2|Overall Study|Lost to Follow-up|2
6005963|NCT00881335|20763702|P1|Overall Study|Lost to Follow-up|3
6005964|NCT00881205|20763722|P2|Overall Study|Condition no longer requires drug|0
6005965|NCT00881205|20763723|P1|Overall Study|Condition no longer requires drug|1
6005966|NCT00881205|20763722|P2|Overall Study|Administrative problems|1
6005967|NCT00881205|20763723|P1|Overall Study|Administrative problems|1
6005968|NCT00881205|20763722|P2|Overall Study|Lost to Follow-up|1
6005969|NCT00881205|20763723|P1|Overall Study|Lost to Follow-up|0
6005970|NCT00881205|20763722|P2|Overall Study|Withdrawal by Subject|2
6005971|NCT00881205|20763723|P1|Overall Study|Withdrawal by Subject|1
6005972|NCT00881205|20763722|P2|Overall Study|Adverse Event|3
6005973|NCT00881205|20763723|P1|Overall Study|Adverse Event|8
6005974|NCT00880906|20763791|P2|Overall Study|Did not meet criteria following patholog|6
6005975|NCT00880906|20763792|P1|Overall Study|Did not meet criteria following patholog|12
6005976|NCT00880906|20763791|P2|Overall Study|Lost to Follow-up|1
6005977|NCT00880906|20763792|P1|Overall Study|Lost to Follow-up|0
6005978|NCT00880893|20763802|P2|Overall Study|Serious adverse event|0
6005979|NCT00880893|20763803|P1|Overall Study|Serious adverse event|3
6005980|NCT00880893|20763802|P2|Overall Study|Lost to Follow-up|33
6005981|NCT00880893|20763803|P1|Overall Study|Lost to Follow-up|76
6005982|NCT00880893|20763802|P2|Overall Study|Withdrawal by Subject|11
6005983|NCT00880893|20763803|P1|Overall Study|Withdrawal by Subject|15
6005984|NCT00880893|20763802|P2|Overall Study|Protocol Violation|1
6005985|NCT00880893|20763803|P1|Overall Study|Protocol Violation|13
6005986|NCT00880763|20763855|P4|Extension Period (Part 2)|Lack of Efficacy|1
6005987|NCT00880763|20763856|P3|Extension Period (Part 2)|Lack of Efficacy|0
6005988|NCT00880763|20763857|P2|Extension Period (Part 2)|Lack of Efficacy|0
6005989|NCT00880763|20763858|P1|Extension Period (Part 2)|Lack of Efficacy|0
6005990|NCT00880763|20763855|P4|Extension Period (Part 2)|Physician Decision|0
6005991|NCT00880763|20763856|P3|Extension Period (Part 2)|Physician Decision|1
6005992|NCT00880763|20763857|P2|Extension Period (Part 2)|Physician Decision|1
6005993|NCT00880763|20763858|P1|Extension Period (Part 2)|Physician Decision|0
6005994|NCT00880763|20763855|P4|Extension Period (Part 2)|Withdrawal by Subject|1
6005995|NCT00880763|20763856|P3|Extension Period (Part 2)|Withdrawal by Subject|1
6005996|NCT00880763|20763857|P2|Extension Period (Part 2)|Withdrawal by Subject|2
6005997|NCT00880763|20763858|P1|Extension Period (Part 2)|Withdrawal by Subject|0
6005998|NCT00880763|20763855|P4|Extension Period (Part 2)|Adverse Event|1
6005999|NCT00880763|20763856|P3|Extension Period (Part 2)|Adverse Event|1
6006000|NCT00880763|20763857|P2|Extension Period (Part 2)|Adverse Event|0
6006001|NCT00880763|20763858|P1|Extension Period (Part 2)|Adverse Event|0
6006002|NCT00880750|20763890|P2|Second Intervention|Unable to collect urine|0
6006003|NCT00880750|20763891|P1|Second Intervention|Unable to collect urine|1
6006004|NCT00880750|20763890|P2|Second Intervention|Protocol Violation|0
6006005|NCT00880750|20763891|P1|Second Intervention|Protocol Violation|1
6006006|NCT00880750|20763890|P2|Second Intervention|Withdrawal by Subject|2
6006007|NCT00880750|20763891|P1|Second Intervention|Withdrawal by Subject|2
6006008|NCT00880750|20763890|P2|First Intervention|Lost to Follow-up|0
6006009|NCT00880750|20763891|P1|First Intervention|Lost to Follow-up|2
6006010|NCT00880750|20763890|P2|First Intervention|Withdrawal by Subject|0
6006011|NCT00880750|20763891|P1|First Intervention|Withdrawal by Subject|2
6006012|NCT00880750|20763890|P2|First Intervention|Non-compliance with meals|1
6006013|NCT00880750|20763891|P1|First Intervention|Non-compliance with meals|0
6006014|NCT00880750|20763890|P2|First Intervention|Unable to collect urine|0
6006015|NCT00880750|20763891|P1|First Intervention|Unable to collect urine|4
6006016|NCT00880750|20763890|P2|First Intervention|Adverse Event|0
6006017|NCT00880750|20763891|P1|First Intervention|Adverse Event|1
6006018|NCT00880698|20763909|P4|Overall Study|Lost to Follow-up|1
6006019|NCT00880698|20763910|P3|Overall Study|Lost to Follow-up|0
6006020|NCT00880698|20763911|P2|Overall Study|Lost to Follow-up|3
6006021|NCT00880698|20763912|P1|Overall Study|Lost to Follow-up|1
6006022|NCT00880698|20763909|P4|Overall Study|Death|2
6006023|NCT00880698|20763910|P3|Overall Study|Death|1
6006024|NCT00880698|20763911|P2|Overall Study|Death|0
6006025|NCT00880698|20763912|P1|Overall Study|Death|0
6006026|NCT00880685|20763938|P1|Memantine 20mg|Withdrawal by Subject|1
6006027|NCT00880685|20763938|P1|Memantine 10mg|Lost to Follow-up|2
6006028|NCT00880620|20763950|P4|Overall Study|Other|2
6006029|NCT00880620|20763951|P3|Overall Study|Other|2
6006030|NCT00880620|20763952|P2|Overall Study|Other|1
6006031|NCT00880620|20763953|P1|Overall Study|Other|1
6006032|NCT00880620|20763950|P4|Overall Study|Noncompliance|1
6006033|NCT00880620|20763951|P3|Overall Study|Noncompliance|1
6006034|NCT00880620|20763952|P2|Overall Study|Noncompliance|0
6006035|NCT00880620|20763953|P1|Overall Study|Noncompliance|0
6006036|NCT00880620|20763950|P4|Overall Study|Withdrawal by Subject|3
6006037|NCT00880620|20763951|P3|Overall Study|Withdrawal by Subject|1
6006038|NCT00880620|20763952|P2|Overall Study|Withdrawal by Subject|3
6006039|NCT00880620|20763953|P1|Overall Study|Withdrawal by Subject|4
6006040|NCT00880620|20763950|P4|Overall Study|Protocol Violation|2
6006041|NCT00880620|20763951|P3|Overall Study|Protocol Violation|0
6006042|NCT00880620|20763952|P2|Overall Study|Protocol Violation|1
6006043|NCT00880620|20763953|P1|Overall Study|Protocol Violation|0
6006044|NCT00880620|20763950|P4|Overall Study|Lost to Follow-up|0
6006045|NCT00880620|20763951|P3|Overall Study|Lost to Follow-up|1
6006046|NCT00880620|20763952|P2|Overall Study|Lost to Follow-up|1
6006047|NCT00880620|20763953|P1|Overall Study|Lost to Follow-up|0
6006048|NCT00880620|20763950|P4|Overall Study|Lack of Efficacy|1
6006049|NCT00880620|20763951|P3|Overall Study|Lack of Efficacy|0
6006050|NCT00880620|20763952|P2|Overall Study|Lack of Efficacy|4
6006051|NCT00880620|20763953|P1|Overall Study|Lack of Efficacy|12
6006052|NCT00880620|20763950|P4|Overall Study|Death|0
6006053|NCT00880620|20763951|P3|Overall Study|Death|1
6006054|NCT00880620|20763952|P2|Overall Study|Death|0
6006055|NCT00880620|20763953|P1|Overall Study|Death|0
6006056|NCT00880620|20763950|P4|Overall Study|Adverse Event|15
6006057|NCT00880620|20763951|P3|Overall Study|Adverse Event|15
6006058|NCT00880620|20763952|P2|Overall Study|Adverse Event|5
6006059|NCT00880620|20763953|P1|Overall Study|Adverse Event|4
6006060|NCT00880607|20763969|P2|Overall Study|surgery did not extend past L1 level|0
6006061|NCT00880607|20763970|P1|Overall Study|surgery did not extend past L1 level|3
6006062|NCT00880607|20763969|P2|Overall Study|Protocol Violation|1
6006063|NCT00880607|20763970|P1|Overall Study|Protocol Violation|2
6006064|NCT00880607|20763969|P2|Overall Study|Physician Decision|2
6006065|NCT00880607|20763970|P1|Overall Study|Physician Decision|2
6006066|NCT00880568|20764002|P9|Overall Study|Withdrawal by Subject|0
6006067|NCT00880568|20764003|P8|Overall Study|Withdrawal by Subject|1
6006068|NCT00880568|20764004|P7|Overall Study|Withdrawal by Subject|0
6006069|NCT00880568|20764005|P6|Overall Study|Withdrawal by Subject|0
6006070|NCT00880568|20764006|P5|Overall Study|Withdrawal by Subject|0
6006071|NCT00880568|20764007|P4|Overall Study|Withdrawal by Subject|0
6006072|NCT00880568|20764008|P3|Overall Study|Withdrawal by Subject|0
6006073|NCT00880568|20764009|P2|Overall Study|Withdrawal by Subject|0
6006074|NCT00880568|20764010|P1|Overall Study|Withdrawal by Subject|0
6006075|NCT00880568|20764002|P9|Overall Study|Adverse Event|0
6006076|NCT00880568|20764003|P8|Overall Study|Adverse Event|1
6006077|NCT00880568|20764004|P7|Overall Study|Adverse Event|1
6006078|NCT00880568|20764005|P6|Overall Study|Adverse Event|0
6006079|NCT00880568|20764006|P5|Overall Study|Adverse Event|0
6006080|NCT00880568|20764007|P4|Overall Study|Adverse Event|0
6006081|NCT00880568|20764008|P3|Overall Study|Adverse Event|0
6006082|NCT00880568|20764009|P2|Overall Study|Adverse Event|0
6006083|NCT00880568|20764010|P1|Overall Study|Adverse Event|0
6006084|NCT00880568|20764002|P9|Overall Study|Disease progression|3
6006085|NCT00880568|20764003|P8|Overall Study|Disease progression|0
6006086|NCT00880568|20764004|P7|Overall Study|Disease progression|5
6006087|NCT00880568|20764005|P6|Overall Study|Disease progression|3
6006088|NCT00880568|20764006|P5|Overall Study|Disease progression|3
6006089|NCT00880568|20764007|P4|Overall Study|Disease progression|1
6006090|NCT00880568|20764008|P3|Overall Study|Disease progression|3
6006091|NCT00880568|20764009|P2|Overall Study|Disease progression|3
6006092|NCT00880568|20764010|P1|Overall Study|Disease progression|3
6006093|NCT00880555|20764056|P6|Overall Study|Lost to Follow-up|0
6006094|NCT00880555|20764057|P5|Overall Study|Lost to Follow-up|0
6006095|NCT00880555|20764058|P4|Overall Study|Lost to Follow-up|0
6006096|NCT00880555|20764059|P3|Overall Study|Lost to Follow-up|0
6006097|NCT00880555|20764060|P2|Overall Study|Lost to Follow-up|1
6006098|NCT00880555|20764061|P1|Overall Study|Lost to Follow-up|0
6006099|NCT00880555|20764056|P6|Overall Study|Death|1
6006100|NCT00880555|20764057|P5|Overall Study|Death|0
6006101|NCT00880555|20764058|P4|Overall Study|Death|0
6006102|NCT00880555|20764059|P3|Overall Study|Death|0
6006103|NCT00880555|20764060|P2|Overall Study|Death|0
6006104|NCT00880555|20764061|P1|Overall Study|Death|0
6006105|NCT00880555|20764056|P6|Overall Study|Lack of resources (hired rater)|0
6006106|NCT00880555|20764057|P5|Overall Study|Lack of resources (hired rater)|0
6006107|NCT00880555|20764058|P4|Overall Study|Lack of resources (hired rater)|0
6006108|NCT00880555|20764059|P3|Overall Study|Lack of resources (hired rater)|5
6006109|NCT00880555|20764060|P2|Overall Study|Lack of resources (hired rater)|7
6006110|NCT00880555|20764061|P1|Overall Study|Lack of resources (hired rater)|9
6006111|NCT00880555|20764056|P6|Overall Study|Withdrawal by Subject|0
6006112|NCT00880555|20764057|P5|Overall Study|Withdrawal by Subject|0
6006113|NCT00880555|20764058|P4|Overall Study|Withdrawal by Subject|0
6006114|NCT00880555|20764059|P3|Overall Study|Withdrawal by Subject|0
6006115|NCT00880555|20764060|P2|Overall Study|Withdrawal by Subject|1
6006116|NCT00880555|20764061|P1|Overall Study|Withdrawal by Subject|1
6006117|NCT00880555|20764056|P6|Overall Study|Physician Decision|0
6006118|NCT00880555|20764057|P5|Overall Study|Physician Decision|1
6006119|NCT00880555|20764058|P4|Overall Study|Physician Decision|2
6006120|NCT00880555|20764059|P3|Overall Study|Physician Decision|0
6006121|NCT00880555|20764060|P2|Overall Study|Physician Decision|8
6006122|NCT00880555|20764061|P1|Overall Study|Physician Decision|0
6006123|NCT00880542|20764072|P1|REP: Surgical Resection|progressive disease|1
6006124|NCT00880542|20764072|P1|Treatment Period (Sorafenib+Ifosfamide)|disease progression|2
6006125|NCT00880542|20764072|P1|Treatment Period (Sorafenib+Ifosfamide)|Adverse Event|1
6006126|NCT00880399|20764089|P3|Overall Study|Withdrawal by Subject|3
6006127|NCT00880399|20764090|P2|Overall Study|Withdrawal by Subject|3
6006128|NCT00880399|20764091|P1|Overall Study|Withdrawal by Subject|6
6006129|NCT00880399|20764089|P3|Overall Study|Physician Decision|3
6006130|NCT00880399|20764090|P2|Overall Study|Physician Decision|0
6006131|NCT00880399|20764091|P1|Overall Study|Physician Decision|5
6006132|NCT00880399|20764089|P3|Overall Study|Lost to Follow-up|3
6006133|NCT00880399|20764090|P2|Overall Study|Lost to Follow-up|5
6006134|NCT00880399|20764091|P1|Overall Study|Lost to Follow-up|8
6006135|NCT00880399|20764089|P3|Overall Study|Study closed/terminated|4
6006136|NCT00880399|20764090|P2|Overall Study|Study closed/terminated|7
6006137|NCT00880399|20764091|P1|Overall Study|Study closed/terminated|3
6006138|NCT00880399|20764089|P3|Overall Study|Protocol Violation|6
6006139|NCT00880399|20764090|P2|Overall Study|Protocol Violation|4
6006140|NCT00880399|20764091|P1|Overall Study|Protocol Violation|4
6006141|NCT00880399|20764089|P3|Overall Study|Lack of Efficacy|2
6006142|NCT00880399|20764090|P2|Overall Study|Lack of Efficacy|4
6006143|NCT00880399|20764091|P1|Overall Study|Lack of Efficacy|1
6006144|NCT00880399|20764089|P3|Overall Study|Adverse Event|5
6006145|NCT00880399|20764090|P2|Overall Study|Adverse Event|6
6006146|NCT00880399|20764091|P1|Overall Study|Adverse Event|4
6006147|NCT00880334|20764154|P2|Randomized Phase|Crossover Participants|37
6006148|NCT00880334|20764155|P1|Randomized Phase|Crossover Participants|0
6006149|NCT00880334|20764154|P2|Randomized Phase|Brain Metastasis|1
6006150|NCT00880334|20764155|P1|Randomized Phase|Brain Metastasis|0
6006151|NCT00880334|20764154|P2|Randomized Phase|Inadequate Labs|1
6006152|NCT00880334|20764155|P1|Randomized Phase|Inadequate Labs|1
6006153|NCT00880334|20764154|P2|Randomized Phase|Withdrawal by Subject|1
6006154|NCT00880334|20764155|P1|Randomized Phase|Withdrawal by Subject|2
6006155|NCT00880334|20764154|P2|Randomized Phase|Physician Decision|0
6006156|NCT00880334|20764155|P1|Randomized Phase|Physician Decision|1
6006157|NCT00880269|20764172|P2|Overall Study|Adverse Event|9
6006158|NCT00880269|20764173|P1|Overall Study|Adverse Event|10
6006159|NCT00880269|20764172|P2|Overall Study|Withdrawal by Subject|4
6006160|NCT00880269|20764173|P1|Overall Study|Withdrawal by Subject|3
6006161|NCT00880269|20764172|P2|Overall Study|Lost to Follow-up|1
6006162|NCT00880269|20764173|P1|Overall Study|Lost to Follow-up|0
6006163|NCT00880269|20764172|P2|Overall Study|Death|2
6006164|NCT00880269|20764173|P1|Overall Study|Death|4
6006165|NCT00880269|20764172|P2|Overall Study|New Cancer Therapy|0
6006166|NCT00880269|20764173|P1|Overall Study|New Cancer Therapy|1
6006167|NCT00880269|20764172|P2|Overall Study|Disease Progression|11
6006168|NCT00880269|20764173|P1|Overall Study|Disease Progression|13
6006169|NCT00880269|20764172|P2|Overall Study|Protocol Violation|0
6006170|NCT00880269|20764173|P1|Overall Study|Protocol Violation|1
6006171|NCT00880256|20764189|P1|Overall Study|Lost to Follow-up|28
6006172|NCT00880191|20764216|P2|Overall Study|Hospitalization/efficacy|1
6006173|NCT00880191|20764217|P1|Overall Study|Hospitalization/efficacy|1
6006174|NCT00880191|20764216|P2|Overall Study|Adverse Event|6
6006175|NCT00880191|20764217|P1|Overall Study|Adverse Event|8
6006176|NCT00880191|20764216|P2|Overall Study|Refused further treatment|1
6006177|NCT00880191|20764217|P1|Overall Study|Refused further treatment|4
6006178|NCT00880165|20764237|P2|Overall Study|Lost to follow|15
6006179|NCT00880165|20764238|P1|Overall Study|Lost to follow|9
6006180|NCT00880165|20764237|P2|Overall Study|Required BIPAP or oxygen treatment|4
6006181|NCT00880165|20764238|P1|Overall Study|Required BIPAP or oxygen treatment|12
6006182|NCT00880165|20764237|P2|Overall Study|Not diagnosed with OSA|8
6006183|NCT00880165|20764238|P1|Overall Study|Not diagnosed with OSA|14
6006184|NCT00880165|20764237|P2|Overall Study|Withdrawal by Subject|23
6006185|NCT00880165|20764238|P1|Overall Study|Withdrawal by Subject|27
6006186|NCT00880100|20764248|P1|Treatment Phase With Ultrase® MT12|Protocol Violation|2
6006187|NCT00880100|20764248|P1|Treatment Phase With Ultrase® MT12|Adverse Event|1
6006188|NCT00880100|20764248|P1|Baseline Phase-Usual Pancreatic Enzymes|Protocol Violation|1
6006189|NCT00880087|20764261|P2|Overall Study|Lost to Follow-up|2
6006190|NCT00880087|20764262|P1|Overall Study|Lost to Follow-up|0
6006191|NCT00880048|20764277|P3|Overall Study|Study closed/terminated|6
6006192|NCT00880048|20764278|P2|Overall Study|Study closed/terminated|7
6006193|NCT00880048|20764279|P1|Overall Study|Study closed/terminated|9
6006194|NCT00880048|20764277|P3|Overall Study|Withdrawal by Subject|5
6006195|NCT00880048|20764278|P2|Overall Study|Withdrawal by Subject|8
6006196|NCT00880048|20764279|P1|Overall Study|Withdrawal by Subject|5
6006197|NCT00880048|20764277|P3|Overall Study|Physician Decision|7
6006198|NCT00880048|20764278|P2|Overall Study|Physician Decision|1
6006199|NCT00880048|20764279|P1|Overall Study|Physician Decision|1
6006200|NCT00880048|20764277|P3|Overall Study|Lost to Follow-up|5
6006201|NCT00880048|20764278|P2|Overall Study|Lost to Follow-up|6
6006202|NCT00880048|20764279|P1|Overall Study|Lost to Follow-up|6
6006203|NCT00880048|20764277|P3|Overall Study|Protocol Violation|5
6006204|NCT00880048|20764278|P2|Overall Study|Protocol Violation|6
6006205|NCT00880048|20764279|P1|Overall Study|Protocol Violation|4
6006206|NCT00880048|20764277|P3|Overall Study|Lack of Efficacy|2
6006207|NCT00880048|20764278|P2|Overall Study|Lack of Efficacy|2
6006208|NCT00880048|20764279|P1|Overall Study|Lack of Efficacy|1
6006209|NCT00880048|20764277|P3|Overall Study|Adverse Event|5
6006210|NCT00880048|20764278|P2|Overall Study|Adverse Event|3
6006211|NCT00880048|20764279|P1|Overall Study|Adverse Event|2
6006212|NCT00880009|20764346|P1|Overall Study|Protocol Violation|1
6006213|NCT00880009|20764346|P1|Overall Study|Withdrawal by Subject|1
6006214|NCT00880009|20764346|P1|Overall Study|Study terminated by sponsor|14
6006215|NCT00879996|20764370|P2|Overall Study|put on parole|0
6006216|NCT00879996|20764371|P1|Overall Study|put on parole|1
6006217|NCT00879996|20764370|P2|Overall Study|psychiatric problem|1
6006218|NCT00879996|20764371|P1|Overall Study|psychiatric problem|0
6006219|NCT00879996|20764370|P2|Overall Study|Physician Decision|2
6006220|NCT00879996|20764371|P1|Overall Study|Physician Decision|1
6006221|NCT00879996|20764370|P2|Overall Study|non-compliance|4
6006222|NCT00879996|20764371|P1|Overall Study|non-compliance|6
6006223|NCT00879996|20764370|P2|Overall Study|Lost to Follow-up|6
6006224|NCT00879996|20764371|P1|Overall Study|Lost to Follow-up|7
6006225|NCT00879970|20764386|P5|Period 2 Vitamin D Randomization|Death|0
6006226|NCT00879970|20764387|P4|Period 2 Vitamin D Randomization|Death|2
6006227|NCT00879970|20764388|P3|Period 2 Vitamin D Randomization|Death|0
6006228|NCT00879970|20764389|P2|Period 2 Vitamin D Randomization|Death|0
6006229|NCT00879970|20764390|P1|Period 2 Vitamin D Randomization|Death|0
6006230|NCT00879970|20764386|P5|Period 2 Vitamin D Randomization|Lost to Follow-up|1
6006231|NCT00879970|20764387|P4|Period 2 Vitamin D Randomization|Lost to Follow-up|0
6006232|NCT00879970|20764388|P3|Period 2 Vitamin D Randomization|Lost to Follow-up|0
6006233|NCT00879970|20764389|P2|Period 2 Vitamin D Randomization|Lost to Follow-up|0
6006234|NCT00879970|20764390|P1|Period 2 Vitamin D Randomization|Lost to Follow-up|0
6006235|NCT00879970|20764386|P5|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|6
6006236|NCT00879970|20764387|P4|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|2
6006237|NCT00879970|20764388|P3|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0
6006238|NCT00879970|20764389|P2|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0
6006239|NCT00879970|20764390|P1|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0
6006240|NCT00879970|20764386|P5|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0
6006241|NCT00879970|20764387|P4|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0
6006242|NCT00879970|20764388|P3|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|1
6006243|NCT00879970|20764389|P2|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0
6006244|NCT00879970|20764390|P1|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|2
6006245|NCT00879970|20764386|P5|Period 1 TZD Randomization|Death|0
6006246|NCT00879970|20764387|P4|Period 1 TZD Randomization|Death|0
6006247|NCT00879970|20764388|P3|Period 1 TZD Randomization|Death|0
6006248|NCT00879970|20764389|P2|Period 1 TZD Randomization|Death|1
6006249|NCT00879970|20764390|P1|Period 1 TZD Randomization|Death|2
6006250|NCT00879970|20764386|P5|Period 1 TZD Randomization|Lost to Follow-up|0
6006251|NCT00879970|20764387|P4|Period 1 TZD Randomization|Lost to Follow-up|0
6006252|NCT00879970|20764388|P3|Period 1 TZD Randomization|Lost to Follow-up|1
6006253|NCT00879970|20764389|P2|Period 1 TZD Randomization|Lost to Follow-up|0
6006254|NCT00879970|20764390|P1|Period 1 TZD Randomization|Lost to Follow-up|1
6006255|NCT00879970|20764386|P5|Period 1 TZD Randomization|Refused to Attend Final Visit|0
6006256|NCT00879970|20764387|P4|Period 1 TZD Randomization|Refused to Attend Final Visit|0
6006257|NCT00879970|20764388|P3|Period 1 TZD Randomization|Refused to Attend Final Visit|4
6006258|NCT00879970|20764389|P2|Period 1 TZD Randomization|Refused to Attend Final Visit|3
6006259|NCT00879970|20764390|P1|Period 1 TZD Randomization|Refused to Attend Final Visit|3
6006263|NCT00879814|20764480|P4|Overall Study|Other|0
6006264|NCT00879814|20764481|P3|Overall Study|Other|1
6006265|NCT00879814|20764482|P2|Overall Study|Other|0
6006266|NCT00879814|20764483|P1|Overall Study|Other|0
6006267|NCT00879814|20764480|P4|Overall Study|Physician Decision|0
6006268|NCT00879814|20764481|P3|Overall Study|Physician Decision|1
6006269|NCT00879814|20764482|P2|Overall Study|Physician Decision|0
6006270|NCT00879814|20764483|P1|Overall Study|Physician Decision|0
6006271|NCT00879814|20764480|P4|Overall Study|Withdrawal by Subject|2
6006272|NCT00879814|20764481|P3|Overall Study|Withdrawal by Subject|1
6006273|NCT00879814|20764482|P2|Overall Study|Withdrawal by Subject|1
6006274|NCT00879814|20764483|P1|Overall Study|Withdrawal by Subject|3
6006275|NCT00879814|20764480|P4|Overall Study|Participant Failed to Return|1
6006276|NCT00879814|20764481|P3|Overall Study|Participant Failed to Return|0
6006277|NCT00879814|20764482|P2|Overall Study|Participant Failed to Return|0
6006278|NCT00879814|20764483|P1|Overall Study|Participant Failed to Return|0
6006279|NCT00879814|20764480|P4|Overall Study|Lost to Follow-up|2
6006280|NCT00879814|20764481|P3|Overall Study|Lost to Follow-up|0
6006281|NCT00879814|20764482|P2|Overall Study|Lost to Follow-up|0
6006282|NCT00879814|20764483|P1|Overall Study|Lost to Follow-up|1
6006283|NCT00879814|20764480|P4|Overall Study|Adverse Event|0
6006284|NCT00879814|20764481|P3|Overall Study|Adverse Event|0
6006285|NCT00879814|20764482|P2|Overall Study|Adverse Event|1
6006286|NCT00879814|20764483|P1|Overall Study|Adverse Event|0
6006287|NCT00879775|20764591|P2|Overall Study|Lost to Follow-up|1
6006288|NCT00879775|20764592|P1|Overall Study|Lost to Follow-up|2
6006289|NCT00879710|20764608|P4|Phase 1 - 6 Weeks|Adverse Event|0
6006290|NCT00879710|20764609|P3|Phase 1 - 6 Weeks|Adverse Event|1
6006291|NCT00879710|20764610|P2|Phase 1 - 6 Weeks|Adverse Event|0
6006292|NCT00879710|20764611|P1|Phase 1 - 6 Weeks|Adverse Event|0
6006293|NCT00879710|20764608|P4|Phase 1 - 6 Weeks|Lost to Follow-up|4
6006294|NCT00879710|20764609|P3|Phase 1 - 6 Weeks|Lost to Follow-up|1
6006295|NCT00879710|20764610|P2|Phase 1 - 6 Weeks|Lost to Follow-up|3
6006296|NCT00879710|20764611|P1|Phase 1 - 6 Weeks|Lost to Follow-up|2
6006297|NCT00879697|20764621|P2|Overall Study|Physician Decision|2
6006298|NCT00879697|20764622|P1|Overall Study|Physician Decision|2
6006299|NCT00879684|20764628|P7|Stage 2: Expanded Cohort|Investigator declined participation|1
6006300|NCT00879684|20764629|P6|Stage 2: Expanded Cohort|Investigator declined participation|0
6006301|NCT00879684|20764630|P5|Stage 2: Expanded Cohort|Investigator declined participation|0
6006302|NCT00879684|20764631|P4|Stage 2: Expanded Cohort|Investigator declined participation|0
6006303|NCT00879684|20764632|P3|Stage 2: Expanded Cohort|Investigator declined participation|0
6006304|NCT00879684|20764633|P2|Stage 2: Expanded Cohort|Investigator declined participation|0
6006305|NCT00879684|20764634|P1|Stage 2: Expanded Cohort|Investigator declined participation|0
6006306|NCT00879684|20764628|P7|Stage 2: Expanded Cohort|Progressive Disease|11
6006307|NCT00879684|20764629|P6|Stage 2: Expanded Cohort|Progressive Disease|0
6006308|NCT00879684|20764630|P5|Stage 2: Expanded Cohort|Progressive Disease|0
6006309|NCT00879684|20764631|P4|Stage 2: Expanded Cohort|Progressive Disease|0
6006310|NCT00879684|20764632|P3|Stage 2: Expanded Cohort|Progressive Disease|0
6006311|NCT00879684|20764633|P2|Stage 2: Expanded Cohort|Progressive Disease|0
6006312|NCT00879684|20764634|P1|Stage 2: Expanded Cohort|Progressive Disease|0
6006313|NCT00879684|20764628|P7|Stage 2: Expanded Cohort|Lost to Follow-up|1
6006314|NCT00879684|20764629|P6|Stage 2: Expanded Cohort|Lost to Follow-up|0
6006315|NCT00879684|20764630|P5|Stage 2: Expanded Cohort|Lost to Follow-up|0
6006316|NCT00879684|20764631|P4|Stage 2: Expanded Cohort|Lost to Follow-up|0
6006317|NCT00879684|20764632|P3|Stage 2: Expanded Cohort|Lost to Follow-up|0
6006318|NCT00879684|20764633|P2|Stage 2: Expanded Cohort|Lost to Follow-up|0
6006319|NCT00879684|20764634|P1|Stage 2: Expanded Cohort|Lost to Follow-up|0
6006320|NCT00879684|20764628|P7|Stage 1: Dose Escalation|Death|0
6006321|NCT00879684|20764629|P6|Stage 1: Dose Escalation|Death|0
6006322|NCT00879684|20764630|P5|Stage 1: Dose Escalation|Death|0
6006323|NCT00879684|20764631|P4|Stage 1: Dose Escalation|Death|0
6006324|NCT00879684|20764632|P3|Stage 1: Dose Escalation|Death|1
6006325|NCT00879684|20764633|P2|Stage 1: Dose Escalation|Death|0
6006326|NCT00879684|20764634|P1|Stage 1: Dose Escalation|Death|0
6006327|NCT00879684|20764628|P7|Stage 1: Dose Escalation|Investigator declined participation|0
6006328|NCT00879684|20764629|P6|Stage 1: Dose Escalation|Investigator declined participation|0
6006329|NCT00879684|20764630|P5|Stage 1: Dose Escalation|Investigator declined participation|0
6006330|NCT00879684|20764631|P4|Stage 1: Dose Escalation|Investigator declined participation|2
6006331|NCT00879684|20764632|P3|Stage 1: Dose Escalation|Investigator declined participation|2
6006332|NCT00879684|20764633|P2|Stage 1: Dose Escalation|Investigator declined participation|0
6006333|NCT00879684|20764634|P1|Stage 1: Dose Escalation|Investigator declined participation|0
6006334|NCT00879684|20764628|P7|Stage 1: Dose Escalation|Progressive Disease|0
6006335|NCT00879684|20764629|P6|Stage 1: Dose Escalation|Progressive Disease|3
6006336|NCT00879684|20764630|P5|Stage 1: Dose Escalation|Progressive Disease|3
6006337|NCT00879684|20764631|P4|Stage 1: Dose Escalation|Progressive Disease|4
6006338|NCT00879684|20764632|P3|Stage 1: Dose Escalation|Progressive Disease|0
6006339|NCT00879684|20764633|P2|Stage 1: Dose Escalation|Progressive Disease|3
6006340|NCT00879684|20764634|P1|Stage 1: Dose Escalation|Progressive Disease|2
6006341|NCT00879684|20764628|P7|Stage 1: Dose Escalation|Adverse Event|0
6006342|NCT00879684|20764629|P6|Stage 1: Dose Escalation|Adverse Event|0
6006343|NCT00879684|20764630|P5|Stage 1: Dose Escalation|Adverse Event|0
6006344|NCT00879684|20764631|P4|Stage 1: Dose Escalation|Adverse Event|0
6006345|NCT00879684|20764632|P3|Stage 1: Dose Escalation|Adverse Event|0
6006346|NCT00879684|20764633|P2|Stage 1: Dose Escalation|Adverse Event|0
6006347|NCT00879684|20764634|P1|Stage 1: Dose Escalation|Adverse Event|1
6006348|NCT00879658|20764703|P7|Overall Study|misrandomized (never received study med)|0
6006349|NCT00879658|20764704|P6|Overall Study|misrandomized (never received study med)|0
6006350|NCT00879658|20764705|P5|Overall Study|misrandomized (never received study med)|0
6006351|NCT00879658|20764706|P4|Overall Study|misrandomized (never received study med)|1
6006352|NCT00879658|20764707|P3|Overall Study|misrandomized (never received study med)|0
6006353|NCT00879658|20764708|P2|Overall Study|misrandomized (never received study med)|0
6006354|NCT00879658|20764709|P1|Overall Study|misrandomized (never received study med)|0
6006355|NCT00879658|20764703|P7|Overall Study|Lack of Efficacy|0
6006356|NCT00879658|20764704|P6|Overall Study|Lack of Efficacy|0
6006357|NCT00879658|20764705|P5|Overall Study|Lack of Efficacy|0
6006358|NCT00879658|20764706|P4|Overall Study|Lack of Efficacy|0
6006359|NCT00879658|20764707|P3|Overall Study|Lack of Efficacy|2
6006360|NCT00879658|20764708|P2|Overall Study|Lack of Efficacy|0
6006361|NCT00879658|20764709|P1|Overall Study|Lack of Efficacy|0
6006362|NCT00879658|20764703|P7|Overall Study|Withdrawal by Subject|0
6006363|NCT00879658|20764704|P6|Overall Study|Withdrawal by Subject|1
6006364|NCT00879658|20764705|P5|Overall Study|Withdrawal by Subject|0
6006365|NCT00879658|20764706|P4|Overall Study|Withdrawal by Subject|0
6006366|NCT00879658|20764707|P3|Overall Study|Withdrawal by Subject|2
6006367|NCT00879658|20764708|P2|Overall Study|Withdrawal by Subject|0
6006368|NCT00879658|20764709|P1|Overall Study|Withdrawal by Subject|3
6006369|NCT00879658|20764703|P7|Overall Study|Protocol Violation|0
6006370|NCT00879658|20764704|P6|Overall Study|Protocol Violation|0
6006371|NCT00879658|20764705|P5|Overall Study|Protocol Violation|0
6006372|NCT00879658|20764706|P4|Overall Study|Protocol Violation|0
6006373|NCT00879658|20764707|P3|Overall Study|Protocol Violation|0
6006374|NCT00879658|20764708|P2|Overall Study|Protocol Violation|0
6006375|NCT00879658|20764709|P1|Overall Study|Protocol Violation|1
6006376|NCT00879658|20764703|P7|Overall Study|Adverse Event|0
6006377|NCT00879658|20764704|P6|Overall Study|Adverse Event|0
6006378|NCT00879658|20764705|P5|Overall Study|Adverse Event|2
6006379|NCT00879658|20764706|P4|Overall Study|Adverse Event|1
6006380|NCT00879658|20764707|P3|Overall Study|Adverse Event|3
6006381|NCT00879658|20764708|P2|Overall Study|Adverse Event|4
6006382|NCT00879658|20764709|P1|Overall Study|Adverse Event|6
6006383|NCT00879658|20764703|P7|Overall Study|Administrative problems|0
6006384|NCT00879658|20764704|P6|Overall Study|Administrative problems|0
6006385|NCT00879658|20764705|P5|Overall Study|Administrative problems|0
6006386|NCT00879658|20764706|P4|Overall Study|Administrative problems|1
6006387|NCT00879658|20764707|P3|Overall Study|Administrative problems|0
6006388|NCT00879658|20764708|P2|Overall Study|Administrative problems|1
6006389|NCT00879658|20764709|P1|Overall Study|Administrative problems|2
6006390|NCT00879658|20764703|P7|Overall Study|Abnormal laboratory value(s)|0
6006391|NCT00879658|20764704|P6|Overall Study|Abnormal laboratory value(s)|0
6006392|NCT00879658|20764705|P5|Overall Study|Abnormal laboratory value(s)|0
6006393|NCT00879658|20764706|P4|Overall Study|Abnormal laboratory value(s)|1
6006394|NCT00879658|20764707|P3|Overall Study|Abnormal laboratory value(s)|0
6006395|NCT00879658|20764708|P2|Overall Study|Abnormal laboratory value(s)|0
6006396|NCT00879658|20764709|P1|Overall Study|Abnormal laboratory value(s)|3
6006397|NCT00879645|20764795|P4|Overall Study|Adverse Event|0
6006398|NCT00879645|20764796|P3|Overall Study|Adverse Event|0
6006399|NCT00879645|20764797|P2|Overall Study|Adverse Event|0
6006400|NCT00879645|20764798|P1|Overall Study|Adverse Event|1
6006401|NCT00879411|20764825|P1|Overall Study|lost to follow-up (non-AE)|162
6006402|NCT00879398|20764831|P1|Overall Study|Other Reasons|171
6006403|NCT00879398|20764831|P1|Overall Study|Adverse Event|41
6006404|NCT00879398|20764831|P1|Overall Study|Lack of Efficacy|64
6006405|NCT00879398|20764831|P1|Overall Study|Visit Stop|399
6006406|NCT00879333|20764849|P2|Overall Study|Protocol Violation|1
6006407|NCT00879333|20764850|P1|Overall Study|Protocol Violation|1
6006408|NCT00879333|20764849|P2|Overall Study|Disease Progression|169
6006409|NCT00879333|20764850|P1|Overall Study|Disease Progression|292
6006410|NCT00879333|20764849|P2|Overall Study|Death|5
6006411|NCT00879333|20764850|P1|Overall Study|Death|16
6006412|NCT00879333|20764849|P2|Overall Study|Administrative Problems|0
6006413|NCT00879333|20764850|P1|Overall Study|Administrative Problems|2
6006414|NCT00879333|20764849|P2|Overall Study|Lost to Follow-up|1
6006415|NCT00879333|20764850|P1|Overall Study|Lost to Follow-up|2
6006416|NCT00879333|20764849|P2|Overall Study|Withdrawal by Subject|7
6006417|NCT00879333|20764850|P1|Overall Study|Withdrawal by Subject|20
6006418|NCT00879333|20764849|P2|Overall Study|Abnormal Laboratory Value|0
6006419|NCT00879333|20764850|P1|Overall Study|Abnormal Laboratory Value|1
6006420|NCT00879333|20764849|P2|Overall Study|Adverse Event|34
6006421|NCT00879333|20764850|P1|Overall Study|Adverse Event|94
6006422|NCT00879229|20764883|P2|Overall Study|Other|0
6006423|NCT00879229|20764884|P1|Overall Study|Other|1
6006424|NCT00879229|20764883|P2|Overall Study|Clinical status did not improve|0
6006425|NCT00879229|20764884|P1|Overall Study|Clinical status did not improve|1
6006426|NCT00879229|20764883|P2|Overall Study|Withdrawal by Subject|0
6006427|NCT00879229|20764884|P1|Overall Study|Withdrawal by Subject|1
6006428|NCT00879229|20764883|P2|Overall Study|Adverse Event|0
6006429|NCT00879229|20764884|P1|Overall Study|Adverse Event|2
6006430|NCT00879229|20764883|P2|Overall Study|Death|2
6006431|NCT00879229|20764884|P1|Overall Study|Death|4
6006432|NCT00879229|20764883|P2|Overall Study|Study terminated by Sponsor|12
6006433|NCT00879229|20764884|P1|Overall Study|Study terminated by Sponsor|13
6006434|NCT00878995|20764932|P2|Baseline Study - Midpoint Study|Withdrawal by Subject|2
6006435|NCT00878995|20764933|P1|Baseline Study - Midpoint Study|Withdrawal by Subject|0
6006436|NCT00878969|20765034|P3|Overall Study|Pregnancy|0
6006437|NCT00878969|20765035|P2|Overall Study|Pregnancy|1
6006438|NCT00878969|20765036|P1|Overall Study|Pregnancy|0
6006439|NCT00878969|20765034|P3|Overall Study|Death|2
6006440|NCT00878969|20765035|P2|Overall Study|Death|0
6006441|NCT00878969|20765036|P1|Overall Study|Death|0
6006442|NCT00878969|20765034|P3|Overall Study|Protocol Violation|0
6006443|NCT00878969|20765035|P2|Overall Study|Protocol Violation|0
6006444|NCT00878969|20765036|P1|Overall Study|Protocol Violation|2
6006445|NCT00878969|20765034|P3|Overall Study|Lost to Follow-up|0
6006446|NCT00878969|20765035|P2|Overall Study|Lost to Follow-up|1
6006447|NCT00878969|20765036|P1|Overall Study|Lost to Follow-up|2
6006448|NCT00878969|20765034|P3|Overall Study|Adverse Event|2
6006449|NCT00878969|20765035|P2|Overall Study|Adverse Event|1
6006450|NCT00878969|20765036|P1|Overall Study|Adverse Event|3
6006451|NCT00878969|20765034|P3|Overall Study|kidney transplant|2
6006452|NCT00878969|20765035|P2|Overall Study|kidney transplant|3
6006453|NCT00878969|20765036|P1|Overall Study|kidney transplant|2
6006454|NCT00878969|20765034|P3|Overall Study|Withdrawal by Subject|3
6006455|NCT00878969|20765035|P2|Overall Study|Withdrawal by Subject|6
6006456|NCT00878969|20765036|P1|Overall Study|Withdrawal by Subject|1
6006457|NCT00878969|20765034|P3|Overall Study|Physician Decision|2
6006458|NCT00878969|20765035|P2|Overall Study|Physician Decision|3
6006459|NCT00878969|20765036|P1|Overall Study|Physician Decision|5
6006460|NCT00878800|20765084|P5|Overall Study|Other|1
6006461|NCT00878800|20765085|P4|Overall Study|Other|0
6006462|NCT00878800|20765086|P3|Overall Study|Other|0
6006463|NCT00878800|20765087|P2|Overall Study|Other|1
6006464|NCT00878800|20765088|P1|Overall Study|Other|1
6006465|NCT00878800|20765084|P5|Overall Study|Death|0
6006466|NCT00878800|20765085|P4|Overall Study|Death|0
6006467|NCT00878800|20765086|P3|Overall Study|Death|1
6006468|NCT00878800|20765087|P2|Overall Study|Death|0
6006469|NCT00878800|20765088|P1|Overall Study|Death|0
6006470|NCT00878800|20765084|P5|Overall Study|Withdrew consent|1
6006471|NCT00878800|20765085|P4|Overall Study|Withdrew consent|1
6006472|NCT00878800|20765086|P3|Overall Study|Withdrew consent|0
6006473|NCT00878800|20765087|P2|Overall Study|Withdrew consent|1
6006474|NCT00878800|20765088|P1|Overall Study|Withdrew consent|1
6006475|NCT00878800|20765084|P5|Overall Study|Progressive disease|13
6006476|NCT00878800|20765085|P4|Overall Study|Progressive disease|5
6006477|NCT00878800|20765086|P3|Overall Study|Progressive disease|6
6006478|NCT00878800|20765087|P2|Overall Study|Progressive disease|5
6006479|NCT00878800|20765088|P1|Overall Study|Progressive disease|1
6006480|NCT00878800|20765084|P5|Overall Study|Adverse Event|1
6006481|NCT00878800|20765085|P4|Overall Study|Adverse Event|0
6006482|NCT00878800|20765086|P3|Overall Study|Adverse Event|2
6006483|NCT00878800|20765087|P2|Overall Study|Adverse Event|0
6006484|NCT00878800|20765088|P1|Overall Study|Adverse Event|0
6006485|NCT00878722|20765123|P8|Overall Study|Relapse|0
6006486|NCT00878722|20765124|P7|Overall Study|Relapse|0
6006487|NCT00878722|20765125|P6|Overall Study|Relapse|0
6006488|NCT00878722|20765126|P5|Overall Study|Relapse|0
6006489|NCT00878722|20765127|P4|Overall Study|Relapse|1
6006490|NCT00878722|20765128|P3|Overall Study|Relapse|0
6006491|NCT00878722|20765129|P2|Overall Study|Relapse|0
6006492|NCT00878722|20765130|P1|Overall Study|Relapse|0
6006493|NCT00878722|20765123|P8|Overall Study|Withdrawal by Subject|2
6006494|NCT00878722|20765124|P7|Overall Study|Withdrawal by Subject|0
6006495|NCT00878722|20765125|P6|Overall Study|Withdrawal by Subject|0
6006496|NCT00878722|20765126|P5|Overall Study|Withdrawal by Subject|0
6006497|NCT00878722|20765127|P4|Overall Study|Withdrawal by Subject|0
6006498|NCT00878722|20765128|P3|Overall Study|Withdrawal by Subject|0
6006499|NCT00878722|20765129|P2|Overall Study|Withdrawal by Subject|0
6006500|NCT00878722|20765130|P1|Overall Study|Withdrawal by Subject|0
6006501|NCT00878722|20765123|P8|Overall Study|Adverse Event|0
6006502|NCT00878722|20765124|P7|Overall Study|Adverse Event|2
6006503|NCT00878722|20765125|P6|Overall Study|Adverse Event|0
6006504|NCT00878722|20765126|P5|Overall Study|Adverse Event|0
6006505|NCT00878722|20765127|P4|Overall Study|Adverse Event|0
6006506|NCT00878722|20765128|P3|Overall Study|Adverse Event|0
6006507|NCT00878722|20765129|P2|Overall Study|Adverse Event|0
6006508|NCT00878722|20765130|P1|Overall Study|Adverse Event|0
6006509|NCT00878722|20765123|P8|Overall Study|Death|2
6006510|NCT00878722|20765124|P7|Overall Study|Death|0
6006511|NCT00878722|20765125|P6|Overall Study|Death|1
6006512|NCT00878722|20765126|P5|Overall Study|Death|0
6006513|NCT00878722|20765127|P4|Overall Study|Death|1
6006514|NCT00878722|20765128|P3|Overall Study|Death|0
6006515|NCT00878722|20765129|P2|Overall Study|Death|0
6006516|NCT00878722|20765130|P1|Overall Study|Death|0
6006517|NCT00878722|20765123|P8|Overall Study|Progressive disease|3
6006518|NCT00878722|20765124|P7|Overall Study|Progressive disease|4
6006519|NCT00878722|20765125|P6|Overall Study|Progressive disease|1
6006520|NCT00878722|20765126|P5|Overall Study|Progressive disease|7
6006521|NCT00878722|20765127|P4|Overall Study|Progressive disease|7
6006522|NCT00878722|20765128|P3|Overall Study|Progressive disease|3
6006523|NCT00878722|20765129|P2|Overall Study|Progressive disease|3
6006524|NCT00878722|20765130|P1|Overall Study|Progressive disease|3
6006525|NCT00878709|20765215|P2|Overall Study|Other Reasons|84
6006526|NCT00878709|20765216|P1|Overall Study|Other Reasons|93
6006527|NCT00878709|20765215|P2|Overall Study|Lost to Follow-up|33
6006528|NCT00878709|20765216|P1|Overall Study|Lost to Follow-up|35
6006529|NCT00878709|20765215|P2|Overall Study|Withdrawal by Subject|120
6006530|NCT00878709|20765216|P1|Overall Study|Withdrawal by Subject|197
6006531|NCT00878553|20765290|P5|PK Study|Withdrawal by Subject|0
6006532|NCT00878553|20765291|P4|PK Study|Withdrawal by Subject|1
6006533|NCT00878553|20765292|P3|PK Study|Withdrawal by Subject|0
6006534|NCT00878553|20765293|P2|PK Study|Withdrawal by Subject|0
6006535|NCT00878553|20765294|P1|PK Study|Withdrawal by Subject|0
6006536|NCT00878553|20765290|P5|Sleep Study|family emergency|0
6006537|NCT00878553|20765291|P4|Sleep Study|family emergency|0
6006538|NCT00878553|20765292|P3|Sleep Study|family emergency|0
6006539|NCT00878553|20765293|P2|Sleep Study|family emergency|0
6006540|NCT00878553|20765294|P1|Sleep Study|family emergency|1
6006541|NCT00878553|20765290|P5|Sleep Study|car accident|0
6006542|NCT00878553|20765291|P4|Sleep Study|car accident|0
6006543|NCT00878553|20765292|P3|Sleep Study|car accident|0
6006544|NCT00878553|20765293|P2|Sleep Study|car accident|0
6006545|NCT00878553|20765294|P1|Sleep Study|car accident|1
6006546|NCT00878553|20765290|P5|Sleep Study|Lost to Follow-up|0
6006547|NCT00878553|20765291|P4|Sleep Study|Lost to Follow-up|0
6006548|NCT00878553|20765292|P3|Sleep Study|Lost to Follow-up|0
6006549|NCT00878553|20765293|P2|Sleep Study|Lost to Follow-up|0
6006550|NCT00878553|20765294|P1|Sleep Study|Lost to Follow-up|1
6006551|NCT00878553|20765290|P5|Sleep Study|Withdrawal by Subject|0
6006552|NCT00878553|20765291|P4|Sleep Study|Withdrawal by Subject|0
6006553|NCT00878553|20765292|P3|Sleep Study|Withdrawal by Subject|0
6006554|NCT00878553|20765293|P2|Sleep Study|Withdrawal by Subject|0
6006555|NCT00878553|20765294|P1|Sleep Study|Withdrawal by Subject|2
6006556|NCT00878501|20765353|P3|Overall Study|Administrative|1
6006557|NCT00878501|20765354|P2|Overall Study|Administrative|0
6006558|NCT00878501|20765355|P1|Overall Study|Administrative|0
6006559|NCT00878501|20765353|P3|Overall Study|Mis-randomisation of patient|0
6006560|NCT00878501|20765354|P2|Overall Study|Mis-randomisation of patient|0
6006561|NCT00878501|20765355|P1|Overall Study|Mis-randomisation of patient|1
6006562|NCT00878501|20765353|P3|Overall Study|Intake of prohibited concom. medication|1
6006563|NCT00878501|20765354|P2|Overall Study|Intake of prohibited concom. medication|0
6006564|NCT00878501|20765355|P1|Overall Study|Intake of prohibited concom. medication|0
6006565|NCT00878501|20765353|P3|Overall Study|Incorrect enrolment|0
6006566|NCT00878501|20765354|P2|Overall Study|Incorrect enrolment|2
6006567|NCT00878501|20765355|P1|Overall Study|Incorrect enrolment|1
6006568|NCT00878501|20765353|P3|Overall Study|Protocol Violation|1
6006569|NCT00878501|20765354|P2|Overall Study|Protocol Violation|0
6006570|NCT00878501|20765355|P1|Overall Study|Protocol Violation|0
6006571|NCT00878501|20765353|P3|Overall Study|Withdrawal by Subject|2
6006572|NCT00878501|20765354|P2|Overall Study|Withdrawal by Subject|1
6006573|NCT00878501|20765355|P1|Overall Study|Withdrawal by Subject|2
6006574|NCT00878501|20765353|P3|Overall Study|Lack of Efficacy|0
6006575|NCT00878501|20765354|P2|Overall Study|Lack of Efficacy|1
6006576|NCT00878501|20765355|P1|Overall Study|Lack of Efficacy|2
6006577|NCT00878501|20765353|P3|Overall Study|Adverse Event|3
6006578|NCT00878501|20765354|P2|Overall Study|Adverse Event|3
6006579|NCT00878501|20765355|P1|Overall Study|Adverse Event|11
6006580|NCT00878215|20765404|P4|Overall Study|Determined to be ineligible|0
6006581|NCT00878215|20765405|P3|Overall Study|Determined to be ineligible|0
6006582|NCT00878215|20765406|P2|Overall Study|Determined to be ineligible|10
6006583|NCT00878215|20765407|P1|Overall Study|Determined to be ineligible|0
6006584|NCT00878189|20765419|P9|Overall Study|Objection Progression or Relapse|3
6006585|NCT00878189|20765420|P8|Overall Study|Objection Progression or Relapse|0
6006586|NCT00878189|20765421|P7|Overall Study|Objection Progression or Relapse|0
6006587|NCT00878189|20765422|P6|Overall Study|Objection Progression or Relapse|0
6006588|NCT00878189|20765423|P5|Overall Study|Objection Progression or Relapse|0
6006589|NCT00878189|20765424|P4|Overall Study|Objection Progression or Relapse|0
6006590|NCT00878189|20765425|P3|Overall Study|Objection Progression or Relapse|0
6006591|NCT00878189|20765426|P2|Overall Study|Objection Progression or Relapse|0
6006592|NCT00878189|20765427|P1|Overall Study|Objection Progression or Relapse|0
6006593|NCT00878189|20765419|P9|Overall Study|Lost to Follow-up|0
6006594|NCT00878189|20765420|P8|Overall Study|Lost to Follow-up|0
6006595|NCT00878189|20765421|P7|Overall Study|Lost to Follow-up|1
6006596|NCT00878189|20765422|P6|Overall Study|Lost to Follow-up|1
6006597|NCT00878189|20765423|P5|Overall Study|Lost to Follow-up|0
6006598|NCT00878189|20765424|P4|Overall Study|Lost to Follow-up|0
6006599|NCT00878189|20765425|P3|Overall Study|Lost to Follow-up|0
6006600|NCT00878189|20765426|P2|Overall Study|Lost to Follow-up|0
6006601|NCT00878189|20765427|P1|Overall Study|Lost to Follow-up|0
6006602|NCT00878189|20765419|P9|Overall Study|Other|4
6006603|NCT00878189|20765420|P8|Overall Study|Other|3
6006604|NCT00878189|20765421|P7|Overall Study|Other|15
6006605|NCT00878189|20765422|P6|Overall Study|Other|18
6006606|NCT00878189|20765423|P5|Overall Study|Other|4
6006607|NCT00878189|20765424|P4|Overall Study|Other|7
6006608|NCT00878189|20765425|P3|Overall Study|Other|4
6006609|NCT00878189|20765426|P2|Overall Study|Other|2
6006610|NCT00878189|20765427|P1|Overall Study|Other|3
6006611|NCT00878189|20765419|P9|Overall Study|Participant Refused to Follow-up|0
6006612|NCT00878189|20765420|P8|Overall Study|Participant Refused to Follow-up|0
6006613|NCT00878189|20765421|P7|Overall Study|Participant Refused to Follow-up|0
6006614|NCT00878189|20765422|P6|Overall Study|Participant Refused to Follow-up|4
6006615|NCT00878189|20765423|P5|Overall Study|Participant Refused to Follow-up|0
6006616|NCT00878189|20765424|P4|Overall Study|Participant Refused to Follow-up|0
6006617|NCT00878189|20765425|P3|Overall Study|Participant Refused to Follow-up|0
6006618|NCT00878189|20765426|P2|Overall Study|Participant Refused to Follow-up|0
6006619|NCT00878189|20765427|P1|Overall Study|Participant Refused to Follow-up|0
6006620|NCT00878189|20765419|P9|Overall Study|Death|1
6006621|NCT00878189|20765420|P8|Overall Study|Death|0
6006622|NCT00878189|20765421|P7|Overall Study|Death|0
6006623|NCT00878189|20765422|P6|Overall Study|Death|0
6006624|NCT00878189|20765423|P5|Overall Study|Death|0
6006625|NCT00878189|20765424|P4|Overall Study|Death|1
6006626|NCT00878189|20765425|P3|Overall Study|Death|0
6006627|NCT00878189|20765426|P2|Overall Study|Death|1
6006628|NCT00878189|20765427|P1|Overall Study|Death|0
6006629|NCT00877929|20765695|P2|Overall Study|Other reason (not specified)|6
6006630|NCT00877929|20765696|P1|Overall Study|Other reason (not specified)|2
6006631|NCT00877929|20765695|P2|Overall Study|Lack of Efficacy|1
6006632|NCT00877929|20765696|P1|Overall Study|Lack of Efficacy|0
6006633|NCT00877929|20765695|P2|Overall Study|Withdrawal by Subject|4
6006634|NCT00877929|20765696|P1|Overall Study|Withdrawal by Subject|4
6006635|NCT00877929|20765695|P2|Overall Study|Lost to Follow-up|1
6006636|NCT00877929|20765696|P1|Overall Study|Lost to Follow-up|0
6006637|NCT00877929|20765695|P2|Overall Study|Protocol Violation|3
6006638|NCT00877929|20765696|P1|Overall Study|Protocol Violation|3
6006639|NCT00877929|20765695|P2|Overall Study|Adverse Event|20
6006640|NCT00877929|20765696|P1|Overall Study|Adverse Event|11
6006641|NCT00877890|20765784|P2|Overall Study|Loss of Glucose Control|4
6006642|NCT00877890|20765785|P1|Overall Study|Loss of Glucose Control|3
6006643|NCT00877890|20765784|P2|Overall Study|Investigator Decision|2
6006644|NCT00877890|20765785|P1|Overall Study|Investigator Decision|0
6006645|NCT00877890|20765784|P2|Overall Study|Withdrawal of Consent|12
6006646|NCT00877890|20765785|P1|Overall Study|Withdrawal of Consent|6
6006647|NCT00877890|20765784|P2|Overall Study|Protocol Violation|1
6006648|NCT00877890|20765785|P1|Overall Study|Protocol Violation|0
6006649|NCT00877890|20765784|P2|Overall Study|Lost to Follow-up|5
6006650|NCT00877890|20765785|P1|Overall Study|Lost to Follow-up|5
6006651|NCT00877890|20765784|P2|Overall Study|Adverse Event|6
6006652|NCT00877890|20765785|P1|Overall Study|Adverse Event|6
6006653|NCT00877799|20765850|P5|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1
6006654|NCT00877799|20765851|P4|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1
6006655|NCT00877799|20765852|P3|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0
6006656|NCT00877799|20765853|P2|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0
6006657|NCT00877799|20765854|P1|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0
6006658|NCT00877799|20765850|P5|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0
6006659|NCT00877799|20765851|P4|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|1
6006660|NCT00877799|20765852|P3|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0
6006661|NCT00877799|20765853|P2|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0
6006662|NCT00877799|20765854|P1|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0
6006663|NCT00877799|20765850|P5|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0
6006664|NCT00877799|20765851|P4|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0
6006665|NCT00877799|20765852|P3|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0
6006666|NCT00877799|20765853|P2|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|3
6006667|NCT00877799|20765854|P1|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0
6006668|NCT00877799|20765850|P5|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0
6006669|NCT00877799|20765851|P4|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0
6006670|NCT00877799|20765852|P3|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|2
6006671|NCT00877799|20765853|P2|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1
6006672|NCT00877799|20765854|P1|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1
6006673|NCT00877799|20765850|P5|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0
6006674|NCT00877799|20765851|P4|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0
6006675|NCT00877799|20765852|P3|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1
6006676|NCT00877799|20765853|P2|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1
6006677|NCT00877799|20765854|P1|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|2
6006678|NCT00877773|20765869|P1|Overall Study|Disease Progression|44
6006679|NCT00877487|20765882|P2|Double-blind Randomized Withdrawal Phase|Moved out of state|0
6006680|NCT00877487|20765883|P1|Double-blind Randomized Withdrawal Phase|Moved out of state|1
6006681|NCT00877487|20765882|P2|Double-blind Randomized Withdrawal Phase|Protocol Violation|1
6006682|NCT00877487|20765883|P1|Double-blind Randomized Withdrawal Phase|Protocol Violation|0
6006683|NCT00877487|20765882|P2|Double-blind Randomized Withdrawal Phase|Adverse Event|1
6006684|NCT00877487|20765883|P1|Double-blind Randomized Withdrawal Phase|Adverse Event|0
6006685|NCT00877487|20765882|P2|Double-blind Randomized Withdrawal Phase|Relapse criteria met|45
6006686|NCT00877487|20765883|P1|Double-blind Randomized Withdrawal Phase|Relapse criteria met|5
6006687|NCT00877487|20765882|P2|Open-label Treatment Phase|Out of country for business|0
6006688|NCT00877487|20765883|P1|Open-label Treatment Phase|Out of country for business|1
6006689|NCT00877487|20765882|P2|Open-label Treatment Phase|Lost to Follow-up|0
6006690|NCT00877487|20765883|P1|Open-label Treatment Phase|Lost to Follow-up|1
6006691|NCT00877487|20765882|P2|Open-label Treatment Phase|Withdrawal by Subject|0
6006692|NCT00877487|20765883|P1|Open-label Treatment Phase|Withdrawal by Subject|1
6006693|NCT00877487|20765882|P2|Open-label Treatment Phase|Protocol Violation|0
6006694|NCT00877487|20765883|P1|Open-label Treatment Phase|Protocol Violation|3
6006695|NCT00877487|20765882|P2|Open-label Treatment Phase|Adverse Event|0
6006696|NCT00877487|20765883|P1|Open-label Treatment Phase|Adverse Event|1
6006697|NCT00877383|20765931|P2|Overall Study|Death|2
6006698|NCT00877383|20765932|P1|Overall Study|Death|1
6006699|NCT00877383|20765931|P2|Overall Study|Unsatisfactory therapeutic effect|0
6006700|NCT00877383|20765932|P1|Overall Study|Unsatisfactory therapeutic effect|1
6006701|NCT00877383|20765931|P2|Overall Study|Protocol deviation|6
6006702|NCT00877383|20765932|P1|Overall Study|Protocol deviation|2
6006703|NCT00877383|20765931|P2|Overall Study|Administrative problems|0
6006704|NCT00877383|20765932|P1|Overall Study|Administrative problems|2
6006705|NCT00877383|20765931|P2|Overall Study|Subject no longer requires study drug|0
6006706|NCT00877383|20765932|P1|Overall Study|Subject no longer requires study drug|2
6006707|NCT00877383|20765931|P2|Overall Study|Subject withdrew consent|12
6006708|NCT00877383|20765932|P1|Overall Study|Subject withdrew consent|3
6006709|NCT00877383|20765931|P2|Overall Study|Lost to Follow-up|3
6006710|NCT00877383|20765932|P1|Overall Study|Lost to Follow-up|5
6006711|NCT00877383|20765931|P2|Overall Study|Adverse Event|14
6006712|NCT00877383|20765932|P1|Overall Study|Adverse Event|13
6006713|NCT00877071|20765952|P1|Overall Study|disease progression|2
6006714|NCT00877032|20765985|P7|Overall Study|Did not meet entrance criteria|2
6006715|NCT00877032|20765986|P6|Overall Study|Did not meet entrance criteria|0
6006716|NCT00877032|20765987|P5|Overall Study|Did not meet entrance criteria|0
6006717|NCT00877032|20765988|P4|Overall Study|Did not meet entrance criteria|1
6006718|NCT00877032|20765989|P3|Overall Study|Did not meet entrance criteria|0
6006719|NCT00877032|20765990|P2|Overall Study|Did not meet entrance criteria|0
6006720|NCT00877032|20765991|P1|Overall Study|Did not meet entrance criteria|0
6006721|NCT00877006|20766092|P2|Long-Term Follow-up Period|Other|9
6006722|NCT00877006|20766093|P1|Long-Term Follow-up Period|Other|7
6006723|NCT00877006|20766092|P2|Long-Term Follow-up Period|Death|18
6006724|NCT00877006|20766093|P1|Long-Term Follow-up Period|Death|26
6006725|NCT00877006|20766092|P2|Long-Term Follow-up Period|Lost to Follow-up|9
6006726|NCT00877006|20766093|P1|Long-Term Follow-up Period|Lost to Follow-up|8
6006727|NCT00877006|20766092|P2|Long-Term Follow-up Period|Withdrawal by Subject|19
6006728|NCT00877006|20766093|P1|Long-Term Follow-up Period|Withdrawal by Subject|12
6006729|NCT00877006|20766092|P2|Treatment Period|Randomized but Not Treated|8
6006730|NCT00877006|20766093|P1|Treatment Period|Randomized but Not Treated|3
6006731|NCT00877006|20766092|P2|Treatment Period|Other|4
6006732|NCT00877006|20766093|P1|Treatment Period|Other|4
6006733|NCT00877006|20766092|P2|Treatment Period|Started New Treatment Regimen|5
6006734|NCT00877006|20766093|P1|Treatment Period|Started New Treatment Regimen|2
6006735|NCT00877006|20766092|P2|Treatment Period|Disease Progression|2
6006736|NCT00877006|20766093|P1|Treatment Period|Disease Progression|1
6006737|NCT00877006|20766092|P2|Treatment Period|Lost to Follow-up|1
6006738|NCT00877006|20766093|P1|Treatment Period|Lost to Follow-up|0
6006739|NCT00877006|20766092|P2|Treatment Period|Protocol Violation|0
6006740|NCT00877006|20766093|P1|Treatment Period|Protocol Violation|1
6006741|NCT00877006|20766092|P2|Treatment Period|Withdrawal by Subject|3
6006742|NCT00877006|20766093|P1|Treatment Period|Withdrawal by Subject|2
6006743|NCT00877006|20766092|P2|Treatment Period|Adverse Event|3
6006744|NCT00877006|20766093|P1|Treatment Period|Adverse Event|10
6006745|NCT00877006|20766092|P2|Treatment Period|Death|1
6006746|NCT00877006|20766093|P1|Treatment Period|Death|2
6006747|NCT00876928|20766169|P2|Overall Study|Hypokalemia-affects insulin secretion|0
6006748|NCT00876928|20766170|P1|Overall Study|Hypokalemia-affects insulin secretion|1
6006749|NCT00876928|20766169|P2|Overall Study|Lost to Follow-up|5
6006750|NCT00876928|20766170|P1|Overall Study|Lost to Follow-up|2
6006751|NCT00876733|20766207|P4|Overall Study|Data not available|1
6006752|NCT00876733|20766208|P3|Overall Study|Data not available|7
6006753|NCT00876733|20766209|P2|Overall Study|Data not available|3
6006754|NCT00876733|20766210|P1|Overall Study|Data not available|14
6006755|NCT00876733|20766207|P4|Overall Study|Lost to Follow-up|2
6006756|NCT00876733|20766208|P3|Overall Study|Lost to Follow-up|3
6006757|NCT00876733|20766209|P2|Overall Study|Lost to Follow-up|10
6006758|NCT00876733|20766210|P1|Overall Study|Lost to Follow-up|26
6006759|NCT00876733|20766207|P4|Overall Study|Lack of Efficacy|1
6006760|NCT00876733|20766208|P3|Overall Study|Lack of Efficacy|10
6006761|NCT00876733|20766209|P2|Overall Study|Lack of Efficacy|9
6006762|NCT00876733|20766210|P1|Overall Study|Lack of Efficacy|17
6006763|NCT00876733|20766207|P4|Overall Study|Adverse Event|3
6006764|NCT00876733|20766208|P3|Overall Study|Adverse Event|10
6006765|NCT00876733|20766209|P2|Overall Study|Adverse Event|20
6006766|NCT00876733|20766210|P1|Overall Study|Adverse Event|34
6006767|NCT00876694|20766318|P2|Overall Study|Death|0
6006768|NCT00876694|20766319|P1|Overall Study|Death|1
6006769|NCT00876694|20766318|P2|Overall Study|Administrative problems|1
6006770|NCT00876694|20766319|P1|Overall Study|Administrative problems|1
6006771|NCT00876694|20766318|P2|Overall Study|Abnormal test procedure result(s)|0
6006772|NCT00876694|20766319|P1|Overall Study|Abnormal test procedure result(s)|1
6006773|NCT00876694|20766318|P2|Overall Study|Unsatisfactory therapeutic effect|0
6006774|NCT00876694|20766319|P1|Overall Study|Unsatisfactory therapeutic effect|2
6006775|NCT00876694|20766318|P2|Overall Study|Subject withdrew consent|4
6006776|NCT00876694|20766319|P1|Overall Study|Subject withdrew consent|6
6006777|NCT00876694|20766318|P2|Overall Study|Adverse Event|7
6006778|NCT00876694|20766319|P1|Overall Study|Adverse Event|10
6006779|NCT00876460|20766345|P8|Mono Therapy Phase|Adverse Event|0
6006780|NCT00876460|20766346|P7|Mono Therapy Phase|Adverse Event|0
6006781|NCT00876460|20766347|P6|Mono Therapy Phase|Adverse Event|0
6006782|NCT00876460|20766348|P5|Mono Therapy Phase|Adverse Event|0
6006783|NCT00876460|20766349|P4|Mono Therapy Phase|Adverse Event|1
6006784|NCT00876460|20766350|P3|Mono Therapy Phase|Adverse Event|0
6006785|NCT00876460|20766351|P2|Mono Therapy Phase|Adverse Event|0
6006786|NCT00876460|20766352|P1|Mono Therapy Phase|Adverse Event|0
6006787|NCT00876460|20766345|P8|Mono Therapy Phase|Withdrawal by Subject|0
6006788|NCT00876460|20766346|P7|Mono Therapy Phase|Withdrawal by Subject|0
6006789|NCT00876460|20766347|P6|Mono Therapy Phase|Withdrawal by Subject|0
6006790|NCT00876460|20766348|P5|Mono Therapy Phase|Withdrawal by Subject|0
6006791|NCT00876460|20766349|P4|Mono Therapy Phase|Withdrawal by Subject|0
6006792|NCT00876460|20766350|P3|Mono Therapy Phase|Withdrawal by Subject|0
6006793|NCT00876460|20766351|P2|Mono Therapy Phase|Withdrawal by Subject|1
6006794|NCT00876460|20766352|P1|Mono Therapy Phase|Withdrawal by Subject|0
6006795|NCT00876460|20766345|P8|Mono Therapy Phase|Progressive disease|3
6006796|NCT00876460|20766346|P7|Mono Therapy Phase|Progressive disease|1
6006797|NCT00876460|20766347|P6|Mono Therapy Phase|Progressive disease|0
6006798|NCT00876460|20766348|P5|Mono Therapy Phase|Progressive disease|2
6006799|NCT00876460|20766349|P4|Mono Therapy Phase|Progressive disease|0
6006800|NCT00876460|20766350|P3|Mono Therapy Phase|Progressive disease|0
6006801|NCT00876460|20766351|P2|Mono Therapy Phase|Progressive disease|0
6006802|NCT00876460|20766352|P1|Mono Therapy Phase|Progressive disease|0
6006803|NCT00876460|20766345|P8|Combination Therapy Phase|Not treated|0
6006804|NCT00876460|20766346|P7|Combination Therapy Phase|Not treated|1
6006805|NCT00876460|20766347|P6|Combination Therapy Phase|Not treated|0
6006806|NCT00876460|20766348|P5|Combination Therapy Phase|Not treated|0
6006807|NCT00876460|20766349|P4|Combination Therapy Phase|Not treated|0
6006808|NCT00876460|20766350|P3|Combination Therapy Phase|Not treated|0
6006809|NCT00876460|20766351|P2|Combination Therapy Phase|Not treated|0
6006810|NCT00876460|20766352|P1|Combination Therapy Phase|Not treated|0
6006811|NCT00876460|20766345|P8|Combination Therapy Phase|Other reason not defined above|2
6006812|NCT00876460|20766346|P7|Combination Therapy Phase|Other reason not defined above|1
6006813|NCT00876460|20766347|P6|Combination Therapy Phase|Other reason not defined above|0
6006814|NCT00876460|20766348|P5|Combination Therapy Phase|Other reason not defined above|0
6006815|NCT00876460|20766349|P4|Combination Therapy Phase|Other reason not defined above|0
6006816|NCT00876460|20766350|P3|Combination Therapy Phase|Other reason not defined above|0
6006817|NCT00876460|20766351|P2|Combination Therapy Phase|Other reason not defined above|0
6006818|NCT00876460|20766352|P1|Combination Therapy Phase|Other reason not defined above|0
6006819|NCT00876460|20766345|P8|Combination Therapy Phase|Withdrawal by Subject|0
6006820|NCT00876460|20766346|P7|Combination Therapy Phase|Withdrawal by Subject|0
6006821|NCT00876460|20766347|P6|Combination Therapy Phase|Withdrawal by Subject|0
6006822|NCT00876460|20766348|P5|Combination Therapy Phase|Withdrawal by Subject|1
6006823|NCT00876460|20766349|P4|Combination Therapy Phase|Withdrawal by Subject|0
6006824|NCT00876460|20766350|P3|Combination Therapy Phase|Withdrawal by Subject|0
6006825|NCT00876460|20766351|P2|Combination Therapy Phase|Withdrawal by Subject|1
6006826|NCT00876460|20766352|P1|Combination Therapy Phase|Withdrawal by Subject|1
6006827|NCT00876460|20766345|P8|Combination Therapy Phase|Adverse Event|2
6006828|NCT00876460|20766346|P7|Combination Therapy Phase|Adverse Event|3
6006829|NCT00876460|20766347|P6|Combination Therapy Phase|Adverse Event|0
6006830|NCT00876460|20766348|P5|Combination Therapy Phase|Adverse Event|2
6006831|NCT00876460|20766349|P4|Combination Therapy Phase|Adverse Event|2
6006832|NCT00876460|20766350|P3|Combination Therapy Phase|Adverse Event|0
6006833|NCT00876460|20766351|P2|Combination Therapy Phase|Adverse Event|2
6006834|NCT00876460|20766352|P1|Combination Therapy Phase|Adverse Event|0
6006835|NCT00876460|20766345|P8|Combination Therapy Phase|Dose limiting toxicity|1
6006836|NCT00876460|20766346|P7|Combination Therapy Phase|Dose limiting toxicity|2
6006837|NCT00876460|20766347|P6|Combination Therapy Phase|Dose limiting toxicity|2
6006838|NCT00876460|20766348|P5|Combination Therapy Phase|Dose limiting toxicity|1
6006839|NCT00876460|20766349|P4|Combination Therapy Phase|Dose limiting toxicity|1
6006840|NCT00876460|20766350|P3|Combination Therapy Phase|Dose limiting toxicity|0
6006841|NCT00876460|20766351|P2|Combination Therapy Phase|Dose limiting toxicity|1
6006842|NCT00876460|20766352|P1|Combination Therapy Phase|Dose limiting toxicity|0
6006843|NCT00876460|20766345|P8|Combination Therapy Phase|Progressive disease|1
6006844|NCT00876460|20766346|P7|Combination Therapy Phase|Progressive disease|1
6006845|NCT00876460|20766347|P6|Combination Therapy Phase|Progressive disease|1
6006846|NCT00876460|20766348|P5|Combination Therapy Phase|Progressive disease|3
6006847|NCT00876460|20766349|P4|Combination Therapy Phase|Progressive disease|3
6006848|NCT00876460|20766350|P3|Combination Therapy Phase|Progressive disease|3
6006849|NCT00876460|20766351|P2|Combination Therapy Phase|Progressive disease|3
6006850|NCT00876460|20766352|P1|Combination Therapy Phase|Progressive disease|2
6006851|NCT00876447|20766424|P2|Overall Study|Adverse Event|8
6006852|NCT00876447|20766425|P1|Overall Study|Adverse Event|4
6006853|NCT00876447|20766424|P2|Overall Study|Lack of Efficacy|3
6006854|NCT00876447|20766425|P1|Overall Study|Lack of Efficacy|5
6006855|NCT00876447|20766424|P2|Overall Study|Pregnancy|2
6006856|NCT00876447|20766425|P1|Overall Study|Pregnancy|4
6006857|NCT00876447|20766424|P2|Overall Study|Lost to Follow-up|15
6006858|NCT00876447|20766425|P1|Overall Study|Lost to Follow-up|6
6006859|NCT00876447|20766424|P2|Overall Study|Personal reasons|28
6006860|NCT00876447|20766425|P1|Overall Study|Personal reasons|30
6006861|NCT00876447|20766424|P2|Overall Study|Protocol Violation|3
6006862|NCT00876447|20766425|P1|Overall Study|Protocol Violation|9
6006863|NCT00876447|20766424|P2|Overall Study|Site closure|14
6006864|NCT00876447|20766425|P1|Overall Study|Site closure|19
6006865|NCT00876447|20766424|P2|Overall Study|Other miscellaneous reasons|8
6006866|NCT00876447|20766425|P1|Overall Study|Other miscellaneous reasons|3
6006867|NCT00876395|20766485|P2|Overall Study|Death|0
6006868|NCT00876395|20766486|P1|Overall Study|Death|12
6006869|NCT00876395|20766485|P2|Overall Study|Administrative problems|23
6006870|NCT00876395|20766486|P1|Overall Study|Administrative problems|39
6006871|NCT00876395|20766485|P2|Overall Study|Lost to Follow-up|0
6006872|NCT00876395|20766486|P1|Overall Study|Lost to Follow-up|2
6006873|NCT00876395|20766485|P2|Overall Study|Withdrawal by Subject|33
6006874|NCT00876395|20766486|P1|Overall Study|Withdrawal by Subject|66
6006875|NCT00876395|20766485|P2|Overall Study|Protocol Violation|2
6006876|NCT00876395|20766486|P1|Overall Study|Protocol Violation|5
6006877|NCT00876395|20766485|P2|Overall Study|New cancer therapy|7
6006878|NCT00876395|20766486|P1|Overall Study|New cancer therapy|25
6006879|NCT00876395|20766485|P2|Overall Study|Disease progression|162
6006880|NCT00876395|20766486|P1|Overall Study|Disease progression|259
6006881|NCT00876395|20766485|P2|Overall Study|Abnormal test procedure result(s)|0
6006882|NCT00876395|20766486|P1|Overall Study|Abnormal test procedure result(s)|1
6006883|NCT00876395|20766485|P2|Overall Study|Adverse Event|11
6006884|NCT00876395|20766486|P1|Overall Study|Adverse Event|63
6006885|NCT00876395|20766485|P2|Overall Study|Untreated|1
6006886|NCT00876395|20766486|P1|Overall Study|Untreated|8
6006887|NCT00876343|20766527|P3|Overall Study|Change of residence or other commitments|3
6006888|NCT00876343|20766528|P2|Overall Study|Change of residence or other commitments|2
6006889|NCT00876343|20766529|P1|Overall Study|Change of residence or other commitments|2
6006890|NCT00876343|20766527|P3|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1
6006891|NCT00876343|20766528|P2|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1
6006892|NCT00876343|20766529|P1|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0
6006893|NCT00876343|20766527|P3|Overall Study|Physician Decision|1
6006894|NCT00876343|20766528|P2|Overall Study|Physician Decision|1
6006895|NCT00876343|20766529|P1|Overall Study|Physician Decision|0
6006896|NCT00876343|20766527|P3|Overall Study|Protocol Violation|1
6006897|NCT00876343|20766528|P2|Overall Study|Protocol Violation|1
6006898|NCT00876343|20766529|P1|Overall Study|Protocol Violation|4
6006899|NCT00876343|20766527|P3|Overall Study|Lack of Efficacy|1
6006900|NCT00876343|20766528|P2|Overall Study|Lack of Efficacy|0
6006901|NCT00876343|20766529|P1|Overall Study|Lack of Efficacy|0
6006902|NCT00876343|20766527|P3|Overall Study|Withdrawal by Subject|3
6006903|NCT00876343|20766528|P2|Overall Study|Withdrawal by Subject|4
6006904|NCT00876343|20766529|P1|Overall Study|Withdrawal by Subject|4
6006905|NCT00876343|20766527|P3|Overall Study|Adverse Event|2
6006906|NCT00876343|20766528|P2|Overall Study|Adverse Event|8
6006907|NCT00876343|20766529|P1|Overall Study|Adverse Event|7
6006908|NCT00876265|20766543|P1|Overall Study|Withdrawal by Subject|2
6006909|NCT00876265|20766543|P1|Overall Study|Lost to Follow-up|6
6006910|NCT00876265|20766543|P1|Overall Study|Miscellaneous reasons|4
6006911|NCT00876018|20766561|P3|Overall Study|Withdrew Consent due to Adverse Event|2
6006912|NCT00876018|20766562|P2|Overall Study|Withdrew Consent due to Adverse Event|4
6006913|NCT00876018|20766563|P1|Overall Study|Withdrew Consent due to Adverse Event|5
6006914|NCT00876018|20766561|P3|Overall Study|Lost to Follow-up|1
6006915|NCT00876018|20766562|P2|Overall Study|Lost to Follow-up|1
6006916|NCT00876018|20766563|P1|Overall Study|Lost to Follow-up|0
6006917|NCT00875979|20766618|P2|Dose Expansion Phase - 3.6 mg/kg|Death|1
6006918|NCT00875979|20766619|P1|Dose Expansion Phase - 3.6 mg/kg|Death|0
6006919|NCT00875979|20766618|P2|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|3
6006920|NCT00875979|20766619|P1|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|0
6006921|NCT00875979|20766618|P2|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|3
6006922|NCT00875979|20766619|P1|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|0
6006923|NCT00875979|20766618|P2|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|3
6006924|NCT00875979|20766619|P1|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|0
6006925|NCT00875979|20766618|P2|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|37
6006926|NCT00875979|20766619|P1|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|0
6006927|NCT00875979|20766618|P2|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|6
6006928|NCT00875979|20766619|P1|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|0
6006929|NCT00875979|20766618|P2|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|0
6006930|NCT00875979|20766619|P1|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|1
6006931|NCT00875979|20766618|P2|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|0
6006932|NCT00875979|20766619|P1|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|1
6006933|NCT00875979|20766618|P2|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|0
6006934|NCT00875979|20766619|P1|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|1
6006935|NCT00875810|20766642|P1|Overall Study|Device explanted|1
6006936|NCT00875810|20766642|P1|Overall Study|Patient enroled but not implanted|2
6006937|NCT00875810|20766642|P1|Overall Study|Lost to Follow-up|39
6006938|NCT00875810|20766642|P1|Overall Study|Physician Decision|3
6006939|NCT00875810|20766642|P1|Overall Study|Withdrawal by Subject|1
6006940|NCT00875797|20766651|P2|Overall Study|Protocol Violation|3
6006941|NCT00875797|20766652|P1|Overall Study|Protocol Violation|6
6006942|NCT00875706|20766665|P3|Overall Study|Withdrawal by Subject|0
6006943|NCT00875706|20766666|P2|Overall Study|Withdrawal by Subject|0
6006944|NCT00875706|20766667|P1|Overall Study|Withdrawal by Subject|1
6006945|NCT00875667|20766686|P2|Overall Study|Randomized but no Study Drug Given|1
6006946|NCT00875667|20766687|P1|Overall Study|Randomized but no Study Drug Given|3
6006947|NCT00875667|20766686|P2|Overall Study|Miscellaneous|6
6006948|NCT00875667|20766687|P1|Overall Study|Miscellaneous|12
6006949|NCT00875667|20766686|P2|Overall Study|Disease Progression|49
6006950|NCT00875667|20766687|P1|Overall Study|Disease Progression|100
6006951|NCT00875667|20766686|P2|Overall Study|Protocol Violation|0
6006952|NCT00875667|20766687|P1|Overall Study|Protocol Violation|2
6006953|NCT00875667|20766686|P2|Overall Study|Death|2
6006954|NCT00875667|20766687|P1|Overall Study|Death|7
6006955|NCT00875667|20766686|P2|Overall Study|Withdrawal by Subject|5
6006956|NCT00875667|20766687|P1|Overall Study|Withdrawal by Subject|17
6006957|NCT00875667|20766686|P2|Overall Study|Adverse Event|10
6006958|NCT00875667|20766687|P1|Overall Study|Adverse Event|29
6006959|NCT00875615|20766822|P1|Overall Study|Withdrawal by Subject|1
6006960|NCT00875563|20766836|P1|Overall Study|Still be eligible for follow-up|7
6006961|NCT00875563|20766836|P1|Overall Study|No long-term (3-5 year) consent|6
6006962|NCT00875563|20766836|P1|Overall Study|Withdrawal by Subject|7
6006963|NCT00875563|20766836|P1|Overall Study|Death|4
6006964|NCT00875524|20766861|P2|Overall Study|Withdrawal by Subject|5
6006965|NCT00875524|20766862|P1|Overall Study|Withdrawal by Subject|3
6006966|NCT00875524|20766861|P2|Overall Study|Lost to Follow-up|0
6006967|NCT00875524|20766862|P1|Overall Study|Lost to Follow-up|1
6006968|NCT00875524|20766861|P2|Overall Study|Protocol Violation|0
6006969|NCT00875524|20766862|P1|Overall Study|Protocol Violation|4
6006970|NCT00875524|20766861|P2|Overall Study|Serious adverse event|1
6006971|NCT00875524|20766862|P1|Overall Study|Serious adverse event|0
6006972|NCT00875485|20766880|P2|Challenge Dose Epoch|Pregnancy|0
6006973|NCT00875485|20766881|P1|Challenge Dose Epoch|Pregnancy|1
6006974|NCT00875433|20766921|P1|Overall Study|Other|3
6006975|NCT00875433|20766921|P1|Overall Study|Withdrawal by Subject|2
6006976|NCT00875433|20766921|P1|Overall Study|Other Adverse Event|14
6006977|NCT00875433|20766921|P1|Overall Study|Progressive disease|41
6006978|NCT00875420|20766951|P5|Overall Study|Withdrawal by Subject|0
6006979|NCT00875420|20766952|P4|Overall Study|Withdrawal by Subject|0
6006980|NCT00875420|20766953|P3|Overall Study|Withdrawal by Subject|1
6006981|NCT00875420|20766954|P2|Overall Study|Withdrawal by Subject|0
6006982|NCT00875420|20766955|P1|Overall Study|Withdrawal by Subject|0
6006983|NCT00875420|20766951|P5|Overall Study|Sponsor decision|0
6006984|NCT00875420|20766952|P4|Overall Study|Sponsor decision|0
6006985|NCT00875420|20766953|P3|Overall Study|Sponsor decision|0
6006986|NCT00875420|20766954|P2|Overall Study|Sponsor decision|1
6006987|NCT00875420|20766955|P1|Overall Study|Sponsor decision|0
6006988|NCT00875420|20766951|P5|Overall Study|Prohibited medication|0
6006989|NCT00875420|20766952|P4|Overall Study|Prohibited medication|1
6006990|NCT00875420|20766953|P3|Overall Study|Prohibited medication|0
6006991|NCT00875420|20766954|P2|Overall Study|Prohibited medication|0
6006992|NCT00875420|20766955|P1|Overall Study|Prohibited medication|0
6006993|NCT00875420|20766951|P5|Overall Study|Personal reason|1
6006994|NCT00875420|20766952|P4|Overall Study|Personal reason|0
6006995|NCT00875420|20766953|P3|Overall Study|Personal reason|0
6006996|NCT00875420|20766954|P2|Overall Study|Personal reason|0
6006997|NCT00875420|20766955|P1|Overall Study|Personal reason|0
6006998|NCT00875420|20766951|P5|Overall Study|Lost to Follow-up|0
6006999|NCT00875420|20766952|P4|Overall Study|Lost to Follow-up|0
6007000|NCT00875420|20766953|P3|Overall Study|Lost to Follow-up|0
6007001|NCT00875420|20766954|P2|Overall Study|Lost to Follow-up|0
6007002|NCT00875420|20766955|P1|Overall Study|Lost to Follow-up|1
6007003|NCT00875420|20766951|P5|Overall Study|Inability to complete study procedures|1
6007004|NCT00875420|20766952|P4|Overall Study|Inability to complete study procedures|1
6007005|NCT00875420|20766953|P3|Overall Study|Inability to complete study procedures|1
6007006|NCT00875420|20766954|P2|Overall Study|Inability to complete study procedures|0
6007007|NCT00875420|20766955|P1|Overall Study|Inability to complete study procedures|1
6007008|NCT00875420|20766951|P5|Overall Study|Adverse Event|0
6007009|NCT00875420|20766952|P4|Overall Study|Adverse Event|0
6007010|NCT00875420|20766953|P3|Overall Study|Adverse Event|1
6007011|NCT00875420|20766954|P2|Overall Study|Adverse Event|1
6007012|NCT00875420|20766955|P1|Overall Study|Adverse Event|0
6007013|NCT00875056|20767094|P3|Overall Study|Withdrawal by Subject|1
6007014|NCT00875056|20767095|P2|Overall Study|Withdrawal by Subject|0
6007015|NCT00875056|20767096|P1|Overall Study|Withdrawal by Subject|3
6007016|NCT00875056|20767094|P3|Overall Study|Progressive Disease|3
6007017|NCT00875056|20767095|P2|Overall Study|Progressive Disease|8
6007018|NCT00875056|20767096|P1|Overall Study|Progressive Disease|14
6007019|NCT00875056|20767094|P3|Overall Study|Adverse Event|2
6007020|NCT00875056|20767095|P2|Overall Study|Adverse Event|1
6007021|NCT00875056|20767096|P1|Overall Study|Adverse Event|6
6007022|NCT00875017|20767122|P6|Fourth Intervention|Inability to comply with fasting|1
6007023|NCT00875017|20767123|P5|Fourth Intervention|Inability to comply with fasting|0
6007024|NCT00875017|20767124|P4|Fourth Intervention|Inability to comply with fasting|0
6007025|NCT00875017|20767125|P3|Fourth Intervention|Inability to comply with fasting|0
6007026|NCT00875017|20767126|P2|Fourth Intervention|Inability to comply with fasting|0
6007027|NCT00875017|20767127|P1|Fourth Intervention|Inability to comply with fasting|0
6007028|NCT00875017|20767122|P6|Washout|Withdrawal by Subject|0
6007029|NCT00875017|20767123|P5|Washout|Withdrawal by Subject|1
6007030|NCT00875017|20767124|P4|Washout|Withdrawal by Subject|0
6007031|NCT00875017|20767125|P3|Washout|Withdrawal by Subject|0
6007032|NCT00875017|20767126|P2|Washout|Withdrawal by Subject|0
6007033|NCT00875017|20767127|P1|Washout|Withdrawal by Subject|0
6007034|NCT00875017|20767122|P6|Third Intervention|Adverse Event|0
6007035|NCT00875017|20767123|P5|Third Intervention|Adverse Event|0
6007036|NCT00875017|20767124|P4|Third Intervention|Adverse Event|0
6007037|NCT00875017|20767125|P3|Third Intervention|Adverse Event|1
6007038|NCT00875017|20767126|P2|Third Intervention|Adverse Event|1
6007039|NCT00875017|20767127|P1|Third Intervention|Adverse Event|0
6007040|NCT00875017|20767122|P6|Washout|Problems collecting rectal effluent|0
6007041|NCT00875017|20767123|P5|Washout|Problems collecting rectal effluent|0
6007042|NCT00875017|20767124|P4|Washout|Problems collecting rectal effluent|0
6007043|NCT00875017|20767125|P3|Washout|Problems collecting rectal effluent|0
6007044|NCT00875017|20767126|P2|Washout|Problems collecting rectal effluent|1
6007045|NCT00875017|20767127|P1|Washout|Problems collecting rectal effluent|0
6007046|NCT00875017|20767122|P6|Second Intervention|Adverse Event|0
6007047|NCT00875017|20767123|P5|Second Intervention|Adverse Event|0
6007048|NCT00875017|20767124|P4|Second Intervention|Adverse Event|1
6007049|NCT00875017|20767125|P3|Second Intervention|Adverse Event|0
6007050|NCT00875017|20767126|P2|Second Intervention|Adverse Event|0
6007051|NCT00875017|20767127|P1|Second Intervention|Adverse Event|0
6007052|NCT00875017|20767122|P6|Washout|Problem collecting rectal effluent|0
6007053|NCT00875017|20767123|P5|Washout|Problem collecting rectal effluent|0
6007054|NCT00875017|20767124|P4|Washout|Problem collecting rectal effluent|0
6007055|NCT00875017|20767125|P3|Washout|Problem collecting rectal effluent|1
6007056|NCT00875017|20767126|P2|Washout|Problem collecting rectal effluent|0
6007057|NCT00875017|20767127|P1|Washout|Problem collecting rectal effluent|0
6007058|NCT00875017|20767122|P6|First Intervention|Intolerance to nasogastric tube|0
6007059|NCT00875017|20767123|P5|First Intervention|Intolerance to nasogastric tube|1
6007060|NCT00875017|20767124|P4|First Intervention|Intolerance to nasogastric tube|0
6007061|NCT00875017|20767125|P3|First Intervention|Intolerance to nasogastric tube|0
6007062|NCT00875017|20767126|P2|First Intervention|Intolerance to nasogastric tube|0
6007063|NCT00875017|20767127|P1|First Intervention|Intolerance to nasogastric tube|0
6007064|NCT00875017|20767122|P6|First Intervention|Problems collecting rectal effluent|0
6007065|NCT00875017|20767123|P5|First Intervention|Problems collecting rectal effluent|0
6007066|NCT00875017|20767124|P4|First Intervention|Problems collecting rectal effluent|0
6007067|NCT00875017|20767125|P3|First Intervention|Problems collecting rectal effluent|0
6007068|NCT00875017|20767126|P2|First Intervention|Problems collecting rectal effluent|0
6007069|NCT00875017|20767127|P1|First Intervention|Problems collecting rectal effluent|1
6007070|NCT00875017|20767122|P6|First Intervention|Adverse Event|0
6007071|NCT00875017|20767123|P5|First Intervention|Adverse Event|0
6007072|NCT00875017|20767124|P4|First Intervention|Adverse Event|1
6007073|NCT00875017|20767125|P3|First Intervention|Adverse Event|0
6007074|NCT00875017|20767126|P2|First Intervention|Adverse Event|0
6007075|NCT00875017|20767127|P1|First Intervention|Adverse Event|0
6007076|NCT00875017|20767122|P6|First Intervention|Withdrawal by Subject|0
6007077|NCT00875017|20767123|P5|First Intervention|Withdrawal by Subject|0
6007078|NCT00875017|20767124|P4|First Intervention|Withdrawal by Subject|0
6007079|NCT00875017|20767125|P3|First Intervention|Withdrawal by Subject|1
6007080|NCT00875017|20767126|P2|First Intervention|Withdrawal by Subject|0
6007081|NCT00875017|20767127|P1|First Intervention|Withdrawal by Subject|1
6007082|NCT00874939|20767141|P1|Overall Study|Study terminated|4
6007083|NCT00874848|20767174|P2|Overall Study|Physician Decision|2
6007084|NCT00874848|20767175|P1|Overall Study|Physician Decision|0
6007085|NCT00874848|20767174|P2|Overall Study|Failure to comply with protocol|1
6007086|NCT00874848|20767175|P1|Overall Study|Failure to comply with protocol|0
6007087|NCT00874848|20767174|P2|Overall Study|Noncompliance|1
6007088|NCT00874848|20767175|P1|Overall Study|Noncompliance|1
6007089|NCT00874848|20767174|P2|Overall Study|Withdrawal by Subject|4
6007090|NCT00874848|20767175|P1|Overall Study|Withdrawal by Subject|7
6007091|NCT00874848|20767174|P2|Overall Study|Progressive neoplastic disease|18
6007092|NCT00874848|20767175|P1|Overall Study|Progressive neoplastic disease|38
6007093|NCT00874848|20767174|P2|Overall Study|Adverse Event|2
6007094|NCT00874848|20767175|P1|Overall Study|Adverse Event|13
6007095|NCT00874822|20767191|P1|Overall Study|excluded by criteria|8
6007096|NCT00874770|20767199|P4|Overall Study|Subject no Longer Meets Study Criteria|0
6007097|NCT00874770|20767200|P3|Overall Study|Subject no Longer Meets Study Criteria|0
6007098|NCT00874770|20767201|P2|Overall Study|Subject no Longer Meets Study Criteria|0
6007099|NCT00874770|20767202|P1|Overall Study|Subject no Longer Meets Study Criteria|1
6007100|NCT00874770|20767199|P4|Overall Study|Lost to Follow-up|1
6007101|NCT00874770|20767200|P3|Overall Study|Lost to Follow-up|0
6007102|NCT00874770|20767201|P2|Overall Study|Lost to Follow-up|0
6007103|NCT00874770|20767202|P1|Overall Study|Lost to Follow-up|1
6007104|NCT00874770|20767199|P4|Overall Study|Adverse Event|2
6007105|NCT00874770|20767200|P3|Overall Study|Adverse Event|4
6007106|NCT00874770|20767201|P2|Overall Study|Adverse Event|1
6007107|NCT00874770|20767202|P1|Overall Study|Adverse Event|1
6007108|NCT00874770|20767199|P4|Overall Study|Lack of Efficacy|2
6007109|NCT00874770|20767200|P3|Overall Study|Lack of Efficacy|0
6007110|NCT00874770|20767201|P2|Overall Study|Lack of Efficacy|0
6007111|NCT00874770|20767202|P1|Overall Study|Lack of Efficacy|2
6007112|NCT00874731|20767236|P3|Part 2: Ridaforolimus 40 mg|Disease Progression|19
6007113|NCT00874731|20767237|P2|Part 2: Ridaforolimus 40 mg|Disease Progression|0
6007114|NCT00874731|20767238|P1|Part 2: Ridaforolimus 40 mg|Disease Progression|0
6007115|NCT00874731|20767236|P3|Part 2: Ridaforolimus 40 mg|Adverse Event|3
6007116|NCT00874731|20767237|P2|Part 2: Ridaforolimus 40 mg|Adverse Event|0
6007117|NCT00874731|20767238|P1|Part 2: Ridaforolimus 40 mg|Adverse Event|0
6007118|NCT00874731|20767236|P3|Part 1, Day 1: Placebo|Disease Progression|0
6007119|NCT00874731|20767237|P2|Part 1, Day 1: Placebo|Disease Progression|0
6007120|NCT00874731|20767238|P1|Part 1, Day 1: Placebo|Disease Progression|1
6007121|NCT00874549|20767279|P4|Overall Study|Withdrawal by Subject|1
6007122|NCT00874549|20767280|P3|Overall Study|Withdrawal by Subject|0
6007123|NCT00874549|20767281|P2|Overall Study|Withdrawal by Subject|1
6007124|NCT00874549|20767282|P1|Overall Study|Withdrawal by Subject|0
6007125|NCT00874549|20767279|P4|Overall Study|Lost to Follow-up|0
6007126|NCT00874549|20767280|P3|Overall Study|Lost to Follow-up|1
6007127|NCT00874549|20767281|P2|Overall Study|Lost to Follow-up|0
6007128|NCT00874549|20767282|P1|Overall Study|Lost to Follow-up|0
6007129|NCT00874549|20767279|P4|Overall Study|Protocol Violation|1
6007130|NCT00874549|20767280|P3|Overall Study|Protocol Violation|2
6007131|NCT00874549|20767281|P2|Overall Study|Protocol Violation|0
6007132|NCT00874549|20767282|P1|Overall Study|Protocol Violation|1
6007133|NCT00874549|20767279|P4|Overall Study|Adverse Event|0
6007134|NCT00874549|20767280|P3|Overall Study|Adverse Event|1
6007135|NCT00874549|20767281|P2|Overall Study|Adverse Event|0
6007136|NCT00874549|20767282|P1|Overall Study|Adverse Event|0
6007137|NCT00874497|20767359|P2|Overall Study|Withdrawal by Subject|4
6007138|NCT00874497|20767360|P1|Overall Study|Withdrawal by Subject|5
6007139|NCT00874497|20767359|P2|Overall Study|Physician Decision|1
6007140|NCT00874497|20767360|P1|Overall Study|Physician Decision|1
6007141|NCT00874497|20767359|P2|Overall Study|Met Withdrawal Criteria|2
6007142|NCT00874497|20767360|P1|Overall Study|Met Withdrawal Criteria|4
6007143|NCT00874497|20767359|P2|Overall Study|Sponsor Discontinued Trial|3
6007144|NCT00874497|20767360|P1|Overall Study|Sponsor Discontinued Trial|7
6007145|NCT00874497|20767359|P2|Overall Study|Adverse Event|4
6007146|NCT00874497|20767360|P1|Overall Study|Adverse Event|9
6007147|NCT00874497|20767359|P2|Overall Study|Lost to Follow-up|4
6007148|NCT00874497|20767360|P1|Overall Study|Lost to Follow-up|2
6007149|NCT00874432|20767402|P4|Overall Study|Other|3
6007150|NCT00874432|20767403|P3|Overall Study|Other|8
6007151|NCT00874432|20767404|P2|Overall Study|Other|2
6007152|NCT00874432|20767405|P1|Overall Study|Other|1
6007153|NCT00874432|20767402|P4|Overall Study|Physician Decision|0
6007154|NCT00874432|20767403|P3|Overall Study|Physician Decision|0
6007155|NCT00874432|20767404|P2|Overall Study|Physician Decision|0
6007156|NCT00874432|20767405|P1|Overall Study|Physician Decision|1
6007157|NCT00874432|20767402|P4|Overall Study|Withdrawal by Subject|0
6007158|NCT00874432|20767403|P3|Overall Study|Withdrawal by Subject|0
6007159|NCT00874432|20767404|P2|Overall Study|Withdrawal by Subject|0
6007160|NCT00874432|20767405|P1|Overall Study|Withdrawal by Subject|1
6007161|NCT00874276|20767423|P2|Overall Study|Withdrawal by Subject|1
6007162|NCT00874276|20767424|P1|Overall Study|Withdrawal by Subject|1
6007163|NCT00874237|20767444|P6|Overall Study|Withdrawal by Subject|0
6007164|NCT00874237|20767445|P5|Overall Study|Withdrawal by Subject|0
6007165|NCT00874237|20767446|P4|Overall Study|Withdrawal by Subject|0
6007166|NCT00874237|20767447|P3|Overall Study|Withdrawal by Subject|1
6007167|NCT00874237|20767448|P2|Overall Study|Withdrawal by Subject|0
6007168|NCT00874237|20767449|P1|Overall Study|Withdrawal by Subject|0
6007169|NCT00874237|20767444|P6|Overall Study|Physician Decision|0
6007170|NCT00874237|20767445|P5|Overall Study|Physician Decision|0
6007171|NCT00874237|20767446|P4|Overall Study|Physician Decision|0
6007172|NCT00874237|20767447|P3|Overall Study|Physician Decision|0
6007173|NCT00874237|20767448|P2|Overall Study|Physician Decision|1
6007174|NCT00874237|20767449|P1|Overall Study|Physician Decision|0
6007175|NCT00874120|20767467|P2|Second Intervention|Protocol Violation|0
6007176|NCT00874120|20767468|P1|Second Intervention|Protocol Violation|1
6007177|NCT00874120|20767467|P2|Second Intervention|Withdrawal by Subject|0
6007178|NCT00874120|20767468|P1|Second Intervention|Withdrawal by Subject|1
6007179|NCT00874120|20767467|P2|First Intervention|positive drug test|0
6007180|NCT00874120|20767468|P1|First Intervention|positive drug test|1
6007181|NCT00874120|20767467|P2|First Intervention|Protocol Violation|0
6007182|NCT00874120|20767468|P1|First Intervention|Protocol Violation|3
6007183|NCT00874120|20767467|P2|First Intervention|Lost to Follow-up|1
6007184|NCT00874120|20767468|P1|First Intervention|Lost to Follow-up|0
6007185|NCT00874120|20767467|P2|First Intervention|Withdrawal by Subject|0
6007186|NCT00874120|20767468|P1|First Intervention|Withdrawal by Subject|2
6007187|NCT00874120|20767467|P2|First Intervention|Adverse Event|1
6007188|NCT00874120|20767468|P1|First Intervention|Adverse Event|0
6007189|NCT00874029|20767481|P1|Overall Study|Lost to Follow-up|5
6007190|NCT00874029|20767481|P1|Overall Study|Adverse Event|1
6007191|NCT00874029|20767481|P1|Overall Study|Physician Decision|1
6007192|NCT00874029|20767481|P1|Overall Study|Pregnancy|4
6007193|NCT00874029|20767481|P1|Overall Study|Withdrawal by Subject|10
6007194|NCT00873912|20767497|P2|Overall Study|Lost to Follow-up|0
6007195|NCT00873912|20767498|P1|Overall Study|Lost to Follow-up|2
6007196|NCT00873912|20767497|P2|Overall Study|Withdrawal by Subject|0
6007197|NCT00873912|20767498|P1|Overall Study|Withdrawal by Subject|1
6007198|NCT00873860|20767537|P4|Overall Study|Other|0
6007199|NCT00873860|20767538|P3|Overall Study|Other|1
6007200|NCT00873860|20767539|P2|Overall Study|Other|0
6007201|NCT00873860|20767540|P1|Overall Study|Other|1
6007202|NCT00873860|20767537|P4|Overall Study|Death|0
6007203|NCT00873860|20767538|P3|Overall Study|Death|0
6007204|NCT00873860|20767539|P2|Overall Study|Death|0
6007205|NCT00873860|20767540|P1|Overall Study|Death|1
6007206|NCT00873860|20767537|P4|Overall Study|Withdrawal by Subject|0
6007207|NCT00873860|20767538|P3|Overall Study|Withdrawal by Subject|2
6007208|NCT00873860|20767539|P2|Overall Study|Withdrawal by Subject|0
6007209|NCT00873860|20767540|P1|Overall Study|Withdrawal by Subject|1
6007210|NCT00873860|20767537|P4|Overall Study|Lost to Follow-up|1
6007211|NCT00873860|20767538|P3|Overall Study|Lost to Follow-up|0
6007212|NCT00873860|20767539|P2|Overall Study|Lost to Follow-up|0
6007213|NCT00873860|20767540|P1|Overall Study|Lost to Follow-up|1
6007214|NCT00873730|20767628|P2|Overall Study|Sponsor decision|0
6007215|NCT00873730|20767629|P1|Overall Study|Sponsor decision|1
6007216|NCT00873730|20767628|P2|Overall Study|Withdrawal by Subject|1
6007217|NCT00873730|20767629|P1|Overall Study|Withdrawal by Subject|0
6007218|NCT00873730|20767628|P2|Overall Study|Adverse Event|2
6007219|NCT00873730|20767629|P1|Overall Study|Adverse Event|0
6007220|NCT00873730|20767628|P2|Overall Study|Protocol Deviation|2
6007221|NCT00873730|20767629|P1|Overall Study|Protocol Deviation|5
6007222|NCT00873366|20767672|P1|Overall Study|Refused to continue DM-BT testing|3
6007223|NCT00873366|20767672|P1|Overall Study|Off tamoxifen due to side effects|2
6007224|NCT00873366|20767672|P1|Overall Study|Off tamoxifen for reconstructive surgery|1
6007225|NCT00873119|20767697|P2|Overall Study|Not treated|0
6007226|NCT00873119|20767698|P1|Overall Study|Not treated|2
6007227|NCT00873119|20767697|P2|Overall Study|Other|5
6007228|NCT00873119|20767698|P1|Overall Study|Other|2
6007229|NCT00873119|20767697|P2|Overall Study|Death|1
6007230|NCT00873119|20767698|P1|Overall Study|Death|2
6007231|NCT00873119|20767697|P2|Overall Study|Progressive disease|18
6007232|NCT00873119|20767698|P1|Overall Study|Progressive disease|26
6007233|NCT00873119|20767697|P2|Overall Study|Adverse Event|0
6007234|NCT00873119|20767698|P1|Overall Study|Adverse Event|8
6007235|NCT00873119|20767697|P2|Overall Study|Patient request|2
6007236|NCT00873119|20767698|P1|Overall Study|Patient request|4
6007237|NCT00873093|20767719|P5|Overall Study|Ineligible|0
6007238|NCT00873093|20767720|P4|Overall Study|Ineligible|1
6007239|NCT00873093|20767721|P3|Overall Study|Ineligible|0
6007240|NCT00873093|20767722|P2|Overall Study|Ineligible|1
6007241|NCT00873093|20767723|P1|Overall Study|Ineligible|0
6007242|NCT00873093|20767719|P5|Overall Study|Withdrawal by Subject|0
6007243|NCT00873093|20767720|P4|Overall Study|Withdrawal by Subject|0
6007244|NCT00873093|20767721|P3|Overall Study|Withdrawal by Subject|4
6007245|NCT00873093|20767722|P2|Overall Study|Withdrawal by Subject|4
6007246|NCT00873093|20767723|P1|Overall Study|Withdrawal by Subject|1
6007247|NCT00873093|20767719|P5|Overall Study|Physician Decision|2
6007248|NCT00873093|20767720|P4|Overall Study|Physician Decision|10
6007249|NCT00873093|20767721|P3|Overall Study|Physician Decision|10
6007250|NCT00873093|20767722|P2|Overall Study|Physician Decision|17
6007251|NCT00873093|20767723|P1|Overall Study|Physician Decision|0
6007252|NCT00873093|20767719|P5|Overall Study|Death|0
6007253|NCT00873093|20767720|P4|Overall Study|Death|0
6007254|NCT00873093|20767721|P3|Overall Study|Death|2
6007255|NCT00873093|20767722|P2|Overall Study|Death|3
6007256|NCT00873093|20767723|P1|Overall Study|Death|0
6007257|NCT00873093|20767719|P5|Overall Study|Adverse Event|0
6007258|NCT00873093|20767720|P4|Overall Study|Adverse Event|0
6007259|NCT00873093|20767721|P3|Overall Study|Adverse Event|0
6007260|NCT00873093|20767722|P2|Overall Study|Adverse Event|2
6007261|NCT00873093|20767723|P1|Overall Study|Adverse Event|0
6007262|NCT00873041|20767780|P3|Extension Study|Administrative reasons|1
6007263|NCT00873041|20767781|P2|Extension Study|Administrative reasons|0
6007264|NCT00873041|20767782|P1|Extension Study|Administrative reasons|0
6007265|NCT00873041|20767780|P3|Extension Study|Adverse Event|1
6007266|NCT00873041|20767781|P2|Extension Study|Adverse Event|0
6007267|NCT00873041|20767782|P1|Extension Study|Adverse Event|1
6007268|NCT00873041|20767780|P3|Core Study|Protocol deviation|1
6007269|NCT00873041|20767781|P2|Core Study|Protocol deviation|0
6007270|NCT00873041|20767782|P1|Core Study|Protocol deviation|1
6007271|NCT00873041|20767780|P3|Core Study|Abnormal laboratory value|1
6007272|NCT00873041|20767781|P2|Core Study|Abnormal laboratory value|0
6007273|NCT00873041|20767782|P1|Core Study|Abnormal laboratory value|0
6007274|NCT00873041|20767780|P3|Core Study|Lost to Follow-up|0
6007275|NCT00873041|20767781|P2|Core Study|Lost to Follow-up|1
6007276|NCT00873041|20767782|P1|Core Study|Lost to Follow-up|3
6007277|NCT00873041|20767780|P3|Core Study|Withdrawal by Subject|2
6007278|NCT00873041|20767781|P2|Core Study|Withdrawal by Subject|2
6007279|NCT00873041|20767782|P1|Core Study|Withdrawal by Subject|1
6007280|NCT00873041|20767780|P3|Core Study|Adverse Event|1
6007281|NCT00873041|20767781|P2|Core Study|Adverse Event|3
6007282|NCT00873041|20767782|P1|Core Study|Adverse Event|2
6007283|NCT00873015|20767840|P4|Overall Study|Withdrawal by Subject|0
6007284|NCT00873015|20767841|P3|Overall Study|Withdrawal by Subject|0
6007285|NCT00873015|20767842|P2|Overall Study|Withdrawal by Subject|1
6007286|NCT00873015|20767843|P1|Overall Study|Withdrawal by Subject|0
6007287|NCT00872989|20767860|P2|Overall Study|Not protocol specified|8
6007288|NCT00872989|20767861|P1|Overall Study|Not protocol specified|3
6007289|NCT00872989|20767860|P2|Overall Study|Progression/relapse|35
6007290|NCT00872989|20767861|P1|Overall Study|Progression/relapse|47
6007291|NCT00872989|20767860|P2|Overall Study|Withdrawal by Subject|5
6007292|NCT00872989|20767861|P1|Overall Study|Withdrawal by Subject|8
6007293|NCT00872989|20767860|P2|Overall Study|Adverse Event|15
6007294|NCT00872989|20767861|P1|Overall Study|Adverse Event|7
6007295|NCT00872898|20767880|P2|Part Two - Double Blind|Other reasons|0
6007296|NCT00872898|20767881|P1|Part Two - Double Blind|Other reasons|2
6007297|NCT00872898|20767880|P2|Part Two - Double Blind|Lost to Follow-up|2
6007298|NCT00872898|20767881|P1|Part Two - Double Blind|Lost to Follow-up|0
6007299|NCT00872898|20767880|P2|Part Two - Double Blind|Withdrawal by Subject|1
6007300|NCT00872898|20767881|P1|Part Two - Double Blind|Withdrawal by Subject|3
6007301|NCT00872898|20767880|P2|Part Two - Double Blind|Protocol Violation|0
6007302|NCT00872898|20767881|P1|Part Two - Double Blind|Protocol Violation|1
6007303|NCT00872898|20767880|P2|Part Two - Double Blind|Lack of Efficacy|0
6007304|NCT00872898|20767881|P1|Part Two - Double Blind|Lack of Efficacy|1
6007305|NCT00872898|20767880|P2|Part Two - Double Blind|Adverse Event|3
6007306|NCT00872898|20767881|P1|Part Two - Double Blind|Adverse Event|4
6007307|NCT00872599|20767955|P2|Second Washout Period|Adverse Event|1
6007308|NCT00872599|20767956|P1|Second Washout Period|Adverse Event|1
6007309|NCT00872521|20767976|P3|Secondary Endpoint Analysis|Efficacy data unavailable|1
6007310|NCT00872521|20767977|P2|Secondary Endpoint Analysis|Efficacy data unavailable|2
6007311|NCT00872521|20767978|P1|Secondary Endpoint Analysis|Efficacy data unavailable|0
6007312|NCT00872521|20767976|P3|Completed 3-month Follow up|Physician Decision|0
6007313|NCT00872521|20767977|P2|Completed 3-month Follow up|Physician Decision|1
6007314|NCT00872521|20767978|P1|Completed 3-month Follow up|Physician Decision|0
6007315|NCT00872521|20767976|P3|Completed 3-month Follow up|Other|0
6007316|NCT00872521|20767977|P2|Completed 3-month Follow up|Other|2
6007317|NCT00872521|20767978|P1|Completed 3-month Follow up|Other|0
6007318|NCT00872521|20767976|P3|Primary Endpoint Analysis|Patient response missing|1
6007319|NCT00872521|20767977|P2|Primary Endpoint Analysis|Patient response missing|0
6007320|NCT00872521|20767978|P1|Primary Endpoint Analysis|Patient response missing|0
6007321|NCT00872521|20767976|P3|Primary Endpoint Analysis|Efficacy data unavailable|0
6007322|NCT00872521|20767977|P2|Primary Endpoint Analysis|Efficacy data unavailable|2
6007323|NCT00872521|20767978|P1|Primary Endpoint Analysis|Efficacy data unavailable|0
6007324|NCT00872521|20767976|P3|Primary Endpoint Analysis|Patient choice|0
6007325|NCT00872521|20767977|P2|Primary Endpoint Analysis|Patient choice|1
6007326|NCT00872521|20767978|P1|Primary Endpoint Analysis|Patient choice|0
6007327|NCT00872521|20767976|P3|Primary Endpoint Analysis|Other|0
6007328|NCT00872521|20767977|P2|Primary Endpoint Analysis|Other|2
6007329|NCT00872521|20767978|P1|Primary Endpoint Analysis|Other|1
6007330|NCT00872521|20767976|P3|Completed PAD Induction|Death|0
6007331|NCT00872521|20767977|P2|Completed PAD Induction|Death|1
6007332|NCT00872521|20767978|P1|Completed PAD Induction|Death|1
6007333|NCT00872521|20767976|P3|Completed PAD Induction|Adverse Event|0
6007334|NCT00872521|20767977|P2|Completed PAD Induction|Adverse Event|0
6007335|NCT00872521|20767978|P1|Completed PAD Induction|Adverse Event|4
6007336|NCT00872521|20767976|P3|Completed PAD Induction|Disease progression|0
6007337|NCT00872521|20767977|P2|Completed PAD Induction|Disease progression|2
6007338|NCT00872521|20767978|P1|Completed PAD Induction|Disease progression|0
6007339|NCT00872521|20767976|P3|Completed PAD Induction|Patient choice|0
6007340|NCT00872521|20767977|P2|Completed PAD Induction|Patient choice|1
6007341|NCT00872521|20767978|P1|Completed PAD Induction|Patient choice|0
6007342|NCT00872170|20768049|P2|Overall Study|Adverse Event|0
6007343|NCT00872170|20768050|P1|Overall Study|Adverse Event|1
6007344|NCT00872001|20768080|P2|Overall Study|Administrative|15
6007345|NCT00872001|20768081|P1|Overall Study|Administrative|23
6007346|NCT00872001|20768080|P2|Overall Study|Did Not Meet Protocol Eligibility|36
6007347|NCT00872001|20768081|P1|Overall Study|Did Not Meet Protocol Eligibility|38
6007348|NCT00872001|20768080|P2|Overall Study|Protocol Violation|8
6007349|NCT00872001|20768081|P1|Overall Study|Protocol Violation|5
6007350|NCT00872001|20768080|P2|Overall Study|Withdrawal by Subject|30
6007351|NCT00872001|20768081|P1|Overall Study|Withdrawal by Subject|18
6007352|NCT00872001|20768080|P2|Overall Study|Lost to Follow-up|12
6007353|NCT00872001|20768081|P1|Overall Study|Lost to Follow-up|13
6007354|NCT00872001|20768080|P2|Overall Study|Protocol Defined Clinical Event|7
6007355|NCT00872001|20768081|P1|Overall Study|Protocol Defined Clinical Event|5
6007356|NCT00872001|20768080|P2|Overall Study|Adverse Event|23
6007357|NCT00872001|20768081|P1|Overall Study|Adverse Event|34
6007358|NCT00871975|20768089|P1|Overall Study|Motion artifact, tracing uninterpretable|5
6007359|NCT00871975|20768089|P1|Overall Study|Patient unable to void/insufficient vol|13
6007360|NCT00871975|20768089|P1|Overall Study|Catheters could not be inserted|1
6007361|NCT00871975|20768089|P1|Overall Study|Technical difficulty w155-1ith equipment|3
6007362|NCT00871871|20768095|P4|Part II|Protocol Violation|1
6007363|NCT00871871|20768096|P3|Part II|Protocol Violation|0
6007364|NCT00871871|20768097|P2|Part II|Protocol Violation|0
6007365|NCT00871871|20768098|P1|Part II|Protocol Violation|0
6007366|NCT00871871|20768095|P4|Part II|Adverse Event|2
6007367|NCT00871871|20768096|P3|Part II|Adverse Event|1
6007368|NCT00871871|20768097|P2|Part II|Adverse Event|0
6007369|NCT00871871|20768098|P1|Part II|Adverse Event|0
6007370|NCT00871871|20768095|P4|Part II|Withdrawal by Subject|1
6007371|NCT00871871|20768096|P3|Part II|Withdrawal by Subject|2
6007372|NCT00871871|20768097|P2|Part II|Withdrawal by Subject|0
6007373|NCT00871871|20768098|P1|Part II|Withdrawal by Subject|0
6007374|NCT00871871|20768095|P4|Part II|Lack of Efficacy|0
6007375|NCT00871871|20768096|P3|Part II|Lack of Efficacy|1
6007376|NCT00871871|20768097|P2|Part II|Lack of Efficacy|0
6007377|NCT00871871|20768098|P1|Part II|Lack of Efficacy|0
6007378|NCT00871871|20768095|P4|Part I|Laboratory abnormality|0
6007379|NCT00871871|20768096|P3|Part I|Laboratory abnormality|0
6007380|NCT00871871|20768097|P2|Part I|Laboratory abnormality|1
6007381|NCT00871871|20768098|P1|Part I|Laboratory abnormality|0
6007382|NCT00871871|20768095|P4|Part I|Withdrawal by Subject|0
6007383|NCT00871871|20768096|P3|Part I|Withdrawal by Subject|0
6007384|NCT00871871|20768097|P2|Part I|Withdrawal by Subject|0
6007385|NCT00871871|20768098|P1|Part I|Withdrawal by Subject|3
6007386|NCT00871871|20768095|P4|Part I|Adverse Event|0
6007387|NCT00871871|20768096|P3|Part I|Adverse Event|0
6007388|NCT00871871|20768097|P2|Part I|Adverse Event|2
6007389|NCT00871871|20768098|P1|Part I|Adverse Event|0
6007390|NCT00871780|20768135|P1|Overall Study|Physician Decision|1
6007391|NCT00871780|20768135|P1|Overall Study|Death|1
6007392|NCT00871780|20768135|P1|Overall Study|Voluntary Discontinuation|4
6007393|NCT00871780|20768135|P1|Overall Study|Adverse Event|6
6007394|NCT00871780|20768135|P1|Overall Study|Withdrawal by Subject|9
6007395|NCT00871780|20768135|P1|Overall Study|Enrolled But Not Treated|6
6007396|NCT00871741|20768155|P2|Overall Study|Premature study termination|7
6007397|NCT00871741|20768156|P1|Overall Study|Premature study termination|9
6007398|NCT00871728|20768170|P1|Overall Study|Withdrawal of Informed Consent|5
6007399|NCT00871728|20768170|P1|Overall Study|Participant Non-compliance|1
6007400|NCT00871728|20768170|P1|Overall Study|Failed to Visit Hospital|4
6007401|NCT00871728|20768170|P1|Overall Study|Lost to Follow-up|2
6007402|NCT00871728|20768170|P1|Overall Study|Protocol Violation|7
6007403|NCT00871728|20768170|P1|Overall Study|Adverse Event|1
6007404|NCT00871715|20768183|P3|Overall Study|Lost to Follow-up|9
6007405|NCT00871715|20768184|P2|Overall Study|Lost to Follow-up|6
6007406|NCT00871715|20768185|P1|Overall Study|Lost to Follow-up|3
6007407|NCT00871715|20768183|P3|Overall Study|Physician Decision|2
6007408|NCT00871715|20768184|P2|Overall Study|Physician Decision|0
6007409|NCT00871715|20768185|P1|Overall Study|Physician Decision|6
6007410|NCT00871715|20768183|P3|Overall Study|Withdrawal by Subject|15
6007411|NCT00871715|20768184|P2|Overall Study|Withdrawal by Subject|10
6007412|NCT00871715|20768185|P1|Overall Study|Withdrawal by Subject|6
6007413|NCT00871572|20768262|P4|Overall Study|Withdrawal by Subject|1
6007414|NCT00871572|20768263|P3|Overall Study|Withdrawal by Subject|3
6007415|NCT00871572|20768264|P2|Overall Study|Withdrawal by Subject|2
6007416|NCT00871572|20768265|P1|Overall Study|Withdrawal by Subject|1
6007417|NCT00871572|20768262|P4|Overall Study|Sponsor Decision|0
6007418|NCT00871572|20768263|P3|Overall Study|Sponsor Decision|0
6007419|NCT00871572|20768264|P2|Overall Study|Sponsor Decision|0
6007420|NCT00871572|20768265|P1|Overall Study|Sponsor Decision|1
6007421|NCT00871572|20768262|P4|Overall Study|Protocol Violation|1
6007422|NCT00871572|20768263|P3|Overall Study|Protocol Violation|1
6007423|NCT00871572|20768264|P2|Overall Study|Protocol Violation|0
6007424|NCT00871572|20768265|P1|Overall Study|Protocol Violation|0
6007425|NCT00871572|20768262|P4|Overall Study|Lost to Follow-up|1
6007426|NCT00871572|20768263|P3|Overall Study|Lost to Follow-up|0
6007427|NCT00871572|20768264|P2|Overall Study|Lost to Follow-up|1
6007428|NCT00871572|20768265|P1|Overall Study|Lost to Follow-up|0
6007429|NCT00871572|20768262|P4|Overall Study|Investigator Decision|1
6007430|NCT00871572|20768263|P3|Overall Study|Investigator Decision|0
6007431|NCT00871572|20768264|P2|Overall Study|Investigator Decision|1
6007432|NCT00871572|20768265|P1|Overall Study|Investigator Decision|0
6007433|NCT00871572|20768262|P4|Overall Study|Adverse Event|3
6007434|NCT00871572|20768263|P3|Overall Study|Adverse Event|0
6007435|NCT00871572|20768264|P2|Overall Study|Adverse Event|2
6007436|NCT00871572|20768265|P1|Overall Study|Adverse Event|0
6007437|NCT00871494|20768335|P1|Overall Study|Lost to Follow-up|1
6007438|NCT00871494|20768335|P1|Overall Study|Adverse Event|4
6007439|NCT00871494|20768335|P1|Overall Study|Lack of Efficacy|4
6007440|NCT00871494|20768335|P1|Overall Study|Protocol Violation|5
6007441|NCT00871429|20768342|P1|Overall Study|Questionnaire not completed|1
6007442|NCT00871429|20768342|P1|Overall Study|Withdrawal by Subject|17
6007443|NCT00871429|20768342|P1|Overall Study|Lost to Follow-up|6
6007444|NCT00871403|20768353|P3|Monotherapy Treatment Phase|Adverse Event|0
6007445|NCT00871403|20768354|P2|Monotherapy Treatment Phase|Adverse Event|4
6007446|NCT00871403|20768355|P1|Monotherapy Treatment Phase|Adverse Event|0
6007447|NCT00871403|20768353|P3|Monotherapy Treatment Phase|Disease Progression|1
6007448|NCT00871403|20768354|P2|Monotherapy Treatment Phase|Disease Progression|9
6007449|NCT00871403|20768355|P1|Monotherapy Treatment Phase|Disease Progression|0
6007450|NCT00871403|20768353|P3|Combination Treatment Phase|Physician Decision|3
6007451|NCT00871403|20768354|P2|Combination Treatment Phase|Physician Decision|1
6007452|NCT00871403|20768355|P1|Combination Treatment Phase|Physician Decision|0
6007453|NCT00871403|20768353|P3|Combination Treatment Phase|Withdrawal by Subject|1
6007454|NCT00871403|20768354|P2|Combination Treatment Phase|Withdrawal by Subject|3
6007455|NCT00871403|20768355|P1|Combination Treatment Phase|Withdrawal by Subject|0
6007456|NCT00871403|20768353|P3|Combination Treatment Phase|Disease Progression|5
6007457|NCT00871403|20768354|P2|Combination Treatment Phase|Disease Progression|8
6007458|NCT00871403|20768355|P1|Combination Treatment Phase|Disease Progression|0
6007459|NCT00871403|20768353|P3|Combination Treatment Phase|Adverse Event|2
6007460|NCT00871403|20768354|P2|Combination Treatment Phase|Adverse Event|17
6007461|NCT00871403|20768355|P1|Combination Treatment Phase|Adverse Event|0
6007462|NCT00871403|20768353|P3|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|0
6007463|NCT00871403|20768354|P2|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|19
6007464|NCT00871403|20768355|P1|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|8
6007465|NCT00871403|20768353|P3|Combination Treatment Phase|Randomized but Not Treated|1
6007466|NCT00871403|20768354|P2|Combination Treatment Phase|Randomized but Not Treated|1
6007467|NCT00871403|20768355|P1|Combination Treatment Phase|Randomized but Not Treated|1
6007468|NCT00871377|20768368|P6|Third Intervention (10 Weeks)|Death|0
6007469|NCT00871377|20768369|P5|Third Intervention (10 Weeks)|Death|0
6007470|NCT00871377|20768370|P4|Third Intervention (10 Weeks)|Death|1
6007471|NCT00871377|20768371|P3|Third Intervention (10 Weeks)|Death|0
6007472|NCT00871377|20768372|P2|Third Intervention (10 Weeks)|Death|0
6007473|NCT00871377|20768373|P1|Third Intervention (10 Weeks)|Death|0
6007474|NCT00871377|20768368|P6|Washout (6 Weeks)|Withdrawal by Subject|1
6007475|NCT00871377|20768369|P5|Washout (6 Weeks)|Withdrawal by Subject|0
6007476|NCT00871377|20768370|P4|Washout (6 Weeks)|Withdrawal by Subject|0
6007477|NCT00871377|20768371|P3|Washout (6 Weeks)|Withdrawal by Subject|0
6007478|NCT00871377|20768372|P2|Washout (6 Weeks)|Withdrawal by Subject|0
6007479|NCT00871377|20768373|P1|Washout (6 Weeks)|Withdrawal by Subject|0
6007480|NCT00871377|20768368|P6|Washout (6 Weeks)|Withdrawal by Subject|0
6007481|NCT00871377|20768369|P5|Washout (6 Weeks)|Withdrawal by Subject|0
6007482|NCT00871377|20768370|P4|Washout (6 Weeks)|Withdrawal by Subject|0
6007483|NCT00871377|20768371|P3|Washout (6 Weeks)|Withdrawal by Subject|0
6007484|NCT00871377|20768372|P2|Washout (6 Weeks)|Withdrawal by Subject|0
6007485|NCT00871377|20768373|P1|Washout (6 Weeks)|Withdrawal by Subject|1
6007486|NCT00871377|20768368|P6|First Intervention (10 Weeks)|Lost to Follow-up|1
6007487|NCT00871377|20768369|P5|First Intervention (10 Weeks)|Lost to Follow-up|0
6007488|NCT00871377|20768370|P4|First Intervention (10 Weeks)|Lost to Follow-up|0
6007489|NCT00871377|20768371|P3|First Intervention (10 Weeks)|Lost to Follow-up|0
6007490|NCT00871377|20768372|P2|First Intervention (10 Weeks)|Lost to Follow-up|0
6007491|NCT00871377|20768373|P1|First Intervention (10 Weeks)|Lost to Follow-up|0
6007492|NCT00871377|20768368|P6|First Intervention (10 Weeks)|Withdrawal by Subject|0
6007493|NCT00871377|20768369|P5|First Intervention (10 Weeks)|Withdrawal by Subject|0
6007494|NCT00871377|20768370|P4|First Intervention (10 Weeks)|Withdrawal by Subject|0
6007495|NCT00871377|20768371|P3|First Intervention (10 Weeks)|Withdrawal by Subject|1
6007496|NCT00871377|20768372|P2|First Intervention (10 Weeks)|Withdrawal by Subject|0
6007497|NCT00871377|20768373|P1|First Intervention (10 Weeks)|Withdrawal by Subject|0
6007498|NCT00871351|20768384|P3|Overall Study|Adverse Event|0
6007499|NCT00871351|20768385|P2|Overall Study|Adverse Event|1
6007500|NCT00871351|20768386|P1|Overall Study|Adverse Event|3
6007501|NCT00871351|20768384|P3|Overall Study|Withdrawal by Subject|0
6007502|NCT00871351|20768385|P2|Overall Study|Withdrawal by Subject|0
6007503|NCT00871351|20768386|P1|Overall Study|Withdrawal by Subject|1
6007504|NCT00871338|20768408|P2|Prior to Booster|Lost to Follow-up|0
6007505|NCT00871338|20768409|P1|Prior to Booster|Lost to Follow-up|1
6007506|NCT00871338|20768408|P2|Prior to Booster|Withdrawal by Subject|3
6007507|NCT00871338|20768409|P1|Prior to Booster|Withdrawal by Subject|1
6007508|NCT00871234|20768498|P1|Overall Study|Lost to Follow-up|3
6007509|NCT00871234|20768498|P1|Overall Study|Adverse Event|2
6007510|NCT00871169|20768502|P1|Overall Study|Patient did not receive study treatment|2
6007511|NCT00871169|20768502|P1|Overall Study|Protocol Violation|1
6007512|NCT00871117|20768530|P2|Overall Study|Other|4
6007513|NCT00871117|20768531|P1|Overall Study|Other|0
6007514|NCT00871117|20768530|P2|Overall Study|Lost to Follow-up|6
6007515|NCT00871117|20768531|P1|Overall Study|Lost to Follow-up|5
6007516|NCT00871000|20768565|P2|Overall Study|Withdrawal by Subject|0
6007517|NCT00871000|20768566|P1|Overall Study|Withdrawal by Subject|1
6007518|NCT00870870|20768618|P4|Overall Study|Adverse Event|2
6007519|NCT00870870|20768619|P3|Overall Study|Adverse Event|2
6007520|NCT00870870|20768620|P2|Overall Study|Adverse Event|0
6007521|NCT00870870|20768621|P1|Overall Study|Adverse Event|0
6007522|NCT00870870|20768618|P4|Overall Study|Withdrawal by Subject|3
6007523|NCT00870870|20768619|P3|Overall Study|Withdrawal by Subject|1
6007524|NCT00870870|20768620|P2|Overall Study|Withdrawal by Subject|1
6007525|NCT00870870|20768621|P1|Overall Study|Withdrawal by Subject|0
6007526|NCT00870740|20768665|P6|Overall Study|Other|5
6007527|NCT00870740|20768666|P5|Overall Study|Other|3
6007528|NCT00870740|20768667|P4|Overall Study|Other|4
6007529|NCT00870740|20768668|P3|Overall Study|Other|2
6007530|NCT00870740|20768669|P2|Overall Study|Other|5
6007531|NCT00870740|20768670|P1|Overall Study|Other|2
6007532|NCT00870740|20768665|P6|Overall Study|Death|0
6007533|NCT00870740|20768666|P5|Overall Study|Death|1
6007534|NCT00870740|20768667|P4|Overall Study|Death|0
6007535|NCT00870740|20768668|P3|Overall Study|Death|0
6007536|NCT00870740|20768669|P2|Overall Study|Death|0
6007537|NCT00870740|20768670|P1|Overall Study|Death|0
6007538|NCT00870740|20768665|P6|Overall Study|Subject Non-compliance|1
6007539|NCT00870740|20768666|P5|Overall Study|Subject Non-compliance|0
6007540|NCT00870740|20768667|P4|Overall Study|Subject Non-compliance|0
6007541|NCT00870740|20768668|P3|Overall Study|Subject Non-compliance|0
6007542|NCT00870740|20768669|P2|Overall Study|Subject Non-compliance|0
6007543|NCT00870740|20768670|P1|Overall Study|Subject Non-compliance|0
6007544|NCT00870740|20768665|P6|Overall Study|Investigator Decision|0
6007545|NCT00870740|20768666|P5|Overall Study|Investigator Decision|0
6007546|NCT00870740|20768667|P4|Overall Study|Investigator Decision|0
6007547|NCT00870740|20768668|P3|Overall Study|Investigator Decision|1
6007548|NCT00870740|20768669|P2|Overall Study|Investigator Decision|0
6007549|NCT00870740|20768670|P1|Overall Study|Investigator Decision|2
6007550|NCT00870740|20768665|P6|Overall Study|Consent Withdrawn|5
6007551|NCT00870740|20768666|P5|Overall Study|Consent Withdrawn|6
6007552|NCT00870740|20768667|P4|Overall Study|Consent Withdrawn|6
6007553|NCT00870740|20768668|P3|Overall Study|Consent Withdrawn|4
6007554|NCT00870740|20768669|P2|Overall Study|Consent Withdrawn|3
6007555|NCT00870740|20768670|P1|Overall Study|Consent Withdrawn|6
6007556|NCT00870740|20768665|P6|Overall Study|Adverse Event|6
6007557|NCT00870740|20768666|P5|Overall Study|Adverse Event|1
6007558|NCT00870740|20768667|P4|Overall Study|Adverse Event|2
6007559|NCT00870740|20768668|P3|Overall Study|Adverse Event|3
6007560|NCT00870740|20768669|P2|Overall Study|Adverse Event|1
6007561|NCT00870740|20768670|P1|Overall Study|Adverse Event|2
6007562|NCT00870727|20768746|P2|Overall Study|Adverse Event|1
6007563|NCT00870727|20768747|P1|Overall Study|Adverse Event|0
6007564|NCT00870727|20768746|P2|Overall Study|Lack of Efficacy|3
6007565|NCT00870727|20768747|P1|Overall Study|Lack of Efficacy|1
6007566|NCT00870727|20768746|P2|Overall Study|Lost to Follow-up|1
6007567|NCT00870727|20768747|P1|Overall Study|Lost to Follow-up|0
6007568|NCT00870688|20768763|P1|Overall Study|Granules in the Stools|1
6007569|NCT00870688|20768763|P1|Overall Study|Death, Unrelated|1
6007570|NCT00870688|20768763|P1|Overall Study|Lost to Follow-up|2
6007571|NCT00870584|20768768|P2|Overall Study|Protocol Deviation|2
6007572|NCT00870584|20768769|P1|Overall Study|Protocol Deviation|2
6007573|NCT00870584|20768768|P2|Overall Study|Lost to Follow-up|1
6007574|NCT00870584|20768769|P1|Overall Study|Lost to Follow-up|5
6007575|NCT00870584|20768768|P2|Overall Study|Withdrawal by Subject|7
6007576|NCT00870584|20768769|P1|Overall Study|Withdrawal by Subject|6
6007577|NCT00870584|20768768|P2|Overall Study|Adverse Event|3
6007578|NCT00870584|20768769|P1|Overall Study|Adverse Event|3
6007579|NCT00870233|20768878|P1|Overall Study|Death|1
6007580|NCT00870233|20768878|P1|Overall Study|Incompatible internet browser|2
6007581|NCT00870233|20768878|P1|Overall Study|Did not undergo laparotomy|3
6007582|NCT00870233|20768878|P1|Overall Study|Withdrawal by Subject|18
6007583|NCT00870194|20768887|P2|Overall Study|Subject Decision|2
6007584|NCT00870194|20768888|P1|Overall Study|Subject Decision|7
6007585|NCT00870194|20768887|P2|Overall Study|Entry Criteria Not Met|2
6007586|NCT00870194|20768888|P1|Overall Study|Entry Criteria Not Met|1
6007587|NCT00870194|20768887|P2|Overall Study|Protocol Violation|3
6007588|NCT00870194|20768888|P1|Overall Study|Protocol Violation|3
6007589|NCT00870194|20768887|P2|Overall Study|Physician Decision|1
6007590|NCT00870194|20768888|P1|Overall Study|Physician Decision|3
6007591|NCT00870194|20768887|P2|Overall Study|Lost to Follow-up|0
6007592|NCT00870194|20768888|P1|Overall Study|Lost to Follow-up|2
6007593|NCT00870194|20768887|P2|Overall Study|Lack of Efficacy|1
6007594|NCT00870194|20768888|P1|Overall Study|Lack of Efficacy|0
6007595|NCT00870194|20768887|P2|Overall Study|Adverse Event|5
6007596|NCT00870194|20768888|P1|Overall Study|Adverse Event|10
6007597|NCT00870103|20768926|P1|Overall Study|Lost to Follow-up|2
6007598|NCT00870103|20768926|P1|Overall Study|Physician Decision|2
6007599|NCT00869999|20768931|P1|Overall Study|removed prior to starting therapy|1
6007600|NCT00869999|20768931|P1|Overall Study|Withdrawal by Subject|1
6007601|NCT00869960|20768937|P1|Overall Study|Lost to Follow-up|2
6007602|NCT00869778|20768986|P3|Overall Study|Unblinding|0
6007603|NCT00869778|20768987|P2|Overall Study|Unblinding|0
6007604|NCT00869778|20768988|P1|Overall Study|Unblinding|1
6007605|NCT00869778|20768986|P3|Overall Study|Protocol Violation|5
6007606|NCT00869778|20768987|P2|Overall Study|Protocol Violation|3
6007607|NCT00869778|20768988|P1|Overall Study|Protocol Violation|5
6007608|NCT00869778|20768986|P3|Overall Study|Pregnancy|0
6007609|NCT00869778|20768987|P2|Overall Study|Pregnancy|0
6007610|NCT00869778|20768988|P1|Overall Study|Pregnancy|1
6007611|NCT00869778|20768986|P3|Overall Study|Withdrawal by Subject|5
6007612|NCT00869778|20768987|P2|Overall Study|Withdrawal by Subject|4
6007613|NCT00869778|20768988|P1|Overall Study|Withdrawal by Subject|3
6007614|NCT00869778|20768986|P3|Overall Study|Adverse Event|0
6007615|NCT00869778|20768987|P2|Overall Study|Adverse Event|0
6007616|NCT00869778|20768988|P1|Overall Study|Adverse Event|2
6007617|NCT00869557|20769063|P2|Extension Phase|Withdrew Consent|0
6007618|NCT00869557|20769064|P1|Extension Phase|Withdrew Consent|2
6007619|NCT00869557|20769063|P2|Extension Phase|Investigator's Discretion|0
6007620|NCT00869557|20769064|P1|Extension Phase|Investigator's Discretion|2
6007621|NCT00869557|20769063|P2|Extension Phase|Lost to Follow-up|1
6007622|NCT00869557|20769064|P1|Extension Phase|Lost to Follow-up|3
6007623|NCT00869557|20769063|P2|Extension Phase|Lack of Efficacy|0
6007624|NCT00869557|20769064|P1|Extension Phase|Lack of Efficacy|1
6007625|NCT00869557|20769063|P2|Extension Phase|Adverse Event|2
6007626|NCT00869557|20769064|P1|Extension Phase|Adverse Event|2
6007627|NCT00869557|20769063|P2|Randomized Phase|Withdrew Consent|1
6007628|NCT00869557|20769064|P1|Randomized Phase|Withdrew Consent|0
6007629|NCT00869557|20769063|P2|Randomized Phase|Investigator's Discretion|0
6007630|NCT00869557|20769064|P1|Randomized Phase|Investigator's Discretion|1
6007631|NCT00869557|20769063|P2|Randomized Phase|Lost to Follow-up|1
6007632|NCT00869557|20769064|P1|Randomized Phase|Lost to Follow-up|2
6007633|NCT00869518|20769083|P2|Overall Study|Lost to Follow-up|1
6007634|NCT00869518|20769084|P1|Overall Study|Lost to Follow-up|1
6007635|NCT00869440|20769100|P4|Overall Study|Physician Decision|0
6007636|NCT00869440|20769101|P3|Overall Study|Physician Decision|0
6007637|NCT00869440|20769102|P2|Overall Study|Physician Decision|1
6007638|NCT00869440|20769103|P1|Overall Study|Physician Decision|1
6007639|NCT00869440|20769100|P4|Overall Study|Withdrawal by Subject|0
6007640|NCT00869440|20769101|P3|Overall Study|Withdrawal by Subject|0
6007641|NCT00869440|20769102|P2|Overall Study|Withdrawal by Subject|0
6007642|NCT00869440|20769103|P1|Overall Study|Withdrawal by Subject|1
6007643|NCT00869401|20769137|P5|Overall Study|Withdrawal by Subject|3
6007644|NCT00869401|20769138|P4|Overall Study|Withdrawal by Subject|5
6007645|NCT00869401|20769139|P3|Overall Study|Withdrawal by Subject|0
6007646|NCT00869401|20769140|P2|Overall Study|Withdrawal by Subject|0
6007647|NCT00869401|20769141|P1|Overall Study|Withdrawal by Subject|0
6007648|NCT00869362|20769170|P2|Overall Study|Lost to Follow-up|3
6007649|NCT00869362|20769171|P1|Overall Study|Lost to Follow-up|1
6007650|NCT00869362|20769170|P2|Overall Study|Death|2
6007651|NCT00869362|20769171|P1|Overall Study|Death|0
6007652|NCT00869323|20769192|P1|Maintenance Therapy|concurrent illness|1
6007653|NCT00869258|20769200|P1|Overall Study|Physician Decision|1
6007654|NCT00869128|20769265|P2|Overall Study|lack of Compliance|6
6007655|NCT00869128|20769266|P1|Overall Study|lack of Compliance|6
6007656|NCT00869089|20769270|P1|Overall Study|Screen Fail|1
6007657|NCT00869089|20769270|P1|Overall Study|Withdrawal by Subject|1
6007658|NCT00869089|20769270|P1|Overall Study|Lost to Follow-up|1
6007659|NCT00869050|20769274|P1|Overall Study|Screen Failure|3
6007660|NCT00869024|20769281|P2|Overall Study|Protocol Violation|1
6007661|NCT00869024|20769282|P1|Overall Study|Protocol Violation|0
6007662|NCT00869024|20769281|P2|Overall Study|Lost to Follow-up|1
6007663|NCT00869024|20769282|P1|Overall Study|Lost to Follow-up|0
6007664|NCT00869024|20769281|P2|Overall Study|Death|3
6007665|NCT00869024|20769282|P1|Overall Study|Death|2
6007666|NCT00868998|20769298|P1|Overall Study|Death|1
6007667|NCT00868998|20769298|P1|Overall Study|Progression of disease|2
6007668|NCT00868998|20769298|P1|Overall Study|Withdrawal by Subject|1
6007669|NCT00868998|20769298|P1|Overall Study|Screen Failure|1
6007670|NCT00868790|20769309|P14|Post-study|Excluded Medication|0
6007671|NCT00868790|20769310|P13|Post-study|Excluded Medication|0
6007672|NCT00868790|20769311|P12|Post-study|Excluded Medication|0
6007673|NCT00868790|20769312|P11|Post-study|Excluded Medication|0
6007674|NCT00868790|20769313|P10|Post-study|Excluded Medication|1
6007675|NCT00868790|20769314|P9|Post-study|Excluded Medication|0
6007676|NCT00868790|20769315|P8|Post-study|Excluded Medication|2
6007677|NCT00868790|20769316|P7|Post-study|Excluded Medication|0
6007678|NCT00868790|20769317|P6|Post-study|Excluded Medication|0
6007679|NCT00868790|20769318|P5|Post-study|Excluded Medication|0
6007680|NCT00868790|20769319|P4|Post-study|Excluded Medication|0
6007681|NCT00868790|20769320|P3|Post-study|Excluded Medication|0
6007682|NCT00868790|20769321|P2|Post-study|Excluded Medication|0
6007683|NCT00868790|20769322|P1|Post-study|Excluded Medication|0
6007684|NCT00868790|20769309|P14|Post-study|Withdrawal by Subject|0
6007685|NCT00868790|20769310|P13|Post-study|Withdrawal by Subject|0
6007686|NCT00868790|20769311|P12|Post-study|Withdrawal by Subject|0
6007687|NCT00868790|20769312|P11|Post-study|Withdrawal by Subject|0
6007688|NCT00868790|20769313|P10|Post-study|Withdrawal by Subject|0
6007689|NCT00868790|20769314|P9|Post-study|Withdrawal by Subject|0
6007690|NCT00868790|20769315|P8|Post-study|Withdrawal by Subject|0
6007691|NCT00868790|20769316|P7|Post-study|Withdrawal by Subject|0
6007692|NCT00868790|20769317|P6|Post-study|Withdrawal by Subject|0
6007693|NCT00868790|20769318|P5|Post-study|Withdrawal by Subject|1
6007694|NCT00868790|20769319|P4|Post-study|Withdrawal by Subject|0
6007695|NCT00868790|20769320|P3|Post-study|Withdrawal by Subject|0
6007696|NCT00868790|20769321|P2|Post-study|Withdrawal by Subject|0
6007697|NCT00868790|20769322|P1|Post-study|Withdrawal by Subject|0
6007698|NCT00868790|20769309|P14|Period 4|Abnormal ALT/AST|0
6007699|NCT00868790|20769310|P13|Period 4|Abnormal ALT/AST|0
6007700|NCT00868790|20769311|P12|Period 4|Abnormal ALT/AST|0
6007701|NCT00868790|20769312|P11|Period 4|Abnormal ALT/AST|0
6007702|NCT00868790|20769313|P10|Period 4|Abnormal ALT/AST|0
6007703|NCT00868790|20769314|P9|Period 4|Abnormal ALT/AST|0
6007704|NCT00868790|20769315|P8|Period 4|Abnormal ALT/AST|0
6007705|NCT00868790|20769316|P7|Period 4|Abnormal ALT/AST|0
6007706|NCT00868790|20769317|P6|Period 4|Abnormal ALT/AST|0
6007707|NCT00868790|20769318|P5|Period 4|Abnormal ALT/AST|0
6007708|NCT00868790|20769319|P4|Period 4|Abnormal ALT/AST|0
6007709|NCT00868790|20769320|P3|Period 4|Abnormal ALT/AST|1
6007710|NCT00868790|20769321|P2|Period 4|Abnormal ALT/AST|0
6007711|NCT00868790|20769322|P1|Period 4|Abnormal ALT/AST|0
6007712|NCT00868790|20769309|P14|Period 4|Study Terminated by Sponsor|1
6007713|NCT00868790|20769310|P13|Period 4|Study Terminated by Sponsor|0
6007714|NCT00868790|20769311|P12|Period 4|Study Terminated by Sponsor|1
6007715|NCT00868790|20769312|P11|Period 4|Study Terminated by Sponsor|2
6007716|NCT00868790|20769313|P10|Period 4|Study Terminated by Sponsor|0
6007717|NCT00868790|20769314|P9|Period 4|Study Terminated by Sponsor|2
6007718|NCT00868790|20769315|P8|Period 4|Study Terminated by Sponsor|1
6007719|NCT00868790|20769316|P7|Period 4|Study Terminated by Sponsor|0
6007720|NCT00868790|20769317|P6|Period 4|Study Terminated by Sponsor|0
6007721|NCT00868790|20769318|P5|Period 4|Study Terminated by Sponsor|0
6007722|NCT00868790|20769319|P4|Period 4|Study Terminated by Sponsor|0
6007723|NCT00868790|20769320|P3|Period 4|Study Terminated by Sponsor|0
6007724|NCT00868790|20769321|P2|Period 4|Study Terminated by Sponsor|0
6007725|NCT00868790|20769322|P1|Period 4|Study Terminated by Sponsor|2
6007726|NCT00868790|20769309|P14|Period 4|Lost to Follow-up|0
6007727|NCT00868790|20769310|P13|Period 4|Lost to Follow-up|0
6007728|NCT00868790|20769311|P12|Period 4|Lost to Follow-up|0
6007729|NCT00868790|20769312|P11|Period 4|Lost to Follow-up|0
6007730|NCT00868790|20769313|P10|Period 4|Lost to Follow-up|0
6007731|NCT00868790|20769314|P9|Period 4|Lost to Follow-up|0
6007732|NCT00868790|20769315|P8|Period 4|Lost to Follow-up|1
6007733|NCT00868790|20769316|P7|Period 4|Lost to Follow-up|0
6007734|NCT00868790|20769317|P6|Period 4|Lost to Follow-up|0
6007735|NCT00868790|20769318|P5|Period 4|Lost to Follow-up|0
6007736|NCT00868790|20769319|P4|Period 4|Lost to Follow-up|0
6007737|NCT00868790|20769320|P3|Period 4|Lost to Follow-up|0
6007738|NCT00868790|20769321|P2|Period 4|Lost to Follow-up|0
6007739|NCT00868790|20769322|P1|Period 4|Lost to Follow-up|0
6007740|NCT00868790|20769309|P14|Period 4|Adverse Event|0
6007741|NCT00868790|20769310|P13|Period 4|Adverse Event|1
6007742|NCT00868790|20769311|P12|Period 4|Adverse Event|0
6007743|NCT00868790|20769312|P11|Period 4|Adverse Event|1
6007744|NCT00868790|20769313|P10|Period 4|Adverse Event|0
6007745|NCT00868790|20769314|P9|Period 4|Adverse Event|0
6007746|NCT00868790|20769315|P8|Period 4|Adverse Event|1
6007747|NCT00868790|20769316|P7|Period 4|Adverse Event|0
6007748|NCT00868790|20769317|P6|Period 4|Adverse Event|0
6007749|NCT00868790|20769318|P5|Period 4|Adverse Event|0
6007750|NCT00868790|20769319|P4|Period 4|Adverse Event|0
6007751|NCT00868790|20769320|P3|Period 4|Adverse Event|0
6007752|NCT00868790|20769321|P2|Period 4|Adverse Event|0
6007753|NCT00868790|20769322|P1|Period 4|Adverse Event|0
6007754|NCT00868790|20769309|P14|Period 3|Study Terminated by Sponsor|0
6007755|NCT00868790|20769310|P13|Period 3|Study Terminated by Sponsor|0
6007756|NCT00868790|20769311|P12|Period 3|Study Terminated by Sponsor|0
6007757|NCT00868790|20769312|P11|Period 3|Study Terminated by Sponsor|0
6007758|NCT00868790|20769313|P10|Period 3|Study Terminated by Sponsor|0
6007759|NCT00868790|20769314|P9|Period 3|Study Terminated by Sponsor|0
6007760|NCT00868790|20769315|P8|Period 3|Study Terminated by Sponsor|0
6007761|NCT00868790|20769316|P7|Period 3|Study Terminated by Sponsor|0
6007762|NCT00868790|20769317|P6|Period 3|Study Terminated by Sponsor|0
6007763|NCT00868790|20769318|P5|Period 3|Study Terminated by Sponsor|0
6007764|NCT00868790|20769319|P4|Period 3|Study Terminated by Sponsor|1
6007765|NCT00868790|20769320|P3|Period 3|Study Terminated by Sponsor|0
6007766|NCT00868790|20769321|P2|Period 3|Study Terminated by Sponsor|0
6007767|NCT00868790|20769322|P1|Period 3|Study Terminated by Sponsor|0
6007768|NCT00868790|20769309|P14|Period 3|Protocol Violation|0
6007769|NCT00868790|20769310|P13|Period 3|Protocol Violation|0
6007770|NCT00868790|20769311|P12|Period 3|Protocol Violation|0
6007771|NCT00868790|20769312|P11|Period 3|Protocol Violation|1
6007772|NCT00868790|20769313|P10|Period 3|Protocol Violation|0
6007773|NCT00868790|20769314|P9|Period 3|Protocol Violation|0
6007774|NCT00868790|20769315|P8|Period 3|Protocol Violation|0
6007775|NCT00868790|20769316|P7|Period 3|Protocol Violation|0
6007776|NCT00868790|20769317|P6|Period 3|Protocol Violation|0
6007777|NCT00868790|20769318|P5|Period 3|Protocol Violation|0
6007778|NCT00868790|20769319|P4|Period 3|Protocol Violation|0
6007779|NCT00868790|20769320|P3|Period 3|Protocol Violation|0
6007780|NCT00868790|20769321|P2|Period 3|Protocol Violation|0
6007781|NCT00868790|20769322|P1|Period 3|Protocol Violation|0
6007782|NCT00868790|20769309|P14|Period 3|Adverse Event|0
6007783|NCT00868790|20769310|P13|Period 3|Adverse Event|0
6007784|NCT00868790|20769311|P12|Period 3|Adverse Event|0
6007785|NCT00868790|20769312|P11|Period 3|Adverse Event|0
6007786|NCT00868790|20769313|P10|Period 3|Adverse Event|1
6007787|NCT00868790|20769314|P9|Period 3|Adverse Event|0
6007788|NCT00868790|20769315|P8|Period 3|Adverse Event|0
6007789|NCT00868790|20769316|P7|Period 3|Adverse Event|0
6007790|NCT00868790|20769317|P6|Period 3|Adverse Event|0
6007791|NCT00868790|20769318|P5|Period 3|Adverse Event|0
6007792|NCT00868790|20769319|P4|Period 3|Adverse Event|0
6007793|NCT00868790|20769320|P3|Period 3|Adverse Event|0
6007794|NCT00868790|20769321|P2|Period 3|Adverse Event|0
6007795|NCT00868790|20769322|P1|Period 3|Adverse Event|0
6007796|NCT00868790|20769309|P14|Period 2|Withdrawal by Subject|1
6007797|NCT00868790|20769310|P13|Period 2|Withdrawal by Subject|0
6007798|NCT00868790|20769311|P12|Period 2|Withdrawal by Subject|0
6007799|NCT00868790|20769312|P11|Period 2|Withdrawal by Subject|0
6007800|NCT00868790|20769313|P10|Period 2|Withdrawal by Subject|0
6007801|NCT00868790|20769314|P9|Period 2|Withdrawal by Subject|1
6007802|NCT00868790|20769315|P8|Period 2|Withdrawal by Subject|0
6007803|NCT00868790|20769316|P7|Period 2|Withdrawal by Subject|0
6007804|NCT00868790|20769317|P6|Period 2|Withdrawal by Subject|0
6007805|NCT00868790|20769318|P5|Period 2|Withdrawal by Subject|0
6007806|NCT00868790|20769319|P4|Period 2|Withdrawal by Subject|0
6007807|NCT00868790|20769320|P3|Period 2|Withdrawal by Subject|0
6007808|NCT00868790|20769321|P2|Period 2|Withdrawal by Subject|0
6007809|NCT00868790|20769322|P1|Period 2|Withdrawal by Subject|0
6007810|NCT00868790|20769309|P14|Period 2|Lost to Follow-up|0
6007811|NCT00868790|20769310|P13|Period 2|Lost to Follow-up|0
6007812|NCT00868790|20769311|P12|Period 2|Lost to Follow-up|0
6007813|NCT00868790|20769312|P11|Period 2|Lost to Follow-up|0
6007814|NCT00868790|20769313|P10|Period 2|Lost to Follow-up|0
6007815|NCT00868790|20769314|P9|Period 2|Lost to Follow-up|0
6007816|NCT00868790|20769315|P8|Period 2|Lost to Follow-up|0
6007817|NCT00868790|20769316|P7|Period 2|Lost to Follow-up|0
6007818|NCT00868790|20769317|P6|Period 2|Lost to Follow-up|1
6007819|NCT00868790|20769318|P5|Period 2|Lost to Follow-up|0
6007820|NCT00868790|20769319|P4|Period 2|Lost to Follow-up|0
6007821|NCT00868790|20769320|P3|Period 2|Lost to Follow-up|0
6007822|NCT00868790|20769321|P2|Period 2|Lost to Follow-up|1
6007823|NCT00868790|20769322|P1|Period 2|Lost to Follow-up|0
6007824|NCT00868790|20769309|P14|Period 2|Adverse Event|0
6007825|NCT00868790|20769310|P13|Period 2|Adverse Event|0
6007826|NCT00868790|20769311|P12|Period 2|Adverse Event|0
6007827|NCT00868790|20769312|P11|Period 2|Adverse Event|0
6007828|NCT00868790|20769313|P10|Period 2|Adverse Event|0
6007829|NCT00868790|20769314|P9|Period 2|Adverse Event|1
6007830|NCT00868790|20769315|P8|Period 2|Adverse Event|0
6007831|NCT00868790|20769316|P7|Period 2|Adverse Event|0
6007832|NCT00868790|20769317|P6|Period 2|Adverse Event|0
6007833|NCT00868790|20769318|P5|Period 2|Adverse Event|0
6007834|NCT00868790|20769319|P4|Period 2|Adverse Event|0
6007835|NCT00868790|20769320|P3|Period 2|Adverse Event|0
6007836|NCT00868790|20769321|P2|Period 2|Adverse Event|0
6007837|NCT00868790|20769322|P1|Period 2|Adverse Event|0
6007838|NCT00868790|20769309|P14|Period 1|Lost to Follow-up|0
6007839|NCT00868790|20769310|P13|Period 1|Lost to Follow-up|0
6007840|NCT00868790|20769311|P12|Period 1|Lost to Follow-up|0
6007841|NCT00868790|20769312|P11|Period 1|Lost to Follow-up|0
6007842|NCT00868790|20769313|P10|Period 1|Lost to Follow-up|0
6007843|NCT00868790|20769314|P9|Period 1|Lost to Follow-up|0
6007844|NCT00868790|20769315|P8|Period 1|Lost to Follow-up|0
6007845|NCT00868790|20769316|P7|Period 1|Lost to Follow-up|0
6007846|NCT00868790|20769317|P6|Period 1|Lost to Follow-up|1
6007847|NCT00868790|20769318|P5|Period 1|Lost to Follow-up|0
6007848|NCT00868790|20769319|P4|Period 1|Lost to Follow-up|0
6007849|NCT00868790|20769320|P3|Period 1|Lost to Follow-up|0
6007850|NCT00868790|20769321|P2|Period 1|Lost to Follow-up|0
6007851|NCT00868790|20769322|P1|Period 1|Lost to Follow-up|0
6007852|NCT00868790|20769309|P14|Period 1|Abnormal Triglycerides|0
6007853|NCT00868790|20769310|P13|Period 1|Abnormal Triglycerides|0
6007854|NCT00868790|20769311|P12|Period 1|Abnormal Triglycerides|0
6007855|NCT00868790|20769312|P11|Period 1|Abnormal Triglycerides|0
6007856|NCT00868790|20769313|P10|Period 1|Abnormal Triglycerides|0
6007857|NCT00868790|20769314|P9|Period 1|Abnormal Triglycerides|0
6007858|NCT00868790|20769315|P8|Period 1|Abnormal Triglycerides|0
6007859|NCT00868790|20769316|P7|Period 1|Abnormal Triglycerides|0
6007860|NCT00868790|20769317|P6|Period 1|Abnormal Triglycerides|0
6007861|NCT00868790|20769318|P5|Period 1|Abnormal Triglycerides|1
6007862|NCT00868790|20769319|P4|Period 1|Abnormal Triglycerides|0
6007863|NCT00868790|20769320|P3|Period 1|Abnormal Triglycerides|0
6007864|NCT00868790|20769321|P2|Period 1|Abnormal Triglycerides|0
6007865|NCT00868790|20769322|P1|Period 1|Abnormal Triglycerides|0
6007866|NCT00868790|20769309|P14|Period 1|Withdrawal by Subject|1
6007867|NCT00868790|20769310|P13|Period 1|Withdrawal by Subject|0
6007868|NCT00868790|20769311|P12|Period 1|Withdrawal by Subject|0
6007869|NCT00868790|20769312|P11|Period 1|Withdrawal by Subject|0
6007870|NCT00868790|20769313|P10|Period 1|Withdrawal by Subject|0
6007871|NCT00868790|20769314|P9|Period 1|Withdrawal by Subject|0
6007872|NCT00868790|20769315|P8|Period 1|Withdrawal by Subject|0
6007873|NCT00868790|20769316|P7|Period 1|Withdrawal by Subject|0
6007874|NCT00868790|20769317|P6|Period 1|Withdrawal by Subject|0
6007875|NCT00868790|20769318|P5|Period 1|Withdrawal by Subject|0
6007876|NCT00868790|20769319|P4|Period 1|Withdrawal by Subject|0
6007877|NCT00868790|20769320|P3|Period 1|Withdrawal by Subject|0
6007878|NCT00868790|20769321|P2|Period 1|Withdrawal by Subject|1
6007879|NCT00868790|20769322|P1|Period 1|Withdrawal by Subject|0
6007880|NCT00868790|20769309|P14|Period 1|Protocol Violation|0
6007881|NCT00868790|20769310|P13|Period 1|Protocol Violation|0
6007882|NCT00868790|20769311|P12|Period 1|Protocol Violation|0
6007883|NCT00868790|20769312|P11|Period 1|Protocol Violation|0
6007884|NCT00868790|20769313|P10|Period 1|Protocol Violation|0
6007885|NCT00868790|20769314|P9|Period 1|Protocol Violation|0
6007886|NCT00868790|20769315|P8|Period 1|Protocol Violation|0
6007887|NCT00868790|20769316|P7|Period 1|Protocol Violation|0
6007888|NCT00868790|20769317|P6|Period 1|Protocol Violation|0
6007889|NCT00868790|20769318|P5|Period 1|Protocol Violation|0
6007890|NCT00868790|20769319|P4|Period 1|Protocol Violation|0
6007891|NCT00868790|20769320|P3|Period 1|Protocol Violation|0
6007892|NCT00868790|20769321|P2|Period 1|Protocol Violation|0
6007893|NCT00868790|20769322|P1|Period 1|Protocol Violation|1
6007894|NCT00868790|20769309|P14|Period 1|Adverse Event|1
6007895|NCT00868790|20769310|P13|Period 1|Adverse Event|0
6007896|NCT00868790|20769311|P12|Period 1|Adverse Event|0
6007897|NCT00868790|20769312|P11|Period 1|Adverse Event|0
6007898|NCT00868790|20769313|P10|Period 1|Adverse Event|0
6007899|NCT00868790|20769314|P9|Period 1|Adverse Event|1
6007900|NCT00868790|20769315|P8|Period 1|Adverse Event|3
6007901|NCT00868790|20769316|P7|Period 1|Adverse Event|0
6007902|NCT00868790|20769317|P6|Period 1|Adverse Event|0
6007903|NCT00868790|20769318|P5|Period 1|Adverse Event|0
6007904|NCT00868790|20769319|P4|Period 1|Adverse Event|0
6007905|NCT00868790|20769320|P3|Period 1|Adverse Event|0
6007906|NCT00868790|20769321|P2|Period 1|Adverse Event|0
6007907|NCT00868790|20769322|P1|Period 1|Adverse Event|1
6007908|NCT00868608|20769405|P3|Overall Study|Other - Unspecified|0
6007909|NCT00868608|20769406|P2|Overall Study|Other - Unspecified|0
6007910|NCT00868608|20769407|P1|Overall Study|Other - Unspecified|1
6007911|NCT00868608|20769405|P3|Overall Study|Death|4
6007912|NCT00868608|20769406|P2|Overall Study|Death|2
6007913|NCT00868608|20769407|P1|Overall Study|Death|16
6007914|NCT00868608|20769405|P3|Overall Study|Lost to Follow-up|1
6007915|NCT00868608|20769406|P2|Overall Study|Lost to Follow-up|0
6007916|NCT00868608|20769407|P1|Overall Study|Lost to Follow-up|3
6007917|NCT00868608|20769405|P3|Overall Study|Withdrawal by Subject|0
6007918|NCT00868608|20769406|P2|Overall Study|Withdrawal by Subject|1
6007919|NCT00868608|20769407|P1|Overall Study|Withdrawal by Subject|3
6007920|NCT00868530|20769431|P1|Overall Study|Lost to Follow-up|1
6007921|NCT00868530|20769431|P1|Overall Study|Adverse Event|3
6007922|NCT00868517|20769446|P3|Overall Study|Protocol Violation|0
6007923|NCT00868517|20769447|P2|Overall Study|Protocol Violation|1
6007924|NCT00868517|20769448|P1|Overall Study|Protocol Violation|1
6007925|NCT00868517|20769446|P3|Overall Study|Withdrawal by Subject|2
6007926|NCT00868517|20769447|P2|Overall Study|Withdrawal by Subject|3
6007927|NCT00868517|20769448|P1|Overall Study|Withdrawal by Subject|3
6007928|NCT00868439|20769486|P2|Overall Study|Withdrawal by Subject|1
6007929|NCT00868439|20769487|P1|Overall Study|Withdrawal by Subject|0
6007930|NCT00868439|20769486|P2|Overall Study|Physician Decision|0
6007931|NCT00868439|20769487|P1|Overall Study|Physician Decision|1
6007932|NCT00868439|20769486|P2|Overall Study|Protocol Violation|1
6007933|NCT00868439|20769487|P1|Overall Study|Protocol Violation|1
6007934|NCT00868439|20769486|P2|Overall Study|Death|1
6007935|NCT00868439|20769487|P1|Overall Study|Death|0
6007936|NCT00868439|20769486|P2|Overall Study|Prot-Specified W/D Criteria (Serum K+)|3
6007937|NCT00868439|20769487|P1|Overall Study|Prot-Specified W/D Criteria (Serum K+)|2
6007938|NCT00868439|20769486|P2|Overall Study|Adverse Event|3
6007939|NCT00868439|20769487|P1|Overall Study|Adverse Event|4
6007940|NCT00868296|20769544|P2|Overall Study|Withdrawal by Subject|1
6007941|NCT00868296|20769545|P1|Overall Study|Withdrawal by Subject|0
6007942|NCT00868296|20769544|P2|Overall Study|Adverse Event|2
6007943|NCT00868296|20769545|P1|Overall Study|Adverse Event|0
6007944|NCT00868231|20769553|P6|Treatment Period 3|Adverse Event|0
6007945|NCT00868231|20769554|P5|Treatment Period 3|Adverse Event|0
6007946|NCT00868231|20769555|P4|Treatment Period 3|Adverse Event|0
6007947|NCT00868231|20769556|P3|Treatment Period 3|Adverse Event|1
6007948|NCT00868231|20769557|P2|Treatment Period 3|Adverse Event|0
6007949|NCT00868231|20769558|P1|Treatment Period 3|Adverse Event|0
6007950|NCT00868231|20769553|P6|Treatment Period 2|Adverse Event|0
6007951|NCT00868231|20769554|P5|Treatment Period 2|Adverse Event|0
6007952|NCT00868231|20769555|P4|Treatment Period 2|Adverse Event|0
6007953|NCT00868231|20769556|P3|Treatment Period 2|Adverse Event|0
6007954|NCT00868231|20769557|P2|Treatment Period 2|Adverse Event|0
6007955|NCT00868231|20769558|P1|Treatment Period 2|Adverse Event|1
6007956|NCT00868231|20769553|P6|Treatment Period 1|Adverse Event|0
6007957|NCT00868231|20769554|P5|Treatment Period 1|Adverse Event|1
6007958|NCT00868231|20769555|P4|Treatment Period 1|Adverse Event|0
6007959|NCT00868231|20769556|P3|Treatment Period 1|Adverse Event|0
6007960|NCT00868231|20769557|P2|Treatment Period 1|Adverse Event|0
6007961|NCT00868231|20769558|P1|Treatment Period 1|Adverse Event|0
6007962|NCT00868192|20769624|P1|Overall Study|Ineligible|4
6007963|NCT00868166|20769641|P2|Overall Study|Non-compliance with IMP|1
6007964|NCT00868166|20769642|P1|Overall Study|Non-compliance with IMP|1
6007965|NCT00868166|20769641|P2|Overall Study|Lack of efficacy, logistics, unwell|10
6007966|NCT00868166|20769642|P1|Overall Study|Lack of efficacy, logistics, unwell|9
6007967|NCT00868166|20769641|P2|Overall Study|Adverse Event|10
6007968|NCT00868166|20769642|P1|Overall Study|Adverse Event|9
6007969|NCT00868166|20769641|P2|Overall Study|Lost to Follow-up|3
6007970|NCT00868166|20769642|P1|Overall Study|Lost to Follow-up|1
6007971|NCT00868166|20769641|P2|Overall Study|Protocol Violation|0
6007972|NCT00868166|20769642|P1|Overall Study|Protocol Violation|1
6007973|NCT00868166|20769641|P2|Overall Study|Withdrawal by Subject|25
6007974|NCT00868166|20769642|P1|Overall Study|Withdrawal by Subject|33
6007975|NCT00868166|20769641|P2|Overall Study|Death|65
6007976|NCT00868166|20769642|P1|Overall Study|Death|58
6007977|NCT00867815|20769704|P1|Overall Study|Lost to Follow-up|1
6007978|NCT00867568|20769724|P1|Overall Study|Withdrawal by Subject|1
6007979|NCT00867568|20769724|P1|Overall Study|Adverse Event|4
6007980|NCT00867568|20769724|P1|Overall Study|Lack of Efficacy|10
6007981|NCT00867503|20769741|P1|Overall Study|Withdrawal by Subject|1
6007982|NCT00867490|20769747|P1|Phase 2 - Aliskiren+HCTZ|Withdrawal by Subject|1
6007983|NCT00867490|20769747|P1|Phase 2 - Aliskiren+HCTZ|Adverse Event|2
6007984|NCT00867490|20769747|P1|Phase 1 - Candesartan+HCTZ|Administrative Problems|1
6007985|NCT00867490|20769747|P1|Phase 1 - Candesartan+HCTZ|Withdrawal by Subject|4
6007986|NCT00867490|20769747|P1|Phase 1 - Candesartan+HCTZ|Adverse Event|5
6007987|NCT00867360|20769789|P2|Overall Study|Physician Decision|1
6007988|NCT00867360|20769790|P1|Overall Study|Physician Decision|0
6007989|NCT00867360|20769789|P2|Overall Study|Withdrawal by Subject|0
6007990|NCT00867360|20769790|P1|Overall Study|Withdrawal by Subject|1
6007991|NCT00867334|20769802|P2|Overall Study|Withdrawal by Subject|0
6007992|NCT00867334|20769803|P1|Overall Study|Withdrawal by Subject|1
6007993|NCT00867334|20769802|P2|Overall Study|Withdrawal by Subject|0
6007994|NCT00867334|20769803|P1|Overall Study|Withdrawal by Subject|1
6007995|NCT00867334|20769802|P2|Overall Study|Withdrawal by Subject|1
6007996|NCT00867334|20769803|P1|Overall Study|Withdrawal by Subject|0
6007997|NCT00867308|20769839|P2|Overall Study|Withdrawal by Subject|2
6007998|NCT00867308|20769840|P1|Overall Study|Withdrawal by Subject|1
6007999|NCT00867308|20769839|P2|Overall Study|Lack of Efficacy|12
6008000|NCT00867308|20769840|P1|Overall Study|Lack of Efficacy|6
6008001|NCT00867308|20769839|P2|Overall Study|Adverse Event|4
6008002|NCT00867308|20769840|P1|Overall Study|Adverse Event|1
6008003|NCT00867308|20769839|P2|Overall Study|Death|0
6008004|NCT00867308|20769840|P1|Overall Study|Death|1
6008005|NCT00867165|20769859|P2|Overall Study|Withdrawal by Subject|0
6008006|NCT00867165|20769860|P1|Overall Study|Withdrawal by Subject|1
6008007|NCT00867165|20769859|P2|Overall Study|Adverse Event|0
6008008|NCT00867165|20769860|P1|Overall Study|Adverse Event|3
6008009|NCT00867113|20770008|P1|Post Treatment After Survival Follow-up|Administrative problems|4
6008010|NCT00867113|20770008|P1|Post Treatment After Survival Follow-up|Lost to Follow-up|5
6008011|NCT00867113|20770008|P1|Post Treatment After Survival Follow-up|Withdrawal by Subject|1
6008012|NCT00867113|20770008|P1|Post Treatment After Survival Follow-up|Death|1
6008013|NCT00867113|20770008|P1|Treatment Period|Protocol Violation|4
6008014|NCT00867113|20770008|P1|Treatment Period|Disease progression/relapse|1
6008015|NCT00867113|20770008|P1|Treatment Period|Administrative problems|1
6008016|NCT00867113|20770008|P1|Treatment Period|Lost to Follow-up|3
6008017|NCT00867113|20770008|P1|Treatment Period|Withdrawal by Subject|19
6008018|NCT00867113|20770008|P1|Treatment Period|Death|2
6008019|NCT00867113|20770008|P1|Treatment Period|Adverse Event|15
6008020|NCT00867087|20770072|P1|Overall Study|Death|37
6008021|NCT00867087|20770072|P1|Overall Study|Withdrawal by Subject|4
6008022|NCT00867087|20770072|P1|Overall Study|Other|1
6008023|NCT00867035|20770088|P2|Baseline to 1 Week|Withdrawal by Subject|0
6008024|NCT00867035|20770089|P1|Baseline to 1 Week|Withdrawal by Subject|1
6008025|NCT00867035|20770088|P2|Baseline to 1 Hour|Withdrawal by Subject|1
6008026|NCT00867035|20770089|P1|Baseline to 1 Hour|Withdrawal by Subject|1
6008027|NCT00867009|20770115|P1|Maintenance Period|On-going in the Study at Data Cut-off|4
6008028|NCT00867009|20770115|P1|Induction Period|Progressive Disease (PD)|25
6008029|NCT00867009|20770115|P1|Induction Period|Physician Decision|3
6008030|NCT00867009|20770115|P1|Induction Period|Withdrawal by Subject|8
6008031|NCT00867009|20770115|P1|Induction Period|Protocol Violation|1
6008032|NCT00867009|20770115|P1|Induction Period|Death due to Study Disease|4
6008033|NCT00867009|20770115|P1|Induction Period|Death due to serious adverse event|6
6008034|NCT00867009|20770115|P1|Induction Period|Serious Adverse Event|10
6008035|NCT00867009|20770115|P1|Induction Period|Nonserious Adverse Event|5
6008036|NCT00866918|20770124|P2|Overall Study|Secondary malignancy|0
6008037|NCT00866918|20770125|P1|Overall Study|Secondary malignancy|1
6008038|NCT00866918|20770124|P2|Overall Study|Inevaluable- RQPCR negative at diagnosi|0
6008039|NCT00866918|20770125|P1|Overall Study|Inevaluable- RQPCR negative at diagnosi|1
6008040|NCT00866918|20770124|P2|Overall Study|Ineligible|4
6008041|NCT00866918|20770125|P1|Overall Study|Ineligible|2
6008042|NCT00866918|20770124|P2|Overall Study|Physician Decision|2
6008043|NCT00866918|20770125|P1|Overall Study|Physician Decision|10
6008044|NCT00866918|20770124|P2|Overall Study|Lack of Efficacy|1
6008045|NCT00866918|20770125|P1|Overall Study|Lack of Efficacy|1
6008046|NCT00866918|20770124|P2|Overall Study|Death|5
6008047|NCT00866918|20770125|P1|Overall Study|Death|1
6008048|NCT00866814|20770159|P1|Overall Study|Moved to area without study site|1
6008049|NCT00866814|20770159|P1|Overall Study|Unable to meet follow-up requirements|2
6008050|NCT00866814|20770159|P1|Overall Study|No longer wished to participate|1
6008051|NCT00866814|20770159|P1|Overall Study|Death|1
6008052|NCT00866814|20770159|P1|Overall Study|Physician Decision|1
6008053|NCT00866814|20770159|P1|Overall Study|Adverse Event|2
6008054|NCT00866814|20770159|P1|Overall Study|Lost to Follow-up|12
6008055|NCT00866788|20770172|P4|Overall Study|Physician Decision|1
6008056|NCT00866788|20770173|P3|Overall Study|Physician Decision|1
6008057|NCT00866788|20770174|P2|Overall Study|Physician Decision|0
6008058|NCT00866788|20770175|P1|Overall Study|Physician Decision|0
6008059|NCT00866788|20770172|P4|Overall Study|Disease progression|0
6008060|NCT00866788|20770173|P3|Overall Study|Disease progression|1
6008061|NCT00866788|20770174|P2|Overall Study|Disease progression|1
6008062|NCT00866788|20770175|P1|Overall Study|Disease progression|3
6008063|NCT00866788|20770172|P4|Overall Study|Pregnancy|0
6008064|NCT00866788|20770173|P3|Overall Study|Pregnancy|0
6008065|NCT00866788|20770174|P2|Overall Study|Pregnancy|1
6008066|NCT00866788|20770175|P1|Overall Study|Pregnancy|0
6008067|NCT00866788|20770172|P4|Overall Study|Withdrawal by Subject|1
6008068|NCT00866788|20770173|P3|Overall Study|Withdrawal by Subject|0
6008069|NCT00866788|20770174|P2|Overall Study|Withdrawal by Subject|1
6008070|NCT00866788|20770175|P1|Overall Study|Withdrawal by Subject|2
6008071|NCT00866788|20770172|P4|Overall Study|Lost to Follow-up|2
6008072|NCT00866788|20770173|P3|Overall Study|Lost to Follow-up|0
6008073|NCT00866788|20770174|P2|Overall Study|Lost to Follow-up|1
6008074|NCT00866788|20770175|P1|Overall Study|Lost to Follow-up|1
6008075|NCT00866788|20770172|P4|Overall Study|Adverse Event|1
6008076|NCT00866788|20770173|P3|Overall Study|Adverse Event|0
6008077|NCT00866788|20770174|P2|Overall Study|Adverse Event|2
6008078|NCT00866788|20770175|P1|Overall Study|Adverse Event|0
6008079|NCT00866775|20770223|P2|Overall Study|discontinued due to communication error|1
6008080|NCT00866775|20770224|P1|Overall Study|discontinued due to communication error|0
6008081|NCT00866775|20770223|P2|Overall Study|met exit criteria|17
6008082|NCT00866775|20770224|P1|Overall Study|met exit criteria|23
6008083|NCT00866775|20770223|P2|Overall Study|Withdrawal by Subject|4
6008084|NCT00866775|20770224|P1|Overall Study|Withdrawal by Subject|4
6008085|NCT00866775|20770223|P2|Overall Study|Protocol Violation|4
6008086|NCT00866775|20770224|P1|Overall Study|Protocol Violation|3
6008087|NCT00866775|20770223|P2|Overall Study|Physician Decision|3
6008088|NCT00866775|20770224|P1|Overall Study|Physician Decision|0
6008089|NCT00866775|20770223|P2|Overall Study|Lost to Follow-up|4
6008090|NCT00866775|20770224|P1|Overall Study|Lost to Follow-up|0
6008091|NCT00866775|20770223|P2|Overall Study|Death|0
6008092|NCT00866775|20770224|P1|Overall Study|Death|1
6008093|NCT00866775|20770223|P2|Overall Study|Adverse Event|19
6008094|NCT00866775|20770224|P1|Overall Study|Adverse Event|5
6008095|NCT00866723|20770267|P1|Overall Study|Disease Progression|4
6008096|NCT00866723|20770267|P1|Overall Study|Withdrawal by Subject|1
6008105|NCT00866658|20770317|P2|Overall Study|Familial and Personal Reasons|5
6008106|NCT00866658|20770318|P1|Overall Study|Familial and Personal Reasons|4
6008107|NCT00866658|20770317|P2|Overall Study|Protocol Violation|1
6008108|NCT00866658|20770318|P1|Overall Study|Protocol Violation|1
6008109|NCT00866658|20770317|P2|Overall Study|Withdrawal by Subject|0
6008110|NCT00866658|20770318|P1|Overall Study|Withdrawal by Subject|1
6008111|NCT00866658|20770317|P2|Overall Study|Lack of Efficacy|1
6008112|NCT00866658|20770318|P1|Overall Study|Lack of Efficacy|2
6008113|NCT00866658|20770317|P2|Overall Study|Adverse Event|14
6008114|NCT00866658|20770318|P1|Overall Study|Adverse Event|5
6008115|NCT00866619|20770350|P4|Overall Study|Lost to Follow-up|425
6008116|NCT00866619|20770351|P3|Overall Study|Lost to Follow-up|568
6008117|NCT00866619|20770352|P2|Overall Study|Lost to Follow-up|830
6008118|NCT00866619|20770353|P1|Overall Study|Lost to Follow-up|1145
6008119|NCT00866619|20770350|P4|Overall Study|Withdrawal by Subject|144
6008120|NCT00866619|20770351|P3|Overall Study|Withdrawal by Subject|272
6008121|NCT00866619|20770352|P2|Overall Study|Withdrawal by Subject|295
6008122|NCT00866619|20770353|P1|Overall Study|Withdrawal by Subject|587
6008123|NCT00866619|20770350|P4|Overall Study|Protocol Violation|17
6008124|NCT00866619|20770351|P3|Overall Study|Protocol Violation|2
6008125|NCT00866619|20770352|P2|Overall Study|Protocol Violation|39
6008126|NCT00866619|20770353|P1|Overall Study|Protocol Violation|2
6008127|NCT00866619|20770350|P4|Overall Study|Adverse Event|44
6008128|NCT00866619|20770351|P3|Overall Study|Adverse Event|47
6008129|NCT00866619|20770352|P2|Overall Study|Adverse Event|106
6008130|NCT00866619|20770353|P1|Overall Study|Adverse Event|112
6008131|NCT00866606|20770673|P1|Overall Study|Adverse Event|1
6008132|NCT00866606|20770673|P1|Overall Study|Lost to Follow-up|3
6008133|NCT00866359|20770687|P4|Extension Phase (Day 86 to 169)|Adverse Event|3
6008134|NCT00866359|20770688|P3|Extension Phase (Day 86 to 169)|Adverse Event|1
6008135|NCT00866359|20770689|P2|Extension Phase (Day 86 to 169)|Adverse Event|0
6008136|NCT00866359|20770690|P1|Extension Phase (Day 86 to 169)|Adverse Event|0
6008137|NCT00866359|20770687|P4|Treatment Phase (Days 1 to 85)|Other|0
6008138|NCT00866359|20770688|P3|Treatment Phase (Days 1 to 85)|Other|0
6008139|NCT00866359|20770689|P2|Treatment Phase (Days 1 to 85)|Other|0
6008140|NCT00866359|20770690|P1|Treatment Phase (Days 1 to 85)|Other|1
6008141|NCT00866359|20770687|P4|Treatment Phase (Days 1 to 85)|Protocol Violation|0
6008142|NCT00866359|20770688|P3|Treatment Phase (Days 1 to 85)|Protocol Violation|0
6008143|NCT00866359|20770689|P2|Treatment Phase (Days 1 to 85)|Protocol Violation|1
6008144|NCT00866359|20770690|P1|Treatment Phase (Days 1 to 85)|Protocol Violation|1
6008145|NCT00866359|20770687|P4|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0
6008146|NCT00866359|20770688|P3|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0
6008147|NCT00866359|20770689|P2|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0
6008148|NCT00866359|20770690|P1|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|1
6008149|NCT00866359|20770687|P4|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0
6008150|NCT00866359|20770688|P3|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0
6008151|NCT00866359|20770689|P2|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0
6008152|NCT00866359|20770690|P1|Treatment Phase (Days 1 to 85)|Lack of Efficacy|3
6008153|NCT00866359|20770687|P4|Treatment Phase (Days 1 to 85)|Adverse Event|0
6008154|NCT00866359|20770688|P3|Treatment Phase (Days 1 to 85)|Adverse Event|0
6008155|NCT00866359|20770689|P2|Treatment Phase (Days 1 to 85)|Adverse Event|4
6008156|NCT00866359|20770690|P1|Treatment Phase (Days 1 to 85)|Adverse Event|5
6008157|NCT00866333|20770746|P3|Overall Study|Study Terminated by Sponsor|9
6008158|NCT00866333|20770747|P2|Overall Study|Study Terminated by Sponsor|5
6008159|NCT00866333|20770748|P1|Overall Study|Study Terminated by Sponsor|2
6008160|NCT00866333|20770746|P3|Overall Study|Reason not Specified|1
6008161|NCT00866333|20770747|P2|Overall Study|Reason not Specified|1
6008162|NCT00866333|20770748|P1|Overall Study|Reason not Specified|3
6008163|NCT00866333|20770746|P3|Overall Study|Withdrawal of consent|2
6008164|NCT00866333|20770747|P2|Overall Study|Withdrawal of consent|1
6008165|NCT00866333|20770748|P1|Overall Study|Withdrawal of consent|0
6008166|NCT00866320|20770765|P1|Overall Study|Death|2
6008167|NCT00866320|20770765|P1|Overall Study|Withdrawal by Subject|4
6008168|NCT00866307|20770772|P3|Consolidation/Maintenance|Patient moved to non-participating inst|0
6008169|NCT00866307|20770773|P2|Consolidation/Maintenance|Patient moved to non-participating inst|1
6008170|NCT00866307|20770774|P1|Consolidation/Maintenance|Patient moved to non-participating inst|0
6008171|NCT00866307|20770772|P3|Consolidation/Maintenance|Non-compliance|1
6008172|NCT00866307|20770773|P2|Consolidation/Maintenance|Non-compliance|0
6008173|NCT00866307|20770774|P1|Consolidation/Maintenance|Non-compliance|0
6008174|NCT00866307|20770772|P3|Consolidation/Maintenance|Therapy error|0
6008175|NCT00866307|20770773|P2|Consolidation/Maintenance|Therapy error|1
6008176|NCT00866307|20770774|P1|Consolidation/Maintenance|Therapy error|0
6008177|NCT00866307|20770772|P3|Consolidation/Maintenance|Recurrent leukemia following remission|1
6008178|NCT00866307|20770773|P2|Consolidation/Maintenance|Recurrent leukemia following remission|3
6008179|NCT00866307|20770774|P1|Consolidation/Maintenance|Recurrent leukemia following remission|0
6008180|NCT00866307|20770772|P3|Consolidation/Maintenance|Development of 2nd malignant neoplasm|2
6008181|NCT00866307|20770773|P2|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0
6008182|NCT00866307|20770774|P1|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0
6008183|NCT00866307|20770772|P3|Consolidation/Maintenance|Withdrawal by Subject|1
6008184|NCT00866307|20770773|P2|Consolidation/Maintenance|Withdrawal by Subject|1
6008185|NCT00866307|20770774|P1|Consolidation/Maintenance|Withdrawal by Subject|0
6008186|NCT00866307|20770772|P3|Consolidation/Maintenance|Physician Decision|2
6008187|NCT00866307|20770773|P2|Consolidation/Maintenance|Physician Decision|3
6008188|NCT00866307|20770774|P1|Consolidation/Maintenance|Physician Decision|0
6008189|NCT00866307|20770772|P3|Consolidation/Maintenance|Death|1
6008190|NCT00866307|20770773|P2|Consolidation/Maintenance|Death|0
6008191|NCT00866307|20770774|P1|Consolidation/Maintenance|Death|0
6008192|NCT00866307|20770772|P3|Consolidation/Maintenance|Adverse Event|8
6008193|NCT00866307|20770773|P2|Consolidation/Maintenance|Adverse Event|0
6008194|NCT00866307|20770774|P1|Consolidation/Maintenance|Adverse Event|0
6008195|NCT00866307|20770772|P3|Induction|Study was closed at the time|0
6008196|NCT00866307|20770773|P2|Induction|Study was closed at the time|0
6008197|NCT00866307|20770774|P1|Induction|Study was closed at the time|1
6008198|NCT00866307|20770772|P3|Induction|Improper post-induction consent|0
6008199|NCT00866307|20770773|P2|Induction|Improper post-induction consent|0
6008200|NCT00866307|20770774|P1|Induction|Improper post-induction consent|2
6008201|NCT00866307|20770772|P3|Induction|Inadequate cytognetic samples th|0
6008202|NCT00866307|20770773|P2|Induction|Inadequate cytognetic samples th|0
6008203|NCT00866307|20770774|P1|Induction|Inadequate cytognetic samples th|1
6008204|NCT00866307|20770772|P3|Induction|Identification of Patients with Day 29 M|0
6008205|NCT00866307|20770773|P2|Induction|Identification of Patients with Day 29 M|0
6008206|NCT00866307|20770774|P1|Induction|Identification of Patients with Day 29 M|3
6008207|NCT00866307|20770772|P3|Induction|Progressive Disease|0
6008208|NCT00866307|20770773|P2|Induction|Progressive Disease|0
6008209|NCT00866307|20770774|P1|Induction|Progressive Disease|1
6008210|NCT00866307|20770772|P3|Induction|Physician Decision|0
6008211|NCT00866307|20770773|P2|Induction|Physician Decision|0
6008212|NCT00866307|20770774|P1|Induction|Physician Decision|5
6008213|NCT00866307|20770772|P3|Induction|Death|0
6008214|NCT00866307|20770773|P2|Induction|Death|0
6008215|NCT00866307|20770774|P1|Induction|Death|2
6008216|NCT00866307|20770772|P3|Induction|Adverse Event|0
6008217|NCT00866307|20770773|P2|Induction|Adverse Event|0
6008218|NCT00866307|20770774|P1|Induction|Adverse Event|5
6008219|NCT00866294|20770784|P3|Overall Study|Physician Decision|1
6008220|NCT00866294|20770785|P2|Overall Study|Physician Decision|2
6008221|NCT00866294|20770786|P1|Overall Study|Physician Decision|6
6008222|NCT00866294|20770784|P3|Overall Study|Lost to Follow-up|0
6008223|NCT00866294|20770785|P2|Overall Study|Lost to Follow-up|3
6008224|NCT00866294|20770786|P1|Overall Study|Lost to Follow-up|1
6008225|NCT00866294|20770784|P3|Overall Study|Met Protocol-defined Stopping Criteria|1
6008226|NCT00866294|20770785|P2|Overall Study|Met Protocol-defined Stopping Criteria|1
6008227|NCT00866294|20770786|P1|Overall Study|Met Protocol-defined Stopping Criteria|5
6008228|NCT00866294|20770784|P3|Overall Study|Protocol Violation|0
6008229|NCT00866294|20770785|P2|Overall Study|Protocol Violation|0
6008230|NCT00866294|20770786|P1|Overall Study|Protocol Violation|2
6008231|NCT00866294|20770784|P3|Overall Study|Lack of Efficacy|0
6008232|NCT00866294|20770785|P2|Overall Study|Lack of Efficacy|1
6008233|NCT00866294|20770786|P1|Overall Study|Lack of Efficacy|7
6008234|NCT00866294|20770784|P3|Overall Study|Adverse Event|9
6008235|NCT00866294|20770785|P2|Overall Study|Adverse Event|13
6008236|NCT00866294|20770786|P1|Overall Study|Adverse Event|12
6008237|NCT00866281|20770815|P2|Overall Study|New cancer therapy|4
6008238|NCT00866281|20770816|P1|Overall Study|New cancer therapy|0
6008239|NCT00866281|20770815|P2|Overall Study|Disease progression|11
6008240|NCT00866281|20770816|P1|Overall Study|Disease progression|3
6008241|NCT00866281|20770815|P2|Overall Study|Withdrawal by participants|0
6008242|NCT00866281|20770816|P1|Overall Study|Withdrawal by participants|3
6008243|NCT00866281|20770815|P2|Overall Study|Adverse Event|0
6008244|NCT00866281|20770816|P1|Overall Study|Adverse Event|1
6008245|NCT00866177|20770832|P1|Overall Study|Not Treated|151
6008246|NCT00866177|20770832|P1|Overall Study|Withdrawal by Subject|1
6008247|NCT00866047|20770836|P1|Follow-up Period|Lost to Follow-up|5
6008248|NCT00866047|20770836|P1|Treatment Period|Withdrawal by Subject|5
6008249|NCT00866047|20770836|P1|Treatment Period|Physician Decision|14
6008250|NCT00866047|20770836|P1|Treatment Period|Adverse Event|16
6008251|NCT00866047|20770836|P1|Treatment Period|Progressive disease|13
6008252|NCT00865904|20770868|P5|Overall Study|Randomized but not Treated|1
6008253|NCT00865904|20770869|P4|Overall Study|Randomized but not Treated|1
6008254|NCT00865904|20770870|P3|Overall Study|Randomized but not Treated|0
6008255|NCT00865904|20770871|P2|Overall Study|Randomized but not Treated|0
6008256|NCT00865904|20770872|P1|Overall Study|Randomized but not Treated|2
6008257|NCT00865709|20770929|P2|Treatment|Surgery|3
6008258|NCT00865709|20770930|P1|Treatment|Surgery|8
6008259|NCT00865709|20770929|P2|Treatment|Physician Decision|2
6008260|NCT00865709|20770930|P1|Treatment|Physician Decision|3
6008261|NCT00865709|20770929|P2|Treatment|Withdrawal by Subject|7
6008262|NCT00865709|20770930|P1|Treatment|Withdrawal by Subject|10
6008263|NCT00865709|20770929|P2|Treatment|Adverse Event|6
6008264|NCT00865709|20770930|P1|Treatment|Adverse Event|9
6008265|NCT00865566|20770948|P2|Overall Study|HIV infection|7
6008266|NCT00865566|20770949|P1|Overall Study|HIV infection|5
6008267|NCT00865566|20770948|P2|Overall Study|Other; N=245 due to early study closure|139
6008268|NCT00865566|20770949|P1|Overall Study|Other; N=245 due to early study closure|154
6008269|NCT00865566|20770948|P2|Overall Study|Participant unable to adhere|42
6008270|NCT00865566|20770949|P1|Overall Study|Participant unable to adhere|27
6008271|NCT00865566|20770948|P2|Overall Study|Participant relocated|107
6008272|NCT00865566|20770949|P1|Overall Study|Participant relocated|78
6008273|NCT00865566|20770948|P2|Overall Study|Physician Decision|1
6008274|NCT00865566|20770949|P1|Overall Study|Physician Decision|0
6008275|NCT00865566|20770948|P2|Overall Study|Withdrawal by Subject|65
6008276|NCT00865566|20770949|P1|Overall Study|Withdrawal by Subject|45
6008277|NCT00865566|20770948|P2|Overall Study|Lost to Follow-up|315
6008278|NCT00865566|20770949|P1|Overall Study|Lost to Follow-up|314
6008279|NCT00865566|20770948|P2|Overall Study|Death|11
6008280|NCT00865566|20770949|P1|Overall Study|Death|1
6008281|NCT00865514|20770969|P1|Overall Study|Infusion cost exceeded funding|2
6008282|NCT00865345|20770974|P1|Overall Study|Withdrawal by Subject|2
6008283|NCT00865306|20770981|P2|Controlled Trial|Withdrawal by Subject|1
6008284|NCT00865306|20770982|P1|Controlled Trial|Withdrawal by Subject|0
6008285|NCT00865306|20770981|P2|Controlled Trial|Sought treatment for conduct disorder|0
6008286|NCT00865306|20770982|P1|Controlled Trial|Sought treatment for conduct disorder|1
6008287|NCT00865306|20770981|P2|Controlled Trial|Improved btw baseline and first session|0
6008288|NCT00865306|20770982|P1|Controlled Trial|Improved btw baseline and first session|1
6008289|NCT00865306|20770981|P2|Controlled Trial|Difficulty commuting|0
6008290|NCT00865306|20770982|P1|Controlled Trial|Difficulty commuting|2
6008291|NCT00865306|20770981|P2|Controlled Trial|Lost to Follow-up|1
6008292|NCT00865306|20770982|P1|Controlled Trial|Lost to Follow-up|1
6008293|NCT00865189|20771011|P2|Overall Study|Withdrawal by Subject|0
6008294|NCT00865189|20771012|P1|Overall Study|Withdrawal by Subject|1
6008295|NCT00865189|20771011|P2|Overall Study|Lost to Follow-up|6
6008296|NCT00865189|20771012|P1|Overall Study|Lost to Follow-up|6
6008297|NCT00865189|20771011|P2|Overall Study|Death|11
6008298|NCT00865189|20771012|P1|Overall Study|Death|4
6008299|NCT00865189|20771011|P2|Overall Study|Other|2
6008300|NCT00865189|20771012|P1|Overall Study|Other|1
6008301|NCT00865124|20771040|P3|Overall Study|Withdrawn consent|0
6008302|NCT00865124|20771041|P2|Overall Study|Withdrawn consent|0
6008303|NCT00865124|20771042|P1|Overall Study|Withdrawn consent|2
6008304|NCT00865124|20771040|P3|Overall Study|Physician Decision|0
6008305|NCT00865124|20771041|P2|Overall Study|Physician Decision|1
6008306|NCT00865124|20771042|P1|Overall Study|Physician Decision|2
6008307|NCT00865098|20771059|P1|Overall Study|Progressive disease|1
6008308|NCT00865046|20771071|P3|Overall Study|Withdrawal by Subject|0
6008309|NCT00865046|20771072|P2|Overall Study|Withdrawal by Subject|0
6008310|NCT00865046|20771073|P1|Overall Study|Withdrawal by Subject|5
6008311|NCT00865046|20771071|P3|Overall Study|Death|1
6008312|NCT00865046|20771072|P2|Overall Study|Death|1
6008313|NCT00865046|20771073|P1|Overall Study|Death|0
6008314|NCT00865046|20771071|P3|Overall Study|Lost to Follow-up|0
6008315|NCT00865046|20771072|P2|Overall Study|Lost to Follow-up|4
6008316|NCT00865046|20771073|P1|Overall Study|Lost to Follow-up|1
6008317|NCT00865020|20771083|P2|Overall Study|Randomized but discontinued|4
6008318|NCT00865020|20771084|P1|Overall Study|Randomized but discontinued|2
6008319|NCT00865020|20771083|P2|Overall Study|Death|1
6008320|NCT00865020|20771084|P1|Overall Study|Death|0
6008321|NCT00865020|20771083|P2|Overall Study|Abnormal laboratory value(s)|1
6008322|NCT00865020|20771084|P1|Overall Study|Abnormal laboratory value(s)|0
6008323|NCT00865020|20771083|P2|Overall Study|Administrative problems|2
6008324|NCT00865020|20771084|P1|Overall Study|Administrative problems|0
6008325|NCT00865020|20771083|P2|Overall Study|Protocol deviation|1
6008326|NCT00865020|20771084|P1|Overall Study|Protocol deviation|4
6008327|NCT00865020|20771083|P2|Overall Study|Lost to Follow-up|4
6008328|NCT00865020|20771084|P1|Overall Study|Lost to Follow-up|6
6008329|NCT00865020|20771083|P2|Overall Study|Abnormal test procedure result(s)|8
6008330|NCT00865020|20771084|P1|Overall Study|Abnormal test procedure result(s)|6
6008331|NCT00865020|20771083|P2|Overall Study|Adverse Event|14
6008332|NCT00865020|20771084|P1|Overall Study|Adverse Event|9
6008333|NCT00865020|20771083|P2|Overall Study|Withdrawal by Subject|16
6008334|NCT00865020|20771084|P1|Overall Study|Withdrawal by Subject|22
6008335|NCT00864916|20771100|P2|Overall Study|Withdrawal by Subject|0
6008336|NCT00864916|20771101|P1|Overall Study|Withdrawal by Subject|1
6008337|NCT00864916|20771100|P2|Overall Study|Protocol Violation|0
6008338|NCT00864916|20771101|P1|Overall Study|Protocol Violation|1
6008339|NCT00864916|20771100|P2|Overall Study|Lost to Follow-up|4
6008340|NCT00864916|20771101|P1|Overall Study|Lost to Follow-up|4
6008341|NCT00864851|20771110|P3|Overall Study|Patient uncooperative|0
6008342|NCT00864851|20771111|P2|Overall Study|Patient uncooperative|0
6008343|NCT00864851|20771112|P1|Overall Study|Patient uncooperative|1
6008344|NCT00864851|20771110|P3|Overall Study|Death|0
6008345|NCT00864851|20771111|P2|Overall Study|Death|0
6008346|NCT00864851|20771112|P1|Overall Study|Death|1
6008347|NCT00864851|20771110|P3|Overall Study|Physician Decision|0
6008348|NCT00864851|20771111|P2|Overall Study|Physician Decision|0
6008349|NCT00864851|20771112|P1|Overall Study|Physician Decision|1
6008350|NCT00864851|20771110|P3|Overall Study|Withdrawal by Subject|0
6008351|NCT00864851|20771111|P2|Overall Study|Withdrawal by Subject|1
6008352|NCT00864851|20771112|P1|Overall Study|Withdrawal by Subject|0
6008353|NCT00864721|20771146|P1|Overall Study|Adverse Event|21
6008354|NCT00864721|20771146|P1|Overall Study|Drug hold/delay more than 4 weeks|1
6008355|NCT00864721|20771146|P1|Overall Study|Hospitalized|1
6008356|NCT00864721|20771146|P1|Overall Study|Patient request|11
6008357|NCT00864682|20771166|P3|Overall Study|Protocol Violation|2
6008358|NCT00864682|20771167|P2|Overall Study|Protocol Violation|1
6008359|NCT00864682|20771168|P1|Overall Study|Protocol Violation|2
6008360|NCT00864513|20771207|P1|Overall Study|Withdrawal by Subject|3
6008361|NCT00864253|20771291|P2|Overall Study|Untreated|7
6008362|NCT00864253|20771292|P1|Overall Study|Untreated|7
6008363|NCT00864253|20771291|P2|Overall Study|Ongoing|3
6008364|NCT00864253|20771292|P1|Overall Study|Ongoing|2
6008365|NCT00864253|20771291|P2|Overall Study|Death|0
6008366|NCT00864253|20771292|P1|Overall Study|Death|1
6008367|NCT00864253|20771291|P2|Overall Study|Withdrawal by Subject|18
6008368|NCT00864253|20771292|P1|Overall Study|Withdrawal by Subject|18
6008369|NCT00864253|20771291|P2|Overall Study|Lost to Follow-up|1
6008370|NCT00864253|20771292|P1|Overall Study|Lost to Follow-up|1
6008371|NCT00864253|20771291|P2|Overall Study|Protocol Violation|2
6008372|NCT00864253|20771292|P1|Overall Study|Protocol Violation|0
6008373|NCT00864253|20771291|P2|Overall Study|Physician Decision|15
6008374|NCT00864253|20771292|P1|Overall Study|Physician Decision|11
6008375|NCT00864253|20771291|P2|Overall Study|Unrelated Adverse Event|1
6008376|NCT00864253|20771292|P1|Overall Study|Unrelated Adverse Event|3
6008377|NCT00864253|20771291|P2|Overall Study|Adverse Event|11
6008378|NCT00864253|20771292|P1|Overall Study|Adverse Event|56
6008379|NCT00864227|20771322|P1|Overall Study|Disease Relapse/Progression|3
6008380|NCT00864227|20771322|P1|Overall Study|Withdrawal by Subject|1
6008381|NCT00863928|20771383|P2|Overall Study|medication allergy|0
6008382|NCT00863928|20771384|P1|Overall Study|medication allergy|3
6008383|NCT00863928|20771383|P2|Overall Study|surgery cancellation|0
6008384|NCT00863928|20771384|P1|Overall Study|surgery cancellation|4
6008385|NCT00863928|20771383|P2|Overall Study|Withdrawal by Subject|0
6008386|NCT00863928|20771384|P1|Overall Study|Withdrawal by Subject|3
6008387|NCT00863928|20771383|P2|Overall Study|Protocol Violation|0
6008388|NCT00863928|20771384|P1|Overall Study|Protocol Violation|26
6008389|NCT00863798|20771393|P3|Overall Study|Randomized not treated|3
6008390|NCT00863798|20771394|P2|Overall Study|Randomized not treated|2
6008391|NCT00863798|20771395|P1|Overall Study|Randomized not treated|4
6008392|NCT00863798|20771393|P3|Overall Study|Withdrawal by Subject|4
6008393|NCT00863798|20771394|P2|Overall Study|Withdrawal by Subject|7
6008394|NCT00863798|20771395|P1|Overall Study|Withdrawal by Subject|8
6008395|NCT00863798|20771393|P3|Overall Study|Protocol Violation|1
6008396|NCT00863798|20771394|P2|Overall Study|Protocol Violation|1
6008397|NCT00863798|20771395|P1|Overall Study|Protocol Violation|0
6008398|NCT00863798|20771393|P3|Overall Study|Other|1
6008399|NCT00863798|20771394|P2|Overall Study|Other|3
6008400|NCT00863798|20771395|P1|Overall Study|Other|2
6008401|NCT00863798|20771393|P3|Overall Study|Lost to Follow-up|5
6008402|NCT00863798|20771394|P2|Overall Study|Lost to Follow-up|9
6008403|NCT00863798|20771395|P1|Overall Study|Lost to Follow-up|6
6008404|NCT00863798|20771393|P3|Overall Study|Lack of Efficacy|6
6008405|NCT00863798|20771394|P2|Overall Study|Lack of Efficacy|3
6008406|NCT00863798|20771395|P1|Overall Study|Lack of Efficacy|4
6008407|NCT00863798|20771393|P3|Overall Study|Investigator request|1
6008408|NCT00863798|20771394|P2|Overall Study|Investigator request|2
6008409|NCT00863798|20771395|P1|Overall Study|Investigator request|1
6008410|NCT00863798|20771393|P3|Overall Study|Participant failed to return|0
6008411|NCT00863798|20771394|P2|Overall Study|Participant failed to return|1
6008412|NCT00863798|20771395|P1|Overall Study|Participant failed to return|2
6008413|NCT00863798|20771393|P3|Overall Study|Adverse Event|4
6008414|NCT00863798|20771394|P2|Overall Study|Adverse Event|2
6008415|NCT00863798|20771395|P1|Overall Study|Adverse Event|5
6008416|NCT00863746|20771447|P2|Survival Follow up|Consent Withdrawn|8
6008417|NCT00863746|20771448|P1|Survival Follow up|Consent Withdrawn|7
6008418|NCT00863746|20771447|P2|Survival Follow up|Lost to Follow-up|1
6008419|NCT00863746|20771448|P1|Survival Follow up|Lost to Follow-up|2
6008420|NCT00863746|20771447|P2|Survival Follow up|Death|271
6008421|NCT00863746|20771448|P1|Survival Follow up|Death|244
6008422|NCT00863746|20771447|P2|Treatment|Other|0
6008423|NCT00863746|20771448|P1|Treatment|Other|1
6008424|NCT00863746|20771447|P2|Treatment|Protocol Violation|3
6008425|NCT00863746|20771448|P1|Treatment|Protocol Violation|5
6008426|NCT00863746|20771447|P2|Treatment|Lost to Follow-up|0
6008427|NCT00863746|20771448|P1|Treatment|Lost to Follow-up|1
6008428|NCT00863746|20771447|P2|Treatment|Consent withdrawn|14
6008429|NCT00863746|20771448|P1|Treatment|Consent withdrawn|15
6008430|NCT00863746|20771447|P2|Treatment|non-compliant with study medication|0
6008431|NCT00863746|20771448|P1|Treatment|non-compliant with study medication|4
6008432|NCT00863746|20771447|P2|Treatment|Adverse Event|16
6008433|NCT00863746|20771448|P1|Treatment|Adverse Event|41
6008434|NCT00863746|20771447|P2|Treatment|Not treated|2
6008435|NCT00863746|20771448|P1|Treatment|Not treated|4
6008436|NCT00863707|20771474|P2|Overall Study|Randomized, but drug not received|3
6008437|NCT00863707|20771475|P1|Overall Study|Randomized, but drug not received|4
6008438|NCT00863681|20771484|P3|Overall Study|Non-compliance with study drug|0
6008439|NCT00863681|20771485|P2|Overall Study|Non-compliance with study drug|3
6008440|NCT00863681|20771486|P1|Overall Study|Non-compliance with study drug|1
6008441|NCT00863681|20771484|P3|Overall Study|Lack of Efficacy|1
6008442|NCT00863681|20771485|P2|Overall Study|Lack of Efficacy|2
6008443|NCT00863681|20771486|P1|Overall Study|Lack of Efficacy|2
6008444|NCT00863681|20771484|P3|Overall Study|Adverse Event|6
6008445|NCT00863681|20771485|P2|Overall Study|Adverse Event|10
6008446|NCT00863681|20771486|P1|Overall Study|Adverse Event|28
6008447|NCT00863681|20771484|P3|Overall Study|Lost to Follow-up|3
6008448|NCT00863681|20771485|P2|Overall Study|Lost to Follow-up|0
6008449|NCT00863681|20771486|P1|Overall Study|Lost to Follow-up|3
6008450|NCT00863681|20771484|P3|Overall Study|Protocol Violation|0
6008451|NCT00863681|20771485|P2|Overall Study|Protocol Violation|0
6008452|NCT00863681|20771486|P1|Overall Study|Protocol Violation|2
6008453|NCT00863681|20771484|P3|Overall Study|Withdrawal by Subject|2
6008454|NCT00863681|20771485|P2|Overall Study|Withdrawal by Subject|5
6008455|NCT00863681|20771486|P1|Overall Study|Withdrawal by Subject|12
6008456|NCT00863681|20771484|P3|Overall Study|Death|6
6008457|NCT00863681|20771485|P2|Overall Study|Death|23
6008458|NCT00863681|20771486|P1|Overall Study|Death|40
6008459|NCT00863681|20771484|P3|Overall Study|Missing|0
6008460|NCT00863681|20771485|P2|Overall Study|Missing|0
6008461|NCT00863681|20771486|P1|Overall Study|Missing|1
6008462|NCT00863681|20771484|P3|Overall Study|Other|0
6008463|NCT00863681|20771485|P2|Overall Study|Other|0
6008464|NCT00863681|20771486|P1|Overall Study|Other|2
6008465|NCT00863655|20771571|P2|Overall Study|Treatment completed as per protocol|1
6008466|NCT00863655|20771572|P1|Overall Study|Treatment completed as per protocol|5
6008467|NCT00863655|20771571|P2|Overall Study|Disease progression|221
6008468|NCT00863655|20771572|P1|Overall Study|Disease progression|364
6008469|NCT00863655|20771571|P2|Overall Study|New cancer therapy|1
6008470|NCT00863655|20771572|P1|Overall Study|New cancer therapy|5
6008471|NCT00863655|20771571|P2|Overall Study|Death|1
6008472|NCT00863655|20771572|P1|Overall Study|Death|7
6008473|NCT00863655|20771571|P2|Overall Study|Administrative problems|0
6008474|NCT00863655|20771572|P1|Overall Study|Administrative problems|1
6008475|NCT00863655|20771571|P2|Overall Study|Withdrawal by Subject|7
6008476|NCT00863655|20771572|P1|Overall Study|Withdrawal by Subject|47
6008477|NCT00863655|20771571|P2|Overall Study|Adverse Event|8
6008478|NCT00863655|20771572|P1|Overall Study|Adverse Event|52
6008479|NCT00863655|20771571|P2|Overall Study|Protocol Violation|0
6008480|NCT00863655|20771572|P1|Overall Study|Protocol Violation|4
6008481|NCT00863512|20771609|P2|Overall Study|Physician Decision|0
6008482|NCT00863512|20771610|P1|Overall Study|Physician Decision|1
6008483|NCT00863512|20771609|P2|Overall Study|Withdrawal by Subject|0
6008484|NCT00863512|20771610|P1|Overall Study|Withdrawal by Subject|11
6008485|NCT00863512|20771609|P2|Overall Study|Adverse Event|0
6008486|NCT00863512|20771610|P1|Overall Study|Adverse Event|2
6008487|NCT00863330|20771641|P1|Overall Study|study terminated early due to administra|6
6008488|NCT00863317|20771647|P2|Overall Study|Lost to Follow-up|9
6008489|NCT00863317|20771648|P1|Overall Study|Lost to Follow-up|8
6008490|NCT00863057|20771705|P4|Period 2 (Weeks 6-10)|Physician Decision|1
6008491|NCT00863057|20771706|P3|Period 2 (Weeks 6-10)|Physician Decision|0
6008492|NCT00863057|20771707|P2|Period 2 (Weeks 6-10)|Physician Decision|0
6008493|NCT00863057|20771708|P1|Period 2 (Weeks 6-10)|Physician Decision|0
6008494|NCT00863057|20771705|P4|Period 2 (Weeks 6-10)|Adverse Event|0
6008495|NCT00863057|20771706|P3|Period 2 (Weeks 6-10)|Adverse Event|1
6008496|NCT00863057|20771707|P2|Period 2 (Weeks 6-10)|Adverse Event|1
6008497|NCT00863057|20771708|P1|Period 2 (Weeks 6-10)|Adverse Event|0
6008498|NCT00863057|20771705|P4|Milestones Period 1 (Weeks 0-5)|Physician Decision|0
6008499|NCT00863057|20771706|P3|Milestones Period 1 (Weeks 0-5)|Physician Decision|0
6008500|NCT00863057|20771707|P2|Milestones Period 1 (Weeks 0-5)|Physician Decision|1
6008501|NCT00863057|20771708|P1|Milestones Period 1 (Weeks 0-5)|Physician Decision|0
6008502|NCT00863057|20771705|P4|Milestones Period 1 (Weeks 0-5)|Adverse Event|1
6008503|NCT00863057|20771706|P3|Milestones Period 1 (Weeks 0-5)|Adverse Event|0
6008504|NCT00863057|20771707|P2|Milestones Period 1 (Weeks 0-5)|Adverse Event|1
6008505|NCT00863057|20771708|P1|Milestones Period 1 (Weeks 0-5)|Adverse Event|1
6008506|NCT00862979|20771766|P2|Overall Study|Death|1
6008507|NCT00862979|20771767|P1|Overall Study|Death|0
6008508|NCT00862979|20771766|P2|Overall Study|Administrative problems|1
6008509|NCT00862979|20771767|P1|Overall Study|Administrative problems|0
6008510|NCT00862979|20771766|P2|Overall Study|Patient withdrew consent|1
6008511|NCT00862979|20771767|P1|Overall Study|Patient withdrew consent|2
6008512|NCT00862979|20771766|P2|Overall Study|Protocol Violation|1
6008513|NCT00862979|20771767|P1|Overall Study|Protocol Violation|0
6008514|NCT00862979|20771766|P2|Overall Study|Adverse Event|3
6008515|NCT00862979|20771767|P1|Overall Study|Adverse Event|6
6008516|NCT00862940|20771785|P2|Overall Study|Administrative or other reason(s)|3
6008517|NCT00862940|20771786|P1|Overall Study|Administrative or other reason(s)|4
6008518|NCT00862940|20771785|P2|Overall Study|Lost to Follow-up|1
6008519|NCT00862940|20771786|P1|Overall Study|Lost to Follow-up|0
6008520|NCT00862940|20771785|P2|Overall Study|Non-compliance|0
6008521|NCT00862940|20771786|P1|Overall Study|Non-compliance|4
6008522|NCT00862940|20771785|P2|Overall Study|Withdrawal by Subject|6
6008523|NCT00862940|20771786|P1|Overall Study|Withdrawal by Subject|4
6008524|NCT00862940|20771785|P2|Overall Study|Protocol Violation|5
6008525|NCT00862940|20771786|P1|Overall Study|Protocol Violation|2
6008526|NCT00862940|20771785|P2|Overall Study|Lack of Efficacy|3
6008527|NCT00862940|20771786|P1|Overall Study|Lack of Efficacy|1
6008528|NCT00862940|20771785|P2|Overall Study|Adverse Event|12
6008529|NCT00862940|20771786|P1|Overall Study|Adverse Event|15
6008530|NCT00862849|20771798|P6|Washout 2 (3 to 14 Days)|Protocol Violation|0
6008531|NCT00862849|20771799|P5|Washout 2 (3 to 14 Days)|Protocol Violation|0
6008532|NCT00862849|20771800|P4|Washout 2 (3 to 14 Days)|Protocol Violation|0
6008533|NCT00862849|20771801|P3|Washout 2 (3 to 14 Days)|Protocol Violation|0
6008534|NCT00862849|20771802|P2|Washout 2 (3 to 14 Days)|Protocol Violation|1
6008535|NCT00862849|20771803|P1|Washout 2 (3 to 14 Days)|Protocol Violation|0
6008536|NCT00862849|20771798|P6|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0
6008537|NCT00862849|20771799|P5|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0
6008538|NCT00862849|20771800|P4|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0
6008539|NCT00862849|20771801|P3|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0
6008540|NCT00862849|20771802|P2|Washout 1 (3 to 14 Days)|Withdrawal by Subject|1
6008541|NCT00862849|20771803|P1|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0
6008542|NCT00862836|20771826|P1|Overall Study|Withdrawal by Subject|1
6008543|NCT00862823|20771837|P2|First Intervention|Withdrawal by Subject|1
6008544|NCT00862823|20771838|P1|First Intervention|Withdrawal by Subject|1
6008545|NCT00862719|20771887|P4|Overall Study|Veno-Occlusive Disease|0
6008546|NCT00862719|20771888|P3|Overall Study|Veno-Occlusive Disease|1
6008547|NCT00862719|20771889|P2|Overall Study|Veno-Occlusive Disease|0
6008548|NCT00862719|20771890|P1|Overall Study|Veno-Occlusive Disease|0
6008549|NCT00862719|20771887|P4|Overall Study|Engraftment failure|0
6008550|NCT00862719|20771888|P3|Overall Study|Engraftment failure|1
6008551|NCT00862719|20771889|P2|Overall Study|Engraftment failure|0
6008552|NCT00862719|20771890|P1|Overall Study|Engraftment failure|0
6008553|NCT00862719|20771887|P4|Overall Study|Death|1
6008554|NCT00862719|20771888|P3|Overall Study|Death|1
6008555|NCT00862719|20771889|P2|Overall Study|Death|6
6008556|NCT00862719|20771890|P1|Overall Study|Death|5
6008557|NCT00862719|20771887|P4|Overall Study|Disease Progression|0
6008558|NCT00862719|20771888|P3|Overall Study|Disease Progression|1
6008559|NCT00862719|20771889|P2|Overall Study|Disease Progression|0
6008560|NCT00862719|20771890|P1|Overall Study|Disease Progression|5
6008597|NCT00862641|20771930|P4|Overall Study|Randomized, but drug not received|4
6008598|NCT00862641|20771931|P3|Overall Study|Randomized, but drug not received|1
6008599|NCT00862641|20771932|P2|Overall Study|Randomized, but drug not received|4
6008600|NCT00862641|20771933|P1|Overall Study|Randomized, but drug not received|1
6008601|NCT00862459|20772027|P3|Overall Study|Administrative problems|0
6008602|NCT00862459|20772028|P2|Overall Study|Administrative problems|1
6008603|NCT00862459|20772029|P1|Overall Study|Administrative problems|0
6008604|NCT00862459|20772027|P3|Overall Study|Inclusion/exclusion criteria not met|0
6008605|NCT00862459|20772028|P2|Overall Study|Inclusion/exclusion criteria not met|1
6008606|NCT00862459|20772029|P1|Overall Study|Inclusion/exclusion criteria not met|0
6008607|NCT00862459|20772027|P3|Overall Study|Unable to hold still for imaging|0
6008608|NCT00862459|20772028|P2|Overall Study|Unable to hold still for imaging|1
6008609|NCT00862459|20772029|P1|Overall Study|Unable to hold still for imaging|0
6008610|NCT00862459|20772027|P3|Overall Study|Intravenous (IV) site problems|1
6008611|NCT00862459|20772028|P2|Overall Study|Intravenous (IV) site problems|0
6008612|NCT00862459|20772029|P1|Overall Study|Intravenous (IV) site problems|1
6008613|NCT00862459|20772027|P3|Overall Study|Operation|0
6008614|NCT00862459|20772028|P2|Overall Study|Operation|1
6008615|NCT00862459|20772029|P1|Overall Study|Operation|1
6008616|NCT00862459|20772027|P3|Overall Study|Personal reasons|0
6008617|NCT00862459|20772028|P2|Overall Study|Personal reasons|0
6008618|NCT00862459|20772029|P1|Overall Study|Personal reasons|1
6008619|NCT00862459|20772027|P3|Overall Study|Adverse Event|0
6008620|NCT00862459|20772028|P2|Overall Study|Adverse Event|1
6008621|NCT00862459|20772029|P1|Overall Study|Adverse Event|0
6008622|NCT00862459|20772027|P3|Overall Study|Withdrawal by Subject|3
6008623|NCT00862459|20772028|P2|Overall Study|Withdrawal by Subject|1
6008624|NCT00862459|20772029|P1|Overall Study|Withdrawal by Subject|1
6008625|NCT00862459|20772027|P3|Overall Study|Protocol Violation|0
6008626|NCT00862459|20772028|P2|Overall Study|Protocol Violation|0
6008627|NCT00862459|20772029|P1|Overall Study|Protocol Violation|1
6008628|NCT00862459|20772027|P3|Overall Study|Lost to Follow-up|2
6008629|NCT00862459|20772028|P2|Overall Study|Lost to Follow-up|2
6008630|NCT00862459|20772029|P1|Overall Study|Lost to Follow-up|1
6008631|NCT00862277|20772180|P3|Overall Study|Protocol Violation|5
6008632|NCT00862277|20772181|P2|Overall Study|Protocol Violation|2
6008633|NCT00862277|20772182|P1|Overall Study|Protocol Violation|1
6008634|NCT00862251|20772196|P3|Overall Study|Withdrawal by Subject|6
6008635|NCT00862251|20772197|P2|Overall Study|Withdrawal by Subject|2
6008636|NCT00862251|20772198|P1|Overall Study|Withdrawal by Subject|9
6008637|NCT00862251|20772196|P3|Overall Study|Protocol Violation|1
6008638|NCT00862251|20772197|P2|Overall Study|Protocol Violation|0
6008639|NCT00862251|20772198|P1|Overall Study|Protocol Violation|2
6008640|NCT00862251|20772196|P3|Overall Study|Lost to Follow-up|1
6008641|NCT00862251|20772197|P2|Overall Study|Lost to Follow-up|0
6008642|NCT00862251|20772198|P1|Overall Study|Lost to Follow-up|0
6008643|NCT00862251|20772196|P3|Overall Study|Adverse Event|1
6008644|NCT00862251|20772197|P2|Overall Study|Adverse Event|3
6008645|NCT00862251|20772198|P1|Overall Study|Adverse Event|8
6008646|NCT00862134|20772258|P2|Overall Study|Withdrew prior to dosing|0
6008647|NCT00862134|20772259|P1|Overall Study|Withdrew prior to dosing|2
6008648|NCT00862134|20772258|P2|Overall Study|Adverse Event|2
6008649|NCT00862134|20772259|P1|Overall Study|Adverse Event|2
6008650|NCT00862134|20772258|P2|Overall Study|Sponsor terminated study|7
6008651|NCT00862134|20772259|P1|Overall Study|Sponsor terminated study|5
6008652|NCT00862134|20772258|P2|Overall Study|Withdrawal by Subject|2
6008653|NCT00862134|20772259|P1|Overall Study|Withdrawal by Subject|1
6008654|NCT00862134|20772258|P2|Overall Study|Physician Decision|1
6008655|NCT00862134|20772259|P1|Overall Study|Physician Decision|0
6008656|NCT00862134|20772258|P2|Overall Study|Death|0
6008657|NCT00862134|20772259|P1|Overall Study|Death|1
6008658|NCT00862121|20772271|P2|Overall Study|Incorrect randomisation|1
6008659|NCT00862121|20772272|P1|Overall Study|Incorrect randomisation|0
6008660|NCT00862121|20772271|P2|Overall Study|Exclusion criterion violation|1
6008661|NCT00862121|20772272|P1|Overall Study|Exclusion criterion violation|0
6008662|NCT00862121|20772271|P2|Overall Study|Protocol Violation|1
6008663|NCT00862121|20772272|P1|Overall Study|Protocol Violation|0
6008664|NCT00862121|20772271|P2|Overall Study|Lack of Efficacy|3
6008665|NCT00862121|20772272|P1|Overall Study|Lack of Efficacy|0
6008666|NCT00862121|20772271|P2|Overall Study|Adverse Event|2
6008667|NCT00862121|20772272|P1|Overall Study|Adverse Event|1
6008668|NCT00862082|20772290|P2|Overall Study|Withdrawal by Subject|1
6008669|NCT00862082|20772291|P1|Overall Study|Withdrawal by Subject|0
6008670|NCT00862082|20772290|P2|Overall Study|Sponsor decision to terminate the study|0
6008671|NCT00862082|20772291|P1|Overall Study|Sponsor decision to terminate the study|5
6008672|NCT00861757|20772346|P4|Overall Study|Withdrawal by Subject|2
6008673|NCT00861757|20772347|P3|Overall Study|Withdrawal by Subject|5
6008674|NCT00861757|20772348|P2|Overall Study|Withdrawal by Subject|5
6008675|NCT00861757|20772349|P1|Overall Study|Withdrawal by Subject|1
6008676|NCT00861757|20772346|P4|Overall Study|Protocol Violation|1
6008677|NCT00861757|20772347|P3|Overall Study|Protocol Violation|4
6008678|NCT00861757|20772348|P2|Overall Study|Protocol Violation|2
6008679|NCT00861757|20772349|P1|Overall Study|Protocol Violation|2
6008680|NCT00861757|20772346|P4|Overall Study|Physician Decision|1
6008681|NCT00861757|20772347|P3|Overall Study|Physician Decision|0
6008682|NCT00861757|20772348|P2|Overall Study|Physician Decision|0
6008683|NCT00861757|20772349|P1|Overall Study|Physician Decision|0
6008684|NCT00861757|20772346|P4|Overall Study|Lost to Follow-up|1
6008685|NCT00861757|20772347|P3|Overall Study|Lost to Follow-up|1
6008686|NCT00861757|20772348|P2|Overall Study|Lost to Follow-up|0
6008687|NCT00861757|20772349|P1|Overall Study|Lost to Follow-up|1
6008688|NCT00861757|20772346|P4|Overall Study|Lack of Efficacy|1
6008689|NCT00861757|20772347|P3|Overall Study|Lack of Efficacy|0
6008690|NCT00861757|20772348|P2|Overall Study|Lack of Efficacy|1
6008691|NCT00861757|20772349|P1|Overall Study|Lack of Efficacy|3
6008692|NCT00861757|20772346|P4|Overall Study|Entry Criteria Not Met|1
6008693|NCT00861757|20772347|P3|Overall Study|Entry Criteria Not Met|1
6008694|NCT00861757|20772348|P2|Overall Study|Entry Criteria Not Met|2
6008695|NCT00861757|20772349|P1|Overall Study|Entry Criteria Not Met|1
6008696|NCT00861757|20772346|P4|Overall Study|Adverse Event|2
6008697|NCT00861757|20772347|P3|Overall Study|Adverse Event|7
6008698|NCT00861757|20772348|P2|Overall Study|Adverse Event|5
6008699|NCT00861757|20772349|P1|Overall Study|Adverse Event|1
6008700|NCT00861744|20772407|P4|Overall Study|Blood draws|1
6008701|NCT00861744|20772408|P3|Overall Study|Blood draws|0
6008702|NCT00861744|20772409|P2|Overall Study|Blood draws|0
6008703|NCT00861744|20772410|P1|Overall Study|Blood draws|0
6008704|NCT00861744|20772407|P4|Overall Study|Migration from study area|0
6008705|NCT00861744|20772408|P3|Overall Study|Migration from study area|1
6008706|NCT00861744|20772409|P2|Overall Study|Migration from study area|3
6008707|NCT00861744|20772410|P1|Overall Study|Migration from study area|0
6008708|NCT00861744|20772407|P4|Overall Study|Protocol Violation|0
6008709|NCT00861744|20772408|P3|Overall Study|Protocol Violation|0
6008710|NCT00861744|20772409|P2|Overall Study|Protocol Violation|1
6008711|NCT00861744|20772410|P1|Overall Study|Protocol Violation|0
6008712|NCT00861744|20772407|P4|Overall Study|Withdrawal by Subject|19
6008713|NCT00861744|20772408|P3|Overall Study|Withdrawal by Subject|6
6008714|NCT00861744|20772409|P2|Overall Study|Withdrawal by Subject|6
6008715|NCT00861744|20772410|P1|Overall Study|Withdrawal by Subject|10
6008716|NCT00861744|20772407|P4|Overall Study|Lost to Follow-up|12
6008717|NCT00861744|20772408|P3|Overall Study|Lost to Follow-up|17
6008718|NCT00861744|20772409|P2|Overall Study|Lost to Follow-up|19
6008719|NCT00861744|20772410|P1|Overall Study|Lost to Follow-up|7
6008720|NCT00861744|20772407|P4|Overall Study|Adverse Event|1
6008721|NCT00861744|20772408|P3|Overall Study|Adverse Event|0
6008722|NCT00861744|20772409|P2|Overall Study|Adverse Event|0
6008723|NCT00861744|20772410|P1|Overall Study|Adverse Event|0
6008728|NCT00861692|20772635|P1|Overall Study|Death|6
6008729|NCT00861614|20772647|P2|Overall Study|Other|22
6008730|NCT00861614|20772648|P1|Overall Study|Other|17
6008731|NCT00861614|20772647|P2|Overall Study|Withdrawal by Subject|35
6008732|NCT00861614|20772648|P1|Overall Study|Withdrawal by Subject|34
6008733|NCT00861614|20772647|P2|Overall Study|Adverse Event|23
6008734|NCT00861614|20772648|P1|Overall Study|Adverse Event|27
6008735|NCT00861614|20772647|P2|Overall Study|Death|19
6008736|NCT00861614|20772648|P1|Overall Study|Death|32
6008737|NCT00861614|20772647|P2|Overall Study|Study Drug Toxicity|6
6008738|NCT00861614|20772648|P1|Overall Study|Study Drug Toxicity|79
6008739|NCT00861614|20772647|P2|Overall Study|Disease Progression|263
6008740|NCT00861614|20772648|P1|Overall Study|Disease Progression|182
6008741|NCT00861471|20772733|P1|Overall Study|Physician Decision|2
6008742|NCT00861471|20772733|P1|Overall Study|treatment for lumbar laminectomy|1
6008743|NCT00861471|20772733|P1|Overall Study|Lack of Efficacy|3
6008744|NCT00861471|20772733|P1|Overall Study|Adverse Event|2
6008745|NCT00861471|20772733|P1|Overall Study|Withdrawal by Subject|1
6008746|NCT00861380|20772748|P7|Overall Study|Withdrawal Information not recorded|3020
6008747|NCT00861380|20772749|P6|Overall Study|Withdrawal Information not recorded|6249
6008748|NCT00861380|20772750|P5|Overall Study|Withdrawal Information not recorded|1812
6008749|NCT00861380|20772751|P4|Overall Study|Withdrawal Information not recorded|3689
6008750|NCT00861380|20772752|P3|Overall Study|Withdrawal Information not recorded|8872
6008751|NCT00861380|20772753|P2|Overall Study|Withdrawal Information not recorded|9112
6008752|NCT00861380|20772754|P1|Overall Study|Withdrawal Information not recorded|8427
6008753|NCT00861341|20772850|P1|Overall Study|Withdrawal by Subject|2
6008754|NCT00861198|20772859|P1|Overall Study|SpyGlass Failed|5
6008755|NCT00860951|20772876|P1|Overall Study|Lost to Follow-up|5
6008756|NCT00860951|20772876|P1|Overall Study|Withdrawal by Subject|2
6008757|NCT00860743|20772933|P2|Overall Study|Withdrawal by Subject|0
6008758|NCT00860743|20772934|P1|Overall Study|Withdrawal by Subject|3
6008759|NCT00860470|20772947|P2|Overall Study|Lost to Follow-up|39
6008760|NCT00860470|20772948|P1|Overall Study|Lost to Follow-up|34
6008761|NCT00860470|20772947|P2|Overall Study|Moved away|10
6008762|NCT00860470|20772948|P1|Overall Study|Moved away|8
6008763|NCT00860470|20772947|P2|Overall Study|Death|10
6008764|NCT00860470|20772948|P1|Overall Study|Death|6
6008765|NCT00860405|20772978|P2|Overall Study|Main reason: Follow-up data not complete|4
6008766|NCT00860405|20772979|P1|Overall Study|Main reason: Follow-up data not complete|5
6008767|NCT00860262|20773019|P3|Overall Study|Other|1
6008768|NCT00860262|20773020|P2|Overall Study|Other|3
6008769|NCT00860262|20773021|P1|Overall Study|Other|5
6008770|NCT00860262|20773019|P3|Overall Study|Lack of Efficacy|3
6008771|NCT00860262|20773020|P2|Overall Study|Lack of Efficacy|4
6008772|NCT00860262|20773021|P1|Overall Study|Lack of Efficacy|0
6008773|NCT00860262|20773019|P3|Overall Study|Withdrawal by Subject|6
6008774|NCT00860262|20773020|P2|Overall Study|Withdrawal by Subject|8
6008775|NCT00860262|20773021|P1|Overall Study|Withdrawal by Subject|4
6008776|NCT00860262|20773019|P3|Overall Study|Lost to Follow-up|1
6008777|NCT00860262|20773020|P2|Overall Study|Lost to Follow-up|0
6008778|NCT00860262|20773021|P1|Overall Study|Lost to Follow-up|2
6008779|NCT00860262|20773019|P3|Overall Study|Protocol Violation|0
6008780|NCT00860262|20773020|P2|Overall Study|Protocol Violation|1
6008781|NCT00860262|20773021|P1|Overall Study|Protocol Violation|0
6008782|NCT00860262|20773019|P3|Overall Study|Adverse Event|7
6008783|NCT00860262|20773020|P2|Overall Study|Adverse Event|6
6008784|NCT00860262|20773021|P1|Overall Study|Adverse Event|9
6008785|NCT00860249|20773134|P3|Overall Study|trial was terminated prior to completion|21
6008786|NCT00860249|20773135|P2|Overall Study|trial was terminated prior to completion|18
6008787|NCT00860249|20773136|P1|Overall Study|trial was terminated prior to completion|21
6008788|NCT00860158|20773156|P1|Overall Study|Study Terminated|1
6008789|NCT00860067|20773168|P3|Overall Study|Pregnancy|0
6008790|NCT00860067|20773169|P2|Overall Study|Pregnancy|0
6008791|NCT00860067|20773170|P1|Overall Study|Pregnancy|1
6008792|NCT00860067|20773168|P3|Overall Study|Withdrawal by Subject|0
6008793|NCT00860067|20773169|P2|Overall Study|Withdrawal by Subject|0
6008794|NCT00860067|20773170|P1|Overall Study|Withdrawal by Subject|4
6008795|NCT00860067|20773168|P3|Overall Study|Lost to Follow-up|9
6008796|NCT00860067|20773169|P2|Overall Study|Lost to Follow-up|9
6008797|NCT00860067|20773170|P1|Overall Study|Lost to Follow-up|46
6008798|NCT00860028|20773230|P2|Placebo Controlled Pretreatment Period|No longer interested in treatment|1
6008799|NCT00860028|20773231|P1|Placebo Controlled Pretreatment Period|No longer interested in treatment|2
6008800|NCT00859937|20773273|P2|Overall Study|Protocol Violation|0
6008801|NCT00859937|20773274|P1|Overall Study|Protocol Violation|1
6008802|NCT00859898|20773289|P3|Overall Study|non-specified|1
6008803|NCT00859898|20773290|P2|Overall Study|non-specified|1
6008804|NCT00859898|20773291|P1|Overall Study|non-specified|1
6008805|NCT00859898|20773289|P3|Overall Study|No longer meets criteria|0
6008806|NCT00859898|20773290|P2|Overall Study|No longer meets criteria|1
6008807|NCT00859898|20773291|P1|Overall Study|No longer meets criteria|0
6008808|NCT00859898|20773289|P3|Overall Study|poor/non-compliance|0
6008809|NCT00859898|20773290|P2|Overall Study|poor/non-compliance|0
6008810|NCT00859898|20773291|P1|Overall Study|poor/non-compliance|2
6008811|NCT00859898|20773289|P3|Overall Study|Lost to Follow-up|5
6008812|NCT00859898|20773290|P2|Overall Study|Lost to Follow-up|11
6008813|NCT00859898|20773291|P1|Overall Study|Lost to Follow-up|10
6008814|NCT00859898|20773289|P3|Overall Study|Death|1
6008815|NCT00859898|20773290|P2|Overall Study|Death|0
6008816|NCT00859898|20773291|P1|Overall Study|Death|0
6008817|NCT00859898|20773289|P3|Overall Study|Withdrawal by Subject|11
6008818|NCT00859898|20773290|P2|Overall Study|Withdrawal by Subject|8
6008819|NCT00859898|20773291|P1|Overall Study|Withdrawal by Subject|11
6008820|NCT00859898|20773289|P3|Overall Study|Adverse Event|8
6008821|NCT00859898|20773290|P2|Overall Study|Adverse Event|9
6008822|NCT00859898|20773291|P1|Overall Study|Adverse Event|4
6008823|NCT00859898|20773289|P3|Overall Study|Lack of Efficacy|1
6008824|NCT00859898|20773290|P2|Overall Study|Lack of Efficacy|1
6008825|NCT00859898|20773291|P1|Overall Study|Lack of Efficacy|0
6008826|NCT00859638|20773350|P2|Overall Study|Ill health|1
6008827|NCT00859638|20773351|P1|Overall Study|Ill health|1
6008828|NCT00859638|20773350|P2|Overall Study|Withdrawal by Subject|2
6008829|NCT00859638|20773351|P1|Overall Study|Withdrawal by Subject|3
6008830|NCT00859638|20773350|P2|Overall Study|Lost to Follow-up|1
6008831|NCT00859638|20773351|P1|Overall Study|Lost to Follow-up|6
6008832|NCT00859586|20773357|P1|Overall Study|Donors|4
6008833|NCT00859573|20773373|P2|Overall Study|Physician Decision|1
6008834|NCT00859573|20773374|P1|Overall Study|Physician Decision|1
6008835|NCT00859573|20773373|P2|Overall Study|Withdrawal by Subject|1
6008836|NCT00859573|20773374|P1|Overall Study|Withdrawal by Subject|4
6008837|NCT00859547|20773380|P1|Overall Study|Parent withdrew consent|1
6008838|NCT00859547|20773380|P1|Overall Study|Lost to Follow-up|1
6008839|NCT00859521|20773393|P2|Washout|Withdrawal by Subject|1
6008840|NCT00859521|20773394|P1|Washout|Withdrawal by Subject|0
6008841|NCT00859469|20773415|P1|Overall Study|Death|16
6008842|NCT00859469|20773415|P1|Overall Study|Withdrawal by Subject|1
6008843|NCT00859469|20773415|P1|Overall Study|Lack of Efficacy|9
6008844|NCT00859469|20773415|P1|Overall Study|Adverse Event|2
6008845|NCT00859456|20773421|P1|Overall Study|Non-compliance|3
6008846|NCT00859456|20773421|P1|Overall Study|Progressive disease|2
6008847|NCT00859456|20773421|P1|Overall Study|Adverse Event|3
6008848|NCT00859430|20773427|P2|First Intervention|Withdrawal by Subject|1
6008849|NCT00859430|20773428|P1|First Intervention|Withdrawal by Subject|0
6008850|NCT00859313|20773444|P1|Overall Study|staff error|1
6008851|NCT00859313|20773444|P1|Overall Study|Adverse Event|1
6008852|NCT00859313|20773444|P1|Overall Study|Lack of Efficacy|2
6008853|NCT00859222|20773451|P5|Overall Study|DLT|0
6008854|NCT00859222|20773452|P4|Overall Study|DLT|0
6008855|NCT00859222|20773453|P3|Overall Study|DLT|0
6008856|NCT00859222|20773454|P2|Overall Study|DLT|0
6008857|NCT00859222|20773455|P1|Overall Study|DLT|1
6008858|NCT00859222|20773451|P5|Overall Study|Adverse Event|15
6008859|NCT00859222|20773452|P4|Overall Study|Adverse Event|24
6008860|NCT00859222|20773453|P3|Overall Study|Adverse Event|6
6008861|NCT00859222|20773454|P2|Overall Study|Adverse Event|3
6008862|NCT00859222|20773455|P1|Overall Study|Adverse Event|2
6008863|NCT00859014|20773577|P1|Overall Study|Lost to Follow-up|1
6008864|NCT00859014|20773577|P1|Overall Study|Death|4
6008865|NCT00858988|20773584|P2|Analysis|Lactulose unable to be detected in urine|1
6008866|NCT00858988|20773585|P1|Analysis|Lactulose unable to be detected in urine|2
6008867|NCT00858845|20773601|P2|Overall Study|Patient underwent heart transplant.|1
6008868|NCT00858845|20773602|P1|Overall Study|Patient underwent heart transplant.|0
6008869|NCT00858832|20773614|P2|Overall Study|Adverse Event|1
6008870|NCT00858832|20773615|P1|Overall Study|Adverse Event|0
6008871|NCT00858832|20773614|P2|Overall Study|became ineligible: delivered vaginally|0
6008872|NCT00858832|20773615|P1|Overall Study|became ineligible: delivered vaginally|1
6008873|NCT00858780|20773621|P5|OL Re-Treatment (Failure to Week 48)|Other|1
6008874|NCT00858780|20773622|P4|OL Re-Treatment (Failure to Week 48)|Other|0
6008875|NCT00858780|20773623|P3|OL Re-Treatment (Failure to Week 48)|Other|0
6008876|NCT00858780|20773624|P2|OL Re-Treatment (Failure to Week 48)|Other|0
6008877|NCT00858780|20773625|P1|OL Re-Treatment (Failure to Week 48)|Other|0
6008878|NCT00858780|20773621|P5|OL Re-Treatment (Failure to Week 48)|Protocol Violation|1
6008879|NCT00858780|20773622|P4|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0
6008880|NCT00858780|20773623|P3|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0
6008881|NCT00858780|20773624|P2|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0
6008882|NCT00858780|20773625|P1|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0
6008883|NCT00858780|20773621|P5|Double-Blind (Week 0 to Failure/Week 48)|Other|0
6008884|NCT00858780|20773622|P4|Double-Blind (Week 0 to Failure/Week 48)|Other|0
6008885|NCT00858780|20773623|P3|Double-Blind (Week 0 to Failure/Week 48)|Other|0
6008886|NCT00858780|20773624|P2|Double-Blind (Week 0 to Failure/Week 48)|Other|1
6008887|NCT00858780|20773625|P1|Double-Blind (Week 0 to Failure/Week 48)|Other|0
6008888|NCT00858780|20773621|P5|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0
6008889|NCT00858780|20773622|P4|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1
6008890|NCT00858780|20773623|P3|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1
6008891|NCT00858780|20773624|P2|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1
6008892|NCT00858780|20773625|P1|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0
6008893|NCT00858780|20773621|P5|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0
6008894|NCT00858780|20773622|P4|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0
6008895|NCT00858780|20773623|P3|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|1
6008896|NCT00858780|20773624|P2|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0
6008897|NCT00858780|20773625|P1|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0
6008898|NCT00858780|20773621|P5|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0
6008899|NCT00858780|20773622|P4|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0
6008900|NCT00858780|20773623|P3|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0
6008901|NCT00858780|20773624|P2|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0
6008902|NCT00858780|20773625|P1|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|18
6008903|NCT00858702|20773700|P2|Overall Study|Withdrawal by Subject|0
6008904|NCT00858702|20773701|P1|Overall Study|Withdrawal by Subject|1
6008905|NCT00858702|20773700|P2|Overall Study|Other|1
6008906|NCT00858702|20773701|P1|Overall Study|Other|2
6008907|NCT00858702|20773700|P2|Overall Study|Protocol Violation|1
6008908|NCT00858702|20773701|P1|Overall Study|Protocol Violation|1
6008909|NCT00858702|20773700|P2|Overall Study|Lack of Efficacy|0
6008910|NCT00858702|20773701|P1|Overall Study|Lack of Efficacy|1
6008911|NCT00858637|20773716|P6|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|1
6008912|NCT00858637|20773717|P5|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0
6008913|NCT00858637|20773718|P4|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0
6008914|NCT00858637|20773719|P3|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0
6008915|NCT00858637|20773720|P2|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0
6008916|NCT00858637|20773721|P1|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0
6008917|NCT00858637|20773716|P6|Placebo-controlled Withdrawal Phase|Death|0
6008918|NCT00858637|20773717|P5|Placebo-controlled Withdrawal Phase|Death|1
6008919|NCT00858637|20773718|P4|Placebo-controlled Withdrawal Phase|Death|0
6008920|NCT00858637|20773719|P3|Placebo-controlled Withdrawal Phase|Death|1
6008921|NCT00858637|20773720|P2|Placebo-controlled Withdrawal Phase|Death|0
6008922|NCT00858637|20773721|P1|Placebo-controlled Withdrawal Phase|Death|0
6008923|NCT00858637|20773716|P6|Active Comparison Phase|Other Reasons|0
6008924|NCT00858637|20773717|P5|Active Comparison Phase|Other Reasons|0
6008925|NCT00858637|20773718|P4|Active Comparison Phase|Other Reasons|1
6008926|NCT00858637|20773719|P3|Active Comparison Phase|Other Reasons|0
6008927|NCT00858637|20773720|P2|Active Comparison Phase|Other Reasons|0
6008928|NCT00858637|20773721|P1|Active Comparison Phase|Other Reasons|1
6008929|NCT00858637|20773716|P6|Active Comparison Phase|Withdrawal by Subject|0
6008930|NCT00858637|20773717|P5|Active Comparison Phase|Withdrawal by Subject|0
6008931|NCT00858637|20773718|P4|Active Comparison Phase|Withdrawal by Subject|6
6008932|NCT00858637|20773719|P3|Active Comparison Phase|Withdrawal by Subject|0
6008933|NCT00858637|20773720|P2|Active Comparison Phase|Withdrawal by Subject|0
6008934|NCT00858637|20773721|P1|Active Comparison Phase|Withdrawal by Subject|7
6008935|NCT00858637|20773716|P6|Active Comparison Phase|Physician Decision|0
6008936|NCT00858637|20773717|P5|Active Comparison Phase|Physician Decision|0
6008937|NCT00858637|20773718|P4|Active Comparison Phase|Physician Decision|1
6008938|NCT00858637|20773719|P3|Active Comparison Phase|Physician Decision|0
6008939|NCT00858637|20773720|P2|Active Comparison Phase|Physician Decision|0
6008940|NCT00858637|20773721|P1|Active Comparison Phase|Physician Decision|1
6008941|NCT00858637|20773716|P6|Active Comparison Phase|Death|0
6008942|NCT00858637|20773717|P5|Active Comparison Phase|Death|0
6008943|NCT00858637|20773718|P4|Active Comparison Phase|Death|1
6008944|NCT00858637|20773719|P3|Active Comparison Phase|Death|0
6008945|NCT00858637|20773720|P2|Active Comparison Phase|Death|0
6008946|NCT00858637|20773721|P1|Active Comparison Phase|Death|1
6008947|NCT00858637|20773716|P6|Active Comparison Phase|Adverse Event|0
6008948|NCT00858637|20773717|P5|Active Comparison Phase|Adverse Event|0
6008949|NCT00858637|20773718|P4|Active Comparison Phase|Adverse Event|9
6008950|NCT00858637|20773719|P3|Active Comparison Phase|Adverse Event|0
6008951|NCT00858637|20773720|P2|Active Comparison Phase|Adverse Event|0
6008952|NCT00858637|20773721|P1|Active Comparison Phase|Adverse Event|14
6008953|NCT00858442|20773762|P2|Compression:Start to Finish|Lost to Follow-up|3
6008954|NCT00858442|20773763|P1|Compression:Start to Finish|Lost to Follow-up|1
6008955|NCT00858403|20773773|P1|Overall Study|Disease Progression|1
6008956|NCT00858403|20773773|P1|Overall Study|Death|3
6008957|NCT00858403|20773773|P1|Overall Study|Withdrawal by Subject|1
6008958|NCT00858364|20773794|P2|Overall Study|Still on-study|247
6008959|NCT00858364|20773795|P1|Overall Study|Still on-study|114
6008960|NCT00858364|20773794|P2|Overall Study|Missing|1
6008961|NCT00858364|20773795|P1|Overall Study|Missing|1
6008962|NCT00858364|20773794|P2|Overall Study|Other|17
6008963|NCT00858364|20773795|P1|Overall Study|Other|9
6008964|NCT00858364|20773794|P2|Overall Study|Protocol Deviation|2
6008965|NCT00858364|20773795|P1|Overall Study|Protocol Deviation|0
6008966|NCT00858364|20773794|P2|Overall Study|Noncompliance|4
6008967|NCT00858364|20773795|P1|Overall Study|Noncompliance|3
6008968|NCT00858364|20773794|P2|Overall Study|Lost to Follow-up|54
6008969|NCT00858364|20773795|P1|Overall Study|Lost to Follow-up|24
6008970|NCT00858364|20773794|P2|Overall Study|Ineligibility Determined|10
6008971|NCT00858364|20773795|P1|Overall Study|Ineligibility Determined|1
6008972|NCT00858364|20773794|P2|Overall Study|Withdrawal by Subject|118
6008973|NCT00858364|20773795|P1|Overall Study|Withdrawal by Subject|44
6008974|NCT00858364|20773794|P2|Overall Study|Adverse Event|2
6008975|NCT00858364|20773795|P1|Overall Study|Adverse Event|5
6008976|NCT00858364|20773794|P2|Overall Study|Administrative Decision|2
6008977|NCT00858364|20773795|P1|Overall Study|Administrative Decision|3
6008978|NCT00858247|20773817|P2|Week 12 Follow-up|Withdrawal by Subject|1
6008979|NCT00858247|20773818|P1|Week 12 Follow-up|Withdrawal by Subject|0
6008980|NCT00858247|20773817|P2|Baseline Assessment|Protocol Violation|1
6008981|NCT00858247|20773818|P1|Baseline Assessment|Protocol Violation|0
6008982|NCT00858247|20773817|P2|Baseline Assessment|Poor IV access|0
6008983|NCT00858247|20773818|P1|Baseline Assessment|Poor IV access|1
6008984|NCT00858247|20773817|P2|Baseline Assessment|Withdrawal by Subject|1
6008985|NCT00858247|20773818|P1|Baseline Assessment|Withdrawal by Subject|1
6008986|NCT00858208|20773834|P1|Overall Study|Other|10
6008987|NCT00858208|20773834|P1|Overall Study|Participant refused|40
6008988|NCT00858208|20773834|P1|Overall Study|Lost to Follow-up|26
6008989|NCT00858208|20773834|P1|Overall Study|Adverse Event|3
6008990|NCT00858143|20773851|P1|Overall Study|Other|23
6008991|NCT00858143|20773851|P1|Overall Study|Death|7
6008992|NCT00858143|20773851|P1|Overall Study|Lack of Efficacy|4
6008993|NCT00858143|20773851|P1|Overall Study|Adverse Event|16
6008994|NCT00858117|20773908|P1|Follow up for 5 Years|No further data collected for study|9
6008995|NCT00858117|20773908|P1|Follow up for 5 Years|Death|4
6008996|NCT00858117|20773908|P1|Treatment on Study|Adverse Event|2
6008997|NCT00857948|20773971|P4|Overall Study|Protocol Violation|0
6008998|NCT00857948|20773972|P3|Overall Study|Protocol Violation|1
6008999|NCT00857948|20773973|P2|Overall Study|Protocol Violation|0
6009000|NCT00857948|20773974|P1|Overall Study|Protocol Violation|1
6009001|NCT00857948|20773971|P4|Overall Study|Withdrawal by Subject|0
6009002|NCT00857948|20773972|P3|Overall Study|Withdrawal by Subject|0
6009003|NCT00857948|20773973|P2|Overall Study|Withdrawal by Subject|0
6009004|NCT00857948|20773974|P1|Overall Study|Withdrawal by Subject|2
6009005|NCT00857896|20773996|P1|Baseline to Week 4|Withdrawal by Subject|1
6009006|NCT00857818|20774152|P2|Overall Study|Investigator decision|0
6009007|NCT00857818|20774153|P1|Overall Study|Investigator decision|1
6009008|NCT00857818|20774152|P2|Overall Study|Sponsor terminated study|4
6009009|NCT00857818|20774153|P1|Overall Study|Sponsor terminated study|6
6009010|NCT00857818|20774152|P2|Overall Study|Withdrawal by Subject|4
6009011|NCT00857818|20774153|P1|Overall Study|Withdrawal by Subject|0
6009012|NCT00857818|20774152|P2|Overall Study|Adverse Event|0
6009013|NCT00857818|20774153|P1|Overall Study|Adverse Event|3
6009014|NCT00857818|20774152|P2|Overall Study|Lack of Efficacy|0
6009015|NCT00857818|20774153|P1|Overall Study|Lack of Efficacy|1
6009016|NCT00857792|20774181|P1|Overall Study|inadequate image quality for analysis|12
6009017|NCT00857766|20774187|P2|Overall Study|Participant Withdrew Consent|4
6009018|NCT00857766|20774188|P1|Overall Study|Participant Withdrew Consent|4
6009019|NCT00857766|20774187|P2|Overall Study|Investigator Discretion|3
6009020|NCT00857766|20774188|P1|Overall Study|Investigator Discretion|2
6009021|NCT00857766|20774187|P2|Overall Study|Lost to Follow-up|0
6009022|NCT00857766|20774188|P1|Overall Study|Lost to Follow-up|1
6009023|NCT00857766|20774187|P2|Overall Study|Protocol Violation|11
6009024|NCT00857766|20774188|P1|Overall Study|Protocol Violation|11
6009025|NCT00857766|20774187|P2|Overall Study|Adverse Event|12
6009026|NCT00857766|20774188|P1|Overall Study|Adverse Event|13
6009027|NCT00857649|20774230|P2|Overall Study|Other Reasons|3
6009028|NCT00857649|20774231|P1|Overall Study|Other Reasons|1
6009029|NCT00857649|20774230|P2|Overall Study|Nursing Home Placement|9
6009030|NCT00857649|20774231|P1|Overall Study|Nursing Home Placement|2
6009031|NCT00857649|20774230|P2|Overall Study|Withdrawal of Consent|7
6009032|NCT00857649|20774231|P1|Overall Study|Withdrawal of Consent|10
6009033|NCT00857649|20774230|P2|Overall Study|Protocol Violation|2
6009034|NCT00857649|20774231|P1|Overall Study|Protocol Violation|2
6009035|NCT00857649|20774230|P2|Overall Study|Non-compliance|1
6009036|NCT00857649|20774231|P1|Overall Study|Non-compliance|1
6009037|NCT00857649|20774230|P2|Overall Study|Adverse Event|10
6009038|NCT00857649|20774231|P1|Overall Study|Adverse Event|15
6009039|NCT00857623|20774247|P2|Overall Study|Positive for HEP C|1
6009040|NCT00857623|20774248|P1|Overall Study|Positive for HEP C|0
6009041|NCT00857623|20774247|P2|Overall Study|Intake of prohibited medication|1
6009042|NCT00857623|20774248|P1|Overall Study|Intake of prohibited medication|0
6009043|NCT00857623|20774247|P2|Overall Study|Severe non-compliance to protocol|1
6009044|NCT00857623|20774248|P1|Overall Study|Severe non-compliance to protocol|1
6009045|NCT00857623|20774247|P2|Overall Study|Lack of Efficacy|1
6009046|NCT00857623|20774248|P1|Overall Study|Lack of Efficacy|1
6009047|NCT00857623|20774247|P2|Overall Study|Withdrawal by Subject|1
6009048|NCT00857623|20774248|P1|Overall Study|Withdrawal by Subject|2
6009049|NCT00857623|20774247|P2|Overall Study|Study-specific discontinuation criteria|3
6009050|NCT00857623|20774248|P1|Overall Study|Study-specific discontinuation criteria|5
6009051|NCT00857623|20774247|P2|Overall Study|Adverse Event|2
6009052|NCT00857623|20774248|P1|Overall Study|Adverse Event|5
6009053|NCT00857584|20774272|P2|Overall Study|Physician Decision|1
6009054|NCT00857584|20774273|P1|Overall Study|Physician Decision|1
6009055|NCT00857584|20774272|P2|Overall Study|Adverse Event|2
6009056|NCT00857584|20774273|P1|Overall Study|Adverse Event|2
6009057|NCT00857584|20774272|P2|Overall Study|Lack of Efficacy|2
6009058|NCT00857584|20774273|P1|Overall Study|Lack of Efficacy|1
6009059|NCT00857454|20774400|P1|Overall Study|MTE09 enrollment criteria not met|6
6009060|NCT00857454|20774400|P1|Overall Study|Total Testosterone <300 ng/dL|8
6009061|NCT00857454|20774400|P1|Overall Study|Total Testosterone >1050 ng/dL|1
6009062|NCT00857454|20774400|P1|Overall Study|Adverse Event|2
6009063|NCT00857454|20774400|P1|Overall Study|Lost to Follow-up|1
6009064|NCT00857454|20774400|P1|Overall Study|Withdrawal by Subject|2
6009065|NCT00857415|20774413|P2|Overall Study|Deceased with no autopsy|0
6009066|NCT00857415|20774414|P1|Overall Study|Deceased with no autopsy|2
6009067|NCT00857415|20774413|P2|Overall Study|Subject still living at end of study|0
6009068|NCT00857415|20774414|P1|Overall Study|Subject still living at end of study|110
6009069|NCT00857415|20774413|P2|Overall Study|Invalid image or not imaged|0
6009070|NCT00857415|20774414|P1|Overall Study|Invalid image or not imaged|3
6009071|NCT00857415|20774413|P2|Overall Study|Image acquisition failure|0
6009072|NCT00857415|20774414|P1|Overall Study|Image acquisition failure|2
6009073|NCT00857389|20774421|P1|Overall Study|Did not proceed to transplant|2
6009074|NCT00857311|20774435|P4|Overall Study|Lost to Follow-up|0
6009075|NCT00857311|20774436|P3|Overall Study|Lost to Follow-up|0
6009076|NCT00857311|20774437|P2|Overall Study|Lost to Follow-up|0
6009077|NCT00857311|20774438|P1|Overall Study|Lost to Follow-up|1
6009078|NCT00857285|20774450|P2|Overall Study|Randomization criteria not met|1
6009079|NCT00857285|20774451|P1|Overall Study|Randomization criteria not met|1
6009080|NCT00857285|20774450|P2|Overall Study|Withdrawal by Subject|0
6009081|NCT00857285|20774451|P1|Overall Study|Withdrawal by Subject|4
6009082|NCT00857285|20774450|P2|Overall Study|Protocol Violation|1
6009083|NCT00857285|20774451|P1|Overall Study|Protocol Violation|3
6009084|NCT00857285|20774450|P2|Overall Study|Lack of Efficacy|2
6009085|NCT00857285|20774451|P1|Overall Study|Lack of Efficacy|0
6009086|NCT00857285|20774450|P2|Overall Study|Adverse Event|2
6009087|NCT00857285|20774451|P1|Overall Study|Adverse Event|4
6009088|NCT00857259|20774467|P3|Overall Study|Protocol Violation|1
6009089|NCT00857259|20774468|P2|Overall Study|Protocol Violation|0
6009090|NCT00857259|20774469|P1|Overall Study|Protocol Violation|1
6009091|NCT00857246|20774479|P1|ChemoRT|Adverse Event|2
6009092|NCT00857246|20774479|P1|ChemoRT|Withdrawal by Subject|1
6009093|NCT00857246|20774479|P1|Surgery (Curative)|disease progression|6
6009094|NCT00857246|20774479|P1|Induction Regimen|Withdrawal by Subject|1
6009095|NCT00857246|20774479|P1|Induction Regimen|disease-related complications|1
6009096|NCT00857246|20774479|P1|Induction Regimen|Adverse Event|1
6009097|NCT00857233|20774489|P1|Overall Study|Other Reasons|2
6009098|NCT00857233|20774489|P1|Overall Study|Nursing Home Placement|14
6009099|NCT00857233|20774489|P1|Overall Study|Lost to Follow-up|4
6009100|NCT00857233|20774489|P1|Overall Study|Withdrawal of Consent|9
6009101|NCT00857233|20774489|P1|Overall Study|Non-compliance|1
6009102|NCT00857233|20774489|P1|Overall Study|Lack of Efficacy|1
6009103|NCT00857233|20774489|P1|Overall Study|Adverse Event|24
6009104|NCT00857220|20774498|P1|Overall Study|Miscellaneous|8
6009105|NCT00857220|20774498|P1|Overall Study|Site Closed|5
6009106|NCT00857220|20774498|P1|Overall Study|Clinical Hold|6
6009107|NCT00857220|20774498|P1|Overall Study|Withdrawal by Subject|67
6009108|NCT00857220|20774498|P1|Overall Study|Protocol Violation|16
6009109|NCT00857220|20774498|P1|Overall Study|Physician Decision|4
6009110|NCT00857220|20774498|P1|Overall Study|Lost to Follow-up|30
6009111|NCT00857220|20774498|P1|Overall Study|Lack of Efficacy|11
6009112|NCT00857220|20774498|P1|Overall Study|Death|1
6009113|NCT00857220|20774498|P1|Overall Study|Adverse Event|35
6009114|NCT00856999|20774515|P1|Overall Study|Withdrawal by Subject|5
6009115|NCT00856986|20774525|P5|Extension Period, Weeks 26-52|Unclassified|0
6009116|NCT00856986|20774526|P4|Extension Period, Weeks 26-52|Unclassified|0
6009117|NCT00856986|20774527|P3|Extension Period, Weeks 26-52|Unclassified|11
6009118|NCT00856986|20774528|P2|Extension Period, Weeks 26-52|Unclassified|2
6009119|NCT00856986|20774529|P1|Extension Period, Weeks 26-52|Unclassified|4
6009120|NCT00856986|20774525|P5|Extension Period, Weeks 26-52|Lack of Efficacy|0
6009121|NCT00856986|20774526|P4|Extension Period, Weeks 26-52|Lack of Efficacy|0
6009122|NCT00856986|20774527|P3|Extension Period, Weeks 26-52|Lack of Efficacy|2
6009123|NCT00856986|20774528|P2|Extension Period, Weeks 26-52|Lack of Efficacy|2
6009124|NCT00856986|20774529|P1|Extension Period, Weeks 26-52|Lack of Efficacy|4
6009125|NCT00856986|20774525|P5|Extension Period, Weeks 26-52|Lost to Follow-up|0
6009126|NCT00856986|20774526|P4|Extension Period, Weeks 26-52|Lost to Follow-up|0
6009127|NCT00856986|20774527|P3|Extension Period, Weeks 26-52|Lost to Follow-up|2
6009128|NCT00856986|20774528|P2|Extension Period, Weeks 26-52|Lost to Follow-up|5
6009129|NCT00856986|20774529|P1|Extension Period, Weeks 26-52|Lost to Follow-up|0
6009130|NCT00856986|20774525|P5|Extension Period, Weeks 26-52|Withdrawal Criteria|0
6009131|NCT00856986|20774526|P4|Extension Period, Weeks 26-52|Withdrawal Criteria|0
6009132|NCT00856986|20774527|P3|Extension Period, Weeks 26-52|Withdrawal Criteria|8
6009133|NCT00856986|20774528|P2|Extension Period, Weeks 26-52|Withdrawal Criteria|0
6009134|NCT00856986|20774529|P1|Extension Period, Weeks 26-52|Withdrawal Criteria|2
6009135|NCT00856986|20774525|P5|Extension Period, Weeks 26-52|Protocol Violation|0
6009136|NCT00856986|20774526|P4|Extension Period, Weeks 26-52|Protocol Violation|0
6009137|NCT00856986|20774527|P3|Extension Period, Weeks 26-52|Protocol Violation|5
6009138|NCT00856986|20774528|P2|Extension Period, Weeks 26-52|Protocol Violation|2
6009139|NCT00856986|20774529|P1|Extension Period, Weeks 26-52|Protocol Violation|6
6009140|NCT00856986|20774525|P5|Extension Period, Weeks 26-52|Adverse Event|0
6009141|NCT00856986|20774526|P4|Extension Period, Weeks 26-52|Adverse Event|0
6009142|NCT00856986|20774527|P3|Extension Period, Weeks 26-52|Adverse Event|10
6009143|NCT00856986|20774528|P2|Extension Period, Weeks 26-52|Adverse Event|3
6009144|NCT00856986|20774529|P1|Extension Period, Weeks 26-52|Adverse Event|3
6009145|NCT00856986|20774525|P5|Main Period, Weeks 0-26|Unclassified|0
6009146|NCT00856986|20774526|P4|Main Period, Weeks 0-26|Unclassified|0
6009147|NCT00856986|20774527|P3|Main Period, Weeks 0-26|Unclassified|7
6009148|NCT00856986|20774528|P2|Main Period, Weeks 0-26|Unclassified|6
6009149|NCT00856986|20774529|P1|Main Period, Weeks 0-26|Unclassified|7
6009150|NCT00856986|20774525|P5|Main Period, Weeks 0-26|Lack of Efficacy|0
6009151|NCT00856986|20774526|P4|Main Period, Weeks 0-26|Lack of Efficacy|0
6009152|NCT00856986|20774527|P3|Main Period, Weeks 0-26|Lack of Efficacy|0
6009153|NCT00856986|20774528|P2|Main Period, Weeks 0-26|Lack of Efficacy|2
6009154|NCT00856986|20774529|P1|Main Period, Weeks 0-26|Lack of Efficacy|5
6009155|NCT00856986|20774525|P5|Main Period, Weeks 0-26|Lost to Follow-up|0
6009156|NCT00856986|20774526|P4|Main Period, Weeks 0-26|Lost to Follow-up|0
6009157|NCT00856986|20774527|P3|Main Period, Weeks 0-26|Lost to Follow-up|2
6009158|NCT00856986|20774528|P2|Main Period, Weeks 0-26|Lost to Follow-up|1
6009159|NCT00856986|20774529|P1|Main Period, Weeks 0-26|Lost to Follow-up|1
6009160|NCT00856986|20774525|P5|Main Period, Weeks 0-26|Withdrawal Criteria|0
6009161|NCT00856986|20774526|P4|Main Period, Weeks 0-26|Withdrawal Criteria|0
6009162|NCT00856986|20774527|P3|Main Period, Weeks 0-26|Withdrawal Criteria|3
6009163|NCT00856986|20774528|P2|Main Period, Weeks 0-26|Withdrawal Criteria|0
6009164|NCT00856986|20774529|P1|Main Period, Weeks 0-26|Withdrawal Criteria|11
6009165|NCT00856986|20774525|P5|Main Period, Weeks 0-26|Protocol Violation|0
6009166|NCT00856986|20774526|P4|Main Period, Weeks 0-26|Protocol Violation|0
6009167|NCT00856986|20774527|P3|Main Period, Weeks 0-26|Protocol Violation|7
6009168|NCT00856986|20774528|P2|Main Period, Weeks 0-26|Protocol Violation|5
6009169|NCT00856986|20774529|P1|Main Period, Weeks 0-26|Protocol Violation|4
6009170|NCT00856986|20774525|P5|Main Period, Weeks 0-26|Adverse Event|0
6009171|NCT00856986|20774526|P4|Main Period, Weeks 0-26|Adverse Event|0
6009172|NCT00856986|20774527|P3|Main Period, Weeks 0-26|Adverse Event|9
6009173|NCT00856986|20774528|P2|Main Period, Weeks 0-26|Adverse Event|4
6009174|NCT00856986|20774529|P1|Main Period, Weeks 0-26|Adverse Event|6
6009175|NCT00856986|20774525|P5|Run-in Period, Weeks -12-0|Unclassified|0
6009176|NCT00856986|20774526|P4|Run-in Period, Weeks -12-0|Unclassified|24
6009177|NCT00856986|20774527|P3|Run-in Period, Weeks -12-0|Unclassified|0
6009178|NCT00856986|20774528|P2|Run-in Period, Weeks -12-0|Unclassified|0
6009179|NCT00856986|20774529|P1|Run-in Period, Weeks -12-0|Unclassified|0
6009180|NCT00856986|20774525|P5|Run-in Period, Weeks -12-0|Lack of Efficacy|0
6009181|NCT00856986|20774526|P4|Run-in Period, Weeks -12-0|Lack of Efficacy|6
6009182|NCT00856986|20774527|P3|Run-in Period, Weeks -12-0|Lack of Efficacy|0
6009183|NCT00856986|20774528|P2|Run-in Period, Weeks -12-0|Lack of Efficacy|0
6009184|NCT00856986|20774529|P1|Run-in Period, Weeks -12-0|Lack of Efficacy|0
6009185|NCT00856986|20774525|P5|Run-in Period, Weeks -12-0|Lost to Follow-up|0
6009186|NCT00856986|20774526|P4|Run-in Period, Weeks -12-0|Lost to Follow-up|11
6009187|NCT00856986|20774527|P3|Run-in Period, Weeks -12-0|Lost to Follow-up|0
6009188|NCT00856986|20774528|P2|Run-in Period, Weeks -12-0|Lost to Follow-up|0
6009189|NCT00856986|20774529|P1|Run-in Period, Weeks -12-0|Lost to Follow-up|0
6009190|NCT00856986|20774525|P5|Run-in Period, Weeks -12-0|Withdrawal Criteria|0
6009191|NCT00856986|20774526|P4|Run-in Period, Weeks -12-0|Withdrawal Criteria|10
6009192|NCT00856986|20774527|P3|Run-in Period, Weeks -12-0|Withdrawal Criteria|0
6009193|NCT00856986|20774528|P2|Run-in Period, Weeks -12-0|Withdrawal Criteria|0
6009194|NCT00856986|20774529|P1|Run-in Period, Weeks -12-0|Withdrawal Criteria|0
6009195|NCT00856986|20774525|P5|Run-in Period, Weeks -12-0|Protocol Violation|0
6009196|NCT00856986|20774526|P4|Run-in Period, Weeks -12-0|Protocol Violation|24
6009197|NCT00856986|20774527|P3|Run-in Period, Weeks -12-0|Protocol Violation|0
6009198|NCT00856986|20774528|P2|Run-in Period, Weeks -12-0|Protocol Violation|0
6009199|NCT00856986|20774529|P1|Run-in Period, Weeks -12-0|Protocol Violation|0
6009200|NCT00856986|20774525|P5|Run-in Period, Weeks -12-0|Adverse Event|0
6009201|NCT00856986|20774526|P4|Run-in Period, Weeks -12-0|Adverse Event|92
6009202|NCT00856986|20774527|P3|Run-in Period, Weeks -12-0|Adverse Event|0
6009203|NCT00856986|20774528|P2|Run-in Period, Weeks -12-0|Adverse Event|0
6009204|NCT00856986|20774529|P1|Run-in Period, Weeks -12-0|Adverse Event|0
6009205|NCT00856973|20774699|P3|Overall Study|Other|13
6009206|NCT00856973|20774700|P2|Overall Study|Other|12
6009207|NCT00856973|20774701|P1|Overall Study|Other|11
6009208|NCT00856973|20774699|P3|Overall Study|Withdrawal by Subject|15
6009209|NCT00856973|20774700|P2|Overall Study|Withdrawal by Subject|16
6009210|NCT00856973|20774701|P1|Overall Study|Withdrawal by Subject|13
6009211|NCT00856973|20774699|P3|Overall Study|Protocol Violation|1
6009212|NCT00856973|20774700|P2|Overall Study|Protocol Violation|2
6009213|NCT00856973|20774701|P1|Overall Study|Protocol Violation|1
6009214|NCT00856973|20774699|P3|Overall Study|Physician Decision|1
6009215|NCT00856973|20774700|P2|Overall Study|Physician Decision|3
6009216|NCT00856973|20774701|P1|Overall Study|Physician Decision|0
6009217|NCT00856973|20774699|P3|Overall Study|Lost to Follow-up|5
6009218|NCT00856973|20774700|P2|Overall Study|Lost to Follow-up|3
6009219|NCT00856973|20774701|P1|Overall Study|Lost to Follow-up|6
6009220|NCT00856973|20774699|P3|Overall Study|Adverse Event|3
6009221|NCT00856973|20774700|P2|Overall Study|Adverse Event|5
6009222|NCT00856973|20774701|P1|Overall Study|Adverse Event|5
6009223|NCT00856908|20774781|P2|Overall Study|Lost to Follow-up|0
6009224|NCT00856908|20774782|P1|Overall Study|Lost to Follow-up|1
6009225|NCT00856856|20774807|P1|4-year Clinical Follow-up|Missed visit|1
6009226|NCT00856856|20774807|P1|2-year Clinical Follow-up|Lost to Follow-up|1
6009227|NCT00856843|20775006|P2|Overall Study|Lack of Efficacy|0
6009228|NCT00856843|20775007|P1|Overall Study|Lack of Efficacy|1
6009229|NCT00856843|20775006|P2|Overall Study|Withdrawal by Subject|5
6009230|NCT00856843|20775007|P1|Overall Study|Withdrawal by Subject|1
6009231|NCT00856830|20775043|P4|Irinotecan & Bendamustine|Physician Decision|1
6009232|NCT00856830|20775044|P3|Irinotecan & Bendamustine|Physician Decision|0
6009233|NCT00856830|20775045|P2|Irinotecan & Bendamustine|Physician Decision|0
6009234|NCT00856830|20775046|P1|Irinotecan & Bendamustine|Physician Decision|0
6009235|NCT00856830|20775043|P4|Irinotecan & Bendamustine|Death|2
6009236|NCT00856830|20775044|P3|Irinotecan & Bendamustine|Death|0
6009237|NCT00856830|20775045|P2|Irinotecan & Bendamustine|Death|0
6009238|NCT00856830|20775046|P1|Irinotecan & Bendamustine|Death|0
6009239|NCT00856778|20775057|P1|Overall Study|Lost to Follow-up|5
6009240|NCT00856778|20775057|P1|Overall Study|Study deviation|2
6009241|NCT00856778|20775057|P1|Overall Study|Withdrawal by Subject|10
6009242|NCT00856778|20775057|P1|Overall Study|Adverse Event|7
6009243|NCT00856661|20775100|P2|Overall Study|Physician Judgement|5
6009244|NCT00856661|20775101|P1|Overall Study|Physician Judgement|8
6009245|NCT00856661|20775100|P2|Overall Study|Lost to Follow-up|3
6009246|NCT00856661|20775101|P1|Overall Study|Lost to Follow-up|1
6009247|NCT00856661|20775100|P2|Overall Study|Withdrawal by Subject|2
6009248|NCT00856661|20775101|P1|Overall Study|Withdrawal by Subject|1
6009249|NCT00856661|20775100|P2|Overall Study|Protocol Violation|1
6009250|NCT00856661|20775101|P1|Overall Study|Protocol Violation|2
6009251|NCT00856661|20775100|P2|Overall Study|Death|18
6009252|NCT00856661|20775101|P1|Overall Study|Death|15
6009253|NCT00856635|20775115|P2|Overall Study|Discontinued at Randomization|2
6009254|NCT00856635|20775116|P1|Overall Study|Discontinued at Randomization|2
6009255|NCT00856635|20775115|P2|Overall Study|Other|0
6009256|NCT00856635|20775116|P1|Overall Study|Other|1
6009257|NCT00856635|20775115|P2|Overall Study|Serious Adverse Event|0
6009258|NCT00856635|20775116|P1|Overall Study|Serious Adverse Event|1
6009259|NCT00856635|20775115|P2|Overall Study|Withdrawal by Subject|1
6009260|NCT00856635|20775116|P1|Overall Study|Withdrawal by Subject|3
6009261|NCT00856635|20775115|P2|Overall Study|Pregnancy|0
6009262|NCT00856635|20775116|P1|Overall Study|Pregnancy|1
6009263|NCT00856635|20775115|P2|Overall Study|Lost to Follow-up|5
6009264|NCT00856635|20775116|P1|Overall Study|Lost to Follow-up|2
6009265|NCT00856609|20775126|P2|Overall Study|Adverse Event|0
6009266|NCT00856609|20775127|P1|Overall Study|Adverse Event|1
6009267|NCT00856583|20775139|P2|Overall Study|Non-evaluable: Patient on Polytherapy|604
6009268|NCT00856583|20775140|P1|Overall Study|Non-evaluable: Patient on Polytherapy|694
6009269|NCT00856583|20775139|P2|Overall Study|Other|104
6009270|NCT00856583|20775140|P1|Overall Study|Other|92
6009271|NCT00856583|20775139|P2|Overall Study|Pregnancy|5
6009272|NCT00856583|20775140|P1|Overall Study|Pregnancy|14
6009273|NCT00856583|20775139|P2|Overall Study|Physician Decision|82
6009274|NCT00856583|20775140|P1|Overall Study|Physician Decision|59
6009275|NCT00856583|20775139|P2|Overall Study|Withdrawal by Subject|919
6009276|NCT00856583|20775140|P1|Overall Study|Withdrawal by Subject|1092
6009277|NCT00856583|20775139|P2|Overall Study|Non-compliance|262
6009278|NCT00856583|20775140|P1|Overall Study|Non-compliance|305
6009279|NCT00856583|20775139|P2|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|179
6009280|NCT00856583|20775140|P1|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|393
6009281|NCT00856583|20775139|P2|Overall Study|Serious Adverse Event (SAE)|65
6009282|NCT00856583|20775140|P1|Overall Study|Serious Adverse Event (SAE)|99
6009283|NCT00856583|20775139|P2|Overall Study|Lack of Efficacy|377
6009284|NCT00856583|20775140|P1|Overall Study|Lack of Efficacy|389
6009285|NCT00856557|20775170|P2|Overall Study|No patients with contextual flags|16
6009286|NCT00856557|20775171|P1|Overall Study|No patients with contextual flags|12
6009287|NCT00856544|20775185|P4|Overall Study|Withdrawal by Subject|1
6009288|NCT00856544|20775186|P3|Overall Study|Withdrawal by Subject|0
6009289|NCT00856544|20775187|P2|Overall Study|Withdrawal by Subject|5
6009290|NCT00856544|20775188|P1|Overall Study|Withdrawal by Subject|8
6009291|NCT00856544|20775185|P4|Overall Study|Lost to Follow-up|0
6009292|NCT00856544|20775186|P3|Overall Study|Lost to Follow-up|2
6009293|NCT00856544|20775187|P2|Overall Study|Lost to Follow-up|2
6009294|NCT00856544|20775188|P1|Overall Study|Lost to Follow-up|1
6009295|NCT00856544|20775185|P4|Overall Study|Other|6
6009296|NCT00856544|20775186|P3|Overall Study|Other|1
6009297|NCT00856544|20775187|P2|Overall Study|Other|16
6009298|NCT00856544|20775188|P1|Overall Study|Other|9
6009299|NCT00856544|20775185|P4|Overall Study|Lack of Efficacy|3
6009300|NCT00856544|20775186|P3|Overall Study|Lack of Efficacy|3
6009301|NCT00856544|20775187|P2|Overall Study|Lack of Efficacy|12
6009302|NCT00856544|20775188|P1|Overall Study|Lack of Efficacy|16
6009303|NCT00856544|20775185|P4|Overall Study|Adverse Event|3
6009304|NCT00856544|20775186|P3|Overall Study|Adverse Event|2
6009305|NCT00856544|20775187|P2|Overall Study|Adverse Event|29
6009306|NCT00856544|20775188|P1|Overall Study|Adverse Event|20
6009307|NCT00856544|20775185|P4|Overall Study|Death|0
6009308|NCT00856544|20775186|P3|Overall Study|Death|0
6009309|NCT00856544|20775187|P2|Overall Study|Death|2
6009310|NCT00856544|20775188|P1|Overall Study|Death|0
6009311|NCT00856544|20775185|P4|Overall Study|Randomized but not treated|0
6009312|NCT00856544|20775186|P3|Overall Study|Randomized but not treated|0
6009313|NCT00856544|20775187|P2|Overall Study|Randomized but not treated|0
6009314|NCT00856544|20775188|P1|Overall Study|Randomized but not treated|3
6009315|NCT00856518|20775367|P2|Overall Study|Lost to Follow-up|2
6009316|NCT00856518|20775368|P1|Overall Study|Lost to Follow-up|4
6009317|NCT00856492|20775381|P3|Overall Study|Ineligible or withdrew consent|2
6009318|NCT00856492|20775382|P2|Overall Study|Ineligible or withdrew consent|1
6009319|NCT00856492|20775383|P1|Overall Study|Ineligible or withdrew consent|1
6009320|NCT00856388|20775405|P1|Overall Study|Other|1
6009321|NCT00856349|20775416|P1|Overall Study|Subject changed Dr, insurance issue, etc|130
6009322|NCT00856349|20775416|P1|Overall Study|Site closure|78
6009323|NCT00856349|20775416|P1|Overall Study|Device explant|33
6009324|NCT00856349|20775416|P1|Overall Study|Subject relocation|104
6009325|NCT00856349|20775416|P1|Overall Study|Physician Decision|13
6009326|NCT00856349|20775416|P1|Overall Study|Protocol Violation|38
6009327|NCT00856349|20775416|P1|Overall Study|Lost to Follow-up|91
6009328|NCT00856349|20775416|P1|Overall Study|Withdrawal by Subject|116
6009329|NCT00856349|20775416|P1|Overall Study|Death|418
6009330|NCT00856323|20775425|P1|Overall Study|Withdrawal by Subject|2
6009331|NCT00856297|20775437|P5|Overall Study|Unable to classify|0
6009332|NCT00856297|20775438|P4|Overall Study|Unable to classify|0
6009333|NCT00856297|20775439|P3|Overall Study|Unable to classify|0
6009334|NCT00856297|20775440|P2|Overall Study|Unable to classify|0
6009335|NCT00856297|20775441|P1|Overall Study|Unable to classify|2
6009336|NCT00856284|20775474|P3|Overall Study|Randomized in error|1
6009337|NCT00856284|20775475|P2|Overall Study|Randomized in error|0
6009338|NCT00856284|20775476|P1|Overall Study|Randomized in error|0
6009339|NCT00856284|20775474|P3|Overall Study|Other|14
6009340|NCT00856284|20775475|P2|Overall Study|Other|17
6009341|NCT00856284|20775476|P1|Overall Study|Other|15
6009342|NCT00856284|20775474|P3|Overall Study|Investigator discretion|10
6009343|NCT00856284|20775475|P2|Overall Study|Investigator discretion|8
6009344|NCT00856284|20775476|P1|Overall Study|Investigator discretion|9
6009345|NCT00856284|20775474|P3|Overall Study|Pregnancy|0
6009346|NCT00856284|20775475|P2|Overall Study|Pregnancy|2
6009347|NCT00856284|20775476|P1|Overall Study|Pregnancy|1
6009348|NCT00856284|20775474|P3|Overall Study|Voluntary withdrawal|62
6009349|NCT00856284|20775475|P2|Overall Study|Voluntary withdrawal|52
6009350|NCT00856284|20775476|P1|Overall Study|Voluntary withdrawal|48
6009351|NCT00856284|20775474|P3|Overall Study|Lost to Follow-up|28
6009352|NCT00856284|20775475|P2|Overall Study|Lost to Follow-up|22
6009353|NCT00856284|20775476|P1|Overall Study|Lost to Follow-up|20
6009354|NCT00856284|20775474|P3|Overall Study|Major protocol deviation|15
6009355|NCT00856284|20775475|P2|Overall Study|Major protocol deviation|16
6009356|NCT00856284|20775476|P1|Overall Study|Major protocol deviation|24
6009357|NCT00856284|20775474|P3|Overall Study|Adverse Event|82
6009358|NCT00856284|20775475|P2|Overall Study|Adverse Event|74
6009359|NCT00856284|20775476|P1|Overall Study|Adverse Event|60
6009360|NCT00856284|20775474|P3|Overall Study|Hyperglycemic rescue|235
6009361|NCT00856284|20775475|P2|Overall Study|Hyperglycemic rescue|201
6009362|NCT00856284|20775476|P1|Overall Study|Hyperglycemic rescue|231
6009363|NCT00856245|20775502|P1|Overall Study|Was not transplanted|5
6009364|NCT00856206|20775525|P2|Overall Study|Other than specified above|10
6009365|NCT00856206|20775526|P1|Overall Study|Other than specified above|3
6009366|NCT00856206|20775525|P2|Overall Study|Decision by the Sponsor|8
6009367|NCT00856206|20775526|P1|Overall Study|Decision by the Sponsor|4
6009368|NCT00856206|20775525|P2|Overall Study|Death|2
6009369|NCT00856206|20775526|P1|Overall Study|Death|2
6009370|NCT00856206|20775525|P2|Overall Study|Lost to Follow-up|39
6009371|NCT00856206|20775526|P1|Overall Study|Lost to Follow-up|13
6009372|NCT00856206|20775525|P2|Overall Study|Withdrawal by Subject|36
6009373|NCT00856206|20775526|P1|Overall Study|Withdrawal by Subject|15
6009374|NCT00856206|20775525|P2|Overall Study|Lack of Efficacy|2
6009375|NCT00856206|20775526|P1|Overall Study|Lack of Efficacy|1
6009376|NCT00856206|20775525|P2|Overall Study|Adverse Event|46
6009377|NCT00856206|20775526|P1|Overall Study|Adverse Event|10
6009378|NCT00856206|20775525|P2|Overall Study|Protocol Violation|18
6009379|NCT00856206|20775526|P1|Overall Study|Protocol Violation|6
6009380|NCT00856193|20775540|P2|Period 2|Lost to Follow-up|1
6009381|NCT00856193|20775541|P1|Period 2|Lost to Follow-up|0
6009382|NCT00856193|20775540|P2|Period 2|Abnormal test procedure results|1
6009383|NCT00856193|20775541|P1|Period 2|Abnormal test procedure results|0
6009384|NCT00856180|20775553|P1|Overall Study|Progressive Disease|16
6009385|NCT00856180|20775553|P1|Overall Study|Adverse Event|4
6009386|NCT00855959|20775578|P1|Overall Study|Incorrect enrolment|1
6009387|NCT00855959|20775578|P1|Overall Study|Pregnancy|1
6009388|NCT00855959|20775578|P1|Overall Study|Withdrawal by Subject|3
6009389|NCT00855959|20775578|P1|Overall Study|Lost to Follow-up|2
6009390|NCT00855959|20775578|P1|Overall Study|Adverse Event|2
6009391|NCT00855933|20775595|P2|Overall Study|Withdrawal by Subject|1
6009392|NCT00855933|20775596|P1|Overall Study|Withdrawal by Subject|0
6009393|NCT00855920|20775605|P3|Overall Study|Other than specified above|1
6009394|NCT00855920|20775606|P2|Overall Study|Other than specified above|1
6009395|NCT00855920|20775607|P1|Overall Study|Other than specified above|1
6009396|NCT00855920|20775605|P3|Overall Study|Decision by the sponsor|1
6009397|NCT00855920|20775606|P2|Overall Study|Decision by the sponsor|1
6009398|NCT00855920|20775607|P1|Overall Study|Decision by the sponsor|0
6009399|NCT00855920|20775605|P3|Overall Study|Death|0
6009400|NCT00855920|20775606|P2|Overall Study|Death|1
6009401|NCT00855920|20775607|P1|Overall Study|Death|0
6009402|NCT00855920|20775605|P3|Overall Study|Lost to Follow-up|2
6009403|NCT00855920|20775606|P2|Overall Study|Lost to Follow-up|0
6009404|NCT00855920|20775607|P1|Overall Study|Lost to Follow-up|1
6009405|NCT00855920|20775605|P3|Overall Study|Withdrawal by Subject|2
6009406|NCT00855920|20775606|P2|Overall Study|Withdrawal by Subject|3
6009407|NCT00855920|20775607|P1|Overall Study|Withdrawal by Subject|2
6009408|NCT00855920|20775605|P3|Overall Study|Lack of Efficacy|2
6009409|NCT00855920|20775606|P2|Overall Study|Lack of Efficacy|2
6009410|NCT00855920|20775607|P1|Overall Study|Lack of Efficacy|2
6009411|NCT00855920|20775605|P3|Overall Study|Adverse Event|1
6009412|NCT00855920|20775606|P2|Overall Study|Adverse Event|1
6009413|NCT00855920|20775607|P1|Overall Study|Adverse Event|2
6009414|NCT00855920|20775605|P3|Overall Study|Protocol Violation|2
6009415|NCT00855920|20775606|P2|Overall Study|Protocol Violation|0
6009416|NCT00855920|20775607|P1|Overall Study|Protocol Violation|0
6009417|NCT00855894|20775624|P1|Overall Study|Disease progression|1
6009418|NCT00855894|20775624|P1|Overall Study|Patient's decision|1
6009419|NCT00855894|20775624|P1|Overall Study|Death|31
6009420|NCT00855816|20775647|P2|Overall Study|Became ineligible|1
6009421|NCT00855816|20775648|P1|Overall Study|Became ineligible|0
6009422|NCT00855816|20775647|P2|Overall Study|Death|0
6009423|NCT00855816|20775648|P1|Overall Study|Death|1
6009424|NCT00855816|20775647|P2|Overall Study|Lost to Follow-up|5
6009425|NCT00855816|20775648|P1|Overall Study|Lost to Follow-up|3
6009426|NCT00855816|20775647|P2|Overall Study|Withdrawal by Subject|15
6009427|NCT00855816|20775648|P1|Overall Study|Withdrawal by Subject|22
6009428|NCT00855738|20775654|P1|Overall Study|Death|1
6009429|NCT00855738|20775654|P1|Overall Study|Subject Defaulted|1
6009430|NCT00855738|20775654|P1|Overall Study|Adverse Event|1
6009431|NCT00855738|20775654|P1|Overall Study|Lost to Follow-up|2
6009432|NCT00855595|20775682|P2|Overall Study|patient left country|1
6009433|NCT00855595|20775683|P1|Overall Study|patient left country|0
6009434|NCT00855595|20775682|P2|Overall Study|patient moved out of state|0
6009435|NCT00855595|20775683|P1|Overall Study|patient moved out of state|1
6009436|NCT00855595|20775682|P2|Overall Study|Adverse Event|1
6009437|NCT00855595|20775683|P1|Overall Study|Adverse Event|1
6009438|NCT00855595|20775682|P2|Overall Study|Lost to Follow-up|3
6009439|NCT00855595|20775683|P1|Overall Study|Lost to Follow-up|3
6009440|NCT00855595|20775682|P2|Overall Study|Withdrawal by Subject|2
6009441|NCT00855595|20775683|P1|Overall Study|Withdrawal by Subject|1
6009442|NCT00855582|20775722|P3|Overall Study|Withdrawal by Subject|8
6009443|NCT00855582|20775723|P2|Overall Study|Withdrawal by Subject|4
6009444|NCT00855582|20775724|P1|Overall Study|Withdrawal by Subject|7
6009445|NCT00855582|20775722|P3|Overall Study|Entry Criteria Not Met|3
6009446|NCT00855582|20775723|P2|Overall Study|Entry Criteria Not Met|6
6009447|NCT00855582|20775724|P1|Overall Study|Entry Criteria Not Met|8
6009448|NCT00855582|20775722|P3|Overall Study|Protocol Violation|6
6009449|NCT00855582|20775723|P2|Overall Study|Protocol Violation|2
6009450|NCT00855582|20775724|P1|Overall Study|Protocol Violation|6
6009451|NCT00855582|20775722|P3|Overall Study|Physician Decision|1
6009452|NCT00855582|20775723|P2|Overall Study|Physician Decision|0
6009453|NCT00855582|20775724|P1|Overall Study|Physician Decision|0
6009454|NCT00855582|20775722|P3|Overall Study|Lost to Follow-up|1
6009455|NCT00855582|20775723|P2|Overall Study|Lost to Follow-up|3
6009456|NCT00855582|20775724|P1|Overall Study|Lost to Follow-up|1
6009457|NCT00855582|20775722|P3|Overall Study|Lack of Efficacy|8
6009458|NCT00855582|20775723|P2|Overall Study|Lack of Efficacy|3
6009459|NCT00855582|20775724|P1|Overall Study|Lack of Efficacy|1
6009460|NCT00855582|20775722|P3|Overall Study|Death|0
6009461|NCT00855582|20775723|P2|Overall Study|Death|0
6009462|NCT00855582|20775724|P1|Overall Study|Death|1
6009463|NCT00855582|20775722|P3|Overall Study|Adverse Event|3
6009464|NCT00855582|20775723|P2|Overall Study|Adverse Event|6
6009465|NCT00855582|20775724|P1|Overall Study|Adverse Event|2
6009466|NCT00855465|20775813|P2|Follow-up Period (FUP)|Missing|0
6009467|NCT00855465|20775814|P1|Follow-up Period (FUP)|Missing|1
6009468|NCT00855465|20775813|P2|Follow-up Period (FUP)|Withdrawal by Subject|0
6009469|NCT00855465|20775814|P1|Follow-up Period (FUP)|Withdrawal by Subject|4
6009470|NCT00855465|20775813|P2|Follow-up Period (FUP)|Lost to Follow-up|0
6009471|NCT00855465|20775814|P1|Follow-up Period (FUP)|Lost to Follow-up|3
6009472|NCT00855465|20775813|P2|Follow-up Period (FUP)|Death|1
6009473|NCT00855465|20775814|P1|Follow-up Period (FUP)|Death|0
6009474|NCT00855465|20775813|P2|Follow-up Period (FUP)|Adverse Event|1
6009475|NCT00855465|20775814|P1|Follow-up Period (FUP)|Adverse Event|0
6009476|NCT00855465|20775813|P2|Treatment Period|Not treated|0
6009477|NCT00855465|20775814|P1|Treatment Period|Not treated|1
6009478|NCT00855465|20775813|P2|Treatment Period|Withdrawal by Subject|0
6009479|NCT00855465|20775814|P1|Treatment Period|Withdrawal by Subject|2
6009480|NCT00855465|20775813|P2|Treatment Period|Protocol Violation|0
6009481|NCT00855465|20775814|P1|Treatment Period|Protocol Violation|2
6009482|NCT00855465|20775813|P2|Treatment Period|Non-compliance|0
6009483|NCT00855465|20775814|P1|Treatment Period|Non-compliance|1
6009484|NCT00855465|20775813|P2|Treatment Period|Lack of Efficacy|1
6009485|NCT00855465|20775814|P1|Treatment Period|Lack of Efficacy|2
6009486|NCT00855465|20775813|P2|Treatment Period|Death|2
6009487|NCT00855465|20775814|P1|Treatment Period|Death|2
6009488|NCT00855465|20775813|P2|Treatment Period|Adverse Event|2
6009489|NCT00855465|20775814|P1|Treatment Period|Adverse Event|4
6009490|NCT00855439|20775904|P2|Overall Study|Pregnancy|0
6009491|NCT00855439|20775905|P1|Overall Study|Pregnancy|1
6009492|NCT00855439|20775904|P2|Overall Study|Withdrawal by Subject|0
6009493|NCT00855439|20775905|P1|Overall Study|Withdrawal by Subject|2
6009494|NCT00855335|20775963|P5|Overall Study|Other|1
6009495|NCT00855335|20775964|P4|Overall Study|Other|5
6009496|NCT00855335|20775965|P3|Overall Study|Other|2
6009497|NCT00855335|20775966|P2|Overall Study|Other|1
6009498|NCT00855335|20775967|P1|Overall Study|Other|2
6009499|NCT00855335|20775963|P5|Overall Study|Physician Decision|0
6009500|NCT00855335|20775964|P4|Overall Study|Physician Decision|0
6009501|NCT00855335|20775965|P3|Overall Study|Physician Decision|0
6009502|NCT00855335|20775966|P2|Overall Study|Physician Decision|1
6009503|NCT00855335|20775967|P1|Overall Study|Physician Decision|1
6009504|NCT00855335|20775963|P5|Overall Study|Adverse Event|0
6009505|NCT00855335|20775964|P4|Overall Study|Adverse Event|0
6009506|NCT00855335|20775965|P3|Overall Study|Adverse Event|0
6009507|NCT00855335|20775966|P2|Overall Study|Adverse Event|0
6009508|NCT00855335|20775967|P1|Overall Study|Adverse Event|2
6009509|NCT00855335|20775963|P5|Overall Study|Withdrawal by Subject|0
6009510|NCT00855335|20775964|P4|Overall Study|Withdrawal by Subject|1
6009511|NCT00855335|20775965|P3|Overall Study|Withdrawal by Subject|0
6009512|NCT00855335|20775966|P2|Overall Study|Withdrawal by Subject|0
6009513|NCT00855335|20775967|P1|Overall Study|Withdrawal by Subject|0
6009514|NCT00855335|20775963|P5|Overall Study|Lost to Follow-up|0
6009515|NCT00855335|20775964|P4|Overall Study|Lost to Follow-up|1
6009516|NCT00855335|20775965|P3|Overall Study|Lost to Follow-up|3
6009517|NCT00855335|20775966|P2|Overall Study|Lost to Follow-up|0
6009518|NCT00855335|20775967|P1|Overall Study|Lost to Follow-up|0
6009519|NCT00855309|20776054|P2|Overall Study|patient never recieved drug|0
6009520|NCT00855309|20776055|P1|Overall Study|patient never recieved drug|1
6009521|NCT00855218|20776063|P2|Overall Study|Clinical endpoint reached|13
6009522|NCT00855218|20776064|P1|Overall Study|Clinical endpoint reached|10
6009523|NCT00855218|20776063|P2|Overall Study|Progression measurement proven|15
6009524|NCT00855218|20776064|P1|Overall Study|Progression measurement proven|7
6009525|NCT00855218|20776063|P2|Overall Study|Second malignancy|1
6009526|NCT00855218|20776064|P1|Overall Study|Second malignancy|0
6009527|NCT00855218|20776063|P2|Overall Study|Untreatable disease progression|67
6009528|NCT00855218|20776064|P1|Overall Study|Untreatable disease progression|54
6009529|NCT00855218|20776063|P2|Overall Study|Still treated with study medication|1
6009530|NCT00855218|20776064|P1|Overall Study|Still treated with study medication|0
6009531|NCT00855218|20776063|P2|Overall Study|technical problems|1
6009532|NCT00855218|20776064|P1|Overall Study|technical problems|2
6009533|NCT00855218|20776063|P2|Overall Study|patient convenience|0
6009534|NCT00855218|20776064|P1|Overall Study|patient convenience|2
6009535|NCT00855218|20776063|P2|Overall Study|non-compliant with study drug|1
6009536|NCT00855218|20776064|P1|Overall Study|non-compliant with study drug|3
6009537|NCT00855218|20776063|P2|Overall Study|Protocol Violation|9
6009538|NCT00855218|20776064|P1|Overall Study|Protocol Violation|5
6009539|NCT00855218|20776063|P2|Overall Study|Lost to Follow-up|1
6009540|NCT00855218|20776064|P1|Overall Study|Lost to Follow-up|0
6009541|NCT00855218|20776063|P2|Overall Study|Physician Decision|11
6009542|NCT00855218|20776064|P1|Overall Study|Physician Decision|18
6009543|NCT00855218|20776063|P2|Overall Study|Withdrawal by Subject|6
6009544|NCT00855218|20776064|P1|Overall Study|Withdrawal by Subject|10
6009545|NCT00855218|20776063|P2|Overall Study|Adverse Event|27
6009546|NCT00855218|20776064|P1|Overall Study|Adverse Event|43
6009547|NCT00855166|20776082|P2|Overall Study|Subject no longer meets study criteria|1
6009548|NCT00855166|20776083|P1|Overall Study|Subject no longer meets study criteria|1
6009549|NCT00855166|20776082|P2|Overall Study|Administrative reasons by sponsor|0
6009550|NCT00855166|20776083|P1|Overall Study|Administrative reasons by sponsor|1
6009551|NCT00855166|20776082|P2|Overall Study|Poor/non-compliance|0
6009552|NCT00855166|20776083|P1|Overall Study|Poor/non-compliance|2
6009553|NCT00855166|20776082|P2|Overall Study|Withdrawal by Subject|4
6009554|NCT00855166|20776083|P1|Overall Study|Withdrawal by Subject|1
6009555|NCT00855166|20776082|P2|Overall Study|Death|1
6009556|NCT00855166|20776083|P1|Overall Study|Death|0
6009557|NCT00855166|20776082|P2|Overall Study|Adverse Event|2
6009558|NCT00855166|20776083|P1|Overall Study|Adverse Event|0
6009559|NCT00855062|20776103|P2|Step2|Initiation of antiretroviral therapy/ART|1
6009560|NCT00855062|20776104|P1|Step2|Initiation of antiretroviral therapy/ART|0
6009561|NCT00855062|20776103|P2|Step2|Adverse Event|3
6009562|NCT00855062|20776104|P1|Step2|Adverse Event|0
6009563|NCT00855062|20776103|P2|Step2|Early Study Closure|2
6009564|NCT00855062|20776104|P1|Step2|Early Study Closure|6
6009565|NCT00855062|20776103|P2|Step1|Withdrawal by Subject|3
6009566|NCT00855062|20776104|P1|Step1|Withdrawal by Subject|2
6009567|NCT00855062|20776103|P2|Step1|Pregnancy|0
6009568|NCT00855062|20776104|P1|Step1|Pregnancy|1
6009569|NCT00855062|20776103|P2|Step1|Protocol Violation|0
6009570|NCT00855062|20776104|P1|Step1|Protocol Violation|1
6009571|NCT00855062|20776103|P2|Step1|Adverse Event|1
6009572|NCT00855062|20776104|P1|Step1|Adverse Event|1
6009573|NCT00855062|20776103|P2|Step1|Early Study Closure|7
6009574|NCT00855062|20776104|P1|Step1|Early Study Closure|5
6009575|NCT00854906|20776153|P1|Overall Study|One person had no ocular history|1
6009576|NCT00854724|20776162|P2|Second Intervention|Physician Decision|1
6009577|NCT00854724|20776163|P1|Second Intervention|Physician Decision|0
6009578|NCT00854724|20776162|P2|Second Intervention|Protocol Violation|0
6009579|NCT00854724|20776163|P1|Second Intervention|Protocol Violation|1
6009580|NCT00854724|20776162|P2|Washout|Withdrawal by Subject|1
6009581|NCT00854724|20776163|P1|Washout|Withdrawal by Subject|0
6009582|NCT00854724|20776162|P2|Washout|Protocol Violation|0
6009583|NCT00854724|20776163|P1|Washout|Protocol Violation|1
6009584|NCT00854724|20776162|P2|First Intervention|Withdrawal by Subject|1
6009585|NCT00854724|20776163|P1|First Intervention|Withdrawal by Subject|1
6009586|NCT00854620|20776169|P1|Overall Study|Adverse Event|1
6009587|NCT00854607|20776173|P1|2 Weeks After Start Anti-fungal Therapy|Diagnosed with Possible IA|65
6009588|NCT00854581|20776221|P1|Part 2 Maintenance (Up to 12 Months)|Lack of Efficacy|3
6009589|NCT00854581|20776221|P1|Induction (Up to Day 21)|Physician Decision|1
6009590|NCT00854581|20776221|P1|Induction (Up to Day 21)|Death|1
6009591|NCT00854581|20776221|P1|Induction (Up to Day 21)|Lack of Efficacy|4
6009592|NCT00854373|20776236|P2|Overall Study|Forgot to take study drug|1
6009593|NCT00854373|20776237|P1|Overall Study|Forgot to take study drug|1
6009594|NCT00854373|20776236|P2|Overall Study|Withdrawal by Subject|3
6009595|NCT00854373|20776237|P1|Overall Study|Withdrawal by Subject|1
6009596|NCT00854360|20776251|P4|Overall Study|Other|3
6009597|NCT00854360|20776252|P3|Overall Study|Other|0
6009598|NCT00854360|20776253|P2|Overall Study|Other|0
6009599|NCT00854360|20776254|P1|Overall Study|Other|0
6009600|NCT00854360|20776251|P4|Overall Study|Lack of Efficacy|0
6009601|NCT00854360|20776252|P3|Overall Study|Lack of Efficacy|0
6009602|NCT00854360|20776253|P2|Overall Study|Lack of Efficacy|1
6009603|NCT00854360|20776254|P1|Overall Study|Lack of Efficacy|2
6009604|NCT00854360|20776251|P4|Overall Study|Pregnancy|0
6009605|NCT00854360|20776252|P3|Overall Study|Pregnancy|0
6009606|NCT00854360|20776253|P2|Overall Study|Pregnancy|1
6009607|NCT00854360|20776254|P1|Overall Study|Pregnancy|0
6009608|NCT00854360|20776251|P4|Overall Study|Withdrawal by Subject|1
6009609|NCT00854360|20776252|P3|Overall Study|Withdrawal by Subject|0
6009610|NCT00854360|20776253|P2|Overall Study|Withdrawal by Subject|0
6009611|NCT00854360|20776254|P1|Overall Study|Withdrawal by Subject|0
6009612|NCT00854360|20776251|P4|Overall Study|Adverse Event|6
6009613|NCT00854360|20776252|P3|Overall Study|Adverse Event|2
6009614|NCT00854360|20776253|P2|Overall Study|Adverse Event|1
6009615|NCT00854360|20776254|P1|Overall Study|Adverse Event|0
6009616|NCT00854308|20776286|P2|Overall Study|Sponsor's decision to terminate study|1
6009617|NCT00854308|20776287|P1|Overall Study|Sponsor's decision to terminate study|0
6009618|NCT00854308|20776286|P2|Overall Study|Withdrawal by Subject|2
6009619|NCT00854308|20776287|P1|Overall Study|Withdrawal by Subject|4
6009620|NCT00854308|20776286|P2|Overall Study|Physician Decision|6
6009621|NCT00854308|20776287|P1|Overall Study|Physician Decision|6
6009622|NCT00854308|20776286|P2|Overall Study|Death|5
6009623|NCT00854308|20776287|P1|Overall Study|Death|2
6009624|NCT00854308|20776286|P2|Overall Study|Adverse Event|3
6009625|NCT00854308|20776287|P1|Overall Study|Adverse Event|8
6009626|NCT00854308|20776286|P2|Overall Study|Disease progression|50
6009627|NCT00854308|20776287|P1|Overall Study|Disease progression|42
6009628|NCT00854113|20776312|P11|Overall Study|Withdrawal by Subject|0
6009629|NCT00854113|20776313|P10|Overall Study|Withdrawal by Subject|0
6009630|NCT00854113|20776314|P9|Overall Study|Withdrawal by Subject|1
6009631|NCT00854113|20776315|P8|Overall Study|Withdrawal by Subject|1
6009632|NCT00854113|20776316|P7|Overall Study|Withdrawal by Subject|0
6009633|NCT00854113|20776317|P6|Overall Study|Withdrawal by Subject|0
6009634|NCT00854113|20776318|P5|Overall Study|Withdrawal by Subject|0
6009635|NCT00854113|20776319|P4|Overall Study|Withdrawal by Subject|0
6009636|NCT00854113|20776320|P3|Overall Study|Withdrawal by Subject|0
6009637|NCT00854113|20776321|P2|Overall Study|Withdrawal by Subject|0
6009638|NCT00854113|20776322|P1|Overall Study|Withdrawal by Subject|0
6009639|NCT00854113|20776312|P11|Overall Study|Adverse Event|0
6009640|NCT00854113|20776313|P10|Overall Study|Adverse Event|0
6009641|NCT00854113|20776314|P9|Overall Study|Adverse Event|0
6009642|NCT00854113|20776315|P8|Overall Study|Adverse Event|2
6009643|NCT00854113|20776316|P7|Overall Study|Adverse Event|0
6009644|NCT00854113|20776317|P6|Overall Study|Adverse Event|0
6009645|NCT00854113|20776318|P5|Overall Study|Adverse Event|0
6009646|NCT00854113|20776319|P4|Overall Study|Adverse Event|0
6009647|NCT00854113|20776320|P3|Overall Study|Adverse Event|0
6009648|NCT00854113|20776321|P2|Overall Study|Adverse Event|0
6009649|NCT00854113|20776322|P1|Overall Study|Adverse Event|0
6009650|NCT00854100|20776426|P3|Overall Study|Adverse Event|2
6009651|NCT00854100|20776427|P2|Overall Study|Adverse Event|1
6009652|NCT00854100|20776428|P1|Overall Study|Adverse Event|2
6009653|NCT00854100|20776426|P3|Overall Study|Protocol Violation|3
6009654|NCT00854100|20776427|P2|Overall Study|Protocol Violation|4
6009655|NCT00854100|20776428|P1|Overall Study|Protocol Violation|2
6009656|NCT00854100|20776426|P3|Overall Study|Withdrawal by Subject|2
6009657|NCT00854100|20776427|P2|Overall Study|Withdrawal by Subject|1
6009658|NCT00854100|20776428|P1|Overall Study|Withdrawal by Subject|3
6009659|NCT00854100|20776426|P3|Overall Study|Lost to Follow-up|3
6009660|NCT00854100|20776427|P2|Overall Study|Lost to Follow-up|0
6009661|NCT00854100|20776428|P1|Overall Study|Lost to Follow-up|2
6009662|NCT00854100|20776426|P3|Overall Study|Inability to complete the study visits|1
6009663|NCT00854100|20776427|P2|Overall Study|Inability to complete the study visits|0
6009664|NCT00854100|20776428|P1|Overall Study|Inability to complete the study visits|0
6009665|NCT00853970|20776467|P2|Overall Study|Cancelled surgery|2
6009666|NCT00853970|20776468|P1|Overall Study|Cancelled surgery|4
6009667|NCT00853970|20776467|P2|Overall Study|Withdrawal by Subject|1
6009668|NCT00853970|20776468|P1|Overall Study|Withdrawal by Subject|2
6009669|NCT00853957|20776478|P2|Overall Study|Protocol deviation|3
6009670|NCT00853957|20776479|P1|Overall Study|Protocol deviation|0
6009671|NCT00853957|20776478|P2|Overall Study|Lost to Follow-up|6
6009672|NCT00853957|20776479|P1|Overall Study|Lost to Follow-up|1
6009673|NCT00853957|20776478|P2|Overall Study|Subject withdrew consent|5
6009674|NCT00853957|20776479|P1|Overall Study|Subject withdrew consent|4
6009675|NCT00853957|20776478|P2|Overall Study|Unsatisfactory therapeutic effect|2
6009676|NCT00853957|20776479|P1|Overall Study|Unsatisfactory therapeutic effect|0
6009677|NCT00853957|20776478|P2|Overall Study|Adverse Event|3
6009678|NCT00853957|20776479|P1|Overall Study|Adverse Event|9
6009679|NCT00853905|20776497|P2|Overall Study|never had surgery|0
6009680|NCT00853905|20776498|P1|Overall Study|never had surgery|1
6009681|NCT00853905|20776497|P2|Overall Study|Withdrawal by Subject|1
6009682|NCT00853905|20776498|P1|Overall Study|Withdrawal by Subject|0
6009683|NCT00853905|20776497|P2|Overall Study|Lost to Follow-up|3
6009684|NCT00853905|20776498|P1|Overall Study|Lost to Follow-up|1
6009685|NCT00853827|20776530|P2|Double Blind Period (103 Weeks)|Death|6
6009686|NCT00853827|20776531|P1|Double Blind Period (103 Weeks)|Death|1
6009687|NCT00853827|20776530|P2|Double Blind Period (103 Weeks)|Administrative problems|56
6009688|NCT00853827|20776531|P1|Double Blind Period (103 Weeks)|Administrative problems|45
6009689|NCT00853827|20776530|P2|Double Blind Period (103 Weeks)|Lost to Follow-up|10
6009690|NCT00853827|20776531|P1|Double Blind Period (103 Weeks)|Lost to Follow-up|8
6009691|NCT00853827|20776530|P2|Double Blind Period (103 Weeks)|Withdrawal by Subject|18
6009692|NCT00853827|20776531|P1|Double Blind Period (103 Weeks)|Withdrawal by Subject|19
6009693|NCT00853827|20776530|P2|Double Blind Period (103 Weeks)|Protocol Violation|1
6009694|NCT00853827|20776531|P1|Double Blind Period (103 Weeks)|Protocol Violation|2
6009695|NCT00853827|20776530|P2|Double Blind Period (103 Weeks)|Patient's no longer requires study drug|1
6009696|NCT00853827|20776531|P1|Double Blind Period (103 Weeks)|Patient's no longer requires study drug|3
6009697|NCT00853827|20776530|P2|Double Blind Period (103 Weeks)|Lack of Efficacy|0
6009698|NCT00853827|20776531|P1|Double Blind Period (103 Weeks)|Lack of Efficacy|1
6009699|NCT00853827|20776530|P2|Double Blind Period (103 Weeks)|Abnormal laboratory values|3
6009700|NCT00853827|20776531|P1|Double Blind Period (103 Weeks)|Abnormal laboratory values|0
6009701|NCT00853827|20776530|P2|Double Blind Period (103 Weeks)|Adverse Event|14
6009702|NCT00853827|20776531|P1|Double Blind Period (103 Weeks)|Adverse Event|25
6009703|NCT00853827|20776530|P2|Single Blind Period (1 Week)|Protocol Violation|0
6009704|NCT00853827|20776531|P1|Single Blind Period (1 Week)|Protocol Violation|12
6009705|NCT00853827|20776530|P2|Single Blind Period (1 Week)|Lost to Follow-up|0
6009706|NCT00853827|20776531|P1|Single Blind Period (1 Week)|Lost to Follow-up|1
6009707|NCT00853827|20776530|P2|Single Blind Period (1 Week)|Withdrawal by Subject|0
6009708|NCT00853827|20776531|P1|Single Blind Period (1 Week)|Withdrawal by Subject|9
6009709|NCT00853827|20776530|P2|Single Blind Period (1 Week)|Abnormal test procedure result|0
6009710|NCT00853827|20776531|P1|Single Blind Period (1 Week)|Abnormal test procedure result|1
6009711|NCT00853827|20776530|P2|Single Blind Period (1 Week)|Abnormal laboratory value|0
6009712|NCT00853827|20776531|P1|Single Blind Period (1 Week)|Abnormal laboratory value|3
6009713|NCT00853827|20776530|P2|Single Blind Period (1 Week)|Adverse Event|0
6009714|NCT00853827|20776531|P1|Single Blind Period (1 Week)|Adverse Event|9
6009715|NCT00853827|20776530|P2|Single Blind Period (1 Week)|Other|0
6009716|NCT00853827|20776531|P1|Single Blind Period (1 Week)|Other|4
6009717|NCT00853762|20776547|P4|Overall Study|Randomised but not Treated|0
6009718|NCT00853762|20776548|P3|Overall Study|Randomised but not Treated|2
6009719|NCT00853762|20776549|P2|Overall Study|Randomised but not Treated|2
6009720|NCT00853762|20776550|P1|Overall Study|Randomised but not Treated|0
6009721|NCT00853762|20776547|P4|Overall Study|Other|0
6009722|NCT00853762|20776548|P3|Overall Study|Other|0
6009723|NCT00853762|20776549|P2|Overall Study|Other|2
6009724|NCT00853762|20776550|P1|Overall Study|Other|0
6009725|NCT00853762|20776547|P4|Overall Study|Withdrawal by Subject|0
6009726|NCT00853762|20776548|P3|Overall Study|Withdrawal by Subject|1
6009727|NCT00853762|20776549|P2|Overall Study|Withdrawal by Subject|0
6009728|NCT00853762|20776550|P1|Overall Study|Withdrawal by Subject|0
6009729|NCT00853762|20776547|P4|Overall Study|Protocol Violation|1
6009730|NCT00853762|20776548|P3|Overall Study|Protocol Violation|0
6009731|NCT00853762|20776549|P2|Overall Study|Protocol Violation|0
6009732|NCT00853762|20776550|P1|Overall Study|Protocol Violation|0
6009733|NCT00853762|20776547|P4|Overall Study|Premature Termination|21
6009734|NCT00853762|20776548|P3|Overall Study|Premature Termination|14
6009735|NCT00853762|20776549|P2|Overall Study|Premature Termination|15
6009736|NCT00853762|20776550|P1|Overall Study|Premature Termination|16
6009737|NCT00853749|20776618|P2|Overall Study|Lost to Follow-up|1
6009738|NCT00853749|20776619|P1|Overall Study|Lost to Follow-up|0
6009739|NCT00853723|20776640|P3|Overall Study|Protocol Violation|1
6009740|NCT00853723|20776641|P2|Overall Study|Protocol Violation|2
6009741|NCT00853723|20776642|P1|Overall Study|Protocol Violation|1
6009742|NCT00853723|20776640|P3|Overall Study|Withdrawal by Subject|0
6009743|NCT00853723|20776641|P2|Overall Study|Withdrawal by Subject|1
6009744|NCT00853723|20776642|P1|Overall Study|Withdrawal by Subject|2
6009745|NCT00853723|20776640|P3|Overall Study|Adverse Event|1
6009746|NCT00853723|20776641|P2|Overall Study|Adverse Event|4
6009747|NCT00853723|20776642|P1|Overall Study|Adverse Event|3
6009748|NCT00853658|20776696|P3|Overall Study|Missing study completion information|6
6009749|NCT00853658|20776697|P2|Overall Study|Missing study completion information|4
6009750|NCT00853658|20776698|P1|Overall Study|Missing study completion information|5
6009751|NCT00853658|20776696|P3|Overall Study|Patient's request|11
6009752|NCT00853658|20776697|P2|Overall Study|Patient's request|17
6009753|NCT00853658|20776698|P1|Overall Study|Patient's request|21
6009754|NCT00853658|20776696|P3|Overall Study|Vital Status at study end N/A|10
6009755|NCT00853658|20776697|P2|Overall Study|Vital Status at study end N/A|10
6009756|NCT00853658|20776698|P1|Overall Study|Vital Status at study end N/A|8
6009757|NCT00853658|20776696|P3|Overall Study|Vital Status unknown at study end|0
6009758|NCT00853658|20776697|P2|Overall Study|Vital Status unknown at study end|1
6009759|NCT00853658|20776698|P1|Overall Study|Vital Status unknown at study end|1
6009760|NCT00853658|20776696|P3|Overall Study|Vital Status known (alive) at study end|3
6009761|NCT00853658|20776697|P2|Overall Study|Vital Status known (alive) at study end|3
6009762|NCT00853658|20776698|P1|Overall Study|Vital Status known (alive) at study end|2
6009763|NCT00853658|20776696|P3|Overall Study|IRB request|2
6009764|NCT00853658|20776697|P2|Overall Study|IRB request|0
6009765|NCT00853658|20776698|P1|Overall Study|IRB request|0
6009766|NCT00853658|20776696|P3|Overall Study|H.A. Request|19
6009767|NCT00853658|20776697|P2|Overall Study|H.A. Request|23
6009768|NCT00853658|20776698|P1|Overall Study|H.A. Request|26
6009769|NCT00853658|20776696|P3|Overall Study|Lost to Follow-up|11
6009770|NCT00853658|20776697|P2|Overall Study|Lost to Follow-up|6
6009771|NCT00853658|20776698|P1|Overall Study|Lost to Follow-up|11
6009772|NCT00853658|20776696|P3|Overall Study|Death|753
6009773|NCT00853658|20776697|P2|Overall Study|Death|768
6009774|NCT00853658|20776698|P1|Overall Study|Death|713
6009775|NCT00853593|20776718|P1|Overall Study|Implant not attempted|4
6009776|NCT00853593|20776718|P1|Overall Study|Model 4396 lead not attempted|29
6009777|NCT00853593|20776718|P1|Overall Study|Subjects did not receive a 4396 lead|12
6009778|NCT00853580|20776745|P2|Overall Study|Commenced contraindicated therapy|2
6009779|NCT00853580|20776746|P1|Overall Study|Commenced contraindicated therapy|0
6009780|NCT00853580|20776745|P2|Overall Study|Withdrawal by Subject|8
6009781|NCT00853580|20776746|P1|Overall Study|Withdrawal by Subject|2
6009782|NCT00853580|20776745|P2|Overall Study|Protocol Violation|1
6009783|NCT00853580|20776746|P1|Overall Study|Protocol Violation|2
6009784|NCT00853580|20776745|P2|Overall Study|Lost to Follow-up|5
6009785|NCT00853580|20776746|P1|Overall Study|Lost to Follow-up|3
6009786|NCT00853567|20776793|P1|Overall Study|Study prematurely terminated|71
6009787|NCT00853489|20776803|P2|Overall Study|Lost to Follow-up|2
6009788|NCT00853489|20776804|P1|Overall Study|Lost to Follow-up|5
6009789|NCT00853385|20776819|P5|Overall Study|Other|12
6009790|NCT00853385|20776820|P4|Overall Study|Other|4
6009791|NCT00853385|20776821|P3|Overall Study|Other|4
6009792|NCT00853385|20776822|P2|Overall Study|Other|9
6009793|NCT00853385|20776823|P1|Overall Study|Other|18
6009794|NCT00853385|20776819|P5|Overall Study|Withdrawal by Subject|1
6009795|NCT00853385|20776820|P4|Overall Study|Withdrawal by Subject|1
6009796|NCT00853385|20776821|P3|Overall Study|Withdrawal by Subject|0
6009797|NCT00853385|20776822|P2|Overall Study|Withdrawal by Subject|2
6009798|NCT00853385|20776823|P1|Overall Study|Withdrawal by Subject|4
6009799|NCT00853385|20776819|P5|Overall Study|Lost to Follow-up|0
6009800|NCT00853385|20776820|P4|Overall Study|Lost to Follow-up|0
6009801|NCT00853385|20776821|P3|Overall Study|Lost to Follow-up|0
6009802|NCT00853385|20776822|P2|Overall Study|Lost to Follow-up|1
6009803|NCT00853385|20776823|P1|Overall Study|Lost to Follow-up|2
6009804|NCT00853385|20776819|P5|Overall Study|Lack of Efficacy|6
6009805|NCT00853385|20776820|P4|Overall Study|Lack of Efficacy|3
6009806|NCT00853385|20776821|P3|Overall Study|Lack of Efficacy|3
6009807|NCT00853385|20776822|P2|Overall Study|Lack of Efficacy|7
6009808|NCT00853385|20776823|P1|Overall Study|Lack of Efficacy|6
6009809|NCT00853385|20776819|P5|Overall Study|Adverse Event|22
6009810|NCT00853385|20776820|P4|Overall Study|Adverse Event|5
6009811|NCT00853385|20776821|P3|Overall Study|Adverse Event|2
6009812|NCT00853385|20776822|P2|Overall Study|Adverse Event|24
6009813|NCT00853385|20776823|P1|Overall Study|Adverse Event|24
6009814|NCT00853385|20776819|P5|Overall Study|Death|1
6009815|NCT00853385|20776820|P4|Overall Study|Death|0
6009816|NCT00853385|20776821|P3|Overall Study|Death|0
6009817|NCT00853385|20776822|P2|Overall Study|Death|0
6009818|NCT00853385|20776823|P1|Overall Study|Death|0
6009819|NCT00853372|20777038|P2|Overall Study|Full Consent Withdrawn|1
6009820|NCT00853372|20777039|P1|Overall Study|Full Consent Withdrawn|1
6009821|NCT00853372|20777038|P2|Overall Study|Lost to Follow-up|2
6009822|NCT00853372|20777039|P1|Overall Study|Lost to Follow-up|1
6009823|NCT00853372|20777038|P2|Overall Study|Death|26
6009824|NCT00853372|20777039|P1|Overall Study|Death|30
6009825|NCT00853307|20777088|P2|Overall Study|Reason Not Specified|1
6009826|NCT00853307|20777089|P1|Overall Study|Reason Not Specified|0
6009827|NCT00853307|20777088|P2|Overall Study|Withdrawal by Subject|2
6009828|NCT00853307|20777089|P1|Overall Study|Withdrawal by Subject|1
6009829|NCT00853307|20777088|P2|Overall Study|Adverse Event|2
6009830|NCT00853307|20777089|P1|Overall Study|Adverse Event|1
6009831|NCT00853242|20777116|P7|Overall Study|Other|2
6009832|NCT00853242|20777117|P6|Overall Study|Other|1
6009833|NCT00853242|20777118|P5|Overall Study|Other|0
6009834|NCT00853242|20777119|P4|Overall Study|Other|0
6009835|NCT00853242|20777120|P3|Overall Study|Other|2
6009836|NCT00853242|20777121|P2|Overall Study|Other|0
6009837|NCT00853242|20777122|P1|Overall Study|Other|2
6009838|NCT00853242|20777116|P7|Overall Study|Withdrawal by Subject|2
6009839|NCT00853242|20777117|P6|Overall Study|Withdrawal by Subject|0
6009840|NCT00853242|20777118|P5|Overall Study|Withdrawal by Subject|0
6009841|NCT00853242|20777119|P4|Overall Study|Withdrawal by Subject|4
6009842|NCT00853242|20777120|P3|Overall Study|Withdrawal by Subject|0
6009843|NCT00853242|20777121|P2|Overall Study|Withdrawal by Subject|2
6009844|NCT00853242|20777122|P1|Overall Study|Withdrawal by Subject|1
6009845|NCT00853242|20777116|P7|Overall Study|Noncompliant|0
6009846|NCT00853242|20777117|P6|Overall Study|Noncompliant|0
6009847|NCT00853242|20777118|P5|Overall Study|Noncompliant|1
6009848|NCT00853242|20777119|P4|Overall Study|Noncompliant|0
6009849|NCT00853242|20777120|P3|Overall Study|Noncompliant|0
6009850|NCT00853242|20777121|P2|Overall Study|Noncompliant|0
6009851|NCT00853242|20777122|P1|Overall Study|Noncompliant|0
6009852|NCT00853242|20777116|P7|Overall Study|Adverse Event|1
6009853|NCT00853242|20777117|P6|Overall Study|Adverse Event|1
6009854|NCT00853242|20777118|P5|Overall Study|Adverse Event|3
6009855|NCT00853242|20777119|P4|Overall Study|Adverse Event|0
6009856|NCT00853242|20777120|P3|Overall Study|Adverse Event|1
6009857|NCT00853242|20777121|P2|Overall Study|Adverse Event|1
6009858|NCT00853242|20777122|P1|Overall Study|Adverse Event|0
6009859|NCT00853229|20777164|P2|Phase 1: Initial Intervention|Early study termination, poor enrollment|8
6009860|NCT00853229|20777165|P1|Phase 1: Initial Intervention|Early study termination, poor enrollment|8
6009861|NCT00853151|20777175|P4|Overall Study|Sponsor Decision|0
6009862|NCT00853151|20777176|P3|Overall Study|Sponsor Decision|0
6009863|NCT00853151|20777177|P2|Overall Study|Sponsor Decision|3
6009864|NCT00853151|20777178|P1|Overall Study|Sponsor Decision|0
6009865|NCT00853151|20777175|P4|Overall Study|Physician Decision|0
6009866|NCT00853151|20777176|P3|Overall Study|Physician Decision|1
6009867|NCT00853151|20777177|P2|Overall Study|Physician Decision|2
6009868|NCT00853151|20777178|P1|Overall Study|Physician Decision|0
6009869|NCT00853151|20777175|P4|Overall Study|Withdrawal by Subject|1
6009870|NCT00853151|20777176|P3|Overall Study|Withdrawal by Subject|2
6009871|NCT00853151|20777177|P2|Overall Study|Withdrawal by Subject|4
6009872|NCT00853151|20777178|P1|Overall Study|Withdrawal by Subject|5
6009873|NCT00853151|20777175|P4|Overall Study|Protocol Violation|1
6009874|NCT00853151|20777176|P3|Overall Study|Protocol Violation|0
6009875|NCT00853151|20777177|P2|Overall Study|Protocol Violation|0
6009876|NCT00853151|20777178|P1|Overall Study|Protocol Violation|0
6009877|NCT00853151|20777175|P4|Overall Study|Death|1
6009878|NCT00853151|20777176|P3|Overall Study|Death|0
6009879|NCT00853151|20777177|P2|Overall Study|Death|0
6009880|NCT00853151|20777178|P1|Overall Study|Death|1
6009881|NCT00853151|20777175|P4|Overall Study|Lost to Follow-up|0
6009882|NCT00853151|20777176|P3|Overall Study|Lost to Follow-up|3
6009883|NCT00853151|20777177|P2|Overall Study|Lost to Follow-up|0
6009884|NCT00853151|20777178|P1|Overall Study|Lost to Follow-up|2
6009885|NCT00853151|20777175|P4|Overall Study|Inclusion/Exclusion Criteria Not Met|0
6009886|NCT00853151|20777176|P3|Overall Study|Inclusion/Exclusion Criteria Not Met|0
6009887|NCT00853151|20777177|P2|Overall Study|Inclusion/Exclusion Criteria Not Met|0
6009888|NCT00853151|20777178|P1|Overall Study|Inclusion/Exclusion Criteria Not Met|1
6009889|NCT00853151|20777175|P4|Overall Study|Adverse Event|0
6009890|NCT00853151|20777176|P3|Overall Study|Adverse Event|2
6009891|NCT00853151|20777177|P2|Overall Study|Adverse Event|4
6009892|NCT00853151|20777178|P1|Overall Study|Adverse Event|1
6009893|NCT00853125|20777320|P1|Overall Study|Study participant's donor was CMV +|1
6009894|NCT00853112|20777332|P7|Overall Study|Randomized but not treated|1
6009895|NCT00853112|20777333|P6|Overall Study|Randomized but not treated|0
6009896|NCT00853112|20777334|P5|Overall Study|Randomized but not treated|0
6009897|NCT00853112|20777335|P4|Overall Study|Randomized but not treated|2
6009898|NCT00853112|20777336|P3|Overall Study|Randomized but not treated|0
6009899|NCT00853112|20777337|P2|Overall Study|Randomized but not treated|1
6009900|NCT00853112|20777338|P1|Overall Study|Randomized but not treated|0
6009901|NCT00853099|20777448|P4|Double-blind + Open-label Periods|Other|6
6009902|NCT00853099|20777449|P3|Double-blind + Open-label Periods|Other|0
6009903|NCT00853099|20777450|P2|Double-blind + Open-label Periods|Other|0
6009904|NCT00853099|20777451|P1|Double-blind + Open-label Periods|Other|0
6009905|NCT00853099|20777448|P4|Double-blind + Open-label Periods|Withdrawal by Subject|20
6009906|NCT00853099|20777449|P3|Double-blind + Open-label Periods|Withdrawal by Subject|0
6009907|NCT00853099|20777450|P2|Double-blind + Open-label Periods|Withdrawal by Subject|0
6009908|NCT00853099|20777451|P1|Double-blind + Open-label Periods|Withdrawal by Subject|0
6009909|NCT00853099|20777448|P4|Double-blind + Open-label Periods|Adverse Event|47
6009910|NCT00853099|20777449|P3|Double-blind + Open-label Periods|Adverse Event|0
6009911|NCT00853099|20777450|P2|Double-blind + Open-label Periods|Adverse Event|0
6009912|NCT00853099|20777451|P1|Double-blind + Open-label Periods|Adverse Event|0
6009913|NCT00853099|20777448|P4|Double-blind + Open-label Periods|Lack of Efficacy|74
6009914|NCT00853099|20777449|P3|Double-blind + Open-label Periods|Lack of Efficacy|0
6009915|NCT00853099|20777450|P2|Double-blind + Open-label Periods|Lack of Efficacy|0
6009916|NCT00853099|20777451|P1|Double-blind + Open-label Periods|Lack of Efficacy|0
6009917|NCT00853099|20777448|P4|Double-blind Period|Mistreated with rescue study drug|0
6009918|NCT00853099|20777449|P3|Double-blind Period|Mistreated with rescue study drug|1
6009919|NCT00853099|20777450|P2|Double-blind Period|Mistreated with rescue study drug|0
6009920|NCT00853099|20777451|P1|Double-blind Period|Mistreated with rescue study drug|0
6009921|NCT00853099|20777448|P4|Double-blind Period|Other|0
6009922|NCT00853099|20777449|P3|Double-blind Period|Other|1
6009923|NCT00853099|20777450|P2|Double-blind Period|Other|0
6009924|NCT00853099|20777451|P1|Double-blind Period|Other|0
6009925|NCT00853099|20777448|P4|Double-blind Period|Lack of Efficacy|0
6009926|NCT00853099|20777449|P3|Double-blind Period|Lack of Efficacy|16
6009927|NCT00853099|20777450|P2|Double-blind Period|Lack of Efficacy|17
6009928|NCT00853099|20777451|P1|Double-blind Period|Lack of Efficacy|14
6009929|NCT00853099|20777448|P4|Double-blind Period|Withdrawal by Subject|0
6009930|NCT00853099|20777449|P3|Double-blind Period|Withdrawal by Subject|0
6009931|NCT00853099|20777450|P2|Double-blind Period|Withdrawal by Subject|3
6009932|NCT00853099|20777451|P1|Double-blind Period|Withdrawal by Subject|2
6009933|NCT00853099|20777448|P4|Double-blind Period|Adverse Event|0
6009934|NCT00853099|20777449|P3|Double-blind Period|Adverse Event|13
6009935|NCT00853099|20777450|P2|Double-blind Period|Adverse Event|9
6009936|NCT00853099|20777451|P1|Double-blind Period|Adverse Event|7
6009937|NCT00853073|20777493|P2|Overall Study|Withdrawal by Subject|2
6009938|NCT00853073|20777494|P1|Overall Study|Withdrawal by Subject|3
6009939|NCT00853047|20777507|P6|Open-Label Extension Phase|Reason Not Specified|6
6009940|NCT00853047|20777508|P5|Open-Label Extension Phase|Reason Not Specified|0
6009941|NCT00853047|20777509|P4|Open-Label Extension Phase|Reason Not Specified|0
6009942|NCT00853047|20777510|P3|Open-Label Extension Phase|Reason Not Specified|0
6009943|NCT00853047|20777511|P2|Open-Label Extension Phase|Reason Not Specified|0
6009944|NCT00853047|20777512|P1|Open-Label Extension Phase|Reason Not Specified|0
6009945|NCT00853047|20777507|P6|Open-Label Extension Phase|Investigator Decision|1
6009946|NCT00853047|20777508|P5|Open-Label Extension Phase|Investigator Decision|0
6009947|NCT00853047|20777509|P4|Open-Label Extension Phase|Investigator Decision|0
6009948|NCT00853047|20777510|P3|Open-Label Extension Phase|Investigator Decision|0
6009949|NCT00853047|20777511|P2|Open-Label Extension Phase|Investigator Decision|0
6009950|NCT00853047|20777512|P1|Open-Label Extension Phase|Investigator Decision|0
6009951|NCT00853047|20777507|P6|Open-Label Extension Phase|Transfer to LX1606-302|2
6009952|NCT00853047|20777508|P5|Open-Label Extension Phase|Transfer to LX1606-302|0
6009953|NCT00853047|20777509|P4|Open-Label Extension Phase|Transfer to LX1606-302|0
6009954|NCT00853047|20777510|P3|Open-Label Extension Phase|Transfer to LX1606-302|0
6009955|NCT00853047|20777511|P2|Open-Label Extension Phase|Transfer to LX1606-302|0
6009956|NCT00853047|20777512|P1|Open-Label Extension Phase|Transfer to LX1606-302|0
6009957|NCT00853047|20777507|P6|Open-Label Extension Phase|Lost to Follow-up|1
6009958|NCT00853047|20777508|P5|Open-Label Extension Phase|Lost to Follow-up|0
6009959|NCT00853047|20777509|P4|Open-Label Extension Phase|Lost to Follow-up|0
6009960|NCT00853047|20777510|P3|Open-Label Extension Phase|Lost to Follow-up|0
6009961|NCT00853047|20777511|P2|Open-Label Extension Phase|Lost to Follow-up|0
6009962|NCT00853047|20777512|P1|Open-Label Extension Phase|Lost to Follow-up|0
6009963|NCT00853047|20777507|P6|Open-Label Extension Phase|Participant Request|7
6009964|NCT00853047|20777508|P5|Open-Label Extension Phase|Participant Request|0
6009965|NCT00853047|20777509|P4|Open-Label Extension Phase|Participant Request|0
6009966|NCT00853047|20777510|P3|Open-Label Extension Phase|Participant Request|0
6009967|NCT00853047|20777511|P2|Open-Label Extension Phase|Participant Request|0
6009968|NCT00853047|20777512|P1|Open-Label Extension Phase|Participant Request|0
6009969|NCT00853047|20777507|P6|Core Phase|Participant Request|0
6009970|NCT00853047|20777508|P5|Core Phase|Participant Request|0
6009971|NCT00853047|20777509|P4|Core Phase|Participant Request|1
6009972|NCT00853047|20777510|P3|Core Phase|Participant Request|0
6009973|NCT00853047|20777511|P2|Core Phase|Participant Request|0
6009974|NCT00853047|20777512|P1|Core Phase|Participant Request|0
6009975|NCT00853021|20777578|P1|Overall Study|Death|1
6009976|NCT00853021|20777578|P1|Overall Study|Withdrawal by Subject|2
6009977|NCT00853021|20777578|P1|Overall Study|Adverse Event|2
6009978|NCT00852995|20777590|P5|Overall Study|Moved Out of Area|0
6009979|NCT00852995|20777591|P4|Overall Study|Moved Out of Area|0
6009980|NCT00852995|20777592|P3|Overall Study|Moved Out of Area|0
6009981|NCT00852995|20777593|P2|Overall Study|Moved Out of Area|0
6009982|NCT00852995|20777594|P1|Overall Study|Moved Out of Area|1
6009983|NCT00852995|20777590|P5|Overall Study|Protocol Violation|1
6009984|NCT00852995|20777591|P4|Overall Study|Protocol Violation|0
6009985|NCT00852995|20777592|P3|Overall Study|Protocol Violation|0
6009986|NCT00852995|20777593|P2|Overall Study|Protocol Violation|0
6009987|NCT00852995|20777594|P1|Overall Study|Protocol Violation|0
6009988|NCT00852995|20777590|P5|Overall Study|Physician Decision|0
6009989|NCT00852995|20777591|P4|Overall Study|Physician Decision|0
6009990|NCT00852995|20777592|P3|Overall Study|Physician Decision|0
6009991|NCT00852995|20777593|P2|Overall Study|Physician Decision|0
6009992|NCT00852995|20777594|P1|Overall Study|Physician Decision|1
6009993|NCT00852995|20777590|P5|Overall Study|Progressive Disease|1
6009994|NCT00852995|20777591|P4|Overall Study|Progressive Disease|2
6009995|NCT00852995|20777592|P3|Overall Study|Progressive Disease|0
6009996|NCT00852995|20777593|P2|Overall Study|Progressive Disease|0
6009997|NCT00852995|20777594|P1|Overall Study|Progressive Disease|1
6009998|NCT00852995|20777590|P5|Overall Study|Non-Compliance|0
6009999|NCT00852995|20777591|P4|Overall Study|Non-Compliance|2
6010000|NCT00852995|20777592|P3|Overall Study|Non-Compliance|0
6010001|NCT00852995|20777593|P2|Overall Study|Non-Compliance|0
6010002|NCT00852995|20777594|P1|Overall Study|Non-Compliance|0
6010003|NCT00852995|20777590|P5|Overall Study|Withdrawal by Subject|2
6010004|NCT00852995|20777591|P4|Overall Study|Withdrawal by Subject|1
6010005|NCT00852995|20777592|P3|Overall Study|Withdrawal by Subject|0
6010006|NCT00852995|20777593|P2|Overall Study|Withdrawal by Subject|0
6010007|NCT00852995|20777594|P1|Overall Study|Withdrawal by Subject|4
6010008|NCT00852995|20777590|P5|Overall Study|Lost to Follow-up|0
6010009|NCT00852995|20777591|P4|Overall Study|Lost to Follow-up|0
6010010|NCT00852995|20777592|P3|Overall Study|Lost to Follow-up|1
6010011|NCT00852995|20777593|P2|Overall Study|Lost to Follow-up|1
6010012|NCT00852995|20777594|P1|Overall Study|Lost to Follow-up|0
6010013|NCT00852995|20777590|P5|Overall Study|Adverse Event|0
6010014|NCT00852995|20777591|P4|Overall Study|Adverse Event|0
6010015|NCT00852995|20777592|P3|Overall Study|Adverse Event|4
6010016|NCT00852995|20777593|P2|Overall Study|Adverse Event|0
6010017|NCT00852995|20777594|P1|Overall Study|Adverse Event|1
6010018|NCT00852969|20777638|P2|Overall Study|Lost to Follow-up|1
6010019|NCT00852969|20777639|P1|Overall Study|Lost to Follow-up|0
6010020|NCT00852969|20777638|P2|Overall Study|Adverse Event|1
6010021|NCT00852969|20777639|P1|Overall Study|Adverse Event|0
6010022|NCT00852930|20777650|P3|Overall Study|Physician Decision|1
6010023|NCT00852930|20777651|P2|Overall Study|Physician Decision|0
6010024|NCT00852930|20777652|P1|Overall Study|Physician Decision|0
6010025|NCT00852930|20777650|P3|Overall Study|Withdrawal by Subject|1
6010026|NCT00852930|20777651|P2|Overall Study|Withdrawal by Subject|1
6010027|NCT00852930|20777652|P1|Overall Study|Withdrawal by Subject|1
6010028|NCT00852917|20777673|P4|Overall Study|Death|1
6010029|NCT00852917|20777674|P3|Overall Study|Death|0
6010030|NCT00852917|20777675|P2|Overall Study|Death|0
6010031|NCT00852917|20777676|P1|Overall Study|Death|0
6010032|NCT00852917|20777673|P4|Overall Study|Physician Decision|19
6010033|NCT00852917|20777674|P3|Overall Study|Physician Decision|2
6010034|NCT00852917|20777675|P2|Overall Study|Physician Decision|7
6010035|NCT00852917|20777676|P1|Overall Study|Physician Decision|6
6010036|NCT00852917|20777673|P4|Overall Study|Withdrawal by Subject|9
6010037|NCT00852917|20777674|P3|Overall Study|Withdrawal by Subject|10
6010038|NCT00852917|20777675|P2|Overall Study|Withdrawal by Subject|8
6010039|NCT00852917|20777676|P1|Overall Study|Withdrawal by Subject|4
6010040|NCT00852917|20777673|P4|Overall Study|Lack of Efficacy|47
6010041|NCT00852917|20777674|P3|Overall Study|Lack of Efficacy|11
6010042|NCT00852917|20777675|P2|Overall Study|Lack of Efficacy|11
6010043|NCT00852917|20777676|P1|Overall Study|Lack of Efficacy|21
6010044|NCT00852917|20777673|P4|Overall Study|Adverse Event|17
6010045|NCT00852917|20777674|P3|Overall Study|Adverse Event|35
6010046|NCT00852917|20777675|P2|Overall Study|Adverse Event|20
6010047|NCT00852917|20777676|P1|Overall Study|Adverse Event|13
6010048|NCT00852540|20777804|P2|Overall Study|Did Not Receive Study Drug|3
6010049|NCT00852540|20777805|P1|Overall Study|Did Not Receive Study Drug|3
6010050|NCT00852540|20777804|P2|Overall Study|Withdrawal by Subject|1
6010051|NCT00852540|20777805|P1|Overall Study|Withdrawal by Subject|3
6010052|NCT00852540|20777804|P2|Overall Study|Investigator Discretion|3
6010053|NCT00852540|20777805|P1|Overall Study|Investigator Discretion|2
6010054|NCT00852540|20777804|P2|Overall Study|Lost to Follow-up|3
6010055|NCT00852540|20777805|P1|Overall Study|Lost to Follow-up|2
6010056|NCT00852540|20777804|P2|Overall Study|Protocol Violation|2
6010057|NCT00852540|20777805|P1|Overall Study|Protocol Violation|1
6010058|NCT00852540|20777804|P2|Overall Study|Lack of Efficacy|3
6010059|NCT00852540|20777805|P1|Overall Study|Lack of Efficacy|15
6010060|NCT00852540|20777804|P2|Overall Study|Adverse Event|3
6010061|NCT00852540|20777805|P1|Overall Study|Adverse Event|10
6010062|NCT00852475|20777839|P2|Overall Study|Lost to Follow-up|4
6010063|NCT00852475|20777840|P1|Overall Study|Lost to Follow-up|3
6010064|NCT00852397|20777851|P3|Overall Study|Protocol Violation|1
6010065|NCT00852397|20777852|P2|Overall Study|Protocol Violation|0
6010066|NCT00852397|20777853|P1|Overall Study|Protocol Violation|0
6010067|NCT00852397|20777851|P3|Overall Study|Difficulty in study site visit|0
6010068|NCT00852397|20777852|P2|Overall Study|Difficulty in study site visit|0
6010069|NCT00852397|20777853|P1|Overall Study|Difficulty in study site visit|1
6010070|NCT00852397|20777851|P3|Overall Study|Study terminated by sponsor|6
6010071|NCT00852397|20777852|P2|Overall Study|Study terminated by sponsor|1
6010072|NCT00852397|20777853|P1|Overall Study|Study terminated by sponsor|2
6010073|NCT00852397|20777851|P3|Overall Study|Withdrawal by Subject|2
6010074|NCT00852397|20777852|P2|Overall Study|Withdrawal by Subject|1
6010075|NCT00852397|20777853|P1|Overall Study|Withdrawal by Subject|4
6010076|NCT00852397|20777851|P3|Overall Study|Death|1
6010077|NCT00852397|20777852|P2|Overall Study|Death|0
6010078|NCT00852397|20777853|P1|Overall Study|Death|0
6010079|NCT00852397|20777851|P3|Overall Study|Adverse Event|4
6010080|NCT00852397|20777852|P2|Overall Study|Adverse Event|6
6010081|NCT00852397|20777853|P1|Overall Study|Adverse Event|4
6010082|NCT00852241|20777882|P1|Overall Study|Physician Decision|18
6010083|NCT00852202|20777889|P3|Overall Study|pregnancy,moving away and surgery|2
6010084|NCT00852202|20777890|P2|Overall Study|pregnancy,moving away and surgery|0
6010085|NCT00852202|20777891|P1|Overall Study|pregnancy,moving away and surgery|1
6010086|NCT00852202|20777889|P3|Overall Study|Lost to Follow-up|6
6010087|NCT00852202|20777890|P2|Overall Study|Lost to Follow-up|5
6010088|NCT00852202|20777891|P1|Overall Study|Lost to Follow-up|5
6010089|NCT00852202|20777889|P3|Overall Study|Withdrawal by Subject|2
6010090|NCT00852202|20777890|P2|Overall Study|Withdrawal by Subject|1
6010091|NCT00852202|20777891|P1|Overall Study|Withdrawal by Subject|3
6010092|NCT00852202|20777889|P3|Overall Study|Protocol Violation|7
6010093|NCT00852202|20777890|P2|Overall Study|Protocol Violation|2
6010094|NCT00852202|20777891|P1|Overall Study|Protocol Violation|2
6010095|NCT00852202|20777889|P3|Overall Study|Lack of Efficacy|2
6010096|NCT00852202|20777890|P2|Overall Study|Lack of Efficacy|1
6010097|NCT00852202|20777891|P1|Overall Study|Lack of Efficacy|4
6010098|NCT00852202|20777889|P3|Overall Study|Adverse Event|7
6010099|NCT00852202|20777890|P2|Overall Study|Adverse Event|3
6010100|NCT00852202|20777891|P1|Overall Study|Adverse Event|2
6010101|NCT00851903|20777933|P1|Overall Study|Withdrawal by Subject|2
6010102|NCT00851890|20777947|P4|Overall Study|Lost to Follow-up|1
6010103|NCT00851890|20777948|P3|Overall Study|Lost to Follow-up|0
6010104|NCT00851890|20777949|P2|Overall Study|Lost to Follow-up|1
6010105|NCT00851890|20777950|P1|Overall Study|Lost to Follow-up|0
6010106|NCT00851877|20778007|P3|Phase II|Withdrawal by Subject|3
6010107|NCT00851877|20778008|P2|Phase II|Withdrawal by Subject|0
6010108|NCT00851877|20778009|P1|Phase II|Withdrawal by Subject|0
6010109|NCT00851877|20778007|P3|Phase I-1|Death|0
6010110|NCT00851877|20778008|P2|Phase I-1|Death|0
6010111|NCT00851877|20778009|P1|Phase I-1|Death|1
6010112|NCT00851799|20778019|P3|Overall Study|Completed protocol due to pregnancy|1
6010113|NCT00851799|20778020|P2|Overall Study|Completed protocol due to pregnancy|0
6010114|NCT00851799|20778021|P1|Overall Study|Completed protocol due to pregnancy|0
6010115|NCT00851799|20778019|P3|Overall Study|Severe Debilitation|0
6010116|NCT00851799|20778020|P2|Overall Study|Severe Debilitation|1
6010117|NCT00851799|20778021|P1|Overall Study|Severe Debilitation|0
6010118|NCT00851799|20778019|P3|Overall Study|Withdrew consent prior study completion|1
6010119|NCT00851799|20778020|P2|Overall Study|Withdrew consent prior study completion|2
6010120|NCT00851799|20778021|P1|Overall Study|Withdrew consent prior study completion|1
6010121|NCT00851799|20778019|P3|Overall Study|Not willing to adhere to requirements|2
6010122|NCT00851799|20778020|P2|Overall Study|Not willing to adhere to requirements|2
6010123|NCT00851799|20778021|P1|Overall Study|Not willing to adhere to requirements|1
6010124|NCT00851799|20778019|P3|Overall Study|Not able to get to clinic|9
6010125|NCT00851799|20778020|P2|Overall Study|Not able to get to clinic|5
6010126|NCT00851799|20778021|P1|Overall Study|Not able to get to clinic|8
6010127|NCT00851799|20778019|P3|Overall Study|Lost to Follow-up|10
6010128|NCT00851799|20778020|P2|Overall Study|Lost to Follow-up|3
6010129|NCT00851799|20778021|P1|Overall Study|Lost to Follow-up|5
6010130|NCT00851799|20778019|P3|Overall Study|Death|1
6010131|NCT00851799|20778020|P2|Overall Study|Death|0
6010132|NCT00851799|20778021|P1|Overall Study|Death|1
6010133|NCT00851786|20778109|P2|Overall Study|Cannot Adhere to Protocol Requirement|0
6010134|NCT00851786|20778110|P1|Overall Study|Cannot Adhere to Protocol Requirement|2
6010135|NCT00851786|20778109|P2|Overall Study|Site Closure|0
6010136|NCT00851786|20778110|P1|Overall Study|Site Closure|1
6010137|NCT00851786|20778109|P2|Overall Study|Incarceration|0
6010138|NCT00851786|20778110|P1|Overall Study|Incarceration|1
6010139|NCT00851786|20778109|P2|Overall Study|Lost to Follow-up|0
6010140|NCT00851786|20778110|P1|Overall Study|Lost to Follow-up|1
6010141|NCT00851786|20778109|P2|Overall Study|Protocol Violation|1
6010142|NCT00851786|20778110|P1|Overall Study|Protocol Violation|0
6010143|NCT00851786|20778109|P2|Overall Study|Withdrawal by Subject|1
6010144|NCT00851786|20778110|P1|Overall Study|Withdrawal by Subject|0
6010145|NCT00851747|20778123|P3|Overall Study|Physician Decision|6
6010146|NCT00851747|20778124|P2|Overall Study|Physician Decision|6
6010147|NCT00851747|20778125|P1|Overall Study|Physician Decision|6
6010148|NCT00851721|20778134|P2|Overall Study|Adverse Event|1
6010149|NCT00851721|20778135|P1|Overall Study|Adverse Event|0
6010150|NCT00851721|20778134|P2|Overall Study|Death|0
6010151|NCT00851721|20778135|P1|Overall Study|Death|1
6010152|NCT00851721|20778134|P2|Overall Study|planned surgery|0
6010153|NCT00851721|20778135|P1|Overall Study|planned surgery|1
6010154|NCT00851682|20778225|P2|Overall Study|screen failure|0
6010155|NCT00851682|20778226|P1|Overall Study|screen failure|5
6010156|NCT00851643|20778240|P6|Extension Study (Up to 36 Months)|Moved|1
6010157|NCT00851643|20778241|P5|Extension Study (Up to 36 Months)|Moved|0
6010158|NCT00851643|20778242|P4|Extension Study (Up to 36 Months)|Moved|1
6010159|NCT00851643|20778243|P3|Extension Study (Up to 36 Months)|Moved|1
6010160|NCT00851643|20778244|P2|Extension Study (Up to 36 Months)|Moved|2
6010161|NCT00851643|20778245|P1|Extension Study (Up to 36 Months)|Moved|0
6010162|NCT00851643|20778240|P6|Extension Study (Up to 36 Months)|Lost to Follow-up|0
6010163|NCT00851643|20778241|P5|Extension Study (Up to 36 Months)|Lost to Follow-up|2
6010164|NCT00851643|20778242|P4|Extension Study (Up to 36 Months)|Lost to Follow-up|1
6010165|NCT00851643|20778243|P3|Extension Study (Up to 36 Months)|Lost to Follow-up|4
6010166|NCT00851643|20778244|P2|Extension Study (Up to 36 Months)|Lost to Follow-up|2
6010167|NCT00851643|20778245|P1|Extension Study (Up to 36 Months)|Lost to Follow-up|4
6010168|NCT00851643|20778240|P6|Base Study (Up to 12 Months)|Other|1
6010169|NCT00851643|20778241|P5|Base Study (Up to 12 Months)|Other|0
6010170|NCT00851643|20778242|P4|Base Study (Up to 12 Months)|Other|0
6010171|NCT00851643|20778243|P3|Base Study (Up to 12 Months)|Other|0
6010172|NCT00851643|20778244|P2|Base Study (Up to 12 Months)|Other|0
6010173|NCT00851643|20778245|P1|Base Study (Up to 12 Months)|Other|0
6010174|NCT00851643|20778240|P6|Base Study (Up to 12 Months)|Withdrawal by Subject|0
6010175|NCT00851643|20778241|P5|Base Study (Up to 12 Months)|Withdrawal by Subject|0
6010176|NCT00851643|20778242|P4|Base Study (Up to 12 Months)|Withdrawal by Subject|0
6010177|NCT00851643|20778243|P3|Base Study (Up to 12 Months)|Withdrawal by Subject|0
6010178|NCT00851643|20778244|P2|Base Study (Up to 12 Months)|Withdrawal by Subject|0
6010179|NCT00851643|20778245|P1|Base Study (Up to 12 Months)|Withdrawal by Subject|1
6010180|NCT00851630|20778266|P2|Overall Study|Clinical failure|1
6010181|NCT00851630|20778267|P1|Overall Study|Clinical failure|0
6010182|NCT00851630|20778266|P2|Overall Study|Death|1
6010183|NCT00851630|20778267|P1|Overall Study|Death|2
6010184|NCT00851591|20778281|P2|Overall Study|Withdrawal by Subject|0
6010185|NCT00851591|20778282|P1|Overall Study|Withdrawal by Subject|2
6010186|NCT00851552|20778288|P1|Overall Study|Disease Progression|4
6010187|NCT00851552|20778288|P1|Overall Study|Adverse Event|1
6010188|NCT00851552|20778288|P1|Overall Study|Death|2
6010189|NCT00851318|20778318|P4|Overall Study|Physician Decision|1
6010190|NCT00851318|20778319|P3|Overall Study|Physician Decision|1
6010191|NCT00851318|20778320|P2|Overall Study|Physician Decision|0
6010192|NCT00851318|20778321|P1|Overall Study|Physician Decision|0
6010193|NCT00851318|20778318|P4|Overall Study|Non-compliance with Study Procedures|0
6010194|NCT00851318|20778319|P3|Overall Study|Non-compliance with Study Procedures|1
6010195|NCT00851318|20778320|P2|Overall Study|Non-compliance with Study Procedures|0
6010196|NCT00851318|20778321|P1|Overall Study|Non-compliance with Study Procedures|2
6010197|NCT00851318|20778318|P4|Overall Study|Lack of Efficacy|2
6010198|NCT00851318|20778319|P3|Overall Study|Lack of Efficacy|4
6010199|NCT00851318|20778320|P2|Overall Study|Lack of Efficacy|2
6010200|NCT00851318|20778321|P1|Overall Study|Lack of Efficacy|8
6010201|NCT00851318|20778318|P4|Overall Study|Pregnancy|1
6010202|NCT00851318|20778319|P3|Overall Study|Pregnancy|1
6010203|NCT00851318|20778320|P2|Overall Study|Pregnancy|0
6010204|NCT00851318|20778321|P1|Overall Study|Pregnancy|0
6010205|NCT00851318|20778318|P4|Overall Study|Adverse Event|12
6010206|NCT00851318|20778319|P3|Overall Study|Adverse Event|9
6010207|NCT00851318|20778320|P2|Overall Study|Adverse Event|2
6010208|NCT00851318|20778321|P1|Overall Study|Adverse Event|13
6010209|NCT00851318|20778318|P4|Overall Study|Withdrawal by Subject|3
6010210|NCT00851318|20778319|P3|Overall Study|Withdrawal by Subject|5
6010211|NCT00851318|20778320|P2|Overall Study|Withdrawal by Subject|1
6010212|NCT00851318|20778321|P1|Overall Study|Withdrawal by Subject|7
6010213|NCT00851253|20778357|P2|Overall Study|Disease Progression|0
6010214|NCT00851253|20778358|P1|Overall Study|Disease Progression|1
6010215|NCT00851084|20778368|P2|Overall Study|Other|1
6010216|NCT00851084|20778369|P1|Overall Study|Other|7
6010217|NCT00851084|20778368|P2|Overall Study|Metastatic surgery|6
6010218|NCT00851084|20778369|P1|Overall Study|Metastatic surgery|6
6010219|NCT00851084|20778368|P2|Overall Study|Withdrawal by Subject|12
6010220|NCT00851084|20778369|P1|Overall Study|Withdrawal by Subject|11
6010221|NCT00851084|20778368|P2|Overall Study|Consent withdrawn|2
6010222|NCT00851084|20778369|P1|Overall Study|Consent withdrawn|0
6010223|NCT00851084|20778368|P2|Overall Study|Physician Decision|14
6010224|NCT00851084|20778369|P1|Overall Study|Physician Decision|13
6010225|NCT00851084|20778368|P2|Overall Study|Poor compliance to protocol|1
6010226|NCT00851084|20778369|P1|Overall Study|Poor compliance to protocol|1
6010227|NCT00851084|20778368|P2|Overall Study|Disease progression|47
6010228|NCT00851084|20778369|P1|Overall Study|Disease progression|52
6010229|NCT00851084|20778368|P2|Overall Study|Adverse Event|36
6010230|NCT00851084|20778369|P1|Overall Study|Adverse Event|26
6010231|NCT00851084|20778368|P2|Overall Study|Randomized but not treated|0
6010232|NCT00851084|20778369|P1|Overall Study|Randomized but not treated|1
6010233|NCT00850993|20778397|P4|Overall Study|Parent/Guardian Voluntarily Withdrew|1
6010234|NCT00850993|20778398|P3|Overall Study|Parent/Guardian Voluntarily Withdrew|0
6010235|NCT00850993|20778399|P2|Overall Study|Parent/Guardian Voluntarily Withdrew|0
6010236|NCT00850993|20778400|P1|Overall Study|Parent/Guardian Voluntarily Withdrew|1
6010237|NCT00850759|20778429|P4|Overall Study|Lost to Follow-up|3
6010238|NCT00850759|20778430|P3|Overall Study|Lost to Follow-up|5
6010239|NCT00850759|20778431|P2|Overall Study|Lost to Follow-up|5
6010240|NCT00850759|20778432|P1|Overall Study|Lost to Follow-up|7
6010241|NCT00850564|20778513|P1|Overall Study|Withdrawal by Subject|2
6010242|NCT00850538|20778518|P1|Overall Study|Protocol Violation|2
6010243|NCT00850538|20778518|P1|Overall Study|radiology error|2
6010244|NCT00850538|20778518|P1|Overall Study|Withdrawal by Subject|3
6010245|NCT00850538|20778518|P1|Overall Study|specimen unusable|7
6010246|NCT00850538|20778518|P1|Overall Study|specimen missed due to scheduling error|14
6010247|NCT00850538|20778518|P1|Overall Study|unable/unwilling to complete MRI|13
6010248|NCT00850499|20778524|P2|Overall Study|Lack of Efficacy|1
6010249|NCT00850499|20778525|P1|Overall Study|Lack of Efficacy|0
6010250|NCT00850499|20778524|P2|Overall Study|Adverse Event|1
6010251|NCT00850499|20778525|P1|Overall Study|Adverse Event|3
6010252|NCT00850460|20778539|P2|Overall Study|Lost to Follow-up|4
6010253|NCT00850460|20778540|P1|Overall Study|Lost to Follow-up|4
6010254|NCT00850395|20778554|P1|Overall Study|Other|5
6010255|NCT00850395|20778554|P1|Overall Study|Insufficient clinical response|3
6010256|NCT00850395|20778554|P1|Overall Study|Adverse Event|1
6010257|NCT00850395|20778554|P1|Overall Study|Death|1
6010258|NCT00850343|20778574|P4|Overall Study|Physician Decision|1
6010259|NCT00850343|20778575|P3|Overall Study|Physician Decision|1
6010260|NCT00850343|20778576|P2|Overall Study|Physician Decision|1
6010261|NCT00850343|20778577|P1|Overall Study|Physician Decision|2
6010262|NCT00850343|20778574|P4|Overall Study|Non-compliance with Study Procedures|1
6010263|NCT00850343|20778575|P3|Overall Study|Non-compliance with Study Procedures|1
6010350|NCT00849693|20778857|P4|Extension Phase|Lack of Efficacy|1
6010264|NCT00850343|20778576|P2|Overall Study|Non-compliance with Study Procedures|0
6010265|NCT00850343|20778577|P1|Overall Study|Non-compliance with Study Procedures|1
6010266|NCT00850343|20778574|P4|Overall Study|Lack of Efficacy|2
6010267|NCT00850343|20778575|P3|Overall Study|Lack of Efficacy|3
6010268|NCT00850343|20778576|P2|Overall Study|Lack of Efficacy|0
6010269|NCT00850343|20778577|P1|Overall Study|Lack of Efficacy|17
6010270|NCT00850343|20778574|P4|Overall Study|Pregnancy|1
6010271|NCT00850343|20778575|P3|Overall Study|Pregnancy|0
6010272|NCT00850343|20778576|P2|Overall Study|Pregnancy|0
6010273|NCT00850343|20778577|P1|Overall Study|Pregnancy|0
6010274|NCT00850343|20778574|P4|Overall Study|Adverse Event|6
6010275|NCT00850343|20778575|P3|Overall Study|Adverse Event|6
6010276|NCT00850343|20778576|P2|Overall Study|Adverse Event|2
6010277|NCT00850343|20778577|P1|Overall Study|Adverse Event|15
6010278|NCT00850343|20778574|P4|Overall Study|Withdrawal by Subject|2
6010279|NCT00850343|20778575|P3|Overall Study|Withdrawal by Subject|3
6010280|NCT00850343|20778576|P2|Overall Study|Withdrawal by Subject|0
6010281|NCT00850343|20778577|P1|Overall Study|Withdrawal by Subject|11
6010282|NCT00850200|20778607|P1|Overall Study|Withdrawal by Subject|1
6010283|NCT00850200|20778607|P1|Overall Study|Did not recieve treatment|2
6010284|NCT00850200|20778607|P1|Overall Study|Physician Decision|2
6010285|NCT00850174|20778617|P2|Second Intervention|Withdrawal by Subject|0
6010286|NCT00850174|20778618|P1|Second Intervention|Withdrawal by Subject|1
6010287|NCT00850174|20778617|P2|Washout: One Week|Withdrawal by Subject|2
6010288|NCT00850174|20778618|P1|Washout: One Week|Withdrawal by Subject|0
6010289|NCT00850135|20778632|P1|Overall Study|Physician Decision|1
6010290|NCT00850070|20778651|P2|Overall Study|Adverse Event|0
6010291|NCT00850070|20778652|P1|Overall Study|Adverse Event|2
6010292|NCT00850070|20778651|P2|Overall Study|Lack of Efficacy|1
6010293|NCT00850070|20778652|P1|Overall Study|Lack of Efficacy|1
6010294|NCT00849940|20778681|P1|Overall Study|Physician Decision|4
6010295|NCT00849901|20778692|P3|Extension Phase|Lack of Efficacy|1
6010296|NCT00849901|20778693|P2|Extension Phase|Lack of Efficacy|4
6010297|NCT00849901|20778694|P1|Extension Phase|Lack of Efficacy|2
6010298|NCT00849901|20778692|P3|Extension Phase|Physician Decision|0
6010299|NCT00849901|20778693|P2|Extension Phase|Physician Decision|2
6010300|NCT00849901|20778694|P1|Extension Phase|Physician Decision|1
6010301|NCT00849901|20778692|P3|Extension Phase|Parent or Caregiver Decision|4
6010302|NCT00849901|20778693|P2|Extension Phase|Parent or Caregiver Decision|4
6010303|NCT00849901|20778694|P1|Extension Phase|Parent or Caregiver Decision|10
6010304|NCT00849901|20778692|P3|Extension Phase|Withdrawal by Subject|3
6010305|NCT00849901|20778693|P2|Extension Phase|Withdrawal by Subject|6
6010306|NCT00849901|20778694|P1|Extension Phase|Withdrawal by Subject|7
6010307|NCT00849901|20778692|P3|Extension Phase|Protocol Violation|4
6010308|NCT00849901|20778693|P2|Extension Phase|Protocol Violation|2
6010309|NCT00849901|20778694|P1|Extension Phase|Protocol Violation|2
6010310|NCT00849901|20778692|P3|Extension Phase|Lost to Follow-up|1
6010311|NCT00849901|20778693|P2|Extension Phase|Lost to Follow-up|0
6010312|NCT00849901|20778694|P1|Extension Phase|Lost to Follow-up|3
6010313|NCT00849901|20778692|P3|Extension Phase|Adverse Event|4
6010314|NCT00849901|20778693|P2|Extension Phase|Adverse Event|8
6010315|NCT00849901|20778694|P1|Extension Phase|Adverse Event|2
6010316|NCT00849901|20778692|P3|Acute Treatment Phase|Lack of Efficacy|2
6010317|NCT00849901|20778693|P2|Acute Treatment Phase|Lack of Efficacy|3
6010318|NCT00849901|20778694|P1|Acute Treatment Phase|Lack of Efficacy|2
6010319|NCT00849901|20778692|P3|Acute Treatment Phase|Sponsor Decision|0
6010320|NCT00849901|20778693|P2|Acute Treatment Phase|Sponsor Decision|0
6010321|NCT00849901|20778694|P1|Acute Treatment Phase|Sponsor Decision|1
6010322|NCT00849901|20778692|P3|Acute Treatment Phase|Physician Decision|1
6010323|NCT00849901|20778693|P2|Acute Treatment Phase|Physician Decision|1
6010324|NCT00849901|20778694|P1|Acute Treatment Phase|Physician Decision|1
6010325|NCT00849901|20778692|P3|Acute Treatment Phase|Parent or Caregiver Decision|4
6010326|NCT00849901|20778693|P2|Acute Treatment Phase|Parent or Caregiver Decision|5
6010327|NCT00849901|20778694|P1|Acute Treatment Phase|Parent or Caregiver Decision|11
6010328|NCT00849901|20778692|P3|Acute Treatment Phase|Withdrawal by Subject|4
6010329|NCT00849901|20778693|P2|Acute Treatment Phase|Withdrawal by Subject|10
6010330|NCT00849901|20778694|P1|Acute Treatment Phase|Withdrawal by Subject|4
6010331|NCT00849901|20778692|P3|Acute Treatment Phase|Protocol Violation|1
6010332|NCT00849901|20778693|P2|Acute Treatment Phase|Protocol Violation|2
6010333|NCT00849901|20778694|P1|Acute Treatment Phase|Protocol Violation|0
6010334|NCT00849901|20778692|P3|Acute Treatment Phase|Lost to Follow-up|1
6010335|NCT00849901|20778693|P2|Acute Treatment Phase|Lost to Follow-up|4
6010336|NCT00849901|20778694|P1|Acute Treatment Phase|Lost to Follow-up|2
6010337|NCT00849901|20778692|P3|Acute Treatment Phase|Adverse Event|3
6010338|NCT00849901|20778693|P2|Acute Treatment Phase|Adverse Event|1
6010339|NCT00849901|20778694|P1|Acute Treatment Phase|Adverse Event|9
6010340|NCT00849875|20778741|P1|Overall Study|Lost to Follow-up|2
6010341|NCT00849875|20778741|P1|Overall Study|Others|6
6010342|NCT00849875|20778741|P1|Overall Study|Ongoing (unknown completion status)|11
6010343|NCT00849875|20778741|P1|Overall Study|Death|28
6010344|NCT00849797|20778838|P2|Washout: One Week|Withdrawal by Subject|2
6010345|NCT00849797|20778839|P1|Washout: One Week|Withdrawal by Subject|0
6010346|NCT00849797|20778838|P2|First Intervention|Adverse Event|1
6010347|NCT00849797|20778839|P1|First Intervention|Adverse Event|0
6010348|NCT00849797|20778838|P2|First Intervention|bad veins|0
6010349|NCT00849797|20778839|P1|First Intervention|bad veins|1
6010351|NCT00849693|20778858|P3|Extension Phase|Lack of Efficacy|2
6010352|NCT00849693|20778859|P2|Extension Phase|Lack of Efficacy|2
6010353|NCT00849693|20778860|P1|Extension Phase|Lack of Efficacy|2
6010354|NCT00849693|20778857|P4|Extension Phase|Sponsor decision|1
6010355|NCT00849693|20778858|P3|Extension Phase|Sponsor decision|0
6010356|NCT00849693|20778859|P2|Extension Phase|Sponsor decision|0
6010357|NCT00849693|20778860|P1|Extension Phase|Sponsor decision|1
6010358|NCT00849693|20778857|P4|Extension Phase|Physician Decision|0
6010359|NCT00849693|20778858|P3|Extension Phase|Physician Decision|2
6010360|NCT00849693|20778859|P2|Extension Phase|Physician Decision|1
6010361|NCT00849693|20778860|P1|Extension Phase|Physician Decision|1
6010362|NCT00849693|20778857|P4|Extension Phase|Parent or caregiver decision|5
6010363|NCT00849693|20778858|P3|Extension Phase|Parent or caregiver decision|10
6010364|NCT00849693|20778859|P2|Extension Phase|Parent or caregiver decision|4
6010365|NCT00849693|20778860|P1|Extension Phase|Parent or caregiver decision|9
6010366|NCT00849693|20778857|P4|Extension Phase|Withdrawal by Subject|15
6010367|NCT00849693|20778858|P3|Extension Phase|Withdrawal by Subject|10
6010368|NCT00849693|20778859|P2|Extension Phase|Withdrawal by Subject|9
6010369|NCT00849693|20778860|P1|Extension Phase|Withdrawal by Subject|6
6010370|NCT00849693|20778857|P4|Extension Phase|Protocol Violation|3
6010371|NCT00849693|20778858|P3|Extension Phase|Protocol Violation|2
6010372|NCT00849693|20778859|P2|Extension Phase|Protocol Violation|3
6010373|NCT00849693|20778860|P1|Extension Phase|Protocol Violation|0
6010374|NCT00849693|20778857|P4|Extension Phase|Lost to Follow-up|6
6010375|NCT00849693|20778858|P3|Extension Phase|Lost to Follow-up|6
6010376|NCT00849693|20778859|P2|Extension Phase|Lost to Follow-up|5
6010377|NCT00849693|20778860|P1|Extension Phase|Lost to Follow-up|7
6010378|NCT00849693|20778857|P4|Extension Phase|Adverse Event|7
6010379|NCT00849693|20778858|P3|Extension Phase|Adverse Event|3
6010380|NCT00849693|20778859|P2|Extension Phase|Adverse Event|6
6010381|NCT00849693|20778860|P1|Extension Phase|Adverse Event|4
6010382|NCT00849693|20778857|P4|Acute Treatment Phase|Lack of Efficacy|2
6010383|NCT00849693|20778858|P3|Acute Treatment Phase|Lack of Efficacy|1
6010384|NCT00849693|20778859|P2|Acute Treatment Phase|Lack of Efficacy|3
6010385|NCT00849693|20778860|P1|Acute Treatment Phase|Lack of Efficacy|1
6010386|NCT00849693|20778857|P4|Acute Treatment Phase|Sponsor decision|0
6010387|NCT00849693|20778858|P3|Acute Treatment Phase|Sponsor decision|1
6010388|NCT00849693|20778859|P2|Acute Treatment Phase|Sponsor decision|0
6010389|NCT00849693|20778860|P1|Acute Treatment Phase|Sponsor decision|0
6010390|NCT00849693|20778857|P4|Acute Treatment Phase|Physician Decision|1
6010391|NCT00849693|20778858|P3|Acute Treatment Phase|Physician Decision|2
6010392|NCT00849693|20778859|P2|Acute Treatment Phase|Physician Decision|1
6010393|NCT00849693|20778860|P1|Acute Treatment Phase|Physician Decision|2
6010394|NCT00849693|20778857|P4|Acute Treatment Phase|Parent or caregiver decision|7
6010395|NCT00849693|20778858|P3|Acute Treatment Phase|Parent or caregiver decision|7
6010396|NCT00849693|20778859|P2|Acute Treatment Phase|Parent or caregiver decision|6
6010397|NCT00849693|20778860|P1|Acute Treatment Phase|Parent or caregiver decision|7
6010398|NCT00849693|20778857|P4|Acute Treatment Phase|Withdrawal by Subject|8
6010399|NCT00849693|20778858|P3|Acute Treatment Phase|Withdrawal by Subject|3
6010400|NCT00849693|20778859|P2|Acute Treatment Phase|Withdrawal by Subject|5
6010401|NCT00849693|20778860|P1|Acute Treatment Phase|Withdrawal by Subject|5
6010402|NCT00849693|20778857|P4|Acute Treatment Phase|Protocol Violation|6
6010403|NCT00849693|20778858|P3|Acute Treatment Phase|Protocol Violation|2
6010404|NCT00849693|20778859|P2|Acute Treatment Phase|Protocol Violation|5
6010405|NCT00849693|20778860|P1|Acute Treatment Phase|Protocol Violation|1
6010406|NCT00849693|20778857|P4|Acute Treatment Phase|Lost to Follow-up|9
6010407|NCT00849693|20778858|P3|Acute Treatment Phase|Lost to Follow-up|11
6010408|NCT00849693|20778859|P2|Acute Treatment Phase|Lost to Follow-up|8
6010409|NCT00849693|20778860|P1|Acute Treatment Phase|Lost to Follow-up|5
6010410|NCT00849693|20778857|P4|Acute Treatment Phase|Adverse Event|4
6010411|NCT00849693|20778858|P3|Acute Treatment Phase|Adverse Event|6
6010412|NCT00849693|20778859|P2|Acute Treatment Phase|Adverse Event|7
6010413|NCT00849693|20778860|P1|Acute Treatment Phase|Adverse Event|12
6010414|NCT00849680|20778927|P8|Overall Study|Subject unable to comply with protocol|0
6010415|NCT00849680|20778928|P7|Overall Study|Subject unable to comply with protocol|0
6010416|NCT00849680|20778929|P6|Overall Study|Subject unable to comply with protocol|0
6010417|NCT00849680|20778930|P5|Overall Study|Subject unable to comply with protocol|0
6010418|NCT00849680|20778931|P4|Overall Study|Subject unable to comply with protocol|0
6010419|NCT00849680|20778932|P3|Overall Study|Subject unable to comply with protocol|0
6010420|NCT00849680|20778933|P2|Overall Study|Subject unable to comply with protocol|0
6010421|NCT00849680|20778934|P1|Overall Study|Subject unable to comply with protocol|1
6010422|NCT00849680|20778927|P8|Overall Study|Withdrawal by Subject|1
6010423|NCT00849680|20778928|P7|Overall Study|Withdrawal by Subject|1
6010424|NCT00849680|20778929|P6|Overall Study|Withdrawal by Subject|2
6010425|NCT00849680|20778930|P5|Overall Study|Withdrawal by Subject|2
6010426|NCT00849680|20778931|P4|Overall Study|Withdrawal by Subject|2
6010427|NCT00849680|20778932|P3|Overall Study|Withdrawal by Subject|0
6010428|NCT00849680|20778933|P2|Overall Study|Withdrawal by Subject|0
6010429|NCT00849680|20778934|P1|Overall Study|Withdrawal by Subject|2
6010430|NCT00849680|20778927|P8|Overall Study|Subject moved|2
6010431|NCT00849680|20778928|P7|Overall Study|Subject moved|2
6010432|NCT00849680|20778929|P6|Overall Study|Subject moved|2
6010433|NCT00849680|20778930|P5|Overall Study|Subject moved|0
6010434|NCT00849680|20778931|P4|Overall Study|Subject moved|1
6010435|NCT00849680|20778932|P3|Overall Study|Subject moved|3
6010436|NCT00849680|20778933|P2|Overall Study|Subject moved|0
6010437|NCT00849680|20778934|P1|Overall Study|Subject moved|1
6010438|NCT00849680|20778927|P8|Overall Study|Lost to Follow-up|5
6010439|NCT00849680|20778928|P7|Overall Study|Lost to Follow-up|12
6010440|NCT00849680|20778929|P6|Overall Study|Lost to Follow-up|11
6010441|NCT00849680|20778930|P5|Overall Study|Lost to Follow-up|8
6010442|NCT00849680|20778931|P4|Overall Study|Lost to Follow-up|11
6010443|NCT00849680|20778932|P3|Overall Study|Lost to Follow-up|12
6010444|NCT00849680|20778933|P2|Overall Study|Lost to Follow-up|3
6010445|NCT00849680|20778934|P1|Overall Study|Lost to Follow-up|7
6010446|NCT00849680|20778927|P8|Overall Study|Adverse Event|0
6010447|NCT00849680|20778928|P7|Overall Study|Adverse Event|2
6010448|NCT00849680|20778929|P6|Overall Study|Adverse Event|0
6010449|NCT00849680|20778930|P5|Overall Study|Adverse Event|0
6010450|NCT00849680|20778931|P4|Overall Study|Adverse Event|0
6010451|NCT00849680|20778932|P3|Overall Study|Adverse Event|0
6010452|NCT00849680|20778933|P2|Overall Study|Adverse Event|0
6010453|NCT00849680|20778934|P1|Overall Study|Adverse Event|0
6010454|NCT00849524|20778976|P1|Overall Study|Lack of Efficacy|3
6010455|NCT00849472|20778993|P1|Pazopanib Postsurgery Treatment|Site Thought Treatment Was Completed|1
6010456|NCT00849472|20778993|P1|Pazopanib Postsurgery Treatment|Moved|1
6010457|NCT00849472|20778993|P1|Pazopanib Postsurgery Treatment|Withdrawal by Subject|5
6010458|NCT00849472|20778993|P1|Pazopanib Postsurgery Treatment|Adverse Event|19
6010459|NCT00849472|20778993|P1|Pazopanib Presurgery Treatment (PPT)|Never Started Pre-operative Pazopanib|1
6010460|NCT00849472|20778993|P1|Pazopanib Presurgery Treatment (PPT)|Physician Decision|1
6010461|NCT00849472|20778993|P1|Pazopanib Presurgery Treatment (PPT)|Withdrawal by Subject|4
6010462|NCT00849472|20778993|P1|Pazopanib Presurgery Treatment (PPT)|Adverse Event|52
6010463|NCT00849472|20778993|P1|Weekly Paclitaxel|Physician Decision|3
6010464|NCT00849472|20778993|P1|Weekly Paclitaxel|Withdrawal by Subject|1
6010465|NCT00849472|20778993|P1|Weekly Paclitaxel|Adverse Event|11
6010466|NCT00849472|20778993|P1|Weekly Paclitaxel|Disease Progression|1
6010467|NCT00849472|20778993|P1|Doxorubicin and Cyclophosphamide (AC)|Participant Moved|1
6010468|NCT00849472|20778993|P1|Doxorubicin and Cyclophosphamide (AC)|Physician Decision|1
6010469|NCT00849472|20778993|P1|Doxorubicin and Cyclophosphamide (AC)|Withdrawal by Subject|1
6010470|NCT00849472|20778993|P1|Doxorubicin and Cyclophosphamide (AC)|Adverse Event|1
6010471|NCT00849472|20778993|P1|Doxorubicin and Cyclophosphamide (AC)|Disease Progression|2
6010472|NCT00849381|20779007|P1|Overall Study|Other|4
6010473|NCT00849381|20779007|P1|Overall Study|Withdrawal by Subject|6
6010474|NCT00849381|20779007|P1|Overall Study|Protocol Violation|5
6010475|NCT00849381|20779007|P1|Overall Study|Lost to Follow-up|129
6010476|NCT00849381|20779007|P1|Overall Study|Adverse Event|1
6010477|NCT00849290|20779013|P1|Overall Study|Disease Progression|20
6010478|NCT00849290|20779013|P1|Overall Study|Protocol Violation|5
6010479|NCT00849290|20779013|P1|Overall Study|Lost to Follow-up|2
6010480|NCT00849290|20779013|P1|Overall Study|Withdrawal by Subject|11
6010481|NCT00849290|20779013|P1|Overall Study|Death|14
6010482|NCT00849290|20779013|P1|Overall Study|Adverse Event|3
6010483|NCT00849212|20779024|P1|Overall Study|Miscellaneous|1
6010484|NCT00849212|20779024|P1|Overall Study|Adverse Event|2
6010485|NCT00849212|20779024|P1|Overall Study|Withdrawal by Subject|3
6010486|NCT00849212|20779024|P1|Overall Study|Lack of Efficacy|1
6010487|NCT00849186|20779029|P1|Overall Study|Other|1
6010488|NCT00849186|20779029|P1|Overall Study|not treated|6
6010489|NCT00849186|20779029|P1|Overall Study|Withdrawal by Subject|1
6010490|NCT00849186|20779029|P1|Overall Study|Adverse Event|2
6010491|NCT00849147|20779035|P1|Overall Study|Disease Relapse/Progression|2
6010492|NCT00849147|20779035|P1|Overall Study|Protocol Violation|2
6010493|NCT00849147|20779035|P1|Overall Study|Withdrawal by Subject|1
6010494|NCT00849108|20779068|P2|Cohort 2 Efficacy|Other|9
6010495|NCT00849108|20779069|P1|Cohort 2 Efficacy|Other|0
6010496|NCT00849108|20779068|P2|Cohort 2 Efficacy|Adverse Event|1
6010497|NCT00849108|20779069|P1|Cohort 2 Efficacy|Adverse Event|0
6010498|NCT00849108|20779068|P2|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|0
6010499|NCT00849108|20779069|P1|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|1
6010500|NCT00849056|20779079|P2|Follow-up Period (FUP) (8 Weeks)|Early Termination|0
6010501|NCT00849056|20779080|P1|Follow-up Period (FUP) (8 Weeks)|Early Termination|1
6010502|NCT00849056|20779079|P2|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|4
6010503|NCT00849056|20779080|P1|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|1
6010504|NCT00849056|20779079|P2|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1
6010505|NCT00849056|20779080|P1|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1
6010506|NCT00849056|20779079|P2|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|7
6010507|NCT00849056|20779080|P1|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|9
6010508|NCT00849056|20779079|P2|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|9
6010509|NCT00849056|20779080|P1|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|14
6010510|NCT00849056|20779079|P2|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1
6010511|NCT00849056|20779080|P1|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0
6010512|NCT00849056|20779079|P2|Follow-up Period (FUP) (8 Weeks)|Adverse Event|3
6010513|NCT00849056|20779080|P1|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1
6010514|NCT00849056|20779079|P2|Treatment Period (TP) (156 Weeks)|Pregnancy|0
6010515|NCT00849056|20779080|P1|Treatment Period (TP) (156 Weeks)|Pregnancy|1
6010516|NCT00849056|20779079|P2|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|0
6010517|NCT00849056|20779080|P1|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|1
6010518|NCT00849056|20779079|P2|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|4
6010519|NCT00849056|20779080|P1|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|1
6010520|NCT00849056|20779079|P2|Treatment Period (TP) (156 Weeks)|Physician Decision|3
6010521|NCT00849056|20779080|P1|Treatment Period (TP) (156 Weeks)|Physician Decision|3
6010522|NCT00849056|20779079|P2|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|18
6010523|NCT00849056|20779080|P1|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|31
6010524|NCT00849056|20779079|P2|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|5
6010525|NCT00849056|20779080|P1|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7
6010526|NCT00849056|20779079|P2|Treatment Period (TP) (156 Weeks)|Noncompliance|3
6010527|NCT00849056|20779080|P1|Treatment Period (TP) (156 Weeks)|Noncompliance|3
6010528|NCT00849056|20779079|P2|Treatment Period (TP) (156 Weeks)|Protocol Violation|6
6010529|NCT00849056|20779080|P1|Treatment Period (TP) (156 Weeks)|Protocol Violation|3
6010530|NCT00849056|20779079|P2|Treatment Period (TP) (156 Weeks)|Adverse Event|11
6010531|NCT00849056|20779080|P1|Treatment Period (TP) (156 Weeks)|Adverse Event|13
6010532|NCT00849017|20779105|P3|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0
6010533|NCT00849017|20779106|P2|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0
6010534|NCT00849017|20779107|P1|Follow-up Period (8 Weeks)|Participant Relocating to Africa|1
6010535|NCT00849017|20779105|P3|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1
6010536|NCT00849017|20779106|P2|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1
6010537|NCT00849017|20779107|P1|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|3
6010538|NCT00849017|20779105|P3|Follow-up Period (8 Weeks)|Physician Decision|1
6010539|NCT00849017|20779106|P2|Follow-up Period (8 Weeks)|Physician Decision|1
6010540|NCT00849017|20779107|P1|Follow-up Period (8 Weeks)|Physician Decision|0
6010541|NCT00849017|20779105|P3|Follow-up Period (8 Weeks)|Withdrawal by Subject|3
6010542|NCT00849017|20779106|P2|Follow-up Period (8 Weeks)|Withdrawal by Subject|2
6010543|NCT00849017|20779107|P1|Follow-up Period (8 Weeks)|Withdrawal by Subject|4
6010544|NCT00849017|20779105|P3|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|4
6010545|NCT00849017|20779106|P2|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1
6010546|NCT00849017|20779107|P1|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1
6010547|NCT00849017|20779105|P3|Follow-up Period (8 Weeks)|Lost to Follow-up|16
6010548|NCT00849017|20779106|P2|Follow-up Period (8 Weeks)|Lost to Follow-up|12
6010549|NCT00849017|20779107|P1|Follow-up Period (8 Weeks)|Lost to Follow-up|13
6010550|NCT00849017|20779105|P3|Follow-up Period (8 Weeks)|Noncompliance|0
6010551|NCT00849017|20779106|P2|Follow-up Period (8 Weeks)|Noncompliance|1
6010552|NCT00849017|20779107|P1|Follow-up Period (8 Weeks)|Noncompliance|2
6010553|NCT00849017|20779105|P3|Follow-up Period (8 Weeks)|Adverse Event|0
6010554|NCT00849017|20779106|P2|Follow-up Period (8 Weeks)|Adverse Event|0
6010555|NCT00849017|20779107|P1|Follow-up Period (8 Weeks)|Adverse Event|1
6010556|NCT00849017|20779105|P3|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|1
6010557|NCT00849017|20779106|P2|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0
6010558|NCT00849017|20779107|P1|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0
6010559|NCT00849017|20779105|P3|Treatment Period (156 Weeks)|Pregnancy|1
6010560|NCT00849017|20779106|P2|Treatment Period (156 Weeks)|Pregnancy|0
6010561|NCT00849017|20779107|P1|Treatment Period (156 Weeks)|Pregnancy|1
6010562|NCT00849017|20779105|P3|Treatment Period (156 Weeks)|Participant Moved to Africa|0
6010563|NCT00849017|20779106|P2|Treatment Period (156 Weeks)|Participant Moved to Africa|0
6010564|NCT00849017|20779107|P1|Treatment Period (156 Weeks)|Participant Moved to Africa|1
6010565|NCT00849017|20779105|P3|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0
6010566|NCT00849017|20779106|P2|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0
6010567|NCT00849017|20779107|P1|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|1
6010568|NCT00849017|20779105|P3|Treatment Period (156 Weeks)|Increased Calcitonin|0
6010569|NCT00849017|20779106|P2|Treatment Period (156 Weeks)|Increased Calcitonin|0
6010570|NCT00849017|20779107|P1|Treatment Period (156 Weeks)|Increased Calcitonin|1
6010571|NCT00849017|20779105|P3|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1
6010572|NCT00849017|20779106|P2|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1
6010573|NCT00849017|20779107|P1|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|3
6010574|NCT00849017|20779105|P3|Treatment Period (156 Weeks)|Physician Decision|1
6010575|NCT00849017|20779106|P2|Treatment Period (156 Weeks)|Physician Decision|2
6010576|NCT00849017|20779107|P1|Treatment Period (156 Weeks)|Physician Decision|0
6010577|NCT00849017|20779105|P3|Treatment Period (156 Weeks)|Withdrawal by Subject|11
6010578|NCT00849017|20779106|P2|Treatment Period (156 Weeks)|Withdrawal by Subject|14
6010579|NCT00849017|20779107|P1|Treatment Period (156 Weeks)|Withdrawal by Subject|18
6010580|NCT00849017|20779105|P3|Treatment Period (156 Weeks)|Lost to Follow-up|8
6010581|NCT00849017|20779106|P2|Treatment Period (156 Weeks)|Lost to Follow-up|7
6010582|NCT00849017|20779107|P1|Treatment Period (156 Weeks)|Lost to Follow-up|10
6010583|NCT00849017|20779105|P3|Treatment Period (156 Weeks)|Noncompliance|4
6010584|NCT00849017|20779106|P2|Treatment Period (156 Weeks)|Noncompliance|3
6010585|NCT00849017|20779107|P1|Treatment Period (156 Weeks)|Noncompliance|3
6010586|NCT00849017|20779105|P3|Treatment Period (156 Weeks)|Adverse Event|15
6010587|NCT00849017|20779106|P2|Treatment Period (156 Weeks)|Adverse Event|6
6010588|NCT00849017|20779107|P1|Treatment Period (156 Weeks)|Adverse Event|5
6010589|NCT00848965|20779150|P1|Overall Study|Withdrawal by Subject|1
6010590|NCT00848965|20779150|P1|Overall Study|Adverse Event|1
6010591|NCT00848926|20779192|P1|Follow-up Period|Other|2
6010592|NCT00848926|20779192|P1|Follow-up Period|Withdrawal by Subject|3
6010593|NCT00848926|20779192|P1|Follow-up Period|Lost to Follow-up|7
6010594|NCT00848926|20779192|P1|Treatment Period|Withdrawal by Subject|7
6010595|NCT00848926|20779192|P1|Treatment Period|Physician Decision|12
6010596|NCT00848926|20779192|P1|Treatment Period|Adverse Event|20
6010597|NCT00848926|20779192|P1|Treatment Period|Progressive disease|45
6010598|NCT00848718|20779242|P13|Overall Study|Progressive disease during treatment|2
6010599|NCT00848718|20779243|P12|Overall Study|Progressive disease during treatment|0
6010600|NCT00848718|20779244|P11|Overall Study|Progressive disease during treatment|0
6010601|NCT00848718|20779245|P10|Overall Study|Progressive disease during treatment|0
6010602|NCT00848718|20779246|P9|Overall Study|Progressive disease during treatment|0
6010603|NCT00848718|20779247|P8|Overall Study|Progressive disease during treatment|2
6010604|NCT00848718|20779248|P7|Overall Study|Progressive disease during treatment|0
6010605|NCT00848718|20779249|P6|Overall Study|Progressive disease during treatment|0
6010606|NCT00848718|20779250|P5|Overall Study|Progressive disease during treatment|0
6010607|NCT00848718|20779251|P4|Overall Study|Progressive disease during treatment|0
6010608|NCT00848718|20779252|P3|Overall Study|Progressive disease during treatment|3
6010609|NCT00848718|20779253|P2|Overall Study|Progressive disease during treatment|0
6010610|NCT00848718|20779254|P1|Overall Study|Progressive disease during treatment|3
6010611|NCT00848718|20779242|P13|Overall Study|Withdrawal by Subject|0
6010612|NCT00848718|20779243|P12|Overall Study|Withdrawal by Subject|0
6010613|NCT00848718|20779244|P11|Overall Study|Withdrawal by Subject|1
6010614|NCT00848718|20779245|P10|Overall Study|Withdrawal by Subject|0
6010615|NCT00848718|20779246|P9|Overall Study|Withdrawal by Subject|0
6010616|NCT00848718|20779247|P8|Overall Study|Withdrawal by Subject|0
6010617|NCT00848718|20779248|P7|Overall Study|Withdrawal by Subject|0
6010618|NCT00848718|20779249|P6|Overall Study|Withdrawal by Subject|0
6010619|NCT00848718|20779250|P5|Overall Study|Withdrawal by Subject|0
6010620|NCT00848718|20779251|P4|Overall Study|Withdrawal by Subject|1
6010621|NCT00848718|20779252|P3|Overall Study|Withdrawal by Subject|0
6010622|NCT00848718|20779253|P2|Overall Study|Withdrawal by Subject|0
6010623|NCT00848718|20779254|P1|Overall Study|Withdrawal by Subject|1
6010624|NCT00848718|20779242|P13|Overall Study|Protocol Violation|1
6010625|NCT00848718|20779243|P12|Overall Study|Protocol Violation|0
6010626|NCT00848718|20779244|P11|Overall Study|Protocol Violation|0
6010627|NCT00848718|20779245|P10|Overall Study|Protocol Violation|0
6010628|NCT00848718|20779246|P9|Overall Study|Protocol Violation|0
6010629|NCT00848718|20779247|P8|Overall Study|Protocol Violation|1
6010630|NCT00848718|20779248|P7|Overall Study|Protocol Violation|0
6010631|NCT00848718|20779249|P6|Overall Study|Protocol Violation|0
6010632|NCT00848718|20779250|P5|Overall Study|Protocol Violation|0
6010633|NCT00848718|20779251|P4|Overall Study|Protocol Violation|0
6010634|NCT00848718|20779252|P3|Overall Study|Protocol Violation|0
6010635|NCT00848718|20779253|P2|Overall Study|Protocol Violation|1
6010636|NCT00848718|20779254|P1|Overall Study|Protocol Violation|0
6010637|NCT00848718|20779242|P13|Overall Study|Progressive disease before treatment|2
6010638|NCT00848718|20779243|P12|Overall Study|Progressive disease before treatment|6
6010639|NCT00848718|20779244|P11|Overall Study|Progressive disease before treatment|3
6010640|NCT00848718|20779245|P10|Overall Study|Progressive disease before treatment|7
6010641|NCT00848718|20779246|P9|Overall Study|Progressive disease before treatment|2
6010642|NCT00848718|20779247|P8|Overall Study|Progressive disease before treatment|1
6010643|NCT00848718|20779248|P7|Overall Study|Progressive disease before treatment|2
6010644|NCT00848718|20779249|P6|Overall Study|Progressive disease before treatment|4
6010645|NCT00848718|20779250|P5|Overall Study|Progressive disease before treatment|4
6010646|NCT00848718|20779251|P4|Overall Study|Progressive disease before treatment|3
6010647|NCT00848718|20779252|P3|Overall Study|Progressive disease before treatment|1
6010648|NCT00848718|20779253|P2|Overall Study|Progressive disease before treatment|5
6010649|NCT00848718|20779254|P1|Overall Study|Progressive disease before treatment|1
6010650|NCT00848718|20779242|P13|Overall Study|Physician Decision|1
6010651|NCT00848718|20779243|P12|Overall Study|Physician Decision|0
6010652|NCT00848718|20779244|P11|Overall Study|Physician Decision|0
6010653|NCT00848718|20779245|P10|Overall Study|Physician Decision|2
6010654|NCT00848718|20779246|P9|Overall Study|Physician Decision|1
6010655|NCT00848718|20779247|P8|Overall Study|Physician Decision|0
6010656|NCT00848718|20779248|P7|Overall Study|Physician Decision|0
6010657|NCT00848718|20779249|P6|Overall Study|Physician Decision|1
6010658|NCT00848718|20779250|P5|Overall Study|Physician Decision|1
6010659|NCT00848718|20779251|P4|Overall Study|Physician Decision|0
6010660|NCT00848718|20779252|P3|Overall Study|Physician Decision|0
6010661|NCT00848718|20779253|P2|Overall Study|Physician Decision|1
6010662|NCT00848718|20779254|P1|Overall Study|Physician Decision|0
6010663|NCT00848718|20779242|P13|Overall Study|Lack of Efficacy|0
6010664|NCT00848718|20779243|P12|Overall Study|Lack of Efficacy|0
6010665|NCT00848718|20779244|P11|Overall Study|Lack of Efficacy|0
6010666|NCT00848718|20779245|P10|Overall Study|Lack of Efficacy|0
6010667|NCT00848718|20779246|P9|Overall Study|Lack of Efficacy|0
6010668|NCT00848718|20779247|P8|Overall Study|Lack of Efficacy|0
6010669|NCT00848718|20779248|P7|Overall Study|Lack of Efficacy|1
6010670|NCT00848718|20779249|P6|Overall Study|Lack of Efficacy|0
6010671|NCT00848718|20779250|P5|Overall Study|Lack of Efficacy|0
6010672|NCT00848718|20779251|P4|Overall Study|Lack of Efficacy|0
6010673|NCT00848718|20779252|P3|Overall Study|Lack of Efficacy|1
6010674|NCT00848718|20779253|P2|Overall Study|Lack of Efficacy|0
6010675|NCT00848718|20779254|P1|Overall Study|Lack of Efficacy|0
6010676|NCT00848718|20779242|P13|Overall Study|Adverse Event|2
6010677|NCT00848718|20779243|P12|Overall Study|Adverse Event|0
6010678|NCT00848718|20779244|P11|Overall Study|Adverse Event|0
6010679|NCT00848718|20779245|P10|Overall Study|Adverse Event|0
6010680|NCT00848718|20779246|P9|Overall Study|Adverse Event|1
6010681|NCT00848718|20779247|P8|Overall Study|Adverse Event|1
6010682|NCT00848718|20779248|P7|Overall Study|Adverse Event|0
6010683|NCT00848718|20779249|P6|Overall Study|Adverse Event|0
6010684|NCT00848718|20779250|P5|Overall Study|Adverse Event|1
6010685|NCT00848718|20779251|P4|Overall Study|Adverse Event|1
6010686|NCT00848718|20779252|P3|Overall Study|Adverse Event|1
6010687|NCT00848718|20779253|P2|Overall Study|Adverse Event|2
6010688|NCT00848718|20779254|P1|Overall Study|Adverse Event|2
6010689|NCT00848549|20779355|P2|E2090-E044-314 (Extension Study)|Other|6
6010690|NCT00848549|20779356|P1|E2090-E044-314 (Extension Study)|Other|5
6010691|NCT00848549|20779355|P2|E2090-E044-314 (Extension Study)|Physician Decision|2
6010692|NCT00848549|20779356|P1|E2090-E044-314 (Extension Study)|Physician Decision|0
6010693|NCT00848549|20779355|P2|E2090-E044-314 (Extension Study)|Lack of Efficacy|1
6010694|NCT00848549|20779356|P1|E2090-E044-314 (Extension Study)|Lack of Efficacy|1
6010695|NCT00848549|20779355|P2|E2090-E044-314 (Extension Study)|Withdrawal by Subject|12
6010696|NCT00848549|20779356|P1|E2090-E044-314 (Extension Study)|Withdrawal by Subject|8
6010697|NCT00848549|20779355|P2|E2090-E044-314 (Extension Study)|Protocol Violation|2
6010698|NCT00848549|20779356|P1|E2090-E044-314 (Extension Study)|Protocol Violation|1
6010699|NCT00848549|20779355|P2|E2090-E044-314 (Extension Study)|Adverse Event|1
6010700|NCT00848549|20779356|P1|E2090-E044-314 (Extension Study)|Adverse Event|2
6010701|NCT00848549|20779355|P2|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|34
6010702|NCT00848549|20779356|P1|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|24
6010703|NCT00848549|20779355|P2|E2090-E044-310 (Base Study) Disposition|Other|3
6010704|NCT00848549|20779356|P1|E2090-E044-310 (Base Study) Disposition|Other|4
6010705|NCT00848549|20779355|P2|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|11
6010706|NCT00848549|20779356|P1|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|21
6010707|NCT00848549|20779355|P2|E2090-E044-310 (Base Study) Disposition|Physician Decision|5
6010708|NCT00848549|20779356|P1|E2090-E044-310 (Base Study) Disposition|Physician Decision|4
6010709|NCT00848549|20779355|P2|E2090-E044-310 (Base Study) Disposition|Protocol Violation|8
6010710|NCT00848549|20779356|P1|E2090-E044-310 (Base Study) Disposition|Protocol Violation|3
6010711|NCT00848549|20779355|P2|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23
6010712|NCT00848549|20779356|P1|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23
6010713|NCT00848549|20779355|P2|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|24
6010714|NCT00848549|20779356|P1|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|35
6010715|NCT00848549|20779355|P2|E2090-E044-310 (Base Study) Disposition|Adverse Event|35
6010716|NCT00848549|20779356|P1|E2090-E044-310 (Base Study) Disposition|Adverse Event|31
6010717|NCT00848536|20779374|P2|Overall Study|Patient Moved|2
6010718|NCT00848536|20779375|P1|Overall Study|Patient Moved|0
6010719|NCT00848536|20779374|P2|Overall Study|Inadequate Control of IOP|1
6010720|NCT00848536|20779375|P1|Overall Study|Inadequate Control of IOP|1
6010721|NCT00848536|20779374|P2|Overall Study|Noncompliance|0
6010722|NCT00848536|20779375|P1|Overall Study|Noncompliance|1
6010723|NCT00848536|20779374|P2|Overall Study|Protocol Violation|1
6010724|NCT00848536|20779375|P1|Overall Study|Protocol Violation|0
6010725|NCT00848536|20779374|P2|Overall Study|Withdrawal by Subject|1
6010726|NCT00848536|20779375|P1|Overall Study|Withdrawal by Subject|0
6010727|NCT00848536|20779374|P2|Overall Study|Adverse Event|2
6010728|NCT00848536|20779375|P1|Overall Study|Adverse Event|2
6010729|NCT00848497|20779440|P2|Overall Study|Withdrawal by Subject|1
6010730|NCT00848497|20779441|P1|Overall Study|Withdrawal by Subject|0
6010731|NCT00848497|20779440|P2|Overall Study|Screen failure|0
6010732|NCT00848497|20779441|P1|Overall Study|Screen failure|2
6010733|NCT00848484|20779455|P2|Second Intervention (Treatment Period 2)|Lost to Follow-up|1
6010734|NCT00848484|20779456|P1|Second Intervention (Treatment Period 2)|Lost to Follow-up|0
6010735|NCT00848484|20779455|P2|Washout Period of Two Weeks|Withdrawal by Subject|3
6010736|NCT00848484|20779456|P1|Washout Period of Two Weeks|Withdrawal by Subject|0
6010737|NCT00848484|20779455|P2|First Intervention (Treatment Period 1)|Withdrawal by Subject|1
6010738|NCT00848484|20779456|P1|First Intervention (Treatment Period 1)|Withdrawal by Subject|0
6010739|NCT00848484|20779455|P2|First Intervention (Treatment Period 1)|Physician Decision|1
6010740|NCT00848484|20779456|P1|First Intervention (Treatment Period 1)|Physician Decision|0
6010741|NCT00848484|20779455|P2|First Intervention (Treatment Period 1)|Adverse Event|1
6010742|NCT00848484|20779456|P1|First Intervention (Treatment Period 1)|Adverse Event|2
6010743|NCT00848393|20779475|P3|Overall Study|surgical complications unrelated to stud|2
6010744|NCT00848393|20779476|P2|Overall Study|surgical complications unrelated to stud|0
6010745|NCT00848393|20779477|P1|Overall Study|surgical complications unrelated to stud|0
6010746|NCT00848393|20779475|P3|Overall Study|Protocol Violation|1
6010747|NCT00848393|20779476|P2|Overall Study|Protocol Violation|0
6010748|NCT00848393|20779477|P1|Overall Study|Protocol Violation|0
6010749|NCT00848354|20779516|P2|Phase 2 Year 2|Unsatisfactory Response - Efficacy|0
6010750|NCT00848354|20779517|P1|Phase 2 Year 2|Unsatisfactory Response - Efficacy|2
6010751|NCT00848354|20779516|P2|Phase 2 Year 2|Subject Request|1
6010752|NCT00848354|20779517|P1|Phase 2 Year 2|Subject Request|1
6010753|NCT00848354|20779516|P2|Phase 2 Year 2|Protocol Violation|1
6010754|NCT00848354|20779517|P1|Phase 2 Year 2|Protocol Violation|1
6010755|NCT00848354|20779516|P2|Phase 2 Year 2|Unspecified Reason|0
6010756|NCT00848354|20779517|P1|Phase 2 Year 2|Unspecified Reason|1
6010757|NCT00848354|20779516|P2|Phase 2 Year 2|Lost to Follow-up|3
6010758|NCT00848354|20779517|P1|Phase 2 Year 2|Lost to Follow-up|1
6010759|NCT00848354|20779516|P2|Phase 2 Year 2|Failed to return|0
6010760|NCT00848354|20779517|P1|Phase 2 Year 2|Failed to return|3
6010761|NCT00848354|20779516|P2|Phase 2 Year 2|Death|0
6010762|NCT00848354|20779517|P1|Phase 2 Year 2|Death|2
6010763|NCT00848354|20779516|P2|Phase 2 Year 2|Adverse Event|2
6010764|NCT00848354|20779517|P1|Phase 2 Year 2|Adverse Event|12
6010765|NCT00848354|20779516|P2|Phase 2 Year 1|Subject Request|2
6010766|NCT00848354|20779517|P1|Phase 2 Year 1|Subject Request|1
6010767|NCT00848354|20779516|P2|Phase 2 Year 1|Protocol Violation|1
6010768|NCT00848354|20779517|P1|Phase 2 Year 1|Protocol Violation|4
6010769|NCT00848354|20779516|P2|Phase 2 Year 1|Unspecified Reason|0
6010770|NCT00848354|20779517|P1|Phase 2 Year 1|Unspecified Reason|3
6010771|NCT00848354|20779516|P2|Phase 2 Year 1|Lost to Follow-up|0
6010772|NCT00848354|20779517|P1|Phase 2 Year 1|Lost to Follow-up|1
6010773|NCT00848354|20779516|P2|Phase 2 Year 1|Failed to Return|1
6010774|NCT00848354|20779517|P1|Phase 2 Year 1|Failed to Return|1
6010775|NCT00848354|20779516|P2|Phase 2 Year 1|Death|0
6010776|NCT00848354|20779517|P1|Phase 2 Year 1|Death|1
6010777|NCT00848354|20779516|P2|Phase 2 Year 1|Adverse Event|2
6010778|NCT00848354|20779517|P1|Phase 2 Year 1|Adverse Event|7
6010779|NCT00848354|20779516|P2|Phase 1|Lack of Efficacy|1
6010780|NCT00848354|20779517|P1|Phase 1|Lack of Efficacy|0
6010781|NCT00848354|20779516|P2|Phase 1|Withdrawal by Subject|4
6010782|NCT00848354|20779517|P1|Phase 1|Withdrawal by Subject|2
6010783|NCT00848354|20779516|P2|Phase 1|Protocol Violation|1
6010784|NCT00848354|20779517|P1|Phase 1|Protocol Violation|1
6010785|NCT00848354|20779516|P2|Phase 1|Unspecified Reason|1
6010786|NCT00848354|20779517|P1|Phase 1|Unspecified Reason|1
6010787|NCT00848354|20779516|P2|Phase 1|Lost to Follow-up|1
6010788|NCT00848354|20779517|P1|Phase 1|Lost to Follow-up|1
6010789|NCT00848354|20779516|P2|Phase 1|Failed to return|1
6010790|NCT00848354|20779517|P1|Phase 1|Failed to return|0
6010791|NCT00848354|20779516|P2|Phase 1|Discontinuation of study by sponsor|1
6010792|NCT00848354|20779517|P1|Phase 1|Discontinuation of study by sponsor|2
6010793|NCT00848354|20779516|P2|Phase 1|Adverse Event|4
6010794|NCT00848354|20779517|P1|Phase 1|Adverse Event|5
6010795|NCT00848250|20779669|P2|Overall Study|surgery was completed without cardiopulm|1
6010796|NCT00848250|20779670|P1|Overall Study|surgery was completed without cardiopulm|0
6010797|NCT00848211|20779701|P4|Overall Study|Adverse Event|0
6010798|NCT00848211|20779702|P3|Overall Study|Adverse Event|0
6010799|NCT00848211|20779703|P2|Overall Study|Adverse Event|0
6010800|NCT00848211|20779704|P1|Overall Study|Adverse Event|0
6010801|NCT00848211|20779701|P4|Overall Study|Protocol Violation|0
6010802|NCT00848211|20779702|P3|Overall Study|Protocol Violation|1
6010803|NCT00848211|20779703|P2|Overall Study|Protocol Violation|1
6010804|NCT00848211|20779704|P1|Overall Study|Protocol Violation|0
6010805|NCT00848198|20779722|P1|Overall Study|Incomplete Case Report Forms|15
6010806|NCT00848120|20779787|P1|Overall Study|Adverse Event|1
6010807|NCT00848107|20779799|P1|Overall Study|Pregnancy|1
6010808|NCT00848107|20779799|P1|Overall Study|Death|1
6010809|NCT00848107|20779799|P1|Overall Study|Adverse Event|9
6010810|NCT00848107|20779799|P1|Overall Study|Withdrawal by Subject|8
6010811|NCT00848107|20779799|P1|Overall Study|Lost to Follow-up|2
6010812|NCT00848081|20779809|P2|Overall Study|Withdrawal by Subject|3
6010813|NCT00848081|20779810|P1|Overall Study|Withdrawal by Subject|5
6010814|NCT00848081|20779809|P2|Overall Study|Physician Decision|3
6010815|NCT00848081|20779810|P1|Overall Study|Physician Decision|0
6010816|NCT00848081|20779809|P2|Overall Study|Lost to Follow-up|0
6010817|NCT00848081|20779810|P1|Overall Study|Lost to Follow-up|1
6010818|NCT00848081|20779809|P2|Overall Study|Protocol Violation|5
6010819|NCT00848081|20779810|P1|Overall Study|Protocol Violation|8
6010820|NCT00848081|20779809|P2|Overall Study|Adverse Event|7
6010821|NCT00848081|20779810|P1|Overall Study|Adverse Event|6
6010822|NCT00848042|20779827|P3|Overall Study|Other Therapy|0
6010823|NCT00848042|20779828|P2|Overall Study|Other Therapy|0
6010824|NCT00848042|20779829|P1|Overall Study|Other Therapy|3
6010825|NCT00848042|20779827|P3|Overall Study|Death|0
6010826|NCT00848042|20779828|P2|Overall Study|Death|2
6010827|NCT00848042|20779829|P1|Overall Study|Death|1
6010832|NCT00847886|20779876|P2|Overall Study|Adverse Event|1
6010833|NCT00847886|20779877|P1|Overall Study|Adverse Event|0
6010834|NCT00847808|20779903|P1|Overall Study|Participant Took Excluded Medication|1
6010835|NCT00847808|20779903|P1|Overall Study|Participant Reported Lack of Efficacy|1
6010836|NCT00847808|20779903|P1|Overall Study|Withdrawal by Subject|4
6010837|NCT00847808|20779903|P1|Overall Study|Lost to Follow-up|1
6010838|NCT00847808|20779903|P1|Overall Study|Protocol Violation|1
6010839|NCT00847808|20779903|P1|Overall Study|Adverse Event|7
6010840|NCT00847730|20779920|P1|Overall Study|Multiple interruptions in therapy|8
6010841|NCT00847704|20779924|P1|Overall Study|Withdrawal by Subject|1
6010842|NCT00847665|20779935|P2|Overall Study|Withdrawal by Subject|0
6010843|NCT00847665|20779936|P1|Overall Study|Withdrawal by Subject|1
6010844|NCT00847626|20779959|P11|Overall Study|Other|3
6010845|NCT00847626|20779960|P10|Overall Study|Other|1
6010846|NCT00847626|20779961|P9|Overall Study|Other|1
6010847|NCT00847626|20779962|P8|Overall Study|Other|3
6010848|NCT00847626|20779963|P7|Overall Study|Other|2
6010849|NCT00847626|20779964|P6|Overall Study|Other|2
6010850|NCT00847626|20779965|P5|Overall Study|Other|2
6010851|NCT00847626|20779966|P4|Overall Study|Other|1
6010852|NCT00847626|20779967|P3|Overall Study|Other|4
6010853|NCT00847626|20779968|P2|Overall Study|Other|5
6010854|NCT00847626|20779969|P1|Overall Study|Other|1
6010855|NCT00847626|20779959|P11|Overall Study|Lack of Efficacy|7
6010856|NCT00847626|20779960|P10|Overall Study|Lack of Efficacy|1
6010857|NCT00847626|20779961|P9|Overall Study|Lack of Efficacy|5
6010858|NCT00847626|20779962|P8|Overall Study|Lack of Efficacy|2
6010859|NCT00847626|20779963|P7|Overall Study|Lack of Efficacy|6
6010860|NCT00847626|20779964|P6|Overall Study|Lack of Efficacy|0
6010861|NCT00847626|20779965|P5|Overall Study|Lack of Efficacy|2
6010862|NCT00847626|20779966|P4|Overall Study|Lack of Efficacy|1
6010863|NCT00847626|20779967|P3|Overall Study|Lack of Efficacy|0
6010864|NCT00847626|20779968|P2|Overall Study|Lack of Efficacy|1
6010865|NCT00847626|20779969|P1|Overall Study|Lack of Efficacy|3
6010866|NCT00847626|20779959|P11|Overall Study|Withdrawal by Subject|2
6010867|NCT00847626|20779960|P10|Overall Study|Withdrawal by Subject|5
6010868|NCT00847626|20779961|P9|Overall Study|Withdrawal by Subject|4
6010869|NCT00847626|20779962|P8|Overall Study|Withdrawal by Subject|4
6010870|NCT00847626|20779963|P7|Overall Study|Withdrawal by Subject|8
6010871|NCT00847626|20779964|P6|Overall Study|Withdrawal by Subject|9
6010872|NCT00847626|20779965|P5|Overall Study|Withdrawal by Subject|12
6010873|NCT00847626|20779966|P4|Overall Study|Withdrawal by Subject|8
6010874|NCT00847626|20779967|P3|Overall Study|Withdrawal by Subject|3
6010875|NCT00847626|20779968|P2|Overall Study|Withdrawal by Subject|5
6010876|NCT00847626|20779969|P1|Overall Study|Withdrawal by Subject|5
6010877|NCT00847626|20779959|P11|Overall Study|Lost to Follow-up|1
6010878|NCT00847626|20779960|P10|Overall Study|Lost to Follow-up|0
6010879|NCT00847626|20779961|P9|Overall Study|Lost to Follow-up|1
6010880|NCT00847626|20779962|P8|Overall Study|Lost to Follow-up|3
6010881|NCT00847626|20779963|P7|Overall Study|Lost to Follow-up|1
6010882|NCT00847626|20779964|P6|Overall Study|Lost to Follow-up|3
6010883|NCT00847626|20779965|P5|Overall Study|Lost to Follow-up|0
6010884|NCT00847626|20779966|P4|Overall Study|Lost to Follow-up|1
6010885|NCT00847626|20779967|P3|Overall Study|Lost to Follow-up|1
6010886|NCT00847626|20779968|P2|Overall Study|Lost to Follow-up|1
6010887|NCT00847626|20779969|P1|Overall Study|Lost to Follow-up|0
6010888|NCT00847626|20779959|P11|Overall Study|Protocol Violation|1
6010889|NCT00847626|20779960|P10|Overall Study|Protocol Violation|1
6010890|NCT00847626|20779961|P9|Overall Study|Protocol Violation|0
6010891|NCT00847626|20779962|P8|Overall Study|Protocol Violation|1
6010892|NCT00847626|20779963|P7|Overall Study|Protocol Violation|1
6010893|NCT00847626|20779964|P6|Overall Study|Protocol Violation|1
6010894|NCT00847626|20779965|P5|Overall Study|Protocol Violation|1
6010895|NCT00847626|20779966|P4|Overall Study|Protocol Violation|1
6010896|NCT00847626|20779967|P3|Overall Study|Protocol Violation|2
6010897|NCT00847626|20779968|P2|Overall Study|Protocol Violation|1
6010898|NCT00847626|20779969|P1|Overall Study|Protocol Violation|2
6010899|NCT00847626|20779959|P11|Overall Study|Adverse Event|6
6010900|NCT00847626|20779960|P10|Overall Study|Adverse Event|6
6010901|NCT00847626|20779961|P9|Overall Study|Adverse Event|3
6010902|NCT00847626|20779962|P8|Overall Study|Adverse Event|6
6010903|NCT00847626|20779963|P7|Overall Study|Adverse Event|4
6010904|NCT00847626|20779964|P6|Overall Study|Adverse Event|22
6010905|NCT00847626|20779965|P5|Overall Study|Adverse Event|11
6010906|NCT00847626|20779966|P4|Overall Study|Adverse Event|19
6010907|NCT00847626|20779967|P3|Overall Study|Adverse Event|6
6010908|NCT00847626|20779968|P2|Overall Study|Adverse Event|10
6010909|NCT00847626|20779969|P1|Overall Study|Adverse Event|10
6010910|NCT00847613|20780168|P4|Overall Study|Other|0
6010911|NCT00847613|20780169|P3|Overall Study|Other|2
6010912|NCT00847613|20780170|P2|Overall Study|Other|1
6010913|NCT00847613|20780171|P1|Overall Study|Other|1
6010914|NCT00847613|20780168|P4|Overall Study|Randomized, but not treated|0
6010915|NCT00847613|20780169|P3|Overall Study|Randomized, but not treated|0
6010916|NCT00847613|20780170|P2|Overall Study|Randomized, but not treated|3
6010917|NCT00847613|20780171|P1|Overall Study|Randomized, but not treated|0
6010918|NCT00847613|20780168|P4|Overall Study|Sponsor request|0
6010919|NCT00847613|20780169|P3|Overall Study|Sponsor request|0
6010920|NCT00847613|20780170|P2|Overall Study|Sponsor request|1
6010921|NCT00847613|20780171|P1|Overall Study|Sponsor request|0
6010922|NCT00847613|20780168|P4|Overall Study|Participant moved|0
6010923|NCT00847613|20780169|P3|Overall Study|Participant moved|0
6010924|NCT00847613|20780170|P2|Overall Study|Participant moved|1
6010925|NCT00847613|20780171|P1|Overall Study|Participant moved|4
6010926|NCT00847613|20780168|P4|Overall Study|Withdrawal by Subject|2
6010927|NCT00847613|20780169|P3|Overall Study|Withdrawal by Subject|2
6010928|NCT00847613|20780170|P2|Overall Study|Withdrawal by Subject|11
6010929|NCT00847613|20780171|P1|Overall Study|Withdrawal by Subject|8
6010930|NCT00847613|20780168|P4|Overall Study|Site closure|1
6010931|NCT00847613|20780169|P3|Overall Study|Site closure|0
6010932|NCT00847613|20780170|P2|Overall Study|Site closure|0
6010933|NCT00847613|20780171|P1|Overall Study|Site closure|1
6010934|NCT00847613|20780168|P4|Overall Study|Pregnancy|0
6010935|NCT00847613|20780169|P3|Overall Study|Pregnancy|0
6010936|NCT00847613|20780170|P2|Overall Study|Pregnancy|1
6010937|NCT00847613|20780171|P1|Overall Study|Pregnancy|1
6010938|NCT00847613|20780168|P4|Overall Study|Protocol Violation|1
6010939|NCT00847613|20780169|P3|Overall Study|Protocol Violation|3
6010940|NCT00847613|20780170|P2|Overall Study|Protocol Violation|6
6010941|NCT00847613|20780171|P1|Overall Study|Protocol Violation|6
6010942|NCT00847613|20780168|P4|Overall Study|Lost to Follow-up|3
6010943|NCT00847613|20780169|P3|Overall Study|Lost to Follow-up|0
6010944|NCT00847613|20780170|P2|Overall Study|Lost to Follow-up|0
6010945|NCT00847613|20780171|P1|Overall Study|Lost to Follow-up|5
6010946|NCT00847613|20780168|P4|Overall Study|Study terminated by Sponsor|1
6010947|NCT00847613|20780169|P3|Overall Study|Study terminated by Sponsor|2
6010948|NCT00847613|20780170|P2|Overall Study|Study terminated by Sponsor|0
6010949|NCT00847613|20780171|P1|Overall Study|Study terminated by Sponsor|1
6010950|NCT00847613|20780168|P4|Overall Study|Lack of Efficacy|1
6010951|NCT00847613|20780169|P3|Overall Study|Lack of Efficacy|3
6010952|NCT00847613|20780170|P2|Overall Study|Lack of Efficacy|3
6010953|NCT00847613|20780171|P1|Overall Study|Lack of Efficacy|7
6010954|NCT00847613|20780168|P4|Overall Study|Adverse Event|6
6010955|NCT00847613|20780169|P3|Overall Study|Adverse Event|5
6010956|NCT00847613|20780170|P2|Overall Study|Adverse Event|26
6010957|NCT00847613|20780171|P1|Overall Study|Adverse Event|36
6010958|NCT00847613|20780168|P4|Overall Study|Death|0
6010959|NCT00847613|20780169|P3|Overall Study|Death|0
6010960|NCT00847613|20780170|P2|Overall Study|Death|1
6010961|NCT00847613|20780171|P1|Overall Study|Death|1
6010962|NCT00847613|20780168|P4|Overall Study|Ongoing at cut-off date|64
6010963|NCT00847613|20780169|P3|Overall Study|Ongoing at cut-off date|64
6010964|NCT00847613|20780170|P2|Overall Study|Ongoing at cut-off date|265
6010965|NCT00847613|20780171|P1|Overall Study|Ongoing at cut-off date|250
6010966|NCT00847561|20780422|P2|Overall Study|Unable to schedule|1
6010967|NCT00847561|20780423|P1|Overall Study|Unable to schedule|9
6010968|NCT00847561|20780422|P2|Overall Study|Withdrawal by Subject|3
6010969|NCT00847561|20780423|P1|Overall Study|Withdrawal by Subject|4
6010970|NCT00847535|20780429|P3|Overall Study|Lost to Follow-up|0
6010971|NCT00847535|20780430|P2|Overall Study|Lost to Follow-up|1
6010972|NCT00847535|20780431|P1|Overall Study|Lost to Follow-up|0
6010973|NCT00847535|20780429|P3|Overall Study|Withdrawal by Subject|1
6010974|NCT00847535|20780430|P2|Overall Study|Withdrawal by Subject|1
6010975|NCT00847535|20780431|P1|Overall Study|Withdrawal by Subject|2
6010976|NCT00847405|20780450|P2|Washout of 7 Days|Withdrawal by Subject|0
6010977|NCT00847405|20780451|P1|Washout of 7 Days|Withdrawal by Subject|1
6010978|NCT00847405|20780450|P2|First Intervention|Adverse Event|1
6010979|NCT00847405|20780451|P1|First Intervention|Adverse Event|0
6010980|NCT00847379|20780462|P3|Overall Study|Study terminated by Sponsor|57
6010981|NCT00847379|20780463|P2|Overall Study|Study terminated by Sponsor|57
6010982|NCT00847379|20780464|P1|Overall Study|Study terminated by Sponsor|59
6010983|NCT00847301|20780562|P1|Overall Study|Other reason not defined above|1
6010984|NCT00847301|20780562|P1|Overall Study|No prescription after hospital discharge|1
6010985|NCT00847301|20780562|P1|Overall Study|Lost to Follow-up|1
6010986|NCT00847301|20780562|P1|Overall Study|Switch to other anticoagulants|16
6010987|NCT00847301|20780562|P1|Overall Study|Adverse Event|35
6010988|NCT00847197|20780610|P2|Overall Study|Withdrawal by Subject|1
6010989|NCT00847197|20780611|P1|Overall Study|Withdrawal by Subject|3
6010990|NCT00847197|20780610|P2|Overall Study|Protocol Violation|1
6010991|NCT00847197|20780611|P1|Overall Study|Protocol Violation|0
6010992|NCT00847197|20780610|P2|Overall Study|Adverse Event|3
6010993|NCT00847197|20780611|P1|Overall Study|Adverse Event|21
6010994|NCT00847145|20780635|P8|Overall Study|Protocol Violation|1
6010995|NCT00847145|20780636|P7|Overall Study|Protocol Violation|0
6010996|NCT00847145|20780637|P6|Overall Study|Protocol Violation|0
6010997|NCT00847145|20780638|P5|Overall Study|Protocol Violation|1
6010998|NCT00847145|20780639|P4|Overall Study|Protocol Violation|0
6010999|NCT00847145|20780640|P3|Overall Study|Protocol Violation|3
6011000|NCT00847145|20780641|P2|Overall Study|Protocol Violation|0
6011001|NCT00847145|20780642|P1|Overall Study|Protocol Violation|0
6011002|NCT00847145|20780635|P8|Overall Study|Inappropriate enrollment|0
6011003|NCT00847145|20780636|P7|Overall Study|Inappropriate enrollment|0
6011004|NCT00847145|20780637|P6|Overall Study|Inappropriate enrollment|0
6011005|NCT00847145|20780638|P5|Overall Study|Inappropriate enrollment|1
6011006|NCT00847145|20780639|P4|Overall Study|Inappropriate enrollment|0
6011007|NCT00847145|20780640|P3|Overall Study|Inappropriate enrollment|0
6011008|NCT00847145|20780641|P2|Overall Study|Inappropriate enrollment|0
6011009|NCT00847145|20780642|P1|Overall Study|Inappropriate enrollment|0
6011010|NCT00847145|20780635|P8|Overall Study|Lost to Follow-up|2
6011011|NCT00847145|20780636|P7|Overall Study|Lost to Follow-up|8
6011012|NCT00847145|20780637|P6|Overall Study|Lost to Follow-up|4
6011013|NCT00847145|20780638|P5|Overall Study|Lost to Follow-up|4
6011014|NCT00847145|20780639|P4|Overall Study|Lost to Follow-up|0
6011015|NCT00847145|20780640|P3|Overall Study|Lost to Follow-up|1
6011016|NCT00847145|20780641|P2|Overall Study|Lost to Follow-up|1
6011017|NCT00847145|20780642|P1|Overall Study|Lost to Follow-up|3
6011018|NCT00847145|20780635|P8|Overall Study|Withdrawal by Subject|1
6011019|NCT00847145|20780636|P7|Overall Study|Withdrawal by Subject|1
6011020|NCT00847145|20780637|P6|Overall Study|Withdrawal by Subject|0
6011021|NCT00847145|20780638|P5|Overall Study|Withdrawal by Subject|0
6011022|NCT00847145|20780639|P4|Overall Study|Withdrawal by Subject|1
6011023|NCT00847145|20780640|P3|Overall Study|Withdrawal by Subject|6
6011024|NCT00847145|20780641|P2|Overall Study|Withdrawal by Subject|4
6011025|NCT00847145|20780642|P1|Overall Study|Withdrawal by Subject|3
6011026|NCT00847145|20780635|P8|Overall Study|AE or Death|0
6011027|NCT00847145|20780636|P7|Overall Study|AE or Death|0
6011028|NCT00847145|20780637|P6|Overall Study|AE or Death|0
6011029|NCT00847145|20780638|P5|Overall Study|AE or Death|0
6011030|NCT00847145|20780639|P4|Overall Study|AE or Death|0
6011031|NCT00847145|20780640|P3|Overall Study|AE or Death|1
6011032|NCT00847145|20780641|P2|Overall Study|AE or Death|1
6011033|NCT00847145|20780642|P1|Overall Study|AE or Death|0
6011034|NCT00847132|20780692|P2|Overall Study|Death|1
6011035|NCT00847132|20780693|P1|Overall Study|Death|1
6011036|NCT00847015|20780701|P1|Overall Study|partial cystectomy vs radical cystectomy|1
6011037|NCT00847015|20780701|P1|Overall Study|declined any surgery|1
6011038|NCT00847015|20780701|P1|Overall Study|Withdrawal by Subject|1
6011039|NCT00846846|20780729|P1|Overall Study|Withdrawal by Subject|19
6011040|NCT00846846|20780729|P1|Overall Study|Death|56
6011041|NCT00846807|20780734|P1|Overall Study|Other|60
6011042|NCT00846807|20780734|P1|Overall Study|No prescription after hospital discharge|56
6011043|NCT00846807|20780734|P1|Overall Study|Switch to other anticoagulants|89
6011044|NCT00846807|20780734|P1|Overall Study|Non compliant with European label|7
6011045|NCT00846807|20780734|P1|Overall Study|Withdrawal by Subject|56
6011046|NCT00846807|20780734|P1|Overall Study|Lost to Follow-up|94
6011047|NCT00846807|20780734|P1|Overall Study|Adverse Event|270
6011048|NCT00846768|20780742|P4|Overall Study|Adverse Event|0
6011049|NCT00846768|20780743|P3|Overall Study|Adverse Event|0
6011050|NCT00846768|20780744|P2|Overall Study|Adverse Event|1
6011051|NCT00846768|20780745|P1|Overall Study|Adverse Event|0
6011052|NCT00846742|20780815|P1|Overall Study|Withdrawal by Subject|1
6011053|NCT00846586|20780842|P2|Overall Study|Unsatisfactory therapeutic effect|1
6011054|NCT00846586|20780843|P1|Overall Study|Unsatisfactory therapeutic effect|0
6011055|NCT00846586|20780842|P2|Overall Study|Lost to Follow-up|4
6011056|NCT00846586|20780843|P1|Overall Study|Lost to Follow-up|1
6011057|NCT00846586|20780842|P2|Overall Study|Abnormal test procedure result(s)|0
6011058|NCT00846586|20780843|P1|Overall Study|Abnormal test procedure result(s)|1
6011059|NCT00846586|20780842|P2|Overall Study|Protocol deviation|6
6011060|NCT00846586|20780843|P1|Overall Study|Protocol deviation|2
6011061|NCT00846586|20780842|P2|Overall Study|Death|0
6011062|NCT00846586|20780843|P1|Overall Study|Death|2
6011063|NCT00846586|20780842|P2|Overall Study|Administrative problems|4
6011064|NCT00846586|20780843|P1|Overall Study|Administrative problems|5
6011065|NCT00846586|20780842|P2|Overall Study|Subject withdrew consent|10
6011066|NCT00846586|20780843|P1|Overall Study|Subject withdrew consent|8
6011067|NCT00846586|20780842|P2|Overall Study|Adverse Event|10
6011068|NCT00846586|20780843|P1|Overall Study|Adverse Event|20
6011069|NCT00846521|20780877|P1|Overall Study|Protocol Violation|1
6011070|NCT00846521|20780877|P1|Overall Study|Did not meet OGTT/ CGMS criteria|5
6011071|NCT00846521|20780877|P1|Overall Study|Withdrawal by Subject|5
6011072|NCT00846495|20780884|P2|Overall Study|Physician Decision|0
6011073|NCT00846495|20780885|P1|Overall Study|Physician Decision|1
6011074|NCT00846495|20780884|P2|Overall Study|Lack of Efficacy|2
6011075|NCT00846495|20780885|P1|Overall Study|Lack of Efficacy|1
6011076|NCT00846495|20780884|P2|Overall Study|Adverse Event|1
6011077|NCT00846495|20780885|P1|Overall Study|Adverse Event|5
6011078|NCT00846495|20780884|P2|Overall Study|Lost to Follow-up|0
6011079|NCT00846495|20780885|P1|Overall Study|Lost to Follow-up|1
6011080|NCT00846391|20780913|P3|Overall Study|Study Terminated by Sponsor|2
6011081|NCT00846391|20780914|P2|Overall Study|Study Terminated by Sponsor|2
6011082|NCT00846391|20780915|P1|Overall Study|Study Terminated by Sponsor|1
6011083|NCT00846391|20780913|P3|Overall Study|Physician Decision|1
6011084|NCT00846391|20780914|P2|Overall Study|Physician Decision|0
6011085|NCT00846391|20780915|P1|Overall Study|Physician Decision|0
6011086|NCT00846365|20780926|P3|Overall Study|Other|6
6011087|NCT00846365|20780927|P2|Overall Study|Other|1
6011088|NCT00846365|20780928|P1|Overall Study|Other|9
6011089|NCT00846365|20780926|P3|Overall Study|Lack of Efficacy|2
6011090|NCT00846365|20780927|P2|Overall Study|Lack of Efficacy|1
6011091|NCT00846365|20780928|P1|Overall Study|Lack of Efficacy|1
6011092|NCT00846365|20780926|P3|Overall Study|Pregnancy|0
6011093|NCT00846365|20780927|P2|Overall Study|Pregnancy|0
6011094|NCT00846365|20780928|P1|Overall Study|Pregnancy|1
6011095|NCT00846365|20780926|P3|Overall Study|Withdrawal by Subject|9
6011096|NCT00846365|20780927|P2|Overall Study|Withdrawal by Subject|11
6011097|NCT00846365|20780928|P1|Overall Study|Withdrawal by Subject|11
6011098|NCT00846365|20780926|P3|Overall Study|Lost to Follow-up|5
6011099|NCT00846365|20780927|P2|Overall Study|Lost to Follow-up|2
6011100|NCT00846365|20780928|P1|Overall Study|Lost to Follow-up|8
6011101|NCT00846365|20780926|P3|Overall Study|Protocol Violation|0
6011102|NCT00846365|20780927|P2|Overall Study|Protocol Violation|4
6011103|NCT00846365|20780928|P1|Overall Study|Protocol Violation|5
6011104|NCT00846365|20780926|P3|Overall Study|Adverse Event|11
6011105|NCT00846365|20780927|P2|Overall Study|Adverse Event|30
6011106|NCT00846365|20780928|P1|Overall Study|Adverse Event|20
6011107|NCT00846053|20781009|P2|Overall Study|Physician Decision|0
6011108|NCT00846053|20781010|P1|Overall Study|Physician Decision|3
6011109|NCT00846027|20781018|P1|Overall Study|Subject Not Treated|7
6011110|NCT00846027|20781018|P1|Overall Study|Protocol Violation|2
6011111|NCT00846027|20781018|P1|Overall Study|Investigator Discretion|29
6011112|NCT00846027|20781018|P1|Overall Study|Patient Decision|7
6011113|NCT00846027|20781018|P1|Overall Study|Toxicity|12
6011114|NCT00846027|20781018|P1|Overall Study|Disease Progression|30
6011115|NCT00846027|20781018|P1|Overall Study|Death|3
6011116|NCT00845897|20781041|P3|Overall Study|Too ill to participate|0
6011117|NCT00845897|20781042|P2|Overall Study|Too ill to participate|1
6011118|NCT00845897|20781043|P1|Overall Study|Too ill to participate|0
6011119|NCT00845897|20781041|P3|Overall Study|Ulcer did not heal|1
6011120|NCT00845897|20781042|P2|Overall Study|Ulcer did not heal|0
6011121|NCT00845897|20781043|P1|Overall Study|Ulcer did not heal|1
6011122|NCT00845897|20781041|P3|Overall Study|Withdrawal by Subject|2
6011123|NCT00845897|20781042|P2|Overall Study|Withdrawal by Subject|3
6011124|NCT00845897|20781043|P1|Overall Study|Withdrawal by Subject|0
6011125|NCT00845897|20781041|P3|Overall Study|Lost to Follow-up|0
6011126|NCT00845897|20781042|P2|Overall Study|Lost to Follow-up|1
6011127|NCT00845897|20781043|P1|Overall Study|Lost to Follow-up|1
6011128|NCT00845858|20781057|P3|Overall Study|not eligible|2
6011129|NCT00845858|20781058|P2|Overall Study|not eligible|3
6011130|NCT00845858|20781059|P1|Overall Study|not eligible|0
6011131|NCT00845858|20781057|P3|Overall Study|Protocol Violation|1
6011132|NCT00845858|20781058|P2|Overall Study|Protocol Violation|0
6011133|NCT00845858|20781059|P1|Overall Study|Protocol Violation|0
6011134|NCT00845858|20781057|P3|Overall Study|Adverse Event|4
6011135|NCT00845858|20781058|P2|Overall Study|Adverse Event|8
6011136|NCT00845858|20781059|P1|Overall Study|Adverse Event|3
6011137|NCT00845858|20781057|P3|Overall Study|Withdrawal by Subject|1
6011138|NCT00845858|20781058|P2|Overall Study|Withdrawal by Subject|1
6011139|NCT00845858|20781059|P1|Overall Study|Withdrawal by Subject|5
6011140|NCT00845845|20781072|P2|Overall Study|Lost to Follow-up|4
6011141|NCT00845845|20781073|P1|Overall Study|Lost to Follow-up|0
6011142|NCT00845832|20781084|P3|Extended Safety Follow-Up|Withdrawal by Subject|7
6011143|NCT00845832|20781085|P2|Extended Safety Follow-Up|Withdrawal by Subject|0
6011144|NCT00845832|20781086|P1|Extended Safety Follow-Up|Withdrawal by Subject|0
6011145|NCT00845832|20781084|P3|Safety Follow-Up|Withdrawal by Subject|0
6011146|NCT00845832|20781085|P2|Safety Follow-Up|Withdrawal by Subject|0
6011147|NCT00845832|20781086|P1|Safety Follow-Up|Withdrawal by Subject|1
6011148|NCT00845832|20781084|P3|Treatment Period|Protocol Violation|0
6011149|NCT00845832|20781085|P2|Treatment Period|Protocol Violation|1
6011150|NCT00845832|20781086|P1|Treatment Period|Protocol Violation|1
6011151|NCT00845832|20781084|P3|Treatment Period|Adverse Event|0
6011152|NCT00845832|20781085|P2|Treatment Period|Adverse Event|2
6011153|NCT00845832|20781086|P1|Treatment Period|Adverse Event|0
6011154|NCT00845728|20781132|P2|Overall Study|Withdrawal by Subject|108
6011155|NCT00845728|20781133|P1|Overall Study|Withdrawal by Subject|105
6011156|NCT00845728|20781132|P2|Overall Study|Adverse Event|96
6011157|NCT00845728|20781133|P1|Overall Study|Adverse Event|101
6011158|NCT00845728|20781132|P2|Overall Study|Lack of Efficacy|39
6011159|NCT00845728|20781133|P1|Overall Study|Lack of Efficacy|51
6011160|NCT00845728|20781132|P2|Overall Study|Protocol Violation|24
6011161|NCT00845728|20781133|P1|Overall Study|Protocol Violation|36
6011162|NCT00845728|20781132|P2|Overall Study|Administrative Problems|26
6011163|NCT00845728|20781133|P1|Overall Study|Administrative Problems|34
6011164|NCT00845728|20781132|P2|Overall Study|Death|26
6011165|NCT00845728|20781133|P1|Overall Study|Death|24
6011166|NCT00845728|20781132|P2|Overall Study|Lost to Follow-up|13
6011167|NCT00845728|20781133|P1|Overall Study|Lost to Follow-up|22
6011168|NCT00845728|20781132|P2|Overall Study|Abnormal test procedure result (s)|2
6011169|NCT00845728|20781133|P1|Overall Study|Abnormal test procedure result (s)|7
6011170|NCT00845728|20781132|P2|Overall Study|Patient's inability to use the device|6
6011171|NCT00845728|20781133|P1|Overall Study|Patient's inability to use the device|4
6011172|NCT00845728|20781132|P2|Overall Study|Abnormal laboratory value (s)|2
6011173|NCT00845728|20781133|P1|Overall Study|Abnormal laboratory value (s)|2
6011174|NCT00845676|20781147|P1|Overall Study|Adverse Event|1
6011175|NCT00845676|20781147|P1|Overall Study|Virologic breakthrough at week 20|1
6011176|NCT00845650|20781210|P6|Overall Study|Unable to access IV line|0
6011177|NCT00845650|20781211|P5|Overall Study|Unable to access IV line|0
6011178|NCT00845650|20781212|P4|Overall Study|Unable to access IV line|0
6011179|NCT00845650|20781213|P3|Overall Study|Unable to access IV line|0
6011180|NCT00845650|20781214|P2|Overall Study|Unable to access IV line|0
6011181|NCT00845650|20781215|P1|Overall Study|Unable to access IV line|1
6011182|NCT00845650|20781210|P6|Overall Study|Sponsor hold on dosing|1
6011183|NCT00845650|20781211|P5|Overall Study|Sponsor hold on dosing|1
6011184|NCT00845650|20781212|P4|Overall Study|Sponsor hold on dosing|0
6011185|NCT00845650|20781213|P3|Overall Study|Sponsor hold on dosing|0
6011186|NCT00845650|20781214|P2|Overall Study|Sponsor hold on dosing|0
6011187|NCT00845650|20781215|P1|Overall Study|Sponsor hold on dosing|0
6011188|NCT00845650|20781210|P6|Overall Study|Lost to Follow-up|1
6011189|NCT00845650|20781211|P5|Overall Study|Lost to Follow-up|0
6011190|NCT00845650|20781212|P4|Overall Study|Lost to Follow-up|1
6011191|NCT00845650|20781213|P3|Overall Study|Lost to Follow-up|3
6011192|NCT00845650|20781214|P2|Overall Study|Lost to Follow-up|0
6011193|NCT00845650|20781215|P1|Overall Study|Lost to Follow-up|0
6011194|NCT00845650|20781210|P6|Overall Study|Withdrawal by Subject|0
6011195|NCT00845650|20781211|P5|Overall Study|Withdrawal by Subject|2
6011196|NCT00845650|20781212|P4|Overall Study|Withdrawal by Subject|0
6011197|NCT00845650|20781213|P3|Overall Study|Withdrawal by Subject|0
6011198|NCT00845650|20781214|P2|Overall Study|Withdrawal by Subject|0
6011199|NCT00845650|20781215|P1|Overall Study|Withdrawal by Subject|0
6011200|NCT00845520|20781253|P3|Overall Study|Adverse Event|1
6011201|NCT00845520|20781254|P2|Overall Study|Adverse Event|0
6011202|NCT00845520|20781255|P1|Overall Study|Adverse Event|0
6011203|NCT00845520|20781253|P3|Overall Study|Lost to Follow-up|0
6011204|NCT00845520|20781254|P2|Overall Study|Lost to Follow-up|0
6011205|NCT00845520|20781255|P1|Overall Study|Lost to Follow-up|1
6011206|NCT00845520|20781253|P3|Overall Study|Death|0
6011207|NCT00845520|20781254|P2|Overall Study|Death|2
6011208|NCT00845520|20781255|P1|Overall Study|Death|1
6011209|NCT00845429|20781292|P3|Overall Study|Serious adverse event|1
6011210|NCT00845429|20781293|P2|Overall Study|Serious adverse event|0
6011211|NCT00845429|20781294|P1|Overall Study|Serious adverse event|0
6011212|NCT00845429|20781292|P3|Overall Study|Withdrawal by Subject|2
6011213|NCT00845429|20781293|P2|Overall Study|Withdrawal by Subject|2
6011214|NCT00845429|20781294|P1|Overall Study|Withdrawal by Subject|2
6011215|NCT00845429|20781292|P3|Overall Study|Lost to Follow-up|10
6011216|NCT00845429|20781293|P2|Overall Study|Lost to Follow-up|9
6011217|NCT00845429|20781294|P1|Overall Study|Lost to Follow-up|7
6011218|NCT00845429|20781292|P3|Overall Study|Protocol Violation|7
6011219|NCT00845429|20781293|P2|Overall Study|Protocol Violation|4
6011220|NCT00845429|20781294|P1|Overall Study|Protocol Violation|5
6011221|NCT00845182|20781329|P3|Overall Study|Physician Decision|1
6011222|NCT00845182|20781330|P2|Overall Study|Physician Decision|0
6011223|NCT00845182|20781331|P1|Overall Study|Physician Decision|0
6011224|NCT00845182|20781329|P3|Overall Study|Adverse Event|1
6011225|NCT00845182|20781330|P2|Overall Study|Adverse Event|1
6011226|NCT00845182|20781331|P1|Overall Study|Adverse Event|0
6011227|NCT00845182|20781329|P3|Overall Study|Lost to Follow-up|4
6011228|NCT00845182|20781330|P2|Overall Study|Lost to Follow-up|3
6011229|NCT00845182|20781331|P1|Overall Study|Lost to Follow-up|3
6011230|NCT00845065|20781356|P2|Overall Study|Non-Medical Reasons|11
6011231|NCT00845065|20781357|P1|Overall Study|Non-Medical Reasons|1
6011232|NCT00845065|20781356|P2|Overall Study|Lack of Efficacy|21
6011233|NCT00845065|20781357|P1|Overall Study|Lack of Efficacy|43
6011234|NCT00845065|20781356|P2|Overall Study|Adverse Event|23
6011235|NCT00845065|20781357|P1|Overall Study|Adverse Event|3
6011236|NCT00844896|20781425|P2|Overall Study|Parents did not have time to complete|1
6011237|NCT00844896|20781426|P1|Overall Study|Parents did not have time to complete|0
6011238|NCT00844896|20781425|P2|Overall Study|Lost to Follow-up|16
6011239|NCT00844896|20781426|P1|Overall Study|Lost to Follow-up|12
6011240|NCT00844883|20781448|P1|Overall Study|Bridged to resection|1
6011241|NCT00844883|20781448|P1|Overall Study|Bridged to liver transplant|3
6011242|NCT00844857|20781460|P2|Overall Study|Good Clinical Practice Violations|11
6011243|NCT00844857|20781461|P1|Overall Study|Good Clinical Practice Violations|21
6011244|NCT00844857|20781460|P2|Overall Study|Did Not Take Study Drug|1
6011245|NCT00844857|20781461|P1|Overall Study|Did Not Take Study Drug|3
6011246|NCT00844857|20781460|P2|Overall Study|Lost to Follow-up|3
6011247|NCT00844857|20781461|P1|Overall Study|Lost to Follow-up|2
6011248|NCT00844857|20781460|P2|Overall Study|Entry Criteria Not Met|1
6011249|NCT00844857|20781461|P1|Overall Study|Entry Criteria Not Met|0
6011250|NCT00844857|20781460|P2|Overall Study|Clinical Relapse|1
6011251|NCT00844857|20781461|P1|Overall Study|Clinical Relapse|0
6011252|NCT00844857|20781460|P2|Overall Study|Lack of Efficacy|5
6011253|NCT00844857|20781461|P1|Overall Study|Lack of Efficacy|5
6011254|NCT00844857|20781460|P2|Overall Study|Protocol Violation|0
6011255|NCT00844857|20781461|P1|Overall Study|Protocol Violation|6
6011256|NCT00844857|20781460|P2|Overall Study|Withdrawal by Subject|7
6011257|NCT00844857|20781461|P1|Overall Study|Withdrawal by Subject|8
6011258|NCT00844857|20781460|P2|Overall Study|Parent/Caregiver Decision|2
6011259|NCT00844857|20781461|P1|Overall Study|Parent/Caregiver Decision|6
6011260|NCT00844857|20781460|P2|Overall Study|Physician Decision|0
6011261|NCT00844857|20781461|P1|Overall Study|Physician Decision|2
6011262|NCT00844857|20781460|P2|Overall Study|Sponsor Decision|1
6011263|NCT00844857|20781461|P1|Overall Study|Sponsor Decision|1
6011264|NCT00844857|20781460|P2|Overall Study|Adverse Event|5
6011265|NCT00844857|20781461|P1|Overall Study|Adverse Event|24
6011266|NCT00844844|20781505|P1|Post Treatment Period|Withdrawal by Subject|1
6011267|NCT00844844|20781505|P1|Extension Treatment Period|Adverse Event|2
6011268|NCT00844844|20781505|P1|Treatment Period (26 Weeks)|Protocol Violation|1
6011269|NCT00844844|20781505|P1|Treatment Period (26 Weeks)|Adverse Event|1
6011270|NCT00844831|20781519|P1|Overall Study|Physician Decision|1
6011271|NCT00844831|20781519|P1|Overall Study|Adverse Event|1
6011272|NCT00844831|20781519|P1|Overall Study|Withdrawal by Subject|4
6011273|NCT00844805|20781529|P4|Follow-Up Phase|Did Not Meet Protocol Eligibility|1
6011274|NCT00844805|20781530|P3|Follow-Up Phase|Did Not Meet Protocol Eligibility|0
6011275|NCT00844805|20781531|P2|Follow-Up Phase|Did Not Meet Protocol Eligibility|0
6011276|NCT00844805|20781532|P1|Follow-Up Phase|Did Not Meet Protocol Eligibility|0
6011277|NCT00844805|20781529|P4|Follow-Up Phase|Relapse/Recurrence|4
6011278|NCT00844805|20781530|P3|Follow-Up Phase|Relapse/Recurrence|2
6011279|NCT00844805|20781531|P2|Follow-Up Phase|Relapse/Recurrence|0
6011280|NCT00844805|20781532|P1|Follow-Up Phase|Relapse/Recurrence|0
6011281|NCT00844805|20781529|P4|Follow-Up Phase|Noncompliance With Protocol|1
6011282|NCT00844805|20781530|P3|Follow-Up Phase|Noncompliance With Protocol|0
6011283|NCT00844805|20781531|P2|Follow-Up Phase|Noncompliance With Protocol|0
6011284|NCT00844805|20781532|P1|Follow-Up Phase|Noncompliance With Protocol|0
6011285|NCT00844805|20781529|P4|Follow-Up Phase|Withdrawal by Subject|3
6011286|NCT00844805|20781530|P3|Follow-Up Phase|Withdrawal by Subject|6
6011287|NCT00844805|20781531|P2|Follow-Up Phase|Withdrawal by Subject|0
6011288|NCT00844805|20781532|P1|Follow-Up Phase|Withdrawal by Subject|0
6011289|NCT00844805|20781529|P4|Follow-Up Phase|Adverse Event|0
6011290|NCT00844805|20781530|P3|Follow-Up Phase|Adverse Event|1
6011291|NCT00844805|20781531|P2|Follow-Up Phase|Adverse Event|0
6011292|NCT00844805|20781532|P1|Follow-Up Phase|Adverse Event|0
6011293|NCT00844805|20781529|P4|Treatment Phase|Did Not Meet Protocol Eligibility|0
6011294|NCT00844805|20781530|P3|Treatment Phase|Did Not Meet Protocol Eligibility|0
6011295|NCT00844805|20781531|P2|Treatment Phase|Did Not Meet Protocol Eligibility|2
6011296|NCT00844805|20781532|P1|Treatment Phase|Did Not Meet Protocol Eligibility|1
6011297|NCT00844805|20781529|P4|Treatment Phase|Noncompliance With Protocol|0
6011298|NCT00844805|20781530|P3|Treatment Phase|Noncompliance With Protocol|0
6011299|NCT00844805|20781531|P2|Treatment Phase|Noncompliance With Protocol|0
6011300|NCT00844805|20781532|P1|Treatment Phase|Noncompliance With Protocol|1
6011301|NCT00844805|20781529|P4|Treatment Phase|Withdrawal by Subject|0
6011302|NCT00844805|20781530|P3|Treatment Phase|Withdrawal by Subject|0
6011303|NCT00844805|20781531|P2|Treatment Phase|Withdrawal by Subject|4
6011304|NCT00844805|20781532|P1|Treatment Phase|Withdrawal by Subject|3
6011305|NCT00844805|20781529|P4|Treatment Phase|Adverse Event|0
6011306|NCT00844805|20781530|P3|Treatment Phase|Adverse Event|0
6011307|NCT00844805|20781531|P2|Treatment Phase|Adverse Event|1
6011308|NCT00844805|20781532|P1|Treatment Phase|Adverse Event|5
6011309|NCT00844753|20781576|P4|Overall Study|Withdrawal by Subject|3
6011310|NCT00844753|20781577|P3|Overall Study|Withdrawal by Subject|0
6011311|NCT00844753|20781578|P2|Overall Study|Withdrawal by Subject|0
6011312|NCT00844753|20781579|P1|Overall Study|Withdrawal by Subject|1
6011313|NCT00844753|20781576|P4|Overall Study|could not swallow medication|0
6011314|NCT00844753|20781577|P3|Overall Study|could not swallow medication|0
6011315|NCT00844753|20781578|P2|Overall Study|could not swallow medication|0
6011316|NCT00844753|20781579|P1|Overall Study|could not swallow medication|2
6011317|NCT00844753|20781576|P4|Overall Study|Lost to Follow-up|1
6011318|NCT00844753|20781577|P3|Overall Study|Lost to Follow-up|0
6011319|NCT00844753|20781578|P2|Overall Study|Lost to Follow-up|1
6011320|NCT00844753|20781579|P1|Overall Study|Lost to Follow-up|1
6011321|NCT00844753|20781576|P4|Overall Study|Adverse Event|5
6011322|NCT00844753|20781577|P3|Overall Study|Adverse Event|5
6011323|NCT00844753|20781578|P2|Overall Study|Adverse Event|2
6011324|NCT00844753|20781579|P1|Overall Study|Adverse Event|3
6011325|NCT00844753|20781576|P4|Overall Study|Lack of Efficacy|2
6011326|NCT00844753|20781577|P3|Overall Study|Lack of Efficacy|2
6011327|NCT00844753|20781578|P2|Overall Study|Lack of Efficacy|0
6011328|NCT00844753|20781579|P1|Overall Study|Lack of Efficacy|1
6011329|NCT00844649|20781597|P2|Overall Study|Withdrew prior to starting treatment|27
6011330|NCT00844649|20781598|P1|Overall Study|Withdrew prior to starting treatment|11
6011331|NCT00844649|20781597|P2|Overall Study|Other|10
6011332|NCT00844649|20781598|P1|Overall Study|Other|7
6011333|NCT00844649|20781597|P2|Overall Study|Withdrawal by Subject|39
6011334|NCT00844649|20781598|P1|Overall Study|Withdrawal by Subject|28
6011335|NCT00844649|20781597|P2|Overall Study|Protocol Violation|6
6011336|NCT00844649|20781598|P1|Overall Study|Protocol Violation|10
6011337|NCT00844649|20781597|P2|Overall Study|Physician Decision|18
6011338|NCT00844649|20781598|P1|Overall Study|Physician Decision|25
6011339|NCT00844649|20781597|P2|Overall Study|Adverse Event|73
6011340|NCT00844649|20781598|P1|Overall Study|Adverse Event|128
6011341|NCT00844649|20781597|P2|Overall Study|Progressive Disease|245
6011342|NCT00844649|20781598|P1|Overall Study|Progressive Disease|196
6011343|NCT00844597|20781622|P6|Overall Study|Adverse Event|0
6011344|NCT00844597|20781623|P5|Overall Study|Adverse Event|0
6011345|NCT00844597|20781624|P4|Overall Study|Adverse Event|1
6011346|NCT00844597|20781625|P3|Overall Study|Adverse Event|0
6011347|NCT00844597|20781626|P2|Overall Study|Adverse Event|0
6011348|NCT00844597|20781627|P1|Overall Study|Adverse Event|0
6011349|NCT00844558|20781647|P2|Overall Study|Physician Decision|0
6011350|NCT00844558|20781648|P1|Overall Study|Physician Decision|1
6011351|NCT00844558|20781647|P2|Overall Study|Lost to Follow-up|1
6011352|NCT00844558|20781648|P1|Overall Study|Lost to Follow-up|0
6011353|NCT00844558|20781647|P2|Overall Study|Protocol Violation|1
6011354|NCT00844558|20781648|P1|Overall Study|Protocol Violation|1
6011355|NCT00844558|20781647|P2|Overall Study|Death|0
6011356|NCT00844558|20781648|P1|Overall Study|Death|1
6011357|NCT00844558|20781647|P2|Overall Study|Withdrawal by Subject|2
6011358|NCT00844558|20781648|P1|Overall Study|Withdrawal by Subject|9
6011359|NCT00844545|20781664|P1|Post Treatment Period|Withdrawal by Subject|1
6011360|NCT00844545|20781664|P1|Extension Treatment Period|Adverse Event|2
6011361|NCT00844545|20781664|P1|Treatment Period (26 Weeks)|Protocol Violation|1
6011362|NCT00844545|20781664|P1|Treatment Period (26 Weeks)|Adverse Event|1
6011363|NCT00844532|20781678|P1|Overall Study|Lost to Follow-up|7
6011364|NCT00844532|20781678|P1|Overall Study|Withdrawal by Subject|16
6011365|NCT00844532|20781678|P1|Overall Study|Death|16
6011366|NCT00844519|20781764|P2|Overall Study|Adverse Event|0
6011367|NCT00844519|20781765|P1|Overall Study|Adverse Event|1
6011368|NCT00844519|20781764|P2|Overall Study|Withdrawal by Subject|1
6011369|NCT00844519|20781765|P1|Overall Study|Withdrawal by Subject|1
6011370|NCT00844480|20781773|P2|Overall Study|Withdrawal by Subject|3
6011371|NCT00844480|20781774|P1|Overall Study|Withdrawal by Subject|2
6011372|NCT00844428|20781782|P1|Post Treatment Period (Patients Who Disc|Death|1
6011373|NCT00844428|20781782|P1|Extension Treatment Period|Death|1
6011374|NCT00844428|20781782|P1|Screening Period|Screen Failure|3
6011375|NCT00844415|20781798|P1|Overall Study|Withdrawal by Subject|1
6011376|NCT00844376|20781812|P2|Period 1: First Intervention|Withdrawal by Subject|0
6011377|NCT00844376|20781813|P1|Period 1: First Intervention|Withdrawal by Subject|1
6011378|NCT00844194|20781837|P2|Overall Study|Other reason (not specified)|0
6011379|NCT00844194|20781838|P1|Overall Study|Other reason (not specified)|1
6011380|NCT00844194|20781837|P2|Overall Study|Lack of Efficacy|0
6011381|NCT00844194|20781838|P1|Overall Study|Lack of Efficacy|3
6011382|NCT00844194|20781837|P2|Overall Study|Withdrawal by Subject|1
6011383|NCT00844194|20781838|P1|Overall Study|Withdrawal by Subject|2
6011384|NCT00844194|20781837|P2|Overall Study|Lost to Follow-up|1
6011385|NCT00844194|20781838|P1|Overall Study|Lost to Follow-up|1
6011386|NCT00844194|20781837|P2|Overall Study|Protocol Violation|1
6011387|NCT00844194|20781838|P1|Overall Study|Protocol Violation|1
6011388|NCT00844194|20781837|P2|Overall Study|Adverse Event|5
6011389|NCT00844194|20781838|P1|Overall Study|Adverse Event|17
6011390|NCT00843856|20782093|P2|Overall Study|Lost to Follow-up|2
6011391|NCT00843856|20782094|P1|Overall Study|Lost to Follow-up|1
6011392|NCT00843843|20782104|P2|Overall Study|Protocol Violation|1
6011393|NCT00843843|20782105|P1|Overall Study|Protocol Violation|1
6011394|NCT00843843|20782104|P2|Overall Study|Physician Decision|1
6011395|NCT00843843|20782105|P1|Overall Study|Physician Decision|1
6011396|NCT00843778|20782118|P1|Overall Study|Withdrawal by Subject|4
6011397|NCT00843778|20782118|P1|Overall Study|Loss of efficacy|2
6011398|NCT00843778|20782118|P1|Overall Study|Lack of Efficacy|14
6011399|NCT00843778|20782118|P1|Overall Study|Adverse Event|15
6011400|NCT00843635|20782163|P3|Overall Study|Adverse Event|0
6011401|NCT00843635|20782164|P2|Overall Study|Adverse Event|2
6011402|NCT00843635|20782165|P1|Overall Study|Adverse Event|2
6011403|NCT00843518|20782204|P2|Period 2 (Double-blind Treatment)|Caregiver decision|7
6011404|NCT00843518|20782205|P1|Period 2 (Double-blind Treatment)|Caregiver decision|7
6011405|NCT00843518|20782204|P2|Period 2 (Double-blind Treatment)|Withdrawal by Subject|0
6011406|NCT00843518|20782205|P1|Period 2 (Double-blind Treatment)|Withdrawal by Subject|2
6011407|NCT00843518|20782204|P2|Period 2 (Double-blind Treatment)|Protocol Violation|5
6011408|NCT00843518|20782205|P1|Period 2 (Double-blind Treatment)|Protocol Violation|2
6011409|NCT00843518|20782204|P2|Period 2 (Double-blind Treatment)|Physician Decision|1
6011410|NCT00843518|20782205|P1|Period 2 (Double-blind Treatment)|Physician Decision|2
6011411|NCT00843518|20782204|P2|Period 2 (Double-blind Treatment)|Lost to Follow-up|3
6011412|NCT00843518|20782205|P1|Period 2 (Double-blind Treatment)|Lost to Follow-up|2
6011413|NCT00843518|20782204|P2|Period 2 (Double-blind Treatment)|Death|1
6011414|NCT00843518|20782205|P1|Period 2 (Double-blind Treatment)|Death|0
6011415|NCT00843518|20782204|P2|Period 2 (Double-blind Treatment)|Adverse Event|3
6011416|NCT00843518|20782205|P1|Period 2 (Double-blind Treatment)|Adverse Event|5
6011417|NCT00843492|20782235|P2|Overall Study|Deep-vein Thrombosis|0
6011418|NCT00843492|20782236|P1|Overall Study|Deep-vein Thrombosis|1
6011419|NCT00843492|20782235|P2|Overall Study|Visit Not Performed|0
6011420|NCT00843492|20782236|P1|Overall Study|Visit Not Performed|1
6011421|NCT00843492|20782235|P2|Overall Study|Orthopedic Surgery|2
6011422|NCT00843492|20782236|P1|Overall Study|Orthopedic Surgery|0
6011423|NCT00843492|20782235|P2|Overall Study|Investigator/Orthopedic Surgeon Decision|1
6011424|NCT00843492|20782236|P1|Overall Study|Investigator/Orthopedic Surgeon Decision|1
6011425|NCT00843492|20782235|P2|Overall Study|Immobilization Stopped|0
6011426|NCT00843492|20782236|P1|Overall Study|Immobilization Stopped|1
6011427|NCT00843492|20782235|P2|Overall Study|Withdrawal by Subject|4
6011428|NCT00843492|20782236|P1|Overall Study|Withdrawal by Subject|0
6011429|NCT00843492|20782235|P2|Overall Study|Lost to Follow-up|4
6011430|NCT00843492|20782236|P1|Overall Study|Lost to Follow-up|4
6011431|NCT00843492|20782235|P2|Overall Study|Adverse Event|3
6011432|NCT00843492|20782236|P1|Overall Study|Adverse Event|0
6011439|NCT00843193|20782317|P2|Overall Study|Withdrawal by Subject|3
6011440|NCT00843193|20782318|P1|Overall Study|Withdrawal by Subject|3
6011441|NCT00843193|20782317|P2|Overall Study|Physician Decision|1
6011442|NCT00843193|20782318|P1|Overall Study|Physician Decision|0
6011443|NCT00843193|20782317|P2|Overall Study|Lost to Follow-up|0
6011444|NCT00843193|20782318|P1|Overall Study|Lost to Follow-up|1
6011445|NCT00843193|20782317|P2|Overall Study|Protocol Violation|2
6011446|NCT00843193|20782318|P1|Overall Study|Protocol Violation|1
6011447|NCT00843193|20782317|P2|Overall Study|Lack of Efficacy|1
6011448|NCT00843193|20782318|P1|Overall Study|Lack of Efficacy|1
6011449|NCT00843193|20782317|P2|Overall Study|Adverse Event|4
6011450|NCT00843193|20782318|P1|Overall Study|Adverse Event|2
6011451|NCT00843167|20782369|P2|Treatment Period|Withdrawal by Subject|3
6011452|NCT00843167|20782370|P1|Treatment Period|Withdrawal by Subject|2
6011453|NCT00843167|20782369|P2|Treatment Period|Adverse Event|5
6011454|NCT00843167|20782370|P1|Treatment Period|Adverse Event|1
6011455|NCT00843115|20782383|P1|Overall Study|Syndrome De Glissement|1
6011456|NCT00843115|20782383|P1|Overall Study|week 12 not done|1
6011457|NCT00843115|20782383|P1|Overall Study|hospitalized due to deterioration|1
6011458|NCT00843115|20782383|P1|Overall Study|patient never took the medication|1
6011459|NCT00843115|20782383|P1|Overall Study|patient took for 2 days then stopped|1
6011460|NCT00843115|20782383|P1|Overall Study|Family discontinued meds|1
6011461|NCT00843115|20782383|P1|Overall Study|Physician Decision|1
6011462|NCT00843115|20782383|P1|Overall Study|Does not meet entrance criteria|1
6011463|NCT00843115|20782383|P1|Overall Study|Patient forgot to take meds|1
6011464|NCT00843115|20782383|P1|Overall Study|Family does not want continuation|1
6011465|NCT00843115|20782383|P1|Overall Study|Family wanted meds stopped|1
6011466|NCT00843115|20782383|P1|Overall Study|Withdrawal by Subject|17
6011467|NCT00843115|20782383|P1|Overall Study|Lost to Follow-up|4
6011468|NCT00843115|20782383|P1|Overall Study|Adverse Event|30
6011469|NCT00843115|20782383|P1|Overall Study|Death|4
6011470|NCT00843024|20782439|P6|Double-blind Treatment Phase|Lack of Efficacy|0
6011471|NCT00843024|20782440|P5|Double-blind Treatment Phase|Lack of Efficacy|1
6011472|NCT00843024|20782441|P4|Double-blind Treatment Phase|Lack of Efficacy|0
6011473|NCT00843024|20782442|P3|Double-blind Treatment Phase|Lack of Efficacy|0
6011474|NCT00843024|20782443|P2|Double-blind Treatment Phase|Lack of Efficacy|0
6011475|NCT00843024|20782444|P1|Double-blind Treatment Phase|Lack of Efficacy|0
6011476|NCT00843024|20782439|P6|Double-blind Treatment Phase|Adverse Event|1
6011477|NCT00843024|20782440|P5|Double-blind Treatment Phase|Adverse Event|1
6011478|NCT00843024|20782441|P4|Double-blind Treatment Phase|Adverse Event|0
6011479|NCT00843024|20782442|P3|Double-blind Treatment Phase|Adverse Event|0
6011480|NCT00843024|20782443|P2|Double-blind Treatment Phase|Adverse Event|0
6011481|NCT00843024|20782444|P1|Double-blind Treatment Phase|Adverse Event|0
6011482|NCT00843024|20782439|P6|Double-blind Treatment Phase|Physician Decision|1
6011483|NCT00843024|20782440|P5|Double-blind Treatment Phase|Physician Decision|1
6011484|NCT00843024|20782441|P4|Double-blind Treatment Phase|Physician Decision|3
6011485|NCT00843024|20782442|P3|Double-blind Treatment Phase|Physician Decision|0
6011486|NCT00843024|20782443|P2|Double-blind Treatment Phase|Physician Decision|0
6011487|NCT00843024|20782444|P1|Double-blind Treatment Phase|Physician Decision|0
6011488|NCT00843024|20782439|P6|Double-blind Treatment Phase|Protocol Violation|3
6011489|NCT00843024|20782440|P5|Double-blind Treatment Phase|Protocol Violation|0
6011490|NCT00843024|20782441|P4|Double-blind Treatment Phase|Protocol Violation|0
6011491|NCT00843024|20782442|P3|Double-blind Treatment Phase|Protocol Violation|3
6011492|NCT00843024|20782443|P2|Double-blind Treatment Phase|Protocol Violation|0
6011493|NCT00843024|20782444|P1|Double-blind Treatment Phase|Protocol Violation|0
6011494|NCT00843024|20782439|P6|Double-blind Treatment Phase|Withdrawal by Subject|2
6011495|NCT00843024|20782440|P5|Double-blind Treatment Phase|Withdrawal by Subject|0
6011496|NCT00843024|20782441|P4|Double-blind Treatment Phase|Withdrawal by Subject|6
6011497|NCT00843024|20782442|P3|Double-blind Treatment Phase|Withdrawal by Subject|0
6011498|NCT00843024|20782443|P2|Double-blind Treatment Phase|Withdrawal by Subject|0
6011499|NCT00843024|20782444|P1|Double-blind Treatment Phase|Withdrawal by Subject|0
6011500|NCT00843024|20782439|P6|Double-blind Treatment Phase|Lost to Follow-up|4
6011501|NCT00843024|20782440|P5|Double-blind Treatment Phase|Lost to Follow-up|4
6011502|NCT00843024|20782441|P4|Double-blind Treatment Phase|Lost to Follow-up|4
6011503|NCT00843024|20782442|P3|Double-blind Treatment Phase|Lost to Follow-up|8
6011504|NCT00843024|20782443|P2|Double-blind Treatment Phase|Lost to Follow-up|0
6011505|NCT00843024|20782444|P1|Double-blind Treatment Phase|Lost to Follow-up|0
6011506|NCT00843024|20782439|P6|Double-blind Treatment Phase|No opportunity to treat migraine|14
6011507|NCT00843024|20782440|P5|Double-blind Treatment Phase|No opportunity to treat migraine|13
6011508|NCT00843024|20782441|P4|Double-blind Treatment Phase|No opportunity to treat migraine|10
6011509|NCT00843024|20782442|P3|Double-blind Treatment Phase|No opportunity to treat migraine|20
6011510|NCT00843024|20782443|P2|Double-blind Treatment Phase|No opportunity to treat migraine|0
6011511|NCT00843024|20782444|P1|Double-blind Treatment Phase|No opportunity to treat migraine|0
6011512|NCT00843024|20782439|P6|Single-blind Placebo Run-In Phase|Other|0
6011513|NCT00843024|20782440|P5|Single-blind Placebo Run-In Phase|Other|0
6011514|NCT00843024|20782441|P4|Single-blind Placebo Run-In Phase|Other|0
6011515|NCT00843024|20782442|P3|Single-blind Placebo Run-In Phase|Other|0
6011516|NCT00843024|20782443|P2|Single-blind Placebo Run-In Phase|Other|1
6011517|NCT00843024|20782444|P1|Single-blind Placebo Run-In Phase|Other|0
6011518|NCT00843024|20782439|P6|Single-blind Placebo Run-In Phase|Adverse Event|0
6011519|NCT00843024|20782440|P5|Single-blind Placebo Run-In Phase|Adverse Event|0
6011520|NCT00843024|20782441|P4|Single-blind Placebo Run-In Phase|Adverse Event|0
6011521|NCT00843024|20782442|P3|Single-blind Placebo Run-In Phase|Adverse Event|0
6011522|NCT00843024|20782443|P2|Single-blind Placebo Run-In Phase|Adverse Event|1
6011523|NCT00843024|20782444|P1|Single-blind Placebo Run-In Phase|Adverse Event|0
6011524|NCT00843024|20782439|P6|Single-blind Placebo Run-In Phase|Physician Decision|0
6011525|NCT00843024|20782440|P5|Single-blind Placebo Run-In Phase|Physician Decision|0
6011526|NCT00843024|20782441|P4|Single-blind Placebo Run-In Phase|Physician Decision|0
6011527|NCT00843024|20782442|P3|Single-blind Placebo Run-In Phase|Physician Decision|0
6011528|NCT00843024|20782443|P2|Single-blind Placebo Run-In Phase|Physician Decision|6
6011529|NCT00843024|20782444|P1|Single-blind Placebo Run-In Phase|Physician Decision|2
6011530|NCT00843024|20782439|P6|Single-blind Placebo Run-In Phase|Protocol Violation|0
6011531|NCT00843024|20782440|P5|Single-blind Placebo Run-In Phase|Protocol Violation|0
6011532|NCT00843024|20782441|P4|Single-blind Placebo Run-In Phase|Protocol Violation|0
6011533|NCT00843024|20782442|P3|Single-blind Placebo Run-In Phase|Protocol Violation|0
6011534|NCT00843024|20782443|P2|Single-blind Placebo Run-In Phase|Protocol Violation|5
6011535|NCT00843024|20782444|P1|Single-blind Placebo Run-In Phase|Protocol Violation|4
6011536|NCT00843024|20782439|P6|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0
6011537|NCT00843024|20782440|P5|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0
6011538|NCT00843024|20782441|P4|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0
6011539|NCT00843024|20782442|P3|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0
6011540|NCT00843024|20782443|P2|Single-blind Placebo Run-In Phase|Withdrawal by Subject|18
6011541|NCT00843024|20782444|P1|Single-blind Placebo Run-In Phase|Withdrawal by Subject|19
6011542|NCT00843024|20782439|P6|Single-blind Placebo Run-In Phase|Lost to Follow-up|0
6011543|NCT00843024|20782440|P5|Single-blind Placebo Run-In Phase|Lost to Follow-up|0
6011544|NCT00843024|20782441|P4|Single-blind Placebo Run-In Phase|Lost to Follow-up|0
6011545|NCT00843024|20782442|P3|Single-blind Placebo Run-In Phase|Lost to Follow-up|0
6011546|NCT00843024|20782443|P2|Single-blind Placebo Run-In Phase|Lost to Follow-up|31
6011547|NCT00843024|20782444|P1|Single-blind Placebo Run-In Phase|Lost to Follow-up|36
6011548|NCT00843024|20782439|P6|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0
6011549|NCT00843024|20782440|P5|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0
6011550|NCT00843024|20782441|P4|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0
6011551|NCT00843024|20782442|P3|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0
6011552|NCT00843024|20782443|P2|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|74
6011553|NCT00843024|20782444|P1|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|79
6011554|NCT00842985|20782509|P1|Washout Period of GE 4 Days|Withdrawal by Subject|2
6011555|NCT00842985|20782509|P1|Washout Period of GE 4 Days|Withdrawal by Subject|2
6011556|NCT00842985|20782509|P1|First Intervention|Protocol Violation|3
6011557|NCT00842985|20782509|P1|First Intervention|Withdrawal by Subject|3
6011558|NCT00842985|20782509|P1|Screening|Did not meet entrance requirements|27
6011559|NCT00842829|20782527|P3|Continuation Period|Non-compliance to study drug|1
6011560|NCT00842829|20782528|P2|Continuation Period|Non-compliance to study drug|0
6011561|NCT00842829|20782529|P1|Continuation Period|Non-compliance to study drug|0
6011562|NCT00842829|20782527|P3|Continuation Period|Non-compliance to study procedures|2
6011563|NCT00842829|20782528|P2|Continuation Period|Non-compliance to study procedures|0
6011564|NCT00842829|20782529|P1|Continuation Period|Non-compliance to study procedures|0
6011565|NCT00842829|20782527|P3|Continuation Period|Other|7
6011566|NCT00842829|20782528|P2|Continuation Period|Other|0
6011567|NCT00842829|20782529|P1|Continuation Period|Other|0
6011568|NCT00842829|20782527|P3|Continuation Period|Withdrawal by Subject|10
6011569|NCT00842829|20782528|P2|Continuation Period|Withdrawal by Subject|0
6011570|NCT00842829|20782529|P1|Continuation Period|Withdrawal by Subject|0
6011571|NCT00842829|20782527|P3|Continuation Period|Unstable persistent cancer pain|3
6011572|NCT00842829|20782528|P2|Continuation Period|Unstable persistent cancer pain|0
6011573|NCT00842829|20782529|P1|Continuation Period|Unstable persistent cancer pain|0
6011574|NCT00842829|20782527|P3|Continuation Period|Lack of Efficacy|6
6011575|NCT00842829|20782528|P2|Continuation Period|Lack of Efficacy|0
6011576|NCT00842829|20782529|P1|Continuation Period|Lack of Efficacy|0
6011577|NCT00842829|20782527|P3|Continuation Period|Adverse Event|32
6011578|NCT00842829|20782528|P2|Continuation Period|Adverse Event|0
6011579|NCT00842829|20782529|P1|Continuation Period|Adverse Event|0
6011580|NCT00842829|20782527|P3|Treatment Period|Unclear completion status|1
6011581|NCT00842829|20782528|P2|Treatment Period|Unclear completion status|0
6011582|NCT00842829|20782529|P1|Treatment Period|Unclear completion status|0
6011583|NCT00842829|20782527|P3|Treatment Period|Non-compliance to study procedures|4
6011584|NCT00842829|20782528|P2|Treatment Period|Non-compliance to study procedures|0
6011585|NCT00842829|20782529|P1|Treatment Period|Non-compliance to study procedures|0
6011586|NCT00842829|20782527|P3|Treatment Period|Other|18
6011587|NCT00842829|20782528|P2|Treatment Period|Other|0
6011588|NCT00842829|20782529|P1|Treatment Period|Other|0
6011589|NCT00842829|20782527|P3|Treatment Period|Protocol Violation|2
6011590|NCT00842829|20782528|P2|Treatment Period|Protocol Violation|0
6011591|NCT00842829|20782529|P1|Treatment Period|Protocol Violation|0
6011592|NCT00842829|20782527|P3|Treatment Period|Consistently >4 BTP episodes daily|1
6011593|NCT00842829|20782528|P2|Treatment Period|Consistently >4 BTP episodes daily|0
6011594|NCT00842829|20782529|P1|Treatment Period|Consistently >4 BTP episodes daily|0
6011595|NCT00842829|20782527|P3|Treatment Period|Withdrawal by Subject|11
6011596|NCT00842829|20782528|P2|Treatment Period|Withdrawal by Subject|0
6011597|NCT00842829|20782529|P1|Treatment Period|Withdrawal by Subject|0
6011598|NCT00842829|20782527|P3|Treatment Period|Unstable persistent cancer pain|5
6011599|NCT00842829|20782528|P2|Treatment Period|Unstable persistent cancer pain|0
6011600|NCT00842829|20782529|P1|Treatment Period|Unstable persistent cancer pain|0
6011601|NCT00842829|20782527|P3|Treatment Period|Lack of Efficacy|6
6011602|NCT00842829|20782528|P2|Treatment Period|Lack of Efficacy|0
6011603|NCT00842829|20782529|P1|Treatment Period|Lack of Efficacy|0
6011604|NCT00842829|20782527|P3|Treatment Period|Adverse Event|15
6011605|NCT00842829|20782528|P2|Treatment Period|Adverse Event|0
6011606|NCT00842829|20782529|P1|Treatment Period|Adverse Event|0
6011607|NCT00842829|20782527|P3|Dose Titration Period|Non-compliance to study drug|0
6011608|NCT00842829|20782528|P2|Dose Titration Period|Non-compliance to study drug|1
6011609|NCT00842829|20782529|P1|Dose Titration Period|Non-compliance to study drug|2
6011610|NCT00842829|20782527|P3|Dose Titration Period|Non-compliance to study procedures|0
6011611|NCT00842829|20782528|P2|Dose Titration Period|Non-compliance to study procedures|1
6011612|NCT00842829|20782529|P1|Dose Titration Period|Non-compliance to study procedures|1
6011613|NCT00842829|20782527|P3|Dose Titration Period|Other|0
6011614|NCT00842829|20782528|P2|Dose Titration Period|Other|4
6011615|NCT00842829|20782529|P1|Dose Titration Period|Other|5
6011616|NCT00842829|20782527|P3|Dose Titration Period|Withdrawal by Subject|0
6011617|NCT00842829|20782528|P2|Dose Titration Period|Withdrawal by Subject|6
6011618|NCT00842829|20782529|P1|Dose Titration Period|Withdrawal by Subject|2
6011619|NCT00842829|20782527|P3|Dose Titration Period|Unstable persistent cancer pain|0
6011620|NCT00842829|20782528|P2|Dose Titration Period|Unstable persistent cancer pain|0
6011621|NCT00842829|20782529|P1|Dose Titration Period|Unstable persistent cancer pain|1
6011622|NCT00842829|20782527|P3|Dose Titration Period|Lack of Efficacy|0
6011623|NCT00842829|20782528|P2|Dose Titration Period|Lack of Efficacy|1
6011624|NCT00842829|20782529|P1|Dose Titration Period|Lack of Efficacy|4
6011625|NCT00842829|20782527|P3|Dose Titration Period|Adverse Event|0
6011626|NCT00842829|20782528|P2|Dose Titration Period|Adverse Event|10
6011627|NCT00842829|20782529|P1|Dose Titration Period|Adverse Event|11
6011628|NCT00842712|20782588|P7|Randomized Part|Ongoing at cut-off date|2
6011629|NCT00842712|20782589|P6|Randomized Part|Ongoing at cut-off date|0
6011630|NCT00842712|20782590|P5|Randomized Part|Ongoing at cut-off date|0
6011631|NCT00842712|20782591|P4|Randomized Part|Ongoing at cut-off date|0
6011632|NCT00842712|20782592|P3|Randomized Part|Ongoing at cut-off date|0
6011633|NCT00842712|20782593|P2|Randomized Part|Ongoing at cut-off date|0
6011634|NCT00842712|20782594|P1|Randomized Part|Ongoing at cut-off date|0
6011635|NCT00842712|20782588|P7|Randomized Part|Randomized but not treated|4
6011636|NCT00842712|20782589|P6|Randomized Part|Randomized but not treated|1
6011637|NCT00842712|20782590|P5|Randomized Part|Randomized but not treated|0
6011638|NCT00842712|20782591|P4|Randomized Part|Randomized but not treated|0
6011639|NCT00842712|20782592|P3|Randomized Part|Randomized but not treated|0
6011640|NCT00842712|20782593|P2|Randomized Part|Randomized but not treated|0
6011641|NCT00842712|20782594|P1|Randomized Part|Randomized but not treated|0
6011642|NCT00842712|20782588|P7|Safety Run-in Part|Progressive disease|0
6011643|NCT00842712|20782589|P6|Safety Run-in Part|Progressive disease|0
6011644|NCT00842712|20782590|P5|Safety Run-in Part|Progressive disease|0
6011645|NCT00842712|20782591|P4|Safety Run-in Part|Progressive disease|1
6011646|NCT00842712|20782592|P3|Safety Run-in Part|Progressive disease|0
6011647|NCT00842712|20782593|P2|Safety Run-in Part|Progressive disease|1
6011648|NCT00842712|20782594|P1|Safety Run-in Part|Progressive disease|3
6011649|NCT00842712|20782588|P7|Safety Run-in Part|Adverse Event|0
6011650|NCT00842712|20782589|P6|Safety Run-in Part|Adverse Event|0
6011651|NCT00842712|20782590|P5|Safety Run-in Part|Adverse Event|0
6011652|NCT00842712|20782591|P4|Safety Run-in Part|Adverse Event|0
6011653|NCT00842712|20782592|P3|Safety Run-in Part|Adverse Event|0
6011654|NCT00842712|20782593|P2|Safety Run-in Part|Adverse Event|1
6011655|NCT00842712|20782594|P1|Safety Run-in Part|Adverse Event|0
6011656|NCT00842543|20782651|P4|Overall Study|Withdrawal by Subject|4
6011657|NCT00842543|20782652|P3|Overall Study|Withdrawal by Subject|3
6011658|NCT00842543|20782653|P2|Overall Study|Withdrawal by Subject|0
6011659|NCT00842543|20782654|P1|Overall Study|Withdrawal by Subject|2
6011660|NCT00842530|20782668|P2|Overall Study|Withdrawal by Subject|28
6011661|NCT00842530|20782669|P1|Overall Study|Withdrawal by Subject|73
6011662|NCT00842530|20782668|P2|Overall Study|Lost to Follow-up|8
6011663|NCT00842530|20782669|P1|Overall Study|Lost to Follow-up|6
6011664|NCT00842530|20782668|P2|Overall Study|Protocol Violation|14
6011665|NCT00842530|20782669|P1|Overall Study|Protocol Violation|32
6011666|NCT00842530|20782668|P2|Overall Study|Other adverse event|1
6011667|NCT00842530|20782669|P1|Overall Study|Other adverse event|6
6011668|NCT00842530|20782668|P2|Overall Study|Serious adverse event|6
6011669|NCT00842530|20782669|P1|Overall Study|Serious adverse event|0
6011670|NCT00842361|20782699|P2|Overall Study|Unclassified|2
6011671|NCT00842361|20782700|P1|Overall Study|Unclassified|0
6011672|NCT00842361|20782699|P2|Overall Study|Protocol Violation|0
6011673|NCT00842361|20782700|P1|Overall Study|Protocol Violation|1
6011674|NCT00842348|20782720|P2|Study 729|Surgical resection|0
6011675|NCT00842348|20782721|P1|Study 729|Surgical resection|1
6011676|NCT00842348|20782720|P2|Study 729|Sponsor's decision|0
6011677|NCT00842348|20782721|P1|Study 729|Sponsor's decision|1
6011678|NCT00842348|20782720|P2|Study 729|Due to non-availability of IP|1
6011679|NCT00842348|20782721|P1|Study 729|Due to non-availability of IP|0
6011680|NCT00842348|20782720|P2|Study 729|Due to Sponsor stopping the study|1
6011681|NCT00842348|20782721|P1|Study 729|Due to Sponsor stopping the study|1
6011682|NCT00842348|20782720|P2|Study 729|Withdrawal by Subject|4
6011683|NCT00842348|20782721|P1|Study 729|Withdrawal by Subject|2
6011684|NCT00842348|20782720|P2|Study 729|Protocol Violation|1
6011685|NCT00842348|20782721|P1|Study 729|Protocol Violation|1
6011686|NCT00842348|20782720|P2|Study 729|Adverse Event|1
6011687|NCT00842348|20782721|P1|Study 729|Adverse Event|1
6011688|NCT00842348|20782720|P2|Study 729|Disease progression/death|30
6011689|NCT00842348|20782721|P1|Study 729|Disease progression/death|19
6011690|NCT00842348|20782720|P2|Patients Randomised in Study 726|Did not enter Study 729|56
6011691|NCT00842348|20782721|P1|Patients Randomised in Study 726|Did not enter Study 729|59
6011692|NCT00842309|20782740|P2|Overall Study|Withdrawal by Subject|1
6011693|NCT00842309|20782741|P1|Overall Study|Withdrawal by Subject|3
6011694|NCT00842257|20782775|P1|Overall Study|Adverse Event|1
6011695|NCT00842244|20782782|P1|Overall Study|Other|17
6011696|NCT00842244|20782782|P1|Overall Study|Withdrawal by Subject|1
6011697|NCT00842244|20782782|P1|Overall Study|Death|3
6011698|NCT00842153|20782809|P2|Overall Study|Lost to Follow-up|2
6011699|NCT00842153|20782810|P1|Overall Study|Lost to Follow-up|1
6011700|NCT00842153|20782809|P2|Overall Study|Adverse Event|1
6011701|NCT00842153|20782810|P1|Overall Study|Adverse Event|0
6011702|NCT00841906|20782885|P2|Overall Study|Withdrawal by Subject|0
6011703|NCT00841906|20782886|P1|Overall Study|Withdrawal by Subject|2
6011704|NCT00841815|20782911|P2|Washout|Withdrawal by Subject|1
6011705|NCT00841815|20782912|P1|Washout|Withdrawal by Subject|0
6011706|NCT00841776|20782922|P2|Overall Study|Withdrawal by Subject|1
6011707|NCT00841776|20782923|P1|Overall Study|Withdrawal by Subject|0
6011708|NCT00841776|20782922|P2|Overall Study|Lost to Follow-up|1
6011709|NCT00841776|20782923|P1|Overall Study|Lost to Follow-up|2
6011710|NCT00841776|20782922|P2|Overall Study|Lack of Efficacy|1
6011711|NCT00841776|20782923|P1|Overall Study|Lack of Efficacy|0
6011712|NCT00841763|20782941|P4|Overall Study|Unable to Classify|0
6011713|NCT00841763|20782942|P3|Overall Study|Unable to Classify|0
6011714|NCT00841763|20782943|P2|Overall Study|Unable to Classify|1
6011715|NCT00841763|20782944|P1|Overall Study|Unable to Classify|7
6011716|NCT00841763|20782941|P4|Overall Study|Administrative Reasons|0
6011717|NCT00841763|20782942|P3|Overall Study|Administrative Reasons|0
6011718|NCT00841763|20782943|P2|Overall Study|Administrative Reasons|1
6011719|NCT00841763|20782944|P1|Overall Study|Administrative Reasons|3
6011720|NCT00841763|20782941|P4|Overall Study|Protocol Violation|0
6011721|NCT00841763|20782942|P3|Overall Study|Protocol Violation|1
6011722|NCT00841763|20782943|P2|Overall Study|Protocol Violation|3
6011723|NCT00841763|20782944|P1|Overall Study|Protocol Violation|20
6011724|NCT00841763|20782941|P4|Overall Study|Lost to Follow-up|0
6011725|NCT00841763|20782942|P3|Overall Study|Lost to Follow-up|0
6011726|NCT00841763|20782943|P2|Overall Study|Lost to Follow-up|25
6011727|NCT00841763|20782944|P1|Overall Study|Lost to Follow-up|63
6011728|NCT00841763|20782941|P4|Overall Study|Adverse Event|2
6011729|NCT00841763|20782942|P3|Overall Study|Adverse Event|3
6011730|NCT00841763|20782943|P2|Overall Study|Adverse Event|10
6011731|NCT00841763|20782944|P1|Overall Study|Adverse Event|9
6011732|NCT00841763|20782941|P4|Overall Study|Withdrawal by Subject|1
6011733|NCT00841763|20782942|P3|Overall Study|Withdrawal by Subject|4
6011734|NCT00841763|20782943|P2|Overall Study|Withdrawal by Subject|17
6011735|NCT00841763|20782944|P1|Overall Study|Withdrawal by Subject|60
6011736|NCT00841698|20783006|P2|First Intervention|Withdrawal by Subject|0
6011737|NCT00841698|20783007|P1|First Intervention|Withdrawal by Subject|1
6011738|NCT00841672|20783017|P2|Overall Study|Protocol Deviation|1
6011739|NCT00841672|20783018|P1|Overall Study|Protocol Deviation|0
6011740|NCT00841672|20783017|P2|Overall Study|Misrandomized|0
6011741|NCT00841672|20783018|P1|Overall Study|Misrandomized|1
6011742|NCT00841672|20783017|P2|Overall Study|Administrative problems|9
6011743|NCT00841672|20783018|P1|Overall Study|Administrative problems|9
6011744|NCT00841672|20783017|P2|Overall Study|Lost to Follow-up|1
6011745|NCT00841672|20783018|P1|Overall Study|Lost to Follow-up|1
6011746|NCT00841672|20783017|P2|Overall Study|Subject withdrew consent|4
6011747|NCT00841672|20783018|P1|Overall Study|Subject withdrew consent|2
6011748|NCT00841672|20783017|P2|Overall Study|Abnormal test procedure result(s)|1
6011749|NCT00841672|20783018|P1|Overall Study|Abnormal test procedure result(s)|0
6011750|NCT00841672|20783017|P2|Overall Study|Adverse Event|16
6011751|NCT00841672|20783018|P1|Overall Study|Adverse Event|7
6011752|NCT00841659|20783034|P2|Washout: 2 Weeks|Protocol Violation|0
6011753|NCT00841659|20783035|P1|Washout: 2 Weeks|Protocol Violation|1
6011754|NCT00841568|20783043|P1|Overall Study|Creatinine over the withdrawal criteria|1
6011755|NCT00841568|20783043|P1|Overall Study|Withdrawal by Subject|2
6011756|NCT00841568|20783043|P1|Overall Study|Death|1
6011757|NCT00841568|20783043|P1|Overall Study|Adverse Event|1
6011758|NCT00841542|20783071|P2|Period 1|Adverse Event|0
6011759|NCT00841542|20783072|P1|Period 1|Adverse Event|1
6011760|NCT00841321|20783087|P2|Overall Study|Adverse Event|2
6011761|NCT00841321|20783088|P1|Overall Study|Adverse Event|0
6011762|NCT00841321|20783087|P2|Overall Study|Lost to Follow-up|1
6011763|NCT00841321|20783088|P1|Overall Study|Lost to Follow-up|1
6011764|NCT00841100|20783135|P1|Phase 1 (28 Days)|Participant non-compliance|2
6011765|NCT00841100|20783135|P1|Phase 1 (28 Days)|Adverse Event|1
6011766|NCT00841035|20783160|P1|Phase 1 Overall Study|Physician Decision|13
6011767|NCT00840996|20783167|P2|Overall Study|Withdrawal by Subject|0
6011768|NCT00840996|20783168|P1|Overall Study|Withdrawal by Subject|1
6011769|NCT00840970|20783186|P3|Overall Study|Adverse Event|1
6011770|NCT00840970|20783187|P2|Overall Study|Adverse Event|0
6011771|NCT00840970|20783188|P1|Overall Study|Adverse Event|0
6011772|NCT00840879|20783208|P2|Second Intervention|Withdrawal by Subject|0
6011773|NCT00840879|20783209|P1|Second Intervention|Withdrawal by Subject|1
6011774|NCT00840827|20783245|P1|Overall Study|Physician Decision|1
6011775|NCT00840827|20783245|P1|Overall Study|Lack of Efficacy|4
6011776|NCT00840827|20783245|P1|Overall Study|Adverse Event|1
6011777|NCT00840749|20783260|P2|Overall Study|study closed|14
6011778|NCT00840749|20783261|P1|Overall Study|study closed|19
6011779|NCT00840749|20783260|P2|Overall Study|not treated on study arm|11
6011780|NCT00840749|20783261|P1|Overall Study|not treated on study arm|11
6011781|NCT00840749|20783260|P2|Overall Study|Death|2
6011782|NCT00840749|20783261|P1|Overall Study|Death|1
6011783|NCT00840658|20783273|P4|Overall Study|Lost to Follow-up|1
6011784|NCT00840658|20783274|P3|Overall Study|Lost to Follow-up|2
6011785|NCT00840658|20783275|P2|Overall Study|Lost to Follow-up|1
6011786|NCT00840658|20783276|P1|Overall Study|Lost to Follow-up|3
6011787|NCT00840658|20783273|P4|Overall Study|Death|3
6011788|NCT00840658|20783274|P3|Overall Study|Death|3
6011789|NCT00840658|20783275|P2|Overall Study|Death|2
6011790|NCT00840658|20783276|P1|Overall Study|Death|2
6011791|NCT00840632|20783294|P2|Washout|Withdrawal by Subject|1
6011792|NCT00840632|20783295|P1|Washout|Withdrawal by Subject|1
6011793|NCT00840632|20783294|P2|First Intervention|Withdrawal by Subject|1
6011794|NCT00840632|20783295|P1|First Intervention|Withdrawal by Subject|0
6011795|NCT00840463|20783322|P2|Overall Study|Adverse Event|0
6011796|NCT00840463|20783323|P1|Overall Study|Adverse Event|1
6011797|NCT00840450|20783337|P1|Overall Study|Lack of Efficacy|2
6011798|NCT00840450|20783337|P1|Overall Study|Adverse Event|1
6011799|NCT00840411|20783345|P2|Washout|Withdrawal by Subject|0
6011800|NCT00840411|20783346|P1|Washout|Withdrawal by Subject|1
6011801|NCT00840411|20783345|P2|First Intervention|Adverse Event|0
6011802|NCT00840411|20783346|P1|First Intervention|Adverse Event|1
6011803|NCT00840294|20783360|P2|Overall Study|Illness|1
6011804|NCT00840294|20783361|P1|Overall Study|Illness|0
6011805|NCT00840294|20783360|P2|Overall Study|Protocol Violation|3
6011806|NCT00840294|20783361|P1|Overall Study|Protocol Violation|1
6011807|NCT00840294|20783360|P2|Overall Study|Withdrawal by Subject|1
6011808|NCT00840294|20783361|P1|Overall Study|Withdrawal by Subject|2
6011809|NCT00840216|20783382|P2|Washout: 7 Days|Withdrawal by Subject|0
6011810|NCT00840216|20783383|P1|Washout: 7 Days|Withdrawal by Subject|1
6011811|NCT00840203|20783393|P2|Washout|Protocol Violation|0
6011812|NCT00840203|20783394|P1|Washout|Protocol Violation|1
6011813|NCT00840203|20783393|P2|First Intervention|Protocol Violation|1
6011814|NCT00840203|20783394|P1|First Intervention|Protocol Violation|1
6011836|NCT00840086|20783447|P1|Overall Study|Lost to Follow-up|1
6011837|NCT00840086|20783447|P1|Overall Study|Protocol Violation|2
6011838|NCT00840086|20783447|P1|Overall Study|Adverse Event|1
6011839|NCT00840073|20783456|P2|Second Intervention|Missed 72 hour blood draw|1
6011840|NCT00840073|20783457|P1|Second Intervention|Missed 72 hour blood draw|1
6011841|NCT00840060|20783471|P2|Overall Study|Change in emotional/behavioral status|1
6011842|NCT00840060|20783472|P1|Overall Study|Change in emotional/behavioral status|0
6011843|NCT00840060|20783471|P2|Overall Study|Withdrawal by Subject|0
6011844|NCT00840060|20783472|P1|Overall Study|Withdrawal by Subject|1
6011845|NCT00840034|20783482|P2|Taper Phase|Withdrawal by Subject|1
6011846|NCT00840034|20783483|P1|Taper Phase|Withdrawal by Subject|1
6011847|NCT00840034|20783482|P2|Taper Phase|Lost to Follow-up|1
6011848|NCT00840034|20783483|P1|Taper Phase|Lost to Follow-up|1
6011849|NCT00840034|20783482|P2|Taper Phase|Adverse Event|0
6011850|NCT00840034|20783483|P1|Taper Phase|Adverse Event|1
6011851|NCT00840034|20783482|P2|Acute Treatment Phase|Withdrawal by Subject|11
6011852|NCT00840034|20783483|P1|Acute Treatment Phase|Withdrawal by Subject|6
6011853|NCT00840034|20783482|P2|Acute Treatment Phase|Protocol Violation|4
6011854|NCT00840034|20783483|P1|Acute Treatment Phase|Protocol Violation|2
6011855|NCT00840034|20783482|P2|Acute Treatment Phase|Physician Decision|1
6011856|NCT00840034|20783483|P1|Acute Treatment Phase|Physician Decision|0
6011857|NCT00840034|20783482|P2|Acute Treatment Phase|Lost to Follow-up|12
6011858|NCT00840034|20783483|P1|Acute Treatment Phase|Lost to Follow-up|5
6011859|NCT00840034|20783482|P2|Acute Treatment Phase|Lack of Efficacy|0
6011860|NCT00840034|20783483|P1|Acute Treatment Phase|Lack of Efficacy|2
6011861|NCT00840034|20783482|P2|Acute Treatment Phase|Adverse Event|8
6011862|NCT00840034|20783483|P1|Acute Treatment Phase|Adverse Event|6
6011863|NCT00839956|20783536|P1|Overall Study|Withdrawal by Subject|3
6011864|NCT00839956|20783536|P1|Overall Study|Physician Decision|1
6011865|NCT00839956|20783536|P1|Overall Study|Lack of Efficacy|6
6011866|NCT00839956|20783536|P1|Overall Study|Adverse Event|2
6011867|NCT00839917|20783556|P2|Overall Study|Did not receive vaccine|1
6011868|NCT00839917|20783557|P1|Overall Study|Did not receive vaccine|0
6011869|NCT00839917|20783556|P2|Overall Study|Lost to Follow-up|0
6011870|NCT00839917|20783557|P1|Overall Study|Lost to Follow-up|1
6011871|NCT00839852|20783593|P1|Overall Study|Pregnancy|1
6011872|NCT00839852|20783593|P1|Overall Study|Lack of Compliance While in Jail|1
6011873|NCT00839852|20783593|P1|Overall Study|Lost to Follow-up|7
6011874|NCT00839852|20783593|P1|Overall Study|Withdrawal of Consent|16
6011875|NCT00839852|20783593|P1|Overall Study|Protocol Violation|9
6011876|NCT00839852|20783593|P1|Overall Study|Insufficient Therapeutic Response|3
6011877|NCT00839852|20783593|P1|Overall Study|Adverse Event|10
6011878|NCT00839800|20783600|P2|Overall Study|Severe Non-Compliance to Protocol|7
6011879|NCT00839800|20783601|P1|Overall Study|Severe Non-Compliance to Protocol|7
6011880|NCT00839800|20783600|P2|Overall Study|Other|14
6011881|NCT00839800|20783601|P1|Overall Study|Other|8
6011882|NCT00839800|20783600|P2|Overall Study|Safety Reasons|1
6011883|NCT00839800|20783601|P1|Overall Study|Safety Reasons|2
6011884|NCT00839800|20783600|P2|Overall Study|Study-Specific Discontinuation Criteria|13
6011885|NCT00839800|20783601|P1|Overall Study|Study-Specific Discontinuation Criteria|6
6011886|NCT00839800|20783600|P2|Overall Study|Incorrect Enrolment|3
6011887|NCT00839800|20783601|P1|Overall Study|Incorrect Enrolment|3
6011888|NCT00839800|20783600|P2|Overall Study|Withdrawal by Subject|34
6011889|NCT00839800|20783601|P1|Overall Study|Withdrawal by Subject|28
6011890|NCT00839800|20783600|P2|Overall Study|Lost to Follow-up|26
6011891|NCT00839800|20783601|P1|Overall Study|Lost to Follow-up|31
6011892|NCT00839800|20783600|P2|Overall Study|Adverse Event|12
6011893|NCT00839800|20783601|P1|Overall Study|Adverse Event|8
6011894|NCT00839527|20783647|P3|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1
6011895|NCT00839527|20783648|P2|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1
6011896|NCT00839527|20783649|P1|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|0
6011897|NCT00839527|20783647|P3|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0
6011898|NCT00839527|20783648|P2|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|1
6011899|NCT00839527|20783649|P1|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0
6011900|NCT00839527|20783647|P3|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1
6011901|NCT00839527|20783648|P2|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|0
6011902|NCT00839527|20783649|P1|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1
6011903|NCT00839527|20783647|P3|Follow-up Period (FUP) (8 Weeks)|Site Closed|0
6011904|NCT00839527|20783648|P2|Follow-up Period (FUP) (8 Weeks)|Site Closed|1
6011905|NCT00839527|20783649|P1|Follow-up Period (FUP) (8 Weeks)|Site Closed|0
6011906|NCT00839527|20783647|P3|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0
6011907|NCT00839527|20783648|P2|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0
6011908|NCT00839527|20783649|P1|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|1
6011909|NCT00839527|20783647|P3|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0
6011910|NCT00839527|20783648|P2|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0
6011911|NCT00839527|20783649|P1|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|1
6011912|NCT00839527|20783647|P3|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|5
6011913|NCT00839527|20783648|P2|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|10
6011914|NCT00839527|20783649|P1|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|3
6011915|NCT00839527|20783647|P3|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1
6011916|NCT00839527|20783648|P2|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0
6011917|NCT00839527|20783649|P1|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0
6011918|NCT00839527|20783647|P3|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|19
6011919|NCT00839527|20783648|P2|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|21
6011920|NCT00839527|20783649|P1|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|12
6011921|NCT00839527|20783647|P3|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|29
6011922|NCT00839527|20783648|P2|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|20
6011923|NCT00839527|20783649|P1|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|8
6011924|NCT00839527|20783647|P3|Follow-up Period (FUP) (8 Weeks)|Noncompliance|5
6011925|NCT00839527|20783648|P2|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0
6011926|NCT00839527|20783649|P1|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1
6011927|NCT00839527|20783647|P3|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1
6011928|NCT00839527|20783648|P2|Follow-up Period (FUP) (8 Weeks)|Adverse Event|2
6011929|NCT00839527|20783649|P1|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1
6011930|NCT00839527|20783647|P3|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|1
6011931|NCT00839527|20783648|P2|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0
6011932|NCT00839527|20783649|P1|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0
6011933|NCT00839527|20783647|P3|Treatment Period (TP) (156 Weeks)|Site Closed|0
6011934|NCT00839527|20783648|P2|Treatment Period (TP) (156 Weeks)|Site Closed|2
6011935|NCT00839527|20783649|P1|Treatment Period (TP) (156 Weeks)|Site Closed|1
6011936|NCT00839527|20783647|P3|Treatment Period (TP) (156 Weeks)|Pregnancy|1
6011937|NCT00839527|20783648|P2|Treatment Period (TP) (156 Weeks)|Pregnancy|1
6011938|NCT00839527|20783649|P1|Treatment Period (TP) (156 Weeks)|Pregnancy|0
6011939|NCT00839527|20783647|P3|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|1
6011940|NCT00839527|20783648|P2|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0
6011941|NCT00839527|20783649|P1|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0
6011942|NCT00839527|20783647|P3|Treatment Period (TP) (156 Weeks)|Missing|0
6011943|NCT00839527|20783648|P2|Treatment Period (TP) (156 Weeks)|Missing|1
6011944|NCT00839527|20783649|P1|Treatment Period (TP) (156 Weeks)|Missing|0
6011945|NCT00839527|20783647|P3|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|5
6011946|NCT00839527|20783648|P2|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|8
6011947|NCT00839527|20783649|P1|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|3
6011948|NCT00839527|20783647|P3|Treatment Period (TP) (156 Weeks)|Physician Decision|1
6011949|NCT00839527|20783648|P2|Treatment Period (TP) (156 Weeks)|Physician Decision|6
6011950|NCT00839527|20783649|P1|Treatment Period (TP) (156 Weeks)|Physician Decision|1
6011951|NCT00839527|20783647|P3|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|64
6011952|NCT00839527|20783648|P2|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|46
6011953|NCT00839527|20783649|P1|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|32
6011954|NCT00839527|20783647|P3|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7
6011955|NCT00839527|20783648|P2|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|12
6011956|NCT00839527|20783649|P1|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|3
6011957|NCT00839527|20783647|P3|Treatment Period (TP) (156 Weeks)|Noncompliance|16
6011958|NCT00839527|20783648|P2|Treatment Period (TP) (156 Weeks)|Noncompliance|6
6011959|NCT00839527|20783649|P1|Treatment Period (TP) (156 Weeks)|Noncompliance|5
6011960|NCT00839527|20783647|P3|Treatment Period (TP) (156 Weeks)|Protocol Violation|1
6011961|NCT00839527|20783648|P2|Treatment Period (TP) (156 Weeks)|Protocol Violation|7
6011962|NCT00839527|20783649|P1|Treatment Period (TP) (156 Weeks)|Protocol Violation|4
6011963|NCT00839527|20783647|P3|Treatment Period (TP) (156 Weeks)|Adverse Event|22
6011964|NCT00839527|20783648|P2|Treatment Period (TP) (156 Weeks)|Adverse Event|29
6011965|NCT00839527|20783649|P1|Treatment Period (TP) (156 Weeks)|Adverse Event|11
6011966|NCT00839436|20783684|P3|Overall Study|Study drug no longer available|1
6011967|NCT00839436|20783685|P2|Overall Study|Study drug no longer available|0
6011968|NCT00839436|20783686|P1|Overall Study|Study drug no longer available|0
6011969|NCT00839436|20783684|P3|Overall Study|Withdrawal by Subject|0
6011970|NCT00839436|20783685|P2|Overall Study|Withdrawal by Subject|1
6011971|NCT00839436|20783686|P1|Overall Study|Withdrawal by Subject|0
6011972|NCT00839436|20783684|P3|Overall Study|Developed exclusionary condition|0
6011973|NCT00839436|20783685|P2|Overall Study|Developed exclusionary condition|0
6011974|NCT00839436|20783686|P1|Overall Study|Developed exclusionary condition|1
6011975|NCT00839423|20783698|P4|Overall Study|Administrative or other reasons|0
6011976|NCT00839423|20783699|P3|Overall Study|Administrative or other reasons|1
6011977|NCT00839423|20783700|P2|Overall Study|Administrative or other reasons|0
6011978|NCT00839423|20783701|P1|Overall Study|Administrative or other reasons|3
6011979|NCT00839423|20783698|P4|Overall Study|Lost to Follow-up|0
6011980|NCT00839423|20783699|P3|Overall Study|Lost to Follow-up|1
6011981|NCT00839423|20783700|P2|Overall Study|Lost to Follow-up|0
6011982|NCT00839423|20783701|P1|Overall Study|Lost to Follow-up|1
6011983|NCT00839423|20783698|P4|Overall Study|Withdrawal of consent|1
6011984|NCT00839423|20783699|P3|Overall Study|Withdrawal of consent|4
6011985|NCT00839423|20783700|P2|Overall Study|Withdrawal of consent|0
6011986|NCT00839423|20783701|P1|Overall Study|Withdrawal of consent|4
6011987|NCT00839423|20783698|P4|Overall Study|Protocol Violation|0
6011988|NCT00839423|20783699|P3|Overall Study|Protocol Violation|2
6011989|NCT00839423|20783700|P2|Overall Study|Protocol Violation|1
6011990|NCT00839423|20783701|P1|Overall Study|Protocol Violation|0
6011991|NCT00839423|20783698|P4|Overall Study|Non-compliance|1
6011992|NCT00839423|20783699|P3|Overall Study|Non-compliance|0
6011993|NCT00839423|20783700|P2|Overall Study|Non-compliance|0
6011994|NCT00839423|20783701|P1|Overall Study|Non-compliance|0
6011995|NCT00839423|20783698|P4|Overall Study|Lack of Efficacy|2
6011996|NCT00839423|20783699|P3|Overall Study|Lack of Efficacy|3
6011997|NCT00839423|20783700|P2|Overall Study|Lack of Efficacy|6
6011998|NCT00839423|20783701|P1|Overall Study|Lack of Efficacy|6
6011999|NCT00839423|20783698|P4|Overall Study|Adverse Event|16
6012000|NCT00839423|20783699|P3|Overall Study|Adverse Event|7
6012001|NCT00839423|20783700|P2|Overall Study|Adverse Event|3
6012002|NCT00839423|20783701|P1|Overall Study|Adverse Event|4
6012003|NCT00839332|20783742|P3|Phase 2|Lost to Follow-up|1
6012004|NCT00839332|20783743|P2|Phase 2|Lost to Follow-up|0
6012005|NCT00839332|20783744|P1|Phase 2|Lost to Follow-up|0
6012006|NCT00839332|20783742|P3|Phase 2|Physician Decision|1
6012007|NCT00839332|20783743|P2|Phase 2|Physician Decision|4
6012008|NCT00839332|20783744|P1|Phase 2|Physician Decision|0
6012009|NCT00839332|20783742|P3|Phase 2|Withdrawal by Subject|8
6012010|NCT00839332|20783743|P2|Phase 2|Withdrawal by Subject|5
6012011|NCT00839332|20783744|P1|Phase 2|Withdrawal by Subject|0
6012012|NCT00839332|20783742|P3|Phase 2|Death|2
6012013|NCT00839332|20783743|P2|Phase 2|Death|4
6012014|NCT00839332|20783744|P1|Phase 2|Death|0
6012015|NCT00839332|20783742|P3|Phase 2|Adverse Event|6
6012016|NCT00839332|20783743|P2|Phase 2|Adverse Event|8
6012017|NCT00839332|20783744|P1|Phase 2|Adverse Event|0
6012018|NCT00839332|20783742|P3|Phase 2|Disease Progression|21
6012019|NCT00839332|20783743|P2|Phase 2|Disease Progression|46
6012020|NCT00839332|20783744|P1|Phase 2|Disease Progression|0
6012021|NCT00839332|20783742|P3|Phase 2|Protocol Violation|0
6012022|NCT00839332|20783743|P2|Phase 2|Protocol Violation|1
6012023|NCT00839332|20783744|P1|Phase 2|Protocol Violation|0
6012024|NCT00839332|20783742|P3|Phase 1|Physician Decision|0
6012025|NCT00839332|20783743|P2|Phase 1|Physician Decision|0
6012026|NCT00839332|20783744|P1|Phase 1|Physician Decision|2
6012027|NCT00839332|20783742|P3|Phase 1|Withdrawal by Subject|0
6012028|NCT00839332|20783743|P2|Phase 1|Withdrawal by Subject|0
6012029|NCT00839332|20783744|P1|Phase 1|Withdrawal by Subject|4
6012030|NCT00839332|20783742|P3|Phase 1|Adverse Event|0
6012031|NCT00839332|20783743|P2|Phase 1|Adverse Event|0
6012032|NCT00839332|20783744|P1|Phase 1|Adverse Event|6
6012033|NCT00839332|20783742|P3|Phase 1|Disease Progression|0
6012034|NCT00839332|20783743|P2|Phase 1|Disease Progression|0
6012035|NCT00839332|20783744|P1|Phase 1|Disease Progression|38
6012036|NCT00839306|20783805|P2|Overall Study|Other|18
6012037|NCT00839306|20783806|P1|Overall Study|Other|6
6012038|NCT00839306|20783805|P2|Overall Study|Lack of Efficacy|4
6012039|NCT00839306|20783806|P1|Overall Study|Lack of Efficacy|5
6012040|NCT00839306|20783805|P2|Overall Study|Withdrawal by Subject|7
6012041|NCT00839306|20783806|P1|Overall Study|Withdrawal by Subject|5
6012042|NCT00839306|20783805|P2|Overall Study|Lost to Follow-up|9
6012043|NCT00839306|20783806|P1|Overall Study|Lost to Follow-up|6
6012044|NCT00839306|20783805|P2|Overall Study|Adverse Event|5
6012045|NCT00839306|20783806|P1|Overall Study|Adverse Event|3
6012046|NCT00839254|20783822|P8|Overall Study|Lost to Follow-up|2
6012047|NCT00839254|20783823|P7|Overall Study|Lost to Follow-up|4
6012048|NCT00839254|20783824|P6|Overall Study|Lost to Follow-up|8
6012049|NCT00839254|20783825|P5|Overall Study|Lost to Follow-up|8
6012050|NCT00839254|20783826|P4|Overall Study|Lost to Follow-up|24
6012051|NCT00839254|20783827|P3|Overall Study|Lost to Follow-up|32
6012052|NCT00839254|20783828|P2|Overall Study|Lost to Follow-up|30
6012053|NCT00839254|20783829|P1|Overall Study|Lost to Follow-up|51
6012054|NCT00839254|20783822|P8|Overall Study|Withdrawn due to non-compliance|0
6012055|NCT00839254|20783823|P7|Overall Study|Withdrawn due to non-compliance|0
6012056|NCT00839254|20783824|P6|Overall Study|Withdrawn due to non-compliance|0
6012057|NCT00839254|20783825|P5|Overall Study|Withdrawn due to non-compliance|0
6012058|NCT00839254|20783826|P4|Overall Study|Withdrawn due to non-compliance|0
6012059|NCT00839254|20783827|P3|Overall Study|Withdrawn due to non-compliance|0
6012060|NCT00839254|20783828|P2|Overall Study|Withdrawn due to non-compliance|0
6012061|NCT00839254|20783829|P1|Overall Study|Withdrawn due to non-compliance|2
6012062|NCT00839254|20783822|P8|Overall Study|Parents wanted pneumococcal vaccine|0
6012063|NCT00839254|20783823|P7|Overall Study|Parents wanted pneumococcal vaccine|0
6012064|NCT00839254|20783824|P6|Overall Study|Parents wanted pneumococcal vaccine|1
6012065|NCT00839254|20783825|P5|Overall Study|Parents wanted pneumococcal vaccine|0
6012066|NCT00839254|20783826|P4|Overall Study|Parents wanted pneumococcal vaccine|0
6012067|NCT00839254|20783827|P3|Overall Study|Parents wanted pneumococcal vaccine|0
6012068|NCT00839254|20783828|P2|Overall Study|Parents wanted pneumococcal vaccine|0
6012069|NCT00839254|20783829|P1|Overall Study|Parents wanted pneumococcal vaccine|1
6012070|NCT00839254|20783822|P8|Overall Study|Wrong group allocation|0
6012071|NCT00839254|20783823|P7|Overall Study|Wrong group allocation|1
6012072|NCT00839254|20783824|P6|Overall Study|Wrong group allocation|0
6012073|NCT00839254|20783825|P5|Overall Study|Wrong group allocation|0
6012074|NCT00839254|20783826|P4|Overall Study|Wrong group allocation|0
6012075|NCT00839254|20783827|P3|Overall Study|Wrong group allocation|0
6012076|NCT00839254|20783828|P2|Overall Study|Wrong group allocation|0
6012077|NCT00839254|20783829|P1|Overall Study|Wrong group allocation|0
6012078|NCT00839254|20783822|P8|Overall Study|Withdrawal by Subject|9
6012079|NCT00839254|20783823|P7|Overall Study|Withdrawal by Subject|22
6012080|NCT00839254|20783824|P6|Overall Study|Withdrawal by Subject|15
6012081|NCT00839254|20783825|P5|Overall Study|Withdrawal by Subject|27
6012082|NCT00839254|20783826|P4|Overall Study|Withdrawal by Subject|32
6012083|NCT00839254|20783827|P3|Overall Study|Withdrawal by Subject|54
6012084|NCT00839254|20783828|P2|Overall Study|Withdrawal by Subject|53
6012085|NCT00839254|20783829|P1|Overall Study|Withdrawal by Subject|87
6012086|NCT00839254|20783822|P8|Overall Study|Adverse Event|1
6012087|NCT00839254|20783823|P7|Overall Study|Adverse Event|0
6012088|NCT00839254|20783824|P6|Overall Study|Adverse Event|1
6012089|NCT00839254|20783825|P5|Overall Study|Adverse Event|2
6012090|NCT00839254|20783826|P4|Overall Study|Adverse Event|5
6012091|NCT00839254|20783827|P3|Overall Study|Adverse Event|3
6012092|NCT00839254|20783828|P2|Overall Study|Adverse Event|6
6012093|NCT00839254|20783829|P1|Overall Study|Adverse Event|12
6012094|NCT00839254|20783822|P8|Overall Study|Wrong treatment number allocation|0
6012095|NCT00839254|20783823|P7|Overall Study|Wrong treatment number allocation|0
6012096|NCT00839254|20783824|P6|Overall Study|Wrong treatment number allocation|1
6012097|NCT00839254|20783825|P5|Overall Study|Wrong treatment number allocation|0
6012098|NCT00839254|20783826|P4|Overall Study|Wrong treatment number allocation|0
6012099|NCT00839254|20783827|P3|Overall Study|Wrong treatment number allocation|0
6012100|NCT00839254|20783828|P2|Overall Study|Wrong treatment number allocation|1
6012101|NCT00839254|20783829|P1|Overall Study|Wrong treatment number allocation|0
6012102|NCT00839254|20783822|P8|Overall Study|Physician Decision|1
6012103|NCT00839254|20783823|P7|Overall Study|Physician Decision|0
6012104|NCT00839254|20783824|P6|Overall Study|Physician Decision|0
6012105|NCT00839254|20783825|P5|Overall Study|Physician Decision|0
6012106|NCT00839254|20783826|P4|Overall Study|Physician Decision|0
6012107|NCT00839254|20783827|P3|Overall Study|Physician Decision|0
6012108|NCT00839254|20783828|P2|Overall Study|Physician Decision|1
6012109|NCT00839254|20783829|P1|Overall Study|Physician Decision|0
6012110|NCT00839254|20783822|P8|Overall Study|Protocol Violation|2
6012111|NCT00839254|20783823|P7|Overall Study|Protocol Violation|1
6012112|NCT00839254|20783824|P6|Overall Study|Protocol Violation|0
6012113|NCT00839254|20783825|P5|Overall Study|Protocol Violation|0
6012114|NCT00839254|20783826|P4|Overall Study|Protocol Violation|1
6012115|NCT00839254|20783827|P3|Overall Study|Protocol Violation|1
6012116|NCT00839254|20783828|P2|Overall Study|Protocol Violation|1
6012117|NCT00839254|20783829|P1|Overall Study|Protocol Violation|0
6012118|NCT00839098|20784153|P3|Overall Study|Withdrawal by Subject|7
6012119|NCT00839098|20784154|P2|Overall Study|Withdrawal by Subject|1
6012120|NCT00839098|20784155|P1|Overall Study|Withdrawal by Subject|2
6012121|NCT00839072|20784181|P2|Second Intervention Period|Withdrawal by Subject|0
6012122|NCT00839072|20784182|P1|Second Intervention Period|Withdrawal by Subject|1
6012123|NCT00839072|20784181|P2|First Intervention Period|Adverse Event|1
6012124|NCT00839072|20784182|P1|First Intervention Period|Adverse Event|1
6012125|NCT00839072|20784181|P2|First Intervention Period|Withdrawal by Subject|0
6012126|NCT00839072|20784182|P1|First Intervention Period|Withdrawal by Subject|1
6012127|NCT00838929|20784226|P3|Overall Study|Disease progression|1
6012128|NCT00838929|20784227|P2|Overall Study|Disease progression|2
6012129|NCT00838929|20784228|P1|Overall Study|Disease progression|0
6012130|NCT00838929|20784226|P3|Overall Study|Protocol Violation|0
6012131|NCT00838929|20784227|P2|Overall Study|Protocol Violation|1
6012132|NCT00838929|20784228|P1|Overall Study|Protocol Violation|0
6012133|NCT00838916|20784236|P2|Follow-up Period (8 Weeks)|Missing|0
6012134|NCT00838916|20784237|P1|Follow-up Period (8 Weeks)|Missing|3
6012135|NCT00838916|20784236|P2|Follow-up Period (8 Weeks)|Withdrawal by Subject|0
6012136|NCT00838916|20784237|P1|Follow-up Period (8 Weeks)|Withdrawal by Subject|2
6012137|NCT00838916|20784236|P2|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0
6012138|NCT00838916|20784237|P1|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|2
6012139|NCT00838916|20784236|P2|Follow-up Period (8 Weeks)|Physician Decision|0
6012140|NCT00838916|20784237|P1|Follow-up Period (8 Weeks)|Physician Decision|2
6012141|NCT00838916|20784236|P2|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|12
6012142|NCT00838916|20784237|P1|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|26
6012143|NCT00838916|20784236|P2|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7
6012144|NCT00838916|20784237|P1|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7
6012145|NCT00838916|20784236|P2|Follow-up Period (8 Weeks)|Lost to Follow-up|22
6012146|NCT00838916|20784237|P1|Follow-up Period (8 Weeks)|Lost to Follow-up|38
6012147|NCT00838916|20784236|P2|Follow-up Period (8 Weeks)|Noncompliance|5
6012148|NCT00838916|20784237|P1|Follow-up Period (8 Weeks)|Noncompliance|6
6012149|NCT00838916|20784236|P2|Follow-up Period (8 Weeks)|Adverse Event|5
6012150|NCT00838916|20784237|P1|Follow-up Period (8 Weeks)|Adverse Event|10
6012151|NCT00838916|20784236|P2|Treatment Period (156 Weeks)|Pregnancy|0
6012152|NCT00838916|20784237|P1|Treatment Period (156 Weeks)|Pregnancy|2
6012153|NCT00838916|20784236|P2|Treatment Period (156 Weeks)|Missing|1
6012154|NCT00838916|20784237|P1|Treatment Period (156 Weeks)|Missing|3
6012155|NCT00838916|20784236|P2|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|0
6012156|NCT00838916|20784237|P1|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|1
6012157|NCT00838916|20784236|P2|Treatment Period (156 Weeks)|Physician Decision|1
6012158|NCT00838916|20784237|P1|Treatment Period (156 Weeks)|Physician Decision|6
6012159|NCT00838916|20784236|P2|Treatment Period (156 Weeks)|Withdrawal by Subject|29
6012160|NCT00838916|20784237|P1|Treatment Period (156 Weeks)|Withdrawal by Subject|81
6012161|NCT00838916|20784236|P2|Treatment Period (156 Weeks)|Lost to Follow-up|18
6012162|NCT00838916|20784237|P1|Treatment Period (156 Weeks)|Lost to Follow-up|19
6012163|NCT00838916|20784236|P2|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0
6012164|NCT00838916|20784237|P1|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1
6012165|NCT00838916|20784236|P2|Treatment Period (156 Weeks)|Noncompliance|14
6012166|NCT00838916|20784237|P1|Treatment Period (156 Weeks)|Noncompliance|21
6012167|NCT00838916|20784236|P2|Treatment Period (156 Weeks)|Protocol Violation|3
6012168|NCT00838916|20784237|P1|Treatment Period (156 Weeks)|Protocol Violation|12
6012169|NCT00838916|20784236|P2|Treatment Period (156 Weeks)|Adverse Event|11
6012170|NCT00838916|20784237|P1|Treatment Period (156 Weeks)|Adverse Event|50
6012171|NCT00838903|20784266|P4|Follow-up Period (8 Weeks)|Missing|1
6012172|NCT00838903|20784267|P3|Follow-up Period (8 Weeks)|Missing|1
6012173|NCT00838903|20784268|P2|Follow-up Period (8 Weeks)|Missing|2
6012174|NCT00838903|20784269|P1|Follow-up Period (8 Weeks)|Missing|1
6012175|NCT00838903|20784266|P4|Follow-up Period (8 Weeks)|Subject Moved out of Town|1
6012176|NCT00838903|20784267|P3|Follow-up Period (8 Weeks)|Subject Moved out of Town|0
6012177|NCT00838903|20784268|P2|Follow-up Period (8 Weeks)|Subject Moved out of Town|0
6012178|NCT00838903|20784269|P1|Follow-up Period (8 Weeks)|Subject Moved out of Town|0
6012179|NCT00838903|20784266|P4|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0
6012180|NCT00838903|20784267|P3|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0
6012181|NCT00838903|20784268|P2|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|1
6012182|NCT00838903|20784269|P1|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0
6012183|NCT00838903|20784266|P4|Follow-up Period (8 Weeks)|ICF Withdrawn|0
6012184|NCT00838903|20784267|P3|Follow-up Period (8 Weeks)|ICF Withdrawn|0
6012185|NCT00838903|20784268|P2|Follow-up Period (8 Weeks)|ICF Withdrawn|1
6012186|NCT00838903|20784269|P1|Follow-up Period (8 Weeks)|ICF Withdrawn|0
6012187|NCT00838903|20784266|P4|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4
6012188|NCT00838903|20784267|P3|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|6
6012189|NCT00838903|20784268|P2|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4
6012190|NCT00838903|20784269|P1|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|3
6012191|NCT00838903|20784266|P4|Follow-up Period (8 Weeks)|Physician Decision|1
6012192|NCT00838903|20784267|P3|Follow-up Period (8 Weeks)|Physician Decision|1
6012193|NCT00838903|20784268|P2|Follow-up Period (8 Weeks)|Physician Decision|1
6012194|NCT00838903|20784269|P1|Follow-up Period (8 Weeks)|Physician Decision|1
6012195|NCT00838903|20784266|P4|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14
6012196|NCT00838903|20784267|P3|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14
6012197|NCT00838903|20784268|P2|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|13
6012198|NCT00838903|20784269|P1|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|8
6012199|NCT00838903|20784266|P4|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7
6012200|NCT00838903|20784267|P3|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|12
6012201|NCT00838903|20784268|P2|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7
6012202|NCT00838903|20784269|P1|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|5
6012203|NCT00838903|20784266|P4|Follow-up Period (8 Weeks)|Lost to Follow-up|24
6012204|NCT00838903|20784267|P3|Follow-up Period (8 Weeks)|Lost to Follow-up|22
6012205|NCT00838903|20784268|P2|Follow-up Period (8 Weeks)|Lost to Follow-up|28
6012206|NCT00838903|20784269|P1|Follow-up Period (8 Weeks)|Lost to Follow-up|6
6012207|NCT00838903|20784266|P4|Follow-up Period (8 Weeks)|Noncompliance|5
6012208|NCT00838903|20784267|P3|Follow-up Period (8 Weeks)|Noncompliance|5
6012209|NCT00838903|20784268|P2|Follow-up Period (8 Weeks)|Noncompliance|8
6012210|NCT00838903|20784269|P1|Follow-up Period (8 Weeks)|Noncompliance|2
6012211|NCT00838903|20784266|P4|Follow-up Period (8 Weeks)|Adverse Event|1
6012212|NCT00838903|20784267|P3|Follow-up Period (8 Weeks)|Adverse Event|3
6012213|NCT00838903|20784268|P2|Follow-up Period (8 Weeks)|Adverse Event|0
6012214|NCT00838903|20784269|P1|Follow-up Period (8 Weeks)|Adverse Event|0
6012215|NCT00838903|20784266|P4|Treatment Period (156 Weeks)|Missing Active Treatment Status|0
6012216|NCT00838903|20784267|P3|Treatment Period (156 Weeks)|Missing Active Treatment Status|0
6012217|NCT00838903|20784268|P2|Treatment Period (156 Weeks)|Missing Active Treatment Status|0
6012218|NCT00838903|20784269|P1|Treatment Period (156 Weeks)|Missing Active Treatment Status|1
6012219|NCT00838903|20784266|P4|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1
6012220|NCT00838903|20784267|P3|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0
6012221|NCT00838903|20784268|P2|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1
6012222|NCT00838903|20784269|P1|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0
6012223|NCT00838903|20784266|P4|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0
6012224|NCT00838903|20784267|P3|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0
6012225|NCT00838903|20784268|P2|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0
6012226|NCT00838903|20784269|P1|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|1
6012227|NCT00838903|20784266|P4|Treatment Period (156 Weeks)|Site closed|0
6012228|NCT00838903|20784267|P3|Treatment Period (156 Weeks)|Site closed|1
6012229|NCT00838903|20784268|P2|Treatment Period (156 Weeks)|Site closed|0
6012230|NCT00838903|20784269|P1|Treatment Period (156 Weeks)|Site closed|0
6012231|NCT00838903|20784266|P4|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0
6012232|NCT00838903|20784267|P3|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|1
6012233|NCT00838903|20784268|P2|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0
6012234|NCT00838903|20784269|P1|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0
6012235|NCT00838903|20784266|P4|Treatment Period (156 Weeks)|Pregnancy|0
6012236|NCT00838903|20784267|P3|Treatment Period (156 Weeks)|Pregnancy|1
6012237|NCT00838903|20784268|P2|Treatment Period (156 Weeks)|Pregnancy|0
6012238|NCT00838903|20784269|P1|Treatment Period (156 Weeks)|Pregnancy|0
6012239|NCT00838903|20784266|P4|Treatment Period (156 Weeks)|Poor Therapeutic Response|0
6012240|NCT00838903|20784267|P3|Treatment Period (156 Weeks)|Poor Therapeutic Response|0
6012241|NCT00838903|20784268|P2|Treatment Period (156 Weeks)|Poor Therapeutic Response|0
6012242|NCT00838903|20784269|P1|Treatment Period (156 Weeks)|Poor Therapeutic Response|1
6012243|NCT00838903|20784266|P4|Treatment Period (156 Weeks)|Poor Glycemic Control|1
6012244|NCT00838903|20784267|P3|Treatment Period (156 Weeks)|Poor Glycemic Control|0
6012245|NCT00838903|20784268|P2|Treatment Period (156 Weeks)|Poor Glycemic Control|0
6012246|NCT00838903|20784269|P1|Treatment Period (156 Weeks)|Poor Glycemic Control|0
6012247|NCT00838903|20784266|P4|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0
6012248|NCT00838903|20784267|P3|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0
6012249|NCT00838903|20784268|P2|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|1
6012250|NCT00838903|20784269|P1|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0
6012251|NCT00838903|20784266|P4|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|4
6012252|NCT00838903|20784267|P3|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5
6012253|NCT00838903|20784268|P2|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5
6012254|NCT00838903|20784269|P1|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|3
6012255|NCT00838903|20784266|P4|Treatment Period (156 Weeks)|Physician Decision|2
6012256|NCT00838903|20784267|P3|Treatment Period (156 Weeks)|Physician Decision|1
6012257|NCT00838903|20784268|P2|Treatment Period (156 Weeks)|Physician Decision|2
6012258|NCT00838903|20784269|P1|Treatment Period (156 Weeks)|Physician Decision|1
6012259|NCT00838903|20784266|P4|Treatment Period (156 Weeks)|Withdrawal by Subject|53
6012260|NCT00838903|20784267|P3|Treatment Period (156 Weeks)|Withdrawal by Subject|56
6012261|NCT00838903|20784268|P2|Treatment Period (156 Weeks)|Withdrawal by Subject|55
6012262|NCT00838903|20784269|P1|Treatment Period (156 Weeks)|Withdrawal by Subject|20
6012263|NCT00838903|20784266|P4|Treatment Period (156 Weeks)|Lost to Follow-up|13
6012264|NCT00838903|20784267|P3|Treatment Period (156 Weeks)|Lost to Follow-up|15
6012265|NCT00838903|20784268|P2|Treatment Period (156 Weeks)|Lost to Follow-up|16
6012266|NCT00838903|20784269|P1|Treatment Period (156 Weeks)|Lost to Follow-up|4
6012267|NCT00838903|20784266|P4|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0
6012268|NCT00838903|20784267|P3|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1
6012269|NCT00838903|20784268|P2|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0
6012270|NCT00838903|20784269|P1|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0
6012271|NCT00838903|20784266|P4|Treatment Period (156 Weeks)|Noncompliance|6
6012272|NCT00838903|20784267|P3|Treatment Period (156 Weeks)|Noncompliance|12
6012273|NCT00838903|20784268|P2|Treatment Period (156 Weeks)|Noncompliance|13
6012274|NCT00838903|20784269|P1|Treatment Period (156 Weeks)|Noncompliance|9
6012275|NCT00838903|20784266|P4|Treatment Period (156 Weeks)|Protocol Violation|5
6012276|NCT00838903|20784267|P3|Treatment Period (156 Weeks)|Protocol Violation|6
6012277|NCT00838903|20784268|P2|Treatment Period (156 Weeks)|Protocol Violation|6
6012278|NCT00838903|20784269|P1|Treatment Period (156 Weeks)|Protocol Violation|1
6012279|NCT00838903|20784266|P4|Treatment Period (156 Weeks)|Adverse Event|25
6012280|NCT00838903|20784267|P3|Treatment Period (156 Weeks)|Adverse Event|17
6012281|NCT00838903|20784268|P2|Treatment Period (156 Weeks)|Adverse Event|13
6012282|NCT00838903|20784269|P1|Treatment Period (156 Weeks)|Adverse Event|5
6012283|NCT00838682|20784324|P2|Overall Study|Withdrawal by Subject|1
6012284|NCT00838682|20784325|P1|Overall Study|Withdrawal by Subject|0
6012285|NCT00838682|20784324|P2|Overall Study|Protocol Violation|1
6012286|NCT00838682|20784325|P1|Overall Study|Protocol Violation|0
6012287|NCT00838682|20784324|P2|Overall Study|detection of exclusion criteria|3
6012288|NCT00838682|20784325|P1|Overall Study|detection of exclusion criteria|4
6012289|NCT00838682|20784324|P2|Overall Study|Lost to Follow-up|14
6012290|NCT00838682|20784325|P1|Overall Study|Lost to Follow-up|21
6012291|NCT00838630|20784343|P2|Washout: 7 Days|Protocol Violation|0
6012292|NCT00838630|20784344|P1|Washout: 7 Days|Protocol Violation|1
6012293|NCT00838630|20784343|P2|First Intervention|Adverse Event|0
6012294|NCT00838630|20784344|P1|First Intervention|Adverse Event|1
6012295|NCT00838578|20784352|P1|Overall Study|Protocol Violation|2
6012296|NCT00838565|20784366|P6|Overall Study|Randomized but not Treated|0
6012297|NCT00838565|20784367|P5|Overall Study|Randomized but not Treated|0
6012298|NCT00838565|20784368|P4|Overall Study|Randomized but not Treated|0
6012299|NCT00838565|20784369|P3|Overall Study|Randomized but not Treated|0
6012300|NCT00838565|20784370|P2|Overall Study|Randomized but not Treated|1
6012301|NCT00838565|20784371|P1|Overall Study|Randomized but not Treated|0
6012302|NCT00838565|20784366|P6|Overall Study|Other|0
6012303|NCT00838565|20784367|P5|Overall Study|Other|0
6012304|NCT00838565|20784368|P4|Overall Study|Other|0
6012305|NCT00838565|20784369|P3|Overall Study|Other|0
6012306|NCT00838565|20784370|P2|Overall Study|Other|2
6012307|NCT00838565|20784371|P1|Overall Study|Other|0
6012308|NCT00838565|20784366|P6|Overall Study|Withdrawal by Subject|2
6012309|NCT00838565|20784367|P5|Overall Study|Withdrawal by Subject|0
6012310|NCT00838565|20784368|P4|Overall Study|Withdrawal by Subject|0
6012311|NCT00838565|20784369|P3|Overall Study|Withdrawal by Subject|1
6012312|NCT00838565|20784370|P2|Overall Study|Withdrawal by Subject|0
6012313|NCT00838565|20784371|P1|Overall Study|Withdrawal by Subject|0
6012314|NCT00838539|20784476|P12|Overall Study|Symptomatic Deterioration|0
6012315|NCT00838539|20784477|P11|Overall Study|Symptomatic Deterioration|0
6012316|NCT00838539|20784478|P10|Overall Study|Symptomatic Deterioration|1
6012317|NCT00838539|20784479|P9|Overall Study|Symptomatic Deterioration|0
6012318|NCT00838539|20784480|P8|Overall Study|Symptomatic Deterioration|0
6012319|NCT00838539|20784481|P7|Overall Study|Symptomatic Deterioration|0
6012320|NCT00838539|20784482|P6|Overall Study|Symptomatic Deterioration|1
6012321|NCT00838539|20784483|P5|Overall Study|Symptomatic Deterioration|0
6012322|NCT00838539|20784484|P4|Overall Study|Symptomatic Deterioration|1
6012323|NCT00838539|20784485|P3|Overall Study|Symptomatic Deterioration|1
6012324|NCT00838539|20784486|P2|Overall Study|Symptomatic Deterioration|0
6012325|NCT00838539|20784487|P1|Overall Study|Symptomatic Deterioration|0
6012326|NCT00838539|20784476|P12|Overall Study|Clinical Progression|0
6012327|NCT00838539|20784477|P11|Overall Study|Clinical Progression|0
6012328|NCT00838539|20784478|P10|Overall Study|Clinical Progression|0
6012329|NCT00838539|20784479|P9|Overall Study|Clinical Progression|0
6012330|NCT00838539|20784480|P8|Overall Study|Clinical Progression|0
6012331|NCT00838539|20784481|P7|Overall Study|Clinical Progression|1
6012332|NCT00838539|20784482|P6|Overall Study|Clinical Progression|0
6012333|NCT00838539|20784483|P5|Overall Study|Clinical Progression|0
6012334|NCT00838539|20784484|P4|Overall Study|Clinical Progression|0
6012335|NCT00838539|20784485|P3|Overall Study|Clinical Progression|0
6012336|NCT00838539|20784486|P2|Overall Study|Clinical Progression|0
6012337|NCT00838539|20784487|P1|Overall Study|Clinical Progression|0
6012338|NCT00838539|20784476|P12|Overall Study|Physician Decision|0
6012339|NCT00838539|20784477|P11|Overall Study|Physician Decision|0
6012340|NCT00838539|20784478|P10|Overall Study|Physician Decision|0
6012341|NCT00838539|20784479|P9|Overall Study|Physician Decision|1
6012342|NCT00838539|20784480|P8|Overall Study|Physician Decision|0
6012343|NCT00838539|20784481|P7|Overall Study|Physician Decision|0
6012344|NCT00838539|20784482|P6|Overall Study|Physician Decision|0
6012345|NCT00838539|20784483|P5|Overall Study|Physician Decision|0
6012346|NCT00838539|20784484|P4|Overall Study|Physician Decision|0
6012347|NCT00838539|20784485|P3|Overall Study|Physician Decision|0
6012348|NCT00838539|20784486|P2|Overall Study|Physician Decision|0
6012349|NCT00838539|20784487|P1|Overall Study|Physician Decision|0
6012350|NCT00838539|20784476|P12|Overall Study|Death|0
6012351|NCT00838539|20784477|P11|Overall Study|Death|0
6012352|NCT00838539|20784478|P10|Overall Study|Death|0
6012353|NCT00838539|20784479|P9|Overall Study|Death|0
6012354|NCT00838539|20784480|P8|Overall Study|Death|0
6012355|NCT00838539|20784481|P7|Overall Study|Death|1
6012356|NCT00838539|20784482|P6|Overall Study|Death|0
6012357|NCT00838539|20784483|P5|Overall Study|Death|0
6012358|NCT00838539|20784484|P4|Overall Study|Death|0
6012359|NCT00838539|20784485|P3|Overall Study|Death|0
6012360|NCT00838539|20784486|P2|Overall Study|Death|0
6012361|NCT00838539|20784487|P1|Overall Study|Death|0
6012362|NCT00838539|20784476|P12|Overall Study|Withdrawal by Subject|0
6012363|NCT00838539|20784477|P11|Overall Study|Withdrawal by Subject|2
6012364|NCT00838539|20784478|P10|Overall Study|Withdrawal by Subject|1
6012365|NCT00838539|20784479|P9|Overall Study|Withdrawal by Subject|0
6012366|NCT00838539|20784480|P8|Overall Study|Withdrawal by Subject|0
6012367|NCT00838539|20784481|P7|Overall Study|Withdrawal by Subject|0
6012368|NCT00838539|20784482|P6|Overall Study|Withdrawal by Subject|0
6012369|NCT00838539|20784483|P5|Overall Study|Withdrawal by Subject|0
6012370|NCT00838539|20784484|P4|Overall Study|Withdrawal by Subject|0
6012371|NCT00838539|20784485|P3|Overall Study|Withdrawal by Subject|0
6012372|NCT00838539|20784486|P2|Overall Study|Withdrawal by Subject|1
6012373|NCT00838539|20784487|P1|Overall Study|Withdrawal by Subject|0
6012374|NCT00838539|20784476|P12|Overall Study|Adverse Event|0
6012375|NCT00838539|20784477|P11|Overall Study|Adverse Event|2
6012376|NCT00838539|20784478|P10|Overall Study|Adverse Event|1
6012377|NCT00838539|20784479|P9|Overall Study|Adverse Event|0
6012378|NCT00838539|20784480|P8|Overall Study|Adverse Event|2
6012379|NCT00838539|20784481|P7|Overall Study|Adverse Event|0
6012380|NCT00838539|20784482|P6|Overall Study|Adverse Event|1
6012381|NCT00838539|20784483|P5|Overall Study|Adverse Event|2
6012382|NCT00838539|20784484|P4|Overall Study|Adverse Event|1
6012383|NCT00838539|20784485|P3|Overall Study|Adverse Event|1
6012384|NCT00838539|20784486|P2|Overall Study|Adverse Event|1
6012385|NCT00838539|20784487|P1|Overall Study|Adverse Event|1
6012386|NCT00838539|20784476|P12|Overall Study|Disease Progression|4
6012387|NCT00838539|20784477|P11|Overall Study|Disease Progression|1
6012388|NCT00838539|20784478|P10|Overall Study|Disease Progression|5
6012389|NCT00838539|20784479|P9|Overall Study|Disease Progression|4
6012390|NCT00838539|20784480|P8|Overall Study|Disease Progression|4
6012391|NCT00838539|20784481|P7|Overall Study|Disease Progression|3
6012392|NCT00838539|20784482|P6|Overall Study|Disease Progression|2
6012393|NCT00838539|20784483|P5|Overall Study|Disease Progression|4
6012394|NCT00838539|20784484|P4|Overall Study|Disease Progression|2
6012395|NCT00838539|20784485|P3|Overall Study|Disease Progression|3
6012396|NCT00838539|20784486|P2|Overall Study|Disease Progression|4
6012397|NCT00838539|20784487|P1|Overall Study|Disease Progression|2
6012398|NCT00838526|20784537|P2|Overall Study|Other|7
6012399|NCT00838526|20784538|P1|Overall Study|Other|11
6012400|NCT00838526|20784537|P2|Overall Study|Lack of Efficacy|3
6012401|NCT00838526|20784538|P1|Overall Study|Lack of Efficacy|2
6012402|NCT00838526|20784537|P2|Overall Study|Withdrawal by Subject|5
6012403|NCT00838526|20784538|P1|Overall Study|Withdrawal by Subject|4
6012404|NCT00838526|20784537|P2|Overall Study|Lost to Follow-up|12
6012405|NCT00838526|20784538|P1|Overall Study|Lost to Follow-up|4
6012406|NCT00838526|20784537|P2|Overall Study|Adverse Event|12
6012407|NCT00838526|20784538|P1|Overall Study|Adverse Event|3
6012408|NCT00838513|20784546|P1|Post Treatment Period (Patients Who Disc|Death|1
6012409|NCT00838513|20784546|P1|Extension Treatment Period|Death|1
6012410|NCT00838513|20784546|P1|Screening Period|Screen Failure|3
6012411|NCT00838435|20784562|P1|Part 2 (7 Years)|Withdrawal by Subject|5
6012412|NCT00838435|20784562|P1|Part 2 (7 Years)|Sponsor Decision|6
6012413|NCT00838435|20784562|P1|Part 2 (7 Years)|Physician Decision|1
6012414|NCT00838435|20784562|P1|Part 2 (7 Years)|Lost to Follow-up|2
6012415|NCT00838435|20784562|P1|Part 2 (7 Years)|Adverse Event|2
6012416|NCT00838435|20784562|P1|Safety/Efficacy Sub-Study 1 (6 Months)|Adverse Event|2
6012417|NCT00838435|20784562|P1|PK Sub-Study 2 (4 Weeks)|no postdose blood sample|1
6012418|NCT00838331|20784575|P1|Aged Blood Transfusion|Withdrawal by Subject|9
6012419|NCT00838279|20784581|P2|Washout|Withdrawal by Subject|1
6012420|NCT00838279|20784582|P1|Washout|Withdrawal by Subject|0
6012421|NCT00838279|20784581|P2|Washout|Protocol Violation|0
6012422|NCT00838279|20784582|P1|Washout|Protocol Violation|1
6012423|NCT00838201|20784592|P2|Overall Study|Death|13
6012424|NCT00838201|20784593|P1|Overall Study|Death|11
6012425|NCT00838201|20784592|P2|Overall Study|Adverse Event|9
6012426|NCT00838201|20784593|P1|Overall Study|Adverse Event|5
6012427|NCT00838201|20784592|P2|Overall Study|Lost to Follow-up|3
6012428|NCT00838201|20784593|P1|Overall Study|Lost to Follow-up|4
6012429|NCT00838201|20784592|P2|Overall Study|Consent withdrawn|19
6012430|NCT00838201|20784593|P1|Overall Study|Consent withdrawn|16
6012431|NCT00838201|20784592|P2|Overall Study|Disease progression|3
6012432|NCT00838201|20784593|P1|Overall Study|Disease progression|3
6012433|NCT00838201|20784592|P2|Overall Study|Administrative decision|2
6012434|NCT00838201|20784593|P1|Overall Study|Administrative decision|1
6012435|NCT00838201|20784592|P2|Overall Study|Noncompliance|1
6012436|NCT00838201|20784593|P1|Overall Study|Noncompliance|0
6012437|NCT00838201|20784592|P2|Overall Study|Investigator decision, or other reasons|3
6012438|NCT00838201|20784593|P1|Overall Study|Investigator decision, or other reasons|2
6012439|NCT00838110|20784661|P4|Overall Study|Randomized but not treated|0
6012440|NCT00838110|20784662|P3|Overall Study|Randomized but not treated|0
6012441|NCT00838110|20784663|P2|Overall Study|Randomized but not treated|1
6012442|NCT00838110|20784664|P1|Overall Study|Randomized but not treated|0
6012443|NCT00838110|20784661|P4|Overall Study|Did not meet eligibility criteria|2
6012444|NCT00838110|20784662|P3|Overall Study|Did not meet eligibility criteria|1
6012445|NCT00838110|20784663|P2|Overall Study|Did not meet eligibility criteria|0
6012446|NCT00838110|20784664|P1|Overall Study|Did not meet eligibility criteria|0
6012447|NCT00838110|20784661|P4|Overall Study|Lost to Follow-up|0
6012448|NCT00838110|20784662|P3|Overall Study|Lost to Follow-up|0
6012449|NCT00838110|20784663|P2|Overall Study|Lost to Follow-up|0
6012450|NCT00838110|20784664|P1|Overall Study|Lost to Follow-up|3
6012451|NCT00838110|20784661|P4|Overall Study|Protocol Violation|1
6012452|NCT00838110|20784662|P3|Overall Study|Protocol Violation|1
6012453|NCT00838110|20784663|P2|Overall Study|Protocol Violation|2
6012454|NCT00838110|20784664|P1|Overall Study|Protocol Violation|0
6012455|NCT00838110|20784661|P4|Overall Study|Other|2
6012456|NCT00838110|20784662|P3|Overall Study|Other|3
6012457|NCT00838110|20784663|P2|Overall Study|Other|3
6012458|NCT00838110|20784664|P1|Overall Study|Other|3
6012459|NCT00838110|20784661|P4|Overall Study|Withdrawal by Subject|4
6012460|NCT00838110|20784662|P3|Overall Study|Withdrawal by Subject|3
6012461|NCT00838110|20784663|P2|Overall Study|Withdrawal by Subject|6
6012462|NCT00838110|20784664|P1|Overall Study|Withdrawal by Subject|5
6012463|NCT00838110|20784661|P4|Overall Study|Adverse Event|7
6012464|NCT00838110|20784662|P3|Overall Study|Adverse Event|8
6012465|NCT00838110|20784663|P2|Overall Study|Adverse Event|10
6012466|NCT00838110|20784664|P1|Overall Study|Adverse Event|11
6012467|NCT00838110|20784661|P4|Overall Study|Death|2
6012468|NCT00838110|20784662|P3|Overall Study|Death|1
6012469|NCT00838110|20784663|P2|Overall Study|Death|0
6012470|NCT00838110|20784664|P1|Overall Study|Death|0
6012471|NCT00838097|20784684|P1|Overall Study|Protocol-specified criteria|142
6012472|NCT00838097|20784684|P1|Overall Study|Death|6
6012473|NCT00838097|20784684|P1|Overall Study|Lost to Follow-up|11
6012474|NCT00838097|20784684|P1|Overall Study|Physician Decision|4
6012475|NCT00838097|20784684|P1|Overall Study|Requirement for alternative therapy|2
6012476|NCT00838097|20784684|P1|Overall Study|Withdrawal by Subject|3
6012477|NCT00838097|20784684|P1|Overall Study|Adverse Event|2
6012478|NCT00838097|20784684|P1|Overall Study|Ineligibility determined|6
6012479|NCT00837967|20784708|P2|Washout Period of 7 - 14 Days|Adverse Event|0
6012480|NCT00837967|20784709|P1|Washout Period of 7 - 14 Days|Adverse Event|2
6012481|NCT00837876|20784735|P1|Overall Study|disease progression|24
6012482|NCT00837876|20784735|P1|Overall Study|Withdrawal by Subject|3
6012483|NCT00837876|20784735|P1|Overall Study|Physician Decision|1
6012484|NCT00837876|20784735|P1|Overall Study|Adverse Event|7
6012485|NCT00837876|20784735|P1|Overall Study|Death|2
6012486|NCT00837811|20784757|P3|Overall Study|Sponsor Decision|0
6012487|NCT00837811|20784758|P2|Overall Study|Sponsor Decision|2
6012488|NCT00837811|20784759|P1|Overall Study|Sponsor Decision|0
6012489|NCT00837811|20784757|P3|Overall Study|Withdrawal by Subject|0
6012490|NCT00837811|20784758|P2|Overall Study|Withdrawal by Subject|9
6012491|NCT00837811|20784759|P1|Overall Study|Withdrawal by Subject|1
6012492|NCT00837811|20784757|P3|Overall Study|Physician Decision|1
6012493|NCT00837811|20784758|P2|Overall Study|Physician Decision|2
6012494|NCT00837811|20784759|P1|Overall Study|Physician Decision|0
6012495|NCT00837811|20784757|P3|Overall Study|Lost to Follow-up|0
6012496|NCT00837811|20784758|P2|Overall Study|Lost to Follow-up|3
6012497|NCT00837811|20784759|P1|Overall Study|Lost to Follow-up|1
6012498|NCT00837811|20784757|P3|Overall Study|Lack of Efficacy|0
6012499|NCT00837811|20784758|P2|Overall Study|Lack of Efficacy|11
6012500|NCT00837811|20784759|P1|Overall Study|Lack of Efficacy|0
6012501|NCT00837811|20784757|P3|Overall Study|Death|0
6012502|NCT00837811|20784758|P2|Overall Study|Death|1
6012503|NCT00837811|20784759|P1|Overall Study|Death|1
6012504|NCT00837811|20784757|P3|Overall Study|Adverse Event|0
6012505|NCT00837811|20784758|P2|Overall Study|Adverse Event|6
6012506|NCT00837811|20784759|P1|Overall Study|Adverse Event|4
6012507|NCT00837759|20784844|P1|Overall Study|Lost to Follow-up|1
6012508|NCT00837759|20784844|P1|Overall Study|Protocol Violation|3
6012509|NCT00837694|20784859|P6|Overall Study|Lost to Follow-up|1
6012510|NCT00837694|20784860|P5|Overall Study|Lost to Follow-up|1
6012511|NCT00837694|20784861|P4|Overall Study|Lost to Follow-up|1
6012512|NCT00837694|20784862|P3|Overall Study|Lost to Follow-up|2
6012513|NCT00837694|20784863|P2|Overall Study|Lost to Follow-up|0
6012514|NCT00837694|20784864|P1|Overall Study|Lost to Follow-up|2
6012515|NCT00837616|20784880|P2|Overall Study|Withdrawal by Subject|1
6012516|NCT00837616|20784881|P1|Overall Study|Withdrawal by Subject|0
6012517|NCT00837577|20784920|P2|Open-label Period|Other Reason|1
6012518|NCT00837577|20784921|P1|Open-label Period|Other Reason|1
6012519|NCT00837577|20784920|P2|Open-label Period|Withdrawal by Subject|2
6012520|NCT00837577|20784921|P1|Open-label Period|Withdrawal by Subject|1
6012521|NCT00837577|20784920|P2|Open-label Period|Lack of Efficacy|3
6012522|NCT00837577|20784921|P1|Open-label Period|Lack of Efficacy|4
6012523|NCT00837577|20784920|P2|Open-label Period|Laboratory Adverse Event|1
6012524|NCT00837577|20784921|P1|Open-label Period|Laboratory Adverse Event|0
6012525|NCT00837577|20784920|P2|Open-label Period|Clinical Adverse Event|2
6012526|NCT00837577|20784921|P1|Open-label Period|Clinical Adverse Event|2
6012527|NCT00837577|20784920|P2|Double-blind Period|Withdrawal by Subject|0
6012528|NCT00837577|20784921|P1|Double-blind Period|Withdrawal by Subject|1
6012529|NCT00837577|20784920|P2|Double-blind Period|Clinical Adverse Event|0
6012530|NCT00837577|20784921|P1|Double-blind Period|Clinical Adverse Event|1
6012531|NCT00837486|20784941|P2|Long-term Follow-up Phase - Open Label|Death|0
6012532|NCT00837486|20784942|P1|Long-term Follow-up Phase - Open Label|Death|1
6012533|NCT00837486|20784941|P2|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|0
6012534|NCT00837486|20784942|P1|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|2
6012535|NCT00837486|20784941|P2|Long-term Follow-up Phase - Open Label|Physician Decision|0
6012536|NCT00837486|20784942|P1|Long-term Follow-up Phase - Open Label|Physician Decision|2
6012537|NCT00837486|20784941|P2|Blinded-treatment Phase|Physician Decision|0
6012538|NCT00837486|20784942|P1|Blinded-treatment Phase|Physician Decision|1
6012539|NCT00837473|20784954|P1|Overall Study|Withdrawal by Subject|2
6012540|NCT00837473|20784954|P1|Overall Study|Lost to Follow-up|1
6012541|NCT00837434|20784974|P2|Overall Study|Unable to obtain study drug|0
6012542|NCT00837434|20784975|P1|Overall Study|Unable to obtain study drug|1
6012543|NCT00837434|20784974|P2|Overall Study|Baseline assessments not done in time|0
6012544|NCT00837434|20784975|P1|Overall Study|Baseline assessments not done in time|1
6012545|NCT00837434|20784974|P2|Overall Study|Noncompliant|0
6012546|NCT00837434|20784975|P1|Overall Study|Noncompliant|2
6012547|NCT00837434|20784974|P2|Overall Study|Withdrawn by sponsor/regulatory agency|0
6012548|NCT00837434|20784975|P1|Overall Study|Withdrawn by sponsor/regulatory agency|1
6012549|NCT00837434|20784974|P2|Overall Study|Lost to Follow-up|1
6012550|NCT00837434|20784975|P1|Overall Study|Lost to Follow-up|1
6012551|NCT00837434|20784974|P2|Overall Study|Physician Decision|0
6012552|NCT00837434|20784975|P1|Overall Study|Physician Decision|3
6012553|NCT00837330|20784995|P2|Overall Study|Lost to Follow-up|3
6012554|NCT00837330|20784996|P1|Overall Study|Lost to Follow-up|1
6012555|NCT00837213|20785019|P2|Overall Study|not stated|1
6012556|NCT00837213|20785020|P1|Overall Study|not stated|1
6012557|NCT00837213|20785019|P2|Overall Study|Withdrawal by Subject|2
6012558|NCT00837213|20785020|P1|Overall Study|Withdrawal by Subject|2
6012559|NCT00837213|20785019|P2|Overall Study|Lost to Follow-up|2
6012560|NCT00837213|20785020|P1|Overall Study|Lost to Follow-up|3
6012561|NCT00837161|20785046|P1|Overall Study|refused hysterectomy|2
6012562|NCT00837148|20785054|P1|Overall Study|Death|1
6012563|NCT00837148|20785054|P1|Overall Study|Adverse Event|1
6012564|NCT00837096|20785060|P2|Overall Study|Not reported|8
6012565|NCT00837096|20785061|P1|Overall Study|Not reported|9
6012566|NCT00837096|20785060|P2|Overall Study|Physician Decision|1
6012567|NCT00837096|20785061|P1|Overall Study|Physician Decision|1
6012568|NCT00836953|20785073|P1|Overall Study|Lost to Follow-up|1
6012569|NCT00836953|20785073|P1|Overall Study|Withdrawal by Subject|1
6012570|NCT00836927|20785084|P5|Overall Study|Withdrawal by Subject|0
6012571|NCT00836927|20785085|P4|Overall Study|Withdrawal by Subject|0
6012572|NCT00836927|20785086|P3|Overall Study|Withdrawal by Subject|0
6012573|NCT00836927|20785087|P2|Overall Study|Withdrawal by Subject|0
6012574|NCT00836927|20785088|P1|Overall Study|Withdrawal by Subject|1
6012575|NCT00836927|20785084|P5|Overall Study|Progressive disease|1
6012576|NCT00836927|20785085|P4|Overall Study|Progressive disease|1
6012577|NCT00836927|20785086|P3|Overall Study|Progressive disease|0
6012578|NCT00836927|20785087|P2|Overall Study|Progressive disease|0
6012579|NCT00836927|20785088|P1|Overall Study|Progressive disease|2
6012580|NCT00836901|20785124|P2|First Intervention|Withdrawal by Subject|0
6012581|NCT00836901|20785125|P1|First Intervention|Withdrawal by Subject|1
6012582|NCT00836875|20785174|P2|Overall Study|Withdrawal by Subject|1
6012583|NCT00836875|20785175|P1|Overall Study|Withdrawal by Subject|0
6012584|NCT00836875|20785174|P2|Overall Study|Death|2
6012585|NCT00836875|20785175|P1|Overall Study|Death|3
6012586|NCT00836810|20785191|P2|Overall Study|New diagnosis|0
6012587|NCT00836810|20785192|P1|Overall Study|New diagnosis|1
6012588|NCT00836745|20785214|P1|Overall Study|Other|2
6012589|NCT00836745|20785214|P1|Overall Study|Objective progression or relapse|4
6012590|NCT00836745|20785214|P1|Overall Study|Adverse Event|3
6012591|NCT00836745|20785214|P1|Overall Study|Lost to Follow-up|10
6012592|NCT00836745|20785214|P1|Overall Study|Death|2
6012593|NCT00836706|20785228|P2|Washout: 7 Days|Withdrawal by Subject|1
6012594|NCT00836706|20785229|P1|Washout: 7 Days|Withdrawal by Subject|0
6012595|NCT00836693|20785239|P2|Overall Study|Lost to Follow-up|0
6012596|NCT00836693|20785240|P1|Overall Study|Lost to Follow-up|1
6012597|NCT00836693|20785239|P2|Overall Study|Protocol Violation|0
6012598|NCT00836693|20785240|P1|Overall Study|Protocol Violation|1
6012599|NCT00836693|20785239|P2|Overall Study|Withdrawal by Subject|4
6012600|NCT00836693|20785240|P1|Overall Study|Withdrawal by Subject|9
6012601|NCT00836693|20785239|P2|Overall Study|Physician Decision|0
6012602|NCT00836693|20785240|P1|Overall Study|Physician Decision|2
6012603|NCT00836693|20785239|P2|Overall Study|Sponsor Decision|1
6012604|NCT00836693|20785240|P1|Overall Study|Sponsor Decision|0
6012605|NCT00836693|20785239|P2|Overall Study|Adverse Event|1
6012606|NCT00836693|20785240|P1|Overall Study|Adverse Event|4
6012607|NCT00836589|20785290|P1|Overall Study|Withdrawal by Subject or Physician|591
6012608|NCT00836589|20785290|P1|Overall Study|Death|429
6012609|NCT00836589|20785290|P1|Overall Study|Lost to Follow-up|246
6012610|NCT00836498|20785323|P2|Overall Study|Withdrawal by Subject|1
6012611|NCT00836498|20785324|P1|Overall Study|Withdrawal by Subject|2
6012612|NCT00836498|20785323|P2|Overall Study|Lost to Follow-up|0
6012613|NCT00836498|20785324|P1|Overall Study|Lost to Follow-up|1
6012614|NCT00836498|20785323|P2|Overall Study|Adverse Event|0
6012615|NCT00836498|20785324|P1|Overall Study|Adverse Event|1
6012616|NCT00836472|20785356|P2|Washout|Withdrawal by Subject|1
6012617|NCT00836472|20785357|P1|Washout|Withdrawal by Subject|1
6012618|NCT00836472|20785356|P2|Washout|Adverse Event|2
6012619|NCT00836472|20785357|P1|Washout|Adverse Event|1
6012620|NCT00836277|20785434|P1|Overall Study|Not evaluable for response|6
6012621|NCT00836186|20785442|P1|Overall Study|Blood could not be drawn|1
6012622|NCT00836095|20785450|P2|Overall Study|Physician Decision|3
6012623|NCT00836095|20785451|P1|Overall Study|Physician Decision|0
6012624|NCT00836056|20785461|P2|First Intervention|Adverse Event|0
6012625|NCT00836056|20785462|P1|First Intervention|Adverse Event|1
6012626|NCT00835991|20785491|P2|Washout|Withdrawal by Subject|1
6012627|NCT00835991|20785492|P1|Washout|Withdrawal by Subject|3
6012628|NCT00835991|20785491|P2|Washout|Protocol Violation|2
6012629|NCT00835991|20785492|P1|Washout|Protocol Violation|0
6012630|NCT00835991|20785491|P2|First Intervention|Adverse Event|1
6012631|NCT00835991|20785492|P1|First Intervention|Adverse Event|0
6012632|NCT00835978|20785510|P4|Overall Study|Study terminated by sponsor|0
6012633|NCT00835978|20785511|P3|Overall Study|Study terminated by sponsor|30
6012634|NCT00835978|20785512|P2|Overall Study|Study terminated by sponsor|8
6012635|NCT00835978|20785513|P1|Overall Study|Study terminated by sponsor|12
6012636|NCT00835978|20785510|P4|Overall Study|Withdrawal by Subject|5
6012637|NCT00835978|20785511|P3|Overall Study|Withdrawal by Subject|0
6012638|NCT00835978|20785512|P2|Overall Study|Withdrawal by Subject|3
6012639|NCT00835978|20785513|P1|Overall Study|Withdrawal by Subject|0
6012640|NCT00835978|20785510|P4|Overall Study|Adverse Event|0
6012641|NCT00835978|20785511|P3|Overall Study|Adverse Event|1
6012642|NCT00835978|20785512|P2|Overall Study|Adverse Event|0
6012643|NCT00835978|20785513|P1|Overall Study|Adverse Event|1
6012644|NCT00835978|20785510|P4|Overall Study|Objective progression or relapse|0
6012645|NCT00835978|20785511|P3|Overall Study|Objective progression or relapse|1
6012646|NCT00835978|20785512|P2|Overall Study|Objective progression or relapse|0
6012647|NCT00835978|20785513|P1|Overall Study|Objective progression or relapse|2
6012648|NCT00835978|20785510|P4|Overall Study|Other|0
6012649|NCT00835978|20785511|P3|Overall Study|Other|8
6012650|NCT00835978|20785512|P2|Overall Study|Other|1
6012651|NCT00835978|20785513|P1|Overall Study|Other|5
6012652|NCT00835978|20785510|P4|Overall Study|Lost to Follow-up|1
6012653|NCT00835978|20785511|P3|Overall Study|Lost to Follow-up|2
6012654|NCT00835978|20785512|P2|Overall Study|Lost to Follow-up|4
6012655|NCT00835978|20785513|P1|Overall Study|Lost to Follow-up|3
6012656|NCT00835978|20785510|P4|Overall Study|Death|4
6012657|NCT00835978|20785511|P3|Overall Study|Death|49
6012658|NCT00835978|20785512|P2|Overall Study|Death|40
6012659|NCT00835978|20785513|P1|Overall Study|Death|33
6012660|NCT00835796|20785624|P2|First Intervention|Withdrawal by Subject|1
6012661|NCT00835796|20785625|P1|First Intervention|Withdrawal by Subject|0
6012662|NCT00835770|20785635|P2|Overall Study|Other|1
6012663|NCT00835770|20785636|P1|Overall Study|Other|2
6012664|NCT00835770|20785635|P2|Overall Study|Other|104
6012665|NCT00835770|20785636|P1|Overall Study|Other|115
6012666|NCT00835770|20785635|P2|Overall Study|Death|6
6012667|NCT00835770|20785636|P1|Overall Study|Death|4
6012668|NCT00835770|20785635|P2|Overall Study|Participant Non-Compliance|9
6012669|NCT00835770|20785636|P1|Overall Study|Participant Non-Compliance|11
6012670|NCT00835770|20785635|P2|Overall Study|Investigator Decision|42
6012671|NCT00835770|20785636|P1|Overall Study|Investigator Decision|42
6012672|NCT00835770|20785635|P2|Overall Study|Consent Withdrawn|156
6012673|NCT00835770|20785636|P1|Overall Study|Consent Withdrawn|144
6012674|NCT00835770|20785635|P2|Overall Study|Lost to Follow-up|19
6012675|NCT00835770|20785636|P1|Overall Study|Lost to Follow-up|22
6012676|NCT00835770|20785635|P2|Overall Study|Adverse Event|124
6012677|NCT00835770|20785636|P1|Overall Study|Adverse Event|113
6012678|NCT00835770|20785635|P2|Overall Study|MS Progression|9
6012679|NCT00835770|20785636|P1|Overall Study|MS Progression|14
6012680|NCT00835770|20785635|P2|Overall Study|MS Relapse|23
6012681|NCT00835770|20785636|P1|Overall Study|MS Relapse|17
6012682|NCT00835731|20785734|P2|Overall Study|Physician Decision|1
6012683|NCT00835731|20785735|P1|Overall Study|Physician Decision|1
6012684|NCT00835731|20785734|P2|Overall Study|Withdrawal by Subject|0
6012685|NCT00835731|20785735|P1|Overall Study|Withdrawal by Subject|1
6012686|NCT00835705|20785755|P2|Second Intervention|Difficulty with vein|0
6012687|NCT00835705|20785756|P1|Second Intervention|Difficulty with vein|1
6012688|NCT00835705|20785755|P2|First Intervention|Difficulty with vein|0
6012689|NCT00835705|20785756|P1|First Intervention|Difficulty with vein|1
6012690|NCT00835692|20785772|P2|First Intervention|Withdrawal by Subject|0
6012691|NCT00835692|20785773|P1|First Intervention|Withdrawal by Subject|1
6012692|NCT00835679|20785785|P4|Overall Study|Withdrawal by Subject|0
6012693|NCT00835679|20785786|P3|Overall Study|Withdrawal by Subject|0
6012694|NCT00835679|20785787|P2|Overall Study|Withdrawal by Subject|0
6012695|NCT00835679|20785788|P1|Overall Study|Withdrawal by Subject|1
6012696|NCT00835666|20785812|P2|Washout|Withdrawal by Subject|0
6012697|NCT00835666|20785813|P1|Washout|Withdrawal by Subject|1
6012698|NCT00835666|20785812|P2|Washout|Protocol Violation|0
6012699|NCT00835666|20785813|P1|Washout|Protocol Violation|1
6012700|NCT00835640|20785823|P2|Second Intervention|Protocol Violation|0
6012701|NCT00835640|20785824|P1|Second Intervention|Protocol Violation|1
6012702|NCT00835575|20785856|P2|Washout of 14 Days|Withdrawal by Subject|0
6012703|NCT00835575|20785857|P1|Washout of 14 Days|Withdrawal by Subject|1
6012704|NCT00835549|20785867|P2|Washout of 7 Days|Withdrawal by Subject|0
6012705|NCT00835549|20785868|P1|Washout of 7 Days|Withdrawal by Subject|2
6012706|NCT00835536|20785878|P2|Washout of 5 Weeks|Withdrawal by Subject|0
6012707|NCT00835536|20785879|P1|Washout of 5 Weeks|Withdrawal by Subject|1
6012708|NCT00835406|20785940|P2|Period: Washout of 7 Days|Withdrawal by Subject|2
6012709|NCT00835406|20785941|P1|Period: Washout of 7 Days|Withdrawal by Subject|0
6012710|NCT00835406|20785940|P2|Period: First Intervention|Withdrawal by Subject|0
6012711|NCT00835406|20785941|P1|Period: First Intervention|Withdrawal by Subject|2
6012712|NCT00835406|20785940|P2|Period: First Intervention|Adverse Event|1
6012713|NCT00835406|20785941|P1|Period: First Intervention|Adverse Event|0
6012714|NCT00835380|20785947|P1|Overall Study|Withdrawal by Subject|2
6012715|NCT00835367|20785954|P2|Second Intervention|Adverse Event|1
6012716|NCT00835367|20785955|P1|Second Intervention|Adverse Event|1
6012717|NCT00835367|20785954|P2|Washout|Withdrawal by Subject|0
6012718|NCT00835367|20785955|P1|Washout|Withdrawal by Subject|1
6012719|NCT00835367|20785954|P2|Washout|Adverse Event|0
6012720|NCT00835367|20785955|P1|Washout|Adverse Event|2
6012721|NCT00835354|20785977|P2|First Intervention|Adverse Event|1
6012722|NCT00835354|20785978|P1|First Intervention|Adverse Event|0
6012723|NCT00835341|20785988|P2|Overall Study|Lost to Follow-up|12
6012724|NCT00835341|20785989|P1|Overall Study|Lost to Follow-up|3
6012725|NCT00835263|20786052|P2|Second Intervention|Adverse Event|0
6012726|NCT00835263|20786053|P1|Second Intervention|Adverse Event|1
6012727|NCT00835237|20786063|P2|Overall Study|Withdrawal by Subject|0
6012728|NCT00835237|20786064|P1|Overall Study|Withdrawal by Subject|2
6012729|NCT00835237|20786063|P2|Overall Study|Lost to Follow-up|0
6012730|NCT00835237|20786064|P1|Overall Study|Lost to Follow-up|4
6012731|NCT00835211|20786104|P2|Washout: 7 Days|Withdrawal by Subject|0
6012732|NCT00835211|20786105|P1|Washout: 7 Days|Withdrawal by Subject|1
6012733|NCT00835211|20786104|P2|Washout: 7 Days|Adverse Event|1
6012734|NCT00835211|20786105|P1|Washout: 7 Days|Adverse Event|2
6012735|NCT00835211|20786104|P2|First Intervention|Withdrawal by Subject|1
6012736|NCT00835211|20786105|P1|First Intervention|Withdrawal by Subject|0
6012737|NCT00835172|20786151|P2|Washout|Protocol Violation|1
6012738|NCT00835172|20786152|P1|Washout|Protocol Violation|0
6012739|NCT00835120|20786178|P1|Overall Study|Withdrawal by Subject|2
6012740|NCT00835120|20786178|P1|Overall Study|Adverse Event|2
6012741|NCT00835120|20786178|P1|Overall Study|Lost to Follow-up|3
6012742|NCT00835120|20786178|P1|Overall Study|Lack of Efficacy|1
6012743|NCT00835081|20786188|P2|Washout of 7 Days|Withdrawal by Subject|0
6012744|NCT00835081|20786189|P1|Washout of 7 Days|Withdrawal by Subject|1
6012745|NCT00835068|20786199|P2|Overall Study|Withdrawal by Subject|0
6012746|NCT00835068|20786200|P1|Overall Study|Withdrawal by Subject|1
6012747|NCT00835068|20786199|P2|Overall Study|Other|0
6012748|NCT00835068|20786200|P1|Overall Study|Other|8
6012749|NCT00835068|20786199|P2|Overall Study|Adverse Event|1
6012750|NCT00835068|20786200|P1|Overall Study|Adverse Event|0
6012751|NCT00835068|20786199|P2|Overall Study|Death|0
6012752|NCT00835068|20786200|P1|Overall Study|Death|1
6012753|NCT00835042|20786220|P2|Washout of 21 Days|Withdrawal by Subject|2
6012754|NCT00835042|20786221|P1|Washout of 21 Days|Withdrawal by Subject|0
6012755|NCT00835042|20786220|P2|First Intervention|Adverse Event|2
6012756|NCT00835042|20786221|P1|First Intervention|Adverse Event|1
6012757|NCT00835042|20786220|P2|First Intervention|Withdrawal by Subject|0
6012758|NCT00835042|20786221|P1|First Intervention|Withdrawal by Subject|3
6012759|NCT00834912|20786307|P6|Treatment Period 2|Withdrawal by Subject|0
6012760|NCT00834912|20786308|P5|Treatment Period 2|Withdrawal by Subject|1
6012761|NCT00834912|20786309|P4|Treatment Period 2|Withdrawal by Subject|0
6012762|NCT00834912|20786310|P3|Treatment Period 2|Withdrawal by Subject|1
6012763|NCT00834912|20786311|P2|Treatment Period 2|Withdrawal by Subject|0
6012764|NCT00834912|20786312|P1|Treatment Period 2|Withdrawal by Subject|0
6012765|NCT00834912|20786307|P6|Treatment Period 1|Adverse Event|0
6012766|NCT00834912|20786308|P5|Treatment Period 1|Adverse Event|0
6012767|NCT00834912|20786309|P4|Treatment Period 1|Adverse Event|1
6012768|NCT00834912|20786310|P3|Treatment Period 1|Adverse Event|0
6012769|NCT00834912|20786311|P2|Treatment Period 1|Adverse Event|1
6012770|NCT00834912|20786312|P1|Treatment Period 1|Adverse Event|0
6012771|NCT00834899|20786334|P2|Overall Study|Withdrawal by Subject|1
6012772|NCT00834899|20786335|P1|Overall Study|Withdrawal by Subject|1
6012773|NCT00834873|20786374|P2|First Intervention|Adverse Event|1
6012774|NCT00834873|20786375|P1|First Intervention|Adverse Event|0
6012775|NCT00834834|20786385|P2|Overall Study|Withdrawal by Subject|3
6012776|NCT00834834|20786386|P1|Overall Study|Withdrawal by Subject|4
6012777|NCT00834795|20786421|P2|Second Intervention|Adverse Event|0
6012778|NCT00834795|20786422|P1|Second Intervention|Adverse Event|1
6012779|NCT00834795|20786421|P2|Washout: 7 Days|Withdrawal by Subject|1
6012780|NCT00834795|20786422|P1|Washout: 7 Days|Withdrawal by Subject|0
6012781|NCT00834756|20786432|P2|Washout: 21 Days|Withdrawal by Subject|0
6012782|NCT00834756|20786433|P1|Washout: 21 Days|Withdrawal by Subject|1
6012783|NCT00834756|20786432|P2|First Intervention|Adverse Event|0
6012784|NCT00834756|20786433|P1|First Intervention|Adverse Event|1
6012785|NCT00834743|20786443|P2|Second Intervention|Withdrawal by Subject|0
6012786|NCT00834743|20786444|P1|Second Intervention|Withdrawal by Subject|1
6012787|NCT00834717|20786454|P2|First Intervention|Withdrawal by Subject|1
6012788|NCT00834717|20786455|P1|First Intervention|Withdrawal by Subject|0
6012789|NCT00834717|20786454|P2|First Intervention|Adverse Event|0
6012790|NCT00834717|20786455|P1|First Intervention|Adverse Event|1
6012791|NCT00834639|20786486|P2|Second Intervention|Physician Decision|2
6012792|NCT00834639|20786487|P1|Second Intervention|Physician Decision|0
6012793|NCT00834613|20786504|P2|First Intervention|Protocol Violation|0
6012794|NCT00834613|20786505|P1|First Intervention|Protocol Violation|1
6012795|NCT00834587|20786515|P2|Washout: 7 Days|Withdrawal by Subject|0
6012796|NCT00834587|20786516|P1|Washout: 7 Days|Withdrawal by Subject|1
6012797|NCT00834522|20786565|P2|Washout|Withdrawal by Subject|1
6012798|NCT00834522|20786566|P1|Washout|Withdrawal by Subject|2
6012799|NCT00834522|20786565|P2|Washout|Adverse Event|0
6012800|NCT00834522|20786566|P1|Washout|Adverse Event|1
6012801|NCT00834444|20786589|P2|Second Intervention|Adverse Event|0
6012802|NCT00834444|20786590|P1|Second Intervention|Adverse Event|1
6012803|NCT00834444|20786589|P2|Washout of 7 Days|Withdrawal by Subject|1
6012804|NCT00834444|20786590|P1|Washout of 7 Days|Withdrawal by Subject|0
6012805|NCT00834444|20786589|P2|First Intervention|Intolerance to Venopuncture|1
6012806|NCT00834444|20786590|P1|First Intervention|Intolerance to Venopuncture|0
6012807|NCT00834444|20786589|P2|First Intervention|Adverse Event|0
6012808|NCT00834444|20786590|P1|First Intervention|Adverse Event|1
6012809|NCT00834431|20786600|P2|Washout of 7 Days|Withdrawal by Subject|1
6012810|NCT00834431|20786601|P1|Washout of 7 Days|Withdrawal by Subject|0
6012811|NCT00834431|20786600|P2|First Intervention|Adverse Event|1
6012812|NCT00834431|20786601|P1|First Intervention|Adverse Event|0
6012813|NCT00834418|20786611|P2|Overall Study|Adverse Event|2
6012814|NCT00834418|20786612|P1|Overall Study|Adverse Event|0
6012815|NCT00834366|20786629|P2|Treatment Period 1|Adverse Event|1
6012816|NCT00834366|20786630|P1|Treatment Period 1|Adverse Event|1
6012817|NCT00834340|20786646|P2|Washout|Withdrawal by Subject|0
6012818|NCT00834340|20786647|P1|Washout|Withdrawal by Subject|1
6012819|NCT00834340|20786646|P2|Washout|Adverse Event|0
6012820|NCT00834340|20786647|P1|Washout|Adverse Event|1
6012821|NCT00834249|20786691|P2|Second Intervention|Adverse Event|0
6012822|NCT00834249|20786692|P1|Second Intervention|Adverse Event|1
6012823|NCT00834249|20786691|P2|Washout: 7 Days|Withdrawal by Subject|1
6012824|NCT00834249|20786692|P1|Washout: 7 Days|Withdrawal by Subject|1
6012825|NCT00834080|20786788|P1|Overall Study|Subject Relocated|1
6012826|NCT00834080|20786788|P1|Overall Study|Physician Decision|1
6012827|NCT00834080|20786788|P1|Overall Study|Other - False positive tests of the UDS|1
6012828|NCT00834080|20786788|P1|Overall Study|Other - Pregnancy|1
6012829|NCT00834080|20786788|P1|Overall Study|Withdrawal by Subject|5
6012830|NCT00834080|20786788|P1|Overall Study|Lost to Follow-up|7
6012831|NCT00834080|20786788|P1|Overall Study|Adverse Event|7
6012832|NCT00834067|20786794|P2|Washout of 21 Days|Protocol Violation|1
6012833|NCT00834067|20786795|P1|Washout of 21 Days|Protocol Violation|0
6012834|NCT00834041|20786817|P2|Overall Study|Lost to Follow-up|1
6012835|NCT00834041|20786818|P1|Overall Study|Lost to Follow-up|0
6012836|NCT00834041|20786817|P2|Overall Study|Withdrawal by Subject|0
6012837|NCT00834041|20786818|P1|Overall Study|Withdrawal by Subject|1
6012838|NCT00833989|20786836|P4|Overall Study|Withdrawal by Subject|1
6012839|NCT00833989|20786837|P3|Overall Study|Withdrawal by Subject|1
6012840|NCT00833989|20786838|P2|Overall Study|Withdrawal by Subject|0
6012841|NCT00833989|20786839|P1|Overall Study|Withdrawal by Subject|3
6012842|NCT00833989|20786836|P4|Overall Study|Physician Decision|1
6012843|NCT00833989|20786837|P3|Overall Study|Physician Decision|0
6012844|NCT00833989|20786838|P2|Overall Study|Physician Decision|0
6012845|NCT00833989|20786839|P1|Overall Study|Physician Decision|0
6012846|NCT00833976|20786943|P1|Overall Study|Physician Decision|1
6012847|NCT00833976|20786943|P1|Overall Study|Did not meet eligibility criteria|41
6012848|NCT00833976|20786943|P1|Overall Study|Lost to Follow-up|4
6012849|NCT00833976|20786943|P1|Overall Study|Withdrawal by Subject|5
6012850|NCT00833937|20786951|P2|Washout|Withdrawal by Subject|0
6012851|NCT00833937|20786952|P1|Washout|Withdrawal by Subject|1
6012852|NCT00833924|20786960|P1|Overall Study|In study follow-up|71
6012853|NCT00833924|20786960|P1|Overall Study|Withdrawal by Subject|13
6012854|NCT00833924|20786960|P1|Overall Study|Lost to Follow-up|2
6012855|NCT00833924|20786960|P1|Overall Study|Conversion|2
6012856|NCT00833924|20786960|P1|Overall Study|Death|21
6012857|NCT00833911|20786965|P1|Maintenance Phase II|Lack of Efficacy|1
6012858|NCT00833911|20786965|P1|Maintenance Phase II|Withdrawal by Subject|1
6012859|NCT00833911|20786965|P1|Maintenance Phase II|Physician Decision|2
6012860|NCT00833911|20786965|P1|Maintenance Phase II|Adverse Event|6
6012861|NCT00833911|20786965|P1|Maintenance Phase I|Lack of Efficacy|4
6012862|NCT00833911|20786965|P1|Maintenance Phase I|Physician Decision|10
6012863|NCT00833911|20786965|P1|Maintenance Phase I|Withdrawal by Subject|11
6012864|NCT00833911|20786965|P1|Maintenance Phase I|Adverse Event|73
6012865|NCT00833911|20786965|P1|Titration|Withdrawal by Subject|3
6012866|NCT00833911|20786965|P1|Titration|Adverse Event|18
6012867|NCT00833898|20786975|P2|Overall Study|Patient did not receive transplant|2
6012868|NCT00833898|20786976|P1|Overall Study|Patient did not receive transplant|0
6012869|NCT00833898|20786975|P2|Overall Study|Lost to Follow-up|7
6012870|NCT00833898|20786976|P1|Overall Study|Lost to Follow-up|7
6012871|NCT00833898|20786975|P2|Overall Study|Withdrawal by Subject|27
6012872|NCT00833898|20786976|P1|Overall Study|Withdrawal by Subject|33
6012873|NCT00833833|20787035|P6|Phase 2 (as of 01 April 2011)|Lost to Follow-up|1
6012874|NCT00833833|20787036|P5|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0
6012875|NCT00833833|20787037|P4|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0
6012876|NCT00833833|20787038|P3|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0
6012877|NCT00833833|20787039|P2|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0
6012878|NCT00833833|20787040|P1|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0
6012879|NCT00833833|20787035|P6|Phase 2 (as of 01 April 2011)|Other|3
6012880|NCT00833833|20787036|P5|Phase 2 (as of 01 April 2011)|Other|4
6012881|NCT00833833|20787037|P4|Phase 2 (as of 01 April 2011)|Other|0
6012882|NCT00833833|20787038|P3|Phase 2 (as of 01 April 2011)|Other|0
6012883|NCT00833833|20787039|P2|Phase 2 (as of 01 April 2011)|Other|0
6012884|NCT00833833|20787040|P1|Phase 2 (as of 01 April 2011)|Other|0
6012885|NCT00833833|20787035|P6|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|7
6012886|NCT00833833|20787036|P5|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|5
6012887|NCT00833833|20787037|P4|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0
6012888|NCT00833833|20787038|P3|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0
6012889|NCT00833833|20787039|P2|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0
6012890|NCT00833833|20787040|P1|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0
6012891|NCT00833833|20787035|P6|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|6
6012892|NCT00833833|20787036|P5|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|7
6012893|NCT00833833|20787037|P4|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0
6012894|NCT00833833|20787038|P3|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0
6012895|NCT00833833|20787039|P2|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0
6012896|NCT00833833|20787040|P1|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0
6012897|NCT00833833|20787035|P6|Phase 2 (as of 01 April 2011)|Death|9
6012898|NCT00833833|20787036|P5|Phase 2 (as of 01 April 2011)|Death|8
6012899|NCT00833833|20787037|P4|Phase 2 (as of 01 April 2011)|Death|0
6012900|NCT00833833|20787038|P3|Phase 2 (as of 01 April 2011)|Death|0
6012901|NCT00833833|20787039|P2|Phase 2 (as of 01 April 2011)|Death|0
6012902|NCT00833833|20787040|P1|Phase 2 (as of 01 April 2011)|Death|0
6012903|NCT00833833|20787035|P6|Phase 2 (as of 01 April 2011)|Adverse Event|13
6012904|NCT00833833|20787036|P5|Phase 2 (as of 01 April 2011)|Adverse Event|8
6012905|NCT00833833|20787037|P4|Phase 2 (as of 01 April 2011)|Adverse Event|0
6012906|NCT00833833|20787038|P3|Phase 2 (as of 01 April 2011)|Adverse Event|0
6012907|NCT00833833|20787039|P2|Phase 2 (as of 01 April 2011)|Adverse Event|0
6012908|NCT00833833|20787040|P1|Phase 2 (as of 01 April 2011)|Adverse Event|0
6012909|NCT00833833|20787035|P6|Phase 2 (as of 01 April 2011)|Still active in study|22
6012910|NCT00833833|20787036|P5|Phase 2 (as of 01 April 2011)|Still active in study|23
6012911|NCT00833833|20787037|P4|Phase 2 (as of 01 April 2011)|Still active in study|0
6012912|NCT00833833|20787038|P3|Phase 2 (as of 01 April 2011)|Still active in study|0
6012913|NCT00833833|20787039|P2|Phase 2 (as of 01 April 2011)|Still active in study|0
6012914|NCT00833833|20787040|P1|Phase 2 (as of 01 April 2011)|Still active in study|0
6012915|NCT00833833|20787035|P6|Phase 1 (as of 01 April 2011)|Other|0
6012916|NCT00833833|20787036|P5|Phase 1 (as of 01 April 2011)|Other|0
6012917|NCT00833833|20787037|P4|Phase 1 (as of 01 April 2011)|Other|1
6012918|NCT00833833|20787038|P3|Phase 1 (as of 01 April 2011)|Other|0
6012919|NCT00833833|20787039|P2|Phase 1 (as of 01 April 2011)|Other|3
6012920|NCT00833833|20787040|P1|Phase 1 (as of 01 April 2011)|Other|1
6012921|NCT00833833|20787035|P6|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0
6012922|NCT00833833|20787036|P5|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0
6012923|NCT00833833|20787037|P4|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0
6012924|NCT00833833|20787038|P3|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1
6012925|NCT00833833|20787039|P2|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0
6012926|NCT00833833|20787040|P1|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1
6012927|NCT00833833|20787035|P6|Phase 1 (as of 01 April 2011)|Death|0
6012928|NCT00833833|20787036|P5|Phase 1 (as of 01 April 2011)|Death|0
6012929|NCT00833833|20787037|P4|Phase 1 (as of 01 April 2011)|Death|0
6012930|NCT00833833|20787038|P3|Phase 1 (as of 01 April 2011)|Death|2
6012931|NCT00833833|20787039|P2|Phase 1 (as of 01 April 2011)|Death|1
6012932|NCT00833833|20787040|P1|Phase 1 (as of 01 April 2011)|Death|0
6012933|NCT00833833|20787035|P6|Phase 1 (as of 01 April 2011)|Adverse Event|0
6012934|NCT00833833|20787036|P5|Phase 1 (as of 01 April 2011)|Adverse Event|0
6012935|NCT00833833|20787037|P4|Phase 1 (as of 01 April 2011)|Adverse Event|1
6012936|NCT00833833|20787038|P3|Phase 1 (as of 01 April 2011)|Adverse Event|2
6012937|NCT00833833|20787039|P2|Phase 1 (as of 01 April 2011)|Adverse Event|0
6012938|NCT00833833|20787040|P1|Phase 1 (as of 01 April 2011)|Adverse Event|1
6012939|NCT00833833|20787035|P6|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0
6012940|NCT00833833|20787036|P5|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0
6012941|NCT00833833|20787037|P4|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2
6012942|NCT00833833|20787038|P3|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2
6012943|NCT00833833|20787039|P2|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1
6012944|NCT00833833|20787040|P1|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1
6012945|NCT00833833|20787035|P6|Phase 1 (as of 01 April 2011)|Still active in study|0
6012946|NCT00833833|20787036|P5|Phase 1 (as of 01 April 2011)|Still active in study|0
6012947|NCT00833833|20787037|P4|Phase 1 (as of 01 April 2011)|Still active in study|2
6012948|NCT00833833|20787038|P3|Phase 1 (as of 01 April 2011)|Still active in study|2
6012949|NCT00833833|20787039|P2|Phase 1 (as of 01 April 2011)|Still active in study|0
6012950|NCT00833833|20787040|P1|Phase 1 (as of 01 April 2011)|Still active in study|0
6012951|NCT00833794|20787080|P2|Double-blind Phase|Administrative reason|3
6012952|NCT00833794|20787081|P1|Double-blind Phase|Administrative reason|1
6012953|NCT00833794|20787080|P2|Double-blind Phase|Physician Decision|7
6012954|NCT00833794|20787081|P1|Double-blind Phase|Physician Decision|4
6012955|NCT00833794|20787080|P2|Double-blind Phase|Withdrawal by Subject|6
6012956|NCT00833794|20787081|P1|Double-blind Phase|Withdrawal by Subject|23
6012957|NCT00833794|20787080|P2|Double-blind Phase|Lack of Efficacy|22
6012958|NCT00833794|20787081|P1|Double-blind Phase|Lack of Efficacy|34
6012959|NCT00833794|20787080|P2|Double-blind Phase|Adverse Event|11
6012960|NCT00833794|20787081|P1|Double-blind Phase|Adverse Event|44
6012961|NCT00833794|20787080|P2|Open-label Phase|enrolled in error (immediately D/C)|0
6012962|NCT00833794|20787081|P1|Open-label Phase|enrolled in error (immediately D/C)|1
6012963|NCT00833794|20787080|P2|Open-label Phase|Did not complete wash-out period|0
6012964|NCT00833794|20787081|P1|Open-label Phase|Did not complete wash-out period|12
6012965|NCT00833794|20787080|P2|Open-label Phase|Protocol Violation|0
6012966|NCT00833794|20787081|P1|Open-label Phase|Protocol Violation|47
6012967|NCT00833794|20787080|P2|Open-label Phase|Administrative reason|0
6012968|NCT00833794|20787081|P1|Open-label Phase|Administrative reason|1
6012969|NCT00833794|20787080|P2|Open-label Phase|Physician Decision|0
6012970|NCT00833794|20787081|P1|Open-label Phase|Physician Decision|20
6012971|NCT00833794|20787080|P2|Open-label Phase|Withdrawal by Subject|0
6012972|NCT00833794|20787081|P1|Open-label Phase|Withdrawal by Subject|48
6012973|NCT00833794|20787080|P2|Open-label Phase|Lack of Efficacy|0
6012974|NCT00833794|20787081|P1|Open-label Phase|Lack of Efficacy|28
6012975|NCT00833794|20787080|P2|Open-label Phase|Adverse Event|0
6012976|NCT00833794|20787081|P1|Open-label Phase|Adverse Event|225
6012977|NCT00833755|20787125|P4|Overall Study|Subject had scheduling issues|0
6012978|NCT00833755|20787126|P3|Overall Study|Subject had scheduling issues|0
6012979|NCT00833755|20787127|P2|Overall Study|Subject had scheduling issues|1
6012980|NCT00833755|20787128|P1|Overall Study|Subject had scheduling issues|0
6012981|NCT00833755|20787125|P4|Overall Study|Physician Decision|6
6012982|NCT00833755|20787126|P3|Overall Study|Physician Decision|2
6012983|NCT00833755|20787127|P2|Overall Study|Physician Decision|4
6012984|NCT00833755|20787128|P1|Overall Study|Physician Decision|4
6012985|NCT00833703|20787148|P2|Overall Study|Parent(s)/guardian(s)'s request|1
6012986|NCT00833703|20787149|P1|Overall Study|Parent(s)/guardian(s)'s request|0
6012987|NCT00833690|20787162|P3|Overall Study|Discontinued study drug|0
6012988|NCT00833690|20787163|P2|Overall Study|Discontinued study drug|2
6012989|NCT00833690|20787164|P1|Overall Study|Discontinued study drug|3
6012990|NCT00833690|20787162|P3|Overall Study|Withdrawal by Subject|0
6012991|NCT00833690|20787163|P2|Overall Study|Withdrawal by Subject|0
6012992|NCT00833690|20787164|P1|Overall Study|Withdrawal by Subject|1
6012993|NCT00833638|20787300|P3|Phase 3: Open-label Extension Phase|Protocol Violation|2
6012994|NCT00833638|20787301|P2|Phase 3: Open-label Extension Phase|Protocol Violation|1
6012995|NCT00833638|20787302|P1|Phase 3: Open-label Extension Phase|Protocol Violation|0
6012996|NCT00833638|20787300|P3|Phase 3: Open-label Extension Phase|Lost to Follow-up|0
6012997|NCT00833638|20787301|P2|Phase 3: Open-label Extension Phase|Lost to Follow-up|2
6012998|NCT00833638|20787302|P1|Phase 3: Open-label Extension Phase|Lost to Follow-up|1
6012999|NCT00833638|20787300|P3|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|2
6013000|NCT00833638|20787301|P2|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1
6013001|NCT00833638|20787302|P1|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1
6013002|NCT00833638|20787300|P3|Phase 2: Double-blind Treatment Phase|Sponsor Decision|2
6013003|NCT00833638|20787301|P2|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0
6013004|NCT00833638|20787302|P1|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0
6013005|NCT00833638|20787300|P3|Phase 2: Double-blind Treatment Phase|Protocol Violation|3
6013006|NCT00833638|20787301|P2|Phase 2: Double-blind Treatment Phase|Protocol Violation|3
6013007|NCT00833638|20787302|P1|Phase 2: Double-blind Treatment Phase|Protocol Violation|3
6013008|NCT00833638|20787300|P3|Phase 2: Double-blind Treatment Phase|Physician Decision|0
6013009|NCT00833638|20787301|P2|Phase 2: Double-blind Treatment Phase|Physician Decision|0
6013010|NCT00833638|20787302|P1|Phase 2: Double-blind Treatment Phase|Physician Decision|1
6013011|NCT00833638|20787300|P3|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1
6013012|NCT00833638|20787301|P2|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|2
6013013|NCT00833638|20787302|P1|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1
6013014|NCT00833638|20787300|P3|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|1
6013015|NCT00833638|20787301|P2|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|2
6013016|NCT00833638|20787302|P1|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|3
6013017|NCT00833638|20787300|P3|Phase 2: Double-blind Treatment Phase|Adverse Event|0
6013018|NCT00833638|20787301|P2|Phase 2: Double-blind Treatment Phase|Adverse Event|2
6013019|NCT00833638|20787302|P1|Phase 2: Double-blind Treatment Phase|Adverse Event|1
6013020|NCT00833560|20787353|P1|Overall Study|Other|5
6013021|NCT00833560|20787353|P1|Overall Study|Pregression of other disease|1
6013022|NCT00833560|20787353|P1|Overall Study|Death|2
6013023|NCT00833560|20787353|P1|Overall Study|Lack of Efficacy|4
6013024|NCT00833560|20787353|P1|Overall Study|Protocol Violation|6
6013025|NCT00833560|20787353|P1|Overall Study|Adverse Event|11
6013026|NCT00833560|20787353|P1|Overall Study|Toxicity|13
6013027|NCT00833547|20787362|P2|Overall Study|Withdrawal by Subject|2
6013028|NCT00833547|20787363|P1|Overall Study|Withdrawal by Subject|2
6013029|NCT00833482|20787384|P6|Days 21-30|Withdrawal by Subject|0
6013030|NCT00833482|20787385|P5|Days 21-30|Withdrawal by Subject|1
6013031|NCT00833482|20787386|P4|Days 21-30|Withdrawal by Subject|0
6013032|NCT00833482|20787387|P3|Days 21-30|Withdrawal by Subject|0
6013033|NCT00833482|20787388|P2|Days 21-30|Withdrawal by Subject|0
6013034|NCT00833482|20787389|P1|Days 21-30|Withdrawal by Subject|0
6013035|NCT00833482|20787384|P6|Days 21-30|Adverse Event|0
6013036|NCT00833482|20787385|P5|Days 21-30|Adverse Event|0
6013037|NCT00833482|20787386|P4|Days 21-30|Adverse Event|0
6013038|NCT00833482|20787387|P3|Days 21-30|Adverse Event|1
6013039|NCT00833482|20787388|P2|Days 21-30|Adverse Event|0
6013040|NCT00833482|20787389|P1|Days 21-30|Adverse Event|0
6013041|NCT00833482|20787384|P6|Days 11-20|Withdrawal by Subject|0
6013042|NCT00833482|20787385|P5|Days 11-20|Withdrawal by Subject|0
6013043|NCT00833482|20787386|P4|Days 11-20|Withdrawal by Subject|0
6013044|NCT00833482|20787387|P3|Days 11-20|Withdrawal by Subject|0
6013045|NCT00833482|20787388|P2|Days 11-20|Withdrawal by Subject|1
6013046|NCT00833482|20787389|P1|Days 11-20|Withdrawal by Subject|0
6013047|NCT00833482|20787384|P6|Days 11-20|Adverse Event|0
6013048|NCT00833482|20787385|P5|Days 11-20|Adverse Event|0
6013049|NCT00833482|20787386|P4|Days 11-20|Adverse Event|0
6013050|NCT00833482|20787387|P3|Days 11-20|Adverse Event|0
6013051|NCT00833482|20787388|P2|Days 11-20|Adverse Event|2
6013052|NCT00833482|20787389|P1|Days 11-20|Adverse Event|0
6013053|NCT00833469|20787445|P1|Overall Study|Lost to Follow-up|1
6013054|NCT00833469|20787445|P1|Overall Study|Withdrawal by Subject|1
6013055|NCT00833417|20787468|P2|Overall Study|Reason Not Specified|1
6013056|NCT00833417|20787469|P1|Overall Study|Reason Not Specified|0
6013057|NCT00833417|20787468|P2|Overall Study|Disease Progression|17
6013058|NCT00833417|20787469|P1|Overall Study|Disease Progression|18
6013059|NCT00833417|20787468|P2|Overall Study|Sponsor Decision to Terminate Study|2
6013060|NCT00833417|20787469|P1|Overall Study|Sponsor Decision to Terminate Study|1
6013061|NCT00833417|20787468|P2|Overall Study|Patient Decision to Withdraw|23
6013062|NCT00833417|20787469|P1|Overall Study|Patient Decision to Withdraw|4
6013063|NCT00833417|20787468|P2|Overall Study|Physician Decision to Withdraw Patient|7
6013064|NCT00833417|20787469|P1|Overall Study|Physician Decision to Withdraw Patient|3
6013065|NCT00833417|20787468|P2|Overall Study|Lost to Follow-up|2
6013066|NCT00833417|20787469|P1|Overall Study|Lost to Follow-up|1
6013067|NCT00833417|20787468|P2|Overall Study|Death|3
6013068|NCT00833417|20787469|P1|Overall Study|Death|1
6013069|NCT00833417|20787468|P2|Overall Study|Adverse Event|16
6013070|NCT00833417|20787469|P1|Overall Study|Adverse Event|5
6013071|NCT00833261|20787493|P1|Overall Study|Withdrawal by Subject|4
6013072|NCT00833248|20787500|P2|Overall Study|Withdrawal by Subject|1
6013073|NCT00833248|20787501|P1|Overall Study|Withdrawal by Subject|0
6013074|NCT00833248|20787500|P2|Overall Study|Protocol Violation|2
6013075|NCT00833248|20787501|P1|Overall Study|Protocol Violation|1
6013076|NCT00833248|20787500|P2|Overall Study|Adverse Event|0
6013077|NCT00833248|20787501|P1|Overall Study|Adverse Event|3
6013078|NCT00833105|20787523|P1|Overall Study|Adverse Event|2
6013079|NCT00833105|20787523|P1|Overall Study|Withdrawal by Subject|1
6013080|NCT00833092|20787541|P2|Overall Study|constipation|1
6013081|NCT00833092|20787542|P1|Overall Study|constipation|0
6013082|NCT00833092|20787541|P2|Overall Study|Diarrhea|2
6013083|NCT00833092|20787542|P1|Overall Study|Diarrhea|0
6013084|NCT00833092|20787541|P2|Overall Study|Protocol Violation|1
6013085|NCT00833092|20787542|P1|Overall Study|Protocol Violation|2
6013086|NCT00833092|20787541|P2|Overall Study|Withdrawal by Subject|3
6013087|NCT00833092|20787542|P1|Overall Study|Withdrawal by Subject|2
6013088|NCT00833053|20787550|P2|Overall Study|Protocol Violation|1
6013089|NCT00833053|20787551|P1|Overall Study|Protocol Violation|2
6013090|NCT00833053|20787550|P2|Overall Study|Withdrawal by Subject|1
6013091|NCT00833053|20787551|P1|Overall Study|Withdrawal by Subject|0
6013092|NCT00833053|20787550|P2|Overall Study|Treatment Failure|1
6013093|NCT00833053|20787551|P1|Overall Study|Treatment Failure|3
6013094|NCT00833053|20787550|P2|Overall Study|Adverse Event|0
6013095|NCT00833053|20787551|P1|Overall Study|Adverse Event|4
6013096|NCT00833040|20787569|P6|Overall Study|Adverse Event|1
6013097|NCT00833040|20787570|P5|Overall Study|Adverse Event|0
6013098|NCT00833040|20787571|P4|Overall Study|Adverse Event|0
6013099|NCT00833040|20787572|P3|Overall Study|Adverse Event|0
6013100|NCT00833040|20787573|P2|Overall Study|Adverse Event|0
6013101|NCT00833040|20787574|P1|Overall Study|Adverse Event|0
6013102|NCT00833027|20787579|P1|Overall Study|Missing|10
6013103|NCT00833027|20787579|P1|Overall Study|Withdrawal by Subject|16
6013104|NCT00833027|20787579|P1|Overall Study|Protocol Violation|115
6013105|NCT00833027|20787579|P1|Overall Study|Lost to Follow-up|24
6013106|NCT00833027|20787579|P1|Overall Study|Lack of Efficacy|12
6013107|NCT00833027|20787579|P1|Overall Study|Death|1
6013108|NCT00833027|20787579|P1|Overall Study|Adverse Event|33
6013109|NCT00832975|20787584|P1|Overall Study|Other reasons|14
6013110|NCT00832975|20787584|P1|Overall Study|Withdrawal by Subject|3
6013111|NCT00832975|20787584|P1|Overall Study|Physician Decision|4
6013112|NCT00832975|20787584|P1|Overall Study|Death|5
6013113|NCT00832975|20787584|P1|Overall Study|Protocol Violation|6
6013114|NCT00832975|20787584|P1|Overall Study|Lost to Follow-up|7
6013115|NCT00832819|20787598|P3|Overall Study|Protocol Violation|1
6013116|NCT00832819|20787599|P2|Overall Study|Protocol Violation|0
6013117|NCT00832819|20787600|P1|Overall Study|Protocol Violation|0
6013118|NCT00832819|20787598|P3|Overall Study|Adverse Event|0
6013119|NCT00832819|20787599|P2|Overall Study|Adverse Event|1
6013120|NCT00832819|20787600|P1|Overall Study|Adverse Event|0
6013121|NCT00832780|20787606|P1|Overall Study|Physician Decision|1
6013122|NCT00832780|20787606|P1|Overall Study|other complicating condition|2
6013123|NCT00832780|20787606|P1|Overall Study|no reason given|2
6013124|NCT00832780|20787606|P1|Overall Study|Lost to Follow-up|4
6013125|NCT00832780|20787606|P1|Overall Study|Death|16
6013126|NCT00832650|20787648|P3|Overall Study|Randomized but not treated|1
6013127|NCT00832650|20787649|P2|Overall Study|Randomized but not treated|0
6013128|NCT00832650|20787650|P1|Overall Study|Randomized but not treated|0
6013129|NCT00832624|20787690|P1|Overall Study|Study Terminated|10
6013130|NCT00832585|20787700|P1|Overall Study|Lost to Follow-up|1
6013131|NCT00832585|20787700|P1|Overall Study|Withdrawal by Subject|1
6013132|NCT00832455|20787725|P1|Overall Study|Patient moved|1
6013133|NCT00832455|20787725|P1|Overall Study|No improvement|3
6013134|NCT00832455|20787725|P1|Overall Study|Parent dissatisfied|1
6013135|NCT00832455|20787725|P1|Overall Study|Parent misunderstood study|1
6013136|NCT00832455|20787725|P1|Overall Study|Stopped Medication|4
6013137|NCT00832455|20787725|P1|Overall Study|Screening Failure|2
6013138|NCT00832455|20787725|P1|Overall Study|Withdrawal by Subject|17
6013139|NCT00832455|20787725|P1|Overall Study|Protocol Violation|4
6013140|NCT00832455|20787725|P1|Overall Study|Lost to Follow-up|26
6013141|NCT00832455|20787725|P1|Overall Study|Adverse Event|13
6013142|NCT00832416|20787749|P4|Overall Study|Death|0
6013143|NCT00832416|20787750|P3|Overall Study|Death|0
6013144|NCT00832416|20787751|P2|Overall Study|Death|0
6013145|NCT00832416|20787752|P1|Overall Study|Death|1
6013146|NCT00832416|20787749|P4|Overall Study|Adverse Event|10
6013147|NCT00832416|20787750|P3|Overall Study|Adverse Event|41
6013148|NCT00832416|20787751|P2|Overall Study|Adverse Event|19
6013149|NCT00832416|20787752|P1|Overall Study|Adverse Event|21
6013150|NCT00832416|20787749|P4|Overall Study|Administrative|1
6013151|NCT00832416|20787750|P3|Overall Study|Administrative|0
6013152|NCT00832416|20787751|P2|Overall Study|Administrative|0
6013153|NCT00832416|20787752|P1|Overall Study|Administrative|0
6013154|NCT00832416|20787749|P4|Overall Study|Physician Decision|10
6013155|NCT00832416|20787750|P3|Overall Study|Physician Decision|5
6013156|NCT00832416|20787751|P2|Overall Study|Physician Decision|12
6013157|NCT00832416|20787752|P1|Overall Study|Physician Decision|2
6013158|NCT00832416|20787749|P4|Overall Study|Withdrawal by Subject|10
6013159|NCT00832416|20787750|P3|Overall Study|Withdrawal by Subject|2
6013160|NCT00832416|20787751|P2|Overall Study|Withdrawal by Subject|7
6013161|NCT00832416|20787752|P1|Overall Study|Withdrawal by Subject|5
6013162|NCT00832416|20787749|P4|Overall Study|Lack of Efficacy|52
6013163|NCT00832416|20787750|P3|Overall Study|Lack of Efficacy|13
6013164|NCT00832416|20787751|P2|Overall Study|Lack of Efficacy|15
6013165|NCT00832416|20787752|P1|Overall Study|Lack of Efficacy|17
6013166|NCT00832377|20787803|P1|Overall Study|Protocol Violation|1
6013167|NCT00832117|20787849|P1|Overall Study|Disease Progression|11
6013168|NCT00832117|20787849|P1|Overall Study|Death|1
6013169|NCT00832091|20787868|P2|Overall Study|Prohibited Medication|0
6013170|NCT00832091|20787869|P1|Overall Study|Prohibited Medication|1
6013171|NCT00832091|20787868|P2|Overall Study|Withdrawal by Subject|1
6013172|NCT00832091|20787869|P1|Overall Study|Withdrawal by Subject|2
6013173|NCT00832091|20787868|P2|Overall Study|Protocol Violation|0
6013174|NCT00832091|20787869|P1|Overall Study|Protocol Violation|1
6013175|NCT00832091|20787868|P2|Overall Study|Adverse Event|1
6013176|NCT00832091|20787869|P1|Overall Study|Adverse Event|1
6013177|NCT00832078|20787877|P2|Test Day 2 - 2 Period|Lack of Efficacy|0
6013178|NCT00832078|20787878|P1|Test Day 2 - 2 Period|Lack of Efficacy|1
6013179|NCT00832078|20787877|P2|Test Day 1-2 Period|Lack of Efficacy|2
6013180|NCT00832078|20787878|P1|Test Day 1-2 Period|Lack of Efficacy|0
6013181|NCT00832000|20787884|P2|Overall Study|No calls to IVR in period 2|0
6013182|NCT00832000|20787885|P1|Overall Study|No calls to IVR in period 2|2
6013183|NCT00832000|20787884|P2|Overall Study|No calls to IVR in either period|1
6013184|NCT00832000|20787885|P1|Overall Study|No calls to IVR in either period|1
6013185|NCT00832000|20787884|P2|Overall Study|Withdrawal by Subject|0
6013186|NCT00832000|20787885|P1|Overall Study|Withdrawal by Subject|1
6013187|NCT00832000|20787884|P2|Overall Study|Adverse Event|0
6013188|NCT00832000|20787885|P1|Overall Study|Adverse Event|2
6013189|NCT00831844|20787946|P10|Overall Study|Ineligible|0
6013190|NCT00831844|20787947|P9|Overall Study|Ineligible|0
6013191|NCT00831844|20787948|P8|Overall Study|Ineligible|0
6013192|NCT00831844|20787949|P7|Overall Study|Ineligible|0
6013193|NCT00831844|20787950|P6|Overall Study|Ineligible|0
6013194|NCT00831844|20787951|P5|Overall Study|Ineligible|1
6013195|NCT00831844|20787952|P4|Overall Study|Ineligible|0
6013196|NCT00831844|20787953|P3|Overall Study|Ineligible|1
6013197|NCT00831844|20787954|P2|Overall Study|Ineligible|1
6013198|NCT00831844|20787955|P1|Overall Study|Ineligible|0
6013199|NCT00831844|20787946|P10|Overall Study|Withdrawal by Subject|0
6013200|NCT00831844|20787947|P9|Overall Study|Withdrawal by Subject|1
6013201|NCT00831844|20787948|P8|Overall Study|Withdrawal by Subject|1
6013202|NCT00831844|20787949|P7|Overall Study|Withdrawal by Subject|0
6013203|NCT00831844|20787950|P6|Overall Study|Withdrawal by Subject|0
6013204|NCT00831844|20787951|P5|Overall Study|Withdrawal by Subject|0
6013205|NCT00831844|20787952|P4|Overall Study|Withdrawal by Subject|0
6013206|NCT00831844|20787953|P3|Overall Study|Withdrawal by Subject|1
6013207|NCT00831844|20787954|P2|Overall Study|Withdrawal by Subject|0
6013208|NCT00831844|20787955|P1|Overall Study|Withdrawal by Subject|0
6013209|NCT00831844|20787946|P10|Overall Study|Physician Decision|0
6013210|NCT00831844|20787947|P9|Overall Study|Physician Decision|1
6013211|NCT00831844|20787948|P8|Overall Study|Physician Decision|0
6013212|NCT00831844|20787949|P7|Overall Study|Physician Decision|0
6013213|NCT00831844|20787950|P6|Overall Study|Physician Decision|1
6013214|NCT00831844|20787951|P5|Overall Study|Physician Decision|1
6013215|NCT00831844|20787952|P4|Overall Study|Physician Decision|1
6013216|NCT00831844|20787953|P3|Overall Study|Physician Decision|3
6013217|NCT00831844|20787954|P2|Overall Study|Physician Decision|1
6013218|NCT00831844|20787955|P1|Overall Study|Physician Decision|0
6013219|NCT00831844|20787946|P10|Overall Study|Lack of Efficacy|0
6013220|NCT00831844|20787947|P9|Overall Study|Lack of Efficacy|7
6013221|NCT00831844|20787948|P8|Overall Study|Lack of Efficacy|9
6013222|NCT00831844|20787949|P7|Overall Study|Lack of Efficacy|8
6013223|NCT00831844|20787950|P6|Overall Study|Lack of Efficacy|17
6013224|NCT00831844|20787951|P5|Overall Study|Lack of Efficacy|11
6013225|NCT00831844|20787952|P4|Overall Study|Lack of Efficacy|8
6013226|NCT00831844|20787953|P3|Overall Study|Lack of Efficacy|15
6013227|NCT00831844|20787954|P2|Overall Study|Lack of Efficacy|10
6013228|NCT00831844|20787955|P1|Overall Study|Lack of Efficacy|8
6013229|NCT00831844|20787946|P10|Overall Study|Death|0
6013230|NCT00831844|20787947|P9|Overall Study|Death|0
6013231|NCT00831844|20787948|P8|Overall Study|Death|0
6013232|NCT00831844|20787949|P7|Overall Study|Death|0
6013233|NCT00831844|20787950|P6|Overall Study|Death|0
6013234|NCT00831844|20787951|P5|Overall Study|Death|0
6013235|NCT00831844|20787952|P4|Overall Study|Death|1
6013236|NCT00831844|20787953|P3|Overall Study|Death|0
6013237|NCT00831844|20787954|P2|Overall Study|Death|0
6013238|NCT00831844|20787955|P1|Overall Study|Death|0
6013239|NCT00831844|20787946|P10|Overall Study|Adverse Event|0
6013240|NCT00831844|20787947|P9|Overall Study|Adverse Event|0
6013241|NCT00831844|20787948|P8|Overall Study|Adverse Event|0
6013242|NCT00831844|20787949|P7|Overall Study|Adverse Event|2
6013243|NCT00831844|20787950|P6|Overall Study|Adverse Event|1
6013244|NCT00831844|20787951|P5|Overall Study|Adverse Event|1
6013245|NCT00831844|20787952|P4|Overall Study|Adverse Event|0
6013246|NCT00831844|20787953|P3|Overall Study|Adverse Event|0
6013247|NCT00831844|20787954|P2|Overall Study|Adverse Event|0
6013248|NCT00831844|20787955|P1|Overall Study|Adverse Event|2
6013249|NCT00831792|20787977|P1|Overall Study|Lack of Efficacy|1
6013250|NCT00831792|20787977|P1|Overall Study|Death|1
6013251|NCT00831792|20787977|P1|Overall Study|Adverse Event|1
6013252|NCT00831792|20787977|P1|Overall Study|Not Eligible|3
6013253|NCT00831779|20787983|P2|Overall Study|No longer met criteria|1
6013254|NCT00831779|20787984|P1|Overall Study|No longer met criteria|0
6013255|NCT00831779|20787983|P2|Overall Study|Lost to Follow-up|0
6013256|NCT00831779|20787984|P1|Overall Study|Lost to Follow-up|1
6013257|NCT00831701|20788021|P2|Overall Study|Lost to Follow-up|3
6013258|NCT00831701|20788022|P1|Overall Study|Lost to Follow-up|1
6013259|NCT00831701|20788021|P2|Overall Study|Stone expulsion before first medication|2
6013260|NCT00831701|20788022|P1|Overall Study|Stone expulsion before first medication|2
6013261|NCT00831701|20788021|P2|Overall Study|Withdrawal by Subject|0
6013262|NCT00831701|20788022|P1|Overall Study|Withdrawal by Subject|2
6013263|NCT00831493|20788051|P1|Overall Study|Intractable nausea and vomiting|1
6013264|NCT00831441|20788061|P2|Follow Up (30 Days)|missing end of study status|1
6013265|NCT00831441|20788062|P1|Follow Up (30 Days)|missing end of study status|0
6013266|NCT00831441|20788061|P2|Follow Up (30 Days)|non-specified|26
6013267|NCT00831441|20788062|P1|Follow Up (30 Days)|non-specified|16
6013268|NCT00831441|20788061|P2|Follow Up (30 Days)|Death|86
6013269|NCT00831441|20788062|P1|Follow Up (30 Days)|Death|63
6013270|NCT00831441|20788061|P2|Follow Up (30 Days)|Lost to Follow-up|27
6013271|NCT00831441|20788062|P1|Follow Up (30 Days)|Lost to Follow-up|13
6013272|NCT00831441|20788061|P2|Follow Up (30 Days)|Withdrawal by Subject|34
6013273|NCT00831441|20788062|P1|Follow Up (30 Days)|Withdrawal by Subject|41
6013274|NCT00831441|20788061|P2|Randomized|non-specified|266
6013275|NCT00831441|20788062|P1|Randomized|non-specified|276
6013276|NCT00831441|20788061|P2|Randomized|poor/non-compliance|38
6013277|NCT00831441|20788062|P1|Randomized|poor/non-compliance|30
6013278|NCT00831441|20788061|P2|Randomized|Administrative reason by sponsor|2671
6013279|NCT00831441|20788062|P1|Randomized|Administrative reason by sponsor|2780
6013280|NCT00831441|20788061|P2|Randomized|Lost to Follow-up|35
6013281|NCT00831441|20788062|P1|Randomized|Lost to Follow-up|26
6013282|NCT00831441|20788061|P2|Randomized|Withdrawal by Subject|212
6013283|NCT00831441|20788062|P1|Randomized|Withdrawal by Subject|178
6013284|NCT00831441|20788061|P2|Randomized|No longer met criteria|19
6013285|NCT00831441|20788062|P1|Randomized|No longer met criteria|13
6013286|NCT00831441|20788061|P2|Randomized|Physician Decision|35
6013287|NCT00831441|20788062|P1|Randomized|Physician Decision|26
6013288|NCT00831441|20788061|P2|Randomized|Elective procedure|25
6013289|NCT00831441|20788062|P1|Randomized|Elective procedure|26
6013290|NCT00831441|20788061|P2|Randomized|Emergency procedure|2
6013291|NCT00831441|20788062|P1|Randomized|Emergency procedure|2
6013292|NCT00831441|20788061|P2|Randomized|Adverse Event|321
6013293|NCT00831441|20788062|P1|Randomized|Adverse Event|248
6013294|NCT00831441|20788061|P2|Randomized|Death|81
6013295|NCT00831441|20788062|P1|Randomized|Death|82
6013296|NCT00831415|20788094|P1|Overall Study|Death|1
6013297|NCT00831415|20788094|P1|Overall Study|Unsatisfactory response - Efficacy|4
6013298|NCT00831415|20788094|P1|Overall Study|Withdrawal by Subject|35
6013299|NCT00831415|20788094|P1|Overall Study|Protocol Violation|3
6013300|NCT00831415|20788094|P1|Overall Study|Lost to Follow-up|9
6013301|NCT00831415|20788094|P1|Overall Study|Physician Decision|6
6013302|NCT00831415|20788094|P1|Overall Study|Failed to return|3
6013303|NCT00831415|20788094|P1|Overall Study|Adverse Event|14
6013304|NCT00831389|20788103|P2|Overall Study|Withdrawal by Subject|1
6013305|NCT00831389|20788104|P1|Overall Study|Withdrawal by Subject|0
6013306|NCT00831311|20788130|P2|Overall Study|Withdrawal by Subject|4
6013307|NCT00831311|20788131|P1|Overall Study|Withdrawal by Subject|6
6013308|NCT00831311|20788130|P2|Overall Study|Physician Decision|1
6013309|NCT00831311|20788131|P1|Overall Study|Physician Decision|0
6013310|NCT00831311|20788130|P2|Overall Study|Lost to Follow-up|0
6013311|NCT00831311|20788131|P1|Overall Study|Lost to Follow-up|3
6013312|NCT00831311|20788130|P2|Overall Study|Definitive Contraindication|3
6013313|NCT00831311|20788131|P1|Overall Study|Definitive Contraindication|3
6013314|NCT00831233|20788168|P2|Overall Study|Selection Criteria Not Met|0
6013315|NCT00831233|20788169|P1|Overall Study|Selection Criteria Not Met|2
6013316|NCT00831233|20788168|P2|Overall Study|Protocol Violation|0
6013317|NCT00831233|20788169|P1|Overall Study|Protocol Violation|1
6013318|NCT00831233|20788168|P2|Overall Study|Adverse Event|1
6013319|NCT00831233|20788169|P1|Overall Study|Adverse Event|0
6013320|NCT00831181|20788193|P1|Overall Study|Adverse Event|12
6013321|NCT00831129|20788206|P2|Overall Study|9 lost to follow-up reasons uknown|9
6013322|NCT00831129|20788207|P1|Overall Study|9 lost to follow-up reasons uknown|0
6013323|NCT00831129|20788206|P2|Overall Study|Adverse Event|1
6013324|NCT00831129|20788207|P1|Overall Study|Adverse Event|0
6013325|NCT00830960|20788249|P6|Overall Study|No study drug received|7
6013326|NCT00830960|20788250|P5|Overall Study|No study drug received|5
6013327|NCT00830960|20788251|P4|Overall Study|No study drug received|3
6013328|NCT00830960|20788252|P3|Overall Study|No study drug received|4
6013329|NCT00830960|20788253|P2|Overall Study|No study drug received|2
6013330|NCT00830960|20788254|P1|Overall Study|No study drug received|7
6013331|NCT00830960|20788249|P6|Overall Study|Sponsor Decision|7
6013332|NCT00830960|20788250|P5|Overall Study|Sponsor Decision|5
6013333|NCT00830960|20788251|P4|Overall Study|Sponsor Decision|4
6013334|NCT00830960|20788252|P3|Overall Study|Sponsor Decision|3
6013335|NCT00830960|20788253|P2|Overall Study|Sponsor Decision|2
6013336|NCT00830960|20788254|P1|Overall Study|Sponsor Decision|1
6013337|NCT00830960|20788249|P6|Overall Study|Withdrawal by Subject|21
6013338|NCT00830960|20788250|P5|Overall Study|Withdrawal by Subject|16
6013339|NCT00830960|20788251|P4|Overall Study|Withdrawal by Subject|23
6013340|NCT00830960|20788252|P3|Overall Study|Withdrawal by Subject|18
6013341|NCT00830960|20788253|P2|Overall Study|Withdrawal by Subject|19
6013342|NCT00830960|20788254|P1|Overall Study|Withdrawal by Subject|19
6013343|NCT00830960|20788249|P6|Overall Study|Lost to Follow-up|1
6013344|NCT00830960|20788250|P5|Overall Study|Lost to Follow-up|0
6013345|NCT00830960|20788251|P4|Overall Study|Lost to Follow-up|0
6013346|NCT00830960|20788252|P3|Overall Study|Lost to Follow-up|1
6013347|NCT00830960|20788253|P2|Overall Study|Lost to Follow-up|1
6013348|NCT00830960|20788254|P1|Overall Study|Lost to Follow-up|1
6013349|NCT00830960|20788249|P6|Overall Study|Death|1
6013350|NCT00830960|20788250|P5|Overall Study|Death|6
6013351|NCT00830960|20788251|P4|Overall Study|Death|2
6013352|NCT00830960|20788252|P3|Overall Study|Death|3
6013353|NCT00830960|20788253|P2|Overall Study|Death|4
6013354|NCT00830960|20788254|P1|Overall Study|Death|5
6013355|NCT00830947|20788370|P2|Overall Study|Lost to Follow-up|4
6013356|NCT00830947|20788371|P1|Overall Study|Lost to Follow-up|4
6013357|NCT00830869|20788389|P12|Period 2: Part 2|Other|0
6013358|NCT00830869|20788390|P11|Period 2: Part 2|Other|0
6013359|NCT00830869|20788391|P10|Period 2: Part 2|Other|1
6013360|NCT00830869|20788392|P9|Period 2: Part 2|Other|0
6013361|NCT00830869|20788393|P8|Period 2: Part 2|Other|0
6013362|NCT00830869|20788394|P7|Period 2: Part 2|Other|0
6013363|NCT00830869|20788395|P6|Period 2: Part 2|Other|0
6013364|NCT00830869|20788396|P5|Period 2: Part 2|Other|0
6013365|NCT00830869|20788397|P4|Period 2: Part 2|Other|0
6013366|NCT00830869|20788398|P3|Period 2: Part 2|Other|0
6013367|NCT00830869|20788399|P2|Period 2: Part 2|Other|0
6013368|NCT00830869|20788400|P1|Period 2: Part 2|Other|0
6013369|NCT00830869|20788389|P12|Period 2: Part 2|Progressive disease|15
6013370|NCT00830869|20788390|P11|Period 2: Part 2|Progressive disease|8
6013371|NCT00830869|20788391|P10|Period 2: Part 2|Progressive disease|12
6013372|NCT00830869|20788392|P9|Period 2: Part 2|Progressive disease|11
6013373|NCT00830869|20788393|P8|Period 2: Part 2|Progressive disease|14
6013374|NCT00830869|20788394|P7|Period 2: Part 2|Progressive disease|0
6013375|NCT00830869|20788395|P6|Period 2: Part 2|Progressive disease|0
6013376|NCT00830869|20788396|P5|Period 2: Part 2|Progressive disease|0
6013377|NCT00830869|20788397|P4|Period 2: Part 2|Progressive disease|0
6013378|NCT00830869|20788398|P3|Period 2: Part 2|Progressive disease|0
6013379|NCT00830869|20788399|P2|Period 2: Part 2|Progressive disease|0
6013380|NCT00830869|20788400|P1|Period 2: Part 2|Progressive disease|0
6013381|NCT00830869|20788389|P12|Period 2: Part 2|Symptomatic Deterioration|4
6013382|NCT00830869|20788390|P11|Period 2: Part 2|Symptomatic Deterioration|1
6013383|NCT00830869|20788391|P10|Period 2: Part 2|Symptomatic Deterioration|3
6013384|NCT00830869|20788392|P9|Period 2: Part 2|Symptomatic Deterioration|6
6013385|NCT00830869|20788393|P8|Period 2: Part 2|Symptomatic Deterioration|0
6013386|NCT00830869|20788394|P7|Period 2: Part 2|Symptomatic Deterioration|0
6013387|NCT00830869|20788395|P6|Period 2: Part 2|Symptomatic Deterioration|0
6013388|NCT00830869|20788396|P5|Period 2: Part 2|Symptomatic Deterioration|0
6013389|NCT00830869|20788397|P4|Period 2: Part 2|Symptomatic Deterioration|0
6013390|NCT00830869|20788398|P3|Period 2: Part 2|Symptomatic Deterioration|0
6013391|NCT00830869|20788399|P2|Period 2: Part 2|Symptomatic Deterioration|0
6013392|NCT00830869|20788400|P1|Period 2: Part 2|Symptomatic Deterioration|0
6013393|NCT00830869|20788389|P12|Period 2: Part 2|Adverse Event|0
6013394|NCT00830869|20788390|P11|Period 2: Part 2|Adverse Event|2
6013395|NCT00830869|20788391|P10|Period 2: Part 2|Adverse Event|2
6013396|NCT00830869|20788392|P9|Period 2: Part 2|Adverse Event|3
6013397|NCT00830869|20788393|P8|Period 2: Part 2|Adverse Event|4
6013398|NCT00830869|20788394|P7|Period 2: Part 2|Adverse Event|0
6013399|NCT00830869|20788395|P6|Period 2: Part 2|Adverse Event|0
6013400|NCT00830869|20788396|P5|Period 2: Part 2|Adverse Event|0
6013401|NCT00830869|20788397|P4|Period 2: Part 2|Adverse Event|0
6013402|NCT00830869|20788398|P3|Period 2: Part 2|Adverse Event|0
6013403|NCT00830869|20788399|P2|Period 2: Part 2|Adverse Event|0
6013404|NCT00830869|20788400|P1|Period 2: Part 2|Adverse Event|0
6013405|NCT00830869|20788389|P12|Period 2: Part 2|Withdrawal by Subject|1
6013406|NCT00830869|20788390|P11|Period 2: Part 2|Withdrawal by Subject|0
6013407|NCT00830869|20788391|P10|Period 2: Part 2|Withdrawal by Subject|1
6013408|NCT00830869|20788392|P9|Period 2: Part 2|Withdrawal by Subject|2
6013409|NCT00830869|20788393|P8|Period 2: Part 2|Withdrawal by Subject|1
6013410|NCT00830869|20788394|P7|Period 2: Part 2|Withdrawal by Subject|0
6013411|NCT00830869|20788395|P6|Period 2: Part 2|Withdrawal by Subject|0
6013412|NCT00830869|20788396|P5|Period 2: Part 2|Withdrawal by Subject|0
6013413|NCT00830869|20788397|P4|Period 2: Part 2|Withdrawal by Subject|0
6013414|NCT00830869|20788398|P3|Period 2: Part 2|Withdrawal by Subject|0
6013415|NCT00830869|20788399|P2|Period 2: Part 2|Withdrawal by Subject|0
6013416|NCT00830869|20788400|P1|Period 2: Part 2|Withdrawal by Subject|0
6013417|NCT00830869|20788389|P12|Period 2: Part 2|Protocol Violation|0
6013418|NCT00830869|20788390|P11|Period 2: Part 2|Protocol Violation|0
6013419|NCT00830869|20788391|P10|Period 2: Part 2|Protocol Violation|1
6013420|NCT00830869|20788392|P9|Period 2: Part 2|Protocol Violation|0
6013421|NCT00830869|20788393|P8|Period 2: Part 2|Protocol Violation|1
6013422|NCT00830869|20788394|P7|Period 2: Part 2|Protocol Violation|0
6013423|NCT00830869|20788395|P6|Period 2: Part 2|Protocol Violation|0
6013424|NCT00830869|20788396|P5|Period 2: Part 2|Protocol Violation|0
6013425|NCT00830869|20788397|P4|Period 2: Part 2|Protocol Violation|0
6013426|NCT00830869|20788398|P3|Period 2: Part 2|Protocol Violation|0
6013427|NCT00830869|20788399|P2|Period 2: Part 2|Protocol Violation|0
6013428|NCT00830869|20788400|P1|Period 2: Part 2|Protocol Violation|0
6013429|NCT00830869|20788389|P12|Period 1: Part 1|Progressive disease|0
6013430|NCT00830869|20788390|P11|Period 1: Part 1|Progressive disease|0
6013431|NCT00830869|20788391|P10|Period 1: Part 1|Progressive disease|0
6013432|NCT00830869|20788392|P9|Period 1: Part 1|Progressive disease|0
6013433|NCT00830869|20788393|P8|Period 1: Part 1|Progressive disease|0
6013434|NCT00830869|20788394|P7|Period 1: Part 1|Progressive disease|1
6013435|NCT00830869|20788395|P6|Period 1: Part 1|Progressive disease|4
6013436|NCT00830869|20788396|P5|Period 1: Part 1|Progressive disease|4
6013437|NCT00830869|20788397|P4|Period 1: Part 1|Progressive disease|6
6013438|NCT00830869|20788398|P3|Period 1: Part 1|Progressive disease|1
6013439|NCT00830869|20788399|P2|Period 1: Part 1|Progressive disease|0
6013440|NCT00830869|20788400|P1|Period 1: Part 1|Progressive disease|1
6013441|NCT00830869|20788389|P12|Period 1: Part 1|Adverse Event|0
6013442|NCT00830869|20788390|P11|Period 1: Part 1|Adverse Event|0
6013443|NCT00830869|20788391|P10|Period 1: Part 1|Adverse Event|0
6013444|NCT00830869|20788392|P9|Period 1: Part 1|Adverse Event|0
6013445|NCT00830869|20788393|P8|Period 1: Part 1|Adverse Event|0
6013446|NCT00830869|20788394|P7|Period 1: Part 1|Adverse Event|1
6013447|NCT00830869|20788395|P6|Period 1: Part 1|Adverse Event|1
6013448|NCT00830869|20788396|P5|Period 1: Part 1|Adverse Event|0
6013449|NCT00830869|20788397|P4|Period 1: Part 1|Adverse Event|0
6013450|NCT00830869|20788398|P3|Period 1: Part 1|Adverse Event|0
6013451|NCT00830869|20788399|P2|Period 1: Part 1|Adverse Event|0
6013452|NCT00830869|20788400|P1|Period 1: Part 1|Adverse Event|0
6013453|NCT00830869|20788389|P12|Period 1: Part 1|Withdrawal by Subject|0
6013454|NCT00830869|20788390|P11|Period 1: Part 1|Withdrawal by Subject|0
6013455|NCT00830869|20788391|P10|Period 1: Part 1|Withdrawal by Subject|0
6013456|NCT00830869|20788392|P9|Period 1: Part 1|Withdrawal by Subject|0
6013457|NCT00830869|20788393|P8|Period 1: Part 1|Withdrawal by Subject|0
6013458|NCT00830869|20788394|P7|Period 1: Part 1|Withdrawal by Subject|0
6013459|NCT00830869|20788395|P6|Period 1: Part 1|Withdrawal by Subject|0
6013460|NCT00830869|20788396|P5|Period 1: Part 1|Withdrawal by Subject|0
6013461|NCT00830869|20788397|P4|Period 1: Part 1|Withdrawal by Subject|0
6013462|NCT00830869|20788398|P3|Period 1: Part 1|Withdrawal by Subject|0
6013463|NCT00830869|20788399|P2|Period 1: Part 1|Withdrawal by Subject|1
6013464|NCT00830869|20788400|P1|Period 1: Part 1|Withdrawal by Subject|0
6013465|NCT00830869|20788389|P12|Period 1: Part 1|Symptomatic deterioration|0
6013466|NCT00830869|20788390|P11|Period 1: Part 1|Symptomatic deterioration|0
6013467|NCT00830869|20788391|P10|Period 1: Part 1|Symptomatic deterioration|0
6013468|NCT00830869|20788392|P9|Period 1: Part 1|Symptomatic deterioration|0
6013469|NCT00830869|20788393|P8|Period 1: Part 1|Symptomatic deterioration|0
6013470|NCT00830869|20788394|P7|Period 1: Part 1|Symptomatic deterioration|1
6013471|NCT00830869|20788395|P6|Period 1: Part 1|Symptomatic deterioration|1
6013472|NCT00830869|20788396|P5|Period 1: Part 1|Symptomatic deterioration|0
6013473|NCT00830869|20788397|P4|Period 1: Part 1|Symptomatic deterioration|1
6013474|NCT00830869|20788398|P3|Period 1: Part 1|Symptomatic deterioration|0
6013475|NCT00830869|20788399|P2|Period 1: Part 1|Symptomatic deterioration|0
6013476|NCT00830869|20788400|P1|Period 1: Part 1|Symptomatic deterioration|0
6013477|NCT00830804|20788536|P1|Overall Study|Unwilling to adhere to study requirement|1
6013478|NCT00830804|20788536|P1|Overall Study|Consent withdrawn|2
6013479|NCT00830804|20788536|P1|Overall Study|Unable to get to clinic|7
6013480|NCT00830804|20788536|P1|Overall Study|Death|1
6013481|NCT00830804|20788536|P1|Overall Study|Lost to Follow-up|4
6013482|NCT00830765|20788616|P2|Overall Study|Protocol Violation|2
6013483|NCT00830765|20788617|P1|Overall Study|Protocol Violation|3
6013484|NCT00830518|20788650|P2|Overall Study|Reason not Specified|1
6013485|NCT00830518|20788651|P1|Overall Study|Reason not Specified|8
6013486|NCT00830518|20788650|P2|Overall Study|Withdrawal by Patient|0
6013487|NCT00830518|20788651|P1|Overall Study|Withdrawal by Patient|2
6013488|NCT00830518|20788650|P2|Overall Study|Adverse Event|1
6013489|NCT00830518|20788651|P1|Overall Study|Adverse Event|14
6013490|NCT00830518|20788650|P2|Overall Study|Symptomatic Deterioration|1
6013491|NCT00830518|20788651|P1|Overall Study|Symptomatic Deterioration|4
6013492|NCT00830518|20788650|P2|Overall Study|Progressive Disease|8
6013493|NCT00830518|20788651|P1|Overall Study|Progressive Disease|18
6013494|NCT00830440|20788670|P2|Overall Study|Adverse Event|0
6013495|NCT00830440|20788671|P1|Overall Study|Adverse Event|2
6013496|NCT00830440|20788670|P2|Overall Study|unsuccessful procedure|0
6013497|NCT00830440|20788671|P1|Overall Study|unsuccessful procedure|4
6013498|NCT00830440|20788670|P2|Overall Study|Withdrawal by Subject|0
6013499|NCT00830440|20788671|P1|Overall Study|Withdrawal by Subject|1
6013500|NCT00830440|20788670|P2|Overall Study|Protocol Violation|0
6013501|NCT00830440|20788671|P1|Overall Study|Protocol Violation|1
6013502|NCT00830375|20788686|P1|Overall Study|Lost to Follow-up|1
6013503|NCT00830336|20788701|P2|Washout: 21 Days|Withdrawal by Subject|0
6013504|NCT00830336|20788702|P1|Washout: 21 Days|Withdrawal by Subject|1
6013505|NCT00830258|20788729|P2|Washout: 7 Days|Protocol Violation|0
6013506|NCT00830258|20788730|P1|Washout: 7 Days|Protocol Violation|1
6013507|NCT00830258|20788729|P2|First Intervention|Adverse Event|0
6013508|NCT00830258|20788730|P1|First Intervention|Adverse Event|1
6013509|NCT00830219|20788749|P2|Washout of 7 Days|Withdrawal by Subject|1
6013510|NCT00830219|20788750|P1|Washout of 7 Days|Withdrawal by Subject|1
6013511|NCT00830206|20788760|P2|Washout: 21 Days|Withdrawal by Subject|1
6013512|NCT00830206|20788761|P1|Washout: 21 Days|Withdrawal by Subject|1
6013513|NCT00830167|20788771|P2|Overall Study|Other|2
6013514|NCT00830167|20788772|P1|Overall Study|Other|2
6013515|NCT00830167|20788771|P2|Overall Study|Protocol Violation|1
6013516|NCT00830167|20788772|P1|Overall Study|Protocol Violation|0
6013517|NCT00830167|20788771|P2|Overall Study|Lost to Follow-up|1
6013518|NCT00830167|20788772|P1|Overall Study|Lost to Follow-up|0
6013519|NCT00830167|20788771|P2|Overall Study|Withdrawal by Subject|0
6013520|NCT00830167|20788772|P1|Overall Study|Withdrawal by Subject|2
6013521|NCT00830167|20788771|P2|Overall Study|Not meeting entrance criteria|5
6013522|NCT00830167|20788772|P1|Overall Study|Not meeting entrance criteria|2
6013523|NCT00830167|20788771|P2|Overall Study|Adverse Event|24
6013524|NCT00830167|20788772|P1|Overall Study|Adverse Event|8
6013525|NCT00830167|20788771|P2|Overall Study|Lack of Efficacy|10
6013526|NCT00830167|20788772|P1|Overall Study|Lack of Efficacy|26
6013527|NCT00830128|20788842|P1|Overall Study|Operating a vehicle|1
6013528|NCT00830128|20788842|P1|Overall Study|Work obligation|1
6013529|NCT00830128|20788842|P1|Overall Study|Relocation|1
6013530|NCT00830128|20788842|P1|Overall Study|Family obligation|1
6013531|NCT00830128|20788842|P1|Overall Study|Withdrawal by Subject|2
6013532|NCT00830128|20788842|P1|Overall Study|Protocol Violation|1
6013533|NCT00830128|20788842|P1|Overall Study|Lack of Efficacy|7
6013534|NCT00830128|20788842|P1|Overall Study|Adverse Event|5
6013535|NCT00830115|20788857|P1|Overall Study|Improvement/recovery|1
6013536|NCT00830115|20788857|P1|Overall Study|Adverse Event|2
6013537|NCT00830037|20788884|P2|Overall Study|Active when terminated by DSMB|14
6013538|NCT00830037|20788885|P1|Overall Study|Active when terminated by DSMB|15
6013539|NCT00830037|20788884|P2|Overall Study|Lost to Follow-up|2
6013540|NCT00830037|20788885|P1|Overall Study|Lost to Follow-up|1
6013541|NCT00830037|20788884|P2|Overall Study|Withdrawal by Subject|3
6013542|NCT00830037|20788885|P1|Overall Study|Withdrawal by Subject|2
6013543|NCT00830024|20788895|P2|Washout: 7 Days|Withdrawal by Subject|0
6013544|NCT00830024|20788896|P1|Washout: 7 Days|Withdrawal by Subject|1
6013545|NCT00829998|20788906|P2|Washout|Adverse Event|1
6013546|NCT00829998|20788907|P1|Washout|Adverse Event|0
6013547|NCT00829933|20788936|P4|Overall Study|withdrew before treatment started|9
6013548|NCT00829933|20788937|P3|Overall Study|withdrew before treatment started|2
6013549|NCT00829933|20788938|P2|Overall Study|withdrew before treatment started|1
6013550|NCT00829933|20788939|P1|Overall Study|withdrew before treatment started|5
6013551|NCT00829933|20788936|P4|Overall Study|Protocol Violation|0
6013552|NCT00829933|20788937|P3|Overall Study|Protocol Violation|0
6013553|NCT00829933|20788938|P2|Overall Study|Protocol Violation|1
6013554|NCT00829933|20788939|P1|Overall Study|Protocol Violation|2
6013555|NCT00829933|20788936|P4|Overall Study|Pregnancy|2
6013556|NCT00829933|20788937|P3|Overall Study|Pregnancy|0
6013557|NCT00829933|20788938|P2|Overall Study|Pregnancy|0
6013558|NCT00829933|20788939|P1|Overall Study|Pregnancy|0
6013559|NCT00829933|20788936|P4|Overall Study|Physician Decision|1
6013560|NCT00829933|20788937|P3|Overall Study|Physician Decision|8
6013561|NCT00829933|20788938|P2|Overall Study|Physician Decision|7
6013562|NCT00829933|20788939|P1|Overall Study|Physician Decision|5
6013563|NCT00829933|20788936|P4|Overall Study|Lack of Efficacy|0
6013564|NCT00829933|20788937|P3|Overall Study|Lack of Efficacy|0
6013565|NCT00829933|20788938|P2|Overall Study|Lack of Efficacy|1
6013566|NCT00829933|20788939|P1|Overall Study|Lack of Efficacy|0
6013567|NCT00829933|20788936|P4|Overall Study|Death|1
6013568|NCT00829933|20788937|P3|Overall Study|Death|1
6013569|NCT00829933|20788938|P2|Overall Study|Death|0
6013570|NCT00829933|20788939|P1|Overall Study|Death|0
6013571|NCT00829933|20788936|P4|Overall Study|Adverse Event|1
6013572|NCT00829933|20788937|P3|Overall Study|Adverse Event|2
6013573|NCT00829933|20788938|P2|Overall Study|Adverse Event|3
6013574|NCT00829933|20788939|P1|Overall Study|Adverse Event|2
6013575|NCT00829868|20788951|P2|Washout|Physician Decision|0
6013576|NCT00829868|20788952|P1|Washout|Physician Decision|1
6013577|NCT00829829|20788963|P3|Overall Study|Other than specified above|1
6013578|NCT00829829|20788964|P2|Overall Study|Other than specified above|2
6013579|NCT00829829|20788965|P1|Overall Study|Other than specified above|2
6013580|NCT00829829|20788963|P3|Overall Study|Lost to Follow-up|3
6013581|NCT00829829|20788964|P2|Overall Study|Lost to Follow-up|3
6013582|NCT00829829|20788965|P1|Overall Study|Lost to Follow-up|7
6013583|NCT00829829|20788963|P3|Overall Study|Decision by the Sponsor|2
6013584|NCT00829829|20788964|P2|Overall Study|Decision by the Sponsor|0
6013585|NCT00829829|20788965|P1|Overall Study|Decision by the Sponsor|1
6013586|NCT00829829|20788963|P3|Overall Study|Withdrawal by Subject|2
6013587|NCT00829829|20788964|P2|Overall Study|Withdrawal by Subject|4
6013588|NCT00829829|20788965|P1|Overall Study|Withdrawal by Subject|8
6013589|NCT00829829|20788963|P3|Overall Study|Adverse Event|3
6013590|NCT00829829|20788964|P2|Overall Study|Adverse Event|4
6013591|NCT00829829|20788965|P1|Overall Study|Adverse Event|4
6013592|NCT00829829|20788963|P3|Overall Study|Protocol Violation|0
6013593|NCT00829829|20788964|P2|Overall Study|Protocol Violation|3
6013594|NCT00829829|20788965|P1|Overall Study|Protocol Violation|0
6013595|NCT00829790|20788990|P2|Washout of 14 Days|Withdrawal by Subject|1
6013596|NCT00829790|20788991|P1|Washout of 14 Days|Withdrawal by Subject|0
6013597|NCT00829764|20789001|P2|First Intervention|Withdrawal by Subject|1
6013598|NCT00829764|20789002|P1|First Intervention|Withdrawal by Subject|1
6013599|NCT00829764|20789001|P2|First Intervention|Adverse Event|0
6013600|NCT00829764|20789002|P1|First Intervention|Adverse Event|1
6013601|NCT00829712|20789028|P2|Washout of 7 Days|Withdrawal by Subject|1
6013602|NCT00829712|20789029|P1|Washout of 7 Days|Withdrawal by Subject|0
6013603|NCT00829673|20789048|P2|Washout of 7 Days|Withdrawal by Subject|0
6013604|NCT00829673|20789049|P1|Washout of 7 Days|Withdrawal by Subject|1
6013605|NCT00829621|20789059|P2|Overall Study|Lost to Follow-up|4
6013606|NCT00829621|20789060|P1|Overall Study|Lost to Follow-up|3
6013607|NCT00829621|20789059|P2|Overall Study|Death|0
6013608|NCT00829621|20789060|P1|Overall Study|Death|1
6013609|NCT00829530|20789068|P2|Second Intervention|Intolerance to Venopuncture|0
6013610|NCT00829530|20789069|P1|Second Intervention|Intolerance to Venopuncture|1
6013611|NCT00829530|20789068|P2|First Intervention|Intolerance to Venopuncture|1
6013612|NCT00829530|20789069|P1|First Intervention|Intolerance to Venopuncture|0
6013613|NCT00829530|20789068|P2|First Intervention|Adverse Event|1
6013614|NCT00829530|20789069|P1|First Intervention|Adverse Event|0
6013615|NCT00829504|20789083|P2|Second Intervention|Physician Decision|0
6013616|NCT00829504|20789084|P1|Second Intervention|Physician Decision|1
6013617|NCT00829504|20789083|P2|Washout of 7 Days|Withdrawal by Subject|0
6013618|NCT00829504|20789084|P1|Washout of 7 Days|Withdrawal by Subject|1
6013619|NCT00829504|20789083|P2|First Intervention|Adverse Event|0
6013620|NCT00829504|20789084|P1|First Intervention|Adverse Event|1
6013621|NCT00829452|20789094|P2|Second Intervention|Physician Decision|1
6013622|NCT00829452|20789095|P1|Second Intervention|Physician Decision|0
6013623|NCT00829452|20789094|P2|Washout of 42 Days|Withdrawal by Subject|1
6013624|NCT00829452|20789095|P1|Washout of 42 Days|Withdrawal by Subject|0
6013625|NCT00829452|20789094|P2|First Intervention|Withdrawal by Subject|1
6013626|NCT00829452|20789095|P1|First Intervention|Withdrawal by Subject|0
6013627|NCT00829439|20789107|P4|Overall Study|Adverse Event|0
6013628|NCT00829439|20789108|P3|Overall Study|Adverse Event|1
6013629|NCT00829439|20789109|P2|Overall Study|Adverse Event|0
6013630|NCT00829439|20789110|P1|Overall Study|Adverse Event|0
6013631|NCT00829426|20789116|P2|Washout: 7 Days|Withdrawal by Subject|0
6013632|NCT00829426|20789117|P1|Washout: 7 Days|Withdrawal by Subject|1
6013633|NCT00829413|20789125|P1|Overall Study|Indeterminate diagnosis from truth stand|3
6013634|NCT00829413|20789125|P1|Overall Study|Technically inadequate truth standard|2
6013635|NCT00829413|20789125|P1|Overall Study|No truth standard procedure available|9
6013636|NCT00829413|20789125|P1|Overall Study|Training Patients|67
6013637|NCT00829413|20789125|P1|Overall Study|No study drug admimnistered|13
6013638|NCT00829387|20789174|P2|Overall Study|Disqualified by PI|0
6013639|NCT00829387|20789175|P1|Overall Study|Disqualified by PI|1
6013640|NCT00829387|20789174|P2|Overall Study|Withdrawal by Subject|3
6013641|NCT00829387|20789175|P1|Overall Study|Withdrawal by Subject|2
6013642|NCT00829309|20789193|P2|Washout: 7 Days|Protocol Violation|0
6013643|NCT00829309|20789194|P1|Washout: 7 Days|Protocol Violation|1
6013644|NCT00829296|20789204|P2|Overall Study|Adverse Event|4
6013645|NCT00829296|20789205|P1|Overall Study|Adverse Event|5
6013646|NCT00829283|20789219|P2|Overall Study|Lost to Follow-up|25
6013647|NCT00829283|20789220|P1|Overall Study|Lost to Follow-up|7
6013648|NCT00829244|20789230|P2|Overall Study|No embryo cleavage|2
6013649|NCT00829244|20789231|P1|Overall Study|No embryo cleavage|0
6013650|NCT00829244|20789230|P2|Overall Study|All embryos discarded|3
6013651|NCT00829244|20789231|P1|Overall Study|All embryos discarded|0
6013652|NCT00829244|20789230|P2|Overall Study|No fertilization|2
6013653|NCT00829244|20789231|P1|Overall Study|No fertilization|2
6013654|NCT00829244|20789230|P2|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|6
6013655|NCT00829244|20789231|P1|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|1
6013656|NCT00829244|20789230|P2|Overall Study|Lack of ovarian response to stimulation|5
6013657|NCT00829244|20789231|P1|Overall Study|Lack of ovarian response to stimulation|9
6013658|NCT00829244|20789230|P2|Overall Study|Protocol Violation|0
6013659|NCT00829244|20789231|P1|Overall Study|Protocol Violation|1
6013660|NCT00829244|20789230|P2|Overall Study|Adverse Event|3
6013661|NCT00829244|20789231|P1|Overall Study|Adverse Event|1
6013662|NCT00829179|20789261|P1|Overall Study|Withdrawal by Subject|1
6013663|NCT00829166|20789267|P2|Overall Study|Reason Not Specified|3
6013664|NCT00829166|20789268|P1|Overall Study|Reason Not Specified|3
6013665|NCT00829166|20789267|P2|Overall Study|Sponsor's Decision|98
6013666|NCT00829166|20789268|P1|Overall Study|Sponsor's Decision|137
6013667|NCT00829166|20789267|P2|Overall Study|Subject's Decision|55
6013668|NCT00829166|20789268|P1|Overall Study|Subject's Decision|41
6013669|NCT00829166|20789267|P2|Overall Study|Physician's Decision|3
6013670|NCT00829166|20789268|P1|Overall Study|Physician's Decision|4
6013671|NCT00829166|20789267|P2|Overall Study|Lost to Follow-up|4
6013672|NCT00829166|20789268|P1|Overall Study|Lost to Follow-up|5
6013673|NCT00829166|20789267|P2|Overall Study|Death|333
6013674|NCT00829166|20789268|P1|Overall Study|Death|305
6013675|NCT00829010|20789331|P5|Overall Study|Migrated/Moved from study area|0
6013676|NCT00829010|20789332|P4|Overall Study|Migrated/Moved from study area|5
6013677|NCT00829010|20789333|P3|Overall Study|Migrated/Moved from study area|0
6013678|NCT00829010|20789334|P2|Overall Study|Migrated/Moved from study area|4
6013679|NCT00829010|20789335|P1|Overall Study|Migrated/Moved from study area|3
6013680|NCT00829010|20789331|P5|Overall Study|Fatality|0
6013681|NCT00829010|20789332|P4|Overall Study|Fatality|3
6013682|NCT00829010|20789333|P3|Overall Study|Fatality|0
6013683|NCT00829010|20789334|P2|Overall Study|Fatality|4
6013684|NCT00829010|20789335|P1|Overall Study|Fatality|5
6013685|NCT00829010|20789331|P5|Overall Study|Lost to Follow-up|0
6013686|NCT00829010|20789332|P4|Overall Study|Lost to Follow-up|0
6013687|NCT00829010|20789333|P3|Overall Study|Lost to Follow-up|2
6013688|NCT00829010|20789334|P2|Overall Study|Lost to Follow-up|0
6013689|NCT00829010|20789335|P1|Overall Study|Lost to Follow-up|1
6013690|NCT00829010|20789331|P5|Overall Study|Withdrawal by Subject|2
6013691|NCT00829010|20789332|P4|Overall Study|Withdrawal by Subject|0
6013692|NCT00829010|20789333|P3|Overall Study|Withdrawal by Subject|1
6013693|NCT00829010|20789334|P2|Overall Study|Withdrawal by Subject|1
6013694|NCT00829010|20789335|P1|Overall Study|Withdrawal by Subject|0
6013695|NCT00829010|20789331|P5|Overall Study|Adverse Event|0
6013696|NCT00829010|20789332|P4|Overall Study|Adverse Event|0
6013697|NCT00829010|20789333|P3|Overall Study|Adverse Event|0
6013698|NCT00829010|20789334|P2|Overall Study|Adverse Event|0
6013699|NCT00829010|20789335|P1|Overall Study|Adverse Event|1
6013700|NCT00828984|20789500|P3|Overall Study|ConMed|1
6013701|NCT00828984|20789501|P2|Overall Study|ConMed|1
6013702|NCT00828984|20789502|P1|Overall Study|ConMed|1
6013703|NCT00828984|20789500|P3|Overall Study|Noncompliant|3
6013704|NCT00828984|20789501|P2|Overall Study|Noncompliant|2
6013705|NCT00828984|20789502|P1|Overall Study|Noncompliant|1
6013706|NCT00828984|20789500|P3|Overall Study|Medical Contraindication|0
6013707|NCT00828984|20789501|P2|Overall Study|Medical Contraindication|1
6013708|NCT00828984|20789502|P1|Overall Study|Medical Contraindication|0
6013709|NCT00828984|20789500|P3|Overall Study|Ineligable|0
6013710|NCT00828984|20789501|P2|Overall Study|Ineligable|2
6013711|NCT00828984|20789502|P1|Overall Study|Ineligable|1
6013712|NCT00828984|20789500|P3|Overall Study|Withdrawal by Subject|4
6013713|NCT00828984|20789501|P2|Overall Study|Withdrawal by Subject|4
6013714|NCT00828984|20789502|P1|Overall Study|Withdrawal by Subject|4
6013715|NCT00828984|20789500|P3|Overall Study|Lost to Follow-up|1
6013716|NCT00828984|20789501|P2|Overall Study|Lost to Follow-up|3
6013717|NCT00828984|20789502|P1|Overall Study|Lost to Follow-up|5
6013718|NCT00828984|20789500|P3|Overall Study|Adverse Event|0
6013719|NCT00828984|20789501|P2|Overall Study|Adverse Event|3
6013720|NCT00828984|20789502|P1|Overall Study|Adverse Event|2
6013724|NCT00828750|20789557|P1|Overall Study|Normal PC Remained While No Treatment|1
6013725|NCT00828750|20789557|P1|Overall Study|Lack of Efficacy|3
6013726|NCT00828711|20789571|P3|Overall Study|Lost to Follow-up|0
6013727|NCT00828711|20789572|P2|Overall Study|Lost to Follow-up|0
6013728|NCT00828711|20789573|P1|Overall Study|Lost to Follow-up|1
6013729|NCT00828672|20789604|P2|Post-surgery (<30 Days)|No central review materials|1
6013730|NCT00828672|20789605|P1|Post-surgery (<30 Days)|No central review materials|0
6013731|NCT00828672|20789604|P2|Study Treatment|Complete response, no surgery|1
6013732|NCT00828672|20789605|P1|Study Treatment|Complete response, no surgery|1
6013733|NCT00828672|20789604|P2|Study Treatment|Adverse Event|1
6013734|NCT00828672|20789605|P1|Study Treatment|Adverse Event|0
6013735|NCT00828672|20789604|P2|Study Treatment|Lost to Follow-up|0
6013736|NCT00828672|20789605|P1|Study Treatment|Lost to Follow-up|1
6013737|NCT00828568|20789626|P3|Treated - Received at Least One Dose|Protocol Violation|3
6013738|NCT00828568|20789627|P2|Treated - Received at Least One Dose|Protocol Violation|5
6013739|NCT00828568|20789628|P1|Treated - Received at Least One Dose|Protocol Violation|9
6013740|NCT00828568|20789626|P3|Treated - Received at Least One Dose|Lost to Follow-up|1
6013741|NCT00828568|20789627|P2|Treated - Received at Least One Dose|Lost to Follow-up|5
6013742|NCT00828568|20789628|P1|Treated - Received at Least One Dose|Lost to Follow-up|1
6013743|NCT00828568|20789626|P3|Treated - Received at Least One Dose|Withdrawal by Subject|0
6013744|NCT00828568|20789627|P2|Treated - Received at Least One Dose|Withdrawal by Subject|11
6013745|NCT00828568|20789628|P1|Treated - Received at Least One Dose|Withdrawal by Subject|9
6013746|NCT00828568|20789626|P3|Treated - Received at Least One Dose|Adverse Event|1
6013747|NCT00828568|20789627|P2|Treated - Received at Least One Dose|Adverse Event|8
6013748|NCT00828568|20789628|P1|Treated - Received at Least One Dose|Adverse Event|11
6013749|NCT00828568|20789626|P3|Randomized|Withdrawal by Subject|2
6013750|NCT00828568|20789627|P2|Randomized|Withdrawal by Subject|0
6013751|NCT00828568|20789628|P1|Randomized|Withdrawal by Subject|1
6013752|NCT00828516|20789650|P1|Clinical Phase: Series 1|Withdrawal by Subject|2
6013753|NCT00828464|20789655|P1|Overall Study|Withdrawal by Subject|1
6013754|NCT00828451|20789672|P1|Overall Study|Deterioration in clinical status|1
6013755|NCT00828451|20789672|P1|Overall Study|Withdrawal by Subject|1
6013756|NCT00828451|20789672|P1|Overall Study|Lack of intravenous line|7
6013757|NCT00828451|20789672|P1|Overall Study|Death|2
6013758|NCT00828321|20789698|P2|Second Intervention|Protocol Violation|1
6013759|NCT00828321|20789699|P1|Second Intervention|Protocol Violation|0
6013760|NCT00828321|20789698|P2|Washout of 42 Days|Withdrawal by Subject|0
6013761|NCT00828321|20789699|P1|Washout of 42 Days|Withdrawal by Subject|2
6013762|NCT00828204|20789728|P2|Extension Study|Physician Decision|2
6013763|NCT00828204|20789729|P1|Extension Study|Physician Decision|0
6013764|NCT00828204|20789728|P2|Extension Study|Lost to Follow-up|1
6013765|NCT00828204|20789729|P1|Extension Study|Lost to Follow-up|0
6013766|NCT00828204|20789728|P2|Main Study: After Study Restart|Noncompliance|1
6013767|NCT00828204|20789729|P1|Main Study: After Study Restart|Noncompliance|0
6013768|NCT00828204|20789728|P2|Main Study: After Study Restart|Adverse Event|2
6013769|NCT00828204|20789729|P1|Main Study: After Study Restart|Adverse Event|0
6013770|NCT00828204|20789728|P2|Main Study: Prior to Study Suspension|Study Suspension|0
6013771|NCT00828204|20789729|P1|Main Study: Prior to Study Suspension|Study Suspension|11
6013772|NCT00828204|20789728|P2|Main Study: Prior to Study Suspension|Subject Was Withdrawn|0
6013773|NCT00828204|20789729|P1|Main Study: Prior to Study Suspension|Subject Was Withdrawn|2
6013774|NCT00828204|20789728|P2|Main Study: Prior to Study Suspension|Adverse Event|0
6013775|NCT00828204|20789729|P1|Main Study: Prior to Study Suspension|Adverse Event|1
6013776|NCT00828139|20789776|P4|Overall Study|Other|2
6013777|NCT00828139|20789777|P3|Overall Study|Other|5
6013778|NCT00828139|20789778|P2|Overall Study|Other|2
6013779|NCT00828139|20789779|P1|Overall Study|Other|4
6013780|NCT00828139|20789776|P4|Overall Study|Disease Progression|39
6013781|NCT00828139|20789777|P3|Overall Study|Disease Progression|35
6013782|NCT00828139|20789778|P2|Overall Study|Disease Progression|33
6013783|NCT00828139|20789779|P1|Overall Study|Disease Progression|24
6013784|NCT00828139|20789776|P4|Overall Study|Refusal unrelated to toxicity|3
6013785|NCT00828139|20789777|P3|Overall Study|Refusal unrelated to toxicity|5
6013786|NCT00828139|20789778|P2|Overall Study|Refusal unrelated to toxicity|4
6013787|NCT00828139|20789779|P1|Overall Study|Refusal unrelated to toxicity|3
6013788|NCT00828139|20789776|P4|Overall Study|Death|2
6013789|NCT00828139|20789777|P3|Overall Study|Death|0
6013790|NCT00828139|20789778|P2|Overall Study|Death|1
6013791|NCT00828139|20789779|P1|Overall Study|Death|2
6013792|NCT00828139|20789776|P4|Overall Study|Adverse Event|5
6013793|NCT00828139|20789777|P3|Overall Study|Adverse Event|10
6013794|NCT00828139|20789778|P2|Overall Study|Adverse Event|1
6013795|NCT00828139|20789779|P1|Overall Study|Adverse Event|8
6013796|NCT00828113|20789799|P2|Overall Study|Lost to Follow-up|5
6013797|NCT00828113|20789800|P1|Overall Study|Lost to Follow-up|3
6013798|NCT00828113|20789799|P2|Overall Study|Withdrawal by Subject|26
6013799|NCT00828113|20789800|P1|Overall Study|Withdrawal by Subject|27
6013800|NCT00828009|20789838|P1|Step 2 - Maintenance Therapy|Other|1
6013801|NCT00828009|20789838|P1|Step 2 - Maintenance Therapy|Complicating disease|2
6013802|NCT00828009|20789838|P1|Step 2 - Maintenance Therapy|Withdrawal by Subject|4
6013803|NCT00828009|20789838|P1|Step 2 - Maintenance Therapy|Death|1
6013804|NCT00828009|20789838|P1|Step 2 - Maintenance Therapy|Adverse Event|13
6013805|NCT00828009|20789838|P1|Step 2 - Maintenance Therapy|Progressive disease|12
6013806|NCT00828009|20789838|P1|Step 1 - Chemo RT/Consolidation Chemo|Never started therapy|2
6013807|NCT00828009|20789838|P1|Step 1 - Chemo RT/Consolidation Chemo|No show/Patient moved|2
6013808|NCT00828009|20789838|P1|Step 1 - Chemo RT/Consolidation Chemo|Complicating disease|1
6013809|NCT00828009|20789838|P1|Step 1 - Chemo RT/Consolidation Chemo|Progressive disease|11
6013810|NCT00828009|20789838|P1|Step 1 - Chemo RT/Consolidation Chemo|Withdrawal by Subject|3
6013811|NCT00828009|20789838|P1|Step 1 - Chemo RT/Consolidation Chemo|Death|2
6013812|NCT00828009|20789838|P1|Step 1 - Chemo RT/Consolidation Chemo|Adverse Event|10
6013813|NCT00827931|20789881|P2|Overall Study|Other|0
6013814|NCT00827931|20789882|P1|Overall Study|Other|1
6013815|NCT00827931|20789881|P2|Overall Study|Withdrawal by Subject|1
6013816|NCT00827931|20789882|P1|Overall Study|Withdrawal by Subject|0
6013817|NCT00827931|20789881|P2|Overall Study|Lost to Follow-up|0
6013818|NCT00827931|20789882|P1|Overall Study|Lost to Follow-up|1
6013819|NCT00827931|20789881|P2|Overall Study|Adverse Event|0
6013820|NCT00827931|20789882|P1|Overall Study|Adverse Event|1
6013821|NCT00827931|20789881|P2|Overall Study|Death|5
6013822|NCT00827931|20789882|P1|Overall Study|Death|3
6013823|NCT00827918|20789903|P3|Overall Study|Withdrawal by Subject|6
6013824|NCT00827918|20789904|P2|Overall Study|Withdrawal by Subject|2
6013825|NCT00827918|20789905|P1|Overall Study|Withdrawal by Subject|6
6013826|NCT00827918|20789903|P3|Overall Study|Protocol Violation|0
6013827|NCT00827918|20789904|P2|Overall Study|Protocol Violation|1
6013828|NCT00827918|20789905|P1|Overall Study|Protocol Violation|0
6013829|NCT00827918|20789903|P3|Overall Study|Progressive Disease|0
6013830|NCT00827918|20789904|P2|Overall Study|Progressive Disease|1
6013831|NCT00827918|20789905|P1|Overall Study|Progressive Disease|1
6013832|NCT00827918|20789903|P3|Overall Study|Pregnancy|0
6013833|NCT00827918|20789904|P2|Overall Study|Pregnancy|1
6013834|NCT00827918|20789905|P1|Overall Study|Pregnancy|0
6013835|NCT00827918|20789903|P3|Overall Study|Physician Decision|0
6013836|NCT00827918|20789904|P2|Overall Study|Physician Decision|0
6013837|NCT00827918|20789905|P1|Overall Study|Physician Decision|1
6013838|NCT00827918|20789903|P3|Overall Study|Lack of Efficacy|15
6013839|NCT00827918|20789904|P2|Overall Study|Lack of Efficacy|4
6013840|NCT00827918|20789905|P1|Overall Study|Lack of Efficacy|16
6013841|NCT00827918|20789903|P3|Overall Study|Adverse Event|0
6013842|NCT00827918|20789904|P2|Overall Study|Adverse Event|0
6013843|NCT00827918|20789905|P1|Overall Study|Adverse Event|4
6013844|NCT00827827|20789933|P2|Overall Study|Burned with water at home|0
6013845|NCT00827827|20789934|P1|Overall Study|Burned with water at home|1
6013846|NCT00827827|20789933|P2|Overall Study|Transportation issues|0
6013847|NCT00827827|20789934|P1|Overall Study|Transportation issues|1
6013848|NCT00827827|20789933|P2|Overall Study|Gout|0
6013849|NCT00827827|20789934|P1|Overall Study|Gout|1
6013850|NCT00827827|20789933|P2|Overall Study|Another cerebrovascular accident (CVA)|0
6013851|NCT00827827|20789934|P1|Overall Study|Another cerebrovascular accident (CVA)|1
6013852|NCT00827827|20789933|P2|Overall Study|Fall at home- hospitalization|0
6013853|NCT00827827|20789934|P1|Overall Study|Fall at home- hospitalization|1
6013854|NCT00827827|20789933|P2|Overall Study|Lost to Follow-up|0
6013855|NCT00827827|20789934|P1|Overall Study|Lost to Follow-up|3
6013856|NCT00827775|20789978|P2|Overall Study|Withdrawal by Subject|5
6013857|NCT00827775|20789979|P1|Overall Study|Withdrawal by Subject|0
6013858|NCT00827632|20789989|P2|Overall Study|Early withdrawal|11
6013859|NCT00827632|20789990|P1|Overall Study|Early withdrawal|14
6013860|NCT00827632|20789989|P2|Overall Study|Lost to Follow-up|12
6013861|NCT00827632|20789990|P1|Overall Study|Lost to Follow-up|8
6013876|NCT00827567|20790064|P1|Overall Study|Progression of Disease/Screen Failure|4
6013877|NCT00827541|20790070|P2|Overall Study|Lack of effectiveness|0
6013878|NCT00827541|20790071|P1|Overall Study|Lack of effectiveness|1
6013879|NCT00827541|20790070|P2|Overall Study|Pathogen not susceptible|0
6013880|NCT00827541|20790071|P1|Overall Study|Pathogen not susceptible|1
6013881|NCT00827541|20790070|P2|Overall Study|Other|3
6013882|NCT00827541|20790071|P1|Overall Study|Other|1
6013883|NCT00827541|20790070|P2|Overall Study|Exitus|8
6013884|NCT00827541|20790071|P1|Overall Study|Exitus|1
6013885|NCT00827502|20790083|P1|Overall Study|Withdrawal by Subject|5
6013886|NCT00827502|20790083|P1|Overall Study|Lost to Follow-up|4
6013887|NCT00827502|20790083|P1|Overall Study|Adverse Event|1
6013888|NCT00827502|20790083|P1|Overall Study|randomized but not treated|11
6013889|NCT00827372|20790089|P1|Overall Study|Lack of Efficacy|3
6013890|NCT00827372|20790089|P1|Overall Study|Adverse Event|5
6013891|NCT00827242|20790104|P2|Overall Study|Lack of Efficacy|0
6013892|NCT00827242|20790105|P1|Overall Study|Lack of Efficacy|1
6013893|NCT00827242|20790104|P2|Overall Study|Death|0
6013894|NCT00827242|20790105|P1|Overall Study|Death|1
6013895|NCT00827242|20790104|P2|Overall Study|Physician Decision|0
6013896|NCT00827242|20790105|P1|Overall Study|Physician Decision|2
6013897|NCT00827242|20790104|P2|Overall Study|Entry Criteria Not Met|1
6013898|NCT00827242|20790105|P1|Overall Study|Entry Criteria Not Met|4
6013899|NCT00827242|20790104|P2|Overall Study|Adverse Event Excluding Death|1
6013900|NCT00827242|20790105|P1|Overall Study|Adverse Event Excluding Death|2
6013901|NCT00827242|20790104|P2|Overall Study|Lost to Follow-up|3
6013902|NCT00827242|20790105|P1|Overall Study|Lost to Follow-up|0
6013903|NCT00827242|20790104|P2|Overall Study|Protocol Violation|3
6013904|NCT00827242|20790105|P1|Overall Study|Protocol Violation|1
6013905|NCT00827242|20790104|P2|Overall Study|Withdrawal by Subject|4
6013906|NCT00827242|20790105|P1|Overall Study|Withdrawal by Subject|2
6013907|NCT00827112|20790143|P2|Overall Study|Other|3
6013908|NCT00827112|20790144|P1|Overall Study|Other|1
6013909|NCT00827112|20790143|P2|Overall Study|Randomized but not treated|3
6013910|NCT00827112|20790144|P1|Overall Study|Randomized but not treated|5
6013911|NCT00827112|20790143|P2|Overall Study|Withdrawal by Subject|1
6013912|NCT00827112|20790144|P1|Overall Study|Withdrawal by Subject|2
6013913|NCT00827112|20790143|P2|Overall Study|Protocol Violation|2
6013914|NCT00827112|20790144|P1|Overall Study|Protocol Violation|0
6013915|NCT00827112|20790143|P2|Overall Study|Pregnancy|1
6013916|NCT00827112|20790144|P1|Overall Study|Pregnancy|0
6013917|NCT00827112|20790143|P2|Overall Study|Lost to Follow-up|2
6013918|NCT00827112|20790144|P1|Overall Study|Lost to Follow-up|3
6013919|NCT00827112|20790143|P2|Overall Study|Lack of Efficacy|0
6013920|NCT00827112|20790144|P1|Overall Study|Lack of Efficacy|2
6013921|NCT00827112|20790143|P2|Overall Study|Adverse Event|0
6013922|NCT00827112|20790144|P1|Overall Study|Adverse Event|2
6013923|NCT00826943|20790197|P6|Overall Study|Withdrawal by Subject|0
6013924|NCT00826943|20790198|P5|Overall Study|Withdrawal by Subject|1
6013925|NCT00826943|20790199|P4|Overall Study|Withdrawal by Subject|0
6013926|NCT00826943|20790200|P3|Overall Study|Withdrawal by Subject|0
6013927|NCT00826943|20790201|P2|Overall Study|Withdrawal by Subject|0
6013928|NCT00826943|20790202|P1|Overall Study|Withdrawal by Subject|0
6013929|NCT00826748|20790223|P3|Overall Study|Samples Did Not pass QC|1
6013930|NCT00826748|20790224|P2|Overall Study|Samples Did Not pass QC|0
6013931|NCT00826748|20790225|P1|Overall Study|Samples Did Not pass QC|0
6013932|NCT00826748|20790223|P3|Overall Study|Physician Decision|1
6013933|NCT00826748|20790224|P2|Overall Study|Physician Decision|0
6013934|NCT00826748|20790225|P1|Overall Study|Physician Decision|0
6013935|NCT00826748|20790223|P3|Overall Study|Withdrawal by Subject|2
6013936|NCT00826748|20790224|P2|Overall Study|Withdrawal by Subject|0
6013937|NCT00826748|20790225|P1|Overall Study|Withdrawal by Subject|0
6013938|NCT00826618|20790233|P1|Overall Study|Withdrawal by Subject|1
6013939|NCT00826540|20790237|P1|Overall Study|Withdrawal by Subject|1
6013940|NCT00826540|20790237|P1|Overall Study|ineligible|3
6013941|NCT00826449|20790243|P1|Overall Study|Withdrawal by Subject|1
6013942|NCT00826449|20790243|P1|Overall Study|Disease Progression|4
6013943|NCT00826280|20790252|P3|Overall Study|One or more non-interpretable scan|1
6013944|NCT00826280|20790253|P2|Overall Study|One or more non-interpretable scan|1
6013945|NCT00826280|20790254|P1|Overall Study|One or more non-interpretable scan|0
6013946|NCT00826280|20790252|P3|Overall Study|Machine Failure|0
6013947|NCT00826280|20790253|P2|Overall Study|Machine Failure|1
6013948|NCT00826280|20790254|P1|Overall Study|Machine Failure|1
6013949|NCT00826280|20790252|P3|Overall Study|Interpretation Failure|0
6013950|NCT00826280|20790253|P2|Overall Study|Interpretation Failure|0
6013951|NCT00826280|20790254|P1|Overall Study|Interpretation Failure|1
6013952|NCT00826280|20790252|P3|Overall Study|Reversible ischemic defect not present|44
6013953|NCT00826280|20790253|P2|Overall Study|Reversible ischemic defect not present|40
6013954|NCT00826280|20790254|P1|Overall Study|Reversible ischemic defect not present|43
6013955|NCT00826280|20790252|P3|Overall Study|Sponsor discontinued subject or study|0
6013956|NCT00826280|20790253|P2|Overall Study|Sponsor discontinued subject or study|0
6013957|NCT00826280|20790254|P1|Overall Study|Sponsor discontinued subject or study|1
6013958|NCT00826280|20790252|P3|Overall Study|Lost to Follow-up|0
6013959|NCT00826280|20790253|P2|Overall Study|Lost to Follow-up|1
6013960|NCT00826280|20790254|P1|Overall Study|Lost to Follow-up|0
6013961|NCT00826280|20790252|P3|Overall Study|Adverse Event|0
6013962|NCT00826280|20790253|P2|Overall Study|Adverse Event|3
6013963|NCT00826280|20790254|P1|Overall Study|Adverse Event|1
6013964|NCT00826280|20790252|P3|Overall Study|Randomized but drug not received|1
6013965|NCT00826280|20790253|P2|Overall Study|Randomized but drug not received|0
6013966|NCT00826280|20790254|P1|Overall Study|Randomized but drug not received|1
6013967|NCT00826267|20790283|P3|Overall Study|Other Adverse Event|0
6013968|NCT00826267|20790284|P2|Overall Study|Other Adverse Event|0
6013969|NCT00826267|20790285|P1|Overall Study|Other Adverse Event|1
6013970|NCT00826241|20790303|P1|Overall Study|Pt opt not to proceed w/trmt|1
6013971|NCT00826241|20790303|P1|Overall Study|Pt unable to proceed to registration|1
6013972|NCT00826241|20790303|P1|Overall Study|Screen failure|2
6013973|NCT00826241|20790303|P1|Overall Study|Could not obtain records|1
6013974|NCT00826241|20790303|P1|Overall Study|Lost to Follow-up|9
6013975|NCT00826241|20790303|P1|Overall Study|Patient refused follow-up|3
6013976|NCT00826241|20790303|P1|Overall Study|Progression of disease|1
6013977|NCT00826241|20790303|P1|Overall Study|Non-compliance|1
6013978|NCT00826241|20790303|P1|Overall Study|Non-reportable(not qualify as Gr. 5 SAE)|1
6013979|NCT00826241|20790303|P1|Overall Study|Death|4
6013980|NCT00826241|20790303|P1|Overall Study|Withdrew consent|2
6013981|NCT00826241|20790303|P1|Overall Study|Withdrawal from Follow-up|1
6013982|NCT00826228|20790309|P1|Overall Study|Withdrawal by Subject|1
6013983|NCT00826176|20790331|P2|Overall Study|Administrative|0
6013984|NCT00826176|20790332|P1|Overall Study|Administrative|9
6013985|NCT00826176|20790331|P2|Overall Study|Subject Withdrew Consent|0
6013986|NCT00826176|20790332|P1|Overall Study|Subject Withdrew Consent|3
6013987|NCT00826176|20790331|P2|Overall Study|Lost to Follow-up|0
6013988|NCT00826176|20790332|P1|Overall Study|Lost to Follow-up|1
6013989|NCT00826111|20790381|P2|Overall Study|Physician Decision|1
6013990|NCT00826111|20790382|P1|Overall Study|Physician Decision|1
6013991|NCT00826111|20790381|P2|Overall Study|Withdrawal by Subject|0
6013992|NCT00826111|20790382|P1|Overall Study|Withdrawal by Subject|5
6013993|NCT00826111|20790381|P2|Overall Study|Protocol Violation|0
6013994|NCT00826111|20790382|P1|Overall Study|Protocol Violation|1
6013995|NCT00826111|20790381|P2|Overall Study|Lost to Follow-up|1
6013996|NCT00826111|20790382|P1|Overall Study|Lost to Follow-up|0
6013997|NCT00825994|20790417|P1|Overall Study|Placebo Responder at V2|1
6013998|NCT00825994|20790417|P1|Overall Study|Protocol Violation|1
6013999|NCT00825994|20790417|P1|Overall Study|Lost to Follow-up|1
6014000|NCT00825994|20790417|P1|Overall Study|Withdrawal by Subject|2
6014001|NCT00825916|20790425|P3|Overall Study|Lost to Follow-up|1
6014002|NCT00825916|20790426|P2|Overall Study|Lost to Follow-up|2
6014003|NCT00825916|20790427|P1|Overall Study|Lost to Follow-up|4
6014004|NCT00825825|20790468|P6|Third Medication Period (14 Days)|poor data quality|0
6014005|NCT00825825|20790469|P5|Third Medication Period (14 Days)|poor data quality|0
6014006|NCT00825825|20790470|P4|Third Medication Period (14 Days)|poor data quality|0
6014007|NCT00825825|20790471|P3|Third Medication Period (14 Days)|poor data quality|0
6014008|NCT00825825|20790472|P2|Third Medication Period (14 Days)|poor data quality|1
6014009|NCT00825825|20790473|P1|Third Medication Period (14 Days)|poor data quality|0
6014010|NCT00825825|20790468|P6|Third Medication Period (14 Days)|Protocol Violation|2
6014011|NCT00825825|20790469|P5|Third Medication Period (14 Days)|Protocol Violation|0
6014012|NCT00825825|20790470|P4|Third Medication Period (14 Days)|Protocol Violation|0
6014013|NCT00825825|20790471|P3|Third Medication Period (14 Days)|Protocol Violation|0
6014014|NCT00825825|20790472|P2|Third Medication Period (14 Days)|Protocol Violation|0
6014015|NCT00825825|20790473|P1|Third Medication Period (14 Days)|Protocol Violation|0
6014016|NCT00825825|20790468|P6|Third Medication Period (14 Days)|Adverse Event|0
6014017|NCT00825825|20790469|P5|Third Medication Period (14 Days)|Adverse Event|0
6014018|NCT00825825|20790470|P4|Third Medication Period (14 Days)|Adverse Event|0
6014019|NCT00825825|20790471|P3|Third Medication Period (14 Days)|Adverse Event|0
6014020|NCT00825825|20790472|P2|Third Medication Period (14 Days)|Adverse Event|1
6014021|NCT00825825|20790473|P1|Third Medication Period (14 Days)|Adverse Event|0
6014022|NCT00825825|20790468|P6|Second Medication Period (14 Days)|Protocol Violation|0
6014023|NCT00825825|20790469|P5|Second Medication Period (14 Days)|Protocol Violation|1
6014024|NCT00825825|20790470|P4|Second Medication Period (14 Days)|Protocol Violation|0
6014025|NCT00825825|20790471|P3|Second Medication Period (14 Days)|Protocol Violation|0
6014026|NCT00825825|20790472|P2|Second Medication Period (14 Days)|Protocol Violation|0
6014027|NCT00825825|20790473|P1|Second Medication Period (14 Days)|Protocol Violation|1
6014028|NCT00825825|20790468|P6|Second Medication Period (14 Days)|Physician Decision|0
6014029|NCT00825825|20790469|P5|Second Medication Period (14 Days)|Physician Decision|0
6014030|NCT00825825|20790470|P4|Second Medication Period (14 Days)|Physician Decision|2
6014031|NCT00825825|20790471|P3|Second Medication Period (14 Days)|Physician Decision|0
6014032|NCT00825825|20790472|P2|Second Medication Period (14 Days)|Physician Decision|0
6014033|NCT00825825|20790473|P1|Second Medication Period (14 Days)|Physician Decision|1
6014034|NCT00825825|20790468|P6|First Medication Period (14 Days)|Physician Decision|1
6014035|NCT00825825|20790469|P5|First Medication Period (14 Days)|Physician Decision|0
6014036|NCT00825825|20790470|P4|First Medication Period (14 Days)|Physician Decision|0
6014037|NCT00825825|20790471|P3|First Medication Period (14 Days)|Physician Decision|1
6014038|NCT00825825|20790472|P2|First Medication Period (14 Days)|Physician Decision|0
6014039|NCT00825825|20790473|P1|First Medication Period (14 Days)|Physician Decision|2
6014040|NCT00825825|20790468|P6|First Medication Period (14 Days)|Adverse Event|1
6014041|NCT00825825|20790469|P5|First Medication Period (14 Days)|Adverse Event|0
6014042|NCT00825825|20790470|P4|First Medication Period (14 Days)|Adverse Event|0
6014043|NCT00825825|20790471|P3|First Medication Period (14 Days)|Adverse Event|0
6014044|NCT00825825|20790472|P2|First Medication Period (14 Days)|Adverse Event|0
6014045|NCT00825825|20790473|P1|First Medication Period (14 Days)|Adverse Event|1
6014046|NCT00825812|20790489|P4|Overall Study|Administrative|5
6014047|NCT00825812|20790490|P3|Overall Study|Administrative|3
6014048|NCT00825812|20790491|P2|Overall Study|Administrative|1
6014049|NCT00825812|20790492|P1|Overall Study|Administrative|0
6014050|NCT00825812|20790489|P4|Overall Study|Non-compliance with protocol|1
6014051|NCT00825812|20790490|P3|Overall Study|Non-compliance with protocol|0
6014052|NCT00825812|20790491|P2|Overall Study|Non-compliance with protocol|0
6014053|NCT00825812|20790492|P1|Overall Study|Non-compliance with protocol|0
6014054|NCT00825812|20790489|P4|Overall Study|Subject withdrew consent|2
6014055|NCT00825812|20790490|P3|Overall Study|Subject withdrew consent|3
6014056|NCT00825812|20790491|P2|Overall Study|Subject withdrew consent|0
6014057|NCT00825812|20790492|P1|Overall Study|Subject withdrew consent|0
6014058|NCT00825812|20790489|P4|Overall Study|Adverse Event|1
6014059|NCT00825812|20790490|P3|Overall Study|Adverse Event|0
6014060|NCT00825812|20790491|P2|Overall Study|Adverse Event|0
6014061|NCT00825812|20790492|P1|Overall Study|Adverse Event|0
6014062|NCT00825812|20790489|P4|Overall Study|Never entered follow up|1
6014063|NCT00825812|20790490|P3|Overall Study|Never entered follow up|0
6014064|NCT00825812|20790491|P2|Overall Study|Never entered follow up|0
6014065|NCT00825812|20790492|P1|Overall Study|Never entered follow up|0
6014066|NCT00825682|20790539|P2|Overall Study|personal reasons/ inconvenience|5
6014067|NCT00825682|20790540|P1|Overall Study|personal reasons/ inconvenience|13
6014068|NCT00825305|20790631|P2|Overall Study|Can not be classified|1
6014069|NCT00825305|20790632|P1|Overall Study|Can not be classified|0
6014070|NCT00825305|20790631|P2|Overall Study|Protocol Violation|9
6014071|NCT00825305|20790632|P1|Overall Study|Protocol Violation|9
6014072|NCT00825305|20790631|P2|Overall Study|Inappropriate inclusion|0
6014073|NCT00825305|20790632|P1|Overall Study|Inappropriate inclusion|1
6014074|NCT00825305|20790631|P2|Overall Study|Withdrawal by Subject|12
6014075|NCT00825305|20790632|P1|Overall Study|Withdrawal by Subject|6
6014076|NCT00825305|20790631|P2|Overall Study|Adverse Event|1
6014077|NCT00825305|20790632|P1|Overall Study|Adverse Event|1
6014078|NCT00825175|20790672|P2|Overall Study|Withdrawal by Subject|5
6014079|NCT00825175|20790673|P1|Overall Study|Withdrawal by Subject|0
6014080|NCT00825162|20790682|P3|Overall Study|Unable to attend the study visit|0
6014081|NCT00825162|20790683|P2|Overall Study|Unable to attend the study visit|2
6014082|NCT00825162|20790684|P1|Overall Study|Unable to attend the study visit|5
6014083|NCT00825162|20790682|P3|Overall Study|Move away from the study area|0
6014084|NCT00825162|20790683|P2|Overall Study|Move away from the study area|0
6014085|NCT00825162|20790684|P1|Overall Study|Move away from the study area|1
6014086|NCT00825162|20790682|P3|Overall Study|Physician Decision|0
6014087|NCT00825162|20790683|P2|Overall Study|Physician Decision|0
6014088|NCT00825162|20790684|P1|Overall Study|Physician Decision|2
6014089|NCT00825162|20790682|P3|Overall Study|Lost to Follow-up|3
6014090|NCT00825162|20790683|P2|Overall Study|Lost to Follow-up|6
6014091|NCT00825162|20790684|P1|Overall Study|Lost to Follow-up|9
6014092|NCT00825162|20790682|P3|Overall Study|Withdrawal by Subject|3
6014093|NCT00825162|20790683|P2|Overall Study|Withdrawal by Subject|13
6014094|NCT00825162|20790684|P1|Overall Study|Withdrawal by Subject|11
6014095|NCT00824993|20790710|P2|Overall Study|Death|3
6014096|NCT00824993|20790711|P1|Overall Study|Death|0
6014097|NCT00824993|20790710|P2|Overall Study|Insurance Issue|1
6014098|NCT00824993|20790711|P1|Overall Study|Insurance Issue|2
6014099|NCT00824993|20790710|P2|Overall Study|Non-Compliant|1
6014100|NCT00824993|20790711|P1|Overall Study|Non-Compliant|2
6014101|NCT00824993|20790710|P2|Overall Study|Rapid Bone Loss|1
6014102|NCT00824993|20790711|P1|Overall Study|Rapid Bone Loss|0
6014103|NCT00824993|20790710|P2|Overall Study|Malignancy Relapse|10
6014104|NCT00824993|20790711|P1|Overall Study|Malignancy Relapse|9
6014105|NCT00824993|20790710|P2|Overall Study|Withdrawal by Subject|1
6014106|NCT00824993|20790711|P1|Overall Study|Withdrawal by Subject|1
6014107|NCT00824850|20790719|P2|Overall Study|Withdrawal by Subject|1
6014108|NCT00824850|20790720|P1|Overall Study|Withdrawal by Subject|0
6014109|NCT00824772|20790773|P1|Overall Study|Withdrawal by Subject|8
6014110|NCT00824720|20790793|P3|Overall Study|Protocol Violation|1
6014111|NCT00824720|20790794|P2|Overall Study|Protocol Violation|0
6014112|NCT00824720|20790795|P1|Overall Study|Protocol Violation|0
6014113|NCT00824720|20790793|P3|Overall Study|failed plug insertion|0
6014114|NCT00824720|20790794|P2|Overall Study|failed plug insertion|1
6014115|NCT00824720|20790795|P1|Overall Study|failed plug insertion|3
6014116|NCT00824655|20790811|P2|Toddler Dose (12 Months of Age)|Parent/legal guardian request|0
6014117|NCT00824655|20790812|P1|Toddler Dose (12 Months of Age)|Parent/legal guardian request|1
6014118|NCT00824655|20790811|P2|Toddler Dose (12 Months of Age)|Adverse Event|0
6014119|NCT00824655|20790812|P1|Toddler Dose (12 Months of Age)|Adverse Event|1
6014120|NCT00824616|20790832|P2|Overall Study|Withdrawal by Subject|1
6014121|NCT00824616|20790833|P1|Overall Study|Withdrawal by Subject|1
6014122|NCT00824616|20790832|P2|Overall Study|Lost to Follow-up|1
6014123|NCT00824616|20790833|P1|Overall Study|Lost to Follow-up|0
6014124|NCT00824616|20790832|P2|Overall Study|Lack of Efficacy|1
6014125|NCT00824616|20790833|P1|Overall Study|Lack of Efficacy|2
6014126|NCT00824616|20790832|P2|Overall Study|Hyperglycemia|1
6014127|NCT00824616|20790833|P1|Overall Study|Hyperglycemia|1
6014128|NCT00824616|20790832|P2|Overall Study|Creatinine/Creatinine Clearance|2
6014129|NCT00824616|20790833|P1|Overall Study|Creatinine/Creatinine Clearance|0
6014130|NCT00824616|20790832|P2|Overall Study|Adverse Event|1
6014131|NCT00824616|20790833|P1|Overall Study|Adverse Event|2
6014132|NCT00824564|20790843|P2|Overall Study|Randomized, but not treated|0
6014133|NCT00824564|20790844|P1|Overall Study|Randomized, but not treated|1
6014134|NCT00824564|20790843|P2|Overall Study|Other|2
6014135|NCT00824564|20790844|P1|Overall Study|Other|1
6014136|NCT00824564|20790843|P2|Overall Study|Withdrawal by Subject|1
6014137|NCT00824564|20790844|P1|Overall Study|Withdrawal by Subject|1
6014138|NCT00824564|20790843|P2|Overall Study|Lost to Follow-up|7
6014139|NCT00824564|20790844|P1|Overall Study|Lost to Follow-up|5
6014140|NCT00824473|20790923|P2|Overall Study|Other|1
6014141|NCT00824473|20790924|P1|Overall Study|Other|1
6014142|NCT00824473|20790923|P2|Overall Study|Withdrawal by Subject|3
6014143|NCT00824473|20790924|P1|Overall Study|Withdrawal by Subject|2
6014144|NCT00824473|20790923|P2|Overall Study|Non-Compliance|2
6014145|NCT00824473|20790924|P1|Overall Study|Non-Compliance|4
6014146|NCT00824473|20790923|P2|Overall Study|Protocol Violation|0
6014147|NCT00824473|20790924|P1|Overall Study|Protocol Violation|2
6014148|NCT00824473|20790923|P2|Overall Study|Lack of Efficacy|2
6014149|NCT00824473|20790924|P1|Overall Study|Lack of Efficacy|2
6014150|NCT00824473|20790923|P2|Overall Study|Adverse Event|5
6014151|NCT00824473|20790924|P1|Overall Study|Adverse Event|4
6014152|NCT00824421|20791005|P3|Overall Study|Other|0
6014153|NCT00824421|20791006|P2|Overall Study|Other|1
6014154|NCT00824421|20791007|P1|Overall Study|Other|0
6014155|NCT00824421|20791005|P3|Overall Study|Randomized but not Treated|0
6014156|NCT00824421|20791006|P2|Overall Study|Randomized but not Treated|1
6014157|NCT00824421|20791007|P1|Overall Study|Randomized but not Treated|1
6014158|NCT00824421|20791005|P3|Overall Study|Withdrawal by Subject|3
6014159|NCT00824421|20791006|P2|Overall Study|Withdrawal by Subject|3
6014160|NCT00824421|20791007|P1|Overall Study|Withdrawal by Subject|2
6014161|NCT00824421|20791005|P3|Overall Study|Pregnancy|1
6014162|NCT00824421|20791006|P2|Overall Study|Pregnancy|0
6014163|NCT00824421|20791007|P1|Overall Study|Pregnancy|1
6014164|NCT00824421|20791005|P3|Overall Study|Lost to Follow-up|0
6014165|NCT00824421|20791006|P2|Overall Study|Lost to Follow-up|3
6014166|NCT00824421|20791007|P1|Overall Study|Lost to Follow-up|2
6014167|NCT00824421|20791005|P3|Overall Study|Lack of Efficacy|4
6014168|NCT00824421|20791006|P2|Overall Study|Lack of Efficacy|7
6014169|NCT00824421|20791007|P1|Overall Study|Lack of Efficacy|5
6014170|NCT00824421|20791005|P3|Overall Study|Death|0
6014171|NCT00824421|20791006|P2|Overall Study|Death|1
6014172|NCT00824421|20791007|P1|Overall Study|Death|0
6014173|NCT00824421|20791005|P3|Overall Study|Adverse Event|6
6014174|NCT00824421|20791006|P2|Overall Study|Adverse Event|6
6014175|NCT00824421|20791007|P1|Overall Study|Adverse Event|6
6014176|NCT00824408|20791058|P5|Randomized Phase|Other reason not defined above|4
6014177|NCT00824408|20791059|P4|Randomized Phase|Other reason not defined above|2
6014178|NCT00824408|20791060|P3|Randomized Phase|Other reason not defined above|4
6014179|NCT00824408|20791061|P2|Randomized Phase|Other reason not defined above|0
6014180|NCT00824408|20791062|P1|Randomized Phase|Other reason not defined above|0
6014181|NCT00824408|20791058|P5|Randomized Phase|Refused to continue medication|2
6014182|NCT00824408|20791059|P4|Randomized Phase|Refused to continue medication|2
6014183|NCT00824408|20791060|P3|Randomized Phase|Refused to continue medication|2
6014184|NCT00824408|20791061|P2|Randomized Phase|Refused to continue medication|0
6014185|NCT00824408|20791062|P1|Randomized Phase|Refused to continue medication|0
6014186|NCT00824408|20791058|P5|Randomized Phase|Adverse Event|5
6014187|NCT00824408|20791059|P4|Randomized Phase|Adverse Event|5
6014188|NCT00824408|20791060|P3|Randomized Phase|Adverse Event|4
6014189|NCT00824408|20791061|P2|Randomized Phase|Adverse Event|0
6014190|NCT00824408|20791062|P1|Randomized Phase|Adverse Event|0
6014191|NCT00824408|20791058|P5|Randomized Phase|Progressive disease|34
6014192|NCT00824408|20791059|P4|Randomized Phase|Progressive disease|36
6014193|NCT00824408|20791060|P3|Randomized Phase|Progressive disease|25
6014194|NCT00824408|20791061|P2|Randomized Phase|Progressive disease|0
6014195|NCT00824408|20791062|P1|Randomized Phase|Progressive disease|0
6014196|NCT00824408|20791058|P5|Randomized Phase|Not treated|1
6014197|NCT00824408|20791059|P4|Randomized Phase|Not treated|1
6014198|NCT00824408|20791060|P3|Randomized Phase|Not treated|1
6014199|NCT00824408|20791061|P2|Randomized Phase|Not treated|0
6014200|NCT00824408|20791062|P1|Randomized Phase|Not treated|0
6014201|NCT00824408|20791058|P5|Run-in Phase|Other reason not defined above|0
6014202|NCT00824408|20791059|P4|Run-in Phase|Other reason not defined above|0
6014203|NCT00824408|20791060|P3|Run-in Phase|Other reason not defined above|0
6014204|NCT00824408|20791061|P2|Run-in Phase|Other reason not defined above|1
6014205|NCT00824408|20791062|P1|Run-in Phase|Other reason not defined above|0
6014206|NCT00824408|20791058|P5|Run-in Phase|Refused to continue medication|0
6014207|NCT00824408|20791059|P4|Run-in Phase|Refused to continue medication|0
6014208|NCT00824408|20791060|P3|Run-in Phase|Refused to continue medication|0
6014209|NCT00824408|20791061|P2|Run-in Phase|Refused to continue medication|0
6014210|NCT00824408|20791062|P1|Run-in Phase|Refused to continue medication|1
6014211|NCT00824408|20791058|P5|Run-in Phase|Adverse Event|0
6014212|NCT00824408|20791059|P4|Run-in Phase|Adverse Event|0
6014213|NCT00824408|20791060|P3|Run-in Phase|Adverse Event|0
6014214|NCT00824408|20791061|P2|Run-in Phase|Adverse Event|1
6014215|NCT00824408|20791062|P1|Run-in Phase|Adverse Event|1
6014216|NCT00824408|20791058|P5|Run-in Phase|Progressive disease|0
6014217|NCT00824408|20791059|P4|Run-in Phase|Progressive disease|0
6014218|NCT00824408|20791060|P3|Run-in Phase|Progressive disease|0
6014219|NCT00824408|20791061|P2|Run-in Phase|Progressive disease|4
6014220|NCT00824408|20791062|P1|Run-in Phase|Progressive disease|4
6014221|NCT00824382|20791114|P4|Overall Study|Investigator's decision|0
6014222|NCT00824382|20791115|P3|Overall Study|Investigator's decision|2
6014223|NCT00824382|20791116|P2|Overall Study|Investigator's decision|1
6014224|NCT00824382|20791117|P1|Overall Study|Investigator's decision|0
6014225|NCT00824382|20791114|P4|Overall Study|Protocol Violation|1
6014226|NCT00824382|20791115|P3|Overall Study|Protocol Violation|0
6014227|NCT00824382|20791116|P2|Overall Study|Protocol Violation|0
6014228|NCT00824382|20791117|P1|Overall Study|Protocol Violation|1
6014229|NCT00824382|20791114|P4|Overall Study|Adverse Event|4
6014230|NCT00824382|20791115|P3|Overall Study|Adverse Event|1
6014231|NCT00824382|20791116|P2|Overall Study|Adverse Event|1
6014232|NCT00824382|20791117|P1|Overall Study|Adverse Event|4
6014233|NCT00824369|20791193|P6|Overall Study|Lost to Follow-up|0
6014234|NCT00824369|20791194|P5|Overall Study|Lost to Follow-up|1
6014235|NCT00824369|20791195|P4|Overall Study|Lost to Follow-up|0
6014236|NCT00824369|20791196|P3|Overall Study|Lost to Follow-up|0
6014237|NCT00824369|20791197|P2|Overall Study|Lost to Follow-up|0
6014238|NCT00824369|20791198|P1|Overall Study|Lost to Follow-up|0
6014239|NCT00824369|20791193|P6|Overall Study|Nolonger willing to participate in study|1
6014240|NCT00824369|20791194|P5|Overall Study|Nolonger willing to participate in study|0
6014241|NCT00824369|20791195|P4|Overall Study|Nolonger willing to participate in study|2
6014242|NCT00824369|20791196|P3|Overall Study|Nolonger willing to participate in study|1
6014243|NCT00824369|20791197|P2|Overall Study|Nolonger willing to participate in study|0
6014244|NCT00824369|20791198|P1|Overall Study|Nolonger willing to participate in study|1
6014245|NCT00824291|20791238|P2|Overall Study|Participant on prohibited medication|0
6014246|NCT00824291|20791239|P1|Overall Study|Participant on prohibited medication|1
6014247|NCT00824291|20791238|P2|Overall Study|Lack of Efficacy|8
6014248|NCT00824291|20791239|P1|Overall Study|Lack of Efficacy|7
6014249|NCT00824291|20791238|P2|Overall Study|Withdrawal by Subject|8
6014250|NCT00824291|20791239|P1|Overall Study|Withdrawal by Subject|14
6014251|NCT00824291|20791238|P2|Overall Study|Protocol Violation|1
6014252|NCT00824291|20791239|P1|Overall Study|Protocol Violation|4
6014253|NCT00824291|20791238|P2|Overall Study|Non-compliance|1
6014254|NCT00824291|20791239|P1|Overall Study|Non-compliance|1
6014255|NCT00824291|20791238|P2|Overall Study|Lost to Follow-up|9
6014256|NCT00824291|20791239|P1|Overall Study|Lost to Follow-up|11
6014257|NCT00824291|20791238|P2|Overall Study|Discontinuation of Study by Sponsor|2
6014258|NCT00824291|20791239|P1|Overall Study|Discontinuation of Study by Sponsor|1
6014259|NCT00824291|20791238|P2|Overall Study|Adverse Event|6
6014260|NCT00824291|20791239|P1|Overall Study|Adverse Event|15
6014261|NCT00824265|20791261|P2|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|16
6014262|NCT00824265|20791262|P1|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|9
6014263|NCT00824265|20791261|P2|Follow-up Phase|w/drew consent, no f/u, or MD choice|31
6014264|NCT00824265|20791262|P1|Follow-up Phase|w/drew consent, no f/u, or MD choice|18
6014265|NCT00824265|20791261|P2|Treatment Phase|Withdrawal by Subject|15
6014266|NCT00824265|20791262|P1|Treatment Phase|Withdrawal by Subject|6
6014267|NCT00824265|20791261|P2|Treatment Phase|Physician Decision|12
6014268|NCT00824265|20791262|P1|Treatment Phase|Physician Decision|6
6014269|NCT00824265|20791261|P2|Treatment Phase|Lost to Follow-up|1
6014270|NCT00824265|20791262|P1|Treatment Phase|Lost to Follow-up|1
6014271|NCT00824265|20791261|P2|Treatment Phase|Protocol Violation|0
6014272|NCT00824265|20791262|P1|Treatment Phase|Protocol Violation|1
6014273|NCT00824265|20791261|P2|Treatment Phase|Adverse Event,non-fatal|52
6014274|NCT00824265|20791262|P1|Treatment Phase|Adverse Event,non-fatal|50
6014275|NCT00824161|20791323|P1|Overall Study|Screen Failure|1
6014276|NCT00824161|20791323|P1|Overall Study|Withdrawal by Subject|1
6014277|NCT00824005|20791389|P2|Overall Study|Lost to Follow-up|1
6014278|NCT00824005|20791390|P1|Overall Study|Lost to Follow-up|0
6014279|NCT00824005|20791389|P2|Overall Study|Death|1
6014280|NCT00824005|20791390|P1|Overall Study|Death|0
6014281|NCT00823979|20791425|P3|Overall Study|Study Terminated by Sponsor|7
6014282|NCT00823979|20791426|P2|Overall Study|Study Terminated by Sponsor|5
6014283|NCT00823979|20791427|P1|Overall Study|Study Terminated by Sponsor|5
6014284|NCT00823979|20791425|P3|Overall Study|Randomized but not Treated|1
6014285|NCT00823979|20791426|P2|Overall Study|Randomized but not Treated|3
6014286|NCT00823979|20791427|P1|Overall Study|Randomized but not Treated|4
6014287|NCT00823979|20791425|P3|Overall Study|Other|1
6014288|NCT00823979|20791426|P2|Overall Study|Other|0
6014289|NCT00823979|20791427|P1|Overall Study|Other|2
6014290|NCT00823979|20791425|P3|Overall Study|Adverse Event|4
6014291|NCT00823979|20791426|P2|Overall Study|Adverse Event|2
6014292|NCT00823979|20791427|P1|Overall Study|Adverse Event|0
6014293|NCT00823979|20791425|P3|Overall Study|Pregnancy|0
6014294|NCT00823979|20791426|P2|Overall Study|Pregnancy|1
6014295|NCT00823979|20791427|P1|Overall Study|Pregnancy|0
6014296|NCT00823979|20791425|P3|Overall Study|Protocol Violation|0
6014297|NCT00823979|20791426|P2|Overall Study|Protocol Violation|1
6014298|NCT00823979|20791427|P1|Overall Study|Protocol Violation|1
6014299|NCT00823979|20791425|P3|Overall Study|Withdrawal by Subject|2
6014300|NCT00823979|20791426|P2|Overall Study|Withdrawal by Subject|3
6014301|NCT00823979|20791427|P1|Overall Study|Withdrawal by Subject|2
6014302|NCT00823979|20791425|P3|Overall Study|Lost to Follow-up|0
6014303|NCT00823979|20791426|P2|Overall Study|Lost to Follow-up|1
6014304|NCT00823979|20791427|P1|Overall Study|Lost to Follow-up|2
6014305|NCT00823979|20791425|P3|Overall Study|Lack of Efficacy|9
6014306|NCT00823979|20791426|P2|Overall Study|Lack of Efficacy|16
6014307|NCT00823979|20791427|P1|Overall Study|Lack of Efficacy|13
6014308|NCT00823901|20791472|P2|Overall Study|Lost to Follow-up|1
6014309|NCT00823901|20791473|P1|Overall Study|Lost to Follow-up|2
6014310|NCT00823901|20791472|P2|Overall Study|Lack of Efficacy|0
6014311|NCT00823901|20791473|P1|Overall Study|Lack of Efficacy|1
6014312|NCT00823901|20791472|P2|Overall Study|Adverse Event|1
6014313|NCT00823901|20791473|P1|Overall Study|Adverse Event|1
6014314|NCT00823836|20791481|P2|Long-term Phase|Withdrawal by Subject|1
6014315|NCT00823836|20791482|P1|Long-term Phase|Withdrawal by Subject|1
6014316|NCT00823836|20791481|P2|Long-term Phase|Physician Decision|2
6014317|NCT00823836|20791482|P1|Long-term Phase|Physician Decision|1
6014318|NCT00823836|20791481|P2|Long-term Phase|Adverse Event|2
6014319|NCT00823836|20791482|P1|Long-term Phase|Adverse Event|3
6014320|NCT00823836|20791481|P2|NV and PR/XR Switching Phases|Withdrawal by Subject|5
6014321|NCT00823836|20791482|P1|NV and PR/XR Switching Phases|Withdrawal by Subject|4
6014322|NCT00823836|20791481|P2|NV and PR/XR Switching Phases|Physician Decision|2
6014323|NCT00823836|20791482|P1|NV and PR/XR Switching Phases|Physician Decision|5
6014324|NCT00823836|20791481|P2|NV and PR/XR Switching Phases|Protocol Violation|1
6014325|NCT00823836|20791482|P1|NV and PR/XR Switching Phases|Protocol Violation|1
6014326|NCT00823836|20791481|P2|NV and PR/XR Switching Phases|Adverse Event|21
6014327|NCT00823836|20791482|P1|NV and PR/XR Switching Phases|Adverse Event|22
6014328|NCT00823823|20791588|P2|Overall Study|Protocol Violation|5
6014329|NCT00823823|20791589|P1|Overall Study|Protocol Violation|5
6014330|NCT00823823|20791588|P2|Overall Study|Lost to Follow-up|1
6014331|NCT00823823|20791589|P1|Overall Study|Lost to Follow-up|3
6014332|NCT00823719|20791613|P2|Overall Study|Disease Progression|4
6014333|NCT00823719|20791614|P1|Overall Study|Disease Progression|4
6014334|NCT00823719|20791613|P2|Overall Study|Withdrawal by Subject|1
6014335|NCT00823719|20791614|P1|Overall Study|Withdrawal by Subject|0
6014336|NCT00823719|20791613|P2|Overall Study|Physician Decision|4
6014337|NCT00823719|20791614|P1|Overall Study|Physician Decision|1
6014338|NCT00823719|20791613|P2|Overall Study|Adverse Event|2
6014339|NCT00823719|20791614|P1|Overall Study|Adverse Event|1
6014340|NCT00823615|20791667|P2|Period 2|Time/Job Conflict|2
6014341|NCT00823615|20791668|P1|Period 2|Time/Job Conflict|1
6014342|NCT00823615|20791667|P2|Period 2|Lost to Follow-up|0
6014343|NCT00823615|20791668|P1|Period 2|Lost to Follow-up|2
6014344|NCT00823472|20791678|P2|Overall Study|Physician Decision|28
6014345|NCT00823472|20791679|P1|Overall Study|Physician Decision|24
6014346|NCT00823264|20791706|P2|Overall Study|Protocol Violation|0
6014347|NCT00823264|20791707|P1|Overall Study|Protocol Violation|2
6014348|NCT00823212|20791715|P2|Overall Study|Missed 12-month visit|21
6014349|NCT00823212|20791716|P1|Overall Study|Missed 12-month visit|21
6014350|NCT00823212|20791715|P2|Overall Study|Incarcerated|1
6014351|NCT00823212|20791716|P1|Overall Study|Incarcerated|0
6014352|NCT00823212|20791715|P2|Overall Study|Withdrawal by Subject|1
6014353|NCT00823212|20791716|P1|Overall Study|Withdrawal by Subject|6
6014354|NCT00823212|20791715|P2|Overall Study|Death|10
6014355|NCT00823212|20791716|P1|Overall Study|Death|8
6014356|NCT00823199|20791798|P1|Overall Study|Withdrawal by Subject|2
6014357|NCT00823134|20791804|P1|Overall Study|Invalid measurement|1
6014358|NCT00822926|20791877|P2|Second Injection Visit|Withdrawal by Subject|1
6014359|NCT00822926|20791878|P1|Second Injection Visit|Withdrawal by Subject|0
6014360|NCT00822926|20791877|P2|Second Injection Visit|Lost to Follow-up|0
6014361|NCT00822926|20791878|P1|Second Injection Visit|Lost to Follow-up|1
6014362|NCT00822900|20791892|P2|Overall Study|Became a ward of the state|1
6014363|NCT00822900|20791893|P1|Overall Study|Became a ward of the state|2
6014364|NCT00822900|20791892|P2|Overall Study|Death|69
6014365|NCT00822900|20791893|P1|Overall Study|Death|83
6014366|NCT00822900|20791892|P2|Overall Study|Lost to Follow-up|9
6014367|NCT00822900|20791893|P1|Overall Study|Lost to Follow-up|9
6014368|NCT00822900|20791892|P2|Overall Study|Withdrawal by Subject|14
6014369|NCT00822900|20791893|P1|Overall Study|Withdrawal by Subject|14
6014370|NCT00822770|20791923|P2|Overall Study|Death|1
6014371|NCT00822770|20791924|P1|Overall Study|Death|1
6014372|NCT00822770|20791923|P2|Overall Study|Complication/Incomplete treatment|0
6014373|NCT00822770|20791924|P1|Overall Study|Complication/Incomplete treatment|1
6014374|NCT00822770|20791923|P2|Overall Study|Not treated|0
6014375|NCT00822770|20791924|P1|Overall Study|Not treated|1
6014376|NCT00822692|20791946|P2|Overall Study|Lost to Follow-up|25
6014377|NCT00822692|20791947|P1|Overall Study|Lost to Follow-up|17
6014378|NCT00822237|20792085|P2|Dose 2 Vaccination|Lost to Follow-up|9
6014379|NCT00822237|20792086|P1|Dose 2 Vaccination|Lost to Follow-up|2
6014380|NCT00822237|20792085|P2|Dose 2 Vaccination|Withdrawal by Subject|2
6014381|NCT00822237|20792086|P1|Dose 2 Vaccination|Withdrawal by Subject|2
6014382|NCT00822237|20792085|P2|Dose 1 Vaccination|Lost to Follow-up|12
6014383|NCT00822237|20792086|P1|Dose 1 Vaccination|Lost to Follow-up|9
6014384|NCT00822237|20792085|P2|Dose 1 Vaccination|Withdrawal by Subject|14
6014385|NCT00822237|20792086|P1|Dose 1 Vaccination|Withdrawal by Subject|13
6014386|NCT00822237|20792085|P2|Dose 1 Vaccination|Not vaccinated|0
6014387|NCT00822237|20792086|P1|Dose 1 Vaccination|Not vaccinated|3
6014388|NCT00822172|20792167|P2|Overall Study|Other|1
6014389|NCT00822172|20792168|P1|Overall Study|Other|0
6014390|NCT00822172|20792167|P2|Overall Study|site closed|1
6014391|NCT00822172|20792168|P1|Overall Study|site closed|0
6014392|NCT00822172|20792167|P2|Overall Study|Withdrawal by Subject|4
6014393|NCT00822172|20792168|P1|Overall Study|Withdrawal by Subject|1
6014394|NCT00822172|20792167|P2|Overall Study|Lost to Follow-up|1
6014395|NCT00822172|20792168|P1|Overall Study|Lost to Follow-up|3
6014396|NCT00822172|20792167|P2|Overall Study|Death|0
6014397|NCT00822172|20792168|P1|Overall Study|Death|1
6014398|NCT00822172|20792167|P2|Overall Study|Adverse Event|12
6014399|NCT00822172|20792168|P1|Overall Study|Adverse Event|10
6014448|NCT00821873|20792259|P1|Overall Study|Lost to Follow-up|4
6014449|NCT00821678|20792289|P2|Overall Study|Death|2
6014450|NCT00821678|20792290|P1|Overall Study|Death|0
6014451|NCT00821678|20792289|P2|Overall Study|Lost to Follow-up|12
6014452|NCT00821678|20792290|P1|Overall Study|Lost to Follow-up|13
6014453|NCT00821678|20792289|P2|Overall Study|Withdrawal by Subject|0
6014454|NCT00821678|20792290|P1|Overall Study|Withdrawal by Subject|8
6014455|NCT00821587|20792325|P2|Overall Study|Physician Decision|1
6014456|NCT00821587|20792326|P1|Overall Study|Physician Decision|0
6014457|NCT00821509|20792335|P3|Overall Study|Withdrawal by Subject|34
6014458|NCT00821509|20792336|P2|Overall Study|Withdrawal by Subject|11
6014459|NCT00821509|20792337|P1|Overall Study|Withdrawal by Subject|12
6014460|NCT00821431|20792350|P2|Overall Study|Physician Decision|1
6014461|NCT00821431|20792351|P1|Overall Study|Physician Decision|0
6014462|NCT00821431|20792350|P2|Overall Study|Protocol Violation|1
6014463|NCT00821431|20792351|P1|Overall Study|Protocol Violation|3
6014464|NCT00821431|20792350|P2|Overall Study|Lost to Follow-up|0
6014465|NCT00821431|20792351|P1|Overall Study|Lost to Follow-up|1
6014466|NCT00821431|20792350|P2|Overall Study|Withdrawal by Subject|0
6014467|NCT00821431|20792351|P1|Overall Study|Withdrawal by Subject|5
6014468|NCT00821431|20792350|P2|Overall Study|Adverse Event|3
6014469|NCT00821431|20792351|P1|Overall Study|Adverse Event|6
6014470|NCT00821327|20792359|P1|Overall Study|Other/Unknown|5
6014471|NCT00821327|20792359|P1|Overall Study|Disease Progression|13
6014472|NCT00821327|20792359|P1|Overall Study|Sponsor Request|1
6014473|NCT00821327|20792359|P1|Overall Study|Investigator Request|2
6014474|NCT00821327|20792359|P1|Overall Study|Patient Request|1
6014475|NCT00821327|20792359|P1|Overall Study|Adverse Event|13
6014476|NCT00821236|20792368|P1|Overall Study|Lost to Follow-up|3
6014477|NCT00821093|20792408|P2|Overall Study|Administrative problems|2
6014478|NCT00821093|20792409|P1|Overall Study|Administrative problems|1
6014479|NCT00821093|20792408|P2|Overall Study|Abnormal test procedure result(s)|1
6014480|NCT00821093|20792409|P1|Overall Study|Abnormal test procedure result(s)|1
6014481|NCT00821093|20792408|P2|Overall Study|Death|1
6014482|NCT00821093|20792409|P1|Overall Study|Death|2
6014483|NCT00821093|20792408|P2|Overall Study|Lack of Efficacy|2
6014484|NCT00821093|20792409|P1|Overall Study|Lack of Efficacy|2
6014485|NCT00821093|20792408|P2|Overall Study|Abnormal laboratory value(s)|0
6014486|NCT00821093|20792409|P1|Overall Study|Abnormal laboratory value(s)|2
6014487|NCT00821093|20792408|P2|Overall Study|Protocol deviation|6
6014488|NCT00821093|20792409|P1|Overall Study|Protocol deviation|3
6014489|NCT00821093|20792408|P2|Overall Study|Lost to Follow-up|3
6014490|NCT00821093|20792409|P1|Overall Study|Lost to Follow-up|9
6014491|NCT00821093|20792408|P2|Overall Study|Withdrawal by Subject|13
6014492|NCT00821093|20792409|P1|Overall Study|Withdrawal by Subject|9
6014493|NCT00821093|20792408|P2|Overall Study|Adverse Event|12
6014494|NCT00821093|20792409|P1|Overall Study|Adverse Event|20
6014495|NCT00821015|20792428|P1|Overall Study|Lost to Follow-up|12
6014496|NCT00820898|20792439|P1|Overall Study|Inelgible - wrong primary site|1
6014497|NCT00820755|20792453|P3|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45
6014498|NCT00820755|20792454|P2|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45
6014499|NCT00820755|20792455|P1|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|0
6014500|NCT00820755|20792453|P3|Period 1: Combination Therapy Phase|Other|0
6014501|NCT00820755|20792454|P2|Period 1: Combination Therapy Phase|Other|0
6014502|NCT00820755|20792455|P1|Period 1: Combination Therapy Phase|Other|11
6014503|NCT00820755|20792453|P3|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0
6014504|NCT00820755|20792454|P2|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0
6014505|NCT00820755|20792455|P1|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|14
6014506|NCT00820755|20792453|P3|Period 1: Combination Therapy Phase|Progressive disease|0
6014507|NCT00820755|20792454|P2|Period 1: Combination Therapy Phase|Progressive disease|0
6014508|NCT00820755|20792455|P1|Period 1: Combination Therapy Phase|Progressive disease|114
6014509|NCT00820755|20792453|P3|Period 1: Combination Therapy Phase|Withdrawal by Subject|0
6014510|NCT00820755|20792454|P2|Period 1: Combination Therapy Phase|Withdrawal by Subject|0
6014511|NCT00820755|20792455|P1|Period 1: Combination Therapy Phase|Withdrawal by Subject|21
6014512|NCT00820755|20792453|P3|Period 1: Combination Therapy Phase|Lost to Follow-up|0
6014513|NCT00820755|20792454|P2|Period 1: Combination Therapy Phase|Lost to Follow-up|0
6014514|NCT00820755|20792455|P1|Period 1: Combination Therapy Phase|Lost to Follow-up|1
6014515|NCT00820755|20792453|P3|Period 1: Combination Therapy Phase|Protocol Violation|0
6014516|NCT00820755|20792454|P2|Period 1: Combination Therapy Phase|Protocol Violation|0
6014517|NCT00820755|20792455|P1|Period 1: Combination Therapy Phase|Protocol Violation|4
6014518|NCT00820755|20792453|P3|Period 1: Combination Therapy Phase|Death|0
6014519|NCT00820755|20792454|P2|Period 1: Combination Therapy Phase|Death|0
6014520|NCT00820755|20792455|P1|Period 1: Combination Therapy Phase|Death|28
6014521|NCT00820755|20792453|P3|Period 1: Combination Therapy Phase|Adverse Event|0
6014522|NCT00820755|20792454|P2|Period 1: Combination Therapy Phase|Adverse Event|0
6014523|NCT00820755|20792455|P1|Period 1: Combination Therapy Phase|Adverse Event|77
6014524|NCT00820599|20792498|P1|Overall Study|Withdrawal by Subject|2
6014525|NCT00820599|20792498|P1|Overall Study|Death|129
6014526|NCT00820248|20792553|P2|Overall Study|No treated|1
6014527|NCT00820248|20792554|P1|Overall Study|No treated|4
6014528|NCT00820222|20792586|P2|Overall Study|Unkown|7
6014529|NCT00820222|20792587|P1|Overall Study|Unkown|11
6014530|NCT00820222|20792586|P2|Overall Study|Sponsor Terminated Study|65
6014531|NCT00820222|20792587|P1|Overall Study|Sponsor Terminated Study|43
6014532|NCT00820222|20792586|P2|Overall Study|Physician Decision|88
6014533|NCT00820222|20792587|P1|Overall Study|Physician Decision|93
6014534|NCT00820222|20792586|P2|Overall Study|Withdrawal by Subject|21
6014535|NCT00820222|20792587|P1|Overall Study|Withdrawal by Subject|19
6014536|NCT00820222|20792586|P2|Overall Study|Lost to Follow-up|9
6014537|NCT00820222|20792587|P1|Overall Study|Lost to Follow-up|10
6014538|NCT00820170|20792618|P5|Overall Study|Progressive Disease|2
6014539|NCT00820170|20792619|P4|Overall Study|Progressive Disease|0
6014540|NCT00820170|20792620|P3|Overall Study|Progressive Disease|0
6014541|NCT00820170|20792621|P2|Overall Study|Progressive Disease|0
6014542|NCT00820170|20792622|P1|Overall Study|Progressive Disease|0
6014543|NCT00820170|20792618|P5|Overall Study|Adverse Event|2
6014544|NCT00820170|20792619|P4|Overall Study|Adverse Event|0
6014545|NCT00820170|20792620|P3|Overall Study|Adverse Event|0
6014546|NCT00820170|20792621|P2|Overall Study|Adverse Event|0
6014547|NCT00820170|20792622|P1|Overall Study|Adverse Event|0
6014548|NCT00820040|20792670|P1|Overall Study|Screen failure|1
6014549|NCT00820040|20792670|P1|Overall Study|Sponsor terminated study|1
6014550|NCT00820040|20792670|P1|Overall Study|Death|1
6014551|NCT00820027|20792682|P4|Overall Study|Withdrawal by Subject|6
6014552|NCT00820027|20792683|P3|Overall Study|Withdrawal by Subject|4
6014553|NCT00820027|20792684|P2|Overall Study|Withdrawal by Subject|4
6014554|NCT00820027|20792685|P1|Overall Study|Withdrawal by Subject|6
6014555|NCT00820027|20792682|P4|Overall Study|Protocol Violation|0
6014556|NCT00820027|20792683|P3|Overall Study|Protocol Violation|4
6014557|NCT00820027|20792684|P2|Overall Study|Protocol Violation|0
6014558|NCT00820027|20792685|P1|Overall Study|Protocol Violation|3
6014559|NCT00820027|20792682|P4|Overall Study|Physician Decision|0
6014560|NCT00820027|20792683|P3|Overall Study|Physician Decision|1
6014561|NCT00820027|20792684|P2|Overall Study|Physician Decision|1
6014562|NCT00820027|20792685|P1|Overall Study|Physician Decision|0
6014563|NCT00820027|20792682|P4|Overall Study|Lack of Efficacy|2
6014564|NCT00820027|20792683|P3|Overall Study|Lack of Efficacy|2
6014565|NCT00820027|20792684|P2|Overall Study|Lack of Efficacy|1
6014566|NCT00820027|20792685|P1|Overall Study|Lack of Efficacy|2
6014567|NCT00820027|20792682|P4|Overall Study|Adverse Event|5
6014568|NCT00820027|20792683|P3|Overall Study|Adverse Event|10
6014569|NCT00820027|20792684|P2|Overall Study|Adverse Event|8
6014570|NCT00820027|20792685|P1|Overall Study|Adverse Event|15
6014571|NCT00819910|20792727|P4|Overall Study|Lost to Follow-up|0
6014572|NCT00819910|20792728|P3|Overall Study|Lost to Follow-up|0
6014573|NCT00819910|20792729|P2|Overall Study|Lost to Follow-up|0
6014574|NCT00819910|20792730|P1|Overall Study|Lost to Follow-up|1
6014575|NCT00819910|20792727|P4|Overall Study|Withdrawal by Subject|0
6014576|NCT00819910|20792728|P3|Overall Study|Withdrawal by Subject|1
6014577|NCT00819910|20792729|P2|Overall Study|Withdrawal by Subject|1
6014578|NCT00819910|20792730|P1|Overall Study|Withdrawal by Subject|1
6014579|NCT00819910|20792727|P4|Overall Study|Adverse Event|1
6014580|NCT00819910|20792728|P3|Overall Study|Adverse Event|2
6014581|NCT00819910|20792729|P2|Overall Study|Adverse Event|0
6014582|NCT00819910|20792730|P1|Overall Study|Adverse Event|0
6014583|NCT00819832|20792762|P6|Overall Study|Sponsor Termination of Study|0
6014584|NCT00819832|20792763|P5|Overall Study|Sponsor Termination of Study|0
6014585|NCT00819832|20792764|P4|Overall Study|Sponsor Termination of Study|0
6014586|NCT00819832|20792765|P3|Overall Study|Sponsor Termination of Study|0
6014587|NCT00819832|20792766|P2|Overall Study|Sponsor Termination of Study|0
6014588|NCT00819832|20792767|P1|Overall Study|Sponsor Termination of Study|3
6014589|NCT00819780|20792788|P2|Overall Study|Still in treatment|17
6014590|NCT00819780|20792789|P1|Overall Study|Still in treatment|25
6014591|NCT00819780|20792788|P2|Overall Study|Did not receive study drug|4
6014592|NCT00819780|20792789|P1|Overall Study|Did not receive study drug|3
6014593|NCT00819767|20792823|P2|Overall Study|Unsatisfactory therapeutic effect|2
6014594|NCT00819767|20792824|P1|Overall Study|Unsatisfactory therapeutic effect|1
6014595|NCT00819741|20792836|P2|Overall Study|Reasons unknown|3
6014596|NCT00819741|20792837|P1|Overall Study|Reasons unknown|3
6014597|NCT00819741|20792836|P2|Overall Study|Unclassified|0
6014598|NCT00819741|20792837|P1|Overall Study|Unclassified|6
6014599|NCT00819741|20792836|P2|Overall Study|Withdrawal by Subject|2
6014600|NCT00819741|20792837|P1|Overall Study|Withdrawal by Subject|2
6014601|NCT00819741|20792836|P2|Overall Study|Protocol Violation|4
6014602|NCT00819741|20792837|P1|Overall Study|Protocol Violation|3
6014603|NCT00819741|20792836|P2|Overall Study|Lost to Follow-up|1
6014604|NCT00819741|20792837|P1|Overall Study|Lost to Follow-up|3
6014605|NCT00819741|20792836|P2|Overall Study|Lack of Efficacy|2
6014606|NCT00819741|20792837|P1|Overall Study|Lack of Efficacy|0
6014607|NCT00819741|20792836|P2|Overall Study|Adverse Event|2
6014608|NCT00819741|20792837|P1|Overall Study|Adverse Event|5
6014609|NCT00819585|20792891|P11|Extension Study|Death|0
6014610|NCT00819585|20792892|P10|Extension Study|Death|0
6014611|NCT00819585|20792893|P9|Extension Study|Death|2
6014612|NCT00819585|20792894|P8|Extension Study|Death|0
6014613|NCT00819585|20792895|P7|Extension Study|Death|0
6014614|NCT00819585|20792896|P6|Extension Study|Death|0
6014615|NCT00819585|20792897|P5|Extension Study|Death|0
6014616|NCT00819585|20792898|P4|Extension Study|Death|0
6014617|NCT00819585|20792899|P3|Extension Study|Death|0
6014618|NCT00819585|20792900|P2|Extension Study|Death|0
6014619|NCT00819585|20792901|P1|Extension Study|Death|0
6014620|NCT00819585|20792891|P11|Extension Study|Lost to Follow-up|1
6014621|NCT00819585|20792892|P10|Extension Study|Lost to Follow-up|1
6014622|NCT00819585|20792893|P9|Extension Study|Lost to Follow-up|2
6014623|NCT00819585|20792894|P8|Extension Study|Lost to Follow-up|0
6014624|NCT00819585|20792895|P7|Extension Study|Lost to Follow-up|0
6014625|NCT00819585|20792896|P6|Extension Study|Lost to Follow-up|0
6014626|NCT00819585|20792897|P5|Extension Study|Lost to Follow-up|0
6014627|NCT00819585|20792898|P4|Extension Study|Lost to Follow-up|0
6014628|NCT00819585|20792899|P3|Extension Study|Lost to Follow-up|0
6014629|NCT00819585|20792900|P2|Extension Study|Lost to Follow-up|0
6014630|NCT00819585|20792901|P1|Extension Study|Lost to Follow-up|0
6014631|NCT00819585|20792891|P11|Extension Study|Subject Withdrew Consent|1
6014632|NCT00819585|20792892|P10|Extension Study|Subject Withdrew Consent|0
6014633|NCT00819585|20792893|P9|Extension Study|Subject Withdrew Consent|3
6014634|NCT00819585|20792894|P8|Extension Study|Subject Withdrew Consent|0
6014635|NCT00819585|20792895|P7|Extension Study|Subject Withdrew Consent|0
6014636|NCT00819585|20792896|P6|Extension Study|Subject Withdrew Consent|0
6014637|NCT00819585|20792897|P5|Extension Study|Subject Withdrew Consent|0
6014638|NCT00819585|20792898|P4|Extension Study|Subject Withdrew Consent|0
6014639|NCT00819585|20792899|P3|Extension Study|Subject Withdrew Consent|0
6014640|NCT00819585|20792900|P2|Extension Study|Subject Withdrew Consent|0
6014641|NCT00819585|20792901|P1|Extension Study|Subject Withdrew Consent|0
6014642|NCT00819585|20792891|P11|Extension Study|Abnormal Laboratory Value(s)|0
6014643|NCT00819585|20792892|P10|Extension Study|Abnormal Laboratory Value(s)|0
6014644|NCT00819585|20792893|P9|Extension Study|Abnormal Laboratory Value(s)|1
6014645|NCT00819585|20792894|P8|Extension Study|Abnormal Laboratory Value(s)|0
6014646|NCT00819585|20792895|P7|Extension Study|Abnormal Laboratory Value(s)|0
6014647|NCT00819585|20792896|P6|Extension Study|Abnormal Laboratory Value(s)|0
6014648|NCT00819585|20792897|P5|Extension Study|Abnormal Laboratory Value(s)|0
6014649|NCT00819585|20792898|P4|Extension Study|Abnormal Laboratory Value(s)|0
6014650|NCT00819585|20792899|P3|Extension Study|Abnormal Laboratory Value(s)|0
6014651|NCT00819585|20792900|P2|Extension Study|Abnormal Laboratory Value(s)|0
6014652|NCT00819585|20792901|P1|Extension Study|Abnormal Laboratory Value(s)|0
6014653|NCT00819585|20792891|P11|Core Study|Protocol Violation|0
6014654|NCT00819585|20792892|P10|Core Study|Protocol Violation|0
6014655|NCT00819585|20792893|P9|Core Study|Protocol Violation|0
6014656|NCT00819585|20792894|P8|Core Study|Protocol Violation|0
6014657|NCT00819585|20792895|P7|Core Study|Protocol Violation|3
6014658|NCT00819585|20792896|P6|Core Study|Protocol Violation|1
6014659|NCT00819585|20792897|P5|Core Study|Protocol Violation|0
6014660|NCT00819585|20792898|P4|Core Study|Protocol Violation|0
6014661|NCT00819585|20792899|P3|Core Study|Protocol Violation|1
6014662|NCT00819585|20792900|P2|Core Study|Protocol Violation|0
6014663|NCT00819585|20792901|P1|Core Study|Protocol Violation|0
6014664|NCT00819585|20792891|P11|Core Study|Death|0
6014665|NCT00819585|20792892|P10|Core Study|Death|0
6014666|NCT00819585|20792893|P9|Core Study|Death|0
6014667|NCT00819585|20792894|P8|Core Study|Death|0
6014668|NCT00819585|20792895|P7|Core Study|Death|1
6014669|NCT00819585|20792896|P6|Core Study|Death|0
6014670|NCT00819585|20792897|P5|Core Study|Death|0
6014671|NCT00819585|20792898|P4|Core Study|Death|0
6014672|NCT00819585|20792899|P3|Core Study|Death|0
6014673|NCT00819585|20792900|P2|Core Study|Death|0
6014674|NCT00819585|20792901|P1|Core Study|Death|0
6014675|NCT00819585|20792891|P11|Core Study|Administrative Problems|0
6014676|NCT00819585|20792892|P10|Core Study|Administrative Problems|0
6014677|NCT00819585|20792893|P9|Core Study|Administrative Problems|0
6014678|NCT00819585|20792894|P8|Core Study|Administrative Problems|0
6014679|NCT00819585|20792895|P7|Core Study|Administrative Problems|2
6014680|NCT00819585|20792896|P6|Core Study|Administrative Problems|0
6014681|NCT00819585|20792897|P5|Core Study|Administrative Problems|0
6014682|NCT00819585|20792898|P4|Core Study|Administrative Problems|0
6014683|NCT00819585|20792899|P3|Core Study|Administrative Problems|0
6014684|NCT00819585|20792900|P2|Core Study|Administrative Problems|0
6014685|NCT00819585|20792901|P1|Core Study|Administrative Problems|0
6014686|NCT00819585|20792891|P11|Core Study|Lost to Follow-up|0
6014687|NCT00819585|20792892|P10|Core Study|Lost to Follow-up|0
6014688|NCT00819585|20792893|P9|Core Study|Lost to Follow-up|0
6014689|NCT00819585|20792894|P8|Core Study|Lost to Follow-up|0
6014690|NCT00819585|20792895|P7|Core Study|Lost to Follow-up|1
6014691|NCT00819585|20792896|P6|Core Study|Lost to Follow-up|1
6014692|NCT00819585|20792897|P5|Core Study|Lost to Follow-up|1
6014693|NCT00819585|20792898|P4|Core Study|Lost to Follow-up|0
6014694|NCT00819585|20792899|P3|Core Study|Lost to Follow-up|2
6014695|NCT00819585|20792900|P2|Core Study|Lost to Follow-up|1
6014696|NCT00819585|20792901|P1|Core Study|Lost to Follow-up|2
6014697|NCT00819585|20792891|P11|Core Study|Subject Withdrew Consent|0
6014698|NCT00819585|20792892|P10|Core Study|Subject Withdrew Consent|0
6014699|NCT00819585|20792893|P9|Core Study|Subject Withdrew Consent|0
6014700|NCT00819585|20792894|P8|Core Study|Subject Withdrew Consent|0
6014701|NCT00819585|20792895|P7|Core Study|Subject Withdrew Consent|3
6014702|NCT00819585|20792896|P6|Core Study|Subject Withdrew Consent|0
6014703|NCT00819585|20792897|P5|Core Study|Subject Withdrew Consent|0
6014704|NCT00819585|20792898|P4|Core Study|Subject Withdrew Consent|1
6014705|NCT00819585|20792899|P3|Core Study|Subject Withdrew Consent|2
6014706|NCT00819585|20792900|P2|Core Study|Subject Withdrew Consent|3
6014707|NCT00819585|20792901|P1|Core Study|Subject Withdrew Consent|0
6014708|NCT00819585|20792891|P11|Core Study|Subject No Longer Requires Study Drug|0
6014709|NCT00819585|20792892|P10|Core Study|Subject No Longer Requires Study Drug|0
6014710|NCT00819585|20792893|P9|Core Study|Subject No Longer Requires Study Drug|0
6014711|NCT00819585|20792894|P8|Core Study|Subject No Longer Requires Study Drug|0
6014712|NCT00819585|20792895|P7|Core Study|Subject No Longer Requires Study Drug|0
6014713|NCT00819585|20792896|P6|Core Study|Subject No Longer Requires Study Drug|0
6014714|NCT00819585|20792897|P5|Core Study|Subject No Longer Requires Study Drug|1
6014715|NCT00819585|20792898|P4|Core Study|Subject No Longer Requires Study Drug|0
6014716|NCT00819585|20792899|P3|Core Study|Subject No Longer Requires Study Drug|0
6014717|NCT00819585|20792900|P2|Core Study|Subject No Longer Requires Study Drug|0
6014718|NCT00819585|20792901|P1|Core Study|Subject No Longer Requires Study Drug|0
6014719|NCT00819585|20792891|P11|Core Study|Unsatisfactory Therapeutic Effect|0
6014720|NCT00819585|20792892|P10|Core Study|Unsatisfactory Therapeutic Effect|0
6014721|NCT00819585|20792893|P9|Core Study|Unsatisfactory Therapeutic Effect|0
6014722|NCT00819585|20792894|P8|Core Study|Unsatisfactory Therapeutic Effect|0
6014723|NCT00819585|20792895|P7|Core Study|Unsatisfactory Therapeutic Effect|1
6014724|NCT00819585|20792896|P6|Core Study|Unsatisfactory Therapeutic Effect|0
6014725|NCT00819585|20792897|P5|Core Study|Unsatisfactory Therapeutic Effect|0
6014726|NCT00819585|20792898|P4|Core Study|Unsatisfactory Therapeutic Effect|0
6014727|NCT00819585|20792899|P3|Core Study|Unsatisfactory Therapeutic Effect|0
6014728|NCT00819585|20792900|P2|Core Study|Unsatisfactory Therapeutic Effect|1
6014729|NCT00819585|20792901|P1|Core Study|Unsatisfactory Therapeutic Effect|0
6014730|NCT00819585|20792891|P11|Core Study|Abnormal Laboratory Value(s)|0
6014731|NCT00819585|20792892|P10|Core Study|Abnormal Laboratory Value(s)|0
6014732|NCT00819585|20792893|P9|Core Study|Abnormal Laboratory Value(s)|0
6014733|NCT00819585|20792894|P8|Core Study|Abnormal Laboratory Value(s)|0
6014734|NCT00819585|20792895|P7|Core Study|Abnormal Laboratory Value(s)|0
6014735|NCT00819585|20792896|P6|Core Study|Abnormal Laboratory Value(s)|0
6014736|NCT00819585|20792897|P5|Core Study|Abnormal Laboratory Value(s)|0
6014737|NCT00819585|20792898|P4|Core Study|Abnormal Laboratory Value(s)|0
6014738|NCT00819585|20792899|P3|Core Study|Abnormal Laboratory Value(s)|0
6014739|NCT00819585|20792900|P2|Core Study|Abnormal Laboratory Value(s)|0
6014740|NCT00819585|20792901|P1|Core Study|Abnormal Laboratory Value(s)|2
6014741|NCT00819585|20792891|P11|Core Study|Adverse Event|0
6014742|NCT00819585|20792892|P10|Core Study|Adverse Event|0
6014743|NCT00819585|20792893|P9|Core Study|Adverse Event|0
6014744|NCT00819585|20792894|P8|Core Study|Adverse Event|0
6014745|NCT00819585|20792895|P7|Core Study|Adverse Event|2
6014746|NCT00819585|20792896|P6|Core Study|Adverse Event|0
6014747|NCT00819585|20792897|P5|Core Study|Adverse Event|1
6014748|NCT00819585|20792898|P4|Core Study|Adverse Event|4
6014749|NCT00819585|20792899|P3|Core Study|Adverse Event|1
6014750|NCT00819585|20792900|P2|Core Study|Adverse Event|1
6014751|NCT00819585|20792901|P1|Core Study|Adverse Event|2
6014752|NCT00819390|20792992|P4|Overall Study|Adverse Event|0
6014753|NCT00819390|20792993|P3|Overall Study|Adverse Event|1
6014754|NCT00819390|20792994|P2|Overall Study|Adverse Event|0
6014755|NCT00819390|20792995|P1|Overall Study|Adverse Event|0
6014756|NCT00819390|20792992|P4|Overall Study|Withdrawal by Subject|0
6014757|NCT00819390|20792993|P3|Overall Study|Withdrawal by Subject|0
6014758|NCT00819390|20792994|P2|Overall Study|Withdrawal by Subject|0
6014759|NCT00819390|20792995|P1|Overall Study|Withdrawal by Subject|2
6014760|NCT00819390|20792992|P4|Overall Study|Lost to Follow-up|0
6014761|NCT00819390|20792993|P3|Overall Study|Lost to Follow-up|0
6014762|NCT00819390|20792994|P2|Overall Study|Lost to Follow-up|1
6014763|NCT00819390|20792995|P1|Overall Study|Lost to Follow-up|1
6014764|NCT00819247|20793131|P3|Overall Study|Other|0
6014765|NCT00819247|20793132|P2|Overall Study|Other|0
6014766|NCT00819247|20793133|P1|Overall Study|Other|1
6014767|NCT00819247|20793131|P3|Overall Study|Bad prostate-specific antigen response|0
6014768|NCT00819247|20793132|P2|Overall Study|Bad prostate-specific antigen response|2
6014769|NCT00819247|20793133|P1|Overall Study|Bad prostate-specific antigen response|3
6014770|NCT00819247|20793131|P3|Overall Study|Mistakenly withdrawn|0
6014771|NCT00819247|20793132|P2|Overall Study|Mistakenly withdrawn|1
6014772|NCT00819247|20793133|P1|Overall Study|Mistakenly withdrawn|0
6014773|NCT00819247|20793131|P3|Overall Study|Protocol Violation|1
6014774|NCT00819247|20793132|P2|Overall Study|Protocol Violation|0
6014775|NCT00819247|20793133|P1|Overall Study|Protocol Violation|1
6014776|NCT00819247|20793131|P3|Overall Study|Withdrawal by Subject|0
6014777|NCT00819247|20793132|P2|Overall Study|Withdrawal by Subject|0
6014778|NCT00819247|20793133|P1|Overall Study|Withdrawal by Subject|1
6014779|NCT00819247|20793131|P3|Overall Study|Insufficient testosterone response|10
6014780|NCT00819247|20793132|P2|Overall Study|Insufficient testosterone response|8
6014781|NCT00819247|20793133|P1|Overall Study|Insufficient testosterone response|5
6014782|NCT00819247|20793131|P3|Overall Study|Adverse Event|3
6014783|NCT00819247|20793132|P2|Overall Study|Adverse Event|5
6014784|NCT00819247|20793133|P1|Overall Study|Adverse Event|0
6014785|NCT00819234|20793159|P10|Overall Study|Lost to Follow-up|2
6014786|NCT00819234|20793160|P9|Overall Study|Lost to Follow-up|1
6014787|NCT00819234|20793161|P8|Overall Study|Lost to Follow-up|1
6014788|NCT00819234|20793162|P7|Overall Study|Lost to Follow-up|1
6014789|NCT00819234|20793163|P6|Overall Study|Lost to Follow-up|1
6014790|NCT00819234|20793164|P5|Overall Study|Lost to Follow-up|1
6014791|NCT00819234|20793165|P4|Overall Study|Lost to Follow-up|2
6014792|NCT00819234|20793166|P3|Overall Study|Lost to Follow-up|0
6014793|NCT00819234|20793167|P2|Overall Study|Lost to Follow-up|2
6014794|NCT00819234|20793168|P1|Overall Study|Lost to Follow-up|2
6014795|NCT00819234|20793159|P10|Overall Study|Protocol Violation|0
6014796|NCT00819234|20793160|P9|Overall Study|Protocol Violation|0
6014797|NCT00819234|20793161|P8|Overall Study|Protocol Violation|0
6014798|NCT00819234|20793162|P7|Overall Study|Protocol Violation|0
6014799|NCT00819234|20793163|P6|Overall Study|Protocol Violation|0
6014800|NCT00819234|20793164|P5|Overall Study|Protocol Violation|0
6014801|NCT00819234|20793165|P4|Overall Study|Protocol Violation|0
6014802|NCT00819234|20793166|P3|Overall Study|Protocol Violation|1
6014803|NCT00819234|20793167|P2|Overall Study|Protocol Violation|0
6014804|NCT00819234|20793168|P1|Overall Study|Protocol Violation|0
6014805|NCT00819234|20793159|P10|Overall Study|Physician Decision|2
6014806|NCT00819234|20793160|P9|Overall Study|Physician Decision|0
6014807|NCT00819234|20793161|P8|Overall Study|Physician Decision|0
6014808|NCT00819234|20793162|P7|Overall Study|Physician Decision|0
6014809|NCT00819234|20793163|P6|Overall Study|Physician Decision|0
6014810|NCT00819234|20793164|P5|Overall Study|Physician Decision|0
6014811|NCT00819234|20793165|P4|Overall Study|Physician Decision|1
6014812|NCT00819234|20793166|P3|Overall Study|Physician Decision|0
6014813|NCT00819234|20793167|P2|Overall Study|Physician Decision|0
6014814|NCT00819234|20793168|P1|Overall Study|Physician Decision|0
6014815|NCT00819234|20793159|P10|Overall Study|Adverse Event|0
6014816|NCT00819234|20793160|P9|Overall Study|Adverse Event|0
6014817|NCT00819234|20793161|P8|Overall Study|Adverse Event|0
6014818|NCT00819234|20793162|P7|Overall Study|Adverse Event|0
6014819|NCT00819234|20793163|P6|Overall Study|Adverse Event|2
6014820|NCT00819234|20793164|P5|Overall Study|Adverse Event|0
6014821|NCT00819234|20793165|P4|Overall Study|Adverse Event|0
6014822|NCT00819234|20793166|P3|Overall Study|Adverse Event|1
6014823|NCT00819234|20793167|P2|Overall Study|Adverse Event|0
6014824|NCT00819234|20793168|P1|Overall Study|Adverse Event|0
6014825|NCT00819234|20793159|P10|Overall Study|Withdrawal by Subject|3
6014826|NCT00819234|20793160|P9|Overall Study|Withdrawal by Subject|5
6014827|NCT00819234|20793161|P8|Overall Study|Withdrawal by Subject|8
6014828|NCT00819234|20793162|P7|Overall Study|Withdrawal by Subject|4
6014829|NCT00819234|20793163|P6|Overall Study|Withdrawal by Subject|4
6014830|NCT00819234|20793164|P5|Overall Study|Withdrawal by Subject|0
6014831|NCT00819234|20793165|P4|Overall Study|Withdrawal by Subject|3
6014832|NCT00819234|20793166|P3|Overall Study|Withdrawal by Subject|6
6014833|NCT00819234|20793167|P2|Overall Study|Withdrawal by Subject|13
6014834|NCT00819234|20793168|P1|Overall Study|Withdrawal by Subject|8
6014835|NCT00819156|20793367|P6|Overall Study|Prostate-specific antigen progression|0
6014836|NCT00819156|20793368|P5|Overall Study|Prostate-specific antigen progression|1
6014837|NCT00819156|20793369|P4|Overall Study|Prostate-specific antigen progression|0
6014838|NCT00819156|20793370|P3|Overall Study|Prostate-specific antigen progression|0
6014839|NCT00819156|20793371|P2|Overall Study|Prostate-specific antigen progression|0
6014840|NCT00819156|20793372|P1|Overall Study|Prostate-specific antigen progression|0
6014841|NCT00819156|20793367|P6|Overall Study|Testosterone >=.5ng/ml 2 visits|0
6014842|NCT00819156|20793368|P5|Overall Study|Testosterone >=.5ng/ml 2 visits|1
6014843|NCT00819156|20793369|P4|Overall Study|Testosterone >=.5ng/ml 2 visits|0
6014844|NCT00819156|20793370|P3|Overall Study|Testosterone >=.5ng/ml 2 visits|0
6014845|NCT00819156|20793371|P2|Overall Study|Testosterone >=.5ng/ml 2 visits|0
6014846|NCT00819156|20793372|P1|Overall Study|Testosterone >=.5ng/ml 2 visits|3
6014847|NCT00819156|20793367|P6|Overall Study|Testosterone >1ng/ml from Day 28+|2
6014848|NCT00819156|20793368|P5|Overall Study|Testosterone >1ng/ml from Day 28+|1
6014849|NCT00819156|20793369|P4|Overall Study|Testosterone >1ng/ml from Day 28+|1
6014850|NCT00819156|20793370|P3|Overall Study|Testosterone >1ng/ml from Day 28+|1
6014851|NCT00819156|20793371|P2|Overall Study|Testosterone >1ng/ml from Day 28+|2
6014852|NCT00819156|20793372|P1|Overall Study|Testosterone >1ng/ml from Day 28+|5
6014853|NCT00819156|20793367|P6|Overall Study|Lost to Follow-up|2
6014854|NCT00819156|20793368|P5|Overall Study|Lost to Follow-up|0
6014855|NCT00819156|20793369|P4|Overall Study|Lost to Follow-up|0
6014856|NCT00819156|20793370|P3|Overall Study|Lost to Follow-up|0
6014857|NCT00819156|20793371|P2|Overall Study|Lost to Follow-up|1
6014858|NCT00819156|20793372|P1|Overall Study|Lost to Follow-up|0
6014859|NCT00819156|20793367|P6|Overall Study|Protocol Violation|1
6014860|NCT00819156|20793368|P5|Overall Study|Protocol Violation|0
6014861|NCT00819156|20793369|P4|Overall Study|Protocol Violation|0
6014862|NCT00819156|20793370|P3|Overall Study|Protocol Violation|1
6014863|NCT00819156|20793371|P2|Overall Study|Protocol Violation|0
6014864|NCT00819156|20793372|P1|Overall Study|Protocol Violation|1
6014865|NCT00819156|20793367|P6|Overall Study|Withdrawal by Subject|0
6014866|NCT00819156|20793368|P5|Overall Study|Withdrawal by Subject|1
6014867|NCT00819156|20793369|P4|Overall Study|Withdrawal by Subject|0
6014868|NCT00819156|20793370|P3|Overall Study|Withdrawal by Subject|2
6014869|NCT00819156|20793371|P2|Overall Study|Withdrawal by Subject|3
6014870|NCT00819156|20793372|P1|Overall Study|Withdrawal by Subject|0
6014871|NCT00819156|20793367|P6|Overall Study|Adverse Event|3
6014872|NCT00819156|20793368|P5|Overall Study|Adverse Event|2
6014873|NCT00819156|20793369|P4|Overall Study|Adverse Event|1
6014874|NCT00819156|20793370|P3|Overall Study|Adverse Event|2
6014875|NCT00819156|20793371|P2|Overall Study|Adverse Event|4
6014876|NCT00819156|20793372|P1|Overall Study|Adverse Event|1
6014877|NCT00819091|20793462|P2|Overall Study|Other|2
6014878|NCT00819091|20793463|P1|Overall Study|Other|1
6014879|NCT00819091|20793462|P2|Overall Study|Withdrawal by Subject|2
6014880|NCT00819091|20793463|P1|Overall Study|Withdrawal by Subject|1
6014881|NCT00819091|20793462|P2|Overall Study|Lost to Follow-up|0
6014882|NCT00819091|20793463|P1|Overall Study|Lost to Follow-up|2
6014883|NCT00819091|20793462|P2|Overall Study|Protocol Violation|1
6014884|NCT00819091|20793463|P1|Overall Study|Protocol Violation|0
6014885|NCT00819091|20793462|P2|Overall Study|Adverse Event|5
6014886|NCT00819091|20793463|P1|Overall Study|Adverse Event|3
6014887|NCT00819052|20793489|P2|Overall Study|Death or events leading to death|0
6014888|NCT00819052|20793490|P1|Overall Study|Death or events leading to death|1
6014889|NCT00819052|20793489|P2|Overall Study|Pregnancy|2
6014890|NCT00819052|20793490|P1|Overall Study|Pregnancy|1
6014891|NCT00819052|20793489|P2|Overall Study|Lack of Efficacy|1
6014892|NCT00819052|20793490|P1|Overall Study|Lack of Efficacy|1
6014893|NCT00819052|20793489|P2|Overall Study|Withdrawal by Subject|2
6014894|NCT00819052|20793490|P1|Overall Study|Withdrawal by Subject|1
6014895|NCT00819052|20793489|P2|Overall Study|Lost to Follow-up|2
6014896|NCT00819052|20793490|P1|Overall Study|Lost to Follow-up|1
6014897|NCT00819052|20793489|P2|Overall Study|Protocol Violation|2
6014898|NCT00819052|20793490|P1|Overall Study|Protocol Violation|1
6014899|NCT00819052|20793489|P2|Overall Study|Adverse Event|5
6014900|NCT00819052|20793490|P1|Overall Study|Adverse Event|0
6014901|NCT00819039|20793605|P3|Overall Study|Protocol Violation|0
6014902|NCT00819039|20793606|P2|Overall Study|Protocol Violation|0
6014903|NCT00819039|20793607|P1|Overall Study|Protocol Violation|1
6014904|NCT00819039|20793605|P3|Overall Study|Physician Decision|1
6014905|NCT00819039|20793606|P2|Overall Study|Physician Decision|0
6014906|NCT00819039|20793607|P1|Overall Study|Physician Decision|1
6014907|NCT00819013|20793637|P4|Overall Study|Death|1
6014908|NCT00819013|20793638|P3|Overall Study|Death|0
6014909|NCT00819013|20793639|P2|Overall Study|Death|0
6014910|NCT00819013|20793640|P1|Overall Study|Death|0
6014911|NCT00819013|20793637|P4|Overall Study|Lost to Follow-up|2
6014912|NCT00819013|20793638|P3|Overall Study|Lost to Follow-up|1
6014913|NCT00819013|20793639|P2|Overall Study|Lost to Follow-up|0
6014914|NCT00819013|20793640|P1|Overall Study|Lost to Follow-up|0
6014915|NCT00819013|20793637|P4|Overall Study|Withdrawal by Subject|0
6014916|NCT00819013|20793638|P3|Overall Study|Withdrawal by Subject|1
6014917|NCT00819013|20793639|P2|Overall Study|Withdrawal by Subject|0
6014918|NCT00819013|20793640|P1|Overall Study|Withdrawal by Subject|1
6014919|NCT00819013|20793637|P4|Overall Study|Adverse Event|0
6014920|NCT00819013|20793638|P3|Overall Study|Adverse Event|1
6014921|NCT00819013|20793639|P2|Overall Study|Adverse Event|0
6014922|NCT00819013|20793640|P1|Overall Study|Adverse Event|0
6014923|NCT00819013|20793637|P4|Overall Study|Not meeting continuing study eligibility|1
6014924|NCT00819013|20793638|P3|Overall Study|Not meeting continuing study eligibility|2
6014925|NCT00819013|20793639|P2|Overall Study|Not meeting continuing study eligibility|1
6014926|NCT00819013|20793640|P1|Overall Study|Not meeting continuing study eligibility|2
6014927|NCT00818883|20793706|P2|Overall Study|Other|7
6014928|NCT00818883|20793707|P1|Overall Study|Other|2
6014929|NCT00818883|20793706|P2|Overall Study|Lack of Efficacy|2
6014930|NCT00818883|20793707|P1|Overall Study|Lack of Efficacy|0
6014931|NCT00818883|20793706|P2|Overall Study|Withdrawal by Subject|14
6014932|NCT00818883|20793707|P1|Overall Study|Withdrawal by Subject|16
6014933|NCT00818883|20793706|P2|Overall Study|Lost to Follow-up|2
6014934|NCT00818883|20793707|P1|Overall Study|Lost to Follow-up|3
6014935|NCT00818883|20793706|P2|Overall Study|Protocol Violation|2
6014936|NCT00818883|20793707|P1|Overall Study|Protocol Violation|2
6014937|NCT00818883|20793706|P2|Overall Study|Adverse Event|19
6014938|NCT00818883|20793707|P1|Overall Study|Adverse Event|28
6014939|NCT00818779|20793754|P2|Overall Study|Adverse Event|1
6014940|NCT00818779|20793755|P1|Overall Study|Adverse Event|4
6014941|NCT00818779|20793754|P2|Overall Study|Lost to Follow-up|0
6014942|NCT00818779|20793755|P1|Overall Study|Lost to Follow-up|1
6014943|NCT00818779|20793754|P2|Overall Study|Protocol Violation|0
6014944|NCT00818779|20793755|P1|Overall Study|Protocol Violation|1
6014945|NCT00818766|20793771|P2|Overall Study|Did not Receive Allocated Intervention|0
6014946|NCT00818766|20793772|P1|Overall Study|Did not Receive Allocated Intervention|3
6014947|NCT00818766|20793771|P2|Overall Study|Death|0
6014948|NCT00818766|20793772|P1|Overall Study|Death|1
6014949|NCT00818766|20793771|P2|Overall Study|Could not be Contacted on Day 28|10
6014950|NCT00818766|20793772|P1|Overall Study|Could not be Contacted on Day 28|11
6014951|NCT00818753|20793801|P3|Overall Study|Randomised and not treated|0
6014952|NCT00818753|20793802|P2|Overall Study|Randomised and not treated|0
6014953|NCT00818753|20793803|P1|Overall Study|Randomised and not treated|2
6014954|NCT00818753|20793801|P3|Overall Study|Other reason (not specified)|1
6014955|NCT00818753|20793802|P2|Overall Study|Other reason (not specified)|0
6014956|NCT00818753|20793803|P1|Overall Study|Other reason (not specified)|0
6014957|NCT00818753|20793801|P3|Overall Study|Protocol Violation|0
6014958|NCT00818753|20793802|P2|Overall Study|Protocol Violation|0
6014959|NCT00818753|20793803|P1|Overall Study|Protocol Violation|1
6014960|NCT00818662|20793827|P4|Overall Study|Admitted to long term nursing care|0
6014961|NCT00818662|20793828|P3|Overall Study|Admitted to long term nursing care|0
6014962|NCT00818662|20793829|P2|Overall Study|Admitted to long term nursing care|1
6014963|NCT00818662|20793830|P1|Overall Study|Admitted to long term nursing care|0
6014964|NCT00818662|20793827|P4|Overall Study|Study partner decision|1
6014965|NCT00818662|20793828|P3|Overall Study|Study partner decision|0
6014966|NCT00818662|20793829|P2|Overall Study|Study partner decision|0
6014967|NCT00818662|20793830|P1|Overall Study|Study partner decision|0
6014968|NCT00818662|20793827|P4|Overall Study|Change in living situation|1
6014969|NCT00818662|20793828|P3|Overall Study|Change in living situation|0
6014970|NCT00818662|20793829|P2|Overall Study|Change in living situation|0
6014971|NCT00818662|20793830|P1|Overall Study|Change in living situation|0
6014972|NCT00818662|20793827|P4|Overall Study|Declined move to another study site|0
6014973|NCT00818662|20793828|P3|Overall Study|Declined move to another study site|0
6014974|NCT00818662|20793829|P2|Overall Study|Declined move to another study site|0
6014975|NCT00818662|20793830|P1|Overall Study|Declined move to another study site|1
6014976|NCT00818662|20793827|P4|Overall Study|Moving out of state|1
6014977|NCT00818662|20793828|P3|Overall Study|Moving out of state|0
6014978|NCT00818662|20793829|P2|Overall Study|Moving out of state|0
6014979|NCT00818662|20793830|P1|Overall Study|Moving out of state|0
6014980|NCT00818662|20793827|P4|Overall Study|Caregiver to pursue other treatment|0
6014981|NCT00818662|20793828|P3|Overall Study|Caregiver to pursue other treatment|0
6014982|NCT00818662|20793829|P2|Overall Study|Caregiver to pursue other treatment|1
6014983|NCT00818662|20793830|P1|Overall Study|Caregiver to pursue other treatment|0
6014984|NCT00818662|20793827|P4|Overall Study|Participant's health declined|1
6014985|NCT00818662|20793828|P3|Overall Study|Participant's health declined|0
6014986|NCT00818662|20793829|P2|Overall Study|Participant's health declined|0
6014987|NCT00818662|20793830|P1|Overall Study|Participant's health declined|0
6014988|NCT00818662|20793827|P4|Overall Study|Study Partner Unwilling or Unable|1
6014989|NCT00818662|20793828|P3|Overall Study|Study Partner Unwilling or Unable|1
6014990|NCT00818662|20793829|P2|Overall Study|Study Partner Unwilling or Unable|2
6014991|NCT00818662|20793830|P1|Overall Study|Study Partner Unwilling or Unable|3
6014992|NCT00818662|20793827|P4|Overall Study|Safety Risk|1
6014993|NCT00818662|20793828|P3|Overall Study|Safety Risk|0
6014994|NCT00818662|20793829|P2|Overall Study|Safety Risk|1
6014995|NCT00818662|20793830|P1|Overall Study|Safety Risk|1
6014996|NCT00818662|20793827|P4|Overall Study|Requires a Prohibited Medication|0
6014997|NCT00818662|20793828|P3|Overall Study|Requires a Prohibited Medication|0
6014998|NCT00818662|20793829|P2|Overall Study|Requires a Prohibited Medication|0
6014999|NCT00818662|20793830|P1|Overall Study|Requires a Prohibited Medication|1
6015000|NCT00818662|20793827|P4|Overall Study|Protocol Violation|0
6015001|NCT00818662|20793828|P3|Overall Study|Protocol Violation|0
6015002|NCT00818662|20793829|P2|Overall Study|Protocol Violation|1
6015003|NCT00818662|20793830|P1|Overall Study|Protocol Violation|1
6015004|NCT00818662|20793827|P4|Overall Study|Unwilling or Unable to Participate|4
6015005|NCT00818662|20793828|P3|Overall Study|Unwilling or Unable to Participate|2
6015006|NCT00818662|20793829|P2|Overall Study|Unwilling or Unable to Participate|6
6015007|NCT00818662|20793830|P1|Overall Study|Unwilling or Unable to Participate|4
6015008|NCT00818662|20793827|P4|Overall Study|Lost to Follow-up|1
6015009|NCT00818662|20793828|P3|Overall Study|Lost to Follow-up|0
6015010|NCT00818662|20793829|P2|Overall Study|Lost to Follow-up|0
6015011|NCT00818662|20793830|P1|Overall Study|Lost to Follow-up|0
6015012|NCT00818662|20793827|P4|Overall Study|Physician Decision|0
6015013|NCT00818662|20793828|P3|Overall Study|Physician Decision|0
6015014|NCT00818662|20793829|P2|Overall Study|Physician Decision|0
6015015|NCT00818662|20793830|P1|Overall Study|Physician Decision|1
6015016|NCT00818662|20793827|P4|Overall Study|Death|0
6015017|NCT00818662|20793828|P3|Overall Study|Death|0
6015018|NCT00818662|20793829|P2|Overall Study|Death|3
6015019|NCT00818662|20793830|P1|Overall Study|Death|1
6015020|NCT00818662|20793827|P4|Overall Study|Withdrawal by Subject|2
6015021|NCT00818662|20793828|P3|Overall Study|Withdrawal by Subject|2
6015022|NCT00818662|20793829|P2|Overall Study|Withdrawal by Subject|4
6015023|NCT00818662|20793830|P1|Overall Study|Withdrawal by Subject|5
6015024|NCT00818662|20793827|P4|Overall Study|Adverse Event|3
6015025|NCT00818662|20793828|P3|Overall Study|Adverse Event|4
6015026|NCT00818662|20793829|P2|Overall Study|Adverse Event|14
6015027|NCT00818662|20793830|P1|Overall Study|Adverse Event|5
6015028|NCT00818649|20793916|P1|Overall Study|Adverse Event|1
6015029|NCT00818649|20793916|P1|Overall Study|Unrelated hip fracture-unable to proceed|1
6015030|NCT00818649|20793916|P1|Overall Study|Declining performance status|2
6015031|NCT00818623|20793930|P8|Overall Study|Disease progression|0
6015032|NCT00818623|20793931|P7|Overall Study|Disease progression|1
6015033|NCT00818623|20793932|P6|Overall Study|Disease progression|0
6015034|NCT00818623|20793933|P5|Overall Study|Disease progression|0
6015035|NCT00818623|20793934|P4|Overall Study|Disease progression|0
6015036|NCT00818623|20793935|P3|Overall Study|Disease progression|0
6015037|NCT00818623|20793936|P2|Overall Study|Disease progression|0
6015038|NCT00818623|20793937|P1|Overall Study|Disease progression|0
6015039|NCT00818623|20793930|P8|Overall Study|Lack of trial drug at site|0
6015040|NCT00818623|20793931|P7|Overall Study|Lack of trial drug at site|1
6015041|NCT00818623|20793932|P6|Overall Study|Lack of trial drug at site|0
6015042|NCT00818623|20793933|P5|Overall Study|Lack of trial drug at site|2
6015043|NCT00818623|20793934|P4|Overall Study|Lack of trial drug at site|0
6015044|NCT00818623|20793935|P3|Overall Study|Lack of trial drug at site|0
6015045|NCT00818623|20793936|P2|Overall Study|Lack of trial drug at site|0
6015046|NCT00818623|20793937|P1|Overall Study|Lack of trial drug at site|0
6015047|NCT00818623|20793930|P8|Overall Study|Need of additional treatment|0
6015048|NCT00818623|20793931|P7|Overall Study|Need of additional treatment|0
6015049|NCT00818623|20793932|P6|Overall Study|Need of additional treatment|0
6015050|NCT00818623|20793933|P5|Overall Study|Need of additional treatment|1
6015051|NCT00818623|20793934|P4|Overall Study|Need of additional treatment|0
6015052|NCT00818623|20793935|P3|Overall Study|Need of additional treatment|0
6015053|NCT00818623|20793936|P2|Overall Study|Need of additional treatment|0
6015054|NCT00818623|20793937|P1|Overall Study|Need of additional treatment|0
6015055|NCT00818623|20793930|P8|Overall Study|Protocol Violation|0
6015056|NCT00818623|20793931|P7|Overall Study|Protocol Violation|1
6015057|NCT00818623|20793932|P6|Overall Study|Protocol Violation|0
6015058|NCT00818623|20793933|P5|Overall Study|Protocol Violation|1
6015059|NCT00818623|20793934|P4|Overall Study|Protocol Violation|0
6015060|NCT00818623|20793935|P3|Overall Study|Protocol Violation|0
6015061|NCT00818623|20793936|P2|Overall Study|Protocol Violation|0
6015062|NCT00818623|20793937|P1|Overall Study|Protocol Violation|1
6015063|NCT00818623|20793930|P8|Overall Study|Withdrawal by Subject|1
6015064|NCT00818623|20793931|P7|Overall Study|Withdrawal by Subject|1
6015065|NCT00818623|20793932|P6|Overall Study|Withdrawal by Subject|1
6015066|NCT00818623|20793933|P5|Overall Study|Withdrawal by Subject|0
6015067|NCT00818623|20793934|P4|Overall Study|Withdrawal by Subject|0
6015068|NCT00818623|20793935|P3|Overall Study|Withdrawal by Subject|1
6015069|NCT00818623|20793936|P2|Overall Study|Withdrawal by Subject|1
6015070|NCT00818623|20793937|P1|Overall Study|Withdrawal by Subject|0
6015071|NCT00818623|20793930|P8|Overall Study|Bad prostate specific antigen response|0
6015072|NCT00818623|20793931|P7|Overall Study|Bad prostate specific antigen response|0
6015073|NCT00818623|20793932|P6|Overall Study|Bad prostate specific antigen response|1
6015074|NCT00818623|20793933|P5|Overall Study|Bad prostate specific antigen response|0
6015075|NCT00818623|20793934|P4|Overall Study|Bad prostate specific antigen response|5
6015076|NCT00818623|20793935|P3|Overall Study|Bad prostate specific antigen response|2
6015077|NCT00818623|20793936|P2|Overall Study|Bad prostate specific antigen response|3
6015078|NCT00818623|20793937|P1|Overall Study|Bad prostate specific antigen response|0
6015079|NCT00818623|20793930|P8|Overall Study|Adverse Event|0
6015080|NCT00818623|20793931|P7|Overall Study|Adverse Event|0
6015081|NCT00818623|20793932|P6|Overall Study|Adverse Event|1
6015082|NCT00818623|20793933|P5|Overall Study|Adverse Event|0
6015083|NCT00818623|20793934|P4|Overall Study|Adverse Event|0
6015084|NCT00818623|20793935|P3|Overall Study|Adverse Event|1
6015085|NCT00818623|20793936|P2|Overall Study|Adverse Event|0
6015086|NCT00818623|20793937|P1|Overall Study|Adverse Event|1
6015087|NCT00818519|20794013|P2|Overall Study|participant will leave for long tme|0
6015088|NCT00818519|20794014|P1|Overall Study|participant will leave for long tme|1
6015089|NCT00818519|20794013|P2|Overall Study|participant recovered completely|0
6015090|NCT00818519|20794014|P1|Overall Study|participant recovered completely|1
6015091|NCT00818519|20794013|P2|Overall Study|Withdrawal by Subject|9
6015092|NCT00818519|20794014|P1|Overall Study|Withdrawal by Subject|4
6015093|NCT00818519|20794013|P2|Overall Study|Pregnancy|1
6015094|NCT00818519|20794014|P1|Overall Study|Pregnancy|0
6015095|NCT00818519|20794013|P2|Overall Study|Protocol Violation|1
6015096|NCT00818519|20794014|P1|Overall Study|Protocol Violation|2
6015097|NCT00818519|20794013|P2|Overall Study|Lost to Follow-up|6
6015098|NCT00818519|20794014|P1|Overall Study|Lost to Follow-up|4
6015099|NCT00818519|20794013|P2|Overall Study|Adverse Event|2
6015100|NCT00818519|20794014|P1|Overall Study|Adverse Event|2
6015101|NCT00818454|20794044|P4|Treatment Period 3|Adverse Event|1
6015102|NCT00818454|20794045|P3|Treatment Period 3|Adverse Event|0
6015103|NCT00818454|20794046|P2|Treatment Period 3|Adverse Event|0
6015104|NCT00818454|20794047|P1|Treatment Period 3|Adverse Event|0
6015105|NCT00818454|20794044|P4|Treatment Period 2|Other|0
6015106|NCT00818454|20794045|P3|Treatment Period 2|Other|0
6015107|NCT00818454|20794046|P2|Treatment Period 2|Other|1
6015108|NCT00818454|20794047|P1|Treatment Period 2|Other|2
6015109|NCT00818454|20794044|P4|Washout Period of 1 Week|Other|0
6015110|NCT00818454|20794045|P3|Washout Period of 1 Week|Other|0
6015111|NCT00818454|20794046|P2|Washout Period of 1 Week|Other|2
6015112|NCT00818454|20794047|P1|Washout Period of 1 Week|Other|1
6015113|NCT00818454|20794044|P4|Washout Period of 1 Week|Protocol Violation|0
6015114|NCT00818454|20794045|P3|Washout Period of 1 Week|Protocol Violation|0
6015115|NCT00818454|20794046|P2|Washout Period of 1 Week|Protocol Violation|0
6015116|NCT00818454|20794047|P1|Washout Period of 1 Week|Protocol Violation|2
6015117|NCT00818454|20794044|P4|Washout Period of 1 Week|Adverse Event|0
6015118|NCT00818454|20794045|P3|Washout Period of 1 Week|Adverse Event|0
6015119|NCT00818454|20794046|P2|Washout Period of 1 Week|Adverse Event|1
6015120|NCT00818454|20794047|P1|Washout Period of 1 Week|Adverse Event|1
6015121|NCT00818454|20794044|P4|Treatment Period 1|Other|0
6015122|NCT00818454|20794045|P3|Treatment Period 1|Other|0
6015123|NCT00818454|20794046|P2|Treatment Period 1|Other|0
6015124|NCT00818454|20794047|P1|Treatment Period 1|Other|3
6015125|NCT00818454|20794044|P4|Treatment Period 1|Adverse Event|0
6015126|NCT00818454|20794045|P3|Treatment Period 1|Adverse Event|0
6015127|NCT00818454|20794046|P2|Treatment Period 1|Adverse Event|1
6015128|NCT00818454|20794047|P1|Treatment Period 1|Adverse Event|0
6015129|NCT00818441|20794075|P2|Overall Study|Study terminated by sponsor|2
6015130|NCT00818441|20794076|P1|Overall Study|Study terminated by sponsor|11
6015131|NCT00818441|20794075|P2|Overall Study|Adverse Event|1
6015132|NCT00818441|20794076|P1|Overall Study|Adverse Event|0
6015133|NCT00818441|20794075|P2|Overall Study|Withdrawal by Subject|0
6015134|NCT00818441|20794076|P1|Overall Study|Withdrawal by Subject|2
6015135|NCT00818441|20794075|P2|Overall Study|Lost to Follow-up|1
6015136|NCT00818441|20794076|P1|Overall Study|Lost to Follow-up|2
6015137|NCT00818441|20794075|P2|Overall Study|Other|0
6015138|NCT00818441|20794076|P1|Overall Study|Other|5
6015139|NCT00818441|20794075|P2|Overall Study|Death|26
6015140|NCT00818441|20794076|P1|Overall Study|Death|69
6015141|NCT00818389|20794098|P2|Overall Study|Adverse Event|1
6015142|NCT00818389|20794099|P1|Overall Study|Adverse Event|0
6015143|NCT00818389|20794098|P2|Overall Study|Withdrawal by Subject|2
6015144|NCT00818389|20794099|P1|Overall Study|Withdrawal by Subject|2
6015145|NCT00818389|20794098|P2|Overall Study|ALS Disease Progression|0
6015146|NCT00818389|20794099|P1|Overall Study|ALS Disease Progression|1
6015147|NCT00818389|20794098|P2|Overall Study|Death|3
6015148|NCT00818389|20794099|P1|Overall Study|Death|1
6015149|NCT00818259|20794134|P9|Part V|Adverse Event|0
6015150|NCT00818259|20794135|P8|Part V|Adverse Event|1
6015151|NCT00818259|20794136|P7|Part V|Adverse Event|0
6015152|NCT00818259|20794137|P6|Part V|Adverse Event|0
6015153|NCT00818259|20794138|P5|Part V|Adverse Event|0
6015154|NCT00818259|20794139|P4|Part V|Adverse Event|0
6015155|NCT00818259|20794140|P3|Part V|Adverse Event|0
6015156|NCT00818259|20794141|P2|Part V|Adverse Event|0
6015157|NCT00818259|20794142|P1|Part V|Adverse Event|0
6015158|NCT00818259|20794134|P9|Part IV|Physician Decision|0
6015159|NCT00818259|20794135|P8|Part IV|Physician Decision|0
6015160|NCT00818259|20794136|P7|Part IV|Physician Decision|0
6015161|NCT00818259|20794137|P6|Part IV|Physician Decision|1
6015162|NCT00818259|20794138|P5|Part IV|Physician Decision|0
6015163|NCT00818259|20794139|P4|Part IV|Physician Decision|0
6015164|NCT00818259|20794140|P3|Part IV|Physician Decision|0
6015165|NCT00818259|20794141|P2|Part IV|Physician Decision|0
6015166|NCT00818259|20794142|P1|Part IV|Physician Decision|0
6015167|NCT00818259|20794134|P9|Part II|Not Treated|0
6015168|NCT00818259|20794135|P8|Part II|Not Treated|0
6015169|NCT00818259|20794136|P7|Part II|Not Treated|0
6015170|NCT00818259|20794137|P6|Part II|Not Treated|0
6015171|NCT00818259|20794138|P5|Part II|Not Treated|0
6015172|NCT00818259|20794139|P4|Part II|Not Treated|1
6015173|NCT00818259|20794140|P3|Part II|Not Treated|0
6015174|NCT00818259|20794141|P2|Part II|Not Treated|0
6015175|NCT00818259|20794142|P1|Part II|Not Treated|0
6015176|NCT00818259|20794134|P9|Part II|Lack of Efficacy|0
6015177|NCT00818259|20794135|P8|Part II|Lack of Efficacy|0
6015178|NCT00818259|20794136|P7|Part II|Lack of Efficacy|0
6015179|NCT00818259|20794137|P6|Part II|Lack of Efficacy|0
6015180|NCT00818259|20794138|P5|Part II|Lack of Efficacy|0
6015181|NCT00818259|20794139|P4|Part II|Lack of Efficacy|1
6015182|NCT00818259|20794140|P3|Part II|Lack of Efficacy|0
6015183|NCT00818259|20794141|P2|Part II|Lack of Efficacy|0
6015184|NCT00818259|20794142|P1|Part II|Lack of Efficacy|0
6015185|NCT00818259|20794134|P9|Part II|Physician Decision|0
6015186|NCT00818259|20794135|P8|Part II|Physician Decision|0
6015187|NCT00818259|20794136|P7|Part II|Physician Decision|0
6015188|NCT00818259|20794137|P6|Part II|Physician Decision|0
6015189|NCT00818259|20794138|P5|Part II|Physician Decision|0
6015190|NCT00818259|20794139|P4|Part II|Physician Decision|0
6015191|NCT00818259|20794140|P3|Part II|Physician Decision|1
6015192|NCT00818259|20794141|P2|Part II|Physician Decision|0
6015193|NCT00818259|20794142|P1|Part II|Physician Decision|0
6015194|NCT00818259|20794134|P9|Part I|Withdrawal by Subject|0
6015195|NCT00818259|20794135|P8|Part I|Withdrawal by Subject|0
6015196|NCT00818259|20794136|P7|Part I|Withdrawal by Subject|0
6015197|NCT00818259|20794137|P6|Part I|Withdrawal by Subject|0
6015198|NCT00818259|20794138|P5|Part I|Withdrawal by Subject|0
6015199|NCT00818259|20794139|P4|Part I|Withdrawal by Subject|0
6015200|NCT00818259|20794140|P3|Part I|Withdrawal by Subject|0
6015201|NCT00818259|20794141|P2|Part I|Withdrawal by Subject|0
6015202|NCT00818259|20794142|P1|Part I|Withdrawal by Subject|1
6015203|NCT00818246|20794214|P1|Overall Study|Impossible to match pictures|5
6015204|NCT00818207|20794223|P2|Overall Study|Death|5
6015205|NCT00818207|20794224|P1|Overall Study|Death|3
6015206|NCT00818207|20794223|P2|Overall Study|Withdrawal by Subject|104
6015207|NCT00818207|20794224|P1|Overall Study|Withdrawal by Subject|42
6015208|NCT00818207|20794223|P2|Overall Study|Multiple reasons|12
6015209|NCT00818207|20794224|P1|Overall Study|Multiple reasons|11
6015210|NCT00818207|20794223|P2|Overall Study|Lost to Follow-up|146
6015211|NCT00818207|20794224|P1|Overall Study|Lost to Follow-up|160
6015212|NCT00818207|20794223|P2|Overall Study|Adverse Event|0
6015213|NCT00818207|20794224|P1|Overall Study|Adverse Event|6
6015214|NCT00818168|20794238|P1|Overall Study|Participant Moved|2
6015215|NCT00818168|20794238|P1|Overall Study|Reason for Non-completion Not reported|6
6015216|NCT00818168|20794238|P1|Overall Study|Adverse Event|19
6015217|NCT00818168|20794238|P1|Overall Study|Lost to Follow-up|7
6015218|NCT00818168|20794238|P1|Overall Study|Withdrawal by Subject|16
6015219|NCT00818168|20794238|P1|Overall Study|Pregnancy|2
6015220|NCT00818168|20794238|P1|Overall Study|Lack of Efficacy|18
6015221|NCT00817778|20794278|P2|Overall Study|Poor venous access|0
6015222|NCT00817778|20794279|P1|Overall Study|Poor venous access|1
6015223|NCT00817778|20794278|P2|Overall Study|Study-specific discontinuation criteria|1
6015224|NCT00817778|20794279|P1|Overall Study|Study-specific discontinuation criteria|0
6015225|NCT00817778|20794278|P2|Overall Study|Protocol Violation|1
6015226|NCT00817778|20794279|P1|Overall Study|Protocol Violation|0
6015227|NCT00817778|20794278|P2|Overall Study|Withdrawal by Subject|1
6015228|NCT00817778|20794279|P1|Overall Study|Withdrawal by Subject|1
6015229|NCT00817778|20794278|P2|Overall Study|Adverse Event|0
6015230|NCT00817778|20794279|P1|Overall Study|Adverse Event|1
6015231|NCT00817531|20794308|P1|Overall Study|Lack of Efficacy|1
6015232|NCT00817531|20794308|P1|Overall Study|Adverse Event|1
6015233|NCT00817479|20794314|P2|Overall Study|Physician Decision|1
6015234|NCT00817479|20794315|P1|Overall Study|Physician Decision|1
6015235|NCT00817336|20794325|P2|Overall Study|Withdrawal by Subject|1
6015236|NCT00817336|20794326|P1|Overall Study|Withdrawal by Subject|1
6015237|NCT00817206|20794352|P2|Overall Study|Physician Decision|0
6015238|NCT00817206|20794353|P1|Overall Study|Physician Decision|2
6015239|NCT00817206|20794352|P2|Overall Study|Withdrawal by Subject|3
6015240|NCT00817206|20794353|P1|Overall Study|Withdrawal by Subject|7
6015241|NCT00817206|20794352|P2|Overall Study|Death|0
6015242|NCT00817206|20794353|P1|Overall Study|Death|2
6015243|NCT00817206|20794352|P2|Overall Study|Lost to Follow-up|1
6015244|NCT00817206|20794353|P1|Overall Study|Lost to Follow-up|0
6015245|NCT00817206|20794352|P2|Overall Study|Protocol Violation|2
6015246|NCT00817206|20794353|P1|Overall Study|Protocol Violation|0
6015247|NCT00817206|20794352|P2|Overall Study|Adverse Event|3
6015248|NCT00817206|20794353|P1|Overall Study|Adverse Event|10
6015249|NCT00817089|20794363|P4|Second Alcohol Challenge|Lost to Follow-up|0
6015250|NCT00817089|20794364|P3|Second Alcohol Challenge|Lost to Follow-up|0
6015251|NCT00817089|20794365|P2|Second Alcohol Challenge|Lost to Follow-up|1
6015252|NCT00817089|20794366|P1|Second Alcohol Challenge|Lost to Follow-up|0
6015253|NCT00817089|20794363|P4|First Alcohol Challenge|Lost to Follow-up|1
6015254|NCT00817089|20794364|P3|First Alcohol Challenge|Lost to Follow-up|0
6015255|NCT00817089|20794365|P2|First Alcohol Challenge|Lost to Follow-up|0
6015256|NCT00817089|20794366|P1|First Alcohol Challenge|Lost to Follow-up|0
6015257|NCT00817063|20794382|P2|Overall Study|Abnormality of Laboratory Test|1
6015258|NCT00817063|20794383|P1|Overall Study|Abnormality of Laboratory Test|2
6015259|NCT00817063|20794382|P2|Overall Study|Administrative|4
6015260|NCT00817063|20794383|P1|Overall Study|Administrative|10
6015261|NCT00817063|20794382|P2|Overall Study|Early Improvement|4
6015262|NCT00817063|20794383|P1|Overall Study|Early Improvement|19
6015263|NCT00817063|20794382|P2|Overall Study|Withdrawal by Subject|37
6015264|NCT00817063|20794383|P1|Overall Study|Withdrawal by Subject|17
6015265|NCT00817063|20794382|P2|Overall Study|Protocol Violation|8
6015266|NCT00817063|20794383|P1|Overall Study|Protocol Violation|3
6015267|NCT00817063|20794382|P2|Overall Study|Violation of Selection at Entry|4
6015268|NCT00817063|20794383|P1|Overall Study|Violation of Selection at Entry|7
6015269|NCT00817063|20794382|P2|Overall Study|Failure to Return|12
6015270|NCT00817063|20794383|P1|Overall Study|Failure to Return|13
6015271|NCT00817063|20794382|P2|Overall Study|Lack of Efficacy|86
6015272|NCT00817063|20794383|P1|Overall Study|Lack of Efficacy|33
6015273|NCT00817063|20794382|P2|Overall Study|Death|1
6015274|NCT00817063|20794383|P1|Overall Study|Death|1
6015275|NCT00817063|20794382|P2|Overall Study|Adverse Event|13
6015276|NCT00817063|20794383|P1|Overall Study|Adverse Event|32
6015277|NCT00816595|20794511|P2|Overall Study|Withdrawal by Subject|0
6015278|NCT00816595|20794512|P1|Overall Study|Withdrawal by Subject|2
6015279|NCT00816556|20794525|P3|Overall Study|Lost to Follow-up|1
6015280|NCT00816556|20794526|P2|Overall Study|Lost to Follow-up|0
6015281|NCT00816556|20794527|P1|Overall Study|Lost to Follow-up|0
6015282|NCT00816556|20794525|P3|Overall Study|Withdrawal by Subject|1
6015283|NCT00816556|20794526|P2|Overall Study|Withdrawal by Subject|1
6015284|NCT00816556|20794527|P1|Overall Study|Withdrawal by Subject|1
6015285|NCT00816556|20794525|P3|Overall Study|Adverse Event|1
6015286|NCT00816556|20794526|P2|Overall Study|Adverse Event|1
6015287|NCT00816556|20794527|P1|Overall Study|Adverse Event|1
6015288|NCT00816400|20794550|P9|Overall Study|In hospice care at the end of the study|0
6015289|NCT00816400|20794551|P8|Overall Study|In hospice care at the end of the study|0
6015290|NCT00816400|20794552|P7|Overall Study|In hospice care at the end of the study|0
6015291|NCT00816400|20794553|P6|Overall Study|In hospice care at the end of the study|0
6015292|NCT00816400|20794554|P5|Overall Study|In hospice care at the end of the study|0
6015293|NCT00816400|20794555|P4|Overall Study|In hospice care at the end of the study|0
6015294|NCT00816400|20794556|P3|Overall Study|In hospice care at the end of the study|2
6015295|NCT00816400|20794557|P2|Overall Study|In hospice care at the end of the study|0
6015296|NCT00816400|20794558|P1|Overall Study|In hospice care at the end of the study|0
6015297|NCT00816400|20794550|P9|Overall Study|Death|6
6015298|NCT00816400|20794551|P8|Overall Study|Death|5
6015299|NCT00816400|20794552|P7|Overall Study|Death|2
6015300|NCT00816400|20794553|P6|Overall Study|Death|3
6015301|NCT00816400|20794554|P5|Overall Study|Death|2
6015302|NCT00816400|20794555|P4|Overall Study|Death|3
6015303|NCT00816400|20794556|P3|Overall Study|Death|3
6015304|NCT00816400|20794557|P2|Overall Study|Death|3
6015305|NCT00816400|20794558|P1|Overall Study|Death|2
6015306|NCT00816361|20794749|P9|Overall Study|Other|1
6015307|NCT00816361|20794750|P8|Overall Study|Other|0
6015308|NCT00816361|20794751|P7|Overall Study|Other|0
6015309|NCT00816361|20794752|P6|Overall Study|Other|0
6015310|NCT00816361|20794753|P5|Overall Study|Other|0
6015311|NCT00816361|20794754|P4|Overall Study|Other|0
6015312|NCT00816361|20794755|P3|Overall Study|Other|0
6015313|NCT00816361|20794756|P2|Overall Study|Other|0
6015314|NCT00816361|20794757|P1|Overall Study|Other|0
6015315|NCT00816361|20794749|P9|Overall Study|Death|8
6015316|NCT00816361|20794750|P8|Overall Study|Death|7
6015317|NCT00816361|20794751|P7|Overall Study|Death|3
6015318|NCT00816361|20794752|P6|Overall Study|Death|1
6015319|NCT00816361|20794753|P5|Overall Study|Death|1
6015320|NCT00816361|20794754|P4|Overall Study|Death|3
6015321|NCT00816361|20794755|P3|Overall Study|Death|3
6015322|NCT00816361|20794756|P2|Overall Study|Death|3
6015323|NCT00816361|20794757|P1|Overall Study|Death|4
6015324|NCT00816361|20794749|P9|Overall Study|Withdrawal by Subject|1
6015325|NCT00816361|20794750|P8|Overall Study|Withdrawal by Subject|2
6015326|NCT00816361|20794751|P7|Overall Study|Withdrawal by Subject|0
6015327|NCT00816361|20794752|P6|Overall Study|Withdrawal by Subject|2
6015328|NCT00816361|20794753|P5|Overall Study|Withdrawal by Subject|1
6015329|NCT00816361|20794754|P4|Overall Study|Withdrawal by Subject|0
6015330|NCT00816361|20794755|P3|Overall Study|Withdrawal by Subject|0
6015331|NCT00816361|20794756|P2|Overall Study|Withdrawal by Subject|0
6015332|NCT00816361|20794757|P1|Overall Study|Withdrawal by Subject|0
6015333|NCT00816166|20794916|P2|Overall Study|Death|2
6015334|NCT00816166|20794917|P1|Overall Study|Death|4
6015335|NCT00816166|20794916|P2|Overall Study|Lost to Follow-up|10
6015336|NCT00816166|20794917|P1|Overall Study|Lost to Follow-up|6
6015337|NCT00816036|20794949|P2|Overall Study|Withdrawal by Subject|23
6015338|NCT00816036|20794950|P1|Overall Study|Withdrawal by Subject|54
6015339|NCT00816036|20794949|P2|Overall Study|Lost to Follow-up|57
6015340|NCT00816036|20794950|P1|Overall Study|Lost to Follow-up|75
6015341|NCT00816036|20794949|P2|Overall Study|Death|28
6015342|NCT00816036|20794950|P1|Overall Study|Death|47
6015343|NCT00816023|20794964|P4|Overall Study|Randomized Not Treated|11
6015344|NCT00816023|20794965|P3|Overall Study|Randomized Not Treated|6
6015345|NCT00816023|20794966|P2|Overall Study|Randomized Not Treated|4
6015346|NCT00816023|20794967|P1|Overall Study|Randomized Not Treated|6
6015347|NCT00816023|20794964|P4|Overall Study|assessments complete prior to window|1
6015348|NCT00816023|20794965|P3|Overall Study|assessments complete prior to window|2
6015349|NCT00816023|20794966|P2|Overall Study|assessments complete prior to window|1
6015350|NCT00816023|20794967|P1|Overall Study|assessments complete prior to window|1
6015351|NCT00816023|20794964|P4|Overall Study|Physician Decision|0
6015352|NCT00816023|20794965|P3|Overall Study|Physician Decision|1
6015353|NCT00816023|20794966|P2|Overall Study|Physician Decision|0
6015354|NCT00816023|20794967|P1|Overall Study|Physician Decision|0
6015355|NCT00816023|20794964|P4|Overall Study|Withdrawal by Subject|0
6015356|NCT00816023|20794965|P3|Overall Study|Withdrawal by Subject|0
6015357|NCT00816023|20794966|P2|Overall Study|Withdrawal by Subject|0
6015358|NCT00816023|20794967|P1|Overall Study|Withdrawal by Subject|1
6015359|NCT00816023|20794964|P4|Overall Study|Lost to Follow-up|0
6015360|NCT00816023|20794965|P3|Overall Study|Lost to Follow-up|0
6015361|NCT00816023|20794966|P2|Overall Study|Lost to Follow-up|1
6015362|NCT00816023|20794967|P1|Overall Study|Lost to Follow-up|1
6015363|NCT00815919|20795004|P1|Overall Study|Lack of Efficacy|2
6015364|NCT00815919|20795004|P1|Overall Study|AML Relapse|1
6015365|NCT00815919|20795004|P1|Overall Study|Unrelated Fungal Infection|1
6015366|NCT00815659|20795047|P1|Overall Study|Protocol Violation|1
6015367|NCT00815659|20795047|P1|Overall Study|Lost to Follow-up|4
6015368|NCT00815659|20795047|P1|Overall Study|Withdrawal by Subject|9
6015369|NCT00815659|20795047|P1|Overall Study|Adverse Event|9
6015370|NCT00815633|20795090|P1|Overall Study|study terminated|1
6015371|NCT00815516|20795097|P2|Overall Study|Physician Decision|0
6015372|NCT00815516|20795098|P1|Overall Study|Physician Decision|1
6015373|NCT00815516|20795097|P2|Overall Study|Death|1
6015374|NCT00815516|20795098|P1|Overall Study|Death|3
6015375|NCT00815308|20795163|P1|Overall Study|Protocol Violation|6
6015376|NCT00815308|20795163|P1|Overall Study|Withdrawal by Subject|0
6015377|NCT00815308|20795163|P1|Overall Study|Adverse Event|4
6015378|NCT00815295|20795172|P3|Overall Study|Cetuximab hypersensitivity reaction|3
6015379|NCT00815295|20795173|P2|Overall Study|Cetuximab hypersensitivity reaction|1
6015380|NCT00815295|20795174|P1|Overall Study|Cetuximab hypersensitivity reaction|0
6015381|NCT00815191|20795186|P2|Overall Study|Protocol Violation|1
6015382|NCT00815191|20795187|P1|Overall Study|Protocol Violation|1
6015383|NCT00814983|20795224|P2|Overall Study|Graft failure|0
6015384|NCT00814983|20795225|P1|Overall Study|Graft failure|1
6015385|NCT00814983|20795224|P2|Overall Study|Withdrawal by Subject|0
6015386|NCT00814983|20795225|P1|Overall Study|Withdrawal by Subject|1
6015387|NCT00814983|20795224|P2|Overall Study|Screen failure|0
6015388|NCT00814983|20795225|P1|Overall Study|Screen failure|1
6015389|NCT00814892|20795256|P1|Overall Study|Study Termination|1
6015390|NCT00814892|20795256|P1|Overall Study|Disease Progression|1
6015391|NCT00814879|20795268|P2|By Week 48|Death|1
6015392|NCT00814879|20795269|P1|By Week 48|Death|0
6015393|NCT00814879|20795268|P2|By Week 48|Lost to Follow-up|2
6015394|NCT00814879|20795269|P1|By Week 48|Lost to Follow-up|2
6015395|NCT00814879|20795268|P2|By Week 24|Incarceration|1
6015396|NCT00814879|20795269|P1|By Week 24|Incarceration|0
6015397|NCT00814879|20795268|P2|By Week 24|Cancer Diagnosis|0
6015398|NCT00814879|20795269|P1|By Week 24|Cancer Diagnosis|1
6015399|NCT00814801|20795288|P3|Overall Study|Other|4
6015400|NCT00814801|20795289|P2|Overall Study|Other|6
6015401|NCT00814801|20795290|P1|Overall Study|Other|2
6015402|NCT00814801|20795288|P3|Overall Study|Non-compliance|1
6015403|NCT00814801|20795289|P2|Overall Study|Non-compliance|1
6015404|NCT00814801|20795290|P1|Overall Study|Non-compliance|0
6015405|NCT00814801|20795288|P3|Overall Study|Missing or change of caregiver|4
6015406|NCT00814801|20795289|P2|Overall Study|Missing or change of caregiver|2
6015407|NCT00814801|20795290|P1|Overall Study|Missing or change of caregiver|6
6015408|NCT00814801|20795288|P3|Overall Study|Change of patients for CIBIC plus-J|0
6015409|NCT00814801|20795289|P2|Overall Study|Change of patients for CIBIC plus-J|1
6015410|NCT00814801|20795290|P1|Overall Study|Change of patients for CIBIC plus-J|1
6015411|NCT00814801|20795288|P3|Overall Study|Inappropriate as a subject|1
6015412|NCT00814801|20795289|P2|Overall Study|Inappropriate as a subject|1
6015413|NCT00814801|20795290|P1|Overall Study|Inappropriate as a subject|1
6015414|NCT00814801|20795288|P3|Overall Study|Withdrawal by Subject|14
6015415|NCT00814801|20795289|P2|Overall Study|Withdrawal by Subject|11
6015416|NCT00814801|20795290|P1|Overall Study|Withdrawal by Subject|9
6015417|NCT00814801|20795288|P3|Overall Study|Adverse Event|19
6015418|NCT00814801|20795289|P2|Overall Study|Adverse Event|16
6015419|NCT00814801|20795290|P1|Overall Study|Adverse Event|15
6015420|NCT00814710|20795329|P2|Overall Study|Lost to Follow-up|3
6015421|NCT00814710|20795330|P1|Overall Study|Lost to Follow-up|7
6015422|NCT00814710|20795329|P2|Overall Study|Adverse Event|0
6015423|NCT00814710|20795330|P1|Overall Study|Adverse Event|1
6015424|NCT00814658|20795398|P2|Overall Study|Adverse Event|3
6015425|NCT00814658|20795399|P1|Overall Study|Adverse Event|3
6015426|NCT00814658|20795398|P2|Overall Study|Physician Decision|0
6015427|NCT00814658|20795399|P1|Overall Study|Physician Decision|1
6015428|NCT00814658|20795398|P2|Overall Study|Lost to Follow-up|1
6015429|NCT00814658|20795399|P1|Overall Study|Lost to Follow-up|0
6015430|NCT00814632|20795465|P1|Overall Study|Lack of Efficacy|2
6015431|NCT00814580|20795471|P2|Overall Study|Did Not Take Drug|2
6015432|NCT00814580|20795472|P1|Overall Study|Did Not Take Drug|2
6015433|NCT00814580|20795471|P2|Overall Study|Other|3
6015434|NCT00814580|20795472|P1|Overall Study|Other|1
6015435|NCT00814580|20795471|P2|Overall Study|Withdrawal by Subject|2
6015436|NCT00814580|20795472|P1|Overall Study|Withdrawal by Subject|2
6015437|NCT00814580|20795471|P2|Overall Study|Protocol Violation|0
6015438|NCT00814580|20795472|P1|Overall Study|Protocol Violation|2
6015439|NCT00814580|20795471|P2|Overall Study|Lack of Efficacy|25
6015440|NCT00814580|20795472|P1|Overall Study|Lack of Efficacy|18
6015441|NCT00814580|20795471|P2|Overall Study|Adverse Event|15
6015442|NCT00814580|20795472|P1|Overall Study|Adverse Event|6
6015443|NCT00814502|20795602|P2|Overall Study|Withdrawal by Subject|2
6015444|NCT00814502|20795603|P1|Overall Study|Withdrawal by Subject|0
6015445|NCT00814502|20795602|P2|Overall Study|Adverse Event|0
6015446|NCT00814502|20795603|P1|Overall Study|Adverse Event|1
6015447|NCT00814489|20795616|P3|Overall Study|Other|1
6015448|NCT00814489|20795617|P2|Overall Study|Other|0
6015449|NCT00814489|20795618|P1|Overall Study|Other|2
6015450|NCT00814463|20795650|P1|Overall Study|Lost to Follow-up|1
6015451|NCT00814346|20795663|P2|Open Phase (17 Months)|Not otherwise specified|0
6015452|NCT00814346|20795664|P1|Open Phase (17 Months)|Not otherwise specified|1
6015453|NCT00814346|20795663|P2|Open Phase (17 Months)|Lost to Follow-up|0
6015454|NCT00814346|20795664|P1|Open Phase (17 Months)|Lost to Follow-up|2
6015455|NCT00814346|20795663|P2|Open Phase (17 Months)|Consent|0
6015456|NCT00814346|20795664|P1|Open Phase (17 Months)|Consent|2
6015457|NCT00814346|20795663|P2|Open Phase (17 Months)|Adverse Event|0
6015458|NCT00814346|20795664|P1|Open Phase (17 Months)|Adverse Event|5
6015459|NCT00814346|20795663|P2|Double-blind Phase (4 Weeks)|Not otherwise specified|2
6015460|NCT00814346|20795664|P1|Double-blind Phase (4 Weeks)|Not otherwise specified|0
6015461|NCT00814346|20795663|P2|Double-blind Phase (4 Weeks)|Adverse Event|1
6015462|NCT00814346|20795664|P1|Double-blind Phase (4 Weeks)|Adverse Event|0
6015463|NCT00814333|20795730|P2|Enrollment|Lost to Follow-up|0
6015464|NCT00814333|20795731|P1|Enrollment|Lost to Follow-up|1
6015465|NCT00814320|20795739|P2|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|3
6015466|NCT00814320|20795740|P1|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|0
6015467|NCT00814320|20795739|P2|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|1
6015468|NCT00814320|20795740|P1|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|0
6015469|NCT00814320|20795739|P2|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|1
6015470|NCT00814320|20795740|P1|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|0
6015471|NCT00814320|20795739|P2|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|1
6015472|NCT00814320|20795740|P1|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|2
6015473|NCT00814320|20795739|P2|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|4
6015474|NCT00814320|20795740|P1|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|1
6015475|NCT00814320|20795739|P2|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|0
6015476|NCT00814320|20795740|P1|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|1
6015477|NCT00814320|20795739|P2|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|0
6015478|NCT00814320|20795740|P1|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|1
6015479|NCT00814320|20795739|P2|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|1
6015480|NCT00814320|20795740|P1|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|0
6015481|NCT00814320|20795739|P2|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|2
6015482|NCT00814320|20795740|P1|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|0
6015483|NCT00814320|20795739|P2|Epoch 1 (IV Treatment)|Withdrawal by Subject|0
6015484|NCT00814320|20795740|P1|Epoch 1 (IV Treatment)|Withdrawal by Subject|1
6015485|NCT00814307|20795872|P4|Overall Study|Death|0
6015486|NCT00814307|20795873|P3|Overall Study|Death|0
6015487|NCT00814307|20795874|P2|Overall Study|Death|1
6015488|NCT00814307|20795875|P1|Overall Study|Death|0
6015489|NCT00814307|20795872|P4|Overall Study|Withdrawal by Subject|2
6015490|NCT00814307|20795873|P3|Overall Study|Withdrawal by Subject|0
6015491|NCT00814307|20795874|P2|Overall Study|Withdrawal by Subject|6
6015492|NCT00814307|20795875|P1|Overall Study|Withdrawal by Subject|4
6015493|NCT00814307|20795872|P4|Overall Study|Protocol Violation|1
6015494|NCT00814307|20795873|P3|Overall Study|Protocol Violation|1
6015495|NCT00814307|20795874|P2|Overall Study|Protocol Violation|8
6015496|NCT00814307|20795875|P1|Overall Study|Protocol Violation|2
6015497|NCT00814307|20795872|P4|Overall Study|Other|1
6015498|NCT00814307|20795873|P3|Overall Study|Other|0
6015499|NCT00814307|20795874|P2|Overall Study|Other|2
6015500|NCT00814307|20795875|P1|Overall Study|Other|1
6015501|NCT00814307|20795872|P4|Overall Study|Lack of Efficacy|4
6015502|NCT00814307|20795873|P3|Overall Study|Lack of Efficacy|3
6015503|NCT00814307|20795874|P2|Overall Study|Lack of Efficacy|1
6015504|NCT00814307|20795875|P1|Overall Study|Lack of Efficacy|1
6015505|NCT00814307|20795872|P4|Overall Study|Adverse Event|2
6015506|NCT00814307|20795873|P3|Overall Study|Adverse Event|3
6015507|NCT00814307|20795874|P2|Overall Study|Adverse Event|9
6015508|NCT00814307|20795875|P1|Overall Study|Adverse Event|3
6015509|NCT00814307|20795872|P4|Overall Study|Randomized but not treated|0
6015510|NCT00814307|20795873|P3|Overall Study|Randomized but not treated|0
6015511|NCT00814307|20795874|P2|Overall Study|Randomized but not treated|0
6015512|NCT00814307|20795875|P1|Overall Study|Randomized but not treated|1
6015513|NCT00814164|20796071|P1|Overall Study|Death|5
6015514|NCT00814164|20796071|P1|Overall Study|not stated|7
6015515|NCT00814164|20796071|P1|Overall Study|Progression|7
6015516|NCT00813995|20796105|P2|Overall Study|Withdrawal by Subject|5
6015517|NCT00813995|20796106|P1|Overall Study|Withdrawal by Subject|0
6015518|NCT00813995|20796105|P2|Overall Study|Subject moved|0
6015519|NCT00813995|20796106|P1|Overall Study|Subject moved|4
6015520|NCT00813995|20796105|P2|Overall Study|Protocol Violation|2
6015521|NCT00813995|20796106|P1|Overall Study|Protocol Violation|3
6015522|NCT00813995|20796105|P2|Overall Study|Other reason|2
6015523|NCT00813995|20796106|P1|Overall Study|Other reason|2
6015524|NCT00813995|20796105|P2|Overall Study|Lost to Follow-up|2
6015525|NCT00813995|20796106|P1|Overall Study|Lost to Follow-up|4
6015526|NCT00813995|20796105|P2|Overall Study|Lack of Efficacy|0
6015527|NCT00813995|20796106|P1|Overall Study|Lack of Efficacy|1
6015528|NCT00813995|20796105|P2|Overall Study|Laboratory adverse event|2
6015529|NCT00813995|20796106|P1|Overall Study|Laboratory adverse event|0
6015530|NCT00813995|20796105|P2|Overall Study|Clinical adverse event|3
6015531|NCT00813995|20796106|P1|Overall Study|Clinical adverse event|9
6015532|NCT00813943|20796129|P3|Overall Study|Ongoing at cut-off date|3
6015533|NCT00813943|20796130|P2|Overall Study|Ongoing at cut-off date|5
6015534|NCT00813943|20796131|P1|Overall Study|Ongoing at cut-off date|5
6015535|NCT00813917|20796161|P2|Overall Study|Lost to Follow-up|1
6015536|NCT00813917|20796162|P1|Overall Study|Lost to Follow-up|3
6015537|NCT00813917|20796161|P2|Overall Study|Withdrawal by Subject|4
6015538|NCT00813917|20796162|P1|Overall Study|Withdrawal by Subject|3
6015539|NCT00813917|20796161|P2|Overall Study|Adverse Event|1
6015540|NCT00813917|20796162|P1|Overall Study|Adverse Event|0
6015541|NCT00813904|20796168|P1|Overall Study|Death|1
6015542|NCT00813865|20796174|P1|Overall Study|Withdrawal by Subject|1
6015543|NCT00813865|20796174|P1|Overall Study|Lost to Follow-up|3
6015544|NCT00813865|20796174|P1|Overall Study|Failure to Respond|3
6015545|NCT00813813|20796182|P2|Overall Study|Other|1
6015546|NCT00813813|20796183|P1|Overall Study|Other|0
6015547|NCT00813813|20796182|P2|Overall Study|Lost to Follow-up|7
6015548|NCT00813813|20796183|P1|Overall Study|Lost to Follow-up|2
6015549|NCT00813813|20796182|P2|Overall Study|Withdrawal by Subject|1
6015550|NCT00813813|20796183|P1|Overall Study|Withdrawal by Subject|1
6015551|NCT00813800|20796199|P1|Overall Study|Physician Decision|1
6015552|NCT00813800|20796199|P1|Overall Study|Worsening of depression|2
6015553|NCT00813800|20796199|P1|Overall Study|Adverse Event|1
6015554|NCT00813800|20796199|P1|Overall Study|Screen Failure after Consent|2
6015555|NCT00813761|20796207|P4|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0
6015556|NCT00813761|20796208|P3|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|6
6015557|NCT00813761|20796209|P2|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0
6015558|NCT00813761|20796210|P1|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|9
6015559|NCT00813761|20796207|P4|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|3
6015560|NCT00813761|20796208|P3|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|0
6015561|NCT00813761|20796209|P2|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|4
6015562|NCT00813761|20796210|P1|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|1
6015563|NCT00813761|20796207|P4|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|0
6015564|NCT00813761|20796208|P3|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1
6015565|NCT00813761|20796209|P2|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1
6015566|NCT00813761|20796210|P1|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1
6015567|NCT00813761|20796207|P4|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1
6015568|NCT00813761|20796208|P3|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0
6015569|NCT00813761|20796209|P2|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1
6015570|NCT00813761|20796210|P1|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0
6015571|NCT00813761|20796207|P4|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|1
6015572|NCT00813761|20796208|P3|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|2
6015573|NCT00813761|20796209|P2|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|0
6015574|NCT00813761|20796210|P1|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|3
6015575|NCT00813761|20796207|P4|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0
6015576|NCT00813761|20796208|P3|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0
6015577|NCT00813761|20796209|P2|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|3
6015578|NCT00813761|20796210|P1|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|2
6015579|NCT00813761|20796207|P4|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0
6015580|NCT00813761|20796208|P3|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0
6015581|NCT00813761|20796209|P2|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|1
6015582|NCT00813761|20796210|P1|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0
6015583|NCT00813761|20796207|P4|Phase 1 (Baseline to 4 Weeks)|poor comfort|1
6015584|NCT00813761|20796208|P3|Phase 1 (Baseline to 4 Weeks)|poor comfort|5
6015585|NCT00813761|20796209|P2|Phase 1 (Baseline to 4 Weeks)|poor comfort|1
6015586|NCT00813761|20796210|P1|Phase 1 (Baseline to 4 Weeks)|poor comfort|1
6015587|NCT00813761|20796207|P4|Phase 1 (Baseline to 4 Weeks)|poor vision|0
6015588|NCT00813761|20796208|P3|Phase 1 (Baseline to 4 Weeks)|poor vision|3
6015589|NCT00813761|20796209|P2|Phase 1 (Baseline to 4 Weeks)|poor vision|0
6015590|NCT00813761|20796210|P1|Phase 1 (Baseline to 4 Weeks)|poor vision|0
6015591|NCT00813761|20796207|P4|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|0
6015592|NCT00813761|20796208|P3|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1
6015593|NCT00813761|20796209|P2|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1
6015594|NCT00813761|20796210|P1|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1
6015595|NCT00813761|20796207|P4|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|1
6015596|NCT00813761|20796208|P3|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|3
6015597|NCT00813761|20796209|P2|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0
6015598|NCT00813761|20796210|P1|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0
6015599|NCT00813761|20796207|P4|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0
6015600|NCT00813761|20796208|P3|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0
6015601|NCT00813761|20796209|P2|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0
6015602|NCT00813761|20796210|P1|Phase 1 (Baseline to 4 Weeks)|Pregnancy|2
6015603|NCT00813748|20796260|P2|Skin Test Substudy|Physician Decision|1
6015604|NCT00813748|20796261|P1|Skin Test Substudy|Physician Decision|0
6015605|NCT00813709|20796290|P6|Open Label Period|Other|6
6015606|NCT00813709|20796291|P5|Open Label Period|Other|5
6015607|NCT00813709|20796292|P4|Open Label Period|Other|11
6015608|NCT00813709|20796293|P3|Open Label Period|Other|0
6015609|NCT00813709|20796294|P2|Open Label Period|Other|0
6015610|NCT00813709|20796295|P1|Open Label Period|Other|0
6015611|NCT00813709|20796290|P6|Open Label Period|Randomized but not treated|1
6015612|NCT00813709|20796291|P5|Open Label Period|Randomized but not treated|0
6015613|NCT00813709|20796292|P4|Open Label Period|Randomized but not treated|1
6015614|NCT00813709|20796293|P3|Open Label Period|Randomized but not treated|0
6015615|NCT00813709|20796294|P2|Open Label Period|Randomized but not treated|0
6015616|NCT00813709|20796295|P1|Open Label Period|Randomized but not treated|0
6015617|NCT00813709|20796290|P6|Open Label Period|Lack of Efficacy|1
6015618|NCT00813709|20796291|P5|Open Label Period|Lack of Efficacy|1
6015619|NCT00813709|20796292|P4|Open Label Period|Lack of Efficacy|3
6015620|NCT00813709|20796293|P3|Open Label Period|Lack of Efficacy|0
6015621|NCT00813709|20796294|P2|Open Label Period|Lack of Efficacy|0
6015622|NCT00813709|20796295|P1|Open Label Period|Lack of Efficacy|0
6015623|NCT00813709|20796290|P6|Open Label Period|Adverse Event|3
6015624|NCT00813709|20796291|P5|Open Label Period|Adverse Event|4
6015625|NCT00813709|20796292|P4|Open Label Period|Adverse Event|5
6015626|NCT00813709|20796293|P3|Open Label Period|Adverse Event|0
6015627|NCT00813709|20796294|P2|Open Label Period|Adverse Event|0
6015628|NCT00813709|20796295|P1|Open Label Period|Adverse Event|0
6015629|NCT00813709|20796290|P6|Double Blind Period|Other|0
6015630|NCT00813709|20796291|P5|Double Blind Period|Other|0
6015631|NCT00813709|20796292|P4|Double Blind Period|Other|0
6015632|NCT00813709|20796293|P3|Double Blind Period|Other|6
6015633|NCT00813709|20796294|P2|Double Blind Period|Other|9
6015634|NCT00813709|20796295|P1|Double Blind Period|Other|14
6015635|NCT00813709|20796290|P6|Double Blind Period|Randomized but not treated|0
6015636|NCT00813709|20796291|P5|Double Blind Period|Randomized but not treated|0
6015637|NCT00813709|20796292|P4|Double Blind Period|Randomized but not treated|0
6015638|NCT00813709|20796293|P3|Double Blind Period|Randomized but not treated|1
6015639|NCT00813709|20796294|P2|Double Blind Period|Randomized but not treated|3
6015640|NCT00813709|20796295|P1|Double Blind Period|Randomized but not treated|1
6015641|NCT00813709|20796290|P6|Double Blind Period|Switched to open label phase|0
6015642|NCT00813709|20796291|P5|Double Blind Period|Switched to open label phase|0
6015643|NCT00813709|20796292|P4|Double Blind Period|Switched to open label phase|0
6015644|NCT00813709|20796293|P3|Double Blind Period|Switched to open label phase|18
6015645|NCT00813709|20796294|P2|Double Blind Period|Switched to open label phase|26
6015646|NCT00813709|20796295|P1|Double Blind Period|Switched to open label phase|9
6015647|NCT00813709|20796290|P6|Double Blind Period|Lost to Follow-up|0
6015648|NCT00813709|20796291|P5|Double Blind Period|Lost to Follow-up|0
6015649|NCT00813709|20796292|P4|Double Blind Period|Lost to Follow-up|0
6015650|NCT00813709|20796293|P3|Double Blind Period|Lost to Follow-up|2
6015651|NCT00813709|20796294|P2|Double Blind Period|Lost to Follow-up|2
6015652|NCT00813709|20796295|P1|Double Blind Period|Lost to Follow-up|3
6015653|NCT00813709|20796290|P6|Double Blind Period|Adverse Event|0
6015654|NCT00813709|20796291|P5|Double Blind Period|Adverse Event|0
6015655|NCT00813709|20796292|P4|Double Blind Period|Adverse Event|0
6015656|NCT00813709|20796293|P3|Double Blind Period|Adverse Event|4
6015657|NCT00813709|20796294|P2|Double Blind Period|Adverse Event|1
6015658|NCT00813709|20796295|P1|Double Blind Period|Adverse Event|4
6015659|NCT00813592|20796375|P1|Overall Study|Disease assessment was not completed per|2
6015660|NCT00813488|20796384|P2|Open-label Extension|Other|0
6015661|NCT00813488|20796385|P1|Open-label Extension|Other|1
6015662|NCT00813488|20796384|P2|Open-label Extension|Non-compliance study procedures|1
6015663|NCT00813488|20796385|P1|Open-label Extension|Non-compliance study procedures|2
6015664|NCT00813488|20796384|P2|Open-label Extension|Non-compliance study medication|0
6015665|NCT00813488|20796385|P1|Open-label Extension|Non-compliance study medication|4
6015666|NCT00813488|20796384|P2|Open-label Extension|Protocol Violation|2
6015667|NCT00813488|20796385|P1|Open-label Extension|Protocol Violation|1
6015668|NCT00813488|20796384|P2|Open-label Extension|Withdrawal by Subject|2
6015669|NCT00813488|20796385|P1|Open-label Extension|Withdrawal by Subject|0
6015670|NCT00813488|20796384|P2|Open-label Extension|Lack of Efficacy|0
6015671|NCT00813488|20796385|P1|Open-label Extension|Lack of Efficacy|3
6015672|NCT00813488|20796384|P2|Open-label Extension|Adverse Event|2
6015673|NCT00813488|20796385|P1|Open-label Extension|Adverse Event|1
6015674|NCT00813488|20796384|P2|Double-blind Treatment Period 2|Other|0
6015675|NCT00813488|20796385|P1|Double-blind Treatment Period 2|Other|1
6015676|NCT00813488|20796384|P2|Double-blind Treatment Period 2|Protocol Violation|0
6015677|NCT00813488|20796385|P1|Double-blind Treatment Period 2|Protocol Violation|2
6015678|NCT00813488|20796384|P2|Double-blind Treatment Period 2|Withdrawal by Subject|1
6015679|NCT00813488|20796385|P1|Double-blind Treatment Period 2|Withdrawal by Subject|1
6015680|NCT00813488|20796384|P2|Double-blind Treatment Period 2|Adverse Event|0
6015681|NCT00813488|20796385|P1|Double-blind Treatment Period 2|Adverse Event|1
6015682|NCT00813488|20796384|P2|Double-blind Treatment Period 1|Lost to Follow-up|1
6015683|NCT00813488|20796385|P1|Double-blind Treatment Period 1|Lost to Follow-up|0
6015684|NCT00813488|20796384|P2|Double-blind Treatment Period 1|Protocol Violation|2
6015685|NCT00813488|20796385|P1|Double-blind Treatment Period 1|Protocol Violation|0
6015686|NCT00813488|20796384|P2|Double-blind Treatment Period 1|Withdrawal by Subject|1
6015687|NCT00813488|20796385|P1|Double-blind Treatment Period 1|Withdrawal by Subject|0
6015688|NCT00813488|20796384|P2|Double-blind Treatment Period 1|Adverse Event|1
6015689|NCT00813488|20796385|P1|Double-blind Treatment Period 1|Adverse Event|1
6015690|NCT00813488|20796384|P2|Titration Period 2|Non-compliance with study procedures|1
6015691|NCT00813488|20796385|P1|Titration Period 2|Non-compliance with study procedures|2
6015692|NCT00813488|20796384|P2|Titration Period 2|Lost to Follow-up|0
6015693|NCT00813488|20796385|P1|Titration Period 2|Lost to Follow-up|1
6015694|NCT00813488|20796384|P2|Titration Period 2|Protocol Violation|2
6015695|NCT00813488|20796385|P1|Titration Period 2|Protocol Violation|3
6015696|NCT00813488|20796384|P2|Titration Period 2|Lack of Efficacy|4
6015697|NCT00813488|20796385|P1|Titration Period 2|Lack of Efficacy|8
6015698|NCT00813488|20796384|P2|Titration Period 2|Adverse Event|3
6015699|NCT00813488|20796385|P1|Titration Period 2|Adverse Event|2
6015700|NCT00813488|20796384|P2|Titration Period 1|Technical Difficulties|1
6015701|NCT00813488|20796385|P1|Titration Period 1|Technical Difficulties|0
6015702|NCT00813488|20796384|P2|Titration Period 1|Non-compliance to study procedures|2
6015703|NCT00813488|20796385|P1|Titration Period 1|Non-compliance to study procedures|2
6015704|NCT00813488|20796384|P2|Titration Period 1|Non-compliance to study medication|1
6015705|NCT00813488|20796385|P1|Titration Period 1|Non-compliance to study medication|4
6015706|NCT00813488|20796384|P2|Titration Period 1|Protocol Violation|3
6015707|NCT00813488|20796385|P1|Titration Period 1|Protocol Violation|4
6015708|NCT00813488|20796384|P2|Titration Period 1|Withdrawal by Subject|2
6015709|NCT00813488|20796385|P1|Titration Period 1|Withdrawal by Subject|2
6015710|NCT00813488|20796384|P2|Titration Period 1|Lack of Efficacy|7
6015711|NCT00813488|20796385|P1|Titration Period 1|Lack of Efficacy|9
6015712|NCT00813488|20796384|P2|Titration Period 1|Adverse Event|1
6015713|NCT00813488|20796385|P1|Titration Period 1|Adverse Event|6
6015714|NCT00813293|20796496|P2|Overall Study|Adverse Event|1
6015715|NCT00813293|20796497|P1|Overall Study|Adverse Event|0
6015716|NCT00813293|20796496|P2|Overall Study|Intercurrent illness|0
6015717|NCT00813293|20796497|P1|Overall Study|Intercurrent illness|1
6015718|NCT00813150|20796536|P2|Long Term Follow-up|Progression/Relapse|24
6015719|NCT00813150|20796537|P1|Long Term Follow-up|Progression/Relapse|22
6015720|NCT00813150|20796536|P2|Long Term Follow-up|Lost to Follow-up|0
6015721|NCT00813150|20796537|P1|Long Term Follow-up|Lost to Follow-up|2
6015722|NCT00813150|20796536|P2|Long Term Follow-up|Other|3
6015723|NCT00813150|20796537|P1|Long Term Follow-up|Other|0
6015724|NCT00813150|20796536|P2|Long Term Follow-up|Death|4
6015725|NCT00813150|20796537|P1|Long Term Follow-up|Death|0
6015726|NCT00813150|20796536|P2|Treatment Period|Data not available|2
6015727|NCT00813150|20796537|P1|Treatment Period|Data not available|1
6015728|NCT00813150|20796536|P2|Treatment Period|Reason not specified|4
6015729|NCT00813150|20796537|P1|Treatment Period|Reason not specified|3
6015730|NCT00813150|20796536|P2|Treatment Period|Non compliance|1
6015731|NCT00813150|20796537|P1|Treatment Period|Non compliance|0
6015732|NCT00813150|20796536|P2|Treatment Period|Withdrawal by Subject|3
6015733|NCT00813150|20796537|P1|Treatment Period|Withdrawal by Subject|5
6015734|NCT00813150|20796536|P2|Treatment Period|Protocol Violation|4
6015735|NCT00813150|20796537|P1|Treatment Period|Protocol Violation|3
6015736|NCT00813150|20796536|P2|Treatment Period|Stable disease|2
6015737|NCT00813150|20796537|P1|Treatment Period|Stable disease|1
6015738|NCT00813150|20796536|P2|Treatment Period|Complete response|1
6015739|NCT00813150|20796537|P1|Treatment Period|Complete response|0
6015740|NCT00813150|20796536|P2|Treatment Period|Progressive disease|0
6015741|NCT00813150|20796537|P1|Treatment Period|Progressive disease|1
6015742|NCT00813150|20796536|P2|Treatment Period|Death|0
6015743|NCT00813150|20796537|P1|Treatment Period|Death|2
6015744|NCT00813150|20796536|P2|Treatment Period|Adverse Event|15
6015745|NCT00813150|20796537|P1|Treatment Period|Adverse Event|16
6015749|NCT00813098|20796565|P3|Overall Study|Withdrew Consent|0
6015750|NCT00813098|20796566|P2|Overall Study|Withdrew Consent|1
6015751|NCT00813098|20796567|P1|Overall Study|Withdrew Consent|0
6015752|NCT00813098|20796565|P3|Overall Study|Principal Investigator decision|0
6015753|NCT00813098|20796566|P2|Overall Study|Principal Investigator decision|1
6015754|NCT00813098|20796567|P1|Overall Study|Principal Investigator decision|0
6015755|NCT00813098|20796565|P3|Overall Study|Protocol Violation|1
6015756|NCT00813098|20796566|P2|Overall Study|Protocol Violation|0
6015757|NCT00813098|20796567|P1|Overall Study|Protocol Violation|0
6015758|NCT00813098|20796565|P3|Overall Study|Lost to Follow-up|0
6015759|NCT00813098|20796566|P2|Overall Study|Lost to Follow-up|1
6015760|NCT00813098|20796567|P1|Overall Study|Lost to Follow-up|0
6015761|NCT00813098|20796565|P3|Overall Study|Inability to complete study procedures|0
6015762|NCT00813098|20796566|P2|Overall Study|Inability to complete study procedures|0
6015763|NCT00813098|20796567|P1|Overall Study|Inability to complete study procedures|1
6015764|NCT00813098|20796565|P3|Overall Study|Withdrawal by Subject|0
6015765|NCT00813098|20796566|P2|Overall Study|Withdrawal by Subject|1
6015766|NCT00813098|20796567|P1|Overall Study|Withdrawal by Subject|0
6015767|NCT00813098|20796565|P3|Overall Study|Adverse Event|1
6015768|NCT00813098|20796566|P2|Overall Study|Adverse Event|4
6015769|NCT00813098|20796567|P1|Overall Study|Adverse Event|2
6015770|NCT00812981|20796592|P2|Overall Study|Other|1
6015771|NCT00812981|20796593|P1|Overall Study|Other|0
6015772|NCT00812968|20796631|P1|Overall Study|Study closed due to marketing approval|3
6015773|NCT00812968|20796631|P1|Overall Study|No further treatment required|1
6015774|NCT00812968|20796631|P1|Overall Study|Disease progression|1
6015775|NCT00812968|20796631|P1|Overall Study|Relapse after erythroid response|6
6015776|NCT00812955|20796666|P4|Overall Study|randomized in error|0
6015777|NCT00812955|20796667|P3|Overall Study|randomized in error|1
6015778|NCT00812955|20796668|P2|Overall Study|randomized in error|0
6015779|NCT00812955|20796669|P1|Overall Study|randomized in error|0
6015780|NCT00812955|20796666|P4|Overall Study|Withdrawal by Subject|2
6015781|NCT00812955|20796667|P3|Overall Study|Withdrawal by Subject|1
6015782|NCT00812955|20796668|P2|Overall Study|Withdrawal by Subject|0
6015783|NCT00812955|20796669|P1|Overall Study|Withdrawal by Subject|1
6015784|NCT00812955|20796666|P4|Overall Study|Lost to Follow-up|2
6015785|NCT00812955|20796667|P3|Overall Study|Lost to Follow-up|1
6015786|NCT00812955|20796668|P2|Overall Study|Lost to Follow-up|1
6015787|NCT00812955|20796669|P1|Overall Study|Lost to Follow-up|2
6015788|NCT00812955|20796666|P4|Overall Study|Adverse Event|4
6015789|NCT00812955|20796667|P3|Overall Study|Adverse Event|3
6015790|NCT00812955|20796668|P2|Overall Study|Adverse Event|6
6015791|NCT00812955|20796669|P1|Overall Study|Adverse Event|7
6015792|NCT00812929|20796689|P10|Washout Period 3 (7 Days)|Adverse Event|0
6015793|NCT00812929|20796690|P9|Washout Period 3 (7 Days)|Adverse Event|0
6015794|NCT00812929|20796691|P8|Washout Period 3 (7 Days)|Adverse Event|0
6015795|NCT00812929|20796692|P7|Washout Period 3 (7 Days)|Adverse Event|0
6015796|NCT00812929|20796693|P6|Washout Period 3 (7 Days)|Adverse Event|1
6015797|NCT00812929|20796694|P5|Washout Period 3 (7 Days)|Adverse Event|0
6015798|NCT00812929|20796695|P4|Washout Period 3 (7 Days)|Adverse Event|0
6015799|NCT00812929|20796696|P3|Washout Period 3 (7 Days)|Adverse Event|0
6015800|NCT00812929|20796697|P2|Washout Period 3 (7 Days)|Adverse Event|0
6015801|NCT00812929|20796698|P1|Washout Period 3 (7 Days)|Adverse Event|0
6015802|NCT00812929|20796689|P10|Washout Period 2 (7 Days)|Physician Decision|1
6015803|NCT00812929|20796690|P9|Washout Period 2 (7 Days)|Physician Decision|0
6015804|NCT00812929|20796691|P8|Washout Period 2 (7 Days)|Physician Decision|0
6015805|NCT00812929|20796692|P7|Washout Period 2 (7 Days)|Physician Decision|0
6015806|NCT00812929|20796693|P6|Washout Period 2 (7 Days)|Physician Decision|0
6015807|NCT00812929|20796694|P5|Washout Period 2 (7 Days)|Physician Decision|0
6015808|NCT00812929|20796695|P4|Washout Period 2 (7 Days)|Physician Decision|0
6015809|NCT00812929|20796696|P3|Washout Period 2 (7 Days)|Physician Decision|0
6015810|NCT00812929|20796697|P2|Washout Period 2 (7 Days)|Physician Decision|0
6015811|NCT00812929|20796698|P1|Washout Period 2 (7 Days)|Physician Decision|0
6015812|NCT00812929|20796689|P10|Washout Period 1 (7 Days)|Physician Decision|0
6015813|NCT00812929|20796690|P9|Washout Period 1 (7 Days)|Physician Decision|0
6015814|NCT00812929|20796691|P8|Washout Period 1 (7 Days)|Physician Decision|0
6015815|NCT00812929|20796692|P7|Washout Period 1 (7 Days)|Physician Decision|0
6015816|NCT00812929|20796693|P6|Washout Period 1 (7 Days)|Physician Decision|0
6015817|NCT00812929|20796694|P5|Washout Period 1 (7 Days)|Physician Decision|0
6015818|NCT00812929|20796695|P4|Washout Period 1 (7 Days)|Physician Decision|0
6015819|NCT00812929|20796696|P3|Washout Period 1 (7 Days)|Physician Decision|1
6015820|NCT00812929|20796697|P2|Washout Period 1 (7 Days)|Physician Decision|0
6015821|NCT00812929|20796698|P1|Washout Period 1 (7 Days)|Physician Decision|0
6015822|NCT00812812|20796853|P2|Overall Study|Withdrawal by Subject|2
6015823|NCT00812812|20796854|P1|Overall Study|Withdrawal by Subject|0
6015824|NCT00812812|20796853|P2|Overall Study|Lost to Follow-up|1
6015825|NCT00812812|20796854|P1|Overall Study|Lost to Follow-up|0
6015826|NCT00812812|20796853|P2|Overall Study|Lack of Efficacy|0
6015827|NCT00812812|20796854|P1|Overall Study|Lack of Efficacy|1
6015828|NCT00812812|20796853|P2|Overall Study|Adverse Event|1
6015829|NCT00812812|20796854|P1|Overall Study|Adverse Event|2
6015830|NCT00812708|20796867|P1|Overall Study|Signed consent but later withdrew|3
6015831|NCT00812708|20796867|P1|Overall Study|Surgery cancelled due to uveitis|1
6015832|NCT00812708|20796867|P1|Overall Study|Switched to another study|1
6015833|NCT00812708|20796867|P1|Overall Study|Lack of medical insurance|1
6015834|NCT00812708|20796867|P1|Overall Study|Device could not be implanted|2
6015835|NCT00812565|20796895|P8|Overall Study|Reason Not Specified|0
6015836|NCT00812565|20796896|P7|Overall Study|Reason Not Specified|0
6015837|NCT00812565|20796897|P6|Overall Study|Reason Not Specified|1
6015838|NCT00812565|20796898|P5|Overall Study|Reason Not Specified|0
6015839|NCT00812565|20796899|P4|Overall Study|Reason Not Specified|0
6015840|NCT00812565|20796900|P3|Overall Study|Reason Not Specified|0
6015841|NCT00812565|20796901|P2|Overall Study|Reason Not Specified|0
6015842|NCT00812565|20796902|P1|Overall Study|Reason Not Specified|0
6015843|NCT00812565|20796895|P8|Overall Study|Withdrawal of Consent|0
6015844|NCT00812565|20796896|P7|Overall Study|Withdrawal of Consent|0
6015845|NCT00812565|20796897|P6|Overall Study|Withdrawal of Consent|0
6015846|NCT00812565|20796898|P5|Overall Study|Withdrawal of Consent|1
6015847|NCT00812565|20796899|P4|Overall Study|Withdrawal of Consent|0
6015848|NCT00812565|20796900|P3|Overall Study|Withdrawal of Consent|0
6015849|NCT00812565|20796901|P2|Overall Study|Withdrawal of Consent|0
6015850|NCT00812565|20796902|P1|Overall Study|Withdrawal of Consent|1
6015851|NCT00812565|20796895|P8|Overall Study|Did Not Come to Study Visit|0
6015852|NCT00812565|20796896|P7|Overall Study|Did Not Come to Study Visit|0
6015853|NCT00812565|20796897|P6|Overall Study|Did Not Come to Study Visit|0
6015854|NCT00812565|20796898|P5|Overall Study|Did Not Come to Study Visit|0
6015855|NCT00812565|20796899|P4|Overall Study|Did Not Come to Study Visit|0
6015856|NCT00812565|20796900|P3|Overall Study|Did Not Come to Study Visit|0
6015857|NCT00812565|20796901|P2|Overall Study|Did Not Come to Study Visit|0
6015858|NCT00812565|20796902|P1|Overall Study|Did Not Come to Study Visit|1
6015859|NCT00812565|20796895|P8|Overall Study|Adverse Event|1
6015860|NCT00812565|20796896|P7|Overall Study|Adverse Event|0
6015861|NCT00812565|20796897|P6|Overall Study|Adverse Event|0
6015862|NCT00812565|20796898|P5|Overall Study|Adverse Event|0
6015863|NCT00812565|20796899|P4|Overall Study|Adverse Event|2
6015864|NCT00812565|20796900|P3|Overall Study|Adverse Event|0
6015865|NCT00812565|20796901|P2|Overall Study|Adverse Event|0
6015866|NCT00812565|20796902|P1|Overall Study|Adverse Event|0
6015867|NCT00812565|20796895|P8|Overall Study|Did Not Receive Study Medication|0
6015868|NCT00812565|20796896|P7|Overall Study|Did Not Receive Study Medication|0
6015869|NCT00812565|20796897|P6|Overall Study|Did Not Receive Study Medication|0
6015870|NCT00812565|20796898|P5|Overall Study|Did Not Receive Study Medication|0
6015871|NCT00812565|20796899|P4|Overall Study|Did Not Receive Study Medication|0
6015872|NCT00812565|20796900|P3|Overall Study|Did Not Receive Study Medication|0
6015873|NCT00812565|20796901|P2|Overall Study|Did Not Receive Study Medication|1
6015874|NCT00812565|20796902|P1|Overall Study|Did Not Receive Study Medication|1
6015875|NCT00812487|20797026|P2|Overall Study|Protocol Violation|1
6015876|NCT00812487|20797027|P1|Overall Study|Protocol Violation|0
6015877|NCT00812487|20797026|P2|Overall Study|Transfer to ICU prior to intervention|0
6015878|NCT00812487|20797027|P1|Overall Study|Transfer to ICU prior to intervention|1
6015879|NCT00812487|20797026|P2|Overall Study|Withdrawal by Subject|2
6015880|NCT00812487|20797027|P1|Overall Study|Withdrawal by Subject|3
6015881|NCT00812487|20797026|P2|Overall Study|Lost to Follow-up|0
6015882|NCT00812487|20797027|P1|Overall Study|Lost to Follow-up|2
6015883|NCT00812461|20797053|P2|All Treated Patients|Other Reason|21
6015884|NCT00812461|20797054|P1|All Treated Patients|Other Reason|13
6015885|NCT00812461|20797053|P2|All Treated Patients|Lost to Follow-up|14
6015886|NCT00812461|20797054|P1|All Treated Patients|Lost to Follow-up|11
6015887|NCT00812461|20797053|P2|All Treated Patients|Withdrawal by Subject|54
6015888|NCT00812461|20797054|P1|All Treated Patients|Withdrawal by Subject|45
6015889|NCT00812461|20797053|P2|All Treated Patients|Protocol Violation|27
6015890|NCT00812461|20797054|P1|All Treated Patients|Protocol Violation|36
6015891|NCT00812461|20797053|P2|All Treated Patients|Non-compliance|9
6015892|NCT00812461|20797054|P1|All Treated Patients|Non-compliance|6
6015893|NCT00812461|20797053|P2|All Treated Patients|Lack of Efficacy|7
6015894|NCT00812461|20797054|P1|All Treated Patients|Lack of Efficacy|13
6015895|NCT00812461|20797053|P2|All Treated Patients|Adverse Event|15
6015896|NCT00812461|20797054|P1|All Treated Patients|Adverse Event|8
6015897|NCT00812461|20797053|P2|All Randomised Patients|Did not receive placebo/nalmefene|17
6015898|NCT00812461|20797054|P1|All Randomised Patients|Did not receive placebo/nalmefene|23
6015899|NCT00812331|20797077|P5|Overall Study|Adverse Event|0
6015900|NCT00812331|20797078|P4|Overall Study|Adverse Event|0
6015901|NCT00812331|20797079|P3|Overall Study|Adverse Event|0
6015902|NCT00812331|20797080|P2|Overall Study|Adverse Event|0
6015903|NCT00812331|20797081|P1|Overall Study|Adverse Event|1
6015904|NCT00812253|20797156|P2|Overall Study|Lost to Follow-up|0
6015905|NCT00812253|20797157|P1|Overall Study|Lost to Follow-up|2
6015906|NCT00812253|20797156|P2|Overall Study|Protocol Violation|1
6015907|NCT00812253|20797157|P1|Overall Study|Protocol Violation|1
6015908|NCT00812253|20797156|P2|Overall Study|Withdrawal by Subject|2
6015909|NCT00812253|20797157|P1|Overall Study|Withdrawal by Subject|3
6015910|NCT00812097|20797182|P4|Overall Study|Unknown reasons and patient/doctor moves|5
6015911|NCT00812097|20797183|P3|Overall Study|Unknown reasons and patient/doctor moves|15
6015912|NCT00812097|20797184|P2|Overall Study|Unknown reasons and patient/doctor moves|24
6015913|NCT00812097|20797185|P1|Overall Study|Unknown reasons and patient/doctor moves|111
6015914|NCT00812097|20797182|P4|Overall Study|Explantation of study device(s)|20
6015915|NCT00812097|20797183|P3|Overall Study|Explantation of study device(s)|14
6015916|NCT00812097|20797184|P2|Overall Study|Explantation of study device(s)|29
6015917|NCT00812097|20797185|P1|Overall Study|Explantation of study device(s)|27
6015918|NCT00812097|20797182|P4|Overall Study|Lost to Follow-up|5
6015919|NCT00812097|20797183|P3|Overall Study|Lost to Follow-up|17
6015920|NCT00812097|20797184|P2|Overall Study|Lost to Follow-up|14
6015921|NCT00812097|20797185|P1|Overall Study|Lost to Follow-up|90
6015922|NCT00812097|20797182|P4|Overall Study|Withdrawal by Subject|2
6015923|NCT00812097|20797183|P3|Overall Study|Withdrawal by Subject|8
6015924|NCT00812097|20797184|P2|Overall Study|Withdrawal by Subject|12
6015925|NCT00812097|20797185|P1|Overall Study|Withdrawal by Subject|14
6015926|NCT00812097|20797182|P4|Overall Study|Death|3
6015927|NCT00812097|20797183|P3|Overall Study|Death|3
6015928|NCT00812097|20797184|P2|Overall Study|Death|10
6015929|NCT00812097|20797185|P1|Overall Study|Death|3
6015930|NCT00812006|20797214|P3|Overall Study|Lack of Qualifying Event|2
6015931|NCT00812006|20797215|P2|Overall Study|Lack of Qualifying Event|2
6015932|NCT00812006|20797216|P1|Overall Study|Lack of Qualifying Event|4
6015933|NCT00812006|20797214|P3|Overall Study|Withdrawal by Subject|1
6015934|NCT00812006|20797215|P2|Overall Study|Withdrawal by Subject|1
6015935|NCT00812006|20797216|P1|Overall Study|Withdrawal by Subject|2
6015936|NCT00812006|20797214|P3|Overall Study|Physician Decision|1
6015937|NCT00812006|20797215|P2|Overall Study|Physician Decision|0
6015938|NCT00812006|20797216|P1|Overall Study|Physician Decision|0
6015939|NCT00812006|20797214|P3|Overall Study|Lost to Follow-up|2
6015940|NCT00812006|20797215|P2|Overall Study|Lost to Follow-up|0
6015941|NCT00812006|20797216|P1|Overall Study|Lost to Follow-up|0
6015942|NCT00811954|20797233|P3|Overall Study|Complete Protocol: No follow-up|1
6015943|NCT00811954|20797234|P2|Overall Study|Complete Protocol: No follow-up|0
6015944|NCT00811954|20797235|P1|Overall Study|Complete Protocol: No follow-up|0
6015945|NCT00811954|20797233|P3|Overall Study|Severe Debilitation|1
6015946|NCT00811954|20797234|P2|Overall Study|Severe Debilitation|0
6015947|NCT00811954|20797235|P1|Overall Study|Severe Debilitation|2
6015948|NCT00811954|20797233|P3|Overall Study|Site Closure|1
6015949|NCT00811954|20797234|P2|Overall Study|Site Closure|0
6015950|NCT00811954|20797235|P1|Overall Study|Site Closure|4
6015951|NCT00811954|20797233|P3|Overall Study|Withdraw consent prior study completion|5
6015952|NCT00811954|20797234|P2|Overall Study|Withdraw consent prior study completion|6
6015953|NCT00811954|20797235|P1|Overall Study|Withdraw consent prior study completion|4
6015954|NCT00811954|20797233|P3|Overall Study|Not willing to adhere to requirements|16
6015955|NCT00811954|20797234|P2|Overall Study|Not willing to adhere to requirements|2
6015956|NCT00811954|20797235|P1|Overall Study|Not willing to adhere to requirements|12
6015957|NCT00811954|20797233|P3|Overall Study|Not able to get to clinic|30
6015958|NCT00811954|20797234|P2|Overall Study|Not able to get to clinic|35
6015959|NCT00811954|20797235|P1|Overall Study|Not able to get to clinic|28
6015960|NCT00811954|20797233|P3|Overall Study|Lost to Follow-up|34
6015961|NCT00811954|20797234|P2|Overall Study|Lost to Follow-up|23
6015962|NCT00811954|20797235|P1|Overall Study|Lost to Follow-up|29
6015963|NCT00811954|20797233|P3|Overall Study|Death|13
6015964|NCT00811954|20797234|P2|Overall Study|Death|6
6015965|NCT00811954|20797235|P1|Overall Study|Death|10
6015966|NCT00811941|20797299|P2|All Treated Patients|Other Reason|14
6015967|NCT00811941|20797300|P1|All Treated Patients|Other Reason|4
6015968|NCT00811941|20797299|P2|All Treated Patients|Lost to Follow-up|12
6015969|NCT00811941|20797300|P1|All Treated Patients|Lost to Follow-up|3
6015970|NCT00811941|20797299|P2|All Treated Patients|Withdrawal by Subject|94
6015971|NCT00811941|20797300|P1|All Treated Patients|Withdrawal by Subject|35
6015972|NCT00811941|20797299|P2|All Treated Patients|Protocol Violation|17
6015973|NCT00811941|20797300|P1|All Treated Patients|Protocol Violation|5
6015974|NCT00811941|20797299|P2|All Treated Patients|Non-compliance|8
6015975|NCT00811941|20797300|P1|All Treated Patients|Non-compliance|1
6015976|NCT00811941|20797299|P2|All Treated Patients|Lack of Efficacy|3
6015977|NCT00811941|20797300|P1|All Treated Patients|Lack of Efficacy|2
6015978|NCT00811941|20797299|P2|All Treated Patients|Adverse Event|43
6015979|NCT00811941|20797300|P1|All Treated Patients|Adverse Event|2
6015980|NCT00811941|20797299|P2|All Randomised Patients|Did not receive placebo/nalmefene|8
6015981|NCT00811941|20797300|P1|All Randomised Patients|Did not receive placebo/nalmefene|2
6015982|NCT00811928|20797338|P2|Overall Study|Poor Compliance|5
6015983|NCT00811928|20797339|P1|Overall Study|Poor Compliance|2
6015984|NCT00811928|20797338|P2|Overall Study|Investigator Decision|1
6015985|NCT00811928|20797339|P1|Overall Study|Investigator Decision|2
6015986|NCT00811928|20797338|P2|Overall Study|Without Primary Efficacy Endpoint Data|4
6015987|NCT00811928|20797339|P1|Overall Study|Without Primary Efficacy Endpoint Data|7
6015988|NCT00811928|20797338|P2|Overall Study|Did Not Take Study Drug|0
6015989|NCT00811928|20797339|P1|Overall Study|Did Not Take Study Drug|3
6015990|NCT00811928|20797338|P2|Overall Study|Withdrawal by Subject|12
6015991|NCT00811928|20797339|P1|Overall Study|Withdrawal by Subject|18
6015992|NCT00811928|20797338|P2|Overall Study|AEs and SAEs Including Death|11
6015993|NCT00811928|20797339|P1|Overall Study|AEs and SAEs Including Death|7
6015994|NCT00811733|20797383|P2|Overall Study|Withdrawal by Subject|2
6015995|NCT00811733|20797384|P1|Overall Study|Withdrawal by Subject|1
6015996|NCT00811733|20797383|P2|Overall Study|Investigator Discretion|8
6015997|NCT00811733|20797384|P1|Overall Study|Investigator Discretion|10
6015998|NCT00811720|20797432|P2|All Treated Patients|Other Reason|4
6015999|NCT00811720|20797433|P1|All Treated Patients|Other Reason|7
6016000|NCT00811720|20797432|P2|All Treated Patients|Lost to Follow-up|16
6016001|NCT00811720|20797433|P1|All Treated Patients|Lost to Follow-up|10
6016002|NCT00811720|20797432|P2|All Treated Patients|Withdrawal by Subject|34
6016003|NCT00811720|20797433|P1|All Treated Patients|Withdrawal by Subject|28
6016004|NCT00811720|20797432|P2|All Treated Patients|Protocol Violation|16
6016005|NCT00811720|20797433|P1|All Treated Patients|Protocol Violation|9
6016006|NCT00811720|20797432|P2|All Treated Patients|Non-compliance|14
6016007|NCT00811720|20797433|P1|All Treated Patients|Non-compliance|0
6016008|NCT00811720|20797432|P2|All Treated Patients|Lack of Efficacy|18
6016009|NCT00811720|20797433|P1|All Treated Patients|Lack of Efficacy|22
6016010|NCT00811720|20797432|P2|All Treated Patients|Adverse Event|62
6016011|NCT00811720|20797433|P1|All Treated Patients|Adverse Event|20
6016012|NCT00811720|20797432|P2|All Randomised Patients|Did not receive placebo/nalmefene|4
6016013|NCT00811720|20797433|P1|All Randomised Patients|Did not receive placebo/nalmefene|2
6016014|NCT00811655|20797451|P1|Overall Study|Physician Decision|1
6016015|NCT00811642|20797463|P1|Overall Study|Cumulative use of antifungal agent|2
6016016|NCT00811642|20797463|P1|Overall Study|Withdrawal by Subject|7
6016017|NCT00811642|20797463|P1|Overall Study|Death|2
6016018|NCT00811642|20797463|P1|Overall Study|Protocol Violation|1
6016019|NCT00811642|20797463|P1|Overall Study|Adverse Event|3
6016020|NCT00811577|20797479|P2|Overall Study|Withdrawal by Subject|0
6016021|NCT00811577|20797480|P1|Overall Study|Withdrawal by Subject|3
6016022|NCT00811577|20797479|P2|Overall Study|Lost to Follow-up|1
6016023|NCT00811577|20797480|P1|Overall Study|Lost to Follow-up|7
6016024|NCT00811473|20797540|P2|Overall Study|Safety Reasons|0
6016025|NCT00811473|20797541|P1|Overall Study|Safety Reasons|1
6016026|NCT00811473|20797540|P2|Overall Study|Incorrect Enrollment|0
6016027|NCT00811473|20797541|P1|Overall Study|Incorrect Enrollment|1
6016028|NCT00811473|20797540|P2|Overall Study|Other 2|1
6016029|NCT00811473|20797541|P1|Overall Study|Other 2|4
6016030|NCT00811473|20797540|P2|Overall Study|Condition under investigation worsened|3
6016031|NCT00811473|20797541|P1|Overall Study|Condition under investigation worsened|1
6016032|NCT00811473|20797540|P2|Overall Study|Lack of therapeutic response|1
6016033|NCT00811473|20797541|P1|Overall Study|Lack of therapeutic response|4
6016034|NCT00811473|20797540|P2|Overall Study|Severe non-compliance to protocol|4
6016035|NCT00811473|20797541|P1|Overall Study|Severe non-compliance to protocol|2
6016036|NCT00811473|20797540|P2|Overall Study|Withdrawal by Subject|4
6016037|NCT00811473|20797541|P1|Overall Study|Withdrawal by Subject|2
6016038|NCT00811473|20797540|P2|Overall Study|Lost to Follow-up|1
6016039|NCT00811473|20797541|P1|Overall Study|Lost to Follow-up|5
6016040|NCT00811473|20797540|P2|Overall Study|Adverse Event|12
6016041|NCT00811473|20797541|P1|Overall Study|Adverse Event|3
6016042|NCT00811395|20797572|P6|Extension Treatment|Other than above|0
6016043|NCT00811395|20797573|P5|Extension Treatment|Other than above|0
6016044|NCT00811395|20797574|P4|Extension Treatment|Other than above|0
6016045|NCT00811395|20797575|P3|Extension Treatment|Other than above|1
6016046|NCT00811395|20797576|P2|Extension Treatment|Other than above|0
6016047|NCT00811395|20797577|P1|Extension Treatment|Other than above|0
6016048|NCT00811395|20797572|P6|Extension Treatment|Participant did not wish to continue|1
6016049|NCT00811395|20797573|P5|Extension Treatment|Participant did not wish to continue|0
6016050|NCT00811395|20797574|P4|Extension Treatment|Participant did not wish to continue|1
6016051|NCT00811395|20797575|P3|Extension Treatment|Participant did not wish to continue|0
6016052|NCT00811395|20797576|P2|Extension Treatment|Participant did not wish to continue|3
6016053|NCT00811395|20797577|P1|Extension Treatment|Participant did not wish to continue|0
6016054|NCT00811395|20797572|P6|Extension Treatment|Progressive disease|0
6016055|NCT00811395|20797573|P5|Extension Treatment|Progressive disease|0
6016056|NCT00811395|20797574|P4|Extension Treatment|Progressive disease|0
6016057|NCT00811395|20797575|P3|Extension Treatment|Progressive disease|0
6016058|NCT00811395|20797576|P2|Extension Treatment|Progressive disease|1
6016059|NCT00811395|20797577|P1|Extension Treatment|Progressive disease|1
6016060|NCT00811395|20797572|P6|Extension Treatment|Adverse Event|1
6016061|NCT00811395|20797573|P5|Extension Treatment|Adverse Event|0
6016062|NCT00811395|20797574|P4|Extension Treatment|Adverse Event|2
6016063|NCT00811395|20797575|P3|Extension Treatment|Adverse Event|2
6016064|NCT00811395|20797576|P2|Extension Treatment|Adverse Event|2
6016065|NCT00811395|20797577|P1|Extension Treatment|Adverse Event|1
6016066|NCT00811252|20797683|P3|Overall Study|Administrative or Other Reasons|2
6016067|NCT00811252|20797684|P2|Overall Study|Administrative or Other Reasons|3
6016068|NCT00811252|20797685|P1|Overall Study|Administrative or Other Reasons|0
6016069|NCT00811252|20797683|P3|Overall Study|Lost to Follow-up|2
6016070|NCT00811252|20797684|P2|Overall Study|Lost to Follow-up|0
6016071|NCT00811252|20797685|P1|Overall Study|Lost to Follow-up|0
6016072|NCT00811252|20797683|P3|Overall Study|Withdrawal of Consent|2
6016073|NCT00811252|20797684|P2|Overall Study|Withdrawal of Consent|2
6016074|NCT00811252|20797685|P1|Overall Study|Withdrawal of Consent|1
6016075|NCT00811252|20797683|P3|Overall Study|Protocol Violation|2
6016076|NCT00811252|20797684|P2|Overall Study|Protocol Violation|3
6016077|NCT00811252|20797685|P1|Overall Study|Protocol Violation|3
6016078|NCT00811252|20797683|P3|Overall Study|Lack of Efficacy|0
6016079|NCT00811252|20797684|P2|Overall Study|Lack of Efficacy|2
6016080|NCT00811252|20797685|P1|Overall Study|Lack of Efficacy|7
6016081|NCT00811252|20797683|P3|Overall Study|Adverse Event|15
6016082|NCT00811252|20797684|P2|Overall Study|Adverse Event|10
6016083|NCT00811252|20797685|P1|Overall Study|Adverse Event|6
6016084|NCT00811187|20797731|P2|Overall Study|Unable to place device / procedure abort|3
6016085|NCT00811187|20797732|P1|Overall Study|Unable to place device / procedure abort|3
6016086|NCT00811174|20797738|P1|Overall Study|Sponsors Decision|1
6016087|NCT00811174|20797738|P1|Overall Study|Protocol Violation|2
6016088|NCT00811135|20797749|P1|Overall Study|Ongoing|59
6016089|NCT00811135|20797749|P1|Overall Study|Administrative/Other Unspecified|11
6016090|NCT00811135|20797749|P1|Overall Study|Withdrawal by Subject|3
6016091|NCT00811135|20797749|P1|Overall Study|Refused Treatment|1
6016092|NCT00811135|20797749|P1|Overall Study|Violation of Selection Criteria|1
6016093|NCT00811135|20797749|P1|Overall Study|Protocol Violation|2
6016094|NCT00811135|20797749|P1|Overall Study|Death|3
6016095|NCT00811135|20797749|P1|Overall Study|Adverse Event/Intercurrent Illness|8
6016096|NCT00811070|20797767|P6|Overall Study|Physician Decision|1
6016097|NCT00811070|20797768|P5|Overall Study|Physician Decision|0
6016098|NCT00811070|20797769|P4|Overall Study|Physician Decision|0
6016099|NCT00811070|20797770|P3|Overall Study|Physician Decision|0
6016100|NCT00811070|20797771|P2|Overall Study|Physician Decision|0
6016101|NCT00811070|20797772|P1|Overall Study|Physician Decision|0
6016102|NCT00811070|20797767|P6|Overall Study|Withdrawal by Subject|0
6016103|NCT00811070|20797768|P5|Overall Study|Withdrawal by Subject|0
6016104|NCT00811070|20797769|P4|Overall Study|Withdrawal by Subject|0
6016105|NCT00811070|20797770|P3|Overall Study|Withdrawal by Subject|0
6016106|NCT00811070|20797771|P2|Overall Study|Withdrawal by Subject|1
6016107|NCT00811070|20797772|P1|Overall Study|Withdrawal by Subject|0
6016108|NCT00811070|20797767|P6|Overall Study|Other|0
6016109|NCT00811070|20797768|P5|Overall Study|Other|0
6016110|NCT00811070|20797769|P4|Overall Study|Other|0
6016111|NCT00811070|20797770|P3|Overall Study|Other|0
6016112|NCT00811070|20797771|P2|Overall Study|Other|0
6016113|NCT00811070|20797772|P1|Overall Study|Other|1
6016114|NCT00811070|20797767|P6|Overall Study|Death|0
6016115|NCT00811070|20797768|P5|Overall Study|Death|5
6016116|NCT00811070|20797769|P4|Overall Study|Death|2
6016117|NCT00811070|20797770|P3|Overall Study|Death|0
6016118|NCT00811070|20797771|P2|Overall Study|Death|0
6016119|NCT00811070|20797772|P1|Overall Study|Death|0
6016120|NCT00811057|20797832|P3|Overall Study|Protocol Violation|10
6016121|NCT00811057|20797833|P2|Overall Study|Protocol Violation|10
6016122|NCT00811057|20797834|P1|Overall Study|Protocol Violation|5
6016123|NCT00811018|20797845|P1|Overall Study|Other|26
6016124|NCT00811018|20797845|P1|Overall Study|WHO FC deterioration and 6MWD decrease|9
6016125|NCT00811018|20797845|P1|Overall Study|Withdrawal by Subject|70
6016126|NCT00811018|20797845|P1|Overall Study|Sponsor Decision|450
6016127|NCT00811018|20797845|P1|Overall Study|Pregnancy|6
6016128|NCT00811018|20797845|P1|Overall Study|Lost to Follow-up|19
6016129|NCT00811018|20797845|P1|Overall Study|Investigator Decision|57
6016130|NCT00811018|20797845|P1|Overall Study|ALT/AST >5x Upper Limit of Normal (ULN)|70
6016131|NCT00811018|20797845|P1|Overall Study|ALT/AST >3x UNL, Bilirubin >2xUNL|4
6016132|NCT00811018|20797845|P1|Overall Study|Death|147
6016133|NCT00811018|20797845|P1|Overall Study|Adverse Event|79
6016134|NCT00811018|20797845|P1|Overall Study|Additional Chronic Treatment|31
6016135|NCT00810901|20797863|P2|Overall Study|Lost to Follow-up|58
6016136|NCT00810901|20797864|P1|Overall Study|Lost to Follow-up|88
6016137|NCT00810810|20797910|P4|Overall Study|Physician Decision|5
6016138|NCT00810810|20797911|P3|Overall Study|Physician Decision|1
6016139|NCT00810810|20797912|P2|Overall Study|Physician Decision|3
6016140|NCT00810810|20797913|P1|Overall Study|Physician Decision|0
6016141|NCT00810810|20797910|P4|Overall Study|Withdrawal by Subject|8
6016142|NCT00810810|20797911|P3|Overall Study|Withdrawal by Subject|10
6016143|NCT00810810|20797912|P2|Overall Study|Withdrawal by Subject|8
6016144|NCT00810810|20797913|P1|Overall Study|Withdrawal by Subject|0
6016145|NCT00810693|20797966|P3|Follow-up Period (FUP)|Withdrawal by Subject|0
6016146|NCT00810693|20797967|P2|Follow-up Period (FUP)|Withdrawal by Subject|1
6016147|NCT00810693|20797968|P1|Follow-up Period (FUP)|Withdrawal by Subject|2
6016148|NCT00810693|20797966|P3|Follow-up Period (FUP)|Protocol Violation|0
6016149|NCT00810693|20797967|P2|Follow-up Period (FUP)|Protocol Violation|1
6016150|NCT00810693|20797968|P1|Follow-up Period (FUP)|Protocol Violation|0
6016151|NCT00810693|20797966|P3|Follow-up Period (FUP)|Lost to Follow-up|2
6016152|NCT00810693|20797967|P2|Follow-up Period (FUP)|Lost to Follow-up|0
6016153|NCT00810693|20797968|P1|Follow-up Period (FUP)|Lost to Follow-up|1
6016154|NCT00810693|20797966|P3|Follow-up Period (FUP)|Death|1
6016155|NCT00810693|20797967|P2|Follow-up Period (FUP)|Death|0
6016156|NCT00810693|20797968|P1|Follow-up Period (FUP)|Death|2
6016157|NCT00810693|20797966|P3|Follow-up Period (FUP)|Adverse Event|1
6016158|NCT00810693|20797967|P2|Follow-up Period (FUP)|Adverse Event|1
6016159|NCT00810693|20797968|P1|Follow-up Period (FUP)|Adverse Event|3
6016160|NCT00810693|20797966|P3|Treatment Period|Not treated|1
6016161|NCT00810693|20797967|P2|Treatment Period|Not treated|1
6016162|NCT00810693|20797968|P1|Treatment Period|Not treated|0
6016163|NCT00810693|20797966|P3|Treatment Period|Withdrawal by Subject|3
6016164|NCT00810693|20797967|P2|Treatment Period|Withdrawal by Subject|2
6016165|NCT00810693|20797968|P1|Treatment Period|Withdrawal by Subject|6
6016166|NCT00810693|20797966|P3|Treatment Period|Protocol Violation|2
6016167|NCT00810693|20797967|P2|Treatment Period|Protocol Violation|2
6016168|NCT00810693|20797968|P1|Treatment Period|Protocol Violation|1
6016169|NCT00810693|20797966|P3|Treatment Period|Non-compliance|0
6016170|NCT00810693|20797967|P2|Treatment Period|Non-compliance|0
6016171|NCT00810693|20797968|P1|Treatment Period|Non-compliance|1
6016172|NCT00810693|20797966|P3|Treatment Period|Lost to Follow-up|0
6016173|NCT00810693|20797967|P2|Treatment Period|Lost to Follow-up|0
6016174|NCT00810693|20797968|P1|Treatment Period|Lost to Follow-up|1
6016175|NCT00810693|20797966|P3|Treatment Period|Lack of Efficacy|1
6016176|NCT00810693|20797967|P2|Treatment Period|Lack of Efficacy|0
6016177|NCT00810693|20797968|P1|Treatment Period|Lack of Efficacy|0
6016178|NCT00810693|20797966|P3|Treatment Period|Death|2
6016179|NCT00810693|20797967|P2|Treatment Period|Death|1
6016180|NCT00810693|20797968|P1|Treatment Period|Death|0
6016181|NCT00810693|20797966|P3|Treatment Period|Adverse Event|7
6016182|NCT00810693|20797967|P2|Treatment Period|Adverse Event|1
6016183|NCT00810693|20797968|P1|Treatment Period|Adverse Event|8
6016184|NCT00810641|20798000|P3|Overall Study|Withdrawal by Subject|2
6016185|NCT00810641|20798001|P2|Overall Study|Withdrawal by Subject|1
6016186|NCT00810641|20798002|P1|Overall Study|Withdrawal by Subject|0
6016187|NCT00810615|20798012|P2|Overall Study|Withdrawal by Subject|1
6016188|NCT00810615|20798013|P1|Overall Study|Withdrawal by Subject|1
6016189|NCT00810602|20798063|P2|Overall Study|Withdrawal by Subject|3
6016190|NCT00810602|20798064|P1|Overall Study|Withdrawal by Subject|8
6016191|NCT00810511|20798077|P2|Overall Study|deposits on contact lens|1
6016192|NCT00810511|20798078|P1|Overall Study|deposits on contact lens|0
6016193|NCT00810511|20798077|P2|Overall Study|Lost to Follow-up|0
6016194|NCT00810511|20798078|P1|Overall Study|Lost to Follow-up|1
6016195|NCT00810511|20798077|P2|Overall Study|death in the family|1
6016196|NCT00810511|20798078|P1|Overall Study|death in the family|0
6016197|NCT00810511|20798077|P2|Overall Study|Lack of Efficacy|1
6016198|NCT00810511|20798078|P1|Overall Study|Lack of Efficacy|9
6016199|NCT00810511|20798077|P2|Overall Study|Protocol Violation|1
6016200|NCT00810511|20798078|P1|Overall Study|Protocol Violation|0
6016201|NCT00810407|20798096|P1|Overall Study|No Visit After First Day of Treatment|3
6016202|NCT00810407|20798096|P1|Overall Study|Protocol Violation|3
6016203|NCT00810394|20798108|P1|Overall Study|Withdrawal by Subject|3
6016204|NCT00810368|20798116|P2|Overall Study|Lack of Efficacy|0
6016205|NCT00810368|20798117|P1|Overall Study|Lack of Efficacy|2
6016206|NCT00810368|20798116|P2|Overall Study|Lost to Follow-up|2
6016207|NCT00810368|20798117|P1|Overall Study|Lost to Follow-up|4
6016208|NCT00810355|20798138|P3|Overall Study|Withdrawal by Subject|0
6016209|NCT00810355|20798139|P2|Overall Study|Withdrawal by Subject|0
6016210|NCT00810355|20798140|P1|Overall Study|Withdrawal by Subject|1
6016211|NCT00810355|20798138|P3|Overall Study|Lost to Follow-up|11
6016212|NCT00810355|20798139|P2|Overall Study|Lost to Follow-up|17
6016213|NCT00810355|20798140|P1|Overall Study|Lost to Follow-up|13
6016214|NCT00810342|20798156|P2|12-month Followup|Lost to Follow-up|1
6016215|NCT00810342|20798157|P1|12-month Followup|Lost to Follow-up|3
6016216|NCT00810342|20798156|P2|12-month Followup|Pregnancy|10
6016217|NCT00810342|20798157|P1|12-month Followup|Pregnancy|9
6016218|NCT00810342|20798156|P2|6-month Follow-up|Pregnancy|2
6016219|NCT00810342|20798157|P1|6-month Follow-up|Pregnancy|6
6016220|NCT00810342|20798156|P2|6-month Follow-up|Lost to Follow-up|6
6016221|NCT00810342|20798157|P1|6-month Follow-up|Lost to Follow-up|18
6016222|NCT00810342|20798156|P2|Month 1 Follow-up|Pregnancy|0
6016223|NCT00810342|20798157|P1|Month 1 Follow-up|Pregnancy|1
6016224|NCT00810342|20798156|P2|Month 1 Follow-up|Lost to Follow-up|2
6016225|NCT00810342|20798157|P1|Month 1 Follow-up|Lost to Follow-up|4
6016226|NCT00810277|20798190|P1|Overall Study|Adverse Event|1
6016227|NCT00810264|20798203|P1|Overall Study|Death|641
6016228|NCT00810264|20798203|P1|Overall Study|Withdrawal by subject or physician|721
6016229|NCT00810264|20798203|P1|Overall Study|Lost to Follow-up|191
6016230|NCT00810199|20798230|P2|Overall Study|Did not receive study drug|1
6016231|NCT00810199|20798231|P1|Overall Study|Did not receive study drug|2
6016232|NCT00810199|20798230|P2|Overall Study|Failure to return|4
6016233|NCT00810199|20798231|P1|Overall Study|Failure to return|1
6016234|NCT00810199|20798230|P2|Overall Study|Protocol Violation|6
6016235|NCT00810199|20798231|P1|Overall Study|Protocol Violation|2
6016236|NCT00810199|20798230|P2|Overall Study|Administrative/Other|6
6016237|NCT00810199|20798231|P1|Overall Study|Administrative/Other|5
6016238|NCT00810199|20798230|P2|Overall Study|Refused treatment/Did not cooperate|7
6016239|NCT00810199|20798231|P1|Overall Study|Refused treatment/Did not cooperate|7
6016240|NCT00810199|20798230|P2|Overall Study|Insufficient therapeutic response|14
6016241|NCT00810199|20798231|P1|Overall Study|Insufficient therapeutic response|5
6016242|NCT00810199|20798230|P2|Overall Study|Withdrew consent|12
6016243|NCT00810199|20798231|P1|Overall Study|Withdrew consent|9
6016244|NCT00810199|20798230|P2|Overall Study|Death|6
6016245|NCT00810199|20798231|P1|Overall Study|Death|4
6016246|NCT00810199|20798230|P2|Overall Study|Adverse Event|26
6016247|NCT00810199|20798231|P1|Overall Study|Adverse Event|24
6016248|NCT00810108|20798309|P2|Overall Study|Withdrawal by Subject|0
6016249|NCT00810108|20798310|P1|Overall Study|Withdrawal by Subject|1
6016250|NCT00810082|20798324|P2|Overall Study|Lost to Follow-up|4
6016251|NCT00810082|20798325|P1|Overall Study|Lost to Follow-up|0
6016252|NCT00810069|20798333|P3|Double-Blind Period II|Protocol Violation|6
6016253|NCT00810069|20798334|P2|Double-Blind Period II|Protocol Violation|7
6016254|NCT00810069|20798335|P1|Double-Blind Period II|Protocol Violation|0
6016255|NCT00810069|20798333|P3|Double-Blind Period II|Clinical relapse|0
6016256|NCT00810069|20798334|P2|Double-Blind Period II|Clinical relapse|3
6016257|NCT00810069|20798335|P1|Double-Blind Period II|Clinical relapse|0
6016258|NCT00810069|20798333|P3|Double-Blind Period II|Protocol entry criterion not met|1
6016259|NCT00810069|20798334|P2|Double-Blind Period II|Protocol entry criterion not met|0
6016260|NCT00810069|20798335|P1|Double-Blind Period II|Protocol entry criterion not met|0
6016261|NCT00810069|20798333|P3|Double-Blind Period II|Withdrawal by Subject|35
6016262|NCT00810069|20798334|P2|Double-Blind Period II|Withdrawal by Subject|21
6016263|NCT00810069|20798335|P1|Double-Blind Period II|Withdrawal by Subject|0
6016264|NCT00810069|20798333|P3|Double-Blind Period II|Physician Decision|1
6016265|NCT00810069|20798334|P2|Double-Blind Period II|Physician Decision|0
6016266|NCT00810069|20798335|P1|Double-Blind Period II|Physician Decision|0
6016267|NCT00810069|20798333|P3|Double-Blind Period II|Lost to Follow-up|9
6016268|NCT00810069|20798334|P2|Double-Blind Period II|Lost to Follow-up|9
6016269|NCT00810069|20798335|P1|Double-Blind Period II|Lost to Follow-up|0
6016270|NCT00810069|20798333|P3|Double-Blind Period II|Lack of Efficacy|12
6016271|NCT00810069|20798334|P2|Double-Blind Period II|Lack of Efficacy|7
6016272|NCT00810069|20798335|P1|Double-Blind Period II|Lack of Efficacy|0
6016273|NCT00810069|20798333|P3|Double-Blind Period II|Adverse Event|8
6016274|NCT00810069|20798334|P2|Double-Blind Period II|Adverse Event|9
6016275|NCT00810069|20798335|P1|Double-Blind Period II|Adverse Event|0
6016276|NCT00810069|20798333|P3|Lead-in Period I|Randomization criteria not met|0
6016277|NCT00810069|20798334|P2|Lead-in Period I|Randomization criteria not met|0
6016278|NCT00810069|20798335|P1|Lead-in Period I|Randomization criteria not met|158
6016279|NCT00810069|20798333|P3|Lead-in Period I|Protocol entry criterion not met|0
6016280|NCT00810069|20798334|P2|Lead-in Period I|Protocol entry criterion not met|0
6016281|NCT00810069|20798335|P1|Lead-in Period I|Protocol entry criterion not met|5
6016282|NCT00810069|20798333|P3|Lead-in Period I|Withdrawal by Subject|0
6016283|NCT00810069|20798334|P2|Lead-in Period I|Withdrawal by Subject|0
6016284|NCT00810069|20798335|P1|Lead-in Period I|Withdrawal by Subject|46
6016285|NCT00810069|20798333|P3|Lead-in Period I|Protocol Violation|0
6016286|NCT00810069|20798334|P2|Lead-in Period I|Protocol Violation|0
6016287|NCT00810069|20798335|P1|Lead-in Period I|Protocol Violation|1
6016288|NCT00810069|20798333|P3|Lead-in Period I|Physician Decision|0
6016289|NCT00810069|20798334|P2|Lead-in Period I|Physician Decision|0
6016290|NCT00810069|20798335|P1|Lead-in Period I|Physician Decision|1
6016291|NCT00810069|20798333|P3|Lead-in Period I|Lost to Follow-up|0
6016292|NCT00810069|20798334|P2|Lead-in Period I|Lost to Follow-up|0
6016293|NCT00810069|20798335|P1|Lead-in Period I|Lost to Follow-up|19
6016294|NCT00810069|20798333|P3|Lead-in Period I|Lack of Efficacy|0
6016295|NCT00810069|20798334|P2|Lead-in Period I|Lack of Efficacy|0
6016296|NCT00810069|20798335|P1|Lead-in Period I|Lack of Efficacy|1
6016297|NCT00810069|20798333|P3|Lead-in Period I|Adverse Event|0
6016298|NCT00810069|20798334|P2|Lead-in Period I|Adverse Event|0
6016299|NCT00810069|20798335|P1|Lead-in Period I|Adverse Event|43
6016300|NCT00810043|20798380|P3|Overall Study|No longer met enrollment criteria|3
6016301|NCT00810043|20798381|P2|Overall Study|No longer met enrollment criteria|0
6016302|NCT00810043|20798382|P1|Overall Study|No longer met enrollment criteria|0
6016303|NCT00810043|20798380|P3|Overall Study|Non-medical problem|1
6016304|NCT00810043|20798381|P2|Overall Study|Non-medical problem|0
6016305|NCT00810043|20798382|P1|Overall Study|Non-medical problem|0
6016306|NCT00810043|20798380|P3|Overall Study|Unrelated medical problem|0
6016307|NCT00810043|20798381|P2|Overall Study|Unrelated medical problem|1
6016308|NCT00810043|20798382|P1|Overall Study|Unrelated medical problem|0
6016309|NCT00810043|20798380|P3|Overall Study|Death|0
6016310|NCT00810043|20798381|P2|Overall Study|Death|0
6016311|NCT00810043|20798382|P1|Overall Study|Death|2
6016312|NCT00810043|20798380|P3|Overall Study|Physician Decision|2
6016313|NCT00810043|20798381|P2|Overall Study|Physician Decision|0
6016314|NCT00810043|20798382|P1|Overall Study|Physician Decision|0
6016315|NCT00810043|20798380|P3|Overall Study|Lost to Follow-up|0
6016316|NCT00810043|20798381|P2|Overall Study|Lost to Follow-up|0
6016317|NCT00810043|20798382|P1|Overall Study|Lost to Follow-up|1
6016318|NCT00810043|20798380|P3|Overall Study|Withdrawal by Subject|2
6016319|NCT00810043|20798381|P2|Overall Study|Withdrawal by Subject|0
6016320|NCT00810043|20798382|P1|Overall Study|Withdrawal by Subject|1
6016321|NCT00809965|20798404|P3|Overall Study|Other Reason|189
6016322|NCT00809965|20798405|P2|Overall Study|Other Reason|170
6016323|NCT00809965|20798406|P1|Overall Study|Other Reason|167
6016324|NCT00809965|20798404|P3|Overall Study|Withdrawal by Subject|441
6016325|NCT00809965|20798405|P2|Overall Study|Withdrawal by Subject|448
6016326|NCT00809965|20798406|P1|Overall Study|Withdrawal by Subject|405
6016327|NCT00809965|20798404|P3|Overall Study|Lost to Follow-up|18
6016328|NCT00809965|20798405|P2|Overall Study|Lost to Follow-up|10
6016329|NCT00809965|20798406|P1|Overall Study|Lost to Follow-up|17
6016330|NCT00809965|20798404|P3|Overall Study|Death|196
6016331|NCT00809965|20798405|P2|Overall Study|Death|147
6016332|NCT00809965|20798406|P1|Overall Study|Death|194
6016333|NCT00809926|20798428|P2|Overall Study|Protocol deviation|2
6016334|NCT00809926|20798429|P1|Overall Study|Protocol deviation|0
6016335|NCT00809926|20798428|P2|Overall Study|Administrative Problems|1
6016336|NCT00809926|20798429|P1|Overall Study|Administrative Problems|0
6016337|NCT00809926|20798428|P2|Overall Study|Lost to Follow-up|1
6016338|NCT00809926|20798429|P1|Overall Study|Lost to Follow-up|2
6016339|NCT00809926|20798428|P2|Overall Study|Patient withdrew consent|6
6016340|NCT00809926|20798429|P1|Overall Study|Patient withdrew consent|8
6016341|NCT00809926|20798428|P2|Overall Study|Unsatisfactory therapeutic effect|3
6016342|NCT00809926|20798429|P1|Overall Study|Unsatisfactory therapeutic effect|3
6016343|NCT00809926|20798428|P2|Overall Study|Adverse Event|10
6016344|NCT00809926|20798429|P1|Overall Study|Adverse Event|18
6016345|NCT00809835|20798483|P4|Overall Study|Withdrawal by Subject|0
6016346|NCT00809835|20798484|P3|Overall Study|Withdrawal by Subject|1
6016347|NCT00809835|20798485|P2|Overall Study|Withdrawal by Subject|1
6016348|NCT00809835|20798486|P1|Overall Study|Withdrawal by Subject|1
6016349|NCT00809835|20798483|P4|Overall Study|Lost to Follow-up|2
6016350|NCT00809835|20798484|P3|Overall Study|Lost to Follow-up|10
6016351|NCT00809835|20798485|P2|Overall Study|Lost to Follow-up|6
6016352|NCT00809835|20798486|P1|Overall Study|Lost to Follow-up|7
6016353|NCT00809757|20798516|P3|Overall Study|Noncompliance with Medication|1
6016354|NCT00809757|20798517|P2|Overall Study|Noncompliance with Medication|0
6016355|NCT00809757|20798518|P1|Overall Study|Noncompliance with Medication|0
6016356|NCT00809757|20798516|P3|Overall Study|Subject Uncooperative|2
6016357|NCT00809757|20798517|P2|Overall Study|Subject Uncooperative|0
6016358|NCT00809757|20798518|P1|Overall Study|Subject Uncooperative|1
6016359|NCT00809757|20798516|P3|Overall Study|Withdrawal by Subject|3
6016360|NCT00809757|20798517|P2|Overall Study|Withdrawal by Subject|1
6016361|NCT00809757|20798518|P1|Overall Study|Withdrawal by Subject|2
6016362|NCT00809757|20798516|P3|Overall Study|Protocol Violation|1
6016363|NCT00809757|20798517|P2|Overall Study|Protocol Violation|1
6016364|NCT00809757|20798518|P1|Overall Study|Protocol Violation|1
6016365|NCT00809757|20798516|P3|Overall Study|Lost to Follow-up|1
6016366|NCT00809757|20798517|P2|Overall Study|Lost to Follow-up|0
6016367|NCT00809757|20798518|P1|Overall Study|Lost to Follow-up|0
6016368|NCT00809757|20798516|P3|Overall Study|Adverse Event|3
6016369|NCT00809757|20798517|P2|Overall Study|Adverse Event|3
6016370|NCT00809757|20798518|P1|Overall Study|Adverse Event|2
6016371|NCT00809614|20798603|P2|Overall Study|Withdrawal by Subject|1
6016372|NCT00809614|20798604|P1|Overall Study|Withdrawal by Subject|1
6016373|NCT00809614|20798603|P2|Overall Study|Lack of Efficacy|3
6016374|NCT00809614|20798604|P1|Overall Study|Lack of Efficacy|2
6016375|NCT00809471|20798648|P3|Overall Study|Requirement for restricted medication|0
6016376|NCT00809471|20798649|P2|Overall Study|Requirement for restricted medication|1
6016377|NCT00809471|20798650|P1|Overall Study|Requirement for restricted medication|1
6016378|NCT00809471|20798648|P3|Overall Study|Adverse Event|2
6016379|NCT00809471|20798649|P2|Overall Study|Adverse Event|2
6016380|NCT00809471|20798650|P1|Overall Study|Adverse Event|0
6016381|NCT00809471|20798648|P3|Overall Study|Lost to Follow-up|9
6016382|NCT00809471|20798649|P2|Overall Study|Lost to Follow-up|2
6016383|NCT00809471|20798650|P1|Overall Study|Lost to Follow-up|4
6016384|NCT00809471|20798648|P3|Overall Study|Protocol non-compliance|6
6016385|NCT00809471|20798649|P2|Overall Study|Protocol non-compliance|15
6016386|NCT00809471|20798650|P1|Overall Study|Protocol non-compliance|15
6016387|NCT00809445|20798680|P3|6 Month Follow-up|Withdrew consent|1
6016388|NCT00809445|20798681|P2|6 Month Follow-up|Withdrew consent|0
6016389|NCT00809445|20798682|P1|6 Month Follow-up|Withdrew consent|0
6016390|NCT00809445|20798680|P3|6 Month Follow-up|Incarcerated|8
6016391|NCT00809445|20798681|P2|6 Month Follow-up|Incarcerated|8
6016392|NCT00809445|20798682|P1|6 Month Follow-up|Incarcerated|6
6016393|NCT00809445|20798680|P3|6 Month Follow-up|Death|1
6016394|NCT00809445|20798681|P2|6 Month Follow-up|Death|1
6016395|NCT00809445|20798682|P1|6 Month Follow-up|Death|2
6016396|NCT00809445|20798680|P3|6 Month Follow-up|Lost contact|14
6016397|NCT00809445|20798681|P2|6 Month Follow-up|Lost contact|14
6016398|NCT00809445|20798682|P1|6 Month Follow-up|Lost contact|16
6016399|NCT00809445|20798680|P3|1 Month Follow-up|Incarcerated|1
6016400|NCT00809445|20798681|P2|1 Month Follow-up|Incarcerated|0
6016401|NCT00809445|20798682|P1|1 Month Follow-up|Incarcerated|0
6016402|NCT00809445|20798680|P3|1 Month Follow-up|Death|1
6016403|NCT00809445|20798681|P2|1 Month Follow-up|Death|1
6016404|NCT00809445|20798682|P1|1 Month Follow-up|Death|0
6016405|NCT00809445|20798680|P3|1 Month Follow-up|Withdrew consent|1
6016406|NCT00809445|20798681|P2|1 Month Follow-up|Withdrew consent|1
6016407|NCT00809445|20798682|P1|1 Month Follow-up|Withdrew consent|1
6016408|NCT00809445|20798680|P3|1 Month Follow-up|Lost contact|1
6016409|NCT00809445|20798681|P2|1 Month Follow-up|Lost contact|2
6016410|NCT00809445|20798682|P1|1 Month Follow-up|Lost contact|1
6016411|NCT00809341|20798701|P2|Overall Study|Physician Decision|1
6016412|NCT00809341|20798702|P1|Overall Study|Physician Decision|0
6016413|NCT00809328|20798710|P1|Overall Study|Withdrawal by Subject|2
6016414|NCT00809328|20798710|P1|Overall Study|Protocol Violation|3
6016415|NCT00809328|20798710|P1|Overall Study|Adverse Event|6
6016416|NCT00809328|20798710|P1|Overall Study|Lack of Efficacy|18
6016417|NCT00809159|20798732|P6|Part 1 and 2|Withdrawal by Subject|1
6016418|NCT00809159|20798733|P5|Part 1 and 2|Withdrawal by Subject|0
6016419|NCT00809159|20798734|P4|Part 1 and 2|Withdrawal by Subject|0
6016420|NCT00809159|20798735|P3|Part 1 and 2|Withdrawal by Subject|4
6016421|NCT00809159|20798736|P2|Part 1 and 2|Withdrawal by Subject|0
6016422|NCT00809159|20798737|P1|Part 1 and 2|Withdrawal by Subject|0
6016423|NCT00809159|20798732|P6|Part 1 and 2|Lost to Follow-up|0
6016424|NCT00809159|20798733|P5|Part 1 and 2|Lost to Follow-up|0
6016425|NCT00809159|20798734|P4|Part 1 and 2|Lost to Follow-up|1
6016426|NCT00809159|20798735|P3|Part 1 and 2|Lost to Follow-up|1
6016427|NCT00809159|20798736|P2|Part 1 and 2|Lost to Follow-up|0
6016428|NCT00809159|20798737|P1|Part 1 and 2|Lost to Follow-up|0
6016429|NCT00809159|20798732|P6|Part 1 and 2|Adverse Event|1
6016430|NCT00809159|20798733|P5|Part 1 and 2|Adverse Event|1
6016431|NCT00809159|20798734|P4|Part 1 and 2|Adverse Event|0
6016432|NCT00809159|20798735|P3|Part 1 and 2|Adverse Event|1
6016433|NCT00809159|20798736|P2|Part 1 and 2|Adverse Event|0
6016434|NCT00809159|20798737|P1|Part 1 and 2|Adverse Event|0
6016435|NCT00809159|20798732|P6|Part 1 and 2|Administrative problems|0
6016436|NCT00809159|20798733|P5|Part 1 and 2|Administrative problems|0
6016437|NCT00809159|20798734|P4|Part 1 and 2|Administrative problems|1
6016438|NCT00809159|20798735|P3|Part 1 and 2|Administrative problems|0
6016439|NCT00809159|20798736|P2|Part 1 and 2|Administrative problems|0
6016440|NCT00809159|20798737|P1|Part 1 and 2|Administrative problems|0
6016441|NCT00809159|20798732|P6|Part 1 and 2|Unsatisfactory therapeutic effect|1
6016442|NCT00809159|20798733|P5|Part 1 and 2|Unsatisfactory therapeutic effect|5
6016443|NCT00809159|20798734|P4|Part 1 and 2|Unsatisfactory therapeutic effect|3
6016444|NCT00809159|20798735|P3|Part 1 and 2|Unsatisfactory therapeutic effect|4
6016445|NCT00809159|20798736|P2|Part 1 and 2|Unsatisfactory therapeutic effect|0
6016446|NCT00809159|20798737|P1|Part 1 and 2|Unsatisfactory therapeutic effect|0
6016447|NCT00809159|20798732|P6|Part 1|Unsatisfactory therapeutic effect|0
6016448|NCT00809159|20798733|P5|Part 1|Unsatisfactory therapeutic effect|0
6016449|NCT00809159|20798734|P4|Part 1|Unsatisfactory therapeutic effect|0
6016450|NCT00809159|20798735|P3|Part 1|Unsatisfactory therapeutic effect|0
6016451|NCT00809159|20798736|P2|Part 1|Unsatisfactory therapeutic effect|1
6016452|NCT00809159|20798737|P1|Part 1|Unsatisfactory therapeutic effect|3
6016453|NCT00809159|20798732|P6|Part 1|Withdrawal by Subject|0
6016454|NCT00809159|20798733|P5|Part 1|Withdrawal by Subject|0
6016455|NCT00809159|20798734|P4|Part 1|Withdrawal by Subject|0
6016456|NCT00809159|20798735|P3|Part 1|Withdrawal by Subject|0
6016457|NCT00809159|20798736|P2|Part 1|Withdrawal by Subject|1
6016458|NCT00809159|20798737|P1|Part 1|Withdrawal by Subject|3
6016459|NCT00809159|20798732|P6|Part 1|Lost to Follow-up|0
6016460|NCT00809159|20798733|P5|Part 1|Lost to Follow-up|0
6016461|NCT00809159|20798734|P4|Part 1|Lost to Follow-up|0
6016462|NCT00809159|20798735|P3|Part 1|Lost to Follow-up|0
6016463|NCT00809159|20798736|P2|Part 1|Lost to Follow-up|0
6016464|NCT00809159|20798737|P1|Part 1|Lost to Follow-up|1
6016465|NCT00809159|20798732|P6|Part 1|Adverse Event|0
6016466|NCT00809159|20798733|P5|Part 1|Adverse Event|0
6016467|NCT00809159|20798734|P4|Part 1|Adverse Event|0
6016468|NCT00809159|20798735|P3|Part 1|Adverse Event|0
6016469|NCT00809159|20798736|P2|Part 1|Adverse Event|1
6016470|NCT00809159|20798737|P1|Part 1|Adverse Event|1
6016471|NCT00809133|20798842|P14|Overall Study|Other not mentioned above|0
6016472|NCT00809133|20798843|P13|Overall Study|Other not mentioned above|0
6016473|NCT00809133|20798844|P12|Overall Study|Other not mentioned above|0
6016474|NCT00809133|20798845|P11|Overall Study|Other not mentioned above|0
6016475|NCT00809133|20798846|P10|Overall Study|Other not mentioned above|0
6016476|NCT00809133|20798847|P9|Overall Study|Other not mentioned above|0
6016477|NCT00809133|20798848|P8|Overall Study|Other not mentioned above|0
6016478|NCT00809133|20798849|P7|Overall Study|Other not mentioned above|0
6016479|NCT00809133|20798850|P6|Overall Study|Other not mentioned above|1
6016480|NCT00809133|20798851|P5|Overall Study|Other not mentioned above|0
6016481|NCT00809133|20798852|P4|Overall Study|Other not mentioned above|0
6016482|NCT00809133|20798853|P3|Overall Study|Other not mentioned above|0
6016483|NCT00809133|20798854|P2|Overall Study|Other not mentioned above|1
6016484|NCT00809133|20798855|P1|Overall Study|Other not mentioned above|0
6016485|NCT00809133|20798842|P14|Overall Study|Consent withdrawn|0
6016486|NCT00809133|20798843|P13|Overall Study|Consent withdrawn|0
6016487|NCT00809133|20798844|P12|Overall Study|Consent withdrawn|0
6016488|NCT00809133|20798845|P11|Overall Study|Consent withdrawn|0
6016489|NCT00809133|20798846|P10|Overall Study|Consent withdrawn|0
6016490|NCT00809133|20798847|P9|Overall Study|Consent withdrawn|0
6016491|NCT00809133|20798848|P8|Overall Study|Consent withdrawn|0
6016492|NCT00809133|20798849|P7|Overall Study|Consent withdrawn|0
6016493|NCT00809133|20798850|P6|Overall Study|Consent withdrawn|0
6016494|NCT00809133|20798851|P5|Overall Study|Consent withdrawn|1
6016495|NCT00809133|20798852|P4|Overall Study|Consent withdrawn|0
6016496|NCT00809133|20798853|P3|Overall Study|Consent withdrawn|0
6016497|NCT00809133|20798854|P2|Overall Study|Consent withdrawn|0
6016498|NCT00809133|20798855|P1|Overall Study|Consent withdrawn|0
6016499|NCT00809133|20798842|P14|Overall Study|Lost to Follow-up|0
6016500|NCT00809133|20798843|P13|Overall Study|Lost to Follow-up|0
6016501|NCT00809133|20798844|P12|Overall Study|Lost to Follow-up|0
6016502|NCT00809133|20798845|P11|Overall Study|Lost to Follow-up|0
6016503|NCT00809133|20798846|P10|Overall Study|Lost to Follow-up|0
6016504|NCT00809133|20798847|P9|Overall Study|Lost to Follow-up|0
6016505|NCT00809133|20798848|P8|Overall Study|Lost to Follow-up|0
6016506|NCT00809133|20798849|P7|Overall Study|Lost to Follow-up|0
6016507|NCT00809133|20798850|P6|Overall Study|Lost to Follow-up|1
6016508|NCT00809133|20798851|P5|Overall Study|Lost to Follow-up|0
6016509|NCT00809133|20798852|P4|Overall Study|Lost to Follow-up|0
6016510|NCT00809133|20798853|P3|Overall Study|Lost to Follow-up|0
6016511|NCT00809133|20798854|P2|Overall Study|Lost to Follow-up|0
6016512|NCT00809133|20798855|P1|Overall Study|Lost to Follow-up|0
6016513|NCT00809133|20798842|P14|Overall Study|Other adverse event|1
6016514|NCT00809133|20798843|P13|Overall Study|Other adverse event|0
6016515|NCT00809133|20798844|P12|Overall Study|Other adverse event|1
6016516|NCT00809133|20798845|P11|Overall Study|Other adverse event|1
6016517|NCT00809133|20798846|P10|Overall Study|Other adverse event|0
6016518|NCT00809133|20798847|P9|Overall Study|Other adverse event|0
6016519|NCT00809133|20798848|P8|Overall Study|Other adverse event|4
6016520|NCT00809133|20798849|P7|Overall Study|Other adverse event|2
6016521|NCT00809133|20798850|P6|Overall Study|Other adverse event|3
6016522|NCT00809133|20798851|P5|Overall Study|Other adverse event|0
6016523|NCT00809133|20798852|P4|Overall Study|Other adverse event|0
6016524|NCT00809133|20798853|P3|Overall Study|Other adverse event|1
6016525|NCT00809133|20798854|P2|Overall Study|Other adverse event|1
6016526|NCT00809133|20798855|P1|Overall Study|Other adverse event|1
6016527|NCT00809133|20798842|P14|Overall Study|Dose Limiting Toxicity (DLT)|2
6016528|NCT00809133|20798843|P13|Overall Study|Dose Limiting Toxicity (DLT)|0
6016529|NCT00809133|20798844|P12|Overall Study|Dose Limiting Toxicity (DLT)|0
6016530|NCT00809133|20798845|P11|Overall Study|Dose Limiting Toxicity (DLT)|0
6016531|NCT00809133|20798846|P10|Overall Study|Dose Limiting Toxicity (DLT)|0
6016532|NCT00809133|20798847|P9|Overall Study|Dose Limiting Toxicity (DLT)|0
6016533|NCT00809133|20798848|P8|Overall Study|Dose Limiting Toxicity (DLT)|1
6016534|NCT00809133|20798849|P7|Overall Study|Dose Limiting Toxicity (DLT)|1
6016535|NCT00809133|20798850|P6|Overall Study|Dose Limiting Toxicity (DLT)|1
6016536|NCT00809133|20798851|P5|Overall Study|Dose Limiting Toxicity (DLT)|0
6016537|NCT00809133|20798852|P4|Overall Study|Dose Limiting Toxicity (DLT)|0
6016538|NCT00809133|20798853|P3|Overall Study|Dose Limiting Toxicity (DLT)|0
6016539|NCT00809133|20798854|P2|Overall Study|Dose Limiting Toxicity (DLT)|0
6016540|NCT00809133|20798855|P1|Overall Study|Dose Limiting Toxicity (DLT)|0
6016541|NCT00809133|20798842|P14|Overall Study|Progressive disease|4
6016542|NCT00809133|20798843|P13|Overall Study|Progressive disease|5
6016543|NCT00809133|20798844|P12|Overall Study|Progressive disease|7
6016544|NCT00809133|20798845|P11|Overall Study|Progressive disease|5
6016545|NCT00809133|20798846|P10|Overall Study|Progressive disease|9
6016546|NCT00809133|20798847|P9|Overall Study|Progressive disease|3
6016547|NCT00809133|20798848|P8|Overall Study|Progressive disease|3
6016548|NCT00809133|20798849|P7|Overall Study|Progressive disease|3
6016549|NCT00809133|20798850|P6|Overall Study|Progressive disease|1
6016550|NCT00809133|20798851|P5|Overall Study|Progressive disease|4
6016551|NCT00809133|20798852|P4|Overall Study|Progressive disease|3
6016552|NCT00809133|20798853|P3|Overall Study|Progressive disease|5
6016553|NCT00809133|20798854|P2|Overall Study|Progressive disease|5
6016554|NCT00809133|20798855|P1|Overall Study|Progressive disease|2
6016555|NCT00809094|20799009|P2|Overall Study|Lost to Follow-up|1
6016556|NCT00809094|20799010|P1|Overall Study|Lost to Follow-up|0
6016557|NCT00808899|20799055|P1|Overall Study|Physician Decision|3
6016558|NCT00808899|20799055|P1|Overall Study|Death|1
6016559|NCT00808808|20799069|P3|Overall Study|Employee was not vaccinated.|2255
6016560|NCT00808808|20799070|P2|Overall Study|Employee was not vaccinated.|2268
6016561|NCT00808808|20799071|P1|Overall Study|Employee was not vaccinated.|2686
6016562|NCT00808808|20799069|P3|Overall Study|Vaccinated; survey not completed|302
6016563|NCT00808808|20799070|P2|Overall Study|Vaccinated; survey not completed|169
6016564|NCT00808808|20799071|P1|Overall Study|Vaccinated; survey not completed|131
6016565|NCT00808665|20799106|P2|Overall Study|Medication stopped by resident|1
6016566|NCT00808665|20799107|P1|Overall Study|Medication stopped by resident|0
6016567|NCT00808665|20799106|P2|Overall Study|Physician Decision|1
6016568|NCT00808665|20799107|P1|Overall Study|Physician Decision|3
6016569|NCT00808665|20799106|P2|Overall Study|required an additional procedure|1
6016570|NCT00808665|20799107|P1|Overall Study|required an additional procedure|0
6016571|NCT00808665|20799106|P2|Overall Study|surgery cancelled|0
6016572|NCT00808665|20799107|P1|Overall Study|surgery cancelled|1
6016573|NCT00808665|20799106|P2|Overall Study|only required minimally invasive surgery|0
6016574|NCT00808665|20799107|P1|Overall Study|only required minimally invasive surgery|1
6016575|NCT00808665|20799106|P2|Overall Study|Withdrawal by Subject|0
6016576|NCT00808665|20799107|P1|Overall Study|Withdrawal by Subject|1
6016577|NCT00808639|20799113|P1|Overall Study|Disease progression before surgery.|1
6016578|NCT00808509|20799121|P2|Randomized Phase|Patient refused rescue therapy|3
6016579|NCT00808509|20799122|P1|Randomized Phase|Patient refused rescue therapy|0
6016580|NCT00808509|20799121|P2|Randomized Phase|Reduced methotrexate dose|2
6016581|NCT00808509|20799122|P1|Randomized Phase|Reduced methotrexate dose|1
6016582|NCT00808509|20799121|P2|Randomized Phase|Did not meet eligibility criteria|0
6016583|NCT00808509|20799122|P1|Randomized Phase|Did not meet eligibility criteria|1
6016584|NCT00808483|20799220|P2|From 5 Months to 12 Months|Lack of Efficacy|0
6016585|NCT00808483|20799221|P1|From 5 Months to 12 Months|Lack of Efficacy|1
6016586|NCT00808483|20799220|P2|From 3 to 5 Months After Surgery|Lack of Efficacy|0
6016587|NCT00808483|20799221|P1|From 3 to 5 Months After Surgery|Lack of Efficacy|1
6016588|NCT00808483|20799220|P2|From 3 to 5 Months After Surgery|Withdrawal by Subject|1
6016589|NCT00808483|20799221|P1|From 3 to 5 Months After Surgery|Withdrawal by Subject|1
6016590|NCT00808444|20799258|P2|Overall Study|Lost to Follow-up|1
6016591|NCT00808444|20799259|P1|Overall Study|Lost to Follow-up|0
6016592|NCT00808444|20799258|P2|Overall Study|Withdrawal by Subject|0
6016593|NCT00808444|20799259|P1|Overall Study|Withdrawal by Subject|1
6016594|NCT00808249|20799334|P4|Overall Study|All other reasons|1
6016595|NCT00808249|20799335|P3|Overall Study|All other reasons|3
6016596|NCT00808249|20799336|P2|Overall Study|All other reasons|1
6016597|NCT00808249|20799337|P1|Overall Study|All other reasons|2
6016598|NCT00808249|20799334|P4|Overall Study|study specific discontinuation criteria|0
6016599|NCT00808249|20799335|P3|Overall Study|study specific discontinuation criteria|1
6016600|NCT00808249|20799336|P2|Overall Study|study specific discontinuation criteria|0
6016601|NCT00808249|20799337|P1|Overall Study|study specific discontinuation criteria|1
6016602|NCT00808249|20799334|P4|Overall Study|Lack of Efficacy|0
6016603|NCT00808249|20799335|P3|Overall Study|Lack of Efficacy|0
6016604|NCT00808249|20799336|P2|Overall Study|Lack of Efficacy|1
6016605|NCT00808249|20799337|P1|Overall Study|Lack of Efficacy|1
6016606|NCT00808249|20799334|P4|Overall Study|Protocol Violation|0
6016607|NCT00808249|20799335|P3|Overall Study|Protocol Violation|3
6016608|NCT00808249|20799336|P2|Overall Study|Protocol Violation|3
6016609|NCT00808249|20799337|P1|Overall Study|Protocol Violation|3
6016610|NCT00808249|20799334|P4|Overall Study|Withdrawal by Subject|4
6016611|NCT00808249|20799335|P3|Overall Study|Withdrawal by Subject|2
6016612|NCT00808249|20799336|P2|Overall Study|Withdrawal by Subject|0
6016613|NCT00808249|20799337|P1|Overall Study|Withdrawal by Subject|4
6016614|NCT00808249|20799334|P4|Overall Study|Lost to Follow-up|5
6016615|NCT00808249|20799335|P3|Overall Study|Lost to Follow-up|3
6016616|NCT00808249|20799336|P2|Overall Study|Lost to Follow-up|3
6016617|NCT00808249|20799337|P1|Overall Study|Lost to Follow-up|2
6016618|NCT00808249|20799334|P4|Overall Study|Adverse Event|6
6016619|NCT00808249|20799335|P3|Overall Study|Adverse Event|10
6016620|NCT00808249|20799336|P2|Overall Study|Adverse Event|7
6016621|NCT00808249|20799337|P1|Overall Study|Adverse Event|4
6016622|NCT00808236|20799365|P2|Overall Study|Death|30
6016623|NCT00808236|20799366|P1|Overall Study|Death|18
6016624|NCT00808236|20799365|P2|Overall Study|Physician Decision|1
6016625|NCT00808236|20799366|P1|Overall Study|Physician Decision|0
6016626|NCT00808236|20799365|P2|Overall Study|Lost to Follow-up|1
6016627|NCT00808236|20799366|P1|Overall Study|Lost to Follow-up|1
6016628|NCT00808236|20799365|P2|Overall Study|Pre-defined exclusion|3
6016629|NCT00808236|20799366|P1|Overall Study|Pre-defined exclusion|13
6016630|NCT00808236|20799365|P2|Overall Study|Was not resuscitated|56
6016631|NCT00808236|20799366|P1|Overall Study|Was not resuscitated|50
6016632|NCT00808210|20799396|P2|Open Label Ocrelizumab Treatment Period|Sponsor decision to terminate study|4
6016633|NCT00808210|20799397|P1|Open Label Ocrelizumab Treatment Period|Sponsor decision to terminate study|9
6016634|NCT00808210|20799396|P2|Double-Blind TX Period|Other reasons outside Sponsor decision|1
6016635|NCT00808210|20799397|P1|Double-Blind TX Period|Other reasons outside Sponsor decision|1
6016636|NCT00808210|20799396|P2|Double-Blind TX Period|Sponsor decision to terminate study|1
6016637|NCT00808210|20799397|P1|Double-Blind TX Period|Sponsor decision to terminate study|1
6016638|NCT00808210|20799396|P2|Double-Blind TX Period|Adverse Event|1
6016639|NCT00808210|20799397|P1|Double-Blind TX Period|Adverse Event|0
6016640|NCT00808210|20799396|P2|Study Period + 48 Weeks of Follow-up|Other reasons outside Sponsor decision|2
6016641|NCT00808210|20799397|P1|Study Period + 48 Weeks of Follow-up|Other reasons outside Sponsor decision|6
6016642|NCT00808210|20799396|P2|Study Period + 48 Weeks of Follow-up|Sponsor decision to terminate study|7
6016643|NCT00808210|20799397|P1|Study Period + 48 Weeks of Follow-up|Sponsor decision to terminate study|3
6016644|NCT00808132|20799422|P5|Overall Study|Unsatisfactory response|12
6016645|NCT00808132|20799423|P4|Overall Study|Unsatisfactory response|4
6016646|NCT00808132|20799424|P3|Overall Study|Unsatisfactory response|6
6016647|NCT00808132|20799425|P2|Overall Study|Unsatisfactory response|6
6016648|NCT00808132|20799426|P1|Overall Study|Unsatisfactory response|5
6016649|NCT00808132|20799422|P5|Overall Study|Randomized, but not treated|9
6016650|NCT00808132|20799423|P4|Overall Study|Randomized, but not treated|8
6016651|NCT00808132|20799424|P3|Overall Study|Randomized, but not treated|9
6016652|NCT00808132|20799425|P2|Overall Study|Randomized, but not treated|7
6016653|NCT00808132|20799426|P1|Overall Study|Randomized, but not treated|10
6016654|NCT00808132|20799422|P5|Overall Study|Other|15
6016655|NCT00808132|20799423|P4|Overall Study|Other|2
6016656|NCT00808132|20799424|P3|Overall Study|Other|6
6016657|NCT00808132|20799425|P2|Overall Study|Other|4
6016658|NCT00808132|20799426|P1|Overall Study|Other|6
6016659|NCT00808132|20799422|P5|Overall Study|Withdrawal by Subject|16
6016660|NCT00808132|20799423|P4|Overall Study|Withdrawal by Subject|7
6016661|NCT00808132|20799424|P3|Overall Study|Withdrawal by Subject|2
6016662|NCT00808132|20799425|P2|Overall Study|Withdrawal by Subject|18
6016663|NCT00808132|20799426|P1|Overall Study|Withdrawal by Subject|27
6016664|NCT00808132|20799422|P5|Overall Study|Protocol Violation|5
6016665|NCT00808132|20799423|P4|Overall Study|Protocol Violation|9
6016666|NCT00808132|20799424|P3|Overall Study|Protocol Violation|4
6016667|NCT00808132|20799425|P2|Overall Study|Protocol Violation|9
6016668|NCT00808132|20799426|P1|Overall Study|Protocol Violation|8
6016669|NCT00808132|20799422|P5|Overall Study|Lost to Follow-up|9
6016670|NCT00808132|20799423|P4|Overall Study|Lost to Follow-up|8
6016671|NCT00808132|20799424|P3|Overall Study|Lost to Follow-up|11
6016672|NCT00808132|20799425|P2|Overall Study|Lost to Follow-up|10
6016673|NCT00808132|20799426|P1|Overall Study|Lost to Follow-up|8
6016674|NCT00808132|20799422|P5|Overall Study|Physician Decision|0
6016675|NCT00808132|20799423|P4|Overall Study|Physician Decision|0
6016676|NCT00808132|20799424|P3|Overall Study|Physician Decision|0
6016677|NCT00808132|20799425|P2|Overall Study|Physician Decision|1
6016678|NCT00808132|20799426|P1|Overall Study|Physician Decision|0
6016679|NCT00808132|20799422|P5|Overall Study|Death|1
6016680|NCT00808132|20799423|P4|Overall Study|Death|0
6016681|NCT00808132|20799424|P3|Overall Study|Death|0
6016682|NCT00808132|20799425|P2|Overall Study|Death|0
6016683|NCT00808132|20799426|P1|Overall Study|Death|0
6016684|NCT00808132|20799422|P5|Overall Study|Adverse Event|33
6016685|NCT00808132|20799423|P4|Overall Study|Adverse Event|31
6016686|NCT00808132|20799424|P3|Overall Study|Adverse Event|16
6016687|NCT00808132|20799425|P2|Overall Study|Adverse Event|33
6016688|NCT00808132|20799426|P1|Overall Study|Adverse Event|34
6016689|NCT00808080|20799498|P1|Overall Study|Patients Became Ineligible for infusion|6
6016690|NCT00808067|20799505|P2|Overall Study|Excluded from analysis|19
6016691|NCT00808067|20799506|P1|Overall Study|Excluded from analysis|13
6016692|NCT00808067|20799505|P2|Overall Study|Other reason not defined above|5
6016693|NCT00808067|20799506|P1|Overall Study|Other reason not defined above|5
6016694|NCT00808067|20799505|P2|Overall Study|Site closed for cause|19
6016695|NCT00808067|20799506|P1|Overall Study|Site closed for cause|19
6016696|NCT00808067|20799505|P2|Overall Study|Patient elected|9
6016697|NCT00808067|20799506|P1|Overall Study|Patient elected|7
6016698|NCT00808067|20799505|P2|Overall Study|Protocol Violation|11
6016699|NCT00808067|20799506|P1|Overall Study|Protocol Violation|3
6016700|NCT00808067|20799505|P2|Overall Study|Physician Decision|38
6016701|NCT00808067|20799506|P1|Overall Study|Physician Decision|47
6016702|NCT00808067|20799505|P2|Overall Study|Site closed|3
6016703|NCT00808067|20799506|P1|Overall Study|Site closed|4
6016704|NCT00808067|20799505|P2|Overall Study|Withdrawal by Subject|25
6016705|NCT00808067|20799506|P1|Overall Study|Withdrawal by Subject|21
6016706|NCT00808067|20799505|P2|Overall Study|Procedure|7
6016707|NCT00808067|20799506|P1|Overall Study|Procedure|6
6016708|NCT00808067|20799505|P2|Overall Study|Death|1
6016709|NCT00808067|20799506|P1|Overall Study|Death|1
6016710|NCT00808067|20799505|P2|Overall Study|Missing|0
6016711|NCT00808067|20799506|P1|Overall Study|Missing|1
6016712|NCT00808067|20799505|P2|Overall Study|Patient refused to take study medication|76
6016713|NCT00808067|20799506|P1|Overall Study|Patient refused to take study medication|65
6016714|NCT00808067|20799505|P2|Overall Study|Elevated LFT results|3
6016715|NCT00808067|20799506|P1|Overall Study|Elevated LFT results|7
6016716|NCT00808067|20799505|P2|Overall Study|Reduced creatinine clearance|55
6016717|NCT00808067|20799506|P1|Overall Study|Reduced creatinine clearance|53
6016718|NCT00808067|20799505|P2|Overall Study|Hospitalization due to surgery|40
6016719|NCT00808067|20799506|P1|Overall Study|Hospitalization due to surgery|37
6016720|NCT00808067|20799505|P2|Overall Study|Hospitalization (not including surgery)|17
6016721|NCT00808067|20799506|P1|Overall Study|Hospitalization (not including surgery)|18
6016722|NCT00808067|20799505|P2|Overall Study|Adverse Event|121
6016723|NCT00808067|20799506|P1|Overall Study|Adverse Event|111
6016724|NCT00808067|20799505|P2|Overall Study|Outcome event - other|25
6016725|NCT00808067|20799506|P1|Overall Study|Outcome event - other|33
6016726|NCT00808067|20799505|P2|Overall Study|Major/minor bleed|44
6016727|NCT00808067|20799506|P1|Overall Study|Major/minor bleed|30
6016728|NCT00808028|20799542|P4|Stage 2 (Followed up to 48 Months )|Non-compliance|0
6016729|NCT00808028|20799543|P3|Stage 2 (Followed up to 48 Months )|Non-compliance|1
6016730|NCT00808028|20799544|P2|Stage 2 (Followed up to 48 Months )|Non-compliance|0
6016731|NCT00808028|20799545|P1|Stage 2 (Followed up to 48 Months )|Non-compliance|0
6016732|NCT00808028|20799542|P4|Stage 2 (Followed up to 48 Months )|Death|0
6016733|NCT00808028|20799543|P3|Stage 2 (Followed up to 48 Months )|Death|1
6016734|NCT00808028|20799544|P2|Stage 2 (Followed up to 48 Months )|Death|0
6016735|NCT00808028|20799545|P1|Stage 2 (Followed up to 48 Months )|Death|0
6016736|NCT00808028|20799542|P4|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0
6016737|NCT00808028|20799543|P3|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|2
6016738|NCT00808028|20799544|P2|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0
6016739|NCT00808028|20799545|P1|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0
6016740|NCT00808028|20799542|P4|Stage 2 (Followed up to 48 Months )|Other|1
6016741|NCT00808028|20799543|P3|Stage 2 (Followed up to 48 Months )|Other|1
6016742|NCT00808028|20799544|P2|Stage 2 (Followed up to 48 Months )|Other|0
6016743|NCT00808028|20799545|P1|Stage 2 (Followed up to 48 Months )|Other|0
6016744|NCT00808028|20799542|P4|Stage 2 (Followed up to 48 Months )|Adverse Event|0
6016745|NCT00808028|20799543|P3|Stage 2 (Followed up to 48 Months )|Adverse Event|1
6016746|NCT00808028|20799544|P2|Stage 2 (Followed up to 48 Months )|Adverse Event|0
6016747|NCT00808028|20799545|P1|Stage 2 (Followed up to 48 Months )|Adverse Event|1
6016748|NCT00808028|20799542|P4|Stage 2 (Followed up to 48 Months )|Failed to return|4
6016749|NCT00808028|20799543|P3|Stage 2 (Followed up to 48 Months )|Failed to return|5
6016750|NCT00808028|20799544|P2|Stage 2 (Followed up to 48 Months )|Failed to return|0
6016751|NCT00808028|20799545|P1|Stage 2 (Followed up to 48 Months )|Failed to return|2
6016752|NCT00808028|20799542|P4|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|7
6016753|NCT00808028|20799543|P3|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|8
6016754|NCT00808028|20799544|P2|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|0
6016755|NCT00808028|20799545|P1|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|2
6016756|NCT00808028|20799542|P4|Stage 2 (Followed up to 48 Months )|Protocol Violation|0
6016757|NCT00808028|20799543|P3|Stage 2 (Followed up to 48 Months )|Protocol Violation|1
6016758|NCT00808028|20799544|P2|Stage 2 (Followed up to 48 Months )|Protocol Violation|0
6016759|NCT00808028|20799545|P1|Stage 2 (Followed up to 48 Months )|Protocol Violation|0
6016760|NCT00808028|20799542|P4|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|11
6016761|NCT00808028|20799543|P3|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|9
6016762|NCT00808028|20799544|P2|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|0
6016763|NCT00808028|20799545|P1|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|6
6016764|NCT00808028|20799542|P4|Stage 1 (6 Months)|Protocol Violation|1
6016765|NCT00808028|20799543|P3|Stage 1 (6 Months)|Protocol Violation|0
6016766|NCT00808028|20799544|P2|Stage 1 (6 Months)|Protocol Violation|0
6016767|NCT00808028|20799545|P1|Stage 1 (6 Months)|Protocol Violation|0
6016768|NCT00808028|20799542|P4|Stage 1 (6 Months)|Lost to Follow-up|0
6016769|NCT00808028|20799543|P3|Stage 1 (6 Months)|Lost to Follow-up|1
6016770|NCT00808028|20799544|P2|Stage 1 (6 Months)|Lost to Follow-up|0
6016771|NCT00808028|20799545|P1|Stage 1 (6 Months)|Lost to Follow-up|1
6016772|NCT00808028|20799542|P4|Stage 1 (6 Months)|Adverse Event|2
6016773|NCT00808028|20799543|P3|Stage 1 (6 Months)|Adverse Event|1
6016774|NCT00808028|20799544|P2|Stage 1 (6 Months)|Adverse Event|0
6016775|NCT00808028|20799545|P1|Stage 1 (6 Months)|Adverse Event|0
6016776|NCT00808028|20799542|P4|Stage 1 (6 Months)|Parent/legal guardian request|3
6016777|NCT00808028|20799543|P3|Stage 1 (6 Months)|Parent/legal guardian request|1
6016778|NCT00808028|20799544|P2|Stage 1 (6 Months)|Parent/legal guardian request|1
6016779|NCT00808028|20799545|P1|Stage 1 (6 Months)|Parent/legal guardian request|0
6016780|NCT00808028|20799542|P4|Stage 1 (6 Months)|Other|4
6016781|NCT00808028|20799543|P3|Stage 1 (6 Months)|Other|2
6016782|NCT00808028|20799544|P2|Stage 1 (6 Months)|Other|0
6016783|NCT00808028|20799545|P1|Stage 1 (6 Months)|Other|1
6016784|NCT00808028|20799542|P4|Stage 1 (6 Months)|Withdrawal by Subject|5
6016785|NCT00808028|20799543|P3|Stage 1 (6 Months)|Withdrawal by Subject|2
6016786|NCT00808028|20799544|P2|Stage 1 (6 Months)|Withdrawal by Subject|0
6016787|NCT00808028|20799545|P1|Stage 1 (6 Months)|Withdrawal by Subject|3
6016788|NCT00808015|20799581|P1|Overall Study|Enrolled but not treated|4
6016789|NCT00808015|20799581|P1|Overall Study|Other|25
6016790|NCT00808015|20799581|P1|Overall Study|Adverse Event|22
6016791|NCT00808015|20799581|P1|Overall Study|Participants not willing to participate|158
6016792|NCT00808015|20799581|P1|Overall Study|Lost to Follow-up|76
6016793|NCT00808015|20799581|P1|Overall Study|Lack of Efficacy|58
6016794|NCT00808015|20799581|P1|Overall Study|Death|1
6016795|NCT00807937|20799610|P4|Overall Study|All other reasons (not provided)|1
6016796|NCT00807937|20799611|P3|Overall Study|All other reasons (not provided)|0
6016797|NCT00807937|20799612|P2|Overall Study|All other reasons (not provided)|4
6016798|NCT00807937|20799613|P1|Overall Study|All other reasons (not provided)|2
6016799|NCT00807937|20799610|P4|Overall Study|Intake of prohibited medicine|0
6016800|NCT00807937|20799611|P3|Overall Study|Intake of prohibited medicine|2
6016801|NCT00807937|20799612|P2|Overall Study|Intake of prohibited medicine|0
6016802|NCT00807937|20799613|P1|Overall Study|Intake of prohibited medicine|0
6016803|NCT00807937|20799610|P4|Overall Study|Lack of Efficacy|2
6016804|NCT00807937|20799611|P3|Overall Study|Lack of Efficacy|1
6016805|NCT00807937|20799612|P2|Overall Study|Lack of Efficacy|0
6016806|NCT00807937|20799613|P1|Overall Study|Lack of Efficacy|0
6016807|NCT00807937|20799610|P4|Overall Study|Lost to Follow-up|1
6016808|NCT00807937|20799611|P3|Overall Study|Lost to Follow-up|2
6016809|NCT00807937|20799612|P2|Overall Study|Lost to Follow-up|0
6016810|NCT00807937|20799613|P1|Overall Study|Lost to Follow-up|4
6016811|NCT00807937|20799610|P4|Overall Study|Withdrawal by Subject|4
6016812|NCT00807937|20799611|P3|Overall Study|Withdrawal by Subject|1
6016813|NCT00807937|20799612|P2|Overall Study|Withdrawal by Subject|4
6016814|NCT00807937|20799613|P1|Overall Study|Withdrawal by Subject|5
6016815|NCT00807937|20799610|P4|Overall Study|Protocol Violation|3
6016816|NCT00807937|20799611|P3|Overall Study|Protocol Violation|3
6016817|NCT00807937|20799612|P2|Overall Study|Protocol Violation|5
6016818|NCT00807937|20799613|P1|Overall Study|Protocol Violation|4
6016819|NCT00807937|20799610|P4|Overall Study|Adverse Event|4
6016820|NCT00807937|20799611|P3|Overall Study|Adverse Event|5
6016821|NCT00807937|20799612|P2|Overall Study|Adverse Event|12
6016822|NCT00807937|20799613|P1|Overall Study|Adverse Event|12
6016823|NCT00807885|20799648|P9|Overall Study|Lost to Follow-up|0
6016824|NCT00807885|20799649|P8|Overall Study|Lost to Follow-up|0
6016825|NCT00807885|20799650|P7|Overall Study|Lost to Follow-up|0
6016826|NCT00807885|20799651|P6|Overall Study|Lost to Follow-up|1
6016827|NCT00807885|20799652|P5|Overall Study|Lost to Follow-up|0
6016828|NCT00807885|20799653|P4|Overall Study|Lost to Follow-up|0
6016829|NCT00807885|20799654|P3|Overall Study|Lost to Follow-up|0
6016830|NCT00807885|20799655|P2|Overall Study|Lost to Follow-up|0
6016831|NCT00807885|20799656|P1|Overall Study|Lost to Follow-up|0
6016842|NCT00807742|20799759|P2|Overall Study|Lost to Follow-up|51
6016843|NCT00807742|20799760|P1|Overall Study|Lost to Follow-up|35
6016844|NCT00807742|20799759|P2|Overall Study|Withdrawal by Subject|1
6016845|NCT00807742|20799760|P1|Overall Study|Withdrawal by Subject|2
6016846|NCT00807742|20799759|P2|Overall Study|Death|2
6016847|NCT00807742|20799760|P1|Overall Study|Death|9
6016848|NCT00807599|20799819|P3|Overall Study|Withdrawal by Subject|1
6016849|NCT00807599|20799820|P2|Overall Study|Withdrawal by Subject|0
6016850|NCT00807599|20799821|P1|Overall Study|Withdrawal by Subject|0
6016851|NCT00807599|20799819|P3|Overall Study|Inadequate response to induction|9
6016852|NCT00807599|20799820|P2|Overall Study|Inadequate response to induction|0
6016853|NCT00807599|20799821|P1|Overall Study|Inadequate response to induction|0
6016854|NCT00807599|20799819|P3|Overall Study|Adverse Event|5
6016855|NCT00807599|20799820|P2|Overall Study|Adverse Event|0
6016856|NCT00807599|20799821|P1|Overall Study|Adverse Event|0
6016857|NCT00807599|20799819|P3|Overall Study|Not treated on protocol study|2
6016858|NCT00807599|20799820|P2|Overall Study|Not treated on protocol study|0
6016859|NCT00807599|20799821|P1|Overall Study|Not treated on protocol study|0
6016860|NCT00807573|20799848|P1|Overall Study|Adverse Event|1
6016861|NCT00807573|20799848|P1|Overall Study|Withdrawal by Subject|1
6016862|NCT00807495|20799894|P5|Overall Study|Reason Not Specified|3
6016863|NCT00807495|20799895|P4|Overall Study|Reason Not Specified|0
6016864|NCT00807495|20799896|P3|Overall Study|Reason Not Specified|2
6016865|NCT00807495|20799897|P2|Overall Study|Reason Not Specified|3
6016866|NCT00807495|20799898|P1|Overall Study|Reason Not Specified|0
6016867|NCT00807495|20799894|P5|Overall Study|Withdrawal by Patient|0
6016868|NCT00807495|20799895|P4|Overall Study|Withdrawal by Patient|0
6016869|NCT00807495|20799896|P3|Overall Study|Withdrawal by Patient|1
6016870|NCT00807495|20799897|P2|Overall Study|Withdrawal by Patient|0
6016871|NCT00807495|20799898|P1|Overall Study|Withdrawal by Patient|2
6016872|NCT00807495|20799894|P5|Overall Study|Adverse Event|2
6016873|NCT00807495|20799895|P4|Overall Study|Adverse Event|1
6016874|NCT00807495|20799896|P3|Overall Study|Adverse Event|1
6016875|NCT00807495|20799897|P2|Overall Study|Adverse Event|3
6016876|NCT00807495|20799898|P1|Overall Study|Adverse Event|6
6016877|NCT00807365|20799944|P1|Overall Study|Study Terminated|5
6016878|NCT00807248|20799952|P4|Overall Study|Other Reason|0
6016879|NCT00807248|20799953|P3|Overall Study|Other Reason|2
6016880|NCT00807248|20799954|P2|Overall Study|Other Reason|0
6016881|NCT00807248|20799955|P1|Overall Study|Other Reason|0
6016882|NCT00807248|20799952|P4|Overall Study|Lost to Follow-up|0
6016883|NCT00807248|20799953|P3|Overall Study|Lost to Follow-up|0
6016884|NCT00807248|20799954|P2|Overall Study|Lost to Follow-up|0
6016885|NCT00807248|20799955|P1|Overall Study|Lost to Follow-up|1
6016886|NCT00807248|20799952|P4|Overall Study|Withdrawal of Consent|5
6016887|NCT00807248|20799953|P3|Overall Study|Withdrawal of Consent|5
6016888|NCT00807248|20799954|P2|Overall Study|Withdrawal of Consent|5
6016889|NCT00807248|20799955|P1|Overall Study|Withdrawal of Consent|5
6016890|NCT00807248|20799952|P4|Overall Study|Protocol Violation|0
6016891|NCT00807248|20799953|P3|Overall Study|Protocol Violation|1
6016892|NCT00807248|20799954|P2|Overall Study|Protocol Violation|1
6016893|NCT00807248|20799955|P1|Overall Study|Protocol Violation|0
6016894|NCT00807248|20799952|P4|Overall Study|Lack of Efficacy|3
6016895|NCT00807248|20799953|P3|Overall Study|Lack of Efficacy|8
6016896|NCT00807248|20799954|P2|Overall Study|Lack of Efficacy|4
6016897|NCT00807248|20799955|P1|Overall Study|Lack of Efficacy|14
6016898|NCT00807248|20799952|P4|Overall Study|Adverse Event|6
6016899|NCT00807248|20799953|P3|Overall Study|Adverse Event|2
6016900|NCT00807248|20799954|P2|Overall Study|Adverse Event|2
6016901|NCT00807248|20799955|P1|Overall Study|Adverse Event|1
6016902|NCT00807235|20799999|P2|Overall Study|Adverse Event|0
6016903|NCT00807235|20800000|P1|Overall Study|Adverse Event|1
6016904|NCT00807092|20800045|P2|Overall Study|CGMS data collection failed|1
6016905|NCT00807092|20800046|P1|Overall Study|CGMS data collection failed|0
6016906|NCT00807092|20800045|P2|Overall Study|Withdrawal by Subject|0
6016907|NCT00807092|20800046|P1|Overall Study|Withdrawal by Subject|1
6016908|NCT00807092|20800045|P2|Overall Study|Protocol Violation|2
6016909|NCT00807092|20800046|P1|Overall Study|Protocol Violation|0
6016910|NCT00807092|20800045|P2|Overall Study|Adverse Event|1
6016911|NCT00807092|20800046|P1|Overall Study|Adverse Event|0
6016912|NCT00807040|20800076|P2|Overall Study|Lost to Follow-up|6
6016913|NCT00807040|20800077|P1|Overall Study|Lost to Follow-up|4
6016914|NCT00807040|20800076|P2|Overall Study|Withdrawal by Subject|6
6016915|NCT00807040|20800077|P1|Overall Study|Withdrawal by Subject|8
6016916|NCT00807040|20800076|P2|Overall Study|Death|29
6016917|NCT00807040|20800077|P1|Overall Study|Death|24
6016918|NCT00807014|20800087|P2|Overall Study|Missed Visit 2 Due to Personal Reasons|1
6016919|NCT00807014|20800088|P1|Overall Study|Missed Visit 2 Due to Personal Reasons|0
6016920|NCT00807014|20800087|P2|Overall Study|Recovery|0
6016921|NCT00807014|20800088|P1|Overall Study|Recovery|1
6016922|NCT00807014|20800087|P2|Overall Study|Lost to Follow-up|7
6016923|NCT00807014|20800088|P1|Overall Study|Lost to Follow-up|9
6016924|NCT00807014|20800087|P2|Overall Study|Adverse Event|2
6016925|NCT00807014|20800088|P1|Overall Study|Adverse Event|0
6016926|NCT00807014|20800087|P2|Overall Study|Protocol Violation|8
6016927|NCT00807014|20800088|P1|Overall Study|Protocol Violation|2
6016928|NCT00807014|20800087|P2|Overall Study|Participant Considered Disease Not Cured|7
6016929|NCT00807014|20800088|P1|Overall Study|Participant Considered Disease Not Cured|2
6016930|NCT00807014|20800087|P2|Overall Study|Participant Considered Disease Cured|2
6016931|NCT00807014|20800088|P1|Overall Study|Participant Considered Disease Cured|13
6016932|NCT00807001|20800119|P5|Overall Study|Non-compliance|0
6016933|NCT00807001|20800120|P4|Overall Study|Non-compliance|0
6016934|NCT00807001|20800121|P3|Overall Study|Non-compliance|0
6016935|NCT00807001|20800122|P2|Overall Study|Non-compliance|1
6016936|NCT00807001|20800123|P1|Overall Study|Non-compliance|0
6016937|NCT00806988|20800142|P2|Overall Study|Lost to Follow-up|19
6016938|NCT00806988|20800143|P1|Overall Study|Lost to Follow-up|4
6016939|NCT00806988|20800142|P2|Overall Study|Withdrawal by Subject|8
6016940|NCT00806988|20800143|P1|Overall Study|Withdrawal by Subject|8
6016941|NCT00806988|20800142|P2|Overall Study|Death|16
6016942|NCT00806988|20800143|P1|Overall Study|Death|15
6016943|NCT00806819|20800153|P2|Overall Study|Reasons other than stated above|41
6016944|NCT00806819|20800154|P1|Overall Study|Reasons other than stated above|25
6016945|NCT00806819|20800153|P2|Overall Study|Not treated|3
6016946|NCT00806819|20800154|P1|Overall Study|Not treated|6
6016947|NCT00806819|20800153|P2|Overall Study|Withdrawal by Subject|29
6016948|NCT00806819|20800154|P1|Overall Study|Withdrawal by Subject|32
6016949|NCT00806819|20800153|P2|Overall Study|Lost to Follow-up|0
6016950|NCT00806819|20800154|P1|Overall Study|Lost to Follow-up|1
6016951|NCT00806819|20800153|P2|Overall Study|Protocol Violation|4
6016952|NCT00806819|20800154|P1|Overall Study|Protocol Violation|9
6016953|NCT00806819|20800153|P2|Overall Study|Other AE|40
6016954|NCT00806819|20800154|P1|Overall Study|Other AE|38
6016955|NCT00806819|20800153|P2|Overall Study|Worsening or AE of underlying disease|25
6016956|NCT00806819|20800154|P1|Overall Study|Worsening or AE of underlying disease|18
6016957|NCT00806819|20800153|P2|Overall Study|progressive disease (modified RECIST )|216
6016958|NCT00806819|20800154|P1|Overall Study|progressive disease (modified RECIST )|217
6016959|NCT00806624|20800223|P3|Overall Study|discontinued before start of treatment|1
6016960|NCT00806624|20800224|P2|Overall Study|discontinued before start of treatment|0
6016961|NCT00806624|20800225|P1|Overall Study|discontinued before start of treatment|0
6016962|NCT00806624|20800223|P3|Overall Study|Withdrawal by Subject|3
6016963|NCT00806624|20800224|P2|Overall Study|Withdrawal by Subject|3
6016964|NCT00806624|20800225|P1|Overall Study|Withdrawal by Subject|6
6016965|NCT00806624|20800223|P3|Overall Study|Lost to Follow-up|1
6016966|NCT00806624|20800224|P2|Overall Study|Lost to Follow-up|0
6016967|NCT00806624|20800225|P1|Overall Study|Lost to Follow-up|1
6016968|NCT00806624|20800223|P3|Overall Study|Death|1
6016969|NCT00806624|20800224|P2|Overall Study|Death|1
6016970|NCT00806624|20800225|P1|Overall Study|Death|0
6016971|NCT00806624|20800223|P3|Overall Study|Adverse Event|0
6016972|NCT00806624|20800224|P2|Overall Study|Adverse Event|8
6016973|NCT00806624|20800225|P1|Overall Study|Adverse Event|2
6016974|NCT00806585|20800242|P5|Overall Study|Completion status unknown|12
6016975|NCT00806585|20800243|P4|Overall Study|Completion status unknown|4
6016976|NCT00806585|20800244|P3|Overall Study|Completion status unknown|12
6016977|NCT00806585|20800245|P2|Overall Study|Completion status unknown|14
6016978|NCT00806585|20800246|P1|Overall Study|Completion status unknown|15
6016979|NCT00806585|20800242|P5|Overall Study|Withdrawal by Subject|11
6016980|NCT00806585|20800243|P4|Overall Study|Withdrawal by Subject|3
6016981|NCT00806585|20800244|P3|Overall Study|Withdrawal by Subject|9
6016982|NCT00806585|20800245|P2|Overall Study|Withdrawal by Subject|8
6016983|NCT00806585|20800246|P1|Overall Study|Withdrawal by Subject|10
6016984|NCT00806585|20800242|P5|Overall Study|Adverse Event|2
6016985|NCT00806585|20800243|P4|Overall Study|Adverse Event|4
6016986|NCT00806585|20800244|P3|Overall Study|Adverse Event|3
6016987|NCT00806585|20800245|P2|Overall Study|Adverse Event|5
6016988|NCT00806585|20800246|P1|Overall Study|Adverse Event|1
6016989|NCT00806585|20800242|P5|Overall Study|Lack of Efficacy|0
6016990|NCT00806585|20800243|P4|Overall Study|Lack of Efficacy|0
6016991|NCT00806585|20800244|P3|Overall Study|Lack of Efficacy|0
6016992|NCT00806585|20800245|P2|Overall Study|Lack of Efficacy|0
6016993|NCT00806585|20800246|P1|Overall Study|Lack of Efficacy|1
6016994|NCT00806585|20800242|P5|Overall Study|Lost to Follow-up|5
6016995|NCT00806585|20800243|P4|Overall Study|Lost to Follow-up|2
6016996|NCT00806585|20800244|P3|Overall Study|Lost to Follow-up|2
6016997|NCT00806585|20800245|P2|Overall Study|Lost to Follow-up|1
6016998|NCT00806585|20800246|P1|Overall Study|Lost to Follow-up|2
6016999|NCT00806585|20800242|P5|Overall Study|Physician Decision|1
6017000|NCT00806585|20800243|P4|Overall Study|Physician Decision|0
6017001|NCT00806585|20800244|P3|Overall Study|Physician Decision|3
6017002|NCT00806585|20800245|P2|Overall Study|Physician Decision|2
6017003|NCT00806585|20800246|P1|Overall Study|Physician Decision|0
6017004|NCT00806585|20800242|P5|Overall Study|Protocol Violation|0
6017005|NCT00806585|20800243|P4|Overall Study|Protocol Violation|0
6017006|NCT00806585|20800244|P3|Overall Study|Protocol Violation|2
6017007|NCT00806585|20800245|P2|Overall Study|Protocol Violation|1
6017008|NCT00806585|20800246|P1|Overall Study|Protocol Violation|3
6017009|NCT00806585|20800242|P5|Overall Study|Study terminated by Sponsor|0
6017010|NCT00806585|20800243|P4|Overall Study|Study terminated by Sponsor|2
6017011|NCT00806585|20800244|P3|Overall Study|Study terminated by Sponsor|1
6017012|NCT00806585|20800245|P2|Overall Study|Study terminated by Sponsor|0
6017013|NCT00806585|20800246|P1|Overall Study|Study terminated by Sponsor|0
6017014|NCT00806546|20800278|P1|Overall Study|Various|42
6017015|NCT00806546|20800278|P1|Overall Study|Protocol Violation|49
6017016|NCT00806546|20800278|P1|Overall Study|Withdrawal by Subject|75
6017017|NCT00806546|20800278|P1|Overall Study|Adverse Event|74
6017018|NCT00806546|20800278|P1|Overall Study|Lost to Follow-up|32
6017019|NCT00806546|20800278|P1|Overall Study|Enrolled, not treated|35
6017020|NCT00806494|20800282|P1|Overall Study|Withdrawal by Subject|5
6017021|NCT00806494|20800282|P1|Overall Study|Other|30
6017022|NCT00806494|20800282|P1|Overall Study|Lost to Follow-up|10
6017023|NCT00806494|20800282|P1|Overall Study|Lack of Efficacy|6
6017024|NCT00806494|20800282|P1|Overall Study|Adverse Event|29
6017025|NCT00806442|20800306|P2|Overall Study|Withdrawal by Subject|5
6017026|NCT00806442|20800307|P1|Overall Study|Withdrawal by Subject|1
6017027|NCT00806442|20800306|P2|Overall Study|Lost to Follow-up|2
6017028|NCT00806442|20800307|P1|Overall Study|Lost to Follow-up|3
6017029|NCT00806416|20800329|P4|Period 1 - Part II|Withdrawal by Subject|2
6017030|NCT00806416|20800330|P3|Period 1 - Part II|Withdrawal by Subject|0
6017031|NCT00806416|20800331|P2|Period 1 - Part II|Withdrawal by Subject|0
6017032|NCT00806416|20800332|P1|Period 1 - Part II|Withdrawal by Subject|0
6017033|NCT00806416|20800329|P4|Period 1 - Part I|Withdrawal by Subject|0
6017034|NCT00806416|20800330|P3|Period 1 - Part I|Withdrawal by Subject|0
6017035|NCT00806416|20800331|P2|Period 1 - Part I|Withdrawal by Subject|1
6017036|NCT00806416|20800332|P1|Period 1 - Part I|Withdrawal by Subject|3
6017037|NCT00806416|20800329|P4|Period 1 - Part I|Lost to Follow-up|0
6017038|NCT00806416|20800330|P3|Period 1 - Part I|Lost to Follow-up|0
6017039|NCT00806416|20800331|P2|Period 1 - Part I|Lost to Follow-up|2
6017040|NCT00806416|20800332|P1|Period 1 - Part I|Lost to Follow-up|0
6017041|NCT00806416|20800329|P4|Period 1 - Part I|Adverse Event|0
6017042|NCT00806416|20800330|P3|Period 1 - Part I|Adverse Event|0
6017043|NCT00806416|20800331|P2|Period 1 - Part I|Adverse Event|1
6017044|NCT00806416|20800332|P1|Period 1 - Part I|Adverse Event|0
6017045|NCT00806403|20800345|P2|Overall Study|Death|3
6017046|NCT00806403|20800346|P1|Overall Study|Death|4
6017047|NCT00806351|20800369|P2|Overall Study|Death|4
6017048|NCT00806351|20800370|P1|Overall Study|Death|5
6017049|NCT00806286|20800404|P3|Overall Study|Due to a variety of reasons|1
6017050|NCT00806286|20800405|P2|Overall Study|Due to a variety of reasons|2
6017051|NCT00806286|20800406|P1|Overall Study|Due to a variety of reasons|7
6017052|NCT00806286|20800404|P3|Overall Study|Physician Decision|0
6017053|NCT00806286|20800405|P2|Overall Study|Physician Decision|2
6017054|NCT00806286|20800406|P1|Overall Study|Physician Decision|2
6017055|NCT00806286|20800404|P3|Overall Study|Withdrawal by Subject|1
6017056|NCT00806286|20800405|P2|Overall Study|Withdrawal by Subject|3
6017057|NCT00806286|20800406|P1|Overall Study|Withdrawal by Subject|8
6017058|NCT00806286|20800404|P3|Overall Study|Lost to Follow-up|0
6017059|NCT00806286|20800405|P2|Overall Study|Lost to Follow-up|1
6017060|NCT00806286|20800406|P1|Overall Study|Lost to Follow-up|0
6017061|NCT00806286|20800404|P3|Overall Study|Death|0
6017062|NCT00806286|20800405|P2|Overall Study|Death|6
6017063|NCT00806286|20800406|P1|Overall Study|Death|1
6017064|NCT00806286|20800404|P3|Overall Study|Disease progression|1
6017065|NCT00806286|20800405|P2|Overall Study|Disease progression|38
6017066|NCT00806286|20800406|P1|Overall Study|Disease progression|31
6017067|NCT00806286|20800404|P3|Overall Study|Adverse Event|0
6017068|NCT00806286|20800405|P2|Overall Study|Adverse Event|2
6017069|NCT00806286|20800406|P1|Overall Study|Adverse Event|5
6017070|NCT00806260|20800428|P6|Period 3|Pregnancy|0
6017071|NCT00806260|20800429|P5|Period 3|Pregnancy|0
6017072|NCT00806260|20800430|P4|Period 3|Pregnancy|0
6017073|NCT00806260|20800431|P3|Period 3|Pregnancy|0
6017074|NCT00806260|20800432|P2|Period 3|Pregnancy|0
6017075|NCT00806260|20800433|P1|Period 3|Pregnancy|1
6017076|NCT00806260|20800428|P6|Period 3|Protocol Violation|0
6017077|NCT00806260|20800429|P5|Period 3|Protocol Violation|0
6017078|NCT00806260|20800430|P4|Period 3|Protocol Violation|0
6017079|NCT00806260|20800431|P3|Period 3|Protocol Violation|1
6017080|NCT00806260|20800432|P2|Period 3|Protocol Violation|1
6017081|NCT00806260|20800433|P1|Period 3|Protocol Violation|0
6017082|NCT00806260|20800428|P6|Period 2|sponsor request|0
6017083|NCT00806260|20800429|P5|Period 2|sponsor request|0
6017084|NCT00806260|20800430|P4|Period 2|sponsor request|1
6017085|NCT00806260|20800431|P3|Period 2|sponsor request|1
6017086|NCT00806260|20800432|P2|Period 2|sponsor request|0
6017087|NCT00806260|20800433|P1|Period 2|sponsor request|0
6017088|NCT00806260|20800428|P6|Period 2|Need to take concomitant medication|0
6017089|NCT00806260|20800429|P5|Period 2|Need to take concomitant medication|0
6017090|NCT00806260|20800430|P4|Period 2|Need to take concomitant medication|0
6017091|NCT00806260|20800431|P3|Period 2|Need to take concomitant medication|0
6017092|NCT00806260|20800432|P2|Period 2|Need to take concomitant medication|0
6017093|NCT00806260|20800433|P1|Period 2|Need to take concomitant medication|1
6017094|NCT00806260|20800428|P6|Period 2|Protocol Violation|0
6017095|NCT00806260|20800429|P5|Period 2|Protocol Violation|0
6017096|NCT00806260|20800430|P4|Period 2|Protocol Violation|0
6017097|NCT00806260|20800431|P3|Period 2|Protocol Violation|1
6017098|NCT00806260|20800432|P2|Period 2|Protocol Violation|0
6017099|NCT00806260|20800433|P1|Period 2|Protocol Violation|1
6017100|NCT00806260|20800428|P6|Period 2|Adverse Event|0
6017101|NCT00806260|20800429|P5|Period 2|Adverse Event|0
6017102|NCT00806260|20800430|P4|Period 2|Adverse Event|1
6017103|NCT00806260|20800431|P3|Period 2|Adverse Event|0
6017104|NCT00806260|20800432|P2|Period 2|Adverse Event|0
6017105|NCT00806260|20800433|P1|Period 2|Adverse Event|0
6017106|NCT00806260|20800428|P6|Period 1 (1 Day)|Adverse Event|0
6017107|NCT00806260|20800429|P5|Period 1 (1 Day)|Adverse Event|3
6017108|NCT00806260|20800430|P4|Period 1 (1 Day)|Adverse Event|0
6017109|NCT00806260|20800431|P3|Period 1 (1 Day)|Adverse Event|0
6017110|NCT00806260|20800432|P2|Period 1 (1 Day)|Adverse Event|0
6017111|NCT00806260|20800433|P1|Period 1 (1 Day)|Adverse Event|0
6017112|NCT00806195|20800478|P4|Overall Study|Protocol Violation|9
6017113|NCT00806195|20800479|P3|Overall Study|Protocol Violation|26
6017114|NCT00806195|20800480|P2|Overall Study|Protocol Violation|24
6017115|NCT00806195|20800481|P1|Overall Study|Protocol Violation|34
6017116|NCT00806195|20800478|P4|Overall Study|Administrative Reason|26
6017117|NCT00806195|20800479|P3|Overall Study|Administrative Reason|66
6017118|NCT00806195|20800480|P2|Overall Study|Administrative Reason|35
6017119|NCT00806195|20800481|P1|Overall Study|Administrative Reason|113
6017120|NCT00806195|20800478|P4|Overall Study|Inappropriate Enrollment|0
6017121|NCT00806195|20800479|P3|Overall Study|Inappropriate Enrollment|0
6017122|NCT00806195|20800480|P2|Overall Study|Inappropriate Enrollment|1
6017123|NCT00806195|20800481|P1|Overall Study|Inappropriate Enrollment|0
6017124|NCT00806195|20800478|P4|Overall Study|Lost to Follow-up|34
6017125|NCT00806195|20800479|P3|Overall Study|Lost to Follow-up|90
6017126|NCT00806195|20800480|P2|Overall Study|Lost to Follow-up|66
6017127|NCT00806195|20800481|P1|Overall Study|Lost to Follow-up|217
6017128|NCT00806195|20800478|P4|Overall Study|Withdrawal by Subject|35
6017129|NCT00806195|20800479|P3|Overall Study|Withdrawal by Subject|76
6017130|NCT00806195|20800480|P2|Overall Study|Withdrawal by Subject|31
6017131|NCT00806195|20800481|P1|Overall Study|Withdrawal by Subject|119
6017132|NCT00806195|20800478|P4|Overall Study|Adverse Event|2
6017133|NCT00806195|20800479|P3|Overall Study|Adverse Event|11
6017134|NCT00806195|20800480|P2|Overall Study|Adverse Event|5
6017135|NCT00806195|20800481|P1|Overall Study|Adverse Event|25
6017136|NCT00806195|20800478|P4|Overall Study|Death|0
6017137|NCT00806195|20800479|P3|Overall Study|Death|1
6017138|NCT00806195|20800480|P2|Overall Study|Death|0
6017139|NCT00806195|20800481|P1|Overall Study|Death|6
6017140|NCT00806026|20800512|P6|Overall Study|Adverse Event|9
6017141|NCT00806026|20800513|P5|Overall Study|Adverse Event|9
6017142|NCT00806026|20800514|P4|Overall Study|Adverse Event|17
6017143|NCT00806026|20800515|P3|Overall Study|Adverse Event|44
6017144|NCT00806026|20800516|P2|Overall Study|Adverse Event|35
6017145|NCT00806026|20800517|P1|Overall Study|Adverse Event|52
6017146|NCT00806026|20800512|P6|Overall Study|Protocol Violation|3
6017147|NCT00806026|20800513|P5|Overall Study|Protocol Violation|2
6017148|NCT00806026|20800514|P4|Overall Study|Protocol Violation|0
6017149|NCT00806026|20800515|P3|Overall Study|Protocol Violation|9
6017150|NCT00806026|20800516|P2|Overall Study|Protocol Violation|9
6017151|NCT00806026|20800517|P1|Overall Study|Protocol Violation|6
6017152|NCT00806026|20800512|P6|Overall Study|Other|4
6017153|NCT00806026|20800513|P5|Overall Study|Other|0
6017154|NCT00806026|20800514|P4|Overall Study|Other|2
6017155|NCT00806026|20800515|P3|Overall Study|Other|8
6017156|NCT00806026|20800516|P2|Overall Study|Other|6
6017157|NCT00806026|20800517|P1|Overall Study|Other|3
6017158|NCT00806026|20800512|P6|Overall Study|Withdrawal by Subject|3
6017159|NCT00806026|20800513|P5|Overall Study|Withdrawal by Subject|5
6017160|NCT00806026|20800514|P4|Overall Study|Withdrawal by Subject|2
6017161|NCT00806026|20800515|P3|Overall Study|Withdrawal by Subject|9
6017162|NCT00806026|20800516|P2|Overall Study|Withdrawal by Subject|17
6017163|NCT00806026|20800517|P1|Overall Study|Withdrawal by Subject|14
6017164|NCT00806026|20800512|P6|Overall Study|Lost to Follow-up|6
6017165|NCT00806026|20800513|P5|Overall Study|Lost to Follow-up|6
6017166|NCT00806026|20800514|P4|Overall Study|Lost to Follow-up|2
6017167|NCT00806026|20800515|P3|Overall Study|Lost to Follow-up|8
6017168|NCT00806026|20800516|P2|Overall Study|Lost to Follow-up|15
6017169|NCT00806026|20800517|P1|Overall Study|Lost to Follow-up|8
6017170|NCT00806026|20800512|P6|Overall Study|Lack of Efficacy|7
6017171|NCT00806026|20800513|P5|Overall Study|Lack of Efficacy|8
6017172|NCT00806026|20800514|P4|Overall Study|Lack of Efficacy|4
6017173|NCT00806026|20800515|P3|Overall Study|Lack of Efficacy|13
6017174|NCT00806026|20800516|P2|Overall Study|Lack of Efficacy|18
6017175|NCT00806026|20800517|P1|Overall Study|Lack of Efficacy|5
6017176|NCT00806026|20800512|P6|Overall Study|Did not meet entrance criteria|0
6017177|NCT00806026|20800513|P5|Overall Study|Did not meet entrance criteria|0
6017178|NCT00806026|20800514|P4|Overall Study|Did not meet entrance criteria|1
6017179|NCT00806026|20800515|P3|Overall Study|Did not meet entrance criteria|2
6017180|NCT00806026|20800516|P2|Overall Study|Did not meet entrance criteria|1
6017181|NCT00806026|20800517|P1|Overall Study|Did not meet entrance criteria|4
6017182|NCT00806026|20800512|P6|Overall Study|Death|0
6017183|NCT00806026|20800513|P5|Overall Study|Death|0
6017184|NCT00806026|20800514|P4|Overall Study|Death|1
6017185|NCT00806026|20800515|P3|Overall Study|Death|0
6017186|NCT00806026|20800516|P2|Overall Study|Death|0
6017187|NCT00806026|20800517|P1|Overall Study|Death|0
6017188|NCT00805961|20800612|P1|Maintenance Treatment|Withdrawn Consent|1
6017189|NCT00805961|20800612|P1|Maintenance Treatment|Symptomatic Deterioration|2
6017190|NCT00805961|20800612|P1|Maintenance Treatment|Withdrawal by Subject|5
6017191|NCT00805961|20800612|P1|Maintenance Treatment|Adverse Event|6
6017192|NCT00805961|20800612|P1|Maintenance Treatment|Intercurrent Illness|7
6017193|NCT00805961|20800612|P1|Maintenance Treatment|Lack of Efficacy|13
6017194|NCT00805961|20800612|P1|Treatment-Free Interval|Lack of Efficacy|1
6017195|NCT00805961|20800612|P1|Treatment-Free Interval|Physician Decision|1
6017196|NCT00805961|20800612|P1|Treatment-Free Interval|Intercurrent Illness|2
6017197|NCT00805961|20800612|P1|Treatment-Free Interval|Adverse Event|3
6017198|NCT00805961|20800612|P1|Modality Therapy|Disease Progression|2
6017199|NCT00805961|20800612|P1|Modality Therapy|Adverse Event|1
6017200|NCT00805961|20800612|P1|Modality Therapy|Withdrawal by Subject|1
6017201|NCT00805935|20800636|P4|Overall Study|Serious Adverse Event-congenital anomaly|0
6017202|NCT00805935|20800637|P3|Overall Study|Serious Adverse Event-congenital anomaly|0
6017203|NCT00805935|20800638|P2|Overall Study|Serious Adverse Event-congenital anomaly|1
6017204|NCT00805935|20800639|P1|Overall Study|Serious Adverse Event-congenital anomaly|0
6017205|NCT00805935|20800636|P4|Overall Study|Ectopic pregnancy|0
6017206|NCT00805935|20800637|P3|Overall Study|Ectopic pregnancy|1
6017207|NCT00805935|20800638|P2|Overall Study|Ectopic pregnancy|0
6017208|NCT00805935|20800639|P1|Overall Study|Ectopic pregnancy|0
6017209|NCT00805935|20800636|P4|Overall Study|Chemical pregnancy|2
6017210|NCT00805935|20800637|P3|Overall Study|Chemical pregnancy|3
6017211|NCT00805935|20800638|P2|Overall Study|Chemical pregnancy|5
6017212|NCT00805935|20800639|P1|Overall Study|Chemical pregnancy|0
6017213|NCT00805935|20800636|P4|Overall Study|Biochemical pregnancy|0
6017214|NCT00805935|20800637|P3|Overall Study|Biochemical pregnancy|0
6017215|NCT00805935|20800638|P2|Overall Study|Biochemical pregnancy|1
6017216|NCT00805935|20800639|P1|Overall Study|Biochemical pregnancy|0
6017217|NCT00805935|20800636|P4|Overall Study|Pregnancy loss/miscarriage|0
6017218|NCT00805935|20800637|P3|Overall Study|Pregnancy loss/miscarriage|0
6017219|NCT00805935|20800638|P2|Overall Study|Pregnancy loss/miscarriage|0
6017220|NCT00805935|20800639|P1|Overall Study|Pregnancy loss/miscarriage|2
6017221|NCT00805935|20800636|P4|Overall Study|Pregnancy not confirmed by ultrasound|1
6017222|NCT00805935|20800637|P3|Overall Study|Pregnancy not confirmed by ultrasound|0
6017223|NCT00805935|20800638|P2|Overall Study|Pregnancy not confirmed by ultrasound|0
6017224|NCT00805935|20800639|P1|Overall Study|Pregnancy not confirmed by ultrasound|0
6017225|NCT00805935|20800636|P4|Overall Study|No positive serum pregnancy|5
6017226|NCT00805935|20800637|P3|Overall Study|No positive serum pregnancy|6
6017227|NCT00805935|20800638|P2|Overall Study|No positive serum pregnancy|7
6017228|NCT00805935|20800639|P1|Overall Study|No positive serum pregnancy|8
6017229|NCT00805935|20800636|P4|Overall Study|Lost to Follow-up|0
6017230|NCT00805935|20800637|P3|Overall Study|Lost to Follow-up|0
6017231|NCT00805935|20800638|P2|Overall Study|Lost to Follow-up|0
6017232|NCT00805935|20800639|P1|Overall Study|Lost to Follow-up|1
6017233|NCT00805935|20800636|P4|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|1
6017234|NCT00805935|20800637|P3|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0
6017235|NCT00805935|20800638|P2|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0
6017236|NCT00805935|20800639|P1|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0
6017237|NCT00805935|20800636|P4|Overall Study|Cycle cancellation for risk of OHSS|0
6017238|NCT00805935|20800637|P3|Overall Study|Cycle cancellation for risk of OHSS|1
6017239|NCT00805935|20800638|P2|Overall Study|Cycle cancellation for risk of OHSS|0
6017240|NCT00805935|20800639|P1|Overall Study|Cycle cancellation for risk of OHSS|1
6017241|NCT00805935|20800636|P4|Overall Study|Cycle cancelled|0
6017242|NCT00805935|20800637|P3|Overall Study|Cycle cancelled|2
6017243|NCT00805935|20800638|P2|Overall Study|Cycle cancelled|0
6017244|NCT00805935|20800639|P1|Overall Study|Cycle cancelled|0
6017245|NCT00805935|20800636|P4|Overall Study|Stimulation Failure|2
6017246|NCT00805935|20800637|P3|Overall Study|Stimulation Failure|2
6017247|NCT00805935|20800638|P2|Overall Study|Stimulation Failure|5
6017248|NCT00805935|20800639|P1|Overall Study|Stimulation Failure|1
6017249|NCT00805792|20800706|P1|Overall Study|Lost to Follow-up|2
6017250|NCT00805792|20800706|P1|Overall Study|Death|3
6017251|NCT00805766|20800714|P1|Increased Dose Period|Withdrawal by Subject|1
6017252|NCT00805766|20800714|P1|Increased Dose Period|Pregnancy|1
6017253|NCT00805766|20800714|P1|Increased Dose Period|Lack of Efficacy|7
6017254|NCT00805766|20800714|P1|Increased Dose Period|Adverse Event|4
6017255|NCT00805766|20800714|P1|Screening Period|Responder|2
6017256|NCT00805766|20800714|P1|Screening Period|Pregnancy|1
6017257|NCT00805766|20800714|P1|Screening Period|Lack of Efficacy|2
6017258|NCT00805766|20800714|P1|Screening Period|Adverse Event|1
6017259|NCT00805740|20800728|P2|Overall Study|Randomized, but not treated|0
6017260|NCT00805740|20800729|P1|Overall Study|Randomized, but not treated|2
6017261|NCT00805740|20800728|P2|Overall Study|Lost to Follow-up|0
6017262|NCT00805740|20800729|P1|Overall Study|Lost to Follow-up|1
6017263|NCT00805740|20800728|P2|Overall Study|Withdrawal by Subject|0
6017264|NCT00805740|20800729|P1|Overall Study|Withdrawal by Subject|1
6017265|NCT00805740|20800728|P2|Overall Study|Death|4
6017266|NCT00805740|20800729|P1|Overall Study|Death|7
6017267|NCT00805675|20800754|P3|Overall Study|Adverse Event|1
6017268|NCT00805675|20800755|P2|Overall Study|Adverse Event|0
6017269|NCT00805675|20800756|P1|Overall Study|Adverse Event|0
6017270|NCT00805545|20800790|P2|Overall Study|Protocol Violation|1
6017271|NCT00805545|20800791|P1|Overall Study|Protocol Violation|3
6017272|NCT00805545|20800790|P2|Overall Study|Protocol Violation|2
6017273|NCT00805545|20800791|P1|Overall Study|Protocol Violation|3
6017274|NCT00805532|20800799|P2|Overall Study|invalid data|1
6017275|NCT00805532|20800800|P1|Overall Study|invalid data|0
6017276|NCT00805480|20800834|P4|Overall Study|Adverse Event|0
6017277|NCT00805480|20800835|P3|Overall Study|Adverse Event|1
6017278|NCT00805480|20800836|P2|Overall Study|Adverse Event|0
6017279|NCT00805480|20800837|P1|Overall Study|Adverse Event|0
6017280|NCT00805480|20800834|P4|Overall Study|Lost to Follow-up|0
6017281|NCT00805480|20800835|P3|Overall Study|Lost to Follow-up|0
6017282|NCT00805480|20800836|P2|Overall Study|Lost to Follow-up|2
6017283|NCT00805480|20800837|P1|Overall Study|Lost to Follow-up|1
6017284|NCT00805480|20800834|P4|Overall Study|Withdrawal by Subject|5
6017285|NCT00805480|20800835|P3|Overall Study|Withdrawal by Subject|11
6017286|NCT00805480|20800836|P2|Overall Study|Withdrawal by Subject|5
6017287|NCT00805480|20800837|P1|Overall Study|Withdrawal by Subject|13
6017288|NCT00805467|20800866|P4|Overall Study|Not reported|7
6017289|NCT00805467|20800867|P3|Overall Study|Not reported|3
6017290|NCT00805467|20800868|P2|Overall Study|Not reported|0
6017291|NCT00805467|20800869|P1|Overall Study|Not reported|0
6017292|NCT00805467|20800866|P4|Overall Study|Physician Decision|6
6017293|NCT00805467|20800867|P3|Overall Study|Physician Decision|2
6017294|NCT00805467|20800868|P2|Overall Study|Physician Decision|1
6017295|NCT00805467|20800869|P1|Overall Study|Physician Decision|0
6017296|NCT00805467|20800866|P4|Overall Study|Death|5
6017297|NCT00805467|20800867|P3|Overall Study|Death|7
6017298|NCT00805467|20800868|P2|Overall Study|Death|2
6017299|NCT00805467|20800869|P1|Overall Study|Death|0
6017300|NCT00805467|20800866|P4|Overall Study|Adverse Event|57
6017301|NCT00805467|20800867|P3|Overall Study|Adverse Event|26
6017302|NCT00805467|20800868|P2|Overall Study|Adverse Event|13
6017303|NCT00805467|20800869|P1|Overall Study|Adverse Event|0
6017304|NCT00805467|20800866|P4|Overall Study|Protocol Violation|5
6017305|NCT00805467|20800867|P3|Overall Study|Protocol Violation|0
6017306|NCT00805467|20800868|P2|Overall Study|Protocol Violation|3
6017307|NCT00805467|20800869|P1|Overall Study|Protocol Violation|0
6017308|NCT00805467|20800866|P4|Overall Study|Withdrawal by Subject|50
6017309|NCT00805467|20800867|P3|Overall Study|Withdrawal by Subject|45
6017310|NCT00805467|20800868|P2|Overall Study|Withdrawal by Subject|6
6017311|NCT00805467|20800869|P1|Overall Study|Withdrawal by Subject|0
6017312|NCT00805467|20800866|P4|Overall Study|Lost to Follow-up|21
6017313|NCT00805467|20800867|P3|Overall Study|Lost to Follow-up|7
6017314|NCT00805467|20800868|P2|Overall Study|Lost to Follow-up|1
6017315|NCT00805467|20800869|P1|Overall Study|Lost to Follow-up|0
6017316|NCT00805467|20800866|P4|Overall Study|Lack of Efficacy|86
6017317|NCT00805467|20800867|P3|Overall Study|Lack of Efficacy|13
6017318|NCT00805467|20800868|P2|Overall Study|Lack of Efficacy|8
6017319|NCT00805467|20800869|P1|Overall Study|Lack of Efficacy|0
6017320|NCT00805441|20800889|P2|Overall Study|Acute Alcohol Withdrawal|1
6017321|NCT00805441|20800890|P1|Overall Study|Acute Alcohol Withdrawal|0
6017322|NCT00805441|20800889|P2|Overall Study|Physician Decision|1
6017323|NCT00805441|20800890|P1|Overall Study|Physician Decision|0
6017324|NCT00805441|20800889|P2|Overall Study|Withdrawal by Subject|9
6017325|NCT00805441|20800890|P1|Overall Study|Withdrawal by Subject|15
6017326|NCT00805441|20800889|P2|Overall Study|Lost to Follow-up|13
6017327|NCT00805441|20800890|P1|Overall Study|Lost to Follow-up|10
6017328|NCT00805441|20800889|P2|Overall Study|Protocol Violation|8
6017329|NCT00805441|20800890|P1|Overall Study|Protocol Violation|4
6017330|NCT00805441|20800889|P2|Overall Study|Lack of Efficacy|2
6017331|NCT00805441|20800890|P1|Overall Study|Lack of Efficacy|0
6017332|NCT00805441|20800889|P2|Overall Study|Adverse Event|2
6017333|NCT00805441|20800890|P1|Overall Study|Adverse Event|5
6017334|NCT00805389|20800925|P5|Overall Study|Withdrawal by Subject|4
6017335|NCT00805389|20800926|P4|Overall Study|Withdrawal by Subject|5
6017336|NCT00805389|20800927|P3|Overall Study|Withdrawal by Subject|4
6017337|NCT00805389|20800928|P2|Overall Study|Withdrawal by Subject|2
6017338|NCT00805389|20800929|P1|Overall Study|Withdrawal by Subject|3
6017339|NCT00805389|20800925|P5|Overall Study|Protocol Violation|0
6017340|NCT00805389|20800926|P4|Overall Study|Protocol Violation|0
6017341|NCT00805389|20800927|P3|Overall Study|Protocol Violation|1
6017342|NCT00805389|20800928|P2|Overall Study|Protocol Violation|0
6017343|NCT00805389|20800929|P1|Overall Study|Protocol Violation|0
6017344|NCT00805389|20800925|P5|Overall Study|Lost to Follow-up|9
6017345|NCT00805389|20800926|P4|Overall Study|Lost to Follow-up|10
6017346|NCT00805389|20800927|P3|Overall Study|Lost to Follow-up|6
6017347|NCT00805389|20800928|P2|Overall Study|Lost to Follow-up|3
6017348|NCT00805389|20800929|P1|Overall Study|Lost to Follow-up|4
6017349|NCT00805389|20800925|P5|Overall Study|Adverse Event|0
6017350|NCT00805389|20800926|P4|Overall Study|Adverse Event|2
6017351|NCT00805389|20800927|P3|Overall Study|Adverse Event|1
6017352|NCT00805389|20800928|P2|Overall Study|Adverse Event|0
6017353|NCT00805389|20800929|P1|Overall Study|Adverse Event|0
6017354|NCT00805285|20801176|P1|Overall Study|Lack of Efficacy|1
6017355|NCT00805207|20801193|P9|Overall Study|Withdrawal by Subject|0
6017356|NCT00805207|20801194|P8|Overall Study|Withdrawal by Subject|0
6017357|NCT00805207|20801195|P7|Overall Study|Withdrawal by Subject|0
6017358|NCT00805207|20801196|P6|Overall Study|Withdrawal by Subject|2
6017359|NCT00805207|20801197|P5|Overall Study|Withdrawal by Subject|1
6017360|NCT00805207|20801198|P4|Overall Study|Withdrawal by Subject|0
6017361|NCT00805207|20801199|P3|Overall Study|Withdrawal by Subject|0
6017362|NCT00805207|20801200|P2|Overall Study|Withdrawal by Subject|1
6017363|NCT00805207|20801201|P1|Overall Study|Withdrawal by Subject|0
6017364|NCT00805207|20801193|P9|Overall Study|Physician Decision|0
6017365|NCT00805207|20801194|P8|Overall Study|Physician Decision|0
6017366|NCT00805207|20801195|P7|Overall Study|Physician Decision|0
6017367|NCT00805207|20801196|P6|Overall Study|Physician Decision|1
6017368|NCT00805207|20801197|P5|Overall Study|Physician Decision|0
6017369|NCT00805207|20801198|P4|Overall Study|Physician Decision|0
6017370|NCT00805207|20801199|P3|Overall Study|Physician Decision|0
6017371|NCT00805207|20801200|P2|Overall Study|Physician Decision|1
6017372|NCT00805207|20801201|P1|Overall Study|Physician Decision|0
6017373|NCT00805207|20801193|P9|Overall Study|Protocol Violation|0
6017374|NCT00805207|20801194|P8|Overall Study|Protocol Violation|0
6017375|NCT00805207|20801195|P7|Overall Study|Protocol Violation|0
6017376|NCT00805207|20801196|P6|Overall Study|Protocol Violation|0
6017377|NCT00805207|20801197|P5|Overall Study|Protocol Violation|0
6017378|NCT00805207|20801198|P4|Overall Study|Protocol Violation|0
6017379|NCT00805207|20801199|P3|Overall Study|Protocol Violation|1
6017380|NCT00805207|20801200|P2|Overall Study|Protocol Violation|0
6017381|NCT00805207|20801201|P1|Overall Study|Protocol Violation|0
6017382|NCT00805194|20801259|P2|Overall Study|Reasons other than stated above|16
6017383|NCT00805194|20801260|P1|Overall Study|Reasons other than stated above|20
6017384|NCT00805194|20801259|P2|Overall Study|Not treated|4
6017385|NCT00805194|20801260|P1|Overall Study|Not treated|3
6017386|NCT00805194|20801259|P2|Overall Study|Withdrawal by Subject|42
6017387|NCT00805194|20801260|P1|Overall Study|Withdrawal by Subject|60
6017388|NCT00805194|20801259|P2|Overall Study|Lost to Follow-up|5
6017389|NCT00805194|20801260|P1|Overall Study|Lost to Follow-up|5
6017390|NCT00805194|20801259|P2|Overall Study|Protocol Violation|9
6017391|NCT00805194|20801260|P1|Overall Study|Protocol Violation|9
6017392|NCT00805194|20801259|P2|Overall Study|Other AE|73
6017393|NCT00805194|20801260|P1|Overall Study|Other AE|84
6017394|NCT00805194|20801259|P2|Overall Study|Worsening or AE of underlying disease|70
6017395|NCT00805194|20801260|P1|Overall Study|Worsening or AE of underlying disease|64
6017396|NCT00805194|20801259|P2|Overall Study|Progressive disease (modified RECIST)|435
6017397|NCT00805194|20801260|P1|Overall Study|Progressive disease (modified RECIST)|404
6017398|NCT00805142|20801294|P2|Maintenance Period|Other|1
6017399|NCT00805142|20801295|P1|Maintenance Period|Other|0
6017400|NCT00805142|20801294|P2|Maintenance Period|Adverse Event|1
6017401|NCT00805142|20801295|P1|Maintenance Period|Adverse Event|0
6017402|NCT00805142|20801294|P2|Titration Period|Other|3
6017403|NCT00805142|20801295|P1|Titration Period|Other|0
6017404|NCT00805142|20801294|P2|Titration Period|Withdrawal of consent|1
6017405|NCT00805142|20801295|P1|Titration Period|Withdrawal of consent|0
6017406|NCT00805142|20801294|P2|Titration Period|Disease Progression|1
6017407|NCT00805142|20801295|P1|Titration Period|Disease Progression|2
6017408|NCT00805142|20801294|P2|Titration Period|Lost to Follow-up|1
6017409|NCT00805142|20801295|P1|Titration Period|Lost to Follow-up|0
6017410|NCT00805142|20801294|P2|Titration Period|Lack of Efficacy|1
6017411|NCT00805142|20801295|P1|Titration Period|Lack of Efficacy|1
6017412|NCT00805142|20801294|P2|Titration Period|Adverse Event|3
6017413|NCT00805142|20801295|P1|Titration Period|Adverse Event|3
6017414|NCT00805025|20801328|P1|Overall Study|Physician Decision|1
6017415|NCT00805025|20801328|P1|Overall Study|Withdrawal by Subject|2
6017416|NCT00805025|20801328|P1|Overall Study|Adverse Event|4
6017417|NCT00805025|20801328|P1|Overall Study|Screened but not enrolled/treated|42
6017418|NCT00804986|20801357|P6|Overall Study|Physician Decision|0
6017419|NCT00804986|20801358|P5|Overall Study|Physician Decision|0
6017420|NCT00804986|20801359|P4|Overall Study|Physician Decision|0
6017421|NCT00804986|20801360|P3|Overall Study|Physician Decision|0
6017422|NCT00804986|20801361|P2|Overall Study|Physician Decision|0
6017423|NCT00804986|20801362|P1|Overall Study|Physician Decision|1
6017424|NCT00804986|20801357|P6|Overall Study|Sponsor Decision|0
6017425|NCT00804986|20801358|P5|Overall Study|Sponsor Decision|0
6017426|NCT00804986|20801359|P4|Overall Study|Sponsor Decision|0
6017427|NCT00804986|20801360|P3|Overall Study|Sponsor Decision|0
6017428|NCT00804986|20801361|P2|Overall Study|Sponsor Decision|1
6017429|NCT00804986|20801362|P1|Overall Study|Sponsor Decision|0
6017430|NCT00804986|20801357|P6|Overall Study|Inclusion/Exclusion criteria not met|1
6017431|NCT00804986|20801358|P5|Overall Study|Inclusion/Exclusion criteria not met|0
6017432|NCT00804986|20801359|P4|Overall Study|Inclusion/Exclusion criteria not met|1
6017433|NCT00804986|20801360|P3|Overall Study|Inclusion/Exclusion criteria not met|0
6017434|NCT00804986|20801361|P2|Overall Study|Inclusion/Exclusion criteria not met|2
6017435|NCT00804986|20801362|P1|Overall Study|Inclusion/Exclusion criteria not met|0
6017436|NCT00804986|20801357|P6|Overall Study|Withdrawal by Subject|3
6017437|NCT00804986|20801358|P5|Overall Study|Withdrawal by Subject|5
6017438|NCT00804986|20801359|P4|Overall Study|Withdrawal by Subject|3
6017439|NCT00804986|20801360|P3|Overall Study|Withdrawal by Subject|0
6017440|NCT00804986|20801361|P2|Overall Study|Withdrawal by Subject|3
6017441|NCT00804986|20801362|P1|Overall Study|Withdrawal by Subject|0
6017442|NCT00804986|20801357|P6|Overall Study|Protocol Violation|0
6017443|NCT00804986|20801358|P5|Overall Study|Protocol Violation|0
6017444|NCT00804986|20801359|P4|Overall Study|Protocol Violation|1
6017445|NCT00804986|20801360|P3|Overall Study|Protocol Violation|0
6017446|NCT00804986|20801361|P2|Overall Study|Protocol Violation|1
6017447|NCT00804986|20801362|P1|Overall Study|Protocol Violation|0
6017448|NCT00804986|20801357|P6|Overall Study|Lost to Follow-up|3
6017449|NCT00804986|20801358|P5|Overall Study|Lost to Follow-up|1
6017450|NCT00804986|20801359|P4|Overall Study|Lost to Follow-up|1
6017451|NCT00804986|20801360|P3|Overall Study|Lost to Follow-up|0
6017452|NCT00804986|20801361|P2|Overall Study|Lost to Follow-up|0
6017453|NCT00804986|20801362|P1|Overall Study|Lost to Follow-up|0
6017454|NCT00804986|20801357|P6|Overall Study|Lack of Efficacy|3
6017455|NCT00804986|20801358|P5|Overall Study|Lack of Efficacy|0
6017456|NCT00804986|20801359|P4|Overall Study|Lack of Efficacy|1
6017457|NCT00804986|20801360|P3|Overall Study|Lack of Efficacy|0
6017458|NCT00804986|20801361|P2|Overall Study|Lack of Efficacy|0
6017459|NCT00804986|20801362|P1|Overall Study|Lack of Efficacy|0
6017460|NCT00804986|20801357|P6|Overall Study|Adverse Event|0
6017461|NCT00804986|20801358|P5|Overall Study|Adverse Event|3
6017462|NCT00804986|20801359|P4|Overall Study|Adverse Event|1
6017463|NCT00804986|20801360|P3|Overall Study|Adverse Event|2
6017464|NCT00804986|20801361|P2|Overall Study|Adverse Event|1
6017465|NCT00804986|20801362|P1|Overall Study|Adverse Event|0
6017466|NCT00804908|20801497|P3|Overall Study|Other|114
6017467|NCT00804908|20801498|P2|Overall Study|Other|116
6017468|NCT00804908|20801499|P1|Overall Study|Other|115
6017469|NCT00804843|20801530|P2|Overall Study|Withdrawal by Subject|2
6017470|NCT00804843|20801531|P1|Overall Study|Withdrawal by Subject|1
6017471|NCT00804843|20801530|P2|Overall Study|Adverse Event|5
6017472|NCT00804843|20801531|P1|Overall Study|Adverse Event|8
6017473|NCT00804843|20801530|P2|Overall Study|Protocol Violation|0
6017474|NCT00804843|20801531|P1|Overall Study|Protocol Violation|1
6017475|NCT00804687|20801549|P6|Period 5: Treatment Period|Positive drug test|0
6017476|NCT00804687|20801550|P5|Period 5: Treatment Period|Positive drug test|0
6017477|NCT00804687|20801551|P4|Period 5: Treatment Period|Positive drug test|0
6017478|NCT00804687|20801552|P3|Period 5: Treatment Period|Positive drug test|0
6017479|NCT00804687|20801553|P2|Period 5: Treatment Period|Positive drug test|0
6017480|NCT00804687|20801554|P1|Period 5: Treatment Period|Positive drug test|1
6017481|NCT00804687|20801549|P6|Period 5: Treatment Period|Positive drugs of abuse|0
6017482|NCT00804687|20801550|P5|Period 5: Treatment Period|Positive drugs of abuse|0
6017483|NCT00804687|20801551|P4|Period 5: Treatment Period|Positive drugs of abuse|0
6017484|NCT00804687|20801552|P3|Period 5: Treatment Period|Positive drugs of abuse|1
6017485|NCT00804687|20801553|P2|Period 5: Treatment Period|Positive drugs of abuse|0
6017486|NCT00804687|20801554|P1|Period 5: Treatment Period|Positive drugs of abuse|0
6017487|NCT00804687|20801549|P6|Period 5: Treatment Period|Withdrawal by Subject|0
6017488|NCT00804687|20801550|P5|Period 5: Treatment Period|Withdrawal by Subject|1
6017489|NCT00804687|20801551|P4|Period 5: Treatment Period|Withdrawal by Subject|0
6017490|NCT00804687|20801552|P3|Period 5: Treatment Period|Withdrawal by Subject|0
6017491|NCT00804687|20801553|P2|Period 5: Treatment Period|Withdrawal by Subject|0
6017492|NCT00804687|20801554|P1|Period 5: Treatment Period|Withdrawal by Subject|0
6017493|NCT00804687|20801549|P6|Period 3: Treatment Period|Positive Drug screen|0
6017494|NCT00804687|20801550|P5|Period 3: Treatment Period|Positive Drug screen|0
6017495|NCT00804687|20801551|P4|Period 3: Treatment Period|Positive Drug screen|1
6017496|NCT00804687|20801552|P3|Period 3: Treatment Period|Positive Drug screen|0
6017497|NCT00804687|20801553|P2|Period 3: Treatment Period|Positive Drug screen|0
6017498|NCT00804687|20801554|P1|Period 3: Treatment Period|Positive Drug screen|0
6017499|NCT00804570|20801633|P2|Overall Study|Withdrawal by Subject|38
6017500|NCT00804570|20801634|P1|Overall Study|Withdrawal by Subject|21
6017501|NCT00804570|20801633|P2|Overall Study|Sponsor decision|4
6017502|NCT00804570|20801634|P1|Overall Study|Sponsor decision|1
6017503|NCT00804570|20801633|P2|Overall Study|Physician Decision|2
6017504|NCT00804570|20801634|P1|Overall Study|Physician Decision|1
6017505|NCT00804570|20801633|P2|Overall Study|Protocol Violation|16
6017506|NCT00804570|20801634|P1|Overall Study|Protocol Violation|12
6017507|NCT00804570|20801633|P2|Overall Study|Entry criteria not met|5
6017508|NCT00804570|20801634|P1|Overall Study|Entry criteria not met|5
6017509|NCT00804570|20801633|P2|Overall Study|Lost to Follow-up|21
6017510|NCT00804570|20801634|P1|Overall Study|Lost to Follow-up|18
6017511|NCT00804570|20801633|P2|Overall Study|Lack of Efficacy|1
6017512|NCT00804570|20801634|P1|Overall Study|Lack of Efficacy|0
6017513|NCT00804570|20801633|P2|Overall Study|Adverse Event|7
6017514|NCT00804570|20801634|P1|Overall Study|Adverse Event|14
6017515|NCT00804193|20801708|P3|Overall Study|Withdrawal by Subject|2
6017516|NCT00804193|20801709|P2|Overall Study|Withdrawal by Subject|1
6017517|NCT00804193|20801710|P1|Overall Study|Withdrawal by Subject|3
6017518|NCT00804193|20801708|P3|Overall Study|Lost to Follow-up|4
6017519|NCT00804193|20801709|P2|Overall Study|Lost to Follow-up|3
6017520|NCT00804193|20801710|P1|Overall Study|Lost to Follow-up|3
6017521|NCT00804193|20801708|P3|Overall Study|Protocol Violation|2
6017522|NCT00804193|20801709|P2|Overall Study|Protocol Violation|8
6017523|NCT00804193|20801710|P1|Overall Study|Protocol Violation|0
6017524|NCT00804193|20801708|P3|Overall Study|Lack of Efficacy|3
6017525|NCT00804193|20801709|P2|Overall Study|Lack of Efficacy|1
6017526|NCT00804193|20801710|P1|Overall Study|Lack of Efficacy|1
6017527|NCT00804193|20801708|P3|Overall Study|Adverse Event|2
6017528|NCT00804193|20801709|P2|Overall Study|Adverse Event|0
6017529|NCT00804193|20801710|P1|Overall Study|Adverse Event|0
6017530|NCT00804193|20801708|P3|Overall Study|Lack of baseline fungus|19
6017531|NCT00804193|20801709|P2|Overall Study|Lack of baseline fungus|31
6017532|NCT00804193|20801710|P1|Overall Study|Lack of baseline fungus|32
6017533|NCT00804141|20801724|P1|Overall Study|Enrolled but not treated|6
6017534|NCT00804141|20801724|P1|Overall Study|Other than specified|30
6017535|NCT00804141|20801724|P1|Overall Study|Lack of Efficacy|46
6017536|NCT00804141|20801724|P1|Overall Study|Withdrawal by Subject|131
6017537|NCT00804141|20801724|P1|Overall Study|Protocol Violation|85
6017538|NCT00804141|20801724|P1|Overall Study|Investigator request|8
6017539|NCT00804141|20801724|P1|Overall Study|Failed to return|96
6017540|NCT00804141|20801724|P1|Overall Study|Death|4
6017541|NCT00804141|20801724|P1|Overall Study|Adverse Event|157
6017542|NCT00803790|20801764|P4|Period 2|Positive Drug Screen or Personal Reasons|0
6017543|NCT00803790|20801765|P3|Period 2|Positive Drug Screen or Personal Reasons|0
6017544|NCT00803790|20801766|P2|Period 2|Positive Drug Screen or Personal Reasons|0
6017545|NCT00803790|20801767|P1|Period 2|Positive Drug Screen or Personal Reasons|1
6017546|NCT00803790|20801764|P4|Period 2|Withdrawal by Subject|0
6017547|NCT00803790|20801765|P3|Period 2|Withdrawal by Subject|0
6017548|NCT00803790|20801766|P2|Period 2|Withdrawal by Subject|0
6017549|NCT00803790|20801767|P1|Period 2|Withdrawal by Subject|1
6017550|NCT00803790|20801764|P4|Period 2|Adverse Event|1
6017551|NCT00803790|20801765|P3|Period 2|Adverse Event|1
6017552|NCT00803790|20801766|P2|Period 2|Adverse Event|0
6017553|NCT00803790|20801767|P1|Period 2|Adverse Event|0
6017554|NCT00803790|20801764|P4|Period 1|Protocol Violation|0
6017555|NCT00803790|20801765|P3|Period 1|Protocol Violation|1
6017556|NCT00803790|20801766|P2|Period 1|Protocol Violation|0
6017557|NCT00803790|20801767|P1|Period 1|Protocol Violation|0
6017558|NCT00803790|20801764|P4|Period 1|positive drug screen or personal reasons|4
6017559|NCT00803790|20801765|P3|Period 1|positive drug screen or personal reasons|0
6017560|NCT00803790|20801766|P2|Period 1|positive drug screen or personal reasons|3
6017561|NCT00803790|20801767|P1|Period 1|positive drug screen or personal reasons|0
6017562|NCT00803790|20801764|P4|Period 1|Withdrawal by Subject|0
6017563|NCT00803790|20801765|P3|Period 1|Withdrawal by Subject|0
6017564|NCT00803790|20801766|P2|Period 1|Withdrawal by Subject|6
6017565|NCT00803790|20801767|P1|Period 1|Withdrawal by Subject|8
6017566|NCT00803790|20801764|P4|Period 1|Lost to Follow-up|0
6017567|NCT00803790|20801765|P3|Period 1|Lost to Follow-up|0
6017568|NCT00803790|20801766|P2|Period 1|Lost to Follow-up|2
6017569|NCT00803790|20801767|P1|Period 1|Lost to Follow-up|1
6017570|NCT00803790|20801764|P4|Period 1|Adverse Event|0
6017571|NCT00803790|20801765|P3|Period 1|Adverse Event|0
6017572|NCT00803790|20801766|P2|Period 1|Adverse Event|1
6017573|NCT00803790|20801767|P1|Period 1|Adverse Event|0
6017574|NCT00803738|20801807|P2|Overall Study|Positive Results for STD or abnormal PAP|8
6017575|NCT00803738|20801808|P1|Overall Study|Positive Results for STD or abnormal PAP|2
6017576|NCT00803738|20801807|P2|Overall Study|Negative Baseline Culture of Candida|63
6017577|NCT00803738|20801808|P1|Overall Study|Negative Baseline Culture of Candida|56
6017578|NCT00803738|20801807|P2|Overall Study|Lack of Efficacy|16
6017579|NCT00803738|20801808|P1|Overall Study|Lack of Efficacy|10
6017580|NCT00803738|20801807|P2|Overall Study|Withdrawal by Subject|4
6017581|NCT00803738|20801808|P1|Overall Study|Withdrawal by Subject|1
6017582|NCT00803738|20801807|P2|Overall Study|Protocol Violation|10
6017583|NCT00803738|20801808|P1|Overall Study|Protocol Violation|18
6017584|NCT00803738|20801807|P2|Overall Study|Lost to Follow-up|4
6017585|NCT00803738|20801808|P1|Overall Study|Lost to Follow-up|4
6017586|NCT00803738|20801807|P2|Overall Study|Adverse Event|5
6017587|NCT00803738|20801808|P1|Overall Study|Adverse Event|3
6017588|NCT00803712|20801820|P2|Overall Study|Protocol criteria (parathyroidectomy)|1
6017589|NCT00803712|20801821|P1|Overall Study|Protocol criteria (parathyroidectomy)|1
6017590|NCT00803712|20801820|P2|Overall Study|Administrative decision|3
6017591|NCT00803712|20801821|P1|Overall Study|Administrative decision|2
6017592|NCT00803712|20801820|P2|Overall Study|Protocol criteria (renal transplant)|8
6017593|NCT00803712|20801821|P1|Overall Study|Protocol criteria (renal transplant)|12
6017594|NCT00803712|20801820|P2|Overall Study|Protocol criteria (other)|2
6017595|NCT00803712|20801821|P1|Overall Study|Protocol criteria (other)|0
6017596|NCT00803712|20801820|P2|Overall Study|"Other in electronic Case Report Form"|1
6017597|NCT00803712|20801821|P1|Overall Study|"Other in electronic Case Report Form"|0
6017598|NCT00803712|20801820|P2|Overall Study|Withdrawal by Subject|4
6017599|NCT00803712|20801821|P1|Overall Study|Withdrawal by Subject|2
6017600|NCT00803712|20801820|P2|Overall Study|Lost to Follow-up|1
6017601|NCT00803712|20801821|P1|Overall Study|Lost to Follow-up|3
6017602|NCT00803712|20801820|P2|Overall Study|Death|7
6017603|NCT00803712|20801821|P1|Overall Study|Death|8
6017604|NCT00803712|20801820|P2|Overall Study|Adverse Event|0
6017605|NCT00803712|20801821|P1|Overall Study|Adverse Event|5
6017606|NCT00803712|20801820|P2|Overall Study|Noncompliance|0
6017607|NCT00803712|20801821|P1|Overall Study|Noncompliance|3
6017608|NCT00803634|20801920|P2|Overall Study|Death|2
6017609|NCT00803634|20801921|P1|Overall Study|Death|3
6017610|NCT00803634|20801920|P2|Overall Study|Lost to Follow-up|3
6017611|NCT00803634|20801921|P1|Overall Study|Lost to Follow-up|2
6017612|NCT00803634|20801920|P2|Overall Study|Withdrew Consent|0
6017613|NCT00803634|20801921|P1|Overall Study|Withdrew Consent|1
6017614|NCT00803595|20801950|P3|Overall Study|Withdrawal by Subject|3
6017615|NCT00803595|20801951|P2|Overall Study|Withdrawal by Subject|2
6017616|NCT00803595|20801952|P1|Overall Study|Withdrawal by Subject|5
6017617|NCT00803595|20801950|P3|Overall Study|Protocol Violation|12
6017618|NCT00803595|20801951|P2|Overall Study|Protocol Violation|2
6017619|NCT00803595|20801952|P1|Overall Study|Protocol Violation|7
6017620|NCT00803595|20801950|P3|Overall Study|Adverse Event|1
6017621|NCT00803595|20801951|P2|Overall Study|Adverse Event|4
6017622|NCT00803595|20801952|P1|Overall Study|Adverse Event|3
6017623|NCT00803569|20801963|P1|Overall Study|Noncompliance|1
6017624|NCT00803569|20801963|P1|Overall Study|Progressive Disease|3
6017625|NCT00803452|20801997|P2|Overall Study|Lost to Follow-up|3
6017626|NCT00803452|20801998|P1|Overall Study|Lost to Follow-up|0
6017627|NCT00803452|20801997|P2|Overall Study|Adverse Event|2
6017628|NCT00803452|20801998|P1|Overall Study|Adverse Event|0
6017629|NCT00803361|20802036|P2|Overall Study|Withdrawal by Subject|6
6017630|NCT00803361|20802037|P1|Overall Study|Withdrawal by Subject|5
6017631|NCT00803361|20802036|P2|Overall Study|Protocol Violation|4
6017632|NCT00803361|20802037|P1|Overall Study|Protocol Violation|2
6017633|NCT00803361|20802036|P2|Overall Study|Physician Decision|0
6017634|NCT00803361|20802037|P1|Overall Study|Physician Decision|1
6017635|NCT00803361|20802036|P2|Overall Study|Lost to Follow-up|2
6017636|NCT00803361|20802037|P1|Overall Study|Lost to Follow-up|1
6017637|NCT00803361|20802036|P2|Overall Study|Lack of Efficacy|13
6017638|NCT00803361|20802037|P1|Overall Study|Lack of Efficacy|4
6017639|NCT00803361|20802036|P2|Overall Study|Adverse Event|3
6017640|NCT00803361|20802037|P1|Overall Study|Adverse Event|13
6017641|NCT00803270|20802084|P2|Overall Study|Lost to Follow-up|2
6017642|NCT00803270|20802085|P1|Overall Study|Lost to Follow-up|1
6017643|NCT00803244|20802095|P2|Overall Study|Any other reason not above-mentioned|10
6017644|NCT00803244|20802096|P1|Overall Study|Any other reason not above-mentioned|4
6017645|NCT00803244|20802095|P2|Overall Study|Withdrawal by Subject|3
6017646|NCT00803244|20802096|P1|Overall Study|Withdrawal by Subject|2
6017647|NCT00803244|20802095|P2|Overall Study|Adverse Event|2
6017648|NCT00803244|20802096|P1|Overall Study|Adverse Event|1
6017649|NCT00803205|20802106|P2|Overall Study|Sponsor Decision|1
6017650|NCT00803205|20802107|P1|Overall Study|Sponsor Decision|0
6017651|NCT00803205|20802106|P2|Overall Study|Acquired a Lung Infection|1
6017652|NCT00803205|20802107|P1|Overall Study|Acquired a Lung Infection|0
6017653|NCT00803205|20802106|P2|Overall Study|Medical Monitor Decision|0
6017654|NCT00803205|20802107|P1|Overall Study|Medical Monitor Decision|1
6017655|NCT00803205|20802106|P2|Overall Study|Protocol Violation|1
6017656|NCT00803205|20802107|P1|Overall Study|Protocol Violation|1
6017657|NCT00803205|20802106|P2|Overall Study|Physician Decision|0
6017658|NCT00803205|20802107|P1|Overall Study|Physician Decision|1
6017659|NCT00803205|20802106|P2|Overall Study|Withdrawal by Subject|9
6017660|NCT00803205|20802107|P1|Overall Study|Withdrawal by Subject|9
6017661|NCT00803205|20802106|P2|Overall Study|Lost to Follow-up|0
6017662|NCT00803205|20802107|P1|Overall Study|Lost to Follow-up|1
6017663|NCT00803205|20802106|P2|Overall Study|Adverse Event|2
6017664|NCT00803205|20802107|P1|Overall Study|Adverse Event|7
6017665|NCT00803179|20802150|P1|Overall Study|Lost to Follow-up|3
6017666|NCT00803101|20802169|P2|Overall Study|Patient did not have surgery|1
6017667|NCT00803101|20802170|P1|Overall Study|Patient did not have surgery|1
6017668|NCT00803101|20802169|P2|Overall Study|Patient did not attend scheduled visit|1
6017669|NCT00803101|20802170|P1|Overall Study|Patient did not attend scheduled visit|2
6017670|NCT00803101|20802169|P2|Overall Study|Patient died outside SAE report period|0
6017671|NCT00803101|20802170|P1|Overall Study|Patient died outside SAE report period|1
6017672|NCT00803101|20802169|P2|Overall Study|Surgery finished outside protocol window|1
6017673|NCT00803101|20802170|P1|Overall Study|Surgery finished outside protocol window|1
6017674|NCT00803101|20802169|P2|Overall Study|Protocol Violation|7
6017675|NCT00803101|20802170|P1|Overall Study|Protocol Violation|1
6017676|NCT00803101|20802169|P2|Overall Study|Lost to Follow-up|2
6017677|NCT00803101|20802170|P1|Overall Study|Lost to Follow-up|2
6017678|NCT00803101|20802169|P2|Overall Study|Withdrawal by Subject|4
6017679|NCT00803101|20802170|P1|Overall Study|Withdrawal by Subject|6
6017680|NCT00803101|20802169|P2|Overall Study|Death / Serious Adverse Event|6
6017681|NCT00803101|20802170|P1|Overall Study|Death / Serious Adverse Event|4
6017682|NCT00803049|20802221|P4|Overall Study|Other than Specified Above|5
6017683|NCT00803049|20802222|P3|Overall Study|Other than Specified Above|2
6017684|NCT00803049|20802223|P2|Overall Study|Other than Specified Above|9
6017685|NCT00803049|20802224|P1|Overall Study|Other than Specified Above|3
6017686|NCT00803049|20802221|P4|Overall Study|Randomized and Not Treated|2
6017687|NCT00803049|20802222|P3|Overall Study|Randomized and Not Treated|0
6017688|NCT00803049|20802223|P2|Overall Study|Randomized and Not Treated|0
6017689|NCT00803049|20802224|P1|Overall Study|Randomized and Not Treated|0
6017690|NCT00803049|20802221|P4|Overall Study|Protocol Violation|0
6017691|NCT00803049|20802222|P3|Overall Study|Protocol Violation|1
6017692|NCT00803049|20802223|P2|Overall Study|Protocol Violation|1
6017693|NCT00803049|20802224|P1|Overall Study|Protocol Violation|0
6017694|NCT00803049|20802221|P4|Overall Study|Withdrawal by Subject|44
6017695|NCT00803049|20802222|P3|Overall Study|Withdrawal by Subject|16
6017696|NCT00803049|20802223|P2|Overall Study|Withdrawal by Subject|43
6017697|NCT00803049|20802224|P1|Overall Study|Withdrawal by Subject|19
6017698|NCT00803049|20802221|P4|Overall Study|Progressive Disease|6
6017699|NCT00803049|20802222|P3|Overall Study|Progressive Disease|6
6017700|NCT00803049|20802223|P2|Overall Study|Progressive Disease|10
6017701|NCT00803049|20802224|P1|Overall Study|Progressive Disease|6
6017702|NCT00803049|20802221|P4|Overall Study|Death|2
6017703|NCT00803049|20802222|P3|Overall Study|Death|0
6017704|NCT00803049|20802223|P2|Overall Study|Death|1
6017705|NCT00803049|20802224|P1|Overall Study|Death|2
6017706|NCT00803049|20802221|P4|Overall Study|Lost to Follow-up|3
6017707|NCT00803049|20802222|P3|Overall Study|Lost to Follow-up|0
6017708|NCT00803049|20802223|P2|Overall Study|Lost to Follow-up|2
6017709|NCT00803049|20802224|P1|Overall Study|Lost to Follow-up|0
6017710|NCT00803049|20802221|P4|Overall Study|Lack of Efficacy|13
6017711|NCT00803049|20802222|P3|Overall Study|Lack of Efficacy|6
6017712|NCT00803049|20802223|P2|Overall Study|Lack of Efficacy|19
6017713|NCT00803049|20802224|P1|Overall Study|Lack of Efficacy|10
6017714|NCT00803049|20802221|P4|Overall Study|Adverse Event|27
6017715|NCT00803049|20802222|P3|Overall Study|Adverse Event|13
6017716|NCT00803049|20802223|P2|Overall Study|Adverse Event|33
6017717|NCT00803049|20802224|P1|Overall Study|Adverse Event|21
6017718|NCT00803023|20802258|P4|Overall Study|Lack of Efficacy|1
6017719|NCT00803023|20802259|P3|Overall Study|Lack of Efficacy|1
6017720|NCT00803023|20802260|P2|Overall Study|Lack of Efficacy|1
6017721|NCT00803023|20802261|P1|Overall Study|Lack of Efficacy|0
6017722|NCT00803023|20802258|P4|Overall Study|Lost to Follow-up|1
6017723|NCT00803023|20802259|P3|Overall Study|Lost to Follow-up|2
6017724|NCT00803023|20802260|P2|Overall Study|Lost to Follow-up|1
6017725|NCT00803023|20802261|P1|Overall Study|Lost to Follow-up|0
6017726|NCT00803023|20802258|P4|Overall Study|Withdrawal by Subject|0
6017727|NCT00803023|20802259|P3|Overall Study|Withdrawal by Subject|0
6017728|NCT00803023|20802260|P2|Overall Study|Withdrawal by Subject|2
6017729|NCT00803023|20802261|P1|Overall Study|Withdrawal by Subject|0
6017730|NCT00803023|20802258|P4|Overall Study|Adverse Event|6
6017731|NCT00803023|20802259|P3|Overall Study|Adverse Event|8
6017732|NCT00803023|20802260|P2|Overall Study|Adverse Event|4
6017733|NCT00803023|20802261|P1|Overall Study|Adverse Event|5
6017734|NCT00802945|20802299|P2|Overall Study|Terminated by sponsor|12
6017735|NCT00802945|20802300|P1|Overall Study|Terminated by sponsor|8
6017736|NCT00802945|20802299|P2|Overall Study|Death|23
6017737|NCT00802945|20802300|P1|Overall Study|Death|27
6017738|NCT00802893|20802331|P1|Overall Study|study terminated|3
6017739|NCT00802867|20802355|P1|Overall Study|Withdrawal by Subject|1
6017740|NCT00802867|20802355|P1|Overall Study|Protocol Violation|6
6017741|NCT00802867|20802355|P1|Overall Study|Lost to Follow-up|6
6017742|NCT00802841|20802378|P2|Overall Study|Treatment duration completed|76
6017743|NCT00802841|20802379|P1|Overall Study|Treatment duration completed|66
6017744|NCT00802841|20802378|P2|Overall Study|Protocol deviation|6
6017745|NCT00802841|20802379|P1|Overall Study|Protocol deviation|2
6017746|NCT00802841|20802378|P2|Overall Study|Withdrawal by Subject|5
6017747|NCT00802841|20802379|P1|Overall Study|Withdrawal by Subject|9
6017748|NCT00802841|20802378|P2|Overall Study|Disease progression|3
6017749|NCT00802841|20802379|P1|Overall Study|Disease progression|7
6017750|NCT00802841|20802378|P2|Overall Study|Adverse Event|2
6017751|NCT00802841|20802379|P1|Overall Study|Adverse Event|8
6017752|NCT00802841|20802378|P2|Overall Study|Death|2
6017753|NCT00802841|20802379|P1|Overall Study|Death|1
6017754|NCT00802841|20802378|P2|Overall Study|Lost to Follow-up|1
6017755|NCT00802841|20802379|P1|Overall Study|Lost to Follow-up|2
6017756|NCT00802841|20802378|P2|Overall Study|Administrative problems|0
6017757|NCT00802841|20802379|P1|Overall Study|Administrative problems|1
6017758|NCT00802737|20802404|P3|Overall Study|Participant too Unwell|0
6017759|NCT00802737|20802405|P2|Overall Study|Participant too Unwell|2
6017760|NCT00802737|20802406|P1|Overall Study|Participant too Unwell|0
6017761|NCT00802737|20802404|P3|Overall Study|Ongoing CLL-Treatment|0
6017762|NCT00802737|20802405|P2|Overall Study|Ongoing CLL-Treatment|1
6017763|NCT00802737|20802406|P1|Overall Study|Ongoing CLL-Treatment|0
6017764|NCT00802737|20802404|P3|Overall Study|Received Prohibited Therapy|0
6017765|NCT00802737|20802405|P2|Overall Study|Received Prohibited Therapy|0
6017766|NCT00802737|20802406|P1|Overall Study|Received Prohibited Therapy|1
6017767|NCT00802737|20802404|P3|Overall Study|Adverse Event|0
6017768|NCT00802737|20802405|P2|Overall Study|Adverse Event|0
6017769|NCT00802737|20802406|P1|Overall Study|Adverse Event|1
6017770|NCT00802737|20802404|P3|Overall Study|Death|1
6017771|NCT00802737|20802405|P2|Overall Study|Death|5
6017772|NCT00802737|20802406|P1|Overall Study|Death|6
6017773|NCT00802737|20802404|P3|Overall Study|Withdrawn due to Disease Progression|0
6017774|NCT00802737|20802405|P2|Overall Study|Withdrawn due to Disease Progression|3
6017775|NCT00802737|20802406|P1|Overall Study|Withdrawn due to Disease Progression|9
6017776|NCT00802672|20802466|P3|Overall Study|other|2
6017777|NCT00802672|20802467|P2|Overall Study|other|1
6017778|NCT00802672|20802468|P1|Overall Study|other|3
6017779|NCT00802672|20802466|P3|Overall Study|Withdrawal by Subject|2
6017780|NCT00802672|20802467|P2|Overall Study|Withdrawal by Subject|1
6017781|NCT00802672|20802468|P1|Overall Study|Withdrawal by Subject|1
6017782|NCT00802672|20802466|P3|Overall Study|Lost to Follow-up|3
6017783|NCT00802672|20802467|P2|Overall Study|Lost to Follow-up|5
6017784|NCT00802672|20802468|P1|Overall Study|Lost to Follow-up|5
6017785|NCT00802672|20802466|P3|Overall Study|Protocol Violation|1
6017786|NCT00802672|20802467|P2|Overall Study|Protocol Violation|1
6017787|NCT00802672|20802468|P1|Overall Study|Protocol Violation|2
6017788|NCT00802672|20802466|P3|Overall Study|Adverse Event|1
6017789|NCT00802672|20802467|P2|Overall Study|Adverse Event|1
6017790|NCT00802672|20802468|P1|Overall Study|Adverse Event|1
6017791|NCT00802672|20802466|P3|Overall Study|Lack of fungal pathogen at baseline|25
6017792|NCT00802672|20802467|P2|Overall Study|Lack of fungal pathogen at baseline|43
6017793|NCT00802672|20802468|P1|Overall Study|Lack of fungal pathogen at baseline|56
6017794|NCT00802659|20802486|P4|Overall Study|Physician Decision|0
6017795|NCT00802659|20802487|P3|Overall Study|Physician Decision|0
6017796|NCT00802659|20802488|P2|Overall Study|Physician Decision|1
6017797|NCT00802659|20802489|P1|Overall Study|Physician Decision|0
6017798|NCT00802529|20802528|P2|Overall Study|Lost to Follow-up|1
6017799|NCT00802529|20802529|P1|Overall Study|Lost to Follow-up|0
6017800|NCT00802464|20802568|P4|Month 8 - Month 14|Lost to Follow-up|0
6017801|NCT00802464|20802569|P3|Month 8 - Month 14|Lost to Follow-up|1
6017802|NCT00802464|20802570|P2|Month 8 - Month 14|Lost to Follow-up|0
6017803|NCT00802464|20802571|P1|Month 8 - Month 14|Lost to Follow-up|0
6017804|NCT00802464|20802568|P4|Month 8 - Month 14|Withdrawal by Subject|0
6017805|NCT00802464|20802569|P3|Month 8 - Month 14|Withdrawal by Subject|0
6017806|NCT00802464|20802570|P2|Month 8 - Month 14|Withdrawal by Subject|1
6017807|NCT00802464|20802571|P1|Month 8 - Month 14|Withdrawal by Subject|1
6017808|NCT00802464|20802568|P4|Month 8 - Month 14|Adverse Event|0
6017809|NCT00802464|20802569|P3|Month 8 - Month 14|Adverse Event|0
6017810|NCT00802464|20802570|P2|Month 8 - Month 14|Adverse Event|1
6017811|NCT00802464|20802571|P1|Month 8 - Month 14|Adverse Event|0
6017812|NCT00802464|20802568|P4|Month 0 - Month 8|Other|0
6017813|NCT00802464|20802569|P3|Month 0 - Month 8|Other|1
6017814|NCT00802464|20802570|P2|Month 0 - Month 8|Other|0
6017815|NCT00802464|20802571|P1|Month 0 - Month 8|Other|0
6017816|NCT00802464|20802568|P4|Month 0 - Month 8|Lost to Follow-up|2
6017817|NCT00802464|20802569|P3|Month 0 - Month 8|Lost to Follow-up|2
6017818|NCT00802464|20802570|P2|Month 0 - Month 8|Lost to Follow-up|1
6017819|NCT00802464|20802571|P1|Month 0 - Month 8|Lost to Follow-up|0
6017820|NCT00802464|20802568|P4|Month 0 - Month 8|Withdrawal by Subject|5
6017821|NCT00802464|20802569|P3|Month 0 - Month 8|Withdrawal by Subject|2
6017822|NCT00802464|20802570|P2|Month 0 - Month 8|Withdrawal by Subject|1
6017823|NCT00802464|20802571|P1|Month 0 - Month 8|Withdrawal by Subject|0
6017824|NCT00802464|20802568|P4|Month 0 - Month 8|Protocol Violation|0
6017825|NCT00802464|20802569|P3|Month 0 - Month 8|Protocol Violation|1
6017826|NCT00802464|20802570|P2|Month 0 - Month 8|Protocol Violation|0
6017827|NCT00802464|20802571|P1|Month 0 - Month 8|Protocol Violation|0
6017828|NCT00802464|20802568|P4|Month 0 - Month 8|Adverse Event|2
6017829|NCT00802464|20802569|P3|Month 0 - Month 8|Adverse Event|1
6017830|NCT00802464|20802570|P2|Month 0 - Month 8|Adverse Event|1
6017831|NCT00802464|20802571|P1|Month 0 - Month 8|Adverse Event|0
6017832|NCT00802438|20802657|P1|Overall Study|Physician Decision|1
6017833|NCT00802438|20802657|P1|Overall Study|Withdrawal by Subject|7
6017834|NCT00802438|20802657|P1|Overall Study|Screen Failure|20
6017835|NCT00802360|20802677|P4|Overall Study|Other|3
6017836|NCT00802360|20802678|P3|Overall Study|Other|6
6017837|NCT00802360|20802679|P2|Overall Study|Other|3
6017838|NCT00802360|20802680|P1|Overall Study|Other|2
6017839|NCT00802360|20802677|P4|Overall Study|Pregnancy loss/miscarriage|3
6017840|NCT00802360|20802678|P3|Overall Study|Pregnancy loss/miscarriage|0
6017841|NCT00802360|20802679|P2|Overall Study|Pregnancy loss/miscarriage|2
6017842|NCT00802360|20802680|P1|Overall Study|Pregnancy loss/miscarriage|0
6017843|NCT00802360|20802677|P4|Overall Study|Pregnancy not confirmed by ultrasound|0
6017844|NCT00802360|20802678|P3|Overall Study|Pregnancy not confirmed by ultrasound|1
6017845|NCT00802360|20802679|P2|Overall Study|Pregnancy not confirmed by ultrasound|0
6017846|NCT00802360|20802680|P1|Overall Study|Pregnancy not confirmed by ultrasound|1
6017847|NCT00802360|20802677|P4|Overall Study|No positive serum pregnancy|10
6017848|NCT00802360|20802678|P3|Overall Study|No positive serum pregnancy|14
6017849|NCT00802360|20802679|P2|Overall Study|No positive serum pregnancy|20
6017850|NCT00802360|20802680|P1|Overall Study|No positive serum pregnancy|17
6017851|NCT00802360|20802677|P4|Overall Study|Risk of ovarian hyperstimulation syndrom|1
6017852|NCT00802360|20802678|P3|Overall Study|Risk of ovarian hyperstimulation syndrom|0
6017853|NCT00802360|20802679|P2|Overall Study|Risk of ovarian hyperstimulation syndrom|0
6017854|NCT00802360|20802680|P1|Overall Study|Risk of ovarian hyperstimulation syndrom|0
6017855|NCT00802360|20802677|P4|Overall Study|Cycle cancelled|1
6017856|NCT00802360|20802678|P3|Overall Study|Cycle cancelled|1
6017857|NCT00802360|20802679|P2|Overall Study|Cycle cancelled|1
6017858|NCT00802360|20802680|P1|Overall Study|Cycle cancelled|0
6017859|NCT00802360|20802677|P4|Overall Study|Inadequate number of oocytes retrieved|1
6017860|NCT00802360|20802678|P3|Overall Study|Inadequate number of oocytes retrieved|0
6017861|NCT00802360|20802679|P2|Overall Study|Inadequate number of oocytes retrieved|0
6017862|NCT00802360|20802680|P1|Overall Study|Inadequate number of oocytes retrieved|0
6017863|NCT00802360|20802677|P4|Overall Study|Stimulation failure|3
6017864|NCT00802360|20802678|P3|Overall Study|Stimulation failure|3
6017865|NCT00802360|20802679|P2|Overall Study|Stimulation failure|0
6017866|NCT00802360|20802680|P1|Overall Study|Stimulation failure|4
6017867|NCT00802178|20802747|P1|Overall Study|Patients wish and other reason|1
6017868|NCT00802178|20802747|P1|Overall Study|IT and patient wish|8
6017869|NCT00802178|20802747|P1|Overall Study|Lack of efficacy and patient wish|1
6017870|NCT00802178|20802747|P1|Overall Study|Other|32
6017871|NCT00802178|20802747|P1|Overall Study|Withdrawal by Subject|18
6017872|NCT00802178|20802747|P1|Overall Study|Insufficient tolerability (IT)|17
6017873|NCT00802178|20802747|P1|Overall Study|Lack of Efficacy|36
6017874|NCT00802074|20802795|P6|Overall Study|Withdrawal by Subject|0
6017875|NCT00802074|20802796|P5|Overall Study|Withdrawal by Subject|0
6017876|NCT00802074|20802797|P4|Overall Study|Withdrawal by Subject|0
6017877|NCT00802074|20802798|P3|Overall Study|Withdrawal by Subject|0
6017878|NCT00802074|20802799|P2|Overall Study|Withdrawal by Subject|0
6017879|NCT00802074|20802800|P1|Overall Study|Withdrawal by Subject|1
6017880|NCT00802074|20802795|P6|Overall Study|Adverse Event|0
6017881|NCT00802074|20802796|P5|Overall Study|Adverse Event|0
6017882|NCT00802074|20802797|P4|Overall Study|Adverse Event|0
6017883|NCT00802074|20802798|P3|Overall Study|Adverse Event|1
6017884|NCT00802074|20802799|P2|Overall Study|Adverse Event|1
6017885|NCT00802074|20802800|P1|Overall Study|Adverse Event|1
6017886|NCT00801983|20802834|P2|Period 2|Withdrawal by Subject|1
6017887|NCT00801983|20802835|P1|Period 2|Withdrawal by Subject|2
6017888|NCT00801983|20802834|P2|Period 1|Withdrawal by Subject|8
6017889|NCT00801983|20802835|P1|Period 1|Withdrawal by Subject|2
6017890|NCT00801983|20802834|P2|Period 1|Lost to Follow-up|0
6017891|NCT00801983|20802835|P1|Period 1|Lost to Follow-up|2
6017892|NCT00801892|20802850|P2|Sham Crossover Period|Lost to Follow-up|2
6017893|NCT00801892|20802851|P1|Sham Crossover Period|Lost to Follow-up|0
6017894|NCT00801892|20802850|P2|Main Study Period|Withdrawal by Subject|1
6017895|NCT00801892|20802851|P1|Main Study Period|Withdrawal by Subject|0
6017896|NCT00801632|20802911|P1|Overall Study|Re-transplant|1
6017897|NCT00801242|20802989|P1|Overall Study|Miscellaneous reasons|20
6017898|NCT00801242|20802989|P1|Overall Study|Lost to Follow-up|1
6017899|NCT00801242|20802989|P1|Overall Study|Physician Decision|3
6017900|NCT00801242|20802989|P1|Overall Study|Protocol Violation|5
6017901|NCT00801242|20802989|P1|Overall Study|Withdrawal by Subject|13
6017902|NCT00801242|20802989|P1|Overall Study|Adverse Event|10
6017903|NCT00801229|20803002|P2|Received Study Drug/Placebo|Adverse Event|1
6017904|NCT00801229|20803003|P1|Received Study Drug/Placebo|Adverse Event|1
6017905|NCT00801229|20803002|P2|Received Study Drug/Placebo|Lost to Follow-up|1
6017906|NCT00801229|20803003|P1|Received Study Drug/Placebo|Lost to Follow-up|0
6017907|NCT00801229|20803002|P2|Received Study Drug/Placebo|Withdrawal by Subject|0
6017908|NCT00801229|20803003|P1|Received Study Drug/Placebo|Withdrawal by Subject|1
6017909|NCT00801229|20803002|P2|Received Study Drug/Placebo|Simulator sickness|1
6017910|NCT00801229|20803003|P1|Received Study Drug/Placebo|Simulator sickness|1
6017911|NCT00801229|20803002|P2|Received Study Drug/Placebo|Sub-threshold ADHD|1
6017912|NCT00801229|20803003|P1|Received Study Drug/Placebo|Sub-threshold ADHD|0
6017913|NCT00801229|20803002|P2|Received Study Drug/Placebo|Elevated SGOT level|0
6017914|NCT00801229|20803003|P1|Received Study Drug/Placebo|Elevated SGOT level|1
6017915|NCT00801229|20803002|P2|Signed Consent|Found Ineligible|1
6017916|NCT00801229|20803003|P1|Signed Consent|Found Ineligible|1
6017917|NCT00801229|20803002|P2|Signed Consent|Withdrawal by Subject|2
6017918|NCT00801229|20803003|P1|Signed Consent|Withdrawal by Subject|2
6017919|NCT00801099|20803038|P1|Overall Study|Lost to Follow-up|101
6017920|NCT00800982|20803044|P2|Overall Study|Patient moved out of state|0
6017921|NCT00800982|20803045|P1|Overall Study|Patient moved out of state|1
6017922|NCT00800982|20803044|P2|Overall Study|Withdrawal by Subject|1
6017923|NCT00800982|20803045|P1|Overall Study|Withdrawal by Subject|0
6017924|NCT00800982|20803044|P2|Overall Study|Lost to Follow-up|2
6017925|NCT00800982|20803045|P1|Overall Study|Lost to Follow-up|1
6017926|NCT00800735|20803071|P1|Overall Study|Withdrew Consent|3
6017927|NCT00800735|20803071|P1|Overall Study|Violation of Selection Criteria at Entry|7
6017928|NCT00800735|20803071|P1|Overall Study|Insufficient Therapeutic Response|2
6017929|NCT00800735|20803071|P1|Overall Study|Administrative/Other|2
6017930|NCT00800683|20803077|P2|Overall Study|Other|2
6017931|NCT00800683|20803078|P1|Overall Study|Other|1
6017932|NCT00800683|20803077|P2|Overall Study|Lack of Efficacy|1
6017933|NCT00800683|20803078|P1|Overall Study|Lack of Efficacy|1
6017934|NCT00800683|20803077|P2|Overall Study|Withdrawal by Subject|7
6017935|NCT00800683|20803078|P1|Overall Study|Withdrawal by Subject|1
6017936|NCT00800683|20803077|P2|Overall Study|Lost to Follow-up|1
6017937|NCT00800683|20803078|P1|Overall Study|Lost to Follow-up|3
6017938|NCT00800683|20803077|P2|Overall Study|Adverse Event|8
6017939|NCT00800683|20803078|P1|Overall Study|Adverse Event|11
6017940|NCT00800540|20803124|P2|Period 2: 6 Weeks|Adverse Event|1
6017941|NCT00800540|20803125|P1|Period 2: 6 Weeks|Adverse Event|0
6017942|NCT00800540|20803124|P2|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|1
6017943|NCT00800540|20803125|P1|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|0
6017944|NCT00800540|20803124|P2|Period One: 6 Weeks|Noncompliance|0
6017945|NCT00800540|20803125|P1|Period One: 6 Weeks|Noncompliance|1
6017946|NCT00800436|20803160|P7|Overall Study|Withdrawal by Subject|0
6017947|NCT00800436|20803161|P6|Overall Study|Withdrawal by Subject|0
6017948|NCT00800436|20803162|P5|Overall Study|Withdrawal by Subject|0
6017949|NCT00800436|20803163|P4|Overall Study|Withdrawal by Subject|1
6017950|NCT00800436|20803164|P3|Overall Study|Withdrawal by Subject|1
6017951|NCT00800436|20803165|P2|Overall Study|Withdrawal by Subject|0
6017952|NCT00800436|20803166|P1|Overall Study|Withdrawal by Subject|0
6017953|NCT00800384|20803212|P2|Overall Study|Lost to Follow-up|26
6017954|NCT00800384|20803213|P1|Overall Study|Lost to Follow-up|17
6017955|NCT00800384|20803212|P2|Overall Study|Withdrawal by Subject|17
6017956|NCT00800384|20803213|P1|Overall Study|Withdrawal by Subject|24
6017957|NCT00800202|20803251|P2|Overall Study|Disease Progression|18
6017958|NCT00800202|20803252|P1|Overall Study|Disease Progression|54
6017959|NCT00800202|20803251|P2|Overall Study|Other|0
6017960|NCT00800202|20803252|P1|Overall Study|Other|5
6017961|NCT00800202|20803251|P2|Overall Study|Death|0
6017962|NCT00800202|20803252|P1|Overall Study|Death|1
6017963|NCT00800202|20803251|P2|Overall Study|Adverse Event|6
6017964|NCT00800202|20803252|P1|Overall Study|Adverse Event|7
6017965|NCT00800176|20803276|P6|Overall Study|Other|0
6017966|NCT00800176|20803277|P5|Overall Study|Other|2
6017967|NCT00800176|20803278|P4|Overall Study|Other|0
6017968|NCT00800176|20803279|P3|Overall Study|Other|0
6017969|NCT00800176|20803280|P2|Overall Study|Other|0
6017970|NCT00800176|20803281|P1|Overall Study|Other|1
6017971|NCT00800176|20803276|P6|Overall Study|Failure to return|0
6017972|NCT00800176|20803277|P5|Overall Study|Failure to return|0
6017973|NCT00800176|20803278|P4|Overall Study|Failure to return|2
6017974|NCT00800176|20803279|P3|Overall Study|Failure to return|0
6017975|NCT00800176|20803280|P2|Overall Study|Failure to return|3
6017976|NCT00800176|20803281|P1|Overall Study|Failure to return|3
6017977|NCT00800176|20803276|P6|Overall Study|Refused treatment|4
6017978|NCT00800176|20803277|P5|Overall Study|Refused treatment|1
6017979|NCT00800176|20803278|P4|Overall Study|Refused treatment|0
6017980|NCT00800176|20803279|P3|Overall Study|Refused treatment|0
6017981|NCT00800176|20803280|P2|Overall Study|Refused treatment|2
6017982|NCT00800176|20803281|P1|Overall Study|Refused treatment|3
6017983|NCT00800176|20803276|P6|Overall Study|Adverse Event|1
6017984|NCT00800176|20803277|P5|Overall Study|Adverse Event|1
6017985|NCT00800176|20803278|P4|Overall Study|Adverse Event|2
6017986|NCT00800176|20803279|P3|Overall Study|Adverse Event|0
6017987|NCT00800176|20803280|P2|Overall Study|Adverse Event|1
6017988|NCT00800176|20803281|P1|Overall Study|Adverse Event|2
6017989|NCT00799903|20803357|P2|Overall Study|Lost to Follow-up|80
6017990|NCT00799903|20803358|P1|Overall Study|Lost to Follow-up|69
6017991|NCT00799903|20803357|P2|Overall Study|Withdrawal by Subject|175
6017992|NCT00799903|20803358|P1|Overall Study|Withdrawal by Subject|179
6017993|NCT00799903|20803357|P2|Overall Study|Investigator Site Closed|23
6017994|NCT00799903|20803358|P1|Overall Study|Investigator Site Closed|25
6017995|NCT00799825|20803378|P1|Overall Study|Pregnancy|3
6017996|NCT00799825|20803378|P1|Overall Study|Lost to Follow-up|38
6017997|NCT00799825|20803378|P1|Overall Study|Withdrawal by Subject|6
6017998|NCT00799825|20803378|P1|Overall Study|Adverse Event|1
6017999|NCT00799708|20803418|P3|Overall Study|non-compliance|0
6018000|NCT00799708|20803419|P2|Overall Study|non-compliance|0
6018001|NCT00799708|20803420|P1|Overall Study|non-compliance|1
6018002|NCT00799617|20803443|P2|Anemia Trial|Withdrawal by Subject|3
6018003|NCT00799617|20803444|P1|Anemia Trial|Withdrawal by Subject|3
6018004|NCT00799617|20803443|P2|Cognitive Function Trial|Lost to Follow-up|1
6018005|NCT00799617|20803444|P1|Cognitive Function Trial|Lost to Follow-up|0
6018006|NCT00799617|20803443|P2|Bone Trial|Month 12 scan not available|16
6018007|NCT00799617|20803444|P1|Bone Trial|Month 12 scan not available|6
6018008|NCT00799617|20803443|P2|Cardiovascular Trial|Baseline scan not analyzable|2
6018009|NCT00799617|20803444|P1|Cardiovascular Trial|Baseline scan not analyzable|0
6018010|NCT00799617|20803443|P2|Cardiovascular Trial|Month 12 scan not available|15
6018011|NCT00799617|20803444|P1|Cardiovascular Trial|Month 12 scan not available|15
6018012|NCT00799617|20803443|P2|Vitality Trial|Lost to Follow-up|22
6018013|NCT00799617|20803444|P1|Vitality Trial|Lost to Follow-up|7
6018014|NCT00799617|20803443|P2|Physical Function Trial|Lost to Follow-up|11
6018015|NCT00799617|20803444|P1|Physical Function Trial|Lost to Follow-up|6
6018016|NCT00799617|20803443|P2|Sexual Funtion Trial|No Baseline Data|7
6018017|NCT00799617|20803444|P1|Sexual Funtion Trial|No Baseline Data|4
6018018|NCT00799617|20803443|P2|Sexual Funtion Trial|Lost to Follow-up|14
6018019|NCT00799617|20803444|P1|Sexual Funtion Trial|Lost to Follow-up|12
6018020|NCT00799617|20803443|P2|Main Testosterone Trial|Lost to Follow-up|20
6018021|NCT00799617|20803444|P1|Main Testosterone Trial|Lost to Follow-up|18
6018022|NCT00799617|20803443|P2|Main Testosterone Trial|Randomized in error|1
6018023|NCT00799617|20803444|P1|Main Testosterone Trial|Randomized in error|1
6018024|NCT00799591|20803551|P1|Overall Study|Infectious origin not probable|1
6018025|NCT00799591|20803551|P1|Overall Study|Antibiotic changed, no apparent reason|1
6018026|NCT00799591|20803551|P1|Overall Study|Persistance of fever undetermined origin|1
6018027|NCT00799591|20803551|P1|Overall Study|Resistance germ and technical failure|2
6018028|NCT00799591|20803551|P1|Overall Study|New infection|4
6018029|NCT00799591|20803551|P1|Overall Study|Resistant germ|11
6018030|NCT00799591|20803551|P1|Overall Study|Technical failure|12
6018031|NCT00799591|20803551|P1|Overall Study|Death|14
6018032|NCT00799591|20803551|P1|Overall Study|De-escalation of doses|20
6018033|NCT00799487|20803569|P3|Double-Blind Assessment Period|Overslept and missed lab day 2|0
6018034|NCT00799487|20803570|P2|Double-Blind Assessment Period|Overslept and missed lab day 2|1
6018035|NCT00799487|20803571|P1|Double-Blind Assessment Period|Overslept and missed lab day 2|0
6018036|NCT00799487|20803569|P3|Double-Blind Assessment Period|Subject was out of the state|1
6018037|NCT00799487|20803570|P2|Double-Blind Assessment Period|Subject was out of the state|0
6018038|NCT00799487|20803571|P1|Double-Blind Assessment Period|Subject was out of the state|0
6018039|NCT00799487|20803569|P3|Double-Blind Assessment Period|Lost to Follow-up|1
6018040|NCT00799487|20803570|P2|Double-Blind Assessment Period|Lost to Follow-up|0
6018041|NCT00799487|20803571|P1|Double-Blind Assessment Period|Lost to Follow-up|0
6018042|NCT00799487|20803569|P3|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0
6018043|NCT00799487|20803570|P2|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0
6018044|NCT00799487|20803571|P1|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|2
6018045|NCT00799487|20803569|P3|Dose Adjustment Period|Missed laboratory day 1|0
6018046|NCT00799487|20803570|P2|Dose Adjustment Period|Missed laboratory day 1|0
6018047|NCT00799487|20803571|P1|Dose Adjustment Period|Missed laboratory day 1|1
6018048|NCT00799487|20803569|P3|Dose Adjustment Period|Child too young (exclusion)|0
6018049|NCT00799487|20803570|P2|Dose Adjustment Period|Child too young (exclusion)|0
6018050|NCT00799487|20803571|P1|Dose Adjustment Period|Child too young (exclusion)|1
6018051|NCT00799487|20803569|P3|Dose Adjustment Period|Parent to home school child (exclusion)|0
6018052|NCT00799487|20803570|P2|Dose Adjustment Period|Parent to home school child (exclusion)|0
6018053|NCT00799487|20803571|P1|Dose Adjustment Period|Parent to home school child (exclusion)|1
6018054|NCT00799487|20803569|P3|Dose Adjustment Period|Withdrawal by Subject|0
6018055|NCT00799487|20803570|P2|Dose Adjustment Period|Withdrawal by Subject|0
6018056|NCT00799487|20803571|P1|Dose Adjustment Period|Withdrawal by Subject|3
6018057|NCT00799487|20803569|P3|Dose Adjustment Period|Investigator Discretion|0
6018058|NCT00799487|20803570|P2|Dose Adjustment Period|Investigator Discretion|0
6018059|NCT00799487|20803571|P1|Dose Adjustment Period|Investigator Discretion|2
6018060|NCT00799487|20803569|P3|Dose Adjustment Period|Optimal Dose Not Achieved|0
6018061|NCT00799487|20803570|P2|Dose Adjustment Period|Optimal Dose Not Achieved|0
6018062|NCT00799487|20803571|P1|Dose Adjustment Period|Optimal Dose Not Achieved|8
6018063|NCT00799487|20803569|P3|Dose Adjustment Period|Adverse Event|0
6018064|NCT00799487|20803570|P2|Dose Adjustment Period|Adverse Event|0
6018065|NCT00799487|20803571|P1|Dose Adjustment Period|Adverse Event|2
6018066|NCT00799487|20803569|P3|Dose Adjustment Period|Lost to Follow-up|0
6018067|NCT00799487|20803570|P2|Dose Adjustment Period|Lost to Follow-up|0
6018068|NCT00799487|20803571|P1|Dose Adjustment Period|Lost to Follow-up|1
6018069|NCT00799422|20803668|P6|First Week of Wear|Adverse Event|0
6018070|NCT00799422|20803669|P5|First Week of Wear|Adverse Event|0
6018071|NCT00799422|20803670|P4|First Week of Wear|Adverse Event|1
6018072|NCT00799422|20803671|P3|First Week of Wear|Adverse Event|0
6018073|NCT00799422|20803672|P2|First Week of Wear|Adverse Event|0
6018074|NCT00799422|20803673|P1|First Week of Wear|Adverse Event|0
6018075|NCT00799422|20803668|P6|First Week of Wear|Lost to Follow-up|0
6018076|NCT00799422|20803669|P5|First Week of Wear|Lost to Follow-up|0
6018077|NCT00799422|20803670|P4|First Week of Wear|Lost to Follow-up|0
6018078|NCT00799422|20803671|P3|First Week of Wear|Lost to Follow-up|1
6018079|NCT00799422|20803672|P2|First Week of Wear|Lost to Follow-up|0
6018080|NCT00799422|20803673|P1|First Week of Wear|Lost to Follow-up|0
6018081|NCT00799409|20803690|P3|Overall Study|medication compliance|0
6018082|NCT00799409|20803691|P2|Overall Study|medication compliance|0
6018083|NCT00799409|20803692|P1|Overall Study|medication compliance|1
6018084|NCT00799409|20803690|P3|Overall Study|Did not attend lab school day 1|0
6018085|NCT00799409|20803691|P2|Overall Study|Did not attend lab school day 1|0
6018086|NCT00799409|20803692|P1|Overall Study|Did not attend lab school day 1|1
6018087|NCT00799409|20803690|P3|Overall Study|Failure to follow study protocol)|0
6018088|NCT00799409|20803691|P2|Overall Study|Failure to follow study protocol)|0
6018089|NCT00799409|20803692|P1|Overall Study|Failure to follow study protocol)|1
6018090|NCT00799409|20803690|P3|Overall Study|Optimal Dose Not Achieved|0
6018091|NCT00799409|20803691|P2|Overall Study|Optimal Dose Not Achieved|0
6018092|NCT00799409|20803692|P1|Overall Study|Optimal Dose Not Achieved|2
6018093|NCT00799409|20803690|P3|Overall Study|Lost to Follow-up|0
6018094|NCT00799409|20803691|P2|Overall Study|Lost to Follow-up|0
6018095|NCT00799409|20803692|P1|Overall Study|Lost to Follow-up|1
6018096|NCT00799409|20803690|P3|Overall Study|Withdrawal by Subject|0
6018097|NCT00799409|20803691|P2|Overall Study|Withdrawal by Subject|0
6018098|NCT00799409|20803692|P1|Overall Study|Withdrawal by Subject|1
6018099|NCT00799396|20803772|P1|Clopidogrel Plus Aspirin|Physician Decision|4
6018100|NCT00799396|20803772|P1|Clopidogrel Plus Aspirin|Adverse Event|2
6018101|NCT00799396|20803772|P1|Clopidogrel Treatment|Withdrawal by Subject|2
6018102|NCT00799396|20803772|P1|Clopidogrel Treatment|Physician Decision|5
6018103|NCT00799396|20803772|P1|Clopidogrel Treatment|Adverse Event|6
6018104|NCT00799383|20803779|P2|Overall Study|Withdrawal by Subject|1
6018105|NCT00799383|20803780|P1|Overall Study|Withdrawal by Subject|0
6018106|NCT00799383|20803779|P2|Overall Study|Urinary Calcium/Creatinine > 0.2|1
6018107|NCT00799383|20803780|P1|Overall Study|Urinary Calcium/Creatinine > 0.2|1
6018108|NCT00799383|20803779|P2|Overall Study|Lost to Follow-up|2
6018109|NCT00799383|20803780|P1|Overall Study|Lost to Follow-up|1
6018110|NCT00799383|20803779|P2|Overall Study|Adverse Event|1
6018111|NCT00799383|20803780|P1|Overall Study|Adverse Event|0
6018112|NCT00799383|20803779|P2|Overall Study|Protocol Violation|1
6018113|NCT00799383|20803780|P1|Overall Study|Protocol Violation|1
6018114|NCT00799266|20803809|P2|Overall Study|Subject withdrew consent|0
6018115|NCT00799266|20803810|P1|Overall Study|Subject withdrew consent|3
6018116|NCT00799266|20803809|P2|Overall Study|Adverse Event|1
6018117|NCT00799266|20803810|P1|Overall Study|Adverse Event|0
6018118|NCT00798967|20803850|P2|Overall Study|Randomized in error by site|0
6018119|NCT00798967|20803851|P1|Overall Study|Randomized in error by site|1
6018120|NCT00798967|20803850|P2|Overall Study|Physician Decision|0
6018121|NCT00798967|20803851|P1|Overall Study|Physician Decision|1
6018122|NCT00798967|20803850|P2|Overall Study|Withdrawal by Subject|1
6018123|NCT00798967|20803851|P1|Overall Study|Withdrawal by Subject|0
6018124|NCT00798967|20803850|P2|Overall Study|Adverse Event|3
6018125|NCT00798967|20803851|P1|Overall Study|Adverse Event|2
6018126|NCT00798889|20803859|P1|Overall Study|Enrolled, Not treated|3
6018127|NCT00798889|20803859|P1|Overall Study|Decision of Sponsor|11
6018128|NCT00798889|20803859|P1|Overall Study|Lack of Efficacy|213
6018129|NCT00798889|20803859|P1|Overall Study|Lost to Follow-up|1
6018130|NCT00798889|20803859|P1|Overall Study|Withdrawal by Subject|31
6018131|NCT00798889|20803859|P1|Overall Study|Protocol Violation|2
6018132|NCT00798889|20803859|P1|Overall Study|Adverse Event|53
6018133|NCT00798759|20803865|P2|Overall Study|Other|1
6018134|NCT00798759|20803866|P1|Overall Study|Other|0
6018135|NCT00798759|20803865|P2|Overall Study|Protocol Violation|8
6018136|NCT00798759|20803866|P1|Overall Study|Protocol Violation|4
6018137|NCT00798759|20803865|P2|Overall Study|Lost to Follow-up|1
6018138|NCT00798759|20803866|P1|Overall Study|Lost to Follow-up|1
6018139|NCT00798759|20803865|P2|Overall Study|Adverse Event|3
6018140|NCT00798759|20803866|P1|Overall Study|Adverse Event|3
6018141|NCT00798707|20803884|P3|Overall Study|Randomized not treated|1
6018142|NCT00798707|20803885|P2|Overall Study|Randomized not treated|5
6018143|NCT00798707|20803886|P1|Overall Study|Randomized not treated|4
6018144|NCT00798707|20803884|P3|Overall Study|Withdrawal by Subject|2
6018145|NCT00798707|20803885|P2|Overall Study|Withdrawal by Subject|8
6018146|NCT00798707|20803886|P1|Overall Study|Withdrawal by Subject|3
6018147|NCT00798707|20803884|P3|Overall Study|Protocol Violation|2
6018148|NCT00798707|20803885|P2|Overall Study|Protocol Violation|0
6018149|NCT00798707|20803886|P1|Overall Study|Protocol Violation|4
6018150|NCT00798707|20803884|P3|Overall Study|Other|0
6018151|NCT00798707|20803885|P2|Overall Study|Other|1
6018152|NCT00798707|20803886|P1|Overall Study|Other|0
6018153|NCT00798707|20803884|P3|Overall Study|Lost to Follow-up|6
6018154|NCT00798707|20803885|P2|Overall Study|Lost to Follow-up|6
6018155|NCT00798707|20803886|P1|Overall Study|Lost to Follow-up|5
6018156|NCT00798707|20803884|P3|Overall Study|Lack of Efficacy|1
6018157|NCT00798707|20803885|P2|Overall Study|Lack of Efficacy|2
6018158|NCT00798707|20803886|P1|Overall Study|Lack of Efficacy|2
6018159|NCT00798707|20803884|P3|Overall Study|Investigator|2
6018160|NCT00798707|20803885|P2|Overall Study|Investigator|1
6018161|NCT00798707|20803886|P1|Overall Study|Investigator|0
6018162|NCT00798707|20803884|P3|Overall Study|Failed to return|0
6018163|NCT00798707|20803885|P2|Overall Study|Failed to return|2
6018164|NCT00798707|20803886|P1|Overall Study|Failed to return|2
6018165|NCT00798707|20803884|P3|Overall Study|Adverse Event|8
6018166|NCT00798707|20803885|P2|Overall Study|Adverse Event|8
6018167|NCT00798707|20803886|P1|Overall Study|Adverse Event|6
6018168|NCT00798694|20803938|P2|Overall Study|Physician Decision|0
6018169|NCT00798694|20803939|P1|Overall Study|Physician Decision|1
6018170|NCT00798694|20803938|P2|Overall Study|Lost to Follow-up|1
6018171|NCT00798694|20803939|P1|Overall Study|Lost to Follow-up|1
6018172|NCT00798655|20803963|P1|Overall Study|Did not receive at least one dose of pan|2
6018173|NCT00798603|20803968|P1|Overall Study|Lack of insurance coverage|1
6018174|NCT00798603|20803968|P1|Overall Study|Physician Decision|1
6018175|NCT00798603|20803968|P1|Overall Study|Adverse Event|22
6018176|NCT00798603|20803968|P1|Overall Study|Withdrawal by Subject|10
6018177|NCT00798603|20803968|P1|Overall Study|Still on treatment as of 11/6/2012|1
6018178|NCT00798590|20803990|P2|Overall Study|P.I, Left institution. Study terminated|8
6018179|NCT00798590|20803991|P1|Overall Study|P.I, Left institution. Study terminated|11
6018180|NCT00798434|20804025|P2|Open-Label|Not Treated|1
6018181|NCT00798434|20804026|P1|Open-Label|Not Treated|0
6018182|NCT00798434|20804025|P2|Open-Label|Other|2
6018183|NCT00798434|20804026|P1|Open-Label|Other|1
6018184|NCT00798434|20804025|P2|Open-Label|Protocol Violation|0
6018185|NCT00798434|20804026|P1|Open-Label|Protocol Violation|1
6018186|NCT00798434|20804025|P2|Open-Label|Withdrawal by Subject|7
6018187|NCT00798434|20804026|P1|Open-Label|Withdrawal by Subject|2
6018188|NCT00798434|20804025|P2|Open-Label|Lack of Efficacy|11
6018189|NCT00798434|20804026|P1|Open-Label|Lack of Efficacy|5
6018190|NCT00798434|20804025|P2|Open-Label|Adverse Event|11
6018191|NCT00798434|20804026|P1|Open-Label|Adverse Event|33
6018192|NCT00798434|20804025|P2|Double-Blind|Not Treated|6
6018193|NCT00798434|20804026|P1|Double-Blind|Not Treated|3
6018194|NCT00798434|20804025|P2|Double-Blind|Other|0
6018195|NCT00798434|20804026|P1|Double-Blind|Other|1
6018196|NCT00798434|20804025|P2|Double-Blind|Did Not Meet Entrance Criteria|1
6018197|NCT00798434|20804026|P1|Double-Blind|Did Not Meet Entrance Criteria|2
6018198|NCT00798434|20804025|P2|Double-Blind|Protocol Violation|4
6018199|NCT00798434|20804026|P1|Double-Blind|Protocol Violation|1
6018200|NCT00798434|20804025|P2|Double-Blind|Withdrawal by Subject|14
6018201|NCT00798434|20804026|P1|Double-Blind|Withdrawal by Subject|17
6018202|NCT00798434|20804025|P2|Double-Blind|Lack of Efficacy|12
6018203|NCT00798434|20804026|P1|Double-Blind|Lack of Efficacy|8
6018204|NCT00798434|20804025|P2|Double-Blind|Lost to Follow-up|0
6018205|NCT00798434|20804026|P1|Double-Blind|Lost to Follow-up|1
6018206|NCT00798434|20804025|P2|Double-Blind|Death|1
6018207|NCT00798434|20804026|P1|Double-Blind|Death|0
6018208|NCT00798434|20804025|P2|Double-Blind|Adverse Event|46
6018209|NCT00798434|20804026|P1|Double-Blind|Adverse Event|22
6018210|NCT00798369|20804112|P6|Overall Study|Adminstrative problems|1
6018211|NCT00798369|20804113|P5|Overall Study|Adminstrative problems|0
6018212|NCT00798369|20804114|P4|Overall Study|Adminstrative problems|0
6018213|NCT00798369|20804115|P3|Overall Study|Adminstrative problems|0
6018214|NCT00798369|20804116|P2|Overall Study|Adminstrative problems|0
6018215|NCT00798369|20804117|P1|Overall Study|Adminstrative problems|0
6018216|NCT00798369|20804112|P6|Overall Study|Lost to Follow-up|0
6018217|NCT00798369|20804113|P5|Overall Study|Lost to Follow-up|1
6018218|NCT00798369|20804114|P4|Overall Study|Lost to Follow-up|0
6018219|NCT00798369|20804115|P3|Overall Study|Lost to Follow-up|1
6018220|NCT00798369|20804116|P2|Overall Study|Lost to Follow-up|1
6018221|NCT00798369|20804117|P1|Overall Study|Lost to Follow-up|1
6018222|NCT00798369|20804112|P6|Overall Study|Subject withdrew consent|2
6018223|NCT00798369|20804113|P5|Overall Study|Subject withdrew consent|0
6018224|NCT00798369|20804114|P4|Overall Study|Subject withdrew consent|1
6018225|NCT00798369|20804115|P3|Overall Study|Subject withdrew consent|1
6018226|NCT00798369|20804116|P2|Overall Study|Subject withdrew consent|0
6018227|NCT00798369|20804117|P1|Overall Study|Subject withdrew consent|0
6018228|NCT00798317|20804164|P2|Overall Study|Death|0
6018229|NCT00798317|20804165|P1|Overall Study|Death|1
6018230|NCT00798317|20804164|P2|Overall Study|Adverse Event|0
6018231|NCT00798317|20804165|P1|Overall Study|Adverse Event|2
6018232|NCT00798317|20804164|P2|Overall Study|Lost to Follow-up|2
6018233|NCT00798317|20804165|P1|Overall Study|Lost to Follow-up|2
6018234|NCT00798317|20804164|P2|Overall Study|Withdrawal by Subject|4
6018235|NCT00798317|20804165|P1|Overall Study|Withdrawal by Subject|5
6018236|NCT00798317|20804164|P2|Overall Study|Physician Decision|1
6018237|NCT00798317|20804165|P1|Overall Study|Physician Decision|0
6018238|NCT00798304|20804176|P3|Overall Study|Discontinuation by Sponsor|9
6018239|NCT00798304|20804177|P2|Overall Study|Discontinuation by Sponsor|21
6018240|NCT00798304|20804178|P1|Overall Study|Discontinuation by Sponsor|14
6018241|NCT00798304|20804176|P3|Overall Study|Adverse Event|1
6018242|NCT00798304|20804177|P2|Overall Study|Adverse Event|1
6018243|NCT00798304|20804178|P1|Overall Study|Adverse Event|0
6018244|NCT00798174|20804204|P2|Overall Study|Inability to sedate for DFT testing|0
6018245|NCT00798174|20804205|P1|Overall Study|Inability to sedate for DFT testing|1
6018246|NCT00798174|20804204|P2|Overall Study|inability to implant azygos coil|3
6018247|NCT00798174|20804205|P1|Overall Study|inability to implant azygos coil|3
6018248|NCT00798161|20804216|P7|Overall Study|Other reason (incl. lack of efficacy)|5
6018249|NCT00798161|20804217|P6|Overall Study|Other reason (incl. lack of efficacy)|4
6018250|NCT00798161|20804218|P5|Overall Study|Other reason (incl. lack of efficacy)|2
6018251|NCT00798161|20804219|P4|Overall Study|Other reason (incl. lack of efficacy)|5
6018252|NCT00798161|20804220|P3|Overall Study|Other reason (incl. lack of efficacy)|3
6018253|NCT00798161|20804221|P2|Overall Study|Other reason (incl. lack of efficacy)|5
6018254|NCT00798161|20804222|P1|Overall Study|Other reason (incl. lack of efficacy)|7
6018255|NCT00798161|20804216|P7|Overall Study|Withdrawal by Subject|1
6018256|NCT00798161|20804217|P6|Overall Study|Withdrawal by Subject|3
6018257|NCT00798161|20804218|P5|Overall Study|Withdrawal by Subject|2
6018258|NCT00798161|20804219|P4|Overall Study|Withdrawal by Subject|4
6018259|NCT00798161|20804220|P3|Overall Study|Withdrawal by Subject|5
6018260|NCT00798161|20804221|P2|Overall Study|Withdrawal by Subject|4
6018261|NCT00798161|20804222|P1|Overall Study|Withdrawal by Subject|5
6018262|NCT00798161|20804216|P7|Overall Study|Lost to Follow-up|0
6018263|NCT00798161|20804217|P6|Overall Study|Lost to Follow-up|0
6018264|NCT00798161|20804218|P5|Overall Study|Lost to Follow-up|4
6018265|NCT00798161|20804219|P4|Overall Study|Lost to Follow-up|3
6018266|NCT00798161|20804220|P3|Overall Study|Lost to Follow-up|4
6018267|NCT00798161|20804221|P2|Overall Study|Lost to Follow-up|3
6018268|NCT00798161|20804222|P1|Overall Study|Lost to Follow-up|1
6018269|NCT00798161|20804216|P7|Overall Study|Protocol Violation|0
6018270|NCT00798161|20804217|P6|Overall Study|Protocol Violation|2
6018271|NCT00798161|20804218|P5|Overall Study|Protocol Violation|3
6018272|NCT00798161|20804219|P4|Overall Study|Protocol Violation|3
6018273|NCT00798161|20804220|P3|Overall Study|Protocol Violation|3
6018274|NCT00798161|20804221|P2|Overall Study|Protocol Violation|1
6018275|NCT00798161|20804222|P1|Overall Study|Protocol Violation|2
6018276|NCT00798161|20804216|P7|Overall Study|Adverse Event|4
6018277|NCT00798161|20804217|P6|Overall Study|Adverse Event|2
6018278|NCT00798161|20804218|P5|Overall Study|Adverse Event|5
6018279|NCT00798161|20804219|P4|Overall Study|Adverse Event|6
6018280|NCT00798161|20804220|P3|Overall Study|Adverse Event|6
6018281|NCT00798161|20804221|P2|Overall Study|Adverse Event|4
6018282|NCT00798161|20804222|P1|Overall Study|Adverse Event|3
6018283|NCT00798135|20804329|P1|Overall Study|Physician Decision|1
6018284|NCT00798135|20804329|P1|Overall Study|Disease progression, refractory|1
6018285|NCT00798135|20804329|P1|Overall Study|Disease progression, relapse|11
6018286|NCT00798096|20804335|P1|Overall Study|Ongoing|2
6018287|NCT00797966|20804363|P6|Phase A+|Protocol deviation|4
6018288|NCT00797966|20804364|P5|Phase A+|Protocol deviation|0
6018289|NCT00797966|20804365|P4|Phase A+|Protocol deviation|0
6018290|NCT00797966|20804366|P3|Phase A+|Protocol deviation|0
6018291|NCT00797966|20804367|P2|Phase A+|Protocol deviation|0
6018292|NCT00797966|20804368|P1|Phase A+|Protocol deviation|0
6018293|NCT00797966|20804363|P6|Phase A+|Adverse Event|4
6018294|NCT00797966|20804364|P5|Phase A+|Adverse Event|0
6018295|NCT00797966|20804365|P4|Phase A+|Adverse Event|0
6018296|NCT00797966|20804366|P3|Phase A+|Adverse Event|0
6018297|NCT00797966|20804367|P2|Phase A+|Adverse Event|0
6018298|NCT00797966|20804368|P1|Phase A+|Adverse Event|0
6018299|NCT00797966|20804363|P6|Phase A+|Withdrawal by Subject|6
6018300|NCT00797966|20804364|P5|Phase A+|Withdrawal by Subject|0
6018301|NCT00797966|20804365|P4|Phase A+|Withdrawal by Subject|0
6018302|NCT00797966|20804366|P3|Phase A+|Withdrawal by Subject|0
6018303|NCT00797966|20804367|P2|Phase A+|Withdrawal by Subject|0
6018304|NCT00797966|20804368|P1|Phase A+|Withdrawal by Subject|0
6018305|NCT00797966|20804363|P6|Phase A+|Met withdrawal criteria|5
6018306|NCT00797966|20804364|P5|Phase A+|Met withdrawal criteria|0
6018307|NCT00797966|20804365|P4|Phase A+|Met withdrawal criteria|0
6018308|NCT00797966|20804366|P3|Phase A+|Met withdrawal criteria|0
6018309|NCT00797966|20804367|P2|Phase A+|Met withdrawal criteria|0
6018310|NCT00797966|20804368|P1|Phase A+|Met withdrawal criteria|0
6018311|NCT00797966|20804363|P6|Phase A+|Lost to Follow-up|9
6018312|NCT00797966|20804364|P5|Phase A+|Lost to Follow-up|0
6018313|NCT00797966|20804365|P4|Phase A+|Lost to Follow-up|0
6018314|NCT00797966|20804366|P3|Phase A+|Lost to Follow-up|0
6018315|NCT00797966|20804367|P2|Phase A+|Lost to Follow-up|0
6018316|NCT00797966|20804368|P1|Phase A+|Lost to Follow-up|0
6018317|NCT00797966|20804363|P6|Phase B|Lack of Efficacy|0
6018318|NCT00797966|20804364|P5|Phase B|Lack of Efficacy|0
6018319|NCT00797966|20804365|P4|Phase B|Lack of Efficacy|4
6018320|NCT00797966|20804366|P3|Phase B|Lack of Efficacy|1
6018321|NCT00797966|20804367|P2|Phase B|Lack of Efficacy|1
6018322|NCT00797966|20804368|P1|Phase B|Lack of Efficacy|0
6018323|NCT00797966|20804363|P6|Phase B|Protocol Deviation|0
6018324|NCT00797966|20804364|P5|Phase B|Protocol Deviation|0
6018325|NCT00797966|20804365|P4|Phase B|Protocol Deviation|6
6018326|NCT00797966|20804366|P3|Phase B|Protocol Deviation|2
6018327|NCT00797966|20804367|P2|Phase B|Protocol Deviation|8
6018328|NCT00797966|20804368|P1|Phase B|Protocol Deviation|4
6018329|NCT00797966|20804363|P6|Phase B|Withdrawal by Subject|0
6018330|NCT00797966|20804364|P5|Phase B|Withdrawal by Subject|0
6018331|NCT00797966|20804365|P4|Phase B|Withdrawal by Subject|3
6018332|NCT00797966|20804366|P3|Phase B|Withdrawal by Subject|3
6018333|NCT00797966|20804367|P2|Phase B|Withdrawal by Subject|4
6018334|NCT00797966|20804368|P1|Phase B|Withdrawal by Subject|1
6018335|NCT00797966|20804363|P6|Phase B|Physician Decision|0
6018336|NCT00797966|20804364|P5|Phase B|Physician Decision|0
6018337|NCT00797966|20804365|P4|Phase B|Physician Decision|1
6018338|NCT00797966|20804366|P3|Phase B|Physician Decision|3
6018339|NCT00797966|20804367|P2|Phase B|Physician Decision|0
6018340|NCT00797966|20804368|P1|Phase B|Physician Decision|1
6018341|NCT00797966|20804363|P6|Phase B|Met Withdrawal Criteria|0
6018342|NCT00797966|20804364|P5|Phase B|Met Withdrawal Criteria|0
6018343|NCT00797966|20804365|P4|Phase B|Met Withdrawal Criteria|1
6018344|NCT00797966|20804366|P3|Phase B|Met Withdrawal Criteria|6
6018345|NCT00797966|20804367|P2|Phase B|Met Withdrawal Criteria|3
6018346|NCT00797966|20804368|P1|Phase B|Met Withdrawal Criteria|3
6018347|NCT00797966|20804363|P6|Phase B|Adverse Event|0
6018348|NCT00797966|20804364|P5|Phase B|Adverse Event|0
6018349|NCT00797966|20804365|P4|Phase B|Adverse Event|1
6018350|NCT00797966|20804366|P3|Phase B|Adverse Event|3
6018351|NCT00797966|20804367|P2|Phase B|Adverse Event|1
6018352|NCT00797966|20804368|P1|Phase B|Adverse Event|2
6018353|NCT00797966|20804363|P6|Phase B|Lost to Follow-up|0
6018354|NCT00797966|20804364|P5|Phase B|Lost to Follow-up|0
6018355|NCT00797966|20804365|P4|Phase B|Lost to Follow-up|0
6018356|NCT00797966|20804366|P3|Phase B|Lost to Follow-up|3
6018357|NCT00797966|20804367|P2|Phase B|Lost to Follow-up|1
6018358|NCT00797966|20804368|P1|Phase B|Lost to Follow-up|0
6018359|NCT00797966|20804363|P6|Phase A|Protocol deviation|0
6018360|NCT00797966|20804364|P5|Phase A|Protocol deviation|56
6018361|NCT00797966|20804365|P4|Phase A|Protocol deviation|0
6018362|NCT00797966|20804366|P3|Phase A|Protocol deviation|0
6018363|NCT00797966|20804367|P2|Phase A|Protocol deviation|0
6018364|NCT00797966|20804368|P1|Phase A|Protocol deviation|0
6018365|NCT00797966|20804363|P6|Phase A|Withdrawal by Subject|0
6018366|NCT00797966|20804364|P5|Phase A|Withdrawal by Subject|33
6018367|NCT00797966|20804365|P4|Phase A|Withdrawal by Subject|0
6018368|NCT00797966|20804366|P3|Phase A|Withdrawal by Subject|0
6018369|NCT00797966|20804367|P2|Phase A|Withdrawal by Subject|0
6018370|NCT00797966|20804368|P1|Phase A|Withdrawal by Subject|0
6018371|NCT00797966|20804363|P6|Phase A|Physician Decision|0
6018372|NCT00797966|20804364|P5|Phase A|Physician Decision|13
6018373|NCT00797966|20804365|P4|Phase A|Physician Decision|0
6018374|NCT00797966|20804366|P3|Phase A|Physician Decision|0
6018375|NCT00797966|20804367|P2|Phase A|Physician Decision|0
6018376|NCT00797966|20804368|P1|Phase A|Physician Decision|0
6018377|NCT00797966|20804363|P6|Phase A|Met withdrawal criteria|0
6018378|NCT00797966|20804364|P5|Phase A|Met withdrawal criteria|4
6018379|NCT00797966|20804365|P4|Phase A|Met withdrawal criteria|0
6018380|NCT00797966|20804366|P3|Phase A|Met withdrawal criteria|0
6018381|NCT00797966|20804367|P2|Phase A|Met withdrawal criteria|0
6018382|NCT00797966|20804368|P1|Phase A|Met withdrawal criteria|0
6018383|NCT00797966|20804363|P6|Phase A|Adverse Event|0
6018384|NCT00797966|20804364|P5|Phase A|Adverse Event|46
6018385|NCT00797966|20804365|P4|Phase A|Adverse Event|0
6018386|NCT00797966|20804366|P3|Phase A|Adverse Event|0
6018387|NCT00797966|20804367|P2|Phase A|Adverse Event|0
6018388|NCT00797966|20804368|P1|Phase A|Adverse Event|0
6018389|NCT00797966|20804363|P6|Phase A|Lost to Follow-up|0
6018390|NCT00797966|20804364|P5|Phase A|Lost to Follow-up|33
6018391|NCT00797966|20804365|P4|Phase A|Lost to Follow-up|0
6018392|NCT00797966|20804366|P3|Phase A|Lost to Follow-up|0
6018393|NCT00797966|20804367|P2|Phase A|Lost to Follow-up|0
6018394|NCT00797966|20804368|P1|Phase A|Lost to Follow-up|0
6018395|NCT00797862|20804433|P3|Overall Study|Mis-randomized|1
6018396|NCT00797862|20804434|P2|Overall Study|Mis-randomized|3
6018397|NCT00797862|20804435|P1|Overall Study|Mis-randomized|3
6018398|NCT00797862|20804433|P3|Overall Study|Protocol Violation|8
6018399|NCT00797862|20804434|P2|Overall Study|Protocol Violation|6
6018400|NCT00797862|20804435|P1|Overall Study|Protocol Violation|4
6018401|NCT00797862|20804433|P3|Overall Study|Administrative Problem|0
6018402|NCT00797862|20804434|P2|Overall Study|Administrative Problem|0
6018403|NCT00797862|20804435|P1|Overall Study|Administrative Problem|4
6018404|NCT00797862|20804433|P3|Overall Study|Lost to Follow-up|5
6018405|NCT00797862|20804434|P2|Overall Study|Lost to Follow-up|0
6018406|NCT00797862|20804435|P1|Overall Study|Lost to Follow-up|11
6018407|NCT00797862|20804433|P3|Overall Study|Withdrawal by Subject|7
6018408|NCT00797862|20804434|P2|Overall Study|Withdrawal by Subject|7
6018409|NCT00797862|20804435|P1|Overall Study|Withdrawal by Subject|14
6018410|NCT00797862|20804433|P3|Overall Study|No longer required study medication|0
6018411|NCT00797862|20804434|P2|Overall Study|No longer required study medication|0
6018412|NCT00797862|20804435|P1|Overall Study|No longer required study medication|1
6018413|NCT00797862|20804433|P3|Overall Study|Lack of Efficacy|6
6018414|NCT00797862|20804434|P2|Overall Study|Lack of Efficacy|7
6018415|NCT00797862|20804435|P1|Overall Study|Lack of Efficacy|1
6018416|NCT00797862|20804433|P3|Overall Study|Abnormal Test Procedure Result|1
6018417|NCT00797862|20804434|P2|Overall Study|Abnormal Test Procedure Result|1
6018418|NCT00797862|20804435|P1|Overall Study|Abnormal Test Procedure Result|0
6018419|NCT00797862|20804433|P3|Overall Study|Adverse Event|58
6018420|NCT00797862|20804434|P2|Overall Study|Adverse Event|44
6018421|NCT00797862|20804435|P1|Overall Study|Adverse Event|86
6018422|NCT00797823|20804464|P3|First Period (Initial Randomization)|Physician Decision|0
6018423|NCT00797823|20804465|P2|First Period (Initial Randomization)|Physician Decision|0
6018424|NCT00797823|20804466|P1|First Period (Initial Randomization)|Physician Decision|1
6018425|NCT00797732|20804488|P3|Overall Study|Refused to Participate|123
6018426|NCT00797732|20804489|P2|Overall Study|Refused to Participate|0
6018427|NCT00797732|20804490|P1|Overall Study|Refused to Participate|0
6018428|NCT00797732|20804488|P3|Overall Study|Excluded due to time constraints|24
6018429|NCT00797732|20804489|P2|Overall Study|Excluded due to time constraints|0
6018430|NCT00797732|20804490|P1|Overall Study|Excluded due to time constraints|0
6018431|NCT00797732|20804488|P3|Overall Study|Not meet inclusion criteria|7
6018432|NCT00797732|20804489|P2|Overall Study|Not meet inclusion criteria|0
6018433|NCT00797732|20804490|P1|Overall Study|Not meet inclusion criteria|0
6018434|NCT00797732|20804488|P3|Overall Study|Death|0
6018435|NCT00797732|20804489|P2|Overall Study|Death|0
6018436|NCT00797732|20804490|P1|Overall Study|Death|1
6018437|NCT00797732|20804488|P3|Overall Study|Lost to Follow-up|0
6018438|NCT00797732|20804489|P2|Overall Study|Lost to Follow-up|0
6018439|NCT00797732|20804490|P1|Overall Study|Lost to Follow-up|1
6018440|NCT00797732|20804488|P3|Overall Study|Withdrawal by Subject|0
6018441|NCT00797732|20804489|P2|Overall Study|Withdrawal by Subject|3
6018442|NCT00797732|20804490|P1|Overall Study|Withdrawal by Subject|3
6018443|NCT00797667|20804505|P3|Overall Study|Adverse Event|8
6018444|NCT00797667|20804506|P2|Overall Study|Adverse Event|8
6018445|NCT00797667|20804507|P1|Overall Study|Adverse Event|19
6018446|NCT00797667|20804505|P3|Overall Study|Withdrawal by Subject|2
6018447|NCT00797667|20804506|P2|Overall Study|Withdrawal by Subject|14
6018448|NCT00797667|20804507|P1|Overall Study|Withdrawal by Subject|9
6018449|NCT00797667|20804505|P3|Overall Study|Study Terminated by Sponsor|115
6018450|NCT00797667|20804506|P2|Overall Study|Study Terminated by Sponsor|216
6018451|NCT00797667|20804507|P1|Overall Study|Study Terminated by Sponsor|217
6018452|NCT00797667|20804505|P3|Overall Study|Protocol Violation|0
6018453|NCT00797667|20804506|P2|Overall Study|Protocol Violation|7
6018454|NCT00797667|20804507|P1|Overall Study|Protocol Violation|2
6018455|NCT00797667|20804505|P3|Overall Study|Pregnancy|0
6018456|NCT00797667|20804506|P2|Overall Study|Pregnancy|0
6018457|NCT00797667|20804507|P1|Overall Study|Pregnancy|2
6018458|NCT00797667|20804505|P3|Overall Study|Physician Decision|0
6018459|NCT00797667|20804506|P2|Overall Study|Physician Decision|1
6018460|NCT00797667|20804507|P1|Overall Study|Physician Decision|3
6018461|NCT00797667|20804505|P3|Overall Study|Lost to Follow-up|2
6018462|NCT00797667|20804506|P2|Overall Study|Lost to Follow-up|12
6018463|NCT00797667|20804507|P1|Overall Study|Lost to Follow-up|8
6018464|NCT00797667|20804505|P3|Overall Study|Lack of Efficacy|0
6018465|NCT00797667|20804506|P2|Overall Study|Lack of Efficacy|1
6018466|NCT00797667|20804507|P1|Overall Study|Lack of Efficacy|0
6018467|NCT00797563|20804533|P1|Overall Study|Adverse Event|1
6018468|NCT00797511|20804539|P1|Overall Study|Withdrawal by Subject|1
6018469|NCT00797316|20804557|P2|Overall Study|Unsatisfactory therapeutic effect|13
6018470|NCT00797316|20804558|P1|Overall Study|Unsatisfactory therapeutic effect|0
6018471|NCT00797316|20804557|P2|Overall Study|Patient withdrew consent|6
6018472|NCT00797316|20804558|P1|Overall Study|Patient withdrew consent|12
6018473|NCT00797316|20804557|P2|Overall Study|Protocol Deviation|2
6018474|NCT00797316|20804558|P1|Overall Study|Protocol Deviation|1
6018475|NCT00797316|20804557|P2|Overall Study|Lost to Follow-up|8
6018476|NCT00797316|20804558|P1|Overall Study|Lost to Follow-up|4
6018477|NCT00797316|20804557|P2|Overall Study|Adverse Event|3
6018478|NCT00797316|20804558|P1|Overall Study|Adverse Event|5
6018479|NCT00797316|20804557|P2|Overall Study|Administrative problems|0
6018480|NCT00797316|20804558|P1|Overall Study|Administrative problems|1
6018481|NCT00797225|20804587|P8|Weeks 13 to 24|Sponsor Decision|0
6018482|NCT00797225|20804588|P7|Weeks 13 to 24|Sponsor Decision|1
6018483|NCT00797225|20804589|P6|Weeks 13 to 24|Sponsor Decision|0
6018484|NCT00797225|20804590|P5|Weeks 13 to 24|Sponsor Decision|0
6018485|NCT00797225|20804591|P4|Weeks 13 to 24|Sponsor Decision|0
6018486|NCT00797225|20804592|P3|Weeks 13 to 24|Sponsor Decision|0
6018487|NCT00797225|20804593|P2|Weeks 13 to 24|Sponsor Decision|0
6018488|NCT00797225|20804594|P1|Weeks 13 to 24|Sponsor Decision|0
6018489|NCT00797225|20804587|P8|Weeks 13 to 24|Adverse Event|0
6018490|NCT00797225|20804588|P7|Weeks 13 to 24|Adverse Event|1
6018491|NCT00797225|20804589|P6|Weeks 13 to 24|Adverse Event|0
6018492|NCT00797225|20804590|P5|Weeks 13 to 24|Adverse Event|0
6018493|NCT00797225|20804591|P4|Weeks 13 to 24|Adverse Event|0
6018494|NCT00797225|20804592|P3|Weeks 13 to 24|Adverse Event|0
6018495|NCT00797225|20804593|P2|Weeks 13 to 24|Adverse Event|1
6018496|NCT00797225|20804594|P1|Weeks 13 to 24|Adverse Event|0
6018497|NCT00797225|20804587|P8|Weeks 13 to 24|Lost to Follow-up|0
6018498|NCT00797225|20804588|P7|Weeks 13 to 24|Lost to Follow-up|0
6018499|NCT00797225|20804589|P6|Weeks 13 to 24|Lost to Follow-up|0
6018500|NCT00797225|20804590|P5|Weeks 13 to 24|Lost to Follow-up|1
6018501|NCT00797225|20804591|P4|Weeks 13 to 24|Lost to Follow-up|0
6018502|NCT00797225|20804592|P3|Weeks 13 to 24|Lost to Follow-up|1
6018503|NCT00797225|20804593|P2|Weeks 13 to 24|Lost to Follow-up|0
6018504|NCT00797225|20804594|P1|Weeks 13 to 24|Lost to Follow-up|0
6018505|NCT00797225|20804587|P8|Weeks 13 to 24|Withdrawal by Subject|0
6018506|NCT00797225|20804588|P7|Weeks 13 to 24|Withdrawal by Subject|0
6018507|NCT00797225|20804589|P6|Weeks 13 to 24|Withdrawal by Subject|0
6018508|NCT00797225|20804590|P5|Weeks 13 to 24|Withdrawal by Subject|0
6018509|NCT00797225|20804591|P4|Weeks 13 to 24|Withdrawal by Subject|0
6018510|NCT00797225|20804592|P3|Weeks 13 to 24|Withdrawal by Subject|1
6018511|NCT00797225|20804593|P2|Weeks 13 to 24|Withdrawal by Subject|1
6018512|NCT00797225|20804594|P1|Weeks 13 to 24|Withdrawal by Subject|0
6018513|NCT00797225|20804587|P8|Weeks 13 to 24|Non-compliance|0
6018514|NCT00797225|20804588|P7|Weeks 13 to 24|Non-compliance|0
6018515|NCT00797225|20804589|P6|Weeks 13 to 24|Non-compliance|0
6018516|NCT00797225|20804590|P5|Weeks 13 to 24|Non-compliance|0
6018517|NCT00797225|20804591|P4|Weeks 13 to 24|Non-compliance|0
6018518|NCT00797225|20804592|P3|Weeks 13 to 24|Non-compliance|0
6018519|NCT00797225|20804593|P2|Weeks 13 to 24|Non-compliance|2
6018520|NCT00797225|20804594|P1|Weeks 13 to 24|Non-compliance|0
6018521|NCT00797225|20804587|P8|Weeks 1 to 12|Sponsor Decision|0
6018522|NCT00797225|20804588|P7|Weeks 1 to 12|Sponsor Decision|0
6018523|NCT00797225|20804589|P6|Weeks 1 to 12|Sponsor Decision|0
6018524|NCT00797225|20804590|P5|Weeks 1 to 12|Sponsor Decision|0
6018525|NCT00797225|20804591|P4|Weeks 1 to 12|Sponsor Decision|0
6018526|NCT00797225|20804592|P3|Weeks 1 to 12|Sponsor Decision|0
6018527|NCT00797225|20804593|P2|Weeks 1 to 12|Sponsor Decision|0
6018528|NCT00797225|20804594|P1|Weeks 1 to 12|Sponsor Decision|1
6018529|NCT00797225|20804587|P8|Weeks 1 to 12|Lack of Efficacy|0
6018530|NCT00797225|20804588|P7|Weeks 1 to 12|Lack of Efficacy|0
6018531|NCT00797225|20804589|P6|Weeks 1 to 12|Lack of Efficacy|0
6018532|NCT00797225|20804590|P5|Weeks 1 to 12|Lack of Efficacy|0
6018533|NCT00797225|20804591|P4|Weeks 1 to 12|Lack of Efficacy|0
6018534|NCT00797225|20804592|P3|Weeks 1 to 12|Lack of Efficacy|0
6018535|NCT00797225|20804593|P2|Weeks 1 to 12|Lack of Efficacy|0
6018536|NCT00797225|20804594|P1|Weeks 1 to 12|Lack of Efficacy|1
6018537|NCT00797225|20804587|P8|Weeks 1 to 12|Non-compliance|0
6018538|NCT00797225|20804588|P7|Weeks 1 to 12|Non-compliance|0
6018539|NCT00797225|20804589|P6|Weeks 1 to 12|Non-compliance|0
6018540|NCT00797225|20804590|P5|Weeks 1 to 12|Non-compliance|0
6018541|NCT00797225|20804591|P4|Weeks 1 to 12|Non-compliance|0
6018542|NCT00797225|20804592|P3|Weeks 1 to 12|Non-compliance|0
6018543|NCT00797225|20804593|P2|Weeks 1 to 12|Non-compliance|1
6018544|NCT00797225|20804594|P1|Weeks 1 to 12|Non-compliance|0
6018545|NCT00797225|20804587|P8|Weeks 1 to 12|Adverse Event|0
6018546|NCT00797225|20804588|P7|Weeks 1 to 12|Adverse Event|0
6018547|NCT00797225|20804589|P6|Weeks 1 to 12|Adverse Event|0
6018548|NCT00797225|20804590|P5|Weeks 1 to 12|Adverse Event|0
6018549|NCT00797225|20804591|P4|Weeks 1 to 12|Adverse Event|0
6018550|NCT00797225|20804592|P3|Weeks 1 to 12|Adverse Event|1
6018551|NCT00797225|20804593|P2|Weeks 1 to 12|Adverse Event|0
6018552|NCT00797225|20804594|P1|Weeks 1 to 12|Adverse Event|0
6018553|NCT00797108|20804711|P3|Overall Study|Randomized but not Treated|0
6018554|NCT00797108|20804712|P2|Overall Study|Randomized but not Treated|0
6018555|NCT00797108|20804713|P1|Overall Study|Randomized but not Treated|2
6018556|NCT00797108|20804711|P3|Overall Study|Other|2
6018557|NCT00797108|20804712|P2|Overall Study|Other|0
6018558|NCT00797108|20804713|P1|Overall Study|Other|0
6018559|NCT00797108|20804711|P3|Overall Study|Lack of Efficacy|1
6018560|NCT00797108|20804712|P2|Overall Study|Lack of Efficacy|0
6018561|NCT00797108|20804713|P1|Overall Study|Lack of Efficacy|1
6018562|NCT00797108|20804711|P3|Overall Study|Global Deterioration of Health Status|0
6018563|NCT00797108|20804712|P2|Overall Study|Global Deterioration of Health Status|1
6018564|NCT00797108|20804713|P1|Overall Study|Global Deterioration of Health Status|0
6018565|NCT00797108|20804711|P3|Overall Study|Did Not Meet Entrance Criteria|0
6018566|NCT00797108|20804712|P2|Overall Study|Did Not Meet Entrance Criteria|1
6018567|NCT00797108|20804713|P1|Overall Study|Did Not Meet Entrance Criteria|0
6018568|NCT00797108|20804711|P3|Overall Study|Adverse Event|3
6018569|NCT00797108|20804712|P2|Overall Study|Adverse Event|0
6018570|NCT00797108|20804713|P1|Overall Study|Adverse Event|1
6018571|NCT00796991|20804748|P3|Overall Study|Withdrawal by Subject|1
6018572|NCT00796991|20804749|P2|Overall Study|Withdrawal by Subject|0
6018573|NCT00796991|20804750|P1|Overall Study|Withdrawal by Subject|0
6018574|NCT00796991|20804748|P3|Overall Study|Study Drug Toxicity|5
6018575|NCT00796991|20804749|P2|Overall Study|Study Drug Toxicity|3
6018576|NCT00796991|20804750|P1|Overall Study|Study Drug Toxicity|3
6018577|NCT00796991|20804748|P3|Overall Study|Disease Progression|7
6018578|NCT00796991|20804749|P2|Overall Study|Disease Progression|9
6018579|NCT00796991|20804750|P1|Overall Study|Disease Progression|10
6018580|NCT00796991|20804748|P3|Overall Study|Death|0
6018581|NCT00796991|20804749|P2|Overall Study|Death|0
6018582|NCT00796991|20804750|P1|Overall Study|Death|2
6018583|NCT00796991|20804748|P3|Overall Study|Adverse Event|1
6018584|NCT00796991|20804749|P2|Overall Study|Adverse Event|0
6018585|NCT00796991|20804750|P1|Overall Study|Adverse Event|0
6018586|NCT00796978|20804848|P1|Overall Study|Withdrawal by Subject|3
6018587|NCT00796978|20804848|P1|Overall Study|Adverse Event|4
6018588|NCT00796978|20804848|P1|Overall Study|Cardiac adverse event|5
6018589|NCT00796861|20804874|P1|Overall Study|Death|2
6018590|NCT00796861|20804874|P1|Overall Study|Withdrawal by Subject|2
6018591|NCT00796822|20804880|P2|Overall Study|Adverse Event|0
6018592|NCT00796822|20804881|P1|Overall Study|Adverse Event|1
6018593|NCT00796822|20804880|P2|Overall Study|Lost to Follow-up|0
6018594|NCT00796822|20804881|P1|Overall Study|Lost to Follow-up|2
6018595|NCT00796757|20804889|P1|Overall Study|Other|7
6018596|NCT00796757|20804889|P1|Overall Study|Investigator's decision|2
6018597|NCT00796757|20804889|P1|Overall Study|Participant noncompliance|1
6018598|NCT00796757|20804889|P1|Overall Study|Protocol Violation|1
6018599|NCT00796757|20804889|P1|Overall Study|Death|61
6018600|NCT00796757|20804889|P1|Overall Study|Withdrawal by Subject|14
6018601|NCT00796718|20804923|P1|Overall Study|Withdrawal by Informed Consent|1
6018602|NCT00796718|20804923|P1|Overall Study|Lost to Follow-up|5
6018603|NCT00796718|20804923|P1|Overall Study|Exclusion Criteria|1
6018604|NCT00796718|20804923|P1|Overall Study|Adverse Event|2
6018605|NCT00796666|20804975|P2|Overall Study|Randomized and not treated|0
6018606|NCT00796666|20804976|P1|Overall Study|Randomized and not treated|1
6018607|NCT00796666|20804975|P2|Overall Study|Terminated by sponsor|55
6018608|NCT00796666|20804976|P1|Overall Study|Terminated by sponsor|53
6018609|NCT00796666|20804975|P2|Overall Study|Other|0
6018610|NCT00796666|20804976|P1|Overall Study|Other|1
6018611|NCT00796666|20804975|P2|Overall Study|Protocol Violation|0
6018612|NCT00796666|20804976|P1|Overall Study|Protocol Violation|1
6018613|NCT00796666|20804975|P2|Overall Study|Adverse Event|5
6018614|NCT00796666|20804976|P1|Overall Study|Adverse Event|7
6018615|NCT00796666|20804975|P2|Overall Study|Withdrawal by Subject|0
6018616|NCT00796666|20804976|P1|Overall Study|Withdrawal by Subject|2
6018617|NCT00796666|20804975|P2|Overall Study|Death|4
6018618|NCT00796666|20804976|P1|Overall Study|Death|2
6018619|NCT00796653|20805010|P4|Overall Study|Other reason not described above|4
6018620|NCT00796653|20805011|P3|Overall Study|Other reason not described above|7
6018621|NCT00796653|20805012|P2|Overall Study|Other reason not described above|9
6018622|NCT00796653|20805013|P1|Overall Study|Other reason not described above|4
6018623|NCT00796653|20805010|P4|Overall Study|Non compliance with protocol|2
6018624|NCT00796653|20805011|P3|Overall Study|Non compliance with protocol|0
6018625|NCT00796653|20805012|P2|Overall Study|Non compliance with protocol|2
6018626|NCT00796653|20805013|P1|Overall Study|Non compliance with protocol|2
6018627|NCT00796653|20805010|P4|Overall Study|Lack of Efficacy|2
6018628|NCT00796653|20805011|P3|Overall Study|Lack of Efficacy|3
6018629|NCT00796653|20805012|P2|Overall Study|Lack of Efficacy|1
6018630|NCT00796653|20805013|P1|Overall Study|Lack of Efficacy|8
6018631|NCT00796653|20805010|P4|Overall Study|Withdrawal by Subject|13
6018632|NCT00796653|20805011|P3|Overall Study|Withdrawal by Subject|8
6018633|NCT00796653|20805012|P2|Overall Study|Withdrawal by Subject|8
6018634|NCT00796653|20805013|P1|Overall Study|Withdrawal by Subject|16
6018635|NCT00796653|20805010|P4|Overall Study|Lost to Follow-up|3
6018636|NCT00796653|20805011|P3|Overall Study|Lost to Follow-up|2
6018637|NCT00796653|20805012|P2|Overall Study|Lost to Follow-up|1
6018638|NCT00796653|20805013|P1|Overall Study|Lost to Follow-up|2
6018639|NCT00796653|20805010|P4|Overall Study|Adverse Event|16
6018640|NCT00796653|20805011|P3|Overall Study|Adverse Event|16
6018641|NCT00796653|20805012|P2|Overall Study|Adverse Event|16
6018642|NCT00796653|20805013|P1|Overall Study|Adverse Event|19
6018643|NCT00796614|20805298|P4|Overall Study|Other than stated|0
6018644|NCT00796614|20805299|P3|Overall Study|Other than stated|0
6018645|NCT00796614|20805300|P2|Overall Study|Other than stated|0
6018646|NCT00796614|20805301|P1|Overall Study|Other than stated|1
6018647|NCT00796614|20805298|P4|Overall Study|Withdrawal by Subject|1
6018648|NCT00796614|20805299|P3|Overall Study|Withdrawal by Subject|0
6018649|NCT00796614|20805300|P2|Overall Study|Withdrawal by Subject|0
6018650|NCT00796614|20805301|P1|Overall Study|Withdrawal by Subject|1
6018651|NCT00796614|20805298|P4|Overall Study|Lost to Follow-up|0
6018652|NCT00796614|20805299|P3|Overall Study|Lost to Follow-up|1
6018653|NCT00796614|20805300|P2|Overall Study|Lost to Follow-up|2
6018654|NCT00796614|20805301|P1|Overall Study|Lost to Follow-up|2
6018655|NCT00796614|20805298|P4|Overall Study|Protocol Violation|0
6018656|NCT00796614|20805299|P3|Overall Study|Protocol Violation|2
6018657|NCT00796614|20805300|P2|Overall Study|Protocol Violation|0
6018658|NCT00796614|20805301|P1|Overall Study|Protocol Violation|0
6018659|NCT00796614|20805298|P4|Overall Study|Adverse Event|0
6018660|NCT00796614|20805299|P3|Overall Study|Adverse Event|0
6018661|NCT00796614|20805300|P2|Overall Study|Adverse Event|2
6018662|NCT00796614|20805301|P1|Overall Study|Adverse Event|1
6018663|NCT00796562|20805343|P1|Overall Study|Death|49
6018664|NCT00796549|20805352|P1|Overall Study|Progressive disease|56
6018665|NCT00796549|20805352|P1|Overall Study|Other|2
6018666|NCT00796549|20805352|P1|Overall Study|not entered|149
6018667|NCT00796549|20805352|P1|Overall Study|Adverse Event|11
6018668|NCT00796523|20805369|P2|Overall Study|Lost to Follow-up|7
6018669|NCT00796523|20805370|P1|Overall Study|Lost to Follow-up|9
6018670|NCT00796510|20805380|P2|Overall Study|Study Terminated|0
6018671|NCT00796510|20805381|P1|Overall Study|Study Terminated|2
6018672|NCT00796510|20805380|P2|Overall Study|Death|0
6018673|NCT00796510|20805381|P1|Overall Study|Death|1
6018674|NCT00796445|20805393|P2|Overall Study|Withdrawal by Subject|9
6018675|NCT00796445|20805394|P1|Overall Study|Withdrawal by Subject|18
6018676|NCT00796445|20805393|P2|Overall Study|Other|7
6018677|NCT00796445|20805394|P1|Overall Study|Other|10
6018678|NCT00796445|20805393|P2|Overall Study|Disease progression/recurrence|268
6018679|NCT00796445|20805394|P1|Overall Study|Disease progression/recurrence|537
6018680|NCT00796445|20805393|P2|Overall Study|Adverse event, non-fatal|0
6018681|NCT00796445|20805394|P1|Overall Study|Adverse event, non-fatal|4
6018682|NCT00796445|20805393|P2|Overall Study|Adverse event, serious fatal|5
6018683|NCT00796445|20805394|P1|Overall Study|Adverse event, serious fatal|10
6018684|NCT00796445|20805393|P2|Overall Study|Protocol Violation|3
6018685|NCT00796445|20805394|P1|Overall Study|Protocol Violation|5
6018686|NCT00796419|20805446|P2|Overall Study|Death|1
6018687|NCT00796419|20805447|P1|Overall Study|Death|0
6018688|NCT00796367|20805460|P3|Overall Study|other|3
6018689|NCT00796367|20805461|P2|Overall Study|other|4
6018690|NCT00796367|20805462|P1|Overall Study|other|2
6018691|NCT00796367|20805460|P3|Overall Study|Requirement for restricted medication|2
6018692|NCT00796367|20805461|P2|Overall Study|Requirement for restricted medication|0
6018693|NCT00796367|20805462|P1|Overall Study|Requirement for restricted medication|2
6018694|NCT00796367|20805460|P3|Overall Study|Pregnancy|1
6018695|NCT00796367|20805461|P2|Overall Study|Pregnancy|0
6018696|NCT00796367|20805462|P1|Overall Study|Pregnancy|1
6018697|NCT00796367|20805460|P3|Overall Study|non compliance|1
6018698|NCT00796367|20805461|P2|Overall Study|non compliance|1
6018699|NCT00796367|20805462|P1|Overall Study|non compliance|3
6018700|NCT00796367|20805460|P3|Overall Study|Lack of Efficacy|0
6018701|NCT00796367|20805461|P2|Overall Study|Lack of Efficacy|1
6018702|NCT00796367|20805462|P1|Overall Study|Lack of Efficacy|2
6018703|NCT00796367|20805460|P3|Overall Study|Withdrawal by Subject|12
6018704|NCT00796367|20805461|P2|Overall Study|Withdrawal by Subject|11
6018705|NCT00796367|20805462|P1|Overall Study|Withdrawal by Subject|9
6018706|NCT00796367|20805460|P3|Overall Study|Lost to Follow-up|21
6018707|NCT00796367|20805461|P2|Overall Study|Lost to Follow-up|4
6018708|NCT00796367|20805462|P1|Overall Study|Lost to Follow-up|5
6018709|NCT00796367|20805460|P3|Overall Study|Adverse Event|7
6018710|NCT00796367|20805461|P2|Overall Study|Adverse Event|4
6018711|NCT00796367|20805462|P1|Overall Study|Adverse Event|6
6018712|NCT00796328|20805473|P1|Overall Study|experienced hypotension requiring tx|6
6018713|NCT00796315|20805477|P3|Overall Study|Protocol Violation|0
6018714|NCT00796315|20805478|P2|Overall Study|Protocol Violation|1
6018715|NCT00796315|20805479|P1|Overall Study|Protocol Violation|0
6018716|NCT00796224|20805507|P2|Overall Study|Protocol Violation|1
6018717|NCT00796224|20805508|P1|Overall Study|Protocol Violation|0
6018718|NCT00796224|20805507|P2|Overall Study|Adverse Event|0
6018719|NCT00796224|20805508|P1|Overall Study|Adverse Event|1
6018720|NCT00796120|20805528|P2|Overall Study|Randomized but not treated|3
6018721|NCT00796120|20805529|P1|Overall Study|Randomized but not treated|0
6018722|NCT00796120|20805528|P2|Overall Study|Physician Decision|17
6018723|NCT00796120|20805529|P1|Overall Study|Physician Decision|16
6018724|NCT00796120|20805528|P2|Overall Study|Other|17
6018725|NCT00796120|20805529|P1|Overall Study|Other|6
6018726|NCT00796120|20805528|P2|Overall Study|Participant refusal|4
6018727|NCT00796120|20805529|P1|Overall Study|Participant refusal|3
6018728|NCT00796120|20805528|P2|Overall Study|Progressive disease|13
6018729|NCT00796120|20805529|P1|Overall Study|Progressive disease|22
6018730|NCT00796120|20805528|P2|Overall Study|Adverse Event|6
6018731|NCT00796120|20805529|P1|Overall Study|Adverse Event|11
6018732|NCT00796120|20805528|P2|Overall Study|Death|0
6018733|NCT00796120|20805529|P1|Overall Study|Death|3
6018734|NCT00796107|20805543|P1|Overall Study|Progressive Disease|5
6018735|NCT00796107|20805543|P1|Overall Study|Lack of Efficacy|1
6018736|NCT00796003|20805552|P2|Overall Study|Participants Not treated|2
6018737|NCT00796003|20805553|P1|Overall Study|Participants Not treated|0
6018738|NCT00796003|20805552|P2|Overall Study|Other|1
6018739|NCT00796003|20805553|P1|Overall Study|Other|0
6018740|NCT00796003|20805552|P2|Overall Study|Withdrawal by Subject|1
6018741|NCT00796003|20805553|P1|Overall Study|Withdrawal by Subject|0
6018742|NCT00796003|20805552|P2|Overall Study|Physician Decision|4
6018743|NCT00796003|20805553|P1|Overall Study|Physician Decision|0
6018744|NCT00796003|20805552|P2|Overall Study|Specified organ function not met|1
6018745|NCT00796003|20805553|P1|Overall Study|Specified organ function not met|0
6018746|NCT00796003|20805552|P2|Overall Study|Adverse Event|7
6018747|NCT00796003|20805553|P1|Overall Study|Adverse Event|1
6018748|NCT00796003|20805552|P2|Overall Study|Disease Progression|13
6018749|NCT00796003|20805553|P1|Overall Study|Disease Progression|2
6018750|NCT00795951|20805574|P1|Overall Study|Withdrawal by Subject|1
6018751|NCT00795951|20805574|P1|Overall Study|Lost to Follow-up|1
6018752|NCT00795886|20805667|P1|Overall Study|Death|10
6018753|NCT00795821|20805675|P2|Taper Phase|Withdrawal by Subject|0
6018754|NCT00795821|20805676|P1|Taper Phase|Withdrawal by Subject|4
6018755|NCT00795821|20805675|P2|Taper Phase|Physician Decision|0
6018756|NCT00795821|20805676|P1|Taper Phase|Physician Decision|2
6018757|NCT00795821|20805675|P2|Taper Phase|Lost to Follow-up|0
6018758|NCT00795821|20805676|P1|Taper Phase|Lost to Follow-up|1
6018759|NCT00795821|20805675|P2|Taper Phase|Adverse Event|0
6018760|NCT00795821|20805676|P1|Taper Phase|Adverse Event|2
6018761|NCT00795821|20805675|P2|Long-term Extension Phase|Withdrawal by Subject|25
6018762|NCT00795821|20805676|P1|Long-term Extension Phase|Withdrawal by Subject|25
6018763|NCT00795821|20805675|P2|Long-term Extension Phase|Protocol Violation|5
6018764|NCT00795821|20805676|P1|Long-term Extension Phase|Protocol Violation|3
6018765|NCT00795821|20805675|P2|Long-term Extension Phase|Physician Decision|2
6018766|NCT00795821|20805676|P1|Long-term Extension Phase|Physician Decision|1
6018767|NCT00795821|20805675|P2|Long-term Extension Phase|Lost to Follow-up|16
6018768|NCT00795821|20805676|P1|Long-term Extension Phase|Lost to Follow-up|20
6018769|NCT00795821|20805675|P2|Long-term Extension Phase|Lack of Efficacy|12
6018770|NCT00795821|20805676|P1|Long-term Extension Phase|Lack of Efficacy|16
6018771|NCT00795821|20805675|P2|Long-term Extension Phase|Adverse Event|32
6018772|NCT00795821|20805676|P1|Long-term Extension Phase|Adverse Event|25
6018773|NCT00795821|20805675|P2|Acute Treatment Phase|Withdrawal by Subject|10
6018774|NCT00795821|20805676|P1|Acute Treatment Phase|Withdrawal by Subject|16
6018775|NCT00795821|20805675|P2|Acute Treatment Phase|Protocol Violation|2
6018776|NCT00795821|20805676|P1|Acute Treatment Phase|Protocol Violation|1
6018777|NCT00795821|20805675|P2|Acute Treatment Phase|Physician Decision|1
6018778|NCT00795821|20805676|P1|Acute Treatment Phase|Physician Decision|1
6018779|NCT00795821|20805675|P2|Acute Treatment Phase|Lost to Follow-up|12
6018780|NCT00795821|20805676|P1|Acute Treatment Phase|Lost to Follow-up|9
6018781|NCT00795821|20805675|P2|Acute Treatment Phase|Lack of Efficacy|2
6018782|NCT00795821|20805676|P1|Acute Treatment Phase|Lack of Efficacy|5
6018783|NCT00795821|20805675|P2|Acute Treatment Phase|Death|0
6018784|NCT00795821|20805676|P1|Acute Treatment Phase|Death|1
6018785|NCT00795821|20805675|P2|Acute Treatment Phase|Adverse Event|4
6018786|NCT00795821|20805676|P1|Acute Treatment Phase|Adverse Event|23
6018787|NCT00795717|20805751|P2|Phase II|too busy|1
6018788|NCT00795717|20805752|P1|Phase II|too busy|0
6018789|NCT00795717|20805751|P2|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|1
6018790|NCT00795717|20805752|P1|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|0
6018791|NCT00795717|20805751|P2|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1
6018792|NCT00795717|20805752|P1|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1
6018793|NCT00795717|20805751|P2|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|0
6018794|NCT00795717|20805752|P1|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|1
6018795|NCT00795704|20805764|P2|Overall Study|Adverse Event|1
6018796|NCT00795704|20805765|P1|Overall Study|Adverse Event|1
6018797|NCT00795704|20805764|P2|Overall Study|Withdrawal by Subject|2
6018798|NCT00795704|20805765|P1|Overall Study|Withdrawal by Subject|3
6018799|NCT00795639|20805785|P2|Overall Study|Randomized and not treated|1
6018800|NCT00795639|20805786|P1|Overall Study|Randomized and not treated|0
6018801|NCT00795639|20805785|P2|Overall Study|Terminated by sponsor|12
6018802|NCT00795639|20805786|P1|Overall Study|Terminated by sponsor|13
6018803|NCT00795639|20805785|P2|Overall Study|Other|2
6018804|NCT00795639|20805786|P1|Overall Study|Other|0
6018805|NCT00795639|20805785|P2|Overall Study|Adverse Event|2
6018806|NCT00795639|20805786|P1|Overall Study|Adverse Event|5
6018807|NCT00795639|20805785|P2|Overall Study|Pregnancy|0
6018808|NCT00795639|20805786|P1|Overall Study|Pregnancy|1
6018809|NCT00795639|20805785|P2|Overall Study|Withdrawal by Subject|3
6018810|NCT00795639|20805786|P1|Overall Study|Withdrawal by Subject|1
6018811|NCT00795639|20805785|P2|Overall Study|Death|6
6018812|NCT00795639|20805786|P1|Overall Study|Death|1
6018813|NCT00795600|20805798|P2|Overall Study|Unclassified|1
6018814|NCT00795600|20805799|P1|Overall Study|Unclassified|1
6018815|NCT00795600|20805798|P2|Overall Study|Withdrawal by Subject|0
6018816|NCT00795600|20805799|P1|Overall Study|Withdrawal by Subject|1
6018817|NCT00795600|20805798|P2|Overall Study|Protocol Violation|2
6018818|NCT00795600|20805799|P1|Overall Study|Protocol Violation|1
6018819|NCT00795600|20805798|P2|Overall Study|Adverse Event|1
6018820|NCT00795600|20805799|P1|Overall Study|Adverse Event|1
6018821|NCT00795535|20805919|P1|Overall Study|incomplete data and technical problems|20
6018822|NCT00795509|20805926|P1|Overall Study|Protocol Violation|31
6018823|NCT00795184|20805995|P2|Overall Study|Tissue sampling incomplete/conclusive|13
6018824|NCT00795184|20805996|P1|Overall Study|Tissue sampling incomplete/conclusive|8
6018825|NCT00795132|20806057|P1|Overall Study|Relapse|2
6018826|NCT00795132|20806057|P1|Overall Study|Death|1
6018827|NCT00794963|20806084|P2|Overall Study|Withdrawal by Subject|4
6018828|NCT00794963|20806085|P1|Overall Study|Withdrawal by Subject|1
6018829|NCT00794950|20806091|P1|Beginning Sunitinib Treatment|Lost to Follow-up|1
6018830|NCT00794950|20806091|P1|Beginning Sunitinib Treatment|Withdrawal by Subject|1
6018831|NCT00794950|20806091|P1|Beginning Sunitinib Treatment|Physician Decision|5
6018832|NCT00794950|20806091|P1|Beginning Sunitinib Treatment|cystectomy|5
6018833|NCT00794950|20806091|P1|BCG Induction|Adverse Event|1
6018834|NCT00794950|20806091|P1|BCG Induction|noncompliant w. BCG|1
6018835|NCT00794950|20806091|P1|BCG Induction|ineligible|3
6018836|NCT00794950|20806091|P1|BCG Induction|Withdrawal by Subject|2
6018837|NCT00794924|20806100|P2|Overall Study|Adverse Event|2
6018838|NCT00794924|20806101|P1|Overall Study|Adverse Event|6
6018839|NCT00794924|20806100|P2|Overall Study|Withdrawal by Subject|60
6018840|NCT00794924|20806101|P1|Overall Study|Withdrawal by Subject|48
6018841|NCT00794924|20806100|P2|Overall Study|Lost to Follow-up|8
6018842|NCT00794924|20806101|P1|Overall Study|Lost to Follow-up|6
6018843|NCT00794820|20806105|P1|Overall Study|Ineligible/Screen Failure|1
6018844|NCT00794820|20806105|P1|Overall Study|Resistant Disease|2
6018845|NCT00794820|20806105|P1|Overall Study|Secondary Malignancies|2
6018846|NCT00794820|20806105|P1|Overall Study|Adverse Event|11
6018849|NCT00794664|20806136|P2|Follow-up Period|Protocol non-compliance|1
6018850|NCT00794664|20806137|P1|Follow-up Period|Protocol non-compliance|0
6018851|NCT00794664|20806136|P2|Follow-up Period|Withdrawal by Subject|2
6018852|NCT00794664|20806137|P1|Follow-up Period|Withdrawal by Subject|0
6018853|NCT00794664|20806136|P2|Follow-up Period|Other|2
6018854|NCT00794664|20806137|P1|Follow-up Period|Other|1
6018855|NCT00794664|20806136|P2|Treatment Period|Adverse Event|8
6018856|NCT00794664|20806137|P1|Treatment Period|Adverse Event|1
6018857|NCT00794664|20806136|P2|Treatment Period|Other|1
6018858|NCT00794664|20806137|P1|Treatment Period|Other|0
6018859|NCT00794664|20806136|P2|Treatment Period|Protocol non-compliance|1
6018860|NCT00794664|20806137|P1|Treatment Period|Protocol non-compliance|0
6018861|NCT00794664|20806136|P2|Treatment Period|Withdrawal by Subject|2
6018862|NCT00794664|20806137|P1|Treatment Period|Withdrawal by Subject|0
6018863|NCT00794573|20806183|P2|Overall Study|Lost to Follow-up|33
6018864|NCT00794573|20806184|P1|Overall Study|Lost to Follow-up|26
6018865|NCT00794573|20806183|P2|Overall Study|Withdrawal by Subject|12
6018866|NCT00794573|20806184|P1|Overall Study|Withdrawal by Subject|9
6018867|NCT00794573|20806183|P2|Overall Study|Death|0
6018868|NCT00794573|20806184|P1|Overall Study|Death|3
6018869|NCT00794417|20806257|P4|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|13
6018870|NCT00794417|20806258|P3|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0
6018871|NCT00794417|20806259|P2|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0
6018872|NCT00794417|20806260|P1|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0
6018873|NCT00794417|20806257|P4|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|4
6018874|NCT00794417|20806258|P3|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0
6018875|NCT00794417|20806259|P2|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0
6018876|NCT00794417|20806260|P1|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0
6018877|NCT00794417|20806257|P4|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|11
6018878|NCT00794417|20806258|P3|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0
6018879|NCT00794417|20806259|P2|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0
6018880|NCT00794417|20806260|P1|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0
6018881|NCT00794417|20806257|P4|Phase 2: Baseline (Day 421) to Day 972|Death|7
6018882|NCT00794417|20806258|P3|Phase 2: Baseline (Day 421) to Day 972|Death|0
6018883|NCT00794417|20806259|P2|Phase 2: Baseline (Day 421) to Day 972|Death|0
6018884|NCT00794417|20806260|P1|Phase 2: Baseline (Day 421) to Day 972|Death|0
6018885|NCT00794417|20806257|P4|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|0
6018886|NCT00794417|20806258|P3|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|1
6018887|NCT00794417|20806259|P2|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|3
6018888|NCT00794417|20806260|P1|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|3
6018889|NCT00794417|20806257|P4|Phase 1: Baseline (Day 1) up to Day 751|Death|0
6018890|NCT00794417|20806258|P3|Phase 1: Baseline (Day 1) up to Day 751|Death|2
6018891|NCT00794417|20806259|P2|Phase 1: Baseline (Day 1) up to Day 751|Death|0
6018892|NCT00794417|20806260|P1|Phase 1: Baseline (Day 1) up to Day 751|Death|0
6018893|NCT00794365|20806313|P1|Overall Study|Lack of Efficacy|3
6018894|NCT00794365|20806313|P1|Overall Study|Adverse Event|10
6018895|NCT00794365|20806313|P1|Overall Study|Poor Compliance|11
6018896|NCT00794365|20806313|P1|Overall Study|Other|17
6018897|NCT00794365|20806313|P1|Overall Study|Lost to Follow-up|38
6018898|NCT00794196|20806334|P2|Overall Study|Lost to Follow-up|23
6018899|NCT00794196|20806335|P1|Overall Study|Lost to Follow-up|5
6018900|NCT00794157|20806355|P3|Overall Study|Protocol deviation|1
6018901|NCT00794157|20806356|P2|Overall Study|Protocol deviation|1
6018902|NCT00794157|20806357|P1|Overall Study|Protocol deviation|0
6018903|NCT00794157|20806355|P3|Overall Study|Abnormal test procedure result(s)|0
6018904|NCT00794157|20806356|P2|Overall Study|Abnormal test procedure result(s)|1
6018905|NCT00794157|20806357|P1|Overall Study|Abnormal test procedure result(s)|0
6018906|NCT00794157|20806355|P3|Overall Study|Administrative problems|4
6018907|NCT00794157|20806356|P2|Overall Study|Administrative problems|7
6018908|NCT00794157|20806357|P1|Overall Study|Administrative problems|1
6018909|NCT00794157|20806355|P3|Overall Study|Unsatisfactory therapeutic effect|2
6018910|NCT00794157|20806356|P2|Overall Study|Unsatisfactory therapeutic effect|0
6018911|NCT00794157|20806357|P1|Overall Study|Unsatisfactory therapeutic effect|1
6018912|NCT00794157|20806355|P3|Overall Study|Lost to Follow-up|1
6018913|NCT00794157|20806356|P2|Overall Study|Lost to Follow-up|0
6018914|NCT00794157|20806357|P1|Overall Study|Lost to Follow-up|2
6018915|NCT00794157|20806355|P3|Overall Study|Subject withdrew consent|3
6018916|NCT00794157|20806356|P2|Overall Study|Subject withdrew consent|0
6018917|NCT00794157|20806357|P1|Overall Study|Subject withdrew consent|2
6018918|NCT00794157|20806355|P3|Overall Study|Adverse Event|8
6018919|NCT00794157|20806356|P2|Overall Study|Adverse Event|1
6018920|NCT00794157|20806357|P1|Overall Study|Adverse Event|4
6018921|NCT00794118|20806386|P1|Overall Study|Changed hospital center|2
6018922|NCT00794118|20806386|P1|Overall Study|Withdrawal by Subject|9
6018923|NCT00794118|20806386|P1|Overall Study|Lost to Follow-up|16
6018924|NCT00794040|20806446|P2|Overall Study|Physician Decision|1
6018925|NCT00794040|20806447|P1|Overall Study|Physician Decision|0
6018926|NCT00794040|20806446|P2|Overall Study|Withdrawal by Subject|4
6018927|NCT00794040|20806447|P1|Overall Study|Withdrawal by Subject|3
6018928|NCT00793910|20806463|P2|Overall Study|Withdrawal by Subject|1
6018929|NCT00793910|20806464|P1|Overall Study|Withdrawal by Subject|0
6018930|NCT00793910|20806463|P2|Overall Study|decided to undergo LASIK instead of PRK|1
6018931|NCT00793910|20806464|P1|Overall Study|decided to undergo LASIK instead of PRK|2
6018932|NCT00793910|20806463|P2|Overall Study|ineligible based on entry criteria|3
6018933|NCT00793910|20806464|P1|Overall Study|ineligible based on entry criteria|2
6018934|NCT00793910|20806463|P2|Overall Study|did not pick up medications|1
6018935|NCT00793910|20806464|P1|Overall Study|did not pick up medications|1
6018936|NCT00793910|20806463|P2|Overall Study|discarded study pills|1
6018937|NCT00793910|20806464|P1|Overall Study|discarded study pills|0
6018938|NCT00793871|20806478|P1|Overall Study|Study terminated by the Sponsor|7
6018939|NCT00793871|20806478|P1|Overall Study|Lost to Follow-up|3
6018940|NCT00793871|20806478|P1|Overall Study|Death|50
6018941|NCT00793819|20806492|P2|Overall Study|Lost to Follow-up|1
6018942|NCT00793819|20806493|P1|Overall Study|Lost to Follow-up|1
6018943|NCT00793819|20806492|P2|Overall Study|Withdrawal by Subject|3
6018944|NCT00793819|20806493|P1|Overall Study|Withdrawal by Subject|4
6018945|NCT00793819|20806492|P2|Overall Study|Lack of Efficacy|1
6018946|NCT00793819|20806493|P1|Overall Study|Lack of Efficacy|1
6018947|NCT00793819|20806492|P2|Overall Study|Adverse Event|4
6018948|NCT00793819|20806493|P1|Overall Study|Adverse Event|8
6018949|NCT00793793|20806511|P12|Overall Study|reason not specified|4
6018950|NCT00793793|20806512|P11|Overall Study|reason not specified|2
6018951|NCT00793793|20806513|P10|Overall Study|reason not specified|6
6018952|NCT00793793|20806514|P9|Overall Study|reason not specified|7
6018953|NCT00793793|20806515|P8|Overall Study|reason not specified|0
6018954|NCT00793793|20806516|P7|Overall Study|reason not specified|2
6018955|NCT00793793|20806517|P6|Overall Study|reason not specified|1
6018956|NCT00793793|20806518|P5|Overall Study|reason not specified|1
6018957|NCT00793793|20806519|P4|Overall Study|reason not specified|1
6018958|NCT00793793|20806520|P3|Overall Study|reason not specified|0
6018959|NCT00793793|20806521|P2|Overall Study|reason not specified|1
6018960|NCT00793793|20806522|P1|Overall Study|reason not specified|0
6018961|NCT00793793|20806511|P12|Overall Study|Withdrawal by Subject|0
6018962|NCT00793793|20806512|P11|Overall Study|Withdrawal by Subject|0
6018963|NCT00793793|20806513|P10|Overall Study|Withdrawal by Subject|0
6018964|NCT00793793|20806514|P9|Overall Study|Withdrawal by Subject|1
6018965|NCT00793793|20806515|P8|Overall Study|Withdrawal by Subject|0
6018966|NCT00793793|20806516|P7|Overall Study|Withdrawal by Subject|0
6018967|NCT00793793|20806517|P6|Overall Study|Withdrawal by Subject|0
6018968|NCT00793793|20806518|P5|Overall Study|Withdrawal by Subject|1
6018969|NCT00793793|20806519|P4|Overall Study|Withdrawal by Subject|0
6018970|NCT00793793|20806520|P3|Overall Study|Withdrawal by Subject|0
6018971|NCT00793793|20806521|P2|Overall Study|Withdrawal by Subject|0
6018972|NCT00793793|20806522|P1|Overall Study|Withdrawal by Subject|0
6018973|NCT00793793|20806511|P12|Overall Study|Lost to Follow-up|0
6018974|NCT00793793|20806512|P11|Overall Study|Lost to Follow-up|1
6018975|NCT00793793|20806513|P10|Overall Study|Lost to Follow-up|3
6018976|NCT00793793|20806514|P9|Overall Study|Lost to Follow-up|1
6018977|NCT00793793|20806515|P8|Overall Study|Lost to Follow-up|0
6018978|NCT00793793|20806516|P7|Overall Study|Lost to Follow-up|0
6018979|NCT00793793|20806517|P6|Overall Study|Lost to Follow-up|0
6018980|NCT00793793|20806518|P5|Overall Study|Lost to Follow-up|0
6018981|NCT00793793|20806519|P4|Overall Study|Lost to Follow-up|0
6018982|NCT00793793|20806520|P3|Overall Study|Lost to Follow-up|1
6018983|NCT00793793|20806521|P2|Overall Study|Lost to Follow-up|0
6018984|NCT00793793|20806522|P1|Overall Study|Lost to Follow-up|0
6018985|NCT00793793|20806511|P12|Overall Study|Protocol Violation|0
6018986|NCT00793793|20806512|P11|Overall Study|Protocol Violation|0
6018987|NCT00793793|20806513|P10|Overall Study|Protocol Violation|0
6018988|NCT00793793|20806514|P9|Overall Study|Protocol Violation|0
6018989|NCT00793793|20806515|P8|Overall Study|Protocol Violation|0
6018990|NCT00793793|20806516|P7|Overall Study|Protocol Violation|0
6018991|NCT00793793|20806517|P6|Overall Study|Protocol Violation|0
6018992|NCT00793793|20806518|P5|Overall Study|Protocol Violation|0
6018993|NCT00793793|20806519|P4|Overall Study|Protocol Violation|1
6018994|NCT00793793|20806520|P3|Overall Study|Protocol Violation|0
6018995|NCT00793793|20806521|P2|Overall Study|Protocol Violation|0
6018996|NCT00793793|20806522|P1|Overall Study|Protocol Violation|0
6018997|NCT00793793|20806511|P12|Overall Study|Adverse Event|2
6018998|NCT00793793|20806512|P11|Overall Study|Adverse Event|0
6018999|NCT00793793|20806513|P10|Overall Study|Adverse Event|0
6019000|NCT00793793|20806514|P9|Overall Study|Adverse Event|0
6019001|NCT00793793|20806515|P8|Overall Study|Adverse Event|0
6019002|NCT00793793|20806516|P7|Overall Study|Adverse Event|2
6019003|NCT00793793|20806517|P6|Overall Study|Adverse Event|1
6019004|NCT00793793|20806518|P5|Overall Study|Adverse Event|0
6019005|NCT00793793|20806519|P4|Overall Study|Adverse Event|1
6019006|NCT00793793|20806520|P3|Overall Study|Adverse Event|1
6019007|NCT00793793|20806521|P2|Overall Study|Adverse Event|0
6019008|NCT00793793|20806522|P1|Overall Study|Adverse Event|0
6019009|NCT00793780|20806897|P2|Overall Study|Withdrawal by Subject|1
6019010|NCT00793780|20806898|P1|Overall Study|Withdrawal by Subject|2
6019011|NCT00793624|20806929|P4|Overall Study|Other reason not described above|3
6019012|NCT00793624|20806930|P3|Overall Study|Other reason not described above|6
6019013|NCT00793624|20806931|P2|Overall Study|Other reason not described above|4
6019014|NCT00793624|20806932|P1|Overall Study|Other reason not described above|6
6019015|NCT00793624|20806929|P4|Overall Study|Non compliance with protocol|3
6019016|NCT00793624|20806930|P3|Overall Study|Non compliance with protocol|2
6019017|NCT00793624|20806931|P2|Overall Study|Non compliance with protocol|3
6019018|NCT00793624|20806932|P1|Overall Study|Non compliance with protocol|2
6019019|NCT00793624|20806929|P4|Overall Study|Lack of Efficacy|3
6019020|NCT00793624|20806930|P3|Overall Study|Lack of Efficacy|1
6019021|NCT00793624|20806931|P2|Overall Study|Lack of Efficacy|2
6019022|NCT00793624|20806932|P1|Overall Study|Lack of Efficacy|9
6019023|NCT00793624|20806929|P4|Overall Study|Withdrawal by Subject|14
6019024|NCT00793624|20806930|P3|Overall Study|Withdrawal by Subject|11
6019025|NCT00793624|20806931|P2|Overall Study|Withdrawal by Subject|9
6019026|NCT00793624|20806932|P1|Overall Study|Withdrawal by Subject|20
6019027|NCT00793624|20806929|P4|Overall Study|Lost to Follow-up|0
6019028|NCT00793624|20806930|P3|Overall Study|Lost to Follow-up|4
6019029|NCT00793624|20806931|P2|Overall Study|Lost to Follow-up|2
6019030|NCT00793624|20806932|P1|Overall Study|Lost to Follow-up|2
6019031|NCT00793624|20806929|P4|Overall Study|Adverse Event|20
6019032|NCT00793624|20806930|P3|Overall Study|Adverse Event|15
6019033|NCT00793624|20806931|P2|Overall Study|Adverse Event|16
6019034|NCT00793624|20806932|P1|Overall Study|Adverse Event|18
6019035|NCT00793585|20807213|P2|Overall Study|Protocol Violation|2
6019036|NCT00793585|20807214|P1|Overall Study|Protocol Violation|1
6019037|NCT00793585|20807213|P2|Overall Study|Adverse Event|1
6019038|NCT00793585|20807214|P1|Overall Study|Adverse Event|1
6019039|NCT00793546|20807233|P2|Overall Study|Other|0
6019040|NCT00793546|20807234|P1|Overall Study|Other|1
6019041|NCT00793546|20807233|P2|Overall Study|Study Terminated by Sponsor|27
6019042|NCT00793546|20807234|P1|Overall Study|Study Terminated by Sponsor|8
6019043|NCT00793546|20807233|P2|Overall Study|Withdrawal by Subject|1
6019044|NCT00793546|20807234|P1|Overall Study|Withdrawal by Subject|1
6019045|NCT00793546|20807233|P2|Overall Study|Lost to Follow-up|0
6019046|NCT00793546|20807234|P1|Overall Study|Lost to Follow-up|1
6019047|NCT00793546|20807233|P2|Overall Study|Death|0
6019048|NCT00793546|20807234|P1|Overall Study|Death|3
6019049|NCT00793403|20807284|P1|Overall Study|Other|73
6019050|NCT00793325|20807331|P1|Overall Study|Lost to Follow-up|1
6019051|NCT00793325|20807331|P1|Overall Study|Protocol Violation|18
6019052|NCT00793182|20807357|P2|Overall Study|Adverse Event|1
6019053|NCT00793182|20807358|P1|Overall Study|Adverse Event|0
6019054|NCT00793104|20807368|P1|Overall Study|Lost to Follow-up|1
6019055|NCT00792948|20807376|P1|Overall Study|Protocol Violation|1
6019056|NCT00792948|20807376|P1|Overall Study|Physician Decision|11
6019057|NCT00792948|20807376|P1|Overall Study|Insurance denial - not treated|1
6019058|NCT00792948|20807376|P1|Overall Study|Ineligible|2
6019059|NCT00792948|20807376|P1|Overall Study|Withdrawal by Subject|3
6019060|NCT00792948|20807376|P1|Overall Study|Death|4
6019061|NCT00792948|20807376|P1|Overall Study|Adverse Event|6
6019062|NCT00792935|20807387|P2|Overall Study|Withdrawal by Subject|1
6019063|NCT00792935|20807388|P1|Overall Study|Withdrawal by Subject|0
6019064|NCT00792935|20807387|P2|Overall Study|Protocol Violation|0
6019065|NCT00792935|20807388|P1|Overall Study|Protocol Violation|2
6019066|NCT00792935|20807387|P2|Overall Study|Lost to Follow-up|1
6019067|NCT00792935|20807388|P1|Overall Study|Lost to Follow-up|0
6019068|NCT00792935|20807387|P2|Overall Study|Adverse Event|1
6019069|NCT00792935|20807388|P1|Overall Study|Adverse Event|2
6019070|NCT00792909|20807420|P3|Overall Study|Withdrawal by Subject|0
6019071|NCT00792909|20807421|P2|Overall Study|Withdrawal by Subject|1
6019072|NCT00792909|20807422|P1|Overall Study|Withdrawal by Subject|0
6019073|NCT00792805|20807478|P3|Overall Study|Protocol deviation|1
6019074|NCT00792805|20807479|P2|Overall Study|Protocol deviation|1
6019075|NCT00792805|20807480|P1|Overall Study|Protocol deviation|0
6019076|NCT00792805|20807478|P3|Overall Study|Abnormal laboratory value(s)|1
6019077|NCT00792805|20807479|P2|Overall Study|Abnormal laboratory value(s)|0
6019078|NCT00792805|20807480|P1|Overall Study|Abnormal laboratory value(s)|0
6019079|NCT00792805|20807478|P3|Overall Study|Lost to Follow-up|6
6019080|NCT00792805|20807479|P2|Overall Study|Lost to Follow-up|1
6019081|NCT00792805|20807480|P1|Overall Study|Lost to Follow-up|1
6019082|NCT00792805|20807478|P3|Overall Study|Unsatisfactory therapeutic effect|6
6019083|NCT00792805|20807479|P2|Overall Study|Unsatisfactory therapeutic effect|6
6019084|NCT00792805|20807480|P1|Overall Study|Unsatisfactory therapeutic effect|1
6019085|NCT00792805|20807478|P3|Overall Study|Abnormal test procedure result(s)|0
6019086|NCT00792805|20807479|P2|Overall Study|Abnormal test procedure result(s)|2
6019087|NCT00792805|20807480|P1|Overall Study|Abnormal test procedure result(s)|1
6019088|NCT00792805|20807478|P3|Overall Study|Administrative problems|4
6019089|NCT00792805|20807479|P2|Overall Study|Administrative problems|0
6019090|NCT00792805|20807480|P1|Overall Study|Administrative problems|2
6019091|NCT00792805|20807478|P3|Overall Study|Subject withdrew consent|5
6019092|NCT00792805|20807479|P2|Overall Study|Subject withdrew consent|6
6019093|NCT00792805|20807480|P1|Overall Study|Subject withdrew consent|5
6019094|NCT00792805|20807478|P3|Overall Study|Adverse Event|10
6019095|NCT00792805|20807479|P2|Overall Study|Adverse Event|10
6019096|NCT00792805|20807480|P1|Overall Study|Adverse Event|12
6019097|NCT00792701|20807490|P2|Overall Study|Not protocol specified|0
6019098|NCT00792701|20807491|P1|Overall Study|Not protocol specified|17
6019099|NCT00792701|20807490|P2|Overall Study|Withdrawal by Subject|19
6019100|NCT00792701|20807491|P1|Overall Study|Withdrawal by Subject|1
6019101|NCT00792701|20807490|P2|Overall Study|Ineligible|3
6019102|NCT00792701|20807491|P1|Overall Study|Ineligible|1
6019103|NCT00792701|20807490|P2|Overall Study|Adverse Event|22
6019104|NCT00792701|20807491|P1|Overall Study|Adverse Event|0
6019105|NCT00792636|20807521|P3|Overall Study|Investigator Discretion|2
6019106|NCT00792636|20807522|P2|Overall Study|Investigator Discretion|0
6019107|NCT00792636|20807523|P1|Overall Study|Investigator Discretion|2
6019108|NCT00792636|20807521|P3|Overall Study|Adverse Event|3
6019109|NCT00792636|20807522|P2|Overall Study|Adverse Event|2
6019110|NCT00792636|20807523|P1|Overall Study|Adverse Event|4
6019111|NCT00792636|20807521|P3|Overall Study|Lack of Efficacy|13
6019112|NCT00792636|20807522|P2|Overall Study|Lack of Efficacy|4
6019113|NCT00792636|20807523|P1|Overall Study|Lack of Efficacy|3
6019114|NCT00792636|20807521|P3|Overall Study|Withdrew Consent|9
6019115|NCT00792636|20807522|P2|Overall Study|Withdrew Consent|13
6019116|NCT00792636|20807523|P1|Overall Study|Withdrew Consent|10
6019117|NCT00792636|20807521|P3|Overall Study|Lost to Follow-up|14
6019118|NCT00792636|20807522|P2|Overall Study|Lost to Follow-up|19
6019119|NCT00792636|20807523|P1|Overall Study|Lost to Follow-up|13
6019120|NCT00792636|20807521|P3|Overall Study|Met Protocol-defined Stopping Criteria|20
6019121|NCT00792636|20807522|P2|Overall Study|Met Protocol-defined Stopping Criteria|20
6019122|NCT00792636|20807523|P1|Overall Study|Met Protocol-defined Stopping Criteria|19
6019123|NCT00792636|20807521|P3|Overall Study|Protocol Violation|20
6019124|NCT00792636|20807522|P2|Overall Study|Protocol Violation|23
6019125|NCT00792636|20807523|P1|Overall Study|Protocol Violation|17
6019126|NCT00792623|20807560|P1|Overall Study|Withdrawal by Subject|5
6019127|NCT00792623|20807560|P1|Overall Study|Adverse Event|2
6019128|NCT00792571|20807577|P1|Overall Study|Other|4
6019129|NCT00792571|20807577|P1|Overall Study|Withdrawal by Subject|1
6019130|NCT00792571|20807577|P1|Overall Study|Adverse Event|4
6019131|NCT00792571|20807577|P1|Overall Study|Death|1
6019132|NCT00792298|20807597|P8|Treatment Period 2|Withdrawal by Subject|2
6019133|NCT00792298|20807598|P7|Treatment Period 2|Withdrawal by Subject|0
6019134|NCT00792298|20807599|P6|Treatment Period 2|Withdrawal by Subject|0
6019135|NCT00792298|20807600|P5|Treatment Period 2|Withdrawal by Subject|1
6019136|NCT00792298|20807601|P4|Treatment Period 2|Withdrawal by Subject|2
6019137|NCT00792298|20807602|P3|Treatment Period 2|Withdrawal by Subject|0
6019138|NCT00792298|20807603|P2|Treatment Period 2|Withdrawal by Subject|1
6019139|NCT00792298|20807604|P1|Treatment Period 2|Withdrawal by Subject|1
6019140|NCT00792298|20807597|P8|Treatment Period 2|Pregnancy|0
6019141|NCT00792298|20807598|P7|Treatment Period 2|Pregnancy|0
6019142|NCT00792298|20807599|P6|Treatment Period 2|Pregnancy|0
6019143|NCT00792298|20807600|P5|Treatment Period 2|Pregnancy|0
6019144|NCT00792298|20807601|P4|Treatment Period 2|Pregnancy|0
6019145|NCT00792298|20807602|P3|Treatment Period 2|Pregnancy|1
6019146|NCT00792298|20807603|P2|Treatment Period 2|Pregnancy|0
6019147|NCT00792298|20807604|P1|Treatment Period 2|Pregnancy|0
6019148|NCT00792298|20807597|P8|Treatment Period 2|Physician Decision|0
6019149|NCT00792298|20807598|P7|Treatment Period 2|Physician Decision|1
6019150|NCT00792298|20807599|P6|Treatment Period 2|Physician Decision|0
6019151|NCT00792298|20807600|P5|Treatment Period 2|Physician Decision|0
6019152|NCT00792298|20807601|P4|Treatment Period 2|Physician Decision|0
6019153|NCT00792298|20807602|P3|Treatment Period 2|Physician Decision|0
6019154|NCT00792298|20807603|P2|Treatment Period 2|Physician Decision|0
6019155|NCT00792298|20807604|P1|Treatment Period 2|Physician Decision|0
6019156|NCT00792298|20807597|P8|Treatment Period 2|Lack of Efficacy|0
6019157|NCT00792298|20807598|P7|Treatment Period 2|Lack of Efficacy|0
6019158|NCT00792298|20807599|P6|Treatment Period 2|Lack of Efficacy|0
6019159|NCT00792298|20807600|P5|Treatment Period 2|Lack of Efficacy|1
6019160|NCT00792298|20807601|P4|Treatment Period 2|Lack of Efficacy|0
6019161|NCT00792298|20807602|P3|Treatment Period 2|Lack of Efficacy|0
6019162|NCT00792298|20807603|P2|Treatment Period 2|Lack of Efficacy|0
6019163|NCT00792298|20807604|P1|Treatment Period 2|Lack of Efficacy|0
6019164|NCT00792298|20807597|P8|Washout|Withdrawal by Subject|0
6019165|NCT00792298|20807598|P7|Washout|Withdrawal by Subject|0
6019166|NCT00792298|20807599|P6|Washout|Withdrawal by Subject|1
6019167|NCT00792298|20807600|P5|Washout|Withdrawal by Subject|0
6019168|NCT00792298|20807601|P4|Washout|Withdrawal by Subject|0
6019169|NCT00792298|20807602|P3|Washout|Withdrawal by Subject|1
6019170|NCT00792298|20807603|P2|Washout|Withdrawal by Subject|0
6019171|NCT00792298|20807604|P1|Washout|Withdrawal by Subject|0
6019172|NCT00792298|20807597|P8|Washout|Adverse Event|0
6019173|NCT00792298|20807598|P7|Washout|Adverse Event|0
6019174|NCT00792298|20807599|P6|Washout|Adverse Event|1
6019175|NCT00792298|20807600|P5|Washout|Adverse Event|0
6019176|NCT00792298|20807601|P4|Washout|Adverse Event|0
6019177|NCT00792298|20807602|P3|Washout|Adverse Event|0
6019178|NCT00792298|20807603|P2|Washout|Adverse Event|0
6019179|NCT00792298|20807604|P1|Washout|Adverse Event|0
6019180|NCT00792298|20807597|P8|Treatment Period 1|Protocol Violation|1
6019181|NCT00792298|20807598|P7|Treatment Period 1|Protocol Violation|0
6019182|NCT00792298|20807599|P6|Treatment Period 1|Protocol Violation|0
6019183|NCT00792298|20807600|P5|Treatment Period 1|Protocol Violation|0
6019184|NCT00792298|20807601|P4|Treatment Period 1|Protocol Violation|0
6019185|NCT00792298|20807602|P3|Treatment Period 1|Protocol Violation|0
6019186|NCT00792298|20807603|P2|Treatment Period 1|Protocol Violation|0
6019187|NCT00792298|20807604|P1|Treatment Period 1|Protocol Violation|0
6019188|NCT00792298|20807597|P8|Treatment Period 1|Physician Decision|0
6019189|NCT00792298|20807598|P7|Treatment Period 1|Physician Decision|1
6019190|NCT00792298|20807599|P6|Treatment Period 1|Physician Decision|0
6019191|NCT00792298|20807600|P5|Treatment Period 1|Physician Decision|0
6019192|NCT00792298|20807601|P4|Treatment Period 1|Physician Decision|1
6019193|NCT00792298|20807602|P3|Treatment Period 1|Physician Decision|0
6019194|NCT00792298|20807603|P2|Treatment Period 1|Physician Decision|0
6019195|NCT00792298|20807604|P1|Treatment Period 1|Physician Decision|0
6019196|NCT00792298|20807597|P8|Treatment Period 1|Lost to Follow-up|0
6019197|NCT00792298|20807598|P7|Treatment Period 1|Lost to Follow-up|1
6019198|NCT00792298|20807599|P6|Treatment Period 1|Lost to Follow-up|0
6019199|NCT00792298|20807600|P5|Treatment Period 1|Lost to Follow-up|0
6019200|NCT00792298|20807601|P4|Treatment Period 1|Lost to Follow-up|0
6019201|NCT00792298|20807602|P3|Treatment Period 1|Lost to Follow-up|0
6019202|NCT00792298|20807603|P2|Treatment Period 1|Lost to Follow-up|0
6019203|NCT00792298|20807604|P1|Treatment Period 1|Lost to Follow-up|0
6019204|NCT00792298|20807597|P8|Treatment Period 1|Withdrawal by Subject|0
6019205|NCT00792298|20807598|P7|Treatment Period 1|Withdrawal by Subject|1
6019206|NCT00792298|20807599|P6|Treatment Period 1|Withdrawal by Subject|2
6019207|NCT00792298|20807600|P5|Treatment Period 1|Withdrawal by Subject|0
6019208|NCT00792298|20807601|P4|Treatment Period 1|Withdrawal by Subject|2
6019209|NCT00792298|20807602|P3|Treatment Period 1|Withdrawal by Subject|1
6019210|NCT00792298|20807603|P2|Treatment Period 1|Withdrawal by Subject|0
6019211|NCT00792298|20807604|P1|Treatment Period 1|Withdrawal by Subject|1
6019212|NCT00792298|20807597|P8|Treatment Period 1|Lack of Efficacy|0
6019213|NCT00792298|20807598|P7|Treatment Period 1|Lack of Efficacy|0
6019214|NCT00792298|20807599|P6|Treatment Period 1|Lack of Efficacy|0
6019215|NCT00792298|20807600|P5|Treatment Period 1|Lack of Efficacy|0
6019216|NCT00792298|20807601|P4|Treatment Period 1|Lack of Efficacy|0
6019217|NCT00792298|20807602|P3|Treatment Period 1|Lack of Efficacy|1
6019218|NCT00792298|20807603|P2|Treatment Period 1|Lack of Efficacy|0
6019219|NCT00792298|20807604|P1|Treatment Period 1|Lack of Efficacy|0
6019220|NCT00792298|20807597|P8|Treatment Period 1|Adverse Event|0
6019221|NCT00792298|20807598|P7|Treatment Period 1|Adverse Event|1
6019222|NCT00792298|20807599|P6|Treatment Period 1|Adverse Event|1
6019223|NCT00792298|20807600|P5|Treatment Period 1|Adverse Event|0
6019224|NCT00792298|20807601|P4|Treatment Period 1|Adverse Event|1
6019225|NCT00792298|20807602|P3|Treatment Period 1|Adverse Event|0
6019226|NCT00792298|20807603|P2|Treatment Period 1|Adverse Event|1
6019227|NCT00792298|20807604|P1|Treatment Period 1|Adverse Event|0
6019228|NCT00792259|20807634|P3|Overall Study|Poor Quality Scans|0
6019229|NCT00792259|20807635|P2|Overall Study|Poor Quality Scans|0
6019230|NCT00792259|20807636|P1|Overall Study|Poor Quality Scans|1
6019231|NCT00792116|20807653|P2|Overall Study|Discontnued intervention|0
6019232|NCT00792116|20807654|P1|Overall Study|Discontnued intervention|1
6019233|NCT00792116|20807653|P2|Overall Study|Lost to Follow-up|1
6019234|NCT00792116|20807654|P1|Overall Study|Lost to Follow-up|0
6019235|NCT00792103|20807664|P1|Overall Study|Did not apply 6 patches in 1st 3 mths|14
6019236|NCT00792103|20807664|P1|Overall Study|Protocol Violation|10
6019237|NCT00792103|20807664|P1|Overall Study|Withdrawal by Subject|52
6019238|NCT00792103|20807664|P1|Overall Study|Adverse Event|25
6019239|NCT00792103|20807664|P1|Overall Study|Lost to Follow-up|17
6019240|NCT00792103|20807664|P1|Overall Study|Enrolled, not treated|15
6019241|NCT00791999|20807676|P4|Overall Study|Reason other than those above|0
6019242|NCT00791999|20807677|P3|Overall Study|Reason other than those above|1
6019243|NCT00791999|20807678|P2|Overall Study|Reason other than those above|0
6019244|NCT00791999|20807679|P1|Overall Study|Reason other than those above|1
6019245|NCT00791999|20807676|P4|Overall Study|Lack of Efficacy|2
6019246|NCT00791999|20807677|P3|Overall Study|Lack of Efficacy|0
6019247|NCT00791999|20807678|P2|Overall Study|Lack of Efficacy|1
6019248|NCT00791999|20807679|P1|Overall Study|Lack of Efficacy|0
6019249|NCT00791999|20807676|P4|Overall Study|Adverse Event|3
6019250|NCT00791999|20807677|P3|Overall Study|Adverse Event|7
6019251|NCT00791999|20807678|P2|Overall Study|Adverse Event|3
6019252|NCT00791999|20807679|P1|Overall Study|Adverse Event|3
6019253|NCT00791999|20807676|P4|Overall Study|Protocol Violation|0
6019254|NCT00791999|20807677|P3|Overall Study|Protocol Violation|1
6019255|NCT00791999|20807678|P2|Overall Study|Protocol Violation|0
6019256|NCT00791999|20807679|P1|Overall Study|Protocol Violation|3
6019257|NCT00791999|20807676|P4|Overall Study|Withdrawal by Subject|2
6019258|NCT00791999|20807677|P3|Overall Study|Withdrawal by Subject|0
6019259|NCT00791999|20807678|P2|Overall Study|Withdrawal by Subject|1
6019260|NCT00791999|20807679|P1|Overall Study|Withdrawal by Subject|0
6019261|NCT00791999|20807676|P4|Overall Study|Protocol planed withdrawal|45
6019262|NCT00791999|20807677|P3|Overall Study|Protocol planed withdrawal|11
6019263|NCT00791999|20807678|P2|Overall Study|Protocol planed withdrawal|11
6019264|NCT00791999|20807679|P1|Overall Study|Protocol planed withdrawal|14
6019265|NCT00791934|20807704|P1|Overall Study|Did not consent for extended follow-up|13
6019266|NCT00791934|20807704|P1|Overall Study|Withdrawal by Subject|2
6019267|NCT00791921|20807714|P2|Overall Study|Reason other than those above|1
6019268|NCT00791921|20807715|P1|Overall Study|Reason other than those above|0
6019269|NCT00791921|20807714|P2|Overall Study|Lack of study drug administration|1
6019270|NCT00791921|20807715|P1|Overall Study|Lack of study drug administration|1
6019271|NCT00791921|20807714|P2|Overall Study|Lack of Efficacy|2
6019272|NCT00791921|20807715|P1|Overall Study|Lack of Efficacy|0
6019273|NCT00791921|20807714|P2|Overall Study|Adverse Event|2
6019274|NCT00791921|20807715|P1|Overall Study|Adverse Event|8
6019275|NCT00791921|20807714|P2|Overall Study|Withdrawal by Subject|2
6019276|NCT00791921|20807715|P1|Overall Study|Withdrawal by Subject|1
6019277|NCT00791921|20807714|P2|Overall Study|Protocol planed|88
6019278|NCT00791921|20807715|P1|Overall Study|Protocol planed|24
6019279|NCT00791778|20807746|P2|Follow-up|Lost to Follow-up|1
6019280|NCT00791778|20807747|P1|Follow-up|Lost to Follow-up|2
6019281|NCT00791778|20807746|P2|Follow-up|Withdrawal by Subject|0
6019282|NCT00791778|20807747|P1|Follow-up|Withdrawal by Subject|3
6019283|NCT00791778|20807746|P2|Double-blind Treatment|Non-compliant with study medication|0
6019284|NCT00791778|20807747|P1|Double-blind Treatment|Non-compliant with study medication|2
6019285|NCT00791778|20807746|P2|Double-blind Treatment|Withdrawal by Subject|9
6019286|NCT00791778|20807747|P1|Double-blind Treatment|Withdrawal by Subject|20
6019287|NCT00791778|20807746|P2|Double-blind Treatment|Protocol Violation|4
6019288|NCT00791778|20807747|P1|Double-blind Treatment|Protocol Violation|0
6019289|NCT00791778|20807746|P2|Double-blind Treatment|Physician Decision|26
6019290|NCT00791778|20807747|P1|Double-blind Treatment|Physician Decision|6
6019291|NCT00791778|20807746|P2|Double-blind Treatment|Adverse Event|9
6019292|NCT00791778|20807747|P1|Double-blind Treatment|Adverse Event|49
6019293|NCT00791765|20807801|P2|Weeks 13 to 24|Other|1
6019294|NCT00791765|20807802|P1|Weeks 13 to 24|Other|0
6019295|NCT00791765|20807801|P2|Weeks 13 to 24|Lost to Follow-up|2
6019296|NCT00791765|20807802|P1|Weeks 13 to 24|Lost to Follow-up|1
6019297|NCT00791765|20807801|P2|Weeks 13 to 24|Disease progression|1
6019298|NCT00791765|20807802|P1|Weeks 13 to 24|Disease progression|0
6019299|NCT00791765|20807801|P2|Weeks 13 to 24|Withdrawal by Subject|1
6019300|NCT00791765|20807802|P1|Weeks 13 to 24|Withdrawal by Subject|2
6019301|NCT00791765|20807801|P2|Weeks 13 to 24|Adverse Event|3
6019302|NCT00791765|20807802|P1|Weeks 13 to 24|Adverse Event|0
6019303|NCT00791765|20807801|P2|Weeks 13 to 24|Protocol deviation|0
6019304|NCT00791765|20807802|P1|Weeks 13 to 24|Protocol deviation|2
6019305|NCT00791765|20807801|P2|Weeks 1 to 12|Ineligibility determined|3
6019306|NCT00791765|20807802|P1|Weeks 1 to 12|Ineligibility determined|0
6019307|NCT00791765|20807801|P2|Weeks 1 to 12|Disease progression|0
6019308|NCT00791765|20807802|P1|Weeks 1 to 12|Disease progression|3
6019309|NCT00791765|20807801|P2|Weeks 1 to 12|Physician Decision|0
6019310|NCT00791765|20807802|P1|Weeks 1 to 12|Physician Decision|1
6019311|NCT00791765|20807801|P2|Weeks 1 to 12|Withdrawal by Subject|0
6019312|NCT00791765|20807802|P1|Weeks 1 to 12|Withdrawal by Subject|3
6019313|NCT00791765|20807801|P2|Weeks 1 to 12|Lost to Follow-up|0
6019314|NCT00791765|20807802|P1|Weeks 1 to 12|Lost to Follow-up|1
6019315|NCT00791765|20807801|P2|Weeks 1 to 12|Adverse Event|1
6019316|NCT00791765|20807802|P1|Weeks 1 to 12|Adverse Event|0
6019317|NCT00791700|20807817|P4|Overall Study|Adverse Event|1
6019318|NCT00791700|20807818|P3|Overall Study|Adverse Event|1
6019319|NCT00791700|20807819|P2|Overall Study|Adverse Event|0
6019320|NCT00791700|20807820|P1|Overall Study|Adverse Event|0
6019321|NCT00791700|20807817|P4|Overall Study|Lost to Follow-up|6
6019322|NCT00791700|20807818|P3|Overall Study|Lost to Follow-up|4
6019323|NCT00791700|20807819|P2|Overall Study|Lost to Follow-up|3
6019324|NCT00791700|20807820|P1|Overall Study|Lost to Follow-up|4
6019325|NCT00791700|20807817|P4|Overall Study|Death|1
6019326|NCT00791700|20807818|P3|Overall Study|Death|0
6019327|NCT00791700|20807819|P2|Overall Study|Death|0
6019328|NCT00791700|20807820|P1|Overall Study|Death|0
6019329|NCT00791700|20807817|P4|Overall Study|Other|1
6019330|NCT00791700|20807818|P3|Overall Study|Other|0
6019331|NCT00791700|20807819|P2|Overall Study|Other|1
6019332|NCT00791700|20807820|P1|Overall Study|Other|0
6019333|NCT00791700|20807817|P4|Overall Study|Withdrawn due to pregnancy|1
6019334|NCT00791700|20807818|P3|Overall Study|Withdrawn due to pregnancy|0
6019335|NCT00791700|20807819|P2|Overall Study|Withdrawn due to pregnancy|0
6019336|NCT00791700|20807820|P1|Overall Study|Withdrawn due to pregnancy|0
6019337|NCT00791700|20807817|P4|Overall Study|Non-compliance with study treatment|4
6019338|NCT00791700|20807818|P3|Overall Study|Non-compliance with study treatment|0
6019339|NCT00791700|20807819|P2|Overall Study|Non-compliance with study treatment|2
6019340|NCT00791700|20807820|P1|Overall Study|Non-compliance with study treatment|0
6019341|NCT00791700|20807817|P4|Overall Study|No longer willing to participate|8
6019342|NCT00791700|20807818|P3|Overall Study|No longer willing to participate|0
6019343|NCT00791700|20807819|P2|Overall Study|No longer willing to participate|1
6019344|NCT00791700|20807820|P1|Overall Study|No longer willing to participate|1
6019345|NCT00791700|20807817|P4|Overall Study|Insufficient clinical response|8
6019346|NCT00791700|20807818|P3|Overall Study|Insufficient clinical response|1
6019347|NCT00791700|20807819|P2|Overall Study|Insufficient clinical response|4
6019348|NCT00791700|20807820|P1|Overall Study|Insufficient clinical response|1
6019349|NCT00791661|20807908|P3|7 Day Wash-out|Abnormal Clinical Laboratory Test|1
6019350|NCT00791661|20807909|P2|7 Day Wash-out|Abnormal Clinical Laboratory Test|0
6019351|NCT00791661|20807910|P1|7 Day Wash-out|Abnormal Clinical Laboratory Test|0
6019352|NCT00791661|20807908|P3|7 Day Wash-out|Adverse Event|1
6019353|NCT00791661|20807909|P2|7 Day Wash-out|Adverse Event|0
6019354|NCT00791661|20807910|P1|7 Day Wash-out|Adverse Event|0
6019355|NCT00791648|20808003|P2|Overall Study|Withdrawal by Subject|1
6019356|NCT00791648|20808004|P1|Overall Study|Withdrawal by Subject|0
6019357|NCT00791648|20808003|P2|Overall Study|Physician Decision|1
6019358|NCT00791648|20808004|P1|Overall Study|Physician Decision|0
6019359|NCT00791557|20808040|P1|Overall Study|Adverse Event|1
6019360|NCT00791518|20808044|P1|Overall Study|Protocol Violation|93
6019361|NCT00791492|20808072|P2|Overall Study|Liver transplantation|1
6019362|NCT00791492|20808073|P1|Overall Study|Liver transplantation|5
6019363|NCT00791492|20808072|P2|Overall Study|Withdrawal by Subject|2
6019364|NCT00791492|20808073|P1|Overall Study|Withdrawal by Subject|1
6019365|NCT00791479|20808121|P6|Overall Study|Withdrawal by Subject|1
6019366|NCT00791479|20808122|P5|Overall Study|Withdrawal by Subject|0
6019367|NCT00791479|20808123|P4|Overall Study|Withdrawal by Subject|1
6019368|NCT00791479|20808124|P3|Overall Study|Withdrawal by Subject|0
6019369|NCT00791479|20808125|P2|Overall Study|Withdrawal by Subject|0
6019370|NCT00791479|20808126|P1|Overall Study|Withdrawal by Subject|0
6019371|NCT00791479|20808121|P6|Overall Study|Protocol Violation|0
6019372|NCT00791479|20808122|P5|Overall Study|Protocol Violation|0
6019373|NCT00791479|20808123|P4|Overall Study|Protocol Violation|1
6019374|NCT00791479|20808124|P3|Overall Study|Protocol Violation|0
6019375|NCT00791479|20808125|P2|Overall Study|Protocol Violation|1
6019376|NCT00791479|20808126|P1|Overall Study|Protocol Violation|2
6019377|NCT00791479|20808121|P6|Overall Study|Lost to Follow-up|1
6019378|NCT00791479|20808122|P5|Overall Study|Lost to Follow-up|0
6019379|NCT00791479|20808123|P4|Overall Study|Lost to Follow-up|0
6019380|NCT00791479|20808124|P3|Overall Study|Lost to Follow-up|0
6019381|NCT00791479|20808125|P2|Overall Study|Lost to Follow-up|1
6019382|NCT00791479|20808126|P1|Overall Study|Lost to Follow-up|0
6019383|NCT00791479|20808121|P6|Overall Study|Adverse Event|1
6019384|NCT00791479|20808122|P5|Overall Study|Adverse Event|0
6019385|NCT00791479|20808123|P4|Overall Study|Adverse Event|2
6019386|NCT00791479|20808124|P3|Overall Study|Adverse Event|0
6019387|NCT00791479|20808125|P2|Overall Study|Adverse Event|1
6019388|NCT00791479|20808126|P1|Overall Study|Adverse Event|0
6019389|NCT00791479|20808121|P6|Overall Study|Dose Discontinued per Sponsor Decision|0
6019390|NCT00791479|20808122|P5|Overall Study|Dose Discontinued per Sponsor Decision|3
6019391|NCT00791479|20808123|P4|Overall Study|Dose Discontinued per Sponsor Decision|0
6019392|NCT00791479|20808124|P3|Overall Study|Dose Discontinued per Sponsor Decision|0
6019393|NCT00791479|20808125|P2|Overall Study|Dose Discontinued per Sponsor Decision|0
6019394|NCT00791479|20808126|P1|Overall Study|Dose Discontinued per Sponsor Decision|0
6019395|NCT00791388|20808225|P5|Period 4 - 400 mg Dose Group|Adverse Event|4
6019396|NCT00791388|20808226|P4|Period 4 - 400 mg Dose Group|Adverse Event|0
6019397|NCT00791388|20808227|P3|Period 4 - 400 mg Dose Group|Adverse Event|0
6019398|NCT00791388|20808228|P2|Period 4 - 400 mg Dose Group|Adverse Event|0
6019399|NCT00791388|20808229|P1|Period 4 - 400 mg Dose Group|Adverse Event|0
6019400|NCT00791388|20808225|P5|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0
6019401|NCT00791388|20808226|P4|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0
6019402|NCT00791388|20808227|P3|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0
6019403|NCT00791388|20808228|P2|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0
6019404|NCT00791388|20808229|P1|Period 2 - 100 mg Dose Group|Withdrawal by Subject|1
6019405|NCT00791388|20808225|P5|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0
6019406|NCT00791388|20808226|P4|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0
6019407|NCT00791388|20808227|P3|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0
6019408|NCT00791388|20808228|P2|Period 1 - 50 mg Dose Group|Withdrawal by Subject|1
6019409|NCT00791388|20808229|P1|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0
6019410|NCT00791258|20808271|P1|Overall Study|Lack of Efficacy|1
6019411|NCT00791258|20808271|P1|Overall Study|Subject required restricted medication|1
6019412|NCT00791258|20808271|P1|Overall Study|Subject incarcerated|1
6019413|NCT00791258|20808271|P1|Overall Study|non-compliance|3
6019414|NCT00791258|20808271|P1|Overall Study|subject left area|2
6019415|NCT00791258|20808271|P1|Overall Study|Did not take medication for >3 days|1
6019416|NCT00791258|20808271|P1|Overall Study|Withdrawal by Subject|40
6019417|NCT00791258|20808271|P1|Overall Study|Protocol Violation|109
6019418|NCT00791258|20808271|P1|Overall Study|Lost to Follow-up|18
6019419|NCT00791258|20808271|P1|Overall Study|Adverse Event|87
6019420|NCT00791128|20808364|P1|Overall Study|abdominal tumor, unrelated to device|1
6019421|NCT00791128|20808364|P1|Overall Study|non-compliance by subject|2
6019422|NCT00791128|20808364|P1|Overall Study|Device migration|2
6019423|NCT00791128|20808364|P1|Overall Study|Adverse Event|4
6019424|NCT00791076|20808395|P1|Overall Study|Study was terminated,PI left institution|8
6019425|NCT00790933|20808415|P5|Overall Study|Reason Not Specified|9
6019426|NCT00790933|20808416|P4|Overall Study|Reason Not Specified|1
6019427|NCT00790933|20808417|P3|Overall Study|Reason Not Specified|4
6019428|NCT00790933|20808418|P2|Overall Study|Reason Not Specified|16
6019429|NCT00790933|20808419|P1|Overall Study|Reason Not Specified|8
6019430|NCT00790933|20808415|P5|Overall Study|Lost to Follow-up|15
6019431|NCT00790933|20808416|P4|Overall Study|Lost to Follow-up|1
6019432|NCT00790933|20808417|P3|Overall Study|Lost to Follow-up|10
6019433|NCT00790933|20808418|P2|Overall Study|Lost to Follow-up|31
6019434|NCT00790933|20808419|P1|Overall Study|Lost to Follow-up|13
6019435|NCT00790933|20808415|P5|Overall Study|Withdrawal by Subject|50
6019436|NCT00790933|20808416|P4|Overall Study|Withdrawal by Subject|6
6019437|NCT00790933|20808417|P3|Overall Study|Withdrawal by Subject|52
6019438|NCT00790933|20808418|P2|Overall Study|Withdrawal by Subject|120
6019439|NCT00790933|20808419|P1|Overall Study|Withdrawal by Subject|123
6019440|NCT00790933|20808415|P5|Overall Study|Study Terminated by Sponsor|0
6019441|NCT00790933|20808416|P4|Overall Study|Study Terminated by Sponsor|0
6019442|NCT00790933|20808417|P3|Overall Study|Study Terminated by Sponsor|1
6019443|NCT00790933|20808418|P2|Overall Study|Study Terminated by Sponsor|0
6019444|NCT00790933|20808419|P1|Overall Study|Study Terminated by Sponsor|0
6019445|NCT00790933|20808415|P5|Overall Study|Lack of Efficacy|121
6019446|NCT00790933|20808416|P4|Overall Study|Lack of Efficacy|1
6019447|NCT00790933|20808417|P3|Overall Study|Lack of Efficacy|130
6019448|NCT00790933|20808418|P2|Overall Study|Lack of Efficacy|176
6019449|NCT00790933|20808419|P1|Overall Study|Lack of Efficacy|192
6019450|NCT00790933|20808415|P5|Overall Study|Protocol Violation(s)|12
6019451|NCT00790933|20808416|P4|Overall Study|Protocol Violation(s)|0
6019452|NCT00790933|20808417|P3|Overall Study|Protocol Violation(s)|7
6019453|NCT00790933|20808418|P2|Overall Study|Protocol Violation(s)|18
6019454|NCT00790933|20808419|P1|Overall Study|Protocol Violation(s)|8
6019455|NCT00790933|20808415|P5|Overall Study|Adverse Event|69
6019456|NCT00790933|20808416|P4|Overall Study|Adverse Event|5
6019457|NCT00790933|20808417|P3|Overall Study|Adverse Event|65
6019458|NCT00790933|20808418|P2|Overall Study|Adverse Event|119
6019459|NCT00790933|20808419|P1|Overall Study|Adverse Event|94
6019460|NCT00790907|20808950|P3|Overall Study|Did Not Receive Study Drug|0
6019461|NCT00790907|20808951|P2|Overall Study|Did Not Receive Study Drug|0
6019462|NCT00790907|20808952|P1|Overall Study|Did Not Receive Study Drug|10
6019463|NCT00790907|20808950|P3|Overall Study|Verbatim Reason on the Case Report Form|29
6019464|NCT00790907|20808951|P2|Overall Study|Verbatim Reason on the Case Report Form|20
6019465|NCT00790907|20808952|P1|Overall Study|Verbatim Reason on the Case Report Form|74
6019466|NCT00790907|20808950|P3|Overall Study|Qualifying Condition Not Present|16
6019467|NCT00790907|20808951|P2|Overall Study|Qualifying Condition Not Present|14
6019468|NCT00790907|20808952|P1|Overall Study|Qualifying Condition Not Present|29
6019469|NCT00790907|20808950|P3|Overall Study|Required Protocol-prohibited Therapy|7
6019470|NCT00790907|20808951|P2|Overall Study|Required Protocol-prohibited Therapy|5
6019471|NCT00790907|20808952|P1|Overall Study|Required Protocol-prohibited Therapy|17
6019472|NCT00790907|20808950|P3|Overall Study|Bleeding Event|21
6019473|NCT00790907|20808951|P2|Overall Study|Bleeding Event|16
6019474|NCT00790907|20808952|P1|Overall Study|Bleeding Event|11
6019475|NCT00790907|20808950|P3|Overall Study|Withdrawal by Subject|5
6019476|NCT00790907|20808951|P2|Overall Study|Withdrawal by Subject|7
6019477|NCT00790907|20808952|P1|Overall Study|Withdrawal by Subject|1
6019478|NCT00790907|20808950|P3|Overall Study|Physician Decision|255
6019479|NCT00790907|20808951|P2|Overall Study|Physician Decision|271
6019480|NCT00790907|20808952|P1|Overall Study|Physician Decision|304
6019481|NCT00790907|20808950|P3|Overall Study|Adverse Event|6
6019482|NCT00790907|20808951|P2|Overall Study|Adverse Event|7
6019483|NCT00790907|20808952|P1|Overall Study|Adverse Event|9
6019484|NCT00790868|20808975|P2|Overall Study|Lost to Follow-up|12
6019485|NCT00790868|20808976|P1|Overall Study|Lost to Follow-up|2
6019486|NCT00790868|20808975|P2|Overall Study|Withdrawal by Subject|5
6019487|NCT00790868|20808976|P1|Overall Study|Withdrawal by Subject|4
6019488|NCT00790842|20808998|P11|Expansion Cohort|Study Closure|0
6019489|NCT00790842|20808999|P10|Expansion Cohort|Study Closure|0
6019490|NCT00790842|20809000|P9|Expansion Cohort|Study Closure|0
6019491|NCT00790842|20809001|P8|Expansion Cohort|Study Closure|0
6019492|NCT00790842|20809002|P7|Expansion Cohort|Study Closure|0
6019493|NCT00790842|20809003|P6|Expansion Cohort|Study Closure|0
6019494|NCT00790842|20809004|P5|Expansion Cohort|Study Closure|0
6019495|NCT00790842|20809005|P4|Expansion Cohort|Study Closure|0
6019496|NCT00790842|20809006|P3|Expansion Cohort|Study Closure|1
6019497|NCT00790842|20809007|P2|Expansion Cohort|Study Closure|0
6019498|NCT00790842|20809008|P1|Expansion Cohort|Study Closure|0
6019499|NCT00790842|20808998|P11|Expansion Cohort|Withdrawal by Subject|0
6019500|NCT00790842|20808999|P10|Expansion Cohort|Withdrawal by Subject|0
6019501|NCT00790842|20809000|P9|Expansion Cohort|Withdrawal by Subject|0
6019502|NCT00790842|20809001|P8|Expansion Cohort|Withdrawal by Subject|0
6019503|NCT00790842|20809002|P7|Expansion Cohort|Withdrawal by Subject|0
6019504|NCT00790842|20809003|P6|Expansion Cohort|Withdrawal by Subject|0
6019505|NCT00790842|20809004|P5|Expansion Cohort|Withdrawal by Subject|0
6019506|NCT00790842|20809005|P4|Expansion Cohort|Withdrawal by Subject|0
6019507|NCT00790842|20809006|P3|Expansion Cohort|Withdrawal by Subject|3
6019508|NCT00790842|20809007|P2|Expansion Cohort|Withdrawal by Subject|0
6019509|NCT00790842|20809008|P1|Expansion Cohort|Withdrawal by Subject|0
6019510|NCT00790842|20808998|P11|Expansion Cohort|Physician Decision|0
6019511|NCT00790842|20808999|P10|Expansion Cohort|Physician Decision|0
6019512|NCT00790842|20809000|P9|Expansion Cohort|Physician Decision|0
6019513|NCT00790842|20809001|P8|Expansion Cohort|Physician Decision|0
6019514|NCT00790842|20809002|P7|Expansion Cohort|Physician Decision|0
6019515|NCT00790842|20809003|P6|Expansion Cohort|Physician Decision|0
6019516|NCT00790842|20809004|P5|Expansion Cohort|Physician Decision|0
6019517|NCT00790842|20809005|P4|Expansion Cohort|Physician Decision|0
6019518|NCT00790842|20809006|P3|Expansion Cohort|Physician Decision|1
6019519|NCT00790842|20809007|P2|Expansion Cohort|Physician Decision|0
6019520|NCT00790842|20809008|P1|Expansion Cohort|Physician Decision|0
6019521|NCT00790842|20808998|P11|Expansion Cohort|Death|0
6019522|NCT00790842|20808999|P10|Expansion Cohort|Death|0
6019523|NCT00790842|20809000|P9|Expansion Cohort|Death|0
6019524|NCT00790842|20809001|P8|Expansion Cohort|Death|0
6019525|NCT00790842|20809002|P7|Expansion Cohort|Death|0
6019526|NCT00790842|20809003|P6|Expansion Cohort|Death|0
6019527|NCT00790842|20809004|P5|Expansion Cohort|Death|0
6019528|NCT00790842|20809005|P4|Expansion Cohort|Death|0
6019529|NCT00790842|20809006|P3|Expansion Cohort|Death|2
6019530|NCT00790842|20809007|P2|Expansion Cohort|Death|0
6019531|NCT00790842|20809008|P1|Expansion Cohort|Death|0
6019532|NCT00790842|20808998|P11|Expansion Cohort|Adverse Event|0
6019533|NCT00790842|20808999|P10|Expansion Cohort|Adverse Event|0
6019534|NCT00790842|20809000|P9|Expansion Cohort|Adverse Event|0
6019535|NCT00790842|20809001|P8|Expansion Cohort|Adverse Event|0
6019536|NCT00790842|20809002|P7|Expansion Cohort|Adverse Event|1
6019537|NCT00790842|20809003|P6|Expansion Cohort|Adverse Event|0
6019538|NCT00790842|20809004|P5|Expansion Cohort|Adverse Event|0
6019539|NCT00790842|20809005|P4|Expansion Cohort|Adverse Event|0
6019540|NCT00790842|20809006|P3|Expansion Cohort|Adverse Event|0
6019541|NCT00790842|20809007|P2|Expansion Cohort|Adverse Event|0
6019542|NCT00790842|20809008|P1|Expansion Cohort|Adverse Event|0
6019543|NCT00790842|20808998|P11|Dose Level 4|Withdrawal by Subject|1
6019544|NCT00790842|20808999|P10|Dose Level 4|Withdrawal by Subject|0
6019545|NCT00790842|20809000|P9|Dose Level 4|Withdrawal by Subject|0
6019546|NCT00790842|20809001|P8|Dose Level 4|Withdrawal by Subject|0
6019547|NCT00790842|20809002|P7|Dose Level 4|Withdrawal by Subject|0
6019548|NCT00790842|20809003|P6|Dose Level 4|Withdrawal by Subject|0
6019549|NCT00790842|20809004|P5|Dose Level 4|Withdrawal by Subject|0
6019550|NCT00790842|20809005|P4|Dose Level 4|Withdrawal by Subject|0
6019551|NCT00790842|20809006|P3|Dose Level 4|Withdrawal by Subject|0
6019552|NCT00790842|20809007|P2|Dose Level 4|Withdrawal by Subject|0
6019553|NCT00790842|20809008|P1|Dose Level 4|Withdrawal by Subject|0
6019554|NCT00790842|20808998|P11|Dose Level 4|Physician Decision|1
6019555|NCT00790842|20808999|P10|Dose Level 4|Physician Decision|0
6019556|NCT00790842|20809000|P9|Dose Level 4|Physician Decision|0
6019557|NCT00790842|20809001|P8|Dose Level 4|Physician Decision|0
6019558|NCT00790842|20809002|P7|Dose Level 4|Physician Decision|1
6019559|NCT00790842|20809003|P6|Dose Level 4|Physician Decision|0
6019560|NCT00790842|20809004|P5|Dose Level 4|Physician Decision|0
6019561|NCT00790842|20809005|P4|Dose Level 4|Physician Decision|0
6019562|NCT00790842|20809006|P3|Dose Level 4|Physician Decision|0
6019563|NCT00790842|20809007|P2|Dose Level 4|Physician Decision|0
6019564|NCT00790842|20809008|P1|Dose Level 4|Physician Decision|0
6019565|NCT00790842|20808998|P11|Dose Level 4|Adverse Event|0
6019566|NCT00790842|20808999|P10|Dose Level 4|Adverse Event|0
6019567|NCT00790842|20809000|P9|Dose Level 4|Adverse Event|0
6019568|NCT00790842|20809001|P8|Dose Level 4|Adverse Event|0
6019569|NCT00790842|20809002|P7|Dose Level 4|Adverse Event|1
6019570|NCT00790842|20809003|P6|Dose Level 4|Adverse Event|0
6019571|NCT00790842|20809004|P5|Dose Level 4|Adverse Event|0
6019572|NCT00790842|20809005|P4|Dose Level 4|Adverse Event|0
6019573|NCT00790842|20809006|P3|Dose Level 4|Adverse Event|0
6019574|NCT00790842|20809007|P2|Dose Level 4|Adverse Event|0
6019575|NCT00790842|20809008|P1|Dose Level 4|Adverse Event|0
6019576|NCT00790842|20808998|P11|Dose Level 3|Ineligible/Withdrew before Treatment|0
6019577|NCT00790842|20808999|P10|Dose Level 3|Ineligible/Withdrew before Treatment|0
6019578|NCT00790842|20809000|P9|Dose Level 3|Ineligible/Withdrew before Treatment|0
6019579|NCT00790842|20809001|P8|Dose Level 3|Ineligible/Withdrew before Treatment|0
6019580|NCT00790842|20809002|P7|Dose Level 3|Ineligible/Withdrew before Treatment|0
6019581|NCT00790842|20809003|P6|Dose Level 3|Ineligible/Withdrew before Treatment|0
6019582|NCT00790842|20809004|P5|Dose Level 3|Ineligible/Withdrew before Treatment|0
6019583|NCT00790842|20809005|P4|Dose Level 3|Ineligible/Withdrew before Treatment|0
6019584|NCT00790842|20809006|P3|Dose Level 3|Ineligible/Withdrew before Treatment|1
6019585|NCT00790842|20809007|P2|Dose Level 3|Ineligible/Withdrew before Treatment|0
6019586|NCT00790842|20809008|P1|Dose Level 3|Ineligible/Withdrew before Treatment|0
6019587|NCT00790842|20808998|P11|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
6019588|NCT00790842|20808999|P10|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
6019589|NCT00790842|20809000|P9|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
6019590|NCT00790842|20809001|P8|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
6019591|NCT00790842|20809002|P7|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
6019592|NCT00790842|20809003|P6|Dose Level 3|Intercurrent Illness/Alternative Therapy|1
6019593|NCT00790842|20809004|P5|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
6019594|NCT00790842|20809005|P4|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
6019595|NCT00790842|20809006|P3|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
6019596|NCT00790842|20809007|P2|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
6019597|NCT00790842|20809008|P1|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
6019598|NCT00790842|20808998|P11|Dose Level 3|Withdrawal by Subject|0
6019599|NCT00790842|20808999|P10|Dose Level 3|Withdrawal by Subject|2
6019600|NCT00790842|20809000|P9|Dose Level 3|Withdrawal by Subject|0
6019601|NCT00790842|20809001|P8|Dose Level 3|Withdrawal by Subject|0
6019602|NCT00790842|20809002|P7|Dose Level 3|Withdrawal by Subject|0
6019603|NCT00790842|20809003|P6|Dose Level 3|Withdrawal by Subject|0
6019604|NCT00790842|20809004|P5|Dose Level 3|Withdrawal by Subject|0
6019605|NCT00790842|20809005|P4|Dose Level 3|Withdrawal by Subject|0
6019606|NCT00790842|20809006|P3|Dose Level 3|Withdrawal by Subject|3
6019607|NCT00790842|20809007|P2|Dose Level 3|Withdrawal by Subject|0
6019608|NCT00790842|20809008|P1|Dose Level 3|Withdrawal by Subject|0
6019609|NCT00790842|20808998|P11|Dose Level 3|Adverse Event|0
6019610|NCT00790842|20808999|P10|Dose Level 3|Adverse Event|0
6019611|NCT00790842|20809000|P9|Dose Level 3|Adverse Event|0
6019612|NCT00790842|20809001|P8|Dose Level 3|Adverse Event|0
6019613|NCT00790842|20809002|P7|Dose Level 3|Adverse Event|0
6019614|NCT00790842|20809003|P6|Dose Level 3|Adverse Event|0
6019615|NCT00790842|20809004|P5|Dose Level 3|Adverse Event|0
6019616|NCT00790842|20809005|P4|Dose Level 3|Adverse Event|0
6019617|NCT00790842|20809006|P3|Dose Level 3|Adverse Event|1
6019618|NCT00790842|20809007|P2|Dose Level 3|Adverse Event|0
6019619|NCT00790842|20809008|P1|Dose Level 3|Adverse Event|0
6019620|NCT00790842|20808998|P11|Dose Level 2|Intercurrent Illness/Other Treatment|0
6019621|NCT00790842|20808999|P10|Dose Level 2|Intercurrent Illness/Other Treatment|0
6019622|NCT00790842|20809000|P9|Dose Level 2|Intercurrent Illness/Other Treatment|2
6019623|NCT00790842|20809001|P8|Dose Level 2|Intercurrent Illness/Other Treatment|0
6019624|NCT00790842|20809002|P7|Dose Level 2|Intercurrent Illness/Other Treatment|0
6019625|NCT00790842|20809003|P6|Dose Level 2|Intercurrent Illness/Other Treatment|0
6019626|NCT00790842|20809004|P5|Dose Level 2|Intercurrent Illness/Other Treatment|0
6019627|NCT00790842|20809005|P4|Dose Level 2|Intercurrent Illness/Other Treatment|0
6019628|NCT00790842|20809006|P3|Dose Level 2|Intercurrent Illness/Other Treatment|0
6019629|NCT00790842|20809007|P2|Dose Level 2|Intercurrent Illness/Other Treatment|0
6019630|NCT00790842|20809008|P1|Dose Level 2|Intercurrent Illness/Other Treatment|0
6019631|NCT00790842|20808998|P11|Dose Level 2|Withdrawal by Subject|0
6019632|NCT00790842|20808999|P10|Dose Level 2|Withdrawal by Subject|0
6019633|NCT00790842|20809000|P9|Dose Level 2|Withdrawal by Subject|0
6019634|NCT00790842|20809001|P8|Dose Level 2|Withdrawal by Subject|0
6019635|NCT00790842|20809002|P7|Dose Level 2|Withdrawal by Subject|0
6019636|NCT00790842|20809003|P6|Dose Level 2|Withdrawal by Subject|0
6019637|NCT00790842|20809004|P5|Dose Level 2|Withdrawal by Subject|0
6019638|NCT00790842|20809005|P4|Dose Level 2|Withdrawal by Subject|0
6019639|NCT00790842|20809006|P3|Dose Level 2|Withdrawal by Subject|0
6019640|NCT00790842|20809007|P2|Dose Level 2|Withdrawal by Subject|1
6019641|NCT00790842|20809008|P1|Dose Level 2|Withdrawal by Subject|0
6019642|NCT00790842|20808998|P11|Dose Level 2|Physician Decision|0
6019643|NCT00790842|20808999|P10|Dose Level 2|Physician Decision|0
6019644|NCT00790842|20809000|P9|Dose Level 2|Physician Decision|0
6019645|NCT00790842|20809001|P8|Dose Level 2|Physician Decision|0
6019646|NCT00790842|20809002|P7|Dose Level 2|Physician Decision|0
6019647|NCT00790842|20809003|P6|Dose Level 2|Physician Decision|0
6019648|NCT00790842|20809004|P5|Dose Level 2|Physician Decision|0
6019649|NCT00790842|20809005|P4|Dose Level 2|Physician Decision|0
6019650|NCT00790842|20809006|P3|Dose Level 2|Physician Decision|0
6019651|NCT00790842|20809007|P2|Dose Level 2|Physician Decision|1
6019652|NCT00790842|20809008|P1|Dose Level 2|Physician Decision|0
6019653|NCT00790842|20808998|P11|Dose Level 2|Death|0
6019654|NCT00790842|20808999|P10|Dose Level 2|Death|0
6019655|NCT00790842|20809000|P9|Dose Level 2|Death|0
6019656|NCT00790842|20809001|P8|Dose Level 2|Death|0
6019657|NCT00790842|20809002|P7|Dose Level 2|Death|0
6019658|NCT00790842|20809003|P6|Dose Level 2|Death|0
6019659|NCT00790842|20809004|P5|Dose Level 2|Death|1
6019660|NCT00790842|20809005|P4|Dose Level 2|Death|0
6019661|NCT00790842|20809006|P3|Dose Level 2|Death|0
6019662|NCT00790842|20809007|P2|Dose Level 2|Death|1
6019663|NCT00790842|20809008|P1|Dose Level 2|Death|0
6019664|NCT00790842|20808998|P11|Dose Level 1|Withdrawal by Subject|0
6019665|NCT00790842|20808999|P10|Dose Level 1|Withdrawal by Subject|0
6019666|NCT00790842|20809000|P9|Dose Level 1|Withdrawal by Subject|0
6019667|NCT00790842|20809001|P8|Dose Level 1|Withdrawal by Subject|0
6019668|NCT00790842|20809002|P7|Dose Level 1|Withdrawal by Subject|0
6019669|NCT00790842|20809003|P6|Dose Level 1|Withdrawal by Subject|0
6019670|NCT00790842|20809004|P5|Dose Level 1|Withdrawal by Subject|0
6019671|NCT00790842|20809005|P4|Dose Level 1|Withdrawal by Subject|0
6019672|NCT00790842|20809006|P3|Dose Level 1|Withdrawal by Subject|0
6019673|NCT00790842|20809007|P2|Dose Level 1|Withdrawal by Subject|0
6019674|NCT00790842|20809008|P1|Dose Level 1|Withdrawal by Subject|1
6019675|NCT00790842|20808998|P11|Dose Level 1|Physician Decision|0
6019676|NCT00790842|20808999|P10|Dose Level 1|Physician Decision|0
6019677|NCT00790842|20809000|P9|Dose Level 1|Physician Decision|0
6019678|NCT00790842|20809001|P8|Dose Level 1|Physician Decision|1
6019679|NCT00790842|20809002|P7|Dose Level 1|Physician Decision|0
6019680|NCT00790842|20809003|P6|Dose Level 1|Physician Decision|0
6019681|NCT00790842|20809004|P5|Dose Level 1|Physician Decision|0
6019682|NCT00790842|20809005|P4|Dose Level 1|Physician Decision|0
6019683|NCT00790842|20809006|P3|Dose Level 1|Physician Decision|0
6019684|NCT00790842|20809007|P2|Dose Level 1|Physician Decision|0
6019685|NCT00790842|20809008|P1|Dose Level 1|Physician Decision|1
6019686|NCT00790842|20808998|P11|Dose Level 1|Adverse Event|0
6019687|NCT00790842|20808999|P10|Dose Level 1|Adverse Event|0
6019688|NCT00790842|20809000|P9|Dose Level 1|Adverse Event|0
6019689|NCT00790842|20809001|P8|Dose Level 1|Adverse Event|1
6019690|NCT00790842|20809002|P7|Dose Level 1|Adverse Event|0
6019691|NCT00790842|20809003|P6|Dose Level 1|Adverse Event|0
6019692|NCT00790842|20809004|P5|Dose Level 1|Adverse Event|0
6019693|NCT00790842|20809005|P4|Dose Level 1|Adverse Event|2
6019694|NCT00790842|20809006|P3|Dose Level 1|Adverse Event|0
6019695|NCT00790842|20809007|P2|Dose Level 1|Adverse Event|0
6019696|NCT00790842|20809008|P1|Dose Level 1|Adverse Event|1
6019697|NCT00790790|20809076|P3|Study Period 2: Therapy Phase|Physician Decision|0
6019698|NCT00790790|20809077|P2|Study Period 2: Therapy Phase|Physician Decision|1
6019699|NCT00790790|20809078|P1|Study Period 2: Therapy Phase|Physician Decision|0
6019700|NCT00790790|20809076|P3|Study Period 2: Therapy Phase|Lack of Efficacy|3
6019701|NCT00790790|20809077|P2|Study Period 2: Therapy Phase|Lack of Efficacy|0
6019702|NCT00790790|20809078|P1|Study Period 2: Therapy Phase|Lack of Efficacy|1
6019703|NCT00790790|20809076|P3|Study Period 2: Therapy Phase|Withdrawal by Subject|2
6019704|NCT00790790|20809077|P2|Study Period 2: Therapy Phase|Withdrawal by Subject|0
6019705|NCT00790790|20809078|P1|Study Period 2: Therapy Phase|Withdrawal by Subject|7
6019706|NCT00790790|20809076|P3|Study Period 2: Therapy Phase|Protocol Violation|0
6019707|NCT00790790|20809077|P2|Study Period 2: Therapy Phase|Protocol Violation|1
6019708|NCT00790790|20809078|P1|Study Period 2: Therapy Phase|Protocol Violation|1
6019709|NCT00790790|20809076|P3|Study Period 2: Therapy Phase|Adverse Event|16
6019710|NCT00790790|20809077|P2|Study Period 2: Therapy Phase|Adverse Event|16
6019711|NCT00790790|20809078|P1|Study Period 2: Therapy Phase|Adverse Event|3
6019712|NCT00790751|20809155|P4|Overall Study|Physician Decision|1
6019713|NCT00790751|20809156|P3|Overall Study|Physician Decision|0
6019714|NCT00790751|20809157|P2|Overall Study|Physician Decision|0
6019715|NCT00790751|20809158|P1|Overall Study|Physician Decision|0
6019716|NCT00790751|20809155|P4|Overall Study|Death|0
6019717|NCT00790751|20809156|P3|Overall Study|Death|1
6019718|NCT00790751|20809157|P2|Overall Study|Death|0
6019719|NCT00790751|20809158|P1|Overall Study|Death|0
6019720|NCT00790751|20809155|P4|Overall Study|Requirement for restricted medication|0
6019721|NCT00790751|20809156|P3|Overall Study|Requirement for restricted medication|0
6019722|NCT00790751|20809157|P2|Overall Study|Requirement for restricted medication|2
6019723|NCT00790751|20809158|P1|Overall Study|Requirement for restricted medication|0
6019724|NCT00790751|20809155|P4|Overall Study|Adverse Event|4
6019725|NCT00790751|20809156|P3|Overall Study|Adverse Event|5
6019726|NCT00790751|20809157|P2|Overall Study|Adverse Event|3
6019727|NCT00790751|20809158|P1|Overall Study|Adverse Event|5
6019728|NCT00790751|20809155|P4|Overall Study|Lost to Follow-up|5
6019729|NCT00790751|20809156|P3|Overall Study|Lost to Follow-up|4
6019730|NCT00790751|20809157|P2|Overall Study|Lost to Follow-up|9
6019731|NCT00790751|20809158|P1|Overall Study|Lost to Follow-up|4
6019732|NCT00790751|20809155|P4|Overall Study|Protocol non-compliance|11
6019733|NCT00790751|20809156|P3|Overall Study|Protocol non-compliance|10
6019734|NCT00790751|20809157|P2|Overall Study|Protocol non-compliance|16
6019735|NCT00790751|20809158|P1|Overall Study|Protocol non-compliance|16
6019736|NCT00790647|20809217|P1|Overall Study|Adverse Event|1
6019737|NCT00790582|20809226|P2|Overall Study|Withdrawal by Subject|51
6019738|NCT00790582|20809227|P1|Overall Study|Withdrawal by Subject|7
6019739|NCT00790582|20809226|P2|Overall Study|Lost to Follow-up|3
6019740|NCT00790582|20809227|P1|Overall Study|Lost to Follow-up|3
6019741|NCT00790582|20809226|P2|Overall Study|Physician Decision|1
6019742|NCT00790582|20809227|P1|Overall Study|Physician Decision|7
6019743|NCT00790582|20809226|P2|Overall Study|Death|32
6019744|NCT00790582|20809227|P1|Overall Study|Death|14
6019745|NCT00790569|20809238|P3|End of Study (12 Month Interview)|Lost to Follow-up|50
6019746|NCT00790569|20809239|P2|End of Study (12 Month Interview)|Lost to Follow-up|19
6019747|NCT00790569|20809240|P1|End of Study (12 Month Interview)|Lost to Follow-up|66
6019748|NCT00790569|20809238|P3|End of Treatment (6 Month Interview)|Incarcerated|3
6019749|NCT00790569|20809239|P2|End of Treatment (6 Month Interview)|Incarcerated|0
6019750|NCT00790569|20809240|P1|End of Treatment (6 Month Interview)|Incarcerated|0
6019751|NCT00790569|20809238|P3|End of Treatment (6 Month Interview)|Residential Treatment|2
6019752|NCT00790569|20809239|P2|End of Treatment (6 Month Interview)|Residential Treatment|0
6019753|NCT00790569|20809240|P1|End of Treatment (6 Month Interview)|Residential Treatment|0
6019754|NCT00790569|20809238|P3|End of Treatment (6 Month Interview)|Hospitalized|0
6019755|NCT00790569|20809239|P2|End of Treatment (6 Month Interview)|Hospitalized|0
6019756|NCT00790569|20809240|P1|End of Treatment (6 Month Interview)|Hospitalized|2
6019757|NCT00790569|20809238|P3|End of Treatment (6 Month Interview)|Death|1
6019758|NCT00790569|20809239|P2|End of Treatment (6 Month Interview)|Death|2
6019759|NCT00790569|20809240|P1|End of Treatment (6 Month Interview)|Death|0
6019760|NCT00790569|20809238|P3|End of Treatment (6 Month Interview)|Lost to Follow-up|20
6019761|NCT00790569|20809239|P2|End of Treatment (6 Month Interview)|Lost to Follow-up|8
6019762|NCT00790569|20809240|P1|End of Treatment (6 Month Interview)|Lost to Follow-up|20
6019763|NCT00790556|20809281|P2|Treatment Period 1|Withdrawal by Subject|0
6019764|NCT00790556|20809282|P1|Treatment Period 1|Withdrawal by Subject|1
6019765|NCT00790556|20809281|P2|Treatment Period 1|Physician Decision|0
6019766|NCT00790556|20809282|P1|Treatment Period 1|Physician Decision|1
6019767|NCT00790452|20809294|P2|Overall Study|Drug supply issue|0
6019768|NCT00790452|20809295|P1|Overall Study|Drug supply issue|1
6019769|NCT00790400|20809303|P2|Everolimus Period (Core or Extension)|New treatment|0
6019770|NCT00790400|20809304|P1|Everolimus Period (Core or Extension)|New treatment|2
6019771|NCT00790400|20809303|P2|Everolimus Period (Core or Extension)|Protocol Violation|0
6019772|NCT00790400|20809304|P1|Everolimus Period (Core or Extension)|Protocol Violation|1
6019773|NCT00790400|20809303|P2|Everolimus Period (Core or Extension)|Disease progression|0
6019774|NCT00790400|20809304|P1|Everolimus Period (Core or Extension)|Disease progression|5
6019775|NCT00790400|20809303|P2|Everolimus Period (Core or Extension)|Death|0
6019776|NCT00790400|20809304|P1|Everolimus Period (Core or Extension)|Death|1
6019777|NCT00790400|20809303|P2|Everolimus Period (Core or Extension)|Administrative problems|0
6019778|NCT00790400|20809304|P1|Everolimus Period (Core or Extension)|Administrative problems|2
6019779|NCT00790400|20809303|P2|Everolimus Period (Core or Extension)|Lost to Follow-up|0
6019780|NCT00790400|20809304|P1|Everolimus Period (Core or Extension)|Lost to Follow-up|1
6019781|NCT00790400|20809303|P2|Everolimus Period (Core or Extension)|Withdrawal by Subject|0
6019782|NCT00790400|20809304|P1|Everolimus Period (Core or Extension)|Withdrawal by Subject|7
6019783|NCT00790400|20809303|P2|Everolimus Period (Core or Extension)|Abnormal lab value (s)|0
6019784|NCT00790400|20809304|P1|Everolimus Period (Core or Extension)|Abnormal lab value (s)|1
6019785|NCT00790400|20809303|P2|Everolimus Period (Core or Extension)|Adverse Event|0
6019786|NCT00790400|20809304|P1|Everolimus Period (Core or Extension)|Adverse Event|9
6019787|NCT00790400|20809303|P2|Double-blind Period (Core Phase)|Death|0
6019788|NCT00790400|20809304|P1|Double-blind Period (Core Phase)|Death|1
6019789|NCT00790400|20809303|P2|Double-blind Period (Core Phase)|Administrative problems|0
6019790|NCT00790400|20809304|P1|Double-blind Period (Core Phase)|Administrative problems|1
6019791|NCT00790400|20809303|P2|Double-blind Period (Core Phase)|Withdrawal by Subject|0
6019792|NCT00790400|20809304|P1|Double-blind Period (Core Phase)|Withdrawal by Subject|1
6019793|NCT00790400|20809303|P2|Double-blind Period (Core Phase)|Abnormal lab value (s)|0
6019794|NCT00790400|20809304|P1|Double-blind Period (Core Phase)|Abnormal lab value (s)|1
6019795|NCT00790400|20809303|P2|Double-blind Period (Core Phase)|Adverse Event|4
6019796|NCT00790400|20809304|P1|Double-blind Period (Core Phase)|Adverse Event|2
6019797|NCT00790400|20809303|P2|Double-blind Period (Core Phase)|Progressive disease|9
6019798|NCT00790400|20809304|P1|Double-blind Period (Core Phase)|Progressive disease|0
6019799|NCT00790400|20809303|P2|Double-blind Period (Core Phase)|Protocol Violation|0
6019800|NCT00790400|20809304|P1|Double-blind Period (Core Phase)|Protocol Violation|1
6019801|NCT00790296|20809394|P2|Overall Study|Adverse Event|1
6019802|NCT00790296|20809395|P1|Overall Study|Adverse Event|0
6019803|NCT00790296|20809394|P2|Overall Study|Did not meet study eligibility criteria|1
6019804|NCT00790296|20809395|P1|Overall Study|Did not meet study eligibility criteria|1
6019805|NCT00790218|20809417|P3|Overall Study|Death|0
6019806|NCT00790218|20809418|P2|Overall Study|Death|0
6019807|NCT00790218|20809419|P1|Overall Study|Death|1
6019808|NCT00790205|20809429|P2|Overall Study|Withdrawal by Subject|363
6019809|NCT00790205|20809430|P1|Overall Study|Withdrawal by Subject|299
6019810|NCT00790205|20809429|P2|Overall Study|Lost to Follow-up|71
6019811|NCT00790205|20809430|P1|Overall Study|Lost to Follow-up|61
6019812|NCT00790088|20809491|P1|Overall Study|Physician Decision|4
6019813|NCT00790088|20809491|P1|Overall Study|Lost to Follow-up|7
6019814|NCT00790088|20809491|P1|Overall Study|Withdrawal by Subject|17
6019815|NCT00790088|20809491|P1|Overall Study|Protocol Violation|11
6019816|NCT00790036|20809537|P2|Overall Study|Subject/guardian decision|7
6019817|NCT00790036|20809538|P1|Overall Study|Subject/guardian decision|20
6019818|NCT00790036|20809537|P2|Overall Study|Withdrawal by Subject|7
6019819|NCT00790036|20809538|P1|Overall Study|Withdrawal by Subject|18
6019820|NCT00790036|20809537|P2|Overall Study|Protocol Violation|2
6019821|NCT00790036|20809538|P1|Overall Study|Protocol Violation|10
6019822|NCT00790036|20809537|P2|Overall Study|Lost to Follow-up|2
6019823|NCT00790036|20809538|P1|Overall Study|Lost to Follow-up|1
6019824|NCT00790036|20809537|P2|Overall Study|Disease progression|48
6019825|NCT00790036|20809538|P1|Overall Study|Disease progression|24
6019826|NCT00790036|20809537|P2|Overall Study|Death|0
6019827|NCT00790036|20809538|P1|Overall Study|Death|1
6019828|NCT00790036|20809537|P2|Overall Study|Adverse Event|44
6019829|NCT00790036|20809538|P1|Overall Study|Adverse Event|113
6019830|NCT00790036|20809537|P2|Overall Study|Administrative problems|9
6019831|NCT00790036|20809538|P1|Overall Study|Administrative problems|5
6019832|NCT00790036|20809537|P2|Overall Study|Abnormal lab values|2
6019833|NCT00790036|20809538|P1|Overall Study|Abnormal lab values|3
6019834|NCT00790023|20809552|P3|Overall Study|Other|8
6019835|NCT00790023|20809553|P2|Overall Study|Other|5
6019836|NCT00790023|20809554|P1|Overall Study|Other|5
6019837|NCT00790023|20809552|P3|Overall Study|Lost to Follow-up|1
6019838|NCT00790023|20809553|P2|Overall Study|Lost to Follow-up|0
6019839|NCT00790023|20809554|P1|Overall Study|Lost to Follow-up|0
6019840|NCT00790023|20809552|P3|Overall Study|Withdrawal by Subject|6
6019841|NCT00790023|20809553|P2|Overall Study|Withdrawal by Subject|0
6019842|NCT00790023|20809554|P1|Overall Study|Withdrawal by Subject|2
6019843|NCT00790023|20809552|P3|Overall Study|Protocol Violation|2
6019844|NCT00790023|20809553|P2|Overall Study|Protocol Violation|4
6019845|NCT00790023|20809554|P1|Overall Study|Protocol Violation|2
6019846|NCT00790023|20809552|P3|Overall Study|Adverse Event|4
6019847|NCT00790023|20809553|P2|Overall Study|Adverse Event|1
6019848|NCT00790023|20809554|P1|Overall Study|Adverse Event|2
6019849|NCT00789958|20809653|P1|Overall Study|Not eligible/not analyzable|26
6019850|NCT00789958|20809653|P1|Overall Study|not protocol specified|1
6019851|NCT00789958|20809653|P1|Overall Study|Progression|3
6019852|NCT00789958|20809653|P1|Overall Study|Withdrawal by Subject|4
6019853|NCT00789958|20809653|P1|Overall Study|Adverse Event|3
6019854|NCT00789880|20809672|P6|Overall Study|Withdrawal by Subject|0
6019855|NCT00789880|20809673|P5|Overall Study|Withdrawal by Subject|2
6019856|NCT00789880|20809674|P4|Overall Study|Withdrawal by Subject|0
6019857|NCT00789880|20809675|P3|Overall Study|Withdrawal by Subject|0
6019858|NCT00789880|20809676|P2|Overall Study|Withdrawal by Subject|0
6019859|NCT00789880|20809677|P1|Overall Study|Withdrawal by Subject|1
6019860|NCT00789880|20809672|P6|Overall Study|Protocol Violation|0
6019861|NCT00789880|20809673|P5|Overall Study|Protocol Violation|0
6019862|NCT00789880|20809674|P4|Overall Study|Protocol Violation|1
6019863|NCT00789880|20809675|P3|Overall Study|Protocol Violation|0
6019864|NCT00789880|20809676|P2|Overall Study|Protocol Violation|1
6019865|NCT00789880|20809677|P1|Overall Study|Protocol Violation|0
6019866|NCT00789880|20809672|P6|Overall Study|Adverse Event|0
6019867|NCT00789880|20809673|P5|Overall Study|Adverse Event|1
6019868|NCT00789880|20809674|P4|Overall Study|Adverse Event|0
6019869|NCT00789880|20809675|P3|Overall Study|Adverse Event|0
6019870|NCT00789880|20809676|P2|Overall Study|Adverse Event|0
6019871|NCT00789880|20809677|P1|Overall Study|Adverse Event|0
6019872|NCT00789854|20809734|P3|Overall Study|Other|5
6019873|NCT00789854|20809735|P2|Overall Study|Other|0
6019874|NCT00789854|20809736|P1|Overall Study|Other|6
6019875|NCT00789854|20809734|P3|Overall Study|Safety reasons|2
6019876|NCT00789854|20809735|P2|Overall Study|Safety reasons|0
6019877|NCT00789854|20809736|P1|Overall Study|Safety reasons|0
6019878|NCT00789854|20809734|P3|Overall Study|Severe non-compliance to the protocol|0
6019879|NCT00789854|20809735|P2|Overall Study|Severe non-compliance to the protocol|0
6019880|NCT00789854|20809736|P1|Overall Study|Severe non-compliance to the protocol|3
6019881|NCT00789854|20809734|P3|Overall Study|Eligibility criteria not fulfilled|1
6019882|NCT00789854|20809735|P2|Overall Study|Eligibility criteria not fulfilled|5
6019883|NCT00789854|20809736|P1|Overall Study|Eligibility criteria not fulfilled|2
6019884|NCT00789854|20809734|P3|Overall Study|Withdrawal by Subject|17
6019885|NCT00789854|20809735|P2|Overall Study|Withdrawal by Subject|6
6019886|NCT00789854|20809736|P1|Overall Study|Withdrawal by Subject|9
6019887|NCT00789854|20809734|P3|Overall Study|Lost to Follow-up|4
6019888|NCT00789854|20809735|P2|Overall Study|Lost to Follow-up|1
6019889|NCT00789854|20809736|P1|Overall Study|Lost to Follow-up|1
6019890|NCT00789854|20809734|P3|Overall Study|Adverse Event|18
6019891|NCT00789854|20809735|P2|Overall Study|Adverse Event|23
6019892|NCT00789854|20809736|P1|Overall Study|Adverse Event|28
6019893|NCT00789828|20809833|P2|Open-label Extension Period (4 Years)|New treatment for indication under study|0
6019894|NCT00789828|20809834|P1|Open-label Extension Period (4 Years)|New treatment for indication under study|1
6019895|NCT00789828|20809833|P2|Open-label Extension Period (4 Years)|Disease progression|0
6019896|NCT00789828|20809834|P1|Open-label Extension Period (4 Years)|Disease progression|1
6019897|NCT00789828|20809833|P2|Open-label Extension Period (4 Years)|Death|0
6019898|NCT00789828|20809834|P1|Open-label Extension Period (4 Years)|Death|1
6019899|NCT00789828|20809833|P2|Open-label Extension Period (4 Years)|Administrative problems|0
6019900|NCT00789828|20809834|P1|Open-label Extension Period (4 Years)|Administrative problems|7
6019901|NCT00789828|20809833|P2|Open-label Extension Period (4 Years)|Lost to Follow-up|0
6019902|NCT00789828|20809834|P1|Open-label Extension Period (4 Years)|Lost to Follow-up|3
6019903|NCT00789828|20809833|P2|Open-label Extension Period (4 Years)|Withdrawal by Subject|0
6019904|NCT00789828|20809834|P1|Open-label Extension Period (4 Years)|Withdrawal by Subject|6
6019905|NCT00789828|20809833|P2|Open-label Extension Period (4 Years)|Adverse Event|0
6019906|NCT00789828|20809834|P1|Open-label Extension Period (4 Years)|Adverse Event|10
6019907|NCT00789828|20809833|P2|Core Period (48 Weeks)|Lost to Follow-up|1
6019908|NCT00789828|20809834|P1|Core Period (48 Weeks)|Lost to Follow-up|0
6019909|NCT00789828|20809833|P2|Core Period (48 Weeks)|Withdrawal by Subject|4
6019910|NCT00789828|20809834|P1|Core Period (48 Weeks)|Withdrawal by Subject|0
6019911|NCT00789828|20809833|P2|Core Period (48 Weeks)|Administrative problems|1
6019912|NCT00789828|20809834|P1|Core Period (48 Weeks)|Administrative problems|0
6019913|NCT00789815|20809868|P2|Overall Study|Intubation due to massive bleeding|0
6019914|NCT00789815|20809869|P1|Overall Study|Intubation due to massive bleeding|1
6019915|NCT00789815|20809868|P2|Overall Study|Protocol Violation|1
6019916|NCT00789815|20809869|P1|Overall Study|Protocol Violation|6
6019917|NCT00789737|20809979|P2|Overall Study|Other|7
6019918|NCT00789737|20809980|P1|Overall Study|Other|11
6019919|NCT00789737|20809979|P2|Overall Study|hyperglycemia that met protocol-specifie|4
6019920|NCT00789737|20809980|P1|Overall Study|hyperglycemia that met protocol-specifie|0
6019921|NCT00789737|20809979|P2|Overall Study|Lack of Efficacy|0
6019922|NCT00789737|20809980|P1|Overall Study|Lack of Efficacy|3
6019923|NCT00789737|20809979|P2|Overall Study|Protocol Violation|0
6019924|NCT00789737|20809980|P1|Overall Study|Protocol Violation|3
6019925|NCT00789737|20809979|P2|Overall Study|Adverse Event|8
6019926|NCT00789737|20809980|P1|Overall Study|Adverse Event|8
6019927|NCT00789737|20809979|P2|Overall Study|Lost to Follow-up|14
6019928|NCT00789737|20809980|P1|Overall Study|Lost to Follow-up|10
6019929|NCT00789737|20809979|P2|Overall Study|Withdrawal by Subject|22
6019930|NCT00789737|20809980|P1|Overall Study|Withdrawal by Subject|13
6019931|NCT00789698|20810023|P4|Overall Study|Administrative|1
6019932|NCT00789698|20810024|P3|Overall Study|Administrative|3
6019933|NCT00789698|20810025|P2|Overall Study|Administrative|3
6019934|NCT00789698|20810026|P1|Overall Study|Administrative|0
6019935|NCT00789698|20810023|P4|Overall Study|Withdrawal by Subject|19
6019936|NCT00789698|20810024|P3|Overall Study|Withdrawal by Subject|12
6019937|NCT00789698|20810025|P2|Overall Study|Withdrawal by Subject|15
6019938|NCT00789698|20810026|P1|Overall Study|Withdrawal by Subject|14
6019939|NCT00789698|20810023|P4|Overall Study|Protocol Violation|1
6019940|NCT00789698|20810024|P3|Overall Study|Protocol Violation|2
6019941|NCT00789698|20810025|P2|Overall Study|Protocol Violation|1
6019942|NCT00789698|20810026|P1|Overall Study|Protocol Violation|6
6019943|NCT00789698|20810023|P4|Overall Study|Lost to Follow-up|9
6019944|NCT00789698|20810024|P3|Overall Study|Lost to Follow-up|2
6019945|NCT00789698|20810025|P2|Overall Study|Lost to Follow-up|5
6019946|NCT00789698|20810026|P1|Overall Study|Lost to Follow-up|5
6019947|NCT00789698|20810023|P4|Overall Study|Adverse Event|4
6019948|NCT00789698|20810024|P3|Overall Study|Adverse Event|3
6019949|NCT00789698|20810025|P2|Overall Study|Adverse Event|5
6019950|NCT00789698|20810026|P1|Overall Study|Adverse Event|5
6019951|NCT00789698|20810023|P4|Overall Study|Lack of Efficacy|18
6019952|NCT00789698|20810024|P3|Overall Study|Lack of Efficacy|5
6019953|NCT00789698|20810025|P2|Overall Study|Lack of Efficacy|4
6019954|NCT00789698|20810026|P1|Overall Study|Lack of Efficacy|10
6019955|NCT00789581|20810081|P2|Adjuvant Therapy|Other|1
6019956|NCT00789581|20810082|P1|Adjuvant Therapy|Other|0
6019957|NCT00789581|20810081|P2|Adjuvant Therapy|Protocol Violation|1
6019958|NCT00789581|20810082|P1|Adjuvant Therapy|Protocol Violation|1
6019959|NCT00789581|20810081|P2|Adjuvant Therapy|Intercurrent Illness|3
6019960|NCT00789581|20810082|P1|Adjuvant Therapy|Intercurrent Illness|1
6019961|NCT00789581|20810081|P2|Adjuvant Therapy|Disease recurrence|1
6019962|NCT00789581|20810082|P1|Adjuvant Therapy|Disease recurrence|2
6019963|NCT00789581|20810081|P2|Adjuvant Therapy|Withdrawal by Subject|5
6019964|NCT00789581|20810082|P1|Adjuvant Therapy|Withdrawal by Subject|14
6019965|NCT00789581|20810081|P2|Adjuvant Therapy|Adverse Event|44
6019966|NCT00789581|20810082|P1|Adjuvant Therapy|Adverse Event|20
6019967|NCT00789581|20810081|P2|Adjuvant Therapy|Never treated|2
6019968|NCT00789581|20810082|P1|Adjuvant Therapy|Never treated|2
6019969|NCT00789581|20810081|P2|AC Therapy|Other|2
6019970|NCT00789581|20810082|P1|AC Therapy|Other|0
6019971|NCT00789581|20810081|P2|AC Therapy|Never Treated|4
6019972|NCT00789581|20810082|P1|AC Therapy|Never Treated|1
6019973|NCT00789581|20810081|P2|AC Therapy|Intercurrent Illness|0
6019974|NCT00789581|20810082|P1|AC Therapy|Intercurrent Illness|1
6019975|NCT00789581|20810081|P2|AC Therapy|Disease recurrence|1
6019976|NCT00789581|20810082|P1|AC Therapy|Disease recurrence|3
6019977|NCT00789581|20810081|P2|AC Therapy|Withdrawal by Subject|7
6019978|NCT00789581|20810082|P1|AC Therapy|Withdrawal by Subject|4
6019979|NCT00789581|20810081|P2|AC Therapy|Adverse Event|3
6019980|NCT00789581|20810082|P1|AC Therapy|Adverse Event|2
6019981|NCT00789555|20810093|P3|Overall Study|Protocol Violation|13
6019982|NCT00789555|20810094|P2|Overall Study|Protocol Violation|9
6019983|NCT00789555|20810095|P1|Overall Study|Protocol Violation|6
6019984|NCT00789555|20810093|P3|Overall Study|Treatment failure|12
6019985|NCT00789555|20810094|P2|Overall Study|Treatment failure|8
6019986|NCT00789555|20810095|P1|Overall Study|Treatment failure|11
6019987|NCT00789555|20810093|P3|Overall Study|Patient decision unnrelated to adv event|26
6019988|NCT00789555|20810094|P2|Overall Study|Patient decision unnrelated to adv event|29
6019989|NCT00789555|20810095|P1|Overall Study|Patient decision unnrelated to adv event|38
6019990|NCT00789555|20810093|P3|Overall Study|Lost to Follow-up|18
6019991|NCT00789555|20810094|P2|Overall Study|Lost to Follow-up|10
6019992|NCT00789555|20810095|P1|Overall Study|Lost to Follow-up|9
6019993|NCT00789555|20810093|P3|Overall Study|Adverse Event|10
6019994|NCT00789555|20810094|P2|Overall Study|Adverse Event|7
6019995|NCT00789555|20810095|P1|Overall Study|Adverse Event|17
6019996|NCT00789555|20810093|P3|Overall Study|Protocol Amendment|80
6019997|NCT00789555|20810094|P2|Overall Study|Protocol Amendment|76
6019998|NCT00789555|20810095|P1|Overall Study|Protocol Amendment|78
6019999|NCT00789529|20810120|P2|Overall Study|Other Reason|0
6020000|NCT00789529|20810121|P1|Overall Study|Other Reason|1
6020001|NCT00789529|20810120|P2|Overall Study|Withdrawal by Subject|1
6020002|NCT00789529|20810121|P1|Overall Study|Withdrawal by Subject|0
6020003|NCT00789477|20810134|P5|Overall Study|Other|0
6020004|NCT00789477|20810135|P4|Overall Study|Other|3
6020005|NCT00789477|20810136|P3|Overall Study|Other|1
6020006|NCT00789477|20810137|P2|Overall Study|Other|0
6020007|NCT00789477|20810138|P1|Overall Study|Other|2
6020008|NCT00789477|20810134|P5|Overall Study|Lack of Efficacy|0
6020009|NCT00789477|20810135|P4|Overall Study|Lack of Efficacy|0
6020010|NCT00789477|20810136|P3|Overall Study|Lack of Efficacy|0
6020011|NCT00789477|20810137|P2|Overall Study|Lack of Efficacy|0
6020012|NCT00789477|20810138|P1|Overall Study|Lack of Efficacy|2
6020013|NCT00789477|20810134|P5|Overall Study|Lost to Follow-up|4
6020014|NCT00789477|20810135|P4|Overall Study|Lost to Follow-up|2
6020015|NCT00789477|20810136|P3|Overall Study|Lost to Follow-up|4
6020016|NCT00789477|20810137|P2|Overall Study|Lost to Follow-up|1
6020017|NCT00789477|20810138|P1|Overall Study|Lost to Follow-up|0
6020018|NCT00789477|20810134|P5|Overall Study|Death|0
6020019|NCT00789477|20810135|P4|Overall Study|Death|2
6020020|NCT00789477|20810136|P3|Overall Study|Death|2
6020021|NCT00789477|20810137|P2|Overall Study|Death|1
6020022|NCT00789477|20810138|P1|Overall Study|Death|1
6020023|NCT00789477|20810134|P5|Overall Study|Adverse Event|0
6020024|NCT00789477|20810135|P4|Overall Study|Adverse Event|0
6020025|NCT00789477|20810136|P3|Overall Study|Adverse Event|1
6020026|NCT00789477|20810137|P2|Overall Study|Adverse Event|3
6020027|NCT00789477|20810138|P1|Overall Study|Adverse Event|3
6020028|NCT00789477|20810134|P5|Overall Study|Protocol Violation|0
6020029|NCT00789477|20810135|P4|Overall Study|Protocol Violation|1
6020030|NCT00789477|20810136|P3|Overall Study|Protocol Violation|0
6020031|NCT00789477|20810137|P2|Overall Study|Protocol Violation|0
6020032|NCT00789477|20810138|P1|Overall Study|Protocol Violation|1
6020033|NCT00789477|20810134|P5|Overall Study|Withdrawal by Subject|3
6020034|NCT00789477|20810135|P4|Overall Study|Withdrawal by Subject|2
6020035|NCT00789477|20810136|P3|Overall Study|Withdrawal by Subject|3
6020036|NCT00789477|20810137|P2|Overall Study|Withdrawal by Subject|1
6020037|NCT00789477|20810138|P1|Overall Study|Withdrawal by Subject|2
6020038|NCT00789373|20810183|P3|Maintenance|Participants On-Going at Data Cut-Off|0
6020039|NCT00789373|20810184|P2|Maintenance|Participants On-Going at Data Cut-Off|4
6020040|NCT00789373|20810185|P1|Maintenance|Participants On-Going at Data Cut-Off|0
6020041|NCT00789373|20810183|P3|Maintenance|Sponsor Decision|2
6020042|NCT00789373|20810184|P2|Maintenance|Sponsor Decision|0
6020043|NCT00789373|20810185|P1|Maintenance|Sponsor Decision|0
6020044|NCT00789373|20810183|P3|Maintenance|Withdrawal by Subject|8
6020045|NCT00789373|20810184|P2|Maintenance|Withdrawal by Subject|21
6020046|NCT00789373|20810185|P1|Maintenance|Withdrawal by Subject|0
6020047|NCT00789373|20810183|P3|Maintenance|Progressive Disease|152
6020048|NCT00789373|20810184|P2|Maintenance|Progressive Disease|253
6020049|NCT00789373|20810185|P1|Maintenance|Progressive Disease|0
6020050|NCT00789373|20810183|P3|Maintenance|Lost to Follow-up|0
6020051|NCT00789373|20810184|P2|Maintenance|Lost to Follow-up|2
6020052|NCT00789373|20810185|P1|Maintenance|Lost to Follow-up|0
6020053|NCT00789373|20810183|P3|Maintenance|Protocol entry criteria not met|0
6020054|NCT00789373|20810184|P2|Maintenance|Protocol entry criteria not met|2
6020055|NCT00789373|20810185|P1|Maintenance|Protocol entry criteria not met|0
6020056|NCT00789373|20810183|P3|Maintenance|Investigator Decision|2
6020057|NCT00789373|20810184|P2|Maintenance|Investigator Decision|4
6020058|NCT00789373|20810185|P1|Maintenance|Investigator Decision|0
6020059|NCT00789373|20810183|P3|Maintenance|Death due to toxicity|2
6020060|NCT00789373|20810184|P2|Maintenance|Death due to toxicity|1
6020061|NCT00789373|20810185|P1|Maintenance|Death due to toxicity|0
6020062|NCT00789373|20810183|P3|Maintenance|Death due to adverse event|1
6020063|NCT00789373|20810184|P2|Maintenance|Death due to adverse event|4
6020064|NCT00789373|20810185|P1|Maintenance|Death due to adverse event|0
6020065|NCT00789373|20810183|P3|Maintenance|Death due to study disease|1
6020066|NCT00789373|20810184|P2|Maintenance|Death due to study disease|3
6020067|NCT00789373|20810185|P1|Maintenance|Death due to study disease|0
6020068|NCT00789373|20810183|P3|Maintenance|Adverse Event|12
6020069|NCT00789373|20810184|P2|Maintenance|Adverse Event|65
6020070|NCT00789373|20810185|P1|Maintenance|Adverse Event|0
6020071|NCT00789373|20810183|P3|Induction|Withdrawal by Subject|0
6020072|NCT00789373|20810184|P2|Induction|Withdrawal by Subject|0
6020073|NCT00789373|20810185|P1|Induction|Withdrawal by Subject|37
6020074|NCT00789373|20810183|P3|Induction|Progressive Disease|0
6020075|NCT00789373|20810184|P2|Induction|Progressive Disease|0
6020076|NCT00789373|20810185|P1|Induction|Progressive Disease|220
6020077|NCT00789373|20810183|P3|Induction|Protocol Violation|0
6020078|NCT00789373|20810184|P2|Induction|Protocol Violation|0
6020079|NCT00789373|20810185|P1|Induction|Protocol Violation|1
6020080|NCT00789373|20810183|P3|Induction|Lost to Follow-up|0
6020081|NCT00789373|20810184|P2|Induction|Lost to Follow-up|0
6020082|NCT00789373|20810185|P1|Induction|Lost to Follow-up|6
6020083|NCT00789373|20810183|P3|Induction|Protocol entry criteria not met|0
6020084|NCT00789373|20810184|P2|Induction|Protocol entry criteria not met|0
6020085|NCT00789373|20810185|P1|Induction|Protocol entry criteria not met|9
6020086|NCT00789373|20810183|P3|Induction|Investigator decision|0
6020087|NCT00789373|20810184|P2|Induction|Investigator decision|0
6020088|NCT00789373|20810185|P1|Induction|Investigator decision|7
6020089|NCT00789373|20810183|P3|Induction|Death due to procedure|0
6020090|NCT00789373|20810184|P2|Induction|Death due to procedure|0
6020091|NCT00789373|20810185|P1|Induction|Death due to procedure|1
6020092|NCT00789373|20810183|P3|Induction|Death due to toxicity|0
6020093|NCT00789373|20810184|P2|Induction|Death due to toxicity|0
6020094|NCT00789373|20810185|P1|Induction|Death due to toxicity|11
6020095|NCT00789373|20810183|P3|Induction|Death due to adverse event|0
6020096|NCT00789373|20810184|P2|Induction|Death due to adverse event|0
6020097|NCT00789373|20810185|P1|Induction|Death due to adverse event|19
6020098|NCT00789373|20810183|P3|Induction|Death Due to study disease|0
6020099|NCT00789373|20810184|P2|Induction|Death Due to study disease|0
6020100|NCT00789373|20810185|P1|Induction|Death Due to study disease|24
6020101|NCT00789373|20810183|P3|Induction|Adverse Event|0
6020102|NCT00789373|20810184|P2|Induction|Adverse Event|0
6020103|NCT00789373|20810185|P1|Induction|Adverse Event|64
6020104|NCT00789360|20810212|P2|Overall Study|Protocol Violation|1
6020105|NCT00789360|20810213|P1|Overall Study|Protocol Violation|3
6020106|NCT00789321|20810223|P2|Overall Study|Adverse Event|1
6020107|NCT00789321|20810224|P1|Overall Study|Adverse Event|0
6020108|NCT00789191|20810246|P2|Overall Study|Unclassified|3
6020109|NCT00789191|20810247|P1|Overall Study|Unclassified|5
6020110|NCT00789191|20810246|P2|Overall Study|Withdrawal Criteria|4
6020111|NCT00789191|20810247|P1|Overall Study|Withdrawal Criteria|2
6020112|NCT00789191|20810246|P2|Overall Study|Protocol Violation|3
6020113|NCT00789191|20810247|P1|Overall Study|Protocol Violation|5
6020114|NCT00789191|20810246|P2|Overall Study|Lack of Efficacy|5
6020115|NCT00789191|20810247|P1|Overall Study|Lack of Efficacy|0
6020116|NCT00789191|20810246|P2|Overall Study|Adverse Event|4
6020117|NCT00789191|20810247|P1|Overall Study|Adverse Event|2
6020118|NCT00789035|20810304|P5|Overall Study|Other reason not defined above|1
6020119|NCT00789035|20810305|P4|Overall Study|Other reason not defined above|0
6020120|NCT00789035|20810306|P3|Overall Study|Other reason not defined above|1
6020121|NCT00789035|20810307|P2|Overall Study|Other reason not defined above|3
6020122|NCT00789035|20810308|P1|Overall Study|Other reason not defined above|2
6020123|NCT00789035|20810304|P5|Overall Study|Withdrawal by Subject|0
6020124|NCT00789035|20810305|P4|Overall Study|Withdrawal by Subject|0
6020125|NCT00789035|20810306|P3|Overall Study|Withdrawal by Subject|0
6020126|NCT00789035|20810307|P2|Overall Study|Withdrawal by Subject|2
6020127|NCT00789035|20810308|P1|Overall Study|Withdrawal by Subject|0
6020128|NCT00789035|20810304|P5|Overall Study|Protocol Violation|0
6020129|NCT00789035|20810305|P4|Overall Study|Protocol Violation|0
6020130|NCT00789035|20810306|P3|Overall Study|Protocol Violation|0
6020131|NCT00789035|20810307|P2|Overall Study|Protocol Violation|0
6020132|NCT00789035|20810308|P1|Overall Study|Protocol Violation|1
6020133|NCT00789035|20810304|P5|Overall Study|Lack of Efficacy|2
6020134|NCT00789035|20810305|P4|Overall Study|Lack of Efficacy|0
6020135|NCT00789035|20810306|P3|Overall Study|Lack of Efficacy|0
6020136|NCT00789035|20810307|P2|Overall Study|Lack of Efficacy|0
6020137|NCT00789035|20810308|P1|Overall Study|Lack of Efficacy|3
6020138|NCT00789035|20810304|P5|Overall Study|Adverse Event|3
6020139|NCT00789035|20810305|P4|Overall Study|Adverse Event|1
6020140|NCT00789035|20810306|P3|Overall Study|Adverse Event|0
6020141|NCT00789035|20810307|P2|Overall Study|Adverse Event|2
6020142|NCT00789035|20810308|P1|Overall Study|Adverse Event|0
6020143|NCT00788957|20810367|P6|Part 3|On-study at time of data cut-off|0
6020144|NCT00788957|20810368|P5|Part 3|On-study at time of data cut-off|1
6020145|NCT00788957|20810369|P4|Part 3|On-study at time of data cut-off|0
6020146|NCT00788957|20810370|P3|Part 3|On-study at time of data cut-off|0
6020147|NCT00788957|20810371|P2|Part 3|On-study at time of data cut-off|0
6020148|NCT00788957|20810372|P1|Part 3|On-study at time of data cut-off|0
6020149|NCT00788957|20810367|P6|Part 3|Death|9
6020150|NCT00788957|20810368|P5|Part 3|Death|8
6020151|NCT00788957|20810369|P4|Part 3|Death|0
6020152|NCT00788957|20810370|P3|Part 3|Death|0
6020153|NCT00788957|20810371|P2|Part 3|Death|0
6020154|NCT00788957|20810372|P1|Part 3|Death|0
6020155|NCT00788957|20810367|P6|Part 3|Withdrawal by Subject|2
6020156|NCT00788957|20810368|P5|Part 3|Withdrawal by Subject|0
6020157|NCT00788957|20810369|P4|Part 3|Withdrawal by Subject|0
6020158|NCT00788957|20810370|P3|Part 3|Withdrawal by Subject|0
6020159|NCT00788957|20810371|P2|Part 3|Withdrawal by Subject|0
6020160|NCT00788957|20810372|P1|Part 3|Withdrawal by Subject|0
6020161|NCT00788957|20810367|P6|Part 2|On-study at time of data cut-off|0
6020162|NCT00788957|20810368|P5|Part 2|On-study at time of data cut-off|0
6020163|NCT00788957|20810369|P4|Part 2|On-study at time of data cut-off|1
6020164|NCT00788957|20810370|P3|Part 2|On-study at time of data cut-off|1
6020165|NCT00788957|20810371|P2|Part 2|On-study at time of data cut-off|1
6020166|NCT00788957|20810372|P1|Part 2|On-study at time of data cut-off|0
6020167|NCT00788957|20810367|P6|Part 2|Lost to Follow-up|0
6020168|NCT00788957|20810368|P5|Part 2|Lost to Follow-up|0
6020169|NCT00788957|20810369|P4|Part 2|Lost to Follow-up|0
6020170|NCT00788957|20810370|P3|Part 2|Lost to Follow-up|3
6020171|NCT00788957|20810371|P2|Part 2|Lost to Follow-up|0
6020172|NCT00788957|20810372|P1|Part 2|Lost to Follow-up|0
6020173|NCT00788957|20810367|P6|Part 2|Death|0
6020174|NCT00788957|20810368|P5|Part 2|Death|0
6020175|NCT00788957|20810369|P4|Part 2|Death|37
6020176|NCT00788957|20810370|P3|Part 2|Death|35
6020177|NCT00788957|20810371|P2|Part 2|Death|32
6020178|NCT00788957|20810372|P1|Part 2|Death|0
6020179|NCT00788957|20810367|P6|Part 2|Withdrawal by Subject|0
6020180|NCT00788957|20810368|P5|Part 2|Withdrawal by Subject|0
6020181|NCT00788957|20810369|P4|Part 2|Withdrawal by Subject|3
6020182|NCT00788957|20810370|P3|Part 2|Withdrawal by Subject|5
6020183|NCT00788957|20810371|P2|Part 2|Withdrawal by Subject|9
6020184|NCT00788957|20810372|P1|Part 2|Withdrawal by Subject|0
6020185|NCT00788957|20810367|P6|Part 1|Lost to Follow-up|0
6020186|NCT00788957|20810368|P5|Part 1|Lost to Follow-up|0
6020187|NCT00788957|20810369|P4|Part 1|Lost to Follow-up|0
6020188|NCT00788957|20810370|P3|Part 1|Lost to Follow-up|0
6020189|NCT00788957|20810371|P2|Part 1|Lost to Follow-up|0
6020190|NCT00788957|20810372|P1|Part 1|Lost to Follow-up|1
6020191|NCT00788957|20810367|P6|Part 1|Death|0
6020192|NCT00788957|20810368|P5|Part 1|Death|0
6020193|NCT00788957|20810369|P4|Part 1|Death|0
6020194|NCT00788957|20810370|P3|Part 1|Death|0
6020195|NCT00788957|20810371|P2|Part 1|Death|0
6020196|NCT00788957|20810372|P1|Part 1|Death|8
6020197|NCT00788827|20810445|P1|Overall Study|Lack of Efficacy|2
6020198|NCT00788775|20810459|P2|Overall Study|Patient's measurable disease resected.|0
6020199|NCT00788775|20810460|P1|Overall Study|Patient's measurable disease resected.|1
6020200|NCT00788775|20810459|P2|Overall Study|Patient Non-Compliance|0
6020201|NCT00788775|20810460|P1|Overall Study|Patient Non-Compliance|1
6020202|NCT00788775|20810459|P2|Overall Study|Withdrawal by Subject|2
6020203|NCT00788775|20810460|P1|Overall Study|Withdrawal by Subject|0
6020204|NCT00788775|20810459|P2|Overall Study|Progressive Disease|6
6020205|NCT00788775|20810460|P1|Overall Study|Progressive Disease|8
6020206|NCT00788710|20810475|P3|Overall Study|Withdrawal by Subject|0
6020207|NCT00788710|20810476|P2|Overall Study|Withdrawal by Subject|2
6020208|NCT00788710|20810477|P1|Overall Study|Withdrawal by Subject|2
6020209|NCT00788710|20810475|P3|Overall Study|Protocol Violation|1
6020210|NCT00788710|20810476|P2|Overall Study|Protocol Violation|1
6020211|NCT00788710|20810477|P1|Overall Study|Protocol Violation|0
6020212|NCT00788710|20810475|P3|Overall Study|Physician Decision|0
6020213|NCT00788710|20810476|P2|Overall Study|Physician Decision|1
6020214|NCT00788710|20810477|P1|Overall Study|Physician Decision|2
6020215|NCT00788710|20810475|P3|Overall Study|Lost to Follow-up|0
6020216|NCT00788710|20810476|P2|Overall Study|Lost to Follow-up|1
6020217|NCT00788710|20810477|P1|Overall Study|Lost to Follow-up|0
6020218|NCT00788710|20810475|P3|Overall Study|Lack of Efficacy|1
6020219|NCT00788710|20810476|P2|Overall Study|Lack of Efficacy|0
6020220|NCT00788710|20810477|P1|Overall Study|Lack of Efficacy|0
6020221|NCT00788710|20810475|P3|Overall Study|Adverse Event|4
6020222|NCT00788710|20810476|P2|Overall Study|Adverse Event|3
6020223|NCT00788710|20810477|P1|Overall Study|Adverse Event|1
6020224|NCT00788697|20810491|P1|Overall Study|Indeterminate diagnosis from truth stand|17
6020225|NCT00788697|20810491|P1|Overall Study|Technically inadequate truth standard|1
6020226|NCT00788697|20810491|P1|Overall Study|no truth standard procedure available|5
6020227|NCT00788697|20810491|P1|Overall Study|Training Patients|74
6020228|NCT00788697|20810491|P1|Overall Study|No study drug administered|12
6020229|NCT00788593|20810538|P3|Second Intervention Period|Other|1
6020230|NCT00788593|20810539|P2|Second Intervention Period|Other|0
6020231|NCT00788593|20810540|P1|Second Intervention Period|Other|0
6020232|NCT00788593|20810538|P3|Second Intervention Period|Lost to Follow-up|0
6020233|NCT00788593|20810539|P2|Second Intervention Period|Lost to Follow-up|1
6020234|NCT00788593|20810540|P1|Second Intervention Period|Lost to Follow-up|0
6020235|NCT00788593|20810538|P3|First Intervention Period|Adverse Event|0
6020236|NCT00788593|20810539|P2|First Intervention Period|Adverse Event|1
6020237|NCT00788593|20810540|P1|First Intervention Period|Adverse Event|0
6020238|NCT00788593|20810538|P3|Placebo Run-in Phase|Protocol Violation|0
6020239|NCT00788593|20810539|P2|Placebo Run-in Phase|Protocol Violation|0
6020240|NCT00788593|20810540|P1|Placebo Run-in Phase|Protocol Violation|2
6020241|NCT00788593|20810538|P3|Placebo Run-in Phase|Withdrawal by Subject|0
6020242|NCT00788593|20810539|P2|Placebo Run-in Phase|Withdrawal by Subject|0
6020243|NCT00788593|20810540|P1|Placebo Run-in Phase|Withdrawal by Subject|2
6020244|NCT00788593|20810538|P3|Placebo Run-in Phase|Adverse Event|0
6020245|NCT00788593|20810539|P2|Placebo Run-in Phase|Adverse Event|0
6020246|NCT00788593|20810540|P1|Placebo Run-in Phase|Adverse Event|2
6020247|NCT00788372|20810557|P1|Period 2 (Week 4 to Week 52)|Aggravated symptoms|1
6020248|NCT00788372|20810557|P1|Period 2 (Week 4 to Week 52)|Withdrawal of informed consent|9
6020249|NCT00788372|20810557|P1|Period 2 (Week 4 to Week 52)|Physician Decision|9
6020250|NCT00788372|20810557|P1|Period 2 (Week 4 to Week 52)|Adverse Event|13
6020251|NCT00788372|20810557|P1|Period 1 (up to 4 Weeks)|Withdrawal of informed consent|4
6020252|NCT00788372|20810557|P1|Period 1 (up to 4 Weeks)|Ineligible for transfer to period 2|9
6020253|NCT00788372|20810557|P1|Period 1 (up to 4 Weeks)|Adverse Event|18
6020254|NCT00788151|20810586|P2|Overall Study|Enrolled but not treated|1
6020255|NCT00788151|20810587|P1|Overall Study|Enrolled but not treated|1
6020256|NCT00788151|20810586|P2|Overall Study|Withdrawal by Subject|6
6020257|NCT00788151|20810587|P1|Overall Study|Withdrawal by Subject|13
6020258|NCT00788151|20810586|P2|Overall Study|Protocol Violation|1
6020259|NCT00788151|20810587|P1|Overall Study|Protocol Violation|0
6020260|NCT00788151|20810586|P2|Overall Study|Other adverse event|2
6020261|NCT00788151|20810587|P1|Overall Study|Other adverse event|0
6020262|NCT00788073|20810631|P2|Placebo Then STX209|Protocol Violation|1
6020263|NCT00788073|20810632|P1|Placebo Then STX209|Protocol Violation|0
6020264|NCT00788073|20810631|P2|Placebo Then STX209|Adverse Event|0
6020265|NCT00788073|20810632|P1|Placebo Then STX209|Adverse Event|2
6020266|NCT00788073|20810631|P2|STX209 Then Placebo|unable to return due to travel|1
6020267|NCT00788073|20810632|P1|STX209 Then Placebo|unable to return due to travel|0
6020268|NCT00788073|20810631|P2|STX209 Then Placebo|Withdrawal by Subject|1
6020269|NCT00788073|20810632|P1|STX209 Then Placebo|Withdrawal by Subject|0
6020270|NCT00788073|20810631|P2|STX209 Then Placebo|Lost to Follow-up|1
6020271|NCT00788073|20810632|P1|STX209 Then Placebo|Lost to Follow-up|0
6020272|NCT00788073|20810631|P2|STX209 Then Placebo|Adverse Event|0
6020273|NCT00788073|20810632|P1|STX209 Then Placebo|Adverse Event|1
6020274|NCT00787930|20810657|P1|Continuation Treatment -- up to 12 Month|Withdrawal by Subject|3
6020275|NCT00787917|20810672|P2|Open Label|Administrative problems|0
6020276|NCT00787917|20810673|P1|Open Label|Administrative problems|3
6020277|NCT00787917|20810672|P2|Open Label|Unsatisfactory therapeutic effect|0
6020278|NCT00787917|20810673|P1|Open Label|Unsatisfactory therapeutic effect|1
6020279|NCT00787917|20810672|P2|Blinded Treatment|Administrative problems|2
6020280|NCT00787917|20810673|P1|Blinded Treatment|Administrative problems|3
6020281|NCT00787917|20810672|P2|Blinded Treatment|Lack of Efficacy|0
6020282|NCT00787917|20810673|P1|Blinded Treatment|Lack of Efficacy|1
6020283|NCT00787917|20810672|P2|Blinded Treatment|Adverse Event|0
6020284|NCT00787917|20810673|P1|Blinded Treatment|Adverse Event|1
6020285|NCT00787891|20810703|P2|Maintenance Double-blind Phase (Part 2)|Other|2
6020286|NCT00787891|20810704|P1|Maintenance Double-blind Phase (Part 2)|Other|5
6020287|NCT00787891|20810703|P2|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|3
6020288|NCT00787891|20810704|P1|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|1
6020289|NCT00787891|20810703|P2|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1
6020290|NCT00787891|20810704|P1|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1
6020291|NCT00787891|20810703|P2|Maintenance Double-blind Phase (Part 2)|Adverse Event|1
6020292|NCT00787891|20810704|P1|Maintenance Double-blind Phase (Part 2)|Adverse Event|0
6020293|NCT00787891|20810703|P2|Short-term Double-blind Phase (Part 1)|Other|2
6020294|NCT00787891|20810704|P1|Short-term Double-blind Phase (Part 1)|Other|0
6020295|NCT00787891|20810703|P2|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|2
6020296|NCT00787891|20810704|P1|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|6
6020297|NCT00787891|20810703|P2|Short-term Double-blind Phase (Part 1)|Physician Decision|0
6020298|NCT00787891|20810704|P1|Short-term Double-blind Phase (Part 1)|Physician Decision|1
6020299|NCT00787891|20810703|P2|Short-term Double-blind Phase (Part 1)|Protocol Violation|1
6020300|NCT00787891|20810704|P1|Short-term Double-blind Phase (Part 1)|Protocol Violation|0
6020301|NCT00787891|20810703|P2|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2
6020302|NCT00787891|20810704|P1|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2
6020303|NCT00787891|20810703|P2|Short-term Double-blind Phase (Part 1)|Adverse Event|2
6020304|NCT00787891|20810704|P1|Short-term Double-blind Phase (Part 1)|Adverse Event|1
6020305|NCT00787839|20810731|P1|Overall Study|Failure to have the OGTT was most common|404
6020306|NCT00787800|20810754|P2|Overall Study|Death|2
6020307|NCT00787800|20810755|P1|Overall Study|Death|0
6020308|NCT00787800|20810754|P2|Overall Study|Withdrawal by Subject|5
6020309|NCT00787800|20810755|P1|Overall Study|Withdrawal by Subject|3
6020310|NCT00787787|20810771|P1|Overall Study|Adverse Event|3
6020311|NCT00787787|20810771|P1|Overall Study|Lack of Efficacy|4
6020312|NCT00787644|20810799|P2|Overall Study|Withdrawal by Subject|1
6020313|NCT00787644|20810800|P1|Overall Study|Withdrawal by Subject|1
6020314|NCT00787644|20810799|P2|Overall Study|Lost to Follow-up|1
6020315|NCT00787644|20810800|P1|Overall Study|Lost to Follow-up|1
6020316|NCT00787605|20810821|P2|Overall Study|Lack of Efficacy|9
6020317|NCT00787605|20810822|P1|Overall Study|Lack of Efficacy|13
6020318|NCT00787605|20810821|P2|Overall Study|Withdrawal by Subject|13
6020319|NCT00787605|20810822|P1|Overall Study|Withdrawal by Subject|6
6020320|NCT00787605|20810821|P2|Overall Study|Protocol Violation|3
6020321|NCT00787605|20810822|P1|Overall Study|Protocol Violation|7
6020322|NCT00787605|20810821|P2|Overall Study|Lost to Follow-up|6
6020323|NCT00787605|20810822|P1|Overall Study|Lost to Follow-up|3
6020324|NCT00787605|20810821|P2|Overall Study|Adverse Event|25
6020325|NCT00787605|20810822|P1|Overall Study|Adverse Event|14
6020326|NCT00787605|20810821|P2|Overall Study|Administrative Problems|0
6020327|NCT00787605|20810822|P1|Overall Study|Administrative Problems|3
6020328|NCT00787566|20810841|P3|Overall Study|AE related to chemotherapy|0
6020329|NCT00787566|20810842|P2|Overall Study|AE related to chemotherapy|1
6020330|NCT00787566|20810843|P1|Overall Study|AE related to chemotherapy|0
6020331|NCT00787527|20810851|P1|Overall Study|Toxicity|3
6020332|NCT00787319|20810868|P1|Overall Study|Inactive disease|5
6020333|NCT00787319|20810868|P1|Overall Study|Stabilized disease findings|3
6020334|NCT00787319|20810868|P1|Overall Study|No health insurance reimbursement|2
6020335|NCT00787319|20810868|P1|Overall Study|Unresponsiveness to visit invitation|1
6020336|NCT00787319|20810868|P1|Overall Study|Budget exhausted/exceeded|1
6020337|NCT00787319|20810868|P1|Overall Study|Lack of Efficacy|1
6020338|NCT00787319|20810868|P1|Overall Study|Objective progression or relapse|30
6020339|NCT00787319|20810868|P1|Overall Study|Adverse Event|3
6020340|NCT00787319|20810868|P1|Overall Study|Withdrawal by Subject|15
6020341|NCT00787319|20810868|P1|Overall Study|Lost to Follow-up|2
6020342|NCT00787267|20810880|P1|Overall Study|Withdrawal by Subject|1
6020343|NCT00787267|20810880|P1|Overall Study|No Reason Provided|1
6020344|NCT00787267|20810880|P1|Overall Study|Screen failure/Ineligible|10
6020345|NCT00787254|20810890|P2|Overall Study|Physician Decision|8
6020346|NCT00787254|20810891|P1|Overall Study|Physician Decision|4
6020347|NCT00787254|20810890|P2|Overall Study|Institution closed|0
6020348|NCT00787254|20810891|P1|Overall Study|Institution closed|1
6020349|NCT00787254|20810890|P2|Overall Study|NSAIDs discontinuation|2
6020350|NCT00787254|20810891|P1|Overall Study|NSAIDs discontinuation|1
6020351|NCT00787254|20810890|P2|Overall Study|Lack of Efficacy|15
6020352|NCT00787254|20810891|P1|Overall Study|Lack of Efficacy|4
6020353|NCT00787254|20810890|P2|Overall Study|Withdrawal by Subject|11
6020354|NCT00787254|20810891|P1|Overall Study|Withdrawal by Subject|16
6020355|NCT00787254|20810890|P2|Overall Study|Protocol Violation|23
6020356|NCT00787254|20810891|P1|Overall Study|Protocol Violation|26
6020357|NCT00787254|20810890|P2|Overall Study|Adverse Event|23
6020358|NCT00787254|20810891|P1|Overall Study|Adverse Event|24
6020359|NCT00787202|20811015|P5|Overall Study|Randomized, not treated|0
6020360|NCT00787202|20811016|P4|Overall Study|Randomized, not treated|0
6020361|NCT00787202|20811017|P3|Overall Study|Randomized, not treated|0
6020362|NCT00787202|20811018|P2|Overall Study|Randomized, not treated|0
6020363|NCT00787202|20811019|P1|Overall Study|Randomized, not treated|1
6020364|NCT00787202|20811015|P5|Overall Study|Protocol Violation|1
6020365|NCT00787202|20811016|P4|Overall Study|Protocol Violation|0
6020366|NCT00787202|20811017|P3|Overall Study|Protocol Violation|0
6020367|NCT00787202|20811018|P2|Overall Study|Protocol Violation|1
6020368|NCT00787202|20811019|P1|Overall Study|Protocol Violation|2
6020369|NCT00787202|20811015|P5|Overall Study|Withdrawal by Subject|0
6020370|NCT00787202|20811016|P4|Overall Study|Withdrawal by Subject|0
6020371|NCT00787202|20811017|P3|Overall Study|Withdrawal by Subject|2
6020372|NCT00787202|20811018|P2|Overall Study|Withdrawal by Subject|2
6020373|NCT00787202|20811019|P1|Overall Study|Withdrawal by Subject|2
6020374|NCT00787202|20811015|P5|Overall Study|Lost to Follow-up|0
6020375|NCT00787202|20811016|P4|Overall Study|Lost to Follow-up|0
6020376|NCT00787202|20811017|P3|Overall Study|Lost to Follow-up|0
6020377|NCT00787202|20811018|P2|Overall Study|Lost to Follow-up|0
6020378|NCT00787202|20811019|P1|Overall Study|Lost to Follow-up|1
6020379|NCT00787202|20811015|P5|Overall Study|Lack of Efficacy|1
6020380|NCT00787202|20811016|P4|Overall Study|Lack of Efficacy|2
6020381|NCT00787202|20811017|P3|Overall Study|Lack of Efficacy|5
6020382|NCT00787202|20811018|P2|Overall Study|Lack of Efficacy|6
6020383|NCT00787202|20811019|P1|Overall Study|Lack of Efficacy|5
6020384|NCT00787202|20811015|P5|Overall Study|Adverse Event|2
6020385|NCT00787202|20811016|P4|Overall Study|Adverse Event|0
6020386|NCT00787202|20811017|P3|Overall Study|Adverse Event|0
6020387|NCT00787202|20811018|P2|Overall Study|Adverse Event|2
6020388|NCT00787202|20811019|P1|Overall Study|Adverse Event|3
6020389|NCT00787189|20811072|P2|Overall Study|Lost to Follow-up|2
6020390|NCT00787189|20811073|P1|Overall Study|Lost to Follow-up|2
6020391|NCT00787150|20811082|P3|Overall Study|Dosing incorrect study durg|0
6020392|NCT00787150|20811083|P2|Overall Study|Dosing incorrect study durg|0
6020393|NCT00787150|20811084|P1|Overall Study|Dosing incorrect study durg|2
6020394|NCT00787150|20811082|P3|Overall Study|Withdrawal by Subject|0
6020395|NCT00787150|20811083|P2|Overall Study|Withdrawal by Subject|1
6020396|NCT00787150|20811084|P1|Overall Study|Withdrawal by Subject|2
6020397|NCT00787150|20811082|P3|Overall Study|Physician Decision|1
6020398|NCT00787150|20811083|P2|Overall Study|Physician Decision|2
6020399|NCT00787150|20811084|P1|Overall Study|Physician Decision|1
6020400|NCT00787150|20811082|P3|Overall Study|Adverse Event|4
6020401|NCT00787150|20811083|P2|Overall Study|Adverse Event|4
6020402|NCT00787150|20811084|P1|Overall Study|Adverse Event|4
6020403|NCT00787137|20811129|P3|Overall Study|Study Termination|1
6020404|NCT00787137|20811130|P2|Overall Study|Study Termination|0
6020405|NCT00787137|20811131|P1|Overall Study|Study Termination|0
6020406|NCT00786864|20811206|P2|Overall Study|Sustained serious back injury|0
6020407|NCT00786864|20811207|P1|Overall Study|Sustained serious back injury|1
6020408|NCT00786864|20811206|P2|Overall Study|Lost to Follow-up|1
6020409|NCT00786864|20811207|P1|Overall Study|Lost to Follow-up|0
6020410|NCT00786838|20811219|P1|Overall Study|Withdrawal by Subject|4
6020411|NCT00786838|20811219|P1|Overall Study|Progressive disease|31
6020412|NCT00786838|20811219|P1|Overall Study|Adverse Event|6
6020413|NCT00786838|20811219|P1|Overall Study|Death|4
6020414|NCT00786838|20811219|P1|Overall Study|Physician Decision|4
6020415|NCT00786799|20811255|P2|Overall Study|Lost to Follow-up|1
6020416|NCT00786799|20811256|P1|Overall Study|Lost to Follow-up|1
6020417|NCT00786565|20811286|P1|Post Surgery|Adapt AO implanted posterior side up|1
6020418|NCT00786565|20811286|P1|Post Surgery|Abnormal macular pucker|1
6020419|NCT00786565|20811286|P1|Enrollment Prior to Surgery|Protocol Violation|3
6020420|NCT00786565|20811286|P1|Enrollment Prior to Surgery|Site Closed|3
6020421|NCT00786474|20811343|P2|Overall Study|Other|4
6020422|NCT00786474|20811344|P1|Overall Study|Other|4
6020423|NCT00786474|20811343|P2|Overall Study|Physician Decision|1
6020424|NCT00786474|20811344|P1|Overall Study|Physician Decision|2
6020425|NCT00786474|20811343|P2|Overall Study|Lost to Follow-up|3
6020426|NCT00786474|20811344|P1|Overall Study|Lost to Follow-up|3
6020427|NCT00786474|20811343|P2|Overall Study|Withdrawal by Subject|31
6020428|NCT00786474|20811344|P1|Overall Study|Withdrawal by Subject|23
6020429|NCT00786474|20811343|P2|Overall Study|Death|4
6020430|NCT00786474|20811344|P1|Overall Study|Death|5
6020431|NCT00786422|20811356|P1|Follow-up Period|End-of-study done up to 4 days early|2
6020432|NCT00786422|20811356|P1|Follow-up Period|Death|1
6020433|NCT00786422|20811356|P1|Rivaroxaban Treatment|Adverse Event|2
6020434|NCT00786422|20811356|P1|Rivaroxaban Treatment|Non-compliance with study drug treatment|1
6020435|NCT00786422|20811356|P1|Rivaroxaban Treatment|Withdrawal by Subject|1
6020436|NCT00786422|20811356|P1|Rivaroxaban Treatment|Physician Decision|1
6020437|NCT00786422|20811356|P1|Rivaroxaban Treatment|Lack of Efficacy|1
6020438|NCT00786422|20811356|P1|Rivaroxaban Treatment|Final visit earlier than planned|3
6020439|NCT00786422|20811356|P1|Rivaroxaban Treatment|Death|2
6020440|NCT00786409|20811372|P1|Overall Study|Lost to Follow-up|1
6020441|NCT00786409|20811372|P1|Overall Study|Pregnancy|2
6020442|NCT00786409|20811372|P1|Overall Study|Adverse Event|2
6020443|NCT00786409|20811372|P1|Overall Study|Withdrawal by Subject|2
6020444|NCT00786188|20811389|P2|Overall Study|Withdrawal by Subject|0
6020445|NCT00786188|20811390|P1|Overall Study|Withdrawal by Subject|2
6020446|NCT00786188|20811389|P2|Overall Study|Adverse Event|1
6020447|NCT00786188|20811390|P1|Overall Study|Adverse Event|3
6020448|NCT00786032|20811416|P1|Overall Study|Did not complete in the timeframe|6
6020449|NCT00786032|20811416|P1|Overall Study|Withdrawal by Subject|14
6020450|NCT00786032|20811416|P1|Overall Study|Death|4
6020451|NCT00785980|20811437|P1|7 Day Washout Period|Protocol Violation|3
6020452|NCT00785928|20811455|P7|Treatment Phase|Withdrawal by Subject|0
6020453|NCT00785928|20811456|P6|Treatment Phase|Withdrawal by Subject|0
6020454|NCT00785928|20811457|P5|Treatment Phase|Withdrawal by Subject|1
6020455|NCT00785928|20811458|P4|Treatment Phase|Withdrawal by Subject|0
6020456|NCT00785928|20811459|P3|Treatment Phase|Withdrawal by Subject|0
6020457|NCT00785928|20811460|P2|Treatment Phase|Withdrawal by Subject|2
6020458|NCT00785928|20811461|P1|Treatment Phase|Withdrawal by Subject|1
6020459|NCT00785928|20811455|P7|Treatment Phase|Sponsor Decision|1
6020460|NCT00785928|20811456|P6|Treatment Phase|Sponsor Decision|0
6020461|NCT00785928|20811457|P5|Treatment Phase|Sponsor Decision|0
6020462|NCT00785928|20811458|P4|Treatment Phase|Sponsor Decision|0
6020463|NCT00785928|20811459|P3|Treatment Phase|Sponsor Decision|0
6020464|NCT00785928|20811460|P2|Treatment Phase|Sponsor Decision|0
6020465|NCT00785928|20811461|P1|Treatment Phase|Sponsor Decision|1
6020466|NCT00785928|20811455|P7|Treatment Phase|Physician Decision|0
6020467|NCT00785928|20811456|P6|Treatment Phase|Physician Decision|0
6020468|NCT00785928|20811457|P5|Treatment Phase|Physician Decision|1
6020469|NCT00785928|20811458|P4|Treatment Phase|Physician Decision|0
6020470|NCT00785928|20811459|P3|Treatment Phase|Physician Decision|0
6020471|NCT00785928|20811460|P2|Treatment Phase|Physician Decision|0
6020472|NCT00785928|20811461|P1|Treatment Phase|Physician Decision|0
6020473|NCT00785928|20811455|P7|Treatment Phase|Lack of Efficacy|0
6020474|NCT00785928|20811456|P6|Treatment Phase|Lack of Efficacy|0
6020475|NCT00785928|20811457|P5|Treatment Phase|Lack of Efficacy|0
6020476|NCT00785928|20811458|P4|Treatment Phase|Lack of Efficacy|0
6020477|NCT00785928|20811459|P3|Treatment Phase|Lack of Efficacy|1
6020478|NCT00785928|20811460|P2|Treatment Phase|Lack of Efficacy|1
6020479|NCT00785928|20811461|P1|Treatment Phase|Lack of Efficacy|0
6020480|NCT00785928|20811455|P7|Treatment Phase|Inadequate Response|0
6020481|NCT00785928|20811456|P6|Treatment Phase|Inadequate Response|0
6020482|NCT00785928|20811457|P5|Treatment Phase|Inadequate Response|0
6020483|NCT00785928|20811458|P4|Treatment Phase|Inadequate Response|0
6020484|NCT00785928|20811459|P3|Treatment Phase|Inadequate Response|0
6020485|NCT00785928|20811460|P2|Treatment Phase|Inadequate Response|1
6020486|NCT00785928|20811461|P1|Treatment Phase|Inadequate Response|0
6020487|NCT00785928|20811455|P7|Treatment Phase|Adverse Event|2
6020488|NCT00785928|20811456|P6|Treatment Phase|Adverse Event|0
6020489|NCT00785928|20811457|P5|Treatment Phase|Adverse Event|0
6020490|NCT00785928|20811458|P4|Treatment Phase|Adverse Event|0
6020491|NCT00785928|20811459|P3|Treatment Phase|Adverse Event|2
6020492|NCT00785928|20811460|P2|Treatment Phase|Adverse Event|1
6020493|NCT00785928|20811461|P1|Treatment Phase|Adverse Event|1
6020494|NCT00785785|20811608|P2|Optional Extension Phase|Study terminated by sponsor|37
6020495|NCT00785785|20811609|P1|Optional Extension Phase|Study terminated by sponsor|3
6020496|NCT00785785|20811608|P2|Optional Extension Phase|Protocol deviation|2
6020497|NCT00785785|20811609|P1|Optional Extension Phase|Protocol deviation|0
6020498|NCT00785785|20811608|P2|Optional Extension Phase|Disease progression|70
6020499|NCT00785785|20811609|P1|Optional Extension Phase|Disease progression|22
6020500|NCT00785785|20811608|P2|Optional Extension Phase|Death|5
6020501|NCT00785785|20811609|P1|Optional Extension Phase|Death|1
6020502|NCT00785785|20811608|P2|Optional Extension Phase|Administrative problems|0
6020503|NCT00785785|20811609|P1|Optional Extension Phase|Administrative problems|2
6020504|NCT00785785|20811608|P2|Optional Extension Phase|Lost to Follow-up|0
6020505|NCT00785785|20811609|P1|Optional Extension Phase|Lost to Follow-up|1
6020506|NCT00785785|20811608|P2|Optional Extension Phase|Withdrawal by Subject|6
6020507|NCT00785785|20811609|P1|Optional Extension Phase|Withdrawal by Subject|6
6020508|NCT00785785|20811608|P2|Optional Extension Phase|Adverse Event|5
6020509|NCT00785785|20811609|P1|Optional Extension Phase|Adverse Event|4
6020510|NCT00785785|20811608|P2|Core Phase up to 36 Months|Study terminated by sponsor|133
6020511|NCT00785785|20811609|P1|Core Phase up to 36 Months|Study terminated by sponsor|116
6020512|NCT00785785|20811608|P2|Core Phase up to 36 Months|Protocol deviation|6
6020513|NCT00785785|20811609|P1|Core Phase up to 36 Months|Protocol deviation|5
6020514|NCT00785785|20811608|P2|Core Phase up to 36 Months|Disease progression|119
6020515|NCT00785785|20811609|P1|Core Phase up to 36 Months|Disease progression|139
6020516|NCT00785785|20811608|P2|Core Phase up to 36 Months|Death|8
6020517|NCT00785785|20811609|P1|Core Phase up to 36 Months|Death|5
6020518|NCT00785785|20811608|P2|Core Phase up to 36 Months|Administrative problems|3
6020519|NCT00785785|20811609|P1|Core Phase up to 36 Months|Administrative problems|3
6020520|NCT00785785|20811608|P2|Core Phase up to 36 Months|Lost to Follow-up|7
6020521|NCT00785785|20811609|P1|Core Phase up to 36 Months|Lost to Follow-up|3
6020522|NCT00785785|20811608|P2|Core Phase up to 36 Months|Withdrawal by Subject|17
6020523|NCT00785785|20811609|P1|Core Phase up to 36 Months|Withdrawal by Subject|16
6020524|NCT00785785|20811608|P2|Core Phase up to 36 Months|Abnormal test procedure result|2
6020525|NCT00785785|20811609|P1|Core Phase up to 36 Months|Abnormal test procedure result|2
6020526|NCT00785785|20811608|P2|Core Phase up to 36 Months|Abnormal laboratory value|0
6020527|NCT00785785|20811609|P1|Core Phase up to 36 Months|Abnormal laboratory value|1
6020528|NCT00785785|20811608|P2|Core Phase up to 36 Months|Adverse Event|21
6020529|NCT00785785|20811609|P1|Core Phase up to 36 Months|Adverse Event|31
6020530|NCT00785785|20811608|P2|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|4
6020531|NCT00785785|20811609|P1|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|3
6020532|NCT00785707|20811623|P1|Overall Study|Lost to Follow-up|7
6020533|NCT00785629|20811632|P4|Overall Study|Withdrawal by Subject|2
6020534|NCT00785629|20811633|P3|Overall Study|Withdrawal by Subject|2
6020535|NCT00785629|20811634|P2|Overall Study|Withdrawal by Subject|1
6020536|NCT00785629|20811635|P1|Overall Study|Withdrawal by Subject|0
6020537|NCT00785629|20811632|P4|Overall Study|administrative decision|4
6020538|NCT00785629|20811633|P3|Overall Study|administrative decision|3
6020539|NCT00785629|20811634|P2|Overall Study|administrative decision|1
6020540|NCT00785629|20811635|P1|Overall Study|administrative decision|5
6020541|NCT00785629|20811632|P4|Overall Study|Protocol Violation|5
6020542|NCT00785629|20811633|P3|Overall Study|Protocol Violation|4
6020543|NCT00785629|20811634|P2|Overall Study|Protocol Violation|2
6020544|NCT00785629|20811635|P1|Overall Study|Protocol Violation|1
6020545|NCT00785629|20811632|P4|Overall Study|Adverse Event|5
6020546|NCT00785629|20811633|P3|Overall Study|Adverse Event|1
6020547|NCT00785629|20811634|P2|Overall Study|Adverse Event|1
6020548|NCT00785629|20811635|P1|Overall Study|Adverse Event|2
6020549|NCT00785577|20811648|P5|Study Period 3: 1-Week Washout Phase|Death|1
6020550|NCT00785577|20811649|P4|Study Period 3: 1-Week Washout Phase|Death|0
6020551|NCT00785577|20811650|P3|Study Period 3: 1-Week Washout Phase|Death|0
6020552|NCT00785577|20811651|P2|Study Period 3: 1-Week Washout Phase|Death|0
6020553|NCT00785577|20811652|P1|Study Period 3: 1-Week Washout Phase|Death|0
6020554|NCT00785577|20811648|P5|Study Period 3: 1-Week Washout Phase|Adverse Event|0
6020555|NCT00785577|20811649|P4|Study Period 3: 1-Week Washout Phase|Adverse Event|1
6020556|NCT00785577|20811650|P3|Study Period 3: 1-Week Washout Phase|Adverse Event|0
6020557|NCT00785577|20811651|P2|Study Period 3: 1-Week Washout Phase|Adverse Event|0
6020558|NCT00785577|20811652|P1|Study Period 3: 1-Week Washout Phase|Adverse Event|0
6020559|NCT00785577|20811648|P5|Study Period 2: Therapy Phase|Sponsor Decision|0
6020560|NCT00785577|20811649|P4|Study Period 2: Therapy Phase|Sponsor Decision|1
6020561|NCT00785577|20811650|P3|Study Period 2: Therapy Phase|Sponsor Decision|1
6020562|NCT00785577|20811651|P2|Study Period 2: Therapy Phase|Sponsor Decision|0
6020563|NCT00785577|20811652|P1|Study Period 2: Therapy Phase|Sponsor Decision|1
6020564|NCT00785577|20811648|P5|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0
6020565|NCT00785577|20811649|P4|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1
6020566|NCT00785577|20811650|P3|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1
6020567|NCT00785577|20811651|P2|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0
6020568|NCT00785577|20811652|P1|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1
6020569|NCT00785577|20811648|P5|Study Period 2: Therapy Phase|Withdrawal by Subject|1
6020570|NCT00785577|20811649|P4|Study Period 2: Therapy Phase|Withdrawal by Subject|0
6020571|NCT00785577|20811650|P3|Study Period 2: Therapy Phase|Withdrawal by Subject|1
6020572|NCT00785577|20811651|P2|Study Period 2: Therapy Phase|Withdrawal by Subject|1
6020573|NCT00785577|20811652|P1|Study Period 2: Therapy Phase|Withdrawal by Subject|2
6020574|NCT00785577|20811648|P5|Study Period 2: Therapy Phase|Protocol Violation|1
6020575|NCT00785577|20811649|P4|Study Period 2: Therapy Phase|Protocol Violation|0
6020576|NCT00785577|20811650|P3|Study Period 2: Therapy Phase|Protocol Violation|1
6020577|NCT00785577|20811651|P2|Study Period 2: Therapy Phase|Protocol Violation|1
6020578|NCT00785577|20811652|P1|Study Period 2: Therapy Phase|Protocol Violation|1
6020579|NCT00785577|20811648|P5|Study Period 2: Therapy Phase|Physician Decision|0
6020580|NCT00785577|20811649|P4|Study Period 2: Therapy Phase|Physician Decision|0
6020581|NCT00785577|20811650|P3|Study Period 2: Therapy Phase|Physician Decision|0
6020582|NCT00785577|20811651|P2|Study Period 2: Therapy Phase|Physician Decision|0
6020583|NCT00785577|20811652|P1|Study Period 2: Therapy Phase|Physician Decision|1
6020584|NCT00785577|20811648|P5|Study Period 2: Therapy Phase|Lost to Follow-up|0
6020585|NCT00785577|20811649|P4|Study Period 2: Therapy Phase|Lost to Follow-up|1
6020586|NCT00785577|20811650|P3|Study Period 2: Therapy Phase|Lost to Follow-up|0
6020587|NCT00785577|20811651|P2|Study Period 2: Therapy Phase|Lost to Follow-up|0
6020588|NCT00785577|20811652|P1|Study Period 2: Therapy Phase|Lost to Follow-up|0
6020589|NCT00785577|20811648|P5|Study Period 2: Therapy Phase|Lack of Efficacy|1
6020590|NCT00785577|20811649|P4|Study Period 2: Therapy Phase|Lack of Efficacy|0
6020591|NCT00785577|20811650|P3|Study Period 2: Therapy Phase|Lack of Efficacy|0
6020592|NCT00785577|20811651|P2|Study Period 2: Therapy Phase|Lack of Efficacy|0
6020593|NCT00785577|20811652|P1|Study Period 2: Therapy Phase|Lack of Efficacy|0
6020594|NCT00785577|20811648|P5|Study Period 2: Therapy Phase|Adverse Event|17
6020595|NCT00785577|20811649|P4|Study Period 2: Therapy Phase|Adverse Event|10
6020596|NCT00785577|20811650|P3|Study Period 2: Therapy Phase|Adverse Event|14
6020597|NCT00785577|20811651|P2|Study Period 2: Therapy Phase|Adverse Event|7
6020598|NCT00785577|20811652|P1|Study Period 2: Therapy Phase|Adverse Event|5
6020599|NCT00785538|20811792|P4|Treatment Period|Withdrawal by Subject|1
6020600|NCT00785538|20811793|P3|Treatment Period|Withdrawal by Subject|0
6020601|NCT00785538|20811794|P2|Treatment Period|Withdrawal by Subject|0
6020602|NCT00785538|20811795|P1|Treatment Period|Withdrawal by Subject|0
6020603|NCT00785538|20811792|P4|Treatment Period|Adverse Event|0
6020604|NCT00785538|20811793|P3|Treatment Period|Adverse Event|2
6020605|NCT00785538|20811794|P2|Treatment Period|Adverse Event|2
6020606|NCT00785538|20811795|P1|Treatment Period|Adverse Event|1
6020607|NCT00785512|20811843|P2|Overall Study|Lack of compliance|1
6020608|NCT00785512|20811844|P1|Overall Study|Lack of compliance|0
6020609|NCT00785512|20811843|P2|Overall Study|Physician Decision|0
6020610|NCT00785512|20811844|P1|Overall Study|Physician Decision|0
6020611|NCT00785512|20811843|P2|Overall Study|IVRS Programing Error|0
6020612|NCT00785512|20811844|P1|Overall Study|IVRS Programing Error|0
6020613|NCT00785512|20811843|P2|Overall Study|Precedure Refused|0
6020614|NCT00785512|20811844|P1|Overall Study|Precedure Refused|0
6020615|NCT00785512|20811843|P2|Overall Study|Lost to Follow-up|0
6020616|NCT00785512|20811844|P1|Overall Study|Lost to Follow-up|3
6020617|NCT00785512|20811843|P2|Overall Study|Withdrawal by Subject|1
6020618|NCT00785512|20811844|P1|Overall Study|Withdrawal by Subject|0
6020619|NCT00785512|20811843|P2|Overall Study|Lack of Efficacy|2
6020620|NCT00785512|20811844|P1|Overall Study|Lack of Efficacy|0
6020621|NCT00785512|20811843|P2|Overall Study|Adverse Event|0
6020622|NCT00785512|20811844|P1|Overall Study|Adverse Event|0
6020623|NCT00785512|20811843|P2|Overall Study|Inclusion/Exclusion not meet|0
6020624|NCT00785512|20811844|P1|Overall Study|Inclusion/Exclusion not meet|0
6020625|NCT00785486|20811853|P1|Midazolam Alone|Withdrawal by Subject|1
6020626|NCT00785356|20811877|P1|Overall Study|Study prematurely terminated|8
6020648|NCT00785213|20811910|P1|Rosiglitazone With Quinine Sulfate|Adverse Event|1
6020649|NCT00785213|20811910|P1|Quinine Sulfate Alone|Adverse Event|4
6020650|NCT00785044|20811921|P1|Overall Study|Withdrawal by Subject|1
6020651|NCT00785044|20811921|P1|Overall Study|Lost to Follow-up|266
6020652|NCT00785044|20811921|P1|Overall Study|Death|77
6020653|NCT00785044|20811921|P1|Overall Study|Dosed at non-participating sites|152
6020654|NCT00784979|20811926|P1|Overall Study|incomplete data|6
6020655|NCT00784927|20811930|P1|Overall Study|Ineligible|1
6020656|NCT00784927|20811930|P1|Overall Study|Protocol Violation|1
6020657|NCT00784927|20811930|P1|Overall Study|Cancel Prior to Initiating Treatment|1
6020658|NCT00784875|20811942|P4|Period D|Lost to Follow-up|1
6020659|NCT00784875|20811943|P3|Period D|Lost to Follow-up|1
6020660|NCT00784875|20811944|P2|Period D|Lost to Follow-up|0
6020661|NCT00784875|20811945|P1|Period D|Lost to Follow-up|1
6020662|NCT00784875|20811942|P4|Period D|Sponsor Decision|0
6020663|NCT00784875|20811943|P3|Period D|Sponsor Decision|1
6020664|NCT00784875|20811944|P2|Period D|Sponsor Decision|1
6020665|NCT00784875|20811945|P1|Period D|Sponsor Decision|1
6020666|NCT00784875|20811942|P4|Period D|Physician Decision|0
6020667|NCT00784875|20811943|P3|Period D|Physician Decision|0
6020668|NCT00784875|20811944|P2|Period D|Physician Decision|1
6020669|NCT00784875|20811945|P1|Period D|Physician Decision|0
6020670|NCT00784875|20811942|P4|Period D|Withdrawal by Subject|0
6020671|NCT00784875|20811943|P3|Period D|Withdrawal by Subject|2
6020672|NCT00784875|20811944|P2|Period D|Withdrawal by Subject|0
6020673|NCT00784875|20811945|P1|Period D|Withdrawal by Subject|2
6020674|NCT00784875|20811942|P4|Period D|Protocol Violation|0
6020675|NCT00784875|20811943|P3|Period D|Protocol Violation|0
6020676|NCT00784875|20811944|P2|Period D|Protocol Violation|0
6020677|NCT00784875|20811945|P1|Period D|Protocol Violation|1
6020678|NCT00784875|20811942|P4|Period D|Adverse Event|0
6020679|NCT00784875|20811943|P3|Period D|Adverse Event|2
6020680|NCT00784875|20811944|P2|Period D|Adverse Event|2
6020681|NCT00784875|20811945|P1|Period D|Adverse Event|0
6020682|NCT00784875|20811942|P4|Period C|Sponsor Decision|2
6020683|NCT00784875|20811943|P3|Period C|Sponsor Decision|4
6020684|NCT00784875|20811944|P2|Period C|Sponsor Decision|5
6020685|NCT00784875|20811945|P1|Period C|Sponsor Decision|5
6020686|NCT00784875|20811942|P4|Period C|Physician Decision|1
6020687|NCT00784875|20811943|P3|Period C|Physician Decision|1
6020688|NCT00784875|20811944|P2|Period C|Physician Decision|0
6020689|NCT00784875|20811945|P1|Period C|Physician Decision|0
6020690|NCT00784875|20811942|P4|Period C|Withdrawal by Subject|0
6020691|NCT00784875|20811943|P3|Period C|Withdrawal by Subject|2
6020692|NCT00784875|20811944|P2|Period C|Withdrawal by Subject|1
6020693|NCT00784875|20811945|P1|Period C|Withdrawal by Subject|1
6020694|NCT00784875|20811942|P4|Period C|Lack of Efficacy|0
6020695|NCT00784875|20811943|P3|Period C|Lack of Efficacy|1
6020696|NCT00784875|20811944|P2|Period C|Lack of Efficacy|0
6020697|NCT00784875|20811945|P1|Period C|Lack of Efficacy|0
6020698|NCT00784875|20811942|P4|Period C|Protocol Violation|2
6020699|NCT00784875|20811943|P3|Period C|Protocol Violation|1
6020700|NCT00784875|20811944|P2|Period C|Protocol Violation|0
6020701|NCT00784875|20811945|P1|Period C|Protocol Violation|0
6020702|NCT00784875|20811942|P4|Period C|Adverse Event|2
6020703|NCT00784875|20811943|P3|Period C|Adverse Event|4
6020704|NCT00784875|20811944|P2|Period C|Adverse Event|0
6020705|NCT00784875|20811945|P1|Period C|Adverse Event|1
6020706|NCT00784875|20811942|P4|Period B - Efficacy Endpoint|Lost to Follow-up|0
6020707|NCT00784875|20811943|P3|Period B - Efficacy Endpoint|Lost to Follow-up|1
6020708|NCT00784875|20811944|P2|Period B - Efficacy Endpoint|Lost to Follow-up|0
6020709|NCT00784875|20811945|P1|Period B - Efficacy Endpoint|Lost to Follow-up|0
6020710|NCT00784875|20811942|P4|Period B - Efficacy Endpoint|Sponsor Decision|12
6020711|NCT00784875|20811943|P3|Period B - Efficacy Endpoint|Sponsor Decision|12
6020712|NCT00784875|20811944|P2|Period B - Efficacy Endpoint|Sponsor Decision|6
6020713|NCT00784875|20811945|P1|Period B - Efficacy Endpoint|Sponsor Decision|9
6020714|NCT00784875|20811942|P4|Period B - Efficacy Endpoint|Physician Decision|0
6020715|NCT00784875|20811943|P3|Period B - Efficacy Endpoint|Physician Decision|1
6020716|NCT00784875|20811944|P2|Period B - Efficacy Endpoint|Physician Decision|0
6020717|NCT00784875|20811945|P1|Period B - Efficacy Endpoint|Physician Decision|0
6020718|NCT00784875|20811942|P4|Period B - Efficacy Endpoint|Withdrawal by Subject|2
6020719|NCT00784875|20811943|P3|Period B - Efficacy Endpoint|Withdrawal by Subject|1
6020720|NCT00784875|20811944|P2|Period B - Efficacy Endpoint|Withdrawal by Subject|1
6020721|NCT00784875|20811945|P1|Period B - Efficacy Endpoint|Withdrawal by Subject|4
6020722|NCT00784875|20811942|P4|Period B - Efficacy Endpoint|Lack of Efficacy|0
6020723|NCT00784875|20811943|P3|Period B - Efficacy Endpoint|Lack of Efficacy|0
6020724|NCT00784875|20811944|P2|Period B - Efficacy Endpoint|Lack of Efficacy|1
6020725|NCT00784875|20811945|P1|Period B - Efficacy Endpoint|Lack of Efficacy|0
6020726|NCT00784875|20811942|P4|Period B - Efficacy Endpoint|Protocol Violation|3
6020727|NCT00784875|20811943|P3|Period B - Efficacy Endpoint|Protocol Violation|2
6020728|NCT00784875|20811944|P2|Period B - Efficacy Endpoint|Protocol Violation|1
6020729|NCT00784875|20811945|P1|Period B - Efficacy Endpoint|Protocol Violation|1
6020730|NCT00784875|20811942|P4|Period B - Efficacy Endpoint|Adverse Event|1
6020731|NCT00784875|20811943|P3|Period B - Efficacy Endpoint|Adverse Event|2
6020732|NCT00784875|20811944|P2|Period B - Efficacy Endpoint|Adverse Event|3
6020733|NCT00784875|20811945|P1|Period B - Efficacy Endpoint|Adverse Event|0
6020734|NCT00784875|20811942|P4|Period B - Efficacy Endpoint|Entry Criteria Not Met|1
6020735|NCT00784875|20811943|P3|Period B - Efficacy Endpoint|Entry Criteria Not Met|2
6020736|NCT00784875|20811944|P2|Period B - Efficacy Endpoint|Entry Criteria Not Met|0
6020737|NCT00784875|20811945|P1|Period B - Efficacy Endpoint|Entry Criteria Not Met|0
6020738|NCT00784875|20811942|P4|Period A - Baseline|Lost to Follow-up|2
6020739|NCT00784875|20811943|P3|Period A - Baseline|Lost to Follow-up|0
6020740|NCT00784875|20811944|P2|Period A - Baseline|Lost to Follow-up|0
6020741|NCT00784875|20811945|P1|Period A - Baseline|Lost to Follow-up|0
6020742|NCT00784875|20811942|P4|Period A - Baseline|Sponsor Decision|113
6020743|NCT00784875|20811943|P3|Period A - Baseline|Sponsor Decision|0
6020744|NCT00784875|20811944|P2|Period A - Baseline|Sponsor Decision|0
6020745|NCT00784875|20811945|P1|Period A - Baseline|Sponsor Decision|0
6020746|NCT00784875|20811942|P4|Period A - Baseline|Physician Decision|2
6020747|NCT00784875|20811943|P3|Period A - Baseline|Physician Decision|0
6020748|NCT00784875|20811944|P2|Period A - Baseline|Physician Decision|0
6020749|NCT00784875|20811945|P1|Period A - Baseline|Physician Decision|0
6020750|NCT00784875|20811942|P4|Period A - Baseline|Withdrawal by Subject|27
6020751|NCT00784875|20811943|P3|Period A - Baseline|Withdrawal by Subject|0
6020752|NCT00784875|20811944|P2|Period A - Baseline|Withdrawal by Subject|0
6020753|NCT00784875|20811945|P1|Period A - Baseline|Withdrawal by Subject|0
6020754|NCT00784875|20811942|P4|Period A - Baseline|Protocol Violation|25
6020755|NCT00784875|20811943|P3|Period A - Baseline|Protocol Violation|0
6020756|NCT00784875|20811944|P2|Period A - Baseline|Protocol Violation|0
6020757|NCT00784875|20811945|P1|Period A - Baseline|Protocol Violation|0
6020758|NCT00784875|20811942|P4|Period A - Baseline|Adverse Event|8
6020759|NCT00784875|20811943|P3|Period A - Baseline|Adverse Event|0
6020760|NCT00784875|20811944|P2|Period A - Baseline|Adverse Event|0
6020761|NCT00784875|20811945|P1|Period A - Baseline|Adverse Event|0
6020762|NCT00784875|20811942|P4|Period A - Baseline|Entry Criteria Not Met|5
6020763|NCT00784875|20811943|P3|Period A - Baseline|Entry Criteria Not Met|0
6020764|NCT00784875|20811944|P2|Period A - Baseline|Entry Criteria Not Met|0
6020765|NCT00784875|20811945|P1|Period A - Baseline|Entry Criteria Not Met|0
6020766|NCT00784836|20812065|P1|Overall Study|Early Study Termination|3
6020767|NCT00784810|20812072|P2|Overall Study|Lost to Follow-up|1
6020768|NCT00784810|20812073|P1|Overall Study|Lost to Follow-up|1
6020769|NCT00784810|20812072|P2|Overall Study|Administrative|8
6020770|NCT00784810|20812073|P1|Overall Study|Administrative|5
6020771|NCT00784810|20812072|P2|Overall Study|Withdrawal by Subject|9
6020772|NCT00784810|20812073|P1|Overall Study|Withdrawal by Subject|11
6020773|NCT00784810|20812072|P2|Overall Study|Lack of Efficacy|11
6020774|NCT00784810|20812073|P1|Overall Study|Lack of Efficacy|14
6020775|NCT00784810|20812072|P2|Overall Study|Adverse Event|20
6020776|NCT00784810|20812073|P1|Overall Study|Adverse Event|32
6020777|NCT00784784|20812083|P2|Overall Study|Withdrawal by Subject|2
6020778|NCT00784784|20812084|P1|Overall Study|Withdrawal by Subject|2
6020779|NCT00784758|20812094|P2|Overall Study|Adverse Event|0
6020780|NCT00784758|20812095|P1|Overall Study|Adverse Event|1
6020781|NCT00784758|20812094|P2|Overall Study|Withdrawal by Subject|0
6020782|NCT00784758|20812095|P1|Overall Study|Withdrawal by Subject|3
6020783|NCT00784719|20812144|P7|Overall Study|Withdrawal by Subject|1
6020784|NCT00784719|20812145|P6|Overall Study|Withdrawal by Subject|0
6020785|NCT00784719|20812146|P5|Overall Study|Withdrawal by Subject|2
6020786|NCT00784719|20812147|P4|Overall Study|Withdrawal by Subject|0
6020787|NCT00784719|20812148|P3|Overall Study|Withdrawal by Subject|0
6020788|NCT00784719|20812149|P2|Overall Study|Withdrawal by Subject|0
6020789|NCT00784719|20812150|P1|Overall Study|Withdrawal by Subject|1
6020790|NCT00784719|20812144|P7|Overall Study|Other|3
6020791|NCT00784719|20812145|P6|Overall Study|Other|1
6020792|NCT00784719|20812146|P5|Overall Study|Other|2
6020793|NCT00784719|20812147|P4|Overall Study|Other|0
6020794|NCT00784719|20812148|P3|Overall Study|Other|1
6020795|NCT00784719|20812149|P2|Overall Study|Other|1
6020796|NCT00784719|20812150|P1|Overall Study|Other|2
6020797|NCT00784719|20812144|P7|Overall Study|Lost to Follow-up|0
6020798|NCT00784719|20812145|P6|Overall Study|Lost to Follow-up|1
6020799|NCT00784719|20812146|P5|Overall Study|Lost to Follow-up|1
6020800|NCT00784719|20812147|P4|Overall Study|Lost to Follow-up|0
6020801|NCT00784719|20812148|P3|Overall Study|Lost to Follow-up|0
6020802|NCT00784719|20812149|P2|Overall Study|Lost to Follow-up|0
6020803|NCT00784719|20812150|P1|Overall Study|Lost to Follow-up|0
6020804|NCT00784719|20812144|P7|Overall Study|Adverse Event|1
6020805|NCT00784719|20812145|P6|Overall Study|Adverse Event|1
6020806|NCT00784719|20812146|P5|Overall Study|Adverse Event|1
6020807|NCT00784719|20812147|P4|Overall Study|Adverse Event|0
6020808|NCT00784719|20812148|P3|Overall Study|Adverse Event|0
6020809|NCT00784719|20812149|P2|Overall Study|Adverse Event|2
6020810|NCT00784719|20812150|P1|Overall Study|Adverse Event|0
6020811|NCT00784654|20812320|P3|Randomized Withdrawal Period|Family reasons|1
6020812|NCT00784654|20812321|P2|Randomized Withdrawal Period|Family reasons|0
6020813|NCT00784654|20812322|P1|Randomized Withdrawal Period|Family reasons|0
6020814|NCT00784654|20812320|P3|Randomized Withdrawal Period|Did not complete a visit|0
6020815|NCT00784654|20812321|P2|Randomized Withdrawal Period|Did not complete a visit|1
6020816|NCT00784654|20812322|P1|Randomized Withdrawal Period|Did not complete a visit|0
6020817|NCT00784654|20812320|P3|Randomized Withdrawal Period|Adverse Event|1
6020818|NCT00784654|20812321|P2|Randomized Withdrawal Period|Adverse Event|1
6020819|NCT00784654|20812322|P1|Randomized Withdrawal Period|Adverse Event|0
6020820|NCT00784654|20812320|P3|Randomized Withdrawal Period|Protocol Violation|1
6020821|NCT00784654|20812321|P2|Randomized Withdrawal Period|Protocol Violation|2
6020822|NCT00784654|20812322|P1|Randomized Withdrawal Period|Protocol Violation|0
6020823|NCT00784654|20812320|P3|Randomized Withdrawal Period|Withdrawal by Subject|7
6020824|NCT00784654|20812321|P2|Randomized Withdrawal Period|Withdrawal by Subject|1
6020825|NCT00784654|20812322|P1|Randomized Withdrawal Period|Withdrawal by Subject|0
6020826|NCT00784654|20812320|P3|Randomized Withdrawal Period|Lack of Efficacy|18
6020827|NCT00784654|20812321|P2|Randomized Withdrawal Period|Lack of Efficacy|5
6020828|NCT00784654|20812322|P1|Randomized Withdrawal Period|Lack of Efficacy|0
6020829|NCT00784654|20812320|P3|Randomized Withdrawal Period|Met relapse criteria per investigator|35
6020830|NCT00784654|20812321|P2|Randomized Withdrawal Period|Met relapse criteria per investigator|8
6020831|NCT00784654|20812322|P1|Randomized Withdrawal Period|Met relapse criteria per investigator|0
6020832|NCT00784654|20812320|P3|Open-Label Period (Non-Randomized)|Did not provide end of study page|0
6020833|NCT00784654|20812321|P2|Open-Label Period (Non-Randomized)|Did not provide end of study page|0
6020834|NCT00784654|20812322|P1|Open-Label Period (Non-Randomized)|Did not provide end of study page|1
6020835|NCT00784654|20812320|P3|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0
6020836|NCT00784654|20812321|P2|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0
6020837|NCT00784654|20812322|P1|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|1
6020838|NCT00784654|20812320|P3|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0
6020839|NCT00784654|20812321|P2|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0
6020840|NCT00784654|20812322|P1|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|1
6020841|NCT00784654|20812320|P3|Open-Label Period (Non-Randomized)|Home situation intolerable|0
6020842|NCT00784654|20812321|P2|Open-Label Period (Non-Randomized)|Home situation intolerable|0
6020843|NCT00784654|20812322|P1|Open-Label Period (Non-Randomized)|Home situation intolerable|1
6020844|NCT00784654|20812320|P3|Open-Label Period (Non-Randomized)|Decision of medical monitor|0
6020845|NCT00784654|20812321|P2|Open-Label Period (Non-Randomized)|Decision of medical monitor|0
6020846|NCT00784654|20812322|P1|Open-Label Period (Non-Randomized)|Decision of medical monitor|1
6020847|NCT00784654|20812320|P3|Open-Label Period (Non-Randomized)|Mother is a drug addict|0
6020848|NCT00784654|20812321|P2|Open-Label Period (Non-Randomized)|Mother is a drug addict|0
6020849|NCT00784654|20812322|P1|Open-Label Period (Non-Randomized)|Mother is a drug addict|1
6020850|NCT00784654|20812320|P3|Open-Label Period (Non-Randomized)|Protocol Violation|0
6020851|NCT00784654|20812321|P2|Open-Label Period (Non-Randomized)|Protocol Violation|0
6020852|NCT00784654|20812322|P1|Open-Label Period (Non-Randomized)|Protocol Violation|7
6020853|NCT00784654|20812320|P3|Open-Label Period (Non-Randomized)|Lost to Follow-up|0
6020854|NCT00784654|20812321|P2|Open-Label Period (Non-Randomized)|Lost to Follow-up|0
6020855|NCT00784654|20812322|P1|Open-Label Period (Non-Randomized)|Lost to Follow-up|11
6020856|NCT00784654|20812320|P3|Open-Label Period (Non-Randomized)|Lack of Efficacy|0
6020857|NCT00784654|20812321|P2|Open-Label Period (Non-Randomized)|Lack of Efficacy|0
6020858|NCT00784654|20812322|P1|Open-Label Period (Non-Randomized)|Lack of Efficacy|21
6020859|NCT00784654|20812320|P3|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0
6020860|NCT00784654|20812321|P2|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0
6020861|NCT00784654|20812322|P1|Open-Label Period (Non-Randomized)|Withdrawal by Subject|22
6020862|NCT00784654|20812320|P3|Open-Label Period (Non-Randomized)|Adverse Event|0
6020863|NCT00784654|20812321|P2|Open-Label Period (Non-Randomized)|Adverse Event|0
6020864|NCT00784654|20812322|P1|Open-Label Period (Non-Randomized)|Adverse Event|44
6020865|NCT00784563|20812370|P3|Year 3|Adverse Event|1
6020866|NCT00784563|20812371|P2|Year 3|Adverse Event|0
6020867|NCT00784563|20812372|P1|Year 3|Adverse Event|0
6020868|NCT00784563|20812370|P3|Year 3|Withdrawal by Subject|2
6020869|NCT00784563|20812371|P2|Year 3|Withdrawal by Subject|0
6020870|NCT00784563|20812372|P1|Year 3|Withdrawal by Subject|0
6020871|NCT00784563|20812370|P3|Years 1 & 2|Adverse Event|0
6020872|NCT00784563|20812371|P2|Years 1 & 2|Adverse Event|3
6020873|NCT00784563|20812372|P1|Years 1 & 2|Adverse Event|0
6020874|NCT00784563|20812370|P3|Years 1 & 2|Withdrawal by Subject|0
6020875|NCT00784563|20812371|P2|Years 1 & 2|Withdrawal by Subject|2
6020876|NCT00784563|20812372|P1|Years 1 & 2|Withdrawal by Subject|3
6020877|NCT00784550|20812390|P2|Overall Study|Withdrawal by Subject|13
6020878|NCT00784550|20812391|P1|Overall Study|Withdrawal by Subject|4
6020879|NCT00784550|20812390|P2|Overall Study|Physician Decision|3
6020880|NCT00784550|20812391|P1|Overall Study|Physician Decision|2
6020881|NCT00784550|20812390|P2|Overall Study|Lost to Follow-up|5
6020882|NCT00784550|20812391|P1|Overall Study|Lost to Follow-up|8
6020883|NCT00784550|20812390|P2|Overall Study|Protocol Violation|10
6020884|NCT00784550|20812391|P1|Overall Study|Protocol Violation|10
6020885|NCT00784550|20812390|P2|Overall Study|Lack of Efficacy|1
6020886|NCT00784550|20812391|P1|Overall Study|Lack of Efficacy|0
6020887|NCT00784550|20812390|P2|Overall Study|Adverse Event|10
6020888|NCT00784550|20812391|P1|Overall Study|Adverse Event|12
6020889|NCT00784459|20812417|P2|Overall Study|Adverse Event|2
6020890|NCT00784459|20812418|P1|Overall Study|Adverse Event|0
6020891|NCT00784368|20812429|P3|Overall Study|Withdrawal of informed consent|0
6020892|NCT00784368|20812430|P2|Overall Study|Withdrawal of informed consent|1
6020893|NCT00784368|20812431|P1|Overall Study|Withdrawal of informed consent|0
6020894|NCT00784368|20812429|P3|Overall Study|Worsening of symptoms|0
6020895|NCT00784368|20812430|P2|Overall Study|Worsening of symptoms|1
6020896|NCT00784368|20812431|P1|Overall Study|Worsening of symptoms|0
6020897|NCT00784368|20812429|P3|Overall Study|Worsening of complications|1
6020898|NCT00784368|20812430|P2|Overall Study|Worsening of complications|0
6020899|NCT00784368|20812431|P1|Overall Study|Worsening of complications|0
6020900|NCT00784368|20812429|P3|Overall Study|Diagnosis of fever|1
6020901|NCT00784368|20812430|P2|Overall Study|Diagnosis of fever|0
6020902|NCT00784368|20812431|P1|Overall Study|Diagnosis of fever|0
6020903|NCT00784368|20812429|P3|Overall Study|Adverse Event|2
6020904|NCT00784368|20812430|P2|Overall Study|Adverse Event|9
6020905|NCT00784368|20812431|P1|Overall Study|Adverse Event|6
6020906|NCT00784368|20812429|P3|Overall Study|Lack of Efficacy|1
6020907|NCT00784368|20812430|P2|Overall Study|Lack of Efficacy|0
6020908|NCT00784368|20812431|P1|Overall Study|Lack of Efficacy|2
6020909|NCT00784368|20812429|P3|Overall Study|Physician Decision|6
6020910|NCT00784368|20812430|P2|Overall Study|Physician Decision|0
6020911|NCT00784368|20812431|P1|Overall Study|Physician Decision|0
6020912|NCT00784277|20812507|P7|ER Treatment|Other|2
6020913|NCT00784277|20812508|P6|ER Treatment|Other|3
6020914|NCT00784277|20812509|P5|ER Treatment|Other|1
6020915|NCT00784277|20812510|P4|ER Treatment|Other|0
6020916|NCT00784277|20812511|P3|ER Treatment|Other|0
6020917|NCT00784277|20812512|P2|ER Treatment|Other|0
6020918|NCT00784277|20812513|P1|ER Treatment|Other|0
6020919|NCT00784277|20812507|P7|ER Treatment|Study Medication Non-Compliant|3
6020920|NCT00784277|20812508|P6|ER Treatment|Study Medication Non-Compliant|3
6020921|NCT00784277|20812509|P5|ER Treatment|Study Medication Non-Compliant|2
6020922|NCT00784277|20812510|P4|ER Treatment|Study Medication Non-Compliant|0
6020923|NCT00784277|20812511|P3|ER Treatment|Study Medication Non-Compliant|0
6020924|NCT00784277|20812512|P2|ER Treatment|Study Medication Non-Compliant|0
6020925|NCT00784277|20812513|P1|ER Treatment|Study Medication Non-Compliant|0
6020926|NCT00784277|20812507|P7|ER Treatment|Withdrawal by Subject|3
6020927|NCT00784277|20812508|P6|ER Treatment|Withdrawal by Subject|5
6020928|NCT00784277|20812509|P5|ER Treatment|Withdrawal by Subject|2
6020929|NCT00784277|20812510|P4|ER Treatment|Withdrawal by Subject|0
6020930|NCT00784277|20812511|P3|ER Treatment|Withdrawal by Subject|0
6020931|NCT00784277|20812512|P2|ER Treatment|Withdrawal by Subject|0
6020932|NCT00784277|20812513|P1|ER Treatment|Withdrawal by Subject|0
6020933|NCT00784277|20812507|P7|ER Treatment|Lost to Follow-up|0
6020934|NCT00784277|20812508|P6|ER Treatment|Lost to Follow-up|2
6020935|NCT00784277|20812509|P5|ER Treatment|Lost to Follow-up|0
6020936|NCT00784277|20812510|P4|ER Treatment|Lost to Follow-up|0
6020937|NCT00784277|20812511|P3|ER Treatment|Lost to Follow-up|0
6020938|NCT00784277|20812512|P2|ER Treatment|Lost to Follow-up|0
6020939|NCT00784277|20812513|P1|ER Treatment|Lost to Follow-up|0
6020940|NCT00784277|20812507|P7|ER Treatment|Lack of Efficacy|0
6020941|NCT00784277|20812508|P6|ER Treatment|Lack of Efficacy|4
6020942|NCT00784277|20812509|P5|ER Treatment|Lack of Efficacy|3
6020943|NCT00784277|20812510|P4|ER Treatment|Lack of Efficacy|0
6020944|NCT00784277|20812511|P3|ER Treatment|Lack of Efficacy|0
6020945|NCT00784277|20812512|P2|ER Treatment|Lack of Efficacy|0
6020946|NCT00784277|20812513|P1|ER Treatment|Lack of Efficacy|0
6020947|NCT00784277|20812507|P7|ER Treatment|Adverse Event|7
6020948|NCT00784277|20812508|P6|ER Treatment|Adverse Event|7
6020949|NCT00784277|20812509|P5|ER Treatment|Adverse Event|1
6020950|NCT00784277|20812510|P4|ER Treatment|Adverse Event|0
6020951|NCT00784277|20812511|P3|ER Treatment|Adverse Event|0
6020952|NCT00784277|20812512|P2|ER Treatment|Adverse Event|0
6020953|NCT00784277|20812513|P1|ER Treatment|Adverse Event|0
6020954|NCT00784277|20812507|P7|IR Treatment|Other|0
6020955|NCT00784277|20812508|P6|IR Treatment|Other|0
6020956|NCT00784277|20812509|P5|IR Treatment|Other|0
6020957|NCT00784277|20812510|P4|IR Treatment|Other|2
6020958|NCT00784277|20812511|P3|IR Treatment|Other|3
6020959|NCT00784277|20812512|P2|IR Treatment|Other|3
6020960|NCT00784277|20812513|P1|IR Treatment|Other|2
6020961|NCT00784277|20812507|P7|IR Treatment|Resolution Of Pain|0
6020962|NCT00784277|20812508|P6|IR Treatment|Resolution Of Pain|0
6020963|NCT00784277|20812509|P5|IR Treatment|Resolution Of Pain|0
6020964|NCT00784277|20812510|P4|IR Treatment|Resolution Of Pain|0
6020965|NCT00784277|20812511|P3|IR Treatment|Resolution Of Pain|0
6020966|NCT00784277|20812512|P2|IR Treatment|Resolution Of Pain|1
6020967|NCT00784277|20812513|P1|IR Treatment|Resolution Of Pain|0
6020968|NCT00784277|20812507|P7|IR Treatment|Withdrawal by Subject|0
6020969|NCT00784277|20812508|P6|IR Treatment|Withdrawal by Subject|0
6020970|NCT00784277|20812509|P5|IR Treatment|Withdrawal by Subject|0
6020971|NCT00784277|20812510|P4|IR Treatment|Withdrawal by Subject|6
6020972|NCT00784277|20812511|P3|IR Treatment|Withdrawal by Subject|4
6020973|NCT00784277|20812512|P2|IR Treatment|Withdrawal by Subject|1
6020974|NCT00784277|20812513|P1|IR Treatment|Withdrawal by Subject|5
6020975|NCT00784277|20812507|P7|IR Treatment|Lost to Follow-up|0
6020976|NCT00784277|20812508|P6|IR Treatment|Lost to Follow-up|0
6020977|NCT00784277|20812509|P5|IR Treatment|Lost to Follow-up|0
6020978|NCT00784277|20812510|P4|IR Treatment|Lost to Follow-up|0
6020979|NCT00784277|20812511|P3|IR Treatment|Lost to Follow-up|1
6020980|NCT00784277|20812512|P2|IR Treatment|Lost to Follow-up|0
6020981|NCT00784277|20812513|P1|IR Treatment|Lost to Follow-up|1
6020982|NCT00784277|20812507|P7|IR Treatment|Lack of Efficacy|0
6020983|NCT00784277|20812508|P6|IR Treatment|Lack of Efficacy|0
6020984|NCT00784277|20812509|P5|IR Treatment|Lack of Efficacy|0
6020985|NCT00784277|20812510|P4|IR Treatment|Lack of Efficacy|0
6020986|NCT00784277|20812511|P3|IR Treatment|Lack of Efficacy|1
6020987|NCT00784277|20812512|P2|IR Treatment|Lack of Efficacy|4
6020988|NCT00784277|20812513|P1|IR Treatment|Lack of Efficacy|4
6020989|NCT00784277|20812507|P7|IR Treatment|Adverse Event|0
6020990|NCT00784277|20812508|P6|IR Treatment|Adverse Event|0
6020991|NCT00784277|20812509|P5|IR Treatment|Adverse Event|0
6020992|NCT00784277|20812510|P4|IR Treatment|Adverse Event|35
6020993|NCT00784277|20812511|P3|IR Treatment|Adverse Event|19
6020994|NCT00784277|20812512|P2|IR Treatment|Adverse Event|8
6020995|NCT00784277|20812513|P1|IR Treatment|Adverse Event|4
6020996|NCT00784238|20812530|P1|Overall Study|Other|14
6020997|NCT00784238|20812530|P1|Overall Study|Withdrawal by Subject|26
6020998|NCT00784238|20812530|P1|Overall Study|Pregnancy|1
6020999|NCT00784238|20812530|P1|Overall Study|Lost to Follow-up|29
6021000|NCT00784238|20812530|P1|Overall Study|Lack of Efficacy|33
6021001|NCT00784238|20812530|P1|Overall Study|Death|2
6021002|NCT00784238|20812530|P1|Overall Study|Adverse Event|14
6021003|NCT00784147|20812602|P2|Overall Study|Death|0
6021004|NCT00784147|20812603|P1|Overall Study|Death|2
6021005|NCT00784147|20812602|P2|Overall Study|Protocol Violation|1
6021006|NCT00784147|20812603|P1|Overall Study|Protocol Violation|1
6021007|NCT00784147|20812602|P2|Overall Study|Physician Decision|1
6021008|NCT00784147|20812603|P1|Overall Study|Physician Decision|2
6021009|NCT00784147|20812602|P2|Overall Study|Withdrawal by Subject|3
6021010|NCT00784147|20812603|P1|Overall Study|Withdrawal by Subject|1
6021011|NCT00784147|20812602|P2|Overall Study|Lost to Follow-up|4
6021012|NCT00784147|20812603|P1|Overall Study|Lost to Follow-up|2
6021013|NCT00784134|20812623|P2|Overall Study|Lost to Follow-up|6
6021014|NCT00784134|20812624|P1|Overall Study|Lost to Follow-up|3
6021015|NCT00784043|20812747|P2|Overall Study|Protocol Terminated|1
6021016|NCT00784043|20812748|P1|Overall Study|Protocol Terminated|23
6021017|NCT00784043|20812747|P2|Overall Study|Withdrawal by Subject|5
6021018|NCT00784043|20812748|P1|Overall Study|Withdrawal by Subject|8
6021019|NCT00783835|20812783|P1|Overall Study|Participant not Adherent|3
6021020|NCT00783835|20812783|P1|Overall Study|Lost to Follow-up|1
6021021|NCT00783835|20812783|P1|Overall Study|Withdrawal by Subject|2
6021022|NCT00783835|20812783|P1|Overall Study|Medical Criteria|1
6021023|NCT00783835|20812783|P1|Overall Study|Adverse Event|3
6021024|NCT00783796|20812795|P1|Overall Study|Received commercial XIENCE V stent|1
6021025|NCT00783796|20812795|P1|Overall Study|Received non-XIENCE V stent|1
6021026|NCT00783796|20812795|P1|Overall Study|Did not receive any stent|4
6021027|NCT00783718|20812900|P7|Maintenance Phase|Lost to Follow-up|2
6021028|NCT00783718|20812901|P6|Maintenance Phase|Lost to Follow-up|0
6021029|NCT00783718|20812902|P5|Maintenance Phase|Lost to Follow-up|2
6021030|NCT00783718|20812903|P4|Maintenance Phase|Lost to Follow-up|0
6021031|NCT00783718|20812904|P3|Maintenance Phase|Lost to Follow-up|0
6021032|NCT00783718|20812905|P2|Maintenance Phase|Lost to Follow-up|0
6021033|NCT00783718|20812906|P1|Maintenance Phase|Lost to Follow-up|3
6021034|NCT00783718|20812900|P7|Maintenance Phase|Withdrawal by Subject|20
6021035|NCT00783718|20812901|P6|Maintenance Phase|Withdrawal by Subject|2
6021036|NCT00783718|20812902|P5|Maintenance Phase|Withdrawal by Subject|5
6021037|NCT00783718|20812903|P4|Maintenance Phase|Withdrawal by Subject|2
6021038|NCT00783718|20812904|P3|Maintenance Phase|Withdrawal by Subject|0
6021039|NCT00783718|20812905|P2|Maintenance Phase|Withdrawal by Subject|0
6021040|NCT00783718|20812906|P1|Maintenance Phase|Withdrawal by Subject|6
6021041|NCT00783718|20812900|P7|Maintenance Phase|Lack of Efficacy|155
6021042|NCT00783718|20812901|P6|Maintenance Phase|Lack of Efficacy|33
6021043|NCT00783718|20812902|P5|Maintenance Phase|Lack of Efficacy|31
6021044|NCT00783718|20812903|P4|Maintenance Phase|Lack of Efficacy|61
6021045|NCT00783718|20812904|P3|Maintenance Phase|Lack of Efficacy|0
6021046|NCT00783718|20812905|P2|Maintenance Phase|Lack of Efficacy|0
6021047|NCT00783718|20812906|P1|Maintenance Phase|Lack of Efficacy|83
6021048|NCT00783718|20812900|P7|Maintenance Phase|Protocol Violation|2
6021049|NCT00783718|20812901|P6|Maintenance Phase|Protocol Violation|0
6021050|NCT00783718|20812902|P5|Maintenance Phase|Protocol Violation|0
6021051|NCT00783718|20812903|P4|Maintenance Phase|Protocol Violation|0
6021052|NCT00783718|20812904|P3|Maintenance Phase|Protocol Violation|0
6021053|NCT00783718|20812905|P2|Maintenance Phase|Protocol Violation|0
6021054|NCT00783718|20812906|P1|Maintenance Phase|Protocol Violation|1
6021055|NCT00783718|20812900|P7|Maintenance Phase|Adverse Event|16
6021056|NCT00783718|20812901|P6|Maintenance Phase|Adverse Event|6
6021057|NCT00783718|20812902|P5|Maintenance Phase|Adverse Event|7
6021058|NCT00783718|20812903|P4|Maintenance Phase|Adverse Event|15
6021059|NCT00783718|20812904|P3|Maintenance Phase|Adverse Event|0
6021060|NCT00783718|20812905|P2|Maintenance Phase|Adverse Event|0
6021061|NCT00783718|20812906|P1|Maintenance Phase|Adverse Event|12
6021062|NCT00783718|20812900|P7|Induction Phase|Lost to Follow-up|0
6021063|NCT00783718|20812901|P6|Induction Phase|Lost to Follow-up|0
6021064|NCT00783718|20812902|P5|Induction Phase|Lost to Follow-up|0
6021065|NCT00783718|20812903|P4|Induction Phase|Lost to Follow-up|0
6021066|NCT00783718|20812904|P3|Induction Phase|Lost to Follow-up|1
6021067|NCT00783718|20812905|P2|Induction Phase|Lost to Follow-up|0
6021068|NCT00783718|20812906|P1|Induction Phase|Lost to Follow-up|1
6021069|NCT00783718|20812900|P7|Induction Phase|Withdrawal by Subject|0
6021070|NCT00783718|20812901|P6|Induction Phase|Withdrawal by Subject|0
6021071|NCT00783718|20812902|P5|Induction Phase|Withdrawal by Subject|0
6021072|NCT00783718|20812903|P4|Induction Phase|Withdrawal by Subject|0
6021073|NCT00783718|20812904|P3|Induction Phase|Withdrawal by Subject|8
6021074|NCT00783718|20812905|P2|Induction Phase|Withdrawal by Subject|4
6021075|NCT00783718|20812906|P1|Induction Phase|Withdrawal by Subject|3
6021076|NCT00783718|20812900|P7|Induction Phase|Lack of Efficacy|0
6021077|NCT00783718|20812901|P6|Induction Phase|Lack of Efficacy|0
6021078|NCT00783718|20812902|P5|Induction Phase|Lack of Efficacy|0
6021079|NCT00783718|20812903|P4|Induction Phase|Lack of Efficacy|0
6021080|NCT00783718|20812904|P3|Induction Phase|Lack of Efficacy|14
6021081|NCT00783718|20812905|P2|Induction Phase|Lack of Efficacy|2
6021082|NCT00783718|20812906|P1|Induction Phase|Lack of Efficacy|5
6021083|NCT00783718|20812900|P7|Induction Phase|Protocol Violation|0
6021084|NCT00783718|20812901|P6|Induction Phase|Protocol Violation|0
6021085|NCT00783718|20812902|P5|Induction Phase|Protocol Violation|0
6021086|NCT00783718|20812903|P4|Induction Phase|Protocol Violation|0
6021087|NCT00783718|20812904|P3|Induction Phase|Protocol Violation|6
6021088|NCT00783718|20812905|P2|Induction Phase|Protocol Violation|1
6021089|NCT00783718|20812906|P1|Induction Phase|Protocol Violation|1
6021090|NCT00783718|20812900|P7|Induction Phase|Adverse Event|0
6021091|NCT00783718|20812901|P6|Induction Phase|Adverse Event|0
6021092|NCT00783718|20812902|P5|Induction Phase|Adverse Event|0
6021093|NCT00783718|20812903|P4|Induction Phase|Adverse Event|0
6021094|NCT00783718|20812904|P3|Induction Phase|Adverse Event|7
6021095|NCT00783718|20812905|P2|Induction Phase|Adverse Event|0
6021096|NCT00783718|20812906|P1|Induction Phase|Adverse Event|4
6021097|NCT00783705|20812934|P2|Overall Study|Lost to Follow-up|3
6021098|NCT00783705|20812935|P1|Overall Study|Lost to Follow-up|1
6021099|NCT00783705|20812934|P2|Overall Study|Withdrawal by Subject|2
6021100|NCT00783705|20812935|P1|Overall Study|Withdrawal by Subject|3
6021101|NCT00783705|20812934|P2|Overall Study|Adverse Event|0
6021102|NCT00783705|20812935|P1|Overall Study|Adverse Event|2
6021103|NCT00783692|20812982|P7|Maintenance Phase|Other|1
6021104|NCT00783692|20812983|P6|Maintenance Phase|Other|1
6021105|NCT00783692|20812984|P5|Maintenance Phase|Other|0
6021106|NCT00783692|20812985|P4|Maintenance Phase|Other|1
6021107|NCT00783692|20812986|P3|Maintenance Phase|Other|0
6021108|NCT00783692|20812987|P2|Maintenance Phase|Other|0
6021109|NCT00783692|20812988|P1|Maintenance Phase|Other|0
6021110|NCT00783692|20812982|P7|Maintenance Phase|Lost to Follow-up|5
6021111|NCT00783692|20812983|P6|Maintenance Phase|Lost to Follow-up|2
6021112|NCT00783692|20812984|P5|Maintenance Phase|Lost to Follow-up|3
6021113|NCT00783692|20812985|P4|Maintenance Phase|Lost to Follow-up|1
6021114|NCT00783692|20812986|P3|Maintenance Phase|Lost to Follow-up|0
6021115|NCT00783692|20812987|P2|Maintenance Phase|Lost to Follow-up|0
6021116|NCT00783692|20812988|P1|Maintenance Phase|Lost to Follow-up|2
6021117|NCT00783692|20812982|P7|Maintenance Phase|Withdrawal by Subject|24
6021118|NCT00783692|20812983|P6|Maintenance Phase|Withdrawal by Subject|9
6021119|NCT00783692|20812984|P5|Maintenance Phase|Withdrawal by Subject|6
6021120|NCT00783692|20812985|P4|Maintenance Phase|Withdrawal by Subject|7
6021121|NCT00783692|20812986|P3|Maintenance Phase|Withdrawal by Subject|0
6021122|NCT00783692|20812987|P2|Maintenance Phase|Withdrawal by Subject|0
6021123|NCT00783692|20812988|P1|Maintenance Phase|Withdrawal by Subject|7
6021124|NCT00783692|20812982|P7|Maintenance Phase|Lack of Efficacy|177
6021125|NCT00783692|20812983|P6|Maintenance Phase|Lack of Efficacy|48
6021126|NCT00783692|20812984|P5|Maintenance Phase|Lack of Efficacy|58
6021127|NCT00783692|20812985|P4|Maintenance Phase|Lack of Efficacy|64
6021128|NCT00783692|20812986|P3|Maintenance Phase|Lack of Efficacy|0
6021129|NCT00783692|20812987|P2|Maintenance Phase|Lack of Efficacy|0
6021130|NCT00783692|20812988|P1|Maintenance Phase|Lack of Efficacy|79
6021131|NCT00783692|20812982|P7|Maintenance Phase|Protocol Violation|4
6021132|NCT00783692|20812983|P6|Maintenance Phase|Protocol Violation|3
6021133|NCT00783692|20812984|P5|Maintenance Phase|Protocol Violation|2
6021134|NCT00783692|20812985|P4|Maintenance Phase|Protocol Violation|1
6021135|NCT00783692|20812986|P3|Maintenance Phase|Protocol Violation|0
6021136|NCT00783692|20812987|P2|Maintenance Phase|Protocol Violation|0
6021137|NCT00783692|20812988|P1|Maintenance Phase|Protocol Violation|0
6021138|NCT00783692|20812982|P7|Maintenance Phase|Adverse Event|38
6021139|NCT00783692|20812983|P6|Maintenance Phase|Adverse Event|9
6021140|NCT00783692|20812984|P5|Maintenance Phase|Adverse Event|12
6021141|NCT00783692|20812985|P4|Maintenance Phase|Adverse Event|15
6021142|NCT00783692|20812986|P3|Maintenance Phase|Adverse Event|0
6021143|NCT00783692|20812987|P2|Maintenance Phase|Adverse Event|0
6021144|NCT00783692|20812988|P1|Maintenance Phase|Adverse Event|7
6021145|NCT00783692|20812982|P7|Induction Phase|Other|0
6021146|NCT00783692|20812983|P6|Induction Phase|Other|0
6021147|NCT00783692|20812984|P5|Induction Phase|Other|0
6021148|NCT00783692|20812985|P4|Induction Phase|Other|0
6021149|NCT00783692|20812986|P3|Induction Phase|Other|2
6021150|NCT00783692|20812987|P2|Induction Phase|Other|0
6021151|NCT00783692|20812988|P1|Induction Phase|Other|0
6021152|NCT00783692|20812982|P7|Induction Phase|Lost to Follow-up|0
6021153|NCT00783692|20812983|P6|Induction Phase|Lost to Follow-up|0
6021154|NCT00783692|20812984|P5|Induction Phase|Lost to Follow-up|0
6021155|NCT00783692|20812985|P4|Induction Phase|Lost to Follow-up|0
6021156|NCT00783692|20812986|P3|Induction Phase|Lost to Follow-up|3
6021157|NCT00783692|20812987|P2|Induction Phase|Lost to Follow-up|0
6021158|NCT00783692|20812988|P1|Induction Phase|Lost to Follow-up|0
6021159|NCT00783692|20812982|P7|Induction Phase|Withdrawal by Subject|0
6021160|NCT00783692|20812983|P6|Induction Phase|Withdrawal by Subject|0
6021161|NCT00783692|20812984|P5|Induction Phase|Withdrawal by Subject|0
6021162|NCT00783692|20812985|P4|Induction Phase|Withdrawal by Subject|0
6021163|NCT00783692|20812986|P3|Induction Phase|Withdrawal by Subject|16
6021164|NCT00783692|20812987|P2|Induction Phase|Withdrawal by Subject|9
6021165|NCT00783692|20812988|P1|Induction Phase|Withdrawal by Subject|3
6021166|NCT00783692|20812982|P7|Induction Phase|Lack of Efficacy|0
6021167|NCT00783692|20812983|P6|Induction Phase|Lack of Efficacy|0
6021168|NCT00783692|20812984|P5|Induction Phase|Lack of Efficacy|0
6021169|NCT00783692|20812985|P4|Induction Phase|Lack of Efficacy|0
6021170|NCT00783692|20812986|P3|Induction Phase|Lack of Efficacy|28
6021171|NCT00783692|20812987|P2|Induction Phase|Lack of Efficacy|3
6021172|NCT00783692|20812988|P1|Induction Phase|Lack of Efficacy|1
6021173|NCT00783692|20812982|P7|Induction Phase|Protocol Violation|0
6021174|NCT00783692|20812983|P6|Induction Phase|Protocol Violation|0
6021175|NCT00783692|20812984|P5|Induction Phase|Protocol Violation|0
6021176|NCT00783692|20812985|P4|Induction Phase|Protocol Violation|0
6021177|NCT00783692|20812986|P3|Induction Phase|Protocol Violation|1
6021178|NCT00783692|20812987|P2|Induction Phase|Protocol Violation|0
6021179|NCT00783692|20812988|P1|Induction Phase|Protocol Violation|0
6021180|NCT00783692|20812982|P7|Induction Phase|Adverse Event|0
6021181|NCT00783692|20812983|P6|Induction Phase|Adverse Event|0
6021182|NCT00783692|20812984|P5|Induction Phase|Adverse Event|0
6021183|NCT00783692|20812985|P4|Induction Phase|Adverse Event|0
6021184|NCT00783692|20812986|P3|Induction Phase|Adverse Event|24
6021185|NCT00783692|20812987|P2|Induction Phase|Adverse Event|9
6021186|NCT00783692|20812988|P1|Induction Phase|Adverse Event|7
6021187|NCT00783432|20813034|P2|Overall Study|Protocol Violation|9
6021188|NCT00783432|20813035|P1|Overall Study|Protocol Violation|6
6021189|NCT00783432|20813034|P2|Overall Study|subject moved|5
6021190|NCT00783432|20813035|P1|Overall Study|subject moved|3
6021191|NCT00783432|20813034|P2|Overall Study|Withdrawal by Subject|20
6021192|NCT00783432|20813035|P1|Overall Study|Withdrawal by Subject|23
6021193|NCT00783432|20813034|P2|Overall Study|Lost to Follow-up|6
6021194|NCT00783432|20813035|P1|Overall Study|Lost to Follow-up|11
6021195|NCT00783432|20813034|P2|Overall Study|Lack of Efficacy|21
6021196|NCT00783432|20813035|P1|Overall Study|Lack of Efficacy|20
6021197|NCT00783432|20813034|P2|Overall Study|Adverse Event|17
6021198|NCT00783432|20813035|P1|Overall Study|Adverse Event|22
6021199|NCT00783302|20813045|P1|Overall Study|Withdrawal by Subject|3
6021200|NCT00783302|20813045|P1|Overall Study|Physician Decision|1
6021201|NCT00783302|20813045|P1|Overall Study|Protocol Violation|3
6021202|NCT00783302|20813045|P1|Overall Study|Technical Problems|11
6021203|NCT00783302|20813045|P1|Overall Study|Lost to Follow-up|17
6021204|NCT00783289|20813067|P4|Overall Study|Protocol Violation|0
6021205|NCT00783289|20813068|P3|Overall Study|Protocol Violation|0
6021206|NCT00783289|20813069|P2|Overall Study|Protocol Violation|1
6021207|NCT00783289|20813070|P1|Overall Study|Protocol Violation|0
6021208|NCT00783263|20813100|P4|Overall Study|Withdrawal by Subject|2
6021209|NCT00783263|20813101|P3|Overall Study|Withdrawal by Subject|1
6021210|NCT00783263|20813102|P2|Overall Study|Withdrawal by Subject|1
6021211|NCT00783263|20813103|P1|Overall Study|Withdrawal by Subject|0
6021212|NCT00783263|20813100|P4|Overall Study|Lost to Follow-up|0
6021213|NCT00783263|20813101|P3|Overall Study|Lost to Follow-up|0
6021214|NCT00783263|20813102|P2|Overall Study|Lost to Follow-up|1
6021215|NCT00783263|20813103|P1|Overall Study|Lost to Follow-up|1
6021216|NCT00783263|20813100|P4|Overall Study|Adverse Event|1
6021217|NCT00783263|20813101|P3|Overall Study|Adverse Event|2
6021218|NCT00783263|20813102|P2|Overall Study|Adverse Event|0
6021219|NCT00783263|20813103|P1|Overall Study|Adverse Event|3
6021220|NCT00783224|20813133|P4|Overall Study|Inappropriate as a study subject|1
6021221|NCT00783224|20813134|P3|Overall Study|Inappropriate as a study subject|0
6021222|NCT00783224|20813135|P2|Overall Study|Inappropriate as a study subject|0
6021223|NCT00783224|20813136|P1|Overall Study|Inappropriate as a study subject|0
6021224|NCT00783224|20813133|P4|Overall Study|Discarded the Investigational Drug Used|1
6021225|NCT00783224|20813134|P3|Overall Study|Discarded the Investigational Drug Used|0
6021226|NCT00783224|20813135|P2|Overall Study|Discarded the Investigational Drug Used|0
6021227|NCT00783224|20813136|P1|Overall Study|Discarded the Investigational Drug Used|0
6021228|NCT00783224|20813133|P4|Overall Study|Adverse Event|0
6021229|NCT00783224|20813134|P3|Overall Study|Adverse Event|1
6021230|NCT00783224|20813135|P2|Overall Study|Adverse Event|0
6021231|NCT00783224|20813136|P1|Overall Study|Adverse Event|0
6021232|NCT00783198|20813148|P3|Overall Study|Administrative|2
6021233|NCT00783198|20813149|P2|Overall Study|Administrative|1
6021234|NCT00783198|20813150|P1|Overall Study|Administrative|2
6021235|NCT00783198|20813148|P3|Overall Study|Did not meet protocol eligibility|0
6021236|NCT00783198|20813149|P2|Overall Study|Did not meet protocol eligibility|1
6021237|NCT00783198|20813150|P1|Overall Study|Did not meet protocol eligibility|0
6021238|NCT00783198|20813148|P3|Overall Study|Noncompliance with protocol|10
6021239|NCT00783198|20813149|P2|Overall Study|Noncompliance with protocol|7
6021240|NCT00783198|20813150|P1|Overall Study|Noncompliance with protocol|7
6021241|NCT00783198|20813148|P3|Overall Study|Withdrawal by Subject|20
6021242|NCT00783198|20813149|P2|Overall Study|Withdrawal by Subject|14
6021243|NCT00783198|20813150|P1|Overall Study|Withdrawal by Subject|22
6021244|NCT00783198|20813148|P3|Overall Study|Lost to Follow-up|7
6021245|NCT00783198|20813149|P2|Overall Study|Lost to Follow-up|1
6021246|NCT00783198|20813150|P1|Overall Study|Lost to Follow-up|11
6021247|NCT00783198|20813148|P3|Overall Study|Adverse Event|3
6021248|NCT00783198|20813149|P2|Overall Study|Adverse Event|19
6021249|NCT00783198|20813150|P1|Overall Study|Adverse Event|15
6021250|NCT00783094|20813173|P3|Open-Label Extension Period|Lack of Efficacy|0
6021251|NCT00783094|20813174|P2|Open-Label Extension Period|Lack of Efficacy|4
6021252|NCT00783094|20813175|P1|Open-Label Extension Period|Lack of Efficacy|1
6021253|NCT00783094|20813173|P3|Open-Label Extension Period|Physician Decision|3
6021254|NCT00783094|20813174|P2|Open-Label Extension Period|Physician Decision|2
6021255|NCT00783094|20813175|P1|Open-Label Extension Period|Physician Decision|4
6021256|NCT00783094|20813173|P3|Open-Label Extension Period|Withdrawal by Subject|3
6021257|NCT00783094|20813174|P2|Open-Label Extension Period|Withdrawal by Subject|1
6021258|NCT00783094|20813175|P1|Open-Label Extension Period|Withdrawal by Subject|1
6021259|NCT00783094|20813173|P3|Open-Label Extension Period|Protocol Violation|7
6021260|NCT00783094|20813174|P2|Open-Label Extension Period|Protocol Violation|5
6021261|NCT00783094|20813175|P1|Open-Label Extension Period|Protocol Violation|4
6021262|NCT00783094|20813173|P3|Open-Label Extension Period|Death|1
6021263|NCT00783094|20813174|P2|Open-Label Extension Period|Death|0
6021264|NCT00783094|20813175|P1|Open-Label Extension Period|Death|0
6021265|NCT00783094|20813173|P3|Open-Label Extension Period|Adverse Event|16
6021266|NCT00783094|20813174|P2|Open-Label Extension Period|Adverse Event|7
6021267|NCT00783094|20813175|P1|Open-Label Extension Period|Adverse Event|12
6021268|NCT00783094|20813173|P3|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2
6021269|NCT00783094|20813174|P2|Randomized Double-Blind Treatment Period|Withdrawal by Subject|1
6021270|NCT00783094|20813175|P1|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2
6021271|NCT00783094|20813173|P3|Randomized Double-Blind Treatment Period|Protocol Violation|1
6021272|NCT00783094|20813174|P2|Randomized Double-Blind Treatment Period|Protocol Violation|2
6021273|NCT00783094|20813175|P1|Randomized Double-Blind Treatment Period|Protocol Violation|1
6021274|NCT00783094|20813173|P3|Randomized Double-Blind Treatment Period|Physician Decision|0
6021275|NCT00783094|20813174|P2|Randomized Double-Blind Treatment Period|Physician Decision|2
6021276|NCT00783094|20813175|P1|Randomized Double-Blind Treatment Period|Physician Decision|0
6021277|NCT00783094|20813173|P3|Randomized Double-Blind Treatment Period|Lack of Efficacy|1
6021278|NCT00783094|20813174|P2|Randomized Double-Blind Treatment Period|Lack of Efficacy|2
6021279|NCT00783094|20813175|P1|Randomized Double-Blind Treatment Period|Lack of Efficacy|0
6021280|NCT00783094|20813173|P3|Randomized Double-Blind Treatment Period|Adverse Event|5
6021281|NCT00783094|20813174|P2|Randomized Double-Blind Treatment Period|Adverse Event|5
6021282|NCT00783094|20813175|P1|Randomized Double-Blind Treatment Period|Adverse Event|4
6021283|NCT00782834|20813251|P1|Treatment Phase|fibrous tumor not GIST|1
6021284|NCT00782795|20813291|P2|Overall Study|Withdrawal by Subject|2
6021285|NCT00782795|20813292|P1|Overall Study|Withdrawal by Subject|1
6021286|NCT00782717|20813332|P2|Overall Study|Exited in error|2
6021287|NCT00782717|20813333|P1|Overall Study|Exited in error|0
6021288|NCT00782717|20813332|P2|Overall Study|Did not meet entrance criteria|3
6021289|NCT00782717|20813333|P1|Overall Study|Did not meet entrance criteria|1
6021290|NCT00782717|20813332|P2|Overall Study|Enrollment close prior to surgery|0
6021291|NCT00782717|20813333|P1|Overall Study|Enrollment close prior to surgery|1
6021292|NCT00782717|20813332|P2|Overall Study|Treatment failure|14
6021293|NCT00782717|20813333|P1|Overall Study|Treatment failure|3
6021294|NCT00782717|20813332|P2|Overall Study|Noncompliance|1
6021295|NCT00782717|20813333|P1|Overall Study|Noncompliance|2
6021296|NCT00782717|20813332|P2|Overall Study|Patient decision unrelated to AE|3
6021297|NCT00782717|20813333|P1|Overall Study|Patient decision unrelated to AE|6
6021298|NCT00782717|20813332|P2|Overall Study|Adverse Event|5
6021299|NCT00782717|20813333|P1|Overall Study|Adverse Event|2
6021300|NCT00782626|20813360|P1|Overall Study|Other Complicating Disease|1
6021301|NCT00782626|20813360|P1|Overall Study|Progressive Disease|5
6021302|NCT00782626|20813360|P1|Overall Study|Adverse Event|1
6021303|NCT00782509|20813367|P3|Overall Study|Lack of Efficacy|2
6021304|NCT00782509|20813368|P2|Overall Study|Lack of Efficacy|5
6021305|NCT00782509|20813369|P1|Overall Study|Lack of Efficacy|10
6021306|NCT00782509|20813367|P3|Overall Study|Other reasons not stated above|3
6021307|NCT00782509|20813368|P2|Overall Study|Other reasons not stated above|2
6021308|NCT00782509|20813369|P1|Overall Study|Other reasons not stated above|5
6021309|NCT00782509|20813367|P3|Overall Study|Non compliance with protocol|0
6021310|NCT00782509|20813368|P2|Overall Study|Non compliance with protocol|0
6021311|NCT00782509|20813369|P1|Overall Study|Non compliance with protocol|2
6021312|NCT00782509|20813367|P3|Overall Study|Withdrawal by Subject|8
6021313|NCT00782509|20813368|P2|Overall Study|Withdrawal by Subject|5
6021314|NCT00782509|20813369|P1|Overall Study|Withdrawal by Subject|3
6021315|NCT00782509|20813367|P3|Overall Study|Lost to Follow-up|3
6021316|NCT00782509|20813368|P2|Overall Study|Lost to Follow-up|2
6021317|NCT00782509|20813369|P1|Overall Study|Lost to Follow-up|1
6021318|NCT00782509|20813367|P3|Overall Study|Adverse Event|20
6021319|NCT00782509|20813368|P2|Overall Study|Adverse Event|10
6021320|NCT00782509|20813369|P1|Overall Study|Adverse Event|20
6021321|NCT00782496|20813562|P2|Overall Study|Lost to Follow-up|15
6021322|NCT00782496|20813563|P1|Overall Study|Lost to Follow-up|14
6021323|NCT00782483|20813570|P1|Overall Study|Early Termination of Protocol - PI Reloc|6
6021324|NCT00782418|20813574|P7|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0
6021325|NCT00782418|20813575|P6|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1
6021326|NCT00782418|20813576|P5|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1
6021327|NCT00782418|20813577|P4|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0
6021328|NCT00782418|20813578|P3|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0
6021329|NCT00782418|20813579|P2|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0
6021330|NCT00782418|20813580|P1|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1
6021331|NCT00782418|20813574|P7|Period 1 Procedure/Treatment Groups|Adverse Event|0
6021332|NCT00782418|20813575|P6|Period 1 Procedure/Treatment Groups|Adverse Event|0
6021333|NCT00782418|20813576|P5|Period 1 Procedure/Treatment Groups|Adverse Event|0
6021334|NCT00782418|20813577|P4|Period 1 Procedure/Treatment Groups|Adverse Event|0
6021335|NCT00782418|20813578|P3|Period 1 Procedure/Treatment Groups|Adverse Event|0
6021336|NCT00782418|20813579|P2|Period 1 Procedure/Treatment Groups|Adverse Event|0
6021337|NCT00782418|20813580|P1|Period 1 Procedure/Treatment Groups|Adverse Event|1
6021338|NCT00782340|20813617|P3|Open Label Titration|Randomized in error|0
6021339|NCT00782340|20813618|P2|Open Label Titration|Randomized in error|0
6021340|NCT00782340|20813619|P1|Open Label Titration|Randomized in error|6
6021341|NCT00782340|20813617|P3|Open Label Titration|Lost to Follow-up|0
6021342|NCT00782340|20813618|P2|Open Label Titration|Lost to Follow-up|0
6021343|NCT00782340|20813619|P1|Open Label Titration|Lost to Follow-up|5
6021344|NCT00782340|20813617|P3|Open Label Titration|Did not meet responder criteria|0
6021345|NCT00782340|20813618|P2|Open Label Titration|Did not meet responder criteria|0
6021346|NCT00782340|20813619|P1|Open Label Titration|Did not meet responder criteria|2
6021347|NCT00782340|20813617|P3|Open Label Titration|Enrollment capped|0
6021348|NCT00782340|20813618|P2|Open Label Titration|Enrollment capped|0
6021349|NCT00782340|20813619|P1|Open Label Titration|Enrollment capped|16
6021350|NCT00782340|20813617|P3|Open Label Titration|Withdrawal by Subject|0
6021351|NCT00782340|20813618|P2|Open Label Titration|Withdrawal by Subject|0
6021352|NCT00782340|20813619|P1|Open Label Titration|Withdrawal by Subject|5
6021353|NCT00782340|20813617|P3|Open Label Titration|Protocol Violation|0
6021354|NCT00782340|20813618|P2|Open Label Titration|Protocol Violation|0
6021355|NCT00782340|20813619|P1|Open Label Titration|Protocol Violation|5
6021356|NCT00782340|20813617|P3|Open Label Titration|Treatment failure|0
6021357|NCT00782340|20813618|P2|Open Label Titration|Treatment failure|0
6021358|NCT00782340|20813619|P1|Open Label Titration|Treatment failure|50
6021359|NCT00782340|20813617|P3|Open Label Titration|Adverse Event|0
6021360|NCT00782340|20813618|P2|Open Label Titration|Adverse Event|0
6021361|NCT00782340|20813619|P1|Open Label Titration|Adverse Event|12
6021362|NCT00782275|20813689|P1|Overall Study|Other|3
6021363|NCT00782275|20813689|P1|Overall Study|Not started treatment|1
6021364|NCT00782275|20813689|P1|Overall Study|Physician Decision|4
6021365|NCT00782275|20813689|P1|Overall Study|Progressive Disease|21
6021366|NCT00782275|20813689|P1|Overall Study|Withdrawal by Subject|1
6021367|NCT00782275|20813689|P1|Overall Study|Adverse Event|11
6021368|NCT00782210|20813698|P3|Overall Study|Other reason not described above|3
6021369|NCT00782210|20813699|P2|Overall Study|Other reason not described above|2
6021370|NCT00782210|20813700|P1|Overall Study|Other reason not described above|3
6021371|NCT00782210|20813698|P3|Overall Study|Lack of Efficacy|1
6021372|NCT00782210|20813699|P2|Overall Study|Lack of Efficacy|4
6021373|NCT00782210|20813700|P1|Overall Study|Lack of Efficacy|13
6021374|NCT00782210|20813698|P3|Overall Study|Non compliance with protocol|2
6021375|NCT00782210|20813699|P2|Overall Study|Non compliance with protocol|3
6021376|NCT00782210|20813700|P1|Overall Study|Non compliance with protocol|0
6021377|NCT00782210|20813698|P3|Overall Study|Withdrawal by Subject|11
6021378|NCT00782210|20813699|P2|Overall Study|Withdrawal by Subject|8
6021379|NCT00782210|20813700|P1|Overall Study|Withdrawal by Subject|11
6021380|NCT00782210|20813698|P3|Overall Study|Lost to Follow-up|2
6021381|NCT00782210|20813699|P2|Overall Study|Lost to Follow-up|1
6021382|NCT00782210|20813700|P1|Overall Study|Lost to Follow-up|2
6021383|NCT00782210|20813698|P3|Overall Study|Adverse Event|16
6021384|NCT00782210|20813699|P2|Overall Study|Adverse Event|17
6021385|NCT00782210|20813700|P1|Overall Study|Adverse Event|21
6021386|NCT00782184|20813893|P2|Overall Study|Withdrawal by Subject|2
6021387|NCT00782184|20813894|P1|Overall Study|Withdrawal by Subject|3
6021388|NCT00782184|20813893|P2|Overall Study|Protocol Violation|1
6021389|NCT00782184|20813894|P1|Overall Study|Protocol Violation|0
6021390|NCT00782184|20813893|P2|Overall Study|Adverse Event|2
6021391|NCT00782184|20813894|P1|Overall Study|Adverse Event|1
6021392|NCT00782171|20813931|P2|Overall Study|not eligible|6
6021393|NCT00782171|20813932|P1|Overall Study|not eligible|8
6021394|NCT00782171|20813931|P2|Overall Study|others|9
6021395|NCT00782171|20813932|P1|Overall Study|others|7
6021396|NCT00782171|20813931|P2|Overall Study|complications|1
6021397|NCT00782171|20813932|P1|Overall Study|complications|3
6021398|NCT00782171|20813931|P2|Overall Study|Withdrawal by Subject|1
6021399|NCT00782171|20813932|P1|Overall Study|Withdrawal by Subject|2
6021400|NCT00782171|20813931|P2|Overall Study|Lost to Follow-up|2
6021401|NCT00782171|20813932|P1|Overall Study|Lost to Follow-up|2
6021402|NCT00782067|20813964|P1|Overall Study|Protocol deviation|2
6021403|NCT00782067|20813964|P1|Overall Study|Disease progression|43
6021404|NCT00782067|20813964|P1|Overall Study|Death|9
6021405|NCT00782067|20813964|P1|Overall Study|Administrative problems|14
6021406|NCT00782067|20813964|P1|Overall Study|Lost to Follow-up|2
6021407|NCT00782067|20813964|P1|Overall Study|Subject withdrew consent|11
6021408|NCT00782067|20813964|P1|Overall Study|Adverse Event|35
6021409|NCT00781963|20813976|P2|Overall Study|Refused follow-up|0
6021410|NCT00781963|20813977|P1|Overall Study|Refused follow-up|9
6021411|NCT00781963|20813976|P2|Overall Study|Withdrawal by Subject|1
6021412|NCT00781963|20813977|P1|Overall Study|Withdrawal by Subject|3
6021413|NCT00781963|20813976|P2|Overall Study|Lost to Follow-up|1
6021414|NCT00781963|20813977|P1|Overall Study|Lost to Follow-up|2
6021415|NCT00781963|20813976|P2|Overall Study|Death|0
6021416|NCT00781963|20813977|P1|Overall Study|Death|3
6021417|NCT00781937|20814006|P2|Follow up Period (Week 56-68)|Unclassified|4
6021418|NCT00781937|20814007|P1|Follow up Period (Week 56-68)|Unclassified|5
6021419|NCT00781937|20814006|P2|Follow up Period (Week 56-68)|Protocol Violation|1
6021420|NCT00781937|20814007|P1|Follow up Period (Week 56-68)|Protocol Violation|1
6021421|NCT00781937|20814006|P2|Main Trial Period Through Week 56|Unclassified|15
6021422|NCT00781937|20814007|P1|Main Trial Period Through Week 56|Unclassified|10
6021423|NCT00781937|20814006|P2|Main Trial Period Through Week 56|Withdrawal by Subject|24
6021424|NCT00781937|20814007|P1|Main Trial Period Through Week 56|Withdrawal by Subject|17
6021425|NCT00781937|20814006|P2|Main Trial Period Through Week 56|Protocol Violation|5
6021426|NCT00781937|20814007|P1|Main Trial Period Through Week 56|Protocol Violation|8
6021427|NCT00781937|20814006|P2|Main Trial Period Through Week 56|Lack of Efficacy|2
6021428|NCT00781937|20814007|P1|Main Trial Period Through Week 56|Lack of Efficacy|0
6021429|NCT00781937|20814006|P2|Main Trial Period Through Week 56|Adverse Event|18
6021430|NCT00781937|20814007|P1|Main Trial Period Through Week 56|Adverse Event|18
6021431|NCT00781911|20814065|P2|Overall Study|Sponsor Decision|0
6021432|NCT00781911|20814066|P1|Overall Study|Sponsor Decision|1
6021433|NCT00781911|20814065|P2|Overall Study|Physician Decision|2
6021434|NCT00781911|20814066|P1|Overall Study|Physician Decision|0
6021435|NCT00781911|20814065|P2|Overall Study|Withdrawal by Subject|2
6021436|NCT00781911|20814066|P1|Overall Study|Withdrawal by Subject|1
6021437|NCT00781911|20814065|P2|Overall Study|Adverse Event|4
6021438|NCT00781911|20814066|P1|Overall Study|Adverse Event|4
6021439|NCT00781885|20814101|P1|Overall Study|Physician Decision|1
6021440|NCT00781859|20814118|P2|Overall Study|Death|0
6021441|NCT00781859|20814119|P1|Overall Study|Death|3
6021442|NCT00781859|20814118|P2|Overall Study|Lost to Follow-up|3
6021443|NCT00781859|20814119|P1|Overall Study|Lost to Follow-up|6
6021444|NCT00781859|20814118|P2|Overall Study|Withdrawal by Subject|4
6021445|NCT00781859|20814119|P1|Overall Study|Withdrawal by Subject|8
6021446|NCT00781859|20814118|P2|Overall Study|Adverse Event|2
6021447|NCT00781859|20814119|P1|Overall Study|Adverse Event|2
6021448|NCT00781768|20814129|P2|Overall Study|Not transplanted.|2
6021449|NCT00781768|20814130|P1|Overall Study|Not transplanted.|0
6021450|NCT00781599|20814138|P2|Overall Study|Lost to Follow-up|4
6021451|NCT00781599|20814139|P1|Overall Study|Lost to Follow-up|7
6021452|NCT00781456|20814164|P2|Overall Study|Other Reason, Unknown|1
6021453|NCT00781456|20814165|P1|Overall Study|Other Reason, Unknown|0
6021454|NCT00781456|20814164|P2|Overall Study|Lost to Follow-up|5
6021455|NCT00781456|20814165|P1|Overall Study|Lost to Follow-up|10
6021456|NCT00781456|20814164|P2|Overall Study|Noncompliance With Protocol|1
6021457|NCT00781456|20814165|P1|Overall Study|Noncompliance With Protocol|1
6021458|NCT00781456|20814164|P2|Overall Study|Protocol Violation|1
6021459|NCT00781456|20814165|P1|Overall Study|Protocol Violation|4
6021460|NCT00781456|20814164|P2|Overall Study|Withdrawal by Subject|5
6021461|NCT00781456|20814165|P1|Overall Study|Withdrawal by Subject|3
6021462|NCT00781456|20814164|P2|Overall Study|Adverse Event|3
6021463|NCT00781456|20814165|P1|Overall Study|Adverse Event|3
6021464|NCT00781391|20814188|P3|Overall Study|Lost to Follow-up|1
6021465|NCT00781391|20814189|P2|Overall Study|Lost to Follow-up|0
6021466|NCT00781391|20814190|P1|Overall Study|Lost to Follow-up|0
6021467|NCT00781391|20814188|P3|Overall Study|Withdrawal by Subject|25
6021468|NCT00781391|20814189|P2|Overall Study|Withdrawal by Subject|37
6021469|NCT00781391|20814190|P1|Overall Study|Withdrawal by Subject|47
6021470|NCT00781391|20814188|P3|Overall Study|Death|706
6021471|NCT00781391|20814189|P2|Overall Study|Death|730
6021472|NCT00781391|20814190|P1|Overall Study|Death|789
6021473|NCT00781391|20814188|P3|Overall Study|Protocol Violation|20
6021474|NCT00781391|20814189|P2|Overall Study|Protocol Violation|17
6021475|NCT00781391|20814190|P1|Overall Study|Protocol Violation|19
6021476|NCT00781391|20814188|P3|Overall Study|never received study drug|32
6021477|NCT00781391|20814189|P2|Overall Study|never received study drug|23
6021478|NCT00781391|20814190|P1|Overall Study|never received study drug|24
6021479|NCT00781365|20814224|P2|Overall Study|Language barrier|0
6021480|NCT00781365|20814225|P1|Overall Study|Language barrier|1
6021481|NCT00781365|20814224|P2|Overall Study|Did Not Attend Visit|28
6021482|NCT00781365|20814225|P1|Overall Study|Did Not Attend Visit|20
6021483|NCT00781365|20814224|P2|Overall Study|Withdrawal by Subject|8
6021484|NCT00781365|20814225|P1|Overall Study|Withdrawal by Subject|13
6021485|NCT00781326|20814235|P1|Phase I|Physician Decision|2
6021486|NCT00781326|20814235|P1|Phase I|Withdrawal by Subject|1
6021487|NCT00781326|20814235|P1|Phase I|Adverse Event|1
6021488|NCT00781274|20814239|P1|Overall Study|Withdrawal by Subject|2
6021489|NCT00780975|20814262|P1|Overall Study|Toxicity|5
6021490|NCT00780975|20814262|P1|Overall Study|Progressive disease|3
6021491|NCT00780910|20814280|P1|Overall Study|Adverse Event|2
6021492|NCT00780559|20814342|P2|Overall Study|Death|0
6021493|NCT00780559|20814343|P1|Overall Study|Death|1
6021494|NCT00780559|20814342|P2|Overall Study|Lost to Follow-up|7
6021495|NCT00780559|20814343|P1|Overall Study|Lost to Follow-up|2
6021496|NCT00780416|20814411|P2|Overall Study|Withdrawal by Subject|6
6021497|NCT00780416|20814412|P1|Overall Study|Withdrawal by Subject|8
6021498|NCT00780416|20814411|P2|Overall Study|Protocol Violation|0
6021499|NCT00780416|20814412|P1|Overall Study|Protocol Violation|1
6021500|NCT00780416|20814411|P2|Overall Study|Physician Decision|3
6021501|NCT00780416|20814412|P1|Overall Study|Physician Decision|3
6021502|NCT00780273|20814457|P1|Overall Study|Lost to Follow-up|1
6021503|NCT00780273|20814457|P1|Overall Study|Death|1
6021504|NCT00780143|20814480|P1|Overall Study|Adverse Event|1
6021505|NCT00780143|20814480|P1|Overall Study|Toxicity|1
6021506|NCT00780143|20814480|P1|Overall Study|Progressive disease|1
6021507|NCT00779909|20814511|P4|Overall Study|Withdrawal by Subject|0
6021508|NCT00779909|20814512|P3|Overall Study|Withdrawal by Subject|0
6021509|NCT00779909|20814513|P2|Overall Study|Withdrawal by Subject|1
6021510|NCT00779909|20814514|P1|Overall Study|Withdrawal by Subject|0
6021511|NCT00779909|20814511|P4|Overall Study|Lost to Follow-up|1
6021512|NCT00779909|20814512|P3|Overall Study|Lost to Follow-up|0
6021513|NCT00779909|20814513|P2|Overall Study|Lost to Follow-up|0
6021514|NCT00779909|20814514|P1|Overall Study|Lost to Follow-up|1
6021515|NCT00779857|20814578|P1|Overall Study|Missed Visit|2
6021516|NCT00779857|20814578|P1|Overall Study|Withdrawal by Subject|3
6021517|NCT00779857|20814578|P1|Overall Study|Death|1
6021518|NCT00779779|20814583|P1|Overall Study|Lost to Follow-up|5
6021519|NCT00779779|20814583|P1|Overall Study|Withdrawal by Subject|4
6021520|NCT00779779|20814583|P1|Overall Study|Protocol Violation|14
6021521|NCT00779779|20814583|P1|Overall Study|Adverse Event|1
6021522|NCT00779766|20814592|P2|Month 72|Other|1
6021523|NCT00779766|20814593|P1|Month 72|Other|0
6021524|NCT00779766|20814592|P2|Month 72|Lost to Follow-up|8
6021525|NCT00779766|20814593|P1|Month 72|Lost to Follow-up|6
6021526|NCT00779766|20814592|P2|Month 72|Migrated/moved from study area|109
6021527|NCT00779766|20814593|P1|Month 72|Migrated/moved from study area|124
6021528|NCT00779766|20814592|P2|Month 72|Withdrawal by Subject|71
6021529|NCT00779766|20814593|P1|Month 72|Withdrawal by Subject|55
6021530|NCT00779766|20814592|P2|Month 48|Other|0
6021531|NCT00779766|20814593|P1|Month 48|Other|1
6021532|NCT00779766|20814592|P2|Month 48|Lost to Follow-up|30
6021533|NCT00779766|20814593|P1|Month 48|Lost to Follow-up|29
6021534|NCT00779766|20814592|P2|Month 48|Migrated/moved from study area|75
6021535|NCT00779766|20814593|P1|Month 48|Migrated/moved from study area|76
6021536|NCT00779766|20814592|P2|Month 48|Withdrawal by Subject|63
6021537|NCT00779766|20814593|P1|Month 48|Withdrawal by Subject|68
6021538|NCT00779766|20814592|P2|Month 24|Other|27
6021539|NCT00779766|20814593|P1|Month 24|Other|18
6021540|NCT00779766|20814592|P2|Month 24|Lost to Follow-up|9
6021541|NCT00779766|20814593|P1|Month 24|Lost to Follow-up|9
6021542|NCT00779766|20814592|P2|Month 24|Migrated/moved from study area|162
6021543|NCT00779766|20814593|P1|Month 24|Migrated/moved from study area|138
6021544|NCT00779766|20814592|P2|Month 24|Withdrawal by Subject|127
6021545|NCT00779766|20814593|P1|Month 24|Withdrawal by Subject|159
6021546|NCT00779766|20814592|P2|Month 24|Protocol Violation|1
6021547|NCT00779766|20814593|P1|Month 24|Protocol Violation|3
6021548|NCT00779766|20814592|P2|Month 24|Adverse Event|3
6021549|NCT00779766|20814593|P1|Month 24|Adverse Event|3
6021550|NCT00779766|20814592|P2|Month 24|Serious Adverse Event|3
6021551|NCT00779766|20814593|P1|Month 24|Serious Adverse Event|2
6021552|NCT00779675|20814681|P1|Extended Treatment Period|Lost to Follow-up|6
6021553|NCT00779675|20814681|P1|Extended Treatment Period|Protocol defined clinical event|1
6021554|NCT00779675|20814681|P1|Extended Treatment Period|Treatment Failure|11
6021555|NCT00779675|20814681|P1|Extended Treatment Period|Adverse Event|6
6021556|NCT00779675|20814681|P1|Extended Treatment Period|Protocol Violation|13
6021557|NCT00779675|20814681|P1|Extended Treatment Period|Reasons unrelated to study treatment|9
6021558|NCT00779675|20814681|P1|Treatment Period|Administrative|3
6021559|NCT00779675|20814681|P1|Treatment Period|Did Not Meet Protocol Eligibility|1
6021560|NCT00779675|20814681|P1|Treatment Period|Protocol Violation|54
6021561|NCT00779675|20814681|P1|Treatment Period|Withdrawal by Subject|46
6021562|NCT00779675|20814681|P1|Treatment Period|Lost to Follow-up|23
6021563|NCT00779675|20814681|P1|Treatment Period|Transferred to Another Study|38
6021564|NCT00779675|20814681|P1|Treatment Period|Treatment Failure|80
6021565|NCT00779675|20814681|P1|Treatment Period|Adverse Event|87
6021566|NCT00779584|20814709|P9|Overall Study|Ongoing in Study|0
6021567|NCT00779584|20814710|P8|Overall Study|Ongoing in Study|0
6021568|NCT00779584|20814711|P7|Overall Study|Ongoing in Study|0
6021569|NCT00779584|20814712|P6|Overall Study|Ongoing in Study|1
6021570|NCT00779584|20814713|P5|Overall Study|Ongoing in Study|1
6021571|NCT00779584|20814714|P4|Overall Study|Ongoing in Study|0
6021572|NCT00779584|20814715|P3|Overall Study|Ongoing in Study|0
6021573|NCT00779584|20814716|P2|Overall Study|Ongoing in Study|0
6021574|NCT00779584|20814717|P1|Overall Study|Ongoing in Study|0
6021575|NCT00779584|20814709|P9|Overall Study|Symptomatic Deterioration|0
6021576|NCT00779584|20814710|P8|Overall Study|Symptomatic Deterioration|0
6021577|NCT00779584|20814711|P7|Overall Study|Symptomatic Deterioration|1
6021578|NCT00779584|20814712|P6|Overall Study|Symptomatic Deterioration|1
6021579|NCT00779584|20814713|P5|Overall Study|Symptomatic Deterioration|0
6021580|NCT00779584|20814714|P4|Overall Study|Symptomatic Deterioration|0
6021581|NCT00779584|20814715|P3|Overall Study|Symptomatic Deterioration|1
6021582|NCT00779584|20814716|P2|Overall Study|Symptomatic Deterioration|1
6021583|NCT00779584|20814717|P1|Overall Study|Symptomatic Deterioration|1
6021584|NCT00779584|20814709|P9|Overall Study|Adverse Event|1
6021585|NCT00779584|20814710|P8|Overall Study|Adverse Event|1
6021586|NCT00779584|20814711|P7|Overall Study|Adverse Event|2
6021587|NCT00779584|20814712|P6|Overall Study|Adverse Event|0
6021588|NCT00779584|20814713|P5|Overall Study|Adverse Event|0
6021589|NCT00779584|20814714|P4|Overall Study|Adverse Event|0
6021590|NCT00779584|20814715|P3|Overall Study|Adverse Event|2
6021591|NCT00779584|20814716|P2|Overall Study|Adverse Event|0
6021592|NCT00779584|20814717|P1|Overall Study|Adverse Event|1
6021593|NCT00779584|20814709|P9|Overall Study|Progression of Disease|1
6021594|NCT00779584|20814710|P8|Overall Study|Progression of Disease|2
6021595|NCT00779584|20814711|P7|Overall Study|Progression of Disease|4
6021596|NCT00779584|20814712|P6|Overall Study|Progression of Disease|1
6021597|NCT00779584|20814713|P5|Overall Study|Progression of Disease|5
6021598|NCT00779584|20814714|P4|Overall Study|Progression of Disease|6
6021599|NCT00779584|20814715|P3|Overall Study|Progression of Disease|2
6021600|NCT00779584|20814716|P2|Overall Study|Progression of Disease|1
6021601|NCT00779584|20814717|P1|Overall Study|Progression of Disease|0
6021602|NCT00779584|20814709|P9|Overall Study|Lost to Follow-up|0
6021603|NCT00779584|20814710|P8|Overall Study|Lost to Follow-up|0
6021604|NCT00779584|20814711|P7|Overall Study|Lost to Follow-up|0
6021605|NCT00779584|20814712|P6|Overall Study|Lost to Follow-up|0
6021606|NCT00779584|20814713|P5|Overall Study|Lost to Follow-up|1
6021607|NCT00779584|20814714|P4|Overall Study|Lost to Follow-up|0
6021608|NCT00779584|20814715|P3|Overall Study|Lost to Follow-up|0
6021609|NCT00779584|20814716|P2|Overall Study|Lost to Follow-up|0
6021610|NCT00779584|20814717|P1|Overall Study|Lost to Follow-up|0
6021611|NCT00779584|20814709|P9|Overall Study|Withdrawal by Subject|0
6021612|NCT00779584|20814710|P8|Overall Study|Withdrawal by Subject|0
6021613|NCT00779584|20814711|P7|Overall Study|Withdrawal by Subject|1
6021614|NCT00779584|20814712|P6|Overall Study|Withdrawal by Subject|2
6021615|NCT00779584|20814713|P5|Overall Study|Withdrawal by Subject|0
6021616|NCT00779584|20814714|P4|Overall Study|Withdrawal by Subject|0
6021617|NCT00779584|20814715|P3|Overall Study|Withdrawal by Subject|2
6021618|NCT00779584|20814716|P2|Overall Study|Withdrawal by Subject|1
6021619|NCT00779584|20814717|P1|Overall Study|Withdrawal by Subject|1
6021620|NCT00779584|20814709|P9|Overall Study|Protocol Violation|0
6021621|NCT00779584|20814710|P8|Overall Study|Protocol Violation|0
6021622|NCT00779584|20814711|P7|Overall Study|Protocol Violation|0
6021623|NCT00779584|20814712|P6|Overall Study|Protocol Violation|1
6021624|NCT00779584|20814713|P5|Overall Study|Protocol Violation|0
6021625|NCT00779584|20814714|P4|Overall Study|Protocol Violation|0
6021626|NCT00779584|20814715|P3|Overall Study|Protocol Violation|0
6021627|NCT00779584|20814716|P2|Overall Study|Protocol Violation|0
6021628|NCT00779584|20814717|P1|Overall Study|Protocol Violation|0
6021629|NCT00779506|20814808|P1|Overall Study|Lost to Follow-up|1
6021630|NCT00779506|20814808|P1|Overall Study|Withdrawal by Subject|6
6021631|NCT00779506|20814808|P1|Overall Study|Protocol Violation|5
6021632|NCT00779506|20814808|P1|Overall Study|Lack of Efficacy|11
6021633|NCT00779506|20814808|P1|Overall Study|Adverse Event|4
6021634|NCT00779506|20814808|P1|Overall Study|Screening Failed|2
6021635|NCT00779467|20814822|P4|Overall Study|unavailable research staff|1
6021636|NCT00779467|20814823|P3|Overall Study|unavailable research staff|0
6021637|NCT00779467|20814824|P2|Overall Study|unavailable research staff|0
6021638|NCT00779467|20814825|P1|Overall Study|unavailable research staff|0
6021639|NCT00779467|20814822|P4|Overall Study|technical issue|1
6021640|NCT00779467|20814823|P3|Overall Study|technical issue|2
6021641|NCT00779467|20814824|P2|Overall Study|technical issue|0
6021642|NCT00779467|20814825|P1|Overall Study|technical issue|0
6021643|NCT00779467|20814822|P4|Overall Study|missing data|4
6021644|NCT00779467|20814823|P3|Overall Study|missing data|1
6021645|NCT00779467|20814824|P2|Overall Study|missing data|0
6021646|NCT00779467|20814825|P1|Overall Study|missing data|1
6021647|NCT00779467|20814822|P4|Overall Study|failed inclusion criteria|2
6021648|NCT00779467|20814823|P3|Overall Study|failed inclusion criteria|1
6021649|NCT00779467|20814824|P2|Overall Study|failed inclusion criteria|3
6021650|NCT00779467|20814825|P1|Overall Study|failed inclusion criteria|3
6021651|NCT00779467|20814822|P4|Overall Study|Lack of Efficacy|11
6021652|NCT00779467|20814823|P3|Overall Study|Lack of Efficacy|6
6021653|NCT00779467|20814824|P2|Overall Study|Lack of Efficacy|2
6021654|NCT00779467|20814825|P1|Overall Study|Lack of Efficacy|11
6021655|NCT00779402|20814865|P2|Long-term Follow-up|Completed Protocol Visits|2
6021656|NCT00779402|20814866|P1|Long-term Follow-up|Completed Protocol Visits|6
6021657|NCT00779402|20814865|P2|Long-term Follow-up|Closure of Study|4
6021658|NCT00779402|20814866|P1|Long-term Follow-up|Closure of Study|8
6021659|NCT00779402|20814865|P2|Long-term Follow-up|Other|0
6021660|NCT00779402|20814866|P1|Long-term Follow-up|Other|5
6021661|NCT00779402|20814865|P2|Long-term Follow-up|Patient refused to continue|0
6021662|NCT00779402|20814866|P1|Long-term Follow-up|Patient refused to continue|2
6021663|NCT00779402|20814865|P2|Surveillance Phase|Completed Protocol Visits|2
6021664|NCT00779402|20814866|P1|Surveillance Phase|Completed Protocol Visits|3
6021665|NCT00779402|20814865|P2|Surveillance Phase|Closure of study|6
6021666|NCT00779402|20814866|P1|Surveillance Phase|Closure of study|5
6021667|NCT00779402|20814865|P2|Surveillance Phase|Withdrawal by Subject|1
6021668|NCT00779402|20814866|P1|Surveillance Phase|Withdrawal by Subject|4
6021669|NCT00779402|20814865|P2|Surveillance Phase|Other|5
6021670|NCT00779402|20814866|P1|Surveillance Phase|Other|5
6021671|NCT00779402|20814865|P2|Surveillance Phase|Intercurrent Illness|0
6021672|NCT00779402|20814866|P1|Surveillance Phase|Intercurrent Illness|2
6021673|NCT00779402|20814865|P2|Surveillance Phase|Death|1
6021674|NCT00779402|20814866|P1|Surveillance Phase|Death|0
6021675|NCT00779402|20814865|P2|Surveillance Phase|Lost to Follow-up|1
6021676|NCT00779402|20814866|P1|Surveillance Phase|Lost to Follow-up|2
6021677|NCT00779402|20814865|P2|Surveillance Phase|Patient refused to continue|14
6021678|NCT00779402|20814866|P1|Surveillance Phase|Patient refused to continue|22
6021679|NCT00779402|20814865|P2|Surveillance Phase|Protocol Violation|1
6021680|NCT00779402|20814866|P1|Surveillance Phase|Protocol Violation|0
6021681|NCT00779402|20814865|P2|Treatment Phase 1|Completed Protocol Visits|6
6021682|NCT00779402|20814866|P1|Treatment Phase 1|Completed Protocol Visits|3
6021683|NCT00779402|20814865|P2|Treatment Phase 1|Closure of Study|2
6021684|NCT00779402|20814866|P1|Treatment Phase 1|Closure of Study|3
6021685|NCT00779402|20814865|P2|Treatment Phase 1|Other|2
6021686|NCT00779402|20814866|P1|Treatment Phase 1|Other|4
6021687|NCT00779402|20814865|P2|Treatment Phase 1|Withdrawal by Subject|0
6021688|NCT00779402|20814866|P1|Treatment Phase 1|Withdrawal by Subject|1
6021689|NCT00779402|20814865|P2|Treatment Phase 1|Intercurrent Illness|1
6021690|NCT00779402|20814866|P1|Treatment Phase 1|Intercurrent Illness|1
6021691|NCT00779402|20814865|P2|Treatment Phase 1|Death|1
6021692|NCT00779402|20814866|P1|Treatment Phase 1|Death|0
6021693|NCT00779402|20814865|P2|Treatment Phase 1|Lost to Follow-up|1
6021694|NCT00779402|20814866|P1|Treatment Phase 1|Lost to Follow-up|0
6021695|NCT00779402|20814865|P2|Treatment Phase 1|Patient Refused to Continue|2
6021696|NCT00779402|20814866|P1|Treatment Phase 1|Patient Refused to Continue|17
6021697|NCT00779402|20814865|P2|Treatment Phase 1|Protocol Violation|0
6021698|NCT00779402|20814866|P1|Treatment Phase 1|Protocol Violation|1
6021699|NCT00779402|20814865|P2|Treatment Phase 1|Adverse Event|0
6021700|NCT00779402|20814866|P1|Treatment Phase 1|Adverse Event|2
6021701|NCT00779402|20814865|P2|Treatment Phase 1|Disease Progression|0
6021702|NCT00779402|20814866|P1|Treatment Phase 1|Disease Progression|1
6021703|NCT00779259|20814909|P1|Quinine Alone|Adverse Event|2
6021704|NCT00779246|20814930|P2|Overall Study|Missing sufficient data for analysis|53
6021705|NCT00779246|20814931|P1|Overall Study|Missing sufficient data for analysis|33
6021706|NCT00779142|20814950|P1|Overall Study|Screen Failures|3
6021707|NCT00779038|20814982|P1|Overall Study|Study Prematurely Terminated|13
6021708|NCT00779025|20814991|P1|Overall Study|Withdrawal by Subject|1
6021709|NCT00778999|20815002|P2|Overall Study|Did not receive recFSH|20
6021710|NCT00778999|20815003|P1|Overall Study|Did not receive recFSH|14
6021711|NCT00778999|20815002|P2|Overall Study|Discontinuation: no embryo transfer|14
6021712|NCT00778999|20815003|P1|Overall Study|Discontinuation: no embryo transfer|14
6021713|NCT00778921|20815012|P3|Overall Study|Not treated|2
6021714|NCT00778921|20815013|P2|Overall Study|Not treated|2
6021715|NCT00778921|20815014|P1|Overall Study|Not treated|0
6021716|NCT00778921|20815012|P3|Overall Study|Protocol Violation|2
6021717|NCT00778921|20815013|P2|Overall Study|Protocol Violation|0
6021718|NCT00778921|20815014|P1|Overall Study|Protocol Violation|3
6021719|NCT00778921|20815012|P3|Overall Study|Administrative Problems|0
6021720|NCT00778921|20815013|P2|Overall Study|Administrative Problems|2
6021721|NCT00778921|20815014|P1|Overall Study|Administrative Problems|1
6021722|NCT00778921|20815012|P3|Overall Study|Lost to Follow-up|1
6021723|NCT00778921|20815013|P2|Overall Study|Lost to Follow-up|2
6021724|NCT00778921|20815014|P1|Overall Study|Lost to Follow-up|0
6021725|NCT00778921|20815012|P3|Overall Study|Patient withdrew request|6
6021726|NCT00778921|20815013|P2|Overall Study|Patient withdrew request|1
6021727|NCT00778921|20815014|P1|Overall Study|Patient withdrew request|3
6021728|NCT00778921|20815012|P3|Overall Study|Patient No Longer Requires Study Drug|0
6021729|NCT00778921|20815013|P2|Overall Study|Patient No Longer Requires Study Drug|1
6021730|NCT00778921|20815014|P1|Overall Study|Patient No Longer Requires Study Drug|0
6021731|NCT00778921|20815012|P3|Overall Study|Unsatisfactory therapeutic response|1
6021732|NCT00778921|20815013|P2|Overall Study|Unsatisfactory therapeutic response|1
6021733|NCT00778921|20815014|P1|Overall Study|Unsatisfactory therapeutic response|1
6021734|NCT00778921|20815012|P3|Overall Study|Abnormal Test Procedure Result(s)|2
6021735|NCT00778921|20815013|P2|Overall Study|Abnormal Test Procedure Result(s)|0
6021736|NCT00778921|20815014|P1|Overall Study|Abnormal Test Procedure Result(s)|0
6021737|NCT00778921|20815012|P3|Overall Study|Abnormal Laboratory Value(s)|0
6021738|NCT00778921|20815013|P2|Overall Study|Abnormal Laboratory Value(s)|0
6021739|NCT00778921|20815014|P1|Overall Study|Abnormal Laboratory Value(s)|1
6021740|NCT00778921|20815012|P3|Overall Study|Adverse Event|14
6021741|NCT00778921|20815013|P2|Overall Study|Adverse Event|10
6021742|NCT00778921|20815014|P1|Overall Study|Adverse Event|9
6021743|NCT00778895|20815031|P3|ESFU Phase|Other|0
6021744|NCT00778895|20815032|P2|ESFU Phase|Other|0
6021745|NCT00778895|20815033|P1|ESFU Phase|Other|2
6021746|NCT00778895|20815031|P3|ESFU Phase|Lost to Follow-up|2
6021747|NCT00778895|20815032|P2|ESFU Phase|Lost to Follow-up|7
6021748|NCT00778895|20815033|P1|ESFU Phase|Lost to Follow-up|6
6021749|NCT00778895|20815031|P3|ESFU Phase|Withdrawal by Subject|0
6021750|NCT00778895|20815032|P2|ESFU Phase|Withdrawal by Subject|4
6021751|NCT00778895|20815033|P1|ESFU Phase|Withdrawal by Subject|1
6021752|NCT00778895|20815031|P3|ESFU Phase|Adverse Event|0
6021753|NCT00778895|20815032|P2|ESFU Phase|Adverse Event|1
6021754|NCT00778895|20815033|P1|ESFU Phase|Adverse Event|2
6021755|NCT00778895|20815031|P3|Active Phase|Other|0
6021756|NCT00778895|20815032|P2|Active Phase|Other|0
6021757|NCT00778895|20815033|P1|Active Phase|Other|2
6021758|NCT00778895|20815031|P3|Active Phase|Lost to Follow-up|0
6021759|NCT00778895|20815032|P2|Active Phase|Lost to Follow-up|1
6021760|NCT00778895|20815033|P1|Active Phase|Lost to Follow-up|1
6021761|NCT00778895|20815031|P3|Active Phase|Withdrawal by Subject|0
6021762|NCT00778895|20815032|P2|Active Phase|Withdrawal by Subject|4
6021763|NCT00778895|20815033|P1|Active Phase|Withdrawal by Subject|1
6021764|NCT00778895|20815031|P3|Active Phase|Adverse Event|0
6021765|NCT00778895|20815032|P2|Active Phase|Adverse Event|1
6021766|NCT00778895|20815033|P1|Active Phase|Adverse Event|3
6021767|NCT00778830|20815077|P2|Overall Study|Ongoing at data cut-off|1
6021768|NCT00778830|20815078|P1|Overall Study|Ongoing at data cut-off|0
6021769|NCT00778817|20815090|P1|Overall Study|Withdrawal by Subject|2
6021770|NCT00778817|20815090|P1|Overall Study|Adverse Event|2
6021771|NCT00778622|20815117|P3|Overall Study|Other|1
6021772|NCT00778622|20815118|P2|Overall Study|Other|0
6021773|NCT00778622|20815119|P1|Overall Study|Other|1
6021774|NCT00778622|20815117|P3|Overall Study|immigration|0
6021775|NCT00778622|20815118|P2|Overall Study|immigration|0
6021776|NCT00778622|20815119|P1|Overall Study|immigration|1
6021777|NCT00778622|20815117|P3|Overall Study|Lack of Efficacy|0
6021778|NCT00778622|20815118|P2|Overall Study|Lack of Efficacy|0
6021779|NCT00778622|20815119|P1|Overall Study|Lack of Efficacy|2
6021780|NCT00778622|20815117|P3|Overall Study|Protocol Violation|0
6021781|NCT00778622|20815118|P2|Overall Study|Protocol Violation|3
6021782|NCT00778622|20815119|P1|Overall Study|Protocol Violation|0
6021783|NCT00778622|20815117|P3|Overall Study|Lost to Follow-up|2
6021784|NCT00778622|20815118|P2|Overall Study|Lost to Follow-up|3
6021785|NCT00778622|20815119|P1|Overall Study|Lost to Follow-up|3
6021786|NCT00778622|20815117|P3|Overall Study|Withdrawal by Subject|5
6021787|NCT00778622|20815118|P2|Overall Study|Withdrawal by Subject|5
6021788|NCT00778622|20815119|P1|Overall Study|Withdrawal by Subject|4
6021789|NCT00778622|20815117|P3|Overall Study|Adverse Event|7
6021790|NCT00778622|20815118|P2|Overall Study|Adverse Event|4
6021791|NCT00778622|20815119|P1|Overall Study|Adverse Event|5
6021792|NCT00778375|20815172|P1|Overall Study|Ineligible|3
6021793|NCT00778336|20815186|P4|3 Month Follow Up|Death|0
6021794|NCT00778336|20815187|P3|3 Month Follow Up|Death|2
6021795|NCT00778336|20815188|P2|3 Month Follow Up|Death|3
6021796|NCT00778336|20815189|P1|3 Month Follow Up|Death|8
6021797|NCT00778336|20815186|P4|3 Month Follow Up|Lost to Follow-up|0
6021798|NCT00778336|20815187|P3|3 Month Follow Up|Lost to Follow-up|3
6021799|NCT00778336|20815188|P2|3 Month Follow Up|Lost to Follow-up|20
6021800|NCT00778336|20815189|P1|3 Month Follow Up|Lost to Follow-up|15
6021801|NCT00778336|20815186|P4|Index Procedure-Discharge|Death|0
6021802|NCT00778336|20815187|P3|Index Procedure-Discharge|Death|2
6021803|NCT00778336|20815188|P2|Index Procedure-Discharge|Death|3
6021804|NCT00778336|20815189|P1|Index Procedure-Discharge|Death|6
6021805|NCT00778258|20815227|P9|Overall Study|Other|0
6021806|NCT00778258|20815228|P8|Overall Study|Other|0
6021807|NCT00778258|20815229|P7|Overall Study|Other|1
6021808|NCT00778258|20815230|P6|Overall Study|Other|0
6021809|NCT00778258|20815231|P5|Overall Study|Other|0
6021810|NCT00778258|20815232|P4|Overall Study|Other|0
6021811|NCT00778258|20815233|P3|Overall Study|Other|0
6021812|NCT00778258|20815234|P2|Overall Study|Other|0
6021813|NCT00778258|20815235|P1|Overall Study|Other|0
6021814|NCT00778258|20815227|P9|Overall Study|Non-compliance|0
6021815|NCT00778258|20815228|P8|Overall Study|Non-compliance|0
6021816|NCT00778258|20815229|P7|Overall Study|Non-compliance|0
6021817|NCT00778258|20815230|P6|Overall Study|Non-compliance|0
6021818|NCT00778258|20815231|P5|Overall Study|Non-compliance|0
6021819|NCT00778258|20815232|P4|Overall Study|Non-compliance|1
6021820|NCT00778258|20815233|P3|Overall Study|Non-compliance|0
6021821|NCT00778258|20815234|P2|Overall Study|Non-compliance|0
6021822|NCT00778258|20815235|P1|Overall Study|Non-compliance|0
6021823|NCT00778258|20815227|P9|Overall Study|New Contraindication|0
6021824|NCT00778258|20815228|P8|Overall Study|New Contraindication|1
6021825|NCT00778258|20815229|P7|Overall Study|New Contraindication|0
6021826|NCT00778258|20815230|P6|Overall Study|New Contraindication|0
6021827|NCT00778258|20815231|P5|Overall Study|New Contraindication|0
6021828|NCT00778258|20815232|P4|Overall Study|New Contraindication|0
6021829|NCT00778258|20815233|P3|Overall Study|New Contraindication|0
6021830|NCT00778258|20815234|P2|Overall Study|New Contraindication|0
6021831|NCT00778258|20815235|P1|Overall Study|New Contraindication|0
6021832|NCT00778258|20815227|P9|Overall Study|Withdrawal by Subject|4
6021833|NCT00778258|20815228|P8|Overall Study|Withdrawal by Subject|12
6021834|NCT00778258|20815229|P7|Overall Study|Withdrawal by Subject|12
6021835|NCT00778258|20815230|P6|Overall Study|Withdrawal by Subject|6
6021836|NCT00778258|20815231|P5|Overall Study|Withdrawal by Subject|0
6021837|NCT00778258|20815232|P4|Overall Study|Withdrawal by Subject|2
6021838|NCT00778258|20815233|P3|Overall Study|Withdrawal by Subject|8
6021839|NCT00778258|20815234|P2|Overall Study|Withdrawal by Subject|2
6021840|NCT00778258|20815235|P1|Overall Study|Withdrawal by Subject|6
6021841|NCT00778258|20815227|P9|Overall Study|Lost to Follow-up|0
6021842|NCT00778258|20815228|P8|Overall Study|Lost to Follow-up|2
6021843|NCT00778258|20815229|P7|Overall Study|Lost to Follow-up|2
6021844|NCT00778258|20815230|P6|Overall Study|Lost to Follow-up|3
6021845|NCT00778258|20815231|P5|Overall Study|Lost to Follow-up|0
6021846|NCT00778258|20815232|P4|Overall Study|Lost to Follow-up|0
6021847|NCT00778258|20815233|P3|Overall Study|Lost to Follow-up|2
6021848|NCT00778258|20815234|P2|Overall Study|Lost to Follow-up|0
6021849|NCT00778258|20815235|P1|Overall Study|Lost to Follow-up|0
6021850|NCT00778258|20815227|P9|Overall Study|Adverse Event|0
6021851|NCT00778258|20815228|P8|Overall Study|Adverse Event|0
6021852|NCT00778258|20815229|P7|Overall Study|Adverse Event|0
6021853|NCT00778258|20815230|P6|Overall Study|Adverse Event|1
6021854|NCT00778258|20815231|P5|Overall Study|Adverse Event|0
6021855|NCT00778258|20815232|P4|Overall Study|Adverse Event|0
6021856|NCT00778258|20815233|P3|Overall Study|Adverse Event|0
6021857|NCT00778258|20815234|P2|Overall Study|Adverse Event|0
6021858|NCT00778258|20815235|P1|Overall Study|Adverse Event|1
6021859|NCT00778102|20815302|P2|Overall Study|Administrative Reason|10
6021860|NCT00778102|20815303|P1|Overall Study|Administrative Reason|7
6021861|NCT00778102|20815302|P2|Overall Study|Withdrawal by Subject|1
6021862|NCT00778102|20815303|P1|Overall Study|Withdrawal by Subject|1
6021863|NCT00778102|20815302|P2|Overall Study|Refused Treatment|3
6021864|NCT00778102|20815303|P1|Overall Study|Refused Treatment|2
6021865|NCT00778102|20815302|P2|Overall Study|Protocol Violation|1
6021866|NCT00778102|20815303|P1|Overall Study|Protocol Violation|0
6021867|NCT00778102|20815302|P2|Overall Study|Violation of Selection Criteria|1
6021868|NCT00778102|20815303|P1|Overall Study|Violation of Selection Criteria|1
6021869|NCT00778102|20815302|P2|Overall Study|Lost to Follow-up|0
6021870|NCT00778102|20815303|P1|Overall Study|Lost to Follow-up|1
6021871|NCT00778102|20815302|P2|Overall Study|Death|1
6021872|NCT00778102|20815303|P1|Overall Study|Death|1
6021873|NCT00778102|20815302|P2|Overall Study|Adverse Event|5
6021874|NCT00778102|20815303|P1|Overall Study|Adverse Event|8
6021875|NCT00777946|20815338|P3|Overall Study|Randomized in error|0
6021876|NCT00777946|20815339|P2|Overall Study|Randomized in error|1
6021877|NCT00777946|20815340|P1|Overall Study|Randomized in error|1
6021878|NCT00777946|20815338|P3|Overall Study|Protocol deviation|1
6021879|NCT00777946|20815339|P2|Overall Study|Protocol deviation|1
6021880|NCT00777946|20815340|P1|Overall Study|Protocol deviation|2
6021881|NCT00777946|20815338|P3|Overall Study|Lost to Follow-up|0
6021882|NCT00777946|20815339|P2|Overall Study|Lost to Follow-up|1
6021883|NCT00777946|20815340|P1|Overall Study|Lost to Follow-up|3
6021884|NCT00777946|20815338|P3|Overall Study|Patient withdrew consent|3
6021885|NCT00777946|20815339|P2|Overall Study|Patient withdrew consent|2
6021886|NCT00777946|20815340|P1|Overall Study|Patient withdrew consent|3
6021887|NCT00777946|20815338|P3|Overall Study|Condition no longer required study drug|0
6021888|NCT00777946|20815339|P2|Overall Study|Condition no longer required study drug|0
6021889|NCT00777946|20815340|P1|Overall Study|Condition no longer required study drug|1
6021890|NCT00777946|20815338|P3|Overall Study|Lack of Efficacy|9
6021891|NCT00777946|20815339|P2|Overall Study|Lack of Efficacy|0
6021892|NCT00777946|20815340|P1|Overall Study|Lack of Efficacy|0
6021893|NCT00777946|20815338|P3|Overall Study|Adverse Event|3
6021894|NCT00777946|20815339|P2|Overall Study|Adverse Event|1
6021895|NCT00777946|20815340|P1|Overall Study|Adverse Event|11
6021896|NCT00777920|20815363|P1|Overall Study|Other, not specified|4
6021897|NCT00777920|20815363|P1|Overall Study|Clinical status did not improve|1
6021898|NCT00777920|20815363|P1|Overall Study|Investigator's discretion|1
6021899|NCT00777920|20815363|P1|Overall Study|Lost to Follow-up|1
6021900|NCT00777920|20815363|P1|Overall Study|Withdrawal of Consent|4
6021901|NCT00777920|20815363|P1|Overall Study|Adverse Event|39
6021902|NCT00777803|20815379|P2|Overall Study|Non-compliance|2
6021903|NCT00777803|20815380|P1|Overall Study|Non-compliance|2
6021904|NCT00777803|20815379|P2|Overall Study|Adverse Event|0
6021905|NCT00777803|20815380|P1|Overall Study|Adverse Event|1
6021906|NCT00777803|20815379|P2|Overall Study|Lost to Follow-up|5
6021907|NCT00777803|20815380|P1|Overall Study|Lost to Follow-up|12
6021908|NCT00777608|20815459|P2|Overall Study|Investigator Decision|2
6021909|NCT00777608|20815460|P1|Overall Study|Investigator Decision|1
6021910|NCT00777608|20815459|P2|Overall Study|Protocol Violation|0
6021911|NCT00777608|20815460|P1|Overall Study|Protocol Violation|1
6021912|NCT00777608|20815459|P2|Overall Study|Withdrawal by Subject|3
6021913|NCT00777608|20815460|P1|Overall Study|Withdrawal by Subject|1
6021914|NCT00777608|20815459|P2|Overall Study|Lost to Follow-up|1
6021915|NCT00777608|20815460|P1|Overall Study|Lost to Follow-up|1
6021916|NCT00777556|20815470|P1|Overall Study|Did not complete all 3 follow-up visits|20
6021917|NCT00777556|20815470|P1|Overall Study|Dispensed but did not use product|12
6021918|NCT00777556|20815470|P1|Overall Study|Inappropriate self-selection|34
6021923|NCT00777296|20815513|P4|Overall Study|CRF form not completed|0
6021924|NCT00777296|20815514|P3|Overall Study|CRF form not completed|2
6021925|NCT00777296|20815515|P2|Overall Study|CRF form not completed|0
6021926|NCT00777296|20815516|P1|Overall Study|CRF form not completed|0
6021927|NCT00777296|20815513|P4|Overall Study|Withdrawal by Subject|0
6021928|NCT00777296|20815514|P3|Overall Study|Withdrawal by Subject|0
6021929|NCT00777296|20815515|P2|Overall Study|Withdrawal by Subject|0
6021930|NCT00777296|20815516|P1|Overall Study|Withdrawal by Subject|1
6021931|NCT00777296|20815513|P4|Overall Study|Adverse Event|1
6021932|NCT00777296|20815514|P3|Overall Study|Adverse Event|0
6021933|NCT00777296|20815515|P2|Overall Study|Adverse Event|1
6021934|NCT00777296|20815516|P1|Overall Study|Adverse Event|0
6021935|NCT00777257|20815558|P3|Overall Study|Withdrawal by Subject|5
6021936|NCT00777257|20815559|P2|Overall Study|Withdrawal by Subject|6
6021937|NCT00777257|20815560|P1|Overall Study|Withdrawal by Subject|3
6021938|NCT00777257|20815558|P3|Overall Study|Protocol Violation|2
6021939|NCT00777257|20815559|P2|Overall Study|Protocol Violation|2
6021940|NCT00777257|20815560|P1|Overall Study|Protocol Violation|2
6021941|NCT00777257|20815558|P3|Overall Study|Lost to Follow-up|2
6021942|NCT00777257|20815559|P2|Overall Study|Lost to Follow-up|3
6021943|NCT00777257|20815560|P1|Overall Study|Lost to Follow-up|3
6021944|NCT00777257|20815558|P3|Overall Study|Adverse Event|0
6021945|NCT00777257|20815559|P2|Overall Study|Adverse Event|1
6021946|NCT00777257|20815560|P1|Overall Study|Adverse Event|3
6021947|NCT00777205|20815579|P2|Overall Study|Protocol Violation|56
6021948|NCT00777205|20815580|P1|Overall Study|Protocol Violation|0
6021949|NCT00777205|20815579|P2|Overall Study|Death|2
6021950|NCT00777205|20815580|P1|Overall Study|Death|0
6021951|NCT00777205|20815579|P2|Overall Study|Withdrawal by Subject|4
6021952|NCT00777205|20815580|P1|Overall Study|Withdrawal by Subject|6
6021953|NCT00777205|20815579|P2|Overall Study|Lost to Follow-up|9
6021954|NCT00777205|20815580|P1|Overall Study|Lost to Follow-up|25
6021955|NCT00777153|20815614|P3|Overall Study|Incorrect enrol/elig crit not fulfilled|1
6021956|NCT00777153|20815615|P2|Overall Study|Incorrect enrol/elig crit not fulfilled|5
6021957|NCT00777153|20815616|P1|Overall Study|Incorrect enrol/elig crit not fulfilled|1
6021958|NCT00777153|20815614|P3|Overall Study|Withdrawal by Subject|3
6021959|NCT00777153|20815615|P2|Overall Study|Withdrawal by Subject|4
6021960|NCT00777153|20815616|P1|Overall Study|Withdrawal by Subject|3
6021961|NCT00777153|20815614|P3|Overall Study|Death|33
6021962|NCT00777153|20815615|P2|Overall Study|Death|73
6021963|NCT00777153|20815616|P1|Overall Study|Death|85
6021964|NCT00777153|20815614|P3|Overall Study|Lost to Follow-up|0
6021965|NCT00777153|20815615|P2|Overall Study|Lost to Follow-up|1
6021966|NCT00777153|20815616|P1|Overall Study|Lost to Follow-up|1
6021967|NCT00777101|20815641|P2|Overall Study|Failed to Return|1
6021968|NCT00777101|20815642|P1|Overall Study|Failed to Return|0
6021969|NCT00777101|20815641|P2|Overall Study|Discontinuation of Study by Sponsor|0
6021970|NCT00777101|20815642|P1|Overall Study|Discontinuation of Study by Sponsor|1
6021971|NCT00777101|20815641|P2|Overall Study|Lost to Follow-up|1
6021972|NCT00777101|20815642|P1|Overall Study|Lost to Follow-up|2
6021973|NCT00777101|20815641|P2|Overall Study|Withdrawal by Subject|6
6021974|NCT00777101|20815642|P1|Overall Study|Withdrawal by Subject|11
6021975|NCT00777101|20815641|P2|Overall Study|Death|43
6021976|NCT00777101|20815642|P1|Overall Study|Death|48
6021977|NCT00777088|20815660|P1|Overall Study|PED Treatment not attempted|1
6021978|NCT00777049|20815685|P2|Overall Study|No treatment (elevated liver enzymes)|1
6021979|NCT00777049|20815686|P1|Overall Study|No treatment (elevated liver enzymes)|0
6021980|NCT00777049|20815685|P2|Overall Study|Withdrawal by Subject|0
6021981|NCT00777049|20815686|P1|Overall Study|Withdrawal by Subject|1
6021982|NCT00777036|20815695|P3|Follow-Up|Death|0
6021983|NCT00777036|20815696|P2|Follow-Up|Death|8
6021984|NCT00777036|20815697|P1|Follow-Up|Death|1
6021985|NCT00777036|20815695|P3|Follow-Up|Withdrawal by Subject|4
6021986|NCT00777036|20815696|P2|Follow-Up|Withdrawal by Subject|0
6021987|NCT00777036|20815697|P1|Follow-Up|Withdrawal by Subject|1
6021988|NCT00777036|20815695|P3|Follow-Up|Reason Not Specified|0
6021989|NCT00777036|20815696|P2|Follow-Up|Reason Not Specified|0
6021990|NCT00777036|20815697|P1|Follow-Up|Reason Not Specified|2
6021991|NCT00777036|20815695|P3|Follow-Up|Lost to Follow-up|0
6021992|NCT00777036|20815696|P2|Follow-Up|Lost to Follow-up|0
6021993|NCT00777036|20815697|P1|Follow-Up|Lost to Follow-up|1
6021994|NCT00777036|20815695|P3|On Treatment|Progressive Disease|6
6021995|NCT00777036|20815696|P2|On Treatment|Progressive Disease|4
6021996|NCT00777036|20815697|P1|On Treatment|Progressive Disease|5
6021997|NCT00777036|20815695|P3|On Treatment|Study Drug Toxicity|1
6021998|NCT00777036|20815696|P2|On Treatment|Study Drug Toxicity|0
6021999|NCT00777036|20815697|P1|On Treatment|Study Drug Toxicity|0
6022000|NCT00777036|20815695|P3|On Treatment|Death|0
6022001|NCT00777036|20815696|P2|On Treatment|Death|2
6022002|NCT00777036|20815697|P1|On Treatment|Death|0
6022003|NCT00777036|20815695|P3|On Treatment|Withdrawal by Subject|3
6022004|NCT00777036|20815696|P2|On Treatment|Withdrawal by Subject|2
6022005|NCT00777036|20815697|P1|On Treatment|Withdrawal by Subject|3
6022006|NCT00777036|20815695|P3|On Treatment|Maximum Clinical Benefit|1
6022007|NCT00777036|20815696|P2|On Treatment|Maximum Clinical Benefit|0
6022008|NCT00777036|20815697|P1|On Treatment|Maximum Clinical Benefit|2
6022009|NCT00777036|20815695|P3|On Treatment|Non-compliance with Study Drug|0
6022010|NCT00777036|20815696|P2|On Treatment|Non-compliance with Study Drug|0
6022011|NCT00777036|20815697|P1|On Treatment|Non-compliance with Study Drug|1
6022012|NCT00777036|20815695|P3|On Treatment|Failure to Meet Study Criteria|0
6022013|NCT00777036|20815696|P2|On Treatment|Failure to Meet Study Criteria|1
6022014|NCT00777036|20815697|P1|On Treatment|Failure to Meet Study Criteria|0
6022015|NCT00777036|20815695|P3|On Treatment|Reason Not Specified|12
6022016|NCT00777036|20815696|P2|On Treatment|Reason Not Specified|7
6022017|NCT00777036|20815697|P1|On Treatment|Reason Not Specified|4
6022018|NCT00777023|20815793|P3|Overall Study|Last dose date unknown|1
6022019|NCT00777023|20815794|P2|Overall Study|Last dose date unknown|3
6022020|NCT00777023|20815795|P1|Overall Study|Last dose date unknown|3
6022021|NCT00777023|20815793|P3|Overall Study|Reasons not specified|2
6022022|NCT00777023|20815794|P2|Overall Study|Reasons not specified|4
6022023|NCT00777023|20815795|P1|Overall Study|Reasons not specified|4
6022024|NCT00777023|20815793|P3|Overall Study|Missing data|0
6022025|NCT00777023|20815794|P2|Overall Study|Missing data|1
6022026|NCT00777023|20815795|P1|Overall Study|Missing data|1
6022027|NCT00777023|20815793|P3|Overall Study|Withdrawal by Subject|8
6022028|NCT00777023|20815794|P2|Overall Study|Withdrawal by Subject|7
6022029|NCT00777023|20815795|P1|Overall Study|Withdrawal by Subject|7
6022030|NCT00777023|20815793|P3|Overall Study|Death|0
6022031|NCT00777023|20815794|P2|Overall Study|Death|1
6022032|NCT00777023|20815795|P1|Overall Study|Death|0
6022033|NCT00777023|20815793|P3|Overall Study|Lost to Follow-up|3
6022034|NCT00777023|20815794|P2|Overall Study|Lost to Follow-up|3
6022035|NCT00777023|20815795|P1|Overall Study|Lost to Follow-up|2
6022036|NCT00777023|20815793|P3|Overall Study|Protocol Violation|1
6022037|NCT00777023|20815794|P2|Overall Study|Protocol Violation|1
6022038|NCT00777023|20815795|P1|Overall Study|Protocol Violation|2
6022039|NCT00777023|20815793|P3|Overall Study|Lack of Efficacy|14
6022040|NCT00777023|20815794|P2|Overall Study|Lack of Efficacy|0
6022041|NCT00777023|20815795|P1|Overall Study|Lack of Efficacy|1
6022042|NCT00777023|20815793|P3|Overall Study|Adverse Event|8
6022043|NCT00777023|20815794|P2|Overall Study|Adverse Event|21
6022044|NCT00777023|20815795|P1|Overall Study|Adverse Event|15
6022045|NCT00776997|20815812|P1|Overall Study|Adverse Event|2
6022046|NCT00776984|20815821|P2|Overall Study|Other|9
6022047|NCT00776984|20815822|P1|Overall Study|Other|5
6022048|NCT00776984|20815821|P2|Overall Study|Lack of Efficacy|1
6022049|NCT00776984|20815822|P1|Overall Study|Lack of Efficacy|0
6022050|NCT00776984|20815821|P2|Overall Study|Withdrawal by Subject|7
6022051|NCT00776984|20815822|P1|Overall Study|Withdrawal by Subject|12
6022052|NCT00776984|20815821|P2|Overall Study|Lost to Follow-up|0
6022053|NCT00776984|20815822|P1|Overall Study|Lost to Follow-up|2
6022054|NCT00776984|20815821|P2|Overall Study|Protocol Violation|2
6022055|NCT00776984|20815822|P1|Overall Study|Protocol Violation|4
6022056|NCT00776984|20815821|P2|Overall Study|Adverse Event|2
6022057|NCT00776984|20815822|P1|Overall Study|Adverse Event|8
6022058|NCT00776919|20815896|P4|Overall Study|Other: Lack of Efficacy/Lost Medication|2
6022059|NCT00776919|20815897|P3|Overall Study|Other: Lack of Efficacy/Lost Medication|4
6022060|NCT00776919|20815898|P2|Overall Study|Other: Lack of Efficacy/Lost Medication|5
6022061|NCT00776919|20815899|P1|Overall Study|Other: Lack of Efficacy/Lost Medication|1
6022062|NCT00776919|20815896|P4|Overall Study|Protocol Violation|1
6022063|NCT00776919|20815897|P3|Overall Study|Protocol Violation|0
6022064|NCT00776919|20815898|P2|Overall Study|Protocol Violation|2
6022065|NCT00776919|20815899|P1|Overall Study|Protocol Violation|1
6022066|NCT00776919|20815896|P4|Overall Study|Adverse Event|2
6022067|NCT00776919|20815897|P3|Overall Study|Adverse Event|2
6022068|NCT00776919|20815898|P2|Overall Study|Adverse Event|0
6022069|NCT00776919|20815899|P1|Overall Study|Adverse Event|1
6022070|NCT00776919|20815896|P4|Overall Study|Lost to Follow-up|8
6022071|NCT00776919|20815897|P3|Overall Study|Lost to Follow-up|11
6022072|NCT00776919|20815898|P2|Overall Study|Lost to Follow-up|12
6022073|NCT00776919|20815899|P1|Overall Study|Lost to Follow-up|8
6022074|NCT00776919|20815896|P4|Overall Study|Withdrawal by Subject|26
6022075|NCT00776919|20815897|P3|Overall Study|Withdrawal by Subject|15
6022076|NCT00776919|20815898|P2|Overall Study|Withdrawal by Subject|14
6022077|NCT00776919|20815899|P1|Overall Study|Withdrawal by Subject|16
6022078|NCT00776789|20815963|P2|Overall Study|Poor quality video|1
6022079|NCT00776789|20815964|P1|Overall Study|Poor quality video|1
6022080|NCT00776789|20815963|P2|Overall Study|Consent refusal|2
6022081|NCT00776789|20815964|P1|Overall Study|Consent refusal|2
6022082|NCT00776659|20815976|P1|Overall Study|Study Terminated by Sponsor|1
6022083|NCT00776659|20815976|P1|Overall Study|Withdrawal by Subject|10
6022084|NCT00776659|20815976|P1|Overall Study|Lost to Follow-up|15
6022085|NCT00776555|20816003|P2|Overall Study|Study terminated|0
6022086|NCT00776555|20816004|P1|Overall Study|Study terminated|3
6022087|NCT00776230|20816022|P3|Overall Study|Subject missed Visit 4|0
6022088|NCT00776230|20816023|P2|Overall Study|Subject missed Visit 4|1
6022089|NCT00776230|20816024|P1|Overall Study|Subject missed Visit 4|0
6022090|NCT00776230|20816022|P3|Overall Study|Withdrawal by Subject|0
6022091|NCT00776230|20816023|P2|Overall Study|Withdrawal by Subject|1
6022092|NCT00776230|20816024|P1|Overall Study|Withdrawal by Subject|0
6022093|NCT00776230|20816022|P3|Overall Study|Not vaccinated at Day 0|0
6022094|NCT00776230|20816023|P2|Overall Study|Not vaccinated at Day 0|0
6022095|NCT00776230|20816024|P1|Overall Study|Not vaccinated at Day 0|1
6022096|NCT00776230|20816022|P3|Overall Study|Lost to Follow-up|5
6022097|NCT00776230|20816023|P2|Overall Study|Lost to Follow-up|1
6022098|NCT00776230|20816024|P1|Overall Study|Lost to Follow-up|2
6022099|NCT00776100|20816034|P2|Overall Study|Disease Progression|0
6022100|NCT00776100|20816035|P1|Overall Study|Disease Progression|1
6022101|NCT00776009|20816057|P6|Period 3: Third Intervention|Withdrawal by Subject|0
6022102|NCT00776009|20816058|P5|Period 3: Third Intervention|Withdrawal by Subject|0
6022103|NCT00776009|20816059|P4|Period 3: Third Intervention|Withdrawal by Subject|0
6022104|NCT00776009|20816060|P3|Period 3: Third Intervention|Withdrawal by Subject|0
6022105|NCT00776009|20816061|P2|Period 3: Third Intervention|Withdrawal by Subject|0
6022106|NCT00776009|20816062|P1|Period 3: Third Intervention|Withdrawal by Subject|1
6022107|NCT00776009|20816057|P6|Period 2: Second Intervention|Protocol Violation|0
6022108|NCT00776009|20816058|P5|Period 2: Second Intervention|Protocol Violation|0
6022109|NCT00776009|20816059|P4|Period 2: Second Intervention|Protocol Violation|0
6022110|NCT00776009|20816060|P3|Period 2: Second Intervention|Protocol Violation|1
6022111|NCT00776009|20816061|P2|Period 2: Second Intervention|Protocol Violation|0
6022112|NCT00776009|20816062|P1|Period 2: Second Intervention|Protocol Violation|1
6022113|NCT00776009|20816057|P6|Period 2: Second Intervention|Withdrawal by Subject|1
6022114|NCT00776009|20816058|P5|Period 2: Second Intervention|Withdrawal by Subject|0
6022115|NCT00776009|20816059|P4|Period 2: Second Intervention|Withdrawal by Subject|0
6022116|NCT00776009|20816060|P3|Period 2: Second Intervention|Withdrawal by Subject|0
6022117|NCT00776009|20816061|P2|Period 2: Second Intervention|Withdrawal by Subject|0
6022118|NCT00776009|20816062|P1|Period 2: Second Intervention|Withdrawal by Subject|0
6022119|NCT00776009|20816057|P6|Period 1: First Intervention|Protocol Violation|0
6022120|NCT00776009|20816058|P5|Period 1: First Intervention|Protocol Violation|1
6022121|NCT00776009|20816059|P4|Period 1: First Intervention|Protocol Violation|0
6022122|NCT00776009|20816060|P3|Period 1: First Intervention|Protocol Violation|0
6022123|NCT00776009|20816061|P2|Period 1: First Intervention|Protocol Violation|1
6022124|NCT00776009|20816062|P1|Period 1: First Intervention|Protocol Violation|0
6022125|NCT00776009|20816057|P6|Period 1: First Intervention|Withdrawal by Subject|0
6022126|NCT00776009|20816058|P5|Period 1: First Intervention|Withdrawal by Subject|1
6022127|NCT00776009|20816059|P4|Period 1: First Intervention|Withdrawal by Subject|0
6022128|NCT00776009|20816060|P3|Period 1: First Intervention|Withdrawal by Subject|1
6022129|NCT00776009|20816061|P2|Period 1: First Intervention|Withdrawal by Subject|0
6022130|NCT00776009|20816062|P1|Period 1: First Intervention|Withdrawal by Subject|0
6022131|NCT00775983|20816084|P2|Overall Study|Protocol Violation|2
6022132|NCT00775983|20816085|P1|Overall Study|Protocol Violation|1
6022133|NCT00775606|20816211|P2|Overall Study|Study sponsor terminated funding|0
6022134|NCT00775606|20816212|P1|Overall Study|Study sponsor terminated funding|3
6022135|NCT00775593|20816222|P1|Overall Study|Death|1
6022136|NCT00775593|20816222|P1|Overall Study|Unmet eligibility criteria|6
6022137|NCT00775528|20816229|P1|Overall Study|Protocol Violation|1
6022138|NCT00775463|20816238|P2|Overall Study|Lack of Efficacy|1
6022139|NCT00775463|20816239|P1|Overall Study|Lack of Efficacy|1
6022140|NCT00775463|20816238|P2|Overall Study|Lost to Follow-up|0
6022141|NCT00775463|20816239|P1|Overall Study|Lost to Follow-up|1
6022142|NCT00775463|20816238|P2|Overall Study|Protocol Violation|2
6022143|NCT00775463|20816239|P1|Overall Study|Protocol Violation|2
6022144|NCT00775463|20816238|P2|Overall Study|Adverse Event|9
6022145|NCT00775463|20816239|P1|Overall Study|Adverse Event|7
6022146|NCT00775463|20816238|P2|Overall Study|Withdrawal by Subject|1
6022147|NCT00775463|20816239|P1|Overall Study|Withdrawal by Subject|0
6022148|NCT00775450|20816276|P5|Overall Study|Withdrawal by Subject|1
6022149|NCT00775450|20816277|P4|Overall Study|Withdrawal by Subject|0
6022150|NCT00775450|20816278|P3|Overall Study|Withdrawal by Subject|0
6022151|NCT00775450|20816279|P2|Overall Study|Withdrawal by Subject|0
6022152|NCT00775450|20816280|P1|Overall Study|Withdrawal by Subject|1
6022153|NCT00775450|20816276|P5|Overall Study|Protocol Violation|1
6022154|NCT00775450|20816277|P4|Overall Study|Protocol Violation|0
6022155|NCT00775450|20816278|P3|Overall Study|Protocol Violation|0
6022156|NCT00775450|20816279|P2|Overall Study|Protocol Violation|0
6022157|NCT00775450|20816280|P1|Overall Study|Protocol Violation|0
6022158|NCT00775450|20816276|P5|Overall Study|Serious Adverse Event|0
6022159|NCT00775450|20816277|P4|Overall Study|Serious Adverse Event|0
6022160|NCT00775450|20816278|P3|Overall Study|Serious Adverse Event|0
6022161|NCT00775450|20816279|P2|Overall Study|Serious Adverse Event|0
6022162|NCT00775450|20816280|P1|Overall Study|Serious Adverse Event|2
6022163|NCT00775437|20816307|P1|Overall Study|Lost to Follow-up|1
6022164|NCT00775437|20816307|P1|Overall Study|Withdrawal by Subject|3
6022165|NCT00775437|20816307|P1|Overall Study|Loss of efficacy|2
6022166|NCT00775203|20816382|P2|Overall Study|Physician Decision|1
6022167|NCT00775203|20816383|P1|Overall Study|Physician Decision|0
6022168|NCT00775203|20816382|P2|Overall Study|Entered other study|0
6022169|NCT00775203|20816383|P1|Overall Study|Entered other study|1
6022170|NCT00775203|20816382|P2|Overall Study|Protocol Violation|1
6022171|NCT00775203|20816383|P1|Overall Study|Protocol Violation|0
6022172|NCT00775203|20816382|P2|Overall Study|Noncompliance|2
6022173|NCT00775203|20816383|P1|Overall Study|Noncompliance|4
6022174|NCT00775203|20816382|P2|Overall Study|Administrative reason|0
6022175|NCT00775203|20816383|P1|Overall Study|Administrative reason|2
6022176|NCT00775203|20816382|P2|Overall Study|Lost to Follow-up|15
6022177|NCT00775203|20816383|P1|Overall Study|Lost to Follow-up|11
6022178|NCT00775203|20816382|P2|Overall Study|Withdrawal by Subject|9
6022179|NCT00775203|20816383|P1|Overall Study|Withdrawal by Subject|11
6022180|NCT00775203|20816382|P2|Overall Study|Lack of Efficacy|9
6022181|NCT00775203|20816383|P1|Overall Study|Lack of Efficacy|8
6022182|NCT00775203|20816382|P2|Overall Study|Adverse Event|6
6022183|NCT00775203|20816383|P1|Overall Study|Adverse Event|25
6022184|NCT00775190|20816417|P2|Overall Study|Protocol Violation|0
6022185|NCT00775190|20816418|P1|Overall Study|Protocol Violation|1
6022186|NCT00775190|20816417|P2|Overall Study|Withdrawal by Subject|2
6022187|NCT00775190|20816418|P1|Overall Study|Withdrawal by Subject|1
6022188|NCT00775190|20816417|P2|Overall Study|Lost to Follow-up|3
6022189|NCT00775190|20816418|P1|Overall Study|Lost to Follow-up|2
6022190|NCT00775138|20816444|P4|Overall Study|Adverse Event|0
6022191|NCT00775138|20816445|P3|Overall Study|Adverse Event|1
6022192|NCT00775138|20816446|P2|Overall Study|Adverse Event|0
6022193|NCT00775138|20816447|P1|Overall Study|Adverse Event|0
6022194|NCT00775138|20816444|P4|Overall Study|Withdrawal by Subject|2
6022195|NCT00775138|20816445|P3|Overall Study|Withdrawal by Subject|2
6022196|NCT00775138|20816446|P2|Overall Study|Withdrawal by Subject|0
6022197|NCT00775138|20816447|P1|Overall Study|Withdrawal by Subject|0
6022198|NCT00775021|20816493|P2|Second Intervention|Adverse Event|1
6022199|NCT00775021|20816494|P1|Second Intervention|Adverse Event|0
6022200|NCT00775021|20816493|P2|First Intervention|Lost to Follow-up|0
6022201|NCT00775021|20816494|P1|First Intervention|Lost to Follow-up|1
6022202|NCT00774995|20816512|P4|Overall Study|Protocol Violation|0
6022203|NCT00774995|20816513|P3|Overall Study|Protocol Violation|1
6022204|NCT00774995|20816514|P2|Overall Study|Protocol Violation|0
6022205|NCT00774995|20816515|P1|Overall Study|Protocol Violation|0
6022206|NCT00774930|20816555|P2|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|1
6022207|NCT00774930|20816556|P1|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|0
6022208|NCT00774930|20816555|P2|LTOLE Phase|Tumour Progression of Hepatic Metastases|1
6022209|NCT00774930|20816556|P1|LTOLE Phase|Tumour Progression of Hepatic Metastases|0
6022210|NCT00774930|20816555|P2|LTOLE Phase|Disease Progression|5
6022211|NCT00774930|20816556|P1|LTOLE Phase|Disease Progression|2
6022212|NCT00774930|20816555|P2|LTOLE Phase|Sponsor decision|1
6022213|NCT00774930|20816556|P1|LTOLE Phase|Sponsor decision|2
6022214|NCT00774930|20816555|P2|LTOLE Phase|Physician Decision|1
6022215|NCT00774930|20816556|P1|LTOLE Phase|Physician Decision|4
6022216|NCT00774930|20816555|P2|LTOLE Phase|Subject decision|5
6022217|NCT00774930|20816556|P1|LTOLE Phase|Subject decision|0
6022218|NCT00774930|20816555|P2|LTOLE Phase|Adverse Event|3
6022219|NCT00774930|20816556|P1|LTOLE Phase|Adverse Event|7
6022220|NCT00774930|20816555|P2|IOL Phase|Brain radiation|1
6022221|NCT00774930|20816556|P1|IOL Phase|Brain radiation|0
6022222|NCT00774930|20816555|P2|IOL Phase|Other|0
6022223|NCT00774930|20816556|P1|IOL Phase|Other|1
6022224|NCT00774930|20816555|P2|IOL Phase|Peptide Receptor Radionuclide Therapy|1
6022225|NCT00774930|20816556|P1|IOL Phase|Peptide Receptor Radionuclide Therapy|0
6022226|NCT00774930|20816555|P2|IOL Phase|Subject Consumed Prohibited Medication|0
6022227|NCT00774930|20816556|P1|IOL Phase|Subject Consumed Prohibited Medication|1
6022228|NCT00774930|20816555|P2|IOL Phase|Disease Progression|1
6022229|NCT00774930|20816556|P1|IOL Phase|Disease Progression|2
6022230|NCT00774930|20816555|P2|IOL Phase|Sponsor Decision|0
6022231|NCT00774930|20816556|P1|IOL Phase|Sponsor Decision|1
6022232|NCT00774930|20816555|P2|IOL Phase|Physician Decision|2
6022233|NCT00774930|20816556|P1|IOL Phase|Physician Decision|3
6022234|NCT00774930|20816555|P2|IOL Phase|Subject Decision|3
6022235|NCT00774930|20816556|P1|IOL Phase|Subject Decision|4
6022236|NCT00774930|20816555|P2|IOL Phase|Adverse Event|1
6022237|NCT00774930|20816556|P1|IOL Phase|Adverse Event|1
6022238|NCT00774930|20816555|P2|DB Phase|Started Nonprotocol Radiation therapy|1
6022239|NCT00774930|20816556|P1|DB Phase|Started Nonprotocol Radiation therapy|0
6022240|NCT00774930|20816555|P2|DB Phase|Disease Progression|1
6022241|NCT00774930|20816556|P1|DB Phase|Disease Progression|1
6022242|NCT00774930|20816555|P2|DB Phase|Sponsor Decision|1
6022243|NCT00774930|20816556|P1|DB Phase|Sponsor Decision|0
6022244|NCT00774930|20816555|P2|DB Phase|Subject Decision|5
6022245|NCT00774930|20816556|P1|DB Phase|Subject Decision|1
6022246|NCT00774930|20816555|P2|DB Phase|Adverse Event|2
6022247|NCT00774930|20816556|P1|DB Phase|Adverse Event|1
6022248|NCT00774930|20816555|P2|DB Phase|Early Roll Over (ERO) to IOL phase|12
6022249|NCT00774930|20816556|P1|DB Phase|Early Roll Over (ERO) to IOL phase|11
6022250|NCT00774852|20816584|P2|Overall Study|Subject received prohibited medication|0
6022251|NCT00774852|20816585|P1|Overall Study|Subject received prohibited medication|1
6022252|NCT00774852|20816584|P2|Overall Study|Protocol Violation|0
6022253|NCT00774852|20816585|P1|Overall Study|Protocol Violation|1
6022254|NCT00774852|20816584|P2|Overall Study|Subject non-compliance|1
6022255|NCT00774852|20816585|P1|Overall Study|Subject non-compliance|0
6022256|NCT00774852|20816584|P2|Overall Study|Non-responder|11
6022257|NCT00774852|20816585|P1|Overall Study|Non-responder|15
6022258|NCT00774852|20816584|P2|Overall Study|Withdrawal by Subject|2
6022259|NCT00774852|20816585|P1|Overall Study|Withdrawal by Subject|2
6022260|NCT00774852|20816584|P2|Overall Study|Pregnancy|2
6022261|NCT00774852|20816585|P1|Overall Study|Pregnancy|1
6022262|NCT00774852|20816584|P2|Overall Study|Physician Decision|6
6022263|NCT00774852|20816585|P1|Overall Study|Physician Decision|2
6022264|NCT00774852|20816584|P2|Overall Study|Lost to Follow-up|5
6022265|NCT00774852|20816585|P1|Overall Study|Lost to Follow-up|9
6022266|NCT00774852|20816584|P2|Overall Study|Lack of Efficacy|7
6022267|NCT00774852|20816585|P1|Overall Study|Lack of Efficacy|3
6022268|NCT00774852|20816584|P2|Overall Study|Death|1
6022269|NCT00774852|20816585|P1|Overall Study|Death|2
6022270|NCT00774852|20816584|P2|Overall Study|Adverse Event|6
6022271|NCT00774852|20816585|P1|Overall Study|Adverse Event|9
6022272|NCT00774800|20816633|P1|Intervention 4|Withdrawal by Subject|1
6022273|NCT00774787|20816655|P1|Overall Study|Lost to Follow-up|1
6022274|NCT00774748|20816662|P1|Overall Study|Lost to Follow-up|3
6022275|NCT00774397|20816688|P7|Overall Study|Other than those stated above|1
6022276|NCT00774397|20816689|P6|Overall Study|Other than those stated above|0
6022277|NCT00774397|20816690|P5|Overall Study|Other than those stated above|2
6022278|NCT00774397|20816691|P4|Overall Study|Other than those stated above|2
6022279|NCT00774397|20816692|P3|Overall Study|Other than those stated above|3
6022280|NCT00774397|20816693|P2|Overall Study|Other than those stated above|1
6022281|NCT00774397|20816694|P1|Overall Study|Other than those stated above|1
6022282|NCT00774397|20816688|P7|Overall Study|Not treated|1
6022283|NCT00774397|20816689|P6|Overall Study|Not treated|0
6022284|NCT00774397|20816690|P5|Overall Study|Not treated|1
6022285|NCT00774397|20816691|P4|Overall Study|Not treated|0
6022286|NCT00774397|20816692|P3|Overall Study|Not treated|0
6022287|NCT00774397|20816693|P2|Overall Study|Not treated|0
6022288|NCT00774397|20816694|P1|Overall Study|Not treated|0
6022289|NCT00774397|20816688|P7|Overall Study|Refused to continue trial medication|3
6022290|NCT00774397|20816689|P6|Overall Study|Refused to continue trial medication|2
6022291|NCT00774397|20816690|P5|Overall Study|Refused to continue trial medication|6
6022292|NCT00774397|20816691|P4|Overall Study|Refused to continue trial medication|2
6022293|NCT00774397|20816692|P3|Overall Study|Refused to continue trial medication|2
6022294|NCT00774397|20816693|P2|Overall Study|Refused to continue trial medication|3
6022295|NCT00774397|20816694|P1|Overall Study|Refused to continue trial medication|1
6022296|NCT00774397|20816688|P7|Overall Study|Lost to Follow-up|0
6022297|NCT00774397|20816689|P6|Overall Study|Lost to Follow-up|1
6022298|NCT00774397|20816690|P5|Overall Study|Lost to Follow-up|0
6022299|NCT00774397|20816691|P4|Overall Study|Lost to Follow-up|1
6022300|NCT00774397|20816692|P3|Overall Study|Lost to Follow-up|1
6022301|NCT00774397|20816693|P2|Overall Study|Lost to Follow-up|1
6022302|NCT00774397|20816694|P1|Overall Study|Lost to Follow-up|0
6022303|NCT00774397|20816688|P7|Overall Study|Protocol Violation|0
6022304|NCT00774397|20816689|P6|Overall Study|Protocol Violation|1
6022305|NCT00774397|20816690|P5|Overall Study|Protocol Violation|2
6022306|NCT00774397|20816691|P4|Overall Study|Protocol Violation|1
6022307|NCT00774397|20816692|P3|Overall Study|Protocol Violation|3
6022308|NCT00774397|20816693|P2|Overall Study|Protocol Violation|1
6022309|NCT00774397|20816694|P1|Overall Study|Protocol Violation|0
6022310|NCT00774397|20816688|P7|Overall Study|Lack of Efficacy|9
6022311|NCT00774397|20816689|P6|Overall Study|Lack of Efficacy|15
6022312|NCT00774397|20816690|P5|Overall Study|Lack of Efficacy|27
6022313|NCT00774397|20816691|P4|Overall Study|Lack of Efficacy|3
6022314|NCT00774397|20816692|P3|Overall Study|Lack of Efficacy|5
6022315|NCT00774397|20816693|P2|Overall Study|Lack of Efficacy|4
6022316|NCT00774397|20816694|P1|Overall Study|Lack of Efficacy|11
6022317|NCT00774397|20816688|P7|Overall Study|Adverse Event|16
6022318|NCT00774397|20816689|P6|Overall Study|Adverse Event|3
6022319|NCT00774397|20816690|P5|Overall Study|Adverse Event|8
6022320|NCT00774397|20816691|P4|Overall Study|Adverse Event|8
6022321|NCT00774397|20816692|P3|Overall Study|Adverse Event|16
6022322|NCT00774397|20816693|P2|Overall Study|Adverse Event|3
6022323|NCT00774397|20816694|P1|Overall Study|Adverse Event|1
6022324|NCT00774306|20816930|P4|Overall Study|Death|0
6022325|NCT00774306|20816931|P3|Overall Study|Death|0
6022326|NCT00774306|20816932|P2|Overall Study|Death|1
6022327|NCT00774306|20816933|P1|Overall Study|Death|1
6022328|NCT00774306|20816930|P4|Overall Study|Lost to Follow-up|5
6022329|NCT00774306|20816931|P3|Overall Study|Lost to Follow-up|4
6022330|NCT00774306|20816932|P2|Overall Study|Lost to Follow-up|0
6022331|NCT00774306|20816933|P1|Overall Study|Lost to Follow-up|6
6022332|NCT00774306|20816930|P4|Overall Study|Withdrawal by Subject|0
6022333|NCT00774306|20816931|P3|Overall Study|Withdrawal by Subject|1
6022334|NCT00774306|20816932|P2|Overall Study|Withdrawal by Subject|1
6022335|NCT00774306|20816933|P1|Overall Study|Withdrawal by Subject|6
6022336|NCT00774306|20816930|P4|Overall Study|Protocol Violation|0
6022337|NCT00774306|20816931|P3|Overall Study|Protocol Violation|3
6022338|NCT00774306|20816932|P2|Overall Study|Protocol Violation|0
6022339|NCT00774306|20816933|P1|Overall Study|Protocol Violation|2
6022340|NCT00774306|20816930|P4|Overall Study|Adverse Event|0
6022341|NCT00774306|20816931|P3|Overall Study|Adverse Event|0
6022342|NCT00774306|20816932|P2|Overall Study|Adverse Event|0
6022343|NCT00774306|20816933|P1|Overall Study|Adverse Event|3
6022344|NCT00774046|20817014|P1|Stem Cell Mobilization|Count too low (2), sudden death (1)|3
6022345|NCT00774046|20817014|P1|Enrollment|Desired other therapy/refused|28
6022346|NCT00774046|20817014|P1|Screening|Not eligible|56
6022347|NCT00773968|20817024|P1|Overall Study|Other|8
6022348|NCT00773968|20817024|P1|Overall Study|Screen Failure|17
6022349|NCT00773968|20817024|P1|Overall Study|Withdrawal by Subject|11
6022350|NCT00773968|20817024|P1|Overall Study|Protocol Violation|1
6022351|NCT00773968|20817024|P1|Overall Study|Lack of Efficacy|3
6022352|NCT00773968|20817024|P1|Overall Study|Failure to Return|2
6022353|NCT00773968|20817024|P1|Overall Study|Death|1
6022354|NCT00773968|20817024|P1|Overall Study|Adverse Event|2
6022355|NCT00773734|20817055|P6|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0
6022356|NCT00773734|20817056|P5|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0
6022357|NCT00773734|20817057|P4|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4
6022358|NCT00773734|20817058|P3|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4
6022359|NCT00773734|20817059|P2|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0
6022360|NCT00773734|20817060|P1|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0
6022361|NCT00773734|20817055|P6|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0
6022362|NCT00773734|20817056|P5|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0
6022363|NCT00773734|20817057|P4|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|3
6022364|NCT00773734|20817058|P3|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|6
6022365|NCT00773734|20817059|P2|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0
6022366|NCT00773734|20817060|P1|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0
6022367|NCT00773734|20817055|P6|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0
6022368|NCT00773734|20817056|P5|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0
6022369|NCT00773734|20817057|P4|LTE Period: Week 52 to 6 Years|Lack of Efficacy|4
6022370|NCT00773734|20817058|P3|LTE Period: Week 52 to 6 Years|Lack of Efficacy|2
6022371|NCT00773734|20817059|P2|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0
6022372|NCT00773734|20817060|P1|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0
6022373|NCT00773734|20817055|P6|LTE Period: Week 52 to 6 Years|Adverse Event|0
6022374|NCT00773734|20817056|P5|LTE Period: Week 52 to 6 Years|Adverse Event|0
6022375|NCT00773734|20817057|P4|LTE Period: Week 52 to 6 Years|Adverse Event|1
6022376|NCT00773734|20817058|P3|LTE Period: Week 52 to 6 Years|Adverse Event|0
6022377|NCT00773734|20817059|P2|LTE Period: Week 52 to 6 Years|Adverse Event|0
6022378|NCT00773734|20817060|P1|LTE Period: Week 52 to 6 Years|Adverse Event|0
6022379|NCT00773734|20817055|P6|Extension: Active Treatment Week 24-52|Other|1
6022380|NCT00773734|20817056|P5|Extension: Active Treatment Week 24-52|Other|0
6022381|NCT00773734|20817057|P4|Extension: Active Treatment Week 24-52|Other|2
6022382|NCT00773734|20817058|P3|Extension: Active Treatment Week 24-52|Other|1
6022383|NCT00773734|20817059|P2|Extension: Active Treatment Week 24-52|Other|0
6022384|NCT00773734|20817060|P1|Extension: Active Treatment Week 24-52|Other|0
6022385|NCT00773734|20817055|P6|Extension: Active Treatment Week 24-52|Lost to Follow-up|1
6022386|NCT00773734|20817056|P5|Extension: Active Treatment Week 24-52|Lost to Follow-up|0
6022387|NCT00773734|20817057|P4|Extension: Active Treatment Week 24-52|Lost to Follow-up|3
6022388|NCT00773734|20817058|P3|Extension: Active Treatment Week 24-52|Lost to Follow-up|5
6022389|NCT00773734|20817059|P2|Extension: Active Treatment Week 24-52|Lost to Follow-up|2
6022390|NCT00773734|20817060|P1|Extension: Active Treatment Week 24-52|Lost to Follow-up|0
6022391|NCT00773734|20817055|P6|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3
6022392|NCT00773734|20817056|P5|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2
6022393|NCT00773734|20817057|P4|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2
6022394|NCT00773734|20817058|P3|Extension: Active Treatment Week 24-52|Withdrawal by Subject|1
6022395|NCT00773734|20817059|P2|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3
6022396|NCT00773734|20817060|P1|Extension: Active Treatment Week 24-52|Withdrawal by Subject|0
6022397|NCT00773734|20817055|P6|Extension: Active Treatment Week 24-52|Lack of Efficacy|2
6022398|NCT00773734|20817056|P5|Extension: Active Treatment Week 24-52|Lack of Efficacy|1
6022399|NCT00773734|20817057|P4|Extension: Active Treatment Week 24-52|Lack of Efficacy|3
6022400|NCT00773734|20817058|P3|Extension: Active Treatment Week 24-52|Lack of Efficacy|10
6022401|NCT00773734|20817059|P2|Extension: Active Treatment Week 24-52|Lack of Efficacy|8
6022402|NCT00773734|20817060|P1|Extension: Active Treatment Week 24-52|Lack of Efficacy|0
6022403|NCT00773734|20817055|P6|Extension: Active Treatment Week 24-52|Adverse Event|1
6022404|NCT00773734|20817056|P5|Extension: Active Treatment Week 24-52|Adverse Event|2
6022405|NCT00773734|20817057|P4|Extension: Active Treatment Week 24-52|Adverse Event|0
6022406|NCT00773734|20817058|P3|Extension: Active Treatment Week 24-52|Adverse Event|0
6022407|NCT00773734|20817059|P2|Extension: Active Treatment Week 24-52|Adverse Event|0
6022408|NCT00773734|20817060|P1|Extension: Active Treatment Week 24-52|Adverse Event|0
6022409|NCT00773734|20817055|P6|Core: Active Treatment Phase Week 16-24|Other|0
6022410|NCT00773734|20817056|P5|Core: Active Treatment Phase Week 16-24|Other|0
6022411|NCT00773734|20817057|P4|Core: Active Treatment Phase Week 16-24|Other|0
6022412|NCT00773734|20817058|P3|Core: Active Treatment Phase Week 16-24|Other|0
6022413|NCT00773734|20817059|P2|Core: Active Treatment Phase Week 16-24|Other|1
6022414|NCT00773734|20817060|P1|Core: Active Treatment Phase Week 16-24|Other|0
6022415|NCT00773734|20817055|P6|Core: Active Treatment Phase Week 16-24|Protocol Violation|1
6022416|NCT00773734|20817056|P5|Core: Active Treatment Phase Week 16-24|Protocol Violation|0
6022417|NCT00773734|20817057|P4|Core: Active Treatment Phase Week 16-24|Protocol Violation|1
6022418|NCT00773734|20817058|P3|Core: Active Treatment Phase Week 16-24|Protocol Violation|1
6022490|NCT00773513|20817629|P1|Overall Study|Reason Not Specified|159
6022419|NCT00773734|20817059|P2|Core: Active Treatment Phase Week 16-24|Protocol Violation|1
6022420|NCT00773734|20817060|P1|Core: Active Treatment Phase Week 16-24|Protocol Violation|0
6022421|NCT00773734|20817055|P6|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0
6022422|NCT00773734|20817056|P5|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0
6022423|NCT00773734|20817057|P4|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0
6022424|NCT00773734|20817058|P3|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1
6022425|NCT00773734|20817059|P2|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1
6022426|NCT00773734|20817060|P1|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0
6022427|NCT00773734|20817055|P6|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|2
6022428|NCT00773734|20817056|P5|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0
6022429|NCT00773734|20817057|P4|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0
6022430|NCT00773734|20817058|P3|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1
6022431|NCT00773734|20817059|P2|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1
6022432|NCT00773734|20817060|P1|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0
6022433|NCT00773734|20817055|P6|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0
6022434|NCT00773734|20817056|P5|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0
6022435|NCT00773734|20817057|P4|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|1
6022436|NCT00773734|20817058|P3|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4
6022437|NCT00773734|20817059|P2|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4
6022438|NCT00773734|20817060|P1|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0
6022439|NCT00773734|20817055|P6|Core: Active Treatment Phase Week 16-24|Adverse Event|2
6022440|NCT00773734|20817056|P5|Core: Active Treatment Phase Week 16-24|Adverse Event|1
6022441|NCT00773734|20817057|P4|Core: Active Treatment Phase Week 16-24|Adverse Event|0
6022442|NCT00773734|20817058|P3|Core: Active Treatment Phase Week 16-24|Adverse Event|0
6022443|NCT00773734|20817059|P2|Core: Active Treatment Phase Week 16-24|Adverse Event|4
6022444|NCT00773734|20817060|P1|Core: Active Treatment Phase Week 16-24|Adverse Event|0
6022445|NCT00773734|20817055|P6|Core: Placebo Controlled Phase Week 0-16|Other|0
6022446|NCT00773734|20817056|P5|Core: Placebo Controlled Phase Week 0-16|Other|0
6022447|NCT00773734|20817057|P4|Core: Placebo Controlled Phase Week 0-16|Other|1
6022448|NCT00773734|20817058|P3|Core: Placebo Controlled Phase Week 0-16|Other|1
6022449|NCT00773734|20817059|P2|Core: Placebo Controlled Phase Week 0-16|Other|1
6022450|NCT00773734|20817060|P1|Core: Placebo Controlled Phase Week 0-16|Other|1
6022451|NCT00773734|20817055|P6|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0
6022452|NCT00773734|20817056|P5|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0
6022453|NCT00773734|20817057|P4|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0
6022454|NCT00773734|20817058|P3|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|4
6022455|NCT00773734|20817059|P2|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|3
6022456|NCT00773734|20817060|P1|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|1
6022457|NCT00773734|20817055|P6|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0
6022458|NCT00773734|20817056|P5|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0
6022459|NCT00773734|20817057|P4|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|1
6022460|NCT00773734|20817058|P3|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0
6022461|NCT00773734|20817059|P2|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0
6022462|NCT00773734|20817060|P1|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|2
6022463|NCT00773734|20817055|P6|Core: Placebo Controlled Phase Week 0-16|Death|0
6022464|NCT00773734|20817056|P5|Core: Placebo Controlled Phase Week 0-16|Death|0
6022465|NCT00773734|20817057|P4|Core: Placebo Controlled Phase Week 0-16|Death|0
6022466|NCT00773734|20817058|P3|Core: Placebo Controlled Phase Week 0-16|Death|0
6022467|NCT00773734|20817059|P2|Core: Placebo Controlled Phase Week 0-16|Death|0
6022468|NCT00773734|20817060|P1|Core: Placebo Controlled Phase Week 0-16|Death|1
6022469|NCT00773734|20817055|P6|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0
6022470|NCT00773734|20817056|P5|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0
6022471|NCT00773734|20817057|P4|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|4
6022472|NCT00773734|20817058|P3|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|6
6022473|NCT00773734|20817059|P2|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2
6022474|NCT00773734|20817060|P1|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2
6022475|NCT00773734|20817055|P6|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0
6022476|NCT00773734|20817056|P5|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0
6022477|NCT00773734|20817057|P4|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2
6022478|NCT00773734|20817058|P3|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2
6022479|NCT00773734|20817059|P2|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|3
6022480|NCT00773734|20817060|P1|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|4
6022481|NCT00773734|20817055|P6|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0
6022482|NCT00773734|20817056|P5|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0
6022483|NCT00773734|20817057|P4|Core: Placebo Controlled Phase Week 0-16|Adverse Event|10
6022484|NCT00773734|20817058|P3|Core: Placebo Controlled Phase Week 0-16|Adverse Event|8
6022485|NCT00773734|20817059|P2|Core: Placebo Controlled Phase Week 0-16|Adverse Event|1
6022486|NCT00773734|20817060|P1|Core: Placebo Controlled Phase Week 0-16|Adverse Event|5
6022487|NCT00773513|20817628|P2|Overall Study|Death|545
6022488|NCT00773513|20817629|P1|Overall Study|Death|531
6022489|NCT00773513|20817628|P2|Overall Study|Reason Not Specified|126
6022491|NCT00773513|20817628|P2|Overall Study|Insufficient Therapeutic Response|18
6022492|NCT00773513|20817629|P1|Overall Study|Insufficient Therapeutic Response|1
6022493|NCT00773513|20817628|P2|Overall Study|Failure to Return|8
6022494|NCT00773513|20817629|P1|Overall Study|Failure to Return|22
6022495|NCT00773513|20817628|P2|Overall Study|Refused Treatment / Did not Cooperate|32
6022496|NCT00773513|20817629|P1|Overall Study|Refused Treatment / Did not Cooperate|26
6022497|NCT00773513|20817628|P2|Overall Study|Withdrew Consent|69
6022498|NCT00773513|20817629|P1|Overall Study|Withdrew Consent|68
6022499|NCT00773513|20817628|P2|Overall Study|Adverse Event / Intercurrent Illness|48
6022500|NCT00773513|20817629|P1|Overall Study|Adverse Event / Intercurrent Illness|40
6022501|NCT00773513|20817628|P2|Overall Study|Renal Transplant|263
6022502|NCT00773513|20817629|P1|Overall Study|Renal Transplant|254
6022503|NCT00773461|20817658|P2|Overall Study|Withdrawal by Subject|1
6022504|NCT00773461|20817659|P1|Overall Study|Withdrawal by Subject|4
6022505|NCT00773461|20817658|P2|Overall Study|Adverse Event|3
6022506|NCT00773461|20817659|P1|Overall Study|Adverse Event|1
6022507|NCT00773383|20817713|P1|Overall Study|No study dose received|1
6022508|NCT00773383|20817713|P1|Overall Study|Other|2
6022509|NCT00773383|20817713|P1|Overall Study|Progression of Disease|23
6022510|NCT00773383|20817713|P1|Overall Study|Death|1
6022511|NCT00773383|20817713|P1|Overall Study|Adverse Event|4
6022512|NCT00773279|20817748|P2|Period 2|Unclassified|2
6022513|NCT00773279|20817749|P1|Period 2|Unclassified|2
6022514|NCT00773279|20817748|P2|Period 2|Protocol Violation|3
6022515|NCT00773279|20817749|P1|Period 2|Protocol Violation|0
6022516|NCT00773279|20817748|P2|Period 2|Lack of Efficacy|0
6022517|NCT00773279|20817749|P1|Period 2|Lack of Efficacy|1
6022518|NCT00773279|20817748|P2|Period 2|Adverse Event|1
6022519|NCT00773279|20817749|P1|Period 2|Adverse Event|0
6022520|NCT00773279|20817748|P2|Period 1|Unclassified|1
6022521|NCT00773279|20817749|P1|Period 1|Unclassified|5
6022522|NCT00773279|20817748|P2|Period 1|Lack of Efficacy|2
6022523|NCT00773279|20817749|P1|Period 1|Lack of Efficacy|0
6022524|NCT00773279|20817748|P2|Period 1|Adverse Event|1
6022525|NCT00773279|20817749|P1|Period 1|Adverse Event|2
6022526|NCT00773253|20817770|P2|First Intervention (Week 0-24)|Frontalis Test Negative|1
6022527|NCT00773253|20817771|P1|First Intervention (Week 0-24)|Frontalis Test Negative|0
6022528|NCT00773175|20817781|P2|Overall Study|Consent Withdrawn|2
6022529|NCT00773175|20817782|P1|Overall Study|Consent Withdrawn|0
6022530|NCT00773175|20817781|P2|Overall Study|Adverse Event|0
6022531|NCT00773175|20817782|P1|Overall Study|Adverse Event|2
6022532|NCT00773136|20817874|P1|Overall Study|Physician Decision|2
6022533|NCT00773097|20817879|P1|Overall Study|Physician Decision|6
6022534|NCT00773097|20817879|P1|Overall Study|Withdrawal by Subject|1
6022535|NCT00772967|20817885|P6|Crossover Treatment 3|Adverse Event|0
6022536|NCT00772967|20817886|P5|Crossover Treatment 3|Adverse Event|1
6022537|NCT00772967|20817887|P4|Crossover Treatment 3|Adverse Event|0
6022538|NCT00772967|20817888|P3|Crossover Treatment 3|Adverse Event|0
6022539|NCT00772967|20817889|P2|Crossover Treatment 3|Adverse Event|0
6022540|NCT00772967|20817890|P1|Crossover Treatment 3|Adverse Event|0
6022541|NCT00772967|20817885|P6|Break 1 (4-7 Days)|Withdrawal by Subject|0
6022542|NCT00772967|20817886|P5|Break 1 (4-7 Days)|Withdrawal by Subject|0
6022543|NCT00772967|20817887|P4|Break 1 (4-7 Days)|Withdrawal by Subject|0
6022544|NCT00772967|20817888|P3|Break 1 (4-7 Days)|Withdrawal by Subject|0
6022545|NCT00772967|20817889|P2|Break 1 (4-7 Days)|Withdrawal by Subject|1
6022546|NCT00772967|20817890|P1|Break 1 (4-7 Days)|Withdrawal by Subject|0
6022547|NCT00772967|20817885|P6|Crossover Treatment 1|Adverse Event (Pain)|0
6022548|NCT00772967|20817886|P5|Crossover Treatment 1|Adverse Event (Pain)|0
6022549|NCT00772967|20817887|P4|Crossover Treatment 1|Adverse Event (Pain)|1
6022550|NCT00772967|20817888|P3|Crossover Treatment 1|Adverse Event (Pain)|0
6022551|NCT00772967|20817889|P2|Crossover Treatment 1|Adverse Event (Pain)|0
6022552|NCT00772967|20817890|P1|Crossover Treatment 1|Adverse Event (Pain)|0
6022553|NCT00772954|20817910|P3|Overall Study|Adverse Event|1
6022554|NCT00772954|20817911|P2|Overall Study|Adverse Event|0
6022555|NCT00772954|20817912|P1|Overall Study|Adverse Event|0
6022556|NCT00772941|20817920|P1|Overall Study|GPSP Violation|90
6022557|NCT00772941|20817920|P1|Overall Study|Poor Compliance|7
6022558|NCT00772941|20817920|P1|Overall Study|Missed Visits|374
6022559|NCT00772941|20817920|P1|Overall Study|Study not completed|16
6022560|NCT00772941|20817920|P1|Overall Study|CRFs not available|195
6022561|NCT00772928|20817951|P2|Overall Study|Did not receive vaccine|1
6022562|NCT00772928|20817952|P1|Overall Study|Did not receive vaccine|0
6022563|NCT00772928|20817951|P2|Overall Study|Withdrawal by Subject|22
6022564|NCT00772928|20817952|P1|Overall Study|Withdrawal by Subject|25
6022565|NCT00772928|20817951|P2|Overall Study|Protocol Violation|12
6022566|NCT00772928|20817952|P1|Overall Study|Protocol Violation|10
6022567|NCT00772928|20817951|P2|Overall Study|Lost to Follow-up|6
6022568|NCT00772928|20817952|P1|Overall Study|Lost to Follow-up|9
6022569|NCT00772889|20817973|P3|Overall Study|Lost to Follow-up|7
6022570|NCT00772889|20817974|P2|Overall Study|Lost to Follow-up|6
6022571|NCT00772889|20817975|P1|Overall Study|Lost to Follow-up|6
6022572|NCT00772889|20817973|P3|Overall Study|Withdrawal by Subject|9
6022573|NCT00772889|20817974|P2|Overall Study|Withdrawal by Subject|8
6022574|NCT00772889|20817975|P1|Overall Study|Withdrawal by Subject|9
6022575|NCT00772889|20817973|P3|Overall Study|Adverse Event|0
6022576|NCT00772889|20817974|P2|Overall Study|Adverse Event|4
6022577|NCT00772889|20817975|P1|Overall Study|Adverse Event|7
6022578|NCT00772707|20818033|P1|Overall Study|Withdrawn|3
6022579|NCT00772668|20818038|P1|Overall Study|Physician Decision|3
6022580|NCT00772629|20818047|P2|Overall Study|Subject was not vaccinated|0
6022581|NCT00772629|20818048|P1|Overall Study|Subject was not vaccinated|1
6022582|NCT00772603|20818057|P3|Overall Study|Other|2
6022583|NCT00772603|20818058|P2|Overall Study|Other|0
6022584|NCT00772603|20818059|P1|Overall Study|Other|2
6022585|NCT00772603|20818057|P3|Overall Study|Physician Decision|1
6022586|NCT00772603|20818058|P2|Overall Study|Physician Decision|0
6022587|NCT00772603|20818059|P1|Overall Study|Physician Decision|0
6022588|NCT00772603|20818057|P3|Overall Study|Lost to Follow-up|2
6022589|NCT00772603|20818058|P2|Overall Study|Lost to Follow-up|5
6022590|NCT00772603|20818059|P1|Overall Study|Lost to Follow-up|1
6022591|NCT00772603|20818057|P3|Overall Study|Protocol Violation|1
6022592|NCT00772603|20818058|P2|Overall Study|Protocol Violation|1
6022593|NCT00772603|20818059|P1|Overall Study|Protocol Violation|0
6022594|NCT00772603|20818057|P3|Overall Study|Subject Non-compliance|4
6022595|NCT00772603|20818058|P2|Overall Study|Subject Non-compliance|6
6022596|NCT00772603|20818059|P1|Overall Study|Subject Non-compliance|1
6022597|NCT00772603|20818057|P3|Overall Study|Adverse Event|10
6022598|NCT00772603|20818058|P2|Overall Study|Adverse Event|18
6022599|NCT00772603|20818059|P1|Overall Study|Adverse Event|37
6022600|NCT00772603|20818057|P3|Overall Study|Withdrawal by Subject|6
6022601|NCT00772603|20818058|P2|Overall Study|Withdrawal by Subject|10
6022602|NCT00772603|20818059|P1|Overall Study|Withdrawal by Subject|11
6022603|NCT00772577|20818098|P2|Overall Study|Protocol Deviation|2
6022604|NCT00772577|20818099|P1|Overall Study|Protocol Deviation|3
6022605|NCT00772577|20818098|P2|Overall Study|Administrative problems|1
6022606|NCT00772577|20818099|P1|Overall Study|Administrative problems|2
6022607|NCT00772577|20818098|P2|Overall Study|Lost to Follow-up|3
6022608|NCT00772577|20818099|P1|Overall Study|Lost to Follow-up|4
6022609|NCT00772577|20818098|P2|Overall Study|Patient withdrew consent|5
6022610|NCT00772577|20818099|P1|Overall Study|Patient withdrew consent|8
6022611|NCT00772577|20818098|P2|Overall Study|Unsatisfactory therapeutic effect|8
6022612|NCT00772577|20818099|P1|Overall Study|Unsatisfactory therapeutic effect|0
6022613|NCT00772577|20818098|P2|Overall Study|Abnormal laboratory values|1
6022614|NCT00772577|20818099|P1|Overall Study|Abnormal laboratory values|0
6022615|NCT00772577|20818098|P2|Overall Study|Adverse Event|3
6022616|NCT00772577|20818099|P1|Overall Study|Adverse Event|6
6022617|NCT00772538|20818115|P2|Overall Study|Other|7
6022618|NCT00772538|20818116|P1|Overall Study|Other|7
6022619|NCT00772538|20818115|P2|Overall Study|Lack of Efficacy|1
6022620|NCT00772538|20818116|P1|Overall Study|Lack of Efficacy|0
6022621|NCT00772538|20818115|P2|Overall Study|Withdrawal by Subject|8
6022622|NCT00772538|20818116|P1|Overall Study|Withdrawal by Subject|3
6022623|NCT00772538|20818115|P2|Overall Study|Lost to Follow-up|1
6022624|NCT00772538|20818116|P1|Overall Study|Lost to Follow-up|1
6022625|NCT00772538|20818115|P2|Overall Study|Protocol Violation|3
6022626|NCT00772538|20818116|P1|Overall Study|Protocol Violation|3
6022627|NCT00772538|20818115|P2|Overall Study|Adverse Event|6
6022628|NCT00772538|20818116|P1|Overall Study|Adverse Event|6
6022629|NCT00772447|20818188|P2|Overall Study|all others|2
6022630|NCT00772447|20818189|P1|Overall Study|all others|2
6022631|NCT00772447|20818188|P2|Overall Study|Protocol Violation|1
6022632|NCT00772447|20818189|P1|Overall Study|Protocol Violation|0
6022633|NCT00772447|20818188|P2|Overall Study|incorrect enrolment|4
6022634|NCT00772447|20818189|P1|Overall Study|incorrect enrolment|3
6022635|NCT00772447|20818188|P2|Overall Study|Lost to Follow-up|4
6022636|NCT00772447|20818189|P1|Overall Study|Lost to Follow-up|2
6022637|NCT00772447|20818188|P2|Overall Study|Physician Decision|8
6022638|NCT00772447|20818189|P1|Overall Study|Physician Decision|4
6022639|NCT00772447|20818188|P2|Overall Study|Withdrawal by Subject|5
6022640|NCT00772447|20818189|P1|Overall Study|Withdrawal by Subject|9
6022641|NCT00772382|20818217|P1|Overall Study|Other Reasons|10
6022642|NCT00772382|20818217|P1|Overall Study|Withdrawal by Subject|10
6022643|NCT00772382|20818217|P1|Overall Study|Protocol Violation|1
6022644|NCT00772382|20818217|P1|Overall Study|Physician Decision|5
6022645|NCT00772382|20818217|P1|Overall Study|Lack of Efficacy|4
6022646|NCT00772382|20818217|P1|Overall Study|Death|6
6022647|NCT00772382|20818217|P1|Overall Study|Adverse Event|19
6022648|NCT00772369|20818222|P1|Overall Study|Did not return record release form|1
6022649|NCT00772148|20818233|P2|Maintenance Phase (Week 52)|Administrative/other|2
6022650|NCT00772148|20818234|P1|Maintenance Phase (Week 52)|Administrative/other|1
6022651|NCT00772148|20818233|P2|Maintenance Phase (Week 52)|Withdrawal by Subject|1
6022652|NCT00772148|20818234|P1|Maintenance Phase (Week 52)|Withdrawal by Subject|0
6022653|NCT00772148|20818233|P2|Maintenance Phase (Week 52)|Adverse Event|0
6022654|NCT00772148|20818234|P1|Maintenance Phase (Week 52)|Adverse Event|1
6022655|NCT00772148|20818233|P2|Maintenance Phase (Week 52)|Death|2
6022656|NCT00772148|20818234|P1|Maintenance Phase (Week 52)|Death|2
6022657|NCT00772148|20818233|P2|Pharmacokinetic Phase (14 Days)|Administrative/other|0
6022658|NCT00772148|20818234|P1|Pharmacokinetic Phase (14 Days)|Administrative/other|2
6022659|NCT00772148|20818233|P2|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|5
6022660|NCT00772148|20818234|P1|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|3
6022661|NCT00772148|20818233|P2|Pharmacokinetic Phase (14 Days)|Adverse Event|1
6022662|NCT00772148|20818234|P1|Pharmacokinetic Phase (14 Days)|Adverse Event|3
6022663|NCT00772109|20818254|P4|Overall Study|Withdrawal by Subject|16
6022664|NCT00772109|20818255|P3|Overall Study|Withdrawal by Subject|6
6022665|NCT00772109|20818256|P2|Overall Study|Withdrawal by Subject|8
6022666|NCT00772109|20818257|P1|Overall Study|Withdrawal by Subject|8
6022667|NCT00772109|20818254|P4|Overall Study|Lost to Follow-up|9
6022668|NCT00772109|20818255|P3|Overall Study|Lost to Follow-up|5
6022669|NCT00772109|20818256|P2|Overall Study|Lost to Follow-up|3
6022670|NCT00772109|20818257|P1|Overall Study|Lost to Follow-up|7
6022671|NCT00772109|20818254|P4|Overall Study|Protocol Violation|6
6022672|NCT00772109|20818255|P3|Overall Study|Protocol Violation|7
6022673|NCT00772109|20818256|P2|Overall Study|Protocol Violation|8
6022674|NCT00772109|20818257|P1|Overall Study|Protocol Violation|5
6022675|NCT00772109|20818254|P4|Overall Study|Serious adverse event|0
6022676|NCT00772109|20818255|P3|Overall Study|Serious adverse event|1
6022677|NCT00772109|20818256|P2|Overall Study|Serious adverse event|0
6022678|NCT00772109|20818257|P1|Overall Study|Serious adverse event|1
6022679|NCT00772070|20818281|P2|Overall Study|Vaccination error-wrong dose/expired lot|0
6022680|NCT00772070|20818282|P1|Overall Study|Vaccination error-wrong dose/expired lot|2
6022681|NCT00772070|20818281|P2|Overall Study|Withdrawal by Subject|2
6022682|NCT00772070|20818282|P1|Overall Study|Withdrawal by Subject|0
6022683|NCT00772070|20818281|P2|Overall Study|Lost to Follow-up|8
6022684|NCT00772070|20818282|P1|Overall Study|Lost to Follow-up|0
6022685|NCT00772031|20818294|P2|Overall Study|Lost to Follow-up|33
6022686|NCT00772031|20818295|P1|Overall Study|Lost to Follow-up|20
6022687|NCT00772031|20818294|P2|Overall Study|Early termination of trial|10
6022688|NCT00772031|20818295|P1|Overall Study|Early termination of trial|12
6022689|NCT00772005|20818321|P4|Overall Study|Non-compliance with drug administration|1
6022690|NCT00772005|20818322|P3|Overall Study|Non-compliance with drug administration|1
6022691|NCT00772005|20818323|P2|Overall Study|Non-compliance with drug administration|0
6022692|NCT00772005|20818324|P1|Overall Study|Non-compliance with drug administration|3
6022693|NCT00772005|20818321|P4|Overall Study|Non-compliance with study procedures|1
6022694|NCT00772005|20818322|P3|Overall Study|Non-compliance with study procedures|0
6022695|NCT00772005|20818323|P2|Overall Study|Non-compliance with study procedures|1
6022696|NCT00772005|20818324|P1|Overall Study|Non-compliance with study procedures|1
6022697|NCT00772005|20818321|P4|Overall Study|Lost to Follow-up|3
6022698|NCT00772005|20818322|P3|Overall Study|Lost to Follow-up|6
6022699|NCT00772005|20818323|P2|Overall Study|Lost to Follow-up|3
6022700|NCT00772005|20818324|P1|Overall Study|Lost to Follow-up|7
6022701|NCT00772005|20818321|P4|Overall Study|Protocol Violation|6
6022702|NCT00772005|20818322|P3|Overall Study|Protocol Violation|1
6022703|NCT00772005|20818323|P2|Overall Study|Protocol Violation|4
6022704|NCT00772005|20818324|P1|Overall Study|Protocol Violation|2
6022705|NCT00772005|20818321|P4|Overall Study|Withdrawal by Subject|2
6022706|NCT00772005|20818322|P3|Overall Study|Withdrawal by Subject|10
6022707|NCT00772005|20818323|P2|Overall Study|Withdrawal by Subject|7
6022708|NCT00772005|20818324|P1|Overall Study|Withdrawal by Subject|3
6022709|NCT00772005|20818321|P4|Overall Study|Lack of Efficacy|0
6022710|NCT00772005|20818322|P3|Overall Study|Lack of Efficacy|0
6022711|NCT00772005|20818323|P2|Overall Study|Lack of Efficacy|1
6022712|NCT00772005|20818324|P1|Overall Study|Lack of Efficacy|0
6022713|NCT00772005|20818321|P4|Overall Study|Adverse Event|13
6022714|NCT00772005|20818322|P3|Overall Study|Adverse Event|10
6022715|NCT00772005|20818323|P2|Overall Study|Adverse Event|14
6022716|NCT00772005|20818324|P1|Overall Study|Adverse Event|9
6022717|NCT00771953|20819012|P2|Overall Study|Withdrawal by Subject|3
6022718|NCT00771953|20819013|P1|Overall Study|Withdrawal by Subject|0
6022719|NCT00771953|20819012|P2|Overall Study|Other complicating disease|0
6022720|NCT00771953|20819013|P1|Overall Study|Other complicating disease|1
6022721|NCT00771953|20819012|P2|Overall Study|Sponsor decision|0
6022722|NCT00771953|20819013|P1|Overall Study|Sponsor decision|1
6022723|NCT00771953|20819012|P2|Overall Study|Progression before active Tx|2
6022724|NCT00771953|20819013|P1|Overall Study|Progression before active Tx|1
6022725|NCT00771953|20819012|P2|Overall Study|Death|2
6022726|NCT00771953|20819013|P1|Overall Study|Death|2
6022727|NCT00771953|20819012|P2|Overall Study|Adverse Event|3
6022728|NCT00771953|20819013|P1|Overall Study|Adverse Event|5
6022729|NCT00771927|20819023|P2|Overall Study|Other reason|27
6022730|NCT00771927|20819024|P1|Overall Study|Other reason|23
6022731|NCT00771927|20819023|P2|Overall Study|Withdrawal by Subject|17
6022732|NCT00771927|20819024|P1|Overall Study|Withdrawal by Subject|16
6022733|NCT00771927|20819023|P2|Overall Study|Lost to Follow-up|46
6022734|NCT00771927|20819024|P1|Overall Study|Lost to Follow-up|46
6022735|NCT00771927|20819023|P2|Overall Study|Lack of Efficacy|42
6022736|NCT00771927|20819024|P1|Overall Study|Lack of Efficacy|70
6022737|NCT00771927|20819023|P2|Overall Study|Adverse Event|105
6022738|NCT00771927|20819024|P1|Overall Study|Adverse Event|100
6022739|NCT00771914|20819036|P4|Overall Study|Lost to Follow-up|1
6022740|NCT00771914|20819037|P3|Overall Study|Lost to Follow-up|0
6022741|NCT00771914|20819038|P2|Overall Study|Lost to Follow-up|0
6022742|NCT00771914|20819039|P1|Overall Study|Lost to Follow-up|0
6022743|NCT00771914|20819036|P4|Overall Study|Physician Decision|1
6022744|NCT00771914|20819037|P3|Overall Study|Physician Decision|0
6022745|NCT00771914|20819038|P2|Overall Study|Physician Decision|0
6022746|NCT00771914|20819039|P1|Overall Study|Physician Decision|0
6022747|NCT00771901|20819052|P3|Overall Study|Dissat w/# of study medication (40/day)|4
6022748|NCT00771901|20819053|P2|Overall Study|Dissat w/# of study medication (40/day)|0
6022749|NCT00771901|20819054|P1|Overall Study|Dissat w/# of study medication (40/day)|0
6022750|NCT00771849|20819101|P2|Overall Study|Not vaccinated|1
6022751|NCT00771849|20819102|P1|Overall Study|Not vaccinated|0
6022752|NCT00771849|20819101|P2|Overall Study|Withdrawal by Subject|1
6022753|NCT00771849|20819102|P1|Overall Study|Withdrawal by Subject|1
6022754|NCT00771849|20819101|P2|Overall Study|Lost to Follow-up|2
6022755|NCT00771849|20819102|P1|Overall Study|Lost to Follow-up|1
6022756|NCT00771810|20819113|P3|Overall Study|Other|1
6022757|NCT00771810|20819114|P2|Overall Study|Other|0
6022758|NCT00771810|20819115|P1|Overall Study|Other|0
6022759|NCT00771810|20819113|P3|Overall Study|Withdrawal by Subject|0
6022760|NCT00771810|20819114|P2|Overall Study|Withdrawal by Subject|2
6022761|NCT00771810|20819115|P1|Overall Study|Withdrawal by Subject|1
6022762|NCT00771810|20819113|P3|Overall Study|Protocol Violation|1
6022763|NCT00771810|20819114|P2|Overall Study|Protocol Violation|1
6022764|NCT00771810|20819115|P1|Overall Study|Protocol Violation|0
6022765|NCT00771810|20819113|P3|Overall Study|Physician Decision|2
6022766|NCT00771810|20819114|P2|Overall Study|Physician Decision|2
6022767|NCT00771810|20819115|P1|Overall Study|Physician Decision|1
6022768|NCT00771810|20819113|P3|Overall Study|Lost to Follow-up|1
6022769|NCT00771810|20819114|P2|Overall Study|Lost to Follow-up|0
6022770|NCT00771810|20819115|P1|Overall Study|Lost to Follow-up|0
6022771|NCT00771810|20819113|P3|Overall Study|Adverse Event|2
6022772|NCT00771810|20819114|P2|Overall Study|Adverse Event|0
6022773|NCT00771810|20819115|P1|Overall Study|Adverse Event|3
6022774|NCT00771758|20819153|P3|Overall Study|Other|0
6022775|NCT00771758|20819154|P2|Overall Study|Other|2
6022776|NCT00771758|20819155|P1|Overall Study|Other|3
6022777|NCT00771758|20819153|P3|Overall Study|Withdrawal by Subject|0
6022778|NCT00771758|20819154|P2|Overall Study|Withdrawal by Subject|0
6022779|NCT00771758|20819155|P1|Overall Study|Withdrawal by Subject|1
6022780|NCT00771758|20819153|P3|Overall Study|Protocol Violation|0
6022781|NCT00771758|20819154|P2|Overall Study|Protocol Violation|0
6022782|NCT00771758|20819155|P1|Overall Study|Protocol Violation|1
6022783|NCT00771758|20819153|P3|Overall Study|Lost to Follow-up|0
6022784|NCT00771758|20819154|P2|Overall Study|Lost to Follow-up|0
6022785|NCT00771758|20819155|P1|Overall Study|Lost to Follow-up|1
6022786|NCT00771758|20819153|P3|Overall Study|Lack of Efficacy|1
6022787|NCT00771758|20819154|P2|Overall Study|Lack of Efficacy|2
6022788|NCT00771758|20819155|P1|Overall Study|Lack of Efficacy|0
6022789|NCT00771758|20819153|P3|Overall Study|Adverse Event|1
6022790|NCT00771758|20819154|P2|Overall Study|Adverse Event|8
6022791|NCT00771758|20819155|P1|Overall Study|Adverse Event|2
6022792|NCT00771667|20819316|P10|Maintenance Phase|Other|3
6022793|NCT00771667|20819317|P9|Maintenance Phase|Other|3
6022794|NCT00771667|20819318|P8|Maintenance Phase|Other|2
6022795|NCT00771667|20819319|P7|Maintenance Phase|Other|2
6022796|NCT00771667|20819320|P6|Maintenance Phase|Other|1
6022797|NCT00771667|20819321|P5|Maintenance Phase|Other|0
6022798|NCT00771667|20819322|P4|Maintenance Phase|Other|0
6022799|NCT00771667|20819323|P3|Maintenance Phase|Other|0
6022800|NCT00771667|20819324|P2|Maintenance Phase|Other|0
6022801|NCT00771667|20819325|P1|Maintenance Phase|Other|0
6022802|NCT00771667|20819316|P10|Maintenance Phase|Lack of Efficacy|7
6022803|NCT00771667|20819317|P9|Maintenance Phase|Lack of Efficacy|11
6022804|NCT00771667|20819318|P8|Maintenance Phase|Lack of Efficacy|2
6022805|NCT00771667|20819319|P7|Maintenance Phase|Lack of Efficacy|3
6022806|NCT00771667|20819320|P6|Maintenance Phase|Lack of Efficacy|3
6022807|NCT00771667|20819321|P5|Maintenance Phase|Lack of Efficacy|1
6022808|NCT00771667|20819322|P4|Maintenance Phase|Lack of Efficacy|0
6022809|NCT00771667|20819323|P3|Maintenance Phase|Lack of Efficacy|0
6022810|NCT00771667|20819324|P2|Maintenance Phase|Lack of Efficacy|0
6022811|NCT00771667|20819325|P1|Maintenance Phase|Lack of Efficacy|0
6022812|NCT00771667|20819316|P10|Maintenance Phase|Adverse Event|7
6022813|NCT00771667|20819317|P9|Maintenance Phase|Adverse Event|8
6022814|NCT00771667|20819318|P8|Maintenance Phase|Adverse Event|1
6022815|NCT00771667|20819319|P7|Maintenance Phase|Adverse Event|5
6022816|NCT00771667|20819320|P6|Maintenance Phase|Adverse Event|3
6022817|NCT00771667|20819321|P5|Maintenance Phase|Adverse Event|1
6022818|NCT00771667|20819322|P4|Maintenance Phase|Adverse Event|0
6022819|NCT00771667|20819323|P3|Maintenance Phase|Adverse Event|0
6022820|NCT00771667|20819324|P2|Maintenance Phase|Adverse Event|0
6022821|NCT00771667|20819325|P1|Maintenance Phase|Adverse Event|0
6022822|NCT00771667|20819316|P10|Induction Phase|Other|0
6022823|NCT00771667|20819317|P9|Induction Phase|Other|0
6022824|NCT00771667|20819318|P8|Induction Phase|Other|0
6022825|NCT00771667|20819319|P7|Induction Phase|Other|0
6022826|NCT00771667|20819320|P6|Induction Phase|Other|0
6022827|NCT00771667|20819321|P5|Induction Phase|Other|0
6022828|NCT00771667|20819322|P4|Induction Phase|Other|4
6022829|NCT00771667|20819323|P3|Induction Phase|Other|3
6022830|NCT00771667|20819324|P2|Induction Phase|Other|6
6022831|NCT00771667|20819325|P1|Induction Phase|Other|4
6022832|NCT00771667|20819316|P10|Induction Phase|Lost to Follow-up|0
6022833|NCT00771667|20819317|P9|Induction Phase|Lost to Follow-up|0
6022834|NCT00771667|20819318|P8|Induction Phase|Lost to Follow-up|0
6022835|NCT00771667|20819319|P7|Induction Phase|Lost to Follow-up|0
6022836|NCT00771667|20819320|P6|Induction Phase|Lost to Follow-up|0
6022837|NCT00771667|20819321|P5|Induction Phase|Lost to Follow-up|0
6022838|NCT00771667|20819322|P4|Induction Phase|Lost to Follow-up|0
6022839|NCT00771667|20819323|P3|Induction Phase|Lost to Follow-up|1
6022840|NCT00771667|20819324|P2|Induction Phase|Lost to Follow-up|0
6022841|NCT00771667|20819325|P1|Induction Phase|Lost to Follow-up|1
6022842|NCT00771667|20819316|P10|Induction Phase|Lack of Efficacy|0
6022843|NCT00771667|20819317|P9|Induction Phase|Lack of Efficacy|0
6022844|NCT00771667|20819318|P8|Induction Phase|Lack of Efficacy|0
6022845|NCT00771667|20819319|P7|Induction Phase|Lack of Efficacy|0
6022846|NCT00771667|20819320|P6|Induction Phase|Lack of Efficacy|0
6022847|NCT00771667|20819321|P5|Induction Phase|Lack of Efficacy|0
6022848|NCT00771667|20819322|P4|Induction Phase|Lack of Efficacy|3
6022849|NCT00771667|20819323|P3|Induction Phase|Lack of Efficacy|4
6022850|NCT00771667|20819324|P2|Induction Phase|Lack of Efficacy|2
6022851|NCT00771667|20819325|P1|Induction Phase|Lack of Efficacy|9
6022852|NCT00771667|20819316|P10|Induction Phase|Adverse Event|0
6022853|NCT00771667|20819317|P9|Induction Phase|Adverse Event|0
6022854|NCT00771667|20819318|P8|Induction Phase|Adverse Event|0
6022855|NCT00771667|20819319|P7|Induction Phase|Adverse Event|0
6022856|NCT00771667|20819320|P6|Induction Phase|Adverse Event|0
6022857|NCT00771667|20819321|P5|Induction Phase|Adverse Event|0
6022858|NCT00771667|20819322|P4|Induction Phase|Adverse Event|1
6022859|NCT00771667|20819323|P3|Induction Phase|Adverse Event|4
6022860|NCT00771667|20819324|P2|Induction Phase|Adverse Event|2
6022861|NCT00771667|20819325|P1|Induction Phase|Adverse Event|5
6022862|NCT00771615|20819370|P9|Overall Study|Lost to Follow-up|0
6022863|NCT00771615|20819371|P8|Overall Study|Lost to Follow-up|0
6022864|NCT00771615|20819372|P7|Overall Study|Lost to Follow-up|1
6022865|NCT00771615|20819373|P6|Overall Study|Lost to Follow-up|1
6022866|NCT00771615|20819374|P5|Overall Study|Lost to Follow-up|0
6022867|NCT00771615|20819375|P4|Overall Study|Lost to Follow-up|1
6022868|NCT00771615|20819376|P3|Overall Study|Lost to Follow-up|1
6022869|NCT00771615|20819377|P2|Overall Study|Lost to Follow-up|1
6022870|NCT00771615|20819378|P1|Overall Study|Lost to Follow-up|1
6022871|NCT00771615|20819370|P9|Overall Study|Withdrawal by Subject|0
6022872|NCT00771615|20819371|P8|Overall Study|Withdrawal by Subject|1
6022873|NCT00771615|20819372|P7|Overall Study|Withdrawal by Subject|0
6022874|NCT00771615|20819373|P6|Overall Study|Withdrawal by Subject|0
6022875|NCT00771615|20819374|P5|Overall Study|Withdrawal by Subject|0
6022876|NCT00771615|20819375|P4|Overall Study|Withdrawal by Subject|0
6022877|NCT00771615|20819376|P3|Overall Study|Withdrawal by Subject|0
6022878|NCT00771615|20819377|P2|Overall Study|Withdrawal by Subject|1
6022879|NCT00771615|20819378|P1|Overall Study|Withdrawal by Subject|0
6022880|NCT00771472|20819639|P2|Overall Study|Protocol Violation|0
6022881|NCT00771472|20819640|P1|Overall Study|Protocol Violation|1
6022882|NCT00771472|20819639|P2|Overall Study|Progressive Disease|1
6022883|NCT00771472|20819640|P1|Overall Study|Progressive Disease|3
6022884|NCT00771472|20819639|P2|Overall Study|Physician Decision|3
6022885|NCT00771472|20819640|P1|Overall Study|Physician Decision|2
6022886|NCT00771316|20819660|P2|Overall Study|Discontinued due to early termination|0
6022887|NCT00771316|20819661|P1|Overall Study|Discontinued due to early termination|1
6022888|NCT00771316|20819660|P2|Overall Study|Patient withdrew consent|0
6022889|NCT00771316|20819661|P1|Overall Study|Patient withdrew consent|1
6022890|NCT00771316|20819660|P2|Overall Study|Adverse Event|1
6022891|NCT00771316|20819661|P1|Overall Study|Adverse Event|0
6022892|NCT00770991|20819713|P2|Overall Study|Pregnancy|0
6022893|NCT00770991|20819714|P1|Overall Study|Pregnancy|1
6022894|NCT00770991|20819713|P2|Overall Study|Adverse Event|5
6022895|NCT00770991|20819714|P1|Overall Study|Adverse Event|1
6022896|NCT00770991|20819713|P2|Overall Study|Withdrawal by Subject|0
6022897|NCT00770991|20819714|P1|Overall Study|Withdrawal by Subject|1
6022898|NCT00770991|20819713|P2|Overall Study|Physician Decision|0
6022899|NCT00770991|20819714|P1|Overall Study|Physician Decision|2
6022900|NCT00770965|20819730|P4|Excluded Set|Withdrawal by Subject|3
6022901|NCT00770965|20819731|P3|Excluded Set|Withdrawal by Subject|2
6022902|NCT00770965|20819732|P2|Excluded Set|Withdrawal by Subject|1
6022903|NCT00770965|20819733|P1|Excluded Set|Withdrawal by Subject|1
6022904|NCT00770965|20819730|P4|Excluded Set|Administrative problems|10
6022905|NCT00770965|20819731|P3|Excluded Set|Administrative problems|12
6022906|NCT00770965|20819732|P2|Excluded Set|Administrative problems|12
6022907|NCT00770965|20819733|P1|Excluded Set|Administrative problems|14
6022908|NCT00770965|20819730|P4|Safety Set|Protocol deviation|0
6022909|NCT00770965|20819731|P3|Safety Set|Protocol deviation|1
6022910|NCT00770965|20819732|P2|Safety Set|Protocol deviation|0
6022911|NCT00770965|20819733|P1|Safety Set|Protocol deviation|0
6022912|NCT00770965|20819730|P4|Safety Set|Withdrawal by Subject|1
6022913|NCT00770965|20819731|P3|Safety Set|Withdrawal by Subject|0
6022914|NCT00770965|20819732|P2|Safety Set|Withdrawal by Subject|0
6022915|NCT00770965|20819733|P1|Safety Set|Withdrawal by Subject|0
6022916|NCT00770913|20819754|P3|Overall Study|Incorrect drug was allocated|0
6022917|NCT00770913|20819755|P2|Overall Study|Incorrect drug was allocated|0
6022918|NCT00770913|20819756|P1|Overall Study|Incorrect drug was allocated|1
6022919|NCT00770913|20819754|P3|Overall Study|Protocol Violation|1
6022920|NCT00770913|20819755|P2|Overall Study|Protocol Violation|0
6022921|NCT00770913|20819756|P1|Overall Study|Protocol Violation|3
6022922|NCT00770913|20819754|P3|Overall Study|Physician Decision|1
6022923|NCT00770913|20819755|P2|Overall Study|Physician Decision|1
6022924|NCT00770913|20819756|P1|Overall Study|Physician Decision|0
6022925|NCT00770913|20819754|P3|Overall Study|Refusal to continue participation|5
6022926|NCT00770913|20819755|P2|Overall Study|Refusal to continue participation|4
6022927|NCT00770913|20819756|P1|Overall Study|Refusal to continue participation|6
6022928|NCT00770913|20819754|P3|Overall Study|Adverse Event|6
6022929|NCT00770913|20819755|P2|Overall Study|Adverse Event|3
6022930|NCT00770913|20819756|P1|Overall Study|Adverse Event|1
6022931|NCT00770809|20819789|P3|Overall Study|Other Medical Reasons|3
6022932|NCT00770809|20819790|P2|Overall Study|Other Medical Reasons|4
6022933|NCT00770809|20819791|P1|Overall Study|Other Medical Reasons|2
6022934|NCT00770809|20819789|P3|Overall Study|Complicating illness|1
6022935|NCT00770809|20819790|P2|Overall Study|Complicating illness|0
6022936|NCT00770809|20819791|P1|Overall Study|Complicating illness|0
6022937|NCT00770809|20819789|P3|Overall Study|Progression|0
6022938|NCT00770809|20819790|P2|Overall Study|Progression|2
6022939|NCT00770809|20819791|P1|Overall Study|Progression|2
6022940|NCT00770809|20819789|P3|Overall Study|Withdrawal by Subject|7
6022941|NCT00770809|20819790|P2|Overall Study|Withdrawal by Subject|3
6022942|NCT00770809|20819791|P1|Overall Study|Withdrawal by Subject|3
6022943|NCT00770809|20819789|P3|Overall Study|Death|0
6022944|NCT00770809|20819790|P2|Overall Study|Death|0
6022945|NCT00770809|20819791|P1|Overall Study|Death|1
6022946|NCT00770809|20819789|P3|Overall Study|Adverse Event|12
6022947|NCT00770809|20819790|P2|Overall Study|Adverse Event|1
6022948|NCT00770809|20819791|P1|Overall Study|Adverse Event|9
6022949|NCT00770770|20819801|P2|Overall Study|Study Terminated|0
6022950|NCT00770770|20819802|P1|Overall Study|Study Terminated|8
6022951|NCT00770770|20819801|P2|Overall Study|Death|1
6022952|NCT00770770|20819802|P1|Overall Study|Death|0
6022953|NCT00770770|20819801|P2|Overall Study|Withdrawal by Subject|0
6022954|NCT00770770|20819802|P1|Overall Study|Withdrawal by Subject|1
6022955|NCT00770770|20819801|P2|Overall Study|Lost to Follow-up|0
6022956|NCT00770770|20819802|P1|Overall Study|Lost to Follow-up|1
6022957|NCT00770692|20819820|P4|Overall Study|Investigator judgment|1
6022958|NCT00770692|20819821|P3|Overall Study|Investigator judgment|1
6022959|NCT00770692|20819822|P2|Overall Study|Investigator judgment|0
6022960|NCT00770692|20819823|P1|Overall Study|Investigator judgment|2
6022961|NCT00770692|20819820|P4|Overall Study|Adverse Event|4
6022962|NCT00770692|20819821|P3|Overall Study|Adverse Event|4
6022963|NCT00770692|20819822|P2|Overall Study|Adverse Event|0
6022964|NCT00770692|20819823|P1|Overall Study|Adverse Event|3
6022965|NCT00770692|20819820|P4|Overall Study|Withdrawal by Subject|6
6022966|NCT00770692|20819821|P3|Overall Study|Withdrawal by Subject|9
6022967|NCT00770692|20819822|P2|Overall Study|Withdrawal by Subject|9
6022968|NCT00770692|20819823|P1|Overall Study|Withdrawal by Subject|7
6022969|NCT00770679|20819849|P1|Overall Study|Follow-up LDL measurement not collected|3
6022970|NCT00770679|20819849|P1|Overall Study|Lost to Follow-up|3
6022971|NCT00770653|20819857|P2|Overall Study|Physician Decision|0
6022972|NCT00770653|20819858|P1|Overall Study|Physician Decision|1
6022973|NCT00770653|20819857|P2|Overall Study|Lost to Follow-up|2
6022974|NCT00770653|20819858|P1|Overall Study|Lost to Follow-up|1
6022975|NCT00770653|20819857|P2|Overall Study|> Three Moderate Hypoglycemic Episodes|2
6022976|NCT00770653|20819858|P1|Overall Study|> Three Moderate Hypoglycemic Episodes|0
6022977|NCT00770653|20819857|P2|Overall Study|Fasting Glucose > 240 mg/dL|1
6022978|NCT00770653|20819858|P1|Overall Study|Fasting Glucose > 240 mg/dL|2
6022979|NCT00770653|20819857|P2|Overall Study|Worsening of Glycosolated Hemoglobin|2
6022980|NCT00770653|20819858|P1|Overall Study|Worsening of Glycosolated Hemoglobin|2
6022981|NCT00770653|20819857|P2|Overall Study|Lack of Compliance|4
6022982|NCT00770653|20819858|P1|Overall Study|Lack of Compliance|1
6022983|NCT00770653|20819857|P2|Overall Study|Withdrawal by Subject|7
6022984|NCT00770653|20819858|P1|Overall Study|Withdrawal by Subject|4
6022985|NCT00770653|20819857|P2|Overall Study|Protocol Violation|6
6022986|NCT00770653|20819858|P1|Overall Study|Protocol Violation|8
6022987|NCT00770653|20819857|P2|Overall Study|Adverse Event|5
6022988|NCT00770653|20819858|P1|Overall Study|Adverse Event|13
6022989|NCT00770588|20819928|P2|Overall Study|Withdrawal by Subject|1
6022990|NCT00770588|20819929|P1|Overall Study|Withdrawal by Subject|1
6022991|NCT00770588|20819928|P2|Overall Study|Lost to Follow-up|1
6022992|NCT00770588|20819929|P1|Overall Study|Lost to Follow-up|1
6022993|NCT00770588|20819928|P2|Overall Study|Death caused by progression of disease|91
6022994|NCT00770588|20819929|P1|Overall Study|Death caused by progression of disease|70
6022995|NCT00770588|20819928|P2|Overall Study|Adverse Event|2
6022996|NCT00770588|20819929|P1|Overall Study|Adverse Event|9
6022997|NCT00770562|20819945|P2|Overall Study|Did not take treatment|1
6022998|NCT00770562|20819946|P1|Overall Study|Did not take treatment|1
6022999|NCT00770510|20819957|P1|Overall Study|Withdrawal by Subject|2
6023000|NCT00770510|20819957|P1|Overall Study|Pregnancy|1
6023001|NCT00770510|20819957|P1|Overall Study|Lost to Follow-up|2
6023002|NCT00770484|20819996|P2|Overall Study|Withdrawal by Subject|0
6023003|NCT00770484|20819997|P1|Overall Study|Withdrawal by Subject|1
6023004|NCT00770432|20820005|P2|Overall Study|Non-compliance|1
6023005|NCT00770432|20820006|P1|Overall Study|Non-compliance|0
6023006|NCT00770432|20820005|P2|Overall Study|Other|6
6023007|NCT00770432|20820006|P1|Overall Study|Other|4
6023008|NCT00770367|20820014|P2|Second Intervention|Lost to Follow-up|0
6023009|NCT00770367|20820015|P1|Second Intervention|Lost to Follow-up|2
6023010|NCT00770367|20820014|P2|Washout Period of 4 Weeks|Withdrawal by Subject|1
6023011|NCT00770367|20820015|P1|Washout Period of 4 Weeks|Withdrawal by Subject|0
6023012|NCT00770367|20820014|P2|First Intervention|Withdrawal by Subject|2
6023013|NCT00770367|20820015|P1|First Intervention|Withdrawal by Subject|0
6023014|NCT00770341|20820026|P3|Overall Study|Not treated|0
6023015|NCT00770341|20820027|P2|Overall Study|Not treated|0
6023016|NCT00770341|20820028|P1|Overall Study|Not treated|1
6023017|NCT00770341|20820026|P3|Overall Study|Other|0
6023018|NCT00770341|20820027|P2|Overall Study|Other|0
6023019|NCT00770341|20820028|P1|Overall Study|Other|1
6023020|NCT00770341|20820026|P3|Overall Study|Lack of Efficacy|1
6023021|NCT00770341|20820027|P2|Overall Study|Lack of Efficacy|0
6023022|NCT00770341|20820028|P1|Overall Study|Lack of Efficacy|3
6023023|NCT00770341|20820026|P3|Overall Study|Laboratory adverse event|0
6023024|NCT00770341|20820027|P2|Overall Study|Laboratory adverse event|3
6023025|NCT00770341|20820028|P1|Overall Study|Laboratory adverse event|3
6023026|NCT00770341|20820026|P3|Overall Study|Clinical Adverse Event|2
6023027|NCT00770341|20820027|P2|Overall Study|Clinical Adverse Event|1
6023028|NCT00770341|20820028|P1|Overall Study|Clinical Adverse Event|3
6023029|NCT00770341|20820026|P3|Overall Study|Withdrawal by Subject|0
6023030|NCT00770341|20820027|P2|Overall Study|Withdrawal by Subject|1
6023031|NCT00770341|20820028|P1|Overall Study|Withdrawal by Subject|0
6023032|NCT00770341|20820026|P3|Overall Study|Did not meet eligibility criteria|0
6023033|NCT00770341|20820027|P2|Overall Study|Did not meet eligibility criteria|0
6023034|NCT00770341|20820028|P1|Overall Study|Did not meet eligibility criteria|1
6023035|NCT00770328|20820054|P2|Overall Study|Lost to Follow-up|2
6023036|NCT00770328|20820055|P1|Overall Study|Lost to Follow-up|2
6023037|NCT00770328|20820054|P2|Overall Study|Adverse Event|2
6023038|NCT00770328|20820055|P1|Overall Study|Adverse Event|11
6023039|NCT00770315|20820071|P4|Overall Study|Noncompliance with Protocol|9
6023040|NCT00770315|20820072|P3|Overall Study|Noncompliance with Protocol|7
6023041|NCT00770315|20820073|P2|Overall Study|Noncompliance with Protocol|4
6023042|NCT00770315|20820074|P1|Overall Study|Noncompliance with Protocol|7
6023043|NCT00770315|20820071|P4|Overall Study|Withdrawal by Subject|20
6023044|NCT00770315|20820072|P3|Overall Study|Withdrawal by Subject|24
6023045|NCT00770315|20820073|P2|Overall Study|Withdrawal by Subject|17
6023046|NCT00770315|20820074|P1|Overall Study|Withdrawal by Subject|13
6023047|NCT00770315|20820071|P4|Overall Study|Lost to Follow-up|3
6023048|NCT00770315|20820072|P3|Overall Study|Lost to Follow-up|10
6023049|NCT00770315|20820073|P2|Overall Study|Lost to Follow-up|5
6023050|NCT00770315|20820074|P1|Overall Study|Lost to Follow-up|9
6023051|NCT00770315|20820071|P4|Overall Study|Adverse Event|6
6023052|NCT00770315|20820072|P3|Overall Study|Adverse Event|16
6023053|NCT00770315|20820073|P2|Overall Study|Adverse Event|17
6023054|NCT00770315|20820074|P1|Overall Study|Adverse Event|11
6023055|NCT00770289|20820100|P1|Overall Study|Other|6
6023056|NCT00770224|20820109|P2|Step 2: Maintenance|Ineligible|2
6023057|NCT00770224|20820110|P1|Step 2: Maintenance|Ineligible|0
6023058|NCT00770224|20820109|P2|Step 2: Maintenance|Other reason not protocol specified|7
6023059|NCT00770224|20820110|P1|Step 2: Maintenance|Other reason not protocol specified|0
6023060|NCT00770224|20820109|P2|Step 2: Maintenance|Death|2
6023061|NCT00770224|20820110|P1|Step 2: Maintenance|Death|0
6023062|NCT00770224|20820109|P2|Step 2: Maintenance|Progression/relapse|1
6023063|NCT00770224|20820110|P1|Step 2: Maintenance|Progression/relapse|0
6023064|NCT00770224|20820109|P2|Step 2: Maintenance|Refusal unrelated to adverse event|8
6023065|NCT00770224|20820110|P1|Step 2: Maintenance|Refusal unrelated to adverse event|0
6023066|NCT00770224|20820109|P2|Step 2: Maintenance|Adverse Event|10
6023067|NCT00770224|20820110|P1|Step 2: Maintenance|Adverse Event|0
6023068|NCT00770224|20820109|P2|Step 1: Induction|No protocol treatment given|0
6023069|NCT00770224|20820110|P1|Step 1: Induction|No protocol treatment given|1
6023070|NCT00770224|20820109|P2|Step 1: Induction|Ineligible|0
6023071|NCT00770224|20820110|P1|Step 1: Induction|Ineligible|2
6023072|NCT00770224|20820109|P2|Step 1: Induction|Other reason not protocol specified|0
6023073|NCT00770224|20820110|P1|Step 1: Induction|Other reason not protocol specified|2
6023074|NCT00770224|20820109|P2|Step 1: Induction|Refusal unrelated to adverse event|0
6023075|NCT00770224|20820110|P1|Step 1: Induction|Refusal unrelated to adverse event|6
6023076|NCT00770224|20820109|P2|Step 1: Induction|Adverse Event|0
6023077|NCT00770224|20820110|P1|Step 1: Induction|Adverse Event|3
6023078|NCT00770211|20820122|P2|Overall Study|Withdrawal by Subject|2
6023079|NCT00770211|20820123|P1|Overall Study|Withdrawal by Subject|0
6023080|NCT00770211|20820122|P2|Overall Study|Lost to Follow-up|0
6023081|NCT00770211|20820123|P1|Overall Study|Lost to Follow-up|1
6023082|NCT00770146|20820139|P2|Follow-up Period|Other|5
6023083|NCT00770146|20820140|P1|Follow-up Period|Other|4
6023084|NCT00770146|20820139|P2|Follow-up Period|Adverse Event|2
6023085|NCT00770146|20820140|P1|Follow-up Period|Adverse Event|0
6023086|NCT00770146|20820139|P2|Follow-up Period|Withdrawal by Subject|13
6023087|NCT00770146|20820140|P1|Follow-up Period|Withdrawal by Subject|7
6023088|NCT00770146|20820139|P2|Treatment Period|Protocol non-compliance|1
6023089|NCT00770146|20820140|P1|Treatment Period|Protocol non-compliance|0
6023090|NCT00770146|20820139|P2|Treatment Period|Other|5
6023091|NCT00770146|20820140|P1|Treatment Period|Other|1
6023092|NCT00770146|20820139|P2|Treatment Period|Adverse Event|26
6023093|NCT00770146|20820140|P1|Treatment Period|Adverse Event|2
6023094|NCT00770146|20820139|P2|Treatment Period|Withdrawal by Subject|13
6023095|NCT00770146|20820140|P1|Treatment Period|Withdrawal by Subject|6
6023096|NCT00770120|20820229|P1|Overall Study|Reason under Review|1
6023097|NCT00770120|20820229|P1|Overall Study|Never Received Treatment/Not Analyzable|1
6023098|NCT00770120|20820229|P1|Overall Study|Ineligible|1
6023099|NCT00770120|20820229|P1|Overall Study|Withdrawal by Subject|2
6023100|NCT00770120|20820229|P1|Overall Study|Death|3
6023101|NCT00770120|20820229|P1|Overall Study|Not Protocol Specified|11
6023102|NCT00770120|20820229|P1|Overall Study|Adverse Event|11
6023103|NCT00770120|20820229|P1|Overall Study|Progression|31
6023104|NCT00770029|20820238|P2|Overall Study|Adverse Event|0
6023105|NCT00770029|20820239|P1|Overall Study|Adverse Event|1
6023106|NCT00770029|20820238|P2|Overall Study|Withdrawal by Subject|3
6023107|NCT00770029|20820239|P1|Overall Study|Withdrawal by Subject|3
6023108|NCT00770029|20820238|P2|Overall Study|Lost to Follow-up|0
6023109|NCT00770029|20820239|P1|Overall Study|Lost to Follow-up|2
6023110|NCT00769860|20820300|P2|Overall Study|Withdrawal by Subject|0
6023111|NCT00769860|20820301|P1|Overall Study|Withdrawal by Subject|2
6023112|NCT00769704|20820339|P2|Overall Study|Other|2
6023113|NCT00769704|20820340|P1|Overall Study|Other|1
6023114|NCT00769704|20820339|P2|Overall Study|Withdrawal by Subject|5
6023115|NCT00769704|20820340|P1|Overall Study|Withdrawal by Subject|12
6023116|NCT00769704|20820339|P2|Overall Study|Death|190
6023117|NCT00769704|20820340|P1|Overall Study|Death|95
6023118|NCT00769704|20820339|P2|Overall Study|Lost to Follow-up|2
6023119|NCT00769704|20820340|P1|Overall Study|Lost to Follow-up|3
6023120|NCT00769561|20820390|P2|Overall Study|Lost to Follow-up|3
6023121|NCT00769561|20820391|P1|Overall Study|Lost to Follow-up|1
6023122|NCT00769561|20820390|P2|Overall Study|Withdrawal by Subject|2
6023123|NCT00769561|20820391|P1|Overall Study|Withdrawal by Subject|2
6023124|NCT00769483|20820417|P6|Overall Study|Withdrawal by Subject|0
6023125|NCT00769483|20820418|P5|Overall Study|Withdrawal by Subject|1
6023126|NCT00769483|20820419|P4|Overall Study|Withdrawal by Subject|0
6023127|NCT00769483|20820420|P3|Overall Study|Withdrawal by Subject|0
6023128|NCT00769483|20820421|P2|Overall Study|Withdrawal by Subject|1
6023129|NCT00769483|20820422|P1|Overall Study|Withdrawal by Subject|0
6023130|NCT00769184|20820494|P2|No Treatment (6 Weeks)|Adverse Event|1
6023131|NCT00769184|20820495|P1|No Treatment (6 Weeks)|Adverse Event|1
6023132|NCT00769184|20820494|P2|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|1
6023133|NCT00769184|20820495|P1|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|0
6023134|NCT00769184|20820494|P2|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|0
6023135|NCT00769184|20820495|P1|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|1
6023136|NCT00769132|20820503|P4|Period 4|Withdrawal by Subject|0
6023137|NCT00769132|20820504|P3|Period 4|Withdrawal by Subject|0
6023138|NCT00769132|20820505|P2|Period 4|Withdrawal by Subject|1
6023139|NCT00769132|20820506|P1|Period 4|Withdrawal by Subject|0
6023140|NCT00769132|20820503|P4|Period 3|Withdrawal by Subject|0
6023141|NCT00769132|20820504|P3|Period 3|Withdrawal by Subject|0
6023142|NCT00769132|20820505|P2|Period 3|Withdrawal by Subject|0
6023143|NCT00769132|20820506|P1|Period 3|Withdrawal by Subject|1
6023144|NCT00769132|20820503|P4|Period 2|Withdrawal by Subject|1
6023145|NCT00769132|20820504|P3|Period 2|Withdrawal by Subject|0
6023146|NCT00769132|20820505|P2|Period 2|Withdrawal by Subject|0
6023147|NCT00769132|20820506|P1|Period 2|Withdrawal by Subject|0
6023148|NCT00769132|20820503|P4|Period 1|Adverse Event|1
6023149|NCT00769132|20820504|P3|Period 1|Adverse Event|0
6023150|NCT00769132|20820505|P2|Period 1|Adverse Event|0
6023151|NCT00769132|20820506|P1|Period 1|Adverse Event|1
6023152|NCT00769119|20820522|P2|Overall Study|Disallowed medication|0
6023153|NCT00769119|20820523|P1|Overall Study|Disallowed medication|1
6023154|NCT00769119|20820522|P2|Overall Study|Adverse Event|1
6023155|NCT00769119|20820523|P1|Overall Study|Adverse Event|1
6023156|NCT00769119|20820522|P2|Overall Study|Voluntary discontinuation|2
6023157|NCT00769119|20820523|P1|Overall Study|Voluntary discontinuation|0
6023158|NCT00769067|20820569|P2|Overall Study|Withdrawal by Subject|1
6023159|NCT00769067|20820570|P1|Overall Study|Withdrawal by Subject|0
6023160|NCT00769067|20820569|P2|Overall Study|Other|3
6023161|NCT00769067|20820570|P1|Overall Study|Other|1
6023162|NCT00769067|20820569|P2|Overall Study|Study terminated by sponsor|3
6023163|NCT00769067|20820570|P1|Overall Study|Study terminated by sponsor|1
6023164|NCT00769067|20820569|P2|Overall Study|Lost to Follow-up|1
6023165|NCT00769067|20820570|P1|Overall Study|Lost to Follow-up|3
6023166|NCT00769067|20820569|P2|Overall Study|Death|86
6023167|NCT00769067|20820570|P1|Overall Study|Death|89
6023168|NCT00769002|20820620|P2|Overall Study|Study was not completed, no data|9
6023169|NCT00769002|20820621|P1|Overall Study|Study was not completed, no data|9
6023170|NCT00768989|20820628|P2|On or After Week 36|Sponsor Termination|26
6023171|NCT00768989|20820629|P1|On or After Week 36|Sponsor Termination|45
6023172|NCT00768989|20820628|P2|On or After Week 36|Did not attend termination visit|0
6023173|NCT00768989|20820629|P1|On or After Week 36|Did not attend termination visit|2
6023174|NCT00768989|20820628|P2|On or After Week 36|Protocol Violation|0
6023175|NCT00768989|20820629|P1|On or After Week 36|Protocol Violation|1
6023176|NCT00768989|20820628|P2|On or After Week 36|Poor Compliance|0
6023177|NCT00768989|20820629|P1|On or After Week 36|Poor Compliance|1
6023178|NCT00768989|20820628|P2|On or After Week 36|Lost to Follow-up|0
6023179|NCT00768989|20820629|P1|On or After Week 36|Lost to Follow-up|1
6023180|NCT00768989|20820628|P2|On or After Week 36|Adverse Event|1
6023181|NCT00768989|20820629|P1|On or After Week 36|Adverse Event|0
6023182|NCT00768989|20820628|P2|On or After Week 36|Lack of Efficacy|0
6023183|NCT00768989|20820629|P1|On or After Week 36|Lack of Efficacy|1
6023184|NCT00768989|20820628|P2|Week 24 to Prior to Week 36|Withdrawal by Subject|0
6023185|NCT00768989|20820629|P1|Week 24 to Prior to Week 36|Withdrawal by Subject|1
6023186|NCT00768989|20820628|P2|Week 24 to Prior to Week 36|Lack of Efficacy|0
6023187|NCT00768989|20820629|P1|Week 24 to Prior to Week 36|Lack of Efficacy|6
6023188|NCT00768989|20820628|P2|Week 24 to Prior to Week 36|Adverse Event|0
6023189|NCT00768989|20820629|P1|Week 24 to Prior to Week 36|Adverse Event|1
6023190|NCT00768989|20820628|P2|Prior to Week 24|Protocol Violation|2
6023191|NCT00768989|20820629|P1|Prior to Week 24|Protocol Violation|0
6023192|NCT00768989|20820628|P2|Prior to Week 24|Lost to Follow-up|1
6023193|NCT00768989|20820629|P1|Prior to Week 24|Lost to Follow-up|0
6023194|NCT00768989|20820628|P2|Prior to Week 24|Adverse Event|0
6023195|NCT00768989|20820629|P1|Prior to Week 24|Adverse Event|3
6023196|NCT00768989|20820628|P2|Prior to Week 24|Withdrawal by Subject|0
6023197|NCT00768989|20820629|P1|Prior to Week 24|Withdrawal by Subject|1
6023198|NCT00768898|20820677|P1|Overall Study|Headache|1
6023199|NCT00768898|20820677|P1|Overall Study|Unrelated injury|1
6023200|NCT00768755|20820701|P4|Phase 2|Randomized but not treated|2
6023201|NCT00768755|20820702|P3|Phase 2|Randomized but not treated|0
6023202|NCT00768755|20820703|P2|Phase 2|Randomized but not treated|0
6023203|NCT00768755|20820704|P1|Phase 2|Randomized but not treated|0
6023204|NCT00768755|20820701|P4|Phase 2|Study Terminated by Sponsor|14
6023205|NCT00768755|20820702|P3|Phase 2|Study Terminated by Sponsor|7
6023206|NCT00768755|20820703|P2|Phase 2|Study Terminated by Sponsor|13
6023207|NCT00768755|20820704|P1|Phase 2|Study Terminated by Sponsor|0
6023208|NCT00768755|20820701|P4|Phase 2|Other|4
6023209|NCT00768755|20820702|P3|Phase 2|Other|2
6023210|NCT00768755|20820703|P2|Phase 2|Other|1
6023211|NCT00768755|20820704|P1|Phase 2|Other|0
6023212|NCT00768755|20820701|P4|Phase 2|Withdrawal by Subject|1
6023213|NCT00768755|20820702|P3|Phase 2|Withdrawal by Subject|0
6023214|NCT00768755|20820703|P2|Phase 2|Withdrawal by Subject|1
6023215|NCT00768755|20820704|P1|Phase 2|Withdrawal by Subject|0
6023216|NCT00768755|20820701|P4|Phase 2|Lost to Follow-up|4
6023217|NCT00768755|20820702|P3|Phase 2|Lost to Follow-up|1
6023218|NCT00768755|20820703|P2|Phase 2|Lost to Follow-up|1
6023219|NCT00768755|20820704|P1|Phase 2|Lost to Follow-up|0
6023220|NCT00768755|20820701|P4|Phase 2|Protocol Violation|1
6023221|NCT00768755|20820702|P3|Phase 2|Protocol Violation|0
6023222|NCT00768755|20820703|P2|Phase 2|Protocol Violation|2
6023223|NCT00768755|20820704|P1|Phase 2|Protocol Violation|0
6023224|NCT00768755|20820701|P4|Phase 2|Death|31
6023225|NCT00768755|20820702|P3|Phase 2|Death|48
6023226|NCT00768755|20820703|P2|Phase 2|Death|37
6023227|NCT00768755|20820704|P1|Phase 2|Death|0
6023228|NCT00768755|20820701|P4|Phase 1|Other|0
6023229|NCT00768755|20820702|P3|Phase 1|Other|0
6023230|NCT00768755|20820703|P2|Phase 1|Other|0
6023231|NCT00768755|20820704|P1|Phase 1|Other|4
6023232|NCT00768755|20820701|P4|Phase 1|Death|0
6023233|NCT00768755|20820702|P3|Phase 1|Death|0
6023234|NCT00768755|20820703|P2|Phase 1|Death|0
6023235|NCT00768755|20820704|P1|Phase 1|Death|6
6023236|NCT00768651|20820752|P1|Overall Study|Withdrawal by Subject|1
6023237|NCT00768560|20820791|P6|Intervention Set 1|Adverse Event|0
6023238|NCT00768560|20820792|P5|Intervention Set 1|Adverse Event|0
6023239|NCT00768560|20820793|P4|Intervention Set 1|Adverse Event|0
6023240|NCT00768560|20820794|P3|Intervention Set 1|Adverse Event|0
6023241|NCT00768560|20820795|P2|Intervention Set 1|Adverse Event|1
6023242|NCT00768560|20820796|P1|Intervention Set 1|Adverse Event|0
6023243|NCT00768469|20820833|P2|Overall Study|Withdrawal by Subject|1
6023244|NCT00768469|20820834|P1|Overall Study|Withdrawal by Subject|0
6023245|NCT00768469|20820833|P2|Overall Study|Disease Progression|4
6023246|NCT00768469|20820834|P1|Overall Study|Disease Progression|3
6023247|NCT00768469|20820833|P2|Overall Study|Adverse Event|2
6023248|NCT00768469|20820834|P1|Overall Study|Adverse Event|0
6023249|NCT00768430|20820849|P2|7 Day Endpoint|Withdrawal by Subject|3
6023250|NCT00768430|20820850|P1|7 Day Endpoint|Withdrawal by Subject|2
6023251|NCT00768300|20820858|P2|Overall Study|Missing data|0
6023252|NCT00768300|20820859|P1|Overall Study|Missing data|1
6023253|NCT00768300|20820858|P2|Overall Study|Treated but never dosed with Study drug|0
6023254|NCT00768300|20820859|P1|Overall Study|Treated but never dosed with Study drug|1
6023255|NCT00768300|20820858|P2|Overall Study|Began prohibited concomitant medication|1
6023256|NCT00768300|20820859|P1|Overall Study|Began prohibited concomitant medication|0
6023257|NCT00768300|20820858|P2|Overall Study|Lost to Follow-up|1
6023258|NCT00768300|20820859|P1|Overall Study|Lost to Follow-up|0
6023259|NCT00768300|20820858|P2|Overall Study|Received lung transplant|1
6023260|NCT00768300|20820859|P1|Overall Study|Received lung transplant|1
6023261|NCT00768300|20820858|P2|Overall Study|Screen failure following randomization|0
6023262|NCT00768300|20820859|P1|Overall Study|Screen failure following randomization|1
6023263|NCT00768300|20820858|P2|Overall Study|Subject moved to pursue lung transplant|1
6023264|NCT00768300|20820859|P1|Overall Study|Subject moved to pursue lung transplant|1
6023265|NCT00768300|20820858|P2|Overall Study|Death|5
6023266|NCT00768300|20820859|P1|Overall Study|Death|21
6023267|NCT00768300|20820858|P2|Overall Study|Study discontinued by Sponsor|140
6023268|NCT00768300|20820859|P1|Overall Study|Study discontinued by Sponsor|271
6023269|NCT00768300|20820858|P2|Overall Study|Physician Decision|3
6023270|NCT00768300|20820859|P1|Overall Study|Physician Decision|2
6023271|NCT00768300|20820858|P2|Overall Study|Withdrawal by Subject|7
6023272|NCT00768300|20820859|P1|Overall Study|Withdrawal by Subject|13
6023273|NCT00768300|20820858|P2|Overall Study|Protocol Violation|1
6023274|NCT00768300|20820859|P1|Overall Study|Protocol Violation|6
6023275|NCT00768300|20820858|P2|Overall Study|Adverse Event|2
6023276|NCT00768300|20820859|P1|Overall Study|Adverse Event|10
6023277|NCT00768300|20820858|P2|Overall Study|Randomized but not treated|1
6023278|NCT00768300|20820859|P1|Overall Study|Randomized but not treated|1
6023279|NCT00768248|20820943|P2|Overall Study|Research coordinator didn't collect data|1
6023280|NCT00768248|20820944|P1|Overall Study|Research coordinator didn't collect data|1
6023281|NCT00768222|20820960|P2|Overall Study|Protocol Violation|2
6023282|NCT00768222|20820961|P1|Overall Study|Protocol Violation|0
6023283|NCT00768222|20820960|P2|Overall Study|Withdrawal by Subject|1
6023284|NCT00768222|20820961|P1|Overall Study|Withdrawal by Subject|3
6023285|NCT00768222|20820960|P2|Overall Study|Lost to Follow-up|1
6023286|NCT00768222|20820961|P1|Overall Study|Lost to Follow-up|1
6023287|NCT00768144|20820983|P1|Overall Study|Pt Withdrew Consent|1
6023288|NCT00768144|20820983|P1|Overall Study|Patient or MD Decision to End Treatment|1
6023289|NCT00768144|20820983|P1|Overall Study|Progressive Disease|21
6023290|NCT00768144|20820983|P1|Overall Study|Adverse Event|13
6023291|NCT00768079|20820996|P3|Overall Study|Participant incarcerated|0
6023292|NCT00768079|20820997|P2|Overall Study|Participant incarcerated|1
6023293|NCT00768079|20820998|P1|Overall Study|Participant incarcerated|0
6023294|NCT00768079|20820996|P3|Overall Study|Lost to Follow-up|4
6023295|NCT00768079|20820997|P2|Overall Study|Lost to Follow-up|0
6023296|NCT00768079|20820998|P1|Overall Study|Lost to Follow-up|2
6023297|NCT00768066|20821055|P3|Overall Study|Did not receive study product injection.|0
6023298|NCT00768066|20821056|P2|Overall Study|Did not receive study product injection.|3
6023299|NCT00768066|20821057|P1|Overall Study|Did not receive study product injection.|3
6023300|NCT00768053|20821089|P1|Overall Study|Lost to Follow-up|1
6023301|NCT00768053|20821089|P1|Overall Study|Adverse Event|10
6023302|NCT00768040|20821120|P2|Overall Study|Abnormal laboratory value|1
6023303|NCT00768040|20821121|P1|Overall Study|Abnormal laboratory value|1
6023304|NCT00768040|20821120|P2|Overall Study|Adverse Event|2
6023305|NCT00768040|20821121|P1|Overall Study|Adverse Event|3
6023306|NCT00767819|20821130|P3|Overall Study|Lost to Follow-up|0
6023307|NCT00767819|20821131|P2|Overall Study|Lost to Follow-up|0
6023308|NCT00767819|20821132|P1|Overall Study|Lost to Follow-up|1
6023309|NCT00767819|20821130|P3|Overall Study|Abnormal lab values|0
6023310|NCT00767819|20821131|P2|Overall Study|Abnormal lab values|0
6023311|NCT00767819|20821132|P1|Overall Study|Abnormal lab values|1
6023312|NCT00767819|20821130|P3|Overall Study|Adverse Event|0
6023313|NCT00767819|20821131|P2|Overall Study|Adverse Event|0
6023314|NCT00767819|20821132|P1|Overall Study|Adverse Event|2
6023315|NCT00767819|20821130|P3|Overall Study|Death|0
6023316|NCT00767819|20821131|P2|Overall Study|Death|3
6023317|NCT00767819|20821132|P1|Overall Study|Death|2
6023318|NCT00767819|20821130|P3|Overall Study|Administrative problems|0
6023319|NCT00767819|20821131|P2|Overall Study|Administrative problems|1
6023320|NCT00767819|20821132|P1|Overall Study|Administrative problems|0
6023321|NCT00767819|20821130|P3|Overall Study|Withdrawal by Subject|0
6023322|NCT00767819|20821131|P2|Overall Study|Withdrawal by Subject|1
6023323|NCT00767819|20821132|P1|Overall Study|Withdrawal by Subject|1
6023324|NCT00767819|20821130|P3|Overall Study|Unsatisfactory therapeutic effect|0
6023325|NCT00767819|20821131|P2|Overall Study|Unsatisfactory therapeutic effect|14
6023326|NCT00767819|20821132|P1|Overall Study|Unsatisfactory therapeutic effect|18
6023327|NCT00767806|20821157|P2|Overall Study|Sponsor Decision|1
6023328|NCT00767806|20821158|P1|Overall Study|Sponsor Decision|0
6023329|NCT00767806|20821157|P2|Overall Study|Entry Criteria Not Met|1
6023330|NCT00767806|20821158|P1|Overall Study|Entry Criteria Not Met|1
6023331|NCT00767806|20821157|P2|Overall Study|Lost to Follow-up|4
6023332|NCT00767806|20821158|P1|Overall Study|Lost to Follow-up|1
6023333|NCT00767806|20821157|P2|Overall Study|Physician Decision|3
6023334|NCT00767806|20821158|P1|Overall Study|Physician Decision|4
6023335|NCT00767806|20821157|P2|Overall Study|Lack of Efficacy|9
6023336|NCT00767806|20821158|P1|Overall Study|Lack of Efficacy|1
6023337|NCT00767806|20821157|P2|Overall Study|Protocol Violation|5
6023338|NCT00767806|20821158|P1|Overall Study|Protocol Violation|6
6023339|NCT00767806|20821157|P2|Overall Study|Withdrawal by Subject|13
6023340|NCT00767806|20821158|P1|Overall Study|Withdrawal by Subject|8
6023341|NCT00767806|20821157|P2|Overall Study|Adverse Event|11
6023342|NCT00767806|20821158|P1|Overall Study|Adverse Event|30
6023343|NCT00767676|20821235|P1|Overall Study|Investigator error|54
6023344|NCT00767520|20821258|P2|Overall Study|Randomized in error and Never treated|2
6023345|NCT00767520|20821259|P1|Overall Study|Randomized in error and Never treated|0
6023346|NCT00767520|20821258|P2|Overall Study|Participants still on treatment|15
6023347|NCT00767520|20821259|P1|Overall Study|Participants still on treatment|11
6023348|NCT00767455|20821312|P1|Overall Study|Investigator error|19
6023349|NCT00767325|20821346|P1|Overall Study|Missed visit due to family reasons|1
6023350|NCT00767325|20821346|P1|Overall Study|No longer met study criteria|2
6023351|NCT00767325|20821346|P1|Overall Study|Lost to Follow-up|3
6023352|NCT00767325|20821346|P1|Overall Study|Adverse Event|7
6023353|NCT00767325|20821346|P1|Overall Study|Lack of Efficacy|2
6023354|NCT00767104|20821357|P2|Overall Study|Lost to Follow-up|2
6023355|NCT00767104|20821358|P1|Overall Study|Lost to Follow-up|1
6023356|NCT00767039|20821368|P2|Overall Study|Death|2
6023357|NCT00767039|20821369|P1|Overall Study|Death|5
6023358|NCT00767000|20821400|P5|Optional 104-week Extension|Study terminated by sponsor|4
6023359|NCT00767000|20821401|P4|Optional 104-week Extension|Study terminated by sponsor|2
6023360|NCT00767000|20821402|P3|Optional 104-week Extension|Study terminated by sponsor|7
6023361|NCT00767000|20821403|P2|Optional 104-week Extension|Study terminated by sponsor|3
6023362|NCT00767000|20821404|P1|Optional 104-week Extension|Study terminated by sponsor|7
6023363|NCT00767000|20821400|P5|54-week Study|Reason not reported|0
6023364|NCT00767000|20821401|P4|54-week Study|Reason not reported|1
6023365|NCT00767000|20821402|P3|54-week Study|Reason not reported|0
6023366|NCT00767000|20821403|P2|54-week Study|Reason not reported|0
6023367|NCT00767000|20821404|P1|54-week Study|Reason not reported|0
6023368|NCT00767000|20821400|P5|54-week Study|Study terminated by sponsor|194
6023369|NCT00767000|20821401|P4|54-week Study|Study terminated by sponsor|196
6023370|NCT00767000|20821402|P3|54-week Study|Study terminated by sponsor|89
6023371|NCT00767000|20821403|P2|54-week Study|Study terminated by sponsor|102
6023372|NCT00767000|20821404|P1|54-week Study|Study terminated by sponsor|90
6023373|NCT00767000|20821400|P5|54-week Study|Withdrawal by Subject|13
6023374|NCT00767000|20821401|P4|54-week Study|Withdrawal by Subject|11
6023375|NCT00767000|20821402|P3|54-week Study|Withdrawal by Subject|5
6023376|NCT00767000|20821403|P2|54-week Study|Withdrawal by Subject|3
6023377|NCT00767000|20821404|P1|54-week Study|Withdrawal by Subject|2
6023378|NCT00767000|20821400|P5|54-week Study|Protocol Violation|0
6023379|NCT00767000|20821401|P4|54-week Study|Protocol Violation|2
6023380|NCT00767000|20821402|P3|54-week Study|Protocol Violation|1
6023381|NCT00767000|20821403|P2|54-week Study|Protocol Violation|0
6023382|NCT00767000|20821404|P1|54-week Study|Protocol Violation|0
6023383|NCT00767000|20821400|P5|54-week Study|Progressive disease|0
6023384|NCT00767000|20821401|P4|54-week Study|Progressive disease|0
6023385|NCT00767000|20821402|P3|54-week Study|Progressive disease|1
6023386|NCT00767000|20821403|P2|54-week Study|Progressive disease|0
6023387|NCT00767000|20821404|P1|54-week Study|Progressive disease|0
6023388|NCT00767000|20821400|P5|54-week Study|Physician Decision|1
6023389|NCT00767000|20821401|P4|54-week Study|Physician Decision|1
6023390|NCT00767000|20821402|P3|54-week Study|Physician Decision|1
6023391|NCT00767000|20821403|P2|54-week Study|Physician Decision|0
6023392|NCT00767000|20821404|P1|54-week Study|Physician Decision|4
6023393|NCT00767000|20821400|P5|54-week Study|Lost to Follow-up|2
6023394|NCT00767000|20821401|P4|54-week Study|Lost to Follow-up|4
6023395|NCT00767000|20821402|P3|54-week Study|Lost to Follow-up|1
6023396|NCT00767000|20821403|P2|54-week Study|Lost to Follow-up|0
6023397|NCT00767000|20821404|P1|54-week Study|Lost to Follow-up|4
6023398|NCT00767000|20821400|P5|54-week Study|Lack of Efficacy|5
6023399|NCT00767000|20821401|P4|54-week Study|Lack of Efficacy|0
6023400|NCT00767000|20821402|P3|54-week Study|Lack of Efficacy|1
6023401|NCT00767000|20821403|P2|54-week Study|Lack of Efficacy|0
6023402|NCT00767000|20821404|P1|54-week Study|Lack of Efficacy|2
6023403|NCT00767000|20821400|P5|54-week Study|Interruption of study medication|0
6023404|NCT00767000|20821401|P4|54-week Study|Interruption of study medication|0
6023405|NCT00767000|20821402|P3|54-week Study|Interruption of study medication|1
6023406|NCT00767000|20821403|P2|54-week Study|Interruption of study medication|0
6023407|NCT00767000|20821404|P1|54-week Study|Interruption of study medication|0
6023408|NCT00767000|20821400|P5|54-week Study|Hypoglycemia|0
6023409|NCT00767000|20821401|P4|54-week Study|Hypoglycemia|0
6023410|NCT00767000|20821402|P3|54-week Study|Hypoglycemia|0
6023411|NCT00767000|20821403|P2|54-week Study|Hypoglycemia|1
6023412|NCT00767000|20821404|P1|54-week Study|Hypoglycemia|0
6023413|NCT00767000|20821400|P5|54-week Study|Hyperglycemia|1
6023414|NCT00767000|20821401|P4|54-week Study|Hyperglycemia|0
6023415|NCT00767000|20821402|P3|54-week Study|Hyperglycemia|1
6023416|NCT00767000|20821403|P2|54-week Study|Hyperglycemia|0
6023417|NCT00767000|20821404|P1|54-week Study|Hyperglycemia|0
6023418|NCT00767000|20821400|P5|54-week Study|Creaninine/creatinine clearance|4
6023419|NCT00767000|20821401|P4|54-week Study|Creaninine/creatinine clearance|2
6023420|NCT00767000|20821402|P3|54-week Study|Creaninine/creatinine clearance|2
6023421|NCT00767000|20821403|P2|54-week Study|Creaninine/creatinine clearance|1
6023422|NCT00767000|20821404|P1|54-week Study|Creaninine/creatinine clearance|2
6023423|NCT00767000|20821400|P5|54-week Study|Adverse Event|4
6023424|NCT00767000|20821401|P4|54-week Study|Adverse Event|8
6023425|NCT00767000|20821402|P3|54-week Study|Adverse Event|6
6023426|NCT00767000|20821403|P2|54-week Study|Adverse Event|6
6023427|NCT00767000|20821404|P1|54-week Study|Adverse Event|4
6023428|NCT00766831|20821446|P1|Overall Study|Other|28
6023429|NCT00766831|20821446|P1|Overall Study|Non cooperation by participants|14
6023430|NCT00766831|20821446|P1|Overall Study|Withdrawal of consent|26
6023431|NCT00766831|20821446|P1|Overall Study|Physician Decision|5
6023432|NCT00766831|20821446|P1|Overall Study|Protocol Violation|15
6023433|NCT00766831|20821446|P1|Overall Study|Adverse Event|20
6023434|NCT00766831|20821446|P1|Overall Study|Lost to Follow-up|3
6023435|NCT00766831|20821446|P1|Overall Study|Withdrawal by Subject|4
6023436|NCT00766675|20821482|P1|Overall Study|Insufficient therapy|1
6023437|NCT00766675|20821482|P1|Overall Study|Receive other anti-neoplastic treatment|1
6023438|NCT00766675|20821482|P1|Overall Study|Participant took prohibited medication|1
6023439|NCT00766675|20821482|P1|Overall Study|Protocol Violation|8
6023440|NCT00766675|20821482|P1|Overall Study|Withdrawal by Subject|11
6023441|NCT00766675|20821482|P1|Overall Study|Lost to Follow-up|2
6023442|NCT00766675|20821482|P1|Overall Study|Adverse Event|16
6023443|NCT00766636|20821511|P2|Overall Study|Disease Progression|0
6023444|NCT00766636|20821512|P1|Overall Study|Disease Progression|1
6023445|NCT00766636|20821511|P2|Overall Study|Adverse Event|0
6023446|NCT00766636|20821512|P1|Overall Study|Adverse Event|1
6023447|NCT00766636|20821511|P2|Overall Study|Incomplete Treatment|1
6023448|NCT00766636|20821512|P1|Overall Study|Incomplete Treatment|0
6023449|NCT00766636|20821511|P2|Overall Study|Withdrawal by Subject|1
6023450|NCT00766636|20821512|P1|Overall Study|Withdrawal by Subject|1
6023451|NCT00766597|20821518|P1|Overall Study|Without CCR5-tropic virus|5
6023452|NCT00766597|20821518|P1|Overall Study|Unexpected closure of study|4
6023453|NCT00766532|20821530|P1|Overall Study|Protocol Violation|2
6023454|NCT00766506|20821536|P2|Overall Study|Other|2
6023455|NCT00766506|20821537|P1|Overall Study|Other|2
6023456|NCT00766506|20821536|P2|Overall Study|Use rescue medication after 3 hours|0
6023457|NCT00766506|20821537|P1|Overall Study|Use rescue medication after 3 hours|3
6023458|NCT00766493|20821561|P1|30 Days Post-Procedure|Missed Visit - No Phone Contact|1
6023459|NCT00766493|20821561|P1|30 Days Post-Procedure|Missed Visit - Phone Contact f/u|4
6023460|NCT00766493|20821561|P1|30 Days Post-Procedure|Discontinued|7
6023461|NCT00766467|20821571|P2|Overall Study|Physician Decision|0
6023462|NCT00766467|20821572|P1|Overall Study|Physician Decision|1
6023463|NCT00766467|20821571|P2|Overall Study|Tumor Progression on Study|1
6023464|NCT00766467|20821572|P1|Overall Study|Tumor Progression on Study|0
6023465|NCT00766467|20821571|P2|Overall Study|Protocol Violation|4
6023466|NCT00766467|20821572|P1|Overall Study|Protocol Violation|2
6023467|NCT00766467|20821571|P2|Overall Study|Adverse Event|1
6023468|NCT00766467|20821572|P1|Overall Study|Adverse Event|1
6023469|NCT00766467|20821571|P2|Overall Study|Withdrawal by Subject|2
6023470|NCT00766467|20821572|P1|Overall Study|Withdrawal by Subject|7
6023471|NCT00766415|20821584|P2|Overall Study|Withdrawal by Subject|1
6023472|NCT00766415|20821585|P1|Overall Study|Withdrawal by Subject|0
6023473|NCT00766376|20821633|P1|Overall Study|Withdrawal by Subject|27
6023474|NCT00766363|20821642|P4|Overall Study|Adverse Event Prior to Randomization|0
6023475|NCT00766363|20821643|P3|Overall Study|Adverse Event Prior to Randomization|0
6023476|NCT00766363|20821644|P2|Overall Study|Adverse Event Prior to Randomization|1
6023477|NCT00766363|20821645|P1|Overall Study|Adverse Event Prior to Randomization|0
6023478|NCT00766363|20821642|P4|Overall Study|Withdrawal by Subject|0
6023479|NCT00766363|20821643|P3|Overall Study|Withdrawal by Subject|0
6023480|NCT00766363|20821644|P2|Overall Study|Withdrawal by Subject|0
6023481|NCT00766363|20821645|P1|Overall Study|Withdrawal by Subject|1
6023482|NCT00766142|20821682|P1|Overall Study|Protocol Violation|4
6023483|NCT00766090|20821698|P12|Treatment Period 3 (28 Days)|Lost to Follow-up|0
6023484|NCT00766090|20821699|P11|Treatment Period 3 (28 Days)|Lost to Follow-up|0
6023485|NCT00766090|20821700|P10|Treatment Period 3 (28 Days)|Lost to Follow-up|0
6023486|NCT00766090|20821701|P9|Treatment Period 3 (28 Days)|Lost to Follow-up|0
6023487|NCT00766090|20821702|P8|Treatment Period 3 (28 Days)|Lost to Follow-up|0
6023488|NCT00766090|20821703|P7|Treatment Period 3 (28 Days)|Lost to Follow-up|0
6023489|NCT00766090|20821704|P6|Treatment Period 3 (28 Days)|Lost to Follow-up|0
6023490|NCT00766090|20821705|P5|Treatment Period 3 (28 Days)|Lost to Follow-up|1
6023491|NCT00766090|20821706|P4|Treatment Period 3 (28 Days)|Lost to Follow-up|0
6023492|NCT00766090|20821707|P3|Treatment Period 3 (28 Days)|Lost to Follow-up|0
6023493|NCT00766090|20821708|P2|Treatment Period 3 (28 Days)|Lost to Follow-up|0
6023494|NCT00766090|20821709|P1|Treatment Period 3 (28 Days)|Lost to Follow-up|0
6023495|NCT00766090|20821698|P12|Treatment Period 3 (28 Days)|Lack of Efficacy|1
6023496|NCT00766090|20821699|P11|Treatment Period 3 (28 Days)|Lack of Efficacy|0
6023497|NCT00766090|20821700|P10|Treatment Period 3 (28 Days)|Lack of Efficacy|0
6023498|NCT00766090|20821701|P9|Treatment Period 3 (28 Days)|Lack of Efficacy|0
6023499|NCT00766090|20821702|P8|Treatment Period 3 (28 Days)|Lack of Efficacy|0
6023500|NCT00766090|20821703|P7|Treatment Period 3 (28 Days)|Lack of Efficacy|0
6023501|NCT00766090|20821704|P6|Treatment Period 3 (28 Days)|Lack of Efficacy|0
6023502|NCT00766090|20821705|P5|Treatment Period 3 (28 Days)|Lack of Efficacy|0
6023503|NCT00766090|20821706|P4|Treatment Period 3 (28 Days)|Lack of Efficacy|1
6023504|NCT00766090|20821707|P3|Treatment Period 3 (28 Days)|Lack of Efficacy|0
6023505|NCT00766090|20821708|P2|Treatment Period 3 (28 Days)|Lack of Efficacy|1
6023506|NCT00766090|20821709|P1|Treatment Period 3 (28 Days)|Lack of Efficacy|0
6023507|NCT00766090|20821698|P12|Treatment Period 3 (28 Days)|Protocol Violation|0
6023508|NCT00766090|20821699|P11|Treatment Period 3 (28 Days)|Protocol Violation|0
6023509|NCT00766090|20821700|P10|Treatment Period 3 (28 Days)|Protocol Violation|0
6023510|NCT00766090|20821701|P9|Treatment Period 3 (28 Days)|Protocol Violation|0
6023511|NCT00766090|20821702|P8|Treatment Period 3 (28 Days)|Protocol Violation|0
6023512|NCT00766090|20821703|P7|Treatment Period 3 (28 Days)|Protocol Violation|0
6023513|NCT00766090|20821704|P6|Treatment Period 3 (28 Days)|Protocol Violation|1
6023514|NCT00766090|20821705|P5|Treatment Period 3 (28 Days)|Protocol Violation|0
6023515|NCT00766090|20821706|P4|Treatment Period 3 (28 Days)|Protocol Violation|0
6023516|NCT00766090|20821707|P3|Treatment Period 3 (28 Days)|Protocol Violation|0
6023517|NCT00766090|20821708|P2|Treatment Period 3 (28 Days)|Protocol Violation|0
6023518|NCT00766090|20821709|P1|Treatment Period 3 (28 Days)|Protocol Violation|0
6023519|NCT00766090|20821698|P12|Washout Period 2 (14 Days)|Physician Decision|0
6023520|NCT00766090|20821699|P11|Washout Period 2 (14 Days)|Physician Decision|0
6023521|NCT00766090|20821700|P10|Washout Period 2 (14 Days)|Physician Decision|0
6023522|NCT00766090|20821701|P9|Washout Period 2 (14 Days)|Physician Decision|0
6023523|NCT00766090|20821702|P8|Washout Period 2 (14 Days)|Physician Decision|0
6023524|NCT00766090|20821703|P7|Washout Period 2 (14 Days)|Physician Decision|0
6023525|NCT00766090|20821704|P6|Washout Period 2 (14 Days)|Physician Decision|0
6023526|NCT00766090|20821705|P5|Washout Period 2 (14 Days)|Physician Decision|0
6023527|NCT00766090|20821706|P4|Washout Period 2 (14 Days)|Physician Decision|0
6023528|NCT00766090|20821707|P3|Washout Period 2 (14 Days)|Physician Decision|1
6023529|NCT00766090|20821708|P2|Washout Period 2 (14 Days)|Physician Decision|0
6023530|NCT00766090|20821709|P1|Washout Period 2 (14 Days)|Physician Decision|0
6023531|NCT00766090|20821698|P12|Treatment Period 2 (28 Days)|Lack of Efficacy|0
6023532|NCT00766090|20821699|P11|Treatment Period 2 (28 Days)|Lack of Efficacy|0
6023533|NCT00766090|20821700|P10|Treatment Period 2 (28 Days)|Lack of Efficacy|0
6023534|NCT00766090|20821701|P9|Treatment Period 2 (28 Days)|Lack of Efficacy|0
6023535|NCT00766090|20821702|P8|Treatment Period 2 (28 Days)|Lack of Efficacy|0
6023536|NCT00766090|20821703|P7|Treatment Period 2 (28 Days)|Lack of Efficacy|0
6023537|NCT00766090|20821704|P6|Treatment Period 2 (28 Days)|Lack of Efficacy|0
6023538|NCT00766090|20821705|P5|Treatment Period 2 (28 Days)|Lack of Efficacy|0
6023539|NCT00766090|20821706|P4|Treatment Period 2 (28 Days)|Lack of Efficacy|0
6023540|NCT00766090|20821707|P3|Treatment Period 2 (28 Days)|Lack of Efficacy|1
6023541|NCT00766090|20821708|P2|Treatment Period 2 (28 Days)|Lack of Efficacy|0
6023542|NCT00766090|20821709|P1|Treatment Period 2 (28 Days)|Lack of Efficacy|0
6023543|NCT00766090|20821698|P12|Treatment Period 2 (28 Days)|Lost to Follow-up|0
6023544|NCT00766090|20821699|P11|Treatment Period 2 (28 Days)|Lost to Follow-up|0
6023545|NCT00766090|20821700|P10|Treatment Period 2 (28 Days)|Lost to Follow-up|0
6023546|NCT00766090|20821701|P9|Treatment Period 2 (28 Days)|Lost to Follow-up|0
6023547|NCT00766090|20821702|P8|Treatment Period 2 (28 Days)|Lost to Follow-up|0
6023548|NCT00766090|20821703|P7|Treatment Period 2 (28 Days)|Lost to Follow-up|0
6023549|NCT00766090|20821704|P6|Treatment Period 2 (28 Days)|Lost to Follow-up|0
6023550|NCT00766090|20821705|P5|Treatment Period 2 (28 Days)|Lost to Follow-up|2
6023551|NCT00766090|20821706|P4|Treatment Period 2 (28 Days)|Lost to Follow-up|0
6023552|NCT00766090|20821707|P3|Treatment Period 2 (28 Days)|Lost to Follow-up|0
6023553|NCT00766090|20821708|P2|Treatment Period 2 (28 Days)|Lost to Follow-up|0
6023554|NCT00766090|20821709|P1|Treatment Period 2 (28 Days)|Lost to Follow-up|0
6023555|NCT00766090|20821698|P12|Washout Period 1 (14 Days)|Protocol Violation|0
6023556|NCT00766090|20821699|P11|Washout Period 1 (14 Days)|Protocol Violation|0
6023557|NCT00766090|20821700|P10|Washout Period 1 (14 Days)|Protocol Violation|0
6023558|NCT00766090|20821701|P9|Washout Period 1 (14 Days)|Protocol Violation|0
6023559|NCT00766090|20821702|P8|Washout Period 1 (14 Days)|Protocol Violation|0
6023560|NCT00766090|20821703|P7|Washout Period 1 (14 Days)|Protocol Violation|0
6023561|NCT00766090|20821704|P6|Washout Period 1 (14 Days)|Protocol Violation|0
6023562|NCT00766090|20821705|P5|Washout Period 1 (14 Days)|Protocol Violation|0
6023563|NCT00766090|20821706|P4|Washout Period 1 (14 Days)|Protocol Violation|0
6023564|NCT00766090|20821707|P3|Washout Period 1 (14 Days)|Protocol Violation|1
6023565|NCT00766090|20821708|P2|Washout Period 1 (14 Days)|Protocol Violation|0
6023566|NCT00766090|20821709|P1|Washout Period 1 (14 Days)|Protocol Violation|0
6023567|NCT00766090|20821698|P12|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
6023568|NCT00766090|20821699|P11|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
6023569|NCT00766090|20821700|P10|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
6023570|NCT00766090|20821701|P9|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
6023571|NCT00766090|20821702|P8|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
6023572|NCT00766090|20821703|P7|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
6023573|NCT00766090|20821704|P6|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
6023574|NCT00766090|20821705|P5|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
6023575|NCT00766090|20821706|P4|Treatment Period 1 (28 Days)|Withdrawal by Subject|1
6023576|NCT00766090|20821707|P3|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
6023577|NCT00766090|20821708|P2|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
6023578|NCT00766090|20821709|P1|Treatment Period 1 (28 Days)|Withdrawal by Subject|1
6023579|NCT00766090|20821698|P12|Treatment Period 1 (28 Days)|Lack of Efficacy|0
6023580|NCT00766090|20821699|P11|Treatment Period 1 (28 Days)|Lack of Efficacy|0
6023581|NCT00766090|20821700|P10|Treatment Period 1 (28 Days)|Lack of Efficacy|0
6023582|NCT00766090|20821701|P9|Treatment Period 1 (28 Days)|Lack of Efficacy|0
6023583|NCT00766090|20821702|P8|Treatment Period 1 (28 Days)|Lack of Efficacy|0
6023584|NCT00766090|20821703|P7|Treatment Period 1 (28 Days)|Lack of Efficacy|0
6023585|NCT00766090|20821704|P6|Treatment Period 1 (28 Days)|Lack of Efficacy|0
6023586|NCT00766090|20821705|P5|Treatment Period 1 (28 Days)|Lack of Efficacy|0
6023587|NCT00766090|20821706|P4|Treatment Period 1 (28 Days)|Lack of Efficacy|0
6023588|NCT00766090|20821707|P3|Treatment Period 1 (28 Days)|Lack of Efficacy|0
6023589|NCT00766090|20821708|P2|Treatment Period 1 (28 Days)|Lack of Efficacy|0
6023590|NCT00766090|20821709|P1|Treatment Period 1 (28 Days)|Lack of Efficacy|2
6023591|NCT00766090|20821698|P12|Treatment Period 1 (28 Days)|Lost to Follow-up|0
6023592|NCT00766090|20821699|P11|Treatment Period 1 (28 Days)|Lost to Follow-up|0
6023593|NCT00766090|20821700|P10|Treatment Period 1 (28 Days)|Lost to Follow-up|0
6023594|NCT00766090|20821701|P9|Treatment Period 1 (28 Days)|Lost to Follow-up|1
6023595|NCT00766090|20821702|P8|Treatment Period 1 (28 Days)|Lost to Follow-up|0
6023596|NCT00766090|20821703|P7|Treatment Period 1 (28 Days)|Lost to Follow-up|0
6023597|NCT00766090|20821704|P6|Treatment Period 1 (28 Days)|Lost to Follow-up|0
6023598|NCT00766090|20821705|P5|Treatment Period 1 (28 Days)|Lost to Follow-up|0
6023599|NCT00766090|20821706|P4|Treatment Period 1 (28 Days)|Lost to Follow-up|0
6023600|NCT00766090|20821707|P3|Treatment Period 1 (28 Days)|Lost to Follow-up|0
6023601|NCT00766090|20821708|P2|Treatment Period 1 (28 Days)|Lost to Follow-up|0
6023602|NCT00766090|20821709|P1|Treatment Period 1 (28 Days)|Lost to Follow-up|0
6023603|NCT00766051|20821750|P2|Overall Study|Withdrawal by Subject|0
6023604|NCT00766051|20821751|P1|Overall Study|Withdrawal by Subject|2
6023605|NCT00766038|20821763|P2|Overall Study|Lost to Follow-up|14
6023606|NCT00766038|20821764|P1|Overall Study|Lost to Follow-up|15
6023607|NCT00765999|20821780|P1|Overall Study|Other Miscellaneous Reasons|51
6023608|NCT00765999|20821780|P1|Overall Study|Study Terminated by Sponsor|2
6023609|NCT00765999|20821780|P1|Overall Study|Lost to Follow-up|131
6023610|NCT00765999|20821780|P1|Overall Study|Consent Withdrawn|202
6023611|NCT00765999|20821780|P1|Overall Study|Protocol Violation|95
6023612|NCT00765999|20821780|P1|Overall Study|Insufficient Therapeutic Response|100
6023613|NCT00765999|20821780|P1|Overall Study|Adverse Event|203
6023614|NCT00765882|20821807|P3|Overall Study|Other Reason|2
6023615|NCT00765882|20821808|P2|Overall Study|Other Reason|1
6023616|NCT00765882|20821809|P1|Overall Study|Other Reason|3
6023617|NCT00765882|20821807|P3|Overall Study|Lost to Follow-up|6
6023618|NCT00765882|20821808|P2|Overall Study|Lost to Follow-up|9
6023619|NCT00765882|20821809|P1|Overall Study|Lost to Follow-up|1
6023620|NCT00765882|20821807|P3|Overall Study|Withdrawal by Subject|6
6023621|NCT00765882|20821808|P2|Overall Study|Withdrawal by Subject|6
6023622|NCT00765882|20821809|P1|Overall Study|Withdrawal by Subject|2
6023623|NCT00765882|20821807|P3|Overall Study|Protocol Violation|1
6023624|NCT00765882|20821808|P2|Overall Study|Protocol Violation|3
6023625|NCT00765882|20821809|P1|Overall Study|Protocol Violation|4
6023626|NCT00765882|20821807|P3|Overall Study|Lack of Efficacy|1
6023627|NCT00765882|20821808|P2|Overall Study|Lack of Efficacy|0
6023628|NCT00765882|20821809|P1|Overall Study|Lack of Efficacy|4
6023629|NCT00765882|20821807|P3|Overall Study|Adverse Event|20
6023630|NCT00765882|20821808|P2|Overall Study|Adverse Event|21
6023631|NCT00765882|20821809|P1|Overall Study|Adverse Event|10
6023632|NCT00765843|20821855|P3|Overall Study|Adverse Event|1
6023633|NCT00765843|20821856|P2|Overall Study|Adverse Event|0
6023634|NCT00765843|20821857|P1|Overall Study|Adverse Event|0
6023635|NCT00765843|20821855|P3|Overall Study|did not return to receive intervention|0
6023636|NCT00765843|20821856|P2|Overall Study|did not return to receive intervention|1
6023637|NCT00765843|20821857|P1|Overall Study|did not return to receive intervention|0
6023638|NCT00765843|20821855|P3|Overall Study|Lost to Follow-up|2
6023639|NCT00765843|20821856|P2|Overall Study|Lost to Follow-up|3
6023640|NCT00765843|20821857|P1|Overall Study|Lost to Follow-up|1
6023641|NCT00765817|20821867|P2|Overall Study|Subject decision|11
6023642|NCT00765817|20821868|P1|Overall Study|Subject decision|7
6023643|NCT00765817|20821867|P2|Overall Study|Protocol Violation|1
6023644|NCT00765817|20821868|P1|Overall Study|Protocol Violation|1
6023645|NCT00765817|20821867|P2|Overall Study|Physician Decision|1
6023646|NCT00765817|20821868|P1|Overall Study|Physician Decision|2
6023647|NCT00765817|20821867|P2|Overall Study|Lost to Follow-up|3
6023648|NCT00765817|20821868|P1|Overall Study|Lost to Follow-up|1
6023649|NCT00765817|20821867|P2|Overall Study|Loss of glucose control|2
6023650|NCT00765817|20821868|P1|Overall Study|Loss of glucose control|0
6023651|NCT00765817|20821867|P2|Overall Study|Entry criteria not met|2
6023652|NCT00765817|20821868|P1|Overall Study|Entry criteria not met|2
6023653|NCT00765817|20821867|P2|Overall Study|Death|1
6023654|NCT00765817|20821868|P1|Overall Study|Death|0
6023655|NCT00765817|20821867|P2|Overall Study|Adverse Event|1
6023656|NCT00765817|20821868|P1|Overall Study|Adverse Event|13
6023657|NCT00765726|20821916|P1|Overall Study|Discontinuation of study by sponsor|8
6023658|NCT00765726|20821916|P1|Overall Study|Withdrawal by Subject|1
6023659|NCT00765674|20821924|P4|Overall Study|Randomized in Error - No Study Drug|1
6023660|NCT00765674|20821925|P3|Overall Study|Randomized in Error - No Study Drug|0
6023661|NCT00765674|20821926|P2|Overall Study|Randomized in Error - No Study Drug|1
6023662|NCT00765674|20821927|P1|Overall Study|Randomized in Error - No Study Drug|0
6023663|NCT00765674|20821924|P4|Overall Study|Lost to Follow-up|1
6023664|NCT00765674|20821925|P3|Overall Study|Lost to Follow-up|2
6023665|NCT00765674|20821926|P2|Overall Study|Lost to Follow-up|6
6023666|NCT00765674|20821927|P1|Overall Study|Lost to Follow-up|4
6023667|NCT00765674|20821924|P4|Overall Study|Withdrawal by Subject|8
6023668|NCT00765674|20821925|P3|Overall Study|Withdrawal by Subject|3
6023669|NCT00765674|20821926|P2|Overall Study|Withdrawal by Subject|7
6023670|NCT00765674|20821927|P1|Overall Study|Withdrawal by Subject|5
6023671|NCT00765674|20821924|P4|Overall Study|Protocol Violation|0
6023672|NCT00765674|20821925|P3|Overall Study|Protocol Violation|1
6023673|NCT00765674|20821926|P2|Overall Study|Protocol Violation|0
6023674|NCT00765674|20821927|P1|Overall Study|Protocol Violation|2
6023675|NCT00765674|20821924|P4|Overall Study|Lack of Efficacy|2
6023676|NCT00765674|20821925|P3|Overall Study|Lack of Efficacy|1
6023677|NCT00765674|20821926|P2|Overall Study|Lack of Efficacy|3
6023678|NCT00765674|20821927|P1|Overall Study|Lack of Efficacy|2
6023679|NCT00765674|20821924|P4|Overall Study|Abnormal Test Procedure Result(s)|2
6023680|NCT00765674|20821925|P3|Overall Study|Abnormal Test Procedure Result(s)|1
6023681|NCT00765674|20821926|P2|Overall Study|Abnormal Test Procedure Result(s)|3
6023682|NCT00765674|20821927|P1|Overall Study|Abnormal Test Procedure Result(s)|1
6023683|NCT00765674|20821924|P4|Overall Study|Abnormal Laboratory Value(s)|0
6023684|NCT00765674|20821925|P3|Overall Study|Abnormal Laboratory Value(s)|1
6023685|NCT00765674|20821926|P2|Overall Study|Abnormal Laboratory Value(s)|0
6023686|NCT00765674|20821927|P1|Overall Study|Abnormal Laboratory Value(s)|0
6023687|NCT00765674|20821924|P4|Overall Study|Adverse Event|11
6023688|NCT00765674|20821925|P3|Overall Study|Adverse Event|8
6023689|NCT00765674|20821926|P2|Overall Study|Adverse Event|2
6023690|NCT00765674|20821927|P1|Overall Study|Adverse Event|7
6023691|NCT00765388|20821994|P2|Period 1|Hip operation|1
6023692|NCT00765388|20821995|P1|Period 1|Hip operation|0
6023693|NCT00765388|20821994|P2|Period 1|Herpes Zoster|1
6023694|NCT00765388|20821995|P1|Period 1|Herpes Zoster|0
6023695|NCT00765388|20821994|P2|Period 1|Lost to Follow-up|1
6023696|NCT00765388|20821995|P1|Period 1|Lost to Follow-up|0
6023697|NCT00765388|20821994|P2|Period 1|Lack of Efficacy|2
6023698|NCT00765388|20821995|P1|Period 1|Lack of Efficacy|1
6023699|NCT00765362|20822029|P1|Overall Study|Lost to Follow-up|95
6023700|NCT00765362|20822029|P1|Overall Study|Withdrawal by Subject|13
6023701|NCT00765362|20822029|P1|Overall Study|Protocol Violation|18
6023702|NCT00765362|20822029|P1|Overall Study|Adverse Event|2
6023703|NCT00765362|20822029|P1|Overall Study|Death|9
6023704|NCT00765336|20822037|P2|Overall Study|Adverse Event|1
6023705|NCT00765336|20822038|P1|Overall Study|Adverse Event|2
6023706|NCT00765336|20822037|P2|Overall Study|Lost to Follow-up|9
6023707|NCT00765336|20822038|P1|Overall Study|Lost to Follow-up|7
6023708|NCT00765336|20822037|P2|Overall Study|Withdrawal by Subject|4
6023709|NCT00765336|20822038|P1|Overall Study|Withdrawal by Subject|6
6023710|NCT00765336|20822037|P2|Overall Study|Protocol Violation|2
6023711|NCT00765336|20822038|P1|Overall Study|Protocol Violation|4
6023712|NCT00765245|20822046|P2|Overall Study|Death|0
6023713|NCT00765245|20822047|P1|Overall Study|Death|1
6023714|NCT00765245|20822046|P2|Overall Study|Physician Decision|0
6023715|NCT00765245|20822047|P1|Overall Study|Physician Decision|1
6023716|NCT00765245|20822046|P2|Overall Study|Adverse Event|0
6023717|NCT00765245|20822047|P1|Overall Study|Adverse Event|5
6023718|NCT00765245|20822046|P2|Overall Study|Withdrawal by Subject|0
6023719|NCT00765245|20822047|P1|Overall Study|Withdrawal by Subject|3
6023720|NCT00765245|20822046|P2|Overall Study|disease progression|2
6023721|NCT00765245|20822047|P1|Overall Study|disease progression|3
6023722|NCT00765102|20822093|P1|Overall Study|Protocol Violation|1
6023723|NCT00765102|20822093|P1|Overall Study|Withdrawal by Subject|2
6023724|NCT00765102|20822093|P1|Overall Study|Physician Decision|4
6023725|NCT00765102|20822093|P1|Overall Study|Adverse Event|6
6023726|NCT00765102|20822093|P1|Overall Study|Progressive disease|18
6023727|NCT00765076|20822118|P3|Overall Study|Withdrawal by Subject|1
6023728|NCT00765076|20822119|P2|Overall Study|Withdrawal by Subject|0
6023729|NCT00765076|20822120|P1|Overall Study|Withdrawal by Subject|0
6023730|NCT00765076|20822118|P3|Overall Study|Adverse Event|0
6023731|NCT00765076|20822119|P2|Overall Study|Adverse Event|0
6023732|NCT00765076|20822120|P1|Overall Study|Adverse Event|1
6023733|NCT00765063|20822173|P1|Overall Study|Adverse Event|4
6023734|NCT00765063|20822173|P1|Overall Study|Protocol Violation|6
6023735|NCT00765063|20822173|P1|Overall Study|Other|16
6023736|NCT00765063|20822173|P1|Overall Study|Withdrawal by Subject|1
6023737|NCT00765063|20822173|P1|Overall Study|Lack of Efficacy|5
6023738|NCT00765037|20822189|P1|Overall Study|Adverse Event|1
6023739|NCT00765037|20822189|P1|Overall Study|Lost to Follow-up|5
6023740|NCT00764946|20822196|P3|Overall Study|Never Treated|1
6023741|NCT00764946|20822197|P2|Overall Study|Never Treated|1
6023742|NCT00764946|20822198|P1|Overall Study|Never Treated|1
6023743|NCT00764946|20822196|P3|Overall Study|Withdrawal by Subject|2
6023744|NCT00764946|20822197|P2|Overall Study|Withdrawal by Subject|6
6023745|NCT00764946|20822198|P1|Overall Study|Withdrawal by Subject|3
6023746|NCT00764946|20822196|P3|Overall Study|Adverse Event|1
6023747|NCT00764946|20822197|P2|Overall Study|Adverse Event|2
6023748|NCT00764946|20822198|P1|Overall Study|Adverse Event|3
6023749|NCT00764946|20822196|P3|Overall Study|Physician Decision|0
6023750|NCT00764946|20822197|P2|Overall Study|Physician Decision|4
6023751|NCT00764946|20822198|P1|Overall Study|Physician Decision|2
6023752|NCT00764946|20822196|P3|Overall Study|Lost to Follow-up|0
6023753|NCT00764946|20822197|P2|Overall Study|Lost to Follow-up|4
6023754|NCT00764946|20822198|P1|Overall Study|Lost to Follow-up|3
6023755|NCT00764946|20822196|P3|Overall Study|Lack of Efficacy|0
6023756|NCT00764946|20822197|P2|Overall Study|Lack of Efficacy|0
6023757|NCT00764946|20822198|P1|Overall Study|Lack of Efficacy|1
6023758|NCT00764881|20822226|P2|Overall Study|no treatment or no observation|2
6023759|NCT00764881|20822227|P1|Overall Study|no treatment or no observation|2
6023760|NCT00764881|20822226|P2|Overall Study|Possibly noncompliant (study drug)|2
6023761|NCT00764881|20822227|P1|Overall Study|Possibly noncompliant (study drug)|0
6023762|NCT00764881|20822226|P2|Overall Study|Carcinoma detected|0
6023763|NCT00764881|20822227|P1|Overall Study|Carcinoma detected|1
6023764|NCT00764881|20822226|P2|Overall Study|Wished to become pregnant|0
6023765|NCT00764881|20822227|P1|Overall Study|Wished to become pregnant|1
6023766|NCT00764881|20822226|P2|Overall Study|Accidentally discontinued study drug|0
6023767|NCT00764881|20822227|P1|Overall Study|Accidentally discontinued study drug|1
6023768|NCT00764881|20822226|P2|Overall Study|Noncompliant|0
6023769|NCT00764881|20822227|P1|Overall Study|Noncompliant|1
6023770|NCT00764881|20822226|P2|Overall Study|Lost to Follow-up|0
6023771|NCT00764881|20822227|P1|Overall Study|Lost to Follow-up|2
6023772|NCT00764881|20822226|P2|Overall Study|Protocol Violation|2
6023773|NCT00764881|20822227|P1|Overall Study|Protocol Violation|2
6023774|NCT00764881|20822226|P2|Overall Study|Withdrawal by Subject|3
6023775|NCT00764881|20822227|P1|Overall Study|Withdrawal by Subject|1
6023776|NCT00764881|20822226|P2|Overall Study|Adverse Event|1
6023777|NCT00764881|20822227|P1|Overall Study|Adverse Event|5
6023778|NCT00764868|20822451|P1|Overall Study|Sponsor requested withdrawal|1
6023779|NCT00764868|20822451|P1|Overall Study|Positive drug screen|2
6023780|NCT00764868|20822451|P1|Overall Study|Met an exclusion criteria|1
6023781|NCT00764868|20822451|P1|Overall Study|Subject sent to boarding school|1
6023782|NCT00764868|20822451|P1|Overall Study|Misuse and compliance of study drug|1
6023783|NCT00764868|20822451|P1|Overall Study|Out of town|1
6023784|NCT00764868|20822451|P1|Overall Study|Prohibited medication|1
6023785|NCT00764868|20822451|P1|Overall Study|Pregnancy|3
6023786|NCT00764868|20822451|P1|Overall Study|Subject moved|7
6023787|NCT00764868|20822451|P1|Overall Study|Lack of Efficacy|5
6023788|NCT00764868|20822451|P1|Overall Study|Lost to Follow-up|25
6023789|NCT00764868|20822451|P1|Overall Study|Non-compliance|16
6023790|NCT00764868|20822451|P1|Overall Study|Withdrawal by Subject|31
6023791|NCT00764868|20822451|P1|Overall Study|Adverse Event|18
6023792|NCT00764790|20822460|P3|Overall Study|Lost to Follow-up|23
6023793|NCT00764790|20822461|P2|Overall Study|Lost to Follow-up|29
6023794|NCT00764790|20822462|P1|Overall Study|Lost to Follow-up|28
6023795|NCT00764790|20822460|P3|Overall Study|Withdrawal by Subject|6
6023796|NCT00764790|20822461|P2|Overall Study|Withdrawal by Subject|12
6023797|NCT00764790|20822462|P1|Overall Study|Withdrawal by Subject|10
6023798|NCT00764790|20822460|P3|Overall Study|Protocol Violation|1
6023799|NCT00764790|20822461|P2|Overall Study|Protocol Violation|0
6023800|NCT00764790|20822462|P1|Overall Study|Protocol Violation|0
6023801|NCT00764751|20822496|P2|Overall Study|Psoriasis flare up on the scalp|0
6023802|NCT00764751|20822497|P1|Overall Study|Psoriasis flare up on the scalp|1
6023803|NCT00764751|20822496|P2|Overall Study|Adverse Event|1
6023804|NCT00764751|20822497|P1|Overall Study|Adverse Event|1
6023805|NCT00764699|20822560|P1|Overall Study|PI left and study terminated|3
6023806|NCT00764673|20822564|P1|Overall Study|Revision of Device|2
6023807|NCT00764673|20822564|P1|Overall Study|Withdrawal by Subject|6
6023808|NCT00764673|20822564|P1|Overall Study|Lost to Follow-up|3
6023809|NCT00764673|20822564|P1|Overall Study|Death|1
6023810|NCT00764660|20822574|P2|Overall Study|Did Not Meet Protocol Eligibility|0
6023811|NCT00764660|20822575|P1|Overall Study|Did Not Meet Protocol Eligibility|1
6023812|NCT00764660|20822574|P2|Overall Study|Noncompliance With Protocol|1
6023813|NCT00764660|20822575|P1|Overall Study|Noncompliance With Protocol|5
6023814|NCT00764660|20822574|P2|Overall Study|Withdrawal by Subject|3
6023815|NCT00764660|20822575|P1|Overall Study|Withdrawal by Subject|7
6023816|NCT00764660|20822574|P2|Overall Study|Lost to Follow-up|4
6023817|NCT00764660|20822575|P1|Overall Study|Lost to Follow-up|3
6023818|NCT00764660|20822574|P2|Overall Study|Adverse Event|3
6023819|NCT00764660|20822575|P1|Overall Study|Adverse Event|6
6023820|NCT00764517|20822609|P2|Overall Study|Physician Decision|0
6023821|NCT00764517|20822610|P1|Overall Study|Physician Decision|3
6023822|NCT00764517|20822609|P2|Overall Study|Death|11
6023823|NCT00764517|20822610|P1|Overall Study|Death|3
6023824|NCT00764517|20822609|P2|Overall Study|Adverse Event|3
6023825|NCT00764517|20822610|P1|Overall Study|Adverse Event|9
6023826|NCT00764504|20822631|P3|Overall Study|Lost to Follow-up|72
6023827|NCT00764504|20822632|P2|Overall Study|Lost to Follow-up|34
6023828|NCT00764504|20822633|P1|Overall Study|Lost to Follow-up|40
6023829|NCT00764504|20822631|P3|Overall Study|Withdrawal by Subject|4
6023830|NCT00764504|20822632|P2|Overall Study|Withdrawal by Subject|7
6023831|NCT00764504|20822633|P1|Overall Study|Withdrawal by Subject|1
6023832|NCT00764504|20822631|P3|Overall Study|Physician Decision|0
6023833|NCT00764504|20822632|P2|Overall Study|Physician Decision|0
6023834|NCT00764504|20822633|P1|Overall Study|Physician Decision|1
6023835|NCT00764504|20822631|P3|Overall Study|Revision of Device|14
6023836|NCT00764504|20822632|P2|Overall Study|Revision of Device|23
6023837|NCT00764504|20822633|P1|Overall Study|Revision of Device|12
6023838|NCT00764504|20822631|P3|Overall Study|Death|13
6023839|NCT00764504|20822632|P2|Overall Study|Death|6
6023840|NCT00764504|20822633|P1|Overall Study|Death|12
6023841|NCT00764478|20822662|P3|Overall Study|Protocol Violation|1
6023842|NCT00764478|20822663|P2|Overall Study|Protocol Violation|1
6023843|NCT00764478|20822664|P1|Overall Study|Protocol Violation|0
6023844|NCT00764478|20822662|P3|Overall Study|Lost to Follow-up|5
6023845|NCT00764478|20822663|P2|Overall Study|Lost to Follow-up|8
6023846|NCT00764478|20822664|P1|Overall Study|Lost to Follow-up|7
6023847|NCT00764478|20822662|P3|Overall Study|Withdrawal by Subject|1
6023848|NCT00764478|20822663|P2|Overall Study|Withdrawal by Subject|12
6023849|NCT00764478|20822664|P1|Overall Study|Withdrawal by Subject|7
6023850|NCT00764478|20822662|P3|Overall Study|Adverse Event|1
6023851|NCT00764478|20822663|P2|Overall Study|Adverse Event|1
6023852|NCT00764478|20822664|P1|Overall Study|Adverse Event|1
6023853|NCT00764465|20822744|P6|Overall Study|Withdrawal by Subject|0
6023854|NCT00764465|20822745|P5|Overall Study|Withdrawal by Subject|0
6023855|NCT00764465|20822746|P4|Overall Study|Withdrawal by Subject|0
6023856|NCT00764465|20822747|P3|Overall Study|Withdrawal by Subject|1
6023857|NCT00764465|20822748|P2|Overall Study|Withdrawal by Subject|1
6023858|NCT00764465|20822749|P1|Overall Study|Withdrawal by Subject|0
6023859|NCT00764465|20822744|P6|Overall Study|Adverse Event|1
6023860|NCT00764465|20822745|P5|Overall Study|Adverse Event|1
6023861|NCT00764465|20822746|P4|Overall Study|Adverse Event|1
6023862|NCT00764465|20822747|P3|Overall Study|Adverse Event|0
6023863|NCT00764465|20822748|P2|Overall Study|Adverse Event|0
6023864|NCT00764465|20822749|P1|Overall Study|Adverse Event|2
6023865|NCT00764361|20822777|P2|Overall Study|Adverse Event|1
6023866|NCT00764361|20822778|P1|Overall Study|Adverse Event|0
6023867|NCT00764361|20822777|P2|Overall Study|Withdrawal by Subject|3
6023868|NCT00764361|20822778|P1|Overall Study|Withdrawal by Subject|2
6023869|NCT00764322|20822786|P1|Overall Study|No CYP2D6 genotyping|9
6023870|NCT00764322|20822786|P1|Overall Study|Withdrawal by Subject|11
6023871|NCT00763971|20822813|P3|Overall Study|Participation in 489-326 required|0
6023872|NCT00763971|20822814|P2|Overall Study|Participation in 489-326 required|0
6023873|NCT00763971|20822815|P1|Overall Study|Participation in 489-326 required|1
6023874|NCT00763971|20822813|P3|Overall Study|Performed final visit on phone|0
6023875|NCT00763971|20822814|P2|Overall Study|Performed final visit on phone|1
6023876|NCT00763971|20822815|P1|Overall Study|Performed final visit on phone|0
6023877|NCT00763971|20822813|P3|Overall Study|Lack of availability|0
6023878|NCT00763971|20822814|P2|Overall Study|Lack of availability|1
6023879|NCT00763971|20822815|P1|Overall Study|Lack of availability|0
6023880|NCT00763971|20822813|P3|Overall Study|Subject wanted dose reduction|0
6023881|NCT00763971|20822814|P2|Overall Study|Subject wanted dose reduction|1
6023882|NCT00763971|20822815|P1|Overall Study|Subject wanted dose reduction|0
6023883|NCT00763971|20822813|P3|Overall Study|Moved to another country|0
6023884|NCT00763971|20822814|P2|Overall Study|Moved to another country|1
6023885|NCT00763971|20822815|P1|Overall Study|Moved to another country|0
6023886|NCT00763971|20822813|P3|Overall Study|Medical monitor decision|1
6023887|NCT00763971|20822814|P2|Overall Study|Medical monitor decision|0
6023888|NCT00763971|20822815|P1|Overall Study|Medical monitor decision|0
6023889|NCT00763971|20822813|P3|Overall Study|Randomization error|1
6023890|NCT00763971|20822814|P2|Overall Study|Randomization error|0
6023891|NCT00763971|20822815|P1|Overall Study|Randomization error|0
6023892|NCT00763971|20822813|P3|Overall Study|Due to holiday season|1
6023893|NCT00763971|20822814|P2|Overall Study|Due to holiday season|0
6023894|NCT00763971|20822815|P1|Overall Study|Due to holiday season|2
6023895|NCT00763971|20822813|P3|Overall Study|Sponsor decision|0
6023896|NCT00763971|20822814|P2|Overall Study|Sponsor decision|0
6023897|NCT00763971|20822815|P1|Overall Study|Sponsor decision|1
6023898|NCT00763971|20822813|P3|Overall Study|Exclusion criteria met|0
6023899|NCT00763971|20822814|P2|Overall Study|Exclusion criteria met|0
6023900|NCT00763971|20822815|P1|Overall Study|Exclusion criteria met|1
6023901|NCT00763971|20822813|P3|Overall Study|Personal reason|0
6023902|NCT00763971|20822814|P2|Overall Study|Personal reason|0
6023903|NCT00763971|20822815|P1|Overall Study|Personal reason|3
6023904|NCT00763971|20822813|P3|Overall Study|Unable to swallow capsule|1
6023905|NCT00763971|20822814|P2|Overall Study|Unable to swallow capsule|1
6023906|NCT00763971|20822815|P1|Overall Study|Unable to swallow capsule|2
6023907|NCT00763971|20822813|P3|Overall Study|Lack of Efficacy|54
6023908|NCT00763971|20822814|P2|Overall Study|Lack of Efficacy|22
6023909|NCT00763971|20822815|P1|Overall Study|Lack of Efficacy|11
6023910|NCT00763971|20822813|P3|Overall Study|Lost to Follow-up|0
6023911|NCT00763971|20822814|P2|Overall Study|Lost to Follow-up|1
6023912|NCT00763971|20822815|P1|Overall Study|Lost to Follow-up|0
6023913|NCT00763971|20822813|P3|Overall Study|Withdrawal by Subject|5
6023914|NCT00763971|20822814|P2|Overall Study|Withdrawal by Subject|5
6023915|NCT00763971|20822815|P1|Overall Study|Withdrawal by Subject|4
6023916|NCT00763971|20822813|P3|Overall Study|Protocol Violation|2
6023917|NCT00763971|20822814|P2|Overall Study|Protocol Violation|3
6023918|NCT00763971|20822815|P1|Overall Study|Protocol Violation|3
6023919|NCT00763971|20822813|P3|Overall Study|Adverse Event|4
6023920|NCT00763971|20822814|P2|Overall Study|Adverse Event|2
6023921|NCT00763971|20822815|P1|Overall Study|Adverse Event|5
6023922|NCT00763958|20822846|P2|Overall Study|Believed they were receiving placebo|5
6023923|NCT00763958|20822847|P1|Overall Study|Believed they were receiving placebo|0
6023924|NCT00763958|20822846|P2|Overall Study|Lost to Follow-up|2
6023925|NCT00763958|20822847|P1|Overall Study|Lost to Follow-up|10
6023926|NCT00763958|20822846|P2|Overall Study|did not meet final criteria|4
6023927|NCT00763958|20822847|P1|Overall Study|did not meet final criteria|4
6023928|NCT00763815|20822982|P2|Overall Study|Sponsor's Decision|1
6023929|NCT00763815|20822983|P1|Overall Study|Sponsor's Decision|0
6023930|NCT00763815|20822982|P2|Overall Study|Protocol Violation|5
6023931|NCT00763815|20822983|P1|Overall Study|Protocol Violation|2
6023932|NCT00763815|20822982|P2|Overall Study|Withdrawal by Subject|12
6023933|NCT00763815|20822983|P1|Overall Study|Withdrawal by Subject|7
6023934|NCT00763815|20822982|P2|Overall Study|Physician Decision|0
6023935|NCT00763815|20822983|P1|Overall Study|Physician Decision|1
6023936|NCT00763815|20822982|P2|Overall Study|Familial and Personal Reasons|16
6023937|NCT00763815|20822983|P1|Overall Study|Familial and Personal Reasons|9
6023938|NCT00763815|20822982|P2|Overall Study|Early Termination|0
6023939|NCT00763815|20822983|P1|Overall Study|Early Termination|1
6023940|NCT00763815|20822982|P2|Overall Study|Lost to Follow-up|4
6023941|NCT00763815|20822983|P1|Overall Study|Lost to Follow-up|2
6023942|NCT00763815|20822982|P2|Overall Study|Poor Compliance to Protocol|6
6023943|NCT00763815|20822983|P1|Overall Study|Poor Compliance to Protocol|6
6023944|NCT00763815|20822982|P2|Overall Study|Lack of Efficacy|11
6023945|NCT00763815|20822983|P1|Overall Study|Lack of Efficacy|10
6023946|NCT00763815|20822982|P2|Overall Study|Adverse Event|29
6023947|NCT00763815|20822983|P1|Overall Study|Adverse Event|14
6023948|NCT00763698|20823011|P1|Overall Study|Withdrawal by Subject|1
6023949|NCT00763698|20823011|P1|Overall Study|Death|4
6023950|NCT00763698|20823011|P1|Overall Study|Unsuccessful Implant|5
6023951|NCT00763451|20823028|P4|Overall Study|Study Site Reason|1
6023952|NCT00763451|20823029|P3|Overall Study|Study Site Reason|1
6023953|NCT00763451|20823030|P2|Overall Study|Study Site Reason|1
6023954|NCT00763451|20823031|P1|Overall Study|Study Site Reason|0
6023955|NCT00763451|20823028|P4|Overall Study|Randomized but not Treated|0
6023956|NCT00763451|20823029|P3|Overall Study|Randomized but not Treated|0
6023957|NCT00763451|20823030|P2|Overall Study|Randomized but not Treated|1
6023958|NCT00763451|20823031|P1|Overall Study|Randomized but not Treated|1
6023959|NCT00763451|20823028|P4|Overall Study|Familial and Personal Reasons|4
6023960|NCT00763451|20823029|P3|Overall Study|Familial and Personal Reasons|5
6023961|NCT00763451|20823030|P2|Overall Study|Familial and Personal Reasons|3
6023962|NCT00763451|20823031|P1|Overall Study|Familial and Personal Reasons|5
6023963|NCT00763451|20823028|P4|Overall Study|Poor Compliance to Protocol|2
6023964|NCT00763451|20823029|P3|Overall Study|Poor Compliance to Protocol|2
6023965|NCT00763451|20823030|P2|Overall Study|Poor Compliance to Protocol|1
6023966|NCT00763451|20823031|P1|Overall Study|Poor Compliance to Protocol|1
6023967|NCT00763451|20823028|P4|Overall Study|Protocol Violation|0
6023968|NCT00763451|20823029|P3|Overall Study|Protocol Violation|1
6023969|NCT00763451|20823030|P2|Overall Study|Protocol Violation|0
6023970|NCT00763451|20823031|P1|Overall Study|Protocol Violation|0
6023971|NCT00763451|20823028|P4|Overall Study|Withdrawal by Subject|7
6023972|NCT00763451|20823029|P3|Overall Study|Withdrawal by Subject|9
6023973|NCT00763451|20823030|P2|Overall Study|Withdrawal by Subject|6
6023974|NCT00763451|20823031|P1|Overall Study|Withdrawal by Subject|1
6023975|NCT00763451|20823028|P4|Overall Study|Lack of Efficacy|2
6023976|NCT00763451|20823029|P3|Overall Study|Lack of Efficacy|3
6023977|NCT00763451|20823030|P2|Overall Study|Lack of Efficacy|4
6023978|NCT00763451|20823031|P1|Overall Study|Lack of Efficacy|1
6023979|NCT00763451|20823028|P4|Overall Study|Adverse Event|14
6023980|NCT00763451|20823029|P3|Overall Study|Adverse Event|19
6023981|NCT00763451|20823030|P2|Overall Study|Adverse Event|6
6023982|NCT00763451|20823031|P1|Overall Study|Adverse Event|4
6023983|NCT00763386|20823090|P2|Overall Study|Study Prosthesis Removed|0
6023984|NCT00763386|20823091|P1|Overall Study|Study Prosthesis Removed|1
6023985|NCT00763386|20823090|P2|Overall Study|CRF missing|1
6023986|NCT00763386|20823091|P1|Overall Study|CRF missing|0
6023987|NCT00763386|20823090|P2|Overall Study|Withdrawal by Subject|1
6023988|NCT00763386|20823091|P1|Overall Study|Withdrawal by Subject|0
6023989|NCT00763386|20823090|P2|Overall Study|Lost to Follow-up|3
6023990|NCT00763386|20823091|P1|Overall Study|Lost to Follow-up|3
6023991|NCT00763386|20823090|P2|Overall Study|Death|2
6023992|NCT00763386|20823091|P1|Overall Study|Death|1
6023993|NCT00763386|20823090|P2|Overall Study|Adverse Event|33
6023994|NCT00763386|20823091|P1|Overall Study|Adverse Event|43
6023995|NCT00763321|20823124|P3|Double-blind Period|Other|3
6023996|NCT00763321|20823125|P2|Double-blind Period|Other|2
6023997|NCT00763321|20823126|P1|Double-blind Period|Other|0
6023998|NCT00763321|20823124|P3|Double-blind Period|Withdrawal by Subject|3
6023999|NCT00763321|20823125|P2|Double-blind Period|Withdrawal by Subject|2
6024000|NCT00763321|20823126|P1|Double-blind Period|Withdrawal by Subject|0
6024001|NCT00763321|20823124|P3|Double-blind Period|Lost to Follow-up|2
6024002|NCT00763321|20823125|P2|Double-blind Period|Lost to Follow-up|4
6024003|NCT00763321|20823126|P1|Double-blind Period|Lost to Follow-up|0
6024004|NCT00763321|20823124|P3|Double-blind Period|Adverse Event|4
6024005|NCT00763321|20823125|P2|Double-blind Period|Adverse Event|4
6024006|NCT00763321|20823126|P1|Double-blind Period|Adverse Event|0
6024007|NCT00763321|20823124|P3|Double-blind Period|Lack of Efficacy|17
6024008|NCT00763321|20823125|P2|Double-blind Period|Lack of Efficacy|9
6024009|NCT00763321|20823126|P1|Double-blind Period|Lack of Efficacy|0
6024010|NCT00763321|20823124|P3|Open-label Period|Other|0
6024011|NCT00763321|20823125|P2|Open-label Period|Other|0
6024012|NCT00763321|20823126|P1|Open-label Period|Other|4
6024013|NCT00763321|20823124|P3|Open-label Period|Lack of Efficacy|0
6024014|NCT00763321|20823125|P2|Open-label Period|Lack of Efficacy|0
6024015|NCT00763321|20823126|P1|Open-label Period|Lack of Efficacy|2
6024016|NCT00763321|20823124|P3|Open-label Period|Did not meet DB randomization criteria|0
6024017|NCT00763321|20823125|P2|Open-label Period|Did not meet DB randomization criteria|0
6024018|NCT00763321|20823126|P1|Open-label Period|Did not meet DB randomization criteria|5
6024019|NCT00763321|20823124|P3|Open-label Period|Subject noncompliant|0
6024020|NCT00763321|20823125|P2|Open-label Period|Subject noncompliant|0
6024021|NCT00763321|20823126|P1|Open-label Period|Subject noncompliant|7
6024022|NCT00763321|20823124|P3|Open-label Period|Withdrawal by Subject|0
6024023|NCT00763321|20823125|P2|Open-label Period|Withdrawal by Subject|0
6024024|NCT00763321|20823126|P1|Open-label Period|Withdrawal by Subject|7
6024025|NCT00763321|20823124|P3|Open-label Period|Lost to Follow-up|0
6024026|NCT00763321|20823125|P2|Open-label Period|Lost to Follow-up|0
6024027|NCT00763321|20823126|P1|Open-label Period|Lost to Follow-up|14
6024028|NCT00763321|20823124|P3|Open-label Period|Adverse Event|0
6024029|NCT00763321|20823125|P2|Open-label Period|Adverse Event|0
6024030|NCT00763321|20823126|P1|Open-label Period|Adverse Event|24
6024031|NCT00763282|20823137|P2|Overall Study|Lost to Follow-up|26
6024032|NCT00763282|20823138|P1|Overall Study|Lost to Follow-up|22
6024033|NCT00763282|20823137|P2|Overall Study|Death|3
6024034|NCT00763282|20823138|P1|Overall Study|Death|4
6024035|NCT00763282|20823137|P2|Overall Study|Withdrawal by Subject|5
6024036|NCT00763282|20823138|P1|Overall Study|Withdrawal by Subject|6
6024037|NCT00763269|20823154|P2|Overall Study|Lost to Follow-up|13
6024038|NCT00763269|20823155|P1|Overall Study|Lost to Follow-up|12
6024039|NCT00763256|20823169|P2|Overall Study|Didn't return for appointments|10
6024040|NCT00763256|20823170|P1|Overall Study|Didn't return for appointments|7
6024041|NCT00763139|20823206|P2|Overall Study|med change not allowed by protocol|0
6024042|NCT00763139|20823207|P1|Overall Study|med change not allowed by protocol|1
6024043|NCT00763139|20823206|P2|Overall Study|Withdrawal by Subject|1
6024044|NCT00763139|20823207|P1|Overall Study|Withdrawal by Subject|0
6024045|NCT00763139|20823206|P2|Overall Study|Adverse Event|2
6024046|NCT00763139|20823207|P1|Overall Study|Adverse Event|4
6024047|NCT00763035|20823269|P2|Second Intervention|Physician Decision|0
6024048|NCT00763035|20823270|P1|Second Intervention|Physician Decision|2
6024049|NCT00763035|20823269|P2|Second Intervention|Adverse Event|0
6024050|NCT00763035|20823270|P1|Second Intervention|Adverse Event|1
6024051|NCT00763035|20823269|P2|First Intervention|Adverse Event|1
6024052|NCT00763035|20823270|P1|First Intervention|Adverse Event|0
6024053|NCT00763035|20823269|P2|First Intervention|Did not meeting inclusion/exclusion|0
6024054|NCT00763035|20823270|P1|First Intervention|Did not meeting inclusion/exclusion|1
6024055|NCT00763009|20823288|P1|Overall Study|Coronary Anatomy unsuitable|1
6024056|NCT00762996|20823293|P4|Period One|Withdrawal by Subject|0
6024057|NCT00762996|20823294|P3|Period One|Withdrawal by Subject|1
6024058|NCT00762996|20823295|P2|Period One|Withdrawal by Subject|0
6024059|NCT00762996|20823296|P1|Period One|Withdrawal by Subject|0
6024060|NCT00762996|20823293|P4|Period One|Adverse Event|0
6024061|NCT00762996|20823294|P3|Period One|Adverse Event|1
6024062|NCT00762996|20823295|P2|Period One|Adverse Event|0
6024063|NCT00762996|20823296|P1|Period One|Adverse Event|0
6024064|NCT00762996|20823293|P4|Period One|ineligible|1
6024065|NCT00762996|20823294|P3|Period One|ineligible|1
6024066|NCT00762996|20823295|P2|Period One|ineligible|0
6024067|NCT00762996|20823296|P1|Period One|ineligible|0
6024068|NCT00762996|20823293|P4|Period One|Protocol Violation|0
6024069|NCT00762996|20823294|P3|Period One|Protocol Violation|1
6024070|NCT00762996|20823295|P2|Period One|Protocol Violation|0
6024071|NCT00762996|20823296|P1|Period One|Protocol Violation|0
6024072|NCT00762970|20823309|P3|Overall Study|Difficulty of handling lens|0
6024073|NCT00762970|20823310|P2|Overall Study|Difficulty of handling lens|2
6024074|NCT00762970|20823311|P1|Overall Study|Difficulty of handling lens|1
6024075|NCT00762970|20823309|P3|Overall Study|Lost to Follow-up|0
6024076|NCT00762970|20823310|P2|Overall Study|Lost to Follow-up|2
6024077|NCT00762970|20823311|P1|Overall Study|Lost to Follow-up|1
6024078|NCT00762970|20823309|P3|Overall Study|Protocol Violation|1
6024079|NCT00762970|20823310|P2|Overall Study|Protocol Violation|1
6024080|NCT00762970|20823311|P1|Overall Study|Protocol Violation|3
6024081|NCT00762970|20823309|P3|Overall Study|Withdrawal by Subject|0
6024082|NCT00762970|20823310|P2|Overall Study|Withdrawal by Subject|4
6024083|NCT00762970|20823311|P1|Overall Study|Withdrawal by Subject|7
6024084|NCT00762892|20823329|P2|Overall Study|Incarceration|0
6024085|NCT00762892|20823330|P1|Overall Study|Incarceration|1
6024086|NCT00762892|20823329|P2|Overall Study|Pregnancy|0
6024087|NCT00762892|20823330|P1|Overall Study|Pregnancy|1
6024088|NCT00762892|20823329|P2|Overall Study|Death|0
6024089|NCT00762892|20823330|P1|Overall Study|Death|1
6024090|NCT00762892|20823329|P2|Overall Study|Withdrawal by Subject|1
6024091|NCT00762892|20823330|P1|Overall Study|Withdrawal by Subject|0
6024092|NCT00762892|20823329|P2|Overall Study|Lost to Follow-up|5
6024093|NCT00762892|20823330|P1|Overall Study|Lost to Follow-up|2
6024094|NCT00762788|20823359|P6|Overall Study|Lost to Follow-up|21
6024095|NCT00762788|20823360|P5|Overall Study|Lost to Follow-up|13
6024096|NCT00762788|20823361|P4|Overall Study|Lost to Follow-up|26
6024097|NCT00762788|20823362|P3|Overall Study|Lost to Follow-up|21
6024098|NCT00762788|20823363|P2|Overall Study|Lost to Follow-up|37
6024099|NCT00762788|20823364|P1|Overall Study|Lost to Follow-up|26
6024100|NCT00762762|20823386|P2|Overall Study|Did not report for appointments|10
6024101|NCT00762762|20823387|P1|Overall Study|Did not report for appointments|8
6024102|NCT00762723|20823404|P3|Overall Study|Study Terminated slow enrollement|3
6024103|NCT00762723|20823405|P2|Overall Study|Study Terminated slow enrollement|5
6024104|NCT00762723|20823406|P1|Overall Study|Study Terminated slow enrollement|5
6024105|NCT00762606|20823579|P2|Overall Study|Lost to Follow-up|13
6024106|NCT00762606|20823580|P1|Overall Study|Lost to Follow-up|18
6024107|NCT00762502|20823625|P3|Month 3 to Month 6 (Period 2)|Pregnancy|0
6024108|NCT00762502|20823626|P2|Month 3 to Month 6 (Period 2)|Pregnancy|1
6024109|NCT00762502|20823627|P1|Month 3 to Month 6 (Period 2)|Pregnancy|0
6024110|NCT00762502|20823625|P3|Baseline to Month 3 (Period 1)|Lost to Follow-up|13
6024111|NCT00762502|20823626|P2|Baseline to Month 3 (Period 1)|Lost to Follow-up|3
6024112|NCT00762502|20823627|P1|Baseline to Month 3 (Period 1)|Lost to Follow-up|6
6024113|NCT00762502|20823625|P3|Baseline to Month 3 (Period 1)|Adverse Event|6
6024114|NCT00762502|20823626|P2|Baseline to Month 3 (Period 1)|Adverse Event|3
6024115|NCT00762502|20823627|P1|Baseline to Month 3 (Period 1)|Adverse Event|4
6024116|NCT00762476|20823641|P2|Overall Study|Seasonal allergies|0
6024117|NCT00762476|20823642|P1|Overall Study|Seasonal allergies|1
6024118|NCT00762476|20823641|P2|Overall Study|non-compliance with study visits|2
6024119|NCT00762476|20823642|P1|Overall Study|non-compliance with study visits|0
6024120|NCT00762476|20823641|P2|Overall Study|antibiotic use|1
6024121|NCT00762476|20823642|P1|Overall Study|antibiotic use|0
6024122|NCT00762476|20823641|P2|Overall Study|Withdrawal by Subject|12
6024123|NCT00762476|20823642|P1|Overall Study|Withdrawal by Subject|6
6024124|NCT00762476|20823641|P2|Overall Study|Physician Decision|14
6024125|NCT00762476|20823642|P1|Overall Study|Physician Decision|2
6024126|NCT00762476|20823641|P2|Overall Study|Protocol Violation|6
6024127|NCT00762476|20823642|P1|Overall Study|Protocol Violation|5
6024128|NCT00762476|20823641|P2|Overall Study|Lost to Follow-up|0
6024129|NCT00762476|20823642|P1|Overall Study|Lost to Follow-up|2
6024130|NCT00762476|20823641|P2|Overall Study|Adverse Event|1
6024131|NCT00762476|20823642|P1|Overall Study|Adverse Event|7
6024164|NCT00762411|20823763|P2|Safety Follow Up (SFU)-Optional|No safety visit or SFU|54
6024165|NCT00762411|20823764|P1|Safety Follow Up (SFU)-Optional|No safety visit or SFU|48
6024166|NCT00762411|20823763|P2|Safety Follow Up (SFU)-Optional|Caregiver Decision|8
6024167|NCT00762411|20823764|P1|Safety Follow Up (SFU)-Optional|Caregiver Decision|8
6024168|NCT00762411|20823763|P2|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1
6024169|NCT00762411|20823764|P1|Safety Follow Up (SFU)-Optional|Lost to Follow-up|6
6024170|NCT00762411|20823763|P2|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|46
6024171|NCT00762411|20823764|P1|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|21
6024172|NCT00762411|20823763|P2|Safety Follow Up (SFU)-Optional|Adverse Event|1
6024173|NCT00762411|20823764|P1|Safety Follow Up (SFU)-Optional|Adverse Event|0
6024174|NCT00762411|20823763|P2|Safety Follow Up (SFU)-Optional|Death|8
6024175|NCT00762411|20823764|P1|Safety Follow Up (SFU)-Optional|Death|1
6024176|NCT00762411|20823763|P2|Delayed Start|Caregiver Decision|1
6024177|NCT00762411|20823764|P1|Delayed Start|Caregiver Decision|1
6024178|NCT00762411|20823763|P2|Delayed Start|Sponsor Decision|20
6024179|NCT00762411|20823764|P1|Delayed Start|Sponsor Decision|16
6024180|NCT00762411|20823763|P2|Delayed Start|Protocol Violation|1
6024181|NCT00762411|20823764|P1|Delayed Start|Protocol Violation|0
6024182|NCT00762411|20823763|P2|Delayed Start|Adverse Event|4
6024183|NCT00762411|20823764|P1|Delayed Start|Adverse Event|0
6024184|NCT00762411|20823763|P2|Initial Treatment|Entry Criteria Exclusion|1
6024185|NCT00762411|20823764|P1|Initial Treatment|Entry Criteria Exclusion|0
6024186|NCT00762411|20823763|P2|Initial Treatment|Abnormal Lab/ECG Result|4
6024187|NCT00762411|20823764|P1|Initial Treatment|Abnormal Lab/ECG Result|6
6024188|NCT00762411|20823763|P2|Initial Treatment|Caregiver Decision|16
6024189|NCT00762411|20823764|P1|Initial Treatment|Caregiver Decision|21
6024190|NCT00762411|20823763|P2|Initial Treatment|Lost to Follow-up|0
6024191|NCT00762411|20823764|P1|Initial Treatment|Lost to Follow-up|5
6024192|NCT00762411|20823763|P2|Initial Treatment|Sponsor Decision|401
6024193|NCT00762411|20823764|P1|Initial Treatment|Sponsor Decision|293
6024194|NCT00762411|20823763|P2|Initial Treatment|Physician Decision|0
6024195|NCT00762411|20823764|P1|Initial Treatment|Physician Decision|1
6024196|NCT00762411|20823763|P2|Initial Treatment|Withdrawal by Subject|52
6024197|NCT00762411|20823764|P1|Initial Treatment|Withdrawal by Subject|65
6024198|NCT00762411|20823763|P2|Initial Treatment|Protocol Violation|1
6024199|NCT00762411|20823764|P1|Initial Treatment|Protocol Violation|4
6024200|NCT00762411|20823763|P2|Initial Treatment|Adverse Event|40
6024201|NCT00762411|20823764|P1|Initial Treatment|Adverse Event|132
6024202|NCT00762411|20823763|P2|Initial Treatment|Death|6
6024203|NCT00762411|20823764|P1|Initial Treatment|Death|7
6024204|NCT00762385|20823828|P2|Second Intervention|Protocol Violation|3
6024205|NCT00762385|20823829|P1|Second Intervention|Protocol Violation|3
6024206|NCT00762385|20823828|P2|First Intervention|Protocol Violation|1
6024207|NCT00762385|20823829|P1|First Intervention|Protocol Violation|0
6024208|NCT00762385|20823828|P2|First Intervention|Ineligible|0
6024209|NCT00762385|20823829|P1|First Intervention|Ineligible|1
6024210|NCT00762385|20823828|P2|First Intervention|Lost to Follow-up|2
6024211|NCT00762385|20823829|P1|First Intervention|Lost to Follow-up|0
6024212|NCT00762385|20823828|P2|First Intervention|Lens Issue|1
6024213|NCT00762385|20823829|P1|First Intervention|Lens Issue|1
6024214|NCT00762372|20823842|P3|Overall Study|Adverse Event|0
6024215|NCT00762372|20823843|P2|Overall Study|Adverse Event|0
6024216|NCT00762372|20823844|P1|Overall Study|Adverse Event|1
6024217|NCT00762359|20823920|P2|Overall Study|Withdrew consent|0
6024218|NCT00762359|20823921|P1|Overall Study|Withdrew consent|1
6024219|NCT00762359|20823920|P2|Overall Study|Removal|1
6024220|NCT00762359|20823921|P1|Overall Study|Removal|0
6024221|NCT00762359|20823920|P2|Overall Study|Physician Decision|3
6024222|NCT00762359|20823921|P1|Overall Study|Physician Decision|2
6024223|NCT00762359|20823920|P2|Overall Study|Institution closed|3
6024224|NCT00762359|20823921|P1|Overall Study|Institution closed|2
6024225|NCT00762359|20823920|P2|Overall Study|Lack of Efficacy|4
6024226|NCT00762359|20823921|P1|Overall Study|Lack of Efficacy|0
6024227|NCT00762359|20823920|P2|Overall Study|Withdrawal by Subject|10
6024228|NCT00762359|20823921|P1|Overall Study|Withdrawal by Subject|13
6024229|NCT00762359|20823920|P2|Overall Study|Protocol Violation|13
6024230|NCT00762359|20823921|P1|Overall Study|Protocol Violation|21
6024231|NCT00762359|20823920|P2|Overall Study|Adverse Event|23
6024232|NCT00762359|20823921|P1|Overall Study|Adverse Event|20
6024233|NCT00762268|20824038|P2|Overall Study|Withdrawal by Subject|3
6024234|NCT00762268|20824039|P1|Overall Study|Withdrawal by Subject|3
6024235|NCT00762229|20824051|P2|Overall Study|did not recveive intervention|1
6024236|NCT00762229|20824052|P1|Overall Study|did not recveive intervention|0
6024237|NCT00762229|20824051|P2|Overall Study|Lost to Follow-up|1
6024238|NCT00762229|20824052|P1|Overall Study|Lost to Follow-up|1
6024239|NCT00762164|20824149|P2|Overall Study|Withdrawal by Subject|1
6024240|NCT00762164|20824150|P1|Overall Study|Withdrawal by Subject|0
6024241|NCT00762164|20824149|P2|Overall Study|Discontinued medication|0
6024242|NCT00762164|20824150|P1|Overall Study|Discontinued medication|2
6024243|NCT00762164|20824149|P2|Overall Study|Lost to Follow-up|1
6024244|NCT00762164|20824150|P1|Overall Study|Lost to Follow-up|1
6024245|NCT00762086|20824160|P2|Overall Study|Ineligible to participate in the study|0
6024246|NCT00762086|20824161|P1|Overall Study|Ineligible to participate in the study|1
6024247|NCT00762086|20824160|P2|Overall Study|Withdrawal by Subject|2
6024248|NCT00762086|20824161|P1|Overall Study|Withdrawal by Subject|2
6024249|NCT00762086|20824160|P2|Overall Study|Non compliance|0
6024250|NCT00762086|20824161|P1|Overall Study|Non compliance|1
6024251|NCT00762086|20824160|P2|Overall Study|Lost to Follow-up|2
6024252|NCT00762086|20824161|P1|Overall Study|Lost to Follow-up|0
6024253|NCT00762086|20824160|P2|Overall Study|Adverse Event|0
6024254|NCT00762086|20824161|P1|Overall Study|Adverse Event|2
6024255|NCT00762073|20824171|P4|Overall Study|Not on treatment for >/= 77 days|0
6024256|NCT00762073|20824172|P3|Overall Study|Not on treatment for >/= 77 days|0
6024257|NCT00762073|20824173|P2|Overall Study|Not on treatment for >/= 77 days|0
6024258|NCT00762073|20824174|P1|Overall Study|Not on treatment for >/= 77 days|1
6024259|NCT00762073|20824171|P4|Overall Study|Withdrawal by Subject|1
6024260|NCT00762073|20824172|P3|Overall Study|Withdrawal by Subject|1
6024261|NCT00762073|20824173|P2|Overall Study|Withdrawal by Subject|2
6024262|NCT00762073|20824174|P1|Overall Study|Withdrawal by Subject|1
6024263|NCT00762073|20824171|P4|Overall Study|Significant Subject Noncompliance|1
6024264|NCT00762073|20824172|P3|Overall Study|Significant Subject Noncompliance|0
6024265|NCT00762073|20824173|P2|Overall Study|Significant Subject Noncompliance|1
6024266|NCT00762073|20824174|P1|Overall Study|Significant Subject Noncompliance|0
6024267|NCT00762073|20824171|P4|Overall Study|Adverse Event|1
6024268|NCT00762073|20824172|P3|Overall Study|Adverse Event|1
6024269|NCT00762073|20824173|P2|Overall Study|Adverse Event|0
6024270|NCT00762073|20824174|P1|Overall Study|Adverse Event|1
6024271|NCT00762073|20824171|P4|Overall Study|Lack of Efficacy|0
6024272|NCT00762073|20824172|P3|Overall Study|Lack of Efficacy|0
6024273|NCT00762073|20824173|P2|Overall Study|Lack of Efficacy|1
6024274|NCT00762073|20824174|P1|Overall Study|Lack of Efficacy|1
6024275|NCT00762034|20824238|P2|Maintenance Period|Other|1
6024276|NCT00762034|20824239|P1|Maintenance Period|Other|1
6024277|NCT00762034|20824238|P2|Maintenance Period|Death due to study disease|3
6024278|NCT00762034|20824239|P1|Maintenance Period|Death due to study disease|3
6024279|NCT00762034|20824238|P2|Maintenance Period|Death not due to study disease|5
6024280|NCT00762034|20824239|P1|Maintenance Period|Death not due to study disease|2
6024281|NCT00762034|20824238|P2|Maintenance Period|Withdrawal by Subject|14
6024282|NCT00762034|20824239|P1|Maintenance Period|Withdrawal by Subject|34
6024283|NCT00762034|20824238|P2|Maintenance Period|Physician Decision|20
6024284|NCT00762034|20824239|P1|Maintenance Period|Physician Decision|25
6024285|NCT00762034|20824238|P2|Maintenance Period|Progressive Disease|224
6024286|NCT00762034|20824239|P1|Maintenance Period|Progressive Disease|186
6024287|NCT00762034|20824238|P2|Maintenance Period|Adverse Event|26
6024288|NCT00762034|20824239|P1|Maintenance Period|Adverse Event|42
6024289|NCT00762034|20824238|P2|Maintenance Period|Entry Criterion Not Met|2
6024290|NCT00762034|20824239|P1|Maintenance Period|Entry Criterion Not Met|0
6024291|NCT00762034|20824238|P2|Maintenance Period|Protocol Violation|3
6024292|NCT00762034|20824239|P1|Maintenance Period|Protocol Violation|1
6024293|NCT00762034|20824238|P2|Induction Period|Deaths Due to Study Disease|9
6024294|NCT00762034|20824239|P1|Induction Period|Deaths Due to Study Disease|9
6024295|NCT00762034|20824238|P2|Induction Period|Deaths Not Due to Study Disease|14
6024296|NCT00762034|20824239|P1|Induction Period|Deaths Not Due to Study Disease|19
6024297|NCT00762034|20824238|P2|Induction Period|Withdrawal by Subject|19
6024298|NCT00762034|20824239|P1|Induction Period|Withdrawal by Subject|15
6024299|NCT00762034|20824238|P2|Induction Period|Physician Decision|20
6024300|NCT00762034|20824239|P1|Induction Period|Physician Decision|21
6024301|NCT00762034|20824238|P2|Induction Period|Progressive Disease|55
6024302|NCT00762034|20824239|P1|Induction Period|Progressive Disease|73
6024303|NCT00762034|20824238|P2|Induction Period|Lost to Follow-up|1
6024304|NCT00762034|20824239|P1|Induction Period|Lost to Follow-up|1
6024305|NCT00762034|20824238|P2|Induction Period|Adverse Event|38
6024306|NCT00762034|20824239|P1|Induction Period|Adverse Event|27
6024307|NCT00762034|20824238|P2|Induction Period|Entry Criterion Not Met|11
6024308|NCT00762034|20824239|P1|Induction Period|Entry Criterion Not Met|12
6024309|NCT00762034|20824238|P2|Induction Period|Protocol Violation|2
6024310|NCT00762034|20824239|P1|Induction Period|Protocol Violation|1
6024311|NCT00761969|20824311|P2|Overall Study|Lost to Follow-up|93
6024312|NCT00761969|20824312|P1|Overall Study|Lost to Follow-up|88
6024313|NCT00761969|20824311|P2|Overall Study|Death|47
6024314|NCT00761969|20824312|P1|Overall Study|Death|112
6024315|NCT00761956|20824322|P2|Overall Study|Adverse Event|34
6024316|NCT00761956|20824323|P1|Overall Study|Adverse Event|26
6024317|NCT00761956|20824322|P2|Overall Study|Death|1
6024318|NCT00761956|20824323|P1|Overall Study|Death|0
6024319|NCT00761956|20824322|P2|Overall Study|Withdrawal by Subject|8
6024320|NCT00761956|20824323|P1|Overall Study|Withdrawal by Subject|3
6024321|NCT00761956|20824322|P2|Overall Study|Lost to Follow-up|11
6024322|NCT00761956|20824323|P1|Overall Study|Lost to Follow-up|6
6024323|NCT00761891|20824350|P1|Overall Study|Withdrawal by Subject|10
6024324|NCT00761865|20824357|P2|Overall Study|Lost to Follow-up|7
6024325|NCT00761865|20824358|P1|Overall Study|Lost to Follow-up|8
6024326|NCT00761774|20824379|P1|Overall Study|IP stopped by hospital physician|1
6024327|NCT00761774|20824379|P1|Overall Study|Subject IP non-compliance|1
6024328|NCT00761774|20824379|P1|Overall Study|Coordinator leaving site|1
6024329|NCT00761774|20824379|P1|Overall Study|Patient moved out of study area|1
6024330|NCT00761774|20824379|P1|Overall Study|Investigator clinical judgement|1
6024331|NCT00761774|20824379|P1|Overall Study|Sponsor decision|1
6024332|NCT00761774|20824379|P1|Overall Study|Medical decision to read SUSAR reports|1
6024333|NCT00761774|20824379|P1|Overall Study|Reclassification of seizures|1
6024334|NCT00761774|20824379|P1|Overall Study|End of study|2
6024335|NCT00761774|20824379|P1|Overall Study|Non-compliance|4
6024336|NCT00761774|20824379|P1|Overall Study|Withdrawal by Subject|9
6024337|NCT00761774|20824379|P1|Overall Study|Lost to Follow-up|2
6024338|NCT00761774|20824379|P1|Overall Study|Lack of Efficacy|37
6024339|NCT00761774|20824379|P1|Overall Study|Adverse Event|17
6024340|NCT00761761|20824390|P2|Overall Study|Withdrawal by Subject|0
6024341|NCT00761761|20824391|P1|Overall Study|Withdrawal by Subject|3
6024342|NCT00761761|20824390|P2|Overall Study|Lost to Follow-up|1
6024343|NCT00761761|20824391|P1|Overall Study|Lost to Follow-up|3
6024344|NCT00761748|20824403|P2|First Intervention (21 +/- 3 Days)|Lost to Follow-up|3
6024345|NCT00761748|20824404|P1|First Intervention (21 +/- 3 Days)|Lost to Follow-up|0
6024346|NCT00761748|20824403|P2|First Intervention (21 +/- 3 Days)|Adverse Event|0
6024347|NCT00761748|20824404|P1|First Intervention (21 +/- 3 Days)|Adverse Event|3
6024348|NCT00761735|20824410|P1|Overall Study|Administrative|1
6024349|NCT00761735|20824410|P1|Overall Study|Non-compliance with protocol|1
6024350|NCT00761735|20824410|P1|Overall Study|Withdrawal by Subject|6
6024351|NCT00761735|20824410|P1|Overall Study|Lost to Follow-up|6
6024352|NCT00761631|20824426|P6|Overall Study|Other|1
6024353|NCT00761631|20824427|P5|Overall Study|Other|1
6024354|NCT00761631|20824428|P4|Overall Study|Other|0
6024355|NCT00761631|20824429|P3|Overall Study|Other|0
6024356|NCT00761631|20824430|P2|Overall Study|Other|0
6024357|NCT00761631|20824431|P1|Overall Study|Other|0
6024358|NCT00761631|20824426|P6|Overall Study|Physician Decision|0
6024359|NCT00761631|20824427|P5|Overall Study|Physician Decision|0
6024360|NCT00761631|20824428|P4|Overall Study|Physician Decision|0
6024361|NCT00761631|20824429|P3|Overall Study|Physician Decision|0
6024362|NCT00761631|20824430|P2|Overall Study|Physician Decision|0
6024363|NCT00761631|20824431|P1|Overall Study|Physician Decision|1
6024364|NCT00761631|20824426|P6|Overall Study|Failed to return|2
6024365|NCT00761631|20824427|P5|Overall Study|Failed to return|5
6024366|NCT00761631|20824428|P4|Overall Study|Failed to return|1
6024367|NCT00761631|20824429|P3|Overall Study|Failed to return|1
6024368|NCT00761631|20824430|P2|Overall Study|Failed to return|0
6024369|NCT00761631|20824431|P1|Overall Study|Failed to return|1
6024370|NCT00761631|20824426|P6|Overall Study|Randomized, not treated|0
6024371|NCT00761631|20824427|P5|Overall Study|Randomized, not treated|0
6024372|NCT00761631|20824428|P4|Overall Study|Randomized, not treated|0
6024373|NCT00761631|20824429|P3|Overall Study|Randomized, not treated|0
6024374|NCT00761631|20824430|P2|Overall Study|Randomized, not treated|0
6024375|NCT00761631|20824431|P1|Overall Study|Randomized, not treated|1
6024376|NCT00761631|20824426|P6|Overall Study|Protocol Violation|1
6024377|NCT00761631|20824427|P5|Overall Study|Protocol Violation|5
6024378|NCT00761631|20824428|P4|Overall Study|Protocol Violation|1
6024379|NCT00761631|20824429|P3|Overall Study|Protocol Violation|0
6024380|NCT00761631|20824430|P2|Overall Study|Protocol Violation|0
6024381|NCT00761631|20824431|P1|Overall Study|Protocol Violation|2
6024382|NCT00761631|20824426|P6|Overall Study|Lost to Follow-up|1
6024383|NCT00761631|20824427|P5|Overall Study|Lost to Follow-up|6
6024384|NCT00761631|20824428|P4|Overall Study|Lost to Follow-up|1
6024385|NCT00761631|20824429|P3|Overall Study|Lost to Follow-up|7
6024386|NCT00761631|20824430|P2|Overall Study|Lost to Follow-up|4
6024387|NCT00761631|20824431|P1|Overall Study|Lost to Follow-up|2
6024388|NCT00761631|20824426|P6|Overall Study|Parent/legal guardian request|0
6024389|NCT00761631|20824427|P5|Overall Study|Parent/legal guardian request|5
6024390|NCT00761631|20824428|P4|Overall Study|Parent/legal guardian request|0
6024391|NCT00761631|20824429|P3|Overall Study|Parent/legal guardian request|8
6024392|NCT00761631|20824430|P2|Overall Study|Parent/legal guardian request|3
6024393|NCT00761631|20824431|P1|Overall Study|Parent/legal guardian request|8
6024394|NCT00761605|20824466|P1|Overall Study|Other|21
6024395|NCT00761605|20824466|P1|Overall Study|Withdrawal by Subject|37
6024396|NCT00761605|20824466|P1|Overall Study|Lost to Follow-up|29
6024397|NCT00761605|20824466|P1|Overall Study|Lack of Efficacy|26
6024398|NCT00761605|20824466|P1|Overall Study|Death|2
6024399|NCT00761605|20824466|P1|Overall Study|Adverse Event|26
6024400|NCT00761579|20824510|P1|Overall Study|Intake of prohibited concomitant drug|1
6024401|NCT00761579|20824510|P1|Overall Study|Lost survey form|1
6024402|NCT00761579|20824510|P1|Overall Study|Aggravation of symptoms by changing drug|1
6024403|NCT00761579|20824510|P1|Overall Study|Aggravation of depression|1
6024404|NCT00761579|20824510|P1|Overall Study|Drug overdose|1
6024405|NCT00761579|20824510|P1|Overall Study|Protocol deviation|1
6024406|NCT00761579|20824510|P1|Overall Study|Lack of compliance|2
6024407|NCT00761579|20824510|P1|Overall Study|Withdrawal by Subject|34
6024408|NCT00761579|20824510|P1|Overall Study|Pregnancy|1
6024409|NCT00761579|20824510|P1|Overall Study|Lost to Follow-up|16
6024410|NCT00761579|20824510|P1|Overall Study|Lack of Efficacy|21
6024411|NCT00761579|20824510|P1|Overall Study|Death|2
6024412|NCT00761579|20824510|P1|Overall Study|Adverse Event|10
6024413|NCT00761527|20824543|P1|Overall Study|Unknown reason|2
6024414|NCT00761527|20824543|P1|Overall Study|Lost to Follow-up|9
6024415|NCT00761527|20824543|P1|Overall Study|Poor Compliance|8
6024416|NCT00761527|20824543|P1|Overall Study|Adverse Event|3
6024417|NCT00761514|20824550|P1|Overall Study|Unable to pay for medications|1
6024418|NCT00761514|20824550|P1|Overall Study|Problem complying with study visit|1
6024419|NCT00761514|20824550|P1|Overall Study|Health insurance didn't cover study drug|1
6024420|NCT00761514|20824550|P1|Overall Study|Lost to Follow-up|1
6024421|NCT00761514|20824550|P1|Overall Study|Withdrawal by Subject|2
6024422|NCT00761514|20824550|P1|Overall Study|Adverse Event|1
6024423|NCT00761462|20824557|P2|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|21
6024424|NCT00761462|20824558|P1|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|75
6024425|NCT00761462|20824557|P2|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|30
6024426|NCT00761462|20824558|P1|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|75
6024427|NCT00761462|20824557|P2|2 or 5 Years Long-term Safety Follow-up|Death|0
6024428|NCT00761462|20824558|P1|2 or 5 Years Long-term Safety Follow-up|Death|4
6024429|NCT00761462|20824557|P2|Treatment|Subjects never received study medication|12
6024430|NCT00761462|20824558|P1|Treatment|Subjects never received study medication|23
6024431|NCT00761319|20824572|P2|Overall Study|Missing|0
6024432|NCT00761319|20824573|P1|Overall Study|Missing|1
6024433|NCT00761319|20824572|P2|Overall Study|Nonspecified|2
6024434|NCT00761319|20824573|P1|Overall Study|Nonspecified|2
6024435|NCT00761319|20824572|P2|Overall Study|Lost to Follow-up|1
6024436|NCT00761319|20824573|P1|Overall Study|Lost to Follow-up|1
6024437|NCT00761319|20824572|P2|Overall Study|Noncompliance|3
6024438|NCT00761319|20824573|P1|Overall Study|Noncompliance|4
6024439|NCT00761319|20824572|P2|Overall Study|Withdrawal by Subject|7
6024440|NCT00761319|20824573|P1|Overall Study|Withdrawal by Subject|8
6024441|NCT00761319|20824572|P2|Overall Study|Adverse Event|7
6024442|NCT00761319|20824573|P1|Overall Study|Adverse Event|11
6024443|NCT00761319|20824572|P2|Overall Study|Protocol Violation|14
6024444|NCT00761319|20824573|P1|Overall Study|Protocol Violation|21
6024445|NCT00761306|20824581|P1|Overall Study|Administrative or Other Reasons|5
6024446|NCT00761306|20824581|P1|Overall Study|Lost to Follow-up|1
6024447|NCT00761306|20824581|P1|Overall Study|Withdrawal of Consent|3
6024448|NCT00761306|20824581|P1|Overall Study|Protocol Violation|2
6024449|NCT00761306|20824581|P1|Overall Study|Lack of Efficacy|4
6024450|NCT00761306|20824581|P1|Overall Study|Adverse Event|5
6024451|NCT00761280|20824592|P2|First Dose to End of Study|Lost to Follow-up|1
6024452|NCT00761280|20824593|P1|First Dose to End of Study|Lost to Follow-up|0
6024453|NCT00761280|20824592|P2|First Dose to End of Study|Death|0
6024454|NCT00761280|20824593|P1|First Dose to End of Study|Death|1
6024455|NCT00761280|20824592|P2|First Dose to End of Study|Sponsor decision|2
6024456|NCT00761280|20824593|P1|First Dose to End of Study|Sponsor decision|1
6024457|NCT00761280|20824592|P2|First Dose to End of Study|Progressive disease|3
6024458|NCT00761280|20824593|P1|First Dose to End of Study|Progressive disease|5
6024459|NCT00761280|20824592|P2|First Dose to End of Study|End of trial|5
6024460|NCT00761280|20824593|P1|First Dose to End of Study|End of trial|5
6024461|NCT00761280|20824592|P2|Randomization to First Dose|Other|0
6024462|NCT00761280|20824593|P1|Randomization to First Dose|Other|1
6024463|NCT00761280|20824592|P2|Randomization to First Dose|Sponsor decision|0
6024464|NCT00761280|20824593|P1|Randomization to First Dose|Sponsor decision|1
6024465|NCT00761280|20824592|P2|Randomization to First Dose|Withdrawal by Subject|2
6024466|NCT00761280|20824593|P1|Randomization to First Dose|Withdrawal by Subject|0
6024467|NCT00761267|20824624|P3|Overall Study|Withdrawal by Subject|0
6024468|NCT00761267|20824625|P2|Overall Study|Withdrawal by Subject|1
6024469|NCT00761267|20824626|P1|Overall Study|Withdrawal by Subject|0
6024470|NCT00761267|20824624|P3|Overall Study|Randomized but not treated|0
6024471|NCT00761267|20824625|P2|Overall Study|Randomized but not treated|1
6024472|NCT00761267|20824626|P1|Overall Study|Randomized but not treated|1
6024473|NCT00761267|20824624|P3|Overall Study|Lost to Follow-up|1
6024474|NCT00761267|20824625|P2|Overall Study|Lost to Follow-up|0
6024475|NCT00761267|20824626|P1|Overall Study|Lost to Follow-up|0
6024476|NCT00761267|20824624|P3|Overall Study|Death|5
6024477|NCT00761267|20824625|P2|Overall Study|Death|2
6024478|NCT00761267|20824626|P1|Overall Study|Death|1
6024479|NCT00761215|20824677|P3|Overall Study|Bacteremia|0
6024480|NCT00761215|20824678|P2|Overall Study|Bacteremia|0
6024481|NCT00761215|20824679|P1|Overall Study|Bacteremia|1
6024482|NCT00761215|20824677|P3|Overall Study|Withdrawal by Subject|0
6024483|NCT00761215|20824678|P2|Overall Study|Withdrawal by Subject|0
6024484|NCT00761215|20824679|P1|Overall Study|Withdrawal by Subject|1
6024485|NCT00761215|20824677|P3|Overall Study|Lost to Follow-up|6
6024486|NCT00761215|20824678|P2|Overall Study|Lost to Follow-up|3
6024487|NCT00761215|20824679|P1|Overall Study|Lost to Follow-up|6
6024488|NCT00761215|20824677|P3|Overall Study|Randomized but didn't receive drug|2
6024489|NCT00761215|20824678|P2|Overall Study|Randomized but didn't receive drug|1
6024490|NCT00761215|20824679|P1|Overall Study|Randomized but didn't receive drug|1
6024491|NCT00761189|20824721|P1|Overall Study|Other|13
6024492|NCT00761189|20824721|P1|Overall Study|Withdrawal by Subject|49
6024493|NCT00761189|20824721|P1|Overall Study|Lost to Follow-up|36
6024494|NCT00761189|20824721|P1|Overall Study|Lack of Efficacy|45
6024495|NCT00761189|20824721|P1|Overall Study|Adverse Event|42
6024496|NCT00761176|20824738|P2|Overall Study|Withdrawal by Subject|1
6024497|NCT00761176|20824739|P1|Overall Study|Withdrawal by Subject|1
6024498|NCT00761176|20824738|P2|Overall Study|Death|0
6024499|NCT00761176|20824739|P1|Overall Study|Death|1
6024500|NCT00761150|20824748|P3|Double-blind Period|Other|3
6024501|NCT00761150|20824749|P2|Double-blind Period|Other|3
6024502|NCT00761150|20824750|P1|Double-blind Period|Other|0
6024503|NCT00761150|20824748|P3|Double-blind Period|Noncompliance|0
6024504|NCT00761150|20824749|P2|Double-blind Period|Noncompliance|1
6024505|NCT00761150|20824750|P1|Double-blind Period|Noncompliance|0
6024506|NCT00761150|20824748|P3|Double-blind Period|Did not meet DB randomization criteria|1
6024507|NCT00761150|20824749|P2|Double-blind Period|Did not meet DB randomization criteria|0
6024508|NCT00761150|20824750|P1|Double-blind Period|Did not meet DB randomization criteria|0
6024509|NCT00761150|20824748|P3|Double-blind Period|Lost to Follow-up|1
6024510|NCT00761150|20824749|P2|Double-blind Period|Lost to Follow-up|2
6024511|NCT00761150|20824750|P1|Double-blind Period|Lost to Follow-up|0
6024512|NCT00761150|20824748|P3|Double-blind Period|Withdrawal by Subject|2
6024513|NCT00761150|20824749|P2|Double-blind Period|Withdrawal by Subject|3
6024514|NCT00761150|20824750|P1|Double-blind Period|Withdrawal by Subject|0
6024515|NCT00761150|20824748|P3|Double-blind Period|Adverse Event|3
6024516|NCT00761150|20824749|P2|Double-blind Period|Adverse Event|3
6024517|NCT00761150|20824750|P1|Double-blind Period|Adverse Event|0
6024518|NCT00761150|20824748|P3|Double-blind Period|Lack of Efficacy|19
6024519|NCT00761150|20824749|P2|Double-blind Period|Lack of Efficacy|2
6024520|NCT00761150|20824750|P1|Double-blind Period|Lack of Efficacy|0
6024521|NCT00761150|20824748|P3|Open-label Period|Other|0
6024522|NCT00761150|20824749|P2|Open-label Period|Other|0
6024523|NCT00761150|20824750|P1|Open-label Period|Other|5
6024524|NCT00761150|20824748|P3|Open-label Period|Noncompliance|0
6024525|NCT00761150|20824749|P2|Open-label Period|Noncompliance|0
6024526|NCT00761150|20824750|P1|Open-label Period|Noncompliance|2
6024527|NCT00761150|20824748|P3|Open-label Period|Withdrawal by Subject|0
6024528|NCT00761150|20824749|P2|Open-label Period|Withdrawal by Subject|0
6024529|NCT00761150|20824750|P1|Open-label Period|Withdrawal by Subject|5
6024530|NCT00761150|20824748|P3|Open-label Period|Lack of Efficacy|0
6024531|NCT00761150|20824749|P2|Open-label Period|Lack of Efficacy|0
6024532|NCT00761150|20824750|P1|Open-label Period|Lack of Efficacy|4
6024533|NCT00761150|20824748|P3|Open-label Period|Lost to Follow-up|0
6024534|NCT00761150|20824749|P2|Open-label Period|Lost to Follow-up|0
6024535|NCT00761150|20824750|P1|Open-label Period|Lost to Follow-up|7
6024536|NCT00761150|20824748|P3|Open-label Period|Did not meet DB randomization criteria|0
6024537|NCT00761150|20824749|P2|Open-label Period|Did not meet DB randomization criteria|0
6024538|NCT00761150|20824750|P1|Open-label Period|Did not meet DB randomization criteria|11
6024539|NCT00761150|20824748|P3|Open-label Period|Adverse Event|0
6024540|NCT00761150|20824749|P2|Open-label Period|Adverse Event|0
6024541|NCT00761150|20824750|P1|Open-label Period|Adverse Event|36
6024542|NCT00760994|20824823|P3|Overall Study|Lost to Follow-up|3
6024543|NCT00760994|20824824|P2|Overall Study|Lost to Follow-up|4
6024544|NCT00760994|20824825|P1|Overall Study|Lost to Follow-up|4
6024545|NCT00760929|20824840|P4|Overall Study|Violation of Selection Criteria at Entry|1
6024546|NCT00760929|20824841|P3|Overall Study|Violation of Selection Criteria at Entry|0
6024547|NCT00760929|20824842|P2|Overall Study|Violation of Selection Criteria at Entry|0
6024548|NCT00760929|20824843|P1|Overall Study|Violation of Selection Criteria at Entry|0
6024549|NCT00760929|20824840|P4|Overall Study|Death|0
6024550|NCT00760929|20824841|P3|Overall Study|Death|1
6024551|NCT00760929|20824842|P2|Overall Study|Death|0
6024552|NCT00760929|20824843|P1|Overall Study|Death|0
6024553|NCT00760929|20824840|P4|Overall Study|Other|1
6024554|NCT00760929|20824841|P3|Overall Study|Other|2
6024555|NCT00760929|20824842|P2|Overall Study|Other|0
6024556|NCT00760929|20824843|P1|Overall Study|Other|2
6024557|NCT00760929|20824840|P4|Overall Study|Progression of Disease|42
6024558|NCT00760929|20824841|P3|Overall Study|Progression of Disease|38
6024559|NCT00760929|20824842|P2|Overall Study|Progression of Disease|26
6024560|NCT00760929|20824843|P1|Overall Study|Progression of Disease|21
6024561|NCT00760929|20824840|P4|Overall Study|Lost to Follow-up|0
6024562|NCT00760929|20824841|P3|Overall Study|Lost to Follow-up|1
6024563|NCT00760929|20824842|P2|Overall Study|Lost to Follow-up|0
6024564|NCT00760929|20824843|P1|Overall Study|Lost to Follow-up|0
6024565|NCT00760929|20824840|P4|Overall Study|Withdrawal by Subject|1
6024566|NCT00760929|20824841|P3|Overall Study|Withdrawal by Subject|9
6024567|NCT00760929|20824842|P2|Overall Study|Withdrawal by Subject|0
6024568|NCT00760929|20824843|P1|Overall Study|Withdrawal by Subject|1
6024569|NCT00760929|20824840|P4|Overall Study|Lack of Efficacy|0
6024570|NCT00760929|20824841|P3|Overall Study|Lack of Efficacy|1
6024571|NCT00760929|20824842|P2|Overall Study|Lack of Efficacy|2
6024572|NCT00760929|20824843|P1|Overall Study|Lack of Efficacy|0
6024573|NCT00760929|20824840|P4|Overall Study|Adverse Event|10
6024574|NCT00760929|20824841|P3|Overall Study|Adverse Event|6
6024575|NCT00760929|20824842|P2|Overall Study|Adverse Event|0
6024576|NCT00760929|20824843|P1|Overall Study|Adverse Event|2
6024577|NCT00760877|20824866|P2|Overall Study|Treatment failure|0
6024578|NCT00760877|20824867|P1|Overall Study|Treatment failure|1
6024579|NCT00760877|20824866|P2|Overall Study|Participants transferred to AMN107A2408|1
6024580|NCT00760877|20824867|P1|Overall Study|Participants transferred to AMN107A2408|11
6024581|NCT00760877|20824866|P2|Overall Study|Physician Decision|2
6024582|NCT00760877|20824867|P1|Overall Study|Physician Decision|1
6024583|NCT00760877|20824866|P2|Overall Study|Participant not eligible to cross-over|1
6024584|NCT00760877|20824867|P1|Overall Study|Participant not eligible to cross-over|0
6024585|NCT00760877|20824866|P2|Overall Study|Participant diagnosed with AML|1
6024586|NCT00760877|20824867|P1|Overall Study|Participant diagnosed with AML|0
6024587|NCT00760877|20824866|P2|Overall Study|Adverse Event|12
6024588|NCT00760877|20824867|P1|Overall Study|Adverse Event|19
6024589|NCT00760877|20824866|P2|Overall Study|Withdrawal by Subject|3
6024590|NCT00760877|20824867|P1|Overall Study|Withdrawal by Subject|7
6024591|NCT00760877|20824866|P2|Overall Study|Death|1
6024592|NCT00760877|20824867|P1|Overall Study|Death|2
6024593|NCT00760877|20824866|P2|Overall Study|Pregnancy|4
6024594|NCT00760877|20824867|P1|Overall Study|Pregnancy|1
6024595|NCT00760877|20824866|P2|Overall Study|Non-compliance with protocol treatment|1
6024596|NCT00760877|20824867|P1|Overall Study|Non-compliance with protocol treatment|2
6024597|NCT00760877|20824866|P2|Overall Study|Protocol Violation|0
6024598|NCT00760877|20824867|P1|Overall Study|Protocol Violation|1
6024599|NCT00760838|20824885|P2|Overall Study|Withdrawal by Subject|1
6024600|NCT00760838|20824886|P1|Overall Study|Withdrawal by Subject|1
6024601|NCT00760838|20824885|P2|Overall Study|Lost to Follow-up|0
6024602|NCT00760838|20824886|P1|Overall Study|Lost to Follow-up|2
6024603|NCT00760838|20824885|P2|Overall Study|Lack of Efficacy|0
6024604|NCT00760838|20824886|P1|Overall Study|Lack of Efficacy|1
6024605|NCT00760838|20824885|P2|Overall Study|Adverse Event|1
6024606|NCT00760838|20824886|P1|Overall Study|Adverse Event|1
6024607|NCT00760747|20824904|P2|Study Period III|Physician Decision|1
6024608|NCT00760747|20824905|P1|Study Period III|Physician Decision|0
6024609|NCT00760747|20824904|P2|Study Period III|Protocol Violation|1
6024610|NCT00760747|20824905|P1|Study Period III|Protocol Violation|1
6024611|NCT00760747|20824904|P2|Study Period III|Parent/Caregiver Decision|1
6024612|NCT00760747|20824905|P1|Study Period III|Parent/Caregiver Decision|0
6024613|NCT00760747|20824904|P2|Study Period III|Lack of Efficacy|0
6024614|NCT00760747|20824905|P1|Study Period III|Lack of Efficacy|1
6024615|NCT00760747|20824904|P2|Study Period III|Adverse Event|0
6024616|NCT00760747|20824905|P1|Study Period III|Adverse Event|1
6024617|NCT00760747|20824904|P2|Study Period II|No drug administered|1
6024618|NCT00760747|20824905|P1|Study Period II|No drug administered|0
6024619|NCT00760747|20824904|P2|Study Period II|Withdrawal by Subject|0
6024620|NCT00760747|20824905|P1|Study Period II|Withdrawal by Subject|1
6024621|NCT00760747|20824904|P2|Study Period II|Protocol Violation|3
6024622|NCT00760747|20824905|P1|Study Period II|Protocol Violation|6
6024623|NCT00760747|20824904|P2|Study Period II|Parent/Caregiver Decision|0
6024624|NCT00760747|20824905|P1|Study Period II|Parent/Caregiver Decision|3
6024625|NCT00760747|20824904|P2|Study Period II|Lack of Efficacy|6
6024626|NCT00760747|20824905|P1|Study Period II|Lack of Efficacy|0
6024627|NCT00760747|20824904|P2|Study Period II|Adverse Event|4
6024628|NCT00760747|20824905|P1|Study Period II|Adverse Event|3
6024629|NCT00760669|20824933|P1|Overall Study|Took drug before entering in contract|5
6024630|NCT00760669|20824933|P1|Overall Study|Participants with overlapping cases|1
6024631|NCT00760669|20824933|P1|Overall Study|Participants missing efficacy assessment|6
6024632|NCT00760669|20824933|P1|Overall Study|Not assessed for overall improvement|18
6024633|NCT00760617|20824950|P3|Overall Study|Lost to Follow-up|5
6024634|NCT00760617|20824951|P2|Overall Study|Lost to Follow-up|0
6024635|NCT00760617|20824952|P1|Overall Study|Lost to Follow-up|0
6024636|NCT00760617|20824950|P3|Overall Study|Adverse Event|0
6024637|NCT00760617|20824951|P2|Overall Study|Adverse Event|2
6024638|NCT00760617|20824952|P1|Overall Study|Adverse Event|5
6024639|NCT00760552|20825066|P2|Overall Study|Lost to Follow-up|10
6024640|NCT00760552|20825067|P1|Overall Study|Lost to Follow-up|11
6024641|NCT00760552|20825066|P2|Overall Study|Death|0
6024642|NCT00760552|20825067|P1|Overall Study|Death|2
6024643|NCT00760513|20825103|P2|Overall Study|Withdrawal by Subject|7
6024644|NCT00760513|20825104|P1|Overall Study|Withdrawal by Subject|5
6024645|NCT00760487|20825114|P1|Overall Study|Unilateral implantation|3
6024646|NCT00760474|20825120|P2|Period 2 (P2)|Adverse Event|1
6024647|NCT00760474|20825121|P1|Period 2 (P2)|Adverse Event|0
6024648|NCT00760474|20825120|P2|Period 2 (P2)|Lost to Follow-up|0
6024649|NCT00760474|20825121|P1|Period 2 (P2)|Lost to Follow-up|1
6024650|NCT00760474|20825120|P2|Placebo Washout Period|Other|1
6024651|NCT00760474|20825121|P1|Placebo Washout Period|Other|0
6024652|NCT00760474|20825120|P2|Period 1 (P1)|Discontinued then re-entered|1
6024653|NCT00760474|20825121|P1|Period 1 (P1)|Discontinued then re-entered|1
6024654|NCT00760383|20825178|P2|Overall Study|moved away; withdrew; medical reasons|7
6024655|NCT00760383|20825179|P1|Overall Study|moved away; withdrew; medical reasons|5
6024656|NCT00760266|20825191|P2|Overall Study|Administrative Problems|1
6024657|NCT00760266|20825192|P1|Overall Study|Administrative Problems|0
6024658|NCT00760266|20825191|P2|Overall Study|Lost to Follow-up|1
6024659|NCT00760266|20825192|P1|Overall Study|Lost to Follow-up|2
6024660|NCT00760266|20825191|P2|Overall Study|Patient withdrew consent|3
6024661|NCT00760266|20825192|P1|Overall Study|Patient withdrew consent|3
6024662|NCT00760266|20825191|P2|Overall Study|Protocol deviation|4
6024663|NCT00760266|20825192|P1|Overall Study|Protocol deviation|2
6024664|NCT00760266|20825191|P2|Overall Study|Lack of Efficacy|2
6024665|NCT00760266|20825192|P1|Overall Study|Lack of Efficacy|2
6024666|NCT00760266|20825191|P2|Overall Study|Abnormal test procedure result(s)|0
6024667|NCT00760266|20825192|P1|Overall Study|Abnormal test procedure result(s)|1
6024668|NCT00760266|20825191|P2|Overall Study|Abnormal laboratory value(s)|0
6024669|NCT00760266|20825192|P1|Overall Study|Abnormal laboratory value(s)|1
6024670|NCT00760266|20825191|P2|Overall Study|Adverse Event|7
6024671|NCT00760266|20825192|P1|Overall Study|Adverse Event|13
6024672|NCT00760214|20825209|P3|Overall Study|Other|6
6024673|NCT00760214|20825210|P2|Overall Study|Other|4
6024674|NCT00760214|20825211|P1|Overall Study|Other|3
6024675|NCT00760214|20825209|P3|Overall Study|Physician Decision|1
6024676|NCT00760214|20825210|P2|Overall Study|Physician Decision|1
6024677|NCT00760214|20825211|P1|Overall Study|Physician Decision|1
6024678|NCT00760214|20825209|P3|Overall Study|Pregnancy|1
6024679|NCT00760214|20825210|P2|Overall Study|Pregnancy|0
6024680|NCT00760214|20825211|P1|Overall Study|Pregnancy|0
6024681|NCT00760214|20825209|P3|Overall Study|Lack of Efficacy|4
6024682|NCT00760214|20825210|P2|Overall Study|Lack of Efficacy|2
6024683|NCT00760214|20825211|P1|Overall Study|Lack of Efficacy|3
6024684|NCT00760214|20825209|P3|Overall Study|Withdrawal by Subject|13
6024685|NCT00760214|20825210|P2|Overall Study|Withdrawal by Subject|14
6024686|NCT00760214|20825211|P1|Overall Study|Withdrawal by Subject|12
6024687|NCT00760214|20825209|P3|Overall Study|Lost to Follow-up|1
6024688|NCT00760214|20825210|P2|Overall Study|Lost to Follow-up|0
6024689|NCT00760214|20825211|P1|Overall Study|Lost to Follow-up|0
6024690|NCT00760214|20825209|P3|Overall Study|Protocol Violation|3
6024691|NCT00760214|20825210|P2|Overall Study|Protocol Violation|0
6024692|NCT00760214|20825211|P1|Overall Study|Protocol Violation|3
6024693|NCT00760214|20825209|P3|Overall Study|Adverse Event|12
6024694|NCT00760214|20825210|P2|Overall Study|Adverse Event|9
6024695|NCT00760214|20825211|P1|Overall Study|Adverse Event|8
6024696|NCT00760084|20825252|P1|Overall Study|Progressive Disease|3
6024697|NCT00760084|20825252|P1|Overall Study|Withdrawal by Subject|2
6024698|NCT00760084|20825252|P1|Overall Study|Physician Decision|5
6024699|NCT00759954|20825295|P2|Overall Study|Adverse Event|2
6024700|NCT00759954|20825296|P1|Overall Study|Adverse Event|1
6024701|NCT00759954|20825295|P2|Overall Study|Personal reason|0
6024702|NCT00759954|20825296|P1|Overall Study|Personal reason|1
6024703|NCT00759941|20825310|P2|Overall Study|Exited in error by site|1
6024704|NCT00759941|20825311|P1|Overall Study|Exited in error by site|1
6024705|NCT00759941|20825310|P2|Overall Study|Adverse Event|0
6024706|NCT00759941|20825311|P1|Overall Study|Adverse Event|1
6024707|NCT00759941|20825310|P2|Overall Study|Use of medication|0
6024708|NCT00759941|20825311|P1|Overall Study|Use of medication|1
6024709|NCT00759915|20825325|P2|Overall Study|Adverse Event|1
6024710|NCT00759915|20825326|P1|Overall Study|Adverse Event|0
6024711|NCT00759915|20825325|P2|Overall Study|Withdrawal by Subject|0
6024712|NCT00759915|20825326|P1|Overall Study|Withdrawal by Subject|1
6024713|NCT00759902|20825340|P2|Overall Study|Adverse Event|1
6024714|NCT00759902|20825341|P1|Overall Study|Adverse Event|0
6024715|NCT00759876|20825353|P1|Overall Study|Sponsor terminated study early|36
6024716|NCT00759863|20825377|P2|Overall Study|Death, moved, or lost contact|18
6024717|NCT00759863|20825378|P1|Overall Study|Death, moved, or lost contact|20
6024718|NCT00759785|20825399|P2|Overall Study|Withdrawal by Subject|1
6024719|NCT00759785|20825400|P1|Overall Study|Withdrawal by Subject|0
6024720|NCT00759785|20825399|P2|Overall Study|Physician Decision|1
6024721|NCT00759785|20825400|P1|Overall Study|Physician Decision|0
6024722|NCT00759785|20825399|P2|Overall Study|Protocol Violation|0
6024723|NCT00759785|20825400|P1|Overall Study|Protocol Violation|1
6024724|NCT00759785|20825399|P2|Overall Study|Participant sample lost|1
6024725|NCT00759785|20825400|P1|Overall Study|Participant sample lost|0
6024726|NCT00759785|20825399|P2|Overall Study|Participant sample not evaluable|2
6024727|NCT00759785|20825400|P1|Overall Study|Participant sample not evaluable|11
6024728|NCT00759759|20825423|P2|Overall Study|Withdrawal by Subject|1
6024729|NCT00759759|20825424|P1|Overall Study|Withdrawal by Subject|2
6024730|NCT00759759|20825423|P2|Overall Study|Didn't receive drug in period 2|0
6024731|NCT00759759|20825424|P1|Overall Study|Didn't receive drug in period 2|1
6024732|NCT00759759|20825423|P2|Overall Study|didn't return for period 2|0
6024733|NCT00759759|20825424|P1|Overall Study|didn't return for period 2|1
6024734|NCT00759681|20825442|P2|Overall Study|Lost to Follow-up|5
6024735|NCT00759681|20825443|P1|Overall Study|Lost to Follow-up|8
6024736|NCT00759681|20825442|P2|Overall Study|Death|5
6024737|NCT00759681|20825443|P1|Overall Study|Death|2
6024738|NCT00759655|20825470|P1|Overall Study|Termination of the study by sponsor|1
6024739|NCT00759564|20825498|P5|Washout Period (at Least 14 Days)|Adverse Event|1
6024740|NCT00759564|20825499|P4|Washout Period (at Least 14 Days)|Adverse Event|0
6024741|NCT00759564|20825500|P3|Washout Period (at Least 14 Days)|Adverse Event|0
6024742|NCT00759564|20825501|P2|Washout Period (at Least 14 Days)|Adverse Event|0
6024743|NCT00759564|20825502|P1|Washout Period (at Least 14 Days)|Adverse Event|0
6024744|NCT00759395|20825679|P2|Overall Study|Lack of Efficacy|2
6024745|NCT00759395|20825680|P1|Overall Study|Lack of Efficacy|0
6024746|NCT00759395|20825679|P2|Overall Study|Withdrawal by Subject|0
6024747|NCT00759395|20825680|P1|Overall Study|Withdrawal by Subject|1
6024748|NCT00759395|20825679|P2|Overall Study|Adverse Event|0
6024749|NCT00759395|20825680|P1|Overall Study|Adverse Event|1
6024750|NCT00759356|20825696|P2|Overall Study|Subject was unable to return|0
6024751|NCT00759356|20825697|P1|Overall Study|Subject was unable to return|1
6024752|NCT00759356|20825696|P2|Overall Study|Withdrawal by Subject|2
6024753|NCT00759356|20825697|P1|Overall Study|Withdrawal by Subject|0
6024754|NCT00759356|20825696|P2|Overall Study|Adverse Event|1
6024755|NCT00759356|20825697|P1|Overall Study|Adverse Event|0
6024758|NCT00759148|20825802|P2|Overall Study|Reason not given|0
6024759|NCT00759148|20825803|P1|Overall Study|Reason not given|1
6024760|NCT00759148|20825802|P2|Overall Study|Treatment Failure|10
6024761|NCT00759148|20825803|P1|Overall Study|Treatment Failure|6
6024762|NCT00759148|20825802|P2|Overall Study|Lost to Follow-up|9
6024763|NCT00759148|20825803|P1|Overall Study|Lost to Follow-up|3
6024764|NCT00759148|20825802|P2|Overall Study|Withdrawal by Subject|7
6024765|NCT00759148|20825803|P1|Overall Study|Withdrawal by Subject|3
6024766|NCT00759148|20825802|P2|Overall Study|Adverse Event|6
6024767|NCT00759148|20825803|P1|Overall Study|Adverse Event|1
6024768|NCT00759109|20825813|P2|Overall Study|Lost during study|0
6024769|NCT00759109|20825814|P1|Overall Study|Lost during study|1
6024770|NCT00759109|20825813|P2|Overall Study|Participant had a liver transplant|1
6024771|NCT00759109|20825814|P1|Overall Study|Participant had a liver transplant|0
6024772|NCT00759109|20825813|P2|Overall Study|Participant moved to a different city|1
6024773|NCT00759109|20825814|P1|Overall Study|Participant moved to a different city|0
6024774|NCT00759109|20825813|P2|Overall Study|HCV RNA negative|0
6024775|NCT00759109|20825814|P1|Overall Study|HCV RNA negative|1
6024776|NCT00759109|20825813|P2|Overall Study|Started new therapy|6
6024777|NCT00759109|20825814|P1|Overall Study|Started new therapy|2
6024778|NCT00759109|20825813|P2|Overall Study|Lost to Follow-up|6
6024779|NCT00759109|20825814|P1|Overall Study|Lost to Follow-up|4
6024780|NCT00759109|20825813|P2|Overall Study|Death|3
6024781|NCT00759109|20825814|P1|Overall Study|Death|4
6024782|NCT00759109|20825813|P2|Overall Study|Withdrawal by Subject|5
6024783|NCT00759109|20825814|P1|Overall Study|Withdrawal by Subject|9
6024784|NCT00759109|20825813|P2|Overall Study|Inability to comply|1
6024785|NCT00759109|20825814|P1|Overall Study|Inability to comply|1
6024786|NCT00759109|20825813|P2|Overall Study|Adverse Event|12
6024787|NCT00759109|20825814|P1|Overall Study|Adverse Event|17
6024788|NCT00759031|20825836|P2|First Intervention (1 Day)|Screening failure|0
6024789|NCT00759031|20825837|P1|First Intervention (1 Day)|Screening failure|1
6024790|NCT00759031|20825836|P2|First Intervention (1 Day)|Withdrawal by Subject|1
6024791|NCT00759031|20825837|P1|First Intervention (1 Day)|Withdrawal by Subject|0
6024792|NCT00759031|20825836|P2|First Intervention (1 Day)|Physician Decision|0
6024793|NCT00759031|20825837|P1|First Intervention (1 Day)|Physician Decision|1
6024794|NCT00758771|20825896|P2|Overall Study|Did not meet eligibility criteria|4
6024795|NCT00758771|20825897|P1|Overall Study|Did not meet eligibility criteria|2
6024796|NCT00758771|20825896|P2|Overall Study|Withdrawal by Subject|1
6024797|NCT00758771|20825897|P1|Overall Study|Withdrawal by Subject|1
6024798|NCT00758706|20825955|P2|Overall Study|Adverse Event|4
6024799|NCT00758706|20825956|P1|Overall Study|Adverse Event|4
6024800|NCT00758680|20825992|P10|Overall Study|Withdrawal by Subject|0
6024801|NCT00758680|20825993|P9|Overall Study|Withdrawal by Subject|1
6024802|NCT00758680|20825994|P8|Overall Study|Withdrawal by Subject|0
6024803|NCT00758680|20825995|P7|Overall Study|Withdrawal by Subject|1
6024804|NCT00758680|20825996|P6|Overall Study|Withdrawal by Subject|0
6024805|NCT00758680|20825997|P5|Overall Study|Withdrawal by Subject|0
6024806|NCT00758680|20825998|P4|Overall Study|Withdrawal by Subject|0
6024807|NCT00758680|20825999|P3|Overall Study|Withdrawal by Subject|0
6024808|NCT00758680|20826000|P2|Overall Study|Withdrawal by Subject|0
6024809|NCT00758680|20826001|P1|Overall Study|Withdrawal by Subject|0
6024810|NCT00758680|20825992|P10|Overall Study|Laboratory Adverse Event|0
6024811|NCT00758680|20825993|P9|Overall Study|Laboratory Adverse Event|1
6024812|NCT00758680|20825994|P8|Overall Study|Laboratory Adverse Event|0
6024813|NCT00758680|20825995|P7|Overall Study|Laboratory Adverse Event|0
6024814|NCT00758680|20825996|P6|Overall Study|Laboratory Adverse Event|0
6024815|NCT00758680|20825997|P5|Overall Study|Laboratory Adverse Event|0
6024816|NCT00758680|20825998|P4|Overall Study|Laboratory Adverse Event|0
6024817|NCT00758680|20825999|P3|Overall Study|Laboratory Adverse Event|0
6024818|NCT00758680|20826000|P2|Overall Study|Laboratory Adverse Event|0
6024819|NCT00758680|20826001|P1|Overall Study|Laboratory Adverse Event|0
6024820|NCT00758680|20825992|P10|Overall Study|Adverse Event|1
6024821|NCT00758680|20825993|P9|Overall Study|Adverse Event|0
6024822|NCT00758680|20825994|P8|Overall Study|Adverse Event|1
6024823|NCT00758680|20825995|P7|Overall Study|Adverse Event|0
6024824|NCT00758680|20825996|P6|Overall Study|Adverse Event|0
6024825|NCT00758680|20825997|P5|Overall Study|Adverse Event|0
6024826|NCT00758680|20825998|P4|Overall Study|Adverse Event|0
6024827|NCT00758680|20825999|P3|Overall Study|Adverse Event|0
6024828|NCT00758680|20826000|P2|Overall Study|Adverse Event|0
6024829|NCT00758680|20826001|P1|Overall Study|Adverse Event|0
6024830|NCT00758602|20826054|P2|Overall Study|Reason not specified|3
6024831|NCT00758602|20826055|P1|Overall Study|Reason not specified|3
6024832|NCT00758602|20826054|P2|Overall Study|Death|1
6024833|NCT00758602|20826055|P1|Overall Study|Death|0
6024834|NCT00758602|20826054|P2|Overall Study|Protocol Violation|2
6024835|NCT00758602|20826055|P1|Overall Study|Protocol Violation|0
6024836|NCT00758602|20826054|P2|Overall Study|Withdrawal by Subject|3
6024837|NCT00758602|20826055|P1|Overall Study|Withdrawal by Subject|1
6024838|NCT00758602|20826054|P2|Overall Study|Lost to Follow-up|3
6024839|NCT00758602|20826055|P1|Overall Study|Lost to Follow-up|4
6024840|NCT00758602|20826054|P2|Overall Study|Adverse Event|10
6024841|NCT00758602|20826055|P1|Overall Study|Adverse Event|11
6024842|NCT00758589|20826081|P4|Overall Study|Palm stopped to work|1
6024843|NCT00758589|20826082|P3|Overall Study|Palm stopped to work|0
6024844|NCT00758589|20826083|P2|Overall Study|Palm stopped to work|0
6024845|NCT00758589|20826084|P1|Overall Study|Palm stopped to work|0
6024846|NCT00758589|20826081|P4|Overall Study|Withdrawal by Subject|1
6024847|NCT00758589|20826082|P3|Overall Study|Withdrawal by Subject|1
6024848|NCT00758589|20826083|P2|Overall Study|Withdrawal by Subject|1
6024849|NCT00758589|20826084|P1|Overall Study|Withdrawal by Subject|0
6024850|NCT00758589|20826081|P4|Overall Study|Adverse Event|4
6024851|NCT00758589|20826082|P3|Overall Study|Adverse Event|5
6024852|NCT00758589|20826083|P2|Overall Study|Adverse Event|2
6024853|NCT00758589|20826084|P1|Overall Study|Adverse Event|3
6024854|NCT00758498|20826177|P3|Overall Study|Noncompliance to study procedures|1
6024855|NCT00758498|20826178|P2|Overall Study|Noncompliance to study procedures|0
6024856|NCT00758498|20826179|P1|Overall Study|Noncompliance to study procedures|0
6024857|NCT00758498|20826177|P3|Overall Study|Withdrawal by Subject|1
6024858|NCT00758498|20826178|P2|Overall Study|Withdrawal by Subject|0
6024859|NCT00758498|20826179|P1|Overall Study|Withdrawal by Subject|0
6024860|NCT00758498|20826177|P3|Overall Study|Subject legally detained out of state|0
6024861|NCT00758498|20826178|P2|Overall Study|Subject legally detained out of state|0
6024862|NCT00758498|20826179|P1|Overall Study|Subject legally detained out of state|1
6024863|NCT00758498|20826177|P3|Overall Study|Adverse Event|3
6024864|NCT00758498|20826178|P2|Overall Study|Adverse Event|2
6024865|NCT00758498|20826179|P1|Overall Study|Adverse Event|2
6024866|NCT00758485|20826264|P2|Overall Study|Not Treated|2
6024867|NCT00758485|20826265|P1|Overall Study|Not Treated|1
6024868|NCT00758485|20826264|P2|Overall Study|Lost to Follow-up|1
6024869|NCT00758485|20826265|P1|Overall Study|Lost to Follow-up|0
6024870|NCT00758459|20826277|P2|Overall Study|Withdrawal by Subject|1
6024871|NCT00758459|20826278|P1|Overall Study|Withdrawal by Subject|0
6024872|NCT00758459|20826277|P2|Overall Study|Protocol Violation|1
6024873|NCT00758459|20826278|P1|Overall Study|Protocol Violation|0
6024874|NCT00758459|20826277|P2|Overall Study|Adverse Event|2
6024875|NCT00758459|20826278|P1|Overall Study|Adverse Event|3
6024876|NCT00758394|20826323|P4|3rd Intervention|Lost to Follow-up|1
6024877|NCT00758394|20826324|P3|3rd Intervention|Lost to Follow-up|0
6024878|NCT00758394|20826325|P2|3rd Intervention|Lost to Follow-up|0
6024879|NCT00758394|20826326|P1|3rd Intervention|Lost to Follow-up|1
6024880|NCT00758394|20826323|P4|2nd Intervention Order|Lost to Follow-up|0
6024881|NCT00758394|20826324|P3|2nd Intervention Order|Lost to Follow-up|0
6024882|NCT00758394|20826325|P2|2nd Intervention Order|Lost to Follow-up|1
6024883|NCT00758394|20826326|P1|2nd Intervention Order|Lost to Follow-up|0
6024884|NCT00758264|20826355|P3|Active Phase|Other|4
6024885|NCT00758264|20826356|P2|Active Phase|Other|0
6024886|NCT00758264|20826357|P1|Active Phase|Other|0
6024887|NCT00758264|20826355|P3|Active Phase|Lost to Follow-up|0
6024888|NCT00758264|20826356|P2|Active Phase|Lost to Follow-up|0
6024889|NCT00758264|20826357|P1|Active Phase|Lost to Follow-up|1
6024890|NCT00758264|20826355|P3|Active Phase|Withdrawal by Subject|1
6024891|NCT00758264|20826356|P2|Active Phase|Withdrawal by Subject|0
6024892|NCT00758264|20826357|P1|Active Phase|Withdrawal by Subject|0
6024893|NCT00758160|20826416|P1|Overall Study|Withdrawal by Subject|8
6024894|NCT00758160|20826416|P1|Overall Study|Protocol Violation|12
6024895|NCT00758160|20826416|P1|Overall Study|Lost to Follow-up|14
6024896|NCT00758160|20826416|P1|Overall Study|Lack of Efficacy|10
6024897|NCT00758160|20826416|P1|Overall Study|Adverse Event|15
6024898|NCT00758160|20826416|P1|Overall Study|Administration Problems|3
6024899|NCT00758160|20826416|P1|Overall Study|No Longer Requires Study Medication|4
6024900|NCT00758069|20826437|P3|Overall Study|Incorrect Study Drug|0
6024901|NCT00758069|20826438|P2|Overall Study|Incorrect Study Drug|0
6024902|NCT00758069|20826439|P1|Overall Study|Incorrect Study Drug|1
6024903|NCT00758069|20826437|P3|Overall Study|Lack of Efficacy|1
6024904|NCT00758069|20826438|P2|Overall Study|Lack of Efficacy|0
6024905|NCT00758069|20826439|P1|Overall Study|Lack of Efficacy|0
6024906|NCT00758043|20826454|P4|Overall Study|Other Reasons|5
6024907|NCT00758043|20826455|P3|Overall Study|Other Reasons|0
6024908|NCT00758043|20826456|P2|Overall Study|Other Reasons|1
6024909|NCT00758043|20826457|P1|Overall Study|Other Reasons|0
6024910|NCT00758043|20826454|P4|Overall Study|Non-Compliant With study Drug|1
6024911|NCT00758043|20826455|P3|Overall Study|Non-Compliant With study Drug|0
6024912|NCT00758043|20826456|P2|Overall Study|Non-Compliant With study Drug|0
6024913|NCT00758043|20826457|P1|Overall Study|Non-Compliant With study Drug|0
6024914|NCT00758043|20826454|P4|Overall Study|Required Prohibited Medication|3
6024915|NCT00758043|20826455|P3|Overall Study|Required Prohibited Medication|1
6024916|NCT00758043|20826456|P2|Overall Study|Required Prohibited Medication|0
6024917|NCT00758043|20826457|P1|Overall Study|Required Prohibited Medication|0
6024918|NCT00758043|20826454|P4|Overall Study|Withdrawal by Subject|4
6024919|NCT00758043|20826455|P3|Overall Study|Withdrawal by Subject|1
6024920|NCT00758043|20826456|P2|Overall Study|Withdrawal by Subject|1
6024921|NCT00758043|20826457|P1|Overall Study|Withdrawal by Subject|0
6024922|NCT00758043|20826454|P4|Overall Study|Lost to Follow-up|5
6024923|NCT00758043|20826455|P3|Overall Study|Lost to Follow-up|2
6024924|NCT00758043|20826456|P2|Overall Study|Lost to Follow-up|2
6024925|NCT00758043|20826457|P1|Overall Study|Lost to Follow-up|0
6024926|NCT00758043|20826454|P4|Overall Study|Refused Further Treatment|8
6024927|NCT00758043|20826455|P3|Overall Study|Refused Further Treatment|5
6024928|NCT00758043|20826456|P2|Overall Study|Refused Further Treatment|11
6024929|NCT00758043|20826457|P1|Overall Study|Refused Further Treatment|0
6024930|NCT00758043|20826454|P4|Overall Study|Lack of Efficacy|12
6024931|NCT00758043|20826455|P3|Overall Study|Lack of Efficacy|18
6024932|NCT00758043|20826456|P2|Overall Study|Lack of Efficacy|6
6024933|NCT00758043|20826457|P1|Overall Study|Lack of Efficacy|0
6024934|NCT00758043|20826454|P4|Overall Study|Adverse Event|62
6024935|NCT00758043|20826455|P3|Overall Study|Adverse Event|12
6024936|NCT00758043|20826456|P2|Overall Study|Adverse Event|20
6024937|NCT00758043|20826457|P1|Overall Study|Adverse Event|1
6024938|NCT00757848|20826485|P2|Overall Study|Incorrect enrolment|0
6024939|NCT00757848|20826486|P1|Overall Study|Incorrect enrolment|1
6024940|NCT00757848|20826485|P2|Overall Study|Adverse Event|2
6024941|NCT00757848|20826486|P1|Overall Study|Adverse Event|1
6024942|NCT00757848|20826485|P2|Overall Study|Voluntary discontinuation|0
6024943|NCT00757848|20826486|P1|Overall Study|Voluntary discontinuation|1
6024944|NCT00757783|20826555|P2|Overall Study|Other|2
6024945|NCT00757783|20826556|P1|Overall Study|Other|1
6024946|NCT00757783|20826555|P2|Overall Study|Withdrawal by Subject|1
6024947|NCT00757783|20826556|P1|Overall Study|Withdrawal by Subject|2
6024948|NCT00757783|20826555|P2|Overall Study|Protocol Violation|0
6024949|NCT00757783|20826556|P1|Overall Study|Protocol Violation|1
6024950|NCT00757783|20826555|P2|Overall Study|Lost to Follow-up|1
6024951|NCT00757783|20826556|P1|Overall Study|Lost to Follow-up|1
6024952|NCT00757783|20826555|P2|Overall Study|Adverse Event|2
6024953|NCT00757783|20826556|P1|Overall Study|Adverse Event|0
6024954|NCT00757705|20826592|P1|Overall Study|Other|18
6024955|NCT00757705|20826592|P1|Overall Study|Non-compliant|9
6024956|NCT00757705|20826592|P1|Overall Study|Ineligible to continue|8
6024957|NCT00757705|20826592|P1|Overall Study|Insufficient Response|26
6024958|NCT00757705|20826592|P1|Overall Study|Withdrawal by Subject|25
6024959|NCT00757705|20826592|P1|Overall Study|Lost to Follow-up|16
6024960|NCT00757705|20826592|P1|Overall Study|Adverse Event|19
6024961|NCT00757627|20826621|P1|Overall Study|Other|1
6024962|NCT00757627|20826621|P1|Overall Study|Withdrawal by Subject|27
6024963|NCT00757627|20826621|P1|Overall Study|Lost to Follow-up|28
6024964|NCT00757627|20826621|P1|Overall Study|Lack of Efficacy|10
6024965|NCT00757627|20826621|P1|Overall Study|Adverse Event|15
6024966|NCT00757588|20826756|P2|Period 2: Long-term (52-week) Phase|Other|0
6024967|NCT00757588|20826757|P1|Period 2: Long-term (52-week) Phase|Other|1
6024968|NCT00757588|20826756|P2|Period 2: Long-term (52-week) Phase|No longer meets study criteria|4
6024969|NCT00757588|20826757|P1|Period 2: Long-term (52-week) Phase|No longer meets study criteria|5
6024970|NCT00757588|20826756|P2|Period 2: Long-term (52-week) Phase|Pregnancy|0
6024971|NCT00757588|20826757|P1|Period 2: Long-term (52-week) Phase|Pregnancy|1
6024972|NCT00757588|20826756|P2|Period 2: Long-term (52-week) Phase|Poor or noncompliance|2
6024973|NCT00757588|20826757|P1|Period 2: Long-term (52-week) Phase|Poor or noncompliance|5
6024974|NCT00757588|20826756|P2|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1
6024975|NCT00757588|20826757|P1|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1
6024976|NCT00757588|20826756|P2|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|2
6024977|NCT00757588|20826757|P1|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|4
6024978|NCT00757588|20826756|P2|Period 2: Long-term (52-week) Phase|Adverse Event|0
6024979|NCT00757588|20826757|P1|Period 2: Long-term (52-week) Phase|Adverse Event|4
6024980|NCT00757588|20826756|P2|Period 2: Long-term (52-week) Phase|Lack of Efficacy|0
6024981|NCT00757588|20826757|P1|Period 2: Long-term (52-week) Phase|Lack of Efficacy|1
6024982|NCT00757588|20826756|P2|Period 1: Short-term (24-week) Phase|Other|1
6024983|NCT00757588|20826757|P1|Period 1: Short-term (24-week) Phase|Other|0
6024984|NCT00757588|20826756|P2|Period 1: Short-term (24-week) Phase|No longer meets study criteria|0
6024985|NCT00757588|20826757|P1|Period 1: Short-term (24-week) Phase|No longer meets study criteria|5
6024986|NCT00757588|20826756|P2|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|1
6024987|NCT00757588|20826757|P1|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|5
6024988|NCT00757588|20826756|P2|Period 1: Short-term (24-week) Phase|Lost to Follow-up|5
6024989|NCT00757588|20826757|P1|Period 1: Short-term (24-week) Phase|Lost to Follow-up|3
6024990|NCT00757588|20826756|P2|Period 1: Short-term (24-week) Phase|Death|0
6024991|NCT00757588|20826757|P1|Period 1: Short-term (24-week) Phase|Death|1
6024992|NCT00757588|20826756|P2|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|5
6024993|NCT00757588|20826757|P1|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|13
6024994|NCT00757588|20826756|P2|Period 1: Short-term (24-week) Phase|Adverse Event|3
6024995|NCT00757588|20826757|P1|Period 1: Short-term (24-week) Phase|Adverse Event|6
6024996|NCT00757588|20826756|P2|Period 1: Short-term (24-week) Phase|Lack of Efficacy|2
6024997|NCT00757588|20826757|P1|Period 1: Short-term (24-week) Phase|Lack of Efficacy|3
6024998|NCT00757237|20826798|P2|Overall Study|Other|2
6024999|NCT00757237|20826799|P1|Overall Study|Other|0
6025000|NCT00757237|20826798|P2|Overall Study|Safety or Tolerability|5
6025001|NCT00757237|20826799|P1|Overall Study|Safety or Tolerability|3
6025002|NCT00757237|20826798|P2|Overall Study|Withdrawal by Subject|12
6025003|NCT00757237|20826799|P1|Overall Study|Withdrawal by Subject|8
6025004|NCT00757237|20826798|P2|Overall Study|Physician Decision|3
6025005|NCT00757237|20826799|P1|Overall Study|Physician Decision|2
6025006|NCT00757237|20826798|P2|Overall Study|Protocol Violation|2
6025007|NCT00757237|20826799|P1|Overall Study|Protocol Violation|0
6025008|NCT00757237|20826798|P2|Overall Study|Lost to Follow-up|1
6025009|NCT00757237|20826799|P1|Overall Study|Lost to Follow-up|0
6025010|NCT00757172|20826827|P1|Overall Study|Progression|4
6025011|NCT00757172|20826827|P1|Overall Study|Physician Decision|3
6025012|NCT00757172|20826827|P1|Overall Study|Withdrawal by Subject|4
6025013|NCT00757003|20826835|P1|Overall Study|Not implanted|1
6025014|NCT00757003|20826835|P1|Overall Study|Surgically explanted|2
6025015|NCT00757003|20826835|P1|Overall Study|Withdrawal by Subject|4
6025016|NCT00757003|20826835|P1|Overall Study|Lost to Follow-up|9
6025017|NCT00757003|20826835|P1|Overall Study|Death|33
6025018|NCT00756938|20826882|P4|Optional Extension|Adverse Event|1
6025019|NCT00756938|20826883|P3|Optional Extension|Adverse Event|0
6025020|NCT00756938|20826884|P2|Optional Extension|Adverse Event|0
6025021|NCT00756938|20826885|P1|Optional Extension|Adverse Event|0
6025022|NCT00756938|20826882|P4|Optional Extension|Withdrawal by Subject|10
6025023|NCT00756938|20826883|P3|Optional Extension|Withdrawal by Subject|0
6025024|NCT00756938|20826884|P2|Optional Extension|Withdrawal by Subject|0
6025025|NCT00756938|20826885|P1|Optional Extension|Withdrawal by Subject|0
6025026|NCT00756938|20826882|P4|Optional Extension|Protocol Violation|1
6025027|NCT00756938|20826883|P3|Optional Extension|Protocol Violation|0
6025028|NCT00756938|20826884|P2|Optional Extension|Protocol Violation|0
6025029|NCT00756938|20826885|P1|Optional Extension|Protocol Violation|0
6025030|NCT00756938|20826882|P4|Optional Extension|Lost to Follow-up|1
6025031|NCT00756938|20826883|P3|Optional Extension|Lost to Follow-up|0
6025032|NCT00756938|20826884|P2|Optional Extension|Lost to Follow-up|0
6025033|NCT00756938|20826885|P1|Optional Extension|Lost to Follow-up|0
6025034|NCT00756938|20826882|P4|Optional Extension|Physician Decision|3
6025035|NCT00756938|20826883|P3|Optional Extension|Physician Decision|0
6025036|NCT00756938|20826884|P2|Optional Extension|Physician Decision|0
6025037|NCT00756938|20826885|P1|Optional Extension|Physician Decision|0
6025038|NCT00756938|20826882|P4|Optional Extension|Protocol-specific criteria met|9
6025039|NCT00756938|20826883|P3|Optional Extension|Protocol-specific criteria met|0
6025040|NCT00756938|20826884|P2|Optional Extension|Protocol-specific criteria met|0
6025041|NCT00756938|20826885|P1|Optional Extension|Protocol-specific criteria met|0
6025042|NCT00756938|20826882|P4|Optional Extension|End of Study|11
6025043|NCT00756938|20826883|P3|Optional Extension|End of Study|0
6025044|NCT00756938|20826884|P2|Optional Extension|End of Study|0
6025045|NCT00756938|20826885|P1|Optional Extension|End of Study|0
6025046|NCT00756938|20826882|P4|Optional Extension|Lack of Efficacy|1
6025047|NCT00756938|20826883|P3|Optional Extension|Lack of Efficacy|0
6025048|NCT00756938|20826884|P2|Optional Extension|Lack of Efficacy|0
6025049|NCT00756938|20826885|P1|Optional Extension|Lack of Efficacy|0
6025050|NCT00756938|20826882|P4|12-week Base Study|Lost to Follow-up|0
6025051|NCT00756938|20826883|P3|12-week Base Study|Lost to Follow-up|0
6025052|NCT00756938|20826884|P2|12-week Base Study|Lost to Follow-up|0
6025053|NCT00756938|20826885|P1|12-week Base Study|Lost to Follow-up|1
6025054|NCT00756938|20826882|P4|12-week Base Study|Protocol Violation|0
6025055|NCT00756938|20826883|P3|12-week Base Study|Protocol Violation|1
6025056|NCT00756938|20826884|P2|12-week Base Study|Protocol Violation|0
6025057|NCT00756938|20826885|P1|12-week Base Study|Protocol Violation|0
6025058|NCT00756938|20826882|P4|12-week Base Study|Protocol-specific Criteria Met|0
6025059|NCT00756938|20826883|P3|12-week Base Study|Protocol-specific Criteria Met|1
6025060|NCT00756938|20826884|P2|12-week Base Study|Protocol-specific Criteria Met|0
6025061|NCT00756938|20826885|P1|12-week Base Study|Protocol-specific Criteria Met|1
6025062|NCT00756886|20826913|P2|Overall Study|Ineligible|4
6025063|NCT00756886|20826914|P1|Overall Study|Ineligible|9
6025064|NCT00756886|20826913|P2|Overall Study|Lack of Efficacy|0
6025065|NCT00756886|20826914|P1|Overall Study|Lack of Efficacy|1
6025066|NCT00756886|20826913|P2|Overall Study|Adverse Event|3
6025067|NCT00756886|20826914|P1|Overall Study|Adverse Event|0
6025068|NCT00756886|20826913|P2|Overall Study|Lost to Follow-up|0
6025069|NCT00756886|20826914|P1|Overall Study|Lost to Follow-up|1
6025070|NCT00756730|20826922|P2|Overall Study|persistent low-level viremmia|1
6025071|NCT00756730|20826923|P1|Overall Study|persistent low-level viremmia|0
6025072|NCT00756730|20826922|P2|Overall Study|discontinued due to rash prior to week 4|1
6025073|NCT00756730|20826923|P1|Overall Study|discontinued due to rash prior to week 4|0
6025074|NCT00756717|20826943|P1|Overall Study|Withdrawal by Subject|2
6025075|NCT00756652|20826960|P2|Re-Op Phase|Withdrawn after explant|0
6025076|NCT00756652|20826961|P1|Re-Op Phase|Withdrawn after explant|14
6025077|NCT00756652|20826960|P2|Re-Op Phase|Site Closed|0
6025078|NCT00756652|20826961|P1|Re-Op Phase|Site Closed|2454
6025079|NCT00756652|20826960|P2|Re-Op Phase|Lost to Follow-up|0
6025080|NCT00756652|20826961|P1|Re-Op Phase|Lost to Follow-up|340
6025081|NCT00756652|20826960|P2|Re-Op Phase|Death|0
6025082|NCT00756652|20826961|P1|Re-Op Phase|Death|6
6025083|NCT00756652|20826960|P2|Re-Op Phase|Withdrawal by Subject|0
6025084|NCT00756652|20826961|P1|Re-Op Phase|Withdrawal by Subject|62
6025085|NCT00756652|20826960|P2|Original Phase|Not due for F/U at Phase One closure|2
6025086|NCT00756652|20826961|P1|Original Phase|Not due for F/U at Phase One closure|11076
6025087|NCT00756652|20826960|P2|Original Phase|Death|1
6025088|NCT00756652|20826961|P1|Original Phase|Death|168
6025089|NCT00756652|20826960|P2|Original Phase|Participants without data|466
6025090|NCT00756652|20826961|P1|Original Phase|Participants without data|3259
6025091|NCT00756652|20826960|P2|Original Phase|Unknown Discontinuation Reason|0
6025092|NCT00756652|20826961|P1|Original Phase|Unknown Discontinuation Reason|2
6025093|NCT00756652|20826960|P2|Original Phase|Participant Noncompliance|424
6025094|NCT00756652|20826961|P1|Original Phase|Participant Noncompliance|18622
6025095|NCT00756652|20826960|P2|Original Phase|Other Discontinuation|5
6025096|NCT00756652|20826961|P1|Original Phase|Other Discontinuation|797
6025097|NCT00756652|20826960|P2|Original Phase|Lost to Follow-up|0
6025098|NCT00756652|20826961|P1|Original Phase|Lost to Follow-up|601
6025099|NCT00756652|20826960|P2|Original Phase|Withdrawal by Subject|23
6025100|NCT00756652|20826961|P1|Original Phase|Withdrawal by Subject|864
6025101|NCT00756574|20827072|P2|Overall Study|Lost to Follow-up|4
6025102|NCT00756574|20827073|P1|Overall Study|Lost to Follow-up|4
6025103|NCT00756574|20827072|P2|Overall Study|Withdrawal by Subject|7
6025104|NCT00756574|20827073|P1|Overall Study|Withdrawal by Subject|9
6025105|NCT00756470|20827122|P1|Overall Study|Adverse Event|4
6025106|NCT00756470|20827122|P1|Overall Study|Withdrawal by Subject|1
6025107|NCT00756457|20827129|P2|Overall Study|Lost to Follow-up|2
6025108|NCT00756457|20827130|P1|Overall Study|Lost to Follow-up|1
6025109|NCT00756444|20827160|P2|Overall Study|Ineligibility Determined|0
6025110|NCT00756444|20827161|P1|Overall Study|Ineligibility Determined|1
6025111|NCT00756444|20827160|P2|Overall Study|Disease Progression|7
6025112|NCT00756444|20827161|P1|Overall Study|Disease Progression|2
6025113|NCT00756444|20827160|P2|Overall Study|Death|4
6025114|NCT00756444|20827161|P1|Overall Study|Death|5
6025115|NCT00756444|20827160|P2|Overall Study|Lost to Follow-up|1
6025116|NCT00756444|20827161|P1|Overall Study|Lost to Follow-up|0
6025117|NCT00756444|20827160|P2|Overall Study|Withdrawal by Subject|8
6025118|NCT00756444|20827161|P1|Overall Study|Withdrawal by Subject|6
6025119|NCT00756444|20827160|P2|Overall Study|Adverse Event|1
6025120|NCT00756444|20827161|P1|Overall Study|Adverse Event|1
6025121|NCT00756314|20827172|P2|Overall Study|Lost to Follow-up|59
6025122|NCT00756314|20827173|P1|Overall Study|Lost to Follow-up|2
6025123|NCT00756275|20827189|P2|Overall Study|Withdrawal by Subject|7
6025124|NCT00756275|20827190|P1|Overall Study|Withdrawal by Subject|4
6025125|NCT00756275|20827189|P2|Overall Study|Lost to Follow-up|21
6025126|NCT00756275|20827190|P1|Overall Study|Lost to Follow-up|25
6025127|NCT00756002|20827254|P2|Double-Blind Treatment Period|Other|2
6025128|NCT00756002|20827255|P1|Double-Blind Treatment Period|Other|2
6025129|NCT00756002|20827254|P2|Double-Blind Treatment Period|Protocol Violation|5
6025130|NCT00756002|20827255|P1|Double-Blind Treatment Period|Protocol Violation|6
6025131|NCT00756002|20827254|P2|Double-Blind Treatment Period|Withdrawal by Subject|6
6025132|NCT00756002|20827255|P1|Double-Blind Treatment Period|Withdrawal by Subject|6
6025133|NCT00756002|20827254|P2|Double-Blind Treatment Period|Lost to Follow-up|1
6025134|NCT00756002|20827255|P1|Double-Blind Treatment Period|Lost to Follow-up|0
6025135|NCT00756002|20827254|P2|Double-Blind Treatment Period|Lack of Efficacy|1
6025136|NCT00756002|20827255|P1|Double-Blind Treatment Period|Lack of Efficacy|1
6025137|NCT00755937|20827349|P1|Observational Follow-up|Lost to Follow-up|148
6025138|NCT00755937|20827349|P1|Recruitment|Unknown if infliximab received|164
6025139|NCT00755846|20827376|P6|Overall Study|Participant Non-compliance|0
6025140|NCT00755846|20827377|P5|Overall Study|Participant Non-compliance|1
6025141|NCT00755846|20827378|P4|Overall Study|Participant Non-compliance|0
6025142|NCT00755846|20827379|P3|Overall Study|Participant Non-compliance|0
6025143|NCT00755846|20827380|P2|Overall Study|Participant Non-compliance|0
6025144|NCT00755846|20827381|P1|Overall Study|Participant Non-compliance|0
6025145|NCT00755846|20827376|P6|Overall Study|Administrative Error|0
6025146|NCT00755846|20827377|P5|Overall Study|Administrative Error|0
6025147|NCT00755846|20827378|P4|Overall Study|Administrative Error|0
6025148|NCT00755846|20827379|P3|Overall Study|Administrative Error|0
6025149|NCT00755846|20827380|P2|Overall Study|Administrative Error|1
6025150|NCT00755846|20827381|P1|Overall Study|Administrative Error|0
6025151|NCT00755846|20827376|P6|Overall Study|Physician Decision|1
6025152|NCT00755846|20827377|P5|Overall Study|Physician Decision|0
6025153|NCT00755846|20827378|P4|Overall Study|Physician Decision|1
6025154|NCT00755846|20827379|P3|Overall Study|Physician Decision|0
6025155|NCT00755846|20827380|P2|Overall Study|Physician Decision|3
6025156|NCT00755846|20827381|P1|Overall Study|Physician Decision|1
6025157|NCT00755846|20827376|P6|Overall Study|Hyperglycemic Rescue|7
6025158|NCT00755846|20827377|P5|Overall Study|Hyperglycemic Rescue|8
6025159|NCT00755846|20827378|P4|Overall Study|Hyperglycemic Rescue|8
6025160|NCT00755846|20827379|P3|Overall Study|Hyperglycemic Rescue|5
6025161|NCT00755846|20827380|P2|Overall Study|Hyperglycemic Rescue|7
6025162|NCT00755846|20827381|P1|Overall Study|Hyperglycemic Rescue|21
6025163|NCT00755846|20827376|P6|Overall Study|Withdrawal by Subject|1
6025164|NCT00755846|20827377|P5|Overall Study|Withdrawal by Subject|0
6025165|NCT00755846|20827378|P4|Overall Study|Withdrawal by Subject|2
6025166|NCT00755846|20827379|P3|Overall Study|Withdrawal by Subject|5
6025167|NCT00755846|20827380|P2|Overall Study|Withdrawal by Subject|3
6025168|NCT00755846|20827381|P1|Overall Study|Withdrawal by Subject|2
6025169|NCT00755846|20827376|P6|Overall Study|Lost to Follow-up|2
6025170|NCT00755846|20827377|P5|Overall Study|Lost to Follow-up|4
6025171|NCT00755846|20827378|P4|Overall Study|Lost to Follow-up|0
6025172|NCT00755846|20827379|P3|Overall Study|Lost to Follow-up|1
6025173|NCT00755846|20827380|P2|Overall Study|Lost to Follow-up|2
6025174|NCT00755846|20827381|P1|Overall Study|Lost to Follow-up|0
6025175|NCT00755846|20827376|P6|Overall Study|Protocol Violation|1
6025176|NCT00755846|20827377|P5|Overall Study|Protocol Violation|1
6025177|NCT00755846|20827378|P4|Overall Study|Protocol Violation|1
6025178|NCT00755846|20827379|P3|Overall Study|Protocol Violation|1
6025179|NCT00755846|20827380|P2|Overall Study|Protocol Violation|1
6025180|NCT00755846|20827381|P1|Overall Study|Protocol Violation|1
6025181|NCT00755846|20827376|P6|Overall Study|Adverse Event|2
6025182|NCT00755846|20827377|P5|Overall Study|Adverse Event|3
6025183|NCT00755846|20827378|P4|Overall Study|Adverse Event|1
6025184|NCT00755846|20827379|P3|Overall Study|Adverse Event|0
6025185|NCT00755846|20827380|P2|Overall Study|Adverse Event|0
6025186|NCT00755846|20827381|P1|Overall Study|Adverse Event|0
6025187|NCT00755807|20827481|P2|Open-label Extension Phase|Sponsor Decision|1
6025188|NCT00755807|20827482|P1|Open-label Extension Phase|Sponsor Decision|0
6025189|NCT00755807|20827481|P2|Open-label Extension Phase|Lost to Follow-up|0
6025190|NCT00755807|20827482|P1|Open-label Extension Phase|Lost to Follow-up|2
6025191|NCT00755807|20827481|P2|Open-label Extension Phase|Withdrawal by Subject|3
6025192|NCT00755807|20827482|P1|Open-label Extension Phase|Withdrawal by Subject|1
6025193|NCT00755807|20827481|P2|Open-label Extension Phase|Lack of Efficacy|3
6025194|NCT00755807|20827482|P1|Open-label Extension Phase|Lack of Efficacy|3
6025195|NCT00755807|20827481|P2|Open-label Extension Phase|Protocol Violation|2
6025196|NCT00755807|20827482|P1|Open-label Extension Phase|Protocol Violation|5
6025197|NCT00755807|20827481|P2|Open-label Extension Phase|Adverse Event|7
6025198|NCT00755807|20827482|P1|Open-label Extension Phase|Adverse Event|7
6025199|NCT00755807|20827481|P2|Acute Phase|Physician Decision|1
6025200|NCT00755807|20827482|P1|Acute Phase|Physician Decision|0
6025201|NCT00755807|20827481|P2|Acute Phase|Lack of Efficacy|1
6025202|NCT00755807|20827482|P1|Acute Phase|Lack of Efficacy|0
6025203|NCT00755807|20827481|P2|Acute Phase|Withdrawal by Subject|2
6025204|NCT00755807|20827482|P1|Acute Phase|Withdrawal by Subject|1
6025205|NCT00755807|20827481|P2|Acute Phase|Protocol Violation|3
6025206|NCT00755807|20827482|P1|Acute Phase|Protocol Violation|1
6025207|NCT00755807|20827481|P2|Acute Phase|Adverse Event|5
6025208|NCT00755807|20827482|P1|Acute Phase|Adverse Event|16
6025209|NCT00755716|20827562|P3|Overall Study|work schedule issues|1
6025210|NCT00755716|20827563|P2|Overall Study|work schedule issues|1
6025211|NCT00755716|20827564|P1|Overall Study|work schedule issues|0
6025212|NCT00755716|20827562|P3|Overall Study|Lost to Follow-up|1
6025213|NCT00755716|20827563|P2|Overall Study|Lost to Follow-up|3
6025214|NCT00755716|20827564|P1|Overall Study|Lost to Follow-up|5
6025215|NCT00755716|20827562|P3|Overall Study|Lack of Efficacy|0
6025216|NCT00755716|20827563|P2|Overall Study|Lack of Efficacy|0
6025217|NCT00755716|20827564|P1|Overall Study|Lack of Efficacy|2
6025218|NCT00755716|20827562|P3|Overall Study|Adverse Event|1
6025219|NCT00755716|20827563|P2|Overall Study|Adverse Event|4
6025220|NCT00755716|20827564|P1|Overall Study|Adverse Event|1
6025221|NCT00755417|20827578|P3|Overall Study|Not specified or missing data|12
6025222|NCT00755417|20827579|P2|Overall Study|Not specified or missing data|18
6025223|NCT00755417|20827580|P1|Overall Study|Not specified or missing data|9
6025224|NCT00755417|20827578|P3|Overall Study|Withdrawal by Subject|12
6025225|NCT00755417|20827579|P2|Overall Study|Withdrawal by Subject|12
6025226|NCT00755417|20827580|P1|Overall Study|Withdrawal by Subject|12
6025227|NCT00755417|20827578|P3|Overall Study|Lost to Follow-up|1
6025228|NCT00755417|20827579|P2|Overall Study|Lost to Follow-up|0
6025229|NCT00755417|20827580|P1|Overall Study|Lost to Follow-up|3
6025230|NCT00755417|20827578|P3|Overall Study|Protocol Violation|1
6025231|NCT00755417|20827579|P2|Overall Study|Protocol Violation|1
6025232|NCT00755417|20827580|P1|Overall Study|Protocol Violation|2
6025233|NCT00755417|20827578|P3|Overall Study|Lack of Efficacy|9
6025234|NCT00755417|20827579|P2|Overall Study|Lack of Efficacy|4
6025235|NCT00755417|20827580|P1|Overall Study|Lack of Efficacy|8
6025236|NCT00755417|20827578|P3|Overall Study|Adverse Event|7
6025237|NCT00755417|20827579|P2|Overall Study|Adverse Event|20
6025238|NCT00755417|20827580|P1|Overall Study|Adverse Event|28
6025239|NCT00755326|20827599|P2|Overall Study|Lost to Follow-up|3
6025240|NCT00755326|20827600|P1|Overall Study|Lost to Follow-up|2
6025241|NCT00755222|20827650|P2|Overall Study|Protocol Violation|0
6025242|NCT00755222|20827651|P1|Overall Study|Protocol Violation|2
6025243|NCT00755222|20827650|P2|Overall Study|Adverse Event|0
6025244|NCT00755222|20827651|P1|Overall Study|Adverse Event|2
6025245|NCT00755222|20827650|P2|Overall Study|Withdrawal by Subject|2
6025246|NCT00755222|20827651|P1|Overall Study|Withdrawal by Subject|4
6025247|NCT00755196|20827665|P1|Overall Study|Lack of Efficiency|1
6025248|NCT00755196|20827665|P1|Overall Study|Lost to Follow-up|1
6025249|NCT00755183|20827672|P2|Overall Study|Administrative|1
6025250|NCT00755183|20827673|P1|Overall Study|Administrative|2
6025251|NCT00755183|20827672|P2|Overall Study|Withdrawal by Subject|2
6025252|NCT00755183|20827673|P1|Overall Study|Withdrawal by Subject|0
6025253|NCT00755183|20827672|P2|Overall Study|Protocol Violation|1
6025254|NCT00755183|20827673|P1|Overall Study|Protocol Violation|0
6025255|NCT00755183|20827672|P2|Overall Study|Adverse Event|2
6025256|NCT00755183|20827673|P1|Overall Study|Adverse Event|5
6025257|NCT00755105|20827697|P3|Overall Study|Withdrawal by Subject|4
6025258|NCT00755105|20827698|P2|Overall Study|Withdrawal by Subject|11
6025259|NCT00755105|20827699|P1|Overall Study|Withdrawal by Subject|9
6025260|NCT00755079|20827709|P2|Overall Study|Withdrawal by Subject|2
6025261|NCT00755079|20827710|P1|Overall Study|Withdrawal by Subject|0
6025262|NCT00755079|20827709|P2|Overall Study|Adverse Event|1
6025263|NCT00755079|20827710|P1|Overall Study|Adverse Event|0
6025264|NCT00755079|20827709|P2|Overall Study|Lost to Follow-up|3
6025265|NCT00755079|20827710|P1|Overall Study|Lost to Follow-up|1
6025266|NCT00754936|20827729|P1|Overall Study|Inter-current medical events|3
6025267|NCT00754936|20827729|P1|Overall Study|Side Effects|3
6025268|NCT00754936|20827729|P1|Overall Study|Withdrawal by Subject|2
6025269|NCT00754936|20827729|P1|Overall Study|Physician Decision|1
6025270|NCT00754936|20827729|P1|Overall Study|Lost to Follow-up|3
6025271|NCT00754793|20827769|P2|Overall Study|voluntary withdrawn from study|1
6025272|NCT00754793|20827770|P1|Overall Study|voluntary withdrawn from study|0
6025273|NCT00754741|20827788|P3|Overall Study|Died or disenrolled|54
6025274|NCT00754741|20827789|P2|Overall Study|Died or disenrolled|69
6025275|NCT00754741|20827790|P1|Overall Study|Died or disenrolled|57
6025276|NCT00754650|20827837|P1|Overall Study|Disease Progression|2
6025277|NCT00754624|20827842|P1|Overall Study|Lost to Follow-up|3
6025278|NCT00754624|20827842|P1|Overall Study|Various|12
6025279|NCT00754624|20827842|P1|Overall Study|Withdrawal by Subject|28
6025280|NCT00754624|20827842|P1|Overall Study|Protocol Violation|1
6025281|NCT00754624|20827842|P1|Overall Study|Physician Decision|8
6025282|NCT00754624|20827842|P1|Overall Study|Death|1
6025283|NCT00754624|20827842|P1|Overall Study|Adverse Event|16
6025284|NCT00754572|20827852|P1|Overall Study|Lost to Follow-up|1
6025285|NCT00754572|20827852|P1|Overall Study|Administrative Reason|3
6025286|NCT00754572|20827852|P1|Overall Study|Death|1
6025287|NCT00754572|20827852|P1|Overall Study|Lack of Efficacy|2
6025288|NCT00754572|20827852|P1|Overall Study|Withdrawal by Subject|3
6025289|NCT00754572|20827852|P1|Overall Study|Protocol Violation|3
6025290|NCT00754572|20827852|P1|Overall Study|Other|39
6025291|NCT00754572|20827852|P1|Overall Study|Adverse Event|19
6025292|NCT00754559|20827879|P1|Overall Study|Withdrawal by Subject|3
6025293|NCT00754559|20827879|P1|Overall Study|Other|5
6025294|NCT00754559|20827879|P1|Overall Study|Administrative reason|1
6025295|NCT00754559|20827879|P1|Overall Study|Lost to Follow-up|2
6025296|NCT00754559|20827879|P1|Overall Study|Lack of Efficacy|10
6025297|NCT00754559|20827879|P1|Overall Study|Protocol Violation|11
6025298|NCT00754559|20827879|P1|Overall Study|Adverse Event|15
6025299|NCT00754442|20827979|P2|Overall Study|Withdrawal by Subject|3
6025300|NCT00754442|20827980|P1|Overall Study|Withdrawal by Subject|5
6025301|NCT00754390|20827987|P1|Ca/Phytate Test Meal 4 (Randomized)|Protocol Violation|1
6025302|NCT00754390|20827987|P1|Ca/Phytate Test Meal 3 (Randomized)|Protocol Violation|1
6025303|NCT00754390|20827987|P1|Ca/Phytate Test Meal 1 (Randomized)|Protocol Violation|2
6025304|NCT00754390|20827987|P1|Ca/Phytate Test Meal 1 (Randomized)|Withdrawal by Subject|3
6025305|NCT00754338|20828009|P4|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1
6025306|NCT00754338|20828010|P3|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0
6025307|NCT00754338|20828011|P2|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1
6025308|NCT00754338|20828012|P1|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0
6025309|NCT00754338|20828009|P4|First Intervention for Phase1&Phase2|Withdrawal by Subject|0
6025310|NCT00754338|20828010|P3|First Intervention for Phase1&Phase2|Withdrawal by Subject|3
6025311|NCT00754338|20828011|P2|First Intervention for Phase1&Phase2|Withdrawal by Subject|3
6025312|NCT00754338|20828012|P1|First Intervention for Phase1&Phase2|Withdrawal by Subject|0
6025313|NCT00754325|20828044|P2|Initial Treatment|Disease Progression|35
6025314|NCT00754325|20828045|P1|Initial Treatment|Disease Progression|35
6025315|NCT00754325|20828044|P2|Initial Treatment|Sponsor Request|1
6025316|NCT00754325|20828045|P1|Initial Treatment|Sponsor Request|0
6025317|NCT00754325|20828044|P2|Initial Treatment|Physician Decision|0
6025318|NCT00754325|20828045|P1|Initial Treatment|Physician Decision|2
6025319|NCT00754325|20828044|P2|Initial Treatment|Withdrawal by Subject|2
6025320|NCT00754325|20828045|P1|Initial Treatment|Withdrawal by Subject|2
6025321|NCT00754325|20828044|P2|Initial Treatment|Adverse Event|6
6025322|NCT00754325|20828045|P1|Initial Treatment|Adverse Event|7
6025323|NCT00754325|20828044|P2|Initial Treatment|Continuing Active Treatment|5
6025324|NCT00754325|20828045|P1|Initial Treatment|Continuing Active Treatment|4
6025325|NCT00754234|20828098|P1|Overall Study|Withdrawal by Subject|3
6025326|NCT00754065|20828184|P2|Overall Study|Reason not specified or unknown, etc.|27
6025327|NCT00754065|20828185|P1|Overall Study|Reason not specified or unknown, etc.|21
6025328|NCT00754065|20828184|P2|Overall Study|Pregnancy|0
6025329|NCT00754065|20828185|P1|Overall Study|Pregnancy|6
6025330|NCT00754065|20828184|P2|Overall Study|Withdrawal by Subject|5
6025331|NCT00754065|20828185|P1|Overall Study|Withdrawal by Subject|4
6025332|NCT00754065|20828184|P2|Overall Study|Protocol Violation|10
6025333|NCT00754065|20828185|P1|Overall Study|Protocol Violation|12
6025334|NCT00754065|20828184|P2|Overall Study|Lost to Follow-up|11
6025335|NCT00754065|20828185|P1|Overall Study|Lost to Follow-up|7
6025336|NCT00754065|20828184|P2|Overall Study|Adverse Event|25
6025337|NCT00754065|20828185|P1|Overall Study|Adverse Event|19
6025338|NCT00754065|20828184|P2|Overall Study|Never received treatment|2
6025339|NCT00754065|20828185|P1|Overall Study|Never received treatment|12
6025340|NCT00754052|20828425|P2|Overall Study|Study terminated by Sponsor|3
6025341|NCT00754052|20828426|P1|Overall Study|Study terminated by Sponsor|5
6025342|NCT00754013|20828440|P2|Overall Study|didn't return after study termed|4
6025343|NCT00754013|20828441|P1|Overall Study|didn't return after study termed|3
6025344|NCT00754013|20828440|P2|Overall Study|Lost to Follow-up|1
6025345|NCT00754013|20828441|P1|Overall Study|Lost to Follow-up|1
6025346|NCT00753922|20828478|P4|Overall Study|Discontinuation Due to Explantation|4
6025347|NCT00753922|20828479|P3|Overall Study|Discontinuation Due to Explantation|14
6025348|NCT00753922|20828480|P2|Overall Study|Discontinuation Due to Explantation|14
6025349|NCT00753922|20828481|P1|Overall Study|Discontinuation Due to Explantation|14
6025350|NCT00753922|20828478|P4|Overall Study|Death|1
6025351|NCT00753922|20828479|P3|Overall Study|Death|2
6025352|NCT00753922|20828480|P2|Overall Study|Death|23
6025353|NCT00753922|20828481|P1|Overall Study|Death|2
6025354|NCT00753922|20828478|P4|Overall Study|Patients Not Completing Visit|0
6025355|NCT00753922|20828479|P3|Overall Study|Patients Not Completing Visit|1
6025356|NCT00753922|20828480|P2|Overall Study|Patients Not Completing Visit|0
6025357|NCT00753922|20828481|P1|Overall Study|Patients Not Completing Visit|11
6025358|NCT00753922|20828478|P4|Overall Study|Patient Non-compliance|11
6025359|NCT00753922|20828479|P3|Overall Study|Patient Non-compliance|14
6025360|NCT00753922|20828480|P2|Overall Study|Patient Non-compliance|22
6025361|NCT00753922|20828481|P1|Overall Study|Patient Non-compliance|55
6025362|NCT00753922|20828478|P4|Overall Study|Withdrawal by Subject|2
6025363|NCT00753922|20828479|P3|Overall Study|Withdrawal by Subject|4
6025364|NCT00753922|20828480|P2|Overall Study|Withdrawal by Subject|11
6025365|NCT00753922|20828481|P1|Overall Study|Withdrawal by Subject|9
6025366|NCT00753922|20828478|P4|Overall Study|Lost to Follow-up|5
6025367|NCT00753922|20828479|P3|Overall Study|Lost to Follow-up|28
6025368|NCT00753922|20828480|P2|Overall Study|Lost to Follow-up|24
6025369|NCT00753922|20828481|P1|Overall Study|Lost to Follow-up|155
6025370|NCT00753896|20828511|P1|Overall Study|Entry Criteria Not Met|4
6025371|NCT00753896|20828511|P1|Overall Study|Withdrawal by Subject|4
6025372|NCT00753896|20828511|P1|Overall Study|Protocol Violation|1
6025373|NCT00753896|20828511|P1|Overall Study|Lost to Follow-up|2
6025374|NCT00753896|20828511|P1|Overall Study|Death|1
6025375|NCT00753896|20828511|P1|Overall Study|Adverse Event|4
6025376|NCT00753766|20828527|P2|Overall Study|Physician Decision|0
6025377|NCT00753766|20828528|P1|Overall Study|Physician Decision|1
6025378|NCT00753714|20828550|P2|Overall Study|Other|5
6025379|NCT00753714|20828551|P1|Overall Study|Other|7
6025380|NCT00753714|20828550|P2|Overall Study|Death|3
6025381|NCT00753714|20828551|P1|Overall Study|Death|3
6025382|NCT00753714|20828550|P2|Overall Study|Withdrawal by Subject|1
6025383|NCT00753714|20828551|P1|Overall Study|Withdrawal by Subject|2
6025384|NCT00753714|20828550|P2|Overall Study|Lost to Follow-up|1
6025385|NCT00753714|20828551|P1|Overall Study|Lost to Follow-up|0
6025386|NCT00753714|20828550|P2|Overall Study|Protocol Violation|0
6025387|NCT00753714|20828551|P1|Overall Study|Protocol Violation|1
6025388|NCT00753714|20828550|P2|Overall Study|Adverse Event|18
6025389|NCT00753714|20828551|P1|Overall Study|Adverse Event|26
6025390|NCT00753714|20828550|P2|Overall Study|Lack of Efficacy|34
6025391|NCT00753714|20828551|P1|Overall Study|Lack of Efficacy|21
6025392|NCT00753688|20828567|P2|Overall Study|Adverse Event|1
6025393|NCT00753688|20828568|P1|Overall Study|Adverse Event|0
6025394|NCT00753688|20828567|P2|Overall Study|Ongoing - in Follow-up|31
6025395|NCT00753688|20828568|P1|Overall Study|Ongoing - in Follow-up|15
6025396|NCT00753688|20828567|P2|Overall Study|Participant Withdrew Consent|2
6025397|NCT00753688|20828568|P1|Overall Study|Participant Withdrew Consent|2
6025398|NCT00753688|20828567|P2|Overall Study|Missing|9
6025399|NCT00753688|20828568|P1|Overall Study|Missing|4
6025400|NCT00753688|20828567|P2|Overall Study|Death|203
6025401|NCT00753688|20828568|P1|Overall Study|Death|102
6025402|NCT00753675|20828597|P3|Overall Study|Lost to Follow-up|0
6025403|NCT00753675|20828598|P2|Overall Study|Lost to Follow-up|0
6025404|NCT00753675|20828599|P1|Overall Study|Lost to Follow-up|1
6025405|NCT00753675|20828597|P3|Overall Study|Withdrawal by Subject|0
6025406|NCT00753675|20828598|P2|Overall Study|Withdrawal by Subject|1
6025407|NCT00753675|20828599|P1|Overall Study|Withdrawal by Subject|0
6025408|NCT00753675|20828597|P3|Overall Study|Objective progression of disease|35
6025409|NCT00753675|20828598|P2|Overall Study|Objective progression of disease|35
6025410|NCT00753675|20828599|P1|Overall Study|Objective progression of disease|35
6025411|NCT00753675|20828597|P3|Overall Study|Adverse Event|4
6025412|NCT00753675|20828598|P2|Overall Study|Adverse Event|9
6025413|NCT00753675|20828599|P1|Overall Study|Adverse Event|11
6025414|NCT00753675|20828597|P3|Overall Study|Death|4
6025415|NCT00753675|20828598|P2|Overall Study|Death|2
6025416|NCT00753675|20828599|P1|Overall Study|Death|1
6025417|NCT00753675|20828597|P3|Overall Study|other reason|13
6025418|NCT00753675|20828598|P2|Overall Study|other reason|12
6025419|NCT00753675|20828599|P1|Overall Study|other reason|11
6025420|NCT00753649|20828621|P2|Overall Study|Protocol Violation|0
6025421|NCT00753649|20828622|P1|Overall Study|Protocol Violation|2
6025422|NCT00753649|20828621|P2|Overall Study|Lost to follow-up-complete vaccination|0
6025423|NCT00753649|20828622|P1|Overall Study|Lost to follow-up-complete vaccination|1
6025424|NCT00753649|20828621|P2|Overall Study|Lost to follow-up-incomplete vaccination|0
6025425|NCT00753649|20828622|P1|Overall Study|Lost to follow-up-incomplete vaccination|3
6025426|NCT00753649|20828621|P2|Overall Study|Migrated/moved from study area|0
6025427|NCT00753649|20828622|P1|Overall Study|Migrated/moved from study area|1
6025428|NCT00753623|20828654|P2|Phase II (14 Days)|Physician Decision|1
6025429|NCT00753623|20828655|P1|Phase II (14 Days)|Physician Decision|0
6025430|NCT00753623|20828654|P2|Washout (7 Days)|Physician Decision|0
6025431|NCT00753623|20828655|P1|Washout (7 Days)|Physician Decision|1
6025432|NCT00753623|20828654|P2|Phase I (14 Days)|Adverse Event|1
6025433|NCT00753623|20828655|P1|Phase I (14 Days)|Adverse Event|0
6025434|NCT00753623|20828654|P2|Phase I (14 Days)|Physician Decision|2
6025435|NCT00753623|20828655|P1|Phase I (14 Days)|Physician Decision|1
6025436|NCT00753623|20828654|P2|Phase I (14 Days)|Withdrawal by Subject|1
6025437|NCT00753623|20828655|P1|Phase I (14 Days)|Withdrawal by Subject|1
6025438|NCT00753545|20828663|P2|Overall Study|Voluntary Discontinuation of Patient|3
6025439|NCT00753545|20828664|P1|Overall Study|Voluntary Discontinuation of Patient|7
6025440|NCT00753545|20828663|P2|Overall Study|Protocol Violation|0
6025441|NCT00753545|20828664|P1|Overall Study|Protocol Violation|1
6025442|NCT00753545|20828663|P2|Overall Study|Lost to Follow-up|3
6025443|NCT00753545|20828664|P1|Overall Study|Lost to Follow-up|2
6025444|NCT00753545|20828663|P2|Overall Study|Death|112
6025445|NCT00753545|20828664|P1|Overall Study|Death|98
6025446|NCT00753519|20828702|P2|Overall Study|Withdrawal by Subject|2
6025447|NCT00753519|20828703|P1|Overall Study|Withdrawal by Subject|0
6025448|NCT00753506|20828725|P2|Overall Study|Other reason|1
6025449|NCT00753506|20828726|P1|Overall Study|Other reason|1
6025450|NCT00753506|20828725|P2|Overall Study|Lost to Follow-up|0
6025451|NCT00753506|20828726|P1|Overall Study|Lost to Follow-up|2
6025452|NCT00753506|20828725|P2|Overall Study|Withdrawal by Subject|1
6025453|NCT00753506|20828726|P1|Overall Study|Withdrawal by Subject|4
6025454|NCT00753454|20828732|P1|Overall Study|Investigator Decision|1
6025455|NCT00753454|20828732|P1|Overall Study|Withdrawal by Subject|5
6025456|NCT00753454|20828732|P1|Overall Study|Lost to Follow-up|3
6025457|NCT00753454|20828732|P1|Overall Study|Lack of Efficacy|1
6025458|NCT00753454|20828732|P1|Overall Study|Adverse Event|4
6025459|NCT00753415|20828766|P10|Part B|Disease progression|1
6025460|NCT00753415|20828767|P9|Part B|Disease progression|2
6025461|NCT00753415|20828768|P8|Part B|Disease progression|0
6025462|NCT00753415|20828769|P7|Part B|Disease progression|0
6025463|NCT00753415|20828770|P6|Part B|Disease progression|0
6025464|NCT00753415|20828771|P5|Part B|Disease progression|0
6025465|NCT00753415|20828772|P4|Part B|Disease progression|0
6025466|NCT00753415|20828773|P3|Part B|Disease progression|0
6025467|NCT00753415|20828774|P2|Part B|Disease progression|0
6025468|NCT00753415|20828775|P1|Part B|Disease progression|0
6025469|NCT00753415|20828766|P10|Part B|Lost to Follow-up|0
6025470|NCT00753415|20828767|P9|Part B|Lost to Follow-up|1
6025471|NCT00753415|20828768|P8|Part B|Lost to Follow-up|1
6025472|NCT00753415|20828769|P7|Part B|Lost to Follow-up|0
6025473|NCT00753415|20828770|P6|Part B|Lost to Follow-up|0
6025474|NCT00753415|20828771|P5|Part B|Lost to Follow-up|0
6025475|NCT00753415|20828772|P4|Part B|Lost to Follow-up|0
6025476|NCT00753415|20828773|P3|Part B|Lost to Follow-up|0
6025477|NCT00753415|20828774|P2|Part B|Lost to Follow-up|0
6025478|NCT00753415|20828775|P1|Part B|Lost to Follow-up|0
6025479|NCT00753415|20828766|P10|Part A|Withdrawal by Subject|0
6025480|NCT00753415|20828767|P9|Part A|Withdrawal by Subject|0
6025481|NCT00753415|20828768|P8|Part A|Withdrawal by Subject|0
6025482|NCT00753415|20828769|P7|Part A|Withdrawal by Subject|0
6025483|NCT00753415|20828770|P6|Part A|Withdrawal by Subject|0
6025484|NCT00753415|20828771|P5|Part A|Withdrawal by Subject|0
6025485|NCT00753415|20828772|P4|Part A|Withdrawal by Subject|0
6025486|NCT00753415|20828773|P3|Part A|Withdrawal by Subject|1
6025487|NCT00753415|20828774|P2|Part A|Withdrawal by Subject|0
6025488|NCT00753415|20828775|P1|Part A|Withdrawal by Subject|0
6025489|NCT00753415|20828766|P10|Part A|Disease progression|0
6025490|NCT00753415|20828767|P9|Part A|Disease progression|0
6025491|NCT00753415|20828768|P8|Part A|Disease progression|0
6025492|NCT00753415|20828769|P7|Part A|Disease progression|0
6025493|NCT00753415|20828770|P6|Part A|Disease progression|0
6025494|NCT00753415|20828771|P5|Part A|Disease progression|0
6025495|NCT00753415|20828772|P4|Part A|Disease progression|2
6025496|NCT00753415|20828773|P3|Part A|Disease progression|1
6025497|NCT00753415|20828774|P2|Part A|Disease progression|0
6025498|NCT00753415|20828775|P1|Part A|Disease progression|1
6025499|NCT00753272|20828865|P2|Overall Study|Other|1088
6025500|NCT00753272|20828866|P1|Overall Study|Other|1104
6025501|NCT00753272|20828865|P2|Overall Study|Lost to Follow-up|497
6025502|NCT00753272|20828866|P1|Overall Study|Lost to Follow-up|491
6025503|NCT00753272|20828865|P2|Overall Study|Withdrawal by Subject|2407
6025504|NCT00753272|20828866|P1|Overall Study|Withdrawal by Subject|2481
6025505|NCT00753272|20828865|P2|Overall Study|Protocol Violation|46
6025506|NCT00753272|20828866|P1|Overall Study|Protocol Violation|28
6025507|NCT00753272|20828865|P2|Overall Study|Adverse Event|869
6025508|NCT00753272|20828866|P1|Overall Study|Adverse Event|878
6025509|NCT00753012|20828950|P2|Overall Study|Confounded endpoint data|0
6025510|NCT00753012|20828951|P1|Overall Study|Confounded endpoint data|1
6025511|NCT00753012|20828950|P2|Overall Study|Lost to Follow-up|0
6025512|NCT00753012|20828951|P1|Overall Study|Lost to Follow-up|4
6025513|NCT00753012|20828950|P2|Overall Study|Withdrawal by Subject|1
6025514|NCT00753012|20828951|P1|Overall Study|Withdrawal by Subject|0
6025515|NCT00753012|20828950|P2|Overall Study|Adverse Event|0
6025516|NCT00753012|20828951|P1|Overall Study|Adverse Event|2
6025517|NCT00753012|20828950|P2|Overall Study|Ineligible, abnormal cardiac histo|0
6025518|NCT00753012|20828951|P1|Overall Study|Ineligible, abnormal cardiac histo|1
6025519|NCT00752986|20828964|P3|Overall Study|Protocol Violation|0
6025520|NCT00752986|20828965|P2|Overall Study|Protocol Violation|0
6025521|NCT00752986|20828966|P1|Overall Study|Protocol Violation|3
6025522|NCT00752986|20828964|P3|Overall Study|Withdrawal by Subject|2
6025523|NCT00752986|20828965|P2|Overall Study|Withdrawal by Subject|1
6025524|NCT00752986|20828966|P1|Overall Study|Withdrawal by Subject|2
6025525|NCT00752895|20829006|P2|Overall Study|Withdrawal by Subject|3
6025526|NCT00752895|20829007|P1|Overall Study|Withdrawal by Subject|8
6025527|NCT00752856|20829017|P2|Overall Study|randomized but did not do viral kinetics|1
6025528|NCT00752856|20829018|P1|Overall Study|randomized but did not do viral kinetics|0
6025529|NCT00752791|20829030|P1|Overall Study|Protocol deviation|1
6025530|NCT00752791|20829030|P1|Overall Study|Switched to hemodialysis|2
6025531|NCT00752791|20829030|P1|Overall Study|Renal transplant|3
6025532|NCT00752791|20829030|P1|Overall Study|Death|1
6025533|NCT00752791|20829030|P1|Overall Study|Physician Decision|1
6025534|NCT00752791|20829030|P1|Overall Study|Withdrawal by Subject|1
6025535|NCT00752791|20829030|P1|Overall Study|Adverse Event|7
6025536|NCT00752726|20829042|P2|Overall Study|Other Reason|2
6025537|NCT00752726|20829043|P1|Overall Study|Other Reason|1
6025538|NCT00752726|20829042|P2|Overall Study|Withdrawal by Subject|10
6025539|NCT00752726|20829043|P1|Overall Study|Withdrawal by Subject|5
6025540|NCT00752726|20829042|P2|Overall Study|Adverse Event|0
6025541|NCT00752726|20829043|P1|Overall Study|Adverse Event|3
6025542|NCT00752726|20829042|P2|Overall Study|Lost to Follow-up|1
6025543|NCT00752726|20829043|P1|Overall Study|Lost to Follow-up|2
6025544|NCT00752622|20829068|P1|Interventional Phase|Premature Study Termination|5
6025545|NCT00752622|20829068|P1|Interventional Phase|Physician Decision|1
6025546|NCT00752622|20829068|P1|Interventional Phase|Non-responder|2
6025547|NCT00752622|20829068|P1|Observational Phase|Other|2
6025548|NCT00752622|20829068|P1|Observational Phase|Adverse Event|1
6025549|NCT00752622|20829068|P1|Observational Phase|Withdrawal by Subject|2
6025550|NCT00752622|20829068|P1|Observational Phase|Non-responder|2
6025551|NCT00752622|20829068|P1|Observational Phase|Premature Study Termination|36
6025552|NCT00752622|20829068|P1|Induction Phase|Premature study termination|14
6025553|NCT00752622|20829068|P1|Induction Phase|Withdrawal by Subject|1
6025554|NCT00752622|20829068|P1|Induction Phase|Non-responder|14
6025555|NCT00752622|20829068|P1|Induction Phase|Other|3
6025556|NCT00752622|20829068|P1|Induction Phase|Adverse Event|3
6025557|NCT00752609|20829081|P2|Overall Study|Received Aranesp in error|0
6025558|NCT00752609|20829082|P1|Overall Study|Received Aranesp in error|1
6025559|NCT00752609|20829081|P2|Overall Study|Met exclusion criteria|0
6025560|NCT00752609|20829082|P1|Overall Study|Met exclusion criteria|1
6025561|NCT00752609|20829081|P2|Overall Study|Death|0
6025562|NCT00752609|20829082|P1|Overall Study|Death|1
6025563|NCT00752609|20829081|P2|Overall Study|Physician Decision|0
6025564|NCT00752609|20829082|P1|Overall Study|Physician Decision|1
6025565|NCT00752609|20829081|P2|Overall Study|Withdrawal by Subject|0
6025566|NCT00752609|20829082|P1|Overall Study|Withdrawal by Subject|3
6025567|NCT00752609|20829081|P2|Overall Study|Adverse Event|2
6025568|NCT00752609|20829082|P1|Overall Study|Adverse Event|2
6025569|NCT00752557|20829104|P3|Overall Study|Lost to Follow-up|1
6025570|NCT00752557|20829105|P2|Overall Study|Lost to Follow-up|0
6025571|NCT00752557|20829106|P1|Overall Study|Lost to Follow-up|1
6025572|NCT00752557|20829104|P3|Overall Study|Unspecified resaons|2
6025573|NCT00752557|20829105|P2|Overall Study|Unspecified resaons|2
6025574|NCT00752557|20829106|P1|Overall Study|Unspecified resaons|0
6025575|NCT00752557|20829104|P3|Overall Study|Withdrawal by Subject|3
6025576|NCT00752557|20829105|P2|Overall Study|Withdrawal by Subject|3
6025577|NCT00752557|20829106|P1|Overall Study|Withdrawal by Subject|4
6025578|NCT00752232|20829138|P7|Overall Study|Caregiver could not attend the subject|0
6025579|NCT00752232|20829139|P6|Overall Study|Caregiver could not attend the subject|0
6025580|NCT00752232|20829140|P5|Overall Study|Caregiver could not attend the subject|1
6025581|NCT00752232|20829141|P4|Overall Study|Caregiver could not attend the subject|0
6025582|NCT00752232|20829142|P3|Overall Study|Caregiver could not attend the subject|0
6025583|NCT00752232|20829143|P2|Overall Study|Caregiver could not attend the subject|0
6025584|NCT00752232|20829144|P1|Overall Study|Caregiver could not attend the subject|0
6025585|NCT00752232|20829138|P7|Overall Study|Group home admission|0
6025586|NCT00752232|20829139|P6|Overall Study|Group home admission|0
6025587|NCT00752232|20829140|P5|Overall Study|Group home admission|0
6025588|NCT00752232|20829141|P4|Overall Study|Group home admission|1
6025589|NCT00752232|20829142|P3|Overall Study|Group home admission|0
6025590|NCT00752232|20829143|P2|Overall Study|Group home admission|0
6025591|NCT00752232|20829144|P1|Overall Study|Group home admission|0
6025592|NCT00752232|20829138|P7|Overall Study|Subject request|0
6025593|NCT00752232|20829139|P6|Overall Study|Subject request|0
6025594|NCT00752232|20829140|P5|Overall Study|Subject request|0
6025595|NCT00752232|20829141|P4|Overall Study|Subject request|0
6025596|NCT00752232|20829142|P3|Overall Study|Subject request|1
6025597|NCT00752232|20829143|P2|Overall Study|Subject request|0
6025598|NCT00752232|20829144|P1|Overall Study|Subject request|0
6025599|NCT00752232|20829138|P7|Overall Study|Investigator request|0
6025600|NCT00752232|20829139|P6|Overall Study|Investigator request|0
6025601|NCT00752232|20829140|P5|Overall Study|Investigator request|1
6025602|NCT00752232|20829141|P4|Overall Study|Investigator request|0
6025603|NCT00752232|20829142|P3|Overall Study|Investigator request|0
6025604|NCT00752232|20829143|P2|Overall Study|Investigator request|0
6025605|NCT00752232|20829144|P1|Overall Study|Investigator request|0
6025606|NCT00752232|20829138|P7|Overall Study|Caregiver request|0
6025607|NCT00752232|20829139|P6|Overall Study|Caregiver request|0
6025608|NCT00752232|20829140|P5|Overall Study|Caregiver request|1
6025609|NCT00752232|20829141|P4|Overall Study|Caregiver request|0
6025610|NCT00752232|20829142|P3|Overall Study|Caregiver request|0
6025611|NCT00752232|20829143|P2|Overall Study|Caregiver request|0
6025612|NCT00752232|20829144|P1|Overall Study|Caregiver request|2
6025613|NCT00752232|20829138|P7|Overall Study|Protocol Violation|0
6025614|NCT00752232|20829139|P6|Overall Study|Protocol Violation|1
6025615|NCT00752232|20829140|P5|Overall Study|Protocol Violation|0
6025616|NCT00752232|20829141|P4|Overall Study|Protocol Violation|0
6025617|NCT00752232|20829142|P3|Overall Study|Protocol Violation|0
6025618|NCT00752232|20829143|P2|Overall Study|Protocol Violation|0
6025619|NCT00752232|20829144|P1|Overall Study|Protocol Violation|0
6025620|NCT00752219|20829218|P2|Overall Study|Other|0
6025621|NCT00752219|20829219|P1|Overall Study|Other|3
6025622|NCT00752219|20829218|P2|Overall Study|Randomized but not treated|0
6025623|NCT00752219|20829219|P1|Overall Study|Randomized but not treated|1
6025624|NCT00752219|20829218|P2|Overall Study|Lost to Follow-up|2
6025625|NCT00752219|20829219|P1|Overall Study|Lost to Follow-up|1
6025626|NCT00752219|20829218|P2|Overall Study|Protocol deviation|0
6025627|NCT00752219|20829219|P1|Overall Study|Protocol deviation|1
6025628|NCT00752219|20829218|P2|Overall Study|Adverse Event|3
6025629|NCT00752219|20829219|P1|Overall Study|Adverse Event|5
6025630|NCT00752219|20829218|P2|Overall Study|Clinical failure|1
6025631|NCT00752219|20829219|P1|Overall Study|Clinical failure|0
6025632|NCT00752206|20829245|P2|Overall Study|Pregnancy|0
6025633|NCT00752206|20829246|P1|Overall Study|Pregnancy|1
6025634|NCT00752206|20829245|P2|Overall Study|Disease progression|11
6025635|NCT00752206|20829246|P1|Overall Study|Disease progression|8
6025636|NCT00752128|20829264|P1|Overall Study|Withdrawal by Subject|4
6025637|NCT00752089|20829278|P1|Overall Study|Cannot continue the study|1
6025638|NCT00752089|20829278|P1|Overall Study|Not capable of wearing partial denture|1
6025639|NCT00752089|20829278|P1|Overall Study|Could not attend visit 9|1
6025640|NCT00752089|20829278|P1|Overall Study|Protocol Deviation|2
6025641|NCT00752089|20829278|P1|Overall Study|Adverse Event|1
6025642|NCT00751998|20829292|P1|Overall Study|Withdrawal by Subject|2
6025643|NCT00751998|20829292|P1|Overall Study|Death|11
6025644|NCT00751998|20829292|P1|Overall Study|Lost to Follow-up|7
6025645|NCT00751933|20829311|P4|Overall Study|Physician Decision|1
6025646|NCT00751933|20829312|P3|Overall Study|Physician Decision|1
6025647|NCT00751933|20829313|P2|Overall Study|Physician Decision|0
6025648|NCT00751933|20829314|P1|Overall Study|Physician Decision|0
6025649|NCT00751933|20829311|P4|Overall Study|Withdrawal by Subject|0
6025650|NCT00751933|20829312|P3|Overall Study|Withdrawal by Subject|0
6025651|NCT00751933|20829313|P2|Overall Study|Withdrawal by Subject|1
6025652|NCT00751933|20829314|P1|Overall Study|Withdrawal by Subject|0
6025653|NCT00751881|20829322|P3|Extension Study Period|Other than specified above|18
6025654|NCT00751881|20829323|P2|Extension Study Period|Other than specified above|30
6025655|NCT00751881|20829324|P1|Extension Study Period|Other than specified above|26
6025656|NCT00751881|20829322|P3|Extension Study Period|Poor Compliance to Protocol|1
6025657|NCT00751881|20829323|P2|Extension Study Period|Poor Compliance to Protocol|2
6025658|NCT00751881|20829324|P1|Extension Study Period|Poor Compliance to Protocol|3
6025659|NCT00751881|20829322|P3|Extension Study Period|Lost to Follow-up|6
6025660|NCT00751881|20829323|P2|Extension Study Period|Lost to Follow-up|9
6025661|NCT00751881|20829324|P1|Extension Study Period|Lost to Follow-up|4
6025662|NCT00751881|20829322|P3|Extension Study Period|Lack of Efficacy|20
6025663|NCT00751881|20829323|P2|Extension Study Period|Lack of Efficacy|10
6025664|NCT00751881|20829324|P1|Extension Study Period|Lack of Efficacy|14
6025665|NCT00751881|20829322|P3|Extension Study Period|Adverse Event|21
6025666|NCT00751881|20829323|P2|Extension Study Period|Adverse Event|20
6025667|NCT00751881|20829324|P1|Extension Study Period|Adverse Event|18
6025668|NCT00751881|20829322|P3|Core Treatment Period|Other:participant's decision/unspecified|16
6025669|NCT00751881|20829323|P2|Core Treatment Period|Other:participant's decision/unspecified|22
6025670|NCT00751881|20829324|P1|Core Treatment Period|Other:participant's decision/unspecified|19
6025671|NCT00751881|20829322|P3|Core Treatment Period|Other: tolerability complaints|0
6025672|NCT00751881|20829323|P2|Core Treatment Period|Other: tolerability complaints|0
6025673|NCT00751881|20829324|P1|Core Treatment Period|Other: tolerability complaints|2
6025674|NCT00751881|20829322|P3|Core Treatment Period|Other: MS treatment change|4
6025675|NCT00751881|20829323|P2|Core Treatment Period|Other: MS treatment change|4
6025676|NCT00751881|20829324|P1|Core Treatment Period|Other: MS treatment change|6
6025677|NCT00751881|20829322|P3|Core Treatment Period|Other: personal/family constraints|10
6025678|NCT00751881|20829323|P2|Core Treatment Period|Other: personal/family constraints|7
6025679|NCT00751881|20829324|P1|Core Treatment Period|Other: personal/family constraints|6
6025680|NCT00751881|20829322|P3|Core Treatment Period|Other: wish to parent|4
6025681|NCT00751881|20829323|P2|Core Treatment Period|Other: wish to parent|7
6025682|NCT00751881|20829324|P1|Core Treatment Period|Other: wish to parent|5
6025683|NCT00751881|20829322|P3|Core Treatment Period|Other: protocol deviation|7
6025684|NCT00751881|20829323|P2|Core Treatment Period|Other: protocol deviation|3
6025685|NCT00751881|20829324|P1|Core Treatment Period|Other: protocol deviation|3
6025686|NCT00751881|20829322|P3|Core Treatment Period|Lost to Follow-up|3
6025687|NCT00751881|20829323|P2|Core Treatment Period|Lost to Follow-up|4
6025688|NCT00751881|20829324|P1|Core Treatment Period|Lost to Follow-up|6
6025689|NCT00751881|20829322|P3|Core Treatment Period|Poor compliance to protocol|4
6025690|NCT00751881|20829323|P2|Core Treatment Period|Poor compliance to protocol|3
6025691|NCT00751881|20829324|P1|Core Treatment Period|Poor compliance to protocol|15
6025692|NCT00751881|20829322|P3|Core Treatment Period|Lack of Efficacy|20
6025693|NCT00751881|20829323|P2|Core Treatment Period|Lack of Efficacy|30
6025694|NCT00751881|20829324|P1|Core Treatment Period|Lack of Efficacy|37
6025695|NCT00751881|20829322|P3|Core Treatment Period|Adverse Event|58
6025696|NCT00751881|20829323|P2|Core Treatment Period|Adverse Event|54
6025697|NCT00751881|20829324|P1|Core Treatment Period|Adverse Event|26
6025698|NCT00751881|20829322|P3|Core Treatment Period|Not treated|2
6025699|NCT00751881|20829323|P2|Core Treatment Period|Not treated|1
6025700|NCT00751881|20829324|P1|Core Treatment Period|Not treated|1
6025701|NCT00751790|20829371|P1|Overall Study|Withdrawal by Subject|1
6025702|NCT00751790|20829371|P1|Overall Study|Death|3
6025703|NCT00751790|20829371|P1|Overall Study|Lost to Follow-up|1
6025704|NCT00751621|20829402|P1|Overall Study|Poor adherence to asthma treatment|1
6025705|NCT00751621|20829402|P1|Overall Study|Subject moved to another country|1
6025706|NCT00751621|20829402|P1|Overall Study|Withdrawal by Subject|1
6025707|NCT00751621|20829402|P1|Overall Study|Adverse Event|1
6025708|NCT00751400|20829436|P1|Overall Study|Lost to Follow-up|10
6025709|NCT00751348|20829451|P2|Overall Study|Migration from study area|0
6025710|NCT00751348|20829452|P1|Overall Study|Migration from study area|1
6025711|NCT00751348|20829451|P2|Overall Study|Withdrawal by Subject|2
6025712|NCT00751348|20829452|P1|Overall Study|Withdrawal by Subject|5
6025713|NCT00751296|20829485|P1|Overall Study|Adverse Event|2
6025714|NCT00751140|20829513|P1|Overall Study|benign angioma excluded from analysis|1
6025715|NCT00751114|20829523|P2|Overall Study|Move to another city|0
6025716|NCT00751114|20829524|P1|Overall Study|Move to another city|1
6025717|NCT00751114|20829523|P2|Overall Study|Out of country for 2 months|0
6025718|NCT00751114|20829524|P1|Overall Study|Out of country for 2 months|1
6025719|NCT00751114|20829523|P2|Overall Study|Not Treated|1
6025720|NCT00751114|20829524|P1|Overall Study|Not Treated|13
6025721|NCT00751114|20829523|P2|Overall Study|Lack of Efficacy|7
6025722|NCT00751114|20829524|P1|Overall Study|Lack of Efficacy|0
6025723|NCT00751114|20829523|P2|Overall Study|Lost to Follow-up|7
6025724|NCT00751114|20829524|P1|Overall Study|Lost to Follow-up|4
6025725|NCT00751114|20829523|P2|Overall Study|Withdrawal by Subject|4
6025726|NCT00751114|20829524|P1|Overall Study|Withdrawal by Subject|9
6025727|NCT00751114|20829523|P2|Overall Study|Protocol Violation|9
6025728|NCT00751114|20829524|P1|Overall Study|Protocol Violation|8
6025729|NCT00751114|20829523|P2|Overall Study|Adverse Event|4
6025730|NCT00751114|20829524|P1|Overall Study|Adverse Event|2
6025731|NCT00751101|20829549|P2|Overall Study|Physician Decision|1
6025732|NCT00751101|20829550|P1|Overall Study|Physician Decision|0
6025733|NCT00751101|20829549|P2|Overall Study|Never began capecitabine|0
6025734|NCT00751101|20829550|P1|Overall Study|Never began capecitabine|1
6025735|NCT00751101|20829549|P2|Overall Study|No HFS / Never Started Patch/|4
6025736|NCT00751101|20829550|P1|Overall Study|No HFS / Never Started Patch/|0
6025737|NCT00751101|20829549|P2|Overall Study|Withdrawal by Subject|0
6025738|NCT00751101|20829550|P1|Overall Study|Withdrawal by Subject|1
6025739|NCT00751036|20829570|P2|Overall Study|Missing end of Treatment Page|3
6025740|NCT00751036|20829571|P1|Overall Study|Missing end of Treatment Page|2
6025741|NCT00751036|20829570|P2|Overall Study|Protocol Violation|0
6025742|NCT00751036|20829571|P1|Overall Study|Protocol Violation|1
6025743|NCT00751036|20829570|P2|Overall Study|Lost to Follow-up|1
6025744|NCT00751036|20829571|P1|Overall Study|Lost to Follow-up|0
6025745|NCT00751036|20829570|P2|Overall Study|Death|3
6025746|NCT00751036|20829571|P1|Overall Study|Death|3
6025747|NCT00751036|20829570|P2|Overall Study|Withdrawal by Subject|2
6025748|NCT00751036|20829571|P1|Overall Study|Withdrawal by Subject|5
6025749|NCT00751036|20829570|P2|Overall Study|Administrative Problems|4
6025750|NCT00751036|20829571|P1|Overall Study|Administrative Problems|3
6025751|NCT00751036|20829570|P2|Overall Study|Adverse Event|4
6025752|NCT00751036|20829571|P1|Overall Study|Adverse Event|6
6025753|NCT00751036|20829570|P2|Overall Study|Disease Progression|29
6025754|NCT00751036|20829571|P1|Overall Study|Disease Progression|28
6025755|NCT00751023|20829585|P2|Overall Study|Lost to Follow-up|7
6025756|NCT00751023|20829586|P1|Overall Study|Lost to Follow-up|11
6025762|NCT00750893|20829614|P1|Overall Study|Other|17
6025763|NCT00750893|20829614|P1|Overall Study|Lost to Follow-up|510
6025764|NCT00750893|20829614|P1|Overall Study|Withdrawal by Subject|10
6025765|NCT00750893|20829614|P1|Overall Study|Adverse Event|5
6025766|NCT00750880|20829626|P1|Overall Study|Administrative|11
6025767|NCT00750880|20829626|P1|Overall Study|Physician Decision|20
6025768|NCT00750880|20829626|P1|Overall Study|Withdrawal by Subject|33
6025769|NCT00750880|20829626|P1|Overall Study|Protocol Violation|15
6025770|NCT00750880|20829626|P1|Overall Study|Lost to Follow-up|10
6025771|NCT00750880|20829626|P1|Overall Study|Lack of Efficacy|46
6025772|NCT00750880|20829626|P1|Overall Study|Death|4
6025773|NCT00750880|20829626|P1|Overall Study|Adverse Event|76
6025774|NCT00750867|20829649|P1|Overall Study|Adverse Event|2
6025775|NCT00750737|20829670|P2|Overall Study|Withdrawal by Subject|3
6025776|NCT00750737|20829671|P1|Overall Study|Withdrawal by Subject|3
6025777|NCT00750438|20829686|P2|Overall Study|Withdrawal by Subject|1
6025778|NCT00750438|20829687|P1|Overall Study|Withdrawal by Subject|1
6025779|NCT00750438|20829686|P2|Overall Study|Physician Decision|2
6025780|NCT00750438|20829687|P1|Overall Study|Physician Decision|2
6025781|NCT00750438|20829686|P2|Overall Study|Protocol Violation|1
6025782|NCT00750438|20829687|P1|Overall Study|Protocol Violation|4
6025783|NCT00750308|20829753|P12|Third Treatment|Withdrawal by Subject|0
6025784|NCT00750308|20829754|P11|Third Treatment|Withdrawal by Subject|0
6025785|NCT00750308|20829755|P10|Third Treatment|Withdrawal by Subject|0
6025786|NCT00750308|20829756|P9|Third Treatment|Withdrawal by Subject|0
6025787|NCT00750308|20829757|P8|Third Treatment|Withdrawal by Subject|0
6025788|NCT00750308|20829758|P7|Third Treatment|Withdrawal by Subject|0
6025789|NCT00750308|20829759|P6|Third Treatment|Withdrawal by Subject|0
6025790|NCT00750308|20829760|P5|Third Treatment|Withdrawal by Subject|0
6025791|NCT00750308|20829761|P4|Third Treatment|Withdrawal by Subject|0
6025792|NCT00750308|20829762|P3|Third Treatment|Withdrawal by Subject|0
6025793|NCT00750308|20829763|P2|Third Treatment|Withdrawal by Subject|1
6025794|NCT00750308|20829764|P1|Third Treatment|Withdrawal by Subject|0
6025795|NCT00750308|20829753|P12|Second Treatment|Withdrawal by Subject|0
6025796|NCT00750308|20829754|P11|Second Treatment|Withdrawal by Subject|0
6025797|NCT00750308|20829755|P10|Second Treatment|Withdrawal by Subject|0
6025798|NCT00750308|20829756|P9|Second Treatment|Withdrawal by Subject|0
6025799|NCT00750308|20829757|P8|Second Treatment|Withdrawal by Subject|0
6025800|NCT00750308|20829758|P7|Second Treatment|Withdrawal by Subject|0
6025801|NCT00750308|20829759|P6|Second Treatment|Withdrawal by Subject|0
6025802|NCT00750308|20829760|P5|Second Treatment|Withdrawal by Subject|1
6025803|NCT00750308|20829761|P4|Second Treatment|Withdrawal by Subject|0
6025804|NCT00750308|20829762|P3|Second Treatment|Withdrawal by Subject|0
6025805|NCT00750308|20829763|P2|Second Treatment|Withdrawal by Subject|0
6025806|NCT00750308|20829764|P1|Second Treatment|Withdrawal by Subject|0
6025807|NCT00750308|20829753|P12|Second Treatment|Adverse Event|0
6025808|NCT00750308|20829754|P11|Second Treatment|Adverse Event|0
6025809|NCT00750308|20829755|P10|Second Treatment|Adverse Event|0
6025810|NCT00750308|20829756|P9|Second Treatment|Adverse Event|1
6025811|NCT00750308|20829757|P8|Second Treatment|Adverse Event|0
6025812|NCT00750308|20829758|P7|Second Treatment|Adverse Event|0
6025813|NCT00750308|20829759|P6|Second Treatment|Adverse Event|1
6025814|NCT00750308|20829760|P5|Second Treatment|Adverse Event|0
6025815|NCT00750308|20829761|P4|Second Treatment|Adverse Event|0
6025816|NCT00750308|20829762|P3|Second Treatment|Adverse Event|0
6025817|NCT00750308|20829763|P2|Second Treatment|Adverse Event|0
6025818|NCT00750308|20829764|P1|Second Treatment|Adverse Event|0
6025819|NCT00750308|20829753|P12|First Treatment|Withdrawal by Subject|0
6025820|NCT00750308|20829754|P11|First Treatment|Withdrawal by Subject|0
6025821|NCT00750308|20829755|P10|First Treatment|Withdrawal by Subject|0
6025822|NCT00750308|20829756|P9|First Treatment|Withdrawal by Subject|0
6025823|NCT00750308|20829757|P8|First Treatment|Withdrawal by Subject|1
6025824|NCT00750308|20829758|P7|First Treatment|Withdrawal by Subject|0
6025825|NCT00750308|20829759|P6|First Treatment|Withdrawal by Subject|0
6025826|NCT00750308|20829760|P5|First Treatment|Withdrawal by Subject|0
6025827|NCT00750308|20829761|P4|First Treatment|Withdrawal by Subject|1
6025828|NCT00750308|20829762|P3|First Treatment|Withdrawal by Subject|0
6025829|NCT00750308|20829763|P2|First Treatment|Withdrawal by Subject|0
6025830|NCT00750308|20829764|P1|First Treatment|Withdrawal by Subject|0
6025831|NCT00750308|20829753|P12|First Treatment|Adverse Event|1
6025832|NCT00750308|20829754|P11|First Treatment|Adverse Event|1
6025833|NCT00750308|20829755|P10|First Treatment|Adverse Event|0
6025834|NCT00750308|20829756|P9|First Treatment|Adverse Event|0
6025835|NCT00750308|20829757|P8|First Treatment|Adverse Event|0
6025836|NCT00750308|20829758|P7|First Treatment|Adverse Event|0
6025837|NCT00750308|20829759|P6|First Treatment|Adverse Event|0
6025838|NCT00750308|20829760|P5|First Treatment|Adverse Event|0
6025839|NCT00750308|20829761|P4|First Treatment|Adverse Event|0
6025840|NCT00750308|20829762|P3|First Treatment|Adverse Event|0
6025841|NCT00750308|20829763|P2|First Treatment|Adverse Event|1
6025842|NCT00750308|20829764|P1|First Treatment|Adverse Event|0
6025843|NCT00750269|20829814|P5|Overall Study|Fiducials could not be placed|1
6025844|NCT00750269|20829815|P4|Overall Study|Fiducials could not be placed|0
6025845|NCT00750269|20829816|P3|Overall Study|Fiducials could not be placed|0
6025846|NCT00750269|20829817|P2|Overall Study|Fiducials could not be placed|0
6025847|NCT00750269|20829818|P1|Overall Study|Fiducials could not be placed|0
6025848|NCT00750269|20829814|P5|Overall Study|SBRT plan could not be drawn|1
6025849|NCT00750269|20829815|P4|Overall Study|SBRT plan could not be drawn|0
6025850|NCT00750269|20829816|P3|Overall Study|SBRT plan could not be drawn|0
6025851|NCT00750269|20829817|P2|Overall Study|SBRT plan could not be drawn|0
6025852|NCT00750269|20829818|P1|Overall Study|SBRT plan could not be drawn|0
6025853|NCT00750269|20829814|P5|Overall Study|Site error|0
6025854|NCT00750269|20829815|P4|Overall Study|Site error|1
6025855|NCT00750269|20829816|P3|Overall Study|Site error|0
6025856|NCT00750269|20829817|P2|Overall Study|Site error|0
6025857|NCT00750269|20829818|P1|Overall Study|Site error|0
6025858|NCT00750269|20829814|P5|Overall Study|Patient too large for positioning|0
6025859|NCT00750269|20829815|P4|Overall Study|Patient too large for positioning|0
6025860|NCT00750269|20829816|P3|Overall Study|Patient too large for positioning|1
6025861|NCT00750269|20829817|P2|Overall Study|Patient too large for positioning|0
6025862|NCT00750269|20829818|P1|Overall Study|Patient too large for positioning|0
6025863|NCT00750269|20829814|P5|Overall Study|Physician Decision|2
6025864|NCT00750269|20829815|P4|Overall Study|Physician Decision|0
6025865|NCT00750269|20829816|P3|Overall Study|Physician Decision|0
6025866|NCT00750269|20829817|P2|Overall Study|Physician Decision|0
6025867|NCT00750269|20829818|P1|Overall Study|Physician Decision|0
6025868|NCT00750269|20829814|P5|Overall Study|Withdrawal by Subject|2
6025869|NCT00750269|20829815|P4|Overall Study|Withdrawal by Subject|2
6025870|NCT00750269|20829816|P3|Overall Study|Withdrawal by Subject|2
6025871|NCT00750269|20829817|P2|Overall Study|Withdrawal by Subject|0
6025872|NCT00750269|20829818|P1|Overall Study|Withdrawal by Subject|0
6025873|NCT00750269|20829814|P5|Overall Study|Protocol Violation|4
6025874|NCT00750269|20829815|P4|Overall Study|Protocol Violation|2
6025875|NCT00750269|20829816|P3|Overall Study|Protocol Violation|1
6025876|NCT00750269|20829817|P2|Overall Study|Protocol Violation|1
6025877|NCT00750269|20829818|P1|Overall Study|Protocol Violation|0
6025878|NCT00750204|20829865|P2|Overall Study|study halted prematurely|1
6025879|NCT00750204|20829866|P1|Overall Study|study halted prematurely|1
6025880|NCT00750152|20829896|P2|Overall Study|Other|8
6025881|NCT00750152|20829897|P1|Overall Study|Other|7
6025882|NCT00750152|20829896|P2|Overall Study|Termination by sponsor|0
6025883|NCT00750152|20829897|P1|Overall Study|Termination by sponsor|1
6025884|NCT00750152|20829896|P2|Overall Study|Non-compliance|1
6025885|NCT00750152|20829897|P1|Overall Study|Non-compliance|0
6025886|NCT00750152|20829896|P2|Overall Study|Physician Decision|1
6025887|NCT00750152|20829897|P1|Overall Study|Physician Decision|1
6025888|NCT00750152|20829896|P2|Overall Study|Withdrawal by Subject|3
6025889|NCT00750152|20829897|P1|Overall Study|Withdrawal by Subject|3
6025890|NCT00750152|20829896|P2|Overall Study|Lost to Follow-up|13
6025891|NCT00750152|20829897|P1|Overall Study|Lost to Follow-up|8
6025892|NCT00750152|20829896|P2|Overall Study|Adverse Event|1
6025893|NCT00750152|20829897|P1|Overall Study|Adverse Event|2
6025894|NCT00750139|20829909|P4|Overall Study|Non-specific|33
6025895|NCT00750139|20829910|P3|Overall Study|Non-specific|79
6025896|NCT00750139|20829911|P2|Overall Study|Non-specific|42
6025897|NCT00750139|20829912|P1|Overall Study|Non-specific|62
6025898|NCT00750139|20829909|P4|Overall Study|Termination by sponsor|1
6025899|NCT00750139|20829910|P3|Overall Study|Termination by sponsor|0
6025900|NCT00750139|20829911|P2|Overall Study|Termination by sponsor|0
6025901|NCT00750139|20829912|P1|Overall Study|Termination by sponsor|4
6025902|NCT00750139|20829909|P4|Overall Study|Non-compliance|3
6025903|NCT00750139|20829910|P3|Overall Study|Non-compliance|1
6025904|NCT00750139|20829911|P2|Overall Study|Non-compliance|0
6025905|NCT00750139|20829912|P1|Overall Study|Non-compliance|1
6025906|NCT00750139|20829909|P4|Overall Study|Physician Decision|0
6025907|NCT00750139|20829910|P3|Overall Study|Physician Decision|0
6025908|NCT00750139|20829911|P2|Overall Study|Physician Decision|1
6025909|NCT00750139|20829912|P1|Overall Study|Physician Decision|1
6025910|NCT00750139|20829909|P4|Overall Study|Withdrawal by Subject|2
6025911|NCT00750139|20829910|P3|Overall Study|Withdrawal by Subject|6
6025912|NCT00750139|20829911|P2|Overall Study|Withdrawal by Subject|2
6025913|NCT00750139|20829912|P1|Overall Study|Withdrawal by Subject|3
6025914|NCT00750139|20829909|P4|Overall Study|Lost to Follow-up|6
6025915|NCT00750139|20829910|P3|Overall Study|Lost to Follow-up|15
6025916|NCT00750139|20829911|P2|Overall Study|Lost to Follow-up|12
6025917|NCT00750139|20829912|P1|Overall Study|Lost to Follow-up|17
6025918|NCT00750139|20829909|P4|Overall Study|Adverse Event|1
6025919|NCT00750139|20829910|P3|Overall Study|Adverse Event|0
6025920|NCT00750139|20829911|P2|Overall Study|Adverse Event|2
6025921|NCT00750139|20829912|P1|Overall Study|Adverse Event|1
6025922|NCT00750061|20829928|P2|Overall Study|Physician Decision|1
6025923|NCT00750061|20829929|P1|Overall Study|Physician Decision|0
6025924|NCT00750061|20829928|P2|Overall Study|Withdrawal by Subject|1
6025925|NCT00750061|20829929|P1|Overall Study|Withdrawal by Subject|0
6025926|NCT00750061|20829928|P2|Overall Study|Adverse Event|0
6025927|NCT00750061|20829929|P1|Overall Study|Adverse Event|2
6025928|NCT00749996|20829939|P2|Overall Study|Death|0
6025929|NCT00749996|20829940|P1|Overall Study|Death|1
6025930|NCT00749996|20829939|P2|Overall Study|Adverse Event|0
6025931|NCT00749996|20829940|P1|Overall Study|Adverse Event|1
6025932|NCT00749996|20829939|P2|Overall Study|Pregnancy|2
6025933|NCT00749996|20829940|P1|Overall Study|Pregnancy|0
6025934|NCT00749996|20829939|P2|Overall Study|Physician Decision|0
6025935|NCT00749996|20829940|P1|Overall Study|Physician Decision|2
6025936|NCT00749996|20829939|P2|Overall Study|Protocol Violation|3
6025937|NCT00749996|20829940|P1|Overall Study|Protocol Violation|2
6025938|NCT00749996|20829939|P2|Overall Study|Withdrawal by Subject|4
6025939|NCT00749996|20829940|P1|Overall Study|Withdrawal by Subject|5
6025940|NCT00749996|20829939|P2|Overall Study|Lost to Follow-up|4
6025941|NCT00749996|20829940|P1|Overall Study|Lost to Follow-up|7
6025942|NCT00749944|20829963|P2|Overall Study|Withdrawal by Subject|0
6025943|NCT00749944|20829964|P1|Overall Study|Withdrawal by Subject|2
6025944|NCT00749944|20829963|P2|Overall Study|Other|0
6025945|NCT00749944|20829964|P1|Overall Study|Other|1
6025946|NCT00749944|20829963|P2|Overall Study|Lost to Follow-up|1
6025947|NCT00749944|20829964|P1|Overall Study|Lost to Follow-up|2
6025948|NCT00749892|20830043|P1|Overall Study|Withdrawal by Subject|3
6025949|NCT00749775|20830079|P1|Overall Study|No drug administration|3
6025950|NCT00749775|20830079|P1|Overall Study|No visit after first day of treatment|44
6025951|NCT00749775|20830079|P1|Overall Study|Lost to Follow-up|36
6025952|NCT00749775|20830079|P1|Overall Study|Protocol Violation|24
6025953|NCT00749684|20830116|P1|Overall Study|Missing|9
6025954|NCT00749684|20830116|P1|Overall Study|AE+discontinuation on participants wish|1
6025955|NCT00749684|20830116|P1|Overall Study|Therapy according to protocol + AE|2
6025956|NCT00749684|20830116|P1|Overall Study|Progressive Desease|31
6025957|NCT00749684|20830116|P1|Overall Study|Not Documented|1
6025958|NCT00749684|20830116|P1|Overall Study|Participant's Wish|10
6025959|NCT00749684|20830116|P1|Overall Study|Adverse Event|27
6025960|NCT00749684|20830116|P1|Overall Study|Death|1
6025961|NCT00749580|20830164|P2|Overall Study|Adverse Event|1
6025962|NCT00749580|20830165|P1|Overall Study|Adverse Event|0
6025963|NCT00749580|20830164|P2|Overall Study|Lost to Follow-up|8
6025964|NCT00749580|20830165|P1|Overall Study|Lost to Follow-up|4
6025965|NCT00749463|20830199|P3|Overall Study|Withdrawal by Subject|0
6025966|NCT00749463|20830200|P2|Overall Study|Withdrawal by Subject|0
6025967|NCT00749463|20830201|P1|Overall Study|Withdrawal by Subject|1
6025968|NCT00749463|20830199|P3|Overall Study|Adverse Event|1
6025969|NCT00749463|20830200|P2|Overall Study|Adverse Event|4
6025970|NCT00749463|20830201|P1|Overall Study|Adverse Event|0
6025971|NCT00749411|20830229|P2|Overall Study|Protocol-defined stopping criteria|1
6025972|NCT00749411|20830230|P1|Overall Study|Protocol-defined stopping criteria|0
6025973|NCT00749411|20830229|P2|Overall Study|Protocol Violation|1
6025974|NCT00749411|20830230|P1|Overall Study|Protocol Violation|1
6025975|NCT00749411|20830229|P2|Overall Study|Lack of Efficacy|1
6025976|NCT00749411|20830230|P1|Overall Study|Lack of Efficacy|0
6025977|NCT00749411|20830229|P2|Overall Study|Adverse Event|2
6025978|NCT00749411|20830230|P1|Overall Study|Adverse Event|0
6025979|NCT00749398|20830238|P1|Overall Study|Unknown reason|1
6025980|NCT00749398|20830238|P1|Overall Study|Reason not specified|2
6025981|NCT00749398|20830238|P1|Overall Study|Lost to Follow-up|11
6025982|NCT00749398|20830238|P1|Overall Study|Withdrawal by Subject|17
6025983|NCT00749398|20830238|P1|Overall Study|Serious adverse event|11
6025984|NCT00749398|20830238|P1|Overall Study|Adverse Event|4
6025985|NCT00749398|20830238|P1|Overall Study|Lack of Efficacy|7
6025986|NCT00749203|20830281|P2|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|1
6025987|NCT00749203|20830282|P1|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|0
6025988|NCT00749203|20830281|P2|Second Infusion at 2 Weeks|Protocol Violation|1
6025989|NCT00749203|20830282|P1|Second Infusion at 2 Weeks|Protocol Violation|0
6025990|NCT00749203|20830281|P2|no Infusion at Week 1|low baseline PTSD symptoms level|1
6025991|NCT00749203|20830282|P1|no Infusion at Week 1|low baseline PTSD symptoms level|0
6025992|NCT00749203|20830281|P2|no Infusion at Week 1|delayed-onset sedation|1
6025993|NCT00749203|20830282|P1|no Infusion at Week 1|delayed-onset sedation|0
6025994|NCT00749203|20830281|P2|no Infusion at Week 1|Withdrawal by Subject|1
6025995|NCT00749203|20830282|P1|no Infusion at Week 1|Withdrawal by Subject|0
6025996|NCT00749203|20830281|P2|no Infusion at Week 1|Lost to Follow-up|1
6025997|NCT00749203|20830282|P1|no Infusion at Week 1|Lost to Follow-up|0
6025998|NCT00749190|20830303|P7|Overall Study|Other reason not defined above|0
6025999|NCT00749190|20830304|P6|Overall Study|Other reason not defined above|0
6026000|NCT00749190|20830305|P5|Overall Study|Other reason not defined above|0
6026001|NCT00749190|20830306|P4|Overall Study|Other reason not defined above|1
6026002|NCT00749190|20830307|P3|Overall Study|Other reason not defined above|0
6026003|NCT00749190|20830308|P2|Overall Study|Other reason not defined above|0
6026004|NCT00749190|20830309|P1|Overall Study|Other reason not defined above|0
6026005|NCT00749190|20830303|P7|Overall Study|Protocol Violation|1
6026006|NCT00749190|20830304|P6|Overall Study|Protocol Violation|0
6026007|NCT00749190|20830305|P5|Overall Study|Protocol Violation|0
6026008|NCT00749190|20830306|P4|Overall Study|Protocol Violation|0
6026009|NCT00749190|20830307|P3|Overall Study|Protocol Violation|0
6026010|NCT00749190|20830308|P2|Overall Study|Protocol Violation|1
6026011|NCT00749190|20830309|P1|Overall Study|Protocol Violation|0
6026012|NCT00749190|20830303|P7|Overall Study|Withdrawal by Subject|0
6026013|NCT00749190|20830304|P6|Overall Study|Withdrawal by Subject|1
6026014|NCT00749190|20830305|P5|Overall Study|Withdrawal by Subject|0
6026015|NCT00749190|20830306|P4|Overall Study|Withdrawal by Subject|0
6026016|NCT00749190|20830307|P3|Overall Study|Withdrawal by Subject|0
6026017|NCT00749190|20830308|P2|Overall Study|Withdrawal by Subject|1
6026018|NCT00749190|20830309|P1|Overall Study|Withdrawal by Subject|2
6026019|NCT00749190|20830303|P7|Overall Study|Lack of Efficacy|0
6026020|NCT00749190|20830304|P6|Overall Study|Lack of Efficacy|1
6026021|NCT00749190|20830305|P5|Overall Study|Lack of Efficacy|0
6026022|NCT00749190|20830306|P4|Overall Study|Lack of Efficacy|0
6026023|NCT00749190|20830307|P3|Overall Study|Lack of Efficacy|1
6026024|NCT00749190|20830308|P2|Overall Study|Lack of Efficacy|1
6026025|NCT00749190|20830309|P1|Overall Study|Lack of Efficacy|3
6026026|NCT00749190|20830303|P7|Overall Study|Adverse Event|0
6026027|NCT00749190|20830304|P6|Overall Study|Adverse Event|3
6026028|NCT00749190|20830305|P5|Overall Study|Adverse Event|0
6026029|NCT00749190|20830306|P4|Overall Study|Adverse Event|4
6026030|NCT00749190|20830307|P3|Overall Study|Adverse Event|0
6026031|NCT00749190|20830308|P2|Overall Study|Adverse Event|2
6026032|NCT00749190|20830309|P1|Overall Study|Adverse Event|0
6026033|NCT00748969|20830418|P2|Overall Study|Withdrawal by Subject|1
6026034|NCT00748969|20830419|P1|Overall Study|Withdrawal by Subject|0
6026035|NCT00748969|20830418|P2|Overall Study|Withdrawal by Subject|0
6026036|NCT00748969|20830419|P1|Overall Study|Withdrawal by Subject|1
6026037|NCT00748709|20830469|P1|Overall Study|Other Reasons|1
6026038|NCT00748709|20830469|P1|Overall Study|Withdrawal by Subject|1
6026039|NCT00748709|20830469|P1|Overall Study|Other Adverse Event|1
6026040|NCT00748709|20830469|P1|Overall Study|Drug reducing Toxity|2
6026041|NCT00748709|20830469|P1|Overall Study|Progressive disease|15
6026042|NCT00748566|20830512|P1|Overall Study|Other|9
6026043|NCT00748566|20830512|P1|Overall Study|Study terminated by sponsor|5
6026044|NCT00748566|20830512|P1|Overall Study|Withdrawal by Subject|22
6026045|NCT00748566|20830512|P1|Overall Study|Protocol Violation|13
6026046|NCT00748566|20830512|P1|Overall Study|Lost to Follow-up|1
6026047|NCT00748566|20830512|P1|Overall Study|Lack of Efficacy|12
6026048|NCT00748566|20830512|P1|Overall Study|Death|1
6026049|NCT00748566|20830512|P1|Overall Study|Adverse Event|49
6026050|NCT00748553|20830542|P2|Overall Study|noncompliance|0
6026051|NCT00748553|20830543|P1|Overall Study|noncompliance|1
6026052|NCT00748553|20830542|P2|Overall Study|disease progression|0
6026053|NCT00748553|20830543|P1|Overall Study|disease progression|2
6026054|NCT00748553|20830542|P2|Overall Study|Adverse Event|1
6026055|NCT00748553|20830543|P1|Overall Study|Adverse Event|0
6026056|NCT00748540|20830550|P1|Overall Study|Physician Decision|1
6026057|NCT00748241|20830576|P1|Overall Study|Death|2
6026058|NCT00748241|20830576|P1|Overall Study|Lost to Follow-up|5
6026059|NCT00748241|20830576|P1|Overall Study|Implant failure|1
6026060|NCT00748215|20830586|P2|Overall Study|Adverse Event|5
6026061|NCT00748215|20830587|P1|Overall Study|Adverse Event|0
6026062|NCT00748215|20830586|P2|Overall Study|Non-compliant|2
6026063|NCT00748215|20830587|P1|Overall Study|Non-compliant|0
6026064|NCT00748215|20830586|P2|Overall Study|Change in patient condition|3
6026065|NCT00748215|20830587|P1|Overall Study|Change in patient condition|0
6026066|NCT00748215|20830586|P2|Overall Study|Treatment change|1
6026067|NCT00748215|20830587|P1|Overall Study|Treatment change|2
6026068|NCT00748215|20830586|P2|Overall Study|Withdrawal by Subject|7
6026069|NCT00748215|20830587|P1|Overall Study|Withdrawal by Subject|7
6026070|NCT00748189|20830595|P2|Overall Study|Study terminated by Sponsor|79
6026071|NCT00748189|20830596|P1|Overall Study|Study terminated by Sponsor|70
6026072|NCT00748189|20830595|P2|Overall Study|Lost to Follow-up|15
6026073|NCT00748189|20830596|P1|Overall Study|Lost to Follow-up|8
6026074|NCT00748189|20830595|P2|Overall Study|Physician Decision|5
6026075|NCT00748189|20830596|P1|Overall Study|Physician Decision|16
6026076|NCT00748189|20830595|P2|Overall Study|Withdrawal by Subject|29
6026077|NCT00748189|20830596|P1|Overall Study|Withdrawal by Subject|23
6026078|NCT00748189|20830595|P2|Overall Study|Death|84
6026079|NCT00748189|20830596|P1|Overall Study|Death|99
6026080|NCT00748098|20830651|P2|Second Treatment Intervention Period|Withdrawal by Subject|1
6026081|NCT00748098|20830652|P1|Second Treatment Intervention Period|Withdrawal by Subject|1
6026082|NCT00748098|20830651|P2|Second Treatment Intervention Period|Lost to Follow-up|1
6026083|NCT00748098|20830652|P1|Second Treatment Intervention Period|Lost to Follow-up|1
6026084|NCT00748098|20830651|P2|Second Treatment Intervention Period|Adverse Event|1
6026085|NCT00748098|20830652|P1|Second Treatment Intervention Period|Adverse Event|4
6026086|NCT00748098|20830651|P2|1-Week Washout Period|Withdrawal by Subject|0
6026087|NCT00748098|20830652|P1|1-Week Washout Period|Withdrawal by Subject|2
6026088|NCT00748098|20830651|P2|1-Week Washout Period|Adverse Event|1
6026089|NCT00748098|20830652|P1|1-Week Washout Period|Adverse Event|0
6026090|NCT00748098|20830651|P2|First Taper Period|Protocol Stopping Criteria Met|1
6026091|NCT00748098|20830652|P1|First Taper Period|Protocol Stopping Criteria Met|0
6026092|NCT00748098|20830651|P2|First Taper Period|Withdrawal by Subject|0
6026093|NCT00748098|20830652|P1|First Taper Period|Withdrawal by Subject|2
6026094|NCT00748098|20830651|P2|First Taper Period|Protocol Violation|0
6026095|NCT00748098|20830652|P1|First Taper Period|Protocol Violation|1
6026096|NCT00748098|20830651|P2|First Treatment Intervention Period|Withdrawal by Subject|0
6026097|NCT00748098|20830652|P1|First Treatment Intervention Period|Withdrawal by Subject|2
6026098|NCT00748098|20830651|P2|First Treatment Intervention Period|Lost to Follow-up|0
6026099|NCT00748098|20830652|P1|First Treatment Intervention Period|Lost to Follow-up|1
6026100|NCT00748098|20830651|P2|First Treatment Intervention Period|Protocol Violation|0
6026101|NCT00748098|20830652|P1|First Treatment Intervention Period|Protocol Violation|1
6026102|NCT00748098|20830651|P2|First Treatment Intervention Period|Adverse Event|1
6026103|NCT00748098|20830652|P1|First Treatment Intervention Period|Adverse Event|1
6026104|NCT00747812|20830733|P2|Overall Study|Research Site Staff Relocation|3
6026105|NCT00747812|20830734|P1|Overall Study|Research Site Staff Relocation|5
6026106|NCT00747643|20830772|P2|Overall Study|Withdrawal by Subject|27
6026107|NCT00747643|20830773|P1|Overall Study|Withdrawal by Subject|36
6026108|NCT00747617|20830787|P2|Overall Study|Lost to Follow-up|1
6026109|NCT00747617|20830788|P1|Overall Study|Lost to Follow-up|3
6026110|NCT00747565|20830798|P2|Overall Study|Lost to Follow-up|1
6026111|NCT00747565|20830799|P1|Overall Study|Lost to Follow-up|4
6026112|NCT00747565|20830798|P2|Overall Study|Withdrawal by Subject|6
6026113|NCT00747565|20830799|P1|Overall Study|Withdrawal by Subject|10
6026114|NCT00747474|20830812|P12|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
6026115|NCT00747474|20830813|P11|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
6026116|NCT00747474|20830814|P10|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
6026117|NCT00747474|20830815|P9|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
6026118|NCT00747474|20830816|P8|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|1
6026119|NCT00747474|20830817|P7|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
6026120|NCT00747474|20830818|P6|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
6026121|NCT00747474|20830819|P5|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
6026122|NCT00747474|20830820|P4|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
6026123|NCT00747474|20830821|P3|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
6026124|NCT00747474|20830822|P2|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
6026125|NCT00747474|20830823|P1|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
6026126|NCT00747461|20830849|P1|Overall Study|study terminated by sponsor|5
6026127|NCT00747435|20830854|P1|Overall Study|Still undergoing follow up|1
6026128|NCT00747435|20830854|P1|Overall Study|Withdrawal by Subject|3
6026129|NCT00747435|20830854|P1|Overall Study|Lost to Follow-up|2
6026130|NCT00747344|20830864|P4|After Controlled Period|Adverse Event|1
6026131|NCT00747344|20830865|P3|After Controlled Period|Adverse Event|0
6026132|NCT00747344|20830866|P2|After Controlled Period|Adverse Event|0
6026133|NCT00747344|20830867|P1|After Controlled Period|Adverse Event|0
6026134|NCT00747344|20830864|P4|Controlled Period|Other|0
6026135|NCT00747344|20830865|P3|Controlled Period|Other|0
6026136|NCT00747344|20830866|P2|Controlled Period|Other|3
6026137|NCT00747344|20830867|P1|Controlled Period|Other|0
6026138|NCT00747344|20830864|P4|Controlled Period|Lack of Efficacy|0
6026139|NCT00747344|20830865|P3|Controlled Period|Lack of Efficacy|0
6026140|NCT00747344|20830866|P2|Controlled Period|Lack of Efficacy|1
6026141|NCT00747344|20830867|P1|Controlled Period|Lack of Efficacy|2
6026142|NCT00747344|20830864|P4|Controlled Period|Adverse Event|0
6026143|NCT00747344|20830865|P3|Controlled Period|Adverse Event|0
6026144|NCT00747344|20830866|P2|Controlled Period|Adverse Event|0
6026145|NCT00747344|20830867|P1|Controlled Period|Adverse Event|3
6026146|NCT00747227|20830881|P2|Overall Study|Illness|1
6026147|NCT00747227|20830882|P1|Overall Study|Illness|1
6026148|NCT00747227|20830881|P2|Overall Study|Lost to Follow-up|2
6026149|NCT00747227|20830882|P1|Overall Study|Lost to Follow-up|1
6026150|NCT00747227|20830881|P2|Overall Study|Withdrawal by Subject|0
6026151|NCT00747227|20830882|P1|Overall Study|Withdrawal by Subject|1
6026152|NCT00747227|20830881|P2|Overall Study|Death|1
6026153|NCT00747227|20830882|P1|Overall Study|Death|3
6026154|NCT00747149|20830911|P2|Overall Study|Not reported|4
6026155|NCT00747149|20830912|P1|Overall Study|Not reported|1
6026156|NCT00747149|20830911|P2|Overall Study|Severe non-compliance to protocol|1
6026157|NCT00747149|20830912|P1|Overall Study|Severe non-compliance to protocol|0
6026158|NCT00747149|20830911|P2|Overall Study|Incorrect enrollment|6
6026159|NCT00747149|20830912|P1|Overall Study|Incorrect enrollment|0
6026160|NCT00747149|20830911|P2|Overall Study|Did not receive treatment|1
6026161|NCT00747149|20830912|P1|Overall Study|Did not receive treatment|0
6026162|NCT00747149|20830911|P2|Overall Study|Withdrawal by Subject|6
6026163|NCT00747149|20830912|P1|Overall Study|Withdrawal by Subject|0
6026164|NCT00747149|20830911|P2|Overall Study|Lost to Follow-up|10
6026165|NCT00747149|20830912|P1|Overall Study|Lost to Follow-up|0
6026166|NCT00747149|20830911|P2|Overall Study|Adverse Event|15
6026167|NCT00747149|20830912|P1|Overall Study|Adverse Event|0
6026168|NCT00747006|20830927|P3|Overall Study|Physician Decision|1
6026169|NCT00747006|20830928|P2|Overall Study|Physician Decision|0
6026170|NCT00747006|20830929|P1|Overall Study|Physician Decision|2
6026171|NCT00747006|20830927|P3|Overall Study|Lost to Follow-up|0
6026172|NCT00747006|20830928|P2|Overall Study|Lost to Follow-up|1
6026173|NCT00747006|20830929|P1|Overall Study|Lost to Follow-up|0
6026174|NCT00747006|20830927|P3|Overall Study|Adverse Event|0
6026175|NCT00747006|20830928|P2|Overall Study|Adverse Event|0
6026176|NCT00747006|20830929|P1|Overall Study|Adverse Event|1
6026177|NCT00746941|20831007|P4|Overall Study|Adverse Event|1
6026178|NCT00746941|20831008|P3|Overall Study|Adverse Event|0
6026179|NCT00746941|20831009|P2|Overall Study|Adverse Event|0
6026180|NCT00746941|20831010|P1|Overall Study|Adverse Event|0
6026181|NCT00746941|20831007|P4|Overall Study|Other, reason not provided|4
6026182|NCT00746941|20831008|P3|Overall Study|Other, reason not provided|0
6026183|NCT00746941|20831009|P2|Overall Study|Other, reason not provided|4
6026184|NCT00746941|20831010|P1|Overall Study|Other, reason not provided|2
6026185|NCT00746941|20831007|P4|Overall Study|Withdrawal by Subject|2
6026186|NCT00746941|20831008|P3|Overall Study|Withdrawal by Subject|0
6026187|NCT00746941|20831009|P2|Overall Study|Withdrawal by Subject|0
6026188|NCT00746941|20831010|P1|Overall Study|Withdrawal by Subject|3
6026189|NCT00746941|20831007|P4|Overall Study|Physician Decision|0
6026190|NCT00746941|20831008|P3|Overall Study|Physician Decision|2
6026191|NCT00746941|20831009|P2|Overall Study|Physician Decision|0
6026192|NCT00746941|20831010|P1|Overall Study|Physician Decision|0
6026193|NCT00746941|20831007|P4|Overall Study|Death|6
6026194|NCT00746941|20831008|P3|Overall Study|Death|0
6026195|NCT00746941|20831009|P2|Overall Study|Death|0
6026196|NCT00746941|20831010|P1|Overall Study|Death|2
6026197|NCT00746798|20831068|P4|Overall Study|Participant unable to return for visit|0
6026198|NCT00746798|20831069|P3|Overall Study|Participant unable to return for visit|0
6026199|NCT00746798|20831070|P2|Overall Study|Participant unable to return for visit|0
6026200|NCT00746798|20831071|P1|Overall Study|Participant unable to return for visit|1
6026201|NCT00746798|20831068|P4|Overall Study|Death|0
6026202|NCT00746798|20831069|P3|Overall Study|Death|2
6026203|NCT00746798|20831070|P2|Overall Study|Death|0
6026204|NCT00746798|20831071|P1|Overall Study|Death|0
6026205|NCT00746798|20831068|P4|Overall Study|Withdrawal by Subject|0
6026206|NCT00746798|20831069|P3|Overall Study|Withdrawal by Subject|1
6026207|NCT00746798|20831070|P2|Overall Study|Withdrawal by Subject|1
6026208|NCT00746798|20831071|P1|Overall Study|Withdrawal by Subject|0
6026209|NCT00746798|20831068|P4|Overall Study|Protocol Violation|0
6026210|NCT00746798|20831069|P3|Overall Study|Protocol Violation|0
6026211|NCT00746798|20831070|P2|Overall Study|Protocol Violation|1
6026212|NCT00746798|20831071|P1|Overall Study|Protocol Violation|0
6026213|NCT00746785|20831096|P3|Overall Study|Lost to Follow-up|27
6026214|NCT00746785|20831097|P2|Overall Study|Lost to Follow-up|25
6026215|NCT00746785|20831098|P1|Overall Study|Lost to Follow-up|29
6026216|NCT00746733|20831106|P2|Third Intervention|Withdrawal by Subject|1
6026217|NCT00746733|20831107|P1|Third Intervention|Withdrawal by Subject|1
6026218|NCT00746733|20831106|P2|Second Intervention|Adverse Event|0
6026219|NCT00746733|20831107|P1|Second Intervention|Adverse Event|1
6026220|NCT00746590|20831191|P1|Overall Study|Death|1
6026221|NCT00746564|20831195|P1|Overall Study|Required Pacemaker/ICD Implant|2
6026222|NCT00746551|20831210|P2|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|8
6026223|NCT00746551|20831211|P1|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|6
6026224|NCT00746551|20831210|P2|At Delivery (GA of 39 Weeks)|Lost to Follow-up|7
6026225|NCT00746551|20831211|P1|At Delivery (GA of 39 Weeks)|Lost to Follow-up|9
6026226|NCT00746551|20831210|P2|At Gestational Age of 36 Weeks|Lost to Follow-up|4
6026227|NCT00746551|20831211|P1|At Gestational Age of 36 Weeks|Lost to Follow-up|2
6026228|NCT00746356|20831262|P2|Overall Study|Patient relocated|0
6026229|NCT00746356|20831263|P1|Overall Study|Patient relocated|1
6026230|NCT00746356|20831262|P2|Overall Study|Removal of Device|1
6026231|NCT00746356|20831263|P1|Overall Study|Removal of Device|0
6026232|NCT00746356|20831262|P2|Overall Study|Lost to Follow-up|0
6026233|NCT00746356|20831263|P1|Overall Study|Lost to Follow-up|1
6026234|NCT00746356|20831262|P2|Overall Study|Death|3
6026235|NCT00746356|20831263|P1|Overall Study|Death|7
6026236|NCT00746356|20831262|P2|Overall Study|Withdrawal by Subject|3
6026237|NCT00746356|20831263|P1|Overall Study|Withdrawal by Subject|2
6026238|NCT00746330|20831275|P4|Period 1|Abnormal test procedure result|0
6026239|NCT00746330|20831276|P3|Period 1|Abnormal test procedure result|1
6026240|NCT00746330|20831277|P2|Period 1|Abnormal test procedure result|0
6026241|NCT00746330|20831278|P1|Period 1|Abnormal test procedure result|0
6026242|NCT00746252|20831308|P2|Overall Study|weight gain >7.5 %|2
6026243|NCT00746252|20831309|P1|Overall Study|weight gain >7.5 %|1
6026244|NCT00746096|20831344|P2|Overall Study|No study drug treatment|1
6026245|NCT00746096|20831345|P1|Overall Study|No study drug treatment|1
6026246|NCT00746096|20831344|P2|Overall Study|Protocol Violation|0
6026247|NCT00746096|20831345|P1|Overall Study|Protocol Violation|1
6026248|NCT00746096|20831344|P2|Overall Study|Lost to Follow-up|1
6026249|NCT00746096|20831345|P1|Overall Study|Lost to Follow-up|2
6026250|NCT00746096|20831344|P2|Overall Study|Withdrawal by Subject|1
6026251|NCT00746096|20831345|P1|Overall Study|Withdrawal by Subject|5
6026252|NCT00746096|20831344|P2|Overall Study|Adverse Event|0
6026253|NCT00746096|20831345|P1|Overall Study|Adverse Event|1
6026254|NCT00745901|20831376|P2|Overall Study|Patient didn't take any study medication|3
6026255|NCT00745901|20831377|P1|Overall Study|Patient didn't take any study medication|7
6026256|NCT00745901|20831376|P2|Overall Study|Chlamydia test at Visit 1 was positive|1
6026257|NCT00745901|20831377|P1|Overall Study|Chlamydia test at Visit 1 was positive|1
6026258|NCT00745901|20831376|P2|Overall Study|Results of Pap smear at Vis 1 malignant|2
6026259|NCT00745901|20831377|P1|Overall Study|Results of Pap smear at Vis 1 malignant|0
6026260|NCT00745901|20831376|P2|Overall Study|Patient's next menses did not start with|0
6026261|NCT00745901|20831377|P1|Overall Study|Patient's next menses did not start with|1
6026262|NCT00745901|20831376|P2|Overall Study|Lack of compliance|2
6026263|NCT00745901|20831377|P1|Overall Study|Lack of compliance|2
6026264|NCT00745901|20831376|P2|Overall Study|Pregnancy|4
6026265|NCT00745901|20831377|P1|Overall Study|Pregnancy|2
6026266|NCT00745901|20831376|P2|Overall Study|Lost to Follow-up|4
6026267|NCT00745901|20831377|P1|Overall Study|Lost to Follow-up|7
6026268|NCT00745901|20831376|P2|Overall Study|Withdrawal by Subject|0
6026269|NCT00745901|20831377|P1|Overall Study|Withdrawal by Subject|1
6026270|NCT00745901|20831376|P2|Overall Study|Protocol Violation|1
6026271|NCT00745901|20831377|P1|Overall Study|Protocol Violation|0
6026272|NCT00745901|20831376|P2|Overall Study|Adverse Event|4
6026273|NCT00745901|20831377|P1|Overall Study|Adverse Event|3
6026274|NCT00745875|20831423|P2|Overall Study|Continuing study treatment|4
6026275|NCT00745875|20831424|P1|Overall Study|Continuing study treatment|4
6026276|NCT00745849|20831432|P2|Second Intervention|Lost to Follow-up|1
6026277|NCT00745849|20831433|P1|Second Intervention|Lost to Follow-up|2
6026278|NCT00745849|20831432|P2|First Intervention|Lost to Follow-up|1
6026279|NCT00745849|20831433|P1|First Intervention|Lost to Follow-up|1
6026280|NCT00745849|20831432|P2|First Intervention|Withdrawal by Subject|1
6026281|NCT00745849|20831433|P1|First Intervention|Withdrawal by Subject|0
6026282|NCT00745823|20831441|P2|Overall Study|Study Terminated by Sponsor|349
6026283|NCT00745823|20831442|P1|Overall Study|Study Terminated by Sponsor|326
6026284|NCT00745823|20831441|P2|Overall Study|Withdrawal by Subject|8
6026285|NCT00745823|20831442|P1|Overall Study|Withdrawal by Subject|14
6026286|NCT00745823|20831441|P2|Overall Study|Pregnancy|4
6026287|NCT00745823|20831442|P1|Overall Study|Pregnancy|0
6026288|NCT00745823|20831441|P2|Overall Study|Physician Decision|5
6026289|NCT00745823|20831442|P1|Overall Study|Physician Decision|10
6026290|NCT00745823|20831441|P2|Overall Study|Lost to Follow-up|11
6026291|NCT00745823|20831442|P1|Overall Study|Lost to Follow-up|10
6026292|NCT00745823|20831441|P2|Overall Study|Lack of Efficacy|6
6026293|NCT00745823|20831442|P1|Overall Study|Lack of Efficacy|20
6026294|NCT00745823|20831441|P2|Overall Study|Adverse Event|3
6026295|NCT00745823|20831442|P1|Overall Study|Adverse Event|5
6026296|NCT00745615|20831470|P6|Open-Label (up to Approx 10.5 Years)|Other Than Specified|10
6026297|NCT00745615|20831471|P5|Open-Label (up to Approx 10.5 Years)|Other Than Specified|8
6026298|NCT00745615|20831472|P4|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0
6026299|NCT00745615|20831473|P3|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0
6026300|NCT00745615|20831474|P2|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0
6026301|NCT00745615|20831475|P1|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0
6026302|NCT00745615|20831470|P6|Open-Label (up to Approx 10.5 Years)|Death|1
6026303|NCT00745615|20831471|P5|Open-Label (up to Approx 10.5 Years)|Death|0
6026304|NCT00745615|20831472|P4|Open-Label (up to Approx 10.5 Years)|Death|0
6026305|NCT00745615|20831473|P3|Open-Label (up to Approx 10.5 Years)|Death|0
6026306|NCT00745615|20831474|P2|Open-Label (up to Approx 10.5 Years)|Death|0
6026307|NCT00745615|20831475|P1|Open-Label (up to Approx 10.5 Years)|Death|0
6026308|NCT00745615|20831470|P6|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|1
6026309|NCT00745615|20831471|P5|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0
6026310|NCT00745615|20831472|P4|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0
6026311|NCT00745615|20831473|P3|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0
6026312|NCT00745615|20831474|P2|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0
6026313|NCT00745615|20831475|P1|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0
6026314|NCT00745615|20831470|P6|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|3
6026315|NCT00745615|20831471|P5|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|1
6026316|NCT00745615|20831472|P4|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0
6026317|NCT00745615|20831473|P3|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0
6026318|NCT00745615|20831474|P2|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0
6026319|NCT00745615|20831475|P1|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0
6026320|NCT00745615|20831470|P6|Open-Label (up to Approx 10.5 Years)|Pregnancy|5
6026321|NCT00745615|20831471|P5|Open-Label (up to Approx 10.5 Years)|Pregnancy|2
6026322|NCT00745615|20831472|P4|Open-Label (up to Approx 10.5 Years)|Pregnancy|0
6026323|NCT00745615|20831473|P3|Open-Label (up to Approx 10.5 Years)|Pregnancy|0
6026324|NCT00745615|20831474|P2|Open-Label (up to Approx 10.5 Years)|Pregnancy|0
6026325|NCT00745615|20831475|P1|Open-Label (up to Approx 10.5 Years)|Pregnancy|0
6026326|NCT00745615|20831470|P6|Open-Label (up to Approx 10.5 Years)|Adverse Event|8
6026327|NCT00745615|20831471|P5|Open-Label (up to Approx 10.5 Years)|Adverse Event|2
6026328|NCT00745615|20831472|P4|Open-Label (up to Approx 10.5 Years)|Adverse Event|0
6026329|NCT00745615|20831473|P3|Open-Label (up to Approx 10.5 Years)|Adverse Event|0
6026330|NCT00745615|20831474|P2|Open-Label (up to Approx 10.5 Years)|Adverse Event|0
6026331|NCT00745615|20831475|P1|Open-Label (up to Approx 10.5 Years)|Adverse Event|0
6026332|NCT00745615|20831470|P6|Open-Label (up to Approx 10.5 Years)|Physician Decision|11
6026333|NCT00745615|20831471|P5|Open-Label (up to Approx 10.5 Years)|Physician Decision|9
6026334|NCT00745615|20831472|P4|Open-Label (up to Approx 10.5 Years)|Physician Decision|0
6026335|NCT00745615|20831473|P3|Open-Label (up to Approx 10.5 Years)|Physician Decision|0
6026336|NCT00745615|20831474|P2|Open-Label (up to Approx 10.5 Years)|Physician Decision|0
6026337|NCT00745615|20831475|P1|Open-Label (up to Approx 10.5 Years)|Physician Decision|0
6026338|NCT00745615|20831470|P6|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19
6026339|NCT00745615|20831471|P5|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19
6026340|NCT00745615|20831472|P4|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0
6026341|NCT00745615|20831473|P3|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0
6026342|NCT00745615|20831474|P2|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0
6026343|NCT00745615|20831475|P1|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0
6026344|NCT00745615|20831470|P6|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50
6026345|NCT00745615|20831471|P5|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50
6026346|NCT00745615|20831472|P4|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0
6026347|NCT00745615|20831473|P3|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0
6026348|NCT00745615|20831474|P2|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0
6026349|NCT00745615|20831475|P1|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0
6026350|NCT00745615|20831470|P6|Double-Blind Extension (36 Weeks)|Other Than Specified|0
6026351|NCT00745615|20831471|P5|Double-Blind Extension (36 Weeks)|Other Than Specified|0
6026352|NCT00745615|20831472|P4|Double-Blind Extension (36 Weeks)|Other Than Specified|0
6026353|NCT00745615|20831473|P3|Double-Blind Extension (36 Weeks)|Other Than Specified|0
6026354|NCT00745615|20831474|P2|Double-Blind Extension (36 Weeks)|Other Than Specified|1
6026355|NCT00745615|20831475|P1|Double-Blind Extension (36 Weeks)|Other Than Specified|0
6026356|NCT00745615|20831470|P6|Double-Blind Extension (36 Weeks)|Pregnancy|0
6026357|NCT00745615|20831471|P5|Double-Blind Extension (36 Weeks)|Pregnancy|0
6026358|NCT00745615|20831472|P4|Double-Blind Extension (36 Weeks)|Pregnancy|0
6026359|NCT00745615|20831473|P3|Double-Blind Extension (36 Weeks)|Pregnancy|0
6026360|NCT00745615|20831474|P2|Double-Blind Extension (36 Weeks)|Pregnancy|1
6026361|NCT00745615|20831475|P1|Double-Blind Extension (36 Weeks)|Pregnancy|0
6026362|NCT00745615|20831470|P6|Double-Blind Extension (36 Weeks)|Adverse Event|0
6026363|NCT00745615|20831471|P5|Double-Blind Extension (36 Weeks)|Adverse Event|0
6026364|NCT00745615|20831472|P4|Double-Blind Extension (36 Weeks)|Adverse Event|1
6026365|NCT00745615|20831473|P3|Double-Blind Extension (36 Weeks)|Adverse Event|1
6026366|NCT00745615|20831474|P2|Double-Blind Extension (36 Weeks)|Adverse Event|3
6026367|NCT00745615|20831475|P1|Double-Blind Extension (36 Weeks)|Adverse Event|2
6026368|NCT00745615|20831470|P6|Double-Blind Extension (36 Weeks)|Physician Decision|0
6026369|NCT00745615|20831471|P5|Double-Blind Extension (36 Weeks)|Physician Decision|0
6026370|NCT00745615|20831472|P4|Double-Blind Extension (36 Weeks)|Physician Decision|0
6026371|NCT00745615|20831473|P3|Double-Blind Extension (36 Weeks)|Physician Decision|0
6026372|NCT00745615|20831474|P2|Double-Blind Extension (36 Weeks)|Physician Decision|1
6026373|NCT00745615|20831475|P1|Double-Blind Extension (36 Weeks)|Physician Decision|0
6026374|NCT00745615|20831470|P6|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0
6026375|NCT00745615|20831471|P5|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0
6026376|NCT00745615|20831472|P4|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|4
6026377|NCT00745615|20831473|P3|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0
6026378|NCT00745615|20831474|P2|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|1
6026379|NCT00745615|20831475|P1|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|3
6026380|NCT00745498|20831524|P3|Overall Study|Edophthalmitis after preoperative IVB|0
6026381|NCT00745498|20831525|P2|Overall Study|Edophthalmitis after preoperative IVB|0
6026382|NCT00745498|20831526|P1|Overall Study|Edophthalmitis after preoperative IVB|1
6026383|NCT00745498|20831524|P3|Overall Study|Non-PDR related VH|1
6026384|NCT00745498|20831525|P2|Overall Study|Non-PDR related VH|1
6026385|NCT00745498|20831526|P1|Overall Study|Non-PDR related VH|0
6026386|NCT00745498|20831524|P3|Overall Study|Injection of intravitreal silicone oil o|4
6026387|NCT00745498|20831525|P2|Overall Study|Injection of intravitreal silicone oil o|4
6026388|NCT00745498|20831526|P1|Overall Study|Injection of intravitreal silicone oil o|3
6026389|NCT00745498|20831524|P3|Overall Study|Lost to Follow-up|3
6026390|NCT00745498|20831525|P2|Overall Study|Lost to Follow-up|1
6026391|NCT00745498|20831526|P1|Overall Study|Lost to Follow-up|1
6026392|NCT00745420|20831540|P1|Overall Study|Ineligible|1
6026393|NCT00745368|20831557|P1|Overall Study|Unable to provide sample|3
6026394|NCT00745251|20831579|P2|Overall Study|Withdrawal by Subject|1
6026395|NCT00745251|20831580|P1|Overall Study|Withdrawal by Subject|1
6026396|NCT00745251|20831579|P2|Overall Study|Adverse Event|2
6026397|NCT00745251|20831580|P1|Overall Study|Adverse Event|1
6026398|NCT00745121|20831590|P2|Overall Study|Withdrawal by Subject|2
6026399|NCT00745121|20831591|P1|Overall Study|Withdrawal by Subject|4
6026400|NCT00745121|20831590|P2|Overall Study|Lost to Follow-up|0
6026401|NCT00745121|20831591|P1|Overall Study|Lost to Follow-up|1
6026402|NCT00745121|20831590|P2|Overall Study|Adverse Event|0
6026403|NCT00745121|20831591|P1|Overall Study|Adverse Event|1
6026404|NCT00745121|20831590|P2|Overall Study|Death|0
6026405|NCT00745121|20831591|P1|Overall Study|Death|3
6026406|NCT00745095|20831603|P6|Overall Study|Ineligible due to GFR criteria|28
6026407|NCT00745095|20831604|P5|Overall Study|Ineligible due to GFR criteria|30
6026408|NCT00745095|20831605|P4|Overall Study|Ineligible due to GFR criteria|3
6026409|NCT00745095|20831606|P3|Overall Study|Ineligible due to GFR criteria|3
6026410|NCT00745095|20831607|P2|Overall Study|Ineligible due to GFR criteria|2
6026411|NCT00745095|20831608|P1|Overall Study|Ineligible due to GFR criteria|0
6026412|NCT00745095|20831603|P6|Overall Study|Declined to participate|95
6026413|NCT00745095|20831604|P5|Overall Study|Declined to participate|92
6026414|NCT00745095|20831605|P4|Overall Study|Declined to participate|0
6026415|NCT00745095|20831606|P3|Overall Study|Declined to participate|0
6026416|NCT00745095|20831607|P2|Overall Study|Declined to participate|0
6026417|NCT00745095|20831608|P1|Overall Study|Declined to participate|1
6026418|NCT00744991|20831637|P1|Overall Study|Protocol Entry Criteria Unmet|1
6026419|NCT00744991|20831637|P1|Overall Study|Adverse Event|2
6026420|NCT00744991|20831637|P1|Overall Study|Physician Decision|3
6026421|NCT00744991|20831637|P1|Overall Study|Withdrawal by Subject|8
6026422|NCT00744991|20831637|P1|Overall Study|Progressive Disease|11
6026423|NCT00744978|20831654|P2|Period 2|Adverse Event|1
6026424|NCT00744978|20831655|P1|Period 2|Adverse Event|0
6026425|NCT00744978|20831654|P2|Period 1|Randomized but not Treated|1
6026426|NCT00744978|20831655|P1|Period 1|Randomized but not Treated|1
6026427|NCT00744978|20831654|P2|Period 1|Adverse Event|0
6026428|NCT00744978|20831655|P1|Period 1|Adverse Event|4
6026429|NCT00744978|20831654|P2|Period 1|Other|2
6026430|NCT00744978|20831655|P1|Period 1|Other|0
6026431|NCT00744978|20831654|P2|Period 1|Withdrawal by Subject|2
6026432|NCT00744978|20831655|P1|Period 1|Withdrawal by Subject|0
6026433|NCT00744978|20831654|P2|Period 1|Lost to Follow-up|0
6026434|NCT00744978|20831655|P1|Period 1|Lost to Follow-up|1
6026435|NCT00744939|20831736|P1|Overall Study|incorrect race|1
6026436|NCT00744939|20831736|P1|Overall Study|coma|1
6026437|NCT00744939|20831736|P1|Overall Study|Failed inclusion/exclusion criteria|19
6026438|NCT00744939|20831736|P1|Overall Study|Did not receive Magnevist|7
6026439|NCT00744939|20831736|P1|Overall Study|Medical history exclusionary|1
6026440|NCT00744939|20831736|P1|Overall Study|Lost to Follow-up|12
6026441|NCT00744939|20831736|P1|Overall Study|distance|4
6026442|NCT00744939|20831736|P1|Overall Study|Death|24
6026443|NCT00744939|20831736|P1|Overall Study|Protocol Violation|13
6026444|NCT00744939|20831736|P1|Overall Study|Withdrawal by Subject|9
6026445|NCT00744874|20831772|P1|Overall Study|Unable to accomodate schedule|1
6026446|NCT00744874|20831772|P1|Overall Study|Study Device not available at procedure|1
6026447|NCT00744874|20831772|P1|Overall Study|Withdrawal by Subject|1
6026448|NCT00744874|20831772|P1|Overall Study|Lost to Follow-up|1
6026449|NCT00744796|20831797|P1|Post-Operative 6-9 Months|Lost to Follow-up|12
6026450|NCT00744757|20831803|P1|Overall Study|Adverse Event|2
6026451|NCT00744757|20831803|P1|Overall Study|Death|6
6026452|NCT00744757|20831803|P1|Overall Study|Withdrawal by Subject|1
6026453|NCT00744757|20831803|P1|Overall Study|Physician Decision|5
6026454|NCT00744757|20831803|P1|Overall Study|Objective disease progression|7
6026455|NCT00744653|20831828|P1|Overall Study|Physician Decision|3
6026456|NCT00744653|20831828|P1|Overall Study|Lost to Follow-up|1
6026457|NCT00744653|20831828|P1|Overall Study|Death|1
6026458|NCT00744653|20831828|P1|Overall Study|antineoplastic treatment|11
6026459|NCT00744627|20831836|P2|Overall Study|Other|0
6026460|NCT00744627|20831837|P1|Overall Study|Other|1
6026461|NCT00744627|20831836|P2|Overall Study|Lost to Follow-up|1
6026462|NCT00744627|20831837|P1|Overall Study|Lost to Follow-up|2
6026463|NCT00744627|20831836|P2|Overall Study|Voluntary Withdrawal|6
6026464|NCT00744627|20831837|P1|Overall Study|Voluntary Withdrawal|9
6026465|NCT00744627|20831836|P2|Overall Study|Protocol Deviations|2
6026466|NCT00744627|20831837|P1|Overall Study|Protocol Deviations|0
6026467|NCT00744627|20831836|P2|Overall Study|Noncompliance|1
6026468|NCT00744627|20831837|P1|Overall Study|Noncompliance|0
6026469|NCT00744627|20831836|P2|Overall Study|Lack of Efficacy|3
6026470|NCT00744627|20831837|P1|Overall Study|Lack of Efficacy|7
6026471|NCT00744627|20831836|P2|Overall Study|Adverse Event|9
6026472|NCT00744627|20831837|P1|Overall Study|Adverse Event|6
6026473|NCT00744523|20831893|P2|30 Days After the Procedure|Insufficient follow-up|5
6026474|NCT00744523|20831894|P1|30 Days After the Procedure|Insufficient follow-up|0
6026475|NCT00744497|20831914|P2|Overall Study|Not defined|13
6026476|NCT00744497|20831915|P1|Overall Study|Not defined|19
6026477|NCT00744497|20831914|P2|Overall Study|Maximum clinical benefit|142
6026478|NCT00744497|20831915|P1|Overall Study|Maximum clinical benefit|141
6026479|NCT00744497|20831914|P2|Overall Study|Patient requested to stop study drug|80
6026480|NCT00744497|20831915|P1|Overall Study|Patient requested to stop study drug|65
6026481|NCT00744497|20831914|P2|Overall Study|Adverse event unrelated to study drug|122
6026482|NCT00744497|20831915|P1|Overall Study|Adverse event unrelated to study drug|78
6026483|NCT00744497|20831914|P2|Overall Study|Study drug toxicity|141
6026484|NCT00744497|20831915|P1|Overall Study|Study drug toxicity|68
6026485|NCT00744497|20831914|P2|Overall Study|Disease progression|219
6026486|NCT00744497|20831915|P1|Overall Study|Disease progression|312
6026487|NCT00744497|20831914|P2|Overall Study|Administrative Reason By Sponsor|8
6026488|NCT00744497|20831915|P1|Overall Study|Administrative Reason By Sponsor|25
6026489|NCT00744497|20831914|P2|Overall Study|No longer meets study criteria|3
6026490|NCT00744497|20831915|P1|Overall Study|No longer meets study criteria|7
6026491|NCT00744497|20831914|P2|Overall Study|Poor compliance/noncompliance|5
6026492|NCT00744497|20831915|P1|Overall Study|Poor compliance/noncompliance|9
6026493|NCT00744497|20831914|P2|Overall Study|Lost to Follow-up|2
6026494|NCT00744497|20831915|P1|Overall Study|Lost to Follow-up|4
6026495|NCT00744497|20831914|P2|Overall Study|Death|9
6026496|NCT00744497|20831915|P1|Overall Study|Death|11
6026497|NCT00744497|20831914|P2|Overall Study|Withdrawal by Subject|18
6026498|NCT00744497|20831915|P1|Overall Study|Withdrawal by Subject|21
6026499|NCT00744328|20831975|P3|Overall Study|Found ineligible after randomization|1
6026500|NCT00744328|20831976|P2|Overall Study|Found ineligible after randomization|0
6026501|NCT00744328|20831977|P1|Overall Study|Found ineligible after randomization|0
6026502|NCT00744328|20831975|P3|Overall Study|Withdrawal by Subject|4
6026503|NCT00744328|20831976|P2|Overall Study|Withdrawal by Subject|3
6026504|NCT00744328|20831977|P1|Overall Study|Withdrawal by Subject|5
6026505|NCT00744328|20831975|P3|Overall Study|Lost to Follow-up|3
6026506|NCT00744328|20831976|P2|Overall Study|Lost to Follow-up|5
6026507|NCT00744328|20831977|P1|Overall Study|Lost to Follow-up|2
6026508|NCT00744263|20831990|P2|Overall Study|Other|2
6026509|NCT00744263|20831991|P1|Overall Study|Other|2
6026510|NCT00744263|20831990|P2|Overall Study|Adverse Event|0
6026511|NCT00744263|20831991|P1|Overall Study|Adverse Event|1
6026512|NCT00744263|20831990|P2|Overall Study|Protocol Violation|5
6026513|NCT00744263|20831991|P1|Overall Study|Protocol Violation|3
6026514|NCT00744263|20831990|P2|Overall Study|Physician Decision|23
6026515|NCT00744263|20831991|P1|Overall Study|Physician Decision|20
6026516|NCT00744263|20831990|P2|Overall Study|Withdrawal by Subject|150
6026517|NCT00744263|20831991|P1|Overall Study|Withdrawal by Subject|166
6026518|NCT00744263|20831990|P2|Overall Study|Lost to Follow-up|2135
6026519|NCT00744263|20831991|P1|Overall Study|Lost to Follow-up|2038
6026520|NCT00744263|20831990|P2|Overall Study|Death|3005
6026521|NCT00744263|20831991|P1|Overall Study|Death|3006
6026522|NCT00744237|20832014|P3|Overall Study|Adverse Event|5
6026523|NCT00744237|20832015|P2|Overall Study|Adverse Event|13
6026524|NCT00744237|20832016|P1|Overall Study|Adverse Event|9
6026525|NCT00744237|20832014|P3|Overall Study|Administrative. Site Closed|1
6026526|NCT00744237|20832015|P2|Overall Study|Administrative. Site Closed|1
6026527|NCT00744237|20832016|P1|Overall Study|Administrative. Site Closed|1
6026528|NCT00744237|20832014|P3|Overall Study|Poor Compliance|0
6026529|NCT00744237|20832015|P2|Overall Study|Poor Compliance|2
6026530|NCT00744237|20832016|P1|Overall Study|Poor Compliance|0
6026531|NCT00744237|20832014|P3|Overall Study|Prohibited Concomitant Medication|1
6026532|NCT00744237|20832015|P2|Overall Study|Prohibited Concomitant Medication|0
6026533|NCT00744237|20832016|P1|Overall Study|Prohibited Concomitant Medication|0
6026534|NCT00744237|20832014|P3|Overall Study|Study Drug Error|0
6026535|NCT00744237|20832015|P2|Overall Study|Study Drug Error|0
6026536|NCT00744237|20832016|P1|Overall Study|Study Drug Error|1
6026537|NCT00744237|20832014|P3|Overall Study|Dosing Error|1
6026538|NCT00744237|20832015|P2|Overall Study|Dosing Error|0
6026539|NCT00744237|20832016|P1|Overall Study|Dosing Error|1
6026540|NCT00744237|20832014|P3|Overall Study|Inclusion/Exclusion criteria not met|0
6026541|NCT00744237|20832015|P2|Overall Study|Inclusion/Exclusion criteria not met|0
6026542|NCT00744237|20832016|P1|Overall Study|Inclusion/Exclusion criteria not met|1
6026543|NCT00744237|20832014|P3|Overall Study|Protocol Violation|3
6026544|NCT00744237|20832015|P2|Overall Study|Protocol Violation|4
6026545|NCT00744237|20832016|P1|Overall Study|Protocol Violation|3
6026546|NCT00744237|20832014|P3|Overall Study|Lost to Follow-up|1
6026547|NCT00744237|20832015|P2|Overall Study|Lost to Follow-up|1
6026548|NCT00744237|20832016|P1|Overall Study|Lost to Follow-up|1
6026549|NCT00744237|20832014|P3|Overall Study|Withdrawal by Subject|3
6026550|NCT00744237|20832015|P2|Overall Study|Withdrawal by Subject|5
6026551|NCT00744237|20832016|P1|Overall Study|Withdrawal by Subject|9
6026552|NCT00744237|20832014|P3|Overall Study|Lack of Efficacy|0
6026553|NCT00744237|20832015|P2|Overall Study|Lack of Efficacy|1
6026554|NCT00744237|20832016|P1|Overall Study|Lack of Efficacy|1
6026555|NCT00744055|20832050|P2|Overall Study|Lost to Follow-up|1
6026556|NCT00744055|20832051|P1|Overall Study|Lost to Follow-up|0
6026557|NCT00744055|20832050|P2|Overall Study|Protocol Violation|1
6026558|NCT00744055|20832051|P1|Overall Study|Protocol Violation|1
6026559|NCT00744055|20832050|P2|Overall Study|Physician Decision|2
6026560|NCT00744055|20832051|P1|Overall Study|Physician Decision|0
6026561|NCT00744055|20832050|P2|Overall Study|Lack of Efficacy|1
6026562|NCT00744055|20832051|P1|Overall Study|Lack of Efficacy|0
6026563|NCT00744055|20832050|P2|Overall Study|Withdrawal by Subject|9
6026564|NCT00744055|20832051|P1|Overall Study|Withdrawal by Subject|6
6026565|NCT00744042|20832059|P1|Overall Study|Withdrawal by Subject|1
6026566|NCT00743652|20832105|P5|Overall Study|Lost to Follow-up|0
6026567|NCT00743652|20832106|P4|Overall Study|Lost to Follow-up|0
6026568|NCT00743652|20832107|P3|Overall Study|Lost to Follow-up|0
6026569|NCT00743652|20832108|P2|Overall Study|Lost to Follow-up|0
6026570|NCT00743652|20832109|P1|Overall Study|Lost to Follow-up|1
6026571|NCT00743652|20832105|P5|Overall Study|Other|0
6026572|NCT00743652|20832106|P4|Overall Study|Other|0
6026573|NCT00743652|20832107|P3|Overall Study|Other|0
6026574|NCT00743652|20832108|P2|Overall Study|Other|1
6026575|NCT00743652|20832109|P1|Overall Study|Other|1
6026576|NCT00743652|20832105|P5|Overall Study|Investigator Request|0
6026577|NCT00743652|20832106|P4|Overall Study|Investigator Request|2
6026578|NCT00743652|20832107|P3|Overall Study|Investigator Request|0
6026579|NCT00743652|20832108|P2|Overall Study|Investigator Request|0
6026580|NCT00743652|20832109|P1|Overall Study|Investigator Request|0
6026581|NCT00743652|20832105|P5|Overall Study|Death|0
6026582|NCT00743652|20832106|P4|Overall Study|Death|0
6026583|NCT00743652|20832107|P3|Overall Study|Death|0
6026584|NCT00743652|20832108|P2|Overall Study|Death|0
6026585|NCT00743652|20832109|P1|Overall Study|Death|2
6026586|NCT00743652|20832105|P5|Overall Study|Adverse Event|0
6026587|NCT00743652|20832106|P4|Overall Study|Adverse Event|0
6026588|NCT00743652|20832107|P3|Overall Study|Adverse Event|0
6026589|NCT00743652|20832108|P2|Overall Study|Adverse Event|0
6026590|NCT00743652|20832109|P1|Overall Study|Adverse Event|3
6026591|NCT00743652|20832105|P5|Overall Study|Parent/Legal Guardian Request|0
6026592|NCT00743652|20832106|P4|Overall Study|Parent/Legal Guardian Request|2
6026593|NCT00743652|20832107|P3|Overall Study|Parent/Legal Guardian Request|2
6026594|NCT00743652|20832108|P2|Overall Study|Parent/Legal Guardian Request|2
6026595|NCT00743652|20832109|P1|Overall Study|Parent/Legal Guardian Request|3
6026596|NCT00743509|20832193|P1|Overall Study|Withdrawal by Subject|2
6026597|NCT00743483|20832198|P1|Treatment Period|Adverse Event|1
6026598|NCT00743483|20832198|P1|Baseline Period|Physician Decision|1
6026599|NCT00743444|20832202|P2|Washout Period|Adverse Event|1
6026600|NCT00743444|20832203|P1|Washout Period|Adverse Event|0
6026601|NCT00743444|20832202|P2|First Intervention|Catheter placement problems|1
6026602|NCT00743444|20832203|P1|First Intervention|Catheter placement problems|0
6026603|NCT00743431|20832212|P1|Overall Study|No documentation available|13
6026604|NCT00743431|20832212|P1|Overall Study|Reason for discontinuation not specified|29
6026605|NCT00743431|20832212|P1|Overall Study|Death|9
6026606|NCT00743431|20832212|P1|Overall Study|Withdrawal by Subject|13
6026607|NCT00743431|20832212|P1|Overall Study|Tumor progression|56
6026608|NCT00743431|20832212|P1|Overall Study|Toxicity|6
6026609|NCT00743366|20832216|P2|Intervention 1 (8 Days)|Withdrawal by Subject|3
6026610|NCT00743366|20832217|P1|Intervention 1 (8 Days)|Withdrawal by Subject|3
6026611|NCT00743340|20832223|P1|Overall Study|Participant Relocated|1
6026612|NCT00743340|20832223|P1|Overall Study|Rolled over to other Gilead Study|23
6026613|NCT00743340|20832223|P1|Overall Study|Pregnancy|1
6026614|NCT00743340|20832223|P1|Overall Study|Virologic failure|8
6026615|NCT00743340|20832223|P1|Overall Study|Protocol Violation|1
6026616|NCT00743340|20832223|P1|Overall Study|Withdrawal from the Study|5
6026617|NCT00743340|20832223|P1|Overall Study|Lost to Follow-up|1
6026618|NCT00743340|20832223|P1|Overall Study|Study medication non-compliance|1
6026619|NCT00743288|20832227|P7|Overall Study|Worsening of condition (Not PD)|0
6026620|NCT00743288|20832228|P6|Overall Study|Worsening of condition (Not PD)|0
6026621|NCT00743288|20832229|P5|Overall Study|Worsening of condition (Not PD)|0
6026622|NCT00743288|20832230|P4|Overall Study|Worsening of condition (Not PD)|1
6026623|NCT00743288|20832231|P3|Overall Study|Worsening of condition (Not PD)|1
6026624|NCT00743288|20832232|P2|Overall Study|Worsening of condition (Not PD)|2
6026625|NCT00743288|20832233|P1|Overall Study|Worsening of condition (Not PD)|0
6026626|NCT00743288|20832227|P7|Overall Study|Progressive disease (PD)|6
6026627|NCT00743288|20832228|P6|Overall Study|Progressive disease (PD)|3
6026628|NCT00743288|20832229|P5|Overall Study|Progressive disease (PD)|5
6026629|NCT00743288|20832230|P4|Overall Study|Progressive disease (PD)|4
6026630|NCT00743288|20832231|P3|Overall Study|Progressive disease (PD)|1
6026631|NCT00743288|20832232|P2|Overall Study|Progressive disease (PD)|0
6026632|NCT00743288|20832233|P1|Overall Study|Progressive disease (PD)|2
6026633|NCT00743288|20832227|P7|Overall Study|Withdrawal by Subject|1
6026634|NCT00743288|20832228|P6|Overall Study|Withdrawal by Subject|1
6026635|NCT00743288|20832229|P5|Overall Study|Withdrawal by Subject|0
6026636|NCT00743288|20832230|P4|Overall Study|Withdrawal by Subject|0
6026637|NCT00743288|20832231|P3|Overall Study|Withdrawal by Subject|1
6026638|NCT00743288|20832232|P2|Overall Study|Withdrawal by Subject|0
6026639|NCT00743288|20832233|P1|Overall Study|Withdrawal by Subject|0
6026640|NCT00743288|20832227|P7|Overall Study|Adverse Event|2
6026641|NCT00743288|20832228|P6|Overall Study|Adverse Event|1
6026642|NCT00743288|20832229|P5|Overall Study|Adverse Event|1
6026643|NCT00743288|20832230|P4|Overall Study|Adverse Event|2
6026644|NCT00743288|20832231|P3|Overall Study|Adverse Event|2
6026645|NCT00743288|20832232|P2|Overall Study|Adverse Event|1
6026646|NCT00743288|20832233|P1|Overall Study|Adverse Event|1
6026647|NCT00743275|20832247|P2|Overall Study|Protocol Violation|1
6026648|NCT00743275|20832248|P1|Overall Study|Protocol Violation|0
6026649|NCT00743249|20832268|P2|Overall Study|Unsuccessful insertion of stent|1
6026650|NCT00743249|20832269|P1|Overall Study|Unsuccessful insertion of stent|2
6026651|NCT00743249|20832268|P2|Overall Study|Patient Decision Unrelated to Ad Event|1
6026652|NCT00743249|20832269|P1|Overall Study|Patient Decision Unrelated to Ad Event|0
6026653|NCT00743249|20832268|P2|Overall Study|Adverse Event|4
6026654|NCT00743249|20832269|P1|Overall Study|Adverse Event|0
6026655|NCT00743197|20832279|P2|Overall Study|Study terminated due to departure of PI.|2
6026656|NCT00743197|20832280|P1|Overall Study|Study terminated due to departure of PI.|1
6026657|NCT00743145|20832286|P1|Overall Study|Pregnancy|1
6026658|NCT00743145|20832286|P1|Overall Study|Adverse Event|2
6026659|NCT00743145|20832286|P1|Overall Study|Withdrawal by Subject|1
6026660|NCT00743119|20832300|P1|Overall Study|Withdrawal by Subject|1
6026661|NCT00743119|20832300|P1|Overall Study|unreliable|3
6026662|NCT00743106|20832314|P2|Overall Study|Met intraoperative exclusion criterion|5
6026663|NCT00743106|20832315|P1|Overall Study|Met intraoperative exclusion criterion|8
6026664|NCT00742924|20832342|P4|Overall Study|Withdrawal by Subject|0
6026665|NCT00742924|20832343|P3|Overall Study|Withdrawal by Subject|1
6026666|NCT00742924|20832344|P2|Overall Study|Withdrawal by Subject|1
6026667|NCT00742924|20832345|P1|Overall Study|Withdrawal by Subject|0
6026668|NCT00742924|20832342|P4|Overall Study|Physician Decision|1
6026669|NCT00742924|20832343|P3|Overall Study|Physician Decision|0
6026670|NCT00742924|20832344|P2|Overall Study|Physician Decision|0
6026671|NCT00742924|20832345|P1|Overall Study|Physician Decision|0
6026672|NCT00742924|20832342|P4|Overall Study|Lack of Efficacy|4
6026673|NCT00742924|20832343|P3|Overall Study|Lack of Efficacy|2
6026674|NCT00742924|20832344|P2|Overall Study|Lack of Efficacy|1
6026675|NCT00742924|20832345|P1|Overall Study|Lack of Efficacy|5
6026676|NCT00742924|20832342|P4|Overall Study|Adverse Event|1
6026677|NCT00742924|20832343|P3|Overall Study|Adverse Event|1
6026678|NCT00742924|20832344|P2|Overall Study|Adverse Event|0
6026679|NCT00742924|20832345|P1|Overall Study|Adverse Event|0
6026680|NCT00742885|20832357|P2|Overall Study|Lost to Follow-up|0
6026681|NCT00742885|20832358|P1|Overall Study|Lost to Follow-up|1
6026682|NCT00742859|20832417|P4|Overall Study|Site error|1
6026683|NCT00742859|20832418|P3|Overall Study|Site error|1
6026684|NCT00742859|20832419|P2|Overall Study|Site error|0
6026685|NCT00742859|20832420|P1|Overall Study|Site error|0
6026686|NCT00742859|20832417|P4|Overall Study|Sponsor request patient out of town|1
6026687|NCT00742859|20832418|P3|Overall Study|Sponsor request patient out of town|1
6026688|NCT00742859|20832419|P2|Overall Study|Sponsor request patient out of town|0
6026689|NCT00742859|20832420|P1|Overall Study|Sponsor request patient out of town|0
6026690|NCT00742859|20832417|P4|Overall Study|Sponsor req visit schedule noncompliance|1
6026691|NCT00742859|20832418|P3|Overall Study|Sponsor req visit schedule noncompliance|0
6026692|NCT00742859|20832419|P2|Overall Study|Sponsor req visit schedule noncompliance|0
6026693|NCT00742859|20832420|P1|Overall Study|Sponsor req visit schedule noncompliance|0
6026694|NCT00742859|20832417|P4|Overall Study|Amendment 2 patient off study drug >4wks|0
6026695|NCT00742859|20832418|P3|Overall Study|Amendment 2 patient off study drug >4wks|1
6026696|NCT00742859|20832419|P2|Overall Study|Amendment 2 patient off study drug >4wks|1
6026697|NCT00742859|20832420|P1|Overall Study|Amendment 2 patient off study drug >4wks|0
6026698|NCT00742859|20832417|P4|Overall Study|Endpoint|2
6026699|NCT00742859|20832418|P3|Overall Study|Endpoint|1
6026700|NCT00742859|20832419|P2|Overall Study|Endpoint|1
6026701|NCT00742859|20832420|P1|Overall Study|Endpoint|0
6026702|NCT00742859|20832417|P4|Overall Study|Withdrawal by Subject|1
6026703|NCT00742859|20832418|P3|Overall Study|Withdrawal by Subject|4
6026704|NCT00742859|20832419|P2|Overall Study|Withdrawal by Subject|2
6026705|NCT00742859|20832420|P1|Overall Study|Withdrawal by Subject|4
6026706|NCT00742859|20832417|P4|Overall Study|Physician Decision|0
6026707|NCT00742859|20832418|P3|Overall Study|Physician Decision|0
6026708|NCT00742859|20832419|P2|Overall Study|Physician Decision|2
6026709|NCT00742859|20832420|P1|Overall Study|Physician Decision|1
6026710|NCT00742859|20832417|P4|Overall Study|Death|1
6026711|NCT00742859|20832418|P3|Overall Study|Death|0
6026712|NCT00742859|20832419|P2|Overall Study|Death|0
6026713|NCT00742859|20832420|P1|Overall Study|Death|1
6026714|NCT00742859|20832417|P4|Overall Study|Adverse Event|1
6026715|NCT00742859|20832418|P3|Overall Study|Adverse Event|3
6026716|NCT00742859|20832419|P2|Overall Study|Adverse Event|6
6026717|NCT00742859|20832420|P1|Overall Study|Adverse Event|5
6026718|NCT00742781|20832434|P1|Overall Study|Withdrawal by Subject|3
6026719|NCT00742625|20832443|P1|Consolidation|Non protocol therapy|13
6026720|NCT00742625|20832443|P1|Consolidation|Refused|1
6026721|NCT00742625|20832443|P1|Consolidation|Death|1
6026722|NCT00742625|20832443|P1|Consolidation|Adverse Event|1
6026723|NCT00742625|20832443|P1|Consolidation|Progression|5
6026724|NCT00742625|20832443|P1|Remission Induction|Other, not specified|5
6026725|NCT00742625|20832443|P1|Remission Induction|Non protocol treatment|17
6026726|NCT00742625|20832443|P1|Remission Induction|Refusal|5
6026727|NCT00742625|20832443|P1|Remission Induction|Death|10
6026728|NCT00742625|20832443|P1|Remission Induction|Adverse Event|3
6026729|NCT00742625|20832443|P1|Remission Induction|Failed induction|8
6026730|NCT00742625|20832443|P1|Remission Induction|Progression|6
6026731|NCT00742560|20832468|P5|Overall Study|MIssing|1
6026732|NCT00742560|20832469|P4|Overall Study|MIssing|0
6026733|NCT00742560|20832470|P3|Overall Study|MIssing|0
6026734|NCT00742560|20832471|P2|Overall Study|MIssing|0
6026735|NCT00742560|20832472|P1|Overall Study|MIssing|0
6026736|NCT00742560|20832468|P5|Overall Study|Other|9
6026737|NCT00742560|20832469|P4|Overall Study|Other|9
6026738|NCT00742560|20832470|P3|Overall Study|Other|8
6026739|NCT00742560|20832471|P2|Overall Study|Other|1
6026740|NCT00742560|20832472|P1|Overall Study|Other|0
6026741|NCT00742560|20832468|P5|Overall Study|New Multiple Myeloma Therapy|4
6026742|NCT00742560|20832469|P4|Overall Study|New Multiple Myeloma Therapy|3
6026743|NCT00742560|20832470|P3|Overall Study|New Multiple Myeloma Therapy|2
6026744|NCT00742560|20832471|P2|Overall Study|New Multiple Myeloma Therapy|0
6026745|NCT00742560|20832472|P1|Overall Study|New Multiple Myeloma Therapy|1
6026746|NCT00742560|20832468|P5|Overall Study|Disease Progression|16
6026747|NCT00742560|20832469|P4|Overall Study|Disease Progression|17
6026748|NCT00742560|20832470|P3|Overall Study|Disease Progression|5
6026749|NCT00742560|20832471|P2|Overall Study|Disease Progression|0
6026750|NCT00742560|20832472|P1|Overall Study|Disease Progression|1
6026751|NCT00742560|20832468|P5|Overall Study|Investigator's Decision|0
6026752|NCT00742560|20832469|P4|Overall Study|Investigator's Decision|1
6026753|NCT00742560|20832470|P3|Overall Study|Investigator's Decision|4
6026754|NCT00742560|20832471|P2|Overall Study|Investigator's Decision|0
6026755|NCT00742560|20832472|P1|Overall Study|Investigator's Decision|0
6026756|NCT00742560|20832468|P5|Overall Study|Subject's Decision|3
6026757|NCT00742560|20832469|P4|Overall Study|Subject's Decision|3
6026758|NCT00742560|20832470|P3|Overall Study|Subject's Decision|2
6026759|NCT00742560|20832471|P2|Overall Study|Subject's Decision|0
6026760|NCT00742560|20832472|P1|Overall Study|Subject's Decision|1
6026761|NCT00742560|20832468|P5|Overall Study|Death|3
6026762|NCT00742560|20832469|P4|Overall Study|Death|2
6026763|NCT00742560|20832470|P3|Overall Study|Death|0
6026764|NCT00742560|20832471|P2|Overall Study|Death|2
6026765|NCT00742560|20832472|P1|Overall Study|Death|0
6026766|NCT00742560|20832468|P5|Overall Study|Adverse Event|1
6026767|NCT00742560|20832469|P4|Overall Study|Adverse Event|1
6026768|NCT00742560|20832470|P3|Overall Study|Adverse Event|1
6026769|NCT00742560|20832471|P2|Overall Study|Adverse Event|0
6026770|NCT00742560|20832472|P1|Overall Study|Adverse Event|0
6026771|NCT00742508|20832546|P2|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|1
6026772|NCT00742508|20832547|P1|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|0
6026773|NCT00742508|20832546|P2|8-Week Primary Evaluation Period|Withdrawal by Subject|2
6026774|NCT00742508|20832547|P1|8-Week Primary Evaluation Period|Withdrawal by Subject|0
6026775|NCT00742508|20832546|P2|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|5
6026776|NCT00742508|20832547|P1|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|8
6026777|NCT00742508|20832546|P2|8-Week Primary Evaluation Period|Protocol Violation|0
6026778|NCT00742508|20832547|P1|8-Week Primary Evaluation Period|Protocol Violation|1
6026779|NCT00742508|20832546|P2|8-Week Primary Evaluation Period|Adverse Event|4
6026780|NCT00742508|20832547|P1|8-Week Primary Evaluation Period|Adverse Event|2
6026781|NCT00742417|20832620|P2|Intensive Period|Adverse Event|0
6026782|NCT00742417|20832621|P1|Intensive Period|Adverse Event|2
6026783|NCT00742417|20832620|P2|Intensive Period|Withdrawal by Subject|1
6026784|NCT00742417|20832621|P1|Intensive Period|Withdrawal by Subject|1
6026785|NCT00742417|20832620|P2|Randomized|Physician Decision|0
6026786|NCT00742417|20832621|P1|Randomized|Physician Decision|1
6026787|NCT00742417|20832620|P2|Randomized|Withdrawal by Subject|0
6026788|NCT00742417|20832621|P1|Randomized|Withdrawal by Subject|1
6026789|NCT00742417|20832620|P2|Randomized|Withdrawal by legal representative|1
6026790|NCT00742417|20832621|P1|Randomized|Withdrawal by legal representative|0
6026791|NCT00742391|20832645|P2|Overall Study|Protocol Violation|0
6026792|NCT00742391|20832646|P1|Overall Study|Protocol Violation|1
6026793|NCT00742391|20832645|P2|Overall Study|Lost to Follow-up|0
6026794|NCT00742391|20832646|P1|Overall Study|Lost to Follow-up|1
6026795|NCT00742391|20832645|P2|Overall Study|Adverse Event|1
6026796|NCT00742391|20832646|P1|Overall Study|Adverse Event|2
6026797|NCT00742326|20832656|P2|Overall Study|Physician Decision|1
6026798|NCT00742326|20832657|P1|Overall Study|Physician Decision|0
6026799|NCT00742274|20832676|P2|Overall Study|Removed for medical reasons|1
6026800|NCT00742274|20832677|P1|Overall Study|Removed for medical reasons|1
6026801|NCT00742274|20832676|P2|Overall Study|Withdrawal by Subject|2
6026802|NCT00742274|20832677|P1|Overall Study|Withdrawal by Subject|1
6026803|NCT00742274|20832676|P2|Overall Study|Death|0
6026804|NCT00742274|20832677|P1|Overall Study|Death|1
6026805|NCT00742235|20832685|P2|Overall Study|Lost to Follow-up|31
6026806|NCT00742235|20832686|P1|Overall Study|Lost to Follow-up|0
6026807|NCT00742209|20832699|P5|Overall Study|Investigator Discretion|1
6026808|NCT00742209|20832700|P4|Overall Study|Investigator Discretion|1
6026809|NCT00742209|20832701|P3|Overall Study|Investigator Discretion|5
6026810|NCT00742209|20832702|P2|Overall Study|Investigator Discretion|0
6026811|NCT00742209|20832703|P1|Overall Study|Investigator Discretion|0
6026812|NCT00742209|20832699|P5|Overall Study|Lack of Efficacy|1
6026813|NCT00742209|20832700|P4|Overall Study|Lack of Efficacy|3
6026814|NCT00742209|20832701|P3|Overall Study|Lack of Efficacy|1
6026815|NCT00742209|20832702|P2|Overall Study|Lack of Efficacy|1
6026816|NCT00742209|20832703|P1|Overall Study|Lack of Efficacy|6
6026817|NCT00742209|20832699|P5|Overall Study|Lost to Follow-up|3
6026818|NCT00742209|20832700|P4|Overall Study|Lost to Follow-up|5
6026819|NCT00742209|20832701|P3|Overall Study|Lost to Follow-up|5
6026820|NCT00742209|20832702|P2|Overall Study|Lost to Follow-up|4
6026821|NCT00742209|20832703|P1|Overall Study|Lost to Follow-up|3
6026822|NCT00742209|20832699|P5|Overall Study|Protocol Violation|3
6026823|NCT00742209|20832700|P4|Overall Study|Protocol Violation|5
6026824|NCT00742209|20832701|P3|Overall Study|Protocol Violation|4
6026825|NCT00742209|20832702|P2|Overall Study|Protocol Violation|5
6026826|NCT00742209|20832703|P1|Overall Study|Protocol Violation|6
6026827|NCT00742209|20832699|P5|Overall Study|Participant Withdrew Consent|4
6026828|NCT00742209|20832700|P4|Overall Study|Participant Withdrew Consent|7
6026829|NCT00742209|20832701|P3|Overall Study|Participant Withdrew Consent|14
6026830|NCT00742209|20832702|P2|Overall Study|Participant Withdrew Consent|4
6026831|NCT00742209|20832703|P1|Overall Study|Participant Withdrew Consent|8
6026832|NCT00742209|20832699|P5|Overall Study|Adverse Event|13
6026833|NCT00742209|20832700|P4|Overall Study|Adverse Event|16
6026834|NCT00742209|20832701|P3|Overall Study|Adverse Event|17
6026835|NCT00742209|20832702|P2|Overall Study|Adverse Event|4
6026836|NCT00742209|20832703|P1|Overall Study|Adverse Event|11
6026837|NCT00742183|20832806|P2|Overall Study|Lack of Efficacy|3
6026838|NCT00742183|20832807|P1|Overall Study|Lack of Efficacy|0
6026839|NCT00742183|20832806|P2|Overall Study|Withdrawal by Subject|0
6026840|NCT00742183|20832807|P1|Overall Study|Withdrawal by Subject|1
6026841|NCT00742183|20832806|P2|Overall Study|Required skin-graft|1
6026842|NCT00742183|20832807|P1|Overall Study|Required skin-graft|1
6026843|NCT00742183|20832806|P2|Overall Study|Lost to Follow-up|4
6026844|NCT00742183|20832807|P1|Overall Study|Lost to Follow-up|4
6026845|NCT00742183|20832806|P2|Overall Study|Physician Decision|2
6026846|NCT00742183|20832807|P1|Overall Study|Physician Decision|0
6026847|NCT00742183|20832806|P2|Overall Study|Death|0
6026848|NCT00742183|20832807|P1|Overall Study|Death|1
6026849|NCT00742183|20832806|P2|Overall Study|Adverse Event|2
6026850|NCT00742183|20832807|P1|Overall Study|Adverse Event|2
6026851|NCT00742079|20832826|P2|Overall Study|Lost to Follow-up|1
6026852|NCT00742079|20832827|P1|Overall Study|Lost to Follow-up|0
6026853|NCT00742001|20832848|P3|Overall Study|Withdrawn; health exclusion (flu)|1
6026854|NCT00742001|20832849|P2|Overall Study|Withdrawn; health exclusion (flu)|0
6026855|NCT00742001|20832850|P1|Overall Study|Withdrawn; health exclusion (flu)|0
6026856|NCT00741988|20832866|P2|Overall Study|Lack of Efficacy|0
6026857|NCT00741988|20832867|P1|Overall Study|Lack of Efficacy|2
6026858|NCT00741988|20832866|P2|Overall Study|Adverse Event|4
6026859|NCT00741988|20832867|P1|Overall Study|Adverse Event|2
6026860|NCT00741936|20832879|P2|Overall Study|Low compliance|0
6026861|NCT00741936|20832880|P1|Overall Study|Low compliance|3
6026862|NCT00741936|20832879|P2|Overall Study|Lack of Efficacy|2
6026863|NCT00741936|20832880|P1|Overall Study|Lack of Efficacy|0
6026864|NCT00741936|20832879|P2|Overall Study|Protocol Violation|0
6026865|NCT00741936|20832880|P1|Overall Study|Protocol Violation|2
6026866|NCT00741936|20832879|P2|Overall Study|Pregnancy|1
6026867|NCT00741936|20832880|P1|Overall Study|Pregnancy|0
6026868|NCT00741936|20832879|P2|Overall Study|Adverse Event|4
6026869|NCT00741936|20832880|P1|Overall Study|Adverse Event|3
6026870|NCT00741936|20832879|P2|Overall Study|Lost to Follow-up|1
6026871|NCT00741936|20832880|P1|Overall Study|Lost to Follow-up|1
6026872|NCT00741819|20832915|P1|Overall Study|Disease progression|1
6026873|NCT00741819|20832915|P1|Overall Study|Death|1
6026874|NCT00741819|20832915|P1|Overall Study|Withdrawal by Subject|3
6026875|NCT00741819|20832915|P1|Overall Study|Adverse Event|3
6026876|NCT00741611|20832929|P3|Overall Study|Withdrawal by Subject|2
6026877|NCT00741611|20832930|P2|Overall Study|Withdrawal by Subject|2
6026878|NCT00741611|20832931|P1|Overall Study|Withdrawal by Subject|0
6026879|NCT00741611|20832929|P3|Overall Study|Death|1
6026880|NCT00741611|20832930|P2|Overall Study|Death|0
6026881|NCT00741611|20832931|P1|Overall Study|Death|0
6026882|NCT00741598|20832950|P2|Overall Study|Withdrawal by Subject|2
6026883|NCT00741598|20832951|P1|Overall Study|Withdrawal by Subject|3
6026884|NCT00741598|20832950|P2|Overall Study|Pregnancy|0
6026885|NCT00741598|20832951|P1|Overall Study|Pregnancy|1
6026886|NCT00741598|20832950|P2|Overall Study|Physician Decision|1
6026887|NCT00741598|20832951|P1|Overall Study|Physician Decision|1
6026888|NCT00741598|20832950|P2|Overall Study|Lack of Efficacy|2
6026889|NCT00741598|20832951|P1|Overall Study|Lack of Efficacy|1
6026890|NCT00741598|20832950|P2|Overall Study|Lost to Follow-up|4
6026891|NCT00741598|20832951|P1|Overall Study|Lost to Follow-up|3
6026892|NCT00741338|20833006|P2|Overall Study|Adverse Event|1
6026893|NCT00741338|20833007|P1|Overall Study|Adverse Event|0
6026894|NCT00741286|20833017|P2|Overall Study|Primary Outcome|1
6026895|NCT00741286|20833018|P1|Overall Study|Primary Outcome|1
6026896|NCT00741286|20833017|P2|Overall Study|Protocol Violation|2
6026897|NCT00741286|20833018|P1|Overall Study|Protocol Violation|3
6026898|NCT00741286|20833017|P2|Overall Study|Adverse Event|6
6026899|NCT00741286|20833018|P1|Overall Study|Adverse Event|1
6026900|NCT00741286|20833017|P2|Overall Study|Lost to Follow-up|10
6026901|NCT00741286|20833018|P1|Overall Study|Lost to Follow-up|15
6026902|NCT00741260|20833052|P7|Overall Study|Other|1
6026903|NCT00741260|20833053|P6|Overall Study|Other|3
6026904|NCT00741260|20833054|P5|Overall Study|Other|1
6026905|NCT00741260|20833055|P4|Overall Study|Other|2
6026906|NCT00741260|20833056|P3|Overall Study|Other|1
6026907|NCT00741260|20833057|P2|Overall Study|Other|1
6026908|NCT00741260|20833058|P1|Overall Study|Other|2
6026909|NCT00741260|20833052|P7|Overall Study|Physician Decision|0
6026910|NCT00741260|20833053|P6|Overall Study|Physician Decision|0
6026911|NCT00741260|20833054|P5|Overall Study|Physician Decision|0
6026912|NCT00741260|20833055|P4|Overall Study|Physician Decision|0
6026913|NCT00741260|20833056|P3|Overall Study|Physician Decision|0
6026914|NCT00741260|20833057|P2|Overall Study|Physician Decision|1
6026915|NCT00741260|20833058|P1|Overall Study|Physician Decision|1
6026916|NCT00741260|20833052|P7|Overall Study|Withdrawal by Subject|1
6026917|NCT00741260|20833053|P6|Overall Study|Withdrawal by Subject|3
6026918|NCT00741260|20833054|P5|Overall Study|Withdrawal by Subject|1
6026919|NCT00741260|20833055|P4|Overall Study|Withdrawal by Subject|0
6026920|NCT00741260|20833056|P3|Overall Study|Withdrawal by Subject|0
6026921|NCT00741260|20833057|P2|Overall Study|Withdrawal by Subject|0
6026922|NCT00741260|20833058|P1|Overall Study|Withdrawal by Subject|0
6026923|NCT00741260|20833052|P7|Overall Study|Death|1
6026924|NCT00741260|20833053|P6|Overall Study|Death|2
6026925|NCT00741260|20833054|P5|Overall Study|Death|2
6026926|NCT00741260|20833055|P4|Overall Study|Death|1
6026927|NCT00741260|20833056|P3|Overall Study|Death|0
6026928|NCT00741260|20833057|P2|Overall Study|Death|1
6026929|NCT00741260|20833058|P1|Overall Study|Death|0
6026930|NCT00741260|20833052|P7|Overall Study|Disease Progression|4
6026931|NCT00741260|20833053|P6|Overall Study|Disease Progression|37
6026932|NCT00741260|20833054|P5|Overall Study|Disease Progression|5
6026933|NCT00741260|20833055|P4|Overall Study|Disease Progression|3
6026934|NCT00741260|20833056|P3|Overall Study|Disease Progression|3
6026935|NCT00741260|20833057|P2|Overall Study|Disease Progression|5
6026936|NCT00741260|20833058|P1|Overall Study|Disease Progression|3
6026937|NCT00741091|20833107|P1|Overall Study|Missed Visit|22
6026938|NCT00741091|20833107|P1|Overall Study|Withdrawal by Subject|6
6026939|NCT00741091|20833107|P1|Overall Study|Lost to Follow-up|16
6026940|NCT00741091|20833107|P1|Overall Study|Death|13
6026941|NCT00741039|20833117|P2|Overall Study|Patient non-compliance|0
6026942|NCT00741039|20833118|P1|Overall Study|Patient non-compliance|2
6026943|NCT00741013|20833155|P3|Overall Study|Discovered failed screen after enrolled|0
6026944|NCT00741013|20833156|P2|Overall Study|Discovered failed screen after enrolled|2
6026945|NCT00741013|20833157|P1|Overall Study|Discovered failed screen after enrolled|0
6026946|NCT00741013|20833155|P3|Overall Study|Withdrawal by Subject|1
6026947|NCT00741013|20833156|P2|Overall Study|Withdrawal by Subject|0
6026948|NCT00741013|20833157|P1|Overall Study|Withdrawal by Subject|0
6026949|NCT00741013|20833155|P3|Overall Study|Adverse Event|0
6026950|NCT00741013|20833156|P2|Overall Study|Adverse Event|0
6026951|NCT00741013|20833157|P1|Overall Study|Adverse Event|1
6026952|NCT00740870|20833168|P1|Overall Study|Further testing contraindicated implant|17
6026953|NCT00740870|20833168|P1|Overall Study|Not Catheterized|4
6026954|NCT00740857|20833183|P3|Overall Study|Withdrawal by Subject|0
6026955|NCT00740857|20833184|P2|Overall Study|Withdrawal by Subject|0
6026956|NCT00740857|20833185|P1|Overall Study|Withdrawal by Subject|1
6026957|NCT00740792|20833240|P4|Overall Study|administrative|2
6026958|NCT00740792|20833241|P3|Overall Study|administrative|8
6026959|NCT00740792|20833242|P2|Overall Study|administrative|3
6026960|NCT00740792|20833243|P1|Overall Study|administrative|3
6026961|NCT00740792|20833240|P4|Overall Study|Withdrawal by Subject|0
6026962|NCT00740792|20833241|P3|Overall Study|Withdrawal by Subject|0
6026963|NCT00740792|20833242|P2|Overall Study|Withdrawal by Subject|1
6026964|NCT00740792|20833243|P1|Overall Study|Withdrawal by Subject|1
6026965|NCT00740792|20833240|P4|Overall Study|Protocol Violation|2
6026966|NCT00740792|20833241|P3|Overall Study|Protocol Violation|0
6026967|NCT00740792|20833242|P2|Overall Study|Protocol Violation|1
6026968|NCT00740792|20833243|P1|Overall Study|Protocol Violation|0
6026969|NCT00740792|20833240|P4|Overall Study|Lost to Follow-up|0
6026970|NCT00740792|20833241|P3|Overall Study|Lost to Follow-up|0
6026971|NCT00740792|20833242|P2|Overall Study|Lost to Follow-up|1
6026972|NCT00740792|20833243|P1|Overall Study|Lost to Follow-up|2
6026973|NCT00740792|20833240|P4|Overall Study|Lack of Efficacy|3
6026974|NCT00740792|20833241|P3|Overall Study|Lack of Efficacy|0
6026975|NCT00740792|20833242|P2|Overall Study|Lack of Efficacy|1
6026976|NCT00740792|20833243|P1|Overall Study|Lack of Efficacy|1
6026977|NCT00740792|20833240|P4|Overall Study|Adverse Event|3
6026978|NCT00740792|20833241|P3|Overall Study|Adverse Event|1
6026979|NCT00740792|20833242|P2|Overall Study|Adverse Event|1
6026980|NCT00740792|20833243|P1|Overall Study|Adverse Event|3
6026981|NCT00740779|20833264|P3|Overall Study|Lost to Follow-up|5
6026982|NCT00740779|20833265|P2|Overall Study|Lost to Follow-up|3
6026983|NCT00740779|20833266|P1|Overall Study|Lost to Follow-up|2
6026984|NCT00740779|20833264|P3|Overall Study|Withdrawal by Subject|2
6026985|NCT00740779|20833265|P2|Overall Study|Withdrawal by Subject|4
6026986|NCT00740779|20833266|P1|Overall Study|Withdrawal by Subject|2
6026987|NCT00740779|20833264|P3|Overall Study|Lack of Efficacy|2
6026988|NCT00740779|20833265|P2|Overall Study|Lack of Efficacy|0
6026989|NCT00740779|20833266|P1|Overall Study|Lack of Efficacy|0
6026990|NCT00740779|20833264|P3|Overall Study|Protocol Violation|1
6026991|NCT00740779|20833265|P2|Overall Study|Protocol Violation|1
6026992|NCT00740779|20833266|P1|Overall Study|Protocol Violation|1
6026993|NCT00740779|20833264|P3|Overall Study|Adverse Event|3
6026994|NCT00740779|20833265|P2|Overall Study|Adverse Event|6
6026995|NCT00740779|20833266|P1|Overall Study|Adverse Event|4
6026996|NCT00740714|20833283|P3|Overall Study|Withdrawal by Subject|29
6026997|NCT00740714|20833284|P2|Overall Study|Withdrawal by Subject|19
6026998|NCT00740714|20833285|P1|Overall Study|Withdrawal by Subject|17
6026999|NCT00740636|20833361|P2|Overall Study|Death|0
6027000|NCT00740636|20833362|P1|Overall Study|Death|1
6027001|NCT00740636|20833361|P2|Overall Study|Progressive Disease|0
6027002|NCT00740636|20833362|P1|Overall Study|Progressive Disease|1
6027003|NCT00740636|20833361|P2|Overall Study|Patient Not Treated|1
6027004|NCT00740636|20833362|P1|Overall Study|Patient Not Treated|0
6027005|NCT00740636|20833361|P2|Overall Study|Patient Ineligible|1
6027006|NCT00740636|20833362|P1|Overall Study|Patient Ineligible|0
6027007|NCT00740636|20833361|P2|Overall Study|Adverse Event|2
6027008|NCT00740636|20833362|P1|Overall Study|Adverse Event|0
6027009|NCT00740597|20833368|P1|Overall Study|insurance would not cover treatment|1
6027010|NCT00740584|20833372|P1|Overall Study|Withdrawal by Subject|1
6027011|NCT00740480|20833377|P1|Overall Study|Physician Decision|1
6027012|NCT00740480|20833377|P1|Overall Study|Adverse Event|1
6027013|NCT00740220|20833402|P1|Overall Study|screen failures (non-COPD patients)|9
6027014|NCT00740051|20833427|P2|Overall Study|Other reason (not specified)|1
6027015|NCT00740051|20833428|P1|Overall Study|Other reason (not specified)|4
6027016|NCT00740051|20833427|P2|Overall Study|Withdrawal by Subject|8
6027017|NCT00740051|20833428|P1|Overall Study|Withdrawal by Subject|6
6027018|NCT00740051|20833427|P2|Overall Study|Lost to Follow-up|8
6027019|NCT00740051|20833428|P1|Overall Study|Lost to Follow-up|3
6027020|NCT00740051|20833427|P2|Overall Study|Protocol Violation|6
6027021|NCT00740051|20833428|P1|Overall Study|Protocol Violation|2
6027022|NCT00740051|20833427|P2|Overall Study|Adverse Event|4
6027023|NCT00740051|20833428|P1|Overall Study|Adverse Event|1
6027024|NCT00740051|20833427|P2|Overall Study|Lack of Efficacy|5
6027025|NCT00740051|20833428|P1|Overall Study|Lack of Efficacy|2
6027026|NCT00739973|20833531|P9|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
6027027|NCT00739973|20833532|P8|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
6027028|NCT00739973|20833533|P7|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|2
6027029|NCT00739973|20833534|P6|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
6027030|NCT00739973|20833535|P5|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
6027031|NCT00739973|20833536|P4|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
6027032|NCT00739973|20833537|P3|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
6027033|NCT00739973|20833538|P2|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|1
6027034|NCT00739973|20833539|P1|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
6027035|NCT00739973|20833531|P9|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3
6027036|NCT00739973|20833532|P8|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2
6027037|NCT00739973|20833533|P7|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2
6027038|NCT00739973|20833534|P6|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1
6027039|NCT00739973|20833535|P5|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3
6027040|NCT00739973|20833536|P4|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2
6027041|NCT00739973|20833537|P3|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1
6027042|NCT00739973|20833538|P2|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3
6027043|NCT00739973|20833539|P1|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|5
6027044|NCT00739973|20833531|P9|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
6027045|NCT00739973|20833532|P8|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
6027046|NCT00739973|20833533|P7|Double-blind:Randomized Period (8 Weeks)|Administrative problems|1
6027047|NCT00739973|20833534|P6|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
6027048|NCT00739973|20833535|P5|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
6027049|NCT00739973|20833536|P4|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
6027050|NCT00739973|20833537|P3|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
6027051|NCT00739973|20833538|P2|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
6027052|NCT00739973|20833539|P1|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
6027053|NCT00739973|20833531|P9|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1
6027054|NCT00739973|20833532|P8|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|3
6027055|NCT00739973|20833533|P7|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0
6027056|NCT00739973|20833534|P6|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2
6027057|NCT00739973|20833535|P5|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2
6027058|NCT00739973|20833536|P4|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1
6027059|NCT00739973|20833537|P3|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|4
6027060|NCT00739973|20833538|P2|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2
6027061|NCT00739973|20833539|P1|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0
6027062|NCT00739973|20833531|P9|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4
6027063|NCT00739973|20833532|P8|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2
6027064|NCT00739973|20833533|P7|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3
6027065|NCT00739973|20833534|P6|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4
6027066|NCT00739973|20833535|P5|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4
6027067|NCT00739973|20833536|P4|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3
6027068|NCT00739973|20833537|P3|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4
6027069|NCT00739973|20833538|P2|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2
6027070|NCT00739973|20833539|P1|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4
6027071|NCT00739973|20833531|P9|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
6027072|NCT00739973|20833532|P8|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
6027073|NCT00739973|20833533|P7|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
6027074|NCT00739973|20833534|P6|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
6027075|NCT00739973|20833535|P5|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
6027076|NCT00739973|20833536|P4|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
6027077|NCT00739973|20833537|P3|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|1
6027078|NCT00739973|20833538|P2|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
6027079|NCT00739973|20833539|P1|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
6027080|NCT00739973|20833531|P9|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2
6027081|NCT00739973|20833532|P8|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1
6027082|NCT00739973|20833533|P7|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1
6027083|NCT00739973|20833534|P6|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2
6027084|NCT00739973|20833535|P5|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2
6027085|NCT00739973|20833536|P4|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|4
6027086|NCT00739973|20833537|P3|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8
6027087|NCT00739973|20833538|P2|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8
6027088|NCT00739973|20833539|P1|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|17
6027089|NCT00739973|20833531|P9|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
6027090|NCT00739973|20833532|P8|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
6027091|NCT00739973|20833533|P7|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
6027092|NCT00739973|20833534|P6|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
6027093|NCT00739973|20833535|P5|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
6027094|NCT00739973|20833536|P4|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
6027095|NCT00739973|20833537|P3|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
6027096|NCT00739973|20833538|P2|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1
6027097|NCT00739973|20833539|P1|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1
6027098|NCT00739973|20833531|P9|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
6027099|NCT00739973|20833532|P8|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1
6027100|NCT00739973|20833533|P7|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
6027101|NCT00739973|20833534|P6|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
6027102|NCT00739973|20833535|P5|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1
6027103|NCT00739973|20833536|P4|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
6027104|NCT00739973|20833537|P3|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
6027105|NCT00739973|20833538|P2|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
6027106|NCT00739973|20833539|P1|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
6027107|NCT00739973|20833531|P9|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4
6027108|NCT00739973|20833532|P8|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1
6027109|NCT00739973|20833533|P7|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4
6027110|NCT00739973|20833534|P6|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3
6027111|NCT00739973|20833535|P5|Double-blind:Randomized Period (8 Weeks)|Adverse Event|7
6027112|NCT00739973|20833536|P4|Double-blind:Randomized Period (8 Weeks)|Adverse Event|2
6027113|NCT00739973|20833537|P3|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1
6027114|NCT00739973|20833538|P2|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3
6027115|NCT00739973|20833539|P1|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3
6027116|NCT00739973|20833531|P9|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
6027117|NCT00739973|20833532|P8|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
6027118|NCT00739973|20833533|P7|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
6027119|NCT00739973|20833534|P6|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
6027120|NCT00739973|20833535|P5|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
6027121|NCT00739973|20833536|P4|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
6027122|NCT00739973|20833537|P3|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
6027123|NCT00739973|20833538|P2|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
6027124|NCT00739973|20833539|P1|Single-blind Period (2 to 4 Weeks)|Protocol deviation|11
6027125|NCT00739973|20833531|P9|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
6027126|NCT00739973|20833532|P8|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
6027127|NCT00739973|20833533|P7|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
6027128|NCT00739973|20833534|P6|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
6027129|NCT00739973|20833535|P5|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
6027130|NCT00739973|20833536|P4|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
6027131|NCT00739973|20833537|P3|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
6027132|NCT00739973|20833538|P2|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
6027133|NCT00739973|20833539|P1|Single-blind Period (2 to 4 Weeks)|Administrative problems|12
6027134|NCT00739973|20833531|P9|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
6027135|NCT00739973|20833532|P8|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
6027136|NCT00739973|20833533|P7|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
6027137|NCT00739973|20833534|P6|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
6027138|NCT00739973|20833535|P5|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
6027139|NCT00739973|20833536|P4|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
6027140|NCT00739973|20833537|P3|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
6027141|NCT00739973|20833538|P2|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
6027142|NCT00739973|20833539|P1|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|17
6027143|NCT00739973|20833531|P9|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
6027144|NCT00739973|20833532|P8|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
6027145|NCT00739973|20833533|P7|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
6027146|NCT00739973|20833534|P6|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
6027147|NCT00739973|20833535|P5|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
6027148|NCT00739973|20833536|P4|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
6027149|NCT00739973|20833537|P3|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
6027150|NCT00739973|20833538|P2|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
6027151|NCT00739973|20833539|P1|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|86
6027152|NCT00739973|20833531|P9|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
6027153|NCT00739973|20833532|P8|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
6027154|NCT00739973|20833533|P7|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
6027155|NCT00739973|20833534|P6|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
6027156|NCT00739973|20833535|P5|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
6027157|NCT00739973|20833536|P4|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
6027158|NCT00739973|20833537|P3|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
6027159|NCT00739973|20833538|P2|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
6027160|NCT00739973|20833539|P1|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|810
6027161|NCT00739973|20833531|P9|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
6027162|NCT00739973|20833532|P8|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
6027163|NCT00739973|20833533|P7|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
6027164|NCT00739973|20833534|P6|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
6027165|NCT00739973|20833535|P5|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
6027166|NCT00739973|20833536|P4|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
6027167|NCT00739973|20833537|P3|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
6027168|NCT00739973|20833538|P2|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
6027169|NCT00739973|20833539|P1|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|38
6027170|NCT00739973|20833531|P9|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
6027171|NCT00739973|20833532|P8|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
6027172|NCT00739973|20833533|P7|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
6027173|NCT00739973|20833534|P6|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
6027174|NCT00739973|20833535|P5|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
6027175|NCT00739973|20833536|P4|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
6027176|NCT00739973|20833537|P3|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
6027177|NCT00739973|20833538|P2|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
6027178|NCT00739973|20833539|P1|Single-blind Period (2 to 4 Weeks)|Adverse Event|35
6027179|NCT00739934|20833630|P1|Voriconazole Oral|Other|3
6027180|NCT00739934|20833630|P1|Voriconazole IV|Adverse Event|6
6027181|NCT00739908|20833652|P2|Overall Study|Relocation|1
6027182|NCT00739908|20833653|P1|Overall Study|Relocation|0
6027183|NCT00739908|20833652|P2|Overall Study|Lack of Efficacy|1
6027184|NCT00739908|20833653|P1|Overall Study|Lack of Efficacy|0
6027185|NCT00739908|20833652|P2|Overall Study|Non-Compliance With Study Medication|3
6027186|NCT00739908|20833653|P1|Overall Study|Non-Compliance With Study Medication|0
6027187|NCT00739908|20833652|P2|Overall Study|Non-Compliance With Study Procedures|3
6027188|NCT00739908|20833653|P1|Overall Study|Non-Compliance With Study Procedures|2
6027189|NCT00739908|20833652|P2|Overall Study|Lost to Follow-up|9
6027190|NCT00739908|20833653|P1|Overall Study|Lost to Follow-up|14
6027191|NCT00739908|20833652|P2|Overall Study|Withdrawal by Subject|2
6027192|NCT00739908|20833653|P1|Overall Study|Withdrawal by Subject|4
6027193|NCT00739908|20833652|P2|Overall Study|Adverse Event|6
6027194|NCT00739908|20833653|P1|Overall Study|Adverse Event|5
6027195|NCT00739882|20833673|P2|Open-label Period|Other|5
6027196|NCT00739882|20833674|P1|Open-label Period|Other|9
6027197|NCT00739882|20833673|P2|Open-label Period|Adverse Event|0
6027198|NCT00739882|20833674|P1|Open-label Period|Adverse Event|1
6027199|NCT00739882|20833673|P2|Double-blind Period|Other|8
6027200|NCT00739882|20833674|P1|Double-blind Period|Other|16
6027201|NCT00739882|20833673|P2|Double-blind Period|Lack of Efficacy|1
6027202|NCT00739882|20833674|P1|Double-blind Period|Lack of Efficacy|1
6027203|NCT00739882|20833673|P2|Double-blind Period|Protocol Violation|0
6027204|NCT00739882|20833674|P1|Double-blind Period|Protocol Violation|1
6027205|NCT00739882|20833673|P2|Double-blind Period|Adverse Event|2
6027206|NCT00739882|20833674|P1|Double-blind Period|Adverse Event|1
6027207|NCT00739674|20833735|P2|Overall Study|Erectile dysfunction|1
6027208|NCT00739674|20833736|P1|Overall Study|Erectile dysfunction|0
6027209|NCT00739674|20833735|P2|Overall Study|Home monitoring off meds|0
6027210|NCT00739674|20833736|P1|Overall Study|Home monitoring off meds|1
6027211|NCT00739674|20833735|P2|Overall Study|Unable to attend visit|1
6027212|NCT00739674|20833736|P1|Overall Study|Unable to attend visit|3
6027213|NCT00739674|20833735|P2|Overall Study|Non compliant|0
6027214|NCT00739674|20833736|P1|Overall Study|Non compliant|4
6027215|NCT00739674|20833735|P2|Overall Study|Patient moved|2
6027216|NCT00739674|20833736|P1|Overall Study|Patient moved|3
6027217|NCT00739674|20833735|P2|Overall Study|Clinic closed|4
6027218|NCT00739674|20833736|P1|Overall Study|Clinic closed|6
6027219|NCT00739674|20833735|P2|Overall Study|Reason missing|0
6027220|NCT00739674|20833736|P1|Overall Study|Reason missing|2
6027221|NCT00739674|20833735|P2|Overall Study|Withdrawal by Subject|9
6027222|NCT00739674|20833736|P1|Overall Study|Withdrawal by Subject|9
6027223|NCT00739674|20833735|P2|Overall Study|Protocol Violation|5
6027224|NCT00739674|20833736|P1|Overall Study|Protocol Violation|5
6027225|NCT00739674|20833735|P2|Overall Study|Lost to Follow-up|30
6027226|NCT00739674|20833736|P1|Overall Study|Lost to Follow-up|52
6027227|NCT00739674|20833735|P2|Overall Study|Lack of Efficacy|0
6027228|NCT00739674|20833736|P1|Overall Study|Lack of Efficacy|1
6027229|NCT00739674|20833735|P2|Overall Study|Death|0
6027230|NCT00739674|20833736|P1|Overall Study|Death|1
6027231|NCT00739674|20833735|P2|Overall Study|Adverse Event|13
6027232|NCT00739674|20833736|P1|Overall Study|Adverse Event|22
6027233|NCT00739674|20833735|P2|Overall Study|Dietician consultation >30 days|9
6027234|NCT00739674|20833736|P1|Overall Study|Dietician consultation >30 days|1
6027235|NCT00739674|20833735|P2|Overall Study|No follow-up data|18
6027236|NCT00739674|20833736|P1|Overall Study|No follow-up data|33
6027237|NCT00739674|20833735|P2|Overall Study|Site 212 removal|13
6027238|NCT00739674|20833736|P1|Overall Study|Site 212 removal|19
6027239|NCT00739674|20833735|P2|Overall Study|Screening failures|17
6027240|NCT00739674|20833736|P1|Overall Study|Screening failures|19
6027241|NCT00739661|20833764|P2|Overall Study|Reason for discontinuation not available|1
6027242|NCT00739661|20833765|P1|Overall Study|Reason for discontinuation not available|1
6027243|NCT00739661|20833764|P2|Overall Study|Disease progression, radiographic|37
6027244|NCT00739661|20833765|P1|Overall Study|Disease progression, radiographic|33
6027245|NCT00739661|20833764|P2|Overall Study|Patient decision to withdraw|4
6027246|NCT00739661|20833765|P1|Overall Study|Patient decision to withdraw|9
6027247|NCT00739661|20833764|P2|Overall Study|Physician decision to withdraw patient|0
6027248|NCT00739661|20833765|P1|Overall Study|Physician decision to withdraw patient|1
6027249|NCT00739661|20833764|P2|Overall Study|Adverse Event|0
6027250|NCT00739661|20833765|P1|Overall Study|Adverse Event|2
6027251|NCT00739648|20833777|P2|Overall Study|Do not know|6
6027252|NCT00739648|20833778|P1|Overall Study|Do not know|4
6027253|NCT00739648|20833777|P2|Overall Study|Death|0
6027254|NCT00739648|20833778|P1|Overall Study|Death|2
6027255|NCT00739648|20833777|P2|Overall Study|Lost to Follow-up|7
6027256|NCT00739648|20833778|P1|Overall Study|Lost to Follow-up|4
6027257|NCT00739648|20833777|P2|Overall Study|Withdrawal by Subject|25
6027258|NCT00739648|20833778|P1|Overall Study|Withdrawal by Subject|13
6027259|NCT00739648|20833777|P2|Overall Study|Adverse Event|15
6027260|NCT00739648|20833778|P1|Overall Study|Adverse Event|3
6027261|NCT00739596|20833792|P2|Overall Study|Protocol Deviation|1
6027262|NCT00739596|20833793|P1|Overall Study|Protocol Deviation|1
6027263|NCT00739596|20833792|P2|Overall Study|Lost to Follow-up|2
6027264|NCT00739596|20833793|P1|Overall Study|Lost to Follow-up|0
6027265|NCT00739596|20833792|P2|Overall Study|Patient Withdrew Consent|8
6027266|NCT00739596|20833793|P1|Overall Study|Patient Withdrew Consent|8
6027267|NCT00739596|20833792|P2|Overall Study|Unsatisfactory Therapeutic Effect|0
6027268|NCT00739596|20833793|P1|Overall Study|Unsatisfactory Therapeutic Effect|4
6027269|NCT00739596|20833792|P2|Overall Study|Adverse Event|6
6027270|NCT00739596|20833793|P1|Overall Study|Adverse Event|12
6027271|NCT00739310|20833835|P1|Overall Study|Lost to Follow-up|2
6027272|NCT00739310|20833835|P1|Overall Study|Withdrawal by Subject|1
6027273|NCT00739310|20833835|P1|Overall Study|Poor adherance to prescribed therapy|4
6027274|NCT00739297|20833840|P7|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1
6027275|NCT00739297|20833841|P6|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1
6027276|NCT00739297|20833842|P5|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0
6027277|NCT00739297|20833843|P4|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0
6027278|NCT00739297|20833844|P3|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0
6027279|NCT00739297|20833845|P2|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0
6027280|NCT00739297|20833846|P1|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0
6027281|NCT00739297|20833840|P7|First Washout Period of 4-7 Days|Adverse Event|2
6027282|NCT00739297|20833841|P6|First Washout Period of 4-7 Days|Adverse Event|0
6027283|NCT00739297|20833842|P5|First Washout Period of 4-7 Days|Adverse Event|0
6027284|NCT00739297|20833843|P4|First Washout Period of 4-7 Days|Adverse Event|2
6027285|NCT00739297|20833844|P3|First Washout Period of 4-7 Days|Adverse Event|0
6027286|NCT00739297|20833845|P2|First Washout Period of 4-7 Days|Adverse Event|0
6027287|NCT00739297|20833846|P1|First Washout Period of 4-7 Days|Adverse Event|0
6027288|NCT00739102|20833874|P1|Overall Study|Withdrawal by Subject|10
6027289|NCT00739102|20833874|P1|Overall Study|Death|5
6027290|NCT00739063|20833890|P1|Overall Study|Screen failures|8
6027291|NCT00738894|20833935|P2|Overall Study|Death|0
6027292|NCT00738894|20833936|P1|Overall Study|Death|2
6027293|NCT00738894|20833935|P2|Overall Study|Physician Decision|5
6027294|NCT00738894|20833936|P1|Overall Study|Physician Decision|4
6027295|NCT00738894|20833935|P2|Overall Study|Withdrawal by Subject|15
6027296|NCT00738894|20833936|P1|Overall Study|Withdrawal by Subject|10
6027297|NCT00738894|20833935|P2|Overall Study|Lost to Follow-up|13
6027298|NCT00738894|20833936|P1|Overall Study|Lost to Follow-up|23
6027299|NCT00738881|20833949|P2|Overall Study|Withdrawal by Subject|2
6027300|NCT00738881|20833950|P1|Overall Study|Withdrawal by Subject|0
6027301|NCT00738699|20833964|P2|Overall Study|Other|0
6027302|NCT00738699|20833965|P1|Overall Study|Other|2
6027303|NCT00738699|20833964|P2|Overall Study|Discontinuation of study by Sponsor|72
6027304|NCT00738699|20833965|P1|Overall Study|Discontinuation of study by Sponsor|123
6027305|NCT00738699|20833964|P2|Overall Study|Death|68
6027306|NCT00738699|20833965|P1|Overall Study|Death|144
6027307|NCT00738699|20833964|P2|Overall Study|Lost to Follow-up|0
6027308|NCT00738699|20833965|P1|Overall Study|Lost to Follow-up|1
6027309|NCT00738699|20833964|P2|Overall Study|Withdrawal by Subject|0
6027310|NCT00738699|20833965|P1|Overall Study|Withdrawal by Subject|5
6027311|NCT00738673|20833983|P2|Overall Study|Withdrawal by Subject|1
6027312|NCT00738673|20833984|P1|Overall Study|Withdrawal by Subject|3
6027313|NCT00738673|20833983|P2|Overall Study|Protocol Violation|2
6027314|NCT00738673|20833984|P1|Overall Study|Protocol Violation|1
6027315|NCT00738673|20833983|P2|Overall Study|Lack of Efficacy|8
6027316|NCT00738673|20833984|P1|Overall Study|Lack of Efficacy|19
6027317|NCT00738673|20833983|P2|Overall Study|Adverse Event|0
6027318|NCT00738673|20833984|P1|Overall Study|Adverse Event|1
6027319|NCT00738530|20834022|P2|Overall Study|Withdrawal by Subject|8
6027320|NCT00738530|20834023|P1|Overall Study|Withdrawal by Subject|6
6027321|NCT00738530|20834022|P2|Overall Study|Lost to Follow-up|6
6027322|NCT00738530|20834023|P1|Overall Study|Lost to Follow-up|8
6027323|NCT00738530|20834022|P2|Overall Study|Death|224
6027324|NCT00738530|20834023|P1|Overall Study|Death|220
6027325|NCT00738400|20834058|P2|Overall Study|Non-compliant with study medication|1
6027326|NCT00738400|20834059|P1|Overall Study|Non-compliant with study medication|0
6027327|NCT00738400|20834058|P2|Overall Study|Protocol Violation|0
6027328|NCT00738400|20834059|P1|Overall Study|Protocol Violation|1
6027329|NCT00738400|20834058|P2|Overall Study|Lost to Follow-up|3
6027330|NCT00738400|20834059|P1|Overall Study|Lost to Follow-up|0
6027331|NCT00738400|20834058|P2|Overall Study|Lack of Efficacy|1
6027332|NCT00738400|20834059|P1|Overall Study|Lack of Efficacy|0
6027333|NCT00738400|20834058|P2|Overall Study|Withdrawal by Subject|1
6027334|NCT00738400|20834059|P1|Overall Study|Withdrawal by Subject|0
6027335|NCT00738400|20834058|P2|Overall Study|Adverse Event|1
6027336|NCT00738400|20834059|P1|Overall Study|Adverse Event|3
6027337|NCT00738374|20834080|P4|Maintenance Treatment/Observation Phase|Other|0
6027338|NCT00738374|20834081|P3|Maintenance Treatment/Observation Phase|Other|0
6027339|NCT00738374|20834082|P2|Maintenance Treatment/Observation Phase|Other|1
6027340|NCT00738374|20834083|P1|Maintenance Treatment/Observation Phase|Other|0
6027341|NCT00738374|20834080|P4|Maintenance Treatment/Observation Phase|Protocol Violation|0
6027342|NCT00738374|20834081|P3|Maintenance Treatment/Observation Phase|Protocol Violation|0
6027343|NCT00738374|20834082|P2|Maintenance Treatment/Observation Phase|Protocol Violation|1
6027344|NCT00738374|20834083|P1|Maintenance Treatment/Observation Phase|Protocol Violation|0
6027345|NCT00738374|20834080|P4|Maintenance Treatment/Observation Phase|Withdrawal by Subject|1
6027346|NCT00738374|20834081|P3|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0
6027347|NCT00738374|20834082|P2|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0
6027348|NCT00738374|20834083|P1|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0
6027349|NCT00738374|20834080|P4|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|11
6027350|NCT00738374|20834081|P3|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|5
6027351|NCT00738374|20834082|P2|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|4
6027352|NCT00738374|20834083|P1|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|0
6027353|NCT00738374|20834080|P4|Maintenance Treatment/Observation Phase|Adverse Event|0
6027354|NCT00738374|20834081|P3|Maintenance Treatment/Observation Phase|Adverse Event|2
6027355|NCT00738374|20834082|P2|Maintenance Treatment/Observation Phase|Adverse Event|1
6027356|NCT00738374|20834083|P1|Maintenance Treatment/Observation Phase|Adverse Event|0
6027357|NCT00738374|20834080|P4|Induction Treatment Phase|Withdrawal by Subject|0
6027358|NCT00738374|20834081|P3|Induction Treatment Phase|Withdrawal by Subject|0
6027359|NCT00738374|20834082|P2|Induction Treatment Phase|Withdrawal by Subject|0
6027360|NCT00738374|20834083|P1|Induction Treatment Phase|Withdrawal by Subject|1
6027361|NCT00738374|20834080|P4|Induction Treatment Phase|Non-compliance|0
6027362|NCT00738374|20834081|P3|Induction Treatment Phase|Non-compliance|0
6027363|NCT00738374|20834082|P2|Induction Treatment Phase|Non-compliance|0
6027364|NCT00738374|20834083|P1|Induction Treatment Phase|Non-compliance|1
6027365|NCT00738374|20834080|P4|Induction Treatment Phase|Protocol Violation|0
6027366|NCT00738374|20834081|P3|Induction Treatment Phase|Protocol Violation|0
6027367|NCT00738374|20834082|P2|Induction Treatment Phase|Protocol Violation|0
6027368|NCT00738374|20834083|P1|Induction Treatment Phase|Protocol Violation|2
6027369|NCT00738374|20834080|P4|Induction Treatment Phase|Physician Decision|0
6027370|NCT00738374|20834081|P3|Induction Treatment Phase|Physician Decision|0
6027371|NCT00738374|20834082|P2|Induction Treatment Phase|Physician Decision|0
6027372|NCT00738374|20834083|P1|Induction Treatment Phase|Physician Decision|2
6027373|NCT00738374|20834080|P4|Induction Treatment Phase|Disease progression/relapse/stable|0
6027374|NCT00738374|20834081|P3|Induction Treatment Phase|Disease progression/relapse/stable|0
6027375|NCT00738374|20834082|P2|Induction Treatment Phase|Disease progression/relapse/stable|0
6027376|NCT00738374|20834083|P1|Induction Treatment Phase|Disease progression/relapse/stable|4
6027377|NCT00738374|20834080|P4|Induction Treatment Phase|Adverse Event|0
6027378|NCT00738374|20834081|P3|Induction Treatment Phase|Adverse Event|0
6027379|NCT00738374|20834082|P2|Induction Treatment Phase|Adverse Event|0
6027380|NCT00738374|20834083|P1|Induction Treatment Phase|Adverse Event|14
6027381|NCT00738283|20834121|P1|Overall Study|Discharge home prior to end of study|1
6027382|NCT00738283|20834121|P1|Overall Study|Transfer to another facility|2
6027383|NCT00738283|20834121|P1|Overall Study|Death|1
6027384|NCT00738101|20834125|P1|Overall Study|Repeat enrollment|1
6027385|NCT00738101|20834125|P1|Overall Study|Death|1
6027386|NCT00738101|20834125|P1|Overall Study|Physician Decision|5
6027387|NCT00738062|20834140|P3|Open-Label Extension|Study Terminated|0
6027388|NCT00738062|20834141|P2|Open-Label Extension|Study Terminated|0
6027389|NCT00738062|20834142|P1|Open-Label Extension|Study Terminated|2
6027390|NCT00738062|20834140|P3|Open-Label Extension|Protocol Violation|0
6027391|NCT00738062|20834141|P2|Open-Label Extension|Protocol Violation|0
6027392|NCT00738062|20834142|P1|Open-Label Extension|Protocol Violation|1
6027393|NCT00738062|20834140|P3|Open-Label Extension|Withdrawal by Subject|0
6027394|NCT00738062|20834141|P2|Open-Label Extension|Withdrawal by Subject|0
6027395|NCT00738062|20834142|P1|Open-Label Extension|Withdrawal by Subject|6
6027396|NCT00738062|20834140|P3|Open-Label Extension|Lack of Efficacy|0
6027397|NCT00738062|20834141|P2|Open-Label Extension|Lack of Efficacy|0
6027398|NCT00738062|20834142|P1|Open-Label Extension|Lack of Efficacy|2
6027399|NCT00738062|20834140|P3|Open-Label Extension|Physician Decision|0
6027400|NCT00738062|20834141|P2|Open-Label Extension|Physician Decision|0
6027401|NCT00738062|20834142|P1|Open-Label Extension|Physician Decision|1
6027402|NCT00738062|20834140|P3|Open-Label Extension|Adverse Event|0
6027403|NCT00738062|20834141|P2|Open-Label Extension|Adverse Event|0
6027404|NCT00738062|20834142|P1|Open-Label Extension|Adverse Event|5
6027405|NCT00738062|20834140|P3|Open Label Treatment|Investigator Decision|0
6027406|NCT00738062|20834141|P2|Open Label Treatment|Investigator Decision|0
6027407|NCT00738062|20834142|P1|Open Label Treatment|Investigator Decision|1
6027408|NCT00738062|20834140|P3|Open Label Treatment|Withdrawal by Subject|0
6027409|NCT00738062|20834141|P2|Open Label Treatment|Withdrawal by Subject|0
6027410|NCT00738062|20834142|P1|Open Label Treatment|Withdrawal by Subject|9
6027411|NCT00738062|20834140|P3|Open Label Treatment|Protocol Violation|0
6027412|NCT00738062|20834141|P2|Open Label Treatment|Protocol Violation|0
6027413|NCT00738062|20834142|P1|Open Label Treatment|Protocol Violation|2
6027414|NCT00738062|20834140|P3|Open Label Treatment|Adverse Event|0
6027415|NCT00738062|20834141|P2|Open Label Treatment|Adverse Event|0
6027416|NCT00738062|20834142|P1|Open Label Treatment|Adverse Event|11
6027417|NCT00738062|20834140|P3|Open Label Treatment|Lack of Efficacy|0
6027418|NCT00738062|20834141|P2|Open Label Treatment|Lack of Efficacy|0
6027419|NCT00738062|20834142|P1|Open Label Treatment|Lack of Efficacy|5
6027420|NCT00737711|20834255|P1|Overall Study|Other|5
6027421|NCT00737711|20834255|P1|Overall Study|Blood transfusion|6
6027422|NCT00737711|20834255|P1|Overall Study|Withdrawal by Subject|5
6027423|NCT00737711|20834255|P1|Overall Study|Protocol Violation|1
6027424|NCT00737711|20834255|P1|Overall Study|Failure to return|4
6027425|NCT00737711|20834255|P1|Overall Study|Death|8
6027426|NCT00737711|20834255|P1|Overall Study|Adverse Event|2
6027427|NCT00737698|20834289|P3|Overall Study|Death|1
6027428|NCT00737698|20834290|P2|Overall Study|Death|0
6027429|NCT00737698|20834291|P1|Overall Study|Death|0
6027430|NCT00737698|20834289|P3|Overall Study|Withdrawal by Subject|3
6027431|NCT00737698|20834290|P2|Overall Study|Withdrawal by Subject|5
6027432|NCT00737698|20834291|P1|Overall Study|Withdrawal by Subject|6
6027433|NCT00737672|20834301|P2|Overall Study|Physician Decision|2
6027434|NCT00737672|20834302|P1|Overall Study|Physician Decision|0
6027435|NCT00737672|20834301|P2|Overall Study|Miscellaneous|1
6027436|NCT00737672|20834302|P1|Overall Study|Miscellaneous|7
6027437|NCT00737672|20834301|P2|Overall Study|Lost to Follow-up|0
6027438|NCT00737672|20834302|P1|Overall Study|Lost to Follow-up|1
6027439|NCT00737672|20834301|P2|Overall Study|Withdrawal by Subject|2
6027440|NCT00737672|20834302|P1|Overall Study|Withdrawal by Subject|1
6027441|NCT00737672|20834301|P2|Overall Study|Death|22
6027442|NCT00737672|20834302|P1|Overall Study|Death|23
6027443|NCT00737672|20834301|P2|Overall Study|Graft Abandonment|56
6027444|NCT00737672|20834302|P1|Overall Study|Graft Abandonment|48
6027445|NCT00737633|20834340|P2|Overall Study|protocol non-compliance|1
6027446|NCT00737633|20834341|P1|Overall Study|protocol non-compliance|0
6027447|NCT00737633|20834340|P2|Overall Study|Lost to Follow-up|1
6027448|NCT00737633|20834341|P1|Overall Study|Lost to Follow-up|0
6027449|NCT00737633|20834340|P2|Overall Study|Study terminated by sponsor|55
6027450|NCT00737633|20834341|P1|Overall Study|Study terminated by sponsor|44
6027451|NCT00737568|20834364|P2|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|0
6027452|NCT00737568|20834365|P1|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|1
6027453|NCT00737568|20834364|P2|Treatment-Free Follow-up (TFFU) Period|Death|1
6027454|NCT00737568|20834365|P1|Treatment-Free Follow-up (TFFU) Period|Death|0
6027455|NCT00737568|20834364|P2|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|17
6027456|NCT00737568|20834365|P1|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|25
6027457|NCT00737568|20834364|P2|Treatment Period Through Week 240|Study Discontinued by Sponsor|0
6027458|NCT00737568|20834365|P1|Treatment Period Through Week 240|Study Discontinued by Sponsor|1
6027459|NCT00737568|20834364|P2|Treatment Period Through Week 240|Protocol Violation|3
6027460|NCT00737568|20834365|P1|Treatment Period Through Week 240|Protocol Violation|2
6027461|NCT00737568|20834364|P2|Treatment Period Through Week 240|Lost to Follow-up|3
6027462|NCT00737568|20834365|P1|Treatment Period Through Week 240|Lost to Follow-up|3
6027463|NCT00737568|20834364|P2|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|4
6027464|NCT00737568|20834365|P1|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|3
6027465|NCT00737568|20834364|P2|Treatment Period Through Week 240|Withdrew Consent|6
6027466|NCT00737568|20834365|P1|Treatment Period Through Week 240|Withdrew Consent|5
6027467|NCT00737568|20834364|P2|Treatment Period Through Week 240|Investigator's Discretion|5
6027468|NCT00737568|20834365|P1|Treatment Period Through Week 240|Investigator's Discretion|6
6027469|NCT00737529|20834395|P1|Overall Study|Other|4
6027470|NCT00737529|20834395|P1|Overall Study|Protocol Violation|1
6027471|NCT00737529|20834395|P1|Overall Study|Death|4
6027472|NCT00737529|20834395|P1|Overall Study|Withdrawal by Subject|5
6027473|NCT00737529|20834395|P1|Overall Study|Adverse Event|24
6027474|NCT00737529|20834395|P1|Overall Study|Disease Progression|95
6027475|NCT00737477|20834409|P1|Overall Study|Other|4
6027476|NCT00737477|20834409|P1|Overall Study|Renal Transplantation|10
6027477|NCT00737477|20834409|P1|Overall Study|Withdrawal by Subject|1
6027478|NCT00737477|20834409|P1|Overall Study|Treatment Refusal|1
6027479|NCT00737477|20834409|P1|Overall Study|Death|9
6027480|NCT00737477|20834409|P1|Overall Study|Adverse Event|9
6027481|NCT00737464|20834425|P1|Overall Study|Other reasons|4
6027482|NCT00737464|20834425|P1|Overall Study|Refused Treatment / Withdrew Consent|6
6027483|NCT00737464|20834425|P1|Overall Study|Other - Failure to Return|1
6027484|NCT00737464|20834425|P1|Overall Study|Death|6
6027485|NCT00737464|20834425|P1|Overall Study|Adverse Event|1
6027486|NCT00737438|20834446|P1|Overall Study|Patient ineligible|1
6027487|NCT00737438|20834446|P1|Overall Study|Withdrawal by Subject|2
6027488|NCT00737282|20834459|P1|Overall Study|Study prematurely terminated|175
6027489|NCT00737100|20834502|P3|Overall Study|Reason discontinued not explained above|1
6027490|NCT00737100|20834503|P2|Overall Study|Reason discontinued not explained above|1
6027491|NCT00737100|20834504|P1|Overall Study|Reason discontinued not explained above|1
6027492|NCT00737100|20834502|P3|Overall Study|Withdrawal by Subject|3
6027493|NCT00737100|20834503|P2|Overall Study|Withdrawal by Subject|0
6027494|NCT00737100|20834504|P1|Overall Study|Withdrawal by Subject|0
6027495|NCT00737100|20834502|P3|Overall Study|Lost to Follow-up|0
6027496|NCT00737100|20834503|P2|Overall Study|Lost to Follow-up|1
6027497|NCT00737100|20834504|P1|Overall Study|Lost to Follow-up|0
6027498|NCT00737100|20834502|P3|Overall Study|Adverse Event|3
6027499|NCT00737100|20834503|P2|Overall Study|Adverse Event|5
6027500|NCT00737100|20834504|P1|Overall Study|Adverse Event|6
6027501|NCT00737061|20834548|P1|1 Year Wearing Period|Terminated for protocol non-compliance|1
6027502|NCT00737061|20834548|P1|1 Year Wearing Period|Discontinued reilance|3
6027503|NCT00737061|20834548|P1|1 Year Wearing Period|Withdrawal by Subject|2
6027504|NCT00737061|20834548|P1|1 Year Wearing Period|Lost to Follow-up|11
6027505|NCT00737061|20834548|P1|Waiting Period|Elected surgical tubal ligation|5
6027506|NCT00737061|20834548|P1|Waiting Period|Alternative contraception failure|3
6027507|NCT00737061|20834548|P1|Waiting Period|Deemed patent following HSG|26
6027508|NCT00737061|20834548|P1|Waiting Period|Bilateral placement failure|34
6027509|NCT00737061|20834548|P1|Waiting Period|Withdrawal by Subject|1
6027510|NCT00737061|20834548|P1|Waiting Period|Lost to Follow-up|6
6027511|NCT00737048|20834565|P3|Overall Study|Worsening of the symptoms|3
6027512|NCT00737048|20834566|P2|Overall Study|Worsening of the symptoms|5
6027513|NCT00737048|20834567|P1|Overall Study|Worsening of the symptoms|3
6027514|NCT00737048|20834565|P3|Overall Study|Adverse Event|0
6027515|NCT00737048|20834566|P2|Overall Study|Adverse Event|1
6027516|NCT00737048|20834567|P1|Overall Study|Adverse Event|0
6027517|NCT00737048|20834565|P3|Overall Study|Physician Decision|1
6027518|NCT00737048|20834566|P2|Overall Study|Physician Decision|0
6027519|NCT00737048|20834567|P1|Overall Study|Physician Decision|0
6027520|NCT00736996|20834611|P3|Overall Study|Lost to Follow-up|2
6027521|NCT00736996|20834612|P2|Overall Study|Lost to Follow-up|9
6027522|NCT00736996|20834613|P1|Overall Study|Lost to Follow-up|1
6027523|NCT00736957|20834627|P1|Overall Study|Physician Decision|5
6027524|NCT00736957|20834627|P1|Overall Study|not eligible for Treatment Period I|22
6027525|NCT00736957|20834627|P1|Overall Study|did not attend hospital appointments|1
6027526|NCT00736957|20834627|P1|Overall Study|violation of eligibility criteria|2
6027527|NCT00736957|20834627|P1|Overall Study|Withdrawal by Subject|49
6027528|NCT00736957|20834627|P1|Overall Study|Adverse Event|43
6027529|NCT00736944|20834637|P1|Definitive Treatment|Physician Decision|1
6027530|NCT00736944|20834637|P1|Induction|Death|1
6027531|NCT00736879|20834671|P4|Follow up Period - No Drug Treatment|non-specified|0
6027532|NCT00736879|20834672|P3|Follow up Period - No Drug Treatment|non-specified|0
6027533|NCT00736879|20834673|P2|Follow up Period - No Drug Treatment|non-specified|2
6027534|NCT00736879|20834674|P1|Follow up Period - No Drug Treatment|non-specified|1
6027535|NCT00736879|20834671|P4|Follow up Period - No Drug Treatment|Withdrawal by Subject|0
6027536|NCT00736879|20834672|P3|Follow up Period - No Drug Treatment|Withdrawal by Subject|0
6027537|NCT00736879|20834673|P2|Follow up Period - No Drug Treatment|Withdrawal by Subject|1
6027538|NCT00736879|20834674|P1|Follow up Period - No Drug Treatment|Withdrawal by Subject|0
6027539|NCT00736879|20834671|P4|Double Blind Treatment Period|non-specified|0
6027540|NCT00736879|20834672|P3|Double Blind Treatment Period|non-specified|0
6027541|NCT00736879|20834673|P2|Double Blind Treatment Period|non-specified|1
6027542|NCT00736879|20834674|P1|Double Blind Treatment Period|non-specified|0
6027543|NCT00736879|20834671|P4|Double Blind Treatment Period|No longer met criteria|0
6027544|NCT00736879|20834672|P3|Double Blind Treatment Period|No longer met criteria|0
6027545|NCT00736879|20834673|P2|Double Blind Treatment Period|No longer met criteria|1
6027546|NCT00736879|20834674|P1|Double Blind Treatment Period|No longer met criteria|0
6027547|NCT00736879|20834671|P4|Double Blind Treatment Period|Poor non-compliance|1
6027548|NCT00736879|20834672|P3|Double Blind Treatment Period|Poor non-compliance|1
6027549|NCT00736879|20834673|P2|Double Blind Treatment Period|Poor non-compliance|0
6027550|NCT00736879|20834674|P1|Double Blind Treatment Period|Poor non-compliance|0
6027551|NCT00736879|20834671|P4|Double Blind Treatment Period|Lost to Follow-up|1
6027552|NCT00736879|20834672|P3|Double Blind Treatment Period|Lost to Follow-up|2
6027553|NCT00736879|20834673|P2|Double Blind Treatment Period|Lost to Follow-up|0
6027554|NCT00736879|20834674|P1|Double Blind Treatment Period|Lost to Follow-up|0
6027555|NCT00736879|20834671|P4|Double Blind Treatment Period|Withdrawal by Subject|3
6027556|NCT00736879|20834672|P3|Double Blind Treatment Period|Withdrawal by Subject|3
6027557|NCT00736879|20834673|P2|Double Blind Treatment Period|Withdrawal by Subject|1
6027558|NCT00736879|20834674|P1|Double Blind Treatment Period|Withdrawal by Subject|2
6027559|NCT00736879|20834671|P4|Double Blind Treatment Period|Adverse Event|0
6027560|NCT00736879|20834672|P3|Double Blind Treatment Period|Adverse Event|1
6027561|NCT00736879|20834673|P2|Double Blind Treatment Period|Adverse Event|1
6027562|NCT00736879|20834674|P1|Double Blind Treatment Period|Adverse Event|0
6027563|NCT00736879|20834671|P4|Double Blind Treatment Period|Lack of Efficacy|0
6027564|NCT00736879|20834672|P3|Double Blind Treatment Period|Lack of Efficacy|0
6027565|NCT00736879|20834673|P2|Double Blind Treatment Period|Lack of Efficacy|0
6027566|NCT00736879|20834674|P1|Double Blind Treatment Period|Lack of Efficacy|1
6027567|NCT00736853|20834728|P3|Double-Blind Period|Ineligible to participate the study|0
6027568|NCT00736853|20834729|P2|Double-Blind Period|Ineligible to participate the study|1
6027569|NCT00736853|20834730|P1|Double-Blind Period|Ineligible to participate the study|0
6027570|NCT00736853|20834728|P3|Double-Blind Period|Withdrawal by Subject|4
6027571|NCT00736853|20834729|P2|Double-Blind Period|Withdrawal by Subject|1
6027572|NCT00736853|20834730|P1|Double-Blind Period|Withdrawal by Subject|0
6027573|NCT00736853|20834728|P3|Double-Blind Period|Adverse Event|2
6027574|NCT00736853|20834729|P2|Double-Blind Period|Adverse Event|3
6027575|NCT00736853|20834730|P1|Double-Blind Period|Adverse Event|0
6027576|NCT00736853|20834728|P3|Double-Blind Period|Lack of Efficacy|42
6027577|NCT00736853|20834729|P2|Double-Blind Period|Lack of Efficacy|19
6027578|NCT00736853|20834730|P1|Double-Blind Period|Lack of Efficacy|0
6027579|NCT00736853|20834728|P3|Open-Label Period|Unable to attend hospital appointments|0
6027580|NCT00736853|20834729|P2|Open-Label Period|Unable to attend hospital appointments|0
6027581|NCT00736853|20834730|P1|Open-Label Period|Unable to attend hospital appointments|1
6027582|NCT00736853|20834728|P3|Open-Label Period|Failed to meet the transfer criteria|0
6027583|NCT00736853|20834729|P2|Open-Label Period|Failed to meet the transfer criteria|0
6027584|NCT00736853|20834730|P1|Open-Label Period|Failed to meet the transfer criteria|40
6027585|NCT00736853|20834728|P3|Open-Label Period|Started but not treated|0
6027586|NCT00736853|20834729|P2|Open-Label Period|Started but not treated|0
6027587|NCT00736853|20834730|P1|Open-Label Period|Started but not treated|42
6027588|NCT00736853|20834728|P3|Open-Label Period|Withdrawal by Subject|0
6027589|NCT00736853|20834729|P2|Open-Label Period|Withdrawal by Subject|0
6027590|NCT00736853|20834730|P1|Open-Label Period|Withdrawal by Subject|16
6027591|NCT00736853|20834728|P3|Open-Label Period|Adverse Event|0
6027592|NCT00736853|20834729|P2|Open-Label Period|Adverse Event|0
6027593|NCT00736853|20834730|P1|Open-Label Period|Adverse Event|31
6027594|NCT00736853|20834728|P3|Open-Label Period|Physician Decision|0
6027595|NCT00736853|20834729|P2|Open-Label Period|Physician Decision|0
6027596|NCT00736853|20834730|P1|Open-Label Period|Physician Decision|2
6027597|NCT00736840|20834770|P1|Overall Study|Lost to Follow-up|13
6027598|NCT00736723|20834777|P2|Overall Study|Withdrawal by Subject|3
6027599|NCT00736723|20834778|P1|Overall Study|Withdrawal by Subject|4
6027600|NCT00736645|20834788|P4|Overall Study|Adverse Event|0
6027601|NCT00736645|20834789|P3|Overall Study|Adverse Event|0
6027602|NCT00736645|20834790|P2|Overall Study|Adverse Event|2
6027603|NCT00736645|20834791|P1|Overall Study|Adverse Event|0
6027604|NCT00736502|20834841|P1|Overall Study|Lost to Follow-up|27
6027605|NCT00736502|20834841|P1|Overall Study|Lack of Efficacy|16
6027606|NCT00736502|20834841|P1|Overall Study|Adverse Event|22
6027607|NCT00736489|20834847|P6|Period 1|Withdrawal by Subject|1
6027608|NCT00736489|20834848|P5|Period 1|Withdrawal by Subject|0
6027609|NCT00736489|20834849|P4|Period 1|Withdrawal by Subject|0
6027610|NCT00736489|20834850|P3|Period 1|Withdrawal by Subject|0
6027611|NCT00736489|20834851|P2|Period 1|Withdrawal by Subject|0
6027612|NCT00736489|20834852|P1|Period 1|Withdrawal by Subject|0
6027613|NCT00736489|20834847|P6|Period 1|Lost to Follow-up|0
6027614|NCT00736489|20834848|P5|Period 1|Lost to Follow-up|0
6027615|NCT00736489|20834849|P4|Period 1|Lost to Follow-up|0
6027616|NCT00736489|20834850|P3|Period 1|Lost to Follow-up|0
6027617|NCT00736489|20834851|P2|Period 1|Lost to Follow-up|0
6027618|NCT00736489|20834852|P1|Period 1|Lost to Follow-up|1
6027619|NCT00736476|20835006|P2|Overall Study|Adverse Event|0
6027620|NCT00736476|20835007|P1|Overall Study|Adverse Event|1
6027621|NCT00736450|20835027|P1|Overall Study|Physician Decision|1
6027622|NCT00736450|20835027|P1|Overall Study|Withdrawal by Subject|5
6027623|NCT00736450|20835027|P1|Overall Study|Not ABC gene eligible|19
6027624|NCT00736385|20835035|P2|Overall Study|Adverse Event|1
6027625|NCT00736385|20835036|P1|Overall Study|Adverse Event|0
6027626|NCT00736385|20835035|P2|Overall Study|Withdrawal by Subject|2
6027627|NCT00736385|20835036|P1|Overall Study|Withdrawal by Subject|2
6027628|NCT00736333|20835048|P1|Overall Study|Other|4
6027629|NCT00736333|20835048|P1|Overall Study|Death|7
6027630|NCT00736333|20835048|P1|Overall Study|Withdrawal by Subject|10
6027631|NCT00736333|20835048|P1|Overall Study|Toxicity|6
6027632|NCT00736333|20835048|P1|Overall Study|Tumor Progression|75
6027633|NCT00736333|20835048|P1|Overall Study|Data Missing|2
6027634|NCT00736333|20835048|P1|Overall Study|Did Not Receive Drug or Not Documented|7
6027635|NCT00736255|20835059|P2|Overall Study|Non-compliance|1
6027636|NCT00736255|20835060|P1|Overall Study|Non-compliance|1
6027637|NCT00736255|20835059|P2|Overall Study|Physician Decision|0
6027638|NCT00736255|20835060|P1|Overall Study|Physician Decision|1
6027639|NCT00736255|20835059|P2|Overall Study|Adverse Event|0
6027640|NCT00736255|20835060|P1|Overall Study|Adverse Event|1
6027641|NCT00736190|20835107|P1|Overall Study|Adverse Event|1
6027642|NCT00736190|20835107|P1|Overall Study|Withdrawal by Subject|1
6027643|NCT00736190|20835107|P1|Overall Study|Pregnancy|1
6027644|NCT00736099|20835137|P2|Overall Study|Other reason|10
6027645|NCT00736099|20835138|P1|Overall Study|Other reason|43
6027646|NCT00736099|20835137|P2|Overall Study|Lack of Efficacy|8
6027647|NCT00736099|20835138|P1|Overall Study|Lack of Efficacy|15
6027648|NCT00736099|20835137|P2|Overall Study|Withdrawal by Subject|13
6027649|NCT00736099|20835138|P1|Overall Study|Withdrawal by Subject|42
6027650|NCT00736099|20835137|P2|Overall Study|Lost to Follow-up|5
6027651|NCT00736099|20835138|P1|Overall Study|Lost to Follow-up|12
6027652|NCT00736099|20835137|P2|Overall Study|Protocol Violation|4
6027653|NCT00736099|20835138|P1|Overall Study|Protocol Violation|10
6027654|NCT00736099|20835137|P2|Overall Study|Adverse Event|18
6027655|NCT00736099|20835138|P1|Overall Study|Adverse Event|61
6027656|NCT00736034|20835247|P1|Overall Study|Adverse Event|2
6027657|NCT00735943|20835255|P1|Overall Study|Adverse Event|1
6027658|NCT00735943|20835255|P1|Overall Study|Lost to Follow-up|1
6027659|NCT00735904|20835280|P1|Overall Study|Other|8
6027660|NCT00735904|20835280|P1|Overall Study|Study Terminated by Sponsor|5
6027661|NCT00735904|20835280|P1|Overall Study|Withdrawal by Subject|1
6027662|NCT00735904|20835280|P1|Overall Study|Protocol Violation|1
6027663|NCT00735904|20835280|P1|Overall Study|Death|20
6027664|NCT00735904|20835280|P1|Overall Study|Adverse Event|3
6027665|NCT00735878|20835290|P3|Phase I- Dose Determination|Withdrawal by Subject|1
6027666|NCT00735878|20835291|P2|Phase I- Dose Determination|Withdrawal by Subject|0
6027667|NCT00735878|20835292|P1|Phase I- Dose Determination|Withdrawal by Subject|0
6027668|NCT00735709|20835371|P4|Overall Study|Excluded medication|1
6027669|NCT00735709|20835372|P3|Overall Study|Excluded medication|0
6027670|NCT00735709|20835373|P2|Overall Study|Excluded medication|0
6027671|NCT00735709|20835374|P1|Overall Study|Excluded medication|1
6027672|NCT00735709|20835371|P4|Overall Study|Lost to Follow-up|1
6027673|NCT00735709|20835372|P3|Overall Study|Lost to Follow-up|1
6027674|NCT00735709|20835373|P2|Overall Study|Lost to Follow-up|1
6027675|NCT00735709|20835374|P1|Overall Study|Lost to Follow-up|0
6027676|NCT00735709|20835371|P4|Overall Study|Voluntary Withdrawal|7
6027677|NCT00735709|20835372|P3|Overall Study|Voluntary Withdrawal|5
6027678|NCT00735709|20835373|P2|Overall Study|Voluntary Withdrawal|3
6027679|NCT00735709|20835374|P1|Overall Study|Voluntary Withdrawal|1
6027680|NCT00735709|20835371|P4|Overall Study|Protocol deviations|1
6027681|NCT00735709|20835372|P3|Overall Study|Protocol deviations|1
6027682|NCT00735709|20835373|P2|Overall Study|Protocol deviations|2
6027683|NCT00735709|20835374|P1|Overall Study|Protocol deviations|1
6027684|NCT00735709|20835371|P4|Overall Study|Noncompliance|0
6027685|NCT00735709|20835372|P3|Overall Study|Noncompliance|1
6027686|NCT00735709|20835373|P2|Overall Study|Noncompliance|0
6027687|NCT00735709|20835374|P1|Overall Study|Noncompliance|0
6027688|NCT00735709|20835371|P4|Overall Study|Lack of Efficacy|3
6027689|NCT00735709|20835372|P3|Overall Study|Lack of Efficacy|2
6027690|NCT00735709|20835373|P2|Overall Study|Lack of Efficacy|4
6027691|NCT00735709|20835374|P1|Overall Study|Lack of Efficacy|8
6027692|NCT00735709|20835371|P4|Overall Study|Adverse Event|5
6027693|NCT00735709|20835372|P3|Overall Study|Adverse Event|1
6027694|NCT00735709|20835373|P2|Overall Study|Adverse Event|3
6027695|NCT00735709|20835374|P1|Overall Study|Adverse Event|2
6027696|NCT00735696|20835484|P1|Overall Study|Enrolled but never Treated|1
6027697|NCT00735696|20835484|P1|Overall Study|Withdrawal by Subject|1
6027698|NCT00735644|20835512|P5|Overall Study|Withdrawal by Subject|0
6027699|NCT00735644|20835513|P4|Overall Study|Withdrawal by Subject|1
6027700|NCT00735644|20835514|P3|Overall Study|Withdrawal by Subject|1
6027701|NCT00735644|20835515|P2|Overall Study|Withdrawal by Subject|1
6027702|NCT00735644|20835516|P1|Overall Study|Withdrawal by Subject|0
6027703|NCT00735644|20835512|P5|Overall Study|Did not receive study vaccine|0
6027704|NCT00735644|20835513|P4|Overall Study|Did not receive study vaccine|0
6027705|NCT00735644|20835514|P3|Overall Study|Did not receive study vaccine|0
6027706|NCT00735644|20835515|P2|Overall Study|Did not receive study vaccine|1
6027707|NCT00735644|20835516|P1|Overall Study|Did not receive study vaccine|0
6027708|NCT00735553|20835560|P1|Overall Study|Study prematurely terminated|77
6027709|NCT00735475|20835570|P2|Overall Study|Withdrawal by Subject|5
6027710|NCT00735475|20835571|P1|Overall Study|Withdrawal by Subject|4
6027711|NCT00735475|20835570|P2|Overall Study|Physician Decision|1
6027712|NCT00735475|20835571|P1|Overall Study|Physician Decision|0
6027713|NCT00735475|20835570|P2|Overall Study|Lost to Follow-up|3
6027714|NCT00735475|20835571|P1|Overall Study|Lost to Follow-up|3
6027715|NCT00735475|20835570|P2|Overall Study|Death|1
6027716|NCT00735475|20835571|P1|Overall Study|Death|1
6027717|NCT00735475|20835570|P2|Overall Study|Adverse Event|1
6027718|NCT00735475|20835571|P1|Overall Study|Adverse Event|0
6027719|NCT00735397|20835631|P1|Overall Study|Administrative/Other|502
6027720|NCT00735397|20835631|P1|Overall Study|Inadequate therapeutic effect|202
6027721|NCT00735397|20835631|P1|Overall Study|Participant choice|252
6027722|NCT00735397|20835631|P1|Overall Study|Lost to Follow-up|33
6027723|NCT00735397|20835631|P1|Overall Study|Adverse Event|194
6027724|NCT00735371|20835645|P4|Overall Study|Exclusion criteria|0
6027725|NCT00735371|20835646|P3|Overall Study|Exclusion criteria|0
6027726|NCT00735371|20835647|P2|Overall Study|Exclusion criteria|0
6027727|NCT00735371|20835648|P1|Overall Study|Exclusion criteria|1
6027728|NCT00735371|20835645|P4|Overall Study|Prior Vyvanse Exposure|0
6027729|NCT00735371|20835646|P3|Overall Study|Prior Vyvanse Exposure|0
6027730|NCT00735371|20835647|P2|Overall Study|Prior Vyvanse Exposure|1
6027731|NCT00735371|20835648|P1|Overall Study|Prior Vyvanse Exposure|1
6027732|NCT00735371|20835645|P4|Overall Study|Protocol Violation|0
6027733|NCT00735371|20835646|P3|Overall Study|Protocol Violation|2
6027734|NCT00735371|20835647|P2|Overall Study|Protocol Violation|1
6027735|NCT00735371|20835648|P1|Overall Study|Protocol Violation|0
6027736|NCT00735371|20835645|P4|Overall Study|Sponsor Decision|1
6027737|NCT00735371|20835646|P3|Overall Study|Sponsor Decision|0
6027738|NCT00735371|20835647|P2|Overall Study|Sponsor Decision|1
6027739|NCT00735371|20835648|P1|Overall Study|Sponsor Decision|3
6027740|NCT00735371|20835645|P4|Overall Study|Lack of Efficacy|4
6027741|NCT00735371|20835646|P3|Overall Study|Lack of Efficacy|0
6027742|NCT00735371|20835647|P2|Overall Study|Lack of Efficacy|2
6027743|NCT00735371|20835648|P1|Overall Study|Lack of Efficacy|4
6027744|NCT00735371|20835645|P4|Overall Study|Lost to Follow-up|1
6027745|NCT00735371|20835646|P3|Overall Study|Lost to Follow-up|3
6027746|NCT00735371|20835647|P2|Overall Study|Lost to Follow-up|1
6027747|NCT00735371|20835648|P1|Overall Study|Lost to Follow-up|1
6027748|NCT00735371|20835645|P4|Overall Study|Withdrawal by Subject|0
6027749|NCT00735371|20835646|P3|Overall Study|Withdrawal by Subject|2
6027750|NCT00735371|20835647|P2|Overall Study|Withdrawal by Subject|2
6027751|NCT00735371|20835648|P1|Overall Study|Withdrawal by Subject|0
6027752|NCT00735371|20835645|P4|Overall Study|Protocol Violation|3
6027753|NCT00735371|20835646|P3|Overall Study|Protocol Violation|0
6027754|NCT00735371|20835647|P2|Overall Study|Protocol Violation|2
6027755|NCT00735371|20835648|P1|Overall Study|Protocol Violation|2
6027756|NCT00735371|20835645|P4|Overall Study|Adverse Event|1
6027757|NCT00735371|20835646|P3|Overall Study|Adverse Event|4
6027758|NCT00735371|20835647|P2|Overall Study|Adverse Event|3
6027759|NCT00735371|20835648|P1|Overall Study|Adverse Event|3
6027760|NCT00735254|20835676|P4|Overall Study|Protocol Violation|0
6027761|NCT00735254|20835677|P3|Overall Study|Protocol Violation|1
6027762|NCT00735254|20835678|P2|Overall Study|Protocol Violation|1
6027763|NCT00735254|20835679|P1|Overall Study|Protocol Violation|1
6027764|NCT00735072|20835691|P2|Overall Study|Subject interrupted ARVs (non-adherence)|1
6027765|NCT00735072|20835692|P1|Overall Study|Subject interrupted ARVs (non-adherence)|0
6027766|NCT00735072|20835691|P2|Overall Study|interrupted study med during ARV change|0
6027767|NCT00735072|20835692|P1|Overall Study|interrupted study med during ARV change|1
6027768|NCT00735007|20835706|P1|Overall Study|Protocol Violation|1
6027769|NCT00735007|20835706|P1|Overall Study|Adverse Event|4
6027770|NCT00734994|20835731|P1|Overall Study|Withdrawal by Subject|1
6027771|NCT00734929|20835751|P2|Overall Study|No intervention/ screen fail|3
6027772|NCT00734929|20835752|P1|Overall Study|No intervention/ screen fail|5
6027773|NCT00734929|20835751|P2|Overall Study|Lost to Follow-up|2
6027774|NCT00734929|20835752|P1|Overall Study|Lost to Follow-up|1
6027775|NCT00734851|20835809|P1|Overall Study|Physician Decision|18
6027776|NCT00734851|20835809|P1|Overall Study|Lost to Follow-up|1
6027777|NCT00734851|20835809|P1|Overall Study|Withdrawal by Subject|2
6027778|NCT00734747|20835830|P1|6 Month Follow-up|Did not meet inclusion criteria|3
6027779|NCT00734747|20835830|P1|SRS Procedure|No staples placed|3
6027780|NCT00734656|20835844|P4|Lab Session 4|Withdrawal by Subject|1
6027781|NCT00734656|20835845|P3|Lab Session 4|Withdrawal by Subject|0
6027782|NCT00734656|20835846|P2|Lab Session 4|Withdrawal by Subject|0
6027783|NCT00734656|20835847|P1|Lab Session 4|Withdrawal by Subject|0
6027784|NCT00734656|20835844|P4|Washout 3|Withdrawal by Subject|1
6027785|NCT00734656|20835845|P3|Washout 3|Withdrawal by Subject|0
6027786|NCT00734656|20835846|P2|Washout 3|Withdrawal by Subject|0
6027787|NCT00734656|20835847|P1|Washout 3|Withdrawal by Subject|1
6027788|NCT00734656|20835844|P4|Washout 2|Withdrawal by Subject|0
6027789|NCT00734656|20835845|P3|Washout 2|Withdrawal by Subject|1
6027790|NCT00734656|20835846|P2|Washout 2|Withdrawal by Subject|1
6027791|NCT00734656|20835847|P1|Washout 2|Withdrawal by Subject|1
6027792|NCT00734656|20835844|P4|Lab Session 2|Withdrawal by Subject|1
6027793|NCT00734656|20835845|P3|Lab Session 2|Withdrawal by Subject|0
6027794|NCT00734656|20835846|P2|Lab Session 2|Withdrawal by Subject|0
6027795|NCT00734656|20835847|P1|Lab Session 2|Withdrawal by Subject|1
6027796|NCT00734656|20835844|P4|Washout 1|Withdrawal by Subject|3
6027797|NCT00734656|20835845|P3|Washout 1|Withdrawal by Subject|2
6027798|NCT00734656|20835846|P2|Washout 1|Withdrawal by Subject|5
6027799|NCT00734656|20835847|P1|Washout 1|Withdrawal by Subject|1
6027800|NCT00734656|20835844|P4|Lab Session 1|Withdrawal by Subject|0
6027801|NCT00734656|20835845|P3|Lab Session 1|Withdrawal by Subject|0
6027802|NCT00734656|20835846|P2|Lab Session 1|Withdrawal by Subject|0
6027803|NCT00734656|20835847|P1|Lab Session 1|Withdrawal by Subject|2
6027804|NCT00734630|20835871|P2|Overall Study|Poor Compliance|1
6027805|NCT00734630|20835872|P1|Overall Study|Poor Compliance|1
6027806|NCT00734630|20835871|P2|Overall Study|Tested Positive for Illegal Drug Use|1
6027807|NCT00734630|20835872|P1|Overall Study|Tested Positive for Illegal Drug Use|1
6027808|NCT00734630|20835871|P2|Overall Study|Randomized in Error|1
6027809|NCT00734630|20835872|P1|Overall Study|Randomized in Error|0
6027810|NCT00734630|20835871|P2|Overall Study|Adverse Event|6
6027811|NCT00734630|20835872|P1|Overall Study|Adverse Event|3
6027812|NCT00734630|20835871|P2|Overall Study|Inclusion/Exclusion criteria not met|1
6027813|NCT00734630|20835872|P1|Overall Study|Inclusion/Exclusion criteria not met|0
6027814|NCT00734630|20835871|P2|Overall Study|Protocol Violation|3
6027815|NCT00734630|20835872|P1|Overall Study|Protocol Violation|0
6027816|NCT00734630|20835871|P2|Overall Study|Lost to Follow-up|7
6027817|NCT00734630|20835872|P1|Overall Study|Lost to Follow-up|13
6027818|NCT00734630|20835871|P2|Overall Study|Withdrawal by Subject|9
6027819|NCT00734630|20835872|P1|Overall Study|Withdrawal by Subject|7
6027820|NCT00734630|20835871|P2|Overall Study|Lack of Efficacy|4
6027821|NCT00734630|20835872|P1|Overall Study|Lack of Efficacy|4
6027822|NCT00734617|20835882|P2|Overall Study|Withdrawal by Subject|95
6027823|NCT00734617|20835883|P1|Overall Study|Withdrawal by Subject|103
6027824|NCT00734617|20835882|P2|Overall Study|Adverse Event|7
6027825|NCT00734617|20835883|P1|Overall Study|Adverse Event|4
6027826|NCT00734604|20835895|P6|Overall Study|Lack of Efficacy|0
6027827|NCT00734604|20835896|P5|Overall Study|Lack of Efficacy|0
6027828|NCT00734604|20835897|P4|Overall Study|Lack of Efficacy|0
6027829|NCT00734604|20835898|P3|Overall Study|Lack of Efficacy|1
6027830|NCT00734604|20835899|P2|Overall Study|Lack of Efficacy|1
6027831|NCT00734604|20835900|P1|Overall Study|Lack of Efficacy|0
6027832|NCT00734604|20835895|P6|Overall Study|Withdrawal by Subject|1
6027833|NCT00734604|20835896|P5|Overall Study|Withdrawal by Subject|2
6027834|NCT00734604|20835897|P4|Overall Study|Withdrawal by Subject|1
6027835|NCT00734604|20835898|P3|Overall Study|Withdrawal by Subject|0
6027836|NCT00734604|20835899|P2|Overall Study|Withdrawal by Subject|2
6027837|NCT00734604|20835900|P1|Overall Study|Withdrawal by Subject|0
6027838|NCT00734604|20835895|P6|Overall Study|Sponsor Decision|0
6027839|NCT00734604|20835896|P5|Overall Study|Sponsor Decision|2
6027840|NCT00734604|20835897|P4|Overall Study|Sponsor Decision|0
6027841|NCT00734604|20835898|P3|Overall Study|Sponsor Decision|1
6027842|NCT00734604|20835899|P2|Overall Study|Sponsor Decision|2
6027843|NCT00734604|20835900|P1|Overall Study|Sponsor Decision|1
6027844|NCT00734604|20835895|P6|Overall Study|Protocol Violation|0
6027845|NCT00734604|20835896|P5|Overall Study|Protocol Violation|1
6027846|NCT00734604|20835897|P4|Overall Study|Protocol Violation|0
6027847|NCT00734604|20835898|P3|Overall Study|Protocol Violation|0
6027848|NCT00734604|20835899|P2|Overall Study|Protocol Violation|2
6027849|NCT00734604|20835900|P1|Overall Study|Protocol Violation|0
6027850|NCT00734604|20835895|P6|Overall Study|Physician Decision|0
6027851|NCT00734604|20835896|P5|Overall Study|Physician Decision|0
6027852|NCT00734604|20835897|P4|Overall Study|Physician Decision|0
6027853|NCT00734604|20835898|P3|Overall Study|Physician Decision|1
6027854|NCT00734604|20835899|P2|Overall Study|Physician Decision|1
6027855|NCT00734604|20835900|P1|Overall Study|Physician Decision|0
6027856|NCT00734604|20835895|P6|Overall Study|Lost to Follow-up|3
6027857|NCT00734604|20835896|P5|Overall Study|Lost to Follow-up|2
6027858|NCT00734604|20835897|P4|Overall Study|Lost to Follow-up|4
6027859|NCT00734604|20835898|P3|Overall Study|Lost to Follow-up|2
6027860|NCT00734604|20835899|P2|Overall Study|Lost to Follow-up|2
6027861|NCT00734604|20835900|P1|Overall Study|Lost to Follow-up|1
6027862|NCT00734604|20835895|P6|Overall Study|Serious Adverse Event|1
6027863|NCT00734604|20835896|P5|Overall Study|Serious Adverse Event|0
6027864|NCT00734604|20835897|P4|Overall Study|Serious Adverse Event|2
6027865|NCT00734604|20835898|P3|Overall Study|Serious Adverse Event|1
6027866|NCT00734604|20835899|P2|Overall Study|Serious Adverse Event|0
6027867|NCT00734604|20835900|P1|Overall Study|Serious Adverse Event|1
6027868|NCT00734604|20835895|P6|Overall Study|Adverse Event|1
6027869|NCT00734604|20835896|P5|Overall Study|Adverse Event|1
6027870|NCT00734604|20835897|P4|Overall Study|Adverse Event|2
6027871|NCT00734604|20835898|P3|Overall Study|Adverse Event|0
6027872|NCT00734604|20835899|P2|Overall Study|Adverse Event|2
6027873|NCT00734604|20835900|P1|Overall Study|Adverse Event|0
6027874|NCT00734591|20835950|P2|Prospective Period|Other|2
6027875|NCT00734591|20835951|P1|Prospective Period|Other|2
6027876|NCT00734591|20835950|P2|Prospective Period|Study Terminated|0
6027877|NCT00734591|20835951|P1|Prospective Period|Study Terminated|1
6027878|NCT00734591|20835950|P2|Prospective Period|Lost to Follow-up|33
6027879|NCT00734591|20835951|P1|Prospective Period|Lost to Follow-up|37
6027880|NCT00734591|20835950|P2|Prospective Period|Withdrawal by Subject|9
6027881|NCT00734591|20835951|P1|Prospective Period|Withdrawal by Subject|11
6027882|NCT00734591|20835950|P2|Screening for Prospective Period|Patient at partic. site not enrolled|803
6027883|NCT00734591|20835951|P1|Screening for Prospective Period|Patient at partic. site not enrolled|913
6027884|NCT00734591|20835950|P2|Screening for Prospective Period|Site did not participate|1488
6027885|NCT00734591|20835951|P1|Screening for Prospective Period|Site did not participate|1604
6027886|NCT00734578|20835966|P3|Overall Study|Exclusion criteria|0
6027887|NCT00734578|20835967|P2|Overall Study|Exclusion criteria|0
6027888|NCT00734578|20835968|P1|Overall Study|Exclusion criteria|1
6027889|NCT00734578|20835966|P3|Overall Study|Randomized in error|0
6027890|NCT00734578|20835967|P2|Overall Study|Randomized in error|0
6027891|NCT00734578|20835968|P1|Overall Study|Randomized in error|1
6027892|NCT00734578|20835966|P3|Overall Study|Lack of Efficacy|5
6027893|NCT00734578|20835967|P2|Overall Study|Lack of Efficacy|2
6027894|NCT00734578|20835968|P1|Overall Study|Lack of Efficacy|3
6027895|NCT00734578|20835966|P3|Overall Study|Lost to Follow-up|5
6027896|NCT00734578|20835967|P2|Overall Study|Lost to Follow-up|3
6027897|NCT00734578|20835968|P1|Overall Study|Lost to Follow-up|9
6027898|NCT00734578|20835966|P3|Overall Study|Withdrawal by Subject|11
6027899|NCT00734578|20835967|P2|Overall Study|Withdrawal by Subject|8
6027900|NCT00734578|20835968|P1|Overall Study|Withdrawal by Subject|7
6027901|NCT00734578|20835966|P3|Overall Study|Protocol Violation|3
6027902|NCT00734578|20835967|P2|Overall Study|Protocol Violation|6
6027903|NCT00734578|20835968|P1|Overall Study|Protocol Violation|8
6027904|NCT00734578|20835966|P3|Overall Study|Adverse Event|1
6027905|NCT00734578|20835967|P2|Overall Study|Adverse Event|6
6027906|NCT00734578|20835968|P1|Overall Study|Adverse Event|4
6027907|NCT00734539|20836002|P2|Main Study|Enrolled in error; ineligible|0
6027908|NCT00734539|20836003|P1|Main Study|Enrolled in error; ineligible|1
6027909|NCT00734539|20836002|P2|Main Study|Withdrawal by Subject|3
6027910|NCT00734539|20836003|P1|Main Study|Withdrawal by Subject|1
6027911|NCT00734539|20836002|P2|Main Study|Physician Decision|0
6027912|NCT00734539|20836003|P1|Main Study|Physician Decision|2
6027913|NCT00734539|20836002|P2|Main Study|Death|32
6027914|NCT00734539|20836003|P1|Main Study|Death|33
6027915|NCT00734474|20836045|P9|Overall Study|Lack of Efficacy|6
6027916|NCT00734474|20836046|P8|Overall Study|Lack of Efficacy|4
6027917|NCT00734474|20836047|P7|Overall Study|Lack of Efficacy|0
6027918|NCT00734474|20836048|P6|Overall Study|Lack of Efficacy|0
6027919|NCT00734474|20836049|P5|Overall Study|Lack of Efficacy|0
6027920|NCT00734474|20836050|P4|Overall Study|Lack of Efficacy|0
6027921|NCT00734474|20836051|P3|Overall Study|Lack of Efficacy|4
6027922|NCT00734474|20836052|P2|Overall Study|Lack of Efficacy|0
6027923|NCT00734474|20836053|P1|Overall Study|Lack of Efficacy|0
6027924|NCT00734474|20836045|P9|Overall Study|Death|1
6027925|NCT00734474|20836046|P8|Overall Study|Death|2
6027926|NCT00734474|20836047|P7|Overall Study|Death|0
6027927|NCT00734474|20836048|P6|Overall Study|Death|0
6027928|NCT00734474|20836049|P5|Overall Study|Death|0
6027929|NCT00734474|20836050|P4|Overall Study|Death|0
6027930|NCT00734474|20836051|P3|Overall Study|Death|1
6027931|NCT00734474|20836052|P2|Overall Study|Death|0
6027932|NCT00734474|20836053|P1|Overall Study|Death|0
6027933|NCT00734474|20836045|P9|Overall Study|Sponsor Decision|0
6027934|NCT00734474|20836046|P8|Overall Study|Sponsor Decision|0
6027935|NCT00734474|20836047|P7|Overall Study|Sponsor Decision|0
6027936|NCT00734474|20836048|P6|Overall Study|Sponsor Decision|0
6027937|NCT00734474|20836049|P5|Overall Study|Sponsor Decision|2
6027938|NCT00734474|20836050|P4|Overall Study|Sponsor Decision|0
6027939|NCT00734474|20836051|P3|Overall Study|Sponsor Decision|0
6027940|NCT00734474|20836052|P2|Overall Study|Sponsor Decision|0
6027941|NCT00734474|20836053|P1|Overall Study|Sponsor Decision|0
6027942|NCT00734474|20836045|P9|Overall Study|Sponsor Decision, Arm Discontinued|0
6027943|NCT00734474|20836046|P8|Overall Study|Sponsor Decision, Arm Discontinued|0
6027944|NCT00734474|20836047|P7|Overall Study|Sponsor Decision, Arm Discontinued|23
6027945|NCT00734474|20836048|P6|Overall Study|Sponsor Decision, Arm Discontinued|21
6027946|NCT00734474|20836049|P5|Overall Study|Sponsor Decision, Arm Discontinued|0
6027947|NCT00734474|20836050|P4|Overall Study|Sponsor Decision, Arm Discontinued|8
6027948|NCT00734474|20836051|P3|Overall Study|Sponsor Decision, Arm Discontinued|0
6027949|NCT00734474|20836052|P2|Overall Study|Sponsor Decision, Arm Discontinued|25
6027950|NCT00734474|20836053|P1|Overall Study|Sponsor Decision, Arm Discontinued|8
6027951|NCT00734474|20836045|P9|Overall Study|Protocol Violation|1
6027952|NCT00734474|20836046|P8|Overall Study|Protocol Violation|3
6027953|NCT00734474|20836047|P7|Overall Study|Protocol Violation|0
6027954|NCT00734474|20836048|P6|Overall Study|Protocol Violation|0
6027955|NCT00734474|20836049|P5|Overall Study|Protocol Violation|3
6027956|NCT00734474|20836050|P4|Overall Study|Protocol Violation|0
6027957|NCT00734474|20836051|P3|Overall Study|Protocol Violation|4
6027958|NCT00734474|20836052|P2|Overall Study|Protocol Violation|0
6027959|NCT00734474|20836053|P1|Overall Study|Protocol Violation|0
6027960|NCT00734474|20836045|P9|Overall Study|Adverse Event|39
6027961|NCT00734474|20836046|P8|Overall Study|Adverse Event|65
6027962|NCT00734474|20836047|P7|Overall Study|Adverse Event|1
6027963|NCT00734474|20836048|P6|Overall Study|Adverse Event|0
6027964|NCT00734474|20836049|P5|Overall Study|Adverse Event|64
6027965|NCT00734474|20836050|P4|Overall Study|Adverse Event|1
6027966|NCT00734474|20836051|P3|Overall Study|Adverse Event|63
6027967|NCT00734474|20836052|P2|Overall Study|Adverse Event|4
6027968|NCT00734474|20836053|P1|Overall Study|Adverse Event|4
6027969|NCT00734474|20836045|P9|Overall Study|Physician Decision|9
6027970|NCT00734474|20836046|P8|Overall Study|Physician Decision|9
6027971|NCT00734474|20836047|P7|Overall Study|Physician Decision|0
6027972|NCT00734474|20836048|P6|Overall Study|Physician Decision|0
6027973|NCT00734474|20836049|P5|Overall Study|Physician Decision|11
6027974|NCT00734474|20836050|P4|Overall Study|Physician Decision|1
6027975|NCT00734474|20836051|P3|Overall Study|Physician Decision|4
6027976|NCT00734474|20836052|P2|Overall Study|Physician Decision|0
6027977|NCT00734474|20836053|P1|Overall Study|Physician Decision|0
6027978|NCT00734474|20836045|P9|Overall Study|Withdrawal by Subject|21
6027979|NCT00734474|20836046|P8|Overall Study|Withdrawal by Subject|36
6027980|NCT00734474|20836047|P7|Overall Study|Withdrawal by Subject|0
6027981|NCT00734474|20836048|P6|Overall Study|Withdrawal by Subject|2
6027982|NCT00734474|20836049|P5|Overall Study|Withdrawal by Subject|24
6027983|NCT00734474|20836050|P4|Overall Study|Withdrawal by Subject|0
6027984|NCT00734474|20836051|P3|Overall Study|Withdrawal by Subject|18
6027985|NCT00734474|20836052|P2|Overall Study|Withdrawal by Subject|1
6027986|NCT00734474|20836053|P1|Overall Study|Withdrawal by Subject|2
6027987|NCT00734474|20836045|P9|Overall Study|Lost to Follow-up|4
6027988|NCT00734474|20836046|P8|Overall Study|Lost to Follow-up|9
6027989|NCT00734474|20836047|P7|Overall Study|Lost to Follow-up|0
6027990|NCT00734474|20836048|P6|Overall Study|Lost to Follow-up|1
6027991|NCT00734474|20836049|P5|Overall Study|Lost to Follow-up|11
6027992|NCT00734474|20836050|P4|Overall Study|Lost to Follow-up|0
6027993|NCT00734474|20836051|P3|Overall Study|Lost to Follow-up|13
6027994|NCT00734474|20836052|P2|Overall Study|Lost to Follow-up|0
6027995|NCT00734474|20836053|P1|Overall Study|Lost to Follow-up|1
6027996|NCT00734474|20836045|P9|Overall Study|Entry Criteria Not Met|1
6027997|NCT00734474|20836046|P8|Overall Study|Entry Criteria Not Met|1
6027998|NCT00734474|20836047|P7|Overall Study|Entry Criteria Not Met|0
6027999|NCT00734474|20836048|P6|Overall Study|Entry Criteria Not Met|1
6028000|NCT00734474|20836049|P5|Overall Study|Entry Criteria Not Met|3
6028001|NCT00734474|20836050|P4|Overall Study|Entry Criteria Not Met|0
6028002|NCT00734474|20836051|P3|Overall Study|Entry Criteria Not Met|5
6028003|NCT00734474|20836052|P2|Overall Study|Entry Criteria Not Met|0
6028004|NCT00734474|20836053|P1|Overall Study|Entry Criteria Not Met|0
6028005|NCT00734214|20836343|P2|Overall Study|MD withdrawal|0
6028006|NCT00734214|20836344|P1|Overall Study|MD withdrawal|1
6028007|NCT00734214|20836343|P2|Overall Study|Withdrawal by Subject|4
6028008|NCT00734214|20836344|P1|Overall Study|Withdrawal by Subject|3
6028009|NCT00734162|20836354|P4|Open-Label Phase|Did Not Meet Entrance Criteria|1
6028010|NCT00734162|20836355|P3|Open-Label Phase|Did Not Meet Entrance Criteria|0
6028011|NCT00734162|20836356|P2|Open-Label Phase|Did Not Meet Entrance Criteria|0
6028012|NCT00734162|20836357|P1|Open-Label Phase|Did Not Meet Entrance Criteria|0
6028013|NCT00734162|20836354|P4|Open-Label Phase|Lost to Follow-up|1
6028014|NCT00734162|20836355|P3|Open-Label Phase|Lost to Follow-up|0
6028015|NCT00734162|20836356|P2|Open-Label Phase|Lost to Follow-up|2
6028016|NCT00734162|20836357|P1|Open-Label Phase|Lost to Follow-up|1
6028017|NCT00734162|20836354|P4|Open-Label Phase|Withdrew Consent|1
6028018|NCT00734162|20836355|P3|Open-Label Phase|Withdrew Consent|1
6028019|NCT00734162|20836356|P2|Open-Label Phase|Withdrew Consent|0
6028020|NCT00734162|20836357|P1|Open-Label Phase|Withdrew Consent|1
6028021|NCT00734162|20836354|P4|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0
6028022|NCT00734162|20836355|P3|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0
6028023|NCT00734162|20836356|P2|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0
6028024|NCT00734162|20836357|P1|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|1
6028025|NCT00734162|20836354|P4|Randomized Phase (Through Week 72)|Per protocol ALT elevation|2
6028026|NCT00734162|20836355|P3|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0
6028027|NCT00734162|20836356|P2|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0
6028028|NCT00734162|20836357|P1|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0
6028029|NCT00734162|20836354|P4|Randomized Phase (Through Week 72)|Investigator's Discretion|2
6028030|NCT00734162|20836355|P3|Randomized Phase (Through Week 72)|Investigator's Discretion|0
6028031|NCT00734162|20836356|P2|Randomized Phase (Through Week 72)|Investigator's Discretion|1
6028032|NCT00734162|20836357|P1|Randomized Phase (Through Week 72)|Investigator's Discretion|0
6028033|NCT00734149|20836581|P1|Overall Study|Withdrawal by Subject|1
6028034|NCT00734097|20836588|P1|Open Label|Protocol Violation|4
6028035|NCT00734097|20836588|P1|Open Label|Withdrawal by Subject|5
6028036|NCT00734097|20836588|P1|Open Label|Lost to Follow-up|7
6028037|NCT00734097|20836588|P1|Screening|Unconfirmed pregnancy|1
6028038|NCT00734097|20836588|P1|Screening|Lost to Follow-up|2
6028039|NCT00734097|20836588|P1|Screening|Withdrawal by Subject|5
6028040|NCT00734097|20836588|P1|Screening|Protocol Violation|12
6028041|NCT00734071|20836605|P2|Overall Study|Other|2
6028042|NCT00734071|20836606|P1|Overall Study|Other|1
6028043|NCT00734071|20836605|P2|Overall Study|Lost to Follow-up|8
6028044|NCT00734071|20836606|P1|Overall Study|Lost to Follow-up|16
6028045|NCT00734071|20836605|P2|Overall Study|Voluntary Withdrawal|7
6028046|NCT00734071|20836606|P1|Overall Study|Voluntary Withdrawal|9
6028047|NCT00734071|20836605|P2|Overall Study|Protocol Deviations|4
6028048|NCT00734071|20836606|P1|Overall Study|Protocol Deviations|3
6028049|NCT00734071|20836605|P2|Overall Study|Noncompliance|2
6028050|NCT00734071|20836606|P1|Overall Study|Noncompliance|2
6028051|NCT00734071|20836605|P2|Overall Study|Lack of Efficacy|1
6028052|NCT00734071|20836606|P1|Overall Study|Lack of Efficacy|3
6028053|NCT00734071|20836605|P2|Overall Study|Adverse Event|3
6028054|NCT00734071|20836606|P1|Overall Study|Adverse Event|4
6028055|NCT00734032|20836664|P4|Overall Study|Adverse Event|0
6028056|NCT00734032|20836665|P3|Overall Study|Adverse Event|0
6028057|NCT00734032|20836666|P2|Overall Study|Adverse Event|1
6028058|NCT00734032|20836667|P1|Overall Study|Adverse Event|0
6028059|NCT00733980|20836723|P2|Overall Study|Withdrawal by Subject|2
6028060|NCT00733980|20836724|P1|Overall Study|Withdrawal by Subject|6
6028061|NCT00733980|20836723|P2|Overall Study|Physician Decision|3
6028062|NCT00733980|20836724|P1|Overall Study|Physician Decision|2
6028063|NCT00733980|20836723|P2|Overall Study|Lost to Follow-up|11
6028064|NCT00733980|20836724|P1|Overall Study|Lost to Follow-up|6
6028065|NCT00733980|20836723|P2|Overall Study|Protocol defined stopping criteria reach|1
6028066|NCT00733980|20836724|P1|Overall Study|Protocol defined stopping criteria reach|1
6028067|NCT00733980|20836723|P2|Overall Study|Protocol Violation|1
6028068|NCT00733980|20836724|P1|Overall Study|Protocol Violation|2
6028069|NCT00733980|20836723|P2|Overall Study|Lack of Efficacy|1
6028070|NCT00733980|20836724|P1|Overall Study|Lack of Efficacy|0
6028071|NCT00733980|20836723|P2|Overall Study|Adverse Event|2
6028072|NCT00733980|20836724|P1|Overall Study|Adverse Event|5
6028073|NCT00733954|20836768|P2|Overall Study|Withdrawal by Subject|0
6028074|NCT00733954|20836769|P1|Overall Study|Withdrawal by Subject|2
6028075|NCT00733954|20836768|P2|Overall Study|Protocol Violation|0
6028076|NCT00733954|20836769|P1|Overall Study|Protocol Violation|1
6028077|NCT00733954|20836768|P2|Overall Study|Lost to Follow-up|2
6028078|NCT00733954|20836769|P1|Overall Study|Lost to Follow-up|5
6028079|NCT00733824|20836816|P5|Phase I|Withdrawal by Subject|0
6028080|NCT00733824|20836817|P4|Phase I|Withdrawal by Subject|0
6028081|NCT00733824|20836818|P3|Phase I|Withdrawal by Subject|0
6028082|NCT00733824|20836819|P2|Phase I|Withdrawal by Subject|0
6028083|NCT00733824|20836820|P1|Phase I|Withdrawal by Subject|1
6028084|NCT00733746|20836839|P1|Overall Study|Ineligible|5
6028085|NCT00733499|20836854|P2|10 Year Followup|missing, unable to locate|2
6028086|NCT00733499|20836855|P1|10 Year Followup|missing, unable to locate|0
6028087|NCT00733499|20836854|P2|10 Year Followup|Withdrawal by Subject|5
6028088|NCT00733499|20836855|P1|10 Year Followup|Withdrawal by Subject|5
6028089|NCT00733499|20836854|P2|10 Year Followup|Lost to Follow-up|2
6028090|NCT00733499|20836855|P1|10 Year Followup|Lost to Follow-up|3
6028091|NCT00733499|20836854|P2|10 Year Followup|Adverse Event|3
6028092|NCT00733499|20836855|P1|10 Year Followup|Adverse Event|3
6028093|NCT00733499|20836854|P2|10 Year Followup|Death|7
6028094|NCT00733499|20836855|P1|10 Year Followup|Death|9
6028095|NCT00733499|20836854|P2|5 Year Followup|Withdrawal by Subject|1
6028096|NCT00733499|20836855|P1|5 Year Followup|Withdrawal by Subject|4
6028097|NCT00733499|20836854|P2|5 Year Followup|missing, unable to locate|1
6028098|NCT00733499|20836855|P1|5 Year Followup|missing, unable to locate|0
6028099|NCT00733499|20836854|P2|5 Year Followup|Death|19
6028100|NCT00733499|20836855|P1|5 Year Followup|Death|13
6028101|NCT00733499|20836854|P2|5 Year Followup|Lost to Follow-up|0
6028102|NCT00733499|20836855|P1|5 Year Followup|Lost to Follow-up|2
6028103|NCT00733499|20836854|P2|5 Year Followup|Revision of Study Implant|1
6028104|NCT00733499|20836855|P1|5 Year Followup|Revision of Study Implant|0
6028105|NCT00733499|20836854|P2|5 Year Followup|Non device related AE|1
6028106|NCT00733499|20836855|P1|5 Year Followup|Non device related AE|0
6028107|NCT00733499|20836854|P2|5 Year Followup|Adverse Event|2
6028108|NCT00733499|20836855|P1|5 Year Followup|Adverse Event|2
6028109|NCT00733499|20836854|P2|24 Months Follow-up|Death|1
6028110|NCT00733499|20836855|P1|24 Months Follow-up|Death|0
6028111|NCT00733499|20836854|P2|12 Months Follow-up|Death|1
6028112|NCT00733499|20836855|P1|12 Months Follow-up|Death|2
6028113|NCT00733499|20836854|P2|6 Months Follow-up|Adverse Event|1
6028114|NCT00733499|20836855|P1|6 Months Follow-up|Adverse Event|0
6028115|NCT00733499|20836854|P2|6 Months Follow-up|Death|2
6028116|NCT00733499|20836855|P1|6 Months Follow-up|Death|0
6028117|NCT00733499|20836854|P2|3 Months Follow-up|Death|2
6028118|NCT00733499|20836855|P1|3 Months Follow-up|Death|1
6028119|NCT00733499|20836854|P2|Pre-operative|Protocol Violation|1
6028120|NCT00733499|20836855|P1|Pre-operative|Protocol Violation|0
6028121|NCT00733421|20836915|P2|Overall Study|Withdrawal by Subject|1
6028122|NCT00733421|20836916|P1|Overall Study|Withdrawal by Subject|1
6028123|NCT00733408|20836938|P1|Overall Study|Adverse Event|4
6028124|NCT00733369|20836950|P2|Overall Study|Protocol Violation|4
6028125|NCT00733369|20836951|P1|Overall Study|Protocol Violation|4
6028126|NCT00733369|20836950|P2|Overall Study|Adverse Event|4
6028127|NCT00733369|20836951|P1|Overall Study|Adverse Event|4
6028128|NCT00733369|20836950|P2|Overall Study|Lost to Follow-up|1
6028129|NCT00733369|20836951|P1|Overall Study|Lost to Follow-up|2
6028130|NCT00733304|20837250|P3|Overall Study|Withdrawal by Subject|0
6028131|NCT00733304|20837251|P2|Overall Study|Withdrawal by Subject|1
6028132|NCT00733304|20837252|P1|Overall Study|Withdrawal by Subject|1
6028133|NCT00733304|20837250|P3|Overall Study|Physician Decision|3
6028134|NCT00733304|20837251|P2|Overall Study|Physician Decision|1
6028135|NCT00733304|20837252|P1|Overall Study|Physician Decision|3
6028136|NCT00733304|20837250|P3|Overall Study|Lost to Follow-up|0
6028137|NCT00733304|20837251|P2|Overall Study|Lost to Follow-up|1
6028138|NCT00733304|20837252|P1|Overall Study|Lost to Follow-up|0
6028139|NCT00733304|20837250|P3|Overall Study|Lack of Efficacy|2
6028140|NCT00733304|20837251|P2|Overall Study|Lack of Efficacy|0
6028141|NCT00733304|20837252|P1|Overall Study|Lack of Efficacy|0
6028142|NCT00733304|20837250|P3|Overall Study|Adverse Event|0
6028143|NCT00733304|20837251|P2|Overall Study|Adverse Event|0
6028144|NCT00733304|20837252|P1|Overall Study|Adverse Event|3
6028145|NCT00733291|20837334|P4|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0
6028146|NCT00733291|20837335|P3|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0
6028147|NCT00733291|20837336|P2|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0
6028148|NCT00733291|20837337|P1|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|1
6028149|NCT00733226|20837366|P2|Overall Study|moved to another place|0
6028150|NCT00733226|20837367|P1|Overall Study|moved to another place|2
6028151|NCT00733226|20837366|P2|Overall Study|Lost to Follow-up|0
6028152|NCT00733226|20837367|P1|Overall Study|Lost to Follow-up|2
6028153|NCT00733226|20837366|P2|Overall Study|Withdrawal by Subject|0
6028154|NCT00733226|20837367|P1|Overall Study|Withdrawal by Subject|1
6028155|NCT00733005|20837416|P2|Overall Study|Protocol Violation|0
6028156|NCT00733005|20837417|P1|Overall Study|Protocol Violation|2
6028157|NCT00733005|20837416|P2|Overall Study|Withdrawal by Subject|1
6028158|NCT00733005|20837417|P1|Overall Study|Withdrawal by Subject|0
6028159|NCT00733005|20837416|P2|Overall Study|Treatment Failure|1
6028160|NCT00733005|20837417|P1|Overall Study|Treatment Failure|0
6028161|NCT00733005|20837416|P2|Overall Study|Adverse Event|1
6028162|NCT00733005|20837417|P1|Overall Study|Adverse Event|0
6028163|NCT00732992|20837427|P2|Overall Study|Withdrawal by Subject|0
6028164|NCT00732992|20837428|P1|Overall Study|Withdrawal by Subject|1
6028165|NCT00732992|20837427|P2|Overall Study|Global Deterioration of Health Status|0
6028166|NCT00732992|20837428|P1|Overall Study|Global Deterioration of Health Status|1
6028167|NCT00732992|20837427|P2|Overall Study|Objective Progression or Relapse|5
6028168|NCT00732992|20837428|P1|Overall Study|Objective Progression or Relapse|3
6028169|NCT00732992|20837427|P2|Overall Study|Adverse Event|1
6028170|NCT00732992|20837428|P1|Overall Study|Adverse Event|1
6028171|NCT00732940|20837447|P2|Overall Study|Lost to Follow-up|0
6028172|NCT00732940|20837448|P1|Overall Study|Lost to Follow-up|1
6028173|NCT00732940|20837447|P2|Overall Study|Adverse Event|1
6028174|NCT00732940|20837448|P1|Overall Study|Adverse Event|0
6028175|NCT00732940|20837447|P2|Overall Study|Withdrawal by Subject|2
6028176|NCT00732940|20837448|P1|Overall Study|Withdrawal by Subject|1
6028177|NCT00732875|20837529|P1|Overall Study|Lack of Efficacy|13
6028178|NCT00732875|20837529|P1|Overall Study|Withdrawal by Subject|6
6028179|NCT00732875|20837529|P1|Overall Study|Adverse Event|16
6028180|NCT00732758|20837537|P2|Overall Study|Lost to Follow-up|16
6028181|NCT00732758|20837538|P1|Overall Study|Lost to Follow-up|8
6028182|NCT00732641|20837578|P2|Overall Study|Other|5
6028183|NCT00732641|20837579|P1|Overall Study|Other|18
6028184|NCT00732641|20837578|P2|Overall Study|Unable to Complete|1
6028185|NCT00732641|20837579|P1|Overall Study|Unable to Complete|1
6028186|NCT00732641|20837578|P2|Overall Study|Withdrawal by Subject|2
6028187|NCT00732641|20837579|P1|Overall Study|Withdrawal by Subject|4
6028188|NCT00732641|20837578|P2|Overall Study|Physician Decision|0
6028189|NCT00732641|20837579|P1|Overall Study|Physician Decision|6
6028190|NCT00732641|20837578|P2|Overall Study|Serious Adverse Events|3
6028191|NCT00732641|20837579|P1|Overall Study|Serious Adverse Events|12
6028192|NCT00732641|20837578|P2|Overall Study|Relapse or Progressive Disease|101
6028193|NCT00732641|20837579|P1|Overall Study|Relapse or Progressive Disease|65
6028194|NCT00732615|20837599|P2|Overall Study|Non-Compliance, Subject/Physician Dec.|1
6028195|NCT00732615|20837600|P1|Overall Study|Non-Compliance, Subject/Physician Dec.|1
6028196|NCT00732615|20837599|P2|Overall Study|Physician Decision|0
6028197|NCT00732615|20837600|P1|Overall Study|Physician Decision|3
6028198|NCT00732615|20837599|P2|Overall Study|Adverse Event|2
6028199|NCT00732615|20837600|P1|Overall Study|Adverse Event|0
6028200|NCT00732615|20837599|P2|Overall Study|Lost to Follow-up|1
6028201|NCT00732615|20837600|P1|Overall Study|Lost to Follow-up|0
6028202|NCT00732615|20837599|P2|Overall Study|Withdrawal by Subject|1
6028203|NCT00732615|20837600|P1|Overall Study|Withdrawal by Subject|3
6028204|NCT00732498|20837612|P1|Overall Study|Physician Decision|3
6028205|NCT00732498|20837612|P1|Overall Study|Adverse Event|2
6028206|NCT00732498|20837612|P1|Overall Study|Ineligible|1
6028207|NCT00732472|20837623|P4|Overall Study|Withdrawal by Subject|1
6028208|NCT00732472|20837624|P3|Overall Study|Withdrawal by Subject|0
6028209|NCT00732472|20837625|P2|Overall Study|Withdrawal by Subject|2
6028210|NCT00732472|20837626|P1|Overall Study|Withdrawal by Subject|0
6028211|NCT00732472|20837623|P4|Overall Study|Protocol Violation|1
6028212|NCT00732472|20837624|P3|Overall Study|Protocol Violation|0
6028213|NCT00732472|20837625|P2|Overall Study|Protocol Violation|0
6028214|NCT00732472|20837626|P1|Overall Study|Protocol Violation|0
6028215|NCT00732472|20837623|P4|Overall Study|Adverse Event|1
6028216|NCT00732472|20837624|P3|Overall Study|Adverse Event|1
6028217|NCT00732472|20837625|P2|Overall Study|Adverse Event|1
6028218|NCT00732472|20837626|P1|Overall Study|Adverse Event|0
6028219|NCT00732381|20837726|P2|Overall Study|Treatment Failure|1
6028220|NCT00732381|20837727|P1|Overall Study|Treatment Failure|1
6028221|NCT00732381|20837726|P2|Overall Study|Adverse Event|0
6028222|NCT00732381|20837727|P1|Overall Study|Adverse Event|1
6028223|NCT00732303|20837735|P1|Overall Study|Study Terminated|2
6028224|NCT00732251|20837741|P1|Overall Study|Early Term due to Site Closure|1
6028225|NCT00732251|20837741|P1|Overall Study|Withdrawal by Subject|3
6028226|NCT00732251|20837741|P1|Overall Study|Lost to Follow-up|3
6028227|NCT00732238|20837749|P2|Overall Study|Asymptomatic bacteriuria|0
6028228|NCT00732238|20837750|P1|Overall Study|Asymptomatic bacteriuria|1
6028229|NCT00732238|20837749|P2|Overall Study|Bacteremia|1
6028230|NCT00732238|20837750|P1|Overall Study|Bacteremia|4
6028231|NCT00732199|20837851|P2|Overall Study|sleep apnea, inadequate signals/sleep|8
6028232|NCT00732199|20837852|P1|Overall Study|sleep apnea, inadequate signals/sleep|9
6028233|NCT00732199|20837851|P2|Overall Study|Withdrawal by Subject|18
6028234|NCT00732199|20837852|P1|Overall Study|Withdrawal by Subject|25
6028235|NCT00732160|20837867|P4|Overall Study|scheduling|1
6028236|NCT00732160|20837868|P3|Overall Study|scheduling|2
6028237|NCT00732160|20837869|P2|Overall Study|scheduling|4
6028238|NCT00732160|20837870|P1|Overall Study|scheduling|4
6028239|NCT00732160|20837867|P4|Overall Study|Adverse Event|1
6028240|NCT00732160|20837868|P3|Overall Study|Adverse Event|1
6028241|NCT00732160|20837869|P2|Overall Study|Adverse Event|0
6028242|NCT00732160|20837870|P1|Overall Study|Adverse Event|1
6028243|NCT00732069|20837884|P6|Washout After First Study Drug|Adverse Event|0
6028244|NCT00732069|20837885|P5|Washout After First Study Drug|Adverse Event|0
6028245|NCT00732069|20837886|P4|Washout After First Study Drug|Adverse Event|0
6028246|NCT00732069|20837887|P3|Washout After First Study Drug|Adverse Event|0
6028247|NCT00732069|20837888|P2|Washout After First Study Drug|Adverse Event|0
6028248|NCT00732069|20837889|P1|Washout After First Study Drug|Adverse Event|1
6028249|NCT00731939|20837907|P1|Overall Study|Did not meet enrollment criteria|2
6028250|NCT00731939|20837907|P1|Overall Study|Withdrawal by Subject|2
6028251|NCT00731939|20837907|P1|Overall Study|Not implanted with study device|9
6028252|NCT00731939|20837907|P1|Overall Study|Lost to Follow-up|15
6028253|NCT00731939|20837907|P1|Overall Study|Adverse Event|6
6028254|NCT00731822|20837984|P2|Overall Study|Lost to Follow-up|0
6028255|NCT00731822|20837985|P1|Overall Study|Lost to Follow-up|1
6028256|NCT00731822|20837984|P2|Overall Study|Protocol Violation|0
6028257|NCT00731822|20837985|P1|Overall Study|Protocol Violation|1
6028258|NCT00731822|20837984|P2|Overall Study|Adverse Event|1
6028259|NCT00731822|20837985|P1|Overall Study|Adverse Event|2
6028260|NCT00731783|20837999|P2|12 Month Follow-Up Visit|Lost to Follow-up|7
6028261|NCT00731783|20838000|P1|12 Month Follow-Up Visit|Lost to Follow-up|6
6028262|NCT00731783|20837999|P2|Six Month Follow-Up Visit|Lost to Follow-up|3
6028263|NCT00731783|20838000|P1|Six Month Follow-Up Visit|Lost to Follow-up|6
6028264|NCT00731783|20837999|P2|Three Month Follow-Up Visit|Lost to Follow-up|16
6028265|NCT00731783|20838000|P1|Three Month Follow-Up Visit|Lost to Follow-up|7
6028266|NCT00731783|20837999|P2|One Month Follow-Up Visit|Lost to Follow-up|22
6028267|NCT00731783|20838000|P1|One Month Follow-Up Visit|Lost to Follow-up|14
6028268|NCT00731731|20838034|P3|Overall Study|Cancel prior to treatment|2
6028269|NCT00731731|20838035|P2|Overall Study|Cancel prior to treatment|0
6028270|NCT00731731|20838036|P1|Overall Study|Cancel prior to treatment|0
6028271|NCT00731731|20838034|P3|Overall Study|Protocol Violation|1
6028272|NCT00731731|20838035|P2|Overall Study|Protocol Violation|0
6028273|NCT00731731|20838036|P1|Overall Study|Protocol Violation|0
6028274|NCT00731692|20838054|P3|Extension Phase|Adverse Event|15
6028275|NCT00731692|20838055|P2|Extension Phase|Adverse Event|1
6028276|NCT00731692|20838056|P1|Extension Phase|Adverse Event|1
6028277|NCT00731692|20838054|P3|Extension Phase|Withdrawal by Subject|3
6028278|NCT00731692|20838055|P2|Extension Phase|Withdrawal by Subject|5
6028279|NCT00731692|20838056|P1|Extension Phase|Withdrawal by Subject|4
6028280|NCT00731692|20838054|P3|Extension Phase|Lost to Follow-up|4
6028281|NCT00731692|20838055|P2|Extension Phase|Lost to Follow-up|1
6028282|NCT00731692|20838056|P1|Extension Phase|Lost to Follow-up|0
6028283|NCT00731692|20838054|P3|Extension Phase|Abnormal lab values|1
6028284|NCT00731692|20838055|P2|Extension Phase|Abnormal lab values|0
6028285|NCT00731692|20838056|P1|Extension Phase|Abnormal lab values|0
6028286|NCT00731692|20838054|P3|Extension Phase|Abnormal test procedure|1
6028287|NCT00731692|20838055|P2|Extension Phase|Abnormal test procedure|0
6028288|NCT00731692|20838056|P1|Extension Phase|Abnormal test procedure|0
6028289|NCT00731692|20838054|P3|Extension Phase|Admin Problems: Terminated # patients|277
6028290|NCT00731692|20838055|P2|Extension Phase|Admin Problems: Terminated # patients|189
6028291|NCT00731692|20838056|P1|Extension Phase|Admin Problems: Terminated # patients|69
6028292|NCT00731692|20838054|P3|Core Study (36 Months)|Withdrawal by Subject|46
6028293|NCT00731692|20838055|P2|Core Study (36 Months)|Withdrawal by Subject|32
6028294|NCT00731692|20838056|P1|Core Study (36 Months)|Withdrawal by Subject|12
6028295|NCT00731692|20838054|P3|Core Study (36 Months)|Adverse Event|29
6028296|NCT00731692|20838055|P2|Core Study (36 Months)|Adverse Event|28
6028297|NCT00731692|20838056|P1|Core Study (36 Months)|Adverse Event|25
6028298|NCT00731692|20838054|P3|Core Study (36 Months)|Abnormal Lab values|5
6028299|NCT00731692|20838055|P2|Core Study (36 Months)|Abnormal Lab values|19
6028300|NCT00731692|20838056|P1|Core Study (36 Months)|Abnormal Lab values|6
6028301|NCT00731692|20838054|P3|Core Study (36 Months)|Protocol Violation|8
6028302|NCT00731692|20838055|P2|Core Study (36 Months)|Protocol Violation|5
6028303|NCT00731692|20838056|P1|Core Study (36 Months)|Protocol Violation|4
6028304|NCT00731692|20838054|P3|Core Study (36 Months)|Abnormal Test Procedure Result|5
6028305|NCT00731692|20838055|P2|Core Study (36 Months)|Abnormal Test Procedure Result|3
6028306|NCT00731692|20838056|P1|Core Study (36 Months)|Abnormal Test Procedure Result|4
6028307|NCT00731692|20838054|P3|Core Study (36 Months)|Administrative|6
6028308|NCT00731692|20838055|P2|Core Study (36 Months)|Administrative|2
6028309|NCT00731692|20838056|P1|Core Study (36 Months)|Administrative|2
6028310|NCT00731692|20838054|P3|Core Study (36 Months)|Lost to Follow-up|3
6028311|NCT00731692|20838055|P2|Core Study (36 Months)|Lost to Follow-up|3
6028312|NCT00731692|20838056|P1|Core Study (36 Months)|Lost to Follow-up|1
6028313|NCT00731692|20838054|P3|Core Study (36 Months)|Death|2
6028314|NCT00731692|20838055|P2|Core Study (36 Months)|Death|1
6028315|NCT00731692|20838056|P1|Core Study (36 Months)|Death|2
6028316|NCT00731692|20838054|P3|Core Study (36 Months)|Physician Decision|2
6028317|NCT00731692|20838055|P2|Core Study (36 Months)|Physician Decision|0
6028318|NCT00731692|20838056|P1|Core Study (36 Months)|Physician Decision|1
6028319|NCT00731692|20838054|P3|Core Study (36 Months)|Lack of Efficacy|64
6028320|NCT00731692|20838055|P2|Core Study (36 Months)|Lack of Efficacy|23
6028321|NCT00731692|20838056|P1|Core Study (36 Months)|Lack of Efficacy|11
6028322|NCT00731679|20838102|P2|Overall Study|Pregnancy|1
6028323|NCT00731679|20838103|P1|Overall Study|Pregnancy|0
6028324|NCT00731679|20838102|P2|Overall Study|Noncompliance|1
6028325|NCT00731679|20838103|P1|Overall Study|Noncompliance|0
6028326|NCT00731679|20838102|P2|Overall Study|Lost to Follow-up|8
6028327|NCT00731679|20838103|P1|Overall Study|Lost to Follow-up|7
6028328|NCT00731679|20838102|P2|Overall Study|Withdrawal by Subject|8
6028329|NCT00731679|20838103|P1|Overall Study|Withdrawal by Subject|8
6028330|NCT00731679|20838102|P2|Overall Study|Adverse Event|8
6028331|NCT00731679|20838103|P1|Overall Study|Adverse Event|7
6028332|NCT00731666|20838111|P1|Overall Study|Withdrawal by Subject|2
6028333|NCT00731666|20838111|P1|Overall Study|Lost to Follow-up|8
6028334|NCT00731666|20838111|P1|Overall Study|Adverse Event|2
6028335|NCT00731549|20838147|P1|Overall Study|Lack of efficacy without AE|6
6028336|NCT00731549|20838147|P1|Overall Study|Lack of efficacy with AE|37
6028337|NCT00731549|20838147|P1|Overall Study|Adverse Event|31
6028338|NCT00731549|20838147|P1|Overall Study|Protocol deviation|1
6028339|NCT00731549|20838147|P1|Overall Study|Withdrawal by Subject|89
6028340|NCT00731549|20838147|P1|Overall Study|Physician Decision|16
6028341|NCT00731549|20838147|P1|Overall Study|Met withdrawal criteria|24
6028342|NCT00731549|20838147|P1|Overall Study|Lost to Follow-up|19
6028343|NCT00731133|20838187|P1|Overall Study|Withdrawal by Subject|10
6028344|NCT00731120|20838195|P3|Overall Study|Other|1
6028345|NCT00731120|20838196|P2|Overall Study|Other|0
6028346|NCT00731120|20838197|P1|Overall Study|Other|4
6028347|NCT00731120|20838195|P3|Overall Study|Lost to Follow-up|17
6028348|NCT00731120|20838196|P2|Overall Study|Lost to Follow-up|15
6028349|NCT00731120|20838197|P1|Overall Study|Lost to Follow-up|10
6028350|NCT00731120|20838195|P3|Overall Study|Withdrawal of Consent|4
6028351|NCT00731120|20838196|P2|Overall Study|Withdrawal of Consent|8
6028352|NCT00731120|20838197|P1|Overall Study|Withdrawal of Consent|13
6028353|NCT00731120|20838195|P3|Overall Study|Protocol Deviations|1
6028354|NCT00731120|20838196|P2|Overall Study|Protocol Deviations|6
6028355|NCT00731120|20838197|P1|Overall Study|Protocol Deviations|1
6028356|NCT00731120|20838195|P3|Overall Study|Noncompliance with Study Drug|1
6028357|NCT00731120|20838196|P2|Overall Study|Noncompliance with Study Drug|3
6028358|NCT00731120|20838197|P1|Overall Study|Noncompliance with Study Drug|3
6028359|NCT00731120|20838195|P3|Overall Study|Lack of Efficacy|4
6028360|NCT00731120|20838196|P2|Overall Study|Lack of Efficacy|5
6028361|NCT00731120|20838197|P1|Overall Study|Lack of Efficacy|4
6028362|NCT00731120|20838195|P3|Overall Study|Adverse Event|8
6028363|NCT00731120|20838196|P2|Overall Study|Adverse Event|6
6028364|NCT00731120|20838197|P1|Overall Study|Adverse Event|7
6028365|NCT00731042|20838314|P2|Second Intervention|Did not meet inclusion criteria|2
6028366|NCT00731042|20838315|P1|Second Intervention|Did not meet inclusion criteria|0
6028367|NCT00730925|20838326|P1|Overall Study|Other|1
6028368|NCT00730925|20838326|P1|Overall Study|Switch to combination therapy|8
6028369|NCT00730925|20838326|P1|Overall Study|Withdrawal by Subject|1
6028370|NCT00730925|20838326|P1|Overall Study|Protocol Violation|1
6028371|NCT00730925|20838326|P1|Overall Study|Other Averse Event|7
6028372|NCT00730925|20838326|P1|Overall Study|Dose reducing Event|2
6028373|NCT00730925|20838326|P1|Overall Study|Progressive Disease|21
6028374|NCT00730912|20838336|P3|Overall Study|Discontinued|1
6028375|NCT00730912|20838337|P2|Overall Study|Discontinued|0
6028376|NCT00730912|20838338|P1|Overall Study|Discontinued|0
6028377|NCT00730886|20838351|P2|Overall Study|Physician Decision|0
6028378|NCT00730886|20838352|P1|Overall Study|Physician Decision|1
6028379|NCT00730886|20838351|P2|Overall Study|Lost to Follow-up|0
6028380|NCT00730886|20838352|P1|Overall Study|Lost to Follow-up|1
6028381|NCT00730847|20838376|P1|Overall Study|Other|24
6028382|NCT00730847|20838376|P1|Overall Study|Unknown completion status|21
6028383|NCT00730847|20838376|P1|Overall Study|Lost to Follow-up|67
6028384|NCT00730847|20838376|P1|Overall Study|Withdrawal by Subject|16
6028385|NCT00730847|20838376|P1|Overall Study|Protocol Violation|2
6028386|NCT00730847|20838376|P1|Overall Study|Adverse Event|1
6028387|NCT00730756|20838385|P2|Overall Study|Withdrew Consent|1
6028388|NCT00730756|20838386|P1|Overall Study|Withdrew Consent|0
6028389|NCT00730756|20838385|P2|Overall Study|Lost to Follow-up|1
6028390|NCT00730756|20838386|P1|Overall Study|Lost to Follow-up|0
6028391|NCT00730756|20838385|P2|Overall Study|Protocol Deviation|2
6028392|NCT00730756|20838386|P1|Overall Study|Protocol Deviation|1
6028393|NCT00730756|20838385|P2|Overall Study|Lack of Efficacy|1
6028394|NCT00730756|20838386|P1|Overall Study|Lack of Efficacy|1
6028395|NCT00730756|20838385|P2|Overall Study|Adverse Event|0
6028396|NCT00730756|20838386|P1|Overall Study|Adverse Event|2
6028397|NCT00730691|20838420|P5|Overall Study|Other|2
6028398|NCT00730691|20838421|P4|Overall Study|Other|2
6028399|NCT00730691|20838422|P3|Overall Study|Other|1
6028400|NCT00730691|20838423|P2|Overall Study|Other|1
6028401|NCT00730691|20838424|P1|Overall Study|Other|1
6028402|NCT00730691|20838420|P5|Overall Study|Lost to Follow-up|13
6028403|NCT00730691|20838421|P4|Overall Study|Lost to Follow-up|15
6028404|NCT00730691|20838422|P3|Overall Study|Lost to Follow-up|13
6028405|NCT00730691|20838423|P2|Overall Study|Lost to Follow-up|8
6028406|NCT00730691|20838424|P1|Overall Study|Lost to Follow-up|11
6028407|NCT00730691|20838420|P5|Overall Study|Withdrawal of Consent|3
6028408|NCT00730691|20838421|P4|Overall Study|Withdrawal of Consent|6
6028409|NCT00730691|20838422|P3|Overall Study|Withdrawal of Consent|3
6028410|NCT00730691|20838423|P2|Overall Study|Withdrawal of Consent|9
6028411|NCT00730691|20838424|P1|Overall Study|Withdrawal of Consent|7
6028412|NCT00730691|20838420|P5|Overall Study|Protocol Deviations|5
6028413|NCT00730691|20838421|P4|Overall Study|Protocol Deviations|7
6028414|NCT00730691|20838422|P3|Overall Study|Protocol Deviations|3
6028415|NCT00730691|20838423|P2|Overall Study|Protocol Deviations|5
6028416|NCT00730691|20838424|P1|Overall Study|Protocol Deviations|3
6028417|NCT00730691|20838420|P5|Overall Study|Non-compliance with Study Drug|3
6028418|NCT00730691|20838421|P4|Overall Study|Non-compliance with Study Drug|3
6028419|NCT00730691|20838422|P3|Overall Study|Non-compliance with Study Drug|6
6028420|NCT00730691|20838423|P2|Overall Study|Non-compliance with Study Drug|1
6028421|NCT00730691|20838424|P1|Overall Study|Non-compliance with Study Drug|6
6028422|NCT00730691|20838420|P5|Overall Study|Lack of Efficacy|1
6028423|NCT00730691|20838421|P4|Overall Study|Lack of Efficacy|1
6028424|NCT00730691|20838422|P3|Overall Study|Lack of Efficacy|2
6028425|NCT00730691|20838423|P2|Overall Study|Lack of Efficacy|4
6028426|NCT00730691|20838424|P1|Overall Study|Lack of Efficacy|4
6028427|NCT00730691|20838420|P5|Overall Study|Adverse Event|23
6028428|NCT00730691|20838421|P4|Overall Study|Adverse Event|11
6028429|NCT00730691|20838422|P3|Overall Study|Adverse Event|11
6028430|NCT00730691|20838423|P2|Overall Study|Adverse Event|8
6028431|NCT00730691|20838424|P1|Overall Study|Adverse Event|4
6028432|NCT00730639|20838516|P5|Overall Study|Treatment on-going|4
6028433|NCT00730639|20838517|P4|Overall Study|Treatment on-going|4
6028434|NCT00730639|20838518|P3|Overall Study|Treatment on-going|5
6028435|NCT00730639|20838519|P2|Overall Study|Treatment on-going|5
6028436|NCT00730639|20838520|P1|Overall Study|Treatment on-going|2
6028437|NCT00730639|20838516|P5|Overall Study|Withdrawal by Subject|4
6028438|NCT00730639|20838517|P4|Overall Study|Withdrawal by Subject|3
6028439|NCT00730639|20838518|P3|Overall Study|Withdrawal by Subject|6
6028440|NCT00730639|20838519|P2|Overall Study|Withdrawal by Subject|0
6028441|NCT00730639|20838520|P1|Overall Study|Withdrawal by Subject|0
6028442|NCT00730639|20838516|P5|Overall Study|Protocol Violation|0
6028443|NCT00730639|20838517|P4|Overall Study|Protocol Violation|0
6028444|NCT00730639|20838518|P3|Overall Study|Protocol Violation|1
6028445|NCT00730639|20838519|P2|Overall Study|Protocol Violation|0
6028446|NCT00730639|20838520|P1|Overall Study|Protocol Violation|0
6028447|NCT00730639|20838516|P5|Overall Study|non-specified|3
6028448|NCT00730639|20838517|P4|Overall Study|non-specified|2
6028449|NCT00730639|20838518|P3|Overall Study|non-specified|4
6028450|NCT00730639|20838519|P2|Overall Study|non-specified|0
6028451|NCT00730639|20838520|P1|Overall Study|non-specified|0
6028452|NCT00730639|20838516|P5|Overall Study|Disease Progression|88
6028453|NCT00730639|20838517|P4|Overall Study|Disease Progression|32
6028454|NCT00730639|20838518|P3|Overall Study|Disease Progression|48
6028455|NCT00730639|20838519|P2|Overall Study|Disease Progression|13
6028456|NCT00730639|20838520|P1|Overall Study|Disease Progression|12
6028457|NCT00730639|20838516|P5|Overall Study|Death|2
6028458|NCT00730639|20838517|P4|Overall Study|Death|0
6028459|NCT00730639|20838518|P3|Overall Study|Death|0
6028460|NCT00730639|20838519|P2|Overall Study|Death|0
6028461|NCT00730639|20838520|P1|Overall Study|Death|0
6028462|NCT00730639|20838516|P5|Overall Study|Completed Maximum Cycles|6
6028463|NCT00730639|20838517|P4|Overall Study|Completed Maximum Cycles|3
6028464|NCT00730639|20838518|P3|Overall Study|Completed Maximum Cycles|11
6028465|NCT00730639|20838519|P2|Overall Study|Completed Maximum Cycles|0
6028466|NCT00730639|20838520|P1|Overall Study|Completed Maximum Cycles|0
6028467|NCT00730639|20838516|P5|Overall Study|Complete Response|1
6028468|NCT00730639|20838517|P4|Overall Study|Complete Response|2
6028469|NCT00730639|20838518|P3|Overall Study|Complete Response|2
6028470|NCT00730639|20838519|P2|Overall Study|Complete Response|0
6028471|NCT00730639|20838520|P1|Overall Study|Complete Response|0
6028472|NCT00730639|20838516|P5|Overall Study|Adverse Event|23
6028473|NCT00730639|20838517|P4|Overall Study|Adverse Event|8
6028474|NCT00730639|20838518|P3|Overall Study|Adverse Event|9
6028475|NCT00730639|20838519|P2|Overall Study|Adverse Event|0
6028476|NCT00730639|20838520|P1|Overall Study|Adverse Event|3
6028477|NCT00730405|20838608|P5|Overall Study-follow-up Phase|Atrial fibrillation history|0
6028478|NCT00730405|20838609|P4|Overall Study-follow-up Phase|Atrial fibrillation history|0
6028479|NCT00730405|20838610|P3|Overall Study-follow-up Phase|Atrial fibrillation history|0
6028480|NCT00730405|20838611|P2|Overall Study-follow-up Phase|Atrial fibrillation history|0
6028481|NCT00730405|20838612|P1|Overall Study-follow-up Phase|Atrial fibrillation history|1
6028482|NCT00730405|20838608|P5|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0
6028483|NCT00730405|20838609|P4|Overall Study-follow-up Phase|discontinued AE, investigator discretion|1
6028484|NCT00730405|20838610|P3|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0
6028485|NCT00730405|20838611|P2|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0
6028486|NCT00730405|20838612|P1|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0
6028487|NCT00730405|20838608|P5|Overall Study-follow-up Phase|Other Protocol violation|0
6028488|NCT00730405|20838609|P4|Overall Study-follow-up Phase|Other Protocol violation|0
6028489|NCT00730405|20838610|P3|Overall Study-follow-up Phase|Other Protocol violation|1
6028490|NCT00730405|20838611|P2|Overall Study-follow-up Phase|Other Protocol violation|0
6028491|NCT00730405|20838612|P1|Overall Study-follow-up Phase|Other Protocol violation|0
6028492|NCT00730405|20838608|P5|Overall Study-follow-up Phase|Mis-randomized|0
6028493|NCT00730405|20838609|P4|Overall Study-follow-up Phase|Mis-randomized|0
6028494|NCT00730405|20838610|P3|Overall Study-follow-up Phase|Mis-randomized|0
6028495|NCT00730405|20838611|P2|Overall Study-follow-up Phase|Mis-randomized|1
6028496|NCT00730405|20838612|P1|Overall Study-follow-up Phase|Mis-randomized|0
6028497|NCT00730405|20838608|P5|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0
6028498|NCT00730405|20838609|P4|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0
6028499|NCT00730405|20838610|P3|Overall Study-follow-up Phase|Human immunodeficiency virus positive|1
6028500|NCT00730405|20838611|P2|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0
6028501|NCT00730405|20838612|P1|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0
6028502|NCT00730405|20838608|P5|Overall Study-follow-up Phase|Use an exclusionary medication|1
6028503|NCT00730405|20838609|P4|Overall Study-follow-up Phase|Use an exclusionary medication|0
6028504|NCT00730405|20838610|P3|Overall Study-follow-up Phase|Use an exclusionary medication|0
6028505|NCT00730405|20838611|P2|Overall Study-follow-up Phase|Use an exclusionary medication|0
6028506|NCT00730405|20838612|P1|Overall Study-follow-up Phase|Use an exclusionary medication|0
6028507|NCT00730405|20838608|P5|Overall Study-follow-up Phase|Missing|0
6028508|NCT00730405|20838609|P4|Overall Study-follow-up Phase|Missing|0
6028509|NCT00730405|20838610|P3|Overall Study-follow-up Phase|Missing|2
6028510|NCT00730405|20838611|P2|Overall Study-follow-up Phase|Missing|0
6028511|NCT00730405|20838612|P1|Overall Study-follow-up Phase|Missing|0
6028512|NCT00730405|20838608|P5|Overall Study-follow-up Phase|Non-compliance|0
6028513|NCT00730405|20838609|P4|Overall Study-follow-up Phase|Non-compliance|0
6028514|NCT00730405|20838610|P3|Overall Study-follow-up Phase|Non-compliance|2
6028515|NCT00730405|20838611|P2|Overall Study-follow-up Phase|Non-compliance|0
6028516|NCT00730405|20838612|P1|Overall Study-follow-up Phase|Non-compliance|1
6028517|NCT00730405|20838608|P5|Overall Study-follow-up Phase|Use of restricted medication|0
6028518|NCT00730405|20838609|P4|Overall Study-follow-up Phase|Use of restricted medication|0
6028519|NCT00730405|20838610|P3|Overall Study-follow-up Phase|Use of restricted medication|0
6028520|NCT00730405|20838611|P2|Overall Study-follow-up Phase|Use of restricted medication|1
6028521|NCT00730405|20838612|P1|Overall Study-follow-up Phase|Use of restricted medication|0
6028522|NCT00730405|20838608|P5|Overall Study-follow-up Phase|Declined to continue with follow-up|0
6028523|NCT00730405|20838609|P4|Overall Study-follow-up Phase|Declined to continue with follow-up|0
6028524|NCT00730405|20838610|P3|Overall Study-follow-up Phase|Declined to continue with follow-up|0
6028525|NCT00730405|20838611|P2|Overall Study-follow-up Phase|Declined to continue with follow-up|1
6028526|NCT00730405|20838612|P1|Overall Study-follow-up Phase|Declined to continue with follow-up|1
6028527|NCT00730405|20838608|P5|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0
6028528|NCT00730405|20838609|P4|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0
6028529|NCT00730405|20838610|P3|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1
6028530|NCT00730405|20838611|P2|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1
6028531|NCT00730405|20838612|P1|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0
6028532|NCT00730405|20838608|P5|Overall Study-follow-up Phase|Refused follow-up due to AE|0
6028533|NCT00730405|20838609|P4|Overall Study-follow-up Phase|Refused follow-up due to AE|1
6028534|NCT00730405|20838610|P3|Overall Study-follow-up Phase|Refused follow-up due to AE|0
6028535|NCT00730405|20838611|P2|Overall Study-follow-up Phase|Refused follow-up due to AE|0
6028536|NCT00730405|20838612|P1|Overall Study-follow-up Phase|Refused follow-up due to AE|0
6028537|NCT00730405|20838608|P5|Overall Study-follow-up Phase|Prohibited concomitant medication|0
6028538|NCT00730405|20838609|P4|Overall Study-follow-up Phase|Prohibited concomitant medication|0
6028539|NCT00730405|20838610|P3|Overall Study-follow-up Phase|Prohibited concomitant medication|0
6028540|NCT00730405|20838611|P2|Overall Study-follow-up Phase|Prohibited concomitant medication|0
6028541|NCT00730405|20838612|P1|Overall Study-follow-up Phase|Prohibited concomitant medication|1
6028542|NCT00730405|20838608|P5|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|1
6028543|NCT00730405|20838609|P4|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0
6028544|NCT00730405|20838610|P3|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0
6028545|NCT00730405|20838611|P2|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0
6028546|NCT00730405|20838612|P1|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0
6028547|NCT00730405|20838608|P5|Overall Study-follow-up Phase|Participant meets exclusion criteria|0
6028548|NCT00730405|20838609|P4|Overall Study-follow-up Phase|Participant meets exclusion criteria|0
6028549|NCT00730405|20838610|P3|Overall Study-follow-up Phase|Participant meets exclusion criteria|1
6028550|NCT00730405|20838611|P2|Overall Study-follow-up Phase|Participant meets exclusion criteria|0
6028551|NCT00730405|20838612|P1|Overall Study-follow-up Phase|Participant meets exclusion criteria|0
6028552|NCT00730405|20838608|P5|Overall Study-follow-up Phase|Non-compliance with study treatment|0
6028553|NCT00730405|20838609|P4|Overall Study-follow-up Phase|Non-compliance with study treatment|0
6028703|NCT00730041|20838796|P2|Overall Study|Lost to Follow-up|2
6028554|NCT00730405|20838610|P3|Overall Study-follow-up Phase|Non-compliance with study treatment|1
6028555|NCT00730405|20838611|P2|Overall Study-follow-up Phase|Non-compliance with study treatment|0
6028556|NCT00730405|20838612|P1|Overall Study-follow-up Phase|Non-compliance with study treatment|0
6028557|NCT00730405|20838608|P5|Overall Study-follow-up Phase|Did not met eligibility|0
6028558|NCT00730405|20838609|P4|Overall Study-follow-up Phase|Did not met eligibility|0
6028559|NCT00730405|20838610|P3|Overall Study-follow-up Phase|Did not met eligibility|1
6028560|NCT00730405|20838611|P2|Overall Study-follow-up Phase|Did not met eligibility|0
6028561|NCT00730405|20838612|P1|Overall Study-follow-up Phase|Did not met eligibility|0
6028562|NCT00730405|20838608|P5|Overall Study-follow-up Phase|Change of location|0
6028563|NCT00730405|20838609|P4|Overall Study-follow-up Phase|Change of location|1
6028564|NCT00730405|20838610|P3|Overall Study-follow-up Phase|Change of location|0
6028565|NCT00730405|20838611|P2|Overall Study-follow-up Phase|Change of location|1
6028566|NCT00730405|20838612|P1|Overall Study-follow-up Phase|Change of location|1
6028567|NCT00730405|20838608|P5|Overall Study-follow-up Phase|Death|0
6028568|NCT00730405|20838609|P4|Overall Study-follow-up Phase|Death|1
6028569|NCT00730405|20838610|P3|Overall Study-follow-up Phase|Death|0
6028570|NCT00730405|20838611|P2|Overall Study-follow-up Phase|Death|1
6028571|NCT00730405|20838612|P1|Overall Study-follow-up Phase|Death|0
6028572|NCT00730405|20838608|P5|Overall Study-follow-up Phase|Withdrawal by Subject|10
6028573|NCT00730405|20838609|P4|Overall Study-follow-up Phase|Withdrawal by Subject|6
6028574|NCT00730405|20838610|P3|Overall Study-follow-up Phase|Withdrawal by Subject|3
6028575|NCT00730405|20838611|P2|Overall Study-follow-up Phase|Withdrawal by Subject|3
6028576|NCT00730405|20838612|P1|Overall Study-follow-up Phase|Withdrawal by Subject|7
6028577|NCT00730405|20838608|P5|Overall Study-follow-up Phase|Lost to Follow-up|6
6028578|NCT00730405|20838609|P4|Overall Study-follow-up Phase|Lost to Follow-up|4
6028579|NCT00730405|20838610|P3|Overall Study-follow-up Phase|Lost to Follow-up|8
6028580|NCT00730405|20838611|P2|Overall Study-follow-up Phase|Lost to Follow-up|6
6028581|NCT00730405|20838612|P1|Overall Study-follow-up Phase|Lost to Follow-up|7
6028582|NCT00730405|20838608|P5|Overall Study-follow-up Phase|Adverse Event|4
6028583|NCT00730405|20838609|P4|Overall Study-follow-up Phase|Adverse Event|3
6028584|NCT00730405|20838610|P3|Overall Study-follow-up Phase|Adverse Event|2
6028585|NCT00730405|20838611|P2|Overall Study-follow-up Phase|Adverse Event|6
6028586|NCT00730405|20838612|P1|Overall Study-follow-up Phase|Adverse Event|2
6028587|NCT00730405|20838608|P5|Overall Study-Treatment Phase|Atrial fibrillation history|0
6028588|NCT00730405|20838609|P4|Overall Study-Treatment Phase|Atrial fibrillation history|0
6028589|NCT00730405|20838610|P3|Overall Study-Treatment Phase|Atrial fibrillation history|0
6028590|NCT00730405|20838611|P2|Overall Study-Treatment Phase|Atrial fibrillation history|0
6028591|NCT00730405|20838612|P1|Overall Study-Treatment Phase|Atrial fibrillation history|1
6028592|NCT00730405|20838608|P5|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|1
6028593|NCT00730405|20838609|P4|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0
6028594|NCT00730405|20838610|P3|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0
6028595|NCT00730405|20838611|P2|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0
6028596|NCT00730405|20838612|P1|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0
6028597|NCT00730405|20838608|P5|Overall Study-Treatment Phase|Pregnancy|0
6028598|NCT00730405|20838609|P4|Overall Study-Treatment Phase|Pregnancy|0
6028599|NCT00730405|20838610|P3|Overall Study-Treatment Phase|Pregnancy|0
6028600|NCT00730405|20838611|P2|Overall Study-Treatment Phase|Pregnancy|1
6028601|NCT00730405|20838612|P1|Overall Study-Treatment Phase|Pregnancy|0
6028602|NCT00730405|20838608|P5|Overall Study-Treatment Phase|Change of location|0
6028603|NCT00730405|20838609|P4|Overall Study-Treatment Phase|Change of location|1
6028604|NCT00730405|20838610|P3|Overall Study-Treatment Phase|Change of location|0
6028605|NCT00730405|20838611|P2|Overall Study-Treatment Phase|Change of location|0
6028606|NCT00730405|20838612|P1|Overall Study-Treatment Phase|Change of location|0
6028607|NCT00730405|20838608|P5|Overall Study-Treatment Phase|Protocol violation due to eligibility|0
6028608|NCT00730405|20838609|P4|Overall Study-Treatment Phase|Protocol violation due to eligibility|0
6028609|NCT00730405|20838610|P3|Overall Study-Treatment Phase|Protocol violation due to eligibility|1
6028610|NCT00730405|20838611|P2|Overall Study-Treatment Phase|Protocol violation due to eligibility|0
6028611|NCT00730405|20838612|P1|Overall Study-Treatment Phase|Protocol violation due to eligibility|0
6028612|NCT00730405|20838608|P5|Overall Study-Treatment Phase|Due to in-vitro fertilization|0
6028613|NCT00730405|20838609|P4|Overall Study-Treatment Phase|Due to in-vitro fertilization|1
6028614|NCT00730405|20838610|P3|Overall Study-Treatment Phase|Due to in-vitro fertilization|0
6028615|NCT00730405|20838611|P2|Overall Study-Treatment Phase|Due to in-vitro fertilization|0
6028616|NCT00730405|20838612|P1|Overall Study-Treatment Phase|Due to in-vitro fertilization|0
6028617|NCT00730405|20838608|P5|Overall Study-Treatment Phase|Study drug interrupted|0
6028618|NCT00730405|20838609|P4|Overall Study-Treatment Phase|Study drug interrupted|0
6028619|NCT00730405|20838610|P3|Overall Study-Treatment Phase|Study drug interrupted|0
6028620|NCT00730405|20838611|P2|Overall Study-Treatment Phase|Study drug interrupted|1
6028621|NCT00730405|20838612|P1|Overall Study-Treatment Phase|Study drug interrupted|0
6028622|NCT00730405|20838608|P5|Overall Study-Treatment Phase|Misrandomized|0
6028623|NCT00730405|20838609|P4|Overall Study-Treatment Phase|Misrandomized|0
6028624|NCT00730405|20838610|P3|Overall Study-Treatment Phase|Misrandomized|0
6028625|NCT00730405|20838611|P2|Overall Study-Treatment Phase|Misrandomized|1
6028626|NCT00730405|20838612|P1|Overall Study-Treatment Phase|Misrandomized|0
6028704|NCT00730041|20838797|P1|Overall Study|Lost to Follow-up|0
6028627|NCT00730405|20838608|P5|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0
6028628|NCT00730405|20838609|P4|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0
6028629|NCT00730405|20838610|P3|Overall Study-Treatment Phase|Human immunodeficiency virus positive|1
6028630|NCT00730405|20838611|P2|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0
6028631|NCT00730405|20838612|P1|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0
6028632|NCT00730405|20838608|P5|Overall Study-Treatment Phase|Use of prohibited medication|2
6028633|NCT00730405|20838609|P4|Overall Study-Treatment Phase|Use of prohibited medication|0
6028634|NCT00730405|20838610|P3|Overall Study-Treatment Phase|Use of prohibited medication|0
6028635|NCT00730405|20838611|P2|Overall Study-Treatment Phase|Use of prohibited medication|1
6028636|NCT00730405|20838612|P1|Overall Study-Treatment Phase|Use of prohibited medication|0
6028637|NCT00730405|20838608|P5|Overall Study-Treatment Phase|Withdrew from study treatment|0
6028638|NCT00730405|20838609|P4|Overall Study-Treatment Phase|Withdrew from study treatment|0
6028639|NCT00730405|20838610|P3|Overall Study-Treatment Phase|Withdrew from study treatment|0
6028640|NCT00730405|20838611|P2|Overall Study-Treatment Phase|Withdrew from study treatment|1
6028641|NCT00730405|20838612|P1|Overall Study-Treatment Phase|Withdrew from study treatment|0
6028642|NCT00730405|20838608|P5|Overall Study-Treatment Phase|Prohibited concomitant medication|0
6028643|NCT00730405|20838609|P4|Overall Study-Treatment Phase|Prohibited concomitant medication|0
6028644|NCT00730405|20838610|P3|Overall Study-Treatment Phase|Prohibited concomitant medication|0
6028645|NCT00730405|20838611|P2|Overall Study-Treatment Phase|Prohibited concomitant medication|0
6028646|NCT00730405|20838612|P1|Overall Study-Treatment Phase|Prohibited concomitant medication|1
6028647|NCT00730405|20838608|P5|Overall Study-Treatment Phase|Participant meets exclusion|0
6028648|NCT00730405|20838609|P4|Overall Study-Treatment Phase|Participant meets exclusion|0
6028649|NCT00730405|20838610|P3|Overall Study-Treatment Phase|Participant meets exclusion|1
6028650|NCT00730405|20838611|P2|Overall Study-Treatment Phase|Participant meets exclusion|0
6028651|NCT00730405|20838612|P1|Overall Study-Treatment Phase|Participant meets exclusion|0
6028652|NCT00730405|20838608|P5|Overall Study-Treatment Phase|Did not met eligibility|0
6028653|NCT00730405|20838609|P4|Overall Study-Treatment Phase|Did not met eligibility|0
6028654|NCT00730405|20838610|P3|Overall Study-Treatment Phase|Did not met eligibility|1
6028655|NCT00730405|20838611|P2|Overall Study-Treatment Phase|Did not met eligibility|0
6028656|NCT00730405|20838612|P1|Overall Study-Treatment Phase|Did not met eligibility|0
6028657|NCT00730405|20838608|P5|Overall Study-Treatment Phase|Withdrawal by Subject|8
6028658|NCT00730405|20838609|P4|Overall Study-Treatment Phase|Withdrawal by Subject|5
6028659|NCT00730405|20838610|P3|Overall Study-Treatment Phase|Withdrawal by Subject|2
6028660|NCT00730405|20838611|P2|Overall Study-Treatment Phase|Withdrawal by Subject|1
6028661|NCT00730405|20838612|P1|Overall Study-Treatment Phase|Withdrawal by Subject|7
6028662|NCT00730405|20838608|P5|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1
6028663|NCT00730405|20838609|P4|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0
6028664|NCT00730405|20838610|P3|Overall Study-Treatment Phase|Non-compliance with Study Treatment|5
6028665|NCT00730405|20838611|P2|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0
6028666|NCT00730405|20838612|P1|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1
6028667|NCT00730405|20838608|P5|Overall Study-Treatment Phase|Lost to Follow-up|4
6028668|NCT00730405|20838609|P4|Overall Study-Treatment Phase|Lost to Follow-up|4
6028669|NCT00730405|20838610|P3|Overall Study-Treatment Phase|Lost to Follow-up|6
6028670|NCT00730405|20838611|P2|Overall Study-Treatment Phase|Lost to Follow-up|5
6028671|NCT00730405|20838612|P1|Overall Study-Treatment Phase|Lost to Follow-up|4
6028672|NCT00730405|20838608|P5|Overall Study-Treatment Phase|Adverse Event|4
6028673|NCT00730405|20838609|P4|Overall Study-Treatment Phase|Adverse Event|8
6028674|NCT00730405|20838610|P3|Overall Study-Treatment Phase|Adverse Event|4
6028675|NCT00730405|20838611|P2|Overall Study-Treatment Phase|Adverse Event|10
6028676|NCT00730405|20838612|P1|Overall Study-Treatment Phase|Adverse Event|5
6028677|NCT00730327|20838659|P2|Overall Study|Subject withdrew (reason not specified)|7
6028678|NCT00730327|20838660|P1|Overall Study|Subject withdrew (reason not specified)|2
6028679|NCT00730327|20838659|P2|Overall Study|Withdrawal by Subject|13
6028680|NCT00730327|20838660|P1|Overall Study|Withdrawal by Subject|3
6028681|NCT00730327|20838659|P2|Overall Study|Adverse Event|1
6028682|NCT00730327|20838660|P1|Overall Study|Adverse Event|8
6028683|NCT00730327|20838659|P2|Overall Study|Lost to Follow-up|16
6028684|NCT00730327|20838660|P1|Overall Study|Lost to Follow-up|14
6028685|NCT00730275|20838685|P4|Overall Study|Withdrawal by Subject|1
6028686|NCT00730275|20838686|P3|Overall Study|Withdrawal by Subject|0
6028687|NCT00730275|20838687|P2|Overall Study|Withdrawal by Subject|0
6028688|NCT00730275|20838688|P1|Overall Study|Withdrawal by Subject|0
6028689|NCT00730236|20838714|P1|Overall Study|Non-compliance|1
6028690|NCT00730236|20838714|P1|Overall Study|Withdrawal by Subject|1
6028691|NCT00730236|20838714|P1|Overall Study|Adverse Event|4
6028692|NCT00730171|20838729|P1|Overall Study|Other|61
6028693|NCT00730171|20838729|P1|Overall Study|Insufficient Therapeutic Response|141
6028694|NCT00730171|20838729|P1|Overall Study|Lost to Follow-up|121
6028695|NCT00730171|20838729|P1|Overall Study|Withdrawal by Subject|202
6028696|NCT00730171|20838729|P1|Overall Study|Protocol Violation|48
6028697|NCT00730171|20838729|P1|Overall Study|Adverse Event|193
6028698|NCT00730171|20838729|P1|Overall Study|Didn't Meet Inclusion/Exclusion Criteria|5
6028699|NCT00730158|20838739|P2|Overall Study|Withdrawal by Subject|1
6028700|NCT00730158|20838740|P1|Overall Study|Withdrawal by Subject|1
6028701|NCT00730132|20838778|P1|Overall Study|Death|1
6028702|NCT00730132|20838778|P1|Overall Study|Protocol Violation|154
6028705|NCT00730028|20838820|P5|Overall Study|Randomization Error|2
6028706|NCT00730028|20838821|P4|Overall Study|Randomization Error|0
6028707|NCT00730028|20838822|P3|Overall Study|Randomization Error|0
6028708|NCT00730028|20838823|P2|Overall Study|Randomization Error|0
6028709|NCT00730028|20838824|P1|Overall Study|Randomization Error|1
6028710|NCT00730028|20838820|P5|Overall Study|Treatment Failure|1
6028711|NCT00730028|20838821|P4|Overall Study|Treatment Failure|0
6028712|NCT00730028|20838822|P3|Overall Study|Treatment Failure|0
6028713|NCT00730028|20838823|P2|Overall Study|Treatment Failure|5
6028714|NCT00730028|20838824|P1|Overall Study|Treatment Failure|5
6028715|NCT00730028|20838820|P5|Overall Study|Physician Decision|2
6028716|NCT00730028|20838821|P4|Overall Study|Physician Decision|3
6028717|NCT00730028|20838822|P3|Overall Study|Physician Decision|2
6028718|NCT00730028|20838823|P2|Overall Study|Physician Decision|3
6028719|NCT00730028|20838824|P1|Overall Study|Physician Decision|3
6028720|NCT00730028|20838820|P5|Overall Study|Withdrawal by Subject|9
6028721|NCT00730028|20838821|P4|Overall Study|Withdrawal by Subject|5
6028722|NCT00730028|20838822|P3|Overall Study|Withdrawal by Subject|4
6028723|NCT00730028|20838823|P2|Overall Study|Withdrawal by Subject|5
6028724|NCT00730028|20838824|P1|Overall Study|Withdrawal by Subject|9
6028725|NCT00730028|20838820|P5|Overall Study|Protocol Violation|0
6028726|NCT00730028|20838821|P4|Overall Study|Protocol Violation|2
6028727|NCT00730028|20838822|P3|Overall Study|Protocol Violation|1
6028728|NCT00730028|20838823|P2|Overall Study|Protocol Violation|1
6028729|NCT00730028|20838824|P1|Overall Study|Protocol Violation|6
6028730|NCT00730028|20838820|P5|Overall Study|Lost to Follow-up|25
6028731|NCT00730028|20838821|P4|Overall Study|Lost to Follow-up|26
6028732|NCT00730028|20838822|P3|Overall Study|Lost to Follow-up|22
6028733|NCT00730028|20838823|P2|Overall Study|Lost to Follow-up|26
6028734|NCT00730028|20838824|P1|Overall Study|Lost to Follow-up|13
6028735|NCT00730028|20838820|P5|Overall Study|Adverse Event|43
6028736|NCT00730028|20838821|P4|Overall Study|Adverse Event|20
6028737|NCT00730028|20838822|P3|Overall Study|Adverse Event|16
6028738|NCT00730028|20838823|P2|Overall Study|Adverse Event|26
6028739|NCT00730028|20838824|P1|Overall Study|Adverse Event|23
6028740|NCT00730015|20838874|P3|Overall Study|Other Reason|1
6028741|NCT00730015|20838875|P2|Overall Study|Other Reason|0
6028742|NCT00730015|20838876|P1|Overall Study|Other Reason|1
6028743|NCT00730015|20838874|P3|Overall Study|Lack of Efficacy|8
6028744|NCT00730015|20838875|P2|Overall Study|Lack of Efficacy|2
6028745|NCT00730015|20838876|P1|Overall Study|Lack of Efficacy|1
6028746|NCT00730015|20838874|P3|Overall Study|Lost to Follow-up|3
6028747|NCT00730015|20838875|P2|Overall Study|Lost to Follow-up|10
6028748|NCT00730015|20838876|P1|Overall Study|Lost to Follow-up|4
6028749|NCT00730015|20838874|P3|Overall Study|Withdrawal by Subject|8
6028750|NCT00730015|20838875|P2|Overall Study|Withdrawal by Subject|12
6028751|NCT00730015|20838876|P1|Overall Study|Withdrawal by Subject|12
6028752|NCT00730015|20838874|P3|Overall Study|Protocol Violation|4
6028753|NCT00730015|20838875|P2|Overall Study|Protocol Violation|6
6028754|NCT00730015|20838876|P1|Overall Study|Protocol Violation|2
6028755|NCT00730015|20838874|P3|Overall Study|Adverse Event|8
6028756|NCT00730015|20838875|P2|Overall Study|Adverse Event|10
6028757|NCT00730015|20838876|P1|Overall Study|Adverse Event|11
6028758|NCT00729937|20838916|P6|Overall Study|Incarcerated|0
6028759|NCT00729937|20838917|P5|Overall Study|Incarcerated|0
6028760|NCT00729937|20838918|P4|Overall Study|Incarcerated|1
6028761|NCT00729937|20838919|P3|Overall Study|Incarcerated|1
6028762|NCT00729937|20838920|P2|Overall Study|Incarcerated|2
6028763|NCT00729937|20838921|P1|Overall Study|Incarcerated|0
6028764|NCT00729937|20838916|P6|Overall Study|Did not meet eligibility criteria|0
6028765|NCT00729937|20838917|P5|Overall Study|Did not meet eligibility criteria|0
6028766|NCT00729937|20838918|P4|Overall Study|Did not meet eligibility criteria|0
6028767|NCT00729937|20838919|P3|Overall Study|Did not meet eligibility criteria|0
6028768|NCT00729937|20838920|P2|Overall Study|Did not meet eligibility criteria|1
6028769|NCT00729937|20838921|P1|Overall Study|Did not meet eligibility criteria|2
6028770|NCT00729937|20838916|P6|Overall Study|Randomized but not treated|3
6028771|NCT00729937|20838917|P5|Overall Study|Randomized but not treated|1
6028772|NCT00729937|20838918|P4|Overall Study|Randomized but not treated|0
6028773|NCT00729937|20838919|P3|Overall Study|Randomized but not treated|1
6028774|NCT00729937|20838920|P2|Overall Study|Randomized but not treated|6
6028775|NCT00729937|20838921|P1|Overall Study|Randomized but not treated|12
6028776|NCT00729937|20838916|P6|Overall Study|Withdrawal by Subject|2
6028777|NCT00729937|20838917|P5|Overall Study|Withdrawal by Subject|4
6028778|NCT00729937|20838918|P4|Overall Study|Withdrawal by Subject|0
6028779|NCT00729937|20838919|P3|Overall Study|Withdrawal by Subject|6
6028780|NCT00729937|20838920|P2|Overall Study|Withdrawal by Subject|5
6028781|NCT00729937|20838921|P1|Overall Study|Withdrawal by Subject|3
6028782|NCT00729937|20838916|P6|Overall Study|Death|1
6028783|NCT00729937|20838917|P5|Overall Study|Death|0
6028784|NCT00729937|20838918|P4|Overall Study|Death|0
6028785|NCT00729937|20838919|P3|Overall Study|Death|1
6028786|NCT00729937|20838920|P2|Overall Study|Death|0
6028787|NCT00729937|20838921|P1|Overall Study|Death|1
6028788|NCT00729937|20838916|P6|Overall Study|Physician Decision|8
6028789|NCT00729937|20838917|P5|Overall Study|Physician Decision|5
6028790|NCT00729937|20838918|P4|Overall Study|Physician Decision|0
6028791|NCT00729937|20838919|P3|Overall Study|Physician Decision|2
6028792|NCT00729937|20838920|P2|Overall Study|Physician Decision|16
6028793|NCT00729937|20838921|P1|Overall Study|Physician Decision|7
6028794|NCT00729937|20838916|P6|Overall Study|Lost to Follow-up|23
6028795|NCT00729937|20838917|P5|Overall Study|Lost to Follow-up|18
6028796|NCT00729937|20838918|P4|Overall Study|Lost to Follow-up|33
6028797|NCT00729937|20838919|P3|Overall Study|Lost to Follow-up|18
6028798|NCT00729937|20838920|P2|Overall Study|Lost to Follow-up|58
6028799|NCT00729937|20838921|P1|Overall Study|Lost to Follow-up|49
6028800|NCT00729859|20839125|P3|Overall Study|Withdrawal by Subject|0
6028801|NCT00729859|20839126|P2|Overall Study|Withdrawal by Subject|1
6028802|NCT00729859|20839127|P1|Overall Study|Withdrawal by Subject|0
6028803|NCT00729859|20839125|P3|Overall Study|Adverse Event|0
6028804|NCT00729859|20839126|P2|Overall Study|Adverse Event|1
6028805|NCT00729859|20839127|P1|Overall Study|Adverse Event|0
6028806|NCT00729833|20839171|P4|Overall Study|Unspecified Reasons|1
6028807|NCT00729833|20839172|P3|Overall Study|Unspecified Reasons|5
6028808|NCT00729833|20839173|P2|Overall Study|Unspecified Reasons|5
6028809|NCT00729833|20839174|P1|Overall Study|Unspecified Reasons|11
6028810|NCT00729833|20839171|P4|Overall Study|Withdrawal by Subject|0
6028811|NCT00729833|20839172|P3|Overall Study|Withdrawal by Subject|3
6028812|NCT00729833|20839173|P2|Overall Study|Withdrawal by Subject|1
6028813|NCT00729833|20839174|P1|Overall Study|Withdrawal by Subject|3
6028814|NCT00729833|20839171|P4|Overall Study|Lost to Follow-up|0
6028815|NCT00729833|20839172|P3|Overall Study|Lost to Follow-up|0
6028816|NCT00729833|20839173|P2|Overall Study|Lost to Follow-up|0
6028817|NCT00729833|20839174|P1|Overall Study|Lost to Follow-up|1
6028818|NCT00729833|20839171|P4|Overall Study|Study Terminated by Sponsor|0
6028819|NCT00729833|20839172|P3|Overall Study|Study Terminated by Sponsor|1
6028820|NCT00729833|20839173|P2|Overall Study|Study Terminated by Sponsor|0
6028821|NCT00729833|20839174|P1|Overall Study|Study Terminated by Sponsor|0
6028822|NCT00729833|20839171|P4|Overall Study|Death|5
6028823|NCT00729833|20839172|P3|Overall Study|Death|3
6028824|NCT00729833|20839173|P2|Overall Study|Death|1
6028825|NCT00729833|20839174|P1|Overall Study|Death|5
6028826|NCT00729690|20839232|P3|Overall Study|IT Catheter Malfunction|2
6028827|NCT00729690|20839233|P2|Overall Study|IT Catheter Malfunction|2
6028828|NCT00729690|20839234|P1|Overall Study|IT Catheter Malfunction|0
6028829|NCT00729651|20839264|P2|Overall Study|Subject's private reason|0
6028830|NCT00729651|20839265|P1|Overall Study|Subject's private reason|2
6028831|NCT00729651|20839264|P2|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|4
6028832|NCT00729651|20839265|P1|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|0
6028833|NCT00729651|20839264|P2|Overall Study|Adverse Event|3
6028834|NCT00729651|20839265|P1|Overall Study|Adverse Event|7
6028835|NCT00729651|20839264|P2|Overall Study|Protocol Violation|1
6028836|NCT00729651|20839265|P1|Overall Study|Protocol Violation|0
6028837|NCT00729651|20839264|P2|Overall Study|Lost to Follow-up|4
6028838|NCT00729651|20839265|P1|Overall Study|Lost to Follow-up|5
6028839|NCT00729651|20839264|P2|Overall Study|Withdrawal by Subject|6
6028840|NCT00729651|20839265|P1|Overall Study|Withdrawal by Subject|5
6028841|NCT00729612|20839277|P1|Overall Study|Non evaluable for response|10
6028842|NCT00729586|20839286|P2|Overall Study|never treated|0
6028843|NCT00729586|20839287|P1|Overall Study|never treated|1
6028844|NCT00729586|20839286|P2|Overall Study|Ineligible|1
6028845|NCT00729586|20839287|P1|Overall Study|Ineligible|0
6028846|NCT00729560|20839300|P1|Overall Study|Withdrawal by Subject|3
6028847|NCT00729469|20839326|P2|Overall Study|Other-Not mentioned|4
6028848|NCT00729469|20839327|P1|Overall Study|Other-Not mentioned|9
6028849|NCT00729469|20839326|P2|Overall Study|Withdrawal by Subject|8
6028850|NCT00729469|20839327|P1|Overall Study|Withdrawal by Subject|19
6028851|NCT00729469|20839326|P2|Overall Study|Protocol Violation|1
6028852|NCT00729469|20839327|P1|Overall Study|Protocol Violation|2
6028853|NCT00729469|20839326|P2|Overall Study|Lost to Follow-up|9
6028854|NCT00729469|20839327|P1|Overall Study|Lost to Follow-up|9
6028855|NCT00729469|20839326|P2|Overall Study|Adverse Event|25
6028856|NCT00729469|20839327|P1|Overall Study|Adverse Event|14
6028857|NCT00729378|20839380|P2|36-months|Lost to Follow-up|6
6028858|NCT00729378|20839381|P1|36-months|Lost to Follow-up|15
6028859|NCT00729378|20839380|P2|24-months|Lost to Follow-up|51
6028860|NCT00729378|20839381|P1|24-months|Lost to Follow-up|72
6028861|NCT00729378|20839380|P2|12-months|Lost to Follow-up|65
6028862|NCT00729378|20839381|P1|12-months|Lost to Follow-up|100
6028863|NCT00729378|20839380|P2|Baseline|Withdrawal by Subject|59
6028864|NCT00729378|20839381|P1|Baseline|Withdrawal by Subject|66
6028865|NCT00729378|20839380|P2|Baseline|Did not complete study measurements|33
6028866|NCT00729378|20839381|P1|Baseline|Did not complete study measurements|72
6028867|NCT00729365|20839580|P3|Overall Study|Physician Decision|7
6028868|NCT00729365|20839581|P2|Overall Study|Physician Decision|6
6028869|NCT00729365|20839582|P1|Overall Study|Physician Decision|33
6028870|NCT00729326|20839595|P2|Overall Study|Sponsor Decision|2
6028871|NCT00729326|20839596|P1|Overall Study|Sponsor Decision|1
6028872|NCT00729326|20839595|P2|Overall Study|Subject Decision|4
6028873|NCT00729326|20839596|P1|Overall Study|Subject Decision|4
6028874|NCT00729326|20839595|P2|Overall Study|Protocol Violation|2
6028875|NCT00729326|20839596|P1|Overall Study|Protocol Violation|3
6028876|NCT00729326|20839595|P2|Overall Study|Physician Decision|1
6028877|NCT00729326|20839596|P1|Overall Study|Physician Decision|0
6028878|NCT00729326|20839595|P2|Overall Study|Lost to Follow-up|0
6028879|NCT00729326|20839596|P1|Overall Study|Lost to Follow-up|2
6028880|NCT00729248|20839638|P1|Overall Study|Physician Decision|2
6028881|NCT00729183|20839645|P2|Overall Study|Withdrawal by Subject|7
6028882|NCT00729183|20839646|P1|Overall Study|Withdrawal by Subject|9
6028883|NCT00729183|20839645|P2|Overall Study|Protocol Violation|0
6028884|NCT00729183|20839646|P1|Overall Study|Protocol Violation|1
6028885|NCT00729183|20839645|P2|Overall Study|Physician Decision|1
6028886|NCT00729183|20839646|P1|Overall Study|Physician Decision|1
6028887|NCT00729183|20839645|P2|Overall Study|Lost to Follow-up|1
6028888|NCT00729183|20839646|P1|Overall Study|Lost to Follow-up|3
6028889|NCT00729183|20839645|P2|Overall Study|Lack of Efficacy|1
6028890|NCT00729183|20839646|P1|Overall Study|Lack of Efficacy|0
6028891|NCT00729183|20839645|P2|Overall Study|Adverse Event|5
6028892|NCT00729183|20839646|P1|Overall Study|Adverse Event|11
6028893|NCT00729157|20839678|P1|Overall Study|Withdrawal by Subject|1
6028904|NCT00728962|20839740|P1|Two Year Post Placement Follow-up|Lost to Follow-up|3
6028905|NCT00728962|20839740|P1|Permanent Prosthesis Placement|Adverse Event|3
6028906|NCT00728962|20839740|P1|Implant Placement Surgery|Protocol Violation|1
6028907|NCT00728962|20839740|P1|Implant Placement Surgery|Lost to Follow-up|1
6028908|NCT00728962|20839740|P1|Implant Placement Surgery|Adverse Event|8
6028909|NCT00728949|20839746|P2|Overall Study|On treatment at cutoff date|0
6028910|NCT00728949|20839747|P1|Overall Study|On treatment at cutoff date|1
6028911|NCT00728949|20839746|P2|Overall Study|Abnormal Lab Results|2
6028912|NCT00728949|20839747|P1|Overall Study|Abnormal Lab Results|0
6028913|NCT00728949|20839746|P2|Overall Study|Withdrawal by Subject|2
6028914|NCT00728949|20839747|P1|Overall Study|Withdrawal by Subject|2
6028915|NCT00728949|20839746|P2|Overall Study|Adverse Event|0
6028916|NCT00728949|20839747|P1|Overall Study|Adverse Event|8
6028917|NCT00728936|20839772|P7|Overall Study|Withdrawal by Subject|0
6028918|NCT00728936|20839773|P6|Overall Study|Withdrawal by Subject|1
6028919|NCT00728936|20839774|P5|Overall Study|Withdrawal by Subject|0
6028920|NCT00728936|20839775|P4|Overall Study|Withdrawal by Subject|0
6028921|NCT00728936|20839776|P3|Overall Study|Withdrawal by Subject|0
6028922|NCT00728936|20839777|P2|Overall Study|Withdrawal by Subject|0
6028923|NCT00728936|20839778|P1|Overall Study|Withdrawal by Subject|0
6028924|NCT00728884|20839811|P1|One Year Post Placement Follow-up|Lost to Follow-up|4
6028925|NCT00728884|20839811|P1|Permanent Prosthesis Placement|Lost to Follow-up|13
6028926|NCT00728754|20839847|P2|One Year Post Placement Follow-up|Adverse Event|0
6028927|NCT00728754|20839848|P1|One Year Post Placement Follow-up|Adverse Event|1
6028928|NCT00728754|20839847|P2|Permanent Prosthesis Placement|Lost to Follow-up|3
6028929|NCT00728754|20839848|P1|Permanent Prosthesis Placement|Lost to Follow-up|3
6028930|NCT00728754|20839847|P2|Permanent Prosthesis Placement|Adverse Event|1
6028931|NCT00728754|20839848|P1|Permanent Prosthesis Placement|Adverse Event|1
6028932|NCT00728689|20839877|P2|Washout Period (Days 4 - 10)|Death in family|0
6028933|NCT00728689|20839878|P1|Washout Period (Days 4 - 10)|Death in family|1
6028934|NCT00728494|20839907|P2|Overall Study|No data available|1
6028935|NCT00728494|20839908|P1|Overall Study|No data available|0
6028936|NCT00728494|20839907|P2|Overall Study|Lack of Efficacy|4
6028937|NCT00728494|20839908|P1|Overall Study|Lack of Efficacy|2
6028938|NCT00728494|20839907|P2|Overall Study|Withdrawal by Subject|2
6028939|NCT00728494|20839908|P1|Overall Study|Withdrawal by Subject|0
6028940|NCT00728494|20839907|P2|Overall Study|Adverse Event|0
6028941|NCT00728494|20839908|P1|Overall Study|Adverse Event|7
6028942|NCT00728481|20839926|P2|Overall Study|Incorrectly assigned to opposite arm|0
6028943|NCT00728481|20839927|P1|Overall Study|Incorrectly assigned to opposite arm|1
6028944|NCT00728481|20839926|P2|Overall Study|Study medication non-compliance|2
6028945|NCT00728481|20839927|P1|Overall Study|Study medication non-compliance|0
6028946|NCT00728481|20839926|P2|Overall Study|Adverse Event|1
6028947|NCT00728481|20839927|P1|Overall Study|Adverse Event|0
6028948|NCT00728481|20839926|P2|Overall Study|Withdrawal by Subject|1
6028949|NCT00728481|20839927|P1|Overall Study|Withdrawal by Subject|0
6028950|NCT00728468|20839943|P1|Overall Study|Study terminated by sponsor|1
6028951|NCT00728468|20839943|P1|Overall Study|Objective progression or relapse|9
6028952|NCT00728468|20839943|P1|Overall Study|Protocol Violation|4
6028953|NCT00728468|20839943|P1|Overall Study|Death|1
6028954|NCT00728468|20839943|P1|Overall Study|Enrolled but not treated|1
6028955|NCT00728416|20839967|P2|Overall Study|Withdrawal by Subject|0
6028956|NCT00728416|20839968|P1|Overall Study|Withdrawal by Subject|1
6028957|NCT00728416|20839967|P2|Overall Study|Treatment Failure|1
6028958|NCT00728416|20839968|P1|Overall Study|Treatment Failure|0
6028959|NCT00728416|20839967|P2|Overall Study|Adverse Event|1
6028960|NCT00728416|20839968|P1|Overall Study|Adverse Event|1
6028961|NCT00728182|20839984|P2|Overall Study|Protocol Noncompliance|1
6028962|NCT00728182|20839985|P1|Overall Study|Protocol Noncompliance|0
6028963|NCT00728182|20839984|P2|Overall Study|Death|2
6028964|NCT00728182|20839985|P1|Overall Study|Death|0
6028965|NCT00728182|20839984|P2|Overall Study|Lost to Follow-up|0
6028966|NCT00728182|20839985|P1|Overall Study|Lost to Follow-up|2
6028967|NCT00728182|20839984|P2|Overall Study|Adverse Event|0
6028968|NCT00728182|20839985|P1|Overall Study|Adverse Event|1
6028969|NCT00728130|20840013|P1|Overall Study|Physician Decision|1
6028970|NCT00728130|20840013|P1|Overall Study|Paperwork not completed in time|1
6028971|NCT00728130|20840013|P1|Overall Study|Withdrawal by Subject|1
6028972|NCT00727961|20840018|P1|Overall Study|Progression|30
6028973|NCT00727961|20840018|P1|Overall Study|Patient's refusal|2
6028974|NCT00727961|20840018|P1|Overall Study|Adverse Event|4
6028975|NCT00727961|20840018|P1|Overall Study|Lost to Follow-up|1
6028976|NCT00727909|20840028|P4|Overall Study|Death|0
6028977|NCT00727909|20840029|P3|Overall Study|Death|1
6028978|NCT00727909|20840030|P2|Overall Study|Death|0
6028979|NCT00727909|20840031|P1|Overall Study|Death|0
6028980|NCT00727909|20840028|P4|Overall Study|Withdrawal by Subject|5
6028981|NCT00727909|20840029|P3|Overall Study|Withdrawal by Subject|8
6028982|NCT00727909|20840030|P2|Overall Study|Withdrawal by Subject|11
6028983|NCT00727909|20840031|P1|Overall Study|Withdrawal by Subject|5
6028984|NCT00727844|20840128|P4|Initial Randomization|Physician Decision|0
6028985|NCT00727844|20840129|P3|Initial Randomization|Physician Decision|0
6028986|NCT00727844|20840130|P2|Initial Randomization|Physician Decision|0
6028987|NCT00727844|20840131|P1|Initial Randomization|Physician Decision|2
6028988|NCT00727714|20840145|P1|Overall Study|Lost to Follow-up|2
6028989|NCT00727649|20840155|P2|Second Intervention (4-weeks)|Withdrawal by Subject|2
6028990|NCT00727649|20840156|P1|Second Intervention (4-weeks)|Withdrawal by Subject|0
6028991|NCT00727649|20840155|P2|Second Intervention (4-weeks)|Lost to Follow-up|1
6028992|NCT00727649|20840156|P1|Second Intervention (4-weeks)|Lost to Follow-up|0
6028993|NCT00727649|20840155|P2|Second Intervention (4-weeks)|Death|0
6028994|NCT00727649|20840156|P1|Second Intervention (4-weeks)|Death|1
6028995|NCT00727649|20840155|P2|Wash-out (2-weeks)|Withdrawal by Subject|2
6028996|NCT00727649|20840156|P1|Wash-out (2-weeks)|Withdrawal by Subject|1
6028997|NCT00727649|20840155|P2|Wash-out (2-weeks)|Lost to Follow-up|1
6028998|NCT00727649|20840156|P1|Wash-out (2-weeks)|Lost to Follow-up|3
6028999|NCT00727649|20840155|P2|First Intervention (4-weeks)|Withdrawal by Subject|1
6029000|NCT00727649|20840156|P1|First Intervention (4-weeks)|Withdrawal by Subject|2
6029001|NCT00727649|20840155|P2|First Intervention (4-weeks)|Lost to Follow-up|2
6029002|NCT00727649|20840156|P1|First Intervention (4-weeks)|Lost to Follow-up|1
6029003|NCT00727571|20840198|P4|Overall Study|Other|0
6029004|NCT00727571|20840199|P3|Overall Study|Other|6
6029005|NCT00727571|20840200|P2|Overall Study|Other|4
6029006|NCT00727571|20840201|P1|Overall Study|Other|0
6029007|NCT00727571|20840198|P4|Overall Study|AE not leading to hospitalization|0
6029008|NCT00727571|20840199|P3|Overall Study|AE not leading to hospitalization|2
6029009|NCT00727571|20840200|P2|Overall Study|AE not leading to hospitalization|0
6029010|NCT00727571|20840201|P1|Overall Study|AE not leading to hospitalization|0
6029011|NCT00727571|20840198|P4|Overall Study|Hospitalization|1
6029012|NCT00727571|20840199|P3|Overall Study|Hospitalization|0
6029013|NCT00727571|20840200|P2|Overall Study|Hospitalization|1
6029014|NCT00727571|20840201|P1|Overall Study|Hospitalization|0
6029015|NCT00727571|20840198|P4|Overall Study|Dismissed from nursing home|0
6029016|NCT00727571|20840199|P3|Overall Study|Dismissed from nursing home|5
6029017|NCT00727571|20840200|P2|Overall Study|Dismissed from nursing home|9
6029018|NCT00727571|20840201|P1|Overall Study|Dismissed from nursing home|0
6029019|NCT00727571|20840198|P4|Overall Study|Subject Non Compliance|4
6029020|NCT00727571|20840199|P3|Overall Study|Subject Non Compliance|0
6029021|NCT00727571|20840200|P2|Overall Study|Subject Non Compliance|6
6029022|NCT00727571|20840201|P1|Overall Study|Subject Non Compliance|0
6029023|NCT00727571|20840198|P4|Overall Study|Withdrawal by Subject|0
6029024|NCT00727571|20840199|P3|Overall Study|Withdrawal by Subject|11
6029025|NCT00727571|20840200|P2|Overall Study|Withdrawal by Subject|10
6029026|NCT00727571|20840201|P1|Overall Study|Withdrawal by Subject|0
6029027|NCT00727571|20840198|P4|Overall Study|Physician Decision|0
6029028|NCT00727571|20840199|P3|Overall Study|Physician Decision|0
6029029|NCT00727571|20840200|P2|Overall Study|Physician Decision|5
6029030|NCT00727571|20840201|P1|Overall Study|Physician Decision|0
6029031|NCT00727571|20840198|P4|Overall Study|Death|1
6029032|NCT00727571|20840199|P3|Overall Study|Death|5
6029033|NCT00727571|20840200|P2|Overall Study|Death|19
6029034|NCT00727571|20840201|P1|Overall Study|Death|0
6029035|NCT00727571|20840198|P4|Overall Study|Ineligibility determined|0
6029036|NCT00727571|20840199|P3|Overall Study|Ineligibility determined|1
6029037|NCT00727571|20840200|P2|Overall Study|Ineligibility determined|1
6029038|NCT00727571|20840201|P1|Overall Study|Ineligibility determined|1
6029039|NCT00727558|20840228|P2|Overall Study|Lost to Follow-up|0
6029040|NCT00727558|20840229|P1|Overall Study|Lost to Follow-up|1
6029041|NCT00727558|20840228|P2|Overall Study|Subject unable to return for follow-up|1
6029042|NCT00727558|20840229|P1|Overall Study|Subject unable to return for follow-up|1
6029043|NCT00727558|20840228|P2|Overall Study|Adverse Event|1
6029044|NCT00727558|20840229|P1|Overall Study|Adverse Event|0
6029045|NCT00727558|20840228|P2|Overall Study|Lens issue|1
6029046|NCT00727558|20840229|P1|Overall Study|Lens issue|0
6029047|NCT00727532|20840247|P1|Overall Study|Withdrawal by Subject|1
6029048|NCT00727532|20840247|P1|Overall Study|Adverse Event|1
6029049|NCT00727506|20840259|P6|Overall Study|Other reason not described above|1
6029050|NCT00727506|20840260|P5|Overall Study|Other reason not described above|1
6029051|NCT00727506|20840261|P4|Overall Study|Other reason not described above|4
6029052|NCT00727506|20840262|P3|Overall Study|Other reason not described above|1
6029053|NCT00727506|20840263|P2|Overall Study|Other reason not described above|0
6029054|NCT00727506|20840264|P1|Overall Study|Other reason not described above|0
6029055|NCT00727506|20840259|P6|Overall Study|Refused to continue medication|2
6029056|NCT00727506|20840260|P5|Overall Study|Refused to continue medication|1
6029057|NCT00727506|20840261|P4|Overall Study|Refused to continue medication|3
6029058|NCT00727506|20840262|P3|Overall Study|Refused to continue medication|2
6029059|NCT00727506|20840263|P2|Overall Study|Refused to continue medication|1
6029060|NCT00727506|20840264|P1|Overall Study|Refused to continue medication|0
6029061|NCT00727506|20840259|P6|Overall Study|Progressive disease|28
6029062|NCT00727506|20840260|P5|Overall Study|Progressive disease|38
6029063|NCT00727506|20840261|P4|Overall Study|Progressive disease|28
6029064|NCT00727506|20840262|P3|Overall Study|Progressive disease|9
6029065|NCT00727506|20840263|P2|Overall Study|Progressive disease|7
6029066|NCT00727506|20840264|P1|Overall Study|Progressive disease|4
6029067|NCT00727506|20840259|P6|Overall Study|Dose Limiting Toxicity (DLT)|0
6029068|NCT00727506|20840260|P5|Overall Study|Dose Limiting Toxicity (DLT)|0
6029069|NCT00727506|20840261|P4|Overall Study|Dose Limiting Toxicity (DLT)|0
6029070|NCT00727506|20840262|P3|Overall Study|Dose Limiting Toxicity (DLT)|2
6029071|NCT00727506|20840263|P2|Overall Study|Dose Limiting Toxicity (DLT)|0
6029072|NCT00727506|20840264|P1|Overall Study|Dose Limiting Toxicity (DLT)|2
6029073|NCT00727506|20840259|P6|Overall Study|Adverse Event|8
6029074|NCT00727506|20840260|P5|Overall Study|Adverse Event|1
6029075|NCT00727506|20840261|P4|Overall Study|Adverse Event|4
6029076|NCT00727506|20840262|P3|Overall Study|Adverse Event|4
6029077|NCT00727506|20840263|P2|Overall Study|Adverse Event|0
6029078|NCT00727506|20840264|P1|Overall Study|Adverse Event|0
6029079|NCT00727441|20840360|P3|Overall Study|Withdrawal by Subject|0
6029080|NCT00727441|20840361|P2|Overall Study|Withdrawal by Subject|1
6029081|NCT00727441|20840362|P1|Overall Study|Withdrawal by Subject|0
6029082|NCT00727441|20840360|P3|Overall Study|Physician Decision|0
6029083|NCT00727441|20840361|P2|Overall Study|Physician Decision|1
6029084|NCT00727441|20840362|P1|Overall Study|Physician Decision|0
6029085|NCT00727441|20840360|P3|Overall Study|Death|1
6029086|NCT00727441|20840361|P2|Overall Study|Death|1
6029087|NCT00727441|20840362|P1|Overall Study|Death|0
6029088|NCT00727441|20840360|P3|Overall Study|Eligibility|7
6029089|NCT00727441|20840361|P2|Overall Study|Eligibility|5
6029090|NCT00727441|20840362|P1|Overall Study|Eligibility|7
6029091|NCT00727441|20840360|P3|Overall Study|Disease Progression|17
6029092|NCT00727441|20840361|P2|Overall Study|Disease Progression|14
6029093|NCT00727441|20840362|P1|Overall Study|Disease Progression|11
6029094|NCT00727415|20840382|P1|Phase I|Dose Limiting Toxicity|2
6029095|NCT00727402|20840391|P1|Overall Study|Physician Decision|116
6029096|NCT00727311|20840420|P1|Overall Study|Multiple reasons|39
6029097|NCT00727311|20840420|P1|Overall Study|Other|97
6029098|NCT00727311|20840420|P1|Overall Study|Withdrawal by Subject|77
6029099|NCT00727311|20840420|P1|Overall Study|Lost to Follow-up|73
6029100|NCT00727311|20840420|P1|Overall Study|Lack of Efficacy|242
6029101|NCT00727311|20840420|P1|Overall Study|Adverse Event|58
6029102|NCT00727311|20840420|P1|Overall Study|Missing end of therapy data|205
6029103|NCT00727311|20840420|P1|Overall Study|Did not receive drug|316
6029104|NCT00727272|20840433|P3|Washout Period B|Withdrawal by Subject|1
6029105|NCT00727272|20840434|P2|Washout Period B|Withdrawal by Subject|0
6029106|NCT00727272|20840435|P1|Washout Period B|Withdrawal by Subject|0
6029107|NCT00727272|20840433|P3|Washout Period A|Adverse Event|1
6029108|NCT00727272|20840434|P2|Washout Period A|Adverse Event|0
6029109|NCT00727272|20840435|P1|Washout Period A|Adverse Event|0
6029110|NCT00727259|20840452|P1|Overall Study|Not all questionnaires completed|1055
6029111|NCT00727246|20840461|P4|Overall Study|withdrawn|0
6029112|NCT00727246|20840462|P3|Overall Study|withdrawn|1
6029113|NCT00727246|20840463|P2|Overall Study|withdrawn|0
6029114|NCT00727246|20840464|P1|Overall Study|withdrawn|0
6029115|NCT00727246|20840461|P4|Overall Study|incidental finding|1
6029116|NCT00727246|20840462|P3|Overall Study|incidental finding|0
6029117|NCT00727246|20840463|P2|Overall Study|incidental finding|0
6029118|NCT00727246|20840464|P1|Overall Study|incidental finding|0
6029119|NCT00727246|20840461|P4|Overall Study|could not complete MRI|1
6029120|NCT00727246|20840462|P3|Overall Study|could not complete MRI|0
6029121|NCT00727246|20840463|P2|Overall Study|could not complete MRI|1
6029122|NCT00727246|20840464|P1|Overall Study|could not complete MRI|0
6029123|NCT00727194|20840487|P3|Treatment Period 2|Lack of Efficacy|0
6029124|NCT00727194|20840488|P2|Treatment Period 2|Lack of Efficacy|1
6029125|NCT00727194|20840489|P1|Treatment Period 2|Lack of Efficacy|0
6029126|NCT00727194|20840487|P3|Screening Period|History of thymoma|1
6029127|NCT00727194|20840488|P2|Screening Period|History of thymoma|0
6029128|NCT00727194|20840489|P1|Screening Period|History of thymoma|0
6029129|NCT00727194|20840487|P3|Screening Period|Severe infections|2
6029130|NCT00727194|20840488|P2|Screening Period|Severe infections|0
6029131|NCT00727194|20840489|P1|Screening Period|Severe infections|0
6029132|NCT00727194|20840487|P3|Screening Period|Not stable on concomitant MG therapy|2
6029133|NCT00727194|20840488|P2|Screening Period|Not stable on concomitant MG therapy|0
6029134|NCT00727194|20840489|P1|Screening Period|Not stable on concomitant MG therapy|0
6029135|NCT00727194|20840487|P3|Screening Period|Lacked AChR antibodies|5
6029136|NCT00727194|20840488|P2|Screening Period|Lacked AChR antibodies|0
6029137|NCT00727194|20840489|P1|Screening Period|Lacked AChR antibodies|0
6029138|NCT00727194|20840487|P3|Screening Period|Low QMG scores|6
6029139|NCT00727194|20840488|P2|Screening Period|Low QMG scores|0
6029140|NCT00727194|20840489|P1|Screening Period|Low QMG scores|0
6029141|NCT00727025|20840561|P1|Overall Study|Physician Decision|23
6029142|NCT00726999|20840573|P2|Overall Study|Protocol Violation|0
6029143|NCT00726999|20840574|P1|Overall Study|Protocol Violation|1
6029144|NCT00726999|20840573|P2|Overall Study|Withdrawal by Subject|0
6029145|NCT00726999|20840574|P1|Overall Study|Withdrawal by Subject|2
6029146|NCT00726999|20840573|P2|Overall Study|Physician Decision|1
6029147|NCT00726999|20840574|P1|Overall Study|Physician Decision|0
6029148|NCT00726986|20840586|P1|Maintenance Phase|Lack of Efficacy|2
6029149|NCT00726986|20840586|P1|Maintenance Phase|Adverse Event|1
6029150|NCT00726986|20840586|P1|Induction Phase|Secondary Disease|2
6029151|NCT00726986|20840586|P1|Induction Phase|Lack of Efficacy|5
6029152|NCT00726986|20840586|P1|Induction Phase|Death|2
6029153|NCT00726986|20840586|P1|Induction Phase|Withdrawal by Subject|2
6029154|NCT00726986|20840586|P1|Induction Phase|Adverse Event|4
6029155|NCT00726895|20840593|P2|Washout Period of 7 Days|Withdrawal by Subject|1
6029156|NCT00726895|20840594|P1|Washout Period of 7 Days|Withdrawal by Subject|0
6029157|NCT00726882|20840607|P1|Overall Study|Other|10
6029158|NCT00726882|20840607|P1|Overall Study|Lost to Follow-up|7
6029159|NCT00726882|20840607|P1|Overall Study|Withdrawal by Subject|5
6029160|NCT00726752|20840622|P1|Overall Study|Lack of Efficacy|6
6029161|NCT00726661|20840684|P2|Overall Study|Other|35
6029162|NCT00726661|20840685|P1|Overall Study|Other|47
6029163|NCT00726661|20840684|P2|Overall Study|Physician Decision|13
6029164|NCT00726661|20840685|P1|Overall Study|Physician Decision|25
6029165|NCT00726661|20840684|P2|Overall Study|Death|159
6029166|NCT00726661|20840685|P1|Overall Study|Death|475
6029167|NCT00726661|20840684|P2|Overall Study|Trial terminated by sponsor|187
6029168|NCT00726661|20840685|P1|Overall Study|Trial terminated by sponsor|214
6029169|NCT00726661|20840684|P2|Overall Study|Withdrawal by Subject|13
6029170|NCT00726661|20840685|P1|Overall Study|Withdrawal by Subject|17
6029171|NCT00726661|20840684|P2|Overall Study|Lost to Follow-up|11
6029172|NCT00726661|20840685|P1|Overall Study|Lost to Follow-up|36
6029173|NCT00726622|20840702|P2|Overall Study|Metastasis|0
6029174|NCT00726622|20840703|P1|Overall Study|Metastasis|2
6029175|NCT00726622|20840702|P2|Overall Study|Physician Decision|1
6029176|NCT00726622|20840703|P1|Overall Study|Physician Decision|0
6029177|NCT00726622|20840702|P2|Overall Study|Withdrawal by Subject|2
6029178|NCT00726622|20840703|P1|Overall Study|Withdrawal by Subject|16
6029179|NCT00726609|20840721|P1|Overall Study|Other|3
6029180|NCT00726609|20840721|P1|Overall Study|Missing|42
6029181|NCT00726609|20840721|P1|Overall Study|Other|16
6029182|NCT00726609|20840721|P1|Overall Study|Lack of Efficacy|25
6029183|NCT00726609|20840721|P1|Overall Study|Withdrawal by Subject|2
6029184|NCT00726609|20840721|P1|Overall Study|Adverse Event|10
6029185|NCT00726557|20840725|P1|Overall Study|Inclusion criteria not met|15
6029186|NCT00726557|20840725|P1|Overall Study|Treatment less than 3 months|17
6029187|NCT00726557|20840725|P1|Overall Study|No follow-up documentation available|55
6029188|NCT00726557|20840725|P1|Overall Study|No end of treatment documentation|37
6029189|NCT00726557|20840725|P1|Overall Study|Screening failure|4
6029190|NCT00726453|20840732|P2|38 mm Length Group|Death|3
6029191|NCT00726453|20840733|P1|38 mm Length Group|Death|0
6029192|NCT00726453|20840732|P2|Primary Enrollment Group|Withdrawal by Subject|0
6029193|NCT00726453|20840733|P1|Primary Enrollment Group|Withdrawal by Subject|13
6029194|NCT00726453|20840732|P2|Primary Enrollment Group|Death|0
6029195|NCT00726453|20840733|P1|Primary Enrollment Group|Death|18
6029196|NCT00726323|20840761|P2|Overall Study|Metastatic lesions inferred cyst|1
6029197|NCT00726323|20840762|P1|Overall Study|Metastatic lesions inferred cyst|0
6029198|NCT00726323|20840761|P2|Overall Study|Participant wished to discontinue|1
6029199|NCT00726323|20840762|P1|Overall Study|Participant wished to discontinue|0
6029200|NCT00726323|20840761|P2|Overall Study|Death|0
6029201|NCT00726323|20840762|P1|Overall Study|Death|1
6029202|NCT00726323|20840761|P2|Overall Study|Adverse Event|9
6029203|NCT00726323|20840762|P1|Overall Study|Adverse Event|9
6029204|NCT00726323|20840761|P2|Overall Study|Clinical progression|3
6029205|NCT00726323|20840762|P1|Overall Study|Clinical progression|0
6029206|NCT00726323|20840761|P2|Overall Study|Progressive disease|16
6029207|NCT00726323|20840762|P1|Overall Study|Progressive disease|23
6029208|NCT00726323|20840761|P2|Overall Study|Physician Decision|0
6029209|NCT00726323|20840762|P1|Overall Study|Physician Decision|1
6029210|NCT00726323|20840761|P2|Overall Study|Withdrawal by Subject|1
6029211|NCT00726323|20840762|P1|Overall Study|Withdrawal by Subject|3
6029212|NCT00726232|20840792|P8|Expansion Phase|Unspecified reason|0
6029213|NCT00726232|20840793|P7|Expansion Phase|Unspecified reason|1
6029214|NCT00726232|20840794|P6|Expansion Phase|Unspecified reason|0
6029215|NCT00726232|20840795|P5|Expansion Phase|Unspecified reason|0
6029216|NCT00726232|20840796|P4|Expansion Phase|Unspecified reason|0
6029217|NCT00726232|20840797|P3|Expansion Phase|Unspecified reason|0
6029218|NCT00726232|20840798|P2|Expansion Phase|Unspecified reason|0
6029219|NCT00726232|20840799|P1|Expansion Phase|Unspecified reason|0
6029220|NCT00726232|20840792|P8|Expansion Phase|Per Investigator: lack of response|7
6029221|NCT00726232|20840793|P7|Expansion Phase|Per Investigator: lack of response|1
6029222|NCT00726232|20840794|P6|Expansion Phase|Per Investigator: lack of response|0
6029223|NCT00726232|20840795|P5|Expansion Phase|Per Investigator: lack of response|0
6029224|NCT00726232|20840796|P4|Expansion Phase|Per Investigator: lack of response|0
6029225|NCT00726232|20840797|P3|Expansion Phase|Per Investigator: lack of response|0
6029226|NCT00726232|20840798|P2|Expansion Phase|Per Investigator: lack of response|0
6029227|NCT00726232|20840799|P1|Expansion Phase|Per Investigator: lack of response|0
6029228|NCT00726232|20840792|P8|Expansion Phase|Termination of the trial by sponsor|16
6029229|NCT00726232|20840793|P7|Expansion Phase|Termination of the trial by sponsor|10
6029230|NCT00726232|20840794|P6|Expansion Phase|Termination of the trial by sponsor|0
6029231|NCT00726232|20840795|P5|Expansion Phase|Termination of the trial by sponsor|0
6029232|NCT00726232|20840796|P4|Expansion Phase|Termination of the trial by sponsor|0
6029233|NCT00726232|20840797|P3|Expansion Phase|Termination of the trial by sponsor|0
6029234|NCT00726232|20840798|P2|Expansion Phase|Termination of the trial by sponsor|0
6029235|NCT00726232|20840799|P1|Expansion Phase|Termination of the trial by sponsor|0
6029236|NCT00726232|20840792|P8|Expansion Phase|Disease progression|0
6029237|NCT00726232|20840793|P7|Expansion Phase|Disease progression|4
6029238|NCT00726232|20840794|P6|Expansion Phase|Disease progression|0
6029239|NCT00726232|20840795|P5|Expansion Phase|Disease progression|0
6029240|NCT00726232|20840796|P4|Expansion Phase|Disease progression|0
6029241|NCT00726232|20840797|P3|Expansion Phase|Disease progression|0
6029242|NCT00726232|20840798|P2|Expansion Phase|Disease progression|0
6029243|NCT00726232|20840799|P1|Expansion Phase|Disease progression|0
6029244|NCT00726232|20840792|P8|Expansion Phase|Withdrawal by Subject|3
6029245|NCT00726232|20840793|P7|Expansion Phase|Withdrawal by Subject|2
6029246|NCT00726232|20840794|P6|Expansion Phase|Withdrawal by Subject|0
6029247|NCT00726232|20840795|P5|Expansion Phase|Withdrawal by Subject|0
6029248|NCT00726232|20840796|P4|Expansion Phase|Withdrawal by Subject|0
6029249|NCT00726232|20840797|P3|Expansion Phase|Withdrawal by Subject|0
6029250|NCT00726232|20840798|P2|Expansion Phase|Withdrawal by Subject|0
6029251|NCT00726232|20840799|P1|Expansion Phase|Withdrawal by Subject|0
6029252|NCT00726232|20840792|P8|Expansion Phase|Adverse Event|11
6029253|NCT00726232|20840793|P7|Expansion Phase|Adverse Event|6
6029254|NCT00726232|20840794|P6|Expansion Phase|Adverse Event|0
6029255|NCT00726232|20840795|P5|Expansion Phase|Adverse Event|0
6029256|NCT00726232|20840796|P4|Expansion Phase|Adverse Event|0
6029257|NCT00726232|20840797|P3|Expansion Phase|Adverse Event|0
6029258|NCT00726232|20840798|P2|Expansion Phase|Adverse Event|0
6029259|NCT00726232|20840799|P1|Expansion Phase|Adverse Event|0
6029260|NCT00726232|20840792|P8|Expansion Phase|Death|1
6029261|NCT00726232|20840793|P7|Expansion Phase|Death|0
6029262|NCT00726232|20840794|P6|Expansion Phase|Death|0
6029263|NCT00726232|20840795|P5|Expansion Phase|Death|0
6029264|NCT00726232|20840796|P4|Expansion Phase|Death|0
6029265|NCT00726232|20840797|P3|Expansion Phase|Death|0
6029266|NCT00726232|20840798|P2|Expansion Phase|Death|0
6029267|NCT00726232|20840799|P1|Expansion Phase|Death|0
6029268|NCT00726232|20840792|P8|Initial Phase (Dose-finding)|Unspecified reason|0
6029269|NCT00726232|20840793|P7|Initial Phase (Dose-finding)|Unspecified reason|0
6029270|NCT00726232|20840794|P6|Initial Phase (Dose-finding)|Unspecified reason|0
6029271|NCT00726232|20840795|P5|Initial Phase (Dose-finding)|Unspecified reason|0
6029272|NCT00726232|20840796|P4|Initial Phase (Dose-finding)|Unspecified reason|0
6029273|NCT00726232|20840797|P3|Initial Phase (Dose-finding)|Unspecified reason|0
6029274|NCT00726232|20840798|P2|Initial Phase (Dose-finding)|Unspecified reason|0
6029275|NCT00726232|20840799|P1|Initial Phase (Dose-finding)|Unspecified reason|1
6029276|NCT00726232|20840792|P8|Initial Phase (Dose-finding)|Per Investigator: lack of response|0
6029277|NCT00726232|20840793|P7|Initial Phase (Dose-finding)|Per Investigator: lack of response|0
6029278|NCT00726232|20840794|P6|Initial Phase (Dose-finding)|Per Investigator: lack of response|1
6029279|NCT00726232|20840795|P5|Initial Phase (Dose-finding)|Per Investigator: lack of response|4
6029280|NCT00726232|20840796|P4|Initial Phase (Dose-finding)|Per Investigator: lack of response|2
6029281|NCT00726232|20840797|P3|Initial Phase (Dose-finding)|Per Investigator: lack of response|0
6029282|NCT00726232|20840798|P2|Initial Phase (Dose-finding)|Per Investigator: lack of response|0
6029283|NCT00726232|20840799|P1|Initial Phase (Dose-finding)|Per Investigator: lack of response|1
6029284|NCT00726232|20840792|P8|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0
6029285|NCT00726232|20840793|P7|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0
6029286|NCT00726232|20840794|P6|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3
6029287|NCT00726232|20840795|P5|Initial Phase (Dose-finding)|Termination of the trial by sponsor|9
6029288|NCT00726232|20840796|P4|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4
6029289|NCT00726232|20840797|P3|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3
6029290|NCT00726232|20840798|P2|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3
6029291|NCT00726232|20840799|P1|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4
6029292|NCT00726232|20840792|P8|Initial Phase (Dose-finding)|Disease progression|0
6029293|NCT00726232|20840793|P7|Initial Phase (Dose-finding)|Disease progression|0
6029294|NCT00726232|20840794|P6|Initial Phase (Dose-finding)|Disease progression|0
6029295|NCT00726232|20840795|P5|Initial Phase (Dose-finding)|Disease progression|0
6029296|NCT00726232|20840796|P4|Initial Phase (Dose-finding)|Disease progression|0
6029297|NCT00726232|20840797|P3|Initial Phase (Dose-finding)|Disease progression|0
6029298|NCT00726232|20840798|P2|Initial Phase (Dose-finding)|Disease progression|1
6029299|NCT00726232|20840799|P1|Initial Phase (Dose-finding)|Disease progression|3
6029300|NCT00726232|20840792|P8|Initial Phase (Dose-finding)|Withdrawal by Subject|0
6029301|NCT00726232|20840793|P7|Initial Phase (Dose-finding)|Withdrawal by Subject|0
6029302|NCT00726232|20840794|P6|Initial Phase (Dose-finding)|Withdrawal by Subject|2
6029303|NCT00726232|20840795|P5|Initial Phase (Dose-finding)|Withdrawal by Subject|0
6029304|NCT00726232|20840796|P4|Initial Phase (Dose-finding)|Withdrawal by Subject|1
6029305|NCT00726232|20840797|P3|Initial Phase (Dose-finding)|Withdrawal by Subject|0
6029306|NCT00726232|20840798|P2|Initial Phase (Dose-finding)|Withdrawal by Subject|0
6029307|NCT00726232|20840799|P1|Initial Phase (Dose-finding)|Withdrawal by Subject|2
6029308|NCT00726232|20840792|P8|Initial Phase (Dose-finding)|Adverse Event|0
6029309|NCT00726232|20840793|P7|Initial Phase (Dose-finding)|Adverse Event|0
6029310|NCT00726232|20840794|P6|Initial Phase (Dose-finding)|Adverse Event|3
6029311|NCT00726232|20840795|P5|Initial Phase (Dose-finding)|Adverse Event|7
6029312|NCT00726232|20840796|P4|Initial Phase (Dose-finding)|Adverse Event|1
6029313|NCT00726232|20840797|P3|Initial Phase (Dose-finding)|Adverse Event|2
6029314|NCT00726232|20840798|P2|Initial Phase (Dose-finding)|Adverse Event|2
6029315|NCT00726232|20840799|P1|Initial Phase (Dose-finding)|Adverse Event|2
6029316|NCT00726232|20840792|P8|Initial Phase (Dose-finding)|Death|0
6029317|NCT00726232|20840793|P7|Initial Phase (Dose-finding)|Death|0
6029318|NCT00726232|20840794|P6|Initial Phase (Dose-finding)|Death|0
6029319|NCT00726232|20840795|P5|Initial Phase (Dose-finding)|Death|1
6029320|NCT00726232|20840796|P4|Initial Phase (Dose-finding)|Death|0
6029321|NCT00726232|20840797|P3|Initial Phase (Dose-finding)|Death|0
6029322|NCT00726232|20840798|P2|Initial Phase (Dose-finding)|Death|0
6029323|NCT00726232|20840799|P1|Initial Phase (Dose-finding)|Death|0
6029324|NCT00726063|20840851|P2|Overall Study|Adverse Event|7
6029325|NCT00726063|20840852|P1|Overall Study|Adverse Event|9
6029326|NCT00725985|20840866|P12|LTFU (No Cladribine Treatment)|Other|14
6029327|NCT00725985|20840867|P11|LTFU (No Cladribine Treatment)|Other|36
6029328|NCT00725985|20840868|P10|LTFU (No Cladribine Treatment)|Other|34
6029329|NCT00725985|20840869|P9|LTFU (No Cladribine Treatment)|Other|0
6029330|NCT00725985|20840870|P8|LTFU (No Cladribine Treatment)|Other|0
6029331|NCT00725985|20840871|P7|LTFU (No Cladribine Treatment)|Other|0
6029332|NCT00725985|20840872|P6|LTFU (No Cladribine Treatment)|Other|0
6029333|NCT00725985|20840873|P5|LTFU (No Cladribine Treatment)|Other|0
6029334|NCT00725985|20840874|P4|LTFU (No Cladribine Treatment)|Other|0
6029335|NCT00725985|20840875|P3|LTFU (No Cladribine Treatment)|Other|0
6029336|NCT00725985|20840876|P2|LTFU (No Cladribine Treatment)|Other|0
6029337|NCT00725985|20840877|P1|LTFU (No Cladribine Treatment)|Other|0
6029338|NCT00725985|20840866|P12|LTFU (With Cladribine Treatment)|Other|0
6029339|NCT00725985|20840867|P11|LTFU (With Cladribine Treatment)|Other|0
6029340|NCT00725985|20840868|P10|LTFU (With Cladribine Treatment)|Other|0
6029341|NCT00725985|20840869|P9|LTFU (With Cladribine Treatment)|Other|16
6029342|NCT00725985|20840870|P8|LTFU (With Cladribine Treatment)|Other|8
6029343|NCT00725985|20840871|P7|LTFU (With Cladribine Treatment)|Other|9
6029344|NCT00725985|20840872|P6|LTFU (With Cladribine Treatment)|Other|0
6029345|NCT00725985|20840873|P5|LTFU (With Cladribine Treatment)|Other|0
6029346|NCT00725985|20840874|P4|LTFU (With Cladribine Treatment)|Other|0
6029347|NCT00725985|20840875|P3|LTFU (With Cladribine Treatment)|Other|0
6029348|NCT00725985|20840876|P2|LTFU (With Cladribine Treatment)|Other|0
6029349|NCT00725985|20840877|P1|LTFU (With Cladribine Treatment)|Other|0
6029350|NCT00725985|20840866|P12|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
6029351|NCT00725985|20840867|P11|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
6029352|NCT00725985|20840868|P10|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
6029353|NCT00725985|20840869|P9|LTFU (With Cladribine Treatment)|Lost to Follow-up|1
6029354|NCT00725985|20840870|P8|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
6029355|NCT00725985|20840871|P7|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
6029356|NCT00725985|20840872|P6|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
6029357|NCT00725985|20840873|P5|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
6029358|NCT00725985|20840874|P4|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
6029359|NCT00725985|20840875|P3|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
6029360|NCT00725985|20840876|P2|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
6029361|NCT00725985|20840877|P1|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
6029362|NCT00725985|20840866|P12|LTFU (With Cladribine Treatment)|Adverse Event|0
6029363|NCT00725985|20840867|P11|LTFU (With Cladribine Treatment)|Adverse Event|0
6029364|NCT00725985|20840868|P10|LTFU (With Cladribine Treatment)|Adverse Event|0
6029365|NCT00725985|20840869|P9|LTFU (With Cladribine Treatment)|Adverse Event|0
6029366|NCT00725985|20840870|P8|LTFU (With Cladribine Treatment)|Adverse Event|1
6029367|NCT00725985|20840871|P7|LTFU (With Cladribine Treatment)|Adverse Event|0
6029368|NCT00725985|20840872|P6|LTFU (With Cladribine Treatment)|Adverse Event|0
6029369|NCT00725985|20840873|P5|LTFU (With Cladribine Treatment)|Adverse Event|0
6029370|NCT00725985|20840874|P4|LTFU (With Cladribine Treatment)|Adverse Event|0
6029371|NCT00725985|20840875|P3|LTFU (With Cladribine Treatment)|Adverse Event|0
6029372|NCT00725985|20840876|P2|LTFU (With Cladribine Treatment)|Adverse Event|0
6029373|NCT00725985|20840877|P1|LTFU (With Cladribine Treatment)|Adverse Event|0
6029374|NCT00725985|20840866|P12|OLMP|Other|0
6029375|NCT00725985|20840867|P11|OLMP|Other|0
6029376|NCT00725985|20840868|P10|OLMP|Other|0
6029377|NCT00725985|20840869|P9|OLMP|Other|0
6029378|NCT00725985|20840870|P8|OLMP|Other|0
6029379|NCT00725985|20840871|P7|OLMP|Other|0
6029380|NCT00725985|20840872|P6|OLMP|Other|44
6029381|NCT00725985|20840873|P5|OLMP|Other|20
6029382|NCT00725985|20840874|P4|OLMP|Other|15
6029383|NCT00725985|20840875|P3|OLMP|Other|0
6029384|NCT00725985|20840876|P2|OLMP|Other|0
6029385|NCT00725985|20840877|P1|OLMP|Other|0
6029386|NCT00725985|20840866|P12|OLMP|Disease progression|0
6029387|NCT00725985|20840867|P11|OLMP|Disease progression|0
6029388|NCT00725985|20840868|P10|OLMP|Disease progression|0
6029389|NCT00725985|20840869|P9|OLMP|Disease progression|0
6029390|NCT00725985|20840870|P8|OLMP|Disease progression|0
6029391|NCT00725985|20840871|P7|OLMP|Disease progression|0
6029392|NCT00725985|20840872|P6|OLMP|Disease progression|4
6029393|NCT00725985|20840873|P5|OLMP|Disease progression|0
6029394|NCT00725985|20840874|P4|OLMP|Disease progression|0
6029395|NCT00725985|20840875|P3|OLMP|Disease progression|0
6029396|NCT00725985|20840876|P2|OLMP|Disease progression|0
6029397|NCT00725985|20840877|P1|OLMP|Disease progression|0
6029398|NCT00725985|20840866|P12|OLMP|Lost to Follow-up|0
6029399|NCT00725985|20840867|P11|OLMP|Lost to Follow-up|0
6029400|NCT00725985|20840868|P10|OLMP|Lost to Follow-up|0
6029401|NCT00725985|20840869|P9|OLMP|Lost to Follow-up|0
6029402|NCT00725985|20840870|P8|OLMP|Lost to Follow-up|0
6029403|NCT00725985|20840871|P7|OLMP|Lost to Follow-up|0
6029404|NCT00725985|20840872|P6|OLMP|Lost to Follow-up|0
6029405|NCT00725985|20840873|P5|OLMP|Lost to Follow-up|0
6029406|NCT00725985|20840874|P4|OLMP|Lost to Follow-up|1
6029407|NCT00725985|20840875|P3|OLMP|Lost to Follow-up|0
6029408|NCT00725985|20840876|P2|OLMP|Lost to Follow-up|0
6029409|NCT00725985|20840877|P1|OLMP|Lost to Follow-up|0
6029410|NCT00725985|20840866|P12|OLMP|Death|0
6029411|NCT00725985|20840867|P11|OLMP|Death|0
6029412|NCT00725985|20840868|P10|OLMP|Death|0
6029413|NCT00725985|20840869|P9|OLMP|Death|0
6029414|NCT00725985|20840870|P8|OLMP|Death|0
6029415|NCT00725985|20840871|P7|OLMP|Death|0
6029416|NCT00725985|20840872|P6|OLMP|Death|0
6029417|NCT00725985|20840873|P5|OLMP|Death|1
6029418|NCT00725985|20840874|P4|OLMP|Death|0
6029419|NCT00725985|20840875|P3|OLMP|Death|0
6029420|NCT00725985|20840876|P2|OLMP|Death|0
6029421|NCT00725985|20840877|P1|OLMP|Death|0
6029422|NCT00725985|20840866|P12|OLMP|Adverse Event|0
6029423|NCT00725985|20840867|P11|OLMP|Adverse Event|0
6029424|NCT00725985|20840868|P10|OLMP|Adverse Event|0
6029425|NCT00725985|20840869|P9|OLMP|Adverse Event|0
6029426|NCT00725985|20840870|P8|OLMP|Adverse Event|0
6029427|NCT00725985|20840871|P7|OLMP|Adverse Event|0
6029428|NCT00725985|20840872|P6|OLMP|Adverse Event|5
6029429|NCT00725985|20840873|P5|OLMP|Adverse Event|2
6029430|NCT00725985|20840874|P4|OLMP|Adverse Event|2
6029431|NCT00725985|20840875|P3|OLMP|Adverse Event|0
6029432|NCT00725985|20840876|P2|OLMP|Adverse Event|0
6029433|NCT00725985|20840877|P1|OLMP|Adverse Event|0
6029434|NCT00725985|20840866|P12|ITP (Up to 96 Weeks)|Other|0
6029435|NCT00725985|20840867|P11|ITP (Up to 96 Weeks)|Other|0
6029436|NCT00725985|20840868|P10|ITP (Up to 96 Weeks)|Other|0
6029437|NCT00725985|20840869|P9|ITP (Up to 96 Weeks)|Other|0
6029438|NCT00725985|20840870|P8|ITP (Up to 96 Weeks)|Other|0
6029439|NCT00725985|20840871|P7|ITP (Up to 96 Weeks)|Other|0
6029440|NCT00725985|20840872|P6|ITP (Up to 96 Weeks)|Other|0
6029441|NCT00725985|20840873|P5|ITP (Up to 96 Weeks)|Other|0
6029442|NCT00725985|20840874|P4|ITP (Up to 96 Weeks)|Other|0
6029443|NCT00725985|20840875|P3|ITP (Up to 96 Weeks)|Other|24
6029444|NCT00725985|20840876|P2|ITP (Up to 96 Weeks)|Other|38
6029445|NCT00725985|20840877|P1|ITP (Up to 96 Weeks)|Other|50
6029446|NCT00725985|20840866|P12|ITP (Up to 96 Weeks)|Converted to CDMS|0
6029447|NCT00725985|20840867|P11|ITP (Up to 96 Weeks)|Converted to CDMS|0
6029448|NCT00725985|20840868|P10|ITP (Up to 96 Weeks)|Converted to CDMS|0
6029449|NCT00725985|20840869|P9|ITP (Up to 96 Weeks)|Converted to CDMS|0
6029450|NCT00725985|20840870|P8|ITP (Up to 96 Weeks)|Converted to CDMS|0
6029451|NCT00725985|20840871|P7|ITP (Up to 96 Weeks)|Converted to CDMS|0
6029452|NCT00725985|20840872|P6|ITP (Up to 96 Weeks)|Converted to CDMS|0
6029453|NCT00725985|20840873|P5|ITP (Up to 96 Weeks)|Converted to CDMS|0
6029454|NCT00725985|20840874|P4|ITP (Up to 96 Weeks)|Converted to CDMS|0
6029455|NCT00725985|20840875|P3|ITP (Up to 96 Weeks)|Converted to CDMS|71
6029456|NCT00725985|20840876|P2|ITP (Up to 96 Weeks)|Converted to CDMS|27
6029457|NCT00725985|20840877|P1|ITP (Up to 96 Weeks)|Converted to CDMS|30
6029458|NCT00725985|20840866|P12|ITP (Up to 96 Weeks)|Randomized but not treated|0
6029459|NCT00725985|20840867|P11|ITP (Up to 96 Weeks)|Randomized but not treated|0
6029460|NCT00725985|20840868|P10|ITP (Up to 96 Weeks)|Randomized but not treated|0
6029461|NCT00725985|20840869|P9|ITP (Up to 96 Weeks)|Randomized but not treated|0
6029462|NCT00725985|20840870|P8|ITP (Up to 96 Weeks)|Randomized but not treated|0
6029463|NCT00725985|20840871|P7|ITP (Up to 96 Weeks)|Randomized but not treated|0
6029464|NCT00725985|20840872|P6|ITP (Up to 96 Weeks)|Randomized but not treated|0
6029465|NCT00725985|20840873|P5|ITP (Up to 96 Weeks)|Randomized but not treated|0
6029466|NCT00725985|20840874|P4|ITP (Up to 96 Weeks)|Randomized but not treated|0
6029467|NCT00725985|20840875|P3|ITP (Up to 96 Weeks)|Randomized but not treated|0
6029468|NCT00725985|20840876|P2|ITP (Up to 96 Weeks)|Randomized but not treated|0
6029469|NCT00725985|20840877|P1|ITP (Up to 96 Weeks)|Randomized but not treated|1
6029470|NCT00725985|20840866|P12|ITP (Up to 96 Weeks)|Lost to Follow-up|0
6029471|NCT00725985|20840867|P11|ITP (Up to 96 Weeks)|Lost to Follow-up|0
6029472|NCT00725985|20840868|P10|ITP (Up to 96 Weeks)|Lost to Follow-up|0
6029473|NCT00725985|20840869|P9|ITP (Up to 96 Weeks)|Lost to Follow-up|0
6029474|NCT00725985|20840870|P8|ITP (Up to 96 Weeks)|Lost to Follow-up|0
6029475|NCT00725985|20840871|P7|ITP (Up to 96 Weeks)|Lost to Follow-up|0
6029476|NCT00725985|20840872|P6|ITP (Up to 96 Weeks)|Lost to Follow-up|0
6029477|NCT00725985|20840873|P5|ITP (Up to 96 Weeks)|Lost to Follow-up|0
6029478|NCT00725985|20840874|P4|ITP (Up to 96 Weeks)|Lost to Follow-up|0
6029479|NCT00725985|20840875|P3|ITP (Up to 96 Weeks)|Lost to Follow-up|2
6029480|NCT00725985|20840876|P2|ITP (Up to 96 Weeks)|Lost to Follow-up|0
6029481|NCT00725985|20840877|P1|ITP (Up to 96 Weeks)|Lost to Follow-up|0
6029482|NCT00725985|20840866|P12|ITP (Up to 96 Weeks)|Adverse Event|0
6029483|NCT00725985|20840867|P11|ITP (Up to 96 Weeks)|Adverse Event|0
6029484|NCT00725985|20840868|P10|ITP (Up to 96 Weeks)|Adverse Event|0
6029485|NCT00725985|20840869|P9|ITP (Up to 96 Weeks)|Adverse Event|0
6029486|NCT00725985|20840870|P8|ITP (Up to 96 Weeks)|Adverse Event|0
6029487|NCT00725985|20840871|P7|ITP (Up to 96 Weeks)|Adverse Event|0
6029488|NCT00725985|20840872|P6|ITP (Up to 96 Weeks)|Adverse Event|0
6029489|NCT00725985|20840873|P5|ITP (Up to 96 Weeks)|Adverse Event|0
6029490|NCT00725985|20840874|P4|ITP (Up to 96 Weeks)|Adverse Event|0
6029491|NCT00725985|20840875|P3|ITP (Up to 96 Weeks)|Adverse Event|5
6029492|NCT00725985|20840876|P2|ITP (Up to 96 Weeks)|Adverse Event|10
6029493|NCT00725985|20840877|P1|ITP (Up to 96 Weeks)|Adverse Event|20
6029494|NCT00725920|20840914|P2|Overall Study|Lack of Efficacy|6
6029495|NCT00725920|20840915|P1|Overall Study|Lack of Efficacy|3
6029496|NCT00725842|20840921|P1|Overall Study|No Visit 1 data|1
6029497|NCT00725842|20840921|P1|Overall Study|Inclusion criterion not met|1
6029498|NCT00725842|20840921|P1|Overall Study|Consent date prior to study start date|5
6029499|NCT00725842|20840921|P1|Overall Study|Positive HCV-RNA at Visit 2|13
6029500|NCT00725842|20840921|P1|Overall Study|Death|1
6029501|NCT00725842|20840921|P1|Overall Study|Lost to Follow-up|19
6029502|NCT00725764|20840928|P1|Overall Study|Decline in performance status|1
6029503|NCT00725764|20840928|P1|Overall Study|Participant non compliant with protocol|1
6029504|NCT00725764|20840928|P1|Overall Study|Death|1
6029505|NCT00725764|20840928|P1|Overall Study|Lost to Follow-up|1
6029506|NCT00725764|20840928|P1|Overall Study|Progressive Disease|7
6029507|NCT00725764|20840928|P1|Overall Study|Physician Decision|1
6029508|NCT00725764|20840928|P1|Overall Study|Withdrawal by Subject|2
6029509|NCT00725725|20840961|P3|Overall Study|Protocol Violation|0
6029510|NCT00725725|20840962|P2|Overall Study|Protocol Violation|1
6029511|NCT00725725|20840963|P1|Overall Study|Protocol Violation|0
6029512|NCT00725725|20840961|P3|Overall Study|Withdrawal by Subject|1
6029513|NCT00725725|20840962|P2|Overall Study|Withdrawal by Subject|0
6029514|NCT00725725|20840963|P1|Overall Study|Withdrawal by Subject|1
6029515|NCT00725725|20840961|P3|Overall Study|Lost to Follow-up|2
6029516|NCT00725725|20840962|P2|Overall Study|Lost to Follow-up|0
6029517|NCT00725725|20840963|P1|Overall Study|Lost to Follow-up|2
6029518|NCT00725725|20840961|P3|Overall Study|Adverse Event|2
6029519|NCT00725725|20840962|P2|Overall Study|Adverse Event|3
6029520|NCT00725725|20840963|P1|Overall Study|Adverse Event|1
6029521|NCT00725712|20841006|P2|Overall Study|Hospitalized, unable to continue|1
6029522|NCT00725712|20841007|P1|Overall Study|Hospitalized, unable to continue|0
6029523|NCT00725712|20841006|P2|Overall Study|Other: Death|0
6029524|NCT00725712|20841007|P1|Overall Study|Other: Death|1
6029525|NCT00725712|20841006|P2|Overall Study|Death|0
6029526|NCT00725712|20841007|P1|Overall Study|Death|2
6029527|NCT00725712|20841006|P2|Overall Study|Adverse Event|5
6029528|NCT00725712|20841007|P1|Overall Study|Adverse Event|5
6029529|NCT00725712|20841006|P2|Overall Study|Clinical progression not based on RECIST|3
6029530|NCT00725712|20841007|P1|Overall Study|Clinical progression not based on RECIST|0
6029531|NCT00725712|20841006|P2|Overall Study|Progressive disease|16
6029532|NCT00725712|20841007|P1|Overall Study|Progressive disease|37
6029533|NCT00725712|20841006|P2|Overall Study|Protocol Violation|0
6029534|NCT00725712|20841007|P1|Overall Study|Protocol Violation|1
6029535|NCT00725712|20841006|P2|Overall Study|Withdrawal by Subject|1
6029536|NCT00725712|20841007|P1|Overall Study|Withdrawal by Subject|2
6029537|NCT00725621|20841043|P1|Overall Study|Reason not specified|55
6029538|NCT00725621|20841043|P1|Overall Study|Prepared for elective surgery|1
6029539|NCT00725621|20841043|P1|Overall Study|Switched to other drug|1
6029540|NCT00725621|20841043|P1|Overall Study|Switched to other study|1
6029541|NCT00725621|20841043|P1|Overall Study|Continued treatment by other physician|6
6029542|NCT00725621|20841043|P1|Overall Study|Non-compliance|8
6029543|NCT00725621|20841043|P1|Overall Study|Lost to Follow-up|52
6029544|NCT00725621|20841043|P1|Overall Study|Physician Decision|19
6029545|NCT00725621|20841043|P1|Overall Study|Withdrawal by Subject|57
6029546|NCT00725621|20841043|P1|Overall Study|Lack of Efficacy|46
6029547|NCT00725621|20841043|P1|Overall Study|Adverse Event|25
6029548|NCT00725608|20841066|P1|Overall Study|Other|7
6029549|NCT00725608|20841066|P1|Overall Study|Individual reasons|86
6029550|NCT00725608|20841066|P1|Overall Study|Adverse Event|14
6029551|NCT00725608|20841066|P1|Overall Study|Lost to Follow-up|60
6029552|NCT00725543|20841072|P1|Overall Study|Other|119
6029553|NCT00725543|20841072|P1|Overall Study|Non-compliance|2
6029554|NCT00725543|20841072|P1|Overall Study|Lost to Follow-up|4
6029555|NCT00725543|20841072|P1|Overall Study|Physician Decision|5
6029556|NCT00725543|20841072|P1|Overall Study|Withdrawal by Subject|10
6029557|NCT00725543|20841072|P1|Overall Study|Lack of Efficacy|3
6029558|NCT00725543|20841072|P1|Overall Study|Adverse Event|10
6029559|NCT00725491|20841097|P2|Overall Study|No/too few embryos/ bad quality embryos|2
6029560|NCT00725491|20841098|P1|Overall Study|No/too few embryos/ bad quality embryos|3
6029561|NCT00725491|20841097|P2|Overall Study|Fertilization failure|1
6029562|NCT00725491|20841098|P1|Overall Study|Fertilization failure|0
6029563|NCT00725491|20841097|P2|Overall Study|No/too few oocytes/bad quality oocytes|1
6029564|NCT00725491|20841098|P1|Overall Study|No/too few oocytes/bad quality oocytes|1
6029565|NCT00725491|20841097|P2|Overall Study|Risk for hyperstimulation|9
6029566|NCT00725491|20841098|P1|Overall Study|Risk for hyperstimulation|2
6029567|NCT00725491|20841097|P2|Overall Study|Pregnancy|3
6029568|NCT00725491|20841098|P1|Overall Study|Pregnancy|0
6029569|NCT00725491|20841097|P2|Overall Study|Adverse Event|2
6029570|NCT00725491|20841098|P1|Overall Study|Adverse Event|3
6029571|NCT00725452|20841104|P1|Overall Study|Lost to Follow-up|1
6029572|NCT00725452|20841104|P1|Overall Study|Withdrawal by Subject|3
6029573|NCT00725452|20841104|P1|Overall Study|Physician Decision|1
6029574|NCT00725452|20841104|P1|Overall Study|Reason not specified|1
6029575|NCT00725452|20841104|P1|Overall Study|Lack of Efficacy|2
6029576|NCT00725452|20841104|P1|Overall Study|Adverse Event|3
6029577|NCT00725322|20841123|P2|Washout (28 Days)|Protocol Violation|1
6029578|NCT00725322|20841124|P1|Washout (28 Days)|Protocol Violation|0
6029579|NCT00725322|20841123|P2|Washout (28 Days)|Withdrawal by Subject|0
6029580|NCT00725322|20841124|P1|Washout (28 Days)|Withdrawal by Subject|2
6029581|NCT00725296|20841132|P1|Overall Study|Other|38
6029582|NCT00725296|20841132|P1|Overall Study|Lost to Follow-up|1
6029583|NCT00725296|20841132|P1|Overall Study|Non-Compliance|2
6029584|NCT00725296|20841132|P1|Overall Study|Withdrawal by Subject|3
6029585|NCT00725296|20841132|P1|Overall Study|Lack of Efficacy|7
6029586|NCT00725296|20841132|P1|Overall Study|Adverse Event|11
6029587|NCT00725283|20841141|P1|Overall Study|Withdrawal by Subject|10
6029588|NCT00725283|20841141|P1|Overall Study|Other|6
6029589|NCT00725283|20841141|P1|Overall Study|Death|5
6029590|NCT00725283|20841141|P1|Overall Study|Missing Code|3
6029591|NCT00725205|20841162|P1|Overall Study|Treatment Failure|41
6029592|NCT00725205|20841162|P1|Overall Study|Protocol Defined Clinical Event|1
6029593|NCT00725205|20841162|P1|Overall Study|Other|8
6029594|NCT00725205|20841162|P1|Overall Study|Non-compliance With Protocol|14
6029595|NCT00725205|20841162|P1|Overall Study|Investigator Discontinued|1
6029596|NCT00725205|20841162|P1|Overall Study|Adverse Event|22
6029597|NCT00725101|20841175|P1|Overall Study|not specified/no reason given|11
6029598|NCT00725101|20841175|P1|Overall Study|Withdrawal by Subject|127
6029599|NCT00725101|20841175|P1|Overall Study|Protocol Violation|1
6029600|NCT00725101|20841175|P1|Overall Study|Lost to Follow-up|353
6029601|NCT00725101|20841175|P1|Overall Study|Death|3
6029602|NCT00725075|20841198|P3|Overall Study|Other|0
6029603|NCT00725075|20841199|P2|Overall Study|Other|0
6029604|NCT00725075|20841200|P1|Overall Study|Other|1
6029605|NCT00725075|20841198|P3|Overall Study|Inclusion/Exclusion Criteria|1
6029606|NCT00725075|20841199|P2|Overall Study|Inclusion/Exclusion Criteria|0
6029607|NCT00725075|20841200|P1|Overall Study|Inclusion/Exclusion Criteria|1
6029608|NCT00725075|20841198|P3|Overall Study|Worsening of Disease|2
6029609|NCT00725075|20841199|P2|Overall Study|Worsening of Disease|1
6029610|NCT00725075|20841200|P1|Overall Study|Worsening of Disease|2
6029611|NCT00725075|20841198|P3|Overall Study|Adverse Event|1
6029612|NCT00725075|20841199|P2|Overall Study|Adverse Event|1
6029613|NCT00725075|20841200|P1|Overall Study|Adverse Event|2
6029614|NCT00725075|20841198|P3|Overall Study|Withdrawal by Subject|4
6029615|NCT00725075|20841199|P2|Overall Study|Withdrawal by Subject|5
6029616|NCT00725075|20841200|P1|Overall Study|Withdrawal by Subject|4
6029617|NCT00725075|20841198|P3|Overall Study|Lost to Follow-up|0
6029618|NCT00725075|20841199|P2|Overall Study|Lost to Follow-up|0
6029619|NCT00725075|20841200|P1|Overall Study|Lost to Follow-up|1
6029620|NCT00725075|20841198|P3|Overall Study|Protocol Violation|1
6029621|NCT00725075|20841199|P2|Overall Study|Protocol Violation|0
6029622|NCT00725075|20841200|P1|Overall Study|Protocol Violation|0
6029623|NCT00725075|20841198|P3|Overall Study|Use of Excluded Medication|0
6029624|NCT00725075|20841199|P2|Overall Study|Use of Excluded Medication|1
6029625|NCT00725075|20841200|P1|Overall Study|Use of Excluded Medication|0
6029626|NCT00725010|20841253|P1|Overall Study|Intensified treatment scheme: 3 on 1 off|2
6029627|NCT00725010|20841253|P1|Overall Study|No further documentation|1
6029628|NCT00725010|20841253|P1|Overall Study|Suspect lymph nodes neck thorax abdomen|1
6029629|NCT00725010|20841253|P1|Overall Study|Hepatopathy probably not Temodal-related|1
6029630|NCT00725010|20841253|P1|Overall Study|Lost to Follow-up|1
6029631|NCT00725010|20841253|P1|Overall Study|Death|1
6029632|NCT00725010|20841253|P1|Overall Study|Withdrawal by Subject|2
6029633|NCT00725010|20841253|P1|Overall Study|Tumor Progression|7
6029634|NCT00725010|20841253|P1|Overall Study|Toxicity|9
6029635|NCT00724971|20841286|P1|Overall Study|Withdrawal by Subject|1
6029636|NCT00724971|20841286|P1|Overall Study|Adverse Event|5
6029637|NCT00724958|20841301|P1|Overall Study|No documentation for end of therapy|13
6029638|NCT00724958|20841301|P1|Overall Study|Other Reason|76
6029639|NCT00724958|20841301|P1|Overall Study|Remission|7
6029640|NCT00724958|20841301|P1|Overall Study|No Response|18
6029641|NCT00724958|20841301|P1|Overall Study|Loss of Response|40
6029642|NCT00724958|20841301|P1|Overall Study|Adverse Event|28
6029643|NCT00724945|20841310|P2|Period 2|lens physiology issue|0
6029644|NCT00724945|20841311|P1|Period 2|lens physiology issue|1
6029645|NCT00724945|20841310|P2|Period 2|lens comfort issue|0
6029646|NCT00724945|20841311|P1|Period 2|lens comfort issue|3
6029647|NCT00724945|20841310|P2|Period 1|Lost to Follow-up|0
6029648|NCT00724945|20841311|P1|Period 1|Lost to Follow-up|1
6029649|NCT00724945|20841310|P2|Period 1|Adverse Event|1
6029650|NCT00724945|20841311|P1|Period 1|Adverse Event|1
6029651|NCT00724945|20841310|P2|Period 1|non-compliance|0
6029652|NCT00724945|20841311|P1|Period 1|non-compliance|1
6029653|NCT00724932|20841323|P2|Overall Study|Not treated|3
6029654|NCT00724932|20841324|P1|Overall Study|Not treated|4
6029655|NCT00724932|20841323|P2|Overall Study|Lost to Follow-up|0
6029656|NCT00724932|20841324|P1|Overall Study|Lost to Follow-up|1
6029657|NCT00724893|20841395|P2|Overall Study|Unknown, missing data|1
6029658|NCT00724893|20841396|P1|Overall Study|Unknown, missing data|1
6029659|NCT00724893|20841395|P2|Overall Study|Lost to Follow-up|52
6029660|NCT00724893|20841396|P1|Overall Study|Lost to Follow-up|0
6029661|NCT00724893|20841395|P2|Overall Study|Assigned shorter treatment|2
6029662|NCT00724893|20841396|P1|Overall Study|Assigned shorter treatment|0
6029663|NCT00724893|20841395|P2|Overall Study|Financial reasons|2
6029664|NCT00724893|20841396|P1|Overall Study|Financial reasons|0
6029665|NCT00724893|20841395|P2|Overall Study|Substance abuse|3
6029666|NCT00724893|20841396|P1|Overall Study|Substance abuse|0
6029667|NCT00724893|20841395|P2|Overall Study|Incarceration|9
6029668|NCT00724893|20841396|P1|Overall Study|Incarceration|0
6029669|NCT00724893|20841395|P2|Overall Study|Geographic reasons|11
6029670|NCT00724893|20841396|P1|Overall Study|Geographic reasons|0
6029671|NCT00724893|20841395|P2|Overall Study|Patient choice|26
6029672|NCT00724893|20841396|P1|Overall Study|Patient choice|0
6029673|NCT00724893|20841395|P2|Overall Study|Reason not specified|7
6029674|NCT00724893|20841396|P1|Overall Study|Reason not specified|193
6029675|NCT00724893|20841395|P2|Overall Study|Lack of virologic response|202
6029676|NCT00724893|20841396|P1|Overall Study|Lack of virologic response|94
6029677|NCT00724893|20841395|P2|Overall Study|Withdrawal by Subject|1
6029678|NCT00724893|20841396|P1|Overall Study|Withdrawal by Subject|0
6029679|NCT00724893|20841395|P2|Overall Study|Adverse Event|142
6029680|NCT00724893|20841396|P1|Overall Study|Adverse Event|76
6029681|NCT00724867|20841464|P1|Overall Study|Elected to exit due to site closure|2
6029682|NCT00724867|20841464|P1|Overall Study|Subject moved out of state|1
6029683|NCT00724867|20841464|P1|Overall Study|Developed withdrawal criteria- pregnancy|4
6029684|NCT00724867|20841464|P1|Overall Study|Subject incarcerated|1
6029685|NCT00724867|20841464|P1|Overall Study|Sponsor decision to end study|14
6029686|NCT00724867|20841464|P1|Overall Study|Withdrawal by Subject|31
6029687|NCT00724867|20841464|P1|Overall Study|Protocol Violation|1
6029688|NCT00724867|20841464|P1|Overall Study|Physician Decision|17
6029689|NCT00724867|20841464|P1|Overall Study|Non-compliance with study drug|6
6029690|NCT00724867|20841464|P1|Overall Study|Lost to Follow-up|12
6029691|NCT00724867|20841464|P1|Overall Study|Lack of Efficacy|14
6029692|NCT00724867|20841464|P1|Overall Study|Adverse Event|25
6029693|NCT00724854|20841504|P2|Overall Study|Adverse event + lack of efficacy|1
6029694|NCT00724854|20841505|P1|Overall Study|Adverse event + lack of efficacy|2
6029695|NCT00724854|20841504|P2|Overall Study|Withdrawal by Subject|0
6029696|NCT00724854|20841505|P1|Overall Study|Withdrawal by Subject|5
6029697|NCT00724854|20841504|P2|Overall Study|Change of treatment|0
6029698|NCT00724854|20841505|P1|Overall Study|Change of treatment|7
6029699|NCT00724854|20841504|P2|Overall Study|Death|0
6029700|NCT00724854|20841505|P1|Overall Study|Death|11
6029701|NCT00724854|20841504|P2|Overall Study|Other|3
6029702|NCT00724854|20841505|P1|Overall Study|Other|42
6029703|NCT00724854|20841504|P2|Overall Study|Adverse Event|4
6029704|NCT00724854|20841505|P1|Overall Study|Adverse Event|62
6029705|NCT00724854|20841504|P2|Overall Study|Lost to Follow-up|10
6029706|NCT00724854|20841505|P1|Overall Study|Lost to Follow-up|87
6029707|NCT00724854|20841504|P2|Overall Study|Lack of Efficacy|13
6029708|NCT00724854|20841505|P1|Overall Study|Lack of Efficacy|187
6029709|NCT00724815|20841522|P2|Overall Study|Other Various|5
6029710|NCT00724815|20841523|P1|Overall Study|Other Various|3
6029711|NCT00724815|20841522|P2|Overall Study|Lost to Follow-up|1
6029712|NCT00724815|20841523|P1|Overall Study|Lost to Follow-up|4
6029713|NCT00724815|20841522|P2|Overall Study|Adverse Event|3
6029714|NCT00724815|20841523|P1|Overall Study|Adverse Event|5
6029715|NCT00724815|20841522|P2|Overall Study|Randomized, not treated|30
6029716|NCT00724815|20841523|P1|Overall Study|Randomized, not treated|31
6029717|NCT00724711|20841556|P2|Overall Study|Protocol Violation|0
6029718|NCT00724711|20841557|P1|Overall Study|Protocol Violation|1
6029719|NCT00724711|20841556|P2|Overall Study|Lost to Follow-up|5
6029720|NCT00724711|20841557|P1|Overall Study|Lost to Follow-up|4
6029721|NCT00724711|20841556|P2|Overall Study|Withdrawal by Subject|4
6029722|NCT00724711|20841557|P1|Overall Study|Withdrawal by Subject|5
6029723|NCT00724711|20841556|P2|Overall Study|Physician Decision|3
6029724|NCT00724711|20841557|P1|Overall Study|Physician Decision|0
6029725|NCT00724711|20841556|P2|Overall Study|Lack of Efficacy|1
6029726|NCT00724711|20841557|P1|Overall Study|Lack of Efficacy|0
6029727|NCT00724711|20841556|P2|Overall Study|Pregnancy|1
6029728|NCT00724711|20841557|P1|Overall Study|Pregnancy|0
6029729|NCT00724711|20841556|P2|Overall Study|Adverse Event|3
6029730|NCT00724711|20841557|P1|Overall Study|Adverse Event|7
6029731|NCT00724698|20841589|P1|Overall Study|No Info|25
6029732|NCT00724698|20841589|P1|Overall Study|Lost to Follow-up|36
6029733|NCT00724698|20841589|P1|Overall Study|Poor Compliance|16
6029734|NCT00724698|20841589|P1|Overall Study|Failure of Therapy|4
6029735|NCT00724698|20841589|P1|Overall Study|Adverse Event|9
6029736|NCT00724503|20841642|P2|Overall Study|Not otherwise specified|7
6029737|NCT00724503|20841643|P1|Overall Study|Not otherwise specified|4
6029738|NCT00724503|20841642|P2|Overall Study|Adverse Event|0
6029739|NCT00724503|20841643|P1|Overall Study|Adverse Event|1
6029740|NCT00724503|20841642|P2|Overall Study|Death|182
6029741|NCT00724503|20841643|P1|Overall Study|Death|190
6029742|NCT00724503|20841642|P2|Overall Study|Withdrawal by Subject|23
6029743|NCT00724503|20841643|P1|Overall Study|Withdrawal by Subject|11
6029744|NCT00724503|20841642|P2|Overall Study|Lost to Follow-up|8
6029745|NCT00724503|20841643|P1|Overall Study|Lost to Follow-up|4
6029746|NCT00724451|20841667|P1|Overall Study|Investigator + Participant Decision|13
6029747|NCT00724451|20841667|P1|Overall Study|Withdrawal by Subject|45
6029748|NCT00724451|20841667|P1|Overall Study|Physician Decision|116
6029749|NCT00724451|20841667|P1|Overall Study|Unknown; No Data Sources Available|9
6029750|NCT00724451|20841667|P1|Overall Study|Never Started Treatment|89
6029751|NCT00724451|20841667|P1|Overall Study|Participant Refused Treatment|89
6029752|NCT00724451|20841667|P1|Overall Study|Not Eligible for Treatment|431
6029753|NCT00724451|20841667|P1|Overall Study|Excluded - Hepatitis C Virus Negative|3
6029754|NCT00724451|20841667|P1|Overall Study|Excluded - Prior Use of Peginterferon|7
6029755|NCT00724373|20841673|P1|Overall Study|Tolerability|23
6029756|NCT00724373|20841673|P1|Overall Study|Drug Relapse|1
6029757|NCT00724373|20841673|P1|Overall Study|Acute HCV infection|1
6029758|NCT00724373|20841673|P1|Overall Study|Viral Relapse|1
6029759|NCT00724373|20841673|P1|Overall Study|Only to have 24 week regimen|1
6029760|NCT00724373|20841673|P1|Overall Study|Responder at 12 weeks, PCR + at 24 weeks|2
6029761|NCT00724373|20841673|P1|Overall Study|Participant moved away|1
6029762|NCT00724373|20841673|P1|Overall Study|HCV RNA negative after 4 weeks|9
6029763|NCT00724373|20841673|P1|Overall Study|Non-compliance|2
6029764|NCT00724373|20841673|P1|Overall Study|Lost to Follow-up|7
6029765|NCT00724373|20841673|P1|Overall Study|Lack of Efficacy|82
6029766|NCT00724373|20841673|P1|Overall Study|Adverse Event|41
6029767|NCT00724282|20841698|P1|Overall Study|Physician Decision|1
6029768|NCT00724282|20841698|P1|Overall Study|Withdrawal by Subject|3
6029769|NCT00724243|20841702|P1|Overall Study|Adverse Event|5
6029770|NCT00724243|20841702|P1|Overall Study|Lack of Efficacy|10
6029771|NCT00724152|20841712|P3|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1
6029772|NCT00724152|20841713|P2|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|2
6029773|NCT00724152|20841714|P1|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1
6029774|NCT00724152|20841712|P3|Two-arm Study Period|Withdrawal by Subject|0
6029775|NCT00724152|20841713|P2|Two-arm Study Period|Withdrawal by Subject|2
6029776|NCT00724152|20841714|P1|Two-arm Study Period|Withdrawal by Subject|3
6029777|NCT00724126|20841731|P2|Overall Study|Subject had to leave vicinity of site|1
6029778|NCT00724126|20841732|P1|Overall Study|Subject had to leave vicinity of site|0
6029779|NCT00724126|20841731|P2|Overall Study|Subject randomized although ineligible|1
6029780|NCT00724126|20841732|P1|Overall Study|Subject randomized although ineligible|1
6029781|NCT00724126|20841731|P2|Overall Study|Noncompliance|1
6029782|NCT00724126|20841732|P1|Overall Study|Noncompliance|2
6029783|NCT00724126|20841731|P2|Overall Study|Lost to Follow-up|6
6029784|NCT00724126|20841732|P1|Overall Study|Lost to Follow-up|6
6029785|NCT00724126|20841731|P2|Overall Study|Withdrawal by Subject|6
6029786|NCT00724126|20841732|P1|Overall Study|Withdrawal by Subject|8
6029787|NCT00724126|20841731|P2|Overall Study|Adverse Event|0
6029788|NCT00724126|20841732|P1|Overall Study|Adverse Event|2
6029789|NCT00724061|20841740|P1|Dose Escalation Phase|Disease Progression|3
6029790|NCT00724061|20841740|P1|Dose Escalation Phase|Adverse Event|2
6029791|NCT00723957|20841760|P2|Overall Study|Never received treatment|3
6029792|NCT00723957|20841761|P1|Overall Study|Never received treatment|3
6029793|NCT00723957|20841760|P2|Overall Study|Reason not analyzed|0
6029794|NCT00723957|20841761|P1|Overall Study|Reason not analyzed|1
6029795|NCT00723957|20841760|P2|Overall Study|Withdrawal by Subject|5
6029796|NCT00723957|20841761|P1|Overall Study|Withdrawal by Subject|7
6029797|NCT00723957|20841760|P2|Overall Study|Study drug toxicity|6
6029798|NCT00723957|20841761|P1|Overall Study|Study drug toxicity|4
6029799|NCT00723957|20841760|P2|Overall Study|Investigator decision|1
6029800|NCT00723957|20841761|P1|Overall Study|Investigator decision|1
6029801|NCT00723957|20841760|P2|Overall Study|Maximum clinical benefit|5
6029802|NCT00723957|20841761|P1|Overall Study|Maximum clinical benefit|4
6029803|NCT00723957|20841760|P2|Overall Study|Disease progression|25
6029804|NCT00723957|20841761|P1|Overall Study|Disease progression|27
6029805|NCT00723957|20841760|P2|Overall Study|Death|4
6029806|NCT00723957|20841761|P1|Overall Study|Death|3
6029807|NCT00723957|20841760|P2|Overall Study|Adverse event unrelated to study drug|4
6029808|NCT00723957|20841761|P1|Overall Study|Adverse event unrelated to study drug|1
6029809|NCT00723944|20841785|P2|One Year Post Placement Follow-up|Lost to Follow-up|4
6029810|NCT00723944|20841786|P1|One Year Post Placement Follow-up|Lost to Follow-up|1
6029811|NCT00723944|20841785|P2|Permanent Prosthesis Placement|Lost to Follow-up|2
6029812|NCT00723944|20841786|P1|Permanent Prosthesis Placement|Lost to Follow-up|2
6029813|NCT00723944|20841785|P2|Permanent Prosthesis Placement|Adverse Event|7
6029814|NCT00723944|20841786|P1|Permanent Prosthesis Placement|Adverse Event|1
6029815|NCT00723892|20841799|P2|Overall Study|Drug addiction|0
6029816|NCT00723892|20841800|P1|Overall Study|Drug addiction|1
6029817|NCT00723892|20841799|P2|Overall Study|Intercurrent infection|0
6029818|NCT00723892|20841800|P1|Overall Study|Intercurrent infection|2
6029819|NCT00723892|20841799|P2|Overall Study|Alcohol abuse|1
6029820|NCT00723892|20841800|P1|Overall Study|Alcohol abuse|0
6029821|NCT00723892|20841799|P2|Overall Study|Weight loss|3
6029822|NCT00723892|20841800|P1|Overall Study|Weight loss|1
6029823|NCT00723892|20841799|P2|Overall Study|Study end|3
6029824|NCT00723892|20841800|P1|Overall Study|Study end|1
6029825|NCT00723892|20841799|P2|Overall Study|Other|3
6029826|NCT00723892|20841800|P1|Overall Study|Other|6
6029827|NCT00723892|20841799|P2|Overall Study|Multiple reasons|12
6029828|NCT00723892|20841800|P1|Overall Study|Multiple reasons|17
6029829|NCT00723892|20841799|P2|Overall Study|Bad tolerance|5
6029830|NCT00723892|20841800|P1|Overall Study|Bad tolerance|5
6029831|NCT00723892|20841799|P2|Overall Study|End planned|7
6029832|NCT00723892|20841800|P1|Overall Study|End planned|11
6029833|NCT00723892|20841799|P2|Overall Study|Withdrawal by Subject|9
6029834|NCT00723892|20841800|P1|Overall Study|Withdrawal by Subject|6
6029835|NCT00723892|20841799|P2|Overall Study|Virological criterion|9
6029836|NCT00723892|20841800|P1|Overall Study|Virological criterion|24
6029837|NCT00723892|20841799|P2|Overall Study|Participant not tracked|35
6029838|NCT00723892|20841800|P1|Overall Study|Participant not tracked|33
6029839|NCT00723840|20841807|P1|Overall Study|Unspecified reason|2
6029840|NCT00723840|20841807|P1|Overall Study|Other Medical Event|2
6029841|NCT00723840|20841807|P1|Overall Study|Serious Adverse Events|3
6029842|NCT00723840|20841807|P1|Overall Study|Withdrawal by Subject|55
6029843|NCT00723840|20841807|P1|Overall Study|Failure to return|18
6029844|NCT00723840|20841807|P1|Overall Study|Lost to Follow-up|2
6029845|NCT00723801|20841828|P2|Overall Study|Protocol Violation|1
6029846|NCT00723801|20841829|P1|Overall Study|Protocol Violation|2
6029847|NCT00723801|20841828|P2|Overall Study|Lost to Follow-up|2
6029848|NCT00723801|20841829|P1|Overall Study|Lost to Follow-up|1
6029849|NCT00723710|20841854|P1|Overall Study|Physician Decision|2
6029850|NCT00723710|20841854|P1|Overall Study|Withdrawal by Subject|36
6029851|NCT00723710|20841854|P1|Overall Study|Adverse Event|88
6029852|NCT00723710|20841854|P1|Overall Study|Disease progression|48
6029853|NCT00723697|20841858|P1|Overall Study|Other exclusion criteria applied|6
6029854|NCT00723697|20841858|P1|Overall Study|Missing Informed Consent Form|10
6029855|NCT00723697|20841858|P1|Overall Study|Physician questionnaires not received|2
6029856|NCT00723606|20841879|P2|Overall Study|Withdrawal by Subject|2
6029857|NCT00723606|20841880|P1|Overall Study|Withdrawal by Subject|0
6029858|NCT00723606|20841879|P2|Overall Study|Other|0
6029859|NCT00723606|20841880|P1|Overall Study|Other|2
6029860|NCT00723606|20841879|P2|Overall Study|Adverse Event|5
6029861|NCT00723606|20841880|P1|Overall Study|Adverse Event|2
6029862|NCT00723554|20841900|P1|Overall Study|Non-compliance|1
6029863|NCT00723554|20841900|P1|Overall Study|Lost to Follow-up|1
6029864|NCT00723554|20841900|P1|Overall Study|Other|3
6029865|NCT00723554|20841900|P1|Overall Study|Withdrawal of consent|3
6029866|NCT00723554|20841900|P1|Overall Study|Inhaled medication other than iloprost|4
6029867|NCT00723554|20841900|P1|Overall Study|Investigator's judgement|5
6029868|NCT00723554|20841900|P1|Overall Study|Adverse Event|12
6029869|NCT00723528|20841950|P7|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|1
6029870|NCT00723528|20841951|P6|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
6029871|NCT00723528|20841952|P5|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
6029872|NCT00723528|20841953|P4|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
6029873|NCT00723528|20841954|P3|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
6029874|NCT00723528|20841955|P2|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
6029875|NCT00723528|20841956|P1|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
6029876|NCT00723528|20841950|P7|Period 2: After Controlled Period|Use of prohibited concomitant medication|1
6029877|NCT00723528|20841951|P6|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
6029878|NCT00723528|20841952|P5|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
6029879|NCT00723528|20841953|P4|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
6029880|NCT00723528|20841954|P3|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
6029881|NCT00723528|20841955|P2|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
6029882|NCT00723528|20841956|P1|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
6029883|NCT00723528|20841950|P7|Period 2: After Controlled Period|Adverse Event|1
6029884|NCT00723528|20841951|P6|Period 2: After Controlled Period|Adverse Event|0
6029885|NCT00723528|20841952|P5|Period 2: After Controlled Period|Adverse Event|1
6029886|NCT00723528|20841953|P4|Period 2: After Controlled Period|Adverse Event|0
6029887|NCT00723528|20841954|P3|Period 2: After Controlled Period|Adverse Event|0
6029888|NCT00723528|20841955|P2|Period 2: After Controlled Period|Adverse Event|0
6029889|NCT00723528|20841956|P1|Period 2: After Controlled Period|Adverse Event|0
6029890|NCT00723528|20841950|P7|Period 2: After Controlled Period|Other|0
6029891|NCT00723528|20841951|P6|Period 2: After Controlled Period|Other|4
6029892|NCT00723528|20841952|P5|Period 2: After Controlled Period|Other|1
6029893|NCT00723528|20841953|P4|Period 2: After Controlled Period|Other|0
6029894|NCT00723528|20841954|P3|Period 2: After Controlled Period|Other|0
6029895|NCT00723528|20841955|P2|Period 2: After Controlled Period|Other|0
6029896|NCT00723528|20841956|P1|Period 2: After Controlled Period|Other|0
6029897|NCT00723528|20841950|P7|Period 2: After Controlled Period|Onset of tuberculosis infection|0
6029898|NCT00723528|20841951|P6|Period 2: After Controlled Period|Onset of tuberculosis infection|1
6029899|NCT00723528|20841952|P5|Period 2: After Controlled Period|Onset of tuberculosis infection|0
6029900|NCT00723528|20841953|P4|Period 2: After Controlled Period|Onset of tuberculosis infection|0
6029901|NCT00723528|20841954|P3|Period 2: After Controlled Period|Onset of tuberculosis infection|0
6029902|NCT00723528|20841955|P2|Period 2: After Controlled Period|Onset of tuberculosis infection|0
6029903|NCT00723528|20841956|P1|Period 2: After Controlled Period|Onset of tuberculosis infection|0
6029904|NCT00723528|20841950|P7|Period 2: After Controlled Period|Withdrawal by Subject|1
6029905|NCT00723528|20841951|P6|Period 2: After Controlled Period|Withdrawal by Subject|1
6029906|NCT00723528|20841952|P5|Period 2: After Controlled Period|Withdrawal by Subject|0
6029907|NCT00723528|20841953|P4|Period 2: After Controlled Period|Withdrawal by Subject|1
6029908|NCT00723528|20841954|P3|Period 2: After Controlled Period|Withdrawal by Subject|0
6029909|NCT00723528|20841955|P2|Period 2: After Controlled Period|Withdrawal by Subject|0
6029910|NCT00723528|20841956|P1|Period 2: After Controlled Period|Withdrawal by Subject|0
6029911|NCT00723528|20841950|P7|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0
6029912|NCT00723528|20841951|P6|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0
6029913|NCT00723528|20841952|P5|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0
6029914|NCT00723528|20841953|P4|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0
6029915|NCT00723528|20841954|P3|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|1
6029916|NCT00723528|20841955|P2|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0
6029917|NCT00723528|20841956|P1|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|2
6029918|NCT00723528|20841950|P7|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
6029919|NCT00723528|20841951|P6|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
6029920|NCT00723528|20841952|P5|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
6029921|NCT00723528|20841953|P4|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
6029922|NCT00723528|20841954|P3|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|1
6029923|NCT00723528|20841955|P2|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
6029924|NCT00723528|20841956|P1|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
6029925|NCT00723528|20841950|P7|Period 1: Controlled Period (CP)|Physician Decision|0
6029926|NCT00723528|20841951|P6|Period 1: Controlled Period (CP)|Physician Decision|0
6029927|NCT00723528|20841952|P5|Period 1: Controlled Period (CP)|Physician Decision|0
6029928|NCT00723528|20841953|P4|Period 1: Controlled Period (CP)|Physician Decision|0
6029929|NCT00723528|20841954|P3|Period 1: Controlled Period (CP)|Physician Decision|1
6029930|NCT00723528|20841955|P2|Period 1: Controlled Period (CP)|Physician Decision|0
6029931|NCT00723528|20841956|P1|Period 1: Controlled Period (CP)|Physician Decision|0
6029932|NCT00723528|20841950|P7|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
6029933|NCT00723528|20841951|P6|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
6029934|NCT00723528|20841952|P5|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
6029935|NCT00723528|20841953|P4|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
6029936|NCT00723528|20841954|P3|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
6029937|NCT00723528|20841955|P2|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
6029938|NCT00723528|20841956|P1|Period 1: Controlled Period (CP)|Withdrawal by Subject|2
6029939|NCT00723528|20841950|P7|Period 1: Controlled Period (CP)|Adverse Event|0
6029940|NCT00723528|20841951|P6|Period 1: Controlled Period (CP)|Adverse Event|0
6029941|NCT00723528|20841952|P5|Period 1: Controlled Period (CP)|Adverse Event|0
6029942|NCT00723528|20841953|P4|Period 1: Controlled Period (CP)|Adverse Event|0
6029943|NCT00723528|20841954|P3|Period 1: Controlled Period (CP)|Adverse Event|1
6029944|NCT00723528|20841955|P2|Period 1: Controlled Period (CP)|Adverse Event|0
6029945|NCT00723528|20841956|P1|Period 1: Controlled Period (CP)|Adverse Event|0
6029946|NCT00723489|20842018|P4|Overall Study|Samples Collected Out of Window|0
6029947|NCT00723489|20842019|P3|Overall Study|Samples Collected Out of Window|0
6029948|NCT00723489|20842020|P2|Overall Study|Samples Collected Out of Window|3
6029949|NCT00723489|20842021|P1|Overall Study|Samples Collected Out of Window|0
6029950|NCT00723489|20842018|P4|Overall Study|Prohibited Medication|1
6029951|NCT00723489|20842019|P3|Overall Study|Prohibited Medication|0
6029952|NCT00723489|20842020|P2|Overall Study|Prohibited Medication|0
6029953|NCT00723489|20842021|P1|Overall Study|Prohibited Medication|0
6029954|NCT00723489|20842018|P4|Overall Study|Seropositive at baseline|0
6029955|NCT00723489|20842019|P3|Overall Study|Seropositive at baseline|0
6029956|NCT00723489|20842020|P2|Overall Study|Seropositive at baseline|0
6029957|NCT00723489|20842021|P1|Overall Study|Seropositive at baseline|1
6029958|NCT00723489|20842018|P4|Overall Study|Withdrawal by Subject|1
6029959|NCT00723489|20842019|P3|Overall Study|Withdrawal by Subject|0
6029960|NCT00723489|20842020|P2|Overall Study|Withdrawal by Subject|0
6029961|NCT00723489|20842021|P1|Overall Study|Withdrawal by Subject|0
6029962|NCT00723489|20842018|P4|Overall Study|Pregnancy|1
6029963|NCT00723489|20842019|P3|Overall Study|Pregnancy|0
6029964|NCT00723489|20842020|P2|Overall Study|Pregnancy|0
6029965|NCT00723489|20842021|P1|Overall Study|Pregnancy|0
6029966|NCT00723489|20842018|P4|Overall Study|Physician Decision|0
6029967|NCT00723489|20842019|P3|Overall Study|Physician Decision|0
6029968|NCT00723489|20842020|P2|Overall Study|Physician Decision|1
6029969|NCT00723489|20842021|P1|Overall Study|Physician Decision|0
6029970|NCT00723450|20842049|P3|Randomized Phase|Withdrawal by Subject|22
6029971|NCT00723450|20842050|P2|Randomized Phase|Withdrawal by Subject|14
6029972|NCT00723450|20842051|P1|Randomized Phase|Withdrawal by Subject|0
6029973|NCT00723450|20842049|P3|Randomized Phase|Physician Decision|1
6029974|NCT00723450|20842050|P2|Randomized Phase|Physician Decision|3
6029975|NCT00723450|20842051|P1|Randomized Phase|Physician Decision|0
6029976|NCT00723450|20842049|P3|Randomized Phase|Lost to Follow-up|3
6029977|NCT00723450|20842050|P2|Randomized Phase|Lost to Follow-up|2
6029978|NCT00723450|20842051|P1|Randomized Phase|Lost to Follow-up|0
6029979|NCT00723450|20842049|P3|Randomized Phase|Protocol Violation|13
6029980|NCT00723450|20842050|P2|Randomized Phase|Protocol Violation|9
6029981|NCT00723450|20842051|P1|Randomized Phase|Protocol Violation|0
6029982|NCT00723450|20842049|P3|Randomized Phase|Lack of Efficacy|11
6029983|NCT00723450|20842050|P2|Randomized Phase|Lack of Efficacy|11
6029984|NCT00723450|20842051|P1|Randomized Phase|Lack of Efficacy|0
6029985|NCT00723450|20842049|P3|Randomized Phase|Adverse Event|17
6029986|NCT00723450|20842050|P2|Randomized Phase|Adverse Event|26
6029987|NCT00723450|20842051|P1|Randomized Phase|Adverse Event|0
6029988|NCT00723450|20842049|P3|Open-Label Phase|Withdrawal by Subject|0
6029989|NCT00723450|20842050|P2|Open-Label Phase|Withdrawal by Subject|0
6029990|NCT00723450|20842051|P1|Open-Label Phase|Withdrawal by Subject|37
6029991|NCT00723450|20842049|P3|Open-Label Phase|Physician Decision|0
6029992|NCT00723450|20842050|P2|Open-Label Phase|Physician Decision|0
6029993|NCT00723450|20842051|P1|Open-Label Phase|Physician Decision|2
6029994|NCT00723450|20842049|P3|Open-Label Phase|Lost to Follow-up|0
6029995|NCT00723450|20842050|P2|Open-Label Phase|Lost to Follow-up|0
6029996|NCT00723450|20842051|P1|Open-Label Phase|Lost to Follow-up|7
6029997|NCT00723450|20842049|P3|Open-Label Phase|Protocol Violation|0
6029998|NCT00723450|20842050|P2|Open-Label Phase|Protocol Violation|0
6029999|NCT00723450|20842051|P1|Open-Label Phase|Protocol Violation|35
6030000|NCT00723450|20842049|P3|Open-Label Phase|Lack of Efficacy|0
6030001|NCT00723450|20842050|P2|Open-Label Phase|Lack of Efficacy|0
6030002|NCT00723450|20842051|P1|Open-Label Phase|Lack of Efficacy|18
6030003|NCT00723450|20842049|P3|Open-Label Phase|Adverse Event|0
6030004|NCT00723450|20842050|P2|Open-Label Phase|Adverse Event|0
6030005|NCT00723450|20842051|P1|Open-Label Phase|Adverse Event|26
6030006|NCT00723398|20842097|P5|Overall Study|Lost to Follow-up|0
6030007|NCT00723398|20842098|P4|Overall Study|Lost to Follow-up|0
6030008|NCT00723398|20842099|P3|Overall Study|Lost to Follow-up|0
6030009|NCT00723398|20842100|P2|Overall Study|Lost to Follow-up|1
6030010|NCT00723398|20842101|P1|Overall Study|Lost to Follow-up|0
6030011|NCT00723398|20842097|P5|Overall Study|Adverse Event|4
6030012|NCT00723398|20842098|P4|Overall Study|Adverse Event|1
6030013|NCT00723398|20842099|P3|Overall Study|Adverse Event|3
6030014|NCT00723398|20842100|P2|Overall Study|Adverse Event|5
6030015|NCT00723398|20842101|P1|Overall Study|Adverse Event|0
6030016|NCT00723398|20842097|P5|Overall Study|Physician Decision|1
6030017|NCT00723398|20842098|P4|Overall Study|Physician Decision|0
6030018|NCT00723398|20842099|P3|Overall Study|Physician Decision|5
6030019|NCT00723398|20842100|P2|Overall Study|Physician Decision|2
6030020|NCT00723398|20842101|P1|Overall Study|Physician Decision|2
6030021|NCT00723398|20842097|P5|Overall Study|Protocol Violation|0
6030022|NCT00723398|20842098|P4|Overall Study|Protocol Violation|0
6030023|NCT00723398|20842099|P3|Overall Study|Protocol Violation|5
6030024|NCT00723398|20842100|P2|Overall Study|Protocol Violation|1
6030025|NCT00723398|20842101|P1|Overall Study|Protocol Violation|2
6030026|NCT00723398|20842097|P5|Overall Study|Withdrawal by Subject|4
6030027|NCT00723398|20842098|P4|Overall Study|Withdrawal by Subject|4
6030028|NCT00723398|20842099|P3|Overall Study|Withdrawal by Subject|4
6030029|NCT00723398|20842100|P2|Overall Study|Withdrawal by Subject|6
6030030|NCT00723398|20842101|P1|Overall Study|Withdrawal by Subject|2
6030031|NCT00723294|20842163|P1|Overall Study|No treatment due to probe failure|1
6030032|NCT00723294|20842163|P1|Overall Study|Withdrawal by Subject|1
6030033|NCT00723294|20842163|P1|Overall Study|Benign lesion|1
6030034|NCT00723294|20842163|P1|Overall Study|Treated by non-credentialed surgeon|1
6030035|NCT00723294|20842163|P1|Overall Study|Treated prior to registration|1
6030036|NCT00723294|20842163|P1|Overall Study|Did not undergo surgery|1
6030037|NCT00723294|20842163|P1|Overall Study|No cryoabalation|2
6030038|NCT00723294|20842163|P1|Overall Study|1.0-Tesla MRI|1
6030039|NCT00723294|20842163|P1|Overall Study|No MRI tumor enhancement|1
6030040|NCT00723294|20842163|P1|Overall Study|>25% intraductal component|1
6030041|NCT00723294|20842163|P1|Overall Study|Lobular histology|2
6030042|NCT00723255|20842168|P1|Overall Study|Ineligible: Wrong Primary|2
6030043|NCT00723255|20842168|P1|Overall Study|Ineligible: Second primary|1
6030044|NCT00723255|20842168|P1|Overall Study|Ineligible: Inadequate pathology|1
6030045|NCT00723229|20842195|P2|First Intervention|Lost to Follow-up|3
6030046|NCT00723229|20842196|P1|First Intervention|Lost to Follow-up|7
6030047|NCT00723203|20842208|P1|Overall Study|Withdrawal by Subject|3
6030048|NCT00723190|20842212|P1|Overall Study|Other-Not included in safety population|2
6030049|NCT00723190|20842212|P1|Overall Study|Other-Premature Discontinuation|9
6030050|NCT00723190|20842212|P1|Overall Study|Protocol Violation|15
6030051|NCT00723190|20842212|P1|Overall Study|Lack of Efficacy|16
6030052|NCT00723190|20842212|P1|Overall Study|Adverse Event|18
6030053|NCT00723190|20842212|P1|Overall Study|Lost to Follow-up|37
6030054|NCT00723190|20842212|P1|Overall Study|Withdrawal by Subject|45
6030055|NCT00723125|20842245|P2|Overall Study|Adverse Event|0
6030056|NCT00723125|20842246|P1|Overall Study|Adverse Event|2
6030057|NCT00723125|20842245|P2|Overall Study|Withdrawal by Subject|6
6030058|NCT00723125|20842246|P1|Overall Study|Withdrawal by Subject|15
6030059|NCT00723125|20842245|P2|Overall Study|Met Dx|0
6030060|NCT00723125|20842246|P1|Overall Study|Met Dx|1
6030061|NCT00723021|20842295|P5|Intervention Period 4|Adverse Event|1
6030062|NCT00723021|20842296|P4|Intervention Period 4|Adverse Event|0
6030063|NCT00723021|20842297|P3|Intervention Period 4|Adverse Event|0
6030064|NCT00723021|20842298|P2|Intervention Period 4|Adverse Event|0
6030065|NCT00723021|20842299|P1|Intervention Period 4|Adverse Event|0
6030066|NCT00723008|20842353|P2|4-Week Unblinded Treatment|Lost to Follow-up|1
6030067|NCT00723008|20842354|P1|4-Week Unblinded Treatment|Lost to Follow-up|0
6030068|NCT00723008|20842353|P2|4-Week Unblinded Treatment|Adverse Event|0
6030069|NCT00723008|20842354|P1|4-Week Unblinded Treatment|Adverse Event|1
6030070|NCT00723008|20842353|P2|4-Week Double Blinded|Lost to Follow-up|3
6030071|NCT00723008|20842354|P1|4-Week Double Blinded|Lost to Follow-up|4
6030072|NCT00723008|20842353|P2|4-Week Double Blinded|Withdrawal by Subject|1
6030073|NCT00723008|20842354|P1|4-Week Double Blinded|Withdrawal by Subject|1
6030074|NCT00723008|20842353|P2|4-Week Double Blinded|Lack of Efficacy|1
6030075|NCT00723008|20842354|P1|4-Week Double Blinded|Lack of Efficacy|0
6030076|NCT00723008|20842353|P2|Enrollment|Lost to Follow-up|0
6030077|NCT00723008|20842354|P1|Enrollment|Lost to Follow-up|1
6030078|NCT00722800|20842386|P2|Overall Study|Physician Decision|0
6030079|NCT00722800|20842387|P1|Overall Study|Physician Decision|1
6030080|NCT00722800|20842386|P2|Overall Study|Withdrawal by Subject|0
6030081|NCT00722800|20842387|P1|Overall Study|Withdrawal by Subject|1
6030082|NCT00722761|20842399|P2|Overall Study|Withdrawal by Subject|2
6030083|NCT00722761|20842400|P1|Overall Study|Withdrawal by Subject|5
6030084|NCT00722761|20842399|P2|Overall Study|Lost to Follow-up|4
6030085|NCT00722761|20842400|P1|Overall Study|Lost to Follow-up|1
6030086|NCT00722423|20842457|P2|Overall Study|Protocol Violation|1
6030087|NCT00722423|20842458|P1|Overall Study|Protocol Violation|0
6030088|NCT00722371|20842473|P7|Overall Study|Withdrawal by Subject|26
6030089|NCT00722371|20842474|P6|Overall Study|Withdrawal by Subject|18
6030090|NCT00722371|20842475|P5|Overall Study|Withdrawal by Subject|19
6030091|NCT00722371|20842476|P4|Overall Study|Withdrawal by Subject|23
6030092|NCT00722371|20842477|P3|Overall Study|Withdrawal by Subject|19
6030093|NCT00722371|20842478|P2|Overall Study|Withdrawal by Subject|27
6030094|NCT00722371|20842479|P1|Overall Study|Withdrawal by Subject|18
6030095|NCT00722371|20842473|P7|Overall Study|Protocol Violation|1
6030096|NCT00722371|20842474|P6|Overall Study|Protocol Violation|2
6030097|NCT00722371|20842475|P5|Overall Study|Protocol Violation|4
6030098|NCT00722371|20842476|P4|Overall Study|Protocol Violation|1
6030099|NCT00722371|20842477|P3|Overall Study|Protocol Violation|0
6030100|NCT00722371|20842478|P2|Overall Study|Protocol Violation|1
6030101|NCT00722371|20842479|P1|Overall Study|Protocol Violation|6
6030102|NCT00722371|20842473|P7|Overall Study|Pregnancy|0
6030103|NCT00722371|20842474|P6|Overall Study|Pregnancy|1
6030104|NCT00722371|20842475|P5|Overall Study|Pregnancy|0
6030105|NCT00722371|20842476|P4|Overall Study|Pregnancy|0
6030106|NCT00722371|20842477|P3|Overall Study|Pregnancy|0
6030107|NCT00722371|20842478|P2|Overall Study|Pregnancy|1
6030108|NCT00722371|20842479|P1|Overall Study|Pregnancy|1
6030109|NCT00722371|20842473|P7|Overall Study|Physician Decision|4
6030110|NCT00722371|20842474|P6|Overall Study|Physician Decision|3
6030111|NCT00722371|20842475|P5|Overall Study|Physician Decision|2
6030112|NCT00722371|20842476|P4|Overall Study|Physician Decision|5
6030113|NCT00722371|20842477|P3|Overall Study|Physician Decision|2
6030114|NCT00722371|20842478|P2|Overall Study|Physician Decision|2
6030115|NCT00722371|20842479|P1|Overall Study|Physician Decision|5
6030116|NCT00722371|20842473|P7|Overall Study|Lost to Follow-up|13
6030117|NCT00722371|20842474|P6|Overall Study|Lost to Follow-up|16
6030118|NCT00722371|20842475|P5|Overall Study|Lost to Follow-up|8
6030119|NCT00722371|20842476|P4|Overall Study|Lost to Follow-up|13
6030120|NCT00722371|20842477|P3|Overall Study|Lost to Follow-up|21
6030121|NCT00722371|20842478|P2|Overall Study|Lost to Follow-up|14
6030122|NCT00722371|20842479|P1|Overall Study|Lost to Follow-up|11
6030123|NCT00722371|20842473|P7|Overall Study|Lack of Efficacy|0
6030124|NCT00722371|20842474|P6|Overall Study|Lack of Efficacy|3
6030125|NCT00722371|20842475|P5|Overall Study|Lack of Efficacy|2
6030126|NCT00722371|20842476|P4|Overall Study|Lack of Efficacy|6
6030127|NCT00722371|20842477|P3|Overall Study|Lack of Efficacy|6
6030128|NCT00722371|20842478|P2|Overall Study|Lack of Efficacy|6
6030129|NCT00722371|20842479|P1|Overall Study|Lack of Efficacy|4
6030130|NCT00722371|20842473|P7|Overall Study|Hypoglycemia|0
6030131|NCT00722371|20842474|P6|Overall Study|Hypoglycemia|0
6030132|NCT00722371|20842475|P5|Overall Study|Hypoglycemia|0
6030133|NCT00722371|20842476|P4|Overall Study|Hypoglycemia|0
6030134|NCT00722371|20842477|P3|Overall Study|Hypoglycemia|0
6030135|NCT00722371|20842478|P2|Overall Study|Hypoglycemia|0
6030136|NCT00722371|20842479|P1|Overall Study|Hypoglycemia|1
6030137|NCT00722371|20842473|P7|Overall Study|Hyperglycemia|1
6030138|NCT00722371|20842474|P6|Overall Study|Hyperglycemia|1
6030139|NCT00722371|20842475|P5|Overall Study|Hyperglycemia|5
6030140|NCT00722371|20842476|P4|Overall Study|Hyperglycemia|2
6030141|NCT00722371|20842477|P3|Overall Study|Hyperglycemia|4
6030142|NCT00722371|20842478|P2|Overall Study|Hyperglycemia|6
6030143|NCT00722371|20842479|P1|Overall Study|Hyperglycemia|2
6030144|NCT00722371|20842473|P7|Overall Study|Excluded medication|1
6030145|NCT00722371|20842474|P6|Overall Study|Excluded medication|0
6030146|NCT00722371|20842475|P5|Overall Study|Excluded medication|0
6030147|NCT00722371|20842476|P4|Overall Study|Excluded medication|0
6030148|NCT00722371|20842477|P3|Overall Study|Excluded medication|1
6030149|NCT00722371|20842478|P2|Overall Study|Excluded medication|1
6030150|NCT00722371|20842479|P1|Overall Study|Excluded medication|0
6030151|NCT00722371|20842473|P7|Overall Study|Creatinine / Creatinine clearance|1
6030152|NCT00722371|20842474|P6|Overall Study|Creatinine / Creatinine clearance|1
6030153|NCT00722371|20842475|P5|Overall Study|Creatinine / Creatinine clearance|2
6030154|NCT00722371|20842476|P4|Overall Study|Creatinine / Creatinine clearance|3
6030155|NCT00722371|20842477|P3|Overall Study|Creatinine / Creatinine clearance|2
6030156|NCT00722371|20842478|P2|Overall Study|Creatinine / Creatinine clearance|1
6030157|NCT00722371|20842479|P1|Overall Study|Creatinine / Creatinine clearance|2
6030158|NCT00722371|20842473|P7|Overall Study|Contraindication|0
6030159|NCT00722371|20842474|P6|Overall Study|Contraindication|0
6030160|NCT00722371|20842475|P5|Overall Study|Contraindication|0
6030161|NCT00722371|20842476|P4|Overall Study|Contraindication|0
6030162|NCT00722371|20842477|P3|Overall Study|Contraindication|1
6030163|NCT00722371|20842478|P2|Overall Study|Contraindication|0
6030164|NCT00722371|20842479|P1|Overall Study|Contraindication|0
6030165|NCT00722371|20842473|P7|Overall Study|Adverse Event|4
6030166|NCT00722371|20842474|P6|Overall Study|Adverse Event|8
6030167|NCT00722371|20842475|P5|Overall Study|Adverse Event|6
6030168|NCT00722371|20842476|P4|Overall Study|Adverse Event|10
6030169|NCT00722371|20842477|P3|Overall Study|Adverse Event|9
6030170|NCT00722371|20842478|P2|Overall Study|Adverse Event|13
6030171|NCT00722371|20842479|P1|Overall Study|Adverse Event|6
6030172|NCT00722137|20842532|P2|Overall Study|Randomized But Not Treated|3
6030173|NCT00722137|20842533|P1|Overall Study|Randomized But Not Treated|2
6030174|NCT00722137|20842532|P2|Overall Study|Other Reason Unknown|4
6030175|NCT00722137|20842533|P1|Overall Study|Other Reason Unknown|3
6030176|NCT00722137|20842532|P2|Overall Study|Withdrawal by Subject|9
6030177|NCT00722137|20842533|P1|Overall Study|Withdrawal by Subject|6
6030178|NCT00722137|20842532|P2|Overall Study|Death|7
6030179|NCT00722137|20842533|P1|Overall Study|Death|12
6030180|NCT00722137|20842532|P2|Overall Study|Adverse Event|21
6030181|NCT00722137|20842533|P1|Overall Study|Adverse Event|17
6030182|NCT00722137|20842532|P2|Overall Study|Overt Disease Progression|4
6030183|NCT00722137|20842533|P1|Overall Study|Overt Disease Progression|5
6030184|NCT00721968|20842611|P2|Overall Study|Lost to Follow-up|0
6030185|NCT00721968|20842612|P1|Overall Study|Lost to Follow-up|2
6030186|NCT00721955|20842623|P3|Overall Study|Adverse Event|2
6030187|NCT00721955|20842624|P2|Overall Study|Adverse Event|0
6030188|NCT00721955|20842625|P1|Overall Study|Adverse Event|0
6030189|NCT00721799|20842639|P1|Overall Study|withdraw by subject after scan 1|1
6030190|NCT00721799|20842639|P1|Overall Study|Withdrawal by Subject|7
6030191|NCT00721734|20842679|P5|Overall Study|Other|0
6030192|NCT00721734|20842680|P4|Overall Study|Other|1
6030193|NCT00721734|20842681|P3|Overall Study|Other|0
6030194|NCT00721734|20842682|P2|Overall Study|Other|0
6030195|NCT00721734|20842683|P1|Overall Study|Other|0
6030196|NCT00721734|20842679|P5|Overall Study|Withdrawal by Subject|1
6030197|NCT00721734|20842680|P4|Overall Study|Withdrawal by Subject|0
6030198|NCT00721734|20842681|P3|Overall Study|Withdrawal by Subject|0
6030199|NCT00721734|20842682|P2|Overall Study|Withdrawal by Subject|1
6030200|NCT00721734|20842683|P1|Overall Study|Withdrawal by Subject|2
6030201|NCT00721734|20842679|P5|Overall Study|Adverse Event|3
6030202|NCT00721734|20842680|P4|Overall Study|Adverse Event|0
6030203|NCT00721734|20842681|P3|Overall Study|Adverse Event|4
6030204|NCT00721734|20842682|P2|Overall Study|Adverse Event|1
6030205|NCT00721734|20842683|P1|Overall Study|Adverse Event|3
6030206|NCT00721734|20842679|P5|Overall Study|Progressive Disease|2
6030207|NCT00721734|20842680|P4|Overall Study|Progressive Disease|5
6030208|NCT00721734|20842681|P3|Overall Study|Progressive Disease|4
6030209|NCT00721734|20842682|P2|Overall Study|Progressive Disease|10
6030210|NCT00721734|20842683|P1|Overall Study|Progressive Disease|3
6030211|NCT00721630|20842795|P1|Overall Study|Participant found to be ineligible|1
6030212|NCT00721578|20842824|P2|Overall Study|Withdrawal by Subject|1
6030213|NCT00721578|20842825|P1|Overall Study|Withdrawal by Subject|1
6030214|NCT00721578|20842824|P2|Overall Study|Death|1
6030215|NCT00721578|20842825|P1|Overall Study|Death|1
6030216|NCT00721409|20842880|P3|Overall Study|Objective progression or relapse|62
6030217|NCT00721409|20842881|P2|Overall Study|Objective progression or relapse|55
6030218|NCT00721409|20842882|P1|Overall Study|Objective progression or relapse|8
6030219|NCT00721409|20842880|P3|Overall Study|Withdrawal by Subject|5
6030220|NCT00721409|20842881|P2|Overall Study|Withdrawal by Subject|6
6030221|NCT00721409|20842882|P1|Overall Study|Withdrawal by Subject|1
6030222|NCT00721409|20842880|P3|Overall Study|Lost to Follow-up|1
6030223|NCT00721409|20842881|P2|Overall Study|Lost to Follow-up|0
6030224|NCT00721409|20842882|P1|Overall Study|Lost to Follow-up|0
6030225|NCT00721409|20842880|P3|Overall Study|Adverse Event|2
6030226|NCT00721409|20842881|P2|Overall Study|Adverse Event|13
6030227|NCT00721409|20842882|P1|Overall Study|Adverse Event|0
6030228|NCT00721409|20842880|P3|Overall Study|Reason not specified|2
6030229|NCT00721409|20842881|P2|Overall Study|Reason not specified|0
6030230|NCT00721409|20842882|P1|Overall Study|Reason not specified|1
6030231|NCT00721409|20842880|P3|Overall Study|Randomized not Treated|4
6030232|NCT00721409|20842881|P2|Overall Study|Randomized not Treated|1
6030233|NCT00721409|20842882|P1|Overall Study|Randomized not Treated|0
6030234|NCT00721409|20842880|P3|Overall Study|Death|0
6030235|NCT00721409|20842881|P2|Overall Study|Death|1
6030236|NCT00721409|20842882|P1|Overall Study|Death|0
6030237|NCT00721409|20842880|P3|Overall Study|Global deterioration of health status|3
6030238|NCT00721409|20842881|P2|Overall Study|Global deterioration of health status|6
6030239|NCT00721409|20842882|P1|Overall Study|Global deterioration of health status|2
6030240|NCT00721396|20843009|P4|Overall Study|Administrative reason|0
6030241|NCT00721396|20843010|P3|Overall Study|Administrative reason|1
6030242|NCT00721396|20843011|P2|Overall Study|Administrative reason|0
6030243|NCT00721396|20843012|P1|Overall Study|Administrative reason|3
6030244|NCT00721396|20843009|P4|Overall Study|Inappropriate enrollment|0
6030245|NCT00721396|20843010|P3|Overall Study|Inappropriate enrollment|0
6030246|NCT00721396|20843011|P2|Overall Study|Inappropriate enrollment|2
6030247|NCT00721396|20843012|P1|Overall Study|Inappropriate enrollment|0
6030248|NCT00721396|20843009|P4|Overall Study|Protocol Violation|0
6030249|NCT00721396|20843010|P3|Overall Study|Protocol Violation|1
6030250|NCT00721396|20843011|P2|Overall Study|Protocol Violation|3
6030251|NCT00721396|20843012|P1|Overall Study|Protocol Violation|4
6030252|NCT00721396|20843009|P4|Overall Study|Lost to Follow-up|3
6030253|NCT00721396|20843010|P3|Overall Study|Lost to Follow-up|3
6030254|NCT00721396|20843011|P2|Overall Study|Lost to Follow-up|9
6030255|NCT00721396|20843012|P1|Overall Study|Lost to Follow-up|7
6030256|NCT00721396|20843009|P4|Overall Study|Withdrawal by Subject|7
6030257|NCT00721396|20843010|P3|Overall Study|Withdrawal by Subject|3
6030258|NCT00721396|20843011|P2|Overall Study|Withdrawal by Subject|15
6030259|NCT00721396|20843012|P1|Overall Study|Withdrawal by Subject|12
6030260|NCT00721396|20843009|P4|Overall Study|Adverse Event|0
6030261|NCT00721396|20843010|P3|Overall Study|Adverse Event|2
6030262|NCT00721396|20843011|P2|Overall Study|Adverse Event|7
6030263|NCT00721396|20843012|P1|Overall Study|Adverse Event|4
6030264|NCT00721279|20843063|P2|Overall Study|Other|16
6030265|NCT00721279|20843064|P1|Overall Study|Other|12
6030266|NCT00721279|20843063|P2|Overall Study|Withdrawal by Subject|3
6030267|NCT00721279|20843064|P1|Overall Study|Withdrawal by Subject|13
6030268|NCT00721279|20843063|P2|Overall Study|Tolerability insufficient|2
6030269|NCT00721279|20843064|P1|Overall Study|Tolerability insufficient|5
6030270|NCT00721279|20843063|P2|Overall Study|Lack of Efficacy|3
6030271|NCT00721279|20843064|P1|Overall Study|Lack of Efficacy|6
6030272|NCT00721227|20843092|P2|Overall Study|Noncompliance with scheduled visits.|0
6030273|NCT00721227|20843093|P1|Overall Study|Noncompliance with scheduled visits.|1
6030274|NCT00721227|20843092|P2|Overall Study|Lost to Follow-up|0
6030275|NCT00721227|20843093|P1|Overall Study|Lost to Follow-up|3
6030276|NCT00721214|20843103|P1|Overall Study|Death|3
6030277|NCT00721214|20843103|P1|Overall Study|Chose another center for transplant|1
6030278|NCT00721149|20843153|P1|Overall Study|Physician Decision|1
6030279|NCT00721123|20843187|P1|Overall Study|Withdrawal by Subject|5
6030280|NCT00721123|20843187|P1|Overall Study|Failure to Return|9
6030281|NCT00721123|20843187|P1|Overall Study|Refused Treatment|41
6030282|NCT00721123|20843187|P1|Overall Study|Protocol Violation|1
6030283|NCT00721123|20843187|P1|Overall Study|Insufficient Therapeutic Response|21
6030284|NCT00721123|20843187|P1|Overall Study|Death|10
6030285|NCT00721123|20843187|P1|Overall Study|Adverse Event|96
6030286|NCT00721110|20843265|P4|Overall Study|vertical incision|0
6030287|NCT00721110|20843266|P3|Overall Study|vertical incision|1
6030288|NCT00721110|20843267|P2|Overall Study|vertical incision|0
6030289|NCT00721110|20843268|P1|Overall Study|vertical incision|0
6030290|NCT00721110|20843265|P4|Overall Study|Ultram use|0
6030291|NCT00721110|20843266|P3|Overall Study|Ultram use|0
6030292|NCT00721110|20843267|P2|Overall Study|Ultram use|0
6030293|NCT00721110|20843268|P1|Overall Study|Ultram use|1
6030294|NCT00720941|20843296|P2|Overall Study|Ongoing|23
6030295|NCT00720941|20843297|P1|Overall Study|Ongoing|34
6030296|NCT00720941|20843296|P2|Overall Study|Withdrawal by Subject|35
6030297|NCT00720941|20843297|P1|Overall Study|Withdrawal by Subject|27
6030298|NCT00720941|20843296|P2|Overall Study|Physician Decision|5
6030299|NCT00720941|20843297|P1|Overall Study|Physician Decision|1
6030300|NCT00720941|20843296|P2|Overall Study|Lost to Follow-up|15
6030301|NCT00720941|20843297|P1|Overall Study|Lost to Follow-up|17
6030302|NCT00720941|20843296|P2|Overall Study|Protocol Violation|2
6030303|NCT00720941|20843297|P1|Overall Study|Protocol Violation|0
6030304|NCT00720941|20843296|P2|Overall Study|Death|335
6030305|NCT00720941|20843297|P1|Overall Study|Death|334
6030306|NCT00720876|20843337|P1|Overall Study|found to be ineligible after starting tx|2
6030307|NCT00720798|20843343|P1|Overall Study|Reason not Specified|83
6030308|NCT00720798|20843343|P1|Overall Study|Failure to Return|46
6030309|NCT00720798|20843343|P1|Overall Study|Refused Treatment|151
6030310|NCT00720798|20843343|P1|Overall Study|Protocol Violation|4
6030311|NCT00720798|20843343|P1|Overall Study|Insufficient Therapeutic Response|129
6030312|NCT00720798|20843343|P1|Overall Study|Death|39
6030313|NCT00720798|20843343|P1|Overall Study|Adverse Event|304
6030314|NCT00720759|20843366|P4|Overall Study|Lost to Follow-up|0
6030315|NCT00720759|20843367|P3|Overall Study|Lost to Follow-up|1
6030316|NCT00720759|20843368|P2|Overall Study|Lost to Follow-up|1
6030317|NCT00720759|20843369|P1|Overall Study|Lost to Follow-up|0
6030318|NCT00720499|20843389|P2|Treatment Period 2 (4 Weeks)|Adverse Event|3
6030319|NCT00720499|20843390|P1|Treatment Period 2 (4 Weeks)|Adverse Event|2
6030320|NCT00720499|20843389|P2|Treatment Period 1 (4 Weeks)|Protocol Violation|2
6030321|NCT00720499|20843390|P1|Treatment Period 1 (4 Weeks)|Protocol Violation|1
6030322|NCT00720499|20843389|P2|Treatment Period 1 (4 Weeks)|Adverse Event|0
6030323|NCT00720499|20843390|P1|Treatment Period 1 (4 Weeks)|Adverse Event|2
6030324|NCT00720434|20843483|P4|Open-Label Period (Week 5-72)|Other|2
6030325|NCT00720434|20843484|P3|Open-Label Period (Week 5-72)|Other|3
6030326|NCT00720434|20843485|P2|Open-Label Period (Week 5-72)|Other|3
6030327|NCT00720434|20843486|P1|Open-Label Period (Week 5-72)|Other|4
6030328|NCT00720434|20843483|P4|Open-Label Period (Week 5-72)|Withdrawal by Subject|0
6030329|NCT00720434|20843484|P3|Open-Label Period (Week 5-72)|Withdrawal by Subject|1
6030330|NCT00720434|20843485|P2|Open-Label Period (Week 5-72)|Withdrawal by Subject|0
6030331|NCT00720434|20843486|P1|Open-Label Period (Week 5-72)|Withdrawal by Subject|1
6030332|NCT00720434|20843483|P4|Open-Label Period (Week 5-72)|Lost to Follow-up|0
6030333|NCT00720434|20843484|P3|Open-Label Period (Week 5-72)|Lost to Follow-up|0
6030334|NCT00720434|20843485|P2|Open-Label Period (Week 5-72)|Lost to Follow-up|0
6030335|NCT00720434|20843486|P1|Open-Label Period (Week 5-72)|Lost to Follow-up|1
6030336|NCT00720434|20843483|P4|Open-Label Period (Week 5-72)|Adverse Event|2
6030337|NCT00720434|20843484|P3|Open-Label Period (Week 5-72)|Adverse Event|0
6030338|NCT00720434|20843485|P2|Open-Label Period (Week 5-72)|Adverse Event|0
6030339|NCT00720434|20843486|P1|Open-Label Period (Week 5-72)|Adverse Event|0
6030340|NCT00720434|20843483|P4|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0
6030341|NCT00720434|20843484|P3|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0
6030342|NCT00720434|20843485|P2|Double-Blind Period (Week 1-4)|Withdrawal by Subject|1
6030343|NCT00720434|20843486|P1|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0
6030344|NCT00720382|20843510|P2|Overall Study|administrative|5
6030345|NCT00720382|20843511|P1|Overall Study|administrative|14
6030346|NCT00720382|20843510|P2|Overall Study|Lost to Follow-up|14
6030347|NCT00720382|20843511|P1|Overall Study|Lost to Follow-up|28
6030348|NCT00720382|20843510|P2|Overall Study|Withdrawal by Subject|11
6030349|NCT00720382|20843511|P1|Overall Study|Withdrawal by Subject|47
6030350|NCT00720382|20843510|P2|Overall Study|Non-Compliance|5
6030351|NCT00720382|20843511|P1|Overall Study|Non-Compliance|15
6030352|NCT00720382|20843510|P2|Overall Study|Lack of Efficacy|7
6030353|NCT00720382|20843511|P1|Overall Study|Lack of Efficacy|18
6030354|NCT00720382|20843510|P2|Overall Study|Adverse Event|17
6030355|NCT00720382|20843511|P1|Overall Study|Adverse Event|54
6030356|NCT00720356|20843530|P1|Follow up Until Death|Alive at last data collection|4
6030357|NCT00720356|20843530|P1|Follow up Until Death|Withdrawal by Subject|1
6030358|NCT00720356|20843530|P1|Went on to be Treated Cycle 3|Physician Decision|1
6030359|NCT00720356|20843530|P1|Went on to be Treated Cycle 3|Adverse Event|1
6030360|NCT00720356|20843530|P1|Reached 1st Response/2 Cycles|Withdrawal by Subject|1
6030361|NCT00720356|20843530|P1|Reached 1st Response/2 Cycles|Progressive Disease|1
6030362|NCT00720356|20843530|P1|Registration to Study|Determined to have methylated MGMT|67
6030363|NCT00720343|20843544|P1|Overall Study|No data|3
6030364|NCT00720343|20843544|P1|Overall Study|Physician Decision|3
6030365|NCT00720278|20843578|P3|Overall Study|eligibility criteria violation|1
6030366|NCT00720278|20843579|P2|Overall Study|eligibility criteria violation|0
6030367|NCT00720278|20843580|P1|Overall Study|eligibility criteria violation|1
6030368|NCT00720278|20843578|P3|Overall Study|Non-compliance|0
6030369|NCT00720278|20843579|P2|Overall Study|Non-compliance|0
6030370|NCT00720278|20843580|P1|Overall Study|Non-compliance|1
6030371|NCT00720278|20843578|P3|Overall Study|Lost to Follow-up|1
6030372|NCT00720278|20843579|P2|Overall Study|Lost to Follow-up|0
6030373|NCT00720278|20843580|P1|Overall Study|Lost to Follow-up|0
6030374|NCT00720278|20843578|P3|Overall Study|Withdrawal by Subject|0
6030375|NCT00720278|20843579|P2|Overall Study|Withdrawal by Subject|1
6030376|NCT00720278|20843580|P1|Overall Study|Withdrawal by Subject|0
6030377|NCT00720278|20843578|P3|Overall Study|Adverse Event|4
6030378|NCT00720278|20843579|P2|Overall Study|Adverse Event|3
6030379|NCT00720278|20843580|P1|Overall Study|Adverse Event|5
6030380|NCT00720226|20843602|P2|Overall Study|Withdrawal by Subject|4
6030381|NCT00720226|20843603|P1|Overall Study|Withdrawal by Subject|7
6030382|NCT00720213|20843611|P3|Screening Phase With Diagnostic PSG|Screen Failure|0
6030383|NCT00720213|20843612|P2|Screening Phase With Diagnostic PSG|Screen Failure|0
6030384|NCT00720213|20843613|P1|Screening Phase With Diagnostic PSG|Screen Failure|7
6030385|NCT00720122|20843651|P1|Overall Study|Withdrawal by Subject|7
6030386|NCT00720122|20843651|P1|Overall Study|Physician Decision|1
6030387|NCT00720122|20843651|P1|Overall Study|Lost to Follow-up|1
6030388|NCT00720109|20843655|P3|Risk Stratification Period|Development of second malignant neoplasm|0
6030389|NCT00720109|20843656|P2|Risk Stratification Period|Development of second malignant neoplasm|1
6030390|NCT00720109|20843657|P1|Risk Stratification Period|Development of second malignant neoplasm|0
6030391|NCT00720109|20843655|P3|Risk Stratification Period|Disease progression or relapse|0
6030392|NCT00720109|20843656|P2|Risk Stratification Period|Disease progression or relapse|2
6030393|NCT00720109|20843657|P1|Risk Stratification Period|Disease progression or relapse|0
6030394|NCT00720109|20843655|P3|Risk Stratification Period|Bone marrow transplant|7
6030395|NCT00720109|20843656|P2|Risk Stratification Period|Bone marrow transplant|9
6030396|NCT00720109|20843657|P1|Risk Stratification Period|Bone marrow transplant|0
6030397|NCT00720109|20843655|P3|Risk Stratification Period|Physician Decision|1
6030398|NCT00720109|20843656|P2|Risk Stratification Period|Physician Decision|2
6030399|NCT00720109|20843657|P1|Risk Stratification Period|Physician Decision|0
6030400|NCT00720109|20843655|P3|Risk Stratification Period|Adverse Event|0
6030401|NCT00720109|20843656|P2|Risk Stratification Period|Adverse Event|1
6030402|NCT00720109|20843657|P1|Risk Stratification Period|Adverse Event|0
6030403|NCT00720109|20843655|P3|Induction Period|Physician Decision|0
6030404|NCT00720109|20843656|P2|Induction Period|Physician Decision|0
6030405|NCT00720109|20843657|P1|Induction Period|Physician Decision|1
6030406|NCT00720109|20843655|P3|Induction Period|Bone Marrow Transplant|0
6030407|NCT00720109|20843656|P2|Induction Period|Bone Marrow Transplant|0
6030408|NCT00720109|20843657|P1|Induction Period|Bone Marrow Transplant|2
6030409|NCT00720109|20843655|P3|Induction Period|Did not meet eligibility criteria|0
6030410|NCT00720109|20843656|P2|Induction Period|Did not meet eligibility criteria|0
6030411|NCT00720109|20843657|P1|Induction Period|Did not meet eligibility criteria|3
6030412|NCT00720096|20843677|P2|Overall Study|Withdrawal by Subject|2
6030413|NCT00720096|20843678|P1|Overall Study|Withdrawal by Subject|0
6030414|NCT00720083|20843690|P2|Overall Study|Ineligible|2
6030415|NCT00720083|20843691|P1|Overall Study|Ineligible|1
6030416|NCT00720057|20843699|P2|Overall Study|Withdrawal by Subject|1
6030417|NCT00720057|20843700|P1|Overall Study|Withdrawal by Subject|0
6030418|NCT00720057|20843699|P2|Overall Study|Protocol Violation|0
6030419|NCT00720057|20843700|P1|Overall Study|Protocol Violation|1
6030420|NCT00720057|20843699|P2|Overall Study|Lost to Follow-up|2
6030421|NCT00720057|20843700|P1|Overall Study|Lost to Follow-up|0
6030422|NCT00719953|20843716|P1|Overall Study|Adverse Event|4
6030423|NCT00719901|20843729|P1|Overall Study|Availability of Study Drug|1
6030424|NCT00719901|20843729|P1|Overall Study|Disease Progression|3
6030425|NCT00719901|20843729|P1|Overall Study|Alternate Treatment|1
6030426|NCT00719901|20843729|P1|Overall Study|Withdrawal by Subject|1
6030427|NCT00719901|20843729|P1|Overall Study|Adverse Event|5
6030428|NCT00719862|20843741|P2|Overall Study|Other|3
6030429|NCT00719862|20843742|P1|Overall Study|Other|2
6030430|NCT00719862|20843741|P2|Overall Study|Lost to Follow-up|1
6030431|NCT00719862|20843742|P1|Overall Study|Lost to Follow-up|0
6030432|NCT00719862|20843741|P2|Overall Study|Withdrawal by Subject|0
6030433|NCT00719862|20843742|P1|Overall Study|Withdrawal by Subject|1
6030434|NCT00719862|20843741|P2|Overall Study|Non-Compliance|0
6030435|NCT00719862|20843742|P1|Overall Study|Non-Compliance|1
6030436|NCT00719862|20843741|P2|Overall Study|Lack of Efficacy|0
6030437|NCT00719862|20843742|P1|Overall Study|Lack of Efficacy|3
6030438|NCT00719862|20843741|P2|Overall Study|Adverse Event|2
6030439|NCT00719862|20843742|P1|Overall Study|Adverse Event|1
6030440|NCT00719849|20843760|P2|Overall Study|Death|1
6030441|NCT00719849|20843761|P1|Overall Study|Death|0
6030442|NCT00719810|20843800|P3|Overall Study|Withdrawal by Subject|2
6030443|NCT00719810|20843801|P2|Overall Study|Withdrawal by Subject|1
6030444|NCT00719810|20843802|P1|Overall Study|Withdrawal by Subject|1
6030445|NCT00719810|20843800|P3|Overall Study|Physician Decision|0
6030446|NCT00719810|20843801|P2|Overall Study|Physician Decision|1
6030447|NCT00719810|20843802|P1|Overall Study|Physician Decision|0
6030448|NCT00719810|20843800|P3|Overall Study|Lost to Follow-up|3
6030449|NCT00719810|20843801|P2|Overall Study|Lost to Follow-up|0
6030450|NCT00719810|20843802|P1|Overall Study|Lost to Follow-up|2
6030451|NCT00719810|20843800|P3|Overall Study|Adverse Event|3
6030452|NCT00719810|20843801|P2|Overall Study|Adverse Event|2
6030453|NCT00719810|20843802|P1|Overall Study|Adverse Event|0
6030454|NCT00719732|20843813|P1|Overall Study|Illness not associated with device|1
6030455|NCT00719732|20843813|P1|Overall Study|Unilateral (not bilateral) implantation|1
6030456|NCT00719732|20843813|P1|Overall Study|Lost to Follow-up|20
6030457|NCT00719706|20843819|P2|Overall Study|Protocol Violation|0
6030458|NCT00719706|20843820|P1|Overall Study|Protocol Violation|3
6030459|NCT00719706|20843819|P2|Overall Study|Withdrawal by Subject|2
6030460|NCT00719706|20843820|P1|Overall Study|Withdrawal by Subject|1
6030461|NCT00719706|20843819|P2|Overall Study|Adverse Event|4
6030462|NCT00719706|20843820|P1|Overall Study|Adverse Event|5
6030463|NCT00719680|20843834|P1|Overall Study|Withdrawal by Subject|3
6030464|NCT00719680|20843834|P1|Overall Study|Lost to Follow-up|1
6030465|NCT00719680|20843834|P1|Overall Study|Adverse Event|1
6030466|NCT00719563|20843890|P2|Overall Study|Lost to Follow-up|3
6030467|NCT00719563|20843891|P1|Overall Study|Lost to Follow-up|5
6030468|NCT00719563|20843890|P2|Overall Study|Noncompliant|1
6030469|NCT00719563|20843891|P1|Overall Study|Noncompliant|1
6030470|NCT00719563|20843890|P2|Overall Study|Unknown reasons|6
6030471|NCT00719563|20843891|P1|Overall Study|Unknown reasons|4
6030472|NCT00719563|20843890|P2|Overall Study|Personal reasons|7
6030473|NCT00719563|20843891|P1|Overall Study|Personal reasons|6
6030474|NCT00719563|20843890|P2|Overall Study|Lack of Efficacy|7
6030475|NCT00719563|20843891|P1|Overall Study|Lack of Efficacy|3
6030476|NCT00719563|20843890|P2|Overall Study|Medical condition changed|5
6030477|NCT00719563|20843891|P1|Overall Study|Medical condition changed|3
6030478|NCT00719563|20843890|P2|Overall Study|Adverse Event|13
6030479|NCT00719563|20843891|P1|Overall Study|Adverse Event|16
6030480|NCT00719537|20843923|P2|Overall Study|Lost to Follow-up|1
6030481|NCT00719537|20843924|P1|Overall Study|Lost to Follow-up|0
6030482|NCT00719537|20843923|P2|Overall Study|Withdrawal by Subject|0
6030483|NCT00719537|20843924|P1|Overall Study|Withdrawal by Subject|1
6030484|NCT00719472|20843930|P1|Received Cycle 2 Treatment|Various Reasons|25
6030485|NCT00719472|20843930|P1|Received Cycle 2 Treatment|Subject decision to withdraw|6
6030486|NCT00719472|20843930|P1|Received Cycle 2 Treatment|Physician decision to withdraw patient|13
6030487|NCT00719472|20843930|P1|Received Cycle 2 Treatment|Lost to Follow-up|3
6030488|NCT00719472|20843930|P1|Received Cycle 2 Treatment|Disease progression|3
6030489|NCT00719472|20843930|P1|Received Cycle 2 Treatment|Death|6
6030490|NCT00719472|20843930|P1|Received Cycle 2 Treatment|Adverse Event|12
6030491|NCT00719472|20843930|P1|Received Cycle 1 Treatment|Various Reasons|13
6030492|NCT00719472|20843930|P1|Received Cycle 1 Treatment|Subject decision to withdraw|9
6030493|NCT00719472|20843930|P1|Received Cycle 1 Treatment|Physician decision to withdraw patient|7
6030494|NCT00719472|20843930|P1|Received Cycle 1 Treatment|Eligibility criteria for Cycle 2 not met|11
6030495|NCT00719472|20843930|P1|Received Cycle 1 Treatment|Death|5
6030496|NCT00719472|20843930|P1|Received Cycle 1 Treatment|Adverse Event|8
6030497|NCT00719472|20843930|P1|Enrolled in Study|Various Reasons|17
6030498|NCT00719472|20843930|P1|Enrolled in Study|Subject decision to withdraw|8
6030499|NCT00719472|20843930|P1|Enrolled in Study|Physician decision to withdraw patient|1
6030500|NCT00719355|20843941|P2|Overall Study|Moved|1
6030501|NCT00719355|20843942|P1|Overall Study|Moved|0
6030502|NCT00719355|20843941|P2|Overall Study|Compliance|6
6030503|NCT00719355|20843942|P1|Overall Study|Compliance|4
6030504|NCT00719355|20843941|P2|Overall Study|Medical|5
6030505|NCT00719355|20843942|P1|Overall Study|Medical|14
6030506|NCT00719355|20843941|P2|Overall Study|Death|1
6030507|NCT00719355|20843942|P1|Overall Study|Death|0
6030508|NCT00719264|20843971|P2|Overall Study|Disease Progression|107
6030509|NCT00719264|20843972|P1|Overall Study|Disease Progression|104
6030510|NCT00719264|20843971|P2|Overall Study|New Cancer Therapy|2
6030511|NCT00719264|20843972|P1|Overall Study|New Cancer Therapy|4
6030512|NCT00719264|20843971|P2|Overall Study|Protocol Deviation|3
6030513|NCT00719264|20843972|P1|Overall Study|Protocol Deviation|1
6030514|NCT00719264|20843971|P2|Overall Study|Withdrawal by Subject|7
6030515|NCT00719264|20843972|P1|Overall Study|Withdrawal by Subject|12
6030516|NCT00719264|20843971|P2|Overall Study|Lost to Follow-up|1
6030517|NCT00719264|20843972|P1|Overall Study|Lost to Follow-up|1
6030518|NCT00719264|20843971|P2|Overall Study|Administrative Problems|4
6030519|NCT00719264|20843972|P1|Overall Study|Administrative Problems|6
6030520|NCT00719264|20843971|P2|Overall Study|Death|10
6030521|NCT00719264|20843972|P1|Overall Study|Death|13
6030522|NCT00719264|20843971|P2|Overall Study|Adverse Event|49
6030523|NCT00719264|20843972|P1|Overall Study|Adverse Event|41
6030524|NCT00719212|20843991|P1|Overall Study|Withdrawal by Subject|1
6030525|NCT00719212|20843991|P1|Overall Study|Lost to Follow-up|2
6030526|NCT00719212|20843991|P1|Overall Study|Death|41
6030527|NCT00719043|20844039|P7|Overall Study|Withdrawal by Subject|14
6030528|NCT00719043|20844040|P6|Overall Study|Withdrawal by Subject|18
6030529|NCT00719043|20844041|P5|Overall Study|Withdrawal by Subject|16
6030530|NCT00719043|20844042|P4|Overall Study|Withdrawal by Subject|10
6030531|NCT00719043|20844043|P3|Overall Study|Withdrawal by Subject|9
6030532|NCT00719043|20844044|P2|Overall Study|Withdrawal by Subject|14
6030533|NCT00719043|20844045|P1|Overall Study|Withdrawal by Subject|12
6030534|NCT00719043|20844039|P7|Overall Study|Other|1
6030535|NCT00719043|20844040|P6|Overall Study|Other|2
6030536|NCT00719043|20844041|P5|Overall Study|Other|0
6030537|NCT00719043|20844042|P4|Overall Study|Other|2
6030538|NCT00719043|20844043|P3|Overall Study|Other|1
6030539|NCT00719043|20844044|P2|Overall Study|Other|0
6030540|NCT00719043|20844045|P1|Overall Study|Other|1
6030541|NCT00719043|20844039|P7|Overall Study|Protocol Violation|0
6030542|NCT00719043|20844040|P6|Overall Study|Protocol Violation|1
6030543|NCT00719043|20844041|P5|Overall Study|Protocol Violation|0
6030544|NCT00719043|20844042|P4|Overall Study|Protocol Violation|0
6030545|NCT00719043|20844043|P3|Overall Study|Protocol Violation|0
6030546|NCT00719043|20844044|P2|Overall Study|Protocol Violation|0
6030547|NCT00719043|20844045|P1|Overall Study|Protocol Violation|0
6030548|NCT00719043|20844039|P7|Overall Study|Lost to Follow-up|9
6030549|NCT00719043|20844040|P6|Overall Study|Lost to Follow-up|9
6030550|NCT00719043|20844041|P5|Overall Study|Lost to Follow-up|10
6030551|NCT00719043|20844042|P4|Overall Study|Lost to Follow-up|9
6030552|NCT00719043|20844043|P3|Overall Study|Lost to Follow-up|8
6030553|NCT00719043|20844044|P2|Overall Study|Lost to Follow-up|10
6030554|NCT00719043|20844045|P1|Overall Study|Lost to Follow-up|14
6030555|NCT00719043|20844039|P7|Overall Study|Adverse Event|4
6030556|NCT00719043|20844040|P6|Overall Study|Adverse Event|4
6030557|NCT00719043|20844041|P5|Overall Study|Adverse Event|1
6030558|NCT00719043|20844042|P4|Overall Study|Adverse Event|2
6030559|NCT00719043|20844043|P3|Overall Study|Adverse Event|2
6030560|NCT00719043|20844044|P2|Overall Study|Adverse Event|1
6030561|NCT00719043|20844045|P1|Overall Study|Adverse Event|5
6030562|NCT00718887|20844169|P2|Overall Study|Not identified|7
6030563|NCT00718887|20844170|P1|Overall Study|Not identified|2
6030564|NCT00718887|20844169|P2|Overall Study|Withdrawal by Subject|2
6030565|NCT00718887|20844170|P1|Overall Study|Withdrawal by Subject|3
6030566|NCT00718861|20844194|P2|Overall Study|Death|5
6030567|NCT00718861|20844195|P1|Overall Study|Death|1
6030568|NCT00718861|20844194|P2|Overall Study|Administrative Problems|1
6030569|NCT00718861|20844195|P1|Overall Study|Administrative Problems|1
6030570|NCT00718861|20844194|P2|Overall Study|Lost to Follow-up|1
6030571|NCT00718861|20844195|P1|Overall Study|Lost to Follow-up|2
6030572|NCT00718861|20844194|P2|Overall Study|Adverse Event|1
6030573|NCT00718861|20844195|P1|Overall Study|Adverse Event|2
6030574|NCT00718861|20844194|P2|Overall Study|Withdrawal by Subject|10
6030575|NCT00718861|20844195|P1|Overall Study|Withdrawal by Subject|15
6030576|NCT00718809|20844223|P2|Overall Study|Noncompliance|0
6030577|NCT00718809|20844224|P1|Overall Study|Noncompliance|1
6030578|NCT00718809|20844223|P2|Overall Study|Lost to Follow-up|0
6030579|NCT00718809|20844224|P1|Overall Study|Lost to Follow-up|1
6030580|NCT00718809|20844223|P2|Overall Study|Withdrawal by Subject|1
6030581|NCT00718809|20844224|P1|Overall Study|Withdrawal by Subject|0
6030582|NCT00718809|20844223|P2|Overall Study|Adverse Event|1
6030583|NCT00718809|20844224|P1|Overall Study|Adverse Event|1
6030584|NCT00718809|20844223|P2|Overall Study|Disease progression|7
6030585|NCT00718809|20844224|P1|Overall Study|Disease progression|9
6030586|NCT00718770|20844238|P1|Overall Study|Adverse Event|1
6030587|NCT00718770|20844238|P1|Overall Study|Lack of Efficacy|1
6030588|NCT00718770|20844238|P1|Overall Study|Adverse Event|1
6030589|NCT00718770|20844238|P1|Overall Study|Lack of Efficacy|1
6030590|NCT00718770|20844238|P1|Overall Study|Adverse Event|1
6030591|NCT00718770|20844238|P1|Overall Study|Lack of Efficacy|1
6030592|NCT00718770|20844238|P1|Overall Study|Lack of Efficacy|1
6030593|NCT00718770|20844238|P1|Overall Study|Adverse Event|1
6030594|NCT00718718|20844249|P10|Week 12 to End of Study|Other|0
6030595|NCT00718718|20844250|P9|Week 12 to End of Study|Other|0
6030596|NCT00718718|20844251|P8|Week 12 to End of Study|Other|0
6030597|NCT00718718|20844252|P7|Week 12 to End of Study|Other|1
6030598|NCT00718718|20844253|P6|Week 12 to End of Study|Other|0
6030599|NCT00718718|20844254|P5|Week 12 to End of Study|Other|0
6030600|NCT00718718|20844255|P4|Week 12 to End of Study|Other|1
6030601|NCT00718718|20844256|P3|Week 12 to End of Study|Other|0
6030602|NCT00718718|20844257|P2|Week 12 to End of Study|Other|1
6030603|NCT00718718|20844258|P1|Week 12 to End of Study|Other|0
6030604|NCT00718718|20844249|P10|Week 12 to End of Study|Lost to Follow-up|0
6030605|NCT00718718|20844250|P9|Week 12 to End of Study|Lost to Follow-up|1
6030606|NCT00718718|20844251|P8|Week 12 to End of Study|Lost to Follow-up|0
6030607|NCT00718718|20844252|P7|Week 12 to End of Study|Lost to Follow-up|0
6030608|NCT00718718|20844253|P6|Week 12 to End of Study|Lost to Follow-up|0
6030609|NCT00718718|20844254|P5|Week 12 to End of Study|Lost to Follow-up|0
6030610|NCT00718718|20844255|P4|Week 12 to End of Study|Lost to Follow-up|0
6030611|NCT00718718|20844256|P3|Week 12 to End of Study|Lost to Follow-up|0
6030612|NCT00718718|20844257|P2|Week 12 to End of Study|Lost to Follow-up|0
6030613|NCT00718718|20844258|P1|Week 12 to End of Study|Lost to Follow-up|0
6030614|NCT00718718|20844249|P10|Week 12 to End of Study|Withdrawal by Subject|0
6030615|NCT00718718|20844250|P9|Week 12 to End of Study|Withdrawal by Subject|0
6030616|NCT00718718|20844251|P8|Week 12 to End of Study|Withdrawal by Subject|0
6030617|NCT00718718|20844252|P7|Week 12 to End of Study|Withdrawal by Subject|1
6030618|NCT00718718|20844253|P6|Week 12 to End of Study|Withdrawal by Subject|2
6030619|NCT00718718|20844254|P5|Week 12 to End of Study|Withdrawal by Subject|0
6030620|NCT00718718|20844255|P4|Week 12 to End of Study|Withdrawal by Subject|0
6030621|NCT00718718|20844256|P3|Week 12 to End of Study|Withdrawal by Subject|0
6030622|NCT00718718|20844257|P2|Week 12 to End of Study|Withdrawal by Subject|0
6030623|NCT00718718|20844258|P1|Week 12 to End of Study|Withdrawal by Subject|0
6030624|NCT00718718|20844249|P10|Week 12 to End of Study|Death|0
6030625|NCT00718718|20844250|P9|Week 12 to End of Study|Death|0
6030626|NCT00718718|20844251|P8|Week 12 to End of Study|Death|0
6030627|NCT00718718|20844252|P7|Week 12 to End of Study|Death|0
6030628|NCT00718718|20844253|P6|Week 12 to End of Study|Death|1
6030629|NCT00718718|20844254|P5|Week 12 to End of Study|Death|0
6030630|NCT00718718|20844255|P4|Week 12 to End of Study|Death|0
6030631|NCT00718718|20844256|P3|Week 12 to End of Study|Death|0
6030632|NCT00718718|20844257|P2|Week 12 to End of Study|Death|0
6030633|NCT00718718|20844258|P1|Week 12 to End of Study|Death|0
6030634|NCT00718718|20844249|P10|Week 12 to End of Study|Adverse Event|0
6030635|NCT00718718|20844250|P9|Week 12 to End of Study|Adverse Event|0
6030636|NCT00718718|20844251|P8|Week 12 to End of Study|Adverse Event|1
6030637|NCT00718718|20844252|P7|Week 12 to End of Study|Adverse Event|0
6030638|NCT00718718|20844253|P6|Week 12 to End of Study|Adverse Event|0
6030639|NCT00718718|20844254|P5|Week 12 to End of Study|Adverse Event|0
6030640|NCT00718718|20844255|P4|Week 12 to End of Study|Adverse Event|0
6030641|NCT00718718|20844256|P3|Week 12 to End of Study|Adverse Event|0
6030642|NCT00718718|20844257|P2|Week 12 to End of Study|Adverse Event|0
6030643|NCT00718718|20844258|P1|Week 12 to End of Study|Adverse Event|0
6030644|NCT00718718|20844249|P10|Prior to Week 12|Other|0
6030645|NCT00718718|20844250|P9|Prior to Week 12|Other|0
6030646|NCT00718718|20844251|P8|Prior to Week 12|Other|0
6030647|NCT00718718|20844252|P7|Prior to Week 12|Other|0
6030648|NCT00718718|20844253|P6|Prior to Week 12|Other|0
6030649|NCT00718718|20844254|P5|Prior to Week 12|Other|0
6030650|NCT00718718|20844255|P4|Prior to Week 12|Other|0
6030651|NCT00718718|20844256|P3|Prior to Week 12|Other|1
6030652|NCT00718718|20844257|P2|Prior to Week 12|Other|0
6030653|NCT00718718|20844258|P1|Prior to Week 12|Other|1
6030654|NCT00718718|20844249|P10|Prior to Week 12|Withdrawal by Subject|0
6030655|NCT00718718|20844250|P9|Prior to Week 12|Withdrawal by Subject|1
6030656|NCT00718718|20844251|P8|Prior to Week 12|Withdrawal by Subject|1
6030657|NCT00718718|20844252|P7|Prior to Week 12|Withdrawal by Subject|1
6030658|NCT00718718|20844253|P6|Prior to Week 12|Withdrawal by Subject|0
6030659|NCT00718718|20844254|P5|Prior to Week 12|Withdrawal by Subject|3
6030660|NCT00718718|20844255|P4|Prior to Week 12|Withdrawal by Subject|0
6030661|NCT00718718|20844256|P3|Prior to Week 12|Withdrawal by Subject|0
6030662|NCT00718718|20844257|P2|Prior to Week 12|Withdrawal by Subject|0
6030663|NCT00718718|20844258|P1|Prior to Week 12|Withdrawal by Subject|0
6030664|NCT00718718|20844249|P10|Prior to Week 12|Adverse Event|0
6030665|NCT00718718|20844250|P9|Prior to Week 12|Adverse Event|1
6030666|NCT00718718|20844251|P8|Prior to Week 12|Adverse Event|1
6030667|NCT00718718|20844252|P7|Prior to Week 12|Adverse Event|0
6030668|NCT00718718|20844253|P6|Prior to Week 12|Adverse Event|0
6030669|NCT00718718|20844254|P5|Prior to Week 12|Adverse Event|0
6030670|NCT00718718|20844255|P4|Prior to Week 12|Adverse Event|0
6030671|NCT00718718|20844256|P3|Prior to Week 12|Adverse Event|0
6030672|NCT00718718|20844257|P2|Prior to Week 12|Adverse Event|0
6030673|NCT00718718|20844258|P1|Prior to Week 12|Adverse Event|0
6030674|NCT00718666|20844301|P3|Booster Phase Year 5|Lost to Follow-up|4
6030675|NCT00718666|20844302|P2|Booster Phase Year 5|Lost to Follow-up|0
6030676|NCT00718666|20844303|P1|Booster Phase Year 5|Lost to Follow-up|1
6030677|NCT00718666|20844301|P3|Booster Phase Year 5|Withdrawal by Subject|1
6030678|NCT00718666|20844302|P2|Booster Phase Year 5|Withdrawal by Subject|0
6030679|NCT00718666|20844303|P1|Booster Phase Year 5|Withdrawal by Subject|0
6030680|NCT00718666|20844301|P3|Booster Phase Year 5|Declined v-4 serology|0
6030681|NCT00718666|20844302|P2|Booster Phase Year 5|Declined v-4 serology|0
6030682|NCT00718666|20844303|P1|Booster Phase Year 5|Declined v-4 serology|1
6030683|NCT00718666|20844301|P3|Booster Phase Year 5|No active participation request|1
6030684|NCT00718666|20844302|P2|Booster Phase Year 5|No active participation request|0
6030685|NCT00718666|20844303|P1|Booster Phase Year 5|No active participation request|0
6030686|NCT00718640|20844387|P1|Overall Study|Unresolved toxicity after 2 weeks|2
6030687|NCT00718640|20844387|P1|Overall Study|Death|1
6030688|NCT00718640|20844387|P1|Overall Study|Adverse Event|4
6030689|NCT00718549|20844399|P3|Maintenance/ Observation Phase|Relapse|2
6030690|NCT00718549|20844400|P2|Maintenance/ Observation Phase|Relapse|3
6030691|NCT00718549|20844401|P1|Maintenance/ Observation Phase|Relapse|0
6030692|NCT00718549|20844399|P3|Maintenance/ Observation Phase|Progression|14
6030693|NCT00718549|20844400|P2|Maintenance/ Observation Phase|Progression|5
6030694|NCT00718549|20844401|P1|Maintenance/ Observation Phase|Progression|0
6030695|NCT00718549|20844399|P3|Maintenance/ Observation Phase|Lost to Follow-up|4
6030696|NCT00718549|20844400|P2|Maintenance/ Observation Phase|Lost to Follow-up|4
6030697|NCT00718549|20844401|P1|Maintenance/ Observation Phase|Lost to Follow-up|0
6030698|NCT00718549|20844399|P3|Maintenance/ Observation Phase|Death|2
6030699|NCT00718549|20844400|P2|Maintenance/ Observation Phase|Death|1
6030700|NCT00718549|20844401|P1|Maintenance/ Observation Phase|Death|0
6030701|NCT00718549|20844399|P3|Maintenance/ Observation Phase|Early Termination - No Additional Info|8
6030702|NCT00718549|20844400|P2|Maintenance/ Observation Phase|Early Termination - No Additional Info|15
6030703|NCT00718549|20844401|P1|Maintenance/ Observation Phase|Early Termination - No Additional Info|0
6030704|NCT00718549|20844399|P3|Induction Phase|Early Termination - No Additional Info|0
6030705|NCT00718549|20844400|P2|Induction Phase|Early Termination - No Additional Info|0
6030706|NCT00718549|20844401|P1|Induction Phase|Early Termination - No Additional Info|59
6030707|NCT00718549|20844399|P3|Induction Phase|Eligibility Criteria Violation|0
6030708|NCT00718549|20844400|P2|Induction Phase|Eligibility Criteria Violation|0
6030709|NCT00718549|20844401|P1|Induction Phase|Eligibility Criteria Violation|2
6030710|NCT00718549|20844399|P3|Induction Phase|Disease Progression|0
6030711|NCT00718549|20844400|P2|Induction Phase|Disease Progression|0
6030712|NCT00718549|20844401|P1|Induction Phase|Disease Progression|1
6030713|NCT00718523|20844426|P2|Overall Study|Death|17
6030714|NCT00718523|20844427|P1|Overall Study|Death|13
6030715|NCT00718523|20844426|P2|Overall Study|Withdrawal by Subject|7
6030716|NCT00718523|20844427|P1|Overall Study|Withdrawal by Subject|5
6030717|NCT00718510|20844439|P2|Second Intervention (3 Weeks)|Withdrawal by Subject|0
6030718|NCT00718510|20844440|P1|Second Intervention (3 Weeks)|Withdrawal by Subject|1
6030719|NCT00718510|20844439|P2|First Intervention (3 Weeks)|Withdrawal by Subject|1
6030720|NCT00718510|20844440|P1|First Intervention (3 Weeks)|Withdrawal by Subject|0
6030721|NCT00718419|20844452|P2|Overall Study|Death Due to Adverse Events|0
6030722|NCT00718419|20844453|P1|Overall Study|Death Due to Adverse Events|1
6030723|NCT00718419|20844452|P2|Overall Study|Death Due to Study Drug Related|1
6030724|NCT00718419|20844453|P1|Overall Study|Death Due to Study Drug Related|0
6030725|NCT00718419|20844452|P2|Overall Study|Death Due to Progressive Disease|0
6030726|NCT00718419|20844453|P1|Overall Study|Death Due to Progressive Disease|2
6030727|NCT00718419|20844452|P2|Overall Study|Progressive Disease|25
6030728|NCT00718419|20844453|P1|Overall Study|Progressive Disease|7
6030729|NCT00718419|20844452|P2|Overall Study|Withdrawal by Subject|5
6030730|NCT00718419|20844453|P1|Overall Study|Withdrawal by Subject|0
6030731|NCT00718419|20844452|P2|Overall Study|Sponsor decision|1
6030732|NCT00718419|20844453|P1|Overall Study|Sponsor decision|0
6030733|NCT00718419|20844452|P2|Overall Study|Physician Decision|6
6030734|NCT00718419|20844453|P1|Overall Study|Physician Decision|1
6030735|NCT00718419|20844452|P2|Overall Study|Adverse Event|1
6030736|NCT00718419|20844453|P1|Overall Study|Adverse Event|2
6030737|NCT00718328|20844469|P2|Overall Study|Lost to Follow-up|0
6030738|NCT00718328|20844470|P1|Overall Study|Lost to Follow-up|1
6030739|NCT00718315|20844479|P3|Overall Study|Use of ATB and Corticoids|2
6030740|NCT00718315|20844480|P2|Overall Study|Use of ATB and Corticoids|1
6030741|NCT00718315|20844481|P1|Overall Study|Use of ATB and Corticoids|0
6030742|NCT00718315|20844479|P3|Overall Study|Other|1
6030743|NCT00718315|20844480|P2|Overall Study|Other|0
6030744|NCT00718315|20844481|P1|Overall Study|Other|0
6030745|NCT00718315|20844479|P3|Overall Study|Disease progression|1
6030746|NCT00718315|20844480|P2|Overall Study|Disease progression|1
6030747|NCT00718315|20844481|P1|Overall Study|Disease progression|0
6030748|NCT00718315|20844479|P3|Overall Study|Use of Minocyclin|1
6030749|NCT00718315|20844480|P2|Overall Study|Use of Minocyclin|1
6030750|NCT00718315|20844481|P1|Overall Study|Use of Minocyclin|1
6030751|NCT00718315|20844479|P3|Overall Study|Erlotinib dose decreased|1
6030752|NCT00718315|20844480|P2|Overall Study|Erlotinib dose decreased|3
6030753|NCT00718315|20844481|P1|Overall Study|Erlotinib dose decreased|4
6030754|NCT00718315|20844479|P3|Overall Study|Protocol Violation|3
6030755|NCT00718315|20844480|P2|Overall Study|Protocol Violation|5
6030756|NCT00718315|20844481|P1|Overall Study|Protocol Violation|5
6030757|NCT00718315|20844479|P3|Overall Study|Lost to Follow-up|4
6030758|NCT00718315|20844480|P2|Overall Study|Lost to Follow-up|3
6030759|NCT00718315|20844481|P1|Overall Study|Lost to Follow-up|2
6030760|NCT00718315|20844479|P3|Overall Study|Death|5
6030761|NCT00718315|20844480|P2|Overall Study|Death|6
6030762|NCT00718315|20844481|P1|Overall Study|Death|6
6030763|NCT00718315|20844479|P3|Overall Study|Adverse Event|3
6030764|NCT00718315|20844480|P2|Overall Study|Adverse Event|2
6030765|NCT00718315|20844481|P1|Overall Study|Adverse Event|1
6030766|NCT00718237|20844532|P2|Overall Study|Withdrawal by Subject|10
6030767|NCT00718237|20844533|P1|Overall Study|Withdrawal by Subject|9
6030768|NCT00718237|20844532|P2|Overall Study|Physician Decision|0
6030769|NCT00718237|20844533|P1|Overall Study|Physician Decision|1
6030770|NCT00718237|20844532|P2|Overall Study|Lost to Follow-up|2
6030771|NCT00718237|20844533|P1|Overall Study|Lost to Follow-up|2
6030772|NCT00718237|20844532|P2|Overall Study|Adverse Event|3
6030773|NCT00718237|20844533|P1|Overall Study|Adverse Event|1
6030774|NCT00718159|20844550|P7|Overall Study|Investigator Decision|1
6030775|NCT00718159|20844551|P6|Overall Study|Investigator Decision|1
6030776|NCT00718159|20844552|P5|Overall Study|Investigator Decision|0
6030777|NCT00718159|20844553|P4|Overall Study|Investigator Decision|0
6030778|NCT00718159|20844554|P3|Overall Study|Investigator Decision|0
6030779|NCT00718159|20844555|P2|Overall Study|Investigator Decision|0
6030780|NCT00718159|20844556|P1|Overall Study|Investigator Decision|0
6030781|NCT00718159|20844550|P7|Overall Study|Death due to Study Drug Toxicity|0
6030782|NCT00718159|20844551|P6|Overall Study|Death due to Study Drug Toxicity|0
6030783|NCT00718159|20844552|P5|Overall Study|Death due to Study Drug Toxicity|0
6030784|NCT00718159|20844553|P4|Overall Study|Death due to Study Drug Toxicity|2
6030785|NCT00718159|20844554|P3|Overall Study|Death due to Study Drug Toxicity|1
6030786|NCT00718159|20844555|P2|Overall Study|Death due to Study Drug Toxicity|0
6030787|NCT00718159|20844556|P1|Overall Study|Death due to Study Drug Toxicity|0
6030788|NCT00718159|20844550|P7|Overall Study|Death due to Adverse Event|0
6030789|NCT00718159|20844551|P6|Overall Study|Death due to Adverse Event|0
6030790|NCT00718159|20844552|P5|Overall Study|Death due to Adverse Event|2
6030791|NCT00718159|20844553|P4|Overall Study|Death due to Adverse Event|2
6030792|NCT00718159|20844554|P3|Overall Study|Death due to Adverse Event|0
6030793|NCT00718159|20844555|P2|Overall Study|Death due to Adverse Event|0
6030794|NCT00718159|20844556|P1|Overall Study|Death due to Adverse Event|0
6030795|NCT00718159|20844550|P7|Overall Study|Progressive Disease|0
6030796|NCT00718159|20844551|P6|Overall Study|Progressive Disease|0
6030797|NCT00718159|20844552|P5|Overall Study|Progressive Disease|6
6030798|NCT00718159|20844553|P4|Overall Study|Progressive Disease|0
6030799|NCT00718159|20844554|P3|Overall Study|Progressive Disease|2
6030800|NCT00718159|20844555|P2|Overall Study|Progressive Disease|3
6030801|NCT00718159|20844556|P1|Overall Study|Progressive Disease|3
6030802|NCT00718081|20844613|P3|Overall Study|Lack of Efficacy|21
6030803|NCT00718081|20844614|P2|Overall Study|Lack of Efficacy|3
6030804|NCT00718081|20844615|P1|Overall Study|Lack of Efficacy|7
6030805|NCT00718081|20844613|P3|Overall Study|Adverse Event|0
6030806|NCT00718081|20844614|P2|Overall Study|Adverse Event|1
6030807|NCT00718081|20844615|P1|Overall Study|Adverse Event|0
6030808|NCT00718042|20844632|P6|Donor Follow-up|Lost to Follow-up|0
6030809|NCT00718042|20844633|P5|Donor Follow-up|Lost to Follow-up|19
6030810|NCT00718042|20844634|P4|Donor Follow-up|Lost to Follow-up|0
6030811|NCT00718042|20844635|P3|Donor Follow-up|Lost to Follow-up|0
6030812|NCT00718042|20844636|P2|Donor Follow-up|Lost to Follow-up|0
6030813|NCT00718042|20844637|P1|Donor Follow-up|Lost to Follow-up|13
6030814|NCT00718042|20844632|P6|ABBOTT PRISM Chagas Testing|No result on comparator assay|0
6030815|NCT00718042|20844633|P5|ABBOTT PRISM Chagas Testing|No result on comparator assay|0
6030816|NCT00718042|20844634|P4|ABBOTT PRISM Chagas Testing|No result on comparator assay|0
6030817|NCT00718042|20844635|P3|ABBOTT PRISM Chagas Testing|No result on comparator assay|0
6030818|NCT00718042|20844636|P2|ABBOTT PRISM Chagas Testing|No result on comparator assay|1
6030819|NCT00718042|20844637|P1|ABBOTT PRISM Chagas Testing|No result on comparator assay|0
6030820|NCT00718042|20844632|P6|ABBOTT PRISM Chagas Testing|Insufficient sample|0
6030821|NCT00718042|20844633|P5|ABBOTT PRISM Chagas Testing|Insufficient sample|0
6030822|NCT00718042|20844634|P4|ABBOTT PRISM Chagas Testing|Insufficient sample|0
6030823|NCT00718042|20844635|P3|ABBOTT PRISM Chagas Testing|Insufficient sample|1
6030824|NCT00718042|20844636|P2|ABBOTT PRISM Chagas Testing|Insufficient sample|1
6030825|NCT00718042|20844637|P1|ABBOTT PRISM Chagas Testing|Insufficient sample|0
6030826|NCT00718042|20844632|P6|ABBOTT PRISM Chagas Testing|Protocol Violation|0
6030827|NCT00718042|20844633|P5|ABBOTT PRISM Chagas Testing|Protocol Violation|36
6030828|NCT00718042|20844634|P4|ABBOTT PRISM Chagas Testing|Protocol Violation|0
6030829|NCT00718042|20844635|P3|ABBOTT PRISM Chagas Testing|Protocol Violation|0
6030830|NCT00718042|20844636|P2|ABBOTT PRISM Chagas Testing|Protocol Violation|0
6030831|NCT00718042|20844637|P1|ABBOTT PRISM Chagas Testing|Protocol Violation|64
6030832|NCT00718042|20844632|P6|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0
6030833|NCT00718042|20844633|P5|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|2
6030834|NCT00718042|20844634|P4|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0
6030835|NCT00718042|20844635|P3|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0
6030836|NCT00718042|20844636|P2|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0
6030837|NCT00718042|20844637|P1|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0
6030838|NCT00717886|20844693|P1|Overall Study|Treatment Failure|1
6030839|NCT00717886|20844693|P1|Overall Study|Withdrawal by Subject|3
6030840|NCT00717860|20844708|P2|Overall Study|Withdrew consent|3
6030841|NCT00717860|20844709|P1|Overall Study|Withdrew consent|7
6030842|NCT00717860|20844708|P2|Overall Study|Discontinued for other reason|1
6030843|NCT00717860|20844709|P1|Overall Study|Discontinued for other reason|6
6030844|NCT00717860|20844708|P2|Overall Study|Lack of Efficacy|13
6030845|NCT00717860|20844709|P1|Overall Study|Lack of Efficacy|7
6030846|NCT00717860|20844708|P2|Overall Study|Laboratory adverse experience|2
6030847|NCT00717860|20844709|P1|Overall Study|Laboratory adverse experience|2
6030848|NCT00717860|20844708|P2|Overall Study|Clinical adverse experience|9
6030849|NCT00717860|20844709|P1|Overall Study|Clinical adverse experience|5
6030850|NCT00717756|20844719|P1|Overall Study|Withdrawal by Subject|1
6030851|NCT00717522|20844742|P1|Overall Study|Death|1
6030852|NCT00717522|20844742|P1|Overall Study|Adverse Event|1
6030853|NCT00717522|20844742|P1|Overall Study|Disease Progression|5
6030854|NCT00717366|20844778|P2|Extension Period (52 Weeks)|Withdrew consent|1
6030855|NCT00717366|20844779|P1|Extension Period (52 Weeks)|Withdrew consent|1
6030856|NCT00717366|20844778|P2|Extension Period (52 Weeks)|Admin/Other than specified|2
6030857|NCT00717366|20844779|P1|Extension Period (52 Weeks)|Admin/Other than specified|0
6030858|NCT00717366|20844778|P2|Extension Period (52 Weeks)|Renal transplant|13
6030859|NCT00717366|20844779|P1|Extension Period (52 Weeks)|Renal transplant|3
6030860|NCT00717366|20844778|P2|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|1
6030861|NCT00717366|20844779|P1|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|0
6030862|NCT00717366|20844778|P2|Core Study Period (20 Weeks)|Death|1
6030863|NCT00717366|20844779|P1|Core Study Period (20 Weeks)|Death|0
6030864|NCT00717366|20844778|P2|Core Study Period (20 Weeks)|Admin/Other than specified|2
6030865|NCT00717366|20844779|P1|Core Study Period (20 Weeks)|Admin/Other than specified|0
6030866|NCT00717366|20844778|P2|Core Study Period (20 Weeks)|Renal transplant|9
6030867|NCT00717366|20844779|P1|Core Study Period (20 Weeks)|Renal transplant|4
6030868|NCT00717314|20844803|P2|Overall Study|Withdrawal by Subject|3
6030869|NCT00717314|20844804|P1|Overall Study|Withdrawal by Subject|1
6030870|NCT00717314|20844803|P2|Overall Study|Lost to Follow-up|5
6030871|NCT00717314|20844804|P1|Overall Study|Lost to Follow-up|1
6030872|NCT00717314|20844803|P2|Overall Study|Protocol Violation|0
6030873|NCT00717314|20844804|P1|Overall Study|Protocol Violation|1
6030874|NCT00717314|20844803|P2|Overall Study|Adverse Event|2
6030875|NCT00717314|20844804|P1|Overall Study|Adverse Event|3
6030876|NCT00717275|20844841|P1|Overall Study|Premature study termination.|3
6030877|NCT00717249|20844847|P2|Overall Study|Headaches|0
6030878|NCT00717249|20844848|P1|Overall Study|Headaches|1
6030879|NCT00717249|20844847|P2|Overall Study|Subject relocated|0
6030880|NCT00717249|20844848|P1|Overall Study|Subject relocated|1
6030881|NCT00717249|20844847|P2|Overall Study|Diagnosed with Multiple Scletosis|0
6030882|NCT00717249|20844848|P1|Overall Study|Diagnosed with Multiple Scletosis|1
6030883|NCT00717249|20844847|P2|Overall Study|Diagnosed with Diabetes|0
6030884|NCT00717249|20844848|P1|Overall Study|Diagnosed with Diabetes|1
6030885|NCT00717249|20844847|P2|Overall Study|Gastric Surgery|1
6030886|NCT00717249|20844848|P1|Overall Study|Gastric Surgery|0
6030887|NCT00717249|20844847|P2|Overall Study|Unsatisfactory Physiological Response|1
6030888|NCT00717249|20844848|P1|Overall Study|Unsatisfactory Physiological Response|0
6030889|NCT00717249|20844847|P2|Overall Study|Subject became Ineligible|1
6030890|NCT00717249|20844848|P1|Overall Study|Subject became Ineligible|1
6030891|NCT00717249|20844847|P2|Overall Study|Protocol Violation|2
6030892|NCT00717249|20844848|P1|Overall Study|Protocol Violation|0
6030893|NCT00717249|20844847|P2|Overall Study|Pregnancy|3
6030894|NCT00717249|20844848|P1|Overall Study|Pregnancy|6
6030895|NCT00717249|20844847|P2|Overall Study|Withdrawal by Subject|2
6030896|NCT00717249|20844848|P1|Overall Study|Withdrawal by Subject|1
6030897|NCT00717249|20844847|P2|Overall Study|Lost to Follow-up|0
6030898|NCT00717249|20844848|P1|Overall Study|Lost to Follow-up|2
6030899|NCT00717249|20844847|P2|Overall Study|Adverse Event|2
6030900|NCT00717249|20844848|P1|Overall Study|Adverse Event|4
6030901|NCT00717249|20844847|P2|Overall Study|Unsatisfactory visual Response|2
6030902|NCT00717249|20844848|P1|Overall Study|Unsatisfactory visual Response|0
6030903|NCT00717249|20844847|P2|Overall Study|Lens Discomfort|1
6030904|NCT00717249|20844848|P1|Overall Study|Lens Discomfort|4
6030905|NCT00717236|20844862|P2|Open-Label Period|Other: Medical Monitor Recommendation|0
6030906|NCT00717236|20844863|P1|Open-Label Period|Other: Medical Monitor Recommendation|1
6030907|NCT00717236|20844862|P2|Open-Label Period|Other: Completion Accidently Performed|0
6030908|NCT00717236|20844863|P1|Open-Label Period|Other: Completion Accidently Performed|1
6030909|NCT00717236|20844862|P2|Open-Label Period|Other: Administration of Golimumab|0
6030910|NCT00717236|20844863|P1|Open-Label Period|Other: Administration of Golimumab|1
6030911|NCT00717236|20844862|P2|Open-Label Period|Other: Cataract Surgery|0
6030912|NCT00717236|20844863|P1|Open-Label Period|Other: Cataract Surgery|1
6030913|NCT00717236|20844862|P2|Open-Label Period|Other: Sponsor Request|0
6030914|NCT00717236|20844863|P1|Open-Label Period|Other: Sponsor Request|3
6030915|NCT00717236|20844862|P2|Open-Label Period|Other: Loss of Staff (unblinded)|0
6030916|NCT00717236|20844863|P1|Open-Label Period|Other: Loss of Staff (unblinded)|1
6030917|NCT00717236|20844862|P2|Open-Label Period|Other: Investigator Decision|0
6030918|NCT00717236|20844863|P1|Open-Label Period|Other: Investigator Decision|1
6030919|NCT00717236|20844862|P2|Open-Label Period|Other: Moved|0
6030920|NCT00717236|20844863|P1|Open-Label Period|Other: Moved|1
6030921|NCT00717236|20844862|P2|Open-Label Period|Other: History of Basal Cell Carcinoma|0
6030922|NCT00717236|20844863|P1|Open-Label Period|Other: History of Basal Cell Carcinoma|1
6030923|NCT00717236|20844862|P2|Open-Label Period|Other: Lack of Compliance|1
6030924|NCT00717236|20844863|P1|Open-Label Period|Other: Lack of Compliance|1
6030925|NCT00717236|20844862|P2|Open-Label Period|Other: Peripheral Neuropathy|1
6030926|NCT00717236|20844863|P1|Open-Label Period|Other: Peripheral Neuropathy|0
6030927|NCT00717236|20844862|P2|Open-Label Period|Loss of Efficacy|1
6030928|NCT00717236|20844863|P1|Open-Label Period|Loss of Efficacy|6
6030929|NCT00717236|20844862|P2|Open-Label Period|Withdrawal by Subject|2
6030930|NCT00717236|20844863|P1|Open-Label Period|Withdrawal by Subject|20
6030931|NCT00717236|20844862|P2|Open-Label Period|Lost to Follow-up|4
6030932|NCT00717236|20844863|P1|Open-Label Period|Lost to Follow-up|28
6030933|NCT00717236|20844862|P2|Open-Label Period|Lack of Efficacy|8
6030934|NCT00717236|20844863|P1|Open-Label Period|Lack of Efficacy|30
6030935|NCT00717236|20844862|P2|Open-Label Period|Adverse Event|4
6030936|NCT00717236|20844863|P1|Open-Label Period|Adverse Event|29
6030937|NCT00717236|20844862|P2|Double-Blind Period|Other: Investigator Decision|1
6030938|NCT00717236|20844863|P1|Double-Blind Period|Other: Investigator Decision|0
6030939|NCT00717236|20844862|P2|Double-Blind Period|Other: Transportation problems|1
6030940|NCT00717236|20844863|P1|Double-Blind Period|Other: Transportation problems|0
6030941|NCT00717236|20844862|P2|Double-Blind Period|Other: Prohibited medication taken|2
6030942|NCT00717236|20844863|P1|Double-Blind Period|Other: Prohibited medication taken|2
6030943|NCT00717236|20844862|P2|Double-Blind Period|Other: Stopped taking DMARD|0
6030944|NCT00717236|20844863|P1|Double-Blind Period|Other: Stopped taking DMARD|1
6030945|NCT00717236|20844862|P2|Double-Blind Period|Other: Subject moved|1
6030946|NCT00717236|20844863|P1|Double-Blind Period|Other: Subject moved|1
6030947|NCT00717236|20844862|P2|Double-Blind Period|Other: Detection of Hepatitis C Virus|0
6030948|NCT00717236|20844863|P1|Double-Blind Period|Other: Detection of Hepatitis C Virus|1
6030949|NCT00717236|20844862|P2|Double-Blind Period|Other: Inappropriate randomization|0
6030950|NCT00717236|20844863|P1|Double-Blind Period|Other: Inappropriate randomization|1
6030951|NCT00717236|20844862|P2|Double-Blind Period|Other: Sponsor request|0
6030952|NCT00717236|20844863|P1|Double-Blind Period|Other: Sponsor request|1
6030953|NCT00717236|20844862|P2|Double-Blind Period|Other: History of cancer|0
6030954|NCT00717236|20844863|P1|Double-Blind Period|Other: History of cancer|1
6030955|NCT00717236|20844862|P2|Double-Blind Period|Other: History of adenoid grown|0
6030956|NCT00717236|20844863|P1|Double-Blind Period|Other: History of adenoid grown|1
6030957|NCT00717236|20844862|P2|Double-Blind Period|Other: Abnormal chest X-ray|1
6030958|NCT00717236|20844863|P1|Double-Blind Period|Other: Abnormal chest X-ray|2
6030959|NCT00717236|20844862|P2|Double-Blind Period|Other: subject withdrew consent|1
6030960|NCT00717236|20844863|P1|Double-Blind Period|Other: subject withdrew consent|1
6030961|NCT00717236|20844862|P2|Double-Blind Period|Other: Screening failure|0
6030962|NCT00717236|20844863|P1|Double-Blind Period|Other: Screening failure|1
6030963|NCT00717236|20844862|P2|Double-Blind Period|Other: Site withdrew|0
6030964|NCT00717236|20844863|P1|Double-Blind Period|Other: Site withdrew|2
6030965|NCT00717236|20844862|P2|Double-Blind Period|Other: Inclusion/Exclusion criteria|2
6030966|NCT00717236|20844863|P1|Double-Blind Period|Other: Inclusion/Exclusion criteria|6
6030967|NCT00717236|20844862|P2|Double-Blind Period|Other: Protocol Violation|0
6030968|NCT00717236|20844863|P1|Double-Blind Period|Other: Protocol Violation|2
6030969|NCT00717236|20844862|P2|Double-Blind Period|Other: Pregnancy|0
6030970|NCT00717236|20844863|P1|Double-Blind Period|Other: Pregnancy|1
6030971|NCT00717236|20844862|P2|Double-Blind Period|Other: Death|0
6030972|NCT00717236|20844863|P1|Double-Blind Period|Other: Death|1
6030973|NCT00717236|20844862|P2|Double-Blind Period|Loss of efficacy|0
6030974|NCT00717236|20844863|P1|Double-Blind Period|Loss of efficacy|3
6030975|NCT00717236|20844862|P2|Double-Blind Period|Withdrawal by Subject|2
6030976|NCT00717236|20844863|P1|Double-Blind Period|Withdrawal by Subject|10
6030977|NCT00717236|20844862|P2|Double-Blind Period|Lost to Follow-up|5
6030978|NCT00717236|20844863|P1|Double-Blind Period|Lost to Follow-up|3
6030979|NCT00717236|20844862|P2|Double-Blind Period|Lack of Efficacy|6
6030980|NCT00717236|20844863|P1|Double-Blind Period|Lack of Efficacy|6
6030981|NCT00717236|20844862|P2|Double-Blind Period|Adverse Event|6
6030982|NCT00717236|20844863|P1|Double-Blind Period|Adverse Event|33
6030983|NCT00717197|20844932|P1|Overall Study|Physician Decision|1
6030984|NCT00717197|20844932|P1|Overall Study|Tumor Progression|1
6030985|NCT00717197|20844932|P1|Overall Study|Unable to purchase study drug|5
6030986|NCT00717093|20844938|P2|Overall Study|Randomized but not treated|0
6030987|NCT00717093|20844939|P1|Overall Study|Randomized but not treated|1
6030988|NCT00717093|20844938|P2|Overall Study|Other|1
6030989|NCT00717093|20844939|P1|Overall Study|Other|0
6030990|NCT00717093|20844938|P2|Overall Study|Withdrawal by Subject|19
6030991|NCT00717093|20844939|P1|Overall Study|Withdrawal by Subject|12
6030992|NCT00717093|20844938|P2|Overall Study|Lost to Follow-up|6
6030993|NCT00717093|20844939|P1|Overall Study|Lost to Follow-up|9
6030994|NCT00717093|20844938|P2|Overall Study|Lack of Efficacy|13
6030995|NCT00717093|20844939|P1|Overall Study|Lack of Efficacy|3
6030996|NCT00717093|20844938|P2|Overall Study|Adverse Event|9
6030997|NCT00717093|20844939|P1|Overall Study|Adverse Event|19
6030998|NCT00717067|20844956|P5|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0
6030999|NCT00717067|20844957|P4|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0
6031000|NCT00717067|20844958|P3|Part 1a: Normal/Mild/Moderate Group|Adverse Event|1
6031001|NCT00717067|20844959|P2|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0
6031002|NCT00717067|20844960|P1|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0
6031003|NCT00716976|20845067|P2|Overall Study|Ineligibles|2
6031004|NCT00716976|20845068|P1|Overall Study|Ineligibles|4
6031005|NCT00716976|20845067|P2|Overall Study|Radiation during protocol|0
6031006|NCT00716976|20845068|P1|Overall Study|Radiation during protocol|1
6031007|NCT00716976|20845067|P2|Overall Study|Premature discontinuation cisplatin|4
6031008|NCT00716976|20845068|P1|Overall Study|Premature discontinuation cisplatin|5
6031009|NCT00716976|20845067|P2|Overall Study|Withdrawal by Subject|1
6031010|NCT00716976|20845068|P1|Overall Study|Withdrawal by Subject|5
6031011|NCT00716976|20845067|P2|Overall Study|Physician Decision|2
6031012|NCT00716976|20845068|P1|Overall Study|Physician Decision|2
6031013|NCT00716976|20845067|P2|Overall Study|Death|0
6031014|NCT00716976|20845068|P1|Overall Study|Death|1
6031015|NCT00716976|20845067|P2|Overall Study|Adverse Event|0
6031016|NCT00716976|20845068|P1|Overall Study|Adverse Event|2
6031025|NCT00716625|20845194|P1|Overall Study|Safety was not Assessable|1
6031026|NCT00716482|20845219|P1|Overall Study|inclusion/exclusion criteria not met|25
6031027|NCT00716482|20845219|P1|Overall Study|technical/machine error|28
6031028|NCT00716482|20845219|P1|Overall Study|no pathology obtained|10
6031029|NCT00716482|20845219|P1|Overall Study|Inadequate acquisition or analysis|50
6031030|NCT00716482|20845219|P1|Overall Study|Lost to Follow-up|6
6031031|NCT00716456|20845232|P3|Overall Study|Adverse Event|0
6031032|NCT00716456|20845233|P2|Overall Study|Adverse Event|2
6031033|NCT00716456|20845234|P1|Overall Study|Adverse Event|0
6031034|NCT00716417|20845285|P10|Overall Study|On patient request due to toxicities|0
6031035|NCT00716417|20845286|P9|Overall Study|On patient request due to toxicities|0
6031036|NCT00716417|20845287|P8|Overall Study|On patient request due to toxicities|1
6031037|NCT00716417|20845288|P7|Overall Study|On patient request due to toxicities|0
6031038|NCT00716417|20845289|P6|Overall Study|On patient request due to toxicities|0
6031039|NCT00716417|20845290|P5|Overall Study|On patient request due to toxicities|0
6031040|NCT00716417|20845291|P4|Overall Study|On patient request due to toxicities|0
6031041|NCT00716417|20845292|P3|Overall Study|On patient request due to toxicities|0
6031042|NCT00716417|20845293|P2|Overall Study|On patient request due to toxicities|0
6031043|NCT00716417|20845294|P1|Overall Study|On patient request due to toxicities|0
6031044|NCT00716417|20845285|P10|Overall Study|Dose limiting toxicity (DLT)|0
6031045|NCT00716417|20845286|P9|Overall Study|Dose limiting toxicity (DLT)|0
6031046|NCT00716417|20845287|P8|Overall Study|Dose limiting toxicity (DLT)|0
6031047|NCT00716417|20845288|P7|Overall Study|Dose limiting toxicity (DLT)|0
6031048|NCT00716417|20845289|P6|Overall Study|Dose limiting toxicity (DLT)|0
6031049|NCT00716417|20845290|P5|Overall Study|Dose limiting toxicity (DLT)|1
6031050|NCT00716417|20845291|P4|Overall Study|Dose limiting toxicity (DLT)|0
6031051|NCT00716417|20845292|P3|Overall Study|Dose limiting toxicity (DLT)|0
6031052|NCT00716417|20845293|P2|Overall Study|Dose limiting toxicity (DLT)|0
6031053|NCT00716417|20845294|P1|Overall Study|Dose limiting toxicity (DLT)|0
6031054|NCT00716417|20845285|P10|Overall Study|Progressive disease|0
6031055|NCT00716417|20845286|P9|Overall Study|Progressive disease|5
6031056|NCT00716417|20845287|P8|Overall Study|Progressive disease|1
6031057|NCT00716417|20845288|P7|Overall Study|Progressive disease|3
6031058|NCT00716417|20845289|P6|Overall Study|Progressive disease|3
6031059|NCT00716417|20845290|P5|Overall Study|Progressive disease|0
6031060|NCT00716417|20845291|P4|Overall Study|Progressive disease|8
6031061|NCT00716417|20845292|P3|Overall Study|Progressive disease|3
6031062|NCT00716417|20845293|P2|Overall Study|Progressive disease|5
6031063|NCT00716417|20845294|P1|Overall Study|Progressive disease|3
6031064|NCT00716417|20845285|P10|Overall Study|Withdrawal by Subject|0
6031065|NCT00716417|20845286|P9|Overall Study|Withdrawal by Subject|0
6031066|NCT00716417|20845287|P8|Overall Study|Withdrawal by Subject|0
6031067|NCT00716417|20845288|P7|Overall Study|Withdrawal by Subject|1
6031068|NCT00716417|20845289|P6|Overall Study|Withdrawal by Subject|0
6031069|NCT00716417|20845290|P5|Overall Study|Withdrawal by Subject|0
6031070|NCT00716417|20845291|P4|Overall Study|Withdrawal by Subject|2
6031071|NCT00716417|20845292|P3|Overall Study|Withdrawal by Subject|0
6031072|NCT00716417|20845293|P2|Overall Study|Withdrawal by Subject|1
6031073|NCT00716417|20845294|P1|Overall Study|Withdrawal by Subject|0
6031074|NCT00716417|20845285|P10|Overall Study|Adverse Event|3
6031075|NCT00716417|20845286|P9|Overall Study|Adverse Event|0
6031076|NCT00716417|20845287|P8|Overall Study|Adverse Event|1
6031077|NCT00716417|20845288|P7|Overall Study|Adverse Event|3
6031078|NCT00716417|20845289|P6|Overall Study|Adverse Event|0
6031079|NCT00716417|20845290|P5|Overall Study|Adverse Event|0
6031080|NCT00716417|20845291|P4|Overall Study|Adverse Event|1
6031081|NCT00716417|20845292|P3|Overall Study|Adverse Event|2
6031082|NCT00716417|20845293|P2|Overall Study|Adverse Event|0
6031083|NCT00716417|20845294|P1|Overall Study|Adverse Event|0
6031084|NCT00716274|20845341|P6|Study Period III (16-Weeks)|Adverse Event|0
6031085|NCT00716274|20845342|P5|Study Period III (16-Weeks)|Adverse Event|1
6031086|NCT00716274|20845343|P4|Study Period III (16-Weeks)|Adverse Event|0
6031087|NCT00716274|20845344|P3|Study Period III (16-Weeks)|Adverse Event|0
6031088|NCT00716274|20845345|P2|Study Period III (16-Weeks)|Adverse Event|0
6031089|NCT00716274|20845346|P1|Study Period III (16-Weeks)|Adverse Event|0
6031090|NCT00716274|20845341|P6|Study Period III (16-Weeks)|Parent Caregiver Decision|0
6031091|NCT00716274|20845342|P5|Study Period III (16-Weeks)|Parent Caregiver Decision|1
6031092|NCT00716274|20845343|P4|Study Period III (16-Weeks)|Parent Caregiver Decision|1
6031093|NCT00716274|20845344|P3|Study Period III (16-Weeks)|Parent Caregiver Decision|0
6031094|NCT00716274|20845345|P2|Study Period III (16-Weeks)|Parent Caregiver Decision|0
6031095|NCT00716274|20845346|P1|Study Period III (16-Weeks)|Parent Caregiver Decision|0
6031096|NCT00716274|20845341|P6|Study Period III (16-Weeks)|Physician Decision|0
6031097|NCT00716274|20845342|P5|Study Period III (16-Weeks)|Physician Decision|1
6031098|NCT00716274|20845343|P4|Study Period III (16-Weeks)|Physician Decision|0
6031099|NCT00716274|20845344|P3|Study Period III (16-Weeks)|Physician Decision|0
6031100|NCT00716274|20845345|P2|Study Period III (16-Weeks)|Physician Decision|0
6031101|NCT00716274|20845346|P1|Study Period III (16-Weeks)|Physician Decision|0
6031102|NCT00716274|20845341|P6|Study Period III (16-Weeks)|Withdrawal by Subject|0
6031103|NCT00716274|20845342|P5|Study Period III (16-Weeks)|Withdrawal by Subject|0
6031104|NCT00716274|20845343|P4|Study Period III (16-Weeks)|Withdrawal by Subject|0
6031105|NCT00716274|20845344|P3|Study Period III (16-Weeks)|Withdrawal by Subject|2
6031106|NCT00716274|20845345|P2|Study Period III (16-Weeks)|Withdrawal by Subject|0
6031107|NCT00716274|20845346|P1|Study Period III (16-Weeks)|Withdrawal by Subject|0
6031108|NCT00716274|20845341|P6|Study Period II (16-Weeks)|Lost to Follow-up|0
6031109|NCT00716274|20845342|P5|Study Period II (16-Weeks)|Lost to Follow-up|0
6031110|NCT00716274|20845343|P4|Study Period II (16-Weeks)|Lost to Follow-up|0
6031111|NCT00716274|20845344|P3|Study Period II (16-Weeks)|Lost to Follow-up|0
6031112|NCT00716274|20845345|P2|Study Period II (16-Weeks)|Lost to Follow-up|2
6031113|NCT00716274|20845346|P1|Study Period II (16-Weeks)|Lost to Follow-up|0
6031114|NCT00716274|20845341|P6|Study Period II (16-Weeks)|Parent/Caregiver Decision|0
6031115|NCT00716274|20845342|P5|Study Period II (16-Weeks)|Parent/Caregiver Decision|0
6031116|NCT00716274|20845343|P4|Study Period II (16-Weeks)|Parent/Caregiver Decision|0
6031117|NCT00716274|20845344|P3|Study Period II (16-Weeks)|Parent/Caregiver Decision|0
6031118|NCT00716274|20845345|P2|Study Period II (16-Weeks)|Parent/Caregiver Decision|3
6031119|NCT00716274|20845346|P1|Study Period II (16-Weeks)|Parent/Caregiver Decision|3
6031120|NCT00716274|20845341|P6|Study Period II (16-Weeks)|Physician Decision|1
6031121|NCT00716274|20845342|P5|Study Period II (16-Weeks)|Physician Decision|0
6031122|NCT00716274|20845343|P4|Study Period II (16-Weeks)|Physician Decision|0
6031123|NCT00716274|20845344|P3|Study Period II (16-Weeks)|Physician Decision|0
6031124|NCT00716274|20845345|P2|Study Period II (16-Weeks)|Physician Decision|1
6031125|NCT00716274|20845346|P1|Study Period II (16-Weeks)|Physician Decision|3
6031126|NCT00716274|20845341|P6|Study Period II (16-Weeks)|Withdrawal by Subject|0
6031127|NCT00716274|20845342|P5|Study Period II (16-Weeks)|Withdrawal by Subject|0
6031128|NCT00716274|20845343|P4|Study Period II (16-Weeks)|Withdrawal by Subject|0
6031129|NCT00716274|20845344|P3|Study Period II (16-Weeks)|Withdrawal by Subject|0
6031130|NCT00716274|20845345|P2|Study Period II (16-Weeks)|Withdrawal by Subject|0
6031131|NCT00716274|20845346|P1|Study Period II (16-Weeks)|Withdrawal by Subject|1
6031132|NCT00716274|20845341|P6|Study Period II (16-Weeks)|Protocol Violation|1
6031133|NCT00716274|20845342|P5|Study Period II (16-Weeks)|Protocol Violation|0
6031134|NCT00716274|20845343|P4|Study Period II (16-Weeks)|Protocol Violation|0
6031135|NCT00716274|20845344|P3|Study Period II (16-Weeks)|Protocol Violation|0
6031136|NCT00716274|20845345|P2|Study Period II (16-Weeks)|Protocol Violation|3
6031137|NCT00716274|20845346|P1|Study Period II (16-Weeks)|Protocol Violation|0
6031138|NCT00716274|20845341|P6|Study Period II (16-Weeks)|Entry Criteria Not Met|0
6031139|NCT00716274|20845342|P5|Study Period II (16-Weeks)|Entry Criteria Not Met|0
6031140|NCT00716274|20845343|P4|Study Period II (16-Weeks)|Entry Criteria Not Met|0
6031141|NCT00716274|20845344|P3|Study Period II (16-Weeks)|Entry Criteria Not Met|0
6031142|NCT00716274|20845345|P2|Study Period II (16-Weeks)|Entry Criteria Not Met|0
6031143|NCT00716274|20845346|P1|Study Period II (16-Weeks)|Entry Criteria Not Met|2
6031144|NCT00716144|20845480|P4|Overall Study|Clinical Depression|0
6031145|NCT00716144|20845481|P3|Overall Study|Clinical Depression|0
6031146|NCT00716144|20845482|P2|Overall Study|Clinical Depression|1
6031147|NCT00716144|20845483|P1|Overall Study|Clinical Depression|0
6031148|NCT00716144|20845480|P4|Overall Study|Adverse event: left foot pain|0
6031149|NCT00716144|20845481|P3|Overall Study|Adverse event: left foot pain|0
6031150|NCT00716144|20845482|P2|Overall Study|Adverse event: left foot pain|1
6031151|NCT00716144|20845483|P1|Overall Study|Adverse event: left foot pain|0
6031152|NCT00716144|20845480|P4|Overall Study|Withdrew consent, allowed use of data|0
6031153|NCT00716144|20845481|P3|Overall Study|Withdrew consent, allowed use of data|1
6031154|NCT00716144|20845482|P2|Overall Study|Withdrew consent, allowed use of data|0
6031155|NCT00716144|20845483|P1|Overall Study|Withdrew consent, allowed use of data|0
6031156|NCT00716144|20845480|P4|Overall Study|Intercurrent illness|0
6031157|NCT00716144|20845481|P3|Overall Study|Intercurrent illness|1
6031158|NCT00716144|20845482|P2|Overall Study|Intercurrent illness|0
6031159|NCT00716144|20845483|P1|Overall Study|Intercurrent illness|0
6031160|NCT00716144|20845480|P4|Overall Study|Physician Decision|2
6031161|NCT00716144|20845481|P3|Overall Study|Physician Decision|2
6031162|NCT00716144|20845482|P2|Overall Study|Physician Decision|1
6031163|NCT00716144|20845483|P1|Overall Study|Physician Decision|0
6031164|NCT00716144|20845480|P4|Overall Study|Protocol Violation|0
6031165|NCT00716144|20845481|P3|Overall Study|Protocol Violation|1
6031166|NCT00716144|20845482|P2|Overall Study|Protocol Violation|0
6031167|NCT00716144|20845483|P1|Overall Study|Protocol Violation|2
6031168|NCT00716144|20845480|P4|Overall Study|Non-compliance|0
6031169|NCT00716144|20845481|P3|Overall Study|Non-compliance|0
6031170|NCT00716144|20845482|P2|Overall Study|Non-compliance|0
6031171|NCT00716144|20845483|P1|Overall Study|Non-compliance|1
6031172|NCT00716144|20845480|P4|Overall Study|Adverse Event|2
6031173|NCT00716144|20845481|P3|Overall Study|Adverse Event|0
6031174|NCT00716144|20845482|P2|Overall Study|Adverse Event|0
6031175|NCT00716144|20845483|P1|Overall Study|Adverse Event|0
6031176|NCT00716144|20845480|P4|Overall Study|Lost to Follow-up|2
6031177|NCT00716144|20845481|P3|Overall Study|Lost to Follow-up|1
6031178|NCT00716144|20845482|P2|Overall Study|Lost to Follow-up|2
6031179|NCT00716144|20845483|P1|Overall Study|Lost to Follow-up|2
6031180|NCT00716144|20845480|P4|Overall Study|Withdrawal by Subject|6
6031181|NCT00716144|20845481|P3|Overall Study|Withdrawal by Subject|6
6031182|NCT00716144|20845482|P2|Overall Study|Withdrawal by Subject|2
6031183|NCT00716144|20845483|P1|Overall Study|Withdrawal by Subject|4
6031184|NCT00716092|20845508|P3|Overall Study|Other incl. Lack of Efficacy|0
6031185|NCT00716092|20845509|P2|Overall Study|Other incl. Lack of Efficacy|1
6031186|NCT00716092|20845510|P1|Overall Study|Other incl. Lack of Efficacy|2
6031187|NCT00715949|20845563|P1|Overall Study|could not finish first test|4
6031188|NCT00715910|20845571|P6|Booster and ESFU Phase|Other|0
6031189|NCT00715910|20845572|P5|Booster and ESFU Phase|Other|1
6031190|NCT00715910|20845573|P4|Booster and ESFU Phase|Other|5
6031191|NCT00715910|20845574|P3|Booster and ESFU Phase|Other|0
6031192|NCT00715910|20845575|P2|Booster and ESFU Phase|Other|0
6031193|NCT00715910|20845576|P1|Booster and ESFU Phase|Other|0
6031194|NCT00715910|20845571|P6|Booster and ESFU Phase|Lost to Follow-up|13
6031195|NCT00715910|20845572|P5|Booster and ESFU Phase|Lost to Follow-up|1
6031196|NCT00715910|20845573|P4|Booster and ESFU Phase|Lost to Follow-up|6
6031197|NCT00715910|20845574|P3|Booster and ESFU Phase|Lost to Follow-up|0
6031198|NCT00715910|20845575|P2|Booster and ESFU Phase|Lost to Follow-up|0
6031199|NCT00715910|20845576|P1|Booster and ESFU Phase|Lost to Follow-up|0
6031200|NCT00715793|20845695|P2|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|2
6031201|NCT00715793|20845696|P1|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|0
6031202|NCT00715793|20845695|P2|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|0
6031203|NCT00715793|20845696|P1|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|1
6031204|NCT00715676|20845757|P3|Overall Study|Elevated Blood Glucose|0
6031205|NCT00715676|20845758|P2|Overall Study|Elevated Blood Glucose|1
6031206|NCT00715676|20845759|P1|Overall Study|Elevated Blood Glucose|0
6031207|NCT00715676|20845757|P3|Overall Study|Use of Exclusionary Medication|1
6031208|NCT00715676|20845758|P2|Overall Study|Use of Exclusionary Medication|0
6031209|NCT00715676|20845759|P1|Overall Study|Use of Exclusionary Medication|0
6031210|NCT00715676|20845757|P3|Overall Study|Did Not Meet Entry Criteria|1
6031211|NCT00715676|20845758|P2|Overall Study|Did Not Meet Entry Criteria|0
6031212|NCT00715676|20845759|P1|Overall Study|Did Not Meet Entry Criteria|0
6031213|NCT00715676|20845757|P3|Overall Study|Terminated by Sponsor|0
6031214|NCT00715676|20845758|P2|Overall Study|Terminated by Sponsor|0
6031215|NCT00715676|20845759|P1|Overall Study|Terminated by Sponsor|1
6031216|NCT00715676|20845757|P3|Overall Study|Lost to Follow-up|1
6031217|NCT00715676|20845758|P2|Overall Study|Lost to Follow-up|2
6031218|NCT00715676|20845759|P1|Overall Study|Lost to Follow-up|1
6031219|NCT00715676|20845757|P3|Overall Study|Withdrawal by Subject|8
6031220|NCT00715676|20845758|P2|Overall Study|Withdrawal by Subject|3
6031221|NCT00715676|20845759|P1|Overall Study|Withdrawal by Subject|1
6031222|NCT00715676|20845757|P3|Overall Study|Adverse Event|21
6031223|NCT00715676|20845758|P2|Overall Study|Adverse Event|5
6031224|NCT00715676|20845759|P1|Overall Study|Adverse Event|3
6031225|NCT00715624|20845802|P2|Overall Study|Other|1
6031226|NCT00715624|20845803|P1|Overall Study|Other|0
6031227|NCT00715624|20845802|P2|Overall Study|Incorrect randomization (not treated)|1
6031228|NCT00715624|20845803|P1|Overall Study|Incorrect randomization (not treated)|0
6031229|NCT00715624|20845802|P2|Overall Study|Sponsor decision|4
6031230|NCT00715624|20845803|P1|Overall Study|Sponsor decision|0
6031231|NCT00715624|20845802|P2|Overall Study|Poor compliance|13
6031232|NCT00715624|20845803|P1|Overall Study|Poor compliance|6
6031233|NCT00715624|20845802|P2|Overall Study|Familial and personal reasons|22
6031234|NCT00715624|20845803|P1|Overall Study|Familial and personal reasons|10
6031235|NCT00715624|20845802|P2|Overall Study|Withdrawal by Subject|25
6031236|NCT00715624|20845803|P1|Overall Study|Withdrawal by Subject|11
6031237|NCT00715624|20845802|P2|Overall Study|Protocol Violation|0
6031238|NCT00715624|20845803|P1|Overall Study|Protocol Violation|1
6031239|NCT00715624|20845802|P2|Overall Study|Lost to Follow-up|2
6031240|NCT00715624|20845803|P1|Overall Study|Lost to Follow-up|1
6031241|NCT00715624|20845802|P2|Overall Study|Lack of Efficacy|11
6031242|NCT00715624|20845803|P1|Overall Study|Lack of Efficacy|11
6031243|NCT00715624|20845802|P2|Overall Study|Adverse Event|37
6031244|NCT00715624|20845803|P1|Overall Study|Adverse Event|12
6031245|NCT00715559|20845831|P1|Overall Study|medication not tolerated - nausea|1
6031246|NCT00715520|20845841|P3|Overall Study|Withdrawal by Subject|1
6031247|NCT00715520|20845842|P2|Overall Study|Withdrawal by Subject|0
6031248|NCT00715520|20845843|P1|Overall Study|Withdrawal by Subject|2
6031249|NCT00715520|20845841|P3|Overall Study|Screen failure|1
6031250|NCT00715520|20845842|P2|Overall Study|Screen failure|1
6031251|NCT00715520|20845843|P1|Overall Study|Screen failure|8
6031252|NCT00715429|20845858|P2|Overall Study|Did not complete the study diary|1
6031253|NCT00715429|20845859|P1|Overall Study|Did not complete the study diary|0
6031254|NCT00715403|20845874|P7|Overall Study|Other reason not defined above|0
6031255|NCT00715403|20845875|P6|Overall Study|Other reason not defined above|1
6031256|NCT00715403|20845876|P5|Overall Study|Other reason not defined above|1
6031257|NCT00715403|20845877|P4|Overall Study|Other reason not defined above|0
6031258|NCT00715403|20845878|P3|Overall Study|Other reason not defined above|1
6031259|NCT00715403|20845879|P2|Overall Study|Other reason not defined above|0
6031260|NCT00715403|20845880|P1|Overall Study|Other reason not defined above|0
6031261|NCT00715403|20845874|P7|Overall Study|Protocol Violation|0
6031262|NCT00715403|20845875|P6|Overall Study|Protocol Violation|1
6031263|NCT00715403|20845876|P5|Overall Study|Protocol Violation|0
6031264|NCT00715403|20845877|P4|Overall Study|Protocol Violation|0
6031265|NCT00715403|20845878|P3|Overall Study|Protocol Violation|0
6031266|NCT00715403|20845879|P2|Overall Study|Protocol Violation|0
6031267|NCT00715403|20845880|P1|Overall Study|Protocol Violation|0
6031268|NCT00715403|20845874|P7|Overall Study|Other Adverse Event than DLT|0
6031269|NCT00715403|20845875|P6|Overall Study|Other Adverse Event than DLT|2
6031270|NCT00715403|20845876|P5|Overall Study|Other Adverse Event than DLT|0
6031271|NCT00715403|20845877|P4|Overall Study|Other Adverse Event than DLT|0
6031272|NCT00715403|20845878|P3|Overall Study|Other Adverse Event than DLT|0
6031273|NCT00715403|20845879|P2|Overall Study|Other Adverse Event than DLT|0
6031274|NCT00715403|20845880|P1|Overall Study|Other Adverse Event than DLT|1
6031275|NCT00715403|20845874|P7|Overall Study|Dose limiting Toxicity (DLT)|0
6031276|NCT00715403|20845875|P6|Overall Study|Dose limiting Toxicity (DLT)|1
6031277|NCT00715403|20845876|P5|Overall Study|Dose limiting Toxicity (DLT)|0
6031278|NCT00715403|20845877|P4|Overall Study|Dose limiting Toxicity (DLT)|0
6031279|NCT00715403|20845878|P3|Overall Study|Dose limiting Toxicity (DLT)|0
6031280|NCT00715403|20845879|P2|Overall Study|Dose limiting Toxicity (DLT)|0
6031281|NCT00715403|20845880|P1|Overall Study|Dose limiting Toxicity (DLT)|0
6031282|NCT00715403|20845874|P7|Overall Study|Progressive disease|1
6031283|NCT00715403|20845875|P6|Overall Study|Progressive disease|14
6031284|NCT00715403|20845876|P5|Overall Study|Progressive disease|5
6031285|NCT00715403|20845877|P4|Overall Study|Progressive disease|9
6031286|NCT00715403|20845878|P3|Overall Study|Progressive disease|3
6031287|NCT00715403|20845879|P2|Overall Study|Progressive disease|1
6031288|NCT00715403|20845880|P1|Overall Study|Progressive disease|0
6031289|NCT00715299|20846019|P1|Overall Study|failed the pre-screen exercise test|2
6031290|NCT00715299|20846019|P1|Overall Study|Adverse Event|3
6031291|NCT00715299|20846019|P1|Overall Study|Withdrawal by Subject|1
6031292|NCT00715208|20846025|P2|Overall Study|Lack of Efficacy|2
6031293|NCT00715208|20846026|P1|Overall Study|Lack of Efficacy|0
6031294|NCT00715208|20846025|P2|Overall Study|Adverse Event|6
6031295|NCT00715208|20846026|P1|Overall Study|Adverse Event|0
6031296|NCT00715208|20846025|P2|Overall Study|Withdrawal by Subject|1
6031297|NCT00715208|20846026|P1|Overall Study|Withdrawal by Subject|1
6031298|NCT00715117|20846042|P2|Overall Study|Crohn's flare and rescue with steroids|1
6031299|NCT00715117|20846043|P1|Overall Study|Crohn's flare and rescue with steroids|0
6031300|NCT00715078|20846111|P3|Overall Study|Unable to start due to disease prog.|1
6031301|NCT00715078|20846112|P2|Overall Study|Unable to start due to disease prog.|0
6031302|NCT00715078|20846113|P1|Overall Study|Unable to start due to disease prog.|0
6031303|NCT00715078|20846111|P3|Overall Study|Withdrawal by Subject|1
6031304|NCT00715078|20846112|P2|Overall Study|Withdrawal by Subject|0
6031305|NCT00715078|20846113|P1|Overall Study|Withdrawal by Subject|1
6031306|NCT00715078|20846111|P3|Overall Study|Death|36
6031307|NCT00715078|20846112|P2|Overall Study|Death|36
6031308|NCT00715078|20846113|P1|Overall Study|Death|29
6031309|NCT00715026|20846121|P1|Overall Study|Surgery done on non-study consented hip|1
6031310|NCT00715026|20846121|P1|Overall Study|Protocol Violation|1
6031311|NCT00715026|20846121|P1|Overall Study|Lost to Follow-up|3
6031312|NCT00715026|20846121|P1|Overall Study|Withdrawal by Subject|5
6031313|NCT00714948|20846126|P1|Overall Study|Adverse Event|2
6031314|NCT00714870|20846132|P2|Overall Study|did not attend minimum of 4 sessions|0
6031315|NCT00714870|20846133|P1|Overall Study|did not attend minimum of 4 sessions|4
6031316|NCT00714870|20846132|P2|Overall Study|patient unable to come b/c back pain|0
6031317|NCT00714870|20846133|P1|Overall Study|patient unable to come b/c back pain|1
6031318|NCT00714870|20846132|P2|Overall Study|Lost to Follow-up|5
6031319|NCT00714870|20846133|P1|Overall Study|Lost to Follow-up|22
6031320|NCT00714714|20846157|P1|Overall Study|Adverse Event|1
6031321|NCT00714688|20846166|P3|Overall Study|Other|5
6031322|NCT00714688|20846167|P2|Overall Study|Other|6
6031323|NCT00714688|20846168|P1|Overall Study|Other|1
6031324|NCT00714688|20846166|P3|Overall Study|Sponsor's Decision|0
6031325|NCT00714688|20846167|P2|Overall Study|Sponsor's Decision|2
6031326|NCT00714688|20846168|P1|Overall Study|Sponsor's Decision|0
6031327|NCT00714688|20846166|P3|Overall Study|Ineligible to Continue the Study|1
6031328|NCT00714688|20846167|P2|Overall Study|Ineligible to Continue the Study|1
6031329|NCT00714688|20846168|P1|Overall Study|Ineligible to Continue the Study|0
6031330|NCT00714688|20846166|P3|Overall Study|Subject Non-compliant|5
6031331|NCT00714688|20846167|P2|Overall Study|Subject Non-compliant|5
6031332|NCT00714688|20846168|P1|Overall Study|Subject Non-compliant|3
6031333|NCT00714688|20846166|P3|Overall Study|Adverse Event|19
6031334|NCT00714688|20846167|P2|Overall Study|Adverse Event|15
6031335|NCT00714688|20846168|P1|Overall Study|Adverse Event|2
6031336|NCT00714688|20846166|P3|Overall Study|Lost to Follow-up|0
6031337|NCT00714688|20846167|P2|Overall Study|Lost to Follow-up|2
6031338|NCT00714688|20846168|P1|Overall Study|Lost to Follow-up|5
6031339|NCT00714688|20846166|P3|Overall Study|Withdrawal by Subject|3
6031340|NCT00714688|20846167|P2|Overall Study|Withdrawal by Subject|3
6031341|NCT00714688|20846168|P1|Overall Study|Withdrawal by Subject|4
6031342|NCT00714688|20846166|P3|Overall Study|Lack of Efficacy|4
6031343|NCT00714688|20846167|P2|Overall Study|Lack of Efficacy|1
6031344|NCT00714688|20846168|P1|Overall Study|Lack of Efficacy|14
6031345|NCT00714493|20846210|P1|Overall Study|OTHER|2
6031346|NCT00714493|20846210|P1|Overall Study|SUBJECT CHOICE (SUBJECT WITHDREW CONSENT|8
6031347|NCT00714493|20846210|P1|Overall Study|Protocol Violation|12
6031348|NCT00714493|20846210|P1|Overall Study|Lost to Follow-up|3
6031349|NCT00714493|20846210|P1|Overall Study|Lack of Efficacy|10
6031350|NCT00714493|20846210|P1|Overall Study|Death|3
6031351|NCT00714493|20846210|P1|Overall Study|Adverse Event|11
6031352|NCT00714415|20846222|P2|Overall Study|Death|0
6031353|NCT00714415|20846223|P1|Overall Study|Death|1
6031354|NCT00714415|20846222|P2|Overall Study|Lack of Efficacy|0
6031355|NCT00714415|20846223|P1|Overall Study|Lack of Efficacy|1
6031356|NCT00714285|20846273|P4|Overall Study|Migrated/moved from study area|0
6031357|NCT00714285|20846274|P3|Overall Study|Migrated/moved from study area|0
6031358|NCT00714285|20846275|P2|Overall Study|Migrated/moved from study area|1
6031359|NCT00714285|20846276|P1|Overall Study|Migrated/moved from study area|0
6031360|NCT00714285|20846273|P4|Overall Study|Lost to Follow-up|1
6031361|NCT00714285|20846274|P3|Overall Study|Lost to Follow-up|0
6031362|NCT00714285|20846275|P2|Overall Study|Lost to Follow-up|2
6031363|NCT00714285|20846276|P1|Overall Study|Lost to Follow-up|0
6031364|NCT00714259|20846337|P1|Overall Study|Death|2
6031365|NCT00714168|20846383|P2|Overall Study|Non-study medical condition|2
6031366|NCT00714168|20846384|P1|Overall Study|Non-study medical condition|3
6031367|NCT00714168|20846383|P2|Overall Study|Relocation|3
6031368|NCT00714168|20846384|P1|Overall Study|Relocation|4
6031369|NCT00714168|20846383|P2|Overall Study|Lost to Follow-up|50
6031370|NCT00714168|20846384|P1|Overall Study|Lost to Follow-up|32
6031371|NCT00714168|20846383|P2|Overall Study|Pregnancy|4
6031372|NCT00714168|20846384|P1|Overall Study|Pregnancy|5
6031373|NCT00714051|20846400|P2|Overall Study|Death|1
6031374|NCT00714051|20846401|P1|Overall Study|Death|0
6031375|NCT00714051|20846400|P2|Overall Study|Withdrawal by Subject|0
6031376|NCT00714051|20846401|P1|Overall Study|Withdrawal by Subject|1
6031377|NCT00713830|20846409|P2|Overall Study|Sponsor Decision|10
6031378|NCT00713830|20846410|P1|Overall Study|Sponsor Decision|4
6031379|NCT00713830|20846409|P2|Overall Study|Familial and Personal Reasons|34
6031380|NCT00713830|20846410|P1|Overall Study|Familial and Personal Reasons|9
6031381|NCT00713830|20846409|P2|Overall Study|Poor Compliance to Protocol|14
6031382|NCT00713830|20846410|P1|Overall Study|Poor Compliance to Protocol|7
6031383|NCT00713830|20846409|P2|Overall Study|Withdrawal by Subject|23
6031384|NCT00713830|20846410|P1|Overall Study|Withdrawal by Subject|13
6031385|NCT00713830|20846409|P2|Overall Study|Lost to Follow-up|9
6031386|NCT00713830|20846410|P1|Overall Study|Lost to Follow-up|2
6031387|NCT00713830|20846409|P2|Overall Study|Lack of Efficacy|16
6031388|NCT00713830|20846410|P1|Overall Study|Lack of Efficacy|24
6031389|NCT00713830|20846409|P2|Overall Study|Adverse Event|71
6031390|NCT00713830|20846410|P1|Overall Study|Adverse Event|23
6031391|NCT00713700|20846467|P1|Overall Study|Withdrawal by Subject|1
6031392|NCT00713700|20846467|P1|Overall Study|Lost to Follow-up|3
6031393|NCT00713648|20846493|P1|Overall Study|Development of antibodies|3
6031394|NCT00713648|20846493|P1|Overall Study|According to Protocol|2
6031395|NCT00713648|20846493|P1|Overall Study|Unclassified|2
6031396|NCT00713648|20846493|P1|Overall Study|Adverse Event|1
6031397|NCT00713609|20846506|P6|Overall Study|Protocol Violation|0
6031398|NCT00713609|20846507|P5|Overall Study|Protocol Violation|2
6031399|NCT00713609|20846508|P4|Overall Study|Protocol Violation|1
6031400|NCT00713609|20846509|P3|Overall Study|Protocol Violation|1
6031401|NCT00713609|20846510|P2|Overall Study|Protocol Violation|3
6031402|NCT00713609|20846511|P1|Overall Study|Protocol Violation|6
6031403|NCT00713609|20846506|P6|Overall Study|Withdrawal by Subject|7
6031404|NCT00713609|20846507|P5|Overall Study|Withdrawal by Subject|5
6031405|NCT00713609|20846508|P4|Overall Study|Withdrawal by Subject|1
6031406|NCT00713609|20846509|P3|Overall Study|Withdrawal by Subject|5
6031407|NCT00713609|20846510|P2|Overall Study|Withdrawal by Subject|1
6031408|NCT00713609|20846511|P1|Overall Study|Withdrawal by Subject|6
6031409|NCT00713609|20846506|P6|Overall Study|Non-Compliance with Study Treatment|0
6031410|NCT00713609|20846507|P5|Overall Study|Non-Compliance with Study Treatment|1
6031411|NCT00713609|20846508|P4|Overall Study|Non-Compliance with Study Treatment|0
6031412|NCT00713609|20846509|P3|Overall Study|Non-Compliance with Study Treatment|2
6031413|NCT00713609|20846510|P2|Overall Study|Non-Compliance with Study Treatment|1
6031414|NCT00713609|20846511|P1|Overall Study|Non-Compliance with Study Treatment|1
6031415|NCT00713609|20846506|P6|Overall Study|Lack of Efficacy|0
6031416|NCT00713609|20846507|P5|Overall Study|Lack of Efficacy|1
6031417|NCT00713609|20846508|P4|Overall Study|Lack of Efficacy|0
6031418|NCT00713609|20846509|P3|Overall Study|Lack of Efficacy|0
6031419|NCT00713609|20846510|P2|Overall Study|Lack of Efficacy|3
6031420|NCT00713609|20846511|P1|Overall Study|Lack of Efficacy|1
6031421|NCT00713609|20846506|P6|Overall Study|Lost to Follow-up|0
6031422|NCT00713609|20846507|P5|Overall Study|Lost to Follow-up|7
6031423|NCT00713609|20846508|P4|Overall Study|Lost to Follow-up|5
6031424|NCT00713609|20846509|P3|Overall Study|Lost to Follow-up|5
6031425|NCT00713609|20846510|P2|Overall Study|Lost to Follow-up|7
6031426|NCT00713609|20846511|P1|Overall Study|Lost to Follow-up|5
6031427|NCT00713609|20846506|P6|Overall Study|Adverse Event|1
6031428|NCT00713609|20846507|P5|Overall Study|Adverse Event|3
6031429|NCT00713609|20846508|P4|Overall Study|Adverse Event|2
6031430|NCT00713609|20846509|P3|Overall Study|Adverse Event|2
6031431|NCT00713609|20846510|P2|Overall Study|Adverse Event|0
6031432|NCT00713609|20846511|P1|Overall Study|Adverse Event|2
6031433|NCT00713596|20846546|P3|Overall Study|Study was terminated|2
6031434|NCT00713596|20846547|P2|Overall Study|Study was terminated|3
6031435|NCT00713596|20846548|P1|Overall Study|Study was terminated|2
6031436|NCT00713544|20846574|P6|Overall Study|Hepatotoxicity - not an AE|0
6031437|NCT00713544|20846575|P5|Overall Study|Hepatotoxicity - not an AE|1
6031438|NCT00713544|20846576|P4|Overall Study|Hepatotoxicity - not an AE|0
6031439|NCT00713544|20846577|P3|Overall Study|Hepatotoxicity - not an AE|0
6031440|NCT00713544|20846578|P2|Overall Study|Hepatotoxicity - not an AE|0
6031441|NCT00713544|20846579|P1|Overall Study|Hepatotoxicity - not an AE|0
6031442|NCT00713544|20846574|P6|Overall Study|Incorrect enrollment|0
6031443|NCT00713544|20846575|P5|Overall Study|Incorrect enrollment|0
6031444|NCT00713544|20846576|P4|Overall Study|Incorrect enrollment|0
6031445|NCT00713544|20846577|P3|Overall Study|Incorrect enrollment|0
6031446|NCT00713544|20846578|P2|Overall Study|Incorrect enrollment|1
6031447|NCT00713544|20846579|P1|Overall Study|Incorrect enrollment|0
6031448|NCT00713544|20846574|P6|Overall Study|AZ decision - Hepatitis C ab reactive|0
6031449|NCT00713544|20846575|P5|Overall Study|AZ decision - Hepatitis C ab reactive|0
6031450|NCT00713544|20846576|P4|Overall Study|AZ decision - Hepatitis C ab reactive|0
6031451|NCT00713544|20846577|P3|Overall Study|AZ decision - Hepatitis C ab reactive|0
6031452|NCT00713544|20846578|P2|Overall Study|AZ decision - Hepatitis C ab reactive|1
6031453|NCT00713544|20846579|P1|Overall Study|AZ decision - Hepatitis C ab reactive|0
6031454|NCT00713544|20846574|P6|Overall Study|Lost to Follow-up|0
6031455|NCT00713544|20846575|P5|Overall Study|Lost to Follow-up|0
6031456|NCT00713544|20846576|P4|Overall Study|Lost to Follow-up|0
6031457|NCT00713544|20846577|P3|Overall Study|Lost to Follow-up|1
6031458|NCT00713544|20846578|P2|Overall Study|Lost to Follow-up|0
6031459|NCT00713544|20846579|P1|Overall Study|Lost to Follow-up|0
6031460|NCT00713544|20846574|P6|Overall Study|Lack of Efficacy|0
6031461|NCT00713544|20846575|P5|Overall Study|Lack of Efficacy|1
6031462|NCT00713544|20846576|P4|Overall Study|Lack of Efficacy|1
6031463|NCT00713544|20846577|P3|Overall Study|Lack of Efficacy|0
6031464|NCT00713544|20846578|P2|Overall Study|Lack of Efficacy|1
6031465|NCT00713544|20846579|P1|Overall Study|Lack of Efficacy|0
6031466|NCT00713544|20846574|P6|Overall Study|Physician Decision|2
6031467|NCT00713544|20846575|P5|Overall Study|Physician Decision|0
6031468|NCT00713544|20846576|P4|Overall Study|Physician Decision|0
6031469|NCT00713544|20846577|P3|Overall Study|Physician Decision|0
6031470|NCT00713544|20846578|P2|Overall Study|Physician Decision|0
6031471|NCT00713544|20846579|P1|Overall Study|Physician Decision|0
6031472|NCT00713544|20846574|P6|Overall Study|Protocol Violation|1
6031473|NCT00713544|20846575|P5|Overall Study|Protocol Violation|0
6031474|NCT00713544|20846576|P4|Overall Study|Protocol Violation|0
6031475|NCT00713544|20846577|P3|Overall Study|Protocol Violation|0
6031476|NCT00713544|20846578|P2|Overall Study|Protocol Violation|0
6031477|NCT00713544|20846579|P1|Overall Study|Protocol Violation|0
6031478|NCT00713544|20846574|P6|Overall Study|Withdrawal by Subject|1
6031479|NCT00713544|20846575|P5|Overall Study|Withdrawal by Subject|3
6031480|NCT00713544|20846576|P4|Overall Study|Withdrawal by Subject|2
6031481|NCT00713544|20846577|P3|Overall Study|Withdrawal by Subject|3
6031482|NCT00713544|20846578|P2|Overall Study|Withdrawal by Subject|0
6031483|NCT00713544|20846579|P1|Overall Study|Withdrawal by Subject|2
6031484|NCT00713544|20846574|P6|Overall Study|Adverse Event|5
6031485|NCT00713544|20846575|P5|Overall Study|Adverse Event|3
6031486|NCT00713544|20846576|P4|Overall Study|Adverse Event|7
6031487|NCT00713544|20846577|P3|Overall Study|Adverse Event|7
6031488|NCT00713544|20846578|P2|Overall Study|Adverse Event|3
6031489|NCT00713544|20846579|P1|Overall Study|Adverse Event|5
6031490|NCT00713349|20846630|P1|Overall Study|Protocol Violation|1
6031491|NCT00713323|20846636|P1|Overall Study|Treatment that may interact with Sativex|1
6031492|NCT00713323|20846636|P1|Overall Study|Subject travelling to Dominica Republic|1
6031493|NCT00713323|20846636|P1|Overall Study|Subject travelling to USA|1
6031494|NCT00713323|20846636|P1|Overall Study|Pain resolved|1
6031495|NCT00713323|20846636|P1|Overall Study|Non-compliance|1
6031496|NCT00713323|20846636|P1|Overall Study|Pain free|1
6031497|NCT00713323|20846636|P1|Overall Study|Surgery cured allodynic pain|1
6031498|NCT00713323|20846636|P1|Overall Study|Withdrawn due to exclusion criteria 11|1
6031499|NCT00713323|20846636|P1|Overall Study|Low creatine clearance at screening|1
6031500|NCT00713323|20846636|P1|Overall Study|Lack of Efficacy|36
6031501|NCT00713323|20846636|P1|Overall Study|Lost to Follow-up|11
6031502|NCT00713323|20846636|P1|Overall Study|Withdrawal by Subject|15
6031503|NCT00713323|20846636|P1|Overall Study|Adverse Event|75
6031504|NCT00713310|20846649|P2|Overall Study|Withdrawal by Subject|2
6031505|NCT00713310|20846650|P1|Overall Study|Withdrawal by Subject|0
6031506|NCT00713310|20846649|P2|Overall Study|Lack of Efficacy|2
6031507|NCT00713310|20846650|P1|Overall Study|Lack of Efficacy|0
6031508|NCT00713310|20846649|P2|Overall Study|Adverse Event|2
6031509|NCT00713310|20846650|P1|Overall Study|Adverse Event|5
6031510|NCT00713258|20846664|P2|Overall Study|Other|1
6031511|NCT00713258|20846665|P1|Overall Study|Other|1
6031512|NCT00713258|20846664|P2|Overall Study|Non-Compliance|1
6031513|NCT00713258|20846665|P1|Overall Study|Non-Compliance|2
6031514|NCT00713258|20846664|P2|Overall Study|Adverse Event|4
6031515|NCT00713258|20846665|P1|Overall Study|Adverse Event|2
6031516|NCT00713219|20846673|P1|Overall Study|Protocol Violation|1
6031517|NCT00713219|20846673|P1|Overall Study|Death|1
6031518|NCT00713206|20846679|P2|Overall Study|Adverse Event|1
6031519|NCT00713206|20846680|P1|Overall Study|Adverse Event|2
6031520|NCT00713206|20846679|P2|Overall Study|Lost to Follow-up|2
6031521|NCT00713206|20846680|P1|Overall Study|Lost to Follow-up|5
6031522|NCT00712985|20846686|P1|Overall Study|Lack of Efficacy|3
6031523|NCT00712985|20846686|P1|Overall Study|1 patient moved out of state|1
6031524|NCT00712985|20846686|P1|Overall Study|1 withdrew prior to start of drug|1
6031525|NCT00712959|20846692|P2|Overall Study|Withdrawal by Subject|0
6031526|NCT00712959|20846693|P1|Overall Study|Withdrawal by Subject|3
6031527|NCT00712959|20846692|P2|Overall Study|Lost to Follow-up|2
6031528|NCT00712959|20846693|P1|Overall Study|Lost to Follow-up|13
6031529|NCT00712959|20846692|P2|Overall Study|Protocol Violation|1
6031530|NCT00712959|20846693|P1|Overall Study|Protocol Violation|3
6031531|NCT00712933|20846711|P1|Overall Study|Withdrawal by Subject|151
6031532|NCT00712933|20846711|P1|Overall Study|Protocol Violation|4
6031533|NCT00712933|20846711|P1|Overall Study|Physician Decision|36
6031534|NCT00712933|20846711|P1|Overall Study|Participant received medication|1
6031535|NCT00712933|20846711|P1|Overall Study|Not committed to contraception|1
6031536|NCT00712933|20846711|P1|Overall Study|Other Physician decision|1
6031537|NCT00712933|20846711|P1|Overall Study|Death of patient|1
6031538|NCT00712933|20846711|P1|Overall Study|Participant travelled overseas|2
6031539|NCT00712933|20846711|P1|Overall Study|Participant hospitalized|1
6031540|NCT00712933|20846711|P1|Overall Study|Involved in Clinical research|3
6031541|NCT00712933|20846711|P1|Overall Study|Hip replacement surgery|1
6031542|NCT00712933|20846711|P1|Overall Study|Withdrew consent|4
6031543|NCT00712933|20846711|P1|Overall Study|Sponsor decision|14
6031544|NCT00712933|20846711|P1|Overall Study|Other Pregnancy|37
6031545|NCT00712933|20846711|P1|Overall Study|Non-compliance with study drug|13
6031546|NCT00712933|20846711|P1|Overall Study|Lost to Follow-up|22
6031547|NCT00712933|20846711|P1|Overall Study|Lack of Efficacy|6
6031548|NCT00712933|20846711|P1|Overall Study|Adverse Event|69
6031549|NCT00712920|20846741|P3|Overall Study|Non-compliance|0
6031550|NCT00712920|20846742|P2|Overall Study|Non-compliance|0
6031551|NCT00712920|20846743|P1|Overall Study|Non-compliance|3
6031552|NCT00712920|20846741|P3|Overall Study|Other|3
6031553|NCT00712920|20846742|P2|Overall Study|Other|7
6031554|NCT00712920|20846743|P1|Overall Study|Other|5
6031555|NCT00712920|20846741|P3|Overall Study|Lack of Efficacy|1
6031556|NCT00712920|20846742|P2|Overall Study|Lack of Efficacy|0
6031557|NCT00712920|20846743|P1|Overall Study|Lack of Efficacy|1
6031558|NCT00712920|20846741|P3|Overall Study|Lost to Follow-up|0
6031559|NCT00712920|20846742|P2|Overall Study|Lost to Follow-up|4
6031560|NCT00712920|20846743|P1|Overall Study|Lost to Follow-up|1
6031561|NCT00712920|20846741|P3|Overall Study|Withdrawal by Subject|1
6031562|NCT00712920|20846742|P2|Overall Study|Withdrawal by Subject|2
6031563|NCT00712920|20846743|P1|Overall Study|Withdrawal by Subject|4
6031564|NCT00712920|20846741|P3|Overall Study|Adverse Event|7
6031565|NCT00712920|20846742|P2|Overall Study|Adverse Event|4
6031566|NCT00712920|20846743|P1|Overall Study|Adverse Event|3
6031567|NCT00712725|20846771|P8|Overall Study|Protocol Specified Criteria|1
6031568|NCT00712725|20846772|P7|Overall Study|Protocol Specified Criteria|2
6031569|NCT00712725|20846773|P6|Overall Study|Protocol Specified Criteria|0
6031570|NCT00712725|20846774|P5|Overall Study|Protocol Specified Criteria|1
6031571|NCT00712725|20846775|P4|Overall Study|Protocol Specified Criteria|2
6031572|NCT00712725|20846776|P3|Overall Study|Protocol Specified Criteria|1
6031573|NCT00712725|20846777|P2|Overall Study|Protocol Specified Criteria|0
6031574|NCT00712725|20846778|P1|Overall Study|Protocol Specified Criteria|3
6031575|NCT00712725|20846771|P8|Overall Study|Lack of Qualifying Event|6
6031576|NCT00712725|20846772|P7|Overall Study|Lack of Qualifying Event|11
6031577|NCT00712725|20846773|P6|Overall Study|Lack of Qualifying Event|13
6031578|NCT00712725|20846774|P5|Overall Study|Lack of Qualifying Event|11
6031579|NCT00712725|20846775|P4|Overall Study|Lack of Qualifying Event|8
6031580|NCT00712725|20846776|P3|Overall Study|Lack of Qualifying Event|6
6031581|NCT00712725|20846777|P2|Overall Study|Lack of Qualifying Event|2
6031582|NCT00712725|20846778|P1|Overall Study|Lack of Qualifying Event|16
6031583|NCT00712725|20846771|P8|Overall Study|Withdrawal by Subject|2
6031584|NCT00712725|20846772|P7|Overall Study|Withdrawal by Subject|1
6031585|NCT00712725|20846773|P6|Overall Study|Withdrawal by Subject|1
6031586|NCT00712725|20846774|P5|Overall Study|Withdrawal by Subject|1
6031587|NCT00712725|20846775|P4|Overall Study|Withdrawal by Subject|2
6031588|NCT00712725|20846776|P3|Overall Study|Withdrawal by Subject|1
6031589|NCT00712725|20846777|P2|Overall Study|Withdrawal by Subject|1
6031590|NCT00712725|20846778|P1|Overall Study|Withdrawal by Subject|2
6031591|NCT00712725|20846771|P8|Overall Study|Protocol Violation|1
6031592|NCT00712725|20846772|P7|Overall Study|Protocol Violation|1
6031593|NCT00712725|20846773|P6|Overall Study|Protocol Violation|0
6031594|NCT00712725|20846774|P5|Overall Study|Protocol Violation|2
6031595|NCT00712725|20846775|P4|Overall Study|Protocol Violation|3
6031596|NCT00712725|20846776|P3|Overall Study|Protocol Violation|1
6031597|NCT00712725|20846777|P2|Overall Study|Protocol Violation|0
6031598|NCT00712725|20846778|P1|Overall Study|Protocol Violation|2
6031599|NCT00712725|20846771|P8|Overall Study|Pregnancy|0
6031600|NCT00712725|20846772|P7|Overall Study|Pregnancy|2
6031601|NCT00712725|20846773|P6|Overall Study|Pregnancy|0
6031602|NCT00712725|20846774|P5|Overall Study|Pregnancy|1
6031603|NCT00712725|20846775|P4|Overall Study|Pregnancy|0
6031604|NCT00712725|20846776|P3|Overall Study|Pregnancy|0
6031605|NCT00712725|20846777|P2|Overall Study|Pregnancy|1
6031606|NCT00712725|20846778|P1|Overall Study|Pregnancy|0
6031607|NCT00712725|20846771|P8|Overall Study|Physician Decision|0
6031608|NCT00712725|20846772|P7|Overall Study|Physician Decision|2
6031609|NCT00712725|20846773|P6|Overall Study|Physician Decision|0
6031610|NCT00712725|20846774|P5|Overall Study|Physician Decision|1
6031611|NCT00712725|20846775|P4|Overall Study|Physician Decision|0
6031612|NCT00712725|20846776|P3|Overall Study|Physician Decision|0
6031613|NCT00712725|20846777|P2|Overall Study|Physician Decision|0
6031614|NCT00712725|20846778|P1|Overall Study|Physician Decision|2
6031615|NCT00712725|20846771|P8|Overall Study|Lost to Follow-up|1
6031616|NCT00712725|20846772|P7|Overall Study|Lost to Follow-up|3
6031617|NCT00712725|20846773|P6|Overall Study|Lost to Follow-up|2
6031618|NCT00712725|20846774|P5|Overall Study|Lost to Follow-up|2
6031619|NCT00712725|20846775|P4|Overall Study|Lost to Follow-up|1
6031620|NCT00712725|20846776|P3|Overall Study|Lost to Follow-up|1
6031621|NCT00712725|20846777|P2|Overall Study|Lost to Follow-up|2
6031622|NCT00712725|20846778|P1|Overall Study|Lost to Follow-up|3
6031623|NCT00712725|20846771|P8|Overall Study|Adverse Event|0
6031624|NCT00712725|20846772|P7|Overall Study|Adverse Event|0
6031625|NCT00712725|20846773|P6|Overall Study|Adverse Event|0
6031626|NCT00712725|20846774|P5|Overall Study|Adverse Event|0
6031627|NCT00712725|20846775|P4|Overall Study|Adverse Event|1
6031628|NCT00712725|20846776|P3|Overall Study|Adverse Event|0
6031629|NCT00712725|20846777|P2|Overall Study|Adverse Event|0
6031630|NCT00712725|20846778|P1|Overall Study|Adverse Event|1
6031631|NCT00712673|20846839|P4|Overall Study|Protocol Violation|0
6031632|NCT00712673|20846840|P3|Overall Study|Protocol Violation|2
6031633|NCT00712673|20846841|P2|Overall Study|Protocol Violation|0
6031634|NCT00712673|20846842|P1|Overall Study|Protocol Violation|0
6031635|NCT00712673|20846839|P4|Overall Study|Investigator's Decision|0
6031636|NCT00712673|20846840|P3|Overall Study|Investigator's Decision|0
6031637|NCT00712673|20846841|P2|Overall Study|Investigator's Decision|0
6031638|NCT00712673|20846842|P1|Overall Study|Investigator's Decision|1
6031639|NCT00712673|20846839|P4|Overall Study|Familial and Personal Reasons|2
6031640|NCT00712673|20846840|P3|Overall Study|Familial and Personal Reasons|5
6031641|NCT00712673|20846841|P2|Overall Study|Familial and Personal Reasons|0
6031642|NCT00712673|20846842|P1|Overall Study|Familial and Personal Reasons|5
6031643|NCT00712673|20846839|P4|Overall Study|Withdrawal by Subject|20
6031644|NCT00712673|20846840|P3|Overall Study|Withdrawal by Subject|15
6031645|NCT00712673|20846841|P2|Overall Study|Withdrawal by Subject|7
6031646|NCT00712673|20846842|P1|Overall Study|Withdrawal by Subject|6
6031647|NCT00712673|20846839|P4|Overall Study|Lost to Follow-up|0
6031648|NCT00712673|20846840|P3|Overall Study|Lost to Follow-up|2
6031649|NCT00712673|20846841|P2|Overall Study|Lost to Follow-up|0
6031650|NCT00712673|20846842|P1|Overall Study|Lost to Follow-up|1
6031651|NCT00712673|20846839|P4|Overall Study|Poor Compliance to Protocol|16
6031652|NCT00712673|20846840|P3|Overall Study|Poor Compliance to Protocol|4
6031653|NCT00712673|20846841|P2|Overall Study|Poor Compliance to Protocol|3
6031654|NCT00712673|20846842|P1|Overall Study|Poor Compliance to Protocol|3
6031655|NCT00712673|20846839|P4|Overall Study|Lack of Efficacy|6
6031656|NCT00712673|20846840|P3|Overall Study|Lack of Efficacy|8
6031657|NCT00712673|20846841|P2|Overall Study|Lack of Efficacy|8
6031658|NCT00712673|20846842|P1|Overall Study|Lack of Efficacy|2
6031659|NCT00712673|20846839|P4|Overall Study|Adverse Event|26
6031660|NCT00712673|20846840|P3|Overall Study|Adverse Event|21
6031661|NCT00712673|20846841|P2|Overall Study|Adverse Event|3
6031662|NCT00712673|20846842|P1|Overall Study|Adverse Event|3
6031663|NCT00712543|20846906|P2|Day 8-14|Lost to Follow-up|2
6031664|NCT00712543|20846907|P1|Day 8-14|Lost to Follow-up|0
6031665|NCT00712348|20846941|P1|Overall Study|Withdrawal by Subject|1
6031666|NCT00712335|20846953|P5|Overall Study|Other Reason|0
6031667|NCT00712335|20846954|P4|Overall Study|Other Reason|0
6031668|NCT00712335|20846955|P3|Overall Study|Other Reason|1
6031669|NCT00712335|20846956|P2|Overall Study|Other Reason|3
6031670|NCT00712335|20846957|P1|Overall Study|Other Reason|0
6031671|NCT00712335|20846953|P5|Overall Study|Lack of Efficacy|0
6031672|NCT00712335|20846954|P4|Overall Study|Lack of Efficacy|1
6031673|NCT00712335|20846955|P3|Overall Study|Lack of Efficacy|1
6031674|NCT00712335|20846956|P2|Overall Study|Lack of Efficacy|0
6031675|NCT00712335|20846957|P1|Overall Study|Lack of Efficacy|0
6031676|NCT00712335|20846953|P5|Overall Study|Protocol Violation|0
6031677|NCT00712335|20846954|P4|Overall Study|Protocol Violation|0
6031678|NCT00712335|20846955|P3|Overall Study|Protocol Violation|1
6031679|NCT00712335|20846956|P2|Overall Study|Protocol Violation|2
6031680|NCT00712335|20846957|P1|Overall Study|Protocol Violation|1
6031681|NCT00712335|20846953|P5|Overall Study|Lost to Follow-up|0
6031682|NCT00712335|20846954|P4|Overall Study|Lost to Follow-up|1
6031683|NCT00712335|20846955|P3|Overall Study|Lost to Follow-up|0
6031684|NCT00712335|20846956|P2|Overall Study|Lost to Follow-up|5
6031685|NCT00712335|20846957|P1|Overall Study|Lost to Follow-up|2
6031686|NCT00712335|20846953|P5|Overall Study|Withdrawal by Subject|0
6031687|NCT00712335|20846954|P4|Overall Study|Withdrawal by Subject|3
6031688|NCT00712335|20846955|P3|Overall Study|Withdrawal by Subject|2
6031689|NCT00712335|20846956|P2|Overall Study|Withdrawal by Subject|7
6031690|NCT00712335|20846957|P1|Overall Study|Withdrawal by Subject|0
6031691|NCT00712270|20847087|P1|Overall Study|Screen Failure|3
6031692|NCT00712270|20847087|P1|Overall Study|Withdrawal by Subject|11
6031693|NCT00712166|20847151|P2|Overall Study|Noncompliance|1
6031694|NCT00712166|20847152|P1|Overall Study|Noncompliance|0
6031695|NCT00712010|20847195|P1|Washout (7 Days)|Withdrawal by Subject|1
6031696|NCT00711971|20847234|P3|Overall Study|Lost to Follow-up|1
6031697|NCT00711971|20847235|P2|Overall Study|Lost to Follow-up|4
6031698|NCT00711971|20847236|P1|Overall Study|Lost to Follow-up|3
6031699|NCT00711958|20847270|P2|Overall Study|Progression of disease|0
6031700|NCT00711958|20847271|P1|Overall Study|Progression of disease|1
6031701|NCT00711958|20847270|P2|Overall Study|Death|5
6031702|NCT00711958|20847271|P1|Overall Study|Death|10
6031703|NCT00711958|20847270|P2|Overall Study|Lost to Follow-up|2
6031704|NCT00711958|20847271|P1|Overall Study|Lost to Follow-up|2
6031705|NCT00711958|20847270|P2|Overall Study|Protocol Violation|0
6031706|NCT00711958|20847271|P1|Overall Study|Protocol Violation|1
6031707|NCT00711958|20847270|P2|Overall Study|Adverse Event|7
6031708|NCT00711958|20847271|P1|Overall Study|Adverse Event|9
6031709|NCT00711958|20847270|P2|Overall Study|Clinical deterioration|0
6031710|NCT00711958|20847271|P1|Overall Study|Clinical deterioration|1
6031711|NCT00711958|20847270|P2|Overall Study|Lack of Efficacy|1
6031712|NCT00711958|20847271|P1|Overall Study|Lack of Efficacy|3
6031713|NCT00711958|20847270|P2|Overall Study|Withdrawal by Subject|8
6031714|NCT00711958|20847271|P1|Overall Study|Withdrawal by Subject|6
6031721|NCT00711802|20847342|P8|Overall Study|Reason not reported|0
6031722|NCT00711802|20847343|P7|Overall Study|Reason not reported|1
6031723|NCT00711802|20847344|P6|Overall Study|Reason not reported|0
6031724|NCT00711802|20847345|P5|Overall Study|Reason not reported|1
6031725|NCT00711802|20847346|P4|Overall Study|Reason not reported|0
6031726|NCT00711802|20847347|P3|Overall Study|Reason not reported|1
6031727|NCT00711802|20847348|P2|Overall Study|Reason not reported|1
6031728|NCT00711802|20847349|P1|Overall Study|Reason not reported|0
6031729|NCT00711802|20847342|P8|Overall Study|Lost to Follow-up|2
6031730|NCT00711802|20847343|P7|Overall Study|Lost to Follow-up|4
6031731|NCT00711802|20847344|P6|Overall Study|Lost to Follow-up|6
6031732|NCT00711802|20847345|P5|Overall Study|Lost to Follow-up|10
6031733|NCT00711802|20847346|P4|Overall Study|Lost to Follow-up|1
6031734|NCT00711802|20847347|P3|Overall Study|Lost to Follow-up|3
6031735|NCT00711802|20847348|P2|Overall Study|Lost to Follow-up|0
6031736|NCT00711802|20847349|P1|Overall Study|Lost to Follow-up|0
6031737|NCT00711802|20847342|P8|Overall Study|Withdrawal by Subject|0
6031738|NCT00711802|20847343|P7|Overall Study|Withdrawal by Subject|0
6031739|NCT00711802|20847344|P6|Overall Study|Withdrawal by Subject|0
6031740|NCT00711802|20847345|P5|Overall Study|Withdrawal by Subject|0
6031741|NCT00711802|20847346|P4|Overall Study|Withdrawal by Subject|1
6031742|NCT00711802|20847347|P3|Overall Study|Withdrawal by Subject|0
6031743|NCT00711802|20847348|P2|Overall Study|Withdrawal by Subject|1
6031744|NCT00711802|20847349|P1|Overall Study|Withdrawal by Subject|0
6031745|NCT00711802|20847342|P8|Overall Study|Physician Decision|0
6031746|NCT00711802|20847343|P7|Overall Study|Physician Decision|0
6031747|NCT00711802|20847344|P6|Overall Study|Physician Decision|0
6031748|NCT00711802|20847345|P5|Overall Study|Physician Decision|0
6031749|NCT00711802|20847346|P4|Overall Study|Physician Decision|0
6031750|NCT00711802|20847347|P3|Overall Study|Physician Decision|0
6031751|NCT00711802|20847348|P2|Overall Study|Physician Decision|2
6031752|NCT00711802|20847349|P1|Overall Study|Physician Decision|0
6031753|NCT00711802|20847342|P8|Overall Study|Protocol Violation|0
6031754|NCT00711802|20847343|P7|Overall Study|Protocol Violation|0
6031755|NCT00711802|20847344|P6|Overall Study|Protocol Violation|0
6031756|NCT00711802|20847345|P5|Overall Study|Protocol Violation|0
6031757|NCT00711802|20847346|P4|Overall Study|Protocol Violation|1
6031758|NCT00711802|20847347|P3|Overall Study|Protocol Violation|0
6031759|NCT00711802|20847348|P2|Overall Study|Protocol Violation|0
6031760|NCT00711802|20847349|P1|Overall Study|Protocol Violation|0
6031761|NCT00711802|20847342|P8|Overall Study|Microbiological failure|0
6031762|NCT00711802|20847343|P7|Overall Study|Microbiological failure|0
6031763|NCT00711802|20847344|P6|Overall Study|Microbiological failure|1
6031764|NCT00711802|20847345|P5|Overall Study|Microbiological failure|0
6031765|NCT00711802|20847346|P4|Overall Study|Microbiological failure|0
6031766|NCT00711802|20847347|P3|Overall Study|Microbiological failure|0
6031767|NCT00711802|20847348|P2|Overall Study|Microbiological failure|1
6031768|NCT00711802|20847349|P1|Overall Study|Microbiological failure|0
6031769|NCT00711802|20847342|P8|Overall Study|Adverse Event|0
6031770|NCT00711802|20847343|P7|Overall Study|Adverse Event|0
6031771|NCT00711802|20847344|P6|Overall Study|Adverse Event|1
6031772|NCT00711802|20847345|P5|Overall Study|Adverse Event|1
6031773|NCT00711802|20847346|P4|Overall Study|Adverse Event|0
6031774|NCT00711802|20847347|P3|Overall Study|Adverse Event|0
6031775|NCT00711802|20847348|P2|Overall Study|Adverse Event|0
6031776|NCT00711802|20847349|P1|Overall Study|Adverse Event|0
6031777|NCT00711802|20847342|P8|Overall Study|Not treated (no further detail)|0
6031778|NCT00711802|20847343|P7|Overall Study|Not treated (no further detail)|0
6031779|NCT00711802|20847344|P6|Overall Study|Not treated (no further detail)|0
6031780|NCT00711802|20847345|P5|Overall Study|Not treated (no further detail)|2
6031781|NCT00711802|20847346|P4|Overall Study|Not treated (no further detail)|0
6031782|NCT00711802|20847347|P3|Overall Study|Not treated (no further detail)|2
6031783|NCT00711802|20847348|P2|Overall Study|Not treated (no further detail)|1
6031784|NCT00711802|20847349|P1|Overall Study|Not treated (no further detail)|2
6031785|NCT00711646|20847392|P2|Overall Study|patient non-compliance|0
6031786|NCT00711646|20847393|P1|Overall Study|patient non-compliance|1
6031787|NCT00711646|20847392|P2|Overall Study|administrative decision|1
6031788|NCT00711646|20847393|P1|Overall Study|administrative decision|0
6031789|NCT00711646|20847392|P2|Overall Study|Lost to Follow-up|0
6031790|NCT00711646|20847393|P1|Overall Study|Lost to Follow-up|1
6031791|NCT00711646|20847392|P2|Overall Study|Protocol Violation|1
6031792|NCT00711646|20847393|P1|Overall Study|Protocol Violation|0
6031793|NCT00711646|20847392|P2|Overall Study|Withdrawal by Subject|0
6031794|NCT00711646|20847393|P1|Overall Study|Withdrawal by Subject|4
6031795|NCT00711646|20847392|P2|Overall Study|Adverse Event|1
6031796|NCT00711646|20847393|P1|Overall Study|Adverse Event|6
6031797|NCT00711594|20847415|P4|Overall Study|Withdrawal by Subject|2
6031798|NCT00711594|20847416|P3|Overall Study|Withdrawal by Subject|0
6031799|NCT00711594|20847417|P2|Overall Study|Withdrawal by Subject|1
6031800|NCT00711594|20847418|P1|Overall Study|Withdrawal by Subject|0
6031801|NCT00711594|20847415|P4|Overall Study|Other Adverse Event|16
6031802|NCT00711594|20847416|P3|Overall Study|Other Adverse Event|0
6031803|NCT00711594|20847417|P2|Overall Study|Other Adverse Event|0
6031804|NCT00711594|20847418|P1|Overall Study|Other Adverse Event|1
6031805|NCT00711594|20847415|P4|Overall Study|Progressive disease|44
6031806|NCT00711594|20847416|P3|Overall Study|Progressive disease|6
6031807|NCT00711594|20847417|P2|Overall Study|Progressive disease|2
6031808|NCT00711594|20847418|P1|Overall Study|Progressive disease|2
6031809|NCT00711555|20847455|P1|Overall Study|Adverse Event|3
6031810|NCT00711529|20847464|P2|Overall Study|Withdrawal by Subject|6
6031811|NCT00711529|20847465|P1|Overall Study|Withdrawal by Subject|2
6031812|NCT00711529|20847464|P2|Overall Study|Protocol Violation|0
6031813|NCT00711529|20847465|P1|Overall Study|Protocol Violation|2
6031814|NCT00711516|20847489|P2|Overall Study|Protocol Violation|1
6031815|NCT00711516|20847490|P1|Overall Study|Protocol Violation|0
6031816|NCT00711516|20847489|P2|Overall Study|Withdrawal by Subject|1
6031817|NCT00711516|20847490|P1|Overall Study|Withdrawal by Subject|0
6031818|NCT00711516|20847489|P2|Overall Study|Adverse Event|1
6031819|NCT00711516|20847490|P1|Overall Study|Adverse Event|1
6031820|NCT00711477|20847597|P2|Overall Study|Noncompliance|1
6031821|NCT00711477|20847598|P1|Overall Study|Noncompliance|0
6031822|NCT00711477|20847597|P2|Overall Study|Lost to Follow-up|1
6031823|NCT00711477|20847598|P1|Overall Study|Lost to Follow-up|0
6031824|NCT00711477|20847597|P2|Overall Study|Adverse Event|1
6031825|NCT00711477|20847598|P1|Overall Study|Adverse Event|3
6031826|NCT00711425|20847644|P1|Overall Study|Lost to Follow-up|1
6031827|NCT00711425|20847644|P1|Overall Study|Death|2
6031828|NCT00711425|20847644|P1|Overall Study|Protocol Violation|1
6031829|NCT00711412|20847650|P1|Survival Follow up Until Death|Other|12
6031830|NCT00711412|20847650|P1|Evaluation for Response and Surgery|Death|1
6031831|NCT00711412|20847650|P1|Evaluation for Response and Surgery|Withdrawal by Subject|1
6031832|NCT00711412|20847650|P1|Evaluation for Response and Surgery|Too high risk for surgery|2
6031833|NCT00711412|20847650|P1|Evaluation for Response and Surgery|Progressive Disease|2
6031834|NCT00711412|20847650|P1|Combination Treatment|Progressive Disease|1
6031835|NCT00711412|20847650|P1|Evaluated for Combination Treatment|Progressive disease|2
6031836|NCT00711412|20847650|P1|Evaluated for Combination Treatment|Withdrawal by Subject|1
6031837|NCT00711412|20847650|P1|Evaluated for Combination Treatment|Death|1
6031838|NCT00711412|20847650|P1|Evaluated for Combination Treatment|Adverse Event|2
6031839|NCT00711412|20847650|P1|Induction Treatment|Other|1
6031840|NCT00711412|20847650|P1|Induction Treatment|Adverse Event|1
6031841|NCT00711412|20847650|P1|Induction Treatment|Death|2
6031842|NCT00711243|20847728|P6|Follow up Every 3 Months Until Death|Lost to Follow-up|2
6031843|NCT00711243|20847729|P5|Follow up Every 3 Months Until Death|Lost to Follow-up|0
6031844|NCT00711243|20847730|P4|Follow up Every 3 Months Until Death|Lost to Follow-up|0
6031845|NCT00711243|20847731|P3|Follow up Every 3 Months Until Death|Lost to Follow-up|0
6031846|NCT00711243|20847732|P2|Follow up Every 3 Months Until Death|Lost to Follow-up|0
6031847|NCT00711243|20847733|P1|Follow up Every 3 Months Until Death|Lost to Follow-up|0
6031848|NCT00711243|20847728|P6|Treated Cycle 5 After First Response|Decline in performance status|1
6031849|NCT00711243|20847729|P5|Treated Cycle 5 After First Response|Decline in performance status|0
6031850|NCT00711243|20847730|P4|Treated Cycle 5 After First Response|Decline in performance status|0
6031851|NCT00711243|20847731|P3|Treated Cycle 5 After First Response|Decline in performance status|0
6031852|NCT00711243|20847732|P2|Treated Cycle 5 After First Response|Decline in performance status|0
6031853|NCT00711243|20847733|P1|Treated Cycle 5 After First Response|Decline in performance status|0
6031854|NCT00711243|20847728|P6|Treated Cycle 5 After First Response|Death|2
6031855|NCT00711243|20847729|P5|Treated Cycle 5 After First Response|Death|0
6031856|NCT00711243|20847730|P4|Treated Cycle 5 After First Response|Death|0
6031857|NCT00711243|20847731|P3|Treated Cycle 5 After First Response|Death|0
6031858|NCT00711243|20847732|P2|Treated Cycle 5 After First Response|Death|0
6031859|NCT00711243|20847733|P1|Treated Cycle 5 After First Response|Death|0
6031860|NCT00711243|20847728|P6|Treated Cycle 5 After First Response|Progressive disease|1
6031861|NCT00711243|20847729|P5|Treated Cycle 5 After First Response|Progressive disease|1
6031862|NCT00711243|20847730|P4|Treated Cycle 5 After First Response|Progressive disease|0
6031863|NCT00711243|20847731|P3|Treated Cycle 5 After First Response|Progressive disease|0
6031864|NCT00711243|20847732|P2|Treated Cycle 5 After First Response|Progressive disease|2
6031865|NCT00711243|20847733|P1|Treated Cycle 5 After First Response|Progressive disease|1
6031866|NCT00711243|20847728|P6|Reached First Response/4 Cycles|Progressive disease|0
6031867|NCT00711243|20847729|P5|Reached First Response/4 Cycles|Progressive disease|0
6031868|NCT00711243|20847730|P4|Reached First Response/4 Cycles|Progressive disease|1
6031869|NCT00711243|20847731|P3|Reached First Response/4 Cycles|Progressive disease|0
6031870|NCT00711243|20847732|P2|Reached First Response/4 Cycles|Progressive disease|0
6031871|NCT00711243|20847733|P1|Reached First Response/4 Cycles|Progressive disease|0
6031872|NCT00711243|20847728|P6|Reached First Response/4 Cycles|Death|2
6031873|NCT00711243|20847729|P5|Reached First Response/4 Cycles|Death|0
6031874|NCT00711243|20847730|P4|Reached First Response/4 Cycles|Death|0
6031875|NCT00711243|20847731|P3|Reached First Response/4 Cycles|Death|0
6031876|NCT00711243|20847732|P2|Reached First Response/4 Cycles|Death|0
6031877|NCT00711243|20847733|P1|Reached First Response/4 Cycles|Death|0
6031878|NCT00711243|20847728|P6|Registed and Started Treatment|Withdrawal by Subject|1
6031879|NCT00711243|20847729|P5|Registed and Started Treatment|Withdrawal by Subject|0
6031880|NCT00711243|20847730|P4|Registed and Started Treatment|Withdrawal by Subject|0
6032049|NCT00710021|20848363|P3|Overall Study|Lost to Follow-up|0
6031881|NCT00711243|20847731|P3|Registed and Started Treatment|Withdrawal by Subject|0
6031882|NCT00711243|20847732|P2|Registed and Started Treatment|Withdrawal by Subject|0
6031883|NCT00711243|20847733|P1|Registed and Started Treatment|Withdrawal by Subject|0
6031884|NCT00711191|20847756|P3|Overall Study|Withdrawal by Subject|3
6031885|NCT00711191|20847757|P2|Overall Study|Withdrawal by Subject|1
6031886|NCT00711191|20847758|P1|Overall Study|Withdrawal by Subject|0
6031887|NCT00711191|20847756|P3|Overall Study|Objective progression or relapse|7
6031888|NCT00711191|20847757|P2|Overall Study|Objective progression or relapse|3
6031889|NCT00711191|20847758|P1|Overall Study|Objective progression or relapse|2
6031890|NCT00711191|20847756|P3|Overall Study|Adverse Event|2
6031891|NCT00711191|20847757|P2|Overall Study|Adverse Event|1
6031892|NCT00711191|20847758|P1|Overall Study|Adverse Event|1
6031893|NCT00711113|20847795|P1|Overall Study|Implant lost|2
6031894|NCT00711113|20847795|P1|Overall Study|Lost to Follow-up|9
6031895|NCT00711100|20847801|P1|Overall Study|Withdrawal by Subject|8
6031896|NCT00711100|20847801|P1|Overall Study|Lack of Efficacy|5
6031897|NCT00711087|20847819|P2|Overall Study|Lost to Follow-up|0
6031898|NCT00711087|20847820|P1|Overall Study|Lost to Follow-up|1
6031899|NCT00711009|20847832|P2|Overall Study|Dose adjustment|0
6031900|NCT00711009|20847833|P1|Overall Study|Dose adjustment|1
6031901|NCT00711009|20847832|P2|Overall Study|Site closing|1
6031902|NCT00711009|20847833|P1|Overall Study|Site closing|0
6031903|NCT00711009|20847832|P2|Overall Study|Pregnancy|0
6031904|NCT00711009|20847833|P1|Overall Study|Pregnancy|1
6031905|NCT00711009|20847832|P2|Overall Study|Virologic Failure|1
6031906|NCT00711009|20847833|P1|Overall Study|Virologic Failure|2
6031907|NCT00711009|20847832|P2|Overall Study|Participant Noncompliant|1
6031908|NCT00711009|20847833|P1|Overall Study|Participant Noncompliant|0
6031909|NCT00711009|20847832|P2|Overall Study|Lost to Follow-up|9
6031910|NCT00711009|20847833|P1|Overall Study|Lost to Follow-up|3
6031911|NCT00711009|20847832|P2|Overall Study|Withdrawal by Subject|2
6031912|NCT00711009|20847833|P1|Overall Study|Withdrawal by Subject|4
6031913|NCT00711009|20847832|P2|Overall Study|Adverse Event/HIV-Related Event|5
6031914|NCT00711009|20847833|P1|Overall Study|Adverse Event/HIV-Related Event|4
6031915|NCT00710970|20848014|P1|Overall Study|Never took drug|2
6031916|NCT00710970|20848014|P1|Overall Study|Lost to Follow-up|8
6031917|NCT00710879|20848041|P2|Overall Study|Protocol Violation|3
6031918|NCT00710879|20848042|P1|Overall Study|Protocol Violation|0
6031919|NCT00710879|20848041|P2|Overall Study|Lost to Follow-up|1
6031920|NCT00710879|20848042|P1|Overall Study|Lost to Follow-up|2
6031921|NCT00710866|20848054|P2|Overall Study|Failed to meet eligibility|1
6031922|NCT00710866|20848055|P1|Overall Study|Failed to meet eligibility|1
6031923|NCT00710866|20848054|P2|Overall Study|Lost to Follow-up|0
6031924|NCT00710866|20848055|P1|Overall Study|Lost to Follow-up|1
6031925|NCT00710866|20848054|P2|Overall Study|Withdrawal by Subject|1
6031926|NCT00710866|20848055|P1|Overall Study|Withdrawal by Subject|2
6031927|NCT00710866|20848054|P2|Overall Study|Protocol Violation|4
6031928|NCT00710866|20848055|P1|Overall Study|Protocol Violation|5
6031929|NCT00710762|20848101|P2|Overall Study|Reason other than listed above|2
6031930|NCT00710762|20848102|P1|Overall Study|Reason other than listed above|2
6031931|NCT00710762|20848101|P2|Overall Study|Lost to Follow-up|0
6031932|NCT00710762|20848102|P1|Overall Study|Lost to Follow-up|1
6031933|NCT00710762|20848101|P2|Overall Study|Other Adverse Event|7
6031934|NCT00710762|20848102|P1|Overall Study|Other Adverse Event|7
6031935|NCT00710762|20848101|P2|Overall Study|Adverse Event other disease worsening|1
6031936|NCT00710762|20848102|P1|Overall Study|Adverse Event other disease worsening|2
6031937|NCT00710762|20848101|P2|Overall Study|Progressive disease|30
6031938|NCT00710762|20848102|P1|Overall Study|Progressive disease|27
6031939|NCT00710749|20848118|P2|First Intervention|Withdrawal by Subject|0
6031940|NCT00710749|20848119|P1|First Intervention|Withdrawal by Subject|1
6031941|NCT00710684|20848130|P3|Overall Study|Did not continue after week 24|16
6031942|NCT00710684|20848131|P2|Overall Study|Did not continue after week 24|21
6031943|NCT00710684|20848132|P1|Overall Study|Did not continue after week 24|25
6031944|NCT00710684|20848130|P3|Overall Study|Missing|0
6031945|NCT00710684|20848131|P2|Overall Study|Missing|0
6031946|NCT00710684|20848132|P1|Overall Study|Missing|1
6031947|NCT00710684|20848130|P3|Overall Study|Withdrawal by Subject|11
6031948|NCT00710684|20848131|P2|Overall Study|Withdrawal by Subject|18
6031949|NCT00710684|20848132|P1|Overall Study|Withdrawal by Subject|24
6031950|NCT00710684|20848130|P3|Overall Study|Physician Decision|4
6031951|NCT00710684|20848131|P2|Overall Study|Physician Decision|2
6031952|NCT00710684|20848132|P1|Overall Study|Physician Decision|0
6031953|NCT00710684|20848130|P3|Overall Study|Lost to Follow-up|7
6031954|NCT00710684|20848131|P2|Overall Study|Lost to Follow-up|6
6031955|NCT00710684|20848132|P1|Overall Study|Lost to Follow-up|4
6031956|NCT00710684|20848130|P3|Overall Study|Protocol Violation|5
6031957|NCT00710684|20848131|P2|Overall Study|Protocol Violation|5
6031958|NCT00710684|20848132|P1|Overall Study|Protocol Violation|5
6031959|NCT00710684|20848130|P3|Overall Study|Lack of Efficacy|5
6031960|NCT00710684|20848131|P2|Overall Study|Lack of Efficacy|3
6031961|NCT00710684|20848132|P1|Overall Study|Lack of Efficacy|4
6031962|NCT00710684|20848130|P3|Overall Study|Adverse Event|16
6031963|NCT00710684|20848131|P2|Overall Study|Adverse Event|19
6031964|NCT00710684|20848132|P1|Overall Study|Adverse Event|11
6031965|NCT00710606|20848189|P2|Overall Study|Adverse Event|2
6031966|NCT00710606|20848190|P1|Overall Study|Adverse Event|0
6031967|NCT00710593|20848202|P2|Overall Study|Prem disc vaccine, completed all visits|2
6031968|NCT00710593|20848203|P1|Overall Study|Prem disc vaccine, completed all visits|6
6031969|NCT00710593|20848202|P2|Overall Study|Protocol Violation|1
6031970|NCT00710593|20848203|P1|Overall Study|Protocol Violation|1
6031971|NCT00710593|20848202|P2|Overall Study|Failure to adhere or complete study eval|1
6031972|NCT00710593|20848203|P1|Overall Study|Failure to adhere or complete study eval|1
6031973|NCT00710593|20848202|P2|Overall Study|Moved out of area|0
6031974|NCT00710593|20848203|P1|Overall Study|Moved out of area|1
6031975|NCT00710593|20848202|P2|Overall Study|Lost to Follow-up|1
6031976|NCT00710593|20848203|P1|Overall Study|Lost to Follow-up|3
6031977|NCT00710593|20848202|P2|Overall Study|Unable to complete Wk 48 within window|0
6031978|NCT00710593|20848203|P1|Overall Study|Unable to complete Wk 48 within window|2
6031979|NCT00710593|20848202|P2|Overall Study|Incarceration|0
6031980|NCT00710593|20848203|P1|Overall Study|Incarceration|1
6031981|NCT00710554|20848246|P2|Overall Study|Receiving radiotherapy - prostate cancer|1
6031982|NCT00710554|20848247|P1|Overall Study|Receiving radiotherapy - prostate cancer|0
6031983|NCT00710554|20848246|P2|Overall Study|Lack of Efficacy|12
6031984|NCT00710554|20848247|P1|Overall Study|Lack of Efficacy|11
6031985|NCT00710554|20848246|P2|Overall Study|Lost to Follow-up|1
6031986|NCT00710554|20848247|P1|Overall Study|Lost to Follow-up|7
6031987|NCT00710554|20848246|P2|Overall Study|Withdrawal by Subject|3
6031988|NCT00710554|20848247|P1|Overall Study|Withdrawal by Subject|7
6031989|NCT00710554|20848246|P2|Overall Study|Adverse Event|7
6031990|NCT00710554|20848247|P1|Overall Study|Adverse Event|24
6031991|NCT00710424|20848275|P2|Overall Study|Felt good so stopped treatment|1
6031992|NCT00710424|20848276|P1|Overall Study|Felt good so stopped treatment|0
6031993|NCT00710424|20848275|P2|Overall Study|Subject preferred paracetamol|1
6031994|NCT00710424|20848276|P1|Overall Study|Subject preferred paracetamol|0
6031995|NCT00710424|20848275|P2|Overall Study|Ceased treatment due to travel|0
6031996|NCT00710424|20848276|P1|Overall Study|Ceased treatment due to travel|1
6031997|NCT00710424|20848275|P2|Overall Study|Subject thought medication changed|0
6031998|NCT00710424|20848276|P1|Overall Study|Subject thought medication changed|1
6031999|NCT00710424|20848275|P2|Overall Study|Did not meet entry criteria at visit 1|0
6032000|NCT00710424|20848276|P1|Overall Study|Did not meet entry criteria at visit 1|1
6032001|NCT00710424|20848275|P2|Overall Study|Non-compliance with stable analgesia|0
6032002|NCT00710424|20848276|P1|Overall Study|Non-compliance with stable analgesia|1
6032003|NCT00710424|20848275|P2|Overall Study|Refused medication, no side effects|0
6032004|NCT00710424|20848276|P1|Overall Study|Refused medication, no side effects|1
6032005|NCT00710424|20848275|P2|Overall Study|Lost to Follow-up|1
6032006|NCT00710424|20848276|P1|Overall Study|Lost to Follow-up|0
6032007|NCT00710424|20848275|P2|Overall Study|Withdrawal by Subject|3
6032008|NCT00710424|20848276|P1|Overall Study|Withdrawal by Subject|5
6032009|NCT00710424|20848275|P2|Overall Study|Lack of Efficacy|5
6032010|NCT00710424|20848276|P1|Overall Study|Lack of Efficacy|4
6032011|NCT00710424|20848275|P2|Overall Study|Adverse Event|12
6032012|NCT00710424|20848276|P1|Overall Study|Adverse Event|30
6032013|NCT00710385|20848300|P1|Overall Study|Undisclosed excessive methadone use|1
6032014|NCT00710385|20848300|P1|Overall Study|Physician Decision|1
6032015|NCT00710385|20848300|P1|Overall Study|Undisclosed back pain|1
6032016|NCT00710385|20848300|P1|Overall Study|Withdrawal by Subject|1
6032017|NCT00710385|20848300|P1|Overall Study|Did not qualify|1
6032018|NCT00710034|20848345|P2|Completed 12 Weeks of Treatment|Withdrawal by Subject|2
6032019|NCT00710034|20848346|P1|Completed 12 Weeks of Treatment|Withdrawal by Subject|8
6032020|NCT00710034|20848345|P2|Completed 12 Weeks of Treatment|Product Dissatisfaction|1
6032021|NCT00710034|20848346|P1|Completed 12 Weeks of Treatment|Product Dissatisfaction|0
6032022|NCT00710034|20848345|P2|Completed 12 Weeks of Treatment|Lost to Follow-up|5
6032023|NCT00710034|20848346|P1|Completed 12 Weeks of Treatment|Lost to Follow-up|5
6032024|NCT00710034|20848345|P2|Completed 12 Weeks of Treatment|Lack of Efficacy|2
6032025|NCT00710034|20848346|P1|Completed 12 Weeks of Treatment|Lack of Efficacy|0
6032026|NCT00710034|20848345|P2|Completed 12 Weeks of Treatment|Adverse Event|1
6032027|NCT00710034|20848346|P1|Completed 12 Weeks of Treatment|Adverse Event|0
6032028|NCT00710034|20848345|P2|Completed 6 Weeks of Treatment|Physician Decision|0
6032029|NCT00710034|20848346|P1|Completed 6 Weeks of Treatment|Physician Decision|1
6032030|NCT00710034|20848345|P2|Completed 6 Weeks of Treatment|Withdrawal by Subject|4
6032031|NCT00710034|20848346|P1|Completed 6 Weeks of Treatment|Withdrawal by Subject|6
6032032|NCT00710034|20848345|P2|Completed 6 Weeks of Treatment|Product dissatisfaction|6
6032033|NCT00710034|20848346|P1|Completed 6 Weeks of Treatment|Product dissatisfaction|2
6032034|NCT00710034|20848345|P2|Completed 6 Weeks of Treatment|Lost to Follow-up|17
6032035|NCT00710034|20848346|P1|Completed 6 Weeks of Treatment|Lost to Follow-up|15
6032036|NCT00710034|20848345|P2|Completed 6 Weeks of Treatment|Lack of Efficacy|8
6032037|NCT00710034|20848346|P1|Completed 6 Weeks of Treatment|Lack of Efficacy|12
6032038|NCT00710034|20848345|P2|Completed 6 Weeks of Treatment|Adverse Event|12
6032039|NCT00710034|20848346|P1|Completed 6 Weeks of Treatment|Adverse Event|5
6032040|NCT00710021|20848363|P3|Overall Study|Physician Decision|0
6032041|NCT00710021|20848364|P2|Overall Study|Physician Decision|1
6032042|NCT00710021|20848365|P1|Overall Study|Physician Decision|0
6032043|NCT00710021|20848363|P3|Overall Study|Subject misrandomized|1
6032044|NCT00710021|20848364|P2|Overall Study|Subject misrandomized|1
6032045|NCT00710021|20848365|P1|Overall Study|Subject misrandomized|0
6032046|NCT00710021|20848363|P3|Overall Study|Subject's Decision|0
6032047|NCT00710021|20848364|P2|Overall Study|Subject's Decision|1
6032048|NCT00710021|20848365|P1|Overall Study|Subject's Decision|0
6032050|NCT00710021|20848364|P2|Overall Study|Lost to Follow-up|0
6032051|NCT00710021|20848365|P1|Overall Study|Lost to Follow-up|1
6032052|NCT00709995|20848480|P2|Overall Study|Withdrawal by Subject|3
6032053|NCT00709995|20848481|P1|Overall Study|Withdrawal by Subject|1
6032054|NCT00709995|20848480|P2|Overall Study|Adverse Event|2
6032055|NCT00709995|20848481|P1|Overall Study|Adverse Event|4
6032056|NCT00709956|20848499|P2|Overall Study|Inclusion/exclusion criteria violation|3
6032057|NCT00709956|20848500|P1|Overall Study|Inclusion/exclusion criteria violation|2
6032058|NCT00709956|20848499|P2|Overall Study|Withdrawal by Subject|1
6032059|NCT00709956|20848500|P1|Overall Study|Withdrawal by Subject|1
6032060|NCT00709852|20848530|P2|Period 2|No 72-hour follow-up|0
6032061|NCT00709852|20848531|P1|Period 2|No 72-hour follow-up|3
6032062|NCT00709852|20848530|P2|Period 2|Lost to Follow-up|0
6032063|NCT00709852|20848531|P1|Period 2|Lost to Follow-up|1
6032064|NCT00709852|20848530|P2|Period 2|Adverse Event|1
6032065|NCT00709852|20848531|P1|Period 2|Adverse Event|1
6032066|NCT00709852|20848530|P2|Period 2|Protocol Violation|1
6032067|NCT00709852|20848531|P1|Period 2|Protocol Violation|4
6032068|NCT00709852|20848530|P2|Period 1|Lost to Follow-up|0
6032069|NCT00709852|20848531|P1|Period 1|Lost to Follow-up|1
6032070|NCT00709852|20848530|P2|Period 1|Defective scanner|1
6032071|NCT00709852|20848531|P1|Period 1|Defective scanner|0
6032072|NCT00709852|20848530|P2|Period 1|Protocol Violation|0
6032073|NCT00709852|20848531|P1|Period 1|Protocol Violation|1
6032074|NCT00709852|20848530|P2|Period 1|Withdrawal by Subject|2
6032075|NCT00709852|20848531|P1|Period 1|Withdrawal by Subject|4
6032076|NCT00709852|20848530|P2|Period 1|Adverse Event|0
6032077|NCT00709852|20848531|P1|Period 1|Adverse Event|2
6032078|NCT00709761|20848695|P1|Overall Study|Lost to Follow-up|2
6032079|NCT00709761|20848695|P1|Overall Study|study closed/terminated|17
6032080|NCT00709761|20848695|P1|Overall Study|Withdrawal by Subject|8
6032081|NCT00709735|20848706|P2|Overall Study|Did not meet PTSD Diagnostic Criteria|0
6032082|NCT00709735|20848707|P1|Overall Study|Did not meet PTSD Diagnostic Criteria|2
6032083|NCT00709735|20848706|P2|Overall Study|Relapse into Opioid Abuse|1
6032084|NCT00709735|20848707|P1|Overall Study|Relapse into Opioid Abuse|0
6032085|NCT00709735|20848706|P2|Overall Study|Lost to Follow-up|1
6032086|NCT00709735|20848707|P1|Overall Study|Lost to Follow-up|1
6032087|NCT00709722|20848715|P1|Overall Study|Adverse Event|1
6032088|NCT00709618|20848730|P1|Overall Study|Study Closed/Terminated|25
6032089|NCT00709618|20848730|P1|Overall Study|Lost to Follow-up|1
6032090|NCT00709618|20848730|P1|Overall Study|Withdrawal by Subject|4
6032091|NCT00709592|20848742|P2|Overall Study|Unable to proceed to transplant|1
6032092|NCT00709592|20848743|P1|Overall Study|Unable to proceed to transplant|0
6032093|NCT00709319|20848765|P1|Overall Study|Withdrawal by Subject|2
6032094|NCT00709319|20848765|P1|Overall Study|Death|4
6032095|NCT00709228|20848794|P1|Overall Study|Non-compliance|5
6032096|NCT00709228|20848794|P1|Overall Study|Lost to Follow-up|6
6032097|NCT00709228|20848794|P1|Overall Study|Disease progression|1
6032098|NCT00709228|20848794|P1|Overall Study|Discontinued follow-up|5
6032099|NCT00709228|20848794|P1|Overall Study|Did not enter follow-up|4
6032100|NCT00709228|20848794|P1|Overall Study|Discontinued treatment|14
6032101|NCT00709228|20848794|P1|Overall Study|Adverse events|2
6032102|NCT00709228|20848794|P1|Overall Study|Eligibility criteria not met|281
6032103|NCT00709228|20848794|P1|Overall Study|Not treated|14
6032104|NCT00709202|20848800|P2|Overall Study|Withdrawal by Subject|6
6032105|NCT00709202|20848801|P1|Overall Study|Withdrawal by Subject|6
6032106|NCT00709124|20848829|P2|Overall Study|encephalopathy; can't do assessment|0
6032107|NCT00709124|20848830|P1|Overall Study|encephalopathy; can't do assessment|1
6032108|NCT00709124|20848829|P2|Overall Study|Death|1
6032109|NCT00709124|20848830|P1|Overall Study|Death|3
6032110|NCT00709111|20848864|P1|Overall Study|Unable to attend clinic visits|1
6032111|NCT00709111|20848864|P1|Overall Study|Withdrawal by Subject|1
6032112|NCT00709098|20848905|P3|Open-label Period|Lost to Follow-up|1
6032113|NCT00709098|20848906|P2|Open-label Period|Lost to Follow-up|0
6032114|NCT00709098|20848907|P1|Open-label Period|Lost to Follow-up|0
6032115|NCT00709098|20848905|P3|Open-label Period|Death|1
6032116|NCT00709098|20848906|P2|Open-label Period|Death|0
6032117|NCT00709098|20848907|P1|Open-label Period|Death|0
6032118|NCT00709098|20848905|P3|Open-label Period|Administrative reason|5
6032119|NCT00709098|20848906|P2|Open-label Period|Administrative reason|0
6032120|NCT00709098|20848907|P1|Open-label Period|Administrative reason|0
6032121|NCT00709098|20848905|P3|Open-label Period|Withdrawal of consent|7
6032122|NCT00709098|20848906|P2|Open-label Period|Withdrawal of consent|0
6032123|NCT00709098|20848907|P1|Open-label Period|Withdrawal of consent|0
6032124|NCT00709098|20848905|P3|Double-blind Period|Lost to Follow-up|0
6032125|NCT00709098|20848906|P2|Double-blind Period|Lost to Follow-up|1
6032126|NCT00709098|20848907|P1|Double-blind Period|Lost to Follow-up|1
6032127|NCT00709098|20848905|P3|Double-blind Period|Death|0
6032128|NCT00709098|20848906|P2|Double-blind Period|Death|1
6032129|NCT00709098|20848907|P1|Double-blind Period|Death|1
6032130|NCT00709098|20848905|P3|Double-blind Period|Administrative reason|0
6032131|NCT00709098|20848906|P2|Double-blind Period|Administrative reason|3
6032132|NCT00709098|20848907|P1|Double-blind Period|Administrative reason|1
6032133|NCT00709098|20848905|P3|Double-blind Period|Withdrawal of consent|0
6032134|NCT00709098|20848906|P2|Double-blind Period|Withdrawal of consent|3
6032135|NCT00709098|20848907|P1|Double-blind Period|Withdrawal of consent|3
6032136|NCT00709059|20848926|P1|Overall Study|Serious side effects|11
6032137|NCT00709059|20848926|P1|Overall Study|Side effects|20
6032138|NCT00709059|20848926|P1|Overall Study|Disease complication|3
6032139|NCT00709059|20848926|P1|Overall Study|Physician Decision|7
6032140|NCT00709059|20848926|P1|Overall Study|Withdrawal by Subject|19
6032141|NCT00709059|20848926|P1|Overall Study|Lost to Follow-up|34
6032142|NCT00708734|20848973|P1|Overall Study|leg fracture|1
6032143|NCT00708734|20848973|P1|Overall Study|vertigo|1
6032144|NCT00708734|20848973|P1|Overall Study|knee replacement|1
6032145|NCT00708734|20848973|P1|Overall Study|leg injury|1
6032146|NCT00708734|20848973|P1|Overall Study|moved|1
6032147|NCT00708734|20848973|P1|Overall Study|scheduling conflict|2
6032148|NCT00708708|20848993|P1|Overall Study|Missing values|392
6032149|NCT00708708|20848993|P1|Overall Study|Adverse Event|3
6032150|NCT00708708|20848993|P1|Overall Study|Pregnancy|3
6032151|NCT00708708|20848993|P1|Overall Study|Lack of compliance|3
6032152|NCT00708708|20848993|P1|Overall Study|Lack of effectiveness|4
6032153|NCT00708708|20848993|P1|Overall Study|Administrative reasons|7
6032154|NCT00708708|20848993|P1|Overall Study|Ineffectiveness (no systemic therapy)|9
6032155|NCT00708708|20848993|P1|Overall Study|Good effectiveness|9
6032156|NCT00708708|20848993|P1|Overall Study|Other unspecified|11
6032157|NCT00708708|20848993|P1|Overall Study|Another therapy along with Enbrel|15
6032158|NCT00708708|20848993|P1|Overall Study|Intolerance|42
6032159|NCT00708708|20848993|P1|Overall Study|Withdrawal by Subject|51
6032160|NCT00708708|20848993|P1|Overall Study|Lost to Follow-up|52
6032161|NCT00708708|20848993|P1|Overall Study|Another therapy instead of Enbrel|141
6032162|NCT00708682|20849041|P1|Toddler Dose|Failed to Return|4
6032163|NCT00708682|20849041|P1|Toddler Dose|Lost to Follow-up|3
6032164|NCT00708682|20849041|P1|Toddler Dose|Parent/Legal Guardian Request|1
6032165|NCT00708682|20849041|P1|After Infant Series|Parent/Legal Guardian Request|1
6032166|NCT00708682|20849041|P1|Infant Series|Other|19
6032167|NCT00708682|20849041|P1|Infant Series|Failed to return|2
6032168|NCT00708682|20849041|P1|Infant Series|Parent/legal guardian request|6
6032169|NCT00708682|20849041|P1|Infant Series|Protocol Violation|1
6032170|NCT00708682|20849041|P1|Infant Series|Lost to Follow-up|4
6032171|NCT00708682|20849041|P1|Infant Series|Adverse Event|1
6032172|NCT00708643|20849062|P2|Overall Study|Adverse Event|1
6032173|NCT00708643|20849063|P1|Overall Study|Adverse Event|0
6032174|NCT00708552|20849083|P4|Overall Study|Withdrawal by Subject|10
6032175|NCT00708552|20849084|P3|Overall Study|Withdrawal by Subject|8
6032176|NCT00708552|20849085|P2|Overall Study|Withdrawal by Subject|7
6032177|NCT00708552|20849086|P1|Overall Study|Withdrawal by Subject|12
6032178|NCT00708552|20849083|P4|Overall Study|Physician Decision|0
6032179|NCT00708552|20849084|P3|Overall Study|Physician Decision|0
6032180|NCT00708552|20849085|P2|Overall Study|Physician Decision|2
6032181|NCT00708552|20849086|P1|Overall Study|Physician Decision|1
6032182|NCT00708552|20849083|P4|Overall Study|Lost to Follow-up|1
6032183|NCT00708552|20849084|P3|Overall Study|Lost to Follow-up|0
6032184|NCT00708552|20849085|P2|Overall Study|Lost to Follow-up|2
6032185|NCT00708552|20849086|P1|Overall Study|Lost to Follow-up|4
6032186|NCT00708552|20849083|P4|Overall Study|Protocol Violation|4
6032187|NCT00708552|20849084|P3|Overall Study|Protocol Violation|2
6032188|NCT00708552|20849085|P2|Overall Study|Protocol Violation|0
6032189|NCT00708552|20849086|P1|Overall Study|Protocol Violation|0
6032190|NCT00708552|20849083|P4|Overall Study|Lack of Efficacy|0
6032191|NCT00708552|20849084|P3|Overall Study|Lack of Efficacy|1
6032192|NCT00708552|20849085|P2|Overall Study|Lack of Efficacy|4
6032193|NCT00708552|20849086|P1|Overall Study|Lack of Efficacy|0
6032194|NCT00708552|20849083|P4|Overall Study|Adverse Event|6
6032195|NCT00708552|20849084|P3|Overall Study|Adverse Event|4
6032196|NCT00708552|20849085|P2|Overall Study|Adverse Event|3
6032197|NCT00708552|20849086|P1|Overall Study|Adverse Event|10
6032198|NCT00708500|20849248|P3|FOLLOWUP|Non-compliance with protocol|1
6032199|NCT00708500|20849249|P2|FOLLOWUP|Non-compliance with protocol|0
6032200|NCT00708500|20849250|P1|FOLLOWUP|Non-compliance with protocol|5
6032201|NCT00708500|20849248|P3|FOLLOWUP|Subject withdrew consent|5
6032202|NCT00708500|20849249|P2|FOLLOWUP|Subject withdrew consent|4
6032203|NCT00708500|20849250|P1|FOLLOWUP|Subject withdrew consent|31
6032204|NCT00708500|20849248|P3|FOLLOWUP|Subject withdrawal unrelated to Tx|5
6032205|NCT00708500|20849249|P2|FOLLOWUP|Subject withdrawal unrelated to Tx|4
6032206|NCT00708500|20849250|P1|FOLLOWUP|Subject withdrawal unrelated to Tx|3
6032207|NCT00708500|20849248|P3|FOLLOWUP|Lost to Follow-up|4
6032208|NCT00708500|20849249|P2|FOLLOWUP|Lost to Follow-up|6
6032209|NCT00708500|20849250|P1|FOLLOWUP|Lost to Follow-up|1
6032210|NCT00708500|20849248|P3|FOLLOWUP|Adverse Event|0
6032211|NCT00708500|20849249|P2|FOLLOWUP|Adverse Event|1
6032212|NCT00708500|20849250|P1|FOLLOWUP|Adverse Event|0
6032213|NCT00708500|20849248|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0
6032214|NCT00708500|20849249|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|1
6032215|NCT00708500|20849250|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0
6032216|NCT00708500|20849248|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1
6032217|NCT00708500|20849249|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1
6032218|NCT00708500|20849250|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|0
6032219|NCT00708500|20849248|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|1
6032220|NCT00708500|20849249|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|2
6032221|NCT00708500|20849250|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|0
6032222|NCT00708500|20849248|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|1
6032223|NCT00708500|20849249|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|0
6032224|NCT00708500|20849250|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|2
6032225|NCT00708500|20849248|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|4
6032226|NCT00708500|20849249|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|1
6032227|NCT00708500|20849250|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|3
6032228|NCT00708500|20849248|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0
6032229|NCT00708500|20849249|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|1
6032230|NCT00708500|20849250|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0
6032231|NCT00708500|20849248|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|29
6032232|NCT00708500|20849249|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|36
6032233|NCT00708500|20849250|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|49
6032234|NCT00708500|20849248|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|19
6032235|NCT00708500|20849249|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|10
6032236|NCT00708500|20849250|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|1
6032237|NCT00708500|20849248|P3|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|1
6032238|NCT00708500|20849249|P2|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0
6032239|NCT00708500|20849250|P1|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0
6032240|NCT00708500|20849248|P3|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0
6032241|NCT00708500|20849249|P2|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|2
6032242|NCT00708500|20849250|P1|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0
6032243|NCT00708500|20849248|P3|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0
6032244|NCT00708500|20849249|P2|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|1
6032245|NCT00708500|20849250|P1|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0
6032246|NCT00708500|20849248|P3|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0
6032247|NCT00708500|20849249|P2|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0
6032248|NCT00708500|20849250|P1|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|1
6032249|NCT00708500|20849248|P3|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1
6032250|NCT00708500|20849249|P2|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|3
6032251|NCT00708500|20849250|P1|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1
6032252|NCT00708461|20849269|P2|Overall Study|left workforce|180
6032253|NCT00708461|20849270|P1|Overall Study|left workforce|115
6032254|NCT00708461|20849269|P2|Overall Study|Withdrawal by Subject|9
6032255|NCT00708461|20849270|P1|Overall Study|Withdrawal by Subject|8
6032256|NCT00708461|20849269|P2|Overall Study|Lost to Follow-up|11
6032257|NCT00708461|20849270|P1|Overall Study|Lost to Follow-up|18
6032258|NCT00708435|20849278|P2|Overall Study|Refused hospitalization|0
6032259|NCT00708435|20849279|P1|Overall Study|Refused hospitalization|1
6032260|NCT00708435|20849278|P2|Overall Study|Intervention by primary care physician|0
6032261|NCT00708435|20849279|P1|Overall Study|Intervention by primary care physician|1
6032262|NCT00708435|20849278|P2|Overall Study|Protocol Violation|1
6032263|NCT00708435|20849279|P1|Overall Study|Protocol Violation|0
6032264|NCT00708435|20849278|P2|Overall Study|Adverse Event|0
6032265|NCT00708435|20849279|P1|Overall Study|Adverse Event|1
6032266|NCT00708435|20849278|P2|Overall Study|Withdrawal by Subject|7
6032267|NCT00708435|20849279|P1|Overall Study|Withdrawal by Subject|3
6032268|NCT00708435|20849278|P2|Overall Study|Lost to Follow-up|4
6032269|NCT00708435|20849279|P1|Overall Study|Lost to Follow-up|9
6032270|NCT00708435|20849278|P2|Overall Study|Death / Serious Adverse Event|5
6032271|NCT00708435|20849279|P1|Overall Study|Death / Serious Adverse Event|10
6032272|NCT00708422|20849306|P2|Overall Study|Withdrawal by Subject|0
6032273|NCT00708422|20849307|P1|Overall Study|Withdrawal by Subject|1
6032274|NCT00708422|20849306|P2|Overall Study|Adverse Event|1
6032275|NCT00708422|20849307|P1|Overall Study|Adverse Event|3
6032276|NCT00708305|20849315|P4|Period 3|Other Reason|0
6032277|NCT00708305|20849316|P3|Period 3|Other Reason|0
6032278|NCT00708305|20849317|P2|Period 3|Other Reason|0
6032279|NCT00708305|20849318|P1|Period 3|Other Reason|1
6032280|NCT00708305|20849315|P4|Period 3|Protocol Violation|0
6032281|NCT00708305|20849316|P3|Period 3|Protocol Violation|0
6032282|NCT00708305|20849317|P2|Period 3|Protocol Violation|2
6032283|NCT00708305|20849318|P1|Period 3|Protocol Violation|0
6032284|NCT00708305|20849315|P4|Period 2|Other Reason|1
6032285|NCT00708305|20849316|P3|Period 2|Other Reason|0
6032286|NCT00708305|20849317|P2|Period 2|Other Reason|0
6032287|NCT00708305|20849318|P1|Period 2|Other Reason|1
6032288|NCT00708305|20849315|P4|Period 2|Protocol Violation|0
6032289|NCT00708305|20849316|P3|Period 2|Protocol Violation|0
6032290|NCT00708305|20849317|P2|Period 2|Protocol Violation|1
6032291|NCT00708305|20849318|P1|Period 2|Protocol Violation|0
6032292|NCT00708305|20849315|P4|Period 2|Lost to Follow-up|0
6032293|NCT00708305|20849316|P3|Period 2|Lost to Follow-up|0
6032294|NCT00708305|20849317|P2|Period 2|Lost to Follow-up|1
6032295|NCT00708305|20849318|P1|Period 2|Lost to Follow-up|0
6032296|NCT00708305|20849315|P4|Period 1|Other Reason|2
6032297|NCT00708305|20849316|P3|Period 1|Other Reason|0
6032298|NCT00708305|20849317|P2|Period 1|Other Reason|0
6032299|NCT00708305|20849318|P1|Period 1|Other Reason|0
6032300|NCT00708305|20849315|P4|Period 1|Protocol Violation|0
6032301|NCT00708305|20849316|P3|Period 1|Protocol Violation|1
6032302|NCT00708305|20849317|P2|Period 1|Protocol Violation|0
6032303|NCT00708305|20849318|P1|Period 1|Protocol Violation|1
6032304|NCT00708227|20849354|P4|Overall Study|Withdrawal by Subject|1
6032305|NCT00708227|20849355|P3|Overall Study|Withdrawal by Subject|0
6032306|NCT00708227|20849356|P2|Overall Study|Withdrawal by Subject|2
6032307|NCT00708227|20849357|P1|Overall Study|Withdrawal by Subject|1
6032308|NCT00708227|20849354|P4|Overall Study|Physician Decision|2
6032309|NCT00708227|20849355|P3|Overall Study|Physician Decision|1
6032310|NCT00708227|20849356|P2|Overall Study|Physician Decision|3
6032311|NCT00708227|20849357|P1|Overall Study|Physician Decision|0
6032312|NCT00708214|20849390|P3|Overall Study|Progressive Disease|5
6032313|NCT00708214|20849391|P2|Overall Study|Progressive Disease|6
6032314|NCT00708214|20849392|P1|Overall Study|Progressive Disease|4
6032315|NCT00708214|20849390|P3|Overall Study|Other|1
6032316|NCT00708214|20849391|P2|Overall Study|Other|1
6032317|NCT00708214|20849392|P1|Overall Study|Other|0
6032318|NCT00708214|20849390|P3|Overall Study|Other Adverse Event|2
6032319|NCT00708214|20849391|P2|Overall Study|Other Adverse Event|6
6032320|NCT00708214|20849392|P1|Overall Study|Other Adverse Event|3
6032321|NCT00708201|20849435|P2|Overall Study|Protocol Violation|1
6032322|NCT00708201|20849436|P1|Overall Study|Protocol Violation|0
6032323|NCT00708201|20849435|P2|Overall Study|Lost to Follow-up|0
6032324|NCT00708201|20849436|P1|Overall Study|Lost to Follow-up|2
6032325|NCT00708201|20849435|P2|Overall Study|Withdrawal by Subject|1
6032326|NCT00708201|20849436|P1|Overall Study|Withdrawal by Subject|1
6032327|NCT00708201|20849435|P2|Overall Study|Adverse Event|4
6032328|NCT00708201|20849436|P1|Overall Study|Adverse Event|4
6032329|NCT00708175|20849460|P2|Overall Study|BMD loss >7%|3
6032330|NCT00708175|20849461|P1|Overall Study|BMD loss >7%|2
6032331|NCT00708175|20849460|P2|Overall Study|Withdrawal by Subject|7
6032332|NCT00708175|20849461|P1|Overall Study|Withdrawal by Subject|5
6032333|NCT00708175|20849460|P2|Overall Study|Lost to Follow-up|3
6032334|NCT00708175|20849461|P1|Overall Study|Lost to Follow-up|5
6032335|NCT00708175|20849460|P2|Overall Study|Protocol Violation|3
6032336|NCT00708175|20849461|P1|Overall Study|Protocol Violation|2
6032337|NCT00708175|20849460|P2|Overall Study|Adverse Event|5
6032338|NCT00708175|20849461|P1|Overall Study|Adverse Event|4
6032339|NCT00708162|20849477|P2|Open-Label Phase|Other|0
6032340|NCT00708162|20849478|P1|Open-Label Phase|Other|1
6032341|NCT00708162|20849477|P2|Open-Label Phase|Adverse Event|2
6032342|NCT00708162|20849478|P1|Open-Label Phase|Adverse Event|1
6032343|NCT00708162|20849477|P2|Open-Label Phase|Death|1
6032344|NCT00708162|20849478|P1|Open-Label Phase|Death|3
6032345|NCT00708162|20849477|P2|Open-Label Phase|Investigator's Discretion|2
6032346|NCT00708162|20849478|P1|Open-Label Phase|Investigator's Discretion|3
6032347|NCT00708162|20849477|P2|Open-Label Phase|Lack of Efficacy|4
6032348|NCT00708162|20849478|P1|Open-Label Phase|Lack of Efficacy|7
6032349|NCT00708162|20849477|P2|Open-Label Phase|Participant Noncompliance|7
6032350|NCT00708162|20849478|P1|Open-Label Phase|Participant Noncompliance|7
6032351|NCT00708162|20849477|P2|Open-Label Phase|Withdrew Consent|6
6032352|NCT00708162|20849478|P1|Open-Label Phase|Withdrew Consent|12
6032353|NCT00708162|20849477|P2|Open-Label Phase|Lost to Follow-up|8
6032354|NCT00708162|20849478|P1|Open-Label Phase|Lost to Follow-up|10
6032355|NCT00708162|20849477|P2|Randomized Phase|Pregnancy|0
6032356|NCT00708162|20849478|P1|Randomized Phase|Pregnancy|3
6032357|NCT00708162|20849477|P2|Randomized Phase|Death|9
6032358|NCT00708162|20849478|P1|Randomized Phase|Death|2
6032359|NCT00708162|20849477|P2|Randomized Phase|Investigator's Discretion|10
6032360|NCT00708162|20849478|P1|Randomized Phase|Investigator's Discretion|7
6032361|NCT00708162|20849477|P2|Randomized Phase|Adverse Event|12
6032362|NCT00708162|20849478|P1|Randomized Phase|Adverse Event|8
6032363|NCT00708162|20849477|P2|Randomized Phase|Protocol Violation|11
6032364|NCT00708162|20849478|P1|Randomized Phase|Protocol Violation|10
6032365|NCT00708162|20849477|P2|Randomized Phase|Lack of Efficacy|19
6032366|NCT00708162|20849478|P1|Randomized Phase|Lack of Efficacy|14
6032367|NCT00708162|20849477|P2|Randomized Phase|Withdrew Consent|22
6032368|NCT00708162|20849478|P1|Randomized Phase|Withdrew Consent|31
6032369|NCT00708162|20849477|P2|Randomized Phase|Lost to Follow-up|34
6032370|NCT00708162|20849478|P1|Randomized Phase|Lost to Follow-up|34
6032371|NCT00708162|20849477|P2|Randomized Phase|Participant Noncompliance|32
6032372|NCT00708162|20849478|P1|Randomized Phase|Participant Noncompliance|40
6032373|NCT00708162|20849477|P2|Randomized Phase|Randomized but Not Treated|5
6032374|NCT00708162|20849478|P1|Randomized Phase|Randomized but Not Treated|7
6032375|NCT00708123|20849519|P5|Period 4|Protocol Violation|0
6032376|NCT00708123|20849520|P4|Period 4|Protocol Violation|0
6032377|NCT00708123|20849521|P3|Period 4|Protocol Violation|0
6032378|NCT00708123|20849522|P2|Period 4|Protocol Violation|1
6032379|NCT00708123|20849523|P1|Period 4|Protocol Violation|0
6032380|NCT00708123|20849519|P5|Period 3|Lost to Follow-up|0
6032381|NCT00708123|20849520|P4|Period 3|Lost to Follow-up|1
6032382|NCT00708123|20849521|P3|Period 3|Lost to Follow-up|1
6032383|NCT00708123|20849522|P2|Period 3|Lost to Follow-up|0
6032384|NCT00708123|20849523|P1|Period 3|Lost to Follow-up|0
6032385|NCT00708123|20849519|P5|Period 2|Other Reason|0
6032386|NCT00708123|20849520|P4|Period 2|Other Reason|0
6032387|NCT00708123|20849521|P3|Period 2|Other Reason|0
6032388|NCT00708123|20849522|P2|Period 2|Other Reason|0
6032389|NCT00708123|20849523|P1|Period 2|Other Reason|1
6032390|NCT00708123|20849519|P5|Period 2|Protocol Violation|0
6032391|NCT00708123|20849520|P4|Period 2|Protocol Violation|1
6032392|NCT00708123|20849521|P3|Period 2|Protocol Violation|0
6032393|NCT00708123|20849522|P2|Period 2|Protocol Violation|0
6032394|NCT00708123|20849523|P1|Period 2|Protocol Violation|0
6032395|NCT00708123|20849519|P5|Period 1|Adverse Event|0
6032396|NCT00708123|20849520|P4|Period 1|Adverse Event|0
6032397|NCT00708123|20849521|P3|Period 1|Adverse Event|1
6032398|NCT00708123|20849522|P2|Period 1|Adverse Event|0
6032399|NCT00708123|20849523|P1|Period 1|Adverse Event|0
6032400|NCT00708123|20849519|P5|Period 1|Protocol Violation|0
6032401|NCT00708123|20849520|P4|Period 1|Protocol Violation|1
6032402|NCT00708123|20849521|P3|Period 1|Protocol Violation|0
6032403|NCT00708123|20849522|P2|Period 1|Protocol Violation|1
6032404|NCT00708123|20849523|P1|Period 1|Protocol Violation|0
6032405|NCT00708097|20849656|P5|Period 2|Protocol Violation|0
6032406|NCT00708097|20849657|P4|Period 2|Protocol Violation|1
6032407|NCT00708097|20849658|P3|Period 2|Protocol Violation|1
6032408|NCT00708097|20849659|P2|Period 2|Protocol Violation|1
6032409|NCT00708097|20849660|P1|Period 2|Protocol Violation|0
6032410|NCT00708097|20849656|P5|Period 1|Other Reason|1
6032411|NCT00708097|20849657|P4|Period 1|Other Reason|0
6032412|NCT00708097|20849658|P3|Period 1|Other Reason|0
6032413|NCT00708097|20849659|P2|Period 1|Other Reason|0
6032414|NCT00708097|20849660|P1|Period 1|Other Reason|0
6032415|NCT00708097|20849656|P5|Period 1|Protocol Violation|0
6032416|NCT00708097|20849657|P4|Period 1|Protocol Violation|2
6032417|NCT00708097|20849658|P3|Period 1|Protocol Violation|0
6032418|NCT00708097|20849659|P2|Period 1|Protocol Violation|1
6032419|NCT00708097|20849660|P1|Period 1|Protocol Violation|0
6032420|NCT00708032|20849770|P2|Overall Study|Withdrawal by Subject|1
6032421|NCT00708032|20849771|P1|Overall Study|Withdrawal by Subject|0
6032422|NCT00708032|20849770|P2|Overall Study|Protocol Violation|1
6032423|NCT00708032|20849771|P1|Overall Study|Protocol Violation|4
6032424|NCT00708032|20849770|P2|Overall Study|Did not meet protocol criteria|2
6032425|NCT00708032|20849771|P1|Overall Study|Did not meet protocol criteria|1
6032426|NCT00708032|20849770|P2|Overall Study|Visit out of range at month 12|1
6032427|NCT00708032|20849771|P1|Overall Study|Visit out of range at month 12|4
6032428|NCT00708032|20849770|P2|Overall Study|Poor vision|6
6032429|NCT00708032|20849771|P1|Overall Study|Poor vision|0
6032430|NCT00708032|20849770|P2|Overall Study|Pregnancy|1
6032431|NCT00708032|20849771|P1|Overall Study|Pregnancy|0
6032432|NCT00708032|20849770|P2|Overall Study|Lost to Follow-up|2
6032433|NCT00708032|20849771|P1|Overall Study|Lost to Follow-up|1
6032434|NCT00708032|20849770|P2|Overall Study|Adverse Event|2
6032435|NCT00708032|20849771|P1|Overall Study|Adverse Event|0
6032436|NCT00707993|20849798|P2|Overall Study|Other|0
6032437|NCT00707993|20849799|P1|Overall Study|Other|2
6032438|NCT00707993|20849798|P2|Overall Study|Hyperglycemic Rescue|47
6032439|NCT00707993|20849799|P1|Overall Study|Hyperglycemic Rescue|55
6032440|NCT00707993|20849798|P2|Overall Study|Withdrawal by Subject|16
6032441|NCT00707993|20849799|P1|Overall Study|Withdrawal by Subject|12
6032442|NCT00707993|20849798|P2|Overall Study|Lost to Follow-up|4
6032443|NCT00707993|20849799|P1|Overall Study|Lost to Follow-up|0
6032444|NCT00707993|20849798|P2|Overall Study|Protocol Violation|7
6032445|NCT00707993|20849799|P1|Overall Study|Protocol Violation|4
6032446|NCT00707993|20849798|P2|Overall Study|Adverse Event|20
6032447|NCT00707993|20849799|P1|Overall Study|Adverse Event|16
6032448|NCT00707980|20849841|P1|Overall Study|Other|39
6032449|NCT00707980|20849841|P1|Overall Study|Lost to Follow-up|59
6032450|NCT00707980|20849841|P1|Overall Study|Withdrawal of Consent|81
6032451|NCT00707980|20849841|P1|Overall Study|Protocol Deviations|19
6032452|NCT00707980|20849841|P1|Overall Study|Non-Compliance with Study Drug|28
6032453|NCT00707980|20849841|P1|Overall Study|Lack of Efficacy|35
6032454|NCT00707980|20849841|P1|Overall Study|Adverse Event|49
6032455|NCT00707954|20849925|P5|Overall Study|Physician Decision|1
6032456|NCT00707954|20849926|P4|Overall Study|Physician Decision|0
6032457|NCT00707954|20849927|P3|Overall Study|Physician Decision|0
6032458|NCT00707954|20849928|P2|Overall Study|Physician Decision|0
6032459|NCT00707954|20849929|P1|Overall Study|Physician Decision|0
6032460|NCT00707746|20849970|P2|Treatment Period|Ineligibility|1
6032461|NCT00707746|20849971|P1|Treatment Period|Ineligibility|0
6032462|NCT00707746|20849970|P2|Treatment Period|Adverse Event|4
6032463|NCT00707746|20849971|P1|Treatment Period|Adverse Event|2
6032464|NCT00707577|20850032|P2|Overall Study|Pregnancy|1
6032465|NCT00707577|20850033|P1|Overall Study|Pregnancy|4
6032466|NCT00707577|20850032|P2|Overall Study|Left employment|10
6032467|NCT00707577|20850033|P1|Overall Study|Left employment|13
6032468|NCT00707577|20850032|P2|Overall Study|Lost to Follow-up|25
6032469|NCT00707577|20850033|P1|Overall Study|Lost to Follow-up|34
6032470|NCT00707577|20850032|P2|Overall Study|Withdrawal by Subject|2
6032471|NCT00707577|20850033|P1|Overall Study|Withdrawal by Subject|3
6032472|NCT00707486|20850039|P1|Overall Study|Withdrawal by Subject|1
6032473|NCT00707434|20850075|P1|Overall Study|Adverse Event|1
6032474|NCT00707239|20850086|P3|Overall Study|Other|5
6032475|NCT00707239|20850087|P2|Overall Study|Other|3
6032476|NCT00707239|20850088|P1|Overall Study|Other|8
6032477|NCT00707239|20850086|P3|Overall Study|Randomized, but not treated|1
6032478|NCT00707239|20850087|P2|Overall Study|Randomized, but not treated|1
6032479|NCT00707239|20850088|P1|Overall Study|Randomized, but not treated|1
6032480|NCT00707239|20850086|P3|Overall Study|Lack of Efficacy|0
6032481|NCT00707239|20850087|P2|Overall Study|Lack of Efficacy|2
6032482|NCT00707239|20850088|P1|Overall Study|Lack of Efficacy|1
6032483|NCT00707239|20850086|P3|Overall Study|Protocol Violation|1
6032484|NCT00707239|20850087|P2|Overall Study|Protocol Violation|0
6032485|NCT00707239|20850088|P1|Overall Study|Protocol Violation|0
6032486|NCT00707239|20850086|P3|Overall Study|Physician Decision|2
6032487|NCT00707239|20850087|P2|Overall Study|Physician Decision|1
6032488|NCT00707239|20850088|P1|Overall Study|Physician Decision|1
6032489|NCT00707239|20850086|P3|Overall Study|Death|3
6032490|NCT00707239|20850087|P2|Overall Study|Death|1
6032491|NCT00707239|20850088|P1|Overall Study|Death|3
6032492|NCT00707239|20850086|P3|Overall Study|Adverse Event|2
6032493|NCT00707239|20850087|P2|Overall Study|Adverse Event|3
6032494|NCT00707239|20850088|P1|Overall Study|Adverse Event|5
6032495|NCT00707174|20850136|P2|Overall Study|Withdrawal by Subject|1
6032496|NCT00707174|20850137|P1|Overall Study|Withdrawal by Subject|4
6032497|NCT00707174|20850136|P2|Overall Study|Adverse Event|6
6032498|NCT00707174|20850137|P1|Overall Study|Adverse Event|1
6032499|NCT00707161|20850143|P1|Overall Study|Physician Decision|6
6032500|NCT00707057|20850149|P2|Overall Study|Dosed incorrectly|1
6032501|NCT00707057|20850150|P1|Overall Study|Dosed incorrectly|0
6032502|NCT00707057|20850149|P2|Overall Study|Withdrawal by Subject|3
6032503|NCT00707057|20850150|P1|Overall Study|Withdrawal by Subject|8
6032504|NCT00707031|20850184|P2|Overall Study|Sponsor Decision|8
6032505|NCT00707031|20850185|P1|Overall Study|Sponsor Decision|9
6032506|NCT00707031|20850184|P2|Overall Study|Serious Noncompliance|3
6032507|NCT00707031|20850185|P1|Overall Study|Serious Noncompliance|2
6032508|NCT00707031|20850184|P2|Overall Study|Familial or Personal Reasons|15
6032509|NCT00707031|20850185|P1|Overall Study|Familial or Personal Reasons|12
6032510|NCT00707031|20850184|P2|Overall Study|Poor Compliance to Protocol|13
6032511|NCT00707031|20850185|P1|Overall Study|Poor Compliance to Protocol|7
6032512|NCT00707031|20850184|P2|Overall Study|Withdrawal by Subject|8
6032513|NCT00707031|20850185|P1|Overall Study|Withdrawal by Subject|7
6032514|NCT00707031|20850184|P2|Overall Study|Protocol Violation|0
6032515|NCT00707031|20850185|P1|Overall Study|Protocol Violation|1
6032516|NCT00707031|20850184|P2|Overall Study|Lost to Follow-up|1
6032517|NCT00707031|20850185|P1|Overall Study|Lost to Follow-up|2
6032518|NCT00707031|20850184|P2|Overall Study|Lack of Efficacy|6
6032519|NCT00707031|20850185|P1|Overall Study|Lack of Efficacy|19
6032520|NCT00707031|20850184|P2|Overall Study|Adverse Event|45
6032521|NCT00707031|20850185|P1|Overall Study|Adverse Event|45
6032522|NCT00706992|20850214|P7|Overall Study|Disease progression before treatment|0
6032523|NCT00706992|20850215|P6|Overall Study|Disease progression before treatment|0
6032524|NCT00706992|20850216|P5|Overall Study|Disease progression before treatment|1
6032525|NCT00706992|20850217|P4|Overall Study|Disease progression before treatment|0
6032526|NCT00706992|20850218|P3|Overall Study|Disease progression before treatment|0
6032527|NCT00706992|20850219|P2|Overall Study|Disease progression before treatment|0
6032528|NCT00706992|20850220|P1|Overall Study|Disease progression before treatment|0
6032529|NCT00706992|20850214|P7|Overall Study|Study termination|3
6032530|NCT00706992|20850215|P6|Overall Study|Study termination|2
6032531|NCT00706992|20850216|P5|Overall Study|Study termination|3
6032532|NCT00706992|20850217|P4|Overall Study|Study termination|2
6032533|NCT00706992|20850218|P3|Overall Study|Study termination|6
6032534|NCT00706992|20850219|P2|Overall Study|Study termination|5
6032535|NCT00706992|20850220|P1|Overall Study|Study termination|5
6032536|NCT00706966|20850252|P1|Overall Study|Adverse Event|1
6032537|NCT00706914|20850288|P3|Overall Study|Protocol Violation|1
6032538|NCT00706914|20850289|P2|Overall Study|Protocol Violation|1
6032539|NCT00706914|20850290|P1|Overall Study|Protocol Violation|3
6032540|NCT00706914|20850288|P3|Overall Study|Adverse Event|0
6032541|NCT00706914|20850289|P2|Overall Study|Adverse Event|2
6032542|NCT00706914|20850290|P1|Overall Study|Adverse Event|2
6032543|NCT00706914|20850288|P3|Overall Study|Lost to Follow-up|0
6032544|NCT00706914|20850289|P2|Overall Study|Lost to Follow-up|0
6032545|NCT00706914|20850290|P1|Overall Study|Lost to Follow-up|1
6032546|NCT00706914|20850288|P3|Overall Study|Lack of Efficacy|0
6032547|NCT00706914|20850289|P2|Overall Study|Lack of Efficacy|1
6032548|NCT00706914|20850290|P1|Overall Study|Lack of Efficacy|0
6032549|NCT00706901|20850313|P3|Overall Study|Death|0
6032550|NCT00706901|20850314|P2|Overall Study|Death|0
6032551|NCT00706901|20850315|P1|Overall Study|Death|1
6032552|NCT00706901|20850313|P3|Overall Study|In Jail|1
6032553|NCT00706901|20850314|P2|Overall Study|In Jail|0
6032554|NCT00706901|20850315|P1|Overall Study|In Jail|1
6032555|NCT00706901|20850313|P3|Overall Study|Withdrawal by Subject|5
6032556|NCT00706901|20850314|P2|Overall Study|Withdrawal by Subject|2
6032557|NCT00706901|20850315|P1|Overall Study|Withdrawal by Subject|4
6032558|NCT00706901|20850313|P3|Overall Study|Lost to Follow-up|2
6032559|NCT00706901|20850314|P2|Overall Study|Lost to Follow-up|3
6032560|NCT00706901|20850315|P1|Overall Study|Lost to Follow-up|2
6032561|NCT00706849|20850340|P2|Follow-up Period|Protocol non-compliance|1
6032562|NCT00706849|20850341|P1|Follow-up Period|Protocol non-compliance|0
6032563|NCT00706849|20850340|P2|Follow-up Period|Withdrawal by Subject|2
6032564|NCT00706849|20850341|P1|Follow-up Period|Withdrawal by Subject|0
6032565|NCT00706849|20850340|P2|Treatment Period|Other|1
6032566|NCT00706849|20850341|P1|Treatment Period|Other|0
6032567|NCT00706849|20850340|P2|Treatment Period|Adverse Event|9
6032568|NCT00706849|20850341|P1|Treatment Period|Adverse Event|0
6032569|NCT00706797|20850419|P2|Overall Study|Other|0
6032570|NCT00706797|20850420|P1|Overall Study|Other|1
6032571|NCT00706797|20850419|P2|Overall Study|Lost to Follow-up|2
6032572|NCT00706797|20850420|P1|Overall Study|Lost to Follow-up|1
6032573|NCT00706797|20850419|P2|Overall Study|Protocol Violation|2
6032574|NCT00706797|20850420|P1|Overall Study|Protocol Violation|3
6032575|NCT00706797|20850419|P2|Overall Study|Discontinuation of study by sponsor|63
6032576|NCT00706797|20850420|P1|Overall Study|Discontinuation of study by sponsor|52
6032577|NCT00706797|20850419|P2|Overall Study|Death|0
6032578|NCT00706797|20850420|P1|Overall Study|Death|1
6032579|NCT00706797|20850419|P2|Overall Study|Withdrawal by Subject|1
6032580|NCT00706797|20850420|P1|Overall Study|Withdrawal by Subject|8
6032581|NCT00706797|20850419|P2|Overall Study|Adverse Event|3
6032582|NCT00706797|20850420|P1|Overall Study|Adverse Event|0
6032583|NCT00706797|20850419|P2|Overall Study|Lack of Efficacy|0
6032584|NCT00706797|20850420|P1|Overall Study|Lack of Efficacy|3
6032585|NCT00706706|20850489|P1|Overall Study|Study endpoint had reached|45
6032586|NCT00706706|20850489|P1|Overall Study|Lost to Follow-up|7
6032587|NCT00706706|20850489|P1|Overall Study|Death|53
6032588|NCT00706654|20850499|P4|Depot Maintenance Phase|Impending Relapse without Adverse Event|12
6032589|NCT00706654|20850500|P3|Depot Maintenance Phase|Impending Relapse without Adverse Event|9
6032590|NCT00706654|20850501|P2|Depot Maintenance Phase|Impending Relapse without Adverse Event|9
6032591|NCT00706654|20850502|P1|Depot Maintenance Phase|Impending Relapse without Adverse Event|0
6032592|NCT00706654|20850499|P4|Depot Maintenance Phase|Impending Relapse with Adverse Event|17
6032593|NCT00706654|20850500|P3|Depot Maintenance Phase|Impending Relapse with Adverse Event|12
6032594|NCT00706654|20850501|P2|Depot Maintenance Phase|Impending Relapse with Adverse Event|13
6032595|NCT00706654|20850502|P1|Depot Maintenance Phase|Impending Relapse with Adverse Event|0
6032596|NCT00706654|20850499|P4|Depot Maintenance Phase|Adverse Event without Impending Relapse|7
6032597|NCT00706654|20850500|P3|Depot Maintenance Phase|Adverse Event without Impending Relapse|7
6032598|NCT00706654|20850501|P2|Depot Maintenance Phase|Adverse Event without Impending Relapse|8
6032599|NCT00706654|20850502|P1|Depot Maintenance Phase|Adverse Event without Impending Relapse|0
6032600|NCT00706654|20850499|P4|Depot Maintenance Phase|Protocol Deviation|1
6032601|NCT00706654|20850500|P3|Depot Maintenance Phase|Protocol Deviation|3
6032602|NCT00706654|20850501|P2|Depot Maintenance Phase|Protocol Deviation|2
6032603|NCT00706654|20850502|P1|Depot Maintenance Phase|Protocol Deviation|0
6032604|NCT00706654|20850499|P4|Depot Maintenance Phase|Withdrew Consent|14
6032605|NCT00706654|20850500|P3|Depot Maintenance Phase|Withdrew Consent|29
6032606|NCT00706654|20850501|P2|Depot Maintenance Phase|Withdrew Consent|21
6032607|NCT00706654|20850502|P1|Depot Maintenance Phase|Withdrew Consent|0
6032608|NCT00706654|20850499|P4|Depot Maintenance Phase|Withdrawn by Investigator|8
6032609|NCT00706654|20850500|P3|Depot Maintenance Phase|Withdrawn by Investigator|12
6032610|NCT00706654|20850501|P2|Depot Maintenance Phase|Withdrawn by Investigator|8
6032611|NCT00706654|20850502|P1|Depot Maintenance Phase|Withdrawn by Investigator|0
6032612|NCT00706654|20850499|P4|Depot Maintenance Phase|Met Withdrawal Criteria|5
6032613|NCT00706654|20850500|P3|Depot Maintenance Phase|Met Withdrawal Criteria|6
6032614|NCT00706654|20850501|P2|Depot Maintenance Phase|Met Withdrawal Criteria|4
6032615|NCT00706654|20850502|P1|Depot Maintenance Phase|Met Withdrawal Criteria|0
6032616|NCT00706654|20850499|P4|Depot Maintenance Phase|Lost to Follow-up|6
6032617|NCT00706654|20850500|P3|Depot Maintenance Phase|Lost to Follow-up|10
6032618|NCT00706654|20850501|P2|Depot Maintenance Phase|Lost to Follow-up|4
6032619|NCT00706654|20850502|P1|Depot Maintenance Phase|Lost to Follow-up|0
6032620|NCT00706654|20850499|P4|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0
6032621|NCT00706654|20850500|P3|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0
6032622|NCT00706654|20850501|P2|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0
6032623|NCT00706654|20850502|P1|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|10
6032624|NCT00706654|20850499|P4|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0
6032625|NCT00706654|20850500|P3|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0
6032626|NCT00706654|20850501|P2|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0
6032627|NCT00706654|20850502|P1|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|20
6032628|NCT00706654|20850499|P4|Oral Stabilization Phase|Adverse Event|0
6032629|NCT00706654|20850500|P3|Oral Stabilization Phase|Adverse Event|0
6032630|NCT00706654|20850501|P2|Oral Stabilization Phase|Adverse Event|0
6032631|NCT00706654|20850502|P1|Oral Stabilization Phase|Adverse Event|21
6032632|NCT00706654|20850499|P4|Oral Stabilization Phase|Protocol Deviation|0
6032633|NCT00706654|20850500|P3|Oral Stabilization Phase|Protocol Deviation|0
6032634|NCT00706654|20850501|P2|Oral Stabilization Phase|Protocol Deviation|0
6032635|NCT00706654|20850502|P1|Oral Stabilization Phase|Protocol Deviation|2
6032636|NCT00706654|20850499|P4|Oral Stabilization Phase|Withdrew consent|0
6032637|NCT00706654|20850500|P3|Oral Stabilization Phase|Withdrew consent|0
6032638|NCT00706654|20850501|P2|Oral Stabilization Phase|Withdrew consent|0
6032639|NCT00706654|20850502|P1|Oral Stabilization Phase|Withdrew consent|55
6032640|NCT00706654|20850499|P4|Oral Stabilization Phase|Withdrawn by Investigator|0
6032641|NCT00706654|20850500|P3|Oral Stabilization Phase|Withdrawn by Investigator|0
6032642|NCT00706654|20850501|P2|Oral Stabilization Phase|Withdrawn by Investigator|0
6032643|NCT00706654|20850502|P1|Oral Stabilization Phase|Withdrawn by Investigator|21
6032644|NCT00706654|20850499|P4|Oral Stabilization Phase|Met Withdrawal Criteria|0
6032645|NCT00706654|20850500|P3|Oral Stabilization Phase|Met Withdrawal Criteria|0
6032646|NCT00706654|20850501|P2|Oral Stabilization Phase|Met Withdrawal Criteria|0
6032647|NCT00706654|20850502|P1|Oral Stabilization Phase|Met Withdrawal Criteria|15
6032648|NCT00706654|20850499|P4|Oral Stabilization Phase|Sponsor Discontinue Trial|0
6032649|NCT00706654|20850500|P3|Oral Stabilization Phase|Sponsor Discontinue Trial|0
6032650|NCT00706654|20850501|P2|Oral Stabilization Phase|Sponsor Discontinue Trial|0
6032651|NCT00706654|20850502|P1|Oral Stabilization Phase|Sponsor Discontinue Trial|19
6032652|NCT00706654|20850499|P4|Oral Stabilization Phase|Lost to Follow-up|0
6032653|NCT00706654|20850500|P3|Oral Stabilization Phase|Lost to Follow-up|0
6032654|NCT00706654|20850501|P2|Oral Stabilization Phase|Lost to Follow-up|0
6032655|NCT00706654|20850502|P1|Oral Stabilization Phase|Lost to Follow-up|17
6032656|NCT00706654|20850499|P4|Conversion Phase|Lack of Efficacy without Adverse Event|0
6032657|NCT00706654|20850500|P3|Conversion Phase|Lack of Efficacy without Adverse Event|0
6032658|NCT00706654|20850501|P2|Conversion Phase|Lack of Efficacy without Adverse Event|0
6032659|NCT00706654|20850502|P1|Conversion Phase|Lack of Efficacy without Adverse Event|2
6032660|NCT00706654|20850499|P4|Conversion Phase|Lack of Efficacy with Adverse Event|0
6032661|NCT00706654|20850500|P3|Conversion Phase|Lack of Efficacy with Adverse Event|0
6032662|NCT00706654|20850501|P2|Conversion Phase|Lack of Efficacy with Adverse Event|0
6032663|NCT00706654|20850502|P1|Conversion Phase|Lack of Efficacy with Adverse Event|9
6032664|NCT00706654|20850499|P4|Conversion Phase|Adverse Event|0
6032665|NCT00706654|20850500|P3|Conversion Phase|Adverse Event|0
6032666|NCT00706654|20850501|P2|Conversion Phase|Adverse Event|0
6032667|NCT00706654|20850502|P1|Conversion Phase|Adverse Event|18
6032668|NCT00706654|20850499|P4|Conversion Phase|Withdrew Consent|0
6032669|NCT00706654|20850500|P3|Conversion Phase|Withdrew Consent|0
6032670|NCT00706654|20850501|P2|Conversion Phase|Withdrew Consent|0
6032671|NCT00706654|20850502|P1|Conversion Phase|Withdrew Consent|38
6032672|NCT00706654|20850499|P4|Conversion Phase|Withdrawn by Investigator|0
6032673|NCT00706654|20850500|P3|Conversion Phase|Withdrawn by Investigator|0
6032674|NCT00706654|20850501|P2|Conversion Phase|Withdrawn by Investigator|0
6032675|NCT00706654|20850502|P1|Conversion Phase|Withdrawn by Investigator|14
6032676|NCT00706654|20850499|P4|Conversion Phase|Met Withdrawal Criteria|0
6032677|NCT00706654|20850500|P3|Conversion Phase|Met Withdrawal Criteria|0
6032678|NCT00706654|20850501|P2|Conversion Phase|Met Withdrawal Criteria|0
6032679|NCT00706654|20850502|P1|Conversion Phase|Met Withdrawal Criteria|2
6032680|NCT00706654|20850499|P4|Conversion Phase|Sponsor Discontinued Trial|0
6032681|NCT00706654|20850500|P3|Conversion Phase|Sponsor Discontinued Trial|0
6032682|NCT00706654|20850501|P2|Conversion Phase|Sponsor Discontinued Trial|0
6032683|NCT00706654|20850502|P1|Conversion Phase|Sponsor Discontinued Trial|8
6032684|NCT00706654|20850499|P4|Conversion Phase|Lost to Follow-up|0
6032685|NCT00706654|20850500|P3|Conversion Phase|Lost to Follow-up|0
6032686|NCT00706654|20850501|P2|Conversion Phase|Lost to Follow-up|0
6032687|NCT00706654|20850502|P1|Conversion Phase|Lost to Follow-up|4
6032688|NCT00706641|20850521|P1|Radical Cystectomy|Deemed unresectable upon exploration|1
6032689|NCT00706641|20850521|P1|Dasatinib Administration|Ineligible after start of therapy|1
6032690|NCT00706641|20850521|P1|Dasatinib Administration|Withdrawal by Subject|1
6032691|NCT00706628|20850535|P4|Overall Study|Not treated|0
6032692|NCT00706628|20850536|P3|Overall Study|Not treated|0
6032693|NCT00706628|20850537|P2|Overall Study|Not treated|1
6032694|NCT00706628|20850538|P1|Overall Study|Not treated|1
6032695|NCT00706628|20850535|P4|Overall Study|Other than those stated above|0
6032696|NCT00706628|20850536|P3|Overall Study|Other than those stated above|0
6032697|NCT00706628|20850537|P2|Overall Study|Other than those stated above|0
6032698|NCT00706628|20850538|P1|Overall Study|Other than those stated above|4
6032699|NCT00706628|20850535|P4|Overall Study|Progressive disease|1
6032700|NCT00706628|20850536|P3|Overall Study|Progressive disease|8
6032701|NCT00706628|20850537|P2|Overall Study|Progressive disease|13
6032702|NCT00706628|20850538|P1|Overall Study|Progressive disease|20
6032703|NCT00706628|20850535|P4|Overall Study|Consent withdrawn|0
6032704|NCT00706628|20850536|P3|Overall Study|Consent withdrawn|3
6032705|NCT00706628|20850537|P2|Overall Study|Consent withdrawn|1
6032706|NCT00706628|20850538|P1|Overall Study|Consent withdrawn|6
6032707|NCT00706628|20850535|P4|Overall Study|Non compliant with protocol|0
6032708|NCT00706628|20850536|P3|Overall Study|Non compliant with protocol|0
6032709|NCT00706628|20850537|P2|Overall Study|Non compliant with protocol|1
6032710|NCT00706628|20850538|P1|Overall Study|Non compliant with protocol|0
6032711|NCT00706628|20850535|P4|Overall Study|Other Adverse Event|2
6032712|NCT00706628|20850536|P3|Overall Study|Other Adverse Event|5
6032713|NCT00706628|20850537|P2|Overall Study|Other Adverse Event|5
6032714|NCT00706628|20850538|P1|Overall Study|Other Adverse Event|16
6032715|NCT00706511|20850643|P4|Overall Study|Withdrawal by Subject|0
6032716|NCT00706511|20850644|P3|Overall Study|Withdrawal by Subject|0
6032717|NCT00706511|20850645|P2|Overall Study|Withdrawal by Subject|0
6032718|NCT00706511|20850646|P1|Overall Study|Withdrawal by Subject|1
6032719|NCT00706433|20850737|P4|Overall Study|new job|1
6032720|NCT00706433|20850738|P3|Overall Study|new job|0
6032721|NCT00706433|20850739|P2|Overall Study|new job|0
6032722|NCT00706433|20850740|P1|Overall Study|new job|0
6032723|NCT00706433|20850737|P4|Overall Study|Protocol Violation|0
6032724|NCT00706433|20850738|P3|Overall Study|Protocol Violation|0
6032725|NCT00706433|20850739|P2|Overall Study|Protocol Violation|0
6032726|NCT00706433|20850740|P1|Overall Study|Protocol Violation|1
6032727|NCT00706433|20850737|P4|Overall Study|Adverse Event|0
6032728|NCT00706433|20850738|P3|Overall Study|Adverse Event|1
6032729|NCT00706433|20850739|P2|Overall Study|Adverse Event|0
6032730|NCT00706433|20850740|P1|Overall Study|Adverse Event|0
6032731|NCT00706433|20850737|P4|Overall Study|Withdrawal by Subject|1
6032732|NCT00706433|20850738|P3|Overall Study|Withdrawal by Subject|3
6032733|NCT00706433|20850739|P2|Overall Study|Withdrawal by Subject|2
6032734|NCT00706433|20850740|P1|Overall Study|Withdrawal by Subject|1
6032735|NCT00706433|20850737|P4|Overall Study|Lost to Follow-up|0
6032736|NCT00706433|20850738|P3|Overall Study|Lost to Follow-up|6
6032737|NCT00706433|20850739|P2|Overall Study|Lost to Follow-up|1
6032738|NCT00706433|20850740|P1|Overall Study|Lost to Follow-up|3
6032739|NCT00706381|20851067|P4|Overall Study|Lost to Follow-up|0
6032740|NCT00706381|20851068|P3|Overall Study|Lost to Follow-up|1
6032741|NCT00706381|20851069|P2|Overall Study|Lost to Follow-up|1
6032742|NCT00706381|20851070|P1|Overall Study|Lost to Follow-up|0
6032743|NCT00706355|20851091|P4|Period 4: PF-04217903 150 mg|Objective progression or relapse|2
6032744|NCT00706355|20851092|P3|Period 4: PF-04217903 150 mg|Objective progression or relapse|0
6032745|NCT00706355|20851093|P2|Period 4: PF-04217903 150 mg|Objective progression or relapse|0
6032746|NCT00706355|20851094|P1|Period 4: PF-04217903 150 mg|Objective progression or relapse|0
6032747|NCT00706355|20851091|P4|Period 4: PF-04217903 150 mg|Adverse Event|2
6032748|NCT00706355|20851092|P3|Period 4: PF-04217903 150 mg|Adverse Event|0
6032749|NCT00706355|20851093|P2|Period 4: PF-04217903 150 mg|Adverse Event|0
6032750|NCT00706355|20851094|P1|Period 4: PF-04217903 150 mg|Adverse Event|0
6032751|NCT00706355|20851091|P4|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0
6032752|NCT00706355|20851092|P3|Period 3: PF-04217903 200 mg|Withdrawal by Subject|1
6032753|NCT00706355|20851093|P2|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0
6032754|NCT00706355|20851094|P1|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0
6032755|NCT00706355|20851091|P4|Period 3: PF-04217903 200 mg|Adverse Event|0
6032756|NCT00706355|20851092|P3|Period 3: PF-04217903 200 mg|Adverse Event|1
6032757|NCT00706355|20851093|P2|Period 3: PF-04217903 200 mg|Adverse Event|0
6032758|NCT00706355|20851094|P1|Period 3: PF-04217903 200 mg|Adverse Event|0
6032759|NCT00706355|20851091|P4|Period 2: PF-04217903 100 mg|Objective progression or relapse|0
6032760|NCT00706355|20851092|P3|Period 2: PF-04217903 100 mg|Objective progression or relapse|0
6032761|NCT00706355|20851093|P2|Period 2: PF-04217903 100 mg|Objective progression or relapse|5
6032762|NCT00706355|20851094|P1|Period 2: PF-04217903 100 mg|Objective progression or relapse|0
6032763|NCT00706355|20851091|P4|Period 2: PF-04217903 100 mg|Global deterioration of health status|0
6032764|NCT00706355|20851092|P3|Period 2: PF-04217903 100 mg|Global deterioration of health status|0
6032765|NCT00706355|20851093|P2|Period 2: PF-04217903 100 mg|Global deterioration of health status|1
6032766|NCT00706355|20851094|P1|Period 2: PF-04217903 100 mg|Global deterioration of health status|0
6032767|NCT00706355|20851091|P4|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0
6032768|NCT00706355|20851092|P3|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0
6032769|NCT00706355|20851093|P2|Period 2: PF-04217903 100 mg|Withdrawal by Subject|1
6032770|NCT00706355|20851094|P1|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0
6032771|NCT00706355|20851091|P4|Period 1: PF-04217903 50 mg|Objective progression or relapse|0
6032772|NCT00706355|20851092|P3|Period 1: PF-04217903 50 mg|Objective progression or relapse|0
6032773|NCT00706355|20851093|P2|Period 1: PF-04217903 50 mg|Objective progression or relapse|0
6032774|NCT00706355|20851094|P1|Period 1: PF-04217903 50 mg|Objective progression or relapse|2
6032775|NCT00706355|20851091|P4|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0
6032776|NCT00706355|20851092|P3|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0
6032777|NCT00706355|20851093|P2|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0
6032778|NCT00706355|20851094|P1|Period 1: PF-04217903 50 mg|Withdrawal by Subject|1
6032779|NCT00706342|20851146|P1|Overall Study|WIthdrawal of consent|1
6032780|NCT00706342|20851146|P1|Overall Study|Ongoing|6
6032781|NCT00706342|20851146|P1|Overall Study|Non-responder Week 12|1
6032782|NCT00706342|20851146|P1|Overall Study|Investigator discretion|2
6032783|NCT00706342|20851146|P1|Overall Study|Withdrew from the study on his own.|1
6032784|NCT00706342|20851146|P1|Overall Study|Death|1
6032785|NCT00706342|20851146|P1|Overall Study|Withdrawn due to failure to respond|1
6032786|NCT00706342|20851146|P1|Overall Study|Not responding to treatment|2
6032787|NCT00706342|20851146|P1|Overall Study|Adverse Event|3
6032788|NCT00706238|20851159|P1|Overall Study|Other|1
6032789|NCT00706238|20851159|P1|Overall Study|Disease progression|4
6032790|NCT00706134|20851176|P4|Overall Study|Did not meet study criteria|0
6032791|NCT00706134|20851177|P3|Overall Study|Did not meet study criteria|0
6032792|NCT00706134|20851178|P2|Overall Study|Did not meet study criteria|0
6032793|NCT00706134|20851179|P1|Overall Study|Did not meet study criteria|2
6032794|NCT00706134|20851176|P4|Overall Study|Unsatisfactory therapeutic effect|5
6032795|NCT00706134|20851177|P3|Overall Study|Unsatisfactory therapeutic effect|3
6032796|NCT00706134|20851178|P2|Overall Study|Unsatisfactory therapeutic effect|3
6032797|NCT00706134|20851179|P1|Overall Study|Unsatisfactory therapeutic effect|9
6032798|NCT00706134|20851176|P4|Overall Study|Withdrawal by Subject|0
6032799|NCT00706134|20851177|P3|Overall Study|Withdrawal by Subject|1
6032800|NCT00706134|20851178|P2|Overall Study|Withdrawal by Subject|2
6032801|NCT00706134|20851179|P1|Overall Study|Withdrawal by Subject|1
6032802|NCT00706134|20851176|P4|Overall Study|Protocol Violation|3
6032803|NCT00706134|20851177|P3|Overall Study|Protocol Violation|0
6032804|NCT00706134|20851178|P2|Overall Study|Protocol Violation|6
6032805|NCT00706134|20851179|P1|Overall Study|Protocol Violation|0
6032806|NCT00706134|20851176|P4|Overall Study|Lost to Follow-up|0
6032807|NCT00706134|20851177|P3|Overall Study|Lost to Follow-up|0
6032808|NCT00706134|20851178|P2|Overall Study|Lost to Follow-up|1
6032809|NCT00706134|20851179|P1|Overall Study|Lost to Follow-up|0
6032810|NCT00706134|20851176|P4|Overall Study|Adverse Event|3
6032811|NCT00706134|20851177|P3|Overall Study|Adverse Event|2
6032812|NCT00706134|20851178|P2|Overall Study|Adverse Event|7
6032813|NCT00706134|20851179|P1|Overall Study|Adverse Event|8
6032814|NCT00706095|20851245|P3|Overall Study|Withdrawal by Subject|0
6032815|NCT00706095|20851246|P2|Overall Study|Withdrawal by Subject|0
6032816|NCT00706095|20851247|P1|Overall Study|Withdrawal by Subject|1
6032817|NCT00706095|20851245|P3|Overall Study|Clinical Progression|2
6032818|NCT00706095|20851246|P2|Overall Study|Clinical Progression|2
6032819|NCT00706095|20851247|P1|Overall Study|Clinical Progression|1
6032820|NCT00706095|20851245|P3|Overall Study|Progressive Disease|3
6032821|NCT00706095|20851246|P2|Overall Study|Progressive Disease|5
6032822|NCT00706095|20851247|P1|Overall Study|Progressive Disease|4
6032823|NCT00706030|20851265|P4|Overall Study|Death|0
6032824|NCT00706030|20851266|P3|Overall Study|Death|1
6032825|NCT00706030|20851267|P2|Overall Study|Death|0
6032826|NCT00706030|20851268|P1|Overall Study|Death|0
6032827|NCT00706030|20851265|P4|Overall Study|No treatment received|1
6032828|NCT00706030|20851266|P3|Overall Study|No treatment received|0
6032829|NCT00706030|20851267|P2|Overall Study|No treatment received|0
6032830|NCT00706030|20851268|P1|Overall Study|No treatment received|0
6032831|NCT00706030|20851265|P4|Overall Study|Symptomatic Deterioration|0
6032832|NCT00706030|20851266|P3|Overall Study|Symptomatic Deterioration|1
6032833|NCT00706030|20851267|P2|Overall Study|Symptomatic Deterioration|0
6032834|NCT00706030|20851268|P1|Overall Study|Symptomatic Deterioration|0
6032835|NCT00706030|20851265|P4|Overall Study|Failed to return|0
6032836|NCT00706030|20851266|P3|Overall Study|Failed to return|1
6032837|NCT00706030|20851267|P2|Overall Study|Failed to return|0
6032838|NCT00706030|20851268|P1|Overall Study|Failed to return|0
6032839|NCT00706030|20851265|P4|Overall Study|Protocol Violation|1
6032840|NCT00706030|20851266|P3|Overall Study|Protocol Violation|1
6032841|NCT00706030|20851267|P2|Overall Study|Protocol Violation|0
6032842|NCT00706030|20851268|P1|Overall Study|Protocol Violation|0
6032843|NCT00706030|20851265|P4|Overall Study|Not recorded|0
6032844|NCT00706030|20851266|P3|Overall Study|Not recorded|2
6032845|NCT00706030|20851267|P2|Overall Study|Not recorded|0
6032846|NCT00706030|20851268|P1|Overall Study|Not recorded|0
6032847|NCT00706030|20851265|P4|Overall Study|Physician Decision|0
6032848|NCT00706030|20851266|P3|Overall Study|Physician Decision|2
6032849|NCT00706030|20851267|P2|Overall Study|Physician Decision|0
6032850|NCT00706030|20851268|P1|Overall Study|Physician Decision|0
6032851|NCT00706030|20851265|P4|Overall Study|Withdrawal by Subject|0
6032852|NCT00706030|20851266|P3|Overall Study|Withdrawal by Subject|2
6032853|NCT00706030|20851267|P2|Overall Study|Withdrawal by Subject|0
6032854|NCT00706030|20851268|P1|Overall Study|Withdrawal by Subject|1
6032855|NCT00706030|20851265|P4|Overall Study|Adverse Event|2
6032856|NCT00706030|20851266|P3|Overall Study|Adverse Event|4
6032857|NCT00706030|20851267|P2|Overall Study|Adverse Event|0
6032858|NCT00706030|20851268|P1|Overall Study|Adverse Event|1
6032859|NCT00706030|20851265|P4|Overall Study|Disease Progression|12
6032860|NCT00706030|20851266|P3|Overall Study|Disease Progression|46
6032861|NCT00706030|20851267|P2|Overall Study|Disease Progression|6
6032862|NCT00706030|20851268|P1|Overall Study|Disease Progression|4
6032863|NCT00706004|20851283|P1|Overall Study|Did not meet eligibility criteria|2
6032864|NCT00705939|20851311|P3|Overall Study|Physician Decision|0
6032865|NCT00705939|20851312|P2|Overall Study|Physician Decision|1
6032866|NCT00705939|20851313|P1|Overall Study|Physician Decision|0
6032867|NCT00705939|20851311|P3|Overall Study|Withdrawal by Subject|3
6032868|NCT00705939|20851312|P2|Overall Study|Withdrawal by Subject|1
6032869|NCT00705939|20851313|P1|Overall Study|Withdrawal by Subject|0
6032870|NCT00705939|20851311|P3|Overall Study|Protocol Violation|1
6032871|NCT00705939|20851312|P2|Overall Study|Protocol Violation|0
6032872|NCT00705939|20851313|P1|Overall Study|Protocol Violation|0
6032873|NCT00705783|20851367|P3|Depot Maintenance Phase|Impending Relapse without Adverse Event|40
6032874|NCT00705783|20851368|P2|Depot Maintenance Phase|Impending Relapse without Adverse Event|16
6032875|NCT00705783|20851369|P1|Depot Maintenance Phase|Impending Relapse without Adverse Event|0
6032876|NCT00705783|20851367|P3|Depot Maintenance Phase|Impending Relapse with Adverse Event|13
6032877|NCT00705783|20851368|P2|Depot Maintenance Phase|Impending Relapse with Adverse Event|11
6032878|NCT00705783|20851369|P1|Depot Maintenance Phase|Impending Relapse with Adverse Event|0
6032879|NCT00705783|20851367|P3|Depot Maintenance Phase|Adverse Event without Impending Relapse|5
6032880|NCT00705783|20851368|P2|Depot Maintenance Phase|Adverse Event without Impending Relapse|9
6032881|NCT00705783|20851369|P1|Depot Maintenance Phase|Adverse Event without Impending Relapse|0
6032882|NCT00705783|20851367|P3|Depot Maintenance Phase|Protocol Deviation|0
6032883|NCT00705783|20851368|P2|Depot Maintenance Phase|Protocol Deviation|2
6032884|NCT00705783|20851369|P1|Depot Maintenance Phase|Protocol Deviation|0
6032885|NCT00705783|20851367|P3|Depot Maintenance Phase|Withdrew Consent|4
6032886|NCT00705783|20851368|P2|Depot Maintenance Phase|Withdrew Consent|14
6032887|NCT00705783|20851369|P1|Depot Maintenance Phase|Withdrew Consent|0
6032888|NCT00705783|20851367|P3|Depot Maintenance Phase|Withdrawn by Investigator|6
6032889|NCT00705783|20851368|P2|Depot Maintenance Phase|Withdrawn by Investigator|8
6032890|NCT00705783|20851369|P1|Depot Maintenance Phase|Withdrawn by Investigator|0
6032891|NCT00705783|20851367|P3|Depot Maintenance Phase|Met Withdrawal Criteria|2
6032892|NCT00705783|20851368|P2|Depot Maintenance Phase|Met Withdrawal Criteria|2
6032893|NCT00705783|20851369|P1|Depot Maintenance Phase|Met Withdrawal Criteria|0
6032894|NCT00705783|20851367|P3|Depot Maintenance Phase|Lost to Follow-up|3
6032895|NCT00705783|20851368|P2|Depot Maintenance Phase|Lost to Follow-up|5
6032896|NCT00705783|20851369|P1|Depot Maintenance Phase|Lost to Follow-up|0
6032897|NCT00705783|20851367|P3|Depot Maintenance Phase|Sponsor Discontinued Study|58
6032898|NCT00705783|20851368|P2|Depot Maintenance Phase|Sponsor Discontinued Study|179
6032899|NCT00705783|20851369|P1|Depot Maintenance Phase|Sponsor Discontinued Study|0
6032900|NCT00705783|20851367|P3|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0
6032901|NCT00705783|20851368|P2|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0
6032902|NCT00705783|20851369|P1|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|1
6032903|NCT00705783|20851367|P3|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0
6032904|NCT00705783|20851368|P2|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0
6032905|NCT00705783|20851369|P1|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|12
6032906|NCT00705783|20851367|P3|Depot Stabilization Phase|Adverse Event|0
6032907|NCT00705783|20851368|P2|Depot Stabilization Phase|Adverse Event|0
6032908|NCT00705783|20851369|P1|Depot Stabilization Phase|Adverse Event|17
6032909|NCT00705783|20851367|P3|Depot Stabilization Phase|Withdrew Consent|0
6032910|NCT00705783|20851368|P2|Depot Stabilization Phase|Withdrew Consent|0
6032911|NCT00705783|20851369|P1|Depot Stabilization Phase|Withdrew Consent|29
6032912|NCT00705783|20851367|P3|Depot Stabilization Phase|Withdrawn by Investigator|0
6032913|NCT00705783|20851368|P2|Depot Stabilization Phase|Withdrawn by Investigator|0
6032914|NCT00705783|20851369|P1|Depot Stabilization Phase|Withdrawn by Investigator|9
6032915|NCT00705783|20851367|P3|Depot Stabilization Phase|Met Withdrawal Criteria|0
6032916|NCT00705783|20851368|P2|Depot Stabilization Phase|Met Withdrawal Criteria|0
6032917|NCT00705783|20851369|P1|Depot Stabilization Phase|Met Withdrawal Criteria|8
6032918|NCT00705783|20851367|P3|Depot Stabilization Phase|Lost to Follow-up|0
6032919|NCT00705783|20851368|P2|Depot Stabilization Phase|Lost to Follow-up|0
6032920|NCT00705783|20851369|P1|Depot Stabilization Phase|Lost to Follow-up|11
6032921|NCT00705783|20851367|P3|Depot Stabilization Phase|Sponsor Discontinued Study|0
6032922|NCT00705783|20851368|P2|Depot Stabilization Phase|Sponsor Discontinued Study|0
6032923|NCT00705783|20851369|P1|Depot Stabilization Phase|Sponsor Discontinued Study|86
6032924|NCT00705783|20851367|P3|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0
6032925|NCT00705783|20851368|P2|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0
6032926|NCT00705783|20851369|P1|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|4
6032927|NCT00705783|20851367|P3|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0
6032928|NCT00705783|20851368|P2|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0
6032929|NCT00705783|20851369|P1|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|7
6032930|NCT00705783|20851367|P3|Oral Stabilization Phase|Adverse Event|0
6032931|NCT00705783|20851368|P2|Oral Stabilization Phase|Adverse Event|0
6032932|NCT00705783|20851369|P1|Oral Stabilization Phase|Adverse Event|14
6032933|NCT00705783|20851367|P3|Oral Stabilization Phase|Withdrew Consent|0
6032934|NCT00705783|20851368|P2|Oral Stabilization Phase|Withdrew Consent|0
6032935|NCT00705783|20851369|P1|Oral Stabilization Phase|Withdrew Consent|29
6032936|NCT00705783|20851367|P3|Oral Stabilization Phase|Withdrawn by Investigator|0
6032937|NCT00705783|20851368|P2|Oral Stabilization Phase|Withdrawn by Investigator|0
6032938|NCT00705783|20851369|P1|Oral Stabilization Phase|Withdrawn by Investigator|12
6032939|NCT00705783|20851367|P3|Oral Stabilization Phase|Met Withdrawal Criteria|0
6032940|NCT00705783|20851368|P2|Oral Stabilization Phase|Met Withdrawal Criteria|0
6032941|NCT00705783|20851369|P1|Oral Stabilization Phase|Met Withdrawal Criteria|19
6032942|NCT00705783|20851367|P3|Oral Stabilization Phase|Lost to Follow-up|0
6032943|NCT00705783|20851368|P2|Oral Stabilization Phase|Lost to Follow-up|0
6032944|NCT00705783|20851369|P1|Oral Stabilization Phase|Lost to Follow-up|7
6032945|NCT00705783|20851367|P3|Oral Stabilization Phase|Sponsor Discontinue Study|0
6032946|NCT00705783|20851368|P2|Oral Stabilization Phase|Sponsor Discontinue Study|0
6032947|NCT00705783|20851369|P1|Oral Stabilization Phase|Sponsor Discontinue Study|42
6032948|NCT00705783|20851367|P3|Conversion Phase|Lack of Efficacy without Adverse Event|0
6032949|NCT00705783|20851368|P2|Conversion Phase|Lack of Efficacy without Adverse Event|0
6032950|NCT00705783|20851369|P1|Conversion Phase|Lack of Efficacy without Adverse Event|8
6032951|NCT00705783|20851367|P3|Conversion Phase|Lack of Efficacy with Adverse Event|0
6032952|NCT00705783|20851368|P2|Conversion Phase|Lack of Efficacy with Adverse Event|0
6032953|NCT00705783|20851369|P1|Conversion Phase|Lack of Efficacy with Adverse Event|13
6032954|NCT00705783|20851367|P3|Conversion Phase|Adverse Event|0
6032955|NCT00705783|20851368|P2|Conversion Phase|Adverse Event|0
6032956|NCT00705783|20851369|P1|Conversion Phase|Adverse Event|11
6032957|NCT00705783|20851367|P3|Conversion Phase|Protocol Deviation|0
6032958|NCT00705783|20851368|P2|Conversion Phase|Protocol Deviation|0
6032959|NCT00705783|20851369|P1|Conversion Phase|Protocol Deviation|2
6032960|NCT00705783|20851367|P3|Conversion Phase|Withdrew Consent|0
6032961|NCT00705783|20851368|P2|Conversion Phase|Withdrew Consent|0
6032962|NCT00705783|20851369|P1|Conversion Phase|Withdrew Consent|24
6032963|NCT00705783|20851367|P3|Conversion Phase|Withdrawn by Investigator|0
6032964|NCT00705783|20851368|P2|Conversion Phase|Withdrawn by Investigator|0
6032965|NCT00705783|20851369|P1|Conversion Phase|Withdrawn by Investigator|4
6032966|NCT00705783|20851367|P3|Conversion Phase|Met Withdrawal Criteria|0
6032967|NCT00705783|20851368|P2|Conversion Phase|Met Withdrawal Criteria|0
6032968|NCT00705783|20851369|P1|Conversion Phase|Met Withdrawal Criteria|4
6032969|NCT00705783|20851367|P3|Conversion Phase|Lost to Follow-up|0
6032970|NCT00705783|20851368|P2|Conversion Phase|Lost to Follow-up|0
6032971|NCT00705783|20851369|P1|Conversion Phase|Lost to Follow-up|13
6032972|NCT00705783|20851367|P3|Conversion Phase|Sponsor Discontinued Study|0
6032973|NCT00705783|20851368|P2|Conversion Phase|Sponsor Discontinued Study|0
6032974|NCT00705783|20851369|P1|Conversion Phase|Sponsor Discontinued Study|54
6032975|NCT00705757|20851399|P3|Overall Study|Withdrawal by Subject|2
6032976|NCT00705757|20851400|P2|Overall Study|Withdrawal by Subject|1
6032977|NCT00705757|20851401|P1|Overall Study|Withdrawal by Subject|1
6032978|NCT00705757|20851399|P3|Overall Study|Lost to Follow-up|6
6032979|NCT00705757|20851400|P2|Overall Study|Lost to Follow-up|6
6032980|NCT00705757|20851401|P1|Overall Study|Lost to Follow-up|7
6032981|NCT00705757|20851399|P3|Overall Study|Lack of Efficacy|3
6032982|NCT00705757|20851400|P2|Overall Study|Lack of Efficacy|1
6032983|NCT00705757|20851401|P1|Overall Study|Lack of Efficacy|5
6032984|NCT00705718|20851411|P2|Overall Study|Follow up not done|4
6032985|NCT00705718|20851412|P1|Overall Study|Follow up not done|1
6032986|NCT00705718|20851411|P2|Overall Study|Not due for Visit|12
6032987|NCT00705718|20851412|P1|Overall Study|Not due for Visit|0
6032988|NCT00705718|20851411|P2|Overall Study|Death|6
6032989|NCT00705718|20851412|P1|Overall Study|Death|6
6032990|NCT00705679|20851433|P5|Overall Study|Withdrawal by Subject|33
6032991|NCT00705679|20851434|P4|Overall Study|Withdrawal by Subject|47
6032992|NCT00705679|20851435|P3|Overall Study|Withdrawal by Subject|68
6032993|NCT00705679|20851436|P2|Overall Study|Withdrawal by Subject|77
6032994|NCT00705679|20851437|P1|Overall Study|Withdrawal by Subject|32
6032995|NCT00705679|20851433|P5|Overall Study|Physician Decision|0
6032996|NCT00705679|20851434|P4|Overall Study|Physician Decision|1
6032997|NCT00705679|20851435|P3|Overall Study|Physician Decision|0
6032998|NCT00705679|20851436|P2|Overall Study|Physician Decision|1
6032999|NCT00705679|20851437|P1|Overall Study|Physician Decision|0
6033000|NCT00705679|20851433|P5|Overall Study|Lost to Follow-up|35
6033001|NCT00705679|20851434|P4|Overall Study|Lost to Follow-up|30
6033002|NCT00705679|20851435|P3|Overall Study|Lost to Follow-up|44
6033003|NCT00705679|20851436|P2|Overall Study|Lost to Follow-up|60
6033004|NCT00705679|20851437|P1|Overall Study|Lost to Follow-up|32
6033005|NCT00705679|20851433|P5|Overall Study|Death|1
6033006|NCT00705679|20851434|P4|Overall Study|Death|2
6033007|NCT00705679|20851435|P3|Overall Study|Death|3
6033008|NCT00705679|20851436|P2|Overall Study|Death|0
6033009|NCT00705679|20851437|P1|Overall Study|Death|0
6033010|NCT00705679|20851433|P5|Overall Study|Adverse Event|0
6033011|NCT00705679|20851434|P4|Overall Study|Adverse Event|0
6033012|NCT00705679|20851435|P3|Overall Study|Adverse Event|0
6033013|NCT00705679|20851436|P2|Overall Study|Adverse Event|1
6033014|NCT00705679|20851437|P1|Overall Study|Adverse Event|1
6033015|NCT00705666|20851472|P1|Overall Study|Untreated|5
6033016|NCT00705666|20851472|P1|Overall Study|Lack of data|3
6033017|NCT00705666|20851472|P1|Overall Study|Other|2
6033018|NCT00705666|20851472|P1|Overall Study|Other|12
6033019|NCT00705666|20851472|P1|Overall Study|Adverse Event|4
6033020|NCT00705666|20851472|P1|Overall Study|Death|1
6033021|NCT00705666|20851472|P1|Overall Study|Lost to Follow-up|5
6033022|NCT00705666|20851472|P1|Overall Study|Physician Decision|7
6033023|NCT00705666|20851472|P1|Overall Study|Withdrawal by Subject|21
6033024|NCT00705666|20851472|P1|Overall Study|No post-treatment questionnaire|279
6033025|NCT00705614|20851483|P2|Switch to Remicade|Administrative Reason|9
6033026|NCT00705614|20851484|P1|Switch to Remicade|Administrative Reason|0
6033027|NCT00705614|20851483|P2|Switch to Remicade|Withdrawal by Subject|12
6033028|NCT00705614|20851484|P1|Switch to Remicade|Withdrawal by Subject|0
6033029|NCT00705614|20851483|P2|Switch to Remicade|Lost to Follow-up|23
6033030|NCT00705614|20851484|P1|Switch to Remicade|Lost to Follow-up|0
6033031|NCT00705614|20851483|P2|Switch to Remicade|Adverse Event|5
6033032|NCT00705614|20851484|P1|Switch to Remicade|Adverse Event|0
6033033|NCT00705614|20851483|P2|Initial Intervention|Status completion unknown|0
6033034|NCT00705614|20851484|P1|Initial Intervention|Status completion unknown|3
6033035|NCT00705614|20851483|P2|Initial Intervention|Administrative Reason|38
6033036|NCT00705614|20851484|P1|Initial Intervention|Administrative Reason|51
6033037|NCT00705614|20851483|P2|Initial Intervention|Withdrawal by Subject|71
6033038|NCT00705614|20851484|P1|Initial Intervention|Withdrawal by Subject|114
6033039|NCT00705614|20851483|P2|Initial Intervention|Lost to Follow-up|191
6033040|NCT00705614|20851484|P1|Initial Intervention|Lost to Follow-up|310
6033041|NCT00705614|20851483|P2|Initial Intervention|Adverse Event|21
6033042|NCT00705614|20851484|P1|Initial Intervention|Adverse Event|40
6033043|NCT00705575|20851533|P2|Overall Study|Withdrawal by Subject|10
6033044|NCT00705575|20851534|P1|Overall Study|Withdrawal by Subject|5
6033045|NCT00705575|20851533|P2|Overall Study|Protocol Violation|2
6033046|NCT00705575|20851534|P1|Overall Study|Protocol Violation|2
6033047|NCT00705575|20851533|P2|Overall Study|Lost to Follow-up|4
6033048|NCT00705575|20851534|P1|Overall Study|Lost to Follow-up|3
6033049|NCT00705575|20851533|P2|Overall Study|Adverse Event|15
6033050|NCT00705575|20851534|P1|Overall Study|Adverse Event|11
6033051|NCT00705575|20851533|P2|Overall Study|Abnormal test procedure result(s)|12
6033052|NCT00705575|20851534|P1|Overall Study|Abnormal test procedure result(s)|2
6033053|NCT00705575|20851533|P2|Overall Study|Abnormal laboratory value(s)|3
6033054|NCT00705575|20851534|P1|Overall Study|Abnormal laboratory value(s)|0
6033055|NCT00705536|20851548|P4|Start Period 1|Withdrawal by Subject|1
6033056|NCT00705536|20851549|P3|Start Period 1|Withdrawal by Subject|0
6033057|NCT00705536|20851550|P2|Start Period 1|Withdrawal by Subject|0
6033058|NCT00705536|20851551|P1|Start Period 1|Withdrawal by Subject|0
6033059|NCT00705523|20851612|P2|Overall Study|Lost to Follow-up|3
6033060|NCT00705523|20851613|P1|Overall Study|Lost to Follow-up|2
6033061|NCT00705484|20851623|P2|Overall Study|Administrative|59
6033062|NCT00705484|20851624|P1|Overall Study|Administrative|89
6033063|NCT00705484|20851623|P2|Overall Study|Withdrawal by Subject|72
6033064|NCT00705484|20851624|P1|Overall Study|Withdrawal by Subject|96
6033065|NCT00705484|20851623|P2|Overall Study|Lost to Follow-up|250
6033066|NCT00705484|20851624|P1|Overall Study|Lost to Follow-up|169
6033067|NCT00705484|20851623|P2|Overall Study|Adverse Event|27
6033068|NCT00705484|20851624|P1|Overall Study|Adverse Event|28
6033069|NCT00705432|20851638|P6|Follow-up Period (Upto Week 72)|Non medical reason|7
6033070|NCT00705432|20851639|P5|Follow-up Period (Upto Week 72)|Non medical reason|6
6033071|NCT00705432|20851640|P4|Follow-up Period (Upto Week 72)|Non medical reason|14
6033072|NCT00705432|20851641|P3|Follow-up Period (Upto Week 72)|Non medical reason|24
6033073|NCT00705432|20851642|P2|Follow-up Period (Upto Week 72)|Non medical reason|42
6033074|NCT00705432|20851643|P1|Follow-up Period (Upto Week 72)|Non medical reason|69
6033075|NCT00705432|20851638|P6|Follow-up Period (Upto Week 72)|Adverse Event|0
6033076|NCT00705432|20851639|P5|Follow-up Period (Upto Week 72)|Adverse Event|0
6033077|NCT00705432|20851640|P4|Follow-up Period (Upto Week 72)|Adverse Event|0
6033078|NCT00705432|20851641|P3|Follow-up Period (Upto Week 72)|Adverse Event|1
6033079|NCT00705432|20851642|P2|Follow-up Period (Upto Week 72)|Adverse Event|1
6033080|NCT00705432|20851643|P1|Follow-up Period (Upto Week 72)|Adverse Event|2
6033081|NCT00705432|20851638|P6|Treatment Period|Non medical reason|7
6033082|NCT00705432|20851639|P5|Treatment Period|Non medical reason|7
6033083|NCT00705432|20851640|P4|Treatment Period|Non medical reason|4
6033084|NCT00705432|20851641|P3|Treatment Period|Non medical reason|37
6033085|NCT00705432|20851642|P2|Treatment Period|Non medical reason|32
6033086|NCT00705432|20851643|P1|Treatment Period|Non medical reason|26
6033087|NCT00705432|20851638|P6|Treatment Period|Treatment failure|14
6033088|NCT00705432|20851639|P5|Treatment Period|Treatment failure|13
6033089|NCT00705432|20851640|P4|Treatment Period|Treatment failure|25
6033090|NCT00705432|20851641|P3|Treatment Period|Treatment failure|33
6033091|NCT00705432|20851642|P2|Treatment Period|Treatment failure|42
6033092|NCT00705432|20851643|P1|Treatment Period|Treatment failure|92
6033093|NCT00705432|20851638|P6|Treatment Period|Adverse Event|9
6033094|NCT00705432|20851639|P5|Treatment Period|Adverse Event|8
6033095|NCT00705432|20851640|P4|Treatment Period|Adverse Event|12
6033096|NCT00705432|20851641|P3|Treatment Period|Adverse Event|51
6033097|NCT00705432|20851642|P2|Treatment Period|Adverse Event|37
6033098|NCT00705432|20851643|P1|Treatment Period|Adverse Event|45
6033099|NCT00705406|20851680|P2|Overall Study|Did not receive study drug|2
6033100|NCT00705406|20851681|P1|Overall Study|Did not receive study drug|1
6033101|NCT00705406|20851680|P2|Overall Study|Lost to Follow-up|3
6033102|NCT00705406|20851681|P1|Overall Study|Lost to Follow-up|3
6033103|NCT00705367|20851705|P2|Long-term Extension Period|Administrative reason by sponsor|0
6033104|NCT00705367|20851706|P1|Long-term Extension Period|Administrative reason by sponsor|3
6033105|NCT00705367|20851705|P2|Long-term Extension Period|No longer met study criteria|0
6033106|NCT00705367|20851706|P1|Long-term Extension Period|No longer met study criteria|1
6033107|NCT00705367|20851705|P2|Long-term Extension Period|Lack of Efficacy|0
6033108|NCT00705367|20851706|P1|Long-term Extension Period|Lack of Efficacy|1
6033109|NCT00705367|20851705|P2|Long-term Extension Period|Withdrawal by Subject|0
6033110|NCT00705367|20851706|P1|Long-term Extension Period|Withdrawal by Subject|2
6033111|NCT00705367|20851705|P2|Long-term Extension Period|Adverse Event|0
6033112|NCT00705367|20851706|P1|Long-term Extension Period|Adverse Event|2
6033113|NCT00705341|20851733|P4|Phase 2: Trial|Did not meet post-diluent threshold|0
6033114|NCT00705341|20851734|P3|Phase 2: Trial|Did not meet post-diluent threshold|1
6033115|NCT00705341|20851735|P2|Phase 2: Trial|Did not meet post-diluent threshold|0
6033116|NCT00705341|20851736|P1|Phase 2: Trial|Did not meet post-diluent threshold|0
6033117|NCT00705341|20851733|P4|Phase 2: Trial|Withdrawal by Subject|4
6033118|NCT00705341|20851734|P3|Phase 2: Trial|Withdrawal by Subject|6
6033119|NCT00705341|20851735|P2|Phase 2: Trial|Withdrawal by Subject|0
6033120|NCT00705341|20851736|P1|Phase 2: Trial|Withdrawal by Subject|0
6033121|NCT00705289|20851744|P1|Overall Study|Subject or treating physician's choice|131
6033122|NCT00705263|20851768|P1|Overall Study|Withdrawal by Subject|2
6033123|NCT00705250|20851772|P1|Overall Study|Patient died in car accident|1
6033124|NCT00705250|20851772|P1|Overall Study|Withdrawal by Subject|1
6033125|NCT00705224|20851776|P1|Overall Study|Lost to Follow-up|5
6033126|NCT00705224|20851776|P1|Overall Study|Withdrawal by Subject|3
6033127|NCT00705224|20851776|P1|Overall Study|Lack of Efficacy|2
6033128|NCT00705224|20851776|P1|Overall Study|Adverse Event|1
6033129|NCT00705159|20851792|P4|Overall Study|Screen Failure|1
6033130|NCT00705159|20851793|P3|Overall Study|Screen Failure|0
6033131|NCT00705159|20851794|P2|Overall Study|Screen Failure|0
6033132|NCT00705159|20851795|P1|Overall Study|Screen Failure|0
6033133|NCT00705159|20851792|P4|Overall Study|Lost to Follow-up|2
6033134|NCT00705159|20851793|P3|Overall Study|Lost to Follow-up|3
6033135|NCT00705159|20851794|P2|Overall Study|Lost to Follow-up|0
6033136|NCT00705159|20851795|P1|Overall Study|Lost to Follow-up|0
6033137|NCT00705159|20851792|P4|Overall Study|Adverse Event|0
6033138|NCT00705159|20851793|P3|Overall Study|Adverse Event|1
6033139|NCT00705159|20851794|P2|Overall Study|Adverse Event|0
6033140|NCT00705159|20851795|P1|Overall Study|Adverse Event|0
6033141|NCT00705159|20851792|P4|Overall Study|Protocol Violation|0
6033142|NCT00705159|20851793|P3|Overall Study|Protocol Violation|0
6033143|NCT00705159|20851794|P2|Overall Study|Protocol Violation|1
6033144|NCT00705159|20851795|P1|Overall Study|Protocol Violation|0
6033145|NCT00705159|20851792|P4|Overall Study|Withdrawal by Subject|1
6033146|NCT00705159|20851793|P3|Overall Study|Withdrawal by Subject|1
6033147|NCT00705159|20851794|P2|Overall Study|Withdrawal by Subject|1
6033148|NCT00705159|20851795|P1|Overall Study|Withdrawal by Subject|0
6033149|NCT00705146|20851815|P2|Overall Study|Lost to Follow-up|1
6033150|NCT00705146|20851816|P1|Overall Study|Lost to Follow-up|1
6033151|NCT00705016|20851852|P3|Overall Study|Other|6
6033152|NCT00705016|20851853|P2|Overall Study|Other|6
6033153|NCT00705016|20851854|P1|Overall Study|Other|9
6033154|NCT00705016|20851852|P3|Overall Study|Symptomatic Deterioration|1
6033155|NCT00705016|20851853|P2|Overall Study|Symptomatic Deterioration|1
6033156|NCT00705016|20851854|P1|Overall Study|Symptomatic Deterioration|3
6033157|NCT00705016|20851852|P3|Overall Study|Progressive Disease|33
6033158|NCT00705016|20851853|P2|Overall Study|Progressive Disease|29
6033159|NCT00705016|20851854|P1|Overall Study|Progressive Disease|33
6033160|NCT00705016|20851852|P3|Overall Study|Withdrawal by Subject|2
6033161|NCT00705016|20851853|P2|Overall Study|Withdrawal by Subject|3
6033162|NCT00705016|20851854|P1|Overall Study|Withdrawal by Subject|4
6033163|NCT00705016|20851852|P3|Overall Study|Protocol Violation|1
6033164|NCT00705016|20851853|P2|Overall Study|Protocol Violation|1
6033165|NCT00705016|20851854|P1|Overall Study|Protocol Violation|0
6033166|NCT00705016|20851852|P3|Overall Study|Death|5
6033167|NCT00705016|20851853|P2|Overall Study|Death|7
6033168|NCT00705016|20851854|P1|Overall Study|Death|5
6033169|NCT00705016|20851852|P3|Overall Study|Adverse Event|10
6033170|NCT00705016|20851853|P2|Overall Study|Adverse Event|11
6033171|NCT00705016|20851854|P1|Overall Study|Adverse Event|6
6033172|NCT00704964|20851905|P1|Overall Study|Not completed on time|328
6033173|NCT00704808|20851966|P1|Overall Study|Treatment change|1
6033174|NCT00704808|20851966|P1|Overall Study|Lost to Follow-up|1
6033175|NCT00704808|20851966|P1|Overall Study|Adverse Event|1
6033176|NCT00704808|20851966|P1|Overall Study|Early therapy discontinuation|16
6033177|NCT00704808|20851966|P1|Overall Study|Patient's decision|11
6033178|NCT00704808|20851966|P1|Overall Study|Tumor progression|80
6033179|NCT00704808|20851966|P1|Overall Study|Death|7
6033180|NCT00704808|20851966|P1|Overall Study|Discontinued prior to starting treatment|14
6033181|NCT00704730|20851977|P2|Overall Study|Withdrawal by Subject|13
6033182|NCT00704730|20851978|P1|Overall Study|Withdrawal by Subject|9
6033183|NCT00704730|20851977|P2|Overall Study|data unavailable|0
6033184|NCT00704730|20851978|P1|Overall Study|data unavailable|1
6033185|NCT00704730|20851977|P2|Overall Study|Disease progression per PI|67
6033186|NCT00704730|20851978|P1|Overall Study|Disease progression per PI|58
6033187|NCT00704730|20851977|P2|Overall Study|Did not receive drug|2
6033188|NCT00704730|20851978|P1|Overall Study|Did not receive drug|5
6033189|NCT00704730|20851977|P2|Overall Study|Physician Decision|0
6033190|NCT00704730|20851978|P1|Overall Study|Physician Decision|2
6033191|NCT00704730|20851977|P2|Overall Study|Death|5
6033192|NCT00704730|20851978|P1|Overall Study|Death|11
6033193|NCT00704730|20851977|P2|Overall Study|Adverse Event|9
6033194|NCT00704730|20851978|P1|Overall Study|Adverse Event|35
6033195|NCT00704535|20851998|P1|Overall Study|Completed status not on Case Report Form|124
6033196|NCT00704535|20851998|P1|Overall Study|Protocol Violation|10
6033197|NCT00704535|20851998|P1|Overall Study|Lost to Follow-up|8
6033198|NCT00704535|20851998|P1|Overall Study|Death|2
6033199|NCT00704535|20851998|P1|Overall Study|Adverse Event|2
6033200|NCT00704522|20852011|P2|Overall Study|No information on therapy end|2
6033201|NCT00704522|20852012|P1|Overall Study|No information on therapy end|27
6033202|NCT00704522|20852011|P2|Overall Study|Undefined causes|7
6033203|NCT00704522|20852012|P1|Overall Study|Undefined causes|9
6033204|NCT00704522|20852011|P2|Overall Study|Adverse Event|1
6033205|NCT00704522|20852012|P1|Overall Study|Adverse Event|9
6033206|NCT00704522|20852011|P2|Overall Study|Withdrawal by Subject|8
6033207|NCT00704522|20852012|P1|Overall Study|Withdrawal by Subject|17
6033208|NCT00704522|20852011|P2|Overall Study|Failure to appear again at hospital|10
6033209|NCT00704522|20852012|P1|Overall Study|Failure to appear again at hospital|56
6033210|NCT00704522|20852011|P2|Overall Study|Lack of Efficacy|17
6033211|NCT00704522|20852012|P1|Overall Study|Lack of Efficacy|65
6033212|NCT00704418|20852032|P2|Overall Study|Over-enrolled/surgery postponed|6
6033213|NCT00704418|20852033|P1|Overall Study|Over-enrolled/surgery postponed|3
6033214|NCT00704418|20852032|P2|Overall Study|Withdrawal by Subject|0
6033215|NCT00704418|20852033|P1|Overall Study|Withdrawal by Subject|2
6033216|NCT00704405|20852046|P5|Overall Study (C Population)|Lost to Follow-up|0
6033217|NCT00704405|20852047|P4|Overall Study (C Population)|Lost to Follow-up|0
6033218|NCT00704405|20852048|P3|Overall Study (C Population)|Lost to Follow-up|0
6033219|NCT00704405|20852049|P2|Overall Study (C Population)|Lost to Follow-up|2
6033220|NCT00704405|20852050|P1|Overall Study (C Population)|Lost to Follow-up|0
6033221|NCT00704405|20852046|P5|Overall Study (C Population)|Withdrawal by Subject|0
6033222|NCT00704405|20852047|P4|Overall Study (C Population)|Withdrawal by Subject|1
6033223|NCT00704405|20852048|P3|Overall Study (C Population)|Withdrawal by Subject|1
6033224|NCT00704405|20852049|P2|Overall Study (C Population)|Withdrawal by Subject|1
6033225|NCT00704405|20852050|P1|Overall Study (C Population)|Withdrawal by Subject|1
6033226|NCT00704405|20852046|P5|Overall Study (NC Population)|Other|1
6033227|NCT00704405|20852047|P4|Overall Study (NC Population)|Other|0
6033228|NCT00704405|20852048|P3|Overall Study (NC Population)|Other|0
6033229|NCT00704405|20852049|P2|Overall Study (NC Population)|Other|0
6033230|NCT00704405|20852050|P1|Overall Study (NC Population)|Other|0
6033231|NCT00704405|20852046|P5|Overall Study (NC Population)|Withdrawal by Subject|2
6033232|NCT00704405|20852047|P4|Overall Study (NC Population)|Withdrawal by Subject|2
6033233|NCT00704405|20852048|P3|Overall Study (NC Population)|Withdrawal by Subject|2
6033234|NCT00704405|20852049|P2|Overall Study (NC Population)|Withdrawal by Subject|3
6033235|NCT00704405|20852050|P1|Overall Study (NC Population)|Withdrawal by Subject|2
6033236|NCT00704405|20852046|P5|Overall Study (NC Population)|Lost to Follow-up|2
6033237|NCT00704405|20852047|P4|Overall Study (NC Population)|Lost to Follow-up|2
6033238|NCT00704405|20852048|P3|Overall Study (NC Population)|Lost to Follow-up|1
6033239|NCT00704405|20852049|P2|Overall Study (NC Population)|Lost to Follow-up|1
6033240|NCT00704405|20852050|P1|Overall Study (NC Population)|Lost to Follow-up|2
6033241|NCT00704405|20852046|P5|Overall Study (NC Population)|Adverse Event|0
6033242|NCT00704405|20852047|P4|Overall Study (NC Population)|Adverse Event|0
6033243|NCT00704405|20852048|P3|Overall Study (NC Population)|Adverse Event|0
6033244|NCT00704405|20852049|P2|Overall Study (NC Population)|Adverse Event|0
6033245|NCT00704405|20852050|P1|Overall Study (NC Population)|Adverse Event|1
6033246|NCT00704340|20852108|P2|Overall Study|Death|1
6033247|NCT00704340|20852109|P1|Overall Study|Death|0
6033248|NCT00704340|20852108|P2|Overall Study|Lost to Follow-up|1
6033249|NCT00704340|20852109|P1|Overall Study|Lost to Follow-up|2
6033250|NCT00704184|20852140|P5|Open-Label Treatment|Withdrawal by Subject|0
6033251|NCT00704184|20852141|P4|Open-Label Treatment|Withdrawal by Subject|3
6033252|NCT00704184|20852142|P3|Open-Label Treatment|Withdrawal by Subject|0
6033253|NCT00704184|20852143|P2|Open-Label Treatment|Withdrawal by Subject|0
6033254|NCT00704184|20852144|P1|Open-Label Treatment|Withdrawal by Subject|1
6033255|NCT00704184|20852140|P5|Open-Label Treatment|Physician Decision|1
6033256|NCT00704184|20852141|P4|Open-Label Treatment|Physician Decision|0
6033257|NCT00704184|20852142|P3|Open-Label Treatment|Physician Decision|0
6033258|NCT00704184|20852143|P2|Open-Label Treatment|Physician Decision|0
6033259|NCT00704184|20852144|P1|Open-Label Treatment|Physician Decision|0
6033260|NCT00704184|20852140|P5|Open-Label Treatment|Lack of Efficacy|1
6033261|NCT00704184|20852141|P4|Open-Label Treatment|Lack of Efficacy|2
6033262|NCT00704184|20852142|P3|Open-Label Treatment|Lack of Efficacy|2
6033263|NCT00704184|20852143|P2|Open-Label Treatment|Lack of Efficacy|2
6033264|NCT00704184|20852144|P1|Open-Label Treatment|Lack of Efficacy|0
6033265|NCT00704184|20852140|P5|Open-Label Treatment|Adverse Event|1
6033266|NCT00704184|20852141|P4|Open-Label Treatment|Adverse Event|0
6033267|NCT00704184|20852142|P3|Open-Label Treatment|Adverse Event|2
6033268|NCT00704184|20852143|P2|Open-Label Treatment|Adverse Event|0
6033269|NCT00704184|20852144|P1|Open-Label Treatment|Adverse Event|0
6033270|NCT00704184|20852140|P5|Double-Blind Treatment|Withdrawal by Subject|0
6033271|NCT00704184|20852141|P4|Double-Blind Treatment|Withdrawal by Subject|0
6033272|NCT00704184|20852142|P3|Double-Blind Treatment|Withdrawal by Subject|0
6033273|NCT00704184|20852143|P2|Double-Blind Treatment|Withdrawal by Subject|0
6033274|NCT00704184|20852144|P1|Double-Blind Treatment|Withdrawal by Subject|1
6033275|NCT00704171|20852183|P2|Overall Study|Withdrawal by Subject|0
6033276|NCT00704171|20852184|P1|Overall Study|Withdrawal by Subject|1
6033277|NCT00704132|20852202|P2|Overall Study|Withdrawal by Subject|1
6033278|NCT00704132|20852203|P1|Overall Study|Withdrawal by Subject|0
6033279|NCT00704132|20852202|P2|Overall Study|Lack of Efficacy|1
6033280|NCT00704132|20852203|P1|Overall Study|Lack of Efficacy|0
6033281|NCT00704132|20852202|P2|Overall Study|Clinical Adverse Experience|0
6033282|NCT00704132|20852203|P1|Overall Study|Clinical Adverse Experience|1
6033283|NCT00703963|20852231|P2|Overall Study|Physician Decision|1
6033284|NCT00703963|20852232|P1|Overall Study|Physician Decision|0
6033285|NCT00703963|20852231|P2|Overall Study|Withdrawal by Subject|13
6033286|NCT00703963|20852232|P1|Overall Study|Withdrawal by Subject|7
6033287|NCT00703924|20852253|P2|Overall Study|Withdrawal by Subject|1
6033288|NCT00703924|20852254|P1|Overall Study|Withdrawal by Subject|1
6033289|NCT00703911|20852270|P1|Overall Study|Withdrawal by Subject|2
6033290|NCT00703911|20852270|P1|Overall Study|Lost to Follow-up|1
6033291|NCT00703911|20852270|P1|Overall Study|Physician Decision|6
6033292|NCT00703911|20852270|P1|Overall Study|Death|1
6033293|NCT00703846|20852303|P1|Overall Study|Did Not Receive Study Drug|2
6033294|NCT00703846|20852303|P1|Overall Study|Other|14
6033295|NCT00703846|20852303|P1|Overall Study|Death|1
6033296|NCT00703846|20852303|P1|Overall Study|Withdrawal by Subject|40
6033297|NCT00703846|20852303|P1|Overall Study|Noncompliance with Study Treatment|2
6033298|NCT00703846|20852303|P1|Overall Study|Lack of Efficacy|15
6033299|NCT00703846|20852303|P1|Overall Study|Lost to Follow-up|55
6033300|NCT00703846|20852303|P1|Overall Study|Adverse Event|8
6033301|NCT00703820|20852319|P2|Overall Study|Withdrawal by Subject|1
6033302|NCT00703820|20852320|P1|Overall Study|Withdrawal by Subject|2
6033303|NCT00703820|20852319|P2|Overall Study|Physician Decision|5
6033304|NCT00703820|20852320|P1|Overall Study|Physician Decision|4
6033305|NCT00703820|20852319|P2|Overall Study|Received non-protocol therapy|0
6033306|NCT00703820|20852320|P1|Overall Study|Received non-protocol therapy|1
6033307|NCT00703820|20852319|P2|Overall Study|Lack of Efficacy|11
6033308|NCT00703820|20852320|P1|Overall Study|Lack of Efficacy|11
6033309|NCT00703820|20852319|P2|Overall Study|Death|0
6033310|NCT00703820|20852320|P1|Overall Study|Death|5
6033311|NCT00703820|20852319|P2|Overall Study|Adverse Event|17
6033312|NCT00703820|20852320|P1|Overall Study|Adverse Event|12
6033313|NCT00703781|20852329|P2|Overall Study|Cancelled surgery|0
6033314|NCT00703781|20852330|P1|Overall Study|Cancelled surgery|1
6033315|NCT00703781|20852329|P2|Overall Study|Withdrawal by Subject|2
6033316|NCT00703781|20852330|P1|Overall Study|Withdrawal by Subject|1
6033317|NCT00703677|20852375|P1|Overall Study|Dropout-withdrawal not related to drug|3
6033318|NCT00703534|20852415|P2|Overall Study|Severe Non Compliance|5
6033319|NCT00703534|20852416|P1|Overall Study|Severe Non Compliance|1
6033320|NCT00703534|20852415|P2|Overall Study|Lost to Follow-up|4
6033321|NCT00703534|20852416|P1|Overall Study|Lost to Follow-up|1
6033322|NCT00703534|20852415|P2|Overall Study|Incorrect Enrollment|6
6033323|NCT00703534|20852416|P1|Overall Study|Incorrect Enrollment|6
6033324|NCT00703534|20852415|P2|Overall Study|Withdrawal by Subject|7
6033325|NCT00703534|20852416|P1|Overall Study|Withdrawal by Subject|8
6033326|NCT00703534|20852415|P2|Overall Study|Adverse Event|3
6033327|NCT00703534|20852416|P1|Overall Study|Adverse Event|14
6033328|NCT00703326|20852488|P2|Overall Study|Withdrawal by Subject|20
6033329|NCT00703326|20852489|P1|Overall Study|Withdrawal by Subject|42
6033330|NCT00703326|20852488|P2|Overall Study|Lost to Follow-up|8
6033331|NCT00703326|20852489|P1|Overall Study|Lost to Follow-up|25
6033332|NCT00703326|20852488|P2|Overall Study|Still on study|197
6033333|NCT00703326|20852489|P1|Overall Study|Still on study|380
6033334|NCT00703157|20852521|P2|Overall Study|source data permanently lost/ other|1
6033335|NCT00703157|20852522|P1|Overall Study|source data permanently lost/ other|4
6033336|NCT00703157|20852521|P2|Overall Study|Lost to Follow-up|1
6033337|NCT00703157|20852522|P1|Overall Study|Lost to Follow-up|0
6033338|NCT00703118|20852556|P3|Overall Study|Other|1
6033339|NCT00703118|20852557|P2|Overall Study|Other|0
6033340|NCT00703118|20852558|P1|Overall Study|Other|0
6033341|NCT00703118|20852556|P3|Overall Study|Withdrawal by Subject|13
6033342|NCT00703118|20852557|P2|Overall Study|Withdrawal by Subject|7
6033343|NCT00703118|20852558|P1|Overall Study|Withdrawal by Subject|8
6033344|NCT00703118|20852556|P3|Overall Study|Lost to Follow-up|4
6033345|NCT00703118|20852557|P2|Overall Study|Lost to Follow-up|4
6033346|NCT00703118|20852558|P1|Overall Study|Lost to Follow-up|6
6033347|NCT00703118|20852556|P3|Overall Study|Subject Ineligible To Continue The Trial|2
6033348|NCT00703118|20852557|P2|Overall Study|Subject Ineligible To Continue The Trial|3
6033349|NCT00703118|20852558|P1|Overall Study|Subject Ineligible To Continue The Trial|6
6033350|NCT00703118|20852556|P3|Overall Study|Adverse Event|2
6033351|NCT00703118|20852557|P2|Overall Study|Adverse Event|2
6033352|NCT00703118|20852558|P1|Overall Study|Adverse Event|1
6033353|NCT00703092|20852589|P1|Overall Study|Withdrawal by Subject|2
6033354|NCT00703014|20852797|P4|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|42
6033355|NCT00703014|20852798|P3|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|47
6033356|NCT00703014|20852799|P2|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0
6033357|NCT00703014|20852800|P1|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0
6033358|NCT00703014|20852797|P4|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0
6033359|NCT00703014|20852798|P3|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0
6033360|NCT00703014|20852799|P2|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|32
6033361|NCT00703014|20852800|P1|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|33
6033362|NCT00702962|20852820|P2|Overall Study|Hospitalized for other health disorder|0
6033363|NCT00702962|20852821|P1|Overall Study|Hospitalized for other health disorder|1
6033364|NCT00702962|20852820|P2|Overall Study|Progressive disease|1
6033365|NCT00702962|20852821|P1|Overall Study|Progressive disease|0
6033366|NCT00702949|20852832|P3|Overall Study|Other Medical Reason/unknown|3
6033367|NCT00702949|20852833|P2|Overall Study|Other Medical Reason/unknown|1
6033368|NCT00702949|20852834|P1|Overall Study|Other Medical Reason/unknown|1
6033369|NCT00702949|20852832|P3|Overall Study|Adverse Event|3
6033370|NCT00702949|20852833|P2|Overall Study|Adverse Event|6
6033371|NCT00702949|20852834|P1|Overall Study|Adverse Event|1
6033372|NCT00702949|20852832|P3|Overall Study|Refusal|2
6033373|NCT00702949|20852833|P2|Overall Study|Refusal|2
6033374|NCT00702949|20852834|P1|Overall Study|Refusal|3
6033375|NCT00702923|20852859|P1|Overall Study|Adverse Event|1
6033376|NCT00702845|20852882|P2|Overall Study|Not randomized|1
6033377|NCT00702845|20852883|P1|Overall Study|Not randomized|0
6033378|NCT00702845|20852882|P2|Overall Study|Patient's decision|1
6033379|NCT00702845|20852883|P1|Overall Study|Patient's decision|2
6033380|NCT00702845|20852882|P2|Overall Study|No or abnormal fertilization|2
6033381|NCT00702845|20852883|P1|Overall Study|No or abnormal fertilization|4
6033382|NCT00702845|20852882|P2|Overall Study|No/too few/bad quality embryos retrieved|1
6033383|NCT00702845|20852883|P1|Overall Study|No/too few/bad quality embryos retrieved|7
6033384|NCT00702845|20852882|P2|Overall Study|Insufficient ovarian response|0
6033385|NCT00702845|20852883|P1|Overall Study|Insufficient ovarian response|1
6033386|NCT00702845|20852882|P2|Overall Study|Risk of ovarian hyperstimulation synd.|0
6033387|NCT00702845|20852883|P1|Overall Study|Risk of ovarian hyperstimulation synd.|1
6033388|NCT00702845|20852882|P2|Overall Study|Too high ovarian response|1
6033389|NCT00702845|20852883|P1|Overall Study|Too high ovarian response|5
6033390|NCT00702845|20852882|P2|Overall Study|No/too few/bad quality oocytes retrieved|2
6033391|NCT00702845|20852883|P1|Overall Study|No/too few/bad quality oocytes retrieved|2
6033392|NCT00702715|20852945|P2|Overall Study|Lost to Follow-up|0
6033393|NCT00702715|20852946|P1|Overall Study|Lost to Follow-up|1
6033394|NCT00702702|20852959|P1|Overall Study|Study prematurely terminated|56
6033395|NCT00702689|20852967|P1|Overall Study|Adverse Event|1
6033396|NCT00702689|20852967|P1|Overall Study|Recurrent malignancy|1
6033397|NCT00702689|20852967|P1|Overall Study|Withdrawal by Subject|4
6033398|NCT00702650|20852978|P1|Overall Study|Adverse Event|3
6033399|NCT00702650|20852978|P1|Overall Study|Screening Testosterone Levels >300 ng/dL|1
6033400|NCT00702650|20852978|P1|Overall Study|Sponsor Request|1
6033401|NCT00702650|20852978|P1|Overall Study|Non-Compliance with Site Directives|1
6033402|NCT00702650|20852978|P1|Overall Study|Lost to Follow-up|2
6033403|NCT00702650|20852978|P1|Overall Study|Non-Compliance of Study Drug|3
6033404|NCT00702650|20852978|P1|Overall Study|Withdrawal by Subject|9
6033405|NCT00702520|20853040|P4|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0
6033406|NCT00702520|20853041|P3|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0
6033407|NCT00702520|20853042|P2|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|10
6033408|NCT00702520|20853043|P1|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|15
6033409|NCT00702520|20853040|P4|Base Study P05788 - Embryo Transfer|No embryo transfer|0
6033410|NCT00702520|20853041|P3|Base Study P05788 - Embryo Transfer|No embryo transfer|0
6033411|NCT00702520|20853042|P2|Base Study P05788 - Embryo Transfer|No embryo transfer|6
6033412|NCT00702520|20853043|P1|Base Study P05788 - Embryo Transfer|No embryo transfer|3
6033413|NCT00702520|20853040|P4|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0
6033414|NCT00702520|20853041|P3|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0
6033415|NCT00702520|20853042|P2|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|1
6033416|NCT00702520|20853043|P1|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0
6033417|NCT00702507|20853059|P1|Follow-up Phase|Late Enrollment|1
6033418|NCT00702507|20853059|P1|Follow-up Phase|Lost to Follow-up|23
6033419|NCT00702507|20853059|P1|Follow-up Phase|Protocol Violation|2
6033420|NCT00702507|20853059|P1|Follow-up Phase|Participant's Caretaker Withdrew Consent|1
6033421|NCT00702507|20853059|P1|Initial Treatment Phase|Negative Candida Culture|34
6033422|NCT00702507|20853059|P1|Initial Treatment Phase|Lost to Follow-up|2
6033423|NCT00702507|20853059|P1|Initial Treatment Phase|Participant's Caretaker Withdrew Consent|3
6033424|NCT00702507|20853059|P1|Initial Treatment Phase|Adverse Event|2
6033425|NCT00702403|20853096|P1|From Engraftment to Study Completion|Toxicity attributed to Nilotinib|5
6033426|NCT00702403|20853096|P1|From Engraftment to Study Completion|Dyspnea (unrelated to nilotinib)|1
6033427|NCT00702403|20853096|P1|From Engraftment to Study Completion|Acute respiratory distress syndrome|1
6033428|NCT00702403|20853096|P1|From Engraftment to Study Completion|Suicide|1
6033429|NCT00702403|20853096|P1|From Engraftment to Study Completion|Liver GVHD|1
6033430|NCT00702403|20853096|P1|From Engraftment to Study Completion|Adenocarcinoma|1
6033431|NCT00702403|20853096|P1|From Engraftment to Study Completion|Non-compliance|2
6033432|NCT00702403|20853096|P1|From Engraftment to Study Completion|Relapse (1 Central Nervous System, 3 BM)|4
6033433|NCT00702403|20853096|P1|From Engraftment to Study Completion|Failed pre-1st dose criteria|11
6033434|NCT00702403|20853096|P1|From Consent to Engraftment|Miscellaneous (unanticipated) other|2
6033435|NCT00702403|20853096|P1|From Consent to Engraftment|ANC<1500, plts<20K or hyperbilirubinemia|4
6033436|NCT00702403|20853096|P1|From Consent to Engraftment|Myocardial infarction|1
6033437|NCT00702403|20853096|P1|From Consent to Engraftment|Corrected QT interval (QTc) >450 msec|2
6033438|NCT00702403|20853096|P1|From Consent to Engraftment|Critically ill|2
6033439|NCT00702403|20853096|P1|From Consent to Engraftment|Progressive leukemia|6
6033440|NCT00702325|20853150|P2|Overall Study|Incorrectly Discontinued|1
6033441|NCT00702325|20853151|P1|Overall Study|Incorrectly Discontinued|0
6033442|NCT00702325|20853150|P2|Overall Study|Withdrew consent|1
6033443|NCT00702325|20853151|P1|Overall Study|Withdrew consent|0
6033444|NCT00702325|20853150|P2|Overall Study|Didn't follow study medication dosage|2
6033445|NCT00702325|20853151|P1|Overall Study|Didn't follow study medication dosage|0
6033446|NCT00702325|20853150|P2|Overall Study|Termination due to lab results|0
6033447|NCT00702325|20853151|P1|Overall Study|Termination due to lab results|1
6033448|NCT00702325|20853150|P2|Overall Study|Severe noncompliance to protocol|3
6033449|NCT00702325|20853151|P1|Overall Study|Severe noncompliance to protocol|3
6033450|NCT00702325|20853150|P2|Overall Study|Developed study discontinuation criteria|28
6033451|NCT00702325|20853151|P1|Overall Study|Developed study discontinuation criteria|18
6033452|NCT00702325|20853150|P2|Overall Study|Incorrect enrollment|7
6033453|NCT00702325|20853151|P1|Overall Study|Incorrect enrollment|5
6033454|NCT00702325|20853150|P2|Overall Study|Lost to Follow-up|4
6033455|NCT00702325|20853151|P1|Overall Study|Lost to Follow-up|3
6033456|NCT00702325|20853150|P2|Overall Study|Withdrawal by Subject|7
6033457|NCT00702325|20853151|P1|Overall Study|Withdrawal by Subject|7
6033458|NCT00702325|20853150|P2|Overall Study|Adverse Event|0
6033459|NCT00702325|20853151|P1|Overall Study|Adverse Event|1
6033460|NCT00702221|20853247|P2|Overall Study|Adverse Event|3
6033461|NCT00702221|20853248|P1|Overall Study|Adverse Event|4
6033462|NCT00702208|20853254|P1|Overall Study|Unsatisfactory colposcopy|2
6033463|NCT00702208|20853254|P1|Overall Study|Did not self-lavage|1
6033464|NCT00702208|20853254|P1|Overall Study|Lost to Follow-up|28
6033465|NCT00702143|20853263|P3|Overall Study|Lost to Follow-up|1
6033466|NCT00702143|20853264|P2|Overall Study|Lost to Follow-up|0
6033467|NCT00702143|20853265|P1|Overall Study|Lost to Follow-up|0
6033468|NCT00701805|20853325|P4|Overall Study|Resumption criteria were not met|0
6033469|NCT00701805|20853326|P3|Overall Study|Resumption criteria were not met|0
6033470|NCT00701805|20853327|P2|Overall Study|Resumption criteria were not met|1
6033471|NCT00701805|20853328|P1|Overall Study|Resumption criteria were not met|0
6033472|NCT00701805|20853325|P4|Overall Study|Difficult to travel to dialysis site|0
6033473|NCT00701805|20853326|P3|Overall Study|Difficult to travel to dialysis site|1
6033474|NCT00701805|20853327|P2|Overall Study|Difficult to travel to dialysis site|0
6033475|NCT00701805|20853328|P1|Overall Study|Difficult to travel to dialysis site|0
6033476|NCT00701805|20853325|P4|Overall Study|Physician decision, change of therapy|1
6033477|NCT00701805|20853326|P3|Overall Study|Physician decision, change of therapy|0
6033478|NCT00701805|20853327|P2|Overall Study|Physician decision, change of therapy|0
6033479|NCT00701805|20853328|P1|Overall Study|Physician decision, change of therapy|0
6033480|NCT00701805|20853325|P4|Overall Study|Admitted to hospital for 2 weeks|0
6033481|NCT00701805|20853326|P3|Overall Study|Admitted to hospital for 2 weeks|1
6033482|NCT00701805|20853327|P2|Overall Study|Admitted to hospital for 2 weeks|0
6033483|NCT00701805|20853328|P1|Overall Study|Admitted to hospital for 2 weeks|0
6033484|NCT00701805|20853325|P4|Overall Study|Missed 7 consecutive doses|0
6033485|NCT00701805|20853326|P3|Overall Study|Missed 7 consecutive doses|0
6033486|NCT00701805|20853327|P2|Overall Study|Missed 7 consecutive doses|1
6033487|NCT00701805|20853328|P1|Overall Study|Missed 7 consecutive doses|0
6033488|NCT00701805|20853325|P4|Overall Study|Adverse Event|0
6033489|NCT00701805|20853326|P3|Overall Study|Adverse Event|1
6033490|NCT00701805|20853327|P2|Overall Study|Adverse Event|1
6033491|NCT00701805|20853328|P1|Overall Study|Adverse Event|0
6033492|NCT00701805|20853325|P4|Overall Study|Withdrawal by Subject|3
6033493|NCT00701805|20853326|P3|Overall Study|Withdrawal by Subject|4
6033494|NCT00701805|20853327|P2|Overall Study|Withdrawal by Subject|1
6033495|NCT00701805|20853328|P1|Overall Study|Withdrawal by Subject|3
6033496|NCT00701779|20853378|P1|Overall Study|Withdrawal by Subject|2
6033497|NCT00701779|20853378|P1|Overall Study|Lost to Follow-up|1
6033498|NCT00701779|20853378|P1|Overall Study|Adverse Event|6
6033499|NCT00701727|20853390|P2|Second Treatment Period|Withdrawal by Subject|0
6033500|NCT00701727|20853391|P1|Second Treatment Period|Withdrawal by Subject|2
6033501|NCT00701727|20853390|P2|First Treatment Period|Lost to Follow-up|1
6033502|NCT00701727|20853391|P1|First Treatment Period|Lost to Follow-up|0
6033503|NCT00701727|20853390|P2|First Treatment Period|sponsor decision|1
6033504|NCT00701727|20853391|P1|First Treatment Period|sponsor decision|0
6033505|NCT00701727|20853390|P2|First Treatment Period|Withdrawal by Subject|0
6033506|NCT00701727|20853391|P1|First Treatment Period|Withdrawal by Subject|1
6033507|NCT00701727|20853390|P2|First Treatment Period|Adverse Event|0
6033508|NCT00701727|20853391|P1|First Treatment Period|Adverse Event|0
6033509|NCT00701701|20853426|P2|Overall Study|Adverse Event|1
6033510|NCT00701701|20853427|P1|Overall Study|Adverse Event|0
6033511|NCT00701701|20853426|P2|Overall Study|Withdrawal by Subject|1
6033512|NCT00701701|20853427|P1|Overall Study|Withdrawal by Subject|0
6033513|NCT00701662|20853462|P1|Overall Study|Lack of Efficacy|1
6033514|NCT00701558|20853487|P1|Overall Study|Lost to Follow-up|8
6033515|NCT00701558|20853487|P1|Overall Study|Death|7
6033516|NCT00701441|20853495|P2|Overall Study|failure in cpap compliance|4
6033517|NCT00701441|20853496|P1|Overall Study|failure in cpap compliance|0
6033518|NCT00701415|20853508|P2|Overall Study|Social/family issues and needle phobia|0
6033519|NCT00701415|20853509|P1|Overall Study|Social/family issues and needle phobia|1
6033520|NCT00701415|20853508|P2|Overall Study|Adverse Event|1
6033521|NCT00701415|20853509|P1|Overall Study|Adverse Event|0
6033522|NCT00701363|20853568|P4|Treatment Phase 2|Withdrawal by Subject|0
6033523|NCT00701363|20853569|P3|Treatment Phase 2|Withdrawal by Subject|1
6033524|NCT00701363|20853570|P2|Treatment Phase 2|Withdrawal by Subject|0
6033525|NCT00701363|20853571|P1|Treatment Phase 2|Withdrawal by Subject|0
6033526|NCT00701363|20853568|P4|Treatment Phase 2|Adverse Event|0
6033527|NCT00701363|20853569|P3|Treatment Phase 2|Adverse Event|1
6033528|NCT00701363|20853570|P2|Treatment Phase 2|Adverse Event|0
6033529|NCT00701363|20853571|P1|Treatment Phase 2|Adverse Event|0
6033530|NCT00701363|20853568|P4|Treatment Phase 1|Lack of Efficacy|0
6033531|NCT00701363|20853569|P3|Treatment Phase 1|Lack of Efficacy|0
6033532|NCT00701363|20853570|P2|Treatment Phase 1|Lack of Efficacy|0
6033533|NCT00701363|20853571|P1|Treatment Phase 1|Lack of Efficacy|1
6033534|NCT00701363|20853568|P4|Treatment Phase 1|Withdrawal by Subject|0
6033535|NCT00701363|20853569|P3|Treatment Phase 1|Withdrawal by Subject|0
6033536|NCT00701363|20853570|P2|Treatment Phase 1|Withdrawal by Subject|0
6033537|NCT00701363|20853571|P1|Treatment Phase 1|Withdrawal by Subject|5
6033538|NCT00701363|20853568|P4|Treatment Phase 1|Protocol Violation|0
6033539|NCT00701363|20853569|P3|Treatment Phase 1|Protocol Violation|0
6033540|NCT00701363|20853570|P2|Treatment Phase 1|Protocol Violation|0
6033541|NCT00701363|20853571|P1|Treatment Phase 1|Protocol Violation|1
6033542|NCT00701363|20853568|P4|Treatment Phase 1|Adverse Event|0
6033543|NCT00701363|20853569|P3|Treatment Phase 1|Adverse Event|0
6033544|NCT00701363|20853570|P2|Treatment Phase 1|Adverse Event|0
6033545|NCT00701363|20853571|P1|Treatment Phase 1|Adverse Event|7
6033546|NCT00701363|20853568|P4|Treatment Phase 1|Does not meet entry Criteria|0
6033547|NCT00701363|20853569|P3|Treatment Phase 1|Does not meet entry Criteria|0
6033548|NCT00701363|20853570|P2|Treatment Phase 1|Does not meet entry Criteria|0
6033549|NCT00701363|20853571|P1|Treatment Phase 1|Does not meet entry Criteria|1
6033550|NCT00701363|20853568|P4|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0
6033551|NCT00701363|20853569|P3|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0
6033552|NCT00701363|20853570|P2|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0
6033553|NCT00701363|20853571|P1|Screening (Pre-assignment) Phase|Does not meet entry Criteria|4
6033554|NCT00701311|20853611|P1|Overall Study|Withdrawal by Subject|2
6033555|NCT00701311|20853611|P1|Overall Study|Adverse Event|3
6033556|NCT00701311|20853611|P1|Overall Study|Lack of Efficacy|3
6033557|NCT00701129|20853615|P1|Overall Study|Death|2
6033558|NCT00701103|20853637|P11|Overall Study|Other|0
6033559|NCT00701103|20853638|P10|Overall Study|Other|1
6033560|NCT00701103|20853639|P9|Overall Study|Other|1
6033561|NCT00701103|20853640|P8|Overall Study|Other|0
6033562|NCT00701103|20853641|P7|Overall Study|Other|0
6033563|NCT00701103|20853642|P6|Overall Study|Other|0
6033564|NCT00701103|20853643|P5|Overall Study|Other|0
6033565|NCT00701103|20853644|P4|Overall Study|Other|0
6033566|NCT00701103|20853645|P3|Overall Study|Other|0
6033567|NCT00701103|20853646|P2|Overall Study|Other|0
6033568|NCT00701103|20853647|P1|Overall Study|Other|0
6033569|NCT00701103|20853637|P11|Overall Study|Withdrawal by Subject|0
6033570|NCT00701103|20853638|P10|Overall Study|Withdrawal by Subject|0
6033571|NCT00701103|20853639|P9|Overall Study|Withdrawal by Subject|0
6033572|NCT00701103|20853640|P8|Overall Study|Withdrawal by Subject|0
6033573|NCT00701103|20853641|P7|Overall Study|Withdrawal by Subject|0
6033574|NCT00701103|20853642|P6|Overall Study|Withdrawal by Subject|0
6033575|NCT00701103|20853643|P5|Overall Study|Withdrawal by Subject|0
6033576|NCT00701103|20853644|P4|Overall Study|Withdrawal by Subject|0
6033577|NCT00701103|20853645|P3|Overall Study|Withdrawal by Subject|1
6033578|NCT00701103|20853646|P2|Overall Study|Withdrawal by Subject|1
6033579|NCT00701103|20853647|P1|Overall Study|Withdrawal by Subject|0
6033580|NCT00701103|20853637|P11|Overall Study|Progressive Disease|11
6033581|NCT00701103|20853638|P10|Overall Study|Progressive Disease|8
6033582|NCT00701103|20853639|P9|Overall Study|Progressive Disease|8
6033583|NCT00701103|20853640|P8|Overall Study|Progressive Disease|7
6033584|NCT00701103|20853641|P7|Overall Study|Progressive Disease|7
6033585|NCT00701103|20853642|P6|Overall Study|Progressive Disease|5
6033586|NCT00701103|20853643|P5|Overall Study|Progressive Disease|6
6033587|NCT00701103|20853644|P4|Overall Study|Progressive Disease|5
6033588|NCT00701103|20853645|P3|Overall Study|Progressive Disease|6
6033589|NCT00701103|20853646|P2|Overall Study|Progressive Disease|2
6033590|NCT00701103|20853647|P1|Overall Study|Progressive Disease|5
6033591|NCT00701103|20853637|P11|Overall Study|Adverse Event|0
6033592|NCT00701103|20853638|P10|Overall Study|Adverse Event|2
6033593|NCT00701103|20853639|P9|Overall Study|Adverse Event|0
6033594|NCT00701103|20853640|P8|Overall Study|Adverse Event|0
6033595|NCT00701103|20853641|P7|Overall Study|Adverse Event|1
6033596|NCT00701103|20853642|P6|Overall Study|Adverse Event|1
6033597|NCT00701103|20853643|P5|Overall Study|Adverse Event|0
6033598|NCT00701103|20853644|P4|Overall Study|Adverse Event|1
6033599|NCT00701103|20853645|P3|Overall Study|Adverse Event|1
6033600|NCT00701103|20853646|P2|Overall Study|Adverse Event|0
6033601|NCT00701103|20853647|P1|Overall Study|Adverse Event|0
6033602|NCT00701090|20853753|P2|Overall Study|Other|12
6033603|NCT00701090|20853754|P1|Overall Study|Other|7
6033604|NCT00701090|20853753|P2|Overall Study|Withdrawal by Subject|16
6033605|NCT00701090|20853754|P1|Overall Study|Withdrawal by Subject|11
6033606|NCT00701090|20853753|P2|Overall Study|Protocol Violation|3
6033607|NCT00701090|20853754|P1|Overall Study|Protocol Violation|2
6033608|NCT00701090|20853753|P2|Overall Study|Physician Decision|4
6033609|NCT00701090|20853754|P1|Overall Study|Physician Decision|3
6033610|NCT00701090|20853753|P2|Overall Study|Lost to Follow-up|9
6033611|NCT00701090|20853754|P1|Overall Study|Lost to Follow-up|9
6033612|NCT00701090|20853753|P2|Overall Study|Lack of Efficacy|4
6033613|NCT00701090|20853754|P1|Overall Study|Lack of Efficacy|5
6033614|NCT00701090|20853753|P2|Overall Study|Death|1
6033615|NCT00701090|20853754|P1|Overall Study|Death|0
6033616|NCT00701090|20853753|P2|Overall Study|Adverse Event|2
6033617|NCT00701090|20853754|P1|Overall Study|Adverse Event|11
6033618|NCT00701064|20853772|P2|Overall Study|initiated other PTSD treatment|2
6033619|NCT00701064|20853773|P1|Overall Study|initiated other PTSD treatment|2
6033620|NCT00701064|20853772|P2|Overall Study|Withdrawal by Subject|1
6033621|NCT00701064|20853773|P1|Overall Study|Withdrawal by Subject|1
6033622|NCT00701064|20853772|P2|Overall Study|Protocol Violation|1
6033623|NCT00701064|20853773|P1|Overall Study|Protocol Violation|1
6033624|NCT00701051|20853785|P3|Exercise Intervention|time conflict; non-study related illness|3
6033625|NCT00701051|20853786|P2|Exercise Intervention|time conflict; non-study related illness|5
6033626|NCT00701051|20853787|P1|Exercise Intervention|time conflict; non-study related illness|0
6033627|NCT00701051|20853785|P3|Screening|Time conflicts|0
6033628|NCT00701051|20853786|P2|Screening|Time conflicts|0
6033629|NCT00701051|20853787|P1|Screening|Time conflicts|19
6033630|NCT00701051|20853785|P3|Screening|Failed Screening|0
6033631|NCT00701051|20853786|P2|Screening|Failed Screening|0
6033632|NCT00701051|20853787|P1|Screening|Failed Screening|40
6033633|NCT00701038|20853805|P2|Overall Study|study amended pilot group of patients|4
6033634|NCT00701038|20853806|P1|Overall Study|study amended pilot group of patients|4
6033635|NCT00700999|20853814|P2|Overall Study|Withdrawal by Subject|1
6033636|NCT00700999|20853815|P1|Overall Study|Withdrawal by Subject|8
6033637|NCT00700999|20853814|P2|Overall Study|Excluded - did not meet study criteria|1
6033638|NCT00700999|20853815|P1|Overall Study|Excluded - did not meet study criteria|0
6033639|NCT00700999|20853814|P2|Overall Study|Lost to Follow-up|7
6033640|NCT00700999|20853815|P1|Overall Study|Lost to Follow-up|7
6033641|NCT00700882|20853830|P1|Overall Study|No KIT mutation|51
6033642|NCT00700882|20853830|P1|Overall Study|Ineligible|2
6033643|NCT00700882|20853830|P1|Overall Study|Never received treatment|6
6033644|NCT00700817|20853839|P5|Week 52-78 (Extension Period 2)|Unclassified|1
6033645|NCT00700817|20853840|P4|Week 52-78 (Extension Period 2)|Unclassified|0
6033646|NCT00700817|20853841|P3|Week 52-78 (Extension Period 2)|Unclassified|0
6033647|NCT00700817|20853842|P2|Week 52-78 (Extension Period 2)|Unclassified|4
6033648|NCT00700817|20853843|P1|Week 52-78 (Extension Period 2)|Unclassified|2
6033649|NCT00700817|20853839|P5|Week 52-78 (Extension Period 2)|Withdrawal criteria|3
6033650|NCT00700817|20853840|P4|Week 52-78 (Extension Period 2)|Withdrawal criteria|1
6033651|NCT00700817|20853841|P3|Week 52-78 (Extension Period 2)|Withdrawal criteria|0
6033652|NCT00700817|20853842|P2|Week 52-78 (Extension Period 2)|Withdrawal criteria|3
6033653|NCT00700817|20853843|P1|Week 52-78 (Extension Period 2)|Withdrawal criteria|4
6033654|NCT00700817|20853839|P5|Week 52-78 (Extension Period 2)|Lack of Efficacy|0
6033655|NCT00700817|20853840|P4|Week 52-78 (Extension Period 2)|Lack of Efficacy|0
6033656|NCT00700817|20853841|P3|Week 52-78 (Extension Period 2)|Lack of Efficacy|0
6033657|NCT00700817|20853842|P2|Week 52-78 (Extension Period 2)|Lack of Efficacy|3
6033658|NCT00700817|20853843|P1|Week 52-78 (Extension Period 2)|Lack of Efficacy|3
6033659|NCT00700817|20853839|P5|Week 52-78 (Extension Period 2)|Protocol Violation|1
6033660|NCT00700817|20853840|P4|Week 52-78 (Extension Period 2)|Protocol Violation|1
6033661|NCT00700817|20853841|P3|Week 52-78 (Extension Period 2)|Protocol Violation|0
6033662|NCT00700817|20853842|P2|Week 52-78 (Extension Period 2)|Protocol Violation|2
6033663|NCT00700817|20853843|P1|Week 52-78 (Extension Period 2)|Protocol Violation|1
6033664|NCT00700817|20853839|P5|Week 52-78 (Extension Period 2)|Adverse Event|0
6033665|NCT00700817|20853840|P4|Week 52-78 (Extension Period 2)|Adverse Event|6
6033666|NCT00700817|20853841|P3|Week 52-78 (Extension Period 2)|Adverse Event|0
6033667|NCT00700817|20853842|P2|Week 52-78 (Extension Period 2)|Adverse Event|3
6033668|NCT00700817|20853843|P1|Week 52-78 (Extension Period 2)|Adverse Event|0
6033669|NCT00700817|20853839|P5|Week 26-52 (Extension Period 1)|Unclassified|0
6033670|NCT00700817|20853840|P4|Week 26-52 (Extension Period 1)|Unclassified|0
6033671|NCT00700817|20853841|P3|Week 26-52 (Extension Period 1)|Unclassified|1
6033672|NCT00700817|20853842|P2|Week 26-52 (Extension Period 1)|Unclassified|3
6033673|NCT00700817|20853843|P1|Week 26-52 (Extension Period 1)|Unclassified|4
6033674|NCT00700817|20853839|P5|Week 26-52 (Extension Period 1)|Withdrawal criteria|0
6033675|NCT00700817|20853840|P4|Week 26-52 (Extension Period 1)|Withdrawal criteria|0
6033676|NCT00700817|20853841|P3|Week 26-52 (Extension Period 1)|Withdrawal criteria|2
6033677|NCT00700817|20853842|P2|Week 26-52 (Extension Period 1)|Withdrawal criteria|8
6033678|NCT00700817|20853843|P1|Week 26-52 (Extension Period 1)|Withdrawal criteria|6
6033679|NCT00700817|20853839|P5|Week 26-52 (Extension Period 1)|Lack of Efficacy|0
6033680|NCT00700817|20853840|P4|Week 26-52 (Extension Period 1)|Lack of Efficacy|0
6033681|NCT00700817|20853841|P3|Week 26-52 (Extension Period 1)|Lack of Efficacy|7
6033682|NCT00700817|20853842|P2|Week 26-52 (Extension Period 1)|Lack of Efficacy|3
6033683|NCT00700817|20853843|P1|Week 26-52 (Extension Period 1)|Lack of Efficacy|2
6033684|NCT00700817|20853839|P5|Week 26-52 (Extension Period 1)|Protocol Violation|0
6033685|NCT00700817|20853840|P4|Week 26-52 (Extension Period 1)|Protocol Violation|0
6033686|NCT00700817|20853841|P3|Week 26-52 (Extension Period 1)|Protocol Violation|2
6033687|NCT00700817|20853842|P2|Week 26-52 (Extension Period 1)|Protocol Violation|2
6033688|NCT00700817|20853843|P1|Week 26-52 (Extension Period 1)|Protocol Violation|3
6033689|NCT00700817|20853839|P5|Week 26-52 (Extension Period 1)|Adverse Event|0
6033690|NCT00700817|20853840|P4|Week 26-52 (Extension Period 1)|Adverse Event|0
6033691|NCT00700817|20853841|P3|Week 26-52 (Extension Period 1)|Adverse Event|3
6033692|NCT00700817|20853842|P2|Week 26-52 (Extension Period 1)|Adverse Event|10
6033693|NCT00700817|20853843|P1|Week 26-52 (Extension Period 1)|Adverse Event|5
6033694|NCT00700817|20853839|P5|Week 0-26 (Main Period)|Unclassified|0
6033695|NCT00700817|20853840|P4|Week 0-26 (Main Period)|Unclassified|0
6033696|NCT00700817|20853841|P3|Week 0-26 (Main Period)|Unclassified|8
6033697|NCT00700817|20853842|P2|Week 0-26 (Main Period)|Unclassified|4
6033698|NCT00700817|20853843|P1|Week 0-26 (Main Period)|Unclassified|14
6033699|NCT00700817|20853839|P5|Week 0-26 (Main Period)|Withdrawal criteria|0
6033700|NCT00700817|20853840|P4|Week 0-26 (Main Period)|Withdrawal criteria|0
6033701|NCT00700817|20853841|P3|Week 0-26 (Main Period)|Withdrawal criteria|5
6033702|NCT00700817|20853842|P2|Week 0-26 (Main Period)|Withdrawal criteria|7
6033703|NCT00700817|20853843|P1|Week 0-26 (Main Period)|Withdrawal criteria|10
6033704|NCT00700817|20853839|P5|Week 0-26 (Main Period)|Protocol Violation|0
6033705|NCT00700817|20853840|P4|Week 0-26 (Main Period)|Protocol Violation|0
6033706|NCT00700817|20853841|P3|Week 0-26 (Main Period)|Protocol Violation|4
6033707|NCT00700817|20853842|P2|Week 0-26 (Main Period)|Protocol Violation|4
6033708|NCT00700817|20853843|P1|Week 0-26 (Main Period)|Protocol Violation|14
6033709|NCT00700817|20853839|P5|Week 0-26 (Main Period)|Lack of Efficacy|0
6033710|NCT00700817|20853840|P4|Week 0-26 (Main Period)|Lack of Efficacy|0
6033711|NCT00700817|20853841|P3|Week 0-26 (Main Period)|Lack of Efficacy|4
6033712|NCT00700817|20853842|P2|Week 0-26 (Main Period)|Lack of Efficacy|0
6033713|NCT00700817|20853843|P1|Week 0-26 (Main Period)|Lack of Efficacy|4
6033714|NCT00700817|20853839|P5|Week 0-26 (Main Period)|Adverse Event|0
6033715|NCT00700817|20853840|P4|Week 0-26 (Main Period)|Adverse Event|0
6033716|NCT00700817|20853841|P3|Week 0-26 (Main Period)|Adverse Event|4
6033717|NCT00700817|20853842|P2|Week 0-26 (Main Period)|Adverse Event|15
6033718|NCT00700817|20853843|P1|Week 0-26 (Main Period)|Adverse Event|14
6033719|NCT00700804|20854225|P2|Overall Study|Loose Stools|1
6033720|NCT00700804|20854226|P1|Overall Study|Loose Stools|1
6033721|NCT00700804|20854225|P2|Overall Study|Protocol Violation|1
6033722|NCT00700804|20854226|P1|Overall Study|Protocol Violation|1
6033723|NCT00700804|20854225|P2|Overall Study|Withdrawal by Subject|2
6033724|NCT00700804|20854226|P1|Overall Study|Withdrawal by Subject|1
6033725|NCT00700778|20854234|P1|Overall Study|Inconclusive data due to inadequate sample collection|2
6033726|NCT00700752|20854238|P2|First Intervention|Withdrawal by Subject|2
6033727|NCT00700752|20854239|P1|First Intervention|Withdrawal by Subject|0
6033728|NCT00700739|20854247|P2|Overall Study|Lost to Follow-up|4
6033729|NCT00700739|20854248|P1|Overall Study|Lost to Follow-up|4
6033730|NCT00700713|20854287|P3|Overall Study|Withdrawal by Subject|1
6033731|NCT00700713|20854288|P2|Overall Study|Withdrawal by Subject|0
6033732|NCT00700713|20854289|P1|Overall Study|Withdrawal by Subject|0
6033733|NCT00700713|20854287|P3|Overall Study|Protocol Violation|1
6033734|NCT00700713|20854288|P2|Overall Study|Protocol Violation|0
6033735|NCT00700713|20854289|P1|Overall Study|Protocol Violation|1
6033736|NCT00700635|20854306|P3|Overall Study|Withdrawal by Subject|1
6033737|NCT00700635|20854307|P2|Overall Study|Withdrawal by Subject|3
6033738|NCT00700635|20854308|P1|Overall Study|Withdrawal by Subject|7
6033739|NCT00700635|20854306|P3|Overall Study|Protocol Violation|0
6033740|NCT00700635|20854307|P2|Overall Study|Protocol Violation|2
6033741|NCT00700635|20854308|P1|Overall Study|Protocol Violation|2
6033742|NCT00700635|20854306|P3|Overall Study|Lost to Follow-up|0
6033743|NCT00700635|20854307|P2|Overall Study|Lost to Follow-up|3
6033744|NCT00700635|20854308|P1|Overall Study|Lost to Follow-up|1
6033745|NCT00700635|20854306|P3|Overall Study|Adverse Event|0
6033746|NCT00700635|20854307|P2|Overall Study|Adverse Event|0
6033747|NCT00700635|20854308|P1|Overall Study|Adverse Event|1
6033748|NCT00700622|20854330|P2|Overall Study|Other|1
6033749|NCT00700622|20854331|P1|Overall Study|Other|3
6033750|NCT00700622|20854330|P2|Overall Study|Withdrawal by Subject|1
6033751|NCT00700622|20854331|P1|Overall Study|Withdrawal by Subject|4
6033752|NCT00700622|20854330|P2|Overall Study|Protocol Violation|1
6033753|NCT00700622|20854331|P1|Overall Study|Protocol Violation|0
6033754|NCT00700622|20854330|P2|Overall Study|Physician Decision|1
6033755|NCT00700622|20854331|P1|Overall Study|Physician Decision|2
6033756|NCT00700622|20854330|P2|Overall Study|Lost to Follow-up|1
6033757|NCT00700622|20854331|P1|Overall Study|Lost to Follow-up|0
6033758|NCT00700622|20854330|P2|Overall Study|Adverse Event|0
6033759|NCT00700622|20854331|P1|Overall Study|Adverse Event|4
6033760|NCT00700570|20854339|P2|Overall Study|Withdrawal by Subject|6
6033761|NCT00700570|20854340|P1|Overall Study|Withdrawal by Subject|1
6033762|NCT00700570|20854339|P2|Overall Study|Disease Progression|11
6033763|NCT00700570|20854340|P1|Overall Study|Disease Progression|8
6033764|NCT00700570|20854339|P2|Overall Study|Discretion of Investigator or Sponsor|3
6033765|NCT00700570|20854340|P1|Overall Study|Discretion of Investigator or Sponsor|0
6033766|NCT00700570|20854339|P2|Overall Study|Adverse Event|6
6033767|NCT00700570|20854340|P1|Overall Study|Adverse Event|2
6033768|NCT00700427|20854356|P5|Study Period 4 (Open-Label Extension)|Clinical Relapse|1
6033769|NCT00700427|20854357|P4|Study Period 4 (Open-Label Extension)|Clinical Relapse|0
6033770|NCT00700427|20854358|P3|Study Period 4 (Open-Label Extension)|Clinical Relapse|0
6033771|NCT00700427|20854359|P2|Study Period 4 (Open-Label Extension)|Clinical Relapse|0
6033772|NCT00700427|20854360|P1|Study Period 4 (Open-Label Extension)|Clinical Relapse|0
6033773|NCT00700427|20854356|P5|Study Period 4 (Open-Label Extension)|Lost to Follow-up|11
6033774|NCT00700427|20854357|P4|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0
6033775|NCT00700427|20854358|P3|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0
6033776|NCT00700427|20854359|P2|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0
6033777|NCT00700427|20854360|P1|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0
6033778|NCT00700427|20854356|P5|Study Period 4 (Open-Label Extension)|Lack of Efficacy|1
6033779|NCT00700427|20854357|P4|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0
6033780|NCT00700427|20854358|P3|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0
6033781|NCT00700427|20854359|P2|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0
6033782|NCT00700427|20854360|P1|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0
6033783|NCT00700427|20854356|P5|Study Period 4 (Open-Label Extension)|Sponsor Decision|2
6033784|NCT00700427|20854357|P4|Study Period 4 (Open-Label Extension)|Sponsor Decision|0
6033785|NCT00700427|20854358|P3|Study Period 4 (Open-Label Extension)|Sponsor Decision|0
6033786|NCT00700427|20854359|P2|Study Period 4 (Open-Label Extension)|Sponsor Decision|0
6033787|NCT00700427|20854360|P1|Study Period 4 (Open-Label Extension)|Sponsor Decision|0
6033788|NCT00700427|20854356|P5|Study Period 4 (Open-Label Extension)|Physician Decision|2
6033789|NCT00700427|20854357|P4|Study Period 4 (Open-Label Extension)|Physician Decision|0
6033790|NCT00700427|20854358|P3|Study Period 4 (Open-Label Extension)|Physician Decision|0
6033791|NCT00700427|20854359|P2|Study Period 4 (Open-Label Extension)|Physician Decision|0
6033792|NCT00700427|20854360|P1|Study Period 4 (Open-Label Extension)|Physician Decision|0
6033793|NCT00700427|20854356|P5|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|38
6033794|NCT00700427|20854357|P4|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0
6033795|NCT00700427|20854358|P3|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0
6033796|NCT00700427|20854359|P2|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0
6033797|NCT00700427|20854360|P1|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0
6033798|NCT00700427|20854356|P5|Study Period 4 (Open-Label Extension)|Protocol Violation|12
6033799|NCT00700427|20854357|P4|Study Period 4 (Open-Label Extension)|Protocol Violation|0
6033800|NCT00700427|20854358|P3|Study Period 4 (Open-Label Extension)|Protocol Violation|0
6033801|NCT00700427|20854359|P2|Study Period 4 (Open-Label Extension)|Protocol Violation|0
6033802|NCT00700427|20854360|P1|Study Period 4 (Open-Label Extension)|Protocol Violation|0
6033803|NCT00700427|20854356|P5|Study Period 4 (Open-Label Extension)|Death|1
6033804|NCT00700427|20854357|P4|Study Period 4 (Open-Label Extension)|Death|0
6033805|NCT00700427|20854358|P3|Study Period 4 (Open-Label Extension)|Death|0
6033806|NCT00700427|20854359|P2|Study Period 4 (Open-Label Extension)|Death|0
6033807|NCT00700427|20854360|P1|Study Period 4 (Open-Label Extension)|Death|0
6033808|NCT00700427|20854356|P5|Study Period 4 (Open-Label Extension)|Adverse Event|16
6033809|NCT00700427|20854357|P4|Study Period 4 (Open-Label Extension)|Adverse Event|0
6033810|NCT00700427|20854358|P3|Study Period 4 (Open-Label Extension)|Adverse Event|0
6033811|NCT00700427|20854359|P2|Study Period 4 (Open-Label Extension)|Adverse Event|0
6033812|NCT00700427|20854360|P1|Study Period 4 (Open-Label Extension)|Adverse Event|0
6033813|NCT00700427|20854356|P5|Study Period 3B (Randomized Withdrawal)|Death|0
6033814|NCT00700427|20854357|P4|Study Period 3B (Randomized Withdrawal)|Death|0
6033815|NCT00700427|20854358|P3|Study Period 3B (Randomized Withdrawal)|Death|1
6033816|NCT00700427|20854359|P2|Study Period 3B (Randomized Withdrawal)|Death|0
6033817|NCT00700427|20854360|P1|Study Period 3B (Randomized Withdrawal)|Death|0
6033818|NCT00700427|20854356|P5|Study Period 3B (Randomized Withdrawal)|Physician Decision|0
6033819|NCT00700427|20854357|P4|Study Period 3B (Randomized Withdrawal)|Physician Decision|0
6033820|NCT00700427|20854358|P3|Study Period 3B (Randomized Withdrawal)|Physician Decision|2
6033821|NCT00700427|20854359|P2|Study Period 3B (Randomized Withdrawal)|Physician Decision|0
6033822|NCT00700427|20854360|P1|Study Period 3B (Randomized Withdrawal)|Physician Decision|0
6033823|NCT00700427|20854356|P5|Study Period 3B (Randomized Withdrawal)|Missing|0
6033824|NCT00700427|20854357|P4|Study Period 3B (Randomized Withdrawal)|Missing|1
6033825|NCT00700427|20854358|P3|Study Period 3B (Randomized Withdrawal)|Missing|1
6033826|NCT00700427|20854359|P2|Study Period 3B (Randomized Withdrawal)|Missing|0
6033827|NCT00700427|20854360|P1|Study Period 3B (Randomized Withdrawal)|Missing|0
6033828|NCT00700427|20854356|P5|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0
6033829|NCT00700427|20854357|P4|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|3
6033830|NCT00700427|20854358|P3|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0
6033831|NCT00700427|20854359|P2|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0
6033832|NCT00700427|20854360|P1|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0
6033833|NCT00700427|20854356|P5|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0
6033834|NCT00700427|20854357|P4|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|5
6033835|NCT00700427|20854358|P3|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0
6033836|NCT00700427|20854359|P2|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0
6033837|NCT00700427|20854360|P1|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0
6033838|NCT00700427|20854356|P5|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0
6033839|NCT00700427|20854357|P4|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|11
6033840|NCT00700427|20854358|P3|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|3
6033841|NCT00700427|20854359|P2|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0
6033842|NCT00700427|20854360|P1|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0
6033843|NCT00700427|20854356|P5|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0
6033844|NCT00700427|20854357|P4|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|9
6033845|NCT00700427|20854358|P3|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|19
6033846|NCT00700427|20854359|P2|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0
6033847|NCT00700427|20854360|P1|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0
6033848|NCT00700427|20854356|P5|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0
6033849|NCT00700427|20854357|P4|Study Period 3B (Randomized Withdrawal)|Protocol Violation|25
6033850|NCT00700427|20854358|P3|Study Period 3B (Randomized Withdrawal)|Protocol Violation|23
6033851|NCT00700427|20854359|P2|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0
6033852|NCT00700427|20854360|P1|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0
6033853|NCT00700427|20854356|P5|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0
6033854|NCT00700427|20854357|P4|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|34
6033855|NCT00700427|20854358|P3|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|25
6033856|NCT00700427|20854359|P2|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0
6033857|NCT00700427|20854360|P1|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0
6033858|NCT00700427|20854356|P5|Study Period 3B (Randomized Withdrawal)|Adverse Event|0
6033859|NCT00700427|20854357|P4|Study Period 3B (Randomized Withdrawal)|Adverse Event|5
6033860|NCT00700427|20854358|P3|Study Period 3B (Randomized Withdrawal)|Adverse Event|8
6033861|NCT00700427|20854359|P2|Study Period 3B (Randomized Withdrawal)|Adverse Event|0
6033862|NCT00700427|20854360|P1|Study Period 3B (Randomized Withdrawal)|Adverse Event|0
6033863|NCT00700427|20854356|P5|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0
6033864|NCT00700427|20854357|P4|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0
6033865|NCT00700427|20854358|P3|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0
6033866|NCT00700427|20854359|P2|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|5
6033867|NCT00700427|20854360|P1|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0
6033868|NCT00700427|20854356|P5|Study Period 3A (Blinded Maintenance)|Physician Decision|0
6033869|NCT00700427|20854357|P4|Study Period 3A (Blinded Maintenance)|Physician Decision|0
6033870|NCT00700427|20854358|P3|Study Period 3A (Blinded Maintenance)|Physician Decision|0
6033871|NCT00700427|20854359|P2|Study Period 3A (Blinded Maintenance)|Physician Decision|2
6033872|NCT00700427|20854360|P1|Study Period 3A (Blinded Maintenance)|Physician Decision|0
6033873|NCT00700427|20854356|P5|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0
6033874|NCT00700427|20854357|P4|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0
6033875|NCT00700427|20854358|P3|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0
6033876|NCT00700427|20854359|P2|Study Period 3A (Blinded Maintenance)|Sponsor Decision|3
6033877|NCT00700427|20854360|P1|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0
6033878|NCT00700427|20854356|P5|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0
6033879|NCT00700427|20854357|P4|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0
6033880|NCT00700427|20854358|P3|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0
6033881|NCT00700427|20854359|P2|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|32
6033882|NCT00700427|20854360|P1|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0
6033883|NCT00700427|20854356|P5|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0
6033884|NCT00700427|20854357|P4|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0
6033885|NCT00700427|20854358|P3|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0
6033886|NCT00700427|20854359|P2|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|41
6033887|NCT00700427|20854360|P1|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0
6033888|NCT00700427|20854356|P5|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0
6033889|NCT00700427|20854357|P4|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0
6033890|NCT00700427|20854358|P3|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0
6033891|NCT00700427|20854359|P2|Study Period 3A (Blinded Maintenance)|Clinical Relapse|49
6033892|NCT00700427|20854360|P1|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0
6033893|NCT00700427|20854356|P5|Study Period 3A (Blinded Maintenance)|Protocol Violation|0
6033894|NCT00700427|20854357|P4|Study Period 3A (Blinded Maintenance)|Protocol Violation|0
6033895|NCT00700427|20854358|P3|Study Period 3A (Blinded Maintenance)|Protocol Violation|0
6033896|NCT00700427|20854359|P2|Study Period 3A (Blinded Maintenance)|Protocol Violation|56
6033897|NCT00700427|20854360|P1|Study Period 3A (Blinded Maintenance)|Protocol Violation|0
6033898|NCT00700427|20854356|P5|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0
6033899|NCT00700427|20854357|P4|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0
6033900|NCT00700427|20854358|P3|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0
6033901|NCT00700427|20854359|P2|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|81
6033902|NCT00700427|20854360|P1|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0
6033903|NCT00700427|20854356|P5|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0
6033904|NCT00700427|20854357|P4|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0
6033905|NCT00700427|20854358|P3|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0
6033906|NCT00700427|20854359|P2|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|162
6033907|NCT00700427|20854360|P1|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0
6033908|NCT00700427|20854356|P5|Study Period 3A (Blinded Maintenance)|Adverse Event|0
6033909|NCT00700427|20854357|P4|Study Period 3A (Blinded Maintenance)|Adverse Event|0
6033910|NCT00700427|20854358|P3|Study Period 3A (Blinded Maintenance)|Adverse Event|0
6033911|NCT00700427|20854359|P2|Study Period 3A (Blinded Maintenance)|Adverse Event|50
6033912|NCT00700427|20854360|P1|Study Period 3A (Blinded Maintenance)|Adverse Event|0
6033913|NCT00700427|20854356|P5|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0
6033914|NCT00700427|20854357|P4|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0
6033915|NCT00700427|20854358|P3|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0
6033916|NCT00700427|20854359|P2|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0
6033917|NCT00700427|20854360|P1|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|2
6033918|NCT00700427|20854356|P5|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0
6033919|NCT00700427|20854357|P4|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0
6033920|NCT00700427|20854358|P3|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0
6033921|NCT00700427|20854359|P2|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0
6033922|NCT00700427|20854360|P1|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|7
6033923|NCT00700427|20854356|P5|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0
6033924|NCT00700427|20854357|P4|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0
6033925|NCT00700427|20854358|P3|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0
6033926|NCT00700427|20854359|P2|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0
6033927|NCT00700427|20854360|P1|Study Period 2 (Open-Label Acute Trx)|Physician Decision|8
6033928|NCT00700427|20854356|P5|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0
6033929|NCT00700427|20854357|P4|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0
6033930|NCT00700427|20854358|P3|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0
6033931|NCT00700427|20854359|P2|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0
6033932|NCT00700427|20854360|P1|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|90
6033933|NCT00700427|20854356|P5|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0
6033934|NCT00700427|20854357|P4|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0
6033935|NCT00700427|20854358|P3|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0
6033936|NCT00700427|20854359|P2|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0
6033937|NCT00700427|20854360|P1|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|108
6033938|NCT00700427|20854356|P5|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0
6033939|NCT00700427|20854357|P4|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0
6033940|NCT00700427|20854358|P3|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0
6033941|NCT00700427|20854359|P2|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0
6033942|NCT00700427|20854360|P1|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|161
6033943|NCT00700427|20854356|P5|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0
6033944|NCT00700427|20854357|P4|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0
6033945|NCT00700427|20854358|P3|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0
6033946|NCT00700427|20854359|P2|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0
6033947|NCT00700427|20854360|P1|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|164
6033948|NCT00700427|20854356|P5|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0
6033949|NCT00700427|20854357|P4|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0
6033950|NCT00700427|20854358|P3|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0
6033951|NCT00700427|20854359|P2|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0
6033952|NCT00700427|20854360|P1|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|173
6033953|NCT00700427|20854356|P5|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0
6033954|NCT00700427|20854357|P4|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0
6033955|NCT00700427|20854358|P3|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0
6033956|NCT00700427|20854359|P2|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0
6033957|NCT00700427|20854360|P1|Study Period 2 (Open-Label Acute Trx)|Adverse Event|298
6033958|NCT00700401|20854382|P1|Overall Study|Withdrawal by Subject|2
6033959|NCT00700401|20854382|P1|Overall Study|HCV RNA not detected at baseline and SAE|1
6033960|NCT00700401|20854382|P1|Overall Study|Treatment never started|1
6033961|NCT00700401|20854382|P1|Overall Study|Lost to Follow-up|1
6033962|NCT00700401|20854382|P1|Overall Study|Refused Treatment|2
6033963|NCT00700401|20854382|P1|Overall Study|Adverse Event|5
6033964|NCT00700401|20854382|P1|Overall Study|Detectable HCV RNA after Week 4|82
6033965|NCT00700310|20854406|P4|Overall Study|Randomized, Not Treated|2
6033966|NCT00700310|20854407|P3|Overall Study|Randomized, Not Treated|2
6033967|NCT00700310|20854408|P2|Overall Study|Randomized, Not Treated|0
6033968|NCT00700310|20854409|P1|Overall Study|Randomized, Not Treated|2
6033969|NCT00700310|20854406|P4|Overall Study|Administrative/Other|3
6033970|NCT00700310|20854407|P3|Overall Study|Administrative/Other|1
6033971|NCT00700310|20854408|P2|Overall Study|Administrative/Other|3
6033972|NCT00700310|20854409|P1|Overall Study|Administrative/Other|1
6033973|NCT00700310|20854406|P4|Overall Study|Lack of Efficacy|1
6033974|NCT00700310|20854407|P3|Overall Study|Lack of Efficacy|0
6033975|NCT00700310|20854408|P2|Overall Study|Lack of Efficacy|3
6033976|NCT00700310|20854409|P1|Overall Study|Lack of Efficacy|0
6033977|NCT00700310|20854406|P4|Overall Study|Withdrawal by Subject|8
6033978|NCT00700310|20854407|P3|Overall Study|Withdrawal by Subject|8
6033979|NCT00700310|20854408|P2|Overall Study|Withdrawal by Subject|9
6033980|NCT00700310|20854409|P1|Overall Study|Withdrawal by Subject|8
6033981|NCT00700310|20854406|P4|Overall Study|Lost to Follow-up|1
6033982|NCT00700310|20854407|P3|Overall Study|Lost to Follow-up|0
6033983|NCT00700310|20854408|P2|Overall Study|Lost to Follow-up|1
6033984|NCT00700310|20854409|P1|Overall Study|Lost to Follow-up|4
6033985|NCT00700310|20854406|P4|Overall Study|Adverse Event|11
6033986|NCT00700310|20854407|P3|Overall Study|Adverse Event|5
6033987|NCT00700310|20854408|P2|Overall Study|Adverse Event|10
6033988|NCT00700310|20854409|P1|Overall Study|Adverse Event|6
6033989|NCT00700271|20854429|P2|Overall Study|Lost to Follow-up|2
6033990|NCT00700271|20854430|P1|Overall Study|Lost to Follow-up|2
6033991|NCT00700271|20854429|P2|Overall Study|Withdrawal by Subject|4
6033992|NCT00700271|20854430|P1|Overall Study|Withdrawal by Subject|6
6033993|NCT00700271|20854429|P2|Overall Study|Administrative Reasons|0
6033994|NCT00700271|20854430|P1|Overall Study|Administrative Reasons|1
6033995|NCT00700271|20854429|P2|Overall Study|Protocol Violation|0
6033996|NCT00700271|20854430|P1|Overall Study|Protocol Violation|1
6033997|NCT00700271|20854429|P2|Overall Study|Adverse Event|6
6033998|NCT00700271|20854430|P1|Overall Study|Adverse Event|4
6033999|NCT00700180|20854458|P2|Overall Study|Lost to Follow-up|5
6034000|NCT00700180|20854459|P1|Overall Study|Lost to Follow-up|4
6034001|NCT00700180|20854458|P2|Overall Study|Alive in follow-up|27
6034002|NCT00700180|20854459|P1|Overall Study|Alive in follow-up|46
6034003|NCT00700180|20854458|P2|Overall Study|Alive on treatment|3
6034004|NCT00700180|20854459|P1|Overall Study|Alive on treatment|5
6034005|NCT00700180|20854458|P2|Overall Study|Death|114
6034006|NCT00700180|20854459|P1|Overall Study|Death|99
6034007|NCT00700115|20854488|P2|Overall Study|Lost to Follow-up|1
6034008|NCT00700115|20854489|P1|Overall Study|Lost to Follow-up|0
6034009|NCT00700115|20854488|P2|Overall Study|Withdrawal by Subject|0
6034010|NCT00700115|20854489|P1|Overall Study|Withdrawal by Subject|1
6034011|NCT00700102|20854499|P2|Overall Study|Lost to Follow-up|10
6034012|NCT00700102|20854500|P1|Overall Study|Lost to Follow-up|8
6034013|NCT00700102|20854499|P2|Overall Study|Died|385
6034014|NCT00700102|20854500|P1|Overall Study|Died|394
6034015|NCT00700011|20854639|P2|Overall Study|Death|1
6034016|NCT00700011|20854640|P1|Overall Study|Death|0
6034017|NCT00699998|20854656|P4|Overall Study|Lost to Follow-up|1
6034018|NCT00699998|20854657|P3|Overall Study|Lost to Follow-up|3
6034019|NCT00699998|20854658|P2|Overall Study|Lost to Follow-up|1
6034020|NCT00699998|20854659|P1|Overall Study|Lost to Follow-up|2
6034021|NCT00699998|20854656|P4|Overall Study|Physician Decision|1
6034022|NCT00699998|20854657|P3|Overall Study|Physician Decision|1
6034023|NCT00699998|20854658|P2|Overall Study|Physician Decision|2
6034024|NCT00699998|20854659|P1|Overall Study|Physician Decision|3
6034025|NCT00699998|20854656|P4|Overall Study|Withdrawal by Subject|80
6034026|NCT00699998|20854657|P3|Overall Study|Withdrawal by Subject|202
6034027|NCT00699998|20854658|P2|Overall Study|Withdrawal by Subject|83
6034028|NCT00699998|20854659|P1|Overall Study|Withdrawal by Subject|194
6034029|NCT00699972|20854704|P3|Overall Study|Randomized, Not Treated|1
6034030|NCT00699972|20854705|P2|Overall Study|Randomized, Not Treated|0
6034031|NCT00699972|20854706|P1|Overall Study|Randomized, Not Treated|1
6034032|NCT00699972|20854704|P3|Overall Study|Administrative/Other|4
6034033|NCT00699972|20854705|P2|Overall Study|Administrative/Other|1
6034034|NCT00699972|20854706|P1|Overall Study|Administrative/Other|3
6034035|NCT00699972|20854704|P3|Overall Study|Lack of Efficacy|2
6034036|NCT00699972|20854705|P2|Overall Study|Lack of Efficacy|0
6034037|NCT00699972|20854706|P1|Overall Study|Lack of Efficacy|2
6034038|NCT00699972|20854704|P3|Overall Study|Withdrawal by Subject|4
6034039|NCT00699972|20854705|P2|Overall Study|Withdrawal by Subject|7
6034040|NCT00699972|20854706|P1|Overall Study|Withdrawal by Subject|3
6034041|NCT00699972|20854704|P3|Overall Study|Lost to Follow-up|0
6034042|NCT00699972|20854705|P2|Overall Study|Lost to Follow-up|2
6034043|NCT00699972|20854706|P1|Overall Study|Lost to Follow-up|0
6034044|NCT00699972|20854704|P3|Overall Study|Adverse Event|24
6034045|NCT00699972|20854705|P2|Overall Study|Adverse Event|9
6034046|NCT00699972|20854706|P1|Overall Study|Adverse Event|7
6034047|NCT00699907|20854723|P3|Overall Study|No usable sample|8
6034048|NCT00699907|20854724|P2|Overall Study|No usable sample|9
6034049|NCT00699907|20854725|P1|Overall Study|No usable sample|0
6034050|NCT00699907|20854723|P3|Overall Study|Withdrawal by Subject|0
6034051|NCT00699907|20854724|P2|Overall Study|Withdrawal by Subject|1
6034052|NCT00699907|20854725|P1|Overall Study|Withdrawal by Subject|2
6034053|NCT00699842|20854760|P3|Overall Study|Death|0
6034054|NCT00699842|20854761|P2|Overall Study|Death|1
6034055|NCT00699842|20854762|P1|Overall Study|Death|0
6034056|NCT00699816|20854775|P2|Overall Study|Protocol Violation|3
6034057|NCT00699816|20854776|P1|Overall Study|Protocol Violation|1
6034058|NCT00699751|20854803|P2|Period 2:Switched From Placebo to Xofigo|Completion page not expected|4
6034059|NCT00699751|20854804|P1|Period 2:Switched From Placebo to Xofigo|Completion page not expected|0
6034060|NCT00699751|20854803|P2|Period 2:Switched From Placebo to Xofigo|Investigator Request|1
6034061|NCT00699751|20854804|P1|Period 2:Switched From Placebo to Xofigo|Investigator Request|0
6034062|NCT00699751|20854803|P2|Period 2:Switched From Placebo to Xofigo|Adverse Event|4
6034063|NCT00699751|20854804|P1|Period 2:Switched From Placebo to Xofigo|Adverse Event|0
6034064|NCT00699751|20854803|P2|Period 1: Without/Before Drug Switch|Adverse Event|63
6034065|NCT00699751|20854804|P1|Period 1: Without/Before Drug Switch|Adverse Event|97
6034066|NCT00699751|20854803|P2|Period 1: Without/Before Drug Switch|Other|20
6034067|NCT00699751|20854804|P1|Period 1: Without/Before Drug Switch|Other|30
6034068|NCT00699751|20854803|P2|Period 1: Without/Before Drug Switch|Subject Request|23
6034069|NCT00699751|20854804|P1|Period 1: Without/Before Drug Switch|Subject Request|43
6034070|NCT00699751|20854803|P2|Period 1: Without/Before Drug Switch|Death|29
6034071|NCT00699751|20854804|P1|Period 1: Without/Before Drug Switch|Death|28
6034072|NCT00699751|20854803|P2|Period 1: Without/Before Drug Switch|Investigator Request|27
6034073|NCT00699751|20854804|P1|Period 1: Without/Before Drug Switch|Investigator Request|27
6034074|NCT00699699|20854889|P1|Overall Study|Individual different reasons|21
6034075|NCT00699699|20854889|P1|Overall Study|Adverse Event|36
6034076|NCT00699660|20854898|P2|Overall Study|missing reports and recording failures|6
6034077|NCT00699660|20854899|P1|Overall Study|missing reports and recording failures|10
6034078|NCT00699660|20854898|P2|Overall Study|Lost to Follow-up|2
6034079|NCT00699660|20854899|P1|Overall Study|Lost to Follow-up|4
6034080|NCT00699608|20854911|P6|Second Intervention|Withdrawal by Subject|0
6034081|NCT00699608|20854912|P5|Second Intervention|Withdrawal by Subject|0
6034082|NCT00699608|20854913|P4|Second Intervention|Withdrawal by Subject|1
6034083|NCT00699608|20854914|P3|Second Intervention|Withdrawal by Subject|0
6034084|NCT00699608|20854915|P2|Second Intervention|Withdrawal by Subject|0
6034085|NCT00699608|20854916|P1|Second Intervention|Withdrawal by Subject|0
6034086|NCT00699608|20854911|P6|Second Intervention|Adverse Event|0
6034087|NCT00699608|20854912|P5|Second Intervention|Adverse Event|0
6034088|NCT00699608|20854913|P4|Second Intervention|Adverse Event|0
6034089|NCT00699608|20854914|P3|Second Intervention|Adverse Event|1
6034090|NCT00699608|20854915|P2|Second Intervention|Adverse Event|0
6034091|NCT00699608|20854916|P1|Second Intervention|Adverse Event|0
6034092|NCT00699608|20854911|P6|First Intervention|Protocol Violation|0
6034093|NCT00699608|20854912|P5|First Intervention|Protocol Violation|1
6034094|NCT00699608|20854913|P4|First Intervention|Protocol Violation|0
6034095|NCT00699608|20854914|P3|First Intervention|Protocol Violation|0
6034096|NCT00699608|20854915|P2|First Intervention|Protocol Violation|0
6034097|NCT00699608|20854916|P1|First Intervention|Protocol Violation|0
6034098|NCT00699608|20854911|P6|First Intervention|Withdrawal by Subject|0
6034099|NCT00699608|20854912|P5|First Intervention|Withdrawal by Subject|0
6034100|NCT00699608|20854913|P4|First Intervention|Withdrawal by Subject|0
6034101|NCT00699608|20854914|P3|First Intervention|Withdrawal by Subject|1
6034102|NCT00699608|20854915|P2|First Intervention|Withdrawal by Subject|0
6034103|NCT00699608|20854916|P1|First Intervention|Withdrawal by Subject|0
6034104|NCT00699582|20854969|P3|Overall Study|Randomized, Not Treated|0
6034105|NCT00699582|20854970|P2|Overall Study|Randomized, Not Treated|1
6034106|NCT00699582|20854971|P1|Overall Study|Randomized, Not Treated|2
6034107|NCT00699582|20854969|P3|Overall Study|Administrative/Other|0
6034108|NCT00699582|20854970|P2|Overall Study|Administrative/Other|3
6034109|NCT00699582|20854971|P1|Overall Study|Administrative/Other|4
6034110|NCT00699582|20854969|P3|Overall Study|Progressive Disease|0
6034111|NCT00699582|20854970|P2|Overall Study|Progressive Disease|0
6034112|NCT00699582|20854971|P1|Overall Study|Progressive Disease|1
6034113|NCT00699582|20854969|P3|Overall Study|Lack of Efficacy|1
6034114|NCT00699582|20854970|P2|Overall Study|Lack of Efficacy|0
6034115|NCT00699582|20854971|P1|Overall Study|Lack of Efficacy|1
6034116|NCT00699582|20854969|P3|Overall Study|Withdrawal by Subject|4
6034117|NCT00699582|20854970|P2|Overall Study|Withdrawal by Subject|7
6034118|NCT00699582|20854971|P1|Overall Study|Withdrawal by Subject|6
6034119|NCT00699582|20854969|P3|Overall Study|Adverse Event|23
6034120|NCT00699582|20854970|P2|Overall Study|Adverse Event|11
6034121|NCT00699582|20854971|P1|Overall Study|Adverse Event|4
6034122|NCT00699413|20855026|P2|Overall Study|Study terminated by sponsor|2
6034123|NCT00699413|20855027|P1|Overall Study|Study terminated by sponsor|4
6034124|NCT00699413|20855026|P2|Overall Study|Withdrawal by Subject|2
6034125|NCT00699413|20855027|P1|Overall Study|Withdrawal by Subject|0
6034126|NCT00699374|20855081|P2|Overall Study|Died 28 days after last dose|9
6034127|NCT00699374|20855082|P1|Overall Study|Died 28 days after last dose|5
6034128|NCT00699374|20855081|P2|Overall Study|Randomized but not treated|2
6034129|NCT00699374|20855082|P1|Overall Study|Randomized but not treated|4
6034130|NCT00699374|20855081|P2|Overall Study|Study terminated by sponsor|28
6034131|NCT00699374|20855082|P1|Overall Study|Study terminated by sponsor|13
6034132|NCT00699374|20855081|P2|Overall Study|Protocol Violation|6
6034133|NCT00699374|20855082|P1|Overall Study|Protocol Violation|2
6034134|NCT00699374|20855081|P2|Overall Study|Other|15
6034135|NCT00699374|20855082|P1|Overall Study|Other|18
6034136|NCT00699374|20855081|P2|Overall Study|Objective progression or relapse|277
6034137|NCT00699374|20855082|P1|Overall Study|Objective progression or relapse|281
6034138|NCT00699374|20855081|P2|Overall Study|Withdrawal by Subject|44
6034139|NCT00699374|20855082|P1|Overall Study|Withdrawal by Subject|34
6034140|NCT00699374|20855081|P2|Overall Study|Lost to Follow-up|5
6034141|NCT00699374|20855082|P1|Overall Study|Lost to Follow-up|3
6034142|NCT00699374|20855081|P2|Overall Study|Global deterioration of health status|8
6034143|NCT00699374|20855082|P1|Overall Study|Global deterioration of health status|7
6034144|NCT00699374|20855081|P2|Overall Study|Adverse Event|67
6034145|NCT00699374|20855082|P1|Overall Study|Adverse Event|70
6034146|NCT00699374|20855081|P2|Overall Study|Death|83
6034147|NCT00699374|20855082|P1|Overall Study|Death|93
6034148|NCT00699348|20855094|P1|Overall Study|Other|5
6034149|NCT00699348|20855094|P1|Overall Study|Renal transplantation|10
6034150|NCT00699348|20855094|P1|Overall Study|Blood transfusion|24
6034151|NCT00699348|20855094|P1|Overall Study|Failure to return|1
6034152|NCT00699348|20855094|P1|Overall Study|Lack of Efficacy|8
6034153|NCT00699348|20855094|P1|Overall Study|Protocol Violation|10
6034154|NCT00699348|20855094|P1|Overall Study|Withdrawal by Subject|11
6034155|NCT00699348|20855094|P1|Overall Study|Adverse Event|15
6034156|NCT00699348|20855094|P1|Overall Study|Death|6
6034157|NCT00699335|20855103|P1|Overall Study|Missing data|52
6034158|NCT00699335|20855103|P1|Overall Study|Combination of multiple reasons|176
6034159|NCT00699283|20855136|P2|Overall Study|AE of unknown type|0
6034160|NCT00699283|20855137|P1|Overall Study|AE of unknown type|1
6034161|NCT00699283|20855136|P2|Overall Study|AE, non-serious non-fatal|1
6034162|NCT00699283|20855137|P1|Overall Study|AE, non-serious non-fatal|8
6034163|NCT00699283|20855136|P2|Overall Study|SAE, non-fatal|1
6034164|NCT00699283|20855137|P1|Overall Study|SAE, non-fatal|1
6034165|NCT00699283|20855136|P2|Overall Study|Other Reason|1
6034166|NCT00699283|20855137|P1|Overall Study|Other Reason|5
6034167|NCT00699283|20855136|P2|Overall Study|Withdrawal by Subject|0
6034168|NCT00699283|20855137|P1|Overall Study|Withdrawal by Subject|1
6034169|NCT00699283|20855136|P2|Overall Study|Lost to Follow-up|0
6034170|NCT00699283|20855137|P1|Overall Study|Lost to Follow-up|2
6034171|NCT00699283|20855136|P2|Overall Study|Lack of Efficacy|5
6034172|NCT00699283|20855137|P1|Overall Study|Lack of Efficacy|15
6034173|NCT00699192|20855150|P3|Overall Study|Protocol Violation|0
6034174|NCT00699192|20855151|P2|Overall Study|Protocol Violation|2
6034175|NCT00699192|20855152|P1|Overall Study|Protocol Violation|2
6034176|NCT00699192|20855150|P3|Overall Study|Administrative problems|1
6034177|NCT00699192|20855151|P2|Overall Study|Administrative problems|3
6034178|NCT00699192|20855152|P1|Overall Study|Administrative problems|1
6034179|NCT00699192|20855150|P3|Overall Study|Withdrawal by Subject|4
6034180|NCT00699192|20855151|P2|Overall Study|Withdrawal by Subject|2
6034181|NCT00699192|20855152|P1|Overall Study|Withdrawal by Subject|3
6034182|NCT00699192|20855150|P3|Overall Study|Lack of Efficacy|1
6034183|NCT00699192|20855151|P2|Overall Study|Lack of Efficacy|0
6034184|NCT00699192|20855152|P1|Overall Study|Lack of Efficacy|0
6034185|NCT00699192|20855150|P3|Overall Study|Abnormal test procedure result(s)|1
6034186|NCT00699192|20855151|P2|Overall Study|Abnormal test procedure result(s)|0
6034187|NCT00699192|20855152|P1|Overall Study|Abnormal test procedure result(s)|0
6034188|NCT00699192|20855150|P3|Overall Study|Adverse Event|3
6034189|NCT00699192|20855151|P2|Overall Study|Adverse Event|4
6034190|NCT00699192|20855152|P1|Overall Study|Adverse Event|9
6034191|NCT00699192|20855150|P3|Overall Study|Missing|1
6034192|NCT00699192|20855151|P2|Overall Study|Missing|1
6034193|NCT00699192|20855152|P1|Overall Study|Missing|1
6034194|NCT00699153|20855174|P2|Overall Study|Travel Problem|0
6034195|NCT00699153|20855175|P1|Overall Study|Travel Problem|1
6034196|NCT00699153|20855174|P2|Overall Study|Protocol Violation|0
6034197|NCT00699153|20855175|P1|Overall Study|Protocol Violation|1
6034198|NCT00699153|20855174|P2|Overall Study|Adverse Event|2
6034199|NCT00699153|20855175|P1|Overall Study|Adverse Event|0
6034200|NCT00699153|20855174|P2|Overall Study|Lost to Follow-up|0
6034201|NCT00699153|20855175|P1|Overall Study|Lost to Follow-up|1
6034202|NCT00698997|20855210|P2|Overall Study|Withdrawal by Subject|27
6034203|NCT00698997|20855211|P1|Overall Study|Withdrawal by Subject|7
6034204|NCT00698997|20855210|P2|Overall Study|Lost to Follow-up|0
6034205|NCT00698997|20855211|P1|Overall Study|Lost to Follow-up|3
6034206|NCT00698932|20855225|P2|Overall Study|Death|0
6034207|NCT00698932|20855226|P1|Overall Study|Death|1
6034208|NCT00698932|20855225|P2|Overall Study|Safety reasons|2
6034209|NCT00698932|20855226|P1|Overall Study|Safety reasons|0
6034210|NCT00698932|20855225|P2|Overall Study|Severe non-compliance to protocol|2
6034211|NCT00698932|20855226|P1|Overall Study|Severe non-compliance to protocol|1
6034212|NCT00698932|20855225|P2|Overall Study|Lost to Follow-up|1
6034213|NCT00698932|20855226|P1|Overall Study|Lost to Follow-up|6
6034214|NCT00698932|20855225|P2|Overall Study|Withdrawal by Subject|23
6034215|NCT00698932|20855226|P1|Overall Study|Withdrawal by Subject|11
6034216|NCT00698932|20855225|P2|Overall Study|Study specific discontinuation criteria|4
6034217|NCT00698932|20855226|P1|Overall Study|Study specific discontinuation criteria|3
6034218|NCT00698932|20855225|P2|Overall Study|Incorrect enrollment|2
6034219|NCT00698932|20855226|P1|Overall Study|Incorrect enrollment|0
6034220|NCT00698932|20855225|P2|Overall Study|Adverse Event|2
6034221|NCT00698932|20855226|P1|Overall Study|Adverse Event|0
6034222|NCT00698841|20855252|P1|Overall Study|Other|2
6034223|NCT00698841|20855252|P1|Overall Study|Study drug toxicity|2
6034224|NCT00698841|20855252|P1|Overall Study|Failure to meet eligibility criteria|2
6034225|NCT00698841|20855252|P1|Overall Study|Disease progression|7
6034226|NCT00698841|20855252|P1|Overall Study|Adverse Event|3
6034227|NCT00698841|20855252|P1|Overall Study|Withdrawal by Subject|2
6034228|NCT00698815|20855266|P3|Overall Study|Did not receive protocol treatment|2
6034229|NCT00698815|20855267|P2|Overall Study|Did not receive protocol treatment|2
6034230|NCT00698815|20855268|P1|Overall Study|Did not receive protocol treatment|1
6034231|NCT00698815|20855266|P3|Overall Study|MD discretion|2
6034232|NCT00698815|20855267|P2|Overall Study|MD discretion|7
6034233|NCT00698815|20855268|P1|Overall Study|MD discretion|2
6034234|NCT00698815|20855266|P3|Overall Study|Withdrawal by Subject|2
6034235|NCT00698815|20855267|P2|Overall Study|Withdrawal by Subject|3
6034236|NCT00698815|20855268|P1|Overall Study|Withdrawal by Subject|6
6034237|NCT00698815|20855266|P3|Overall Study|Death|4
6034238|NCT00698815|20855267|P2|Overall Study|Death|2
6034239|NCT00698815|20855268|P1|Overall Study|Death|1
6034240|NCT00698685|20855285|P1|Overall Study|Off study pre transplant by clinic MD|1
6034241|NCT00698685|20855285|P1|Overall Study|Sister withdrew as donor|1
6034242|NCT00698646|20855293|P3|Overall Study|Administrative problems|1
6034243|NCT00698646|20855294|P2|Overall Study|Administrative problems|0
6034244|NCT00698646|20855295|P1|Overall Study|Administrative problems|1
6034245|NCT00698646|20855293|P3|Overall Study|Lost to Follow-up|2
6034246|NCT00698646|20855294|P2|Overall Study|Lost to Follow-up|0
6034247|NCT00698646|20855295|P1|Overall Study|Lost to Follow-up|0
6034248|NCT00698646|20855293|P3|Overall Study|Withdrawal by Subject|8
6034249|NCT00698646|20855294|P2|Overall Study|Withdrawal by Subject|11
6034250|NCT00698646|20855295|P1|Overall Study|Withdrawal by Subject|10
6034251|NCT00698646|20855293|P3|Overall Study|Protocol Deviation|3
6034252|NCT00698646|20855294|P2|Overall Study|Protocol Deviation|2
6034253|NCT00698646|20855295|P1|Overall Study|Protocol Deviation|6
6034254|NCT00698646|20855293|P3|Overall Study|Unsatisfactory Therapeutic Effect|7
6034255|NCT00698646|20855294|P2|Overall Study|Unsatisfactory Therapeutic Effect|11
6034256|NCT00698646|20855295|P1|Overall Study|Unsatisfactory Therapeutic Effect|11
6034257|NCT00698646|20855293|P3|Overall Study|Adverse Event|8
6034258|NCT00698646|20855294|P2|Overall Study|Adverse Event|7
6034259|NCT00698646|20855295|P1|Overall Study|Adverse Event|8
6034260|NCT00698581|20855320|P2|Overall Study|AE of unknown type|0
6034261|NCT00698581|20855321|P1|Overall Study|AE of unknown type|1
6034262|NCT00698581|20855320|P2|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0
6034263|NCT00698581|20855321|P1|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
6034264|NCT00698581|20855320|P2|Overall Study|AE, non-serious non-fatal|0
6034265|NCT00698581|20855321|P1|Overall Study|AE, non-serious non-fatal|4
6034266|NCT00698581|20855320|P2|Overall Study|SAE, non-fatal|0
6034267|NCT00698581|20855321|P1|Overall Study|SAE, non-fatal|1
6034268|NCT00698581|20855320|P2|Overall Study|Other reason|1
6034269|NCT00698581|20855321|P1|Overall Study|Other reason|9
6034270|NCT00698581|20855320|P2|Overall Study|Withdrawal by Subject|0
6034271|NCT00698581|20855321|P1|Overall Study|Withdrawal by Subject|6
6034272|NCT00698581|20855320|P2|Overall Study|Lack of Efficacy|11
6034273|NCT00698581|20855321|P1|Overall Study|Lack of Efficacy|23
6034274|NCT00698516|20855332|P1|Overall Study|Withdrawal by Subject|3
6034275|NCT00698516|20855332|P1|Overall Study|Study Termination|2
6034276|NCT00698451|20855350|P1|Overall Study|Disease progression|3
6034277|NCT00698451|20855350|P1|Overall Study|Withdrawal by Subject|6
6034278|NCT00698451|20855350|P1|Overall Study|Protocol Violation|6
6034279|NCT00698451|20855350|P1|Overall Study|Physician Decision|2
6034280|NCT00698451|20855350|P1|Overall Study|Adverse Event|22
6034281|NCT00698204|20855357|P2|Overall Study|Withdrawal by Subject|0
6034282|NCT00698204|20855358|P1|Overall Study|Withdrawal by Subject|1
6034283|NCT00698009|20855418|P1|Overall Study|Withdrawal by Subject|1
6034284|NCT00697827|20855424|P2|Overall Study|enrolled but not treated|1
6034285|NCT00697827|20855425|P1|Overall Study|enrolled but not treated|2
6034286|NCT00697788|20855452|P8|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
6034287|NCT00697788|20855453|P7|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
6034288|NCT00697788|20855454|P6|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
6034289|NCT00697788|20855455|P5|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|1
6034290|NCT00697788|20855456|P4|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
6034291|NCT00697788|20855457|P3|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
6034292|NCT00697788|20855458|P2|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
6034293|NCT00697788|20855459|P1|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
6034294|NCT00697788|20855452|P8|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
6034295|NCT00697788|20855453|P7|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
6034296|NCT00697788|20855454|P6|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
6034297|NCT00697788|20855455|P5|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
6034298|NCT00697788|20855456|P4|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
6034299|NCT00697788|20855457|P3|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
6034383|NCT00696800|20855903|P1|Overall Study|Insufficient ovarian response|4
6034300|NCT00697788|20855458|P2|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|2
6034301|NCT00697788|20855459|P1|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
6034302|NCT00697619|20855514|P2|Overall Study|Adverse Event|6
6034303|NCT00697619|20855515|P1|Overall Study|Adverse Event|4
6034304|NCT00697619|20855514|P2|Overall Study|Lack of Efficacy|2
6034305|NCT00697619|20855515|P1|Overall Study|Lack of Efficacy|2
6034306|NCT00697593|20855521|P1|Overall Study|Suspension of the study by sponsor|12
6034307|NCT00697593|20855521|P1|Overall Study|Lack of Efficacy|3
6034308|NCT00697593|20855521|P1|Overall Study|Protocol Violation|1
6034309|NCT00697593|20855521|P1|Overall Study|Adverse Event|3
6034310|NCT00697515|20855565|P2|Second Intervention (Crossover Period)|Withdrawal by Subject|1
6034311|NCT00697515|20855566|P1|Second Intervention (Crossover Period)|Withdrawal by Subject|1
6034312|NCT00697515|20855565|P2|First Intervention (Crossover Period)|Withdrawal by Subject|1
6034313|NCT00697515|20855566|P1|First Intervention (Crossover Period)|Withdrawal by Subject|2
6034314|NCT00697515|20855565|P2|First Intervention (Crossover Period)|Adverse Event|2
6034315|NCT00697515|20855566|P1|First Intervention (Crossover Period)|Adverse Event|0
6034316|NCT00697515|20855565|P2|First Intervention (Crossover Period)|Natural disaster|9
6034317|NCT00697515|20855566|P1|First Intervention (Crossover Period)|Natural disaster|8
6034318|NCT00697515|20855565|P2|Dose Optimization Period|elevated QTc|0
6034319|NCT00697515|20855566|P1|Dose Optimization Period|elevated QTc|1
6034320|NCT00697515|20855565|P2|Dose Optimization Period|called to active duty|0
6034321|NCT00697515|20855566|P1|Dose Optimization Period|called to active duty|1
6034322|NCT00697515|20855565|P2|Dose Optimization Period|sponsor request|0
6034323|NCT00697515|20855566|P1|Dose Optimization Period|sponsor request|2
6034324|NCT00697515|20855565|P2|Dose Optimization Period|Lost to Follow-up|0
6034325|NCT00697515|20855566|P1|Dose Optimization Period|Lost to Follow-up|2
6034326|NCT00697515|20855565|P2|Dose Optimization Period|Withdrawal by Subject|0
6034327|NCT00697515|20855566|P1|Dose Optimization Period|Withdrawal by Subject|5
6034328|NCT00697515|20855565|P2|Dose Optimization Period|Adverse Event|0
6034329|NCT00697515|20855566|P1|Dose Optimization Period|Adverse Event|4
6034330|NCT00697463|20855594|P1|Overall Study|Withdrawal by Subject|1
6034331|NCT00697346|20855601|P3|Overall Study|Reason not Specified|1
6034332|NCT00697346|20855602|P2|Overall Study|Reason not Specified|0
6034333|NCT00697346|20855603|P1|Overall Study|Reason not Specified|3
6034334|NCT00697346|20855601|P3|Overall Study|Withdrawal by Subject|0
6034335|NCT00697346|20855602|P2|Overall Study|Withdrawal by Subject|2
6034336|NCT00697346|20855603|P1|Overall Study|Withdrawal by Subject|2
6034337|NCT00697346|20855601|P3|Overall Study|Symptomatic Deterioration|0
6034338|NCT00697346|20855602|P2|Overall Study|Symptomatic Deterioration|1
6034339|NCT00697346|20855603|P1|Overall Study|Symptomatic Deterioration|0
6034340|NCT00697346|20855601|P3|Overall Study|Progressive Disease|0
6034341|NCT00697346|20855602|P2|Overall Study|Progressive Disease|18
6034342|NCT00697346|20855603|P1|Overall Study|Progressive Disease|19
6034343|NCT00697346|20855601|P3|Overall Study|Adverse Event|0
6034344|NCT00697346|20855602|P2|Overall Study|Adverse Event|5
6034345|NCT00697346|20855603|P1|Overall Study|Adverse Event|4
6034346|NCT00697255|20855711|P2|Stage 1b|Insufficient ovarian response|1
6034347|NCT00697255|20855712|P1|Stage 1b|Insufficient ovarian response|0
6034348|NCT00697255|20855711|P2|Stage 1b|Not growing of dominant follicle|1
6034349|NCT00697255|20855712|P1|Stage 1b|Not growing of dominant follicle|0
6034350|NCT00697255|20855711|P2|Stage 1a|Not growing of dominant follicle|0
6034351|NCT00697255|20855712|P1|Stage 1a|Not growing of dominant follicle|1
6034352|NCT00697255|20855711|P2|Stage 1a|Multifollicular growth|0
6034353|NCT00697255|20855712|P1|Stage 1a|Multifollicular growth|1
6034354|NCT00697255|20855711|P2|Stage 1a|Insufficient ovarian response|0
6034355|NCT00697255|20855712|P1|Stage 1a|Insufficient ovarian response|1
6034356|NCT00697112|20855800|P1|Overall Study|Did not meet inclusion criteria|1
6034357|NCT00697112|20855800|P1|Overall Study|Lost to Follow-up|1
6034358|NCT00697112|20855800|P1|Overall Study|Adverse Event|8
6034359|NCT00697073|20855824|P1|Overall Study|non compliance and other|6
6034360|NCT00697073|20855824|P1|Overall Study|Pregnancy|1
6034361|NCT00697073|20855824|P1|Overall Study|Withdrawal by Subject|2
6034362|NCT00696878|20855828|P1|Overall Study|Other reason (not specified)|55
6034363|NCT00696878|20855828|P1|Overall Study|Trial stopped|32
6034364|NCT00696878|20855828|P1|Overall Study|Pregnant prior to Treat Cycle 3|304
6034365|NCT00696878|20855828|P1|Overall Study|Stop Treat Cycle 3 not for Adverse Event|18
6034366|NCT00696878|20855828|P1|Overall Study|Withdrawal by Subject|87
6034367|NCT00696878|20855828|P1|Overall Study|Adverse Event|8
6034368|NCT00696800|20855902|P2|Overall Study|Not treated|2
6034369|NCT00696800|20855903|P1|Overall Study|Not treated|1
6034370|NCT00696800|20855902|P2|Overall Study|Other Reasons|3
6034371|NCT00696800|20855903|P1|Overall Study|Other Reasons|5
6034372|NCT00696800|20855902|P2|Overall Study|No/too few/bad quality embryos|18
6034373|NCT00696800|20855903|P1|Overall Study|No/too few/bad quality embryos|24
6034374|NCT00696800|20855902|P2|Overall Study|No/abnormal fertilization|13
6034375|NCT00696800|20855903|P1|Overall Study|No/abnormal fertilization|11
6034376|NCT00696800|20855902|P2|Overall Study|No/too few/bad quality oocytes|3
6034377|NCT00696800|20855903|P1|Overall Study|No/too few/bad quality oocytes|4
6034378|NCT00696800|20855902|P2|Overall Study|Too high ovarian response|1
6034379|NCT00696800|20855903|P1|Overall Study|Too high ovarian response|6
6034380|NCT00696800|20855902|P2|Overall Study|Risk Ovarian Hyperstimulation Syndrome|2
6034381|NCT00696800|20855903|P1|Overall Study|Risk Ovarian Hyperstimulation Syndrome|8
6034382|NCT00696800|20855902|P2|Overall Study|Insufficient ovarian response|1
6034384|NCT00696800|20855902|P2|Overall Study|Insufficient ovarian response on Day 8|1
6034385|NCT00696800|20855903|P1|Overall Study|Insufficient ovarian response on Day 8|4
6034386|NCT00696800|20855902|P2|Overall Study|Insufficient compliance with medication|1
6034387|NCT00696800|20855903|P1|Overall Study|Insufficient compliance with medication|2
6034388|NCT00696800|20855902|P2|Overall Study|Adverse Event|3
6034389|NCT00696800|20855903|P1|Overall Study|Adverse Event|16
6034390|NCT00696787|20855956|P3|Overall Study|Failed to return|1
6034391|NCT00696787|20855957|P2|Overall Study|Failed to return|3
6034392|NCT00696787|20855958|P1|Overall Study|Failed to return|1
6034393|NCT00696787|20855956|P3|Overall Study|Withdrawal by Subject|2
6034394|NCT00696787|20855957|P2|Overall Study|Withdrawal by Subject|3
6034395|NCT00696787|20855958|P1|Overall Study|Withdrawal by Subject|0
6034396|NCT00696787|20855956|P3|Overall Study|Lost to Follow-up|3
6034397|NCT00696787|20855957|P2|Overall Study|Lost to Follow-up|0
6034398|NCT00696787|20855958|P1|Overall Study|Lost to Follow-up|4
6034399|NCT00696787|20855956|P3|Overall Study|Lack of Efficacy|0
6034400|NCT00696787|20855957|P2|Overall Study|Lack of Efficacy|1
6034401|NCT00696787|20855958|P1|Overall Study|Lack of Efficacy|0
6034402|NCT00696787|20855956|P3|Overall Study|Discontinuation by Sponsor|14
6034403|NCT00696787|20855957|P2|Overall Study|Discontinuation by Sponsor|13
6034404|NCT00696787|20855958|P1|Overall Study|Discontinuation by Sponsor|9
6034405|NCT00696787|20855956|P3|Overall Study|Adverse Event|6
6034406|NCT00696787|20855957|P2|Overall Study|Adverse Event|0
6034407|NCT00696787|20855958|P1|Overall Study|Adverse Event|1
6034408|NCT00696774|20855972|P3|Period III|Lack of Efficacy|0
6034409|NCT00696774|20855973|P2|Period III|Lack of Efficacy|2
6034410|NCT00696774|20855974|P1|Period III|Lack of Efficacy|0
6034411|NCT00696774|20855972|P3|Period III|Sponsor Decision|0
6034412|NCT00696774|20855973|P2|Period III|Sponsor Decision|0
6034413|NCT00696774|20855974|P1|Period III|Sponsor Decision|2
6034414|NCT00696774|20855972|P3|Period III|Withdrawal by Subject|0
6034415|NCT00696774|20855973|P2|Period III|Withdrawal by Subject|2
6034416|NCT00696774|20855974|P1|Period III|Withdrawal by Subject|1
6034417|NCT00696774|20855972|P3|Period III|Protocol Violation|0
6034418|NCT00696774|20855973|P2|Period III|Protocol Violation|1
6034419|NCT00696774|20855974|P1|Period III|Protocol Violation|1
6034420|NCT00696774|20855972|P3|Period III|Lost to Follow-up|0
6034421|NCT00696774|20855973|P2|Period III|Lost to Follow-up|1
6034422|NCT00696774|20855974|P1|Period III|Lost to Follow-up|2
6034423|NCT00696774|20855972|P3|Period III|Adverse Event|0
6034424|NCT00696774|20855973|P2|Period III|Adverse Event|1
6034425|NCT00696774|20855974|P1|Period III|Adverse Event|1
6034426|NCT00696774|20855972|P3|Period II|Lack of Efficacy|2
6034427|NCT00696774|20855973|P2|Period II|Lack of Efficacy|0
6034428|NCT00696774|20855974|P1|Period II|Lack of Efficacy|0
6034429|NCT00696774|20855972|P3|Period II|Sponsor Decision|0
6034430|NCT00696774|20855973|P2|Period II|Sponsor Decision|0
6034431|NCT00696774|20855974|P1|Period II|Sponsor Decision|0
6034432|NCT00696774|20855972|P3|Period II|Withdrawal by Subject|4
6034433|NCT00696774|20855973|P2|Period II|Withdrawal by Subject|0
6034434|NCT00696774|20855974|P1|Period II|Withdrawal by Subject|0
6034435|NCT00696774|20855972|P3|Period II|Protocol Violation|11
6034436|NCT00696774|20855973|P2|Period II|Protocol Violation|0
6034437|NCT00696774|20855974|P1|Period II|Protocol Violation|0
6034438|NCT00696774|20855972|P3|Period II|Lost to Follow-up|4
6034439|NCT00696774|20855973|P2|Period II|Lost to Follow-up|0
6034440|NCT00696774|20855974|P1|Period II|Lost to Follow-up|0
6034441|NCT00696774|20855972|P3|Period II|Adverse Event|15
6034442|NCT00696774|20855973|P2|Period II|Adverse Event|0
6034443|NCT00696774|20855974|P1|Period II|Adverse Event|0
6034444|NCT00696709|20856034|P5|Overall Study|Adverse Event|0
6034445|NCT00696709|20856035|P4|Overall Study|Adverse Event|1
6034446|NCT00696709|20856036|P3|Overall Study|Adverse Event|0
6034447|NCT00696709|20856037|P2|Overall Study|Adverse Event|0
6034448|NCT00696709|20856038|P1|Overall Study|Adverse Event|0
6034449|NCT00696709|20856034|P5|Overall Study|Lost to Follow-up|0
6034450|NCT00696709|20856035|P4|Overall Study|Lost to Follow-up|0
6034451|NCT00696709|20856036|P3|Overall Study|Lost to Follow-up|0
6034452|NCT00696709|20856037|P2|Overall Study|Lost to Follow-up|1
6034453|NCT00696709|20856038|P1|Overall Study|Lost to Follow-up|1
6034454|NCT00696709|20856034|P5|Overall Study|Protocol Violation|0
6034455|NCT00696709|20856035|P4|Overall Study|Protocol Violation|0
6034456|NCT00696709|20856036|P3|Overall Study|Protocol Violation|0
6034457|NCT00696709|20856037|P2|Overall Study|Protocol Violation|0
6034458|NCT00696709|20856038|P1|Overall Study|Protocol Violation|1
6034459|NCT00696709|20856034|P5|Overall Study|Withdrawal by Subject|3
6034460|NCT00696709|20856035|P4|Overall Study|Withdrawal by Subject|4
6034461|NCT00696709|20856036|P3|Overall Study|Withdrawal by Subject|1
6034462|NCT00696709|20856037|P2|Overall Study|Withdrawal by Subject|2
6034463|NCT00696709|20856038|P1|Overall Study|Withdrawal by Subject|1
6034464|NCT00696696|20856074|P1|Overall Study|Death|3
6034465|NCT00696696|20856074|P1|Overall Study|Physician Decision|2
6034466|NCT00696696|20856074|P1|Overall Study|Withdrawal by Subject|8
6034467|NCT00696696|20856074|P1|Overall Study|Adverse Event|5
6034468|NCT00696657|20856089|P9|Overall Study|Adverse Event|5
6034469|NCT00696657|20856090|P8|Overall Study|Adverse Event|2
6034470|NCT00696657|20856091|P7|Overall Study|Adverse Event|14
6034471|NCT00696657|20856092|P6|Overall Study|Adverse Event|9
6034472|NCT00696657|20856093|P5|Overall Study|Adverse Event|6
6034473|NCT00696657|20856094|P4|Overall Study|Adverse Event|7
6034474|NCT00696657|20856095|P3|Overall Study|Adverse Event|3
6034475|NCT00696657|20856096|P2|Overall Study|Adverse Event|0
6034476|NCT00696657|20856097|P1|Overall Study|Adverse Event|0
6034477|NCT00696657|20856089|P9|Overall Study|Unclassified|1
6034478|NCT00696657|20856090|P8|Overall Study|Unclassified|0
6034479|NCT00696657|20856091|P7|Overall Study|Unclassified|0
6034480|NCT00696657|20856092|P6|Overall Study|Unclassified|2
6034481|NCT00696657|20856093|P5|Overall Study|Unclassified|4
6034482|NCT00696657|20856094|P4|Overall Study|Unclassified|2
6034483|NCT00696657|20856095|P3|Overall Study|Unclassified|3
6034484|NCT00696657|20856096|P2|Overall Study|Unclassified|1
6034485|NCT00696657|20856097|P1|Overall Study|Unclassified|0
6034486|NCT00696657|20856089|P9|Overall Study|Withdrawal criteria|2
6034487|NCT00696657|20856090|P8|Overall Study|Withdrawal criteria|1
6034488|NCT00696657|20856091|P7|Overall Study|Withdrawal criteria|1
6034489|NCT00696657|20856092|P6|Overall Study|Withdrawal criteria|0
6034490|NCT00696657|20856093|P5|Overall Study|Withdrawal criteria|0
6034491|NCT00696657|20856094|P4|Overall Study|Withdrawal criteria|2
6034492|NCT00696657|20856095|P3|Overall Study|Withdrawal criteria|2
6034493|NCT00696657|20856096|P2|Overall Study|Withdrawal criteria|3
6034494|NCT00696657|20856097|P1|Overall Study|Withdrawal criteria|1
6034495|NCT00696657|20856089|P9|Overall Study|Lack of Efficacy|0
6034496|NCT00696657|20856090|P8|Overall Study|Lack of Efficacy|0
6034497|NCT00696657|20856091|P7|Overall Study|Lack of Efficacy|0
6034498|NCT00696657|20856092|P6|Overall Study|Lack of Efficacy|0
6034499|NCT00696657|20856093|P5|Overall Study|Lack of Efficacy|0
6034500|NCT00696657|20856094|P4|Overall Study|Lack of Efficacy|0
6034501|NCT00696657|20856095|P3|Overall Study|Lack of Efficacy|0
6034502|NCT00696657|20856096|P2|Overall Study|Lack of Efficacy|1
6034503|NCT00696657|20856097|P1|Overall Study|Lack of Efficacy|0
6034504|NCT00696657|20856089|P9|Overall Study|Protocol Violation|1
6034505|NCT00696657|20856090|P8|Overall Study|Protocol Violation|0
6034506|NCT00696657|20856091|P7|Overall Study|Protocol Violation|0
6034507|NCT00696657|20856092|P6|Overall Study|Protocol Violation|1
6034508|NCT00696657|20856093|P5|Overall Study|Protocol Violation|0
6034509|NCT00696657|20856094|P4|Overall Study|Protocol Violation|0
6034510|NCT00696657|20856095|P3|Overall Study|Protocol Violation|0
6034511|NCT00696657|20856096|P2|Overall Study|Protocol Violation|0
6034512|NCT00696657|20856097|P1|Overall Study|Protocol Violation|0
6034513|NCT00696436|20856466|P5|Overall Study|Missing|0
6034514|NCT00696436|20856467|P4|Overall Study|Missing|0
6034515|NCT00696436|20856468|P3|Overall Study|Missing|1
6034516|NCT00696436|20856469|P2|Overall Study|Missing|1
6034517|NCT00696436|20856470|P1|Overall Study|Missing|0
6034518|NCT00696436|20856466|P5|Overall Study|Administrative Decision|0
6034519|NCT00696436|20856467|P4|Overall Study|Administrative Decision|0
6034520|NCT00696436|20856468|P3|Overall Study|Administrative Decision|0
6034521|NCT00696436|20856469|P2|Overall Study|Administrative Decision|0
6034522|NCT00696436|20856470|P1|Overall Study|Administrative Decision|1
6034523|NCT00696436|20856466|P5|Overall Study|Participant Non-compliance|0
6034524|NCT00696436|20856467|P4|Overall Study|Participant Non-compliance|2
6034525|NCT00696436|20856468|P3|Overall Study|Participant Non-compliance|1
6034526|NCT00696436|20856469|P2|Overall Study|Participant Non-compliance|0
6034527|NCT00696436|20856470|P1|Overall Study|Participant Non-compliance|0
6034528|NCT00696436|20856466|P5|Overall Study|Administrative Error|0
6034529|NCT00696436|20856467|P4|Overall Study|Administrative Error|0
6034530|NCT00696436|20856468|P3|Overall Study|Administrative Error|2
6034531|NCT00696436|20856469|P2|Overall Study|Administrative Error|0
6034532|NCT00696436|20856470|P1|Overall Study|Administrative Error|2
6034533|NCT00696436|20856466|P5|Overall Study|Participant Unavailability|0
6034534|NCT00696436|20856467|P4|Overall Study|Participant Unavailability|1
6034535|NCT00696436|20856468|P3|Overall Study|Participant Unavailability|2
6034536|NCT00696436|20856469|P2|Overall Study|Participant Unavailability|0
6034537|NCT00696436|20856470|P1|Overall Study|Participant Unavailability|2
6034538|NCT00696436|20856466|P5|Overall Study|Lack of Efficacy|4
6034539|NCT00696436|20856467|P4|Overall Study|Lack of Efficacy|2
6034540|NCT00696436|20856468|P3|Overall Study|Lack of Efficacy|5
6034541|NCT00696436|20856469|P2|Overall Study|Lack of Efficacy|1
6034542|NCT00696436|20856470|P1|Overall Study|Lack of Efficacy|3
6034543|NCT00696436|20856466|P5|Overall Study|Withdrawal by Subject|1
6034544|NCT00696436|20856467|P4|Overall Study|Withdrawal by Subject|7
6034545|NCT00696436|20856468|P3|Overall Study|Withdrawal by Subject|5
6034546|NCT00696436|20856469|P2|Overall Study|Withdrawal by Subject|11
6034547|NCT00696436|20856470|P1|Overall Study|Withdrawal by Subject|4
6034548|NCT00696436|20856466|P5|Overall Study|Lost to Follow-up|3
6034549|NCT00696436|20856467|P4|Overall Study|Lost to Follow-up|4
6034550|NCT00696436|20856468|P3|Overall Study|Lost to Follow-up|2
6034551|NCT00696436|20856469|P2|Overall Study|Lost to Follow-up|6
6034552|NCT00696436|20856470|P1|Overall Study|Lost to Follow-up|1
6034553|NCT00696436|20856466|P5|Overall Study|Protocol Violation|1
6034554|NCT00696436|20856467|P4|Overall Study|Protocol Violation|0
6034555|NCT00696436|20856468|P3|Overall Study|Protocol Violation|2
6034556|NCT00696436|20856469|P2|Overall Study|Protocol Violation|2
6034557|NCT00696436|20856470|P1|Overall Study|Protocol Violation|3
6034558|NCT00696436|20856466|P5|Overall Study|Adverse Event|4
6034559|NCT00696436|20856467|P4|Overall Study|Adverse Event|6
6034560|NCT00696436|20856468|P3|Overall Study|Adverse Event|8
6034561|NCT00696436|20856469|P2|Overall Study|Adverse Event|9
6034562|NCT00696436|20856470|P1|Overall Study|Adverse Event|7
6034563|NCT00696423|20856554|P2|Overall Study|Lost to Follow-up|5
6034564|NCT00696423|20856555|P1|Overall Study|Lost to Follow-up|0
6034565|NCT00696410|20856587|P2|Overall Study|Physician Decision|0
6034566|NCT00696410|20856588|P1|Overall Study|Physician Decision|3
6034567|NCT00696410|20856587|P2|Overall Study|Withdrawal by Subject|0
6034568|NCT00696410|20856588|P1|Overall Study|Withdrawal by Subject|8
6034569|NCT00696410|20856587|P2|Overall Study|Lost to Follow-up|0
6034570|NCT00696410|20856588|P1|Overall Study|Lost to Follow-up|2
6034571|NCT00696384|20856602|P3|Double Blind Phase|Physician Decision|0
6034572|NCT00696384|20856603|P2|Double Blind Phase|Physician Decision|2
6034573|NCT00696384|20856604|P1|Double Blind Phase|Physician Decision|0
6034574|NCT00696384|20856602|P3|Double Blind Phase|Lack of Efficacy|0
6034575|NCT00696384|20856603|P2|Double Blind Phase|Lack of Efficacy|1
6034576|NCT00696384|20856604|P1|Double Blind Phase|Lack of Efficacy|0
6034577|NCT00696384|20856602|P3|Double Blind Phase|Withdrawal by Subject|3
6034578|NCT00696384|20856603|P2|Double Blind Phase|Withdrawal by Subject|4
6034579|NCT00696384|20856604|P1|Double Blind Phase|Withdrawal by Subject|0
6034580|NCT00696384|20856602|P3|Double Blind Phase|Lost to Follow-up|1
6034581|NCT00696384|20856603|P2|Double Blind Phase|Lost to Follow-up|2
6034582|NCT00696384|20856604|P1|Double Blind Phase|Lost to Follow-up|0
6034583|NCT00696384|20856602|P3|Double Blind Phase|Adverse Event|2
6034584|NCT00696384|20856603|P2|Double Blind Phase|Adverse Event|2
6034585|NCT00696384|20856604|P1|Double Blind Phase|Adverse Event|0
6034586|NCT00696384|20856602|P3|Open Label Phase|Physician Decision|0
6034587|NCT00696384|20856603|P2|Open Label Phase|Physician Decision|0
6034588|NCT00696384|20856604|P1|Open Label Phase|Physician Decision|4
6034589|NCT00696384|20856602|P3|Open Label Phase|Lack of Efficacy|0
6034590|NCT00696384|20856603|P2|Open Label Phase|Lack of Efficacy|0
6034591|NCT00696384|20856604|P1|Open Label Phase|Lack of Efficacy|3
6034592|NCT00696384|20856602|P3|Open Label Phase|Other|0
6034593|NCT00696384|20856603|P2|Open Label Phase|Other|0
6034594|NCT00696384|20856604|P1|Open Label Phase|Other|6
6034595|NCT00696384|20856602|P3|Open Label Phase|Withdrawal by Subject|0
6034596|NCT00696384|20856603|P2|Open Label Phase|Withdrawal by Subject|0
6034597|NCT00696384|20856604|P1|Open Label Phase|Withdrawal by Subject|37
6034598|NCT00696384|20856602|P3|Open Label Phase|Lost to Follow-up|0
6034599|NCT00696384|20856603|P2|Open Label Phase|Lost to Follow-up|0
6034600|NCT00696384|20856604|P1|Open Label Phase|Lost to Follow-up|24
6034601|NCT00696384|20856602|P3|Open Label Phase|Protocol Violation|0
6034602|NCT00696384|20856603|P2|Open Label Phase|Protocol Violation|0
6034603|NCT00696384|20856604|P1|Open Label Phase|Protocol Violation|18
6034604|NCT00696384|20856602|P3|Open Label Phase|Adverse Event|0
6034605|NCT00696384|20856603|P2|Open Label Phase|Adverse Event|0
6034606|NCT00696384|20856604|P1|Open Label Phase|Adverse Event|27
6034607|NCT00696241|20856628|P5|Overall Study|Other|1
6034608|NCT00696241|20856629|P4|Overall Study|Other|2
6034609|NCT00696241|20856630|P3|Overall Study|Other|5
6034610|NCT00696241|20856631|P2|Overall Study|Other|1
6034611|NCT00696241|20856632|P1|Overall Study|Other|6
6034612|NCT00696241|20856628|P5|Overall Study|Lack of Efficacy|3
6034613|NCT00696241|20856629|P4|Overall Study|Lack of Efficacy|5
6034614|NCT00696241|20856630|P3|Overall Study|Lack of Efficacy|4
6034615|NCT00696241|20856631|P2|Overall Study|Lack of Efficacy|5
6034616|NCT00696241|20856632|P1|Overall Study|Lack of Efficacy|1
6034617|NCT00696241|20856628|P5|Overall Study|Withdrawal by Subject|0
6034618|NCT00696241|20856629|P4|Overall Study|Withdrawal by Subject|1
6034619|NCT00696241|20856630|P3|Overall Study|Withdrawal by Subject|6
6034620|NCT00696241|20856631|P2|Overall Study|Withdrawal by Subject|8
6034621|NCT00696241|20856632|P1|Overall Study|Withdrawal by Subject|4
6034622|NCT00696241|20856628|P5|Overall Study|Lost to Follow-up|0
6034623|NCT00696241|20856629|P4|Overall Study|Lost to Follow-up|2
6034624|NCT00696241|20856630|P3|Overall Study|Lost to Follow-up|1
6034625|NCT00696241|20856631|P2|Overall Study|Lost to Follow-up|4
6034626|NCT00696241|20856632|P1|Overall Study|Lost to Follow-up|1
6034627|NCT00696241|20856628|P5|Overall Study|Protocol Violation|3
6034628|NCT00696241|20856629|P4|Overall Study|Protocol Violation|0
6034629|NCT00696241|20856630|P3|Overall Study|Protocol Violation|2
6034630|NCT00696241|20856631|P2|Overall Study|Protocol Violation|1
6034631|NCT00696241|20856632|P1|Overall Study|Protocol Violation|1
6034632|NCT00696241|20856628|P5|Overall Study|Adverse Event|5
6034633|NCT00696241|20856629|P4|Overall Study|Adverse Event|4
6034634|NCT00696241|20856630|P3|Overall Study|Adverse Event|6
6034635|NCT00696241|20856631|P2|Overall Study|Adverse Event|3
6034636|NCT00696241|20856632|P1|Overall Study|Adverse Event|11
6034637|NCT00696137|20856714|P1|Overall Study|Withdrawal by Subject|2
6034638|NCT00696072|20856720|P2|Overall Study|Non-specified|2
6034639|NCT00696072|20856721|P1|Overall Study|Non-specified|1
6034640|NCT00696072|20856720|P2|Overall Study|Disease Progression|30
6034641|NCT00696072|20856721|P1|Overall Study|Disease Progression|32
6034642|NCT00696072|20856720|P2|Overall Study|Sponsor Request|1
6034643|NCT00696072|20856721|P1|Overall Study|Sponsor Request|0
6034644|NCT00696072|20856720|P2|Overall Study|Investigator Request|4
6034645|NCT00696072|20856721|P1|Overall Study|Investigator Request|1
6034646|NCT00696072|20856720|P2|Overall Study|Patient Request|7
6034647|NCT00696072|20856721|P1|Overall Study|Patient Request|3
6034648|NCT00696072|20856720|P2|Overall Study|Adverse Event|6
6034649|NCT00696072|20856721|P1|Overall Study|Adverse Event|10
6034650|NCT00696072|20856720|P2|Overall Study|continuing active treatment|13
6034651|NCT00696072|20856721|P1|Overall Study|continuing active treatment|10
6034652|NCT00696020|20856742|P4|Overall Study|Other not stated above|1
6034653|NCT00696020|20856743|P3|Overall Study|Other not stated above|1
6034654|NCT00696020|20856744|P2|Overall Study|Other not stated above|0
6034655|NCT00696020|20856745|P1|Overall Study|Other not stated above|0
6034656|NCT00696020|20856742|P4|Overall Study|Withdrawal by Subject|1
6034657|NCT00696020|20856743|P3|Overall Study|Withdrawal by Subject|0
6034658|NCT00696020|20856744|P2|Overall Study|Withdrawal by Subject|1
6034659|NCT00696020|20856745|P1|Overall Study|Withdrawal by Subject|0
6034660|NCT00696020|20856742|P4|Overall Study|Protocol Violation|1
6034661|NCT00696020|20856743|P3|Overall Study|Protocol Violation|0
6034662|NCT00696020|20856744|P2|Overall Study|Protocol Violation|0
6034663|NCT00696020|20856745|P1|Overall Study|Protocol Violation|0
6034664|NCT00696020|20856742|P4|Overall Study|Lack of Efficacy|0
6034665|NCT00696020|20856743|P3|Overall Study|Lack of Efficacy|0
6034666|NCT00696020|20856744|P2|Overall Study|Lack of Efficacy|0
6034667|NCT00696020|20856745|P1|Overall Study|Lack of Efficacy|1
6034668|NCT00696020|20856742|P4|Overall Study|Adverse Event|1
6034669|NCT00696020|20856743|P3|Overall Study|Adverse Event|2
6034670|NCT00696020|20856744|P2|Overall Study|Adverse Event|1
6034671|NCT00696020|20856745|P1|Overall Study|Adverse Event|3
6034672|NCT00695955|20856853|P1|Cohort 2|Other|5
6034673|NCT00695955|20856853|P1|Cohort 2|Lack of Efficacy|4
6034674|NCT00695955|20856853|P1|Cohort 2|Withdrawal by Subject|28
6034675|NCT00695955|20856853|P1|Cohort 2|Lost to Follow-up|38
6034676|NCT00695955|20856853|P1|Cohort 2|Protocol Violation|5
6034677|NCT00695955|20856853|P1|Cohort 2|Adverse Event|24
6034678|NCT00695955|20856853|P1|Cohort 1|Other|16
6034679|NCT00695955|20856853|P1|Cohort 1|Lack of Efficacy|3
6034680|NCT00695955|20856853|P1|Cohort 1|Withdrawal by Subject|25
6034681|NCT00695955|20856853|P1|Cohort 1|Lost to Follow-up|30
6034682|NCT00695955|20856853|P1|Cohort 1|Protocol Violation|2
6034683|NCT00695955|20856853|P1|Cohort 1|Adverse Event|26
6034684|NCT00695903|20856865|P2|Had Test of Cure (TOC) Assessment|Adverse Event|1
6034685|NCT00695903|20856866|P1|Had Test of Cure (TOC) Assessment|Adverse Event|0
6034686|NCT00695903|20856865|P2|Had Test of Cure (TOC) Assessment|Lost to Follow-up|0
6034687|NCT00695903|20856866|P1|Had Test of Cure (TOC) Assessment|Lost to Follow-up|1
6034688|NCT00695903|20856865|P2|Had Test of Cure (TOC) Assessment|Lack of Efficacy|0
6034689|NCT00695903|20856866|P1|Had Test of Cure (TOC) Assessment|Lack of Efficacy|1
6034690|NCT00695903|20856865|P2|Had End of Therapy (EOT) Assessment|Protocol Violation|2
6034691|NCT00695903|20856866|P1|Had End of Therapy (EOT) Assessment|Protocol Violation|1
6034692|NCT00695903|20856865|P2|Had End of Therapy (EOT) Assessment|Physician Decision|1
6034693|NCT00695903|20856866|P1|Had End of Therapy (EOT) Assessment|Physician Decision|0
6034694|NCT00695903|20856865|P2|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1
6034695|NCT00695903|20856866|P1|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1
6034696|NCT00695903|20856865|P2|Had End of Therapy (EOT) Assessment|Adverse Event|0
6034697|NCT00695903|20856866|P1|Had End of Therapy (EOT) Assessment|Adverse Event|1
6034698|NCT00695903|20856865|P2|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9
6034699|NCT00695903|20856866|P1|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9
6034700|NCT00695903|20856865|P2|Had End of Therapy (EOT) Assessment|Randomized not treated|2
6034701|NCT00695903|20856866|P1|Had End of Therapy (EOT) Assessment|Randomized not treated|0
6034702|NCT00695864|20856878|P1|Placebo|Physician Decision|4
6034703|NCT00695864|20856878|P1|Placebo|Withdrawal by Subject|1
6034704|NCT00695669|20856888|P4|Overall Study|Lost to Follow-up|4
6034705|NCT00695669|20856889|P3|Overall Study|Lost to Follow-up|1
6034706|NCT00695669|20856890|P2|Overall Study|Lost to Follow-up|4
6034707|NCT00695669|20856891|P1|Overall Study|Lost to Follow-up|4
6034708|NCT00695669|20856888|P4|Overall Study|Adverse Event|0
6034709|NCT00695669|20856889|P3|Overall Study|Adverse Event|2
6034710|NCT00695669|20856890|P2|Overall Study|Adverse Event|0
6034711|NCT00695669|20856891|P1|Overall Study|Adverse Event|0
6034712|NCT00695565|20856976|P2|Overall Study|Subject did not follow instructions|1
6034713|NCT00695565|20856977|P1|Overall Study|Subject did not follow instructions|1
6034714|NCT00695565|20856976|P2|Overall Study|Lack of Efficacy|1
6034715|NCT00695565|20856977|P1|Overall Study|Lack of Efficacy|1
6034716|NCT00695565|20856976|P2|Overall Study|Withdrawal by Subject|1
6034717|NCT00695565|20856977|P1|Overall Study|Withdrawal by Subject|1
6034718|NCT00695565|20856976|P2|Overall Study|Protocol Violation|1
6034719|NCT00695565|20856977|P1|Overall Study|Protocol Violation|3
6034720|NCT00695565|20856976|P2|Overall Study|Adverse Event|1
6034721|NCT00695565|20856977|P1|Overall Study|Adverse Event|3
6034722|NCT00695565|20856976|P2|Overall Study|Lost to Follow-up|4
6034723|NCT00695565|20856977|P1|Overall Study|Lost to Follow-up|4
6034724|NCT00695396|20857050|P3|Overall Study|Withdrawal by Subject|0
6034725|NCT00695396|20857051|P2|Overall Study|Withdrawal by Subject|2
6034726|NCT00695396|20857052|P1|Overall Study|Withdrawal by Subject|2
6034727|NCT00695396|20857050|P3|Overall Study|Study Closed Prematurely|8
6034728|NCT00695396|20857051|P2|Overall Study|Study Closed Prematurely|6
6034729|NCT00695396|20857052|P1|Overall Study|Study Closed Prematurely|5
6034730|NCT00695318|20857068|P2|Overall Study|Study Terminated|0
6034731|NCT00695318|20857069|P1|Overall Study|Study Terminated|1
6034732|NCT00695318|20857068|P2|Overall Study|Death|1
6034733|NCT00695318|20857069|P1|Overall Study|Death|1
6034734|NCT00695318|20857068|P2|Overall Study|Withdrawal by Subject|0
6034735|NCT00695318|20857069|P1|Overall Study|Withdrawal by Subject|2
6034736|NCT00695318|20857068|P2|Overall Study|Lost to Follow-up|0
6034737|NCT00695318|20857069|P1|Overall Study|Lost to Follow-up|1
6034738|NCT00695136|20857094|P1|Overall Study|unrelated adverse event|1
6034739|NCT00695136|20857094|P1|Overall Study|Withdrawal by Subject|1
6034740|NCT00695019|20857110|P3|Overall Study|Various|4
6034741|NCT00695019|20857111|P2|Overall Study|Various|5
6034742|NCT00695019|20857112|P1|Overall Study|Various|4
6034743|NCT00695019|20857110|P3|Overall Study|Lack of Efficacy|1
6034744|NCT00695019|20857111|P2|Overall Study|Lack of Efficacy|0
6034745|NCT00695019|20857112|P1|Overall Study|Lack of Efficacy|0
6034746|NCT00695019|20857110|P3|Overall Study|Protocol Violation|1
6034747|NCT00695019|20857111|P2|Overall Study|Protocol Violation|3
6034748|NCT00695019|20857112|P1|Overall Study|Protocol Violation|1
6034749|NCT00695019|20857110|P3|Overall Study|Withdrawal by Subject|4
6034750|NCT00695019|20857111|P2|Overall Study|Withdrawal by Subject|6
6034751|NCT00695019|20857112|P1|Overall Study|Withdrawal by Subject|8
6034752|NCT00694707|20857146|P5|Overall Study|Notification of Past Head Injury|0
6034753|NCT00694707|20857147|P4|Overall Study|Notification of Past Head Injury|1
6034754|NCT00694707|20857148|P3|Overall Study|Notification of Past Head Injury|0
6034755|NCT00694707|20857149|P2|Overall Study|Notification of Past Head Injury|0
6034756|NCT00694707|20857150|P1|Overall Study|Notification of Past Head Injury|0
6034757|NCT00694707|20857146|P5|Overall Study|Administrative Reasons|0
6034758|NCT00694707|20857147|P4|Overall Study|Administrative Reasons|2
6034759|NCT00694707|20857148|P3|Overall Study|Administrative Reasons|0
6034760|NCT00694707|20857149|P2|Overall Study|Administrative Reasons|1
6034761|NCT00694707|20857150|P1|Overall Study|Administrative Reasons|0
6034762|NCT00694707|20857146|P5|Overall Study|Arrest by Police|0
6034763|NCT00694707|20857147|P4|Overall Study|Arrest by Police|0
6034764|NCT00694707|20857148|P3|Overall Study|Arrest by Police|0
6034765|NCT00694707|20857149|P2|Overall Study|Arrest by Police|1
6034766|NCT00694707|20857150|P1|Overall Study|Arrest by Police|0
6034767|NCT00694707|20857146|P5|Overall Study|Death in the Family|0
6034768|NCT00694707|20857147|P4|Overall Study|Death in the Family|0
6034769|NCT00694707|20857148|P3|Overall Study|Death in the Family|0
6034770|NCT00694707|20857149|P2|Overall Study|Death in the Family|0
6034771|NCT00694707|20857150|P1|Overall Study|Death in the Family|1
6034772|NCT00694707|20857146|P5|Overall Study|Jeopardizing Parole Status|0
6034773|NCT00694707|20857147|P4|Overall Study|Jeopardizing Parole Status|0
6034774|NCT00694707|20857148|P3|Overall Study|Jeopardizing Parole Status|0
6034775|NCT00694707|20857149|P2|Overall Study|Jeopardizing Parole Status|0
6034776|NCT00694707|20857150|P1|Overall Study|Jeopardizing Parole Status|1
6034777|NCT00694707|20857146|P5|Overall Study|Lost to Follow-up|0
6034778|NCT00694707|20857147|P4|Overall Study|Lost to Follow-up|0
6034779|NCT00694707|20857148|P3|Overall Study|Lost to Follow-up|2
6034780|NCT00694707|20857149|P2|Overall Study|Lost to Follow-up|1
6034781|NCT00694707|20857150|P1|Overall Study|Lost to Follow-up|0
6034782|NCT00694707|20857146|P5|Overall Study|Withdrawal of Consent|15
6034783|NCT00694707|20857147|P4|Overall Study|Withdrawal of Consent|16
6034784|NCT00694707|20857148|P3|Overall Study|Withdrawal of Consent|22
6034785|NCT00694707|20857149|P2|Overall Study|Withdrawal of Consent|18
6034786|NCT00694707|20857150|P1|Overall Study|Withdrawal of Consent|14
6034787|NCT00694707|20857146|P5|Overall Study|Protocol Violation|1
6034788|NCT00694707|20857147|P4|Overall Study|Protocol Violation|3
6034789|NCT00694707|20857148|P3|Overall Study|Protocol Violation|1
6034790|NCT00694707|20857149|P2|Overall Study|Protocol Violation|2
6034791|NCT00694707|20857150|P1|Overall Study|Protocol Violation|1
6034792|NCT00694707|20857146|P5|Overall Study|Insufficient Therapeutic Response|10
6034793|NCT00694707|20857147|P4|Overall Study|Insufficient Therapeutic Response|15
6034794|NCT00694707|20857148|P3|Overall Study|Insufficient Therapeutic Response|17
6034795|NCT00694707|20857149|P2|Overall Study|Insufficient Therapeutic Response|18
6034796|NCT00694707|20857150|P1|Overall Study|Insufficient Therapeutic Response|33
6034797|NCT00694707|20857146|P5|Overall Study|Adverse Event|13
6034798|NCT00694707|20857147|P4|Overall Study|Adverse Event|12
6034799|NCT00694707|20857148|P3|Overall Study|Adverse Event|8
6034800|NCT00694707|20857149|P2|Overall Study|Adverse Event|14
6034801|NCT00694707|20857150|P1|Overall Study|Adverse Event|22
6034802|NCT00694707|20857146|P5|Overall Study|Did Not Receive Treatment|1
6034803|NCT00694707|20857147|P4|Overall Study|Did Not Receive Treatment|1
6034804|NCT00694707|20857148|P3|Overall Study|Did Not Receive Treatment|1
6034805|NCT00694707|20857149|P2|Overall Study|Did Not Receive Treatment|0
6034806|NCT00694707|20857150|P1|Overall Study|Did Not Receive Treatment|0
6034807|NCT00694551|20857179|P3|Overall Study|Disease Progression|1
6034808|NCT00694551|20857180|P2|Overall Study|Disease Progression|0
6034809|NCT00694551|20857181|P1|Overall Study|Disease Progression|1
6034810|NCT00694369|20857210|P5|Overall Study|Withdrawal by Subject|2
6034811|NCT00694369|20857211|P4|Overall Study|Withdrawal by Subject|1
6034812|NCT00694369|20857212|P3|Overall Study|Withdrawal by Subject|1
6034813|NCT00694369|20857213|P2|Overall Study|Withdrawal by Subject|1
6034814|NCT00694369|20857214|P1|Overall Study|Withdrawal by Subject|1
6034815|NCT00694369|20857210|P5|Overall Study|Protocol Violation|0
6034816|NCT00694369|20857211|P4|Overall Study|Protocol Violation|0
6034817|NCT00694369|20857212|P3|Overall Study|Protocol Violation|0
6034818|NCT00694369|20857213|P2|Overall Study|Protocol Violation|1
6034819|NCT00694369|20857214|P1|Overall Study|Protocol Violation|0
6034820|NCT00694369|20857210|P5|Overall Study|Physician Decision|1
6034821|NCT00694369|20857211|P4|Overall Study|Physician Decision|0
6034822|NCT00694369|20857212|P3|Overall Study|Physician Decision|0
6034823|NCT00694369|20857213|P2|Overall Study|Physician Decision|0
6034824|NCT00694369|20857214|P1|Overall Study|Physician Decision|0
6034825|NCT00694369|20857210|P5|Overall Study|Lost to Follow-up|0
6034826|NCT00694369|20857211|P4|Overall Study|Lost to Follow-up|1
6034827|NCT00694369|20857212|P3|Overall Study|Lost to Follow-up|1
6034828|NCT00694369|20857213|P2|Overall Study|Lost to Follow-up|0
6034829|NCT00694369|20857214|P1|Overall Study|Lost to Follow-up|0
6034830|NCT00694369|20857210|P5|Overall Study|Adverse Event|3
6034831|NCT00694369|20857211|P4|Overall Study|Adverse Event|1
6034832|NCT00694369|20857212|P3|Overall Study|Adverse Event|0
6034833|NCT00694369|20857213|P2|Overall Study|Adverse Event|1
6034834|NCT00694369|20857214|P1|Overall Study|Adverse Event|0
6034835|NCT00694356|20857234|P3|Overall Study|Progressive Disease|6
6034836|NCT00694356|20857235|P2|Overall Study|Progressive Disease|6
6034837|NCT00694356|20857236|P1|Overall Study|Progressive Disease|2
6034838|NCT00694356|20857234|P3|Overall Study|Adverse Event|0
6034839|NCT00694356|20857235|P2|Overall Study|Adverse Event|0
6034840|NCT00694356|20857236|P1|Overall Study|Adverse Event|1
6034841|NCT00694304|20857271|P1|Overall Study|Administrative or Other Reasons|32
6034842|NCT00694304|20857271|P1|Overall Study|Lost to Follow-up|15
6034843|NCT00694304|20857271|P1|Overall Study|Withdrawal of Consent|61
6034844|NCT00694304|20857271|P1|Overall Study|Protocol Violation|6
6034845|NCT00694304|20857271|P1|Overall Study|Non-compliance With Study Product|16
6034846|NCT00694304|20857271|P1|Overall Study|Lack of Efficacy|35
6034847|NCT00694304|20857271|P1|Overall Study|Adverse Event|42
6034848|NCT00694161|20857284|P1|Part 2 (After Week 6 up to Month 12)|Death|1
6034849|NCT00694161|20857284|P1|Part 2 (After Week 6 up to Month 12)|Physician Decision|1
6034850|NCT00694161|20857284|P1|Part 2 (After Week 6 up to Month 12)|Adverse Event|1
6034851|NCT00694122|20857323|P2|First Intervention (3-4 Weeks)|Did not meet entrance criteria|1
6034852|NCT00694122|20857324|P1|First Intervention (3-4 Weeks)|Did not meet entrance criteria|2
6034853|NCT00694122|20857323|P2|First Intervention (3-4 Weeks)|Lost to Follow-up|1
6034854|NCT00694122|20857324|P1|First Intervention (3-4 Weeks)|Lost to Follow-up|1
6034855|NCT00694122|20857323|P2|First Intervention (3-4 Weeks)|Withdrawal by Subject|0
6034856|NCT00694122|20857324|P1|First Intervention (3-4 Weeks)|Withdrawal by Subject|7
6034857|NCT00694109|20857340|P1|Overall Study|Consented but no additional treatment|3
6034858|NCT00694109|20857340|P1|Overall Study|Other|2
6034859|NCT00694109|20857340|P1|Overall Study|Enrolled but not treated|1
6034860|NCT00694109|20857340|P1|Overall Study|Pregnancy|1
6034861|NCT00694109|20857340|P1|Overall Study|Withdrawal by Subject|13
6034862|NCT00694109|20857340|P1|Overall Study|Lack of Efficacy|2
6034863|NCT00694109|20857340|P1|Overall Study|Not consent of more 2 years of treatment|18
6034864|NCT00694109|20857340|P1|Overall Study|Adverse Event|74
6034865|NCT00694109|20857340|P1|Overall Study|Physician Decision|3
6034866|NCT00694096|20857364|P1|Overall Study|Withdrawal by Subject|5
6034867|NCT00693784|20857404|P1|Overall Study|Withdrawal by Subject|2
6034868|NCT00693784|20857404|P1|Overall Study|Lost to Follow-up|2
6034869|NCT00693706|20857417|P2|Overall Study|Protocol Violation|1
6034870|NCT00693706|20857418|P1|Overall Study|Protocol Violation|0
6034871|NCT00693693|20857445|P3|Overall Study|Lost to Follow-up|2
6034872|NCT00693693|20857446|P2|Overall Study|Lost to Follow-up|1
6034873|NCT00693693|20857447|P1|Overall Study|Lost to Follow-up|1
6034874|NCT00693472|20857506|P4|Part 2|Withdrew - reason unrelated to treatment|2
6034875|NCT00693472|20857507|P3|Part 2|Withdrew - reason unrelated to treatment|1
6034876|NCT00693472|20857508|P2|Part 2|Withdrew - reason unrelated to treatment|0
6034877|NCT00693472|20857509|P1|Part 2|Withdrew - reason unrelated to treatment|0
6034878|NCT00693472|20857506|P4|Part 2|Adverse Event|0
6034879|NCT00693472|20857507|P3|Part 2|Adverse Event|1
6034880|NCT00693472|20857508|P2|Part 2|Adverse Event|0
6034881|NCT00693472|20857509|P1|Part 2|Adverse Event|0
6034882|NCT00693472|20857506|P4|Part 1|Withdrew - reason unrelated to treatment|0
6034883|NCT00693472|20857507|P3|Part 1|Withdrew - reason unrelated to treatment|0
6034884|NCT00693472|20857508|P2|Part 1|Withdrew - reason unrelated to treatment|2
6034885|NCT00693472|20857509|P1|Part 1|Withdrew - reason unrelated to treatment|5
6034886|NCT00693472|20857506|P4|Part 1|Lost to Follow-up|0
6034887|NCT00693472|20857507|P3|Part 1|Lost to Follow-up|0
6034888|NCT00693472|20857508|P2|Part 1|Lost to Follow-up|1
6034889|NCT00693472|20857509|P1|Part 1|Lost to Follow-up|0
6034890|NCT00693472|20857506|P4|Part 1|Adverse Event|0
6034891|NCT00693472|20857507|P3|Part 1|Adverse Event|0
6034892|NCT00693472|20857508|P2|Part 1|Adverse Event|1
6034893|NCT00693472|20857509|P1|Part 1|Adverse Event|1
6034894|NCT00693420|20857529|P2|Overall Study|Personal Reasons|4
6034895|NCT00693420|20857530|P1|Overall Study|Personal Reasons|1
6034896|NCT00693420|20857529|P2|Overall Study|Sponsor Request - Conflict of Interest|2
6034897|NCT00693420|20857530|P1|Overall Study|Sponsor Request - Conflict of Interest|0
6034898|NCT00693420|20857529|P2|Overall Study|Protocol Violation|2
6034899|NCT00693420|20857530|P1|Overall Study|Protocol Violation|0
6034900|NCT00693420|20857529|P2|Overall Study|Withdrawal by Subject|0
6034901|NCT00693420|20857530|P1|Overall Study|Withdrawal by Subject|1
6034902|NCT00693420|20857529|P2|Overall Study|Lost to Follow-up|3
6034903|NCT00693420|20857530|P1|Overall Study|Lost to Follow-up|0
6034904|NCT00693420|20857529|P2|Overall Study|Adverse Event|4
6034905|NCT00693420|20857530|P1|Overall Study|Adverse Event|4
6034906|NCT00693225|20857569|P2|Overall Study|Adverse Event|3
6034907|NCT00693225|20857570|P1|Overall Study|Adverse Event|1
6034908|NCT00693225|20857569|P2|Overall Study|Lost to Follow-up|2
6034909|NCT00693225|20857570|P1|Overall Study|Lost to Follow-up|1
6034910|NCT00693017|20857593|P2|Overall Study|Death|1
6034911|NCT00693017|20857594|P1|Overall Study|Death|0
6034912|NCT00693017|20857593|P2|Overall Study|Sponsor Decision|1
6034913|NCT00693017|20857594|P1|Overall Study|Sponsor Decision|2
6034914|NCT00692913|20857625|P2|Overall Study|Withdrawal by Subject|20
6034915|NCT00692913|20857626|P1|Overall Study|Withdrawal by Subject|15
6034916|NCT00692913|20857625|P2|Overall Study|Protocol Violation|1
6034917|NCT00692913|20857626|P1|Overall Study|Protocol Violation|1
6034918|NCT00692913|20857625|P2|Overall Study|Physician Decision|0
6034919|NCT00692913|20857626|P1|Overall Study|Physician Decision|2
6034920|NCT00692913|20857625|P2|Overall Study|Lost to Follow-up|5
6034921|NCT00692913|20857626|P1|Overall Study|Lost to Follow-up|3
6034922|NCT00692913|20857625|P2|Overall Study|Adverse Event|4
6034923|NCT00692913|20857626|P1|Overall Study|Adverse Event|8
6034924|NCT00692770|20857648|P2|Overall Study|Randomized but not treated|4
6034925|NCT00692770|20857649|P1|Overall Study|Randomized but not treated|3
6034926|NCT00692770|20857648|P2|Overall Study|Study terminated by sponsor|2
6034927|NCT00692770|20857649|P1|Overall Study|Study terminated by sponsor|2
6034928|NCT00692770|20857648|P2|Overall Study|Clinical endpoint reached|43
6034929|NCT00692770|20857649|P1|Overall Study|Clinical endpoint reached|16
6034930|NCT00692770|20857648|P2|Overall Study|Radiological and clinical progression|8
6034931|NCT00692770|20857649|P1|Overall Study|Radiological and clinical progression|8
6034932|NCT00692770|20857648|P2|Overall Study|Completed all planned assessments|101
6034933|NCT00692770|20857649|P1|Overall Study|Completed all planned assessments|79
6034934|NCT00692770|20857648|P2|Overall Study|Protocol driven decision point|7
6034935|NCT00692770|20857649|P1|Overall Study|Protocol driven decision point|3
6034936|NCT00692770|20857648|P2|Overall Study|Disease progression, recurrence/relapse|279
6034937|NCT00692770|20857649|P1|Overall Study|Disease progression, recurrence/relapse|170
6034938|NCT00692770|20857648|P2|Overall Study|Physician decision not protocol driven|14
6034939|NCT00692770|20857649|P1|Overall Study|Physician decision not protocol driven|10
6034940|NCT00692770|20857648|P2|Overall Study|Progression by clinical judgment|3
6034941|NCT00692770|20857649|P1|Overall Study|Progression by clinical judgment|2
6034942|NCT00692770|20857648|P2|Overall Study|Non-compliant with study medication|5
6034943|NCT00692770|20857649|P1|Overall Study|Non-compliant with study medication|11
6034944|NCT00692770|20857648|P2|Overall Study|Lost to Follow-up|3
6034945|NCT00692770|20857649|P1|Overall Study|Lost to Follow-up|7
6034946|NCT00692770|20857648|P2|Overall Study|Death|5
6034947|NCT00692770|20857649|P1|Overall Study|Death|10
6034948|NCT00692770|20857648|P2|Overall Study|Adverse Event|41
6034949|NCT00692770|20857649|P1|Overall Study|Adverse Event|136
6034950|NCT00692770|20857648|P2|Overall Study|Withdrawal by Subject|36
6034951|NCT00692770|20857649|P1|Overall Study|Withdrawal by Subject|97
6034952|NCT00692770|20857648|P2|Overall Study|Protocol Violation|7
6034953|NCT00692770|20857649|P1|Overall Study|Protocol Violation|2
6034954|NCT00692406|20857695|P1|Overall Study|PI dropped, bad data|57
6034955|NCT00692237|20857766|P2|Overall Study|Adverse Event|1
6034956|NCT00692237|20857767|P1|Overall Study|Adverse Event|0
6034957|NCT00692237|20857766|P2|Overall Study|Withdrawal by Subject|3
6034958|NCT00692237|20857767|P1|Overall Study|Withdrawal by Subject|1
6034959|NCT00692003|20857854|P2|Overall Study|Sponsor Decision|1
6034960|NCT00692003|20857855|P1|Overall Study|Sponsor Decision|5
6034961|NCT00691938|20857870|P7|Overall Study|QTc prolongation|0
6034962|NCT00691938|20857871|P6|Overall Study|QTc prolongation|0
6034963|NCT00691938|20857872|P5|Overall Study|QTc prolongation|0
6034964|NCT00691938|20857873|P4|Overall Study|QTc prolongation|0
6034965|NCT00691938|20857874|P3|Overall Study|QTc prolongation|0
6034966|NCT00691938|20857875|P2|Overall Study|QTc prolongation|0
6034967|NCT00691938|20857876|P1|Overall Study|QTc prolongation|1
6034968|NCT00691704|20857943|P1|Two Years of Maintenance Therapy|Withdrawal by Subject|1
6034969|NCT00691704|20857943|P1|Two Years of Maintenance Therapy|Physician Decision|4
6034970|NCT00691704|20857943|P1|Two Years of Maintenance Therapy|Disease Progression|8
6034971|NCT00691704|20857943|P1|Induction Therapy|Active Hepatitis|1
6034972|NCT00691704|20857943|P1|Induction Therapy|Disease Progression|1
6034973|NCT00691483|20858004|P2|Overall Study|Randomized by not treated|1
6034974|NCT00691483|20858005|P1|Overall Study|Randomized by not treated|7
6034975|NCT00691483|20858004|P2|Overall Study|Other known cause|1
6034976|NCT00691483|20858005|P1|Overall Study|Other known cause|6
6034977|NCT00691483|20858004|P2|Overall Study|Withdrawal by Subject|7
6034978|NCT00691483|20858005|P1|Overall Study|Withdrawal by Subject|24
6034979|NCT00691483|20858004|P2|Overall Study|Lost to Follow-up|10
6034980|NCT00691483|20858005|P1|Overall Study|Lost to Follow-up|17
6034981|NCT00691483|20858004|P2|Overall Study|Adverse Event|6
6034982|NCT00691483|20858005|P1|Overall Study|Adverse Event|14
6034983|NCT00691301|20858048|P1|Overall Study|Did not initiate study treatment|1
6034984|NCT00691301|20858048|P1|Overall Study|other reason|3
6034985|NCT00691301|20858048|P1|Overall Study|Concurrent illness|2
6034986|NCT00691301|20858048|P1|Overall Study|Withdrawal by Subject|4
6034987|NCT00691301|20858048|P1|Overall Study|Lack of Efficacy|32
6034988|NCT00691301|20858048|P1|Overall Study|Death|2
6034989|NCT00691301|20858048|P1|Overall Study|Adverse Event|10
6034990|NCT00691210|20858068|P8|Overall Study|Lack of Efficacy|0
6034991|NCT00691210|20858069|P7|Overall Study|Lack of Efficacy|0
6034992|NCT00691210|20858070|P6|Overall Study|Lack of Efficacy|1
6034993|NCT00691210|20858071|P5|Overall Study|Lack of Efficacy|0
6034994|NCT00691210|20858072|P4|Overall Study|Lack of Efficacy|1
6034995|NCT00691210|20858073|P3|Overall Study|Lack of Efficacy|0
6034996|NCT00691210|20858074|P2|Overall Study|Lack of Efficacy|0
6034997|NCT00691210|20858075|P1|Overall Study|Lack of Efficacy|0
6034998|NCT00691210|20858068|P8|Overall Study|Progression of Disease|0
6034999|NCT00691210|20858069|P7|Overall Study|Progression of Disease|0
6035000|NCT00691210|20858070|P6|Overall Study|Progression of Disease|0
6035001|NCT00691210|20858071|P5|Overall Study|Progression of Disease|0
6035002|NCT00691210|20858072|P4|Overall Study|Progression of Disease|2
6035003|NCT00691210|20858073|P3|Overall Study|Progression of Disease|0
6035004|NCT00691210|20858074|P2|Overall Study|Progression of Disease|0
6035005|NCT00691210|20858075|P1|Overall Study|Progression of Disease|0
6035006|NCT00691132|20858110|P2|Overall Study|Withdrawal by Subject|10
6035007|NCT00691132|20858111|P1|Overall Study|Withdrawal by Subject|10
6035008|NCT00691132|20858110|P2|Overall Study|Adverse Event|3
6035009|NCT00691132|20858111|P1|Overall Study|Adverse Event|2
6035010|NCT00691093|20858130|P1|Overall Study|Ongoing at Date of Cut-Off|4
6035011|NCT00691093|20858130|P1|Overall Study|Lack of Efficacy|1
6035012|NCT00691093|20858130|P1|Overall Study|Lost to Follow-up|1
6035013|NCT00691093|20858130|P1|Overall Study|Adverse Event|1
6035014|NCT00691054|20858164|P1|Overall Study|Withdrawal by Subject|1
6035015|NCT00691028|20858176|P4|Double-blind Period|not come to a hospital.|0
6035016|NCT00691028|20858177|P3|Double-blind Period|not come to a hospital.|0
6035017|NCT00691028|20858178|P2|Double-blind Period|not come to a hospital.|1
6035018|NCT00691028|20858179|P1|Double-blind Period|not come to a hospital.|0
6035019|NCT00691028|20858176|P4|Double-blind Period|Withdrawal by Subject|0
6035020|NCT00691028|20858177|P3|Double-blind Period|Withdrawal by Subject|1
6035021|NCT00691028|20858178|P2|Double-blind Period|Withdrawal by Subject|0
6035022|NCT00691028|20858179|P1|Double-blind Period|Withdrawal by Subject|1
6035023|NCT00691028|20858176|P4|Double-blind Period|Lack of Efficacy|0
6035024|NCT00691028|20858177|P3|Double-blind Period|Lack of Efficacy|2
6035025|NCT00691028|20858178|P2|Double-blind Period|Lack of Efficacy|3
6035026|NCT00691028|20858179|P1|Double-blind Period|Lack of Efficacy|4
6035027|NCT00691028|20858176|P4|Double-blind Period|Adverse Event|0
6035028|NCT00691028|20858177|P3|Double-blind Period|Adverse Event|6
6035029|NCT00691028|20858178|P2|Double-blind Period|Adverse Event|9
6035030|NCT00691028|20858179|P1|Double-blind Period|Adverse Event|8
6035031|NCT00691028|20858176|P4|Open-label Period|not come to a hospital|1
6035032|NCT00691028|20858177|P3|Open-label Period|not come to a hospital|0
6035033|NCT00691028|20858178|P2|Open-label Period|not come to a hospital|0
6035034|NCT00691028|20858179|P1|Open-label Period|not come to a hospital|0
6035035|NCT00691028|20858176|P4|Open-label Period|Withdrawal by Subject|3
6035036|NCT00691028|20858177|P3|Open-label Period|Withdrawal by Subject|0
6035037|NCT00691028|20858178|P2|Open-label Period|Withdrawal by Subject|0
6035038|NCT00691028|20858179|P1|Open-label Period|Withdrawal by Subject|0
6035039|NCT00691028|20858176|P4|Open-label Period|Adverse Event|16
6035040|NCT00691028|20858177|P3|Open-label Period|Adverse Event|0
6035041|NCT00691028|20858178|P2|Open-label Period|Adverse Event|0
6035042|NCT00691028|20858179|P1|Open-label Period|Adverse Event|0
6035043|NCT00691015|20858212|P1|Overall Study|Refused further treatment|1
6035044|NCT00690898|20858227|P1|TREATMENT|Other (not otherwise specified)|1
6035045|NCT00690898|20858227|P1|TREATMENT|Withdrawal by Subject|4
6035046|NCT00690898|20858227|P1|TREATMENT|Lack of Efficacy|18
6035047|NCT00690898|20858227|P1|TREATMENT|Adverse Event|3
6035048|NCT00690898|20858227|P1|SCREENING|Screen failure|18
6035049|NCT00690820|20858247|P2|Period 1|Withdrawal by Subject|1
6035050|NCT00690820|20858248|P1|Period 1|Withdrawal by Subject|0
6035051|NCT00690794|20858270|P2|Overall Study|Other not specified|3
6035052|NCT00690794|20858271|P1|Overall Study|Other not specified|1
6035053|NCT00690794|20858270|P2|Overall Study|Noncompliance|2
6035054|NCT00690794|20858271|P1|Overall Study|Noncompliance|1
6035055|NCT00690794|20858270|P2|Overall Study|Protocol Violation|7
6035056|NCT00690794|20858271|P1|Overall Study|Protocol Violation|6
6035057|NCT00690794|20858270|P2|Overall Study|Withdrawal by Subject|9
6035058|NCT00690794|20858271|P1|Overall Study|Withdrawal by Subject|0
6035059|NCT00690794|20858270|P2|Overall Study|Lost to Follow-up|4
6035060|NCT00690794|20858271|P1|Overall Study|Lost to Follow-up|1
6035061|NCT00690794|20858270|P2|Overall Study|Adverse Event|10
6035062|NCT00690794|20858271|P1|Overall Study|Adverse Event|12
6035063|NCT00690755|20858286|P7|Overall Study|Physician Decision|0
6035064|NCT00690755|20858287|P6|Overall Study|Physician Decision|4
6035065|NCT00690755|20858288|P5|Overall Study|Physician Decision|0
6035066|NCT00690755|20858289|P4|Overall Study|Physician Decision|5
6035067|NCT00690755|20858290|P3|Overall Study|Physician Decision|46
6035068|NCT00690755|20858291|P2|Overall Study|Physician Decision|0
6035069|NCT00690755|20858292|P1|Overall Study|Physician Decision|2
6035070|NCT00690612|20858308|P1|Overall Study|Withdrawal by Subject|2
6035071|NCT00690612|20858308|P1|Overall Study|Adverse Event|1
6035072|NCT00690573|20858313|P1|Overall Study|Withdrawal by Subject|1
6035073|NCT00690573|20858313|P1|Overall Study|Lack of Efficacy|8
6035074|NCT00690482|20858332|P2|Overall Study|withdrew consent at rand.day|1
6035075|NCT00690482|20858333|P1|Overall Study|withdrew consent at rand.day|0
6035076|NCT00690482|20858332|P2|Overall Study|Intake of prohibited medicine|0
6035077|NCT00690482|20858333|P1|Overall Study|Intake of prohibited medicine|1
6035078|NCT00690482|20858332|P2|Overall Study|Study-specific discontinuation criteria|0
6035079|NCT00690482|20858333|P1|Overall Study|Study-specific discontinuation criteria|1
6035080|NCT00690482|20858332|P2|Overall Study|Incorrect enrolment|1
6035081|NCT00690482|20858333|P1|Overall Study|Incorrect enrolment|0
6035082|NCT00690482|20858332|P2|Overall Study|Adverse Event|1
6035083|NCT00690482|20858333|P1|Overall Study|Adverse Event|2
6035084|NCT00690443|20858367|P2|Overall Study|Adverse Event|2
6035085|NCT00690443|20858368|P1|Overall Study|Adverse Event|1
6035086|NCT00690430|20858378|P3|Extension Phase|Early Termination|3
6035087|NCT00690430|20858379|P2|Extension Phase|Early Termination|1
6035088|NCT00690430|20858380|P1|Extension Phase|Early Termination|10
6035089|NCT00690430|20858378|P3|Extension Phase|Withdrawal by Subject|2
6035090|NCT00690430|20858379|P2|Extension Phase|Withdrawal by Subject|0
6035091|NCT00690430|20858380|P1|Extension Phase|Withdrawal by Subject|0
6035092|NCT00690430|20858378|P3|Extension Phase|Death|1
6035093|NCT00690430|20858379|P2|Extension Phase|Death|1
6035094|NCT00690430|20858380|P1|Extension Phase|Death|1
6035095|NCT00690430|20858378|P3|Extension Phase|Adverse Event|2
6035096|NCT00690430|20858379|P2|Extension Phase|Adverse Event|1
6035097|NCT00690430|20858380|P1|Extension Phase|Adverse Event|2
6035098|NCT00690430|20858378|P3|Extension Phase|Administrative Problems|1
6035099|NCT00690430|20858379|P2|Extension Phase|Administrative Problems|1
6035100|NCT00690430|20858380|P1|Extension Phase|Administrative Problems|0
6035101|NCT00690430|20858378|P3|Extension Phase|Abnormal test procedure results|0
6035102|NCT00690430|20858379|P2|Extension Phase|Abnormal test procedure results|0
6035103|NCT00690430|20858380|P1|Extension Phase|Abnormal test procedure results|1
6035104|NCT00690430|20858378|P3|Extension Phase|Abnormal Lab Values|0
6035105|NCT00690430|20858379|P2|Extension Phase|Abnormal Lab Values|0
6035106|NCT00690430|20858380|P1|Extension Phase|Abnormal Lab Values|1
6035107|NCT00690430|20858378|P3|Extension Phase|Lack of Efficacy|4
6035108|NCT00690430|20858379|P2|Extension Phase|Lack of Efficacy|1
6035109|NCT00690430|20858380|P1|Extension Phase|Lack of Efficacy|3
6035110|NCT00690430|20858378|P3|Core Phase|Early Termination|0
6035111|NCT00690430|20858379|P2|Core Phase|Early Termination|5
6035112|NCT00690430|20858380|P1|Core Phase|Early Termination|0
6035113|NCT00690430|20858378|P3|Core Phase|Administrative Problems|0
6035114|NCT00690430|20858379|P2|Core Phase|Administrative Problems|1
6035115|NCT00690430|20858380|P1|Core Phase|Administrative Problems|0
6035116|NCT00690430|20858378|P3|Core Phase|Lack of Efficacy|0
6035117|NCT00690430|20858379|P2|Core Phase|Lack of Efficacy|10
6035118|NCT00690430|20858380|P1|Core Phase|Lack of Efficacy|8
6035119|NCT00690430|20858378|P3|Core Phase|Subject no longer requires study drug|0
6035120|NCT00690430|20858379|P2|Core Phase|Subject no longer requires study drug|0
6035121|NCT00690430|20858380|P1|Core Phase|Subject no longer requires study drug|1
6035122|NCT00690430|20858378|P3|Core Phase|Withdrawal by Subject|0
6035123|NCT00690430|20858379|P2|Core Phase|Withdrawal by Subject|3
6035124|NCT00690430|20858380|P1|Core Phase|Withdrawal by Subject|3
6035125|NCT00690430|20858378|P3|Core Phase|Protocol Violation|0
6035126|NCT00690430|20858379|P2|Core Phase|Protocol Violation|0
6035127|NCT00690430|20858380|P1|Core Phase|Protocol Violation|1
6035128|NCT00690430|20858378|P3|Core Phase|Death|0
6035129|NCT00690430|20858379|P2|Core Phase|Death|2
6035130|NCT00690430|20858380|P1|Core Phase|Death|0
6035131|NCT00690430|20858378|P3|Core Phase|Adverse Event|0
6035132|NCT00690430|20858379|P2|Core Phase|Adverse Event|1
6035133|NCT00690430|20858380|P1|Core Phase|Adverse Event|5
6035134|NCT00690430|20858378|P3|Core Phase|Abnormal Laboratory value|0
6035135|NCT00690430|20858379|P2|Core Phase|Abnormal Laboratory value|1
6035136|NCT00690430|20858380|P1|Core Phase|Abnormal Laboratory value|0
6035137|NCT00690378|20858409|P2|Overall Study|Social problem|0
6035138|NCT00690378|20858410|P1|Overall Study|Social problem|1
6035139|NCT00690378|20858409|P2|Overall Study|Did not meet inc/exc criteria|11
6035140|NCT00690378|20858410|P1|Overall Study|Did not meet inc/exc criteria|13
6035141|NCT00690378|20858409|P2|Overall Study|Lost to Follow-up|3
6035142|NCT00690378|20858410|P1|Overall Study|Lost to Follow-up|2
6035143|NCT00690378|20858409|P2|Overall Study|Protocol Violation|0
6035144|NCT00690378|20858410|P1|Overall Study|Protocol Violation|1
6035145|NCT00690378|20858409|P2|Overall Study|Withdrawal by Subject|0
6035146|NCT00690378|20858410|P1|Overall Study|Withdrawal by Subject|2
6035147|NCT00690378|20858409|P2|Overall Study|Adverse Event|0
6035148|NCT00690378|20858410|P1|Overall Study|Adverse Event|1
6035149|NCT00689936|20858507|P3|Long-Term Follow Up Phase|Continue in Long Term Follow Up|144
6035150|NCT00689936|20858508|P2|Long-Term Follow Up Phase|Continue in Long Term Follow Up|188
6035151|NCT00689936|20858509|P1|Long-Term Follow Up Phase|Continue in Long Term Follow Up|127
6035152|NCT00689936|20858507|P3|Active Treatment Phase|Miscellaneous|47
6035153|NCT00689936|20858508|P2|Active Treatment Phase|Miscellaneous|34
6035154|NCT00689936|20858509|P1|Active Treatment Phase|Miscellaneous|52
6035155|NCT00689936|20858507|P3|Active Treatment Phase|Study Close Out|21
6035156|NCT00689936|20858508|P2|Active Treatment Phase|Study Close Out|26
6035157|NCT00689936|20858509|P1|Active Treatment Phase|Study Close Out|64
6035158|NCT00689936|20858507|P3|Active Treatment Phase|Protocol Violation|4
6035159|NCT00689936|20858508|P2|Active Treatment Phase|Protocol Violation|2
6035160|NCT00689936|20858509|P1|Active Treatment Phase|Protocol Violation|2
6035161|NCT00689936|20858507|P3|Active Treatment Phase|Lost to Follow-up|2
6035162|NCT00689936|20858508|P2|Active Treatment Phase|Lost to Follow-up|2
6035163|NCT00689936|20858509|P1|Active Treatment Phase|Lost to Follow-up|0
6035164|NCT00689936|20858507|P3|Active Treatment Phase|Death|37
6035165|NCT00689936|20858508|P2|Active Treatment Phase|Death|28
6035166|NCT00689936|20858509|P1|Active Treatment Phase|Death|60
6035167|NCT00689936|20858507|P3|Active Treatment Phase|Withdrawal by Subject|21
6035168|NCT00689936|20858508|P2|Active Treatment Phase|Withdrawal by Subject|16
6035169|NCT00689936|20858509|P1|Active Treatment Phase|Withdrawal by Subject|16
6035170|NCT00689936|20858507|P3|Active Treatment Phase|Disease Progression|339
6035171|NCT00689936|20858508|P2|Active Treatment Phase|Disease Progression|362
6035172|NCT00689936|20858509|P1|Active Treatment Phase|Disease Progression|273
6035173|NCT00689936|20858507|P3|Active Treatment Phase|Adverse Event|76
6035174|NCT00689936|20858508|P2|Active Treatment Phase|Adverse Event|71
6035175|NCT00689936|20858509|P1|Active Treatment Phase|Adverse Event|68
6035176|NCT00689871|20858658|P4|Overall Study|Physician Decision|0
6035177|NCT00689871|20858659|P3|Overall Study|Physician Decision|1
6035178|NCT00689871|20858660|P2|Overall Study|Physician Decision|1
6035179|NCT00689871|20858661|P1|Overall Study|Physician Decision|2
6035180|NCT00689871|20858658|P4|Overall Study|Death|2
6035181|NCT00689871|20858659|P3|Overall Study|Death|2
6035182|NCT00689871|20858660|P2|Overall Study|Death|10
6035183|NCT00689871|20858661|P1|Overall Study|Death|1
6035184|NCT00689871|20858658|P4|Overall Study|Withdrawal by Subject|1
6035185|NCT00689871|20858659|P3|Overall Study|Withdrawal by Subject|4
6035186|NCT00689871|20858660|P2|Overall Study|Withdrawal by Subject|3
6035187|NCT00689871|20858661|P1|Overall Study|Withdrawal by Subject|13
6035188|NCT00689871|20858658|P4|Overall Study|Explanted of All Study Devices|3
6035189|NCT00689871|20858659|P3|Overall Study|Explanted of All Study Devices|29
6035190|NCT00689871|20858660|P2|Overall Study|Explanted of All Study Devices|25
6035191|NCT00689871|20858661|P1|Overall Study|Explanted of All Study Devices|36
6035192|NCT00689871|20858658|P4|Overall Study|Lost to Follow-up|1
6035193|NCT00689871|20858659|P3|Overall Study|Lost to Follow-up|37
6035194|NCT00689871|20858660|P2|Overall Study|Lost to Follow-up|13
6035195|NCT00689871|20858661|P1|Overall Study|Lost to Follow-up|123
6035196|NCT00689793|20858688|P2|Overall Study|Lost to Follow-up|5
6035197|NCT00689793|20858689|P1|Overall Study|Lost to Follow-up|4
6035198|NCT00689728|20858708|P3|Optional Follow-Up|Withdrawal by Subject|3
6035199|NCT00689728|20858709|P2|Optional Follow-Up|Withdrawal by Subject|4
6035200|NCT00689728|20858710|P1|Optional Follow-Up|Withdrawal by Subject|2
6035201|NCT00689728|20858708|P3|Optional Follow-Up|Protocol Violation|1
6035202|NCT00689728|20858709|P2|Optional Follow-Up|Protocol Violation|0
6035203|NCT00689728|20858710|P1|Optional Follow-Up|Protocol Violation|0
6035204|NCT00689728|20858708|P3|Optional Follow-Up|Lost to Follow-up|1
6035205|NCT00689728|20858709|P2|Optional Follow-Up|Lost to Follow-up|1
6035206|NCT00689728|20858710|P1|Optional Follow-Up|Lost to Follow-up|0
6035207|NCT00689728|20858708|P3|Optional Follow-Up|Lack of Efficacy|1
6035208|NCT00689728|20858709|P2|Optional Follow-Up|Lack of Efficacy|1
6035209|NCT00689728|20858710|P1|Optional Follow-Up|Lack of Efficacy|0
6035210|NCT00689728|20858708|P3|Optional Follow-Up|Adverse Event|0
6035211|NCT00689728|20858709|P2|Optional Follow-Up|Adverse Event|0
6035212|NCT00689728|20858710|P1|Optional Follow-Up|Adverse Event|1
6035213|NCT00689728|20858708|P3|Rescue|Withdrawal by Subject|1
6035214|NCT00689728|20858709|P2|Rescue|Withdrawal by Subject|1
6035215|NCT00689728|20858710|P1|Rescue|Withdrawal by Subject|1
6035216|NCT00689728|20858708|P3|Rescue|Adverse Event|0
6035217|NCT00689728|20858709|P2|Rescue|Adverse Event|1
6035218|NCT00689728|20858710|P1|Rescue|Adverse Event|0
6035219|NCT00689728|20858708|P3|Double-Blind Treatment|Lack of Efficacy|2
6035220|NCT00689728|20858709|P2|Double-Blind Treatment|Lack of Efficacy|1
6035221|NCT00689728|20858710|P1|Double-Blind Treatment|Lack of Efficacy|0
6035222|NCT00689728|20858708|P3|Double-Blind Treatment|Withdrawal by Subject|2
6035223|NCT00689728|20858709|P2|Double-Blind Treatment|Withdrawal by Subject|3
6035224|NCT00689728|20858710|P1|Double-Blind Treatment|Withdrawal by Subject|3
6035225|NCT00689728|20858708|P3|Double-Blind Treatment|Protocol Violation|1
6035226|NCT00689728|20858709|P2|Double-Blind Treatment|Protocol Violation|0
6035227|NCT00689728|20858710|P1|Double-Blind Treatment|Protocol Violation|0
6035228|NCT00689728|20858708|P3|Double-Blind Treatment|Adverse Event|0
6035229|NCT00689728|20858709|P2|Double-Blind Treatment|Adverse Event|0
6035230|NCT00689728|20858710|P1|Double-Blind Treatment|Adverse Event|1
6035231|NCT00689611|20858793|P2|Overall Study|Lost to Follow-up|28
6035232|NCT00689611|20858794|P1|Overall Study|Lost to Follow-up|27
6035233|NCT00689611|20858793|P2|Overall Study|Withdrawal by Subject|9
6035234|NCT00689611|20858794|P1|Overall Study|Withdrawal by Subject|8
6035235|NCT00689611|20858793|P2|Overall Study|Death|9
6035236|NCT00689611|20858794|P1|Overall Study|Death|6
6035237|NCT00689481|20858804|P2|Overall Study|Subject early term, left on vacation|1
6035238|NCT00689481|20858805|P1|Overall Study|Subject early term, left on vacation|0
6035239|NCT00689481|20858804|P2|Overall Study|Excluded medication started during study|1
6035240|NCT00689481|20858805|P1|Overall Study|Excluded medication started during study|0
6035241|NCT00689481|20858804|P2|Overall Study|Withdrawal by Subject|4
6035242|NCT00689481|20858805|P1|Overall Study|Withdrawal by Subject|8
6035243|NCT00689481|20858804|P2|Overall Study|Non-compliance with study treatment|1
6035244|NCT00689481|20858805|P1|Overall Study|Non-compliance with study treatment|1
6035245|NCT00689481|20858804|P2|Overall Study|Lack of Efficacy|3
6035246|NCT00689481|20858805|P1|Overall Study|Lack of Efficacy|4
6035247|NCT00689481|20858804|P2|Overall Study|Lost to Follow-up|3
6035248|NCT00689481|20858805|P1|Overall Study|Lost to Follow-up|4
6035249|NCT00689481|20858804|P2|Overall Study|Adverse Event|1
6035250|NCT00689481|20858805|P1|Overall Study|Adverse Event|7
6035251|NCT00689390|20858823|P2|Overall Study|Administrative|0
6035252|NCT00689390|20858824|P1|Overall Study|Administrative|37
6035253|NCT00689390|20858823|P2|Overall Study|Did Not Meet Protocol Eligibility|0
6035254|NCT00689390|20858824|P1|Overall Study|Did Not Meet Protocol Eligibility|1
6035255|NCT00689390|20858823|P2|Overall Study|Non-Compliance With Protocol|0
6035256|NCT00689390|20858824|P1|Overall Study|Non-Compliance With Protocol|21
6035257|NCT00689390|20858823|P2|Overall Study|Withdrew Consent-Retreatment Opportunity|0
6035429|NCT00688740|20859293|P1|Overall Study|Lost to Follow-up|0
6035258|NCT00689390|20858824|P1|Overall Study|Withdrew Consent-Retreatment Opportunity|52
6035259|NCT00689390|20858823|P2|Overall Study|Withdrawal by Subject|3
6035260|NCT00689390|20858824|P1|Overall Study|Withdrawal by Subject|117
6035261|NCT00689390|20858823|P2|Overall Study|Lost to Follow-up|7
6035262|NCT00689390|20858824|P1|Overall Study|Lost to Follow-up|179
6035263|NCT00689390|20858823|P2|Overall Study|Adverse Event|0
6035264|NCT00689390|20858824|P1|Overall Study|Adverse Event|19
6035265|NCT00689351|20858842|P2|After Infant Series|Parent/legal guardian request|0
6035266|NCT00689351|20858843|P1|After Infant Series|Parent/legal guardian request|1
6035267|NCT00689351|20858842|P2|Infant Series of Dosing|Lost to Follow-up|1
6035268|NCT00689351|20858843|P1|Infant Series of Dosing|Lost to Follow-up|0
6035269|NCT00689351|20858842|P2|Infant Series of Dosing|Adverse Event|0
6035270|NCT00689351|20858843|P1|Infant Series of Dosing|Adverse Event|1
6035271|NCT00689351|20858842|P2|Infant Series of Dosing|Parent/legal guardian request|0
6035272|NCT00689351|20858843|P1|Infant Series of Dosing|Parent/legal guardian request|5
6035273|NCT00689338|20858875|P1|Overall Study|Protocol Violation|15
6035274|NCT00689338|20858875|P1|Overall Study|Withdrawal by Subject|3
6035275|NCT00689338|20858875|P1|Overall Study|Lost to Follow-up|5
6035276|NCT00689338|20858875|P1|Overall Study|Did not Meet Entrance Criteria|27
6035277|NCT00689338|20858875|P1|Overall Study|Other|8
6035278|NCT00689338|20858875|P1|Overall Study|Lack of Efficacy|6
6035279|NCT00689338|20858875|P1|Overall Study|Insufficient Clinical Response|1
6035280|NCT00689338|20858875|P1|Overall Study|Adverse Event|13
6035281|NCT00689338|20858875|P1|Overall Study|Death|65
6035282|NCT00689299|20858888|P3|Overall Study|Protocol Violation|0
6035283|NCT00689299|20858889|P2|Overall Study|Protocol Violation|0
6035284|NCT00689299|20858890|P1|Overall Study|Protocol Violation|1
6035285|NCT00689299|20858888|P3|Overall Study|Withdrawal by Subject|3
6035286|NCT00689299|20858889|P2|Overall Study|Withdrawal by Subject|1
6035287|NCT00689299|20858890|P1|Overall Study|Withdrawal by Subject|4
6035288|NCT00689299|20858888|P3|Overall Study|Lost to Follow-up|1
6035289|NCT00689299|20858889|P2|Overall Study|Lost to Follow-up|1
6035290|NCT00689299|20858890|P1|Overall Study|Lost to Follow-up|0
6035291|NCT00689299|20858888|P3|Overall Study|Adverse Event|1
6035292|NCT00689299|20858889|P2|Overall Study|Adverse Event|1
6035293|NCT00689299|20858890|P1|Overall Study|Adverse Event|2
6035294|NCT00689221|20858919|P2|Overall Study|Ongoing at cut-off date|36
6035295|NCT00689221|20858920|P1|Overall Study|Ongoing at cut-off date|39
6035296|NCT00689117|20858949|P4|Overall Study|Dispensing Error|0
6035297|NCT00689117|20858950|P3|Overall Study|Dispensing Error|0
6035298|NCT00689117|20858951|P2|Overall Study|Dispensing Error|1
6035299|NCT00689117|20858952|P1|Overall Study|Dispensing Error|0
6035300|NCT00689117|20858949|P4|Overall Study|Personal Reason|0
6035301|NCT00689117|20858950|P3|Overall Study|Personal Reason|0
6035302|NCT00689117|20858951|P2|Overall Study|Personal Reason|1
6035303|NCT00689117|20858952|P1|Overall Study|Personal Reason|0
6035304|NCT00689117|20858949|P4|Overall Study|Patient Withdrew from Study|1
6035305|NCT00689117|20858950|P3|Overall Study|Patient Withdrew from Study|0
6035306|NCT00689117|20858951|P2|Overall Study|Patient Withdrew from Study|0
6035307|NCT00689117|20858952|P1|Overall Study|Patient Withdrew from Study|0
6035308|NCT00689117|20858949|P4|Overall Study|Transportation|0
6035309|NCT00689117|20858950|P3|Overall Study|Transportation|0
6035310|NCT00689117|20858951|P2|Overall Study|Transportation|0
6035311|NCT00689117|20858952|P1|Overall Study|Transportation|1
6035312|NCT00689117|20858949|P4|Overall Study|Fear of Birth Defects|0
6035313|NCT00689117|20858950|P3|Overall Study|Fear of Birth Defects|1
6035314|NCT00689117|20858951|P2|Overall Study|Fear of Birth Defects|0
6035315|NCT00689117|20858952|P1|Overall Study|Fear of Birth Defects|0
6035316|NCT00689117|20858949|P4|Overall Study|Incarceration|0
6035317|NCT00689117|20858950|P3|Overall Study|Incarceration|0
6035318|NCT00689117|20858951|P2|Overall Study|Incarceration|0
6035319|NCT00689117|20858952|P1|Overall Study|Incarceration|2
6035320|NCT00689117|20858949|P4|Overall Study|Pregnancy|2
6035321|NCT00689117|20858950|P3|Overall Study|Pregnancy|0
6035322|NCT00689117|20858951|P2|Overall Study|Pregnancy|2
6035323|NCT00689117|20858952|P1|Overall Study|Pregnancy|0
6035324|NCT00689117|20858949|P4|Overall Study|Use of Prohibitive Medication|0
6035325|NCT00689117|20858950|P3|Overall Study|Use of Prohibitive Medication|3
6035326|NCT00689117|20858951|P2|Overall Study|Use of Prohibitive Medication|1
6035327|NCT00689117|20858952|P1|Overall Study|Use of Prohibitive Medication|2
6035328|NCT00689117|20858949|P4|Overall Study|Change/Discontinuation of Birth Control|0
6035329|NCT00689117|20858950|P3|Overall Study|Change/Discontinuation of Birth Control|1
6035330|NCT00689117|20858951|P2|Overall Study|Change/Discontinuation of Birth Control|1
6035331|NCT00689117|20858952|P1|Overall Study|Change/Discontinuation of Birth Control|1
6035332|NCT00689117|20858949|P4|Overall Study|Non-compliance with Treatment Regimen|0
6035333|NCT00689117|20858950|P3|Overall Study|Non-compliance with Treatment Regimen|0
6035334|NCT00689117|20858951|P2|Overall Study|Non-compliance with Treatment Regimen|1
6035335|NCT00689117|20858952|P1|Overall Study|Non-compliance with Treatment Regimen|0
6035336|NCT00689117|20858949|P4|Overall Study|Inclusion/Exclusion Criteria Not Met|0
6035337|NCT00689117|20858950|P3|Overall Study|Inclusion/Exclusion Criteria Not Met|0
6035338|NCT00689117|20858951|P2|Overall Study|Inclusion/Exclusion Criteria Not Met|2
6035339|NCT00689117|20858952|P1|Overall Study|Inclusion/Exclusion Criteria Not Met|1
6035340|NCT00689117|20858949|P4|Overall Study|Unable to Comply with Visit Schedule|1
6035341|NCT00689117|20858950|P3|Overall Study|Unable to Comply with Visit Schedule|1
6035342|NCT00689117|20858951|P2|Overall Study|Unable to Comply with Visit Schedule|0
6035343|NCT00689117|20858952|P1|Overall Study|Unable to Comply with Visit Schedule|0
6035344|NCT00689117|20858949|P4|Overall Study|Withdrawal by Subject|13
6035345|NCT00689117|20858950|P3|Overall Study|Withdrawal by Subject|26
6035346|NCT00689117|20858951|P2|Overall Study|Withdrawal by Subject|18
6035347|NCT00689117|20858952|P1|Overall Study|Withdrawal by Subject|19
6035348|NCT00689117|20858949|P4|Overall Study|Non-Compliance with Study Treatment|1
6035349|NCT00689117|20858950|P3|Overall Study|Non-Compliance with Study Treatment|3
6035350|NCT00689117|20858951|P2|Overall Study|Non-Compliance with Study Treatment|3
6035351|NCT00689117|20858952|P1|Overall Study|Non-Compliance with Study Treatment|3
6035352|NCT00689117|20858949|P4|Overall Study|Lack of Efficacy|2
6035353|NCT00689117|20858950|P3|Overall Study|Lack of Efficacy|2
6035354|NCT00689117|20858951|P2|Overall Study|Lack of Efficacy|2
6035355|NCT00689117|20858952|P1|Overall Study|Lack of Efficacy|1
6035356|NCT00689117|20858949|P4|Overall Study|Lost to Follow-up|11
6035357|NCT00689117|20858950|P3|Overall Study|Lost to Follow-up|17
6035358|NCT00689117|20858951|P2|Overall Study|Lost to Follow-up|19
6035359|NCT00689117|20858952|P1|Overall Study|Lost to Follow-up|26
6035360|NCT00689117|20858949|P4|Overall Study|Adverse Event|0
6035361|NCT00689117|20858950|P3|Overall Study|Adverse Event|5
6035362|NCT00689117|20858951|P2|Overall Study|Adverse Event|0
6035363|NCT00689117|20858952|P1|Overall Study|Adverse Event|6
6035364|NCT00689104|20858982|P4|Overall Study|Non-compliance with study procedures|0
6035365|NCT00689104|20858983|P3|Overall Study|Non-compliance with study procedures|1
6035366|NCT00689104|20858984|P2|Overall Study|Non-compliance with study procedures|0
6035367|NCT00689104|20858985|P1|Overall Study|Non-compliance with study procedures|0
6035368|NCT00689104|20858982|P4|Overall Study|Physician Decision|0
6035369|NCT00689104|20858983|P3|Overall Study|Physician Decision|0
6035370|NCT00689104|20858984|P2|Overall Study|Physician Decision|0
6035371|NCT00689104|20858985|P1|Overall Study|Physician Decision|1
6035372|NCT00689104|20858982|P4|Overall Study|Randomized but never received study drug|0
6035373|NCT00689104|20858983|P3|Overall Study|Randomized but never received study drug|1
6035374|NCT00689104|20858984|P2|Overall Study|Randomized but never received study drug|1
6035375|NCT00689104|20858985|P1|Overall Study|Randomized but never received study drug|2
6035376|NCT00689104|20858982|P4|Overall Study|Protocol Violation|3
6035377|NCT00689104|20858983|P3|Overall Study|Protocol Violation|5
6035378|NCT00689104|20858984|P2|Overall Study|Protocol Violation|3
6035379|NCT00689104|20858985|P1|Overall Study|Protocol Violation|2
6035380|NCT00689104|20858982|P4|Overall Study|Lost to Follow-up|5
6035381|NCT00689104|20858983|P3|Overall Study|Lost to Follow-up|2
6035382|NCT00689104|20858984|P2|Overall Study|Lost to Follow-up|3
6035383|NCT00689104|20858985|P1|Overall Study|Lost to Follow-up|4
6035384|NCT00689104|20858982|P4|Overall Study|Withdrawal by Subject|11
6035385|NCT00689104|20858983|P3|Overall Study|Withdrawal by Subject|18
6035386|NCT00689104|20858984|P2|Overall Study|Withdrawal by Subject|11
6035387|NCT00689104|20858985|P1|Overall Study|Withdrawal by Subject|12
6035388|NCT00689104|20858982|P4|Overall Study|Lack of Efficacy|3
6035389|NCT00689104|20858983|P3|Overall Study|Lack of Efficacy|2
6035390|NCT00689104|20858984|P2|Overall Study|Lack of Efficacy|6
6035391|NCT00689104|20858985|P1|Overall Study|Lack of Efficacy|5
6035392|NCT00689104|20858982|P4|Overall Study|Adverse Event|24
6035393|NCT00689104|20858983|P3|Overall Study|Adverse Event|16
6035394|NCT00689104|20858984|P2|Overall Study|Adverse Event|25
6035395|NCT00689104|20858985|P1|Overall Study|Adverse Event|13
6035396|NCT00689104|20858982|P4|Overall Study|Eligibility criterion not met|4
6035397|NCT00689104|20858983|P3|Overall Study|Eligibility criterion not met|0
6035398|NCT00689104|20858984|P2|Overall Study|Eligibility criterion not met|8
6035399|NCT00689104|20858985|P1|Overall Study|Eligibility criterion not met|5
6035400|NCT00689052|20859191|P2|Overall Study|Early termination of the trial|24
6035401|NCT00689052|20859192|P1|Overall Study|Early termination of the trial|22
6035402|NCT00689052|20859191|P2|Overall Study|Withdrawal by Subject|0
6035403|NCT00689052|20859192|P1|Overall Study|Withdrawal by Subject|2
6035404|NCT00689052|20859191|P2|Overall Study|Lost to Follow-up|0
6035405|NCT00689052|20859192|P1|Overall Study|Lost to Follow-up|2
6035406|NCT00689052|20859191|P2|Overall Study|Protocol Violation|0
6035407|NCT00689052|20859192|P1|Overall Study|Protocol Violation|1
6035408|NCT00689052|20859191|P2|Overall Study|Adverse Event|6
6035409|NCT00689052|20859192|P1|Overall Study|Adverse Event|4
6035410|NCT00689026|20859224|P2|Overall Study|Withdrawal by Subject|6
6035411|NCT00689026|20859225|P1|Overall Study|Withdrawal by Subject|13
6035412|NCT00688870|20859238|P2|Infant Series|Parent or legal guardian request|0
6035413|NCT00688870|20859239|P1|Infant Series|Parent or legal guardian request|4
6035414|NCT00688844|20859271|P1|Overall Study|Lost to Follow-up|10
6035415|NCT00688753|20859281|P1|Overall Study|Lost to Follow-up|3
6035416|NCT00688753|20859281|P1|Overall Study|Protocol Violation|1
6035417|NCT00688753|20859281|P1|Overall Study|Adverse Event|20
6035418|NCT00688753|20859281|P1|Overall Study|Withdrawal by Subject|3
6035419|NCT00688753|20859281|P1|Overall Study|Death|9
6035420|NCT00688753|20859281|P1|Overall Study|Missing|1
6035421|NCT00688753|20859281|P1|Overall Study|Disease progression|55
6035422|NCT00688740|20859292|P2|Overall Study|Violation of Inclusion Criteria|3
6035423|NCT00688740|20859293|P1|Overall Study|Violation of Inclusion Criteria|1
6035424|NCT00688740|20859292|P2|Overall Study|Breast Cancer Relapse|4
6035425|NCT00688740|20859293|P1|Overall Study|Breast Cancer Relapse|1
6035426|NCT00688740|20859292|P2|Overall Study|Consent Withdrawn|17
6035427|NCT00688740|20859293|P1|Overall Study|Consent Withdrawn|17
6035428|NCT00688740|20859292|P2|Overall Study|Lost to Follow-up|1
6035430|NCT00688740|20859292|P2|Overall Study|Death|2
6035431|NCT00688740|20859293|P1|Overall Study|Death|2
6035432|NCT00688740|20859292|P2|Overall Study|Adverse Event|8
6035433|NCT00688740|20859293|P1|Overall Study|Adverse Event|45
6035434|NCT00688701|20859306|P4|Overall Study|Poor compliance to protocol|0
6035435|NCT00688701|20859307|P3|Overall Study|Poor compliance to protocol|1
6035436|NCT00688701|20859308|P2|Overall Study|Poor compliance to protocol|1
6035437|NCT00688701|20859309|P1|Overall Study|Poor compliance to protocol|0
6035438|NCT00688701|20859306|P4|Overall Study|Withdrawal by Subject|8
6035439|NCT00688701|20859307|P3|Overall Study|Withdrawal by Subject|4
6035440|NCT00688701|20859308|P2|Overall Study|Withdrawal by Subject|3
6035441|NCT00688701|20859309|P1|Overall Study|Withdrawal by Subject|3
6035442|NCT00688701|20859306|P4|Overall Study|Lack of Efficacy|0
6035443|NCT00688701|20859307|P3|Overall Study|Lack of Efficacy|0
6035444|NCT00688701|20859308|P2|Overall Study|Lack of Efficacy|1
6035445|NCT00688701|20859309|P1|Overall Study|Lack of Efficacy|0
6035446|NCT00688701|20859306|P4|Overall Study|Adverse Event|3
6035447|NCT00688701|20859307|P3|Overall Study|Adverse Event|5
6035448|NCT00688701|20859308|P2|Overall Study|Adverse Event|0
6035449|NCT00688701|20859309|P1|Overall Study|Adverse Event|1
6035450|NCT00688688|20859350|P3|Overall Study|Violation of exclusion criterion|0
6035451|NCT00688688|20859351|P2|Overall Study|Violation of exclusion criterion|1
6035452|NCT00688688|20859352|P1|Overall Study|Violation of exclusion criterion|0
6035453|NCT00688688|20859350|P3|Overall Study|Site closure|0
6035454|NCT00688688|20859351|P2|Overall Study|Site closure|1
6035455|NCT00688688|20859352|P1|Overall Study|Site closure|0
6035456|NCT00688688|20859350|P3|Overall Study|Taking exclusionary medications|0
6035457|NCT00688688|20859351|P2|Overall Study|Taking exclusionary medications|0
6035458|NCT00688688|20859352|P1|Overall Study|Taking exclusionary medications|1
6035459|NCT00688688|20859350|P3|Overall Study|Non-compliance with study procedures|4
6035460|NCT00688688|20859351|P2|Overall Study|Non-compliance with study procedures|3
6035461|NCT00688688|20859352|P1|Overall Study|Non-compliance with study procedures|5
6035462|NCT00688688|20859350|P3|Overall Study|Randomized but never received study drug|0
6035463|NCT00688688|20859351|P2|Overall Study|Randomized but never received study drug|0
6035464|NCT00688688|20859352|P1|Overall Study|Randomized but never received study drug|1
6035465|NCT00688688|20859350|P3|Overall Study|Protocol Violation|11
6035466|NCT00688688|20859351|P2|Overall Study|Protocol Violation|9
6035467|NCT00688688|20859352|P1|Overall Study|Protocol Violation|6
6035468|NCT00688688|20859350|P3|Overall Study|Lost to Follow-up|7
6035469|NCT00688688|20859351|P2|Overall Study|Lost to Follow-up|7
6035470|NCT00688688|20859352|P1|Overall Study|Lost to Follow-up|14
6035471|NCT00688688|20859350|P3|Overall Study|Withdrawal by Subject|65
6035472|NCT00688688|20859351|P2|Overall Study|Withdrawal by Subject|75
6035473|NCT00688688|20859352|P1|Overall Study|Withdrawal by Subject|66
6035474|NCT00688688|20859350|P3|Overall Study|Lack of Efficacy|45
6035475|NCT00688688|20859351|P2|Overall Study|Lack of Efficacy|25
6035476|NCT00688688|20859352|P1|Overall Study|Lack of Efficacy|34
6035477|NCT00688688|20859350|P3|Overall Study|Adverse Event|50
6035478|NCT00688688|20859351|P2|Overall Study|Adverse Event|51
6035479|NCT00688688|20859352|P1|Overall Study|Adverse Event|52
6035480|NCT00688688|20859350|P3|Overall Study|Eligibility criterion not met|10
6035481|NCT00688688|20859351|P2|Overall Study|Eligibility criterion not met|7
6035482|NCT00688688|20859352|P1|Overall Study|Eligibility criterion not met|7
6035483|NCT00688636|20859454|P2|Overall Study|Adverse Event|1
6035484|NCT00688636|20859455|P1|Overall Study|Adverse Event|2
6035485|NCT00688623|20859469|P1|Overall Study|Protocol Violation|2
6035486|NCT00688623|20859469|P1|Overall Study|disease progression|23
6035487|NCT00688623|20859469|P1|Overall Study|Death|3
6035488|NCT00688623|20859469|P1|Overall Study|Withdrawal by Subject|4
6035489|NCT00688623|20859469|P1|Overall Study|abnormal lab value|1
6035490|NCT00688623|20859469|P1|Overall Study|Adverse Event|22
6035491|NCT00688597|20859483|P3|Overall Study|Physician Decision|0
6035492|NCT00688597|20859484|P2|Overall Study|Physician Decision|0
6035493|NCT00688597|20859485|P1|Overall Study|Physician Decision|1
6035494|NCT00688597|20859483|P3|Overall Study|Adverse Event|0
6035495|NCT00688597|20859484|P2|Overall Study|Adverse Event|0
6035496|NCT00688597|20859485|P1|Overall Study|Adverse Event|2
6035505|NCT00688519|20859509|P2|Overall Study|Pregnancy|1
6035506|NCT00688519|20859510|P1|Overall Study|Pregnancy|0
6035507|NCT00688519|20859509|P2|Overall Study|Subject moved out of area|0
6035508|NCT00688519|20859510|P1|Overall Study|Subject moved out of area|1
6035509|NCT00688519|20859509|P2|Overall Study|Investigator decision|0
6035510|NCT00688519|20859510|P1|Overall Study|Investigator decision|1
6035511|NCT00688519|20859509|P2|Overall Study|Subject moved out of state|0
6035512|NCT00688519|20859510|P1|Overall Study|Subject moved out of state|1
6035513|NCT00688519|20859509|P2|Overall Study|Non-compliance|1
6035514|NCT00688519|20859510|P1|Overall Study|Non-compliance|0
6035515|NCT00688519|20859509|P2|Overall Study|Prohibited medication|0
6035516|NCT00688519|20859510|P1|Overall Study|Prohibited medication|1
6035517|NCT00688519|20859509|P2|Overall Study|Withdrawal by Subject|6
6035518|NCT00688519|20859510|P1|Overall Study|Withdrawal by Subject|7
6035519|NCT00688519|20859509|P2|Overall Study|Lack of Efficacy|1
6035520|NCT00688519|20859510|P1|Overall Study|Lack of Efficacy|3
6035521|NCT00688519|20859509|P2|Overall Study|Lost to Follow-up|3
6035522|NCT00688519|20859510|P1|Overall Study|Lost to Follow-up|3
6035523|NCT00688519|20859509|P2|Overall Study|Adverse Event|3
6035524|NCT00688519|20859510|P1|Overall Study|Adverse Event|2
6035525|NCT00688467|20859528|P2|Treatment Period 2|Adverse Event|1
6035526|NCT00688467|20859529|P1|Treatment Period 2|Adverse Event|0
6035527|NCT00688467|20859528|P2|Treatment Period 2|Protocol Violation|1
6035528|NCT00688467|20859529|P1|Treatment Period 2|Protocol Violation|0
6035529|NCT00688467|20859528|P2|Treatment Period 1|Did not meet protocol eligibility|1
6035530|NCT00688467|20859529|P1|Treatment Period 1|Did not meet protocol eligibility|0
6035531|NCT00688467|20859528|P2|Treatment Period 1|Adverse Event|1
6035532|NCT00688467|20859529|P1|Treatment Period 1|Adverse Event|2
6035533|NCT00688376|20859561|P2|Blinded Extension Phase|Other|0
6035534|NCT00688376|20859562|P1|Blinded Extension Phase|Other|1
6035535|NCT00688376|20859561|P2|Blinded Extension Phase|Physician Decision|0
6035536|NCT00688376|20859562|P1|Blinded Extension Phase|Physician Decision|1
6035537|NCT00688376|20859561|P2|Blinded Extension Phase|Withdrawal by Subject|1
6035538|NCT00688376|20859562|P1|Blinded Extension Phase|Withdrawal by Subject|0
6035539|NCT00688376|20859561|P2|Blinded Extension Phase|Adverse Event|4
6035540|NCT00688376|20859562|P1|Blinded Extension Phase|Adverse Event|3
6035541|NCT00688376|20859561|P2|Double-Blind Phase|Not treated|1
6035542|NCT00688376|20859562|P1|Double-Blind Phase|Not treated|0
6035543|NCT00688376|20859561|P2|Double-Blind Phase|Withdrawal by Subject|0
6035544|NCT00688376|20859562|P1|Double-Blind Phase|Withdrawal by Subject|1
6035545|NCT00688376|20859561|P2|Double-Blind Phase|Protocol Violation|2
6035546|NCT00688376|20859562|P1|Double-Blind Phase|Protocol Violation|1
6035547|NCT00688376|20859561|P2|Double-Blind Phase|Adverse Event|4
6035548|NCT00688376|20859562|P1|Double-Blind Phase|Adverse Event|4
6035549|NCT00688324|20859576|P1|Overall Study|Lost to Follow-up|1
6035550|NCT00688324|20859576|P1|Overall Study|Physician Decision|5
6035551|NCT00688324|20859576|P1|Overall Study|Withdrawal by Subject|2
6035552|NCT00688259|20859621|P2|Overall Study|Hospitalized at Follow-up|1
6035553|NCT00688259|20859622|P1|Overall Study|Hospitalized at Follow-up|0
6035554|NCT00688259|20859621|P2|Overall Study|Declined Interview|3
6035555|NCT00688259|20859622|P1|Overall Study|Declined Interview|2
6035556|NCT00688259|20859621|P2|Overall Study|Withdrawal by Subject|0
6035557|NCT00688259|20859622|P1|Overall Study|Withdrawal by Subject|2
6035558|NCT00688259|20859621|P2|Overall Study|Physician Decision|0
6035559|NCT00688259|20859622|P1|Overall Study|Physician Decision|1
6035560|NCT00688259|20859621|P2|Overall Study|Lost to Follow-up|4
6035561|NCT00688259|20859622|P1|Overall Study|Lost to Follow-up|2
6035562|NCT00688155|20859642|P4|Overall Study|Withdrawal by Subject|1
6035563|NCT00688155|20859643|P3|Overall Study|Withdrawal by Subject|1
6035564|NCT00688155|20859644|P2|Overall Study|Withdrawal by Subject|2
6035565|NCT00688155|20859645|P1|Overall Study|Withdrawal by Subject|2
6035566|NCT00688103|20859665|P2|Overall Study|complex reasons|9
6035567|NCT00688103|20859666|P1|Overall Study|complex reasons|11
6035568|NCT00688103|20859665|P2|Overall Study|Withdrawal by Subject|2
6035569|NCT00688103|20859666|P1|Overall Study|Withdrawal by Subject|4
6035570|NCT00688103|20859665|P2|Overall Study|Lack of Efficacy|1
6035571|NCT00688103|20859666|P1|Overall Study|Lack of Efficacy|11
6035572|NCT00688103|20859665|P2|Overall Study|Adverse Event|1
6035573|NCT00688103|20859666|P1|Overall Study|Adverse Event|4
6035588|NCT00687973|20859695|P2|Overall Study|Withdrawal by Subject|3
6035589|NCT00687973|20859696|P1|Overall Study|Withdrawal by Subject|3
6035590|NCT00687973|20859695|P2|Overall Study|Administrative Reasons|2
6035591|NCT00687973|20859696|P1|Overall Study|Administrative Reasons|0
6035592|NCT00687973|20859695|P2|Overall Study|Protocol Violation|2
6035593|NCT00687973|20859696|P1|Overall Study|Protocol Violation|1
6035594|NCT00687973|20859695|P2|Overall Study|Lack of Efficacy|3
6035595|NCT00687973|20859696|P1|Overall Study|Lack of Efficacy|2
6035596|NCT00687973|20859695|P2|Overall Study|Adverse Event|28
6035597|NCT00687973|20859696|P1|Overall Study|Adverse Event|18
6035598|NCT00687804|20859758|P3|Open-Label Extension Study|Death|3
6035599|NCT00687804|20859759|P2|Open-Label Extension Study|Death|3
6035600|NCT00687804|20859760|P1|Open-Label Extension Study|Death|2
6035601|NCT00687804|20859758|P3|Open-Label Extension Study|Administrative problems|0
6035602|NCT00687804|20859759|P2|Open-Label Extension Study|Administrative problems|1
6035603|NCT00687804|20859760|P1|Open-Label Extension Study|Administrative problems|1
6035604|NCT00687804|20859758|P3|Open-Label Extension Study|Lost to Follow-up|2
6035605|NCT00687804|20859759|P2|Open-Label Extension Study|Lost to Follow-up|1
6035606|NCT00687804|20859760|P1|Open-Label Extension Study|Lost to Follow-up|2
6035607|NCT00687804|20859758|P3|Open-Label Extension Study|Subject withdrew consent|4
6035608|NCT00687804|20859759|P2|Open-Label Extension Study|Subject withdrew consent|4
6035609|NCT00687804|20859760|P1|Open-Label Extension Study|Subject withdrew consent|3
6035610|NCT00687804|20859758|P3|Open-Label Extension Study|Adverse Event|2
6035611|NCT00687804|20859759|P2|Open-Label Extension Study|Adverse Event|2
6035612|NCT00687804|20859760|P1|Open-Label Extension Study|Adverse Event|2
6035613|NCT00687804|20859758|P3|Core Study|Protocol Violation|0
6035614|NCT00687804|20859759|P2|Core Study|Protocol Violation|1
6035615|NCT00687804|20859760|P1|Core Study|Protocol Violation|1
6035616|NCT00687804|20859758|P3|Core Study|Death|2
6035617|NCT00687804|20859759|P2|Core Study|Death|2
6035618|NCT00687804|20859760|P1|Core Study|Death|2
6035619|NCT00687804|20859758|P3|Core Study|Lost to Follow-up|0
6035620|NCT00687804|20859759|P2|Core Study|Lost to Follow-up|1
6035621|NCT00687804|20859760|P1|Core Study|Lost to Follow-up|0
6035622|NCT00687804|20859758|P3|Core Study|Withdrawal by Subject|7
6035623|NCT00687804|20859759|P2|Core Study|Withdrawal by Subject|7
6035624|NCT00687804|20859760|P1|Core Study|Withdrawal by Subject|4
6035625|NCT00687804|20859758|P3|Core Study|Lack of Efficacy|1
6035626|NCT00687804|20859759|P2|Core Study|Lack of Efficacy|1
6035627|NCT00687804|20859760|P1|Core Study|Lack of Efficacy|1
6035628|NCT00687804|20859758|P3|Core Study|Abnormal laboratory value(s)|0
6035629|NCT00687804|20859759|P2|Core Study|Abnormal laboratory value(s)|0
6035630|NCT00687804|20859760|P1|Core Study|Abnormal laboratory value(s)|1
6035631|NCT00687804|20859758|P3|Core Study|Adverse Event|3
6035632|NCT00687804|20859759|P2|Core Study|Adverse Event|3
6035633|NCT00687804|20859760|P1|Core Study|Adverse Event|5
6035634|NCT00687739|20859807|P4|Overall Study|Adverse Event|0
6035635|NCT00687739|20859808|P3|Overall Study|Adverse Event|1
6035636|NCT00687739|20859809|P2|Overall Study|Adverse Event|1
6035637|NCT00687739|20859810|P1|Overall Study|Adverse Event|0
6035638|NCT00687739|20859807|P4|Overall Study|Lost to Follow-up|2
6035639|NCT00687739|20859808|P3|Overall Study|Lost to Follow-up|1
6035640|NCT00687739|20859809|P2|Overall Study|Lost to Follow-up|2
6035641|NCT00687739|20859810|P1|Overall Study|Lost to Follow-up|2
6035642|NCT00687609|20859852|P1|Overall Study|Withdrawal by Subject|2
6035643|NCT00687609|20859852|P1|Overall Study|Physician Decision|1
6035644|NCT00687531|20859875|P1|Overall Study|Lost to Follow-up|26
6035645|NCT00687531|20859875|P1|Overall Study|Adverse Event|5
6035646|NCT00687531|20859875|P1|Overall Study|Did not meet protocol eligibility|104
6035647|NCT00687440|20859898|P1|Overall Study|Missing|1
6035648|NCT00687440|20859898|P1|Overall Study|Other|1
6035649|NCT00687440|20859898|P1|Overall Study|Death|2
6035650|NCT00687440|20859898|P1|Overall Study|Lack of Efficacy|2
6035651|NCT00687440|20859898|P1|Overall Study|Lost to Follow-up|3
6035652|NCT00687440|20859898|P1|Overall Study|Adverse Event|3
6035653|NCT00687401|20859902|P1|Overall Study|For reasons different from those above|4
6035654|NCT00687401|20859902|P1|Overall Study|Did not return for visit|3
6035655|NCT00687401|20859902|P1|Overall Study|Withdrawal by Subject|4
6035656|NCT00687401|20859902|P1|Overall Study|Lack of Efficacy|6
6035657|NCT00687401|20859902|P1|Overall Study|Adverse Event|6
6035658|NCT00687401|20859902|P1|Overall Study|Protocol Violation|7
6035659|NCT00687362|20859907|P1|Overall Study|Withdrawal by Subject|1
6035660|NCT00687362|20859907|P1|Overall Study|Protocol Violation|2
6035661|NCT00687323|20859911|P1|Overall Study|Screen failure|148
6035662|NCT00687323|20859911|P1|Overall Study|Excluded from efficacy evaluations|6
6035663|NCT00687323|20859911|P1|Overall Study|Withdrawal by Subject|1
6035664|NCT00687323|20859911|P1|Overall Study|Death|25
6035665|NCT00687297|20859927|P2|Induction|Other|1
6035666|NCT00687297|20859928|P1|Induction|Other|0
6035667|NCT00687297|20859927|P2|Induction|Physician Decision|2
6035668|NCT00687297|20859928|P1|Induction|Physician Decision|0
6035669|NCT00687297|20859927|P2|Induction|Patient Noncompliance|0
6035670|NCT00687297|20859928|P1|Induction|Patient Noncompliance|1
6035671|NCT00687297|20859927|P2|Induction|Ineligible|1
6035672|NCT00687297|20859928|P1|Induction|Ineligible|0
6035673|NCT00687297|20859927|P2|Induction|Lack of Efficacy|21
6035674|NCT00687297|20859928|P1|Induction|Lack of Efficacy|17
6035675|NCT00687297|20859927|P2|Induction|Death|11
6035676|NCT00687297|20859928|P1|Induction|Death|7
6035677|NCT00687297|20859927|P2|Induction|Adverse Event|15
6035678|NCT00687297|20859928|P1|Induction|Adverse Event|16
6035679|NCT00687297|20859927|P2|Induction|Withdrawal by Subject|4
6035680|NCT00687297|20859928|P1|Induction|Withdrawal by Subject|4
6035681|NCT00687297|20859927|P2|Randomization|Withdrew before treatment, ineligible|1
6035682|NCT00687297|20859928|P1|Randomization|Withdrew before treatment, ineligible|1
6035683|NCT00687297|20859927|P2|Randomization|Withdrawal by Subject|0
6035684|NCT00687297|20859928|P1|Randomization|Withdrawal by Subject|2
6035685|NCT00687271|20859942|P4|Overall Study|Withdrawal by Subject|0
6035686|NCT00687271|20859943|P3|Overall Study|Withdrawal by Subject|3
6035687|NCT00687271|20859944|P2|Overall Study|Withdrawal by Subject|1
6035688|NCT00687271|20859945|P1|Overall Study|Withdrawal by Subject|0
6035689|NCT00687271|20859942|P4|Overall Study|Protocol Violation|0
6035690|NCT00687271|20859943|P3|Overall Study|Protocol Violation|1
6035691|NCT00687271|20859944|P2|Overall Study|Protocol Violation|1
6035692|NCT00687271|20859945|P1|Overall Study|Protocol Violation|2
6035693|NCT00687271|20859942|P4|Overall Study|Lost to Follow-up|0
6035694|NCT00687271|20859943|P3|Overall Study|Lost to Follow-up|0
6035695|NCT00687271|20859944|P2|Overall Study|Lost to Follow-up|1
6035696|NCT00687271|20859945|P1|Overall Study|Lost to Follow-up|0
6035697|NCT00687271|20859942|P4|Overall Study|Adverse Event|0
6035698|NCT00687271|20859943|P3|Overall Study|Adverse Event|1
6035699|NCT00687271|20859944|P2|Overall Study|Adverse Event|3
6035700|NCT00687271|20859945|P1|Overall Study|Adverse Event|1
6035701|NCT00687219|20859983|P1|Overall Study|Lack of Efficacy|1
6035702|NCT00687219|20859983|P1|Overall Study|Withdrawal by Subject|1
6035703|NCT00687219|20859983|P1|Overall Study|HCV-RNA positive conversion|34
6035704|NCT00687219|20859983|P1|Overall Study|Discontinuance criteria met|7
6035705|NCT00687219|20859983|P1|Overall Study|Adverse Event|8
6035706|NCT00687193|20859995|P6|Overall Study|Protocol Violation|0
6035707|NCT00687193|20859996|P5|Overall Study|Protocol Violation|2
6035708|NCT00687193|20859997|P4|Overall Study|Protocol Violation|1
6035709|NCT00687193|20859998|P3|Overall Study|Protocol Violation|0
6035710|NCT00687193|20859999|P2|Overall Study|Protocol Violation|2
6035711|NCT00687193|20860000|P1|Overall Study|Protocol Violation|1
6035712|NCT00687193|20859995|P6|Overall Study|Lack of Efficacy|2
6035713|NCT00687193|20859996|P5|Overall Study|Lack of Efficacy|0
6035714|NCT00687193|20859997|P4|Overall Study|Lack of Efficacy|0
6035715|NCT00687193|20859998|P3|Overall Study|Lack of Efficacy|0
6035716|NCT00687193|20859999|P2|Overall Study|Lack of Efficacy|1
6035717|NCT00687193|20860000|P1|Overall Study|Lack of Efficacy|1
6035718|NCT00687193|20859995|P6|Overall Study|Adverse Event|2
6035719|NCT00687193|20859996|P5|Overall Study|Adverse Event|0
6035720|NCT00687193|20859997|P4|Overall Study|Adverse Event|3
6035721|NCT00687193|20859998|P3|Overall Study|Adverse Event|2
6035722|NCT00687193|20859999|P2|Overall Study|Adverse Event|1
6035723|NCT00687193|20860000|P1|Overall Study|Adverse Event|0
6035724|NCT00686998|20860210|P3|Overall Study|Safety Reasons|0
6035725|NCT00686998|20860211|P2|Overall Study|Safety Reasons|0
6035726|NCT00686998|20860212|P1|Overall Study|Safety Reasons|1
6035727|NCT00686998|20860210|P3|Overall Study|Other|1
6035728|NCT00686998|20860211|P2|Overall Study|Other|0
6035729|NCT00686998|20860212|P1|Overall Study|Other|0
6035730|NCT00686998|20860210|P3|Overall Study|Lack of Efficacy|0
6035731|NCT00686998|20860211|P2|Overall Study|Lack of Efficacy|5
6035732|NCT00686998|20860212|P1|Overall Study|Lack of Efficacy|7
6035733|NCT00686998|20860210|P3|Overall Study|Withdrawal by Subject|2
6035734|NCT00686998|20860211|P2|Overall Study|Withdrawal by Subject|1
6035735|NCT00686998|20860212|P1|Overall Study|Withdrawal by Subject|2
6035736|NCT00686998|20860210|P3|Overall Study|Adverse Event|1
6035737|NCT00686998|20860211|P2|Overall Study|Adverse Event|2
6035738|NCT00686998|20860212|P1|Overall Study|Adverse Event|3
6035739|NCT00686972|20860220|P1|Overall Study|P.I, Left institution. Study terminated|51
6035740|NCT00686959|20860226|P2|Overall Study|Participants censored (no death events)|117
6035741|NCT00686959|20860227|P1|Overall Study|Participants censored (no death events)|124
6035742|NCT00686920|20860247|P2|Overall Study|Principal Investigator Decision|0
6035743|NCT00686920|20860248|P1|Overall Study|Principal Investigator Decision|2
6035744|NCT00686920|20860247|P2|Overall Study|Noncompliance|0
6035745|NCT00686920|20860248|P1|Overall Study|Noncompliance|9
6035746|NCT00686920|20860247|P2|Overall Study|Transferred to Nursing Home|0
6035747|NCT00686920|20860248|P1|Overall Study|Transferred to Nursing Home|1
6035748|NCT00686920|20860247|P2|Overall Study|Moved to Another State|0
6035749|NCT00686920|20860248|P1|Overall Study|Moved to Another State|1
6035750|NCT00686920|20860247|P2|Overall Study|Lost to Follow-up|3
6035751|NCT00686920|20860248|P1|Overall Study|Lost to Follow-up|15
6035752|NCT00686920|20860247|P2|Overall Study|Personal Reason|1
6035753|NCT00686920|20860248|P1|Overall Study|Personal Reason|0
6035754|NCT00686920|20860247|P2|Overall Study|Adverse Event|2
6035755|NCT00686920|20860248|P1|Overall Study|Adverse Event|10
6035756|NCT00686920|20860247|P2|Overall Study|Protocol Violation|1
6035757|NCT00686920|20860248|P1|Overall Study|Protocol Violation|2
6035758|NCT00686920|20860247|P2|Overall Study|Withdrawal by Subject|5
6035759|NCT00686920|20860248|P1|Overall Study|Withdrawal by Subject|23
6035760|NCT00686920|20860247|P2|Overall Study|Recurrent Hepatic Encephalopathy Episode|2
6035761|NCT00686920|20860248|P1|Overall Study|Recurrent Hepatic Encephalopathy Episode|1
6035762|NCT00686920|20860247|P2|Overall Study|Liver Transplant|8
6035763|NCT00686920|20860248|P1|Overall Study|Liver Transplant|23
6035764|NCT00686920|20860247|P2|Overall Study|Death|14
6035765|NCT00686920|20860248|P1|Overall Study|Death|45
6035766|NCT00686894|20860260|P1|Overall Study|Protocol Violation|4
6035767|NCT00686894|20860260|P1|Overall Study|Relapse|2
6035768|NCT00686881|20860266|P2|Overall Study|Never received study drug|6
6035769|NCT00686881|20860267|P1|Overall Study|Never received study drug|2
6035770|NCT00686881|20860266|P2|Overall Study|Study discontinuation|32
6035771|NCT00686881|20860267|P1|Overall Study|Study discontinuation|35
6035772|NCT00686881|20860266|P2|Overall Study|Irregular visits|0
6035773|NCT00686881|20860267|P1|Overall Study|Irregular visits|1
6035774|NCT00686881|20860266|P2|Overall Study|Did not meet protocol eligibility|0
6035775|NCT00686881|20860267|P1|Overall Study|Did not meet protocol eligibility|1
6035776|NCT00686881|20860266|P2|Overall Study|Circumstances of site|1
6035777|NCT00686881|20860267|P1|Overall Study|Circumstances of site|1
6035778|NCT00686881|20860266|P2|Overall Study|Physician Decision|0
6035779|NCT00686881|20860267|P1|Overall Study|Physician Decision|1
6035780|NCT00686881|20860266|P2|Overall Study|Lack of Efficacy|3
6035781|NCT00686881|20860267|P1|Overall Study|Lack of Efficacy|4
6035782|NCT00686881|20860266|P2|Overall Study|Onset of malignant tumor|11
6035783|NCT00686881|20860267|P1|Overall Study|Onset of malignant tumor|11
6035784|NCT00686881|20860266|P2|Overall Study|Met discontinuation criteria|0
6035785|NCT00686881|20860267|P1|Overall Study|Met discontinuation criteria|5
6035786|NCT00686881|20860266|P2|Overall Study|Treatment-related adverse event|9
6035787|NCT00686881|20860267|P1|Overall Study|Treatment-related adverse event|10
6035788|NCT00686881|20860266|P2|Overall Study|Lost to Follow-up|1
6035789|NCT00686881|20860267|P1|Overall Study|Lost to Follow-up|0
6035790|NCT00686881|20860266|P2|Overall Study|Withdrawal by Subject|18
6035791|NCT00686881|20860267|P1|Overall Study|Withdrawal by Subject|11
6035792|NCT00686855|20860279|P2|Overall Study|Progressive GVHD|1
6035793|NCT00686855|20860280|P1|Overall Study|Progressive GVHD|0
6035794|NCT00686855|20860279|P2|Overall Study|Lost to Follow-up|0
6035795|NCT00686855|20860280|P1|Overall Study|Lost to Follow-up|1
6035796|NCT00686829|20860290|P1|Overall Study|Sponsor discontinued VCV|47
6035797|NCT00686829|20860290|P1|Overall Study|Protocol Violation|3
6035798|NCT00686829|20860290|P1|Overall Study|Withdrawal by Subject|14
6035799|NCT00686829|20860290|P1|Overall Study|Lost to Follow-up|4
6035800|NCT00686829|20860290|P1|Overall Study|Lack of Efficacy|6
6035801|NCT00686829|20860290|P1|Overall Study|Adverse Event|5
6035802|NCT00686790|20860320|P1|Overall Study|Lost to Follow-up|12
6035803|NCT00686790|20860320|P1|Overall Study|Death|1
6035804|NCT00686790|20860320|P1|Overall Study|Withdrawal by Subject|1
6035805|NCT00686790|20860320|P1|Overall Study|Adverse Event|2
6035806|NCT00686777|20860328|P1|Overall Study|No Visit|1
6035807|NCT00686777|20860328|P1|Overall Study|Discontinuance Criteria (specified AEs)|4
6035808|NCT00686777|20860328|P1|Overall Study|Withdrawal by Subject|2
6035809|NCT00686777|20860328|P1|Overall Study|Pregnancy|1
6035810|NCT00686777|20860328|P1|Overall Study|Adverse Event|2
6035811|NCT00686725|20860336|P2|Overall Study|Other|3
6035812|NCT00686725|20860337|P1|Overall Study|Other|1
6035813|NCT00686725|20860336|P2|Overall Study|Protocol Violation|3
6035814|NCT00686725|20860337|P1|Overall Study|Protocol Violation|1
6035815|NCT00686725|20860336|P2|Overall Study|Withdrawal by Subject|4
6035816|NCT00686725|20860337|P1|Overall Study|Withdrawal by Subject|13
6035817|NCT00686725|20860336|P2|Overall Study|Death|3
6035818|NCT00686725|20860337|P1|Overall Study|Death|6
6035819|NCT00686725|20860336|P2|Overall Study|Lost to Follow-up|5
6035820|NCT00686725|20860337|P1|Overall Study|Lost to Follow-up|7
6035821|NCT00686725|20860336|P2|Overall Study|Progressive Disease|23
6035822|NCT00686725|20860337|P1|Overall Study|Progressive Disease|17
6035823|NCT00686725|20860336|P2|Overall Study|Adverse Event|1
6035824|NCT00686725|20860337|P1|Overall Study|Adverse Event|1
6035825|NCT00686712|20860362|P3|Overall Study|Adverse Event|0
6035826|NCT00686712|20860363|P2|Overall Study|Adverse Event|1
6035827|NCT00686712|20860364|P1|Overall Study|Adverse Event|1
6035828|NCT00686712|20860362|P3|Overall Study|Lost to Follow-up|3
6035829|NCT00686712|20860363|P2|Overall Study|Lost to Follow-up|2
6035830|NCT00686712|20860364|P1|Overall Study|Lost to Follow-up|1
6035831|NCT00686712|20860362|P3|Overall Study|Protocol Violation|10
6035832|NCT00686712|20860363|P2|Overall Study|Protocol Violation|8
6035833|NCT00686712|20860364|P1|Overall Study|Protocol Violation|8
6035834|NCT00686699|20860392|P2|Treatment Period 1|Adverse Event|2
6035835|NCT00686699|20860393|P1|Treatment Period 1|Adverse Event|0
6035836|NCT00686686|20860417|P1|Overall Study|Lost to Follow-up|3
6035837|NCT00686686|20860417|P1|Overall Study|Adverse Event|2
6035838|NCT00686686|20860417|P1|Overall Study|Non-compliance|1
6035839|NCT00686647|20860425|P1|Overall Study|Death|1
6035840|NCT00686647|20860425|P1|Overall Study|Lost to Follow-up|1
6035841|NCT00686634|20860431|P1|Overall Study|Protocol Violation|6
6035842|NCT00686595|20860438|P1|Overall Study|Poor Compliance|1
6035843|NCT00686595|20860438|P1|Overall Study|Lack of Efficacy|1
6035844|NCT00686595|20860438|P1|Overall Study|Lost to Follow-up|1
6035845|NCT00686595|20860438|P1|Overall Study|Protocol Violation|1
6035846|NCT00686595|20860438|P1|Overall Study|Adverse Event|3
6035847|NCT00686543|20860498|P4|Overall Study|Protocol Violation|1
6035848|NCT00686543|20860499|P3|Overall Study|Protocol Violation|2
6035849|NCT00686543|20860500|P2|Overall Study|Protocol Violation|0
6035850|NCT00686543|20860501|P1|Overall Study|Protocol Violation|3
6035851|NCT00686543|20860498|P4|Overall Study|Withdrawal by Subject|0
6035852|NCT00686543|20860499|P3|Overall Study|Withdrawal by Subject|0
6035853|NCT00686543|20860500|P2|Overall Study|Withdrawal by Subject|0
6035854|NCT00686543|20860501|P1|Overall Study|Withdrawal by Subject|2
6035855|NCT00686543|20860498|P4|Overall Study|Adverse Event|2
6035856|NCT00686543|20860499|P3|Overall Study|Adverse Event|3
6035857|NCT00686543|20860500|P2|Overall Study|Adverse Event|1
6035858|NCT00686543|20860501|P1|Overall Study|Adverse Event|9
6035859|NCT00686517|20860522|P3|Treatment|Protocol Violation|0
6035860|NCT00686517|20860523|P2|Treatment|Protocol Violation|1
6035861|NCT00686517|20860524|P1|Treatment|Protocol Violation|2
6035862|NCT00686517|20860522|P3|Treatment|Poor Protocol Compliance|0
6035863|NCT00686517|20860523|P2|Treatment|Poor Protocol Compliance|0
6035864|NCT00686517|20860524|P1|Treatment|Poor Protocol Compliance|1
6035865|NCT00686517|20860522|P3|Treatment|Adverse Event|0
6035866|NCT00686517|20860523|P2|Treatment|Adverse Event|0
6035867|NCT00686517|20860524|P1|Treatment|Adverse Event|2
6035868|NCT00686517|20860522|P3|Treatment|Serious Adverse Event|1
6035869|NCT00686517|20860523|P2|Treatment|Serious Adverse Event|2
6035870|NCT00686517|20860524|P1|Treatment|Serious Adverse Event|1
6035871|NCT00686374|20860547|P1|Overall Study|Other, not specified|4
6035872|NCT00686374|20860547|P1|Overall Study|Missing reason|33
6035873|NCT00686374|20860547|P1|Overall Study|Lost to Follow-up|1
6035874|NCT00686374|20860547|P1|Overall Study|Withdrew consent|5
6035875|NCT00686374|20860547|P1|Overall Study|Adverse Event|8
6035876|NCT00686374|20860547|P1|Overall Study|Lack of Efficacy|10
6035877|NCT00686335|20860558|P1|Run-in Period|violation of inclusion/exclusion criteri|3
6035878|NCT00686335|20860558|P1|Run-in Period|asthma exacerbation|1
6035879|NCT00686335|20860558|P1|Run-in Period|Adverse Event|1
6035880|NCT00686205|20860602|P2|Overall Study|Specimens not confirmed HIV positive|981
6035881|NCT00686205|20860603|P1|Overall Study|Specimens not confirmed HIV positive|0
6035882|NCT00686205|20860602|P2|Overall Study|Specimen handling procedure altered|0
6035883|NCT00686205|20860603|P1|Overall Study|Specimen handling procedure altered|5878
6035884|NCT00686205|20860602|P2|Overall Study|Withdrawal by Subject|0
6035885|NCT00686205|20860603|P1|Overall Study|Withdrawal by Subject|2
6035886|NCT00686205|20860602|P2|Overall Study|Protocol Violation|0
6035887|NCT00686205|20860603|P1|Overall Study|Protocol Violation|127
6035888|NCT00686166|20860609|P1|Overall Study|Did not begin protocol therapy|4
6035889|NCT00686166|20860609|P1|Overall Study|Ineligible|5
6035890|NCT00686166|20860609|P1|Overall Study|Not Protocol Specified|1
6035891|NCT00686166|20860609|P1|Overall Study|Death|1
6035892|NCT00686166|20860609|P1|Overall Study|Progression/Relapse|1
6035893|NCT00686166|20860609|P1|Overall Study|Withdrawal by Subject|1
6035894|NCT00686166|20860609|P1|Overall Study|Adverse Event|7
6035895|NCT00686127|20860621|P2|Overall Study|Withdrawal by Subject|6
6035896|NCT00686127|20860622|P1|Overall Study|Withdrawal by Subject|14
6035897|NCT00686075|20860638|P10|Overall Study|Other|1
6035898|NCT00686075|20860639|P9|Overall Study|Other|0
6035899|NCT00686075|20860640|P8|Overall Study|Other|0
6035900|NCT00686075|20860641|P7|Overall Study|Other|0
6035901|NCT00686075|20860642|P6|Overall Study|Other|0
6035902|NCT00686075|20860643|P5|Overall Study|Other|0
6035903|NCT00686075|20860644|P4|Overall Study|Other|0
6035904|NCT00686075|20860645|P3|Overall Study|Other|0
6035905|NCT00686075|20860646|P2|Overall Study|Other|1
6035906|NCT00686075|20860647|P1|Overall Study|Other|1
6035907|NCT00686075|20860638|P10|Overall Study|Lost to Follow-up|3
6035908|NCT00686075|20860639|P9|Overall Study|Lost to Follow-up|2
6035909|NCT00686075|20860640|P8|Overall Study|Lost to Follow-up|0
6035910|NCT00686075|20860641|P7|Overall Study|Lost to Follow-up|0
6035911|NCT00686075|20860642|P6|Overall Study|Lost to Follow-up|3
6035912|NCT00686075|20860643|P5|Overall Study|Lost to Follow-up|3
6035913|NCT00686075|20860644|P4|Overall Study|Lost to Follow-up|2
6035914|NCT00686075|20860645|P3|Overall Study|Lost to Follow-up|3
6035915|NCT00686075|20860646|P2|Overall Study|Lost to Follow-up|6
6035916|NCT00686075|20860647|P1|Overall Study|Lost to Follow-up|3
6035917|NCT00686075|20860638|P10|Overall Study|Withdrawal by Subject|6
6035918|NCT00686075|20860639|P9|Overall Study|Withdrawal by Subject|4
6035919|NCT00686075|20860640|P8|Overall Study|Withdrawal by Subject|2
6035920|NCT00686075|20860641|P7|Overall Study|Withdrawal by Subject|0
6035921|NCT00686075|20860642|P6|Overall Study|Withdrawal by Subject|0
6035922|NCT00686075|20860643|P5|Overall Study|Withdrawal by Subject|1
6035923|NCT00686075|20860644|P4|Overall Study|Withdrawal by Subject|7
6035924|NCT00686075|20860645|P3|Overall Study|Withdrawal by Subject|3
6035925|NCT00686075|20860646|P2|Overall Study|Withdrawal by Subject|3
6035926|NCT00686075|20860647|P1|Overall Study|Withdrawal by Subject|4
6035927|NCT00686036|20860841|P2|Overall Study|Other reasons not identified|4
6035928|NCT00686036|20860842|P1|Overall Study|Other reasons not identified|0
6035929|NCT00686036|20860841|P2|Overall Study|PSA ≥ 10ng/mL|0
6035930|NCT00686036|20860842|P1|Overall Study|PSA ≥ 10ng/mL|1
6035931|NCT00686036|20860841|P2|Overall Study|Study terminated by AstraZeneca|1
6035932|NCT00686036|20860842|P1|Overall Study|Study terminated by AstraZeneca|2
6035933|NCT00686036|20860841|P2|Overall Study|Withdrawal by Subject|1
6035934|NCT00686036|20860842|P1|Overall Study|Withdrawal by Subject|3
6035935|NCT00686036|20860841|P2|Overall Study|Adverse Event|0
6035936|NCT00686036|20860842|P1|Overall Study|Adverse Event|3
6035937|NCT00685945|20860854|P1|L-NMMA + Bradykinin|Physician Decision|1
6035938|NCT00685802|20860889|P2|Washout Period of 7 Days|Withdrawal by Subject|1
6035939|NCT00685802|20860890|P1|Washout Period of 7 Days|Withdrawal by Subject|0
6035940|NCT00685802|20860889|P2|Washout Period of 7 Days|Protocol Violation|0
6035941|NCT00685802|20860890|P1|Washout Period of 7 Days|Protocol Violation|2
6035942|NCT00685763|20860900|P1|Overall Study|Protocol Violation|1
6035943|NCT00685763|20860900|P1|Overall Study|Intercurrent death-incomplete treatment|1
6035944|NCT00685750|20860911|P7|Overall Study|Eligibility criteria not fulfilled|0
6035945|NCT00685750|20860912|P6|Overall Study|Eligibility criteria not fulfilled|0
6035946|NCT00685750|20860913|P5|Overall Study|Eligibility criteria not fulfilled|0
6035947|NCT00685750|20860914|P4|Overall Study|Eligibility criteria not fulfilled|0
6035948|NCT00685750|20860915|P3|Overall Study|Eligibility criteria not fulfilled|1
6035949|NCT00685750|20860916|P2|Overall Study|Eligibility criteria not fulfilled|0
6035950|NCT00685750|20860917|P1|Overall Study|Eligibility criteria not fulfilled|0
6035951|NCT00685750|20860911|P7|Overall Study|Patient didn't receive the treatment|1
6035952|NCT00685750|20860912|P6|Overall Study|Patient didn't receive the treatment|0
6035953|NCT00685750|20860913|P5|Overall Study|Patient didn't receive the treatment|0
6035954|NCT00685750|20860914|P4|Overall Study|Patient didn't receive the treatment|0
6035955|NCT00685750|20860915|P3|Overall Study|Patient didn't receive the treatment|0
6035956|NCT00685750|20860916|P2|Overall Study|Patient didn't receive the treatment|0
6035957|NCT00685750|20860917|P1|Overall Study|Patient didn't receive the treatment|0
6035958|NCT00685750|20860911|P7|Overall Study|Tumor sampling failure|0
6035959|NCT00685750|20860912|P6|Overall Study|Tumor sampling failure|0
6035960|NCT00685750|20860913|P5|Overall Study|Tumor sampling failure|0
6035961|NCT00685750|20860914|P4|Overall Study|Tumor sampling failure|0
6035962|NCT00685750|20860915|P3|Overall Study|Tumor sampling failure|1
6035963|NCT00685750|20860916|P2|Overall Study|Tumor sampling failure|0
6035964|NCT00685750|20860917|P1|Overall Study|Tumor sampling failure|0
6035965|NCT00685698|20860945|P1|Overall Study|NO GRAM POSITIVE CULTURE GROWN|1
6035966|NCT00685698|20860945|P1|Overall Study|CULTURE RESULTS: GRAM-VE|1
6035967|NCT00685698|20860945|P1|Overall Study|CULTURE GRAM NEG SPECIES|1
6035968|NCT00685698|20860945|P1|Overall Study|Adverse Event|3
6035969|NCT00685698|20860945|P1|Overall Study|Protocol Violation|6
6035970|NCT00685698|20860945|P1|Overall Study|Withdrawal by Subject|1
6035971|NCT00685685|20860980|P2|Washout Period of 7 Days|Withdrawal by Subject|1
6035972|NCT00685685|20860981|P1|Washout Period of 7 Days|Withdrawal by Subject|0
6035973|NCT00685685|20860980|P2|Washout Period of 7 Days|Adverse Event|0
6035974|NCT00685685|20860981|P1|Washout Period of 7 Days|Adverse Event|2
6035975|NCT00685399|20861134|P8|Extension|Adverse Event|0
6035976|NCT00685399|20861135|P7|Extension|Adverse Event|0
6035977|NCT00685399|20861136|P6|Extension|Adverse Event|0
6035978|NCT00685399|20861137|P5|Extension|Adverse Event|0
6035979|NCT00685399|20861138|P4|Extension|Adverse Event|2
6035980|NCT00685399|20861139|P3|Extension|Adverse Event|0
6035981|NCT00685399|20861140|P2|Extension|Adverse Event|0
6035982|NCT00685399|20861141|P1|Extension|Adverse Event|0
6035983|NCT00685399|20861134|P8|Extension|Lack of Efficacy|0
6035984|NCT00685399|20861135|P7|Extension|Lack of Efficacy|0
6035985|NCT00685399|20861136|P6|Extension|Lack of Efficacy|0
6035986|NCT00685399|20861137|P5|Extension|Lack of Efficacy|0
6035987|NCT00685399|20861138|P4|Extension|Lack of Efficacy|2
6035988|NCT00685399|20861139|P3|Extension|Lack of Efficacy|0
6035989|NCT00685399|20861140|P2|Extension|Lack of Efficacy|0
6035990|NCT00685399|20861141|P1|Extension|Lack of Efficacy|0
6035991|NCT00685399|20861134|P8|Extension|Protocol Violation|0
6035992|NCT00685399|20861135|P7|Extension|Protocol Violation|0
6035993|NCT00685399|20861136|P6|Extension|Protocol Violation|0
6035994|NCT00685399|20861137|P5|Extension|Protocol Violation|0
6035995|NCT00685399|20861138|P4|Extension|Protocol Violation|1
6035996|NCT00685399|20861139|P3|Extension|Protocol Violation|0
6035997|NCT00685399|20861140|P2|Extension|Protocol Violation|0
6035998|NCT00685399|20861141|P1|Extension|Protocol Violation|0
6035999|NCT00685399|20861134|P8|Extension|Withdrawal by Subject|0
6036000|NCT00685399|20861135|P7|Extension|Withdrawal by Subject|0
6036001|NCT00685399|20861136|P6|Extension|Withdrawal by Subject|0
6036002|NCT00685399|20861137|P5|Extension|Withdrawal by Subject|0
6036003|NCT00685399|20861138|P4|Extension|Withdrawal by Subject|1
6036004|NCT00685399|20861139|P3|Extension|Withdrawal by Subject|0
6036005|NCT00685399|20861140|P2|Extension|Withdrawal by Subject|0
6036006|NCT00685399|20861141|P1|Extension|Withdrawal by Subject|0
6036007|NCT00685399|20861134|P8|Extension|Administrative Issues|0
6036008|NCT00685399|20861135|P7|Extension|Administrative Issues|0
6036009|NCT00685399|20861136|P6|Extension|Administrative Issues|0
6036010|NCT00685399|20861137|P5|Extension|Administrative Issues|0
6036011|NCT00685399|20861138|P4|Extension|Administrative Issues|1
6036012|NCT00685399|20861139|P3|Extension|Administrative Issues|0
6036013|NCT00685399|20861140|P2|Extension|Administrative Issues|0
6036014|NCT00685399|20861141|P1|Extension|Administrative Issues|0
6036015|NCT00685399|20861134|P8|Treatment Period 2|Lack of Efficacy|0
6036016|NCT00685399|20861135|P7|Treatment Period 2|Lack of Efficacy|0
6036017|NCT00685399|20861136|P6|Treatment Period 2|Lack of Efficacy|1
6036018|NCT00685399|20861137|P5|Treatment Period 2|Lack of Efficacy|0
6036019|NCT00685399|20861138|P4|Treatment Period 2|Lack of Efficacy|0
6036020|NCT00685399|20861139|P3|Treatment Period 2|Lack of Efficacy|2
6036021|NCT00685399|20861140|P2|Treatment Period 2|Lack of Efficacy|10
6036022|NCT00685399|20861141|P1|Treatment Period 2|Lack of Efficacy|0
6036023|NCT00685399|20861134|P8|Treatment Period 2|Adverse Event|0
6036024|NCT00685399|20861135|P7|Treatment Period 2|Adverse Event|0
6036025|NCT00685399|20861136|P6|Treatment Period 2|Adverse Event|1
6036026|NCT00685399|20861137|P5|Treatment Period 2|Adverse Event|0
6036027|NCT00685399|20861138|P4|Treatment Period 2|Adverse Event|0
6036028|NCT00685399|20861139|P3|Treatment Period 2|Adverse Event|0
6036029|NCT00685399|20861140|P2|Treatment Period 2|Adverse Event|0
6036030|NCT00685399|20861141|P1|Treatment Period 2|Adverse Event|0
6036031|NCT00685399|20861134|P8|Treatment Period 2|Withdrawal by Subject|2
6036032|NCT00685399|20861135|P7|Treatment Period 2|Withdrawal by Subject|0
6036033|NCT00685399|20861136|P6|Treatment Period 2|Withdrawal by Subject|0
6036034|NCT00685399|20861137|P5|Treatment Period 2|Withdrawal by Subject|0
6036035|NCT00685399|20861138|P4|Treatment Period 2|Withdrawal by Subject|0
6036036|NCT00685399|20861139|P3|Treatment Period 2|Withdrawal by Subject|0
6036037|NCT00685399|20861140|P2|Treatment Period 2|Withdrawal by Subject|0
6036038|NCT00685399|20861141|P1|Treatment Period 2|Withdrawal by Subject|0
6036039|NCT00685399|20861134|P8|Treatment Period 2|Administrative Problems|0
6036040|NCT00685399|20861135|P7|Treatment Period 2|Administrative Problems|0
6036041|NCT00685399|20861136|P6|Treatment Period 2|Administrative Problems|0
6036042|NCT00685399|20861137|P5|Treatment Period 2|Administrative Problems|0
6036043|NCT00685399|20861138|P4|Treatment Period 2|Administrative Problems|0
6036044|NCT00685399|20861139|P3|Treatment Period 2|Administrative Problems|1
6036045|NCT00685399|20861140|P2|Treatment Period 2|Administrative Problems|2
6036046|NCT00685399|20861141|P1|Treatment Period 2|Administrative Problems|0
6036047|NCT00685399|20861134|P8|Treatment Period 1|Lack of Efficacy|0
6036048|NCT00685399|20861135|P7|Treatment Period 1|Lack of Efficacy|0
6036049|NCT00685399|20861136|P6|Treatment Period 1|Lack of Efficacy|0
6036050|NCT00685399|20861137|P5|Treatment Period 1|Lack of Efficacy|0
6036051|NCT00685399|20861138|P4|Treatment Period 1|Lack of Efficacy|0
6036052|NCT00685399|20861139|P3|Treatment Period 1|Lack of Efficacy|0
6036053|NCT00685399|20861140|P2|Treatment Period 1|Lack of Efficacy|0
6036054|NCT00685399|20861141|P1|Treatment Period 1|Lack of Efficacy|1
6036055|NCT00685399|20861134|P8|Treatment Period 1|Administrative|0
6036056|NCT00685399|20861135|P7|Treatment Period 1|Administrative|0
6036057|NCT00685399|20861136|P6|Treatment Period 1|Administrative|0
6036058|NCT00685399|20861137|P5|Treatment Period 1|Administrative|0
6036059|NCT00685399|20861138|P4|Treatment Period 1|Administrative|0
6036060|NCT00685399|20861139|P3|Treatment Period 1|Administrative|0
6036061|NCT00685399|20861140|P2|Treatment Period 1|Administrative|0
6036062|NCT00685399|20861141|P1|Treatment Period 1|Administrative|2
6036063|NCT00685399|20861134|P8|Treatment Period 1|Protocol Violation|0
6036064|NCT00685399|20861135|P7|Treatment Period 1|Protocol Violation|0
6036065|NCT00685399|20861136|P6|Treatment Period 1|Protocol Violation|0
6036066|NCT00685399|20861137|P5|Treatment Period 1|Protocol Violation|0
6036067|NCT00685399|20861138|P4|Treatment Period 1|Protocol Violation|0
6036068|NCT00685399|20861139|P3|Treatment Period 1|Protocol Violation|0
6036069|NCT00685399|20861140|P2|Treatment Period 1|Protocol Violation|0
6036070|NCT00685399|20861141|P1|Treatment Period 1|Protocol Violation|1
6036071|NCT00685399|20861134|P8|Treatment Period 1|Withdrawal by Subject|0
6036072|NCT00685399|20861135|P7|Treatment Period 1|Withdrawal by Subject|0
6036073|NCT00685399|20861136|P6|Treatment Period 1|Withdrawal by Subject|0
6036074|NCT00685399|20861137|P5|Treatment Period 1|Withdrawal by Subject|0
6036075|NCT00685399|20861138|P4|Treatment Period 1|Withdrawal by Subject|0
6036076|NCT00685399|20861139|P3|Treatment Period 1|Withdrawal by Subject|0
6036077|NCT00685399|20861140|P2|Treatment Period 1|Withdrawal by Subject|0
6036078|NCT00685399|20861141|P1|Treatment Period 1|Withdrawal by Subject|2
6036079|NCT00685373|20861174|P1|Overall Study|Protocol Violation|1
6036080|NCT00685373|20861174|P1|Overall Study|Lost to Follow-up|2
6036081|NCT00685373|20861174|P1|Overall Study|Condition no longer requires study drug|1
6036082|NCT00685373|20861174|P1|Overall Study|Lack of Efficacy|3
6036083|NCT00685373|20861174|P1|Overall Study|Withdrawal by Subject|5
6036084|NCT00685373|20861174|P1|Overall Study|Adverse Event|3
6036085|NCT00685334|20861183|P2|Overall Study|Chose to enter hospital|1
6036086|NCT00685334|20861184|P1|Overall Study|Chose to enter hospital|1
6036087|NCT00685334|20861183|P2|Overall Study|Lost to Follow-up|0
6036088|NCT00685334|20861184|P1|Overall Study|Lost to Follow-up|4
6036089|NCT00685334|20861183|P2|Overall Study|Withdrawal by Subject|6
6036090|NCT00685334|20861184|P1|Overall Study|Withdrawal by Subject|5
6036091|NCT00685178|20861209|P4|Overall Study|Pregnancy|1
6036092|NCT00685178|20861210|P3|Overall Study|Pregnancy|0
6036093|NCT00685178|20861211|P2|Overall Study|Pregnancy|0
6036094|NCT00685178|20861212|P1|Overall Study|Pregnancy|0
6036095|NCT00685178|20861209|P4|Overall Study|administrative (disciplinary) discharge|2
6036096|NCT00685178|20861210|P3|Overall Study|administrative (disciplinary) discharge|0
6036097|NCT00685178|20861211|P2|Overall Study|administrative (disciplinary) discharge|1
6036098|NCT00685178|20861212|P1|Overall Study|administrative (disciplinary) discharge|0
6036099|NCT00685178|20861209|P4|Overall Study|incarcerated|0
6036100|NCT00685178|20861210|P3|Overall Study|incarcerated|7
6036101|NCT00685178|20861211|P2|Overall Study|incarcerated|3
6036102|NCT00685178|20861212|P1|Overall Study|incarcerated|1
6036103|NCT00685178|20861209|P4|Overall Study|voluntary study discharge|1
6036104|NCT00685178|20861210|P3|Overall Study|voluntary study discharge|1
6036105|NCT00685178|20861211|P2|Overall Study|voluntary study discharge|5
6036106|NCT00685178|20861212|P1|Overall Study|voluntary study discharge|4
6036107|NCT00685178|20861209|P4|Overall Study|missed 3 consecutive methadone clin days|6
6036108|NCT00685178|20861210|P3|Overall Study|missed 3 consecutive methadone clin days|2
6036109|NCT00685178|20861211|P2|Overall Study|missed 3 consecutive methadone clin days|5
6036110|NCT00685178|20861212|P1|Overall Study|missed 3 consecutive methadone clin days|7
6036111|NCT00685178|20861209|P4|Overall Study|Adverse Event|4
6036112|NCT00685178|20861210|P3|Overall Study|Adverse Event|2
6036113|NCT00685178|20861211|P2|Overall Study|Adverse Event|5
6036114|NCT00685178|20861212|P1|Overall Study|Adverse Event|1
6036115|NCT00685165|20861226|P2|Washout Period of 14 Days|Adverse Event|0
6036116|NCT00685165|20861227|P1|Washout Period of 14 Days|Adverse Event|1
6036117|NCT00685035|20861246|P2|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|0
6036118|NCT00685035|20861247|P1|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|1
6036119|NCT00684996|20861271|P1|Overall Study|Other reasons not protocol specified|1
6036120|NCT00684996|20861271|P1|Overall Study|Progression/relapse|2
6036121|NCT00684996|20861271|P1|Overall Study|Refusal unrelated to adverse event|1
6036122|NCT00684996|20861271|P1|Overall Study|Adverse Event|1
6036123|NCT00684814|20861303|P2|Second Intervention|Adverse Event|0
6036124|NCT00684814|20861304|P1|Second Intervention|Adverse Event|1
6036125|NCT00684814|20861303|P2|Washout Period of 7 Days|Withdrawal by Subject|2
6036126|NCT00684814|20861304|P1|Washout Period of 7 Days|Withdrawal by Subject|1
6036127|NCT00684814|20861303|P2|Washout Period of 7 Days|Adverse Event|2
6036128|NCT00684814|20861304|P1|Washout Period of 7 Days|Adverse Event|1
6036129|NCT00684762|20861356|P2|Washout Period of 7 Days|Withdrawal by Subject|2
6036130|NCT00684762|20861357|P1|Washout Period of 7 Days|Withdrawal by Subject|2
6036131|NCT00684671|20861385|P3|Overall Study|Alcoholic dependance|0
6036132|NCT00684671|20861386|P2|Overall Study|Alcoholic dependance|0
6036133|NCT00684671|20861387|P1|Overall Study|Alcoholic dependance|1
6036134|NCT00684671|20861385|P3|Overall Study|Lost to Follow-up|0
6036135|NCT00684671|20861386|P2|Overall Study|Lost to Follow-up|0
6036136|NCT00684671|20861387|P1|Overall Study|Lost to Follow-up|1
6036137|NCT00684671|20861385|P3|Overall Study|Adverse Event|0
6036138|NCT00684671|20861386|P2|Overall Study|Adverse Event|0
6036139|NCT00684671|20861387|P1|Overall Study|Adverse Event|1
6036140|NCT00684645|20861416|P1|Overall Study|Other|15
6036141|NCT00684645|20861416|P1|Overall Study|Lost to Follow-up|3
6036142|NCT00684645|20861416|P1|Overall Study|Adverse Event|27
6036143|NCT00684645|20861416|P1|Overall Study|Progressive disease|67
6036144|NCT00684645|20861416|P1|Overall Study|Death|2
6036145|NCT00684593|20861436|P2|Overall Study|Adverse Event|2
6036146|NCT00684593|20861437|P1|Overall Study|Adverse Event|0
6036147|NCT00684567|20861449|P1|Monotherapy Period|Progression of primary disease|11
6036148|NCT00684567|20861449|P1|Monotherapy Period|Death|1
6036149|NCT00684567|20861449|P1|Monotherapy Period|Adverse Event|2
6036150|NCT00684567|20861449|P1|Concomitant Radiotherapy Period|Adverse Event|2
6036151|NCT00684515|20861482|P3|Overall Study|Protocol-Defined Clinical Event|0
6036152|NCT00684515|20861483|P2|Overall Study|Protocol-Defined Clinical Event|0
6036153|NCT00684515|20861484|P1|Overall Study|Protocol-Defined Clinical Event|1
6036154|NCT00684515|20861482|P3|Overall Study|Adverse Event|1
6036155|NCT00684515|20861483|P2|Overall Study|Adverse Event|3
6036156|NCT00684515|20861484|P1|Overall Study|Adverse Event|3
6036160|NCT00684411|20861522|P1|Overall Study|Adverse Event|1
6036161|NCT00684411|20861522|P1|Overall Study|Disease Progression|10
6036162|NCT00684411|20861522|P1|Overall Study|New Primary Cancer|1
6036163|NCT00684307|20861544|P5|Overall Study|Criteria from the CSR|3
6036164|NCT00684307|20861545|P4|Overall Study|Criteria from the CSR|3
6036165|NCT00684307|20861546|P3|Overall Study|Criteria from the CSR|1
6036166|NCT00684307|20861547|P2|Overall Study|Criteria from the CSR|0
6036167|NCT00684307|20861548|P1|Overall Study|Criteria from the CSR|0
6036168|NCT00684307|20861544|P5|Overall Study|Participant not willing to continue|8
6036169|NCT00684307|20861545|P4|Overall Study|Participant not willing to continue|5
6036170|NCT00684307|20861546|P3|Overall Study|Participant not willing to continue|11
6036171|NCT00684307|20861547|P2|Overall Study|Participant not willing to continue|10
6036172|NCT00684307|20861548|P1|Overall Study|Participant not willing to continue|7
6036173|NCT00684307|20861544|P5|Overall Study|Severe non compliance to protocol|2
6036174|NCT00684307|20861545|P4|Overall Study|Severe non compliance to protocol|1
6036175|NCT00684307|20861546|P3|Overall Study|Severe non compliance to protocol|0
6036176|NCT00684307|20861547|P2|Overall Study|Severe non compliance to protocol|0
6036177|NCT00684307|20861548|P1|Overall Study|Severe non compliance to protocol|1
6036178|NCT00684307|20861544|P5|Overall Study|Interupted IP for more than 7 days|3
6036179|NCT00684307|20861545|P4|Overall Study|Interupted IP for more than 7 days|3
6036180|NCT00684307|20861546|P3|Overall Study|Interupted IP for more than 7 days|1
6036181|NCT00684307|20861547|P2|Overall Study|Interupted IP for more than 7 days|4
6036182|NCT00684307|20861548|P1|Overall Study|Interupted IP for more than 7 days|0
6036183|NCT00684307|20861544|P5|Overall Study|Incorrect enrolment or randomization|0
6036184|NCT00684307|20861545|P4|Overall Study|Incorrect enrolment or randomization|0
6036185|NCT00684307|20861546|P3|Overall Study|Incorrect enrolment or randomization|0
6036186|NCT00684307|20861547|P2|Overall Study|Incorrect enrolment or randomization|0
6036187|NCT00684307|20861548|P1|Overall Study|Incorrect enrolment or randomization|4
6036188|NCT00684307|20861544|P5|Overall Study|Fullfillment of exclusion criteria|1
6036189|NCT00684307|20861545|P4|Overall Study|Fullfillment of exclusion criteria|3
6036190|NCT00684307|20861546|P3|Overall Study|Fullfillment of exclusion criteria|0
6036191|NCT00684307|20861547|P2|Overall Study|Fullfillment of exclusion criteria|0
6036192|NCT00684307|20861548|P1|Overall Study|Fullfillment of exclusion criteria|1
6036193|NCT00684307|20861544|P5|Overall Study|Development of increasing Liver Function|0
6036194|NCT00684307|20861545|P4|Overall Study|Development of increasing Liver Function|1
6036195|NCT00684307|20861546|P3|Overall Study|Development of increasing Liver Function|0
6036196|NCT00684307|20861547|P2|Overall Study|Development of increasing Liver Function|2
6036197|NCT00684307|20861548|P1|Overall Study|Development of increasing Liver Function|0
6036198|NCT00684307|20861544|P5|Overall Study|Adverse Event|8
6036199|NCT00684307|20861545|P4|Overall Study|Adverse Event|16
6036200|NCT00684307|20861546|P3|Overall Study|Adverse Event|15
6036201|NCT00684307|20861547|P2|Overall Study|Adverse Event|6
6036202|NCT00684307|20861548|P1|Overall Study|Adverse Event|11
6036203|NCT00684203|20861630|P6|Overall Study|Did not meet protocol eligibility|0
6036204|NCT00684203|20861631|P5|Overall Study|Did not meet protocol eligibility|0
6036205|NCT00684203|20861632|P4|Overall Study|Did not meet protocol eligibility|0
6036206|NCT00684203|20861633|P3|Overall Study|Did not meet protocol eligibility|0
6036207|NCT00684203|20861634|P2|Overall Study|Did not meet protocol eligibility|1
6036208|NCT00684203|20861635|P1|Overall Study|Did not meet protocol eligibility|0
6036209|NCT00684203|20861630|P6|Overall Study|Withdrawal by Subject|0
6036210|NCT00684203|20861631|P5|Overall Study|Withdrawal by Subject|0
6036211|NCT00684203|20861632|P4|Overall Study|Withdrawal by Subject|0
6036212|NCT00684203|20861633|P3|Overall Study|Withdrawal by Subject|1
6036213|NCT00684203|20861634|P2|Overall Study|Withdrawal by Subject|2
6036214|NCT00684203|20861635|P1|Overall Study|Withdrawal by Subject|0
6036215|NCT00684203|20861630|P6|Overall Study|Protocol-defined clinical event|0
6036216|NCT00684203|20861631|P5|Overall Study|Protocol-defined clinical event|0
6036217|NCT00684203|20861632|P4|Overall Study|Protocol-defined clinical event|0
6036218|NCT00684203|20861633|P3|Overall Study|Protocol-defined clinical event|0
6036219|NCT00684203|20861634|P2|Overall Study|Protocol-defined clinical event|1
6036220|NCT00684203|20861635|P1|Overall Study|Protocol-defined clinical event|3
6036221|NCT00684203|20861630|P6|Overall Study|Adverse Event|0
6036222|NCT00684203|20861631|P5|Overall Study|Adverse Event|0
6036223|NCT00684203|20861632|P4|Overall Study|Adverse Event|0
6036224|NCT00684203|20861633|P3|Overall Study|Adverse Event|8
6036225|NCT00684203|20861634|P2|Overall Study|Adverse Event|4
6036226|NCT00684203|20861635|P1|Overall Study|Adverse Event|6
6036227|NCT00684177|20861696|P2|Overall Study|Other|2
6036228|NCT00684177|20861697|P1|Overall Study|Other|1
6036229|NCT00684177|20861696|P2|Overall Study|Withdrawal by Subject|2
6036230|NCT00684177|20861697|P1|Overall Study|Withdrawal by Subject|1
6036231|NCT00684177|20861696|P2|Overall Study|Physician Decision|0
6036232|NCT00684177|20861697|P1|Overall Study|Physician Decision|2
6036233|NCT00684177|20861696|P2|Overall Study|Lost to Follow-up|1
6036234|NCT00684177|20861697|P1|Overall Study|Lost to Follow-up|2
6036235|NCT00684177|20861696|P2|Overall Study|Protocol Violation|0
6036236|NCT00684177|20861697|P1|Overall Study|Protocol Violation|1
6036237|NCT00684177|20861696|P2|Overall Study|Lack of Efficacy|15
6036238|NCT00684177|20861697|P1|Overall Study|Lack of Efficacy|10
6036239|NCT00684177|20861696|P2|Overall Study|Adverse Event|3
6036240|NCT00684177|20861697|P1|Overall Study|Adverse Event|4
6036241|NCT00684073|20861732|P1|Treatment (Days 1 Through 5)|non-respect of eligibility criteria|1
6036242|NCT00684073|20861732|P1|Selection|request of the sponsor|1
6036243|NCT00684073|20861732|P1|Selection|Lost to Follow-up|1
6036244|NCT00684073|20861732|P1|Selection|noncompliance|1
6036245|NCT00684073|20861732|P1|Selection|Death|1
6036246|NCT00684073|20861732|P1|Selection|Selection/non-selection criteria|3
6036247|NCT00684060|20861742|P2|Overall Study|Death|1
6036248|NCT00684060|20861743|P1|Overall Study|Death|0
6036249|NCT00684060|20861742|P2|Overall Study|Unable to collect MRI|2
6036250|NCT00684060|20861743|P1|Overall Study|Unable to collect MRI|1
6036251|NCT00684060|20861742|P2|Overall Study|New stenosis identified|0
6036252|NCT00684060|20861743|P1|Overall Study|New stenosis identified|1
6036253|NCT00684060|20861742|P2|Overall Study|Lost to Follow-up|0
6036254|NCT00684060|20861743|P1|Overall Study|Lost to Follow-up|1
6036255|NCT00684021|20861782|P4|Overall Study|Death|0
6036256|NCT00684021|20861783|P3|Overall Study|Death|0
6036257|NCT00684021|20861784|P2|Overall Study|Death|0
6036258|NCT00684021|20861785|P1|Overall Study|Death|1
6036259|NCT00684021|20861782|P4|Overall Study|MRI not performed|2
6036260|NCT00684021|20861783|P3|Overall Study|MRI not performed|1
6036261|NCT00684021|20861784|P2|Overall Study|MRI not performed|1
6036262|NCT00684021|20861785|P1|Overall Study|MRI not performed|0
6036263|NCT00684021|20861782|P4|Overall Study|MRI Contraindicated|0
6036264|NCT00684021|20861783|P3|Overall Study|MRI Contraindicated|1
6036265|NCT00684021|20861784|P2|Overall Study|MRI Contraindicated|1
6036266|NCT00684021|20861785|P1|Overall Study|MRI Contraindicated|1
6036267|NCT00683917|20861846|P1|Overall Study|Study prematurely terminated|10
6036268|NCT00683904|20861856|P2|Dose Level 2|Adverse Event|2
6036269|NCT00683904|20861857|P1|Dose Level 2|Adverse Event|0
6036270|NCT00683904|20861856|P2|Dose Level 1|Adverse Event|0
6036271|NCT00683904|20861857|P1|Dose Level 1|Adverse Event|1
6036272|NCT00683904|20861856|P2|Dose Level 1|Disease progression|0
6036273|NCT00683904|20861857|P1|Dose Level 1|Disease progression|2
6036274|NCT00683878|20861893|P3|Overall Study|Non-compliance, not met criteria etc.|0
6036275|NCT00683878|20861894|P2|Overall Study|Non-compliance, not met criteria etc.|2
6036276|NCT00683878|20861895|P1|Overall Study|Non-compliance, not met criteria etc.|3
6036277|NCT00683878|20861893|P3|Overall Study|Lost to Follow-up|4
6036278|NCT00683878|20861894|P2|Overall Study|Lost to Follow-up|2
6036279|NCT00683878|20861895|P1|Overall Study|Lost to Follow-up|4
6036280|NCT00683878|20861893|P3|Overall Study|Death|0
6036281|NCT00683878|20861894|P2|Overall Study|Death|1
6036282|NCT00683878|20861895|P1|Overall Study|Death|0
6036283|NCT00683878|20861893|P3|Overall Study|Withdrawal by Subject|6
6036284|NCT00683878|20861894|P2|Overall Study|Withdrawal by Subject|8
6036285|NCT00683878|20861895|P1|Overall Study|Withdrawal by Subject|9
6036286|NCT00683878|20861893|P3|Overall Study|Adverse Event|3
6036287|NCT00683878|20861894|P2|Overall Study|Adverse Event|3
6036288|NCT00683878|20861895|P1|Overall Study|Adverse Event|4
6036289|NCT00683878|20861893|P3|Overall Study|Lack of Efficacy|1
6036290|NCT00683878|20861894|P2|Overall Study|Lack of Efficacy|0
6036291|NCT00683878|20861895|P1|Overall Study|Lack of Efficacy|3
6036292|NCT00683800|20861969|P2|Overall Study|Randomized, not treated|33
6036293|NCT00683800|20861970|P1|Overall Study|Randomized, not treated|35
6036294|NCT00683800|20861969|P2|Overall Study|Lack of Efficacy|104
6036295|NCT00683800|20861970|P1|Overall Study|Lack of Efficacy|61
6036296|NCT00683800|20861969|P2|Overall Study|Withdrawal by Subject|64
6036297|NCT00683800|20861970|P1|Overall Study|Withdrawal by Subject|66
6036298|NCT00683800|20861969|P2|Overall Study|Protocol Violation|16
6036299|NCT00683800|20861970|P1|Overall Study|Protocol Violation|13
6036300|NCT00683800|20861969|P2|Overall Study|Other|2
6036301|NCT00683800|20861970|P1|Overall Study|Other|5
6036302|NCT00683800|20861969|P2|Overall Study|Lost to Follow-up|44
6036303|NCT00683800|20861970|P1|Overall Study|Lost to Follow-up|57
6036304|NCT00683800|20861969|P2|Overall Study|Death|1
6036305|NCT00683800|20861970|P1|Overall Study|Death|0
6036306|NCT00683800|20861969|P2|Overall Study|Adverse Event|102
6036307|NCT00683800|20861970|P1|Overall Study|Adverse Event|195
6036308|NCT00683787|20862037|P3|Overall Study|Adverse Event|2
6036309|NCT00683787|20862038|P2|Overall Study|Adverse Event|0
6036310|NCT00683787|20862039|P1|Overall Study|Adverse Event|0
6036311|NCT00683787|20862037|P3|Overall Study|Progression|0
6036312|NCT00683787|20862038|P2|Overall Study|Progression|3
6036313|NCT00683787|20862039|P1|Overall Study|Progression|3
6036314|NCT00683774|20862058|P2|Overall Study|Physician Decision|0
6036315|NCT00683774|20862059|P1|Overall Study|Physician Decision|3
6036316|NCT00683774|20862058|P2|Overall Study|Withdrawal by Subject|1
6036317|NCT00683774|20862059|P1|Overall Study|Withdrawal by Subject|0
6036318|NCT00683696|20862069|P2|Overall Study|Death|30
6036319|NCT00683696|20862070|P1|Overall Study|Death|46
6036320|NCT00683696|20862069|P2|Overall Study|Vital status follow-up only|3
6036321|NCT00683696|20862070|P1|Overall Study|Vital status follow-up only|3
6036322|NCT00683696|20862069|P2|Overall Study|Lost to Follow-up|6
6036323|NCT00683696|20862070|P1|Overall Study|Lost to Follow-up|5
6036324|NCT00683696|20862069|P2|Overall Study|Withdrawn prior to study closure|28
6036325|NCT00683696|20862070|P1|Overall Study|Withdrawn prior to study closure|13
6036326|NCT00683696|20862069|P2|Overall Study|Withdrawn due to study closure|338
6036327|NCT00683696|20862070|P1|Overall Study|Withdrawn due to study closure|337
6036328|NCT00683657|20862089|P2|Overall Study|Subject Withdrew Consent|0
6036329|NCT00683657|20862090|P1|Overall Study|Subject Withdrew Consent|1
6036330|NCT00683657|20862089|P2|Overall Study|Adverse Event|1
6036331|NCT00683657|20862090|P1|Overall Study|Adverse Event|0
6036332|NCT00683644|20862106|P2|Overall Study|Low copper, other health problems,|6
6036333|NCT00683644|20862107|P1|Overall Study|Low copper, other health problems,|7
6036334|NCT00683644|20862106|P2|Overall Study|Adverse Event|2
6036335|NCT00683644|20862107|P1|Overall Study|Adverse Event|1
6036336|NCT00683644|20862106|P2|Overall Study|Lost to Follow-up|4
6036337|NCT00683644|20862107|P1|Overall Study|Lost to Follow-up|1
6036338|NCT00683644|20862106|P2|Overall Study|Withdrawal by Subject|2
6036339|NCT00683644|20862107|P1|Overall Study|Withdrawal by Subject|4
6036340|NCT00683618|20862120|P3|Extension Treatment Period|Protocol Violation|0
6036341|NCT00683618|20862121|P2|Extension Treatment Period|Protocol Violation|0
6036342|NCT00683618|20862122|P1|Extension Treatment Period|Protocol Violation|1
6036343|NCT00683618|20862120|P3|Extension Treatment Period|Adverse Event|0
6036344|NCT00683618|20862121|P2|Extension Treatment Period|Adverse Event|0
6036345|NCT00683618|20862122|P1|Extension Treatment Period|Adverse Event|1
6036346|NCT00683618|20862120|P3|Extension Treatment Period|Withdrawal by Subject|0
6036347|NCT00683618|20862121|P2|Extension Treatment Period|Withdrawal by Subject|0
6036348|NCT00683618|20862122|P1|Extension Treatment Period|Withdrawal by Subject|1
6036349|NCT00683618|20862120|P3|Randomised Treatment Period|Reason not provided|2
6036350|NCT00683618|20862121|P2|Randomised Treatment Period|Reason not provided|0
6036351|NCT00683618|20862122|P1|Randomised Treatment Period|Reason not provided|0
6036352|NCT00683618|20862120|P3|Randomised Treatment Period|Adverse Event|2
6036353|NCT00683618|20862121|P2|Randomised Treatment Period|Adverse Event|0
6036354|NCT00683618|20862122|P1|Randomised Treatment Period|Adverse Event|2
6036355|NCT00683618|20862120|P3|Randomised Treatment Period|Protocol Violation|0
6036356|NCT00683618|20862121|P2|Randomised Treatment Period|Protocol Violation|1
6036357|NCT00683618|20862122|P1|Randomised Treatment Period|Protocol Violation|0
6036358|NCT00683618|20862120|P3|Randomised Treatment Period|Withdrawal by Subject|2
6036359|NCT00683618|20862121|P2|Randomised Treatment Period|Withdrawal by Subject|1
6036360|NCT00683618|20862122|P1|Randomised Treatment Period|Withdrawal by Subject|4
6036361|NCT00683592|20862172|P2|Overall Study|Other|1
6036362|NCT00683592|20862173|P1|Overall Study|Other|1
6036363|NCT00683592|20862172|P2|Overall Study|Non-compliance|5
6036364|NCT00683592|20862173|P1|Overall Study|Non-compliance|3
6036365|NCT00683592|20862172|P2|Overall Study|Physician Decision|1
6036366|NCT00683592|20862173|P1|Overall Study|Physician Decision|0
6036367|NCT00683592|20862172|P2|Overall Study|Lack of Efficacy|7
6036368|NCT00683592|20862173|P1|Overall Study|Lack of Efficacy|3
6036369|NCT00683592|20862172|P2|Overall Study|Lost to Follow-up|17
6036370|NCT00683592|20862173|P1|Overall Study|Lost to Follow-up|17
6036371|NCT00683592|20862172|P2|Overall Study|Withdrawal by Subject|11
6036372|NCT00683592|20862173|P1|Overall Study|Withdrawal by Subject|11
6036373|NCT00683592|20862172|P2|Overall Study|Adverse Event|4
6036374|NCT00683592|20862173|P1|Overall Study|Adverse Event|12
6036375|NCT00683475|20862191|P2|Overall Study|Never Treated: Progressive Disease|0
6036376|NCT00683475|20862192|P1|Overall Study|Never Treated: Progressive Disease|1
6036377|NCT00683475|20862191|P2|Overall Study|Never Treated: Adverse Event|3
6036378|NCT00683475|20862192|P1|Overall Study|Never Treated: Adverse Event|2
6036379|NCT00683475|20862191|P2|Overall Study|Withdrawal by Subject|0
6036380|NCT00683475|20862192|P1|Overall Study|Withdrawal by Subject|1
6036381|NCT00683449|20862227|P5|Overall Study|Lost to Follow-up|0
6036382|NCT00683449|20862228|P4|Overall Study|Lost to Follow-up|0
6036383|NCT00683449|20862229|P3|Overall Study|Lost to Follow-up|0
6036384|NCT00683449|20862230|P2|Overall Study|Lost to Follow-up|1
6036385|NCT00683449|20862231|P1|Overall Study|Lost to Follow-up|0
6036386|NCT00683384|20862257|P1|Overall Study|Adverse Event|1
6036387|NCT00683384|20862257|P1|Overall Study|Death|1
6036388|NCT00683293|20862267|P2|Overall Study|Withdrawal by Subject|3
6036389|NCT00683293|20862268|P1|Overall Study|Withdrawal by Subject|2
6036390|NCT00682929|20862331|P3|Overall Study|lag in DEA renewal|0
6036391|NCT00682929|20862332|P2|Overall Study|lag in DEA renewal|0
6036392|NCT00682929|20862333|P1|Overall Study|lag in DEA renewal|1
6036393|NCT00682929|20862331|P3|Overall Study|dosing compliance < 80%|0
6036394|NCT00682929|20862332|P2|Overall Study|dosing compliance < 80%|2
6036395|NCT00682929|20862333|P1|Overall Study|dosing compliance < 80%|0
6036396|NCT00682929|20862331|P3|Overall Study|Withdrawal by Subject|1
6036397|NCT00682929|20862332|P2|Overall Study|Withdrawal by Subject|2
6036398|NCT00682929|20862333|P1|Overall Study|Withdrawal by Subject|1
6036399|NCT00682929|20862331|P3|Overall Study|Adverse Event|1
6036400|NCT00682929|20862332|P2|Overall Study|Adverse Event|1
6036401|NCT00682929|20862333|P1|Overall Study|Adverse Event|4
6036402|NCT00682890|20862502|P2|Overall Study|heavy menstrual bleeding|0
6036403|NCT00682890|20862503|P1|Overall Study|heavy menstrual bleeding|1
6036404|NCT00682890|20862502|P2|Overall Study|subject moved away|1
6036405|NCT00682890|20862503|P1|Overall Study|subject moved away|0
6036406|NCT00682890|20862502|P2|Overall Study|Lost to Follow-up|1
6036407|NCT00682890|20862503|P1|Overall Study|Lost to Follow-up|1
6036408|NCT00682786|20862545|P2|Overall Study|Did not receive irinotecan|1
6036409|NCT00682786|20862546|P1|Overall Study|Did not receive irinotecan|0
6036410|NCT00682786|20862545|P2|Overall Study|Withdrawal by Subject|2
6036411|NCT00682786|20862546|P1|Overall Study|Withdrawal by Subject|2
6036412|NCT00682643|20862595|P2|Overall Study|Did Not Receive Study Drug|1
6036413|NCT00682643|20862596|P1|Overall Study|Did Not Receive Study Drug|1
6036414|NCT00682643|20862595|P2|Overall Study|Withdrawal by Subject|53
6036415|NCT00682643|20862596|P1|Overall Study|Withdrawal by Subject|19
6036416|NCT00682643|20862595|P2|Overall Study|Physician Decision|6
6036417|NCT00682643|20862596|P1|Overall Study|Physician Decision|2
6036418|NCT00682643|20862595|P2|Overall Study|Lost to Follow-up|6
6036419|NCT00682643|20862596|P1|Overall Study|Lost to Follow-up|1
6036420|NCT00682643|20862595|P2|Overall Study|Met Protocol-defined Stopping Criteria|4
6036421|NCT00682643|20862596|P1|Overall Study|Met Protocol-defined Stopping Criteria|3
6036422|NCT00682643|20862595|P2|Overall Study|Protocol Violation|76
6036423|NCT00682643|20862596|P1|Overall Study|Protocol Violation|38
6036424|NCT00682643|20862595|P2|Overall Study|Lack of Efficacy|0
6036425|NCT00682643|20862596|P1|Overall Study|Lack of Efficacy|2
6036426|NCT00682643|20862595|P2|Overall Study|Adverse Event|23
6036427|NCT00682643|20862596|P1|Overall Study|Adverse Event|12
6036428|NCT00682539|20862670|P3|Ranibizumab vs Triamcinolone|Lost to Follow-up|8
6036429|NCT00682539|20862671|P2|Ranibizumab vs Triamcinolone|Lost to Follow-up|3
6036430|NCT00682539|20862672|P1|Ranibizumab vs Triamcinolone|Lost to Follow-up|0
6036431|NCT00682539|20862670|P3|Bevacizumab vs Triamcinolone|Lost to Follow-up|0
6036432|NCT00682539|20862671|P2|Bevacizumab vs Triamcinolone|Lost to Follow-up|1
6036433|NCT00682539|20862672|P1|Bevacizumab vs Triamcinolone|Lost to Follow-up|3
6036434|NCT00682461|20862685|P2|Overall Study|Withdrawal by Subject|19
6036435|NCT00682461|20862686|P1|Overall Study|Withdrawal by Subject|12
6036436|NCT00682461|20862685|P2|Overall Study|Lost to Follow-up|5
6036437|NCT00682461|20862686|P1|Overall Study|Lost to Follow-up|8
6036438|NCT00682461|20862685|P2|Overall Study|Adverse Event|7
6036439|NCT00682461|20862686|P1|Overall Study|Adverse Event|5
6036440|NCT00682435|20862700|P1|Overall Study|Erroneously enrolled twice|2
6036441|NCT00682435|20862700|P1|Overall Study|Insufficient data|5
6036442|NCT00681863|20862733|P1|Overall Study|Other|18
6036443|NCT00681863|20862733|P1|Overall Study|Lack of Efficacy|2
6036444|NCT00681863|20862733|P1|Overall Study|Lost to Follow-up|2
6036445|NCT00681863|20862733|P1|Overall Study|Adverse Event|1
6036446|NCT00681824|20862781|P3|Overall Study|Death|0
6036447|NCT00681824|20862782|P2|Overall Study|Death|1
6036448|NCT00681824|20862783|P1|Overall Study|Death|0
6036449|NCT00681824|20862781|P3|Overall Study|scheduling conflict|0
6036450|NCT00681824|20862782|P2|Overall Study|scheduling conflict|0
6036451|NCT00681824|20862783|P1|Overall Study|scheduling conflict|1
6036452|NCT00681824|20862781|P3|Overall Study|withdrawn by investigator|1
6036453|NCT00681824|20862782|P2|Overall Study|withdrawn by investigator|0
6036454|NCT00681824|20862783|P1|Overall Study|withdrawn by investigator|0
6036455|NCT00681811|20862801|P2|Overall Study|Non-compliance|1
6036456|NCT00681811|20862802|P1|Overall Study|Non-compliance|0
6036457|NCT00681811|20862801|P2|Overall Study|Withdrawal by Subject|2
6036458|NCT00681811|20862802|P1|Overall Study|Withdrawal by Subject|2
6036459|NCT00681811|20862801|P2|Overall Study|Adverse Event|1
6036460|NCT00681811|20862802|P1|Overall Study|Adverse Event|1
6036461|NCT00681668|20862830|P1|Overall Study|Withdrawal by Subject|1
6036462|NCT00681668|20862830|P1|Overall Study|Protocol Violation|1
6036463|NCT00681629|20862839|P2|Overall Study|Adverse Event|0
6036464|NCT00681629|20862840|P1|Overall Study|Adverse Event|1
6036465|NCT00681629|20862839|P2|Overall Study|Study termination|2
6036466|NCT00681629|20862840|P1|Overall Study|Study termination|4
6036467|NCT00681590|20862886|P2|Overall Study|Withdrawal by Subject|12
6036468|NCT00681590|20862887|P1|Overall Study|Withdrawal by Subject|2
6036469|NCT00681564|20862897|P2|Overall Study|Death|1
6036470|NCT00681564|20862898|P1|Overall Study|Death|0
6036471|NCT00681564|20862897|P2|Overall Study|Withdrawal by Subject|1
6036472|NCT00681564|20862898|P1|Overall Study|Withdrawal by Subject|0
6036473|NCT00681564|20862897|P2|Overall Study|Lost to Follow-up|6
6036474|NCT00681564|20862898|P1|Overall Study|Lost to Follow-up|6
6036475|NCT00681187|20862990|P2|Overall Study|Adverse Event|1
6036476|NCT00681187|20862991|P1|Overall Study|Adverse Event|0
6036477|NCT00681187|20862990|P2|Overall Study|Death|1
6036478|NCT00681187|20862991|P1|Overall Study|Death|0
6036479|NCT00681187|20862990|P2|Overall Study|Withdrawal by Subject|0
6036480|NCT00681187|20862991|P1|Overall Study|Withdrawal by Subject|1
6036481|NCT00681109|20863026|P3|Overall Study|Lost to Follow-up|0
6036482|NCT00681109|20863027|P2|Overall Study|Lost to Follow-up|6
6036483|NCT00681109|20863028|P1|Overall Study|Lost to Follow-up|2
6036484|NCT00680992|20863069|P3|Overall Study|Ineligibility Determined|0
6036485|NCT00680992|20863070|P2|Overall Study|Ineligibility Determined|1
6036486|NCT00680992|20863071|P1|Overall Study|Ineligibility Determined|0
6036487|NCT00680992|20863069|P3|Overall Study|Death|0
6036488|NCT00680992|20863070|P2|Overall Study|Death|1
6036489|NCT00680992|20863071|P1|Overall Study|Death|5
6036490|NCT00680992|20863069|P3|Overall Study|Pregnancy|1
6036491|NCT00680992|20863070|P2|Overall Study|Pregnancy|0
6036492|NCT00680992|20863071|P1|Overall Study|Pregnancy|5
6036493|NCT00680992|20863069|P3|Overall Study|Requirement for Alternative Therapy|0
6036494|NCT00680992|20863070|P2|Overall Study|Requirement for Alternative Therapy|2
6036495|NCT00680992|20863071|P1|Overall Study|Requirement for Alternative Therapy|8
6036496|NCT00680992|20863069|P3|Overall Study|Noncompliance|0
6036497|NCT00680992|20863070|P2|Overall Study|Noncompliance|6
6036498|NCT00680992|20863071|P1|Overall Study|Noncompliance|4
6036499|NCT00680992|20863069|P3|Overall Study|Lost to Follow-up|0
6036500|NCT00680992|20863070|P2|Overall Study|Lost to Follow-up|14
6036501|NCT00680992|20863071|P1|Overall Study|Lost to Follow-up|12
6036502|NCT00680992|20863069|P3|Overall Study|Disease Progression|0
6036503|NCT00680992|20863070|P2|Overall Study|Disease Progression|9
6036504|NCT00680992|20863071|P1|Overall Study|Disease Progression|21
6036505|NCT00680992|20863069|P3|Overall Study|Other|1
6036506|NCT00680992|20863070|P2|Overall Study|Other|14
6036507|NCT00680992|20863071|P1|Overall Study|Other|19
6036508|NCT00680992|20863069|P3|Overall Study|Adverse Event|1
6036509|NCT00680992|20863070|P2|Overall Study|Adverse Event|19
6036510|NCT00680992|20863071|P1|Overall Study|Adverse Event|21
6036511|NCT00680992|20863069|P3|Overall Study|Withdrawal by Subject|1
6036512|NCT00680992|20863070|P2|Overall Study|Withdrawal by Subject|11
6036513|NCT00680992|20863071|P1|Overall Study|Withdrawal by Subject|33
6036514|NCT00680992|20863069|P3|Overall Study|End of Trial|3
6036515|NCT00680992|20863070|P2|Overall Study|End of Trial|12
6036516|NCT00680992|20863071|P1|Overall Study|End of Trial|32
6036517|NCT00680992|20863069|P3|Overall Study|Administrative Decision|5
6036518|NCT00680992|20863070|P2|Overall Study|Administrative Decision|42
6036519|NCT00680992|20863071|P1|Overall Study|Administrative Decision|83
6036520|NCT00680992|20863069|P3|Overall Study|Complete Resection (as per protocol)|0
6036521|NCT00680992|20863070|P2|Overall Study|Complete Resection (as per protocol)|121
6036522|NCT00680992|20863071|P1|Overall Study|Complete Resection (as per protocol)|25
6036523|NCT00680914|20863105|P2|Overall Study|serious adverse event (SAE)|1
6036524|NCT00680914|20863106|P1|Overall Study|serious adverse event (SAE)|0
6036525|NCT00680914|20863105|P2|Overall Study|Lost to Follow-up|0
6036526|NCT00680914|20863106|P1|Overall Study|Lost to Follow-up|4
6036527|NCT00680914|20863105|P2|Overall Study|Consent withdrawal|3
6036528|NCT00680914|20863106|P1|Overall Study|Consent withdrawal|6
6036529|NCT00680901|20863140|P2|Overall Study|Ongoing: In Follow Up|41
6036530|NCT00680901|20863141|P1|Overall Study|Ongoing: In Follow Up|45
6036531|NCT00680901|20863140|P2|Overall Study|Ongoing: On Study Treatment|13
6036532|NCT00680901|20863141|P1|Overall Study|Ongoing: On Study Treatment|16
6036533|NCT00680901|20863140|P2|Overall Study|Physician Decision|1
6036534|NCT00680901|20863141|P1|Overall Study|Physician Decision|0
6036535|NCT00680901|20863140|P2|Overall Study|Withdrawal by Subject|13
6036536|NCT00680901|20863141|P1|Overall Study|Withdrawal by Subject|4
6036537|NCT00680901|20863140|P2|Overall Study|Lost to Follow-up|8
6036538|NCT00680901|20863141|P1|Overall Study|Lost to Follow-up|8
6036539|NCT00680836|20863179|P2|Overall Study|Physician Decision|1
6036540|NCT00680836|20863180|P1|Overall Study|Physician Decision|2
6036541|NCT00680836|20863179|P2|Overall Study|Lost to Follow-up|1
6036542|NCT00680836|20863180|P1|Overall Study|Lost to Follow-up|3
6036543|NCT00680836|20863179|P2|Overall Study|Withdrawal by Subject|0
6036544|NCT00680836|20863180|P1|Overall Study|Withdrawal by Subject|3
6036545|NCT00680771|20863234|P2|Overall Study|Prior Exposure to Hepatitus B Vaccine|2
6036546|NCT00680771|20863235|P1|Overall Study|Prior Exposure to Hepatitus B Vaccine|4
6036547|NCT00680771|20863234|P2|Overall Study|Sleep Apnea suspected after PSG|0
6036548|NCT00680771|20863235|P1|Overall Study|Sleep Apnea suspected after PSG|1
6036549|NCT00680771|20863234|P2|Overall Study|Withdrawal by Subject|0
6036550|NCT00680771|20863235|P1|Overall Study|Withdrawal by Subject|1
6036551|NCT00680745|20863245|P4|Overall Study|False Treatment|0
6036552|NCT00680745|20863246|P3|Overall Study|False Treatment|3
6036553|NCT00680745|20863247|P2|Overall Study|False Treatment|1
6036554|NCT00680745|20863248|P1|Overall Study|False Treatment|0
6036555|NCT00680745|20863245|P4|Overall Study|Subject No Longer Meets Study Criteria|2
6036556|NCT00680745|20863246|P3|Overall Study|Subject No Longer Meets Study Criteria|0
6036557|NCT00680745|20863247|P2|Overall Study|Subject No Longer Meets Study Criteria|2
6036558|NCT00680745|20863248|P1|Overall Study|Subject No Longer Meets Study Criteria|0
6036559|NCT00680745|20863245|P4|Overall Study|Poor/Non-compliance|0
6036560|NCT00680745|20863246|P3|Overall Study|Poor/Non-compliance|0
6036561|NCT00680745|20863247|P2|Overall Study|Poor/Non-compliance|3
6036562|NCT00680745|20863248|P1|Overall Study|Poor/Non-compliance|0
6036563|NCT00680745|20863245|P4|Overall Study|Adverse Event|3
6036564|NCT00680745|20863246|P3|Overall Study|Adverse Event|3
6036565|NCT00680745|20863247|P2|Overall Study|Adverse Event|3
6036566|NCT00680745|20863248|P1|Overall Study|Adverse Event|5
6036567|NCT00680745|20863245|P4|Overall Study|Death|0
6036568|NCT00680745|20863246|P3|Overall Study|Death|1
6036569|NCT00680745|20863247|P2|Overall Study|Death|0
6036570|NCT00680745|20863248|P1|Overall Study|Death|1
6036571|NCT00680745|20863245|P4|Overall Study|Lost to Follow-up|0
6036572|NCT00680745|20863246|P3|Overall Study|Lost to Follow-up|1
6036573|NCT00680745|20863247|P2|Overall Study|Lost to Follow-up|1
6036574|NCT00680745|20863248|P1|Overall Study|Lost to Follow-up|0
6036575|NCT00680745|20863245|P4|Overall Study|Withdrawal by Subject|8
6036576|NCT00680745|20863246|P3|Overall Study|Withdrawal by Subject|2
6036577|NCT00680745|20863247|P2|Overall Study|Withdrawal by Subject|3
6036578|NCT00680745|20863248|P1|Overall Study|Withdrawal by Subject|8
6036579|NCT00680407|20863322|P3|Overall Study|Withdrawal by Subject|2
6036580|NCT00680407|20863323|P2|Overall Study|Withdrawal by Subject|2
6036581|NCT00680407|20863324|P1|Overall Study|Withdrawal by Subject|5
6036582|NCT00680407|20863322|P3|Overall Study|Lost to Follow-up|1
6036583|NCT00680407|20863323|P2|Overall Study|Lost to Follow-up|3
6036584|NCT00680407|20863324|P1|Overall Study|Lost to Follow-up|3
6036585|NCT00680368|20863338|P1|Overall Study|not supervised, not eligible|15
6036586|NCT00680186|20863366|P2|Overall Study|Other|1
6036587|NCT00680186|20863367|P1|Overall Study|Other|4
6036588|NCT00680186|20863366|P2|Overall Study|Withdrawal by Subject|39
6036589|NCT00680186|20863367|P1|Overall Study|Withdrawal by Subject|32
6036590|NCT00680186|20863366|P2|Overall Study|Lost to Follow-up|6
6036591|NCT00680186|20863367|P1|Overall Study|Lost to Follow-up|11
6036592|NCT00680186|20863366|P2|Overall Study|Protocol Violation|26
6036593|NCT00680186|20863367|P1|Overall Study|Protocol Violation|31
6036594|NCT00680186|20863366|P2|Overall Study|Adverse Event|44
6036595|NCT00680186|20863367|P1|Overall Study|Adverse Event|47
6036596|NCT00680121|20863393|P2|Overall Study|Lost to Follow-up|23
6036597|NCT00680121|20863394|P1|Overall Study|Lost to Follow-up|27
6036598|NCT00680056|20863408|P2|Second Intervention|Protocol Violation|1
6036599|NCT00680056|20863409|P1|Second Intervention|Protocol Violation|3
6036600|NCT00680056|20863408|P2|First Intervention|Mainly Exacerbation of COPD|2
6036601|NCT00680056|20863409|P1|First Intervention|Mainly Exacerbation of COPD|1
6036602|NCT00680043|20863420|P3|Overall Study|Renal Transplant|4
6036603|NCT00680043|20863421|P2|Overall Study|Renal Transplant|0
6036604|NCT00680043|20863422|P1|Overall Study|Renal Transplant|1
6036605|NCT00680043|20863420|P3|Overall Study|Patient Not Compliant With Study Reqs.|0
6036606|NCT00680043|20863421|P2|Overall Study|Patient Not Compliant With Study Reqs.|1
6036607|NCT00680043|20863422|P1|Overall Study|Patient Not Compliant With Study Reqs.|0
6036608|NCT00680043|20863420|P3|Overall Study|Withdrawal by Subject|0
6036609|NCT00680043|20863421|P2|Overall Study|Withdrawal by Subject|0
6036610|NCT00680043|20863422|P1|Overall Study|Withdrawal by Subject|1
6036611|NCT00680017|20863438|P2|Overall Study|Lost to Follow-up|0
6036612|NCT00680017|20863439|P1|Overall Study|Lost to Follow-up|2
6036613|NCT00680017|20863438|P2|Overall Study|Withdrawal by Subject|5
6036614|NCT00680017|20863439|P1|Overall Study|Withdrawal by Subject|2
6036615|NCT00680017|20863438|P2|Overall Study|Adverse Event|7
6036616|NCT00680017|20863439|P1|Overall Study|Adverse Event|13
6036617|NCT00679939|20863458|P2|24-Week Open-Label (OL) Period|Withdrawal by Subject|1
6036618|NCT00679939|20863459|P1|24-Week Open-Label (OL) Period|Withdrawal by Subject|2
6036619|NCT00679939|20863458|P2|24-Week Open-Label (OL) Period|Physician Decision|0
6036620|NCT00679939|20863459|P1|24-Week Open-Label (OL) Period|Physician Decision|1
6036621|NCT00679939|20863458|P2|24-Week Open-Label (OL) Period|Met Stopping Criteria|1
6036622|NCT00679939|20863459|P1|24-Week Open-Label (OL) Period|Met Stopping Criteria|3
6036623|NCT00679939|20863458|P2|24-Week Open-Label (OL) Period|Protocol Violation|1
6036624|NCT00679939|20863459|P1|24-Week Open-Label (OL) Period|Protocol Violation|1
6036625|NCT00679939|20863458|P2|24-Week Open-Label (OL) Period|Adverse Event|1
6036626|NCT00679939|20863459|P1|24-Week Open-Label (OL) Period|Adverse Event|0
6036627|NCT00679939|20863458|P2|52-Week Double-Blind (DB) Period|Lost to Follow-up|2
6036628|NCT00679939|20863459|P1|52-Week Double-Blind (DB) Period|Lost to Follow-up|0
6036629|NCT00679939|20863458|P2|52-Week Double-Blind (DB) Period|Protocol Violation|0
6036630|NCT00679939|20863459|P1|52-Week Double-Blind (DB) Period|Protocol Violation|1
6036631|NCT00679939|20863458|P2|52-Week Double-Blind (DB) Period|Investigator Discretion|0
6036632|NCT00679939|20863459|P1|52-Week Double-Blind (DB) Period|Investigator Discretion|5
6036633|NCT00679939|20863458|P2|52-Week Double-Blind (DB) Period|Adverse Event|12
6036634|NCT00679939|20863459|P1|52-Week Double-Blind (DB) Period|Adverse Event|14
6036635|NCT00679939|20863458|P2|52-Week Double-Blind (DB) Period|Withdrew Consent|13
6036636|NCT00679939|20863459|P1|52-Week Double-Blind (DB) Period|Withdrew Consent|17
6036637|NCT00679913|20863625|P2|Overall Study|Protocol Violation|13
6036638|NCT00679913|20863626|P1|Overall Study|Protocol Violation|18
6036639|NCT00679783|20863641|P7|Overall Study|Ongoing at data cut-off|0
6036640|NCT00679783|20863642|P6|Overall Study|Ongoing at data cut-off|0
6036641|NCT00679783|20863643|P5|Overall Study|Ongoing at data cut-off|1
6036642|NCT00679783|20863644|P4|Overall Study|Ongoing at data cut-off|9
6036643|NCT00679783|20863645|P3|Overall Study|Ongoing at data cut-off|0
6036644|NCT00679783|20863646|P2|Overall Study|Ongoing at data cut-off|2
6036645|NCT00679783|20863647|P1|Overall Study|Ongoing at data cut-off|2
6036646|NCT00679783|20863641|P7|Overall Study|Not Captured|0
6036647|NCT00679783|20863642|P6|Overall Study|Not Captured|0
6036648|NCT00679783|20863643|P5|Overall Study|Not Captured|0
6036649|NCT00679783|20863644|P4|Overall Study|Not Captured|5
6036650|NCT00679783|20863645|P3|Overall Study|Not Captured|0
6036651|NCT00679783|20863646|P2|Overall Study|Not Captured|0
6036652|NCT00679783|20863647|P1|Overall Study|Not Captured|0
6036653|NCT00679783|20863641|P7|Overall Study|Withdrawal by Subject|0
6036654|NCT00679783|20863642|P6|Overall Study|Withdrawal by Subject|0
6036655|NCT00679783|20863643|P5|Overall Study|Withdrawal by Subject|0
6036656|NCT00679783|20863644|P4|Overall Study|Withdrawal by Subject|1
6036657|NCT00679783|20863645|P3|Overall Study|Withdrawal by Subject|1
6036658|NCT00679783|20863646|P2|Overall Study|Withdrawal by Subject|0
6036659|NCT00679783|20863647|P1|Overall Study|Withdrawal by Subject|0
6036660|NCT00679783|20863641|P7|Overall Study|Lack of Efficacy|0
6036661|NCT00679783|20863642|P6|Overall Study|Lack of Efficacy|0
6036662|NCT00679783|20863643|P5|Overall Study|Lack of Efficacy|0
6036663|NCT00679783|20863644|P4|Overall Study|Lack of Efficacy|2
6036664|NCT00679783|20863645|P3|Overall Study|Lack of Efficacy|0
6036665|NCT00679783|20863646|P2|Overall Study|Lack of Efficacy|1
6036666|NCT00679783|20863647|P1|Overall Study|Lack of Efficacy|0
6036667|NCT00679783|20863641|P7|Overall Study|Adverse Event|1
6036668|NCT00679783|20863642|P6|Overall Study|Adverse Event|0
6036669|NCT00679783|20863643|P5|Overall Study|Adverse Event|0
6036670|NCT00679783|20863644|P4|Overall Study|Adverse Event|3
6036671|NCT00679783|20863645|P3|Overall Study|Adverse Event|0
6036672|NCT00679783|20863646|P2|Overall Study|Adverse Event|0
6036673|NCT00679783|20863647|P1|Overall Study|Adverse Event|0
6036674|NCT00679627|20863700|P2|Overall Study|Early Study Closure|405
6036675|NCT00679627|20863701|P1|Overall Study|Early Study Closure|425
6036676|NCT00679627|20863700|P2|Overall Study|Lost to Follow-up|26
6036677|NCT00679627|20863701|P1|Overall Study|Lost to Follow-up|22
6036678|NCT00679627|20863700|P2|Overall Study|Withdrawal by Subject|172
6036679|NCT00679627|20863701|P1|Overall Study|Withdrawal by Subject|168
6036680|NCT00679627|20863700|P2|Overall Study|Adverse Event|53
6036681|NCT00679627|20863701|P1|Overall Study|Adverse Event|43
6036682|NCT00679627|20863700|P2|Overall Study|Death|29
6036683|NCT00679627|20863701|P1|Overall Study|Death|41
6036684|NCT00679549|20863725|P2|Overall Study|missing outcome echocardiograms|5
6036685|NCT00679549|20863726|P1|Overall Study|missing outcome echocardiograms|4
6036686|NCT00679549|20863725|P2|Overall Study|dropout|4
6036687|NCT00679549|20863726|P1|Overall Study|dropout|2
6036688|NCT00679432|20863736|P4|Overall Study|Randomization error, return to prior Rx|0
6036689|NCT00679432|20863737|P3|Overall Study|Randomization error, return to prior Rx|3
6036690|NCT00679432|20863738|P2|Overall Study|Randomization error, return to prior Rx|0
6036691|NCT00679432|20863739|P1|Overall Study|Randomization error, return to prior Rx|0
6036692|NCT00679432|20863736|P4|Overall Study|Infectious colitis, normal histology|3
6036693|NCT00679432|20863737|P3|Overall Study|Infectious colitis, normal histology|8
6036694|NCT00679432|20863738|P2|Overall Study|Infectious colitis, normal histology|4
6036695|NCT00679432|20863739|P1|Overall Study|Infectious colitis, normal histology|5
6036696|NCT00679432|20863736|P4|Overall Study|Lack of Efficacy|8
6036697|NCT00679432|20863737|P3|Overall Study|Lack of Efficacy|14
6036698|NCT00679432|20863738|P2|Overall Study|Lack of Efficacy|9
6036699|NCT00679432|20863739|P1|Overall Study|Lack of Efficacy|13
6036700|NCT00679432|20863736|P4|Overall Study|Sponsor decision|0
6036701|NCT00679432|20863737|P3|Overall Study|Sponsor decision|0
6036702|NCT00679432|20863738|P2|Overall Study|Sponsor decision|0
6036703|NCT00679432|20863739|P1|Overall Study|Sponsor decision|1
6036704|NCT00679432|20863736|P4|Overall Study|Physician Decision|2
6036705|NCT00679432|20863737|P3|Overall Study|Physician Decision|2
6036706|NCT00679432|20863738|P2|Overall Study|Physician Decision|2
6036707|NCT00679432|20863739|P1|Overall Study|Physician Decision|3
6036708|NCT00679432|20863736|P4|Overall Study|Lost to Follow-up|2
6036709|NCT00679432|20863737|P3|Overall Study|Lost to Follow-up|4
6036710|NCT00679432|20863738|P2|Overall Study|Lost to Follow-up|5
6036711|NCT00679432|20863739|P1|Overall Study|Lost to Follow-up|1
6036712|NCT00679432|20863736|P4|Overall Study|Withdrawal by Subject|9
6036713|NCT00679432|20863737|P3|Overall Study|Withdrawal by Subject|10
6036714|NCT00679432|20863738|P2|Overall Study|Withdrawal by Subject|11
6036715|NCT00679432|20863739|P1|Overall Study|Withdrawal by Subject|8
6036716|NCT00679432|20863736|P4|Overall Study|Protocol Violation|1
6036717|NCT00679432|20863737|P3|Overall Study|Protocol Violation|2
6036718|NCT00679432|20863738|P2|Overall Study|Protocol Violation|1
6036719|NCT00679432|20863739|P1|Overall Study|Protocol Violation|1
6036720|NCT00679432|20863736|P4|Overall Study|Adverse Event|7
6036721|NCT00679432|20863737|P3|Overall Study|Adverse Event|10
6036722|NCT00679432|20863738|P2|Overall Study|Adverse Event|6
6036723|NCT00679432|20863739|P1|Overall Study|Adverse Event|5
6036724|NCT00679367|20863782|P1|Overall Study|Withdrawal by Subject|1
6036725|NCT00679367|20863782|P1|Overall Study|Lack of Efficacy|3
6036726|NCT00679367|20863782|P1|Overall Study|inability to swallow oral drugs|1
6036727|NCT00679367|20863782|P1|Overall Study|Adverse Event|7
6036728|NCT00679354|20863788|P1|Overall Study|Ineligible|1
6036729|NCT00679354|20863788|P1|Overall Study|Physician Decision|4
6036730|NCT00679354|20863788|P1|Overall Study|Lack of Efficacy|22
6036731|NCT00679354|20863788|P1|Overall Study|Death|3
6036732|NCT00679341|20863806|P2|Overall Study|Physician/patient decision to withdraw|6
6036733|NCT00679341|20863807|P1|Overall Study|Physician/patient decision to withdraw|0
6036734|NCT00679341|20863806|P2|Overall Study|Not treated|2
6036735|NCT00679341|20863807|P1|Overall Study|Not treated|0
6036736|NCT00679341|20863806|P2|Overall Study|Physician Decision|0
6036737|NCT00679341|20863807|P1|Overall Study|Physician Decision|1
6036738|NCT00679341|20863806|P2|Overall Study|Other|0
6036739|NCT00679341|20863807|P1|Overall Study|Other|1
6036740|NCT00679341|20863806|P2|Overall Study|Death|1
6036741|NCT00679341|20863807|P1|Overall Study|Death|1
6036742|NCT00679341|20863806|P2|Overall Study|Subject/guardian decision to discontinue|0
6036743|NCT00679341|20863807|P1|Overall Study|Subject/guardian decision to discontinue|3
6036744|NCT00679341|20863806|P2|Overall Study|Adverse Event|6
6036745|NCT00679341|20863807|P1|Overall Study|Adverse Event|5
6036746|NCT00679341|20863806|P2|Overall Study|Disease progression|36
6036747|NCT00679341|20863807|P1|Overall Study|Disease progression|42
6036748|NCT00679302|20863827|P2|Overall Study|Lost to Follow-up|4
6036749|NCT00679302|20863828|P1|Overall Study|Lost to Follow-up|8
6036750|NCT00679289|20863839|P3|Overall Study|Physician Decision|1
6036751|NCT00679289|20863840|P2|Overall Study|Physician Decision|0
6036752|NCT00679289|20863841|P1|Overall Study|Physician Decision|1
6036753|NCT00679289|20863839|P3|Overall Study|Adverse Event|3
6036754|NCT00679289|20863840|P2|Overall Study|Adverse Event|0
6036755|NCT00679289|20863841|P1|Overall Study|Adverse Event|0
6036756|NCT00679289|20863839|P3|Overall Study|Withdrawal by Subject|1
6036757|NCT00679289|20863840|P2|Overall Study|Withdrawal by Subject|1
6036758|NCT00679289|20863841|P1|Overall Study|Withdrawal by Subject|0
6036759|NCT00679289|20863839|P3|Overall Study|Progressive disease|18
6036760|NCT00679289|20863840|P2|Overall Study|Progressive disease|5
6036761|NCT00679289|20863841|P1|Overall Study|Progressive disease|4
6036762|NCT00679263|20863863|P3|Visit 2/Dose 1|subject not compliance|0
6036763|NCT00679263|20863864|P2|Visit 2/Dose 1|subject not compliance|1
6036764|NCT00679263|20863865|P1|Visit 2/Dose 1|subject not compliance|1
6036765|NCT00679263|20863863|P3|Visit 2/Dose 1|Adverse Event|0
6036766|NCT00679263|20863864|P2|Visit 2/Dose 1|Adverse Event|0
6036767|NCT00679263|20863865|P1|Visit 2/Dose 1|Adverse Event|1
6036768|NCT00679211|20863876|P1|Overall Study|Other|1
6036769|NCT00679211|20863876|P1|Overall Study|Transferred to extension study TDM4529g|12
6036770|NCT00679211|20863876|P1|Overall Study|Refused to undergo protocol procedures|1
6036771|NCT00679211|20863876|P1|Overall Study|Physician Decision|5
6036772|NCT00679211|20863876|P1|Overall Study|Withdrawal by Subject|2
6036773|NCT00679211|20863876|P1|Overall Study|Adverse Event|7
6036774|NCT00679211|20863876|P1|Overall Study|Progressive disease|82
6036775|NCT00679172|20863893|P5|Overall Study|Other not specified|0
6036776|NCT00679172|20863894|P4|Overall Study|Other not specified|0
6036777|NCT00679172|20863895|P3|Overall Study|Other not specified|1
6036778|NCT00679172|20863896|P2|Overall Study|Other not specified|0
6036779|NCT00679172|20863897|P1|Overall Study|Other not specified|0
6036780|NCT00679172|20863893|P5|Overall Study|Non-compliance|0
6036781|NCT00679172|20863894|P4|Overall Study|Non-compliance|1
6036782|NCT00679172|20863895|P3|Overall Study|Non-compliance|0
6036783|NCT00679172|20863896|P2|Overall Study|Non-compliance|1
6036784|NCT00679172|20863897|P1|Overall Study|Non-compliance|1
6036785|NCT00679081|20863960|P1|Overall Study|Lost to Follow-up|1
6036786|NCT00679055|20863970|P2|Overall Study|Study Terminated|1
6036787|NCT00679055|20863971|P1|Overall Study|Study Terminated|2
6036788|NCT00679055|20863970|P2|Overall Study|Other|3
6036789|NCT00679055|20863971|P1|Overall Study|Other|0
6036790|NCT00679055|20863970|P2|Overall Study|Adverse Event|1
6036791|NCT00679055|20863971|P1|Overall Study|Adverse Event|0
6036792|NCT00679029|20863981|P1|Overall Study|Lost to Follow-up|1
6036793|NCT00679029|20863981|P1|Overall Study|Withdrawal by Subject|1
6036794|NCT00679029|20863981|P1|Overall Study|Adverse Event|3
6036795|NCT00678899|20863988|P1|Overall Study|Adverse Event|1
6036796|NCT00678886|20863997|P4|Overall Study|Other|0
6036797|NCT00678886|20863998|P3|Overall Study|Other|1
6036798|NCT00678886|20863999|P2|Overall Study|Other|0
6036799|NCT00678886|20864000|P1|Overall Study|Other|0
6036800|NCT00678886|20863997|P4|Overall Study|Lost to Follow-up|2
6036801|NCT00678886|20863998|P3|Overall Study|Lost to Follow-up|3
6036802|NCT00678886|20863999|P2|Overall Study|Lost to Follow-up|0
6036803|NCT00678886|20864000|P1|Overall Study|Lost to Follow-up|0
6036804|NCT00678886|20863997|P4|Overall Study|Physician Decision|1
6036805|NCT00678886|20863998|P3|Overall Study|Physician Decision|1
6036806|NCT00678886|20863999|P2|Overall Study|Physician Decision|0
6036807|NCT00678886|20864000|P1|Overall Study|Physician Decision|0
6036808|NCT00678886|20863997|P4|Overall Study|Withdrawal by Subject|6
6036809|NCT00678886|20863998|P3|Overall Study|Withdrawal by Subject|4
6036810|NCT00678886|20863999|P2|Overall Study|Withdrawal by Subject|0
6036811|NCT00678886|20864000|P1|Overall Study|Withdrawal by Subject|0
6036812|NCT00678795|20864069|P2|Overall Study|Lack of Efficacy|1
6036813|NCT00678795|20864070|P1|Overall Study|Lack of Efficacy|1
6036814|NCT00678795|20864069|P2|Overall Study|Lost to Follow-up|1
6036815|NCT00678795|20864070|P1|Overall Study|Lost to Follow-up|0
6036816|NCT00678795|20864069|P2|Overall Study|Protocol Violation|1
6036817|NCT00678795|20864070|P1|Overall Study|Protocol Violation|0
6036818|NCT00678795|20864069|P2|Overall Study|Withdrawal by Subject|0
6036819|NCT00678795|20864070|P1|Overall Study|Withdrawal by Subject|3
6036820|NCT00678795|20864069|P2|Overall Study|Adverse Event|3
6036821|NCT00678795|20864070|P1|Overall Study|Adverse Event|7
6036822|NCT00678691|20864092|P2|Overall Study|Adverse Event|4
6036823|NCT00678691|20864093|P1|Overall Study|Adverse Event|6
6036824|NCT00678652|20864103|P4|Overall Study|Relocation|0
6036825|NCT00678652|20864104|P3|Overall Study|Relocation|0
6036826|NCT00678652|20864105|P2|Overall Study|Relocation|0
6036827|NCT00678652|20864106|P1|Overall Study|Relocation|1
6036828|NCT00678652|20864103|P4|Overall Study|Pregnancy|0
6036829|NCT00678652|20864104|P3|Overall Study|Pregnancy|1
6036830|NCT00678652|20864105|P2|Overall Study|Pregnancy|0
6036831|NCT00678652|20864106|P1|Overall Study|Pregnancy|0
6036832|NCT00678652|20864103|P4|Overall Study|Protocol Violation|0
6036833|NCT00678652|20864104|P3|Overall Study|Protocol Violation|0
6036834|NCT00678652|20864105|P2|Overall Study|Protocol Violation|0
6036835|NCT00678652|20864106|P1|Overall Study|Protocol Violation|2
6036836|NCT00678639|20864130|P2|Overall Study|Lost to Follow-up at 30 days|0
6036837|NCT00678639|20864131|P1|Overall Study|Lost to Follow-up at 30 days|2
6036838|NCT00678587|20864146|P2|Overall Study|Withdrew Consent|3
6036839|NCT00678587|20864147|P1|Overall Study|Withdrew Consent|8
6036840|NCT00678587|20864146|P2|Overall Study|Investigator Discretion|6
6036841|NCT00678587|20864147|P1|Overall Study|Investigator Discretion|2
6036842|NCT00678587|20864146|P2|Overall Study|Lost to Follow-up|5
6036843|NCT00678587|20864147|P1|Overall Study|Lost to Follow-up|3
6036844|NCT00678587|20864146|P2|Overall Study|Study Closed/Terminated|0
6036845|NCT00678587|20864147|P1|Overall Study|Study Closed/Terminated|1
6036846|NCT00678587|20864146|P2|Overall Study|Protocol Violation|1
6036847|NCT00678587|20864147|P1|Overall Study|Protocol Violation|2
6036848|NCT00678587|20864146|P2|Overall Study|Lack of Efficacy|0
6036849|NCT00678587|20864147|P1|Overall Study|Lack of Efficacy|1
6036850|NCT00678587|20864146|P2|Overall Study|Adverse Event|3
6036851|NCT00678587|20864147|P1|Overall Study|Adverse Event|3
6036852|NCT00678561|20864196|P8|Overall Study|Withdrawal by Subject|1
6036853|NCT00678561|20864197|P7|Overall Study|Withdrawal by Subject|0
6036854|NCT00678561|20864198|P6|Overall Study|Withdrawal by Subject|0
6036855|NCT00678561|20864199|P5|Overall Study|Withdrawal by Subject|0
6036856|NCT00678561|20864200|P4|Overall Study|Withdrawal by Subject|0
6036857|NCT00678561|20864201|P3|Overall Study|Withdrawal by Subject|0
6036858|NCT00678561|20864202|P2|Overall Study|Withdrawal by Subject|0
6036859|NCT00678561|20864203|P1|Overall Study|Withdrawal by Subject|0
6036860|NCT00678561|20864196|P8|Overall Study|Protocol Violation|0
6036861|NCT00678561|20864197|P7|Overall Study|Protocol Violation|0
6036862|NCT00678561|20864198|P6|Overall Study|Protocol Violation|1
6036863|NCT00678561|20864199|P5|Overall Study|Protocol Violation|1
6036864|NCT00678561|20864200|P4|Overall Study|Protocol Violation|0
6036865|NCT00678561|20864201|P3|Overall Study|Protocol Violation|0
6036866|NCT00678561|20864202|P2|Overall Study|Protocol Violation|0
6036867|NCT00678561|20864203|P1|Overall Study|Protocol Violation|0
6036868|NCT00678561|20864196|P8|Overall Study|Adverse Event|0
6036869|NCT00678561|20864197|P7|Overall Study|Adverse Event|0
6036870|NCT00678561|20864198|P6|Overall Study|Adverse Event|0
6036871|NCT00678561|20864199|P5|Overall Study|Adverse Event|1
6036872|NCT00678561|20864200|P4|Overall Study|Adverse Event|0
6036873|NCT00678561|20864201|P3|Overall Study|Adverse Event|1
6036874|NCT00678561|20864202|P2|Overall Study|Adverse Event|1
6036875|NCT00678561|20864203|P1|Overall Study|Adverse Event|0
6036876|NCT00678392|20864309|P2|Overall Study|Other|53
6036877|NCT00678392|20864310|P1|Overall Study|Other|56
6036878|NCT00678392|20864309|P2|Overall Study|Randomized But Not Treated|7
6036879|NCT00678392|20864310|P1|Overall Study|Randomized But Not Treated|2
6036880|NCT00678392|20864309|P2|Overall Study|Withdrawal by Subject|4
6036881|NCT00678392|20864310|P1|Overall Study|Withdrawal by Subject|4
6036882|NCT00678392|20864309|P2|Overall Study|Sponsor's Decision|2
6036883|NCT00678392|20864310|P1|Overall Study|Sponsor's Decision|1
6036884|NCT00678392|20864309|P2|Overall Study|Objective Progression or Relapse|8
6036885|NCT00678392|20864310|P1|Overall Study|Objective Progression or Relapse|3
6036886|NCT00678392|20864309|P2|Overall Study|Lost to Follow-up|13
6036887|NCT00678392|20864310|P1|Overall Study|Lost to Follow-up|15
6036888|NCT00678392|20864309|P2|Overall Study|Death|269
6036889|NCT00678392|20864310|P1|Overall Study|Death|280
6036890|NCT00678392|20864309|P2|Overall Study|Adverse Event|6
6036891|NCT00678392|20864310|P1|Overall Study|Adverse Event|0
6036892|NCT00678379|20864345|P3|Overall Study|Incomplete Data|3
6036893|NCT00678379|20864346|P2|Overall Study|Incomplete Data|3
6036894|NCT00678379|20864347|P1|Overall Study|Incomplete Data|4
6036895|NCT00678379|20864345|P3|Overall Study|Injection performed after tonsillectomy|1
6036896|NCT00678379|20864346|P2|Overall Study|Injection performed after tonsillectomy|0
6036897|NCT00678379|20864347|P1|Overall Study|Injection performed after tonsillectomy|2
6036898|NCT00678301|20864375|P2|Overall Study|Lost to Follow-up|1
6036899|NCT00678301|20864376|P1|Overall Study|Lost to Follow-up|3
6036900|NCT00678301|20864375|P2|Overall Study|Withdrawal by Subject|0
6036901|NCT00678301|20864376|P1|Overall Study|Withdrawal by Subject|4
6036902|NCT00678301|20864375|P2|Overall Study|Adverse Event|0
6036903|NCT00678301|20864376|P1|Overall Study|Adverse Event|1
6036904|NCT00678301|20864375|P2|Overall Study|Non-compliance with study procedures|1
6036905|NCT00678301|20864376|P1|Overall Study|Non-compliance with study procedures|0
6036906|NCT00678288|20864434|P2|Overall Study|Disease progression/recurrence/relapse|1
6036907|NCT00678288|20864435|P1|Overall Study|Disease progression/recurrence/relapse|6
6036908|NCT00678288|20864434|P2|Overall Study|Reason not reported|0
6036909|NCT00678288|20864435|P1|Overall Study|Reason not reported|1
6036910|NCT00678288|20864434|P2|Overall Study|Switch to commercial drug|1
6036911|NCT00678288|20864435|P1|Overall Study|Switch to commercial drug|0
6036912|NCT00678288|20864434|P2|Overall Study|Not compliant with study medication|1
6036913|NCT00678288|20864435|P1|Overall Study|Not compliant with study medication|0
6037004|NCT00677352|20864777|P1|Tapering Phase|Adverse Event|1
6036914|NCT00678288|20864434|P2|Overall Study|Study terminated by the sponsor|0
6036915|NCT00678288|20864435|P1|Overall Study|Study terminated by the sponsor|2
6036916|NCT00678288|20864434|P2|Overall Study|Withdrawal by Subject|1
6036917|NCT00678288|20864435|P1|Overall Study|Withdrawal by Subject|1
6036918|NCT00678288|20864434|P2|Overall Study|Adverse Event|2
6036919|NCT00678288|20864435|P1|Overall Study|Adverse Event|0
6036920|NCT00678210|20864490|P4|Overall Study|Other|0
6036921|NCT00678210|20864491|P3|Overall Study|Other|1
6036922|NCT00678210|20864492|P2|Overall Study|Other|0
6036923|NCT00678210|20864493|P1|Overall Study|Other|1
6036924|NCT00678210|20864490|P4|Overall Study|Withdrawal by Subject|7
6036925|NCT00678210|20864491|P3|Overall Study|Withdrawal by Subject|1
6036926|NCT00678210|20864492|P2|Overall Study|Withdrawal by Subject|4
6036927|NCT00678210|20864493|P1|Overall Study|Withdrawal by Subject|3
6036928|NCT00678210|20864490|P4|Overall Study|Lost to Follow-up|1
6036929|NCT00678210|20864491|P3|Overall Study|Lost to Follow-up|0
6036930|NCT00678210|20864492|P2|Overall Study|Lost to Follow-up|2
6036931|NCT00678210|20864493|P1|Overall Study|Lost to Follow-up|4
6036932|NCT00678210|20864490|P4|Overall Study|Lack of Efficacy|9
6036933|NCT00678210|20864491|P3|Overall Study|Lack of Efficacy|1
6036934|NCT00678210|20864492|P2|Overall Study|Lack of Efficacy|3
6036935|NCT00678210|20864493|P1|Overall Study|Lack of Efficacy|2
6036936|NCT00678210|20864490|P4|Overall Study|Adverse Event|3
6036937|NCT00678210|20864491|P3|Overall Study|Adverse Event|3
6036938|NCT00678210|20864492|P2|Overall Study|Adverse Event|2
6036939|NCT00678210|20864493|P1|Overall Study|Adverse Event|1
6036940|NCT00678080|20864529|P2|Overall Study|Withdrawal by Subject|1
6036941|NCT00678080|20864530|P1|Overall Study|Withdrawal by Subject|0
6036942|NCT00678080|20864529|P2|Overall Study|Lost to Follow-up|0
6036943|NCT00678080|20864530|P1|Overall Study|Lost to Follow-up|1
6036944|NCT00678080|20864529|P2|Overall Study|Physician Decision|0
6036945|NCT00678080|20864530|P1|Overall Study|Physician Decision|2
6036946|NCT00678041|20864556|P2|Overall Study|Physician Decision|5
6036947|NCT00678041|20864557|P1|Overall Study|Physician Decision|5
6036948|NCT00677833|20864610|P4|Overall Study|Lost to Follow-up|0
6036949|NCT00677833|20864611|P3|Overall Study|Lost to Follow-up|1
6036950|NCT00677833|20864612|P2|Overall Study|Lost to Follow-up|0
6036951|NCT00677833|20864613|P1|Overall Study|Lost to Follow-up|0
6036952|NCT00677833|20864610|P4|Overall Study|Withdrawal by Subject|3
6036953|NCT00677833|20864611|P3|Overall Study|Withdrawal by Subject|1
6036954|NCT00677833|20864612|P2|Overall Study|Withdrawal by Subject|0
6036955|NCT00677833|20864613|P1|Overall Study|Withdrawal by Subject|4
6036956|NCT00677820|20864663|P2|Overall Study|Lost to Follow-up|0
6036957|NCT00677820|20864664|P1|Overall Study|Lost to Follow-up|1
6036958|NCT00677807|20864685|P3|Overall Study|Protocol Deviation|0
6036959|NCT00677807|20864686|P2|Overall Study|Protocol Deviation|3
6036960|NCT00677807|20864687|P1|Overall Study|Protocol Deviation|1
6036961|NCT00677807|20864685|P3|Overall Study|Death|1
6036962|NCT00677807|20864686|P2|Overall Study|Death|1
6036963|NCT00677807|20864687|P1|Overall Study|Death|0
6036964|NCT00677807|20864685|P3|Overall Study|Administrative problems|2
6036965|NCT00677807|20864686|P2|Overall Study|Administrative problems|1
6036966|NCT00677807|20864687|P1|Overall Study|Administrative problems|1
6036967|NCT00677807|20864685|P3|Overall Study|Lost to Follow-up|2
6036968|NCT00677807|20864686|P2|Overall Study|Lost to Follow-up|2
6036969|NCT00677807|20864687|P1|Overall Study|Lost to Follow-up|2
6036970|NCT00677807|20864685|P3|Overall Study|Withdrawal by Subject|6
6036971|NCT00677807|20864686|P2|Overall Study|Withdrawal by Subject|3
6036972|NCT00677807|20864687|P1|Overall Study|Withdrawal by Subject|10
6036973|NCT00677807|20864685|P3|Overall Study|Participant no longer needs study drug|1
6036974|NCT00677807|20864686|P2|Overall Study|Participant no longer needs study drug|0
6036975|NCT00677807|20864687|P1|Overall Study|Participant no longer needs study drug|0
6036976|NCT00677807|20864685|P3|Overall Study|Lack of Efficacy|2
6036977|NCT00677807|20864686|P2|Overall Study|Lack of Efficacy|0
6036978|NCT00677807|20864687|P1|Overall Study|Lack of Efficacy|0
6036979|NCT00677807|20864685|P3|Overall Study|Adverse Event|6
6036980|NCT00677807|20864686|P2|Overall Study|Adverse Event|1
6036981|NCT00677807|20864687|P1|Overall Study|Adverse Event|4
6036982|NCT00677534|20864733|P1|Washout (Weeks 1-4)|Withdrawal by Subject|1
6036983|NCT00677534|20864733|P1|Washout (Weeks 1-4)|Withdrawal by Subject|1
6036984|NCT00677534|20864733|P1|Washout (Weeks 1-4)|did not qualify after signing consent|1
6036985|NCT00677365|20864741|P4|Overall Study|Other reason|1
6036986|NCT00677365|20864742|P3|Overall Study|Other reason|0
6036987|NCT00677365|20864743|P2|Overall Study|Other reason|0
6036988|NCT00677365|20864744|P1|Overall Study|Other reason|0
6036989|NCT00677365|20864741|P4|Overall Study|Withdrawal by Subject|0
6036990|NCT00677365|20864742|P3|Overall Study|Withdrawal by Subject|1
6036991|NCT00677365|20864743|P2|Overall Study|Withdrawal by Subject|0
6036992|NCT00677365|20864744|P1|Overall Study|Withdrawal by Subject|0
6036993|NCT00677365|20864741|P4|Overall Study|Adverse Event|2
6036994|NCT00677365|20864742|P3|Overall Study|Adverse Event|1
6036995|NCT00677365|20864743|P2|Overall Study|Adverse Event|1
6036996|NCT00677365|20864744|P1|Overall Study|Adverse Event|2
6036997|NCT00677352|20864776|P2|Tapering Phase|Job transfer|1
6036998|NCT00677352|20864777|P1|Tapering Phase|Job transfer|0
6036999|NCT00677352|20864776|P2|Tapering Phase|Pregnancy|1
6037000|NCT00677352|20864777|P1|Tapering Phase|Pregnancy|0
6037001|NCT00677352|20864776|P2|Tapering Phase|Withdrawal by Subject|3
6037002|NCT00677352|20864777|P1|Tapering Phase|Withdrawal by Subject|5
6037003|NCT00677352|20864776|P2|Tapering Phase|Adverse Event|5
6037005|NCT00677352|20864776|P2|Treatment Phase|Not treated|2
6037006|NCT00677352|20864777|P1|Treatment Phase|Not treated|0
6037007|NCT00677352|20864776|P2|Treatment Phase|Transference or work related matter|5
6037008|NCT00677352|20864777|P1|Treatment Phase|Transference or work related matter|0
6037009|NCT00677352|20864776|P2|Treatment Phase|Protocol Violation|1
6037010|NCT00677352|20864777|P1|Treatment Phase|Protocol Violation|1
6037011|NCT00677352|20864776|P2|Treatment Phase|Pregnancy|1
6037012|NCT00677352|20864777|P1|Treatment Phase|Pregnancy|0
6037013|NCT00677352|20864776|P2|Treatment Phase|Physician Decision|0
6037014|NCT00677352|20864777|P1|Treatment Phase|Physician Decision|1
6037015|NCT00677352|20864776|P2|Treatment Phase|Withdrawal by Subject|7
6037016|NCT00677352|20864777|P1|Treatment Phase|Withdrawal by Subject|7
6037017|NCT00677352|20864776|P2|Treatment Phase|Lost to Follow-up|1
6037018|NCT00677352|20864777|P1|Treatment Phase|Lost to Follow-up|0
6037019|NCT00677352|20864776|P2|Treatment Phase|Lack of Efficacy|3
6037020|NCT00677352|20864777|P1|Treatment Phase|Lack of Efficacy|2
6037021|NCT00677352|20864776|P2|Treatment Phase|Adverse Event|22
6037022|NCT00677352|20864777|P1|Treatment Phase|Adverse Event|14
6037023|NCT00677235|20864797|P2|Overall Study|Adverse Experience|0
6037024|NCT00677235|20864798|P1|Overall Study|Adverse Experience|1
6037025|NCT00677235|20864797|P2|Overall Study|Death|36
6037026|NCT00677235|20864798|P1|Overall Study|Death|37
6037027|NCT00677235|20864797|P2|Overall Study|Lost to Follow-up|1
6037028|NCT00677235|20864798|P1|Overall Study|Lost to Follow-up|2
6037029|NCT00677235|20864797|P2|Overall Study|Withdrawal by Subject|1
6037030|NCT00677235|20864798|P1|Overall Study|Withdrawal by Subject|1
6037031|NCT00677092|20864838|P1|Overall Study|Death Prior to Receiving Treatment|1
6037032|NCT00677092|20864838|P1|Overall Study|Withdrawal by Subject|3
6037033|NCT00677092|20864838|P1|Overall Study|Lost to Follow-up|1
6037034|NCT00677092|20864838|P1|Overall Study|Adverse Event|1
6037035|NCT00677014|20864855|P3|Overall Study|Unavailable or unreadable 6 month LVESV|18
6037036|NCT00677014|20864856|P2|Overall Study|Unavailable or unreadable 6 month LVESV|14
6037037|NCT00677014|20864857|P1|Overall Study|Unavailable or unreadable 6 month LVESV|18
6037038|NCT00677014|20864855|P3|Overall Study|Death|7
6037039|NCT00677014|20864856|P2|Overall Study|Death|15
6037040|NCT00677014|20864857|P1|Overall Study|Death|6
6037041|NCT00677014|20864855|P3|Overall Study|Lost to Follow-up|24
6037042|NCT00677014|20864856|P2|Overall Study|Lost to Follow-up|12
6037043|NCT00677014|20864857|P1|Overall Study|Lost to Follow-up|20
6037044|NCT00676715|20864910|P4|Overall Study|Participants Ongoing|24
6037045|NCT00676715|20864911|P3|Overall Study|Participants Ongoing|17
6037046|NCT00676715|20864912|P2|Overall Study|Participants Ongoing|29
6037047|NCT00676715|20864913|P1|Overall Study|Participants Ongoing|29
6037048|NCT00676715|20864910|P4|Overall Study|Adverse Event|0
6037049|NCT00676715|20864911|P3|Overall Study|Adverse Event|2
6037050|NCT00676715|20864912|P2|Overall Study|Adverse Event|1
6037051|NCT00676715|20864913|P1|Overall Study|Adverse Event|0
6037052|NCT00676715|20864910|P4|Overall Study|Death|0
6037053|NCT00676715|20864911|P3|Overall Study|Death|1
6037054|NCT00676715|20864912|P2|Overall Study|Death|1
6037055|NCT00676715|20864913|P1|Overall Study|Death|1
6037056|NCT00676715|20864910|P4|Overall Study|Lost to Follow-up|3
6037057|NCT00676715|20864911|P3|Overall Study|Lost to Follow-up|7
6037058|NCT00676715|20864912|P2|Overall Study|Lost to Follow-up|1
6037059|NCT00676715|20864913|P1|Overall Study|Lost to Follow-up|1
6037060|NCT00676715|20864910|P4|Overall Study|Other|3
6037061|NCT00676715|20864911|P3|Overall Study|Other|4
6037062|NCT00676715|20864912|P2|Overall Study|Other|6
6037063|NCT00676715|20864913|P1|Overall Study|Other|2
6037064|NCT00676715|20864910|P4|Overall Study|Withdrawal by Subject|10
6037065|NCT00676715|20864911|P3|Overall Study|Withdrawal by Subject|10
6037066|NCT00676715|20864912|P2|Overall Study|Withdrawal by Subject|9
6037067|NCT00676715|20864913|P1|Overall Study|Withdrawal by Subject|7
6037068|NCT00676689|20864943|P1|Overall Study|Continuing FU|49
6037069|NCT00676689|20864943|P1|Overall Study|Withdrawal by Subject|3
6037070|NCT00676689|20864943|P1|Overall Study|Physician Decision|1
6037071|NCT00676689|20864943|P1|Overall Study|Lost to Follow-up|4
6037072|NCT00676689|20864943|P1|Overall Study|Death|2
6037073|NCT00676689|20864943|P1|Overall Study|Screen Failure|2
6037074|NCT00676663|20864955|P2|Overall Study|Lost to Follow-up|3
6037075|NCT00676663|20864956|P1|Overall Study|Lost to Follow-up|1
6037076|NCT00676663|20864955|P2|Overall Study|Withdrew Consent|8
6037077|NCT00676663|20864956|P1|Overall Study|Withdrew Consent|1
6037078|NCT00676663|20864955|P2|Overall Study|Death|27
6037079|NCT00676663|20864956|P1|Overall Study|Death|43
6037080|NCT00676650|20864972|P2|Overall Study|Randomized but not treated|4
6037081|NCT00676650|20864973|P1|Overall Study|Randomized but not treated|3
6037082|NCT00676650|20864972|P2|Overall Study|Withdrawal by Subject|24
6037083|NCT00676650|20864973|P1|Overall Study|Withdrawal by Subject|48
6037084|NCT00676650|20864972|P2|Overall Study|Study terminated by sponsor|43
6037085|NCT00676650|20864973|P1|Overall Study|Study terminated by sponsor|57
6037086|NCT00676650|20864972|P2|Overall Study|Protocol Violation|1
6037087|NCT00676650|20864973|P1|Overall Study|Protocol Violation|3
6037088|NCT00676650|20864972|P2|Overall Study|Other|10
6037089|NCT00676650|20864973|P1|Overall Study|Other|14
6037090|NCT00676650|20864972|P2|Overall Study|Objective progression or relapse|140
6037091|NCT00676650|20864973|P1|Overall Study|Objective progression or relapse|189
6037092|NCT00676650|20864972|P2|Overall Study|Lost to Follow-up|1
6037093|NCT00676650|20864973|P1|Overall Study|Lost to Follow-up|0
6037094|NCT00676650|20864972|P2|Overall Study|Global deterioration of health status|31
6037095|NCT00676650|20864973|P1|Overall Study|Global deterioration of health status|66
6037096|NCT00676650|20864972|P2|Overall Study|Adverse Event|21
6037097|NCT00676650|20864973|P1|Overall Study|Adverse Event|159
6037098|NCT00676650|20864972|P2|Overall Study|Death|14
6037099|NCT00676650|20864973|P1|Overall Study|Death|45
6037100|NCT00676520|20865015|P1|Overall Study|Other Reason|18
6037101|NCT00676520|20865015|P1|Overall Study|Ineligible for Randomization to DAPT|209
6037102|NCT00676520|20865015|P1|Overall Study|Physician Decision|20
6037103|NCT00676520|20865015|P1|Overall Study|Death|159
6037104|NCT00676520|20865015|P1|Overall Study|Lost to Follow-up|162
6037105|NCT00676520|20865015|P1|Overall Study|Withdrawal by Subject|163
6037106|NCT00676494|20865072|P1|Overall Study|Withdrawal by Subject|6
6037107|NCT00676494|20865072|P1|Overall Study|Missed Visit|8
6037132|NCT00676338|20865237|P4|Overall Study|Lack of Efficacy-Loss of Glucose Control|3
6037133|NCT00676338|20865238|P3|Overall Study|Lack of Efficacy-Loss of Glucose Control|5
6037134|NCT00676338|20865239|P2|Overall Study|Lack of Efficacy-Loss of Glucose Control|3
6037135|NCT00676338|20865240|P1|Overall Study|Lack of Efficacy-Loss of Glucose Control|3
6037136|NCT00676338|20865237|P4|Overall Study|Entry Criteria Not Met|1
6037137|NCT00676338|20865238|P3|Overall Study|Entry Criteria Not Met|1
6037138|NCT00676338|20865239|P2|Overall Study|Entry Criteria Not Met|2
6037139|NCT00676338|20865240|P1|Overall Study|Entry Criteria Not Met|0
6037140|NCT00676338|20865237|P4|Overall Study|Withdrawal by Subject|6
6037141|NCT00676338|20865238|P3|Overall Study|Withdrawal by Subject|12
6037142|NCT00676338|20865239|P2|Overall Study|Withdrawal by Subject|9
6037143|NCT00676338|20865240|P1|Overall Study|Withdrawal by Subject|17
6037144|NCT00676338|20865237|P4|Overall Study|Protocol Violation|5
6037145|NCT00676338|20865238|P3|Overall Study|Protocol Violation|2
6037146|NCT00676338|20865239|P2|Overall Study|Protocol Violation|9
6037147|NCT00676338|20865240|P1|Overall Study|Protocol Violation|5
6037148|NCT00676338|20865237|P4|Overall Study|Physician Decision|3
6037149|NCT00676338|20865238|P3|Overall Study|Physician Decision|2
6037150|NCT00676338|20865239|P2|Overall Study|Physician Decision|3
6037151|NCT00676338|20865240|P1|Overall Study|Physician Decision|3
6037152|NCT00676338|20865237|P4|Overall Study|Lost to Follow-up|4
6037153|NCT00676338|20865238|P3|Overall Study|Lost to Follow-up|3
6037154|NCT00676338|20865239|P2|Overall Study|Lost to Follow-up|1
6037155|NCT00676338|20865240|P1|Overall Study|Lost to Follow-up|4
6037156|NCT00676338|20865237|P4|Overall Study|Adverse Event|1
6037157|NCT00676338|20865238|P3|Overall Study|Adverse Event|5
6037158|NCT00676338|20865239|P2|Overall Study|Adverse Event|6
6037159|NCT00676338|20865240|P1|Overall Study|Adverse Event|6
6037160|NCT00676208|20865292|P2|Overall Study|Incomplete data|4
6037161|NCT00676208|20865293|P1|Overall Study|Incomplete data|2
6037162|NCT00676208|20865292|P2|Overall Study|Lost to Follow-up|2
6037163|NCT00676208|20865293|P1|Overall Study|Lost to Follow-up|0
6037164|NCT00676195|20865301|P1|Overall Study|Physician Decision|1
6037165|NCT00676195|20865301|P1|Overall Study|Adverse Event|1
6037166|NCT00676195|20865301|P1|Overall Study|Lost to Follow-up|1
6037167|NCT00676143|20865326|P2|Overall Study|Vasogenic edema recurrence|3
6037168|NCT00676143|20865327|P1|Overall Study|Vasogenic edema recurrence|1
6037169|NCT00676143|20865326|P2|Overall Study|Participant participation unknown|4
6037170|NCT00676143|20865327|P1|Overall Study|Participant participation unknown|1
6037171|NCT00676143|20865326|P2|Overall Study|Other|20
6037172|NCT00676143|20865327|P1|Overall Study|Other|11
6037173|NCT00676143|20865326|P2|Overall Study|Loss of caregiver|3
6037174|NCT00676143|20865327|P1|Overall Study|Loss of caregiver|5
6037175|NCT00676143|20865326|P2|Overall Study|Failed to return|1
6037176|NCT00676143|20865327|P1|Overall Study|Failed to return|2
6037177|NCT00676143|20865326|P2|Overall Study|Discontinuation of study by sponsor|88
6037178|NCT00676143|20865327|P1|Overall Study|Discontinuation of study by sponsor|65
6037179|NCT00676143|20865326|P2|Overall Study|Withdrawal by Subject|42
6037180|NCT00676143|20865327|P1|Overall Study|Withdrawal by Subject|24
6037181|NCT00676143|20865326|P2|Overall Study|Protocol Violation|8
6037182|NCT00676143|20865327|P1|Overall Study|Protocol Violation|4
6037183|NCT00676143|20865326|P2|Overall Study|Physician Decision|8
6037184|NCT00676143|20865327|P1|Overall Study|Physician Decision|5
6037185|NCT00676143|20865326|P2|Overall Study|Lost to Follow-up|13
6037186|NCT00676143|20865327|P1|Overall Study|Lost to Follow-up|0
6037187|NCT00676143|20865326|P2|Overall Study|Lack of Efficacy|6
6037188|NCT00676143|20865327|P1|Overall Study|Lack of Efficacy|0
6037189|NCT00676143|20865326|P2|Overall Study|Death|4
6037190|NCT00676143|20865327|P1|Overall Study|Death|4
6037191|NCT00676143|20865326|P2|Overall Study|Adverse Event|60
6037192|NCT00676143|20865327|P1|Overall Study|Adverse Event|34
6037193|NCT00676130|20865367|P2|Overall Study|Withdrawal by Subject|1
6037194|NCT00676130|20865368|P1|Overall Study|Withdrawal by Subject|0
6037195|NCT00676130|20865367|P2|Overall Study|Found ineligible|2
6037196|NCT00676130|20865368|P1|Overall Study|Found ineligible|3
6037197|NCT00676130|20865367|P2|Overall Study|Lost to Follow-up|1
6037198|NCT00676130|20865368|P1|Overall Study|Lost to Follow-up|0
6037199|NCT00676091|20865378|P2|Toddler Dose|Parent or legal guardian request|0
6037200|NCT00676091|20865379|P1|Toddler Dose|Parent or legal guardian request|1
6037201|NCT00676091|20865378|P2|Toddler Dose|Failed to return|0
6037202|NCT00676091|20865379|P1|Toddler Dose|Failed to return|2
6037203|NCT00676091|20865378|P2|After Infant Series|Failed to return|1
6037204|NCT00676091|20865379|P1|After Infant Series|Failed to return|1
6037205|NCT00676091|20865378|P2|After Infant Series|Protocol Violation|1
6037206|NCT00676091|20865379|P1|After Infant Series|Protocol Violation|0
6037207|NCT00676091|20865378|P2|After Infant Series|Adverse Event|1
6037208|NCT00676091|20865379|P1|After Infant Series|Adverse Event|0
6037209|NCT00676091|20865378|P2|Infant Series|Died prior to receiving 7vPnC|1
6037210|NCT00676091|20865379|P1|Infant Series|Died prior to receiving 7vPnC|0
6037211|NCT00676091|20865378|P2|Infant Series|Lost to Follow-up|0
6037212|NCT00676091|20865379|P1|Infant Series|Lost to Follow-up|1
6037213|NCT00676091|20865378|P2|Infant Series|Failed to return|3
6037214|NCT00676091|20865379|P1|Infant Series|Failed to return|1
6037215|NCT00676091|20865378|P2|Infant Series|Adverse Event|3
6037216|NCT00676091|20865379|P1|Infant Series|Adverse Event|2
6037217|NCT00676091|20865378|P2|Infant Series|Protocol Violation|3
6037218|NCT00676091|20865379|P1|Infant Series|Protocol Violation|6
6037219|NCT00676091|20865378|P2|Infant Series|Parent or legal guardian request|8
6037220|NCT00676091|20865379|P1|Infant Series|Parent or legal guardian request|10
6037221|NCT00676052|20865436|P6|Overall Study|Withdrawal by Subject|0
6037222|NCT00676052|20865437|P5|Overall Study|Withdrawal by Subject|0
6037223|NCT00676052|20865438|P4|Overall Study|Withdrawal by Subject|0
6037224|NCT00676052|20865439|P3|Overall Study|Withdrawal by Subject|1
6037225|NCT00676052|20865440|P2|Overall Study|Withdrawal by Subject|0
6037226|NCT00676052|20865441|P1|Overall Study|Withdrawal by Subject|1
6037227|NCT00676052|20865436|P6|Overall Study|Physician Decision|1
6037228|NCT00676052|20865437|P5|Overall Study|Physician Decision|0
6037229|NCT00676052|20865438|P4|Overall Study|Physician Decision|0
6037230|NCT00676052|20865439|P3|Overall Study|Physician Decision|1
6037231|NCT00676052|20865440|P2|Overall Study|Physician Decision|1
6037232|NCT00676052|20865441|P1|Overall Study|Physician Decision|1
6037233|NCT00676052|20865436|P6|Overall Study|Lost to Follow-up|0
6037234|NCT00676052|20865437|P5|Overall Study|Lost to Follow-up|1
6037235|NCT00676052|20865438|P4|Overall Study|Lost to Follow-up|0
6037236|NCT00676052|20865439|P3|Overall Study|Lost to Follow-up|0
6037237|NCT00676052|20865440|P2|Overall Study|Lost to Follow-up|0
6037238|NCT00676052|20865441|P1|Overall Study|Lost to Follow-up|0
6037239|NCT00676052|20865436|P6|Overall Study|Protocol Violation|2
6037240|NCT00676052|20865437|P5|Overall Study|Protocol Violation|1
6037241|NCT00676052|20865438|P4|Overall Study|Protocol Violation|2
6037242|NCT00676052|20865439|P3|Overall Study|Protocol Violation|2
6037243|NCT00676052|20865440|P2|Overall Study|Protocol Violation|3
6037244|NCT00676052|20865441|P1|Overall Study|Protocol Violation|5
6037245|NCT00676052|20865436|P6|Overall Study|Lack of Efficacy|1
6037246|NCT00676052|20865437|P5|Overall Study|Lack of Efficacy|2
6037247|NCT00676052|20865438|P4|Overall Study|Lack of Efficacy|1
6037248|NCT00676052|20865439|P3|Overall Study|Lack of Efficacy|1
6037249|NCT00676052|20865440|P2|Overall Study|Lack of Efficacy|2
6037250|NCT00676052|20865441|P1|Overall Study|Lack of Efficacy|2
6037251|NCT00676052|20865436|P6|Overall Study|Adverse Event|2
6037252|NCT00676052|20865437|P5|Overall Study|Adverse Event|2
6037253|NCT00676052|20865438|P4|Overall Study|Adverse Event|2
6037254|NCT00676052|20865439|P3|Overall Study|Adverse Event|1
6037255|NCT00676052|20865440|P2|Overall Study|Adverse Event|1
6037256|NCT00676052|20865441|P1|Overall Study|Adverse Event|0
6037257|NCT00675948|20865511|P2|Overall Study|Patient feels unable to take medication|1
6037258|NCT00675948|20865512|P1|Overall Study|Patient feels unable to take medication|0
6037259|NCT00675948|20865511|P2|Overall Study|Patient unable to comply with diaries|0
6037260|NCT00675948|20865512|P1|Overall Study|Patient unable to comply with diaries|1
6037261|NCT00675948|20865511|P2|Overall Study|Patient died|0
6037262|NCT00675948|20865512|P1|Overall Study|Patient died|1
6037263|NCT00675948|20865511|P2|Overall Study|Sponsor decision|1
6037264|NCT00675948|20865512|P1|Overall Study|Sponsor decision|0
6037265|NCT00675948|20865511|P2|Overall Study|Pain under control|0
6037266|NCT00675948|20865512|P1|Overall Study|Pain under control|1
6037267|NCT00675948|20865511|P2|Overall Study|Protocol Violation|0
6037268|NCT00675948|20865512|P1|Overall Study|Protocol Violation|1
6037269|NCT00675948|20865511|P2|Overall Study|Lost to Follow-up|0
6037270|NCT00675948|20865512|P1|Overall Study|Lost to Follow-up|2
6037271|NCT00675948|20865511|P2|Overall Study|Withdrawal by Subject|0
6037272|NCT00675948|20865512|P1|Overall Study|Withdrawal by Subject|7
6037273|NCT00675948|20865511|P2|Overall Study|Lack of Efficacy|0
6037274|NCT00675948|20865512|P1|Overall Study|Lack of Efficacy|3
6037275|NCT00675948|20865511|P2|Overall Study|Adverse Event|1
6037276|NCT00675948|20865512|P1|Overall Study|Adverse Event|23
6037277|NCT00675766|20865575|P4|Overall Study|Lost to Follow-up|26
6037278|NCT00675766|20865576|P3|Overall Study|Lost to Follow-up|21
6037279|NCT00675766|20865577|P2|Overall Study|Lost to Follow-up|5
6037280|NCT00675766|20865578|P1|Overall Study|Lost to Follow-up|6
6037281|NCT00675597|20865588|P1|Overall Study|Withdrawal by Subject|3
6037282|NCT00675506|20865642|P2|Overall Study|Schedule conflict|1
6037283|NCT00675506|20865643|P1|Overall Study|Schedule conflict|0
6037284|NCT00675506|20865642|P2|Overall Study|Declined participation|0
6037285|NCT00675506|20865643|P1|Overall Study|Declined participation|1
6037286|NCT00675506|20865642|P2|Overall Study|Disclosed history of cancer|0
6037287|NCT00675506|20865643|P1|Overall Study|Disclosed history of cancer|1
6037288|NCT00675506|20865642|P2|Overall Study|Hypersensitivity Reaction|0
6037289|NCT00675506|20865643|P1|Overall Study|Hypersensitivity Reaction|1
6037290|NCT00675506|20865642|P2|Overall Study|Elevated IGF-1|0
6037291|NCT00675506|20865643|P1|Overall Study|Elevated IGF-1|2
6037292|NCT00675506|20865642|P2|Overall Study|Elevated IGF-1 prior to treatment|0
6037293|NCT00675506|20865643|P1|Overall Study|Elevated IGF-1 prior to treatment|1
6037294|NCT00675506|20865642|P2|Overall Study|Elevated fasting glucose|1
6037295|NCT00675506|20865643|P1|Overall Study|Elevated fasting glucose|2
6037296|NCT00675506|20865642|P2|Overall Study|Lost interest|5
6037297|NCT00675506|20865643|P1|Overall Study|Lost interest|3
6037298|NCT00675506|20865642|P2|Overall Study|Lost to Follow-up|5
6037299|NCT00675506|20865643|P1|Overall Study|Lost to Follow-up|1
6037300|NCT00675441|20865659|P1|Overall Study|Death|1
6037301|NCT00675441|20865659|P1|Overall Study|Withdrawal by Subject|2
6037302|NCT00675428|20865665|P2|Overall Study|Physician Decision|0
6037303|NCT00675428|20865666|P1|Overall Study|Physician Decision|1
6037304|NCT00675428|20865665|P2|Overall Study|No Disease Response After Cycle 6|1
6037305|NCT00675428|20865666|P1|Overall Study|No Disease Response After Cycle 6|0
6037306|NCT00675428|20865665|P2|Overall Study|Disease Progression|2
6037307|NCT00675428|20865666|P1|Overall Study|Disease Progression|2
6037308|NCT00675103|20865708|P1|Overall Study|Adverse Event|1
6037309|NCT00675103|20865708|P1|Overall Study|Lack of Efficacy|2
6037310|NCT00674986|20865715|P2|Overall Study|Other reasons|8
6037311|NCT00674986|20865716|P1|Overall Study|Other reasons|4
6037312|NCT00674986|20865715|P2|Overall Study|Lost to Follow-up|53
6037313|NCT00674986|20865716|P1|Overall Study|Lost to Follow-up|25
6037314|NCT00674986|20865715|P2|Overall Study|Subject withdrew consent|19
6037315|NCT00674986|20865716|P1|Overall Study|Subject withdrew consent|12
6037316|NCT00674986|20865715|P2|Overall Study|Adverse Event|1
6037317|NCT00674986|20865716|P1|Overall Study|Adverse Event|2
6037318|NCT00674973|20865737|P2|Overall Study|Protocol Violation|1
6037319|NCT00674973|20865738|P1|Overall Study|Protocol Violation|0
6037320|NCT00674973|20865737|P2|Overall Study|Death|15
6037321|NCT00674973|20865738|P1|Overall Study|Death|19
6037322|NCT00674973|20865737|P2|Overall Study|Adverse Event|9
6037323|NCT00674973|20865738|P1|Overall Study|Adverse Event|2
6037324|NCT00674973|20865737|P2|Overall Study|Failure to Return|0
6037325|NCT00674973|20865738|P1|Overall Study|Failure to Return|1
6037326|NCT00674973|20865737|P2|Overall Study|Refused Treatment|5
6037327|NCT00674973|20865738|P1|Overall Study|Refused Treatment|1
6037328|NCT00674973|20865737|P2|Overall Study|Insufficient Therapeutic Response|72
6037329|NCT00674973|20865738|P1|Overall Study|Insufficient Therapeutic Response|77
6037330|NCT00674817|20865752|P1|Period 4|Adverse Event|1
6037331|NCT00674817|20865752|P1|Period 3|Protocol Violation|1
6037332|NCT00674817|20865752|P1|Period 3|Adverse Event|1
6037333|NCT00674817|20865752|P1|Period 1|Protocol Violation|1
6037334|NCT00674817|20865752|P1|Period 1|Withdrawal by Subject|2
6037335|NCT00674700|20865929|P3|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|7
6037336|NCT00674700|20865930|P2|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|10
6037337|NCT00674700|20865931|P1|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|5
6037338|NCT00674700|20865929|P3|Year 2 Follow-up Without Treatment|Withdrawal by Subject|4
6037339|NCT00674700|20865930|P2|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1
6037340|NCT00674700|20865931|P1|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1
6037341|NCT00674700|20865929|P3|Year 2 Follow-up Without Treatment|Adverse Event|1
6037342|NCT00674700|20865930|P2|Year 2 Follow-up Without Treatment|Adverse Event|1
6037343|NCT00674700|20865931|P1|Year 2 Follow-up Without Treatment|Adverse Event|0
6037344|NCT00674700|20865929|P3|Year 1|Any other reason not above-mentioned|6
6037345|NCT00674700|20865930|P2|Year 1|Any other reason not above-mentioned|7
6037346|NCT00674700|20865931|P1|Year 1|Any other reason not above-mentioned|7
6037347|NCT00674700|20865929|P3|Year 1|Withdrawal by Subject|6
6037348|NCT00674700|20865930|P2|Year 1|Withdrawal by Subject|7
6037349|NCT00674700|20865931|P1|Year 1|Withdrawal by Subject|7
6037350|NCT00674700|20865929|P3|Year 1|Adverse Event|5
6037351|NCT00674700|20865930|P2|Year 1|Adverse Event|20
6037352|NCT00674700|20865931|P1|Year 1|Adverse Event|17
6037353|NCT00674661|20865944|P2|Overall Study|Withdrawal by Subject|5
6037354|NCT00674661|20865945|P1|Overall Study|Withdrawal by Subject|0
6037355|NCT00674661|20865944|P2|Overall Study|Lost to Follow-up|3
6037356|NCT00674661|20865945|P1|Overall Study|Lost to Follow-up|6
6037357|NCT00674661|20865944|P2|Overall Study|Other|7
6037358|NCT00674661|20865945|P1|Overall Study|Other|5
6037359|NCT00674570|20866043|P3|Overall Study|Withdrawal by Subject|0
6037360|NCT00674570|20866044|P2|Overall Study|Withdrawal by Subject|2
6037361|NCT00674570|20866045|P1|Overall Study|Withdrawal by Subject|0
6037362|NCT00674362|20866084|P2|Open Label|Other: Subject moved to extension study|0
6037363|NCT00674362|20866085|P1|Open Label|Other: Subject moved to extension study|1
6037364|NCT00674362|20866084|P2|Open Label|Adverse Event|0
6037365|NCT00674362|20866085|P1|Open Label|Adverse Event|1
6037366|NCT00674362|20866084|P2|Double Blind|Other: Surgery|1
6037367|NCT00674362|20866085|P1|Double Blind|Other: Surgery|0
6037368|NCT00674362|20866084|P2|Double Blind|Other: Loss of Patient Compliance|1
6037369|NCT00674362|20866085|P1|Double Blind|Other: Loss of Patient Compliance|0
6037370|NCT00674362|20866084|P2|Double Blind|Withdrawal by Subject|3
6037371|NCT00674362|20866085|P1|Double Blind|Withdrawal by Subject|4
6037372|NCT00674362|20866084|P2|Double Blind|Loss of efficacy|1
6037373|NCT00674362|20866085|P1|Double Blind|Loss of efficacy|0
6037374|NCT00674362|20866084|P2|Double Blind|Lack of Efficacy|6
6037375|NCT00674362|20866085|P1|Double Blind|Lack of Efficacy|2
6037376|NCT00674362|20866084|P2|Double Blind|Adverse Event|6
6037377|NCT00674362|20866085|P1|Double Blind|Adverse Event|6
6037378|NCT00674323|20866153|P3|Overall Study|Protocol Violation|0
6037379|NCT00674323|20866154|P2|Overall Study|Protocol Violation|0
6037380|NCT00674323|20866155|P1|Overall Study|Protocol Violation|1
6037381|NCT00674323|20866153|P3|Overall Study|Adverse Event|0
6037382|NCT00674323|20866154|P2|Overall Study|Adverse Event|1
6037383|NCT00674323|20866155|P1|Overall Study|Adverse Event|0
6037384|NCT00674154|20866206|P2|Overall Study|Did not want parathyroidectomy|2
6037385|NCT00674154|20866207|P1|Overall Study|Did not want parathyroidectomy|0
6037386|NCT00674154|20866206|P2|Overall Study|Withdrawal by Subject|1
6037387|NCT00674154|20866207|P1|Overall Study|Withdrawal by Subject|3
6037388|NCT00674128|20866215|P2|Overall Study|Withdrawal by Subject|23
6037389|NCT00674128|20866216|P1|Overall Study|Withdrawal by Subject|25
6037390|NCT00673933|20866241|P1|Overall Study|Lost to Follow-up|1
6037391|NCT00673933|20866241|P1|Overall Study|Withdrawal by Subject|2
6037392|NCT00673920|20866265|P8|Week 24 to Week 48|Adminstrative/Other|0
6037393|NCT00673920|20866266|P7|Week 24 to Week 48|Adminstrative/Other|0
6037394|NCT00673920|20866267|P6|Week 24 to Week 48|Adminstrative/Other|0
6037395|NCT00673920|20866268|P5|Week 24 to Week 48|Adminstrative/Other|0
6037396|NCT00673920|20866269|P4|Week 24 to Week 48|Adminstrative/Other|1
6037397|NCT00673920|20866270|P3|Week 24 to Week 48|Adminstrative/Other|0
6037398|NCT00673920|20866271|P2|Week 24 to Week 48|Adminstrative/Other|0
6037399|NCT00673920|20866272|P1|Week 24 to Week 48|Adminstrative/Other|0
6037400|NCT00673920|20866265|P8|Week 24 to Week 48|Death|0
6037401|NCT00673920|20866266|P7|Week 24 to Week 48|Death|0
6037402|NCT00673920|20866267|P6|Week 24 to Week 48|Death|1
6037403|NCT00673920|20866268|P5|Week 24 to Week 48|Death|0
6037404|NCT00673920|20866269|P4|Week 24 to Week 48|Death|0
6037405|NCT00673920|20866270|P3|Week 24 to Week 48|Death|0
6037406|NCT00673920|20866271|P2|Week 24 to Week 48|Death|0
6037407|NCT00673920|20866272|P1|Week 24 to Week 48|Death|0
6037408|NCT00673920|20866265|P8|Week 24 to Week 48|Insufficient therapeutic response|0
6037409|NCT00673920|20866266|P7|Week 24 to Week 48|Insufficient therapeutic response|0
6037410|NCT00673920|20866267|P6|Week 24 to Week 48|Insufficient therapeutic response|1
6037411|NCT00673920|20866268|P5|Week 24 to Week 48|Insufficient therapeutic response|0
6037412|NCT00673920|20866269|P4|Week 24 to Week 48|Insufficient therapeutic response|0
6037413|NCT00673920|20866270|P3|Week 24 to Week 48|Insufficient therapeutic response|0
6037414|NCT00673920|20866271|P2|Week 24 to Week 48|Insufficient therapeutic response|0
6037415|NCT00673920|20866272|P1|Week 24 to Week 48|Insufficient therapeutic response|0
6037416|NCT00673920|20866265|P8|Week 24 to Week 48|Failure to return|0
6037417|NCT00673920|20866266|P7|Week 24 to Week 48|Failure to return|0
6037418|NCT00673920|20866267|P6|Week 24 to Week 48|Failure to return|1
6037419|NCT00673920|20866268|P5|Week 24 to Week 48|Failure to return|0
6037420|NCT00673920|20866269|P4|Week 24 to Week 48|Failure to return|0
6037421|NCT00673920|20866270|P3|Week 24 to Week 48|Failure to return|0
6037422|NCT00673920|20866271|P2|Week 24 to Week 48|Failure to return|0
6037423|NCT00673920|20866272|P1|Week 24 to Week 48|Failure to return|0
6037424|NCT00673920|20866265|P8|Week 24 to Week 48|Adverse event/intercurrent illness|0
6037425|NCT00673920|20866266|P7|Week 24 to Week 48|Adverse event/intercurrent illness|1
6037426|NCT00673920|20866267|P6|Week 24 to Week 48|Adverse event/intercurrent illness|0
6037427|NCT00673920|20866268|P5|Week 24 to Week 48|Adverse event/intercurrent illness|0
6037428|NCT00673920|20866269|P4|Week 24 to Week 48|Adverse event/intercurrent illness|0
6037429|NCT00673920|20866270|P3|Week 24 to Week 48|Adverse event/intercurrent illness|0
6037430|NCT00673920|20866271|P2|Week 24 to Week 48|Adverse event/intercurrent illness|0
6037431|NCT00673920|20866272|P1|Week 24 to Week 48|Adverse event/intercurrent illness|0
6037432|NCT00673920|20866265|P8|Baseline up to Week 48|Adverse event/intercurrent illness|0
6037433|NCT00673920|20866266|P7|Baseline up to Week 48|Adverse event/intercurrent illness|0
6037434|NCT00673920|20866267|P6|Baseline up to Week 48|Adverse event/intercurrent illness|0
6037435|NCT00673920|20866268|P5|Baseline up to Week 48|Adverse event/intercurrent illness|0
6037436|NCT00673920|20866269|P4|Baseline up to Week 48|Adverse event/intercurrent illness|0
6037437|NCT00673920|20866270|P3|Baseline up to Week 48|Adverse event/intercurrent illness|1
6037438|NCT00673920|20866271|P2|Baseline up to Week 48|Adverse event/intercurrent illness|1
6037439|NCT00673920|20866272|P1|Baseline up to Week 48|Adverse event/intercurrent illness|0
6037440|NCT00673920|20866265|P8|Baseline up to Week 48|Administrative/Other|0
6037441|NCT00673920|20866266|P7|Baseline up to Week 48|Administrative/Other|0
6037442|NCT00673920|20866267|P6|Baseline up to Week 48|Administrative/Other|0
6037443|NCT00673920|20866268|P5|Baseline up to Week 48|Administrative/Other|0
6037444|NCT00673920|20866269|P4|Baseline up to Week 48|Administrative/Other|0
6037445|NCT00673920|20866270|P3|Baseline up to Week 48|Administrative/Other|2
6037446|NCT00673920|20866271|P2|Baseline up to Week 48|Administrative/Other|1
6037447|NCT00673920|20866272|P1|Baseline up to Week 48|Administrative/Other|0
6037448|NCT00673920|20866265|P8|Baseline up to Week 48|Violation of selection criteria at entry|0
6037449|NCT00673920|20866266|P7|Baseline up to Week 48|Violation of selection criteria at entry|0
6037450|NCT00673920|20866267|P6|Baseline up to Week 48|Violation of selection criteria at entry|0
6037451|NCT00673920|20866268|P5|Baseline up to Week 48|Violation of selection criteria at entry|0
6037452|NCT00673920|20866269|P4|Baseline up to Week 48|Violation of selection criteria at entry|0
6037453|NCT00673920|20866270|P3|Baseline up to Week 48|Violation of selection criteria at entry|1
6037454|NCT00673920|20866271|P2|Baseline up to Week 48|Violation of selection criteria at entry|0
6037455|NCT00673920|20866272|P1|Baseline up to Week 48|Violation of selection criteria at entry|0
6037456|NCT00673920|20866265|P8|Baseline up to Week 48|Protocol Violation|0
6037457|NCT00673920|20866266|P7|Baseline up to Week 48|Protocol Violation|0
6037458|NCT00673920|20866267|P6|Baseline up to Week 48|Protocol Violation|0
6037459|NCT00673920|20866268|P5|Baseline up to Week 48|Protocol Violation|0
6037460|NCT00673920|20866269|P4|Baseline up to Week 48|Protocol Violation|0
6037461|NCT00673920|20866270|P3|Baseline up to Week 48|Protocol Violation|1
6037462|NCT00673920|20866271|P2|Baseline up to Week 48|Protocol Violation|0
6037463|NCT00673920|20866272|P1|Baseline up to Week 48|Protocol Violation|0
6037464|NCT00673920|20866265|P8|Baseline up to Week 48|Insufficient therapeutic response|0
6037465|NCT00673920|20866266|P7|Baseline up to Week 48|Insufficient therapeutic response|0
6037466|NCT00673920|20866267|P6|Baseline up to Week 48|Insufficient therapeutic response|0
6037467|NCT00673920|20866268|P5|Baseline up to Week 48|Insufficient therapeutic response|0
6037468|NCT00673920|20866269|P4|Baseline up to Week 48|Insufficient therapeutic response|0
6037469|NCT00673920|20866270|P3|Baseline up to Week 48|Insufficient therapeutic response|0
6037470|NCT00673920|20866271|P2|Baseline up to Week 48|Insufficient therapeutic response|1
6037471|NCT00673920|20866272|P1|Baseline up to Week 48|Insufficient therapeutic response|2
6037472|NCT00673920|20866265|P8|Baseline up to Week 48|Refused treatment|0
6037473|NCT00673920|20866266|P7|Baseline up to Week 48|Refused treatment|0
6037474|NCT00673920|20866267|P6|Baseline up to Week 48|Refused treatment|0
6037475|NCT00673920|20866268|P5|Baseline up to Week 48|Refused treatment|0
6037476|NCT00673920|20866269|P4|Baseline up to Week 48|Refused treatment|0
6037477|NCT00673920|20866270|P3|Baseline up to Week 48|Refused treatment|0
6037478|NCT00673920|20866271|P2|Baseline up to Week 48|Refused treatment|0
6037479|NCT00673920|20866272|P1|Baseline up to Week 48|Refused treatment|1
6037480|NCT00673920|20866265|P8|Baseline up to Week 48|Withdrew consent|0
6037481|NCT00673920|20866266|P7|Baseline up to Week 48|Withdrew consent|0
6037482|NCT00673920|20866267|P6|Baseline up to Week 48|Withdrew consent|0
6037483|NCT00673920|20866268|P5|Baseline up to Week 48|Withdrew consent|0
6037484|NCT00673920|20866269|P4|Baseline up to Week 48|Withdrew consent|0
6037485|NCT00673920|20866270|P3|Baseline up to Week 48|Withdrew consent|2
6037486|NCT00673920|20866271|P2|Baseline up to Week 48|Withdrew consent|0
6037487|NCT00673920|20866272|P1|Baseline up to Week 48|Withdrew consent|1
6037488|NCT00673894|20866418|P2|First Intervention 4 Weeks|Adverse Event|0
6037489|NCT00673894|20866419|P1|First Intervention 4 Weeks|Adverse Event|1
6037490|NCT00673894|20866418|P2|First Intervention 4 Weeks|Withdrawal by Subject|0
6037491|NCT00673894|20866419|P1|First Intervention 4 Weeks|Withdrawal by Subject|1
6037492|NCT00673881|20866427|P1|Overall Study|Withdrawal by Subject|1
6037493|NCT00673816|20866441|P1|Overall Study|Withdrawal by Subject|1
6037494|NCT00673816|20866441|P1|Overall Study|Adverse Event|1
6037495|NCT00673790|20866451|P3|Overall Study|Randomization criteria not met|0
6037496|NCT00673790|20866452|P2|Overall Study|Randomization criteria not met|1
6037497|NCT00673790|20866453|P1|Overall Study|Randomization criteria not met|0
6037498|NCT00673790|20866451|P3|Overall Study|Unconfirmed pregnancy|0
6037499|NCT00673790|20866452|P2|Overall Study|Unconfirmed pregnancy|1
6037500|NCT00673790|20866453|P1|Overall Study|Unconfirmed pregnancy|0
6037501|NCT00673790|20866451|P3|Overall Study|Participated in two Nebivolol studies|1
6037502|NCT00673790|20866452|P2|Overall Study|Participated in two Nebivolol studies|0
6037503|NCT00673790|20866453|P1|Overall Study|Participated in two Nebivolol studies|0
6037504|NCT00673790|20866451|P3|Overall Study|Poor compliance|0
6037505|NCT00673790|20866452|P2|Overall Study|Poor compliance|0
6037506|NCT00673790|20866453|P1|Overall Study|Poor compliance|1
6037507|NCT00673790|20866451|P3|Overall Study|Sponsor Terminated due to PI oversight|0
6037508|NCT00673790|20866452|P2|Overall Study|Sponsor Terminated due to PI oversight|1
6037509|NCT00673790|20866453|P1|Overall Study|Sponsor Terminated due to PI oversight|0
6037510|NCT00673790|20866451|P3|Overall Study|Lost to Follow-up|5
6037511|NCT00673790|20866452|P2|Overall Study|Lost to Follow-up|6
6037512|NCT00673790|20866453|P1|Overall Study|Lost to Follow-up|6
6037513|NCT00673790|20866451|P3|Overall Study|Withdrawal by Subject|1
6037514|NCT00673790|20866452|P2|Overall Study|Withdrawal by Subject|4
6037515|NCT00673790|20866453|P1|Overall Study|Withdrawal by Subject|7
6037516|NCT00673790|20866451|P3|Overall Study|Protocol Violation|1
6037517|NCT00673790|20866452|P2|Overall Study|Protocol Violation|9
6037518|NCT00673790|20866453|P1|Overall Study|Protocol Violation|6
6037519|NCT00673790|20866451|P3|Overall Study|Lack of Efficacy|2
6037520|NCT00673790|20866452|P2|Overall Study|Lack of Efficacy|2
6037521|NCT00673790|20866453|P1|Overall Study|Lack of Efficacy|2
6037522|NCT00673790|20866451|P3|Overall Study|Adverse Event|2
6037523|NCT00673790|20866452|P2|Overall Study|Adverse Event|14
6037524|NCT00673790|20866453|P1|Overall Study|Adverse Event|23
6037525|NCT00673673|20866491|P1|Overall Study|Investigators' discretion|2
6037526|NCT00673673|20866491|P1|Overall Study|Withdrawal by Subject|3
6037527|NCT00673673|20866491|P1|Overall Study|Adverse Event|4
6037528|NCT00673673|20866491|P1|Overall Study|Progressive disease|27
6037530|NCT00673465|20866519|P12|Part 1/Period 2 (United States)|Protocol Violation|0
6037531|NCT00673465|20866520|P11|Part 1/Period 2 (United States)|Protocol Violation|0
6037532|NCT00673465|20866521|P10|Part 1/Period 2 (United States)|Protocol Violation|0
6037533|NCT00673465|20866522|P9|Part 1/Period 2 (United States)|Protocol Violation|0
6037534|NCT00673465|20866523|P8|Part 1/Period 2 (United States)|Protocol Violation|0
6037535|NCT00673465|20866524|P7|Part 1/Period 2 (United States)|Protocol Violation|0
6037536|NCT00673465|20866525|P6|Part 1/Period 2 (United States)|Protocol Violation|0
6037537|NCT00673465|20866526|P5|Part 1/Period 2 (United States)|Protocol Violation|1
6037538|NCT00673465|20866527|P4|Part 1/Period 2 (United States)|Protocol Violation|0
6037539|NCT00673465|20866528|P3|Part 1/Period 2 (United States)|Protocol Violation|0
6037540|NCT00673465|20866529|P2|Part 1/Period 2 (United States)|Protocol Violation|0
6037541|NCT00673465|20866530|P1|Part 1/Period 2 (United States)|Protocol Violation|0
6037542|NCT00673465|20866519|P12|Part 1/Period 1 (United States)|Protocol Violation|0
6037543|NCT00673465|20866520|P11|Part 1/Period 1 (United States)|Protocol Violation|0
6037544|NCT00673465|20866521|P10|Part 1/Period 1 (United States)|Protocol Violation|0
6037545|NCT00673465|20866522|P9|Part 1/Period 1 (United States)|Protocol Violation|0
6037546|NCT00673465|20866523|P8|Part 1/Period 1 (United States)|Protocol Violation|0
6037547|NCT00673465|20866524|P7|Part 1/Period 1 (United States)|Protocol Violation|0
6037548|NCT00673465|20866525|P6|Part 1/Period 1 (United States)|Protocol Violation|1
6037549|NCT00673465|20866526|P5|Part 1/Period 1 (United States)|Protocol Violation|1
6037550|NCT00673465|20866527|P4|Part 1/Period 1 (United States)|Protocol Violation|0
6037551|NCT00673465|20866528|P3|Part 1/Period 1 (United States)|Protocol Violation|0
6037552|NCT00673465|20866529|P2|Part 1/Period 1 (United States)|Protocol Violation|0
6037553|NCT00673465|20866530|P1|Part 1/Period 1 (United States)|Protocol Violation|0
6037554|NCT00673452|20866579|P2|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|0
6037555|NCT00673452|20866580|P1|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|1
6037556|NCT00673452|20866579|P2|Continuation Double-Blind Phase|Physician Decision|0
6037557|NCT00673452|20866580|P1|Continuation Double-Blind Phase|Physician Decision|2
6037558|NCT00673452|20866579|P2|Continuation Double-Blind Phase|Sponsor Decision|3
6037559|NCT00673452|20866580|P1|Continuation Double-Blind Phase|Sponsor Decision|0
6037560|NCT00673452|20866579|P2|Continuation Double-Blind Phase|Protocol Violation|3
6037561|NCT00673452|20866580|P1|Continuation Double-Blind Phase|Protocol Violation|2
6037562|NCT00673452|20866579|P2|Continuation Double-Blind Phase|Lack of Efficacy|5
6037563|NCT00673452|20866580|P1|Continuation Double-Blind Phase|Lack of Efficacy|2
6037564|NCT00673452|20866579|P2|Continuation Double-Blind Phase|Lost to Follow-up|5
6037565|NCT00673452|20866580|P1|Continuation Double-Blind Phase|Lost to Follow-up|4
6037566|NCT00673452|20866579|P2|Continuation Double-Blind Phase|Withdrawal by Subject|5
6037567|NCT00673452|20866580|P1|Continuation Double-Blind Phase|Withdrawal by Subject|9
6037568|NCT00673452|20866579|P2|Continuation Double-Blind Phase|Adverse Event|13
6037569|NCT00673452|20866580|P1|Continuation Double-Blind Phase|Adverse Event|5
6037570|NCT00673452|20866579|P2|Acute Double-Blind Phase|Withdrawal by Subject|13
6037571|NCT00673452|20866580|P1|Acute Double-Blind Phase|Withdrawal by Subject|16
6037572|NCT00673452|20866579|P2|Acute Double-Blind Phase|Sponsor Decision|1
6037573|NCT00673452|20866580|P1|Acute Double-Blind Phase|Sponsor Decision|0
6037574|NCT00673452|20866579|P2|Acute Double-Blind Phase|Protocol Violation|3
6037575|NCT00673452|20866580|P1|Acute Double-Blind Phase|Protocol Violation|5
6037576|NCT00673452|20866579|P2|Acute Double-Blind Phase|Physician Decision|6
6037577|NCT00673452|20866580|P1|Acute Double-Blind Phase|Physician Decision|0
6037578|NCT00673452|20866579|P2|Acute Double-Blind Phase|Lost to Follow-up|19
6037579|NCT00673452|20866580|P1|Acute Double-Blind Phase|Lost to Follow-up|16
6037580|NCT00673452|20866579|P2|Acute Double-Blind Phase|Lack of Efficacy|14
6037581|NCT00673452|20866580|P1|Acute Double-Blind Phase|Lack of Efficacy|9
6037582|NCT00673452|20866579|P2|Acute Double-Blind Phase|Adverse Event|24
6037583|NCT00673452|20866580|P1|Acute Double-Blind Phase|Adverse Event|41
6037584|NCT00673387|20866644|P8|Overall Study|Lost to Follow-up|5
6037585|NCT00673387|20866645|P7|Overall Study|Lost to Follow-up|8
6037586|NCT00673387|20866646|P6|Overall Study|Lost to Follow-up|5
6037587|NCT00673387|20866647|P5|Overall Study|Lost to Follow-up|6
6037588|NCT00673387|20866648|P4|Overall Study|Lost to Follow-up|6
6037589|NCT00673387|20866649|P3|Overall Study|Lost to Follow-up|5
6037590|NCT00673387|20866650|P2|Overall Study|Lost to Follow-up|6
6037591|NCT00673387|20866651|P1|Overall Study|Lost to Follow-up|8
6037592|NCT00673387|20866644|P8|Overall Study|Protocol Violation|3
6037593|NCT00673387|20866645|P7|Overall Study|Protocol Violation|1
6037594|NCT00673387|20866646|P6|Overall Study|Protocol Violation|1
6037595|NCT00673387|20866647|P5|Overall Study|Protocol Violation|0
6037596|NCT00673387|20866648|P4|Overall Study|Protocol Violation|2
6037597|NCT00673387|20866649|P3|Overall Study|Protocol Violation|1
6037598|NCT00673387|20866650|P2|Overall Study|Protocol Violation|0
6037599|NCT00673387|20866651|P1|Overall Study|Protocol Violation|3
6037600|NCT00673387|20866644|P8|Overall Study|Physician Decision|1
6037601|NCT00673387|20866645|P7|Overall Study|Physician Decision|1
6037602|NCT00673387|20866646|P6|Overall Study|Physician Decision|5
6037603|NCT00673387|20866647|P5|Overall Study|Physician Decision|0
6037604|NCT00673387|20866648|P4|Overall Study|Physician Decision|0
6037605|NCT00673387|20866649|P3|Overall Study|Physician Decision|0
6037606|NCT00673387|20866650|P2|Overall Study|Physician Decision|0
6037607|NCT00673387|20866651|P1|Overall Study|Physician Decision|0
6037608|NCT00673387|20866644|P8|Overall Study|Adverse Event|5
6037609|NCT00673387|20866645|P7|Overall Study|Adverse Event|5
6037610|NCT00673387|20866646|P6|Overall Study|Adverse Event|2
6037611|NCT00673387|20866647|P5|Overall Study|Adverse Event|6
6037612|NCT00673387|20866648|P4|Overall Study|Adverse Event|2
6037613|NCT00673387|20866649|P3|Overall Study|Adverse Event|5
6037614|NCT00673387|20866650|P2|Overall Study|Adverse Event|1
6037615|NCT00673387|20866651|P1|Overall Study|Adverse Event|3
6037616|NCT00673387|20866644|P8|Overall Study|Withdrawal by Subject|21
6037617|NCT00673387|20866645|P7|Overall Study|Withdrawal by Subject|15
6037618|NCT00673387|20866646|P6|Overall Study|Withdrawal by Subject|21
6037619|NCT00673387|20866647|P5|Overall Study|Withdrawal by Subject|18
6037620|NCT00673387|20866648|P4|Overall Study|Withdrawal by Subject|16
6037621|NCT00673387|20866649|P3|Overall Study|Withdrawal by Subject|20
6037622|NCT00673387|20866650|P2|Overall Study|Withdrawal by Subject|16
6037623|NCT00673387|20866651|P1|Overall Study|Withdrawal by Subject|15
6037624|NCT00673361|20866867|P1|Overall Study|Screen Failure|2
6037625|NCT00673257|20866903|P1|Overall Study|Unable to obtain specimen|1
6037626|NCT00673257|20866903|P1|Overall Study|Withdrawal by Subject|4
6037627|NCT00673231|20866921|P4|Overall Study|Study criteria,compliance,safety, other|4
6037628|NCT00673231|20866922|P3|Overall Study|Study criteria,compliance,safety, other|7
6037629|NCT00673231|20866923|P2|Overall Study|Study criteria,compliance,safety, other|5
6037630|NCT00673231|20866924|P1|Overall Study|Study criteria,compliance,safety, other|8
6037631|NCT00673231|20866921|P4|Overall Study|Death|0
6037632|NCT00673231|20866922|P3|Overall Study|Death|1
6037633|NCT00673231|20866923|P2|Overall Study|Death|0
6037634|NCT00673231|20866924|P1|Overall Study|Death|0
6037635|NCT00673231|20866921|P4|Overall Study|Lost to Follow-up|2
6037636|NCT00673231|20866922|P3|Overall Study|Lost to Follow-up|1
6037637|NCT00673231|20866923|P2|Overall Study|Lost to Follow-up|2
6037638|NCT00673231|20866924|P1|Overall Study|Lost to Follow-up|1
6037639|NCT00673231|20866921|P4|Overall Study|Adverse Event|6
6037640|NCT00673231|20866922|P3|Overall Study|Adverse Event|9
6037641|NCT00673231|20866923|P2|Overall Study|Adverse Event|5
6037642|NCT00673231|20866924|P1|Overall Study|Adverse Event|6
6037643|NCT00673231|20866921|P4|Overall Study|Withdrawal by Subject|6
6037644|NCT00673231|20866922|P3|Overall Study|Withdrawal by Subject|8
6037645|NCT00673231|20866923|P2|Overall Study|Withdrawal by Subject|10
6037646|NCT00673231|20866924|P1|Overall Study|Withdrawal by Subject|14
6037647|NCT00673179|20866956|P2|Overall Study|Toxicity/Complications|0
6037648|NCT00673179|20866957|P1|Overall Study|Toxicity/Complications|3
6037649|NCT00673049|20867006|P4|After Progression on Erlotinib|study terminated by sponsor|4
6037650|NCT00673049|20867007|P3|After Progression on Erlotinib|study terminated by sponsor|0
6037651|NCT00673049|20867008|P2|After Progression on Erlotinib|study terminated by sponsor|0
6037652|NCT00673049|20867009|P1|After Progression on Erlotinib|study terminated by sponsor|0
6037653|NCT00673049|20867006|P4|After Progression on Erlotinib|Withdrawal by Subject|5
6037654|NCT00673049|20867007|P3|After Progression on Erlotinib|Withdrawal by Subject|0
6037655|NCT00673049|20867008|P2|After Progression on Erlotinib|Withdrawal by Subject|0
6037656|NCT00673049|20867009|P1|After Progression on Erlotinib|Withdrawal by Subject|0
6037657|NCT00673049|20867006|P4|After Progression on Erlotinib|Lost to Follow-up|3
6037658|NCT00673049|20867007|P3|After Progression on Erlotinib|Lost to Follow-up|0
6037659|NCT00673049|20867008|P2|After Progression on Erlotinib|Lost to Follow-up|0
6037660|NCT00673049|20867009|P1|After Progression on Erlotinib|Lost to Follow-up|0
6037661|NCT00673049|20867006|P4|After Progression on Erlotinib|Death|71
6037662|NCT00673049|20867007|P3|After Progression on Erlotinib|Death|0
6037663|NCT00673049|20867008|P2|After Progression on Erlotinib|Death|0
6037664|NCT00673049|20867009|P1|After Progression on Erlotinib|Death|0
6037665|NCT00673049|20867006|P4|Before Progression on Erlotinib|Switched to figitumumab|0
6037666|NCT00673049|20867007|P3|Before Progression on Erlotinib|Switched to figitumumab|0
6037667|NCT00673049|20867008|P2|Before Progression on Erlotinib|Switched to figitumumab|83
6037668|NCT00673049|20867009|P1|Before Progression on Erlotinib|Switched to figitumumab|0
6037669|NCT00673049|20867006|P4|Before Progression on Erlotinib|study terminated by sponsor|0
6037670|NCT00673049|20867007|P3|Before Progression on Erlotinib|study terminated by sponsor|0
6037671|NCT00673049|20867008|P2|Before Progression on Erlotinib|study terminated by sponsor|14
6037672|NCT00673049|20867009|P1|Before Progression on Erlotinib|study terminated by sponsor|18
6037673|NCT00673049|20867006|P4|Before Progression on Erlotinib|Other|0
6037674|NCT00673049|20867007|P3|Before Progression on Erlotinib|Other|0
6037675|NCT00673049|20867008|P2|Before Progression on Erlotinib|Other|2
6037676|NCT00673049|20867009|P1|Before Progression on Erlotinib|Other|1
6037677|NCT00673049|20867006|P4|Before Progression on Erlotinib|Withdrawal by Subject|0
6037678|NCT00673049|20867007|P3|Before Progression on Erlotinib|Withdrawal by Subject|0
6037679|NCT00673049|20867008|P2|Before Progression on Erlotinib|Withdrawal by Subject|18
6037680|NCT00673049|20867009|P1|Before Progression on Erlotinib|Withdrawal by Subject|26
6037681|NCT00673049|20867006|P4|Before Progression on Erlotinib|Lost to Follow-up|0
6037682|NCT00673049|20867007|P3|Before Progression on Erlotinib|Lost to Follow-up|0
6037683|NCT00673049|20867008|P2|Before Progression on Erlotinib|Lost to Follow-up|5
6037684|NCT00673049|20867009|P1|Before Progression on Erlotinib|Lost to Follow-up|9
6037685|NCT00673049|20867006|P4|Before Progression on Erlotinib|Death|0
6037686|NCT00673049|20867007|P3|Before Progression on Erlotinib|Death|1
6037687|NCT00673049|20867008|P2|Before Progression on Erlotinib|Death|167
6037688|NCT00673049|20867009|P1|Before Progression on Erlotinib|Death|235
6037689|NCT00673049|20867006|P4|Before Progression on Erlotinib|Randomized but not treated|0
6037690|NCT00673049|20867007|P3|Before Progression on Erlotinib|Randomized but not treated|0
6037691|NCT00673049|20867008|P2|Before Progression on Erlotinib|Randomized but not treated|1
6037692|NCT00673049|20867009|P1|Before Progression on Erlotinib|Randomized but not treated|3
6037693|NCT00672984|20867033|P3|Third Intervention|Adverse Event|1
6037694|NCT00672984|20867034|P2|Third Intervention|Adverse Event|0
6037695|NCT00672984|20867035|P1|Third Intervention|Adverse Event|1
6037696|NCT00672984|20867033|P3|Second Intervention|Protocol Violation|1
6037697|NCT00672984|20867034|P2|Second Intervention|Protocol Violation|1
6037698|NCT00672984|20867035|P1|Second Intervention|Protocol Violation|0
6037699|NCT00672984|20867033|P3|Second Intervention|Withdrawal by Subject|0
6037700|NCT00672984|20867034|P2|Second Intervention|Withdrawal by Subject|3
6037701|NCT00672984|20867035|P1|Second Intervention|Withdrawal by Subject|0
6037702|NCT00672984|20867033|P3|Second Intervention|Non-compliance with facility policies|0
6037703|NCT00672984|20867034|P2|Second Intervention|Non-compliance with facility policies|2
6037704|NCT00672984|20867035|P1|Second Intervention|Non-compliance with facility policies|0
6037705|NCT00672984|20867033|P3|First Intervention|Sponsor decision|0
6037706|NCT00672984|20867034|P2|First Intervention|Sponsor decision|0
6037707|NCT00672984|20867035|P1|First Intervention|Sponsor decision|3
6037708|NCT00672984|20867033|P3|First Intervention|Withdrawal by Subject|2
6037709|NCT00672984|20867034|P2|First Intervention|Withdrawal by Subject|2
6037710|NCT00672984|20867035|P1|First Intervention|Withdrawal by Subject|1
6037711|NCT00672984|20867033|P3|First Intervention|Adverse Event|0
6037712|NCT00672984|20867034|P2|First Intervention|Adverse Event|0
6037713|NCT00672984|20867035|P1|First Intervention|Adverse Event|5
6037714|NCT00672958|20867086|P2|Overall Study|Reason not specified|3
6037715|NCT00672958|20867087|P1|Overall Study|Reason not specified|0
6037716|NCT00672958|20867086|P2|Overall Study|Lost to Follow-up|17
6037717|NCT00672958|20867087|P1|Overall Study|Lost to Follow-up|22
6037718|NCT00672958|20867086|P2|Overall Study|Voluntary withdrawal|8
6037719|NCT00672958|20867087|P1|Overall Study|Voluntary withdrawal|12
6037720|NCT00672958|20867086|P2|Overall Study|Protocol deviations|5
6037721|NCT00672958|20867087|P1|Overall Study|Protocol deviations|11
6037722|NCT00672958|20867086|P2|Overall Study|Non-compliance with study drug|3
6037723|NCT00672958|20867087|P1|Overall Study|Non-compliance with study drug|2
6037724|NCT00672958|20867086|P2|Overall Study|Lack of Efficacy|11
6037725|NCT00672958|20867087|P1|Overall Study|Lack of Efficacy|6
6037726|NCT00672958|20867086|P2|Overall Study|Adverse Event|9
6037727|NCT00672958|20867087|P1|Overall Study|Adverse Event|11
6037728|NCT00672841|20867153|P2|Overall Study|Pregnancy|1
6037729|NCT00672841|20867154|P1|Overall Study|Pregnancy|0
6037730|NCT00672841|20867153|P2|Overall Study|Adverse Event|3
6037731|NCT00672841|20867154|P1|Overall Study|Adverse Event|0
6037732|NCT00672841|20867153|P2|Overall Study|Antifungal therapy, negative glucan|4
6037733|NCT00672841|20867154|P1|Overall Study|Antifungal therapy, negative glucan|0
6037734|NCT00672841|20867153|P2|Overall Study|icteric specimens|3
6037735|NCT00672841|20867154|P1|Overall Study|icteric specimens|0
6037736|NCT00672841|20867153|P2|Overall Study|Comfort care|4
6037737|NCT00672841|20867154|P1|Overall Study|Comfort care|1
6037738|NCT00672646|20867176|P3|Overall Study|Withdrawal by Subject|1
6037739|NCT00672646|20867177|P2|Overall Study|Withdrawal by Subject|0
6037740|NCT00672646|20867178|P1|Overall Study|Withdrawal by Subject|0
6037741|NCT00672646|20867176|P3|Overall Study|Lost to Follow-up|2
6037742|NCT00672646|20867177|P2|Overall Study|Lost to Follow-up|1
6037743|NCT00672646|20867178|P1|Overall Study|Lost to Follow-up|0
6037744|NCT00672633|20867203|P2|Overall Study|Withdrawal by Subject|1
6037745|NCT00672633|20867204|P1|Overall Study|Withdrawal by Subject|0
6037746|NCT00672620|20867218|P4|Overall Study|Reason not Specified|1
6037747|NCT00672620|20867219|P3|Overall Study|Reason not Specified|2
6037748|NCT00672620|20867220|P2|Overall Study|Reason not Specified|3
6037749|NCT00672620|20867221|P1|Overall Study|Reason not Specified|3
6037750|NCT00672620|20867218|P4|Overall Study|Lost to Follow-up|11
6037751|NCT00672620|20867219|P3|Overall Study|Lost to Follow-up|8
6037752|NCT00672620|20867220|P2|Overall Study|Lost to Follow-up|19
6037753|NCT00672620|20867221|P1|Overall Study|Lost to Follow-up|8
6037754|NCT00672620|20867218|P4|Overall Study|Withdrawal of Consent|6
6037755|NCT00672620|20867219|P3|Overall Study|Withdrawal of Consent|5
6037756|NCT00672620|20867220|P2|Overall Study|Withdrawal of Consent|12
6037757|NCT00672620|20867221|P1|Overall Study|Withdrawal of Consent|6
6037758|NCT00672620|20867218|P4|Overall Study|Protocol Deviations|5
6037759|NCT00672620|20867219|P3|Overall Study|Protocol Deviations|2
6037760|NCT00672620|20867220|P2|Overall Study|Protocol Deviations|7
6037761|NCT00672620|20867221|P1|Overall Study|Protocol Deviations|5
6037762|NCT00672620|20867218|P4|Overall Study|Noncompliance with Study Drug|2
6037763|NCT00672620|20867219|P3|Overall Study|Noncompliance with Study Drug|0
6037764|NCT00672620|20867220|P2|Overall Study|Noncompliance with Study Drug|4
6037765|NCT00672620|20867221|P1|Overall Study|Noncompliance with Study Drug|3
6037766|NCT00672620|20867218|P4|Overall Study|Lack of Efficacy|0
6037767|NCT00672620|20867219|P3|Overall Study|Lack of Efficacy|2
6037768|NCT00672620|20867220|P2|Overall Study|Lack of Efficacy|2
6037769|NCT00672620|20867221|P1|Overall Study|Lack of Efficacy|1
6037770|NCT00672620|20867218|P4|Overall Study|Adverse Event|17
6037771|NCT00672620|20867219|P3|Overall Study|Adverse Event|12
6037772|NCT00672620|20867220|P2|Overall Study|Adverse Event|7
6037773|NCT00672620|20867221|P1|Overall Study|Adverse Event|7
6037774|NCT00672555|20867286|P1|Overall Study|Did not want to answer questionnaire|2
6037775|NCT00672555|20867286|P1|Overall Study|Lost to Follow-up|4
6037776|NCT00672490|20867297|P2|Overall Study|No reason was provided|2
6037777|NCT00672490|20867298|P1|Overall Study|No reason was provided|6
6037778|NCT00672490|20867297|P2|Overall Study|Lost to Follow-up|5
6037779|NCT00672490|20867298|P1|Overall Study|Lost to Follow-up|1
6037780|NCT00672490|20867297|P2|Overall Study|Intolerance|2
6037781|NCT00672490|20867298|P1|Overall Study|Intolerance|0
6037782|NCT00672490|20867297|P2|Overall Study|Violation of Concomitant Medicine|0
6037783|NCT00672490|20867298|P1|Overall Study|Violation of Concomitant Medicine|1
6037784|NCT00672490|20867297|P2|Overall Study|Adverse Event|8
6037785|NCT00672490|20867298|P1|Overall Study|Adverse Event|5
6037786|NCT00672490|20867297|P2|Overall Study|Mismatch Include/Exclude Criteria|0
6037787|NCT00672490|20867298|P1|Overall Study|Mismatch Include/Exclude Criteria|1
6037788|NCT00672490|20867297|P2|Overall Study|Lack of Compliance|7
6037789|NCT00672490|20867298|P1|Overall Study|Lack of Compliance|2
6037790|NCT00672490|20867297|P2|Overall Study|Withdrawal by Subject|8
6037791|NCT00672490|20867298|P1|Overall Study|Withdrawal by Subject|8
6037792|NCT00672477|20867322|P2|Overall Study|no study drug for low GFR, health cond.|3
6037793|NCT00672477|20867323|P1|Overall Study|no study drug for low GFR, health cond.|1
6037794|NCT00672477|20867322|P2|Overall Study|Lack of Efficacy|1
6037795|NCT00672477|20867323|P1|Overall Study|Lack of Efficacy|1
6037796|NCT00672477|20867322|P2|Overall Study|Withdrawal by Subject|3
6037797|NCT00672477|20867323|P1|Overall Study|Withdrawal by Subject|5
6037798|NCT00672477|20867322|P2|Overall Study|Protocol Violation|1
6037799|NCT00672477|20867323|P1|Overall Study|Protocol Violation|1
6037800|NCT00672477|20867322|P2|Overall Study|Physician Decision|0
6037801|NCT00672477|20867323|P1|Overall Study|Physician Decision|2
6037802|NCT00672477|20867322|P2|Overall Study|Death|11
6037803|NCT00672477|20867323|P1|Overall Study|Death|7
6037804|NCT00672477|20867322|P2|Overall Study|Adverse Event|7
6037805|NCT00672477|20867323|P1|Overall Study|Adverse Event|10
6037806|NCT00672256|20867376|P1|Overall Study|PI dropped, bad data|44
6037807|NCT00672139|20867401|P2|Overall Study|hospice discharge, caregiver requests|2
6037808|NCT00672139|20867402|P1|Overall Study|hospice discharge, caregiver requests|3
6037809|NCT00672139|20867401|P2|Overall Study|Protocol Violation|1
6037810|NCT00672139|20867402|P1|Overall Study|Protocol Violation|1
6037811|NCT00672139|20867401|P2|Overall Study|Lack of Efficacy|1
6037812|NCT00672139|20867402|P1|Overall Study|Lack of Efficacy|4
6037813|NCT00672139|20867401|P2|Overall Study|Physician Decision|0
6037814|NCT00672139|20867402|P1|Overall Study|Physician Decision|2
6037815|NCT00672139|20867401|P2|Overall Study|Adverse Event|7
6037816|NCT00672139|20867402|P1|Overall Study|Adverse Event|4
6037817|NCT00672139|20867401|P2|Overall Study|Withdrawal by Subject|11
6037818|NCT00672139|20867402|P1|Overall Study|Withdrawal by Subject|2
6037819|NCT00672139|20867401|P2|Overall Study|Death|23
6037820|NCT00672139|20867402|P1|Overall Study|Death|14
6037821|NCT00671931|20867459|P5|Overall Study|Physician Decision|1
6037822|NCT00671931|20867460|P4|Overall Study|Physician Decision|2
6037823|NCT00671931|20867461|P3|Overall Study|Physician Decision|0
6037824|NCT00671931|20867462|P2|Overall Study|Physician Decision|0
6037825|NCT00671931|20867463|P1|Overall Study|Physician Decision|1
6037826|NCT00671879|20867483|P3|Overall Study|Withdrawal by Subject|6
6037827|NCT00671879|20867484|P2|Overall Study|Withdrawal by Subject|4
6037828|NCT00671879|20867485|P1|Overall Study|Withdrawal by Subject|0
6037829|NCT00671853|20867498|P2|Overall Study|Non-adherence with study procedures|4
6037830|NCT00671853|20867499|P1|Overall Study|Non-adherence with study procedures|1
6037831|NCT00671853|20867498|P2|Overall Study|Physician Decision|2
6037832|NCT00671853|20867499|P1|Overall Study|Physician Decision|0
6037833|NCT00671853|20867498|P2|Overall Study|Lost to Follow-up|8
6037834|NCT00671853|20867499|P1|Overall Study|Lost to Follow-up|8
6037835|NCT00671853|20867498|P2|Overall Study|Withdrawal by Subject|5
6037836|NCT00671853|20867499|P1|Overall Study|Withdrawal by Subject|1
6037837|NCT00671853|20867498|P2|Overall Study|Adverse Event|1
6037838|NCT00671853|20867499|P1|Overall Study|Adverse Event|7
6037839|NCT00671853|20867498|P2|Overall Study|Lack of Efficacy|7
6037840|NCT00671853|20867499|P1|Overall Study|Lack of Efficacy|3
6037841|NCT00671788|20867515|P1|Overall Study|Other|1
6037842|NCT00671788|20867515|P1|Overall Study|MD Decision|1
6037843|NCT00671788|20867515|P1|Overall Study|Ineligible|1
6037844|NCT00671788|20867515|P1|Overall Study|Refused further treatment|3
6037845|NCT00671788|20867515|P1|Overall Study|Adverse Event|8
6037846|NCT00671749|20867522|P1|Overall Study|Lost to Follow-up|1
6037847|NCT00671749|20867522|P1|Overall Study|Protocol Violation|1
6037848|NCT00671749|20867522|P1|Overall Study|Withdrawal by Subject|4
6037849|NCT00671749|20867522|P1|Overall Study|Adverse Event|2
6037850|NCT00671658|20867577|P1|Overall Study|Physician Decision|5
6037851|NCT00671554|20867585|P1|Overall Study|Disease progression|3
6037852|NCT00671437|20867624|P1|Overall Study|Ineligible post-hoc|1
6037853|NCT00671437|20867624|P1|Overall Study|Adverse Event|3
6037854|NCT00671437|20867624|P1|Overall Study|Cutaneous SCC of head and neck|3
6037855|NCT00671437|20867624|P1|Overall Study|Progressive disease before C1 week 8|8
6037856|NCT00671060|20867658|P2|Overall Study|Physician Decision|1
6037857|NCT00671060|20867659|P1|Overall Study|Physician Decision|0
6037858|NCT00671060|20867658|P2|Overall Study|Protocol Violation|0
6037859|NCT00671060|20867659|P1|Overall Study|Protocol Violation|1
6037860|NCT00671034|20867668|P3|Overall Study|includes Alternative therapy, etc.|7
6037861|NCT00671034|20867669|P2|Overall Study|includes Alternative therapy, etc.|1
6037862|NCT00671034|20867670|P1|Overall Study|includes Alternative therapy, etc.|6
6037863|NCT00671034|20867668|P3|Overall Study|Refusal|5
6037864|NCT00671034|20867669|P2|Overall Study|Refusal|3
6037865|NCT00671034|20867670|P1|Overall Study|Refusal|5
6037866|NCT00671034|20867668|P3|Overall Study|VHR ALL feature|5
6037867|NCT00671034|20867669|P2|Overall Study|VHR ALL feature|3
6037868|NCT00671034|20867670|P1|Overall Study|VHR ALL feature|8
6037869|NCT00671034|20867668|P3|Overall Study|Physician Decision|5
6037870|NCT00671034|20867669|P2|Overall Study|Physician Decision|4
6037871|NCT00671034|20867670|P1|Overall Study|Physician Decision|12
6037872|NCT00671034|20867668|P3|Overall Study|Death|1
6037873|NCT00671034|20867669|P2|Overall Study|Death|2
6037874|NCT00671034|20867670|P1|Overall Study|Death|3
6037875|NCT00671034|20867668|P3|Overall Study|Adverse Event|1
6037876|NCT00671034|20867669|P2|Overall Study|Adverse Event|7
6037877|NCT00671034|20867670|P1|Overall Study|Adverse Event|5
6037878|NCT00670930|20867725|P2|Overall Study|Lost to Follow-up|0
6037879|NCT00670930|20867726|P1|Overall Study|Lost to Follow-up|1
6037880|NCT00670930|20867725|P2|Overall Study|Adminstrative Problem|1
6037881|NCT00670930|20867726|P1|Overall Study|Adminstrative Problem|0
6037882|NCT00670800|20867742|P2|Overall Study|2 controls were insulin resistant|2
6037883|NCT00670800|20867743|P1|Overall Study|2 controls were insulin resistant|0
6037884|NCT00670748|20867774|P4|Overall Study|Not off study|1
6037885|NCT00670748|20867775|P3|Overall Study|Not off study|1
6037886|NCT00670748|20867776|P2|Overall Study|Not off study|1
6037887|NCT00670748|20867777|P1|Overall Study|Not off study|2
6037888|NCT00670748|20867774|P4|Overall Study|Death during treatment|0
6037889|NCT00670748|20867775|P3|Overall Study|Death during treatment|1
6037890|NCT00670748|20867776|P2|Overall Study|Death during treatment|1
6037891|NCT00670748|20867777|P1|Overall Study|Death during treatment|1
6037892|NCT00670540|20867812|P1|Overall Study|missing information inclusion criteria|1
6037893|NCT00670540|20867812|P1|Overall Study|controls randomised for no follow up|2770
6037894|NCT00670540|20867812|P1|Overall Study|refused to participate|189
6037895|NCT00670540|20867812|P1|Overall Study|not living in France|348
6037896|NCT00670540|20867812|P1|Overall Study|ineligible|17
6037897|NCT00670488|20867832|P10|Overall Study|Withdrawal by Subject|0
6037898|NCT00670488|20867833|P9|Overall Study|Withdrawal by Subject|1
6037899|NCT00670488|20867834|P8|Overall Study|Withdrawal by Subject|0
6037900|NCT00670488|20867835|P7|Overall Study|Withdrawal by Subject|1
6037901|NCT00670488|20867836|P6|Overall Study|Withdrawal by Subject|0
6037902|NCT00670488|20867837|P5|Overall Study|Withdrawal by Subject|0
6037903|NCT00670488|20867838|P4|Overall Study|Withdrawal by Subject|1
6037904|NCT00670488|20867839|P3|Overall Study|Withdrawal by Subject|0
6037905|NCT00670488|20867840|P2|Overall Study|Withdrawal by Subject|1
6037906|NCT00670488|20867841|P1|Overall Study|Withdrawal by Subject|0
6037907|NCT00670488|20867832|P10|Overall Study|Progressive Disease|1
6037908|NCT00670488|20867833|P9|Overall Study|Progressive Disease|2
6037909|NCT00670488|20867834|P8|Overall Study|Progressive Disease|2
6037910|NCT00670488|20867835|P7|Overall Study|Progressive Disease|11
6037911|NCT00670488|20867836|P6|Overall Study|Progressive Disease|4
6037912|NCT00670488|20867837|P5|Overall Study|Progressive Disease|2
6037913|NCT00670488|20867838|P4|Overall Study|Progressive Disease|2
6037914|NCT00670488|20867839|P3|Overall Study|Progressive Disease|3
6037915|NCT00670488|20867840|P2|Overall Study|Progressive Disease|41
6037916|NCT00670488|20867841|P1|Overall Study|Progressive Disease|2
6037917|NCT00670488|20867832|P10|Overall Study|Physician Decision|0
6037918|NCT00670488|20867833|P9|Overall Study|Physician Decision|0
6037919|NCT00670488|20867834|P8|Overall Study|Physician Decision|0
6037920|NCT00670488|20867835|P7|Overall Study|Physician Decision|0
6037921|NCT00670488|20867836|P6|Overall Study|Physician Decision|0
6037922|NCT00670488|20867837|P5|Overall Study|Physician Decision|0
6037923|NCT00670488|20867838|P4|Overall Study|Physician Decision|1
6037924|NCT00670488|20867839|P3|Overall Study|Physician Decision|0
6037925|NCT00670488|20867840|P2|Overall Study|Physician Decision|9
6037926|NCT00670488|20867841|P1|Overall Study|Physician Decision|1
6037927|NCT00670488|20867832|P10|Overall Study|Adverse Event|1
6037928|NCT00670488|20867833|P9|Overall Study|Adverse Event|0
6037929|NCT00670488|20867834|P8|Overall Study|Adverse Event|1
6037930|NCT00670488|20867835|P7|Overall Study|Adverse Event|5
6037931|NCT00670488|20867836|P6|Overall Study|Adverse Event|1
6037932|NCT00670488|20867837|P5|Overall Study|Adverse Event|1
6037933|NCT00670488|20867838|P4|Overall Study|Adverse Event|3
6037934|NCT00670488|20867839|P3|Overall Study|Adverse Event|0
6037935|NCT00670488|20867840|P2|Overall Study|Adverse Event|7
6037936|NCT00670488|20867841|P1|Overall Study|Adverse Event|0
6037937|NCT00670449|20868028|P4|Overall Study|Abnormal Laboratory Value(s)|0
6037938|NCT00670449|20868029|P3|Overall Study|Abnormal Laboratory Value(s)|0
6037939|NCT00670449|20868030|P2|Overall Study|Abnormal Laboratory Value(s)|2
6037940|NCT00670449|20868031|P1|Overall Study|Abnormal Laboratory Value(s)|0
6037941|NCT00670449|20868028|P4|Overall Study|Unsatisfactory Therapeutic Effect|0
6037942|NCT00670449|20868029|P3|Overall Study|Unsatisfactory Therapeutic Effect|1
6037943|NCT00670449|20868030|P2|Overall Study|Unsatisfactory Therapeutic Effect|0
6037944|NCT00670449|20868031|P1|Overall Study|Unsatisfactory Therapeutic Effect|2
6037945|NCT00670449|20868028|P4|Overall Study|Subject Withdrew Consent|1
6037946|NCT00670449|20868029|P3|Overall Study|Subject Withdrew Consent|0
6037947|NCT00670449|20868030|P2|Overall Study|Subject Withdrew Consent|2
6037948|NCT00670449|20868031|P1|Overall Study|Subject Withdrew Consent|0
6037949|NCT00670449|20868028|P4|Overall Study|Administrative Problems|1
6037950|NCT00670449|20868029|P3|Overall Study|Administrative Problems|0
6037951|NCT00670449|20868030|P2|Overall Study|Administrative Problems|2
6037952|NCT00670449|20868031|P1|Overall Study|Administrative Problems|0
6037953|NCT00670449|20868028|P4|Overall Study|Protocol Deviation|1
6037954|NCT00670449|20868029|P3|Overall Study|Protocol Deviation|0
6037955|NCT00670449|20868030|P2|Overall Study|Protocol Deviation|2
6037956|NCT00670449|20868031|P1|Overall Study|Protocol Deviation|1
6037957|NCT00670449|20868028|P4|Overall Study|Adverse Event|5
6037958|NCT00670449|20868029|P3|Overall Study|Adverse Event|8
6037959|NCT00670449|20868030|P2|Overall Study|Adverse Event|2
6037960|NCT00670449|20868031|P1|Overall Study|Adverse Event|6
6037961|NCT00670306|20868055|P1|Overall Study|incl/excl criterias did not meet|19
6037962|NCT00670306|20868055|P1|Overall Study|Lost to Follow-up|8
6037963|NCT00670306|20868055|P1|Overall Study|Physician Decision|1
6037964|NCT00670306|20868055|P1|Overall Study|Withdrawal by Subject|9
6037965|NCT00670306|20868055|P1|Overall Study|Lack of Efficacy|10
6037966|NCT00670306|20868055|P1|Overall Study|Adverse Event|8
6037967|NCT00670228|20868094|P2|Overall Study|Not meeting the selection criteria|0
6037968|NCT00670228|20868095|P1|Overall Study|Not meeting the selection criteria|2
6037969|NCT00670228|20868094|P2|Overall Study|Not treated|2
6037970|NCT00670228|20868095|P1|Overall Study|Not treated|2
6037971|NCT00670228|20868094|P2|Overall Study|Death or MACE|1
6037972|NCT00670228|20868095|P1|Overall Study|Death or MACE|0
6037973|NCT00670228|20868094|P2|Overall Study|Adverse Event|0
6037974|NCT00670228|20868095|P1|Overall Study|Adverse Event|1
6037975|NCT00670111|20868119|P3|Enrollment to One Month|Physician Decision|0
6037976|NCT00670111|20868120|P2|Enrollment to One Month|Physician Decision|0
6037977|NCT00670111|20868121|P1|Enrollment to One Month|Physician Decision|1
6037978|NCT00670111|20868119|P3|Enrollment to One Month|Ebrolled Patients but not Implanted|6
6037979|NCT00670111|20868120|P2|Enrollment to One Month|Ebrolled Patients but not Implanted|0
6037980|NCT00670111|20868121|P1|Enrollment to One Month|Ebrolled Patients but not Implanted|0
6037981|NCT00670111|20868119|P3|Enrollment to One Month|Testing Failure|13
6037982|NCT00670111|20868120|P2|Enrollment to One Month|Testing Failure|0
6037983|NCT00670111|20868121|P1|Enrollment to One Month|Testing Failure|0
6037984|NCT00670046|20868131|P2|Overall Study|Withdrawal by Subject|1
6037985|NCT00670046|20868132|P1|Overall Study|Withdrawal by Subject|0
6037986|NCT00670046|20868131|P2|Overall Study|Lost to Follow-up|1
6037987|NCT00670046|20868132|P1|Overall Study|Lost to Follow-up|1
6037988|NCT00670007|20868146|P1|Overall Study|Withdrawal by Subject|4
6037989|NCT00670007|20868146|P1|Overall Study|Adverse Event|1
6037990|NCT00670007|20868146|P1|Overall Study|Adverse event, serious fatal|1
6037991|NCT00670007|20868146|P1|Overall Study|Travel/Vacation|1
6037992|NCT00670007|20868146|P1|Overall Study|Lung transplant|1
6037993|NCT00670007|20868146|P1|Overall Study|Drug abuse|1
6037994|NCT00669955|20868173|P2|Overall Study|not compliant with study drug/visit|3
6037995|NCT00669955|20868174|P1|Overall Study|not compliant with study drug/visit|2
6037996|NCT00669955|20868173|P2|Overall Study|Investigator Sponsor Judgement|1
6037997|NCT00669955|20868174|P1|Overall Study|Investigator Sponsor Judgement|0
6037998|NCT00669955|20868173|P2|Overall Study|Protocol Violation|7
6037999|NCT00669955|20868174|P1|Overall Study|Protocol Violation|2
6038000|NCT00669955|20868173|P2|Overall Study|Lost to Follow-up|7
6038001|NCT00669955|20868174|P1|Overall Study|Lost to Follow-up|5
6038002|NCT00669955|20868173|P2|Overall Study|Withdrawal by Subject|3
6038003|NCT00669955|20868174|P1|Overall Study|Withdrawal by Subject|2
6038004|NCT00669955|20868173|P2|Overall Study|Death|1
6038005|NCT00669955|20868174|P1|Overall Study|Death|0
6038006|NCT00669955|20868173|P2|Overall Study|Adverse Event|5
6038007|NCT00669955|20868174|P1|Overall Study|Adverse Event|3
6038008|NCT00669942|20868204|P12|Parts 2 and 3|Protocol Violation|0
6038009|NCT00669942|20868205|P11|Parts 2 and 3|Protocol Violation|0
6038010|NCT00669942|20868206|P10|Parts 2 and 3|Protocol Violation|0
6038011|NCT00669942|20868207|P9|Parts 2 and 3|Protocol Violation|0
6038012|NCT00669942|20868208|P8|Parts 2 and 3|Protocol Violation|0
6038013|NCT00669942|20868209|P7|Parts 2 and 3|Protocol Violation|0
6038014|NCT00669942|20868210|P6|Parts 2 and 3|Protocol Violation|1
6038015|NCT00669942|20868211|P5|Parts 2 and 3|Protocol Violation|0
6038016|NCT00669942|20868212|P4|Parts 2 and 3|Protocol Violation|0
6038017|NCT00669942|20868213|P3|Parts 2 and 3|Protocol Violation|0
6038018|NCT00669942|20868214|P2|Parts 2 and 3|Protocol Violation|0
6038019|NCT00669942|20868215|P1|Parts 2 and 3|Protocol Violation|0
6038020|NCT00669942|20868204|P12|Parts 2 and 3|Withdrawal by Subject|0
6038021|NCT00669942|20868205|P11|Parts 2 and 3|Withdrawal by Subject|0
6038022|NCT00669942|20868206|P10|Parts 2 and 3|Withdrawal by Subject|0
6038023|NCT00669942|20868207|P9|Parts 2 and 3|Withdrawal by Subject|2
6038024|NCT00669942|20868208|P8|Parts 2 and 3|Withdrawal by Subject|0
6038025|NCT00669942|20868209|P7|Parts 2 and 3|Withdrawal by Subject|0
6038026|NCT00669942|20868210|P6|Parts 2 and 3|Withdrawal by Subject|1
6038027|NCT00669942|20868211|P5|Parts 2 and 3|Withdrawal by Subject|0
6038028|NCT00669942|20868212|P4|Parts 2 and 3|Withdrawal by Subject|0
6038029|NCT00669942|20868213|P3|Parts 2 and 3|Withdrawal by Subject|0
6038030|NCT00669942|20868214|P2|Parts 2 and 3|Withdrawal by Subject|0
6038031|NCT00669942|20868215|P1|Parts 2 and 3|Withdrawal by Subject|0
6038032|NCT00669942|20868204|P12|Parts 2 and 3|Adverse Event|0
6038033|NCT00669942|20868205|P11|Parts 2 and 3|Adverse Event|0
6038034|NCT00669942|20868206|P10|Parts 2 and 3|Adverse Event|0
6038035|NCT00669942|20868207|P9|Parts 2 and 3|Adverse Event|1
6038036|NCT00669942|20868208|P8|Parts 2 and 3|Adverse Event|2
6038037|NCT00669942|20868209|P7|Parts 2 and 3|Adverse Event|0
6038038|NCT00669942|20868210|P6|Parts 2 and 3|Adverse Event|0
6038039|NCT00669942|20868211|P5|Parts 2 and 3|Adverse Event|0
6038040|NCT00669942|20868212|P4|Parts 2 and 3|Adverse Event|0
6038041|NCT00669942|20868213|P3|Parts 2 and 3|Adverse Event|0
6038042|NCT00669942|20868214|P2|Parts 2 and 3|Adverse Event|0
6038043|NCT00669942|20868215|P1|Parts 2 and 3|Adverse Event|0
6038044|NCT00669903|20868298|P4|Overall Study|Protocol Violation|0
6038045|NCT00669903|20868299|P3|Overall Study|Protocol Violation|0
6038046|NCT00669903|20868300|P2|Overall Study|Protocol Violation|1
6038047|NCT00669903|20868301|P1|Overall Study|Protocol Violation|0
6038048|NCT00669903|20868298|P4|Overall Study|Lost to Follow-up|1
6038049|NCT00669903|20868299|P3|Overall Study|Lost to Follow-up|0
6038050|NCT00669903|20868300|P2|Overall Study|Lost to Follow-up|1
6038051|NCT00669903|20868301|P1|Overall Study|Lost to Follow-up|1
6038052|NCT00669903|20868298|P4|Overall Study|Withdrawal by Subject|2
6038053|NCT00669903|20868299|P3|Overall Study|Withdrawal by Subject|2
6038054|NCT00669903|20868300|P2|Overall Study|Withdrawal by Subject|2
6038055|NCT00669903|20868301|P1|Overall Study|Withdrawal by Subject|0
6038056|NCT00669903|20868298|P4|Overall Study|Adverse Event|1
6038057|NCT00669903|20868299|P3|Overall Study|Adverse Event|3
6038058|NCT00669903|20868300|P2|Overall Study|Adverse Event|1
6038059|NCT00669903|20868301|P1|Overall Study|Adverse Event|0
6038060|NCT00669877|20868331|P1|Overall Study|Disease Progression/Death|4
6038061|NCT00669864|20868336|P1|Overall Study|Other|2
6038062|NCT00669864|20868336|P1|Overall Study|Withdrawal by Subject|3
6038063|NCT00669864|20868336|P1|Overall Study|Protocol Violation|2
6038064|NCT00669864|20868336|P1|Overall Study|Lost to Follow-up|2
6038065|NCT00669669|20868350|P1|Overall Study|To late to start treatment|1
6038066|NCT00669617|20868355|P5|Period 3|Lost to Follow-up|0
6038067|NCT00669617|20868356|P4|Period 3|Lost to Follow-up|0
6038068|NCT00669617|20868357|P3|Period 3|Lost to Follow-up|0
6038069|NCT00669617|20868358|P2|Period 3|Lost to Follow-up|0
6038070|NCT00669617|20868359|P1|Period 3|Lost to Follow-up|1
6038071|NCT00669617|20868355|P5|Period 1|Protocol Deviation|1
6038072|NCT00669617|20868356|P4|Period 1|Protocol Deviation|0
6038073|NCT00669617|20868357|P3|Period 1|Protocol Deviation|0
6038074|NCT00669617|20868358|P2|Period 1|Protocol Deviation|0
6038075|NCT00669617|20868359|P1|Period 1|Protocol Deviation|0
6038076|NCT00669617|20868355|P5|Period 1|Withdrawal by Subject|0
6038077|NCT00669617|20868356|P4|Period 1|Withdrawal by Subject|0
6038078|NCT00669617|20868357|P3|Period 1|Withdrawal by Subject|1
6038079|NCT00669617|20868358|P2|Period 1|Withdrawal by Subject|0
6038080|NCT00669617|20868359|P1|Period 1|Withdrawal by Subject|0
6038081|NCT00669396|20868407|P2|Overall Study|Lost to Follow-up|12
6038082|NCT00669396|20868408|P1|Overall Study|Lost to Follow-up|10
6038083|NCT00669331|20868435|P2|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2
6038084|NCT00669331|20868436|P1|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2
6038085|NCT00669331|20868435|P2|Blinded Treatment Period|Physician Decision|3
6038086|NCT00669331|20868436|P1|Blinded Treatment Period|Physician Decision|3
6038087|NCT00669331|20868435|P2|Blinded Treatment Period|Death|2
6038088|NCT00669331|20868436|P1|Blinded Treatment Period|Death|0
6038089|NCT00669331|20868435|P2|Blinded Treatment Period|Lost to Follow-up|2
6038090|NCT00669331|20868436|P1|Blinded Treatment Period|Lost to Follow-up|3
6038091|NCT00669331|20868435|P2|Blinded Treatment Period|Withdrawal by Subject|19
6038092|NCT00669331|20868436|P1|Blinded Treatment Period|Withdrawal by Subject|17
6038093|NCT00669331|20868435|P2|Blinded Treatment Period|Protocol Violation|1
6038094|NCT00669331|20868436|P1|Blinded Treatment Period|Protocol Violation|1
6038095|NCT00669331|20868435|P2|Blinded Treatment Period|Adverse Event|10
6038096|NCT00669331|20868436|P1|Blinded Treatment Period|Adverse Event|16
6038097|NCT00669331|20868435|P2|Randomisation to First Dose|Randomised in error|10
6038098|NCT00669331|20868436|P1|Randomisation to First Dose|Randomised in error|3
6038099|NCT00669331|20868435|P2|Randomisation to First Dose|Sponsor decision|1
6038100|NCT00669331|20868436|P1|Randomisation to First Dose|Sponsor decision|0
6038101|NCT00669331|20868435|P2|Randomisation to First Dose|Death|0
6038102|NCT00669331|20868436|P1|Randomisation to First Dose|Death|1
6038103|NCT00669331|20868435|P2|Randomisation to First Dose|Lost to Follow-up|0
6038104|NCT00669331|20868436|P1|Randomisation to First Dose|Lost to Follow-up|2
6038105|NCT00669331|20868435|P2|Randomisation to First Dose|Withdrawal by Subject|2
6038106|NCT00669331|20868436|P1|Randomisation to First Dose|Withdrawal by Subject|3
6038107|NCT00669331|20868435|P2|Randomisation to First Dose|Protocol Violation|0
6038108|NCT00669331|20868436|P1|Randomisation to First Dose|Protocol Violation|1
6038109|NCT00669331|20868435|P2|Randomisation to First Dose|Adverse Event|0
6038110|NCT00669331|20868436|P1|Randomisation to First Dose|Adverse Event|1
6038111|NCT00669318|20868478|P1|Overall Study|Withdrawal by Subject|2
6038112|NCT00669240|20868495|P1|Overall Study|Enrolled but no dosing record|1
6038113|NCT00669240|20868495|P1|Overall Study|Enrolled but not treated|15
6038114|NCT00669240|20868495|P1|Overall Study|Other|19
6038115|NCT00669240|20868495|P1|Overall Study|Adverse Event|21
6038116|NCT00669240|20868495|P1|Overall Study|Lost to Follow-up|34
6038117|NCT00669240|20868495|P1|Overall Study|Withdrawal by Subject|42
6038118|NCT00669240|20868495|P1|Overall Study|Lack of Efficacy|33
6038119|NCT00669162|20868544|P1|Overall Study|Withdrawal by Subject|1
6038120|NCT00669110|20868550|P2|Overall Study|Withdrawal by Subject|2
6038121|NCT00669110|20868551|P1|Overall Study|Withdrawal by Subject|0
6038122|NCT00669110|20868550|P2|Overall Study|Protocol Violation|5
6038123|NCT00669110|20868551|P1|Overall Study|Protocol Violation|0
6038124|NCT00669110|20868550|P2|Overall Study|Lost to Follow-up|0
6038125|NCT00669110|20868551|P1|Overall Study|Lost to Follow-up|1
6038126|NCT00669110|20868550|P2|Overall Study|Physician Decision|1
6038127|NCT00669110|20868551|P1|Overall Study|Physician Decision|0
6038128|NCT00669110|20868550|P2|Overall Study|Caregiver request|2
6038129|NCT00669110|20868551|P1|Overall Study|Caregiver request|3
6038130|NCT00669110|20868550|P2|Overall Study|Adverse Event|3
6038131|NCT00669110|20868551|P1|Overall Study|Adverse Event|4
6038132|NCT00669071|20868587|P1|Overall Study|Final visit 40 days out of window|1
6038133|NCT00669071|20868587|P1|Overall Study|Lost to Follow-up|3
6038134|NCT00669032|20868608|P2|Overall Study|No fulfilment of the selection criteria|5
6038135|NCT00669032|20868609|P1|Overall Study|No fulfilment of the selection criteria|5
6038136|NCT00669032|20868608|P2|Overall Study|Physician Decision|1
6038137|NCT00669032|20868609|P1|Overall Study|Physician Decision|1
6038138|NCT00669032|20868608|P2|Overall Study|Adverse Event|16
6038139|NCT00669032|20868609|P1|Overall Study|Adverse Event|12
6038140|NCT00669032|20868608|P2|Overall Study|Withdrawal by Subject|13
6038141|NCT00669032|20868609|P1|Overall Study|Withdrawal by Subject|12
6038142|NCT00669032|20868608|P2|Overall Study|Lack of Efficacy|19
6038143|NCT00669032|20868609|P1|Overall Study|Lack of Efficacy|8
6038144|NCT00669032|20868608|P2|Overall Study|Lost to Follow-up|5
6038145|NCT00669032|20868609|P1|Overall Study|Lost to Follow-up|6
6038146|NCT00668863|20868655|P1|Overall Study|Physician Decision|1
6038147|NCT00668863|20868655|P1|Overall Study|Subject's work scheduling problem|1
6038148|NCT00668863|20868655|P1|Overall Study|Surgery|1
6038149|NCT00668863|20868655|P1|Overall Study|Withdrawal by Subject|1
6038150|NCT00668863|20868655|P1|Overall Study|Global Deterioration of Health Status|4
6038151|NCT00668863|20868655|P1|Overall Study|Study Terminated by Sponsor|8
6038152|NCT00668863|20868655|P1|Overall Study|Adverse Event|13
6038153|NCT00668863|20868655|P1|Overall Study|Objective Progression or Relapse|42
6038154|NCT00668746|20868687|P2|Overall Study|Lost to Follow-up|1
6038155|NCT00668746|20868688|P1|Overall Study|Lost to Follow-up|2
6038156|NCT00668733|20868708|P2|Overall Study|Withdrawal by Subject|4
6038157|NCT00668733|20868709|P1|Overall Study|Withdrawal by Subject|0
6038158|NCT00668733|20868708|P2|Overall Study|Lost to Follow-up|3
6038159|NCT00668733|20868709|P1|Overall Study|Lost to Follow-up|2
6038160|NCT00668395|20868754|P3|Overall Study|Physician Decision|0
6038161|NCT00668395|20868755|P2|Overall Study|Physician Decision|1
6038162|NCT00668395|20868756|P1|Overall Study|Physician Decision|1
6038163|NCT00668395|20868754|P3|Overall Study|Adverse Event|0
6038164|NCT00668395|20868755|P2|Overall Study|Adverse Event|1
6038165|NCT00668395|20868756|P1|Overall Study|Adverse Event|1
6038166|NCT00668395|20868754|P3|Overall Study|Withdrawal by Subject|1
6038167|NCT00668395|20868755|P2|Overall Study|Withdrawal by Subject|4
6038168|NCT00668395|20868756|P1|Overall Study|Withdrawal by Subject|4
6038169|NCT00668317|20868768|P1|Overall Study|Adverse Event|2
6038170|NCT00668200|20868783|P1|Overall Study|Lost to Follow-up|1
6038171|NCT00668200|20868783|P1|Overall Study|Withdrawal by Subject|2
6038172|NCT00668148|20868789|P1|Overall Study|Withdrawal of Consent|2
6038173|NCT00668148|20868789|P1|Overall Study|Progressive Disease Before Treatment|2
6038174|NCT00668148|20868789|P1|Overall Study|Subject Non-compliance|1
6038175|NCT00668148|20868789|P1|Overall Study|Adverse Event|5
6038176|NCT00667992|20868828|P2|Third Intervention 100 Mcg Twice Daily|Adverse Event|1
6038177|NCT00667992|20868829|P1|Third Intervention 100 Mcg Twice Daily|Adverse Event|0
6038178|NCT00667992|20868828|P2|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0
6038179|NCT00667992|20868829|P1|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|1
6038180|NCT00667992|20868828|P2|Wash-out|Withdrawal by Subject|0
6038181|NCT00667992|20868829|P1|Wash-out|Withdrawal by Subject|1
6038182|NCT00667992|20868828|P2|Wash-out|Failure to wash-out|2
6038183|NCT00667992|20868829|P1|Wash-out|Failure to wash-out|2
6038184|NCT00667992|20868828|P2|Wash-out|Not within one doubling dilution|3
6038185|NCT00667992|20868829|P1|Wash-out|Not within one doubling dilution|4
6038186|NCT00667992|20868828|P2|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|1
6038187|NCT00667992|20868829|P1|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|0
6038188|NCT00667992|20868828|P2|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|3
6038189|NCT00667992|20868829|P1|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|2
6038190|NCT00667992|20868828|P2|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|0
6038191|NCT00667992|20868829|P1|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|1
6038192|NCT00667992|20868828|P2|First Intervention 100 Mcg Twice Daily|Adverse Event|1
6038193|NCT00667992|20868829|P1|First Intervention 100 Mcg Twice Daily|Adverse Event|0
6038194|NCT00667992|20868828|P2|First Intervention 100 Mcg Twice Daily|Pregnancy|0
6038195|NCT00667992|20868829|P1|First Intervention 100 Mcg Twice Daily|Pregnancy|1
6038196|NCT00667992|20868828|P2|First Intervention 100 Mcg Twice Daily|Adverse Event|1
6038197|NCT00667992|20868829|P1|First Intervention 100 Mcg Twice Daily|Adverse Event|0
6038198|NCT00667992|20868828|P2|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0
6038199|NCT00667992|20868829|P1|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|2
6038288|NCT00667576|20869121|P2|Overall Study|Missed Visit|0
6038200|NCT00667992|20868828|P2|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|3
6038201|NCT00667992|20868829|P1|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|2
6038202|NCT00667888|20868885|P2|Overall Study|Ineligible after SIM|2
6038203|NCT00667888|20868886|P1|Overall Study|Ineligible after SIM|0
6038204|NCT00667888|20868885|P2|Overall Study|Proceed with other treatment|3
6038205|NCT00667888|20868886|P1|Overall Study|Proceed with other treatment|3
6038206|NCT00667888|20868885|P2|Overall Study|Withdrawal by Subject|3
6038207|NCT00667888|20868886|P1|Overall Study|Withdrawal by Subject|6
6038208|NCT00667888|20868885|P2|Overall Study|Death|1
6038209|NCT00667888|20868886|P1|Overall Study|Death|1
6038210|NCT00667875|20868895|P3|Overall Study|Withdrawal by Subject|7
6038211|NCT00667875|20868896|P2|Overall Study|Withdrawal by Subject|9
6038212|NCT00667875|20868897|P1|Overall Study|Withdrawal by Subject|10
6038213|NCT00667875|20868895|P3|Overall Study|Adverse Event|6
6038214|NCT00667875|20868896|P2|Overall Study|Adverse Event|2
6038215|NCT00667875|20868897|P1|Overall Study|Adverse Event|0
6038216|NCT00667810|20868931|P4|Overall Study|Other|0
6038217|NCT00667810|20868932|P3|Overall Study|Other|5
6038218|NCT00667810|20868933|P2|Overall Study|Other|6
6038219|NCT00667810|20868934|P1|Overall Study|Other|6
6038220|NCT00667810|20868931|P4|Overall Study|Vasogenic Edema Recurrence|0
6038221|NCT00667810|20868932|P3|Overall Study|Vasogenic Edema Recurrence|0
6038222|NCT00667810|20868933|P2|Overall Study|Vasogenic Edema Recurrence|3
6038223|NCT00667810|20868934|P1|Overall Study|Vasogenic Edema Recurrence|0
6038224|NCT00667810|20868931|P4|Overall Study|Loss of Caregiver|0
6038225|NCT00667810|20868932|P3|Overall Study|Loss of Caregiver|3
6038226|NCT00667810|20868933|P2|Overall Study|Loss of Caregiver|1
6038227|NCT00667810|20868934|P1|Overall Study|Loss of Caregiver|0
6038228|NCT00667810|20868931|P4|Overall Study|Failed to Return|0
6038229|NCT00667810|20868932|P3|Overall Study|Failed to Return|2
6038230|NCT00667810|20868933|P2|Overall Study|Failed to Return|0
6038231|NCT00667810|20868934|P1|Overall Study|Failed to Return|0
6038232|NCT00667810|20868931|P4|Overall Study|Discontinuation of Study by Sponsor|0
6038233|NCT00667810|20868932|P3|Overall Study|Discontinuation of Study by Sponsor|155
6038234|NCT00667810|20868933|P2|Overall Study|Discontinuation of Study by Sponsor|118
6038235|NCT00667810|20868934|P1|Overall Study|Discontinuation of Study by Sponsor|130
6038236|NCT00667810|20868931|P4|Overall Study|Withdrawal by Subject|1
6038237|NCT00667810|20868932|P3|Overall Study|Withdrawal by Subject|29
6038238|NCT00667810|20868933|P2|Overall Study|Withdrawal by Subject|20
6038239|NCT00667810|20868934|P1|Overall Study|Withdrawal by Subject|14
6038240|NCT00667810|20868931|P4|Overall Study|Protocol Violation|0
6038241|NCT00667810|20868932|P3|Overall Study|Protocol Violation|0
6038242|NCT00667810|20868933|P2|Overall Study|Protocol Violation|2
6038243|NCT00667810|20868934|P1|Overall Study|Protocol Violation|0
6038244|NCT00667810|20868931|P4|Overall Study|Physician Decision|0
6038245|NCT00667810|20868932|P3|Overall Study|Physician Decision|2
6038246|NCT00667810|20868933|P2|Overall Study|Physician Decision|1
6038247|NCT00667810|20868934|P1|Overall Study|Physician Decision|1
6038248|NCT00667810|20868931|P4|Overall Study|Lost to Follow-up|0
6038249|NCT00667810|20868932|P3|Overall Study|Lost to Follow-up|2
6038250|NCT00667810|20868933|P2|Overall Study|Lost to Follow-up|4
6038251|NCT00667810|20868934|P1|Overall Study|Lost to Follow-up|1
6038252|NCT00667810|20868931|P4|Overall Study|Lack of Efficacy|0
6038253|NCT00667810|20868932|P3|Overall Study|Lack of Efficacy|2
6038254|NCT00667810|20868933|P2|Overall Study|Lack of Efficacy|0
6038255|NCT00667810|20868934|P1|Overall Study|Lack of Efficacy|1
6038256|NCT00667810|20868931|P4|Overall Study|Death|0
6038257|NCT00667810|20868932|P3|Overall Study|Death|3
6038258|NCT00667810|20868933|P2|Overall Study|Death|1
6038259|NCT00667810|20868934|P1|Overall Study|Death|1
6038260|NCT00667810|20868931|P4|Overall Study|Adverse Event|1
6038261|NCT00667810|20868932|P3|Overall Study|Adverse Event|19
6038262|NCT00667810|20868933|P2|Overall Study|Adverse Event|14
6038263|NCT00667810|20868934|P1|Overall Study|Adverse Event|13
6038264|NCT00667732|20869010|P3|Randomization (24 Weeks)|Withdrawal by Subject|0
6038265|NCT00667732|20869011|P2|Randomization (24 Weeks)|Withdrawal by Subject|1
6038266|NCT00667732|20869012|P1|Randomization (24 Weeks)|Withdrawal by Subject|0
6038267|NCT00667732|20869010|P3|Run -In (8 Weeks)|Withdrawal by Subject|0
6038268|NCT00667732|20869011|P2|Run -In (8 Weeks)|Withdrawal by Subject|0
6038269|NCT00667732|20869012|P1|Run -In (8 Weeks)|Withdrawal by Subject|3
6038270|NCT00667732|20869010|P3|Run -In (8 Weeks)|Adverse Event|0
6038271|NCT00667732|20869011|P2|Run -In (8 Weeks)|Adverse Event|0
6038272|NCT00667732|20869012|P1|Run -In (8 Weeks)|Adverse Event|4
6038273|NCT00667602|20869048|P3|Overall Study|Protocol Violation|0
6038274|NCT00667602|20869049|P2|Overall Study|Protocol Violation|1
6038275|NCT00667602|20869050|P1|Overall Study|Protocol Violation|0
6038276|NCT00667602|20869048|P3|Overall Study|Administrative reason|2
6038277|NCT00667602|20869049|P2|Overall Study|Administrative reason|0
6038278|NCT00667602|20869050|P1|Overall Study|Administrative reason|0
6038279|NCT00667602|20869048|P3|Overall Study|Lost to Follow-up|6
6038280|NCT00667602|20869049|P2|Overall Study|Lost to Follow-up|5
6038281|NCT00667602|20869050|P1|Overall Study|Lost to Follow-up|4
6038282|NCT00667602|20869048|P3|Overall Study|Withdrawal by Subject|10
6038283|NCT00667602|20869049|P2|Overall Study|Withdrawal by Subject|9
6038284|NCT00667602|20869050|P1|Overall Study|Withdrawal by Subject|4
6038285|NCT00667576|20869118|P5|Overall Study|Missed Visit|0
6038286|NCT00667576|20869119|P4|Overall Study|Missed Visit|1
6038287|NCT00667576|20869120|P3|Overall Study|Missed Visit|0
6038289|NCT00667576|20869122|P1|Overall Study|Missed Visit|0
6038290|NCT00667576|20869118|P5|Overall Study|Physician Decision|0
6038291|NCT00667576|20869119|P4|Overall Study|Physician Decision|1
6038292|NCT00667576|20869120|P3|Overall Study|Physician Decision|0
6038293|NCT00667576|20869121|P2|Overall Study|Physician Decision|0
6038294|NCT00667576|20869122|P1|Overall Study|Physician Decision|0
6038295|NCT00667576|20869118|P5|Overall Study|Protocol Violation|0
6038296|NCT00667576|20869119|P4|Overall Study|Protocol Violation|1
6038297|NCT00667576|20869120|P3|Overall Study|Protocol Violation|0
6038298|NCT00667576|20869121|P2|Overall Study|Protocol Violation|0
6038299|NCT00667576|20869122|P1|Overall Study|Protocol Violation|0
6038300|NCT00667576|20869118|P5|Overall Study|Lost to Follow-up|0
6038301|NCT00667576|20869119|P4|Overall Study|Lost to Follow-up|0
6038302|NCT00667576|20869120|P3|Overall Study|Lost to Follow-up|1
6038303|NCT00667576|20869121|P2|Overall Study|Lost to Follow-up|0
6038304|NCT00667576|20869122|P1|Overall Study|Lost to Follow-up|0
6038305|NCT00667576|20869118|P5|Overall Study|Adverse Event|0
6038306|NCT00667576|20869119|P4|Overall Study|Adverse Event|0
6038307|NCT00667576|20869120|P3|Overall Study|Adverse Event|0
6038308|NCT00667576|20869121|P2|Overall Study|Adverse Event|1
6038309|NCT00667576|20869122|P1|Overall Study|Adverse Event|1
6038310|NCT00667576|20869118|P5|Overall Study|Withdrawal by Subject|1
6038311|NCT00667576|20869119|P4|Overall Study|Withdrawal by Subject|1
6038312|NCT00667576|20869120|P3|Overall Study|Withdrawal by Subject|1
6038313|NCT00667576|20869121|P2|Overall Study|Withdrawal by Subject|0
6038314|NCT00667576|20869122|P1|Overall Study|Withdrawal by Subject|1
6038315|NCT00667563|20869169|P1|Overall Study|Protocol Violation|24
6038316|NCT00667459|20869189|P2|Overall Study|Lost to Follow-up|43
6038317|NCT00667459|20869190|P1|Overall Study|Lost to Follow-up|8
6038318|NCT00667459|20869189|P2|Overall Study|Death|2
6038319|NCT00667459|20869190|P1|Overall Study|Death|0
6038320|NCT00667446|20869232|P2|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|1
6038321|NCT00667446|20869233|P1|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|0
6038322|NCT00667446|20869232|P2|Treatment Period (36 Months)|Therapeutic Failure|1
6038323|NCT00667446|20869233|P1|Treatment Period (36 Months)|Therapeutic Failure|1
6038324|NCT00667446|20869232|P2|Treatment Period (36 Months)|Protocol Violation|1
6038325|NCT00667446|20869233|P1|Treatment Period (36 Months)|Protocol Violation|1
6038326|NCT00667446|20869232|P2|Treatment Period (36 Months)|Lost to Follow-up|0
6038327|NCT00667446|20869233|P1|Treatment Period (36 Months)|Lost to Follow-up|1
6038328|NCT00667446|20869232|P2|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|0
6038329|NCT00667446|20869233|P1|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|3
6038330|NCT00667446|20869232|P2|Treatment Period (36 Months)|Withdrawal by Subject|4
6038331|NCT00667446|20869233|P1|Treatment Period (36 Months)|Withdrawal by Subject|0
6038332|NCT00667446|20869232|P2|Treatment Period (36 Months)|Personal reasons|2
6038333|NCT00667446|20869233|P1|Treatment Period (36 Months)|Personal reasons|2
6038334|NCT00667446|20869232|P2|Treatment Period (36 Months)|Other|2
6038335|NCT00667446|20869233|P1|Treatment Period (36 Months)|Other|2
6038336|NCT00667446|20869232|P2|Treatment Period (36 Months)|Ready to enter puberty based on age|15
6038337|NCT00667446|20869233|P1|Treatment Period (36 Months)|Ready to enter puberty based on age|13
6038338|NCT00667420|20869255|P1|Overall Study|Withdrawal by Subject|2
6038339|NCT00667420|20869255|P1|Overall Study|Physician Decision|1
6038340|NCT00667420|20869255|P1|Overall Study|Lack of Efficacy|5
6038341|NCT00667420|20869255|P1|Overall Study|Adverse Event|2
6038342|NCT00667394|20869265|P2|Overall Study|Progressive disease|0
6038343|NCT00667394|20869266|P1|Overall Study|Progressive disease|1
6038344|NCT00667394|20869265|P2|Overall Study|Adverse Event|0
6038345|NCT00667394|20869266|P1|Overall Study|Adverse Event|3
6038346|NCT00667368|20869293|P2|Overall Study|Discontinued early|17
6038347|NCT00667368|20869294|P1|Overall Study|Discontinued early|24
6038348|NCT00667368|20869293|P2|Overall Study|Lost to Follow-up|155
6038349|NCT00667368|20869294|P1|Overall Study|Lost to Follow-up|176
6038350|NCT00667355|20869302|P1|Overall Study|Other reason was not specified|5
6038351|NCT00667355|20869302|P1|Overall Study|Lost to Follow-up|1
6038352|NCT00667355|20869302|P1|Overall Study|Adverse Event|5
6038353|NCT00667342|20869327|P3|Overall Study|Ineligible|1
6038354|NCT00667342|20869328|P2|Overall Study|Ineligible|0
6038355|NCT00667342|20869329|P1|Overall Study|Ineligible|0
6038356|NCT00667342|20869327|P3|Overall Study|Adverse Event|1
6038357|NCT00667342|20869328|P2|Overall Study|Adverse Event|0
6038358|NCT00667342|20869329|P1|Overall Study|Adverse Event|0
6038359|NCT00667342|20869327|P3|Overall Study|Relapse or tumor progression|7
6038360|NCT00667342|20869328|P2|Overall Study|Relapse or tumor progression|0
6038361|NCT00667342|20869329|P1|Overall Study|Relapse or tumor progression|9
6038362|NCT00667342|20869327|P3|Overall Study|Physician Decision|0
6038363|NCT00667342|20869328|P2|Overall Study|Physician Decision|0
6038364|NCT00667342|20869329|P1|Overall Study|Physician Decision|3
6038365|NCT00667342|20869327|P3|Overall Study|Withdrawal by Subject|0
6038366|NCT00667342|20869328|P2|Overall Study|Withdrawal by Subject|0
6038367|NCT00667342|20869329|P1|Overall Study|Withdrawal by Subject|1
6038368|NCT00667342|20869327|P3|Overall Study|Protocol Violation|0
6038369|NCT00667342|20869328|P2|Overall Study|Protocol Violation|0
6038370|NCT00667342|20869329|P1|Overall Study|Protocol Violation|1
6038371|NCT00667277|20869367|P1|Overall Study|Withdrawal by Subject|2
6038372|NCT00667251|20869374|P2|Overall Study|Symptomatic progression|2
6038373|NCT00667251|20869375|P1|Overall Study|Symptomatic progression|1
6038374|NCT00667251|20869374|P2|Overall Study|Intercurrent Illness|3
6038375|NCT00667251|20869375|P1|Overall Study|Intercurrent Illness|4
6038376|NCT00667251|20869374|P2|Overall Study|Other/missing|84
6038377|NCT00667251|20869375|P1|Overall Study|Other/missing|46
6038378|NCT00667251|20869374|P2|Overall Study|Withdrawal by Subject|2
6038379|NCT00667251|20869375|P1|Overall Study|Withdrawal by Subject|6
6038380|NCT00667251|20869374|P2|Overall Study|Adverse Event|4
6038381|NCT00667251|20869375|P1|Overall Study|Adverse Event|13
6038382|NCT00667225|20869401|P2|Overall Study|Lost to Follow-up|1
6038383|NCT00667225|20869402|P1|Overall Study|Lost to Follow-up|0
6038384|NCT00667225|20869401|P2|Overall Study|Subject had no more lesions to treat.|0
6038385|NCT00667225|20869402|P1|Overall Study|Subject had no more lesions to treat.|1
6038386|NCT00667095|20869423|P2|Overall Study|Withdrawal by Subject|1
6038387|NCT00667095|20869424|P1|Overall Study|Withdrawal by Subject|0
6038388|NCT00667017|20869440|P1|Overall Study|Withdrawal by Subject|1
6038389|NCT00666965|20869469|P4|Overall Study|Withdrawal by Subject|2
6038390|NCT00666965|20869470|P3|Overall Study|Withdrawal by Subject|0
6038391|NCT00666965|20869471|P2|Overall Study|Withdrawal by Subject|0
6038392|NCT00666965|20869472|P1|Overall Study|Withdrawal by Subject|0
6038393|NCT00666965|20869469|P4|Overall Study|Discontinuation criteria|2
6038394|NCT00666965|20869470|P3|Overall Study|Discontinuation criteria|1
6038395|NCT00666965|20869471|P2|Overall Study|Discontinuation criteria|1
6038396|NCT00666965|20869472|P1|Overall Study|Discontinuation criteria|2
6038397|NCT00666965|20869469|P4|Overall Study|Protocol Violation|2
6038398|NCT00666965|20869470|P3|Overall Study|Protocol Violation|0
6038399|NCT00666965|20869471|P2|Overall Study|Protocol Violation|0
6038400|NCT00666965|20869472|P1|Overall Study|Protocol Violation|0
6038401|NCT00666965|20869469|P4|Overall Study|Lack of Efficacy|0
6038402|NCT00666965|20869470|P3|Overall Study|Lack of Efficacy|0
6038403|NCT00666965|20869471|P2|Overall Study|Lack of Efficacy|1
6038404|NCT00666965|20869472|P1|Overall Study|Lack of Efficacy|1
6038405|NCT00666965|20869469|P4|Overall Study|Adverse Event|9
6038406|NCT00666965|20869470|P3|Overall Study|Adverse Event|1
6038407|NCT00666965|20869471|P2|Overall Study|Adverse Event|2
6038408|NCT00666965|20869472|P1|Overall Study|Adverse Event|0
6038409|NCT00666926|20869502|P16|Overall Study|Death|0
6038410|NCT00666926|20869503|P15|Overall Study|Death|0
6038411|NCT00666926|20869504|P14|Overall Study|Death|0
6038412|NCT00666926|20869505|P13|Overall Study|Death|0
6038413|NCT00666926|20869506|P12|Overall Study|Death|1
6038414|NCT00666926|20869507|P11|Overall Study|Death|0
6038415|NCT00666926|20869508|P10|Overall Study|Death|0
6038416|NCT00666926|20869509|P9|Overall Study|Death|0
6038417|NCT00666926|20869510|P8|Overall Study|Death|0
6038418|NCT00666926|20869511|P7|Overall Study|Death|0
6038419|NCT00666926|20869512|P6|Overall Study|Death|0
6038420|NCT00666926|20869513|P5|Overall Study|Death|0
6038421|NCT00666926|20869514|P4|Overall Study|Death|0
6038422|NCT00666926|20869515|P3|Overall Study|Death|0
6038423|NCT00666926|20869516|P2|Overall Study|Death|0
6038424|NCT00666926|20869517|P1|Overall Study|Death|0
6038425|NCT00666926|20869502|P16|Overall Study|Withdrawal by Subject|3
6038426|NCT00666926|20869503|P15|Overall Study|Withdrawal by Subject|3
6038427|NCT00666926|20869504|P14|Overall Study|Withdrawal by Subject|1
6038428|NCT00666926|20869505|P13|Overall Study|Withdrawal by Subject|0
6038429|NCT00666926|20869506|P12|Overall Study|Withdrawal by Subject|3
6038430|NCT00666926|20869507|P11|Overall Study|Withdrawal by Subject|0
6038431|NCT00666926|20869508|P10|Overall Study|Withdrawal by Subject|3
6038432|NCT00666926|20869509|P9|Overall Study|Withdrawal by Subject|0
6038433|NCT00666926|20869510|P8|Overall Study|Withdrawal by Subject|1
6038434|NCT00666926|20869511|P7|Overall Study|Withdrawal by Subject|0
6038435|NCT00666926|20869512|P6|Overall Study|Withdrawal by Subject|0
6038436|NCT00666926|20869513|P5|Overall Study|Withdrawal by Subject|0
6038437|NCT00666926|20869514|P4|Overall Study|Withdrawal by Subject|0
6038438|NCT00666926|20869515|P3|Overall Study|Withdrawal by Subject|0
6038439|NCT00666926|20869516|P2|Overall Study|Withdrawal by Subject|0
6038440|NCT00666926|20869517|P1|Overall Study|Withdrawal by Subject|0
6038441|NCT00666926|20869502|P16|Overall Study|Other|4
6038442|NCT00666926|20869503|P15|Overall Study|Other|4
6038443|NCT00666926|20869504|P14|Overall Study|Other|2
6038444|NCT00666926|20869505|P13|Overall Study|Other|3
6038445|NCT00666926|20869506|P12|Overall Study|Other|26
6038446|NCT00666926|20869507|P11|Overall Study|Other|3
6038447|NCT00666926|20869508|P10|Overall Study|Other|5
6038448|NCT00666926|20869509|P9|Overall Study|Other|3
6038449|NCT00666926|20869510|P8|Overall Study|Other|0
6038450|NCT00666926|20869511|P7|Overall Study|Other|4
6038451|NCT00666926|20869512|P6|Overall Study|Other|3
6038452|NCT00666926|20869513|P5|Overall Study|Other|3
6038453|NCT00666926|20869514|P4|Overall Study|Other|3
6038454|NCT00666926|20869515|P3|Overall Study|Other|3
6038455|NCT00666926|20869516|P2|Overall Study|Other|4
6038456|NCT00666926|20869517|P1|Overall Study|Other|2
6038457|NCT00666926|20869502|P16|Overall Study|Lost to Follow-up|0
6038458|NCT00666926|20869503|P15|Overall Study|Lost to Follow-up|0
6038459|NCT00666926|20869504|P14|Overall Study|Lost to Follow-up|0
6038460|NCT00666926|20869505|P13|Overall Study|Lost to Follow-up|0
6038461|NCT00666926|20869506|P12|Overall Study|Lost to Follow-up|0
6038462|NCT00666926|20869507|P11|Overall Study|Lost to Follow-up|0
6038463|NCT00666926|20869508|P10|Overall Study|Lost to Follow-up|0
6038464|NCT00666926|20869509|P9|Overall Study|Lost to Follow-up|0
6038465|NCT00666926|20869510|P8|Overall Study|Lost to Follow-up|0
6038466|NCT00666926|20869511|P7|Overall Study|Lost to Follow-up|0
6038467|NCT00666926|20869512|P6|Overall Study|Lost to Follow-up|0
6038468|NCT00666926|20869513|P5|Overall Study|Lost to Follow-up|0
6038469|NCT00666926|20869514|P4|Overall Study|Lost to Follow-up|1
6038470|NCT00666926|20869515|P3|Overall Study|Lost to Follow-up|0
6038471|NCT00666926|20869516|P2|Overall Study|Lost to Follow-up|0
6038472|NCT00666926|20869517|P1|Overall Study|Lost to Follow-up|0
6038473|NCT00666926|20869502|P16|Overall Study|Lack of Efficacy|0
6038474|NCT00666926|20869503|P15|Overall Study|Lack of Efficacy|0
6038475|NCT00666926|20869504|P14|Overall Study|Lack of Efficacy|0
6038476|NCT00666926|20869505|P13|Overall Study|Lack of Efficacy|0
6038477|NCT00666926|20869506|P12|Overall Study|Lack of Efficacy|1
6038478|NCT00666926|20869507|P11|Overall Study|Lack of Efficacy|0
6038479|NCT00666926|20869508|P10|Overall Study|Lack of Efficacy|0
6038480|NCT00666926|20869509|P9|Overall Study|Lack of Efficacy|0
6038481|NCT00666926|20869510|P8|Overall Study|Lack of Efficacy|0
6038482|NCT00666926|20869511|P7|Overall Study|Lack of Efficacy|0
6038483|NCT00666926|20869512|P6|Overall Study|Lack of Efficacy|1
6038484|NCT00666926|20869513|P5|Overall Study|Lack of Efficacy|0
6038485|NCT00666926|20869514|P4|Overall Study|Lack of Efficacy|0
6038486|NCT00666926|20869515|P3|Overall Study|Lack of Efficacy|0
6038487|NCT00666926|20869516|P2|Overall Study|Lack of Efficacy|0
6038488|NCT00666926|20869517|P1|Overall Study|Lack of Efficacy|0
6038489|NCT00666926|20869502|P16|Overall Study|Laboratory abnormality|1
6038490|NCT00666926|20869503|P15|Overall Study|Laboratory abnormality|0
6038491|NCT00666926|20869504|P14|Overall Study|Laboratory abnormality|0
6038492|NCT00666926|20869505|P13|Overall Study|Laboratory abnormality|0
6038493|NCT00666926|20869506|P12|Overall Study|Laboratory abnormality|0
6038494|NCT00666926|20869507|P11|Overall Study|Laboratory abnormality|1
6038495|NCT00666926|20869508|P10|Overall Study|Laboratory abnormality|0
6038496|NCT00666926|20869509|P9|Overall Study|Laboratory abnormality|0
6038497|NCT00666926|20869510|P8|Overall Study|Laboratory abnormality|0
6038498|NCT00666926|20869511|P7|Overall Study|Laboratory abnormality|0
6038499|NCT00666926|20869512|P6|Overall Study|Laboratory abnormality|0
6038500|NCT00666926|20869513|P5|Overall Study|Laboratory abnormality|0
6038501|NCT00666926|20869514|P4|Overall Study|Laboratory abnormality|0
6038502|NCT00666926|20869515|P3|Overall Study|Laboratory abnormality|0
6038503|NCT00666926|20869516|P2|Overall Study|Laboratory abnormality|0
6038504|NCT00666926|20869517|P1|Overall Study|Laboratory abnormality|0
6038505|NCT00666926|20869502|P16|Overall Study|Adverse Event|0
6038506|NCT00666926|20869503|P15|Overall Study|Adverse Event|0
6038507|NCT00666926|20869504|P14|Overall Study|Adverse Event|1
6038508|NCT00666926|20869505|P13|Overall Study|Adverse Event|0
6038509|NCT00666926|20869506|P12|Overall Study|Adverse Event|2
6038510|NCT00666926|20869507|P11|Overall Study|Adverse Event|2
6038511|NCT00666926|20869508|P10|Overall Study|Adverse Event|2
6038512|NCT00666926|20869509|P9|Overall Study|Adverse Event|0
6038513|NCT00666926|20869510|P8|Overall Study|Adverse Event|0
6038514|NCT00666926|20869511|P7|Overall Study|Adverse Event|0
6038515|NCT00666926|20869512|P6|Overall Study|Adverse Event|0
6038516|NCT00666926|20869513|P5|Overall Study|Adverse Event|0
6038517|NCT00666926|20869514|P4|Overall Study|Adverse Event|0
6038518|NCT00666926|20869515|P3|Overall Study|Adverse Event|0
6038519|NCT00666926|20869516|P2|Overall Study|Adverse Event|0
6038520|NCT00666926|20869517|P1|Overall Study|Adverse Event|0
6038521|NCT00666835|20869826|P2|Overall Study|Physician Decision|2
6038522|NCT00666835|20869827|P1|Overall Study|Physician Decision|1
6038523|NCT00666835|20869826|P2|Overall Study|Planned operation|0
6038524|NCT00666835|20869827|P1|Overall Study|Planned operation|2
6038525|NCT00666835|20869826|P2|Overall Study|Hemoglobulin concentration|3
6038526|NCT00666835|20869827|P1|Overall Study|Hemoglobulin concentration|4
6038527|NCT00666835|20869826|P2|Overall Study|Kidney Transplantation (NTX)|2
6038528|NCT00666835|20869827|P1|Overall Study|Kidney Transplantation (NTX)|10
6038529|NCT00666835|20869826|P2|Overall Study|Death|4
6038530|NCT00666835|20869827|P1|Overall Study|Death|15
6038531|NCT00666835|20869826|P2|Overall Study|Protocol Violation|0
6038532|NCT00666835|20869827|P1|Overall Study|Protocol Violation|2
6038533|NCT00666835|20869826|P2|Overall Study|Adverse Event|6
6038534|NCT00666835|20869827|P1|Overall Study|Adverse Event|7
6038535|NCT00666835|20869826|P2|Overall Study|Incl./excl. not fulfilled|2
6038536|NCT00666835|20869827|P1|Overall Study|Incl./excl. not fulfilled|7
6038537|NCT00666835|20869826|P2|Overall Study|Lack of Efficacy|1
6038538|NCT00666835|20869827|P1|Overall Study|Lack of Efficacy|0
6038539|NCT00666835|20869826|P2|Overall Study|Withdrawal by Subject|2
6038540|NCT00666835|20869827|P1|Overall Study|Withdrawal by Subject|5
6038541|NCT00666757|20869837|P2|Overall Study|Sponsor decision|1
6038542|NCT00666757|20869838|P1|Overall Study|Sponsor decision|0
6038543|NCT00666757|20869837|P2|Overall Study|Physician Decision|2
6038544|NCT00666757|20869838|P1|Overall Study|Physician Decision|0
6038545|NCT00666757|20869837|P2|Overall Study|Lack of Efficacy|6
6038546|NCT00666757|20869838|P1|Overall Study|Lack of Efficacy|3
6038547|NCT00666757|20869837|P2|Overall Study|Withdrawal by Subject|17
6038548|NCT00666757|20869838|P1|Overall Study|Withdrawal by Subject|13
6038549|NCT00666757|20869837|P2|Overall Study|Adverse Event|12
6038550|NCT00666757|20869838|P1|Overall Study|Adverse Event|22
6038551|NCT00666757|20869837|P2|Overall Study|Protocol Violation|24
6038552|NCT00666757|20869838|P1|Overall Study|Protocol Violation|23
6038553|NCT00666757|20869837|P2|Overall Study|Lost to Follow-up|35
6038554|NCT00666757|20869838|P1|Overall Study|Lost to Follow-up|39
6038555|NCT00666718|20869897|P2|Overall Study|Physician Decision|2
6038556|NCT00666718|20869898|P1|Overall Study|Physician Decision|0
6038557|NCT00666718|20869897|P2|Overall Study|Withdrawal by Subject|12
6038558|NCT00666718|20869898|P1|Overall Study|Withdrawal by Subject|7
6038559|NCT00666718|20869897|P2|Overall Study|Protocol Violation|3
6038560|NCT00666718|20869898|P1|Overall Study|Protocol Violation|1
6038561|NCT00666718|20869897|P2|Overall Study|Entry Criteria Not Met|0
6038562|NCT00666718|20869898|P1|Overall Study|Entry Criteria Not Met|2
6038563|NCT00666718|20869897|P2|Overall Study|Lost to Follow-up|0
6038564|NCT00666718|20869898|P1|Overall Study|Lost to Follow-up|1
6038565|NCT00666718|20869897|P2|Overall Study|Death|0
6038566|NCT00666718|20869898|P1|Overall Study|Death|1
6038567|NCT00666718|20869897|P2|Overall Study|Adverse Event|1
6038568|NCT00666718|20869898|P1|Overall Study|Adverse Event|0
6038569|NCT00666705|20869924|P1|Overall Study|Withdrawal by Subject|1
6038570|NCT00666679|20869943|P2|Second Intervention|Death|1
6038571|NCT00666679|20869944|P1|Second Intervention|Death|0
6038572|NCT00666679|20869943|P2|Second Intervention|Adverse Event|0
6038573|NCT00666679|20869944|P1|Second Intervention|Adverse Event|1
6038574|NCT00666679|20869943|P2|Washout Period of 1 Week|Protocol Violation|1
6038575|NCT00666679|20869944|P1|Washout Period of 1 Week|Protocol Violation|0
6038576|NCT00666679|20869943|P2|Washout Period of 1 Week|Lost to Follow-up|1
6038577|NCT00666679|20869944|P1|Washout Period of 1 Week|Lost to Follow-up|0
6038578|NCT00666679|20869943|P2|First Intervention|Randomized did not start treatment|1
6038579|NCT00666679|20869944|P1|First Intervention|Randomized did not start treatment|1
6038580|NCT00666679|20869943|P2|First Intervention|Withdrawal by Subject|0
6038581|NCT00666679|20869944|P1|First Intervention|Withdrawal by Subject|1
6038582|NCT00666679|20869943|P2|First Intervention|Protocol Violation|0
6038583|NCT00666679|20869944|P1|First Intervention|Protocol Violation|1
6038584|NCT00666679|20869943|P2|First Intervention|Lost to Follow-up|0
6038585|NCT00666679|20869944|P1|First Intervention|Lost to Follow-up|1
6038586|NCT00666588|20869974|P4|Overall Study|inevaluable|0
6038587|NCT00666588|20869975|P3|Overall Study|inevaluable|0
6038588|NCT00666588|20869976|P2|Overall Study|inevaluable|0
6038589|NCT00666588|20869977|P1|Overall Study|inevaluable|2
6038590|NCT00666588|20869974|P4|Overall Study|ineligible|2
6038591|NCT00666588|20869975|P3|Overall Study|ineligible|0
6038592|NCT00666588|20869976|P2|Overall Study|ineligible|0
6038593|NCT00666588|20869977|P1|Overall Study|ineligible|2
6038594|NCT00666562|20870010|P3|Overall Study|Concomitant Medication|0
6038595|NCT00666562|20870011|P2|Overall Study|Concomitant Medication|1
6038596|NCT00666562|20870012|P1|Overall Study|Concomitant Medication|0
6038597|NCT00666562|20870010|P3|Overall Study|Withdrawal by Subject|0
6038598|NCT00666562|20870011|P2|Overall Study|Withdrawal by Subject|1
6038599|NCT00666562|20870012|P1|Overall Study|Withdrawal by Subject|0
6038600|NCT00666536|20870059|P2|Overall Study|Lost to Follow-up|3
6038601|NCT00666536|20870060|P1|Overall Study|Lost to Follow-up|4
6038602|NCT00666536|20870059|P2|Overall Study|Withdrawal by Subject|9
6038603|NCT00666536|20870060|P1|Overall Study|Withdrawal by Subject|10
6038604|NCT00666536|20870059|P2|Overall Study|Protocol deviation(s)|6
6038605|NCT00666536|20870060|P1|Overall Study|Protocol deviation(s)|8
6038606|NCT00666536|20870059|P2|Overall Study|Unsatisfactory therapeutic effect|0
6038607|NCT00666536|20870060|P1|Overall Study|Unsatisfactory therapeutic effect|2
6038608|NCT00666536|20870059|P2|Overall Study|Adverse Event|19
6038609|NCT00666536|20870060|P1|Overall Study|Adverse Event|9
6038610|NCT00666458|20870078|P2|Overall Study|Medical history of anemia|0
6038611|NCT00666458|20870079|P1|Overall Study|Medical history of anemia|1
6038612|NCT00666458|20870078|P2|Overall Study|Safety reasons|0
6038613|NCT00666458|20870079|P1|Overall Study|Safety reasons|1
6038614|NCT00666458|20870078|P2|Overall Study|Severe non-compliance to the protocol|1
6038615|NCT00666458|20870079|P1|Overall Study|Severe non-compliance to the protocol|1
6038616|NCT00666458|20870078|P2|Overall Study|Study specific discontinuation criteria|7
6038617|NCT00666458|20870079|P1|Overall Study|Study specific discontinuation criteria|14
6038618|NCT00666458|20870078|P2|Overall Study|Incorrect enrollment|1
6038619|NCT00666458|20870079|P1|Overall Study|Incorrect enrollment|7
6038620|NCT00666458|20870078|P2|Overall Study|Administrative reason by sponsor|1
6038621|NCT00666458|20870079|P1|Overall Study|Administrative reason by sponsor|1
6038622|NCT00666458|20870078|P2|Overall Study|Lost to Follow-up|3
6038623|NCT00666458|20870079|P1|Overall Study|Lost to Follow-up|0
6038624|NCT00666458|20870078|P2|Overall Study|Withdrawal by Subject|4
6038625|NCT00666458|20870079|P1|Overall Study|Withdrawal by Subject|5
6038626|NCT00666458|20870078|P2|Overall Study|Adverse Event|7
6038627|NCT00666458|20870079|P1|Overall Study|Adverse Event|8
6038628|NCT00666328|20870167|P1|Overall Study|No longer met eligibility criteria|1
6038629|NCT00666328|20870167|P1|Overall Study|Lost to Follow-up|2
6038630|NCT00666328|20870167|P1|Overall Study|Death|2
6038631|NCT00666276|20870180|P1|Overall Study|Protocol Violation|34
6038632|NCT00666263|20870204|P2|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|1
6038633|NCT00666263|20870205|P1|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|0
6038634|NCT00666263|20870204|P2|Study Part 4 (Cross-over Period 2)|Adverse Event|0
6038635|NCT00666263|20870205|P1|Study Part 4 (Cross-over Period 2)|Adverse Event|1
6038636|NCT00666263|20870204|P2|Study Part 1 (Stabilization Phase 1)|Adverse Event|1
6038637|NCT00666263|20870205|P1|Study Part 1 (Stabilization Phase 1)|Adverse Event|0
6038638|NCT00666224|20870349|P2|Open-Label|Undefined/Unknown|1
6038639|NCT00666224|20870350|P1|Open-Label|Undefined/Unknown|1
6038640|NCT00666224|20870349|P2|Open-Label|Noncompliance|1
6038641|NCT00666224|20870350|P1|Open-Label|Noncompliance|2
6038642|NCT00666224|20870349|P2|Open-Label|Pregnancy|5
6038643|NCT00666224|20870350|P1|Open-Label|Pregnancy|1
6038644|NCT00666224|20870349|P2|Open-Label|Physician Decision|5
6038645|NCT00666224|20870350|P1|Open-Label|Physician Decision|7
6038646|NCT00666224|20870349|P2|Open-Label|Withdrawal by Subject|25
6038647|NCT00666224|20870350|P1|Open-Label|Withdrawal by Subject|12
6038648|NCT00666224|20870349|P2|Open-Label|Lost to Follow-up|5
6038649|NCT00666224|20870350|P1|Open-Label|Lost to Follow-up|4
6038650|NCT00666224|20870349|P2|Open-Label|Adverse Event|43
6038651|NCT00666224|20870350|P1|Open-Label|Adverse Event|8
6038652|NCT00666224|20870349|P2|Double-Blind|Undefined/Unknown|1
6038653|NCT00666224|20870350|P1|Double-Blind|Undefined/Unknown|4
6038654|NCT00666224|20870349|P2|Double-Blind|Death|0
6038655|NCT00666224|20870350|P1|Double-Blind|Death|1
6038656|NCT00666224|20870349|P2|Double-Blind|Noncompliance|0
6038657|NCT00666224|20870350|P1|Double-Blind|Noncompliance|1
6038658|NCT00666224|20870349|P2|Double-Blind|Pregnancy|2
6038659|NCT00666224|20870350|P1|Double-Blind|Pregnancy|3
6038660|NCT00666224|20870349|P2|Double-Blind|Sponsor decision|0
6038661|NCT00666224|20870350|P1|Double-Blind|Sponsor decision|1
6038662|NCT00666224|20870349|P2|Double-Blind|Physician Decision|3
6038663|NCT00666224|20870350|P1|Double-Blind|Physician Decision|0
6038664|NCT00666224|20870349|P2|Double-Blind|Withdrawal by Subject|14
6038665|NCT00666224|20870350|P1|Double-Blind|Withdrawal by Subject|18
6038666|NCT00666224|20870349|P2|Double-Blind|Lost to Follow-up|2
6038667|NCT00666224|20870350|P1|Double-Blind|Lost to Follow-up|2
6038668|NCT00666224|20870349|P2|Double-Blind|Adverse Event|5
6038669|NCT00666224|20870350|P1|Double-Blind|Adverse Event|15
6038670|NCT00666211|20870369|P2|Overall Study|Physician Decision|1
6038671|NCT00666211|20870370|P1|Overall Study|Physician Decision|0
6038672|NCT00666211|20870369|P2|Overall Study|off tx for other complicating disease|1
6038673|NCT00666211|20870370|P1|Overall Study|off tx for other complicating disease|0
6038674|NCT00666211|20870369|P2|Overall Study|Death|2
6038675|NCT00666211|20870370|P1|Overall Study|Death|0
6038676|NCT00666211|20870369|P2|Overall Study|hospital admission|5
6038677|NCT00666211|20870370|P1|Overall Study|hospital admission|0
6038678|NCT00666211|20870369|P2|Overall Study|toxicity|2
6038679|NCT00666211|20870370|P1|Overall Study|toxicity|0
6038680|NCT00666211|20870369|P2|Overall Study|Lost to Follow-up|0
6038681|NCT00666211|20870370|P1|Overall Study|Lost to Follow-up|2
6038682|NCT00666211|20870369|P2|Overall Study|disease progression|8
6038683|NCT00666211|20870370|P1|Overall Study|disease progression|1
6038684|NCT00666211|20870369|P2|Overall Study|patient non-compliant|6
6038685|NCT00666211|20870370|P1|Overall Study|patient non-compliant|6
6038686|NCT00666211|20870369|P2|Overall Study|went off medication, no more pain|0
6038687|NCT00666211|20870370|P1|Overall Study|went off medication, no more pain|1
6038688|NCT00666211|20870369|P2|Overall Study|Withdrawal by Subject|13
6038689|NCT00666211|20870370|P1|Overall Study|Withdrawal by Subject|10
6038694|NCT00665925|20870416|P4|Overall Study|Due to exclusion criteria|0
6038695|NCT00665925|20870417|P3|Overall Study|Due to exclusion criteria|0
6038696|NCT00665925|20870418|P2|Overall Study|Due to exclusion criteria|0
6038697|NCT00665925|20870419|P1|Overall Study|Due to exclusion criteria|1
6038698|NCT00665925|20870416|P4|Overall Study|Enrolled by mistake|1
6038699|NCT00665925|20870417|P3|Overall Study|Enrolled by mistake|0
6038700|NCT00665925|20870418|P2|Overall Study|Enrolled by mistake|0
6038701|NCT00665925|20870419|P1|Overall Study|Enrolled by mistake|0
6038702|NCT00665925|20870416|P4|Overall Study|Adverse Event|5
6038703|NCT00665925|20870417|P3|Overall Study|Adverse Event|10
6038704|NCT00665925|20870418|P2|Overall Study|Adverse Event|5
6038705|NCT00665925|20870419|P1|Overall Study|Adverse Event|1
6038706|NCT00665925|20870416|P4|Overall Study|Severe Non-Compliance to Protocol|1
6038707|NCT00665925|20870417|P3|Overall Study|Severe Non-Compliance to Protocol|1
6038708|NCT00665925|20870418|P2|Overall Study|Severe Non-Compliance to Protocol|0
6038709|NCT00665925|20870419|P1|Overall Study|Severe Non-Compliance to Protocol|0
6038710|NCT00665925|20870416|P4|Overall Study|Physician Decision|2
6038711|NCT00665925|20870417|P3|Overall Study|Physician Decision|1
6038712|NCT00665925|20870418|P2|Overall Study|Physician Decision|0
6038713|NCT00665925|20870419|P1|Overall Study|Physician Decision|0
6038714|NCT00665925|20870416|P4|Overall Study|Withdrawal by Subject|2
6038715|NCT00665925|20870417|P3|Overall Study|Withdrawal by Subject|3
6038716|NCT00665925|20870418|P2|Overall Study|Withdrawal by Subject|2
6038717|NCT00665925|20870419|P1|Overall Study|Withdrawal by Subject|2
6038718|NCT00665925|20870416|P4|Overall Study|Lost to Follow-up|2
6038719|NCT00665925|20870417|P3|Overall Study|Lost to Follow-up|2
6038720|NCT00665925|20870418|P2|Overall Study|Lost to Follow-up|2
6038721|NCT00665925|20870419|P1|Overall Study|Lost to Follow-up|1
6038722|NCT00665925|20870416|P4|Overall Study|Lack of Efficacy|8
6038723|NCT00665925|20870417|P3|Overall Study|Lack of Efficacy|9
6038724|NCT00665925|20870418|P2|Overall Study|Lack of Efficacy|8
6038725|NCT00665925|20870419|P1|Overall Study|Lack of Efficacy|10
6038726|NCT00665847|20870830|P1|Overall Study|Switch to Commercial Medication|1
6038727|NCT00665847|20870830|P1|Overall Study|Subject ineligible to continue the trial|1
6038728|NCT00665847|20870830|P1|Overall Study|Resistance to TMC125|1
6038729|NCT00665847|20870830|P1|Overall Study|Subject reached a virologic endpoint|4
6038730|NCT00665847|20870830|P1|Overall Study|Subject non-compliant|8
6038731|NCT00665847|20870830|P1|Overall Study|Withdrawal by Subject|2
6038732|NCT00665847|20870830|P1|Overall Study|Adverse Event|8
6038733|NCT00665652|20870847|P1|Overall Study|No longer met inclusion criteria.|1
6038734|NCT00665652|20870847|P1|Overall Study|Death|1
6038735|NCT00665652|20870847|P1|Overall Study|Adverse Event|4
6038736|NCT00665626|20870853|P2|Overall Study|Death|0
6038737|NCT00665626|20870854|P1|Overall Study|Death|1
6038738|NCT00665626|20870853|P2|Overall Study|Unably to comply with dosing regimen|1
6038739|NCT00665626|20870854|P1|Overall Study|Unably to comply with dosing regimen|0
6038740|NCT00665626|20870853|P2|Overall Study|Did not fulfil inclusion criteria|1
6038741|NCT00665626|20870854|P1|Overall Study|Did not fulfil inclusion criteria|0
6038742|NCT00665626|20870853|P2|Overall Study|Due to exclusion criteria|1
6038743|NCT00665626|20870854|P1|Overall Study|Due to exclusion criteria|0
6038744|NCT00665626|20870853|P2|Overall Study|Adverse Event|9
6038745|NCT00665626|20870854|P1|Overall Study|Adverse Event|1
6038746|NCT00665626|20870853|P2|Overall Study|Protocol Violation|2
6038747|NCT00665626|20870854|P1|Overall Study|Protocol Violation|0
6038748|NCT00665626|20870853|P2|Overall Study|Withdrawal by Subject|1
6038749|NCT00665626|20870854|P1|Overall Study|Withdrawal by Subject|0
6038750|NCT00665626|20870853|P2|Overall Study|Lost to Follow-up|2
6038751|NCT00665626|20870854|P1|Overall Study|Lost to Follow-up|0
6038752|NCT00665626|20870853|P2|Overall Study|Lack of Efficacy|5
6038753|NCT00665626|20870854|P1|Overall Study|Lack of Efficacy|8
6038754|NCT00665561|20870922|P2|Overall Study|Withdrawn due to pregnancy|1
6038755|NCT00665561|20870923|P1|Overall Study|Withdrawn due to pregnancy|0
6038756|NCT00665561|20870922|P2|Overall Study|Site closed|0
6038757|NCT00665561|20870923|P1|Overall Study|Site closed|8
6038758|NCT00665561|20870922|P2|Overall Study|Other|108
6038759|NCT00665561|20870923|P1|Overall Study|Other|123
6038760|NCT00665561|20870922|P2|Overall Study|Withdrawal by Subject|65
6038761|NCT00665561|20870923|P1|Overall Study|Withdrawal by Subject|74
6038762|NCT00665561|20870922|P2|Overall Study|Lost to Follow-up|264
6038763|NCT00665561|20870923|P1|Overall Study|Lost to Follow-up|203
6038764|NCT00665561|20870922|P2|Overall Study|Does not meet entrance criteria|21
6038765|NCT00665561|20870923|P1|Overall Study|Does not meet entrance criteria|19
6038766|NCT00665561|20870922|P2|Overall Study|Death recorded on subject summary pages|75
6038767|NCT00665561|20870923|P1|Overall Study|Death recorded on subject summary pages|75
6038768|NCT00665444|20870973|P1|Overall Study|Study Terminated by Study Sponsor|1
6038769|NCT00665444|20870973|P1|Overall Study|Physician Decision|1
6038770|NCT00665431|20870985|P3|Overall Study|Other|2
6038771|NCT00665431|20870986|P2|Overall Study|Other|7
6038772|NCT00665431|20870987|P1|Overall Study|Other|4
6038773|NCT00665431|20870985|P3|Overall Study|Lost to Follow-up|1
6038774|NCT00665431|20870986|P2|Overall Study|Lost to Follow-up|3
6038775|NCT00665431|20870987|P1|Overall Study|Lost to Follow-up|3
6038776|NCT00665431|20870985|P3|Overall Study|Withdrawal by Subject|15
6038777|NCT00665431|20870986|P2|Overall Study|Withdrawal by Subject|25
6038778|NCT00665431|20870987|P1|Overall Study|Withdrawal by Subject|17
6038779|NCT00665431|20870985|P3|Overall Study|Adverse Event|6
6038780|NCT00665431|20870986|P2|Overall Study|Adverse Event|22
6038781|NCT00665431|20870987|P1|Overall Study|Adverse Event|16
6038782|NCT00665366|20871030|P2|Overall Study|Other reasons|1
6038783|NCT00665366|20871031|P1|Overall Study|Other reasons|4
6038784|NCT00665366|20871030|P2|Overall Study|No longer meets study criteria|1
6038785|NCT00665366|20871031|P1|Overall Study|No longer meets study criteria|0
6038786|NCT00665366|20871030|P2|Overall Study|Pregnancy|0
6038787|NCT00665366|20871031|P1|Overall Study|Pregnancy|1
6038788|NCT00665366|20871030|P2|Overall Study|Poor compliance/noncompliance|5
6038789|NCT00665366|20871031|P1|Overall Study|Poor compliance/noncompliance|3
6038790|NCT00665366|20871030|P2|Overall Study|Lost to Follow-up|5
6038791|NCT00665366|20871031|P1|Overall Study|Lost to Follow-up|3
6038792|NCT00665366|20871030|P2|Overall Study|Withdrawal by Subject|14
6038793|NCT00665366|20871031|P1|Overall Study|Withdrawal by Subject|11
6038794|NCT00665366|20871030|P2|Overall Study|Adverse Event|23
6038795|NCT00665366|20871031|P1|Overall Study|Adverse Event|25
6038796|NCT00665366|20871030|P2|Overall Study|Lack of Efficacy|10
6038797|NCT00665366|20871031|P1|Overall Study|Lack of Efficacy|11
6038798|NCT00665353|20871059|P1|Study Step 2|Lack of Efficacy|12
6038799|NCT00665353|20871059|P1|Study Step 2|Lost to Follow-up|2
6038800|NCT00665353|20871059|P1|Study Step 1|Withdrawal by Subject|2
6038801|NCT00665353|20871059|P1|Study Step 1|Adverse Event|1
6038802|NCT00665002|20871076|P1|Overall Study|Cytogenetic resistance|1
6038803|NCT00665002|20871076|P1|Overall Study|Progression/relapse during treatment|11
6038804|NCT00664859|20871084|P3|Overall Study|Other|2
6038805|NCT00664859|20871085|P2|Overall Study|Other|1
6038806|NCT00664859|20871086|P1|Overall Study|Other|0
6038807|NCT00664859|20871084|P3|Overall Study|Lost to Follow-up|1
6038808|NCT00664859|20871085|P2|Overall Study|Lost to Follow-up|2
6038809|NCT00664859|20871086|P1|Overall Study|Lost to Follow-up|2
6038810|NCT00664859|20871084|P3|Overall Study|Withdrawal by Subject|3
6038811|NCT00664859|20871085|P2|Overall Study|Withdrawal by Subject|1
6038812|NCT00664859|20871086|P1|Overall Study|Withdrawal by Subject|4
6038813|NCT00664859|20871084|P3|Overall Study|Laboratory abnormality|4
6038814|NCT00664859|20871085|P2|Overall Study|Laboratory abnormality|1
6038815|NCT00664859|20871086|P1|Overall Study|Laboratory abnormality|2
6038816|NCT00664859|20871084|P3|Overall Study|Noncompliance with protocol|4
6038817|NCT00664859|20871085|P2|Overall Study|Noncompliance with protocol|0
6038818|NCT00664859|20871086|P1|Overall Study|Noncompliance with protocol|1
6038819|NCT00664859|20871084|P3|Overall Study|DB Study (LCP-AtorFen-2001) AE|4
6038820|NCT00664859|20871085|P2|Overall Study|DB Study (LCP-AtorFen-2001) AE|4
6038821|NCT00664859|20871086|P1|Overall Study|DB Study (LCP-AtorFen-2001) AE|6
6038822|NCT00664859|20871084|P3|Overall Study|Adverse Event|3
6038823|NCT00664859|20871085|P2|Overall Study|Adverse Event|1
6038824|NCT00664859|20871086|P1|Overall Study|Adverse Event|2
6038825|NCT00664742|20871106|P1|Overall Study|Lost to Follow-up|92
6038826|NCT00664742|20871106|P1|Overall Study|Withdrawal by Subject|31
6038827|NCT00664742|20871106|P1|Overall Study|Withdrawn due to adverse events|3
6038828|NCT00664560|20871114|P3|Overall Study|Other|5
6038829|NCT00664560|20871115|P2|Overall Study|Other|4
6038830|NCT00664560|20871116|P1|Overall Study|Other|11
6038831|NCT00664560|20871114|P3|Overall Study|Lost to Follow-up|0
6038832|NCT00664560|20871115|P2|Overall Study|Lost to Follow-up|2
6038833|NCT00664560|20871116|P1|Overall Study|Lost to Follow-up|0
6038834|NCT00664560|20871114|P3|Overall Study|Withdrawal by Subject|7
6038835|NCT00664560|20871115|P2|Overall Study|Withdrawal by Subject|13
6038836|NCT00664560|20871116|P1|Overall Study|Withdrawal by Subject|9
6038837|NCT00664560|20871114|P3|Overall Study|Adverse Event|7
6038838|NCT00664560|20871115|P2|Overall Study|Adverse Event|16
6038839|NCT00664560|20871116|P1|Overall Study|Adverse Event|19
6038840|NCT00664534|20871159|P2|Overall Study|Sponsor decision|6
6038841|NCT00664534|20871160|P1|Overall Study|Sponsor decision|8
6038842|NCT00664534|20871159|P2|Overall Study|Physician Decision|0
6038843|NCT00664534|20871160|P1|Overall Study|Physician Decision|8
6038844|NCT00664534|20871159|P2|Overall Study|Withdrawal by Subject|6
6038845|NCT00664534|20871160|P1|Overall Study|Withdrawal by Subject|7
6038846|NCT00664534|20871159|P2|Overall Study|Protocol Violation|8
6038847|NCT00664534|20871160|P1|Overall Study|Protocol Violation|10
6038848|NCT00664534|20871159|P2|Overall Study|Lost to Follow-up|10
6038849|NCT00664534|20871160|P1|Overall Study|Lost to Follow-up|6
6038850|NCT00664534|20871159|P2|Overall Study|Adverse Event|3
6038851|NCT00664534|20871160|P1|Overall Study|Adverse Event|2
6038852|NCT00664521|20871188|P2|Overall Study|Other|0
6038853|NCT00664521|20871189|P1|Overall Study|Other|1
6038854|NCT00664521|20871188|P2|Overall Study|Lost to Follow-up|0
6038855|NCT00664521|20871189|P1|Overall Study|Lost to Follow-up|1
6038856|NCT00664521|20871188|P2|Overall Study|Adverse Event|1
6038857|NCT00664521|20871189|P1|Overall Study|Adverse Event|4
6038858|NCT00664209|20871215|P1|Study Treatment Period|Withdrawal by Subject|2
6038859|NCT00664209|20871215|P1|Study Treatment Period|Physician Decision|4
6038860|NCT00664209|20871215|P1|Motor Fluctuations Screen|Negative for motor fluctuation|7
6038861|NCT00664105|20871223|P1|Overall Study|Disease progression|7
6038862|NCT00664105|20871223|P1|Overall Study|Adverse Event|9
6038863|NCT00664105|20871223|P1|Overall Study|Withdrawal by Subject|5
6038864|NCT00664105|20871223|P1|Overall Study|Death|3
6038865|NCT00664066|20871230|P1|Overall Study|Study terminated|3
6038866|NCT00663962|20871236|P2|Overall Study|somnolence|0
6038867|NCT00663962|20871237|P1|Overall Study|somnolence|1
6038868|NCT00663923|20871243|P1|Overall Study|Lost to Follow-up|2
6038869|NCT00663858|20871260|P3|Overall Study|Other|4
6038870|NCT00663858|20871261|P2|Overall Study|Other|2
6038871|NCT00663858|20871262|P1|Overall Study|Other|8
6038872|NCT00663858|20871260|P3|Overall Study|Protocol Violation|4
6038873|NCT00663858|20871261|P2|Overall Study|Protocol Violation|3
6038874|NCT00663858|20871262|P1|Overall Study|Protocol Violation|5
6038875|NCT00663858|20871260|P3|Overall Study|Withdrawal by Subject|3
6038876|NCT00663858|20871261|P2|Overall Study|Withdrawal by Subject|3
6038877|NCT00663858|20871262|P1|Overall Study|Withdrawal by Subject|7
6038878|NCT00663858|20871260|P3|Overall Study|Lack of Efficacy|3
6038879|NCT00663858|20871261|P2|Overall Study|Lack of Efficacy|1
6038880|NCT00663858|20871262|P1|Overall Study|Lack of Efficacy|5
6038881|NCT00663858|20871260|P3|Overall Study|Adverse Event|6
6038882|NCT00663858|20871261|P2|Overall Study|Adverse Event|1
6038883|NCT00663858|20871262|P1|Overall Study|Adverse Event|9
6038884|NCT00663702|20871300|P2|Overall Study|Lack of Efficacy|3
6038885|NCT00663702|20871301|P1|Overall Study|Lack of Efficacy|3
6038886|NCT00663702|20871300|P2|Overall Study|Death|1
6038887|NCT00663702|20871301|P1|Overall Study|Death|1
6038888|NCT00663702|20871300|P2|Overall Study|Lost to Follow-up|0
6038889|NCT00663702|20871301|P1|Overall Study|Lost to Follow-up|3
6038890|NCT00663702|20871300|P2|Overall Study|Pregnancy|1
6038891|NCT00663702|20871301|P1|Overall Study|Pregnancy|0
6038892|NCT00663702|20871300|P2|Overall Study|Withdrawal by Subject|1
6038893|NCT00663702|20871301|P1|Overall Study|Withdrawal by Subject|3
6038894|NCT00663702|20871300|P2|Overall Study|Adverse Event|4
6038895|NCT00663702|20871301|P1|Overall Study|Adverse Event|8
6038896|NCT00663260|20871337|P3|Overall Study|non-compliance, not met criteria, etc.|3
6038897|NCT00663260|20871338|P2|Overall Study|non-compliance, not met criteria, etc.|2
6038898|NCT00663260|20871339|P1|Overall Study|non-compliance, not met criteria, etc.|3
6038899|NCT00663260|20871337|P3|Overall Study|Lost to Follow-up|0
6038900|NCT00663260|20871338|P2|Overall Study|Lost to Follow-up|1
6038901|NCT00663260|20871339|P1|Overall Study|Lost to Follow-up|0
6038902|NCT00663260|20871337|P3|Overall Study|Death|1
6038903|NCT00663260|20871338|P2|Overall Study|Death|0
6038904|NCT00663260|20871339|P1|Overall Study|Death|1
6038905|NCT00663260|20871337|P3|Overall Study|Withdrawal by Subject|6
6038906|NCT00663260|20871338|P2|Overall Study|Withdrawal by Subject|1
6038907|NCT00663260|20871339|P1|Overall Study|Withdrawal by Subject|3
6038908|NCT00663260|20871337|P3|Overall Study|Adverse Event|6
6038909|NCT00663260|20871338|P2|Overall Study|Adverse Event|7
6038910|NCT00663260|20871339|P1|Overall Study|Adverse Event|12
6038911|NCT00663260|20871337|P3|Overall Study|Lack of Efficacy|0
6038912|NCT00663260|20871338|P2|Overall Study|Lack of Efficacy|0
6038913|NCT00663260|20871339|P1|Overall Study|Lack of Efficacy|2
6038914|NCT00663234|20871353|P1|Overall Study|Not willing to adhere to requirements|1
6038915|NCT00663208|20871386|P7|Follow-up Period|Other reason|1
6038916|NCT00663208|20871387|P6|Follow-up Period|Other reason|0
6038917|NCT00663208|20871388|P5|Follow-up Period|Other reason|0
6038918|NCT00663208|20871389|P4|Follow-up Period|Other reason|0
6038919|NCT00663208|20871390|P3|Follow-up Period|Other reason|0
6038920|NCT00663208|20871391|P2|Follow-up Period|Other reason|0
6038921|NCT00663208|20871392|P1|Follow-up Period|Other reason|1
6038922|NCT00663208|20871386|P7|Follow-up Period|Lost to Follow-up|0
6038923|NCT00663208|20871387|P6|Follow-up Period|Lost to Follow-up|0
6038924|NCT00663208|20871388|P5|Follow-up Period|Lost to Follow-up|0
6038925|NCT00663208|20871389|P4|Follow-up Period|Lost to Follow-up|2
6038926|NCT00663208|20871390|P3|Follow-up Period|Lost to Follow-up|3
6038927|NCT00663208|20871391|P2|Follow-up Period|Lost to Follow-up|0
6038928|NCT00663208|20871392|P1|Follow-up Period|Lost to Follow-up|2
6038929|NCT00663208|20871386|P7|Treatment Period|Lost to Follow-up|0
6038930|NCT00663208|20871387|P6|Treatment Period|Lost to Follow-up|0
6038931|NCT00663208|20871388|P5|Treatment Period|Lost to Follow-up|0
6038932|NCT00663208|20871389|P4|Treatment Period|Lost to Follow-up|0
6038933|NCT00663208|20871390|P3|Treatment Period|Lost to Follow-up|0
6038934|NCT00663208|20871391|P2|Treatment Period|Lost to Follow-up|1
6038935|NCT00663208|20871392|P1|Treatment Period|Lost to Follow-up|0
6038936|NCT00663117|20871570|P2|Overall Study|Lack of Efficacy|0
6038937|NCT00663117|20871571|P1|Overall Study|Lack of Efficacy|1
6038938|NCT00663052|20871585|P2|Overall Study|Other|1
6038939|NCT00663052|20871586|P1|Overall Study|Other|0
6038940|NCT00663052|20871585|P2|Overall Study|Unsatisfactory Response - Efficacy|1
6038941|NCT00663052|20871586|P1|Overall Study|Unsatisfactory Response - Efficacy|1
6038942|NCT00663052|20871585|P2|Overall Study|Withdrawal by Subject|5
6038943|NCT00663052|20871586|P1|Overall Study|Withdrawal by Subject|2
6038944|NCT00663052|20871585|P2|Overall Study|Protocol Violation|0
6038945|NCT00663052|20871586|P1|Overall Study|Protocol Violation|1
6038946|NCT00663052|20871585|P2|Overall Study|Discontinuation of Study by Sponsor|0
6038947|NCT00663052|20871586|P1|Overall Study|Discontinuation of Study by Sponsor|2
6038948|NCT00663052|20871585|P2|Overall Study|Adverse Event|3
6038949|NCT00663052|20871586|P1|Overall Study|Adverse Event|6
6038950|NCT00663026|20871692|P3|Overall Study|Withdrawal by Subject|1
6038951|NCT00663026|20871693|P2|Overall Study|Withdrawal by Subject|0
6038952|NCT00663026|20871694|P1|Overall Study|Withdrawal by Subject|0
6038953|NCT00663026|20871692|P3|Overall Study|Caregiver Request|0
6038954|NCT00663026|20871693|P2|Overall Study|Caregiver Request|2
6038955|NCT00663026|20871694|P1|Overall Study|Caregiver Request|0
6038956|NCT00663026|20871692|P3|Overall Study|Adverse Event|3
6038957|NCT00663026|20871693|P2|Overall Study|Adverse Event|2
6038958|NCT00663026|20871694|P1|Overall Study|Adverse Event|0
6038959|NCT00663026|20871692|P3|Overall Study|Other|0
6038960|NCT00663026|20871693|P2|Overall Study|Other|2
6038961|NCT00663026|20871694|P1|Overall Study|Other|1
6038962|NCT00663026|20871692|P3|Overall Study|Lost to Follow-up|0
6038963|NCT00663026|20871693|P2|Overall Study|Lost to Follow-up|0
6038964|NCT00663026|20871694|P1|Overall Study|Lost to Follow-up|1
6038965|NCT00662909|20871717|P3|Overall Study|Eligibility criterion not met|1
6038966|NCT00662909|20871718|P2|Overall Study|Eligibility criterion not met|1
6038967|NCT00662909|20871719|P1|Overall Study|Eligibility criterion not met|0
6038968|NCT00662909|20871717|P3|Overall Study|Physician Decision|2
6038969|NCT00662909|20871718|P2|Overall Study|Physician Decision|1
6038970|NCT00662909|20871719|P1|Overall Study|Physician Decision|1
6038971|NCT00662909|20871717|P3|Overall Study|Non-compliance with study procedures|2
6038972|NCT00662909|20871718|P2|Overall Study|Non-compliance with study procedures|3
6038973|NCT00662909|20871719|P1|Overall Study|Non-compliance with study procedures|3
6038974|NCT00662909|20871717|P3|Overall Study|Randomized- never received study drug|0
6038975|NCT00662909|20871718|P2|Overall Study|Randomized- never received study drug|0
6038976|NCT00662909|20871719|P1|Overall Study|Randomized- never received study drug|1
6038977|NCT00662909|20871717|P3|Overall Study|Protocol Violation|5
6038978|NCT00662909|20871718|P2|Overall Study|Protocol Violation|4
6038979|NCT00662909|20871719|P1|Overall Study|Protocol Violation|7
6038980|NCT00662909|20871717|P3|Overall Study|Lost to Follow-up|3
6038981|NCT00662909|20871718|P2|Overall Study|Lost to Follow-up|9
6038982|NCT00662909|20871719|P1|Overall Study|Lost to Follow-up|2
6038983|NCT00662909|20871717|P3|Overall Study|Withdrawal by Subject|16
6038984|NCT00662909|20871718|P2|Overall Study|Withdrawal by Subject|22
6038985|NCT00662909|20871719|P1|Overall Study|Withdrawal by Subject|29
6038986|NCT00662909|20871717|P3|Overall Study|Lack of Efficacy|5
6038987|NCT00662909|20871718|P2|Overall Study|Lack of Efficacy|1
6038988|NCT00662909|20871719|P1|Overall Study|Lack of Efficacy|9
6038989|NCT00662909|20871717|P3|Overall Study|Adverse Event|19
6038990|NCT00662909|20871718|P2|Overall Study|Adverse Event|18
6038991|NCT00662909|20871719|P1|Overall Study|Adverse Event|17
6038992|NCT00662857|20871817|P2|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|0
6038993|NCT00662857|20871818|P1|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|1
6038994|NCT00662857|20871817|P2|Washout 1 (3 - 14 Days)|Withdrawal by Subject|1
6038995|NCT00662857|20871818|P1|Washout 1 (3 - 14 Days)|Withdrawal by Subject|0
6038996|NCT00662857|20871817|P2|Washout 1 (3 - 14 Days)|Physician Decision|1
6038997|NCT00662857|20871818|P1|Washout 1 (3 - 14 Days)|Physician Decision|0
6038998|NCT00662831|20871833|P2|Overall Study|Adverse Event|16
6038999|NCT00662831|20871834|P1|Overall Study|Adverse Event|23
6039000|NCT00662831|20871833|P2|Overall Study|Protocol Violation|4
6039001|NCT00662831|20871834|P1|Overall Study|Protocol Violation|8
6039002|NCT00662831|20871833|P2|Overall Study|Other|31
6039003|NCT00662831|20871834|P1|Overall Study|Other|62
6039004|NCT00662831|20871833|P2|Overall Study|Withdrawal by Subject|1
6039005|NCT00662831|20871834|P1|Overall Study|Withdrawal by Subject|2
6039006|NCT00662831|20871833|P2|Overall Study|Lost to Follow-up|0
6039007|NCT00662831|20871834|P1|Overall Study|Lost to Follow-up|1
6039008|NCT00662831|20871833|P2|Overall Study|Lack of Efficacy|6
6039009|NCT00662831|20871834|P1|Overall Study|Lack of Efficacy|6
6039010|NCT00662831|20871833|P2|Overall Study|Death|1
6039011|NCT00662831|20871834|P1|Overall Study|Death|4
6039012|NCT00662649|20871914|P5|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3
6039013|NCT00662649|20871915|P4|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1
6039014|NCT00662649|20871916|P3|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|0
6039015|NCT00662649|20871917|P2|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1
6039016|NCT00662649|20871918|P1|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3
6039017|NCT00662649|20871914|P5|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0
6039018|NCT00662649|20871915|P4|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0
6039019|NCT00662649|20871916|P3|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0
6039020|NCT00662649|20871917|P2|Extension Study (Month 24 to 60)|Subject no longer requires study drug|1
6039021|NCT00662649|20871918|P1|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0
6039022|NCT00662649|20871914|P5|Extension Study (Month 24 to 60)|Subject withdrew consent|9
6039023|NCT00662649|20871915|P4|Extension Study (Month 24 to 60)|Subject withdrew consent|15
6039024|NCT00662649|20871916|P3|Extension Study (Month 24 to 60)|Subject withdrew consent|0
6039025|NCT00662649|20871917|P2|Extension Study (Month 24 to 60)|Subject withdrew consent|23
6039026|NCT00662649|20871918|P1|Extension Study (Month 24 to 60)|Subject withdrew consent|19
6039027|NCT00662649|20871914|P5|Extension Study (Month 24 to 60)|Protocol Violation|0
6039028|NCT00662649|20871915|P4|Extension Study (Month 24 to 60)|Protocol Violation|0
6039029|NCT00662649|20871916|P3|Extension Study (Month 24 to 60)|Protocol Violation|0
6039030|NCT00662649|20871917|P2|Extension Study (Month 24 to 60)|Protocol Violation|1
6039031|NCT00662649|20871918|P1|Extension Study (Month 24 to 60)|Protocol Violation|1
6039032|NCT00662649|20871914|P5|Extension Study (Month 24 to 60)|Lost to Follow-up|1
6039033|NCT00662649|20871915|P4|Extension Study (Month 24 to 60)|Lost to Follow-up|1
6039034|NCT00662649|20871916|P3|Extension Study (Month 24 to 60)|Lost to Follow-up|0
6039035|NCT00662649|20871917|P2|Extension Study (Month 24 to 60)|Lost to Follow-up|0
6039036|NCT00662649|20871918|P1|Extension Study (Month 24 to 60)|Lost to Follow-up|2
6039037|NCT00662649|20871914|P5|Extension Study (Month 24 to 60)|Adverse Event|10
6039038|NCT00662649|20871915|P4|Extension Study (Month 24 to 60)|Adverse Event|6
6039039|NCT00662649|20871916|P3|Extension Study (Month 24 to 60)|Adverse Event|0
6039040|NCT00662649|20871917|P2|Extension Study (Month 24 to 60)|Adverse Event|9
6039041|NCT00662649|20871918|P1|Extension Study (Month 24 to 60)|Adverse Event|6
6039042|NCT00662649|20871914|P5|Extension Study (Month 24 to 60)|Administrative problems|0
6039043|NCT00662649|20871915|P4|Extension Study (Month 24 to 60)|Administrative problems|1
6039044|NCT00662649|20871916|P3|Extension Study (Month 24 to 60)|Administrative problems|0
6039045|NCT00662649|20871917|P2|Extension Study (Month 24 to 60)|Administrative problems|0
6039046|NCT00662649|20871918|P1|Extension Study (Month 24 to 60)|Administrative problems|0
6039047|NCT00662649|20871914|P5|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3
6039048|NCT00662649|20871915|P4|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1
6039049|NCT00662649|20871916|P3|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|0
6039050|NCT00662649|20871917|P2|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1
6039051|NCT00662649|20871918|P1|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3
6039052|NCT00662649|20871914|P5|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|3
6039053|NCT00662649|20871915|P4|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|8
6039054|NCT00662649|20871916|P3|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|0
6039055|NCT00662649|20871917|P2|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|5
6039056|NCT00662649|20871918|P1|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|10
6039057|NCT00662649|20871914|P5|Core Study (24 Months)|Death|0
6039058|NCT00662649|20871915|P4|Core Study (24 Months)|Death|0
6039059|NCT00662649|20871916|P3|Core Study (24 Months)|Death|2
6039060|NCT00662649|20871917|P2|Core Study (24 Months)|Death|0
6039061|NCT00662649|20871918|P1|Core Study (24 Months)|Death|1
6039062|NCT00662649|20871914|P5|Core Study (24 Months)|Abnormal test procedure result(s)|0
6039063|NCT00662649|20871915|P4|Core Study (24 Months)|Abnormal test procedure result(s)|0
6039064|NCT00662649|20871916|P3|Core Study (24 Months)|Abnormal test procedure result(s)|1
6039065|NCT00662649|20871917|P2|Core Study (24 Months)|Abnormal test procedure result(s)|1
6039066|NCT00662649|20871918|P1|Core Study (24 Months)|Abnormal test procedure result(s)|2
6039067|NCT00662649|20871914|P5|Core Study (24 Months)|Protocol Violation|0
6039068|NCT00662649|20871915|P4|Core Study (24 Months)|Protocol Violation|0
6039069|NCT00662649|20871916|P3|Core Study (24 Months)|Protocol Violation|4
6039070|NCT00662649|20871917|P2|Core Study (24 Months)|Protocol Violation|5
6039071|NCT00662649|20871918|P1|Core Study (24 Months)|Protocol Violation|5
6039072|NCT00662649|20871914|P5|Core Study (24 Months)|Lost to Follow-up|0
6039073|NCT00662649|20871915|P4|Core Study (24 Months)|Lost to Follow-up|0
6039074|NCT00662649|20871916|P3|Core Study (24 Months)|Lost to Follow-up|7
6039075|NCT00662649|20871917|P2|Core Study (24 Months)|Lost to Follow-up|5
6039076|NCT00662649|20871918|P1|Core Study (24 Months)|Lost to Follow-up|3
6039077|NCT00662649|20871914|P5|Core Study (24 Months)|Abnormal laboratory value(s)|0
6039078|NCT00662649|20871915|P4|Core Study (24 Months)|Abnormal laboratory value(s)|0
6039079|NCT00662649|20871916|P3|Core Study (24 Months)|Abnormal laboratory value(s)|1
6039080|NCT00662649|20871917|P2|Core Study (24 Months)|Abnormal laboratory value(s)|9
6039081|NCT00662649|20871918|P1|Core Study (24 Months)|Abnormal laboratory value(s)|20
6039082|NCT00662649|20871914|P5|Core Study (24 Months)|Unsatisfactory therapeutic effect|0
6039083|NCT00662649|20871915|P4|Core Study (24 Months)|Unsatisfactory therapeutic effect|0
6039084|NCT00662649|20871916|P3|Core Study (24 Months)|Unsatisfactory therapeutic effect|25
6039085|NCT00662649|20871917|P2|Core Study (24 Months)|Unsatisfactory therapeutic effect|6
6039086|NCT00662649|20871918|P1|Core Study (24 Months)|Unsatisfactory therapeutic effect|13
6039087|NCT00662649|20871914|P5|Core Study (24 Months)|Adverse Event|0
6039088|NCT00662649|20871915|P4|Core Study (24 Months)|Adverse Event|0
6039089|NCT00662649|20871916|P3|Core Study (24 Months)|Adverse Event|18
6039090|NCT00662649|20871917|P2|Core Study (24 Months)|Adverse Event|13
6039091|NCT00662649|20871918|P1|Core Study (24 Months)|Adverse Event|22
6039092|NCT00662649|20871914|P5|Core Study (24 Months)|Withdrawal by Subject|0
6039093|NCT00662649|20871915|P4|Core Study (24 Months)|Withdrawal by Subject|0
6039094|NCT00662649|20871916|P3|Core Study (24 Months)|Withdrawal by Subject|28
6039095|NCT00662649|20871917|P2|Core Study (24 Months)|Withdrawal by Subject|17
6039096|NCT00662649|20871918|P1|Core Study (24 Months)|Withdrawal by Subject|31
6039109|NCT00662532|20872010|P2|Overall Study|Lost to Follow-up|1
6039110|NCT00662532|20872011|P1|Overall Study|Lost to Follow-up|0
6039111|NCT00662532|20872010|P2|Overall Study|Adverse Event|1
6039112|NCT00662532|20872011|P1|Overall Study|Adverse Event|0
6039113|NCT00662363|20872026|P2|Overall Study|Protocol Violation|1
6039114|NCT00662363|20872027|P1|Overall Study|Protocol Violation|1
6039115|NCT00662363|20872026|P2|Overall Study|Discharged early from rehab|1
6039116|NCT00662363|20872027|P1|Overall Study|Discharged early from rehab|4
6039117|NCT00662363|20872026|P2|Overall Study|Adverse Event|3
6039118|NCT00662363|20872027|P1|Overall Study|Adverse Event|0
6039119|NCT00662363|20872026|P2|Overall Study|Withdrawal by Subject|5
6039120|NCT00662363|20872027|P1|Overall Study|Withdrawal by Subject|6
6039121|NCT00662311|20872038|P3|Overall Study|Respiratory Infection|0
6039122|NCT00662311|20872039|P2|Overall Study|Respiratory Infection|0
6039123|NCT00662311|20872040|P1|Overall Study|Respiratory Infection|1
6039124|NCT00662259|20872075|P2|Overall Study|Adverse Event|0
6039125|NCT00662259|20872076|P1|Overall Study|Adverse Event|2
6039126|NCT00662129|20872118|P1|Overall Study|Ineligible|1
6039127|NCT00662129|20872118|P1|Overall Study|Cancel prior to beginning treatment|1
6039128|NCT00662129|20872118|P1|Overall Study|Protocol Violation|1
6039129|NCT00662038|20872128|P1|Overall Study|Continued treatment|5
6039130|NCT00662038|20872128|P1|Overall Study|Adverse Event|358
6039131|NCT00662038|20872128|P1|Overall Study|Death|95
6039132|NCT00662038|20872128|P1|Overall Study|Lost to Follow-up|1
6039133|NCT00662038|20872128|P1|Overall Study|Lung transplantation|44
6039134|NCT00662038|20872128|P1|Overall Study|Physician Decision|19
6039135|NCT00662038|20872128|P1|Overall Study|Sponsor decision|1
6039136|NCT00662038|20872128|P1|Overall Study|Withdrawal by Subject|83
6039137|NCT00662038|20872128|P1|Overall Study|Withdrawn consent|22
6039138|NCT00662038|20872128|P1|Overall Study|Reason not specified|3
6039139|NCT00662025|20872132|P1|Overall Study|Domestic circumstances|1
6039140|NCT00662025|20872132|P1|Overall Study|Target lesion cannot be evaluated|1
6039141|NCT00662025|20872132|P1|Overall Study|Results of other clinical study|2
6039142|NCT00662025|20872132|P1|Overall Study|Withdrawal by Subject|1
6039143|NCT00662025|20872132|P1|Overall Study|Adverse Event|7
6039144|NCT00662025|20872132|P1|Overall Study|Objective progression or relapse|51
6039148|NCT00661999|20872160|P3|Overall Study|Other Medical Problems|9
6039149|NCT00661999|20872161|P2|Overall Study|Other Medical Problems|4
6039150|NCT00661999|20872162|P1|Overall Study|Other Medical Problems|4
6039151|NCT00661999|20872160|P3|Overall Study|Alternative Treatment|0
6039152|NCT00661999|20872161|P2|Overall Study|Alternative Treatment|0
6039153|NCT00661999|20872162|P1|Overall Study|Alternative Treatment|1
6039154|NCT00661999|20872160|P3|Overall Study|Withdrawal by Subject|14
6039155|NCT00661999|20872161|P2|Overall Study|Withdrawal by Subject|23
6039156|NCT00661999|20872162|P1|Overall Study|Withdrawal by Subject|30
6039157|NCT00661999|20872160|P3|Overall Study|Other Reasons|23
6039158|NCT00661999|20872161|P2|Overall Study|Other Reasons|12
6039159|NCT00661999|20872162|P1|Overall Study|Other Reasons|5
6039160|NCT00661999|20872160|P3|Overall Study|Death|3
6039161|NCT00661999|20872161|P2|Overall Study|Death|6
6039162|NCT00661999|20872162|P1|Overall Study|Death|8
6039163|NCT00661999|20872160|P3|Overall Study|Adverse Event|8
6039164|NCT00661999|20872161|P2|Overall Study|Adverse Event|5
6039165|NCT00661999|20872162|P1|Overall Study|Adverse Event|11
6039166|NCT00661830|20872239|P2|Overall Study|Other reason|5
6039167|NCT00661830|20872240|P1|Overall Study|Other reason|1
6039168|NCT00661830|20872239|P2|Overall Study|Withdrawal by Subject|1
6039169|NCT00661830|20872240|P1|Overall Study|Withdrawal by Subject|1
6039170|NCT00661830|20872239|P2|Overall Study|Lost to Follow-up|3
6039171|NCT00661830|20872240|P1|Overall Study|Lost to Follow-up|1
6039172|NCT00661830|20872239|P2|Overall Study|Death|33
6039173|NCT00661830|20872240|P1|Overall Study|Death|37
6039174|NCT00661778|20872252|P1|Overall Study|Withdrawal of Consent|1
6039175|NCT00661778|20872252|P1|Overall Study|Protocol Violation|2
6039176|NCT00661778|20872252|P1|Overall Study|Reason not Specified|6
6039177|NCT00661778|20872252|P1|Overall Study|Adverse Event|18
6039178|NCT00661778|20872252|P1|Overall Study|Disease Progression|23
6039179|NCT00661726|20872259|P1|Overall Study|Adverse Event|1
6039180|NCT00661713|20872282|P8|Overall Study|Inappropriate Enrollment|0
6039181|NCT00661713|20872283|P7|Overall Study|Inappropriate Enrollment|1
6039182|NCT00661713|20872284|P6|Overall Study|Inappropriate Enrollment|0
6039183|NCT00661713|20872285|P5|Overall Study|Inappropriate Enrollment|0
6039184|NCT00661713|20872286|P4|Overall Study|Inappropriate Enrollment|0
6039185|NCT00661713|20872287|P3|Overall Study|Inappropriate Enrollment|0
6039186|NCT00661713|20872288|P2|Overall Study|Inappropriate Enrollment|0
6039187|NCT00661713|20872289|P1|Overall Study|Inappropriate Enrollment|0
6039188|NCT00661713|20872282|P8|Overall Study|Adverse Event|0
6039189|NCT00661713|20872283|P7|Overall Study|Adverse Event|1
6039190|NCT00661713|20872284|P6|Overall Study|Adverse Event|0
6039191|NCT00661713|20872285|P5|Overall Study|Adverse Event|0
6039192|NCT00661713|20872286|P4|Overall Study|Adverse Event|0
6039193|NCT00661713|20872287|P3|Overall Study|Adverse Event|0
6039194|NCT00661713|20872288|P2|Overall Study|Adverse Event|0
6039195|NCT00661713|20872289|P1|Overall Study|Adverse Event|0
6039196|NCT00661713|20872282|P8|Overall Study|Administrative Reason|0
6039197|NCT00661713|20872283|P7|Overall Study|Administrative Reason|1
6039198|NCT00661713|20872284|P6|Overall Study|Administrative Reason|2
6039199|NCT00661713|20872285|P5|Overall Study|Administrative Reason|2
6039200|NCT00661713|20872286|P4|Overall Study|Administrative Reason|2
6039201|NCT00661713|20872287|P3|Overall Study|Administrative Reason|0
6039202|NCT00661713|20872288|P2|Overall Study|Administrative Reason|1
6039203|NCT00661713|20872289|P1|Overall Study|Administrative Reason|0
6039204|NCT00661713|20872282|P8|Overall Study|Lost to Follow-up|1
6039205|NCT00661713|20872283|P7|Overall Study|Lost to Follow-up|14
6039206|NCT00661713|20872284|P6|Overall Study|Lost to Follow-up|7
6039207|NCT00661713|20872285|P5|Overall Study|Lost to Follow-up|5
6039208|NCT00661713|20872286|P4|Overall Study|Lost to Follow-up|2
6039209|NCT00661713|20872287|P3|Overall Study|Lost to Follow-up|2
6039210|NCT00661713|20872288|P2|Overall Study|Lost to Follow-up|7
6039211|NCT00661713|20872289|P1|Overall Study|Lost to Follow-up|2
6039212|NCT00661713|20872282|P8|Overall Study|Withdrawal by Subject|9
6039213|NCT00661713|20872283|P7|Overall Study|Withdrawal by Subject|45
6039214|NCT00661713|20872284|P6|Overall Study|Withdrawal by Subject|26
6039215|NCT00661713|20872285|P5|Overall Study|Withdrawal by Subject|12
6039216|NCT00661713|20872286|P4|Overall Study|Withdrawal by Subject|21
6039217|NCT00661713|20872287|P3|Overall Study|Withdrawal by Subject|12
6039218|NCT00661713|20872288|P2|Overall Study|Withdrawal by Subject|25
6039219|NCT00661713|20872289|P1|Overall Study|Withdrawal by Subject|11
6039220|NCT00661713|20872282|P8|Overall Study|Protocol Violation|1
6039221|NCT00661713|20872283|P7|Overall Study|Protocol Violation|2
6039222|NCT00661713|20872284|P6|Overall Study|Protocol Violation|2
6039223|NCT00661713|20872285|P5|Overall Study|Protocol Violation|0
6039224|NCT00661713|20872286|P4|Overall Study|Protocol Violation|3
6039225|NCT00661713|20872287|P3|Overall Study|Protocol Violation|3
6039226|NCT00661713|20872288|P2|Overall Study|Protocol Violation|6
6039227|NCT00661713|20872289|P1|Overall Study|Protocol Violation|1
6039228|NCT00661713|20872282|P8|Overall Study|Unable to Classify|0
6039229|NCT00661713|20872283|P7|Overall Study|Unable to Classify|0
6039230|NCT00661713|20872284|P6|Overall Study|Unable to Classify|0
6039231|NCT00661713|20872285|P5|Overall Study|Unable to Classify|0
6039232|NCT00661713|20872286|P4|Overall Study|Unable to Classify|0
6039233|NCT00661713|20872287|P3|Overall Study|Unable to Classify|0
6039234|NCT00661713|20872288|P2|Overall Study|Unable to Classify|0
6039235|NCT00661713|20872289|P1|Overall Study|Unable to Classify|1
6039236|NCT00661713|20872282|P8|Overall Study|Death|0
6039237|NCT00661713|20872283|P7|Overall Study|Death|0
6039238|NCT00661713|20872284|P6|Overall Study|Death|0
6039239|NCT00661713|20872285|P5|Overall Study|Death|1
6039240|NCT00661713|20872286|P4|Overall Study|Death|0
6039241|NCT00661713|20872287|P3|Overall Study|Death|0
6039242|NCT00661713|20872288|P2|Overall Study|Death|0
6039243|NCT00661713|20872289|P1|Overall Study|Death|1
6039244|NCT00661687|20872381|P1|Overall Study|Adverse Event|2
6039245|NCT00661687|20872381|P1|Overall Study|Physician Decision|1
6039246|NCT00661687|20872381|P1|Overall Study|Inability to maintain wearing schedule|3
6039247|NCT00661687|20872381|P1|Overall Study|Positive slit lamp findings|4
6039248|NCT00661687|20872381|P1|Overall Study|Study related symptoms and complaints|5
6039249|NCT00661661|20872409|P2|Overall Study|Not assigned treatment|0
6039250|NCT00661661|20872410|P1|Overall Study|Not assigned treatment|1
6039251|NCT00661661|20872409|P2|Overall Study|Other|7
6039252|NCT00661661|20872410|P1|Overall Study|Other|22
6039253|NCT00661661|20872409|P2|Overall Study|Withdrawal by Subject|5
6039254|NCT00661661|20872410|P1|Overall Study|Withdrawal by Subject|15
6039255|NCT00661661|20872409|P2|Overall Study|Lost to Follow-up|1
6039256|NCT00661661|20872410|P1|Overall Study|Lost to Follow-up|0
6039257|NCT00661661|20872409|P2|Overall Study|Lack of Efficacy|2
6039258|NCT00661661|20872410|P1|Overall Study|Lack of Efficacy|3
6039259|NCT00661661|20872409|P2|Overall Study|Adverse Event|24
6039260|NCT00661661|20872410|P1|Overall Study|Adverse Event|99
6039261|NCT00661622|20872486|P2|Overall Study|Protocol Violation|0
6039262|NCT00661622|20872487|P1|Overall Study|Protocol Violation|1
6039263|NCT00661609|20872501|P1|Overall Study|Disease progression|3
6039264|NCT00661609|20872501|P1|Overall Study|Survival follow up stage discontinued|11
6039265|NCT00661609|20872501|P1|Overall Study|PI Decision|1
6039266|NCT00661609|20872501|P1|Overall Study|Withdrawal by Subject|2
6039267|NCT00661609|20872501|P1|Overall Study|Death|20
6039268|NCT00661609|20872501|P1|Overall Study|Adverse Event|4
6039269|NCT00661531|20872568|P1|Overall Study|Withdrawal by Subject|3
6039270|NCT00661505|20872573|P1|Overall Study|Other|2
6039271|NCT00661505|20872573|P1|Overall Study|Lost to Follow-up|3
6039272|NCT00661505|20872573|P1|Overall Study|Withdrawal by Subject|8
6039273|NCT00661505|20872573|P1|Overall Study|Protocol Violation|14
6039274|NCT00661505|20872573|P1|Overall Study|Adverse Event|3
6039275|NCT00661492|20872601|P2|Overall Study|Other|0
6039276|NCT00661492|20872602|P1|Overall Study|Other|1
6039277|NCT00661492|20872601|P2|Overall Study|Lost to Follow-up|1
6039278|NCT00661492|20872602|P1|Overall Study|Lost to Follow-up|0
6039279|NCT00661492|20872601|P2|Overall Study|Investigator Request|0
6039280|NCT00661492|20872602|P1|Overall Study|Investigator Request|1
6039281|NCT00661492|20872601|P2|Overall Study|Patient Request|1
6039282|NCT00661492|20872602|P1|Overall Study|Patient Request|6
6039283|NCT00661492|20872601|P2|Overall Study|Disease Progression|14
6039284|NCT00661492|20872602|P1|Overall Study|Disease Progression|44
6039285|NCT00661492|20872601|P2|Overall Study|Adverse Event|13
6039286|NCT00661492|20872602|P1|Overall Study|Adverse Event|16
6039287|NCT00661427|20872677|P2|Overall Study|Patient not treated|2
6039288|NCT00661427|20872678|P1|Overall Study|Patient not treated|0
6039289|NCT00661427|20872677|P2|Overall Study|Adverse Event|5
6039290|NCT00661427|20872678|P1|Overall Study|Adverse Event|5
6039291|NCT00661388|20872686|P1|Overall Study|Administrative reasons|1
6039292|NCT00661388|20872686|P1|Overall Study|Dialysis initiation|1
6039293|NCT00661388|20872686|P1|Overall Study|Renal transplantation|1
6039294|NCT00661388|20872686|P1|Overall Study|Protocol Violation|7
6039295|NCT00661388|20872686|P1|Overall Study|Adverse Event|14
6039296|NCT00661362|20872709|P2|Overall Study|Metformin dose haven't decreasd to 2.5 g|0
6039297|NCT00661362|20872710|P1|Overall Study|Metformin dose haven't decreasd to 2.5 g|1
6039298|NCT00661362|20872709|P2|Overall Study|Safety reasons|0
6039299|NCT00661362|20872710|P1|Overall Study|Safety reasons|1
6039300|NCT00661362|20872709|P2|Overall Study|Severe non-compliance to protocol|1
6039301|NCT00661362|20872710|P1|Overall Study|Severe non-compliance to protocol|0
6039302|NCT00661362|20872709|P2|Overall Study|Lost to Follow-up|1
6039303|NCT00661362|20872710|P1|Overall Study|Lost to Follow-up|3
6039304|NCT00661362|20872709|P2|Overall Study|Withdrawal by Subject|23
6039305|NCT00661362|20872710|P1|Overall Study|Withdrawal by Subject|13
6039306|NCT00661362|20872709|P2|Overall Study|Study specific discontinuation criteria|11
6039307|NCT00661362|20872710|P1|Overall Study|Study specific discontinuation criteria|4
6039308|NCT00661362|20872709|P2|Overall Study|Incorrect enrollment|0
6039309|NCT00661362|20872710|P1|Overall Study|Incorrect enrollment|2
6039310|NCT00661362|20872709|P2|Overall Study|Adverse Event|4
6039311|NCT00661362|20872710|P1|Overall Study|Adverse Event|5
6039312|NCT00661271|20872728|P2|Overall Study|Lost to Follow-up|25
6039313|NCT00661271|20872729|P1|Overall Study|Lost to Follow-up|28
6039314|NCT00661258|20872739|P2|Overall Study|caught by police and in detox center|1
6039315|NCT00661258|20872740|P1|Overall Study|caught by police and in detox center|2
6039316|NCT00661258|20872739|P2|Overall Study|Death|0
6039317|NCT00661258|20872740|P1|Overall Study|Death|1
6039318|NCT00661193|20872750|P2|Overall Study|Not protocol specified|0
6039319|NCT00661193|20872751|P1|Overall Study|Not protocol specified|1
6039320|NCT00661193|20872750|P2|Overall Study|Progression|24
6039321|NCT00661193|20872751|P1|Overall Study|Progression|27
6039322|NCT00661193|20872750|P2|Overall Study|Withdrawal by Subject|1
6039323|NCT00661193|20872751|P1|Overall Study|Withdrawal by Subject|3
6039324|NCT00661193|20872750|P2|Overall Study|Adverse Event|1
6039325|NCT00661193|20872751|P1|Overall Study|Adverse Event|2
6039326|NCT00661089|20872976|P2|Overall Study|death at 8 weeks due to new stroke|1
6039327|NCT00661089|20872977|P1|Overall Study|death at 8 weeks due to new stroke|0
6039328|NCT00661089|20872976|P2|Overall Study|1 subject withdrawal|1
6039329|NCT00661089|20872977|P1|Overall Study|1 subject withdrawal|0
6039330|NCT00660907|20873025|P2|Overall Study|Various|8
6039331|NCT00660907|20873026|P1|Overall Study|Various|11
6039332|NCT00660907|20873025|P2|Overall Study|Death|3
6039333|NCT00660907|20873026|P1|Overall Study|Death|1
6039334|NCT00660907|20873025|P2|Overall Study|Safety|0
6039335|NCT00660907|20873026|P1|Overall Study|Safety|1
6039336|NCT00660907|20873025|P2|Overall Study|Poor/Non-Compliance|1
6039337|NCT00660907|20873026|P1|Overall Study|Poor/Non-Compliance|5
6039338|NCT00660907|20873025|P2|Overall Study|Lost to Follow-up|3
6039339|NCT00660907|20873026|P1|Overall Study|Lost to Follow-up|3
6039340|NCT00660907|20873025|P2|Overall Study|Withdrawal by Subject|32
6039341|NCT00660907|20873026|P1|Overall Study|Withdrawal by Subject|23
6039342|NCT00660907|20873025|P2|Overall Study|Subject No Longer Meets Study Criteria|27
6039343|NCT00660907|20873026|P1|Overall Study|Subject No Longer Meets Study Criteria|6
6039344|NCT00660907|20873025|P2|Overall Study|Adverse Event|19
6039345|NCT00660907|20873026|P1|Overall Study|Adverse Event|33
6039346|NCT00660907|20873025|P2|Overall Study|Incorrect Enrollment|1
6039347|NCT00660907|20873026|P1|Overall Study|Incorrect Enrollment|1
6039348|NCT00660829|20873040|P2|Overall Study|Other|4
6039349|NCT00660829|20873041|P1|Overall Study|Other|9
6039350|NCT00660829|20873040|P2|Overall Study|Lost to Follow-up|2
6039351|NCT00660829|20873041|P1|Overall Study|Lost to Follow-up|3
6039352|NCT00660829|20873040|P2|Overall Study|Withdrawal by Subject|2
6039353|NCT00660829|20873041|P1|Overall Study|Withdrawal by Subject|1
6039354|NCT00660829|20873040|P2|Overall Study|Non-Compliance|4
6039355|NCT00660829|20873041|P1|Overall Study|Non-Compliance|0
6039356|NCT00660829|20873040|P2|Overall Study|Lack of Efficacy|3
6039357|NCT00660829|20873041|P1|Overall Study|Lack of Efficacy|2
6039358|NCT00660829|20873040|P2|Overall Study|Adverse Event|4
6039359|NCT00660829|20873041|P1|Overall Study|Adverse Event|3
6039360|NCT00660816|20873059|P2|Overall Study|Complicating Disease|1
6039361|NCT00660816|20873060|P1|Overall Study|Complicating Disease|0
6039362|NCT00660816|20873059|P2|Overall Study|Disease Progression|12
6039363|NCT00660816|20873060|P1|Overall Study|Disease Progression|16
6039364|NCT00660816|20873059|P2|Overall Study|Protocol Violation|0
6039365|NCT00660816|20873060|P1|Overall Study|Protocol Violation|1
6039366|NCT00660816|20873059|P2|Overall Study|Physician Decision|2
6039367|NCT00660816|20873060|P1|Overall Study|Physician Decision|0
6039368|NCT00660816|20873059|P2|Overall Study|Lack of Efficacy|0
6039369|NCT00660816|20873060|P1|Overall Study|Lack of Efficacy|1
6039370|NCT00660816|20873059|P2|Overall Study|Death|2
6039371|NCT00660816|20873060|P1|Overall Study|Death|0
6039372|NCT00660816|20873059|P2|Overall Study|Withdrawal by Subject|0
6039373|NCT00660816|20873060|P1|Overall Study|Withdrawal by Subject|1
6039374|NCT00660816|20873059|P2|Overall Study|Adverse Event|2
6039375|NCT00660816|20873060|P1|Overall Study|Adverse Event|1
6039376|NCT00660790|20873072|P1|3 Months to 2 Years|Withdrawal by Subject|17
6039377|NCT00660790|20873072|P1|Baseline to 3 Months|Withdrawal by Subject|2
6039378|NCT00660790|20873072|P1|Baseline to 3 Months|Death|1
6039379|NCT00660699|20873076|P1|Overall Study|Withdrawal by Subject|2
6039380|NCT00660660|20873092|P2|Overall Study|New medication after randomization|0
6039381|NCT00660660|20873093|P1|Overall Study|New medication after randomization|1
6039382|NCT00660660|20873092|P2|Overall Study|Incorrect enrollment and other|1
6039383|NCT00660660|20873093|P1|Overall Study|Incorrect enrollment and other|0
6039384|NCT00660660|20873092|P2|Overall Study|Withdrawal by Subject|0
6039385|NCT00660660|20873093|P1|Overall Study|Withdrawal by Subject|3
6039386|NCT00660660|20873092|P2|Overall Study|Lack of Efficacy|2
6039387|NCT00660660|20873093|P1|Overall Study|Lack of Efficacy|0
6039388|NCT00660660|20873092|P2|Overall Study|Lost to Follow-up|6
6039389|NCT00660660|20873093|P1|Overall Study|Lost to Follow-up|0
6039390|NCT00660660|20873092|P2|Overall Study|Adverse Event|0
6039391|NCT00660660|20873093|P1|Overall Study|Adverse Event|1
6039392|NCT00660595|20873193|P2|Overall Study|Non Specified reasons|0
6039393|NCT00660595|20873194|P1|Overall Study|Non Specified reasons|5
6039394|NCT00660595|20873193|P2|Overall Study|Participant left hospital|0
6039395|NCT00660595|20873194|P1|Overall Study|Participant left hospital|1
6039396|NCT00660595|20873193|P2|Overall Study|Did not consent to participate in study|8
6039397|NCT00660595|20873194|P1|Overall Study|Did not consent to participate in study|12
6039398|NCT00660595|20873193|P2|Overall Study|Lost to Follow-up|1
6039399|NCT00660595|20873194|P1|Overall Study|Lost to Follow-up|0
6039400|NCT00660400|20873261|P1|Overall Study|Withdrawal by Subject|1
6039401|NCT00660400|20873261|P1|Overall Study|Intracranial hemorrhage|1
6039402|NCT00660400|20873261|P1|Overall Study|Suboptimal organ function|1
6039403|NCT00660400|20873261|P1|Overall Study|Lack of insurance approval|1
6039404|NCT00660387|20873270|P2|Overall Study|Protocol Violation|0
6039405|NCT00660387|20873271|P1|Overall Study|Protocol Violation|1
6039406|NCT00660387|20873270|P2|Overall Study|Lack of Efficacy|1
6039407|NCT00660387|20873271|P1|Overall Study|Lack of Efficacy|0
6039408|NCT00660387|20873270|P2|Overall Study|Adverse Event|2
6039409|NCT00660387|20873271|P1|Overall Study|Adverse Event|1
6039410|NCT00660348|20873325|P2|Overall Study|Withdrawal by Subject|0
6039411|NCT00660348|20873326|P1|Overall Study|Withdrawal by Subject|1
6039412|NCT00660309|20873334|P2|Overall Study|Withdrawal by Subject|3
6039413|NCT00660309|20873335|P1|Overall Study|Withdrawal by Subject|0
6039414|NCT00660309|20873334|P2|Overall Study|Adverse Event|0
6039415|NCT00660309|20873335|P1|Overall Study|Adverse Event|2
6039416|NCT00660192|20873376|P2|Overall Study|Lost to Follow-up|3
6039417|NCT00660192|20873377|P1|Overall Study|Lost to Follow-up|2
6039418|NCT00660179|20873388|P3|Overall Study|Incorrect randomization|0
6039419|NCT00660179|20873389|P2|Overall Study|Incorrect randomization|0
6039420|NCT00660179|20873390|P1|Overall Study|Incorrect randomization|1
6039421|NCT00660179|20873388|P3|Overall Study|Administrative reason|1
6039422|NCT00660179|20873389|P2|Overall Study|Administrative reason|0
6039423|NCT00660179|20873390|P1|Overall Study|Administrative reason|0
6039424|NCT00660179|20873388|P3|Overall Study|Lost to Follow-up|2
6039425|NCT00660179|20873389|P2|Overall Study|Lost to Follow-up|5
6039426|NCT00660179|20873390|P1|Overall Study|Lost to Follow-up|7
6039427|NCT00660179|20873388|P3|Overall Study|Withdrawal of consent|4
6039428|NCT00660179|20873389|P2|Overall Study|Withdrawal of consent|6
6039429|NCT00660179|20873390|P1|Overall Study|Withdrawal of consent|4
6039430|NCT00660179|20873388|P3|Overall Study|Death|34
6039431|NCT00660179|20873389|P2|Overall Study|Death|47
6039432|NCT00660179|20873390|P1|Overall Study|Death|44
6039433|NCT00660023|20873435|P1|Overall Study|Other Screening Failure|9
6039434|NCT00660023|20873435|P1|Overall Study|Missed Pregnancy Test|1
6039435|NCT00660023|20873435|P1|Overall Study|Withdrawal by Subject|1
6039436|NCT00660023|20873435|P1|Overall Study|Renal Transplantation|3
6039437|NCT00660023|20873435|P1|Overall Study|Blood Transfusion|5
6039438|NCT00660023|20873435|P1|Overall Study|Death|8
6039439|NCT00660023|20873435|P1|Overall Study|Adverse Event|2
6039440|NCT00660010|20873446|P1|Overall Study|Noncompliance with visit schedule|3
6039441|NCT00660010|20873446|P1|Overall Study|Adverse Event|1
6039442|NCT00660010|20873446|P1|Overall Study|Lost to Follow-up|3
6039443|NCT00660010|20873446|P1|Overall Study|Withdrawal by Subject|2
6039444|NCT00659984|20873460|P1|Overall Study|Adverse Event|1
6039445|NCT00659880|20873480|P1|Overall Study|Lost to Follow-up|5
6039446|NCT00659815|20873493|P2|Overall Study|Withdrawal by Subject|1
6039447|NCT00659815|20873494|P1|Overall Study|Withdrawal by Subject|1
6039448|NCT00659815|20873493|P2|Overall Study|Inability to maintain wearing schedule|2
6039449|NCT00659815|20873494|P1|Overall Study|Inability to maintain wearing schedule|1
6039450|NCT00659815|20873493|P2|Overall Study|Study related symptoms and complaints|1
6039451|NCT00659815|20873494|P1|Overall Study|Study related symptoms and complaints|2
6039452|NCT00659607|20873573|P1|Overall Study|Inconsistent BP measuring date|2
6039453|NCT00659607|20873573|P1|Overall Study|No recorded efficacy data|15
6039454|NCT00659607|20873573|P1|Overall Study|'Unable to evaluate' for the final asses|67
6039455|NCT00659607|20873573|P1|Overall Study|Unknown measuring date of blood pressure|85
6039456|NCT00659607|20873573|P1|Overall Study|No blood pressure recorded|147
6039457|NCT00659581|20873591|P1|Overall Study|Other|6393
6039458|NCT00659581|20873591|P1|Overall Study|Lack of Efficacy|1183
6039459|NCT00659581|20873591|P1|Overall Study|Adverse Event|1006
6039460|NCT00659529|20873603|P1|Overall Study|Screen failure|9
6039461|NCT00659529|20873603|P1|Overall Study|Protocol Violation|3
6039462|NCT00659529|20873603|P1|Overall Study|Withdrawal by Subject|4
6039463|NCT00659490|20873610|P3|Overall Study|Lost to Follow-up|1
6039464|NCT00659490|20873611|P2|Overall Study|Lost to Follow-up|0
6039465|NCT00659490|20873612|P1|Overall Study|Lost to Follow-up|2
6039466|NCT00659438|20873685|P2|Overall Study|Lost to Follow-up|0
6039467|NCT00659438|20873686|P1|Overall Study|Lost to Follow-up|1
6039468|NCT00659438|20873685|P2|Overall Study|Death|6
6039469|NCT00659438|20873686|P1|Overall Study|Death|11
6039470|NCT00659438|20873685|P2|Overall Study|Withdrawal by Subject|2
6039471|NCT00659438|20873686|P1|Overall Study|Withdrawal by Subject|2
6039472|NCT00659425|20873718|P10|Overall Study|Other|6
6039473|NCT00659425|20873719|P9|Overall Study|Other|0
6039474|NCT00659425|20873720|P8|Overall Study|Other|2
6039475|NCT00659425|20873721|P7|Overall Study|Other|3
6039476|NCT00659425|20873722|P6|Overall Study|Other|0
6039477|NCT00659425|20873723|P5|Overall Study|Other|4
6039478|NCT00659425|20873724|P4|Overall Study|Other|2
6039479|NCT00659425|20873725|P3|Overall Study|Other|1
6039480|NCT00659425|20873726|P2|Overall Study|Other|1
6039481|NCT00659425|20873727|P1|Overall Study|Other|0
6039482|NCT00659425|20873718|P10|Overall Study|Investigator Discretion|0
6039483|NCT00659425|20873719|P9|Overall Study|Investigator Discretion|0
6039484|NCT00659425|20873720|P8|Overall Study|Investigator Discretion|3
6039485|NCT00659425|20873721|P7|Overall Study|Investigator Discretion|0
6039486|NCT00659425|20873722|P6|Overall Study|Investigator Discretion|1
6039487|NCT00659425|20873723|P5|Overall Study|Investigator Discretion|0
6039488|NCT00659425|20873724|P4|Overall Study|Investigator Discretion|0
6039489|NCT00659425|20873725|P3|Overall Study|Investigator Discretion|0
6039490|NCT00659425|20873726|P2|Overall Study|Investigator Discretion|0
6039491|NCT00659425|20873727|P1|Overall Study|Investigator Discretion|0
6039492|NCT00659425|20873718|P10|Overall Study|Adverse Event|4
6039493|NCT00659425|20873719|P9|Overall Study|Adverse Event|1
6039494|NCT00659425|20873720|P8|Overall Study|Adverse Event|3
6039495|NCT00659425|20873721|P7|Overall Study|Adverse Event|0
6039496|NCT00659425|20873722|P6|Overall Study|Adverse Event|1
6039497|NCT00659425|20873723|P5|Overall Study|Adverse Event|0
6039498|NCT00659425|20873724|P4|Overall Study|Adverse Event|0
6039499|NCT00659425|20873725|P3|Overall Study|Adverse Event|0
6039500|NCT00659425|20873726|P2|Overall Study|Adverse Event|0
6039501|NCT00659425|20873727|P1|Overall Study|Adverse Event|0
6039502|NCT00659425|20873718|P10|Overall Study|Death|0
6039503|NCT00659425|20873719|P9|Overall Study|Death|0
6039504|NCT00659425|20873720|P8|Overall Study|Death|0
6039505|NCT00659425|20873721|P7|Overall Study|Death|1
6039506|NCT00659425|20873722|P6|Overall Study|Death|0
6039507|NCT00659425|20873723|P5|Overall Study|Death|0
6039508|NCT00659425|20873724|P4|Overall Study|Death|1
6039509|NCT00659425|20873725|P3|Overall Study|Death|0
6039510|NCT00659425|20873726|P2|Overall Study|Death|0
6039511|NCT00659425|20873727|P1|Overall Study|Death|0
6039512|NCT00659425|20873718|P10|Overall Study|Disease progression|3
6039513|NCT00659425|20873719|P9|Overall Study|Disease progression|5
6039514|NCT00659425|20873720|P8|Overall Study|Disease progression|3
6039515|NCT00659425|20873721|P7|Overall Study|Disease progression|4
6039516|NCT00659425|20873722|P6|Overall Study|Disease progression|2
6039517|NCT00659425|20873723|P5|Overall Study|Disease progression|0
6039518|NCT00659425|20873724|P4|Overall Study|Disease progression|1
6039519|NCT00659425|20873725|P3|Overall Study|Disease progression|0
6039520|NCT00659425|20873726|P2|Overall Study|Disease progression|0
6039521|NCT00659425|20873727|P1|Overall Study|Disease progression|1
6039522|NCT00659373|20873958|P2|Overall Study|Assessment Missed|2
6039523|NCT00659373|20873959|P1|Overall Study|Assessment Missed|2
6039524|NCT00659373|20873958|P2|Overall Study|Withdrawal by Subject|5
6039525|NCT00659373|20873959|P1|Overall Study|Withdrawal by Subject|3
6039526|NCT00659334|20873981|P7|Overall Study|Screen Failure|1
6039527|NCT00659334|20873982|P6|Overall Study|Screen Failure|0
6039528|NCT00659334|20873983|P5|Overall Study|Screen Failure|0
6039529|NCT00659334|20873984|P4|Overall Study|Screen Failure|0
6039530|NCT00659334|20873985|P3|Overall Study|Screen Failure|0
6039531|NCT00659334|20873986|P2|Overall Study|Screen Failure|5
6039532|NCT00659334|20873987|P1|Overall Study|Screen Failure|8
6039533|NCT00659269|20874014|P2|Overall Study|Physician Decision|1
6039534|NCT00659269|20874015|P1|Overall Study|Physician Decision|1
6039535|NCT00659230|20874045|P2|Overall Study|Did not return post-randomization|3
6039536|NCT00659230|20874046|P1|Overall Study|Did not return post-randomization|2
6039537|NCT00659230|20874045|P2|Overall Study|Lost source documentation|4
6039538|NCT00659230|20874046|P1|Overall Study|Lost source documentation|5
6039539|NCT00659230|20874045|P2|Overall Study|Lost to Follow-up|5
6039540|NCT00659230|20874046|P1|Overall Study|Lost to Follow-up|2
6039541|NCT00659061|20874069|P2|Overall Study|Migration due to political unrest|15
6039542|NCT00659061|20874070|P1|Overall Study|Migration due to political unrest|21
6039543|NCT00658996|20874088|P2|Second Intervention|Positive slit lamp finding|1
6039544|NCT00658996|20874089|P1|Second Intervention|Positive slit lamp finding|0
6039545|NCT00658996|20874088|P2|Second Intervention|Developed a stye on upper lid|0
6039546|NCT00658996|20874089|P1|Second Intervention|Developed a stye on upper lid|1
6039547|NCT00658996|20874088|P2|Crossover Period|Ineligible|1
6039548|NCT00658996|20874089|P1|Crossover Period|Ineligible|1
6039549|NCT00658996|20874088|P2|Crossover Period|Physician Decision|0
6039550|NCT00658996|20874089|P1|Crossover Period|Physician Decision|1
6039551|NCT00658996|20874088|P2|First Intervention|Lack of lenses|1
6039552|NCT00658996|20874089|P1|First Intervention|Lack of lenses|0
6039553|NCT00658996|20874088|P2|First Intervention|Positive slit lamp finding|0
6039554|NCT00658996|20874089|P1|First Intervention|Positive slit lamp finding|1
6039555|NCT00658879|20874099|P1|Overall Study|Protocol Violation|1
6039556|NCT00658814|20874116|P2|Maintenance Therapy|Not eligible|0
6039557|NCT00658814|20874117|P1|Maintenance Therapy|Not eligible|1
6039558|NCT00658814|20874116|P2|Maintenance Therapy|Not protocol specified|0
6039559|NCT00658814|20874117|P1|Maintenance Therapy|Not protocol specified|1
6039560|NCT00658814|20874116|P2|Maintenance Therapy|Adverse Event|1
6039561|NCT00658814|20874117|P1|Maintenance Therapy|Adverse Event|1
6039562|NCT00658814|20874116|P2|Consolidation Therapy|Not eligible|2
6039563|NCT00658814|20874117|P1|Consolidation Therapy|Not eligible|2
6039564|NCT00658814|20874116|P2|Consolidation Therapy|Not protocol specified|1
6039565|NCT00658814|20874117|P1|Consolidation Therapy|Not protocol specified|0
6039566|NCT00658814|20874116|P2|Remission Induction Chemotherapy|Not eligible|2
6039567|NCT00658814|20874117|P1|Remission Induction Chemotherapy|Not eligible|1
6039568|NCT00658814|20874116|P2|Remission Induction Chemotherapy|Not protocol specified|4
6039569|NCT00658814|20874117|P1|Remission Induction Chemotherapy|Not protocol specified|2
6039570|NCT00658814|20874116|P2|Remission Induction Chemotherapy|Death|4
6039571|NCT00658814|20874117|P1|Remission Induction Chemotherapy|Death|1
6039572|NCT00658814|20874116|P2|Remission Induction Chemotherapy|Progression/Relapse|1
6039573|NCT00658814|20874117|P1|Remission Induction Chemotherapy|Progression/Relapse|0
6039574|NCT00658814|20874116|P2|Remission Induction Chemotherapy|Withdrawal by Subject|4
6039575|NCT00658814|20874117|P1|Remission Induction Chemotherapy|Withdrawal by Subject|3
6039576|NCT00658814|20874116|P2|Remission Induction Chemotherapy|Adverse Event|3
6039577|NCT00658814|20874117|P1|Remission Induction Chemotherapy|Adverse Event|1
6039578|NCT00658788|20874131|P1|Overall Study|Treatment Discontinuation|32
6039579|NCT00658788|20874131|P1|Overall Study|Lost to Follow-up|18
6039580|NCT00658788|20874131|P1|Overall Study|Withdrawal by Subject|13
6039581|NCT00658788|20874131|P1|Overall Study|Adverse Event|11
6039582|NCT00658775|20874186|P2|Overall Study|Other|8
6039583|NCT00658775|20874187|P1|Overall Study|Other|7
6039584|NCT00658775|20874186|P2|Overall Study|Withdrawal of consent|7
6039585|NCT00658775|20874187|P1|Overall Study|Withdrawal of consent|8
6039586|NCT00658775|20874186|P2|Overall Study|Withdrawal by Subject|4
6039587|NCT00658775|20874187|P1|Overall Study|Withdrawal by Subject|6
6039588|NCT00658775|20874186|P2|Overall Study|Lost to Follow-up|18
6039589|NCT00658775|20874187|P1|Overall Study|Lost to Follow-up|17
6039590|NCT00658775|20874186|P2|Overall Study|Adverse Event|6
6039591|NCT00658775|20874187|P1|Overall Study|Adverse Event|4
6039592|NCT00658723|20874210|P3|Overall Study|Withdrawal by Subject|1
6039593|NCT00658723|20874211|P2|Overall Study|Withdrawal by Subject|0
6039594|NCT00658723|20874212|P1|Overall Study|Withdrawal by Subject|1
6039595|NCT00658723|20874210|P3|Overall Study|Scheduling Issue|0
6039596|NCT00658723|20874211|P2|Overall Study|Scheduling Issue|1
6039597|NCT00658723|20874212|P1|Overall Study|Scheduling Issue|1
6039598|NCT00658723|20874210|P3|Overall Study|Death|4
6039599|NCT00658723|20874211|P2|Overall Study|Death|1
6039600|NCT00658723|20874212|P1|Overall Study|Death|2
6039601|NCT00658723|20874210|P3|Overall Study|Lost to Follow-up|2
6039602|NCT00658723|20874211|P2|Overall Study|Lost to Follow-up|2
6039603|NCT00658723|20874212|P1|Overall Study|Lost to Follow-up|0
6039604|NCT00658684|20874250|P4|Overall Study|Pregnancy|0
6039605|NCT00658684|20874251|P3|Overall Study|Pregnancy|0
6039606|NCT00658684|20874252|P2|Overall Study|Pregnancy|1
6039607|NCT00658684|20874253|P1|Overall Study|Pregnancy|1
6039608|NCT00658684|20874250|P4|Overall Study|Protocol Violation|0
6039609|NCT00658684|20874251|P3|Overall Study|Protocol Violation|0
6039610|NCT00658684|20874252|P2|Overall Study|Protocol Violation|1
6039611|NCT00658684|20874253|P1|Overall Study|Protocol Violation|1
6039612|NCT00658684|20874250|P4|Overall Study|Lack of Efficacy|0
6039613|NCT00658684|20874251|P3|Overall Study|Lack of Efficacy|0
6039614|NCT00658684|20874252|P2|Overall Study|Lack of Efficacy|1
6039615|NCT00658684|20874253|P1|Overall Study|Lack of Efficacy|1
6039616|NCT00658684|20874250|P4|Overall Study|Withdrawal by Subject|1
6039617|NCT00658684|20874251|P3|Overall Study|Withdrawal by Subject|1
6039618|NCT00658684|20874252|P2|Overall Study|Withdrawal by Subject|4
6039619|NCT00658684|20874253|P1|Overall Study|Withdrawal by Subject|6
6039620|NCT00658684|20874250|P4|Overall Study|Adverse Event|0
6039621|NCT00658684|20874251|P3|Overall Study|Adverse Event|2
6039622|NCT00658684|20874252|P2|Overall Study|Adverse Event|8
6039623|NCT00658684|20874253|P1|Overall Study|Adverse Event|10
6039624|NCT00658658|20874308|P5|Overall Study|Other|1
6039625|NCT00658658|20874309|P4|Overall Study|Other|0
6039626|NCT00658658|20874310|P3|Overall Study|Other|0
6039627|NCT00658658|20874311|P2|Overall Study|Other|0
6039628|NCT00658658|20874312|P1|Overall Study|Other|0
6039629|NCT00658658|20874308|P5|Overall Study|Protocol-specified Criteria|0
6039630|NCT00658658|20874309|P4|Overall Study|Protocol-specified Criteria|0
6039631|NCT00658658|20874310|P3|Overall Study|Protocol-specified Criteria|0
6039632|NCT00658658|20874311|P2|Overall Study|Protocol-specified Criteria|0
6039633|NCT00658658|20874312|P1|Overall Study|Protocol-specified Criteria|1
6039634|NCT00658658|20874308|P5|Overall Study|Disease Progression|3
6039635|NCT00658658|20874309|P4|Overall Study|Disease Progression|1
6039636|NCT00658658|20874310|P3|Overall Study|Disease Progression|0
6039637|NCT00658658|20874311|P2|Overall Study|Disease Progression|1
6039638|NCT00658658|20874312|P1|Overall Study|Disease Progression|0
6039639|NCT00658658|20874308|P5|Overall Study|Death|1
6039640|NCT00658658|20874309|P4|Overall Study|Death|1
6039641|NCT00658658|20874310|P3|Overall Study|Death|0
6039642|NCT00658658|20874311|P2|Overall Study|Death|0
6039643|NCT00658658|20874312|P1|Overall Study|Death|4
6039644|NCT00658658|20874308|P5|Overall Study|Withdrawal by Subject|0
6039645|NCT00658658|20874309|P4|Overall Study|Withdrawal by Subject|0
6039646|NCT00658658|20874310|P3|Overall Study|Withdrawal by Subject|0
6039647|NCT00658658|20874311|P2|Overall Study|Withdrawal by Subject|1
6039648|NCT00658658|20874312|P1|Overall Study|Withdrawal by Subject|0
6039649|NCT00658632|20874371|P2|Overall Study|Other|8
6039650|NCT00658632|20874372|P1|Overall Study|Other|7
6039651|NCT00658632|20874371|P2|Overall Study|Pregnancy|1
6039652|NCT00658632|20874372|P1|Overall Study|Pregnancy|1
6039653|NCT00658632|20874371|P2|Overall Study|Withdrawal of consent|14
6039654|NCT00658632|20874372|P1|Overall Study|Withdrawal of consent|8
6039655|NCT00658632|20874371|P2|Overall Study|Lack of Efficacy|1
6039656|NCT00658632|20874372|P1|Overall Study|Lack of Efficacy|0
6039657|NCT00658632|20874371|P2|Overall Study|Withdrawal by Subject|7
6039658|NCT00658632|20874372|P1|Overall Study|Withdrawal by Subject|10
6039659|NCT00658632|20874371|P2|Overall Study|Lost to Follow-up|23
6039660|NCT00658632|20874372|P1|Overall Study|Lost to Follow-up|25
6039661|NCT00658632|20874371|P2|Overall Study|Adverse Event|11
6039662|NCT00658632|20874372|P1|Overall Study|Adverse Event|13
6039663|NCT00658606|20874413|P2|Overall Study|Lack of Compliance|3
6039664|NCT00658606|20874414|P1|Overall Study|Lack of Compliance|0
6039665|NCT00658606|20874413|P2|Overall Study|Withdrawal by Subject|16
6039666|NCT00658606|20874414|P1|Overall Study|Withdrawal by Subject|7
6039667|NCT00658606|20874413|P2|Overall Study|Lost to Follow-up|0
6039668|NCT00658606|20874414|P1|Overall Study|Lost to Follow-up|1
6039669|NCT00658606|20874413|P2|Overall Study|Lack of Efficacy|3
6039670|NCT00658606|20874414|P1|Overall Study|Lack of Efficacy|6
6039671|NCT00658606|20874413|P2|Overall Study|Adverse Event|1
6039672|NCT00658606|20874414|P1|Overall Study|Adverse Event|2
6039673|NCT00658567|20874443|P3|Overall Study|At Discretion of Sponsor|1
6039674|NCT00658567|20874444|P2|Overall Study|At Discretion of Sponsor|1
6039675|NCT00658567|20874445|P1|Overall Study|At Discretion of Sponsor|1
6039676|NCT00658567|20874443|P3|Overall Study|Physician Decision|0
6039677|NCT00658567|20874444|P2|Overall Study|Physician Decision|1
6039678|NCT00658567|20874445|P1|Overall Study|Physician Decision|0
6039679|NCT00658567|20874443|P3|Overall Study|Voluntary Withdrawal of Consent|2
6039680|NCT00658567|20874444|P2|Overall Study|Voluntary Withdrawal of Consent|0
6039681|NCT00658567|20874445|P1|Overall Study|Voluntary Withdrawal of Consent|2
6039682|NCT00658567|20874443|P3|Overall Study|Adverse Event|3
6039683|NCT00658567|20874444|P2|Overall Study|Adverse Event|2
6039684|NCT00658567|20874445|P1|Overall Study|Adverse Event|5
6039685|NCT00658541|20874456|P2|Washout Period of 7 Days|Withdrawal by Subject|1
6039686|NCT00658541|20874457|P1|Washout Period of 7 Days|Withdrawal by Subject|0
6039687|NCT00658541|20874456|P2|Washout Period of 7 Days|Withdrawal by Subject|1
6039688|NCT00658541|20874457|P1|Washout Period of 7 Days|Withdrawal by Subject|1
6039689|NCT00658528|20874469|P2|Overall Study|Other|4
6039690|NCT00658528|20874470|P1|Overall Study|Other|8
6039691|NCT00658528|20874469|P2|Overall Study|Withdrawal of consent|6
6039692|NCT00658528|20874470|P1|Overall Study|Withdrawal of consent|5
6039693|NCT00658528|20874469|P2|Overall Study|Withdrawal by Subject|6
6039694|NCT00658528|20874470|P1|Overall Study|Withdrawal by Subject|8
6039695|NCT00658528|20874469|P2|Overall Study|Lost to Follow-up|22
6039696|NCT00658528|20874470|P1|Overall Study|Lost to Follow-up|14
6039697|NCT00658528|20874469|P2|Overall Study|Adverse Event|7
6039698|NCT00658528|20874470|P1|Overall Study|Adverse Event|5
6039699|NCT00658359|20874510|P3|Overall Study|Lack of Efficacy|0
6039700|NCT00658359|20874511|P2|Overall Study|Lack of Efficacy|1
6039701|NCT00658359|20874512|P1|Overall Study|Lack of Efficacy|0
6039702|NCT00658359|20874510|P3|Overall Study|Lost to Follow-up|4
6039703|NCT00658359|20874511|P2|Overall Study|Lost to Follow-up|2
6039704|NCT00658359|20874512|P1|Overall Study|Lost to Follow-up|2
6039705|NCT00658359|20874510|P3|Overall Study|Withdrawal by Subject|2
6039706|NCT00658359|20874511|P2|Overall Study|Withdrawal by Subject|4
6039707|NCT00658359|20874512|P1|Overall Study|Withdrawal by Subject|7
6039708|NCT00658359|20874510|P3|Overall Study|Includes protocol Amendments 3 and 4|29
6039709|NCT00658359|20874511|P2|Overall Study|Includes protocol Amendments 3 and 4|31
6039710|NCT00658359|20874512|P1|Overall Study|Includes protocol Amendments 3 and 4|2
6039711|NCT00658359|20874510|P3|Overall Study|Protocol Violation|0
6039712|NCT00658359|20874511|P2|Overall Study|Protocol Violation|0
6039713|NCT00658359|20874512|P1|Overall Study|Protocol Violation|1
6039714|NCT00658359|20874510|P3|Overall Study|Adverse Event|9
6039715|NCT00658359|20874511|P2|Overall Study|Adverse Event|6
6039716|NCT00658359|20874512|P1|Overall Study|Adverse Event|13
6039717|NCT00658359|20874510|P3|Overall Study|Death|2
6039718|NCT00658359|20874511|P2|Overall Study|Death|1
6039719|NCT00658359|20874512|P1|Overall Study|Death|3
6039720|NCT00658333|20874600|P2|Overall Study|Adverse Event|1
6039721|NCT00658333|20874601|P1|Overall Study|Adverse Event|2
6039722|NCT00658320|20874611|P2|Extension Study: After Month 24|Subject withdrew consent|0
6039723|NCT00658320|20874612|P1|Extension Study: After Month 24|Subject withdrew consent|2
6039724|NCT00658320|20874611|P2|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|7
6039725|NCT00658320|20874612|P1|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|3
6039726|NCT00658320|20874611|P2|Extension Study: Month 12 to Month 24|Subject withdrew consent|0
6039727|NCT00658320|20874612|P1|Extension Study: Month 12 to Month 24|Subject withdrew consent|3
6039728|NCT00658320|20874611|P2|Core Study: 12 Months|Subject withdrew consent|3
6039729|NCT00658320|20874612|P1|Core Study: 12 Months|Subject withdrew consent|5
6039730|NCT00658021|20874647|P3|Long-term Safety Follow-up Period|Physician Decision|0
6039731|NCT00658021|20874648|P2|Long-term Safety Follow-up Period|Physician Decision|2
6039732|NCT00658021|20874649|P1|Long-term Safety Follow-up Period|Physician Decision|0
6039733|NCT00658021|20874647|P3|Long-term Safety Follow-up Period|Withdrawal by Subject|0
6039734|NCT00658021|20874648|P2|Long-term Safety Follow-up Period|Withdrawal by Subject|1
6039735|NCT00658021|20874649|P1|Long-term Safety Follow-up Period|Withdrawal by Subject|0
6039736|NCT00658021|20874647|P3|28-Week Treatment Period|Did not receive treatment|0
6039737|NCT00658021|20874648|P2|28-Week Treatment Period|Did not receive treatment|0
6039738|NCT00658021|20874649|P1|28-Week Treatment Period|Did not receive treatment|2
6039739|NCT00658021|20874647|P3|28-Week Treatment Period|Other|1
6039740|NCT00658021|20874648|P2|28-Week Treatment Period|Other|3
6039741|NCT00658021|20874649|P1|28-Week Treatment Period|Other|2
6039742|NCT00658021|20874647|P3|28-Week Treatment Period|Loss of glucose control|10
6039743|NCT00658021|20874648|P2|28-Week Treatment Period|Loss of glucose control|1
6039744|NCT00658021|20874649|P1|28-Week Treatment Period|Loss of glucose control|1
6039745|NCT00658021|20874647|P3|28-Week Treatment Period|Withdrawal by parent/guardian|1
6039746|NCT00658021|20874648|P2|28-Week Treatment Period|Withdrawal by parent/guardian|1
6039747|NCT00658021|20874649|P1|28-Week Treatment Period|Withdrawal by parent/guardian|1
6039748|NCT00658021|20874647|P3|28-Week Treatment Period|Physician Decision|1
6039749|NCT00658021|20874648|P2|28-Week Treatment Period|Physician Decision|2
6039750|NCT00658021|20874649|P1|28-Week Treatment Period|Physician Decision|1
6039751|NCT00658021|20874647|P3|28-Week Treatment Period|Withdrawal by Subject|3
6039752|NCT00658021|20874648|P2|28-Week Treatment Period|Withdrawal by Subject|1
6039753|NCT00658021|20874649|P1|28-Week Treatment Period|Withdrawal by Subject|1
6039754|NCT00658021|20874647|P3|28-Week Treatment Period|Protocol Violation|1
6039755|NCT00658021|20874648|P2|28-Week Treatment Period|Protocol Violation|2
6039756|NCT00658021|20874649|P1|28-Week Treatment Period|Protocol Violation|0
6039757|NCT00658021|20874647|P3|28-Week Treatment Period|Developed study withdrawal criteria|0
6039758|NCT00658021|20874648|P2|28-Week Treatment Period|Developed study withdrawal criteria|2
6039759|NCT00658021|20874649|P1|28-Week Treatment Period|Developed study withdrawal criteria|0
6039760|NCT00658021|20874647|P3|28-Week Treatment Period|Adverse Event|0
6039761|NCT00658021|20874648|P2|28-Week Treatment Period|Adverse Event|1
6039762|NCT00658021|20874649|P1|28-Week Treatment Period|Adverse Event|3
6039763|NCT00657709|20874684|P5|Overall Study|Protocol Violation|2
6039764|NCT00657709|20874685|P4|Overall Study|Protocol Violation|1
6039765|NCT00657709|20874686|P3|Overall Study|Protocol Violation|0
6039766|NCT00657709|20874687|P2|Overall Study|Protocol Violation|2
6039767|NCT00657709|20874688|P1|Overall Study|Protocol Violation|0
6039768|NCT00657709|20874684|P5|Overall Study|Lost to Follow-up|21
6039769|NCT00657709|20874685|P4|Overall Study|Lost to Follow-up|1
6039770|NCT00657709|20874686|P3|Overall Study|Lost to Follow-up|7
6039771|NCT00657709|20874687|P2|Overall Study|Lost to Follow-up|9
6039772|NCT00657709|20874688|P1|Overall Study|Lost to Follow-up|9
6039773|NCT00657709|20874684|P5|Overall Study|Withdrawal by Subject|9
6039774|NCT00657709|20874685|P4|Overall Study|Withdrawal by Subject|5
6039775|NCT00657709|20874686|P3|Overall Study|Withdrawal by Subject|15
6039776|NCT00657709|20874687|P2|Overall Study|Withdrawal by Subject|15
6039777|NCT00657709|20874688|P1|Overall Study|Withdrawal by Subject|7
6039778|NCT00657709|20874684|P5|Overall Study|AE or Death|1
6039779|NCT00657709|20874685|P4|Overall Study|AE or Death|7
6039780|NCT00657709|20874686|P3|Overall Study|AE or Death|6
6039781|NCT00657709|20874687|P2|Overall Study|AE or Death|7
6039782|NCT00657709|20874688|P1|Overall Study|AE or Death|7
6039783|NCT00657618|20874737|P1|Overall Study|didn't start due to schedule conflicts|1
6039784|NCT00657618|20874737|P1|Overall Study|negative for leishmaniasis|2
6039785|NCT00657618|20874737|P1|Overall Study|Withdrawal by Subject|8
6039786|NCT00657618|20874737|P1|Overall Study|Adverse Event|32
6039787|NCT00657553|20874749|P2|Overall Study|low accrual, no analysis run|5
6039788|NCT00657553|20874750|P1|Overall Study|low accrual, no analysis run|5
6039789|NCT00657540|20874758|P2|Overall Study|Lost to Follow-up|4
6039790|NCT00657540|20874759|P1|Overall Study|Lost to Follow-up|1
6039791|NCT00657371|20874773|P1|Overall Study|Pre-existing medical condition|4
6039792|NCT00657371|20874773|P1|Overall Study|Device- related reasons|13
6039793|NCT00657371|20874773|P1|Overall Study|Protocol Violation|2
6039794|NCT00657371|20874773|P1|Overall Study|Unable to intubate the cecum|5
6039795|NCT00657371|20874773|P1|Overall Study|Poor bowel preparation|15
6039796|NCT00657358|20874778|P1|Overall Study|Lack of Efficacy|6
6039797|NCT00657267|20874790|P1|Overall Study|Adverse Event|9
6039798|NCT00657267|20874790|P1|Overall Study|Progressive disease|45
6039799|NCT00657150|20874800|P2|Treatment|Other|15
6039800|NCT00657150|20874801|P1|Treatment|Other|13
6039801|NCT00657150|20874800|P2|Treatment|Withdrawal by Subject|20
6039802|NCT00657150|20874801|P1|Treatment|Withdrawal by Subject|23
6039803|NCT00657150|20874800|P2|Treatment|Lost to Follow-up|0
6039804|NCT00657150|20874801|P1|Treatment|Lost to Follow-up|1
6039805|NCT00657150|20874800|P2|Treatment|Non-compliant with protocol|9
6039806|NCT00657150|20874801|P1|Treatment|Non-compliant with protocol|10
6039807|NCT00657150|20874800|P2|Treatment|Adverse Event|53
6039808|NCT00657150|20874801|P1|Treatment|Adverse Event|60
6039809|NCT00657150|20874800|P2|Overall Study|Other|38
6039810|NCT00657150|20874801|P1|Overall Study|Other|38
6039811|NCT00657150|20874800|P2|Overall Study|Withdrawal by Subject|36
6039812|NCT00657150|20874801|P1|Overall Study|Withdrawal by Subject|51
6039813|NCT00657150|20874800|P2|Overall Study|Lost to Follow-up|0
6039814|NCT00657150|20874801|P1|Overall Study|Lost to Follow-up|2
6039815|NCT00657150|20874800|P2|Overall Study|Non-compliant with protocol|9
6039816|NCT00657150|20874801|P1|Overall Study|Non-compliant with protocol|5
6039817|NCT00657150|20874800|P2|Overall Study|Adverse Event|10
6039818|NCT00657150|20874801|P1|Overall Study|Adverse Event|19
6039819|NCT00657046|20874832|P3|Overall Study|Surgery|1
6039820|NCT00657046|20874833|P2|Overall Study|Surgery|0
6039821|NCT00657046|20874834|P1|Overall Study|Surgery|0
6039822|NCT00657046|20874832|P3|Overall Study|Death|1
6039823|NCT00657046|20874833|P2|Overall Study|Death|0
6039824|NCT00657046|20874834|P1|Overall Study|Death|0
6039825|NCT00657046|20874832|P3|Overall Study|Withdrawal by Subject|0
6039826|NCT00657046|20874833|P2|Overall Study|Withdrawal by Subject|0
6039827|NCT00657046|20874834|P1|Overall Study|Withdrawal by Subject|1
6039828|NCT00657046|20874832|P3|Overall Study|Protocol Violation|0
6039829|NCT00657046|20874833|P2|Overall Study|Protocol Violation|2
6039830|NCT00657046|20874834|P1|Overall Study|Protocol Violation|2
6039831|NCT00657046|20874832|P3|Overall Study|Adverse Event|0
6039832|NCT00657046|20874833|P2|Overall Study|Adverse Event|1
6039833|NCT00657046|20874834|P1|Overall Study|Adverse Event|1
6039834|NCT00657020|20874866|P2|PERIOD 1|Adverse Event|1
6039835|NCT00657020|20874867|P1|PERIOD 1|Adverse Event|0
6039836|NCT00656851|20874917|P2|Overall Study|Withdrawal by Subject|4
6039837|NCT00656851|20874918|P1|Overall Study|Withdrawal by Subject|0
6039838|NCT00656799|20874940|P1|Overall Study|Death|2
6039839|NCT00656669|20874962|P1|AC (Cycles 6-9)|Did not start segment 3|1
6039840|NCT00656669|20874962|P1|AC (Cycles 6-9)|Adverse Event|1
6039841|NCT00656669|20874962|P1|Paclitaxel/Sunitinib (Cycles 2-5)|Physician Decision|2
6039842|NCT00656669|20874962|P1|Paclitaxel/Sunitinib (Cycles 2-5)|Adverse Event|4
6039843|NCT00656617|20875001|P1|Overall Study|Move to different clinical trial|2
6039844|NCT00656617|20875001|P1|Overall Study|Insurance Issues|2
6039845|NCT00656617|20875001|P1|Overall Study|Death|2
6039846|NCT00656617|20875001|P1|Overall Study|Adverse Event|1
6039847|NCT00656513|20875010|P3|Overall Study|Missing baseline form|5
6039848|NCT00656513|20875011|P2|Overall Study|Missing baseline form|5
6039849|NCT00656513|20875012|P1|Overall Study|Missing baseline form|0
6039850|NCT00656513|20875010|P3|Overall Study|Treatment completed outside of timeframe|1
6039851|NCT00656513|20875011|P2|Overall Study|Treatment completed outside of timeframe|3
6039852|NCT00656513|20875012|P1|Overall Study|Treatment completed outside of timeframe|0
6039853|NCT00656513|20875010|P3|Overall Study|Incomplete treatment|0
6039854|NCT00656513|20875011|P2|Overall Study|Incomplete treatment|0
6039855|NCT00656513|20875012|P1|Overall Study|Incomplete treatment|3
6039856|NCT00656513|20875010|P3|Overall Study|Missing data|9
6039857|NCT00656513|20875011|P2|Overall Study|Missing data|11
6039858|NCT00656513|20875012|P1|Overall Study|Missing data|0
6039859|NCT00656513|20875010|P3|Overall Study|Death|1
6039860|NCT00656513|20875011|P2|Overall Study|Death|0
6039861|NCT00656513|20875012|P1|Overall Study|Death|0
6039862|NCT00656513|20875010|P3|Overall Study|Withdrawal by Subject|4
6039863|NCT00656513|20875011|P2|Overall Study|Withdrawal by Subject|11
6039864|NCT00656513|20875012|P1|Overall Study|Withdrawal by Subject|0
6039865|NCT00656513|20875010|P3|Overall Study|Protocol Violation|2
6039866|NCT00656513|20875011|P2|Overall Study|Protocol Violation|0
6039867|NCT00656513|20875012|P1|Overall Study|Protocol Violation|1
6039868|NCT00656474|20875059|P1|Overall Study|Other Reason|1
6039869|NCT00656370|20875077|P1|Overall Study|Alternates|3
6039870|NCT00656370|20875077|P1|Overall Study|Screen Failures|7
6039871|NCT00656292|20875106|P2|Overall Study|Screen failure|2
6039872|NCT00656292|20875107|P1|Overall Study|Screen failure|1
6039873|NCT00656292|20875106|P2|Overall Study|Withdrawal by Subject|3
6039874|NCT00656292|20875107|P1|Overall Study|Withdrawal by Subject|2
6039875|NCT00656175|20875134|P2|Overall Study|Transportation issues|1
6039876|NCT00656175|20875135|P1|Overall Study|Transportation issues|0
6039877|NCT00656175|20875134|P2|Overall Study|Adverse Event|0
6039878|NCT00656175|20875135|P1|Overall Study|Adverse Event|1
6039879|NCT00656136|20875143|P2|Overall Study|Unknown and others|4
6039880|NCT00656136|20875144|P1|Overall Study|Unknown and others|4
6039881|NCT00656136|20875143|P2|Overall Study|Patient refused to take study medication|10
6039882|NCT00656136|20875144|P1|Overall Study|Patient refused to take study medication|7
6039883|NCT00656136|20875143|P2|Overall Study|Protocol Violation|3
6039884|NCT00656136|20875144|P1|Overall Study|Protocol Violation|2
6039885|NCT00656136|20875143|P2|Overall Study|Other Adverse Event|51
6039886|NCT00656136|20875144|P1|Overall Study|Other Adverse Event|5
6039887|NCT00656136|20875143|P2|Overall Study|Progressive disease|322
6039888|NCT00656136|20875144|P1|Overall Study|Progressive disease|177
6039889|NCT00656084|20875154|P1|Overall Study|Investigator Request|1
6039890|NCT00656084|20875154|P1|Overall Study|Patient Request|1
6039891|NCT00656084|20875154|P1|Overall Study|Withdrawal by Subject|1
6039892|NCT00656084|20875154|P1|Overall Study|Adverse Event|4
6039893|NCT00656058|20875161|P1|Overall Study|Withdrawal by Subject|4
6039894|NCT00656058|20875161|P1|Overall Study|Withdrawal by Subject|2
6039895|NCT00656019|20875174|P4|Overall Study|Lost to Follow-up|0
6039896|NCT00656019|20875175|P3|Overall Study|Lost to Follow-up|0
6039897|NCT00656019|20875176|P2|Overall Study|Lost to Follow-up|1
6039898|NCT00656019|20875177|P1|Overall Study|Lost to Follow-up|2
6039899|NCT00656019|20875174|P4|Overall Study|Withdrawal by Subject|0
6039900|NCT00656019|20875175|P3|Overall Study|Withdrawal by Subject|0
6039901|NCT00656019|20875176|P2|Overall Study|Withdrawal by Subject|0
6039902|NCT00656019|20875177|P1|Overall Study|Withdrawal by Subject|2
6039903|NCT00656019|20875174|P4|Overall Study|Not Eligible|0
6039904|NCT00656019|20875175|P3|Overall Study|Not Eligible|0
6039905|NCT00656019|20875176|P2|Overall Study|Not Eligible|0
6039906|NCT00656019|20875177|P1|Overall Study|Not Eligible|10
6039907|NCT00655980|20875190|P3|Overall Study|surgery canceled; or subject or anesthes|5
6039908|NCT00655980|20875191|P2|Overall Study|surgery canceled; or subject or anesthes|31
6039909|NCT00655980|20875192|P1|Overall Study|surgery canceled; or subject or anesthes|26
6039910|NCT00655928|20875205|P2|Overall Study|Physician Decision|1
6039911|NCT00655928|20875206|P1|Overall Study|Physician Decision|1
6039912|NCT00655928|20875205|P2|Overall Study|Withdrawal by Subject|1
6039913|NCT00655928|20875206|P1|Overall Study|Withdrawal by Subject|2
6039914|NCT00655889|20875212|P1|Overall Study|Protocol Violation|1
6039915|NCT00655889|20875212|P1|Overall Study|Inadequate cell growth|1
6039916|NCT00655876|20875219|P2|Overall Study|Protocol Violation|7
6039917|NCT00655876|20875220|P1|Overall Study|Protocol Violation|9
6039918|NCT00655863|20875239|P3|Overall Study|Lost to Follow-up|1
6039919|NCT00655863|20875240|P2|Overall Study|Lost to Follow-up|0
6039920|NCT00655863|20875241|P1|Overall Study|Lost to Follow-up|0
6039921|NCT00655850|20875300|P1|Overall Study|Withdrawal by Subject|1
6039922|NCT00655850|20875300|P1|Overall Study|Death|2
6039923|NCT00655824|20875307|P1|Overall Study|Deterioration of Trial Disease|2
6039924|NCT00655824|20875307|P1|Overall Study|Withdrawal by Subject|4
6039925|NCT00655824|20875307|P1|Overall Study|Protocol Violation|1
6039926|NCT00655824|20875307|P1|Overall Study|Early Termination of Study by Sponsor|74
6039927|NCT00655824|20875307|P1|Overall Study|Adverse Event|3
6039928|NCT00655746|20875355|P1|Overall Study|Withdrawal by Subject|1
6039929|NCT00655733|20875374|P2|Overall Study|Physician Decision|1
6039930|NCT00655733|20875375|P1|Overall Study|Physician Decision|0
6039931|NCT00655733|20875374|P2|Overall Study|Withdrawal by Subject|3
6039932|NCT00655733|20875375|P1|Overall Study|Withdrawal by Subject|3
6039933|NCT00655733|20875374|P2|Overall Study|Adverse Event|2
6039934|NCT00655733|20875375|P1|Overall Study|Adverse Event|2
6039935|NCT00655733|20875374|P2|Overall Study|Lost to Follow-up|2
6039936|NCT00655733|20875375|P1|Overall Study|Lost to Follow-up|2
6039937|NCT00655668|20875408|P1|Overall Study|Withdrawal by Subject|2
6039938|NCT00655668|20875408|P1|Overall Study|New Lymphoma Treatment Started|4
6039939|NCT00655668|20875408|P1|Overall Study|Other|1
6039940|NCT00655668|20875408|P1|Overall Study|Study Terminated|9
6039941|NCT00655668|20875408|P1|Overall Study|Disease Progression|27
6039942|NCT00655668|20875408|P1|Overall Study|Death|5
6039943|NCT00655668|20875408|P1|Overall Study|Adverse Event|6
6039944|NCT00655629|20875435|P2|Overall Study|consent withdrawn|4
6039945|NCT00655629|20875436|P1|Overall Study|consent withdrawn|6
6039946|NCT00655629|20875435|P2|Overall Study|Protocol Violation|3
6039947|NCT00655629|20875436|P1|Overall Study|Protocol Violation|5
6039948|NCT00655629|20875435|P2|Overall Study|Lost to Follow-up|3
6039949|NCT00655629|20875436|P1|Overall Study|Lost to Follow-up|4
6039950|NCT00655629|20875435|P2|Overall Study|Lack of Efficacy|12
6039951|NCT00655629|20875436|P1|Overall Study|Lack of Efficacy|2
6039952|NCT00655629|20875435|P2|Overall Study|Adverse Event|1
6039953|NCT00655629|20875436|P1|Overall Study|Adverse Event|4
6039954|NCT00655564|20875472|P1|Overall Study|Desired Alternate Therapy|1
6039955|NCT00655564|20875472|P1|Overall Study|Lost to Follow-up|1
6039956|NCT00655564|20875472|P1|Overall Study|Adverse Event|1
6039957|NCT00655551|20875480|P3|Period 4 (up to 7 Days)|Adverse Event|0
6039958|NCT00655551|20875481|P2|Period 4 (up to 7 Days)|Adverse Event|2
6039959|NCT00655551|20875482|P1|Period 4 (up to 7 Days)|Adverse Event|0
6039960|NCT00655551|20875480|P3|Period 3 (up to 7 Days)|Adverse Event|4
6039961|NCT00655551|20875481|P2|Period 3 (up to 7 Days)|Adverse Event|0
6039962|NCT00655551|20875482|P1|Period 3 (up to 7 Days)|Adverse Event|0
6039963|NCT00655551|20875480|P3|Period 2 (up to 7 Days)|Adverse Event|0
6039964|NCT00655551|20875481|P2|Period 2 (up to 7 Days)|Adverse Event|1
6039965|NCT00655551|20875482|P1|Period 2 (up to 7 Days)|Adverse Event|0
6039966|NCT00655551|20875480|P3|All Periods Combined|Adverse Event|4
6039967|NCT00655551|20875481|P2|All Periods Combined|Adverse Event|3
6039968|NCT00655551|20875482|P1|All Periods Combined|Adverse Event|0
6039969|NCT00655486|20875519|P1|Overall Study|Other: Abnormal electrocardiogram (ECG)|1
6039970|NCT00655486|20875519|P1|Overall Study|Other: Could not tolerate BID dosing|1
6039971|NCT00655486|20875519|P1|Overall Study|Other: Pregnancy|1
6039972|NCT00655486|20875519|P1|Overall Study|Unsatisfactory compliance|2
6039973|NCT00655486|20875519|P1|Overall Study|Protocol Violation|1
6039974|NCT00655486|20875519|P1|Overall Study|Withdrawal by Subject|4
6039975|NCT00655486|20875519|P1|Overall Study|Lack of Efficacy|8
6039976|NCT00655486|20875519|P1|Overall Study|Adverse Event|10
6039977|NCT00655356|20875547|P2|Overall Study|Other Reason|0
6039978|NCT00655356|20875548|P1|Overall Study|Other Reason|1
6039979|NCT00655356|20875547|P2|Overall Study|Protocol Violation|1
6039980|NCT00655356|20875548|P1|Overall Study|Protocol Violation|2
6039981|NCT00655356|20875547|P2|Overall Study|Adverse Event|1
6039982|NCT00655356|20875548|P1|Overall Study|Adverse Event|1
6039983|NCT00655356|20875547|P2|Overall Study|Sponsor Request|4
6039984|NCT00655356|20875548|P1|Overall Study|Sponsor Request|10
6039985|NCT00655356|20875547|P2|Overall Study|Withdrawal by Subject|4
6039986|NCT00655356|20875548|P1|Overall Study|Withdrawal by Subject|3
6039991|NCT00654901|20875637|P4|Overall Study|Withdrawal by Subject|0
6039992|NCT00654901|20875638|P3|Overall Study|Withdrawal by Subject|1
6039993|NCT00654901|20875639|P2|Overall Study|Withdrawal by Subject|0
6039994|NCT00654901|20875640|P1|Overall Study|Withdrawal by Subject|3
6039995|NCT00654901|20875637|P4|Overall Study|Lost to Follow-up|0
6039996|NCT00654901|20875638|P3|Overall Study|Lost to Follow-up|1
6039997|NCT00654901|20875639|P2|Overall Study|Lost to Follow-up|0
6039998|NCT00654901|20875640|P1|Overall Study|Lost to Follow-up|1
6039999|NCT00654875|20875660|P2|Overall Study|Administrative Problems|0
6040000|NCT00654875|20875661|P1|Overall Study|Administrative Problems|1
6040001|NCT00654875|20875660|P2|Overall Study|Abnormal Test Procedure Result(s)|0
6040002|NCT00654875|20875661|P1|Overall Study|Abnormal Test Procedure Result(s)|1
6040003|NCT00654875|20875660|P2|Overall Study|Lost to Follow-up|3
6040004|NCT00654875|20875661|P1|Overall Study|Lost to Follow-up|1
6040005|NCT00654875|20875660|P2|Overall Study|Lack of Efficacy|2
6040006|NCT00654875|20875661|P1|Overall Study|Lack of Efficacy|2
6040007|NCT00654875|20875660|P2|Overall Study|Protocol Violation|3
6040008|NCT00654875|20875661|P1|Overall Study|Protocol Violation|3
6040009|NCT00654875|20875660|P2|Overall Study|Withdrawal by Subject|4
6040010|NCT00654875|20875661|P1|Overall Study|Withdrawal by Subject|4
6040011|NCT00654875|20875660|P2|Overall Study|Adverse Event|5
6040012|NCT00654875|20875661|P1|Overall Study|Adverse Event|5
6040013|NCT00654745|20875694|P1|Overall Study|poor ABPM, noncompliance, lab MAs|3
6040014|NCT00654745|20875694|P1|Overall Study|Withdrawal by Subject|10
6040015|NCT00654745|20875694|P1|Overall Study|Protocol Violation|11
6040016|NCT00654745|20875694|P1|Overall Study|Lost to Follow-up|7
6040017|NCT00654745|20875694|P1|Overall Study|Adverse Event|12
6040018|NCT00654732|20875734|P2|Overall Study|Adverse Event|6
6040019|NCT00654732|20875735|P1|Overall Study|Adverse Event|4
6040020|NCT00654641|20875748|P2|Overall Study|Lost to Follow-up|3
6040021|NCT00654641|20875749|P1|Overall Study|Lost to Follow-up|2
6040022|NCT00654628|20875755|P1|6 -Week Extension Period (Single Site)|Lost to Follow-up|1
6040023|NCT00654628|20875755|P1|6 -Week Extension Period (Single Site)|Adverse Event|4
6040024|NCT00654628|20875755|P1|6-week Active Treatment Period|Out of window period|1
6040025|NCT00654628|20875755|P1|6-week Active Treatment Period|Transferred to branch hospital|1
6040026|NCT00654628|20875755|P1|6-week Active Treatment Period|Lost to Follow-up|10
6040027|NCT00654628|20875755|P1|6-week Active Treatment Period|Adverse Event|9
6040028|NCT00654498|20875804|P2|Overall Study|Other reason not defined above|5
6040029|NCT00654498|20875805|P1|Overall Study|Other reason not defined above|4
6040030|NCT00654498|20875804|P2|Overall Study|Withdrawal by Subject|0
6040031|NCT00654498|20875805|P1|Overall Study|Withdrawal by Subject|1
6040032|NCT00654498|20875804|P2|Overall Study|Lost to Follow-up|5
6040033|NCT00654498|20875805|P1|Overall Study|Lost to Follow-up|1
6040034|NCT00654498|20875804|P2|Overall Study|Protocol Violation|1
6040035|NCT00654498|20875805|P1|Overall Study|Protocol Violation|1
6040036|NCT00654498|20875804|P2|Overall Study|Adverse Event|1
6040037|NCT00654498|20875805|P1|Overall Study|Adverse Event|6
6040038|NCT00654498|20875804|P2|Overall Study|Not Treated|0
6040039|NCT00654498|20875805|P1|Overall Study|Not Treated|1
6040040|NCT00654420|20875837|P4|Phase II|Missing Disposition Record|0
6040041|NCT00654420|20875838|P3|Phase II|Missing Disposition Record|1
6040042|NCT00654420|20875839|P2|Phase II|Missing Disposition Record|0
6040043|NCT00654420|20875840|P1|Phase II|Missing Disposition Record|0
6040044|NCT00654420|20875837|P4|Phase II|Withdrawal by Subject|1
6040045|NCT00654420|20875838|P3|Phase II|Withdrawal by Subject|4
6040046|NCT00654420|20875839|P2|Phase II|Withdrawal by Subject|0
6040047|NCT00654420|20875840|P1|Phase II|Withdrawal by Subject|0
6040048|NCT00654420|20875837|P4|Phase II|Progressive Disease|29
6040049|NCT00654420|20875838|P3|Phase II|Progressive Disease|29
6040050|NCT00654420|20875839|P2|Phase II|Progressive Disease|0
6040051|NCT00654420|20875840|P1|Phase II|Progressive Disease|0
6040052|NCT00654420|20875837|P4|Phase II|Physician Decision|4
6040053|NCT00654420|20875838|P3|Phase II|Physician Decision|0
6040054|NCT00654420|20875839|P2|Phase II|Physician Decision|0
6040055|NCT00654420|20875840|P1|Phase II|Physician Decision|0
6040056|NCT00654420|20875837|P4|Phase II|Lost to Follow-up|1
6040057|NCT00654420|20875838|P3|Phase II|Lost to Follow-up|0
6040058|NCT00654420|20875839|P2|Phase II|Lost to Follow-up|0
6040059|NCT00654420|20875840|P1|Phase II|Lost to Follow-up|0
6040060|NCT00654420|20875837|P4|Phase II|Adverse Event|3
6040061|NCT00654420|20875838|P3|Phase II|Adverse Event|3
6040062|NCT00654420|20875839|P2|Phase II|Adverse Event|0
6040063|NCT00654420|20875840|P1|Phase II|Adverse Event|0
6040064|NCT00654420|20875837|P4|Phase I (Dose Escalation)|Progressive Disease|0
6040065|NCT00654420|20875838|P3|Phase I (Dose Escalation)|Progressive Disease|0
6040066|NCT00654420|20875839|P2|Phase I (Dose Escalation)|Progressive Disease|15
6040067|NCT00654420|20875840|P1|Phase I (Dose Escalation)|Progressive Disease|4
6040068|NCT00654420|20875837|P4|Phase I (Dose Escalation)|Adverse Event|0
6040069|NCT00654420|20875838|P3|Phase I (Dose Escalation)|Adverse Event|0
6040070|NCT00654420|20875839|P2|Phase I (Dose Escalation)|Adverse Event|1
6040071|NCT00654420|20875840|P1|Phase I (Dose Escalation)|Adverse Event|0
6040072|NCT00654381|20875866|P6|Extension Stage|Closure of the trial site|1
6040073|NCT00654381|20875867|P5|Extension Stage|Closure of the trial site|1
6040074|NCT00654381|20875868|P4|Extension Stage|Closure of the trial site|0
6040075|NCT00654381|20875869|P3|Extension Stage|Closure of the trial site|0
6040076|NCT00654381|20875870|P2|Extension Stage|Closure of the trial site|0
6040077|NCT00654381|20875871|P1|Extension Stage|Closure of the trial site|0
6040078|NCT00654381|20875866|P6|Extension Stage|Withdrawal by Subject|1
6040079|NCT00654381|20875867|P5|Extension Stage|Withdrawal by Subject|1
6040080|NCT00654381|20875868|P4|Extension Stage|Withdrawal by Subject|1
6040081|NCT00654381|20875869|P3|Extension Stage|Withdrawal by Subject|1
6040082|NCT00654381|20875870|P2|Extension Stage|Withdrawal by Subject|0
6040083|NCT00654381|20875871|P1|Extension Stage|Withdrawal by Subject|0
6040084|NCT00654381|20875866|P6|Extension Stage|Lack of Efficacy|0
6040085|NCT00654381|20875867|P5|Extension Stage|Lack of Efficacy|0
6040086|NCT00654381|20875868|P4|Extension Stage|Lack of Efficacy|0
6040087|NCT00654381|20875869|P3|Extension Stage|Lack of Efficacy|1
6040088|NCT00654381|20875870|P2|Extension Stage|Lack of Efficacy|0
6040089|NCT00654381|20875871|P1|Extension Stage|Lack of Efficacy|0
6040090|NCT00654381|20875866|P6|Extension Stage|Protocol Violation|0
6040091|NCT00654381|20875867|P5|Extension Stage|Protocol Violation|0
6040092|NCT00654381|20875868|P4|Extension Stage|Protocol Violation|1
6040093|NCT00654381|20875869|P3|Extension Stage|Protocol Violation|0
6040094|NCT00654381|20875870|P2|Extension Stage|Protocol Violation|0
6040095|NCT00654381|20875871|P1|Extension Stage|Protocol Violation|0
6040096|NCT00654381|20875866|P6|Extension Stage|Adverse Event|1
6040097|NCT00654381|20875867|P5|Extension Stage|Adverse Event|1
6040098|NCT00654381|20875868|P4|Extension Stage|Adverse Event|7
6040099|NCT00654381|20875869|P3|Extension Stage|Adverse Event|9
6040100|NCT00654381|20875870|P2|Extension Stage|Adverse Event|2
6040101|NCT00654381|20875871|P1|Extension Stage|Adverse Event|1
6040102|NCT00654381|20875866|P6|2nd Stage|Investigator's decision|0
6040103|NCT00654381|20875867|P5|2nd Stage|Investigator's decision|0
6040104|NCT00654381|20875868|P4|2nd Stage|Investigator's decision|1
6040105|NCT00654381|20875869|P3|2nd Stage|Investigator's decision|1
6040106|NCT00654381|20875870|P2|2nd Stage|Investigator's decision|0
6040107|NCT00654381|20875871|P1|2nd Stage|Investigator's decision|0
6040108|NCT00654381|20875866|P6|2nd Stage|Withdrawal by Subject|1
6040109|NCT00654381|20875867|P5|2nd Stage|Withdrawal by Subject|1
6040110|NCT00654381|20875868|P4|2nd Stage|Withdrawal by Subject|0
6040111|NCT00654381|20875869|P3|2nd Stage|Withdrawal by Subject|0
6040112|NCT00654381|20875870|P2|2nd Stage|Withdrawal by Subject|0
6040113|NCT00654381|20875871|P1|2nd Stage|Withdrawal by Subject|0
6040114|NCT00654381|20875866|P6|2nd Stage|Adverse Event|2
6040115|NCT00654381|20875867|P5|2nd Stage|Adverse Event|7
6040116|NCT00654381|20875868|P4|2nd Stage|Adverse Event|3
6040117|NCT00654381|20875869|P3|2nd Stage|Adverse Event|2
6040118|NCT00654381|20875870|P2|2nd Stage|Adverse Event|0
6040119|NCT00654381|20875871|P1|2nd Stage|Adverse Event|2
6040120|NCT00654381|20875866|P6|1st Stage|Investigator's decision|0
6040121|NCT00654381|20875867|P5|1st Stage|Investigator's decision|0
6040122|NCT00654381|20875868|P4|1st Stage|Investigator's decision|1
6040123|NCT00654381|20875869|P3|1st Stage|Investigator's decision|0
6040124|NCT00654381|20875870|P2|1st Stage|Investigator's decision|0
6040125|NCT00654381|20875871|P1|1st Stage|Investigator's decision|0
6040126|NCT00654381|20875866|P6|1st Stage|Withdrawal by Subject|1
6040127|NCT00654381|20875867|P5|1st Stage|Withdrawal by Subject|0
6040128|NCT00654381|20875868|P4|1st Stage|Withdrawal by Subject|1
6040129|NCT00654381|20875869|P3|1st Stage|Withdrawal by Subject|0
6040130|NCT00654381|20875870|P2|1st Stage|Withdrawal by Subject|0
6040131|NCT00654381|20875871|P1|1st Stage|Withdrawal by Subject|0
6040132|NCT00654381|20875866|P6|1st Stage|Adverse Event|1
6040133|NCT00654381|20875867|P5|1st Stage|Adverse Event|2
6040134|NCT00654381|20875868|P4|1st Stage|Adverse Event|3
6040135|NCT00654381|20875869|P3|1st Stage|Adverse Event|3
6040136|NCT00654381|20875870|P2|1st Stage|Adverse Event|3
6040137|NCT00654381|20875871|P1|1st Stage|Adverse Event|3
6040138|NCT00654368|20875908|P3|Overall Study|Adverse Event|6
6040139|NCT00654368|20875909|P2|Overall Study|Adverse Event|9
6040140|NCT00654368|20875910|P1|Overall Study|Adverse Event|14
6040141|NCT00654368|20875908|P3|Overall Study|Other|3
6040142|NCT00654368|20875909|P2|Overall Study|Other|2
6040143|NCT00654368|20875910|P1|Overall Study|Other|0
6040144|NCT00654368|20875908|P3|Overall Study|Pregnancy|2
6040145|NCT00654368|20875909|P2|Overall Study|Pregnancy|0
6040146|NCT00654368|20875910|P1|Overall Study|Pregnancy|0
6040147|NCT00654368|20875908|P3|Overall Study|Death|0
6040148|NCT00654368|20875909|P2|Overall Study|Death|0
6040149|NCT00654368|20875910|P1|Overall Study|Death|1
6040150|NCT00654368|20875908|P3|Overall Study|Physician Decision|2
6040151|NCT00654368|20875909|P2|Overall Study|Physician Decision|0
6040152|NCT00654368|20875910|P1|Overall Study|Physician Decision|0
6040153|NCT00654368|20875908|P3|Overall Study|Requirement for alternative therapy|1
6040154|NCT00654368|20875909|P2|Overall Study|Requirement for alternative therapy|1
6040155|NCT00654368|20875910|P1|Overall Study|Requirement for alternative therapy|1
6040156|NCT00654368|20875908|P3|Overall Study|Disease progression|13
6040157|NCT00654368|20875909|P2|Overall Study|Disease progression|31
6040158|NCT00654368|20875910|P1|Overall Study|Disease progression|21
6040159|NCT00654368|20875908|P3|Overall Study|Withdrawal by Subject|2
6040160|NCT00654368|20875909|P2|Overall Study|Withdrawal by Subject|2
6040161|NCT00654368|20875910|P1|Overall Study|Withdrawal by Subject|5
6040162|NCT00654368|20875908|P3|Overall Study|Non-compliance|2
6040163|NCT00654368|20875909|P2|Overall Study|Non-compliance|1
6040164|NCT00654368|20875910|P1|Overall Study|Non-compliance|2
6040165|NCT00654368|20875908|P3|Overall Study|Protocol deviation|1
6040166|NCT00654368|20875909|P2|Overall Study|Protocol deviation|2
6040167|NCT00654368|20875910|P1|Overall Study|Protocol deviation|3
6040168|NCT00654368|20875908|P3|Overall Study|Ineligibility determined|0
6040169|NCT00654368|20875909|P2|Overall Study|Ineligibility determined|0
6040170|NCT00654368|20875910|P1|Overall Study|Ineligibility determined|6
6040171|NCT00654355|20875943|P2|Overall Study|Lost to Follow-up|2
6040172|NCT00654355|20875944|P1|Overall Study|Lost to Follow-up|2
6040173|NCT00654238|20875975|P1|Overall Study|Screen Failures|4
6040174|NCT00654186|20875980|P1|Overall Study|Withdrawal by Subject|5
6040175|NCT00654095|20876005|P1|Overall Study|Did not meet inclusion criteria|1
6040176|NCT00654095|20876005|P1|Overall Study|Adverse reaction did not improve (5)|4
6040177|NCT00654095|20876005|P1|Overall Study|Elevated alanine aminotransferase (4)|7
6040178|NCT00654095|20876005|P1|Overall Study|Withdrawal by Subject|5
6040179|NCT00654095|20876005|P1|Overall Study|Adverse Event|11
6040180|NCT00654095|20876005|P1|Overall Study|Elevated alanine aminotransferase (3)|1
6040181|NCT00654095|20876005|P1|Overall Study|Elevated triglyceride level (2)|1
6040182|NCT00654095|20876005|P1|Overall Study|Drop in low density lipoprotein (1)|2
6040183|NCT00654004|20876028|P2|Overall Study|Lost to Follow-up|0
6040184|NCT00654004|20876029|P1|Overall Study|Lost to Follow-up|1
6040185|NCT00653991|20876045|P2|6 Month Follow-up|Participant would not respond|141
6040186|NCT00653991|20876046|P1|6 Month Follow-up|Participant would not respond|133
6040187|NCT00653991|20876045|P2|3 Month Follow-up|Participant would not respond|157
6040188|NCT00653991|20876046|P1|3 Month Follow-up|Participant would not respond|150
6040189|NCT00653939|20876058|P2|Overall Study|Other|6
6040190|NCT00653939|20876059|P1|Overall Study|Other|2
6040191|NCT00653939|20876058|P2|Overall Study|Disease Progression|3
6040192|NCT00653939|20876059|P1|Overall Study|Disease Progression|2
6040193|NCT00653939|20876058|P2|Overall Study|Physician Decision|0
6040194|NCT00653939|20876059|P1|Overall Study|Physician Decision|4
6040195|NCT00653939|20876058|P2|Overall Study|Withdrawal by Subject|3
6040196|NCT00653939|20876059|P1|Overall Study|Withdrawal by Subject|3
6040197|NCT00653939|20876058|P2|Overall Study|Adverse Event|3
6040198|NCT00653939|20876059|P1|Overall Study|Adverse Event|1
6040199|NCT00653523|20876084|P1|Overall Study|Adverse reaction did not improve (4)|1
6040200|NCT00653523|20876084|P1|Overall Study|Elevated alanine aminotransferase (3)|2
6040201|NCT00653523|20876084|P1|Overall Study|Withdrawal by Subject|6
6040202|NCT00653523|20876084|P1|Overall Study|Adverse Event|7
6040203|NCT00653523|20876084|P1|Overall Study|Elevated creatine phosphokinase (2)|1
6040204|NCT00653523|20876084|P1|Overall Study|Drop in low density lipoprotein (1)|2
6040205|NCT00653432|20876090|P2|Overall Study|Other - Reason Not Provided|3
6040206|NCT00653432|20876091|P1|Overall Study|Other - Reason Not Provided|5
6040207|NCT00653432|20876090|P2|Overall Study|Use/Need of Con Therapy|1
6040208|NCT00653432|20876091|P1|Overall Study|Use/Need of Con Therapy|2
6040209|NCT00653432|20876090|P2|Overall Study|Lost to Follow-up|6
6040210|NCT00653432|20876091|P1|Overall Study|Lost to Follow-up|7
6040211|NCT00653432|20876090|P2|Overall Study|Withdrawal by Subject|5
6040212|NCT00653432|20876091|P1|Overall Study|Withdrawal by Subject|4
6040213|NCT00653432|20876090|P2|Overall Study|Adverse Event|1
6040214|NCT00653432|20876091|P1|Overall Study|Adverse Event|4
6040215|NCT00653328|20876115|P1|Overall Study|Drug manufacturer no longing making drug|2
6040216|NCT00653328|20876115|P1|Overall Study|Disease progression|10
6040217|NCT00653328|20876115|P1|Overall Study|Adverse Event|2
6040218|NCT00653328|20876115|P1|Overall Study|Withdrawal by Subject|1
6040219|NCT00653263|20876122|P1|Overall Study|Physician Decision|1
6040220|NCT00653263|20876122|P1|Overall Study|Withdrawal by Subject|1
6040221|NCT00653224|20876130|P2|Overall Study|Other|4
6040222|NCT00653224|20876131|P1|Overall Study|Other|2
6040223|NCT00653224|20876130|P2|Overall Study|Lost to Follow-up|0
6040224|NCT00653224|20876131|P1|Overall Study|Lost to Follow-up|1
6040225|NCT00653224|20876130|P2|Overall Study|Loss of efficacy|0
6040226|NCT00653224|20876131|P1|Overall Study|Loss of efficacy|1
6040227|NCT00653224|20876130|P2|Overall Study|Lack of Efficacy|2
6040228|NCT00653224|20876131|P1|Overall Study|Lack of Efficacy|1
6040229|NCT00653224|20876130|P2|Overall Study|Adverse Event|1
6040230|NCT00653224|20876131|P1|Overall Study|Adverse Event|2
6040231|NCT00653159|20876317|P2|Overall Study|Lost to Follow-up|2
6040232|NCT00653159|20876318|P1|Overall Study|Lost to Follow-up|1
6040233|NCT00653159|20876317|P2|Overall Study|Adverse Event|1
6040234|NCT00653159|20876318|P1|Overall Study|Adverse Event|4
6040240|NCT00652951|20876359|P3|Booster Phase|Other|0
6040241|NCT00652951|20876360|P2|Booster Phase|Other|0
6040242|NCT00652951|20876361|P1|Booster Phase|Other|1
6040243|NCT00652951|20876359|P3|Booster Phase|Adverse event, non-fatal|0
6040244|NCT00652951|20876360|P2|Booster Phase|Adverse event, non-fatal|1
6040245|NCT00652951|20876361|P1|Booster Phase|Adverse event, non-fatal|0
6040246|NCT00652938|20876498|P3|Overall Study|fear of blood sampling|0
6040247|NCT00652938|20876499|P2|Overall Study|fear of blood sampling|1
6040248|NCT00652938|20876500|P1|Overall Study|fear of blood sampling|0
6040249|NCT00652938|20876498|P3|Overall Study|Lost to Follow-up|2
6040250|NCT00652938|20876499|P2|Overall Study|Lost to Follow-up|0
6040251|NCT00652938|20876500|P1|Overall Study|Lost to Follow-up|0
6040252|NCT00652938|20876498|P3|Overall Study|Withdrawal by Subject|1
6040253|NCT00652938|20876499|P2|Overall Study|Withdrawal by Subject|6
6040254|NCT00652938|20876500|P1|Overall Study|Withdrawal by Subject|0
6040255|NCT00652938|20876498|P3|Overall Study|Adverse Event|2
6040256|NCT00652938|20876499|P2|Overall Study|Adverse Event|0
6040257|NCT00652938|20876500|P1|Overall Study|Adverse Event|1
6040258|NCT00652899|20876565|P1|Overall Study|Treating physician decision|1
6040259|NCT00652899|20876565|P1|Overall Study|Death|1
6040260|NCT00652834|20876575|P1|Overall Study|Lost to Follow-up|2
6040261|NCT00652834|20876575|P1|Overall Study|Withdrawal by Subject|3
6040262|NCT00652743|20876582|P3|Months 36-42|Other|8
6040263|NCT00652743|20876583|P2|Months 36-42|Other|2
6040264|NCT00652743|20876584|P1|Months 36-42|Other|4
6040265|NCT00652743|20876582|P3|Months 36-42|Migrated/moved from study area|0
6040266|NCT00652743|20876583|P2|Months 36-42|Migrated/moved from study area|0
6040267|NCT00652743|20876584|P1|Months 36-42|Migrated/moved from study area|1
6040268|NCT00652743|20876582|P3|Months 36-42|Lost to Follow-up|0
6040269|NCT00652743|20876583|P2|Months 36-42|Lost to Follow-up|1
6040270|NCT00652743|20876584|P1|Months 36-42|Lost to Follow-up|0
6040271|NCT00652743|20876582|P3|Months 36-42|Withdrawal by Subject|0
6040272|NCT00652743|20876583|P2|Months 36-42|Withdrawal by Subject|1
6040273|NCT00652743|20876584|P1|Months 36-42|Withdrawal by Subject|1
6040274|NCT00652743|20876582|P3|Months 36-42|Serious Adverse Events|1
6040275|NCT00652743|20876583|P2|Months 36-42|Serious Adverse Events|1
6040276|NCT00652743|20876584|P1|Months 36-42|Serious Adverse Events|0
6040277|NCT00652743|20876582|P3|Months 24-30|Other|11
6040278|NCT00652743|20876583|P2|Months 24-30|Other|1
6040279|NCT00652743|20876584|P1|Months 24-30|Other|5
6040280|NCT00652743|20876582|P3|Months 12-18|Lost to Follow-up|7
6040281|NCT00652743|20876583|P2|Months 12-18|Lost to Follow-up|2
6040282|NCT00652743|20876584|P1|Months 12-18|Lost to Follow-up|1
6040283|NCT00652626|20876666|P7|Extension Phase|Death|1
6040284|NCT00652626|20876667|P6|Extension Phase|Death|1
6040285|NCT00652626|20876668|P5|Extension Phase|Death|0
6040286|NCT00652626|20876669|P4|Extension Phase|Death|0
6040287|NCT00652626|20876670|P3|Extension Phase|Death|0
6040288|NCT00652626|20876671|P2|Extension Phase|Death|0
6040289|NCT00652626|20876672|P1|Extension Phase|Death|0
6040290|NCT00652626|20876666|P7|Extension Phase|Physician Decision|1
6040291|NCT00652626|20876667|P6|Extension Phase|Physician Decision|1
6040292|NCT00652626|20876668|P5|Extension Phase|Physician Decision|0
6040293|NCT00652626|20876669|P4|Extension Phase|Physician Decision|0
6040294|NCT00652626|20876670|P3|Extension Phase|Physician Decision|0
6040295|NCT00652626|20876671|P2|Extension Phase|Physician Decision|0
6040296|NCT00652626|20876672|P1|Extension Phase|Physician Decision|0
6040297|NCT00652626|20876666|P7|Extension Phase|No Longer Receiving Clinical Benefit|0
6040298|NCT00652626|20876667|P6|Extension Phase|No Longer Receiving Clinical Benefit|6
6040299|NCT00652626|20876668|P5|Extension Phase|No Longer Receiving Clinical Benefit|0
6040300|NCT00652626|20876669|P4|Extension Phase|No Longer Receiving Clinical Benefit|0
6040301|NCT00652626|20876670|P3|Extension Phase|No Longer Receiving Clinical Benefit|0
6040302|NCT00652626|20876671|P2|Extension Phase|No Longer Receiving Clinical Benefit|0
6040303|NCT00652626|20876672|P1|Extension Phase|No Longer Receiving Clinical Benefit|0
6040304|NCT00652626|20876666|P7|Extension Phase|Adverse Event|1
6040305|NCT00652626|20876667|P6|Extension Phase|Adverse Event|2
6040306|NCT00652626|20876668|P5|Extension Phase|Adverse Event|0
6040307|NCT00652626|20876669|P4|Extension Phase|Adverse Event|0
6040308|NCT00652626|20876670|P3|Extension Phase|Adverse Event|0
6040309|NCT00652626|20876671|P2|Extension Phase|Adverse Event|0
6040310|NCT00652626|20876672|P1|Extension Phase|Adverse Event|0
6040311|NCT00652626|20876666|P7|Extension Phase|Withdrawal by Subject|0
6040312|NCT00652626|20876667|P6|Extension Phase|Withdrawal by Subject|2
6040313|NCT00652626|20876668|P5|Extension Phase|Withdrawal by Subject|0
6040314|NCT00652626|20876669|P4|Extension Phase|Withdrawal by Subject|0
6040315|NCT00652626|20876670|P3|Extension Phase|Withdrawal by Subject|0
6040316|NCT00652626|20876671|P2|Extension Phase|Withdrawal by Subject|0
6040317|NCT00652626|20876672|P1|Extension Phase|Withdrawal by Subject|0
6040318|NCT00652626|20876666|P7|Initial Treatment Phase|Lost to Follow-up|0
6040319|NCT00652626|20876667|P6|Initial Treatment Phase|Lost to Follow-up|0
6040320|NCT00652626|20876668|P5|Initial Treatment Phase|Lost to Follow-up|1
6040321|NCT00652626|20876669|P4|Initial Treatment Phase|Lost to Follow-up|0
6040322|NCT00652626|20876670|P3|Initial Treatment Phase|Lost to Follow-up|0
6040323|NCT00652626|20876671|P2|Initial Treatment Phase|Lost to Follow-up|0
6040324|NCT00652626|20876672|P1|Initial Treatment Phase|Lost to Follow-up|0
6040325|NCT00652626|20876666|P7|Initial Treatment Phase|Sponsor Request|0
6040326|NCT00652626|20876667|P6|Initial Treatment Phase|Sponsor Request|0
6040327|NCT00652626|20876668|P5|Initial Treatment Phase|Sponsor Request|0
6040328|NCT00652626|20876669|P4|Initial Treatment Phase|Sponsor Request|0
6040329|NCT00652626|20876670|P3|Initial Treatment Phase|Sponsor Request|1
6040330|NCT00652626|20876671|P2|Initial Treatment Phase|Sponsor Request|0
6040331|NCT00652626|20876672|P1|Initial Treatment Phase|Sponsor Request|0
6040332|NCT00652626|20876666|P7|Initial Treatment Phase|Physician Decision|0
6040333|NCT00652626|20876667|P6|Initial Treatment Phase|Physician Decision|0
6040334|NCT00652626|20876668|P5|Initial Treatment Phase|Physician Decision|1
6040335|NCT00652626|20876669|P4|Initial Treatment Phase|Physician Decision|0
6040336|NCT00652626|20876670|P3|Initial Treatment Phase|Physician Decision|0
6040337|NCT00652626|20876671|P2|Initial Treatment Phase|Physician Decision|0
6040338|NCT00652626|20876672|P1|Initial Treatment Phase|Physician Decision|0
6040339|NCT00652626|20876666|P7|Initial Treatment Phase|Protocol Violation|0
6040340|NCT00652626|20876667|P6|Initial Treatment Phase|Protocol Violation|0
6040341|NCT00652626|20876668|P5|Initial Treatment Phase|Protocol Violation|0
6040342|NCT00652626|20876669|P4|Initial Treatment Phase|Protocol Violation|1
6040343|NCT00652626|20876670|P3|Initial Treatment Phase|Protocol Violation|0
6040344|NCT00652626|20876671|P2|Initial Treatment Phase|Protocol Violation|0
6040345|NCT00652626|20876672|P1|Initial Treatment Phase|Protocol Violation|0
6040346|NCT00652626|20876666|P7|Initial Treatment Phase|Adverse Event|0
6040347|NCT00652626|20876667|P6|Initial Treatment Phase|Adverse Event|0
6040348|NCT00652626|20876668|P5|Initial Treatment Phase|Adverse Event|1
6040349|NCT00652626|20876669|P4|Initial Treatment Phase|Adverse Event|0
6040350|NCT00652626|20876670|P3|Initial Treatment Phase|Adverse Event|0
6040351|NCT00652626|20876671|P2|Initial Treatment Phase|Adverse Event|0
6040352|NCT00652626|20876672|P1|Initial Treatment Phase|Adverse Event|0
6040353|NCT00652366|20876750|P5|Overall Study|Other|0
6040354|NCT00652366|20876751|P4|Overall Study|Other|4
6040355|NCT00652366|20876752|P3|Overall Study|Other|3
6040356|NCT00652366|20876753|P2|Overall Study|Other|2
6040357|NCT00652366|20876754|P1|Overall Study|Other|5
6040358|NCT00652366|20876750|P5|Overall Study|Refused treatment|5
6040359|NCT00652366|20876751|P4|Overall Study|Refused treatment|17
6040360|NCT00652366|20876752|P3|Overall Study|Refused treatment|6
6040361|NCT00652366|20876753|P2|Overall Study|Refused treatment|7
6040362|NCT00652366|20876754|P1|Overall Study|Refused treatment|3
6040363|NCT00652366|20876750|P5|Overall Study|Protocol Violation|0
6040364|NCT00652366|20876751|P4|Overall Study|Protocol Violation|0
6040365|NCT00652366|20876752|P3|Overall Study|Protocol Violation|0
6040366|NCT00652366|20876753|P2|Overall Study|Protocol Violation|0
6040367|NCT00652366|20876754|P1|Overall Study|Protocol Violation|1
6040368|NCT00652366|20876750|P5|Overall Study|Violation of Selection Criteria|0
6040369|NCT00652366|20876751|P4|Overall Study|Violation of Selection Criteria|0
6040370|NCT00652366|20876752|P3|Overall Study|Violation of Selection Criteria|1
6040371|NCT00652366|20876753|P2|Overall Study|Violation of Selection Criteria|0
6040372|NCT00652366|20876754|P1|Overall Study|Violation of Selection Criteria|0
6040373|NCT00652366|20876750|P5|Overall Study|Lack of Efficacy|13
6040374|NCT00652366|20876751|P4|Overall Study|Lack of Efficacy|133
6040375|NCT00652366|20876752|P3|Overall Study|Lack of Efficacy|53
6040376|NCT00652366|20876753|P2|Overall Study|Lack of Efficacy|58
6040377|NCT00652366|20876754|P1|Overall Study|Lack of Efficacy|84
6040378|NCT00652366|20876750|P5|Overall Study|Death|5
6040379|NCT00652366|20876751|P4|Overall Study|Death|8
6040380|NCT00652366|20876752|P3|Overall Study|Death|1
6040381|NCT00652366|20876753|P2|Overall Study|Death|4
6040382|NCT00652366|20876754|P1|Overall Study|Death|5
6040383|NCT00652366|20876750|P5|Overall Study|Adverse Event|13
6040384|NCT00652366|20876751|P4|Overall Study|Adverse Event|17
6040385|NCT00652366|20876752|P3|Overall Study|Adverse Event|7
6040386|NCT00652366|20876753|P2|Overall Study|Adverse Event|4
6040387|NCT00652366|20876754|P1|Overall Study|Adverse Event|8
6040388|NCT00652340|20876789|P2|Overall Study|Had not progressed.|3
6040389|NCT00652340|20876790|P1|Overall Study|Had not progressed.|4
6040390|NCT00652327|20876800|P2|Overall Study|Lost to Follow-up|3
6040391|NCT00652327|20876801|P1|Overall Study|Lost to Follow-up|0
6040392|NCT00652327|20876800|P2|Overall Study|Adverse Event|2
6040393|NCT00652327|20876801|P1|Overall Study|Adverse Event|0
6040394|NCT00652093|20876843|P6|Overall Study|Physician Decision|0
6040395|NCT00652093|20876844|P5|Overall Study|Physician Decision|1
6040396|NCT00652093|20876845|P4|Overall Study|Physician Decision|0
6040397|NCT00652093|20876846|P3|Overall Study|Physician Decision|0
6040398|NCT00652093|20876847|P2|Overall Study|Physician Decision|0
6040399|NCT00652093|20876848|P1|Overall Study|Physician Decision|0
6040400|NCT00652093|20876843|P6|Overall Study|Withdrawal by Subject|0
6040401|NCT00652093|20876844|P5|Overall Study|Withdrawal by Subject|1
6040402|NCT00652093|20876845|P4|Overall Study|Withdrawal by Subject|0
6040403|NCT00652093|20876846|P3|Overall Study|Withdrawal by Subject|1
6040404|NCT00652093|20876847|P2|Overall Study|Withdrawal by Subject|0
6040405|NCT00652093|20876848|P1|Overall Study|Withdrawal by Subject|0
6040406|NCT00652028|20876938|P4|Overall Study|Physician Decision|0
6040407|NCT00652028|20876939|P3|Overall Study|Physician Decision|1
6040408|NCT00652028|20876940|P2|Overall Study|Physician Decision|0
6040409|NCT00652028|20876941|P1|Overall Study|Physician Decision|0
6040410|NCT00652028|20876938|P4|Overall Study|No Longer Meets Entry Criteria|0
6040411|NCT00652028|20876939|P3|Overall Study|No Longer Meets Entry Criteria|0
6040412|NCT00652028|20876940|P2|Overall Study|No Longer Meets Entry Criteria|1
6040413|NCT00652028|20876941|P1|Overall Study|No Longer Meets Entry Criteria|0
6040414|NCT00652028|20876938|P4|Overall Study|Adverse Event|0
6040415|NCT00652028|20876939|P3|Overall Study|Adverse Event|0
6040416|NCT00652028|20876940|P2|Overall Study|Adverse Event|0
6040417|NCT00652028|20876941|P1|Overall Study|Adverse Event|1
6040418|NCT00651937|20876985|P2|Overall Study|Withdrawal by Subject|1
6040419|NCT00651937|20876986|P1|Overall Study|Withdrawal by Subject|4
6040420|NCT00651924|20876996|P2|Overall Study|Withdrawal by Subject|5
6040421|NCT00651924|20876997|P1|Overall Study|Withdrawal by Subject|0
6040422|NCT00651924|20876996|P2|Overall Study|Withdrawal by PI|2
6040423|NCT00651924|20876997|P1|Overall Study|Withdrawal by PI|0
6040424|NCT00651820|20877003|P1|Overall Study|Lost to Follow-up|2
6040425|NCT00651755|20877035|P2|Cycle 2 (Second 21 Days)|Not Evaluable|1
6040426|NCT00651755|20877036|P1|Cycle 2 (Second 21 Days)|Not Evaluable|0
6040427|NCT00651755|20877035|P2|Cycle 1 (First 21 Days)|Withdrawal by Subject|0
6040428|NCT00651755|20877036|P1|Cycle 1 (First 21 Days)|Withdrawal by Subject|1
6040429|NCT00651664|20877062|P10|Overall Study|Reason not Specified|0
6040430|NCT00651664|20877063|P9|Overall Study|Reason not Specified|0
6040431|NCT00651664|20877064|P8|Overall Study|Reason not Specified|0
6040432|NCT00651664|20877065|P7|Overall Study|Reason not Specified|1
6040433|NCT00651664|20877066|P6|Overall Study|Reason not Specified|0
6040434|NCT00651664|20877067|P5|Overall Study|Reason not Specified|0
6040435|NCT00651664|20877068|P4|Overall Study|Reason not Specified|0
6040436|NCT00651664|20877069|P3|Overall Study|Reason not Specified|0
6040437|NCT00651664|20877070|P2|Overall Study|Reason not Specified|0
6040438|NCT00651664|20877071|P1|Overall Study|Reason not Specified|0
6040439|NCT00651664|20877062|P10|Overall Study|Symptomatic Deterioration|0
6040440|NCT00651664|20877063|P9|Overall Study|Symptomatic Deterioration|1
6040441|NCT00651664|20877064|P8|Overall Study|Symptomatic Deterioration|0
6040442|NCT00651664|20877065|P7|Overall Study|Symptomatic Deterioration|1
6040443|NCT00651664|20877066|P6|Overall Study|Symptomatic Deterioration|0
6040444|NCT00651664|20877067|P5|Overall Study|Symptomatic Deterioration|0
6040445|NCT00651664|20877068|P4|Overall Study|Symptomatic Deterioration|1
6040446|NCT00651664|20877069|P3|Overall Study|Symptomatic Deterioration|0
6040447|NCT00651664|20877070|P2|Overall Study|Symptomatic Deterioration|0
6040448|NCT00651664|20877071|P1|Overall Study|Symptomatic Deterioration|0
6040449|NCT00651664|20877062|P10|Overall Study|Patient Declined Further Treatment|1
6040450|NCT00651664|20877063|P9|Overall Study|Patient Declined Further Treatment|0
6040451|NCT00651664|20877064|P8|Overall Study|Patient Declined Further Treatment|0
6040452|NCT00651664|20877065|P7|Overall Study|Patient Declined Further Treatment|0
6040453|NCT00651664|20877066|P6|Overall Study|Patient Declined Further Treatment|1
6040454|NCT00651664|20877067|P5|Overall Study|Patient Declined Further Treatment|1
6040455|NCT00651664|20877068|P4|Overall Study|Patient Declined Further Treatment|1
6040456|NCT00651664|20877069|P3|Overall Study|Patient Declined Further Treatment|0
6040457|NCT00651664|20877070|P2|Overall Study|Patient Declined Further Treatment|0
6040458|NCT00651664|20877071|P1|Overall Study|Patient Declined Further Treatment|0
6040459|NCT00651664|20877062|P10|Overall Study|Progressive Disease|5
6040460|NCT00651664|20877063|P9|Overall Study|Progressive Disease|5
6040461|NCT00651664|20877064|P8|Overall Study|Progressive Disease|6
6040462|NCT00651664|20877065|P7|Overall Study|Progressive Disease|3
6040463|NCT00651664|20877066|P6|Overall Study|Progressive Disease|1
6040464|NCT00651664|20877067|P5|Overall Study|Progressive Disease|4
6040465|NCT00651664|20877068|P4|Overall Study|Progressive Disease|12
6040466|NCT00651664|20877069|P3|Overall Study|Progressive Disease|3
6040467|NCT00651664|20877070|P2|Overall Study|Progressive Disease|3
6040468|NCT00651664|20877071|P1|Overall Study|Progressive Disease|3
6040469|NCT00651664|20877062|P10|Overall Study|Unsatisfactory Therapeutic Response|1
6040470|NCT00651664|20877063|P9|Overall Study|Unsatisfactory Therapeutic Response|0
6040471|NCT00651664|20877064|P8|Overall Study|Unsatisfactory Therapeutic Response|1
6040472|NCT00651664|20877065|P7|Overall Study|Unsatisfactory Therapeutic Response|0
6040473|NCT00651664|20877066|P6|Overall Study|Unsatisfactory Therapeutic Response|1
6040474|NCT00651664|20877067|P5|Overall Study|Unsatisfactory Therapeutic Response|1
6040475|NCT00651664|20877068|P4|Overall Study|Unsatisfactory Therapeutic Response|0
6040476|NCT00651664|20877069|P3|Overall Study|Unsatisfactory Therapeutic Response|0
6040477|NCT00651664|20877070|P2|Overall Study|Unsatisfactory Therapeutic Response|0
6040657|NCT00649389|20878061|P2|Overall Study|Protocol Violation|13
6040478|NCT00651664|20877071|P1|Overall Study|Unsatisfactory Therapeutic Response|0
6040479|NCT00651664|20877062|P10|Overall Study|Occurrence of Adverse Event(s)|0
6040480|NCT00651664|20877063|P9|Overall Study|Occurrence of Adverse Event(s)|1
6040481|NCT00651664|20877064|P8|Overall Study|Occurrence of Adverse Event(s)|0
6040482|NCT00651664|20877065|P7|Overall Study|Occurrence of Adverse Event(s)|1
6040483|NCT00651664|20877066|P6|Overall Study|Occurrence of Adverse Event(s)|0
6040484|NCT00651664|20877067|P5|Overall Study|Occurrence of Adverse Event(s)|0
6040485|NCT00651664|20877068|P4|Overall Study|Occurrence of Adverse Event(s)|0
6040486|NCT00651664|20877069|P3|Overall Study|Occurrence of Adverse Event(s)|0
6040487|NCT00651664|20877070|P2|Overall Study|Occurrence of Adverse Event(s)|0
6040488|NCT00651664|20877071|P1|Overall Study|Occurrence of Adverse Event(s)|0
6040489|NCT00651313|20877243|P2|Overall Study|Adminstrative Discontinuation|3
6040490|NCT00651313|20877244|P1|Overall Study|Adminstrative Discontinuation|2
6040491|NCT00651313|20877243|P2|Overall Study|Lost to Follow-up|1
6040492|NCT00651313|20877244|P1|Overall Study|Lost to Follow-up|1
6040493|NCT00651313|20877243|P2|Overall Study|Withdrawal by Subject|1
6040494|NCT00651313|20877244|P1|Overall Study|Withdrawal by Subject|3
6040495|NCT00651313|20877243|P2|Overall Study|Adverse Event|1
6040496|NCT00651313|20877244|P1|Overall Study|Adverse Event|0
6040497|NCT00651261|20877252|P2|Overall Study|Never treated|3
6040498|NCT00651261|20877253|P1|Overall Study|Never treated|5
6040499|NCT00651261|20877252|P2|Overall Study|Other disease or participant decisions|23
6040500|NCT00651261|20877253|P1|Overall Study|Other disease or participant decisions|23
6040501|NCT00651261|20877252|P2|Overall Study|Alternative therapy|107
6040502|NCT00651261|20877253|P1|Overall Study|Alternative therapy|109
6040503|NCT00651261|20877252|P2|Overall Study|Disease progression|58
6040504|NCT00651261|20877253|P1|Overall Study|Disease progression|58
6040505|NCT00651261|20877252|P2|Overall Study|Induction failure|35
6040506|NCT00651261|20877253|P1|Overall Study|Induction failure|24
6040507|NCT00651261|20877252|P2|Overall Study|Withdrawal by Subject|40
6040508|NCT00651261|20877253|P1|Overall Study|Withdrawal by Subject|22
6040509|NCT00651261|20877252|P2|Overall Study|Death|18
6040510|NCT00651261|20877253|P1|Overall Study|Death|18
6040511|NCT00651261|20877252|P2|Overall Study|Adverse Event|22
6040512|NCT00651261|20877253|P1|Overall Study|Adverse Event|32
6040513|NCT00651183|20877269|P2|Overall Study|missing|0
6040514|NCT00651183|20877270|P1|Overall Study|missing|1
6040515|NCT00651183|20877269|P2|Overall Study|Other reasons|2
6040516|NCT00651183|20877270|P1|Overall Study|Other reasons|4
6040517|NCT00651183|20877269|P2|Overall Study|Lost to Follow-up|1
6040518|NCT00651183|20877270|P1|Overall Study|Lost to Follow-up|3
6040519|NCT00651183|20877269|P2|Overall Study|Withdrawal by Subject|3
6040520|NCT00651183|20877270|P1|Overall Study|Withdrawal by Subject|6
6040521|NCT00651183|20877269|P2|Overall Study|Tolerability insufficient +Patients wish|1
6040522|NCT00651183|20877270|P1|Overall Study|Tolerability insufficient +Patients wish|0
6040523|NCT00651183|20877269|P2|Overall Study|Tolerability insufficient|2
6040524|NCT00651183|20877270|P1|Overall Study|Tolerability insufficient|5
6040525|NCT00651183|20877269|P2|Overall Study|Efficacy insufficient + patients wish|1
6040526|NCT00651183|20877270|P1|Overall Study|Efficacy insufficient + patients wish|0
6040527|NCT00651183|20877269|P2|Overall Study|Lack of Efficacy|0
6040528|NCT00651183|20877270|P1|Overall Study|Lack of Efficacy|1
6040529|NCT00651157|20877282|P1|Overall Study|Protocol Violation|1
6040530|NCT00651157|20877282|P1|Overall Study|Death|1
6040531|NCT00651118|20877292|P4|Overall Study|Withdrawal by Subject|1
6040532|NCT00651118|20877293|P3|Overall Study|Withdrawal by Subject|1
6040533|NCT00651118|20877294|P2|Overall Study|Withdrawal by Subject|1
6040534|NCT00651118|20877295|P1|Overall Study|Withdrawal by Subject|0
6040535|NCT00651118|20877292|P4|Overall Study|administrative|1
6040536|NCT00651118|20877293|P3|Overall Study|administrative|2
6040537|NCT00651118|20877294|P2|Overall Study|administrative|4
6040538|NCT00651118|20877295|P1|Overall Study|administrative|1
6040539|NCT00651118|20877292|P4|Overall Study|Lost to Follow-up|2
6040540|NCT00651118|20877293|P3|Overall Study|Lost to Follow-up|1
6040541|NCT00651118|20877294|P2|Overall Study|Lost to Follow-up|0
6040542|NCT00651118|20877295|P1|Overall Study|Lost to Follow-up|2
6040543|NCT00651118|20877292|P4|Overall Study|Protocol Violation|2
6040544|NCT00651118|20877293|P3|Overall Study|Protocol Violation|6
6040545|NCT00651118|20877294|P2|Overall Study|Protocol Violation|2
6040546|NCT00651118|20877295|P1|Overall Study|Protocol Violation|2
6040547|NCT00651118|20877292|P4|Overall Study|Adverse Event|1
6040548|NCT00651118|20877293|P3|Overall Study|Adverse Event|1
6040549|NCT00651118|20877294|P2|Overall Study|Adverse Event|0
6040550|NCT00651118|20877295|P1|Overall Study|Adverse Event|4
6040551|NCT00650845|20877364|P2|Overall Study|Protocol Violation|13
6040552|NCT00650845|20877365|P1|Overall Study|Protocol Violation|0
6040553|NCT00650845|20877364|P2|Overall Study|Withdrawal by Subject|0
6040554|NCT00650845|20877365|P1|Overall Study|Withdrawal by Subject|5
6040555|NCT00650806|20877385|P4|Overall Study|Other|0
6040556|NCT00650806|20877386|P3|Overall Study|Other|2
6040557|NCT00650806|20877387|P2|Overall Study|Other|1
6040558|NCT00650806|20877388|P1|Overall Study|Other|1
6040559|NCT00650806|20877385|P4|Overall Study|Study terminated by sponsor|4
6040560|NCT00650806|20877386|P3|Overall Study|Study terminated by sponsor|5
6040561|NCT00650806|20877387|P2|Overall Study|Study terminated by sponsor|3
6040562|NCT00650806|20877388|P1|Overall Study|Study terminated by sponsor|2
6040563|NCT00650806|20877385|P4|Overall Study|Noncompliance with study drug regimen|0
6040564|NCT00650806|20877386|P3|Overall Study|Noncompliance with study drug regimen|0
6040565|NCT00650806|20877387|P2|Overall Study|Noncompliance with study drug regimen|1
6040566|NCT00650806|20877388|P1|Overall Study|Noncompliance with study drug regimen|1
6040567|NCT00650806|20877385|P4|Overall Study|Withdrawal by Subject|6
6040568|NCT00650806|20877386|P3|Overall Study|Withdrawal by Subject|8
6040569|NCT00650806|20877387|P2|Overall Study|Withdrawal by Subject|5
6040570|NCT00650806|20877388|P1|Overall Study|Withdrawal by Subject|7
6040571|NCT00650806|20877385|P4|Overall Study|Pregnancy|1
6040572|NCT00650806|20877386|P3|Overall Study|Pregnancy|0
6040573|NCT00650806|20877387|P2|Overall Study|Pregnancy|0
6040574|NCT00650806|20877388|P1|Overall Study|Pregnancy|0
6040575|NCT00650806|20877385|P4|Overall Study|Protocol Violation|1
6040576|NCT00650806|20877386|P3|Overall Study|Protocol Violation|0
6040577|NCT00650806|20877387|P2|Overall Study|Protocol Violation|0
6040578|NCT00650806|20877388|P1|Overall Study|Protocol Violation|0
6040579|NCT00650806|20877385|P4|Overall Study|Lost to Follow-up|10
6040580|NCT00650806|20877386|P3|Overall Study|Lost to Follow-up|11
6040581|NCT00650806|20877387|P2|Overall Study|Lost to Follow-up|6
6040582|NCT00650806|20877388|P1|Overall Study|Lost to Follow-up|7
6040583|NCT00650806|20877385|P4|Overall Study|Adverse Event|4
6040584|NCT00650806|20877386|P3|Overall Study|Adverse Event|3
6040585|NCT00650806|20877387|P2|Overall Study|Adverse Event|5
6040586|NCT00650806|20877388|P1|Overall Study|Adverse Event|0
6040587|NCT00650767|20877430|P4|Overall Study|Other|0
6040588|NCT00650767|20877431|P3|Overall Study|Other|0
6040589|NCT00650767|20877432|P2|Overall Study|Other|1
6040590|NCT00650767|20877433|P1|Overall Study|Other|1
6040591|NCT00650767|20877430|P4|Overall Study|Lost to Follow-up|0
6040592|NCT00650767|20877431|P3|Overall Study|Lost to Follow-up|1
6040593|NCT00650767|20877432|P2|Overall Study|Lost to Follow-up|1
6040594|NCT00650767|20877433|P1|Overall Study|Lost to Follow-up|1
6040595|NCT00650767|20877430|P4|Overall Study|Withdrawal by Subject|3
6040596|NCT00650767|20877431|P3|Overall Study|Withdrawal by Subject|3
6040597|NCT00650767|20877432|P2|Overall Study|Withdrawal by Subject|4
6040598|NCT00650767|20877433|P1|Overall Study|Withdrawal by Subject|2
6040599|NCT00650767|20877430|P4|Overall Study|Death|0
6040600|NCT00650767|20877431|P3|Overall Study|Death|0
6040601|NCT00650767|20877432|P2|Overall Study|Death|0
6040602|NCT00650767|20877433|P1|Overall Study|Death|1
6040603|NCT00650767|20877430|P4|Overall Study|Adverse Event|8
6040604|NCT00650767|20877431|P3|Overall Study|Adverse Event|10
6040605|NCT00650767|20877432|P2|Overall Study|Adverse Event|3
6040606|NCT00650767|20877433|P1|Overall Study|Adverse Event|0
6040607|NCT00650585|20877937|P2|Overall Study|Excluded/ruled ineligible|129
6040608|NCT00650585|20877938|P1|Overall Study|Excluded/ruled ineligible|357
6040609|NCT00650585|20877937|P2|Overall Study|No parental consent|866
6040610|NCT00650585|20877938|P1|Overall Study|No parental consent|935
6040611|NCT00650585|20877937|P2|Overall Study|Lost to Follow-up|482
6040612|NCT00650585|20877938|P1|Overall Study|Lost to Follow-up|505
6040613|NCT00650104|20877982|P1|Overall Study|Sponsor Terminated Dosing|1
6040614|NCT00650104|20877982|P1|Overall Study|Non-compliance|2
6040615|NCT00650104|20877982|P1|Overall Study|Lost to Follow-up|1
6040616|NCT00650104|20877982|P1|Overall Study|Physician Decision|7
6040617|NCT00650104|20877982|P1|Overall Study|Withdrawal by Subject|11
6040618|NCT00650104|20877982|P1|Overall Study|Death|2
6040619|NCT00650104|20877982|P1|Overall Study|Adverse Event|17
6040620|NCT00650091|20877997|P3|Amended Study Design|Other|0
6040621|NCT00650091|20877998|P2|Amended Study Design|Other|3
6040622|NCT00650091|20877999|P1|Amended Study Design|Other|1
6040623|NCT00650091|20877997|P3|Amended Study Design|Lung transplantation|0
6040624|NCT00650091|20877998|P2|Amended Study Design|Lung transplantation|2
6040625|NCT00650091|20877999|P1|Amended Study Design|Lung transplantation|4
6040626|NCT00650091|20877997|P3|Amended Study Design|Adverse Event|0
6040627|NCT00650091|20877998|P2|Amended Study Design|Adverse Event|4
6040628|NCT00650091|20877999|P1|Amended Study Design|Adverse Event|1
6040629|NCT00650091|20877997|P3|Amended Study Design|Physician Decision|0
6040630|NCT00650091|20877998|P2|Amended Study Design|Physician Decision|0
6040631|NCT00650091|20877999|P1|Amended Study Design|Physician Decision|5
6040632|NCT00650091|20877997|P3|Amended Study Design|Withdrawal by Subject|0
6040633|NCT00650091|20877998|P2|Amended Study Design|Withdrawal by Subject|11
6040634|NCT00650091|20877999|P1|Amended Study Design|Withdrawal by Subject|12
6040635|NCT00649428|20878042|P2|Overall Study|Physician Decision|1
6040636|NCT00649428|20878043|P1|Overall Study|Physician Decision|0
6040637|NCT00649428|20878042|P2|Overall Study|Protocol Violation|2
6040638|NCT00649428|20878043|P1|Overall Study|Protocol Violation|6
6040639|NCT00649428|20878042|P2|Overall Study|Insufficient manufacturing yield|1
6040640|NCT00649428|20878043|P1|Overall Study|Insufficient manufacturing yield|5
6040641|NCT00649428|20878042|P2|Overall Study|Lost to Follow-up|3
6040642|NCT00649428|20878043|P1|Overall Study|Lost to Follow-up|1
6040643|NCT00649428|20878042|P2|Overall Study|Withdrawal by Subject|6
6040644|NCT00649428|20878043|P1|Overall Study|Withdrawal by Subject|6
6040645|NCT00649428|20878042|P2|Overall Study|Adverse Event|2
6040646|NCT00649428|20878043|P1|Overall Study|Adverse Event|2
6040647|NCT00649389|20878059|P4|Overall Study|Other|6
6040648|NCT00649389|20878060|P3|Overall Study|Other|1
6040649|NCT00649389|20878061|P2|Overall Study|Other|9
6040650|NCT00649389|20878062|P1|Overall Study|Other|3
6040651|NCT00649389|20878059|P4|Overall Study|Withdrawal by Subject|23
6040652|NCT00649389|20878060|P3|Overall Study|Withdrawal by Subject|19
6040653|NCT00649389|20878061|P2|Overall Study|Withdrawal by Subject|21
6040654|NCT00649389|20878062|P1|Overall Study|Withdrawal by Subject|20
6040655|NCT00649389|20878059|P4|Overall Study|Protocol Violation|8
6040656|NCT00649389|20878060|P3|Overall Study|Protocol Violation|9
6040658|NCT00649389|20878062|P1|Overall Study|Protocol Violation|11
6040659|NCT00649389|20878059|P4|Overall Study|Lost to Follow-up|26
6040660|NCT00649389|20878060|P3|Overall Study|Lost to Follow-up|21
6040661|NCT00649389|20878061|P2|Overall Study|Lost to Follow-up|17
6040662|NCT00649389|20878062|P1|Overall Study|Lost to Follow-up|15
6040663|NCT00649389|20878059|P4|Overall Study|Adverse Event|48
6040664|NCT00649389|20878060|P3|Overall Study|Adverse Event|38
6040665|NCT00649389|20878061|P2|Overall Study|Adverse Event|46
6040666|NCT00649389|20878062|P1|Overall Study|Adverse Event|22
6040667|NCT00649220|20878084|P1|Overall Study|Withdrawal by Subject|1
6040668|NCT00649220|20878084|P1|Overall Study|Adverse Event|2
6040669|NCT00648895|20878105|P2|Overall Study|Lack of Efficacy|1
6040670|NCT00648895|20878106|P1|Overall Study|Lack of Efficacy|0
6040671|NCT00648739|20878112|P7|Overall Study|Follow-up Visits Not Completed|0
6040672|NCT00648739|20878113|P6|Overall Study|Follow-up Visits Not Completed|0
6040673|NCT00648739|20878114|P5|Overall Study|Follow-up Visits Not Completed|0
6040674|NCT00648739|20878115|P4|Overall Study|Follow-up Visits Not Completed|0
6040675|NCT00648739|20878116|P3|Overall Study|Follow-up Visits Not Completed|0
6040676|NCT00648739|20878117|P2|Overall Study|Follow-up Visits Not Completed|1
6040677|NCT00648739|20878118|P1|Overall Study|Follow-up Visits Not Completed|0
6040678|NCT00648739|20878112|P7|Overall Study|Positive Human Anti-human Antibody|0
6040679|NCT00648739|20878113|P6|Overall Study|Positive Human Anti-human Antibody|0
6040680|NCT00648739|20878114|P5|Overall Study|Positive Human Anti-human Antibody|0
6040681|NCT00648739|20878115|P4|Overall Study|Positive Human Anti-human Antibody|0
6040682|NCT00648739|20878116|P3|Overall Study|Positive Human Anti-human Antibody|1
6040683|NCT00648739|20878117|P2|Overall Study|Positive Human Anti-human Antibody|0
6040684|NCT00648739|20878118|P1|Overall Study|Positive Human Anti-human Antibody|0
6040685|NCT00648739|20878112|P7|Overall Study|Death|0
6040686|NCT00648739|20878113|P6|Overall Study|Death|0
6040687|NCT00648739|20878114|P5|Overall Study|Death|0
6040688|NCT00648739|20878115|P4|Overall Study|Death|0
6040689|NCT00648739|20878116|P3|Overall Study|Death|0
6040690|NCT00648739|20878117|P2|Overall Study|Death|1
6040691|NCT00648739|20878118|P1|Overall Study|Death|0
6040692|NCT00648739|20878112|P7|Overall Study|Investigator Considered it Advisable|1
6040693|NCT00648739|20878113|P6|Overall Study|Investigator Considered it Advisable|1
6040694|NCT00648739|20878114|P5|Overall Study|Investigator Considered it Advisable|0
6040695|NCT00648739|20878115|P4|Overall Study|Investigator Considered it Advisable|0
6040696|NCT00648739|20878116|P3|Overall Study|Investigator Considered it Advisable|0
6040697|NCT00648739|20878117|P2|Overall Study|Investigator Considered it Advisable|0
6040698|NCT00648739|20878118|P1|Overall Study|Investigator Considered it Advisable|0
6040699|NCT00648739|20878112|P7|Overall Study|Lack of Efficacy|0
6040700|NCT00648739|20878113|P6|Overall Study|Lack of Efficacy|2
6040701|NCT00648739|20878114|P5|Overall Study|Lack of Efficacy|1
6040702|NCT00648739|20878115|P4|Overall Study|Lack of Efficacy|0
6040703|NCT00648739|20878116|P3|Overall Study|Lack of Efficacy|0
6040704|NCT00648739|20878117|P2|Overall Study|Lack of Efficacy|0
6040705|NCT00648739|20878118|P1|Overall Study|Lack of Efficacy|0
6040706|NCT00648739|20878112|P7|Overall Study|Withdrawal by Subject|0
6040707|NCT00648739|20878113|P6|Overall Study|Withdrawal by Subject|2
6040708|NCT00648739|20878114|P5|Overall Study|Withdrawal by Subject|0
6040709|NCT00648739|20878115|P4|Overall Study|Withdrawal by Subject|0
6040710|NCT00648739|20878116|P3|Overall Study|Withdrawal by Subject|1
6040711|NCT00648739|20878117|P2|Overall Study|Withdrawal by Subject|0
6040712|NCT00648739|20878118|P1|Overall Study|Withdrawal by Subject|1
6040713|NCT00648739|20878112|P7|Overall Study|Adverse Event|0
6040714|NCT00648739|20878113|P6|Overall Study|Adverse Event|0
6040715|NCT00648739|20878114|P5|Overall Study|Adverse Event|1
6040716|NCT00648739|20878115|P4|Overall Study|Adverse Event|2
6040717|NCT00648739|20878116|P3|Overall Study|Adverse Event|1
6040718|NCT00648739|20878117|P2|Overall Study|Adverse Event|0
6040719|NCT00648739|20878118|P1|Overall Study|Adverse Event|1
6040720|NCT00648167|20878452|P1|Overall Study|unable to swallow tablets|1
6040721|NCT00648167|20878452|P1|Overall Study|Adverse Event|6
6040722|NCT00648037|20878472|P1|Overall Study|Other|1
6040723|NCT00648037|20878472|P1|Overall Study|Relapse|2
6040724|NCT00648037|20878472|P1|Overall Study|Adverse Event|11
6040725|NCT00648037|20878472|P1|Overall Study|Withdrawal by Subject|1
6040726|NCT00648037|20878472|P1|Overall Study|Not Treated|1
6040727|NCT00647699|20878491|P2|Overall Study|Withdrawal by Subject|8
6040728|NCT00647699|20878492|P1|Overall Study|Withdrawal by Subject|3
6040729|NCT00647699|20878491|P2|Overall Study|Lost to Follow-up|4
6040730|NCT00647699|20878492|P1|Overall Study|Lost to Follow-up|5
6040731|NCT00647556|20878500|P2|Overall Study|Surgery for pre-existing neck pain|0
6040732|NCT00647556|20878501|P1|Overall Study|Surgery for pre-existing neck pain|1
6040733|NCT00647556|20878500|P2|Overall Study|Withdrawal by Subject|0
6040734|NCT00647556|20878501|P1|Overall Study|Withdrawal by Subject|1
6040735|NCT00647556|20878500|P2|Overall Study|Protocol Violation|1
6040736|NCT00647556|20878501|P1|Overall Study|Protocol Violation|0
6040737|NCT00647556|20878500|P2|Overall Study|Lost to Follow-up|0
6040738|NCT00647556|20878501|P1|Overall Study|Lost to Follow-up|1
6040739|NCT00647556|20878500|P2|Overall Study|Adverse Event|1
6040740|NCT00647556|20878501|P1|Overall Study|Adverse Event|0
6040741|NCT00647426|20878515|P1|Overall Study|Withdrawal by Subject|2
6040742|NCT00647348|20878537|P2|Overall Study|Lost to Follow-up|6
6040743|NCT00647348|20878538|P1|Overall Study|Lost to Follow-up|3
6040744|NCT00647270|20878563|P3|Period 2, Placebo Switched to Adalimumab|Other|0
6040827|NCT00645944|20878769|P2|Received Medication|Adverse Event|1
6040745|NCT00647270|20878564|P2|Period 2, Placebo Switched to Adalimumab|Other|6
6040746|NCT00647270|20878565|P1|Period 2, Placebo Switched to Adalimumab|Other|2
6040747|NCT00647270|20878563|P3|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|4
6040748|NCT00647270|20878564|P2|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0
6040749|NCT00647270|20878565|P1|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0
6040750|NCT00647270|20878563|P3|Period 2, Placebo Switched to Adalimumab|Adverse Event|3
6040751|NCT00647270|20878564|P2|Period 2, Placebo Switched to Adalimumab|Adverse Event|3
6040752|NCT00647270|20878565|P1|Period 2, Placebo Switched to Adalimumab|Adverse Event|1
6040753|NCT00647270|20878563|P3|Period 1, Placebo-control (12 Weeks)|Other|8
6040754|NCT00647270|20878564|P2|Period 1, Placebo-control (12 Weeks)|Other|4
6040755|NCT00647270|20878565|P1|Period 1, Placebo-control (12 Weeks)|Other|4
6040756|NCT00647270|20878563|P3|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|7
6040757|NCT00647270|20878564|P2|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|1
6040758|NCT00647270|20878565|P1|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|2
6040759|NCT00647270|20878563|P3|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1
6040760|NCT00647270|20878564|P2|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1
6040761|NCT00647270|20878565|P1|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|0
6040762|NCT00647270|20878563|P3|Period 1, Placebo-control (12 Weeks)|Adverse Event|7
6040763|NCT00647270|20878564|P2|Period 1, Placebo-control (12 Weeks)|Adverse Event|7
6040764|NCT00647270|20878565|P1|Period 1, Placebo-control (12 Weeks)|Adverse Event|2
6040765|NCT00646958|20878591|P3|Overall Study|Did not receive study drug|2
6040766|NCT00646958|20878592|P2|Overall Study|Did not receive study drug|0
6040767|NCT00646958|20878593|P1|Overall Study|Did not receive study drug|2
6040768|NCT00646958|20878591|P3|Overall Study|Withdrawal by Subject|0
6040769|NCT00646958|20878592|P2|Overall Study|Withdrawal by Subject|2
6040770|NCT00646958|20878593|P1|Overall Study|Withdrawal by Subject|1
6040771|NCT00646958|20878591|P3|Overall Study|Abnormal screening lab tests|0
6040772|NCT00646958|20878592|P2|Overall Study|Abnormal screening lab tests|1
6040773|NCT00646958|20878593|P1|Overall Study|Abnormal screening lab tests|1
6040774|NCT00646958|20878591|P3|Overall Study|Protocol Violation|0
6040775|NCT00646958|20878592|P2|Overall Study|Protocol Violation|1
6040776|NCT00646958|20878593|P1|Overall Study|Protocol Violation|1
6040777|NCT00646958|20878591|P3|Overall Study|Lost to Follow-up|7
6040778|NCT00646958|20878592|P2|Overall Study|Lost to Follow-up|5
6040779|NCT00646958|20878593|P1|Overall Study|Lost to Follow-up|1
6040780|NCT00646958|20878591|P3|Overall Study|Adverse Event|0
6040781|NCT00646958|20878592|P2|Overall Study|Adverse Event|0
6040782|NCT00646958|20878593|P1|Overall Study|Adverse Event|4
6040783|NCT00646958|20878591|P3|Overall Study|Lack of Efficacy|0
6040784|NCT00646958|20878592|P2|Overall Study|Lack of Efficacy|0
6040785|NCT00646958|20878593|P1|Overall Study|Lack of Efficacy|1
6040786|NCT00646906|20878608|P7|Crossover Period 2|Physician Decision|1
6040787|NCT00646906|20878609|P6|Crossover Period 2|Physician Decision|0
6040788|NCT00646906|20878610|P5|Crossover Period 2|Physician Decision|0
6040789|NCT00646906|20878611|P4|Crossover Period 2|Physician Decision|0
6040790|NCT00646906|20878612|P3|Crossover Period 2|Physician Decision|0
6040791|NCT00646906|20878613|P2|Crossover Period 2|Physician Decision|0
6040792|NCT00646906|20878614|P1|Crossover Period 2|Physician Decision|0
6040793|NCT00646906|20878608|P7|Crossover Period 2|Withdrawal by Subject|0
6040794|NCT00646906|20878609|P6|Crossover Period 2|Withdrawal by Subject|0
6040795|NCT00646906|20878610|P5|Crossover Period 2|Withdrawal by Subject|0
6040796|NCT00646906|20878611|P4|Crossover Period 2|Withdrawal by Subject|1
6040797|NCT00646906|20878612|P3|Crossover Period 2|Withdrawal by Subject|2
6040798|NCT00646906|20878613|P2|Crossover Period 2|Withdrawal by Subject|1
6040799|NCT00646906|20878614|P1|Crossover Period 2|Withdrawal by Subject|0
6040800|NCT00646906|20878608|P7|Crossover Period 1|Withdrawal by Subject|0
6040801|NCT00646906|20878609|P6|Crossover Period 1|Withdrawal by Subject|1
6040802|NCT00646906|20878610|P5|Crossover Period 1|Withdrawal by Subject|0
6040803|NCT00646906|20878611|P4|Crossover Period 1|Withdrawal by Subject|0
6040804|NCT00646906|20878612|P3|Crossover Period 1|Withdrawal by Subject|0
6040805|NCT00646906|20878613|P2|Crossover Period 1|Withdrawal by Subject|0
6040806|NCT00646906|20878614|P1|Crossover Period 1|Withdrawal by Subject|1
6040807|NCT00646776|20878633|P2|Overall Study|Investigator discretion|4
6040808|NCT00646776|20878634|P1|Overall Study|Investigator discretion|0
6040809|NCT00646776|20878633|P2|Overall Study|Adverse Event|9
6040810|NCT00646776|20878634|P1|Overall Study|Adverse Event|1
6040811|NCT00646399|20878732|P2|Overall Study|Other Reason|11
6040812|NCT00646399|20878733|P1|Overall Study|Other Reason|11
6040813|NCT00646399|20878732|P2|Overall Study|Withdrawal by Subject|10
6040814|NCT00646399|20878733|P1|Overall Study|Withdrawal by Subject|9
6040815|NCT00646399|20878732|P2|Overall Study|Death|53
6040816|NCT00646399|20878733|P1|Overall Study|Death|63
6040817|NCT00646282|20878741|P2|Overall Study|Protocol terminated|4
6040818|NCT00646282|20878742|P1|Overall Study|Protocol terminated|4
6040819|NCT00646113|20878748|P1|Overall Study|Adverse Event|3
6040820|NCT00646113|20878748|P1|Overall Study|Lost to Follow-up|5
6040821|NCT00645944|20878769|P2|Received Medication|Protocol Violation|1
6040822|NCT00645944|20878770|P1|Received Medication|Protocol Violation|2
6040823|NCT00645944|20878769|P2|Received Medication|Lost to Follow-up|0
6040824|NCT00645944|20878770|P1|Received Medication|Lost to Follow-up|1
6040825|NCT00645944|20878769|P2|Received Medication|Withdrawal by Subject|1
6040826|NCT00645944|20878770|P1|Received Medication|Withdrawal by Subject|1
6040828|NCT00645944|20878770|P1|Received Medication|Adverse Event|2
6040829|NCT00645944|20878769|P2|Randomized|Withdrawal by Subject|2
6040830|NCT00645944|20878770|P1|Randomized|Withdrawal by Subject|1
6040831|NCT00645853|20878778|P2|Overall Study|recall of ICF, planned operation, death|4
6040832|NCT00645853|20878779|P1|Overall Study|recall of ICF, planned operation, death|7
6040833|NCT00645853|20878778|P2|Overall Study|Discontinuation criteria|2
6040834|NCT00645853|20878779|P1|Overall Study|Discontinuation criteria|2
6040835|NCT00645853|20878778|P2|Overall Study|Protocol Violation|2
6040836|NCT00645853|20878779|P1|Overall Study|Protocol Violation|0
6040837|NCT00645853|20878778|P2|Overall Study|Withdrawal by Subject|2
6040838|NCT00645853|20878779|P1|Overall Study|Withdrawal by Subject|5
6040839|NCT00645853|20878778|P2|Overall Study|AZ study closure in Hungary|40
6040840|NCT00645853|20878779|P1|Overall Study|AZ study closure in Hungary|60
6040841|NCT00645853|20878778|P2|Overall Study|Adverse Event|7
6040842|NCT00645853|20878779|P1|Overall Study|Adverse Event|18
6040843|NCT00645840|20878797|P1|Overall Study|Protocol Violation|3
6040844|NCT00645788|20878815|P4|Overall Study|Pulmonary exacerbation|9
6040845|NCT00645788|20878816|P3|Overall Study|Pulmonary exacerbation|11
6040846|NCT00645788|20878817|P2|Overall Study|Pulmonary exacerbation|16
6040847|NCT00645788|20878818|P1|Overall Study|Pulmonary exacerbation|13
6040848|NCT00645788|20878815|P4|Overall Study|Withdrawal by Subject|2
6040849|NCT00645788|20878816|P3|Overall Study|Withdrawal by Subject|0
6040850|NCT00645788|20878817|P2|Overall Study|Withdrawal by Subject|1
6040851|NCT00645788|20878818|P1|Overall Study|Withdrawal by Subject|0
6040852|NCT00645788|20878815|P4|Overall Study|Protocol Violation|0
6040853|NCT00645788|20878816|P3|Overall Study|Protocol Violation|2
6040854|NCT00645788|20878817|P2|Overall Study|Protocol Violation|0
6040855|NCT00645788|20878818|P1|Overall Study|Protocol Violation|1
6040856|NCT00645788|20878815|P4|Overall Study|Lost to Follow-up|0
6040857|NCT00645788|20878816|P3|Overall Study|Lost to Follow-up|0
6040858|NCT00645788|20878817|P2|Overall Study|Lost to Follow-up|0
6040859|NCT00645788|20878818|P1|Overall Study|Lost to Follow-up|1
6040860|NCT00645788|20878815|P4|Overall Study|Adverse Event|3
6040861|NCT00645788|20878816|P3|Overall Study|Adverse Event|5
6040862|NCT00645788|20878817|P2|Overall Study|Adverse Event|9
6040863|NCT00645788|20878818|P1|Overall Study|Adverse Event|4
6040864|NCT00645788|20878815|P4|Overall Study|Did not receive study drug|0
6040865|NCT00645788|20878816|P3|Overall Study|Did not receive study drug|0
6040866|NCT00645788|20878817|P2|Overall Study|Did not receive study drug|1
6040867|NCT00645788|20878818|P1|Overall Study|Did not receive study drug|1
6040868|NCT00645671|20878896|P2|Overall Study|Physician Decision|1
6040869|NCT00645671|20878897|P1|Overall Study|Physician Decision|0
6040870|NCT00645671|20878896|P2|Overall Study|Adverse Event|1
6040871|NCT00645671|20878897|P1|Overall Study|Adverse Event|0
6040872|NCT00645671|20878896|P2|Overall Study|Withdrawal by Subject|4
6040873|NCT00645671|20878897|P1|Overall Study|Withdrawal by Subject|0
6040874|NCT00645671|20878896|P2|Overall Study|Protocol Violation|0
6040875|NCT00645671|20878897|P1|Overall Study|Protocol Violation|1
6040876|NCT00645593|20878911|P2|Overall Study|Later found to be ineligible|0
6040877|NCT00645593|20878912|P1|Overall Study|Later found to be ineligible|1
6040878|NCT00645567|20878924|P1|Overall Study|Adverse Event|1
6040879|NCT00645528|20878932|P1|Overall Study|Did not show up for Visit 2|7
6040880|NCT00645411|20878954|P4|Overall Study|Unable to classify|4
6040881|NCT00645411|20878955|P3|Overall Study|Unable to classify|3
6040882|NCT00645411|20878956|P2|Overall Study|Unable to classify|0
6040883|NCT00645411|20878957|P1|Overall Study|Unable to classify|0
6040884|NCT00645411|20878954|P4|Overall Study|Inappropriate enrollment|1
6040885|NCT00645411|20878955|P3|Overall Study|Inappropriate enrollment|4
6040886|NCT00645411|20878956|P2|Overall Study|Inappropriate enrollment|0
6040887|NCT00645411|20878957|P1|Overall Study|Inappropriate enrollment|0
6040888|NCT00645411|20878954|P4|Overall Study|Protocol Violation|0
6040889|NCT00645411|20878955|P3|Overall Study|Protocol Violation|1
6040890|NCT00645411|20878956|P2|Overall Study|Protocol Violation|0
6040891|NCT00645411|20878957|P1|Overall Study|Protocol Violation|1
6040892|NCT00645411|20878954|P4|Overall Study|Lost to Follow-up|75
6040893|NCT00645411|20878955|P3|Overall Study|Lost to Follow-up|124
6040894|NCT00645411|20878956|P2|Overall Study|Lost to Follow-up|5
6040895|NCT00645411|20878957|P1|Overall Study|Lost to Follow-up|10
6040896|NCT00645411|20878954|P4|Overall Study|Withdrawal by Subject|21
6040897|NCT00645411|20878955|P3|Overall Study|Withdrawal by Subject|19
6040898|NCT00645411|20878956|P2|Overall Study|Withdrawal by Subject|1
6040899|NCT00645411|20878957|P1|Overall Study|Withdrawal by Subject|2
6040900|NCT00645411|20878954|P4|Overall Study|Adverse Event|2
6040901|NCT00645411|20878955|P3|Overall Study|Adverse Event|0
6040902|NCT00645411|20878956|P2|Overall Study|Adverse Event|0
6040903|NCT00645411|20878957|P1|Overall Study|Adverse Event|0
6040904|NCT00645164|20878999|P1|Overall Study|Protocol Violation|1
6040905|NCT00645164|20878999|P1|Overall Study|Withdrawal by Subject|4
6040906|NCT00645164|20878999|P1|Overall Study|Lost to Follow-up|2
6040907|NCT00645099|20879005|P2|Overall Study|Other|5
6040908|NCT00645099|20879006|P1|Overall Study|Other|9
6040909|NCT00645099|20879005|P2|Overall Study|Adverse Event|5
6040910|NCT00645099|20879006|P1|Overall Study|Adverse Event|11
6040911|NCT00645099|20879005|P2|Overall Study|Lost to Follow-up|4
6040912|NCT00645099|20879006|P1|Overall Study|Lost to Follow-up|6
6040913|NCT00645099|20879005|P2|Overall Study|Withdrawal by Subject|22
6040914|NCT00645099|20879006|P1|Overall Study|Withdrawal by Subject|30
6040915|NCT00645099|20879005|P2|Overall Study|Lack of Efficacy|6
6040916|NCT00645099|20879006|P1|Overall Study|Lack of Efficacy|15
6040917|NCT00644995|20879075|P2|Overall Study|Refused|0
6040918|NCT00644995|20879076|P1|Overall Study|Refused|1
6040919|NCT00644995|20879075|P2|Overall Study|Lost to Follow-up|4
6040920|NCT00644995|20879076|P1|Overall Study|Lost to Follow-up|1
6040921|NCT00644969|20879096|P2|Post Treatment Phase|Other|0
6040922|NCT00644969|20879097|P1|Post Treatment Phase|Other|1
6040923|NCT00644969|20879096|P2|Post Treatment Phase|Lost to Follow-up|1
6040924|NCT00644969|20879097|P1|Post Treatment Phase|Lost to Follow-up|4
6040925|NCT00644969|20879096|P2|Post Treatment Phase|Withdrawal by Subject|2
6040926|NCT00644969|20879097|P1|Post Treatment Phase|Withdrawal by Subject|4
6040927|NCT00644969|20879096|P2|Post Treatment Phase|Death|0
6040928|NCT00644969|20879097|P1|Post Treatment Phase|Death|1
6040929|NCT00644969|20879096|P2|Treatment Phase|Other|1
6040930|NCT00644969|20879097|P1|Treatment Phase|Other|4
6040931|NCT00644969|20879096|P2|Treatment Phase|Lost to Follow-up|2
6040932|NCT00644969|20879097|P1|Treatment Phase|Lost to Follow-up|2
6040933|NCT00644969|20879096|P2|Treatment Phase|Withdrawal by Subject|0
6040934|NCT00644969|20879097|P1|Treatment Phase|Withdrawal by Subject|4
6040935|NCT00644969|20879096|P2|Treatment Phase|Adverse Event|0
6040936|NCT00644969|20879097|P1|Treatment Phase|Adverse Event|3
6040937|NCT00644969|20879096|P2|Treatment Phase|Randomized, not treated|0
6040938|NCT00644969|20879097|P1|Treatment Phase|Randomized, not treated|1
6040939|NCT00644917|20879143|P1|Overall Study|Withdrawal by Subject|2
6040940|NCT00644787|20879151|P3|Period 2: Double Blind Phase|Worsening of symptoms|1
6040941|NCT00644787|20879152|P2|Period 2: Double Blind Phase|Worsening of symptoms|0
6040942|NCT00644787|20879153|P1|Period 2: Double Blind Phase|Worsening of symptoms|0
6040943|NCT00644787|20879151|P3|Period 2: Double Blind Phase|Worsening of underlying disease|2
6040944|NCT00644787|20879152|P2|Period 2: Double Blind Phase|Worsening of underlying disease|6
6040945|NCT00644787|20879153|P1|Period 2: Double Blind Phase|Worsening of underlying disease|0
6040946|NCT00644787|20879151|P3|Period 2: Double Blind Phase|Withdrawal by Subject|0
6040947|NCT00644787|20879152|P2|Period 2: Double Blind Phase|Withdrawal by Subject|1
6040948|NCT00644787|20879153|P1|Period 2: Double Blind Phase|Withdrawal by Subject|0
6040949|NCT00644787|20879151|P3|Period 2: Double Blind Phase|Adverse Event|4
6040950|NCT00644787|20879152|P2|Period 2: Double Blind Phase|Adverse Event|2
6040951|NCT00644787|20879153|P1|Period 2: Double Blind Phase|Adverse Event|0
6040952|NCT00644787|20879151|P3|Period 1: Titration Phase|Participant was judged as ineligible|0
6040953|NCT00644787|20879152|P2|Period 1: Titration Phase|Participant was judged as ineligible|0
6040954|NCT00644787|20879153|P1|Period 1: Titration Phase|Participant was judged as ineligible|3
6040955|NCT00644787|20879151|P3|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0
6040956|NCT00644787|20879152|P2|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0
6040957|NCT00644787|20879153|P1|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|3
6040958|NCT00644787|20879151|P3|Period 1: Titration Phase|Worsening of symptoms|0
6040959|NCT00644787|20879152|P2|Period 1: Titration Phase|Worsening of symptoms|0
6040960|NCT00644787|20879153|P1|Period 1: Titration Phase|Worsening of symptoms|1
6040961|NCT00644787|20879151|P3|Period 1: Titration Phase|Worsening of complications|0
6040962|NCT00644787|20879152|P2|Period 1: Titration Phase|Worsening of complications|0
6040963|NCT00644787|20879153|P1|Period 1: Titration Phase|Worsening of complications|1
6040964|NCT00644787|20879151|P3|Period 1: Titration Phase|Worsening of underlying disease|0
6040965|NCT00644787|20879152|P2|Period 1: Titration Phase|Worsening of underlying disease|0
6040966|NCT00644787|20879153|P1|Period 1: Titration Phase|Worsening of underlying disease|5
6040967|NCT00644787|20879151|P3|Period 1: Titration Phase|Physician Decision|0
6040968|NCT00644787|20879152|P2|Period 1: Titration Phase|Physician Decision|0
6040969|NCT00644787|20879153|P1|Period 1: Titration Phase|Physician Decision|1
6040970|NCT00644787|20879151|P3|Period 1: Titration Phase|Withdrawal by Subject|0
6040971|NCT00644787|20879152|P2|Period 1: Titration Phase|Withdrawal by Subject|0
6040972|NCT00644787|20879153|P1|Period 1: Titration Phase|Withdrawal by Subject|2
6040973|NCT00644787|20879151|P3|Period 1: Titration Phase|Adverse Event|0
6040974|NCT00644787|20879152|P2|Period 1: Titration Phase|Adverse Event|0
6040975|NCT00644787|20879153|P1|Period 1: Titration Phase|Adverse Event|11
6040976|NCT00644423|20879197|P2|Overall Study|Lost to Follow-up|1
6040977|NCT00644423|20879198|P1|Overall Study|Lost to Follow-up|1
6040978|NCT00644358|20879216|P1|Overall Study|Other Unspecified|11
6040979|NCT00644358|20879216|P1|Overall Study|Noncompliance|14
6040980|NCT00644358|20879216|P1|Overall Study|Protocol Violation|5
6040981|NCT00644358|20879216|P1|Overall Study|Lack of Effectiveness|39
6040982|NCT00644358|20879216|P1|Overall Study|Consent Withdrawal|64
6040983|NCT00644358|20879216|P1|Overall Study|Lost to Follow-up|105
6040984|NCT00644358|20879216|P1|Overall Study|Adverse Event|124
6040985|NCT00644332|20879223|P1|Overall Study|Could Not Attend Scheduled Visits|1
6040986|NCT00644332|20879223|P1|Overall Study|Did Not Meet Eligibility Requirements|1
6040987|NCT00644332|20879223|P1|Overall Study|Completion Status Unknown|2
6040988|NCT00644332|20879223|P1|Overall Study|Withdrawal by Subject|6
6040989|NCT00644332|20879223|P1|Overall Study|Adverse Event|11
6040990|NCT00644228|20879249|P2|Maintenance|On Treatment|40
6040991|NCT00644228|20879250|P1|Maintenance|On Treatment|26
6040992|NCT00644228|20879249|P2|Maintenance|Not Protocol-Specified|15
6040993|NCT00644228|20879250|P1|Maintenance|Not Protocol-Specified|14
6040994|NCT00644228|20879249|P2|Maintenance|Death|3
6040995|NCT00644228|20879250|P1|Maintenance|Death|3
6040996|NCT00644228|20879249|P2|Maintenance|Progression/Relapse|42
6040997|NCT00644228|20879250|P1|Maintenance|Progression/Relapse|67
6040998|NCT00644228|20879249|P2|Maintenance|Withdrawal by Subject|4
6040999|NCT00644228|20879250|P1|Maintenance|Withdrawal by Subject|6
6041000|NCT00644228|20879249|P2|Maintenance|Adverse Event|31
6041001|NCT00644228|20879250|P1|Maintenance|Adverse Event|27
6041002|NCT00644228|20879249|P2|Induction Therapy|Not Protocol-Specified|28
6041003|NCT00644228|20879250|P1|Induction Therapy|Not Protocol-Specified|24
6041004|NCT00644228|20879249|P2|Induction Therapy|Death|7
6041005|NCT00644228|20879250|P1|Induction Therapy|Death|3
6041006|NCT00644228|20879249|P2|Induction Therapy|Progression/Relapse|12
6041007|NCT00644228|20879250|P1|Induction Therapy|Progression/Relapse|24
6041008|NCT00644228|20879249|P2|Induction Therapy|Withdrawal by Subject|3
6041009|NCT00644228|20879250|P1|Induction Therapy|Withdrawal by Subject|10
6041010|NCT00644228|20879249|P2|Induction Therapy|Adverse Event|55
6041011|NCT00644228|20879250|P1|Induction Therapy|Adverse Event|22
6041012|NCT00644228|20879249|P2|Randomization & Eligibility|Invalid Consent|1
6041013|NCT00644228|20879250|P1|Randomization & Eligibility|Invalid Consent|0
6041014|NCT00644228|20879249|P2|Randomization & Eligibility|Withdrew Consent prior to therapy start|0
6041015|NCT00644228|20879250|P1|Randomization & Eligibility|Withdrew Consent prior to therapy start|1
6041016|NCT00644228|20879249|P2|Randomization & Eligibility|Ineligible|21
6041017|NCT00644228|20879250|P1|Randomization & Eligibility|Ineligible|31
6041018|NCT00644059|20879279|P3|Overall Study|Unable to classify|3
6041019|NCT00644059|20879280|P2|Overall Study|Unable to classify|2
6041020|NCT00644059|20879281|P1|Overall Study|Unable to classify|6
6041021|NCT00644059|20879279|P3|Overall Study|Protocol Deviation/violation|15
6041022|NCT00644059|20879280|P2|Overall Study|Protocol Deviation/violation|19
6041023|NCT00644059|20879281|P1|Overall Study|Protocol Deviation/violation|20
6041024|NCT00644059|20879279|P3|Overall Study|Inappropriate Enrollment|0
6041025|NCT00644059|20879280|P2|Overall Study|Inappropriate Enrollment|3
6041026|NCT00644059|20879281|P1|Overall Study|Inappropriate Enrollment|1
6041027|NCT00644059|20879279|P3|Overall Study|Adverse Event|1
6041028|NCT00644059|20879280|P2|Overall Study|Adverse Event|5
6041029|NCT00644059|20879281|P1|Overall Study|Adverse Event|8
6041030|NCT00644059|20879279|P3|Overall Study|Withdrawal by Subject|30
6041031|NCT00644059|20879280|P2|Overall Study|Withdrawal by Subject|60
6041032|NCT00644059|20879281|P1|Overall Study|Withdrawal by Subject|52
6041033|NCT00644059|20879279|P3|Overall Study|Lost to Follow-up|16
6041034|NCT00644059|20879280|P2|Overall Study|Lost to Follow-up|34
6041035|NCT00644059|20879281|P1|Overall Study|Lost to Follow-up|37
6041036|NCT00643916|20879371|P6|Overall Study|Not Vaccinated|0
6041037|NCT00643916|20879372|P5|Overall Study|Not Vaccinated|2
6041038|NCT00643916|20879373|P4|Overall Study|Not Vaccinated|0
6041039|NCT00643916|20879374|P3|Overall Study|Not Vaccinated|3
6041040|NCT00643916|20879375|P2|Overall Study|Not Vaccinated|2
6041041|NCT00643916|20879376|P1|Overall Study|Not Vaccinated|2
6041042|NCT00643916|20879371|P6|Overall Study|Withdrawal by Subject|1
6041043|NCT00643916|20879372|P5|Overall Study|Withdrawal by Subject|0
6041044|NCT00643916|20879373|P4|Overall Study|Withdrawal by Subject|1
6041045|NCT00643916|20879374|P3|Overall Study|Withdrawal by Subject|2
6041046|NCT00643916|20879375|P2|Overall Study|Withdrawal by Subject|2
6041047|NCT00643916|20879376|P1|Overall Study|Withdrawal by Subject|2
6041048|NCT00643916|20879371|P6|Overall Study|Lost to Follow-up|0
6041049|NCT00643916|20879372|P5|Overall Study|Lost to Follow-up|0
6041050|NCT00643916|20879373|P4|Overall Study|Lost to Follow-up|0
6041051|NCT00643916|20879374|P3|Overall Study|Lost to Follow-up|0
6041052|NCT00643916|20879375|P2|Overall Study|Lost to Follow-up|1
6041053|NCT00643916|20879376|P1|Overall Study|Lost to Follow-up|0
6041054|NCT00643916|20879371|P6|Overall Study|Protocol Violation|0
6041055|NCT00643916|20879372|P5|Overall Study|Protocol Violation|0
6041056|NCT00643916|20879373|P4|Overall Study|Protocol Violation|1
6041057|NCT00643916|20879374|P3|Overall Study|Protocol Violation|1
6041058|NCT00643916|20879375|P2|Overall Study|Protocol Violation|1
6041059|NCT00643916|20879376|P1|Overall Study|Protocol Violation|0
6041060|NCT00643851|20879405|P3|Overall Study|Non-compl., not met criteria, etc.|6
6041061|NCT00643851|20879406|P2|Overall Study|Non-compl., not met criteria, etc.|4
6041062|NCT00643851|20879407|P1|Overall Study|Non-compl., not met criteria, etc.|3
6041063|NCT00643851|20879405|P3|Overall Study|Withdrawal by Subject|9
6041064|NCT00643851|20879406|P2|Overall Study|Withdrawal by Subject|15
6041065|NCT00643851|20879407|P1|Overall Study|Withdrawal by Subject|8
6041066|NCT00643851|20879405|P3|Overall Study|Lost to Follow-up|9
6041067|NCT00643851|20879406|P2|Overall Study|Lost to Follow-up|6
6041068|NCT00643851|20879407|P1|Overall Study|Lost to Follow-up|4
6041069|NCT00643851|20879405|P3|Overall Study|Adverse Event|6
6041070|NCT00643851|20879406|P2|Overall Study|Adverse Event|6
6041071|NCT00643851|20879407|P1|Overall Study|Adverse Event|2
6041072|NCT00643851|20879405|P3|Overall Study|Lack of Efficacy|0
6041073|NCT00643851|20879406|P2|Overall Study|Lack of Efficacy|1
6041074|NCT00643851|20879407|P1|Overall Study|Lack of Efficacy|0
6041075|NCT00643851|20879405|P3|Overall Study|Death|0
6041076|NCT00643851|20879406|P2|Overall Study|Death|1
6041077|NCT00643851|20879407|P1|Overall Study|Death|0
6041078|NCT00643760|20879435|P5|Overall Study|Withdrawal by Subject|1
6041079|NCT00643760|20879436|P4|Overall Study|Withdrawal by Subject|4
6041080|NCT00643760|20879437|P3|Overall Study|Withdrawal by Subject|2
6041081|NCT00643760|20879438|P2|Overall Study|Withdrawal by Subject|1
6041082|NCT00643760|20879439|P1|Overall Study|Withdrawal by Subject|3
6041083|NCT00643760|20879435|P5|Overall Study|Investigator Discretion|0
6041084|NCT00643760|20879436|P4|Overall Study|Investigator Discretion|2
6041085|NCT00643760|20879437|P3|Overall Study|Investigator Discretion|0
6041086|NCT00643760|20879438|P2|Overall Study|Investigator Discretion|0
6041087|NCT00643760|20879439|P1|Overall Study|Investigator Discretion|0
6041088|NCT00643760|20879435|P5|Overall Study|Lost to Follow-up|3
6041089|NCT00643760|20879436|P4|Overall Study|Lost to Follow-up|3
6041090|NCT00643760|20879437|P3|Overall Study|Lost to Follow-up|1
6041091|NCT00643760|20879438|P2|Overall Study|Lost to Follow-up|2
6041092|NCT00643760|20879439|P1|Overall Study|Lost to Follow-up|6
6041093|NCT00643760|20879435|P5|Overall Study|Protocol Violation|6
6041094|NCT00643760|20879436|P4|Overall Study|Protocol Violation|4
6041095|NCT00643760|20879437|P3|Overall Study|Protocol Violation|4
6041096|NCT00643760|20879438|P2|Overall Study|Protocol Violation|6
6041097|NCT00643760|20879439|P1|Overall Study|Protocol Violation|7
6041098|NCT00643760|20879435|P5|Overall Study|Lack of Efficacy|3
6041099|NCT00643760|20879436|P4|Overall Study|Lack of Efficacy|4
6041100|NCT00643760|20879437|P3|Overall Study|Lack of Efficacy|0
6041101|NCT00643760|20879438|P2|Overall Study|Lack of Efficacy|1
6041102|NCT00643760|20879439|P1|Overall Study|Lack of Efficacy|3
6041103|NCT00643760|20879435|P5|Overall Study|Adverse Event|6
6041104|NCT00643760|20879436|P4|Overall Study|Adverse Event|21
6041105|NCT00643760|20879437|P3|Overall Study|Adverse Event|12
6041106|NCT00643760|20879438|P2|Overall Study|Adverse Event|5
6041107|NCT00643760|20879439|P1|Overall Study|Adverse Event|11
6041108|NCT00643682|20879543|P2|Overall Study|did not keep appointment|509
6041109|NCT00643682|20879544|P1|Overall Study|did not keep appointment|522
6041110|NCT00643604|20879556|P1|Overall Study|Death|1
6041111|NCT00643565|20879584|P2|Overall Study|Adverse Event|8
6041112|NCT00643565|20879585|P1|Overall Study|Adverse Event|5
6041113|NCT00643565|20879584|P2|Overall Study|Administrative|16
6041114|NCT00643565|20879585|P1|Overall Study|Administrative|22
6041115|NCT00643565|20879584|P2|Overall Study|Did Not Cooperate|1
6041116|NCT00643565|20879585|P1|Overall Study|Did Not Cooperate|0
6041117|NCT00643565|20879584|P2|Overall Study|Protocol Violation|0
6041118|NCT00643565|20879585|P1|Overall Study|Protocol Violation|3
6041119|NCT00643565|20879584|P2|Overall Study|Progression of Disease|14
6041120|NCT00643565|20879585|P1|Overall Study|Progression of Disease|18
6041121|NCT00643565|20879584|P2|Overall Study|Recurrence of Disease|1
6041122|NCT00643565|20879585|P1|Overall Study|Recurrence of Disease|2
6041123|NCT00643565|20879584|P2|Overall Study|Refused Treatment / Did Not Cooperate|1
6041124|NCT00643565|20879585|P1|Overall Study|Refused Treatment / Did Not Cooperate|0
6041125|NCT00643565|20879584|P2|Overall Study|Other|8
6041126|NCT00643565|20879585|P1|Overall Study|Other|7
6041127|NCT00643565|20879584|P2|Overall Study|Lost to Follow-up|6
6041128|NCT00643565|20879585|P1|Overall Study|Lost to Follow-up|0
6041129|NCT00643565|20879584|P2|Overall Study|Withdrawal by Subject|1
6041130|NCT00643565|20879585|P1|Overall Study|Withdrawal by Subject|4
6041131|NCT00643565|20879584|P2|Overall Study|Death|11
6041132|NCT00643565|20879585|P1|Overall Study|Death|12
6041133|NCT00643487|20879607|P1|Overall Study|Technical difficulty|3
6041134|NCT00643448|20879614|P3|Overall Study|QTcF>550 ms|0
6041135|NCT00643448|20879615|P2|Overall Study|QTcF>550 ms|3
6041136|NCT00643448|20879616|P1|Overall Study|QTcF>550 ms|0
6041137|NCT00643448|20879614|P3|Overall Study|Adverse Event|2
6041138|NCT00643448|20879615|P2|Overall Study|Adverse Event|2
6041139|NCT00643448|20879616|P1|Overall Study|Adverse Event|2
6041140|NCT00643448|20879614|P3|Overall Study|Lack of Efficacy|4
6041141|NCT00643448|20879615|P2|Overall Study|Lack of Efficacy|0
6041142|NCT00643448|20879616|P1|Overall Study|Lack of Efficacy|2
6041143|NCT00643279|20879633|P2|Overall Study|Physician Decision|1
6041144|NCT00643279|20879634|P1|Overall Study|Physician Decision|0
6041145|NCT00643279|20879633|P2|Overall Study|Lost to Follow-up|1
6041146|NCT00643279|20879634|P1|Overall Study|Lost to Follow-up|0
6041147|NCT00643279|20879633|P2|Overall Study|Withdrawal by Subject|0
6041148|NCT00643279|20879634|P1|Overall Study|Withdrawal by Subject|3
6041149|NCT00643279|20879633|P2|Overall Study|Death|11
6041150|NCT00643279|20879634|P1|Overall Study|Death|13
6041151|NCT00643201|20879656|P2|Completed Study Follow Up|non-specified|0
6041152|NCT00643201|20879657|P1|Completed Study Follow Up|non-specified|1
6041153|NCT00643201|20879656|P2|Completed Study Follow Up|Lost to Follow-up|16
6041154|NCT00643201|20879657|P1|Completed Study Follow Up|Lost to Follow-up|18
6041155|NCT00643201|20879656|P2|Completed Study Follow Up|Withdrawal by Subject|29
6041156|NCT00643201|20879657|P1|Completed Study Follow Up|Withdrawal by Subject|23
6041157|NCT00643201|20879656|P2|Completed Study Follow Up|Death|34
6041158|NCT00643201|20879657|P1|Completed Study Follow Up|Death|28
6041159|NCT00643201|20879656|P2|Randomized, Completed 6 Months of Study|Other|107
6041160|NCT00643201|20879657|P1|Randomized, Completed 6 Months of Study|Other|107
6041161|NCT00643201|20879656|P2|Randomized, Completed 6 Months of Study|Administrative reason|1
6041162|NCT00643201|20879657|P1|Randomized, Completed 6 Months of Study|Administrative reason|1
6041163|NCT00643201|20879656|P2|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|9
6041164|NCT00643201|20879657|P1|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|13
6041165|NCT00643201|20879656|P2|Randomized, Completed 6 Months of Study|Pregnancy|2
6041166|NCT00643201|20879657|P1|Randomized, Completed 6 Months of Study|Pregnancy|3
6041167|NCT00643201|20879656|P2|Randomized, Completed 6 Months of Study|Poor or non-compliance|23
6041168|NCT00643201|20879657|P1|Randomized, Completed 6 Months of Study|Poor or non-compliance|20
6041169|NCT00643201|20879656|P2|Randomized, Completed 6 Months of Study|Lost to Follow-up|14
6041170|NCT00643201|20879657|P1|Randomized, Completed 6 Months of Study|Lost to Follow-up|14
6041171|NCT00643201|20879656|P2|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49
6041172|NCT00643201|20879657|P1|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49
6041173|NCT00643201|20879656|P2|Randomized, Completed 6 Months of Study|Adverse Event|182
6041174|NCT00643201|20879657|P1|Randomized, Completed 6 Months of Study|Adverse Event|150
6041175|NCT00643201|20879656|P2|Randomized, Completed 6 Months of Study|Death|26
6041176|NCT00643201|20879657|P1|Randomized, Completed 6 Months of Study|Death|20
6041177|NCT00643162|20879705|P2|Overall Study|Withdrawal by Subject|1
6041178|NCT00643162|20879706|P1|Overall Study|Withdrawal by Subject|1
6041179|NCT00643123|20879718|P2|Overall Study|Withdrawal by Subject|1
6041180|NCT00643123|20879719|P1|Overall Study|Withdrawal by Subject|1
6041181|NCT00643123|20879718|P2|Overall Study|Lost to Follow-up|0
6041182|NCT00643123|20879719|P1|Overall Study|Lost to Follow-up|4
6041183|NCT00643006|20879751|P2|Overall Study|Lost to Follow-up|4
6041184|NCT00643006|20879752|P1|Overall Study|Lost to Follow-up|5
6041185|NCT00642993|20879762|P2|Overall Study|Administrative|0
6041186|NCT00642993|20879763|P1|Overall Study|Administrative|1
6041187|NCT00642993|20879762|P2|Overall Study|Did not meet protocol eligibility|1
6041188|NCT00642993|20879763|P1|Overall Study|Did not meet protocol eligibility|0
6041189|NCT00642993|20879762|P2|Overall Study|Protocol Violation|4
6041190|NCT00642993|20879763|P1|Overall Study|Protocol Violation|1
6041191|NCT00642993|20879762|P2|Overall Study|Withdrew - reason unrelated to treatment|3
6041192|NCT00642993|20879763|P1|Overall Study|Withdrew - reason unrelated to treatment|11
6041193|NCT00642993|20879762|P2|Overall Study|Lost to Follow-up|4
6041194|NCT00642993|20879763|P1|Overall Study|Lost to Follow-up|8
6041195|NCT00642993|20879762|P2|Overall Study|Adverse Event|4
6041196|NCT00642993|20879763|P1|Overall Study|Adverse Event|85
6041197|NCT00642954|20879782|P5|Overall Study|Adverse Event|6
6041198|NCT00642954|20879783|P4|Overall Study|Adverse Event|0
6041199|NCT00642954|20879784|P3|Overall Study|Adverse Event|0
6041200|NCT00642954|20879785|P2|Overall Study|Adverse Event|1
6041201|NCT00642954|20879786|P1|Overall Study|Adverse Event|1
6041202|NCT00642954|20879782|P5|Overall Study|Withdrawal by Subject|1
6041203|NCT00642954|20879783|P4|Overall Study|Withdrawal by Subject|0
6041204|NCT00642954|20879784|P3|Overall Study|Withdrawal by Subject|0
6041205|NCT00642954|20879785|P2|Overall Study|Withdrawal by Subject|0
6041206|NCT00642954|20879786|P1|Overall Study|Withdrawal by Subject|0
6041207|NCT00642954|20879782|P5|Overall Study|Progressive Disease|9
6041208|NCT00642954|20879783|P4|Overall Study|Progressive Disease|3
6041209|NCT00642954|20879784|P3|Overall Study|Progressive Disease|3
6041210|NCT00642954|20879785|P2|Overall Study|Progressive Disease|3
6041211|NCT00642954|20879786|P1|Overall Study|Progressive Disease|3
6041212|NCT00642902|20879812|P4|Overall Study|Other|4
6041213|NCT00642902|20879813|P3|Overall Study|Other|1
6041214|NCT00642902|20879814|P2|Overall Study|Other|5
6041215|NCT00642902|20879815|P1|Overall Study|Other|1
6041216|NCT00642902|20879812|P4|Overall Study|Randomized, but not treated|0
6041217|NCT00642902|20879813|P3|Overall Study|Randomized, but not treated|1
6041218|NCT00642902|20879814|P2|Overall Study|Randomized, but not treated|0
6041219|NCT00642902|20879815|P1|Overall Study|Randomized, but not treated|0
6041220|NCT00642902|20879812|P4|Overall Study|Premature termination of clinical trial|35
6041221|NCT00642902|20879813|P3|Overall Study|Premature termination of clinical trial|35
6041222|NCT00642902|20879814|P2|Overall Study|Premature termination of clinical trial|32
6041223|NCT00642902|20879815|P1|Overall Study|Premature termination of clinical trial|37
6041224|NCT00642902|20879812|P4|Overall Study|Death|0
6041225|NCT00642902|20879813|P3|Overall Study|Death|0
6041226|NCT00642902|20879814|P2|Overall Study|Death|0
6041227|NCT00642902|20879815|P1|Overall Study|Death|1
6041228|NCT00642902|20879812|P4|Overall Study|Lack of Efficacy|0
6041229|NCT00642902|20879813|P3|Overall Study|Lack of Efficacy|3
6041230|NCT00642902|20879814|P2|Overall Study|Lack of Efficacy|3
6041231|NCT00642902|20879815|P1|Overall Study|Lack of Efficacy|0
6041232|NCT00642902|20879812|P4|Overall Study|Lost to Follow-up|0
6041233|NCT00642902|20879813|P3|Overall Study|Lost to Follow-up|0
6041234|NCT00642902|20879814|P2|Overall Study|Lost to Follow-up|1
6041235|NCT00642902|20879815|P1|Overall Study|Lost to Follow-up|1
6041236|NCT00642902|20879812|P4|Overall Study|Adverse Event|1
6041237|NCT00642902|20879813|P3|Overall Study|Adverse Event|3
6041238|NCT00642902|20879814|P2|Overall Study|Adverse Event|1
6041239|NCT00642902|20879815|P1|Overall Study|Adverse Event|0
6041240|NCT00642850|20879837|P1|Overall Study|Other reasons|7
6041241|NCT00642850|20879837|P1|Overall Study|Blood transfusion|6
6041242|NCT00642850|20879837|P1|Overall Study|Kidney transplantation|8
6041243|NCT00642850|20879837|P1|Overall Study|Protocol Violation|2
6041244|NCT00642850|20879837|P1|Overall Study|Lack of Efficacy|1
6041245|NCT00642850|20879837|P1|Overall Study|Adverse Event|2
6041246|NCT00642850|20879837|P1|Overall Study|Death|7
6041247|NCT00642811|20879853|P6|Overall Study|Other|0
6041248|NCT00642811|20879854|P5|Overall Study|Other|0
6041249|NCT00642811|20879855|P4|Overall Study|Other|1
6041250|NCT00642811|20879856|P3|Overall Study|Other|0
6041251|NCT00642811|20879857|P2|Overall Study|Other|1
6041252|NCT00642811|20879858|P1|Overall Study|Other|0
6041253|NCT00642811|20879853|P6|Overall Study|Severe Non-compliance to protocol|0
6041254|NCT00642811|20879854|P5|Overall Study|Severe Non-compliance to protocol|0
6041255|NCT00642811|20879855|P4|Overall Study|Severe Non-compliance to protocol|0
6041256|NCT00642811|20879856|P3|Overall Study|Severe Non-compliance to protocol|0
6041257|NCT00642811|20879857|P2|Overall Study|Severe Non-compliance to protocol|0
6041258|NCT00642811|20879858|P1|Overall Study|Severe Non-compliance to protocol|1
6041259|NCT00642811|20879853|P6|Overall Study|Developement of discontinuation criteria|0
6041260|NCT00642811|20879854|P5|Overall Study|Developement of discontinuation criteria|1
6041261|NCT00642811|20879855|P4|Overall Study|Developement of discontinuation criteria|0
6041262|NCT00642811|20879856|P3|Overall Study|Developement of discontinuation criteria|0
6041263|NCT00642811|20879857|P2|Overall Study|Developement of discontinuation criteria|0
6041264|NCT00642811|20879858|P1|Overall Study|Developement of discontinuation criteria|0
6041265|NCT00642811|20879853|P6|Overall Study|Adverse Event|1
6041266|NCT00642811|20879854|P5|Overall Study|Adverse Event|0
6041267|NCT00642811|20879855|P4|Overall Study|Adverse Event|0
6041268|NCT00642811|20879856|P3|Overall Study|Adverse Event|0
6041269|NCT00642811|20879857|P2|Overall Study|Adverse Event|3
6041270|NCT00642811|20879858|P1|Overall Study|Adverse Event|2
6041271|NCT00642772|20879880|P1|Overall Study|Withdrawal by Subject|7
6041272|NCT00642772|20879880|P1|Overall Study|Lost to Follow-up|3
6041273|NCT00642759|20879884|P1|Overall Study|Protocol Violation|1
6041274|NCT00642746|20879893|P2|Overall Study|Patient unevaluable|0
6041275|NCT00642746|20879894|P1|Overall Study|Patient unevaluable|1
6041276|NCT00642707|20879908|P4|Overall Study|Withdrawal by Subject|0
6041277|NCT00642707|20879909|P3|Overall Study|Withdrawal by Subject|0
6041278|NCT00642707|20879910|P2|Overall Study|Withdrawal by Subject|0
6041279|NCT00642707|20879911|P1|Overall Study|Withdrawal by Subject|1
6041280|NCT00642707|20879908|P4|Overall Study|Adverse Event|2
6041281|NCT00642707|20879909|P3|Overall Study|Adverse Event|0
6041282|NCT00642707|20879910|P2|Overall Study|Adverse Event|0
6041283|NCT00642707|20879911|P1|Overall Study|Adverse Event|0
6041284|NCT00642668|20879946|P1|Overall Study|Blood Transfusion|2
6041285|NCT00642668|20879946|P1|Overall Study|Dialysis Initiation|5
6041286|NCT00642668|20879946|P1|Overall Study|Failure to Return|1
6041287|NCT00642668|20879946|P1|Overall Study|Insufficient Therapeutic Response|1
6041288|NCT00642668|20879946|P1|Overall Study|Death|2
6041289|NCT00642668|20879946|P1|Overall Study|Adverse Event|2
6041290|NCT00642668|20879946|P1|Overall Study|Lost to Follow-up|1
6041291|NCT00642642|20879954|P1|Treatment & Follow Up|Lost to Follow-up|10
6041292|NCT00642642|20879954|P1|Treatment & Follow Up|Withdrawal by Subject|5
6041293|NCT00642642|20879954|P1|Treatment & Follow Up|Adverse Event|2
6041294|NCT00642616|20879971|P4|Overall Study|Physician Decision|1
6041295|NCT00642616|20879972|P3|Overall Study|Physician Decision|1
6041296|NCT00642616|20879973|P2|Overall Study|Physician Decision|0
6041297|NCT00642616|20879974|P1|Overall Study|Physician Decision|0
6041298|NCT00642616|20879971|P4|Overall Study|Protocol Violation|0
6041299|NCT00642616|20879972|P3|Overall Study|Protocol Violation|2
6041300|NCT00642616|20879973|P2|Overall Study|Protocol Violation|0
6041301|NCT00642616|20879974|P1|Overall Study|Protocol Violation|0
6041302|NCT00642616|20879971|P4|Overall Study|Withdrawal by Subject|1
6041303|NCT00642616|20879972|P3|Overall Study|Withdrawal by Subject|1
6041304|NCT00642616|20879973|P2|Overall Study|Withdrawal by Subject|1
6041305|NCT00642616|20879974|P1|Overall Study|Withdrawal by Subject|0
6041306|NCT00642616|20879971|P4|Overall Study|Study Terminated by Sponsor|5
6041307|NCT00642616|20879972|P3|Overall Study|Study Terminated by Sponsor|4
6041308|NCT00642616|20879973|P2|Overall Study|Study Terminated by Sponsor|6
6041309|NCT00642616|20879974|P1|Overall Study|Study Terminated by Sponsor|7
6041310|NCT00642616|20879971|P4|Overall Study|Adverse Event|0
6041311|NCT00642616|20879972|P3|Overall Study|Adverse Event|1
6041312|NCT00642616|20879973|P2|Overall Study|Adverse Event|0
6041313|NCT00642616|20879974|P1|Overall Study|Adverse Event|2
6041314|NCT00642473|20880007|P2|Overall Study|Other|2
6041315|NCT00642473|20880008|P1|Overall Study|Other|2
6041316|NCT00642473|20880007|P2|Overall Study|Progression or death|4
6041317|NCT00642473|20880008|P1|Overall Study|Progression or death|2
6041318|NCT00642473|20880007|P2|Overall Study|Withdrawal by Subject|5
6041319|NCT00642473|20880008|P1|Overall Study|Withdrawal by Subject|0
6041320|NCT00642460|20880022|P6|Part III: Open-Label Up to Week 260|Refused treatment|3
6041321|NCT00642460|20880023|P5|Part III: Open-Label Up to Week 260|Refused treatment|8
6041322|NCT00642460|20880024|P4|Part III: Open-Label Up to Week 260|Refused treatment|0
6041323|NCT00642460|20880025|P3|Part III: Open-Label Up to Week 260|Refused treatment|0
6041324|NCT00642460|20880026|P2|Part III: Open-Label Up to Week 260|Refused treatment|0
6041325|NCT00642460|20880027|P1|Part III: Open-Label Up to Week 260|Refused treatment|0
6041326|NCT00642460|20880022|P6|Part III: Open-Label Up to Week 260|Administrative reason|1
6041327|NCT00642460|20880023|P5|Part III: Open-Label Up to Week 260|Administrative reason|0
6041328|NCT00642460|20880024|P4|Part III: Open-Label Up to Week 260|Administrative reason|0
6041329|NCT00642460|20880025|P3|Part III: Open-Label Up to Week 260|Administrative reason|0
6041330|NCT00642460|20880026|P2|Part III: Open-Label Up to Week 260|Administrative reason|0
6041331|NCT00642460|20880027|P1|Part III: Open-Label Up to Week 260|Administrative reason|0
6041332|NCT00642460|20880022|P6|Part III: Open-Label Up to Week 260|Death|3
6041333|NCT00642460|20880023|P5|Part III: Open-Label Up to Week 260|Death|0
6041334|NCT00642460|20880024|P4|Part III: Open-Label Up to Week 260|Death|0
6041335|NCT00642460|20880025|P3|Part III: Open-Label Up to Week 260|Death|0
6041336|NCT00642460|20880026|P2|Part III: Open-Label Up to Week 260|Death|0
6041337|NCT00642460|20880027|P1|Part III: Open-Label Up to Week 260|Death|0
6041338|NCT00642460|20880022|P6|Part III: Open-Label Up to Week 260|Other|2
6041339|NCT00642460|20880023|P5|Part III: Open-Label Up to Week 260|Other|2
6041340|NCT00642460|20880024|P4|Part III: Open-Label Up to Week 260|Other|0
6041341|NCT00642460|20880025|P3|Part III: Open-Label Up to Week 260|Other|0
6041342|NCT00642460|20880026|P2|Part III: Open-Label Up to Week 260|Other|0
6041343|NCT00642460|20880027|P1|Part III: Open-Label Up to Week 260|Other|0
6041344|NCT00642460|20880022|P6|Part III: Open-Label Up to Week 260|Lost to Follow-up|1
6041345|NCT00642460|20880023|P5|Part III: Open-Label Up to Week 260|Lost to Follow-up|1
6041346|NCT00642460|20880024|P4|Part III: Open-Label Up to Week 260|Lost to Follow-up|0
6041347|NCT00642460|20880025|P3|Part III: Open-Label Up to Week 260|Lost to Follow-up|0
6041348|NCT00642460|20880026|P2|Part III: Open-Label Up to Week 260|Lost to Follow-up|0
6041349|NCT00642460|20880027|P1|Part III: Open-Label Up to Week 260|Lost to Follow-up|0
6041350|NCT00642460|20880022|P6|Part III: Open-Label Up to Week 260|Withdrawal by Subject|1
6041351|NCT00642460|20880023|P5|Part III: Open-Label Up to Week 260|Withdrawal by Subject|4
6041352|NCT00642460|20880024|P4|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0
6041353|NCT00642460|20880025|P3|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0
6041354|NCT00642460|20880026|P2|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0
6041355|NCT00642460|20880027|P1|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0
6041356|NCT00642460|20880022|P6|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|4
6041357|NCT00642460|20880023|P5|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|3
6041358|NCT00642460|20880024|P4|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0
6041359|NCT00642460|20880025|P3|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0
6041360|NCT00642460|20880026|P2|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0
6041361|NCT00642460|20880027|P1|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0
6041362|NCT00642460|20880022|P6|Part III: Open-Label Up to Week 260|Adverse Event|6
6041363|NCT00642460|20880023|P5|Part III: Open-Label Up to Week 260|Adverse Event|7
6041364|NCT00642460|20880024|P4|Part III: Open-Label Up to Week 260|Adverse Event|0
6041365|NCT00642460|20880025|P3|Part III: Open-Label Up to Week 260|Adverse Event|0
6041366|NCT00642460|20880026|P2|Part III: Open-Label Up to Week 260|Adverse Event|0
6041367|NCT00642460|20880027|P1|Part III: Open-Label Up to Week 260|Adverse Event|0
6041368|NCT00642460|20880022|P6|Part II: Open-Label Up to Week 92|Administrative reasons|0
6041369|NCT00642460|20880023|P5|Part II: Open-Label Up to Week 92|Administrative reasons|0
6041370|NCT00642460|20880024|P4|Part II: Open-Label Up to Week 92|Administrative reasons|1
6041371|NCT00642460|20880025|P3|Part II: Open-Label Up to Week 92|Administrative reasons|0
6041372|NCT00642460|20880026|P2|Part II: Open-Label Up to Week 92|Administrative reasons|0
6041373|NCT00642460|20880027|P1|Part II: Open-Label Up to Week 92|Administrative reasons|0
6041374|NCT00642460|20880022|P6|Part II: Open-Label Up to Week 92|Failure to return|0
6041375|NCT00642460|20880023|P5|Part II: Open-Label Up to Week 92|Failure to return|0
6041376|NCT00642460|20880024|P4|Part II: Open-Label Up to Week 92|Failure to return|0
6041377|NCT00642460|20880025|P3|Part II: Open-Label Up to Week 92|Failure to return|0
6041378|NCT00642460|20880026|P2|Part II: Open-Label Up to Week 92|Failure to return|1
6041379|NCT00642460|20880027|P1|Part II: Open-Label Up to Week 92|Failure to return|0
6041380|NCT00642460|20880022|P6|Part II: Open-Label Up to Week 92|Refused treatment|0
6041381|NCT00642460|20880023|P5|Part II: Open-Label Up to Week 92|Refused treatment|0
6041382|NCT00642460|20880024|P4|Part II: Open-Label Up to Week 92|Refused treatment|0
6041383|NCT00642460|20880025|P3|Part II: Open-Label Up to Week 92|Refused treatment|0
6041384|NCT00642460|20880026|P2|Part II: Open-Label Up to Week 92|Refused treatment|1
6041385|NCT00642460|20880027|P1|Part II: Open-Label Up to Week 92|Refused treatment|3
6041386|NCT00642460|20880022|P6|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0
6041387|NCT00642460|20880023|P5|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0
6041388|NCT00642460|20880024|P4|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0
6041389|NCT00642460|20880025|P3|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0
6041390|NCT00642460|20880026|P2|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|3
6041391|NCT00642460|20880027|P1|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|2
6041392|NCT00642460|20880022|P6|Part II: Open-Label Up to Week 92|Death|0
6041393|NCT00642460|20880023|P5|Part II: Open-Label Up to Week 92|Death|0
6041394|NCT00642460|20880024|P4|Part II: Open-Label Up to Week 92|Death|2
6041395|NCT00642460|20880025|P3|Part II: Open-Label Up to Week 92|Death|0
6041396|NCT00642460|20880026|P2|Part II: Open-Label Up to Week 92|Death|1
6041397|NCT00642460|20880027|P1|Part II: Open-Label Up to Week 92|Death|0
6041398|NCT00642460|20880022|P6|Part II: Open-Label Up to Week 92|Adverse Event|0
6041399|NCT00642460|20880023|P5|Part II: Open-Label Up to Week 92|Adverse Event|0
6041400|NCT00642460|20880024|P4|Part II: Open-Label Up to Week 92|Adverse Event|0
6041401|NCT00642460|20880025|P3|Part II: Open-Label Up to Week 92|Adverse Event|0
6041402|NCT00642460|20880026|P2|Part II: Open-Label Up to Week 92|Adverse Event|2
6041403|NCT00642460|20880027|P1|Part II: Open-Label Up to Week 92|Adverse Event|4
6041404|NCT00642460|20880022|P6|Part I: 12 Week Double-Blind|Refused Treatment|0
6041405|NCT00642460|20880023|P5|Part I: 12 Week Double-Blind|Refused Treatment|0
6041406|NCT00642460|20880024|P4|Part I: 12 Week Double-Blind|Refused Treatment|0
6041407|NCT00642460|20880025|P3|Part I: 12 Week Double-Blind|Refused Treatment|0
6041408|NCT00642460|20880026|P2|Part I: 12 Week Double-Blind|Refused Treatment|0
6041409|NCT00642460|20880027|P1|Part I: 12 Week Double-Blind|Refused Treatment|1
6041410|NCT00642460|20880022|P6|Part I: 12 Week Double-Blind|Adverse Event|0
6041411|NCT00642460|20880023|P5|Part I: 12 Week Double-Blind|Adverse Event|0
6041412|NCT00642460|20880024|P4|Part I: 12 Week Double-Blind|Adverse Event|0
6041413|NCT00642460|20880025|P3|Part I: 12 Week Double-Blind|Adverse Event|1
6041414|NCT00642460|20880026|P2|Part I: 12 Week Double-Blind|Adverse Event|1
6041415|NCT00642460|20880027|P1|Part I: 12 Week Double-Blind|Adverse Event|0
6041416|NCT00642369|20880102|P2|Overall Study|Lack of Efficacy|2
6041417|NCT00642369|20880103|P1|Overall Study|Lack of Efficacy|2
6041418|NCT00642369|20880102|P2|Overall Study|misdiagnosis|1
6041419|NCT00642369|20880103|P1|Overall Study|misdiagnosis|0
6041420|NCT00642369|20880102|P2|Overall Study|Withdrawal by Subject|0
6041421|NCT00642369|20880103|P1|Overall Study|Withdrawal by Subject|1
6041422|NCT00642369|20880102|P2|Overall Study|Adverse Event|3
6041423|NCT00642369|20880103|P1|Overall Study|Adverse Event|2
6041424|NCT00642356|20880113|P2|Overall Study|Lack of Efficacy|0
6041425|NCT00642356|20880114|P1|Overall Study|Lack of Efficacy|1
6041426|NCT00642356|20880113|P2|Overall Study|Protocol Violation|3
6041427|NCT00642356|20880114|P1|Overall Study|Protocol Violation|0
6041428|NCT00642356|20880113|P2|Overall Study|Adverse Event|0
6041429|NCT00642356|20880114|P1|Overall Study|Adverse Event|1
6041430|NCT00642304|20880122|P1|Overall Study|Transplantation|1
6041431|NCT00642304|20880122|P1|Overall Study|Erythropoiesis Stimulating Agent Use.|1
6041432|NCT00642304|20880122|P1|Overall Study|Blood transfusion|2
6041433|NCT00642304|20880122|P1|Overall Study|Death|1
6041434|NCT00642304|20880122|P1|Overall Study|Adverse Event|1
6041435|NCT00642278|20880138|P7|Overall Study|Other|0
6041436|NCT00642278|20880139|P6|Overall Study|Other|1
6041437|NCT00642278|20880140|P5|Overall Study|Other|0
6041438|NCT00642278|20880141|P4|Overall Study|Other|1
6041439|NCT00642278|20880142|P3|Overall Study|Other|0
6041440|NCT00642278|20880143|P2|Overall Study|Other|1
6041441|NCT00642278|20880144|P1|Overall Study|Other|2
6041442|NCT00642278|20880138|P7|Overall Study|Noncompliance with study drug regimen|0
6041443|NCT00642278|20880139|P6|Overall Study|Noncompliance with study drug regimen|0
6041444|NCT00642278|20880140|P5|Overall Study|Noncompliance with study drug regimen|0
6041445|NCT00642278|20880141|P4|Overall Study|Noncompliance with study drug regimen|1
6041446|NCT00642278|20880142|P3|Overall Study|Noncompliance with study drug regimen|0
6041447|NCT00642278|20880143|P2|Overall Study|Noncompliance with study drug regimen|0
6041448|NCT00642278|20880144|P1|Overall Study|Noncompliance with study drug regimen|0
6041449|NCT00642278|20880138|P7|Overall Study|Withdrawal by Subject|2
6041450|NCT00642278|20880139|P6|Overall Study|Withdrawal by Subject|2
6041451|NCT00642278|20880140|P5|Overall Study|Withdrawal by Subject|6
6041452|NCT00642278|20880141|P4|Overall Study|Withdrawal by Subject|3
6041453|NCT00642278|20880142|P3|Overall Study|Withdrawal by Subject|1
6041454|NCT00642278|20880143|P2|Overall Study|Withdrawal by Subject|1
6041455|NCT00642278|20880144|P1|Overall Study|Withdrawal by Subject|1
6041456|NCT00642278|20880138|P7|Overall Study|Protocol Violation|2
6041457|NCT00642278|20880139|P6|Overall Study|Protocol Violation|1
6041458|NCT00642278|20880140|P5|Overall Study|Protocol Violation|0
6041459|NCT00642278|20880141|P4|Overall Study|Protocol Violation|1
6041460|NCT00642278|20880142|P3|Overall Study|Protocol Violation|1
6041461|NCT00642278|20880143|P2|Overall Study|Protocol Violation|0
6041462|NCT00642278|20880144|P1|Overall Study|Protocol Violation|0
6041463|NCT00642278|20880138|P7|Overall Study|Physician Decision|0
6041464|NCT00642278|20880139|P6|Overall Study|Physician Decision|0
6041465|NCT00642278|20880140|P5|Overall Study|Physician Decision|0
6041466|NCT00642278|20880141|P4|Overall Study|Physician Decision|1
6041467|NCT00642278|20880142|P3|Overall Study|Physician Decision|0
6041468|NCT00642278|20880143|P2|Overall Study|Physician Decision|0
6041469|NCT00642278|20880144|P1|Overall Study|Physician Decision|0
6041470|NCT00642278|20880138|P7|Overall Study|Lost to Follow-up|1
6041471|NCT00642278|20880139|P6|Overall Study|Lost to Follow-up|1
6041472|NCT00642278|20880140|P5|Overall Study|Lost to Follow-up|0
6041473|NCT00642278|20880141|P4|Overall Study|Lost to Follow-up|1
6041474|NCT00642278|20880142|P3|Overall Study|Lost to Follow-up|0
6041475|NCT00642278|20880143|P2|Overall Study|Lost to Follow-up|1
6041476|NCT00642278|20880144|P1|Overall Study|Lost to Follow-up|5
6041477|NCT00642278|20880138|P7|Overall Study|Lack of Efficacy|0
6041478|NCT00642278|20880139|P6|Overall Study|Lack of Efficacy|0
6041479|NCT00642278|20880140|P5|Overall Study|Lack of Efficacy|0
6041480|NCT00642278|20880141|P4|Overall Study|Lack of Efficacy|0
6041481|NCT00642278|20880142|P3|Overall Study|Lack of Efficacy|0
6041482|NCT00642278|20880143|P2|Overall Study|Lack of Efficacy|1
6041483|NCT00642278|20880144|P1|Overall Study|Lack of Efficacy|0
6041484|NCT00642278|20880138|P7|Overall Study|Adverse Event|0
6041485|NCT00642278|20880139|P6|Overall Study|Adverse Event|2
6041486|NCT00642278|20880140|P5|Overall Study|Adverse Event|2
6041487|NCT00642278|20880141|P4|Overall Study|Adverse Event|1
6041488|NCT00642278|20880142|P3|Overall Study|Adverse Event|3
6041489|NCT00642278|20880143|P2|Overall Study|Adverse Event|1
6041490|NCT00642278|20880144|P1|Overall Study|Adverse Event|2
6041491|NCT00642174|20880197|P2|Period 1 - Initial Drug|Entry Criteria Not Met|1
6041492|NCT00642174|20880198|P1|Period 1 - Initial Drug|Entry Criteria Not Met|0
6041493|NCT00642018|20880214|P2|Overall Study|Entry Criteria Not Met|1
6041494|NCT00642018|20880215|P1|Overall Study|Entry Criteria Not Met|0
6041495|NCT00642018|20880214|P2|Overall Study|Death|3
6041496|NCT00642018|20880215|P1|Overall Study|Death|0
6041497|NCT00642018|20880214|P2|Overall Study|Protocol Violation|1
6041498|NCT00642018|20880215|P1|Overall Study|Protocol Violation|0
6041499|NCT00642018|20880214|P2|Overall Study|Physician Decision|10
6041500|NCT00642018|20880215|P1|Overall Study|Physician Decision|0
6041501|NCT00642018|20880214|P2|Overall Study|Progressive Disease|18
6041502|NCT00642018|20880215|P1|Overall Study|Progressive Disease|13
6041503|NCT00642018|20880214|P2|Overall Study|Withdrawal by Subject|10
6041504|NCT00642018|20880215|P1|Overall Study|Withdrawal by Subject|4
6041505|NCT00642018|20880214|P2|Overall Study|Adverse Event|36
6041506|NCT00642018|20880215|P1|Overall Study|Adverse Event|11
6041507|NCT00641719|20880282|P2|Overall Study|Reason Not Specified|2
6041508|NCT00641719|20880283|P1|Overall Study|Reason Not Specified|1
6041509|NCT00641719|20880282|P2|Overall Study|Withdrawal by Subject|4
6041510|NCT00641719|20880283|P1|Overall Study|Withdrawal by Subject|4
6041511|NCT00641719|20880282|P2|Overall Study|Adverse Event|29
6041512|NCT00641719|20880283|P1|Overall Study|Adverse Event|24
6041513|NCT00641719|20880282|P2|Overall Study|Lack of Efficacy|2
6041514|NCT00641719|20880283|P1|Overall Study|Lack of Efficacy|1
6041515|NCT00641706|20880307|P2|Overall Study|Lead Investigator Decision|1
6041516|NCT00641706|20880308|P1|Overall Study|Lead Investigator Decision|0
6041517|NCT00641706|20880307|P2|Overall Study|Clinical Decline|0
6041518|NCT00641706|20880308|P1|Overall Study|Clinical Decline|1
6041519|NCT00641706|20880307|P2|Overall Study|Withdrawal by Subject|1
6041520|NCT00641706|20880308|P1|Overall Study|Withdrawal by Subject|6
6041521|NCT00641706|20880307|P2|Overall Study|Adverse Event|1
6041522|NCT00641706|20880308|P1|Overall Study|Adverse Event|2
6041523|NCT00641667|20880320|P1|Overall Study|Worsening of underlying disease|3
6041524|NCT00641667|20880320|P1|Overall Study|Physician Decision|1
6041525|NCT00641667|20880320|P1|Overall Study|Adverse Event|1
6041526|NCT00641667|20880320|P1|Overall Study|Withdrawal by Subject|1
6041527|NCT00641537|20880348|P8|24-Week Supplemental Follow-up Period|Other|1
6041528|NCT00641537|20880349|P7|24-Week Supplemental Follow-up Period|Other|1
6041529|NCT00641537|20880350|P6|24-Week Supplemental Follow-up Period|Other|0
6041530|NCT00641537|20880351|P5|24-Week Supplemental Follow-up Period|Other|3
6041531|NCT00641537|20880352|P4|24-Week Supplemental Follow-up Period|Other|1
6041532|NCT00641537|20880353|P3|24-Week Supplemental Follow-up Period|Other|2
6041533|NCT00641537|20880354|P2|24-Week Supplemental Follow-up Period|Other|2
6041534|NCT00641537|20880355|P1|24-Week Supplemental Follow-up Period|Other|0
6041535|NCT00641537|20880348|P8|24-Week Supplemental Follow-up Period|Lost to Follow-up|0
6041536|NCT00641537|20880349|P7|24-Week Supplemental Follow-up Period|Lost to Follow-up|0
6041537|NCT00641537|20880350|P6|24-Week Supplemental Follow-up Period|Lost to Follow-up|1
6041538|NCT00641537|20880351|P5|24-Week Supplemental Follow-up Period|Lost to Follow-up|2
6041539|NCT00641537|20880352|P4|24-Week Supplemental Follow-up Period|Lost to Follow-up|3
6041540|NCT00641537|20880353|P3|24-Week Supplemental Follow-up Period|Lost to Follow-up|1
6041541|NCT00641537|20880354|P2|24-Week Supplemental Follow-up Period|Lost to Follow-up|1
6041542|NCT00641537|20880355|P1|24-Week Supplemental Follow-up Period|Lost to Follow-up|0
6041543|NCT00641537|20880348|P8|96-week Period|Other|6
6041544|NCT00641537|20880349|P7|96-week Period|Other|4
6041545|NCT00641537|20880350|P6|96-week Period|Other|6
6041546|NCT00641537|20880351|P5|96-week Period|Other|11
6041547|NCT00641537|20880352|P4|96-week Period|Other|9
6041548|NCT00641537|20880353|P3|96-week Period|Other|14
6041549|NCT00641537|20880354|P2|96-week Period|Other|7
6041550|NCT00641537|20880355|P1|96-week Period|Other|4
6041551|NCT00641537|20880348|P8|96-week Period|Death|0
6041552|NCT00641537|20880349|P7|96-week Period|Death|0
6041553|NCT00641537|20880350|P6|96-week Period|Death|0
6041554|NCT00641537|20880351|P5|96-week Period|Death|0
6041555|NCT00641537|20880352|P4|96-week Period|Death|0
6041556|NCT00641537|20880353|P3|96-week Period|Death|1
6041557|NCT00641537|20880354|P2|96-week Period|Death|0
6041558|NCT00641537|20880355|P1|96-week Period|Death|2
6041559|NCT00641537|20880348|P8|96-week Period|Protocol Violation|0
6041560|NCT00641537|20880349|P7|96-week Period|Protocol Violation|0
6041561|NCT00641537|20880350|P6|96-week Period|Protocol Violation|1
6041562|NCT00641537|20880351|P5|96-week Period|Protocol Violation|0
6041563|NCT00641537|20880352|P4|96-week Period|Protocol Violation|1
6041564|NCT00641537|20880353|P3|96-week Period|Protocol Violation|0
6041565|NCT00641537|20880354|P2|96-week Period|Protocol Violation|1
6041566|NCT00641537|20880355|P1|96-week Period|Protocol Violation|0
6041567|NCT00641537|20880348|P8|96-week Period|Lost to Follow-up|0
6041568|NCT00641537|20880349|P7|96-week Period|Lost to Follow-up|1
6041569|NCT00641537|20880350|P6|96-week Period|Lost to Follow-up|0
6041570|NCT00641537|20880351|P5|96-week Period|Lost to Follow-up|4
6041571|NCT00641537|20880352|P4|96-week Period|Lost to Follow-up|2
6041572|NCT00641537|20880353|P3|96-week Period|Lost to Follow-up|2
6041573|NCT00641537|20880354|P2|96-week Period|Lost to Follow-up|1
6041574|NCT00641537|20880355|P1|96-week Period|Lost to Follow-up|3
6041575|NCT00641537|20880348|P8|96-week Period|Adverse Event|0
6041576|NCT00641537|20880349|P7|96-week Period|Adverse Event|0
6041577|NCT00641537|20880350|P6|96-week Period|Adverse Event|0
6041578|NCT00641537|20880351|P5|96-week Period|Adverse Event|2
6041579|NCT00641537|20880352|P4|96-week Period|Adverse Event|0
6041580|NCT00641537|20880353|P3|96-week Period|Adverse Event|3
6041581|NCT00641537|20880354|P2|96-week Period|Adverse Event|1
6041582|NCT00641537|20880355|P1|96-week Period|Adverse Event|0
6041583|NCT00641147|20880443|P2|Completed 16 Months.|Lost to Follow-up|0
6041584|NCT00641147|20880444|P1|Completed 16 Months.|Lost to Follow-up|1
6041585|NCT00641147|20880443|P2|Completed 16 Months.|Physician Decision|0
6041586|NCT00641147|20880444|P1|Completed 16 Months.|Physician Decision|1
6041587|NCT00641147|20880443|P2|Completed 12 Months.|Withdrawal by Subject|1
6041588|NCT00641147|20880444|P1|Completed 12 Months.|Withdrawal by Subject|0
6041589|NCT00641147|20880443|P2|Completed 12 Months.|Physician Decision|1
6041590|NCT00641147|20880444|P1|Completed 12 Months.|Physician Decision|1
6041591|NCT00641147|20880443|P2|Completed 8 Months.|Withdrawal by Subject|1
6041592|NCT00641147|20880444|P1|Completed 8 Months.|Withdrawal by Subject|0
6041593|NCT00641147|20880443|P2|Completed 8 Months.|non compliance|0
6041594|NCT00641147|20880444|P1|Completed 8 Months.|non compliance|1
6041595|NCT00641147|20880443|P2|Completed 8 Months.|Physician Decision|1
6041596|NCT00641147|20880444|P1|Completed 8 Months.|Physician Decision|2
6041597|NCT00641147|20880443|P2|Completed 4 Months.|Adverse Event|0
6041598|NCT00641147|20880444|P1|Completed 4 Months.|Adverse Event|1
6041599|NCT00641147|20880443|P2|Completed 4 Months.|Physician Decision|0
6041600|NCT00641147|20880444|P1|Completed 4 Months.|Physician Decision|1
6041601|NCT00641056|20880497|P2|Overall Study|Sponsor Decision|2
6041602|NCT00641056|20880498|P1|Overall Study|Sponsor Decision|1
6041603|NCT00641056|20880497|P2|Overall Study|Subject Decision|19
6041604|NCT00641056|20880498|P1|Overall Study|Subject Decision|6
6041605|NCT00641056|20880497|P2|Overall Study|Entry Criteria Not Met|0
6041606|NCT00641056|20880498|P1|Overall Study|Entry Criteria Not Met|3
6041607|NCT00641056|20880497|P2|Overall Study|Protocol Violation|0
6041608|NCT00641056|20880498|P1|Overall Study|Protocol Violation|2
6041609|NCT00641056|20880497|P2|Overall Study|Physician Decision|1
6041610|NCT00641056|20880498|P1|Overall Study|Physician Decision|3
6041611|NCT00641056|20880497|P2|Overall Study|Lost to Follow-up|1
6041612|NCT00641056|20880498|P1|Overall Study|Lost to Follow-up|2
6041613|NCT00641056|20880497|P2|Overall Study|Adverse Event|2
6041614|NCT00641056|20880498|P1|Overall Study|Adverse Event|12
6041615|NCT00641043|20880526|P2|Overall Study|Other incl. lack of efficacy|2
6041616|NCT00641043|20880527|P1|Overall Study|Other incl. lack of efficacy|4
6041617|NCT00641043|20880526|P2|Overall Study|Withdrawal by Subject|4
6041618|NCT00641043|20880527|P1|Overall Study|Withdrawal by Subject|4
6041619|NCT00641043|20880526|P2|Overall Study|Lost to Follow-up|2
6041620|NCT00641043|20880527|P1|Overall Study|Lost to Follow-up|3
6041621|NCT00641043|20880526|P2|Overall Study|Protocol Violation|3
6041622|NCT00641043|20880527|P1|Overall Study|Protocol Violation|2
6041623|NCT00641043|20880526|P2|Overall Study|Adverse Event|4
6041624|NCT00641043|20880527|P1|Overall Study|Adverse Event|6
6041625|NCT00640926|20880564|P3|Overall Study|Withdrawal by Subject|1
6041626|NCT00640926|20880565|P2|Overall Study|Withdrawal by Subject|0
6041627|NCT00640926|20880566|P1|Overall Study|Withdrawal by Subject|1
6041628|NCT00640926|20880564|P3|Overall Study|Lost to Follow-up|2
6041629|NCT00640926|20880565|P2|Overall Study|Lost to Follow-up|1
6041630|NCT00640926|20880566|P1|Overall Study|Lost to Follow-up|3
6041631|NCT00640926|20880564|P3|Overall Study|Protocol Violation|2
6041632|NCT00640926|20880565|P2|Overall Study|Protocol Violation|0
6041633|NCT00640926|20880566|P1|Overall Study|Protocol Violation|2
6041634|NCT00640926|20880564|P3|Overall Study|Lack of Efficacy|1
6041635|NCT00640926|20880565|P2|Overall Study|Lack of Efficacy|2
6041636|NCT00640926|20880566|P1|Overall Study|Lack of Efficacy|0
6041637|NCT00640926|20880564|P3|Overall Study|Adverse Event|2
6041638|NCT00640926|20880565|P2|Overall Study|Adverse Event|3
6041639|NCT00640926|20880566|P1|Overall Study|Adverse Event|2
6041640|NCT00640835|20880579|P2|Overall Study|Other Reason|4
6041641|NCT00640835|20880580|P1|Overall Study|Other Reason|19
6041642|NCT00640835|20880579|P2|Overall Study|Lost to Follow-up|13
6041643|NCT00640835|20880580|P1|Overall Study|Lost to Follow-up|17
6041644|NCT00640835|20880579|P2|Overall Study|Protocol Violation|2
6041645|NCT00640835|20880580|P1|Overall Study|Protocol Violation|2
6041646|NCT00640835|20880579|P2|Overall Study|Sponsor's Decision|7
6041647|NCT00640835|20880580|P1|Overall Study|Sponsor's Decision|11
6041648|NCT00640835|20880579|P2|Overall Study|Physician Decision|14
6041649|NCT00640835|20880580|P1|Overall Study|Physician Decision|10
6041650|NCT00640835|20880579|P2|Overall Study|Withdrawal by Subject|14
6041651|NCT00640835|20880580|P1|Overall Study|Withdrawal by Subject|12
6041652|NCT00640835|20880579|P2|Overall Study|Adverse Event|3
6041653|NCT00640835|20880580|P1|Overall Study|Adverse Event|5
6041654|NCT00640614|20880644|P2|Overall Study|Lost to Follow-up|0
6041655|NCT00640614|20880645|P1|Overall Study|Lost to Follow-up|1
6041656|NCT00640601|20880687|P1|Overall Study|treatment naive, combination therapy|10
6041657|NCT00640601|20880687|P1|Overall Study|Physician Decision|8
6041658|NCT00640601|20880687|P1|Overall Study|Lost to Follow-up|9
6041659|NCT00640601|20880687|P1|Overall Study|Lack of Efficacy|16
6041660|NCT00640601|20880687|P1|Overall Study|Protocol Violation|6
6041661|NCT00640601|20880687|P1|Overall Study|Withdrawal by Subject|20
6041662|NCT00640601|20880687|P1|Overall Study|Adverse Event|43
6041663|NCT00640562|20880703|P2|Overall Study|Glycosylated Hemoglobin >8|0
6041664|NCT00640562|20880704|P1|Overall Study|Glycosylated Hemoglobin >8|1
6041665|NCT00640562|20880703|P2|Overall Study|Low study drug dose|1
6041666|NCT00640562|20880704|P1|Overall Study|Low study drug dose|0
6041667|NCT00640562|20880703|P2|Overall Study|Past use of Seroquel -stopped due to AE|1
6041668|NCT00640562|20880704|P1|Overall Study|Past use of Seroquel -stopped due to AE|0
6041669|NCT00640562|20880703|P2|Overall Study|Known risperidone intolerance|1
6041670|NCT00640562|20880704|P1|Overall Study|Known risperidone intolerance|0
6041671|NCT00640562|20880703|P2|Overall Study|Withdrawal by Subject|10
6041672|NCT00640562|20880704|P1|Overall Study|Withdrawal by Subject|6
6041673|NCT00640562|20880703|P2|Overall Study|Protocol Violation|4
6041674|NCT00640562|20880704|P1|Overall Study|Protocol Violation|2
6041675|NCT00640562|20880703|P2|Overall Study|Lack of Efficacy|4
6041676|NCT00640562|20880704|P1|Overall Study|Lack of Efficacy|1
6041677|NCT00640562|20880703|P2|Overall Study|Adverse Event|5
6041678|NCT00640562|20880704|P1|Overall Study|Adverse Event|8
6041679|NCT00640510|20880732|P2|Overall Study|Physician Decision|1
6041680|NCT00640510|20880733|P1|Overall Study|Physician Decision|0
6041681|NCT00640510|20880732|P2|Overall Study|Protocol Violation|0
6041682|NCT00640510|20880733|P1|Overall Study|Protocol Violation|1
6041683|NCT00640510|20880732|P2|Overall Study|Lack of Efficacy|1
6041684|NCT00640510|20880733|P1|Overall Study|Lack of Efficacy|0
6041685|NCT00640393|20880745|P3|Part 2|Adverse Event|0
6041686|NCT00640393|20880746|P2|Part 2|Adverse Event|1
6041687|NCT00640393|20880747|P1|Part 2|Adverse Event|0
6041688|NCT00640393|20880745|P3|Part 2|Non-adherence|0
6041689|NCT00640393|20880746|P2|Part 2|Non-adherence|1
6041690|NCT00640393|20880747|P1|Part 2|Non-adherence|0
6041691|NCT00640393|20880745|P3|Part 2|Withdrawal by Subject|1
6041692|NCT00640393|20880746|P2|Part 2|Withdrawal by Subject|6
6041693|NCT00640393|20880747|P1|Part 2|Withdrawal by Subject|0
6041694|NCT00640393|20880745|P3|Part 2|Lost to Follow-up|2
6041695|NCT00640393|20880746|P2|Part 2|Lost to Follow-up|2
6041696|NCT00640393|20880747|P1|Part 2|Lost to Follow-up|0
6041697|NCT00640393|20880745|P3|Randomization|Never randomized by site|0
6041698|NCT00640393|20880746|P2|Randomization|Never randomized by site|0
6041699|NCT00640393|20880747|P1|Randomization|Never randomized by site|2
6041700|NCT00640393|20880745|P3|Randomization|Withdrawn per protocol|0
6041701|NCT00640393|20880746|P2|Randomization|Withdrawn per protocol|0
6041702|NCT00640393|20880747|P1|Randomization|Withdrawn per protocol|17
6041703|NCT00640393|20880745|P3|Part 1|Withdrawal by Subject|0
6041704|NCT00640393|20880746|P2|Part 1|Withdrawal by Subject|0
6041705|NCT00640393|20880747|P1|Part 1|Withdrawal by Subject|3
6041706|NCT00640393|20880745|P3|Part 1|Lost to Follow-up|0
6041707|NCT00640393|20880746|P2|Part 1|Lost to Follow-up|0
6041708|NCT00640393|20880747|P1|Part 1|Lost to Follow-up|2
6041709|NCT00640341|20880812|P3|Overall Study|Adverse event and positive slit lamp|0
6041710|NCT00640341|20880813|P2|Overall Study|Adverse event and positive slit lamp|0
6041711|NCT00640341|20880814|P1|Overall Study|Adverse event and positive slit lamp|1
6041712|NCT00640341|20880812|P3|Overall Study|Ineligable at Baseline|2
6041713|NCT00640341|20880813|P2|Overall Study|Ineligable at Baseline|3
6041714|NCT00640341|20880814|P1|Overall Study|Ineligable at Baseline|5
6041715|NCT00640341|20880812|P3|Overall Study|Poor fit/Uncomfortable|0
6041716|NCT00640341|20880813|P2|Overall Study|Poor fit/Uncomfortable|0
6041717|NCT00640341|20880814|P1|Overall Study|Poor fit/Uncomfortable|4
6041718|NCT00640341|20880812|P3|Overall Study|Unacceptable Lens Movement|0
6041719|NCT00640341|20880813|P2|Overall Study|Unacceptable Lens Movement|0
6041720|NCT00640341|20880814|P1|Overall Study|Unacceptable Lens Movement|1
6041721|NCT00640341|20880812|P3|Overall Study|Withdrawal by Subject|1
6041722|NCT00640341|20880813|P2|Overall Study|Withdrawal by Subject|0
6041723|NCT00640341|20880814|P1|Overall Study|Withdrawal by Subject|4
6041724|NCT00640341|20880812|P3|Overall Study|Lost to Follow-up|0
6041725|NCT00640341|20880813|P2|Overall Study|Lost to Follow-up|0
6041726|NCT00640341|20880814|P1|Overall Study|Lost to Follow-up|2
6041727|NCT00640341|20880812|P3|Overall Study|Failure to Follow Subject Instructions|0
6041728|NCT00640341|20880813|P2|Overall Study|Failure to Follow Subject Instructions|0
6041729|NCT00640341|20880814|P1|Overall Study|Failure to Follow Subject Instructions|1
6041730|NCT00640341|20880812|P3|Overall Study|Inability to Maintain Wearing Schedule|0
6041731|NCT00640341|20880813|P2|Overall Study|Inability to Maintain Wearing Schedule|1
6041732|NCT00640341|20880814|P1|Overall Study|Inability to Maintain Wearing Schedule|1
6041733|NCT00640341|20880812|P3|Overall Study|Study Related Symptoms/Complaints|2
6041734|NCT00640341|20880813|P2|Overall Study|Study Related Symptoms/Complaints|1
6041735|NCT00640341|20880814|P1|Overall Study|Study Related Symptoms/Complaints|2
6041736|NCT00640341|20880812|P3|Overall Study|Positive Slit Lamp Findings|1
6041737|NCT00640341|20880813|P2|Overall Study|Positive Slit Lamp Findings|0
6041738|NCT00640341|20880814|P1|Overall Study|Positive Slit Lamp Findings|0
6041739|NCT00640341|20880812|P3|Overall Study|Adverse Event|1
6041740|NCT00640341|20880813|P2|Overall Study|Adverse Event|0
6041741|NCT00640341|20880814|P1|Overall Study|Adverse Event|0
6041742|NCT00640328|20880834|P6|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0
6041743|NCT00640328|20880835|P5|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0
6041744|NCT00640328|20880836|P4|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1
6041745|NCT00640328|20880837|P3|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0
6041746|NCT00640328|20880838|P2|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1
6041747|NCT00640328|20880839|P1|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0
6041748|NCT00640328|20880834|P6|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0
6041749|NCT00640328|20880835|P5|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0
6041750|NCT00640328|20880836|P4|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0
6041751|NCT00640328|20880837|P3|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|1
6041752|NCT00640328|20880838|P2|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0
6041753|NCT00640328|20880839|P1|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0
6041754|NCT00640328|20880834|P6|Second Treatment Period (Weeks 24-48)|Adverse Event|0
6041755|NCT00640328|20880835|P5|Second Treatment Period (Weeks 24-48)|Adverse Event|1
6041756|NCT00640328|20880836|P4|Second Treatment Period (Weeks 24-48)|Adverse Event|0
6041757|NCT00640328|20880837|P3|Second Treatment Period (Weeks 24-48)|Adverse Event|0
6041758|NCT00640328|20880838|P2|Second Treatment Period (Weeks 24-48)|Adverse Event|0
6041759|NCT00640328|20880839|P1|Second Treatment Period (Weeks 24-48)|Adverse Event|0
6041760|NCT00640328|20880834|P6|First Treatment Period (Weeks 0-24)|Adverse Event|0
6041761|NCT00640328|20880835|P5|First Treatment Period (Weeks 0-24)|Adverse Event|0
6041762|NCT00640328|20880836|P4|First Treatment Period (Weeks 0-24)|Adverse Event|0
6041763|NCT00640328|20880837|P3|First Treatment Period (Weeks 0-24)|Adverse Event|0
6041764|NCT00640328|20880838|P2|First Treatment Period (Weeks 0-24)|Adverse Event|1
6041765|NCT00640328|20880839|P1|First Treatment Period (Weeks 0-24)|Adverse Event|0
6041766|NCT00640315|20881005|P2|Overall Study|Withdrawal by Subject|1
6041767|NCT00640315|20881006|P1|Overall Study|Withdrawal by Subject|0
6041768|NCT00640289|20881132|P1|Overall Study|Missing status|5
6041769|NCT00640289|20881132|P1|Overall Study|Transferred to another center|1
6041770|NCT00640289|20881132|P1|Overall Study|Data collected under different amendment|2
6041771|NCT00640289|20881132|P1|Overall Study|Lost to Follow-up|1
6041772|NCT00640289|20881132|P1|Overall Study|Withdrawal by Subject|1
6041773|NCT00640289|20881132|P1|Overall Study|Death|3
6041774|NCT00640224|20881244|P4|Overall Study|Headaches|0
6041775|NCT00640224|20881245|P3|Overall Study|Headaches|0
6041776|NCT00640224|20881246|P2|Overall Study|Headaches|1
6041777|NCT00640224|20881247|P1|Overall Study|Headaches|0
6041778|NCT00640224|20881244|P4|Overall Study|Withdrawal by Subject|0
6041779|NCT00640224|20881245|P3|Overall Study|Withdrawal by Subject|0
6041780|NCT00640224|20881246|P2|Overall Study|Withdrawal by Subject|0
6041781|NCT00640224|20881247|P1|Overall Study|Withdrawal by Subject|1
6041782|NCT00640224|20881244|P4|Overall Study|Lost to Follow-up|0
6041783|NCT00640224|20881245|P3|Overall Study|Lost to Follow-up|0
6041784|NCT00640224|20881246|P2|Overall Study|Lost to Follow-up|2
6041785|NCT00640224|20881247|P1|Overall Study|Lost to Follow-up|5
6041786|NCT00640146|20881347|P2|Overall Study|Randomized but not treated|3
6041787|NCT00640146|20881348|P1|Overall Study|Randomized but not treated|1
6041788|NCT00640146|20881347|P2|Overall Study|Withdrawal by Subject|1
6041789|NCT00640146|20881348|P1|Overall Study|Withdrawal by Subject|1
6041790|NCT00640146|20881347|P2|Overall Study|Lack of Efficacy|1
6041791|NCT00640146|20881348|P1|Overall Study|Lack of Efficacy|0
6041792|NCT00640146|20881347|P2|Overall Study|Lost to Follow-up|1
6041793|NCT00640146|20881348|P1|Overall Study|Lost to Follow-up|0
6041794|NCT00640146|20881347|P2|Overall Study|Adverse Event|0
6041795|NCT00640146|20881348|P1|Overall Study|Adverse Event|2
6041796|NCT00640133|20881360|P2|Open Label Phase (Month 4-12)|Adverse Event|0
6041797|NCT00640133|20881361|P1|Open Label Phase (Month 4-12)|Adverse Event|1
6041798|NCT00640133|20881360|P2|Open Label Phase (Month 4-12)|Withdrawal by Subject|0
6041799|NCT00640133|20881361|P1|Open Label Phase (Month 4-12)|Withdrawal by Subject|1
6041800|NCT00640133|20881360|P2|Open Label Phase (Month 4-12)|Lack of Efficacy|0
6041801|NCT00640133|20881361|P1|Open Label Phase (Month 4-12)|Lack of Efficacy|1
6041802|NCT00640042|20881381|P1|Enrollment|Did not receive study drug|83
6041803|NCT00640016|20881397|P4|Overall Study|Adverse Event|1
6041804|NCT00640016|20881398|P3|Overall Study|Adverse Event|0
6041805|NCT00640016|20881399|P2|Overall Study|Adverse Event|0
6041806|NCT00640016|20881400|P1|Overall Study|Adverse Event|0
6041807|NCT00640016|20881397|P4|Overall Study|Study termination|2
6041808|NCT00640016|20881398|P3|Overall Study|Study termination|3
6041809|NCT00640016|20881399|P2|Overall Study|Study termination|1
6041810|NCT00640016|20881400|P1|Overall Study|Study termination|2
6041811|NCT00640016|20881397|P4|Overall Study|Withdrawal by Subject|0
6041812|NCT00640016|20881398|P3|Overall Study|Withdrawal by Subject|0
6041813|NCT00640016|20881399|P2|Overall Study|Withdrawal by Subject|1
6041814|NCT00640016|20881400|P1|Overall Study|Withdrawal by Subject|0
6041815|NCT00639769|20881452|P1|Overall Study|Withdrawal by Subject|4
6041816|NCT00639769|20881452|P1|Overall Study|Disease progression|26
6041817|NCT00639769|20881452|P1|Overall Study|Lack of Efficacy|1
6041818|NCT00639769|20881452|P1|Overall Study|Adverse Event|7
6041819|NCT00639769|20881452|P1|Overall Study|Death|2
6041820|NCT00639678|20881469|P4|Overall Study|Lack of Compliance|0
6041821|NCT00639678|20881470|P3|Overall Study|Lack of Compliance|1
6041822|NCT00639678|20881471|P2|Overall Study|Lack of Compliance|0
6041823|NCT00639678|20881472|P1|Overall Study|Lack of Compliance|0
6041824|NCT00639678|20881469|P4|Overall Study|Adverse Event|0
6041825|NCT00639678|20881470|P3|Overall Study|Adverse Event|0
6041826|NCT00639678|20881471|P2|Overall Study|Adverse Event|1
6041827|NCT00639678|20881472|P1|Overall Study|Adverse Event|0
6041828|NCT00639678|20881469|P4|Overall Study|Lost to Follow-up|0
6041829|NCT00639678|20881470|P3|Overall Study|Lost to Follow-up|6
6041830|NCT00639678|20881471|P2|Overall Study|Lost to Follow-up|0
6041831|NCT00639678|20881472|P1|Overall Study|Lost to Follow-up|1
6041832|NCT00639678|20881469|P4|Overall Study|Withdrawal by Subject|0
6041833|NCT00639678|20881470|P3|Overall Study|Withdrawal by Subject|4
6041834|NCT00639678|20881471|P2|Overall Study|Withdrawal by Subject|0
6041835|NCT00639678|20881472|P1|Overall Study|Withdrawal by Subject|3
6041836|NCT00639509|20881537|P1|Overall Study|Death|1
6041837|NCT00639457|20881545|P2|Overall Study|Withdrawal by Subject|3
6041838|NCT00639457|20881546|P1|Overall Study|Withdrawal by Subject|2
6041839|NCT00639379|20881605|P2|Period 1 - 2 Weeks|lens issue|0
6041840|NCT00639379|20881606|P1|Period 1 - 2 Weeks|lens issue|3
6041841|NCT00639379|20881605|P2|Period 1 - 2 Weeks|Lost to Follow-up|0
6041842|NCT00639379|20881606|P1|Period 1 - 2 Weeks|Lost to Follow-up|2
6041843|NCT00639223|20881622|P2|Overall Study|Lost to Follow-up|2
6041844|NCT00639223|20881623|P1|Overall Study|Lost to Follow-up|0
6041845|NCT00639002|20881663|P1|Overall Study|Lack of Efficacy|1
6041846|NCT00639002|20881663|P1|Overall Study|Physician Decision|6
6041847|NCT00639002|20881663|P1|Overall Study|Disease progression|3
6041848|NCT00639002|20881663|P1|Overall Study|Protocol Violation|1
6041849|NCT00639002|20881663|P1|Overall Study|Adverse Event|1
6041850|NCT00639002|20881663|P1|Overall Study|Death|1
6041851|NCT00638989|20881672|P3|Overall Study|Lost to Follow-up|1
6041852|NCT00638989|20881673|P2|Overall Study|Lost to Follow-up|0
6041853|NCT00638989|20881674|P1|Overall Study|Lost to Follow-up|0
6041854|NCT00638963|20881714|P2|Overall Study|Withdrawal by Subject|0
6041855|NCT00638963|20881715|P1|Overall Study|Withdrawal by Subject|1
6041856|NCT00638846|20881756|P2|Overall Study|lens issue|3
6041857|NCT00638846|20881757|P1|Overall Study|lens issue|1
6041858|NCT00638846|20881756|P2|Overall Study|Lost to Follow-up|2
6041859|NCT00638846|20881757|P1|Overall Study|Lost to Follow-up|3
6041860|NCT00638846|20881756|P2|Overall Study|Adverse Event|1
6041861|NCT00638846|20881757|P1|Overall Study|Adverse Event|0
6041862|NCT00638690|20881801|P2|Overall Study|Lost to Follow-up|2
6041863|NCT00638690|20881802|P1|Overall Study|Lost to Follow-up|4
6041864|NCT00638690|20881801|P2|Overall Study|Withdrawal by Subject|5
6041865|NCT00638690|20881802|P1|Overall Study|Withdrawal by Subject|22
6041866|NCT00638690|20881801|P2|Overall Study|Death|335
6041867|NCT00638690|20881802|P1|Overall Study|Death|655
6041868|NCT00638508|20881822|P2|Overall Study|Physician Decision|2
6041869|NCT00638508|20881823|P1|Overall Study|Physician Decision|5
6041870|NCT00638456|20881869|P2|Overall Study|Withdrawal by Subject|2
6041871|NCT00638456|20881870|P1|Overall Study|Withdrawal by Subject|6
6041872|NCT00638443|20881880|P2|First Intervention|Adverse Event|1
6041873|NCT00638443|20881881|P1|First Intervention|Adverse Event|2
6041874|NCT00638404|20881911|P2|Overall Study|Physician Decision|0
6041875|NCT00638404|20881912|P1|Overall Study|Physician Decision|8
6041876|NCT00638378|20881924|P1|Overall Study|Physician Decision|4
6041877|NCT00638378|20881924|P1|Overall Study|Disease progression|15
6041878|NCT00638378|20881924|P1|Overall Study|Adverse Event|1
6041879|NCT00638378|20881924|P1|Overall Study|Death|2
6041880|NCT00638235|20881964|P9|Overall Study|Lost to Follow-up|18
6041881|NCT00638235|20881965|P8|Overall Study|Lost to Follow-up|1
6041882|NCT00638235|20881966|P7|Overall Study|Lost to Follow-up|0
6041883|NCT00638235|20881967|P6|Overall Study|Lost to Follow-up|26
6041884|NCT00638235|20881968|P5|Overall Study|Lost to Follow-up|13
6041885|NCT00638235|20881969|P4|Overall Study|Lost to Follow-up|10
6041886|NCT00638235|20881970|P3|Overall Study|Lost to Follow-up|18
6041887|NCT00638235|20881971|P2|Overall Study|Lost to Follow-up|3
6041888|NCT00638235|20881972|P1|Overall Study|Lost to Follow-up|31
6041889|NCT00638183|20882382|P1|Overall Study|Other reason not defined above|27
6041890|NCT00638183|20882382|P1|Overall Study|Lost to Follow-up|46
6041891|NCT00638183|20882382|P1|Overall Study|Physician Decision|9
6041892|NCT00638183|20882382|P1|Overall Study|Lack of Efficacy|14
6041893|NCT00638183|20882382|P1|Overall Study|Adverse Event|23
6041908|NCT00638027|20882402|P2|Overall Study|Adverse Event|2
6041909|NCT00638027|20882403|P1|Overall Study|Adverse Event|0
6041910|NCT00637806|20882450|P4|Extension Phase|Study Discontinued|1
6041911|NCT00637806|20882451|P3|Extension Phase|Study Discontinued|0
6041912|NCT00637806|20882452|P2|Extension Phase|Study Discontinued|0
6041913|NCT00637806|20882453|P1|Extension Phase|Study Discontinued|0
6041914|NCT00637806|20882450|P4|Double-blind Phase|Study Discontinued|0
6041915|NCT00637806|20882451|P3|Double-blind Phase|Study Discontinued|1
6041916|NCT00637806|20882452|P2|Double-blind Phase|Study Discontinued|0
6041917|NCT00637806|20882453|P1|Double-blind Phase|Study Discontinued|2
6041918|NCT00637728|20882488|P3|Double-blind Phase|Study Discontinued|0
6041919|NCT00637728|20882489|P2|Double-blind Phase|Study Discontinued|1
6041920|NCT00637728|20882490|P1|Double-blind Phase|Study Discontinued|1
6041921|NCT00637728|20882488|P3|Double-blind Phase|Non-compliance|0
6041922|NCT00637728|20882489|P2|Double-blind Phase|Non-compliance|0
6041923|NCT00637728|20882490|P1|Double-blind Phase|Non-compliance|2
6041924|NCT00637728|20882488|P3|Double-blind Phase|Adverse Event|0
6041925|NCT00637728|20882489|P2|Double-blind Phase|Adverse Event|0
6041926|NCT00637728|20882490|P1|Double-blind Phase|Adverse Event|1
6041927|NCT00637572|20882505|P2|Overall Study|Illicit Drug Use|0
6041928|NCT00637572|20882506|P1|Overall Study|Illicit Drug Use|1
6041929|NCT00637572|20882505|P2|Overall Study|Withdrawal by Subject|2
6041930|NCT00637572|20882506|P1|Overall Study|Withdrawal by Subject|0
6041931|NCT00637572|20882505|P2|Overall Study|Physician Decision|1
6041932|NCT00637572|20882506|P1|Overall Study|Physician Decision|1
6041933|NCT00637572|20882505|P2|Overall Study|Lost to Follow-up|1
6041934|NCT00637572|20882506|P1|Overall Study|Lost to Follow-up|0
6041935|NCT00637572|20882505|P2|Overall Study|Death|1
6041936|NCT00637572|20882506|P1|Overall Study|Death|0
6041937|NCT00637572|20882505|P2|Overall Study|Adverse Event|2
6041938|NCT00637572|20882506|P1|Overall Study|Adverse Event|1
6041939|NCT00637416|20882545|P2|Overall Study|Unable to take study drug|1
6041940|NCT00637416|20882546|P1|Overall Study|Unable to take study drug|0
6041941|NCT00637416|20882545|P2|Overall Study|Lost to Follow-up|1
6041942|NCT00637416|20882546|P1|Overall Study|Lost to Follow-up|1
6041943|NCT00637377|20882556|P4|Overall Study|Other (no further information available)|5
6041944|NCT00637377|20882557|P3|Overall Study|Other (no further information available)|10
6041945|NCT00637377|20882558|P2|Overall Study|Other (no further information available)|6
6041946|NCT00637377|20882559|P1|Overall Study|Other (no further information available)|7
6041947|NCT00637377|20882556|P4|Overall Study|Withdrawal by Subject|11
6041948|NCT00637377|20882557|P3|Overall Study|Withdrawal by Subject|13
6041949|NCT00637377|20882558|P2|Overall Study|Withdrawal by Subject|15
6041950|NCT00637377|20882559|P1|Overall Study|Withdrawal by Subject|11
6041951|NCT00637377|20882556|P4|Overall Study|Protocol Violation|0
6041952|NCT00637377|20882557|P3|Overall Study|Protocol Violation|1
6041953|NCT00637377|20882558|P2|Overall Study|Protocol Violation|1
6041954|NCT00637377|20882559|P1|Overall Study|Protocol Violation|2
6041955|NCT00637377|20882556|P4|Overall Study|Lost to Follow-up|2
6041956|NCT00637377|20882557|P3|Overall Study|Lost to Follow-up|2
6041957|NCT00637377|20882558|P2|Overall Study|Lost to Follow-up|1
6041958|NCT00637377|20882559|P1|Overall Study|Lost to Follow-up|4
6041959|NCT00637377|20882556|P4|Overall Study|Lack of Efficacy|1
6041960|NCT00637377|20882557|P3|Overall Study|Lack of Efficacy|1
6041961|NCT00637377|20882558|P2|Overall Study|Lack of Efficacy|0
6041962|NCT00637377|20882559|P1|Overall Study|Lack of Efficacy|0
6041963|NCT00637377|20882556|P4|Overall Study|Death|1
6041964|NCT00637377|20882557|P3|Overall Study|Death|2
6041965|NCT00637377|20882558|P2|Overall Study|Death|3
6041966|NCT00637377|20882559|P1|Overall Study|Death|1
6041967|NCT00637377|20882556|P4|Overall Study|Adverse Event|9
6041968|NCT00637377|20882557|P3|Overall Study|Adverse Event|8
6041969|NCT00637377|20882558|P2|Overall Study|Adverse Event|6
6041970|NCT00637377|20882559|P1|Overall Study|Adverse Event|2
6041971|NCT00637273|20882608|P3|Overall Study|Loss of Glucose Control|1
6041972|NCT00637273|20882609|P2|Overall Study|Loss of Glucose Control|1
6041973|NCT00637273|20882610|P1|Overall Study|Loss of Glucose Control|1
6041974|NCT00637273|20882608|P3|Overall Study|Administrative|0
6041975|NCT00637273|20882609|P2|Overall Study|Administrative|0
6041976|NCT00637273|20882610|P1|Overall Study|Administrative|2
6041977|NCT00637273|20882608|P3|Overall Study|Investigator Decision|1
6041978|NCT00637273|20882609|P2|Overall Study|Investigator Decision|3
6041979|NCT00637273|20882610|P1|Overall Study|Investigator Decision|1
6041980|NCT00637273|20882608|P3|Overall Study|Withdrawal of Consent|18
6041981|NCT00637273|20882609|P2|Overall Study|Withdrawal of Consent|6
6041982|NCT00637273|20882610|P1|Overall Study|Withdrawal of Consent|18
6041983|NCT00637273|20882608|P3|Overall Study|Protocol Violation|1
6041984|NCT00637273|20882609|P2|Overall Study|Protocol Violation|4
6041985|NCT00637273|20882610|P1|Overall Study|Protocol Violation|2
6041986|NCT00637273|20882608|P3|Overall Study|Lost to Follow-up|13
6041987|NCT00637273|20882609|P2|Overall Study|Lost to Follow-up|9
6041988|NCT00637273|20882610|P1|Overall Study|Lost to Follow-up|8
6041989|NCT00637273|20882608|P3|Overall Study|Adverse Event|7
6041990|NCT00637273|20882609|P2|Overall Study|Adverse Event|5
6041991|NCT00637273|20882610|P1|Overall Study|Adverse Event|11
6041992|NCT00637195|20882668|P2|Overall Study|Withdrawal by Subject|1
6041993|NCT00637195|20882669|P1|Overall Study|Withdrawal by Subject|0
6041994|NCT00637195|20882668|P2|Overall Study|Other|0
6041995|NCT00637195|20882669|P1|Overall Study|Other|2
6041996|NCT00637195|20882668|P2|Overall Study|Lost to Follow-up|0
6041997|NCT00637195|20882669|P1|Overall Study|Lost to Follow-up|1
6041998|NCT00637156|20882705|P2|Overall Study|Lost to Follow-up|16
6041999|NCT00637156|20882706|P1|Overall Study|Lost to Follow-up|10
6042000|NCT00637156|20882705|P2|Overall Study|Death|1
6042001|NCT00637156|20882706|P1|Overall Study|Death|0
6042002|NCT00637156|20882705|P2|Overall Study|Withdrawal by Subject|7
6042003|NCT00637156|20882706|P1|Overall Study|Withdrawal by Subject|0
6042004|NCT00637000|20882748|P2|Overall Study|Withdrawal by Subject|3
6042005|NCT00637000|20882749|P1|Overall Study|Withdrawal by Subject|4
6042006|NCT00636987|20882789|P1|Overall Study|5 year visit window not complete|69
6042007|NCT00636987|20882789|P1|Overall Study|Lost to Follow-up|63
6042008|NCT00636987|20882789|P1|Overall Study|Explanted|13
6042009|NCT00636987|20882789|P1|Overall Study|Death|44
6042010|NCT00636961|20882799|P2|Period 2|Adverse Event|0
6042011|NCT00636961|20882800|P1|Period 2|Adverse Event|1
6042012|NCT00636961|20882799|P2|Period 1|Administrative problems|1
6042013|NCT00636961|20882800|P1|Period 1|Administrative problems|1
6042014|NCT00636818|20882814|P1|Overall Study|Withdrawal by Subject|4
6042015|NCT00636818|20882814|P1|Overall Study|Protocol Violation|1
6042016|NCT00636818|20882814|P1|Overall Study|Entry Criteria Exclusion|3
6042017|NCT00636818|20882814|P1|Overall Study|Lost to Follow-up|2
6042018|NCT00636818|20882814|P1|Overall Study|Adverse Event|1
6042019|NCT00636792|20882839|P1|Overall Study|Other|3
6042020|NCT00636792|20882839|P1|Overall Study|Withdrawal by Subject|3
6042021|NCT00636792|20882839|P1|Overall Study|Progressive Disease|4
6042022|NCT00636792|20882839|P1|Overall Study|Physician Decision|7
6042023|NCT00636792|20882839|P1|Overall Study|Adverse Event|16
6042024|NCT00636675|20882855|P2|Overall Study|Withdrawal by Subject|10
6042025|NCT00636675|20882856|P1|Overall Study|Withdrawal by Subject|19
6042026|NCT00636675|20882855|P2|Overall Study|Lost to Follow-up|31
6042027|NCT00636675|20882856|P1|Overall Study|Lost to Follow-up|121
6042028|NCT00636636|20882899|P2|Overall Study|Withdrawal by Subject|9
6042029|NCT00636636|20882900|P1|Overall Study|Withdrawal by Subject|4
6042030|NCT00636636|20882899|P2|Overall Study|Death|1
6042031|NCT00636636|20882900|P1|Overall Study|Death|0
6042032|NCT00636636|20882899|P2|Overall Study|Lost to Follow-up|1
6042033|NCT00636636|20882900|P1|Overall Study|Lost to Follow-up|0
6042034|NCT00636636|20882899|P2|Overall Study|Protocol Violation|2
6042035|NCT00636636|20882900|P1|Overall Study|Protocol Violation|2
6042036|NCT00636636|20882899|P2|Overall Study|Lack of Efficacy|12
6042037|NCT00636636|20882900|P1|Overall Study|Lack of Efficacy|7
6042038|NCT00636636|20882899|P2|Overall Study|Adverse Event|8
6042039|NCT00636636|20882900|P1|Overall Study|Adverse Event|19
6042040|NCT00636636|20882899|P2|Overall Study|Other reason|6
6042041|NCT00636636|20882900|P1|Overall Study|Other reason|4
6042042|NCT00636610|20882916|P2|Overall Study|Reason for discontinuation not available|2
6042043|NCT00636610|20882917|P1|Overall Study|Reason for discontinuation not available|3
6042044|NCT00636610|20882916|P2|Overall Study|Disease progression - clinical|3
6042045|NCT00636610|20882917|P1|Overall Study|Disease progression - clinical|8
6042046|NCT00636610|20882916|P2|Overall Study|Disease progression - radiographic|51
6042047|NCT00636610|20882917|P1|Overall Study|Disease progression - radiographic|41
6042048|NCT00636610|20882916|P2|Overall Study|Subject decision to withdraw|11
6042049|NCT00636610|20882917|P1|Overall Study|Subject decision to withdraw|15
6042050|NCT00636610|20882916|P2|Overall Study|Physician decision to withdraw patient|9
6042051|NCT00636610|20882917|P1|Overall Study|Physician decision to withdraw patient|15
6042052|NCT00636610|20882916|P2|Overall Study|Death|3
6042053|NCT00636610|20882917|P1|Overall Study|Death|6
6042054|NCT00636610|20882916|P2|Overall Study|Adverse Event|4
6042055|NCT00636610|20882917|P1|Overall Study|Adverse Event|4
6042056|NCT00636506|20882927|P1|Overall Study|Procedure aborted|1
6042057|NCT00636506|20882927|P1|Overall Study|Withdrawal by Subject|6
6042058|NCT00636506|20882927|P1|Overall Study|Explanted|1
6042059|NCT00636506|20882927|P1|Overall Study|Lost to Follow-up|8
6042060|NCT00636441|20882974|P7|Overall Study|Screen Failure|17
6042061|NCT00636441|20882975|P6|Overall Study|Screen Failure|0
6042062|NCT00636441|20882976|P5|Overall Study|Screen Failure|0
6042063|NCT00636441|20882977|P4|Overall Study|Screen Failure|0
6042064|NCT00636441|20882978|P3|Overall Study|Screen Failure|0
6042065|NCT00636441|20882979|P2|Overall Study|Screen Failure|0
6042066|NCT00636441|20882980|P1|Overall Study|Screen Failure|0
6042067|NCT00636441|20882974|P7|Overall Study|Late, ineligible|1
6042068|NCT00636441|20882975|P6|Overall Study|Late, ineligible|0
6042069|NCT00636441|20882976|P5|Overall Study|Late, ineligible|0
6042070|NCT00636441|20882977|P4|Overall Study|Late, ineligible|0
6042071|NCT00636441|20882978|P3|Overall Study|Late, ineligible|0
6042072|NCT00636441|20882979|P2|Overall Study|Late, ineligible|0
6042073|NCT00636441|20882980|P1|Overall Study|Late, ineligible|0
6042074|NCT00636441|20882974|P7|Overall Study|Adverse Event|0
6042075|NCT00636441|20882975|P6|Overall Study|Adverse Event|1
6042076|NCT00636441|20882976|P5|Overall Study|Adverse Event|0
6042077|NCT00636441|20882977|P4|Overall Study|Adverse Event|0
6042078|NCT00636441|20882978|P3|Overall Study|Adverse Event|1
6042079|NCT00636441|20882979|P2|Overall Study|Adverse Event|1
6042080|NCT00636441|20882980|P1|Overall Study|Adverse Event|0
6042081|NCT00636363|20883023|P3|Overall Study|Withdrawal by Subject|2
6042082|NCT00636363|20883024|P2|Overall Study|Withdrawal by Subject|3
6042083|NCT00636363|20883025|P1|Overall Study|Withdrawal by Subject|1
6042084|NCT00636363|20883023|P3|Overall Study|Lost to Follow-up|2
6042085|NCT00636363|20883024|P2|Overall Study|Lost to Follow-up|4
6042086|NCT00636363|20883025|P1|Overall Study|Lost to Follow-up|3
6042087|NCT00636363|20883023|P3|Overall Study|Protocol Violation|0
6042088|NCT00636363|20883024|P2|Overall Study|Protocol Violation|3
6042089|NCT00636363|20883025|P1|Overall Study|Protocol Violation|0
6042090|NCT00636363|20883023|P3|Overall Study|Lack of motivation|1
6042091|NCT00636363|20883024|P2|Overall Study|Lack of motivation|0
6042092|NCT00636363|20883025|P1|Overall Study|Lack of motivation|1
6042093|NCT00636363|20883023|P3|Overall Study|Missed > 1 visit|3
6042094|NCT00636363|20883024|P2|Overall Study|Missed > 1 visit|1
6042095|NCT00636363|20883025|P1|Overall Study|Missed > 1 visit|0
6042096|NCT00636363|20883023|P3|Overall Study|Met ineligibility criteria|3
6042097|NCT00636363|20883024|P2|Overall Study|Met ineligibility criteria|0
6042098|NCT00636363|20883025|P1|Overall Study|Met ineligibility criteria|0
6042099|NCT00636363|20883023|P3|Overall Study|Study related symptoms/complaints|4
6042100|NCT00636363|20883024|P2|Overall Study|Study related symptoms/complaints|7
6042101|NCT00636363|20883025|P1|Overall Study|Study related symptoms/complaints|8
6042102|NCT00636363|20883023|P3|Overall Study|Positive slit lamp finding|1
6042103|NCT00636363|20883024|P2|Overall Study|Positive slit lamp finding|2
6042104|NCT00636363|20883025|P1|Overall Study|Positive slit lamp finding|0
6042105|NCT00636363|20883023|P3|Overall Study|Adverse Event|1
6042106|NCT00636363|20883024|P2|Overall Study|Adverse Event|0
6042107|NCT00636363|20883025|P1|Overall Study|Adverse Event|0
6042108|NCT00636363|20883023|P3|Overall Study|Conjunctivitis|1
6042109|NCT00636363|20883024|P2|Overall Study|Conjunctivitis|0
6042110|NCT00636363|20883025|P1|Overall Study|Conjunctivitis|0
6042111|NCT00636207|20883046|P7|Overall Study|Withdrawal by Subject|0
6042112|NCT00636207|20883047|P6|Overall Study|Withdrawal by Subject|0
6042113|NCT00636207|20883048|P5|Overall Study|Withdrawal by Subject|1
6042114|NCT00636207|20883049|P4|Overall Study|Withdrawal by Subject|0
6042115|NCT00636207|20883050|P3|Overall Study|Withdrawal by Subject|0
6042116|NCT00636207|20883051|P2|Overall Study|Withdrawal by Subject|1
6042117|NCT00636207|20883052|P1|Overall Study|Withdrawal by Subject|0
6042118|NCT00636207|20883046|P7|Overall Study|Adverse Event|0
6042119|NCT00636207|20883047|P6|Overall Study|Adverse Event|0
6042120|NCT00636207|20883048|P5|Overall Study|Adverse Event|0
6042121|NCT00636207|20883049|P4|Overall Study|Adverse Event|0
6042122|NCT00636207|20883050|P3|Overall Study|Adverse Event|0
6042123|NCT00636207|20883051|P2|Overall Study|Adverse Event|0
6042124|NCT00636207|20883052|P1|Overall Study|Adverse Event|1
6042125|NCT00636194|20883116|P2|Overall Study|Protocol Violation|0
6042126|NCT00636194|20883117|P1|Overall Study|Protocol Violation|2
6042127|NCT00636194|20883116|P2|Overall Study|Study related symptoms and complaints|0
6042128|NCT00636194|20883117|P1|Overall Study|Study related symptoms and complaints|1
6042129|NCT00636181|20883130|P3|Overall Study|Withdrawal by Subject|10
6042130|NCT00636181|20883131|P2|Overall Study|Withdrawal by Subject|6
6042131|NCT00636181|20883132|P1|Overall Study|Withdrawal by Subject|8
6042132|NCT00636168|20883160|P2|Long Term Follow-Up|Death|9
6042133|NCT00636168|20883161|P1|Long Term Follow-Up|Death|8
6042134|NCT00636168|20883160|P2|Long Term Follow-Up|Participant withdrew consent|2
6042135|NCT00636168|20883161|P1|Long Term Follow-Up|Participant withdrew consent|0
6042136|NCT00636168|20883160|P2|Long Term Follow-Up|Lost to Follow-up|3
6042137|NCT00636168|20883161|P1|Long Term Follow-Up|Lost to Follow-up|3
6042138|NCT00636168|20883160|P2|Treated With Study Drug|Other reason|3
6042139|NCT00636168|20883161|P1|Treated With Study Drug|Other reason|1
6042140|NCT00636168|20883160|P2|Treated With Study Drug|No longer meets study criteria|0
6042141|NCT00636168|20883161|P1|Treated With Study Drug|No longer meets study criteria|1
6042142|NCT00636168|20883160|P2|Treated With Study Drug|Pregnancy|0
6042143|NCT00636168|20883161|P1|Treated With Study Drug|Pregnancy|1
6042144|NCT00636168|20883160|P2|Treated With Study Drug|Death|0
6042145|NCT00636168|20883161|P1|Treated With Study Drug|Death|3
6042146|NCT00636168|20883160|P2|Treated With Study Drug|Poor/non-compliance|3
6042147|NCT00636168|20883161|P1|Treated With Study Drug|Poor/non-compliance|1
6042148|NCT00636168|20883160|P2|Treated With Study Drug|Participant withdrew consent|21
6042149|NCT00636168|20883161|P1|Treated With Study Drug|Participant withdrew consent|16
6042150|NCT00636168|20883160|P2|Treated With Study Drug|Adverse Event|22
6042151|NCT00636168|20883161|P1|Treated With Study Drug|Adverse Event|250
6042152|NCT00636168|20883160|P2|Treated With Study Drug|Recurrence of disease|282
6042153|NCT00636168|20883161|P1|Treated With Study Drug|Recurrence of disease|135
6042154|NCT00636168|20883160|P2|Randomized to Study Drug|No longer meets study criteria|0
6042155|NCT00636168|20883161|P1|Randomized to Study Drug|No longer meets study criteria|1
6042156|NCT00636168|20883160|P2|Randomized to Study Drug|Adverse Event|0
6042157|NCT00636168|20883161|P1|Randomized to Study Drug|Adverse Event|1
6042158|NCT00636168|20883160|P2|Randomized to Study Drug|Withdrawal by Subject|2
6042159|NCT00636168|20883161|P1|Randomized to Study Drug|Withdrawal by Subject|2
6042160|NCT00636155|20883189|P1|Overall Study|Physician Decision|5
6042161|NCT00636155|20883189|P1|Overall Study|Stem cell transplant|1
6042162|NCT00636155|20883189|P1|Overall Study|Withdrawal by Subject|3
6042163|NCT00636155|20883189|P1|Overall Study|Lack of Efficacy|1
6042164|NCT00636155|20883189|P1|Overall Study|Adverse Event|8
6042165|NCT00635999|20883231|P3|Overall Study|Withdrawal by Subject|1
6042166|NCT00635999|20883232|P2|Overall Study|Withdrawal by Subject|2
6042167|NCT00635999|20883233|P1|Overall Study|Withdrawal by Subject|4
6042168|NCT00635882|20883250|P6|Overall Study|Protocol Violation|0
6042169|NCT00635882|20883251|P5|Overall Study|Protocol Violation|0
6042170|NCT00635882|20883252|P4|Overall Study|Protocol Violation|0
6042171|NCT00635882|20883253|P3|Overall Study|Protocol Violation|0
6042172|NCT00635882|20883254|P2|Overall Study|Protocol Violation|0
6042173|NCT00635882|20883255|P1|Overall Study|Protocol Violation|1
6042174|NCT00635804|20883385|P8|Overall Study|Withdrawal by Subject|0
6042175|NCT00635804|20883386|P7|Overall Study|Withdrawal by Subject|0
6042176|NCT00635804|20883387|P6|Overall Study|Withdrawal by Subject|0
6042177|NCT00635804|20883388|P5|Overall Study|Withdrawal by Subject|0
6042178|NCT00635804|20883389|P4|Overall Study|Withdrawal by Subject|0
6042179|NCT00635804|20883390|P3|Overall Study|Withdrawal by Subject|0
6042180|NCT00635804|20883391|P2|Overall Study|Withdrawal by Subject|0
6042181|NCT00635804|20883392|P1|Overall Study|Withdrawal by Subject|1
6042182|NCT00635804|20883385|P8|Overall Study|Adverse Event|0
6042183|NCT00635804|20883386|P7|Overall Study|Adverse Event|0
6042184|NCT00635804|20883387|P6|Overall Study|Adverse Event|1
6042185|NCT00635804|20883388|P5|Overall Study|Adverse Event|0
6042186|NCT00635804|20883389|P4|Overall Study|Adverse Event|0
6042187|NCT00635804|20883390|P3|Overall Study|Adverse Event|0
6042188|NCT00635804|20883391|P2|Overall Study|Adverse Event|0
6042189|NCT00635804|20883392|P1|Overall Study|Adverse Event|0
6042190|NCT00635778|20883496|P7|Overall Study|Progressive disease|4
6042191|NCT00635778|20883497|P6|Overall Study|Progressive disease|14
6042192|NCT00635778|20883498|P5|Overall Study|Progressive disease|5
6042193|NCT00635778|20883499|P4|Overall Study|Progressive disease|4
6042194|NCT00635778|20883500|P3|Overall Study|Progressive disease|3
6042195|NCT00635778|20883501|P2|Overall Study|Progressive disease|3
6042196|NCT00635778|20883502|P1|Overall Study|Progressive disease|0
6042197|NCT00635778|20883496|P7|Overall Study|Withdrawal by Subject|1
6042198|NCT00635778|20883497|P6|Overall Study|Withdrawal by Subject|1
6042199|NCT00635778|20883498|P5|Overall Study|Withdrawal by Subject|0
6042200|NCT00635778|20883499|P4|Overall Study|Withdrawal by Subject|1
6042201|NCT00635778|20883500|P3|Overall Study|Withdrawal by Subject|0
6042202|NCT00635778|20883501|P2|Overall Study|Withdrawal by Subject|0
6042203|NCT00635778|20883502|P1|Overall Study|Withdrawal by Subject|0
6042204|NCT00635778|20883496|P7|Overall Study|Adverse Event|1
6042205|NCT00635778|20883497|P6|Overall Study|Adverse Event|6
6042206|NCT00635778|20883498|P5|Overall Study|Adverse Event|3
6042207|NCT00635778|20883499|P4|Overall Study|Adverse Event|3
6042208|NCT00635778|20883500|P3|Overall Study|Adverse Event|0
6042209|NCT00635778|20883501|P2|Overall Study|Adverse Event|0
6042210|NCT00635778|20883502|P1|Overall Study|Adverse Event|1
6042211|NCT00635661|20883573|P1|Overall Study|Withdrawal by Subject|4
6042212|NCT00635648|20883577|P1|Overall Study|Other reason|2
6042213|NCT00635648|20883577|P1|Overall Study|Noncompliance with protocol|1
6042214|NCT00635648|20883577|P1|Overall Study|No improvement after 7-10 days treatment|4
6042215|NCT00635648|20883577|P1|Overall Study|Use of other antifungal agent needed|1
6042216|NCT00635648|20883577|P1|Overall Study|Rapid progression of baseline disease|4
6042217|NCT00635648|20883577|P1|Overall Study|Physician Decision|4
6042218|NCT00635648|20883577|P1|Overall Study|Withdrawal by Subject|9
6042219|NCT00635648|20883577|P1|Overall Study|Adverse Event|12
6042232|NCT00635492|20883614|P2|Overall Study|Withdrawal by Subject|45
6042233|NCT00635492|20883615|P1|Overall Study|Withdrawal by Subject|82
6042234|NCT00635492|20883614|P2|Overall Study|Sponsor decision|3
6042235|NCT00635492|20883615|P1|Overall Study|Sponsor decision|2
6042236|NCT00635492|20883614|P2|Overall Study|Physician Decision|22
6042237|NCT00635492|20883615|P1|Overall Study|Physician Decision|32
6042238|NCT00635492|20883614|P2|Overall Study|Lost to Follow-up|172
6042239|NCT00635492|20883615|P1|Overall Study|Lost to Follow-up|151
6042240|NCT00635492|20883614|P2|Overall Study|Death|40
6042241|NCT00635492|20883615|P1|Overall Study|Death|12
6042242|NCT00635427|20883688|P5|Overall Study|Withdrawal Of Consent|2
6042243|NCT00635427|20883689|P4|Overall Study|Withdrawal Of Consent|2
6042244|NCT00635427|20883690|P3|Overall Study|Withdrawal Of Consent|0
6042245|NCT00635427|20883691|P2|Overall Study|Withdrawal Of Consent|0
6042246|NCT00635427|20883692|P1|Overall Study|Withdrawal Of Consent|0
6042247|NCT00635427|20883688|P5|Overall Study|Termination Of Study By Sponsor|6
6042248|NCT00635427|20883689|P4|Overall Study|Termination Of Study By Sponsor|6
6042249|NCT00635427|20883690|P3|Overall Study|Termination Of Study By Sponsor|10
6042250|NCT00635427|20883691|P2|Overall Study|Termination Of Study By Sponsor|6
6042251|NCT00635427|20883692|P1|Overall Study|Termination Of Study By Sponsor|12
6042252|NCT00635427|20883688|P5|Overall Study|Death|0
6042253|NCT00635427|20883689|P4|Overall Study|Death|1
6042254|NCT00635427|20883690|P3|Overall Study|Death|0
6042255|NCT00635427|20883691|P2|Overall Study|Death|0
6042256|NCT00635427|20883692|P1|Overall Study|Death|0
6042257|NCT00635427|20883688|P5|Overall Study|Refusal Of Required DiagnosticEvaluation|0
6042258|NCT00635427|20883689|P4|Overall Study|Refusal Of Required DiagnosticEvaluation|0
6042259|NCT00635427|20883690|P3|Overall Study|Refusal Of Required DiagnosticEvaluation|1
6042260|NCT00635427|20883691|P2|Overall Study|Refusal Of Required DiagnosticEvaluation|0
6042261|NCT00635427|20883692|P1|Overall Study|Refusal Of Required DiagnosticEvaluation|0
6042262|NCT00635349|20883731|P2|Overall Study|Adverse Event|9
6042263|NCT00635349|20883732|P1|Overall Study|Adverse Event|11
6042264|NCT00635349|20883731|P2|Overall Study|Lost to Follow-up|3
6042265|NCT00635349|20883732|P1|Overall Study|Lost to Follow-up|4
6042266|NCT00635349|20883731|P2|Overall Study|Withdrawal by Subject|8
6042267|NCT00635349|20883732|P1|Overall Study|Withdrawal by Subject|3
6042268|NCT00635349|20883731|P2|Overall Study|Protocol Violation|22
6042269|NCT00635349|20883732|P1|Overall Study|Protocol Violation|18
6042270|NCT00635349|20883731|P2|Overall Study|Other|6
6042271|NCT00635349|20883732|P1|Overall Study|Other|8
6042272|NCT00635219|20883786|P5|Overall Study|Administrative or Other Reasons|1
6042273|NCT00635219|20883787|P4|Overall Study|Administrative or Other Reasons|0
6042274|NCT00635219|20883788|P3|Overall Study|Administrative or Other Reasons|1
6042275|NCT00635219|20883789|P2|Overall Study|Administrative or Other Reasons|1
6042276|NCT00635219|20883790|P1|Overall Study|Administrative or Other Reasons|0
6042277|NCT00635219|20883786|P5|Overall Study|Lost to Follow-up|3
6042278|NCT00635219|20883787|P4|Overall Study|Lost to Follow-up|0
6042279|NCT00635219|20883788|P3|Overall Study|Lost to Follow-up|2
6042280|NCT00635219|20883789|P2|Overall Study|Lost to Follow-up|0
6042281|NCT00635219|20883790|P1|Overall Study|Lost to Follow-up|0
6042282|NCT00635219|20883786|P5|Overall Study|Withdrawal of Consent|8
6042283|NCT00635219|20883787|P4|Overall Study|Withdrawal of Consent|11
6042284|NCT00635219|20883788|P3|Overall Study|Withdrawal of Consent|8
6042285|NCT00635219|20883789|P2|Overall Study|Withdrawal of Consent|6
6042286|NCT00635219|20883790|P1|Overall Study|Withdrawal of Consent|8
6042287|NCT00635219|20883786|P5|Overall Study|Protocol Violation|4
6042288|NCT00635219|20883787|P4|Overall Study|Protocol Violation|2
6042289|NCT00635219|20883788|P3|Overall Study|Protocol Violation|3
6042290|NCT00635219|20883789|P2|Overall Study|Protocol Violation|2
6042291|NCT00635219|20883790|P1|Overall Study|Protocol Violation|0
6042292|NCT00635219|20883786|P5|Overall Study|Non-compliance With Study Product|1
6042293|NCT00635219|20883787|P4|Overall Study|Non-compliance With Study Product|2
6042294|NCT00635219|20883788|P3|Overall Study|Non-compliance With Study Product|0
6042295|NCT00635219|20883789|P2|Overall Study|Non-compliance With Study Product|0
6042296|NCT00635219|20883790|P1|Overall Study|Non-compliance With Study Product|0
6042297|NCT00635219|20883786|P5|Overall Study|Lack of Efficacy|6
6042298|NCT00635219|20883787|P4|Overall Study|Lack of Efficacy|4
6042299|NCT00635219|20883788|P3|Overall Study|Lack of Efficacy|3
6042300|NCT00635219|20883789|P2|Overall Study|Lack of Efficacy|6
6042301|NCT00635219|20883790|P1|Overall Study|Lack of Efficacy|5
6042302|NCT00635219|20883786|P5|Overall Study|Adverse Event|19
6042303|NCT00635219|20883787|P4|Overall Study|Adverse Event|15
6042304|NCT00635219|20883788|P3|Overall Study|Adverse Event|18
6042305|NCT00635219|20883789|P2|Overall Study|Adverse Event|10
6042306|NCT00635219|20883790|P1|Overall Study|Adverse Event|12
6042307|NCT00635154|20883853|P1|Overall Study|Still on treatment|21
6042308|NCT00635154|20883853|P1|Overall Study|Other|4
6042309|NCT00635154|20883853|P1|Overall Study|Alternative Treatment|8
6042310|NCT00635102|20883896|P2|Overall Study|Withdrawal by Subject|8
6042311|NCT00635102|20883897|P1|Overall Study|Withdrawal by Subject|7
6042312|NCT00635089|20883991|P1|Overall Study|Other|31
6042313|NCT00635089|20883991|P1|Overall Study|Lost to Follow-up|8
6042314|NCT00635089|20883991|P1|Overall Study|Protocol Deviation|4
6042315|NCT00635089|20883991|P1|Overall Study|Lack of Efficacy|28
6042316|NCT00635089|20883991|P1|Overall Study|Adverse Event|7
6042317|NCT00635050|20884018|P1|Overall Study|Withdrawal by Subject|1
6042318|NCT00635024|20884025|P1|Overall Study|Adverse Event|1
6042319|NCT00634933|20884045|P5|Part B: Week 24 to Week 52|Other|1
6042320|NCT00634933|20884046|P4|Part B: Week 24 to Week 52|Other|0
6042321|NCT00634933|20884047|P3|Part B: Week 24 to Week 52|Other|5
6042322|NCT00634933|20884048|P2|Part B: Week 24 to Week 52|Other|0
6042323|NCT00634933|20884049|P1|Part B: Week 24 to Week 52|Other|0
6042324|NCT00634933|20884045|P5|Part B: Week 24 to Week 52|Lack of Efficacy|0
6042325|NCT00634933|20884046|P4|Part B: Week 24 to Week 52|Lack of Efficacy|0
6042326|NCT00634933|20884047|P3|Part B: Week 24 to Week 52|Lack of Efficacy|1
6042327|NCT00634933|20884048|P2|Part B: Week 24 to Week 52|Lack of Efficacy|1
6042328|NCT00634933|20884049|P1|Part B: Week 24 to Week 52|Lack of Efficacy|0
6042329|NCT00634933|20884045|P5|Part B: Week 24 to Week 52|Withdrawal by Subject|1
6042330|NCT00634933|20884046|P4|Part B: Week 24 to Week 52|Withdrawal by Subject|2
6042331|NCT00634933|20884047|P3|Part B: Week 24 to Week 52|Withdrawal by Subject|0
6042332|NCT00634933|20884048|P2|Part B: Week 24 to Week 52|Withdrawal by Subject|0
6042333|NCT00634933|20884049|P1|Part B: Week 24 to Week 52|Withdrawal by Subject|0
6042334|NCT00634933|20884045|P5|Part B: Week 24 to Week 52|Protocol Violation|1
6042335|NCT00634933|20884046|P4|Part B: Week 24 to Week 52|Protocol Violation|0
6042336|NCT00634933|20884047|P3|Part B: Week 24 to Week 52|Protocol Violation|0
6042337|NCT00634933|20884048|P2|Part B: Week 24 to Week 52|Protocol Violation|0
6042338|NCT00634933|20884049|P1|Part B: Week 24 to Week 52|Protocol Violation|0
6042339|NCT00634933|20884045|P5|Part B: Week 24 to Week 52|Physician Decision|0
6042340|NCT00634933|20884046|P4|Part B: Week 24 to Week 52|Physician Decision|0
6042341|NCT00634933|20884047|P3|Part B: Week 24 to Week 52|Physician Decision|1
6042342|NCT00634933|20884048|P2|Part B: Week 24 to Week 52|Physician Decision|1
6042343|NCT00634933|20884049|P1|Part B: Week 24 to Week 52|Physician Decision|0
6042344|NCT00634933|20884045|P5|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|7
6042345|NCT00634933|20884046|P4|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|3
6042346|NCT00634933|20884047|P3|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|14
6042347|NCT00634933|20884048|P2|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|11
6042348|NCT00634933|20884049|P1|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|0
6042349|NCT00634933|20884045|P5|Part B: Week 24 to Week 52|Adverse Event|0
6042350|NCT00634933|20884046|P4|Part B: Week 24 to Week 52|Adverse Event|1
6042351|NCT00634933|20884047|P3|Part B: Week 24 to Week 52|Adverse Event|1
6042352|NCT00634933|20884048|P2|Part B: Week 24 to Week 52|Adverse Event|1
6042353|NCT00634933|20884049|P1|Part B: Week 24 to Week 52|Adverse Event|0
6042354|NCT00634933|20884045|P5|Between Part A and Part B|Physician Decision|0
6042355|NCT00634933|20884046|P4|Between Part A and Part B|Physician Decision|0
6042356|NCT00634933|20884047|P3|Between Part A and Part B|Physician Decision|0
6042357|NCT00634933|20884048|P2|Between Part A and Part B|Physician Decision|1
6042358|NCT00634933|20884049|P1|Between Part A and Part B|Physician Decision|0
6042359|NCT00634933|20884045|P5|Part A: Baseline to Week 24|Other|0
6042360|NCT00634933|20884046|P4|Part A: Baseline to Week 24|Other|0
6042361|NCT00634933|20884047|P3|Part A: Baseline to Week 24|Other|5
6042362|NCT00634933|20884048|P2|Part A: Baseline to Week 24|Other|8
6042363|NCT00634933|20884049|P1|Part A: Baseline to Week 24|Other|1
6042364|NCT00634933|20884045|P5|Part A: Baseline to Week 24|Lack of Efficacy|0
6042365|NCT00634933|20884046|P4|Part A: Baseline to Week 24|Lack of Efficacy|0
6042366|NCT00634933|20884047|P3|Part A: Baseline to Week 24|Lack of Efficacy|0
6042367|NCT00634933|20884048|P2|Part A: Baseline to Week 24|Lack of Efficacy|1
6042368|NCT00634933|20884049|P1|Part A: Baseline to Week 24|Lack of Efficacy|3
6042369|NCT00634933|20884045|P5|Part A: Baseline to Week 24|Withdrawal by Subject|0
6042370|NCT00634933|20884046|P4|Part A: Baseline to Week 24|Withdrawal by Subject|0
6042371|NCT00634933|20884047|P3|Part A: Baseline to Week 24|Withdrawal by Subject|3
6042372|NCT00634933|20884048|P2|Part A: Baseline to Week 24|Withdrawal by Subject|3
6042373|NCT00634933|20884049|P1|Part A: Baseline to Week 24|Withdrawal by Subject|0
6042374|NCT00634933|20884045|P5|Part A: Baseline to Week 24|Lost to Follow-up|0
6042375|NCT00634933|20884046|P4|Part A: Baseline to Week 24|Lost to Follow-up|0
6042376|NCT00634933|20884047|P3|Part A: Baseline to Week 24|Lost to Follow-up|1
6042377|NCT00634933|20884048|P2|Part A: Baseline to Week 24|Lost to Follow-up|1
6042378|NCT00634933|20884049|P1|Part A: Baseline to Week 24|Lost to Follow-up|0
6042379|NCT00634933|20884045|P5|Part A: Baseline to Week 24|Investigator Request|0
6042380|NCT00634933|20884046|P4|Part A: Baseline to Week 24|Investigator Request|0
6042381|NCT00634933|20884047|P3|Part A: Baseline to Week 24|Investigator Request|1
6042382|NCT00634933|20884048|P2|Part A: Baseline to Week 24|Investigator Request|1
6042383|NCT00634933|20884049|P1|Part A: Baseline to Week 24|Investigator Request|1
6042384|NCT00634933|20884045|P5|Part A: Baseline to Week 24|Failed to Return|0
6042385|NCT00634933|20884046|P4|Part A: Baseline to Week 24|Failed to Return|0
6042386|NCT00634933|20884047|P3|Part A: Baseline to Week 24|Failed to Return|0
6042387|NCT00634933|20884048|P2|Part A: Baseline to Week 24|Failed to Return|0
6042388|NCT00634933|20884049|P1|Part A: Baseline to Week 24|Failed to Return|1
6042389|NCT00634933|20884045|P5|Part A: Baseline to Week 24|Death|0
6042390|NCT00634933|20884046|P4|Part A: Baseline to Week 24|Death|0
6042391|NCT00634933|20884047|P3|Part A: Baseline to Week 24|Death|0
6042392|NCT00634933|20884048|P2|Part A: Baseline to Week 24|Death|0
6042393|NCT00634933|20884049|P1|Part A: Baseline to Week 24|Death|1
6042394|NCT00634933|20884045|P5|Part A: Baseline to Week 24|Adverse Event|0
6042395|NCT00634933|20884046|P4|Part A: Baseline to Week 24|Adverse Event|0
6042396|NCT00634933|20884047|P3|Part A: Baseline to Week 24|Adverse Event|8
6042397|NCT00634933|20884048|P2|Part A: Baseline to Week 24|Adverse Event|4
6042398|NCT00634933|20884049|P1|Part A: Baseline to Week 24|Adverse Event|4
6042399|NCT00634920|20884118|P3|Period 2 - Post-Randomization|Patients did not receive study drug|0
6042400|NCT00634920|20884119|P2|Period 2 - Post-Randomization|Patients did not receive study drug|0
6042401|NCT00634920|20884120|P1|Period 2 - Post-Randomization|Patients did not receive study drug|2
6042402|NCT00634920|20884118|P3|Period 2 - Post-Randomization|consent withdrawal, non compliance|0
6042403|NCT00634920|20884119|P2|Period 2 - Post-Randomization|consent withdrawal, non compliance|13
6042404|NCT00634920|20884120|P1|Period 2 - Post-Randomization|consent withdrawal, non compliance|9
6042405|NCT00634920|20884118|P3|Period 2 - Post-Randomization|Death|0
6042406|NCT00634920|20884119|P2|Period 2 - Post-Randomization|Death|5
6042407|NCT00634920|20884120|P1|Period 2 - Post-Randomization|Death|2
6042408|NCT00634920|20884118|P3|Period 2 - Post-Randomization|Rejection|0
6042409|NCT00634920|20884119|P2|Period 2 - Post-Randomization|Rejection|5
6042410|NCT00634920|20884120|P1|Period 2 - Post-Randomization|Rejection|11
6042411|NCT00634920|20884118|P3|Period 2 - Post-Randomization|Adverse Event|0
6042412|NCT00634920|20884119|P2|Period 2 - Post-Randomization|Adverse Event|9
6042413|NCT00634920|20884120|P1|Period 2 - Post-Randomization|Adverse Event|37
6042414|NCT00634920|20884118|P3|Period 1 - Pre-Randomization|Other issues|6
6042415|NCT00634920|20884119|P2|Period 1 - Pre-Randomization|Other issues|0
6042416|NCT00634920|20884120|P1|Period 1 - Pre-Randomization|Other issues|0
6042417|NCT00634920|20884118|P3|Period 1 - Pre-Randomization|Non-Compliance|3
6042418|NCT00634920|20884119|P2|Period 1 - Pre-Randomization|Non-Compliance|0
6042419|NCT00634920|20884120|P1|Period 1 - Pre-Randomization|Non-Compliance|0
6042420|NCT00634920|20884118|P3|Period 1 - Pre-Randomization|Withdrawal by Subject|21
6042421|NCT00634920|20884119|P2|Period 1 - Pre-Randomization|Withdrawal by Subject|0
6042422|NCT00634920|20884120|P1|Period 1 - Pre-Randomization|Withdrawal by Subject|0
6042423|NCT00634920|20884118|P3|Period 1 - Pre-Randomization|Rejections|55
6042424|NCT00634920|20884119|P2|Period 1 - Pre-Randomization|Rejections|0
6042425|NCT00634920|20884120|P1|Period 1 - Pre-Randomization|Rejections|0
6042426|NCT00634920|20884118|P3|Period 1 - Pre-Randomization|Wound healing problems|16
6042427|NCT00634920|20884119|P2|Period 1 - Pre-Randomization|Wound healing problems|0
6042428|NCT00634920|20884120|P1|Period 1 - Pre-Randomization|Wound healing problems|0
6042429|NCT00634920|20884118|P3|Period 1 - Pre-Randomization|Adverse Event|36
6042430|NCT00634920|20884119|P2|Period 1 - Pre-Randomization|Adverse Event|0
6042431|NCT00634920|20884120|P1|Period 1 - Pre-Randomization|Adverse Event|0
6042432|NCT00634907|20884164|P2|Overall Study|Withdrawal by Subject|8
6042433|NCT00634907|20884165|P1|Overall Study|Withdrawal by Subject|11
6042434|NCT00634907|20884164|P2|Overall Study|Physician Decision|9
6042435|NCT00634907|20884165|P1|Overall Study|Physician Decision|3
6042436|NCT00634907|20884164|P2|Overall Study|Withdrawal by Subject|0
6042437|NCT00634907|20884165|P1|Overall Study|Withdrawal by Subject|3
6042438|NCT00634842|20884189|P2|Overall Study|Subject off study drug for too long|1
6042439|NCT00634842|20884190|P1|Overall Study|Subject off study drug for too long|0
6042440|NCT00634842|20884189|P2|Overall Study|No wish to keep taking Avandia|1
6042441|NCT00634842|20884190|P1|Overall Study|No wish to keep taking Avandia|0
6042442|NCT00634842|20884189|P2|Overall Study|No need of study drug to treat diabetes|1
6042443|NCT00634842|20884190|P1|Overall Study|No need of study drug to treat diabetes|0
6042444|NCT00634842|20884189|P2|Overall Study|Discontinued due to injection|2
6042445|NCT00634842|20884190|P1|Overall Study|Discontinued due to injection|0
6042446|NCT00634842|20884189|P2|Overall Study|Lack of time and intolerance to drug|1
6042447|NCT00634842|20884190|P1|Overall Study|Lack of time and intolerance to drug|0
6042448|NCT00634842|20884189|P2|Overall Study|Withdrawal by Subject|3
6042449|NCT00634842|20884190|P1|Overall Study|Withdrawal by Subject|1
6042450|NCT00634842|20884189|P2|Overall Study|Physician Decision|0
6042451|NCT00634842|20884190|P1|Overall Study|Physician Decision|1
6042452|NCT00634842|20884189|P2|Overall Study|Lost to Follow-up|2
6042453|NCT00634842|20884190|P1|Overall Study|Lost to Follow-up|1
6042454|NCT00634842|20884189|P2|Overall Study|Inclusion criteria were not met|0
6042455|NCT00634842|20884190|P1|Overall Study|Inclusion criteria were not met|1
6042456|NCT00634842|20884189|P2|Overall Study|Move to another state|0
6042457|NCT00634842|20884190|P1|Overall Study|Move to another state|1
6042458|NCT00634842|20884189|P2|Overall Study|Protocol Violation|4
6042459|NCT00634842|20884190|P1|Overall Study|Protocol Violation|8
6042460|NCT00634842|20884189|P2|Overall Study|Adverse Event|3
6042461|NCT00634842|20884190|P1|Overall Study|Adverse Event|2
6042462|NCT00634803|20884205|P3|Overall Study|Lost to Follow-up|7
6042463|NCT00634803|20884206|P2|Overall Study|Lost to Follow-up|7
6042464|NCT00634803|20884207|P1|Overall Study|Lost to Follow-up|6
6042465|NCT00634751|20884225|P4|Pancreatic and Bilial Tract Cancer|Death|1
6042466|NCT00634751|20884226|P3|Pancreatic and Bilial Tract Cancer|Death|1
6042467|NCT00634751|20884227|P2|Pancreatic and Bilial Tract Cancer|Death|0
6042468|NCT00634751|20884228|P1|Pancreatic and Bilial Tract Cancer|Death|0
6042469|NCT00634751|20884225|P4|Phase I: 400mg Sorafenib BID+2DOC|Death|0
6042470|NCT00634751|20884226|P3|Phase I: 400mg Sorafenib BID+2DOC|Death|0
6042471|NCT00634751|20884227|P2|Phase I: 400mg Sorafenib BID+2DOC|Death|1
6042472|NCT00634751|20884228|P1|Phase I: 400mg Sorafenib BID+2DOC|Death|0
6042473|NCT00634751|20884225|P4|Phase I: 200mg Sorafenib+2DOC|Death|0
6042474|NCT00634751|20884226|P3|Phase I: 200mg Sorafenib+2DOC|Death|0
6042475|NCT00634751|20884227|P2|Phase I: 200mg Sorafenib+2DOC|Death|0
6042476|NCT00634751|20884228|P1|Phase I: 200mg Sorafenib+2DOC|Death|1
6042477|NCT00634647|20884246|P1|Overall Study|declined to participate before treatment|1
6042478|NCT00634647|20884246|P1|Overall Study|refused further treatment|3
6042479|NCT00634647|20884246|P1|Overall Study|death on study|3
6042480|NCT00634569|20884266|P2|Overall Study|Physician Decision|1
6042481|NCT00634569|20884267|P1|Overall Study|Physician Decision|0
6042482|NCT00634569|20884266|P2|Overall Study|Withdrawal by Subject|4
6042483|NCT00634569|20884267|P1|Overall Study|Withdrawal by Subject|0
6042484|NCT00634543|20884281|P2|Overall Study|Lost to Follow-up|1
6042485|NCT00634543|20884282|P1|Overall Study|Lost to Follow-up|0
6042486|NCT00634543|20884281|P2|Overall Study|Withdrawal by Subject|4
6042487|NCT00634543|20884282|P1|Overall Study|Withdrawal by Subject|4
6042488|NCT00634543|20884281|P2|Overall Study|Adverse Event|11
6042489|NCT00634543|20884282|P1|Overall Study|Adverse Event|11
6042490|NCT00634543|20884281|P2|Overall Study|Protocol Violation|3
6042491|NCT00634543|20884282|P1|Overall Study|Protocol Violation|3
6042492|NCT00634543|20884281|P2|Overall Study|Other|2
6042493|NCT00634543|20884282|P1|Overall Study|Other|1
6042494|NCT00634504|20884300|P2|Overall Study|Protocol Violation|0
6042495|NCT00634504|20884301|P1|Overall Study|Protocol Violation|1
6042496|NCT00634244|20884360|P3|Overall Study|Other complicating disease|0
6042497|NCT00634244|20884361|P2|Overall Study|Other complicating disease|1
6042498|NCT00634244|20884362|P1|Overall Study|Other complicating disease|0
6042499|NCT00634244|20884360|P3|Overall Study|Disease progression/relapse|0
6042500|NCT00634244|20884361|P2|Overall Study|Disease progression/relapse|1
6042501|NCT00634244|20884362|P1|Overall Study|Disease progression/relapse|0
6042502|NCT00634244|20884360|P3|Overall Study|Physician Decision|0
6042503|NCT00634244|20884361|P2|Overall Study|Physician Decision|1
6042504|NCT00634244|20884362|P1|Overall Study|Physician Decision|0
6042505|NCT00634244|20884360|P3|Overall Study|Withdrawal by Subject|0
6042506|NCT00634244|20884361|P2|Overall Study|Withdrawal by Subject|1
6042507|NCT00634244|20884362|P1|Overall Study|Withdrawal by Subject|0
6042508|NCT00634244|20884360|P3|Overall Study|Adverse Event|0
6042509|NCT00634244|20884361|P2|Overall Study|Adverse Event|2
6042510|NCT00634244|20884362|P1|Overall Study|Adverse Event|0
6042511|NCT00634244|20884360|P3|Overall Study|Death|0
6042512|NCT00634244|20884361|P2|Overall Study|Death|6
6042513|NCT00634244|20884362|P1|Overall Study|Death|1
6042514|NCT00634244|20884360|P3|Overall Study|Never started treatment|0
6042515|NCT00634244|20884361|P2|Overall Study|Never started treatment|1
6042516|NCT00634244|20884362|P1|Overall Study|Never started treatment|0
6042517|NCT00634179|20884373|P1|Phase II: Maintenance|Diagnosis changed after re-review|1
6042518|NCT00634114|20884392|P3|Overall Study|Other reason|1
6042519|NCT00634114|20884393|P2|Overall Study|Other reason|1
6042520|NCT00634114|20884394|P1|Overall Study|Other reason|1
6042521|NCT00634114|20884392|P3|Overall Study|Difficult to continue|1
6042522|NCT00634114|20884393|P2|Overall Study|Difficult to continue|1
6042523|NCT00634114|20884394|P1|Overall Study|Difficult to continue|3
6042524|NCT00634114|20884392|P3|Overall Study|Recurrence of reflux esophagitis|21
6042525|NCT00634114|20884393|P2|Overall Study|Recurrence of reflux esophagitis|15
6042526|NCT00634114|20884394|P1|Overall Study|Recurrence of reflux esophagitis|5
6042527|NCT00634114|20884392|P3|Overall Study|Incorrect enrolment|0
6042528|NCT00634114|20884393|P2|Overall Study|Incorrect enrolment|1
6042529|NCT00634114|20884394|P1|Overall Study|Incorrect enrolment|0
6042530|NCT00634114|20884392|P3|Overall Study|Pregnancy|0
6042531|NCT00634114|20884393|P2|Overall Study|Pregnancy|0
6042532|NCT00634114|20884394|P1|Overall Study|Pregnancy|1
6042533|NCT00634114|20884392|P3|Overall Study|Protocol Violation|1
6042534|NCT00634114|20884393|P2|Overall Study|Protocol Violation|3
6042535|NCT00634114|20884394|P1|Overall Study|Protocol Violation|3
6042536|NCT00634114|20884392|P3|Overall Study|Lost to Follow-up|1
6042537|NCT00634114|20884393|P2|Overall Study|Lost to Follow-up|0
6042538|NCT00634114|20884394|P1|Overall Study|Lost to Follow-up|0
6042539|NCT00634114|20884392|P3|Overall Study|Withdrawal by Subject|11
6042540|NCT00634114|20884393|P2|Overall Study|Withdrawal by Subject|6
6042541|NCT00634114|20884394|P1|Overall Study|Withdrawal by Subject|9
6042542|NCT00634114|20884392|P3|Overall Study|Adverse Event|3
6042543|NCT00634114|20884393|P2|Overall Study|Adverse Event|8
6042544|NCT00634114|20884394|P1|Overall Study|Adverse Event|6
6042545|NCT00634101|20884410|P2|Overall Study|Lost to Follow-up|0
6042546|NCT00634101|20884411|P1|Overall Study|Lost to Follow-up|2
6042547|NCT00634101|20884410|P2|Overall Study|Study Terminated|3
6042548|NCT00634101|20884411|P1|Overall Study|Study Terminated|3
6042549|NCT00634088|20884445|P4|Time Period 3: Dose Level 3|Progressive disease|0
6042550|NCT00634088|20884446|P3|Time Period 3: Dose Level 3|Progressive disease|1
6042551|NCT00634088|20884447|P2|Time Period 3: Dose Level 3|Progressive disease|0
6042552|NCT00634088|20884448|P1|Time Period 3: Dose Level 3|Progressive disease|0
6042553|NCT00634088|20884445|P4|Time Period 2: Dose Level 2|Progressive disease|0
6042554|NCT00634088|20884446|P3|Time Period 2: Dose Level 2|Progressive disease|0
6042555|NCT00634088|20884447|P2|Time Period 2: Dose Level 2|Progressive disease|1
6042556|NCT00634088|20884448|P1|Time Period 2: Dose Level 2|Progressive disease|0
6042557|NCT00634088|20884445|P4|Time Period 2: Dose Level 2|Adverse Event|0
6042558|NCT00634088|20884446|P3|Time Period 2: Dose Level 2|Adverse Event|0
6042559|NCT00634088|20884447|P2|Time Period 2: Dose Level 2|Adverse Event|2
6042560|NCT00634088|20884448|P1|Time Period 2: Dose Level 2|Adverse Event|0
6042561|NCT00634088|20884445|P4|Time Period 1: Dose Level 1|Adverse Event|0
6042562|NCT00634088|20884446|P3|Time Period 1: Dose Level 1|Adverse Event|0
6042563|NCT00634088|20884447|P2|Time Period 1: Dose Level 1|Adverse Event|0
6042564|NCT00634088|20884448|P1|Time Period 1: Dose Level 1|Adverse Event|3
6042565|NCT00634088|20884445|P4|Time Period 1: Dose Level 1|Physician Decision|0
6042566|NCT00634088|20884446|P3|Time Period 1: Dose Level 1|Physician Decision|0
6042567|NCT00634088|20884447|P2|Time Period 1: Dose Level 1|Physician Decision|0
6042568|NCT00634088|20884448|P1|Time Period 1: Dose Level 1|Physician Decision|1
6042569|NCT00634088|20884445|P4|Time Period 1: Dose Level 1|Disease progression|0
6042570|NCT00634088|20884446|P3|Time Period 1: Dose Level 1|Disease progression|0
6042571|NCT00634088|20884447|P2|Time Period 1: Dose Level 1|Disease progression|0
6042572|NCT00634088|20884448|P1|Time Period 1: Dose Level 1|Disease progression|2
6042573|NCT00634049|20884499|P1|Overall Study|Screening failure|1
6042574|NCT00634049|20884499|P1|Overall Study|Died prior to receiving study drug|1
6042575|NCT00634049|20884499|P1|Overall Study|Never received study drug|1
6042576|NCT00634036|20884578|P2|Overall Study|Withdrawal by Subject|1
6042577|NCT00634036|20884579|P1|Overall Study|Withdrawal by Subject|1
6042578|NCT00634036|20884578|P2|Overall Study|Lost to Follow-up|1
6042579|NCT00634036|20884579|P1|Overall Study|Lost to Follow-up|1
6042580|NCT00634010|20884593|P2|Overall Study|Non-Compliant|1
6042581|NCT00634010|20884594|P1|Overall Study|Non-Compliant|1
6042582|NCT00634010|20884593|P2|Overall Study|Disease Progression|1
6042583|NCT00634010|20884594|P1|Overall Study|Disease Progression|1
6042584|NCT00634010|20884593|P2|Overall Study|Physician Decision|1
6042585|NCT00634010|20884594|P1|Overall Study|Physician Decision|1
6042586|NCT00634010|20884593|P2|Overall Study|Withdrawal by Subject|6
6042587|NCT00634010|20884594|P1|Overall Study|Withdrawal by Subject|5
6042588|NCT00634010|20884593|P2|Overall Study|Adverse Event|5
6042589|NCT00634010|20884594|P1|Overall Study|Adverse Event|2
6042590|NCT00633984|20884602|P2|Overall Study|Hospitalized|0
6042591|NCT00633984|20884603|P1|Overall Study|Hospitalized|1
6042592|NCT00633984|20884602|P2|Overall Study|Withdrawal by Subject|7
6042593|NCT00633984|20884603|P1|Overall Study|Withdrawal by Subject|8
6042594|NCT00633984|20884602|P2|Overall Study|Lost to Follow-up|6
6042595|NCT00633984|20884603|P1|Overall Study|Lost to Follow-up|0
6042596|NCT00633945|20884611|P1|Overall Study|Physician Decision|2
6042597|NCT00633932|20884627|P3|Overall Study|Moved Away|0
6042598|NCT00633932|20884628|P2|Overall Study|Moved Away|0
6042599|NCT00633932|20884629|P1|Overall Study|Moved Away|1
6042600|NCT00633932|20884627|P3|Overall Study|Doctor's judgement|0
6042601|NCT00633932|20884628|P2|Overall Study|Doctor's judgement|0
6042602|NCT00633932|20884629|P1|Overall Study|Doctor's judgement|1
6042603|NCT00633932|20884627|P3|Overall Study|Physician Decision|1
6042604|NCT00633932|20884628|P2|Overall Study|Physician Decision|0
6042605|NCT00633932|20884629|P1|Overall Study|Physician Decision|0
6042606|NCT00633932|20884627|P3|Overall Study|Protocol Violation|3
6042607|NCT00633932|20884628|P2|Overall Study|Protocol Violation|2
6042608|NCT00633932|20884629|P1|Overall Study|Protocol Violation|5
6042609|NCT00633932|20884627|P3|Overall Study|Lost to Follow-up|2
6042610|NCT00633932|20884628|P2|Overall Study|Lost to Follow-up|0
6042611|NCT00633932|20884629|P1|Overall Study|Lost to Follow-up|1
6042612|NCT00633932|20884627|P3|Overall Study|Withdrawal by Subject|1
6042613|NCT00633932|20884628|P2|Overall Study|Withdrawal by Subject|9
6042614|NCT00633932|20884629|P1|Overall Study|Withdrawal by Subject|3
6042615|NCT00633932|20884627|P3|Overall Study|Adverse Event|4
6042616|NCT00633932|20884628|P2|Overall Study|Adverse Event|3
6042617|NCT00633932|20884629|P1|Overall Study|Adverse Event|1
6042618|NCT00633893|20884660|P3|Overall Study|Other|31
6042619|NCT00633893|20884661|P2|Overall Study|Other|33
6042620|NCT00633893|20884662|P1|Overall Study|Other|28
6042621|NCT00633893|20884660|P3|Overall Study|Not meet/no longer meets criteria|4
6042622|NCT00633893|20884661|P2|Overall Study|Not meet/no longer meets criteria|6
6042623|NCT00633893|20884662|P1|Overall Study|Not meet/no longer meets criteria|4
6042624|NCT00633893|20884660|P3|Overall Study|Pregnancy|1
6042625|NCT00633893|20884661|P2|Overall Study|Pregnancy|1
6042626|NCT00633893|20884662|P1|Overall Study|Pregnancy|2
6042627|NCT00633893|20884660|P3|Overall Study|Poor/non-compliance|3
6042628|NCT00633893|20884661|P2|Overall Study|Poor/non-compliance|12
6042629|NCT00633893|20884662|P1|Overall Study|Poor/non-compliance|5
6042630|NCT00633893|20884660|P3|Overall Study|Lost to Follow-up|8
6042631|NCT00633893|20884661|P2|Overall Study|Lost to Follow-up|4
6042632|NCT00633893|20884662|P1|Overall Study|Lost to Follow-up|2
6042633|NCT00633893|20884660|P3|Overall Study|Withdrawal by Subject|6
6042634|NCT00633893|20884661|P2|Overall Study|Withdrawal by Subject|12
6042635|NCT00633893|20884662|P1|Overall Study|Withdrawal by Subject|7
6042636|NCT00633893|20884660|P3|Overall Study|Adverse Event|126
6042637|NCT00633893|20884661|P2|Overall Study|Adverse Event|58
6042638|NCT00633893|20884662|P1|Overall Study|Adverse Event|65
6042639|NCT00633893|20884660|P3|Overall Study|Death|9
6042640|NCT00633893|20884661|P2|Overall Study|Death|3
6042641|NCT00633893|20884662|P1|Overall Study|Death|1
6042642|NCT00633880|20884736|P3|Open Label Titration|Withdrawal by Subject|0
6042643|NCT00633880|20884737|P2|Open Label Titration|Withdrawal by Subject|0
6042644|NCT00633880|20884738|P1|Open Label Titration|Withdrawal by Subject|4
6042645|NCT00633880|20884736|P3|Open Label Titration|Physician Decision|0
6042646|NCT00633880|20884737|P2|Open Label Titration|Physician Decision|0
6042647|NCT00633880|20884738|P1|Open Label Titration|Physician Decision|1
6042648|NCT00633880|20884736|P3|Open Label Titration|Protocol Violation|0
6042649|NCT00633880|20884737|P2|Open Label Titration|Protocol Violation|0
6042650|NCT00633880|20884738|P1|Open Label Titration|Protocol Violation|6
6042651|NCT00633880|20884736|P3|Open Label Titration|Treatment Failure|0
6042652|NCT00633880|20884737|P2|Open Label Titration|Treatment Failure|0
6042653|NCT00633880|20884738|P1|Open Label Titration|Treatment Failure|55
6042654|NCT00633880|20884736|P3|Open Label Titration|Adverse Event|0
6042655|NCT00633880|20884737|P2|Open Label Titration|Adverse Event|0
6042656|NCT00633880|20884738|P1|Open Label Titration|Adverse Event|13
6042657|NCT00633880|20884736|P3|Open Label Titration|Lack of Efficacy|0
6042658|NCT00633880|20884737|P2|Open Label Titration|Lack of Efficacy|0
6042659|NCT00633880|20884738|P1|Open Label Titration|Lack of Efficacy|1
6042660|NCT00633750|20884774|P1|Overall Study|Withdrawal by Subject|3
6042661|NCT00633750|20884774|P1|Overall Study|Adverse Event|2
6042662|NCT00633594|20884783|P3|Overall Study|Disease Progression|1
6042663|NCT00633594|20884784|P2|Overall Study|Disease Progression|0
6042664|NCT00633594|20884785|P1|Overall Study|Disease Progression|0
6042665|NCT00633594|20884783|P3|Overall Study|Death|2
6042666|NCT00633594|20884784|P2|Overall Study|Death|1
6042667|NCT00633594|20884785|P1|Overall Study|Death|0
6042668|NCT00633594|20884783|P3|Overall Study|Adverse Event|7
6042669|NCT00633594|20884784|P2|Overall Study|Adverse Event|4
6042670|NCT00633594|20884785|P1|Overall Study|Adverse Event|0
6042671|NCT00633477|20884814|P2|Overall Study|Randomized but not treated|0
6042672|NCT00633477|20884815|P1|Overall Study|Randomized but not treated|1
6042673|NCT00633477|20884814|P2|Overall Study|Death|0
6042674|NCT00633477|20884815|P1|Overall Study|Death|1
6042675|NCT00633464|20884831|P2|Overall Study|Never Treated (Randomized in error)|1
6042676|NCT00633464|20884832|P1|Overall Study|Never Treated (Randomized in error)|0
6042677|NCT00633464|20884831|P2|Overall Study|Never Treated (Not met study criteria)|1
6042678|NCT00633464|20884832|P1|Overall Study|Never Treated (Not met study criteria)|0
6042679|NCT00633360|20884867|P2|Overall Study|Protocol Violation|1
6042680|NCT00633360|20884868|P1|Overall Study|Protocol Violation|0
6042681|NCT00633360|20884867|P2|Overall Study|Adverse Event|1
6042682|NCT00633360|20884868|P1|Overall Study|Adverse Event|3
6042683|NCT00633360|20884867|P2|Overall Study|Lost to Follow-up|1
6042684|NCT00633360|20884868|P1|Overall Study|Lost to Follow-up|1
6042685|NCT00633243|20884891|P2|Overall Study|Couldn't tolerate side-effects|1
6042686|NCT00633243|20884892|P1|Overall Study|Couldn't tolerate side-effects|1
6042687|NCT00633243|20884891|P2|Overall Study|Mental Health--Depression|1
6042688|NCT00633243|20884892|P1|Overall Study|Mental Health--Depression|0
6042689|NCT00633243|20884891|P2|Overall Study|Not comfortable with self-injecting|1
6042690|NCT00633243|20884892|P1|Overall Study|Not comfortable with self-injecting|0
6042691|NCT00633243|20884891|P2|Overall Study|Homeless--no refrigeration for meds|1
6042692|NCT00633243|20884892|P1|Overall Study|Homeless--no refrigeration for meds|0
6042693|NCT00633243|20884891|P2|Overall Study|incarceration|2
6042694|NCT00633243|20884892|P1|Overall Study|incarceration|0
6042695|NCT00633243|20884891|P2|Overall Study|Withdrawal by Subject|1
6042696|NCT00633243|20884892|P1|Overall Study|Withdrawal by Subject|0
6042697|NCT00633217|20884900|P2|Overall Study|Withdrew Consent|3
6042698|NCT00633217|20884901|P1|Overall Study|Withdrew Consent|3
6042699|NCT00633217|20884900|P2|Overall Study|Investigator Discretion|0
6042700|NCT00633217|20884901|P1|Overall Study|Investigator Discretion|2
6042701|NCT00633217|20884900|P2|Overall Study|Lost to Follow-up|2
6042702|NCT00633217|20884901|P1|Overall Study|Lost to Follow-up|2
6042703|NCT00633217|20884900|P2|Overall Study|Protocol Violation|7
6042704|NCT00633217|20884901|P1|Overall Study|Protocol Violation|3
6042705|NCT00633217|20884900|P2|Overall Study|Lack of Efficacy|2
6042706|NCT00633217|20884901|P1|Overall Study|Lack of Efficacy|0
6042707|NCT00633217|20884900|P2|Overall Study|Adverse Event|9
6042708|NCT00633217|20884901|P1|Overall Study|Adverse Event|5
6042709|NCT00633152|20884913|P2|Overall Study|Miscellaneous Other|2
6042710|NCT00633152|20884914|P1|Overall Study|Miscellaneous Other|3
6042711|NCT00633152|20884913|P2|Overall Study|Lost to Follow-up|1
6042712|NCT00633152|20884914|P1|Overall Study|Lost to Follow-up|4
6042713|NCT00633152|20884913|P2|Overall Study|Withdrawal by Subject|1
6042714|NCT00633152|20884914|P1|Overall Study|Withdrawal by Subject|1
6042715|NCT00633152|20884913|P2|Overall Study|Randomized, did not receive study drug|2
6042716|NCT00633152|20884914|P1|Overall Study|Randomized, did not receive study drug|5
6042717|NCT00633152|20884913|P2|Overall Study|Adverse Event|0
6042718|NCT00633152|20884914|P1|Overall Study|Adverse Event|1
6042719|NCT00633139|20884925|P3|Overall Study|Withdrawal by Subject|0
6042720|NCT00633139|20884926|P2|Overall Study|Withdrawal by Subject|1
6042721|NCT00633139|20884927|P1|Overall Study|Withdrawal by Subject|0
6042722|NCT00633139|20884925|P3|Overall Study|Non compliance|1
6042723|NCT00633139|20884926|P2|Overall Study|Non compliance|0
6042724|NCT00633139|20884927|P1|Overall Study|Non compliance|0
6042725|NCT00633126|20884941|P1|Overall Study|Did not receive full dose|1
6042726|NCT00633074|20884955|P2|Overall Study|Adverse Event|0
6042727|NCT00633074|20884956|P1|Overall Study|Adverse Event|1
6042728|NCT00633061|20884986|P2|Overall Study|Study closed|0
6042729|NCT00633061|20884987|P1|Overall Study|Study closed|86
6042730|NCT00633022|20884998|P3|Overall Study|Physician Decision|0
6042731|NCT00633022|20884999|P2|Overall Study|Physician Decision|1
6042732|NCT00633022|20885000|P1|Overall Study|Physician Decision|0
6042733|NCT00633022|20884998|P3|Overall Study|Adverse Event|5
6042734|NCT00633022|20884999|P2|Overall Study|Adverse Event|0
6042735|NCT00633022|20885000|P1|Overall Study|Adverse Event|1
6042736|NCT00632931|20885062|P3|Part 2|Withdrawal by Subject|3
6042737|NCT00632931|20885063|P2|Part 2|Withdrawal by Subject|0
6042738|NCT00632931|20885064|P1|Part 2|Withdrawal by Subject|0
6042739|NCT00632931|20885062|P3|Part 2|Lack of Efficacy|17
6042740|NCT00632931|20885063|P2|Part 2|Lack of Efficacy|0
6042741|NCT00632931|20885064|P1|Part 2|Lack of Efficacy|0
6042742|NCT00632931|20885062|P3|Part 2|Death|1
6042743|NCT00632931|20885063|P2|Part 2|Death|0
6042744|NCT00632931|20885064|P1|Part 2|Death|0
6042745|NCT00632931|20885062|P3|Part 2|Adverse Event|3
6042746|NCT00632931|20885063|P2|Part 2|Adverse Event|0
6042747|NCT00632931|20885064|P1|Part 2|Adverse Event|0
6042748|NCT00632931|20885062|P3|Part 1, Period 1|Withdrawal by Subject|0
6042749|NCT00632931|20885063|P2|Part 1, Period 1|Withdrawal by Subject|0
6042750|NCT00632931|20885064|P1|Part 1, Period 1|Withdrawal by Subject|1
6042751|NCT00632931|20885062|P3|Part 1, Period 1|Protocol Violation|0
6042752|NCT00632931|20885063|P2|Part 1, Period 1|Protocol Violation|0
6042753|NCT00632931|20885064|P1|Part 1, Period 1|Protocol Violation|1
6042754|NCT00632827|20885083|P1|Overall Study|Lost to Follow-up|1
6042755|NCT00632827|20885083|P1|Overall Study|Adverse Event|5
6042756|NCT00632827|20885083|P1|Overall Study|Death|2
6042757|NCT00632827|20885083|P1|Overall Study|Excluded after GVD (Not evaluable)|2
6042758|NCT00632749|20885141|P14|Overall Study|Reason other than those specified above|2
6042759|NCT00632749|20885142|P13|Overall Study|Reason other than those specified above|0
6042760|NCT00632749|20885143|P12|Overall Study|Reason other than those specified above|1
6042761|NCT00632749|20885144|P11|Overall Study|Reason other than those specified above|2
6042762|NCT00632749|20885145|P10|Overall Study|Reason other than those specified above|0
6042763|NCT00632749|20885146|P9|Overall Study|Reason other than those specified above|0
6042764|NCT00632749|20885147|P8|Overall Study|Reason other than those specified above|0
6042765|NCT00632749|20885148|P7|Overall Study|Reason other than those specified above|1
6042766|NCT00632749|20885149|P6|Overall Study|Reason other than those specified above|0
6042767|NCT00632749|20885150|P5|Overall Study|Reason other than those specified above|1
6042768|NCT00632749|20885151|P4|Overall Study|Reason other than those specified above|0
6042769|NCT00632749|20885152|P3|Overall Study|Reason other than those specified above|0
6042770|NCT00632749|20885153|P2|Overall Study|Reason other than those specified above|2
6042771|NCT00632749|20885154|P1|Overall Study|Reason other than those specified above|0
6042772|NCT00632749|20885141|P14|Overall Study|Refuse to continue medication|0
6042773|NCT00632749|20885142|P13|Overall Study|Refuse to continue medication|0
6042774|NCT00632749|20885143|P12|Overall Study|Refuse to continue medication|0
6042775|NCT00632749|20885144|P11|Overall Study|Refuse to continue medication|0
6042776|NCT00632749|20885145|P10|Overall Study|Refuse to continue medication|1
6042777|NCT00632749|20885146|P9|Overall Study|Refuse to continue medication|0
6042778|NCT00632749|20885147|P8|Overall Study|Refuse to continue medication|0
6042779|NCT00632749|20885148|P7|Overall Study|Refuse to continue medication|0
6042780|NCT00632749|20885149|P6|Overall Study|Refuse to continue medication|0
6042781|NCT00632749|20885150|P5|Overall Study|Refuse to continue medication|0
6042782|NCT00632749|20885151|P4|Overall Study|Refuse to continue medication|1
6042783|NCT00632749|20885152|P3|Overall Study|Refuse to continue medication|0
6042784|NCT00632749|20885153|P2|Overall Study|Refuse to continue medication|0
6042785|NCT00632749|20885154|P1|Overall Study|Refuse to continue medication|0
6042786|NCT00632749|20885141|P14|Overall Study|Other Adverse event|0
6042787|NCT00632749|20885142|P13|Overall Study|Other Adverse event|1
6042788|NCT00632749|20885143|P12|Overall Study|Other Adverse event|0
6042789|NCT00632749|20885144|P11|Overall Study|Other Adverse event|1
6042790|NCT00632749|20885145|P10|Overall Study|Other Adverse event|0
6042791|NCT00632749|20885146|P9|Overall Study|Other Adverse event|2
6042792|NCT00632749|20885147|P8|Overall Study|Other Adverse event|2
6042793|NCT00632749|20885148|P7|Overall Study|Other Adverse event|1
6042794|NCT00632749|20885149|P6|Overall Study|Other Adverse event|4
6042795|NCT00632749|20885150|P5|Overall Study|Other Adverse event|2
6042796|NCT00632749|20885151|P4|Overall Study|Other Adverse event|1
6042797|NCT00632749|20885152|P3|Overall Study|Other Adverse event|1
6042798|NCT00632749|20885153|P2|Overall Study|Other Adverse event|1
6042799|NCT00632749|20885154|P1|Overall Study|Other Adverse event|1
6042800|NCT00632749|20885141|P14|Overall Study|Progressive disease|4
6042801|NCT00632749|20885142|P13|Overall Study|Progressive disease|2
6042802|NCT00632749|20885143|P12|Overall Study|Progressive disease|3
6042803|NCT00632749|20885144|P11|Overall Study|Progressive disease|4
6042804|NCT00632749|20885145|P10|Overall Study|Progressive disease|2
6042805|NCT00632749|20885146|P9|Overall Study|Progressive disease|3
6042806|NCT00632749|20885147|P8|Overall Study|Progressive disease|2
6042807|NCT00632749|20885148|P7|Overall Study|Progressive disease|3
6042808|NCT00632749|20885149|P6|Overall Study|Progressive disease|4
6042809|NCT00632749|20885150|P5|Overall Study|Progressive disease|4
6042810|NCT00632749|20885151|P4|Overall Study|Progressive disease|2
6042811|NCT00632749|20885152|P3|Overall Study|Progressive disease|2
6042812|NCT00632749|20885153|P2|Overall Study|Progressive disease|2
6042813|NCT00632749|20885154|P1|Overall Study|Progressive disease|3
6042814|NCT00632736|20885448|P1|Overall Study|Other|16
6042815|NCT00632736|20885448|P1|Overall Study|Non-compliance|10
6042816|NCT00632736|20885448|P1|Overall Study|Sponsor terminated study|5
6042817|NCT00632736|20885448|P1|Overall Study|Lack of Efficacy|5
6042818|NCT00632736|20885448|P1|Overall Study|Withdrawal by Subject|99
6042819|NCT00632736|20885448|P1|Overall Study|Protocol Violation|14
6042820|NCT00632736|20885448|P1|Overall Study|Lost to Follow-up|15
6042821|NCT00632736|20885448|P1|Overall Study|Adverse Event|104
6042822|NCT00632541|20885483|P1|Overall Study|Adverse Event|7
6042823|NCT00632502|20885492|P2|Overall Study|Randomized not treated|0
6042824|NCT00632502|20885493|P1|Overall Study|Randomized not treated|3
6042825|NCT00632502|20885492|P2|Overall Study|Adverse Event|1
6042826|NCT00632502|20885493|P1|Overall Study|Adverse Event|0
6042827|NCT00632463|20885537|P3|Overall Study|Adverse Event|0
6042828|NCT00632463|20885538|P2|Overall Study|Adverse Event|1
6042829|NCT00632463|20885539|P1|Overall Study|Adverse Event|0
6042830|NCT00632424|20885556|P1|Overall Study|Study Drug Toxicity|1
6042831|NCT00632424|20885556|P1|Overall Study|Disease Progression|17
6042832|NCT00632359|20885587|P1|Overall Study|Withdrawal by Subject|2
6042833|NCT00632229|20885600|P2|Overall Study|Undisclosed reasons within the first wee|1
6042834|NCT00632229|20885601|P1|Overall Study|Undisclosed reasons within the first wee|0
6042835|NCT00632229|20885600|P2|Overall Study|Lack of Efficacy|2
6042836|NCT00632229|20885601|P1|Overall Study|Lack of Efficacy|0
6042837|NCT00632229|20885600|P2|Overall Study|Lost to Follow-up|3
6042838|NCT00632229|20885601|P1|Overall Study|Lost to Follow-up|0
6042839|NCT00632229|20885600|P2|Overall Study|Adverse Event|0
6042840|NCT00632229|20885601|P1|Overall Study|Adverse Event|6
6042841|NCT00632203|20885611|P2|Overall Study|Did not start study treatment|0
6042842|NCT00632203|20885612|P1|Overall Study|Did not start study treatment|1
6042843|NCT00632125|20885630|P1|Overall Study|Moved to other dialysis unit, etc.|102
6042844|NCT00632125|20885630|P1|Overall Study|Development of uncontrolled hypertension|5
6042845|NCT00632125|20885630|P1|Overall Study|Non-compliance|8
6042846|NCT00632125|20885630|P1|Overall Study|Need for systemic immunosuppressive medi|8
6042847|NCT00632125|20885630|P1|Overall Study|Renal transplantation|17
6042848|NCT00632125|20885630|P1|Overall Study|Adverse Event|36
6042849|NCT00632125|20885630|P1|Overall Study|Withdrawal by Subject|44
6042850|NCT00632125|20885630|P1|Overall Study|Death|82
6042851|NCT00632099|20885636|P2|Overall Study|Lost to Follow-up|3
6042852|NCT00632099|20885637|P1|Overall Study|Lost to Follow-up|3
6042853|NCT00632021|20885645|P2|Overall Study|Withdrawal/death|7
6042854|NCT00632021|20885646|P1|Overall Study|Withdrawal/death|4
6042855|NCT00631969|20885656|P2|Overall Study|No Drug Exposure|2
6042856|NCT00631969|20885657|P1|Overall Study|No Drug Exposure|2
6042857|NCT00631969|20885656|P2|Overall Study|Noncompliant With Study Medication|1
6042858|NCT00631969|20885657|P1|Overall Study|Noncompliant With Study Medication|0
6042859|NCT00631969|20885656|P2|Overall Study|Consent Withdrawn|7
6042860|NCT00631969|20885657|P1|Overall Study|Consent Withdrawn|5
6042861|NCT00631969|20885656|P2|Overall Study|Protocol Violation|1
6042862|NCT00631969|20885657|P1|Overall Study|Protocol Violation|1
6042863|NCT00631969|20885656|P2|Overall Study|Lost to Follow-up|1
6042864|NCT00631969|20885657|P1|Overall Study|Lost to Follow-up|2
6042865|NCT00631969|20885656|P2|Overall Study|Lack of Efficacy|8
6042866|NCT00631969|20885657|P1|Overall Study|Lack of Efficacy|2
6042867|NCT00631969|20885656|P2|Overall Study|Adverse Event|1
6042868|NCT00631969|20885657|P1|Overall Study|Adverse Event|3
6042869|NCT00631917|20885703|P2|Overall Study|Death|0
6042870|NCT00631917|20885704|P1|Overall Study|Death|1
6042871|NCT00631917|20885703|P2|Overall Study|Administrative problems|0
6042872|NCT00631917|20885704|P1|Overall Study|Administrative problems|2
6042873|NCT00631917|20885703|P2|Overall Study|Lost to Follow-up|7
6042874|NCT00631917|20885704|P1|Overall Study|Lost to Follow-up|7
6042875|NCT00631917|20885703|P2|Overall Study|Subject withdrew consent|33
6042876|NCT00631917|20885704|P1|Overall Study|Subject withdrew consent|25
6042877|NCT00631917|20885703|P2|Overall Study|Protocol deviation|5
6042878|NCT00631917|20885704|P1|Overall Study|Protocol deviation|6
6042879|NCT00631917|20885703|P2|Overall Study|No longer required study drug|1
6042880|NCT00631917|20885704|P1|Overall Study|No longer required study drug|0
6042881|NCT00631917|20885703|P2|Overall Study|Unsatisfactory therapeutic effect|14
6042882|NCT00631917|20885704|P1|Overall Study|Unsatisfactory therapeutic effect|8
6042883|NCT00631917|20885703|P2|Overall Study|Abnormal test procedure result(s)|2
6042884|NCT00631917|20885704|P1|Overall Study|Abnormal test procedure result(s)|3
6042885|NCT00631917|20885703|P2|Overall Study|Abnormal laboratory value(s)|1
6042886|NCT00631917|20885704|P1|Overall Study|Abnormal laboratory value(s)|2
6042887|NCT00631917|20885703|P2|Overall Study|Adverse Event|45
6042888|NCT00631917|20885704|P1|Overall Study|Adverse Event|34
6042889|NCT00631696|20885731|P2|Overall Study|Adverse Event|0
6042890|NCT00631696|20885732|P1|Overall Study|Adverse Event|5
6042891|NCT00631696|20885731|P2|Overall Study|Study terminated by sponsor|3
6042892|NCT00631696|20885732|P1|Overall Study|Study terminated by sponsor|3
6042893|NCT00631696|20885731|P2|Overall Study|Protocol Violation|9
6042894|NCT00631696|20885732|P1|Overall Study|Protocol Violation|9
6042895|NCT00631696|20885731|P2|Overall Study|Other|8
6042896|NCT00631696|20885732|P1|Overall Study|Other|8
6042897|NCT00631696|20885731|P2|Overall Study|Withdrawal by Subject|9
6042898|NCT00631696|20885732|P1|Overall Study|Withdrawal by Subject|2
6042899|NCT00631696|20885731|P2|Overall Study|Lost to Follow-up|10
6042900|NCT00631696|20885732|P1|Overall Study|Lost to Follow-up|7
6042901|NCT00631696|20885731|P2|Overall Study|Follow up after database release date|0
6042902|NCT00631696|20885732|P1|Overall Study|Follow up after database release date|1
6042903|NCT00631696|20885731|P2|Overall Study|Discontinued after database release date|0
6042904|NCT00631696|20885732|P1|Overall Study|Discontinued after database release date|1
6042905|NCT00631696|20885731|P2|Overall Study|Entered, not randomized to treatment|1
6042906|NCT00631696|20885732|P1|Overall Study|Entered, not randomized to treatment|1
6042907|NCT00631657|20885775|P3|7-Day Discontinuation Period|Other|0
6042908|NCT00631657|20885776|P2|7-Day Discontinuation Period|Other|0
6042909|NCT00631657|20885777|P1|7-Day Discontinuation Period|Other|1
6042910|NCT00631657|20885775|P3|7-Day Discontinuation Period|Not Treated|1
6042911|NCT00631657|20885776|P2|7-Day Discontinuation Period|Not Treated|1
6042912|NCT00631657|20885777|P1|7-Day Discontinuation Period|Not Treated|1
6042913|NCT00631657|20885775|P3|6-Month Treatment Period|Not Treated|1
6042914|NCT00631657|20885776|P2|6-Month Treatment Period|Not Treated|0
6042915|NCT00631657|20885777|P1|6-Month Treatment Period|Not Treated|2
6042916|NCT00631657|20885775|P3|6-Month Treatment Period|Other|4
6042917|NCT00631657|20885776|P2|6-Month Treatment Period|Other|0
6042918|NCT00631657|20885777|P1|6-Month Treatment Period|Other|16
6042919|NCT00631657|20885775|P3|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|6
6042920|NCT00631657|20885776|P2|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|0
6042921|NCT00631657|20885777|P1|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|21
6042922|NCT00631657|20885775|P3|6-Month Treatment Period|Lost to Follow-up|2
6042923|NCT00631657|20885776|P2|6-Month Treatment Period|Lost to Follow-up|0
6042924|NCT00631657|20885777|P1|6-Month Treatment Period|Lost to Follow-up|7
6042925|NCT00631657|20885775|P3|6-Month Treatment Period|Lack of Efficacy|25
6042926|NCT00631657|20885776|P2|6-Month Treatment Period|Lack of Efficacy|0
6042927|NCT00631657|20885777|P1|6-Month Treatment Period|Lack of Efficacy|34
6042928|NCT00631657|20885775|P3|6-Month Treatment Period|Withdrawal by Subject|5
6042929|NCT00631657|20885776|P2|6-Month Treatment Period|Withdrawal by Subject|0
6042930|NCT00631657|20885777|P1|6-Month Treatment Period|Withdrawal by Subject|14
6042931|NCT00631657|20885775|P3|6-Month Treatment Period|Adverse Event|7
6042932|NCT00631657|20885776|P2|6-Month Treatment Period|Adverse Event|0
6042933|NCT00631657|20885777|P1|6-Month Treatment Period|Adverse Event|47
6042934|NCT00631540|20885826|P1|Overall Study|Core Lab Data Unavailable|3
6042935|NCT00631540|20885826|P1|Overall Study|Lost to Follow-up|2
6042936|NCT00631540|20885826|P1|Overall Study|Death|4
6042937|NCT00631540|20885826|P1|Overall Study|Withdrawal by Subject|5
6042938|NCT00631488|20885838|P3|Overall Study|Protocol Violation|1
6042939|NCT00631488|20885839|P2|Overall Study|Protocol Violation|0
6042940|NCT00631488|20885840|P1|Overall Study|Protocol Violation|0
6042941|NCT00631488|20885838|P3|Overall Study|Physician Decision|1
6042942|NCT00631488|20885839|P2|Overall Study|Physician Decision|0
6042943|NCT00631488|20885840|P1|Overall Study|Physician Decision|1
6042944|NCT00631488|20885838|P3|Overall Study|Lost to Follow-up|0
6042945|NCT00631488|20885839|P2|Overall Study|Lost to Follow-up|2
6042946|NCT00631488|20885840|P1|Overall Study|Lost to Follow-up|2
6042947|NCT00631488|20885838|P3|Overall Study|Adverse Event|0
6042948|NCT00631488|20885839|P2|Overall Study|Adverse Event|0
6042949|NCT00631488|20885840|P1|Overall Study|Adverse Event|1
6042950|NCT00631475|20885860|P1|Overall Study|Preparation for lung transplant|8
6042951|NCT00631475|20885860|P1|Overall Study|Withdrew consent|5
6042952|NCT00631475|20885860|P1|Overall Study|Adverse Event|14
6042953|NCT00631475|20885860|P1|Overall Study|Death|18
6042954|NCT00631410|20885881|P2|Overall Study|Surgery|0
6042955|NCT00631410|20885882|P1|Overall Study|Surgery|1
6042956|NCT00631410|20885881|P2|Overall Study|Objective Progression or Relapse|3
6042957|NCT00631410|20885882|P1|Overall Study|Objective Progression or Relapse|4
6042958|NCT00631410|20885881|P2|Overall Study|Adverse Event|3
6042959|NCT00631410|20885882|P1|Overall Study|Adverse Event|1
6042960|NCT00631371|20885901|P2|Overall Study|Death|239
6042961|NCT00631371|20885902|P1|Overall Study|Death|263
6042962|NCT00631371|20885901|P2|Overall Study|Discontinuation of study by Sponsor|76
6042963|NCT00631371|20885902|P1|Overall Study|Discontinuation of study by Sponsor|70
6042964|NCT00631371|20885901|P2|Overall Study|subject request|45
6042965|NCT00631371|20885902|P1|Overall Study|subject request|38
6042966|NCT00631371|20885901|P2|Overall Study|Other reason|12
6042967|NCT00631371|20885902|P1|Overall Study|Other reason|5
6042968|NCT00631371|20885901|P2|Overall Study|Lost to Follow-up|19
6042969|NCT00631371|20885902|P1|Overall Study|Lost to Follow-up|24
6042970|NCT00631189|20885945|P4|Treatment Phase|patient did not take pravastatin|0
6042971|NCT00631189|20885946|P3|Treatment Phase|patient did not take pravastatin|1
6042972|NCT00631189|20885947|P2|Treatment Phase|patient did not take pravastatin|0
6042973|NCT00631189|20885948|P1|Treatment Phase|patient did not take pravastatin|0
6042974|NCT00631189|20885945|P4|Treatment Phase|Pregnancy|0
6042975|NCT00631189|20885946|P3|Treatment Phase|Pregnancy|1
6042976|NCT00631189|20885947|P2|Treatment Phase|Pregnancy|0
6042977|NCT00631189|20885948|P1|Treatment Phase|Pregnancy|0
6042978|NCT00631189|20885945|P4|Treatment Phase|Lost to Follow-up|0
6042979|NCT00631189|20885946|P3|Treatment Phase|Lost to Follow-up|0
6042980|NCT00631189|20885947|P2|Treatment Phase|Lost to Follow-up|1
6042981|NCT00631189|20885948|P1|Treatment Phase|Lost to Follow-up|0
6042982|NCT00631189|20885945|P4|Treatment Phase|Adverse Event|4
6042983|NCT00631189|20885946|P3|Treatment Phase|Adverse Event|2
6042984|NCT00631189|20885947|P2|Treatment Phase|Adverse Event|3
6042985|NCT00631189|20885948|P1|Treatment Phase|Adverse Event|0
6042986|NCT00631189|20885945|P4|Treatment Phase|Protocol Violation|2
6042987|NCT00631189|20885946|P3|Treatment Phase|Protocol Violation|6
6042988|NCT00631189|20885947|P2|Treatment Phase|Protocol Violation|1
6042989|NCT00631189|20885948|P1|Treatment Phase|Protocol Violation|0
6042990|NCT00631189|20885945|P4|Treatment Phase|Withdrawal by Subject|1
6042991|NCT00631189|20885946|P3|Treatment Phase|Withdrawal by Subject|1
6042992|NCT00631189|20885947|P2|Treatment Phase|Withdrawal by Subject|2
6042993|NCT00631189|20885948|P1|Treatment Phase|Withdrawal by Subject|0
6042994|NCT00631189|20885945|P4|Initial Phase|Withdrawal by Subject|0
6042995|NCT00631189|20885946|P3|Initial Phase|Withdrawal by Subject|0
6042996|NCT00631189|20885947|P2|Initial Phase|Withdrawal by Subject|0
6042997|NCT00631189|20885948|P1|Initial Phase|Withdrawal by Subject|4
6042998|NCT00631189|20885945|P4|Initial Phase|Protocol Violation|0
6042999|NCT00631189|20885946|P3|Initial Phase|Protocol Violation|0
6043000|NCT00631189|20885947|P2|Initial Phase|Protocol Violation|0
6043001|NCT00631189|20885948|P1|Initial Phase|Protocol Violation|347
6043002|NCT00631137|20885992|P2|Overall Study|Withdrawal by Subject|0
6043003|NCT00631137|20885993|P1|Overall Study|Withdrawal by Subject|1
6043004|NCT00631020|20886011|P1|Overall Study|Incarcerated|1
6043005|NCT00631020|20886011|P1|Overall Study|Lost to Follow-up|7
6043006|NCT00631007|20886026|P6|Overall Study|Other|0
6043007|NCT00631007|20886027|P5|Overall Study|Other|1
6043008|NCT00631007|20886028|P4|Overall Study|Other|0
6043009|NCT00631007|20886029|P3|Overall Study|Other|0
6043010|NCT00631007|20886030|P2|Overall Study|Other|1
6043011|NCT00631007|20886031|P1|Overall Study|Other|2
6043012|NCT00631007|20886026|P6|Overall Study|Withdrawal by Subject|3
6043013|NCT00631007|20886027|P5|Overall Study|Withdrawal by Subject|1
6043014|NCT00631007|20886028|P4|Overall Study|Withdrawal by Subject|2
6043015|NCT00631007|20886029|P3|Overall Study|Withdrawal by Subject|2
6043016|NCT00631007|20886030|P2|Overall Study|Withdrawal by Subject|5
6043017|NCT00631007|20886031|P1|Overall Study|Withdrawal by Subject|4
6043018|NCT00631007|20886026|P6|Overall Study|Persistent Hyperglycemia|5
6043019|NCT00631007|20886027|P5|Overall Study|Persistent Hyperglycemia|2
6043020|NCT00631007|20886028|P4|Overall Study|Persistent Hyperglycemia|1
6043021|NCT00631007|20886029|P3|Overall Study|Persistent Hyperglycemia|5
6043022|NCT00631007|20886030|P2|Overall Study|Persistent Hyperglycemia|2
6043023|NCT00631007|20886031|P1|Overall Study|Persistent Hyperglycemia|2
6043024|NCT00631007|20886026|P6|Overall Study|Physician Decision|2
6043025|NCT00631007|20886027|P5|Overall Study|Physician Decision|0
6043026|NCT00631007|20886028|P4|Overall Study|Physician Decision|0
6043027|NCT00631007|20886029|P3|Overall Study|Physician Decision|1
6043028|NCT00631007|20886030|P2|Overall Study|Physician Decision|0
6043029|NCT00631007|20886031|P1|Overall Study|Physician Decision|1
6043030|NCT00631007|20886026|P6|Overall Study|Lost to Follow-up|3
6043031|NCT00631007|20886027|P5|Overall Study|Lost to Follow-up|5
6043032|NCT00631007|20886028|P4|Overall Study|Lost to Follow-up|4
6043033|NCT00631007|20886029|P3|Overall Study|Lost to Follow-up|2
6043034|NCT00631007|20886030|P2|Overall Study|Lost to Follow-up|1
6043035|NCT00631007|20886031|P1|Overall Study|Lost to Follow-up|2
6043036|NCT00631007|20886026|P6|Overall Study|Adverse Event|2
6043037|NCT00631007|20886027|P5|Overall Study|Adverse Event|3
6043038|NCT00631007|20886028|P4|Overall Study|Adverse Event|2
6043039|NCT00631007|20886029|P3|Overall Study|Adverse Event|0
6043040|NCT00631007|20886030|P2|Overall Study|Adverse Event|2
6043041|NCT00631007|20886031|P1|Overall Study|Adverse Event|0
6043042|NCT00630994|20886051|P1|Overall Study|Other|1
6043043|NCT00630994|20886051|P1|Overall Study|Lack of Efficacy|1
6043044|NCT00630994|20886051|P1|Overall Study|Disease Progression|1
6043045|NCT00630994|20886051|P1|Overall Study|Adverse Event|1
6043046|NCT00630916|20886081|P1|Overall Study|Lack of Efficacy|3
6043047|NCT00630916|20886081|P1|Overall Study|Physician Decision|47
6043048|NCT00630916|20886081|P1|Overall Study|Protocol Violation|7
6043049|NCT00630916|20886081|P1|Overall Study|Withdrawal by Subject|30
6043050|NCT00630916|20886081|P1|Overall Study|Lost to Follow-up|5
6043051|NCT00630916|20886081|P1|Overall Study|Explant|8
6043052|NCT00630916|20886081|P1|Overall Study|Death|110
6043053|NCT00630877|20886091|P3|Overall Study|Personal reasons|1
6043054|NCT00630877|20886092|P2|Overall Study|Personal reasons|0
6043055|NCT00630877|20886093|P1|Overall Study|Personal reasons|0
6043056|NCT00630877|20886091|P3|Overall Study|Protocol violation|1
6043057|NCT00630877|20886092|P2|Overall Study|Protocol violation|0
6043058|NCT00630877|20886093|P1|Overall Study|Protocol violation|1
6043059|NCT00630877|20886091|P3|Overall Study|Noncompliance|1
6043060|NCT00630877|20886092|P2|Overall Study|Noncompliance|3
6043061|NCT00630877|20886093|P1|Overall Study|Noncompliance|2
6043062|NCT00630877|20886091|P3|Overall Study|Lost to Follow-up|0
6043063|NCT00630877|20886092|P2|Overall Study|Lost to Follow-up|0
6043064|NCT00630877|20886093|P1|Overall Study|Lost to Follow-up|2
6043065|NCT00630877|20886091|P3|Overall Study|Withdrawal by Subject|0
6043066|NCT00630877|20886092|P2|Overall Study|Withdrawal by Subject|4
6043067|NCT00630877|20886093|P1|Overall Study|Withdrawal by Subject|3
6043068|NCT00630877|20886091|P3|Overall Study|Adverse Event|7
6043069|NCT00630877|20886092|P2|Overall Study|Adverse Event|8
6043070|NCT00630877|20886093|P1|Overall Study|Adverse Event|11
6043071|NCT00630864|20886111|P1|Part 2 (After Week 6 up to Month 12)|Liver transplant|2
6043072|NCT00630864|20886111|P1|Part 1 (up to Week 6)|Adverse Event|1
6043073|NCT00630838|20886150|P2|Overall Study|Lost to Follow-up|1
6043074|NCT00630838|20886151|P1|Overall Study|Lost to Follow-up|0
6043075|NCT00630838|20886150|P2|Overall Study|Death|1
6043076|NCT00630838|20886151|P1|Overall Study|Death|0
6043077|NCT00630825|20886163|P4|Overall Study|Withdrawal by Subject|3
6043078|NCT00630825|20886164|P3|Overall Study|Withdrawal by Subject|2
6043079|NCT00630825|20886165|P2|Overall Study|Withdrawal by Subject|2
6043080|NCT00630825|20886166|P1|Overall Study|Withdrawal by Subject|2
6043081|NCT00630825|20886163|P4|Overall Study|Physician Decision|0
6043082|NCT00630825|20886164|P3|Overall Study|Physician Decision|0
6043083|NCT00630825|20886165|P2|Overall Study|Physician Decision|0
6043084|NCT00630825|20886166|P1|Overall Study|Physician Decision|1
6043085|NCT00630825|20886163|P4|Overall Study|Lost to Follow-up|1
6043086|NCT00630825|20886164|P3|Overall Study|Lost to Follow-up|1
6043087|NCT00630825|20886165|P2|Overall Study|Lost to Follow-up|1
6043088|NCT00630825|20886166|P1|Overall Study|Lost to Follow-up|1
6043089|NCT00630825|20886163|P4|Overall Study|Entry Criteria Not Met|1
6043090|NCT00630825|20886164|P3|Overall Study|Entry Criteria Not Met|2
6043091|NCT00630825|20886165|P2|Overall Study|Entry Criteria Not Met|0
6043092|NCT00630825|20886166|P1|Overall Study|Entry Criteria Not Met|1
6043093|NCT00630825|20886163|P4|Overall Study|Adverse Event|1
6043094|NCT00630825|20886164|P3|Overall Study|Adverse Event|3
6043095|NCT00630825|20886165|P2|Overall Study|Adverse Event|4
6043096|NCT00630825|20886166|P1|Overall Study|Adverse Event|4
6043097|NCT00630812|20886237|P2|Double Blind Treatment Period|Non-compliance|1
6043098|NCT00630812|20886238|P1|Double Blind Treatment Period|Non-compliance|0
6043099|NCT00630812|20886237|P2|Double Blind Treatment Period|Wanted to take drug in non-protocol way|0
6043100|NCT00630812|20886238|P1|Double Blind Treatment Period|Wanted to take drug in non-protocol way|1
6043101|NCT00630812|20886237|P2|Double Blind Treatment Period|Withdrawal by Subject|7
6043102|NCT00630812|20886238|P1|Double Blind Treatment Period|Withdrawal by Subject|13
6043103|NCT00630812|20886237|P2|Double Blind Treatment Period|Protocol Violation|0
6043104|NCT00630812|20886238|P1|Double Blind Treatment Period|Protocol Violation|1
6043105|NCT00630812|20886237|P2|Double Blind Treatment Period|Physician Decision|1
6043106|NCT00630812|20886238|P1|Double Blind Treatment Period|Physician Decision|2
6043107|NCT00630812|20886237|P2|Double Blind Treatment Period|Lost to Follow-up|0
6043108|NCT00630812|20886238|P1|Double Blind Treatment Period|Lost to Follow-up|1
6043109|NCT00630812|20886237|P2|Double Blind Treatment Period|Adverse Event|5
6043110|NCT00630812|20886238|P1|Double Blind Treatment Period|Adverse Event|13
6043111|NCT00630812|20886237|P2|Randomisation to First Dose|Protocol Violation|1
6043112|NCT00630812|20886238|P1|Randomisation to First Dose|Protocol Violation|4
6043113|NCT00630812|20886237|P2|Randomisation to First Dose|Lost to Follow-up|0
6043114|NCT00630812|20886238|P1|Randomisation to First Dose|Lost to Follow-up|1
6043115|NCT00630812|20886237|P2|Randomisation to First Dose|Withdrawal by Subject|3
6043116|NCT00630812|20886238|P1|Randomisation to First Dose|Withdrawal by Subject|2
6043117|NCT00630812|20886237|P2|Randomisation to First Dose|Adverse Event|1
6043118|NCT00630812|20886238|P1|Randomisation to First Dose|Adverse Event|1
6043119|NCT00630786|20886263|P3|Overall Study|Other|0
6043120|NCT00630786|20886264|P2|Overall Study|Other|0
6043121|NCT00630786|20886265|P1|Overall Study|Other|1
6043122|NCT00630786|20886263|P3|Overall Study|Lost to Follow-up|0
6043123|NCT00630786|20886264|P2|Overall Study|Lost to Follow-up|1
6043124|NCT00630786|20886265|P1|Overall Study|Lost to Follow-up|0
6043125|NCT00630786|20886263|P3|Overall Study|Withdrawal by Subject|1
6043126|NCT00630786|20886264|P2|Overall Study|Withdrawal by Subject|1
6043127|NCT00630786|20886265|P1|Overall Study|Withdrawal by Subject|0
6043128|NCT00630786|20886263|P3|Overall Study|Physician Decision|1
6043129|NCT00630786|20886264|P2|Overall Study|Physician Decision|0
6043130|NCT00630786|20886265|P1|Overall Study|Physician Decision|0
6043131|NCT00630747|20886284|P1|Overall Study|Returned to country of origin|1
6043132|NCT00630747|20886284|P1|Overall Study|Transferred to Study TKT031NPU|7
6043133|NCT00630747|20886284|P1|Overall Study|Death|1
6043134|NCT00630539|20886337|P4|Overall Study|Withdrawal by Subject|1
6043135|NCT00630539|20886338|P3|Overall Study|Withdrawal by Subject|0
6043136|NCT00630539|20886339|P2|Overall Study|Withdrawal by Subject|1
6043137|NCT00630539|20886340|P1|Overall Study|Withdrawal by Subject|0
6043138|NCT00630539|20886337|P4|Overall Study|Adverse Event|2
6043139|NCT00630539|20886338|P3|Overall Study|Adverse Event|1
6043140|NCT00630539|20886339|P2|Overall Study|Adverse Event|3
6043141|NCT00630539|20886340|P1|Overall Study|Adverse Event|1
6043142|NCT00630396|20886436|P1|Overall Study|Lost to Follow-up|3
6043143|NCT00630396|20886436|P1|Overall Study|Death|4
6043144|NCT00630344|20886442|P1|Overall Study|Other|1
6043145|NCT00630344|20886442|P1|Overall Study|Intercurrent Illness|1
6043146|NCT00630344|20886442|P1|Overall Study|Withdrawal by Subject|1
6043147|NCT00630344|20886442|P1|Overall Study|Physician Decision|9
6043148|NCT00630344|20886442|P1|Overall Study|Progressive Disease|19
6043149|NCT00630344|20886442|P1|Overall Study|Adverse Event|5
6043150|NCT00630331|20886454|P3|Overall Study|Protocol Violation|6
6043151|NCT00630331|20886455|P2|Overall Study|Protocol Violation|5
6043152|NCT00630331|20886456|P1|Overall Study|Protocol Violation|4
6043153|NCT00630331|20886454|P3|Overall Study|Unable to classify|3
6043154|NCT00630331|20886455|P2|Overall Study|Unable to classify|4
6043155|NCT00630331|20886456|P1|Overall Study|Unable to classify|9
6043156|NCT00630331|20886454|P3|Overall Study|Inappropriate enrollment|3
6043157|NCT00630331|20886455|P2|Overall Study|Inappropriate enrollment|6
6043158|NCT00630331|20886456|P1|Overall Study|Inappropriate enrollment|3
6043159|NCT00630331|20886454|P3|Overall Study|Lost to Follow-up|170
6043160|NCT00630331|20886455|P2|Overall Study|Lost to Follow-up|143
6043161|NCT00630331|20886456|P1|Overall Study|Lost to Follow-up|175
6043162|NCT00630331|20886454|P3|Overall Study|Withdrawal by Subject|5
6043163|NCT00630331|20886455|P2|Overall Study|Withdrawal by Subject|7
6043164|NCT00630331|20886456|P1|Overall Study|Withdrawal by Subject|12
6043165|NCT00630331|20886454|P3|Overall Study|Adverse Event|0
6043166|NCT00630331|20886455|P2|Overall Study|Adverse Event|0
6043167|NCT00630331|20886456|P1|Overall Study|Adverse Event|1
6043168|NCT00630331|20886454|P3|Overall Study|Death|1
6043169|NCT00630331|20886455|P2|Overall Study|Death|1
6043170|NCT00630331|20886456|P1|Overall Study|Death|2
6043171|NCT00630305|20886497|P1|Overall Study|Inability to insert contact lens|1
6043172|NCT00630305|20886497|P1|Overall Study|Withdrawal by Subject|1
6043173|NCT00630292|20886519|P1|Overall Study|Withdrawal by Subject|1
6043174|NCT00630058|20886525|P2|Overall Study|stopping criteria|2
6043175|NCT00630058|20886526|P1|Overall Study|stopping criteria|3
6043176|NCT00630058|20886525|P2|Overall Study|Withdrawal by Subject|1
6043177|NCT00630058|20886526|P1|Overall Study|Withdrawal by Subject|0
6043178|NCT00630058|20886525|P2|Overall Study|Adverse Event|1
6043179|NCT00630058|20886526|P1|Overall Study|Adverse Event|1
6043180|NCT00629772|20886557|P2|Second Intervention Week 14 - Week 26|Lack of Efficacy|1
6043181|NCT00629772|20886558|P1|Second Intervention Week 14 - Week 26|Lack of Efficacy|0
6043182|NCT00629772|20886557|P2|Second Intervention Week 14 - Week 26|Adverse Event|1
6043183|NCT00629772|20886558|P1|Second Intervention Week 14 - Week 26|Adverse Event|1
6043184|NCT00629707|20886578|P2|Overall Study|Physician Decision|1
6043185|NCT00629707|20886579|P1|Overall Study|Physician Decision|0
6043186|NCT00629707|20886578|P2|Overall Study|Withdrawal by Subject|1
6043187|NCT00629707|20886579|P1|Overall Study|Withdrawal by Subject|0
6043188|NCT00629265|20886599|P2|Overall Study|Unknown Reason|2
6043189|NCT00629265|20886600|P1|Overall Study|Unknown Reason|2
6043190|NCT00629265|20886599|P2|Overall Study|Unrelated Medical Complications|1
6043191|NCT00629265|20886600|P1|Overall Study|Unrelated Medical Complications|3
6043192|NCT00629265|20886599|P2|Overall Study|Needed Esophageal Dilation|1
6043193|NCT00629265|20886600|P1|Overall Study|Needed Esophageal Dilation|4
6043194|NCT00629265|20886599|P2|Overall Study|Other CA Requiring Treatment|3
6043195|NCT00629265|20886600|P1|Overall Study|Other CA Requiring Treatment|1
6043196|NCT00629265|20886599|P2|Overall Study|HNC Recurrence|0
6043197|NCT00629265|20886600|P1|Overall Study|HNC Recurrence|4
6043198|NCT00629265|20886599|P2|Overall Study|Adverse Event|0
6043199|NCT00629265|20886600|P1|Overall Study|Adverse Event|2
6043200|NCT00629265|20886599|P2|Overall Study|Death|0
6043201|NCT00629265|20886600|P1|Overall Study|Death|1
6043202|NCT00629265|20886599|P2|Overall Study|Withdrawal by Subject|8
6043203|NCT00629265|20886600|P1|Overall Study|Withdrawal by Subject|11
6043204|NCT00629265|20886599|P2|Overall Study|Lost to Follow-up|5
6043205|NCT00629265|20886600|P1|Overall Study|Lost to Follow-up|4
6043206|NCT00629239|20886610|P2|Overall Study|Physician Decision|0
6043207|NCT00629239|20886611|P1|Overall Study|Physician Decision|1
6043208|NCT00629239|20886610|P2|Overall Study|Adverse Event|4
6043209|NCT00629239|20886611|P1|Overall Study|Adverse Event|7
6043210|NCT00629083|20886664|P2|Overall Study|Refused to return for 12 month visit|0
6043211|NCT00629083|20886665|P1|Overall Study|Refused to return for 12 month visit|1
6043212|NCT00629083|20886664|P2|Overall Study|Moved out of country/state|1
6043213|NCT00629083|20886665|P1|Overall Study|Moved out of country/state|2
6043214|NCT00629083|20886664|P2|Overall Study|Lost to Follow-up|8
6043215|NCT00629083|20886665|P1|Overall Study|Lost to Follow-up|12
6043216|NCT00629083|20886664|P2|Overall Study|Withdrawal by Subject|2
6043217|NCT00629083|20886665|P1|Overall Study|Withdrawal by Subject|10
6043218|NCT00629083|20886664|P2|Overall Study|Lack of Efficacy|1
6043219|NCT00629083|20886665|P1|Overall Study|Lack of Efficacy|3
6043220|NCT00629083|20886664|P2|Overall Study|Adverse Event|2
6043221|NCT00629083|20886665|P1|Overall Study|Adverse Event|0
6043222|NCT00628927|20886696|P2|Overall Study|Equipment failure|0
6043223|NCT00628927|20886697|P1|Overall Study|Equipment failure|1
6043224|NCT00628927|20886696|P2|Overall Study|Lost to Follow-up|0
6043225|NCT00628927|20886697|P1|Overall Study|Lost to Follow-up|1
6043226|NCT00628927|20886696|P2|Overall Study|Problems performing blood draw|0
6043227|NCT00628927|20886697|P1|Overall Study|Problems performing blood draw|6
6043228|NCT00628862|20886742|P3|Overall Study|COPD Exacerbation|0
6043229|NCT00628862|20886743|P2|Overall Study|COPD Exacerbation|1
6043230|NCT00628862|20886744|P1|Overall Study|COPD Exacerbation|0
6043231|NCT00628862|20886742|P3|Overall Study|Protocol Violation|0
6043232|NCT00628862|20886743|P2|Overall Study|Protocol Violation|0
6043233|NCT00628862|20886744|P1|Overall Study|Protocol Violation|1
6043234|NCT00628862|20886742|P3|Overall Study|Lost to Follow-up|1
6043235|NCT00628862|20886743|P2|Overall Study|Lost to Follow-up|2
6043236|NCT00628862|20886744|P1|Overall Study|Lost to Follow-up|0
6043237|NCT00628862|20886742|P3|Overall Study|Withdrawal by Subject|11
6043238|NCT00628862|20886743|P2|Overall Study|Withdrawal by Subject|6
6043239|NCT00628862|20886744|P1|Overall Study|Withdrawal by Subject|4
6043240|NCT00628862|20886742|P3|Overall Study|Adverse Event|10
6043241|NCT00628862|20886743|P2|Overall Study|Adverse Event|8
6043242|NCT00628862|20886744|P1|Overall Study|Adverse Event|6
6043243|NCT00628758|20886790|P2|Overall Study|Treatment Failure|2
6043244|NCT00628758|20886791|P1|Overall Study|Treatment Failure|0
6043245|NCT00628758|20886790|P2|Overall Study|Investigator Moved|0
6043246|NCT00628758|20886791|P1|Overall Study|Investigator Moved|3
6043247|NCT00628758|20886790|P2|Overall Study|Pregnancy|2
6043248|NCT00628758|20886791|P1|Overall Study|Pregnancy|2
6043249|NCT00628758|20886790|P2|Overall Study|Lost to Follow-up|31
6043250|NCT00628758|20886791|P1|Overall Study|Lost to Follow-up|25
6043251|NCT00628758|20886790|P2|Overall Study|Protocol Violation|1
6043252|NCT00628758|20886791|P1|Overall Study|Protocol Violation|5
6043253|NCT00628758|20886790|P2|Overall Study|Death|0
6043254|NCT00628758|20886791|P1|Overall Study|Death|1
6043255|NCT00628758|20886790|P2|Overall Study|Withdrawal by Subject|3
6043256|NCT00628758|20886791|P1|Overall Study|Withdrawal by Subject|6
6043257|NCT00628758|20886790|P2|Overall Study|Adverse Event|3
6043258|NCT00628758|20886791|P1|Overall Study|Adverse Event|2
6043259|NCT00628446|20886835|P1|Overall Study|Protocol Violation|3
6043260|NCT00628446|20886835|P1|Overall Study|Withdrawal by Subject|1
6043261|NCT00628446|20886835|P1|Overall Study|Lost to Follow-up|3
6043262|NCT00628355|20886867|P2|Overall Study|Withdrawal by Subject|1
6043263|NCT00628355|20886868|P1|Overall Study|Withdrawal by Subject|1
6043264|NCT00628251|20886879|P3|Ongoing Initial Study Treatment at DCO|Other|2
6043265|NCT00628251|20886880|P2|Ongoing Initial Study Treatment at DCO|Other|0
6043266|NCT00628251|20886881|P1|Ongoing Initial Study Treatment at DCO|Other|1
6043267|NCT00628251|20886879|P3|Ongoing Initial Study Treatment at DCO|Other reason|6
6043268|NCT00628251|20886880|P2|Ongoing Initial Study Treatment at DCO|Other reason|1
6043269|NCT00628251|20886881|P1|Ongoing Initial Study Treatment at DCO|Other reason|0
6043270|NCT00628251|20886879|P3|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1
6043271|NCT00628251|20886880|P2|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|2
6043272|NCT00628251|20886881|P1|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1
6043273|NCT00628251|20886879|P3|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|13
6043274|NCT00628251|20886880|P2|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|15
6043275|NCT00628251|20886881|P1|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|19
6043276|NCT00628251|20886879|P3|Ongoing Initial Study Treatment at DCO|Adverse Event|3
6043277|NCT00628251|20886880|P2|Ongoing Initial Study Treatment at DCO|Adverse Event|2
6043278|NCT00628251|20886881|P1|Ongoing Initial Study Treatment at DCO|Adverse Event|1
6043279|NCT00628251|20886879|P3|Randomised Part|Withdrawal by Subject|1
6043280|NCT00628251|20886880|P2|Randomised Part|Withdrawal by Subject|0
6043281|NCT00628251|20886881|P1|Randomised Part|Withdrawal by Subject|0
6043282|NCT00628212|20886927|P4|Overall Study|Physician Decision|3
6043283|NCT00628212|20886928|P3|Overall Study|Physician Decision|2
6043284|NCT00628212|20886929|P2|Overall Study|Physician Decision|1
6043285|NCT00628212|20886930|P1|Overall Study|Physician Decision|1
6043286|NCT00628212|20886927|P4|Overall Study|Adverse Event|2
6043287|NCT00628212|20886928|P3|Overall Study|Adverse Event|1
6043288|NCT00628212|20886929|P2|Overall Study|Adverse Event|0
6043289|NCT00628212|20886930|P1|Overall Study|Adverse Event|2
6043290|NCT00628108|20886978|P2|Overall Study|Withdrawal by Subject|0
6043291|NCT00628108|20886979|P1|Overall Study|Withdrawal by Subject|1
6043292|NCT00628108|20886978|P2|Overall Study|Adverse Event|3
6043293|NCT00628108|20886979|P1|Overall Study|Adverse Event|0
6043294|NCT00628030|20887011|P2|Post to 6 Month Follow-up|Lost to Follow-up|30
6043295|NCT00628030|20887012|P1|Post to 6 Month Follow-up|Lost to Follow-up|32
6043296|NCT00628030|20887011|P2|Baseline to Post-Assessment|Withdrawal by Subject|0
6043297|NCT00628030|20887012|P1|Baseline to Post-Assessment|Withdrawal by Subject|5
6043298|NCT00628030|20887011|P2|Baseline to Post-Assessment|Lost to Follow-up|29
6043299|NCT00628030|20887012|P1|Baseline to Post-Assessment|Lost to Follow-up|28
6043300|NCT00627926|20887038|P3|Overall Study|Noncompliance/unspecified|17
6043301|NCT00627926|20887039|P2|Overall Study|Noncompliance/unspecified|23
6043302|NCT00627926|20887040|P1|Overall Study|Noncompliance/unspecified|8
6043303|NCT00627926|20887038|P3|Overall Study|Lack of Efficacy|38
6043304|NCT00627926|20887039|P2|Overall Study|Lack of Efficacy|40
6043305|NCT00627926|20887040|P1|Overall Study|Lack of Efficacy|118
6043306|NCT00627926|20887038|P3|Overall Study|Withdrawal by Subject|0
6043307|NCT00627926|20887039|P2|Overall Study|Withdrawal by Subject|1
6043308|NCT00627926|20887040|P1|Overall Study|Withdrawal by Subject|2
6043309|NCT00627926|20887038|P3|Overall Study|Lost to Follow-up|4
6043310|NCT00627926|20887039|P2|Overall Study|Lost to Follow-up|3
6043311|NCT00627926|20887040|P1|Overall Study|Lost to Follow-up|4
6043312|NCT00627926|20887038|P3|Overall Study|Death|0
6043313|NCT00627926|20887039|P2|Overall Study|Death|0
6043314|NCT00627926|20887040|P1|Overall Study|Death|1
6043315|NCT00627926|20887038|P3|Overall Study|Adverse Event|36
6043316|NCT00627926|20887039|P2|Overall Study|Adverse Event|37
6043317|NCT00627926|20887040|P1|Overall Study|Adverse Event|26
6043318|NCT00627705|20887092|P2|Overall Study|Lost to Follow-up|1
6043319|NCT00627705|20887093|P1|Overall Study|Lost to Follow-up|0
6043320|NCT00627705|20887092|P2|Overall Study|Withdrawal by Subject|2
6043321|NCT00627705|20887093|P1|Overall Study|Withdrawal by Subject|0
6043322|NCT00627705|20887092|P2|Overall Study|Adverse Event|0
6043323|NCT00627705|20887093|P1|Overall Study|Adverse Event|1
6043324|NCT00627705|20887092|P2|Overall Study|Unwilling to take the compound (taste)|3
6043325|NCT00627705|20887093|P1|Overall Study|Unwilling to take the compound (taste)|1
6043326|NCT00627523|20887144|P2|Overall Study|Other|0
6043327|NCT00627523|20887145|P1|Overall Study|Other|1
6043328|NCT00627523|20887144|P2|Overall Study|Withdrawal by Subject|2
6043329|NCT00627523|20887145|P1|Overall Study|Withdrawal by Subject|0
6043330|NCT00627523|20887144|P2|Overall Study|Lack of Efficacy|0
6043331|NCT00627523|20887145|P1|Overall Study|Lack of Efficacy|1
6043332|NCT00627497|20887173|P4|Overall Study|Lost to Follow-up|0
6043333|NCT00627497|20887174|P3|Overall Study|Lost to Follow-up|0
6043334|NCT00627497|20887175|P2|Overall Study|Lost to Follow-up|1
6043335|NCT00627497|20887176|P1|Overall Study|Lost to Follow-up|1
6043336|NCT00627458|20887237|P3|Overall Study|Lost to Follow-up|0
6043337|NCT00627458|20887238|P2|Overall Study|Lost to Follow-up|1
6043338|NCT00627458|20887239|P1|Overall Study|Lost to Follow-up|1
6043339|NCT00627458|20887237|P3|Overall Study|Withdrawal by Subject|5
6043340|NCT00627458|20887238|P2|Overall Study|Withdrawal by Subject|6
6043341|NCT00627458|20887239|P1|Overall Study|Withdrawal by Subject|2
6043342|NCT00627458|20887237|P3|Overall Study|Migrated from study area|1
6043343|NCT00627458|20887238|P2|Overall Study|Migrated from study area|0
6043344|NCT00627458|20887239|P1|Overall Study|Migrated from study area|1
6043345|NCT00627445|20887314|P2|Overall Study|Other|8
6043346|NCT00627445|20887315|P1|Overall Study|Other|6
6043347|NCT00627445|20887314|P2|Overall Study|Lack of Efficacy|1
6043348|NCT00627445|20887315|P1|Overall Study|Lack of Efficacy|0
6043349|NCT00627445|20887314|P2|Overall Study|Adverse Event|3
6043350|NCT00627445|20887315|P1|Overall Study|Adverse Event|3
6043351|NCT00627393|20887358|P2|Per-Protocol Analysis|Withdrawal by patient/family/physician|10
6043352|NCT00627393|20887359|P1|Per-Protocol Analysis|Withdrawal by patient/family/physician|4
6043353|NCT00627393|20887358|P2|Per-Protocol Analysis|Received unstimulated/no granulocytes|3
6043354|NCT00627393|20887359|P1|Per-Protocol Analysis|Received unstimulated/no granulocytes|6
6043355|NCT00627393|20887358|P2|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|5
6043356|NCT00627393|20887359|P1|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|4
6043357|NCT00627393|20887358|P2|Intention-To-Treat Analysis|Adjudication indeterminate|3
6043358|NCT00627393|20887359|P1|Intention-To-Treat Analysis|Adjudication indeterminate|5
6043359|NCT00627094|20887395|P2|Overall Study|Other reason|0
6043360|NCT00627094|20887396|P1|Overall Study|Other reason|1
6043361|NCT00627094|20887395|P2|Overall Study|ulcer healed|7
6043362|NCT00627094|20887396|P1|Overall Study|ulcer healed|1
6043363|NCT00627094|20887395|P2|Overall Study|Withdrawal by Subject|1
6043364|NCT00627094|20887396|P1|Overall Study|Withdrawal by Subject|1
6043365|NCT00627094|20887395|P2|Overall Study|Lost to Follow-up|0
6043366|NCT00627094|20887396|P1|Overall Study|Lost to Follow-up|1
6043367|NCT00627094|20887395|P2|Overall Study|Adverse Event|7
6043368|NCT00627094|20887396|P1|Overall Study|Adverse Event|8
6043369|NCT00627042|20887408|P1|Overall Study|Withdrawal by Subject|2
6043370|NCT00627016|20887420|P2|Overall Study|Pregnancy|0
6043371|NCT00627016|20887421|P1|Overall Study|Pregnancy|1
6043372|NCT00627016|20887420|P2|Overall Study|Placed on Excluded Drugs|0
6043373|NCT00627016|20887421|P1|Overall Study|Placed on Excluded Drugs|1
6043374|NCT00627016|20887420|P2|Overall Study|Lack of Efficacy|0
6043375|NCT00627016|20887421|P1|Overall Study|Lack of Efficacy|1
6043376|NCT00627016|20887420|P2|Overall Study|Failed Inclusion/Exclusion Criteria|1
6043377|NCT00627016|20887421|P1|Overall Study|Failed Inclusion/Exclusion Criteria|0
6043378|NCT00627016|20887420|P2|Overall Study|Withdrawal by Subject|1
6043379|NCT00627016|20887421|P1|Overall Study|Withdrawal by Subject|2
6043380|NCT00627016|20887420|P2|Overall Study|Lost to Follow-up|1
6043381|NCT00627016|20887421|P1|Overall Study|Lost to Follow-up|0
6043382|NCT00627016|20887420|P2|Overall Study|Protocol Violation|2
6043383|NCT00627016|20887421|P1|Overall Study|Protocol Violation|0
6043384|NCT00627016|20887420|P2|Overall Study|Adverse Event|1
6043385|NCT00627016|20887421|P1|Overall Study|Adverse Event|1
6043386|NCT00626925|20887433|P2|Overall Study|Time constraints|1
6043387|NCT00626925|20887434|P1|Overall Study|Time constraints|3
6043388|NCT00626925|20887433|P2|Overall Study|Lack of Efficacy|4
6043389|NCT00626925|20887434|P1|Overall Study|Lack of Efficacy|1
6043390|NCT00626925|20887433|P2|Overall Study|Adverse effect|2
6043391|NCT00626925|20887434|P1|Overall Study|Adverse effect|6
6043392|NCT00626925|20887433|P2|Overall Study|relapse|0
6043393|NCT00626925|20887434|P1|Overall Study|relapse|1
6043394|NCT00626925|20887433|P2|Overall Study|Lost to Follow-up|2
6043395|NCT00626925|20887434|P1|Overall Study|Lost to Follow-up|1
6043396|NCT00626821|20887508|P1|Overall Study|other/unknown reason|104
6043397|NCT00626821|20887508|P1|Overall Study|Product dysfunction|21
6043398|NCT00626821|20887508|P1|Overall Study|Physician Decision|9
6043399|NCT00626821|20887508|P1|Overall Study|Withdrawal by Subject|10
6043400|NCT00626821|20887508|P1|Overall Study|Protocol Violation|33
6043401|NCT00626821|20887508|P1|Overall Study|Adverse Event|44
6043402|NCT00626795|20887588|P3|Blinded Treatment|Missing reason for withdrawal|5
6043403|NCT00626795|20887589|P2|Blinded Treatment|Missing reason for withdrawal|3
6043404|NCT00626795|20887590|P1|Blinded Treatment|Missing reason for withdrawal|5
6043405|NCT00626795|20887588|P3|Blinded Treatment|Other reasons|2
6043406|NCT00626795|20887589|P2|Blinded Treatment|Other reasons|0
6043407|NCT00626795|20887590|P1|Blinded Treatment|Other reasons|2
6043408|NCT00626795|20887588|P3|Blinded Treatment|Withdrawal by Subject|0
6043409|NCT00626795|20887589|P2|Blinded Treatment|Withdrawal by Subject|1
6043410|NCT00626795|20887590|P1|Blinded Treatment|Withdrawal by Subject|1
6043411|NCT00626795|20887588|P3|Blinded Treatment|Protocol Violation|1
6043412|NCT00626795|20887589|P2|Blinded Treatment|Protocol Violation|1
6043413|NCT00626795|20887590|P1|Blinded Treatment|Protocol Violation|0
6043414|NCT00626795|20887588|P3|Blinded Treatment|Unacceptable adverse event|1
6043415|NCT00626795|20887589|P2|Blinded Treatment|Unacceptable adverse event|0
6043416|NCT00626795|20887590|P1|Blinded Treatment|Unacceptable adverse event|0
6043417|NCT00626795|20887588|P3|Blinded Treatment|Lack of Efficacy|0
6043418|NCT00626795|20887589|P2|Blinded Treatment|Lack of Efficacy|0
6043419|NCT00626795|20887590|P1|Blinded Treatment|Lack of Efficacy|2
6043420|NCT00626795|20887588|P3|Open-label TD1414 Cream TID Treatment|Adverse Event|0
6043421|NCT00626795|20887589|P2|Open-label TD1414 Cream TID Treatment|Adverse Event|1
6043422|NCT00626795|20887590|P1|Open-label TD1414 Cream TID Treatment|Adverse Event|0
6043423|NCT00626639|20887641|P2|Overall Study|Occurrence of grade 3 oral mucositis|2
6043424|NCT00626639|20887642|P1|Overall Study|Occurrence of grade 3 oral mucositis|2
6043425|NCT00626561|20887688|P1|Overall Study|Disease Progression|2
6043426|NCT00626561|20887688|P1|Overall Study|Withdrawal by Subject|2
6043427|NCT00626548|20887694|P2|Overall Study|Other termination reason|613
6043428|NCT00626548|20887695|P1|Overall Study|Other termination reason|493
6043429|NCT00626548|20887694|P2|Overall Study|Lost to Follow-up|2
6043430|NCT00626548|20887695|P1|Overall Study|Lost to Follow-up|2
6043431|NCT00626548|20887694|P2|Overall Study|Protocol Violation|11
6043432|NCT00626548|20887695|P1|Overall Study|Protocol Violation|4
6043433|NCT00626548|20887694|P2|Overall Study|Withdrawal by Subject|46
6043434|NCT00626548|20887695|P1|Overall Study|Withdrawal by Subject|42
6043435|NCT00626548|20887694|P2|Overall Study|Adverse Event|44
6043436|NCT00626548|20887695|P1|Overall Study|Adverse Event|164
6043437|NCT00626522|20887709|P6|Overall Study|Non-fulfilment of in/exclusion criteria|0
6043438|NCT00626522|20887710|P5|Overall Study|Non-fulfilment of in/exclusion criteria|0
6043439|NCT00626522|20887711|P4|Overall Study|Non-fulfilment of in/exclusion criteria|1
6043440|NCT00626522|20887712|P3|Overall Study|Non-fulfilment of in/exclusion criteria|1
6043441|NCT00626522|20887713|P2|Overall Study|Non-fulfilment of in/exclusion criteria|0
6043442|NCT00626522|20887714|P1|Overall Study|Non-fulfilment of in/exclusion criteria|1
6043443|NCT00626522|20887709|P6|Overall Study|Inconsistent reason reported|0
6043444|NCT00626522|20887710|P5|Overall Study|Inconsistent reason reported|0
6043445|NCT00626522|20887711|P4|Overall Study|Inconsistent reason reported|0
6043446|NCT00626522|20887712|P3|Overall Study|Inconsistent reason reported|0
6043447|NCT00626522|20887713|P2|Overall Study|Inconsistent reason reported|0
6043448|NCT00626522|20887714|P1|Overall Study|Inconsistent reason reported|1
6043449|NCT00626522|20887709|P6|Overall Study|Lost to Follow-up|0
6043450|NCT00626522|20887710|P5|Overall Study|Lost to Follow-up|0
6043451|NCT00626522|20887711|P4|Overall Study|Lost to Follow-up|0
6043452|NCT00626522|20887712|P3|Overall Study|Lost to Follow-up|0
6043453|NCT00626522|20887713|P2|Overall Study|Lost to Follow-up|1
6043454|NCT00626522|20887714|P1|Overall Study|Lost to Follow-up|0
6043455|NCT00626522|20887709|P6|Overall Study|COPD exacerbation|0
6043456|NCT00626522|20887710|P5|Overall Study|COPD exacerbation|1
6043457|NCT00626522|20887711|P4|Overall Study|COPD exacerbation|1
6043458|NCT00626522|20887712|P3|Overall Study|COPD exacerbation|0
6043459|NCT00626522|20887713|P2|Overall Study|COPD exacerbation|0
6043460|NCT00626522|20887714|P1|Overall Study|COPD exacerbation|0
6043461|NCT00626522|20887709|P6|Overall Study|Withdrawal by Subject|1
6043462|NCT00626522|20887710|P5|Overall Study|Withdrawal by Subject|4
6043463|NCT00626522|20887711|P4|Overall Study|Withdrawal by Subject|0
6043464|NCT00626522|20887712|P3|Overall Study|Withdrawal by Subject|5
6043465|NCT00626522|20887713|P2|Overall Study|Withdrawal by Subject|5
6043466|NCT00626522|20887714|P1|Overall Study|Withdrawal by Subject|2
6043467|NCT00626522|20887709|P6|Overall Study|Adverse Event|1
6043468|NCT00626522|20887710|P5|Overall Study|Adverse Event|1
6043469|NCT00626522|20887711|P4|Overall Study|Adverse Event|0
6043470|NCT00626522|20887712|P3|Overall Study|Adverse Event|2
6043471|NCT00626522|20887713|P2|Overall Study|Adverse Event|1
6043472|NCT00626522|20887714|P1|Overall Study|Adverse Event|2
6043473|NCT00626522|20887709|P6|Overall Study|Protocol Violation|0
6043474|NCT00626522|20887710|P5|Overall Study|Protocol Violation|1
6043475|NCT00626522|20887711|P4|Overall Study|Protocol Violation|0
6043476|NCT00626522|20887712|P3|Overall Study|Protocol Violation|0
6043477|NCT00626522|20887713|P2|Overall Study|Protocol Violation|0
6043478|NCT00626522|20887714|P1|Overall Study|Protocol Violation|0
6043479|NCT00626405|20887777|P2|Overall Study|Withdrawal by Subject|1
6043480|NCT00626405|20887778|P1|Overall Study|Withdrawal by Subject|0
6043481|NCT00626405|20887777|P2|Overall Study|Deemed Ineligible|0
6043482|NCT00626405|20887778|P1|Overall Study|Deemed Ineligible|1
6043483|NCT00626392|20887794|P6|Coadministration Period|Other|1
6043484|NCT00626392|20887795|P5|Coadministration Period|Other|1
6043485|NCT00626392|20887796|P4|Coadministration Period|Other|1
6043486|NCT00626392|20887797|P3|Coadministration Period|Other|3
6043487|NCT00626392|20887798|P2|Coadministration Period|Other|2
6043488|NCT00626392|20887799|P1|Coadministration Period|Other|0
6043489|NCT00626392|20887794|P6|Coadministration Period|Protocol Violation|0
6043490|NCT00626392|20887795|P5|Coadministration Period|Protocol Violation|1
6043491|NCT00626392|20887796|P4|Coadministration Period|Protocol Violation|1
6043492|NCT00626392|20887797|P3|Coadministration Period|Protocol Violation|0
6043493|NCT00626392|20887798|P2|Coadministration Period|Protocol Violation|1
6043494|NCT00626392|20887799|P1|Coadministration Period|Protocol Violation|0
6043495|NCT00626392|20887794|P6|Coadministration Period|Withdrawal by Subject|1
6043496|NCT00626392|20887795|P5|Coadministration Period|Withdrawal by Subject|0
6043497|NCT00626392|20887796|P4|Coadministration Period|Withdrawal by Subject|1
6043498|NCT00626392|20887797|P3|Coadministration Period|Withdrawal by Subject|0
6043499|NCT00626392|20887798|P2|Coadministration Period|Withdrawal by Subject|1
6043500|NCT00626392|20887799|P1|Coadministration Period|Withdrawal by Subject|1
6043501|NCT00626392|20887794|P6|Coadministration Period|Adverse Event|4
6043502|NCT00626392|20887795|P5|Coadministration Period|Adverse Event|3
6043503|NCT00626392|20887796|P4|Coadministration Period|Adverse Event|4
6043504|NCT00626392|20887797|P3|Coadministration Period|Adverse Event|7
6043505|NCT00626392|20887798|P2|Coadministration Period|Adverse Event|1
6043506|NCT00626392|20887799|P1|Coadministration Period|Adverse Event|3
6043507|NCT00626392|20887794|P6|Run-in Period|Noncompliance|0
6043508|NCT00626392|20887795|P5|Run-in Period|Noncompliance|0
6043509|NCT00626392|20887796|P4|Run-in Period|Noncompliance|0
6043510|NCT00626392|20887797|P3|Run-in Period|Noncompliance|1
6043511|NCT00626392|20887798|P2|Run-in Period|Noncompliance|0
6043512|NCT00626392|20887799|P1|Run-in Period|Noncompliance|1
6043513|NCT00626392|20887794|P6|Run-in Period|Withdrawal by Subject|1
6043514|NCT00626392|20887795|P5|Run-in Period|Withdrawal by Subject|3
6043515|NCT00626392|20887796|P4|Run-in Period|Withdrawal by Subject|1
6043516|NCT00626392|20887797|P3|Run-in Period|Withdrawal by Subject|1
6043517|NCT00626392|20887798|P2|Run-in Period|Withdrawal by Subject|1
6043518|NCT00626392|20887799|P1|Run-in Period|Withdrawal by Subject|0
6043519|NCT00626392|20887794|P6|Run-in Period|Adverse Event|0
6043520|NCT00626392|20887795|P5|Run-in Period|Adverse Event|1
6043521|NCT00626392|20887796|P4|Run-in Period|Adverse Event|0
6043522|NCT00626392|20887797|P3|Run-in Period|Adverse Event|1
6043523|NCT00626392|20887798|P2|Run-in Period|Adverse Event|0
6043524|NCT00626392|20887799|P1|Run-in Period|Adverse Event|0
6043525|NCT00626327|20887827|P3|Overall Study|Protocol Violation|26
6043526|NCT00626327|20887828|P2|Overall Study|Protocol Violation|4
6043527|NCT00626327|20887829|P1|Overall Study|Protocol Violation|26
6043528|NCT00626327|20887827|P3|Overall Study|Administrative Reason|6
6043529|NCT00626327|20887828|P2|Overall Study|Administrative Reason|0
6043530|NCT00626327|20887829|P1|Overall Study|Administrative Reason|2
6043531|NCT00626327|20887827|P3|Overall Study|Inappropriate enrollment|3
6043532|NCT00626327|20887828|P2|Overall Study|Inappropriate enrollment|5
6043533|NCT00626327|20887829|P1|Overall Study|Inappropriate enrollment|4
6043534|NCT00626327|20887827|P3|Overall Study|Lost to Follow-up|23
6043535|NCT00626327|20887828|P2|Overall Study|Lost to Follow-up|21
6043536|NCT00626327|20887829|P1|Overall Study|Lost to Follow-up|24
6043537|NCT00626327|20887827|P3|Overall Study|Adverse Event|0
6043538|NCT00626327|20887828|P2|Overall Study|Adverse Event|0
6043539|NCT00626327|20887829|P1|Overall Study|Adverse Event|1
6043540|NCT00626327|20887827|P3|Overall Study|Withdrawal by Subject|30
6043541|NCT00626327|20887828|P2|Overall Study|Withdrawal by Subject|29
6043542|NCT00626327|20887829|P1|Overall Study|Withdrawal by Subject|21
6043543|NCT00626275|20887855|P8|Part B|Withdrawal by Subject|1
6043544|NCT00626275|20887856|P7|Part B|Withdrawal by Subject|0
6043545|NCT00626275|20887857|P6|Part B|Withdrawal by Subject|0
6043546|NCT00626275|20887858|P5|Part B|Withdrawal by Subject|0
6043547|NCT00626275|20887859|P4|Part B|Withdrawal by Subject|0
6043548|NCT00626275|20887860|P3|Part B|Withdrawal by Subject|0
6043549|NCT00626275|20887861|P2|Part B|Withdrawal by Subject|0
6043550|NCT00626275|20887862|P1|Part B|Withdrawal by Subject|0
6043551|NCT00626275|20887855|P8|Part B|Lost to Follow-up|0
6043552|NCT00626275|20887856|P7|Part B|Lost to Follow-up|1
6043553|NCT00626275|20887857|P6|Part B|Lost to Follow-up|0
6043554|NCT00626275|20887858|P5|Part B|Lost to Follow-up|0
6043555|NCT00626275|20887859|P4|Part B|Lost to Follow-up|0
6043556|NCT00626275|20887860|P3|Part B|Lost to Follow-up|0
6043557|NCT00626275|20887861|P2|Part B|Lost to Follow-up|0
6043558|NCT00626275|20887862|P1|Part B|Lost to Follow-up|0
6043559|NCT00626275|20887855|P8|Part A - Treatment Period 1|Withdrawal by Subject|0
6043560|NCT00626275|20887856|P7|Part A - Treatment Period 1|Withdrawal by Subject|0
6043561|NCT00626275|20887857|P6|Part A - Treatment Period 1|Withdrawal by Subject|0
6043562|NCT00626275|20887858|P5|Part A - Treatment Period 1|Withdrawal by Subject|0
6043563|NCT00626275|20887859|P4|Part A - Treatment Period 1|Withdrawal by Subject|0
6043564|NCT00626275|20887860|P3|Part A - Treatment Period 1|Withdrawal by Subject|1
6043565|NCT00626275|20887861|P2|Part A - Treatment Period 1|Withdrawal by Subject|0
6043566|NCT00626275|20887862|P1|Part A - Treatment Period 1|Withdrawal by Subject|0
6043567|NCT00626275|20887855|P8|Part A - Treatment Period 1|Adverse Event|0
6043568|NCT00626275|20887856|P7|Part A - Treatment Period 1|Adverse Event|0
6043569|NCT00626275|20887857|P6|Part A - Treatment Period 1|Adverse Event|0
6043570|NCT00626275|20887858|P5|Part A - Treatment Period 1|Adverse Event|0
6043571|NCT00626275|20887859|P4|Part A - Treatment Period 1|Adverse Event|0
6043572|NCT00626275|20887860|P3|Part A - Treatment Period 1|Adverse Event|0
6043573|NCT00626275|20887861|P2|Part A - Treatment Period 1|Adverse Event|0
6043574|NCT00626275|20887862|P1|Part A - Treatment Period 1|Adverse Event|1
6043575|NCT00626197|20887909|P3|Overall Study|Administrative reasons|55
6043576|NCT00626197|20887910|P2|Overall Study|Administrative reasons|19
6043577|NCT00626197|20887911|P1|Overall Study|Administrative reasons|15
6043578|NCT00626197|20887909|P3|Overall Study|Withdrawal by Subject|7
6043579|NCT00626197|20887910|P2|Overall Study|Withdrawal by Subject|17
6043580|NCT00626197|20887911|P1|Overall Study|Withdrawal by Subject|17
6043581|NCT00626197|20887909|P3|Overall Study|Adverse Event|2
6043582|NCT00626197|20887910|P2|Overall Study|Adverse Event|1
6043583|NCT00626197|20887911|P1|Overall Study|Adverse Event|1
6043584|NCT00626197|20887909|P3|Overall Study|Adverse event, serious fatal|6
6043585|NCT00626197|20887910|P2|Overall Study|Adverse event, serious fatal|6
6043586|NCT00626197|20887911|P1|Overall Study|Adverse event, serious fatal|3
6043587|NCT00626197|20887909|P3|Overall Study|Failure to return|6
6043588|NCT00626197|20887910|P2|Overall Study|Failure to return|5
6043589|NCT00626197|20887911|P1|Overall Study|Failure to return|6
6043590|NCT00626197|20887909|P3|Overall Study|Did not cooperate|1
6043591|NCT00626197|20887910|P2|Overall Study|Did not cooperate|6
6043592|NCT00626197|20887911|P1|Overall Study|Did not cooperate|2
6043593|NCT00626093|20887988|P1|Overall Study|One of the required devices not implante|6
6043594|NCT00626093|20887988|P1|Overall Study|Protocol Violation|1
6043595|NCT00626093|20887988|P1|Overall Study|Withdrawal by Subject|6
6043596|NCT00626093|20887988|P1|Overall Study|Physician Decision|4
6043597|NCT00626093|20887988|P1|Overall Study|Death|1
6043598|NCT00626093|20887988|P1|Overall Study|Lost to Follow-up|5
6043599|NCT00626028|20887995|P2|Overall Study|Inclusion/Exclusion Criteria|6
6043600|NCT00626028|20887996|P1|Overall Study|Inclusion/Exclusion Criteria|3
6043601|NCT00626028|20887995|P2|Overall Study|Physician Decision|1
6043602|NCT00626028|20887996|P1|Overall Study|Physician Decision|2
6043603|NCT00626028|20887995|P2|Overall Study|Device Failure|1
6043604|NCT00626028|20887996|P1|Overall Study|Device Failure|0
6043605|NCT00626028|20887995|P2|Overall Study|Adverse Event|1
6043606|NCT00626028|20887996|P1|Overall Study|Adverse Event|1
6043607|NCT00625872|20888020|P2|Overall Study|Randomized but not treated|1
6043608|NCT00625872|20888021|P1|Overall Study|Randomized but not treated|0
6043609|NCT00625872|20888020|P2|Overall Study|Terminated by sponsor|5
6043610|NCT00625872|20888021|P1|Overall Study|Terminated by sponsor|2
6043611|NCT00625872|20888020|P2|Overall Study|Does not meet inclusion criteria|0
6043612|NCT00625872|20888021|P1|Overall Study|Does not meet inclusion criteria|1
6043613|NCT00625872|20888020|P2|Overall Study|Withdrawal by Subject|0
6043614|NCT00625872|20888021|P1|Overall Study|Withdrawal by Subject|1
6043615|NCT00625846|20888135|P4|Overall Study|Withdrawal by Subject|2
6043616|NCT00625846|20888136|P3|Overall Study|Withdrawal by Subject|1
6043617|NCT00625846|20888137|P2|Overall Study|Withdrawal by Subject|0
6043618|NCT00625846|20888138|P1|Overall Study|Withdrawal by Subject|2
6043619|NCT00625820|20888164|P1|Overall Study|Withdrawal by Subject|1
6043620|NCT00625807|20888172|P2|Overall Study|schedule conflict|8
6043621|NCT00625807|20888173|P1|Overall Study|schedule conflict|2
6043622|NCT00625742|20888189|P1|Overall Study|Ineligible|1
6043623|NCT00625742|20888189|P1|Overall Study|Lost to Follow-up|4
6043624|NCT00625742|20888189|P1|Overall Study|Adverse Event|4
6043625|NCT00625742|20888189|P1|Overall Study|Withdrawal by Subject|1
6043626|NCT00625742|20888189|P1|Overall Study|Disease Progression|2
6043627|NCT00625586|20888208|P1|Overall Study|Adverse Event|1
6043628|NCT00625443|20888221|P3|Overall Study|Other|1
6043629|NCT00625443|20888222|P2|Overall Study|Other|1
6043630|NCT00625443|20888223|P1|Overall Study|Other|0
6043631|NCT00625443|20888221|P3|Overall Study|Physician Decision|2
6043632|NCT00625443|20888222|P2|Overall Study|Physician Decision|4
6043633|NCT00625443|20888223|P1|Overall Study|Physician Decision|0
6043634|NCT00625443|20888221|P3|Overall Study|Withdrawal by Subject|2
6043635|NCT00625443|20888222|P2|Overall Study|Withdrawal by Subject|1
6043636|NCT00625443|20888223|P1|Overall Study|Withdrawal by Subject|0
6043637|NCT00625443|20888221|P3|Overall Study|Platelet count increase >=500,000/mm3|0
6043638|NCT00625443|20888222|P2|Overall Study|Platelet count increase >=500,000/mm3|0
6043639|NCT00625443|20888223|P1|Overall Study|Platelet count increase >=500,000/mm3|1
6043640|NCT00625443|20888221|P3|Overall Study|Non-compliance with protocol|0
6043641|NCT00625443|20888222|P2|Overall Study|Non-compliance with protocol|1
6043642|NCT00625443|20888223|P1|Overall Study|Non-compliance with protocol|0
6043643|NCT00625443|20888221|P3|Overall Study|Adverse Event|0
6043644|NCT00625443|20888222|P2|Overall Study|Adverse Event|4
6043645|NCT00625443|20888223|P1|Overall Study|Adverse Event|1
6043646|NCT00625365|20888303|P1|Overall Study|VSD|1
6043647|NCT00625365|20888303|P1|Overall Study|No IV access|5
6043648|NCT00625365|20888303|P1|Overall Study|Withdrawal by Subject|1
6043649|NCT00625183|20888309|P1|Overall Study|Disease Progression|1
6043650|NCT00625131|20888320|P3|Overall Study|Withdrawal by Subject|5
6043651|NCT00625131|20888321|P2|Overall Study|Withdrawal by Subject|0
6043652|NCT00625131|20888322|P1|Overall Study|Withdrawal by Subject|1
6043653|NCT00625131|20888320|P3|Overall Study|Lost to Follow-up|0
6043654|NCT00625131|20888321|P2|Overall Study|Lost to Follow-up|2
6043655|NCT00625131|20888322|P1|Overall Study|Lost to Follow-up|3
6043656|NCT00624832|20888385|P4|Overall Study|Abnormal Laboratory Value|0
6043657|NCT00624832|20888386|P3|Overall Study|Abnormal Laboratory Value|0
6043658|NCT00624832|20888387|P2|Overall Study|Abnormal Laboratory Value|0
6043659|NCT00624832|20888388|P1|Overall Study|Abnormal Laboratory Value|2
6043660|NCT00624832|20888385|P4|Overall Study|Adverse Event|1
6043661|NCT00624832|20888386|P3|Overall Study|Adverse Event|0
6043662|NCT00624832|20888387|P2|Overall Study|Adverse Event|1
6043663|NCT00624832|20888388|P1|Overall Study|Adverse Event|0
6043664|NCT00624819|20888404|P4|Follow-up Period: Year 4|Lost to Follow-up|0
6043665|NCT00624819|20888405|P3|Follow-up Period: Year 4|Lost to Follow-up|0
6043666|NCT00624819|20888406|P2|Follow-up Period: Year 4|Lost to Follow-up|1
6043667|NCT00624819|20888407|P1|Follow-up Period: Year 4|Lost to Follow-up|1
6043668|NCT00624819|20888404|P4|Follow-up Period: Year 4|Parents decision|0
6043669|NCT00624819|20888405|P3|Follow-up Period: Year 4|Parents decision|1
6043670|NCT00624819|20888406|P2|Follow-up Period: Year 4|Parents decision|0
6043671|NCT00624819|20888407|P1|Follow-up Period: Year 4|Parents decision|0
6043672|NCT00624585|20888587|P1|Overall Study|Adverse Event|3
6043673|NCT00624585|20888587|P1|Overall Study|Disease Progression|6
6043674|NCT00624585|20888587|P1|Overall Study|Death|3
6043675|NCT00624520|20888617|P2|Overall Study|Death|1
6043676|NCT00624520|20888618|P1|Overall Study|Death|0
6043677|NCT00624520|20888617|P2|Overall Study|Withdrawal by Subject|7
6043678|NCT00624520|20888618|P1|Overall Study|Withdrawal by Subject|12
6043679|NCT00624468|20888645|P4|Safety Follow-up (SFU) Period|Other|1
6043680|NCT00624468|20888646|P3|Safety Follow-up (SFU) Period|Other|1
6043681|NCT00624468|20888647|P2|Safety Follow-up (SFU) Period|Other|0
6043682|NCT00624468|20888648|P1|Safety Follow-up (SFU) Period|Other|0
6043683|NCT00624468|20888645|P4|Safety Follow-up (SFU) Period|Lost to Follow-up|2
6043684|NCT00624468|20888646|P3|Safety Follow-up (SFU) Period|Lost to Follow-up|1
6043685|NCT00624468|20888647|P2|Safety Follow-up (SFU) Period|Lost to Follow-up|0
6043686|NCT00624468|20888648|P1|Safety Follow-up (SFU) Period|Lost to Follow-up|0
6043687|NCT00624468|20888645|P4|Double-blind Period|Withdrew Prematurely|0
6043688|NCT00624468|20888646|P3|Double-blind Period|Withdrew Prematurely|0
6043689|NCT00624468|20888647|P2|Double-blind Period|Withdrew Prematurely|1
6043690|NCT00624468|20888648|P1|Double-blind Period|Withdrew Prematurely|1
6043691|NCT00624468|20888645|P4|Double-blind Period|Early Termination Initiated by Sponsor|0
6043692|NCT00624468|20888646|P3|Double-blind Period|Early Termination Initiated by Sponsor|0
6043693|NCT00624468|20888647|P2|Double-blind Period|Early Termination Initiated by Sponsor|12
6043694|NCT00624468|20888648|P1|Double-blind Period|Early Termination Initiated by Sponsor|13
6043695|NCT00624377|20888715|P1|Overall Study|Non-evaluable population|84
6043696|NCT00624377|20888715|P1|Overall Study|Other|91
6043697|NCT00624377|20888715|P1|Overall Study|Adverse Event|14
6043698|NCT00624377|20888715|P1|Overall Study|Withdrawal by Subject|100
6043699|NCT00624377|20888715|P1|Overall Study|Lost to Follow-up|355
6043700|NCT00624338|20888729|P3|Overall Study|Randomized but not treated|3
6043701|NCT00624338|20888730|P2|Overall Study|Randomized but not treated|1
6043702|NCT00624338|20888731|P1|Overall Study|Randomized but not treated|2
6043703|NCT00624338|20888729|P3|Overall Study|Other|9
6043704|NCT00624338|20888730|P2|Overall Study|Other|5
6043705|NCT00624338|20888731|P1|Overall Study|Other|15
6043706|NCT00624338|20888729|P3|Overall Study|Termination of 150 mg group by Sponsor|0
6043707|NCT00624338|20888730|P2|Overall Study|Termination of 150 mg group by Sponsor|55
6043708|NCT00624338|20888731|P1|Overall Study|Termination of 150 mg group by Sponsor|0
6043709|NCT00624338|20888729|P3|Overall Study|Immunoglobulin less than 3gram per liter|0
6043710|NCT00624338|20888730|P2|Overall Study|Immunoglobulin less than 3gram per liter|0
6043711|NCT00624338|20888731|P1|Overall Study|Immunoglobulin less than 3gram per liter|1
6043712|NCT00624338|20888729|P3|Overall Study|Death|0
6043713|NCT00624338|20888730|P2|Overall Study|Death|2
6043714|NCT00624338|20888731|P1|Overall Study|Death|0
6043715|NCT00624338|20888729|P3|Overall Study|Protocol Violation|2
6043716|NCT00624338|20888730|P2|Overall Study|Protocol Violation|3
6043717|NCT00624338|20888731|P1|Overall Study|Protocol Violation|3
6043718|NCT00624338|20888729|P3|Overall Study|Lack of Efficacy|14
6043719|NCT00624338|20888730|P2|Overall Study|Lack of Efficacy|3
6043720|NCT00624338|20888731|P1|Overall Study|Lack of Efficacy|11
6043721|NCT00624338|20888729|P3|Overall Study|Lost to Follow-up|0
6043722|NCT00624338|20888730|P2|Overall Study|Lost to Follow-up|0
6043723|NCT00624338|20888731|P1|Overall Study|Lost to Follow-up|1
6043724|NCT00624338|20888729|P3|Overall Study|Adverse Event|18
6043725|NCT00624338|20888730|P2|Overall Study|Adverse Event|14
6043726|NCT00624338|20888731|P1|Overall Study|Adverse Event|14
6043727|NCT00624286|20888753|P2|Overall Study|Death|1
6043728|NCT00624286|20888754|P1|Overall Study|Death|0
6043729|NCT00624286|20888753|P2|Overall Study|Abnormal test procedure result(s)|1
6043730|NCT00624286|20888754|P1|Overall Study|Abnormal test procedure result(s)|0
6043731|NCT00624286|20888753|P2|Overall Study|Not stated|1
6043732|NCT00624286|20888754|P1|Overall Study|Not stated|0
6043733|NCT00624286|20888753|P2|Overall Study|Lack of Efficacy|6
6043734|NCT00624286|20888754|P1|Overall Study|Lack of Efficacy|1
6043735|NCT00624286|20888753|P2|Overall Study|Administrative problems|0
6043736|NCT00624286|20888754|P1|Overall Study|Administrative problems|3
6043737|NCT00624286|20888753|P2|Overall Study|Lost to Follow-up|2
6043738|NCT00624286|20888754|P1|Overall Study|Lost to Follow-up|3
6043739|NCT00624286|20888753|P2|Overall Study|Withdrawal by Subject|4
6043740|NCT00624286|20888754|P1|Overall Study|Withdrawal by Subject|5
6043741|NCT00624286|20888753|P2|Overall Study|Adverse Event|3
6043742|NCT00624286|20888754|P1|Overall Study|Adverse Event|6
6043743|NCT00624286|20888753|P2|Overall Study|Protocol Deviation|9
6043744|NCT00624286|20888754|P1|Overall Study|Protocol Deviation|7
6043745|NCT00624065|20888782|P2|Overall Study|Met protocol-defined stopping criteria|9
6043746|NCT00624065|20888783|P1|Overall Study|Met protocol-defined stopping criteria|4
6043747|NCT00624065|20888782|P2|Overall Study|Lack of Efficacy|3
6043748|NCT00624065|20888783|P1|Overall Study|Lack of Efficacy|0
6043749|NCT00624065|20888782|P2|Overall Study|Consent withdrawn|5
6043750|NCT00624065|20888783|P1|Overall Study|Consent withdrawn|6
6043751|NCT00624065|20888782|P2|Overall Study|Lost to Follow-up|1
6043752|NCT00624065|20888783|P1|Overall Study|Lost to Follow-up|4
6043753|NCT00624065|20888782|P2|Overall Study|Adverse Event|6
6043754|NCT00624065|20888783|P1|Overall Study|Adverse Event|5
6043755|NCT00624052|20888795|P4|Overall Study|Changed job/ran out if meds|0
6043756|NCT00624052|20888796|P3|Overall Study|Changed job/ran out if meds|0
6043757|NCT00624052|20888797|P2|Overall Study|Changed job/ran out if meds|2
6043758|NCT00624052|20888798|P1|Overall Study|Changed job/ran out if meds|0
6043759|NCT00624052|20888795|P4|Overall Study|Consent withdrawn|0
6043760|NCT00624052|20888796|P3|Overall Study|Consent withdrawn|1
6043761|NCT00624052|20888797|P2|Overall Study|Consent withdrawn|1
6043762|NCT00624052|20888798|P1|Overall Study|Consent withdrawn|3
6043763|NCT00624052|20888795|P4|Overall Study|Non compliant with the protocol|1
6043764|NCT00624052|20888796|P3|Overall Study|Non compliant with the protocol|1
6043765|NCT00624052|20888797|P2|Overall Study|Non compliant with the protocol|1
6043766|NCT00624052|20888798|P1|Overall Study|Non compliant with the protocol|2
6043767|NCT00624052|20888795|P4|Overall Study|Lost to Follow-up|0
6043768|NCT00624052|20888796|P3|Overall Study|Lost to Follow-up|1
6043769|NCT00624052|20888797|P2|Overall Study|Lost to Follow-up|3
6043770|NCT00624052|20888798|P1|Overall Study|Lost to Follow-up|2
6043771|NCT00624052|20888795|P4|Overall Study|Lack of Efficacy|0
6043772|NCT00624052|20888796|P3|Overall Study|Lack of Efficacy|0
6043773|NCT00624052|20888797|P2|Overall Study|Lack of Efficacy|1
6043774|NCT00624052|20888798|P1|Overall Study|Lack of Efficacy|1
6043775|NCT00624052|20888795|P4|Overall Study|Adverse Event|3
6043776|NCT00624052|20888796|P3|Overall Study|Adverse Event|0
6043777|NCT00624052|20888797|P2|Overall Study|Adverse Event|6
6043778|NCT00624052|20888798|P1|Overall Study|Adverse Event|7
6043779|NCT00623935|20888875|P1|Overall Study|Patient Declined Transplant|1
6043780|NCT00623935|20888875|P1|Overall Study|Death|1
6043781|NCT00623831|20888882|P2|Overall Study|Progressive Disease|1
6043782|NCT00623831|20888883|P1|Overall Study|Progressive Disease|0
6043783|NCT00623831|20888882|P2|Overall Study|Withdrawal by Subject|0
6043784|NCT00623831|20888883|P1|Overall Study|Withdrawal by Subject|1
6043785|NCT00623805|20888895|P2|Overall Study|Reason not Specified|6
6043786|NCT00623805|20888896|P1|Overall Study|Reason not Specified|3
6043787|NCT00623805|20888895|P2|Overall Study|Protocol Violation|1
6043788|NCT00623805|20888896|P1|Overall Study|Protocol Violation|1
6043789|NCT00623805|20888895|P2|Overall Study|Lost to Follow-up|2
6043790|NCT00623805|20888896|P1|Overall Study|Lost to Follow-up|2
6043791|NCT00623805|20888895|P2|Overall Study|Lack of Efficacy|7
6043792|NCT00623805|20888896|P1|Overall Study|Lack of Efficacy|3
6043793|NCT00623805|20888895|P2|Overall Study|Death|0
6043794|NCT00623805|20888896|P1|Overall Study|Death|2
6043795|NCT00623805|20888895|P2|Overall Study|Adverse Event|6
6043796|NCT00623805|20888896|P1|Overall Study|Adverse Event|9
6043797|NCT00623779|20888913|P3|Overall Study|Criteria from CSR|1
6043798|NCT00623779|20888914|P2|Overall Study|Criteria from CSR|0
6043799|NCT00623779|20888915|P1|Overall Study|Criteria from CSR|2
6043800|NCT00623779|20888913|P3|Overall Study|Adverse Event|0
6043801|NCT00623779|20888914|P2|Overall Study|Adverse Event|3
6043802|NCT00623779|20888915|P1|Overall Study|Adverse Event|1
6043803|NCT00623766|20888964|P2|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|0
6043804|NCT00623766|20888965|P1|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|1
6043805|NCT00623766|20888964|P2|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|2
6043806|NCT00623766|20888965|P1|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|1
6043807|NCT00623766|20888964|P2|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|0
6043808|NCT00623766|20888965|P1|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|4
6043809|NCT00623766|20888964|P2|Maintenance Phase (Week 24 to Year 2)|Disease progression|0
6043810|NCT00623766|20888965|P1|Maintenance Phase (Week 24 to Year 2)|Disease progression|4
6043811|NCT00623766|20888964|P2|Induction Phase (Day 1 to Week 24)|Off treatment|16
6043812|NCT00623766|20888965|P1|Induction Phase (Day 1 to Week 24)|Off treatment|36
6043813|NCT00623727|20888989|P2|Open Label Follow-up|Participant convenience|1
6043814|NCT00623727|20888990|P1|Open Label Follow-up|Participant convenience|0
6043815|NCT00623727|20888989|P2|Open Label Follow-up|Study termination|6
6043816|NCT00623727|20888990|P1|Open Label Follow-up|Study termination|0
6043817|NCT00623727|20888989|P2|Open Label Follow-up|Withdrawal by Subject|1
6043818|NCT00623727|20888990|P1|Open Label Follow-up|Withdrawal by Subject|0
6043819|NCT00623727|20888989|P2|Double Blind (DB)|Protocol Violation|2
6043820|NCT00623727|20888990|P1|Double Blind (DB)|Protocol Violation|2
6043821|NCT00623727|20888989|P2|Double Blind (DB)|Lost to Follow-up|1
6043822|NCT00623727|20888990|P1|Double Blind (DB)|Lost to Follow-up|1
6043823|NCT00623727|20888989|P2|Double Blind (DB)|Termination of the double-blind period|21
6043824|NCT00623727|20888990|P1|Double Blind (DB)|Termination of the double-blind period|22
6043825|NCT00623727|20888989|P2|Double Blind (DB)|Lack of Efficacy|2
6043826|NCT00623727|20888990|P1|Double Blind (DB)|Lack of Efficacy|2
6043827|NCT00623727|20888989|P2|Double Blind (DB)|Withdrawal by Subject|2
6043828|NCT00623727|20888990|P1|Double Blind (DB)|Withdrawal by Subject|8
6043829|NCT00623727|20888989|P2|Double Blind (DB)|Physician Decision|1
6043830|NCT00623727|20888990|P1|Double Blind (DB)|Physician Decision|0
6043831|NCT00623727|20888989|P2|Double Blind (DB)|Adverse Event|3
6043832|NCT00623727|20888990|P1|Double Blind (DB)|Adverse Event|1
6043833|NCT00623623|20889045|P2|Overall Study|Previous enrolment into this study|1
6043834|NCT00623623|20889046|P1|Overall Study|Previous enrolment into this study|1
6043835|NCT00623597|20889102|P2|Overall Study|Failed to return|0
6043836|NCT00623597|20889103|P1|Overall Study|Failed to return|1
6043837|NCT00623545|20889166|P1|Overall Study|Withdrawal by Subject|4
6043838|NCT00623545|20889166|P1|Overall Study|Adverse Event|6
6043839|NCT00623480|20889186|P2|Overall Study|Site closed by sponsor|1
6043840|NCT00623480|20889187|P1|Overall Study|Site closed by sponsor|0
6043841|NCT00623480|20889186|P2|Overall Study|Protocol Violation|1
6043842|NCT00623480|20889187|P1|Overall Study|Protocol Violation|0
6043843|NCT00623480|20889186|P2|Overall Study|Non-compliant with study medication|0
6043844|NCT00623480|20889187|P1|Overall Study|Non-compliant with study medication|4
6043845|NCT00623480|20889186|P2|Overall Study|Lack of Efficacy|0
6043846|NCT00623480|20889187|P1|Overall Study|Lack of Efficacy|1
6043847|NCT00623480|20889186|P2|Overall Study|Withdrawal by Subject|4
6043848|NCT00623480|20889187|P1|Overall Study|Withdrawal by Subject|2
6043849|NCT00623480|20889186|P2|Overall Study|Lost to Follow-up|1
6043850|NCT00623480|20889187|P1|Overall Study|Lost to Follow-up|0
6043851|NCT00623467|20889199|P1|Overall Study|Withdrawal by Subject|2
6043852|NCT00623467|20889199|P1|Overall Study|Protocol Violation|4
6043853|NCT00623467|20889199|P1|Overall Study|Lost to Follow-up|1
6043854|NCT00623428|20889269|P2|Follow-up Period|Death|1
6043855|NCT00623428|20889270|P1|Follow-up Period|Death|0
6043856|NCT00623428|20889269|P2|Follow-up Period|Reason not specified|1
6043857|NCT00623428|20889270|P1|Follow-up Period|Reason not specified|1
6043858|NCT00623428|20889269|P2|Follow-up Period|Did not cooperate|3
6043859|NCT00623428|20889270|P1|Follow-up Period|Did not cooperate|0
6043860|NCT00623428|20889269|P2|Follow-up Period|HCV-RNA detectable at end of treatment|1
6043861|NCT00623428|20889270|P1|Follow-up Period|HCV-RNA detectable at end of treatment|2
6043862|NCT00623428|20889269|P2|Follow-up Period|Patient withdrew consent|4
6043863|NCT00623428|20889270|P1|Follow-up Period|Patient withdrew consent|5
6043864|NCT00623428|20889269|P2|Follow-up Period|Failure to return|2
6043865|NCT00623428|20889270|P1|Follow-up Period|Failure to return|10
6043866|NCT00623428|20889269|P2|Follow-up Period|Relapse post-treatment|3
6043867|NCT00623428|20889270|P1|Follow-up Period|Relapse post-treatment|11
6043868|NCT00623428|20889269|P2|Treatment Period|Withdrawal by Subject|1
6043869|NCT00623428|20889270|P1|Treatment Period|Withdrawal by Subject|0
6043870|NCT00623428|20889269|P2|Treatment Period|Other|1
6043871|NCT00623428|20889270|P1|Treatment Period|Other|0
6043872|NCT00623428|20889269|P2|Treatment Period|Insufficient therapeutic response|2
6043873|NCT00623428|20889270|P1|Treatment Period|Insufficient therapeutic response|0
6043874|NCT00623428|20889269|P2|Treatment Period|Did not cooperate / refused treatment|13
6043875|NCT00623428|20889270|P1|Treatment Period|Did not cooperate / refused treatment|0
6043876|NCT00623428|20889269|P2|Treatment Period|Death|1
6043877|NCT00623428|20889270|P1|Treatment Period|Death|0
6043878|NCT00623428|20889269|P2|Treatment Period|Adverse event/intercurrent illness|9
6043879|NCT00623428|20889270|P1|Treatment Period|Adverse event/intercurrent illness|0
6043880|NCT00623233|20889288|P1|Overall Study|Withdrawal by Subject|3
6043881|NCT00623233|20889288|P1|Overall Study|Lost to Follow-up|1
6043882|NCT00623233|20889288|P1|Overall Study|Physician Decision|10
6043883|NCT00623233|20889288|P1|Overall Study|Adverse Event|10
6043884|NCT00623194|20889295|P1|Overall Study|Unclassified|1
6043885|NCT00623194|20889295|P1|Overall Study|Protocol Violation|3
6043886|NCT00623194|20889295|P1|Overall Study|Lack of Efficacy|1
6043887|NCT00623103|20889332|P2|Overall Study|Protocol deviation|1
6043888|NCT00623103|20889333|P1|Overall Study|Protocol deviation|2
6043889|NCT00623103|20889332|P2|Overall Study|Death|11
6043890|NCT00623103|20889333|P1|Overall Study|Death|11
6043891|NCT00623103|20889332|P2|Overall Study|Administrative problems|4
6043892|NCT00623103|20889333|P1|Overall Study|Administrative problems|2
6043893|NCT00623103|20889332|P2|Overall Study|Lost to Follow-up|1
6043894|NCT00623103|20889333|P1|Overall Study|Lost to Follow-up|4
6043895|NCT00623103|20889332|P2|Overall Study|Withdrawal by Subject|24
6043896|NCT00623103|20889333|P1|Overall Study|Withdrawal by Subject|18
6043897|NCT00623103|20889332|P2|Overall Study|Unsatisfactory therapeutic effect|12
6043898|NCT00623103|20889333|P1|Overall Study|Unsatisfactory therapeutic effect|4
6043899|NCT00623103|20889332|P2|Overall Study|Adverse Event|60
6043900|NCT00623103|20889333|P1|Overall Study|Adverse Event|70
6043901|NCT00622908|20889361|P2|Overall Study|Termination by study sponser|1
6043902|NCT00622908|20889362|P1|Overall Study|Termination by study sponser|0
6043903|NCT00622908|20889361|P2|Overall Study|Refusal|1
6043904|NCT00622908|20889362|P1|Overall Study|Refusal|0
6043905|NCT00622908|20889361|P2|Overall Study|Lost to Follow-up|0
6043906|NCT00622908|20889362|P1|Overall Study|Lost to Follow-up|1
6043907|NCT00622908|20889361|P2|Overall Study|Lack of Efficacy|7
6043908|NCT00622908|20889362|P1|Overall Study|Lack of Efficacy|1
6043909|NCT00622908|20889361|P2|Overall Study|Adverse Event|1
6043910|NCT00622908|20889362|P1|Overall Study|Adverse Event|0
6043911|NCT00622908|20889361|P2|Overall Study|Protocol Violation|0
6043912|NCT00622908|20889362|P1|Overall Study|Protocol Violation|1
6043913|NCT00622869|20889392|P3|Overall Study|Missing|1
6043914|NCT00622869|20889393|P2|Overall Study|Missing|1
6043915|NCT00622869|20889394|P1|Overall Study|Missing|0
6043916|NCT00622869|20889392|P3|Overall Study|Graft Loss|2
6043917|NCT00622869|20889393|P2|Overall Study|Graft Loss|3
6043918|NCT00622869|20889394|P1|Overall Study|Graft Loss|5
6043919|NCT00622869|20889392|P3|Overall Study|Lost to Follow-up|2
6043920|NCT00622869|20889393|P2|Overall Study|Lost to Follow-up|4
6043921|NCT00622869|20889394|P1|Overall Study|Lost to Follow-up|2
6043922|NCT00622869|20889392|P3|Overall Study|Death|10
6043923|NCT00622869|20889393|P2|Overall Study|Death|15
6043924|NCT00622869|20889394|P1|Overall Study|Death|12
6043925|NCT00622869|20889392|P3|Overall Study|Administrative Problems|13
6043926|NCT00622869|20889393|P2|Overall Study|Administrative Problems|17
6043927|NCT00622869|20889394|P1|Overall Study|Administrative Problems|11
6043928|NCT00622869|20889392|P3|Overall Study|Subject Withdrew Consent|11
6043929|NCT00622869|20889393|P2|Overall Study|Subject Withdrew Consent|17
6043930|NCT00622869|20889394|P1|Overall Study|Subject Withdrew Consent|13
6043931|NCT00622739|20889413|P2|Overall Study|Lost to Follow-up|1
6043932|NCT00622739|20889414|P1|Overall Study|Lost to Follow-up|0
6043933|NCT00622739|20889413|P2|Overall Study|Withdrawal by Subject|1
6043934|NCT00622739|20889414|P1|Overall Study|Withdrawal by Subject|0
6043935|NCT00622739|20889413|P2|Overall Study|Lack of Efficacy|2
6043936|NCT00622739|20889414|P1|Overall Study|Lack of Efficacy|0
6043937|NCT00622739|20889413|P2|Overall Study|Adverse Event|2
6043938|NCT00622739|20889414|P1|Overall Study|Adverse Event|1
6043939|NCT00622739|20889413|P2|Overall Study|Physician Decision|0
6043940|NCT00622739|20889414|P1|Overall Study|Physician Decision|1
6043941|NCT00622726|20889432|P2|August, 2010 to April, 2013|Death|5
6043942|NCT00622726|20889433|P1|August, 2010 to April, 2013|Death|1
6043943|NCT00622726|20889432|P2|March, 2008 to August, 2010|Death|2
6043944|NCT00622726|20889433|P1|March, 2008 to August, 2010|Death|5
6043945|NCT00622713|20889443|P1|Overall Study|Did not meet eligibility criteria|1
6043946|NCT00622713|20889443|P1|Overall Study|Subject no longer required study drug|1
6043947|NCT00622713|20889443|P1|Overall Study|Death|2
6043948|NCT00622713|20889443|P1|Overall Study|Lost to Follow-up|5
6043949|NCT00622713|20889443|P1|Overall Study|Withdrawal by Subject|11
6043950|NCT00622713|20889443|P1|Overall Study|Administrative problems|4
6043951|NCT00622713|20889443|P1|Overall Study|Adverse Event|35
6043952|NCT00622700|20889454|P7|Extension Treatment Period|Other than specified above|1
6043953|NCT00622700|20889455|P6|Extension Treatment Period|Other than specified above|1
6043954|NCT00622700|20889456|P5|Extension Treatment Period|Other than specified above|0
6043955|NCT00622700|20889457|P4|Extension Treatment Period|Other than specified above|0
6043956|NCT00622700|20889458|P3|Extension Treatment Period|Other than specified above|0
6043957|NCT00622700|20889459|P2|Extension Treatment Period|Other than specified above|0
6043958|NCT00622700|20889460|P1|Extension Treatment Period|Other than specified above|0
6043959|NCT00622700|20889454|P7|Extension Treatment Period|Missing|0
6043960|NCT00622700|20889455|P6|Extension Treatment Period|Missing|1
6043961|NCT00622700|20889456|P5|Extension Treatment Period|Missing|3
6043962|NCT00622700|20889457|P4|Extension Treatment Period|Missing|2
6043963|NCT00622700|20889458|P3|Extension Treatment Period|Missing|0
6043964|NCT00622700|20889459|P2|Extension Treatment Period|Missing|0
6043965|NCT00622700|20889460|P1|Extension Treatment Period|Missing|0
6043966|NCT00622700|20889454|P7|Extension Treatment Period|Withdrawal by Subject|10
6043967|NCT00622700|20889455|P6|Extension Treatment Period|Withdrawal by Subject|6
6043968|NCT00622700|20889456|P5|Extension Treatment Period|Withdrawal by Subject|16
6043969|NCT00622700|20889457|P4|Extension Treatment Period|Withdrawal by Subject|11
6043970|NCT00622700|20889458|P3|Extension Treatment Period|Withdrawal by Subject|0
6043971|NCT00622700|20889459|P2|Extension Treatment Period|Withdrawal by Subject|0
6043972|NCT00622700|20889460|P1|Extension Treatment Period|Withdrawal by Subject|0
6043973|NCT00622700|20889454|P7|Extension Treatment Period|Progressive Disease|2
6043974|NCT00622700|20889455|P6|Extension Treatment Period|Progressive Disease|0
6043975|NCT00622700|20889456|P5|Extension Treatment Period|Progressive Disease|2
6043976|NCT00622700|20889457|P4|Extension Treatment Period|Progressive Disease|1
6043977|NCT00622700|20889458|P3|Extension Treatment Period|Progressive Disease|0
6043978|NCT00622700|20889459|P2|Extension Treatment Period|Progressive Disease|0
6043979|NCT00622700|20889460|P1|Extension Treatment Period|Progressive Disease|0
6043980|NCT00622700|20889454|P7|Extension Treatment Period|Lost to Follow-up|0
6043981|NCT00622700|20889455|P6|Extension Treatment Period|Lost to Follow-up|0
6043982|NCT00622700|20889456|P5|Extension Treatment Period|Lost to Follow-up|1
6043983|NCT00622700|20889457|P4|Extension Treatment Period|Lost to Follow-up|0
6043984|NCT00622700|20889458|P3|Extension Treatment Period|Lost to Follow-up|0
6043985|NCT00622700|20889459|P2|Extension Treatment Period|Lost to Follow-up|0
6043986|NCT00622700|20889460|P1|Extension Treatment Period|Lost to Follow-up|0
6043987|NCT00622700|20889454|P7|Extension Treatment Period|Protocol Violation|0
6043988|NCT00622700|20889455|P6|Extension Treatment Period|Protocol Violation|2
6043989|NCT00622700|20889456|P5|Extension Treatment Period|Protocol Violation|0
6043990|NCT00622700|20889457|P4|Extension Treatment Period|Protocol Violation|0
6043991|NCT00622700|20889458|P3|Extension Treatment Period|Protocol Violation|0
6043992|NCT00622700|20889459|P2|Extension Treatment Period|Protocol Violation|0
6043993|NCT00622700|20889460|P1|Extension Treatment Period|Protocol Violation|0
6043994|NCT00622700|20889454|P7|Extension Treatment Period|Lack of Efficacy|9
6043995|NCT00622700|20889455|P6|Extension Treatment Period|Lack of Efficacy|1
6043996|NCT00622700|20889456|P5|Extension Treatment Period|Lack of Efficacy|8
6043997|NCT00622700|20889457|P4|Extension Treatment Period|Lack of Efficacy|2
6043998|NCT00622700|20889458|P3|Extension Treatment Period|Lack of Efficacy|0
6043999|NCT00622700|20889459|P2|Extension Treatment Period|Lack of Efficacy|0
6044000|NCT00622700|20889460|P1|Extension Treatment Period|Lack of Efficacy|0
6044001|NCT00622700|20889454|P7|Extension Treatment Period|Adverse Event|8
6044002|NCT00622700|20889455|P6|Extension Treatment Period|Adverse Event|6
6044003|NCT00622700|20889456|P5|Extension Treatment Period|Adverse Event|9
6044004|NCT00622700|20889457|P4|Extension Treatment Period|Adverse Event|5
6044005|NCT00622700|20889458|P3|Extension Treatment Period|Adverse Event|0
6044006|NCT00622700|20889459|P2|Extension Treatment Period|Adverse Event|0
6044007|NCT00622700|20889460|P1|Extension Treatment Period|Adverse Event|0
6044008|NCT00622700|20889454|P7|Core Treatment Period|Other than specified above|0
6044009|NCT00622700|20889455|P6|Core Treatment Period|Other than specified above|0
6044010|NCT00622700|20889456|P5|Core Treatment Period|Other than specified above|0
6044011|NCT00622700|20889457|P4|Core Treatment Period|Other than specified above|0
6044012|NCT00622700|20889458|P3|Core Treatment Period|Other than specified above|5
6044013|NCT00622700|20889459|P2|Core Treatment Period|Other than specified above|2
6044014|NCT00622700|20889460|P1|Core Treatment Period|Other than specified above|2
6044015|NCT00622700|20889454|P7|Core Treatment Period|Withdrawal by Subject|0
6044016|NCT00622700|20889455|P6|Core Treatment Period|Withdrawal by Subject|0
6044017|NCT00622700|20889456|P5|Core Treatment Period|Withdrawal by Subject|0
6044018|NCT00622700|20889457|P4|Core Treatment Period|Withdrawal by Subject|0
6044019|NCT00622700|20889458|P3|Core Treatment Period|Withdrawal by Subject|15
6044020|NCT00622700|20889459|P2|Core Treatment Period|Withdrawal by Subject|18
6044021|NCT00622700|20889460|P1|Core Treatment Period|Withdrawal by Subject|12
6044022|NCT00622700|20889454|P7|Core Treatment Period|Progressive Disease|0
6044023|NCT00622700|20889455|P6|Core Treatment Period|Progressive Disease|0
6044024|NCT00622700|20889456|P5|Core Treatment Period|Progressive Disease|0
6044025|NCT00622700|20889457|P4|Core Treatment Period|Progressive Disease|0
6044026|NCT00622700|20889458|P3|Core Treatment Period|Progressive Disease|0
6044027|NCT00622700|20889459|P2|Core Treatment Period|Progressive Disease|1
6044028|NCT00622700|20889460|P1|Core Treatment Period|Progressive Disease|3
6044029|NCT00622700|20889454|P7|Core Treatment Period|Death|0
6044030|NCT00622700|20889455|P6|Core Treatment Period|Death|0
6044031|NCT00622700|20889456|P5|Core Treatment Period|Death|0
6044032|NCT00622700|20889457|P4|Core Treatment Period|Death|0
6044033|NCT00622700|20889458|P3|Core Treatment Period|Death|0
6044034|NCT00622700|20889459|P2|Core Treatment Period|Death|0
6044035|NCT00622700|20889460|P1|Core Treatment Period|Death|1
6044036|NCT00622700|20889454|P7|Core Treatment Period|Lost to Follow-up|0
6044037|NCT00622700|20889455|P6|Core Treatment Period|Lost to Follow-up|0
6044038|NCT00622700|20889456|P5|Core Treatment Period|Lost to Follow-up|0
6044039|NCT00622700|20889457|P4|Core Treatment Period|Lost to Follow-up|0
6044040|NCT00622700|20889458|P3|Core Treatment Period|Lost to Follow-up|1
6044041|NCT00622700|20889459|P2|Core Treatment Period|Lost to Follow-up|1
6044042|NCT00622700|20889460|P1|Core Treatment Period|Lost to Follow-up|1
6044043|NCT00622700|20889454|P7|Core Treatment Period|Lack of Efficacy|0
6044044|NCT00622700|20889455|P6|Core Treatment Period|Lack of Efficacy|0
6044045|NCT00622700|20889456|P5|Core Treatment Period|Lack of Efficacy|0
6044046|NCT00622700|20889457|P4|Core Treatment Period|Lack of Efficacy|0
6044047|NCT00622700|20889458|P3|Core Treatment Period|Lack of Efficacy|12
6044048|NCT00622700|20889459|P2|Core Treatment Period|Lack of Efficacy|6
6044049|NCT00622700|20889460|P1|Core Treatment Period|Lack of Efficacy|19
6044050|NCT00622700|20889454|P7|Core Treatment Period|Adverse Event|0
6044051|NCT00622700|20889455|P6|Core Treatment Period|Adverse Event|0
6044052|NCT00622700|20889456|P5|Core Treatment Period|Adverse Event|0
6044053|NCT00622700|20889457|P4|Core Treatment Period|Adverse Event|0
6044054|NCT00622700|20889458|P3|Core Treatment Period|Adverse Event|18
6044055|NCT00622700|20889459|P2|Core Treatment Period|Adverse Event|25
6044056|NCT00622700|20889460|P1|Core Treatment Period|Adverse Event|18
6044057|NCT00622700|20889454|P7|Core Treatment Period|Randomized but Not Treated|0
6044058|NCT00622700|20889455|P6|Core Treatment Period|Randomized but Not Treated|0
6044059|NCT00622700|20889456|P5|Core Treatment Period|Randomized but Not Treated|0
6044060|NCT00622700|20889457|P4|Core Treatment Period|Randomized but Not Treated|0
6044061|NCT00622700|20889458|P3|Core Treatment Period|Randomized but Not Treated|2
6044062|NCT00622700|20889459|P2|Core Treatment Period|Randomized but Not Treated|2
6044063|NCT00622700|20889460|P1|Core Treatment Period|Randomized but Not Treated|0
6044064|NCT00622635|20889519|P6|Treatment Period 3|Withdrawal by Subject|0
6044065|NCT00622635|20889520|P5|Treatment Period 3|Withdrawal by Subject|0
6044066|NCT00622635|20889521|P4|Treatment Period 3|Withdrawal by Subject|1
6044067|NCT00622635|20889522|P3|Treatment Period 3|Withdrawal by Subject|0
6044068|NCT00622635|20889523|P2|Treatment Period 3|Withdrawal by Subject|0
6044069|NCT00622635|20889524|P1|Treatment Period 3|Withdrawal by Subject|0
6044070|NCT00622635|20889519|P6|Treatment Period 3|Adverse Event|0
6044071|NCT00622635|20889520|P5|Treatment Period 3|Adverse Event|0
6044072|NCT00622635|20889521|P4|Treatment Period 3|Adverse Event|2
6044073|NCT00622635|20889522|P3|Treatment Period 3|Adverse Event|0
6044074|NCT00622635|20889523|P2|Treatment Period 3|Adverse Event|0
6044075|NCT00622635|20889524|P1|Treatment Period 3|Adverse Event|0
6044076|NCT00622635|20889519|P6|Treatment Period 2|Adverse Event|0
6044077|NCT00622635|20889520|P5|Treatment Period 2|Adverse Event|0
6044078|NCT00622635|20889521|P4|Treatment Period 2|Adverse Event|0
6044079|NCT00622635|20889522|P3|Treatment Period 2|Adverse Event|0
6044080|NCT00622635|20889523|P2|Treatment Period 2|Adverse Event|0
6044081|NCT00622635|20889524|P1|Treatment Period 2|Adverse Event|1
6044082|NCT00622635|20889519|P6|Treatment Period 1|Abnormal test procedure result(s)|0
6044083|NCT00622635|20889520|P5|Treatment Period 1|Abnormal test procedure result(s)|1
6044084|NCT00622635|20889521|P4|Treatment Period 1|Abnormal test procedure result(s)|0
6044085|NCT00622635|20889522|P3|Treatment Period 1|Abnormal test procedure result(s)|0
6044086|NCT00622635|20889523|P2|Treatment Period 1|Abnormal test procedure result(s)|0
6044087|NCT00622635|20889524|P1|Treatment Period 1|Abnormal test procedure result(s)|0
6044088|NCT00622635|20889519|P6|Treatment Period 1|Withdrawal by Subject|0
6044089|NCT00622635|20889520|P5|Treatment Period 1|Withdrawal by Subject|0
6044090|NCT00622635|20889521|P4|Treatment Period 1|Withdrawal by Subject|0
6044091|NCT00622635|20889522|P3|Treatment Period 1|Withdrawal by Subject|0
6044092|NCT00622635|20889523|P2|Treatment Period 1|Withdrawal by Subject|1
6044093|NCT00622635|20889524|P1|Treatment Period 1|Withdrawal by Subject|0
6044094|NCT00622635|20889519|P6|Treatment Period 1|Adverse Event|0
6044095|NCT00622635|20889520|P5|Treatment Period 1|Adverse Event|0
6044096|NCT00622635|20889521|P4|Treatment Period 1|Adverse Event|0
6044097|NCT00622635|20889522|P3|Treatment Period 1|Adverse Event|1
6044098|NCT00622635|20889523|P2|Treatment Period 1|Adverse Event|0
6044099|NCT00622635|20889524|P1|Treatment Period 1|Adverse Event|0
6044100|NCT00622466|20889605|P1|Overall Study|Withdrawal by Subject|2
6044101|NCT00622466|20889605|P1|Overall Study|Adverse Event|1
6044102|NCT00622466|20889605|P1|Overall Study|Death|1
6044103|NCT00622440|20889618|P2|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|1
6044104|NCT00622440|20889619|P1|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|0
6044105|NCT00622440|20889618|P2|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|1
6044106|NCT00622440|20889619|P1|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|0
6044107|NCT00622440|20889618|P2|Week 12 - Week 48 (Treatment)|Lost to Follow-up|5
6044108|NCT00622440|20889619|P1|Week 12 - Week 48 (Treatment)|Lost to Follow-up|3
6044109|NCT00622440|20889618|P2|Baseline - Week 12 (Treatment)|Received cream but did not return|1
6044110|NCT00622440|20889619|P1|Baseline - Week 12 (Treatment)|Received cream but did not return|4
6044111|NCT00622401|20889645|P3|Overall Study|Disease progression prior to treatment|0
6044112|NCT00622401|20889646|P2|Overall Study|Disease progression prior to treatment|2
6044113|NCT00622401|20889647|P1|Overall Study|Disease progression prior to treatment|3
6044114|NCT00622388|20889654|P1|Overall Study|Insurance Expired|1
6044115|NCT00622388|20889654|P1|Overall Study|Withdrew Consent|1
6044116|NCT00622388|20889654|P1|Overall Study|Took Prohibited Medication|2
6044117|NCT00622388|20889654|P1|Overall Study|Received Alternate Anticancer Therapy|8
6044118|NCT00622388|20889654|P1|Overall Study|Death|3
6044119|NCT00622388|20889654|P1|Overall Study|Participant Refusal|1
6044120|NCT00622388|20889654|P1|Overall Study|Protocol Violation|3
6044121|NCT00622388|20889654|P1|Overall Study|Adverse Event|6
6044122|NCT00622388|20889654|P1|Overall Study|Disease Progression|47
6044123|NCT00622336|20889672|P1|Extension Phase|Other|9
6044124|NCT00622336|20889672|P1|Extension Phase|Lost to Follow-up|1
6044125|NCT00622336|20889672|P1|Extension Phase|Withdrawal by Subject|1
6044126|NCT00622336|20889672|P1|Extension Phase|Lack of therapeutic effect|2
6044127|NCT00622336|20889672|P1|Extension Phase|Progressive Disease|6
6044128|NCT00622336|20889672|P1|Extension Phase|Adverse Event|2
6044129|NCT00622336|20889672|P1|Treatment Phase|Lost to Follow-up|2
6044130|NCT00622336|20889672|P1|Treatment Phase|Withdrawal by Subject|13
6044131|NCT00622336|20889672|P1|Treatment Phase|Lack of therapeutic effect|13
6044132|NCT00622336|20889672|P1|Treatment Phase|Death|14
6044133|NCT00622336|20889672|P1|Treatment Phase|Other|40
6044134|NCT00622336|20889672|P1|Treatment Phase|Adverse Event|46
6044135|NCT00622336|20889672|P1|Treatment Phase|Progression of Disease|181
6044136|NCT00622284|20889683|P2|Overall Study|Other reason (not specified)|24
6044137|NCT00622284|20889684|P1|Overall Study|Other reason (not specified)|33
6044138|NCT00622284|20889683|P2|Overall Study|Withdrawal by Subject|24
6044139|NCT00622284|20889684|P1|Overall Study|Withdrawal by Subject|27
6044140|NCT00622284|20889683|P2|Overall Study|Lost to Follow-up|13
6044141|NCT00622284|20889684|P1|Overall Study|Lost to Follow-up|11
6044142|NCT00622284|20889683|P2|Overall Study|Protocol Violation|5
6044143|NCT00622284|20889684|P1|Overall Study|Protocol Violation|12
6044144|NCT00622284|20889683|P2|Overall Study|Adverse Event|90
6044145|NCT00622284|20889684|P1|Overall Study|Adverse Event|61
6044146|NCT00622284|20889683|P2|Overall Study|Lack of Efficacy|15
6044147|NCT00622284|20889684|P1|Overall Study|Lack of Efficacy|45
6044148|NCT00622180|20889746|P2|Overall Study|Lost to Follow-up|2
6044149|NCT00622180|20889747|P1|Overall Study|Lost to Follow-up|1
6044150|NCT00622167|20889753|P1|Overall Study|Did not meet angiographic criteria|20
6044151|NCT00621985|20889757|P1|Dexamethasone Admission|Adverse Event|1
6044152|NCT00621959|20889765|P2|Overall Study|Other|3
6044153|NCT00621959|20889766|P1|Overall Study|Other|1
6044154|NCT00621959|20889765|P2|Overall Study|Withdrawal by Subject|1
6044155|NCT00621959|20889766|P1|Overall Study|Withdrawal by Subject|1
6044156|NCT00621959|20889765|P2|Overall Study|Lost to Follow-up|2
6044157|NCT00621959|20889766|P1|Overall Study|Lost to Follow-up|0
6044158|NCT00621959|20889765|P2|Overall Study|Lack of Efficacy|1
6044159|NCT00621959|20889766|P1|Overall Study|Lack of Efficacy|1
6044160|NCT00621959|20889765|P2|Overall Study|Adverse Event|2
6044161|NCT00621959|20889766|P1|Overall Study|Adverse Event|4
6044162|NCT00621855|20889805|P5|Overall Study|Patients did not receive study drug|2
6044163|NCT00621855|20889806|P4|Overall Study|Patients did not receive study drug|4
6044164|NCT00621855|20889807|P3|Overall Study|Patients did not receive study drug|5
6044165|NCT00621855|20889808|P2|Overall Study|Patients did not receive study drug|3
6044166|NCT00621855|20889809|P1|Overall Study|Patients did not receive study drug|3
6044167|NCT00621855|20889805|P5|Overall Study|Other|4
6044168|NCT00621855|20889806|P4|Overall Study|Other|5
6044169|NCT00621855|20889807|P3|Overall Study|Other|6
6044170|NCT00621855|20889808|P2|Overall Study|Other|7
6044171|NCT00621855|20889809|P1|Overall Study|Other|9
6044172|NCT00621855|20889805|P5|Overall Study|Withdrawal by Subject|9
6044173|NCT00621855|20889806|P4|Overall Study|Withdrawal by Subject|13
6044174|NCT00621855|20889807|P3|Overall Study|Withdrawal by Subject|13
6044175|NCT00621855|20889808|P2|Overall Study|Withdrawal by Subject|11
6044176|NCT00621855|20889809|P1|Overall Study|Withdrawal by Subject|16
6044177|NCT00621855|20889805|P5|Overall Study|Protocol Violation|8
6044178|NCT00621855|20889806|P4|Overall Study|Protocol Violation|7
6044179|NCT00621855|20889807|P3|Overall Study|Protocol Violation|6
6044180|NCT00621855|20889808|P2|Overall Study|Protocol Violation|8
6044181|NCT00621855|20889809|P1|Overall Study|Protocol Violation|16
6044182|NCT00621855|20889805|P5|Overall Study|Lost to Follow-up|1
6044183|NCT00621855|20889806|P4|Overall Study|Lost to Follow-up|4
6044184|NCT00621855|20889807|P3|Overall Study|Lost to Follow-up|3
6044185|NCT00621855|20889808|P2|Overall Study|Lost to Follow-up|1
6044186|NCT00621855|20889809|P1|Overall Study|Lost to Follow-up|0
6044187|NCT00621855|20889805|P5|Overall Study|Adverse Event|31
6044188|NCT00621855|20889806|P4|Overall Study|Adverse Event|34
6044189|NCT00621855|20889807|P3|Overall Study|Adverse Event|48
6044190|NCT00621855|20889808|P2|Overall Study|Adverse Event|31
6044191|NCT00621855|20889809|P1|Overall Study|Adverse Event|32
6044192|NCT00621842|20889851|P1|Overall Study|Lack of Efficacy|2
6044193|NCT00621842|20889851|P1|Overall Study|Protocol Violation|4
6044194|NCT00621842|20889851|P1|Overall Study|Withdrawal by Subject|7
6044195|NCT00621842|20889851|P1|Overall Study|Adverse Event|6
6044196|NCT00621777|20889868|P2|Randomized Phase|Death|1
6044197|NCT00621777|20889869|P1|Randomized Phase|Death|0
6044198|NCT00621777|20889868|P2|Randomized Phase|administrative|3
6044199|NCT00621777|20889869|P1|Randomized Phase|administrative|0
6044200|NCT00621777|20889868|P2|Randomized Phase|Withdrawal by Subject|9
6044201|NCT00621777|20889869|P1|Randomized Phase|Withdrawal by Subject|1
6044202|NCT00621777|20889868|P2|Randomized Phase|Lost to Follow-up|3
6044203|NCT00621777|20889869|P1|Randomized Phase|Lost to Follow-up|3
6044204|NCT00621777|20889868|P2|Randomized Phase|Adverse Event|3
6044205|NCT00621777|20889869|P1|Randomized Phase|Adverse Event|3
6044206|NCT00621777|20889868|P2|Open Phase|Lost to Follow-up|0
6044207|NCT00621777|20889869|P1|Open Phase|Lost to Follow-up|10
6044208|NCT00621777|20889868|P2|Open Phase|administrative|0
6044209|NCT00621777|20889869|P1|Open Phase|administrative|13
6044210|NCT00621777|20889868|P2|Open Phase|Withdrawal by Subject|0
6044211|NCT00621777|20889869|P1|Open Phase|Withdrawal by Subject|17
6044212|NCT00621777|20889868|P2|Open Phase|Did not abstain during open phase|0
6044213|NCT00621777|20889869|P1|Open Phase|Did not abstain during open phase|56
6044214|NCT00621777|20889868|P2|Open Phase|Adverse Event|0
6044215|NCT00621777|20889869|P1|Open Phase|Adverse Event|20
6044216|NCT00621764|20889884|P4|Overall Study|Protocol Violation|1
6044217|NCT00621764|20889885|P3|Overall Study|Protocol Violation|0
6044218|NCT00621764|20889886|P2|Overall Study|Protocol Violation|0
6044219|NCT00621764|20889887|P1|Overall Study|Protocol Violation|0
6044220|NCT00621621|20889933|P2|Overall Study|Subjects were exited at EP study|0
6044221|NCT00621621|20889934|P1|Overall Study|Subjects were exited at EP study|30
6044222|NCT00621582|20889942|P1|Overall Study|issues not identified by investigators|18
6044223|NCT00621582|20889942|P1|Overall Study|Lost to Follow-up|24
6044224|NCT00621582|20889942|P1|Overall Study|Protocol Violation|57
6044225|NCT00621582|20889942|P1|Overall Study|Adverse Event|7
6044226|NCT00621543|20889949|P1|Overall Study|Lost to Follow-up|23
6044227|NCT00621517|20889973|P2|Overall Study|Adverse Event|0
6044228|NCT00621517|20889974|P1|Overall Study|Adverse Event|1
6044229|NCT00621517|20889973|P2|Overall Study|Withdrawal by Subject|4
6044230|NCT00621517|20889974|P1|Overall Study|Withdrawal by Subject|3
6044231|NCT00621517|20889973|P2|Overall Study|Lost to Follow-up|3
6044232|NCT00621517|20889974|P1|Overall Study|Lost to Follow-up|3
6044233|NCT00621504|20889986|P2|Overall Study|Death|6
6044234|NCT00621504|20889987|P1|Overall Study|Death|6
6044235|NCT00621504|20889986|P2|Overall Study|Other|0
6044236|NCT00621504|20889987|P1|Overall Study|Other|1
6044237|NCT00621504|20889986|P2|Overall Study|Lost to Follow-up|10
6044238|NCT00621504|20889987|P1|Overall Study|Lost to Follow-up|8
6044239|NCT00621504|20889986|P2|Overall Study|Withdrew consent|6
6044240|NCT00621504|20889987|P1|Overall Study|Withdrew consent|9
6044241|NCT00621504|20889986|P2|Overall Study|At the request of sponsor/investigator|0
6044242|NCT00621504|20889987|P1|Overall Study|At the request of sponsor/investigator|1
6044243|NCT00621504|20889986|P2|Overall Study|Adverse Event|3
6044244|NCT00621504|20889987|P1|Overall Study|Adverse Event|1
6044245|NCT00621322|20890021|P6|Overall Study|Migrated/moved from study area|2
6044246|NCT00621322|20890022|P5|Overall Study|Migrated/moved from study area|0
6044247|NCT00621322|20890023|P4|Overall Study|Migrated/moved from study area|1
6044248|NCT00621322|20890024|P3|Overall Study|Migrated/moved from study area|1
6044249|NCT00621322|20890025|P2|Overall Study|Migrated/moved from study area|0
6044250|NCT00621322|20890026|P1|Overall Study|Migrated/moved from study area|1
6044251|NCT00621322|20890021|P6|Overall Study|Withdrawal by Subject|2
6044252|NCT00621322|20890022|P5|Overall Study|Withdrawal by Subject|0
6044253|NCT00621322|20890023|P4|Overall Study|Withdrawal by Subject|1
6044254|NCT00621322|20890024|P3|Overall Study|Withdrawal by Subject|0
6044255|NCT00621322|20890025|P2|Overall Study|Withdrawal by Subject|0
6044256|NCT00621322|20890026|P1|Overall Study|Withdrawal by Subject|0
6044257|NCT00621322|20890021|P6|Overall Study|Physician Decision|0
6044258|NCT00621322|20890022|P5|Overall Study|Physician Decision|0
6044259|NCT00621322|20890023|P4|Overall Study|Physician Decision|1
6044260|NCT00621322|20890024|P3|Overall Study|Physician Decision|1
6044261|NCT00621322|20890025|P2|Overall Study|Physician Decision|0
6044262|NCT00621322|20890026|P1|Overall Study|Physician Decision|0
6044263|NCT00621322|20890021|P6|Overall Study|Lost to Follow-up|0
6044264|NCT00621322|20890022|P5|Overall Study|Lost to Follow-up|1
6044265|NCT00621322|20890023|P4|Overall Study|Lost to Follow-up|0
6044266|NCT00621322|20890024|P3|Overall Study|Lost to Follow-up|0
6044267|NCT00621322|20890025|P2|Overall Study|Lost to Follow-up|0
6044268|NCT00621322|20890026|P1|Overall Study|Lost to Follow-up|0
6044269|NCT00621309|20890106|P6|Overall Study|Withdrawal by Subject|1
6044270|NCT00621309|20890107|P5|Overall Study|Withdrawal by Subject|1
6044271|NCT00621309|20890108|P4|Overall Study|Withdrawal by Subject|1
6044272|NCT00621309|20890109|P3|Overall Study|Withdrawal by Subject|1
6044273|NCT00621309|20890110|P2|Overall Study|Withdrawal by Subject|0
6044274|NCT00621309|20890111|P1|Overall Study|Withdrawal by Subject|2
6044275|NCT00621296|20890117|P1|Overall Study|Stopping Criteria|3
6044276|NCT00621296|20890117|P1|Overall Study|Unmatch Criteria|1
6044277|NCT00621296|20890117|P1|Overall Study|Physician Decision|7
6044278|NCT00621296|20890117|P1|Overall Study|Lack of Efficacy|1
6044279|NCT00621296|20890117|P1|Overall Study|Adverse Event|2
6044280|NCT00621257|20890126|P5|Overall Study|Withdrawal by Subject|1
6044281|NCT00621257|20890127|P4|Overall Study|Withdrawal by Subject|1
6044282|NCT00621257|20890128|P3|Overall Study|Withdrawal by Subject|0
6044283|NCT00621257|20890129|P2|Overall Study|Withdrawal by Subject|0
6044284|NCT00621257|20890130|P1|Overall Study|Withdrawal by Subject|0
6044285|NCT00621257|20890126|P5|Overall Study|Physician Decision|1
6044286|NCT00621257|20890127|P4|Overall Study|Physician Decision|1
6044287|NCT00621257|20890128|P3|Overall Study|Physician Decision|0
6044288|NCT00621257|20890129|P2|Overall Study|Physician Decision|2
6044289|NCT00621257|20890130|P1|Overall Study|Physician Decision|0
6044290|NCT00621257|20890126|P5|Overall Study|Adverse Event|0
6044291|NCT00621257|20890127|P4|Overall Study|Adverse Event|0
6044292|NCT00621257|20890128|P3|Overall Study|Adverse Event|1
6044293|NCT00621257|20890129|P2|Overall Study|Adverse Event|1
6044294|NCT00621257|20890130|P1|Overall Study|Adverse Event|0
6044295|NCT00621257|20890126|P5|Overall Study|Lost to Follow-up|7
6044296|NCT00621257|20890127|P4|Overall Study|Lost to Follow-up|4
6044297|NCT00621257|20890128|P3|Overall Study|Lost to Follow-up|2
6044298|NCT00621257|20890129|P2|Overall Study|Lost to Follow-up|0
6044299|NCT00621257|20890130|P1|Overall Study|Lost to Follow-up|4
6044300|NCT00621244|20890146|P4|Overall Study|Administrative problems|2
6044301|NCT00621244|20890147|P3|Overall Study|Administrative problems|0
6044302|NCT00621244|20890148|P2|Overall Study|Administrative problems|1
6044303|NCT00621244|20890149|P1|Overall Study|Administrative problems|5
6044304|NCT00621244|20890146|P4|Overall Study|Adverse Event|2
6044305|NCT00621244|20890147|P3|Overall Study|Adverse Event|9
6044306|NCT00621244|20890148|P2|Overall Study|Adverse Event|7
6044307|NCT00621244|20890149|P1|Overall Study|Adverse Event|27
6044308|NCT00621244|20890146|P4|Overall Study|Death|1
6044309|NCT00621244|20890147|P3|Overall Study|Death|1
6044310|NCT00621244|20890148|P2|Overall Study|Death|3
6044311|NCT00621244|20890149|P1|Overall Study|Death|3
6044312|NCT00621244|20890146|P4|Overall Study|Disease progression|15
6044313|NCT00621244|20890147|P3|Overall Study|Disease progression|20
6044314|NCT00621244|20890148|P2|Overall Study|Disease progression|20
6044315|NCT00621244|20890149|P1|Overall Study|Disease progression|44
6044316|NCT00621244|20890146|P4|Overall Study|Withdrawal by Subject|3
6044317|NCT00621244|20890147|P3|Overall Study|Withdrawal by Subject|3
6044318|NCT00621244|20890148|P2|Overall Study|Withdrawal by Subject|3
6044319|NCT00621244|20890149|P1|Overall Study|Withdrawal by Subject|7
6044320|NCT00621192|20890253|P4|Overall Study|Final Assessments not Completed|1
6044321|NCT00621192|20890254|P3|Overall Study|Final Assessments not Completed|3
6044322|NCT00621192|20890255|P2|Overall Study|Final Assessments not Completed|0
6044323|NCT00621192|20890256|P1|Overall Study|Final Assessments not Completed|0
6044324|NCT00621192|20890253|P4|Overall Study|Death|0
6044325|NCT00621192|20890254|P3|Overall Study|Death|0
6044326|NCT00621192|20890255|P2|Overall Study|Death|5
6044327|NCT00621192|20890256|P1|Overall Study|Death|2
6044328|NCT00621192|20890253|P4|Overall Study|Adverse Event|1
6044329|NCT00621192|20890254|P3|Overall Study|Adverse Event|0
6044330|NCT00621192|20890255|P2|Overall Study|Adverse Event|1
6044331|NCT00621192|20890256|P1|Overall Study|Adverse Event|0
6044332|NCT00621192|20890253|P4|Overall Study|Protocol Violation|1
6044333|NCT00621192|20890254|P3|Overall Study|Protocol Violation|0
6044334|NCT00621192|20890255|P2|Overall Study|Protocol Violation|0
6044335|NCT00621192|20890256|P1|Overall Study|Protocol Violation|1
6044336|NCT00621192|20890253|P4|Overall Study|Physician Decision|0
6044337|NCT00621192|20890254|P3|Overall Study|Physician Decision|0
6044338|NCT00621192|20890255|P2|Overall Study|Physician Decision|3
6044339|NCT00621192|20890256|P1|Overall Study|Physician Decision|1
6044340|NCT00621192|20890253|P4|Overall Study|Withdrawal by Subject|0
6044341|NCT00621192|20890254|P3|Overall Study|Withdrawal by Subject|2
6044342|NCT00621192|20890255|P2|Overall Study|Withdrawal by Subject|0
6044343|NCT00621192|20890256|P1|Overall Study|Withdrawal by Subject|0
6044344|NCT00621153|20890297|P2|Overall Study|Withdrawal by Subject|5
6044345|NCT00621153|20890298|P1|Overall Study|Withdrawal by Subject|4
6044346|NCT00621153|20890297|P2|Overall Study|Lost to Follow-up|1
6044347|NCT00621153|20890298|P1|Overall Study|Lost to Follow-up|5
6044348|NCT00621153|20890297|P2|Overall Study|Adverse Event|2
6044349|NCT00621153|20890298|P1|Overall Study|Adverse Event|3
6044350|NCT00621153|20890297|P2|Overall Study|Safety Reason|7
6044351|NCT00621153|20890298|P1|Overall Study|Safety Reason|8
6044352|NCT00621140|20890306|P2|Overall Study|Other incl. lack of efficacy|5
6044353|NCT00621140|20890307|P1|Overall Study|Other incl. lack of efficacy|6
6044354|NCT00621140|20890306|P2|Overall Study|Withdrawal by Subject|6
6044355|NCT00621140|20890307|P1|Overall Study|Withdrawal by Subject|4
6044356|NCT00621140|20890306|P2|Overall Study|Lost to Follow-up|2
6044357|NCT00621140|20890307|P1|Overall Study|Lost to Follow-up|1
6044358|NCT00621140|20890306|P2|Overall Study|Adverse Event|5
6044359|NCT00621140|20890307|P1|Overall Study|Adverse Event|4
6044360|NCT00621023|20890354|P1|Overall Study|Follow up discontinued|1
6044361|NCT00621023|20890354|P1|Overall Study|Death|5
6044362|NCT00620854|20890371|P6|Washout 1|Withdrawal by Subject|0
6044363|NCT00620854|20890372|P5|Washout 1|Withdrawal by Subject|0
6044364|NCT00620854|20890373|P4|Washout 1|Withdrawal by Subject|1
6044365|NCT00620854|20890374|P3|Washout 1|Withdrawal by Subject|1
6044366|NCT00620854|20890375|P2|Washout 1|Withdrawal by Subject|0
6044367|NCT00620854|20890376|P1|Washout 1|Withdrawal by Subject|0
6044368|NCT00620815|20890407|P3|Overall Study|Protocol Violation|1
6044369|NCT00620815|20890408|P2|Overall Study|Protocol Violation|2
6044370|NCT00620815|20890409|P1|Overall Study|Protocol Violation|1
6044371|NCT00620815|20890407|P3|Overall Study|Inappropriate enrolment|1
6044372|NCT00620815|20890408|P2|Overall Study|Inappropriate enrolment|0
6044373|NCT00620815|20890409|P1|Overall Study|Inappropriate enrolment|0
6044374|NCT00620815|20890407|P3|Overall Study|Lost to Follow-up|3
6044375|NCT00620815|20890408|P2|Overall Study|Lost to Follow-up|6
6044376|NCT00620815|20890409|P1|Overall Study|Lost to Follow-up|1
6044377|NCT00620815|20890407|P3|Overall Study|Withdrawal by Subject|0
6044378|NCT00620815|20890408|P2|Overall Study|Withdrawal by Subject|2
6044379|NCT00620815|20890409|P1|Overall Study|Withdrawal by Subject|1
6044380|NCT00620815|20890407|P3|Overall Study|Adverse Event|2
6044381|NCT00620815|20890408|P2|Overall Study|Adverse Event|1
6044382|NCT00620815|20890409|P1|Overall Study|Adverse Event|1
6044383|NCT00620776|20890449|P2|Overall Study|Withdrawal by Subject|2
6044384|NCT00620776|20890450|P1|Overall Study|Withdrawal by Subject|3
6044385|NCT00620776|20890449|P2|Overall Study|Lost to Follow-up|5
6044386|NCT00620776|20890450|P1|Overall Study|Lost to Follow-up|2
6044387|NCT00620776|20890449|P2|Overall Study|Lack of Efficacy|1
6044388|NCT00620776|20890450|P1|Overall Study|Lack of Efficacy|2
6044389|NCT00620776|20890449|P2|Overall Study|Adverse Event|3
6044390|NCT00620776|20890450|P1|Overall Study|Adverse Event|2
6044391|NCT00620776|20890449|P2|Overall Study|Did not receive treatment|5
6044392|NCT00620776|20890450|P1|Overall Study|Did not receive treatment|3
6044393|NCT00620763|20890478|P2|Period: Second Intervention|Withdrawal by Subject|0
6044394|NCT00620763|20890479|P1|Period: Second Intervention|Withdrawal by Subject|1
6044395|NCT00620763|20890478|P2|Period: First Intervention|Protocol Violation|3
6044396|NCT00620763|20890479|P1|Period: First Intervention|Protocol Violation|0
6044397|NCT00620763|20890478|P2|Period: First Intervention|Withdrawal by Subject|2
6044398|NCT00620763|20890479|P1|Period: First Intervention|Withdrawal by Subject|0
6044399|NCT00620750|20890485|P1|Overall Study|Lost to Follow-up|25
6044400|NCT00620659|20890500|P6|Treatment Period 3|Withdrawal by Subject|0
6044401|NCT00620659|20890501|P5|Treatment Period 3|Withdrawal by Subject|0
6044402|NCT00620659|20890502|P4|Treatment Period 3|Withdrawal by Subject|1
6044403|NCT00620659|20890503|P3|Treatment Period 3|Withdrawal by Subject|0
6044404|NCT00620659|20890504|P2|Treatment Period 3|Withdrawal by Subject|0
6044405|NCT00620659|20890505|P1|Treatment Period 3|Withdrawal by Subject|0
6044406|NCT00620659|20890500|P6|Treatment Period 3|Adverse Event|0
6044407|NCT00620659|20890501|P5|Treatment Period 3|Adverse Event|0
6044408|NCT00620659|20890502|P4|Treatment Period 3|Adverse Event|0
6044409|NCT00620659|20890503|P3|Treatment Period 3|Adverse Event|0
6044410|NCT00620659|20890504|P2|Treatment Period 3|Adverse Event|2
6044411|NCT00620659|20890505|P1|Treatment Period 3|Adverse Event|0
6044412|NCT00620659|20890500|P6|Placebo Washout Period 2|Adverse Event|0
6044413|NCT00620659|20890501|P5|Placebo Washout Period 2|Adverse Event|0
6044414|NCT00620659|20890502|P4|Placebo Washout Period 2|Adverse Event|0
6044415|NCT00620659|20890503|P3|Placebo Washout Period 2|Adverse Event|0
6044416|NCT00620659|20890504|P2|Placebo Washout Period 2|Adverse Event|0
6044417|NCT00620659|20890505|P1|Placebo Washout Period 2|Adverse Event|2
6044418|NCT00620659|20890500|P6|Treatment Period 2|Withdrawal by Subject|0
6044419|NCT00620659|20890501|P5|Treatment Period 2|Withdrawal by Subject|3
6044420|NCT00620659|20890502|P4|Treatment Period 2|Withdrawal by Subject|0
6044421|NCT00620659|20890503|P3|Treatment Period 2|Withdrawal by Subject|1
6044422|NCT00620659|20890504|P2|Treatment Period 2|Withdrawal by Subject|0
6044423|NCT00620659|20890505|P1|Treatment Period 2|Withdrawal by Subject|0
6044424|NCT00620659|20890500|P6|Treatment Period 2|Adverse Event|0
6044425|NCT00620659|20890501|P5|Treatment Period 2|Adverse Event|2
6044426|NCT00620659|20890502|P4|Treatment Period 2|Adverse Event|0
6044427|NCT00620659|20890503|P3|Treatment Period 2|Adverse Event|0
6044428|NCT00620659|20890504|P2|Treatment Period 2|Adverse Event|3
6044429|NCT00620659|20890505|P1|Treatment Period 2|Adverse Event|0
6044430|NCT00620659|20890500|P6|Placebo Washout Period 1|Withdrawal by Subject|0
6044431|NCT00620659|20890501|P5|Placebo Washout Period 1|Withdrawal by Subject|0
6044432|NCT00620659|20890502|P4|Placebo Washout Period 1|Withdrawal by Subject|1
6044433|NCT00620659|20890503|P3|Placebo Washout Period 1|Withdrawal by Subject|0
6044434|NCT00620659|20890504|P2|Placebo Washout Period 1|Withdrawal by Subject|0
6044435|NCT00620659|20890505|P1|Placebo Washout Period 1|Withdrawal by Subject|0
6044436|NCT00620659|20890500|P6|Treatment Period 1|Withdrawal by Subject|0
6044437|NCT00620659|20890501|P5|Treatment Period 1|Withdrawal by Subject|1
6044438|NCT00620659|20890502|P4|Treatment Period 1|Withdrawal by Subject|0
6044439|NCT00620659|20890503|P3|Treatment Period 1|Withdrawal by Subject|1
6044440|NCT00620659|20890504|P2|Treatment Period 1|Withdrawal by Subject|0
6044441|NCT00620659|20890505|P1|Treatment Period 1|Withdrawal by Subject|1
6044442|NCT00620659|20890500|P6|Treatment Period 1|Protocol Violation|0
6044443|NCT00620659|20890501|P5|Treatment Period 1|Protocol Violation|0
6044444|NCT00620659|20890502|P4|Treatment Period 1|Protocol Violation|0
6044445|NCT00620659|20890503|P3|Treatment Period 1|Protocol Violation|0
6044446|NCT00620659|20890504|P2|Treatment Period 1|Protocol Violation|0
6044447|NCT00620659|20890505|P1|Treatment Period 1|Protocol Violation|1
6044448|NCT00620659|20890500|P6|Treatment Period 1|Adverse Event|0
6044449|NCT00620659|20890501|P5|Treatment Period 1|Adverse Event|0
6044450|NCT00620659|20890502|P4|Treatment Period 1|Adverse Event|3
6044451|NCT00620659|20890503|P3|Treatment Period 1|Adverse Event|0
6044452|NCT00620659|20890504|P2|Treatment Period 1|Adverse Event|0
6044453|NCT00620659|20890505|P1|Treatment Period 1|Adverse Event|1
6044460|NCT00620542|20890532|P4|Part B (2 Year Core Study)|IVUS not available|2
6044461|NCT00620542|20890533|P3|Part B (2 Year Core Study)|IVUS not available|3
6044462|NCT00620542|20890534|P2|Part B (2 Year Core Study)|IVUS not available|0
6044463|NCT00620542|20890535|P1|Part B (2 Year Core Study)|IVUS not available|0
6044464|NCT00620542|20890532|P4|Part B (2 Year Core Study)|Study specific discontinuation criteris|6
6044465|NCT00620542|20890533|P3|Part B (2 Year Core Study)|Study specific discontinuation criteris|6
6044466|NCT00620542|20890534|P2|Part B (2 Year Core Study)|Study specific discontinuation criteris|0
6044467|NCT00620542|20890535|P1|Part B (2 Year Core Study)|Study specific discontinuation criteris|0
6044468|NCT00620542|20890532|P4|Part B (2 Year Core Study)|Safety reasons|3
6044469|NCT00620542|20890533|P3|Part B (2 Year Core Study)|Safety reasons|2
6044470|NCT00620542|20890534|P2|Part B (2 Year Core Study)|Safety reasons|0
6044471|NCT00620542|20890535|P1|Part B (2 Year Core Study)|Safety reasons|0
6044472|NCT00620542|20890532|P4|Part B (2 Year Core Study)|Protocol Violation|16
6044473|NCT00620542|20890533|P3|Part B (2 Year Core Study)|Protocol Violation|13
6044474|NCT00620542|20890534|P2|Part B (2 Year Core Study)|Protocol Violation|0
6044475|NCT00620542|20890535|P1|Part B (2 Year Core Study)|Protocol Violation|0
6044476|NCT00620542|20890532|P4|Part B (2 Year Core Study)|Lost to Follow-up|9
6044477|NCT00620542|20890533|P3|Part B (2 Year Core Study)|Lost to Follow-up|20
6044478|NCT00620542|20890534|P2|Part B (2 Year Core Study)|Lost to Follow-up|0
6044479|NCT00620542|20890535|P1|Part B (2 Year Core Study)|Lost to Follow-up|0
6044480|NCT00620542|20890532|P4|Part B (2 Year Core Study)|Withdrawal by Subject|54
6044481|NCT00620542|20890533|P3|Part B (2 Year Core Study)|Withdrawal by Subject|55
6044482|NCT00620542|20890534|P2|Part B (2 Year Core Study)|Withdrawal by Subject|0
6044483|NCT00620542|20890535|P1|Part B (2 Year Core Study)|Withdrawal by Subject|0
6044484|NCT00620542|20890532|P4|Part B (2 Year Core Study)|Protocol Violation|5
6044485|NCT00620542|20890533|P3|Part B (2 Year Core Study)|Protocol Violation|3
6044486|NCT00620542|20890534|P2|Part B (2 Year Core Study)|Protocol Violation|0
6044487|NCT00620542|20890535|P1|Part B (2 Year Core Study)|Protocol Violation|0
6044488|NCT00620542|20890532|P4|Part B (2 Year Core Study)|Adverse Event|49
6044489|NCT00620542|20890533|P3|Part B (2 Year Core Study)|Adverse Event|46
6044490|NCT00620542|20890534|P2|Part B (2 Year Core Study)|Adverse Event|0
6044491|NCT00620542|20890535|P1|Part B (2 Year Core Study)|Adverse Event|0
6044492|NCT00620542|20890532|P4|Part A (Run-in - 2 Weeks)|IVUS not available|0
6044493|NCT00620542|20890533|P3|Part A (Run-in - 2 Weeks)|IVUS not available|0
6044494|NCT00620542|20890534|P2|Part A (Run-in - 2 Weeks)|IVUS not available|4
6044495|NCT00620542|20890535|P1|Part A (Run-in - 2 Weeks)|IVUS not available|4
6044496|NCT00620542|20890532|P4|Part A (Run-in - 2 Weeks)|Safety reasons|0
6044497|NCT00620542|20890533|P3|Part A (Run-in - 2 Weeks)|Safety reasons|0
6044498|NCT00620542|20890534|P2|Part A (Run-in - 2 Weeks)|Safety reasons|1
6044499|NCT00620542|20890535|P1|Part A (Run-in - 2 Weeks)|Safety reasons|0
6044500|NCT00620542|20890532|P4|Part A (Run-in - 2 Weeks)|Protocol Violation|0
6044501|NCT00620542|20890533|P3|Part A (Run-in - 2 Weeks)|Protocol Violation|0
6044502|NCT00620542|20890534|P2|Part A (Run-in - 2 Weeks)|Protocol Violation|1
6044503|NCT00620542|20890535|P1|Part A (Run-in - 2 Weeks)|Protocol Violation|0
6044504|NCT00620542|20890532|P4|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0
6044505|NCT00620542|20890533|P3|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0
6044506|NCT00620542|20890534|P2|Part A (Run-in - 2 Weeks)|Lost to Follow-up|6
6044507|NCT00620542|20890535|P1|Part A (Run-in - 2 Weeks)|Lost to Follow-up|7
6044508|NCT00620542|20890532|P4|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0
6044509|NCT00620542|20890533|P3|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0
6044510|NCT00620542|20890534|P2|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|40
6044511|NCT00620542|20890535|P1|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|43
6044512|NCT00620542|20890532|P4|Part A (Run-in - 2 Weeks)|Protocol Violation|0
6044513|NCT00620542|20890533|P3|Part A (Run-in - 2 Weeks)|Protocol Violation|0
6044514|NCT00620542|20890534|P2|Part A (Run-in - 2 Weeks)|Protocol Violation|409
6044515|NCT00620542|20890535|P1|Part A (Run-in - 2 Weeks)|Protocol Violation|406
6044516|NCT00620542|20890532|P4|Part A (Run-in - 2 Weeks)|Adverse Event|0
6044517|NCT00620542|20890533|P3|Part A (Run-in - 2 Weeks)|Adverse Event|0
6044518|NCT00620542|20890534|P2|Part A (Run-in - 2 Weeks)|Adverse Event|15
6044519|NCT00620542|20890535|P1|Part A (Run-in - 2 Weeks)|Adverse Event|12
6044520|NCT00620464|20890600|P2|Overall Study|Used prohibited medication|0
6044521|NCT00620464|20890601|P1|Overall Study|Used prohibited medication|1
6044522|NCT00620464|20890600|P2|Overall Study|Personal|2
6044523|NCT00620464|20890601|P1|Overall Study|Personal|2
6044524|NCT00620464|20890600|P2|Overall Study|Planning Pregnancy|4
6044525|NCT00620464|20890601|P1|Overall Study|Planning Pregnancy|1
6044526|NCT00620464|20890600|P2|Overall Study|Lost to Follow-up|1
6044527|NCT00620464|20890601|P1|Overall Study|Lost to Follow-up|1
6044528|NCT00620464|20890600|P2|Overall Study|Adverse Event|17
6044529|NCT00620464|20890601|P1|Overall Study|Adverse Event|15
6044530|NCT00620373|20890620|P1|Overall Study|Unverified cancer status|33
6044531|NCT00620321|20890638|P2|Overall Study|Withdrawal by Subject|1
6044532|NCT00620321|20890639|P1|Overall Study|Withdrawal by Subject|1
6044533|NCT00620321|20890638|P2|Overall Study|Sponsor Decision|1
6044534|NCT00620321|20890639|P1|Overall Study|Sponsor Decision|0
6044535|NCT00620321|20890638|P2|Overall Study|Progressive Disease|5
6044536|NCT00620321|20890639|P1|Overall Study|Progressive Disease|5
6044537|NCT00620321|20890638|P2|Overall Study|Physician Decision|7
6044538|NCT00620321|20890639|P1|Overall Study|Physician Decision|0
6044539|NCT00620321|20890638|P2|Overall Study|Death|1
6044540|NCT00620321|20890639|P1|Overall Study|Death|1
6044541|NCT00620321|20890638|P2|Overall Study|Adverse Event|1
6044542|NCT00620321|20890639|P1|Overall Study|Adverse Event|1
6044543|NCT00620282|20890658|P3|Overall Study|Withdrawal by Subject|0
6044544|NCT00620282|20890659|P2|Overall Study|Withdrawal by Subject|1
6044545|NCT00620282|20890660|P1|Overall Study|Withdrawal by Subject|0
6044546|NCT00620282|20890658|P3|Overall Study|Arterial line unable to be placed|1
6044547|NCT00620282|20890659|P2|Overall Study|Arterial line unable to be placed|0
6044548|NCT00620282|20890660|P1|Overall Study|Arterial line unable to be placed|0
6044549|NCT00620282|20890658|P3|Overall Study|Adverse Event|0
6044550|NCT00620282|20890659|P2|Overall Study|Adverse Event|1
6044551|NCT00620282|20890660|P1|Overall Study|Adverse Event|0
6044552|NCT00620113|20890739|P4|Overall Study|Withdrawal by Subject|5
6044553|NCT00620113|20890740|P3|Overall Study|Withdrawal by Subject|3
6044554|NCT00620113|20890741|P2|Overall Study|Withdrawal by Subject|1
6044555|NCT00620113|20890742|P1|Overall Study|Withdrawal by Subject|5
6044556|NCT00620113|20890739|P4|Overall Study|Protocol Violation|0
6044557|NCT00620113|20890740|P3|Overall Study|Protocol Violation|0
6044558|NCT00620113|20890741|P2|Overall Study|Protocol Violation|1
6044559|NCT00620113|20890742|P1|Overall Study|Protocol Violation|2
6044560|NCT00620113|20890739|P4|Overall Study|Physician Decision|2
6044561|NCT00620113|20890740|P3|Overall Study|Physician Decision|0
6044562|NCT00620113|20890741|P2|Overall Study|Physician Decision|0
6044563|NCT00620113|20890742|P1|Overall Study|Physician Decision|1
6044564|NCT00620113|20890739|P4|Overall Study|Lack of Efficacy|2
6044565|NCT00620113|20890740|P3|Overall Study|Lack of Efficacy|0
6044566|NCT00620113|20890741|P2|Overall Study|Lack of Efficacy|3
6044567|NCT00620113|20890742|P1|Overall Study|Lack of Efficacy|2
6044568|NCT00620113|20890739|P4|Overall Study|Adverse Event|1
6044569|NCT00620113|20890740|P3|Overall Study|Adverse Event|2
6044570|NCT00620113|20890741|P2|Overall Study|Adverse Event|2
6044571|NCT00620113|20890742|P1|Overall Study|Adverse Event|3
6044572|NCT00620074|20890792|P1|Overall Study|Adverse Event|1
6044573|NCT00620035|20890815|P1|Overall Study|Other Reason|38
6044574|NCT00620035|20890815|P1|Overall Study|Withdrawal of Informed Consent|1
6044575|NCT00620035|20890815|P1|Overall Study|Adverse Event|106
6044576|NCT00620022|20890825|P2|Treatment Period 2|Adverse Event|2
6044577|NCT00620022|20890826|P1|Treatment Period 2|Adverse Event|2
6044578|NCT00620022|20890825|P2|Treatment Period 1|Subject withdrew consent|0
6044579|NCT00620022|20890826|P1|Treatment Period 1|Subject withdrew consent|1
6044580|NCT00620022|20890825|P2|Treatment Period 1|Adverse Event|6
6044581|NCT00620022|20890826|P1|Treatment Period 1|Adverse Event|4
6044582|NCT00619983|20890838|P4|Test Drug Alone|Failure of daily diary device|2
6044583|NCT00619983|20890839|P3|Test Drug Alone|Failure of daily diary device|2
6044584|NCT00619983|20890840|P2|Test Drug Alone|Failure of daily diary device|1
6044585|NCT00619983|20890841|P1|Test Drug Alone|Failure of daily diary device|1
6044586|NCT00619983|20890838|P4|Test Drug Alone|Withdrawal by Subject|1
6044587|NCT00619983|20890839|P3|Test Drug Alone|Withdrawal by Subject|0
6044588|NCT00619983|20890840|P2|Test Drug Alone|Withdrawal by Subject|0
6044589|NCT00619983|20890841|P1|Test Drug Alone|Withdrawal by Subject|1
6044590|NCT00619957|20890868|P2|Month 48 Open-Label|Withdrawal by Subject|9
6044591|NCT00619957|20890869|P1|Month 48 Open-Label|Withdrawal by Subject|6
6044592|NCT00619957|20890868|P2|Month 48 Open-Label|Lost to Follow-up|4
6044593|NCT00619957|20890869|P1|Month 48 Open-Label|Lost to Follow-up|2
6044594|NCT00619957|20890868|P2|Month 48 Open-Label|Adverse Event|4
6044595|NCT00619957|20890869|P1|Month 48 Open-Label|Adverse Event|4
6044596|NCT00619957|20890868|P2|Month 24 Double-Blind|Did not take any study medication|1
6044597|NCT00619957|20890869|P1|Month 24 Double-Blind|Did not take any study medication|0
6044598|NCT00619957|20890868|P2|Month 24 Double-Blind|Lost to Follow-up|0
6044599|NCT00619957|20890869|P1|Month 24 Double-Blind|Lost to Follow-up|1
6044600|NCT00619957|20890868|P2|Month 24 Double-Blind|Withdrawal by Subject|9
6044601|NCT00619957|20890869|P1|Month 24 Double-Blind|Withdrawal by Subject|7
6044602|NCT00619957|20890868|P2|Month 24 Double-Blind|Protocol Violation|0
6044603|NCT00619957|20890869|P1|Month 24 Double-Blind|Protocol Violation|1
6044604|NCT00619957|20890868|P2|Month 24 Double-Blind|Adverse Event|7
6044605|NCT00619957|20890869|P1|Month 24 Double-Blind|Adverse Event|9
6044606|NCT00619918|20890951|P2|Overall Study|Left before receiving first dose|8
6044607|NCT00619918|20890952|P1|Overall Study|Left before receiving first dose|5
6044608|NCT00619918|20890951|P2|Overall Study|Transfer to outside facility|3
6044609|NCT00619918|20890952|P1|Overall Study|Transfer to outside facility|3
6044610|NCT00619918|20890951|P2|Overall Study|Physician Decision|8
6044611|NCT00619918|20890952|P1|Overall Study|Physician Decision|8
6044612|NCT00619918|20890951|P2|Overall Study|Withdrawal by Subject|3
6044613|NCT00619918|20890952|P1|Overall Study|Withdrawal by Subject|4
6044614|NCT00619892|20890962|P2|Overall Study|Intercurrent illness|1
6044615|NCT00619892|20890963|P1|Overall Study|Intercurrent illness|0
6044616|NCT00619892|20890962|P2|Overall Study|Lost to Follow-up|1
6044617|NCT00619892|20890963|P1|Overall Study|Lost to Follow-up|0
6044618|NCT00619892|20890962|P2|Overall Study|Adverse Event|0
6044619|NCT00619892|20890963|P1|Overall Study|Adverse Event|3
6044620|NCT00619866|20890974|P5|Weeks 13 - 24|Lost to Follow-up|0
6044621|NCT00619866|20890975|P4|Weeks 13 - 24|Lost to Follow-up|0
6044622|NCT00619866|20890976|P3|Weeks 13 - 24|Lost to Follow-up|0
6044623|NCT00619866|20890977|P2|Weeks 13 - 24|Lost to Follow-up|3
6044624|NCT00619866|20890978|P1|Weeks 13 - 24|Lost to Follow-up|0
6044625|NCT00619866|20890974|P5|Weeks 13 - 24|Non-compliance|0
6044626|NCT00619866|20890975|P4|Weeks 13 - 24|Non-compliance|0
6044627|NCT00619866|20890976|P3|Weeks 13 - 24|Non-compliance|1
6044628|NCT00619866|20890977|P2|Weeks 13 - 24|Non-compliance|1
6044629|NCT00619866|20890978|P1|Weeks 13 - 24|Non-compliance|0
6044630|NCT00619866|20890974|P5|Weeks 13 - 24|Withdrawal by Subject|2
6044631|NCT00619866|20890975|P4|Weeks 13 - 24|Withdrawal by Subject|2
6044632|NCT00619866|20890976|P3|Weeks 13 - 24|Withdrawal by Subject|2
6044633|NCT00619866|20890977|P2|Weeks 13 - 24|Withdrawal by Subject|3
6044634|NCT00619866|20890978|P1|Weeks 13 - 24|Withdrawal by Subject|0
6044635|NCT00619866|20890974|P5|Weeks 13 - 24|Protocol Deviation|0
6044636|NCT00619866|20890975|P4|Weeks 13 - 24|Protocol Deviation|1
6044637|NCT00619866|20890976|P3|Weeks 13 - 24|Protocol Deviation|0
6044638|NCT00619866|20890977|P2|Weeks 13 - 24|Protocol Deviation|0
6044639|NCT00619866|20890978|P1|Weeks 13 - 24|Protocol Deviation|0
6044640|NCT00619866|20890974|P5|Weeks 13 - 24|Adverse Event|0
6044641|NCT00619866|20890975|P4|Weeks 13 - 24|Adverse Event|1
6044642|NCT00619866|20890976|P3|Weeks 13 - 24|Adverse Event|2
6044643|NCT00619866|20890977|P2|Weeks 13 - 24|Adverse Event|0
6044644|NCT00619866|20890978|P1|Weeks 13 - 24|Adverse Event|0
6044645|NCT00619866|20890974|P5|Weeks 1 - 12|Sponsor Decision|0
6044646|NCT00619866|20890975|P4|Weeks 1 - 12|Sponsor Decision|0
6044647|NCT00619866|20890976|P3|Weeks 1 - 12|Sponsor Decision|0
6044648|NCT00619866|20890977|P2|Weeks 1 - 12|Sponsor Decision|1
6044649|NCT00619866|20890978|P1|Weeks 1 - 12|Sponsor Decision|0
6044650|NCT00619866|20890974|P5|Weeks 1 - 12|Lost to Follow-up|0
6044651|NCT00619866|20890975|P4|Weeks 1 - 12|Lost to Follow-up|0
6044652|NCT00619866|20890976|P3|Weeks 1 - 12|Lost to Follow-up|2
6044653|NCT00619866|20890977|P2|Weeks 1 - 12|Lost to Follow-up|0
6044654|NCT00619866|20890978|P1|Weeks 1 - 12|Lost to Follow-up|4
6044655|NCT00619866|20890974|P5|Weeks 1 - 12|Lack of Efficacy|0
6044656|NCT00619866|20890975|P4|Weeks 1 - 12|Lack of Efficacy|0
6044657|NCT00619866|20890976|P3|Weeks 1 - 12|Lack of Efficacy|1
6044658|NCT00619866|20890977|P2|Weeks 1 - 12|Lack of Efficacy|2
6044659|NCT00619866|20890978|P1|Weeks 1 - 12|Lack of Efficacy|3
6044660|NCT00619866|20890974|P5|Weeks 1 - 12|Withdrawal by Subject|0
6044661|NCT00619866|20890975|P4|Weeks 1 - 12|Withdrawal by Subject|0
6044662|NCT00619866|20890976|P3|Weeks 1 - 12|Withdrawal by Subject|4
6044663|NCT00619866|20890977|P2|Weeks 1 - 12|Withdrawal by Subject|2
6044664|NCT00619866|20890978|P1|Weeks 1 - 12|Withdrawal by Subject|7
6044665|NCT00619866|20890974|P5|Weeks 1 - 12|Non-compliance|0
6044666|NCT00619866|20890975|P4|Weeks 1 - 12|Non-compliance|0
6044667|NCT00619866|20890976|P3|Weeks 1 - 12|Non-compliance|1
6044668|NCT00619866|20890977|P2|Weeks 1 - 12|Non-compliance|0
6044669|NCT00619866|20890978|P1|Weeks 1 - 12|Non-compliance|0
6044670|NCT00619866|20890974|P5|Weeks 1 - 12|Adverse Event|0
6044671|NCT00619866|20890975|P4|Weeks 1 - 12|Adverse Event|0
6044672|NCT00619866|20890976|P3|Weeks 1 - 12|Adverse Event|2
6044673|NCT00619866|20890977|P2|Weeks 1 - 12|Adverse Event|1
6044674|NCT00619866|20890978|P1|Weeks 1 - 12|Adverse Event|0
6044675|NCT00619827|20891065|P2|Overall Study|Withdrawal by Subject|2
6044676|NCT00619827|20891066|P1|Overall Study|Withdrawal by Subject|2
6044677|NCT00619827|20891065|P2|Overall Study|Adverse Event|2
6044678|NCT00619827|20891066|P1|Overall Study|Adverse Event|1
6044679|NCT00619801|20891074|P2|Overall Study|Loss of efficacy|1
6044680|NCT00619801|20891075|P1|Overall Study|Loss of efficacy|0
6044681|NCT00619801|20891074|P2|Overall Study|Withdrawal by Subject|1
6044682|NCT00619801|20891075|P1|Overall Study|Withdrawal by Subject|1
6044683|NCT00619801|20891074|P2|Overall Study|Lack of Efficacy|1
6044684|NCT00619801|20891075|P1|Overall Study|Lack of Efficacy|0
6044685|NCT00619645|20891132|P1|Overall Study|Adverse Event|1
6044686|NCT00619619|20891146|P8|Overall Study|Adverse Event|2
6044687|NCT00619619|20891147|P7|Overall Study|Adverse Event|0
6044688|NCT00619619|20891148|P6|Overall Study|Adverse Event|0
6044689|NCT00619619|20891149|P5|Overall Study|Adverse Event|2
6044690|NCT00619619|20891150|P4|Overall Study|Adverse Event|0
6044691|NCT00619619|20891151|P3|Overall Study|Adverse Event|0
6044692|NCT00619619|20891152|P2|Overall Study|Adverse Event|0
6044693|NCT00619619|20891153|P1|Overall Study|Adverse Event|0
6044694|NCT00619619|20891146|P8|Overall Study|Protocol Violation|1
6044695|NCT00619619|20891147|P7|Overall Study|Protocol Violation|1
6044696|NCT00619619|20891148|P6|Overall Study|Protocol Violation|0
6044697|NCT00619619|20891149|P5|Overall Study|Protocol Violation|0
6044698|NCT00619619|20891150|P4|Overall Study|Protocol Violation|1
6044699|NCT00619619|20891151|P3|Overall Study|Protocol Violation|0
6044700|NCT00619619|20891152|P2|Overall Study|Protocol Violation|0
6044701|NCT00619619|20891153|P1|Overall Study|Protocol Violation|0
6044702|NCT00619619|20891146|P8|Overall Study|Physician Decision|0
6044703|NCT00619619|20891147|P7|Overall Study|Physician Decision|0
6044704|NCT00619619|20891148|P6|Overall Study|Physician Decision|0
6044705|NCT00619619|20891149|P5|Overall Study|Physician Decision|0
6044706|NCT00619619|20891150|P4|Overall Study|Physician Decision|0
6044707|NCT00619619|20891151|P3|Overall Study|Physician Decision|1
6044708|NCT00619619|20891152|P2|Overall Study|Physician Decision|0
6044709|NCT00619619|20891153|P1|Overall Study|Physician Decision|0
6044710|NCT00619515|20891238|P1|Overall Study|Study Termination by IRB|73
6044711|NCT00619502|20891252|P2|Overall Study|Lost to Follow-up|10
6044712|NCT00619502|20891253|P1|Overall Study|Lost to Follow-up|8
6044713|NCT00619489|20891265|P2|Overall Study|Rolled over to Study C13008 (NCT00790933|15
6044714|NCT00619489|20891266|P1|Overall Study|Rolled over to Study C13008 (NCT00790933|22
6044715|NCT00619489|20891265|P2|Overall Study|Lack of Efficacy|11
6044716|NCT00619489|20891266|P1|Overall Study|Lack of Efficacy|0
6044717|NCT00619489|20891265|P2|Overall Study|Withdrawal by Subject|1
6044718|NCT00619489|20891266|P1|Overall Study|Withdrawal by Subject|1
6044719|NCT00619489|20891265|P2|Overall Study|Adverse Event|7
6044720|NCT00619489|20891266|P1|Overall Study|Adverse Event|0
6044721|NCT00619476|20891288|P4|Overall Study|Withdrawal by Subject|4
6044722|NCT00619476|20891289|P3|Overall Study|Withdrawal by Subject|5
6044723|NCT00619476|20891290|P2|Overall Study|Withdrawal by Subject|7
6044724|NCT00619476|20891291|P1|Overall Study|Withdrawal by Subject|5
6044725|NCT00619476|20891288|P4|Overall Study|Investigator Discretion|0
6044726|NCT00619476|20891289|P3|Overall Study|Investigator Discretion|2
6044727|NCT00619476|20891290|P2|Overall Study|Investigator Discretion|2
6044728|NCT00619476|20891291|P1|Overall Study|Investigator Discretion|2
6044729|NCT00619476|20891288|P4|Overall Study|Lost to Follow-up|1
6044730|NCT00619476|20891289|P3|Overall Study|Lost to Follow-up|0
6044731|NCT00619476|20891290|P2|Overall Study|Lost to Follow-up|2
6044732|NCT00619476|20891291|P1|Overall Study|Lost to Follow-up|1
6044733|NCT00619476|20891288|P4|Overall Study|Protocol Violation|9
6044734|NCT00619476|20891289|P3|Overall Study|Protocol Violation|4
6044735|NCT00619476|20891290|P2|Overall Study|Protocol Violation|4
6044736|NCT00619476|20891291|P1|Overall Study|Protocol Violation|5
6044737|NCT00619476|20891288|P4|Overall Study|Lack of Efficacy|4
6044738|NCT00619476|20891289|P3|Overall Study|Lack of Efficacy|1
6044739|NCT00619476|20891290|P2|Overall Study|Lack of Efficacy|1
6044740|NCT00619476|20891291|P1|Overall Study|Lack of Efficacy|6
6044741|NCT00619476|20891288|P4|Overall Study|Adverse Event|16
6044742|NCT00619476|20891289|P3|Overall Study|Adverse Event|12
6044743|NCT00619476|20891290|P2|Overall Study|Adverse Event|6
6044744|NCT00619476|20891291|P1|Overall Study|Adverse Event|12
6044745|NCT00619385|20891376|P3|Overall Study|Other|1
6044746|NCT00619385|20891377|P2|Overall Study|Other|2
6044747|NCT00619385|20891378|P1|Overall Study|Other|1
6044748|NCT00619385|20891376|P3|Overall Study|Adverse Event|3
6044749|NCT00619385|20891377|P2|Overall Study|Adverse Event|0
6044750|NCT00619385|20891378|P1|Overall Study|Adverse Event|0
6044751|NCT00619359|20891393|P2|Overall Study|Progressive Disease|1
6044752|NCT00619359|20891394|P1|Overall Study|Progressive Disease|3
6044753|NCT00619359|20891393|P2|Overall Study|Withdrawal by Subject|20
6044754|NCT00619359|20891394|P1|Overall Study|Withdrawal by Subject|19
6044755|NCT00619359|20891393|P2|Overall Study|Protocol Violation|1
6044756|NCT00619359|20891394|P1|Overall Study|Protocol Violation|1
6044757|NCT00619359|20891393|P2|Overall Study|Physician Decision|7
6044758|NCT00619359|20891394|P1|Overall Study|Physician Decision|0
6044759|NCT00619359|20891393|P2|Overall Study|Lost to Follow-up|16
6044760|NCT00619359|20891394|P1|Overall Study|Lost to Follow-up|12
6044761|NCT00619359|20891393|P2|Overall Study|Adverse Event|36
6044762|NCT00619359|20891394|P1|Overall Study|Adverse Event|32
6044763|NCT00619307|20891406|P2|Overall Study|MS attack plus steroids|1
6044764|NCT00619307|20891407|P1|Overall Study|MS attack plus steroids|0
6044765|NCT00619307|20891406|P2|Overall Study|Severe migraine|1
6044766|NCT00619307|20891407|P1|Overall Study|Severe migraine|0
6044767|NCT00619307|20891406|P2|Overall Study|Withdrew consent|0
6044768|NCT00619307|20891407|P1|Overall Study|Withdrew consent|1
6044769|NCT00619307|20891406|P2|Overall Study|Protocol Violation|0
6044770|NCT00619307|20891407|P1|Overall Study|Protocol Violation|3
6044771|NCT00619307|20891406|P2|Overall Study|Lost to Follow-up|1
6044772|NCT00619307|20891407|P1|Overall Study|Lost to Follow-up|0
6044773|NCT00619307|20891406|P2|Overall Study|Adverse Event|1
6044774|NCT00619307|20891407|P1|Overall Study|Adverse Event|0
6044775|NCT00619229|20891444|P2|Overall Study|Investigator planned Cataract Operation|0
6044776|NCT00619229|20891445|P1|Overall Study|Investigator planned Cataract Operation|1
6044777|NCT00619229|20891444|P2|Overall Study|Termination of the Study by the Sponsor|1
6044778|NCT00619229|20891445|P1|Overall Study|Termination of the Study by the Sponsor|1
6044779|NCT00619229|20891444|P2|Overall Study|Lost to Follow-up|0
6044780|NCT00619229|20891445|P1|Overall Study|Lost to Follow-up|1
6044781|NCT00619229|20891444|P2|Overall Study|Withdrawal by Subject|1
6044782|NCT00619229|20891445|P1|Overall Study|Withdrawal by Subject|1
6044783|NCT00619177|20891484|P1|Overall Study|Not specified reasons|6
6044784|NCT00619177|20891484|P1|Overall Study|Missing termination information|481
6044785|NCT00619177|20891484|P1|Overall Study|Lack of Efficacy|1
6044786|NCT00619177|20891484|P1|Overall Study|Lost to Follow-up|2
6044787|NCT00619177|20891484|P1|Overall Study|Adverse Event|18
6044788|NCT00619151|20891494|P2|Overall Study|Study terminated prior to followup|0
6044789|NCT00619151|20891495|P1|Overall Study|Study terminated prior to followup|1
6044790|NCT00619112|20891505|P2|Overall Study|Adverse Event|2
6044791|NCT00619112|20891506|P1|Overall Study|Adverse Event|1
6044792|NCT00619099|20891527|P2|Overall Study|Physician Decision|6
6044793|NCT00619099|20891528|P1|Overall Study|Physician Decision|9
6044794|NCT00619099|20891527|P2|Overall Study|Withdrawal by Subject|2
6044795|NCT00619099|20891528|P1|Overall Study|Withdrawal by Subject|10
6044796|NCT00619099|20891527|P2|Overall Study|Emergence of Clinically Significant Lab|2
6044797|NCT00619099|20891528|P1|Overall Study|Emergence of Clinically Significant Lab|1
6044798|NCT00619099|20891527|P2|Overall Study|Adverse Event|3
6044799|NCT00619099|20891528|P1|Overall Study|Adverse Event|4
6044800|NCT00619099|20891527|P2|Overall Study|Allogeneic Bone Marrow Transplantation|1
6044801|NCT00619099|20891528|P1|Overall Study|Allogeneic Bone Marrow Transplantation|2
6044802|NCT00619099|20891527|P2|Overall Study|Progressive Disease|5
6044803|NCT00619099|20891528|P1|Overall Study|Progressive Disease|7
6044804|NCT00618995|20891550|P4|Period 4|Adverse Event|0
6044805|NCT00618995|20891551|P3|Period 4|Adverse Event|0
6044806|NCT00618995|20891552|P2|Period 4|Adverse Event|0
6044807|NCT00618995|20891553|P1|Period 4|Adverse Event|1
6044808|NCT00618995|20891550|P4|Period 2|Protocol Violation|0
6044809|NCT00618995|20891551|P3|Period 2|Protocol Violation|1
6044810|NCT00618995|20891552|P2|Period 2|Protocol Violation|0
6044811|NCT00618995|20891553|P1|Period 2|Protocol Violation|0
6044812|NCT00618995|20891550|P4|Period 1|Protocol Violation|0
6044813|NCT00618995|20891551|P3|Period 1|Protocol Violation|1
6044814|NCT00618995|20891552|P2|Period 1|Protocol Violation|1
6044815|NCT00618995|20891553|P1|Period 1|Protocol Violation|0
6044816|NCT00618995|20891550|P4|Period 1|Adverse Event|0
6044817|NCT00618995|20891551|P3|Period 1|Adverse Event|1
6044818|NCT00618995|20891552|P2|Period 1|Adverse Event|0
6044819|NCT00618995|20891553|P1|Period 1|Adverse Event|0
6044820|NCT00618982|20891567|P1|Overall Study|ongoing, still treated with study med.|25
6044821|NCT00618982|20891567|P1|Overall Study|Protocol Violation|1
6044822|NCT00618982|20891567|P1|Overall Study|Withdrawal by Subject|1
6044823|NCT00618982|20891567|P1|Overall Study|Adverse Event|23
6044824|NCT00618956|20891590|P2|Overall Study|did not meet criteria, non-compliance|1
6044825|NCT00618956|20891591|P1|Overall Study|did not meet criteria, non-compliance|2
6044826|NCT00618956|20891590|P2|Overall Study|Protocol Violation|2
6044827|NCT00618956|20891591|P1|Overall Study|Protocol Violation|2
6044828|NCT00618956|20891590|P2|Overall Study|Lost to Follow-up|5
6044829|NCT00618956|20891591|P1|Overall Study|Lost to Follow-up|4
6044830|NCT00618956|20891590|P2|Overall Study|Withdrawal by Subject|7
6044831|NCT00618956|20891591|P1|Overall Study|Withdrawal by Subject|5
6044832|NCT00618956|20891590|P2|Overall Study|Lack of Efficacy|1
6044833|NCT00618956|20891591|P1|Overall Study|Lack of Efficacy|2
6044834|NCT00618956|20891590|P2|Overall Study|Adverse Event|34
6044835|NCT00618956|20891591|P1|Overall Study|Adverse Event|10
6044836|NCT00618826|20891616|P1|Overall Study|Adverse Event|1
6044837|NCT00618813|20891621|P1|Overall Study|Withdrawal by Subject|1
6044838|NCT00618813|20891621|P1|Overall Study|Physician Decision|2
6044839|NCT00618813|20891621|P1|Overall Study|Lack of Efficacy|1
6044840|NCT00618787|20891631|P2|Overall Study|Lost to Follow-up|0
6044841|NCT00618787|20891632|P1|Overall Study|Lost to Follow-up|1
6044842|NCT00618787|20891631|P2|Overall Study|Withdrawal by Subject|1
6044843|NCT00618787|20891632|P1|Overall Study|Withdrawal by Subject|2
6044844|NCT00618787|20891631|P2|Overall Study|Adverse Event|1
6044845|NCT00618787|20891632|P1|Overall Study|Adverse Event|0
6044846|NCT00618774|20891640|P2|Overall Study|Withdrawal by Subject|0
6044847|NCT00618774|20891641|P1|Overall Study|Withdrawal by Subject|1
6044848|NCT00618774|20891640|P2|Overall Study|Adverse Event|3
6044849|NCT00618774|20891641|P1|Overall Study|Adverse Event|5
6044850|NCT00618748|20891674|P3|Overall Study|Withdrawal by Subject|5
6044851|NCT00618748|20891675|P2|Overall Study|Withdrawal by Subject|1
6044852|NCT00618748|20891676|P1|Overall Study|Withdrawal by Subject|4
6044853|NCT00618748|20891674|P3|Overall Study|Physician Decision|1
6044854|NCT00618748|20891675|P2|Overall Study|Physician Decision|1
6044855|NCT00618748|20891676|P1|Overall Study|Physician Decision|3
6044856|NCT00618748|20891674|P3|Overall Study|Adverse Event|8
6044857|NCT00618748|20891675|P2|Overall Study|Adverse Event|3
6044858|NCT00618748|20891676|P1|Overall Study|Adverse Event|4
6044859|NCT00618722|20891721|P4|Overall Study|Miscellaneous Reasons|1
6044860|NCT00618722|20891722|P3|Overall Study|Miscellaneous Reasons|1
6044861|NCT00618722|20891723|P2|Overall Study|Miscellaneous Reasons|0
6044862|NCT00618722|20891724|P1|Overall Study|Miscellaneous Reasons|0
6044863|NCT00618722|20891721|P4|Overall Study|Lost to Follow-up|2
6044864|NCT00618722|20891722|P3|Overall Study|Lost to Follow-up|0
6044865|NCT00618722|20891723|P2|Overall Study|Lost to Follow-up|0
6044866|NCT00618722|20891724|P1|Overall Study|Lost to Follow-up|2
6044867|NCT00618722|20891721|P4|Overall Study|Inability to Complete Study Procedure|0
6044868|NCT00618722|20891722|P3|Overall Study|Inability to Complete Study Procedure|0
6044869|NCT00618722|20891723|P2|Overall Study|Inability to Complete Study Procedure|1
6044958|NCT00617851|20892074|P2|Overall Study|Unable to classify|0
6044870|NCT00618722|20891724|P1|Overall Study|Inability to Complete Study Procedure|0
6044871|NCT00618722|20891721|P4|Overall Study|Patient Request|1
6044872|NCT00618722|20891722|P3|Overall Study|Patient Request|1
6044873|NCT00618722|20891723|P2|Overall Study|Patient Request|1
6044874|NCT00618722|20891724|P1|Overall Study|Patient Request|1
6044875|NCT00618722|20891721|P4|Overall Study|Refusal of Treatment|0
6044876|NCT00618722|20891722|P3|Overall Study|Refusal of Treatment|1
6044877|NCT00618722|20891723|P2|Overall Study|Refusal of Treatment|0
6044878|NCT00618722|20891724|P1|Overall Study|Refusal of Treatment|0
6044879|NCT00618618|20891762|P4|Overall Study|Death|0
6044880|NCT00618618|20891763|P3|Overall Study|Death|0
6044881|NCT00618618|20891764|P2|Overall Study|Death|1
6044882|NCT00618618|20891765|P1|Overall Study|Death|0
6044883|NCT00618618|20891762|P4|Overall Study|Did Not Meet Entry Criteria|0
6044884|NCT00618618|20891763|P3|Overall Study|Did Not Meet Entry Criteria|1
6044885|NCT00618618|20891764|P2|Overall Study|Did Not Meet Entry Criteria|0
6044886|NCT00618618|20891765|P1|Overall Study|Did Not Meet Entry Criteria|0
6044887|NCT00618618|20891762|P4|Overall Study|Non-compliance|0
6044888|NCT00618618|20891763|P3|Overall Study|Non-compliance|0
6044889|NCT00618618|20891764|P2|Overall Study|Non-compliance|1
6044890|NCT00618618|20891765|P1|Overall Study|Non-compliance|1
6044891|NCT00618618|20891762|P4|Overall Study|Lost to Follow-up|1
6044892|NCT00618618|20891763|P3|Overall Study|Lost to Follow-up|0
6044893|NCT00618618|20891764|P2|Overall Study|Lost to Follow-up|0
6044894|NCT00618618|20891765|P1|Overall Study|Lost to Follow-up|3
6044895|NCT00618618|20891762|P4|Overall Study|Inability to Complete Study Procedures|0
6044896|NCT00618618|20891763|P3|Overall Study|Inability to Complete Study Procedures|0
6044897|NCT00618618|20891764|P2|Overall Study|Inability to Complete Study Procedures|1
6044898|NCT00618618|20891765|P1|Overall Study|Inability to Complete Study Procedures|0
6044899|NCT00618618|20891762|P4|Overall Study|Patient Request|0
6044900|NCT00618618|20891763|P3|Overall Study|Patient Request|2
6044901|NCT00618618|20891764|P2|Overall Study|Patient Request|0
6044902|NCT00618618|20891765|P1|Overall Study|Patient Request|0
6044903|NCT00618514|20891824|P3|Overall Study|Lost to Follow-up|4
6044904|NCT00618514|20891825|P2|Overall Study|Lost to Follow-up|12
6044905|NCT00618514|20891826|P1|Overall Study|Lost to Follow-up|11
6044906|NCT00618449|20891846|P2|Overall Study|Lost to Follow-up|110
6044907|NCT00618449|20891847|P1|Overall Study|Lost to Follow-up|98
6044908|NCT00618410|20891866|P2|Washout Period (2 Weeks)|Physician Decision|1
6044909|NCT00618410|20891867|P1|Washout Period (2 Weeks)|Physician Decision|0
6044910|NCT00618371|20891883|P1|Overall Study|Withdrawal by Subject|2
6044911|NCT00618072|20891916|P3|Overall Study|Physician Decision|1
6044912|NCT00618072|20891917|P2|Overall Study|Physician Decision|1
6044913|NCT00618072|20891918|P1|Overall Study|Physician Decision|0
6044914|NCT00618072|20891916|P3|Overall Study|Lost to Follow-up|3
6044915|NCT00618072|20891917|P2|Overall Study|Lost to Follow-up|0
6044916|NCT00618072|20891918|P1|Overall Study|Lost to Follow-up|2
6044917|NCT00617929|20891974|P1|Overall Study|Physician Decision|1
6044918|NCT00617903|20891986|P2|Overall Study|noncompliance|1
6044919|NCT00617903|20891987|P1|Overall Study|noncompliance|0
6044920|NCT00617903|20891986|P2|Overall Study|Adverse Event|1
6044921|NCT00617903|20891987|P1|Overall Study|Adverse Event|0
6044922|NCT00617903|20891986|P2|Overall Study|Lack of Efficacy|1
6044923|NCT00617903|20891987|P1|Overall Study|Lack of Efficacy|0
6044924|NCT00617903|20891986|P2|Overall Study|Lost to Follow-up|1
6044925|NCT00617903|20891987|P1|Overall Study|Lost to Follow-up|1
6044926|NCT00617903|20891986|P2|Overall Study|Withdrawal by Subject|3
6044927|NCT00617903|20891987|P1|Overall Study|Withdrawal by Subject|2
6044928|NCT00617890|20892033|P4|Overall Study|Not treated|1
6044929|NCT00617890|20892034|P3|Overall Study|Not treated|1
6044930|NCT00617890|20892035|P2|Overall Study|Not treated|0
6044931|NCT00617890|20892036|P1|Overall Study|Not treated|1
6044932|NCT00617890|20892033|P4|Overall Study|Adverse Event|8
6044933|NCT00617890|20892034|P3|Overall Study|Adverse Event|3
6044934|NCT00617890|20892035|P2|Overall Study|Adverse Event|0
6044935|NCT00617890|20892036|P1|Overall Study|Adverse Event|1
6044936|NCT00617890|20892033|P4|Overall Study|Protocol Violation|0
6044937|NCT00617890|20892034|P3|Overall Study|Protocol Violation|0
6044938|NCT00617890|20892035|P2|Overall Study|Protocol Violation|1
6044939|NCT00617890|20892036|P1|Overall Study|Protocol Violation|2
6044940|NCT00617890|20892033|P4|Overall Study|Withdrawal by Subject|2
6044941|NCT00617890|20892034|P3|Overall Study|Withdrawal by Subject|0
6044942|NCT00617890|20892035|P2|Overall Study|Withdrawal by Subject|1
6044943|NCT00617890|20892036|P1|Overall Study|Withdrawal by Subject|4
6044944|NCT00617890|20892033|P4|Overall Study|Lost to Follow-up|2
6044945|NCT00617890|20892034|P3|Overall Study|Lost to Follow-up|1
6044946|NCT00617890|20892035|P2|Overall Study|Lost to Follow-up|0
6044947|NCT00617890|20892036|P1|Overall Study|Lost to Follow-up|0
6044948|NCT00617890|20892033|P4|Overall Study|Lack of Efficacy|97
6044949|NCT00617890|20892034|P3|Overall Study|Lack of Efficacy|30
6044950|NCT00617890|20892035|P2|Overall Study|Lack of Efficacy|26
6044951|NCT00617890|20892036|P1|Overall Study|Lack of Efficacy|23
6044952|NCT00617890|20892033|P4|Overall Study|Treatment ongoing at data cut-off|5
6044953|NCT00617890|20892034|P3|Overall Study|Treatment ongoing at data cut-off|0
6044954|NCT00617890|20892035|P2|Overall Study|Treatment ongoing at data cut-off|0
6044955|NCT00617890|20892036|P1|Overall Study|Treatment ongoing at data cut-off|0
6044956|NCT00617851|20892072|P4|Overall Study|Unable to classify|0
6044957|NCT00617851|20892073|P3|Overall Study|Unable to classify|1
6044959|NCT00617851|20892075|P1|Overall Study|Unable to classify|1
6044960|NCT00617851|20892072|P4|Overall Study|Inappropriate Enrollment|1
6044961|NCT00617851|20892073|P3|Overall Study|Inappropriate Enrollment|1
6044962|NCT00617851|20892074|P2|Overall Study|Inappropriate Enrollment|4
6044963|NCT00617851|20892075|P1|Overall Study|Inappropriate Enrollment|5
6044964|NCT00617851|20892072|P4|Overall Study|Lost to Follow-up|19
6044965|NCT00617851|20892073|P3|Overall Study|Lost to Follow-up|31
6044966|NCT00617851|20892074|P2|Overall Study|Lost to Follow-up|29
6044967|NCT00617851|20892075|P1|Overall Study|Lost to Follow-up|27
6044968|NCT00617851|20892072|P4|Overall Study|Withdrawal by Subject|4
6044969|NCT00617851|20892073|P3|Overall Study|Withdrawal by Subject|12
6044970|NCT00617851|20892074|P2|Overall Study|Withdrawal by Subject|7
6044971|NCT00617851|20892075|P1|Overall Study|Withdrawal by Subject|14
6044972|NCT00617851|20892072|P4|Overall Study|Death|1
6044973|NCT00617851|20892073|P3|Overall Study|Death|0
6044974|NCT00617851|20892074|P2|Overall Study|Death|0
6044975|NCT00617851|20892075|P1|Overall Study|Death|0
6044976|NCT00617773|20892113|P1|Overall Study|Protocol Violation|1
6044977|NCT00617773|20892113|P1|Overall Study|Progressive disease|19
6044978|NCT00617773|20892113|P1|Overall Study|Death|1
6044979|NCT00617773|20892113|P1|Overall Study|Withdrawal by Subject|1
6044980|NCT00617773|20892113|P1|Overall Study|Lack of compliance with the protocol|1
6044981|NCT00617773|20892113|P1|Overall Study|Physician Decision|1
6044982|NCT00617734|20892130|P2|Overall Study|Lost to Follow-up|1
6044983|NCT00617734|20892131|P1|Overall Study|Lost to Follow-up|0
6044984|NCT00617734|20892130|P2|Overall Study|Found Ineligible After Randomization|4
6044985|NCT00617734|20892131|P1|Overall Study|Found Ineligible After Randomization|1
6044986|NCT00617734|20892130|P2|Overall Study|Protocol Violation|0
6044987|NCT00617734|20892131|P1|Overall Study|Protocol Violation|1
6044988|NCT00617734|20892130|P2|Overall Study|Adverse Event|1
6044989|NCT00617734|20892131|P1|Overall Study|Adverse Event|4
6044990|NCT00617734|20892130|P2|Overall Study|Withdrew Consent|0
6044991|NCT00617734|20892131|P1|Overall Study|Withdrew Consent|2
6044992|NCT00617708|20892152|P3|Overall Study|Not eligible|5
6044993|NCT00617708|20892153|P2|Overall Study|Not eligible|3
6044994|NCT00617708|20892154|P1|Overall Study|Not eligible|1
6044995|NCT00617708|20892152|P3|Overall Study|Not protocol specified|2
6044996|NCT00617708|20892153|P2|Overall Study|Not protocol specified|4
6044997|NCT00617708|20892154|P1|Overall Study|Not protocol specified|1
6044998|NCT00617708|20892152|P3|Overall Study|Progression/Relapse|36
6044999|NCT00617708|20892153|P2|Overall Study|Progression/Relapse|40
6045000|NCT00617708|20892154|P1|Overall Study|Progression/Relapse|7
6045001|NCT00617708|20892152|P3|Overall Study|Death|5
6045002|NCT00617708|20892153|P2|Overall Study|Death|6
6045003|NCT00617708|20892154|P1|Overall Study|Death|0
6045004|NCT00617708|20892152|P3|Overall Study|Withdrawal by Subject|7
6045005|NCT00617708|20892153|P2|Overall Study|Withdrawal by Subject|1
6045006|NCT00617708|20892154|P1|Overall Study|Withdrawal by Subject|1
6045007|NCT00617708|20892152|P3|Overall Study|Adverse Event|9
6045008|NCT00617708|20892153|P2|Overall Study|Adverse Event|6
6045009|NCT00617708|20892154|P1|Overall Study|Adverse Event|0
6045010|NCT00617669|20892171|P2|Overall Study|Patients randomized but not treated|3
6045011|NCT00617669|20892172|P1|Overall Study|Patients randomized but not treated|2
6045012|NCT00617669|20892171|P2|Overall Study|Reason not otherwise captured, eg; death|290
6045013|NCT00617669|20892172|P1|Overall Study|Reason not otherwise captured, eg; death|265
6045014|NCT00617669|20892171|P2|Overall Study|Protocol Violation|3
6045015|NCT00617669|20892172|P1|Overall Study|Protocol Violation|2
6045016|NCT00617669|20892171|P2|Overall Study|Adverse Event|76
6045017|NCT00617669|20892172|P1|Overall Study|Adverse Event|87
6045018|NCT00617669|20892171|P2|Overall Study|Lost to Follow-up|2
6045019|NCT00617669|20892172|P1|Overall Study|Lost to Follow-up|3
6045020|NCT00617669|20892171|P2|Overall Study|Withdrawal by Subject|77
6045021|NCT00617669|20892172|P1|Overall Study|Withdrawal by Subject|71
6045022|NCT00617604|20892194|P2|Overall Study|Randomized but Never Received Study Drug|3
6045023|NCT00617604|20892195|P1|Overall Study|Randomized but Never Received Study Drug|3
6045024|NCT00617604|20892194|P2|Overall Study|Withdrawal by Subject|6
6045025|NCT00617604|20892195|P1|Overall Study|Withdrawal by Subject|4
6045026|NCT00617604|20892194|P2|Overall Study|Miscellaneous Reasons|10
6045027|NCT00617604|20892195|P1|Overall Study|Miscellaneous Reasons|8
6045028|NCT00617604|20892194|P2|Overall Study|Lost to Follow-up|0
6045029|NCT00617604|20892195|P1|Overall Study|Lost to Follow-up|1
6045030|NCT00617604|20892194|P2|Overall Study|Death|1
6045031|NCT00617604|20892195|P1|Overall Study|Death|2
6045032|NCT00617591|20892239|P1|Overall Study|Withdrew consent during Maintenance|6
6045033|NCT00617591|20892239|P1|Overall Study|Withdrew consent during Induction|4
6045034|NCT00617461|20892255|P2|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|2
6045035|NCT00617461|20892256|P1|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|1
6045036|NCT00617461|20892255|P2|6-Day Down-Titration Period|Withdrawal by Subject|0
6045037|NCT00617461|20892256|P1|6-Day Down-Titration Period|Withdrawal by Subject|1
6045038|NCT00617461|20892255|P2|Second Treatment Intervention Period|Lack of Efficacy|3
6045039|NCT00617461|20892256|P1|Second Treatment Intervention Period|Lack of Efficacy|0
6045040|NCT00617461|20892255|P2|Second Treatment Intervention Period|Adverse Event|1
6045041|NCT00617461|20892256|P1|Second Treatment Intervention Period|Adverse Event|0
6045042|NCT00617461|20892255|P2|4-Day Crossover Period|Withdrawal by Subject|0
6045043|NCT00617461|20892256|P1|4-Day Crossover Period|Withdrawal by Subject|1
6045044|NCT00617461|20892255|P2|First Treatment Intervention Period|Withdrawal by Subject|0
6045045|NCT00617461|20892256|P1|First Treatment Intervention Period|Withdrawal by Subject|4
6045046|NCT00617461|20892255|P2|First Treatment Intervention Period|Investigator Discretion|1
6045047|NCT00617461|20892256|P1|First Treatment Intervention Period|Investigator Discretion|1
6045048|NCT00617461|20892255|P2|First Treatment Intervention Period|Lost to Follow-up|1
6045049|NCT00617461|20892256|P1|First Treatment Intervention Period|Lost to Follow-up|0
6045050|NCT00617461|20892255|P2|First Treatment Intervention Period|Protocol Violation|1
6045051|NCT00617461|20892256|P1|First Treatment Intervention Period|Protocol Violation|2
6045052|NCT00617461|20892255|P2|First Treatment Intervention Period|Lack of Efficacy|0
6045053|NCT00617461|20892256|P1|First Treatment Intervention Period|Lack of Efficacy|1
6045054|NCT00617461|20892255|P2|First Treatment Intervention Period|Adverse Event|0
6045055|NCT00617461|20892256|P1|First Treatment Intervention Period|Adverse Event|2
6045056|NCT00617409|20892312|P3|Overall Study|Alternative Therapy|0
6045057|NCT00617409|20892313|P2|Overall Study|Alternative Therapy|2
6045058|NCT00617409|20892314|P1|Overall Study|Alternative Therapy|1
6045059|NCT00617409|20892312|P3|Overall Study|Death|4
6045060|NCT00617409|20892313|P2|Overall Study|Death|5
6045061|NCT00617409|20892314|P1|Overall Study|Death|3
6045062|NCT00617409|20892312|P3|Overall Study|Disease Progression|18
6045063|NCT00617409|20892313|P2|Overall Study|Disease Progression|8
6045064|NCT00617409|20892314|P1|Overall Study|Disease Progression|8
6045065|NCT00617409|20892312|P3|Overall Study|Adverse Event|3
6045066|NCT00617409|20892313|P2|Overall Study|Adverse Event|2
6045067|NCT00617409|20892314|P1|Overall Study|Adverse Event|0
6045068|NCT00617409|20892312|P3|Overall Study|Withdrawal by Subject|2
6045069|NCT00617409|20892313|P2|Overall Study|Withdrawal by Subject|1
6045070|NCT00617409|20892314|P1|Overall Study|Withdrawal by Subject|4
6045071|NCT00617357|20892329|P1|Overall Study|Physician Decision|1
6045072|NCT00617357|20892329|P1|Overall Study|Withdrawal by Subject|1
6045073|NCT00617357|20892329|P1|Overall Study|insurance concerns|2
6045074|NCT00617357|20892329|P1|Overall Study|Death|5
6045075|NCT00617357|20892329|P1|Overall Study|Lost to Follow-up|7
6045076|NCT00617344|20892342|P3|Overall Study|Withdrawal by Subject|2
6045077|NCT00617344|20892343|P2|Overall Study|Withdrawal by Subject|9
6045078|NCT00617344|20892344|P1|Overall Study|Withdrawal by Subject|8
6045079|NCT00617344|20892342|P3|Overall Study|Lost to Follow-up|1
6045080|NCT00617344|20892343|P2|Overall Study|Lost to Follow-up|4
6045081|NCT00617344|20892344|P1|Overall Study|Lost to Follow-up|5
6045082|NCT00617344|20892342|P3|Overall Study|Protocol Violation|5
6045083|NCT00617344|20892343|P2|Overall Study|Protocol Violation|8
6045084|NCT00617344|20892344|P1|Overall Study|Protocol Violation|10
6045085|NCT00617344|20892342|P3|Overall Study|Other Adverse Event|0
6045086|NCT00617344|20892343|P2|Overall Study|Other Adverse Event|1
6045087|NCT00617344|20892344|P1|Overall Study|Other Adverse Event|1
6045088|NCT00617344|20892342|P3|Overall Study|Serious adverse event|0
6045089|NCT00617344|20892343|P2|Overall Study|Serious adverse event|0
6045090|NCT00617344|20892344|P1|Overall Study|Serious adverse event|1
6045091|NCT00617305|20892372|P3|Overall Study|Withdrawal by Subject|0
6045092|NCT00617305|20892373|P2|Overall Study|Withdrawal by Subject|0
6045093|NCT00617305|20892374|P1|Overall Study|Withdrawal by Subject|1
6045094|NCT00617305|20892372|P3|Overall Study|Protocol Violation|1
6045095|NCT00617305|20892373|P2|Overall Study|Protocol Violation|0
6045096|NCT00617305|20892374|P1|Overall Study|Protocol Violation|1
6045097|NCT00617305|20892372|P3|Overall Study|Physician Decision|0
6045098|NCT00617305|20892373|P2|Overall Study|Physician Decision|0
6045099|NCT00617305|20892374|P1|Overall Study|Physician Decision|1
6045100|NCT00617305|20892372|P3|Overall Study|Death|0
6045101|NCT00617305|20892373|P2|Overall Study|Death|0
6045102|NCT00617305|20892374|P1|Overall Study|Death|1
6045103|NCT00617305|20892372|P3|Overall Study|Adverse Event|0
6045104|NCT00617305|20892373|P2|Overall Study|Adverse Event|0
6045105|NCT00617305|20892374|P1|Overall Study|Adverse Event|4
6045106|NCT00617279|20892430|P2|Overall Study|Death|2
6045107|NCT00617279|20892431|P1|Overall Study|Death|1
6045108|NCT00617279|20892430|P2|Overall Study|Lost to Follow-up|0
6045109|NCT00617279|20892431|P1|Overall Study|Lost to Follow-up|1
6045110|NCT00617279|20892430|P2|Overall Study|Graft abandonment|0
6045111|NCT00617279|20892431|P1|Overall Study|Graft abandonment|2
6045112|NCT00617279|20892430|P2|Overall Study|Study terminated by Sponsor|15
6045113|NCT00617279|20892431|P1|Overall Study|Study terminated by Sponsor|10
6045114|NCT00617240|20892487|P2|Overall Study|Lack of Efficacy|0
6045115|NCT00617240|20892488|P1|Overall Study|Lack of Efficacy|1
6045116|NCT00617201|20892508|P2|Overall Study|Lost to Follow-up|13
6045117|NCT00617201|20892509|P1|Overall Study|Lost to Follow-up|9
6045118|NCT00617123|20892537|P2|Study Treatment Period|Noncompliance with Protocol|1
6045119|NCT00617123|20892538|P1|Study Treatment Period|Noncompliance with Protocol|0
6045120|NCT00617123|20892537|P2|Study Treatment Period|Did Not Meet Protocol Eligibility|0
6045121|NCT00617123|20892538|P1|Study Treatment Period|Did Not Meet Protocol Eligibility|2
6045122|NCT00617123|20892537|P2|Study Treatment Period|Adverse Event|3
6045123|NCT00617123|20892538|P1|Study Treatment Period|Adverse Event|7
6045124|NCT00617123|20892537|P2|Study Treatment Period|Withdrawal by Subject|12
6045125|NCT00617123|20892538|P1|Study Treatment Period|Withdrawal by Subject|8
6045126|NCT00617123|20892537|P2|Referral Screening Period|Adverse Event|1
6045127|NCT00617123|20892538|P1|Referral Screening Period|Adverse Event|0
6045128|NCT00617123|20892537|P2|Referral Screening Period|Did Not Wish To Continue|1
6045129|NCT00617123|20892538|P1|Referral Screening Period|Did Not Wish To Continue|3
6045130|NCT00617123|20892537|P2|Referral Screening Period|Did Not Meet Protocol Eligibility|24
6045131|NCT00617123|20892538|P1|Referral Screening Period|Did Not Meet Protocol Eligibility|36
6045132|NCT00617084|20892569|P2|Overall Study|Missed 12 Months visit|19
6045133|NCT00617084|20892570|P1|Overall Study|Missed 12 Months visit|16
6045134|NCT00617084|20892569|P2|Overall Study|Withdrawal by Subject|7
6045135|NCT00617084|20892570|P1|Overall Study|Withdrawal by Subject|5
6045139|NCT00616941|20892650|P3|Overall Study|Vaccination Suspended|3
6045140|NCT00616941|20892651|P2|Overall Study|Vaccination Suspended|0
6045141|NCT00616941|20892652|P1|Overall Study|Vaccination Suspended|0
6045142|NCT00616941|20892650|P3|Overall Study|Unrelated Medical Illness/Complication|0
6045143|NCT00616941|20892651|P2|Overall Study|Unrelated Medical Illness/Complication|2
6045144|NCT00616941|20892652|P1|Overall Study|Unrelated Medical Illness/Complication|0
6045145|NCT00616941|20892650|P3|Overall Study|Subject Non-compliance|1
6045146|NCT00616941|20892651|P2|Overall Study|Subject Non-compliance|0
6045147|NCT00616941|20892652|P1|Overall Study|Subject Non-compliance|0
6045148|NCT00616941|20892650|P3|Overall Study|Adverse Event|1
6045149|NCT00616941|20892651|P2|Overall Study|Adverse Event|1
6045150|NCT00616941|20892652|P1|Overall Study|Adverse Event|0
6045151|NCT00616941|20892650|P3|Overall Study|Progressive Disease|1
6045152|NCT00616941|20892651|P2|Overall Study|Progressive Disease|2
6045153|NCT00616941|20892652|P1|Overall Study|Progressive Disease|1
6045154|NCT00616928|20892679|P4|Overall Study|Lost to Follow-up|0
6045155|NCT00616928|20892680|P3|Overall Study|Lost to Follow-up|0
6045156|NCT00616928|20892681|P2|Overall Study|Lost to Follow-up|7
6045157|NCT00616928|20892682|P1|Overall Study|Lost to Follow-up|5
6045158|NCT00616928|20892679|P4|Overall Study|Other|5
6045159|NCT00616928|20892680|P3|Overall Study|Other|15
6045160|NCT00616928|20892681|P2|Overall Study|Other|8
6045161|NCT00616928|20892682|P1|Overall Study|Other|51
6045162|NCT00616928|20892679|P4|Overall Study|Adverse Event|2
6045163|NCT00616928|20892680|P3|Overall Study|Adverse Event|2
6045164|NCT00616928|20892681|P2|Overall Study|Adverse Event|3
6045165|NCT00616928|20892682|P1|Overall Study|Adverse Event|6
6045166|NCT00616902|20892746|P2|Overall Study|Termination of study|6
6045167|NCT00616902|20892747|P1|Overall Study|Termination of study|6
6045168|NCT00616759|20892790|P2|Overall Study|Withdrawal by Subject|2
6045169|NCT00616759|20892791|P1|Overall Study|Withdrawal by Subject|1
6045170|NCT00616759|20892790|P2|Overall Study|Physician Decision|0
6045171|NCT00616759|20892791|P1|Overall Study|Physician Decision|2
6045172|NCT00616655|20892800|P3|Overall Study|Other|5
6045173|NCT00616655|20892801|P2|Overall Study|Other|6
6045174|NCT00616655|20892802|P1|Overall Study|Other|6
6045175|NCT00616655|20892800|P3|Overall Study|Does not meet in/ex criteria|2
6045176|NCT00616655|20892801|P2|Overall Study|Does not meet in/ex criteria|0
6045177|NCT00616655|20892802|P1|Overall Study|Does not meet in/ex criteria|0
6045178|NCT00616655|20892800|P3|Overall Study|Withdrawal by Subject|11
6045179|NCT00616655|20892801|P2|Overall Study|Withdrawal by Subject|7
6045180|NCT00616655|20892802|P1|Overall Study|Withdrawal by Subject|9
6045181|NCT00616655|20892800|P3|Overall Study|Protocol Violation|3
6045182|NCT00616655|20892801|P2|Overall Study|Protocol Violation|4
6045183|NCT00616655|20892802|P1|Overall Study|Protocol Violation|2
6045184|NCT00616655|20892800|P3|Overall Study|Lost to Follow-up|10
6045185|NCT00616655|20892801|P2|Overall Study|Lost to Follow-up|12
6045186|NCT00616655|20892802|P1|Overall Study|Lost to Follow-up|3
6045187|NCT00616655|20892800|P3|Overall Study|Lack of Efficacy|5
6045188|NCT00616655|20892801|P2|Overall Study|Lack of Efficacy|5
6045189|NCT00616655|20892802|P1|Overall Study|Lack of Efficacy|5
6045190|NCT00616655|20892800|P3|Overall Study|Adverse Event|12
6045191|NCT00616655|20892801|P2|Overall Study|Adverse Event|7
6045192|NCT00616655|20892802|P1|Overall Study|Adverse Event|10
6045193|NCT00616642|20892842|P2|Overall Study|Withdrawal by Subject|1
6045194|NCT00616642|20892843|P1|Overall Study|Withdrawal by Subject|0
6045195|NCT00616629|20892854|P5|Overall Study|AV-block|0
6045196|NCT00616629|20892855|P4|Overall Study|AV-block|0
6045197|NCT00616629|20892856|P3|Overall Study|AV-block|0
6045198|NCT00616629|20892857|P2|Overall Study|AV-block|0
6045199|NCT00616629|20892858|P1|Overall Study|AV-block|1
6045200|NCT00616629|20892854|P5|Overall Study|Protocol Violation|0
6045201|NCT00616629|20892855|P4|Overall Study|Protocol Violation|0
6045202|NCT00616629|20892856|P3|Overall Study|Protocol Violation|1
6045203|NCT00616629|20892857|P2|Overall Study|Protocol Violation|2
6045204|NCT00616629|20892858|P1|Overall Study|Protocol Violation|1
6045205|NCT00616603|20892903|P3|Overall Study|Physician Decision|2
6045206|NCT00616603|20892904|P2|Overall Study|Physician Decision|0
6045207|NCT00616603|20892905|P1|Overall Study|Physician Decision|2
6045208|NCT00616434|20892928|P2|Overall Study|Protocol deviation|1
6045209|NCT00616434|20892929|P1|Overall Study|Protocol deviation|0
6045210|NCT00616434|20892928|P2|Overall Study|Withdrawal by Subject|1
6045211|NCT00616434|20892929|P1|Overall Study|Withdrawal by Subject|1
6045212|NCT00616434|20892928|P2|Overall Study|Physician Decision|4
6045213|NCT00616434|20892929|P1|Overall Study|Physician Decision|0
6045214|NCT00616434|20892928|P2|Overall Study|Adverse Event|2
6045215|NCT00616434|20892929|P1|Overall Study|Adverse Event|5
6045216|NCT00616421|20892942|P3|Overall Study|Unable to classify|0
6045217|NCT00616421|20892943|P2|Overall Study|Unable to classify|0
6045218|NCT00616421|20892944|P1|Overall Study|Unable to classify|1
6045219|NCT00616421|20892942|P3|Overall Study|Protocol Violation|2
6045220|NCT00616421|20892943|P2|Overall Study|Protocol Violation|1
6045221|NCT00616421|20892944|P1|Overall Study|Protocol Violation|0
6045222|NCT00616421|20892942|P3|Overall Study|Administrative reason|0
6045223|NCT00616421|20892943|P2|Overall Study|Administrative reason|0
6045224|NCT00616421|20892944|P1|Overall Study|Administrative reason|1
6045225|NCT00616421|20892942|P3|Overall Study|Inappropriate enrollment|1
6045226|NCT00616421|20892943|P2|Overall Study|Inappropriate enrollment|0
6045227|NCT00616421|20892944|P1|Overall Study|Inappropriate enrollment|3
6045228|NCT00616421|20892942|P3|Overall Study|Lost to Follow-up|30
6045229|NCT00616421|20892943|P2|Overall Study|Lost to Follow-up|26
6045230|NCT00616421|20892944|P1|Overall Study|Lost to Follow-up|12
6045231|NCT00616421|20892942|P3|Overall Study|Withdrawal by Subject|8
6045232|NCT00616421|20892943|P2|Overall Study|Withdrawal by Subject|11
6045233|NCT00616421|20892944|P1|Overall Study|Withdrawal by Subject|9
6045234|NCT00616239|20892985|P1|Overall Study|Withdrawal by Subject|2
6045235|NCT00616018|20893015|P1|Overall Study|Protocol Violation|3
6045236|NCT00615992|20893020|P1|Overall Study|Protocol Violation|67
6045237|NCT00615914|20893046|P1|Overall Study|Irregularly enrolled patients|10
6045238|NCT00615914|20893046|P1|Overall Study|No treatment|2
6045239|NCT00615914|20893046|P1|Overall Study|No data was collected.|65
6045240|NCT00615914|20893046|P1|Overall Study|Physician Decision|4
6045241|NCT00615914|20893046|P1|Overall Study|Withdrawal by Subject|16
6045242|NCT00615914|20893046|P1|Overall Study|Lost to Follow-up|187
6045243|NCT00615914|20893046|P1|Overall Study|Lack of Efficacy|59
6045244|NCT00615914|20893046|P1|Overall Study|Death|20
6045245|NCT00615914|20893046|P1|Overall Study|Adverse Event|274
6045246|NCT00615901|20893053|P1|Overall Study|Adverse Event|7
6045247|NCT00615901|20893053|P1|Overall Study|Withdrawal by Subject|2
6045248|NCT00615836|20893061|P5|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0
6045249|NCT00615836|20893062|P4|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0
6045250|NCT00615836|20893063|P3|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0
6045251|NCT00615836|20893064|P2|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0
6045252|NCT00615836|20893065|P1|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|65
6045253|NCT00615836|20893061|P5|Extension Study (FE992026 CS31)|Not reported|0
6045254|NCT00615836|20893062|P4|Extension Study (FE992026 CS31)|Not reported|4
6045255|NCT00615836|20893063|P3|Extension Study (FE992026 CS31)|Not reported|1
6045256|NCT00615836|20893064|P2|Extension Study (FE992026 CS31)|Not reported|4
6045257|NCT00615836|20893065|P1|Extension Study (FE992026 CS31)|Not reported|6
6045258|NCT00615836|20893061|P5|Extension Study (FE992026 CS31)|Other|0
6045259|NCT00615836|20893062|P4|Extension Study (FE992026 CS31)|Other|8
6045260|NCT00615836|20893063|P3|Extension Study (FE992026 CS31)|Other|8
6045261|NCT00615836|20893064|P2|Extension Study (FE992026 CS31)|Other|7
6045262|NCT00615836|20893065|P1|Extension Study (FE992026 CS31)|Other|10
6045263|NCT00615836|20893061|P5|Extension Study (FE992026 CS31)|Lost to Follow-up|0
6045264|NCT00615836|20893062|P4|Extension Study (FE992026 CS31)|Lost to Follow-up|10
6045265|NCT00615836|20893063|P3|Extension Study (FE992026 CS31)|Lost to Follow-up|5
6045266|NCT00615836|20893064|P2|Extension Study (FE992026 CS31)|Lost to Follow-up|14
6045267|NCT00615836|20893065|P1|Extension Study (FE992026 CS31)|Lost to Follow-up|10
6045268|NCT00615836|20893061|P5|Extension Study (FE992026 CS31)|Withdrawal by Subject|0
6045269|NCT00615836|20893062|P4|Extension Study (FE992026 CS31)|Withdrawal by Subject|43
6045270|NCT00615836|20893063|P3|Extension Study (FE992026 CS31)|Withdrawal by Subject|38
6045271|NCT00615836|20893064|P2|Extension Study (FE992026 CS31)|Withdrawal by Subject|42
6045272|NCT00615836|20893065|P1|Extension Study (FE992026 CS31)|Withdrawal by Subject|37
6045273|NCT00615836|20893061|P5|Extension Study (FE992026 CS31)|Protocol Violation|0
6045274|NCT00615836|20893062|P4|Extension Study (FE992026 CS31)|Protocol Violation|3
6045275|NCT00615836|20893063|P3|Extension Study (FE992026 CS31)|Protocol Violation|2
6045276|NCT00615836|20893064|P2|Extension Study (FE992026 CS31)|Protocol Violation|5
6045277|NCT00615836|20893065|P1|Extension Study (FE992026 CS31)|Protocol Violation|4
6045278|NCT00615836|20893061|P5|Extension Study (FE992026 CS31)|Use of exclusionary medication|0
6045279|NCT00615836|20893062|P4|Extension Study (FE992026 CS31)|Use of exclusionary medication|0
6045280|NCT00615836|20893063|P3|Extension Study (FE992026 CS31)|Use of exclusionary medication|1
6045281|NCT00615836|20893064|P2|Extension Study (FE992026 CS31)|Use of exclusionary medication|2
6045282|NCT00615836|20893065|P1|Extension Study (FE992026 CS31)|Use of exclusionary medication|1
6045283|NCT00615836|20893061|P5|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0
6045284|NCT00615836|20893062|P4|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3
6045285|NCT00615836|20893063|P3|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3
6045286|NCT00615836|20893064|P2|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0
6045287|NCT00615836|20893065|P1|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|1
6045288|NCT00615836|20893061|P5|Extension Study (FE992026 CS31)|Adverse Event|0
6045289|NCT00615836|20893062|P4|Extension Study (FE992026 CS31)|Adverse Event|13
6045290|NCT00615836|20893063|P3|Extension Study (FE992026 CS31)|Adverse Event|15
6045291|NCT00615836|20893064|P2|Extension Study (FE992026 CS31)|Adverse Event|12
6045292|NCT00615836|20893065|P1|Extension Study (FE992026 CS31)|Adverse Event|7
6045293|NCT00615719|20893130|P1|Overall Study|Physician Decision|5
6045294|NCT00615550|20893144|P2|Overall Study|Lost to Follow-up|1
6045295|NCT00615550|20893145|P1|Overall Study|Lost to Follow-up|6
6045296|NCT00615459|20893168|P4|Period III|Unsatisfactory therapeutic effect|0
6045297|NCT00615459|20893169|P3|Period III|Unsatisfactory therapeutic effect|0
6045298|NCT00615459|20893170|P2|Period III|Unsatisfactory therapeutic effect|1
6045299|NCT00615459|20893171|P1|Period III|Unsatisfactory therapeutic effect|0
6045300|NCT00615459|20893168|P4|Period III|Administrative problems|0
6045301|NCT00615459|20893169|P3|Period III|Administrative problems|1
6045302|NCT00615459|20893170|P2|Period III|Administrative problems|1
6045303|NCT00615459|20893171|P1|Period III|Administrative problems|0
6045304|NCT00615459|20893168|P4|Period III|Adverse Event|0
6045305|NCT00615459|20893169|P3|Period III|Adverse Event|0
6045306|NCT00615459|20893170|P2|Period III|Adverse Event|1
6045307|NCT00615459|20893171|P1|Period III|Adverse Event|0
6045308|NCT00615459|20893168|P4|Period II|Lost to Follow-up|1
6045309|NCT00615459|20893169|P3|Period II|Lost to Follow-up|0
6045310|NCT00615459|20893170|P2|Period II|Lost to Follow-up|0
6045311|NCT00615459|20893171|P1|Period II|Lost to Follow-up|0
6045312|NCT00615459|20893168|P4|Period II|Adverse Event|0
6045313|NCT00615459|20893169|P3|Period II|Adverse Event|0
6045314|NCT00615459|20893170|P2|Period II|Adverse Event|0
6045315|NCT00615459|20893171|P1|Period II|Adverse Event|1
6045316|NCT00615459|20893168|P4|Period I|Abnormal test procedure results|0
6045317|NCT00615459|20893169|P3|Period I|Abnormal test procedure results|1
6045318|NCT00615459|20893170|P2|Period I|Abnormal test procedure results|1
6045319|NCT00615459|20893171|P1|Period I|Abnormal test procedure results|1
6045320|NCT00615459|20893168|P4|Period I|Subject withdrew consent|1
6045321|NCT00615459|20893169|P3|Period I|Subject withdrew consent|0
6045322|NCT00615459|20893170|P2|Period I|Subject withdrew consent|0
6045323|NCT00615459|20893171|P1|Period I|Subject withdrew consent|1
6045324|NCT00615459|20893168|P4|Period I|Adverse Event|0
6045325|NCT00615459|20893169|P3|Period I|Adverse Event|1
6045326|NCT00615459|20893170|P2|Period I|Adverse Event|0
6045327|NCT00615459|20893171|P1|Period I|Adverse Event|2
6045328|NCT00615290|20893217|P1|Overall Study|Other|2
6045329|NCT00615290|20893217|P1|Overall Study|Withdrawal by Subject|1
6045330|NCT00615290|20893217|P1|Overall Study|Lost to Follow-up|3
6045331|NCT00615290|20893217|P1|Overall Study|Adverse Event|2
6045332|NCT00615264|20893231|P2|Overall Study|Dermal Hypersensitivity|3
6045333|NCT00615264|20893232|P1|Overall Study|Dermal Hypersensitivity|0
6045334|NCT00615264|20893231|P2|Overall Study|Not defined|4
6045335|NCT00615264|20893232|P1|Overall Study|Not defined|7
6045336|NCT00615264|20893231|P2|Overall Study|Protocol Violation|7
6045337|NCT00615264|20893232|P1|Overall Study|Protocol Violation|11
6045338|NCT00615264|20893231|P2|Overall Study|Death|1
6045339|NCT00615264|20893232|P1|Overall Study|Death|1
6045340|NCT00615264|20893231|P2|Overall Study|Adverse Event|5
6045341|NCT00615264|20893232|P1|Overall Study|Adverse Event|8
6045342|NCT00615264|20893231|P2|Overall Study|Lost to Follow-up|13
6045343|NCT00615264|20893232|P1|Overall Study|Lost to Follow-up|6
6045344|NCT00615264|20893231|P2|Overall Study|Withdrawal by Subject|19
6045345|NCT00615264|20893232|P1|Overall Study|Withdrawal by Subject|17
6045346|NCT00615199|20893244|P4|Overall Study|Withdrawal by Subject|0
6045347|NCT00615199|20893245|P3|Overall Study|Withdrawal by Subject|0
6045348|NCT00615199|20893246|P2|Overall Study|Withdrawal by Subject|1
6045349|NCT00615199|20893247|P1|Overall Study|Withdrawal by Subject|2
6045350|NCT00615199|20893244|P4|Overall Study|Other|1
6045351|NCT00615199|20893245|P3|Overall Study|Other|0
6045352|NCT00615199|20893246|P2|Overall Study|Other|0
6045353|NCT00615199|20893247|P1|Overall Study|Other|0
6045354|NCT00615199|20893244|P4|Overall Study|Lost to Follow-up|0
6045355|NCT00615199|20893245|P3|Overall Study|Lost to Follow-up|0
6045356|NCT00615199|20893246|P2|Overall Study|Lost to Follow-up|0
6045357|NCT00615199|20893247|P1|Overall Study|Lost to Follow-up|1
6045358|NCT00615199|20893244|P4|Overall Study|Lack of Efficacy|1
6045359|NCT00615199|20893245|P3|Overall Study|Lack of Efficacy|0
6045360|NCT00615199|20893246|P2|Overall Study|Lack of Efficacy|0
6045361|NCT00615199|20893247|P1|Overall Study|Lack of Efficacy|2
6045362|NCT00615199|20893244|P4|Overall Study|Adverse Event|0
6045363|NCT00615199|20893245|P3|Overall Study|Adverse Event|1
6045364|NCT00615199|20893246|P2|Overall Study|Adverse Event|1
6045365|NCT00615199|20893247|P1|Overall Study|Adverse Event|3
6045366|NCT00615108|20893281|P1|Overall Study|Lost to Follow-up|15
6045367|NCT00615108|20893281|P1|Overall Study|Other|370
6045368|NCT00615108|20893281|P1|Overall Study|Adverse Event|122
6045369|NCT00615069|20893296|P1|Overall Study|Withdrawal by Subject|4
6045370|NCT00615069|20893296|P1|Overall Study|Physician Decision|2
6045371|NCT00615069|20893296|P1|Overall Study|Death|10
6045372|NCT00615056|20893305|P4|Overall Study|Randomized but not treated|0
6045373|NCT00615056|20893306|P3|Overall Study|Randomized but not treated|0
6045374|NCT00615056|20893307|P2|Overall Study|Randomized but not treated|0
6045375|NCT00615056|20893308|P1|Overall Study|Randomized but not treated|3
6045376|NCT00615056|20893305|P4|Overall Study|Discontinued by Sponsor|0
6045377|NCT00615056|20893306|P3|Overall Study|Discontinued by Sponsor|0
6045378|NCT00615056|20893307|P2|Overall Study|Discontinued by Sponsor|0
6045379|NCT00615056|20893308|P1|Overall Study|Discontinued by Sponsor|1
6045380|NCT00615056|20893305|P4|Overall Study|Withdrawal by Subject|0
6045381|NCT00615056|20893306|P3|Overall Study|Withdrawal by Subject|1
6045382|NCT00615056|20893307|P2|Overall Study|Withdrawal by Subject|1
6045383|NCT00615056|20893308|P1|Overall Study|Withdrawal by Subject|0
6045384|NCT00615056|20893305|P4|Overall Study|Objective progression or relapse|0
6045385|NCT00615056|20893306|P3|Overall Study|Objective progression or relapse|0
6045386|NCT00615056|20893307|P2|Overall Study|Objective progression or relapse|2
6045387|NCT00615056|20893308|P1|Overall Study|Objective progression or relapse|0
6045388|NCT00615056|20893305|P4|Overall Study|Other|7
6045389|NCT00615056|20893306|P3|Overall Study|Other|10
6045390|NCT00615056|20893307|P2|Overall Study|Other|15
6045391|NCT00615056|20893308|P1|Overall Study|Other|13
6045392|NCT00615056|20893305|P4|Overall Study|Lost to Follow-up|5
6045393|NCT00615056|20893306|P3|Overall Study|Lost to Follow-up|4
6045394|NCT00615056|20893307|P2|Overall Study|Lost to Follow-up|2
6045395|NCT00615056|20893308|P1|Overall Study|Lost to Follow-up|1
6045396|NCT00615056|20893305|P4|Overall Study|Death|23
6045397|NCT00615056|20893306|P3|Overall Study|Death|21
6045398|NCT00615056|20893307|P2|Overall Study|Death|31
6045399|NCT00615056|20893308|P1|Overall Study|Death|31
6045400|NCT00615030|20893338|P12|Period III|Administrative problems|0
6045401|NCT00615030|20893339|P11|Period III|Administrative problems|0
6045402|NCT00615030|20893340|P10|Period III|Administrative problems|0
6045403|NCT00615030|20893341|P9|Period III|Administrative problems|0
6045404|NCT00615030|20893342|P8|Period III|Administrative problems|0
6045405|NCT00615030|20893343|P7|Period III|Administrative problems|0
6045406|NCT00615030|20893344|P6|Period III|Administrative problems|0
6045407|NCT00615030|20893345|P5|Period III|Administrative problems|0
6045408|NCT00615030|20893346|P4|Period III|Administrative problems|1
6045409|NCT00615030|20893347|P3|Period III|Administrative problems|0
6045410|NCT00615030|20893348|P2|Period III|Administrative problems|0
6045411|NCT00615030|20893349|P1|Period III|Administrative problems|1
6045412|NCT00615030|20893338|P12|Period II|Subject withdrew consent|0
6045413|NCT00615030|20893339|P11|Period II|Subject withdrew consent|0
6045414|NCT00615030|20893340|P10|Period II|Subject withdrew consent|0
6045415|NCT00615030|20893341|P9|Period II|Subject withdrew consent|0
6045416|NCT00615030|20893342|P8|Period II|Subject withdrew consent|0
6045417|NCT00615030|20893343|P7|Period II|Subject withdrew consent|1
6045418|NCT00615030|20893344|P6|Period II|Subject withdrew consent|0
6045419|NCT00615030|20893345|P5|Period II|Subject withdrew consent|0
6045420|NCT00615030|20893346|P4|Period II|Subject withdrew consent|1
6045421|NCT00615030|20893347|P3|Period II|Subject withdrew consent|0
6045422|NCT00615030|20893348|P2|Period II|Subject withdrew consent|0
6045423|NCT00615030|20893349|P1|Period II|Subject withdrew consent|0
6045424|NCT00615030|20893338|P12|Period II|Adverse Event|0
6045425|NCT00615030|20893339|P11|Period II|Adverse Event|0
6045426|NCT00615030|20893340|P10|Period II|Adverse Event|0
6045427|NCT00615030|20893341|P9|Period II|Adverse Event|1
6045428|NCT00615030|20893342|P8|Period II|Adverse Event|0
6045429|NCT00615030|20893343|P7|Period II|Adverse Event|0
6045430|NCT00615030|20893344|P6|Period II|Adverse Event|0
6045431|NCT00615030|20893345|P5|Period II|Adverse Event|0
6045432|NCT00615030|20893346|P4|Period II|Adverse Event|0
6045433|NCT00615030|20893347|P3|Period II|Adverse Event|1
6045434|NCT00615030|20893348|P2|Period II|Adverse Event|0
6045435|NCT00615030|20893349|P1|Period II|Adverse Event|0
6045436|NCT00615030|20893338|P12|Period I|Abnormal laboratory value(s)|0
6045437|NCT00615030|20893339|P11|Period I|Abnormal laboratory value(s)|0
6045438|NCT00615030|20893340|P10|Period I|Abnormal laboratory value(s)|0
6045439|NCT00615030|20893341|P9|Period I|Abnormal laboratory value(s)|0
6045440|NCT00615030|20893342|P8|Period I|Abnormal laboratory value(s)|0
6045441|NCT00615030|20893343|P7|Period I|Abnormal laboratory value(s)|0
6045442|NCT00615030|20893344|P6|Period I|Abnormal laboratory value(s)|1
6045443|NCT00615030|20893345|P5|Period I|Abnormal laboratory value(s)|0
6045444|NCT00615030|20893346|P4|Period I|Abnormal laboratory value(s)|0
6045445|NCT00615030|20893347|P3|Period I|Abnormal laboratory value(s)|0
6045446|NCT00615030|20893348|P2|Period I|Abnormal laboratory value(s)|0
6045447|NCT00615030|20893349|P1|Period I|Abnormal laboratory value(s)|0
6045448|NCT00615030|20893338|P12|Period I|Subject withdrew consent|1
6045449|NCT00615030|20893339|P11|Period I|Subject withdrew consent|1
6045450|NCT00615030|20893340|P10|Period I|Subject withdrew consent|0
6045451|NCT00615030|20893341|P9|Period I|Subject withdrew consent|1
6045452|NCT00615030|20893342|P8|Period I|Subject withdrew consent|0
6045453|NCT00615030|20893343|P7|Period I|Subject withdrew consent|0
6045454|NCT00615030|20893344|P6|Period I|Subject withdrew consent|0
6045455|NCT00615030|20893345|P5|Period I|Subject withdrew consent|0
6045456|NCT00615030|20893346|P4|Period I|Subject withdrew consent|0
6045457|NCT00615030|20893347|P3|Period I|Subject withdrew consent|0
6045458|NCT00615030|20893348|P2|Period I|Subject withdrew consent|0
6045459|NCT00615030|20893349|P1|Period I|Subject withdrew consent|0
6045460|NCT00615030|20893338|P12|Period I|Protocol deviation|0
6045461|NCT00615030|20893339|P11|Period I|Protocol deviation|0
6045462|NCT00615030|20893340|P10|Period I|Protocol deviation|0
6045463|NCT00615030|20893341|P9|Period I|Protocol deviation|0
6045464|NCT00615030|20893342|P8|Period I|Protocol deviation|0
6045465|NCT00615030|20893343|P7|Period I|Protocol deviation|0
6045466|NCT00615030|20893344|P6|Period I|Protocol deviation|0
6045467|NCT00615030|20893345|P5|Period I|Protocol deviation|0
6045468|NCT00615030|20893346|P4|Period I|Protocol deviation|0
6045469|NCT00615030|20893347|P3|Period I|Protocol deviation|0
6045470|NCT00615030|20893348|P2|Period I|Protocol deviation|0
6045471|NCT00615030|20893349|P1|Period I|Protocol deviation|1
6045472|NCT00615030|20893338|P12|Period I|Administrative problem|0
6045473|NCT00615030|20893339|P11|Period I|Administrative problem|0
6045474|NCT00615030|20893340|P10|Period I|Administrative problem|0
6045475|NCT00615030|20893341|P9|Period I|Administrative problem|0
6045476|NCT00615030|20893342|P8|Period I|Administrative problem|0
6045477|NCT00615030|20893343|P7|Period I|Administrative problem|0
6045478|NCT00615030|20893344|P6|Period I|Administrative problem|0
6045479|NCT00615030|20893345|P5|Period I|Administrative problem|1
6045480|NCT00615030|20893346|P4|Period I|Administrative problem|0
6045481|NCT00615030|20893347|P3|Period I|Administrative problem|0
6045482|NCT00615030|20893348|P2|Period I|Administrative problem|0
6045483|NCT00615030|20893349|P1|Period I|Administrative problem|0
6045484|NCT00615017|20893369|P6|Overall Study|Physician discontinued drug|1
6045485|NCT00615017|20893370|P5|Overall Study|Physician discontinued drug|0
6045486|NCT00615017|20893371|P4|Overall Study|Physician discontinued drug|0
6045487|NCT00615017|20893372|P3|Overall Study|Physician discontinued drug|0
6045488|NCT00615017|20893373|P2|Overall Study|Physician discontinued drug|0
6045489|NCT00615017|20893374|P1|Overall Study|Physician discontinued drug|0
6045490|NCT00615017|20893369|P6|Overall Study|Transferred out of Intensive Care Unit|0
6045491|NCT00615017|20893370|P5|Overall Study|Transferred out of Intensive Care Unit|0
6045492|NCT00615017|20893371|P4|Overall Study|Transferred out of Intensive Care Unit|1
6045493|NCT00615017|20893372|P3|Overall Study|Transferred out of Intensive Care Unit|0
6045494|NCT00615017|20893373|P2|Overall Study|Transferred out of Intensive Care Unit|0
6045495|NCT00615017|20893374|P1|Overall Study|Transferred out of Intensive Care Unit|0
6045496|NCT00615017|20893369|P6|Overall Study|Sepsis resolved|0
6045497|NCT00615017|20893370|P5|Overall Study|Sepsis resolved|0
6045498|NCT00615017|20893371|P4|Overall Study|Sepsis resolved|0
6045499|NCT00615017|20893372|P3|Overall Study|Sepsis resolved|1
6045500|NCT00615017|20893373|P2|Overall Study|Sepsis resolved|0
6045501|NCT00615017|20893374|P1|Overall Study|Sepsis resolved|0
6045502|NCT00615017|20893369|P6|Overall Study|Death|1
6045503|NCT00615017|20893370|P5|Overall Study|Death|1
6045504|NCT00615017|20893371|P4|Overall Study|Death|0
6045505|NCT00615017|20893372|P3|Overall Study|Death|2
6045506|NCT00615017|20893373|P2|Overall Study|Death|0
6045507|NCT00615017|20893374|P1|Overall Study|Death|0
6045508|NCT00615017|20893369|P6|Overall Study|Adverse Event|1
6045509|NCT00615017|20893370|P5|Overall Study|Adverse Event|0
6045510|NCT00615017|20893371|P4|Overall Study|Adverse Event|0
6045511|NCT00615017|20893372|P3|Overall Study|Adverse Event|2
6045512|NCT00615017|20893373|P2|Overall Study|Adverse Event|1
6045513|NCT00615017|20893374|P1|Overall Study|Adverse Event|0
6045514|NCT00614991|20893532|P6|Overall Study|Adverse Event|0
6045515|NCT00614991|20893533|P5|Overall Study|Adverse Event|1
6045516|NCT00614991|20893534|P4|Overall Study|Adverse Event|0
6045517|NCT00614991|20893535|P3|Overall Study|Adverse Event|0
6045518|NCT00614991|20893536|P2|Overall Study|Adverse Event|3
6045519|NCT00614991|20893537|P1|Overall Study|Adverse Event|3
6045520|NCT00614939|20893571|P2|Overall Study|Hospitalized due to kidney transplant|0
6045521|NCT00614939|20893572|P1|Overall Study|Hospitalized due to kidney transplant|1
6045522|NCT00614939|20893571|P2|Overall Study|Poor/non-compliance|0
6045523|NCT00614939|20893572|P1|Overall Study|Poor/non-compliance|4
6045524|NCT00614939|20893571|P2|Overall Study|Death|3
6045525|NCT00614939|20893572|P1|Overall Study|Death|4
6045526|NCT00614939|20893571|P2|Overall Study|Incorrect enrollment|2
6045527|NCT00614939|20893572|P1|Overall Study|Incorrect enrollment|1
6045528|NCT00614939|20893571|P2|Overall Study|Adverse Event|5
6045529|NCT00614939|20893572|P1|Overall Study|Adverse Event|2
6045530|NCT00614939|20893571|P2|Overall Study|Study specific discontinuation criteris|16
6045531|NCT00614939|20893572|P1|Overall Study|Study specific discontinuation criteris|13
6045532|NCT00614939|20893571|P2|Overall Study|Withdrawal by Subject|17
6045533|NCT00614939|20893572|P1|Overall Study|Withdrawal by Subject|10
6045534|NCT00614926|20893606|P2|Overall Study|Adverse Event|0
6045535|NCT00614926|20893607|P1|Overall Study|Adverse Event|3
6045536|NCT00614926|20893606|P2|Overall Study|Burden of travel|0
6045537|NCT00614926|20893607|P1|Overall Study|Burden of travel|1
6045538|NCT00614874|20893620|P1|Overall Study|Withdrawal by Subject|1
6045539|NCT00614874|20893620|P1|Overall Study|Protocol Violation|1
6045540|NCT00614822|20893627|P1|Overall Study|Adverse Event|3
6045541|NCT00614744|20893636|P2|Overall Study|Incomplete for Behavior Issues|2
6045542|NCT00614744|20893637|P1|Overall Study|Incomplete for Behavior Issues|0
6045543|NCT00614744|20893636|P2|Overall Study|Lost to Follow-up|4
6045544|NCT00614744|20893637|P1|Overall Study|Lost to Follow-up|5
6045545|NCT00614614|20893663|P5|Booster Vaccination Phase|Other|1
6045546|NCT00614614|20893664|P4|Booster Vaccination Phase|Other|2
6045547|NCT00614614|20893665|P3|Booster Vaccination Phase|Other|3
6045548|NCT00614614|20893666|P2|Booster Vaccination Phase|Other|1
6045549|NCT00614614|20893667|P1|Booster Vaccination Phase|Other|0
6045550|NCT00614614|20893663|P5|Booster Vaccination Phase|Protocol Violation|0
6045551|NCT00614614|20893664|P4|Booster Vaccination Phase|Protocol Violation|3
6045552|NCT00614614|20893665|P3|Booster Vaccination Phase|Protocol Violation|2
6045553|NCT00614614|20893666|P2|Booster Vaccination Phase|Protocol Violation|0
6045554|NCT00614614|20893667|P1|Booster Vaccination Phase|Protocol Violation|0
6045555|NCT00614614|20893663|P5|Booster Vaccination Phase|Lost to Follow-up|8
6045556|NCT00614614|20893664|P4|Booster Vaccination Phase|Lost to Follow-up|10
6045557|NCT00614614|20893665|P3|Booster Vaccination Phase|Lost to Follow-up|17
6045558|NCT00614614|20893666|P2|Booster Vaccination Phase|Lost to Follow-up|5
6045559|NCT00614614|20893667|P1|Booster Vaccination Phase|Lost to Follow-up|0
6045560|NCT00614614|20893663|P5|Booster Vaccination Phase|Withdrawal by Subject|4
6045561|NCT00614614|20893664|P4|Booster Vaccination Phase|Withdrawal by Subject|3
6045562|NCT00614614|20893665|P3|Booster Vaccination Phase|Withdrawal by Subject|4
6045563|NCT00614614|20893666|P2|Booster Vaccination Phase|Withdrawal by Subject|0
6045564|NCT00614614|20893667|P1|Booster Vaccination Phase|Withdrawal by Subject|0
6045565|NCT00614614|20893663|P5|Booster Vaccination Phase|Adverse Event|0
6045566|NCT00614614|20893664|P4|Booster Vaccination Phase|Adverse Event|1
6045567|NCT00614614|20893665|P3|Booster Vaccination Phase|Adverse Event|1
6045568|NCT00614614|20893666|P2|Booster Vaccination Phase|Adverse Event|0
6045569|NCT00614614|20893667|P1|Booster Vaccination Phase|Adverse Event|0
6045570|NCT00614614|20893663|P5|Primary Vaccination Phase|Other|0
6045571|NCT00614614|20893664|P4|Primary Vaccination Phase|Other|0
6045572|NCT00614614|20893665|P3|Primary Vaccination Phase|Other|0
6045573|NCT00614614|20893666|P2|Primary Vaccination Phase|Other|0
6045574|NCT00614614|20893667|P1|Primary Vaccination Phase|Other|4
6045575|NCT00614614|20893663|P5|Primary Vaccination Phase|Protocol Violation|0
6045576|NCT00614614|20893664|P4|Primary Vaccination Phase|Protocol Violation|0
6045577|NCT00614614|20893665|P3|Primary Vaccination Phase|Protocol Violation|0
6045578|NCT00614614|20893666|P2|Primary Vaccination Phase|Protocol Violation|3
6045579|NCT00614614|20893667|P1|Primary Vaccination Phase|Protocol Violation|9
6045580|NCT00614614|20893663|P5|Primary Vaccination Phase|Lost to Follow-up|0
6045581|NCT00614614|20893664|P4|Primary Vaccination Phase|Lost to Follow-up|0
6045582|NCT00614614|20893665|P3|Primary Vaccination Phase|Lost to Follow-up|0
6045583|NCT00614614|20893666|P2|Primary Vaccination Phase|Lost to Follow-up|8
6045584|NCT00614614|20893667|P1|Primary Vaccination Phase|Lost to Follow-up|26
6045585|NCT00614614|20893663|P5|Primary Vaccination Phase|Withdrawal by Subject|0
6045586|NCT00614614|20893664|P4|Primary Vaccination Phase|Withdrawal by Subject|0
6045587|NCT00614614|20893665|P3|Primary Vaccination Phase|Withdrawal by Subject|0
6045588|NCT00614614|20893666|P2|Primary Vaccination Phase|Withdrawal by Subject|6
6045589|NCT00614614|20893667|P1|Primary Vaccination Phase|Withdrawal by Subject|45
6045590|NCT00614614|20893663|P5|Primary Vaccination Phase|Adverse Event|0
6045591|NCT00614614|20893664|P4|Primary Vaccination Phase|Adverse Event|0
6045592|NCT00614614|20893665|P3|Primary Vaccination Phase|Adverse Event|0
6045593|NCT00614614|20893666|P2|Primary Vaccination Phase|Adverse Event|0
6045594|NCT00614614|20893667|P1|Primary Vaccination Phase|Adverse Event|6
6045595|NCT00614575|20893790|P1|Overall Study|No treatment|1
6045596|NCT00614575|20893790|P1|Overall Study|Irregularly enrolled patients|23
6045597|NCT00614575|20893790|P1|Overall Study|No data were collected.|18
6045598|NCT00614575|20893790|P1|Overall Study|Physician Decision|2
6045599|NCT00614575|20893790|P1|Overall Study|Death|3
6045600|NCT00614575|20893790|P1|Overall Study|Withdrawal by Subject|6
6045601|NCT00614575|20893790|P1|Overall Study|Lack of Efficacy|14
6045602|NCT00614575|20893790|P1|Overall Study|Lost to Follow-up|55
6045603|NCT00614575|20893790|P1|Overall Study|Adverse Event|106
6045604|NCT00614523|20893801|P2|Overall Study|Administrative Decision|46
6045605|NCT00614523|20893802|P1|Overall Study|Administrative Decision|23
6045606|NCT00614523|20893801|P2|Overall Study|Disease Progression|8
6045607|NCT00614523|20893802|P1|Overall Study|Disease Progression|0
6045608|NCT00614523|20893801|P2|Overall Study|Ineligibility Determined|2
6045609|NCT00614523|20893802|P1|Overall Study|Ineligibility Determined|1
6045610|NCT00614523|20893801|P2|Overall Study|Other|11
6045611|NCT00614523|20893802|P1|Overall Study|Other|6
6045612|NCT00614523|20893801|P2|Overall Study|Withdrawal by Subject|22
6045613|NCT00614523|20893802|P1|Overall Study|Withdrawal by Subject|12
6045614|NCT00614523|20893801|P2|Overall Study|Protocol Violation|2
6045615|NCT00614523|20893802|P1|Overall Study|Protocol Violation|3
6045616|NCT00614523|20893801|P2|Overall Study|Lost to Follow-up|1
6045617|NCT00614523|20893802|P1|Overall Study|Lost to Follow-up|0
6045618|NCT00614523|20893801|P2|Overall Study|Lack of Efficacy|11
6045619|NCT00614523|20893802|P1|Overall Study|Lack of Efficacy|9
6045620|NCT00614523|20893801|P2|Overall Study|Death|8
6045621|NCT00614523|20893802|P1|Overall Study|Death|5
6045622|NCT00614523|20893801|P2|Overall Study|Adverse Event|20
6045623|NCT00614523|20893802|P1|Overall Study|Adverse Event|4
6045624|NCT00614393|20893867|P5|Overall Study|Not Treated|2
6045625|NCT00614393|20893868|P4|Overall Study|Not Treated|0
6045626|NCT00614393|20893869|P3|Overall Study|Not Treated|0
6045627|NCT00614393|20893870|P2|Overall Study|Not Treated|0
6045628|NCT00614393|20893871|P1|Overall Study|Not Treated|0
6045629|NCT00614393|20893867|P5|Overall Study|Other|2
6045630|NCT00614393|20893868|P4|Overall Study|Other|4
6045631|NCT00614393|20893869|P3|Overall Study|Other|0
6045632|NCT00614393|20893870|P2|Overall Study|Other|0
6045633|NCT00614393|20893871|P1|Overall Study|Other|4
6045634|NCT00614393|20893867|P5|Overall Study|Withdrawal by Subject|13
6045635|NCT00614393|20893868|P4|Overall Study|Withdrawal by Subject|16
6045636|NCT00614393|20893869|P3|Overall Study|Withdrawal by Subject|1
6045637|NCT00614393|20893870|P2|Overall Study|Withdrawal by Subject|1
6045638|NCT00614393|20893871|P1|Overall Study|Withdrawal by Subject|20
6045639|NCT00614393|20893867|P5|Overall Study|Terminated by Sponsor|1
6045640|NCT00614393|20893868|P4|Overall Study|Terminated by Sponsor|0
6045641|NCT00614393|20893869|P3|Overall Study|Terminated by Sponsor|0
6045642|NCT00614393|20893870|P2|Overall Study|Terminated by Sponsor|0
6045643|NCT00614393|20893871|P1|Overall Study|Terminated by Sponsor|0
6045644|NCT00614393|20893867|P5|Overall Study|Protocol Violation|0
6045645|NCT00614393|20893868|P4|Overall Study|Protocol Violation|0
6045646|NCT00614393|20893869|P3|Overall Study|Protocol Violation|0
6045647|NCT00614393|20893870|P2|Overall Study|Protocol Violation|0
6045648|NCT00614393|20893871|P1|Overall Study|Protocol Violation|1
6045649|NCT00614393|20893867|P5|Overall Study|Progressive Disease|130
6045650|NCT00614393|20893868|P4|Overall Study|Progressive Disease|138
6045651|NCT00614393|20893869|P3|Overall Study|Progressive Disease|5
6045652|NCT00614393|20893870|P2|Overall Study|Progressive Disease|5
6045653|NCT00614393|20893871|P1|Overall Study|Progressive Disease|118
6045654|NCT00614393|20893867|P5|Overall Study|Physician Decision|9
6045655|NCT00614393|20893868|P4|Overall Study|Physician Decision|8
6045656|NCT00614393|20893869|P3|Overall Study|Physician Decision|1
6045657|NCT00614393|20893870|P2|Overall Study|Physician Decision|0
6045658|NCT00614393|20893871|P1|Overall Study|Physician Decision|17
6045659|NCT00614393|20893867|P5|Overall Study|Lost to Follow-up|2
6045660|NCT00614393|20893868|P4|Overall Study|Lost to Follow-up|1
6045661|NCT00614393|20893869|P3|Overall Study|Lost to Follow-up|0
6045662|NCT00614393|20893870|P2|Overall Study|Lost to Follow-up|0
6045663|NCT00614393|20893871|P1|Overall Study|Lost to Follow-up|0
6045664|NCT00614393|20893867|P5|Overall Study|Adverse Event|21
6045665|NCT00614393|20893868|P4|Overall Study|Adverse Event|13
6045666|NCT00614393|20893869|P3|Overall Study|Adverse Event|3
6045667|NCT00614393|20893870|P2|Overall Study|Adverse Event|2
6045668|NCT00614393|20893871|P1|Overall Study|Adverse Event|20
6045669|NCT00614380|20893917|P4|Overall Study|Consent withdrawn|0
6045670|NCT00614380|20893918|P3|Overall Study|Consent withdrawn|0
6045671|NCT00614380|20893919|P2|Overall Study|Consent withdrawn|1
6045672|NCT00614380|20893920|P1|Overall Study|Consent withdrawn|3
6045673|NCT00614380|20893917|P4|Overall Study|Non compliant with the protocol|2
6045674|NCT00614380|20893918|P3|Overall Study|Non compliant with the protocol|1
6045675|NCT00614380|20893919|P2|Overall Study|Non compliant with the protocol|2
6045676|NCT00614380|20893920|P1|Overall Study|Non compliant with the protocol|12
6045677|NCT00614380|20893917|P4|Overall Study|Lost to Follow-up|0
6045678|NCT00614380|20893918|P3|Overall Study|Lost to Follow-up|0
6045679|NCT00614380|20893919|P2|Overall Study|Lost to Follow-up|1
6045680|NCT00614380|20893920|P1|Overall Study|Lost to Follow-up|6
6045681|NCT00614380|20893917|P4|Overall Study|Adverse Event|0
6045682|NCT00614380|20893918|P3|Overall Study|Adverse Event|0
6045683|NCT00614380|20893919|P2|Overall Study|Adverse Event|4
6045684|NCT00614380|20893920|P1|Overall Study|Adverse Event|14
6045685|NCT00614120|20893987|P4|Overall Study|Lost to Follow-up|4
6045686|NCT00614120|20893988|P3|Overall Study|Lost to Follow-up|3
6045687|NCT00614120|20893989|P2|Overall Study|Lost to Follow-up|2
6045688|NCT00614120|20893990|P1|Overall Study|Lost to Follow-up|1
6045689|NCT00614120|20893987|P4|Overall Study|Taken inhibition medication eg Prandin|1
6045690|NCT00614120|20893988|P3|Overall Study|Taken inhibition medication eg Prandin|1
6045691|NCT00614120|20893989|P2|Overall Study|Taken inhibition medication eg Prandin|0
6045692|NCT00614120|20893990|P1|Overall Study|Taken inhibition medication eg Prandin|0
6045693|NCT00614120|20893987|P4|Overall Study|Late syphilis, latent|0
6045694|NCT00614120|20893988|P3|Overall Study|Late syphilis, latent|0
6045695|NCT00614120|20893989|P2|Overall Study|Late syphilis, latent|0
6045696|NCT00614120|20893990|P1|Overall Study|Late syphilis, latent|1
6045697|NCT00614120|20893987|P4|Overall Study|Lack of trial product|0
6045698|NCT00614120|20893988|P3|Overall Study|Lack of trial product|2
6045699|NCT00614120|20893989|P2|Overall Study|Lack of trial product|3
6045700|NCT00614120|20893990|P1|Overall Study|Lack of trial product|3
6045701|NCT00614120|20893987|P4|Overall Study|Hypoglycaemia|1
6045702|NCT00614120|20893988|P3|Overall Study|Hypoglycaemia|0
6045703|NCT00614120|20893989|P2|Overall Study|Hypoglycaemia|0
6045704|NCT00614120|20893990|P1|Overall Study|Hypoglycaemia|0
6045705|NCT00614120|20893987|P4|Overall Study|hCG positive (not pregnant)|0
6045706|NCT00614120|20893988|P3|Overall Study|hCG positive (not pregnant)|1
6045707|NCT00614120|20893989|P2|Overall Study|hCG positive (not pregnant)|0
6045708|NCT00614120|20893990|P1|Overall Study|hCG positive (not pregnant)|0
6045709|NCT00614120|20893987|P4|Overall Study|Did not meet trial criteria|1
6045710|NCT00614120|20893988|P3|Overall Study|Did not meet trial criteria|1
6045711|NCT00614120|20893989|P2|Overall Study|Did not meet trial criteria|1
6045712|NCT00614120|20893990|P1|Overall Study|Did not meet trial criteria|0
6045713|NCT00614120|20893987|P4|Overall Study|Withdrawal by Subject|3
6045714|NCT00614120|20893988|P3|Overall Study|Withdrawal by Subject|16
6045715|NCT00614120|20893989|P2|Overall Study|Withdrawal by Subject|10
6045716|NCT00614120|20893990|P1|Overall Study|Withdrawal by Subject|9
6045717|NCT00614120|20893987|P4|Overall Study|Withdrawal criteria|0
6045718|NCT00614120|20893988|P3|Overall Study|Withdrawal criteria|0
6045719|NCT00614120|20893989|P2|Overall Study|Withdrawal criteria|0
6045720|NCT00614120|20893990|P1|Overall Study|Withdrawal criteria|1
6045721|NCT00614120|20893987|P4|Overall Study|Protocol Violation|1
6045722|NCT00614120|20893988|P3|Overall Study|Protocol Violation|3
6045723|NCT00614120|20893989|P2|Overall Study|Protocol Violation|5
6045724|NCT00614120|20893990|P1|Overall Study|Protocol Violation|2
6045725|NCT00614120|20893987|P4|Overall Study|Lack of Efficacy|2
6045726|NCT00614120|20893988|P3|Overall Study|Lack of Efficacy|2
6045727|NCT00614120|20893989|P2|Overall Study|Lack of Efficacy|3
6045728|NCT00614120|20893990|P1|Overall Study|Lack of Efficacy|3
6045729|NCT00614120|20893987|P4|Overall Study|Adverse Event|3
6045730|NCT00614120|20893988|P3|Overall Study|Adverse Event|30
6045731|NCT00614120|20893989|P2|Overall Study|Adverse Event|22
6045732|NCT00614120|20893990|P1|Overall Study|Adverse Event|9
6045733|NCT00614055|20894031|P3|Overall Study|Unclassified|2
6045734|NCT00614055|20894032|P2|Overall Study|Unclassified|4
6045735|NCT00614055|20894033|P1|Overall Study|Unclassified|1
6045736|NCT00614055|20894031|P3|Overall Study|Lack of Efficacy|2
6045737|NCT00614055|20894032|P2|Overall Study|Lack of Efficacy|0
6045738|NCT00614055|20894033|P1|Overall Study|Lack of Efficacy|0
6045739|NCT00614055|20894031|P3|Overall Study|Protocol Violation|1
6045740|NCT00614055|20894032|P2|Overall Study|Protocol Violation|2
6045741|NCT00614055|20894033|P1|Overall Study|Protocol Violation|2
6045742|NCT00614055|20894031|P3|Overall Study|Adverse Event|0
6045743|NCT00614055|20894032|P2|Overall Study|Adverse Event|0
6045744|NCT00614055|20894033|P1|Overall Study|Adverse Event|1
6045745|NCT00613951|20894080|P3|Overall Study|Unclassified|2
6045746|NCT00613951|20894081|P2|Overall Study|Unclassified|3
6045747|NCT00613951|20894082|P1|Overall Study|Unclassified|5
6045748|NCT00613951|20894080|P3|Overall Study|Protocol Violation|1
6045749|NCT00613951|20894081|P2|Overall Study|Protocol Violation|1
6045750|NCT00613951|20894082|P1|Overall Study|Protocol Violation|1
6045751|NCT00613951|20894080|P3|Overall Study|Lack of Efficacy|1
6045752|NCT00613951|20894081|P2|Overall Study|Lack of Efficacy|1
6045753|NCT00613951|20894082|P1|Overall Study|Lack of Efficacy|0
6045754|NCT00613951|20894080|P3|Overall Study|Adverse Event|1
6045755|NCT00613951|20894081|P2|Overall Study|Adverse Event|0
6045756|NCT00613951|20894082|P1|Overall Study|Adverse Event|1
6045757|NCT00613938|20894127|P4|Overall Study|Other|3
6045758|NCT00613938|20894128|P3|Overall Study|Other|1
6045759|NCT00613938|20894129|P2|Overall Study|Other|2
6045760|NCT00613938|20894130|P1|Overall Study|Other|1
6045761|NCT00613938|20894127|P4|Overall Study|Lack of Efficacy|9
6045762|NCT00613938|20894128|P3|Overall Study|Lack of Efficacy|5
6045763|NCT00613938|20894129|P2|Overall Study|Lack of Efficacy|18
6045764|NCT00613938|20894130|P1|Overall Study|Lack of Efficacy|16
6045765|NCT00613938|20894127|P4|Overall Study|Adverse Event|5
6045766|NCT00613938|20894128|P3|Overall Study|Adverse Event|8
6045767|NCT00613938|20894129|P2|Overall Study|Adverse Event|4
6045768|NCT00613938|20894130|P1|Overall Study|Adverse Event|1
6045769|NCT00613938|20894127|P4|Overall Study|Withdrawal by Subject|9
6045770|NCT00613938|20894128|P3|Overall Study|Withdrawal by Subject|9
6045771|NCT00613938|20894129|P2|Overall Study|Withdrawal by Subject|4
6045772|NCT00613938|20894130|P1|Overall Study|Withdrawal by Subject|2
6045773|NCT00613925|20894162|P2|Overall Study|1 did not tolerate outpatient biopsy|1
6045774|NCT00613925|20894163|P1|Overall Study|1 did not tolerate outpatient biopsy|0
6045775|NCT00613834|20894178|P2|Overall Study|Withdrawal by Subject|3
6045776|NCT00613834|20894179|P1|Overall Study|Withdrawal by Subject|0
6045777|NCT00613821|20894191|P2|Overall Study|Physician Decision|1
6045778|NCT00613821|20894192|P1|Overall Study|Physician Decision|1
6045779|NCT00613821|20894191|P2|Overall Study|Withdrawal by Subject|0
6045780|NCT00613821|20894192|P1|Overall Study|Withdrawal by Subject|1
6045781|NCT00613730|20894198|P1|Overall Study|Administrative decision|1
6045782|NCT00613730|20894198|P1|Overall Study|Disease progression|2
6045783|NCT00613626|20894207|P3|Overall Study|Ineligible|0
6045784|NCT00613626|20894208|P2|Overall Study|Ineligible|1
6045785|NCT00613626|20894209|P1|Overall Study|Ineligible|0
6045786|NCT00613574|20894225|P1|Overall Study|Other|1
6045787|NCT00613574|20894225|P1|Overall Study|Lost to Follow-up|2
6045788|NCT00613574|20894225|P1|Overall Study|Adverse Event|3
6045789|NCT00613509|20894237|P2|Cycle 1|Other administrative reason|1
6045790|NCT00613509|20894238|P1|Cycle 1|Other administrative reason|0
6045791|NCT00613509|20894237|P2|Cycle 1|Unacceptable Toxicity|0
6045792|NCT00613509|20894238|P1|Cycle 1|Unacceptable Toxicity|1
6045793|NCT00613509|20894237|P2|Cycle 1|Disease Progression|6
6045794|NCT00613509|20894238|P1|Cycle 1|Disease Progression|2
6045795|NCT00613509|20894237|P2|Cycle 1|Adverse Event|1
6045796|NCT00613509|20894238|P1|Cycle 1|Adverse Event|2
6045797|NCT00613366|20894284|P2|Overall Study|Withdrawal by Subject|2
6045798|NCT00613366|20894285|P1|Overall Study|Withdrawal by Subject|3
6045799|NCT00613327|20894293|P1|Overall Study|Other|47
6045800|NCT00613327|20894293|P1|Overall Study|Protocol Violation|2
6045801|NCT00613327|20894293|P1|Overall Study|Withdrawal by Subject|6
6045802|NCT00613327|20894293|P1|Overall Study|Lost to Follow-up|8
6045803|NCT00613327|20894293|P1|Overall Study|Adverse Event|38
6045804|NCT00613314|20894312|P1|Overall Study|Other reason not defined above|90
6045805|NCT00613314|20894312|P1|Overall Study|Lost to Follow-up|46
6045806|NCT00613314|20894312|P1|Overall Study|Protocol Violation|14
6045807|NCT00613314|20894312|P1|Overall Study|Adverse Event|5
6045808|NCT00613301|20894320|P1|Overall Study|Irregularly enrolled patients|12
6045809|NCT00613301|20894320|P1|Overall Study|No data was collected|53
6045810|NCT00613301|20894320|P1|Overall Study|Physician Decision|2
6045811|NCT00613301|20894320|P1|Overall Study|Lack of Efficacy|13
6045812|NCT00613301|20894320|P1|Overall Study|Death|6
6045813|NCT00613301|20894320|P1|Overall Study|Withdrawal by Subject|5
6045814|NCT00613301|20894320|P1|Overall Study|Lost to Follow-up|88
6045815|NCT00613301|20894320|P1|Overall Study|Adverse Event|49
6045816|NCT00613106|20894329|P2|Overall Study|misc|3
6045817|NCT00613106|20894330|P1|Overall Study|misc|4
6045818|NCT00613106|20894329|P2|Overall Study|Lost to Follow-up|2
6045819|NCT00613106|20894330|P1|Overall Study|Lost to Follow-up|7
6045820|NCT00613106|20894329|P2|Overall Study|Withdrawal by Subject|3
6045821|NCT00613106|20894330|P1|Overall Study|Withdrawal by Subject|6
6045822|NCT00613106|20894329|P2|Overall Study|Adverse Event|1
6045823|NCT00613106|20894330|P1|Overall Study|Adverse Event|3
6045824|NCT00613080|20894336|P1|Overall Study|Ineligible / no protocol treatment|11
6045825|NCT00613015|20894371|P6|Overall Study|Lost to Follow-up|3
6045826|NCT00613015|20894372|P5|Overall Study|Lost to Follow-up|2
6045827|NCT00613015|20894373|P4|Overall Study|Lost to Follow-up|3
6045828|NCT00613015|20894374|P3|Overall Study|Lost to Follow-up|3
6045829|NCT00613015|20894375|P2|Overall Study|Lost to Follow-up|1
6045830|NCT00613015|20894376|P1|Overall Study|Lost to Follow-up|0
6045831|NCT00612807|20894412|P2|Overall Study|Withdrawal by Subject|0
6045832|NCT00612807|20894413|P1|Overall Study|Withdrawal by Subject|2
6045833|NCT00612690|20894460|P2|Overall Study|Withdrawal by Site|0
6045834|NCT00612690|20894461|P1|Overall Study|Withdrawal by Site|11
6045835|NCT00612690|20894460|P2|Overall Study|Withdrawal by Subject|20
6045836|NCT00612690|20894461|P1|Overall Study|Withdrawal by Subject|32
6045837|NCT00612690|20894460|P2|Overall Study|Lost to Follow-up|98
6045838|NCT00612690|20894461|P1|Overall Study|Lost to Follow-up|72
6045839|NCT00612677|20894469|P1|Overall Study|study closed before treatment started|1
6045840|NCT00612586|20894477|P2|Overall Study|Randomized and Not Treated|1
6045841|NCT00612586|20894478|P1|Overall Study|Randomized and Not Treated|1
6045842|NCT00612586|20894477|P2|Overall Study|Progressive Disease|24
6045843|NCT00612586|20894478|P1|Overall Study|Progressive Disease|26
6045844|NCT00612586|20894477|P2|Overall Study|Sponsor Decision|1
6045845|NCT00612586|20894478|P1|Overall Study|Sponsor Decision|1
6045846|NCT00612586|20894477|P2|Overall Study|Physician Decision|2
6045847|NCT00612586|20894478|P1|Overall Study|Physician Decision|1
6045848|NCT00612586|20894477|P2|Overall Study|Withdrawal by Subject|9
6045849|NCT00612586|20894478|P1|Overall Study|Withdrawal by Subject|7
6045850|NCT00612586|20894477|P2|Overall Study|Entry Criteria Not Met|2
6045851|NCT00612586|20894478|P1|Overall Study|Entry Criteria Not Met|0
6045852|NCT00612586|20894477|P2|Overall Study|Death|0
6045853|NCT00612586|20894478|P1|Overall Study|Death|1
6045854|NCT00612586|20894477|P2|Overall Study|Adverse Event|2
6045855|NCT00612586|20894478|P1|Overall Study|Adverse Event|6
6045856|NCT00612534|20894554|P4|Overall Study|Other Reason|0
6045857|NCT00612534|20894555|P3|Overall Study|Other Reason|0
6045858|NCT00612534|20894556|P2|Overall Study|Other Reason|1
6045859|NCT00612534|20894557|P1|Overall Study|Other Reason|0
6045860|NCT00612534|20894554|P4|Overall Study|Lack of Efficacy|16
6045861|NCT00612534|20894555|P3|Overall Study|Lack of Efficacy|5
6045862|NCT00612534|20894556|P2|Overall Study|Lack of Efficacy|12
6045863|NCT00612534|20894557|P1|Overall Study|Lack of Efficacy|13
6045864|NCT00612534|20894554|P4|Overall Study|Adverse Event|1
6045865|NCT00612534|20894555|P3|Overall Study|Adverse Event|2
6045866|NCT00612534|20894556|P2|Overall Study|Adverse Event|4
6045867|NCT00612534|20894557|P1|Overall Study|Adverse Event|0
6045868|NCT00612508|20894569|P2|Overall Study|Withdrawal by Subject|4
6045869|NCT00612508|20894570|P1|Overall Study|Withdrawal by Subject|3
6045870|NCT00612456|20894581|P3|Overall Study|Withdrawal by Subject|0
6045871|NCT00612456|20894582|P2|Overall Study|Withdrawal by Subject|1
6045872|NCT00612456|20894583|P1|Overall Study|Withdrawal by Subject|0
6045873|NCT00612456|20894581|P3|Overall Study|Lack of Efficacy|0
6045874|NCT00612456|20894582|P2|Overall Study|Lack of Efficacy|1
6045875|NCT00612456|20894583|P1|Overall Study|Lack of Efficacy|1
6045876|NCT00612456|20894581|P3|Overall Study|Adverse Event|0
6045877|NCT00612456|20894582|P2|Overall Study|Adverse Event|0
6045878|NCT00612456|20894583|P1|Overall Study|Adverse Event|1
6045879|NCT00612352|20894646|P2|Overall Study|didn't return calls/show up on test date|1
6045880|NCT00612352|20894647|P1|Overall Study|didn't return calls/show up on test date|4
6045881|NCT00612352|20894646|P2|Overall Study|moved out of state|0
6045882|NCT00612352|20894647|P1|Overall Study|moved out of state|1
6045883|NCT00612352|20894646|P2|Overall Study|Withdrawal by Subject|5
6045884|NCT00612352|20894647|P1|Overall Study|Withdrawal by Subject|3
6045885|NCT00612352|20894646|P2|Overall Study|Adverse Event|0
6045886|NCT00612352|20894647|P1|Overall Study|Adverse Event|1
6045887|NCT00612313|20894767|P2|Overall Study|Lost to Follow-up|4
6045888|NCT00612313|20894768|P1|Overall Study|Lost to Follow-up|11
6045889|NCT00612313|20894767|P2|Overall Study|Withdrawal by Subject|9
6045890|NCT00612313|20894768|P1|Overall Study|Withdrawal by Subject|6
6045891|NCT00612105|20894810|P2|Period Title 3: 3-Week Taper Phase|Other|0
6045892|NCT00612105|20894811|P1|Period Title 3: 3-Week Taper Phase|Other|1
6045893|NCT00612105|20894810|P2|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|0
6045894|NCT00612105|20894811|P1|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|1
6045895|NCT00612105|20894810|P2|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1
6045896|NCT00612105|20894811|P1|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1
6045897|NCT00612105|20894810|P2|Period Title 2: 4-Week Maintenance Phase|Adverse Event|1
6045898|NCT00612105|20894811|P1|Period Title 2: 4-Week Maintenance Phase|Adverse Event|9
6045899|NCT00612105|20894810|P2|Period Title 1: 6-Week Titration Phase|Other|1
6045900|NCT00612105|20894811|P1|Period Title 1: 6-Week Titration Phase|Other|0
6045901|NCT00612105|20894810|P2|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|0
6045902|NCT00612105|20894811|P1|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|5
6045903|NCT00612105|20894810|P2|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|1
6045904|NCT00612105|20894811|P1|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|3
6045905|NCT00612105|20894810|P2|Period Title 1: 6-Week Titration Phase|Protocol Violation|0
6045906|NCT00612105|20894811|P1|Period Title 1: 6-Week Titration Phase|Protocol Violation|1
6045907|NCT00612105|20894810|P2|Period Title 1: 6-Week Titration Phase|Physician Decision|1
6045908|NCT00612105|20894811|P1|Period Title 1: 6-Week Titration Phase|Physician Decision|1
6045909|NCT00612105|20894810|P2|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|0
6045910|NCT00612105|20894811|P1|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|2
6045911|NCT00612105|20894810|P2|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|1
6045912|NCT00612105|20894811|P1|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|6
6045913|NCT00612105|20894810|P2|Period Title 1: 6-Week Titration Phase|Adverse Event|1
6045914|NCT00612105|20894811|P1|Period Title 1: 6-Week Titration Phase|Adverse Event|18
6045915|NCT00612066|20894861|P1|Overall Study|Adverse Event|1
6045916|NCT00612040|20894868|P3|Overall Study|Unclassified|5
6045917|NCT00612040|20894869|P2|Overall Study|Unclassified|2
6045918|NCT00612040|20894870|P1|Overall Study|Unclassified|2
6045919|NCT00612040|20894868|P3|Overall Study|Lack of Efficacy|0
6045920|NCT00612040|20894869|P2|Overall Study|Lack of Efficacy|1
6045921|NCT00612040|20894870|P1|Overall Study|Lack of Efficacy|2
6045922|NCT00612040|20894868|P3|Overall Study|Protocol Violation|1
6045923|NCT00612040|20894869|P2|Overall Study|Protocol Violation|2
6045924|NCT00612040|20894870|P1|Overall Study|Protocol Violation|1
6045925|NCT00612040|20894868|P3|Overall Study|Adverse Event|1
6045926|NCT00612040|20894869|P2|Overall Study|Adverse Event|2
6045927|NCT00612040|20894870|P1|Overall Study|Adverse Event|0
6045928|NCT00611975|20894916|P2|Overall Study|Pregnancy|1
6045929|NCT00611975|20894917|P1|Overall Study|Pregnancy|2
6045930|NCT00611975|20894916|P2|Overall Study|Withdrawal by Subject|7
6045931|NCT00611975|20894917|P1|Overall Study|Withdrawal by Subject|3
6045932|NCT00611923|20894945|P2|Overall Study|Withdrawal by Subject|2
6045933|NCT00611923|20894946|P1|Overall Study|Withdrawal by Subject|2
6045934|NCT00611884|20894991|P4|Overall Study|Unclassified|3
6045935|NCT00611884|20894992|P3|Overall Study|Unclassified|2
6045936|NCT00611884|20894993|P2|Overall Study|Unclassified|4
6045937|NCT00611884|20894994|P1|Overall Study|Unclassified|7
6045938|NCT00611884|20894991|P4|Overall Study|Lack of Efficacy|0
6045939|NCT00611884|20894992|P3|Overall Study|Lack of Efficacy|0
6045940|NCT00611884|20894993|P2|Overall Study|Lack of Efficacy|1
6045941|NCT00611884|20894994|P1|Overall Study|Lack of Efficacy|0
6045942|NCT00611884|20894991|P4|Overall Study|Non-Compliance|2
6045943|NCT00611884|20894992|P3|Overall Study|Non-Compliance|2
6045944|NCT00611884|20894993|P2|Overall Study|Non-Compliance|4
6045945|NCT00611884|20894994|P1|Overall Study|Non-Compliance|1
6045946|NCT00611884|20894991|P4|Overall Study|Adverse Event|1
6045947|NCT00611884|20894992|P3|Overall Study|Adverse Event|0
6045948|NCT00611884|20894993|P2|Overall Study|Adverse Event|0
6045949|NCT00611884|20894994|P1|Overall Study|Adverse Event|1
6045950|NCT00611858|20895048|P1|Overall Study|Withdrawal by Subject|2
6045951|NCT00611858|20895048|P1|Overall Study|Adverse Event|2
6045952|NCT00611806|20895060|P2|Overall Study|Lost to Follow-up|0
6045953|NCT00611806|20895061|P1|Overall Study|Lost to Follow-up|6
6045954|NCT00611806|20895060|P2|Overall Study|Adverse Event|1
6045955|NCT00611806|20895061|P1|Overall Study|Adverse Event|2
6045956|NCT00611806|20895060|P2|Overall Study|Withdrawal by Subject|2
6045957|NCT00611806|20895061|P1|Overall Study|Withdrawal by Subject|8
6045958|NCT00611767|20895075|P2|Overall Study|Physician Decision|0
6045959|NCT00611767|20895076|P1|Overall Study|Physician Decision|1
6045960|NCT00611767|20895075|P2|Overall Study|didn't like the medication|1
6045961|NCT00611767|20895076|P1|Overall Study|didn't like the medication|1
6045962|NCT00611767|20895075|P2|Overall Study|Thiopental not available|0
6045963|NCT00611767|20895076|P1|Overall Study|Thiopental not available|3
6045964|NCT00611767|20895075|P2|Overall Study|Withdrawal by Subject|1
6045965|NCT00611767|20895076|P1|Overall Study|Withdrawal by Subject|4
6045966|NCT00611715|20895238|P2|Overall Study|two patients are still on treatment|0
6045967|NCT00611715|20895239|P1|Overall Study|two patients are still on treatment|2
6045968|NCT00611715|20895238|P2|Overall Study|Death|0
6045969|NCT00611715|20895239|P1|Overall Study|Death|1
6045970|NCT00611715|20895238|P2|Overall Study|Adverse Event|1
6045971|NCT00611715|20895239|P1|Overall Study|Adverse Event|9
6045972|NCT00611715|20895238|P2|Overall Study|Withdrawal by Subject|1
6045973|NCT00611715|20895239|P1|Overall Study|Withdrawal by Subject|5
6045974|NCT00611715|20895238|P2|Overall Study|Disease Progression|4
6045975|NCT00611715|20895239|P1|Overall Study|Disease Progression|24
6045976|NCT00611559|20895259|P3|Overall Study|Protocol Violation|1
6045977|NCT00611559|20895260|P2|Overall Study|Protocol Violation|0
6045978|NCT00611559|20895261|P1|Overall Study|Protocol Violation|1
6045979|NCT00611559|20895259|P3|Overall Study|Lost to Follow-up|0
6045980|NCT00611559|20895260|P2|Overall Study|Lost to Follow-up|1
6045981|NCT00611559|20895261|P1|Overall Study|Lost to Follow-up|0
6045982|NCT00611533|20895320|P2|Second Intervention (6 Weeks)|Adverse Event|2
6045983|NCT00611533|20895321|P1|Second Intervention (6 Weeks)|Adverse Event|0
6045984|NCT00611533|20895320|P2|First Intervention (6 Weeks)|Adverse Event|1
6045985|NCT00611533|20895321|P1|First Intervention (6 Weeks)|Adverse Event|0
6045986|NCT00611533|20895320|P2|First Intervention (6 Weeks)|Never started study|1
6045987|NCT00611533|20895321|P1|First Intervention (6 Weeks)|Never started study|0
6045988|NCT00611455|20895355|P3|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|49
6045989|NCT00611455|20895356|P2|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0
6045990|NCT00611455|20895357|P1|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0
6045991|NCT00611455|20895355|P3|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|13
6045992|NCT00611455|20895356|P2|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0
6045993|NCT00611455|20895357|P1|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0
6045994|NCT00611455|20895355|P3|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|80
6045995|NCT00611455|20895356|P2|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0
6045996|NCT00611455|20895357|P1|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0
6045997|NCT00611455|20895355|P3|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|23
6045998|NCT00611455|20895356|P2|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0
6045999|NCT00611455|20895357|P1|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0
6046000|NCT00611455|20895355|P3|Follow-up Period (Approximately 2 Years)|Protocol Violation|4
6046250|NCT00609609|20896195|P2|Overall Study|Progression|2
6046001|NCT00611455|20895356|P2|Follow-up Period (Approximately 2 Years)|Protocol Violation|0
6046002|NCT00611455|20895357|P1|Follow-up Period (Approximately 2 Years)|Protocol Violation|0
6046003|NCT00611455|20895355|P3|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|12
6046004|NCT00611455|20895356|P2|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0
6046005|NCT00611455|20895357|P1|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0
6046006|NCT00611455|20895355|P3|Follow-up Period (Approximately 2 Years)|Adverse Event|30
6046007|NCT00611455|20895356|P2|Follow-up Period (Approximately 2 Years)|Adverse Event|0
6046008|NCT00611455|20895357|P1|Follow-up Period (Approximately 2 Years)|Adverse Event|0
6046009|NCT00611455|20895355|P3|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0
6046010|NCT00611455|20895356|P2|OL Treatment Period (120 Weeks)|Withdrawal by Subject|18
6046011|NCT00611455|20895357|P1|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0
6046012|NCT00611455|20895355|P3|OL Treatment Period (120 Weeks)|Physician Decision|0
6046013|NCT00611455|20895356|P2|OL Treatment Period (120 Weeks)|Physician Decision|5
6046014|NCT00611455|20895357|P1|OL Treatment Period (120 Weeks)|Physician Decision|0
6046015|NCT00611455|20895355|P3|OL Treatment Period (120 Weeks)|Lost to Follow-up|0
6046016|NCT00611455|20895356|P2|OL Treatment Period (120 Weeks)|Lost to Follow-up|5
6046017|NCT00611455|20895357|P1|OL Treatment Period (120 Weeks)|Lost to Follow-up|0
6046018|NCT00611455|20895355|P3|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0
6046019|NCT00611455|20895356|P2|OL Treatment Period (120 Weeks)|Study Closed/Terminated|110
6046020|NCT00611455|20895357|P1|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0
6046021|NCT00611455|20895355|P3|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0
6046022|NCT00611455|20895356|P2|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|12
6046023|NCT00611455|20895357|P1|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0
6046024|NCT00611455|20895355|P3|OL Treatment Period (120 Weeks)|Protocol Violation|0
6046025|NCT00611455|20895356|P2|OL Treatment Period (120 Weeks)|Protocol Violation|3
6046026|NCT00611455|20895357|P1|OL Treatment Period (120 Weeks)|Protocol Violation|0
6046027|NCT00611455|20895355|P3|OL Treatment Period (120 Weeks)|Lack of Efficacy|0
6046028|NCT00611455|20895356|P2|OL Treatment Period (120 Weeks)|Lack of Efficacy|9
6046029|NCT00611455|20895357|P1|OL Treatment Period (120 Weeks)|Lack of Efficacy|0
6046030|NCT00611455|20895355|P3|OL Treatment Period (120 Weeks)|Adverse Event|0
6046031|NCT00611455|20895356|P2|OL Treatment Period (120 Weeks)|Adverse Event|17
6046032|NCT00611455|20895357|P1|OL Treatment Period (120 Weeks)|Adverse Event|0
6046033|NCT00611455|20895355|P3|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0
6046034|NCT00611455|20895356|P2|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0
6046035|NCT00611455|20895357|P1|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|1
6046036|NCT00611455|20895355|P3|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|0
6046037|NCT00611455|20895356|P2|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2
6046038|NCT00611455|20895357|P1|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2
6046039|NCT00611455|20895355|P3|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0
6046040|NCT00611455|20895356|P2|DB Treatment Period (24 Weeks)|Withdrawal by Subject|3
6046041|NCT00611455|20895357|P1|DB Treatment Period (24 Weeks)|Withdrawal by Subject|2
6046042|NCT00611455|20895355|P3|DB Treatment Period (24 Weeks)|Protocol Violation|0
6046043|NCT00611455|20895356|P2|DB Treatment Period (24 Weeks)|Protocol Violation|1
6046044|NCT00611455|20895357|P1|DB Treatment Period (24 Weeks)|Protocol Violation|4
6046045|NCT00611455|20895355|P3|DB Treatment Period (24 Weeks)|Lack of Efficacy|0
6046046|NCT00611455|20895356|P2|DB Treatment Period (24 Weeks)|Lack of Efficacy|0
6046047|NCT00611455|20895357|P1|DB Treatment Period (24 Weeks)|Lack of Efficacy|2
6046048|NCT00611455|20895355|P3|DB Treatment Period (24 Weeks)|Adverse Event|0
6046049|NCT00611455|20895356|P2|DB Treatment Period (24 Weeks)|Adverse Event|8
6046050|NCT00611455|20895357|P1|DB Treatment Period (24 Weeks)|Adverse Event|2
6046051|NCT00611247|20895537|P2|Overall Study|Lack of Efficacy|16
6046052|NCT00611247|20895538|P1|Overall Study|Lack of Efficacy|1
6046053|NCT00611247|20895537|P2|Overall Study|Death|5
6046054|NCT00611247|20895538|P1|Overall Study|Death|1
6046055|NCT00611130|20895550|P2|Overall Study|Death|0
6046056|NCT00611130|20895551|P1|Overall Study|Death|1
6046057|NCT00611130|20895550|P2|Overall Study|Adverse Event|0
6046058|NCT00611130|20895551|P1|Overall Study|Adverse Event|1
6046059|NCT00611130|20895550|P2|Overall Study|Administrative|1
6046060|NCT00611130|20895551|P1|Overall Study|Administrative|1
6046061|NCT00611130|20895550|P2|Overall Study|Incarceration|2
6046062|NCT00611130|20895551|P1|Overall Study|Incarceration|3
6046063|NCT00611130|20895550|P2|Overall Study|Other|4
6046064|NCT00611130|20895551|P1|Overall Study|Other|5
6046065|NCT00611130|20895550|P2|Overall Study|Withdrawal by Subject|5
6046066|NCT00611130|20895551|P1|Overall Study|Withdrawal by Subject|6
6046067|NCT00611130|20895550|P2|Overall Study|Protocol noncompliance|6
6046068|NCT00611130|20895551|P1|Overall Study|Protocol noncompliance|7
6046069|NCT00611130|20895550|P2|Overall Study|Lost to Follow-up|29
6046070|NCT00611130|20895551|P1|Overall Study|Lost to Follow-up|25
6046071|NCT00611026|20895561|P3|Double-blind Treatment Period|Other|18
6046072|NCT00611026|20895562|P2|Double-blind Treatment Period|Other|20
6046073|NCT00611026|20895563|P1|Double-blind Treatment Period|Other|13
6046074|NCT00611026|20895561|P3|Double-blind Treatment Period|Withdrawal by Subject|16
6046075|NCT00611026|20895562|P2|Double-blind Treatment Period|Withdrawal by Subject|19
6046076|NCT00611026|20895563|P1|Double-blind Treatment Period|Withdrawal by Subject|7
6046077|NCT00611026|20895561|P3|Double-blind Treatment Period|Lost to Follow-up|14
6046078|NCT00611026|20895562|P2|Double-blind Treatment Period|Lost to Follow-up|11
6046079|NCT00611026|20895563|P1|Double-blind Treatment Period|Lost to Follow-up|6
6046080|NCT00611026|20895561|P3|Double-blind Treatment Period|Lack of Efficacy|4
6046081|NCT00611026|20895562|P2|Double-blind Treatment Period|Lack of Efficacy|10
6046082|NCT00611026|20895563|P1|Double-blind Treatment Period|Lack of Efficacy|11
6046083|NCT00611026|20895561|P3|Double-blind Treatment Period|Adverse Event|46
6046084|NCT00611026|20895562|P2|Double-blind Treatment Period|Adverse Event|28
6046085|NCT00611026|20895563|P1|Double-blind Treatment Period|Adverse Event|9
6046086|NCT00611026|20895561|P3|Double-blind Treatment Period|Death|0
6046087|NCT00611026|20895562|P2|Double-blind Treatment Period|Death|0
6046088|NCT00611026|20895563|P1|Double-blind Treatment Period|Death|1
6046089|NCT00611026|20895561|P3|Randomized to Double-blind Treatment|Not treated|3
6046090|NCT00611026|20895562|P2|Randomized to Double-blind Treatment|Not treated|1
6046091|NCT00611026|20895563|P1|Randomized to Double-blind Treatment|Not treated|2
6046092|NCT00610857|20895640|P1|Overall Study|Not evaluable for response|2
6046093|NCT00610714|20895684|P2|Overall Study|Study completion at 120 PFS events|2
6046094|NCT00610714|20895685|P1|Overall Study|Study completion at 120 PFS events|2
6046095|NCT00610714|20895684|P2|Overall Study|Withdrawal by Subject|3
6046096|NCT00610714|20895685|P1|Overall Study|Withdrawal by Subject|9
6046097|NCT00610714|20895684|P2|Overall Study|Death|18
6046098|NCT00610714|20895685|P1|Overall Study|Death|12
6046099|NCT00610714|20895684|P2|Overall Study|Adverse Event|1
6046100|NCT00610714|20895685|P1|Overall Study|Adverse Event|3
6046101|NCT00610675|20895723|P1|Overall Study|Other reason (not specified)|25
6046102|NCT00610675|20895723|P1|Overall Study|Lost to Follow-up|31
6046103|NCT00610675|20895723|P1|Overall Study|Lack of Compliance|7
6046104|NCT00610675|20895723|P1|Overall Study|Reasons unrelated to trial|27
6046105|NCT00610675|20895723|P1|Overall Study|Withdrawal by Subject|28
6046106|NCT00610675|20895723|P1|Overall Study|Insufficient Effect|31
6046107|NCT00610675|20895723|P1|Overall Study|Adverse Event|67
6046108|NCT00610675|20895723|P1|Overall Study|Untreated|4
6046109|NCT00610649|20895745|P11|Overall Study|Withdrawal by Subject|0
6046110|NCT00610649|20895746|P10|Overall Study|Withdrawal by Subject|1
6046111|NCT00610649|20895747|P9|Overall Study|Withdrawal by Subject|0
6046112|NCT00610649|20895748|P8|Overall Study|Withdrawal by Subject|0
6046113|NCT00610649|20895749|P7|Overall Study|Withdrawal by Subject|0
6046114|NCT00610649|20895750|P6|Overall Study|Withdrawal by Subject|0
6046115|NCT00610649|20895751|P5|Overall Study|Withdrawal by Subject|0
6046116|NCT00610649|20895752|P4|Overall Study|Withdrawal by Subject|0
6046117|NCT00610649|20895753|P3|Overall Study|Withdrawal by Subject|0
6046118|NCT00610649|20895754|P2|Overall Study|Withdrawal by Subject|0
6046119|NCT00610649|20895755|P1|Overall Study|Withdrawal by Subject|0
6046120|NCT00610649|20895745|P11|Overall Study|Family Emergency|0
6046121|NCT00610649|20895746|P10|Overall Study|Family Emergency|0
6046122|NCT00610649|20895747|P9|Overall Study|Family Emergency|0
6046123|NCT00610649|20895748|P8|Overall Study|Family Emergency|0
6046124|NCT00610649|20895749|P7|Overall Study|Family Emergency|0
6046125|NCT00610649|20895750|P6|Overall Study|Family Emergency|0
6046126|NCT00610649|20895751|P5|Overall Study|Family Emergency|0
6046127|NCT00610649|20895752|P4|Overall Study|Family Emergency|0
6046128|NCT00610649|20895753|P3|Overall Study|Family Emergency|0
6046129|NCT00610649|20895754|P2|Overall Study|Family Emergency|1
6046130|NCT00610649|20895755|P1|Overall Study|Family Emergency|0
6046131|NCT00610649|20895745|P11|Overall Study|Adverse Event|1
6046132|NCT00610649|20895746|P10|Overall Study|Adverse Event|0
6046133|NCT00610649|20895747|P9|Overall Study|Adverse Event|0
6046134|NCT00610649|20895748|P8|Overall Study|Adverse Event|0
6046135|NCT00610649|20895749|P7|Overall Study|Adverse Event|0
6046136|NCT00610649|20895750|P6|Overall Study|Adverse Event|0
6046137|NCT00610649|20895751|P5|Overall Study|Adverse Event|0
6046138|NCT00610649|20895752|P4|Overall Study|Adverse Event|0
6046139|NCT00610649|20895753|P3|Overall Study|Adverse Event|0
6046140|NCT00610649|20895754|P2|Overall Study|Adverse Event|0
6046141|NCT00610649|20895755|P1|Overall Study|Adverse Event|1
6046142|NCT00610441|20895850|P4|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0
6046143|NCT00610441|20895851|P3|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0
6046144|NCT00610441|20895852|P2|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0
6046145|NCT00610441|20895853|P1|Treatment Period 2 - 3 Weeks|Lack of Efficacy|1
6046146|NCT00610441|20895850|P4|Treatment Period 2 - 3 Weeks|Adverse Event|1
6046147|NCT00610441|20895851|P3|Treatment Period 2 - 3 Weeks|Adverse Event|0
6046148|NCT00610441|20895852|P2|Treatment Period 2 - 3 Weeks|Adverse Event|0
6046149|NCT00610441|20895853|P1|Treatment Period 2 - 3 Weeks|Adverse Event|0
6046150|NCT00610441|20895850|P4|Treatment Period 2 - 3 Weeks|Other|1
6046151|NCT00610441|20895851|P3|Treatment Period 2 - 3 Weeks|Other|0
6046152|NCT00610441|20895852|P2|Treatment Period 2 - 3 Weeks|Other|1
6046153|NCT00610441|20895853|P1|Treatment Period 2 - 3 Weeks|Other|1
6046154|NCT00610441|20895850|P4|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0
6046155|NCT00610441|20895851|P3|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0
6046156|NCT00610441|20895852|P2|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|1
6046157|NCT00610441|20895853|P1|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0
6046158|NCT00610441|20895850|P4|Placebo Washout Period - 2 Weeks|Adverse Event|0
6046159|NCT00610441|20895851|P3|Placebo Washout Period - 2 Weeks|Adverse Event|2
6046160|NCT00610441|20895852|P2|Placebo Washout Period - 2 Weeks|Adverse Event|0
6046161|NCT00610441|20895853|P1|Placebo Washout Period - 2 Weeks|Adverse Event|0
6046162|NCT00610441|20895850|P4|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1
6046163|NCT00610441|20895851|P3|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1
6046164|NCT00610441|20895852|P2|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|0
6046165|NCT00610441|20895853|P1|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1
6046166|NCT00610441|20895850|P4|Treatment Period 1 - 3 Weeks|Lost to Follow-up|0
6046167|NCT00610441|20895851|P3|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1
6046168|NCT00610441|20895852|P2|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1
6046169|NCT00610441|20895853|P1|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1
6046170|NCT00610441|20895850|P4|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0
6046171|NCT00610441|20895851|P3|Treatment Period 1 - 3 Weeks|Lack of Efficacy|1
6046172|NCT00610441|20895852|P2|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0
6046173|NCT00610441|20895853|P1|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0
6046174|NCT00610441|20895850|P4|Treatment Period 1 - 3 Weeks|Adverse Event|1
6046175|NCT00610441|20895851|P3|Treatment Period 1 - 3 Weeks|Adverse Event|4
6046176|NCT00610441|20895852|P2|Treatment Period 1 - 3 Weeks|Adverse Event|1
6046177|NCT00610441|20895853|P1|Treatment Period 1 - 3 Weeks|Adverse Event|1
6046178|NCT00610363|20895962|P2|Overall Study|Other than specified above|1
6046179|NCT00610363|20895963|P1|Overall Study|Other than specified above|1
6046180|NCT00610363|20895962|P2|Overall Study|Withdrawal by Subject|0
6046181|NCT00610363|20895963|P1|Overall Study|Withdrawal by Subject|1
6046182|NCT00610363|20895962|P2|Overall Study|Lost to Follow-up|0
6046183|NCT00610363|20895963|P1|Overall Study|Lost to Follow-up|4
6046184|NCT00610363|20895962|P2|Overall Study|Lack of Efficacy|0
6046185|NCT00610363|20895963|P1|Overall Study|Lack of Efficacy|2
6046186|NCT00610363|20895962|P2|Overall Study|Adverse Event|1
6046187|NCT00610363|20895963|P1|Overall Study|Adverse Event|3
6046188|NCT00610363|20895962|P2|Overall Study|Non-compliance with protocol|1
6046189|NCT00610363|20895963|P1|Overall Study|Non-compliance with protocol|0
6046190|NCT00610207|20895988|P1|Overall Study|Lost to Follow-up|3
6046191|NCT00610168|20895995|P2|Overall Study|Withdrawal by Subject|0
6046192|NCT00610168|20895996|P1|Overall Study|Withdrawal by Subject|2
6046193|NCT00610155|20896015|P6|Period 3|Adverse Event|0
6046194|NCT00610155|20896016|P5|Period 3|Adverse Event|0
6046195|NCT00610155|20896017|P4|Period 3|Adverse Event|0
6046196|NCT00610155|20896018|P3|Period 3|Adverse Event|0
6046197|NCT00610155|20896019|P2|Period 3|Adverse Event|0
6046198|NCT00610155|20896020|P1|Period 3|Adverse Event|1
6046199|NCT00610155|20896015|P6|Period 1|Withdrawal by Subject|0
6046200|NCT00610155|20896016|P5|Period 1|Withdrawal by Subject|0
6046201|NCT00610155|20896017|P4|Period 1|Withdrawal by Subject|0
6046202|NCT00610155|20896018|P3|Period 1|Withdrawal by Subject|1
6046203|NCT00610155|20896019|P2|Period 1|Withdrawal by Subject|0
6046204|NCT00610155|20896020|P1|Period 1|Withdrawal by Subject|0
6046205|NCT00610129|20896067|P1|Overall Study|Not treated since patients ineligible|3
6046206|NCT00609986|20896073|P2|Overall Study|Did not receive transplant or treatment|3
6046207|NCT00609986|20896074|P1|Overall Study|Did not receive transplant or treatment|8
6046208|NCT00609973|20896088|P2|Overall Study|Withdrawal by Subject|1
6046209|NCT00609973|20896089|P1|Overall Study|Withdrawal by Subject|0
6046210|NCT00609973|20896088|P2|Overall Study|Lost to Follow-up|1
6046211|NCT00609973|20896089|P1|Overall Study|Lost to Follow-up|2
6046212|NCT00609973|20896088|P2|Overall Study|Protocol Violation|3
6046213|NCT00609973|20896089|P1|Overall Study|Protocol Violation|4
6046214|NCT00609973|20896088|P2|Overall Study|Adverse Event|1
6046215|NCT00609973|20896089|P1|Overall Study|Adverse Event|2
6046216|NCT00609947|20896097|P1|Overall Study|Death|1
6046217|NCT00609869|20896102|P1|Overall Study|Mantle cell: not evaluable|4
6046218|NCT00609869|20896102|P1|Overall Study|Rituximab reaction prior to lenalidomide|1
6046219|NCT00609869|20896102|P1|Overall Study|Hepatitis B infection|1
6046220|NCT00609869|20896102|P1|Overall Study|Severe tumor flare reaction|1
6046221|NCT00609869|20896102|P1|Overall Study|Seizures|1
6046222|NCT00609869|20896102|P1|Overall Study|Withdrawal by Subject|1
6046223|NCT00609869|20896102|P1|Overall Study|Severe hematologic toxicity|1
6046224|NCT00609869|20896102|P1|Overall Study|Withdrawn, ischemic stroke|1
6046225|NCT00609765|20896121|P1|Overall Study|Study ended prior to 12 months|1
6046226|NCT00609674|20896135|P2|Overall Study|Withdrew consent|1
6046227|NCT00609674|20896136|P1|Overall Study|Withdrew consent|2
6046228|NCT00609674|20896135|P2|Overall Study|Lost to Follow-up|0
6046229|NCT00609674|20896136|P1|Overall Study|Lost to Follow-up|1
6046230|NCT00609674|20896135|P2|Overall Study|Protocol Violation|5
6046231|NCT00609674|20896136|P1|Overall Study|Protocol Violation|3
6046232|NCT00609674|20896135|P2|Overall Study|Adverse Event|1
6046233|NCT00609674|20896136|P1|Overall Study|Adverse Event|1
6046234|NCT00609622|20896172|P2|Overall Study|Global deterioration of health status|2
6046235|NCT00609622|20896173|P1|Overall Study|Global deterioration of health status|6
6046236|NCT00609622|20896172|P2|Overall Study|Other|14
6046237|NCT00609622|20896173|P1|Overall Study|Other|7
6046238|NCT00609622|20896172|P2|Overall Study|Study terminated by sponsor|3
6046239|NCT00609622|20896173|P1|Overall Study|Study terminated by sponsor|16
6046240|NCT00609622|20896172|P2|Overall Study|Objective progression or relapse|41
6046241|NCT00609622|20896173|P1|Overall Study|Objective progression or relapse|47
6046242|NCT00609622|20896172|P2|Overall Study|Protocol Violation|1
6046243|NCT00609622|20896173|P1|Overall Study|Protocol Violation|1
6046244|NCT00609622|20896172|P2|Overall Study|Death|4
6046245|NCT00609622|20896173|P1|Overall Study|Death|1
6046246|NCT00609622|20896172|P2|Overall Study|Withdrawal by Subject|20
6046247|NCT00609622|20896173|P1|Overall Study|Withdrawal by Subject|4
6046248|NCT00609622|20896172|P2|Overall Study|Adverse Event|10
6046249|NCT00609622|20896173|P1|Overall Study|Adverse Event|14
6046251|NCT00609609|20896196|P1|Overall Study|Progression|4
6046252|NCT00609609|20896195|P2|Overall Study|Withdrawal by Subject|0
6046253|NCT00609609|20896196|P1|Overall Study|Withdrawal by Subject|2
6046254|NCT00609518|20896208|P2|Overall Study|Death from Adverse Event|2
6046255|NCT00609518|20896209|P1|Overall Study|Death from Adverse Event|2
6046256|NCT00609518|20896208|P2|Overall Study|Physician Decision|3
6046257|NCT00609518|20896209|P1|Overall Study|Physician Decision|1
6046258|NCT00609518|20896208|P2|Overall Study|Lost to Follow-up|0
6046259|NCT00609518|20896209|P1|Overall Study|Lost to Follow-up|3
6046260|NCT00609518|20896208|P2|Overall Study|Withdrawal by Subject|3
6046261|NCT00609518|20896209|P1|Overall Study|Withdrawal by Subject|5
6046262|NCT00609518|20896208|P2|Overall Study|Death from Study Disease|32
6046263|NCT00609518|20896209|P1|Overall Study|Death from Study Disease|32
6046264|NCT00609492|20896224|P3|Overall Study|Lost to Follow-up|4
6046265|NCT00609492|20896225|P2|Overall Study|Lost to Follow-up|1
6046266|NCT00609492|20896226|P1|Overall Study|Lost to Follow-up|1
6046267|NCT00609492|20896224|P3|Overall Study|Withdrawal by Subject|3
6046268|NCT00609492|20896225|P2|Overall Study|Withdrawal by Subject|2
6046269|NCT00609492|20896226|P1|Overall Study|Withdrawal by Subject|0
6046270|NCT00609466|20896311|P3|Overall Study|Lack of Efficacy|2
6046271|NCT00609466|20896312|P2|Overall Study|Lack of Efficacy|2
6046272|NCT00609466|20896313|P1|Overall Study|Lack of Efficacy|0
6046273|NCT00609466|20896311|P3|Overall Study|Adverse Event|1
6046274|NCT00609466|20896312|P2|Overall Study|Adverse Event|3
6046275|NCT00609466|20896313|P1|Overall Study|Adverse Event|2
6046276|NCT00609466|20896311|P3|Overall Study|Withdrawal by Subject|1
6046277|NCT00609466|20896312|P2|Overall Study|Withdrawal by Subject|1
6046278|NCT00609466|20896313|P1|Overall Study|Withdrawal by Subject|0
6046279|NCT00609362|20896341|P2|Overall Study|Adverse Event|0
6046280|NCT00609362|20896342|P1|Overall Study|Adverse Event|1
6046281|NCT00609362|20896341|P2|Overall Study|Withdrawal by Subject|1
6046282|NCT00609362|20896342|P1|Overall Study|Withdrawal by Subject|2
6046283|NCT00609336|20896352|P1|Overall Study|LA or Met at Surgery|9
6046284|NCT00609336|20896352|P1|Overall Study|Death|1
6046285|NCT00609336|20896352|P1|Overall Study|Protocol Violation|3
6046286|NCT00609245|20896403|P1|Overall Study|Adverse Event|1
6046287|NCT00609167|20896411|P2|Overall Study|Stem Cell Transplant|6
6046288|NCT00609167|20896412|P1|Overall Study|Stem Cell Transplant|0
6046289|NCT00609167|20896411|P2|Overall Study|Disease Progression|0
6046290|NCT00609167|20896412|P1|Overall Study|Disease Progression|1
6046291|NCT00609167|20896411|P2|Overall Study|Adverse Event|1
6046292|NCT00609167|20896412|P1|Overall Study|Adverse Event|5
6046293|NCT00609167|20896411|P2|Overall Study|Lack of Efficacy|0
6046294|NCT00609167|20896412|P1|Overall Study|Lack of Efficacy|1
6046295|NCT00609167|20896411|P2|Overall Study|Withdrawal by Subject|0
6046296|NCT00609167|20896412|P1|Overall Study|Withdrawal by Subject|1
6046297|NCT00608985|20896443|P4|Overall Study|Lost to Follow-up|0
6046298|NCT00608985|20896444|P3|Overall Study|Lost to Follow-up|0
6046299|NCT00608985|20896445|P2|Overall Study|Lost to Follow-up|1
6046300|NCT00608985|20896446|P1|Overall Study|Lost to Follow-up|2
6046301|NCT00608985|20896443|P4|Overall Study|Withdrawal of Consent|1
6046302|NCT00608985|20896444|P3|Overall Study|Withdrawal of Consent|1
6046303|NCT00608985|20896445|P2|Overall Study|Withdrawal of Consent|1
6046304|NCT00608985|20896446|P1|Overall Study|Withdrawal of Consent|5
6046305|NCT00608985|20896443|P4|Overall Study|Administrative/Other|2
6046306|NCT00608985|20896444|P3|Overall Study|Administrative/Other|1
6046307|NCT00608985|20896445|P2|Overall Study|Administrative/Other|4
6046308|NCT00608985|20896446|P1|Overall Study|Administrative/Other|7
6046309|NCT00608985|20896443|P4|Overall Study|Adverse Event|6
6046310|NCT00608985|20896444|P3|Overall Study|Adverse Event|4
6046311|NCT00608985|20896445|P2|Overall Study|Adverse Event|7
6046312|NCT00608985|20896446|P1|Overall Study|Adverse Event|2
6046313|NCT00608959|20896478|P1|Part 1|Did not meet eligibility criteria|1
6046314|NCT00608907|20896491|P3|Overall Study|Progressive Disease|0
6046315|NCT00608907|20896492|P2|Overall Study|Progressive Disease|0
6046316|NCT00608907|20896493|P1|Overall Study|Progressive Disease|1
6046317|NCT00608907|20896491|P3|Overall Study|Withdrawal by Subject|0
6046318|NCT00608907|20896492|P2|Overall Study|Withdrawal by Subject|0
6046319|NCT00608907|20896493|P1|Overall Study|Withdrawal by Subject|4
6046320|NCT00608907|20896491|P3|Overall Study|Death|0
6046321|NCT00608907|20896492|P2|Overall Study|Death|0
6046322|NCT00608907|20896493|P1|Overall Study|Death|1
6046323|NCT00608907|20896491|P3|Overall Study|Adverse Event|1
6046324|NCT00608907|20896492|P2|Overall Study|Adverse Event|0
6046325|NCT00608907|20896493|P1|Overall Study|Adverse Event|6
6046326|NCT00608894|20896503|P2|Overall Study|Withdrawal by Subject|2
6046327|NCT00608894|20896504|P1|Overall Study|Withdrawal by Subject|0
6046328|NCT00608881|20896516|P2|Overall Study|Institutionalized|2
6046329|NCT00608881|20896517|P1|Overall Study|Institutionalized|1
6046330|NCT00608881|20896516|P2|Overall Study|Physician Decision|5
6046331|NCT00608881|20896517|P1|Overall Study|Physician Decision|5
6046332|NCT00608881|20896516|P2|Overall Study|Withdrawal by Subject|29
6046333|NCT00608881|20896517|P1|Overall Study|Withdrawal by Subject|18
6046334|NCT00608881|20896516|P2|Overall Study|Lost to Follow-up|14
6046335|NCT00608881|20896517|P1|Overall Study|Lost to Follow-up|28
6046336|NCT00608881|20896516|P2|Overall Study|Adverse Event|3
6046337|NCT00608881|20896517|P1|Overall Study|Adverse Event|5
6046338|NCT00608881|20896516|P2|Overall Study|Death|13
6046339|NCT00608881|20896517|P1|Overall Study|Death|22
6046340|NCT00608868|20896551|P1|Overall Study|Physician Decision|2
6046341|NCT00608868|20896551|P1|Overall Study|Adverse Event|1
6046342|NCT00608868|20896551|P1|Overall Study|Lost to Follow-up|2
6046343|NCT00608868|20896551|P1|Overall Study|Protocol Violation|3
6046344|NCT00608868|20896551|P1|Overall Study|Withdrawal by Subject|7
6046345|NCT00608842|20896562|P4|Overall Study|Lost to Follow-up|0
6046346|NCT00608842|20896563|P3|Overall Study|Lost to Follow-up|0
6046347|NCT00608842|20896564|P2|Overall Study|Lost to Follow-up|0
6046348|NCT00608842|20896565|P1|Overall Study|Lost to Follow-up|1
6046349|NCT00608842|20896562|P4|Overall Study|Participant's Request|1
6046350|NCT00608842|20896563|P3|Overall Study|Participant's Request|2
6046351|NCT00608842|20896564|P2|Overall Study|Participant's Request|1
6046352|NCT00608842|20896565|P1|Overall Study|Participant's Request|0
6046353|NCT00608829|20896599|P1|Overall Study|Subject refuses to follow up or return.|5
6046354|NCT00608829|20896599|P1|Overall Study|Withdrawal by Subject|4
6046355|NCT00608829|20896599|P1|Overall Study|Death|6
6046356|NCT00608582|20896625|P2|Overall Study|Early stage Design Change|3
6046357|NCT00608582|20896626|P1|Overall Study|Early stage Design Change|0
6046358|NCT00608582|20896625|P2|Overall Study|Illicit Drug Use|0
6046359|NCT00608582|20896626|P1|Overall Study|Illicit Drug Use|1
6046360|NCT00608582|20896625|P2|Overall Study|No Best Response in Phase 1 located|1
6046361|NCT00608582|20896626|P1|Overall Study|No Best Response in Phase 1 located|1
6046362|NCT00608582|20896625|P2|Overall Study|Lost to Follow-up|0
6046363|NCT00608582|20896626|P1|Overall Study|Lost to Follow-up|2
6046364|NCT00608569|20896636|P2|Overall Study|Unable to adhere with study requirements|1
6046365|NCT00608569|20896637|P1|Overall Study|Unable to adhere with study requirements|0
6046366|NCT00608569|20896636|P2|Overall Study|Adverse Event|0
6046367|NCT00608569|20896637|P1|Overall Study|Adverse Event|1
6046368|NCT00608569|20896636|P2|Overall Study|Withdrawal by Subject|0
6046369|NCT00608569|20896637|P1|Overall Study|Withdrawal by Subject|1
6046370|NCT00608569|20896636|P2|Overall Study|Lost to Follow-up|5
6046371|NCT00608569|20896637|P1|Overall Study|Lost to Follow-up|4
6046372|NCT00608569|20896636|P2|Overall Study|Death|3
6046373|NCT00608569|20896637|P1|Overall Study|Death|4
6046374|NCT00608543|20896657|P1|Overall Study|Adverse Event|4
6046375|NCT00608530|20896670|P4|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0
6046376|NCT00608530|20896671|P3|Study 2 Nurse-delivered Treatments|Lost to Follow-up|1
6046377|NCT00608530|20896672|P2|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0
6046378|NCT00608530|20896673|P1|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0
6046379|NCT00608530|20896670|P4|Study 2 Nurse-delivered Treatments|Time demands of study|1
6046380|NCT00608530|20896671|P3|Study 2 Nurse-delivered Treatments|Time demands of study|4
6046381|NCT00608530|20896672|P2|Study 2 Nurse-delivered Treatments|Time demands of study|0
6046382|NCT00608530|20896673|P1|Study 2 Nurse-delivered Treatments|Time demands of study|0
6046383|NCT00608530|20896670|P4|Study 2 Nurse-delivered Treatments|Protocol Violation|0
6046384|NCT00608530|20896671|P3|Study 2 Nurse-delivered Treatments|Protocol Violation|2
6046385|NCT00608530|20896672|P2|Study 2 Nurse-delivered Treatments|Protocol Violation|0
6046386|NCT00608530|20896673|P1|Study 2 Nurse-delivered Treatments|Protocol Violation|0
6046387|NCT00608530|20896670|P4|Study 2 Nurse-delivered Treatments|Lack of Efficacy|3
6046388|NCT00608530|20896671|P3|Study 2 Nurse-delivered Treatments|Lack of Efficacy|2
6046389|NCT00608530|20896672|P2|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0
6046390|NCT00608530|20896673|P1|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0
6046391|NCT00608530|20896670|P4|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3
6046392|NCT00608530|20896671|P3|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3
6046393|NCT00608530|20896672|P2|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0
6046394|NCT00608530|20896673|P1|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0
6046395|NCT00608530|20896670|P4|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0
6046396|NCT00608530|20896671|P3|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0
6046397|NCT00608530|20896672|P2|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|5
6046398|NCT00608530|20896673|P1|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|11
6046399|NCT00608517|20896694|P3|Overall Study|Death|0
6046400|NCT00608517|20896695|P2|Overall Study|Death|0
6046401|NCT00608517|20896696|P1|Overall Study|Death|1
6046402|NCT00608426|20896876|P2|Overall Study|refused, health issues, wrong address|348
6046403|NCT00608426|20896877|P1|Overall Study|refused, health issues, wrong address|319
6046404|NCT00608426|20896876|P2|Overall Study|Lost to Follow-up|521
6046405|NCT00608426|20896877|P1|Overall Study|Lost to Follow-up|485
6046406|NCT00608426|20896876|P2|Overall Study|Death|36
6046407|NCT00608426|20896877|P1|Overall Study|Death|32
6046408|NCT00608322|20896889|P2|Overall Study|Death|1
6046409|NCT00608322|20896890|P1|Overall Study|Death|2
6046410|NCT00608244|20896896|P1|Overall Study|Low trough levels|1
6046411|NCT00608244|20896896|P1|Overall Study|Adverse Event|1
6046412|NCT00608205|20896907|P2|Overall Study|Patient non-compliant|1
6046413|NCT00608205|20896908|P1|Overall Study|Patient non-compliant|0
6046414|NCT00608205|20896907|P2|Overall Study|Adverse Event|2
6046415|NCT00608205|20896908|P1|Overall Study|Adverse Event|3
6046416|NCT00608023|20897092|P3|Overall Study|Unknown reason|0
6046417|NCT00608023|20897093|P2|Overall Study|Unknown reason|3
6046418|NCT00608023|20897094|P1|Overall Study|Unknown reason|0
6046419|NCT00608023|20897092|P3|Overall Study|Protocol Violation|1
6046420|NCT00608023|20897093|P2|Overall Study|Protocol Violation|3
6046421|NCT00608023|20897094|P1|Overall Study|Protocol Violation|1
6046422|NCT00608023|20897092|P3|Overall Study|Lost to Follow-up|1
6046423|NCT00608023|20897093|P2|Overall Study|Lost to Follow-up|2
6046424|NCT00608023|20897094|P1|Overall Study|Lost to Follow-up|2
6046425|NCT00608023|20897092|P3|Overall Study|Adverse Event|5
6046426|NCT00608023|20897093|P2|Overall Study|Adverse Event|4
6046427|NCT00608023|20897094|P1|Overall Study|Adverse Event|1
6046428|NCT00608023|20897092|P3|Overall Study|Withdrawal by Subject|7
6046429|NCT00608023|20897093|P2|Overall Study|Withdrawal by Subject|10
6046430|NCT00608023|20897094|P1|Overall Study|Withdrawal by Subject|8
6046431|NCT00607997|20897118|P4|Overall Study|Other without explanation|1
6046432|NCT00607997|20897119|P3|Overall Study|Other without explanation|4
6046433|NCT00607997|20897120|P2|Overall Study|Other without explanation|0
6046434|NCT00607997|20897121|P1|Overall Study|Other without explanation|2
6046435|NCT00607997|20897118|P4|Overall Study|Relapse, recurrent illness|0
6046436|NCT00607997|20897119|P3|Overall Study|Relapse, recurrent illness|2
6046437|NCT00607997|20897120|P2|Overall Study|Relapse, recurrent illness|0
6046438|NCT00607997|20897121|P1|Overall Study|Relapse, recurrent illness|4
6046439|NCT00607997|20897118|P4|Overall Study|Physician Decision|0
6046440|NCT00607997|20897119|P3|Overall Study|Physician Decision|0
6046441|NCT00607997|20897120|P2|Overall Study|Physician Decision|1
6046442|NCT00607997|20897121|P1|Overall Study|Physician Decision|4
6046443|NCT00607997|20897118|P4|Overall Study|Adverse Event|0
6046444|NCT00607997|20897119|P3|Overall Study|Adverse Event|2
6046445|NCT00607997|20897120|P2|Overall Study|Adverse Event|1
6046446|NCT00607997|20897121|P1|Overall Study|Adverse Event|3
6046447|NCT00607997|20897118|P4|Overall Study|Death|5
6046448|NCT00607997|20897119|P3|Overall Study|Death|2
6046449|NCT00607997|20897120|P2|Overall Study|Death|5
6046450|NCT00607997|20897121|P1|Overall Study|Death|8
6046451|NCT00607997|20897118|P4|Overall Study|Lack of Efficacy|10
6046452|NCT00607997|20897119|P3|Overall Study|Lack of Efficacy|14
6046453|NCT00607997|20897120|P2|Overall Study|Lack of Efficacy|20
6046454|NCT00607997|20897121|P1|Overall Study|Lack of Efficacy|6
6046455|NCT00607919|20897179|P2|Open-Label Phase|Parent/Caregiver Decision|2
6046456|NCT00607919|20897180|P1|Open-Label Phase|Parent/Caregiver Decision|1
6046457|NCT00607919|20897179|P2|Open-Label Phase|Withdrawal by Subject|2
6046458|NCT00607919|20897180|P1|Open-Label Phase|Withdrawal by Subject|2
6046459|NCT00607919|20897179|P2|Open-Label Phase|Protocol Violation|2
6046460|NCT00607919|20897180|P1|Open-Label Phase|Protocol Violation|2
6046461|NCT00607919|20897179|P2|Open-Label Phase|Lost to Follow-up|1
6046462|NCT00607919|20897180|P1|Open-Label Phase|Lost to Follow-up|4
6046463|NCT00607919|20897179|P2|Open-Label Phase|Adverse Event|5
6046464|NCT00607919|20897180|P1|Open-Label Phase|Adverse Event|1
6046465|NCT00607919|20897179|P2|Acute Phase|Withdrawal by Subject|3
6046466|NCT00607919|20897180|P1|Acute Phase|Withdrawal by Subject|3
6046467|NCT00607919|20897179|P2|Acute Phase|Protocol Violation|1
6046468|NCT00607919|20897180|P1|Acute Phase|Protocol Violation|5
6046469|NCT00607919|20897179|P2|Acute Phase|Parent/Caregiver Decision|4
6046470|NCT00607919|20897180|P1|Acute Phase|Parent/Caregiver Decision|6
6046471|NCT00607919|20897179|P2|Acute Phase|Lost to Follow-up|3
6046472|NCT00607919|20897180|P1|Acute Phase|Lost to Follow-up|9
6046473|NCT00607919|20897179|P2|Acute Phase|Lack of Efficacy|2
6046474|NCT00607919|20897180|P1|Acute Phase|Lack of Efficacy|1
6046475|NCT00607919|20897179|P2|Acute Phase|Entry Criteria Not Met|1
6046476|NCT00607919|20897180|P1|Acute Phase|Entry Criteria Not Met|1
6046477|NCT00607919|20897179|P2|Acute Phase|Adverse Event|2
6046478|NCT00607919|20897180|P1|Acute Phase|Adverse Event|9
6046479|NCT00607893|20897238|P2|Overall Study|Withdrew due to hypertensive urgency|1
6046480|NCT00607893|20897239|P1|Overall Study|Withdrew due to hypertensive urgency|1
6046481|NCT00607893|20897238|P2|Overall Study|Declined to be treated|0
6046482|NCT00607893|20897239|P1|Overall Study|Declined to be treated|1
6046483|NCT00607893|20897238|P2|Overall Study|withdrew could not tolerate CPAP|1
6046484|NCT00607893|20897239|P1|Overall Study|withdrew could not tolerate CPAP|0
6046485|NCT00607893|20897238|P2|Overall Study|Withdrew due to osteomyelitis surgery|1
6046486|NCT00607893|20897239|P1|Overall Study|Withdrew due to osteomyelitis surgery|0
6046487|NCT00607893|20897238|P2|Overall Study|withdrew due to loss of interest|1
6046488|NCT00607893|20897239|P1|Overall Study|withdrew due to loss of interest|0
6046489|NCT00607893|20897238|P2|Overall Study|Lost to Follow-up|0
6046490|NCT00607893|20897239|P1|Overall Study|Lost to Follow-up|4
6046491|NCT00607880|20897267|P2|Overall Study|Unable to place port due to occlusion|0
6046492|NCT00607880|20897268|P1|Overall Study|Unable to place port due to occlusion|1
6046493|NCT00607789|20897318|P2|Overall Study|Withdrawal by Subject|0
6046494|NCT00607789|20897319|P1|Overall Study|Withdrawal by Subject|1
6046495|NCT00607789|20897318|P2|Overall Study|Lost to Follow-up|5
6046496|NCT00607789|20897319|P1|Overall Study|Lost to Follow-up|0
6046497|NCT00607789|20897318|P2|Overall Study|Inadequate adherence|0
6046498|NCT00607789|20897319|P1|Overall Study|Inadequate adherence|3
6046499|NCT00607789|20897318|P2|Overall Study|Lack of Efficacy|1
6046500|NCT00607789|20897319|P1|Overall Study|Lack of Efficacy|0
6046501|NCT00607789|20897318|P2|Overall Study|Adverse Event|0
6046502|NCT00607789|20897319|P1|Overall Study|Adverse Event|3
6046503|NCT00607724|20897334|P7|Stage 2: Expanded Cohort|Withdrawal by Subject|0
6046504|NCT00607724|20897335|P6|Stage 2: Expanded Cohort|Withdrawal by Subject|0
6046505|NCT00607724|20897336|P5|Stage 2: Expanded Cohort|Withdrawal by Subject|0
6046506|NCT00607724|20897337|P4|Stage 2: Expanded Cohort|Withdrawal by Subject|1
6046507|NCT00607724|20897338|P3|Stage 2: Expanded Cohort|Withdrawal by Subject|0
6046508|NCT00607724|20897339|P2|Stage 2: Expanded Cohort|Withdrawal by Subject|0
6046509|NCT00607724|20897340|P1|Stage 2: Expanded Cohort|Withdrawal by Subject|0
6046510|NCT00607724|20897334|P7|Stage 2: Expanded Cohort|Physician Decision|0
6046511|NCT00607724|20897335|P6|Stage 2: Expanded Cohort|Physician Decision|1
6046512|NCT00607724|20897336|P5|Stage 2: Expanded Cohort|Physician Decision|1
6046513|NCT00607724|20897337|P4|Stage 2: Expanded Cohort|Physician Decision|0
6046514|NCT00607724|20897338|P3|Stage 2: Expanded Cohort|Physician Decision|0
6046515|NCT00607724|20897339|P2|Stage 2: Expanded Cohort|Physician Decision|0
6046516|NCT00607724|20897340|P1|Stage 2: Expanded Cohort|Physician Decision|0
6046517|NCT00607724|20897334|P7|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|10
6046518|NCT00607724|20897335|P6|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|11
6046519|NCT00607724|20897336|P5|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|8
6046520|NCT00607724|20897337|P4|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|4
6046521|NCT00607724|20897338|P3|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0
6046522|NCT00607724|20897339|P2|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0
6046523|NCT00607724|20897340|P1|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0
6046524|NCT00607724|20897334|P7|Stage 2: Expanded Cohort|Adverse Event|1
6046525|NCT00607724|20897335|P6|Stage 2: Expanded Cohort|Adverse Event|0
6046526|NCT00607724|20897336|P5|Stage 2: Expanded Cohort|Adverse Event|0
6046527|NCT00607724|20897337|P4|Stage 2: Expanded Cohort|Adverse Event|0
6046528|NCT00607724|20897338|P3|Stage 2: Expanded Cohort|Adverse Event|0
6046529|NCT00607724|20897339|P2|Stage 2: Expanded Cohort|Adverse Event|0
6046530|NCT00607724|20897340|P1|Stage 2: Expanded Cohort|Adverse Event|0
6046531|NCT00607724|20897334|P7|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0
6046532|NCT00607724|20897335|P6|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0
6046533|NCT00607724|20897336|P5|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0
6046534|NCT00607724|20897337|P4|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0
6046535|NCT00607724|20897338|P3|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|4
6046536|NCT00607724|20897339|P2|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|8
6046537|NCT00607724|20897340|P1|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|7
6046538|NCT00607386|20897503|P1|Overall Study|Physician Decision|1
6046539|NCT00607373|20897518|P2|Follow-up Period|Withdrawal by Subject|3
6046540|NCT00607373|20897519|P1|Follow-up Period|Withdrawal by Subject|1
6046541|NCT00607373|20897518|P2|Follow-up Period|Protocol Violation|1
6046542|NCT00607373|20897519|P1|Follow-up Period|Protocol Violation|0
6046543|NCT00607373|20897518|P2|Follow-up Period|Other|1
6046544|NCT00607373|20897519|P1|Follow-up Period|Other|0
6046545|NCT00607373|20897518|P2|Treatment Period|Withdrawal by Subject|1
6046546|NCT00607373|20897519|P1|Treatment Period|Withdrawal by Subject|0
6046547|NCT00607373|20897518|P2|Treatment Period|Physician Decision|1
6046548|NCT00607373|20897519|P1|Treatment Period|Physician Decision|0
6046549|NCT00607373|20897518|P2|Treatment Period|Adverse Event|4
6046550|NCT00607373|20897519|P1|Treatment Period|Adverse Event|0
6046551|NCT00607087|20897621|P3|Period 3|Adverse Event|0
6046552|NCT00607087|20897622|P2|Period 3|Adverse Event|1
6046553|NCT00607087|20897623|P1|Period 3|Adverse Event|0
6046554|NCT00607087|20897621|P3|Period 3|Withdrawal by Subject|0
6046555|NCT00607087|20897622|P2|Period 3|Withdrawal by Subject|1
6046556|NCT00607087|20897623|P1|Period 3|Withdrawal by Subject|2
6046557|NCT00607087|20897621|P3|Period 2|Poor compliance to protocol|1
6046558|NCT00607087|20897622|P2|Period 2|Poor compliance to protocol|0
6046559|NCT00607087|20897623|P1|Period 2|Poor compliance to protocol|0
6046560|NCT00607087|20897621|P3|Period 2|Adverse Event|3
6046561|NCT00607087|20897622|P2|Period 2|Adverse Event|1
6046562|NCT00607087|20897623|P1|Period 2|Adverse Event|0
6046563|NCT00607087|20897621|P3|Period 2|Other reason|0
6046564|NCT00607087|20897622|P2|Period 2|Other reason|1
6046565|NCT00607087|20897623|P1|Period 2|Other reason|1
6046566|NCT00607087|20897621|P3|Period 2|Withdrawal by Subject|1
6046567|NCT00607087|20897622|P2|Period 2|Withdrawal by Subject|1
6046568|NCT00607087|20897623|P1|Period 2|Withdrawal by Subject|0
6046569|NCT00607087|20897621|P3|Period 1|Other reason|2
6046570|NCT00607087|20897622|P2|Period 1|Other reason|4
6046571|NCT00607087|20897623|P1|Period 1|Other reason|0
6046572|NCT00607087|20897621|P3|Period 1|Lost to Follow-up|0
6046573|NCT00607087|20897622|P2|Period 1|Lost to Follow-up|0
6046574|NCT00607087|20897623|P1|Period 1|Lost to Follow-up|1
6046575|NCT00607087|20897621|P3|Period 1|Poor compliance to protocol|0
6046576|NCT00607087|20897622|P2|Period 1|Poor compliance to protocol|0
6046577|NCT00607087|20897623|P1|Period 1|Poor compliance to protocol|1
6046578|NCT00607087|20897621|P3|Period 1|Adverse Event|0
6046579|NCT00607087|20897622|P2|Period 1|Adverse Event|0
6046580|NCT00607087|20897623|P1|Period 1|Adverse Event|3
6046581|NCT00607087|20897621|P3|Period 1|Withdrawal by Subject|3
6046582|NCT00607087|20897622|P2|Period 1|Withdrawal by Subject|2
6046583|NCT00607087|20897623|P1|Period 1|Withdrawal by Subject|7
6046584|NCT00607087|20897621|P3|Overall Study|Lost to Follow-up|0
6046585|NCT00607087|20897622|P2|Overall Study|Lost to Follow-up|0
6046586|NCT00607087|20897623|P1|Overall Study|Lost to Follow-up|1
6046587|NCT00607087|20897621|P3|Overall Study|Poor compliance to protocol|1
6046588|NCT00607087|20897622|P2|Overall Study|Poor compliance to protocol|0
6046589|NCT00607087|20897623|P1|Overall Study|Poor compliance to protocol|1
6046590|NCT00607087|20897621|P3|Overall Study|Other reason|2
6046591|NCT00607087|20897622|P2|Overall Study|Other reason|5
6046592|NCT00607087|20897623|P1|Overall Study|Other reason|1
6046593|NCT00607087|20897621|P3|Overall Study|Adverse Event|3
6046594|NCT00607087|20897622|P2|Overall Study|Adverse Event|2
6046595|NCT00607087|20897623|P1|Overall Study|Adverse Event|3
6046596|NCT00607087|20897621|P3|Overall Study|Withdrawal by Subject|4
6046597|NCT00607087|20897622|P2|Overall Study|Withdrawal by Subject|4
6046598|NCT00607087|20897623|P1|Overall Study|Withdrawal by Subject|9
6046599|NCT00607048|20897681|P6|Overall Study|Other|1
6046600|NCT00607048|20897682|P5|Overall Study|Other|0
6046601|NCT00607048|20897683|P4|Overall Study|Other|0
6046602|NCT00607048|20897684|P3|Overall Study|Other|0
6046603|NCT00607048|20897685|P2|Overall Study|Other|1
6046604|NCT00607048|20897686|P1|Overall Study|Other|1
6046605|NCT00607048|20897681|P6|Overall Study|Withdrawal by Subject|2
6046606|NCT00607048|20897682|P5|Overall Study|Withdrawal by Subject|0
6046607|NCT00607048|20897683|P4|Overall Study|Withdrawal by Subject|1
6046608|NCT00607048|20897684|P3|Overall Study|Withdrawal by Subject|0
6046609|NCT00607048|20897685|P2|Overall Study|Withdrawal by Subject|0
6046610|NCT00607048|20897686|P1|Overall Study|Withdrawal by Subject|0
6046611|NCT00607048|20897681|P6|Overall Study|Objective disease progression - relapse|2
6046612|NCT00607048|20897682|P5|Overall Study|Objective disease progression - relapse|2
6046613|NCT00607048|20897683|P4|Overall Study|Objective disease progression - relapse|2
6046614|NCT00607048|20897684|P3|Overall Study|Objective disease progression - relapse|4
6046615|NCT00607048|20897685|P2|Overall Study|Objective disease progression - relapse|2
6046616|NCT00607048|20897686|P1|Overall Study|Objective disease progression - relapse|1
6046617|NCT00607048|20897681|P6|Overall Study|Global deterioration of health|0
6046618|NCT00607048|20897682|P5|Overall Study|Global deterioration of health|0
6046619|NCT00607048|20897683|P4|Overall Study|Global deterioration of health|0
6046620|NCT00607048|20897684|P3|Overall Study|Global deterioration of health|0
6046621|NCT00607048|20897685|P2|Overall Study|Global deterioration of health|0
6046622|NCT00607048|20897686|P1|Overall Study|Global deterioration of health|1
6046623|NCT00607048|20897681|P6|Overall Study|Adverse Event|0
6046624|NCT00607048|20897682|P5|Overall Study|Adverse Event|4
6046625|NCT00607048|20897683|P4|Overall Study|Adverse Event|0
6046626|NCT00607048|20897684|P3|Overall Study|Adverse Event|0
6046627|NCT00607048|20897685|P2|Overall Study|Adverse Event|1
6046628|NCT00607048|20897686|P1|Overall Study|Adverse Event|0
6046629|NCT00607022|20897771|P3|Overall Study|Withdrawal by Subject|0
6046630|NCT00607022|20897772|P2|Overall Study|Withdrawal by Subject|0
6046631|NCT00607022|20897773|P1|Overall Study|Withdrawal by Subject|1
6046632|NCT00606931|20897790|P1|Overall Study|Withdrawal by Subject|3
6046633|NCT00606905|20897798|P2|Overall Study|Withdrew|5
6046634|NCT00606905|20897799|P1|Overall Study|Withdrew|5
6046635|NCT00606905|20897798|P2|Overall Study|Non-Index Pregnancy|4
6046636|NCT00606905|20897799|P1|Overall Study|Non-Index Pregnancy|1
6046637|NCT00606905|20897798|P2|Overall Study|No Pregnancy|6
6046638|NCT00606905|20897799|P1|Overall Study|No Pregnancy|9
6046639|NCT00606892|20897805|P2|First Intervention|Protocol Violation|4
6046640|NCT00606892|20897806|P1|First Intervention|Protocol Violation|1
6046641|NCT00606801|20897840|P2|Intervention|Protocol Violation|3
6046642|NCT00606801|20897841|P1|Intervention|Protocol Violation|3
6046643|NCT00606684|20897869|P7|Double-Blind Treatment Period|Withdrawal by Subject|0
6046644|NCT00606684|20897870|P6|Double-Blind Treatment Period|Withdrawal by Subject|2
6046645|NCT00606684|20897871|P5|Double-Blind Treatment Period|Withdrawal by Subject|1
6046646|NCT00606684|20897872|P4|Double-Blind Treatment Period|Withdrawal by Subject|2
6046647|NCT00606684|20897873|P3|Double-Blind Treatment Period|Withdrawal by Subject|1
6046648|NCT00606684|20897874|P2|Double-Blind Treatment Period|Withdrawal by Subject|1
6046649|NCT00606684|20897875|P1|Double-Blind Treatment Period|Withdrawal by Subject|0
6046650|NCT00606684|20897869|P7|Double-Blind Treatment Period|Physician Decision|2
6046651|NCT00606684|20897870|P6|Double-Blind Treatment Period|Physician Decision|1
6046652|NCT00606684|20897871|P5|Double-Blind Treatment Period|Physician Decision|3
6046653|NCT00606684|20897872|P4|Double-Blind Treatment Period|Physician Decision|0
6046654|NCT00606684|20897873|P3|Double-Blind Treatment Period|Physician Decision|1
6046655|NCT00606684|20897874|P2|Double-Blind Treatment Period|Physician Decision|5
6046656|NCT00606684|20897875|P1|Double-Blind Treatment Period|Physician Decision|0
6046657|NCT00606684|20897869|P7|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1
6046658|NCT00606684|20897870|P6|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|3
6046659|NCT00606684|20897871|P5|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2
6046660|NCT00606684|20897872|P4|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1
6046661|NCT00606684|20897873|P3|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2
6046662|NCT00606684|20897874|P2|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1
6046663|NCT00606684|20897875|P1|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|0
6046664|NCT00606684|20897869|P7|Double-Blind Treatment Period|Protocol Violation|4
6046665|NCT00606684|20897870|P6|Double-Blind Treatment Period|Protocol Violation|3
6046666|NCT00606684|20897871|P5|Double-Blind Treatment Period|Protocol Violation|0
6046667|NCT00606684|20897872|P4|Double-Blind Treatment Period|Protocol Violation|3
6046668|NCT00606684|20897873|P3|Double-Blind Treatment Period|Protocol Violation|5
6046669|NCT00606684|20897874|P2|Double-Blind Treatment Period|Protocol Violation|5
6046670|NCT00606684|20897875|P1|Double-Blind Treatment Period|Protocol Violation|0
6046671|NCT00606684|20897869|P7|Double-Blind Treatment Period|Lack of Efficacy|0
6046672|NCT00606684|20897870|P6|Double-Blind Treatment Period|Lack of Efficacy|0
6046673|NCT00606684|20897871|P5|Double-Blind Treatment Period|Lack of Efficacy|1
6046674|NCT00606684|20897872|P4|Double-Blind Treatment Period|Lack of Efficacy|0
6046675|NCT00606684|20897873|P3|Double-Blind Treatment Period|Lack of Efficacy|0
6046676|NCT00606684|20897874|P2|Double-Blind Treatment Period|Lack of Efficacy|1
6046677|NCT00606684|20897875|P1|Double-Blind Treatment Period|Lack of Efficacy|0
6046678|NCT00606684|20897869|P7|Double-Blind Treatment Period|Adverse Event|1
6046679|NCT00606684|20897870|P6|Double-Blind Treatment Period|Adverse Event|0
6046680|NCT00606684|20897871|P5|Double-Blind Treatment Period|Adverse Event|2
6046681|NCT00606684|20897872|P4|Double-Blind Treatment Period|Adverse Event|4
6046682|NCT00606684|20897873|P3|Double-Blind Treatment Period|Adverse Event|2
6046683|NCT00606684|20897874|P2|Double-Blind Treatment Period|Adverse Event|3
6046684|NCT00606684|20897875|P1|Double-Blind Treatment Period|Adverse Event|0
6046685|NCT00606684|20897869|P7|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
6046686|NCT00606684|20897870|P6|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
6046687|NCT00606684|20897871|P5|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
6046688|NCT00606684|20897872|P4|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
6046689|NCT00606684|20897873|P3|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
6046690|NCT00606684|20897874|P2|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
6046691|NCT00606684|20897875|P1|2-week Single-Blind Run-in Period|Received Study Medication in Error|1
6046692|NCT00606684|20897869|P7|2-week Single-Blind Run-in Period|Adverse Event|0
6046693|NCT00606684|20897870|P6|2-week Single-Blind Run-in Period|Adverse Event|0
6046694|NCT00606684|20897871|P5|2-week Single-Blind Run-in Period|Adverse Event|0
6046695|NCT00606684|20897872|P4|2-week Single-Blind Run-in Period|Adverse Event|0
6046696|NCT00606684|20897873|P3|2-week Single-Blind Run-in Period|Adverse Event|0
6046697|NCT00606684|20897874|P2|2-week Single-Blind Run-in Period|Adverse Event|0
6046698|NCT00606684|20897875|P1|2-week Single-Blind Run-in Period|Adverse Event|2
6046699|NCT00606684|20897869|P7|2-week Single-Blind Run-in Period|Lost to Follow-up|0
6046700|NCT00606684|20897870|P6|2-week Single-Blind Run-in Period|Lost to Follow-up|0
6046701|NCT00606684|20897871|P5|2-week Single-Blind Run-in Period|Lost to Follow-up|0
6046702|NCT00606684|20897872|P4|2-week Single-Blind Run-in Period|Lost to Follow-up|0
6046703|NCT00606684|20897873|P3|2-week Single-Blind Run-in Period|Lost to Follow-up|0
6046704|NCT00606684|20897874|P2|2-week Single-Blind Run-in Period|Lost to Follow-up|0
6046705|NCT00606684|20897875|P1|2-week Single-Blind Run-in Period|Lost to Follow-up|5
6046706|NCT00606684|20897869|P7|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
6046707|NCT00606684|20897870|P6|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
6046708|NCT00606684|20897871|P5|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
6046709|NCT00606684|20897872|P4|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
6046710|NCT00606684|20897873|P3|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
6046711|NCT00606684|20897874|P2|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
6046712|NCT00606684|20897875|P1|2-week Single-Blind Run-in Period|Withdrawal by Subject|15
6046713|NCT00606684|20897869|P7|2-week Single-Blind Run-in Period|Physician Decision|0
6046714|NCT00606684|20897870|P6|2-week Single-Blind Run-in Period|Physician Decision|0
6046715|NCT00606684|20897871|P5|2-week Single-Blind Run-in Period|Physician Decision|0
6046716|NCT00606684|20897872|P4|2-week Single-Blind Run-in Period|Physician Decision|0
6046717|NCT00606684|20897873|P3|2-week Single-Blind Run-in Period|Physician Decision|0
6046718|NCT00606684|20897874|P2|2-week Single-Blind Run-in Period|Physician Decision|0
6046719|NCT00606684|20897875|P1|2-week Single-Blind Run-in Period|Physician Decision|18
6046720|NCT00606684|20897869|P7|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
6046721|NCT00606684|20897870|P6|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
6046722|NCT00606684|20897871|P5|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
6046723|NCT00606684|20897872|P4|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
6046724|NCT00606684|20897873|P3|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
6046725|NCT00606684|20897874|P2|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
6046726|NCT00606684|20897875|P1|2-week Single-Blind Run-in Period|Study Closed/Terminated|32
6046727|NCT00606684|20897869|P7|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
6046728|NCT00606684|20897870|P6|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
6046729|NCT00606684|20897871|P5|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
6046730|NCT00606684|20897872|P4|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
6046731|NCT00606684|20897873|P3|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
6046732|NCT00606684|20897874|P2|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
6046733|NCT00606684|20897875|P1|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|173
6046734|NCT00606632|20897907|P1|Overall Study|Miscellaneous reasons|9
6046735|NCT00606632|20897907|P1|Overall Study|Withdrawal by Subject|13
6046736|NCT00606593|20897920|P10|Overall Study|Administrative/Other|0
6046737|NCT00606593|20897921|P9|Overall Study|Administrative/Other|0
6046738|NCT00606593|20897922|P8|Overall Study|Administrative/Other|0
6046739|NCT00606593|20897923|P7|Overall Study|Administrative/Other|0
6046740|NCT00606593|20897924|P6|Overall Study|Administrative/Other|0
6046741|NCT00606593|20897925|P5|Overall Study|Administrative/Other|0
6046742|NCT00606593|20897926|P4|Overall Study|Administrative/Other|0
6046743|NCT00606593|20897927|P3|Overall Study|Administrative/Other|1
6046744|NCT00606593|20897928|P2|Overall Study|Administrative/Other|0
6046745|NCT00606593|20897929|P1|Overall Study|Administrative/Other|0
6046746|NCT00606593|20897920|P10|Overall Study|Withdrawal of consent|0
6046747|NCT00606593|20897921|P9|Overall Study|Withdrawal of consent|0
6046748|NCT00606593|20897922|P8|Overall Study|Withdrawal of consent|0
6046749|NCT00606593|20897923|P7|Overall Study|Withdrawal of consent|0
6046750|NCT00606593|20897924|P6|Overall Study|Withdrawal of consent|0
6046751|NCT00606593|20897925|P5|Overall Study|Withdrawal of consent|0
6046752|NCT00606593|20897926|P4|Overall Study|Withdrawal of consent|0
6046753|NCT00606593|20897927|P3|Overall Study|Withdrawal of consent|1
6046754|NCT00606593|20897928|P2|Overall Study|Withdrawal of consent|0
6046755|NCT00606593|20897929|P1|Overall Study|Withdrawal of consent|1
6046756|NCT00606593|20897920|P10|Overall Study|Adverse Event|0
6046757|NCT00606593|20897921|P9|Overall Study|Adverse Event|1
6046758|NCT00606593|20897922|P8|Overall Study|Adverse Event|2
6046759|NCT00606593|20897923|P7|Overall Study|Adverse Event|1
6046760|NCT00606593|20897924|P6|Overall Study|Adverse Event|0
6046761|NCT00606593|20897925|P5|Overall Study|Adverse Event|1
6046762|NCT00606593|20897926|P4|Overall Study|Adverse Event|1
6046763|NCT00606593|20897927|P3|Overall Study|Adverse Event|0
6046764|NCT00606593|20897928|P2|Overall Study|Adverse Event|0
6046765|NCT00606593|20897929|P1|Overall Study|Adverse Event|0
6046766|NCT00606580|20897950|P3|Overall Study|Withdrawal by Subject|0
6046767|NCT00606580|20897951|P2|Overall Study|Withdrawal by Subject|1
6046768|NCT00606580|20897952|P1|Overall Study|Withdrawal by Subject|0
6046769|NCT00606580|20897950|P3|Overall Study|Withdrawal by investigator|6
6046770|NCT00606580|20897951|P2|Overall Study|Withdrawal by investigator|1
6046771|NCT00606580|20897952|P1|Overall Study|Withdrawal by investigator|0
6046772|NCT00606580|20897950|P3|Overall Study|Clinical failures|12
6046773|NCT00606580|20897951|P2|Overall Study|Clinical failures|0
6046774|NCT00606580|20897952|P1|Overall Study|Clinical failures|1
6046775|NCT00606580|20897950|P3|Overall Study|Lost to Follow-up|4
6046776|NCT00606580|20897951|P2|Overall Study|Lost to Follow-up|1
6046777|NCT00606580|20897952|P1|Overall Study|Lost to Follow-up|1
6046778|NCT00606502|20898018|P2|Treatment|Treatment ongoing at time of data cutoff|3
6046779|NCT00606502|20898019|P1|Treatment|Treatment ongoing at time of data cutoff|0
6046780|NCT00606502|20898018|P2|Randomization|Randomized but not treated|0
6046781|NCT00606502|20898019|P1|Randomization|Randomized but not treated|3
6046782|NCT00606320|20898040|P1|Overall Study|Progression to depressive phase|4
6046783|NCT00606320|20898040|P1|Overall Study|Withdrawal by Subject|10
6046784|NCT00606320|20898040|P1|Overall Study|Protocol Violation|8
6046785|NCT00606320|20898040|P1|Overall Study|Physician Decision|7
6046786|NCT00606320|20898040|P1|Overall Study|Lack of Efficacy|5
6046787|NCT00606320|20898040|P1|Overall Study|Adverse Event|3
6046788|NCT00606307|20898045|P1|Overall Study|QTc prolongation|1
6046789|NCT00606307|20898045|P1|Overall Study|Disease progression|6
6046790|NCT00606307|20898045|P1|Overall Study|Withdrawal by Subject|2
6046791|NCT00606307|20898045|P1|Overall Study|Adverse Event|2
6046792|NCT00606294|20898053|P2|Overall Study|Withdrawal by Subject|0
6046793|NCT00606294|20898054|P1|Overall Study|Withdrawal by Subject|36
6046794|NCT00606281|20898068|P2|Overall Study|Change of residence or other commitments|1
6046795|NCT00606281|20898069|P1|Overall Study|Change of residence or other commitments|1
6046796|NCT00606281|20898068|P2|Overall Study|Progression to depressive phase|1
6046797|NCT00606281|20898069|P1|Overall Study|Progression to depressive phase|1
6046798|NCT00606281|20898068|P2|Overall Study|Withdrawal by Subject|13
6046799|NCT00606281|20898069|P1|Overall Study|Withdrawal by Subject|11
6046800|NCT00606281|20898068|P2|Overall Study|Protocol Violation|3
6046801|NCT00606281|20898069|P1|Overall Study|Protocol Violation|3
6046802|NCT00606281|20898068|P2|Overall Study|Physician Decision|1
6046803|NCT00606281|20898069|P1|Overall Study|Physician Decision|0
6046804|NCT00606281|20898068|P2|Overall Study|Lack of Efficacy|35
6046805|NCT00606281|20898069|P1|Overall Study|Lack of Efficacy|28
6046806|NCT00606281|20898068|P2|Overall Study|Death|0
6046807|NCT00606281|20898069|P1|Overall Study|Death|1
6046808|NCT00606281|20898068|P2|Overall Study|Adverse Event|12
6046809|NCT00606281|20898069|P1|Overall Study|Adverse Event|11
6046810|NCT00606229|20898077|P1|Overall Study|change of residence or other commitments|2
6046811|NCT00606229|20898077|P1|Overall Study|does not meet inclusion criterion 1-3|4
6046812|NCT00606229|20898077|P1|Overall Study|Withdrawal by Subject|4
6046813|NCT00606229|20898077|P1|Overall Study|Lack of Efficacy|1
6046814|NCT00606229|20898077|P1|Overall Study|Adverse Event|11
6046815|NCT00606177|20898084|P2|Overall Study|Change of residence or other commitments|1
6046816|NCT00606177|20898085|P1|Overall Study|Change of residence or other commitments|1
6046817|NCT00606177|20898084|P2|Overall Study|Diabetic blood glucose level/ High HbA1c|1
6046818|NCT00606177|20898085|P1|Overall Study|Diabetic blood glucose level/ High HbA1c|1
6046819|NCT00606177|20898084|P2|Overall Study|Progression to depressive phase|1
6046820|NCT00606177|20898085|P1|Overall Study|Progression to depressive phase|6
6046821|NCT00606177|20898084|P2|Overall Study|Withdrawal by Subject|6
6046822|NCT00606177|20898085|P1|Overall Study|Withdrawal by Subject|5
6046823|NCT00606177|20898084|P2|Overall Study|Protocol Violation|4
6046824|NCT00606177|20898085|P1|Overall Study|Protocol Violation|1
6046825|NCT00606177|20898084|P2|Overall Study|Physician Decision|0
6046826|NCT00606177|20898085|P1|Overall Study|Physician Decision|1
6046827|NCT00606177|20898084|P2|Overall Study|Lack of Efficacy|7
6046828|NCT00606177|20898085|P1|Overall Study|Lack of Efficacy|3
6046829|NCT00606177|20898084|P2|Overall Study|Adverse Event|5
6046830|NCT00606177|20898085|P1|Overall Study|Adverse Event|9
6046831|NCT00606086|20898112|P2|Overall Study|Randomized, not treated|2
6046832|NCT00606086|20898113|P1|Overall Study|Randomized, not treated|1
6046833|NCT00606086|20898112|P2|Overall Study|Non-compliance|1
6046834|NCT00606086|20898113|P1|Overall Study|Non-compliance|0
6046835|NCT00606086|20898112|P2|Overall Study|Withdrawal by Subject|3
6046836|NCT00606086|20898113|P1|Overall Study|Withdrawal by Subject|5
6046837|NCT00606086|20898112|P2|Overall Study|Protocol Violation|0
6046838|NCT00606086|20898113|P1|Overall Study|Protocol Violation|1
6046839|NCT00606086|20898112|P2|Overall Study|Lost to Follow-up|8
6046840|NCT00606086|20898113|P1|Overall Study|Lost to Follow-up|4
6046841|NCT00606086|20898112|P2|Overall Study|Adverse Event|1
6046842|NCT00606086|20898113|P1|Overall Study|Adverse Event|1
6046843|NCT00606034|20898123|P1|Overall Study|incarceration|1
6046844|NCT00606021|20898131|P3|Maintenance Phase|Lost to Follow-up|2
6046845|NCT00606021|20898132|P2|Maintenance Phase|Lost to Follow-up|5
6046846|NCT00606021|20898133|P1|Maintenance Phase|Lost to Follow-up|0
6046847|NCT00606021|20898131|P3|Maintenance Phase|Physician Decision|0
6046848|NCT00606021|20898132|P2|Maintenance Phase|Physician Decision|1
6046849|NCT00606021|20898133|P1|Maintenance Phase|Physician Decision|0
6046850|NCT00606021|20898131|P3|Maintenance Phase|Death|15
6046851|NCT00606021|20898132|P2|Maintenance Phase|Death|17
6046852|NCT00606021|20898133|P1|Maintenance Phase|Death|0
6046853|NCT00606021|20898131|P3|Induction Phase|Lost to Follow-up|0
6046854|NCT00606021|20898132|P2|Induction Phase|Lost to Follow-up|0
6046855|NCT00606021|20898133|P1|Induction Phase|Lost to Follow-up|10
6046856|NCT00606021|20898131|P3|Induction Phase|Withdrawal by Subject|0
6046857|NCT00606021|20898132|P2|Induction Phase|Withdrawal by Subject|0
6046858|NCT00606021|20898133|P1|Induction Phase|Withdrawal by Subject|2
6046859|NCT00606021|20898131|P3|Induction Phase|Physician Decision|0
6046860|NCT00606021|20898132|P2|Induction Phase|Physician Decision|0
6046861|NCT00606021|20898133|P1|Induction Phase|Physician Decision|2
6046862|NCT00606021|20898131|P3|Induction Phase|Death|0
6046863|NCT00606021|20898132|P2|Induction Phase|Death|0
6046864|NCT00606021|20898133|P1|Induction Phase|Death|73
6046865|NCT00606008|20898151|P1|Overall Study|Withdrawal by Subject|4
6046866|NCT00606008|20898151|P1|Overall Study|Adverse Event|1
6046867|NCT00605839|20898181|P3|Overall Study|Protocol Violation|0
6046868|NCT00605839|20898182|P2|Overall Study|Protocol Violation|0
6046869|NCT00605839|20898183|P1|Overall Study|Protocol Violation|1
6046870|NCT00605722|20898206|P1|Overall Study|Failure to return|1
6046871|NCT00605722|20898206|P1|Overall Study|Insufficient therapeutic response|44
6046872|NCT00605722|20898206|P1|Overall Study|Adverse Event|6
6046873|NCT00605657|20898227|P1|Overall Study|Protocol Violation|1
6046874|NCT00605657|20898227|P1|Overall Study|Adverse Event|1
6046875|NCT00605566|20898253|P1|Overall Study|Poor compliance in run-in period|1
6046876|NCT00605566|20898253|P1|Overall Study|Clinical deterioration|1
6046877|NCT00605566|20898253|P1|Overall Study|Adverse Event|1
6046878|NCT00605540|20898261|P1|Overall Study|Lost to Follow-up|23
6046879|NCT00605540|20898261|P1|Overall Study|Death|15
6046880|NCT00605475|20898279|P10|Overall Study|Withdrawal by Subject|1
6046881|NCT00605475|20898280|P9|Overall Study|Withdrawal by Subject|0
6046882|NCT00605475|20898281|P8|Overall Study|Withdrawal by Subject|0
6046883|NCT00605475|20898282|P7|Overall Study|Withdrawal by Subject|0
6046884|NCT00605475|20898283|P6|Overall Study|Withdrawal by Subject|2
6046885|NCT00605475|20898284|P5|Overall Study|Withdrawal by Subject|0
6046886|NCT00605475|20898285|P4|Overall Study|Withdrawal by Subject|0
6046887|NCT00605475|20898286|P3|Overall Study|Withdrawal by Subject|0
6046888|NCT00605475|20898287|P2|Overall Study|Withdrawal by Subject|0
6046889|NCT00605475|20898288|P1|Overall Study|Withdrawal by Subject|0
6046890|NCT00605475|20898279|P10|Overall Study|Protocol Violation|0
6046891|NCT00605475|20898280|P9|Overall Study|Protocol Violation|0
6046892|NCT00605475|20898281|P8|Overall Study|Protocol Violation|0
6046893|NCT00605475|20898282|P7|Overall Study|Protocol Violation|0
6046894|NCT00605475|20898283|P6|Overall Study|Protocol Violation|0
6046895|NCT00605475|20898284|P5|Overall Study|Protocol Violation|1
6046896|NCT00605475|20898285|P4|Overall Study|Protocol Violation|0
6046897|NCT00605475|20898286|P3|Overall Study|Protocol Violation|0
6046898|NCT00605475|20898287|P2|Overall Study|Protocol Violation|0
6046899|NCT00605475|20898288|P1|Overall Study|Protocol Violation|0
6046900|NCT00605475|20898279|P10|Overall Study|Lost to Follow-up|1
6046901|NCT00605475|20898280|P9|Overall Study|Lost to Follow-up|1
6046902|NCT00605475|20898281|P8|Overall Study|Lost to Follow-up|0
6046903|NCT00605475|20898282|P7|Overall Study|Lost to Follow-up|0
6046904|NCT00605475|20898283|P6|Overall Study|Lost to Follow-up|0
6046905|NCT00605475|20898284|P5|Overall Study|Lost to Follow-up|0
6046906|NCT00605475|20898285|P4|Overall Study|Lost to Follow-up|0
6046907|NCT00605475|20898286|P3|Overall Study|Lost to Follow-up|0
6046908|NCT00605475|20898287|P2|Overall Study|Lost to Follow-up|0
6046909|NCT00605475|20898288|P1|Overall Study|Lost to Follow-up|0
6046910|NCT00605475|20898279|P10|Overall Study|Administrative problems|0
6046911|NCT00605475|20898280|P9|Overall Study|Administrative problems|0
6046912|NCT00605475|20898281|P8|Overall Study|Administrative problems|0
6046913|NCT00605475|20898282|P7|Overall Study|Administrative problems|1
6046914|NCT00605475|20898283|P6|Overall Study|Administrative problems|0
6046915|NCT00605475|20898284|P5|Overall Study|Administrative problems|0
6046916|NCT00605475|20898285|P4|Overall Study|Administrative problems|0
6046917|NCT00605475|20898286|P3|Overall Study|Administrative problems|0
6046918|NCT00605475|20898287|P2|Overall Study|Administrative problems|0
6046919|NCT00605475|20898288|P1|Overall Study|Administrative problems|0
6046920|NCT00605475|20898279|P10|Overall Study|Abnormal Laboratory Values|0
6046921|NCT00605475|20898280|P9|Overall Study|Abnormal Laboratory Values|1
6046922|NCT00605475|20898281|P8|Overall Study|Abnormal Laboratory Values|0
6046923|NCT00605475|20898282|P7|Overall Study|Abnormal Laboratory Values|0
6046924|NCT00605475|20898283|P6|Overall Study|Abnormal Laboratory Values|0
6046925|NCT00605475|20898284|P5|Overall Study|Abnormal Laboratory Values|0
6046926|NCT00605475|20898285|P4|Overall Study|Abnormal Laboratory Values|0
6046927|NCT00605475|20898286|P3|Overall Study|Abnormal Laboratory Values|0
6046928|NCT00605475|20898287|P2|Overall Study|Abnormal Laboratory Values|0
6046929|NCT00605475|20898288|P1|Overall Study|Abnormal Laboratory Values|0
6046930|NCT00605345|20898465|P2|Overall Study|Protocol Violation|2
6046931|NCT00605345|20898466|P1|Overall Study|Protocol Violation|0
6046932|NCT00605345|20898465|P2|Overall Study|Adverse Event|1
6046933|NCT00605345|20898466|P1|Overall Study|Adverse Event|0
6046934|NCT00605345|20898465|P2|Overall Study|Withdrawal by Subject|0
6046935|NCT00605345|20898466|P1|Overall Study|Withdrawal by Subject|1
6046936|NCT00605319|20898482|P1|Overall Study|Adverse Event|6
6046937|NCT00605306|20898494|P2|Overall Study|Adverse Event|1
6046938|NCT00605306|20898495|P1|Overall Study|Adverse Event|0
6046939|NCT00605293|20898509|P2|Overall Study|Principal Investigator Decision|1
6046940|NCT00605293|20898510|P1|Overall Study|Principal Investigator Decision|0
6046941|NCT00605293|20898509|P2|Overall Study|Dialysis Out of Centre for 3 Months|1
6046942|NCT00605293|20898510|P1|Overall Study|Dialysis Out of Centre for 3 Months|0
6046943|NCT00605293|20898509|P2|Overall Study|Incorrect Epoetin Beta Administration|0
6046944|NCT00605293|20898510|P1|Overall Study|Incorrect Epoetin Beta Administration|1
6046945|NCT00605293|20898509|P2|Overall Study|Renal Transplantation|1
6046946|NCT00605293|20898510|P1|Overall Study|Renal Transplantation|3
6046947|NCT00605293|20898509|P2|Overall Study|Blood Transfusion|1
6046948|NCT00605293|20898510|P1|Overall Study|Blood Transfusion|7
6046949|NCT00605293|20898509|P2|Overall Study|Holidays Dialysis Out|0
6046950|NCT00605293|20898510|P1|Overall Study|Holidays Dialysis Out|1
6046951|NCT00605293|20898509|P2|Overall Study|Adverse Event|0
6046952|NCT00605293|20898510|P1|Overall Study|Adverse Event|1
6046953|NCT00605293|20898509|P2|Overall Study|Insufficient Therapeutic Response|0
6046954|NCT00605293|20898510|P1|Overall Study|Insufficient Therapeutic Response|2
6046955|NCT00605293|20898509|P2|Overall Study|Death|1
6046956|NCT00605293|20898510|P1|Overall Study|Death|2
6046957|NCT00605280|20898530|P4|Year 3 Extension|Lost to Follow-up or Patient non-comply|0
6046958|NCT00605280|20898531|P3|Year 3 Extension|Lost to Follow-up or Patient non-comply|0
6046959|NCT00605280|20898532|P2|Year 3 Extension|Lost to Follow-up or Patient non-comply|0
6046960|NCT00605280|20898533|P1|Year 3 Extension|Lost to Follow-up or Patient non-comply|2
6046961|NCT00605280|20898530|P4|Year 3 Extension|Other|0
6046962|NCT00605280|20898531|P3|Year 3 Extension|Other|0
6046963|NCT00605280|20898532|P2|Year 3 Extension|Other|0
6046964|NCT00605280|20898533|P1|Year 3 Extension|Other|2
6046965|NCT00605280|20898530|P4|Year 3 Extension|Withdrawal by Subject|5
6046966|NCT00605280|20898531|P3|Year 3 Extension|Withdrawal by Subject|0
6046967|NCT00605280|20898532|P2|Year 3 Extension|Withdrawal by Subject|0
6046968|NCT00605280|20898533|P1|Year 3 Extension|Withdrawal by Subject|2
6046969|NCT00605280|20898530|P4|Year 3 Extension|Physician Decision|2
6046970|NCT00605280|20898531|P3|Year 3 Extension|Physician Decision|0
6046971|NCT00605280|20898532|P2|Year 3 Extension|Physician Decision|0
6046972|NCT00605280|20898533|P1|Year 3 Extension|Physician Decision|0
6046973|NCT00605280|20898530|P4|Year 3 Extension|Adverse Event|2
6046974|NCT00605280|20898531|P3|Year 3 Extension|Adverse Event|0
6046975|NCT00605280|20898532|P2|Year 3 Extension|Adverse Event|0
6046976|NCT00605280|20898533|P1|Year 3 Extension|Adverse Event|2
6046977|NCT00605280|20898530|P4|Year 2|Lost to Follow-up or Patient non-comply|2
6046978|NCT00605280|20898531|P3|Year 2|Lost to Follow-up or Patient non-comply|0
6046979|NCT00605280|20898532|P2|Year 2|Lost to Follow-up or Patient non-comply|0
6046980|NCT00605280|20898533|P1|Year 2|Lost to Follow-up or Patient non-comply|4
6046981|NCT00605280|20898530|P4|Year 2|Other|1
6046982|NCT00605280|20898531|P3|Year 2|Other|0
6046983|NCT00605280|20898532|P2|Year 2|Other|0
6046984|NCT00605280|20898533|P1|Year 2|Other|1
6046985|NCT00605280|20898530|P4|Year 2|Withdrawal by Subject|4
6046986|NCT00605280|20898531|P3|Year 2|Withdrawal by Subject|0
6046987|NCT00605280|20898532|P2|Year 2|Withdrawal by Subject|0
6046988|NCT00605280|20898533|P1|Year 2|Withdrawal by Subject|4
6046989|NCT00605280|20898530|P4|Year 2|Physician Decision|11
6046990|NCT00605280|20898531|P3|Year 2|Physician Decision|4
6046991|NCT00605280|20898532|P2|Year 2|Physician Decision|6
6046992|NCT00605280|20898533|P1|Year 2|Physician Decision|11
6046993|NCT00605280|20898530|P4|Year 2|Adverse Event|4
6046994|NCT00605280|20898531|P3|Year 2|Adverse Event|2
6046995|NCT00605280|20898532|P2|Year 2|Adverse Event|0
6046996|NCT00605280|20898533|P1|Year 2|Adverse Event|4
6046997|NCT00605280|20898530|P4|Year 1|Lost to Follow-up or Patient non-comply|2
6046998|NCT00605280|20898531|P3|Year 1|Lost to Follow-up or Patient non-comply|0
6046999|NCT00605280|20898532|P2|Year 1|Lost to Follow-up or Patient non-comply|1
6047000|NCT00605280|20898533|P1|Year 1|Lost to Follow-up or Patient non-comply|5
6047001|NCT00605280|20898530|P4|Year 1|Other|1
6047002|NCT00605280|20898531|P3|Year 1|Other|0
6047003|NCT00605280|20898532|P2|Year 1|Other|1
6047004|NCT00605280|20898533|P1|Year 1|Other|2
6047005|NCT00605280|20898530|P4|Year 1|Withdrawal by Subject|4
6047006|NCT00605280|20898531|P3|Year 1|Withdrawal by Subject|0
6047007|NCT00605280|20898532|P2|Year 1|Withdrawal by Subject|4
6047008|NCT00605280|20898533|P1|Year 1|Withdrawal by Subject|2
6047009|NCT00605280|20898530|P4|Year 1|Physician Decision|6
6047010|NCT00605280|20898531|P3|Year 1|Physician Decision|0
6047011|NCT00605280|20898532|P2|Year 1|Physician Decision|4
6047012|NCT00605280|20898533|P1|Year 1|Physician Decision|7
6047013|NCT00605280|20898530|P4|Year 1|Adverse Event|5
6047014|NCT00605280|20898531|P3|Year 1|Adverse Event|1
6047015|NCT00605280|20898532|P2|Year 1|Adverse Event|1
6047016|NCT00605280|20898533|P1|Year 1|Adverse Event|3
6047017|NCT00605280|20898530|P4|Year 1|Protocol Violation|1
6047018|NCT00605280|20898531|P3|Year 1|Protocol Violation|0
6047019|NCT00605280|20898532|P2|Year 1|Protocol Violation|0
6047020|NCT00605280|20898533|P1|Year 1|Protocol Violation|0
6047021|NCT00605267|20898567|P2|Overall Study|Withdrawal by Subject|3
6047022|NCT00605267|20898568|P1|Overall Study|Withdrawal by Subject|2
6047023|NCT00605267|20898567|P2|Overall Study|Lack of Efficacy|5
6047024|NCT00605267|20898568|P1|Overall Study|Lack of Efficacy|1
6047025|NCT00605267|20898567|P2|Overall Study|Adverse Event|1
6047026|NCT00605267|20898568|P1|Overall Study|Adverse Event|0
6047027|NCT00605189|20898616|P3|Overall Study|Other|0
6047028|NCT00605189|20898617|P2|Overall Study|Other|2
6047029|NCT00605189|20898618|P1|Overall Study|Other|2
6047030|NCT00605189|20898616|P3|Overall Study|Adverse Event|0
6047031|NCT00605189|20898617|P2|Overall Study|Adverse Event|0
6047032|NCT00605189|20898618|P1|Overall Study|Adverse Event|1
6047033|NCT00605176|20898629|P3|Overall Study|Other (not due to AE)|0
6047034|NCT00605176|20898630|P2|Overall Study|Other (not due to AE)|1
6047035|NCT00605176|20898631|P1|Overall Study|Other (not due to AE)|1
6047036|NCT00605176|20898629|P3|Overall Study|Use of concomitant therapy|1
6047037|NCT00605176|20898630|P2|Overall Study|Use of concomitant therapy|0
6047038|NCT00605176|20898631|P1|Overall Study|Use of concomitant therapy|1
6047039|NCT00605176|20898629|P3|Overall Study|Non-complicance with study procedures|0
6047040|NCT00605176|20898630|P2|Overall Study|Non-complicance with study procedures|0
6047041|NCT00605176|20898631|P1|Overall Study|Non-complicance with study procedures|1
6047042|NCT00605176|20898629|P3|Overall Study|Lost to Follow-up|1
6047043|NCT00605176|20898630|P2|Overall Study|Lost to Follow-up|2
6047044|NCT00605176|20898631|P1|Overall Study|Lost to Follow-up|2
6047045|NCT00605176|20898629|P3|Overall Study|Withdrawal by Subject|4
6047046|NCT00605176|20898630|P2|Overall Study|Withdrawal by Subject|2
6047047|NCT00605176|20898631|P1|Overall Study|Withdrawal by Subject|4
6047048|NCT00605176|20898629|P3|Overall Study|Adverse Event|3
6047049|NCT00605176|20898630|P2|Overall Study|Adverse Event|1
6047050|NCT00605176|20898631|P1|Overall Study|Adverse Event|2
6047051|NCT00605085|20898655|P2|Overall Study|administrative reasons|8
6047052|NCT00605085|20898656|P1|Overall Study|administrative reasons|18
6047053|NCT00605085|20898655|P2|Overall Study|Lost to Follow-up|5
6047054|NCT00605085|20898656|P1|Overall Study|Lost to Follow-up|10
6047055|NCT00605085|20898655|P2|Overall Study|Protocol Violation|2
6047056|NCT00605085|20898656|P1|Overall Study|Protocol Violation|3
6047057|NCT00605085|20898655|P2|Overall Study|Pregnancy|0
6047058|NCT00605085|20898656|P1|Overall Study|Pregnancy|2
6047059|NCT00605085|20898655|P2|Overall Study|Adverse Event|5
6047060|NCT00605085|20898656|P1|Overall Study|Adverse Event|9
6047061|NCT00605085|20898655|P2|Overall Study|Withdrawal by Subject|5
6047062|NCT00605085|20898656|P1|Overall Study|Withdrawal by Subject|8
6047063|NCT00605033|20898689|P2|Overall Study|Protocol Violation|1
6047064|NCT00605033|20898690|P1|Overall Study|Protocol Violation|1
6047065|NCT00605033|20898689|P2|Overall Study|Withdrawal by Subject|4
6047066|NCT00605033|20898690|P1|Overall Study|Withdrawal by Subject|3
6047067|NCT00605033|20898689|P2|Overall Study|Lost to Follow-up|1
6047068|NCT00605033|20898690|P1|Overall Study|Lost to Follow-up|1
6047069|NCT00605033|20898689|P2|Overall Study|Adverse Event|2
6047070|NCT00605033|20898690|P1|Overall Study|Adverse Event|2
6047071|NCT00604825|20898734|P4|Overall Study|Exclusion criterion met|1
6047072|NCT00604825|20898735|P3|Overall Study|Exclusion criterion met|0
6047073|NCT00604825|20898736|P2|Overall Study|Exclusion criterion met|0
6047074|NCT00604825|20898737|P1|Overall Study|Exclusion criterion met|0
6047075|NCT00604825|20898734|P4|Overall Study|Physician Decision|1
6047076|NCT00604825|20898735|P3|Overall Study|Physician Decision|0
6047077|NCT00604825|20898736|P2|Overall Study|Physician Decision|0
6047078|NCT00604825|20898737|P1|Overall Study|Physician Decision|0
6047079|NCT00604825|20898734|P4|Overall Study|Did not meet eligibility criteria|0
6047080|NCT00604825|20898735|P3|Overall Study|Did not meet eligibility criteria|2
6047081|NCT00604825|20898736|P2|Overall Study|Did not meet eligibility criteria|0
6047082|NCT00604825|20898737|P1|Overall Study|Did not meet eligibility criteria|0
6047083|NCT00604825|20898734|P4|Overall Study|Lack of Efficacy|0
6047084|NCT00604825|20898735|P3|Overall Study|Lack of Efficacy|1
6047085|NCT00604825|20898736|P2|Overall Study|Lack of Efficacy|2
6047086|NCT00604825|20898737|P1|Overall Study|Lack of Efficacy|3
6047087|NCT00604825|20898734|P4|Overall Study|Withdrawal by Subject|5
6047088|NCT00604825|20898735|P3|Overall Study|Withdrawal by Subject|5
6047089|NCT00604825|20898736|P2|Overall Study|Withdrawal by Subject|3
6047090|NCT00604825|20898737|P1|Overall Study|Withdrawal by Subject|4
6047091|NCT00604825|20898734|P4|Overall Study|Protocol Violation|0
6047092|NCT00604825|20898735|P3|Overall Study|Protocol Violation|0
6047093|NCT00604825|20898736|P2|Overall Study|Protocol Violation|1
6047094|NCT00604825|20898737|P1|Overall Study|Protocol Violation|0
6047095|NCT00604825|20898734|P4|Overall Study|Lost to Follow-up|0
6047096|NCT00604825|20898735|P3|Overall Study|Lost to Follow-up|1
6047097|NCT00604825|20898736|P2|Overall Study|Lost to Follow-up|3
6047098|NCT00604825|20898737|P1|Overall Study|Lost to Follow-up|0
6047099|NCT00604825|20898734|P4|Overall Study|Adverse Event|4
6047100|NCT00604825|20898735|P3|Overall Study|Adverse Event|7
6047101|NCT00604825|20898736|P2|Overall Study|Adverse Event|6
6047102|NCT00604825|20898737|P1|Overall Study|Adverse Event|2
6047103|NCT00604786|20898965|P2|Overall Study|Lost to Follow-up|0
6047104|NCT00604786|20898966|P1|Overall Study|Lost to Follow-up|2
6047105|NCT00604721|20898972|P1|Overall Study|Withdrawal by Subject|1
6047106|NCT00604721|20898972|P1|Overall Study|Physician Decision|1
6047107|NCT00604708|20898980|P2|Overall Study|Adverse Event|6
6047108|NCT00604708|20898981|P1|Overall Study|Adverse Event|6
6047109|NCT00604708|20898980|P2|Overall Study|administrative reasons|11
6047110|NCT00604708|20898981|P1|Overall Study|administrative reasons|9
6047111|NCT00604708|20898980|P2|Overall Study|Lost to Follow-up|5
6047112|NCT00604708|20898981|P1|Overall Study|Lost to Follow-up|5
6047113|NCT00604708|20898980|P2|Overall Study|Protocol Violation|8
6047114|NCT00604708|20898981|P1|Overall Study|Protocol Violation|2
6047115|NCT00604708|20898980|P2|Overall Study|Withdrawal by Subject|10
6047116|NCT00604708|20898981|P1|Overall Study|Withdrawal by Subject|9
6047117|NCT00604695|20898991|P2|Overall Study|Did not receive first bolus.|4
6047118|NCT00604695|20898992|P1|Overall Study|Did not receive first bolus.|0
6047119|NCT00604669|20899014|P1|Overall Study|lack of information in chart|7
6047120|NCT00604565|20899020|P2|Overall Study|Study terminated|3
6047121|NCT00604565|20899021|P1|Overall Study|Study terminated|0
6047128|NCT00604383|20899054|P2|Overall Study|Physician Decision|3
6047129|NCT00604383|20899055|P1|Overall Study|Physician Decision|0
6047130|NCT00604383|20899054|P2|Overall Study|Adverse Event|9
6047131|NCT00604383|20899055|P1|Overall Study|Adverse Event|16
6047132|NCT00604383|20899054|P2|Overall Study|Death|22
6047133|NCT00604383|20899055|P1|Overall Study|Death|14
6047134|NCT00604383|20899054|P2|Overall Study|Lost to Follow-up|19
6047135|NCT00604383|20899055|P1|Overall Study|Lost to Follow-up|24
6047136|NCT00604383|20899054|P2|Overall Study|Withdrawal by Subject|31
6047137|NCT00604383|20899055|P1|Overall Study|Withdrawal by Subject|33
6047138|NCT00604279|20899071|P2|Overall Study|Other|4
6047139|NCT00604279|20899072|P1|Overall Study|Other|8
6047140|NCT00604279|20899071|P2|Overall Study|Adverse Event|5
6047141|NCT00604279|20899072|P1|Overall Study|Adverse Event|4
6047142|NCT00604279|20899071|P2|Overall Study|Withdrawal by Subject|5
6047143|NCT00604279|20899072|P1|Overall Study|Withdrawal by Subject|16
6047144|NCT00604279|20899071|P2|Overall Study|Protocol Violation|1
6047145|NCT00604279|20899072|P1|Overall Study|Protocol Violation|3
6047146|NCT00604279|20899071|P2|Overall Study|Pregnancy|0
6047147|NCT00604279|20899072|P1|Overall Study|Pregnancy|2
6047148|NCT00604279|20899071|P2|Overall Study|Lost to Follow-up|14
6047149|NCT00604279|20899072|P1|Overall Study|Lost to Follow-up|9
6047150|NCT00604279|20899071|P2|Overall Study|Lack of Efficacy|9
6047151|NCT00604279|20899072|P1|Overall Study|Lack of Efficacy|22
6047152|NCT00604214|20899088|P2|Day 91 to Day 180|Withdrawal by Subject|1
6047153|NCT00604214|20899089|P1|Day 91 to Day 180|Withdrawal by Subject|1
6047154|NCT00604214|20899088|P2|Day 91 to Day 180|Lost to Follow-up|8
6047155|NCT00604214|20899089|P1|Day 91 to Day 180|Lost to Follow-up|6
6047156|NCT00604214|20899088|P2|Day 91 to Day 180|Death|23
6047157|NCT00604214|20899089|P1|Day 91 to Day 180|Death|19
6047158|NCT00604214|20899088|P2|Day 29 to Day 90|Withdrawal by Subject|6
6047159|NCT00604214|20899089|P1|Day 29 to Day 90|Withdrawal by Subject|0
6047160|NCT00604214|20899088|P2|Day 29 to Day 90|Lost to Follow-up|6
6047161|NCT00604214|20899089|P1|Day 29 to Day 90|Lost to Follow-up|4
6047162|NCT00604214|20899088|P2|Day 29 to Day 90|Death|67
6047163|NCT00604214|20899089|P1|Day 29 to Day 90|Death|64
6047164|NCT00604214|20899088|P2|Baseline to Day 28|Withdrawal by Subject|7
6047165|NCT00604214|20899089|P1|Baseline to Day 28|Withdrawal by Subject|3
6047166|NCT00604214|20899088|P2|Baseline to Day 28|Lost to Follow-up|4
6047167|NCT00604214|20899089|P1|Baseline to Day 28|Lost to Follow-up|2
6047168|NCT00604214|20899088|P2|Baseline to Day 28|Death|202
6047169|NCT00604214|20899089|P1|Baseline to Day 28|Death|223
6047170|NCT00604188|20899137|P2|Overall Study|Did not receive study drug|1
6047171|NCT00604188|20899138|P1|Overall Study|Did not receive study drug|0
6047172|NCT00604188|20899137|P2|Overall Study|Non-compliance with protocol|4
6047173|NCT00604188|20899138|P1|Overall Study|Non-compliance with protocol|4
6047174|NCT00604188|20899137|P2|Overall Study|Withdrawal by Subject|1
6047175|NCT00604188|20899138|P1|Overall Study|Withdrawal by Subject|5
6047176|NCT00604188|20899137|P2|Overall Study|Lost to Follow-up|15
6047177|NCT00604188|20899138|P1|Overall Study|Lost to Follow-up|17
6047178|NCT00604188|20899137|P2|Overall Study|Adverse Event|4
6047179|NCT00604188|20899138|P1|Overall Study|Adverse Event|1
6047180|NCT00604175|20899161|P3|Week 29 Through Week 72|Non-adherence to study requirements|1
6047181|NCT00604175|20899162|P2|Week 29 Through Week 72|Non-adherence to study requirements|0
6047182|NCT00604175|20899163|P1|Week 29 Through Week 72|Non-adherence to study requirements|0
6047183|NCT00604175|20899161|P3|Week 29 Through Week 72|Site closure|0
6047184|NCT00604175|20899162|P2|Week 29 Through Week 72|Site closure|1
6047185|NCT00604175|20899163|P1|Week 29 Through Week 72|Site closure|0
6047186|NCT00604175|20899161|P3|Week 29 Through Week 72|Lost to Follow-up|2
6047187|NCT00604175|20899162|P2|Week 29 Through Week 72|Lost to Follow-up|6
6047188|NCT00604175|20899163|P1|Week 29 Through Week 72|Lost to Follow-up|12
6047189|NCT00604175|20899161|P3|Week 29 Through Week 72|Death|1
6047190|NCT00604175|20899162|P2|Week 29 Through Week 72|Death|0
6047191|NCT00604175|20899163|P1|Week 29 Through Week 72|Death|0
6047192|NCT00604175|20899161|P3|Entry Through Week 28|Did not start intervention|1
6047193|NCT00604175|20899162|P2|Entry Through Week 28|Did not start intervention|0
6047194|NCT00604175|20899163|P1|Entry Through Week 28|Did not start intervention|2
6047195|NCT00604175|20899161|P3|Entry Through Week 28|Ineligible|0
6047196|NCT00604175|20899162|P2|Entry Through Week 28|Ineligible|0
6047197|NCT00604175|20899163|P1|Entry Through Week 28|Ineligible|1
6047198|NCT00604175|20899161|P3|Entry Through Week 28|Lost to Follow-up|0
6047199|NCT00604175|20899162|P2|Entry Through Week 28|Lost to Follow-up|3
6047200|NCT00604175|20899163|P1|Entry Through Week 28|Lost to Follow-up|4
6047201|NCT00604175|20899161|P3|Entry Through Week 28|Withdrawal by Subject|0
6047202|NCT00604175|20899162|P2|Entry Through Week 28|Withdrawal by Subject|0
6047203|NCT00604175|20899163|P1|Entry Through Week 28|Withdrawal by Subject|1
6047204|NCT00604175|20899161|P3|Entry Through Week 28|Death|0
6047205|NCT00604175|20899162|P2|Entry Through Week 28|Death|0
6047206|NCT00604175|20899163|P1|Entry Through Week 28|Death|2
6047207|NCT00604162|20899216|P1|Overall Study|Withdrawal by Subject|1
6047208|NCT00604162|20899216|P1|Overall Study|Physician Decision|3
6047209|NCT00603980|20899258|P1|Main Study|14th subject completed trial|1
6047210|NCT00603980|20899258|P1|Study Qualification|Inconsistent data reporting|13
6047211|NCT00603980|20899258|P1|Study Qualification|Protocol Violation|3
6047212|NCT00603941|20899377|P3|Overall Study|Withdrawal by Subject|0
6047213|NCT00603941|20899378|P2|Overall Study|Withdrawal by Subject|2
6047214|NCT00603941|20899379|P1|Overall Study|Withdrawal by Subject|0
6047215|NCT00603941|20899377|P3|Overall Study|Physician Decision|0
6047216|NCT00603941|20899378|P2|Overall Study|Physician Decision|1
6047217|NCT00603941|20899379|P1|Overall Study|Physician Decision|0
6047218|NCT00603941|20899377|P3|Overall Study|Adverse Event|1
6047219|NCT00603941|20899378|P2|Overall Study|Adverse Event|0
6047220|NCT00603941|20899379|P1|Overall Study|Adverse Event|1
6047221|NCT00603941|20899377|P3|Overall Study|Disease progression|1
6047222|NCT00603941|20899378|P2|Overall Study|Disease progression|7
6047223|NCT00603941|20899379|P1|Overall Study|Disease progression|6
6047224|NCT00603915|20899390|P1|Overall Study|Physician Decision|1
6047225|NCT00603837|20899420|P2|Overall Study|Physician Decision|0
6047226|NCT00603837|20899421|P1|Overall Study|Physician Decision|3
6047227|NCT00603798|20899430|P3|Overall Study|Not due to AE|4
6047228|NCT00603798|20899431|P2|Overall Study|Not due to AE|1
6047229|NCT00603798|20899432|P1|Overall Study|Not due to AE|1
6047230|NCT00603798|20899430|P3|Overall Study|Non-compliance with study procedures|0
6047231|NCT00603798|20899431|P2|Overall Study|Non-compliance with study procedures|1
6047232|NCT00603798|20899432|P1|Overall Study|Non-compliance with study procedures|0
6047233|NCT00603798|20899430|P3|Overall Study|Lost to Follow-up|1
6047234|NCT00603798|20899431|P2|Overall Study|Lost to Follow-up|0
6047235|NCT00603798|20899432|P1|Overall Study|Lost to Follow-up|1
6047236|NCT00603798|20899430|P3|Overall Study|Withdrawal by Subject|4
6047237|NCT00603798|20899431|P2|Overall Study|Withdrawal by Subject|3
6047238|NCT00603798|20899432|P1|Overall Study|Withdrawal by Subject|4
6047239|NCT00603798|20899430|P3|Overall Study|Adverse Event|1
6047240|NCT00603798|20899431|P2|Overall Study|Adverse Event|2
6047241|NCT00603798|20899432|P1|Overall Study|Adverse Event|4
6047242|NCT00603746|20899455|P6|Overall Study|Withdrawal by Subject|1
6047243|NCT00603746|20899456|P5|Overall Study|Withdrawal by Subject|3
6047244|NCT00603746|20899457|P4|Overall Study|Withdrawal by Subject|1
6047245|NCT00603746|20899458|P3|Overall Study|Withdrawal by Subject|0
6047246|NCT00603746|20899459|P2|Overall Study|Withdrawal by Subject|0
6047247|NCT00603746|20899460|P1|Overall Study|Withdrawal by Subject|1
6047248|NCT00603746|20899455|P6|Overall Study|Physician Decision|0
6047249|NCT00603746|20899456|P5|Overall Study|Physician Decision|1
6047250|NCT00603746|20899457|P4|Overall Study|Physician Decision|0
6047251|NCT00603746|20899458|P3|Overall Study|Physician Decision|0
6047252|NCT00603746|20899459|P2|Overall Study|Physician Decision|0
6047253|NCT00603746|20899460|P1|Overall Study|Physician Decision|1
6047254|NCT00603746|20899455|P6|Overall Study|Lost to Follow-up|0
6047255|NCT00603746|20899456|P5|Overall Study|Lost to Follow-up|0
6047256|NCT00603746|20899457|P4|Overall Study|Lost to Follow-up|0
6047257|NCT00603746|20899458|P3|Overall Study|Lost to Follow-up|1
6047258|NCT00603746|20899459|P2|Overall Study|Lost to Follow-up|1
6047259|NCT00603746|20899460|P1|Overall Study|Lost to Follow-up|0
6047260|NCT00603746|20899455|P6|Overall Study|Protocol Violation|0
6047261|NCT00603746|20899456|P5|Overall Study|Protocol Violation|1
6047262|NCT00603746|20899457|P4|Overall Study|Protocol Violation|0
6047263|NCT00603746|20899458|P3|Overall Study|Protocol Violation|1
6047264|NCT00603746|20899459|P2|Overall Study|Protocol Violation|3
6047265|NCT00603746|20899460|P1|Overall Study|Protocol Violation|0
6047266|NCT00603746|20899455|P6|Overall Study|Lack of Efficacy|8
6047267|NCT00603746|20899456|P5|Overall Study|Lack of Efficacy|12
6047268|NCT00603746|20899457|P4|Overall Study|Lack of Efficacy|11
6047269|NCT00603746|20899458|P3|Overall Study|Lack of Efficacy|6
6047270|NCT00603746|20899459|P2|Overall Study|Lack of Efficacy|11
6047271|NCT00603746|20899460|P1|Overall Study|Lack of Efficacy|34
6047272|NCT00603746|20899455|P6|Overall Study|Adverse Event|4
6047273|NCT00603746|20899456|P5|Overall Study|Adverse Event|0
6047274|NCT00603746|20899457|P4|Overall Study|Adverse Event|1
6047275|NCT00603746|20899458|P3|Overall Study|Adverse Event|0
6047276|NCT00603746|20899459|P2|Overall Study|Adverse Event|3
6047277|NCT00603746|20899460|P1|Overall Study|Adverse Event|2
6047278|NCT00603733|20899608|P2|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|5
6047445|NCT00603382|20900065|P5|Overall Study|Protocol Violation|1
6047279|NCT00603733|20899609|P1|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|3
6047280|NCT00603733|20899608|P2|Maintenance Phase ITT|Physician Decision|1
6047281|NCT00603733|20899609|P1|Maintenance Phase ITT|Physician Decision|0
6047282|NCT00603733|20899608|P2|Maintenance Phase ITT|Lack of Efficacy|2
6047283|NCT00603733|20899609|P1|Maintenance Phase ITT|Lack of Efficacy|2
6047284|NCT00603733|20899608|P2|Maintenance Phase ITT|Lost to Follow-up|1
6047285|NCT00603733|20899609|P1|Maintenance Phase ITT|Lost to Follow-up|0
6047286|NCT00603733|20899608|P2|Maintenance Phase ITT|Protocol Violation|1
6047287|NCT00603733|20899609|P1|Maintenance Phase ITT|Protocol Violation|1
6047288|NCT00603733|20899608|P2|Maintenance Phase ITT|Withdrawal by Subject|0
6047289|NCT00603733|20899609|P1|Maintenance Phase ITT|Withdrawal by Subject|1
6047290|NCT00603733|20899608|P2|Maintenance Phase ITT|Adverse Event|6
6047291|NCT00603733|20899609|P1|Maintenance Phase ITT|Adverse Event|3
6047292|NCT00603733|20899608|P2|Run-In Phase - 4 Weeks|Lack of Efficacy|1
6047293|NCT00603733|20899609|P1|Run-In Phase - 4 Weeks|Lack of Efficacy|2
6047294|NCT00603733|20899608|P2|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|10
6047295|NCT00603733|20899609|P1|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|5
6047296|NCT00603733|20899608|P2|Run-In Phase - 4 Weeks|Lost to Follow-up|0
6047297|NCT00603733|20899609|P1|Run-In Phase - 4 Weeks|Lost to Follow-up|1
6047298|NCT00603733|20899608|P2|Run-In Phase - 4 Weeks|Withdrawal by Subject|1
6047299|NCT00603733|20899609|P1|Run-In Phase - 4 Weeks|Withdrawal by Subject|4
6047300|NCT00603733|20899608|P2|Run-In Phase - 4 Weeks|Adverse Event|1
6047301|NCT00603733|20899609|P1|Run-In Phase - 4 Weeks|Adverse Event|2
6047302|NCT00603733|20899608|P2|Active Phase ITT|Subject moved, site closed|1
6047303|NCT00603733|20899609|P1|Active Phase ITT|Subject moved, site closed|1
6047304|NCT00603733|20899608|P2|Active Phase ITT|Lack of Efficacy|2
6047305|NCT00603733|20899609|P1|Active Phase ITT|Lack of Efficacy|1
6047306|NCT00603733|20899608|P2|Active Phase ITT|Did not meet inclusion/exclusion|3
6047307|NCT00603733|20899609|P1|Active Phase ITT|Did not meet inclusion/exclusion|1
6047308|NCT00603733|20899608|P2|Active Phase ITT|Lost to Follow-up|1
6047309|NCT00603733|20899609|P1|Active Phase ITT|Lost to Follow-up|0
6047310|NCT00603733|20899608|P2|Active Phase ITT|Withdrawal by Subject|3
6047311|NCT00603733|20899609|P1|Active Phase ITT|Withdrawal by Subject|0
6047312|NCT00603733|20899608|P2|Active Phase ITT|Adverse Event|7
6047313|NCT00603733|20899609|P1|Active Phase ITT|Adverse Event|8
6047314|NCT00603590|20899659|P2|Overall Study|Cardiovascular event|1
6047315|NCT00603590|20899660|P1|Overall Study|Cardiovascular event|0
6047316|NCT00603590|20899659|P2|Overall Study|Lost to Follow-up|4
6047317|NCT00603590|20899660|P1|Overall Study|Lost to Follow-up|8
6047318|NCT00603590|20899659|P2|Overall Study|Adverse Event|0
6047319|NCT00603590|20899660|P1|Overall Study|Adverse Event|2
6047320|NCT00603590|20899659|P2|Overall Study|Patient discontinued study drug|15
6047321|NCT00603590|20899660|P1|Overall Study|Patient discontinued study drug|22
6047322|NCT00603590|20899659|P2|Overall Study|Refused blood test|1
6047323|NCT00603590|20899660|P1|Overall Study|Refused blood test|5
6047324|NCT00603590|20899659|P2|Overall Study|Did not attend study clinic|30
6047325|NCT00603590|20899660|P1|Overall Study|Did not attend study clinic|39
6047326|NCT00603538|20899684|P3|Overall Study|Objective progression or relapse|0
6047327|NCT00603538|20899685|P2|Overall Study|Objective progression or relapse|0
6047328|NCT00603538|20899686|P1|Overall Study|Objective progression or relapse|3
6047329|NCT00603538|20899684|P3|Overall Study|Adverse Event|2
6047330|NCT00603538|20899685|P2|Overall Study|Adverse Event|4
6047331|NCT00603538|20899686|P1|Overall Study|Adverse Event|0
6047332|NCT00603525|20899726|P3|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|111
6047333|NCT00603525|20899727|P2|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0
6047334|NCT00603525|20899728|P1|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0
6047335|NCT00603525|20899726|P3|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0
6047336|NCT00603525|20899727|P2|OL Treatment Period (120 Weeks)|Withdrawal by Subject|8
6047337|NCT00603525|20899728|P1|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0
6047338|NCT00603525|20899726|P3|OL Treatment Period (120 Weeks)|Physician Decision|0
6047339|NCT00603525|20899727|P2|OL Treatment Period (120 Weeks)|Physician Decision|2
6047340|NCT00603525|20899728|P1|OL Treatment Period (120 Weeks)|Physician Decision|0
6047341|NCT00603525|20899726|P3|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0
6047342|NCT00603525|20899727|P2|OL Treatment Period (120 Weeks)|Study Closed/Terminated|71
6047343|NCT00603525|20899728|P1|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0
6047344|NCT00603525|20899726|P3|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0
6047345|NCT00603525|20899727|P2|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|5
6047346|NCT00603525|20899728|P1|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0
6047347|NCT00603525|20899726|P3|OL Treatment Period (120 Weeks)|Protocol Violation|0
6047348|NCT00603525|20899727|P2|OL Treatment Period (120 Weeks)|Protocol Violation|1
6047349|NCT00603525|20899728|P1|OL Treatment Period (120 Weeks)|Protocol Violation|0
6047350|NCT00603525|20899726|P3|OL Treatment Period (120 Weeks)|Lack of Efficacy|0
6047351|NCT00603525|20899727|P2|OL Treatment Period (120 Weeks)|Lack of Efficacy|13
6047352|NCT00603525|20899728|P1|OL Treatment Period (120 Weeks)|Lack of Efficacy|0
6047353|NCT00603525|20899726|P3|OL Treatment Period (120 Weeks)|Adverse Event|0
6047354|NCT00603525|20899727|P2|OL Treatment Period (120 Weeks)|Adverse Event|12
6047355|NCT00603525|20899728|P1|OL Treatment Period (120 Weeks)|Adverse Event|0
6047356|NCT00603525|20899726|P3|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0
6047357|NCT00603525|20899727|P2|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|1
6047358|NCT00603525|20899728|P1|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0
6047359|NCT00603525|20899726|P3|DB Treatment Period (24 Weeks)|Physician Decision|0
6047360|NCT00603525|20899727|P2|DB Treatment Period (24 Weeks)|Physician Decision|1
6047361|NCT00603525|20899728|P1|DB Treatment Period (24 Weeks)|Physician Decision|0
6047362|NCT00603525|20899726|P3|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0
6047363|NCT00603525|20899727|P2|DB Treatment Period (24 Weeks)|Withdrawal by Subject|6
6047364|NCT00603525|20899728|P1|DB Treatment Period (24 Weeks)|Withdrawal by Subject|5
6047365|NCT00603525|20899726|P3|DB Treatment Period (24 Weeks)|Lost to Follow-up|0
6047366|NCT00603525|20899727|P2|DB Treatment Period (24 Weeks)|Lost to Follow-up|3
6047367|NCT00603525|20899728|P1|DB Treatment Period (24 Weeks)|Lost to Follow-up|1
6047368|NCT00603525|20899726|P3|DB Treatment Period (24 Weeks)|Protocol Violation|0
6047369|NCT00603525|20899727|P2|DB Treatment Period (24 Weeks)|Protocol Violation|2
6047370|NCT00603525|20899728|P1|DB Treatment Period (24 Weeks)|Protocol Violation|1
6047371|NCT00603525|20899726|P3|DB Treatment Period (24 Weeks)|Lack of Efficacy|0
6047372|NCT00603525|20899727|P2|DB Treatment Period (24 Weeks)|Lack of Efficacy|0
6047373|NCT00603525|20899728|P1|DB Treatment Period (24 Weeks)|Lack of Efficacy|7
6047374|NCT00603525|20899726|P3|DB Treatment Period (24 Weeks)|Adverse Event|0
6047375|NCT00603525|20899727|P2|DB Treatment Period (24 Weeks)|Adverse Event|9
6047376|NCT00603525|20899728|P1|DB Treatment Period (24 Weeks)|Adverse Event|3
6047377|NCT00603512|20899860|P5|Overall Study|Randomized but not treated|0
6047378|NCT00603512|20899861|P4|Overall Study|Randomized but not treated|2
6047379|NCT00603512|20899862|P3|Overall Study|Randomized but not treated|1
6047380|NCT00603512|20899863|P2|Overall Study|Randomized but not treated|1
6047381|NCT00603512|20899864|P1|Overall Study|Randomized but not treated|0
6047382|NCT00603512|20899860|P5|Overall Study|Withdrawal by Subject|1
6047383|NCT00603512|20899861|P4|Overall Study|Withdrawal by Subject|0
6047384|NCT00603512|20899862|P3|Overall Study|Withdrawal by Subject|0
6047385|NCT00603512|20899863|P2|Overall Study|Withdrawal by Subject|0
6047386|NCT00603512|20899864|P1|Overall Study|Withdrawal by Subject|0
6047387|NCT00603512|20899860|P5|Overall Study|Other|1
6047388|NCT00603512|20899861|P4|Overall Study|Other|1
6047389|NCT00603512|20899862|P3|Overall Study|Other|0
6047390|NCT00603512|20899863|P2|Overall Study|Other|1
6047391|NCT00603512|20899864|P1|Overall Study|Other|2
6047392|NCT00603512|20899860|P5|Overall Study|Lack of Efficacy|1
6047393|NCT00603512|20899861|P4|Overall Study|Lack of Efficacy|0
6047394|NCT00603512|20899862|P3|Overall Study|Lack of Efficacy|0
6047395|NCT00603512|20899863|P2|Overall Study|Lack of Efficacy|1
6047396|NCT00603512|20899864|P1|Overall Study|Lack of Efficacy|0
6047397|NCT00603512|20899860|P5|Overall Study|Adverse Event|2
6047398|NCT00603512|20899861|P4|Overall Study|Adverse Event|4
6047399|NCT00603512|20899862|P3|Overall Study|Adverse Event|4
6047400|NCT00603512|20899863|P2|Overall Study|Adverse Event|2
6047401|NCT00603512|20899864|P1|Overall Study|Adverse Event|0
6047405|NCT00603447|20900019|P7|Overall Study|Withdrew Consent|1
6047406|NCT00603447|20900020|P6|Overall Study|Withdrew Consent|0
6047407|NCT00603447|20900021|P5|Overall Study|Withdrew Consent|1
6047408|NCT00603447|20900022|P4|Overall Study|Withdrew Consent|0
6047409|NCT00603447|20900023|P3|Overall Study|Withdrew Consent|0
6047410|NCT00603447|20900024|P2|Overall Study|Withdrew Consent|2
6047411|NCT00603447|20900025|P1|Overall Study|Withdrew Consent|0
6047412|NCT00603447|20900019|P7|Overall Study|Other|13
6047413|NCT00603447|20900020|P6|Overall Study|Other|0
6047414|NCT00603447|20900021|P5|Overall Study|Other|3
6047415|NCT00603447|20900022|P4|Overall Study|Other|0
6047416|NCT00603447|20900023|P3|Overall Study|Other|1
6047417|NCT00603447|20900024|P2|Overall Study|Other|0
6047418|NCT00603447|20900025|P1|Overall Study|Other|0
6047419|NCT00603447|20900019|P7|Overall Study|Adverse Event|10
6047420|NCT00603447|20900020|P6|Overall Study|Adverse Event|2
6047421|NCT00603447|20900021|P5|Overall Study|Adverse Event|1
6047422|NCT00603447|20900022|P4|Overall Study|Adverse Event|2
6047423|NCT00603447|20900023|P3|Overall Study|Adverse Event|1
6047424|NCT00603447|20900024|P2|Overall Study|Adverse Event|1
6047425|NCT00603447|20900025|P1|Overall Study|Adverse Event|0
6047426|NCT00603382|20900064|P6|Overall Study|Withdrawal by Subject|1
6047427|NCT00603382|20900065|P5|Overall Study|Withdrawal by Subject|0
6047428|NCT00603382|20900066|P4|Overall Study|Withdrawal by Subject|1
6047429|NCT00603382|20900067|P3|Overall Study|Withdrawal by Subject|1
6047430|NCT00603382|20900068|P2|Overall Study|Withdrawal by Subject|3
6047431|NCT00603382|20900069|P1|Overall Study|Withdrawal by Subject|3
6047432|NCT00603382|20900064|P6|Overall Study|Physician Decision|3
6047433|NCT00603382|20900065|P5|Overall Study|Physician Decision|1
6047434|NCT00603382|20900066|P4|Overall Study|Physician Decision|0
6047435|NCT00603382|20900067|P3|Overall Study|Physician Decision|2
6047436|NCT00603382|20900068|P2|Overall Study|Physician Decision|0
6047437|NCT00603382|20900069|P1|Overall Study|Physician Decision|0
6047438|NCT00603382|20900064|P6|Overall Study|Lost to Follow-up|1
6047439|NCT00603382|20900065|P5|Overall Study|Lost to Follow-up|0
6047440|NCT00603382|20900066|P4|Overall Study|Lost to Follow-up|1
6047441|NCT00603382|20900067|P3|Overall Study|Lost to Follow-up|1
6047442|NCT00603382|20900068|P2|Overall Study|Lost to Follow-up|1
6047443|NCT00603382|20900069|P1|Overall Study|Lost to Follow-up|0
6047444|NCT00603382|20900064|P6|Overall Study|Protocol Violation|0
6047446|NCT00603382|20900066|P4|Overall Study|Protocol Violation|2
6047447|NCT00603382|20900067|P3|Overall Study|Protocol Violation|1
6047448|NCT00603382|20900068|P2|Overall Study|Protocol Violation|0
6047449|NCT00603382|20900069|P1|Overall Study|Protocol Violation|1
6047450|NCT00603382|20900064|P6|Overall Study|Lack of Efficacy|11
6047451|NCT00603382|20900065|P5|Overall Study|Lack of Efficacy|6
6047452|NCT00603382|20900066|P4|Overall Study|Lack of Efficacy|6
6047453|NCT00603382|20900067|P3|Overall Study|Lack of Efficacy|3
6047454|NCT00603382|20900068|P2|Overall Study|Lack of Efficacy|9
6047455|NCT00603382|20900069|P1|Overall Study|Lack of Efficacy|14
6047456|NCT00603382|20900064|P6|Overall Study|Adverse Event|2
6047457|NCT00603382|20900065|P5|Overall Study|Adverse Event|1
6047458|NCT00603382|20900066|P4|Overall Study|Adverse Event|2
6047459|NCT00603382|20900067|P3|Overall Study|Adverse Event|1
6047460|NCT00603382|20900068|P2|Overall Study|Adverse Event|1
6047461|NCT00603382|20900069|P1|Overall Study|Adverse Event|0
6047462|NCT00603304|20900217|P2|Overall Study|Patient Decision|0
6047463|NCT00603304|20900218|P1|Overall Study|Patient Decision|2
6047464|NCT00603304|20900217|P2|Overall Study|Other|0
6047465|NCT00603304|20900218|P1|Overall Study|Other|2
6047466|NCT00603304|20900217|P2|Overall Study|Moved Away|2
6047467|NCT00603304|20900218|P1|Overall Study|Moved Away|0
6047468|NCT00603304|20900217|P2|Overall Study|Non-Compliant|1
6047469|NCT00603304|20900218|P1|Overall Study|Non-Compliant|0
6047470|NCT00603304|20900217|P2|Overall Study|Exclusionary Medication|3
6047471|NCT00603304|20900218|P1|Overall Study|Exclusionary Medication|2
6047472|NCT00603304|20900217|P2|Overall Study|Crossed Over to Open Label Therapy|3
6047473|NCT00603304|20900218|P1|Overall Study|Crossed Over to Open Label Therapy|3
6047474|NCT00603304|20900217|P2|Overall Study|Unacceptable Treatment Toxicity|8
6047475|NCT00603304|20900218|P1|Overall Study|Unacceptable Treatment Toxicity|5
6047476|NCT00603304|20900217|P2|Overall Study|Adverse Event|2
6047477|NCT00603304|20900218|P1|Overall Study|Adverse Event|4
6047478|NCT00603304|20900217|P2|Overall Study|Protocol Violation|0
6047479|NCT00603304|20900218|P1|Overall Study|Protocol Violation|1
6047480|NCT00603304|20900217|P2|Overall Study|Withdrawal by Subject|5
6047481|NCT00603304|20900218|P1|Overall Study|Withdrawal by Subject|8
6047482|NCT00603304|20900217|P2|Overall Study|Lost to Follow-up|7
6047483|NCT00603304|20900218|P1|Overall Study|Lost to Follow-up|5
6047484|NCT00603278|20900274|P6|Overall Study|Lost to Follow-up|0
6047485|NCT00603278|20900275|P5|Overall Study|Lost to Follow-up|1
6047486|NCT00603278|20900276|P4|Overall Study|Lost to Follow-up|0
6047487|NCT00603278|20900277|P3|Overall Study|Lost to Follow-up|0
6047488|NCT00603278|20900278|P2|Overall Study|Lost to Follow-up|0
6047489|NCT00603278|20900279|P1|Overall Study|Lost to Follow-up|1
6047490|NCT00603278|20900274|P6|Overall Study|Physician Decision|1
6047491|NCT00603278|20900275|P5|Overall Study|Physician Decision|2
6047492|NCT00603278|20900276|P4|Overall Study|Physician Decision|0
6047493|NCT00603278|20900277|P3|Overall Study|Physician Decision|0
6047494|NCT00603278|20900278|P2|Overall Study|Physician Decision|1
6047495|NCT00603278|20900279|P1|Overall Study|Physician Decision|0
6047496|NCT00603278|20900274|P6|Overall Study|Protocol Violation|1
6047497|NCT00603278|20900275|P5|Overall Study|Protocol Violation|0
6047498|NCT00603278|20900276|P4|Overall Study|Protocol Violation|1
6047499|NCT00603278|20900277|P3|Overall Study|Protocol Violation|1
6047500|NCT00603278|20900278|P2|Overall Study|Protocol Violation|0
6047501|NCT00603278|20900279|P1|Overall Study|Protocol Violation|3
6047502|NCT00603278|20900274|P6|Overall Study|Withdrawal by Subject|2
6047503|NCT00603278|20900275|P5|Overall Study|Withdrawal by Subject|1
6047504|NCT00603278|20900276|P4|Overall Study|Withdrawal by Subject|2
6047505|NCT00603278|20900277|P3|Overall Study|Withdrawal by Subject|1
6047506|NCT00603278|20900278|P2|Overall Study|Withdrawal by Subject|3
6047507|NCT00603278|20900279|P1|Overall Study|Withdrawal by Subject|2
6047508|NCT00603278|20900274|P6|Overall Study|Adverse Event|1
6047509|NCT00603278|20900275|P5|Overall Study|Adverse Event|2
6047510|NCT00603278|20900276|P4|Overall Study|Adverse Event|0
6047511|NCT00603278|20900277|P3|Overall Study|Adverse Event|1
6047512|NCT00603278|20900278|P2|Overall Study|Adverse Event|3
6047513|NCT00603278|20900279|P1|Overall Study|Adverse Event|0
6047514|NCT00603278|20900274|P6|Overall Study|Lack of Efficacy|14
6047515|NCT00603278|20900275|P5|Overall Study|Lack of Efficacy|7
6047516|NCT00603278|20900276|P4|Overall Study|Lack of Efficacy|8
6047517|NCT00603278|20900277|P3|Overall Study|Lack of Efficacy|11
6047518|NCT00603278|20900278|P2|Overall Study|Lack of Efficacy|10
6047519|NCT00603278|20900279|P1|Overall Study|Lack of Efficacy|35
6047520|NCT00603265|20900428|P3|Overall Study|Protocol Violation|0
6047521|NCT00603265|20900429|P2|Overall Study|Protocol Violation|0
6047522|NCT00603265|20900430|P1|Overall Study|Protocol Violation|1
6047523|NCT00603265|20900428|P3|Overall Study|Participant Left Country, No Responses|0
6047524|NCT00603265|20900429|P2|Overall Study|Participant Left Country, No Responses|1
6047525|NCT00603265|20900430|P1|Overall Study|Participant Left Country, No Responses|0
6047526|NCT00603265|20900428|P3|Overall Study|Out of Town, Ran Out of Study Drug|0
6047527|NCT00603265|20900429|P2|Overall Study|Out of Town, Ran Out of Study Drug|1
6047528|NCT00603265|20900430|P1|Overall Study|Out of Town, Ran Out of Study Drug|0
6047529|NCT00603265|20900428|P3|Overall Study|Lost to Follow-up|0
6047530|NCT00603265|20900429|P2|Overall Study|Lost to Follow-up|1
6047531|NCT00603265|20900430|P1|Overall Study|Lost to Follow-up|0
6047532|NCT00603265|20900428|P3|Overall Study|Lack of Efficacy|3
6047533|NCT00603265|20900429|P2|Overall Study|Lack of Efficacy|0
6047534|NCT00603265|20900430|P1|Overall Study|Lack of Efficacy|3
6047535|NCT00603265|20900428|P3|Overall Study|Withdrawal by Subject|1
6047536|NCT00603265|20900429|P2|Overall Study|Withdrawal by Subject|2
6047537|NCT00603265|20900430|P1|Overall Study|Withdrawal by Subject|1
6047538|NCT00603265|20900428|P3|Overall Study|Adverse Event|1
6047539|NCT00603265|20900429|P2|Overall Study|Adverse Event|11
6047540|NCT00603265|20900430|P1|Overall Study|Adverse Event|2
6047541|NCT00603239|20900458|P2|Overall Study|Subject decision|1
6047542|NCT00603239|20900459|P1|Overall Study|Subject decision|2
6047543|NCT00603239|20900458|P2|Overall Study|Protocol Violation|0
6047544|NCT00603239|20900459|P1|Overall Study|Protocol Violation|2
6047545|NCT00603239|20900458|P2|Overall Study|Physician Decision|0
6047546|NCT00603239|20900459|P1|Overall Study|Physician Decision|2
6047547|NCT00603239|20900458|P2|Overall Study|Lost to Follow-up|1
6047548|NCT00603239|20900459|P1|Overall Study|Lost to Follow-up|2
6047549|NCT00603239|20900458|P2|Overall Study|Loss of glucose control|0
6047550|NCT00603239|20900459|P1|Overall Study|Loss of glucose control|3
6047551|NCT00603239|20900458|P2|Overall Study|Entry criteria not met|1
6047552|NCT00603239|20900459|P1|Overall Study|Entry criteria not met|0
6047553|NCT00603239|20900458|P2|Overall Study|Adverse Event|1
6047554|NCT00603239|20900459|P1|Overall Study|Adverse Event|4
6047555|NCT00602979|20900520|P5|Overall Study|Failed Intubation|0
6047556|NCT00602979|20900521|P4|Overall Study|Failed Intubation|1
6047557|NCT00602979|20900522|P3|Overall Study|Failed Intubation|0
6047558|NCT00602979|20900523|P2|Overall Study|Failed Intubation|1
6047559|NCT00602979|20900524|P1|Overall Study|Failed Intubation|0
6047560|NCT00602979|20900520|P5|Overall Study|Lost to Follow-up|3
6047561|NCT00602979|20900521|P4|Overall Study|Lost to Follow-up|2
6047562|NCT00602979|20900522|P3|Overall Study|Lost to Follow-up|3
6047563|NCT00602979|20900523|P2|Overall Study|Lost to Follow-up|2
6047564|NCT00602979|20900524|P1|Overall Study|Lost to Follow-up|3
6047565|NCT00602927|20900574|P2|Period 3: 13 Days|MRI data quality|2
6047566|NCT00602927|20900575|P1|Period 3: 13 Days|MRI data quality|2
6047567|NCT00602927|20900574|P2|Period 3: 13 Days|Protocol Violation|1
6047568|NCT00602927|20900575|P1|Period 3: 13 Days|Protocol Violation|0
6047569|NCT00602927|20900574|P2|Period 2: 14 Days|Protocol Violation|2
6047570|NCT00602927|20900575|P1|Period 2: 14 Days|Protocol Violation|0
6047571|NCT00602927|20900574|P2|Period 1: 13 Days|Claustrophobia|1
6047572|NCT00602927|20900575|P1|Period 1: 13 Days|Claustrophobia|0
6047573|NCT00602927|20900574|P2|Period 1: 13 Days|Time|0
6047574|NCT00602927|20900575|P1|Period 1: 13 Days|Time|1
6047575|NCT00602927|20900574|P2|Period 1: 13 Days|MRI scanner technical issue|0
6047576|NCT00602927|20900575|P1|Period 1: 13 Days|MRI scanner technical issue|1
6047577|NCT00602927|20900574|P2|Period 1: 13 Days|Protocol Violation|4
6047578|NCT00602927|20900575|P1|Period 1: 13 Days|Protocol Violation|2
6047579|NCT00602797|20900592|P1|Overall Study|Adverse Event|1
6047580|NCT00602667|20900610|P3|Overall Study|Progressive disease prior to therapy|1
6047581|NCT00602667|20900611|P2|Overall Study|Progressive disease prior to therapy|0
6047582|NCT00602667|20900612|P1|Overall Study|Progressive disease prior to therapy|0
6047583|NCT00602667|20900610|P3|Overall Study|Progressive disease|45
6047584|NCT00602667|20900611|P2|Overall Study|Progressive disease|48
6047585|NCT00602667|20900612|P1|Overall Study|Progressive disease|13
6047586|NCT00602667|20900610|P3|Overall Study|Physician Decision|8
6047587|NCT00602667|20900611|P2|Overall Study|Physician Decision|3
6047588|NCT00602667|20900612|P1|Overall Study|Physician Decision|2
6047589|NCT00602667|20900610|P3|Overall Study|Second malignancy|0
6047590|NCT00602667|20900611|P2|Overall Study|Second malignancy|1
6047591|NCT00602667|20900612|P1|Overall Study|Second malignancy|0
6047592|NCT00602667|20900610|P3|Overall Study|Excessive toxicity|0
6047593|NCT00602667|20900611|P2|Overall Study|Excessive toxicity|1
6047594|NCT00602667|20900612|P1|Overall Study|Excessive toxicity|1
6047595|NCT00602667|20900610|P3|Overall Study|Family request|6
6047596|NCT00602667|20900611|P2|Overall Study|Family request|25
6047597|NCT00602667|20900612|P1|Overall Study|Family request|3
6047598|NCT00602667|20900610|P3|Overall Study|Death|1
6047599|NCT00602667|20900611|P2|Overall Study|Death|1
6047600|NCT00602667|20900612|P1|Overall Study|Death|0
6047601|NCT00602667|20900610|P3|Overall Study|Still on Therapy|2
6047602|NCT00602667|20900611|P2|Overall Study|Still on Therapy|2
6047603|NCT00602667|20900612|P1|Overall Study|Still on Therapy|0
6047626|NCT00602537|20900806|P2|Follow Up Study Comparison|Withdrawal by Subject|2
6047627|NCT00602537|20900807|P1|Follow Up Study Comparison|Withdrawal by Subject|2
6047628|NCT00602537|20900806|P2|Follow Up Study Comparison|Lost to Follow-up|1
6047629|NCT00602537|20900807|P1|Follow Up Study Comparison|Lost to Follow-up|8
6047630|NCT00602537|20900806|P2|Follow Up Study Comparison|Adverse Event|0
6047631|NCT00602537|20900807|P1|Follow Up Study Comparison|Adverse Event|1
6047632|NCT00602537|20900806|P2|12 Week Double Blind Comparison|Withdrawal by Subject|13
6047633|NCT00602537|20900807|P1|12 Week Double Blind Comparison|Withdrawal by Subject|3
6047634|NCT00602537|20900806|P2|12 Week Double Blind Comparison|Lost to Follow-up|6
6047635|NCT00602537|20900807|P1|12 Week Double Blind Comparison|Lost to Follow-up|5
6047636|NCT00602537|20900806|P2|12 Week Double Blind Comparison|Lack of Efficacy|23
6047637|NCT00602537|20900807|P1|12 Week Double Blind Comparison|Lack of Efficacy|13
6047638|NCT00602537|20900806|P2|12 Week Double Blind Comparison|Adverse Event|5
6047639|NCT00602537|20900807|P1|12 Week Double Blind Comparison|Adverse Event|2
6047640|NCT00602472|20900817|P2|Overall Study|Other incl. lack of efficacy|2
6047641|NCT00602472|20900818|P1|Overall Study|Other incl. lack of efficacy|4
6047642|NCT00602472|20900817|P2|Overall Study|Withdrawal by Subject|14
6047643|NCT00602472|20900818|P1|Overall Study|Withdrawal by Subject|8
6047644|NCT00602472|20900817|P2|Overall Study|Protocol Violation|19
6047645|NCT00602472|20900818|P1|Overall Study|Protocol Violation|4
6047646|NCT00602472|20900817|P2|Overall Study|Adverse Event|23
6047647|NCT00602472|20900818|P1|Overall Study|Adverse Event|5
6047648|NCT00602420|20900883|P2|Overall Study|Adverse Event|0
6047649|NCT00602420|20900884|P1|Overall Study|Adverse Event|1
6047650|NCT00602420|20900883|P2|Overall Study|Withdrawal by Subject|17
6047651|NCT00602420|20900884|P1|Overall Study|Withdrawal by Subject|18
6047652|NCT00602420|20900883|P2|Overall Study|Chemotoxicity, Inc. Data,Ineligible|3
6047653|NCT00602420|20900884|P1|Overall Study|Chemotoxicity, Inc. Data,Ineligible|5
6047654|NCT00602420|20900883|P2|Overall Study|Death|4
6047655|NCT00602420|20900884|P1|Overall Study|Death|1
6047656|NCT00601900|20900992|P2|Overall Study|Withdrawal by Subject|3
6047657|NCT00601900|20900993|P1|Overall Study|Withdrawal by Subject|0
6047658|NCT00601835|20901017|P2|Overall Study|Relocate|2
6047659|NCT00601835|20901018|P1|Overall Study|Relocate|12
6047660|NCT00601835|20901017|P2|Overall Study|Adverse Event|1
6047661|NCT00601835|20901018|P1|Overall Study|Adverse Event|1
6047662|NCT00601835|20901017|P2|Overall Study|Lost to Follow-up|5
6047663|NCT00601835|20901018|P1|Overall Study|Lost to Follow-up|37
6047664|NCT00601835|20901017|P2|Overall Study|Physician Decision|0
6047665|NCT00601835|20901018|P1|Overall Study|Physician Decision|1
6047666|NCT00601835|20901017|P2|Overall Study|Withdrawal by Subject|6
6047667|NCT00601835|20901018|P1|Overall Study|Withdrawal by Subject|9
6047668|NCT00601705|20901107|P1|Overall Study|Withdrawal by Subject|1
6047669|NCT00601640|20901119|P3|Overall Study|change in eligibility status|1
6047670|NCT00601640|20901120|P2|Overall Study|change in eligibility status|1
6047671|NCT00601640|20901121|P1|Overall Study|change in eligibility status|0
6047672|NCT00601640|20901119|P3|Overall Study|intercurrent illness|0
6047673|NCT00601640|20901120|P2|Overall Study|intercurrent illness|0
6047674|NCT00601640|20901121|P1|Overall Study|intercurrent illness|1
6047675|NCT00601640|20901119|P3|Overall Study|Adverse Event|2
6047676|NCT00601640|20901120|P2|Overall Study|Adverse Event|4
6047677|NCT00601640|20901121|P1|Overall Study|Adverse Event|0
6047678|NCT00601640|20901119|P3|Overall Study|Death|0
6047679|NCT00601640|20901120|P2|Overall Study|Death|0
6047680|NCT00601640|20901121|P1|Overall Study|Death|1
6047681|NCT00601640|20901119|P3|Overall Study|Withdrawal by Subject|7
6047682|NCT00601640|20901120|P2|Overall Study|Withdrawal by Subject|0
6047683|NCT00601640|20901121|P1|Overall Study|Withdrawal by Subject|3
6047684|NCT00601523|20901146|P2|Overall Study|Other|1
6047685|NCT00601523|20901147|P1|Overall Study|Other|9
6047686|NCT00601523|20901146|P2|Overall Study|Withdrawal by Subject|9
6047687|NCT00601523|20901147|P1|Overall Study|Withdrawal by Subject|18
6047688|NCT00601523|20901146|P2|Overall Study|Lost to Follow-up|1
6047689|NCT00601523|20901147|P1|Overall Study|Lost to Follow-up|0
6047690|NCT00601523|20901146|P2|Overall Study|Protocol Violation|1
6047691|NCT00601523|20901147|P1|Overall Study|Protocol Violation|5
6047692|NCT00601523|20901146|P2|Overall Study|Lack of Efficacy|0
6047693|NCT00601523|20901147|P1|Overall Study|Lack of Efficacy|3
6047694|NCT00601523|20901146|P2|Overall Study|Adverse Event|14
6047695|NCT00601523|20901147|P1|Overall Study|Adverse Event|42
6047696|NCT00601458|20901182|P3|Overall Study|Early Termination|1
6047697|NCT00601458|20901183|P2|Overall Study|Early Termination|1
6047698|NCT00601458|20901184|P1|Overall Study|Early Termination|0
6047699|NCT00601458|20901182|P3|Overall Study|Protocol Violation|1
6047700|NCT00601458|20901183|P2|Overall Study|Protocol Violation|2
6047701|NCT00601458|20901184|P1|Overall Study|Protocol Violation|3
6047702|NCT00601458|20901182|P3|Overall Study|Incomplete Data|0
6047703|NCT00601458|20901183|P2|Overall Study|Incomplete Data|2
6047704|NCT00601458|20901184|P1|Overall Study|Incomplete Data|0
6047705|NCT00601458|20901182|P3|Overall Study|Dosing Error|0
6047706|NCT00601458|20901183|P2|Overall Study|Dosing Error|0
6047707|NCT00601458|20901184|P1|Overall Study|Dosing Error|1
6047708|NCT00601419|20901195|P1|Overall Study|Missed Visits|1
6047709|NCT00601419|20901195|P1|Overall Study|Lost to Follow-up|3
6047710|NCT00601354|20901225|P2|Overall Study|Lost to Follow-up|5
6047711|NCT00601354|20901226|P1|Overall Study|Lost to Follow-up|4
6047712|NCT00601250|20901238|P2|Overall Study|Other incl. lack of efficacy|9
6047713|NCT00601250|20901239|P1|Overall Study|Other incl. lack of efficacy|2
6047714|NCT00601250|20901238|P2|Overall Study|Withdrawal by Subject|13
6047715|NCT00601250|20901239|P1|Overall Study|Withdrawal by Subject|4
6047716|NCT00601250|20901238|P2|Overall Study|Lost to Follow-up|6
6047717|NCT00601250|20901239|P1|Overall Study|Lost to Follow-up|2
6047718|NCT00601250|20901238|P2|Overall Study|Protocol Violation|2
6047719|NCT00601250|20901239|P1|Overall Study|Protocol Violation|3
6047720|NCT00601250|20901238|P2|Overall Study|Adverse Event|9
6047721|NCT00601250|20901239|P1|Overall Study|Adverse Event|3
6047722|NCT00601172|20901275|P2|Overall Study|Did not meet continuation criteria|20
6047723|NCT00601172|20901276|P1|Overall Study|Did not meet continuation criteria|19
6047724|NCT00601172|20901275|P2|Overall Study|Withdrawal by Subject|27
6047725|NCT00601172|20901276|P1|Overall Study|Withdrawal by Subject|35
6047726|NCT00601172|20901275|P2|Overall Study|Physician Decision|28
6047727|NCT00601172|20901276|P1|Overall Study|Physician Decision|27
6047728|NCT00601172|20901275|P2|Overall Study|Lost to Follow-up|3
6047729|NCT00601172|20901276|P1|Overall Study|Lost to Follow-up|4
6047730|NCT00601172|20901275|P2|Overall Study|Protocol Violation|5
6047731|NCT00601172|20901276|P1|Overall Study|Protocol Violation|2
6047732|NCT00601172|20901275|P2|Overall Study|Lack of Efficacy|12
6047733|NCT00601172|20901276|P1|Overall Study|Lack of Efficacy|11
6047734|NCT00601172|20901275|P2|Overall Study|Adverse Event|32
6047735|NCT00601172|20901276|P1|Overall Study|Adverse Event|43
6047736|NCT00601107|20901333|P4|Overall Study|Undefined|0
6047737|NCT00601107|20901334|P3|Overall Study|Undefined|1
6047738|NCT00601107|20901335|P2|Overall Study|Undefined|0
6047739|NCT00601107|20901336|P1|Overall Study|Undefined|1
6047740|NCT00601107|20901333|P4|Overall Study|Worsening of Psoriasis|4
6047741|NCT00601107|20901334|P3|Overall Study|Worsening of Psoriasis|1
6047742|NCT00601107|20901335|P2|Overall Study|Worsening of Psoriasis|1
6047743|NCT00601107|20901336|P1|Overall Study|Worsening of Psoriasis|4
6047744|NCT00601107|20901333|P4|Overall Study|Serum Calcium >11.5 milligram/deciliter|1
6047745|NCT00601107|20901334|P3|Overall Study|Serum Calcium >11.5 milligram/deciliter|0
6047746|NCT00601107|20901335|P2|Overall Study|Serum Calcium >11.5 milligram/deciliter|0
6047747|NCT00601107|20901336|P1|Overall Study|Serum Calcium >11.5 milligram/deciliter|0
6047748|NCT00601107|20901333|P4|Overall Study|Lost to Follow-up|3
6047749|NCT00601107|20901334|P3|Overall Study|Lost to Follow-up|0
6047750|NCT00601107|20901335|P2|Overall Study|Lost to Follow-up|3
6047751|NCT00601107|20901336|P1|Overall Study|Lost to Follow-up|3
6047752|NCT00601107|20901333|P4|Overall Study|Withdrawal by Subject|4
6047753|NCT00601107|20901334|P3|Overall Study|Withdrawal by Subject|7
6047754|NCT00601107|20901335|P2|Overall Study|Withdrawal by Subject|4
6047755|NCT00601107|20901336|P1|Overall Study|Withdrawal by Subject|5
6047756|NCT00601107|20901333|P4|Overall Study|Adverse Event|0
6047757|NCT00601107|20901334|P3|Overall Study|Adverse Event|3
6047758|NCT00601107|20901335|P2|Overall Study|Adverse Event|1
6047759|NCT00601107|20901336|P1|Overall Study|Adverse Event|0
6047760|NCT00600938|20901356|P4|Extension Study|Death|0
6047761|NCT00600938|20901357|P3|Extension Study|Death|0
6047762|NCT00600938|20901358|P2|Extension Study|Death|0
6047763|NCT00600938|20901359|P1|Extension Study|Death|1
6047764|NCT00600938|20901356|P4|Extension Study|Lost to Follow-up|0
6047765|NCT00600938|20901357|P3|Extension Study|Lost to Follow-up|2
6047766|NCT00600938|20901358|P2|Extension Study|Lost to Follow-up|1
6047767|NCT00600938|20901359|P1|Extension Study|Lost to Follow-up|1
6047768|NCT00600938|20901356|P4|Extension Study|Withdrawal by Subject|0
6047769|NCT00600938|20901357|P3|Extension Study|Withdrawal by Subject|3
6047770|NCT00600938|20901358|P2|Extension Study|Withdrawal by Subject|2
6047771|NCT00600938|20901359|P1|Extension Study|Withdrawal by Subject|2
6047772|NCT00600938|20901356|P4|Extension Study|Unsatisfactory therapeutic effect|0
6047773|NCT00600938|20901357|P3|Extension Study|Unsatisfactory therapeutic effect|1
6047774|NCT00600938|20901358|P2|Extension Study|Unsatisfactory therapeutic effect|1
6047775|NCT00600938|20901359|P1|Extension Study|Unsatisfactory therapeutic effect|4
6047776|NCT00600938|20901356|P4|Extension Study|Abnormal test procedure results|1
6047777|NCT00600938|20901357|P3|Extension Study|Abnormal test procedure results|1
6047778|NCT00600938|20901358|P2|Extension Study|Abnormal test procedure results|1
6047779|NCT00600938|20901359|P1|Extension Study|Abnormal test procedure results|0
6047780|NCT00600938|20901356|P4|Extension Study|Adverse Event|0
6047781|NCT00600938|20901357|P3|Extension Study|Adverse Event|2
6047782|NCT00600938|20901358|P2|Extension Study|Adverse Event|0
6047783|NCT00600938|20901359|P1|Extension Study|Adverse Event|1
6047784|NCT00600938|20901356|P4|Core Study|Protocol Violation|0
6047785|NCT00600938|20901357|P3|Core Study|Protocol Violation|0
6047786|NCT00600938|20901358|P2|Core Study|Protocol Violation|2
6047787|NCT00600938|20901359|P1|Core Study|Protocol Violation|1
6047788|NCT00600938|20901356|P4|Core Study|Death|0
6047789|NCT00600938|20901357|P3|Core Study|Death|0
6047790|NCT00600938|20901358|P2|Core Study|Death|1
6047791|NCT00600938|20901359|P1|Core Study|Death|1
6047792|NCT00600938|20901356|P4|Core Study|Lost to Follow-up|0
6047793|NCT00600938|20901357|P3|Core Study|Lost to Follow-up|0
6047794|NCT00600938|20901358|P2|Core Study|Lost to Follow-up|2
6047795|NCT00600938|20901359|P1|Core Study|Lost to Follow-up|3
6047796|NCT00600938|20901356|P4|Core Study|Patient withdrew consent|0
6047797|NCT00600938|20901357|P3|Core Study|Patient withdrew consent|0
6047798|NCT00600938|20901358|P2|Core Study|Patient withdrew consent|12
6047799|NCT00600938|20901359|P1|Core Study|Patient withdrew consent|7
6047800|NCT00600938|20901356|P4|Core Study|Unsatisfactory therapeutic effect|0
6047801|NCT00600938|20901357|P3|Core Study|Unsatisfactory therapeutic effect|0
6047802|NCT00600938|20901358|P2|Core Study|Unsatisfactory therapeutic effect|2
6047803|NCT00600938|20901359|P1|Core Study|Unsatisfactory therapeutic effect|1
6047804|NCT00600938|20901356|P4|Core Study|Abnormal test procedure result(s)|0
6047805|NCT00600938|20901357|P3|Core Study|Abnormal test procedure result(s)|0
6047806|NCT00600938|20901358|P2|Core Study|Abnormal test procedure result(s)|2
6047807|NCT00600938|20901359|P1|Core Study|Abnormal test procedure result(s)|3
6047808|NCT00600886|20901423|P2|Extension - After Crossover (CAS)|Death|0
6047809|NCT00600886|20901424|P1|Extension - After Crossover (CAS)|Death|1
6047810|NCT00600886|20901423|P2|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|0
6047811|NCT00600886|20901424|P1|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|3
6047812|NCT00600886|20901423|P2|Extension - After Crossover (CAS)|Subject no longer requires study drug|0
6047813|NCT00600886|20901424|P1|Extension - After Crossover (CAS)|Subject no longer requires study drug|3
6047814|NCT00600886|20901423|P2|Extension - After Crossover (CAS)|Administrative Problems|4
6047815|NCT00600886|20901424|P1|Extension - After Crossover (CAS)|Administrative Problems|4
6047816|NCT00600886|20901423|P2|Extension - After Crossover (CAS)|Lack of Efficacy|4
6047817|NCT00600886|20901424|P1|Extension - After Crossover (CAS)|Lack of Efficacy|13
6047818|NCT00600886|20901423|P2|Extension - After Crossover (CAS)|Withdrawal by Subject|4
6047819|NCT00600886|20901424|P1|Extension - After Crossover (CAS)|Withdrawal by Subject|19
6047820|NCT00600886|20901423|P2|Extension - After Crossover (CAS)|Adverse Event|1
6047821|NCT00600886|20901424|P1|Extension - After Crossover (CAS)|Adverse Event|19
6047822|NCT00600886|20901423|P2|Extension - Same Treatment (FAS)|Condition no longer requires study drug|0
6047823|NCT00600886|20901424|P1|Extension - Same Treatment (FAS)|Condition no longer requires study drug|6
6047824|NCT00600886|20901423|P2|Extension - Same Treatment (FAS)|Death|1
6047825|NCT00600886|20901424|P1|Extension - Same Treatment (FAS)|Death|1
6047826|NCT00600886|20901423|P2|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|0
6047827|NCT00600886|20901424|P1|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|4
6047828|NCT00600886|20901423|P2|Extension - Same Treatment (FAS)|Adverse Event|1
6047829|NCT00600886|20901424|P1|Extension - Same Treatment (FAS)|Adverse Event|4
6047830|NCT00600886|20901423|P2|Extension - Same Treatment (FAS)|Lost to Follow-up|1
6047831|NCT00600886|20901424|P1|Extension - Same Treatment (FAS)|Lost to Follow-up|3
6047832|NCT00600886|20901423|P2|Extension - Same Treatment (FAS)|Administrative Problems|3
6047833|NCT00600886|20901424|P1|Extension - Same Treatment (FAS)|Administrative Problems|9
6047834|NCT00600886|20901423|P2|Extension - Same Treatment (FAS)|Lack of Efficacy|3
6047835|NCT00600886|20901424|P1|Extension - Same Treatment (FAS)|Lack of Efficacy|3
6047836|NCT00600886|20901423|P2|Extension - Same Treatment (FAS)|Withdrawal by Subject|2
6047837|NCT00600886|20901424|P1|Extension - Same Treatment (FAS)|Withdrawal by Subject|16
6047838|NCT00600886|20901423|P2|Core Phase - Full Analysis Set (FAS)|Death|1
6047839|NCT00600886|20901424|P1|Core Phase - Full Analysis Set (FAS)|Death|0
6047840|NCT00600886|20901423|P2|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|0
6047841|NCT00600886|20901424|P1|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|1
6047842|NCT00600886|20901423|P2|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|0
6047843|NCT00600886|20901424|P1|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|1
6047844|NCT00600886|20901423|P2|Core Phase - Full Analysis Set (FAS)|Administrative Problems|0
6047845|NCT00600886|20901424|P1|Core Phase - Full Analysis Set (FAS)|Administrative Problems|2
6047846|NCT00600886|20901423|P2|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|3
6047847|NCT00600886|20901424|P1|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|5
6047848|NCT00600886|20901423|P2|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|8
6047849|NCT00600886|20901424|P1|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|5
6047850|NCT00600886|20901423|P2|Core Phase - Full Analysis Set (FAS)|Protocol Violation|8
6047851|NCT00600886|20901424|P1|Core Phase - Full Analysis Set (FAS)|Protocol Violation|7
6047852|NCT00600886|20901423|P2|Core Phase - Full Analysis Set (FAS)|Adverse Event|6
6047853|NCT00600886|20901424|P1|Core Phase - Full Analysis Set (FAS)|Adverse Event|14
6047854|NCT00600821|20901488|P2|Overall Study|Other|3
6047855|NCT00600821|20901489|P1|Overall Study|Other|2
6047856|NCT00600821|20901488|P2|Overall Study|Randomized but not treated|1
6047857|NCT00600821|20901489|P1|Overall Study|Randomized but not treated|0
6047858|NCT00600821|20901488|P2|Overall Study|Objective progression or relapse|1
6047859|NCT00600821|20901489|P1|Overall Study|Objective progression or relapse|0
6047860|NCT00600821|20901488|P2|Overall Study|Terminated by sponsor|6
6047861|NCT00600821|20901489|P1|Overall Study|Terminated by sponsor|8
6047862|NCT00600821|20901488|P2|Overall Study|Withdrawal by Subject|1
6047863|NCT00600821|20901489|P1|Overall Study|Withdrawal by Subject|1
6047864|NCT00600821|20901488|P2|Overall Study|Lost to Follow-up|2
6047865|NCT00600821|20901489|P1|Overall Study|Lost to Follow-up|2
6047866|NCT00600821|20901488|P2|Overall Study|Death|46
6047867|NCT00600821|20901489|P1|Overall Study|Death|45
6047868|NCT00600756|20901517|P2|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9
6047869|NCT00600756|20901518|P1|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9
6047870|NCT00600756|20901517|P2|Overall Study Analysis After 12 Months|Lost to Follow-up|13
6047871|NCT00600756|20901518|P1|Overall Study Analysis After 12 Months|Lost to Follow-up|16
6047872|NCT00600756|20901517|P2|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|20
6047873|NCT00600756|20901518|P1|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|16
6047874|NCT00600756|20901517|P2|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|20
6047875|NCT00600756|20901518|P1|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|17
6047876|NCT00600756|20901517|P2|Overall Study Analysis After 12 Months|Incorrect enrollment|29
6047877|NCT00600756|20901518|P1|Overall Study Analysis After 12 Months|Incorrect enrollment|21
6047878|NCT00600756|20901517|P2|Overall Study Analysis After 12 Months|Withdrawal by Subject|41
6047879|NCT00600756|20901518|P1|Overall Study Analysis After 12 Months|Withdrawal by Subject|51
6047880|NCT00600756|20901517|P2|Overall Study Analysis After 12 Months|Adverse Event|44
6047881|NCT00600756|20901518|P1|Overall Study Analysis After 12 Months|Adverse Event|53
6047882|NCT00600756|20901517|P2|Analysis After 6 Months|Study-specific discontinuation criteria|3
6047883|NCT00600756|20901518|P1|Analysis After 6 Months|Study-specific discontinuation criteria|6
6047884|NCT00600756|20901517|P2|Analysis After 6 Months|Lost to Follow-up|8
6047885|NCT00600756|20901518|P1|Analysis After 6 Months|Lost to Follow-up|10
6047886|NCT00600756|20901517|P2|Analysis After 6 Months|Severe non-compliance to protocol|11
6047887|NCT00600756|20901518|P1|Analysis After 6 Months|Severe non-compliance to protocol|11
6047888|NCT00600756|20901517|P2|Analysis After 6 Months|worsening symptom, lack of efficacy|14
6047889|NCT00600756|20901518|P1|Analysis After 6 Months|worsening symptom, lack of efficacy|11
6047890|NCT00600756|20901517|P2|Analysis After 6 Months|Incorrect Enrollment|21
6047891|NCT00600756|20901518|P1|Analysis After 6 Months|Incorrect Enrollment|12
6047892|NCT00600756|20901517|P2|Analysis After 6 Months|Withdrawal by Subject|30
6047893|NCT00600756|20901518|P1|Analysis After 6 Months|Withdrawal by Subject|38
6047894|NCT00600756|20901517|P2|Analysis After 6 Months|Adverse Event|33
6047895|NCT00600756|20901518|P1|Analysis After 6 Months|Adverse Event|43
6047896|NCT00600613|20901627|P1|Overall Study|Protocol Deviation|1
6047897|NCT00600353|20901633|P2|Overall Study|History of prepartive regimen|1
6047898|NCT00600353|20901634|P1|Overall Study|History of prepartive regimen|0
6047899|NCT00600353|20901633|P2|Overall Study|history of malignancy within 5 years|0
6047900|NCT00600353|20901634|P1|Overall Study|history of malignancy within 5 years|1
6047901|NCT00600171|20901697|P6|Overall Study|Lost to Follow-up|0
6047902|NCT00600171|20901698|P5|Overall Study|Lost to Follow-up|0
6047903|NCT00600171|20901699|P4|Overall Study|Lost to Follow-up|1
6047904|NCT00600171|20901700|P3|Overall Study|Lost to Follow-up|0
6047905|NCT00600171|20901701|P2|Overall Study|Lost to Follow-up|0
6047906|NCT00600171|20901702|P1|Overall Study|Lost to Follow-up|0
6047907|NCT00600171|20901697|P6|Overall Study|Physician Decision|2
6047908|NCT00600171|20901698|P5|Overall Study|Physician Decision|0
6047909|NCT00600171|20901699|P4|Overall Study|Physician Decision|1
6047910|NCT00600171|20901700|P3|Overall Study|Physician Decision|0
6047911|NCT00600171|20901701|P2|Overall Study|Physician Decision|1
6047912|NCT00600171|20901702|P1|Overall Study|Physician Decision|0
6047913|NCT00600171|20901697|P6|Overall Study|Withdrawal by Subject|1
6047914|NCT00600171|20901698|P5|Overall Study|Withdrawal by Subject|1
6047915|NCT00600171|20901699|P4|Overall Study|Withdrawal by Subject|1
6047916|NCT00600171|20901700|P3|Overall Study|Withdrawal by Subject|0
6047917|NCT00600171|20901701|P2|Overall Study|Withdrawal by Subject|0
6047918|NCT00600171|20901702|P1|Overall Study|Withdrawal by Subject|3
6047919|NCT00600171|20901697|P6|Overall Study|Met Protocol-defined Stopping Criteria|2
6047920|NCT00600171|20901698|P5|Overall Study|Met Protocol-defined Stopping Criteria|2
6047921|NCT00600171|20901699|P4|Overall Study|Met Protocol-defined Stopping Criteria|3
6047922|NCT00600171|20901700|P3|Overall Study|Met Protocol-defined Stopping Criteria|7
6047923|NCT00600171|20901701|P2|Overall Study|Met Protocol-defined Stopping Criteria|1
6047924|NCT00600171|20901702|P1|Overall Study|Met Protocol-defined Stopping Criteria|3
6047925|NCT00600171|20901697|P6|Overall Study|Protocol Violation|0
6047926|NCT00600171|20901698|P5|Overall Study|Protocol Violation|0
6047927|NCT00600171|20901699|P4|Overall Study|Protocol Violation|1
6047928|NCT00600171|20901700|P3|Overall Study|Protocol Violation|0
6047929|NCT00600171|20901701|P2|Overall Study|Protocol Violation|2
6047930|NCT00600171|20901702|P1|Overall Study|Protocol Violation|1
6047931|NCT00600171|20901697|P6|Overall Study|Lack of Efficacy|0
6047932|NCT00600171|20901698|P5|Overall Study|Lack of Efficacy|4
6047933|NCT00600171|20901699|P4|Overall Study|Lack of Efficacy|5
6047934|NCT00600171|20901700|P3|Overall Study|Lack of Efficacy|3
6047935|NCT00600171|20901701|P2|Overall Study|Lack of Efficacy|12
6047936|NCT00600171|20901702|P1|Overall Study|Lack of Efficacy|9
6047937|NCT00600171|20901697|P6|Overall Study|Adverse Event|0
6047938|NCT00600171|20901698|P5|Overall Study|Adverse Event|1
6047939|NCT00600171|20901699|P4|Overall Study|Adverse Event|0
6047940|NCT00600171|20901700|P3|Overall Study|Adverse Event|0
6047941|NCT00600171|20901701|P2|Overall Study|Adverse Event|1
6047942|NCT00600171|20901702|P1|Overall Study|Adverse Event|0
6047943|NCT00600119|20901776|P6|Follow-up Period|Other|0
6047944|NCT00600119|20901777|P5|Follow-up Period|Other|0
6047945|NCT00600119|20901778|P4|Follow-up Period|Other|0
6047946|NCT00600119|20901779|P3|Follow-up Period|Other|0
6047947|NCT00600119|20901780|P2|Follow-up Period|Other|0
6047948|NCT00600119|20901781|P1|Follow-up Period|Other|1
6047949|NCT00600119|20901776|P6|Follow-up Period|Adverse Event|1
6047950|NCT00600119|20901777|P5|Follow-up Period|Adverse Event|0
6047951|NCT00600119|20901778|P4|Follow-up Period|Adverse Event|0
6047952|NCT00600119|20901779|P3|Follow-up Period|Adverse Event|0
6047953|NCT00600119|20901780|P2|Follow-up Period|Adverse Event|0
6047954|NCT00600119|20901781|P1|Follow-up Period|Adverse Event|0
6047955|NCT00600119|20901776|P6|Double-blind Treatment Period|Adverse Event|10
6047956|NCT00600119|20901777|P5|Double-blind Treatment Period|Adverse Event|2
6047957|NCT00600119|20901778|P4|Double-blind Treatment Period|Adverse Event|1
6047958|NCT00600119|20901779|P3|Double-blind Treatment Period|Adverse Event|0
6047959|NCT00600119|20901780|P2|Double-blind Treatment Period|Adverse Event|1
6047960|NCT00600119|20901781|P1|Double-blind Treatment Period|Adverse Event|1
6047961|NCT00600119|20901776|P6|Double-blind Treatment Period|Lost to Follow-up|0
6047962|NCT00600119|20901777|P5|Double-blind Treatment Period|Lost to Follow-up|0
6047963|NCT00600119|20901778|P4|Double-blind Treatment Period|Lost to Follow-up|0
6047964|NCT00600119|20901779|P3|Double-blind Treatment Period|Lost to Follow-up|0
6047965|NCT00600119|20901780|P2|Double-blind Treatment Period|Lost to Follow-up|1
6047966|NCT00600119|20901781|P1|Double-blind Treatment Period|Lost to Follow-up|0
6047967|NCT00600119|20901776|P6|Double-blind Treatment Period|Physician Decision|0
6047968|NCT00600119|20901777|P5|Double-blind Treatment Period|Physician Decision|0
6047969|NCT00600119|20901778|P4|Double-blind Treatment Period|Physician Decision|0
6047970|NCT00600119|20901779|P3|Double-blind Treatment Period|Physician Decision|0
6047971|NCT00600119|20901780|P2|Double-blind Treatment Period|Physician Decision|0
6047972|NCT00600119|20901781|P1|Double-blind Treatment Period|Physician Decision|2
6047973|NCT00600119|20901776|P6|Double-blind Treatment Period|Sponsor Decision|0
6047974|NCT00600119|20901777|P5|Double-blind Treatment Period|Sponsor Decision|1
6047975|NCT00600119|20901778|P4|Double-blind Treatment Period|Sponsor Decision|0
6047976|NCT00600119|20901779|P3|Double-blind Treatment Period|Sponsor Decision|0
6047977|NCT00600119|20901780|P2|Double-blind Treatment Period|Sponsor Decision|1
6047978|NCT00600119|20901781|P1|Double-blind Treatment Period|Sponsor Decision|0
6047979|NCT00600119|20901776|P6|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0
6047980|NCT00600119|20901777|P5|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0
6047981|NCT00600119|20901778|P4|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0
6047982|NCT00600119|20901779|P3|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0
6047983|NCT00600119|20901780|P2|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|1
6047984|NCT00600119|20901781|P1|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0
6047985|NCT00600119|20901776|P6|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0
6047986|NCT00600119|20901777|P5|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1
6047987|NCT00600119|20901778|P4|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0
6047988|NCT00600119|20901779|P3|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0
6047989|NCT00600119|20901780|P2|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1
6047990|NCT00600119|20901781|P1|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0
6047991|NCT00600119|20901776|P6|Double-blind Treatment Period|Other|1
6047992|NCT00600119|20901777|P5|Double-blind Treatment Period|Other|2
6047993|NCT00600119|20901778|P4|Double-blind Treatment Period|Other|0
6047994|NCT00600119|20901779|P3|Double-blind Treatment Period|Other|0
6047995|NCT00600119|20901780|P2|Double-blind Treatment Period|Other|0
6047996|NCT00600119|20901781|P1|Double-blind Treatment Period|Other|0
6047997|NCT00600119|20901776|P6|Double-blind Treatment Period|Withdrawal by Subject|3
6047998|NCT00600119|20901777|P5|Double-blind Treatment Period|Withdrawal by Subject|0
6047999|NCT00600119|20901778|P4|Double-blind Treatment Period|Withdrawal by Subject|1
6048000|NCT00600119|20901779|P3|Double-blind Treatment Period|Withdrawal by Subject|0
6048001|NCT00600119|20901780|P2|Double-blind Treatment Period|Withdrawal by Subject|0
6048002|NCT00600119|20901781|P1|Double-blind Treatment Period|Withdrawal by Subject|2
6048003|NCT00600119|20901776|P6|Single-blind Placebo run-in Period|Withdrawal by Subject|0
6048004|NCT00600119|20901777|P5|Single-blind Placebo run-in Period|Withdrawal by Subject|0
6048005|NCT00600119|20901778|P4|Single-blind Placebo run-in Period|Withdrawal by Subject|0
6048006|NCT00600119|20901779|P3|Single-blind Placebo run-in Period|Withdrawal by Subject|0
6048007|NCT00600119|20901780|P2|Single-blind Placebo run-in Period|Withdrawal by Subject|1
6048008|NCT00600119|20901781|P1|Single-blind Placebo run-in Period|Withdrawal by Subject|2
6048009|NCT00600119|20901776|P6|Single-blind Placebo run-in Period|Adverse Event|1
6048010|NCT00600119|20901777|P5|Single-blind Placebo run-in Period|Adverse Event|0
6048011|NCT00600119|20901778|P4|Single-blind Placebo run-in Period|Adverse Event|1
6048012|NCT00600119|20901779|P3|Single-blind Placebo run-in Period|Adverse Event|0
6048013|NCT00600119|20901780|P2|Single-blind Placebo run-in Period|Adverse Event|0
6048014|NCT00600119|20901781|P1|Single-blind Placebo run-in Period|Adverse Event|0
6048015|NCT00600119|20901776|P6|Single-blind Placebo run-in Period|Lost to Follow-up|0
6048016|NCT00600119|20901777|P5|Single-blind Placebo run-in Period|Lost to Follow-up|0
6048017|NCT00600119|20901778|P4|Single-blind Placebo run-in Period|Lost to Follow-up|0
6048018|NCT00600119|20901779|P3|Single-blind Placebo run-in Period|Lost to Follow-up|0
6048019|NCT00600119|20901780|P2|Single-blind Placebo run-in Period|Lost to Follow-up|0
6048020|NCT00600119|20901781|P1|Single-blind Placebo run-in Period|Lost to Follow-up|1
6048021|NCT00600119|20901776|P6|Single-blind Placebo run-in Period|Sponsor Decision|0
6048022|NCT00600119|20901777|P5|Single-blind Placebo run-in Period|Sponsor Decision|1
6048023|NCT00600119|20901778|P4|Single-blind Placebo run-in Period|Sponsor Decision|0
6048024|NCT00600119|20901779|P3|Single-blind Placebo run-in Period|Sponsor Decision|1
6048025|NCT00600119|20901780|P2|Single-blind Placebo run-in Period|Sponsor Decision|0
6048026|NCT00600119|20901781|P1|Single-blind Placebo run-in Period|Sponsor Decision|0
6048027|NCT00600119|20901776|P6|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0
6048028|NCT00600119|20901777|P5|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0
6048029|NCT00600119|20901778|P4|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0
6048030|NCT00600119|20901779|P3|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1
6048031|NCT00600119|20901780|P2|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1
6048032|NCT00600119|20901781|P1|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0
6048033|NCT00600119|20901776|P6|Single-blind Placebo run-in Period|Other - Not specified|1
6048034|NCT00600119|20901777|P5|Single-blind Placebo run-in Period|Other - Not specified|1
6048035|NCT00600119|20901778|P4|Single-blind Placebo run-in Period|Other - Not specified|0
6048036|NCT00600119|20901779|P3|Single-blind Placebo run-in Period|Other - Not specified|0
6048037|NCT00600119|20901780|P2|Single-blind Placebo run-in Period|Other - Not specified|0
6048038|NCT00600119|20901781|P1|Single-blind Placebo run-in Period|Other - Not specified|1
6048039|NCT00600106|20901815|P2|Overall Study|Withdrawal by Subject|1
6048040|NCT00600106|20901816|P1|Overall Study|Withdrawal by Subject|1
6048041|NCT00600067|20901863|P2|Overall Study|Lack of Efficacy|0
6048042|NCT00600067|20901864|P1|Overall Study|Lack of Efficacy|1
6048043|NCT00600067|20901863|P2|Overall Study|protocol non-compliance|3
6048044|NCT00600067|20901864|P1|Overall Study|protocol non-compliance|0
6048045|NCT00600067|20901863|P2|Overall Study|Lost to Follow-up|3
6048046|NCT00600067|20901864|P1|Overall Study|Lost to Follow-up|2
6048047|NCT00600067|20901863|P2|Overall Study|Adverse Event|1
6048048|NCT00600067|20901864|P1|Overall Study|Adverse Event|0
6048049|NCT00600028|20901874|P2|Second Intervention (12 Weeks)|Adverse Event|2
6048050|NCT00600028|20901875|P1|Second Intervention (12 Weeks)|Adverse Event|0
6048051|NCT00600028|20901874|P2|First Intervention (12 Weeks)|Adverse Event|1
6048052|NCT00600028|20901875|P1|First Intervention (12 Weeks)|Adverse Event|0
6048053|NCT00600028|20901874|P2|First Intervention (12 Weeks)|Withdrawal by Subject|0
6048054|NCT00600028|20901875|P1|First Intervention (12 Weeks)|Withdrawal by Subject|1
6048055|NCT00599924|20901905|P7|Overall Study|Other|2
6048056|NCT00599924|20901906|P6|Overall Study|Other|0
6048057|NCT00599924|20901907|P5|Overall Study|Other|2
6048058|NCT00599924|20901908|P4|Overall Study|Other|1
6048059|NCT00599924|20901909|P3|Overall Study|Other|0
6048060|NCT00599924|20901910|P2|Overall Study|Other|0
6048061|NCT00599924|20901911|P1|Overall Study|Other|0
6048062|NCT00599924|20901905|P7|Overall Study|Withdrawal by Subject|0
6048063|NCT00599924|20901906|P6|Overall Study|Withdrawal by Subject|0
6048064|NCT00599924|20901907|P5|Overall Study|Withdrawal by Subject|1
6048065|NCT00599924|20901908|P4|Overall Study|Withdrawal by Subject|0
6048066|NCT00599924|20901909|P3|Overall Study|Withdrawal by Subject|1
6048067|NCT00599924|20901910|P2|Overall Study|Withdrawal by Subject|0
6048068|NCT00599924|20901911|P1|Overall Study|Withdrawal by Subject|0
6048069|NCT00599924|20901905|P7|Overall Study|Protocol Violation|0
6048070|NCT00599924|20901906|P6|Overall Study|Protocol Violation|0
6048071|NCT00599924|20901907|P5|Overall Study|Protocol Violation|0
6048072|NCT00599924|20901908|P4|Overall Study|Protocol Violation|1
6048073|NCT00599924|20901909|P3|Overall Study|Protocol Violation|0
6048074|NCT00599924|20901910|P2|Overall Study|Protocol Violation|0
6048075|NCT00599924|20901911|P1|Overall Study|Protocol Violation|0
6048076|NCT00599924|20901905|P7|Overall Study|Death|1
6048077|NCT00599924|20901906|P6|Overall Study|Death|2
6048078|NCT00599924|20901907|P5|Overall Study|Death|0
6048079|NCT00599924|20901908|P4|Overall Study|Death|2
6048080|NCT00599924|20901909|P3|Overall Study|Death|0
6048081|NCT00599924|20901910|P2|Overall Study|Death|0
6048082|NCT00599924|20901911|P1|Overall Study|Death|0
6048083|NCT00599924|20901905|P7|Overall Study|Adverse Event|2
6048084|NCT00599924|20901906|P6|Overall Study|Adverse Event|0
6048085|NCT00599924|20901907|P5|Overall Study|Adverse Event|0
6048086|NCT00599924|20901908|P4|Overall Study|Adverse Event|2
6048087|NCT00599924|20901909|P3|Overall Study|Adverse Event|0
6048088|NCT00599924|20901910|P2|Overall Study|Adverse Event|0
6048089|NCT00599924|20901911|P1|Overall Study|Adverse Event|0
6048090|NCT00599924|20901905|P7|Overall Study|Lack of Efficacy|0
6048091|NCT00599924|20901906|P6|Overall Study|Lack of Efficacy|2
6048092|NCT00599924|20901907|P5|Overall Study|Lack of Efficacy|3
6048093|NCT00599924|20901908|P4|Overall Study|Lack of Efficacy|2
6048094|NCT00599924|20901909|P3|Overall Study|Lack of Efficacy|1
6048095|NCT00599924|20901910|P2|Overall Study|Lack of Efficacy|5
6048096|NCT00599924|20901911|P1|Overall Study|Lack of Efficacy|3
6048097|NCT00599755|20902015|P1|Overall Study|No data available|1
6048098|NCT00599755|20902015|P1|Overall Study|Other Reason|2
6048099|NCT00599755|20902015|P1|Overall Study|Progression of Disease|3
6048100|NCT00599755|20902015|P1|Overall Study|Withdrawal by Subject|2
6048101|NCT00599755|20902015|P1|Overall Study|Adverse Event|11
6048114|NCT00599339|20902041|P1|Overall Study|Study Termination Status Unknown|12
6048115|NCT00599339|20902041|P1|Overall Study|No valid data consent|36
6048116|NCT00599339|20902041|P1|Overall Study|Lost to Follow-up|221
6048117|NCT00599339|20902041|P1|Overall Study|Other Reason|179
6048118|NCT00599339|20902041|P1|Overall Study|Withdrawal by Subject|137
6048119|NCT00599339|20902041|P1|Overall Study|Adverse Event|79
6048120|NCT00599326|20902143|P1|Overall Study|Noncompliant|1
6048121|NCT00599326|20902143|P1|Overall Study|Lost to Follow-up|1
6048122|NCT00599313|20902148|P1|Overall Study|Ineligible|1
6048123|NCT00599313|20902148|P1|Overall Study|Patient Request|4
6048124|NCT00599313|20902148|P1|Overall Study|Disease Progression|12
6048125|NCT00599313|20902148|P1|Overall Study|Adverse Event|19
6048126|NCT00599196|20902190|P1|Overall Study|Other: Inv Switched Dopamine Agonist|1
6048127|NCT00599196|20902190|P1|Overall Study|Other: Patient Stopped Due To Moving|1
6048128|NCT00599196|20902190|P1|Overall Study|Other: Pt Moved To Australia|1
6048129|NCT00599196|20902190|P1|Overall Study|Other: Diagnosis No Longer Idiopathic Pd|1
6048130|NCT00599196|20902190|P1|Overall Study|Other: Spouse Withdrew Consent|1
6048131|NCT00599196|20902190|P1|Overall Study|Other: Patient Leaving For Israel|1
6048132|NCT00599196|20902190|P1|Overall Study|Lost to Follow-up|17
6048133|NCT00599196|20902190|P1|Overall Study|Study ended per sponsor|197
6048134|NCT00599196|20902190|P1|Overall Study|Subject withdrew consent|43
6048135|NCT00599196|20902190|P1|Overall Study|Unsatisfactory compliance of subject|3
6048136|NCT00599196|20902190|P1|Overall Study|Adverse Event|93
6048137|NCT00599196|20902190|P1|Overall Study|Lack of Efficacy|22
6048138|NCT00599027|20902221|P2|Overall Study|Treatment Failure|1
6048139|NCT00599027|20902222|P1|Overall Study|Treatment Failure|0
6048140|NCT00599027|20902221|P2|Overall Study|Adverse Event|1
6048141|NCT00599027|20902222|P1|Overall Study|Adverse Event|0
6048142|NCT00599027|20902221|P2|Overall Study|Withdrawal by Subject|1
6048143|NCT00599027|20902222|P1|Overall Study|Withdrawal by Subject|1
6048144|NCT00598871|20902235|P2|Overall Study|Adverse Event|1
6048145|NCT00598871|20902236|P1|Overall Study|Adverse Event|0
6048162|NCT00598702|20902300|P8|Overall Study|Dose limiting toxicity|0
6048163|NCT00598702|20902301|P7|Overall Study|Dose limiting toxicity|0
6048164|NCT00598702|20902302|P6|Overall Study|Dose limiting toxicity|1
6048165|NCT00598702|20902303|P5|Overall Study|Dose limiting toxicity|1
6048166|NCT00598702|20902304|P4|Overall Study|Dose limiting toxicity|1
6048167|NCT00598702|20902305|P3|Overall Study|Dose limiting toxicity|0
6048168|NCT00598702|20902306|P2|Overall Study|Dose limiting toxicity|0
6048169|NCT00598702|20902307|P1|Overall Study|Dose limiting toxicity|0
6048170|NCT00598702|20902300|P8|Overall Study|Physician Decision|0
6048171|NCT00598702|20902301|P7|Overall Study|Physician Decision|0
6048172|NCT00598702|20902302|P6|Overall Study|Physician Decision|0
6048173|NCT00598702|20902303|P5|Overall Study|Physician Decision|1
6048174|NCT00598702|20902304|P4|Overall Study|Physician Decision|0
6048175|NCT00598702|20902305|P3|Overall Study|Physician Decision|0
6048176|NCT00598702|20902306|P2|Overall Study|Physician Decision|0
6048177|NCT00598702|20902307|P1|Overall Study|Physician Decision|0
6048178|NCT00598702|20902300|P8|Overall Study|Withdrawal by Subject|0
6048179|NCT00598702|20902301|P7|Overall Study|Withdrawal by Subject|0
6048180|NCT00598702|20902302|P6|Overall Study|Withdrawal by Subject|0
6048181|NCT00598702|20902303|P5|Overall Study|Withdrawal by Subject|1
6048182|NCT00598702|20902304|P4|Overall Study|Withdrawal by Subject|1
6048183|NCT00598702|20902305|P3|Overall Study|Withdrawal by Subject|0
6048184|NCT00598702|20902306|P2|Overall Study|Withdrawal by Subject|0
6048185|NCT00598702|20902307|P1|Overall Study|Withdrawal by Subject|0
6048186|NCT00598702|20902300|P8|Overall Study|Adverse Event|0
6048187|NCT00598702|20902301|P7|Overall Study|Adverse Event|0
6048188|NCT00598702|20902302|P6|Overall Study|Adverse Event|0
6048189|NCT00598702|20902303|P5|Overall Study|Adverse Event|0
6048190|NCT00598702|20902304|P4|Overall Study|Adverse Event|1
6048191|NCT00598702|20902305|P3|Overall Study|Adverse Event|0
6048192|NCT00598702|20902306|P2|Overall Study|Adverse Event|0
6048193|NCT00598702|20902307|P1|Overall Study|Adverse Event|0
6048194|NCT00598702|20902300|P8|Overall Study|Early discharge from hospital|0
6048195|NCT00598702|20902301|P7|Overall Study|Early discharge from hospital|1
6048196|NCT00598702|20902302|P6|Overall Study|Early discharge from hospital|10
6048197|NCT00598702|20902303|P5|Overall Study|Early discharge from hospital|0
6048198|NCT00598702|20902304|P4|Overall Study|Early discharge from hospital|5
6048199|NCT00598702|20902305|P3|Overall Study|Early discharge from hospital|2
6048200|NCT00598702|20902306|P2|Overall Study|Early discharge from hospital|0
6048201|NCT00598702|20902307|P1|Overall Study|Early discharge from hospital|0
6048202|NCT00598702|20902300|P8|Overall Study|Other|0
6048203|NCT00598702|20902301|P7|Overall Study|Other|0
6048204|NCT00598702|20902302|P6|Overall Study|Other|1
6048205|NCT00598702|20902303|P5|Overall Study|Other|0
6048206|NCT00598702|20902304|P4|Overall Study|Other|0
6048207|NCT00598702|20902305|P3|Overall Study|Other|0
6048208|NCT00598702|20902306|P2|Overall Study|Other|2
6048209|NCT00598702|20902307|P1|Overall Study|Other|0
6048210|NCT00598650|20902383|P1|Overall Study|Physician Decision|2
6048211|NCT00598650|20902383|P1|Overall Study|Prohibited Concomitant Medication|2
6048212|NCT00598650|20902383|P1|Overall Study|Not eligible|1
6048213|NCT00598650|20902383|P1|Overall Study|No treatment for 3 weeks|1
6048214|NCT00598650|20902383|P1|Overall Study|Adverse Event|18
6048215|NCT00598650|20902383|P1|Overall Study|Withdrawal by Subject|3
6048216|NCT00598585|20902392|P2|Overall Study|Lost to Follow-up|0
6048217|NCT00598585|20902393|P1|Overall Study|Lost to Follow-up|1
6048218|NCT00598559|20902402|P3|Overall Study|Subject unable/unwilling to attend visit|0
6048219|NCT00598559|20902403|P2|Overall Study|Subject unable/unwilling to attend visit|7
6048220|NCT00598559|20902404|P1|Overall Study|Subject unable/unwilling to attend visit|4
6048221|NCT00598559|20902402|P3|Overall Study|Early discharge from hospital|3
6048222|NCT00598559|20902403|P2|Overall Study|Early discharge from hospital|12
6048223|NCT00598559|20902404|P1|Overall Study|Early discharge from hospital|9
6048224|NCT00598559|20902402|P3|Overall Study|Protocol Non-compliance|0
6048225|NCT00598559|20902403|P2|Overall Study|Protocol Non-compliance|0
6048226|NCT00598559|20902404|P1|Overall Study|Protocol Non-compliance|1
6048227|NCT00598559|20902402|P3|Overall Study|Withdrawal by Subject|0
6048228|NCT00598559|20902403|P2|Overall Study|Withdrawal by Subject|2
6048229|NCT00598559|20902404|P1|Overall Study|Withdrawal by Subject|2
6048230|NCT00598559|20902402|P3|Overall Study|Adverse Event|0
6048231|NCT00598559|20902403|P2|Overall Study|Adverse Event|7
6048232|NCT00598559|20902404|P1|Overall Study|Adverse Event|11
6048233|NCT00598481|20902428|P1|Treatment|Physician Decision|1
6048234|NCT00598442|20902438|P3|Overall Study|Started dialysis|0
6048235|NCT00598442|20902439|P2|Overall Study|Started dialysis|0
6048236|NCT00598442|20902440|P1|Overall Study|Started dialysis|1
6048237|NCT00598442|20902438|P3|Overall Study|Site closed by sponsor|1
6048238|NCT00598442|20902439|P2|Overall Study|Site closed by sponsor|2
6048239|NCT00598442|20902440|P1|Overall Study|Site closed by sponsor|5
6048240|NCT00598442|20902438|P3|Overall Study|Renal transplant|1
6048241|NCT00598442|20902439|P2|Overall Study|Renal transplant|0
6048242|NCT00598442|20902440|P1|Overall Study|Renal transplant|0
6048243|NCT00598442|20902438|P3|Overall Study|Relocation|0
6048244|NCT00598442|20902439|P2|Overall Study|Relocation|4
6048245|NCT00598442|20902440|P1|Overall Study|Relocation|1
6048246|NCT00598442|20902438|P3|Overall Study|Noncompliance|1
6048247|NCT00598442|20902439|P2|Overall Study|Noncompliance|2
6048248|NCT00598442|20902440|P1|Overall Study|Noncompliance|0
6048249|NCT00598442|20902438|P3|Overall Study|Withdrawal by Subject|6
6048250|NCT00598442|20902439|P2|Overall Study|Withdrawal by Subject|16
6048251|NCT00598442|20902440|P1|Overall Study|Withdrawal by Subject|8
6048252|NCT00598442|20902438|P3|Overall Study|Physician Decision|1
6048253|NCT00598442|20902439|P2|Overall Study|Physician Decision|1
6048254|NCT00598442|20902440|P1|Overall Study|Physician Decision|2
6048255|NCT00598442|20902438|P3|Overall Study|Lost to Follow-up|3
6048256|NCT00598442|20902439|P2|Overall Study|Lost to Follow-up|3
6048257|NCT00598442|20902440|P1|Overall Study|Lost to Follow-up|4
6048258|NCT00598442|20902438|P3|Overall Study|Death|11
6048259|NCT00598442|20902439|P2|Overall Study|Death|11
6048260|NCT00598442|20902440|P1|Overall Study|Death|19
6048261|NCT00598442|20902438|P3|Overall Study|Adverse Event|0
6048262|NCT00598442|20902439|P2|Overall Study|Adverse Event|0
6048263|NCT00598442|20902440|P1|Overall Study|Adverse Event|3
6048264|NCT00598273|20902457|P3|Overall Study|Started dialysis|5
6048265|NCT00598273|20902458|P2|Overall Study|Started dialysis|4
6048266|NCT00598273|20902459|P1|Overall Study|Started dialysis|6
6048267|NCT00598273|20902457|P3|Overall Study|Site elected to close|0
6048268|NCT00598273|20902458|P2|Overall Study|Site elected to close|0
6048269|NCT00598273|20902459|P1|Overall Study|Site elected to close|1
6048270|NCT00598273|20902457|P3|Overall Study|Renal transplant|1
6048271|NCT00598273|20902458|P2|Overall Study|Renal transplant|0
6048272|NCT00598273|20902459|P1|Overall Study|Renal transplant|1
6048273|NCT00598273|20902457|P3|Overall Study|Relocation|4
6048274|NCT00598273|20902458|P2|Overall Study|Relocation|2
6048275|NCT00598273|20902459|P1|Overall Study|Relocation|0
6048276|NCT00598273|20902457|P3|Overall Study|Noncompliance|3
6048277|NCT00598273|20902458|P2|Overall Study|Noncompliance|2
6048278|NCT00598273|20902459|P1|Overall Study|Noncompliance|3
6048279|NCT00598273|20902457|P3|Overall Study|Withdrawal by Subject|10
6048280|NCT00598273|20902458|P2|Overall Study|Withdrawal by Subject|10
6048281|NCT00598273|20902459|P1|Overall Study|Withdrawal by Subject|12
6048282|NCT00598273|20902457|P3|Overall Study|Physician Decision|1
6048283|NCT00598273|20902458|P2|Overall Study|Physician Decision|0
6048284|NCT00598273|20902459|P1|Overall Study|Physician Decision|0
6048285|NCT00598273|20902457|P3|Overall Study|Lost to Follow-up|5
6048286|NCT00598273|20902458|P2|Overall Study|Lost to Follow-up|3
6048287|NCT00598273|20902459|P1|Overall Study|Lost to Follow-up|8
6048288|NCT00598273|20902457|P3|Overall Study|Death|8
6048289|NCT00598273|20902458|P2|Overall Study|Death|12
6048290|NCT00598273|20902459|P1|Overall Study|Death|6
6048291|NCT00598273|20902457|P3|Overall Study|Adverse Event|2
6048292|NCT00598273|20902458|P2|Overall Study|Adverse Event|5
6048293|NCT00598273|20902459|P1|Overall Study|Adverse Event|4
6048294|NCT00598078|20902473|P2|Period 2 (Day 2)|Adverse Event|0
6048295|NCT00598078|20902474|P1|Period 2 (Day 2)|Adverse Event|1
6048296|NCT00597766|20902617|P3|Follow-up 2, Week 8|Lost to Follow-up|1
6048297|NCT00597766|20902618|P2|Follow-up 2, Week 8|Lost to Follow-up|0
6048298|NCT00597766|20902619|P1|Follow-up 2, Week 8|Lost to Follow-up|0
6048299|NCT00597766|20902617|P3|Follow-up 1, Week 4|Withdrawal by Subject|0
6048300|NCT00597766|20902618|P2|Follow-up 1, Week 4|Withdrawal by Subject|0
6048301|NCT00597766|20902619|P1|Follow-up 1, Week 4|Withdrawal by Subject|1
6048302|NCT00597753|20902638|P2|Overall Study|Site elected to close|4
6048303|NCT00597753|20902639|P1|Overall Study|Site elected to close|2
6048304|NCT00597753|20902638|P2|Overall Study|Site closed by sponsor|7
6048305|NCT00597753|20902639|P1|Overall Study|Site closed by sponsor|19
6048306|NCT00597753|20902638|P2|Overall Study|Renal transplant|3
6048307|NCT00597753|20902639|P1|Overall Study|Renal transplant|10
6048308|NCT00597753|20902638|P2|Overall Study|Relocation|6
6048309|NCT00597753|20902639|P1|Overall Study|Relocation|17
6048310|NCT00597753|20902638|P2|Overall Study|Noncompliance|1
6048311|NCT00597753|20902639|P1|Overall Study|Noncompliance|2
6048312|NCT00597753|20902638|P2|Overall Study|Never dosed|0
6048313|NCT00597753|20902639|P1|Overall Study|Never dosed|2
6048314|NCT00597753|20902638|P2|Overall Study|Discontinued Dialysis|1
6048315|NCT00597753|20902639|P1|Overall Study|Discontinued Dialysis|0
6048316|NCT00597753|20902638|P2|Overall Study|Withdrawal by Subject|12
6048317|NCT00597753|20902639|P1|Overall Study|Withdrawal by Subject|35
6048318|NCT00597753|20902638|P2|Overall Study|Pregnancy|0
6048319|NCT00597753|20902639|P1|Overall Study|Pregnancy|1
6048320|NCT00597753|20902638|P2|Overall Study|Physician Decision|1
6048321|NCT00597753|20902639|P1|Overall Study|Physician Decision|5
6048322|NCT00597753|20902638|P2|Overall Study|Lost to Follow-up|3
6048323|NCT00597753|20902639|P1|Overall Study|Lost to Follow-up|10
6048324|NCT00597753|20902638|P2|Overall Study|Lack of Efficacy|0
6048325|NCT00597753|20902639|P1|Overall Study|Lack of Efficacy|2
6048326|NCT00597753|20902638|P2|Overall Study|Death|29
6048327|NCT00597753|20902639|P1|Overall Study|Death|55
6048328|NCT00597753|20902638|P2|Overall Study|Adverse Event|2
6048329|NCT00597753|20902639|P1|Overall Study|Adverse Event|6
6048330|NCT00597714|20902673|P3|Overall Study|Recipient death|10
6048331|NCT00597714|20902674|P2|Overall Study|Recipient death|0
6048332|NCT00597714|20902675|P1|Overall Study|Recipient death|0
6048333|NCT00597714|20902673|P3|Overall Study|Death|0
6048334|NCT00597714|20902674|P2|Overall Study|Death|46
6048335|NCT00597714|20902675|P1|Overall Study|Death|56
6048336|NCT00597701|20902687|P2|Overall Study|Did not start intervention (pharmacy er)|2
6048337|NCT00597701|20902688|P1|Overall Study|Did not start intervention (pharmacy er)|0
6048338|NCT00597701|20902687|P2|Overall Study|Physician Decision|0
6048339|NCT00597701|20902688|P1|Overall Study|Physician Decision|2
6048340|NCT00597701|20902687|P2|Overall Study|Death|1
6048341|NCT00597701|20902688|P1|Overall Study|Death|0
6048342|NCT00597701|20902687|P2|Overall Study|Withdrawal by Subject|5
6048343|NCT00597701|20902688|P1|Overall Study|Withdrawal by Subject|5
6048344|NCT00597584|20902710|P2|Overall Study|Renal transplant|7
6048345|NCT00597584|20902711|P1|Overall Study|Renal transplant|9
6048346|NCT00597584|20902710|P2|Overall Study|Relocation|6
6048347|NCT00597584|20902711|P1|Overall Study|Relocation|8
6048348|NCT00597584|20902710|P2|Overall Study|Never dosed|0
6048349|NCT00597584|20902711|P1|Overall Study|Never dosed|1
6048350|NCT00597584|20902710|P2|Overall Study|Lost ability to consent|1
6048351|NCT00597584|20902711|P1|Overall Study|Lost ability to consent|1
6048352|NCT00597584|20902710|P2|Overall Study|Discontinued Dialysis|1
6048353|NCT00597584|20902711|P1|Overall Study|Discontinued Dialysis|0
6048354|NCT00597584|20902710|P2|Overall Study|Withdrawal by Subject|12
6048355|NCT00597584|20902711|P1|Overall Study|Withdrawal by Subject|44
6048356|NCT00597584|20902710|P2|Overall Study|Pregnancy|0
6048357|NCT00597584|20902711|P1|Overall Study|Pregnancy|2
6048358|NCT00597584|20902710|P2|Overall Study|Physician Decision|0
6048359|NCT00597584|20902711|P1|Overall Study|Physician Decision|3
6048360|NCT00597584|20902710|P2|Overall Study|Lost to Follow-up|4
6048361|NCT00597584|20902711|P1|Overall Study|Lost to Follow-up|2
6048362|NCT00597584|20902710|P2|Overall Study|Lack of Efficacy|0
6048363|NCT00597584|20902711|P1|Overall Study|Lack of Efficacy|1
6048364|NCT00597584|20902710|P2|Overall Study|Death|30
6048365|NCT00597584|20902711|P1|Overall Study|Death|53
6048366|NCT00597584|20902710|P2|Overall Study|Adverse Event|2
6048367|NCT00597584|20902711|P1|Overall Study|Adverse Event|4
6048368|NCT00597519|20902736|P1|Overall Study|Death|1
6048369|NCT00597506|20902740|P1|Overall Study|Subject is being followed for survival|1
6048370|NCT00597376|20902790|P2|Overall Study|Adverse Event|1
6048371|NCT00597376|20902791|P1|Overall Study|Adverse Event|4
6048372|NCT00597376|20902790|P2|Overall Study|Withdrawal by Subject|3
6048373|NCT00597376|20902791|P1|Overall Study|Withdrawal by Subject|4
6048374|NCT00597207|20902837|P2|Overall Study|Lost to Follow-up|7
6048375|NCT00597207|20902838|P1|Overall Study|Lost to Follow-up|5
6048376|NCT00597116|20902846|P2|Overall Study|Progressive disease|6
6048377|NCT00597116|20902847|P1|Overall Study|Progressive disease|11
6048378|NCT00597116|20902846|P2|Overall Study|Lost to Follow-up|0
6048379|NCT00597116|20902847|P1|Overall Study|Lost to Follow-up|1
6048380|NCT00597116|20902846|P2|Overall Study|Death|1
6048381|NCT00597116|20902847|P1|Overall Study|Death|0
6048382|NCT00597116|20902846|P2|Overall Study|Physician Decision|1
6048383|NCT00597116|20902847|P1|Overall Study|Physician Decision|0
6048384|NCT00597116|20902846|P2|Overall Study|Withdrawal by Subject|2
6048385|NCT00597116|20902847|P1|Overall Study|Withdrawal by Subject|0
6048386|NCT00597116|20902846|P2|Overall Study|Adverse Event|1
6048387|NCT00597116|20902847|P1|Overall Study|Adverse Event|2
6048388|NCT00597012|20902873|P2|Overall Study|Lost to Follow-up|2
6048389|NCT00597012|20902874|P1|Overall Study|Lost to Follow-up|0
6048390|NCT00597012|20902873|P2|Overall Study|Ineligible|0
6048391|NCT00597012|20902874|P1|Overall Study|Ineligible|2
6048392|NCT00597012|20902873|P2|Overall Study|Withdrawal by Subject|4
6048393|NCT00597012|20902874|P1|Overall Study|Withdrawal by Subject|7
6048394|NCT00597012|20902873|P2|Overall Study|Underwent Total Knee Replacement (TKR)|1
6048395|NCT00597012|20902874|P1|Overall Study|Underwent Total Knee Replacement (TKR)|3
6048396|NCT00597012|20902873|P2|Overall Study|Death|1
6048397|NCT00597012|20902874|P1|Overall Study|Death|1
6048398|NCT00596960|20902890|P2|Overall Study|No alcohol use data|1
6048399|NCT00596960|20902891|P1|Overall Study|No alcohol use data|0
6048400|NCT00596960|20902890|P2|Overall Study|Protocol Violation|1
6048401|NCT00596960|20902891|P1|Overall Study|Protocol Violation|0
6048402|NCT00596960|20902890|P2|Overall Study|Physician Decision|0
6048403|NCT00596960|20902891|P1|Overall Study|Physician Decision|1
6048404|NCT00596960|20902890|P2|Overall Study|Incarcerated|0
6048405|NCT00596960|20902891|P1|Overall Study|Incarcerated|2
6048406|NCT00596960|20902890|P2|Overall Study|Withdrawal by Subject|0
6048407|NCT00596960|20902891|P1|Overall Study|Withdrawal by Subject|1
6048408|NCT00596960|20902890|P2|Overall Study|Lost to Follow-up|5
6048409|NCT00596960|20902891|P1|Overall Study|Lost to Follow-up|6
6048410|NCT00596960|20902890|P2|Overall Study|Death|2
6048411|NCT00596960|20902891|P1|Overall Study|Death|1
6048412|NCT00596947|20902903|P2|Overall Study|Lost to Follow-up|0
6048413|NCT00596947|20902904|P1|Overall Study|Lost to Follow-up|1
6048414|NCT00596947|20902903|P2|Overall Study|study halted due to low enrollment|3
6048415|NCT00596947|20902904|P1|Overall Study|study halted due to low enrollment|5
6048416|NCT00596934|20902944|P1|Overall Study|Withdrawal by Subject|1
6048417|NCT00596934|20902944|P1|Overall Study|Protocol Violation|1
6048418|NCT00596830|20902957|P2|Overall Study|Randomized but not treated|7
6048419|NCT00596830|20902958|P1|Overall Study|Randomized but not treated|3
6048420|NCT00596830|20902957|P2|Overall Study|Follow-up was discontinued|0
6048421|NCT00596830|20902958|P1|Overall Study|Follow-up was discontinued|1
6048422|NCT00596830|20902957|P2|Overall Study|Study terminated by sponsor|62
6048423|NCT00596830|20902958|P1|Overall Study|Study terminated by sponsor|51
6048424|NCT00596830|20902957|P2|Overall Study|Withdrawal by Subject|12
6048425|NCT00596830|20902958|P1|Overall Study|Withdrawal by Subject|22
6048426|NCT00596830|20902957|P2|Overall Study|Lost to Follow-up|11
6048427|NCT00596830|20902958|P1|Overall Study|Lost to Follow-up|7
6048428|NCT00596830|20902957|P2|Overall Study|Death|247
6048429|NCT00596830|20902958|P1|Overall Study|Death|258
6048430|NCT00596817|20902984|P2|Double-blind Period|Other Reasons|18
6048431|NCT00596817|20902985|P1|Double-blind Period|Other Reasons|10
6048432|NCT00596817|20902984|P2|Double-blind Period|Lost to Follow-up|2
6048433|NCT00596817|20902985|P1|Double-blind Period|Lost to Follow-up|0
6048434|NCT00596817|20902984|P2|Double-blind Period|Withdrawal of Consent|3
6048435|NCT00596817|20902985|P1|Double-blind Period|Withdrawal of Consent|7
6048436|NCT00596817|20902984|P2|Double-blind Period|Protocol Violation|8
6048437|NCT00596817|20902985|P1|Double-blind Period|Protocol Violation|11
6048438|NCT00596817|20902984|P2|Double-blind Period|Non-compliance With Study Product|4
6048439|NCT00596817|20902985|P1|Double-blind Period|Non-compliance With Study Product|3
6048440|NCT00596817|20902984|P2|Double-blind Period|Lack of Efficacy|28
6048441|NCT00596817|20902985|P1|Double-blind Period|Lack of Efficacy|52
6048442|NCT00596817|20902984|P2|Double-blind Period|Adverse Event|16
6048443|NCT00596817|20902985|P1|Double-blind Period|Adverse Event|5
6048444|NCT00596817|20902984|P2|Open-label Period to Double-blind Period|Other Reasons|14
6048445|NCT00596817|20902985|P1|Open-label Period to Double-blind Period|Other Reasons|0
6048446|NCT00596817|20902984|P2|Open-label Period to Double-blind Period|Not Eligible|49
6048447|NCT00596817|20902985|P1|Open-label Period to Double-blind Period|Not Eligible|0
6048448|NCT00596817|20902984|P2|Open-label Period to Double-blind Period|Lack of Efficacy|24
6048449|NCT00596817|20902985|P1|Open-label Period to Double-blind Period|Lack of Efficacy|0
6048450|NCT00596817|20902984|P2|Open-label Period to Double-blind Period|Adverse Event|5
6048451|NCT00596817|20902985|P1|Open-label Period to Double-blind Period|Adverse Event|0
6048452|NCT00596817|20902984|P2|Open-label Period|Other Reasons|65
6048453|NCT00596817|20902985|P1|Open-label Period|Other Reasons|0
6048454|NCT00596817|20902984|P2|Open-label Period|Lack of Efficacy|33
6048455|NCT00596817|20902985|P1|Open-label Period|Lack of Efficacy|0
6048456|NCT00596817|20902984|P2|Open-label Period|Adverse Event|49
6048457|NCT00596817|20902985|P1|Open-label Period|Adverse Event|0
6048458|NCT00596752|20903010|P2|Overall Study|Protocol Violation|0
6048459|NCT00596752|20903011|P1|Overall Study|Protocol Violation|1
6048460|NCT00596752|20903010|P2|Overall Study|Lack of Efficacy|7
6048461|NCT00596752|20903011|P1|Overall Study|Lack of Efficacy|4
6048462|NCT00596752|20903010|P2|Overall Study|Unsatisfactory Compliance|6
6048463|NCT00596752|20903011|P1|Overall Study|Unsatisfactory Compliance|9
6048464|NCT00596752|20903010|P2|Overall Study|Withdrawal by Subject|9
6048465|NCT00596752|20903011|P1|Overall Study|Withdrawal by Subject|12
6048466|NCT00596752|20903010|P2|Overall Study|Lost to Follow-up|38
6048467|NCT00596752|20903011|P1|Overall Study|Lost to Follow-up|22
6048468|NCT00596752|20903010|P2|Overall Study|Adverse Event|34
6048469|NCT00596752|20903011|P1|Overall Study|Adverse Event|34
6048470|NCT00596752|20903010|P2|Overall Study|Other Reason|49
6048471|NCT00596752|20903011|P1|Overall Study|Other Reason|44
6048472|NCT00596687|20903041|P2|Overall Study|cancelled surgery|1
6048473|NCT00596687|20903042|P1|Overall Study|cancelled surgery|1
6048474|NCT00596687|20903041|P2|Overall Study|Withdrawal by Subject|1
6048475|NCT00596687|20903042|P1|Overall Study|Withdrawal by Subject|3
6048476|NCT00596687|20903041|P2|Overall Study|continuous insulin infusion during TPN|1
6048477|NCT00596687|20903042|P1|Overall Study|continuous insulin infusion during TPN|2
6048478|NCT00596687|20903041|P2|Overall Study|< 24 hours of insulin treatment|6
6048479|NCT00596687|20903042|P1|Overall Study|< 24 hours of insulin treatment|8
6048480|NCT00596635|20903053|P3|Overall Study|Could not provide urine specimen|2
6048481|NCT00596635|20903054|P2|Overall Study|Could not provide urine specimen|2
6048482|NCT00596635|20903055|P1|Overall Study|Could not provide urine specimen|1
6048483|NCT00596635|20903053|P3|Overall Study|Hip fracture|3
6048484|NCT00596635|20903054|P2|Overall Study|Hip fracture|3
6048485|NCT00596635|20903055|P1|Overall Study|Hip fracture|2
6048486|NCT00596635|20903053|P3|Overall Study|Treatment for symptomatic UTI|3
6048487|NCT00596635|20903054|P2|Overall Study|Treatment for symptomatic UTI|6
6048488|NCT00596635|20903055|P1|Overall Study|Treatment for symptomatic UTI|4
6048489|NCT00596635|20903053|P3|Overall Study|Lost to Follow-up|0
6048490|NCT00596635|20903054|P2|Overall Study|Lost to Follow-up|2
6048491|NCT00596635|20903055|P1|Overall Study|Lost to Follow-up|0
6048492|NCT00596466|20903081|P1|Overall Study|Enrolled, not treated|2
6048493|NCT00596466|20903081|P1|Overall Study|Unpecified|2
6048494|NCT00596466|20903081|P1|Overall Study|Protocol Violation|2
6048495|NCT00596466|20903081|P1|Overall Study|Withdrawal by Subject|2
6048496|NCT00596466|20903081|P1|Overall Study|Adverse Event|4
6048497|NCT00596466|20903081|P1|Overall Study|Lack of Efficacy|5
6048498|NCT00596427|20903111|P2|Overall Study|Protocol Violation|0
6048499|NCT00596427|20903112|P1|Overall Study|Protocol Violation|1
6048500|NCT00596427|20903111|P2|Overall Study|Increased Fasting Triacylglycerol level|0
6048501|NCT00596427|20903112|P1|Overall Study|Increased Fasting Triacylglycerol level|1
6048502|NCT00596427|20903111|P2|Overall Study|Withdrawal by Subject|2
6048503|NCT00596427|20903112|P1|Overall Study|Withdrawal by Subject|2
6048504|NCT00596362|20903140|P1|Overall Study|Progressive Disease|1
6048505|NCT00596011|20903176|P2|Overall Study|Adverse Event|7
6048506|NCT00596011|20903177|P1|Overall Study|Adverse Event|11
6048507|NCT00596011|20903176|P2|Overall Study|Withdrawal by Subject|3
6048508|NCT00596011|20903177|P1|Overall Study|Withdrawal by Subject|2
6048509|NCT00595959|20903193|P1|Overall Study|Lost to Follow-up|1
6048510|NCT00595959|20903193|P1|Overall Study|Withdrawal by Subject|1
6048511|NCT00595920|20903227|P1|Overall Study|The OLTERMS study was discontinued by th|116
6048512|NCT00595868|20903238|P2|Overall Study|Lost to Follow-up|50
6048513|NCT00595868|20903239|P1|Overall Study|Lost to Follow-up|45
6048514|NCT00595764|20903262|P2|Overall Study|Withdrawal by Subject|0
6048515|NCT00595764|20903263|P1|Overall Study|Withdrawal by Subject|4
6048516|NCT00595764|20903262|P2|Overall Study|Missed 3 PM visits|7
6048517|NCT00595764|20903263|P1|Overall Study|Missed 3 PM visits|1
6048518|NCT00595764|20903262|P2|Overall Study|Missed Medication >1 week|17
6048519|NCT00595764|20903263|P1|Overall Study|Missed Medication >1 week|10
6048520|NCT00595764|20903262|P2|Overall Study|Protocol Violation|19
6048521|NCT00595764|20903263|P1|Overall Study|Protocol Violation|24
6048522|NCT00595621|20903279|P2|Randomization and Study|Withdrawal by Subject|1
6048523|NCT00595621|20903280|P1|Randomization and Study|Withdrawal by Subject|0
6048524|NCT00595621|20903279|P2|Randomization and Study|Adverse Event|0
6048525|NCT00595621|20903280|P1|Randomization and Study|Adverse Event|2
6048526|NCT00595621|20903279|P2|Open Label Run in|Withdrawal by Subject|0
6048527|NCT00595621|20903280|P1|Open Label Run in|Withdrawal by Subject|1
6048528|NCT00595621|20903279|P2|Open Label Run in|Physician Decision|0
6048529|NCT00595621|20903280|P1|Open Label Run in|Physician Decision|1
6048530|NCT00595621|20903279|P2|Open Label Run in|Adverse Event|0
6048531|NCT00595621|20903280|P1|Open Label Run in|Adverse Event|1
6048532|NCT00595582|20903297|P1|Overall Study|Physician Decision|5
6048533|NCT00595582|20903297|P1|Overall Study|Adverse Event|2
6048534|NCT00595582|20903297|P1|Overall Study|Lost to Follow-up|1
6048535|NCT00595582|20903297|P1|Overall Study|Pilot study that PI terminated|2
6048536|NCT00595517|20903323|P1|Overall Study|No intention to attend regularly|1
6048537|NCT00595517|20903323|P1|Overall Study|usage of prohibited treatment|1
6048538|NCT00595517|20903323|P1|Overall Study|Recurrence of ulcer|5
6048539|NCT00595517|20903323|P1|Overall Study|Protocol Violation|2
6048540|NCT00595517|20903323|P1|Overall Study|Withdrawal by Subject|4
6048541|NCT00595517|20903323|P1|Overall Study|Adverse Event|6
6048542|NCT00595504|20903332|P2|Overall Study|Physician Decision|0
6048543|NCT00595504|20903333|P1|Overall Study|Physician Decision|1
6048544|NCT00595504|20903332|P2|Overall Study|Withdrawal by Subject|3
6048545|NCT00595504|20903333|P1|Overall Study|Withdrawal by Subject|1
6048546|NCT00595478|20903345|P2|36-week Follow-up Period|Withdrawal by Subject|4
6048547|NCT00595478|20903346|P1|36-week Follow-up Period|Withdrawal by Subject|4
6048548|NCT00595478|20903345|P2|36-week Follow-up Period|Lost to Follow-up|4
6048549|NCT00595478|20903346|P1|36-week Follow-up Period|Lost to Follow-up|5
6048550|NCT00595465|20903357|P3|Overall Study|administrative reason|1
6048551|NCT00595465|20903358|P2|Overall Study|administrative reason|0
6048552|NCT00595465|20903359|P1|Overall Study|administrative reason|0
6048553|NCT00595465|20903357|P3|Overall Study|Lost to Follow-up|2
6048554|NCT00595465|20903358|P2|Overall Study|Lost to Follow-up|0
6048555|NCT00595465|20903359|P1|Overall Study|Lost to Follow-up|0
6048556|NCT00595465|20903357|P3|Overall Study|Protocol Violation|0
6048557|NCT00595465|20903358|P2|Overall Study|Protocol Violation|1
6048558|NCT00595465|20903359|P1|Overall Study|Protocol Violation|2
6048559|NCT00595465|20903357|P3|Overall Study|Pregnancy|1
6048560|NCT00595465|20903358|P2|Overall Study|Pregnancy|0
6048561|NCT00595465|20903359|P1|Overall Study|Pregnancy|0
6048562|NCT00595465|20903357|P3|Overall Study|Adverse Event|3
6048563|NCT00595465|20903358|P2|Overall Study|Adverse Event|3
6048564|NCT00595465|20903359|P1|Overall Study|Adverse Event|4
6048565|NCT00595413|20903371|P4|Overall Study|Other|0
6048566|NCT00595413|20903372|P3|Overall Study|Other|5
6048567|NCT00595413|20903373|P2|Overall Study|Other|1
6048568|NCT00595413|20903374|P1|Overall Study|Other|5
6048569|NCT00595413|20903371|P4|Overall Study|Death|0
6048570|NCT00595413|20903372|P3|Overall Study|Death|1
6048571|NCT00595413|20903373|P2|Overall Study|Death|0
6048572|NCT00595413|20903374|P1|Overall Study|Death|0
6048573|NCT00595413|20903371|P4|Overall Study|Lost to Follow-up|3
6048574|NCT00595413|20903372|P3|Overall Study|Lost to Follow-up|1
6048575|NCT00595413|20903373|P2|Overall Study|Lost to Follow-up|2
6048576|NCT00595413|20903374|P1|Overall Study|Lost to Follow-up|2
6048577|NCT00595413|20903371|P4|Overall Study|Adverse Event|1
6048578|NCT00595413|20903372|P3|Overall Study|Adverse Event|1
6048579|NCT00595413|20903373|P2|Overall Study|Adverse Event|2
6048580|NCT00595413|20903374|P1|Overall Study|Adverse Event|0
6048581|NCT00595335|20903415|P2|Six Months to Twelve Months|Disease Progression|0
6048582|NCT00595335|20903416|P1|Six Months to Twelve Months|Disease Progression|1
6048583|NCT00595335|20903415|P2|Six Months to Twelve Months|Withdrawal by Subject|1
6048584|NCT00595335|20903416|P1|Six Months to Twelve Months|Withdrawal by Subject|0
6048585|NCT00595335|20903415|P2|Baseline to Six Months|Adverse Event|0
6048586|NCT00595335|20903416|P1|Baseline to Six Months|Adverse Event|1
6048587|NCT00595335|20903415|P2|Baseline to Six Months|Disease Progression|1
6048588|NCT00595335|20903416|P1|Baseline to Six Months|Disease Progression|1
6048589|NCT00595335|20903415|P2|Baseline to Six Months|Withdrawal by Subject|1
6048590|NCT00595335|20903416|P1|Baseline to Six Months|Withdrawal by Subject|0
6048591|NCT00595309|20903436|P1|Overall Study|personal reason|1
6048592|NCT00595309|20903436|P1|Overall Study|acute infection after V0|1
6048593|NCT00595309|20903436|P1|Overall Study|planned vaccination against yellow fever|1
6048594|NCT00595309|20903436|P1|Overall Study|Lost to Follow-up|1
6048595|NCT00595127|20903485|P1|Overall Study|joined another trial|1
6048596|NCT00595127|20903485|P1|Overall Study|Relapsed|3
6048597|NCT00595127|20903485|P1|Overall Study|Death|6
6048598|NCT00595075|20903531|P2|Overall Study|Withdrawal by Subject|0
6048599|NCT00595075|20903532|P1|Overall Study|Withdrawal by Subject|1
6048600|NCT00594958|20903553|P3|Overall Study|administrative|2
6048601|NCT00594958|20903554|P2|Overall Study|administrative|0
6048602|NCT00594958|20903555|P1|Overall Study|administrative|3
6048603|NCT00594958|20903553|P3|Overall Study|Lost to Follow-up|3
6048604|NCT00594958|20903554|P2|Overall Study|Lost to Follow-up|0
6048605|NCT00594958|20903555|P1|Overall Study|Lost to Follow-up|5
6048606|NCT00594958|20903553|P3|Overall Study|Protocol Violation|2
6048607|NCT00594958|20903554|P2|Overall Study|Protocol Violation|0
6048608|NCT00594958|20903555|P1|Overall Study|Protocol Violation|1
6048609|NCT00594958|20903553|P3|Overall Study|Pregnancy|0
6048610|NCT00594958|20903554|P2|Overall Study|Pregnancy|2
6048611|NCT00594958|20903555|P1|Overall Study|Pregnancy|0
6048612|NCT00594958|20903553|P3|Overall Study|Adverse Event|2
6048613|NCT00594958|20903554|P2|Overall Study|Adverse Event|1
6048614|NCT00594958|20903555|P1|Overall Study|Adverse Event|4
6048615|NCT00594958|20903553|P3|Overall Study|Withdrawal by Subject|1
6048616|NCT00594958|20903554|P2|Overall Study|Withdrawal by Subject|0
6048617|NCT00594958|20903555|P1|Overall Study|Withdrawal by Subject|1
6048618|NCT00594932|20903576|P2|Final 3 Months|Withdrawal by Subject|3
6048619|NCT00594932|20903577|P1|Final 3 Months|Withdrawal by Subject|4
6048620|NCT00594932|20903576|P2|First 3 Months|Withdrawal by Subject|3
6048621|NCT00594932|20903577|P1|First 3 Months|Withdrawal by Subject|1
6048622|NCT00594906|20903589|P2|Overall Study|Death|1
6048623|NCT00594906|20903590|P1|Overall Study|Death|0
6048624|NCT00594906|20903589|P2|Overall Study|Physician Decision|1
6048625|NCT00594906|20903590|P1|Overall Study|Physician Decision|0
6048626|NCT00594906|20903589|P2|Overall Study|Physician Decision|0
6048627|NCT00594906|20903590|P1|Overall Study|Physician Decision|1
6048628|NCT00594880|20903598|P2|Overall Study|Lost to Follow-up|0
6048629|NCT00594880|20903599|P1|Overall Study|Lost to Follow-up|1
6048630|NCT00594880|20903598|P2|Overall Study|Withdrawal by Subject|1
6048631|NCT00594880|20903599|P1|Overall Study|Withdrawal by Subject|1
6048632|NCT00594854|20903611|P2|Overall Study|Study terminated|10
6048633|NCT00594854|20903612|P1|Overall Study|Study terminated|7
6048634|NCT00594815|20903622|P1|Overall Study|Toxicity|4
6048635|NCT00594815|20903622|P1|Overall Study|Withdrawal by Subject|2
6048636|NCT00594815|20903622|P1|Overall Study|Never Treated|3
6048637|NCT00594659|20903647|P3|Overall Study|Lost to Follow-up|7
6048638|NCT00594659|20903648|P2|Overall Study|Lost to Follow-up|9
6048639|NCT00594659|20903649|P1|Overall Study|Lost to Follow-up|13
6048640|NCT00594646|20903660|P1|Overall Study|Lost to Follow-up|15
6048641|NCT00594646|20903660|P1|Overall Study|Withdrawal by Subject|1
6048642|NCT00594568|20903668|P3|Safety Follow Up (SFU)-Optional|No safety visit or follow up|18
6048643|NCT00594568|20903669|P2|Safety Follow Up (SFU)-Optional|No safety visit or follow up|22
6048644|NCT00594568|20903670|P1|Safety Follow Up (SFU)-Optional|No safety visit or follow up|25
6048645|NCT00594568|20903668|P3|Safety Follow Up (SFU)-Optional|Caregiver Decision|9
6048646|NCT00594568|20903669|P2|Safety Follow Up (SFU)-Optional|Caregiver Decision|16
6048888|NCT00593554|20904489|P2|Overall Study|Physician Decision|1
6048647|NCT00594568|20903670|P1|Safety Follow Up (SFU)-Optional|Caregiver Decision|17
6048648|NCT00594568|20903668|P3|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2
6048649|NCT00594568|20903669|P2|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1
6048650|NCT00594568|20903670|P1|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2
6048651|NCT00594568|20903668|P3|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|13
6048652|NCT00594568|20903669|P2|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|15
6048653|NCT00594568|20903670|P1|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|12
6048654|NCT00594568|20903668|P3|Safety Follow Up (SFU)-Optional|Adverse Event|0
6048655|NCT00594568|20903669|P2|Safety Follow Up (SFU)-Optional|Adverse Event|0
6048656|NCT00594568|20903670|P1|Safety Follow Up (SFU)-Optional|Adverse Event|5
6048657|NCT00594568|20903668|P3|Safety Follow Up (SFU)-Optional|Death|0
6048658|NCT00594568|20903669|P2|Safety Follow Up (SFU)-Optional|Death|1
6048659|NCT00594568|20903670|P1|Safety Follow Up (SFU)-Optional|Death|0
6048660|NCT00594568|20903668|P3|Delayed Start|Sponsor Decision|59
6048661|NCT00594568|20903669|P2|Delayed Start|Sponsor Decision|66
6048662|NCT00594568|20903670|P1|Delayed Start|Sponsor Decision|77
6048663|NCT00594568|20903668|P3|Delayed Start|Caregiver Decision|2
6048664|NCT00594568|20903669|P2|Delayed Start|Caregiver Decision|6
6048665|NCT00594568|20903670|P1|Delayed Start|Caregiver Decision|5
6048666|NCT00594568|20903668|P3|Delayed Start|Lost to Follow-up|1
6048667|NCT00594568|20903669|P2|Delayed Start|Lost to Follow-up|0
6048668|NCT00594568|20903670|P1|Delayed Start|Lost to Follow-up|0
6048669|NCT00594568|20903668|P3|Delayed Start|Physician Decision|1
6048670|NCT00594568|20903669|P2|Delayed Start|Physician Decision|0
6048671|NCT00594568|20903670|P1|Delayed Start|Physician Decision|0
6048672|NCT00594568|20903668|P3|Delayed Start|Withdrawal by Subject|0
6048673|NCT00594568|20903669|P2|Delayed Start|Withdrawal by Subject|3
6048674|NCT00594568|20903670|P1|Delayed Start|Withdrawal by Subject|4
6048675|NCT00594568|20903668|P3|Delayed Start|Adverse Event|2
6048676|NCT00594568|20903669|P2|Delayed Start|Adverse Event|2
6048677|NCT00594568|20903670|P1|Delayed Start|Adverse Event|12
6048678|NCT00594568|20903668|P3|Delayed Start|Death|1
6048679|NCT00594568|20903669|P2|Delayed Start|Death|0
6048680|NCT00594568|20903670|P1|Delayed Start|Death|0
6048681|NCT00594568|20903668|P3|Initial Treatment|Entry criteria exclusion|1
6048682|NCT00594568|20903669|P2|Initial Treatment|Entry criteria exclusion|1
6048683|NCT00594568|20903670|P1|Initial Treatment|Entry criteria exclusion|0
6048684|NCT00594568|20903668|P3|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|6
6048685|NCT00594568|20903669|P2|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7
6048686|NCT00594568|20903670|P1|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7
6048687|NCT00594568|20903668|P3|Initial Treatment|Caregiver decision|36
6048688|NCT00594568|20903669|P2|Initial Treatment|Caregiver decision|36
6048689|NCT00594568|20903670|P1|Initial Treatment|Caregiver decision|21
6048690|NCT00594568|20903668|P3|Initial Treatment|Sponsor decision|147
6048691|NCT00594568|20903669|P2|Initial Treatment|Sponsor decision|142
6048692|NCT00594568|20903670|P1|Initial Treatment|Sponsor decision|193
6048693|NCT00594568|20903668|P3|Initial Treatment|Withdrawal by Subject|46
6048694|NCT00594568|20903669|P2|Initial Treatment|Withdrawal by Subject|31
6048695|NCT00594568|20903670|P1|Initial Treatment|Withdrawal by Subject|25
6048696|NCT00594568|20903668|P3|Initial Treatment|Protocol Violation|5
6048697|NCT00594568|20903669|P2|Initial Treatment|Protocol Violation|2
6048698|NCT00594568|20903670|P1|Initial Treatment|Protocol Violation|2
6048699|NCT00594568|20903668|P3|Initial Treatment|Physician Decision|4
6048700|NCT00594568|20903669|P2|Initial Treatment|Physician Decision|2
6048701|NCT00594568|20903670|P1|Initial Treatment|Physician Decision|3
6048702|NCT00594568|20903668|P3|Initial Treatment|Lost to Follow-up|4
6048703|NCT00594568|20903669|P2|Initial Treatment|Lost to Follow-up|1
6048704|NCT00594568|20903670|P1|Initial Treatment|Lost to Follow-up|4
6048705|NCT00594568|20903668|P3|Initial Treatment|Death|15
6048706|NCT00594568|20903669|P2|Initial Treatment|Death|11
6048707|NCT00594568|20903670|P1|Initial Treatment|Death|6
6048708|NCT00594568|20903668|P3|Initial Treatment|Adverse Event|144
6048709|NCT00594568|20903669|P2|Initial Treatment|Adverse Event|121
6048710|NCT00594568|20903670|P1|Initial Treatment|Adverse Event|51
6048711|NCT00594516|20903758|P3|DB: Tapentadol IR to ER & ER to IR|Adverse Event|2
6048712|NCT00594516|20903759|P2|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0
6048713|NCT00594516|20903760|P1|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0
6048714|NCT00594516|20903758|P3|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1
6048715|NCT00594516|20903759|P2|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1
6048716|NCT00594516|20903760|P1|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|0
6048717|NCT00594516|20903758|P3|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|2
6048718|NCT00594516|20903759|P2|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|3
6048719|NCT00594516|20903760|P1|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|0
6048720|NCT00594516|20903758|P3|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3
6048721|NCT00594516|20903759|P2|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3
6048722|NCT00594516|20903760|P1|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|0
6048723|NCT00594516|20903758|P3|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0
6048724|NCT00594516|20903759|P2|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0
6048725|NCT00594516|20903760|P1|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|6
6048726|NCT00594516|20903758|P3|Open Label (OL): Tapentadol IR|Lack of Efficacy|0
6048727|NCT00594516|20903759|P2|Open Label (OL): Tapentadol IR|Lack of Efficacy|0
6048728|NCT00594516|20903760|P1|Open Label (OL): Tapentadol IR|Lack of Efficacy|1
6048729|NCT00594516|20903758|P3|Open Label (OL): Tapentadol IR|Adverse Event|0
6048730|NCT00594516|20903759|P2|Open Label (OL): Tapentadol IR|Adverse Event|0
6048731|NCT00594516|20903760|P1|Open Label (OL): Tapentadol IR|Adverse Event|16
6048732|NCT00594516|20903758|P3|Open Label (OL): Tapentadol IR|Lost to Follow-up|0
6048733|NCT00594516|20903759|P2|Open Label (OL): Tapentadol IR|Lost to Follow-up|0
6048734|NCT00594516|20903760|P1|Open Label (OL): Tapentadol IR|Lost to Follow-up|2
6048735|NCT00594516|20903758|P3|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0
6048736|NCT00594516|20903759|P2|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0
6048737|NCT00594516|20903760|P1|Open Label (OL): Tapentadol IR|Withdrawal by Subject|4
6048738|NCT00594464|20903768|P1|Overall Study|Delay in operation|2
6048739|NCT00594464|20903768|P1|Overall Study|Withdrawal by Subject|1
6048740|NCT00594399|20903897|P3|Rerandomization Arm 1 Only|Withdrawal by Subject|0
6048741|NCT00594399|20903898|P2|Rerandomization Arm 1 Only|Withdrawal by Subject|3
6048742|NCT00594399|20903899|P1|Rerandomization Arm 1 Only|Withdrawal by Subject|0
6048743|NCT00594399|20903897|P3|Rerandomization Arm 1 Only|Death|0
6048744|NCT00594399|20903898|P2|Rerandomization Arm 1 Only|Death|1
6048745|NCT00594399|20903899|P1|Rerandomization Arm 1 Only|Death|2
6048746|NCT00594399|20903897|P3|Initial 3 Month Counseling|Family illness|0
6048747|NCT00594399|20903898|P2|Initial 3 Month Counseling|Family illness|0
6048748|NCT00594399|20903899|P1|Initial 3 Month Counseling|Family illness|1
6048749|NCT00594399|20903897|P3|Initial 3 Month Counseling|Moved|0
6048750|NCT00594399|20903898|P2|Initial 3 Month Counseling|Moved|0
6048751|NCT00594399|20903899|P1|Initial 3 Month Counseling|Moved|1
6048752|NCT00594399|20903897|P3|Initial 3 Month Counseling|Pain|0
6048753|NCT00594399|20903898|P2|Initial 3 Month Counseling|Pain|0
6048754|NCT00594399|20903899|P1|Initial 3 Month Counseling|Pain|2
6048755|NCT00594399|20903897|P3|Initial 3 Month Counseling|Too busy|0
6048756|NCT00594399|20903898|P2|Initial 3 Month Counseling|Too busy|1
6048757|NCT00594399|20903899|P1|Initial 3 Month Counseling|Too busy|7
6048758|NCT00594399|20903897|P3|Initial 3 Month Counseling|Personal issues|0
6048759|NCT00594399|20903898|P2|Initial 3 Month Counseling|Personal issues|0
6048760|NCT00594399|20903899|P1|Initial 3 Month Counseling|Personal issues|2
6048761|NCT00594399|20903897|P3|Initial 3 Month Counseling|Lack of Interest|0
6048762|NCT00594399|20903898|P2|Initial 3 Month Counseling|Lack of Interest|3
6048763|NCT00594399|20903899|P1|Initial 3 Month Counseling|Lack of Interest|3
6048764|NCT00594399|20903897|P3|Initial 3 Month Counseling|Not ready to exercise|0
6048765|NCT00594399|20903898|P2|Initial 3 Month Counseling|Not ready to exercise|0
6048766|NCT00594399|20903899|P1|Initial 3 Month Counseling|Not ready to exercise|1
6048767|NCT00594386|20903921|P1|Overall Study|Other: Loss of drivers license|1
6048768|NCT00594386|20903921|P1|Overall Study|Other: Patient wants prescription Neupro|1
6048769|NCT00594386|20903921|P1|Overall Study|Other: Site terminated participation|1
6048770|NCT00594386|20903921|P1|Overall Study|Other: Sponsor closure of study|1
6048771|NCT00594386|20903921|P1|Overall Study|Other: Study terminated per investigator|2
6048772|NCT00594386|20903921|P1|Overall Study|Other: Subject admitted to nursing home|1
6048773|NCT00594386|20903921|P1|Overall Study|Other: Subject moved to Seattle|1
6048774|NCT00594386|20903921|P1|Overall Study|Other: Patient went off patch (hospital)|1
6048775|NCT00594386|20903921|P1|Overall Study|Lost to Follow-up|6
6048776|NCT00594386|20903921|P1|Overall Study|Study ended per sponsor|115
6048777|NCT00594386|20903921|P1|Overall Study|Subject withdrew consent|35
6048778|NCT00594386|20903921|P1|Overall Study|Unsatisfactory compliance of subject|11
6048779|NCT00594386|20903921|P1|Overall Study|Adverse Event|68
6048780|NCT00594386|20903921|P1|Overall Study|Lack of Efficacy|12
6048781|NCT00594386|20903921|P1|Overall Study|Major protocol violation|2
6048782|NCT00594204|20903954|P2|Overall Study|Randomized but not treated|1
6048783|NCT00594204|20903955|P1|Overall Study|Randomized but not treated|4
6048784|NCT00594204|20903954|P2|Overall Study|Lack of Efficacy|4
6048785|NCT00594204|20903955|P1|Overall Study|Lack of Efficacy|3
6048786|NCT00594204|20903954|P2|Overall Study|Other|3
6048787|NCT00594204|20903955|P1|Overall Study|Other|4
6048788|NCT00594204|20903954|P2|Overall Study|Withdrawal by Subject|29
6048789|NCT00594204|20903955|P1|Overall Study|Withdrawal by Subject|23
6048790|NCT00594204|20903954|P2|Overall Study|Lost to Follow-up|5
6048791|NCT00594204|20903955|P1|Overall Study|Lost to Follow-up|9
6048792|NCT00594204|20903954|P2|Overall Study|Adverse Event|3
6048793|NCT00594204|20903955|P1|Overall Study|Adverse Event|15
6048794|NCT00594178|20903965|P1|Overall Study|Physician Decision|5
6048795|NCT00594165|20903970|P1|Overall Study|Other: Site terminated participation|2
6048796|NCT00594165|20903970|P1|Overall Study|Other: Subject enrolled in other trial|1
6048797|NCT00594165|20903970|P1|Overall Study|Other: House bound; can't get to clinic|1
6048798|NCT00594165|20903970|P1|Overall Study|Other: Brain surgery controlled symptoms|1
6048799|NCT00594165|20903970|P1|Overall Study|Other: Subject moving|3
6048800|NCT00594165|20903970|P1|Overall Study|Other: PI discretion|5
6048801|NCT00594165|20903970|P1|Overall Study|Lost to Follow-up|4
6048802|NCT00594165|20903970|P1|Overall Study|Study ended per sponsor|102
6048803|NCT00594165|20903970|P1|Overall Study|Subject withdrew consent|27
6048804|NCT00594165|20903970|P1|Overall Study|Unsatisfactory compliance of subject|6
6048805|NCT00594165|20903970|P1|Overall Study|Adverse Event|52
6048806|NCT00594165|20903970|P1|Overall Study|Lack of Efficacy|12
6048807|NCT00594165|20903970|P1|Overall Study|Major protocol violation|1
6048808|NCT00594100|20903976|P1|Follow-up Through 30 Days Post Procedure|Missed Visit - Phone Contact Follow-up|4
6048889|NCT00593554|20904490|P1|Overall Study|Physician Decision|0
6048809|NCT00594100|20903976|P1|Follow-up Through 30 Days Post Procedure|Discontinued Prior to Visit|6
6048810|NCT00594100|20903976|P1|Follow-up Through 30 Days Post Procedure|Death / Reintervention / Medical Reasons|2
6048811|NCT00594100|20903976|P1|Procedure|Technical Failure|9
6048812|NCT00594035|20903992|P2|Overall Study|Subject couldn't return due to job|1
6048813|NCT00594035|20903993|P1|Overall Study|Subject couldn't return due to job|0
6048814|NCT00594035|20903992|P2|Overall Study|Subject transferred to nursing home|1
6048815|NCT00594035|20903993|P1|Overall Study|Subject transferred to nursing home|0
6048816|NCT00594035|20903992|P2|Overall Study|Withdrawal by Subject|0
6048817|NCT00594035|20903993|P1|Overall Study|Withdrawal by Subject|1
6048818|NCT00594035|20903992|P2|Overall Study|Lost to Follow-up|1
6048819|NCT00594035|20903993|P1|Overall Study|Lost to Follow-up|1
6048820|NCT00593957|20904023|P3|Overall Study|Physician Decision|2
6048821|NCT00593957|20904024|P2|Overall Study|Physician Decision|1
6048822|NCT00593957|20904025|P1|Overall Study|Physician Decision|0
6048823|NCT00593918|20904049|P2|Overall Study|Withdrawal by Subject|24
6048824|NCT00593918|20904050|P1|Overall Study|Withdrawal by Subject|5
6048825|NCT00593840|20904063|P1|Overall Study|Withdrawal by Subject|1
6048826|NCT00593827|20904075|P2|Overall Study|On Active Treatment/Pending|2
6048827|NCT00593827|20904076|P1|Overall Study|On Active Treatment/Pending|0
6048828|NCT00593814|20904100|P2|Overall Study|Physician Decision|0
6048829|NCT00593814|20904101|P1|Overall Study|Physician Decision|3
6048830|NCT00593814|20904100|P2|Overall Study|Lost to Follow-up|0
6048831|NCT00593814|20904101|P1|Overall Study|Lost to Follow-up|7
6048832|NCT00593814|20904100|P2|Overall Study|Withdrawal by Subject|0
6048833|NCT00593814|20904101|P1|Overall Study|Withdrawal by Subject|7
6048834|NCT00593814|20904100|P2|Overall Study|Death|0
6048835|NCT00593814|20904101|P1|Overall Study|Death|7
6048836|NCT00593736|20904113|P4|Treatment Period and Placebo Run-out|Various|0
6048837|NCT00593736|20904114|P3|Treatment Period and Placebo Run-out|Various|1
6048838|NCT00593736|20904115|P2|Treatment Period and Placebo Run-out|Various|1
6048839|NCT00593736|20904116|P1|Treatment Period and Placebo Run-out|Various|1
6048840|NCT00593736|20904113|P4|Treatment Period and Placebo Run-out|Withdrawal by Subject|3
6048841|NCT00593736|20904114|P3|Treatment Period and Placebo Run-out|Withdrawal by Subject|1
6048842|NCT00593736|20904115|P2|Treatment Period and Placebo Run-out|Withdrawal by Subject|0
6048843|NCT00593736|20904116|P1|Treatment Period and Placebo Run-out|Withdrawal by Subject|0
6048844|NCT00593736|20904113|P4|Treatment Period and Placebo Run-out|Protocol Violation|1
6048845|NCT00593736|20904114|P3|Treatment Period and Placebo Run-out|Protocol Violation|1
6048846|NCT00593736|20904115|P2|Treatment Period and Placebo Run-out|Protocol Violation|0
6048847|NCT00593736|20904116|P1|Treatment Period and Placebo Run-out|Protocol Violation|0
6048848|NCT00593736|20904113|P4|Treatment Period and Placebo Run-out|Lost to Follow-up|0
6048849|NCT00593736|20904114|P3|Treatment Period and Placebo Run-out|Lost to Follow-up|2
6048850|NCT00593736|20904115|P2|Treatment Period and Placebo Run-out|Lost to Follow-up|1
6048851|NCT00593736|20904116|P1|Treatment Period and Placebo Run-out|Lost to Follow-up|2
6048852|NCT00593736|20904113|P4|Screening Period and Placebo Run-in|Various|25
6048853|NCT00593736|20904114|P3|Screening Period and Placebo Run-in|Various|0
6048854|NCT00593736|20904115|P2|Screening Period and Placebo Run-in|Various|0
6048855|NCT00593736|20904116|P1|Screening Period and Placebo Run-in|Various|0
6048856|NCT00593736|20904113|P4|Screening Period and Placebo Run-in|Did Not Meet Criteria|322
6048857|NCT00593736|20904114|P3|Screening Period and Placebo Run-in|Did Not Meet Criteria|0
6048858|NCT00593736|20904115|P2|Screening Period and Placebo Run-in|Did Not Meet Criteria|0
6048859|NCT00593736|20904116|P1|Screening Period and Placebo Run-in|Did Not Meet Criteria|0
6048860|NCT00593736|20904113|P4|Screening Period and Placebo Run-in|Study Termination|15
6048861|NCT00593736|20904114|P3|Screening Period and Placebo Run-in|Study Termination|0
6048862|NCT00593736|20904115|P2|Screening Period and Placebo Run-in|Study Termination|0
6048863|NCT00593736|20904116|P1|Screening Period and Placebo Run-in|Study Termination|0
6048864|NCT00593736|20904113|P4|Screening Period and Placebo Run-in|Withdrawal by Subject|43
6048865|NCT00593736|20904114|P3|Screening Period and Placebo Run-in|Withdrawal by Subject|0
6048866|NCT00593736|20904115|P2|Screening Period and Placebo Run-in|Withdrawal by Subject|0
6048867|NCT00593736|20904116|P1|Screening Period and Placebo Run-in|Withdrawal by Subject|0
6048868|NCT00593736|20904113|P4|Screening Period and Placebo Run-in|Lost to Follow-up|9
6048869|NCT00593736|20904114|P3|Screening Period and Placebo Run-in|Lost to Follow-up|0
6048870|NCT00593736|20904115|P2|Screening Period and Placebo Run-in|Lost to Follow-up|0
6048871|NCT00593736|20904116|P1|Screening Period and Placebo Run-in|Lost to Follow-up|0
6048872|NCT00593736|20904113|P4|Screening Period and Placebo Run-in|Adverse Event|3
6048873|NCT00593736|20904114|P3|Screening Period and Placebo Run-in|Adverse Event|0
6048874|NCT00593736|20904115|P2|Screening Period and Placebo Run-in|Adverse Event|0
6048875|NCT00593736|20904116|P1|Screening Period and Placebo Run-in|Adverse Event|0
6048876|NCT00593684|20904364|P2|Overall Study|Death|1
6048877|NCT00593684|20904365|P1|Overall Study|Death|2
6048878|NCT00593606|20904391|P1|Overall Study|Screen Failure|3
6048879|NCT00593606|20904391|P1|Overall Study|Run-In Failure|5
6048880|NCT00593606|20904391|P1|Overall Study|Lost to Follow-up|2
6048881|NCT00593606|20904391|P1|Overall Study|Protocol Violation|3
6048882|NCT00593606|20904391|P1|Overall Study|Withdrawal by Subject|1
6048883|NCT00593606|20904391|P1|Overall Study|Adverse Event|13
6048884|NCT00593554|20904489|P2|Overall Study|Disease Progression|2
6048885|NCT00593554|20904490|P1|Overall Study|Disease Progression|1
6048886|NCT00593554|20904489|P2|Overall Study|Withdrawal by Subject|0
6048887|NCT00593554|20904490|P1|Overall Study|Withdrawal by Subject|1
6048890|NCT00593554|20904489|P2|Overall Study|Death|2
6048891|NCT00593554|20904490|P1|Overall Study|Death|1
6048892|NCT00593489|20904510|P2|Allocation|did not attend workshop; allocation not|1
6048893|NCT00593489|20904511|P1|Allocation|did not attend workshop; allocation not|2
6048894|NCT00593385|20904614|P1|Overall Study|Withdrawal by Subject|9
6048895|NCT00593385|20904614|P1|Overall Study|Lost to Follow-up|17
6048896|NCT00593385|20904614|P1|Overall Study|Death|14
6048897|NCT00593333|20904675|P2|Overall Study|Lost to Follow-up|11
6048898|NCT00593333|20904676|P1|Overall Study|Lost to Follow-up|10
6048899|NCT00593112|20904699|P2|Overall Study|Withdrawal by Subject|0
6048900|NCT00593112|20904700|P1|Overall Study|Withdrawal by Subject|5
6048901|NCT00593112|20904699|P2|Overall Study|Unreadable Scan|0
6048902|NCT00593112|20904700|P1|Overall Study|Unreadable Scan|1
6048903|NCT00593112|20904699|P2|Overall Study|Abnormal Scan|0
6048904|NCT00593112|20904700|P1|Overall Study|Abnormal Scan|1
6048905|NCT00593112|20904699|P2|Overall Study|Scan Anxiety|0
6048906|NCT00593112|20904700|P1|Overall Study|Scan Anxiety|3
6048907|NCT00592904|20904727|P4|Overall Study|Other|0
6048908|NCT00592904|20904728|P3|Overall Study|Other|0
6048909|NCT00592904|20904729|P2|Overall Study|Other|3
6048910|NCT00592904|20904730|P1|Overall Study|Other|3
6048911|NCT00592904|20904727|P4|Overall Study|Physician Decision|0
6048912|NCT00592904|20904728|P3|Overall Study|Physician Decision|1
6048913|NCT00592904|20904729|P2|Overall Study|Physician Decision|3
6048914|NCT00592904|20904730|P1|Overall Study|Physician Decision|0
6048915|NCT00592904|20904727|P4|Overall Study|Lack of Efficacy|3
6048916|NCT00592904|20904728|P3|Overall Study|Lack of Efficacy|2
6048917|NCT00592904|20904729|P2|Overall Study|Lack of Efficacy|7
6048918|NCT00592904|20904730|P1|Overall Study|Lack of Efficacy|2
6048919|NCT00592904|20904727|P4|Overall Study|Withdrawal by Subject|2
6048920|NCT00592904|20904728|P3|Overall Study|Withdrawal by Subject|1
6048921|NCT00592904|20904729|P2|Overall Study|Withdrawal by Subject|16
6048922|NCT00592904|20904730|P1|Overall Study|Withdrawal by Subject|4
6048923|NCT00592904|20904727|P4|Overall Study|Protocol Violation|1
6048924|NCT00592904|20904728|P3|Overall Study|Protocol Violation|0
6048925|NCT00592904|20904729|P2|Overall Study|Protocol Violation|1
6048926|NCT00592904|20904730|P1|Overall Study|Protocol Violation|1
6048927|NCT00592904|20904727|P4|Overall Study|Adverse Event|5
6048928|NCT00592904|20904728|P3|Overall Study|Adverse Event|13
6048929|NCT00592904|20904729|P2|Overall Study|Adverse Event|25
6048930|NCT00592904|20904730|P1|Overall Study|Adverse Event|15
6048931|NCT00592852|20904756|P1|Overall Study|Withdrawal by Subject|1
6048932|NCT00592852|20904756|P1|Overall Study|Found ineligible|1
6048933|NCT00592852|20904756|P1|Overall Study|Adverse Event|3
6048934|NCT00592852|20904756|P1|Overall Study|Non-compliance|1
6048935|NCT00592839|20904764|P3|Overall Study|Lost to Follow-up|1
6048936|NCT00592839|20904765|P2|Overall Study|Lost to Follow-up|1
6048937|NCT00592839|20904766|P1|Overall Study|Lost to Follow-up|0
6048938|NCT00592839|20904764|P3|Overall Study|Adverse Event|0
6048939|NCT00592839|20904765|P2|Overall Study|Adverse Event|1
6048940|NCT00592839|20904766|P1|Overall Study|Adverse Event|0
6048941|NCT00592839|20904764|P3|Overall Study|Protocol Violation|2
6048942|NCT00592839|20904765|P2|Overall Study|Protocol Violation|1
6048943|NCT00592839|20904766|P1|Overall Study|Protocol Violation|1
6048944|NCT00592839|20904764|P3|Overall Study|Withdrawal by Subject|3
6048945|NCT00592839|20904765|P2|Overall Study|Withdrawal by Subject|1
6048946|NCT00592839|20904766|P1|Overall Study|Withdrawal by Subject|1
6048947|NCT00592774|20904794|P5|Overall Study|Other|2
6048948|NCT00592774|20904795|P4|Overall Study|Other|0
6048949|NCT00592774|20904796|P3|Overall Study|Other|1
6048950|NCT00592774|20904797|P2|Overall Study|Other|1
6048951|NCT00592774|20904798|P1|Overall Study|Other|0
6048952|NCT00592774|20904794|P5|Overall Study|Physician Decision|1
6048953|NCT00592774|20904795|P4|Overall Study|Physician Decision|0
6048954|NCT00592774|20904796|P3|Overall Study|Physician Decision|1
6048955|NCT00592774|20904797|P2|Overall Study|Physician Decision|1
6048956|NCT00592774|20904798|P1|Overall Study|Physician Decision|0
6048957|NCT00592774|20904794|P5|Overall Study|Lack of Efficacy|2
6048958|NCT00592774|20904795|P4|Overall Study|Lack of Efficacy|0
6048959|NCT00592774|20904796|P3|Overall Study|Lack of Efficacy|0
6048960|NCT00592774|20904797|P2|Overall Study|Lack of Efficacy|3
6048961|NCT00592774|20904798|P1|Overall Study|Lack of Efficacy|3
6048962|NCT00592774|20904794|P5|Overall Study|Withdrawal by Subject|0
6048963|NCT00592774|20904795|P4|Overall Study|Withdrawal by Subject|0
6048964|NCT00592774|20904796|P3|Overall Study|Withdrawal by Subject|0
6048965|NCT00592774|20904797|P2|Overall Study|Withdrawal by Subject|7
6048966|NCT00592774|20904798|P1|Overall Study|Withdrawal by Subject|3
6048967|NCT00592774|20904794|P5|Overall Study|Protocol Violation|1
6048968|NCT00592774|20904795|P4|Overall Study|Protocol Violation|0
6048969|NCT00592774|20904796|P3|Overall Study|Protocol Violation|0
6048970|NCT00592774|20904797|P2|Overall Study|Protocol Violation|1
6048971|NCT00592774|20904798|P1|Overall Study|Protocol Violation|0
6048972|NCT00592774|20904794|P5|Overall Study|Adverse Event|8
6048973|NCT00592774|20904795|P4|Overall Study|Adverse Event|14
6048974|NCT00592774|20904796|P3|Overall Study|Adverse Event|2
6048975|NCT00592774|20904797|P2|Overall Study|Adverse Event|19
6048976|NCT00592774|20904798|P1|Overall Study|Adverse Event|5
6048977|NCT00592683|20904870|P2|Overall Study|Lost to Follow-up|1
6048978|NCT00592683|20904871|P1|Overall Study|Lost to Follow-up|0
6048979|NCT00592683|20904870|P2|Overall Study|Other|0
6048980|NCT00592683|20904871|P1|Overall Study|Other|1
6048981|NCT00592683|20904870|P2|Overall Study|Study drug expired|0
6048982|NCT00592683|20904871|P1|Overall Study|Study drug expired|1
6048983|NCT00592683|20904870|P2|Overall Study|Protocol Violation|0
6048984|NCT00592683|20904871|P1|Overall Study|Protocol Violation|1
6048985|NCT00592683|20904870|P2|Overall Study|Adverse Event|2
6048986|NCT00592683|20904871|P1|Overall Study|Adverse Event|0
6048987|NCT00592683|20904870|P2|Overall Study|Withdrawal by Subject|0
6048988|NCT00592683|20904871|P1|Overall Study|Withdrawal by Subject|1
6048989|NCT00592683|20904870|P2|Overall Study|Found ineligible|1
6048990|NCT00592683|20904871|P1|Overall Study|Found ineligible|0
6048991|NCT00592631|20904881|P2|Overall Study|Lost to Follow-up|2
6048992|NCT00592631|20904882|P1|Overall Study|Lost to Follow-up|0
6048993|NCT00592553|20904891|P3|Overall Study|Protocol Noncompliance|0
6048994|NCT00592553|20904892|P2|Overall Study|Protocol Noncompliance|0
6048995|NCT00592553|20904893|P1|Overall Study|Protocol Noncompliance|1
6048996|NCT00592384|20905010|P2|Overall Study|Withdrawal by Subject|6
6048997|NCT00592384|20905011|P1|Overall Study|Withdrawal by Subject|5
6048998|NCT00592358|20905019|P1|Overall Study|Inability to swallow pills|1
6048999|NCT00592358|20905019|P1|Overall Study|Lack of Efficacy|2
6049000|NCT00592358|20905019|P1|Overall Study|Adverse Event|1
6049001|NCT00592358|20905019|P1|Overall Study|Withdrawal by Subject|2
6049002|NCT00592319|20905026|P2|Overall Study|Lost to Follow-up|3
6049003|NCT00592319|20905027|P1|Overall Study|Lost to Follow-up|0
6049004|NCT00592072|20905102|P2|Wash Out Period|Lost to Follow-up|1
6049005|NCT00592072|20905103|P1|Wash Out Period|Lost to Follow-up|1
6049006|NCT00592007|20905125|P1|Overall Study|patient ineligible (out of lab range)|1
6049007|NCT00592007|20905125|P1|Overall Study|Withdrawal by Subject|1
6049008|NCT00591864|20905137|P1|Overall Study|Incomplete Imaging|5
6049009|NCT00591851|20905143|P1|Overall Study|Progressive Disease|1
6049010|NCT00591851|20905143|P1|Overall Study|Adverse Event|2
6049011|NCT00591851|20905143|P1|Overall Study|Withdrawal by Subject|3
6049012|NCT00591838|20905152|P5|Overall Study|Withdrawal by Subject|0
6049013|NCT00591838|20905153|P4|Overall Study|Withdrawal by Subject|1
6049014|NCT00591838|20905154|P3|Overall Study|Withdrawal by Subject|0
6049015|NCT00591838|20905155|P2|Overall Study|Withdrawal by Subject|0
6049016|NCT00591838|20905156|P1|Overall Study|Withdrawal by Subject|0
6049017|NCT00591786|20905220|P10|Overall Study|Withdrawal of Informed Consent|0
6049018|NCT00591786|20905221|P9|Overall Study|Withdrawal of Informed Consent|0
6049019|NCT00591786|20905222|P8|Overall Study|Withdrawal of Informed Consent|0
6049020|NCT00591786|20905223|P7|Overall Study|Withdrawal of Informed Consent|0
6049021|NCT00591786|20905224|P6|Overall Study|Withdrawal of Informed Consent|0
6049022|NCT00591786|20905225|P5|Overall Study|Withdrawal of Informed Consent|0
6049023|NCT00591786|20905226|P4|Overall Study|Withdrawal of Informed Consent|0
6049024|NCT00591786|20905227|P3|Overall Study|Withdrawal of Informed Consent|1
6049025|NCT00591786|20905228|P2|Overall Study|Withdrawal of Informed Consent|0
6049026|NCT00591786|20905229|P1|Overall Study|Withdrawal of Informed Consent|0
6049027|NCT00591773|20905274|P3|Overall Study|Other|4
6049028|NCT00591773|20905275|P2|Overall Study|Other|1
6049029|NCT00591773|20905276|P1|Overall Study|Other|1
6049030|NCT00591773|20905274|P3|Overall Study|Lack of Efficacy|2
6049031|NCT00591773|20905275|P2|Overall Study|Lack of Efficacy|2
6049032|NCT00591773|20905276|P1|Overall Study|Lack of Efficacy|1
6049033|NCT00591773|20905274|P3|Overall Study|Withdrawal by Subject|3
6049034|NCT00591773|20905275|P2|Overall Study|Withdrawal by Subject|5
6049035|NCT00591773|20905276|P1|Overall Study|Withdrawal by Subject|2
6049036|NCT00591773|20905274|P3|Overall Study|Lost to Follow-up|1
6049037|NCT00591773|20905275|P2|Overall Study|Lost to Follow-up|4
6049038|NCT00591773|20905276|P1|Overall Study|Lost to Follow-up|1
6049039|NCT00591773|20905274|P3|Overall Study|Protocol Violation|0
6049040|NCT00591773|20905275|P2|Overall Study|Protocol Violation|3
6049041|NCT00591773|20905276|P1|Overall Study|Protocol Violation|2
6049042|NCT00591773|20905274|P3|Overall Study|Adverse Event|6
6049043|NCT00591773|20905275|P2|Overall Study|Adverse Event|9
6049044|NCT00591773|20905276|P1|Overall Study|Adverse Event|9
6049045|NCT00591734|20905335|P1|Overall Study|Intercurrent Illness|8
6049046|NCT00591734|20905335|P1|Overall Study|Physician Decision|5
6049047|NCT00591734|20905335|P1|Overall Study|Adverse Event|5
6049048|NCT00591734|20905335|P1|Overall Study|Lack of Efficacy|35
6049049|NCT00591721|20905341|P2|Overall Study|Intervention not received|8
6049050|NCT00591721|20905342|P1|Overall Study|Intervention not received|10
6049051|NCT00591721|20905341|P2|Overall Study|Lost to Follow-up|4
6049052|NCT00591721|20905342|P1|Overall Study|Lost to Follow-up|1
6049053|NCT00591721|20905341|P2|Overall Study|Withdrawal by Subject|10
6049054|NCT00591721|20905342|P1|Overall Study|Withdrawal by Subject|10
6049055|NCT00591591|20905350|P2|Overall Study|Lack of Efficacy|2
6049056|NCT00591591|20905351|P1|Overall Study|Lack of Efficacy|10
6049057|NCT00591591|20905350|P2|Overall Study|Withdrawal by Subject|37
6049058|NCT00591591|20905351|P1|Overall Study|Withdrawal by Subject|1
6049059|NCT00591578|20905368|P3|Open-Label Extension Phase|Other|0
6049060|NCT00591578|20905369|P2|Open-Label Extension Phase|Other|0
6049061|NCT00591578|20905370|P1|Open-Label Extension Phase|Other|1
6049062|NCT00591578|20905368|P3|Open-Label Extension Phase|Withdrawal by Subject|0
6049063|NCT00591578|20905369|P2|Open-Label Extension Phase|Withdrawal by Subject|1
6049064|NCT00591578|20905370|P1|Open-Label Extension Phase|Withdrawal by Subject|1
6049065|NCT00591578|20905368|P3|Open-Label Extension Phase|Lost to Follow-up|0
6049066|NCT00591578|20905369|P2|Open-Label Extension Phase|Lost to Follow-up|4
6049067|NCT00591578|20905370|P1|Open-Label Extension Phase|Lost to Follow-up|1
6049068|NCT00591578|20905368|P3|Open-Label Extension Phase|Adverse Event|0
6049069|NCT00591578|20905369|P2|Open-Label Extension Phase|Adverse Event|5
6049070|NCT00591578|20905370|P1|Open-Label Extension Phase|Adverse Event|3
6049071|NCT00591578|20905368|P3|Double-Blind Treatment Phase|Other|4
6049072|NCT00591578|20905369|P2|Double-Blind Treatment Phase|Other|9
6049073|NCT00591578|20905370|P1|Double-Blind Treatment Phase|Other|4
6049074|NCT00591578|20905368|P3|Double-Blind Treatment Phase|Lack of Efficacy|25
6049075|NCT00591578|20905369|P2|Double-Blind Treatment Phase|Lack of Efficacy|9
6049076|NCT00591578|20905370|P1|Double-Blind Treatment Phase|Lack of Efficacy|16
6049077|NCT00591578|20905368|P3|Double-Blind Treatment Phase|Pregnancy|0
6049078|NCT00591578|20905369|P2|Double-Blind Treatment Phase|Pregnancy|0
6049079|NCT00591578|20905370|P1|Double-Blind Treatment Phase|Pregnancy|1
6049080|NCT00591578|20905368|P3|Double-Blind Treatment Phase|Withdrawal by Subject|22
6049081|NCT00591578|20905369|P2|Double-Blind Treatment Phase|Withdrawal by Subject|22
6049082|NCT00591578|20905370|P1|Double-Blind Treatment Phase|Withdrawal by Subject|22
6049083|NCT00591578|20905368|P3|Double-Blind Treatment Phase|Lost to Follow-up|11
6049084|NCT00591578|20905369|P2|Double-Blind Treatment Phase|Lost to Follow-up|12
6049085|NCT00591578|20905370|P1|Double-Blind Treatment Phase|Lost to Follow-up|12
6049086|NCT00591578|20905368|P3|Double-Blind Treatment Phase|Protocol Violation|3
6049087|NCT00591578|20905369|P2|Double-Blind Treatment Phase|Protocol Violation|2
6049088|NCT00591578|20905370|P1|Double-Blind Treatment Phase|Protocol Violation|3
6049089|NCT00591578|20905368|P3|Double-Blind Treatment Phase|Adverse Event|19
6049090|NCT00591578|20905369|P2|Double-Blind Treatment Phase|Adverse Event|26
6049091|NCT00591578|20905370|P1|Double-Blind Treatment Phase|Adverse Event|20
6049092|NCT00591565|20905421|P1|Overall Study|lost follow up, withdrawn|5
6049093|NCT00591409|20905435|P10|Overall Study|Not Treated|1
6049094|NCT00591409|20905436|P9|Overall Study|Not Treated|0
6049095|NCT00591409|20905437|P8|Overall Study|Not Treated|0
6049096|NCT00591409|20905438|P7|Overall Study|Not Treated|0
6049097|NCT00591409|20905439|P6|Overall Study|Not Treated|0
6049098|NCT00591409|20905440|P5|Overall Study|Not Treated|1
6049099|NCT00591409|20905441|P4|Overall Study|Not Treated|0
6049100|NCT00591409|20905442|P3|Overall Study|Not Treated|0
6049101|NCT00591409|20905443|P2|Overall Study|Not Treated|0
6049102|NCT00591409|20905444|P1|Overall Study|Not Treated|0
6049103|NCT00591370|20905486|P1|Overall Study|Not Treated|2
6049104|NCT00591344|20905494|P2|Overall Study|Did not want to come off medication|1
6049105|NCT00591344|20905495|P1|Overall Study|Did not want to come off medication|0
6049106|NCT00591344|20905494|P2|Overall Study|Lost to Follow-up|1
6049107|NCT00591344|20905495|P1|Overall Study|Lost to Follow-up|0
6049108|NCT00591344|20905494|P2|Overall Study|Death|1
6049109|NCT00591344|20905495|P1|Overall Study|Death|0
6049110|NCT00591344|20905494|P2|Overall Study|Underwent DBS|2
6049111|NCT00591344|20905495|P1|Overall Study|Underwent DBS|2
6049112|NCT00591344|20905494|P2|Overall Study|Medical complications|3
6049113|NCT00591344|20905495|P1|Overall Study|Medical complications|1
6049114|NCT00591344|20905494|P2|Overall Study|Moved out of state|0
6049115|NCT00591344|20905495|P1|Overall Study|Moved out of state|1
6049116|NCT00591344|20905494|P2|Overall Study|Transportation issues|0
6049117|NCT00591344|20905495|P1|Overall Study|Transportation issues|1
6049118|NCT00591266|20905521|P3|Overall Study|Other|5
6049119|NCT00591266|20905522|P2|Overall Study|Other|4
6049120|NCT00591266|20905523|P1|Overall Study|Other|1
6049121|NCT00591266|20905521|P3|Overall Study|Lack of Efficacy|0
6049122|NCT00591266|20905522|P2|Overall Study|Lack of Efficacy|2
6049123|NCT00591266|20905523|P1|Overall Study|Lack of Efficacy|0
6049124|NCT00591266|20905521|P3|Overall Study|Withdrawal by Subject|5
6049125|NCT00591266|20905522|P2|Overall Study|Withdrawal by Subject|2
6049126|NCT00591266|20905523|P1|Overall Study|Withdrawal by Subject|6
6049127|NCT00591266|20905521|P3|Overall Study|Protocol Violation|1
6049128|NCT00591266|20905522|P2|Overall Study|Protocol Violation|0
6049129|NCT00591266|20905523|P1|Overall Study|Protocol Violation|0
6049130|NCT00591266|20905521|P3|Overall Study|Lost to Follow-up|0
6049131|NCT00591266|20905522|P2|Overall Study|Lost to Follow-up|1
6049132|NCT00591266|20905523|P1|Overall Study|Lost to Follow-up|0
6049133|NCT00591266|20905521|P3|Overall Study|Adverse Event|3
6049134|NCT00591266|20905522|P2|Overall Study|Adverse Event|2
6049135|NCT00591266|20905523|P1|Overall Study|Adverse Event|2
6049136|NCT00591253|20905576|P3|Overall Study|Other|3
6049137|NCT00591253|20905577|P2|Overall Study|Other|5
6049138|NCT00591253|20905578|P1|Overall Study|Other|5
6049139|NCT00591253|20905576|P3|Overall Study|Lack of Efficacy|3
6049140|NCT00591253|20905577|P2|Overall Study|Lack of Efficacy|0
6049141|NCT00591253|20905578|P1|Overall Study|Lack of Efficacy|1
6049142|NCT00591253|20905576|P3|Overall Study|Withdrawal by Subject|6
6049143|NCT00591253|20905577|P2|Overall Study|Withdrawal by Subject|7
6049144|NCT00591253|20905578|P1|Overall Study|Withdrawal by Subject|1
6049145|NCT00591253|20905576|P3|Overall Study|Lost to Follow-up|0
6049146|NCT00591253|20905577|P2|Overall Study|Lost to Follow-up|4
6049147|NCT00591253|20905578|P1|Overall Study|Lost to Follow-up|2
6049148|NCT00591253|20905576|P3|Overall Study|Protocol Violation|2
6049149|NCT00591253|20905577|P2|Overall Study|Protocol Violation|2
6049150|NCT00591253|20905578|P1|Overall Study|Protocol Violation|2
6049151|NCT00591253|20905576|P3|Overall Study|Adverse Event|1
6049152|NCT00591253|20905577|P2|Overall Study|Adverse Event|3
6049153|NCT00591253|20905578|P1|Overall Study|Adverse Event|3
6049154|NCT00591214|20905646|P1|Overall Study|Withdrawal by Subject|1
6049155|NCT00591214|20905646|P1|Overall Study|Physician Decision|7
6049156|NCT00591149|20905655|P1|Overall Study|Withdrawal by Subject|1
6049157|NCT00591149|20905655|P1|Overall Study|Adverse Event|4
6049158|NCT00591006|20905671|P24|Overall Study|Adverse Event|0
6049159|NCT00591006|20905672|P23|Overall Study|Adverse Event|1
6049160|NCT00591006|20905673|P22|Overall Study|Adverse Event|0
6049161|NCT00591006|20905674|P21|Overall Study|Adverse Event|0
6049162|NCT00591006|20905675|P20|Overall Study|Adverse Event|0
6049163|NCT00591006|20905676|P19|Overall Study|Adverse Event|0
6049164|NCT00591006|20905677|P18|Overall Study|Adverse Event|0
6049165|NCT00591006|20905678|P17|Overall Study|Adverse Event|0
6049166|NCT00591006|20905679|P16|Overall Study|Adverse Event|0
6049167|NCT00591006|20905680|P15|Overall Study|Adverse Event|0
6049168|NCT00591006|20905681|P14|Overall Study|Adverse Event|0
6049169|NCT00591006|20905682|P13|Overall Study|Adverse Event|0
6049170|NCT00591006|20905683|P12|Overall Study|Adverse Event|0
6049171|NCT00591006|20905684|P11|Overall Study|Adverse Event|0
6049172|NCT00591006|20905685|P10|Overall Study|Adverse Event|0
6049173|NCT00591006|20905686|P9|Overall Study|Adverse Event|0
6049174|NCT00591006|20905687|P8|Overall Study|Adverse Event|0
6049175|NCT00591006|20905688|P7|Overall Study|Adverse Event|0
6049176|NCT00591006|20905689|P6|Overall Study|Adverse Event|0
6049177|NCT00591006|20905690|P5|Overall Study|Adverse Event|0
6049178|NCT00591006|20905691|P4|Overall Study|Adverse Event|0
6049179|NCT00591006|20905692|P3|Overall Study|Adverse Event|0
6049180|NCT00591006|20905693|P2|Overall Study|Adverse Event|0
6049181|NCT00591006|20905694|P1|Overall Study|Adverse Event|0
6049182|NCT00591006|20905671|P24|Overall Study|Withdrawal by Subject|1
6049183|NCT00591006|20905672|P23|Overall Study|Withdrawal by Subject|0
6049184|NCT00591006|20905673|P22|Overall Study|Withdrawal by Subject|0
6049185|NCT00591006|20905674|P21|Overall Study|Withdrawal by Subject|0
6049186|NCT00591006|20905675|P20|Overall Study|Withdrawal by Subject|0
6049187|NCT00591006|20905676|P19|Overall Study|Withdrawal by Subject|0
6049188|NCT00591006|20905677|P18|Overall Study|Withdrawal by Subject|0
6049189|NCT00591006|20905678|P17|Overall Study|Withdrawal by Subject|0
6049190|NCT00591006|20905679|P16|Overall Study|Withdrawal by Subject|1
6049191|NCT00591006|20905680|P15|Overall Study|Withdrawal by Subject|0
6049192|NCT00591006|20905681|P14|Overall Study|Withdrawal by Subject|0
6049193|NCT00591006|20905682|P13|Overall Study|Withdrawal by Subject|0
6049194|NCT00591006|20905683|P12|Overall Study|Withdrawal by Subject|0
6049195|NCT00591006|20905684|P11|Overall Study|Withdrawal by Subject|0
6049196|NCT00591006|20905685|P10|Overall Study|Withdrawal by Subject|0
6049197|NCT00591006|20905686|P9|Overall Study|Withdrawal by Subject|0
6049198|NCT00591006|20905687|P8|Overall Study|Withdrawal by Subject|0
6049199|NCT00591006|20905688|P7|Overall Study|Withdrawal by Subject|0
6049200|NCT00591006|20905689|P6|Overall Study|Withdrawal by Subject|0
6049201|NCT00591006|20905690|P5|Overall Study|Withdrawal by Subject|0
6049202|NCT00591006|20905691|P4|Overall Study|Withdrawal by Subject|0
6049203|NCT00591006|20905692|P3|Overall Study|Withdrawal by Subject|0
6049204|NCT00591006|20905693|P2|Overall Study|Withdrawal by Subject|0
6049205|NCT00591006|20905694|P1|Overall Study|Withdrawal by Subject|0
6049206|NCT00590980|20905712|P1|Overall Study|Did not meet all inclusion criteria|10
6049207|NCT00590967|20905718|P2|Overall Study|Did not receive chemo per protocol|0
6049208|NCT00590967|20905719|P1|Overall Study|Did not receive chemo per protocol|1
6049209|NCT00590967|20905718|P2|Overall Study|Did not sign consent form|1
6049210|NCT00590967|20905719|P1|Overall Study|Did not sign consent form|0
6049211|NCT00590967|20905718|P2|Overall Study|Non-compliant|2
6049212|NCT00590967|20905719|P1|Overall Study|Non-compliant|0
6049213|NCT00590967|20905718|P2|Overall Study|Poor performance status|1
6049214|NCT00590967|20905719|P1|Overall Study|Poor performance status|0
6049215|NCT00590967|20905718|P2|Overall Study|Ineligible|0
6049216|NCT00590967|20905719|P1|Overall Study|Ineligible|1
6049217|NCT00590967|20905718|P2|Overall Study|Withdrawal by Subject|1
6049218|NCT00590967|20905719|P1|Overall Study|Withdrawal by Subject|1
6049219|NCT00590954|20905731|P1|Overall Study|Inevaluable|2
6049220|NCT00590902|20905737|P1|Overall Study|Death|1
6049221|NCT00590824|20905770|P4|Overall Study|Adverse Event|1
6049222|NCT00590824|20905771|P3|Overall Study|Adverse Event|0
6049223|NCT00590824|20905772|P2|Overall Study|Adverse Event|0
6049224|NCT00590824|20905773|P1|Overall Study|Adverse Event|0
6049225|NCT00590824|20905770|P4|Overall Study|Disease could not be resected|0
6049226|NCT00590824|20905771|P3|Overall Study|Disease could not be resected|1
6049227|NCT00590824|20905772|P2|Overall Study|Disease could not be resected|2
6049228|NCT00590824|20905773|P1|Overall Study|Disease could not be resected|0
6049229|NCT00590759|20905799|P1|Overall Study|Lost to Follow-up|28
6049230|NCT00590759|20905799|P1|Overall Study|Death|52
6049231|NCT00590720|20905806|P2|Overall Study|Withdrawal by Subject|1
6049232|NCT00590720|20905807|P1|Overall Study|Withdrawal by Subject|0
6049233|NCT00590720|20905806|P2|Overall Study|Lost to Follow-up|0
6049234|NCT00590720|20905807|P1|Overall Study|Lost to Follow-up|1
6049235|NCT00590590|20905869|P3|Overall Study|Did not complete study|0
6049236|NCT00590590|20905870|P2|Overall Study|Did not complete study|1
6049237|NCT00590590|20905871|P1|Overall Study|Did not complete study|0
6049238|NCT00590590|20905869|P3|Overall Study|Did not complete due to study closure|1
6049239|NCT00590590|20905870|P2|Overall Study|Did not complete due to study closure|1
6049240|NCT00590590|20905871|P1|Overall Study|Did not complete due to study closure|1
6049241|NCT00590590|20905869|P3|Overall Study|Withdrawal by Subject|1
6049242|NCT00590590|20905870|P2|Overall Study|Withdrawal by Subject|1
6049243|NCT00590590|20905871|P1|Overall Study|Withdrawal by Subject|0
6049244|NCT00590590|20905869|P3|Overall Study|Lost to Follow-up|2
6049245|NCT00590590|20905870|P2|Overall Study|Lost to Follow-up|1
6049246|NCT00590590|20905871|P1|Overall Study|Lost to Follow-up|4
6049247|NCT00590590|20905869|P3|Overall Study|Protocol Violation|2
6049248|NCT00590590|20905870|P2|Overall Study|Protocol Violation|0
6049249|NCT00590590|20905871|P1|Overall Study|Protocol Violation|0
6049250|NCT00590590|20905869|P3|Overall Study|Adverse Event|0
6049251|NCT00590590|20905870|P2|Overall Study|Adverse Event|0
6049252|NCT00590590|20905871|P1|Overall Study|Adverse Event|1
6049253|NCT00590590|20905869|P3|Overall Study|Lack of Efficacy|0
6049254|NCT00590590|20905870|P2|Overall Study|Lack of Efficacy|2
6049255|NCT00590590|20905871|P1|Overall Study|Lack of Efficacy|1
6049256|NCT00590577|20905898|P4|Overall Study|Various reasons|2
6049257|NCT00590577|20905899|P3|Overall Study|Various reasons|1
6049258|NCT00590577|20905900|P2|Overall Study|Various reasons|3
6049259|NCT00590577|20905901|P1|Overall Study|Various reasons|1
6049260|NCT00590577|20905898|P4|Overall Study|Pregnancy|0
6049261|NCT00590577|20905899|P3|Overall Study|Pregnancy|0
6049262|NCT00590577|20905900|P2|Overall Study|Pregnancy|1
6049263|NCT00590577|20905901|P1|Overall Study|Pregnancy|0
6049264|NCT00590577|20905898|P4|Overall Study|Lost to Follow-up|9
6049265|NCT00590577|20905899|P3|Overall Study|Lost to Follow-up|6
6049266|NCT00590577|20905900|P2|Overall Study|Lost to Follow-up|6
6049267|NCT00590577|20905901|P1|Overall Study|Lost to Follow-up|12
6049268|NCT00590577|20905898|P4|Overall Study|Adverse Event|11
6049269|NCT00590577|20905899|P3|Overall Study|Adverse Event|13
6049270|NCT00590577|20905900|P2|Overall Study|Adverse Event|10
6049271|NCT00590577|20905901|P1|Overall Study|Adverse Event|10
6049272|NCT00590577|20905898|P4|Overall Study|Withdrawal by Subject|26
6049273|NCT00590577|20905899|P3|Overall Study|Withdrawal by Subject|30
6049274|NCT00590577|20905900|P2|Overall Study|Withdrawal by Subject|28
6049275|NCT00590577|20905901|P1|Overall Study|Withdrawal by Subject|23
6049276|NCT00590577|20905898|P4|Overall Study|Lack of Efficacy|45
6049277|NCT00590577|20905899|P3|Overall Study|Lack of Efficacy|23
6049278|NCT00590577|20905900|P2|Overall Study|Lack of Efficacy|28
6049279|NCT00590577|20905901|P1|Overall Study|Lack of Efficacy|31
6049280|NCT00590564|20905919|P1|Overall Study|Patient Non-compliance|6
6049281|NCT00590564|20905919|P1|Overall Study|Patient Found to be Ineligible|1
6049282|NCT00590564|20905919|P1|Overall Study|Protocol Violation|1
6049283|NCT00590564|20905919|P1|Overall Study|Lost to Follow-up|6
6049284|NCT00590564|20905919|P1|Overall Study|Withdrawal by Subject|4
6049285|NCT00590538|20905923|P1|Overall Study|Study terminated before completed|2
6049286|NCT00590317|20905969|P2|Overall Study|Lack of Efficacy|5
6049287|NCT00590317|20905970|P1|Overall Study|Lack of Efficacy|1
6049288|NCT00590135|20906000|P1|Overall Study|Primary endpoint measure not obtainable|59
6049289|NCT00590044|20906010|P2|Overall Study|Protocol Violation|0
6049290|NCT00590044|20906011|P1|Overall Study|Protocol Violation|1
6049291|NCT00590044|20906010|P2|Overall Study|wrong insulin arm assigned|0
6049292|NCT00590044|20906011|P1|Overall Study|wrong insulin arm assigned|1
6049293|NCT00590044|20906010|P2|Overall Study|Withdrawal by Subject|2
6049294|NCT00590044|20906011|P1|Overall Study|Withdrawal by Subject|2
6049295|NCT00590031|20906023|P1|Overall Study|Admin Hold|1
6049296|NCT00590031|20906023|P1|Overall Study|Metastatic Disease|1
6049297|NCT00590031|20906023|P1|Overall Study|Withdrawal by Subject|1
6049298|NCT00590031|20906023|P1|Overall Study|Adverse Event|3
6049299|NCT00589979|20906050|P3|Double-Blind Treatment Period 3|Withdrawal by Subject|1
6049300|NCT00589979|20906051|P2|Double-Blind Treatment Period 3|Withdrawal by Subject|0
6049301|NCT00589979|20906052|P1|Double-Blind Treatment Period 3|Withdrawal by Subject|0
6049302|NCT00589979|20906050|P3|Double-Blind Treatment Period 3|Protocol Violation|0
6049303|NCT00589979|20906051|P2|Double-Blind Treatment Period 3|Protocol Violation|1
6049304|NCT00589979|20906052|P1|Double-Blind Treatment Period 3|Protocol Violation|0
6049305|NCT00589979|20906050|P3|Double-Blind Treatment Period 2|Other|1
6049306|NCT00589979|20906051|P2|Double-Blind Treatment Period 2|Other|0
6049307|NCT00589979|20906052|P1|Double-Blind Treatment Period 2|Other|0
6049308|NCT00589979|20906050|P3|Double-Blind Treatment Period 2|Withdrawal by Subject|1
6049309|NCT00589979|20906051|P2|Double-Blind Treatment Period 2|Withdrawal by Subject|0
6049310|NCT00589979|20906052|P1|Double-Blind Treatment Period 2|Withdrawal by Subject|0
6049311|NCT00589979|20906050|P3|Double-Blind Treatment Period 2|Adverse Event|0
6049312|NCT00589979|20906051|P2|Double-Blind Treatment Period 2|Adverse Event|1
6049313|NCT00589979|20906052|P1|Double-Blind Treatment Period 2|Adverse Event|0
6049314|NCT00589979|20906050|P3|Double-Blind Treatment Period 1|Withdrawal by Subject|1
6049315|NCT00589979|20906051|P2|Double-Blind Treatment Period 1|Withdrawal by Subject|0
6049316|NCT00589979|20906052|P1|Double-Blind Treatment Period 1|Withdrawal by Subject|0
6049317|NCT00589979|20906050|P3|Double-Blind Treatment Period 1|Protocol Violation|1
6049318|NCT00589979|20906051|P2|Double-Blind Treatment Period 1|Protocol Violation|1
6049319|NCT00589979|20906052|P1|Double-Blind Treatment Period 1|Protocol Violation|0
6049320|NCT00589979|20906050|P3|Double-Blind Treatment Period 1|Adverse Event|0
6049321|NCT00589979|20906051|P2|Double-Blind Treatment Period 1|Adverse Event|1
6049322|NCT00589979|20906052|P1|Double-Blind Treatment Period 1|Adverse Event|0
6049323|NCT00589979|20906050|P3|Run-In Period|Informed Consent Withdrawn|0
6049324|NCT00589979|20906051|P2|Run-In Period|Informed Consent Withdrawn|0
6049325|NCT00589979|20906052|P1|Run-In Period|Informed Consent Withdrawn|4
6049326|NCT00589979|20906050|P3|Run-In Period|Withdrawal by Subject|0
6049327|NCT00589979|20906051|P2|Run-In Period|Withdrawal by Subject|0
6049328|NCT00589979|20906052|P1|Run-In Period|Withdrawal by Subject|10
6049329|NCT00589979|20906050|P3|Run-In Period|Did not qualify for randomization|0
6049506|NCT00587457|20906813|P3|Overall Study|Disease progression|2
6049330|NCT00589979|20906051|P2|Run-In Period|Did not qualify for randomization|0
6049331|NCT00589979|20906052|P1|Run-In Period|Did not qualify for randomization|54
6049332|NCT00589979|20906050|P3|Run-In Period|Protocol Violation|0
6049333|NCT00589979|20906051|P2|Run-In Period|Protocol Violation|0
6049334|NCT00589979|20906052|P1|Run-In Period|Protocol Violation|3
6049335|NCT00589979|20906050|P3|Run-In Period|Adverse Event|0
6049336|NCT00589979|20906051|P2|Run-In Period|Adverse Event|0
6049337|NCT00589979|20906052|P1|Run-In Period|Adverse Event|5
6049338|NCT00589914|20906091|P2|Overall Study|Other|17
6049339|NCT00589914|20906092|P1|Overall Study|Other|22
6049340|NCT00589914|20906091|P2|Overall Study|Withdrawal by Subject|49
6049341|NCT00589914|20906092|P1|Overall Study|Withdrawal by Subject|55
6049342|NCT00589914|20906091|P2|Overall Study|Pregnancy|0
6049343|NCT00589914|20906092|P1|Overall Study|Pregnancy|1
6049344|NCT00589914|20906091|P2|Overall Study|Lost to Follow-up|18
6049345|NCT00589914|20906092|P1|Overall Study|Lost to Follow-up|11
6049346|NCT00589914|20906091|P2|Overall Study|Lack of Efficacy|43
6049347|NCT00589914|20906092|P1|Overall Study|Lack of Efficacy|40
6049348|NCT00589914|20906091|P2|Overall Study|Death|0
6049349|NCT00589914|20906092|P1|Overall Study|Death|2
6049350|NCT00589914|20906091|P2|Overall Study|Adverse Event|10
6049351|NCT00589914|20906092|P1|Overall Study|Adverse Event|19
6049352|NCT00589797|20906148|P2|Overall Study|Non-Randomized Training Subjects|6
6049353|NCT00589797|20906149|P1|Overall Study|Non-Randomized Training Subjects|46
6049354|NCT00589797|20906148|P2|Overall Study|Withdrawal by Subject|5
6049355|NCT00589797|20906149|P1|Overall Study|Withdrawal by Subject|6
6049356|NCT00589797|20906148|P2|Overall Study|Physician Decision|3
6049357|NCT00589797|20906149|P1|Overall Study|Physician Decision|8
6049358|NCT00589797|20906148|P2|Overall Study|Lost to Follow-up|9
6049359|NCT00589797|20906149|P1|Overall Study|Lost to Follow-up|12
6049360|NCT00589797|20906148|P2|Overall Study|Death|0
6049361|NCT00589797|20906149|P1|Overall Study|Death|1
6049362|NCT00589784|20906173|P2|Overall Study|Adverse Event|4
6049363|NCT00589784|20906174|P1|Overall Study|Adverse Event|0
6049364|NCT00589784|20906173|P2|Overall Study|Patient inevaluable|0
6049365|NCT00589784|20906174|P1|Overall Study|Patient inevaluable|1
6049366|NCT00589784|20906173|P2|Overall Study|Withdrawal by Subject|6
6049367|NCT00589784|20906174|P1|Overall Study|Withdrawal by Subject|0
6049368|NCT00589693|20906181|P2|Overall Study|Protocol Violation|1
6049369|NCT00589693|20906182|P1|Overall Study|Protocol Violation|1
6049370|NCT00589693|20906181|P2|Overall Study|Physician Decision|1
6049371|NCT00589693|20906182|P1|Overall Study|Physician Decision|0
6049372|NCT00589693|20906181|P2|Overall Study|Lost to Follow-up|0
6049373|NCT00589693|20906182|P1|Overall Study|Lost to Follow-up|1
6049374|NCT00589693|20906181|P2|Overall Study|Lack of Efficacy|1
6049375|NCT00589693|20906182|P1|Overall Study|Lack of Efficacy|0
6049376|NCT00589693|20906181|P2|Overall Study|Death|16
6049377|NCT00589693|20906182|P1|Overall Study|Death|26
6049378|NCT00589693|20906181|P2|Overall Study|Adverse Event|4
6049379|NCT00589693|20906182|P1|Overall Study|Adverse Event|4
6049380|NCT00589693|20906181|P2|Overall Study|randomized in error|6
6049381|NCT00589693|20906182|P1|Overall Study|randomized in error|12
6049382|NCT00589667|20906196|P1|Overall Study|Withdrawal by Subject|1
6049383|NCT00589667|20906196|P1|Overall Study|Adverse Event|2
6049384|NCT00589628|20906203|P2|Overall Study|Lost to Follow-up|1
6049385|NCT00589628|20906204|P1|Overall Study|Lost to Follow-up|0
6049386|NCT00589602|20906210|P1|Overall Study|Did not collect enough CD34+ cells|1
6049387|NCT00589472|20906245|P1|Overall Study|Adverse Event|1
6049388|NCT00589303|20906268|P2|Overall Study|Withdrawal by Subject|1
6049389|NCT00589303|20906269|P1|Overall Study|Withdrawal by Subject|2
6049390|NCT00589290|20906275|P1|Overall Study|Withdrawal by Subject|1
6049391|NCT00589121|20906298|P2|Overall Study|No protocol treatment received|1
6049392|NCT00589121|20906299|P1|Overall Study|No protocol treatment received|0
6049393|NCT00589121|20906298|P2|Overall Study|Protocol Violation|6
6049394|NCT00589121|20906299|P1|Overall Study|Protocol Violation|2
6049395|NCT00589108|20906321|P3|Overall Study|Death|4
6049396|NCT00589108|20906322|P2|Overall Study|Death|3
6049397|NCT00589108|20906323|P1|Overall Study|Death|3
6049398|NCT00589108|20906321|P3|Overall Study|Lost to Follow-up|1
6049399|NCT00589108|20906322|P2|Overall Study|Lost to Follow-up|1
6049400|NCT00589108|20906323|P1|Overall Study|Lost to Follow-up|1
6049401|NCT00588952|20906359|P2|Overall Study|Withdrawal by Subject|5
6049402|NCT00588952|20906360|P1|Overall Study|Withdrawal by Subject|3
6049403|NCT00588952|20906359|P2|Overall Study|Adverse Event|2
6049404|NCT00588952|20906360|P1|Overall Study|Adverse Event|0
6049405|NCT00588861|20906388|P2|10 Years|Incomplete due to study termination|114
6049406|NCT00588861|20906389|P1|10 Years|Incomplete due to study termination|107
6049407|NCT00588861|20906388|P2|8 Years|Patients did not return for follow-up|114
6049408|NCT00588861|20906389|P1|8 Years|Patients did not return for follow-up|105
6049409|NCT00588861|20906388|P2|6 Years|Patients did not return for follow-up|109
6049410|NCT00588861|20906389|P1|6 Years|Patients did not return for follow-up|104
6049411|NCT00588861|20906388|P2|4 Years|Patients did not return for follow-up|103
6049412|NCT00588861|20906389|P1|4 Years|Patients did not return for follow-up|91
6049413|NCT00588861|20906388|P2|2 Years|Patients did not return for follow-up|87
6049414|NCT00588861|20906389|P1|2 Years|Patients did not return for follow-up|92
6049415|NCT00588861|20906388|P2|1 Year|Patients did not return for follow-up|82
6049416|NCT00588861|20906389|P1|1 Year|Patients did not return for follow-up|89
6049417|NCT00588861|20906388|P2|6 Months|Patients did not return for follow-up|73
6049418|NCT00588861|20906389|P1|6 Months|Patients did not return for follow-up|98
6049419|NCT00588861|20906388|P2|Pre-Operative|Patients Did Not Complete Preop Data|86
6049420|NCT00588861|20906389|P1|Pre-Operative|Patients Did Not Complete Preop Data|95
6049421|NCT00588848|20906399|P2|Overall Study|Physician Decision|3
6049422|NCT00588848|20906400|P1|Overall Study|Physician Decision|0
6049423|NCT00588822|20906410|P1|Overall Study|progression of disease|8
6049444|NCT00588731|20906443|P2|Overall Study|Withdrawal by Subject|2
6049445|NCT00588731|20906444|P1|Overall Study|Withdrawal by Subject|3
6049446|NCT00588692|20906454|P2|Overall Study|Death|0
6049447|NCT00588692|20906455|P1|Overall Study|Death|1
6049448|NCT00588692|20906454|P2|Overall Study|Cancer|0
6049449|NCT00588692|20906455|P1|Overall Study|Cancer|1
6049450|NCT00588692|20906454|P2|Overall Study|Severe Peptic Ulcer Disease|0
6049451|NCT00588692|20906455|P1|Overall Study|Severe Peptic Ulcer Disease|1
6049452|NCT00588692|20906454|P2|Overall Study|Hip Surgery|1
6049453|NCT00588692|20906455|P1|Overall Study|Hip Surgery|0
6049454|NCT00588692|20906454|P2|Overall Study|Withdrawal by Subject|2
6049455|NCT00588692|20906455|P1|Overall Study|Withdrawal by Subject|4
6049456|NCT00588666|20906491|P1|Overall Study|Adverse Event|4
6049457|NCT00588640|20906496|P1|Overall Study|Ineligible Patient|1
6049458|NCT00588640|20906496|P1|Overall Study|Physician Decision|1
6049459|NCT00588445|20906515|P1|Overall Study|Not Treated|10
6049460|NCT00588445|20906515|P1|Overall Study|Disease Progression|1
6049461|NCT00588445|20906515|P1|Overall Study|Withdrawal by Subject|3
6049462|NCT00588445|20906515|P1|Overall Study|Protocol Violation|1
6049463|NCT00588354|20906539|P2|Baseline to 4 Weeks|Lost to Follow-up|1
6049464|NCT00588354|20906540|P1|Baseline to 4 Weeks|Lost to Follow-up|0
6049465|NCT00588354|20906539|P2|Baseline to 2 Weeks|Lack of Efficacy|0
6049466|NCT00588354|20906540|P1|Baseline to 2 Weeks|Lack of Efficacy|1
6049467|NCT00588354|20906539|P2|Baseline to 2 Weeks|Adverse Event|0
6049468|NCT00588354|20906540|P1|Baseline to 2 Weeks|Adverse Event|1
6049469|NCT00588341|20906560|P1|Overall Study|Patient ineligible|1
6049470|NCT00588341|20906560|P1|Overall Study|Not treated due to metastatic disease|1
6049471|NCT00588341|20906560|P1|Overall Study|Withdrawal by Subject|3
6049472|NCT00588237|20906564|P1|Overall Study|Patien not treated|1
6049473|NCT00588237|20906564|P1|Overall Study|Evaluable for toxicity only|3
6049474|NCT00588146|20906587|P2|First Intervention (Baseline to 6 mo)|Adverse Event|3
6049475|NCT00588146|20906588|P1|First Intervention (Baseline to 6 mo)|Adverse Event|4
6049476|NCT00588094|20906594|P1|Overall Study|Progression of Disease|2
6049477|NCT00588094|20906594|P1|Overall Study|Adverse Event|3
6049478|NCT00587990|20906601|P3|Overall Study|Death|1
6049479|NCT00587990|20906602|P2|Overall Study|Death|0
6049480|NCT00587990|20906603|P1|Overall Study|Death|0
6049481|NCT00587964|20906646|P1|Overall Study|Progression of Disease|4
6049482|NCT00587964|20906646|P1|Overall Study|Patient did not receive intervention|5
6049483|NCT00587964|20906646|P1|Overall Study|Patient found to be ineligible|1
6049484|NCT00587964|20906646|P1|Overall Study|Lost to Follow-up|1
6049485|NCT00587964|20906646|P1|Overall Study|Withdrawal by Subject|1
6049486|NCT00587860|20906652|P2|Overall Study|Withdrawal by Subject|3
6049487|NCT00587860|20906653|P1|Overall Study|Withdrawal by Subject|3
6049488|NCT00587860|20906652|P2|Overall Study|Lost to Follow-up|2
6049489|NCT00587860|20906653|P1|Overall Study|Lost to Follow-up|2
6049490|NCT00587847|20906673|P1|Overall Study|Adverse Event|2
6049491|NCT00587847|20906673|P1|Overall Study|Lack of Efficacy|5
6049492|NCT00587795|20906696|P2|Overall Study|Withdrawal by Subject|0
6049493|NCT00587795|20906697|P1|Overall Study|Withdrawal by Subject|1
6049494|NCT00587639|20906751|P1|Overall Study|Withdrawal by Subject|1
6049495|NCT00587587|20906758|P2|Overall Study|Lost to Follow-up|1
6049496|NCT00587587|20906759|P1|Overall Study|Lost to Follow-up|6
6049497|NCT00587457|20906813|P3|Overall Study|Development of neutralizing Abs|1
6049498|NCT00587457|20906814|P2|Overall Study|Development of neutralizing Abs|0
6049499|NCT00587457|20906815|P1|Overall Study|Development of neutralizing Abs|0
6049500|NCT00587457|20906813|P3|Overall Study|Undefined|1
6049501|NCT00587457|20906814|P2|Overall Study|Undefined|0
6049502|NCT00587457|20906815|P1|Overall Study|Undefined|0
6049503|NCT00587457|20906813|P3|Overall Study|Initiation of alternative therapy|0
6049504|NCT00587457|20906814|P2|Overall Study|Initiation of alternative therapy|1
6049505|NCT00587457|20906815|P1|Overall Study|Initiation of alternative therapy|0
6049507|NCT00587457|20906814|P2|Overall Study|Disease progression|0
6049508|NCT00587457|20906815|P1|Overall Study|Disease progression|2
6049509|NCT00587457|20906813|P3|Overall Study|Adverse Event|1
6049510|NCT00587457|20906814|P2|Overall Study|Adverse Event|2
6049511|NCT00587457|20906815|P1|Overall Study|Adverse Event|1
6049512|NCT00587431|20906852|P2|Overall Study|Withdrawal by Subject|1
6049513|NCT00587431|20906853|P1|Overall Study|Withdrawal by Subject|0
6049514|NCT00587431|20906852|P2|Overall Study|Adverse Event|0
6049515|NCT00587431|20906853|P1|Overall Study|Adverse Event|1
6049516|NCT00587288|20906864|P2|Overall Study|Protocol Violation|0
6049517|NCT00587288|20906865|P1|Overall Study|Protocol Violation|1
6049518|NCT00587288|20906864|P2|Overall Study|Lack of Efficacy|8
6049519|NCT00587288|20906865|P1|Overall Study|Lack of Efficacy|2
6049520|NCT00587288|20906864|P2|Overall Study|Adverse Event|1
6049521|NCT00587288|20906865|P1|Overall Study|Adverse Event|0
6049522|NCT00587223|20906883|P1|Overall Study|Adverse Event|1
6049523|NCT00587171|20906900|P2|Overall Study|Lost to Follow-up|1
6049524|NCT00587171|20906901|P1|Overall Study|Lost to Follow-up|1
6049525|NCT00587158|20906931|P2|Overall Study|Subject did not want to take study med|1
6049526|NCT00587158|20906932|P1|Overall Study|Subject did not want to take study med|0
6049527|NCT00587158|20906931|P2|Overall Study|Death|1
6049528|NCT00587158|20906932|P1|Overall Study|Death|0
6049529|NCT00587158|20906931|P2|Overall Study|Lost to Follow-up|2
6049530|NCT00587158|20906932|P1|Overall Study|Lost to Follow-up|1
6049531|NCT00587158|20906931|P2|Overall Study|Physician Decision|1
6049532|NCT00587158|20906932|P1|Overall Study|Physician Decision|0
6049533|NCT00587158|20906931|P2|Overall Study|Did not want to do 24 hr urine collect.|3
6049534|NCT00587158|20906932|P1|Overall Study|Did not want to do 24 hr urine collect.|4
6049535|NCT00587054|20906985|P1|Overall Study|Patient not treated|9
6049536|NCT00586924|20907011|P6|Overall Study|Other|6
6049537|NCT00586924|20907012|P5|Overall Study|Other|1
6049538|NCT00586924|20907013|P4|Overall Study|Other|1
6049539|NCT00586924|20907014|P3|Overall Study|Other|1
6049540|NCT00586924|20907015|P2|Overall Study|Other|0
6049541|NCT00586924|20907016|P1|Overall Study|Other|1
6049542|NCT00586924|20907011|P6|Overall Study|Complete response|2
6049543|NCT00586924|20907012|P5|Overall Study|Complete response|2
6049544|NCT00586924|20907013|P4|Overall Study|Complete response|0
6049545|NCT00586924|20907014|P3|Overall Study|Complete response|0
6049546|NCT00586924|20907015|P2|Overall Study|Complete response|1
6049547|NCT00586924|20907016|P1|Overall Study|Complete response|0
6049548|NCT00586924|20907011|P6|Overall Study|Development of neutralizing antibodies|22
6049549|NCT00586924|20907012|P5|Overall Study|Development of neutralizing antibodies|0
6049550|NCT00586924|20907013|P4|Overall Study|Development of neutralizing antibodies|0
6049551|NCT00586924|20907014|P3|Overall Study|Development of neutralizing antibodies|2
6049552|NCT00586924|20907015|P2|Overall Study|Development of neutralizing antibodies|2
6049553|NCT00586924|20907016|P1|Overall Study|Development of neutralizing antibodies|2
6049554|NCT00586924|20907011|P6|Overall Study|Disease progression|0
6049555|NCT00586924|20907012|P5|Overall Study|Disease progression|1
6049556|NCT00586924|20907013|P4|Overall Study|Disease progression|1
6049557|NCT00586924|20907014|P3|Overall Study|Disease progression|0
6049558|NCT00586924|20907015|P2|Overall Study|Disease progression|0
6049559|NCT00586924|20907016|P1|Overall Study|Disease progression|0
6049560|NCT00586924|20907011|P6|Overall Study|Initiation of alternative cancer therapy|1
6049561|NCT00586924|20907012|P5|Overall Study|Initiation of alternative cancer therapy|0
6049562|NCT00586924|20907013|P4|Overall Study|Initiation of alternative cancer therapy|0
6049563|NCT00586924|20907014|P3|Overall Study|Initiation of alternative cancer therapy|0
6049564|NCT00586924|20907015|P2|Overall Study|Initiation of alternative cancer therapy|0
6049565|NCT00586924|20907016|P1|Overall Study|Initiation of alternative cancer therapy|0
6049566|NCT00586924|20907011|P6|Overall Study|Adverse event/serious adverse event|2
6049567|NCT00586924|20907012|P5|Overall Study|Adverse event/serious adverse event|0
6049568|NCT00586924|20907013|P4|Overall Study|Adverse event/serious adverse event|1
6049569|NCT00586924|20907014|P3|Overall Study|Adverse event/serious adverse event|0
6049570|NCT00586924|20907015|P2|Overall Study|Adverse event/serious adverse event|0
6049571|NCT00586924|20907016|P1|Overall Study|Adverse event/serious adverse event|0
6049572|NCT00586898|20907216|P1|Overall Study|Evaluable for Toxicity Only|5
6049573|NCT00586898|20907216|P1|Overall Study|Patiemt Non-compliance|1
6049574|NCT00586898|20907216|P1|Overall Study|Adverse Event|1
6049575|NCT00586846|20907220|P1|Overall Study|Evaluable for Toxicity Only|4
6049576|NCT00586846|20907220|P1|Overall Study|Death|1
6049577|NCT00586846|20907220|P1|Overall Study|Physician Decision|1
6049578|NCT00586820|20907226|P2|Overall Study|Unsuccessful PCI|0
6049579|NCT00586820|20907227|P1|Overall Study|Unsuccessful PCI|1
6049580|NCT00586703|20907258|P1|Overall Study|Death|12
6049581|NCT00586690|20907265|P2|Overall Study|Lab can't accommodate|0
6049582|NCT00586690|20907266|P1|Overall Study|Lab can't accommodate|1
6049583|NCT00586690|20907265|P2|Overall Study|Lack of Efficacy|0
6049584|NCT00586690|20907266|P1|Overall Study|Lack of Efficacy|2
6049585|NCT00586690|20907265|P2|Overall Study|Adverse Event|0
6049586|NCT00586690|20907266|P1|Overall Study|Adverse Event|1
6049587|NCT00586690|20907265|P2|Overall Study|Disease Progression|0
6049588|NCT00586690|20907266|P1|Overall Study|Disease Progression|10
6049589|NCT00586690|20907265|P2|Overall Study|Death|0
6049590|NCT00586690|20907266|P1|Overall Study|Death|2
6049591|NCT00586664|20907276|P3|Overall Study|Exclusion criteria met|0
6049592|NCT00586664|20907277|P2|Overall Study|Exclusion criteria met|0
6049593|NCT00586664|20907278|P1|Overall Study|Exclusion criteria met|2
6049594|NCT00586664|20907276|P3|Overall Study|Withdrawal by Subject|1
6049595|NCT00586664|20907277|P2|Overall Study|Withdrawal by Subject|7
6049596|NCT00586664|20907278|P1|Overall Study|Withdrawal by Subject|3
6049597|NCT00586625|20907324|P2|Overall Study|Subject unable to return for visit|0
6049598|NCT00586625|20907325|P1|Overall Study|Subject unable to return for visit|2
6049599|NCT00586625|20907324|P2|Overall Study|Subject non-compliance|1
6049600|NCT00586625|20907325|P1|Overall Study|Subject non-compliance|0
6049601|NCT00586625|20907324|P2|Overall Study|Withdrawal by Subject|10
6049602|NCT00586625|20907325|P1|Overall Study|Withdrawal by Subject|32
6049603|NCT00586625|20907324|P2|Overall Study|Protocol Violation|0
6049604|NCT00586625|20907325|P1|Overall Study|Protocol Violation|3
6049605|NCT00586625|20907324|P2|Overall Study|Adverse Event|6
6049606|NCT00586625|20907325|P1|Overall Study|Adverse Event|6
6049607|NCT00586612|20907333|P2|Booster Phase|Lost to Follow-up|1
6049608|NCT00586612|20907334|P1|Booster Phase|Lost to Follow-up|3
6049609|NCT00586612|20907333|P2|Primary Phase|Withdrawal by Subject|2
6049610|NCT00586612|20907334|P1|Primary Phase|Withdrawal by Subject|0
6049611|NCT00586612|20907333|P2|Primary Phase|Lost to Follow-up|1
6049612|NCT00586612|20907334|P1|Primary Phase|Lost to Follow-up|0
6049613|NCT00586612|20907333|P2|Primary Phase|Protocol Violation|0
6049614|NCT00586612|20907334|P1|Primary Phase|Protocol Violation|1
6049615|NCT00586521|20907404|P1|On Demand Treatment (Months 1-6)|Withdrawal by Subject|1
6049616|NCT00586508|20907413|P2|Overall Study|Withdrawal by Subject|0
6049617|NCT00586508|20907414|P1|Overall Study|Withdrawal by Subject|4
6049618|NCT00586508|20907413|P2|Overall Study|Adverse Event|4
6049619|NCT00586508|20907414|P1|Overall Study|Adverse Event|12
6049620|NCT00586508|20907413|P2|Overall Study|Death|1
6049621|NCT00586508|20907414|P1|Overall Study|Death|0
6049622|NCT00586508|20907413|P2|Overall Study|Progressive disease|8
6049623|NCT00586508|20907414|P1|Overall Study|Progressive disease|52
6049624|NCT00586495|20907430|P1|Follow-up|Switch to commercial drug|10
6049625|NCT00586495|20907430|P1|Follow-up|Protocol driven decision point|37
6049626|NCT00586495|20907430|P1|Follow-up|Withdrawal by Subject|4
6049627|NCT00586495|20907430|P1|Follow-up|Lost to Follow-up|1
6049628|NCT00586495|20907430|P1|Follow-up|Death|40
6049629|NCT00586495|20907430|P1|Treatment Period|Switch to commercial drug|10
6049630|NCT00586495|20907430|P1|Treatment Period|Disease progression, recurrence/relapse|71
6049631|NCT00586495|20907430|P1|Treatment Period|Withdrawal by Subject|1
6049632|NCT00586495|20907430|P1|Treatment Period|Protocol Violation|1
6049633|NCT00586495|20907430|P1|Treatment Period|Death|1
6049634|NCT00586495|20907430|P1|Treatment Period|Adverse Event|11
6049635|NCT00586469|20907459|P2|Overall Study|Adverse Event|1
6049636|NCT00586469|20907460|P1|Overall Study|Adverse Event|0
6049637|NCT00586339|20907487|P3|Overall Study|Lost to Follow-up|1
6049638|NCT00586339|20907488|P2|Overall Study|Lost to Follow-up|2
6049639|NCT00586339|20907489|P1|Overall Study|Lost to Follow-up|3
6049640|NCT00586339|20907487|P3|Overall Study|Migrated/moved from study area|4
6049641|NCT00586339|20907488|P2|Overall Study|Migrated/moved from study area|2
6049642|NCT00586339|20907489|P1|Overall Study|Migrated/moved from study area|3
6049643|NCT00586339|20907487|P3|Overall Study|Withdrawal by Subject|1
6049644|NCT00586339|20907488|P2|Overall Study|Withdrawal by Subject|3
6049645|NCT00586339|20907489|P1|Overall Study|Withdrawal by Subject|1
6049646|NCT00586326|20907590|P1|Treated Through 5-yr Follow Up-Treated|Other|2
6049647|NCT00586326|20907590|P1|Treated Through 5-yr Follow Up-Treated|Lost to Follow-up|14
6049648|NCT00586326|20907590|P1|Treated Through 5-yr Follow Up-Treated|Withdrawal by Subject|5
6049649|NCT00586326|20907590|P1|Treated Through 5-yr Follow Up-Treated|Medical Reason|2
6049650|NCT00586326|20907590|P1|Treated Through 5-yr Follow Up-Treated|Death|2
6049651|NCT00586326|20907590|P1|Treated Through 5-yr Follow Up-Treated|Clinical Reason|1
6049652|NCT00586326|20907590|P1|Device Placed toTreatment-ITT|Physician Decision|1
6049653|NCT00586326|20907590|P1|Device Placed toTreatment-ITT|Positive Margins|3
6049654|NCT00586326|20907590|P1|Device Placed toTreatment-ITT|Microinvasion|1
6049655|NCT00586326|20907590|P1|Device Placed toTreatment-ITT|Cavity Conformance|6
6049656|NCT00586326|20907590|P1|Device Placed toTreatment-ITT|Skin Distance|7
6049657|NCT00586326|20907590|P1|Enrollment to Device Placement-Enrolled|Other|1
6049658|NCT00586326|20907590|P1|Enrollment to Device Placement-Enrolled|Withdrawal by Subject|1
6049659|NCT00586326|20907590|P1|Enrollment to Device Placement-Enrolled|Physician Decision|1
6049660|NCT00586326|20907590|P1|Enrollment to Device Placement-Enrolled|Microinvasion|2
6049661|NCT00586326|20907590|P1|Enrollment to Device Placement-Enrolled|Cavity Conformance|4
6049662|NCT00586326|20907590|P1|Enrollment to Device Placement-Enrolled|Skin Distance|6
6049663|NCT00586313|20907601|P1|Overall Study|Lack of Efficacy|2
6049664|NCT00586157|20907637|P2|Second Intervention|Adverse Event|1
6049665|NCT00586157|20907638|P1|Second Intervention|Adverse Event|0
6049666|NCT00586157|20907637|P2|Second Intervention|Worsening behavior|0
6049667|NCT00586157|20907638|P1|Second Intervention|Worsening behavior|1
6049668|NCT00586157|20907637|P2|Second Intervention|Withdrawal by Subject|0
6049669|NCT00586157|20907638|P1|Second Intervention|Withdrawal by Subject|1
6049670|NCT00586157|20907637|P2|First Intervention|Worsening behavior|0
6049671|NCT00586157|20907638|P1|First Intervention|Worsening behavior|1
6049672|NCT00586105|20907648|P1|Overall Study|Reason not reported|1
6049673|NCT00586105|20907648|P1|Overall Study|Switched to commercial drug|9
6049674|NCT00586105|20907648|P1|Overall Study|Disease progression|19
6049675|NCT00586105|20907648|P1|Overall Study|Withdrawal by Subject|3
6049676|NCT00586105|20907648|P1|Overall Study|Protocol Violation|1
6049677|NCT00586105|20907648|P1|Overall Study|Death|2
6049678|NCT00586105|20907648|P1|Overall Study|Adverse Event|4
6049679|NCT00586066|20907663|P2|Overall Study|Withdrawal of consent|2
6049680|NCT00586066|20907664|P1|Overall Study|Withdrawal of consent|4
6049681|NCT00586066|20907663|P2|Overall Study|Physician Decision|0
6049682|NCT00586066|20907664|P1|Overall Study|Physician Decision|1
6049683|NCT00586066|20907663|P2|Overall Study|Adverse Event|2
6049684|NCT00586066|20907664|P1|Overall Study|Adverse Event|2
6049685|NCT00586066|20907663|P2|Overall Study|Lack of Efficacy|3
6049686|NCT00586066|20907664|P1|Overall Study|Lack of Efficacy|5
6049687|NCT00586066|20907663|P2|Overall Study|Lost to Follow-up|3
6049688|NCT00586066|20907664|P1|Overall Study|Lost to Follow-up|6
6049689|NCT00585975|20907721|P2|Overall Study|Enrollment met/over-enrolled|9
6049690|NCT00585975|20907722|P1|Overall Study|Enrollment met/over-enrolled|10
6049691|NCT00585975|20907721|P2|Overall Study|Lost to Follow-up|1
6049692|NCT00585975|20907722|P1|Overall Study|Lost to Follow-up|2
6049693|NCT00585975|20907721|P2|Overall Study|Withdrawal by Subject|3
6049694|NCT00585975|20907722|P1|Overall Study|Withdrawal by Subject|3
6049695|NCT00585923|20907732|P2|Overall Study|Physician decided not to continue|33
6049696|NCT00585923|20907733|P1|Overall Study|Physician decided not to continue|31
6049697|NCT00585689|20907785|P1|Overall Study|Death|1
6049698|NCT00585689|20907785|P1|Overall Study|Patient had unresectable disease|1
6049699|NCT00585689|20907785|P1|Overall Study|Patient Declined Surgery|1
6049700|NCT00585689|20907785|P1|Overall Study|Adverse Event|1
6049701|NCT00585689|20907785|P1|Overall Study|Received different ABI-007 schedule|3
6049702|NCT00585585|20907844|P1|Overall Study|Adverse Event|1
6049703|NCT00585546|20907848|P1|Clenbuterol Treatment - up to 12 Months|Adverse Event|3
6049704|NCT00585546|20907848|P1|Clenbuterol Treatment - up to 12 Months|Death|1
6049705|NCT00585533|20907862|P1|Overall Study|objective or symptomatic progression|9
6049706|NCT00585468|20907871|P2|First Intervention|Withdrawal by Subject|1
6049707|NCT00585468|20907872|P1|First Intervention|Withdrawal by Subject|1
6049708|NCT00585351|20907904|P8|Enrollment Period (Intervention)|Unknown if alive or deceased|0
6049709|NCT00585351|20907905|P7|Enrollment Period (Intervention)|Unknown if alive or deceased|0
6049710|NCT00585351|20907906|P6|Enrollment Period (Intervention)|Unknown if alive or deceased|2
6049711|NCT00585351|20907907|P5|Enrollment Period (Intervention)|Unknown if alive or deceased|1
6049712|NCT00585351|20907908|P4|Enrollment Period (Intervention)|Unknown if alive or deceased|0
6049713|NCT00585351|20907909|P3|Enrollment Period (Intervention)|Unknown if alive or deceased|0
6049714|NCT00585351|20907910|P2|Enrollment Period (Intervention)|Unknown if alive or deceased|0
6049715|NCT00585351|20907911|P1|Enrollment Period (Intervention)|Unknown if alive or deceased|0
6049716|NCT00585351|20907904|P8|Enrollment Period (Intervention)|Death|0
6049717|NCT00585351|20907905|P7|Enrollment Period (Intervention)|Death|1
6049718|NCT00585351|20907906|P6|Enrollment Period (Intervention)|Death|0
6049719|NCT00585351|20907907|P5|Enrollment Period (Intervention)|Death|1
6049720|NCT00585351|20907908|P4|Enrollment Period (Intervention)|Death|0
6049721|NCT00585351|20907909|P3|Enrollment Period (Intervention)|Death|0
6049722|NCT00585351|20907910|P2|Enrollment Period (Intervention)|Death|0
6049723|NCT00585351|20907911|P1|Enrollment Period (Intervention)|Death|0
6049724|NCT00585351|20907904|P8|Enrollment Period (Intervention)|Lost to Follow-up|1
6049725|NCT00585351|20907905|P7|Enrollment Period (Intervention)|Lost to Follow-up|1
6049726|NCT00585351|20907906|P6|Enrollment Period (Intervention)|Lost to Follow-up|0
6049727|NCT00585351|20907907|P5|Enrollment Period (Intervention)|Lost to Follow-up|0
6049728|NCT00585351|20907908|P4|Enrollment Period (Intervention)|Lost to Follow-up|0
6049729|NCT00585351|20907909|P3|Enrollment Period (Intervention)|Lost to Follow-up|0
6049730|NCT00585351|20907910|P2|Enrollment Period (Intervention)|Lost to Follow-up|0
6049731|NCT00585351|20907911|P1|Enrollment Period (Intervention)|Lost to Follow-up|0
6049732|NCT00585351|20907904|P8|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
6049733|NCT00585351|20907905|P7|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
6049734|NCT00585351|20907906|P6|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
6049735|NCT00585351|20907907|P5|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
6049736|NCT00585351|20907908|P4|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
6049737|NCT00585351|20907909|P3|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
6049738|NCT00585351|20907910|P2|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21
6049739|NCT00585351|20907911|P1|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21
6049740|NCT00585351|20907904|P8|Notification Period (Informed Consent)|No study medication on flight|0
6049741|NCT00585351|20907905|P7|Notification Period (Informed Consent)|No study medication on flight|0
6049742|NCT00585351|20907906|P6|Notification Period (Informed Consent)|No study medication on flight|0
6049743|NCT00585351|20907907|P5|Notification Period (Informed Consent)|No study medication on flight|0
6049744|NCT00585351|20907908|P4|Notification Period (Informed Consent)|No study medication on flight|0
6049745|NCT00585351|20907909|P3|Notification Period (Informed Consent)|No study medication on flight|0
6049746|NCT00585351|20907910|P2|Notification Period (Informed Consent)|No study medication on flight|1
6049747|NCT00585351|20907911|P1|Notification Period (Informed Consent)|No study medication on flight|0
6049748|NCT00585351|20907904|P8|Notification Period (Informed Consent)|Flight aborted|0
6049749|NCT00585351|20907905|P7|Notification Period (Informed Consent)|Flight aborted|0
6049750|NCT00585351|20907906|P6|Notification Period (Informed Consent)|Flight aborted|0
6049751|NCT00585351|20907907|P5|Notification Period (Informed Consent)|Flight aborted|0
6049752|NCT00585351|20907908|P4|Notification Period (Informed Consent)|Flight aborted|0
6049753|NCT00585351|20907909|P3|Notification Period (Informed Consent)|Flight aborted|0
6049754|NCT00585351|20907910|P2|Notification Period (Informed Consent)|Flight aborted|1
6049755|NCT00585351|20907911|P1|Notification Period (Informed Consent)|Flight aborted|2
6049756|NCT00585351|20907904|P8|Notification Period (Informed Consent)|Physician Decision|0
6049757|NCT00585351|20907905|P7|Notification Period (Informed Consent)|Physician Decision|0
6049758|NCT00585351|20907906|P6|Notification Period (Informed Consent)|Physician Decision|0
6049759|NCT00585351|20907907|P5|Notification Period (Informed Consent)|Physician Decision|0
6049760|NCT00585351|20907908|P4|Notification Period (Informed Consent)|Physician Decision|0
6049761|NCT00585351|20907909|P3|Notification Period (Informed Consent)|Physician Decision|0
6049762|NCT00585351|20907910|P2|Notification Period (Informed Consent)|Physician Decision|2
6049763|NCT00585351|20907911|P1|Notification Period (Informed Consent)|Physician Decision|0
6049764|NCT00585325|20907927|P2|Overall Study|Withdrawal by Subject|1
6049765|NCT00585325|20907928|P1|Overall Study|Withdrawal by Subject|1
6049778|NCT00585286|20907949|P1|Overall Study|Lost to Follow-up|1
6049779|NCT00585221|20907965|P1|Overall Study|Protocol Violation|8
6049780|NCT00585169|20907975|P1|Overall Study|Withdrawal by Subject|1
6049781|NCT00585078|20907985|P1|Overall Study|Death|1
6049782|NCT00585078|20907985|P1|Overall Study|Adverse Event|10
6049783|NCT00585078|20907985|P1|Overall Study|Disease Progression|24
6049784|NCT00585078|20907985|P1|Overall Study|Poor performance status|1
6049785|NCT00585078|20907985|P1|Overall Study|Withdrawal by Subject|4
6049786|NCT00585052|20907992|P1|Overall Study|Withdrawal by Subject|1
6049787|NCT00585039|20907999|P2|Overall Study|medication spilled|0
6049788|NCT00585039|20908000|P1|Overall Study|medication spilled|2
6049789|NCT00584987|20908029|P4|Overall Study|Adverse Event|1
6049790|NCT00584987|20908030|P3|Overall Study|Adverse Event|0
6049791|NCT00584987|20908031|P2|Overall Study|Adverse Event|0
6049792|NCT00584987|20908032|P1|Overall Study|Adverse Event|0
6049793|NCT00584987|20908029|P4|Overall Study|Protocol Violation|0
6049794|NCT00584987|20908030|P3|Overall Study|Protocol Violation|1
6049795|NCT00584987|20908031|P2|Overall Study|Protocol Violation|1
6049796|NCT00584987|20908032|P1|Overall Study|Protocol Violation|1
6049797|NCT00584909|20908084|P1|Overall Study|Adverse Event|4
6049798|NCT00584844|20908094|P1|Overall Study|Screen Failure|20
6049799|NCT00584844|20908094|P1|Overall Study|Withdrawal by Subject|59
6049800|NCT00584805|20908144|P1|Overall Study|Screen failures|2
6049801|NCT00584805|20908144|P1|Overall Study|Lost to follow up|3
6049802|NCT00584805|20908144|P1|Overall Study|Non-compliance|1
6049803|NCT00584805|20908144|P1|Overall Study|Withdrawal by Subject|18
6049804|NCT00584805|20908144|P1|Overall Study|Relocation|36
6049805|NCT00584805|20908144|P1|Overall Study|No longer at risk of exposure|39
6049806|NCT00584740|20908157|P2|Overall Study|Lost to Follow-up|1
6049807|NCT00584740|20908158|P1|Overall Study|Lost to Follow-up|0
6049808|NCT00584740|20908157|P2|Overall Study|Withdrawal by Subject|2
6049809|NCT00584740|20908158|P1|Overall Study|Withdrawal by Subject|3
6049810|NCT00584740|20908157|P2|Overall Study|Lack of Efficacy|2
6049811|NCT00584740|20908158|P1|Overall Study|Lack of Efficacy|8
6049812|NCT00584740|20908157|P2|Overall Study|Adverse Event|1
6049813|NCT00584740|20908158|P1|Overall Study|Adverse Event|1
6049814|NCT00584727|20908176|P6|Third Intervention|Protocol Violation|2
6049815|NCT00584727|20908177|P5|Third Intervention|Protocol Violation|4
6049816|NCT00584727|20908178|P4|Third Intervention|Protocol Violation|0
6049817|NCT00584727|20908179|P3|Third Intervention|Protocol Violation|1
6049818|NCT00584727|20908180|P2|Third Intervention|Protocol Violation|0
6049819|NCT00584727|20908181|P1|Third Intervention|Protocol Violation|0
6049820|NCT00584727|20908176|P6|First Intervention|Discontinuation|0
6049821|NCT00584727|20908177|P5|First Intervention|Discontinuation|0
6049822|NCT00584727|20908178|P4|First Intervention|Discontinuation|0
6049823|NCT00584727|20908179|P3|First Intervention|Discontinuation|1
6049824|NCT00584727|20908180|P2|First Intervention|Discontinuation|0
6049825|NCT00584727|20908181|P1|First Intervention|Discontinuation|0
6049826|NCT00584454|20908219|P1|Overall Study|Clinical Hold|2
6049827|NCT00584454|20908219|P1|Overall Study|Relocation|1
6049828|NCT00584454|20908219|P1|Overall Study|Adverse Event|1
6049829|NCT00584415|20908223|P1|Overall Study|Adverse Event|7
6049830|NCT00584194|20908246|P1|Overall Study|Other|135
6049831|NCT00584012|20908259|P1|Overall Study|Withdrawal by Subject|1
6049832|NCT00583947|20908265|P2|Cross-over Period|Other|1
6049833|NCT00583947|20908266|P1|Cross-over Period|Other|1
6049834|NCT00583947|20908265|P2|Cross-over Period|Did not meet-no longer met entry criteri|1
6049835|NCT00583947|20908266|P1|Cross-over Period|Did not meet-no longer met entry criteri|0
6049836|NCT00583947|20908265|P2|Cross-over Period|Withdrawal by Subject|0
6049837|NCT00583947|20908266|P1|Cross-over Period|Withdrawal by Subject|2
6049838|NCT00583947|20908265|P2|Cross-over Period|Adverse Event|0
6049839|NCT00583947|20908266|P1|Cross-over Period|Adverse Event|2
6049840|NCT00583791|20908387|P1|Overall Study|Death|6
6049841|NCT00583791|20908387|P1|Overall Study|Other|67
6049842|NCT00583596|20908442|P1|Overall Study|Outside f-up window|26
6049843|NCT00583596|20908442|P1|Overall Study|Not consented|15
6049844|NCT00583596|20908442|P1|Overall Study|Data not complete|1
6049845|NCT00583596|20908442|P1|Overall Study|Lost to Follow-up|94
6049846|NCT00583596|20908442|P1|Overall Study|Withdrawal by Subject|6
6049847|NCT00583596|20908442|P1|Overall Study|Death|2
6049848|NCT00583596|20908442|P1|Overall Study|Excluded due to Hurricane Katrina|30
6049849|NCT00583596|20908442|P1|Overall Study|Lost to Follow-up|110
6049850|NCT00583557|20908447|P1|Overall Study|Did not receive belimumab in LBRA99|2
6049851|NCT00583557|20908447|P1|Overall Study|Other|5
6049852|NCT00583557|20908447|P1|Overall Study|Lack of Compliance|5
6049853|NCT00583557|20908447|P1|Overall Study|Lack of Efficacy|31
6049854|NCT00583557|20908447|P1|Overall Study|Adverse Event|9
6049855|NCT00583557|20908447|P1|Overall Study|Withdrawal by Subject|18
6049856|NCT00583453|20908478|P2|Overall Study|discontinued intervention|2
6049857|NCT00583453|20908479|P1|Overall Study|discontinued intervention|0
6049858|NCT00583362|20908516|P1|Overall Study|Withdrawal by Subject|57
6049859|NCT00583362|20908516|P1|Overall Study|Protocol Violation|2
6049860|NCT00583362|20908516|P1|Overall Study|Physician Decision|19
6049861|NCT00583362|20908516|P1|Overall Study|Sponsor request due to missed doses|1
6049862|NCT00583362|20908516|P1|Overall Study|Behavioral problems and non-compliance|1
6049863|NCT00583362|20908516|P1|Overall Study|Misunderstanding of protocol|1
6049864|NCT00583362|20908516|P1|Overall Study|Missed visits due to staff changes|1
6049865|NCT00583362|20908516|P1|Overall Study|Subject moved out of the country/state|2
6049866|NCT00583362|20908516|P1|Overall Study|Subject not dosed in LBSL99|1
6049867|NCT00583362|20908516|P1|Overall Study|Current site closed|7
6049868|NCT00583362|20908516|P1|Overall Study|Miscommunication of visit window|5
6049869|NCT00583362|20908516|P1|Overall Study|Pregnancy|7
6049870|NCT00583362|20908516|P1|Overall Study|Non-compliance with study drug|28
6049871|NCT00583362|20908516|P1|Overall Study|Lost to Follow-up|4
6049872|NCT00583362|20908516|P1|Overall Study|Lack of Efficacy|22
6049873|NCT00583362|20908516|P1|Overall Study|Adverse Event|44
6049874|NCT00583219|20908540|P1|Phase 2|Withdrawal by Subject|1
6049875|NCT00583115|20908557|P1|Overall Study|Death|1
6049876|NCT00583102|20908562|P1|Overall Study|Adverse Event|3
6049877|NCT00582972|20908579|P1|Overall Study|Protocol Violation|2
6049878|NCT00582933|20908588|P1|Overall Study|Physician Decision|3
6049879|NCT00582907|20908592|P4|2nd Course|Lack of Efficacy|0
6049880|NCT00582907|20908593|P3|2nd Course|Lack of Efficacy|0
6049881|NCT00582907|20908594|P2|2nd Course|Lack of Efficacy|0
6049882|NCT00582907|20908595|P1|2nd Course|Lack of Efficacy|1
6049883|NCT00582907|20908592|P4|1st Course|Lost to Follow-up|1
6049884|NCT00582907|20908593|P3|1st Course|Lost to Follow-up|0
6049885|NCT00582907|20908594|P2|1st Course|Lost to Follow-up|0
6049886|NCT00582907|20908595|P1|1st Course|Lost to Follow-up|0
6049887|NCT00582907|20908592|P4|1st Course|Withdrawal by Subject|0
6049888|NCT00582907|20908593|P3|1st Course|Withdrawal by Subject|0
6049889|NCT00582907|20908594|P2|1st Course|Withdrawal by Subject|0
6049890|NCT00582907|20908595|P1|1st Course|Withdrawal by Subject|1
6049891|NCT00582816|20908634|P1|Overall Study|Engraftment Failure|3
6049892|NCT00582790|20908644|P1|Overall Study|Rapid progression of disease|1
6049893|NCT00582738|20908653|P2|Overall Study|Withdrawal by Subject|3
6049894|NCT00582738|20908654|P1|Overall Study|Withdrawal by Subject|0
6049895|NCT00582738|20908653|P2|Overall Study|Protocol Violation|1
6049896|NCT00582738|20908654|P1|Overall Study|Protocol Violation|1
6049897|NCT00582738|20908653|P2|Overall Study|Other|0
6049898|NCT00582738|20908654|P1|Overall Study|Other|1
6049899|NCT00582738|20908653|P2|Overall Study|Graft Lost|1
6049900|NCT00582738|20908654|P1|Overall Study|Graft Lost|0
6049901|NCT00582738|20908653|P2|Overall Study|Adverse Event|5
6049902|NCT00582738|20908654|P1|Overall Study|Adverse Event|0
6049903|NCT00582738|20908653|P2|Overall Study|Administrative Problems|8
6049904|NCT00582738|20908654|P1|Overall Study|Administrative Problems|7
6049905|NCT00582712|20908678|P1|Overall Study|Complicating disease requiring treatment|1
6049906|NCT00582712|20908678|P1|Overall Study|Withdrawal by Subject|1
6049907|NCT00582712|20908678|P1|Overall Study|Lack of Efficacy|1
6049908|NCT00582712|20908678|P1|Overall Study|Adverse Event|1
6049909|NCT00582608|20908693|P1|Overall Study|Lack of accrual|4
6049910|NCT00582608|20908693|P1|Overall Study|Patient Ineligible|1
6049911|NCT00582608|20908693|P1|Overall Study|Not Treated|7
6049912|NCT00582556|20908700|P3|Overall Study|Physician Decision|1
6049913|NCT00582556|20908701|P2|Overall Study|Physician Decision|0
6049914|NCT00582556|20908702|P1|Overall Study|Physician Decision|0
6049915|NCT00582556|20908700|P3|Overall Study|Withdrawal by Subject|1
6049916|NCT00582556|20908701|P2|Overall Study|Withdrawal by Subject|1
6049917|NCT00582556|20908702|P1|Overall Study|Withdrawal by Subject|0
6049918|NCT00582491|20908730|P2|Overall Study|Withdrawal by Subject|0
6049919|NCT00582491|20908731|P1|Overall Study|Withdrawal by Subject|1
6049920|NCT00582426|20908755|P2|Overall Study|Use of illicit drugs|0
6049921|NCT00582426|20908756|P1|Overall Study|Use of illicit drugs|1
6049922|NCT00582426|20908755|P2|Overall Study|Disease Progression|2
6049923|NCT00582426|20908756|P1|Overall Study|Disease Progression|2
6049924|NCT00582426|20908755|P2|Overall Study|Withdrawal by Subject|2
6049925|NCT00582426|20908756|P1|Overall Study|Withdrawal by Subject|3
6049926|NCT00582426|20908755|P2|Overall Study|Death|3
6049927|NCT00582426|20908756|P1|Overall Study|Death|4
6049928|NCT00582426|20908755|P2|Overall Study|Protocol Violation|2
6049929|NCT00582426|20908756|P1|Overall Study|Protocol Violation|6
6049930|NCT00582426|20908755|P2|Overall Study|Adverse Event|2
6049931|NCT00582426|20908756|P1|Overall Study|Adverse Event|4
6049932|NCT00582426|20908755|P2|Overall Study|Lost to Follow-up|2
6049933|NCT00582426|20908756|P1|Overall Study|Lost to Follow-up|0
6049934|NCT00582309|20908803|P3|Overall Study|Protocol Violation|2
6049935|NCT00582309|20908804|P2|Overall Study|Protocol Violation|0
6049936|NCT00582309|20908805|P1|Overall Study|Protocol Violation|0
6049937|NCT00582166|20908818|P1|Overall Study|Ineligible pathology|1
6049938|NCT00582166|20908818|P1|Overall Study|Death|1
6049939|NCT00582114|20908828|P2|Overall Study|Stopped by data safety monitoring board|20
6049940|NCT00582114|20908829|P1|Overall Study|Stopped by data safety monitoring board|19
6049941|NCT00582114|20908828|P2|Overall Study|Physician Decision|6
6049942|NCT00582114|20908829|P1|Overall Study|Physician Decision|0
6049943|NCT00582114|20908828|P2|Overall Study|Adverse Event|1
6049944|NCT00582114|20908829|P1|Overall Study|Adverse Event|1
6049945|NCT00582114|20908828|P2|Overall Study|Withdrawal by Subject|16
6049946|NCT00582114|20908829|P1|Overall Study|Withdrawal by Subject|8
6049947|NCT00582114|20908828|P2|Overall Study|Lost to Follow-up|6
6049948|NCT00582114|20908829|P1|Overall Study|Lost to Follow-up|7
6049949|NCT00582114|20908828|P2|Overall Study|Kidney Transplant|1
6049950|NCT00582114|20908829|P1|Overall Study|Kidney Transplant|3
6049951|NCT00582114|20908828|P2|Overall Study|Death|4
6049952|NCT00582114|20908829|P1|Overall Study|Death|4
6049953|NCT00582036|20908844|P2|Overall Study|Withdrawal by Subject|1
6049954|NCT00582036|20908845|P1|Overall Study|Withdrawal by Subject|0
6049955|NCT00582010|20908853|P2|Overall Study|Death|1
6049956|NCT00582010|20908854|P1|Overall Study|Death|0
6049957|NCT00581945|20908883|P2|Overall Study|Death|0
6049958|NCT00581945|20908884|P1|Overall Study|Death|1
6049959|NCT00581945|20908883|P2|Overall Study|Withdrawal by Subject|6
6049960|NCT00581945|20908884|P1|Overall Study|Withdrawal by Subject|2
6049961|NCT00581945|20908883|P2|Overall Study|Unsatisfactory therapeutic effect|0
6049962|NCT00581945|20908884|P1|Overall Study|Unsatisfactory therapeutic effect|2
6049963|NCT00581945|20908883|P2|Overall Study|Adverse Event|4
6049964|NCT00581945|20908884|P1|Overall Study|Adverse Event|4
6049965|NCT00581919|20908900|P1|Overall Study|Withdrawal by Subject|1
6049966|NCT00581919|20908900|P1|Overall Study|Started Non-Protocol Therapy|2
6049967|NCT00581919|20908900|P1|Overall Study|Other Complicating Disease|1
6049968|NCT00581919|20908900|P1|Overall Study|Physician Decision|1
6049969|NCT00581919|20908900|P1|Overall Study|Disease Progression|10
6049970|NCT00581919|20908900|P1|Overall Study|Death|1
6049971|NCT00581919|20908900|P1|Overall Study|Adverse Event|8
6049972|NCT00581828|20908919|P1|Overall Study|Protocol Violation|1
6049973|NCT00581776|20908923|P1|Overall Study|Disease progression or no response|3
6049974|NCT00581555|20908941|P2|Overall Study|Other reasons|4
6049975|NCT00581555|20908942|P1|Overall Study|Other reasons|16
6049976|NCT00581555|20908941|P2|Overall Study|Lost to Follow-up|2
6049977|NCT00581555|20908942|P1|Overall Study|Lost to Follow-up|2
6049978|NCT00581555|20908941|P2|Overall Study|Withdrawal by Subject|9
6049979|NCT00581555|20908942|P1|Overall Study|Withdrawal by Subject|18
6049980|NCT00581555|20908941|P2|Overall Study|Physician Decision|2
6049981|NCT00581555|20908942|P1|Overall Study|Physician Decision|3
6049982|NCT00581555|20908941|P2|Overall Study|Adverse Event|3
6049983|NCT00581555|20908942|P1|Overall Study|Adverse Event|4
6049984|NCT00581542|20908966|P2|Overall Study|Lost to Follow-up|21
6049985|NCT00581542|20908967|P1|Overall Study|Lost to Follow-up|9
6049986|NCT00581542|20908966|P2|Overall Study|they met an exclusion criteria|2
6049987|NCT00581542|20908967|P1|Overall Study|they met an exclusion criteria|2
6049988|NCT00581360|20909021|P1|Overall Study|Withdrawal by Subject|1
6049989|NCT00581308|20909040|P1|Month 12|Other|1
6049990|NCT00581308|20909040|P1|Month 12|Device Removed|1
6049991|NCT00581308|20909040|P1|Month 12|Withdrawal by Subject|3
6049992|NCT00581308|20909040|P1|Month 12|Lost to Follow-up|14
6049993|NCT00581308|20909040|P1|Month 12|Death|1
6049994|NCT00581308|20909040|P1|Month 6|Withdrawal by Subject|2
6049995|NCT00581308|20909040|P1|Month 6|Lost to Follow-up|1
6049996|NCT00581308|20909040|P1|Month 1|Uknown|1
6049997|NCT00581308|20909040|P1|Month 1|Device Removed|2
6049998|NCT00581308|20909040|P1|Month 1|Withdrawal by Subject|2
6049999|NCT00581308|20909040|P1|Month 1|Lost to Follow-up|3
6050000|NCT00581308|20909040|P1|Pre Discharge|Device Removed|1
6050001|NCT00581308|20909040|P1|Pre Discharge|Lost to Follow-up|1
6050002|NCT00581113|20909071|P2|Overall Study|Withdrawal by Subject|1
6050003|NCT00581113|20909072|P1|Overall Study|Withdrawal by Subject|0
6050004|NCT00581100|20909082|P2|Overall Study|Other|0
6050005|NCT00581100|20909083|P1|Overall Study|Other|3
6050006|NCT00581100|20909082|P2|Overall Study|Withdrawal by Subject|4
6050007|NCT00581100|20909083|P1|Overall Study|Withdrawal by Subject|1
6050008|NCT00581100|20909082|P2|Overall Study|Adverse Event|1
6050009|NCT00581100|20909083|P1|Overall Study|Adverse Event|2
6050010|NCT00581100|20909082|P2|Overall Study|Death|0
6050011|NCT00581100|20909083|P1|Overall Study|Death|1
6050012|NCT00580983|20909136|P1|Overall Study|Did not complete 12 mon post RT studies|7
6050013|NCT00580970|20909143|P1|Treatment (Lovastatin)|Death|1
6050014|NCT00580970|20909143|P1|Treatment (Lovastatin)|Development of metastatic second primary|1
6050015|NCT00580970|20909143|P1|Treatment (Lovastatin)|Physician Decision|4
6050016|NCT00580970|20909143|P1|Treatment (Lovastatin)|Intolerance of Lovastatin|7
6050017|NCT00580970|20909143|P1|Treatment (Lovastatin)|Non-compliance|6
6050018|NCT00580970|20909143|P1|Pre-treatment|Non-compliance|1
6050019|NCT00580866|20909158|P2|Overall Study|Lost to Follow-up|2
6050020|NCT00580866|20909159|P1|Overall Study|Lost to Follow-up|2
6050021|NCT00580840|20909183|P4|Double-Blind|Other: Forbidden Medication|0
6050022|NCT00580840|20909184|P3|Double-Blind|Other: Forbidden Medication|1
6050023|NCT00580840|20909185|P2|Double-Blind|Other: Forbidden Medication|0
6050024|NCT00580840|20909186|P1|Double-Blind|Other: Forbidden Medication|0
6050025|NCT00580840|20909183|P4|Double-Blind|Other: Discontinued Methotrexate|0
6050026|NCT00580840|20909184|P3|Double-Blind|Other: Discontinued Methotrexate|0
6050027|NCT00580840|20909185|P2|Double-Blind|Other: Discontinued Methotrexate|1
6050028|NCT00580840|20909186|P1|Double-Blind|Other: Discontinued Methotrexate|0
6050029|NCT00580840|20909183|P4|Double-Blind|Withdrawal by Subject|2
6050030|NCT00580840|20909184|P3|Double-Blind|Withdrawal by Subject|2
6050031|NCT00580840|20909185|P2|Double-Blind|Withdrawal by Subject|1
6050032|NCT00580840|20909186|P1|Double-Blind|Withdrawal by Subject|0
6050033|NCT00580840|20909183|P4|Double-Blind|Lost to Follow-up|2
6050034|NCT00580840|20909184|P3|Double-Blind|Lost to Follow-up|0
6050035|NCT00580840|20909185|P2|Double-Blind|Lost to Follow-up|1
6050036|NCT00580840|20909186|P1|Double-Blind|Lost to Follow-up|0
6050037|NCT00580840|20909183|P4|Double-Blind|Loss of Efficacy|10
6050038|NCT00580840|20909184|P3|Double-Blind|Loss of Efficacy|2
6050039|NCT00580840|20909185|P2|Double-Blind|Loss of Efficacy|1
6050040|NCT00580840|20909186|P1|Double-Blind|Loss of Efficacy|0
6050041|NCT00580840|20909183|P4|Double-Blind|Adverse Event|1
6050042|NCT00580840|20909184|P3|Double-Blind|Adverse Event|4
6050043|NCT00580840|20909185|P2|Double-Blind|Adverse Event|3
6050044|NCT00580840|20909186|P1|Double-Blind|Adverse Event|0
6050045|NCT00580840|20909183|P4|Run-in|Other: Exclusionary Lab Value|0
6050046|NCT00580840|20909184|P3|Run-in|Other: Exclusionary Lab Value|0
6050047|NCT00580840|20909185|P2|Run-in|Other: Exclusionary Lab Value|0
6050048|NCT00580840|20909186|P1|Run-in|Other: Exclusionary Lab Value|1
6050049|NCT00580840|20909183|P4|Run-in|Other: Did Not Meet Joint Count Criteria|0
6050050|NCT00580840|20909184|P3|Run-in|Other: Did Not Meet Joint Count Criteria|0
6050051|NCT00580840|20909185|P2|Run-in|Other: Did Not Meet Joint Count Criteria|0
6050052|NCT00580840|20909186|P1|Run-in|Other: Did Not Meet Joint Count Criteria|1
6050053|NCT00580840|20909183|P4|Run-in|Other: Per Sponsor Request|0
6050054|NCT00580840|20909184|P3|Run-in|Other: Per Sponsor Request|0
6050055|NCT00580840|20909185|P2|Run-in|Other: Per Sponsor Request|0
6050056|NCT00580840|20909186|P1|Run-in|Other: Per Sponsor Request|2
6050057|NCT00580840|20909183|P4|Run-in|Withdrawal by Subject|0
6050058|NCT00580840|20909184|P3|Run-in|Withdrawal by Subject|0
6050059|NCT00580840|20909185|P2|Run-in|Withdrawal by Subject|0
6050060|NCT00580840|20909186|P1|Run-in|Withdrawal by Subject|5
6050061|NCT00580840|20909183|P4|Run-in|Lost to Follow-up|0
6050062|NCT00580840|20909184|P3|Run-in|Lost to Follow-up|0
6050063|NCT00580840|20909185|P2|Run-in|Lost to Follow-up|0
6050064|NCT00580840|20909186|P1|Run-in|Lost to Follow-up|4
6050065|NCT00580840|20909183|P4|Run-in|Loss of Efficacy|0
6050066|NCT00580840|20909184|P3|Run-in|Loss of Efficacy|0
6050067|NCT00580840|20909185|P2|Run-in|Loss of Efficacy|0
6050068|NCT00580840|20909186|P1|Run-in|Loss of Efficacy|1
6050069|NCT00580840|20909183|P4|Run-in|Lack of Efficacy|0
6050070|NCT00580840|20909184|P3|Run-in|Lack of Efficacy|0
6050071|NCT00580840|20909185|P2|Run-in|Lack of Efficacy|0
6050072|NCT00580840|20909186|P1|Run-in|Lack of Efficacy|93
6050073|NCT00580840|20909183|P4|Run-in|Adverse Event|0
6050074|NCT00580840|20909184|P3|Run-in|Adverse Event|0
6050075|NCT00580840|20909185|P2|Run-in|Adverse Event|0
6050076|NCT00580840|20909186|P1|Run-in|Adverse Event|17
6050077|NCT00580801|20909294|P3|Overall Study|Travel|0
6050078|NCT00580801|20909295|P2|Overall Study|Travel|0
6050079|NCT00580801|20909296|P1|Overall Study|Travel|1
6050080|NCT00580801|20909294|P3|Overall Study|Participant non-compliant|1
6050081|NCT00580801|20909295|P2|Overall Study|Participant non-compliant|0
6050082|NCT00580801|20909296|P1|Overall Study|Participant non-compliant|0
6050083|NCT00580801|20909294|P3|Overall Study|Reached a virologic endpoint|2
6050084|NCT00580801|20909295|P2|Overall Study|Reached a virologic endpoint|1
6050085|NCT00580801|20909296|P1|Overall Study|Reached a virologic endpoint|0
6050086|NCT00580801|20909294|P3|Overall Study|Lost to Follow-up|0
6050087|NCT00580801|20909295|P2|Overall Study|Lost to Follow-up|0
6050088|NCT00580801|20909296|P1|Overall Study|Lost to Follow-up|2
6050089|NCT00580801|20909294|P3|Overall Study|Adverse Event|0
6050090|NCT00580801|20909295|P2|Overall Study|Adverse Event|0
6050091|NCT00580801|20909296|P1|Overall Study|Adverse Event|2
6050092|NCT00580801|20909294|P3|Overall Study|Physician Decision|0
6050093|NCT00580801|20909295|P2|Overall Study|Physician Decision|0
6050094|NCT00580801|20909296|P1|Overall Study|Physician Decision|1
6050095|NCT00580788|20909335|P4|Overall Study|Adverse Event|1
6050096|NCT00580788|20909336|P3|Overall Study|Adverse Event|0
6050097|NCT00580788|20909337|P2|Overall Study|Adverse Event|0
6050098|NCT00580788|20909338|P1|Overall Study|Adverse Event|0
6050099|NCT00580723|20909396|P1|Overall Study|Lost to Follow-up|5
6050100|NCT00580723|20909396|P1|Overall Study|Did not want to participate in extension|3
6050101|NCT00580606|20909439|P2|Open Label (OL)|Needed Prohibited Medication|1
6050102|NCT00580606|20909440|P1|Open Label (OL)|Needed Prohibited Medication|0
6050103|NCT00580606|20909439|P2|Open Label (OL)|Physician Decision|1
6050104|NCT00580606|20909440|P1|Open Label (OL)|Physician Decision|1
6050105|NCT00580606|20909439|P2|Open Label (OL)|Non-compliance|0
6050106|NCT00580606|20909440|P1|Open Label (OL)|Non-compliance|2
6050107|NCT00580606|20909439|P2|Open Label (OL)|Pregnancy|1
6050108|NCT00580606|20909440|P1|Open Label (OL)|Pregnancy|0
6050109|NCT00580606|20909439|P2|Open Label (OL)|Lost to Follow-up|1
6050110|NCT00580606|20909440|P1|Open Label (OL)|Lost to Follow-up|0
6050111|NCT00580606|20909439|P2|Open Label (OL)|Dosing Symptoms|1
6050112|NCT00580606|20909440|P1|Open Label (OL)|Dosing Symptoms|0
6050113|NCT00580606|20909439|P2|Open Label (OL)|Withdrawal by Subject|6
6050114|NCT00580606|20909440|P1|Open Label (OL)|Withdrawal by Subject|4
6050115|NCT00580606|20909439|P2|Open Label (OL)|Lack of Efficacy at Week 116 OFC|1
6050116|NCT00580606|20909440|P1|Open Label (OL)|Lack of Efficacy at Week 116 OFC|2
6050117|NCT00580047|20909521|P3|Overall Study|Withdrawal by Subject|0
6050118|NCT00580047|20909522|P2|Overall Study|Withdrawal by Subject|0
6050119|NCT00580047|20909523|P1|Overall Study|Withdrawal by Subject|1
6050120|NCT00580047|20909521|P3|Overall Study|Withdrawal by Subject|2
6050121|NCT00580047|20909522|P2|Overall Study|Withdrawal by Subject|1
6050122|NCT00580047|20909523|P1|Overall Study|Withdrawal by Subject|1
6050123|NCT00580047|20909521|P3|Overall Study|Lost to Follow-up|0
6050124|NCT00580047|20909522|P2|Overall Study|Lost to Follow-up|1
6050125|NCT00580047|20909523|P1|Overall Study|Lost to Follow-up|1
6050126|NCT00580034|20909534|P2|Overall Study|Toxicity|0
6050127|NCT00580034|20909535|P1|Overall Study|Toxicity|10
6050128|NCT00579982|20909541|P1|Overall Study|Protocol Violation|4
6050129|NCT00579982|20909541|P1|Overall Study|Adverse Event|4
6050130|NCT00579826|20909575|P2|Overall Study|Withdrawal by Subject|3
6050131|NCT00579826|20909576|P1|Overall Study|Withdrawal by Subject|5
6050132|NCT00579670|20909610|P5|Overall Study|Withdrawal by Subject|0
6050133|NCT00579670|20909611|P4|Overall Study|Withdrawal by Subject|0
6050134|NCT00579670|20909612|P3|Overall Study|Withdrawal by Subject|1
6050135|NCT00579670|20909613|P2|Overall Study|Withdrawal by Subject|0
6050136|NCT00579670|20909614|P1|Overall Study|Withdrawal by Subject|0
6050137|NCT00579670|20909610|P5|Overall Study|Other|0
6050138|NCT00579670|20909611|P4|Overall Study|Other|2
6050139|NCT00579670|20909612|P3|Overall Study|Other|1
6050140|NCT00579670|20909613|P2|Overall Study|Other|0
6050141|NCT00579670|20909614|P1|Overall Study|Other|0
6050142|NCT00579670|20909610|P5|Overall Study|Lost to Follow-up|0
6050143|NCT00579670|20909611|P4|Overall Study|Lost to Follow-up|4
6050144|NCT00579670|20909612|P3|Overall Study|Lost to Follow-up|0
6050145|NCT00579670|20909613|P2|Overall Study|Lost to Follow-up|1
6050146|NCT00579670|20909614|P1|Overall Study|Lost to Follow-up|0
6050147|NCT00579670|20909610|P5|Overall Study|Lack of Efficacy|0
6050148|NCT00579670|20909611|P4|Overall Study|Lack of Efficacy|14
6050149|NCT00579670|20909612|P3|Overall Study|Lack of Efficacy|1
6050150|NCT00579670|20909613|P2|Overall Study|Lack of Efficacy|0
6050151|NCT00579670|20909614|P1|Overall Study|Lack of Efficacy|0
6050152|NCT00579670|20909610|P5|Overall Study|Adverse Event|0
6050153|NCT00579670|20909611|P4|Overall Study|Adverse Event|2
6050154|NCT00579670|20909612|P3|Overall Study|Adverse Event|1
6050155|NCT00579670|20909613|P2|Overall Study|Adverse Event|0
6050156|NCT00579670|20909614|P1|Overall Study|Adverse Event|1
6050157|NCT00579670|20909610|P5|Overall Study|Death|0
6050158|NCT00579670|20909611|P4|Overall Study|Death|0
6050159|NCT00579670|20909612|P3|Overall Study|Death|0
6050160|NCT00579670|20909613|P2|Overall Study|Death|0
6050161|NCT00579670|20909614|P1|Overall Study|Death|1
6050162|NCT00579527|20909826|P1|Overall Study|Death|4
6050163|NCT00579501|20909838|P1|Overall Study|Radiation therapy before surgery|1
6050164|NCT00579501|20909838|P1|Overall Study|Secondary lesion|1
6050165|NCT00579501|20909838|P1|Overall Study|toxicity|1
6050166|NCT00579501|20909838|P1|Overall Study|End of neoadjuvant therapy|25
6050167|NCT00579501|20909838|P1|Overall Study|Death|1
6050168|NCT00579345|20909866|P8|Overall Study|Death|0
6050169|NCT00579345|20909867|P7|Overall Study|Death|0
6050170|NCT00579345|20909868|P6|Overall Study|Death|0
6050171|NCT00579345|20909869|P5|Overall Study|Death|0
6050172|NCT00579345|20909870|P4|Overall Study|Death|1
6050173|NCT00579345|20909871|P3|Overall Study|Death|1
6050174|NCT00579345|20909872|P2|Overall Study|Death|1
6050175|NCT00579345|20909873|P1|Overall Study|Death|1
6050176|NCT00579345|20909866|P8|Overall Study|Protocol Violation|1
6050177|NCT00579345|20909867|P7|Overall Study|Protocol Violation|0
6050178|NCT00579345|20909868|P6|Overall Study|Protocol Violation|0
6050179|NCT00579345|20909869|P5|Overall Study|Protocol Violation|0
6050180|NCT00579345|20909870|P4|Overall Study|Protocol Violation|0
6050181|NCT00579345|20909871|P3|Overall Study|Protocol Violation|0
6050182|NCT00579345|20909872|P2|Overall Study|Protocol Violation|0
6050183|NCT00579345|20909873|P1|Overall Study|Protocol Violation|1
6050184|NCT00579345|20909866|P8|Overall Study|Adverse Event|0
6050185|NCT00579345|20909867|P7|Overall Study|Adverse Event|0
6050186|NCT00579345|20909868|P6|Overall Study|Adverse Event|0
6050187|NCT00579345|20909869|P5|Overall Study|Adverse Event|0
6050188|NCT00579345|20909870|P4|Overall Study|Adverse Event|0
6050189|NCT00579345|20909871|P3|Overall Study|Adverse Event|1
6050190|NCT00579345|20909872|P2|Overall Study|Adverse Event|0
6050191|NCT00579345|20909873|P1|Overall Study|Adverse Event|0
6050192|NCT00579345|20909866|P8|Overall Study|Lost to Follow-up|0
6050193|NCT00579345|20909867|P7|Overall Study|Lost to Follow-up|0
6050194|NCT00579345|20909868|P6|Overall Study|Lost to Follow-up|0
6050195|NCT00579345|20909869|P5|Overall Study|Lost to Follow-up|0
6050196|NCT00579345|20909870|P4|Overall Study|Lost to Follow-up|0
6050197|NCT00579345|20909871|P3|Overall Study|Lost to Follow-up|0
6050198|NCT00579345|20909872|P2|Overall Study|Lost to Follow-up|0
6050199|NCT00579345|20909873|P1|Overall Study|Lost to Follow-up|1
6050200|NCT00579345|20909866|P8|Overall Study|Withdrawal by Subject|1
6050201|NCT00579345|20909867|P7|Overall Study|Withdrawal by Subject|0
6050202|NCT00579345|20909868|P6|Overall Study|Withdrawal by Subject|0
6050203|NCT00579345|20909869|P5|Overall Study|Withdrawal by Subject|0
6050204|NCT00579345|20909870|P4|Overall Study|Withdrawal by Subject|0
6050205|NCT00579345|20909871|P3|Overall Study|Withdrawal by Subject|0
6050206|NCT00579345|20909872|P2|Overall Study|Withdrawal by Subject|0
6050207|NCT00579345|20909873|P1|Overall Study|Withdrawal by Subject|2
6050208|NCT00579098|20909968|P2|Overall Study|AF returned after ablation|2
6050209|NCT00579098|20909969|P1|Overall Study|AF returned after ablation|3
6050210|NCT00579098|20909968|P2|Overall Study|Withdrawal by Subject|3
6050211|NCT00579098|20909969|P1|Overall Study|Withdrawal by Subject|2
6050212|NCT00579098|20909968|P2|Overall Study|Adverse Event|3
6050213|NCT00579098|20909969|P1|Overall Study|Adverse Event|2
6050214|NCT00579098|20909968|P2|Overall Study|Lost to Follow-up|0
6050215|NCT00579098|20909969|P1|Overall Study|Lost to Follow-up|2
6050216|NCT00579059|20909985|P2|Overall Study|Study Canceled at 1 Year|10
6050217|NCT00579059|20909986|P1|Overall Study|Study Canceled at 1 Year|21
6050218|NCT00578942|20910060|P1|Overall Study|Lost to Follow-up|1
6050219|NCT00578877|20910099|P2|Overall Study|did not provide follow-up data|17
6050220|NCT00578877|20910100|P1|Overall Study|did not provide follow-up data|12
6050221|NCT00578877|20910099|P2|Overall Study|early discontinue|101
6050222|NCT00578877|20910100|P1|Overall Study|early discontinue|61
6050223|NCT00578877|20910099|P2|Overall Study|Lost to Follow-up|10
6050224|NCT00578877|20910100|P1|Overall Study|Lost to Follow-up|8
6050225|NCT00578864|20910108|P2|Overall Study|Death|0
6050226|NCT00578864|20910109|P1|Overall Study|Death|1
6050227|NCT00578812|20910125|P2|Overall Study|Not treated|7
6050228|NCT00578812|20910126|P1|Overall Study|Not treated|6
6050229|NCT00578786|20910165|P3|Overall Study|Qualified but Not Enrolled in Extension|0
6050230|NCT00578786|20910166|P2|Overall Study|Qualified but Not Enrolled in Extension|3
6050231|NCT00578786|20910167|P1|Overall Study|Qualified but Not Enrolled in Extension|0
6050232|NCT00578786|20910165|P3|Overall Study|Not Otherwise Specified|1
6050233|NCT00578786|20910166|P2|Overall Study|Not Otherwise Specified|4
6050234|NCT00578786|20910167|P1|Overall Study|Not Otherwise Specified|0
6050235|NCT00578786|20910165|P3|Overall Study|Pregnancy|0
6050236|NCT00578786|20910166|P2|Overall Study|Pregnancy|1
6050237|NCT00578786|20910167|P1|Overall Study|Pregnancy|0
6050238|NCT00578786|20910165|P3|Overall Study|Lost to Follow-up|0
6050239|NCT00578786|20910166|P2|Overall Study|Lost to Follow-up|4
6050240|NCT00578786|20910167|P1|Overall Study|Lost to Follow-up|0
6050241|NCT00578786|20910165|P3|Overall Study|Sponsor Decision|1
6050242|NCT00578786|20910166|P2|Overall Study|Sponsor Decision|0
6050243|NCT00578786|20910167|P1|Overall Study|Sponsor Decision|0
6050244|NCT00578786|20910165|P3|Overall Study|Physician Decision|1
6050245|NCT00578786|20910166|P2|Overall Study|Physician Decision|0
6050246|NCT00578786|20910167|P1|Overall Study|Physician Decision|1
6050247|NCT00578786|20910165|P3|Overall Study|Protocol Violation|1
6050248|NCT00578786|20910166|P2|Overall Study|Protocol Violation|3
6050249|NCT00578786|20910167|P1|Overall Study|Protocol Violation|0
6050250|NCT00578786|20910165|P3|Overall Study|Withdrawal by Subject|5
6050251|NCT00578786|20910166|P2|Overall Study|Withdrawal by Subject|8
6050252|NCT00578786|20910167|P1|Overall Study|Withdrawal by Subject|7
6050253|NCT00578786|20910165|P3|Overall Study|Early Escape from Prior Study|2
6050254|NCT00578786|20910166|P2|Overall Study|Early Escape from Prior Study|1
6050255|NCT00578786|20910167|P1|Overall Study|Early Escape from Prior Study|2
6050256|NCT00578786|20910165|P3|Overall Study|Lack of Efficacy|2
6050257|NCT00578786|20910166|P2|Overall Study|Lack of Efficacy|5
6050258|NCT00578786|20910167|P1|Overall Study|Lack of Efficacy|2
6050259|NCT00578786|20910165|P3|Overall Study|Adverse Event|17
6050260|NCT00578786|20910166|P2|Overall Study|Adverse Event|37
6050261|NCT00578786|20910167|P1|Overall Study|Adverse Event|27
6050262|NCT00578643|20910268|P1|Overall Study|Lost to Follow-up|1
6050263|NCT00578643|20910268|P1|Overall Study|Death|1
6050264|NCT00578565|20910284|P1|Overall Study|Adverse Event|3
6050265|NCT00578448|20910314|P1|1 Year Long Term Extension (LTE)|Adverse Event|1
6050266|NCT00578448|20910314|P1|Day 1 up to 3 Years of Planned Study|started marketed Cellcept and Prograf|1
6050267|NCT00578448|20910314|P1|Day 1 up to 3 Years of Planned Study|Adverse Event|1
6050268|NCT00578448|20910314|P1|Day 1 up to 3 Years of Planned Study|Death|1
6050269|NCT00578344|20910365|P1|Overall Study|Graft failure|1
6050270|NCT00578344|20910365|P1|Overall Study|Insurance problems|1
6050271|NCT00578318|20910384|P2|Overall Study|Physician Decision|0
6050272|NCT00578318|20910385|P1|Overall Study|Physician Decision|1
6050273|NCT00578318|20910384|P2|Overall Study|Lost to Follow-up|0
6050274|NCT00578318|20910385|P1|Overall Study|Lost to Follow-up|2
6050275|NCT00578292|20910455|P1|Overall Study|Graft failure|2
6050276|NCT00578292|20910455|P1|Overall Study|Death|1
6050277|NCT00578227|20910479|P3|Overall Study|Withdrawal by Subject|3
6050278|NCT00578227|20910480|P2|Overall Study|Withdrawal by Subject|1
6050279|NCT00578227|20910481|P1|Overall Study|Withdrawal by Subject|5
6050280|NCT00578227|20910479|P3|Overall Study|Lost to Follow-up|1
6050281|NCT00578227|20910480|P2|Overall Study|Lost to Follow-up|1
6050282|NCT00578227|20910481|P1|Overall Study|Lost to Follow-up|0
6050283|NCT00578175|20910606|P3|Overall Study|Other reasons|23
6050284|NCT00578175|20910607|P2|Overall Study|Other reasons|42
6050285|NCT00578175|20910608|P1|Overall Study|Other reasons|70
6050286|NCT00578175|20910606|P3|Overall Study|Adverse Event|1
6050287|NCT00578175|20910607|P2|Overall Study|Adverse Event|1
6050288|NCT00578175|20910608|P1|Overall Study|Adverse Event|0
6050289|NCT00578136|20910687|P2|Overall Study|Not given intervention|1
6050290|NCT00578136|20910688|P1|Overall Study|Not given intervention|1
6050291|NCT00577993|20910706|P3|Overall Study|Uninsured|0
6050292|NCT00577993|20910707|P2|Overall Study|Uninsured|0
6050293|NCT00577993|20910708|P1|Overall Study|Uninsured|1
6050294|NCT00577993|20910706|P3|Overall Study|Conversion|0
6050295|NCT00577993|20910707|P2|Overall Study|Conversion|5
6050296|NCT00577993|20910708|P1|Overall Study|Conversion|2
6050297|NCT00577993|20910706|P3|Overall Study|Withdrawal by Subject|2
6050298|NCT00577993|20910707|P2|Overall Study|Withdrawal by Subject|0
6050299|NCT00577993|20910708|P1|Overall Study|Withdrawal by Subject|1
6050300|NCT00577993|20910706|P3|Overall Study|Protocol Violation|0
6050301|NCT00577993|20910707|P2|Overall Study|Protocol Violation|3
6050302|NCT00577993|20910708|P1|Overall Study|Protocol Violation|2
6050303|NCT00577993|20910706|P3|Overall Study|Lack of Efficacy|0
6050304|NCT00577993|20910707|P2|Overall Study|Lack of Efficacy|1
6050305|NCT00577993|20910708|P1|Overall Study|Lack of Efficacy|0
6050306|NCT00577993|20910706|P3|Overall Study|Death|1
6050307|NCT00577993|20910707|P2|Overall Study|Death|1
6050308|NCT00577993|20910708|P1|Overall Study|Death|0
6050309|NCT00577993|20910706|P3|Overall Study|Adverse Event|0
6050310|NCT00577993|20910707|P2|Overall Study|Adverse Event|0
6050311|NCT00577993|20910708|P1|Overall Study|Adverse Event|1
6050312|NCT00577889|20910719|P3|Overall Study|Withdrawal by Subject|0
6050313|NCT00577889|20910720|P2|Overall Study|Withdrawal by Subject|0
6050314|NCT00577889|20910721|P1|Overall Study|Withdrawal by Subject|1
6050315|NCT00577863|20910740|P2|Overall Study|Did Not Receive at Least One Injection|1
6050316|NCT00577863|20910741|P1|Overall Study|Did Not Receive at Least One Injection|0
6050317|NCT00577863|20910740|P2|Overall Study|Sponsor Decision|7
6050318|NCT00577863|20910741|P1|Overall Study|Sponsor Decision|2
6050319|NCT00577863|20910740|P2|Overall Study|Withdrawal by Subject|2
6050320|NCT00577863|20910741|P1|Overall Study|Withdrawal by Subject|0
6050321|NCT00577863|20910740|P2|Overall Study|Entry Criteria Exclusion|0
6050322|NCT00577863|20910741|P1|Overall Study|Entry Criteria Exclusion|1
6050323|NCT00577863|20910740|P2|Overall Study|Lost to Follow-up|2
6050324|NCT00577863|20910741|P1|Overall Study|Lost to Follow-up|2
6050325|NCT00577863|20910740|P2|Overall Study|Death|0
6050326|NCT00577863|20910741|P1|Overall Study|Death|1
6050327|NCT00577863|20910740|P2|Overall Study|Adverse Event|2
6050328|NCT00577863|20910741|P1|Overall Study|Adverse Event|4
6050329|NCT00577824|20910783|P3|Overall Study|Protocol Violation|0
6050330|NCT00577824|20910784|P2|Overall Study|Protocol Violation|1
6050331|NCT00577824|20910785|P1|Overall Study|Protocol Violation|1
6050332|NCT00577824|20910783|P3|Overall Study|Patient decision|1
6050333|NCT00577824|20910784|P2|Overall Study|Patient decision|1
6050334|NCT00577824|20910785|P1|Overall Study|Patient decision|0
6050335|NCT00577824|20910783|P3|Overall Study|Adverse Event|1
6050336|NCT00577824|20910784|P2|Overall Study|Adverse Event|18
6050337|NCT00577824|20910785|P1|Overall Study|Adverse Event|6
6050338|NCT00577772|20910843|P2|Overall Study|Lost to Follow-up|1
6050339|NCT00577772|20910844|P1|Overall Study|Lost to Follow-up|0
6050340|NCT00577720|20910854|P4|Overall Study|Withdrawal by Subject|2
6050341|NCT00577720|20910855|P3|Overall Study|Withdrawal by Subject|0
6050342|NCT00577720|20910856|P2|Overall Study|Withdrawal by Subject|0
6050343|NCT00577720|20910857|P1|Overall Study|Withdrawal by Subject|2
6050344|NCT00577720|20910854|P4|Overall Study|Protocol Violation|1
6050345|NCT00577720|20910855|P3|Overall Study|Protocol Violation|0
6050346|NCT00577720|20910856|P2|Overall Study|Protocol Violation|0
6050347|NCT00577720|20910857|P1|Overall Study|Protocol Violation|0
6050348|NCT00577720|20910854|P4|Overall Study|Lost to Follow-up|0
6050349|NCT00577720|20910855|P3|Overall Study|Lost to Follow-up|1
6050350|NCT00577720|20910856|P2|Overall Study|Lost to Follow-up|0
6050351|NCT00577720|20910857|P1|Overall Study|Lost to Follow-up|0
6050352|NCT00577720|20910854|P4|Overall Study|Adverse Event|4
6050353|NCT00577720|20910855|P3|Overall Study|Adverse Event|0
6050354|NCT00577720|20910856|P2|Overall Study|Adverse Event|1
6050355|NCT00577720|20910857|P1|Overall Study|Adverse Event|2
6050356|NCT00577707|20910875|P1|Overall Study|Withdrawal by Subject|3
6050357|NCT00577655|20910883|P2|Overall Study|Lost to Follow-up|1
6050358|NCT00577655|20910884|P1|Overall Study|Lost to Follow-up|1
6050359|NCT00577655|20910883|P2|Overall Study|Protocol Violation|1
6050360|NCT00577655|20910884|P1|Overall Study|Protocol Violation|0
6050361|NCT00577655|20910883|P2|Overall Study|Patient Request|2
6050362|NCT00577655|20910884|P1|Overall Study|Patient Request|0
6050363|NCT00577642|20910922|P1|Overall Study|Clinical Disease Progression|1
6050364|NCT00577629|20910926|P1|Long Term Follow-Up|Physician Decision|1
6050365|NCT00577629|20910926|P1|Long Term Follow-Up|Withdrawal by Subject|4
6050366|NCT00577629|20910926|P1|Long Term Follow-Up|Lost to Follow-up|5
6050367|NCT00577629|20910926|P1|Long Term Follow-Up|Death|15
6050368|NCT00577629|20910926|P1|Treatment Period|Death|1
6050369|NCT00577473|20910953|P2|Overall Study|Lack of Efficacy|7
6050370|NCT00577473|20910954|P1|Overall Study|Lack of Efficacy|8
6050371|NCT00577473|20910953|P2|Overall Study|Physician Decision|2
6050372|NCT00577473|20910954|P1|Overall Study|Physician Decision|2
6050373|NCT00577473|20910953|P2|Overall Study|Withdrawal by Subject|6
6050374|NCT00577473|20910954|P1|Overall Study|Withdrawal by Subject|2
6050375|NCT00577473|20910953|P2|Overall Study|Adverse Event|5
6050376|NCT00577473|20910954|P1|Overall Study|Adverse Event|8
6050377|NCT00577473|20910953|P2|Overall Study|Protocol Violation|4
6050378|NCT00577473|20910954|P1|Overall Study|Protocol Violation|1
6050379|NCT00577460|20910985|P3|Overall Study|Other|2
6050380|NCT00577460|20910986|P2|Overall Study|Other|3
6050381|NCT00577460|20910987|P1|Overall Study|Other|0
6050382|NCT00577460|20910985|P3|Overall Study|Withdrawal by Subject|6
6050383|NCT00577460|20910986|P2|Overall Study|Withdrawal by Subject|5
6050384|NCT00577460|20910987|P1|Overall Study|Withdrawal by Subject|5
6050385|NCT00577460|20910985|P3|Overall Study|Lost to Follow-up|4
6050386|NCT00577460|20910986|P2|Overall Study|Lost to Follow-up|3
6050387|NCT00577460|20910987|P1|Overall Study|Lost to Follow-up|0
6050388|NCT00577460|20910985|P3|Overall Study|Protocol Violation|1
6050389|NCT00577460|20910986|P2|Overall Study|Protocol Violation|1
6050390|NCT00577460|20910987|P1|Overall Study|Protocol Violation|0
6050391|NCT00577460|20910985|P3|Overall Study|Adverse Event|14
6050392|NCT00577460|20910986|P2|Overall Study|Adverse Event|7
6050393|NCT00577460|20910987|P1|Overall Study|Adverse Event|11
6050394|NCT00577408|20911096|P2|Overall Study|Psychiatric hospitalization|1
6050395|NCT00577408|20911097|P1|Overall Study|Psychiatric hospitalization|0
6050396|NCT00577408|20911096|P2|Overall Study|Death|1
6050397|NCT00577408|20911097|P1|Overall Study|Death|0
6050398|NCT00577408|20911096|P2|Overall Study|Scheduling Issues|3
6050399|NCT00577408|20911097|P1|Overall Study|Scheduling Issues|0
6050400|NCT00577408|20911096|P2|Overall Study|Moved out of state|1
6050401|NCT00577408|20911097|P1|Overall Study|Moved out of state|0
6050402|NCT00577408|20911096|P2|Overall Study|Refused Oral Naltrexone|1
6050403|NCT00577408|20911097|P1|Overall Study|Refused Oral Naltrexone|0
6050404|NCT00577408|20911096|P2|Overall Study|Non-compliance with study meds|3
6050405|NCT00577408|20911097|P1|Overall Study|Non-compliance with study meds|0
6050406|NCT00577408|20911096|P2|Overall Study|Continued opioid use|2
6050407|NCT00577408|20911097|P1|Overall Study|Continued opioid use|3
6050408|NCT00577408|20911096|P2|Overall Study|Stopped attending study visits|11
6050409|NCT00577408|20911097|P1|Overall Study|Stopped attending study visits|9
6050410|NCT00577395|20911105|P2|Overall Study|Study was terminated early by Sponsor|6
6050411|NCT00577395|20911106|P1|Overall Study|Study was terminated early by Sponsor|7
6050412|NCT00577382|20911116|P2|Overall Study|Lost to Follow-up|2
6050413|NCT00577382|20911117|P1|Overall Study|Lost to Follow-up|2
6050414|NCT00577382|20911116|P2|Overall Study|Death|1
6050415|NCT00577382|20911117|P1|Overall Study|Death|1
6050416|NCT00577382|20911116|P2|Overall Study|Intercurrent Illness|2
6050417|NCT00577382|20911117|P1|Overall Study|Intercurrent Illness|1
6050418|NCT00577382|20911116|P2|Overall Study|Progressive Disease|19
6050419|NCT00577382|20911117|P1|Overall Study|Progressive Disease|17
6050420|NCT00577382|20911116|P2|Overall Study|Withdrawal by Subject|1
6050421|NCT00577382|20911117|P1|Overall Study|Withdrawal by Subject|0
6050422|NCT00577382|20911116|P2|Overall Study|Adverse Event|6
6050423|NCT00577382|20911117|P1|Overall Study|Adverse Event|0
6050424|NCT00577122|20911260|P2|Overall Study|Alternative Therapy|1
6050425|NCT00577122|20911261|P1|Overall Study|Alternative Therapy|0
6050426|NCT00577122|20911260|P2|Overall Study|Prog, refract disease during active trt|5
6050427|NCT00577122|20911261|P1|Overall Study|Prog, refract disease during active trt|8
6050428|NCT00577122|20911260|P2|Overall Study|Progression, relapse during active trt|8
6050429|NCT00577122|20911261|P1|Overall Study|Progression, relapse during active trt|6
6050430|NCT00577122|20911260|P2|Overall Study|Adverse Event|2
6050431|NCT00577122|20911261|P1|Overall Study|Adverse Event|0
6050432|NCT00577096|20911275|P2|Short Term Participation|Death|1
6050433|NCT00577096|20911276|P1|Short Term Participation|Death|1
6050434|NCT00577096|20911275|P2|Short Term Participation|Withdrawal by Subject|5
6050435|NCT00577096|20911276|P1|Short Term Participation|Withdrawal by Subject|3
6050436|NCT00577096|20911275|P2|Short Term Participation|withdrew from multiple myeloma treatment|2
6050437|NCT00577096|20911276|P1|Short Term Participation|withdrew from multiple myeloma treatment|3
6050438|NCT00577031|20911315|P1|Overall Study|Death|6
6050439|NCT00577031|20911315|P1|Overall Study|Medical decision|14
6050440|NCT00577031|20911315|P1|Overall Study|Need for surgery|17
6050441|NCT00577031|20911315|P1|Overall Study|Participant non-compliance|5
6050442|NCT00577031|20911315|P1|Overall Study|Participant withdrew consent|13
6050443|NCT00577031|20911315|P1|Overall Study|Protocol Violation|5
6050444|NCT00577031|20911315|P1|Overall Study|Progression of disease|93
6050445|NCT00577031|20911315|P1|Overall Study|Adverse Event|52
6050446|NCT00577005|20911336|P2|Overall Study|Withdrawal by Subject|1
6050447|NCT00577005|20911337|P1|Overall Study|Withdrawal by Subject|2
6050448|NCT00577005|20911336|P2|Overall Study|Lost to Follow-up|2
6050449|NCT00577005|20911337|P1|Overall Study|Lost to Follow-up|3
6050450|NCT00576927|20911351|P1|Sleep Hygiene With the Placebo|Withdrawal by Subject|1
6050451|NCT00576927|20911351|P1|Sleep Hygiene Behavioral Intervention|Withdrawal by Subject|1
6050452|NCT00576927|20911351|P1|Sleep Hygiene Behavioral Intervention|Medication Change by PCP for subject|1
6050453|NCT00576927|20911351|P1|Sleep Hygiene Behavioral Intervention|Death|1
6050454|NCT00576927|20911351|P1|Sleep Hygiene Behavioral Intervention|Responded to intervention|4
6050455|NCT00576927|20911351|P1|Baseline|Withdrawal by Subject|3
6050456|NCT00576927|20911351|P1|Baseline|Medication Change by PCP of subject|1
6050457|NCT00576927|20911351|P1|Baseline|Physician Decision|9
6050458|NCT00576927|20911351|P1|Clinical Assessment|Physician Decision|1
6050459|NCT00576927|20911351|P1|Clinical Assessment|Withdrawal by Subject|10
6050460|NCT00576927|20911351|P1|Clinical Assessment|Death|1
6050461|NCT00576927|20911351|P1|Clinical Assessment|Lack of Efficacy|24
6050462|NCT00576901|20911363|P1|Overall Study|Protocol Violation|1
6050463|NCT00576901|20911363|P1|Overall Study|Disease course|1
6050464|NCT00576901|20911363|P1|Overall Study|Withdrawal by Subject|1
6050465|NCT00576836|20911371|P2|Overall Study|Physician Decision|1
6050466|NCT00576836|20911372|P1|Overall Study|Physician Decision|0
6050467|NCT00576836|20911371|P2|Overall Study|Death|1
6050468|NCT00576836|20911372|P1|Overall Study|Death|0
6050469|NCT00576823|20911387|P3|40-week Safety Extension Phase|Lack of Efficacy|0
6050470|NCT00576823|20911388|P2|40-week Safety Extension Phase|Lack of Efficacy|0
6050471|NCT00576823|20911389|P1|40-week Safety Extension Phase|Lack of Efficacy|1
6050472|NCT00576823|20911387|P3|12-week Efficacy Phase|Parent's schedule issue|0
6050473|NCT00576823|20911388|P2|12-week Efficacy Phase|Parent's schedule issue|0
6050474|NCT00576823|20911389|P1|12-week Efficacy Phase|Parent's schedule issue|1
6050475|NCT00576758|20911405|P2|Follow-up Period|Withdrew consent|1
6050476|NCT00576758|20911406|P1|Follow-up Period|Withdrew consent|2
6050477|NCT00576758|20911405|P2|Follow-up Period|Insufficient therapeutic response|5
6050478|NCT00576758|20911406|P1|Follow-up Period|Insufficient therapeutic response|16
6050479|NCT00576758|20911405|P2|Follow-up Period|Death|3
6050480|NCT00576758|20911406|P1|Follow-up Period|Death|3
6050481|NCT00576758|20911405|P2|Follow-up Period|Administrative/Other|8
6050482|NCT00576758|20911406|P1|Follow-up Period|Administrative/Other|6
6050483|NCT00576758|20911405|P2|Extension Treatment Period|Administrative/Other|1
6050484|NCT00576758|20911406|P1|Extension Treatment Period|Administrative/Other|3
6050485|NCT00576758|20911405|P2|Extension Treatment Period|Insufficient therapeutic response|33
6050486|NCT00576758|20911406|P1|Extension Treatment Period|Insufficient therapeutic response|30
6050487|NCT00576758|20911405|P2|Extension Treatment Period|Refused treatment/did not cooperate|1
6050488|NCT00576758|20911406|P1|Extension Treatment Period|Refused treatment/did not cooperate|2
6050489|NCT00576758|20911405|P2|Extension Treatment Period|Death|1
6050490|NCT00576758|20911406|P1|Extension Treatment Period|Death|1
6050491|NCT00576758|20911405|P2|Extension Treatment Period|Adverse event or Intercurrent illness|7
6050492|NCT00576758|20911406|P1|Extension Treatment Period|Adverse event or Intercurrent illness|6
6050493|NCT00576758|20911405|P2|Induction Treatment Period|Withdrew consent|0
6050494|NCT00576758|20911406|P1|Induction Treatment Period|Withdrew consent|1
6050495|NCT00576758|20911405|P2|Induction Treatment Period|Refused treatment/ Did not Cooperate|1
6050496|NCT00576758|20911406|P1|Induction Treatment Period|Refused treatment/ Did not Cooperate|0
6050497|NCT00576758|20911405|P2|Induction Treatment Period|Death|0
6050498|NCT00576758|20911406|P1|Induction Treatment Period|Death|1
6050499|NCT00576758|20911405|P2|Induction Treatment Period|Violation of selection criteria at entry|1
6050500|NCT00576758|20911406|P1|Induction Treatment Period|Violation of selection criteria at entry|1
6050501|NCT00576758|20911405|P2|Induction Treatment Period|Insufficient therapeutic response|0
6050502|NCT00576758|20911406|P1|Induction Treatment Period|Insufficient therapeutic response|2
6050503|NCT00576758|20911405|P2|Induction Treatment Period|Adverse event or Intercurrent illness|3
6050504|NCT00576758|20911406|P1|Induction Treatment Period|Adverse event or Intercurrent illness|3
6050505|NCT00576732|20911452|P6|OPEN LABEL|Protocol Violation|0
6050506|NCT00576732|20911453|P5|OPEN LABEL|Protocol Violation|1
6050507|NCT00576732|20911454|P4|OPEN LABEL|Protocol Violation|2
6050508|NCT00576732|20911455|P3|OPEN LABEL|Protocol Violation|0
6050509|NCT00576732|20911456|P2|OPEN LABEL|Protocol Violation|0
6050510|NCT00576732|20911457|P1|OPEN LABEL|Protocol Violation|0
6050511|NCT00576732|20911452|P6|OPEN LABEL|Lack of Efficacy|3
6050512|NCT00576732|20911453|P5|OPEN LABEL|Lack of Efficacy|2
6050513|NCT00576732|20911454|P4|OPEN LABEL|Lack of Efficacy|2
6050514|NCT00576732|20911455|P3|OPEN LABEL|Lack of Efficacy|0
6050515|NCT00576732|20911456|P2|OPEN LABEL|Lack of Efficacy|0
6050516|NCT00576732|20911457|P1|OPEN LABEL|Lack of Efficacy|0
6050517|NCT00576732|20911452|P6|OPEN LABEL|OTHER|2
6050518|NCT00576732|20911453|P5|OPEN LABEL|OTHER|0
6050519|NCT00576732|20911454|P4|OPEN LABEL|OTHER|0
6050520|NCT00576732|20911455|P3|OPEN LABEL|OTHER|0
6050521|NCT00576732|20911456|P2|OPEN LABEL|OTHER|0
6050522|NCT00576732|20911457|P1|OPEN LABEL|OTHER|0
6050523|NCT00576732|20911452|P6|OPEN LABEL|Withdrawal by Subject|1
6050524|NCT00576732|20911453|P5|OPEN LABEL|Withdrawal by Subject|0
6050525|NCT00576732|20911454|P4|OPEN LABEL|Withdrawal by Subject|1
6050526|NCT00576732|20911455|P3|OPEN LABEL|Withdrawal by Subject|0
6050527|NCT00576732|20911456|P2|OPEN LABEL|Withdrawal by Subject|0
6050528|NCT00576732|20911457|P1|OPEN LABEL|Withdrawal by Subject|0
6050529|NCT00576732|20911452|P6|OPEN LABEL|Lost to Follow-up|1
6050530|NCT00576732|20911453|P5|OPEN LABEL|Lost to Follow-up|1
6050531|NCT00576732|20911454|P4|OPEN LABEL|Lost to Follow-up|2
6050532|NCT00576732|20911455|P3|OPEN LABEL|Lost to Follow-up|0
6050533|NCT00576732|20911456|P2|OPEN LABEL|Lost to Follow-up|0
6050534|NCT00576732|20911457|P1|OPEN LABEL|Lost to Follow-up|0
6050535|NCT00576732|20911452|P6|OPEN LABEL|Adverse Event|1
6050536|NCT00576732|20911453|P5|OPEN LABEL|Adverse Event|0
6050537|NCT00576732|20911454|P4|OPEN LABEL|Adverse Event|4
6050538|NCT00576732|20911455|P3|OPEN LABEL|Adverse Event|0
6050539|NCT00576732|20911456|P2|OPEN LABEL|Adverse Event|0
6050540|NCT00576732|20911457|P1|OPEN LABEL|Adverse Event|0
6050541|NCT00576732|20911452|P6|DOUBLE BLIND|Protocol Violation|0
6050542|NCT00576732|20911453|P5|DOUBLE BLIND|Protocol Violation|0
6050543|NCT00576732|20911454|P4|DOUBLE BLIND|Protocol Violation|0
6050544|NCT00576732|20911455|P3|DOUBLE BLIND|Protocol Violation|0
6050545|NCT00576732|20911456|P2|DOUBLE BLIND|Protocol Violation|0
6050546|NCT00576732|20911457|P1|DOUBLE BLIND|Protocol Violation|1
6050547|NCT00576732|20911452|P6|DOUBLE BLIND|Lack of Efficacy|0
6050548|NCT00576732|20911453|P5|DOUBLE BLIND|Lack of Efficacy|0
6050549|NCT00576732|20911454|P4|DOUBLE BLIND|Lack of Efficacy|0
6050550|NCT00576732|20911455|P3|DOUBLE BLIND|Lack of Efficacy|0
6050551|NCT00576732|20911456|P2|DOUBLE BLIND|Lack of Efficacy|1
6050552|NCT00576732|20911457|P1|DOUBLE BLIND|Lack of Efficacy|6
6050553|NCT00576732|20911452|P6|DOUBLE BLIND|OTHER|0
6050554|NCT00576732|20911453|P5|DOUBLE BLIND|OTHER|0
6050555|NCT00576732|20911454|P4|DOUBLE BLIND|OTHER|0
6050556|NCT00576732|20911455|P3|DOUBLE BLIND|OTHER|1
6050557|NCT00576732|20911456|P2|DOUBLE BLIND|OTHER|2
6050558|NCT00576732|20911457|P1|DOUBLE BLIND|OTHER|0
6050559|NCT00576732|20911452|P6|DOUBLE BLIND|Withdrawal by Subject|0
6050560|NCT00576732|20911453|P5|DOUBLE BLIND|Withdrawal by Subject|0
6050561|NCT00576732|20911454|P4|DOUBLE BLIND|Withdrawal by Subject|0
6050562|NCT00576732|20911455|P3|DOUBLE BLIND|Withdrawal by Subject|3
6050563|NCT00576732|20911456|P2|DOUBLE BLIND|Withdrawal by Subject|1
6050564|NCT00576732|20911457|P1|DOUBLE BLIND|Withdrawal by Subject|1
6050565|NCT00576732|20911452|P6|DOUBLE BLIND|Lost to Follow-up|0
6050566|NCT00576732|20911453|P5|DOUBLE BLIND|Lost to Follow-up|0
6050567|NCT00576732|20911454|P4|DOUBLE BLIND|Lost to Follow-up|0
6050568|NCT00576732|20911455|P3|DOUBLE BLIND|Lost to Follow-up|1
6050569|NCT00576732|20911456|P2|DOUBLE BLIND|Lost to Follow-up|1
6050570|NCT00576732|20911457|P1|DOUBLE BLIND|Lost to Follow-up|0
6050571|NCT00576732|20911452|P6|DOUBLE BLIND|Adverse Event|0
6050572|NCT00576732|20911453|P5|DOUBLE BLIND|Adverse Event|0
6050573|NCT00576732|20911454|P4|DOUBLE BLIND|Adverse Event|0
6050574|NCT00576732|20911455|P3|DOUBLE BLIND|Adverse Event|1
6050575|NCT00576732|20911456|P2|DOUBLE BLIND|Adverse Event|0
6050576|NCT00576732|20911457|P1|DOUBLE BLIND|Adverse Event|0
6050577|NCT00576693|20911489|P2|Overall Study|Withdrawal by Subject|13
6050578|NCT00576693|20911490|P1|Overall Study|Withdrawal by Subject|3
6050579|NCT00576693|20911489|P2|Overall Study|Lost to Follow-up|11
6050580|NCT00576693|20911490|P1|Overall Study|Lost to Follow-up|7
6050581|NCT00576628|20911502|P1|Overall Study|Dialysis|15
6050582|NCT00576628|20911502|P1|Overall Study|Transplantation|1
6050583|NCT00576628|20911502|P1|Overall Study|The patient move into other town|1
6050584|NCT00576628|20911502|P1|Overall Study|Progression of Renal Failure|1
6050585|NCT00576628|20911502|P1|Overall Study|Progression of Kidney Disease|1
6050586|NCT00576628|20911502|P1|Overall Study|RBC transfusion|1
6050587|NCT00576628|20911502|P1|Overall Study|Pregnancy|1
6050588|NCT00576628|20911502|P1|Overall Study|Refused Treatment|8
6050589|NCT00576628|20911502|P1|Overall Study|Failure to return|1
6050590|NCT00576628|20911502|P1|Overall Study|Death|2
6050591|NCT00576628|20911502|P1|Overall Study|Adverse Event|11
6050592|NCT00576576|20911522|P1|Overall Study|Protocol Violation|1
6050593|NCT00576576|20911522|P1|Overall Study|Lost to Follow-up|6
6050594|NCT00576472|20911556|P15|MPH Home Maintenance Phase|Lost to Follow-up|3
6050595|NCT00576472|20911557|P14|MPH Home Maintenance Phase|Lost to Follow-up|0
6050596|NCT00576472|20911558|P13|MPH Home Maintenance Phase|Lost to Follow-up|0
6050597|NCT00576472|20911559|P12|MPH Home Maintenance Phase|Lost to Follow-up|0
6050598|NCT00576472|20911560|P11|MPH Home Maintenance Phase|Lost to Follow-up|0
6050599|NCT00576472|20911561|P10|MPH Home Maintenance Phase|Lost to Follow-up|0
6050600|NCT00576472|20911562|P9|MPH Home Maintenance Phase|Lost to Follow-up|0
6050601|NCT00576472|20911563|P8|MPH Home Maintenance Phase|Lost to Follow-up|0
6050602|NCT00576472|20911564|P7|MPH Home Maintenance Phase|Lost to Follow-up|0
6050603|NCT00576472|20911565|P6|MPH Home Maintenance Phase|Lost to Follow-up|0
6050604|NCT00576472|20911566|P5|MPH Home Maintenance Phase|Lost to Follow-up|0
6050605|NCT00576472|20911567|P4|MPH Home Maintenance Phase|Lost to Follow-up|0
6050606|NCT00576472|20911568|P3|MPH Home Maintenance Phase|Lost to Follow-up|0
6050607|NCT00576472|20911569|P2|MPH Home Maintenance Phase|Lost to Follow-up|0
6050608|NCT00576472|20911570|P1|MPH Home Maintenance Phase|Lost to Follow-up|0
6050609|NCT00576472|20911556|P15|MPH Home Maintenance Phase|Medical reasons|6
6050610|NCT00576472|20911557|P14|MPH Home Maintenance Phase|Medical reasons|0
6050611|NCT00576472|20911558|P13|MPH Home Maintenance Phase|Medical reasons|0
6050612|NCT00576472|20911559|P12|MPH Home Maintenance Phase|Medical reasons|0
6050613|NCT00576472|20911560|P11|MPH Home Maintenance Phase|Medical reasons|0
6050614|NCT00576472|20911561|P10|MPH Home Maintenance Phase|Medical reasons|0
6050615|NCT00576472|20911562|P9|MPH Home Maintenance Phase|Medical reasons|0
6050616|NCT00576472|20911563|P8|MPH Home Maintenance Phase|Medical reasons|0
6050617|NCT00576472|20911564|P7|MPH Home Maintenance Phase|Medical reasons|0
6050618|NCT00576472|20911565|P6|MPH Home Maintenance Phase|Medical reasons|0
6050619|NCT00576472|20911566|P5|MPH Home Maintenance Phase|Medical reasons|0
6050620|NCT00576472|20911567|P4|MPH Home Maintenance Phase|Medical reasons|0
6050621|NCT00576472|20911568|P3|MPH Home Maintenance Phase|Medical reasons|0
6050622|NCT00576472|20911569|P2|MPH Home Maintenance Phase|Medical reasons|0
6050623|NCT00576472|20911570|P1|MPH Home Maintenance Phase|Medical reasons|0
6050624|NCT00576472|20911556|P15|MPH Home Maintenance Phase|Withdrawal by Subject|6
6050625|NCT00576472|20911557|P14|MPH Home Maintenance Phase|Withdrawal by Subject|0
6050626|NCT00576472|20911558|P13|MPH Home Maintenance Phase|Withdrawal by Subject|0
6050627|NCT00576472|20911559|P12|MPH Home Maintenance Phase|Withdrawal by Subject|0
6050628|NCT00576472|20911560|P11|MPH Home Maintenance Phase|Withdrawal by Subject|0
6050629|NCT00576472|20911561|P10|MPH Home Maintenance Phase|Withdrawal by Subject|0
6050630|NCT00576472|20911562|P9|MPH Home Maintenance Phase|Withdrawal by Subject|0
6050631|NCT00576472|20911563|P8|MPH Home Maintenance Phase|Withdrawal by Subject|0
6050632|NCT00576472|20911564|P7|MPH Home Maintenance Phase|Withdrawal by Subject|0
6050633|NCT00576472|20911565|P6|MPH Home Maintenance Phase|Withdrawal by Subject|0
6050634|NCT00576472|20911566|P5|MPH Home Maintenance Phase|Withdrawal by Subject|0
6050635|NCT00576472|20911567|P4|MPH Home Maintenance Phase|Withdrawal by Subject|0
6050636|NCT00576472|20911568|P3|MPH Home Maintenance Phase|Withdrawal by Subject|0
6050637|NCT00576472|20911569|P2|MPH Home Maintenance Phase|Withdrawal by Subject|0
6050638|NCT00576472|20911570|P1|MPH Home Maintenance Phase|Withdrawal by Subject|0
6050639|NCT00576472|20911556|P15|MPH Home Maintenance Phase|Side effects|8
6050640|NCT00576472|20911557|P14|MPH Home Maintenance Phase|Side effects|0
6050641|NCT00576472|20911558|P13|MPH Home Maintenance Phase|Side effects|0
6050642|NCT00576472|20911559|P12|MPH Home Maintenance Phase|Side effects|0
6050643|NCT00576472|20911560|P11|MPH Home Maintenance Phase|Side effects|0
6050644|NCT00576472|20911561|P10|MPH Home Maintenance Phase|Side effects|0
6050645|NCT00576472|20911562|P9|MPH Home Maintenance Phase|Side effects|0
6050646|NCT00576472|20911563|P8|MPH Home Maintenance Phase|Side effects|0
6050647|NCT00576472|20911564|P7|MPH Home Maintenance Phase|Side effects|0
6050648|NCT00576472|20911565|P6|MPH Home Maintenance Phase|Side effects|0
6050649|NCT00576472|20911566|P5|MPH Home Maintenance Phase|Side effects|0
6050650|NCT00576472|20911567|P4|MPH Home Maintenance Phase|Side effects|0
6050651|NCT00576472|20911568|P3|MPH Home Maintenance Phase|Side effects|0
6050652|NCT00576472|20911569|P2|MPH Home Maintenance Phase|Side effects|0
6050653|NCT00576472|20911570|P1|MPH Home Maintenance Phase|Side effects|0
6050654|NCT00576472|20911556|P15|MPH Home Maintenance Phase|Insufficient data|0
6050655|NCT00576472|20911557|P14|MPH Home Maintenance Phase|Insufficient data|4
6050656|NCT00576472|20911558|P13|MPH Home Maintenance Phase|Insufficient data|0
6050657|NCT00576472|20911559|P12|MPH Home Maintenance Phase|Insufficient data|0
6050658|NCT00576472|20911560|P11|MPH Home Maintenance Phase|Insufficient data|0
6050659|NCT00576472|20911561|P10|MPH Home Maintenance Phase|Insufficient data|0
6050660|NCT00576472|20911562|P9|MPH Home Maintenance Phase|Insufficient data|0
6050661|NCT00576472|20911563|P8|MPH Home Maintenance Phase|Insufficient data|0
6050662|NCT00576472|20911564|P7|MPH Home Maintenance Phase|Insufficient data|0
6050663|NCT00576472|20911565|P6|MPH Home Maintenance Phase|Insufficient data|0
6050664|NCT00576472|20911566|P5|MPH Home Maintenance Phase|Insufficient data|0
6050665|NCT00576472|20911567|P4|MPH Home Maintenance Phase|Insufficient data|0
6050666|NCT00576472|20911568|P3|MPH Home Maintenance Phase|Insufficient data|0
6050667|NCT00576472|20911569|P2|MPH Home Maintenance Phase|Insufficient data|0
6050668|NCT00576472|20911570|P1|MPH Home Maintenance Phase|Insufficient data|0
6050669|NCT00576472|20911556|P15|MPH Home Maintenance Phase|Declined to participate|0
6050670|NCT00576472|20911557|P14|MPH Home Maintenance Phase|Declined to participate|7
6050671|NCT00576472|20911558|P13|MPH Home Maintenance Phase|Declined to participate|0
6050672|NCT00576472|20911559|P12|MPH Home Maintenance Phase|Declined to participate|0
6050673|NCT00576472|20911560|P11|MPH Home Maintenance Phase|Declined to participate|0
6050674|NCT00576472|20911561|P10|MPH Home Maintenance Phase|Declined to participate|0
6050675|NCT00576472|20911562|P9|MPH Home Maintenance Phase|Declined to participate|0
6050676|NCT00576472|20911563|P8|MPH Home Maintenance Phase|Declined to participate|0
6050677|NCT00576472|20911564|P7|MPH Home Maintenance Phase|Declined to participate|0
6050678|NCT00576472|20911565|P6|MPH Home Maintenance Phase|Declined to participate|0
6050679|NCT00576472|20911566|P5|MPH Home Maintenance Phase|Declined to participate|0
6050680|NCT00576472|20911567|P4|MPH Home Maintenance Phase|Declined to participate|0
6050681|NCT00576472|20911568|P3|MPH Home Maintenance Phase|Declined to participate|0
6050682|NCT00576472|20911569|P2|MPH Home Maintenance Phase|Declined to participate|0
6050683|NCT00576472|20911570|P1|MPH Home Maintenance Phase|Declined to participate|0
6050684|NCT00576472|20911556|P15|MPH Home Maintenance Phase|Did not meet response criteria|0
6050685|NCT00576472|20911557|P14|MPH Home Maintenance Phase|Did not meet response criteria|16
6050686|NCT00576472|20911558|P13|MPH Home Maintenance Phase|Did not meet response criteria|0
6050687|NCT00576472|20911559|P12|MPH Home Maintenance Phase|Did not meet response criteria|0
6050688|NCT00576472|20911560|P11|MPH Home Maintenance Phase|Did not meet response criteria|0
6050689|NCT00576472|20911561|P10|MPH Home Maintenance Phase|Did not meet response criteria|0
6050690|NCT00576472|20911562|P9|MPH Home Maintenance Phase|Did not meet response criteria|0
6050691|NCT00576472|20911563|P8|MPH Home Maintenance Phase|Did not meet response criteria|0
6050692|NCT00576472|20911564|P7|MPH Home Maintenance Phase|Did not meet response criteria|0
6050693|NCT00576472|20911565|P6|MPH Home Maintenance Phase|Did not meet response criteria|0
6050694|NCT00576472|20911566|P5|MPH Home Maintenance Phase|Did not meet response criteria|0
6050695|NCT00576472|20911567|P4|MPH Home Maintenance Phase|Did not meet response criteria|0
6050696|NCT00576472|20911568|P3|MPH Home Maintenance Phase|Did not meet response criteria|0
6050697|NCT00576472|20911569|P2|MPH Home Maintenance Phase|Did not meet response criteria|0
6050698|NCT00576472|20911570|P1|MPH Home Maintenance Phase|Did not meet response criteria|0
6050699|NCT00576472|20911556|P15|MPH Cross Over Phase|Did not complete cross over phase|0
6050700|NCT00576472|20911557|P14|MPH Cross Over Phase|Did not complete cross over phase|0
6050701|NCT00576472|20911558|P13|MPH Cross Over Phase|Did not complete cross over phase|0
6050702|NCT00576472|20911559|P12|MPH Cross Over Phase|Did not complete cross over phase|1
6050703|NCT00576472|20911560|P11|MPH Cross Over Phase|Did not complete cross over phase|1
6050704|NCT00576472|20911561|P10|MPH Cross Over Phase|Did not complete cross over phase|0
6050705|NCT00576472|20911562|P9|MPH Cross Over Phase|Did not complete cross over phase|2
6050706|NCT00576472|20911563|P8|MPH Cross Over Phase|Did not complete cross over phase|0
6050707|NCT00576472|20911564|P7|MPH Cross Over Phase|Did not complete cross over phase|0
6050708|NCT00576472|20911565|P6|MPH Cross Over Phase|Did not complete cross over phase|0
6050709|NCT00576472|20911566|P5|MPH Cross Over Phase|Did not complete cross over phase|0
6050710|NCT00576472|20911567|P4|MPH Cross Over Phase|Did not complete cross over phase|0
6050711|NCT00576472|20911568|P3|MPH Cross Over Phase|Did not complete cross over phase|0
6050712|NCT00576472|20911569|P2|MPH Cross Over Phase|Did not complete cross over phase|0
6050713|NCT00576472|20911570|P1|MPH Cross Over Phase|Did not complete cross over phase|0
6050714|NCT00576472|20911556|P15|MPH Cross Over Phase|Physician Decision|0
6050715|NCT00576472|20911557|P14|MPH Cross Over Phase|Physician Decision|0
6050716|NCT00576472|20911558|P13|MPH Cross Over Phase|Physician Decision|0
6050717|NCT00576472|20911559|P12|MPH Cross Over Phase|Physician Decision|0
6050718|NCT00576472|20911560|P11|MPH Cross Over Phase|Physician Decision|0
6050719|NCT00576472|20911561|P10|MPH Cross Over Phase|Physician Decision|0
6050720|NCT00576472|20911562|P9|MPH Cross Over Phase|Physician Decision|0
6050721|NCT00576472|20911563|P8|MPH Cross Over Phase|Physician Decision|0
6050722|NCT00576472|20911564|P7|MPH Cross Over Phase|Physician Decision|4
6050723|NCT00576472|20911565|P6|MPH Cross Over Phase|Physician Decision|0
6050724|NCT00576472|20911566|P5|MPH Cross Over Phase|Physician Decision|0
6050725|NCT00576472|20911567|P4|MPH Cross Over Phase|Physician Decision|0
6050726|NCT00576472|20911568|P3|MPH Cross Over Phase|Physician Decision|0
6050727|NCT00576472|20911569|P2|MPH Cross Over Phase|Physician Decision|0
6050728|NCT00576472|20911570|P1|MPH Cross Over Phase|Physician Decision|0
6050729|NCT00576472|20911556|P15|MPH Cross Over Phase|Ineligible due to disease|0
6050730|NCT00576472|20911557|P14|MPH Cross Over Phase|Ineligible due to disease|0
6050731|NCT00576472|20911558|P13|MPH Cross Over Phase|Ineligible due to disease|0
6050732|NCT00576472|20911559|P12|MPH Cross Over Phase|Ineligible due to disease|0
6050733|NCT00576472|20911560|P11|MPH Cross Over Phase|Ineligible due to disease|0
6050734|NCT00576472|20911561|P10|MPH Cross Over Phase|Ineligible due to disease|0
6050735|NCT00576472|20911562|P9|MPH Cross Over Phase|Ineligible due to disease|0
6050736|NCT00576472|20911563|P8|MPH Cross Over Phase|Ineligible due to disease|0
6050737|NCT00576472|20911564|P7|MPH Cross Over Phase|Ineligible due to disease|2
6050738|NCT00576472|20911565|P6|MPH Cross Over Phase|Ineligible due to disease|0
6050739|NCT00576472|20911566|P5|MPH Cross Over Phase|Ineligible due to disease|0
6050740|NCT00576472|20911567|P4|MPH Cross Over Phase|Ineligible due to disease|0
6050741|NCT00576472|20911568|P3|MPH Cross Over Phase|Ineligible due to disease|0
6050742|NCT00576472|20911569|P2|MPH Cross Over Phase|Ineligible due to disease|0
6050743|NCT00576472|20911570|P1|MPH Cross Over Phase|Ineligible due to disease|0
6050744|NCT00576472|20911556|P15|MPH Cross Over Phase|Withdrawal by Subject|0
6050745|NCT00576472|20911557|P14|MPH Cross Over Phase|Withdrawal by Subject|0
6050746|NCT00576472|20911558|P13|MPH Cross Over Phase|Withdrawal by Subject|0
6050747|NCT00576472|20911559|P12|MPH Cross Over Phase|Withdrawal by Subject|0
6050748|NCT00576472|20911560|P11|MPH Cross Over Phase|Withdrawal by Subject|0
6050749|NCT00576472|20911561|P10|MPH Cross Over Phase|Withdrawal by Subject|0
6050750|NCT00576472|20911562|P9|MPH Cross Over Phase|Withdrawal by Subject|0
6050751|NCT00576472|20911563|P8|MPH Cross Over Phase|Withdrawal by Subject|0
6050752|NCT00576472|20911564|P7|MPH Cross Over Phase|Withdrawal by Subject|6
6050753|NCT00576472|20911565|P6|MPH Cross Over Phase|Withdrawal by Subject|0
6050754|NCT00576472|20911566|P5|MPH Cross Over Phase|Withdrawal by Subject|0
6050755|NCT00576472|20911567|P4|MPH Cross Over Phase|Withdrawal by Subject|0
6050756|NCT00576472|20911568|P3|MPH Cross Over Phase|Withdrawal by Subject|0
6050757|NCT00576472|20911569|P2|MPH Cross Over Phase|Withdrawal by Subject|0
6050758|NCT00576472|20911570|P1|MPH Cross Over Phase|Withdrawal by Subject|0
6050759|NCT00576472|20911556|P15|MPH In-Lab Phase|Psychiatric exclusion|0
6050760|NCT00576472|20911557|P14|MPH In-Lab Phase|Psychiatric exclusion|0
6050761|NCT00576472|20911558|P13|MPH In-Lab Phase|Psychiatric exclusion|0
6050762|NCT00576472|20911559|P12|MPH In-Lab Phase|Psychiatric exclusion|0
6050763|NCT00576472|20911560|P11|MPH In-Lab Phase|Psychiatric exclusion|0
6050764|NCT00576472|20911561|P10|MPH In-Lab Phase|Psychiatric exclusion|0
6050765|NCT00576472|20911562|P9|MPH In-Lab Phase|Psychiatric exclusion|0
6050766|NCT00576472|20911563|P8|MPH In-Lab Phase|Psychiatric exclusion|0
6050767|NCT00576472|20911564|P7|MPH In-Lab Phase|Psychiatric exclusion|0
6050768|NCT00576472|20911565|P6|MPH In-Lab Phase|Psychiatric exclusion|0
6050769|NCT00576472|20911566|P5|MPH In-Lab Phase|Psychiatric exclusion|0
6050770|NCT00576472|20911567|P4|MPH In-Lab Phase|Psychiatric exclusion|10
6050771|NCT00576472|20911568|P3|MPH In-Lab Phase|Psychiatric exclusion|0
6050772|NCT00576472|20911569|P2|MPH In-Lab Phase|Psychiatric exclusion|0
6050773|NCT00576472|20911570|P1|MPH In-Lab Phase|Psychiatric exclusion|0
6050774|NCT00576472|20911556|P15|MPH In-Lab Phase|No attention/academic problems|0
6050775|NCT00576472|20911557|P14|MPH In-Lab Phase|No attention/academic problems|0
6050776|NCT00576472|20911558|P13|MPH In-Lab Phase|No attention/academic problems|0
6050777|NCT00576472|20911559|P12|MPH In-Lab Phase|No attention/academic problems|0
6050778|NCT00576472|20911560|P11|MPH In-Lab Phase|No attention/academic problems|0
6050779|NCT00576472|20911561|P10|MPH In-Lab Phase|No attention/academic problems|0
6050780|NCT00576472|20911562|P9|MPH In-Lab Phase|No attention/academic problems|0
6050781|NCT00576472|20911563|P8|MPH In-Lab Phase|No attention/academic problems|0
6050782|NCT00576472|20911564|P7|MPH In-Lab Phase|No attention/academic problems|0
6050783|NCT00576472|20911565|P6|MPH In-Lab Phase|No attention/academic problems|0
6050784|NCT00576472|20911566|P5|MPH In-Lab Phase|No attention/academic problems|0
6050785|NCT00576472|20911567|P4|MPH In-Lab Phase|No attention/academic problems|245
6050786|NCT00576472|20911568|P3|MPH In-Lab Phase|No attention/academic problems|0
6050787|NCT00576472|20911569|P2|MPH In-Lab Phase|No attention/academic problems|0
6050788|NCT00576472|20911570|P1|MPH In-Lab Phase|No attention/academic problems|0
6050789|NCT00576472|20911556|P15|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
6050790|NCT00576472|20911557|P14|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
6050791|NCT00576472|20911558|P13|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
6050792|NCT00576472|20911559|P12|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
6050793|NCT00576472|20911560|P11|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
6050794|NCT00576472|20911561|P10|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
6050795|NCT00576472|20911562|P9|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
6050796|NCT00576472|20911563|P8|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
6050797|NCT00576472|20911564|P7|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
6050798|NCT00576472|20911565|P6|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
6050799|NCT00576472|20911566|P5|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
6050800|NCT00576472|20911567|P4|MPH In-Lab Phase|Patients did not qualify - IQ < 50|4
6050801|NCT00576472|20911568|P3|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
6050802|NCT00576472|20911569|P2|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
6050803|NCT00576472|20911570|P1|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
6050804|NCT00576472|20911556|P15|MPH In-Lab Phase|Lost to Follow-up|0
6050805|NCT00576472|20911557|P14|MPH In-Lab Phase|Lost to Follow-up|0
6050806|NCT00576472|20911558|P13|MPH In-Lab Phase|Lost to Follow-up|0
6050807|NCT00576472|20911559|P12|MPH In-Lab Phase|Lost to Follow-up|0
6050808|NCT00576472|20911560|P11|MPH In-Lab Phase|Lost to Follow-up|0
6050809|NCT00576472|20911561|P10|MPH In-Lab Phase|Lost to Follow-up|0
6050810|NCT00576472|20911562|P9|MPH In-Lab Phase|Lost to Follow-up|0
6050811|NCT00576472|20911563|P8|MPH In-Lab Phase|Lost to Follow-up|0
6050812|NCT00576472|20911564|P7|MPH In-Lab Phase|Lost to Follow-up|0
6050813|NCT00576472|20911565|P6|MPH In-Lab Phase|Lost to Follow-up|0
6050814|NCT00576472|20911566|P5|MPH In-Lab Phase|Lost to Follow-up|0
6050815|NCT00576472|20911567|P4|MPH In-Lab Phase|Lost to Follow-up|1
6050816|NCT00576472|20911568|P3|MPH In-Lab Phase|Lost to Follow-up|0
6050817|NCT00576472|20911569|P2|MPH In-Lab Phase|Lost to Follow-up|0
6050818|NCT00576472|20911570|P1|MPH In-Lab Phase|Lost to Follow-up|0
6050819|NCT00576472|20911556|P15|MPH In-Lab Phase|Declined participation in medication pha|0
6050820|NCT00576472|20911557|P14|MPH In-Lab Phase|Declined participation in medication pha|0
6050821|NCT00576472|20911558|P13|MPH In-Lab Phase|Declined participation in medication pha|0
6050822|NCT00576472|20911559|P12|MPH In-Lab Phase|Declined participation in medication pha|0
6050823|NCT00576472|20911560|P11|MPH In-Lab Phase|Declined participation in medication pha|0
6050824|NCT00576472|20911561|P10|MPH In-Lab Phase|Declined participation in medication pha|0
6050825|NCT00576472|20911562|P9|MPH In-Lab Phase|Declined participation in medication pha|0
6050826|NCT00576472|20911563|P8|MPH In-Lab Phase|Declined participation in medication pha|0
6050827|NCT00576472|20911564|P7|MPH In-Lab Phase|Declined participation in medication pha|0
6050828|NCT00576472|20911565|P6|MPH In-Lab Phase|Declined participation in medication pha|0
6050829|NCT00576472|20911566|P5|MPH In-Lab Phase|Declined participation in medication pha|0
6050830|NCT00576472|20911567|P4|MPH In-Lab Phase|Declined participation in medication pha|75
6050831|NCT00576472|20911568|P3|MPH In-Lab Phase|Declined participation in medication pha|0
6050832|NCT00576472|20911569|P2|MPH In-Lab Phase|Declined participation in medication pha|0
6050833|NCT00576472|20911570|P1|MPH In-Lab Phase|Declined participation in medication pha|0
6050834|NCT00576420|20911663|P3|Overall Study|Death|1
6050835|NCT00576420|20911664|P2|Overall Study|Death|0
6050836|NCT00576420|20911665|P1|Overall Study|Death|0
6050837|NCT00576407|20911830|P1|Overall Study|Physician Decision|1
6050838|NCT00576407|20911830|P1|Overall Study|Death|7
6050839|NCT00576381|20911842|P1|Overall Study|Adverse Event|4
6050840|NCT00576381|20911842|P1|Overall Study|Reoperation|3
6050841|NCT00576316|20911846|P1|Overall Study|Protocol Violation|9
6050842|NCT00576316|20911846|P1|Overall Study|Withdrawal by Subject|2
6050843|NCT00576316|20911846|P1|Overall Study|Adverse Event|9
6050844|NCT00576303|20911851|P1|Long Term Safety Period|Early withdrawal|16
6050845|NCT00576303|20911851|P1|Efficacy Evaluation Period|Early withdrawal|5
6050846|NCT00576303|20911851|P1|Dose Titration Period|Early withdrawal|17
6050847|NCT00576199|20911869|P1|Overall Study|Reason Unspecified|2
6050848|NCT00576199|20911869|P1|Overall Study|Refused Treatment|2
6050849|NCT00576199|20911869|P1|Overall Study|Insufficient Therapeutic Response|14
6050850|NCT00576199|20911869|P1|Overall Study|Adverse Event|12
6050851|NCT00576056|20911882|P1|Overall Study|Physician Decision|1
6050852|NCT00576056|20911882|P1|Overall Study|did not meet eligibility criteria|8
6050853|NCT00576056|20911882|P1|Overall Study|Withdrawal by Subject|2
6050854|NCT00576056|20911882|P1|Overall Study|Lack of Efficacy|1
6050855|NCT00576056|20911882|P1|Overall Study|Death|1
6050856|NCT00576056|20911882|P1|Overall Study|Adverse Event|1
6050857|NCT00575666|20911898|P2|Overall Study|Physician Decision|1
6050858|NCT00575666|20911899|P1|Overall Study|Physician Decision|1
6050859|NCT00575666|20911898|P2|Overall Study|Withdrawal by Subject|2
6050860|NCT00575666|20911899|P1|Overall Study|Withdrawal by Subject|3
6050861|NCT00575588|20911939|P2|Overall Study|Impossible to determine HbA1c|1
6050862|NCT00575588|20911940|P1|Overall Study|Impossible to determine HbA1c|0
6050863|NCT00575588|20911939|P2|Overall Study|Patient moved|3
6050864|NCT00575588|20911940|P1|Overall Study|Patient moved|1
6050865|NCT00575588|20911939|P2|Overall Study|Elevated triglyceride|0
6050866|NCT00575588|20911940|P1|Overall Study|Elevated triglyceride|1
6050867|NCT00575588|20911939|P2|Overall Study|Safety reasons|1
6050868|NCT00575588|20911940|P1|Overall Study|Safety reasons|2
6050869|NCT00575588|20911939|P2|Overall Study|Severe non-compliance to protocol|7
6050870|NCT00575588|20911940|P1|Overall Study|Severe non-compliance to protocol|5
6050871|NCT00575588|20911939|P2|Overall Study|Study specific discontinuation criteria|218
6050872|NCT00575588|20911940|P1|Overall Study|Study specific discontinuation criteria|203
6050873|NCT00575588|20911939|P2|Overall Study|Incorrect enrollment|4
6050874|NCT00575588|20911940|P1|Overall Study|Incorrect enrollment|8
6050875|NCT00575588|20911939|P2|Overall Study|Death|2
6050876|NCT00575588|20911940|P1|Overall Study|Death|4
6050877|NCT00575588|20911939|P2|Overall Study|Lost to Follow-up|3
6050878|NCT00575588|20911940|P1|Overall Study|Lost to Follow-up|1
6050879|NCT00575588|20911939|P2|Overall Study|Withdrawal by Subject|31
6050880|NCT00575588|20911940|P1|Overall Study|Withdrawal by Subject|27
6050881|NCT00575588|20911939|P2|Overall Study|Adverse Event|13
6050882|NCT00575588|20911940|P1|Overall Study|Adverse Event|11
6050883|NCT00575510|20911963|P3|Overall Study|Pregnancy|1
6050884|NCT00575510|20911964|P2|Overall Study|Pregnancy|0
6050885|NCT00575510|20911965|P1|Overall Study|Pregnancy|0
6050886|NCT00575510|20911963|P3|Overall Study|Clinic Called Patient|7
6050887|NCT00575510|20911964|P2|Overall Study|Clinic Called Patient|7
6050888|NCT00575510|20911965|P1|Overall Study|Clinic Called Patient|7
6050889|NCT00575510|20911963|P3|Overall Study|Withdrawal by Subject|0
6050890|NCT00575510|20911964|P2|Overall Study|Withdrawal by Subject|0
6050891|NCT00575510|20911965|P1|Overall Study|Withdrawal by Subject|1
6050892|NCT00575510|20911963|P3|Overall Study|Lost to Follow-up|9
6050893|NCT00575510|20911964|P2|Overall Study|Lost to Follow-up|6
6050894|NCT00575510|20911965|P1|Overall Study|Lost to Follow-up|4
6050895|NCT00575380|20911978|P2|Overall Study|Various|2
6050896|NCT00575380|20911979|P1|Overall Study|Various|0
6050897|NCT00575380|20911978|P2|Overall Study|Adverse Event|1
6050898|NCT00575380|20911979|P1|Overall Study|Adverse Event|0
6050899|NCT00575380|20911978|P2|Overall Study|Withdrawal by Subject|0
6050900|NCT00575380|20911979|P1|Overall Study|Withdrawal by Subject|1
6050901|NCT00575328|20911998|P2|Overall Study|Lost to Follow-up|1
6050902|NCT00575328|20911999|P1|Overall Study|Lost to Follow-up|2
6050903|NCT00575328|20911998|P2|Overall Study|Adverse Event|1
6050904|NCT00575328|20911999|P1|Overall Study|Adverse Event|1
6050905|NCT00575094|20912132|P1|Overall Study|Withdrawal by Subject|1
6050906|NCT00575094|20912132|P1|Overall Study|Adverse Event|2
6050907|NCT00575042|20912136|P1|Overall Study|Lost to Follow-up|1
6050908|NCT00575042|20912136|P1|Overall Study|Adverse Event|2
6050909|NCT00574951|20912187|P1|Overall Study|Ineligible - improper prior treatment|1
6050910|NCT00574912|20912195|P1|Overall Study|Physician Decision|2
6050911|NCT00574912|20912195|P1|Overall Study|scheduling conflicts|3
6050912|NCT00574912|20912195|P1|Overall Study|Could not place IV lines.|3
6050913|NCT00574873|20912209|P2|Overall Study|Extension Study|0
6050914|NCT00574873|20912210|P1|Overall Study|Extension Study|126
6050915|NCT00574873|20912209|P2|Overall Study|Blank, site closed per local regulations|2
6050916|NCT00574873|20912210|P1|Overall Study|Blank, site closed per local regulations|2
6050917|NCT00574873|20912209|P2|Overall Study|Discontinuation of study by sponsor|199
6050918|NCT00574873|20912210|P1|Overall Study|Discontinuation of study by sponsor|5
6050919|NCT00574873|20912209|P2|Overall Study|Other|4
6050920|NCT00574873|20912210|P1|Overall Study|Other|40
6050921|NCT00574873|20912209|P2|Overall Study|Lost to Follow-up|5
6050922|NCT00574873|20912210|P1|Overall Study|Lost to Follow-up|14
6050923|NCT00574873|20912209|P2|Overall Study|Death|14
6050924|NCT00574873|20912210|P1|Overall Study|Death|15
6050925|NCT00574873|20912209|P2|Overall Study|Investigator request|8
6050926|NCT00574873|20912210|P1|Overall Study|Investigator request|18
6050927|NCT00574873|20912209|P2|Overall Study|Withdrawal by Subject|19
6050928|NCT00574873|20912210|P1|Overall Study|Withdrawal by Subject|18
6050929|NCT00574847|20912228|P2|Overall Study|Did not receive medication (declined)|5
6050930|NCT00574847|20912229|P1|Overall Study|Did not receive medication (declined)|2
6050931|NCT00574847|20912228|P2|Overall Study|Physician Decision|0
6050932|NCT00574847|20912229|P1|Overall Study|Physician Decision|1
6050933|NCT00574847|20912228|P2|Overall Study|Withdrawal by Subject|2
6050934|NCT00574847|20912229|P1|Overall Study|Withdrawal by Subject|2
6050935|NCT00574847|20912228|P2|Overall Study|Death|0
6050936|NCT00574847|20912229|P1|Overall Study|Death|1
6050937|NCT00574847|20912228|P2|Overall Study|Adverse Event|0
6050938|NCT00574847|20912229|P1|Overall Study|Adverse Event|2
6050939|NCT00574795|20912274|P1|Toddler Dose|Withdrawal by Subject|1
6050940|NCT00574795|20912274|P1|After Infant Series|Adverse Event|2
6050941|NCT00574795|20912274|P1|After Infant Series|Withdrawal by Subject|1
6050942|NCT00574795|20912274|P1|Infant Series|Adverse Event|1
6050943|NCT00574795|20912274|P1|Infant Series|Protocol Violation|2
6050944|NCT00574795|20912274|P1|Infant Series|Withdrawal by Subject|2
6050945|NCT00574405|20912375|P2|Overall Study|Withdrawal by Subject|2
6050946|NCT00574405|20912376|P1|Overall Study|Withdrawal by Subject|3
6050947|NCT00574288|20912396|P7|Overall Study|Other|0
6050948|NCT00574288|20912397|P6|Overall Study|Other|0
6050949|NCT00574288|20912398|P5|Overall Study|Other|0
6050950|NCT00574288|20912399|P4|Overall Study|Other|0
6050951|NCT00574288|20912400|P3|Overall Study|Other|0
6050952|NCT00574288|20912401|P2|Overall Study|Other|1
6050953|NCT00574288|20912402|P1|Overall Study|Other|1
6050954|NCT00574288|20912396|P7|Overall Study|Progressive Disease|0
6050955|NCT00574288|20912397|P6|Overall Study|Progressive Disease|0
6050956|NCT00574288|20912398|P5|Overall Study|Progressive Disease|1
6050957|NCT00574288|20912399|P4|Overall Study|Progressive Disease|2
6050958|NCT00574288|20912400|P3|Overall Study|Progressive Disease|3
6050959|NCT00574288|20912401|P2|Overall Study|Progressive Disease|2
6050960|NCT00574288|20912402|P1|Overall Study|Progressive Disease|17
6050961|NCT00574288|20912396|P7|Overall Study|Study Terminated By Sponsor|5
6050962|NCT00574288|20912397|P6|Overall Study|Study Terminated By Sponsor|0
6050963|NCT00574288|20912398|P5|Overall Study|Study Terminated By Sponsor|0
6050964|NCT00574288|20912399|P4|Overall Study|Study Terminated By Sponsor|0
6050965|NCT00574288|20912400|P3|Overall Study|Study Terminated By Sponsor|0
6050966|NCT00574288|20912401|P2|Overall Study|Study Terminated By Sponsor|0
6050967|NCT00574288|20912402|P1|Overall Study|Study Terminated By Sponsor|0
6050968|NCT00574288|20912396|P7|Overall Study|Lost to Follow-up|2
6050969|NCT00574288|20912397|P6|Overall Study|Lost to Follow-up|1
6050970|NCT00574288|20912398|P5|Overall Study|Lost to Follow-up|0
6050971|NCT00574288|20912399|P4|Overall Study|Lost to Follow-up|0
6050972|NCT00574288|20912400|P3|Overall Study|Lost to Follow-up|0
6050973|NCT00574288|20912401|P2|Overall Study|Lost to Follow-up|0
6050974|NCT00574288|20912402|P1|Overall Study|Lost to Follow-up|0
6050975|NCT00574288|20912396|P7|Overall Study|Death|21
6050976|NCT00574288|20912397|P6|Overall Study|Death|25
6050977|NCT00574288|20912398|P5|Overall Study|Death|0
6050978|NCT00574288|20912399|P4|Overall Study|Death|0
6050979|NCT00574288|20912400|P3|Overall Study|Death|0
6050980|NCT00574288|20912401|P2|Overall Study|Death|0
6050981|NCT00574288|20912402|P1|Overall Study|Death|0
6050982|NCT00574288|20912396|P7|Overall Study|Adverse Event|0
6050983|NCT00574288|20912397|P6|Overall Study|Adverse Event|0
6050984|NCT00574288|20912398|P5|Overall Study|Adverse Event|1
6050985|NCT00574288|20912399|P4|Overall Study|Adverse Event|0
6050986|NCT00574288|20912400|P3|Overall Study|Adverse Event|0
6050987|NCT00574288|20912401|P2|Overall Study|Adverse Event|0
6050988|NCT00574288|20912402|P1|Overall Study|Adverse Event|2
6050989|NCT00574275|20912440|P2|Overall Study|Operation for curative intent|1
6050990|NCT00574275|20912441|P1|Overall Study|Operation for curative intent|0
6050991|NCT00574275|20912440|P2|Overall Study|Insurance change|1
6050992|NCT00574275|20912441|P1|Overall Study|Insurance change|0
6050993|NCT00574275|20912440|P2|Overall Study|Patient and Investigator decision|1
6050994|NCT00574275|20912441|P1|Overall Study|Patient and Investigator decision|0
6050995|NCT00574275|20912440|P2|Overall Study|Protocol Violation|1
6050996|NCT00574275|20912441|P1|Overall Study|Protocol Violation|0
6050997|NCT00574275|20912440|P2|Overall Study|Physician Decision|1
6050998|NCT00574275|20912441|P1|Overall Study|Physician Decision|1
6050999|NCT00574275|20912440|P2|Overall Study|Error calculating tumor measurement|0
6051000|NCT00574275|20912441|P1|Overall Study|Error calculating tumor measurement|1
6051001|NCT00574275|20912440|P2|Overall Study|Withdrawal by Subject|17
6051002|NCT00574275|20912441|P1|Overall Study|Withdrawal by Subject|15
6051003|NCT00574275|20912440|P2|Overall Study|Study stopped based on DMC decision|23
6051004|NCT00574275|20912441|P1|Overall Study|Study stopped based on DMC decision|62
6051005|NCT00574275|20912440|P2|Overall Study|Lost to Follow-up|1
6051006|NCT00574275|20912441|P1|Overall Study|Lost to Follow-up|2
6051007|NCT00574275|20912440|P2|Overall Study|Disease progression|146
6051008|NCT00574275|20912441|P1|Overall Study|Disease progression|160
6051009|NCT00574275|20912440|P2|Overall Study|Adverse Event|76
6051010|NCT00574275|20912441|P1|Overall Study|Adverse Event|32
6051011|NCT00574275|20912440|P2|Overall Study|Randomized but not treated|3
6051012|NCT00574275|20912441|P1|Overall Study|Randomized but not treated|2
6051013|NCT00574249|20912459|P2|Overall Study|PPD test taken twice|1
6051014|NCT00574249|20912460|P1|Overall Study|PPD test taken twice|0
6051015|NCT00574249|20912459|P2|Overall Study|Excluded by company|1
6051016|NCT00574249|20912460|P1|Overall Study|Excluded by company|0
6051017|NCT00574249|20912459|P2|Overall Study|Pregnancy|0
6051018|NCT00574249|20912460|P1|Overall Study|Pregnancy|1
6051019|NCT00574249|20912459|P2|Overall Study|Physician Decision|0
6051020|NCT00574249|20912460|P1|Overall Study|Physician Decision|1
6051021|NCT00574249|20912459|P2|Overall Study|Withdrawal by Subject|0
6051022|NCT00574249|20912460|P1|Overall Study|Withdrawal by Subject|3
6051023|NCT00574249|20912459|P2|Overall Study|History of carcinoma|0
6051024|NCT00574249|20912460|P1|Overall Study|History of carcinoma|1
6051025|NCT00574249|20912459|P2|Overall Study|Protocol Violation|2
6051026|NCT00574249|20912460|P1|Overall Study|Protocol Violation|5
6051027|NCT00574249|20912459|P2|Overall Study|Lost to Follow-up|3
6051028|NCT00574249|20912460|P1|Overall Study|Lost to Follow-up|4
6051029|NCT00574249|20912459|P2|Overall Study|Lack of Efficacy|3
6051030|NCT00574249|20912460|P1|Overall Study|Lack of Efficacy|5
6051031|NCT00574249|20912459|P2|Overall Study|Adverse Event|18
6051032|NCT00574249|20912460|P1|Overall Study|Adverse Event|6
6051033|NCT00574145|20912516|P2|Overall Study|Withdrawal by Subject|1
6051034|NCT00574145|20912517|P1|Overall Study|Withdrawal by Subject|2
6051035|NCT00574119|20912527|P1|Overall Study|Physician Decision|1
6051036|NCT00574119|20912527|P1|Overall Study|Withdrawal by Subject|1
6051037|NCT00574119|20912527|P1|Overall Study|Protocol Violation|1
6051038|NCT00574119|20912527|P1|Overall Study|Adverse Event|1
6051039|NCT00574080|20912541|P2|Overall Study|Death|10
6051040|NCT00574080|20912542|P1|Overall Study|Death|10
6051041|NCT00573937|20912611|P2|Overall Study|Study Terminated|1
6051042|NCT00573937|20912612|P1|Overall Study|Study Terminated|0
6051043|NCT00573859|20912626|P1|Smoking Versus Abstinence|Scheduling conflicts|12
6051044|NCT00573859|20912626|P1|Medication Versus Placebo|Scheduling conflicts|12
6051045|NCT00573833|20912632|P1|Overall Study|Not Treated|2
6051046|NCT00573794|20912639|P1|Overall Study|Other|46
6051047|NCT00573794|20912639|P1|Overall Study|Lack of Efficacy|94
6051048|NCT00573794|20912639|P1|Overall Study|Protocol Violation|6
6051049|NCT00573794|20912639|P1|Overall Study|Lost to Follow-up|13
6051050|NCT00573794|20912639|P1|Overall Study|Withdrew Consent|90
6051051|NCT00573794|20912639|P1|Overall Study|Adverse Event|81
6051052|NCT00573768|20912670|P3|Overall Study|Lost to Follow-up|1
6051053|NCT00573768|20912671|P2|Overall Study|Lost to Follow-up|0
6051054|NCT00573768|20912672|P1|Overall Study|Lost to Follow-up|0
6051055|NCT00573768|20912670|P3|Overall Study|Withdrawal by Subject|0
6051056|NCT00573768|20912671|P2|Overall Study|Withdrawal by Subject|1
6051057|NCT00573768|20912672|P1|Overall Study|Withdrawal by Subject|0
6051058|NCT00573768|20912670|P3|Overall Study|Protocol Violation|1
6051059|NCT00573768|20912671|P2|Overall Study|Protocol Violation|0
6051060|NCT00573768|20912672|P1|Overall Study|Protocol Violation|1
6051061|NCT00573768|20912670|P3|Overall Study|Adverse Event|2
6051062|NCT00573768|20912671|P2|Overall Study|Adverse Event|1
6051063|NCT00573768|20912672|P1|Overall Study|Adverse Event|1
6051064|NCT00573755|20912682|P2|Overall Study|Still receiving treatment|0
6051065|NCT00573755|20912683|P1|Overall Study|Still receiving treatment|1
6051066|NCT00573534|20912699|P1|Overall Study|oppositional behavior|3
6051067|NCT00573469|20912740|P3|Overall Study|Other|3
6051068|NCT00573469|20912741|P2|Overall Study|Other|1
6051069|NCT00573469|20912742|P1|Overall Study|Other|5
6051070|NCT00573469|20912740|P3|Overall Study|Withdrawal by Subject|0
6051071|NCT00573469|20912741|P2|Overall Study|Withdrawal by Subject|2
6051072|NCT00573469|20912742|P1|Overall Study|Withdrawal by Subject|0
6051073|NCT00573469|20912740|P3|Overall Study|Adverse Event|1
6051074|NCT00573469|20912741|P2|Overall Study|Adverse Event|1
6051075|NCT00573469|20912742|P1|Overall Study|Adverse Event|1
6051076|NCT00573443|20912765|P3|Open-Label Extension Phase|Other|0
6051077|NCT00573443|20912766|P2|Open-Label Extension Phase|Other|0
6051078|NCT00573443|20912767|P1|Open-Label Extension Phase|Other|2
6051079|NCT00573443|20912765|P3|Open-Label Extension Phase|Protocol Violation|0
6051080|NCT00573443|20912766|P2|Open-Label Extension Phase|Protocol Violation|0
6051081|NCT00573443|20912767|P1|Open-Label Extension Phase|Protocol Violation|2
6051082|NCT00573443|20912765|P3|Open-Label Extension Phase|Withdrawal by Subject|0
6051083|NCT00573443|20912766|P2|Open-Label Extension Phase|Withdrawal by Subject|0
6051084|NCT00573443|20912767|P1|Open-Label Extension Phase|Withdrawal by Subject|3
6051085|NCT00573443|20912765|P3|Open-Label Extension Phase|Serious Adverse Event|0
6051086|NCT00573443|20912766|P2|Open-Label Extension Phase|Serious Adverse Event|0
6051087|NCT00573443|20912767|P1|Open-Label Extension Phase|Serious Adverse Event|5
6051088|NCT00573443|20912765|P3|Open-Label Extension Phase|Adverse Event|0
6051089|NCT00573443|20912766|P2|Open-Label Extension Phase|Adverse Event|0
6051090|NCT00573443|20912767|P1|Open-Label Extension Phase|Adverse Event|3
6051091|NCT00573443|20912765|P3|Open-Label Extension Phase|Exacerbation of MS symptoms|0
6051092|NCT00573443|20912766|P2|Open-Label Extension Phase|Exacerbation of MS symptoms|0
6051093|NCT00573443|20912767|P1|Open-Label Extension Phase|Exacerbation of MS symptoms|2
6051094|NCT00573443|20912765|P3|Open-Label Extension Phase|Lost to Follow-up|0
6051095|NCT00573443|20912766|P2|Open-Label Extension Phase|Lost to Follow-up|0
6051096|NCT00573443|20912767|P1|Open-Label Extension Phase|Lost to Follow-up|1
6051097|NCT00573443|20912765|P3|Double-Blind Phase|Other|3
6051098|NCT00573443|20912766|P2|Double-Blind Phase|Other|2
6051099|NCT00573443|20912767|P1|Double-Blind Phase|Other|0
6051100|NCT00573443|20912765|P3|Double-Blind Phase|Protocol Violation|1
6051101|NCT00573443|20912766|P2|Double-Blind Phase|Protocol Violation|2
6051102|NCT00573443|20912767|P1|Double-Blind Phase|Protocol Violation|0
6051103|NCT00573443|20912765|P3|Double-Blind Phase|Withdrawal by Subject|7
6051104|NCT00573443|20912766|P2|Double-Blind Phase|Withdrawal by Subject|2
6051105|NCT00573443|20912767|P1|Double-Blind Phase|Withdrawal by Subject|2
6051106|NCT00573443|20912765|P3|Double-Blind Phase|Medication refusal due to AE|0
6051107|NCT00573443|20912766|P2|Double-Blind Phase|Medication refusal due to AE|2
6051108|NCT00573443|20912767|P1|Double-Blind Phase|Medication refusal due to AE|2
6051109|NCT00573443|20912765|P3|Double-Blind Phase|Serious Adverse Event (AE)|1
6051110|NCT00573443|20912766|P2|Double-Blind Phase|Serious Adverse Event (AE)|3
6051111|NCT00573443|20912767|P1|Double-Blind Phase|Serious Adverse Event (AE)|2
6051112|NCT00573443|20912765|P3|Double-Blind Phase|Adverse Event|0
6051113|NCT00573443|20912766|P2|Double-Blind Phase|Adverse Event|5
6051114|NCT00573443|20912767|P1|Double-Blind Phase|Adverse Event|1
6051115|NCT00573443|20912765|P3|Double-Blind Phase|Exacerbation of MS symptoms|1
6051116|NCT00573443|20912766|P2|Double-Blind Phase|Exacerbation of MS symptoms|0
6051117|NCT00573443|20912767|P1|Double-Blind Phase|Exacerbation of MS symptoms|1
6051118|NCT00573443|20912765|P3|Double-Blind Phase|Lost to Follow-up|2
6051119|NCT00573443|20912766|P2|Double-Blind Phase|Lost to Follow-up|3
6051120|NCT00573443|20912767|P1|Double-Blind Phase|Lost to Follow-up|1
6051121|NCT00573430|20912797|P3|Overall Study|Eligibility criteria not fulfilled|3
6051122|NCT00573430|20912798|P2|Overall Study|Eligibility criteria not fulfilled|0
6051123|NCT00573430|20912799|P1|Overall Study|Eligibility criteria not fulfilled|0
6051124|NCT00573430|20912797|P3|Overall Study|Protocol Violation|1
6051125|NCT00573430|20912798|P2|Overall Study|Protocol Violation|1
6051126|NCT00573430|20912799|P1|Overall Study|Protocol Violation|0
6051127|NCT00573430|20912797|P3|Overall Study|Withdrawal by Subject|1
6051128|NCT00573430|20912798|P2|Overall Study|Withdrawal by Subject|0
6051129|NCT00573430|20912799|P1|Overall Study|Withdrawal by Subject|1
6051130|NCT00573430|20912797|P3|Overall Study|Adverse Event|2
6051131|NCT00573430|20912798|P2|Overall Study|Adverse Event|0
6051132|NCT00573430|20912799|P1|Overall Study|Adverse Event|0
6051133|NCT00573430|20912797|P3|Overall Study|Incorrect enrollment of randomization|3
6051134|NCT00573430|20912798|P2|Overall Study|Incorrect enrollment of randomization|4
6051135|NCT00573430|20912799|P1|Overall Study|Incorrect enrollment of randomization|0
6051136|NCT00573391|20912821|P2|Overall Study|Death|0
6051137|NCT00573391|20912822|P1|Overall Study|Death|1
6051138|NCT00573391|20912821|P2|Overall Study|study stopped|2
6051139|NCT00573391|20912822|P1|Overall Study|study stopped|2
6051140|NCT00573313|20912832|P4|Overall Study|Protocol Violation|0
6051141|NCT00573313|20912833|P3|Overall Study|Protocol Violation|6
6051142|NCT00573313|20912834|P2|Overall Study|Protocol Violation|0
6051143|NCT00573313|20912835|P1|Overall Study|Protocol Violation|5
6051144|NCT00573248|20912885|P2|Overall Study|scheduling conflicts|11
6051145|NCT00573248|20912886|P1|Overall Study|scheduling conflicts|15
6051146|NCT00573183|20912900|P2|Overall Study|Other|2
6051147|NCT00573183|20912901|P1|Overall Study|Other|5
6051148|NCT00573183|20912900|P2|Overall Study|Incarceration|8
6051149|NCT00573183|20912901|P1|Overall Study|Incarceration|5
6051150|NCT00573183|20912900|P2|Overall Study|Adverse Event|0
6051151|NCT00573183|20912901|P1|Overall Study|Adverse Event|2
6051152|NCT00573183|20912900|P2|Overall Study|Death|1
6051153|NCT00573183|20912901|P1|Overall Study|Death|0
6051154|NCT00573183|20912900|P2|Overall Study|Withdrawal by Subject|2
6051155|NCT00573183|20912901|P1|Overall Study|Withdrawal by Subject|8
6051156|NCT00573183|20912900|P2|Overall Study|Lost to Follow-up|50
6051157|NCT00573183|20912901|P1|Overall Study|Lost to Follow-up|52
6051158|NCT00573170|20912909|P6|Third Treatment Period|Lost to Follow-up|2
6051159|NCT00573170|20912910|P5|Third Treatment Period|Lost to Follow-up|0
6051160|NCT00573170|20912911|P4|Third Treatment Period|Lost to Follow-up|0
6051161|NCT00573170|20912912|P3|Third Treatment Period|Lost to Follow-up|0
6051162|NCT00573170|20912913|P2|Third Treatment Period|Lost to Follow-up|0
6051163|NCT00573170|20912914|P1|Third Treatment Period|Lost to Follow-up|0
6051164|NCT00573170|20912909|P6|Third Treatment Period|Withdrawal by Subject|0
6051165|NCT00573170|20912910|P5|Third Treatment Period|Withdrawal by Subject|0
6051166|NCT00573170|20912911|P4|Third Treatment Period|Withdrawal by Subject|0
6051167|NCT00573170|20912912|P3|Third Treatment Period|Withdrawal by Subject|0
6051168|NCT00573170|20912913|P2|Third Treatment Period|Withdrawal by Subject|0
6051169|NCT00573170|20912914|P1|Third Treatment Period|Withdrawal by Subject|1
6051170|NCT00573170|20912909|P6|Second Washout Period|Other|2
6051171|NCT00573170|20912910|P5|Second Washout Period|Other|6
6051172|NCT00573170|20912911|P4|Second Washout Period|Other|4
6051173|NCT00573170|20912912|P3|Second Washout Period|Other|1
6051174|NCT00573170|20912913|P2|Second Washout Period|Other|2
6051175|NCT00573170|20912914|P1|Second Washout Period|Other|1
6051176|NCT00573170|20912909|P6|Second Washout Period|Lost to Follow-up|0
6051177|NCT00573170|20912910|P5|Second Washout Period|Lost to Follow-up|0
6051178|NCT00573170|20912911|P4|Second Washout Period|Lost to Follow-up|1
6051179|NCT00573170|20912912|P3|Second Washout Period|Lost to Follow-up|0
6051180|NCT00573170|20912913|P2|Second Washout Period|Lost to Follow-up|0
6051181|NCT00573170|20912914|P1|Second Washout Period|Lost to Follow-up|0
6051182|NCT00573170|20912909|P6|Second Washout Period|Withdrawal by Subject|0
6051183|NCT00573170|20912910|P5|Second Washout Period|Withdrawal by Subject|1
6051184|NCT00573170|20912911|P4|Second Washout Period|Withdrawal by Subject|0
6051185|NCT00573170|20912912|P3|Second Washout Period|Withdrawal by Subject|2
6051186|NCT00573170|20912913|P2|Second Washout Period|Withdrawal by Subject|1
6051187|NCT00573170|20912914|P1|Second Washout Period|Withdrawal by Subject|1
6051188|NCT00573170|20912909|P6|Second Washout Period|Protocol Violation|0
6051189|NCT00573170|20912910|P5|Second Washout Period|Protocol Violation|0
6051190|NCT00573170|20912911|P4|Second Washout Period|Protocol Violation|0
6051191|NCT00573170|20912912|P3|Second Washout Period|Protocol Violation|1
6051192|NCT00573170|20912913|P2|Second Washout Period|Protocol Violation|1
6051193|NCT00573170|20912914|P1|Second Washout Period|Protocol Violation|2
6051194|NCT00573170|20912909|P6|Second Washout Period|Adverse Event|0
6051195|NCT00573170|20912910|P5|Second Washout Period|Adverse Event|1
6051196|NCT00573170|20912911|P4|Second Washout Period|Adverse Event|0
6051197|NCT00573170|20912912|P3|Second Washout Period|Adverse Event|0
6051198|NCT00573170|20912913|P2|Second Washout Period|Adverse Event|0
6051199|NCT00573170|20912914|P1|Second Washout Period|Adverse Event|1
6051200|NCT00573170|20912909|P6|First Washout Period|Other|0
6051201|NCT00573170|20912910|P5|First Washout Period|Other|0
6051202|NCT00573170|20912911|P4|First Washout Period|Other|1
6051203|NCT00573170|20912912|P3|First Washout Period|Other|1
6051204|NCT00573170|20912913|P2|First Washout Period|Other|0
6051205|NCT00573170|20912914|P1|First Washout Period|Other|4
6051206|NCT00573170|20912909|P6|First Washout Period|Withdrawal by Subject|3
6051207|NCT00573170|20912910|P5|First Washout Period|Withdrawal by Subject|3
6051208|NCT00573170|20912911|P4|First Washout Period|Withdrawal by Subject|2
6051209|NCT00573170|20912912|P3|First Washout Period|Withdrawal by Subject|0
6051210|NCT00573170|20912913|P2|First Washout Period|Withdrawal by Subject|0
6051211|NCT00573170|20912914|P1|First Washout Period|Withdrawal by Subject|2
6051212|NCT00573170|20912909|P6|First Washout Period|Lost to Follow-up|2
6051213|NCT00573170|20912910|P5|First Washout Period|Lost to Follow-up|0
6051214|NCT00573170|20912911|P4|First Washout Period|Lost to Follow-up|2
6051215|NCT00573170|20912912|P3|First Washout Period|Lost to Follow-up|0
6051216|NCT00573170|20912913|P2|First Washout Period|Lost to Follow-up|1
6051217|NCT00573170|20912914|P1|First Washout Period|Lost to Follow-up|1
6051218|NCT00573170|20912909|P6|First Washout Period|Lack of Efficacy|1
6051219|NCT00573170|20912910|P5|First Washout Period|Lack of Efficacy|0
6051220|NCT00573170|20912911|P4|First Washout Period|Lack of Efficacy|0
6051221|NCT00573170|20912912|P3|First Washout Period|Lack of Efficacy|0
6051222|NCT00573170|20912913|P2|First Washout Period|Lack of Efficacy|0
6051223|NCT00573170|20912914|P1|First Washout Period|Lack of Efficacy|0
6051224|NCT00573170|20912909|P6|First Washout Period|Adverse Event|1
6051225|NCT00573170|20912910|P5|First Washout Period|Adverse Event|0
6051226|NCT00573170|20912911|P4|First Washout Period|Adverse Event|0
6051227|NCT00573170|20912912|P3|First Washout Period|Adverse Event|0
6051228|NCT00573170|20912913|P2|First Washout Period|Adverse Event|1
6051229|NCT00573170|20912914|P1|First Washout Period|Adverse Event|1
6051230|NCT00573170|20912909|P6|First Treatment Period|Did Not Treat Attack 1|0
6051231|NCT00573170|20912910|P5|First Treatment Period|Did Not Treat Attack 1|1
6051232|NCT00573170|20912911|P4|First Treatment Period|Did Not Treat Attack 1|0
6051233|NCT00573170|20912912|P3|First Treatment Period|Did Not Treat Attack 1|0
6051234|NCT00573170|20912913|P2|First Treatment Period|Did Not Treat Attack 1|0
6051235|NCT00573170|20912914|P1|First Treatment Period|Did Not Treat Attack 1|0
6051236|NCT00573157|20912990|P2|Overall Study|Other|1
6051237|NCT00573157|20912991|P1|Overall Study|Other|1
6051238|NCT00573157|20912990|P2|Overall Study|Adverse Event|1
6051239|NCT00573157|20912991|P1|Overall Study|Adverse Event|3
6051240|NCT00573144|20913003|P2|Overall Study|Withdrawal by Subject|3
6051241|NCT00573144|20913004|P1|Overall Study|Withdrawal by Subject|2
6051242|NCT00573131|20913016|P2|Overall Study|Withdrawal by Subject|8
6051243|NCT00573131|20913017|P1|Overall Study|Withdrawal by Subject|10
6051244|NCT00573066|20913023|P1|Overall Study|Postoperative bleeding|1
6051245|NCT00573066|20913023|P1|Overall Study|IV malfunction|1
6051246|NCT00573066|20913023|P1|Overall Study|Exclusion criteria|18
6051247|NCT00572910|20913067|P11|Overall Study|Withdrawal by Subject|1
6051248|NCT00572910|20913068|P10|Overall Study|Withdrawal by Subject|2
6051249|NCT00572910|20913069|P9|Overall Study|Withdrawal by Subject|2
6051250|NCT00572910|20913070|P8|Overall Study|Withdrawal by Subject|2
6051251|NCT00572910|20913071|P7|Overall Study|Withdrawal by Subject|0
6051252|NCT00572910|20913072|P6|Overall Study|Withdrawal by Subject|3
6051253|NCT00572910|20913073|P5|Overall Study|Withdrawal by Subject|1
6051254|NCT00572910|20913074|P4|Overall Study|Withdrawal by Subject|0
6051255|NCT00572910|20913075|P3|Overall Study|Withdrawal by Subject|1
6051256|NCT00572910|20913076|P2|Overall Study|Withdrawal by Subject|0
6051257|NCT00572910|20913077|P1|Overall Study|Withdrawal by Subject|3
6051258|NCT00572910|20913067|P11|Overall Study|Lost to Follow-up|0
6051259|NCT00572910|20913068|P10|Overall Study|Lost to Follow-up|1
6051260|NCT00572910|20913069|P9|Overall Study|Lost to Follow-up|0
6051261|NCT00572910|20913070|P8|Overall Study|Lost to Follow-up|0
6051262|NCT00572910|20913071|P7|Overall Study|Lost to Follow-up|0
6051263|NCT00572910|20913072|P6|Overall Study|Lost to Follow-up|0
6051264|NCT00572910|20913073|P5|Overall Study|Lost to Follow-up|1
6051265|NCT00572910|20913074|P4|Overall Study|Lost to Follow-up|2
6051266|NCT00572910|20913075|P3|Overall Study|Lost to Follow-up|1
6051267|NCT00572910|20913076|P2|Overall Study|Lost to Follow-up|1
6051268|NCT00572910|20913077|P1|Overall Study|Lost to Follow-up|0
6051269|NCT00572910|20913067|P11|Overall Study|Adverse Event|2
6051270|NCT00572910|20913068|P10|Overall Study|Adverse Event|3
6051271|NCT00572910|20913069|P9|Overall Study|Adverse Event|1
6051272|NCT00572910|20913070|P8|Overall Study|Adverse Event|2
6051273|NCT00572910|20913071|P7|Overall Study|Adverse Event|4
6051274|NCT00572910|20913072|P6|Overall Study|Adverse Event|0
6051275|NCT00572910|20913073|P5|Overall Study|Adverse Event|0
6051276|NCT00572910|20913074|P4|Overall Study|Adverse Event|2
6051277|NCT00572910|20913075|P3|Overall Study|Adverse Event|0
6051278|NCT00572910|20913076|P2|Overall Study|Adverse Event|2
6051279|NCT00572910|20913077|P1|Overall Study|Adverse Event|1
6051280|NCT00572832|20913144|P2|Overall Study|Pregnancy|1
6051281|NCT00572832|20913145|P1|Overall Study|Pregnancy|0
6051282|NCT00572832|20913144|P2|Overall Study|Lost to Follow-up|11
6051283|NCT00572832|20913145|P1|Overall Study|Lost to Follow-up|0
6051284|NCT00572728|20913151|P1|Overall Study|Pathology missing|1
6051285|NCT00572728|20913151|P1|Overall Study|FLT2 after second chemotherapy initiated|7
6051286|NCT00572728|20913151|P1|Overall Study|Second chemotherapy not initiated|1
6051287|NCT00572728|20913151|P1|Overall Study|FLT2 not completed|5
6051288|NCT00572728|20913151|P1|Overall Study|First Chemotherapy not initiated|2
6051289|NCT00572728|20913151|P1|Overall Study|FLT1 not completed|4
6051290|NCT00572728|20913151|P1|Overall Study|Offstudy due to complicating disease|1
6051291|NCT00572728|20913151|P1|Overall Study|Enrolled under Amendment 4|5
6051292|NCT00572728|20913151|P1|Overall Study|Ineligible|3
6051293|NCT00572728|20913151|P1|Overall Study|Withdrawal by Subject|10
6051294|NCT00572624|20913165|P2|Overall Study|Health issues unrelated to the study|0
6051295|NCT00572624|20913166|P1|Overall Study|Health issues unrelated to the study|1
6051296|NCT00572624|20913165|P2|Overall Study|Problem with vascular access|0
6051297|NCT00572624|20913166|P1|Overall Study|Problem with vascular access|1
6051298|NCT00572624|20913165|P2|Overall Study|Refused to do the stress test|0
6051299|NCT00572624|20913166|P1|Overall Study|Refused to do the stress test|1
6051300|NCT00572624|20913165|P2|Overall Study|Admitted to being a smoker|0
6051301|NCT00572624|20913166|P1|Overall Study|Admitted to being a smoker|1
6051302|NCT00572624|20913165|P2|Overall Study|Started a new job-- no time for study|0
6051303|NCT00572624|20913166|P1|Overall Study|Started a new job-- no time for study|1
6051304|NCT00572624|20913165|P2|Overall Study|Medication change|0
6051305|NCT00572624|20913166|P1|Overall Study|Medication change|1
6051306|NCT00572624|20913165|P2|Overall Study|Wanted to do a different diet program|0
6051307|NCT00572624|20913166|P1|Overall Study|Wanted to do a different diet program|1
6051308|NCT00572624|20913165|P2|Overall Study|Lost to Follow-up|4
6051309|NCT00572624|20913166|P1|Overall Study|Lost to Follow-up|10
6051310|NCT00572572|20913194|P2|Overall Study|Withdrawal by Subject|6
6051311|NCT00572572|20913195|P1|Overall Study|Withdrawal by Subject|3
6051312|NCT00572533|20913213|P2|Overall Study|Transfer out of Facility|1
6051313|NCT00572533|20913214|P1|Overall Study|Transfer out of Facility|0
6051314|NCT00572533|20913213|P2|Overall Study|Social Issues|0
6051315|NCT00572533|20913214|P1|Overall Study|Social Issues|1
6051316|NCT00572533|20913213|P2|Overall Study|Received Kidney Transplant|1
6051317|NCT00572533|20913214|P1|Overall Study|Received Kidney Transplant|2
6051318|NCT00572533|20913213|P2|Overall Study|Death|1
6051319|NCT00572533|20913214|P1|Overall Study|Death|4
6051320|NCT00572195|20913258|P1|Overall Study|Lost to Follow-up|5
6051321|NCT00572195|20913258|P1|Overall Study|Adverse Event|4
6051322|NCT00572195|20913258|P1|Overall Study|Death|9
6051323|NCT00572195|20913258|P1|Overall Study|Withdrawal by Subject|50
6051324|NCT00572156|20913270|P4|Overall Study|Sponsor Decision|19
6051325|NCT00572156|20913271|P3|Overall Study|Sponsor Decision|17
6051326|NCT00572156|20913272|P2|Overall Study|Sponsor Decision|16
6051327|NCT00572156|20913273|P1|Overall Study|Sponsor Decision|20
6051328|NCT00572156|20913270|P4|Overall Study|Patient/Parent Decision|3
6051329|NCT00572156|20913271|P3|Overall Study|Patient/Parent Decision|4
6051330|NCT00572156|20913272|P2|Overall Study|Patient/Parent Decision|6
6051331|NCT00572156|20913273|P1|Overall Study|Patient/Parent Decision|1
6051332|NCT00572156|20913270|P4|Overall Study|Protocol Violation|2
6051333|NCT00572156|20913271|P3|Overall Study|Protocol Violation|0
6051334|NCT00572156|20913272|P2|Overall Study|Protocol Violation|2
6051335|NCT00572156|20913273|P1|Overall Study|Protocol Violation|1
6051336|NCT00572156|20913270|P4|Overall Study|Lost to Follow-up|0
6051337|NCT00572156|20913271|P3|Overall Study|Lost to Follow-up|1
6051338|NCT00572156|20913272|P2|Overall Study|Lost to Follow-up|1
6051339|NCT00572156|20913273|P1|Overall Study|Lost to Follow-up|1
6051340|NCT00572156|20913270|P4|Overall Study|Adverse Event|1
6051341|NCT00572156|20913271|P3|Overall Study|Adverse Event|5
6051342|NCT00572156|20913272|P2|Overall Study|Adverse Event|1
6051343|NCT00572156|20913273|P1|Overall Study|Adverse Event|3
6051344|NCT00572039|20913344|P2|Overall Study|Ill|1
6051345|NCT00572039|20913345|P1|Overall Study|Ill|5
6051346|NCT00572039|20913344|P2|Overall Study|Death|3
6051347|NCT00572039|20913345|P1|Overall Study|Death|2
6051348|NCT00572039|20913344|P2|Overall Study|Withdrawal by Subject|6
6051349|NCT00572039|20913345|P1|Overall Study|Withdrawal by Subject|9
6051350|NCT00571948|20913377|P2|Overall Study|Parent were afraid of blood colection|5
6051351|NCT00571948|20913378|P1|Overall Study|Parent were afraid of blood colection|2
6051352|NCT00571948|20913377|P2|Overall Study|infant refused study meal|4
6051353|NCT00571948|20913378|P1|Overall Study|infant refused study meal|3
6051354|NCT00571948|20913377|P2|Overall Study|Protocol Violation|3
6051355|NCT00571948|20913378|P1|Overall Study|Protocol Violation|3
6051356|NCT00571948|20913377|P2|Overall Study|Withdrawal by Subject|2
6051357|NCT00571948|20913378|P1|Overall Study|Withdrawal by Subject|1
6051358|NCT00571948|20913377|P2|Overall Study|Lost to Follow-up|0
6051359|NCT00571948|20913378|P1|Overall Study|Lost to Follow-up|2
6051360|NCT00571922|20913386|P2|Overall Study|Completion unknown|36
6051361|NCT00571922|20913387|P1|Overall Study|Completion unknown|36
6051362|NCT00571701|20913397|P2|Second Intervention 12 Months|Withdrawal by Subject|0
6051363|NCT00571701|20913398|P1|Second Intervention 12 Months|Withdrawal by Subject|3
6051364|NCT00571701|20913397|P2|Second Intervention 12 Months|Adverse Event|1
6051365|NCT00571701|20913398|P1|Second Intervention 12 Months|Adverse Event|0
6051366|NCT00571701|20913397|P2|First Intervention 12 Months|Death|0
6051367|NCT00571701|20913398|P1|First Intervention 12 Months|Death|1
6051368|NCT00571701|20913397|P2|First Intervention 12 Months|Withdrawal by Subject|1
6051369|NCT00571701|20913398|P1|First Intervention 12 Months|Withdrawal by Subject|2
6051370|NCT00571688|20913424|P2|Overall Study|subject moved out of the area|0
6051371|NCT00571688|20913425|P1|Overall Study|subject moved out of the area|1
6051372|NCT00571688|20913424|P2|Overall Study|subject did not tolerate Consta|0
6051373|NCT00571688|20913425|P1|Overall Study|subject did not tolerate Consta|1
6051374|NCT00571688|20913424|P2|Overall Study|Lost to Follow-up|6
6051375|NCT00571688|20913425|P1|Overall Study|Lost to Follow-up|3
6051376|NCT00571662|20913431|P1|Overall Study|Adverse Event|5
6051377|NCT00571662|20913431|P1|Overall Study|psychiatric instability|1
6051378|NCT00571662|20913431|P1|Overall Study|Withdrawal by Subject|2
6051379|NCT00571649|20913442|P2|Follow-up Period|Protocol Violation|12
6051380|NCT00571649|20913443|P1|Follow-up Period|Protocol Violation|5
6051381|NCT00571649|20913442|P2|Follow-up Period|Patient convenience|121
6051382|NCT00571649|20913443|P1|Follow-up Period|Patient convenience|136
6051383|NCT00571649|20913442|P2|Follow-up Period|Lost to Follow-up|92
6051384|NCT00571649|20913443|P1|Follow-up Period|Lost to Follow-up|95
6051385|NCT00571649|20913442|P2|Follow-up Period|Physician Decision|13
6051386|NCT00571649|20913443|P1|Follow-up Period|Physician Decision|7
6051387|NCT00571649|20913442|P2|Follow-up Period|Death|133
6051388|NCT00571649|20913443|P1|Follow-up Period|Death|132
6051389|NCT00571649|20913442|P2|Follow-up Period|Withdrawal by Subject|115
6051390|NCT00571649|20913443|P1|Follow-up Period|Withdrawal by Subject|119
6051391|NCT00571649|20913442|P2|Follow-up Period|Clinical endpoint reached|2
6051392|NCT00571649|20913443|P1|Follow-up Period|Clinical endpoint reached|5
6051393|NCT00571649|20913442|P2|Follow-up Period|Adverse Event|40
6051394|NCT00571649|20913443|P1|Follow-up Period|Adverse Event|46
6051395|NCT00571649|20913442|P2|Treatment Period|Technical problems|5
6051396|NCT00571649|20913443|P1|Treatment Period|Technical problems|3
6051397|NCT00571649|20913442|P2|Treatment Period|Protocol Violation|92
6051398|NCT00571649|20913443|P1|Treatment Period|Protocol Violation|90
6051399|NCT00571649|20913442|P2|Treatment Period|Patient convenience|13
6051400|NCT00571649|20913443|P1|Treatment Period|Patient convenience|11
6051401|NCT00571649|20913442|P2|Treatment Period|Non-compliant with study medication|89
6051402|NCT00571649|20913443|P1|Treatment Period|Non-compliant with study medication|88
6051403|NCT00571649|20913442|P2|Treatment Period|Lost to Follow-up|41
6051404|NCT00571649|20913443|P1|Treatment Period|Lost to Follow-up|43
6051405|NCT00571649|20913442|P2|Treatment Period|Physician Decision|9
6051406|NCT00571649|20913443|P1|Treatment Period|Physician Decision|8
6051407|NCT00571649|20913442|P2|Treatment Period|Death|59
6051408|NCT00571649|20913443|P1|Treatment Period|Death|76
6051409|NCT00571649|20913442|P2|Treatment Period|Withdrawal by Subject|255
6051410|NCT00571649|20913443|P1|Treatment Period|Withdrawal by Subject|285
6051411|NCT00571649|20913442|P2|Treatment Period|Clinical endpoint reached|56
6051412|NCT00571649|20913443|P1|Treatment Period|Clinical endpoint reached|50
6051413|NCT00571649|20913442|P2|Treatment Period|Adverse Event|385
6051414|NCT00571649|20913443|P1|Treatment Period|Adverse Event|438
6051415|NCT00571103|20913541|P1|Overall Study|Lost to Follow-up|1
6051416|NCT00571103|20913541|P1|Overall Study|Withdrawal by Subject|1
6051417|NCT00571064|20913546|P1|Overall Study|Other|2
6051418|NCT00571064|20913546|P1|Overall Study|Withdrawal by Subject|2
6051419|NCT00571064|20913546|P1|Overall Study|Protocol Violation|4
6051420|NCT00571064|20913546|P1|Overall Study|Adverse Event|13
6051421|NCT00571038|20913561|P2|Overall Study|Moved out of state|2
6051422|NCT00571038|20913562|P1|Overall Study|Moved out of state|2
6051423|NCT00571038|20913561|P2|Overall Study|Withdrawal by Subject|3
6051424|NCT00571038|20913562|P1|Overall Study|Withdrawal by Subject|1
6051425|NCT00571038|20913561|P2|Overall Study|Death|5
6051426|NCT00571038|20913562|P1|Overall Study|Death|7
6051427|NCT00571038|20913561|P2|Overall Study|Lost to Follow-up|4
6051428|NCT00571038|20913562|P1|Overall Study|Lost to Follow-up|1
6051429|NCT00570921|20913617|P1|Overall Study|Physician Decision|1
6051430|NCT00570921|20913617|P1|Overall Study|Protocol Violation|1
6051431|NCT00570908|20913623|P1|Overall Study|Withdrawal by Subject|2
6051432|NCT00570908|20913623|P1|Overall Study|Adverse Event|5
6051433|NCT00570778|20913627|P4|Overall Study|Subject no longer requires study drug|0
6051434|NCT00570778|20913628|P3|Overall Study|Subject no longer requires study drug|0
6051435|NCT00570778|20913629|P2|Overall Study|Subject no longer requires study drug|1
6051436|NCT00570778|20913630|P1|Overall Study|Subject no longer requires study drug|0
6051437|NCT00570778|20913627|P4|Overall Study|Lost to Follow-up|0
6051438|NCT00570778|20913628|P3|Overall Study|Lost to Follow-up|1
6051439|NCT00570778|20913629|P2|Overall Study|Lost to Follow-up|0
6051440|NCT00570778|20913630|P1|Overall Study|Lost to Follow-up|0
6051441|NCT00570778|20913627|P4|Overall Study|Unsatisfactory therapeutic effect|0
6051442|NCT00570778|20913628|P3|Overall Study|Unsatisfactory therapeutic effect|0
6051443|NCT00570778|20913629|P2|Overall Study|Unsatisfactory therapeutic effect|0
6051444|NCT00570778|20913630|P1|Overall Study|Unsatisfactory therapeutic effect|1
6051445|NCT00570778|20913627|P4|Overall Study|Abnormal test procedure|0
6051446|NCT00570778|20913628|P3|Overall Study|Abnormal test procedure|0
6051447|NCT00570778|20913629|P2|Overall Study|Abnormal test procedure|0
6051448|NCT00570778|20913630|P1|Overall Study|Abnormal test procedure|1
6051449|NCT00570778|20913627|P4|Overall Study|Subject withdrew consent|1
6051450|NCT00570778|20913628|P3|Overall Study|Subject withdrew consent|0
6051451|NCT00570778|20913629|P2|Overall Study|Subject withdrew consent|1
6051452|NCT00570778|20913630|P1|Overall Study|Subject withdrew consent|0
6051453|NCT00570778|20913627|P4|Overall Study|Adverse Event|1
6051454|NCT00570778|20913628|P3|Overall Study|Adverse Event|4
6051455|NCT00570778|20913629|P2|Overall Study|Adverse Event|1
6051456|NCT00570778|20913630|P1|Overall Study|Adverse Event|0
6051457|NCT00570778|20913627|P4|Overall Study|Protocol deviation|2
6051458|NCT00570778|20913628|P3|Overall Study|Protocol deviation|2
6051459|NCT00570778|20913629|P2|Overall Study|Protocol deviation|1
6051460|NCT00570778|20913630|P1|Overall Study|Protocol deviation|2
6051461|NCT00570739|20913671|P4|Overall Study|Other|3
6051462|NCT00570739|20913672|P3|Overall Study|Other|5
6051463|NCT00570739|20913673|P2|Overall Study|Other|2
6051464|NCT00570739|20913674|P1|Overall Study|Other|0
6051465|NCT00570739|20913671|P4|Overall Study|Met discontinuation criteria|1
6051466|NCT00570739|20913672|P3|Overall Study|Met discontinuation criteria|1
6051467|NCT00570739|20913673|P2|Overall Study|Met discontinuation criteria|0
6051468|NCT00570739|20913674|P1|Overall Study|Met discontinuation criteria|1
6051469|NCT00570739|20913671|P4|Overall Study|Required restricted medication|0
6051470|NCT00570739|20913672|P3|Overall Study|Required restricted medication|1
6051471|NCT00570739|20913673|P2|Overall Study|Required restricted medication|0
6051472|NCT00570739|20913674|P1|Overall Study|Required restricted medication|0
6051473|NCT00570739|20913671|P4|Overall Study|Withdrawal by Subject|5
6051474|NCT00570739|20913672|P3|Overall Study|Withdrawal by Subject|3
6051475|NCT00570739|20913673|P2|Overall Study|Withdrawal by Subject|7
6051476|NCT00570739|20913674|P1|Overall Study|Withdrawal by Subject|7
6051477|NCT00570739|20913671|P4|Overall Study|Physician Decision|0
6051478|NCT00570739|20913672|P3|Overall Study|Physician Decision|0
6051479|NCT00570739|20913673|P2|Overall Study|Physician Decision|1
6051480|NCT00570739|20913674|P1|Overall Study|Physician Decision|1
6051481|NCT00570739|20913671|P4|Overall Study|Lost to Follow-up|1
6051482|NCT00570739|20913672|P3|Overall Study|Lost to Follow-up|4
6051483|NCT00570739|20913673|P2|Overall Study|Lost to Follow-up|5
6051484|NCT00570739|20913674|P1|Overall Study|Lost to Follow-up|4
6051485|NCT00570739|20913671|P4|Overall Study|Adverse Event|2
6051486|NCT00570739|20913672|P3|Overall Study|Adverse Event|2
6051487|NCT00570739|20913673|P2|Overall Study|Adverse Event|6
6051488|NCT00570739|20913674|P1|Overall Study|Adverse Event|8
6051489|NCT00570713|20913826|P2|Overall Study|Discontinuation of Study by the Sponsor|7
6051490|NCT00570713|20913827|P1|Overall Study|Discontinuation of Study by the Sponsor|10
6051491|NCT00570713|20913826|P2|Overall Study|Withdrawal by Subject|3
6051492|NCT00570713|20913827|P1|Overall Study|Withdrawal by Subject|3
6051493|NCT00570713|20913826|P2|Overall Study|Physician Decision|2
6051494|NCT00570713|20913827|P1|Overall Study|Physician Decision|2
6051495|NCT00570713|20913826|P2|Overall Study|Lack of Efficacy|49
6051496|NCT00570713|20913827|P1|Overall Study|Lack of Efficacy|40
6051497|NCT00570713|20913826|P2|Overall Study|Death|7
6051498|NCT00570713|20913827|P1|Overall Study|Death|7
6051499|NCT00570713|20913826|P2|Overall Study|Adverse Event|9
6051500|NCT00570713|20913827|P1|Overall Study|Adverse Event|16
6051501|NCT00570687|20913845|P10|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
6051502|NCT00570687|20913846|P9|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
6051503|NCT00570687|20913847|P8|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
6051504|NCT00570687|20913848|P7|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|1
6051505|NCT00570687|20913849|P6|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
6051506|NCT00570687|20913850|P5|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
6051507|NCT00570687|20913851|P4|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
6051508|NCT00570687|20913852|P3|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
6051509|NCT00570687|20913853|P2|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
6051510|NCT00570687|20913854|P1|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
6051511|NCT00570687|20913845|P10|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
6051512|NCT00570687|20913846|P9|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|1
6051513|NCT00570687|20913847|P8|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
6051514|NCT00570687|20913848|P7|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
6051515|NCT00570687|20913849|P6|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
6051516|NCT00570687|20913850|P5|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
6051517|NCT00570687|20913851|P4|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
6051518|NCT00570687|20913852|P3|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
6051519|NCT00570687|20913853|P2|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
6051520|NCT00570687|20913854|P1|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
6051521|NCT00570687|20913845|P10|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3
6051522|NCT00570687|20913846|P9|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2
6051523|NCT00570687|20913847|P8|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3
6051524|NCT00570687|20913848|P7|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2
6051525|NCT00570687|20913849|P6|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3
6051526|NCT00570687|20913850|P5|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3
6051527|NCT00570687|20913851|P4|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0
6051528|NCT00570687|20913852|P3|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0
6051529|NCT00570687|20913853|P2|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0
6051530|NCT00570687|20913854|P1|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0
6051531|NCT00570674|20913880|P7|Overall Study|Withdrawal by Subject|0
6051532|NCT00570674|20913881|P6|Overall Study|Withdrawal by Subject|0
6051533|NCT00570674|20913882|P5|Overall Study|Withdrawal by Subject|0
6051534|NCT00570674|20913883|P4|Overall Study|Withdrawal by Subject|0
6051535|NCT00570674|20913884|P3|Overall Study|Withdrawal by Subject|1
6051536|NCT00570674|20913885|P2|Overall Study|Withdrawal by Subject|0
6051537|NCT00570674|20913886|P1|Overall Study|Withdrawal by Subject|0
6051538|NCT00570505|20913909|P1|Overall Study|Other loss to follow-up|4
6051539|NCT00570505|20913909|P1|Overall Study|Lost to Follow-up|23
6051540|NCT00570505|20913909|P1|Overall Study|Withdrawal by Subject|7
6051541|NCT00570505|20913909|P1|Overall Study|Adverse Event|7
6051542|NCT00570492|20913922|P3|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0
6051543|NCT00570492|20913923|P2|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|3
6051544|NCT00570492|20913924|P1|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0
6051545|NCT00570492|20913922|P3|52-week Double-blind Treatment Period|Lack of Efficacy|0
6051546|NCT00570492|20913923|P2|52-week Double-blind Treatment Period|Lack of Efficacy|3
6051547|NCT00570492|20913924|P1|52-week Double-blind Treatment Period|Lack of Efficacy|0
6051548|NCT00570492|20913922|P3|52-week Double-blind Treatment Period|Physician Decision|4
6051549|NCT00570492|20913923|P2|52-week Double-blind Treatment Period|Physician Decision|2
6051550|NCT00570492|20913924|P1|52-week Double-blind Treatment Period|Physician Decision|0
6051551|NCT00570492|20913922|P3|52-week Double-blind Treatment Period|Adverse Event|5
6051552|NCT00570492|20913923|P2|52-week Double-blind Treatment Period|Adverse Event|5
6051553|NCT00570492|20913924|P1|52-week Double-blind Treatment Period|Adverse Event|0
6051554|NCT00570492|20913922|P3|52-week Double-blind Treatment Period|Lost to Follow-up|7
6051555|NCT00570492|20913923|P2|52-week Double-blind Treatment Period|Lost to Follow-up|5
6051556|NCT00570492|20913924|P1|52-week Double-blind Treatment Period|Lost to Follow-up|0
6051557|NCT00570492|20913922|P3|52-week Double-blind Treatment Period|Protocol Violation|15
6051558|NCT00570492|20913923|P2|52-week Double-blind Treatment Period|Protocol Violation|12
6051559|NCT00570492|20913924|P1|52-week Double-blind Treatment Period|Protocol Violation|0
6051560|NCT00570492|20913922|P3|52-week Double-blind Treatment Period|Withdrawal by Subject|20
6051561|NCT00570492|20913923|P2|52-week Double-blind Treatment Period|Withdrawal by Subject|20
6051562|NCT00570492|20913924|P1|52-week Double-blind Treatment Period|Withdrawal by Subject|0
6051563|NCT00570492|20913922|P3|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0
6051564|NCT00570492|20913923|P2|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0
6051565|NCT00570492|20913924|P1|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|1
6051566|NCT00570492|20913922|P3|16-week Single-blind Baseline Period|Adverse Event|0
6051567|NCT00570492|20913923|P2|16-week Single-blind Baseline Period|Adverse Event|0
6051568|NCT00570492|20913924|P1|16-week Single-blind Baseline Period|Adverse Event|1
6051569|NCT00570492|20913922|P3|16-week Single-blind Baseline Period|Lost to Follow-up|0
6051570|NCT00570492|20913923|P2|16-week Single-blind Baseline Period|Lost to Follow-up|0
6051571|NCT00570492|20913924|P1|16-week Single-blind Baseline Period|Lost to Follow-up|2
6051572|NCT00570492|20913922|P3|16-week Single-blind Baseline Period|Protocol Violation|0
6051573|NCT00570492|20913923|P2|16-week Single-blind Baseline Period|Protocol Violation|0
6051574|NCT00570492|20913924|P1|16-week Single-blind Baseline Period|Protocol Violation|15
6051575|NCT00570492|20913922|P3|16-week Single-blind Baseline Period|Withdrawal by Subject|0
6051576|NCT00570492|20913923|P2|16-week Single-blind Baseline Period|Withdrawal by Subject|0
6051577|NCT00570492|20913924|P1|16-week Single-blind Baseline Period|Withdrawal by Subject|56
6051578|NCT00570492|20913922|P3|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0
6051579|NCT00570492|20913923|P2|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0
6051580|NCT00570492|20913924|P1|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|263
6051581|NCT00570492|20913922|P3|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0
6051582|NCT00570492|20913923|P2|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0
6051583|NCT00570492|20913924|P1|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|98
6051584|NCT00570401|20913962|P1|Overall Study|Adverse Event|2
6051585|NCT00570323|20913996|P2|Complete Study After Start|Physician Decision|0
6051586|NCT00570323|20913997|P1|Complete Study After Start|Physician Decision|1
6051587|NCT00570323|20913996|P2|Complete Study After Start|Withdrawal by Subject|0
6051588|NCT00570323|20913997|P1|Complete Study After Start|Withdrawal by Subject|2
6051589|NCT00570323|20913996|P2|Complete Study After Start|Lost to Follow-up|1
6051590|NCT00570323|20913997|P1|Complete Study After Start|Lost to Follow-up|0
6051591|NCT00570323|20913996|P2|Started Treatment After Randomization|Physician Decision|0
6051592|NCT00570323|20913997|P1|Started Treatment After Randomization|Physician Decision|1
6051593|NCT00570323|20913996|P2|Started Treatment After Randomization|Protocol Violation|0
6051594|NCT00570323|20913997|P1|Started Treatment After Randomization|Protocol Violation|1
6051595|NCT00570323|20913996|P2|Started Treatment After Randomization|Withdrawal by Subject|1
6051596|NCT00570323|20913997|P1|Started Treatment After Randomization|Withdrawal by Subject|0
6051597|NCT00570310|20914009|P2|Overall Study|Lack of Efficacy|4
6051598|NCT00570310|20914010|P1|Overall Study|Lack of Efficacy|1
6051599|NCT00570310|20914009|P2|Overall Study|Adverse Event|2
6051600|NCT00570310|20914010|P1|Overall Study|Adverse Event|1
6051601|NCT00570232|20914029|P1|Overall Study|discontinued due to noncompliance|2
6051602|NCT00570232|20914029|P1|Overall Study|discontinued due to recurrence|8
6051603|NCT00570232|20914029|P1|Overall Study|discontinued due to medical condition|3
6051604|NCT00570232|20914029|P1|Overall Study|Adverse Event|10
6051605|NCT00570141|20914035|P1|Overall Study|Lost to Follow-up|1
6051606|NCT00570141|20914035|P1|Overall Study|Missed visits|1
6051607|NCT00570141|20914035|P1|Overall Study|Adverse Event|1
6051608|NCT00570063|20914051|P2|Overall Study|Sponsor's Decision|3
6051609|NCT00570063|20914052|P1|Overall Study|Sponsor's Decision|7
6051610|NCT00570063|20914051|P2|Overall Study|Withdrawal by Subject|3
6051611|NCT00570063|20914052|P1|Overall Study|Withdrawal by Subject|4
6051612|NCT00570063|20914051|P2|Overall Study|Lack of Efficacy|1
6051613|NCT00570063|20914052|P1|Overall Study|Lack of Efficacy|0
6051614|NCT00570063|20914051|P2|Overall Study|Adverse Event|1
6051615|NCT00570063|20914052|P1|Overall Study|Adverse Event|4
6051616|NCT00570037|20914118|P2|Overall Study|Could not reach for 6-8 week contact|69
6051617|NCT00570037|20914119|P1|Overall Study|Could not reach for 6-8 week contact|44
6051618|NCT00569946|20914129|P1|Overall Study|Global Deterioration of Health Status|1
6051619|NCT00569946|20914129|P1|Overall Study|Objective Progression or Relapse|42
6051620|NCT00569946|20914129|P1|Overall Study|Adverse Event|16
6051621|NCT00569803|20914161|P8|Overall Study|Withdrawal by Subject|1
6051622|NCT00569803|20914162|P7|Overall Study|Withdrawal by Subject|0
6051623|NCT00569803|20914163|P6|Overall Study|Withdrawal by Subject|0
6051624|NCT00569803|20914164|P5|Overall Study|Withdrawal by Subject|0
6051625|NCT00569803|20914165|P4|Overall Study|Withdrawal by Subject|0
6051626|NCT00569803|20914166|P3|Overall Study|Withdrawal by Subject|0
6051627|NCT00569803|20914167|P2|Overall Study|Withdrawal by Subject|0
6051628|NCT00569803|20914168|P1|Overall Study|Withdrawal by Subject|0
6051629|NCT00569803|20914161|P8|Overall Study|injection syringe leaked during dosing|0
6051630|NCT00569803|20914162|P7|Overall Study|injection syringe leaked during dosing|0
6051631|NCT00569803|20914163|P6|Overall Study|injection syringe leaked during dosing|0
6051632|NCT00569803|20914164|P5|Overall Study|injection syringe leaked during dosing|0
6051633|NCT00569803|20914165|P4|Overall Study|injection syringe leaked during dosing|1
6051634|NCT00569803|20914166|P3|Overall Study|injection syringe leaked during dosing|0
6051635|NCT00569803|20914167|P2|Overall Study|injection syringe leaked during dosing|0
6051636|NCT00569803|20914168|P1|Overall Study|injection syringe leaked during dosing|0
6051637|NCT00569803|20914161|P8|Overall Study|Lost to Follow-up|0
6051638|NCT00569803|20914162|P7|Overall Study|Lost to Follow-up|0
6051639|NCT00569803|20914163|P6|Overall Study|Lost to Follow-up|0
6051640|NCT00569803|20914164|P5|Overall Study|Lost to Follow-up|0
6051641|NCT00569803|20914165|P4|Overall Study|Lost to Follow-up|0
6051642|NCT00569803|20914166|P3|Overall Study|Lost to Follow-up|0
6051643|NCT00569803|20914167|P2|Overall Study|Lost to Follow-up|0
6051644|NCT00569803|20914168|P1|Overall Study|Lost to Follow-up|1
6051645|NCT00569777|20914295|P2|Overall Study|pregnant|0
6051646|NCT00569777|20914296|P1|Overall Study|pregnant|1
6051647|NCT00569777|20914295|P2|Overall Study|did not meet exclusion criteria|2
6051648|NCT00569777|20914296|P1|Overall Study|did not meet exclusion criteria|1
6051649|NCT00569777|20914295|P2|Overall Study|scheduled eye surgery|1
6051650|NCT00569777|20914296|P1|Overall Study|scheduled eye surgery|0
6051651|NCT00569777|20914295|P2|Overall Study|Lost to Follow-up|0
6051652|NCT00569777|20914296|P1|Overall Study|Lost to Follow-up|1
6051653|NCT00569777|20914295|P2|Overall Study|Adverse Event|0
6051654|NCT00569777|20914296|P1|Overall Study|Adverse Event|3
6051655|NCT00569777|20914295|P2|Overall Study|Withdrawal by Subject|0
6051656|NCT00569777|20914296|P1|Overall Study|Withdrawal by Subject|4
6051657|NCT00569582|20914347|P1|Overall Study|Subject was non-compliant.|1
6051658|NCT00569582|20914347|P1|Overall Study|Subject was too ill to travel.|1
6051659|NCT00569582|20914347|P1|Overall Study|Adverse Event|7
6051660|NCT00569582|20914347|P1|Overall Study|Death|2
6051661|NCT00569582|20914347|P1|Overall Study|Withdrawal by Subject|5
6051662|NCT00569374|20914363|P1|Overall Study|Withdrawal by Subject|4
6051663|NCT00569270|20914382|P2|Period: First Intervention|Protocol Violation|1
6051664|NCT00569270|20914383|P1|Period: First Intervention|Protocol Violation|0
6051665|NCT00569231|20914418|P1|Overall Study|Non-compliance|2
6051666|NCT00569231|20914418|P1|Overall Study|Car accident injury|1
6051667|NCT00569231|20914418|P1|Overall Study|Withdrawal by Subject|1
6051668|NCT00569231|20914418|P1|Overall Study|Airfare expense|2
6051669|NCT00569231|20914418|P1|Overall Study|Study unrelated surgery|1
6051670|NCT00569166|20914456|P3|Overall Study|Lost to Follow-up|1
6051671|NCT00569166|20914457|P2|Overall Study|Lost to Follow-up|1
6051672|NCT00569166|20914458|P1|Overall Study|Lost to Follow-up|2
6051673|NCT00569166|20914456|P3|Overall Study|Withdrawal by Subject|3
6051674|NCT00569166|20914457|P2|Overall Study|Withdrawal by Subject|5
6051675|NCT00569166|20914458|P1|Overall Study|Withdrawal by Subject|7
6051676|NCT00569127|20914492|P2|Overall Study|Still on Treatment|3
6051677|NCT00569127|20914493|P1|Overall Study|Still on Treatment|7
6051678|NCT00569127|20914492|P2|Overall Study|Not Eligible|11
6051679|NCT00569127|20914493|P1|Overall Study|Not Eligible|14
6051680|NCT00569127|20914492|P2|Overall Study|Lost to Follow-up|3
6051681|NCT00569127|20914493|P1|Overall Study|Lost to Follow-up|0
6051682|NCT00569127|20914492|P2|Overall Study|Other|19
6051683|NCT00569127|20914493|P1|Overall Study|Other|20
6051684|NCT00569127|20914492|P2|Overall Study|Death|3
6051685|NCT00569127|20914493|P1|Overall Study|Death|4
6051686|NCT00569127|20914492|P2|Overall Study|Progression|100
6051687|NCT00569127|20914493|P1|Overall Study|Progression|99
6051688|NCT00569127|20914492|P2|Overall Study|Withdrawal by Subject|27
6051689|NCT00569127|20914493|P1|Overall Study|Withdrawal by Subject|13
6051690|NCT00569127|20914492|P2|Overall Study|Adverse Event|47
6051691|NCT00569127|20914493|P1|Overall Study|Adverse Event|57
6051692|NCT00568958|20914528|P2|Follow-Up|Adverse Event|0
6051693|NCT00568958|20914529|P1|Follow-Up|Adverse Event|1
6051694|NCT00568958|20914528|P2|Follow-Up|Family Emergency|0
6051695|NCT00568958|20914529|P1|Follow-Up|Family Emergency|1
6051696|NCT00568958|20914528|P2|Follow-Up|Physician Decision|1
6051697|NCT00568958|20914529|P1|Follow-Up|Physician Decision|1
6051698|NCT00568958|20914528|P2|Follow-Up|Withdrawal by Subject|6
6051699|NCT00568958|20914529|P1|Follow-Up|Withdrawal by Subject|6
6051700|NCT00568958|20914528|P2|Allocation|Physician Decision|0
6051701|NCT00568958|20914529|P1|Allocation|Physician Decision|2
6051702|NCT00568958|20914528|P2|Allocation|Withdrawal by Subject|3
6051703|NCT00568958|20914529|P1|Allocation|Withdrawal by Subject|7
6051704|NCT00568776|20914576|P4|Overall Study|Miscellaeneous|4
6051705|NCT00568776|20914577|P3|Overall Study|Miscellaeneous|1
6051706|NCT00568776|20914578|P2|Overall Study|Miscellaeneous|3
6051707|NCT00568776|20914579|P1|Overall Study|Miscellaeneous|3
6051708|NCT00568776|20914576|P4|Overall Study|Sponsor Decision|42
6051709|NCT00568776|20914577|P3|Overall Study|Sponsor Decision|41
6051710|NCT00568776|20914578|P2|Overall Study|Sponsor Decision|2
6051711|NCT00568776|20914579|P1|Overall Study|Sponsor Decision|2
6051712|NCT00568776|20914576|P4|Overall Study|Loss of Caregiver|2
6051713|NCT00568776|20914577|P3|Overall Study|Loss of Caregiver|1
6051714|NCT00568776|20914578|P2|Overall Study|Loss of Caregiver|2
6051715|NCT00568776|20914579|P1|Overall Study|Loss of Caregiver|0
6051716|NCT00568776|20914576|P4|Overall Study|Withdrawal by Subject|7
6051717|NCT00568776|20914577|P3|Overall Study|Withdrawal by Subject|13
6051718|NCT00568776|20914578|P2|Overall Study|Withdrawal by Subject|15
6051719|NCT00568776|20914579|P1|Overall Study|Withdrawal by Subject|13
6051720|NCT00568776|20914576|P4|Overall Study|Protocol Violation|1
6051721|NCT00568776|20914577|P3|Overall Study|Protocol Violation|1
6051722|NCT00568776|20914578|P2|Overall Study|Protocol Violation|0
6051723|NCT00568776|20914579|P1|Overall Study|Protocol Violation|1
6051724|NCT00568776|20914576|P4|Overall Study|Lost to Follow-up|1
6051725|NCT00568776|20914577|P3|Overall Study|Lost to Follow-up|1
6051726|NCT00568776|20914578|P2|Overall Study|Lost to Follow-up|1
6051727|NCT00568776|20914579|P1|Overall Study|Lost to Follow-up|1
6051728|NCT00568776|20914576|P4|Overall Study|Lack of Efficacy|4
6051729|NCT00568776|20914577|P3|Overall Study|Lack of Efficacy|2
6051730|NCT00568776|20914578|P2|Overall Study|Lack of Efficacy|2
6051731|NCT00568776|20914579|P1|Overall Study|Lack of Efficacy|2
6051732|NCT00568776|20914576|P4|Overall Study|Physician Decision|0
6051733|NCT00568776|20914577|P3|Overall Study|Physician Decision|0
6051734|NCT00568776|20914578|P2|Overall Study|Physician Decision|2
6051735|NCT00568776|20914579|P1|Overall Study|Physician Decision|0
6051736|NCT00568776|20914576|P4|Overall Study|Death|3
6051737|NCT00568776|20914577|P3|Overall Study|Death|4
6051738|NCT00568776|20914578|P2|Overall Study|Death|1
6051739|NCT00568776|20914579|P1|Overall Study|Death|0
6051740|NCT00568776|20914576|P4|Overall Study|Adverse Event|8
6051741|NCT00568776|20914577|P3|Overall Study|Adverse Event|10
6051742|NCT00568776|20914578|P2|Overall Study|Adverse Event|8
6051743|NCT00568776|20914579|P1|Overall Study|Adverse Event|8
6051744|NCT00568685|20914628|P3|Overall Study|Protocol Violation|0
6051745|NCT00568685|20914629|P2|Overall Study|Protocol Violation|0
6051746|NCT00568685|20914630|P1|Overall Study|Protocol Violation|1
6051747|NCT00568685|20914628|P3|Overall Study|Withdrawal by Subject|2
6051748|NCT00568685|20914629|P2|Overall Study|Withdrawal by Subject|2
6051749|NCT00568685|20914630|P1|Overall Study|Withdrawal by Subject|7
6051750|NCT00568685|20914628|P3|Overall Study|Adverse Event|3
6051751|NCT00568685|20914629|P2|Overall Study|Adverse Event|3
6051752|NCT00568685|20914630|P1|Overall Study|Adverse Event|2
6051753|NCT00568555|20914687|P2|Overall Study|Withdrawal by Subject|1
6051754|NCT00568555|20914688|P1|Overall Study|Withdrawal by Subject|1
6051755|NCT00568451|20914706|P4|Overall Study|Disease Progression|7
6051756|NCT00568451|20914707|P3|Overall Study|Disease Progression|2
6051757|NCT00568451|20914708|P2|Overall Study|Disease Progression|0
6051758|NCT00568451|20914709|P1|Overall Study|Disease Progression|0
6051759|NCT00568399|20914725|P1|Overall Study|Withdrawal by Subject|8
6051760|NCT00568399|20914725|P1|Overall Study|Adverse Event|5
6051761|NCT00568399|20914725|P1|Overall Study|Death|2
6051762|NCT00568334|20914740|P2|Overall Study|Lost to Follow-up|0
6051763|NCT00568334|20914741|P1|Overall Study|Lost to Follow-up|1
6051764|NCT00568334|20914740|P2|Overall Study|Withdrawal by Subject|1
6051765|NCT00568334|20914741|P1|Overall Study|Withdrawal by Subject|0
6051766|NCT00568178|20914767|P6|Open Label Extension|Withdrawal by Subject|4
6051767|NCT00568178|20914768|P5|Open Label Extension|Withdrawal by Subject|4
6051768|NCT00568178|20914769|P4|Open Label Extension|Withdrawal by Subject|0
6051769|NCT00568178|20914770|P3|Open Label Extension|Withdrawal by Subject|0
6051770|NCT00568178|20914771|P2|Open Label Extension|Withdrawal by Subject|0
6051771|NCT00568178|20914772|P1|Open Label Extension|Withdrawal by Subject|0
6051772|NCT00568178|20914767|P6|Open Label Extension|Termination of Trial|47
6051773|NCT00568178|20914768|P5|Open Label Extension|Termination of Trial|45
6051774|NCT00568178|20914769|P4|Open Label Extension|Termination of Trial|0
6051775|NCT00568178|20914770|P3|Open Label Extension|Termination of Trial|0
6051776|NCT00568178|20914771|P2|Open Label Extension|Termination of Trial|0
6051777|NCT00568178|20914772|P1|Open Label Extension|Termination of Trial|0
6051778|NCT00568178|20914767|P6|Open Label Extension|Progressive Disease|1
6051779|NCT00568178|20914768|P5|Open Label Extension|Progressive Disease|3
6051780|NCT00568178|20914769|P4|Open Label Extension|Progressive Disease|0
6051781|NCT00568178|20914770|P3|Open Label Extension|Progressive Disease|0
6051782|NCT00568178|20914771|P2|Open Label Extension|Progressive Disease|0
6051783|NCT00568178|20914772|P1|Open Label Extension|Progressive Disease|0
6051784|NCT00568178|20914767|P6|Open Label Extension|Pregnancy|1
6051785|NCT00568178|20914768|P5|Open Label Extension|Pregnancy|0
6051786|NCT00568178|20914769|P4|Open Label Extension|Pregnancy|0
6051787|NCT00568178|20914770|P3|Open Label Extension|Pregnancy|0
6051788|NCT00568178|20914771|P2|Open Label Extension|Pregnancy|0
6051789|NCT00568178|20914772|P1|Open Label Extension|Pregnancy|0
6051790|NCT00568178|20914767|P6|Open Label Extension|Physician Decision|8
6051791|NCT00568178|20914768|P5|Open Label Extension|Physician Decision|9
6051792|NCT00568178|20914769|P4|Open Label Extension|Physician Decision|0
6051793|NCT00568178|20914770|P3|Open Label Extension|Physician Decision|0
6051794|NCT00568178|20914771|P2|Open Label Extension|Physician Decision|0
6051795|NCT00568178|20914772|P1|Open Label Extension|Physician Decision|0
6051796|NCT00568178|20914767|P6|Open Label Extension|Lost to Follow-up|11
6051797|NCT00568178|20914768|P5|Open Label Extension|Lost to Follow-up|6
6051798|NCT00568178|20914769|P4|Open Label Extension|Lost to Follow-up|0
6051799|NCT00568178|20914770|P3|Open Label Extension|Lost to Follow-up|0
6051800|NCT00568178|20914771|P2|Open Label Extension|Lost to Follow-up|0
6051801|NCT00568178|20914772|P1|Open Label Extension|Lost to Follow-up|0
6051802|NCT00568178|20914767|P6|Open Label Extension|Protocol Violation|0
6051803|NCT00568178|20914768|P5|Open Label Extension|Protocol Violation|1
6051804|NCT00568178|20914769|P4|Open Label Extension|Protocol Violation|0
6051805|NCT00568178|20914770|P3|Open Label Extension|Protocol Violation|0
6051806|NCT00568178|20914771|P2|Open Label Extension|Protocol Violation|0
6051807|NCT00568178|20914772|P1|Open Label Extension|Protocol Violation|0
6051808|NCT00568178|20914767|P6|Open Label Extension|Adverse Event|8
6051809|NCT00568178|20914768|P5|Open Label Extension|Adverse Event|11
6051810|NCT00568178|20914769|P4|Open Label Extension|Adverse Event|0
6051811|NCT00568178|20914770|P3|Open Label Extension|Adverse Event|0
6051812|NCT00568178|20914771|P2|Open Label Extension|Adverse Event|0
6051813|NCT00568178|20914772|P1|Open Label Extension|Adverse Event|0
6051814|NCT00568178|20914767|P6|Double Blind Base Study|Progressive Disease|0
6051815|NCT00568178|20914768|P5|Double Blind Base Study|Progressive Disease|0
6051816|NCT00568178|20914769|P4|Double Blind Base Study|Progressive Disease|1
6051817|NCT00568178|20914770|P3|Double Blind Base Study|Progressive Disease|0
6051818|NCT00568178|20914771|P2|Double Blind Base Study|Progressive Disease|0
6051819|NCT00568178|20914772|P1|Double Blind Base Study|Progressive Disease|0
6051820|NCT00568178|20914767|P6|Double Blind Base Study|Withdrawal by Subject|0
6051821|NCT00568178|20914768|P5|Double Blind Base Study|Withdrawal by Subject|0
6051822|NCT00568178|20914769|P4|Double Blind Base Study|Withdrawal by Subject|0
6051823|NCT00568178|20914770|P3|Double Blind Base Study|Withdrawal by Subject|0
6051824|NCT00568178|20914771|P2|Double Blind Base Study|Withdrawal by Subject|1
6051825|NCT00568178|20914772|P1|Double Blind Base Study|Withdrawal by Subject|1
6051826|NCT00568178|20914767|P6|Double Blind Base Study|Protocol Violation|0
6051827|NCT00568178|20914768|P5|Double Blind Base Study|Protocol Violation|0
6051828|NCT00568178|20914769|P4|Double Blind Base Study|Protocol Violation|0
6051829|NCT00568178|20914770|P3|Double Blind Base Study|Protocol Violation|0
6051830|NCT00568178|20914771|P2|Double Blind Base Study|Protocol Violation|2
6051831|NCT00568178|20914772|P1|Double Blind Base Study|Protocol Violation|3
6051832|NCT00568178|20914767|P6|Double Blind Base Study|Physician Decision|0
6051833|NCT00568178|20914768|P5|Double Blind Base Study|Physician Decision|0
6051834|NCT00568178|20914769|P4|Double Blind Base Study|Physician Decision|1
6051835|NCT00568178|20914770|P3|Double Blind Base Study|Physician Decision|0
6051836|NCT00568178|20914771|P2|Double Blind Base Study|Physician Decision|1
6051837|NCT00568178|20914772|P1|Double Blind Base Study|Physician Decision|1
6051838|NCT00568178|20914767|P6|Double Blind Base Study|Lost to Follow-up|0
6051839|NCT00568178|20914768|P5|Double Blind Base Study|Lost to Follow-up|0
6051840|NCT00568178|20914769|P4|Double Blind Base Study|Lost to Follow-up|1
6051841|NCT00568178|20914770|P3|Double Blind Base Study|Lost to Follow-up|0
6051842|NCT00568178|20914771|P2|Double Blind Base Study|Lost to Follow-up|0
6051843|NCT00568178|20914772|P1|Double Blind Base Study|Lost to Follow-up|1
6051844|NCT00568178|20914767|P6|Double Blind Base Study|Adverse Event|0
6051845|NCT00568178|20914768|P5|Double Blind Base Study|Adverse Event|0
6051846|NCT00568178|20914769|P4|Double Blind Base Study|Adverse Event|2
6051847|NCT00568178|20914770|P3|Double Blind Base Study|Adverse Event|1
6051848|NCT00568178|20914771|P2|Double Blind Base Study|Adverse Event|2
6051849|NCT00568178|20914772|P1|Double Blind Base Study|Adverse Event|0
6051850|NCT00568126|20914790|P2|Overall Study|Physician Decision|2
6051851|NCT00568126|20914791|P1|Overall Study|Physician Decision|2
6051852|NCT00568126|20914790|P2|Overall Study|Lack of Efficacy|1
6051853|NCT00568126|20914791|P1|Overall Study|Lack of Efficacy|0
6051854|NCT00568126|20914790|P2|Overall Study|Lost to Follow-up|3
6051855|NCT00568126|20914791|P1|Overall Study|Lost to Follow-up|4
6051856|NCT00568126|20914790|P2|Overall Study|Withdrawal by Subject|3
6051857|NCT00568126|20914791|P1|Overall Study|Withdrawal by Subject|2
6051858|NCT00568126|20914790|P2|Overall Study|Adverse Event|0
6051859|NCT00568126|20914791|P1|Overall Study|Adverse Event|3
6051860|NCT00568061|20914816|P2|Overall Study|Adverse Event|1
6051861|NCT00568061|20914817|P1|Overall Study|Adverse Event|0
6051862|NCT00568061|20914816|P2|Overall Study|Inclusion / exclusion criteria|1
6051863|NCT00568061|20914817|P1|Overall Study|Inclusion / exclusion criteria|5
6051864|NCT00567996|20914880|P3|Overall Study|Patient's inability to use the device|0
6051865|NCT00567996|20914881|P2|Overall Study|Patient's inability to use the device|1
6051866|NCT00567996|20914882|P1|Overall Study|Patient's inability to use the device|0
6051867|NCT00567996|20914880|P3|Overall Study|Death|2
6051868|NCT00567996|20914881|P2|Overall Study|Death|0
6051869|NCT00567996|20914882|P1|Overall Study|Death|1
6051870|NCT00567996|20914880|P3|Overall Study|Administrative problems|0
6051871|NCT00567996|20914881|P2|Overall Study|Administrative problems|1
6051872|NCT00567996|20914882|P1|Overall Study|Administrative problems|1
6051873|NCT00567996|20914880|P3|Overall Study|Unsatisfactory therapeutic effect|15
6051874|NCT00567996|20914881|P2|Overall Study|Unsatisfactory therapeutic effect|2
6051875|NCT00567996|20914882|P1|Overall Study|Unsatisfactory therapeutic effect|1
6051876|NCT00567996|20914880|P3|Overall Study|Lost to Follow-up|2
6051877|NCT00567996|20914881|P2|Overall Study|Lost to Follow-up|5
6051878|NCT00567996|20914882|P1|Overall Study|Lost to Follow-up|2
6051879|NCT00567996|20914880|P3|Overall Study|Abnormal test procedure result(s)|1
6051880|NCT00567996|20914881|P2|Overall Study|Abnormal test procedure result(s)|1
6051881|NCT00567996|20914882|P1|Overall Study|Abnormal test procedure result(s)|2
6051882|NCT00567996|20914880|P3|Overall Study|Abnormal Lab value(s)|2
6051883|NCT00567996|20914881|P2|Overall Study|Abnormal Lab value(s)|1
6051884|NCT00567996|20914882|P1|Overall Study|Abnormal Lab value(s)|2
6051885|NCT00567996|20914880|P3|Overall Study|Withdrawal by Subject|22
6051886|NCT00567996|20914881|P2|Overall Study|Withdrawal by Subject|12
6051887|NCT00567996|20914882|P1|Overall Study|Withdrawal by Subject|8
6051888|NCT00567996|20914880|P3|Overall Study|Protocol Deviation|13
6051889|NCT00567996|20914881|P2|Overall Study|Protocol Deviation|11
6051890|NCT00567996|20914882|P1|Overall Study|Protocol Deviation|9
6051891|NCT00567996|20914880|P3|Overall Study|Adverse Event|13
6051892|NCT00567996|20914881|P2|Overall Study|Adverse Event|16
6051893|NCT00567996|20914882|P1|Overall Study|Adverse Event|18
6051894|NCT00567892|20914898|P4|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|1
6051895|NCT00567892|20914899|P3|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0
6051896|NCT00567892|20914900|P2|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0
6051897|NCT00567892|20914901|P1|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0
6051898|NCT00567892|20914898|P4|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|4
6051899|NCT00567892|20914899|P3|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|1
6051900|NCT00567892|20914900|P2|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0
6051901|NCT00567892|20914901|P1|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0
6051902|NCT00567879|20914919|P6|Overall Study|Disease progression|3
6051903|NCT00567879|20914920|P5|Overall Study|Disease progression|11
6051904|NCT00567879|20914921|P4|Overall Study|Disease progression|5
6051905|NCT00567879|20914922|P3|Overall Study|Disease progression|15
6051906|NCT00567879|20914923|P2|Overall Study|Disease progression|7
6051907|NCT00567879|20914924|P1|Overall Study|Disease progression|5
6051908|NCT00567879|20914919|P6|Overall Study|New cancer therapy|0
6051909|NCT00567879|20914920|P5|Overall Study|New cancer therapy|0
6051910|NCT00567879|20914921|P4|Overall Study|New cancer therapy|0
6051911|NCT00567879|20914922|P3|Overall Study|New cancer therapy|1
6051912|NCT00567879|20914923|P2|Overall Study|New cancer therapy|0
6051913|NCT00567879|20914924|P1|Overall Study|New cancer therapy|0
6051914|NCT00567879|20914919|P6|Overall Study|Withdrawal by Subject|0
6051915|NCT00567879|20914920|P5|Overall Study|Withdrawal by Subject|0
6051916|NCT00567879|20914921|P4|Overall Study|Withdrawal by Subject|1
6051917|NCT00567879|20914922|P3|Overall Study|Withdrawal by Subject|3
6051918|NCT00567879|20914923|P2|Overall Study|Withdrawal by Subject|0
6051919|NCT00567879|20914924|P1|Overall Study|Withdrawal by Subject|0
6051920|NCT00567879|20914919|P6|Overall Study|Abnormal test procedure(s)|0
6051921|NCT00567879|20914920|P5|Overall Study|Abnormal test procedure(s)|0
6051922|NCT00567879|20914921|P4|Overall Study|Abnormal test procedure(s)|0
6051923|NCT00567879|20914922|P3|Overall Study|Abnormal test procedure(s)|1
6051924|NCT00567879|20914923|P2|Overall Study|Abnormal test procedure(s)|0
6051925|NCT00567879|20914924|P1|Overall Study|Abnormal test procedure(s)|0
6051926|NCT00567879|20914919|P6|Overall Study|Adverse Event|0
6051927|NCT00567879|20914920|P5|Overall Study|Adverse Event|1
6051928|NCT00567879|20914921|P4|Overall Study|Adverse Event|0
6051929|NCT00567879|20914922|P3|Overall Study|Adverse Event|1
6051930|NCT00567879|20914923|P2|Overall Study|Adverse Event|0
6051931|NCT00567879|20914924|P1|Overall Study|Adverse Event|2
6051932|NCT00567593|20914991|P1|Overall Study|Physician Decision|1
6051933|NCT00567593|20914991|P1|Overall Study|Adverse Event|1
6051934|NCT00567567|20914998|P3|Overall Study|Unable adequate stem cell for transplant|2
6051935|NCT00567567|20914999|P2|Overall Study|Unable adequate stem cell for transplant|0
6051936|NCT00567567|20915000|P1|Overall Study|Unable adequate stem cell for transplant|0
6051937|NCT00567567|20914998|P3|Overall Study|Enrolled another COG therapeutic study|0
6051938|NCT00567567|20914999|P2|Overall Study|Enrolled another COG therapeutic study|80
6051939|NCT00567567|20915000|P1|Overall Study|Enrolled another COG therapeutic study|99
6051940|NCT00567567|20914998|P3|Overall Study|Refusal by patient/parent/guardian|122
6051941|NCT00567567|20914999|P2|Overall Study|Refusal by patient/parent/guardian|16
6051942|NCT00567567|20915000|P1|Overall Study|Refusal by patient/parent/guardian|9
6051943|NCT00567567|20914998|P3|Overall Study|Ineligible|9
6051944|NCT00567567|20914999|P2|Overall Study|Ineligible|0
6051945|NCT00567567|20915000|P1|Overall Study|Ineligible|4
6051946|NCT00567567|20914998|P3|Overall Study|Withdrawal by Subject|2
6051947|NCT00567567|20914999|P2|Overall Study|Withdrawal by Subject|0
6051948|NCT00567567|20915000|P1|Overall Study|Withdrawal by Subject|0
6051949|NCT00567567|20914998|P3|Overall Study|Physician Decision|84
6051950|NCT00567567|20914999|P2|Overall Study|Physician Decision|18
6051951|NCT00567567|20915000|P1|Overall Study|Physician Decision|16
6051952|NCT00567567|20914998|P3|Overall Study|Lost to Follow-up|1
6051953|NCT00567567|20914999|P2|Overall Study|Lost to Follow-up|0
6051954|NCT00567567|20915000|P1|Overall Study|Lost to Follow-up|0
6051955|NCT00567567|20914998|P3|Overall Study|Lack of Efficacy|48
6051956|NCT00567567|20914999|P2|Overall Study|Lack of Efficacy|17
6051957|NCT00567567|20915000|P1|Overall Study|Lack of Efficacy|16
6051958|NCT00567567|20914998|P3|Overall Study|Death|5
6051959|NCT00567567|20914999|P2|Overall Study|Death|1
6051960|NCT00567567|20915000|P1|Overall Study|Death|8
6051961|NCT00567567|20914998|P3|Overall Study|Adverse Event|5
6051962|NCT00567567|20914999|P2|Overall Study|Adverse Event|2
6051963|NCT00567567|20915000|P1|Overall Study|Adverse Event|0
6051964|NCT00567541|20915048|P2|Overall Study|Adverse Event|1
6051965|NCT00567541|20915049|P1|Overall Study|Adverse Event|0
6051966|NCT00567502|20915059|P4|Overall Study|Never Initiated Treatment|72
6051967|NCT00567502|20915060|P3|Overall Study|Never Initiated Treatment|0
6051968|NCT00567502|20915061|P2|Overall Study|Never Initiated Treatment|0
6051969|NCT00567502|20915062|P1|Overall Study|Never Initiated Treatment|0
6051970|NCT00567502|20915059|P4|Overall Study|Sponsor request|1
6051971|NCT00567502|20915060|P3|Overall Study|Sponsor request|30
6051972|NCT00567502|20915061|P2|Overall Study|Sponsor request|0
6051973|NCT00567502|20915062|P1|Overall Study|Sponsor request|9
6051974|NCT00567502|20915059|P4|Overall Study|Participant request|1
6051975|NCT00567502|20915060|P3|Overall Study|Participant request|33
6051976|NCT00567502|20915061|P2|Overall Study|Participant request|1
6051977|NCT00567502|20915062|P1|Overall Study|Participant request|12
6051978|NCT00567502|20915059|P4|Overall Study|Other|6
6051979|NCT00567502|20915060|P3|Overall Study|Other|134
6051980|NCT00567502|20915061|P2|Overall Study|Other|2
6051981|NCT00567502|20915062|P1|Overall Study|Other|64
6051982|NCT00567502|20915059|P4|Overall Study|Death|5
6051983|NCT00567502|20915060|P3|Overall Study|Death|360
6051984|NCT00567502|20915061|P2|Overall Study|Death|16
6051985|NCT00567502|20915062|P1|Overall Study|Death|65
6051986|NCT00567502|20915059|P4|Overall Study|Lost to Follow-up|2
6051987|NCT00567502|20915060|P3|Overall Study|Lost to Follow-up|351
6051988|NCT00567502|20915061|P2|Overall Study|Lost to Follow-up|14
6051989|NCT00567502|20915062|P1|Overall Study|Lost to Follow-up|91
6051990|NCT00567489|20915099|P2|Overall Study|Other|0
6051991|NCT00567489|20915100|P1|Overall Study|Other|1
6051992|NCT00567489|20915099|P2|Overall Study|Renal Transplantation|3
6051993|NCT00567489|20915100|P1|Overall Study|Renal Transplantation|0
6051994|NCT00567489|20915099|P2|Overall Study|Withdrawal by Subject|2
6051995|NCT00567489|20915100|P1|Overall Study|Withdrawal by Subject|0
6051996|NCT00567489|20915099|P2|Overall Study|Physician Decision|4
6051997|NCT00567489|20915100|P1|Overall Study|Physician Decision|0
6051998|NCT00567489|20915099|P2|Overall Study|Adverse Event|14
6051999|NCT00567489|20915100|P1|Overall Study|Adverse Event|6
6052000|NCT00567476|20915150|P2|Overall Study|Non-adherence to protocol|1
6052001|NCT00567476|20915151|P1|Overall Study|Non-adherence to protocol|0
6052002|NCT00567476|20915150|P2|Overall Study|Medical Decision|1
6052003|NCT00567476|20915151|P1|Overall Study|Medical Decision|0
6052004|NCT00567476|20915150|P2|Overall Study|Administrative issues|0
6052005|NCT00567476|20915151|P1|Overall Study|Administrative issues|1
6052006|NCT00567476|20915150|P2|Overall Study|Lost to Follow-up|1
6052007|NCT00567476|20915151|P1|Overall Study|Lost to Follow-up|0
6052008|NCT00567476|20915150|P2|Overall Study|Protocol Violation|1
6052009|NCT00567476|20915151|P1|Overall Study|Protocol Violation|4
6052010|NCT00567476|20915150|P2|Overall Study|Pregnancy|0
6052011|NCT00567476|20915151|P1|Overall Study|Pregnancy|1
6052012|NCT00567476|20915150|P2|Overall Study|Adverse Event|0
6052013|NCT00567476|20915151|P1|Overall Study|Adverse Event|2
6052014|NCT00567398|20915177|P2|Overall Study|Other|0
6052015|NCT00567398|20915178|P1|Overall Study|Other|1
6052016|NCT00567398|20915177|P2|Overall Study|Renal Transplantation|3
6052017|NCT00567398|20915178|P1|Overall Study|Renal Transplantation|0
6052018|NCT00567398|20915177|P2|Overall Study|Withdrawal by Subject|2
6052019|NCT00567398|20915178|P1|Overall Study|Withdrawal by Subject|0
6052020|NCT00567398|20915177|P2|Overall Study|Physician Decision|4
6052021|NCT00567398|20915178|P1|Overall Study|Physician Decision|0
6052022|NCT00567398|20915177|P2|Overall Study|Adverse Event|14
6052023|NCT00567398|20915178|P1|Overall Study|Adverse Event|6
6052024|NCT00567359|20915226|P1|Overall Study|Withdrawal by Subject|1
6052030|NCT00567255|20915302|P2|Overall Study|Drug noncompliance,moved,other|15
6052031|NCT00567255|20915303|P1|Overall Study|Drug noncompliance,moved,other|25
6052032|NCT00567255|20915302|P2|Overall Study|Pregnancy|0
6052033|NCT00567255|20915303|P1|Overall Study|Pregnancy|6
6052034|NCT00567255|20915302|P2|Overall Study|Protocol Violation|8
6052035|NCT00567255|20915303|P1|Overall Study|Protocol Violation|20
6052036|NCT00567255|20915302|P2|Overall Study|Lack of Efficacy|33
6052037|NCT00567255|20915303|P1|Overall Study|Lack of Efficacy|19
6052038|NCT00567255|20915302|P2|Overall Study|Withdrawal by Subject|56
6052039|NCT00567255|20915303|P1|Overall Study|Withdrawal by Subject|75
6052040|NCT00567255|20915302|P2|Overall Study|Lost to Follow-up|48
6052041|NCT00567255|20915303|P1|Overall Study|Lost to Follow-up|77
6052042|NCT00567255|20915302|P2|Overall Study|Adverse Event|68
6052043|NCT00567255|20915303|P1|Overall Study|Adverse Event|241
6052044|NCT00567190|20915366|P2|Overall Study|Withdrew Consent or Lost to Follow-up|53
6052045|NCT00567190|20915367|P1|Overall Study|Withdrew Consent or Lost to Follow-up|48
6052046|NCT00567190|20915366|P2|Overall Study|Death|280
6052047|NCT00567190|20915367|P1|Overall Study|Death|235
6052048|NCT00567164|20915418|P3|Overall Study|Missing|0
6052049|NCT00567164|20915419|P2|Overall Study|Missing|0
6052050|NCT00567164|20915420|P1|Overall Study|Missing|1
6052051|NCT00567164|20915418|P3|Overall Study|Primary Reason coded as 'Other'|16
6052052|NCT00567164|20915419|P2|Overall Study|Primary Reason coded as 'Other'|8
6052053|NCT00567164|20915420|P1|Overall Study|Primary Reason coded as 'Other'|37
6052054|NCT00567164|20915418|P3|Overall Study|Pregnancy|6
6052055|NCT00567164|20915419|P2|Overall Study|Pregnancy|4
6052056|NCT00567164|20915420|P1|Overall Study|Pregnancy|20
6052057|NCT00567164|20915418|P3|Overall Study|Lost to Follow-up|21
6052058|NCT00567164|20915419|P2|Overall Study|Lost to Follow-up|23
6052059|NCT00567164|20915420|P1|Overall Study|Lost to Follow-up|202
6052060|NCT00567164|20915418|P3|Overall Study|Death|1
6052061|NCT00567164|20915419|P2|Overall Study|Death|0
6052062|NCT00567164|20915420|P1|Overall Study|Death|0
6052063|NCT00567164|20915418|P3|Overall Study|Adverse Event|9
6052064|NCT00567164|20915419|P2|Overall Study|Adverse Event|13
6052065|NCT00567164|20915420|P1|Overall Study|Adverse Event|92
6052066|NCT00567164|20915418|P3|Overall Study|Protocol Violation|2
6052067|NCT00567164|20915419|P2|Overall Study|Protocol Violation|4
6052068|NCT00567164|20915420|P1|Overall Study|Protocol Violation|23
6052069|NCT00567164|20915418|P3|Overall Study|Withdrawal by Subject|17
6052070|NCT00567164|20915419|P2|Overall Study|Withdrawal by Subject|21
6052071|NCT00567164|20915420|P1|Overall Study|Withdrawal by Subject|171
6052072|NCT00567112|20915492|P3|Washout Period 3 (3 Days)|Protocol Violation|0
6052073|NCT00567112|20915493|P2|Washout Period 3 (3 Days)|Protocol Violation|0
6052074|NCT00567112|20915494|P1|Washout Period 3 (3 Days)|Protocol Violation|1
6052075|NCT00567112|20915492|P3|Washout Period 3 (3 Days)|Lost to Follow-up|0
6052076|NCT00567112|20915493|P2|Washout Period 3 (3 Days)|Lost to Follow-up|0
6052077|NCT00567112|20915494|P1|Washout Period 3 (3 Days)|Lost to Follow-up|2
6052078|NCT00567112|20915492|P3|Treatment Period 2 (3 Days)|Protocol Violation|0
6052079|NCT00567112|20915493|P2|Treatment Period 2 (3 Days)|Protocol Violation|1
6052080|NCT00567112|20915494|P1|Treatment Period 2 (3 Days)|Protocol Violation|0
6052081|NCT00566995|20915525|P1|Overall Study|Withdrew consent|3
6052082|NCT00566995|20915525|P1|Overall Study|Toxicity|4
6052083|NCT00566982|20915540|P2|Overall Study|Other-family problems & doctor's request|2
6052084|NCT00566982|20915541|P1|Overall Study|Other-family problems & doctor's request|0
6052085|NCT00566982|20915540|P2|Overall Study|Lost to Follow-up|1
6052086|NCT00566982|20915541|P1|Overall Study|Lost to Follow-up|0
6052087|NCT00566982|20915540|P2|Overall Study|Protocol Violation|4
6052088|NCT00566982|20915541|P1|Overall Study|Protocol Violation|1
6052089|NCT00566982|20915540|P2|Overall Study|Withdrawal by Subject|14
6052090|NCT00566982|20915541|P1|Overall Study|Withdrawal by Subject|1
6052091|NCT00566982|20915540|P2|Overall Study|Adverse Event|48
6052092|NCT00566982|20915541|P1|Overall Study|Adverse Event|6
6052093|NCT00566852|20915606|P2|Overall Study|Missing reason not reported|20
6052094|NCT00566852|20915607|P1|Overall Study|Missing reason not reported|16
6052095|NCT00566852|20915606|P2|Overall Study|Missing reason not specified|2
6052096|NCT00566852|20915607|P1|Overall Study|Missing reason not specified|1
6052097|NCT00566852|20915606|P2|Overall Study|Not tested due to disability|12
6052098|NCT00566852|20915607|P1|Overall Study|Not tested due to disability|6
6052099|NCT00566852|20915606|P2|Overall Study|Patient refusal|37
6052100|NCT00566852|20915607|P1|Overall Study|Patient refusal|37
6052101|NCT00566852|20915606|P2|Overall Study|Withdrawal by Subject|25
6052102|NCT00566852|20915607|P1|Overall Study|Withdrawal by Subject|30
6052103|NCT00566852|20915606|P2|Overall Study|Death|78
6052104|NCT00566852|20915607|P1|Overall Study|Death|95
6052105|NCT00566852|20915606|P2|Overall Study|Protocol Violation|24
6052106|NCT00566852|20915607|P1|Overall Study|Protocol Violation|22
6052107|NCT00566735|20915638|P2|Overall Study|Switched into a manic episode|1
6052108|NCT00566735|20915639|P1|Overall Study|Switched into a manic episode|0
6052109|NCT00566735|20915638|P2|Overall Study|Refused neuropsychological testing|5
6052110|NCT00566735|20915639|P1|Overall Study|Refused neuropsychological testing|2
6052111|NCT00566735|20915638|P2|Overall Study|Withdrawal by Subject|1
6052112|NCT00566735|20915639|P1|Overall Study|Withdrawal by Subject|0
6052113|NCT00566722|20915652|P3|Overall Study|Noncompliant with drug administration|1
6052114|NCT00566722|20915653|P2|Overall Study|Noncompliant with drug administration|0
6052115|NCT00566722|20915654|P1|Overall Study|Noncompliant with drug administration|0
6052116|NCT00566722|20915652|P3|Overall Study|Serious adverse event|0
6052117|NCT00566722|20915653|P2|Overall Study|Serious adverse event|1
6052118|NCT00566722|20915654|P1|Overall Study|Serious adverse event|0
6052119|NCT00566722|20915652|P3|Overall Study|Did not meet exclusion criteria|2
6052120|NCT00566722|20915653|P2|Overall Study|Did not meet exclusion criteria|0
6052121|NCT00566722|20915654|P1|Overall Study|Did not meet exclusion criteria|0
6052122|NCT00566722|20915652|P3|Overall Study|Lack of Efficacy|4
6052123|NCT00566722|20915653|P2|Overall Study|Lack of Efficacy|2
6052124|NCT00566722|20915654|P1|Overall Study|Lack of Efficacy|1
6052125|NCT00566722|20915652|P3|Overall Study|Lost to Follow-up|1
6052126|NCT00566722|20915653|P2|Overall Study|Lost to Follow-up|1
6052127|NCT00566722|20915654|P1|Overall Study|Lost to Follow-up|1
6052128|NCT00566722|20915652|P3|Overall Study|Withdrawal by Subject|1
6052129|NCT00566722|20915653|P2|Overall Study|Withdrawal by Subject|0
6052130|NCT00566722|20915654|P1|Overall Study|Withdrawal by Subject|0
6052131|NCT00566722|20915652|P3|Overall Study|Adverse Event|0
6052132|NCT00566722|20915653|P2|Overall Study|Adverse Event|1
6052133|NCT00566722|20915654|P1|Overall Study|Adverse Event|0
6052134|NCT00566709|20915700|P2|Overall Study|Protocol Violation|0
6052135|NCT00566709|20915701|P1|Overall Study|Protocol Violation|5
6052136|NCT00566696|20915717|P1|Overall Study|Non-Patient Donors|37
6052137|NCT00566696|20915717|P1|Overall Study|Physician Decision|1
6052138|NCT00566696|20915717|P1|Overall Study|Health Status Change|1
6052139|NCT00566696|20915717|P1|Overall Study|Muromonab not available|1
6052140|NCT00566696|20915717|P1|Overall Study|Met Exclusion Criteria|2
6052141|NCT00566631|20915727|P1|Part 2: Extension Phase|Other|5
6052142|NCT00566631|20915727|P1|Part 2: Extension Phase|Death|1
6052143|NCT00566631|20915727|P1|Part 2: Extension Phase|Lost to Follow-up|6
6052144|NCT00566631|20915727|P1|Part 2: Extension Phase|Adverse Event|11
6052145|NCT00566631|20915727|P1|Part 2: Extension Phase|Withdrawal by Subject|34
6052146|NCT00566631|20915727|P1|Part 2: Extension Phase|Lack of Efficacy|25
6052147|NCT00566631|20915727|P1|Between Treatment and Extension Phase|Participants not willing to participate|95
6052148|NCT00566631|20915727|P1|Part 1: Core Treatment Phase|Met exclusion criteria|1
6052149|NCT00566631|20915727|P1|Part 1: Core Treatment Phase|Moved to a penitentiary hospital|1
6052150|NCT00566631|20915727|P1|Part 1: Core Treatment Phase|Withdrawal by Subject|26
6052151|NCT00566631|20915727|P1|Part 1: Core Treatment Phase|Lost to Follow-up|4
6052152|NCT00566631|20915727|P1|Part 1: Core Treatment Phase|Adverse Event|9
6052153|NCT00566631|20915727|P1|Part 1: Core Treatment Phase|Physician Decision|1
6052154|NCT00566631|20915727|P1|Part 1: Core Treatment Phase|Lack of Efficacy|18
6052155|NCT00566527|20915754|P3|Overall Study|Withdrawal by Subject|43
6052156|NCT00566527|20915755|P2|Overall Study|Withdrawal by Subject|43
6052157|NCT00566527|20915756|P1|Overall Study|Withdrawal by Subject|6
6052158|NCT00566527|20915754|P3|Overall Study|Lost to Follow-up|4
6052159|NCT00566527|20915755|P2|Overall Study|Lost to Follow-up|4
6052160|NCT00566527|20915756|P1|Overall Study|Lost to Follow-up|3
6052161|NCT00566527|20915754|P3|Overall Study|Physician Decision|20
6052162|NCT00566527|20915755|P2|Overall Study|Physician Decision|8
6052163|NCT00566527|20915756|P1|Overall Study|Physician Decision|3
6052164|NCT00566527|20915754|P3|Overall Study|Adverse Event|1
6052165|NCT00566527|20915755|P2|Overall Study|Adverse Event|0
6052166|NCT00566527|20915756|P1|Overall Study|Adverse Event|2
6052167|NCT00566527|20915754|P3|Overall Study|Reason not provided|10
6052168|NCT00566527|20915755|P2|Overall Study|Reason not provided|11
6052169|NCT00566527|20915756|P1|Overall Study|Reason not provided|3
6052170|NCT00566254|20915817|P2|Overall Study|Other|2
6052171|NCT00566254|20915818|P1|Overall Study|Other|0
6052172|NCT00566254|20915817|P2|Overall Study|Lack of Efficacy|6
6052173|NCT00566254|20915818|P1|Overall Study|Lack of Efficacy|5
6052174|NCT00566254|20915817|P2|Overall Study|Withdrawal by Subject|2
6052175|NCT00566254|20915818|P1|Overall Study|Withdrawal by Subject|1
6052176|NCT00566254|20915817|P2|Overall Study|Protocol Violation|3
6052177|NCT00566254|20915818|P1|Overall Study|Protocol Violation|1
6052178|NCT00566254|20915817|P2|Overall Study|Adverse Event|1
6052179|NCT00566254|20915818|P1|Overall Study|Adverse Event|3
6052180|NCT00566228|20915832|P2|Overall Study|progressed before infusion could occur|1
6052181|NCT00566228|20915833|P1|Overall Study|progressed before infusion could occur|0
6052182|NCT00566228|20915832|P2|Overall Study|Unable to collect sufficient CD34 cells|2
6052183|NCT00566228|20915833|P1|Overall Study|Unable to collect sufficient CD34 cells|3
6052184|NCT00566228|20915832|P2|Overall Study|Attempt to mobilize stem cells failed|2
6052185|NCT00566228|20915833|P1|Overall Study|Attempt to mobilize stem cells failed|2
6052186|NCT00566228|20915832|P2|Overall Study|Withdrawal by Subject|0
6052187|NCT00566228|20915833|P1|Overall Study|Withdrawal by Subject|1
6052188|NCT00566111|20915866|P2|Overall Study|Adverse Event|2
6052189|NCT00566111|20915867|P1|Overall Study|Adverse Event|0
6052190|NCT00566098|20915881|P1|Administration of ASCT+MILs|Lack of Efficacy|8
6052191|NCT00566098|20915881|P1|Administration of ASCT+MILs|Death|10
6052192|NCT00566098|20915881|P1|Generation of MILs Product|Relapsed|1
6052193|NCT00566098|20915881|P1|Collection of MILs|Relapsed|1
6052194|NCT00566098|20915881|P1|Collection of MILs|Withdrawal by Subject|1
6052195|NCT00566020|20915891|P2|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|1
6052196|NCT00566020|20915892|P1|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|0
6052197|NCT00566020|20915891|P2|46-week Long-term Administration Phase|Lost to Follow-up|2
6052198|NCT00566020|20915892|P1|46-week Long-term Administration Phase|Lost to Follow-up|0
6052199|NCT00566020|20915891|P2|46-week Long-term Administration Phase|Physician Decision|7
6052200|NCT00566020|20915892|P1|46-week Long-term Administration Phase|Physician Decision|0
6052201|NCT00566020|20915891|P2|46-week Long-term Administration Phase|Adverse Event|7
6052202|NCT00566020|20915892|P1|46-week Long-term Administration Phase|Adverse Event|0
6052203|NCT00566020|20915891|P2|6-week Dosage Adjustment Phase|Lack of Efficacy|0
6052204|NCT00566020|20915892|P1|6-week Dosage Adjustment Phase|Lack of Efficacy|2
6052205|NCT00566020|20915891|P2|6-week Dosage Adjustment Phase|Adverse Event|0
6052206|NCT00566020|20915892|P1|6-week Dosage Adjustment Phase|Adverse Event|5
6052207|NCT00565812|20915981|P3|Overall Study|Physician Decision|0
6052208|NCT00565812|20915982|P2|Overall Study|Physician Decision|0
6052209|NCT00565812|20915983|P1|Overall Study|Physician Decision|2
6052210|NCT00565812|20915981|P3|Overall Study|Follow-up Visit Not Completed|1
6052211|NCT00565812|20915982|P2|Overall Study|Follow-up Visit Not Completed|0
6052212|NCT00565812|20915983|P1|Overall Study|Follow-up Visit Not Completed|2
6052213|NCT00565812|20915981|P3|Overall Study|Low Compliance|1
6052214|NCT00565812|20915982|P2|Overall Study|Low Compliance|0
6052215|NCT00565812|20915983|P1|Overall Study|Low Compliance|1
6052216|NCT00565812|20915981|P3|Overall Study|Surgical Intervention|2
6052217|NCT00565812|20915982|P2|Overall Study|Surgical Intervention|1
6052218|NCT00565812|20915983|P1|Overall Study|Surgical Intervention|0
6052219|NCT00565812|20915981|P3|Overall Study|Research Site Closure|8
6052220|NCT00565812|20915982|P2|Overall Study|Research Site Closure|1
6052221|NCT00565812|20915983|P1|Overall Study|Research Site Closure|6
6052222|NCT00565812|20915981|P3|Overall Study|Domestic Reasons|3
6052223|NCT00565812|20915982|P2|Overall Study|Domestic Reasons|1
6052224|NCT00565812|20915983|P1|Overall Study|Domestic Reasons|7
6052225|NCT00565812|20915981|P3|Overall Study|Sponsor Decision|1
6052226|NCT00565812|20915982|P2|Overall Study|Sponsor Decision|5
6052227|NCT00565812|20915983|P1|Overall Study|Sponsor Decision|1
6052228|NCT00565812|20915981|P3|Overall Study|Relocated Out of Area|9
6052229|NCT00565812|20915982|P2|Overall Study|Relocated Out of Area|8
6052230|NCT00565812|20915983|P1|Overall Study|Relocated Out of Area|5
6052231|NCT00565812|20915981|P3|Overall Study|Jury Duty|0
6052232|NCT00565812|20915982|P2|Overall Study|Jury Duty|0
6052233|NCT00565812|20915983|P1|Overall Study|Jury Duty|1
6052234|NCT00565812|20915981|P3|Overall Study|Adverse Event|40
6052235|NCT00565812|20915982|P2|Overall Study|Adverse Event|54
6052236|NCT00565812|20915983|P1|Overall Study|Adverse Event|41
6052237|NCT00565812|20915981|P3|Overall Study|Protocol Violation|4
6052238|NCT00565812|20915982|P2|Overall Study|Protocol Violation|6
6052239|NCT00565812|20915983|P1|Overall Study|Protocol Violation|2
6052240|NCT00565812|20915981|P3|Overall Study|Work Schedule|1
6052241|NCT00565812|20915982|P2|Overall Study|Work Schedule|3
6052242|NCT00565812|20915983|P1|Overall Study|Work Schedule|5
6052243|NCT00565812|20915981|P3|Overall Study|Withdrawal by Subject|48
6052244|NCT00565812|20915982|P2|Overall Study|Withdrawal by Subject|47
6052245|NCT00565812|20915983|P1|Overall Study|Withdrawal by Subject|58
6052246|NCT00565812|20915981|P3|Overall Study|Lost to Follow-up|8
6052247|NCT00565812|20915982|P2|Overall Study|Lost to Follow-up|8
6052248|NCT00565812|20915983|P1|Overall Study|Lost to Follow-up|10
6052249|NCT00565812|20915981|P3|Overall Study|Did not Meet Entrance Criteria|1
6052250|NCT00565812|20915982|P2|Overall Study|Did not Meet Entrance Criteria|0
6052251|NCT00565812|20915983|P1|Overall Study|Did not Meet Entrance Criteria|1
6052252|NCT00565812|20915981|P3|Overall Study|Death|3
6052253|NCT00565812|20915982|P2|Overall Study|Death|1
6052254|NCT00565812|20915983|P1|Overall Study|Death|2
6052255|NCT00565773|20916120|P1|Overall Study|Physician Decision|1
6052256|NCT00565773|20916120|P1|Overall Study|Withdrawal by Subject|1
6052257|NCT00565747|20916132|P2|Overall Study|No embryo transfer|73
6052258|NCT00565747|20916133|P1|Overall Study|No embryo transfer|67
6052259|NCT00565721|20916143|P1|Overall Study|Other reasons|6
6052260|NCT00565721|20916143|P1|Overall Study|Physician Decision|2
6052261|NCT00565721|20916143|P1|Overall Study|Technical Problems|1
6052262|NCT00565721|20916143|P1|Overall Study|Lost to Follow-up|6
6052263|NCT00565721|20916143|P1|Overall Study|Screen Failure|2
6052264|NCT00565617|20916192|P1|Overall Study|Withdrawal by Subject|1
6052265|NCT00565604|20916196|P1|Overall Study|Lost to Follow-up|2
6052266|NCT00565604|20916196|P1|Overall Study|Failure to treat|2
6052267|NCT00565448|20916242|P2|Overall Study|Withdrawal by Subject|0
6052268|NCT00565448|20916243|P1|Overall Study|Withdrawal by Subject|1
6052269|NCT00565448|20916242|P2|Overall Study|Disease progression|0
6052270|NCT00565448|20916243|P1|Overall Study|Disease progression|1
6052271|NCT00565448|20916242|P2|Overall Study|Adverse Event|2
6052272|NCT00565448|20916243|P1|Overall Study|Adverse Event|1
6052273|NCT00565409|20916254|P4|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|43
6052274|NCT00565409|20916255|P3|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|11
6052275|NCT00565409|20916256|P2|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|4
6052276|NCT00565409|20916257|P1|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|0
6052277|NCT00565409|20916254|P4|Period 2 Double-Blind|Other|9
6052278|NCT00565409|20916255|P3|Period 2 Double-Blind|Other|5
6052279|NCT00565409|20916256|P2|Period 2 Double-Blind|Other|4
6052280|NCT00565409|20916257|P1|Period 2 Double-Blind|Other|0
6052281|NCT00565409|20916254|P4|Period 2 Double-Blind|Lost to Follow-up|0
6052282|NCT00565409|20916255|P3|Period 2 Double-Blind|Lost to Follow-up|1
6052283|NCT00565409|20916256|P2|Period 2 Double-Blind|Lost to Follow-up|0
6052284|NCT00565409|20916257|P1|Period 2 Double-Blind|Lost to Follow-up|0
6052285|NCT00565409|20916254|P4|Period 2 Double-Blind|Protocol Violation|2
6052286|NCT00565409|20916255|P3|Period 2 Double-Blind|Protocol Violation|6
6052287|NCT00565409|20916256|P2|Period 2 Double-Blind|Protocol Violation|4
6052288|NCT00565409|20916257|P1|Period 2 Double-Blind|Protocol Violation|0
6052289|NCT00565409|20916254|P4|Period 2 Double-Blind|Death|0
6052290|NCT00565409|20916255|P3|Period 2 Double-Blind|Death|0
6052291|NCT00565409|20916256|P2|Period 2 Double-Blind|Death|2
6052292|NCT00565409|20916257|P1|Period 2 Double-Blind|Death|0
6052293|NCT00565409|20916254|P4|Period 2 Double-Blind|Adverse Event|5
6052294|NCT00565409|20916255|P3|Period 2 Double-Blind|Adverse Event|4
6052295|NCT00565409|20916256|P2|Period 2 Double-Blind|Adverse Event|7
6052296|NCT00565409|20916257|P1|Period 2 Double-Blind|Adverse Event|0
6052297|NCT00565409|20916254|P4|After Period 1, Prior to Period 2|did not meet criteria|0
6052298|NCT00565409|20916255|P3|After Period 1, Prior to Period 2|did not meet criteria|0
6052299|NCT00565409|20916256|P2|After Period 1, Prior to Period 2|did not meet criteria|0
6052300|NCT00565409|20916257|P1|After Period 1, Prior to Period 2|did not meet criteria|152
6052301|NCT00565409|20916254|P4|Period 1 Open Label|no conclusion of participation record|0
6052302|NCT00565409|20916255|P3|Period 1 Open Label|no conclusion of participation record|0
6052303|NCT00565409|20916256|P2|Period 1 Open Label|no conclusion of participation record|0
6052304|NCT00565409|20916257|P1|Period 1 Open Label|no conclusion of participation record|1
6052305|NCT00565409|20916254|P4|Period 1 Open Label|Unsatisfactory Response-Efficacy|0
6052306|NCT00565409|20916255|P3|Period 1 Open Label|Unsatisfactory Response-Efficacy|0
6052307|NCT00565409|20916256|P2|Period 1 Open Label|Unsatisfactory Response-Efficacy|0
6052308|NCT00565409|20916257|P1|Period 1 Open Label|Unsatisfactory Response-Efficacy|22
6052309|NCT00565409|20916254|P4|Period 1 Open Label|Protocol Violation|0
6052310|NCT00565409|20916255|P3|Period 1 Open Label|Protocol Violation|0
6052311|NCT00565409|20916256|P2|Period 1 Open Label|Protocol Violation|0
6052312|NCT00565409|20916257|P1|Period 1 Open Label|Protocol Violation|14
6052313|NCT00565409|20916254|P4|Period 1 Open Label|Other|0
6052314|NCT00565409|20916255|P3|Period 1 Open Label|Other|0
6052315|NCT00565409|20916256|P2|Period 1 Open Label|Other|0
6052316|NCT00565409|20916257|P1|Period 1 Open Label|Other|21
6052317|NCT00565409|20916254|P4|Period 1 Open Label|Lost to Follow-up|0
6052318|NCT00565409|20916255|P3|Period 1 Open Label|Lost to Follow-up|0
6052319|NCT00565409|20916256|P2|Period 1 Open Label|Lost to Follow-up|0
6052320|NCT00565409|20916257|P1|Period 1 Open Label|Lost to Follow-up|1
6052321|NCT00565409|20916254|P4|Period 1 Open Label|Death|0
6052322|NCT00565409|20916255|P3|Period 1 Open Label|Death|0
6052323|NCT00565409|20916256|P2|Period 1 Open Label|Death|0
6052324|NCT00565409|20916257|P1|Period 1 Open Label|Death|2
6052325|NCT00565409|20916254|P4|Period 1 Open Label|Adverse Event|0
6052326|NCT00565409|20916255|P3|Period 1 Open Label|Adverse Event|0
6052327|NCT00565409|20916256|P2|Period 1 Open Label|Adverse Event|0
6052328|NCT00565409|20916257|P1|Period 1 Open Label|Adverse Event|17
6052329|NCT00565136|20916393|P1|Overall Study|Protocol Violation|1
6052330|NCT00565136|20916393|P1|Overall Study|Withdrawal by Subject|1
6052331|NCT00565136|20916393|P1|Overall Study|Lost to Follow-up|1
6052332|NCT00565058|20916434|P2|Overall Study|Adverse Event|0
6052333|NCT00565058|20916435|P1|Overall Study|Adverse Event|1
6052334|NCT00564902|20916482|P3|Overall Study|Death|0
6052335|NCT00564902|20916483|P2|Overall Study|Death|1
6052336|NCT00564902|20916484|P1|Overall Study|Death|1
6052337|NCT00564902|20916482|P3|Overall Study|Withdrawal by Subject|4
6052338|NCT00564902|20916483|P2|Overall Study|Withdrawal by Subject|3
6052339|NCT00564902|20916484|P1|Overall Study|Withdrawal by Subject|0
6052340|NCT00564889|20916516|P1|Overall Study|Other, not specified|4
6052341|NCT00564889|20916516|P1|Overall Study|Disease progression|3
6052342|NCT00564889|20916516|P1|Overall Study|Alternative treatment|3
6052343|NCT00564889|20916516|P1|Overall Study|Adverse Event|12
6052344|NCT00564889|20916516|P1|Overall Study|Death|7
6052345|NCT00564850|20916531|P1|Overall Study|Protocol Violation|2
6052346|NCT00564733|20916549|P1|Overall Study|Ineligible|5
6052347|NCT00564733|20916549|P1|Overall Study|Withdrawal by Subject|4
6052348|NCT00564629|20916583|P2|Overall Study|Vomited within 2 hours of receiving drug|9
6052349|NCT00564629|20916584|P1|Overall Study|Vomited within 2 hours of receiving drug|15
6052350|NCT00564486|20916609|P4|Overall Study|Lost to Follow-up|2
6052351|NCT00564486|20916610|P3|Overall Study|Lost to Follow-up|2
6052352|NCT00564486|20916611|P2|Overall Study|Lost to Follow-up|0
6052353|NCT00564486|20916612|P1|Overall Study|Lost to Follow-up|3
6052354|NCT00564486|20916609|P4|Overall Study|Subject refused to have blood drawn|0
6052355|NCT00564486|20916610|P3|Overall Study|Subject refused to have blood drawn|1
6052356|NCT00564486|20916611|P2|Overall Study|Subject refused to have blood drawn|0
6052357|NCT00564486|20916612|P1|Overall Study|Subject refused to have blood drawn|0
6052358|NCT00564486|20916609|P4|Overall Study|Withdrawal by Subject|5
6052359|NCT00564486|20916610|P3|Overall Study|Withdrawal by Subject|0
6052360|NCT00564486|20916611|P2|Overall Study|Withdrawal by Subject|0
6052361|NCT00564486|20916612|P1|Overall Study|Withdrawal by Subject|4
6052362|NCT00564486|20916609|P4|Overall Study|Adverse Event|0
6052363|NCT00564486|20916610|P3|Overall Study|Adverse Event|0
6052364|NCT00564486|20916611|P2|Overall Study|Adverse Event|1
6052365|NCT00564486|20916612|P1|Overall Study|Adverse Event|0
6052366|NCT00564395|20916661|P2|First Intervention (10 Days)|Trouble with the CGM tracing|2
6052367|NCT00564395|20916662|P1|First Intervention (10 Days)|Trouble with the CGM tracing|1
6052368|NCT00564395|20916661|P2|First Intervention (10 Days)|Withdrawal by Subject|0
6052369|NCT00564395|20916662|P1|First Intervention (10 Days)|Withdrawal by Subject|1
6052370|NCT00564278|20916670|P2|Overall Study|Withdrawal by Subject|7
6052371|NCT00564278|20916671|P1|Overall Study|Withdrawal by Subject|11
6052372|NCT00564278|20916670|P2|Overall Study|Physician Decision|2
6052373|NCT00564278|20916671|P1|Overall Study|Physician Decision|1
6052374|NCT00564278|20916670|P2|Overall Study|Lost to Follow-up|33
6052375|NCT00564278|20916671|P1|Overall Study|Lost to Follow-up|35
6052376|NCT00564070|20916693|P2|Overall Study|Worsening depression, referred to care|0
6052377|NCT00564070|20916694|P1|Overall Study|Worsening depression, referred to care|3
6052378|NCT00564070|20916693|P2|Overall Study|Lost to Follow-up|7
6052379|NCT00564070|20916694|P1|Overall Study|Lost to Follow-up|9
6052380|NCT00564018|20916721|P3|Overall Study|Withdrawal by Subject|1
6052381|NCT00564018|20916722|P2|Overall Study|Withdrawal by Subject|3
6052382|NCT00564018|20916723|P1|Overall Study|Withdrawal by Subject|2
6052383|NCT00563797|20916736|P2|Overall Study|Lost to Follow-up|2
6052384|NCT00563797|20916737|P1|Overall Study|Lost to Follow-up|7
6052385|NCT00563784|20916749|P1|Overall Study|Screen Failures|20
6052386|NCT00563784|20916749|P1|Overall Study|Withdrawal by Subject|2
6052387|NCT00563706|20916763|P9|DB Treatment Period (Day 1 up to Day 28)|Other|2
6052388|NCT00563706|20916764|P8|DB Treatment Period (Day 1 up to Day 28)|Other|1
6052389|NCT00563706|20916765|P7|DB Treatment Period (Day 1 up to Day 28)|Other|0
6052390|NCT00563706|20916766|P6|DB Treatment Period (Day 1 up to Day 28)|Other|0
6052391|NCT00563706|20916767|P5|DB Treatment Period (Day 1 up to Day 28)|Other|0
6052392|NCT00563706|20916768|P4|DB Treatment Period (Day 1 up to Day 28)|Other|0
6052393|NCT00563706|20916769|P3|DB Treatment Period (Day 1 up to Day 28)|Other|0
6052394|NCT00563706|20916770|P2|DB Treatment Period (Day 1 up to Day 28)|Other|0
6052395|NCT00563706|20916771|P1|DB Treatment Period (Day 1 up to Day 28)|Other|0
6052396|NCT00563706|20916763|P9|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
6052397|NCT00563706|20916764|P8|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|1
6052398|NCT00563706|20916765|P7|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
6052399|NCT00563706|20916766|P6|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
6052400|NCT00563706|20916767|P5|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
6052401|NCT00563706|20916768|P4|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
6052402|NCT00563706|20916769|P3|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
6052403|NCT00563706|20916770|P2|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
6052404|NCT00563706|20916771|P1|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|2
6052405|NCT00563706|20916763|P9|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3
6052406|NCT00563706|20916764|P8|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|6
6052407|NCT00563706|20916765|P7|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|1
6052408|NCT00563706|20916766|P6|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3
6052409|NCT00563706|20916767|P5|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|4
6052410|NCT00563706|20916768|P4|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|5
6052411|NCT00563706|20916769|P3|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|2
6052412|NCT00563706|20916770|P2|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3
6052413|NCT00563706|20916771|P1|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|9
6052414|NCT00563706|20916763|P9|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1
6052415|NCT00563706|20916764|P8|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|5
6052416|NCT00563706|20916765|P7|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2
6052417|NCT00563706|20916766|P6|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2
6052418|NCT00563706|20916767|P5|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1
6052419|NCT00563706|20916768|P4|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|4
6052420|NCT00563706|20916769|P3|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2
6052421|NCT00563706|20916770|P2|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1
6052422|NCT00563706|20916771|P1|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2
6052423|NCT00563706|20916763|P9|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|5
6052424|NCT00563706|20916764|P8|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1
6052425|NCT00563706|20916765|P7|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0
6052426|NCT00563706|20916766|P6|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0
6052427|NCT00563706|20916767|P5|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0
6052428|NCT00563706|20916768|P4|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1
6052429|NCT00563706|20916769|P3|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1
6052430|NCT00563706|20916770|P2|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1
6052431|NCT00563706|20916771|P1|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|4
6052432|NCT00563381|20916889|P2|Overall Study|Individual different reasons|34
6052433|NCT00563381|20916890|P1|Overall Study|Individual different reasons|24
6052434|NCT00563381|20916889|P2|Overall Study|Lack of Efficacy|24
6052435|NCT00563381|20916890|P1|Overall Study|Lack of Efficacy|32
6052436|NCT00563381|20916889|P2|Overall Study|Withdrawal by Subject|209
6052437|NCT00563381|20916890|P1|Overall Study|Withdrawal by Subject|192
6052438|NCT00563381|20916889|P2|Overall Study|Lost to Follow-up|15
6052439|NCT00563381|20916890|P1|Overall Study|Lost to Follow-up|7
6052440|NCT00563381|20916889|P2|Overall Study|Protocol Violation|74
6052441|NCT00563381|20916890|P1|Overall Study|Protocol Violation|66
6052442|NCT00563381|20916889|P2|Overall Study|Adverse Event|292
6052443|NCT00563381|20916890|P1|Overall Study|Adverse Event|264
6052444|NCT00563368|20916963|P7|Overall Study|Other|0
6052445|NCT00563368|20916964|P6|Overall Study|Other|4
6052446|NCT00563368|20916965|P5|Overall Study|Other|4
6052447|NCT00563368|20916966|P4|Overall Study|Other|4
6052448|NCT00563368|20916967|P3|Overall Study|Other|3
6052449|NCT00563368|20916968|P2|Overall Study|Other|5
6052450|NCT00563368|20916969|P1|Overall Study|Other|5
6052451|NCT00563368|20916963|P7|Overall Study|requirement for restricted medication|0
6052452|NCT00563368|20916964|P6|Overall Study|requirement for restricted medication|0
6052453|NCT00563368|20916965|P5|Overall Study|requirement for restricted medication|0
6052454|NCT00563368|20916966|P4|Overall Study|requirement for restricted medication|0
6052455|NCT00563368|20916967|P3|Overall Study|requirement for restricted medication|2
6052456|NCT00563368|20916968|P2|Overall Study|requirement for restricted medication|0
6052457|NCT00563368|20916969|P1|Overall Study|requirement for restricted medication|0
6052458|NCT00563368|20916963|P7|Overall Study|Pregnancy|0
6052459|NCT00563368|20916964|P6|Overall Study|Pregnancy|2
6052460|NCT00563368|20916965|P5|Overall Study|Pregnancy|1
6052461|NCT00563368|20916966|P4|Overall Study|Pregnancy|2
6052462|NCT00563368|20916967|P3|Overall Study|Pregnancy|1
6052463|NCT00563368|20916968|P2|Overall Study|Pregnancy|0
6052464|NCT00563368|20916969|P1|Overall Study|Pregnancy|1
6052465|NCT00563368|20916963|P7|Overall Study|protocol non-compliance|3
6052466|NCT00563368|20916964|P6|Overall Study|protocol non-compliance|1
6052467|NCT00563368|20916965|P5|Overall Study|protocol non-compliance|0
6052468|NCT00563368|20916966|P4|Overall Study|protocol non-compliance|1
6052469|NCT00563368|20916967|P3|Overall Study|protocol non-compliance|2
6052470|NCT00563368|20916968|P2|Overall Study|protocol non-compliance|1
6052471|NCT00563368|20916969|P1|Overall Study|protocol non-compliance|1
6052472|NCT00563368|20916963|P7|Overall Study|Withdrawal by Subject|4
6052473|NCT00563368|20916964|P6|Overall Study|Withdrawal by Subject|5
6052474|NCT00563368|20916965|P5|Overall Study|Withdrawal by Subject|8
6052475|NCT00563368|20916966|P4|Overall Study|Withdrawal by Subject|7
6052476|NCT00563368|20916967|P3|Overall Study|Withdrawal by Subject|5
6052477|NCT00563368|20916968|P2|Overall Study|Withdrawal by Subject|6
6052478|NCT00563368|20916969|P1|Overall Study|Withdrawal by Subject|11
6052479|NCT00563368|20916963|P7|Overall Study|Adverse Event|17
6052480|NCT00563368|20916964|P6|Overall Study|Adverse Event|10
6052481|NCT00563368|20916965|P5|Overall Study|Adverse Event|6
6052482|NCT00563368|20916966|P4|Overall Study|Adverse Event|9
6052483|NCT00563368|20916967|P3|Overall Study|Adverse Event|5
6052484|NCT00563368|20916968|P2|Overall Study|Adverse Event|4
6052485|NCT00563368|20916969|P1|Overall Study|Adverse Event|3
6052486|NCT00563368|20916963|P7|Overall Study|Lost to Follow-up|9
6052487|NCT00563368|20916964|P6|Overall Study|Lost to Follow-up|8
6052488|NCT00563368|20916965|P5|Overall Study|Lost to Follow-up|9
6052489|NCT00563368|20916966|P4|Overall Study|Lost to Follow-up|6
6052490|NCT00563368|20916967|P3|Overall Study|Lost to Follow-up|12
6052491|NCT00563368|20916968|P2|Overall Study|Lost to Follow-up|14
6052492|NCT00563368|20916969|P1|Overall Study|Lost to Follow-up|14
6052493|NCT00563316|20916992|P1|Overall Study|Other|1
6052494|NCT00563316|20916992|P1|Overall Study|On-going in study as of 16 July 2009.|5
6052495|NCT00563316|20916992|P1|Overall Study|Death|1
6052496|NCT00563316|20916992|P1|Overall Study|Lost to Follow-up|2
6052497|NCT00563316|20916992|P1|Overall Study|Physician Decision|1
6052498|NCT00563316|20916992|P1|Overall Study|Adverse Event|2
6052499|NCT00563186|20917017|P2|Overall Study|Incomplete data|1
6052500|NCT00563186|20917018|P1|Overall Study|Incomplete data|1
6052501|NCT00563186|20917017|P2|Overall Study|LOS<48 hours|74
6052502|NCT00563186|20917018|P1|Overall Study|LOS<48 hours|97
6052503|NCT00562965|20917029|P2|Overall Study|Other|1
6052504|NCT00562965|20917030|P1|Overall Study|Other|0
6052505|NCT00562965|20917029|P2|Overall Study|Lost to Follow-up|0
6052506|NCT00562965|20917030|P1|Overall Study|Lost to Follow-up|1
6052507|NCT00562965|20917029|P2|Overall Study|Death|4
6052508|NCT00562965|20917030|P1|Overall Study|Death|2
6052509|NCT00562965|20917029|P2|Overall Study|Withdrawal by Subject|1
6052510|NCT00562965|20917030|P1|Overall Study|Withdrawal by Subject|0
6052511|NCT00562861|20917051|P2|Overall Study|Lost to Follow-up|3
6052512|NCT00562861|20917052|P1|Overall Study|Lost to Follow-up|7
6052513|NCT00562861|20917051|P2|Overall Study|noncompliance, moved|2
6052514|NCT00562861|20917052|P1|Overall Study|noncompliance, moved|7
6052515|NCT00562861|20917051|P2|Overall Study|Lack of Efficacy|5
6052516|NCT00562861|20917052|P1|Overall Study|Lack of Efficacy|5
6052517|NCT00562861|20917051|P2|Overall Study|Adverse Event|1
6052518|NCT00562861|20917052|P1|Overall Study|Adverse Event|1
6052519|NCT00562718|20917058|P1|Overall Study|not stated|1
6052520|NCT00562718|20917058|P1|Overall Study|Lack of Efficacy|2
6052521|NCT00562718|20917058|P1|Overall Study|Adverse Event|4
6052522|NCT00562718|20917058|P1|Overall Study|Withdrawal by Subject|3
6052523|NCT00562718|20917058|P1|Overall Study|Death|1
6052524|NCT00562627|20917067|P3|Overall Study|Protocol Violation|1
6052525|NCT00562627|20917068|P2|Overall Study|Protocol Violation|1
6052526|NCT00562627|20917069|P1|Overall Study|Protocol Violation|1
6052527|NCT00562588|20917085|P2|Overall Study|Other|2
6052528|NCT00562588|20917086|P1|Overall Study|Other|0
6052529|NCT00562588|20917085|P2|Overall Study|Withdrawal by Subject|9
6052530|NCT00562588|20917086|P1|Overall Study|Withdrawal by Subject|10
6052531|NCT00562588|20917085|P2|Overall Study|Lost to Follow-up|4
6052532|NCT00562588|20917086|P1|Overall Study|Lost to Follow-up|12
6052533|NCT00562588|20917085|P2|Overall Study|Protocol Violation|26
6052534|NCT00562588|20917086|P1|Overall Study|Protocol Violation|30
6052535|NCT00562588|20917085|P2|Overall Study|Adverse Event|58
6052536|NCT00562588|20917086|P1|Overall Study|Adverse Event|40
6052537|NCT00562484|20917116|P2|Overall Study|Reason not provided or not specified|12
6052538|NCT00562484|20917117|P1|Overall Study|Reason not provided or not specified|25
6052539|NCT00562484|20917116|P2|Overall Study|Lost to Follow-up|71
6052540|NCT00562484|20917117|P1|Overall Study|Lost to Follow-up|132
6052541|NCT00562484|20917116|P2|Overall Study|Moved away from the study area|9
6052542|NCT00562484|20917117|P1|Overall Study|Moved away from the study area|20
6052543|NCT00562484|20917116|P2|Overall Study|Withdrawal by Subject|9
6052544|NCT00562484|20917117|P1|Overall Study|Withdrawal by Subject|12
6052545|NCT00562484|20917116|P2|Overall Study|Protocol Violation|2
6052546|NCT00562484|20917117|P1|Overall Study|Protocol Violation|11
6052547|NCT00562484|20917116|P2|Overall Study|Adverse Event|1
6052548|NCT00562484|20917117|P1|Overall Study|Adverse Event|6
6052549|NCT00562354|20917149|P2|Overall Study|Lost to Follow-up|1
6052550|NCT00562354|20917150|P1|Overall Study|Lost to Follow-up|0
6052551|NCT00562354|20917149|P2|Overall Study|Physician Decision|1
6052552|NCT00562354|20917150|P1|Overall Study|Physician Decision|0
6052553|NCT00562302|20917216|P2|Overall Study|Not stated|4
6052554|NCT00562302|20917217|P1|Overall Study|Not stated|1
6052555|NCT00562302|20917216|P2|Overall Study|Lung resection prior to study completion|7
6052556|NCT00562302|20917217|P1|Overall Study|Lung resection prior to study completion|7
6052557|NCT00562302|20917216|P2|Overall Study|Death|2
6052558|NCT00562302|20917217|P1|Overall Study|Death|1
6052559|NCT00562302|20917216|P2|Overall Study|Withdrawal by Subject|8
6052560|NCT00562302|20917217|P1|Overall Study|Withdrawal by Subject|7
6052561|NCT00562302|20917216|P2|Overall Study|Non-compliance|2
6052562|NCT00562302|20917217|P1|Overall Study|Non-compliance|1
6052563|NCT00562302|20917216|P2|Overall Study|Adverse Event|6
6052564|NCT00562302|20917217|P1|Overall Study|Adverse Event|0
6052565|NCT00562302|20917216|P2|Overall Study|Lost to Follow-up|3
6052566|NCT00562302|20917217|P1|Overall Study|Lost to Follow-up|3
6052567|NCT00562159|20917239|P2|Overall Study|Did not meet protocol eligibility|1
6052568|NCT00562159|20917240|P1|Overall Study|Did not meet protocol eligibility|1
6052569|NCT00562159|20917239|P2|Overall Study|Protocol Violation|12
6052570|NCT00562159|20917240|P1|Overall Study|Protocol Violation|12
6052571|NCT00562159|20917239|P2|Overall Study|Withdrawal by Subject|8
6052572|NCT00562159|20917240|P1|Overall Study|Withdrawal by Subject|9
6052573|NCT00562159|20917239|P2|Overall Study|Lost to Follow-up|4
6052574|NCT00562159|20917240|P1|Overall Study|Lost to Follow-up|5
6052575|NCT00562159|20917239|P2|Overall Study|Adverse Event|8
6052576|NCT00562159|20917240|P1|Overall Study|Adverse Event|11
6052577|NCT00562120|20917252|P4|First Intervention Period|Randomized but not Treated|0
6052578|NCT00562120|20917253|P3|First Intervention Period|Randomized but not Treated|0
6052579|NCT00562120|20917254|P2|First Intervention Period|Randomized but not Treated|0
6052580|NCT00562120|20917255|P1|First Intervention Period|Randomized but not Treated|1
6052581|NCT00562120|20917252|P4|First Intervention Period|Adverse Event|0
6052582|NCT00562120|20917253|P3|First Intervention Period|Adverse Event|0
6052583|NCT00562120|20917254|P2|First Intervention Period|Adverse Event|0
6052584|NCT00562120|20917255|P1|First Intervention Period|Adverse Event|1
6052585|NCT00562094|20917287|P1|Overall Study|Lost to Follow-up|62
6052586|NCT00561977|20917302|P3|Overall Study|Pregnancy|1
6052587|NCT00561977|20917303|P2|Overall Study|Pregnancy|1
6052588|NCT00561977|20917304|P1|Overall Study|Pregnancy|0
6052589|NCT00561977|20917302|P3|Overall Study|Withdrawal by Subject|1
6052590|NCT00561977|20917303|P2|Overall Study|Withdrawal by Subject|2
6052591|NCT00561977|20917304|P1|Overall Study|Withdrawal by Subject|0
6052592|NCT00561951|20917330|P3|Overall Study|Adverse Event Occured Before Treatment|1
6052593|NCT00561951|20917331|P2|Overall Study|Adverse Event Occured Before Treatment|2
6052594|NCT00561951|20917332|P1|Overall Study|Adverse Event Occured Before Treatment|1
6052595|NCT00561951|20917330|P3|Overall Study|Meet Withdrawal Criterion|1
6052596|NCT00561951|20917331|P2|Overall Study|Meet Withdrawal Criterion|1
6052597|NCT00561951|20917332|P1|Overall Study|Meet Withdrawal Criterion|0
6052598|NCT00561951|20917330|P3|Overall Study|Pregnancy|0
6052599|NCT00561951|20917331|P2|Overall Study|Pregnancy|1
6052600|NCT00561951|20917332|P1|Overall Study|Pregnancy|0
6052601|NCT00561951|20917330|P3|Overall Study|Physician Decision|0
6052602|NCT00561951|20917331|P2|Overall Study|Physician Decision|0
6052603|NCT00561951|20917332|P1|Overall Study|Physician Decision|1
6052604|NCT00561951|20917330|P3|Overall Study|Protocol Violation|4
6052605|NCT00561951|20917331|P2|Overall Study|Protocol Violation|3
6052606|NCT00561951|20917332|P1|Overall Study|Protocol Violation|4
6052607|NCT00561951|20917330|P3|Overall Study|Withdrawal by Subject|10
6052608|NCT00561951|20917331|P2|Overall Study|Withdrawal by Subject|9
6052609|NCT00561951|20917332|P1|Overall Study|Withdrawal by Subject|10
6052610|NCT00561951|20917330|P3|Overall Study|Lost to Follow-up|0
6052611|NCT00561951|20917331|P2|Overall Study|Lost to Follow-up|1
6052612|NCT00561951|20917332|P1|Overall Study|Lost to Follow-up|1
6052613|NCT00561951|20917330|P3|Overall Study|Lack of Efficacy|2
6052614|NCT00561951|20917331|P2|Overall Study|Lack of Efficacy|3
6052615|NCT00561951|20917332|P1|Overall Study|Lack of Efficacy|5
6052616|NCT00561951|20917330|P3|Overall Study|Adverse Event|14
6052617|NCT00561951|20917331|P2|Overall Study|Adverse Event|14
6052618|NCT00561951|20917332|P1|Overall Study|Adverse Event|11
6052619|NCT00561925|20917388|P5|Open-Label Extension Period|Declined entry into extension period|50
6052620|NCT00561925|20917389|P4|Open-Label Extension Period|Declined entry into extension period|43
6052621|NCT00561925|20917390|P3|Open-Label Extension Period|Declined entry into extension period|0
6052622|NCT00561925|20917391|P2|Open-Label Extension Period|Declined entry into extension period|0
6052623|NCT00561925|20917392|P1|Open-Label Extension Period|Declined entry into extension period|0
6052624|NCT00561925|20917388|P5|144-week Double-blind, Double-dummy|Other|0
6052625|NCT00561925|20917389|P4|144-week Double-blind, Double-dummy|Other|0
6052626|NCT00561925|20917390|P3|144-week Double-blind, Double-dummy|Other|11
6052627|NCT00561925|20917391|P2|144-week Double-blind, Double-dummy|Other|8
6052628|NCT00561925|20917392|P1|144-week Double-blind, Double-dummy|Other|0
6052629|NCT00561925|20917388|P5|144-week Double-blind, Double-dummy|Not treated with study drug|0
6052630|NCT00561925|20917389|P4|144-week Double-blind, Double-dummy|Not treated with study drug|0
6052631|NCT00561925|20917390|P3|144-week Double-blind, Double-dummy|Not treated with study drug|0
6052632|NCT00561925|20917391|P2|144-week Double-blind, Double-dummy|Not treated with study drug|2
6052633|NCT00561925|20917392|P1|144-week Double-blind, Double-dummy|Not treated with study drug|0
6052634|NCT00561925|20917388|P5|144-week Double-blind, Double-dummy|Death|0
6052635|NCT00561925|20917389|P4|144-week Double-blind, Double-dummy|Death|0
6052636|NCT00561925|20917390|P3|144-week Double-blind, Double-dummy|Death|3
6052637|NCT00561925|20917391|P2|144-week Double-blind, Double-dummy|Death|6
6052638|NCT00561925|20917392|P1|144-week Double-blind, Double-dummy|Death|0
6052639|NCT00561925|20917388|P5|144-week Double-blind, Double-dummy|Pregnancy|0
6052640|NCT00561925|20917389|P4|144-week Double-blind, Double-dummy|Pregnancy|0
6052641|NCT00561925|20917390|P3|144-week Double-blind, Double-dummy|Pregnancy|9
6052642|NCT00561925|20917391|P2|144-week Double-blind, Double-dummy|Pregnancy|1
6052643|NCT00561925|20917392|P1|144-week Double-blind, Double-dummy|Pregnancy|0
6052644|NCT00561925|20917388|P5|144-week Double-blind, Double-dummy|Lack of Efficacy|0
6052645|NCT00561925|20917389|P4|144-week Double-blind, Double-dummy|Lack of Efficacy|0
6052646|NCT00561925|20917390|P3|144-week Double-blind, Double-dummy|Lack of Efficacy|33
6052647|NCT00561925|20917391|P2|144-week Double-blind, Double-dummy|Lack of Efficacy|36
6052648|NCT00561925|20917392|P1|144-week Double-blind, Double-dummy|Lack of Efficacy|0
6052649|NCT00561925|20917388|P5|144-week Double-blind, Double-dummy|Withdrawal by Subject|0
6052650|NCT00561925|20917389|P4|144-week Double-blind, Double-dummy|Withdrawal by Subject|0
6052651|NCT00561925|20917390|P3|144-week Double-blind, Double-dummy|Withdrawal by Subject|7
6052652|NCT00561925|20917391|P2|144-week Double-blind, Double-dummy|Withdrawal by Subject|19
6052653|NCT00561925|20917392|P1|144-week Double-blind, Double-dummy|Withdrawal by Subject|0
6052654|NCT00561925|20917388|P5|144-week Double-blind, Double-dummy|Lost to Follow-up|0
6052739|NCT00561652|20917590|P2|Overall Study|Withdrawal by Subject|1
6052655|NCT00561925|20917389|P4|144-week Double-blind, Double-dummy|Lost to Follow-up|0
6052656|NCT00561925|20917390|P3|144-week Double-blind, Double-dummy|Lost to Follow-up|12
6052657|NCT00561925|20917391|P2|144-week Double-blind, Double-dummy|Lost to Follow-up|15
6052658|NCT00561925|20917392|P1|144-week Double-blind, Double-dummy|Lost to Follow-up|0
6052659|NCT00561925|20917388|P5|144-week Double-blind, Double-dummy|Protocol Violation|0
6052660|NCT00561925|20917389|P4|144-week Double-blind, Double-dummy|Protocol Violation|0
6052661|NCT00561925|20917390|P3|144-week Double-blind, Double-dummy|Protocol Violation|9
6052662|NCT00561925|20917391|P2|144-week Double-blind, Double-dummy|Protocol Violation|15
6052663|NCT00561925|20917392|P1|144-week Double-blind, Double-dummy|Protocol Violation|0
6052664|NCT00561925|20917388|P5|144-week Double-blind, Double-dummy|Adverse Event|0
6052665|NCT00561925|20917389|P4|144-week Double-blind, Double-dummy|Adverse Event|0
6052666|NCT00561925|20917390|P3|144-week Double-blind, Double-dummy|Adverse Event|43
6052667|NCT00561925|20917391|P2|144-week Double-blind, Double-dummy|Adverse Event|48
6052668|NCT00561925|20917392|P1|144-week Double-blind, Double-dummy|Adverse Event|0
6052669|NCT00561925|20917388|P5|14 Day Lead-In Period|Other|0
6052670|NCT00561925|20917389|P4|14 Day Lead-In Period|Other|0
6052671|NCT00561925|20917390|P3|14 Day Lead-In Period|Other|0
6052672|NCT00561925|20917391|P2|14 Day Lead-In Period|Other|0
6052673|NCT00561925|20917392|P1|14 Day Lead-In Period|Other|5
6052674|NCT00561925|20917388|P5|14 Day Lead-In Period|Withdrawal by Subject|0
6052675|NCT00561925|20917389|P4|14 Day Lead-In Period|Withdrawal by Subject|0
6052676|NCT00561925|20917390|P3|14 Day Lead-In Period|Withdrawal by Subject|0
6052677|NCT00561925|20917391|P2|14 Day Lead-In Period|Withdrawal by Subject|0
6052678|NCT00561925|20917392|P1|14 Day Lead-In Period|Withdrawal by Subject|4
6052679|NCT00561925|20917388|P5|14 Day Lead-In Period|Lost to Follow-up|0
6052680|NCT00561925|20917389|P4|14 Day Lead-In Period|Lost to Follow-up|0
6052681|NCT00561925|20917390|P3|14 Day Lead-In Period|Lost to Follow-up|0
6052682|NCT00561925|20917391|P2|14 Day Lead-In Period|Lost to Follow-up|0
6052683|NCT00561925|20917392|P1|14 Day Lead-In Period|Lost to Follow-up|4
6052684|NCT00561925|20917388|P5|14 Day Lead-In Period|In/Exclusion criteria|0
6052685|NCT00561925|20917389|P4|14 Day Lead-In Period|In/Exclusion criteria|0
6052686|NCT00561925|20917390|P3|14 Day Lead-In Period|In/Exclusion criteria|0
6052687|NCT00561925|20917391|P2|14 Day Lead-In Period|In/Exclusion criteria|0
6052688|NCT00561925|20917392|P1|14 Day Lead-In Period|In/Exclusion criteria|4
6052689|NCT00561925|20917388|P5|14 Day Lead-In Period|Adverse Event|0
6052690|NCT00561925|20917389|P4|14 Day Lead-In Period|Adverse Event|0
6052691|NCT00561925|20917390|P3|14 Day Lead-In Period|Adverse Event|0
6052692|NCT00561925|20917391|P2|14 Day Lead-In Period|Adverse Event|0
6052693|NCT00561925|20917392|P1|14 Day Lead-In Period|Adverse Event|38
6052694|NCT00561912|20917441|P1|Overall Study|ineligible|1
6052695|NCT00561821|20917453|P4|Overall Study|Adverse Event|1
6052696|NCT00561821|20917454|P3|Overall Study|Adverse Event|1
6052697|NCT00561821|20917455|P2|Overall Study|Adverse Event|3
6052698|NCT00561821|20917456|P1|Overall Study|Adverse Event|2
6052699|NCT00561821|20917453|P4|Overall Study|Other (reason not specified)|0
6052700|NCT00561821|20917454|P3|Overall Study|Other (reason not specified)|0
6052701|NCT00561821|20917455|P2|Overall Study|Other (reason not specified)|1
6052702|NCT00561821|20917456|P1|Overall Study|Other (reason not specified)|1
6052703|NCT00561821|20917453|P4|Overall Study|Reasons not related to trial|0
6052704|NCT00561821|20917454|P3|Overall Study|Reasons not related to trial|0
6052705|NCT00561821|20917455|P2|Overall Study|Reasons not related to trial|1
6052706|NCT00561821|20917456|P1|Overall Study|Reasons not related to trial|2
6052707|NCT00561821|20917453|P4|Overall Study|Withdrawal by Subject|2
6052708|NCT00561821|20917454|P3|Overall Study|Withdrawal by Subject|0
6052709|NCT00561821|20917455|P2|Overall Study|Withdrawal by Subject|1
6052710|NCT00561821|20917456|P1|Overall Study|Withdrawal by Subject|0
6052711|NCT00561821|20917453|P4|Overall Study|Not treated|0
6052712|NCT00561821|20917454|P3|Overall Study|Not treated|1
6052713|NCT00561821|20917455|P2|Overall Study|Not treated|0
6052714|NCT00561821|20917456|P1|Overall Study|Not treated|0
6052715|NCT00561795|20917532|P4|Overall Study|Physician Decision|0
6052716|NCT00561795|20917533|P3|Overall Study|Physician Decision|0
6052717|NCT00561795|20917534|P2|Overall Study|Physician Decision|0
6052718|NCT00561795|20917535|P1|Overall Study|Physician Decision|1
6052719|NCT00561795|20917532|P4|Overall Study|Study Closed/Terminated|0
6052720|NCT00561795|20917533|P3|Overall Study|Study Closed/Terminated|0
6052721|NCT00561795|20917534|P2|Overall Study|Study Closed/Terminated|3
6052722|NCT00561795|20917535|P1|Overall Study|Study Closed/Terminated|0
6052723|NCT00561795|20917532|P4|Overall Study|Adverse Event|0
6052724|NCT00561795|20917533|P3|Overall Study|Adverse Event|0
6052725|NCT00561795|20917534|P2|Overall Study|Adverse Event|3
6052726|NCT00561795|20917535|P1|Overall Study|Adverse Event|3
6052727|NCT00561730|20917555|P1|Overall Study|Not specified reasons|1
6052728|NCT00561730|20917555|P1|Overall Study|Lost to Follow-up|5
6052729|NCT00561730|20917555|P1|Overall Study|Handling of the drug|1
6052730|NCT00561730|20917555|P1|Overall Study|Adverse Event|2
6052731|NCT00561678|20917571|P2|Overall Study|anesthesia provider refusal|0
6052732|NCT00561678|20917572|P1|Overall Study|anesthesia provider refusal|1
6052733|NCT00561678|20917571|P2|Overall Study|surgery rescheduled to different site|2
6052734|NCT00561678|20917572|P1|Overall Study|surgery rescheduled to different site|2
6052735|NCT00561678|20917571|P2|Overall Study|surgery cancelled|1
6052736|NCT00561678|20917572|P1|Overall Study|surgery cancelled|1
6052737|NCT00561678|20917571|P2|Overall Study|Withdrawal by Subject|3
6052738|NCT00561678|20917572|P1|Overall Study|Withdrawal by Subject|4
6052740|NCT00561652|20917591|P1|Overall Study|Withdrawal by Subject|0
6052741|NCT00561574|20917674|P2|Overall Study|Other|7
6052742|NCT00561574|20917675|P1|Overall Study|Other|5
6052743|NCT00561574|20917674|P2|Overall Study|Lost to Follow-up|0
6052744|NCT00561574|20917675|P1|Overall Study|Lost to Follow-up|1
6052745|NCT00561574|20917674|P2|Overall Study|Reason Unrelated to Trial|2
6052746|NCT00561574|20917675|P1|Overall Study|Reason Unrelated to Trial|6
6052747|NCT00561574|20917674|P2|Overall Study|Withdrawal by Subject|4
6052748|NCT00561574|20917675|P1|Overall Study|Withdrawal by Subject|4
6052749|NCT00561574|20917674|P2|Overall Study|Lack of Efficacy|21
6052750|NCT00561574|20917675|P1|Overall Study|Lack of Efficacy|11
6052751|NCT00561574|20917674|P2|Overall Study|Adverse Event|24
6052752|NCT00561574|20917675|P1|Overall Study|Adverse Event|21
6052753|NCT00561470|20917701|P2|Overall Study|Ongoing Treatment|14
6052754|NCT00561470|20917702|P1|Overall Study|Ongoing Treatment|11
6052755|NCT00561470|20917701|P2|Overall Study|Planning surgery|1
6052756|NCT00561470|20917702|P1|Overall Study|Planning surgery|1
6052757|NCT00561470|20917701|P2|Overall Study|Missed visit window|4
6052758|NCT00561470|20917702|P1|Overall Study|Missed visit window|1
6052759|NCT00561470|20917701|P2|Overall Study|Randomized but not treated|5
6052760|NCT00561470|20917702|P1|Overall Study|Randomized but not treated|5
6052761|NCT00561470|20917701|P2|Overall Study|Unauthorized procedure|1
6052762|NCT00561470|20917702|P1|Overall Study|Unauthorized procedure|3
6052763|NCT00561470|20917701|P2|Overall Study|Metastatic surgery|12
6052764|NCT00561470|20917702|P1|Overall Study|Metastatic surgery|10
6052765|NCT00561470|20917701|P2|Overall Study|Subject request|77
6052766|NCT00561470|20917702|P1|Overall Study|Subject request|43
6052767|NCT00561470|20917701|P2|Overall Study|Consent Withdrawn|6
6052768|NCT00561470|20917702|P1|Overall Study|Consent Withdrawn|2
6052769|NCT00561470|20917701|P2|Overall Study|Physician Decision|20
6052770|NCT00561470|20917702|P1|Overall Study|Physician Decision|21
6052771|NCT00561470|20917701|P2|Overall Study|Lost to Follow-up|0
6052772|NCT00561470|20917702|P1|Overall Study|Lost to Follow-up|2
6052773|NCT00561470|20917701|P2|Overall Study|poor compliance to protocol|4
6052774|NCT00561470|20917702|P1|Overall Study|poor compliance to protocol|4
6052775|NCT00561470|20917701|P2|Overall Study|Disease progression|305
6052776|NCT00561470|20917702|P1|Overall Study|Disease progression|437
6052777|NCT00561470|20917701|P2|Overall Study|Adverse Event|163
6052778|NCT00561470|20917702|P1|Overall Study|Adverse Event|74
6052779|NCT00561392|20917738|P1|Overall Study|Administrative problems|4
6052780|NCT00561392|20917738|P1|Overall Study|Withdrawal by Subject|8
6052781|NCT00561392|20917738|P1|Overall Study|Protocol Violation|1
6052782|NCT00561392|20917738|P1|Overall Study|Lack of Efficacy|2
6052783|NCT00561392|20917738|P1|Overall Study|Adverse Event|38
6052784|NCT00561353|20917760|P10|Overall Study|Withdrawal by Subject|0
6052785|NCT00561353|20917761|P9|Overall Study|Withdrawal by Subject|0
6052786|NCT00561353|20917762|P8|Overall Study|Withdrawal by Subject|0
6052787|NCT00561353|20917763|P7|Overall Study|Withdrawal by Subject|0
6052788|NCT00561353|20917764|P6|Overall Study|Withdrawal by Subject|0
6052789|NCT00561353|20917765|P5|Overall Study|Withdrawal by Subject|0
6052790|NCT00561353|20917766|P4|Overall Study|Withdrawal by Subject|0
6052791|NCT00561353|20917767|P3|Overall Study|Withdrawal by Subject|0
6052792|NCT00561353|20917768|P2|Overall Study|Withdrawal by Subject|2
6052793|NCT00561353|20917769|P1|Overall Study|Withdrawal by Subject|0
6052794|NCT00561353|20917760|P10|Overall Study|Lost to Follow-up|0
6052795|NCT00561353|20917761|P9|Overall Study|Lost to Follow-up|0
6052796|NCT00561353|20917762|P8|Overall Study|Lost to Follow-up|0
6052797|NCT00561353|20917763|P7|Overall Study|Lost to Follow-up|0
6052798|NCT00561353|20917764|P6|Overall Study|Lost to Follow-up|0
6052799|NCT00561353|20917765|P5|Overall Study|Lost to Follow-up|0
6052800|NCT00561353|20917766|P4|Overall Study|Lost to Follow-up|0
6052801|NCT00561353|20917767|P3|Overall Study|Lost to Follow-up|1
6052802|NCT00561353|20917768|P2|Overall Study|Lost to Follow-up|0
6052803|NCT00561353|20917769|P1|Overall Study|Lost to Follow-up|2
6052804|NCT00561353|20917760|P10|Overall Study|Adverse Event|1
6052805|NCT00561353|20917761|P9|Overall Study|Adverse Event|0
6052806|NCT00561353|20917762|P8|Overall Study|Adverse Event|0
6052807|NCT00561353|20917763|P7|Overall Study|Adverse Event|1
6052808|NCT00561353|20917764|P6|Overall Study|Adverse Event|0
6052809|NCT00561353|20917765|P5|Overall Study|Adverse Event|0
6052810|NCT00561353|20917766|P4|Overall Study|Adverse Event|2
6052811|NCT00561353|20917767|P3|Overall Study|Adverse Event|0
6052812|NCT00561353|20917768|P2|Overall Study|Adverse Event|0
6052813|NCT00561353|20917769|P1|Overall Study|Adverse Event|0
6052814|NCT00561353|20917760|P10|Overall Study|Other|0
6052815|NCT00561353|20917761|P9|Overall Study|Other|0
6052816|NCT00561353|20917762|P8|Overall Study|Other|0
6052817|NCT00561353|20917763|P7|Overall Study|Other|0
6052818|NCT00561353|20917764|P6|Overall Study|Other|2
6052819|NCT00561353|20917765|P5|Overall Study|Other|0
6052820|NCT00561353|20917766|P4|Overall Study|Other|0
6052821|NCT00561353|20917767|P3|Overall Study|Other|1
6052822|NCT00561353|20917768|P2|Overall Study|Other|0
6052823|NCT00561353|20917769|P1|Overall Study|Other|1
6052824|NCT00561353|20917760|P10|Overall Study|Subject ineligible to continue the trial|1
6052825|NCT00561353|20917761|P9|Overall Study|Subject ineligible to continue the trial|2
6052826|NCT00561353|20917762|P8|Overall Study|Subject ineligible to continue the trial|0
6052827|NCT00561353|20917763|P7|Overall Study|Subject ineligible to continue the trial|1
6052828|NCT00561353|20917764|P6|Overall Study|Subject ineligible to continue the trial|1
6052829|NCT00561353|20917765|P5|Overall Study|Subject ineligible to continue the trial|0
6052830|NCT00561353|20917766|P4|Overall Study|Subject ineligible to continue the trial|0
6052831|NCT00561353|20917767|P3|Overall Study|Subject ineligible to continue the trial|0
6052832|NCT00561353|20917768|P2|Overall Study|Subject ineligible to continue the trial|0
6052833|NCT00561353|20917769|P1|Overall Study|Subject ineligible to continue the trial|0
6052834|NCT00561353|20917760|P10|Overall Study|Subject reached a virologic endpoint|0
6052835|NCT00561353|20917761|P9|Overall Study|Subject reached a virologic endpoint|5
6052836|NCT00561353|20917762|P8|Overall Study|Subject reached a virologic endpoint|4
6052837|NCT00561353|20917763|P7|Overall Study|Subject reached a virologic endpoint|4
6052838|NCT00561353|20917764|P6|Overall Study|Subject reached a virologic endpoint|3
6052839|NCT00561353|20917765|P5|Overall Study|Subject reached a virologic endpoint|1
6052840|NCT00561353|20917766|P4|Overall Study|Subject reached a virologic endpoint|4
6052841|NCT00561353|20917767|P3|Overall Study|Subject reached a virologic endpoint|1
6052842|NCT00561353|20917768|P2|Overall Study|Subject reached a virologic endpoint|1
6052843|NCT00561353|20917769|P1|Overall Study|Subject reached a virologic endpoint|2
6052844|NCT00561340|20917924|P2|Overall Study|refused to drink pediasure|0
6052845|NCT00561340|20917925|P1|Overall Study|refused to drink pediasure|6
6052846|NCT00561080|20917945|P3|12-month Post Last Dose Follow-up|Lost to Follow-up|0
6052847|NCT00561080|20917946|P2|12-month Post Last Dose Follow-up|Lost to Follow-up|0
6052848|NCT00561080|20917947|P1|12-month Post Last Dose Follow-up|Lost to Follow-up|2
6052849|NCT00561080|20917945|P3|12-month Post Last Dose Follow-up|Withdrawal by Subject|5
6052850|NCT00561080|20917946|P2|12-month Post Last Dose Follow-up|Withdrawal by Subject|6
6052851|NCT00561080|20917947|P1|12-month Post Last Dose Follow-up|Withdrawal by Subject|2
6052852|NCT00561080|20917945|P3|12-month Post Last Dose Follow-up|Protocol Violation|4
6052853|NCT00561080|20917946|P2|12-month Post Last Dose Follow-up|Protocol Violation|0
6052854|NCT00561080|20917947|P1|12-month Post Last Dose Follow-up|Protocol Violation|0
6052855|NCT00561080|20917945|P3|12-month Post Last Dose Follow-up|Adverse Event|1
6052856|NCT00561080|20917946|P2|12-month Post Last Dose Follow-up|Adverse Event|3
6052857|NCT00561080|20917947|P1|12-month Post Last Dose Follow-up|Adverse Event|3
6052858|NCT00561080|20917945|P3|Vaccination Period (up to Month 4)|Other|1
6052859|NCT00561080|20917946|P2|Vaccination Period (up to Month 4)|Other|2
6052860|NCT00561080|20917947|P1|Vaccination Period (up to Month 4)|Other|0
6052861|NCT00561080|20917945|P3|Vaccination Period (up to Month 4)|Lost to Follow-up|0
6052862|NCT00561080|20917946|P2|Vaccination Period (up to Month 4)|Lost to Follow-up|1
6052863|NCT00561080|20917947|P1|Vaccination Period (up to Month 4)|Lost to Follow-up|0
6052864|NCT00561080|20917945|P3|Vaccination Period (up to Month 4)|Withdrawal by Subject|13
6052865|NCT00561080|20917946|P2|Vaccination Period (up to Month 4)|Withdrawal by Subject|16
6052866|NCT00561080|20917947|P1|Vaccination Period (up to Month 4)|Withdrawal by Subject|3
6052867|NCT00561080|20917945|P3|Vaccination Period (up to Month 4)|Protocol Violation|3
6052868|NCT00561080|20917946|P2|Vaccination Period (up to Month 4)|Protocol Violation|1
6052869|NCT00561080|20917947|P1|Vaccination Period (up to Month 4)|Protocol Violation|0
6052870|NCT00561080|20917945|P3|Vaccination Period (up to Month 4)|Definitive Contra-indication|3
6052871|NCT00561080|20917946|P2|Vaccination Period (up to Month 4)|Definitive Contra-indication|2
6052872|NCT00561080|20917947|P1|Vaccination Period (up to Month 4)|Definitive Contra-indication|0
6052873|NCT00561080|20917945|P3|Vaccination Period (up to Month 4)|Adverse Event|6
6052874|NCT00561080|20917946|P2|Vaccination Period (up to Month 4)|Adverse Event|4
6052875|NCT00561080|20917947|P1|Vaccination Period (up to Month 4)|Adverse Event|0
6052876|NCT00561015|20918024|P6|Overall Study|Participant non-compliance|0
6052877|NCT00561015|20918025|P5|Overall Study|Participant non-compliance|0
6052878|NCT00561015|20918026|P4|Overall Study|Participant non-compliance|0
6052879|NCT00561015|20918027|P3|Overall Study|Participant non-compliance|0
6052880|NCT00561015|20918028|P2|Overall Study|Participant non-compliance|0
6052881|NCT00561015|20918029|P1|Overall Study|Participant non-compliance|2
6052882|NCT00561015|20918024|P6|Overall Study|Lost to Follow-up|3
6052883|NCT00561015|20918025|P5|Overall Study|Lost to Follow-up|0
6052884|NCT00561015|20918026|P4|Overall Study|Lost to Follow-up|1
6052885|NCT00561015|20918027|P3|Overall Study|Lost to Follow-up|0
6052886|NCT00561015|20918028|P2|Overall Study|Lost to Follow-up|0
6052887|NCT00561015|20918029|P1|Overall Study|Lost to Follow-up|2
6052888|NCT00561015|20918024|P6|Overall Study|Adverse Event|0
6052889|NCT00561015|20918025|P5|Overall Study|Adverse Event|1
6052890|NCT00561015|20918026|P4|Overall Study|Adverse Event|0
6052891|NCT00561015|20918027|P3|Overall Study|Adverse Event|0
6052892|NCT00561015|20918028|P2|Overall Study|Adverse Event|0
6052893|NCT00561015|20918029|P1|Overall Study|Adverse Event|0
6052894|NCT00560950|20918120|P2|Overall Study|Lost to Follow-up|0
6052895|NCT00560950|20918121|P1|Overall Study|Lost to Follow-up|1
6052896|NCT00560937|20918159|P2|Overall Study|Physician Decision|1
6052897|NCT00560937|20918160|P1|Overall Study|Physician Decision|1
6052898|NCT00560937|20918159|P2|Overall Study|Withdrawal by Subject|1
6052899|NCT00560937|20918160|P1|Overall Study|Withdrawal by Subject|0
6052900|NCT00560885|20918176|P1|Overall Study|Withdrawal by Subject|1
6052901|NCT00560885|20918176|P1|Overall Study|Death|7
6052902|NCT00560833|20918201|P5|Overall Study|Never received drug|1
6052903|NCT00560833|20918202|P4|Overall Study|Never received drug|0
6052904|NCT00560833|20918203|P3|Overall Study|Never received drug|0
6052905|NCT00560833|20918204|P2|Overall Study|Never received drug|1
6052906|NCT00560833|20918205|P1|Overall Study|Never received drug|0
6052907|NCT00560833|20918201|P5|Overall Study|Other|0
6052908|NCT00560833|20918202|P4|Overall Study|Other|0
6052909|NCT00560833|20918203|P3|Overall Study|Other|3
6052910|NCT00560833|20918204|P2|Overall Study|Other|1
6052911|NCT00560833|20918205|P1|Overall Study|Other|1
6052912|NCT00560833|20918201|P5|Overall Study|Participant uncooperative|2
6052913|NCT00560833|20918202|P4|Overall Study|Participant uncooperative|4
6052914|NCT00560833|20918203|P3|Overall Study|Participant uncooperative|4
6052915|NCT00560833|20918204|P2|Overall Study|Participant uncooperative|5
6052916|NCT00560833|20918205|P1|Overall Study|Participant uncooperative|5
6052917|NCT00560833|20918201|P5|Overall Study|Lack of Efficacy|4
6052918|NCT00560833|20918202|P4|Overall Study|Lack of Efficacy|4
6052919|NCT00560833|20918203|P3|Overall Study|Lack of Efficacy|6
6052920|NCT00560833|20918204|P2|Overall Study|Lack of Efficacy|9
6052921|NCT00560833|20918205|P1|Overall Study|Lack of Efficacy|22
6052922|NCT00560833|20918201|P5|Overall Study|Lost to Follow-up|0
6052923|NCT00560833|20918202|P4|Overall Study|Lost to Follow-up|0
6052924|NCT00560833|20918203|P3|Overall Study|Lost to Follow-up|1
6052925|NCT00560833|20918204|P2|Overall Study|Lost to Follow-up|0
6052926|NCT00560833|20918205|P1|Overall Study|Lost to Follow-up|0
6052927|NCT00560833|20918201|P5|Overall Study|Adverse Event|35
6052928|NCT00560833|20918202|P4|Overall Study|Adverse Event|23
6052929|NCT00560833|20918203|P3|Overall Study|Adverse Event|25
6052930|NCT00560833|20918204|P2|Overall Study|Adverse Event|10
6052931|NCT00560833|20918205|P1|Overall Study|Adverse Event|16
6052932|NCT00560794|20918237|P1|Overall Study|Received Bone Marrow Transplant|6
6052933|NCT00560794|20918237|P1|Overall Study|Hematological Relapse|1
6052934|NCT00560794|20918237|P1|Overall Study|Minimal Residual Disease Relapse|1
6052935|NCT00560794|20918237|P1|Overall Study|Patient was not Compliant|1
6052936|NCT00560794|20918237|P1|Overall Study|Adverse Event|2
6052937|NCT00560755|20918254|P1|Overall Study|Physician Decision|2
6052938|NCT00560755|20918254|P1|Overall Study|Adverse Event|8
6052939|NCT00560755|20918254|P1|Overall Study|Lost to Follow-up|9
6052940|NCT00560755|20918254|P1|Overall Study|Withdrawal by Subject|26
6052941|NCT00560755|20918254|P1|Overall Study|Protocol Violation|15
6052950|NCT00560573|20918299|P6|Overall Study|Enrolled, not treated|0
6052951|NCT00560573|20918300|P5|Overall Study|Enrolled, not treated|1
6052952|NCT00560573|20918301|P4|Overall Study|Enrolled, not treated|0
6052953|NCT00560573|20918302|P3|Overall Study|Enrolled, not treated|0
6052954|NCT00560573|20918303|P2|Overall Study|Enrolled, not treated|0
6052955|NCT00560573|20918304|P1|Overall Study|Enrolled, not treated|0
6052956|NCT00560573|20918299|P6|Overall Study|Other|3
6052957|NCT00560573|20918300|P5|Overall Study|Other|3
6052958|NCT00560573|20918301|P4|Overall Study|Other|3
6052959|NCT00560573|20918302|P3|Overall Study|Other|2
6052960|NCT00560573|20918303|P2|Overall Study|Other|2
6052961|NCT00560573|20918304|P1|Overall Study|Other|2
6052962|NCT00560573|20918299|P6|Overall Study|Withdrawal by Subject|0
6052963|NCT00560573|20918300|P5|Overall Study|Withdrawal by Subject|1
6052964|NCT00560573|20918301|P4|Overall Study|Withdrawal by Subject|1
6052965|NCT00560573|20918302|P3|Overall Study|Withdrawal by Subject|0
6052966|NCT00560573|20918303|P2|Overall Study|Withdrawal by Subject|0
6052967|NCT00560573|20918304|P1|Overall Study|Withdrawal by Subject|0
6052968|NCT00560573|20918299|P6|Overall Study|Lost to Follow-up|0
6052969|NCT00560573|20918300|P5|Overall Study|Lost to Follow-up|1
6052970|NCT00560573|20918301|P4|Overall Study|Lost to Follow-up|1
6052971|NCT00560573|20918302|P3|Overall Study|Lost to Follow-up|0
6052972|NCT00560573|20918303|P2|Overall Study|Lost to Follow-up|0
6052973|NCT00560573|20918304|P1|Overall Study|Lost to Follow-up|0
6052974|NCT00560573|20918299|P6|Overall Study|Death|10
6052975|NCT00560573|20918300|P5|Overall Study|Death|1
6052976|NCT00560573|20918301|P4|Overall Study|Death|5
6052977|NCT00560573|20918302|P3|Overall Study|Death|4
6052978|NCT00560573|20918303|P2|Overall Study|Death|1
6052979|NCT00560573|20918304|P1|Overall Study|Death|4
6052980|NCT00560508|20918381|P2|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1
6052981|NCT00560508|20918382|P1|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1
6052982|NCT00560508|20918381|P2|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|3
6052983|NCT00560508|20918382|P1|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|0
6052984|NCT00560508|20918381|P2|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1
6052985|NCT00560508|20918382|P1|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1
6052986|NCT00560508|20918381|P2|52-week Open-label Period Pramipexole ER|Adverse Event|6
6052987|NCT00560508|20918382|P1|52-week Open-label Period Pramipexole ER|Adverse Event|6
6052988|NCT00560508|20918381|P2|12 Week Double-blind Period|Withdrawal by Subject|1
6052989|NCT00560508|20918382|P1|12 Week Double-blind Period|Withdrawal by Subject|1
6052990|NCT00560508|20918381|P2|12 Week Double-blind Period|Protocol Violation|0
6052991|NCT00560508|20918382|P1|12 Week Double-blind Period|Protocol Violation|1
6052992|NCT00560508|20918381|P2|12 Week Double-blind Period|Adverse Event|2
6052993|NCT00560508|20918382|P1|12 Week Double-blind Period|Adverse Event|3
6052994|NCT00560417|20918441|P2|Overall Study|Withdrawal by Subject|3
6052995|NCT00560417|20918442|P1|Overall Study|Withdrawal by Subject|3
6052996|NCT00560417|20918441|P2|Overall Study|Sponsor Decision|0
6052997|NCT00560417|20918442|P1|Overall Study|Sponsor Decision|2
6052998|NCT00560417|20918441|P2|Overall Study|Protocol Violation|5
6052999|NCT00560417|20918442|P1|Overall Study|Protocol Violation|6
6053000|NCT00560417|20918441|P2|Overall Study|Physician Decision|6
6053001|NCT00560417|20918442|P1|Overall Study|Physician Decision|2
6053002|NCT00560417|20918441|P2|Overall Study|Lost to Follow-up|1
6053003|NCT00560417|20918442|P1|Overall Study|Lost to Follow-up|0
6053004|NCT00560417|20918441|P2|Overall Study|Entry Criteria Not Met|0
6053005|NCT00560417|20918442|P1|Overall Study|Entry Criteria Not Met|1
6053006|NCT00560417|20918441|P2|Overall Study|Adverse Event|2
6053007|NCT00560417|20918442|P1|Overall Study|Adverse Event|3
6053008|NCT00560404|20918470|P2|Overall Study|Other withdrawal reason|5
6053009|NCT00560404|20918471|P1|Overall Study|Other withdrawal reason|13
6053010|NCT00560404|20918470|P2|Overall Study|Failure to return|2
6053011|NCT00560404|20918471|P1|Overall Study|Failure to return|1
6053012|NCT00560404|20918470|P2|Overall Study|Withdrew Consent|0
6053013|NCT00560404|20918471|P1|Overall Study|Withdrew Consent|4
6053014|NCT00560404|20918470|P2|Overall Study|Administrative Reasons|1
6053015|NCT00560404|20918471|P1|Overall Study|Administrative Reasons|1
6053016|NCT00560404|20918470|P2|Overall Study|Protocol Violation|7
6053017|NCT00560404|20918471|P1|Overall Study|Protocol Violation|12
6053018|NCT00560404|20918470|P2|Overall Study|Death|3
6053019|NCT00560404|20918471|P1|Overall Study|Death|3
6053020|NCT00560404|20918470|P2|Overall Study|Adverse Event|3
6053021|NCT00560404|20918471|P1|Overall Study|Adverse Event|2
6053022|NCT00560391|20918518|P5|Overall Study|Still on treatment|2
6053023|NCT00560391|20918519|P4|Overall Study|Still on treatment|1
6053024|NCT00560391|20918520|P3|Overall Study|Still on treatment|0
6053025|NCT00560391|20918521|P2|Overall Study|Still on treatment|0
6053026|NCT00560391|20918522|P1|Overall Study|Still on treatment|0
6053027|NCT00560352|20918578|P3|Overall Study|Maximum clinical benefit|0
6053028|NCT00560352|20918579|P2|Overall Study|Maximum clinical benefit|0
6053029|NCT00560352|20918580|P1|Overall Study|Maximum clinical benefit|1
6053030|NCT00560352|20918578|P3|Overall Study|Withdrawal by Subject|1
6053031|NCT00560352|20918579|P2|Overall Study|Withdrawal by Subject|1
6053032|NCT00560352|20918580|P1|Overall Study|Withdrawal by Subject|1
6053033|NCT00560352|20918578|P3|Overall Study|Disease progression|1
6053034|NCT00560352|20918579|P2|Overall Study|Disease progression|1
6053035|NCT00560352|20918580|P1|Overall Study|Disease progression|0
6053036|NCT00560352|20918578|P3|Overall Study|Study drug toxicity|1
6053037|NCT00560352|20918579|P2|Overall Study|Study drug toxicity|0
6053038|NCT00560352|20918580|P1|Overall Study|Study drug toxicity|3
6053039|NCT00560352|20918578|P3|Overall Study|Adverse event unrelated to study drug|1
6053040|NCT00560352|20918579|P2|Overall Study|Adverse event unrelated to study drug|1
6053041|NCT00560352|20918580|P1|Overall Study|Adverse event unrelated to study drug|2
6053042|NCT00560313|20918597|P1|Overall Study|Protocol Violation|1
6053043|NCT00560313|20918597|P1|Overall Study|Lost to Follow-up|1
6053044|NCT00560313|20918597|P1|Overall Study|Withdrawal by Subject|2
6053045|NCT00560313|20918597|P1|Overall Study|Adverse Events or Death|2
6053046|NCT00560235|20918624|P3|Phase 2|Ongoing at Date of Cut-Off|1
6053047|NCT00560235|20918625|P2|Phase 2|Ongoing at Date of Cut-Off|0
6053048|NCT00560235|20918626|P1|Phase 2|Ongoing at Date of Cut-Off|0
6053049|NCT00560235|20918624|P3|Phase 2|Discontinued|96
6053050|NCT00560235|20918625|P2|Phase 2|Discontinued|0
6053051|NCT00560235|20918626|P1|Phase 2|Discontinued|0
6053052|NCT00560235|20918624|P3|Phase 1B|Discontinued|0
6053053|NCT00560235|20918625|P2|Phase 1B|Discontinued|19
6053054|NCT00560235|20918626|P1|Phase 1B|Discontinued|0
6053055|NCT00560235|20918624|P3|Phase 1|Discontinued|0
6053056|NCT00560235|20918625|P2|Phase 1|Discontinued|0
6053057|NCT00560235|20918626|P1|Phase 1|Discontinued|8
6053058|NCT00560105|20918657|P2|Overall Study|musculoskeletal chest discomfort with us|2
6053059|NCT00560105|20918658|P1|Overall Study|musculoskeletal chest discomfort with us|1
6053060|NCT00560066|20918672|P2|Overall Study|Missing primary reason|2
6053061|NCT00560066|20918673|P1|Overall Study|Missing primary reason|0
6053062|NCT00560066|20918672|P2|Overall Study|Administrative reason|5
6053063|NCT00560066|20918673|P1|Overall Study|Administrative reason|0
6053064|NCT00560066|20918672|P2|Overall Study|Protocol Violation|1
6053065|NCT00560066|20918673|P1|Overall Study|Protocol Violation|0
6053066|NCT00560066|20918672|P2|Overall Study|Lost to Follow-up|10
6053067|NCT00560066|20918673|P1|Overall Study|Lost to Follow-up|4
6053068|NCT00560066|20918672|P2|Overall Study|Withdrawal by Subject|3
6053069|NCT00560066|20918673|P1|Overall Study|Withdrawal by Subject|0
6053070|NCT00560066|20918672|P2|Overall Study|Death|1
6053071|NCT00560066|20918673|P1|Overall Study|Death|2
6053072|NCT00559988|20918705|P2|Overall Study|ICD device explanted|17
6053073|NCT00559988|20918706|P1|Overall Study|ICD device explanted|10
6053074|NCT00559988|20918705|P2|Overall Study|Lost to Follow-up|56
6053075|NCT00559988|20918706|P1|Overall Study|Lost to Follow-up|42
6053076|NCT00559988|20918705|P2|Overall Study|Withdrawal by Subject|139
6053077|NCT00559988|20918706|P1|Overall Study|Withdrawal by Subject|152
6053078|NCT00559988|20918705|P2|Overall Study|Death|140
6053079|NCT00559988|20918706|P1|Overall Study|Death|147
6053080|NCT00559962|20918736|P8|Overall Study|Inclusion/exclusion criteria not met|0
6053081|NCT00559962|20918737|P7|Overall Study|Inclusion/exclusion criteria not met|1
6053082|NCT00559962|20918738|P6|Overall Study|Inclusion/exclusion criteria not met|0
6053083|NCT00559962|20918739|P5|Overall Study|Inclusion/exclusion criteria not met|0
6053084|NCT00559962|20918740|P4|Overall Study|Inclusion/exclusion criteria not met|0
6053085|NCT00559962|20918741|P3|Overall Study|Inclusion/exclusion criteria not met|0
6053086|NCT00559962|20918742|P2|Overall Study|Inclusion/exclusion criteria not met|0
6053087|NCT00559962|20918743|P1|Overall Study|Inclusion/exclusion criteria not met|0
6053088|NCT00559962|20918736|P8|Overall Study|Withdrawal by Subject|2
6053089|NCT00559962|20918737|P7|Overall Study|Withdrawal by Subject|0
6053090|NCT00559962|20918738|P6|Overall Study|Withdrawal by Subject|1
6053091|NCT00559962|20918739|P5|Overall Study|Withdrawal by Subject|3
6053092|NCT00559962|20918740|P4|Overall Study|Withdrawal by Subject|0
6053093|NCT00559962|20918741|P3|Overall Study|Withdrawal by Subject|2
6053094|NCT00559962|20918742|P2|Overall Study|Withdrawal by Subject|1
6053095|NCT00559962|20918743|P1|Overall Study|Withdrawal by Subject|1
6053096|NCT00559962|20918736|P8|Overall Study|Lost to Follow-up|0
6053097|NCT00559962|20918737|P7|Overall Study|Lost to Follow-up|0
6053098|NCT00559962|20918738|P6|Overall Study|Lost to Follow-up|0
6053099|NCT00559962|20918739|P5|Overall Study|Lost to Follow-up|0
6053100|NCT00559962|20918740|P4|Overall Study|Lost to Follow-up|0
6053101|NCT00559962|20918741|P3|Overall Study|Lost to Follow-up|0
6053102|NCT00559962|20918742|P2|Overall Study|Lost to Follow-up|1
6053103|NCT00559962|20918743|P1|Overall Study|Lost to Follow-up|0
6053104|NCT00559962|20918736|P8|Overall Study|Adverse Event|2
6053105|NCT00559962|20918737|P7|Overall Study|Adverse Event|4
6053106|NCT00559962|20918738|P6|Overall Study|Adverse Event|4
6053107|NCT00559962|20918739|P5|Overall Study|Adverse Event|11
6053108|NCT00559962|20918740|P4|Overall Study|Adverse Event|5
6053109|NCT00559962|20918741|P3|Overall Study|Adverse Event|8
6053110|NCT00559962|20918742|P2|Overall Study|Adverse Event|7
6053111|NCT00559962|20918743|P1|Overall Study|Adverse Event|1
6053112|NCT00559949|20918763|P1|Overall Study|No disease evaluation per protocol|1
6053113|NCT00559949|20918763|P1|Overall Study|Withdrawal by Subject|4
6053114|NCT00559949|20918763|P1|Overall Study|Adverse Event|1
6053115|NCT00559949|20918763|P1|Overall Study|Progressive Disease during cycle 1|1
6053116|NCT00559845|20918779|P1|Overall Study|Premature Surgery-Investigator Decision|1
6053117|NCT00559845|20918779|P1|Overall Study|Did Not Attend Cycle 6 Hospital Visit|1
6053118|NCT00559845|20918779|P1|Overall Study|Adverse Event|3
6053119|NCT00559845|20918779|P1|Overall Study|Disease Progression|1
6053120|NCT00559845|20918779|P1|Overall Study|Withdrew Consent|1
6053121|NCT00559754|20918788|P1|Overall Study|Withdrawal by Subject|2
6053122|NCT00559754|20918788|P1|Overall Study|Investigator criteria|2
6053123|NCT00559754|20918788|P1|Overall Study|Protocol Violation|1
6053124|NCT00559754|20918788|P1|Overall Study|Adverse Event|5
6053125|NCT00559754|20918788|P1|Overall Study|Disease progression|1
6053126|NCT00559637|20918812|P1|Overall Study|Inclusion or exclusion criteria violated|2
6053127|NCT00559637|20918812|P1|Overall Study|Change of home|1
6053128|NCT00559637|20918812|P1|Overall Study|Change of center|1
6053129|NCT00559637|20918812|P1|Overall Study|Delayed administration of C.E.R.A|1
6053130|NCT00559637|20918812|P1|Overall Study|Participation in another study|1
6053131|NCT00559637|20918812|P1|Overall Study|Suspected lung cancer|1
6053132|NCT00559637|20918812|P1|Overall Study|Started requiring dialysis after month 7|2
6053133|NCT00559637|20918812|P1|Overall Study|Insufficient response|3
6053134|NCT00559637|20918812|P1|Overall Study|Failure to return|6
6053135|NCT00559637|20918812|P1|Overall Study|Withdrawal criteria fulfilled|4
6053136|NCT00559637|20918812|P1|Overall Study|Protocol Violation|6
6053137|NCT00559637|20918812|P1|Overall Study|Withdrawal by Subject|4
6053138|NCT00559637|20918812|P1|Overall Study|Adverse Event|22
6053139|NCT00559585|20918825|P2|Open Label LT Period Main + Sub-Study|no end of study status page|0
6053140|NCT00559585|20918826|P1|Open Label LT Period Main + Sub-Study|no end of study status page|1
6053141|NCT00559585|20918825|P2|Open Label LT Period Main + Sub-Study|non-specified|0
6053142|NCT00559585|20918826|P1|Open Label LT Period Main + Sub-Study|non-specified|71
6053143|NCT00559585|20918825|P2|Open Label LT Period Main + Sub-Study|Poor/non-compliance|0
6053144|NCT00559585|20918826|P1|Open Label LT Period Main + Sub-Study|Poor/non-compliance|8
6053145|NCT00559585|20918825|P2|Open Label LT Period Main + Sub-Study|Lack of Efficacy|0
6053146|NCT00559585|20918826|P1|Open Label LT Period Main + Sub-Study|Lack of Efficacy|89
6053147|NCT00559585|20918825|P2|Open Label LT Period Main + Sub-Study|No longer met criteria|0
6053148|NCT00559585|20918826|P1|Open Label LT Period Main + Sub-Study|No longer met criteria|1
6053149|NCT00559585|20918825|P2|Open Label LT Period Main + Sub-Study|Death|0
6053150|NCT00559585|20918826|P1|Open Label LT Period Main + Sub-Study|Death|20
6053151|NCT00559585|20918825|P2|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|0
6053152|NCT00559585|20918826|P1|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|9
6053153|NCT00559585|20918825|P2|Open Label LT Period Main + Sub-Study|Lost to Follow-up|0
6053154|NCT00559585|20918826|P1|Open Label LT Period Main + Sub-Study|Lost to Follow-up|32
6053155|NCT00559585|20918825|P2|Open Label LT Period Main + Sub-Study|Pregnancy|0
6053156|NCT00559585|20918826|P1|Open Label LT Period Main + Sub-Study|Pregnancy|16
6053157|NCT00559585|20918825|P2|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|0
6053158|NCT00559585|20918826|P1|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|81
6053159|NCT00559585|20918825|P2|Open Label LT Period Main + Sub-Study|Adverse Event|0
6053160|NCT00559585|20918826|P1|Open Label LT Period Main + Sub-Study|Adverse Event|100
6053161|NCT00559585|20918825|P2|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1
6053162|NCT00559585|20918826|P1|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1
6053163|NCT00559585|20918825|P2|Double Blind ST Period Main Study|Ongoing Infection Risk|0
6053164|NCT00559585|20918826|P1|Double Blind ST Period Main Study|Ongoing Infection Risk|1
6053165|NCT00559585|20918825|P2|Double Blind ST Period Main Study|Investigator Decision|1
6053166|NCT00559585|20918826|P1|Double Blind ST Period Main Study|Investigator Decision|0
6053167|NCT00559585|20918825|P2|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|1
6053168|NCT00559585|20918826|P1|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|0
6053169|NCT00559585|20918825|P2|Double Blind ST Period Main Study|Participant Weight Gain|0
6053170|NCT00559585|20918826|P1|Double Blind ST Period Main Study|Participant Weight Gain|1
6053171|NCT00559585|20918825|P2|Double Blind ST Period Main Study|Early Discontinuation|1
6053172|NCT00559585|20918826|P1|Double Blind ST Period Main Study|Early Discontinuation|0
6053173|NCT00559585|20918825|P2|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|1
6053174|NCT00559585|20918826|P1|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|0
6053175|NCT00559585|20918825|P2|Double Blind ST Period Main Study|Incomplete Breast Exam|1
6053176|NCT00559585|20918826|P1|Double Blind ST Period Main Study|Incomplete Breast Exam|0
6053177|NCT00559585|20918825|P2|Double Blind ST Period Main Study|Missed Doses|1
6053178|NCT00559585|20918826|P1|Double Blind ST Period Main Study|Missed Doses|0
6053179|NCT00559585|20918825|P2|Double Blind ST Period Main Study|Poor/Non-Compliance|0
6053180|NCT00559585|20918826|P1|Double Blind ST Period Main Study|Poor/Non-Compliance|3
6053181|NCT00559585|20918825|P2|Double Blind ST Period Main Study|Lack of Efficacy|1
6053182|NCT00559585|20918826|P1|Double Blind ST Period Main Study|Lack of Efficacy|6
6053183|NCT00559585|20918825|P2|Double Blind ST Period Main Study|No Longer Meets Study Criteria|1
6053184|NCT00559585|20918826|P1|Double Blind ST Period Main Study|No Longer Meets Study Criteria|2
6053185|NCT00559585|20918825|P2|Double Blind ST Period Main Study|Death|1
6053186|NCT00559585|20918826|P1|Double Blind ST Period Main Study|Death|1
6053187|NCT00559585|20918825|P2|Double Blind ST Period Main Study|Administrative Reason By Sponsor|0
6053188|NCT00559585|20918826|P1|Double Blind ST Period Main Study|Administrative Reason By Sponsor|1
6053189|NCT00559585|20918825|P2|Double Blind ST Period Main Study|Lost to Follow-up|6
6053190|NCT00559585|20918826|P1|Double Blind ST Period Main Study|Lost to Follow-up|0
6053191|NCT00559585|20918825|P2|Double Blind ST Period Main Study|Withdrawal by Subject|5
6053192|NCT00559585|20918826|P1|Double Blind ST Period Main Study|Withdrawal by Subject|11
6053193|NCT00559585|20918825|P2|Double Blind ST Period Main Study|Adverse Event|25
6053194|NCT00559585|20918826|P1|Double Blind ST Period Main Study|Adverse Event|17
6053195|NCT00559507|20918886|P1|Overall Study|Not treated, patient ineligible|3
6053196|NCT00559377|20918905|P1|Overall Study|Withdrawal by Subject|9
6053197|NCT00559364|20918915|P2|Overall Study|Inclusion/exclusion criteria failure|0
6053198|NCT00559364|20918916|P1|Overall Study|Inclusion/exclusion criteria failure|1
6053199|NCT00559273|20918928|P2|Evaluation Period (8 Weeks)|Physician Decision|1
6053200|NCT00559273|20918929|P1|Evaluation Period (8 Weeks)|Physician Decision|0
6053201|NCT00559273|20918928|P2|Evaluation Period (8 Weeks)|Withdrawal by Subject|0
6053202|NCT00559273|20918929|P1|Evaluation Period (8 Weeks)|Withdrawal by Subject|2
6053203|NCT00559273|20918928|P2|Evaluation Period (8 Weeks)|Adverse Event|1
6053204|NCT00559273|20918929|P1|Evaluation Period (8 Weeks)|Adverse Event|0
6053205|NCT00559273|20918928|P2|Evaluation Period (8 Weeks)|Death|3
6053206|NCT00559273|20918929|P1|Evaluation Period (8 Weeks)|Death|1
6053207|NCT00559273|20918928|P2|Correction Period (20 Weeks)|Did not received study treatment|0
6053208|NCT00559273|20918929|P1|Correction Period (20 Weeks)|Did not received study treatment|2
6053209|NCT00559273|20918928|P2|Correction Period (20 Weeks)|Participant treated by another center|1
6053210|NCT00559273|20918929|P1|Correction Period (20 Weeks)|Participant treated by another center|0
6053211|NCT00559273|20918928|P2|Correction Period (20 Weeks)|Withdrawal by Subject|6
6053212|NCT00559273|20918929|P1|Correction Period (20 Weeks)|Withdrawal by Subject|2
6053213|NCT00559273|20918928|P2|Correction Period (20 Weeks)|Adverse Event|1
6053214|NCT00559273|20918929|P1|Correction Period (20 Weeks)|Adverse Event|2
6053215|NCT00559273|20918928|P2|Correction Period (20 Weeks)|Death|4
6053216|NCT00559273|20918929|P1|Correction Period (20 Weeks)|Death|3
6053217|NCT00559104|20918951|P2|Overall Study|Lack of Efficacy|0
6053218|NCT00559104|20918952|P1|Overall Study|Lack of Efficacy|9
6053219|NCT00558896|20918973|P7|Overall Study|Continues on treatment|6
6053220|NCT00558896|20918974|P6|Overall Study|Continues on treatment|25
6053221|NCT00558896|20918975|P5|Overall Study|Continues on treatment|9
6053222|NCT00558896|20918976|P4|Overall Study|Continues on treatment|1
6053223|NCT00558896|20918977|P3|Overall Study|Continues on treatment|0
6053224|NCT00558896|20918978|P2|Overall Study|Continues on treatment|1
6053225|NCT00558896|20918979|P1|Overall Study|Continues on treatment|10
6053226|NCT00558896|20918973|P7|Overall Study|Physician discretion|3
6053227|NCT00558896|20918974|P6|Overall Study|Physician discretion|3
6053228|NCT00558896|20918975|P5|Overall Study|Physician discretion|1
6053229|NCT00558896|20918976|P4|Overall Study|Physician discretion|2
6053230|NCT00558896|20918977|P3|Overall Study|Physician discretion|1
6053231|NCT00558896|20918978|P2|Overall Study|Physician discretion|2
6053232|NCT00558896|20918979|P1|Overall Study|Physician discretion|3
6053233|NCT00558896|20918973|P7|Overall Study|Alternative Treatment|1
6053234|NCT00558896|20918974|P6|Overall Study|Alternative Treatment|7
6053235|NCT00558896|20918975|P5|Overall Study|Alternative Treatment|6
6053236|NCT00558896|20918976|P4|Overall Study|Alternative Treatment|2
6053237|NCT00558896|20918977|P3|Overall Study|Alternative Treatment|0
6053238|NCT00558896|20918978|P2|Overall Study|Alternative Treatment|2
6053239|NCT00558896|20918979|P1|Overall Study|Alternative Treatment|2
6053240|NCT00558896|20918973|P7|Overall Study|Withdrawal by Subject|5
6053241|NCT00558896|20918974|P6|Overall Study|Withdrawal by Subject|5
6053242|NCT00558896|20918975|P5|Overall Study|Withdrawal by Subject|1
6053243|NCT00558896|20918976|P4|Overall Study|Withdrawal by Subject|1
6053244|NCT00558896|20918977|P3|Overall Study|Withdrawal by Subject|1
6053245|NCT00558896|20918978|P2|Overall Study|Withdrawal by Subject|1
6053246|NCT00558896|20918979|P1|Overall Study|Withdrawal by Subject|2
6053247|NCT00558896|20918973|P7|Overall Study|Death|6
6053248|NCT00558896|20918974|P6|Overall Study|Death|2
6053249|NCT00558896|20918975|P5|Overall Study|Death|2
6053250|NCT00558896|20918976|P4|Overall Study|Death|3
6053251|NCT00558896|20918977|P3|Overall Study|Death|2
6053252|NCT00558896|20918978|P2|Overall Study|Death|0
6053253|NCT00558896|20918979|P1|Overall Study|Death|3
6053254|NCT00558896|20918973|P7|Overall Study|Adverse Event|3
6053255|NCT00558896|20918974|P6|Overall Study|Adverse Event|10
6053256|NCT00558896|20918975|P5|Overall Study|Adverse Event|4
6053257|NCT00558896|20918976|P4|Overall Study|Adverse Event|3
6053258|NCT00558896|20918977|P3|Overall Study|Adverse Event|1
6053259|NCT00558896|20918978|P2|Overall Study|Adverse Event|1
6053260|NCT00558896|20918979|P1|Overall Study|Adverse Event|1
6053261|NCT00558831|20919081|P1|Overall Study|Lost to Follow-up|1
6053262|NCT00558753|20919138|P2|Overall Study|Lost to Follow-up|7
6053263|NCT00558753|20919139|P1|Overall Study|Lost to Follow-up|5
6053264|NCT00558701|20919151|P2|Overall Study|Protocol Deviations|4
6053265|NCT00558701|20919152|P1|Overall Study|Protocol Deviations|1
6053266|NCT00558636|20919160|P2|Follow-up|Premature termination of the study|7
6053267|NCT00558636|20919161|P1|Follow-up|Premature termination of the study|12
6053268|NCT00558636|20919160|P2|Treatment|Disease progression|5
6053269|NCT00558636|20919161|P1|Treatment|Disease progression|1
6053270|NCT00558636|20919160|P2|Treatment|Premature termination of the study|37
6053271|NCT00558636|20919161|P1|Treatment|Premature termination of the study|35
6053272|NCT00558636|20919160|P2|Treatment|Withdrawal by Subject|0
6053273|NCT00558636|20919161|P1|Treatment|Withdrawal by Subject|2
6053274|NCT00558636|20919160|P2|Treatment|Adverse Event|2
6053275|NCT00558636|20919161|P1|Treatment|Adverse Event|9
6053276|NCT00558558|20919261|P1|Overall Study|Lack of Efficacy|4
6053277|NCT00558558|20919261|P1|Overall Study|Withdrawal by Subject|1
6053278|NCT00558558|20919261|P1|Overall Study|Unable to swallow|1
6053279|NCT00558519|20919265|P1|Overall Study|Never received treatment|1
6053280|NCT00558519|20919265|P1|Overall Study|Insufficient data|1
6053281|NCT00558519|20919265|P1|Overall Study|Ineligible|1
6053282|NCT00558519|20919265|P1|Overall Study|Ph+|20
6053283|NCT00558467|20919275|P2|Overall Study|Patient moving out of state|1
6053284|NCT00558467|20919276|P1|Overall Study|Patient moving out of state|0
6053285|NCT00558467|20919275|P2|Overall Study|Lack of Efficacy|1
6053286|NCT00558467|20919276|P1|Overall Study|Lack of Efficacy|0
6053287|NCT00558467|20919275|P2|Overall Study|Adverse Event|2
6053288|NCT00558467|20919276|P1|Overall Study|Adverse Event|1
6053289|NCT00558428|20919336|P4|Overall Study|Other|1
6053290|NCT00558428|20919337|P3|Overall Study|Other|0
6053291|NCT00558428|20919338|P2|Overall Study|Other|0
6053292|NCT00558428|20919339|P1|Overall Study|Other|3
6053293|NCT00558428|20919336|P4|Overall Study|Consent withdrawn|1
6053294|NCT00558428|20919337|P3|Overall Study|Consent withdrawn|0
6053295|NCT00558428|20919338|P2|Overall Study|Consent withdrawn|1
6053296|NCT00558428|20919339|P1|Overall Study|Consent withdrawn|2
6053297|NCT00558428|20919336|P4|Overall Study|Non compliant with protocol|3
6053298|NCT00558428|20919337|P3|Overall Study|Non compliant with protocol|0
6053299|NCT00558428|20919338|P2|Overall Study|Non compliant with protocol|0
6053300|NCT00558428|20919339|P1|Overall Study|Non compliant with protocol|1
6053301|NCT00558428|20919336|P4|Overall Study|Lack of Efficacy|2
6053302|NCT00558428|20919337|P3|Overall Study|Lack of Efficacy|1
6053303|NCT00558428|20919338|P2|Overall Study|Lack of Efficacy|0
6053304|NCT00558428|20919339|P1|Overall Study|Lack of Efficacy|0
6053305|NCT00558428|20919336|P4|Overall Study|Lost to Follow-up|0
6053306|NCT00558428|20919337|P3|Overall Study|Lost to Follow-up|0
6053307|NCT00558428|20919338|P2|Overall Study|Lost to Follow-up|1
6053308|NCT00558428|20919339|P1|Overall Study|Lost to Follow-up|0
6053309|NCT00558428|20919336|P4|Overall Study|Adverse Event|4
6053310|NCT00558428|20919337|P3|Overall Study|Adverse Event|3
6053311|NCT00558428|20919338|P2|Overall Study|Adverse Event|22
6053312|NCT00558428|20919339|P1|Overall Study|Adverse Event|6
6053313|NCT00558363|20919379|P2|Overall Study|Hospitalized; Unable to Continue|1
6053314|NCT00558363|20919380|P1|Overall Study|Hospitalized; Unable to Continue|0
6053315|NCT00558363|20919379|P2|Overall Study|Randomized in Error|2
6053316|NCT00558363|20919380|P1|Overall Study|Randomized in Error|1
6053317|NCT00558363|20919379|P2|Overall Study|Met Protocol-defined Stopping Criteria|16
6053318|NCT00558363|20919380|P1|Overall Study|Met Protocol-defined Stopping Criteria|32
6053319|NCT00558363|20919379|P2|Overall Study|Lost to Follow-up|1
6053320|NCT00558363|20919380|P1|Overall Study|Lost to Follow-up|0
6053321|NCT00558363|20919379|P2|Overall Study|Protocol Violation|1
6053322|NCT00558363|20919380|P1|Overall Study|Protocol Violation|2
6053323|NCT00558363|20919379|P2|Overall Study|Lack of Efficacy|2
6053324|NCT00558363|20919380|P1|Overall Study|Lack of Efficacy|2
6053325|NCT00558363|20919379|P2|Overall Study|Adverse Event|5
6053326|NCT00558363|20919380|P1|Overall Study|Adverse Event|5
6053327|NCT00558363|20919379|P2|Overall Study|Withdrawal by Subject|4
6053328|NCT00558363|20919380|P1|Overall Study|Withdrawal by Subject|11
6053329|NCT00558363|20919379|P2|Overall Study|Physician Decision|4
6053330|NCT00558363|20919380|P1|Overall Study|Physician Decision|18
6053331|NCT00558285|20919435|P5|Overall Study|Protocol deviation|0
6053332|NCT00558285|20919436|P4|Overall Study|Protocol deviation|1
6053333|NCT00558285|20919437|P3|Overall Study|Protocol deviation|0
6053334|NCT00558285|20919438|P2|Overall Study|Protocol deviation|1
6053335|NCT00558285|20919439|P1|Overall Study|Protocol deviation|1
6053336|NCT00558285|20919435|P5|Overall Study|Administrative problems|1
6053337|NCT00558285|20919436|P4|Overall Study|Administrative problems|1
6053338|NCT00558285|20919437|P3|Overall Study|Administrative problems|0
6053339|NCT00558285|20919438|P2|Overall Study|Administrative problems|0
6053340|NCT00558285|20919439|P1|Overall Study|Administrative problems|0
6053341|NCT00558285|20919435|P5|Overall Study|Lost to Follow-up|0
6053342|NCT00558285|20919436|P4|Overall Study|Lost to Follow-up|0
6053343|NCT00558285|20919437|P3|Overall Study|Lost to Follow-up|0
6053344|NCT00558285|20919438|P2|Overall Study|Lost to Follow-up|1
6053345|NCT00558285|20919439|P1|Overall Study|Lost to Follow-up|1
6053346|NCT00558285|20919435|P5|Overall Study|Subject withdrew consent|1
6053347|NCT00558285|20919436|P4|Overall Study|Subject withdrew consent|1
6053348|NCT00558285|20919437|P3|Overall Study|Subject withdrew consent|1
6053349|NCT00558285|20919438|P2|Overall Study|Subject withdrew consent|0
6053350|NCT00558285|20919439|P1|Overall Study|Subject withdrew consent|2
6053351|NCT00558285|20919435|P5|Overall Study|Abnormal test procedure result(s)|0
6053352|NCT00558285|20919436|P4|Overall Study|Abnormal test procedure result(s)|0
6053353|NCT00558285|20919437|P3|Overall Study|Abnormal test procedure result(s)|0
6053354|NCT00558285|20919438|P2|Overall Study|Abnormal test procedure result(s)|0
6053355|NCT00558285|20919439|P1|Overall Study|Abnormal test procedure result(s)|1
6053356|NCT00558285|20919435|P5|Overall Study|Adverse Event|2
6053357|NCT00558285|20919436|P4|Overall Study|Adverse Event|1
6053358|NCT00558285|20919437|P3|Overall Study|Adverse Event|4
6053359|NCT00558285|20919438|P2|Overall Study|Adverse Event|1
6053360|NCT00558285|20919439|P1|Overall Study|Adverse Event|1
6053361|NCT00558272|20919483|P2|Overall Study|Withdrawal by Subject|1
6053362|NCT00558272|20919484|P1|Overall Study|Withdrawal by Subject|0
6053363|NCT00558272|20919483|P2|Overall Study|Incorrectly enrolled|0
6053364|NCT00558272|20919484|P1|Overall Study|Incorrectly enrolled|1
6053365|NCT00558272|20919483|P2|Overall Study|AZ study team decision|1
6053366|NCT00558272|20919484|P1|Overall Study|AZ study team decision|0
6053367|NCT00558272|20919483|P2|Overall Study|Dev. of study specific discon. criteria|0
6053368|NCT00558272|20919484|P1|Overall Study|Dev. of study specific discon. criteria|1
6053369|NCT00558272|20919483|P2|Overall Study|Death|0
6053370|NCT00558272|20919484|P1|Overall Study|Death|1
6053371|NCT00558272|20919483|P2|Overall Study|Adverse Event|0
6053372|NCT00558272|20919484|P1|Overall Study|Adverse Event|10
6053373|NCT00558259|20919524|P2|Overall Study|Withdrawal by Subject|13
6053374|NCT00558259|20919525|P1|Overall Study|Withdrawal by Subject|12
6053375|NCT00558259|20919524|P2|Overall Study|Protocol Violation|5
6053376|NCT00558259|20919525|P1|Overall Study|Protocol Violation|9
6053377|NCT00558259|20919524|P2|Overall Study|Adverse Event|81
6053378|NCT00558259|20919525|P1|Overall Study|Adverse Event|50
6053379|NCT00558103|20919565|P6|Monotherapy Extension Phase|Disease Progression|8
6053380|NCT00558103|20919566|P5|Monotherapy Extension Phase|Disease Progression|0
6053381|NCT00558103|20919567|P4|Monotherapy Extension Phase|Disease Progression|0
6053382|NCT00558103|20919568|P3|Monotherapy Extension Phase|Disease Progression|0
6053383|NCT00558103|20919569|P2|Monotherapy Extension Phase|Disease Progression|0
6053384|NCT00558103|20919570|P1|Monotherapy Extension Phase|Disease Progression|0
6053385|NCT00558103|20919565|P6|Monotherapy Extension Phase|Protocol Violation|1
6053386|NCT00558103|20919566|P5|Monotherapy Extension Phase|Protocol Violation|0
6053387|NCT00558103|20919567|P4|Monotherapy Extension Phase|Protocol Violation|0
6053388|NCT00558103|20919568|P3|Monotherapy Extension Phase|Protocol Violation|0
6053389|NCT00558103|20919569|P2|Monotherapy Extension Phase|Protocol Violation|0
6053390|NCT00558103|20919570|P1|Monotherapy Extension Phase|Protocol Violation|0
6053391|NCT00558103|20919565|P6|Randomized Treatment Phase|Adverse Event|0
6053392|NCT00558103|20919566|P5|Randomized Treatment Phase|Adverse Event|1
6053393|NCT00558103|20919567|P4|Randomized Treatment Phase|Adverse Event|1
6053394|NCT00558103|20919568|P3|Randomized Treatment Phase|Adverse Event|0
6053395|NCT00558103|20919569|P2|Randomized Treatment Phase|Adverse Event|0
6053396|NCT00558103|20919570|P1|Randomized Treatment Phase|Adverse Event|0
6053397|NCT00558103|20919565|P6|Randomized Treatment Phase|Disease Progression|0
6053398|NCT00558103|20919566|P5|Randomized Treatment Phase|Disease Progression|0
6053399|NCT00558103|20919567|P4|Randomized Treatment Phase|Disease Progression|0
6053400|NCT00558103|20919568|P3|Randomized Treatment Phase|Disease Progression|1
6053401|NCT00558103|20919569|P2|Randomized Treatment Phase|Disease Progression|0
6053402|NCT00558103|20919570|P1|Randomized Treatment Phase|Disease Progression|1
6053403|NCT00558103|20919565|P6|Randomized Treatment Phase|Withdrawal by Subject|0
6053404|NCT00558103|20919566|P5|Randomized Treatment Phase|Withdrawal by Subject|1
6053405|NCT00558103|20919567|P4|Randomized Treatment Phase|Withdrawal by Subject|0
6053406|NCT00558103|20919568|P3|Randomized Treatment Phase|Withdrawal by Subject|0
6053407|NCT00558103|20919569|P2|Randomized Treatment Phase|Withdrawal by Subject|2
6053408|NCT00558103|20919570|P1|Randomized Treatment Phase|Withdrawal by Subject|2
6053409|NCT00558103|20919565|P6|Randomized Treatment Phase|Lost to Follow-up|0
6053410|NCT00558103|20919566|P5|Randomized Treatment Phase|Lost to Follow-up|3
6053411|NCT00558103|20919567|P4|Randomized Treatment Phase|Lost to Follow-up|1
6053412|NCT00558103|20919568|P3|Randomized Treatment Phase|Lost to Follow-up|2
6053413|NCT00558103|20919569|P2|Randomized Treatment Phase|Lost to Follow-up|2
6053414|NCT00558103|20919570|P1|Randomized Treatment Phase|Lost to Follow-up|2
6053415|NCT00558064|20919600|P2|Overall Study|No visit within allowance period|0
6053416|NCT00558064|20919601|P1|Overall Study|No visit within allowance period|1
6053417|NCT00558064|20919600|P2|Overall Study|Withdrawal by Subject|1
6053418|NCT00558064|20919601|P1|Overall Study|Withdrawal by Subject|0
6053419|NCT00558064|20919600|P2|Overall Study|Lost to Follow-up|1
6053420|NCT00558064|20919601|P1|Overall Study|Lost to Follow-up|0
6053421|NCT00558064|20919600|P2|Overall Study|Protocol Violation|0
6053422|NCT00558064|20919601|P1|Overall Study|Protocol Violation|1
6053423|NCT00558064|20919600|P2|Overall Study|Lack of Efficacy|1
6053424|NCT00558064|20919601|P1|Overall Study|Lack of Efficacy|0
6053425|NCT00558064|20919600|P2|Overall Study|Adverse Event|2
6053426|NCT00558064|20919601|P1|Overall Study|Adverse Event|3
6053427|NCT00558025|20919623|P2|Overall Study|Protocol Violation|0
6053428|NCT00558025|20919624|P1|Overall Study|Protocol Violation|1
6053429|NCT00558025|20919623|P2|Overall Study|Withdrawal by Subject|2
6053430|NCT00558025|20919624|P1|Overall Study|Withdrawal by Subject|2
6053431|NCT00558025|20919623|P2|Overall Study|Adverse Event|1
6053432|NCT00558025|20919624|P1|Overall Study|Adverse Event|1
6053433|NCT00557856|20919680|P9|Part 2: Exploratory Phase|global deterioration of health status|1
6053434|NCT00557856|20919681|P8|Part 2: Exploratory Phase|global deterioration of health status|0
6053435|NCT00557856|20919682|P7|Part 2: Exploratory Phase|global deterioration of health status|0
6053436|NCT00557856|20919683|P6|Part 2: Exploratory Phase|global deterioration of health status|0
6053437|NCT00557856|20919684|P5|Part 2: Exploratory Phase|global deterioration of health status|0
6053438|NCT00557856|20919685|P4|Part 2: Exploratory Phase|global deterioration of health status|0
6053439|NCT00557856|20919686|P3|Part 2: Exploratory Phase|global deterioration of health status|0
6053440|NCT00557856|20919687|P2|Part 2: Exploratory Phase|global deterioration of health status|0
6053441|NCT00557856|20919688|P1|Part 2: Exploratory Phase|global deterioration of health status|0
6053442|NCT00557856|20919680|P9|Part 2: Exploratory Phase|Death|2
6053443|NCT00557856|20919681|P8|Part 2: Exploratory Phase|Death|0
6053444|NCT00557856|20919682|P7|Part 2: Exploratory Phase|Death|0
6053445|NCT00557856|20919683|P6|Part 2: Exploratory Phase|Death|0
6053446|NCT00557856|20919684|P5|Part 2: Exploratory Phase|Death|0
6053447|NCT00557856|20919685|P4|Part 2: Exploratory Phase|Death|0
6053448|NCT00557856|20919686|P3|Part 2: Exploratory Phase|Death|0
6053449|NCT00557856|20919687|P2|Part 2: Exploratory Phase|Death|0
6053450|NCT00557856|20919688|P1|Part 2: Exploratory Phase|Death|0
6053451|NCT00557856|20919680|P9|Part 2: Exploratory Phase|Other|1
6053452|NCT00557856|20919681|P8|Part 2: Exploratory Phase|Other|0
6053453|NCT00557856|20919682|P7|Part 2: Exploratory Phase|Other|0
6053454|NCT00557856|20919683|P6|Part 2: Exploratory Phase|Other|0
6053455|NCT00557856|20919684|P5|Part 2: Exploratory Phase|Other|0
6053456|NCT00557856|20919685|P4|Part 2: Exploratory Phase|Other|0
6053457|NCT00557856|20919686|P3|Part 2: Exploratory Phase|Other|0
6053458|NCT00557856|20919687|P2|Part 2: Exploratory Phase|Other|0
6053459|NCT00557856|20919688|P1|Part 2: Exploratory Phase|Other|0
6053460|NCT00557856|20919680|P9|Part 2: Exploratory Phase|Adverse Event|4
6053461|NCT00557856|20919681|P8|Part 2: Exploratory Phase|Adverse Event|0
6053462|NCT00557856|20919682|P7|Part 2: Exploratory Phase|Adverse Event|0
6053463|NCT00557856|20919683|P6|Part 2: Exploratory Phase|Adverse Event|0
6053464|NCT00557856|20919684|P5|Part 2: Exploratory Phase|Adverse Event|0
6053465|NCT00557856|20919685|P4|Part 2: Exploratory Phase|Adverse Event|0
6053466|NCT00557856|20919686|P3|Part 2: Exploratory Phase|Adverse Event|0
6053467|NCT00557856|20919687|P2|Part 2: Exploratory Phase|Adverse Event|0
6053468|NCT00557856|20919688|P1|Part 2: Exploratory Phase|Adverse Event|0
6053469|NCT00557856|20919680|P9|Part 2: Exploratory Phase|Withdrawal by Subject|1
6053470|NCT00557856|20919681|P8|Part 2: Exploratory Phase|Withdrawal by Subject|0
6053471|NCT00557856|20919682|P7|Part 2: Exploratory Phase|Withdrawal by Subject|0
6053472|NCT00557856|20919683|P6|Part 2: Exploratory Phase|Withdrawal by Subject|0
6053473|NCT00557856|20919684|P5|Part 2: Exploratory Phase|Withdrawal by Subject|0
6053474|NCT00557856|20919685|P4|Part 2: Exploratory Phase|Withdrawal by Subject|0
6053475|NCT00557856|20919686|P3|Part 2: Exploratory Phase|Withdrawal by Subject|0
6053476|NCT00557856|20919687|P2|Part 2: Exploratory Phase|Withdrawal by Subject|0
6053477|NCT00557856|20919688|P1|Part 2: Exploratory Phase|Withdrawal by Subject|0
6053478|NCT00557856|20919680|P9|Part 2: Exploratory Phase|objective progression or relapse|15
6053479|NCT00557856|20919681|P8|Part 2: Exploratory Phase|objective progression or relapse|0
6053480|NCT00557856|20919682|P7|Part 2: Exploratory Phase|objective progression or relapse|0
6053481|NCT00557856|20919683|P6|Part 2: Exploratory Phase|objective progression or relapse|0
6053482|NCT00557856|20919684|P5|Part 2: Exploratory Phase|objective progression or relapse|0
6053483|NCT00557856|20919685|P4|Part 2: Exploratory Phase|objective progression or relapse|0
6053484|NCT00557856|20919686|P3|Part 2: Exploratory Phase|objective progression or relapse|0
6053485|NCT00557856|20919687|P2|Part 2: Exploratory Phase|objective progression or relapse|0
6053486|NCT00557856|20919688|P1|Part 2: Exploratory Phase|objective progression or relapse|0
6053487|NCT00557856|20919680|P9|Part 1: Dose Escalation Phase|randomized but not treated|0
6053488|NCT00557856|20919681|P8|Part 1: Dose Escalation Phase|randomized but not treated|0
6053489|NCT00557856|20919682|P7|Part 1: Dose Escalation Phase|randomized but not treated|0
6053490|NCT00557856|20919683|P6|Part 1: Dose Escalation Phase|randomized but not treated|0
6053491|NCT00557856|20919684|P5|Part 1: Dose Escalation Phase|randomized but not treated|0
6053492|NCT00557856|20919685|P4|Part 1: Dose Escalation Phase|randomized but not treated|0
6053493|NCT00557856|20919686|P3|Part 1: Dose Escalation Phase|randomized but not treated|0
6053494|NCT00557856|20919687|P2|Part 1: Dose Escalation Phase|randomized but not treated|0
6053495|NCT00557856|20919688|P1|Part 1: Dose Escalation Phase|randomized but not treated|2
6053496|NCT00557856|20919680|P9|Part 1: Dose Escalation Phase|global deterioration of health status|0
6053497|NCT00557856|20919681|P8|Part 1: Dose Escalation Phase|global deterioration of health status|0
6053498|NCT00557856|20919682|P7|Part 1: Dose Escalation Phase|global deterioration of health status|1
6053499|NCT00557856|20919683|P6|Part 1: Dose Escalation Phase|global deterioration of health status|2
6053500|NCT00557856|20919684|P5|Part 1: Dose Escalation Phase|global deterioration of health status|0
6053501|NCT00557856|20919685|P4|Part 1: Dose Escalation Phase|global deterioration of health status|0
6053502|NCT00557856|20919686|P3|Part 1: Dose Escalation Phase|global deterioration of health status|0
6053503|NCT00557856|20919687|P2|Part 1: Dose Escalation Phase|global deterioration of health status|0
6053504|NCT00557856|20919688|P1|Part 1: Dose Escalation Phase|global deterioration of health status|0
6053505|NCT00557856|20919680|P9|Part 1: Dose Escalation Phase|Death|0
6053506|NCT00557856|20919681|P8|Part 1: Dose Escalation Phase|Death|0
6053507|NCT00557856|20919682|P7|Part 1: Dose Escalation Phase|Death|0
6053508|NCT00557856|20919683|P6|Part 1: Dose Escalation Phase|Death|1
6053509|NCT00557856|20919684|P5|Part 1: Dose Escalation Phase|Death|0
6053510|NCT00557856|20919685|P4|Part 1: Dose Escalation Phase|Death|0
6053511|NCT00557856|20919686|P3|Part 1: Dose Escalation Phase|Death|0
6053512|NCT00557856|20919687|P2|Part 1: Dose Escalation Phase|Death|0
6053513|NCT00557856|20919688|P1|Part 1: Dose Escalation Phase|Death|0
6053514|NCT00557856|20919680|P9|Part 1: Dose Escalation Phase|Other|0
6053515|NCT00557856|20919681|P8|Part 1: Dose Escalation Phase|Other|1
6053516|NCT00557856|20919682|P7|Part 1: Dose Escalation Phase|Other|0
6053517|NCT00557856|20919683|P6|Part 1: Dose Escalation Phase|Other|0
6053518|NCT00557856|20919684|P5|Part 1: Dose Escalation Phase|Other|0
6053519|NCT00557856|20919685|P4|Part 1: Dose Escalation Phase|Other|1
6053520|NCT00557856|20919686|P3|Part 1: Dose Escalation Phase|Other|1
6053521|NCT00557856|20919687|P2|Part 1: Dose Escalation Phase|Other|0
6053522|NCT00557856|20919688|P1|Part 1: Dose Escalation Phase|Other|0
6053523|NCT00557856|20919680|P9|Part 1: Dose Escalation Phase|Adverse Event|0
6053524|NCT00557856|20919681|P8|Part 1: Dose Escalation Phase|Adverse Event|2
6053525|NCT00557856|20919682|P7|Part 1: Dose Escalation Phase|Adverse Event|1
6053526|NCT00557856|20919683|P6|Part 1: Dose Escalation Phase|Adverse Event|3
6053527|NCT00557856|20919684|P5|Part 1: Dose Escalation Phase|Adverse Event|1
6053528|NCT00557856|20919685|P4|Part 1: Dose Escalation Phase|Adverse Event|1
6053529|NCT00557856|20919686|P3|Part 1: Dose Escalation Phase|Adverse Event|1
6053530|NCT00557856|20919687|P2|Part 1: Dose Escalation Phase|Adverse Event|0
6053531|NCT00557856|20919688|P1|Part 1: Dose Escalation Phase|Adverse Event|1
6053532|NCT00557856|20919680|P9|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
6053533|NCT00557856|20919681|P8|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
6053534|NCT00557856|20919682|P7|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
6053535|NCT00557856|20919683|P6|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
6053536|NCT00557856|20919684|P5|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
6053537|NCT00557856|20919685|P4|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
6053538|NCT00557856|20919686|P3|Part 1: Dose Escalation Phase|Withdrawal by Subject|1
6053539|NCT00557856|20919687|P2|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
6053540|NCT00557856|20919688|P1|Part 1: Dose Escalation Phase|Withdrawal by Subject|1
6053541|NCT00557856|20919680|P9|Part 1: Dose Escalation Phase|objective progression or relapse|0
6053542|NCT00557856|20919681|P8|Part 1: Dose Escalation Phase|objective progression or relapse|3
6053543|NCT00557856|20919682|P7|Part 1: Dose Escalation Phase|objective progression or relapse|5
6053544|NCT00557856|20919683|P6|Part 1: Dose Escalation Phase|objective progression or relapse|2
6053545|NCT00557856|20919684|P5|Part 1: Dose Escalation Phase|objective progression or relapse|3
6053546|NCT00557856|20919685|P4|Part 1: Dose Escalation Phase|objective progression or relapse|1
6053547|NCT00557856|20919686|P3|Part 1: Dose Escalation Phase|objective progression or relapse|3
6053548|NCT00557856|20919687|P2|Part 1: Dose Escalation Phase|objective progression or relapse|5
6053549|NCT00557856|20919688|P1|Part 1: Dose Escalation Phase|objective progression or relapse|3
6053550|NCT00557830|20919887|P3|Screening Treatment Phase|Unable to tolerate standard dose|0
6053551|NCT00557830|20919888|P2|Screening Treatment Phase|Unable to tolerate standard dose|0
6053552|NCT00557830|20919889|P1|Screening Treatment Phase|Unable to tolerate standard dose|3
6053553|NCT00557830|20919887|P3|Screening Treatment Phase|Adverse Event|0
6053554|NCT00557830|20919888|P2|Screening Treatment Phase|Adverse Event|0
6053555|NCT00557830|20919889|P1|Screening Treatment Phase|Adverse Event|2
6053556|NCT00557830|20919887|P3|Screening Treatment Phase|Withdrawal by Subject|0
6053557|NCT00557830|20919888|P2|Screening Treatment Phase|Withdrawal by Subject|0
6053558|NCT00557830|20919889|P1|Screening Treatment Phase|Withdrawal by Subject|1
6053559|NCT00557622|20919911|P2|12-Week Treatment Phase|Lost to Follow-up|1
6053560|NCT00557622|20919912|P1|12-Week Treatment Phase|Lost to Follow-up|0
6053561|NCT00557622|20919911|P2|4-Week Run-in Phase|Protocol-defined stopping criteria|0
6053562|NCT00557622|20919912|P1|4-Week Run-in Phase|Protocol-defined stopping criteria|1
6053563|NCT00557622|20919911|P2|4-Week Run-in Phase|Withdrawal by Subject|0
6053564|NCT00557622|20919912|P1|4-Week Run-in Phase|Withdrawal by Subject|1
6053565|NCT00557505|20919941|P9|Overall Study|Withdrawal by Subject|1
6053566|NCT00557505|20919942|P8|Overall Study|Withdrawal by Subject|0
6053567|NCT00557505|20919943|P7|Overall Study|Withdrawal by Subject|0
6053568|NCT00557505|20919944|P6|Overall Study|Withdrawal by Subject|0
6053569|NCT00557505|20919945|P5|Overall Study|Withdrawal by Subject|0
6053570|NCT00557505|20919946|P4|Overall Study|Withdrawal by Subject|1
6053571|NCT00557505|20919947|P3|Overall Study|Withdrawal by Subject|0
6053572|NCT00557505|20919948|P2|Overall Study|Withdrawal by Subject|0
6053573|NCT00557505|20919949|P1|Overall Study|Withdrawal by Subject|0
6053574|NCT00557505|20919941|P9|Overall Study|Objective progression or relapse|15
6053575|NCT00557505|20919942|P8|Overall Study|Objective progression or relapse|5
6053576|NCT00557505|20919943|P7|Overall Study|Objective progression or relapse|2
6053577|NCT00557505|20919944|P6|Overall Study|Objective progression or relapse|3
6053578|NCT00557505|20919945|P5|Overall Study|Objective progression or relapse|2
6053579|NCT00557505|20919946|P4|Overall Study|Objective progression or relapse|2
6053580|NCT00557505|20919947|P3|Overall Study|Objective progression or relapse|3
6053581|NCT00557505|20919948|P2|Overall Study|Objective progression or relapse|3
6053582|NCT00557505|20919949|P1|Overall Study|Objective progression or relapse|2
6053583|NCT00557505|20919941|P9|Overall Study|Global deterioration of health|0
6053584|NCT00557505|20919942|P8|Overall Study|Global deterioration of health|0
6053585|NCT00557505|20919943|P7|Overall Study|Global deterioration of health|0
6053586|NCT00557505|20919944|P6|Overall Study|Global deterioration of health|0
6053587|NCT00557505|20919945|P5|Overall Study|Global deterioration of health|0
6053588|NCT00557505|20919946|P4|Overall Study|Global deterioration of health|0
6053589|NCT00557505|20919947|P3|Overall Study|Global deterioration of health|0
6053590|NCT00557505|20919948|P2|Overall Study|Global deterioration of health|0
6053591|NCT00557505|20919949|P1|Overall Study|Global deterioration of health|1
6053592|NCT00557505|20919941|P9|Overall Study|Adverse Event|0
6053593|NCT00557505|20919942|P8|Overall Study|Adverse Event|0
6053594|NCT00557505|20919943|P7|Overall Study|Adverse Event|1
6053595|NCT00557505|20919944|P6|Overall Study|Adverse Event|0
6053596|NCT00557505|20919945|P5|Overall Study|Adverse Event|0
6053597|NCT00557505|20919946|P4|Overall Study|Adverse Event|0
6053598|NCT00557505|20919947|P3|Overall Study|Adverse Event|1
6053599|NCT00557505|20919948|P2|Overall Study|Adverse Event|0
6053600|NCT00557505|20919949|P1|Overall Study|Adverse Event|0
6053601|NCT00557505|20919941|P9|Overall Study|Death|1
6053602|NCT00557505|20919942|P8|Overall Study|Death|0
6053603|NCT00557505|20919943|P7|Overall Study|Death|0
6053604|NCT00557505|20919944|P6|Overall Study|Death|0
6053605|NCT00557505|20919945|P5|Overall Study|Death|0
6053606|NCT00557505|20919946|P4|Overall Study|Death|0
6053607|NCT00557505|20919947|P3|Overall Study|Death|0
6053608|NCT00557505|20919948|P2|Overall Study|Death|0
6053609|NCT00557505|20919949|P1|Overall Study|Death|0
6053610|NCT00557492|20920113|P1|Overall Study|Change in health insurance|1
6053611|NCT00557466|20920131|P6|Overall Study|Lost to Follow-up|0
6053612|NCT00557466|20920132|P5|Overall Study|Lost to Follow-up|0
6053613|NCT00557466|20920133|P4|Overall Study|Lost to Follow-up|1
6053614|NCT00557466|20920134|P3|Overall Study|Lost to Follow-up|0
6053615|NCT00557466|20920135|P2|Overall Study|Lost to Follow-up|0
6053616|NCT00557466|20920136|P1|Overall Study|Lost to Follow-up|0
6053617|NCT00557466|20920131|P6|Overall Study|Abnormal test procedure results|0
6053618|NCT00557466|20920132|P5|Overall Study|Abnormal test procedure results|0
6053619|NCT00557466|20920133|P4|Overall Study|Abnormal test procedure results|0
6053620|NCT00557466|20920134|P3|Overall Study|Abnormal test procedure results|1
6053621|NCT00557466|20920135|P2|Overall Study|Abnormal test procedure results|0
6053622|NCT00557466|20920136|P1|Overall Study|Abnormal test procedure results|0
6053623|NCT00557466|20920131|P6|Overall Study|Administrative problems|0
6053624|NCT00557466|20920132|P5|Overall Study|Administrative problems|0
6053625|NCT00557466|20920133|P4|Overall Study|Administrative problems|0
6053626|NCT00557466|20920134|P3|Overall Study|Administrative problems|1
6053627|NCT00557466|20920135|P2|Overall Study|Administrative problems|1
6053628|NCT00557466|20920136|P1|Overall Study|Administrative problems|0
6053629|NCT00557466|20920131|P6|Overall Study|Subject withdrew consent|2
6053630|NCT00557466|20920132|P5|Overall Study|Subject withdrew consent|1
6053631|NCT00557466|20920133|P4|Overall Study|Subject withdrew consent|0
6053632|NCT00557466|20920134|P3|Overall Study|Subject withdrew consent|0
6053633|NCT00557466|20920135|P2|Overall Study|Subject withdrew consent|0
6053634|NCT00557466|20920136|P1|Overall Study|Subject withdrew consent|0
6053635|NCT00557466|20920131|P6|Overall Study|Protocol deviation|0
6053636|NCT00557466|20920132|P5|Overall Study|Protocol deviation|0
6053637|NCT00557466|20920133|P4|Overall Study|Protocol deviation|2
6053638|NCT00557466|20920134|P3|Overall Study|Protocol deviation|0
6053639|NCT00557466|20920135|P2|Overall Study|Protocol deviation|1
6053640|NCT00557466|20920136|P1|Overall Study|Protocol deviation|0
6053641|NCT00557466|20920131|P6|Overall Study|Abnormal laboratory value(s)|0
6053642|NCT00557466|20920132|P5|Overall Study|Abnormal laboratory value(s)|0
6053643|NCT00557466|20920133|P4|Overall Study|Abnormal laboratory value(s)|0
6053644|NCT00557466|20920134|P3|Overall Study|Abnormal laboratory value(s)|0
6053645|NCT00557466|20920135|P2|Overall Study|Abnormal laboratory value(s)|2
6053646|NCT00557466|20920136|P1|Overall Study|Abnormal laboratory value(s)|1
6053647|NCT00557466|20920131|P6|Overall Study|Adverse Event|4
6053648|NCT00557466|20920132|P5|Overall Study|Adverse Event|2
6053649|NCT00557466|20920133|P4|Overall Study|Adverse Event|1
6053650|NCT00557466|20920134|P3|Overall Study|Adverse Event|4
6053651|NCT00557466|20920135|P2|Overall Study|Adverse Event|1
6053652|NCT00557466|20920136|P1|Overall Study|Adverse Event|3
6053653|NCT00557440|20920189|P3|Treatment Period 1|Adverse Event|1
6053654|NCT00557440|20920190|P2|Treatment Period 1|Adverse Event|0
6053655|NCT00557440|20920191|P1|Treatment Period 1|Adverse Event|0
6053656|NCT00557323|20920245|P1|Overall Study|Administrative change|2
6053657|NCT00557323|20920245|P1|Overall Study|Withdrawal by Subject|2
6053658|NCT00557323|20920245|P1|Overall Study|Death|3
6053659|NCT00557310|20920250|P1|Extension Phase (18 - 24 Months)|Protocol Violation|1
6053660|NCT00557310|20920250|P1|Extension Phase (18 - 24 Months)|Physician Decision|2
6053661|NCT00557310|20920250|P1|Extension Phase (18 - 24 Months)|Lost to Follow-up|1
6053662|NCT00557310|20920250|P1|Extension Phase (18 - 24 Months)|Adverse Event|1
6053663|NCT00557310|20920250|P1|Main Study (0 - 18 Months)|Withdrawal by Subject|1
6053664|NCT00557310|20920250|P1|Main Study (0 - 18 Months)|Adverse Event|4
6053665|NCT00557245|20920296|P3|Overall Study|Ineligible|2
6053666|NCT00557245|20920297|P2|Overall Study|Ineligible|4
6053667|NCT00557245|20920298|P1|Overall Study|Ineligible|5
6053668|NCT00557245|20920296|P3|Overall Study|Lost to Follow-up|10
6053669|NCT00557245|20920297|P2|Overall Study|Lost to Follow-up|8
6053670|NCT00557245|20920298|P1|Overall Study|Lost to Follow-up|7
6053671|NCT00557193|20920336|P6|Post Induction Therapy by Tx Assignment|Induction Failure|5
6053672|NCT00557193|20920337|P5|Post Induction Therapy by Tx Assignment|Induction Failure|0
6053673|NCT00557193|20920338|P4|Post Induction Therapy by Tx Assignment|Induction Failure|0
6053674|NCT00557193|20920339|P3|Post Induction Therapy by Tx Assignment|Induction Failure|4
6053675|NCT00557193|20920340|P2|Post Induction Therapy by Tx Assignment|Induction Failure|0
6053676|NCT00557193|20920341|P1|Post Induction Therapy by Tx Assignment|Induction Failure|0
6053677|NCT00557193|20920336|P6|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0
6053678|NCT00557193|20920337|P5|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0
6053679|NCT00557193|20920338|P4|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0
6053680|NCT00557193|20920339|P3|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|2
6053681|NCT00557193|20920340|P2|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0
6053682|NCT00557193|20920341|P1|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0
6053683|NCT00557193|20920336|P6|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0
6053684|NCT00557193|20920337|P5|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0
6053685|NCT00557193|20920338|P4|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0
6053686|NCT00557193|20920339|P3|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|1
6053687|NCT00557193|20920340|P2|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0
6053688|NCT00557193|20920341|P1|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0
6053689|NCT00557193|20920336|P6|Post Induction Therapy by Tx Assignment|Relapse|20
6053690|NCT00557193|20920337|P5|Post Induction Therapy by Tx Assignment|Relapse|1
6053691|NCT00557193|20920338|P4|Post Induction Therapy by Tx Assignment|Relapse|3
6053692|NCT00557193|20920339|P3|Post Induction Therapy by Tx Assignment|Relapse|16
6053693|NCT00557193|20920340|P2|Post Induction Therapy by Tx Assignment|Relapse|5
6053694|NCT00557193|20920341|P1|Post Induction Therapy by Tx Assignment|Relapse|0
6053695|NCT00557193|20920336|P6|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|5
6053696|NCT00557193|20920337|P5|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2
6053697|NCT00557193|20920338|P4|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2
6053698|NCT00557193|20920339|P3|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0
6053699|NCT00557193|20920340|P2|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|1
6053700|NCT00557193|20920341|P1|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0
6053701|NCT00557193|20920336|P6|Post Induction Therapy by Tx Assignment|Physician Decision|2
6053702|NCT00557193|20920337|P5|Post Induction Therapy by Tx Assignment|Physician Decision|2
6053703|NCT00557193|20920338|P4|Post Induction Therapy by Tx Assignment|Physician Decision|1
6053704|NCT00557193|20920339|P3|Post Induction Therapy by Tx Assignment|Physician Decision|5
6053705|NCT00557193|20920340|P2|Post Induction Therapy by Tx Assignment|Physician Decision|3
6053706|NCT00557193|20920341|P1|Post Induction Therapy by Tx Assignment|Physician Decision|0
6053707|NCT00557193|20920336|P6|Post Induction Therapy by Tx Assignment|Death|2
6053708|NCT00557193|20920337|P5|Post Induction Therapy by Tx Assignment|Death|2
6053709|NCT00557193|20920338|P4|Post Induction Therapy by Tx Assignment|Death|0
6053710|NCT00557193|20920339|P3|Post Induction Therapy by Tx Assignment|Death|2
6053711|NCT00557193|20920340|P2|Post Induction Therapy by Tx Assignment|Death|0
6053712|NCT00557193|20920341|P1|Post Induction Therapy by Tx Assignment|Death|0
6053713|NCT00557193|20920336|P6|Post Induction Therapy by Tx Assignment|Adverse Event|3
6053714|NCT00557193|20920337|P5|Post Induction Therapy by Tx Assignment|Adverse Event|0
6053715|NCT00557193|20920338|P4|Post Induction Therapy by Tx Assignment|Adverse Event|1
6053716|NCT00557193|20920339|P3|Post Induction Therapy by Tx Assignment|Adverse Event|2
6053717|NCT00557193|20920340|P2|Post Induction Therapy by Tx Assignment|Adverse Event|1
6053718|NCT00557193|20920341|P1|Post Induction Therapy by Tx Assignment|Adverse Event|0
6053719|NCT00557193|20920336|P6|Induction|Unable to receive Lestaurtinib-Not in US|0
6053720|NCT00557193|20920337|P5|Induction|Unable to receive Lestaurtinib-Not in US|0
6053721|NCT00557193|20920338|P4|Induction|Unable to receive Lestaurtinib-Not in US|0
6053722|NCT00557193|20920339|P3|Induction|Unable to receive Lestaurtinib-Not in US|0
6053723|NCT00557193|20920340|P2|Induction|Unable to receive Lestaurtinib-Not in US|0
6053724|NCT00557193|20920341|P1|Induction|Unable to receive Lestaurtinib-Not in US|2
6053725|NCT00557193|20920336|P6|Induction|Inevaluable for post Induction|0
6053726|NCT00557193|20920337|P5|Induction|Inevaluable for post Induction|0
6053727|NCT00557193|20920338|P4|Induction|Inevaluable for post Induction|0
6053728|NCT00557193|20920339|P3|Induction|Inevaluable for post Induction|0
6053729|NCT00557193|20920340|P2|Induction|Inevaluable for post Induction|0
6053730|NCT00557193|20920341|P1|Induction|Inevaluable for post Induction|2
6053731|NCT00557193|20920336|P6|Induction|Ineligible|0
6053732|NCT00557193|20920337|P5|Induction|Ineligible|0
6053733|NCT00557193|20920338|P4|Induction|Ineligible|0
6053734|NCT00557193|20920339|P3|Induction|Ineligible|0
6053735|NCT00557193|20920340|P2|Induction|Ineligible|0
6053736|NCT00557193|20920341|P1|Induction|Ineligible|8
6053737|NCT00557193|20920336|P6|Induction|Refusal of Further Protocol Therapy|0
6053738|NCT00557193|20920337|P5|Induction|Refusal of Further Protocol Therapy|0
6053739|NCT00557193|20920338|P4|Induction|Refusal of Further Protocol Therapy|0
6053740|NCT00557193|20920339|P3|Induction|Refusal of Further Protocol Therapy|0
6053741|NCT00557193|20920340|P2|Induction|Refusal of Further Protocol Therapy|0
6053742|NCT00557193|20920341|P1|Induction|Refusal of Further Protocol Therapy|2
6053743|NCT00557193|20920336|P6|Induction|Withdrawal by Subject|0
6053744|NCT00557193|20920337|P5|Induction|Withdrawal by Subject|0
6053745|NCT00557193|20920338|P4|Induction|Withdrawal by Subject|0
6053746|NCT00557193|20920339|P3|Induction|Withdrawal by Subject|0
6053747|NCT00557193|20920340|P2|Induction|Withdrawal by Subject|0
6053748|NCT00557193|20920341|P1|Induction|Withdrawal by Subject|1
6053749|NCT00557193|20920336|P6|Induction|Physician Decision|0
6053750|NCT00557193|20920337|P5|Induction|Physician Decision|0
6053751|NCT00557193|20920338|P4|Induction|Physician Decision|0
6053752|NCT00557193|20920339|P3|Induction|Physician Decision|0
6053753|NCT00557193|20920340|P2|Induction|Physician Decision|0
6053754|NCT00557193|20920341|P1|Induction|Physician Decision|3
6053755|NCT00557193|20920336|P6|Induction|Death|0
6053756|NCT00557193|20920337|P5|Induction|Death|0
6053757|NCT00557193|20920338|P4|Induction|Death|0
6053758|NCT00557193|20920339|P3|Induction|Death|0
6053759|NCT00557193|20920340|P2|Induction|Death|0
6053760|NCT00557193|20920341|P1|Induction|Death|6
6053761|NCT00557193|20920336|P6|Induction|Adverse Event|0
6053762|NCT00557193|20920337|P5|Induction|Adverse Event|0
6053763|NCT00557193|20920338|P4|Induction|Adverse Event|0
6053764|NCT00557193|20920339|P3|Induction|Adverse Event|0
6053765|NCT00557193|20920340|P2|Induction|Adverse Event|0
6053766|NCT00557193|20920341|P1|Induction|Adverse Event|2
6053767|NCT00557076|20920381|P2|Overall Study|Unblinding|1
6053768|NCT00557076|20920382|P1|Overall Study|Unblinding|0
6053769|NCT00556998|20920390|P1|Voriconazole Oral|Intolerant of oral treatment|1
6053770|NCT00556998|20920390|P1|Voriconazole Oral|Adverse Event|1
6053771|NCT00556998|20920390|P1|Voriconazole Intravenous (IV)|Other|4
6053772|NCT00556998|20920390|P1|Voriconazole Intravenous (IV)|Adverse Event|1
6053773|NCT00556933|20920425|P4|CNI Withdrawal vs. Minimization|Death|1
6053774|NCT00556933|20920426|P3|CNI Withdrawal vs. Minimization|Death|0
6053775|NCT00556933|20920427|P2|CNI Withdrawal vs. Minimization|Death|0
6053776|NCT00556933|20920428|P1|CNI Withdrawal vs. Minimization|Death|0
6053777|NCT00556933|20920425|P4|CNI Withdrawal vs. Minimization|Graft loss|0
6053778|NCT00556933|20920426|P3|CNI Withdrawal vs. Minimization|Graft loss|2
6053779|NCT00556933|20920427|P2|CNI Withdrawal vs. Minimization|Graft loss|1
6053780|NCT00556933|20920428|P1|CNI Withdrawal vs. Minimization|Graft loss|0
6053781|NCT00556933|20920425|P4|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0
6053782|NCT00556933|20920426|P3|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1
6053783|NCT00556933|20920427|P2|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1
6053784|NCT00556933|20920428|P1|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0
6053785|NCT00556933|20920425|P4|CNI Withdrawal vs. Minimization|Lost to Follow-up|1
6053786|NCT00556933|20920426|P3|CNI Withdrawal vs. Minimization|Lost to Follow-up|0
6053787|NCT00556933|20920427|P2|CNI Withdrawal vs. Minimization|Lost to Follow-up|1
6053788|NCT00556933|20920428|P1|CNI Withdrawal vs. Minimization|Lost to Follow-up|0
6053789|NCT00556933|20920425|P4|CNI Withdrawal vs. Minimization|Pancreas transplantation|0
6053790|NCT00556933|20920426|P3|CNI Withdrawal vs. Minimization|Pancreas transplantation|0
6053791|NCT00556933|20920427|P2|CNI Withdrawal vs. Minimization|Pancreas transplantation|1
6053792|NCT00556933|20920428|P1|CNI Withdrawal vs. Minimization|Pancreas transplantation|1
6053793|NCT00556933|20920425|P4|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0
6053794|NCT00556933|20920426|P3|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0
6053795|NCT00556933|20920427|P2|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|1
6053796|NCT00556933|20920428|P1|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0
6053797|NCT00556933|20920425|P4|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0
6053798|NCT00556933|20920426|P3|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0
6053799|NCT00556933|20920427|P2|Single vs. Divided-dose rATG Induction|Lost to Follow-up|1
6053800|NCT00556933|20920428|P1|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0
6053801|NCT00556933|20920425|P4|Single vs. Divided-dose rATG Induction|Death|0
6053802|NCT00556933|20920426|P3|Single vs. Divided-dose rATG Induction|Death|0
6053803|NCT00556933|20920427|P2|Single vs. Divided-dose rATG Induction|Death|1
6053804|NCT00556933|20920428|P1|Single vs. Divided-dose rATG Induction|Death|0
6053805|NCT00556933|20920425|P4|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2
6053806|NCT00556933|20920426|P3|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2
6053807|NCT00556933|20920427|P2|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2
6053808|NCT00556933|20920428|P1|Single vs. Divided-dose rATG Induction|Pancreas transplantation|0
6053809|NCT00556933|20920425|P4|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0
6053810|NCT00556933|20920426|P3|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|1
6053894|NCT00556322|20920788|P2|Overall Study|Death|14
6053811|NCT00556933|20920427|P2|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0
6053812|NCT00556933|20920428|P1|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0
6053813|NCT00556933|20920425|P4|Single vs. Divided-dose rATG Induction|Protocol Violation|0
6053814|NCT00556933|20920426|P3|Single vs. Divided-dose rATG Induction|Protocol Violation|3
6053815|NCT00556933|20920427|P2|Single vs. Divided-dose rATG Induction|Protocol Violation|3
6053816|NCT00556933|20920428|P1|Single vs. Divided-dose rATG Induction|Protocol Violation|2
6053817|NCT00556894|20920485|P3|Overall Study|Withdrawal by Subject|1
6053818|NCT00556894|20920486|P2|Overall Study|Withdrawal by Subject|1
6053819|NCT00556894|20920487|P1|Overall Study|Withdrawal by Subject|1
6053820|NCT00556894|20920485|P3|Overall Study|Change in therapy|2
6053821|NCT00556894|20920486|P2|Overall Study|Change in therapy|1
6053822|NCT00556894|20920487|P1|Overall Study|Change in therapy|2
6053823|NCT00556894|20920485|P3|Overall Study|regulatory decision in Bulgaria|13
6053824|NCT00556894|20920486|P2|Overall Study|regulatory decision in Bulgaria|14
6053825|NCT00556894|20920487|P1|Overall Study|regulatory decision in Bulgaria|10
6053826|NCT00556894|20920485|P3|Overall Study|Death|0
6053827|NCT00556894|20920486|P2|Overall Study|Death|0
6053828|NCT00556894|20920487|P1|Overall Study|Death|1
6053829|NCT00556894|20920485|P3|Overall Study|Adverse Event|3
6053830|NCT00556894|20920486|P2|Overall Study|Adverse Event|3
6053831|NCT00556894|20920487|P1|Overall Study|Adverse Event|2
6053832|NCT00556712|20920516|P2|Overall Study|Ongoing at Data Cutoff|66
6053833|NCT00556712|20920517|P1|Overall Study|Ongoing at Data Cutoff|32
6053834|NCT00556712|20920516|P2|Overall Study|Other|2
6053835|NCT00556712|20920517|P1|Overall Study|Other|2
6053836|NCT00556712|20920516|P2|Overall Study|Failure to Return|3
6053837|NCT00556712|20920517|P1|Overall Study|Failure to Return|2
6053838|NCT00556712|20920516|P2|Overall Study|Refused Treatment|16
6053839|NCT00556712|20920517|P1|Overall Study|Refused Treatment|17
6053840|NCT00556712|20920516|P2|Overall Study|Protocol Violation|2
6053841|NCT00556712|20920517|P1|Overall Study|Protocol Violation|3
6053842|NCT00556712|20920516|P2|Overall Study|Progressive Disease|320
6053843|NCT00556712|20920517|P1|Overall Study|Progressive Disease|383
6053844|NCT00556712|20920516|P2|Overall Study|Death|10
6053845|NCT00556712|20920517|P1|Overall Study|Death|5
6053846|NCT00556712|20920516|P2|Overall Study|Adverse Event|19
6053847|NCT00556712|20920517|P1|Overall Study|Adverse Event|7
6053848|NCT00556673|20920595|P2|Overall Study|Protocol deviation|2
6053849|NCT00556673|20920596|P1|Overall Study|Protocol deviation|3
6053850|NCT00556439|20920732|P4|After Week 12 (Randomized Study Period)|Severe infection|0
6053851|NCT00556439|20920733|P3|After Week 12 (Randomized Study Period)|Severe infection|0
6053852|NCT00556439|20920734|P2|After Week 12 (Randomized Study Period)|Severe infection|0
6053853|NCT00556439|20920735|P1|After Week 12 (Randomized Study Period)|Severe infection|1
6053854|NCT00556439|20920732|P4|After Week 12 (Randomized Study Period)|Malignancy|1
6053855|NCT00556439|20920733|P3|After Week 12 (Randomized Study Period)|Malignancy|0
6053856|NCT00556439|20920734|P2|After Week 12 (Randomized Study Period)|Malignancy|1
6053857|NCT00556439|20920735|P1|After Week 12 (Randomized Study Period)|Malignancy|0
6053858|NCT00556439|20920732|P4|After Week 12 (Randomized Study Period)|Physician Decision|0
6053859|NCT00556439|20920733|P3|After Week 12 (Randomized Study Period)|Physician Decision|0
6053860|NCT00556439|20920734|P2|After Week 12 (Randomized Study Period)|Physician Decision|0
6053861|NCT00556439|20920735|P1|After Week 12 (Randomized Study Period)|Physician Decision|1
6053862|NCT00556439|20920732|P4|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0
6053863|NCT00556439|20920733|P3|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0
6053864|NCT00556439|20920734|P2|After Week 12 (Randomized Study Period)|Withdrawal by Subject|3
6053865|NCT00556439|20920735|P1|After Week 12 (Randomized Study Period)|Withdrawal by Subject|1
6053866|NCT00556439|20920732|P4|Study Entry to Week 12|Malignancy|0
6053867|NCT00556439|20920733|P3|Study Entry to Week 12|Malignancy|1
6053868|NCT00556439|20920734|P2|Study Entry to Week 12|Malignancy|0
6053869|NCT00556439|20920735|P1|Study Entry to Week 12|Malignancy|0
6053870|NCT00556439|20920732|P4|Study Entry to Week 12|Recurrent infection|0
6053871|NCT00556439|20920733|P3|Study Entry to Week 12|Recurrent infection|0
6053872|NCT00556439|20920734|P2|Study Entry to Week 12|Recurrent infection|0
6053873|NCT00556439|20920735|P1|Study Entry to Week 12|Recurrent infection|1
6053874|NCT00556439|20920732|P4|Study Entry to Week 12|Withdrawal by Subject|0
6053875|NCT00556439|20920733|P3|Study Entry to Week 12|Withdrawal by Subject|1
6053876|NCT00556439|20920734|P2|Study Entry to Week 12|Withdrawal by Subject|0
6053877|NCT00556439|20920735|P1|Study Entry to Week 12|Withdrawal by Subject|1
6053878|NCT00556439|20920732|P4|Study Entry to Week 12|Physician Decision|0
6053879|NCT00556439|20920733|P3|Study Entry to Week 12|Physician Decision|0
6053880|NCT00556439|20920734|P2|Study Entry to Week 12|Physician Decision|0
6053881|NCT00556439|20920735|P1|Study Entry to Week 12|Physician Decision|1
6053882|NCT00556439|20920732|P4|Study Entry to Week 12|Lack of Efficacy|0
6053883|NCT00556439|20920733|P3|Study Entry to Week 12|Lack of Efficacy|6
6053884|NCT00556439|20920734|P2|Study Entry to Week 12|Lack of Efficacy|0
6053885|NCT00556439|20920735|P1|Study Entry to Week 12|Lack of Efficacy|5
6053886|NCT00556426|20920745|P1|Overall Study|Death|6
6053887|NCT00556426|20920745|P1|Overall Study|Withdrawal by Subject|3
6053888|NCT00556374|20920767|P2|Overall Study|Lost to Follow-up|5
6053889|NCT00556374|20920768|P1|Overall Study|Lost to Follow-up|7
6053890|NCT00556374|20920767|P2|Overall Study|Death|43
6053891|NCT00556374|20920768|P1|Overall Study|Death|50
6053892|NCT00556374|20920767|P2|Overall Study|Withdrawal by Subject|172
6053893|NCT00556374|20920768|P1|Overall Study|Withdrawal by Subject|190
6053895|NCT00556322|20920789|P1|Overall Study|Death|20
6053896|NCT00556322|20920788|P2|Overall Study|Ongoing at data cutoff|5
6053897|NCT00556322|20920789|P1|Overall Study|Ongoing at data cutoff|3
6053898|NCT00556322|20920788|P2|Overall Study|Protocol Violation|1
6053899|NCT00556322|20920789|P1|Overall Study|Protocol Violation|5
6053900|NCT00556322|20920788|P2|Overall Study|Withdrawal by Subject|7
6053901|NCT00556322|20920789|P1|Overall Study|Withdrawal by Subject|19
6053902|NCT00556322|20920788|P2|Overall Study|Lost to Follow-up|3
6053903|NCT00556322|20920789|P1|Overall Study|Lost to Follow-up|5
6053904|NCT00556322|20920788|P2|Overall Study|Other|1
6053905|NCT00556322|20920789|P1|Overall Study|Other|4
6053906|NCT00556322|20920788|P2|Overall Study|Adverse Event|4
6053907|NCT00556322|20920789|P1|Overall Study|Adverse Event|7
6053908|NCT00556322|20920788|P2|Overall Study|Insufficient therapeutic response|168
6053909|NCT00556322|20920789|P1|Overall Study|Insufficient therapeutic response|158
6053910|NCT00556166|20920837|P1|Overall Study|Withdrawal by Subject|1
6053911|NCT00556075|20920850|P3|Overall Study|Endometrial stripe not viewed on 2 tvu|0
6053912|NCT00556075|20920851|P2|Overall Study|Endometrial stripe not viewed on 2 tvu|1
6053913|NCT00556075|20920852|P1|Overall Study|Endometrial stripe not viewed on 2 tvu|0
6053914|NCT00556075|20920850|P3|Overall Study|Personal issues|0
6053915|NCT00556075|20920851|P2|Overall Study|Personal issues|1
6053916|NCT00556075|20920852|P1|Overall Study|Personal issues|4
6053917|NCT00556075|20920850|P3|Overall Study|Adverse Event|0
6053918|NCT00556075|20920851|P2|Overall Study|Adverse Event|2
6053919|NCT00556075|20920852|P1|Overall Study|Adverse Event|1
6053920|NCT00556075|20920850|P3|Overall Study|Not eligible|2
6053921|NCT00556075|20920851|P2|Overall Study|Not eligible|1
6053922|NCT00556075|20920852|P1|Overall Study|Not eligible|1
6053923|NCT00556075|20920850|P3|Overall Study|Protocol Violation|3
6053924|NCT00556075|20920851|P2|Overall Study|Protocol Violation|1
6053925|NCT00556075|20920852|P1|Overall Study|Protocol Violation|1
6053926|NCT00556075|20920850|P3|Overall Study|Withdrawal by Subject|0
6053927|NCT00556075|20920851|P2|Overall Study|Withdrawal by Subject|3
6053928|NCT00556075|20920852|P1|Overall Study|Withdrawal by Subject|3
6053929|NCT00556075|20920850|P3|Overall Study|Lost to Follow-up|3
6053930|NCT00556075|20920851|P2|Overall Study|Lost to Follow-up|0
6053931|NCT00556075|20920852|P1|Overall Study|Lost to Follow-up|3
6053932|NCT00555971|20920903|P2|Overall Study|Adverse Event|1
6053933|NCT00555971|20920904|P1|Overall Study|Adverse Event|1
6053934|NCT00555906|20920915|P5|Phase 2|Randomized but not Treated|2
6053935|NCT00555906|20920916|P4|Phase 2|Randomized but not Treated|0
6053936|NCT00555906|20920917|P3|Phase 2|Randomized but not Treated|0
6053937|NCT00555906|20920918|P2|Phase 2|Randomized but not Treated|0
6053938|NCT00555906|20920919|P1|Phase 2|Randomized but not Treated|0
6053939|NCT00555906|20920915|P5|Phase 2|Other|6
6053940|NCT00555906|20920916|P4|Phase 2|Other|0
6053941|NCT00555906|20920917|P3|Phase 2|Other|0
6053942|NCT00555906|20920918|P2|Phase 2|Other|0
6053943|NCT00555906|20920919|P1|Phase 2|Other|0
6053944|NCT00555906|20920915|P5|Phase 2|Withdrawal by Subject|2
6053945|NCT00555906|20920916|P4|Phase 2|Withdrawal by Subject|0
6053946|NCT00555906|20920917|P3|Phase 2|Withdrawal by Subject|0
6053947|NCT00555906|20920918|P2|Phase 2|Withdrawal by Subject|0
6053948|NCT00555906|20920919|P1|Phase 2|Withdrawal by Subject|0
6053949|NCT00555906|20920915|P5|Phase 2|Objective Progression or Relapse|16
6053950|NCT00555906|20920916|P4|Phase 2|Objective Progression or Relapse|0
6053951|NCT00555906|20920917|P3|Phase 2|Objective Progression or Relapse|0
6053952|NCT00555906|20920918|P2|Phase 2|Objective Progression or Relapse|0
6053953|NCT00555906|20920919|P1|Phase 2|Objective Progression or Relapse|0
6053954|NCT00555906|20920915|P5|Phase 2|Global Deterioration of Health Status|2
6053955|NCT00555906|20920916|P4|Phase 2|Global Deterioration of Health Status|0
6053956|NCT00555906|20920917|P3|Phase 2|Global Deterioration of Health Status|0
6053957|NCT00555906|20920918|P2|Phase 2|Global Deterioration of Health Status|0
6053958|NCT00555906|20920919|P1|Phase 2|Global Deterioration of Health Status|0
6053959|NCT00555906|20920915|P5|Phase 2|Adverse Event|4
6053960|NCT00555906|20920916|P4|Phase 2|Adverse Event|0
6053961|NCT00555906|20920917|P3|Phase 2|Adverse Event|0
6053962|NCT00555906|20920918|P2|Phase 2|Adverse Event|0
6053963|NCT00555906|20920919|P1|Phase 2|Adverse Event|0
6053964|NCT00555906|20920915|P5|Phase 1|Withdrawal by Subject|0
6053965|NCT00555906|20920916|P4|Phase 1|Withdrawal by Subject|1
6053966|NCT00555906|20920917|P3|Phase 1|Withdrawal by Subject|0
6053967|NCT00555906|20920918|P2|Phase 1|Withdrawal by Subject|0
6053968|NCT00555906|20920919|P1|Phase 1|Withdrawal by Subject|0
6053969|NCT00555906|20920915|P5|Phase 1|Adverse Event|0
6053970|NCT00555906|20920916|P4|Phase 1|Adverse Event|2
6053971|NCT00555906|20920917|P3|Phase 1|Adverse Event|3
6053972|NCT00555906|20920918|P2|Phase 1|Adverse Event|0
6053973|NCT00555906|20920919|P1|Phase 1|Adverse Event|0
6053974|NCT00555906|20920915|P5|Phase 1|Global Deterioration of Health Status|0
6053975|NCT00555906|20920916|P4|Phase 1|Global Deterioration of Health Status|1
6053976|NCT00555906|20920917|P3|Phase 1|Global Deterioration of Health Status|1
6053977|NCT00555906|20920918|P2|Phase 1|Global Deterioration of Health Status|1
6053978|NCT00555906|20920919|P1|Phase 1|Global Deterioration of Health Status|0
6053979|NCT00555906|20920915|P5|Phase 1|Objective Progression or Relapse|0
6053980|NCT00555906|20920916|P4|Phase 1|Objective Progression or Relapse|1
6053981|NCT00555906|20920917|P3|Phase 1|Objective Progression or Relapse|3
6053982|NCT00555906|20920918|P2|Phase 1|Objective Progression or Relapse|5
6053983|NCT00555906|20920919|P1|Phase 1|Objective Progression or Relapse|3
6053984|NCT00555672|20921041|P2|Overall Study|Participant refused|0
6053985|NCT00555672|20921042|P1|Overall Study|Participant refused|2
6053986|NCT00555672|20921041|P2|Overall Study|Other|1
6053987|NCT00555672|20921042|P1|Overall Study|Other|3
6053988|NCT00555672|20921041|P2|Overall Study|Objective progression or relapse|5
6053989|NCT00555672|20921042|P1|Overall Study|Objective progression or relapse|11
6053990|NCT00555672|20921041|P2|Overall Study|Adverse Event|2
6053991|NCT00555672|20921042|P1|Overall Study|Adverse Event|8
6053992|NCT00555672|20921041|P2|Overall Study|Death|2
6053993|NCT00555672|20921042|P1|Overall Study|Death|0
6053994|NCT00555620|20921067|P6|Overall Study|Other|3
6053995|NCT00555620|20921068|P5|Overall Study|Other|0
6053996|NCT00555620|20921069|P4|Overall Study|Other|1
6053997|NCT00555620|20921070|P3|Overall Study|Other|0
6053998|NCT00555620|20921071|P2|Overall Study|Other|0
6053999|NCT00555620|20921072|P1|Overall Study|Other|0
6054000|NCT00555620|20921067|P6|Overall Study|Participant refused treatment|1
6054001|NCT00555620|20921068|P5|Overall Study|Participant refused treatment|0
6054002|NCT00555620|20921069|P4|Overall Study|Participant refused treatment|0
6054003|NCT00555620|20921070|P3|Overall Study|Participant refused treatment|1
6054004|NCT00555620|20921071|P2|Overall Study|Participant refused treatment|1
6054005|NCT00555620|20921072|P1|Overall Study|Participant refused treatment|0
6054006|NCT00555620|20921067|P6|Overall Study|Objective progression or relapse|16
6054007|NCT00555620|20921068|P5|Overall Study|Objective progression or relapse|3
6054008|NCT00555620|20921069|P4|Overall Study|Objective progression or relapse|17
6054009|NCT00555620|20921070|P3|Overall Study|Objective progression or relapse|12
6054010|NCT00555620|20921071|P2|Overall Study|Objective progression or relapse|5
6054011|NCT00555620|20921072|P1|Overall Study|Objective progression or relapse|6
6054012|NCT00555620|20921067|P6|Overall Study|Adverse Event|1
6054013|NCT00555620|20921068|P5|Overall Study|Adverse Event|0
6054014|NCT00555620|20921069|P4|Overall Study|Adverse Event|5
6054015|NCT00555620|20921070|P3|Overall Study|Adverse Event|1
6054016|NCT00555620|20921071|P2|Overall Study|Adverse Event|0
6054017|NCT00555620|20921072|P1|Overall Study|Adverse Event|0
6054018|NCT00555620|20921067|P6|Overall Study|Study terminated by sponsor|0
6054019|NCT00555620|20921068|P5|Overall Study|Study terminated by sponsor|0
6054020|NCT00555620|20921069|P4|Overall Study|Study terminated by sponsor|0
6054021|NCT00555620|20921070|P3|Overall Study|Study terminated by sponsor|1
6054022|NCT00555620|20921071|P2|Overall Study|Study terminated by sponsor|0
6054023|NCT00555620|20921072|P1|Overall Study|Study terminated by sponsor|0
6054024|NCT00555620|20921067|P6|Overall Study|Death|1
6054025|NCT00555620|20921068|P5|Overall Study|Death|0
6054026|NCT00555620|20921069|P4|Overall Study|Death|0
6054027|NCT00555620|20921070|P3|Overall Study|Death|0
6054028|NCT00555620|20921071|P2|Overall Study|Death|1
6054029|NCT00555620|20921072|P1|Overall Study|Death|0
6054030|NCT00555568|20921196|P3|Overall Study|Lost to Follow-up|16
6054031|NCT00555568|20921197|P2|Overall Study|Lost to Follow-up|16
6054032|NCT00555568|20921198|P1|Overall Study|Lost to Follow-up|26
6054033|NCT00555477|20921220|P2|Overall Study|Physician Decision|2
6054034|NCT00555477|20921221|P1|Overall Study|Physician Decision|1
6054035|NCT00555477|20921220|P2|Overall Study|Withdrawal by Subject|2
6054036|NCT00555477|20921221|P1|Overall Study|Withdrawal by Subject|1
6054037|NCT00555477|20921220|P2|Overall Study|Adverse Event|9
6054038|NCT00555477|20921221|P1|Overall Study|Adverse Event|0
6054039|NCT00555438|20921237|P1|Between 10 Days and 30 Days Postoperativ|Death|5
6054040|NCT00555438|20921237|P1|10 Days Post-operative|Death|4
6054041|NCT00555425|20921247|P2|Overall Study|Became pregnant and transferred care|1
6054042|NCT00555425|20921248|P1|Overall Study|Became pregnant and transferred care|0
6054043|NCT00555425|20921247|P2|Overall Study|Met criteria for protective transfer|3
6054044|NCT00555425|20921248|P1|Overall Study|Met criteria for protective transfer|16
6054045|NCT00555425|20921247|P2|Overall Study|Missed 3 physician management visits|0
6054046|NCT00555425|20921248|P1|Overall Study|Missed 3 physician management visits|1
6054047|NCT00555425|20921247|P2|Overall Study|Missed Medication > 1 wk|15
6054048|NCT00555425|20921248|P1|Overall Study|Missed Medication > 1 wk|34
6054049|NCT00555321|20921284|P5|Long-term Extension Phase|Other Reason|0
6054050|NCT00555321|20921285|P4|Long-term Extension Phase|Other Reason|0
6054051|NCT00555321|20921286|P3|Long-term Extension Phase|Other Reason|2
6054052|NCT00555321|20921287|P2|Long-term Extension Phase|Other Reason|0
6054053|NCT00555321|20921288|P1|Long-term Extension Phase|Other Reason|1
6054054|NCT00555321|20921284|P5|Long-term Extension Phase|Participant did not meet study criteria|1
6054055|NCT00555321|20921285|P4|Long-term Extension Phase|Participant did not meet study criteria|0
6054056|NCT00555321|20921286|P3|Long-term Extension Phase|Participant did not meet study criteria|0
6054057|NCT00555321|20921287|P2|Long-term Extension Phase|Participant did not meet study criteria|0
6054058|NCT00555321|20921288|P1|Long-term Extension Phase|Participant did not meet study criteria|0
6054059|NCT00555321|20921284|P5|Long-term Extension Phase|Death|0
6054060|NCT00555321|20921285|P4|Long-term Extension Phase|Death|3
6054061|NCT00555321|20921286|P3|Long-term Extension Phase|Death|0
6054062|NCT00555321|20921287|P2|Long-term Extension Phase|Death|0
6054063|NCT00555321|20921288|P1|Long-term Extension Phase|Death|2
6054064|NCT00555321|20921284|P5|Long-term Extension Phase|Administrative reason by sponsor|23
6054065|NCT00555321|20921285|P4|Long-term Extension Phase|Administrative reason by sponsor|31
6054066|NCT00555321|20921286|P3|Long-term Extension Phase|Administrative reason by sponsor|18
6054067|NCT00555321|20921287|P2|Long-term Extension Phase|Administrative reason by sponsor|21
6054068|NCT00555321|20921288|P1|Long-term Extension Phase|Administrative reason by sponsor|23
6054069|NCT00555321|20921284|P5|Long-term Extension Phase|Withdrawal by Subject|2
6054070|NCT00555321|20921285|P4|Long-term Extension Phase|Withdrawal by Subject|3
6054071|NCT00555321|20921286|P3|Long-term Extension Phase|Withdrawal by Subject|2
6054072|NCT00555321|20921287|P2|Long-term Extension Phase|Withdrawal by Subject|1
6054073|NCT00555321|20921288|P1|Long-term Extension Phase|Withdrawal by Subject|2
6054074|NCT00555321|20921284|P5|Long-term Extension Phase|Adverse Event|0
6054075|NCT00555321|20921285|P4|Long-term Extension Phase|Adverse Event|1
6054076|NCT00555321|20921286|P3|Long-term Extension Phase|Adverse Event|2
6054077|NCT00555321|20921287|P2|Long-term Extension Phase|Adverse Event|5
6054078|NCT00555321|20921288|P1|Long-term Extension Phase|Adverse Event|2
6054079|NCT00555321|20921284|P5|Treatment Phase up to 12-months|Never treated|4
6054080|NCT00555321|20921285|P4|Treatment Phase up to 12-months|Never treated|0
6054081|NCT00555321|20921286|P3|Treatment Phase up to 12-months|Never treated|1
6054082|NCT00555321|20921287|P2|Treatment Phase up to 12-months|Never treated|3
6054083|NCT00555321|20921288|P1|Treatment Phase up to 12-months|Never treated|2
6054084|NCT00555321|20921284|P5|Treatment Phase up to 12-months|Other Reason|0
6054085|NCT00555321|20921285|P4|Treatment Phase up to 12-months|Other Reason|0
6054086|NCT00555321|20921286|P3|Treatment Phase up to 12-months|Other Reason|2
6054087|NCT00555321|20921287|P2|Treatment Phase up to 12-months|Other Reason|3
6054088|NCT00555321|20921288|P1|Treatment Phase up to 12-months|Other Reason|1
6054089|NCT00555321|20921284|P5|Treatment Phase up to 12-months|Lack of Efficacy|0
6054090|NCT00555321|20921285|P4|Treatment Phase up to 12-months|Lack of Efficacy|0
6054091|NCT00555321|20921286|P3|Treatment Phase up to 12-months|Lack of Efficacy|5
6054092|NCT00555321|20921287|P2|Treatment Phase up to 12-months|Lack of Efficacy|8
6054093|NCT00555321|20921288|P1|Treatment Phase up to 12-months|Lack of Efficacy|9
6054094|NCT00555321|20921284|P5|Treatment Phase up to 12-months|Death|0
6054095|NCT00555321|20921285|P4|Treatment Phase up to 12-months|Death|0
6054096|NCT00555321|20921286|P3|Treatment Phase up to 12-months|Death|4
6054097|NCT00555321|20921287|P2|Treatment Phase up to 12-months|Death|1
6054098|NCT00555321|20921288|P1|Treatment Phase up to 12-months|Death|2
6054099|NCT00555321|20921284|P5|Treatment Phase up to 12-months|Withdrawal by Subject|0
6054100|NCT00555321|20921285|P4|Treatment Phase up to 12-months|Withdrawal by Subject|0
6054101|NCT00555321|20921286|P3|Treatment Phase up to 12-months|Withdrawal by Subject|1
6054102|NCT00555321|20921287|P2|Treatment Phase up to 12-months|Withdrawal by Subject|0
6054103|NCT00555321|20921288|P1|Treatment Phase up to 12-months|Withdrawal by Subject|1
6054104|NCT00555321|20921284|P5|Treatment Phase up to 12-months|Adverse Event|18
6054105|NCT00555321|20921285|P4|Treatment Phase up to 12-months|Adverse Event|7
6054106|NCT00555321|20921286|P3|Treatment Phase up to 12-months|Adverse Event|11
6054107|NCT00555321|20921287|P2|Treatment Phase up to 12-months|Adverse Event|7
6054108|NCT00555321|20921288|P1|Treatment Phase up to 12-months|Adverse Event|6
6054109|NCT00555217|20921592|P2|Overall Study|close out sites|17
6054110|NCT00555217|20921593|P1|Overall Study|close out sites|21
6054111|NCT00555217|20921592|P2|Overall Study|Lost to Follow-up|20
6054112|NCT00555217|20921593|P1|Overall Study|Lost to Follow-up|19
6054113|NCT00555217|20921592|P2|Overall Study|Withdrawal by Subject|31
6054114|NCT00555217|20921593|P1|Overall Study|Withdrawal by Subject|35
6054115|NCT00555061|20921630|P1|Overall Study|Participant enrolled, but never treated|1
6054116|NCT00555061|20921630|P1|Overall Study|Withdrawal by Subject|2
6054117|NCT00555061|20921630|P1|Overall Study|Lost to Follow-up|2
6054118|NCT00555061|20921630|P1|Overall Study|Protocol Violation|1
6054119|NCT00555061|20921630|P1|Overall Study|Adverse Event|3
6054120|NCT00555009|20921649|P2|Overall Study|Terminated by Sponsor|5
6054121|NCT00555009|20921650|P1|Overall Study|Terminated by Sponsor|2
6054122|NCT00555009|20921649|P2|Overall Study|Withdrawal by Subject|1
6054123|NCT00555009|20921650|P1|Overall Study|Withdrawal by Subject|0
6054124|NCT00554840|20921730|P2|Overall Study|Physician Decision|1
6054125|NCT00554840|20921731|P1|Overall Study|Physician Decision|0
6054126|NCT00554801|20921749|P2|Overall Study|Withdrawal by Subject|0
6054127|NCT00554801|20921750|P1|Overall Study|Withdrawal by Subject|14
6054128|NCT00554801|20921749|P2|Overall Study|left area before completion|0
6054129|NCT00554801|20921750|P1|Overall Study|left area before completion|5
6054130|NCT00554788|20921761|P3|Overall Study|Ineligible|1
6054131|NCT00554788|20921762|P2|Overall Study|Ineligible|0
6054132|NCT00554788|20921763|P1|Overall Study|Ineligible|2
6054133|NCT00554788|20921761|P3|Overall Study|Progressive disease|3
6054134|NCT00554788|20921762|P2|Overall Study|Progressive disease|0
6054135|NCT00554788|20921763|P1|Overall Study|Progressive disease|0
6054136|NCT00554788|20921761|P3|Overall Study|Refusal of further protocol therapy|1
6054137|NCT00554788|20921762|P2|Overall Study|Refusal of further protocol therapy|1
6054138|NCT00554788|20921763|P1|Overall Study|Refusal of further protocol therapy|0
6054139|NCT00554788|20921761|P3|Overall Study|Withdrawal by Subject|1
6054140|NCT00554788|20921762|P2|Overall Study|Withdrawal by Subject|0
6054141|NCT00554788|20921763|P1|Overall Study|Withdrawal by Subject|0
6054142|NCT00554788|20921761|P3|Overall Study|Physician Decision|3
6054143|NCT00554788|20921762|P2|Overall Study|Physician Decision|1
6054144|NCT00554788|20921763|P1|Overall Study|Physician Decision|1
6054145|NCT00554788|20921761|P3|Overall Study|Lost to Follow-up|3
6054146|NCT00554788|20921762|P2|Overall Study|Lost to Follow-up|3
6054147|NCT00554788|20921763|P1|Overall Study|Lost to Follow-up|4
6054148|NCT00554788|20921761|P3|Overall Study|Adverse Event|2
6054149|NCT00554788|20921762|P2|Overall Study|Adverse Event|1
6054150|NCT00554788|20921763|P1|Overall Study|Adverse Event|0
6054151|NCT00554619|20921795|P1|Overall Study|Liver Function Test Abnormality|1
6054152|NCT00554619|20921795|P1|Overall Study|Physician Decision|1
6054153|NCT00554619|20921795|P1|Overall Study|Adverse Event|1
6054154|NCT00554515|20921807|P1|Overall Study|Misc|15
6054155|NCT00554515|20921807|P1|Overall Study|Other|1
6054156|NCT00554515|20921807|P1|Overall Study|Achieved Stable Disease|7
6054157|NCT00554515|20921807|P1|Overall Study|Death|2
6054158|NCT00554515|20921807|P1|Overall Study|Adverse Event|9
6054159|NCT00554515|20921807|P1|Overall Study|Withdrawal by Subject|11
6054160|NCT00554515|20921807|P1|Overall Study|Physician Decision|18
6054161|NCT00554515|20921807|P1|Overall Study|Disease progression|52
6054162|NCT00554515|20921807|P1|Overall Study|Withdrawal by Subject|3
6054163|NCT00554229|20921870|P2|Overall Study|Randomised but no treatment received|0
6054164|NCT00554229|20921871|P1|Overall Study|Randomised but no treatment received|1
6054165|NCT00554229|20921870|P2|Overall Study|Reason not otherwise captured, eg; death|140
6054166|NCT00554229|20921871|P1|Overall Study|Reason not otherwise captured, eg; death|119
6054167|NCT00554229|20921870|P2|Overall Study|Protocol Violation|3
6054168|NCT00554229|20921871|P1|Overall Study|Protocol Violation|3
6054169|NCT00554229|20921870|P2|Overall Study|Adverse Event|39
6054170|NCT00554229|20921871|P1|Overall Study|Adverse Event|71
6054171|NCT00554229|20921870|P2|Overall Study|Withdrawal by Subject|37
6054172|NCT00554229|20921871|P1|Overall Study|Withdrawal by Subject|29
6054173|NCT00554229|20921870|P2|Overall Study|Lost to Follow-up|6
6054174|NCT00554229|20921871|P1|Overall Study|Lost to Follow-up|3
6054175|NCT00554216|20921896|P3|Overall Study|Lack of Efficacy|0
6054176|NCT00554216|20921897|P2|Overall Study|Lack of Efficacy|3
6054177|NCT00554216|20921898|P1|Overall Study|Lack of Efficacy|15
6054178|NCT00554216|20921896|P3|Overall Study|Other|10
6054179|NCT00554216|20921897|P2|Overall Study|Other|7
6054180|NCT00554216|20921898|P1|Overall Study|Other|12
6054181|NCT00554216|20921896|P3|Overall Study|Restricted med|1
6054182|NCT00554216|20921897|P2|Overall Study|Restricted med|1
6054183|NCT00554216|20921898|P1|Overall Study|Restricted med|3
6054184|NCT00554216|20921896|P3|Overall Study|Pregnancy|14
6054185|NCT00554216|20921897|P2|Overall Study|Pregnancy|1
6054186|NCT00554216|20921898|P1|Overall Study|Pregnancy|2
6054187|NCT00554216|20921896|P3|Overall Study|Non compliance|5
6054188|NCT00554216|20921897|P2|Overall Study|Non compliance|4
6054189|NCT00554216|20921898|P1|Overall Study|Non compliance|10
6054190|NCT00554216|20921896|P3|Overall Study|Withdrawal by Subject|43
6054191|NCT00554216|20921897|P2|Overall Study|Withdrawal by Subject|31
6054192|NCT00554216|20921898|P1|Overall Study|Withdrawal by Subject|92
6054193|NCT00554216|20921896|P3|Overall Study|Adverse Event|36
6054194|NCT00554216|20921897|P2|Overall Study|Adverse Event|16
6054195|NCT00554216|20921898|P1|Overall Study|Adverse Event|16
6054196|NCT00554216|20921896|P3|Overall Study|Lost to Follow-up|63
6054197|NCT00554216|20921897|P2|Overall Study|Lost to Follow-up|31
6054198|NCT00554216|20921898|P1|Overall Study|Lost to Follow-up|92
6054199|NCT00554190|20921909|P1|Overall Study|Termination forms not completed|10
6054200|NCT00554099|20921918|P3|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2
6054201|NCT00554099|20921919|P2|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2
6054202|NCT00554099|20921920|P1|Non-Treatment Phase (9 Months)|Withdrawal by Subject|4
6054203|NCT00554099|20921918|P3|Non-Treatment Phase (9 Months)|Relapse|1
6054204|NCT00554099|20921919|P2|Non-Treatment Phase (9 Months)|Relapse|1
6054205|NCT00554099|20921920|P1|Non-Treatment Phase (9 Months)|Relapse|2
6054206|NCT00554099|20921918|P3|Non-Treatment Phase (9 Months)|Lost to Follow-up|0
6054207|NCT00554099|20921919|P2|Non-Treatment Phase (9 Months)|Lost to Follow-up|2
6054208|NCT00554099|20921920|P1|Non-Treatment Phase (9 Months)|Lost to Follow-up|1
6054209|NCT00554099|20921918|P3|Treatment Period (12 Weeks)|Withdrawal by Subject|4
6054210|NCT00554099|20921919|P2|Treatment Period (12 Weeks)|Withdrawal by Subject|1
6054211|NCT00554099|20921920|P1|Treatment Period (12 Weeks)|Withdrawal by Subject|4
6054212|NCT00554099|20921918|P3|Treatment Period (12 Weeks)|Protocol Violation|2
6054213|NCT00554099|20921919|P2|Treatment Period (12 Weeks)|Protocol Violation|0
6054214|NCT00554099|20921920|P1|Treatment Period (12 Weeks)|Protocol Violation|0
6054215|NCT00554099|20921918|P3|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|0
6054216|NCT00554099|20921919|P2|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|2
6054217|NCT00554099|20921920|P1|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|1
6054218|NCT00554099|20921918|P3|Treatment Period (12 Weeks)|Lost to Follow-up|2
6054219|NCT00554099|20921919|P2|Treatment Period (12 Weeks)|Lost to Follow-up|0
6054220|NCT00554099|20921920|P1|Treatment Period (12 Weeks)|Lost to Follow-up|1
6054221|NCT00554099|20921918|P3|Treatment Period (12 Weeks)|Physician Decision|0
6054222|NCT00554099|20921919|P2|Treatment Period (12 Weeks)|Physician Decision|0
6054223|NCT00554099|20921920|P1|Treatment Period (12 Weeks)|Physician Decision|3
6054224|NCT00554099|20921918|P3|Treatment Period (12 Weeks)|Adverse Event|1
6054225|NCT00554099|20921919|P2|Treatment Period (12 Weeks)|Adverse Event|5
6054226|NCT00554099|20921920|P1|Treatment Period (12 Weeks)|Adverse Event|3
6054227|NCT00553787|20921975|P3|Overall Study|Other|13
6054228|NCT00553787|20921976|P2|Overall Study|Other|10
6054229|NCT00553787|20921977|P1|Overall Study|Other|18
6054230|NCT00553787|20921975|P3|Overall Study|Requirement for restricted medication|5
6054231|NCT00553787|20921976|P2|Overall Study|Requirement for restricted medication|7
6054232|NCT00553787|20921977|P1|Overall Study|Requirement for restricted medication|8
6054233|NCT00553787|20921975|P3|Overall Study|non compliance|11
6054234|NCT00553787|20921976|P2|Overall Study|non compliance|0
6054235|NCT00553787|20921977|P1|Overall Study|non compliance|4
6054236|NCT00553787|20921975|P3|Overall Study|Pregnancy|2
6054237|NCT00553787|20921976|P2|Overall Study|Pregnancy|1
6054238|NCT00553787|20921977|P1|Overall Study|Pregnancy|0
6054239|NCT00553787|20921975|P3|Overall Study|Lack of Efficacy|3
6054240|NCT00553787|20921976|P2|Overall Study|Lack of Efficacy|1
6054241|NCT00553787|20921977|P1|Overall Study|Lack of Efficacy|31
6054242|NCT00553787|20921975|P3|Overall Study|Withdrawal by Subject|83
6054243|NCT00553787|20921976|P2|Overall Study|Withdrawal by Subject|40
6054244|NCT00553787|20921977|P1|Overall Study|Withdrawal by Subject|151
6054245|NCT00553787|20921975|P3|Overall Study|Lost to Follow-up|78
6054246|NCT00553787|20921976|P2|Overall Study|Lost to Follow-up|44
6054247|NCT00553787|20921977|P1|Overall Study|Lost to Follow-up|132
6054248|NCT00553787|20921975|P3|Overall Study|Adverse Event|67
6054249|NCT00553787|20921976|P2|Overall Study|Adverse Event|21
6054250|NCT00553787|20921977|P1|Overall Study|Adverse Event|34
6054251|NCT00553696|20922009|P4|Overall Study|Withdrawal by Subject|0
6054252|NCT00553696|20922010|P3|Overall Study|Withdrawal by Subject|0
6054253|NCT00553696|20922011|P2|Overall Study|Withdrawal by Subject|1
6054254|NCT00553696|20922012|P1|Overall Study|Withdrawal by Subject|0
6054255|NCT00553696|20922009|P4|Overall Study|Objective progression or relapse|0
6054256|NCT00553696|20922010|P3|Overall Study|Objective progression or relapse|6
6054257|NCT00553696|20922011|P2|Overall Study|Objective progression or relapse|9
6054258|NCT00553696|20922012|P1|Overall Study|Objective progression or relapse|2
6054259|NCT00553696|20922009|P4|Overall Study|Global deterioration of health status|0
6054260|NCT00553696|20922010|P3|Overall Study|Global deterioration of health status|0
6054261|NCT00553696|20922011|P2|Overall Study|Global deterioration of health status|2
6054262|NCT00553696|20922012|P1|Overall Study|Global deterioration of health status|0
6054263|NCT00553696|20922009|P4|Overall Study|Adverse Event|1
6054264|NCT00553696|20922010|P3|Overall Study|Adverse Event|0
6054265|NCT00553696|20922011|P2|Overall Study|Adverse Event|4
6054266|NCT00553696|20922012|P1|Overall Study|Adverse Event|2
6054267|NCT00553644|20922050|P1|Overall Study|Alternative therapy|6
6054268|NCT00553644|20922050|P1|Overall Study|Physician Decision|1
6054269|NCT00553644|20922050|P1|Overall Study|Withdrawal by Subject|4
6054270|NCT00553644|20922050|P1|Overall Study|Adverse Event|17
6054271|NCT00553631|20922059|P2|Overall Study|Lost to Follow-up|0
6054272|NCT00553631|20922060|P1|Overall Study|Lost to Follow-up|1
6054273|NCT00553631|20922059|P2|Overall Study|Withdrawal by Subject|1
6054274|NCT00553631|20922060|P1|Overall Study|Withdrawal by Subject|0
6054275|NCT00553605|20922082|P2|Overall Study|Randomized but not treated|0
6054276|NCT00553605|20922083|P1|Overall Study|Randomized but not treated|2
6054277|NCT00553605|20922082|P2|Overall Study|Did not receive full dose|0
6054278|NCT00553605|20922083|P1|Overall Study|Did not receive full dose|1
6054279|NCT00553605|20922082|P2|Overall Study|Did not meet entrance criteria|3
6054280|NCT00553605|20922083|P1|Overall Study|Did not meet entrance criteria|1
6054281|NCT00553540|20922109|P2|Overall Study|discharged after first visit|5
6054282|NCT00553540|20922110|P1|Overall Study|discharged after first visit|2
6054283|NCT00553514|20922121|P5|Overall Study|Other|1
6054284|NCT00553514|20922122|P4|Overall Study|Other|0
6054285|NCT00553514|20922123|P3|Overall Study|Other|0
6054286|NCT00553514|20922124|P2|Overall Study|Other|1
6054287|NCT00553514|20922125|P1|Overall Study|Other|1
6054288|NCT00553514|20922121|P5|Overall Study|Risk of multiple pregnancy|0
6054289|NCT00553514|20922122|P4|Overall Study|Risk of multiple pregnancy|1
6054290|NCT00553514|20922123|P3|Overall Study|Risk of multiple pregnancy|0
6054291|NCT00553514|20922124|P2|Overall Study|Risk of multiple pregnancy|2
6054292|NCT00553514|20922125|P1|Overall Study|Risk of multiple pregnancy|0
6054293|NCT00553514|20922121|P5|Overall Study|Ovarian hyperstimulation syndrome risk|0
6054294|NCT00553514|20922122|P4|Overall Study|Ovarian hyperstimulation syndrome risk|0
6054295|NCT00553514|20922123|P3|Overall Study|Ovarian hyperstimulation syndrome risk|1
6054296|NCT00553514|20922124|P2|Overall Study|Ovarian hyperstimulation syndrome risk|0
6054297|NCT00553514|20922125|P1|Overall Study|Ovarian hyperstimulation syndrome risk|3
6054298|NCT00553514|20922121|P5|Overall Study|Lack of ovarian response|6
6054299|NCT00553514|20922122|P4|Overall Study|Lack of ovarian response|5
6054300|NCT00553514|20922123|P3|Overall Study|Lack of ovarian response|5
6054301|NCT00553514|20922124|P2|Overall Study|Lack of ovarian response|5
6054302|NCT00553514|20922125|P1|Overall Study|Lack of ovarian response|4
6054303|NCT00553514|20922121|P5|Overall Study|Protocol deviation|0
6054304|NCT00553514|20922122|P4|Overall Study|Protocol deviation|1
6054305|NCT00553514|20922123|P3|Overall Study|Protocol deviation|0
6054306|NCT00553514|20922124|P2|Overall Study|Protocol deviation|0
6054307|NCT00553514|20922125|P1|Overall Study|Protocol deviation|0
6054308|NCT00553501|20922162|P1|Overall Study|Progression|1
6054309|NCT00553501|20922162|P1|Overall Study|Death|1
6054310|NCT00553501|20922162|P1|Overall Study|Adverse Event|2
6054311|NCT00553475|20922171|P3|Overall Study|Due to moving|0
6054312|NCT00553475|20922172|P2|Overall Study|Due to moving|1
6054313|NCT00553475|20922173|P1|Overall Study|Due to moving|0
6054314|NCT00553475|20922171|P3|Overall Study|Physician Decision|0
6054315|NCT00553475|20922172|P2|Overall Study|Physician Decision|0
6054316|NCT00553475|20922173|P1|Overall Study|Physician Decision|1
6054317|NCT00553475|20922171|P3|Overall Study|Withdrawal by Subject|0
6054318|NCT00553475|20922172|P2|Overall Study|Withdrawal by Subject|1
6054319|NCT00553475|20922173|P1|Overall Study|Withdrawal by Subject|1
6054320|NCT00553475|20922171|P3|Overall Study|Lack of Efficacy|0
6054321|NCT00553475|20922172|P2|Overall Study|Lack of Efficacy|1
6054322|NCT00553475|20922173|P1|Overall Study|Lack of Efficacy|7
6054323|NCT00553475|20922171|P3|Overall Study|Adverse Event|13
6054324|NCT00553475|20922172|P2|Overall Study|Adverse Event|17
6054325|NCT00553475|20922173|P1|Overall Study|Adverse Event|7
6054326|NCT00553462|20922295|P1|Overall Study|Physician Decision|1
6054327|NCT00553462|20922295|P1|Overall Study|Withdrawal by Subject|5
6054328|NCT00553462|20922295|P1|Overall Study|Progression|4
6054329|NCT00553462|20922295|P1|Overall Study|Adverse Event|4
6054330|NCT00553436|20922301|P1|Overall Study|Conversion to another procedure|1
6054355|NCT00553332|20922353|P1|Overall Study|ineligible, incorrect diagnosis|1
6054356|NCT00553319|20922365|P3|Overall Study|moved|1
6054357|NCT00553319|20922366|P2|Overall Study|moved|0
6054358|NCT00553319|20922367|P1|Overall Study|moved|1
6054359|NCT00553319|20922365|P3|Overall Study|incarceration|0
6054360|NCT00553319|20922366|P2|Overall Study|incarceration|0
6054361|NCT00553319|20922367|P1|Overall Study|incarceration|1
6054362|NCT00553319|20922365|P3|Overall Study|non-compliance|2
6054363|NCT00553319|20922366|P2|Overall Study|non-compliance|0
6054364|NCT00553319|20922367|P1|Overall Study|non-compliance|0
6054365|NCT00553319|20922365|P3|Overall Study|wanted treatment elsewhere|1
6054366|NCT00553319|20922366|P2|Overall Study|wanted treatment elsewhere|1
6054367|NCT00553319|20922367|P1|Overall Study|wanted treatment elsewhere|2
6054368|NCT00553319|20922365|P3|Overall Study|Lost to Follow-up|5
6054369|NCT00553319|20922366|P2|Overall Study|Lost to Follow-up|9
6054370|NCT00553319|20922367|P1|Overall Study|Lost to Follow-up|10
6054371|NCT00553280|20922378|P1|Overall Study|Physician Decision|1
6054372|NCT00553280|20922378|P1|Overall Study|Withdrawal by Subject|3
6054373|NCT00553280|20922378|P1|Overall Study|Lack of Efficacy|3
6054374|NCT00553280|20922378|P1|Overall Study|Adverse Event|19
6054375|NCT00553267|20922390|P3|Overall Study|Specified category|1
6054376|NCT00553267|20922391|P2|Overall Study|Specified category|2
6054377|NCT00553267|20922392|P1|Overall Study|Specified category|1
6054378|NCT00553267|20922390|P3|Overall Study|Consent withdrawn|1
6054379|NCT00553267|20922391|P2|Overall Study|Consent withdrawn|3
6054380|NCT00553267|20922392|P1|Overall Study|Consent withdrawn|2
6054381|NCT00553267|20922390|P3|Overall Study|Lost to Follow-up|1
6054382|NCT00553267|20922391|P2|Overall Study|Lost to Follow-up|0
6054383|NCT00553267|20922392|P1|Overall Study|Lost to Follow-up|0
6054384|NCT00553267|20922390|P3|Overall Study|Non compliant with protocol|2
6054385|NCT00553267|20922391|P2|Overall Study|Non compliant with protocol|3
6054386|NCT00553267|20922392|P1|Overall Study|Non compliant with protocol|3
6054387|NCT00553267|20922390|P3|Overall Study|Adverse Event|5
6054388|NCT00553267|20922391|P2|Overall Study|Adverse Event|10
6054389|NCT00553267|20922392|P1|Overall Study|Adverse Event|8
6054390|NCT00553254|20922429|P3|Overall Study|Other|13
6054391|NCT00553254|20922430|P2|Overall Study|Other|0
6054392|NCT00553254|20922431|P1|Overall Study|Other|1
6054393|NCT00553254|20922429|P3|Overall Study|Study terminated by Sponsor|1
6054394|NCT00553254|20922430|P2|Overall Study|Study terminated by Sponsor|0
6054395|NCT00553254|20922431|P1|Overall Study|Study terminated by Sponsor|0
6054396|NCT00553254|20922429|P3|Overall Study|Withdrawal by Subject|2
6054397|NCT00553254|20922430|P2|Overall Study|Withdrawal by Subject|0
6054398|NCT00553254|20922431|P1|Overall Study|Withdrawal by Subject|2
6054399|NCT00553254|20922429|P3|Overall Study|Lost to Follow-up|2
6054400|NCT00553254|20922430|P2|Overall Study|Lost to Follow-up|0
6054401|NCT00553254|20922431|P1|Overall Study|Lost to Follow-up|0
6054402|NCT00553254|20922429|P3|Overall Study|Death|25
6054403|NCT00553254|20922430|P2|Overall Study|Death|6
6054404|NCT00553254|20922431|P1|Overall Study|Death|3
6054405|NCT00553202|20922473|P1|Overall Study|Fails to meet organ function|6
6054406|NCT00553202|20922473|P1|Overall Study|No donor identified|16
6054407|NCT00553202|20922473|P1|Overall Study|Withdrawal by Subject|1
6054408|NCT00553202|20922473|P1|Overall Study|Physician Decision|28
6054409|NCT00553202|20922473|P1|Overall Study|Lost to Follow-up|1
6054410|NCT00553202|20922473|P1|Overall Study|Death|16
6054411|NCT00553150|20922500|P4|Overall Study|Ineligible|1
6054412|NCT00553150|20922501|P3|Overall Study|Ineligible|0
6054413|NCT00553150|20922502|P2|Overall Study|Ineligible|0
6054414|NCT00553150|20922503|P1|Overall Study|Ineligible|0
6054415|NCT00553150|20922500|P4|Overall Study|Protocol Violation|1
6054416|NCT00553150|20922501|P3|Overall Study|Protocol Violation|0
6054417|NCT00553150|20922502|P2|Overall Study|Protocol Violation|0
6054418|NCT00553150|20922503|P1|Overall Study|Protocol Violation|0
6054419|NCT00553150|20922500|P4|Overall Study|Withdrawal by Subject|2
6054420|NCT00553150|20922501|P3|Overall Study|Withdrawal by Subject|0
6054421|NCT00553150|20922502|P2|Overall Study|Withdrawal by Subject|0
6054422|NCT00553150|20922503|P1|Overall Study|Withdrawal by Subject|0
6054423|NCT00553059|20922531|P2|Overall Study|Drug supply not available|1
6054424|NCT00553059|20922532|P1|Overall Study|Drug supply not available|0
6054425|NCT00553059|20922531|P2|Overall Study|Deemed ineligible|1
6054426|NCT00553059|20922532|P1|Overall Study|Deemed ineligible|1
6054427|NCT00552929|20922560|P10|Overall Study|Not Eligible|0
6054428|NCT00552929|20922561|P9|Overall Study|Not Eligible|0
6054429|NCT00552929|20922562|P8|Overall Study|Not Eligible|0
6054430|NCT00552929|20922563|P7|Overall Study|Not Eligible|0
6054431|NCT00552929|20922564|P6|Overall Study|Not Eligible|1
6054432|NCT00552929|20922565|P5|Overall Study|Not Eligible|0
6054433|NCT00552929|20922566|P4|Overall Study|Not Eligible|0
6054434|NCT00552929|20922567|P3|Overall Study|Not Eligible|0
6054435|NCT00552929|20922568|P2|Overall Study|Not Eligible|0
6054436|NCT00552929|20922569|P1|Overall Study|Not Eligible|0
6054437|NCT00552929|20922560|P10|Overall Study|Lost to Follow-up|0
6054438|NCT00552929|20922561|P9|Overall Study|Lost to Follow-up|1
6054439|NCT00552929|20922562|P8|Overall Study|Lost to Follow-up|0
6054440|NCT00552929|20922563|P7|Overall Study|Lost to Follow-up|0
6054441|NCT00552929|20922564|P6|Overall Study|Lost to Follow-up|0
6054442|NCT00552929|20922565|P5|Overall Study|Lost to Follow-up|0
6054443|NCT00552929|20922566|P4|Overall Study|Lost to Follow-up|0
6054444|NCT00552929|20922567|P3|Overall Study|Lost to Follow-up|0
6054445|NCT00552929|20922568|P2|Overall Study|Lost to Follow-up|0
6054446|NCT00552929|20922569|P1|Overall Study|Lost to Follow-up|0
6054447|NCT00552760|20922640|P2|Overall Study|Medication Change|0
6054448|NCT00552760|20922641|P1|Overall Study|Medication Change|1
6054449|NCT00552760|20922640|P2|Overall Study|Withdrawal by Subject|0
6054450|NCT00552760|20922641|P1|Overall Study|Withdrawal by Subject|3
6054451|NCT00552760|20922640|P2|Overall Study|Medical Condition|1
6054452|NCT00552760|20922641|P1|Overall Study|Medical Condition|1
6054453|NCT00552760|20922640|P2|Overall Study|Non-compliance|1
6054454|NCT00552760|20922641|P1|Overall Study|Non-compliance|1
6054455|NCT00552760|20922640|P2|Overall Study|Lost to Follow-up|1
6054456|NCT00552760|20922641|P1|Overall Study|Lost to Follow-up|1
6054457|NCT00552760|20922640|P2|Overall Study|Protocol Violation|1
6054458|NCT00552760|20922641|P1|Overall Study|Protocol Violation|0
6054459|NCT00552760|20922640|P2|Overall Study|Relapsed- Mixed Event|5
6054460|NCT00552760|20922641|P1|Overall Study|Relapsed- Mixed Event|3
6054461|NCT00552760|20922640|P2|Overall Study|Relapse- Manic Event|3
6054462|NCT00552760|20922641|P1|Overall Study|Relapse- Manic Event|3
6054463|NCT00552760|20922640|P2|Overall Study|Relapsed- Depressed Event|16
6054464|NCT00552760|20922641|P1|Overall Study|Relapsed- Depressed Event|10
6054465|NCT00552760|20922640|P2|Overall Study|Adverse Event|5
6054466|NCT00552760|20922641|P1|Overall Study|Adverse Event|3
6054467|NCT00552669|20922668|P2|Overall Study|Death|7
6054468|NCT00552669|20922669|P1|Overall Study|Death|3
6054469|NCT00552617|20922689|P10|Overall Study|Lost to Follow-up|0
6054470|NCT00552617|20922690|P9|Overall Study|Lost to Follow-up|2
6054471|NCT00552617|20922691|P8|Overall Study|Lost to Follow-up|0
6054472|NCT00552617|20922692|P7|Overall Study|Lost to Follow-up|0
6054473|NCT00552617|20922693|P6|Overall Study|Lost to Follow-up|2
6054474|NCT00552617|20922694|P5|Overall Study|Lost to Follow-up|0
6054475|NCT00552617|20922695|P4|Overall Study|Lost to Follow-up|1
6054476|NCT00552617|20922696|P3|Overall Study|Lost to Follow-up|0
6054477|NCT00552617|20922697|P2|Overall Study|Lost to Follow-up|0
6054478|NCT00552617|20922698|P1|Overall Study|Lost to Follow-up|0
6054479|NCT00552617|20922689|P10|Overall Study|Not Treated|1
6054480|NCT00552617|20922690|P9|Overall Study|Not Treated|0
6054481|NCT00552617|20922691|P8|Overall Study|Not Treated|0
6054482|NCT00552617|20922692|P7|Overall Study|Not Treated|0
6054483|NCT00552617|20922693|P6|Overall Study|Not Treated|0
6054484|NCT00552617|20922694|P5|Overall Study|Not Treated|0
6054485|NCT00552617|20922695|P4|Overall Study|Not Treated|0
6054486|NCT00552617|20922696|P3|Overall Study|Not Treated|1
6054487|NCT00552617|20922697|P2|Overall Study|Not Treated|0
6054488|NCT00552617|20922698|P1|Overall Study|Not Treated|0
6054489|NCT00552578|20922742|P2|Overall Study|Lost to Follow-up|1
6054490|NCT00552578|20922743|P1|Overall Study|Lost to Follow-up|1
6054491|NCT00552513|20922755|P2|Overall Study|Lost to Follow-up|1
6054492|NCT00552513|20922756|P1|Overall Study|Lost to Follow-up|5
6054493|NCT00552396|20922801|P7|Overall Study|protocol withdrawal criteria|9
6054494|NCT00552396|20922802|P6|Overall Study|protocol withdrawal criteria|3
6054495|NCT00552396|20922803|P5|Overall Study|protocol withdrawal criteria|3
6054496|NCT00552396|20922804|P4|Overall Study|protocol withdrawal criteria|6
6054497|NCT00552396|20922805|P3|Overall Study|protocol withdrawal criteria|3
6054498|NCT00552396|20922806|P2|Overall Study|protocol withdrawal criteria|3
6054499|NCT00552396|20922807|P1|Overall Study|protocol withdrawal criteria|3
6054500|NCT00552344|20922844|P1|Overall Study|Other Reason|22
6054501|NCT00552344|20922844|P1|Overall Study|SAE, fatal + AE, non-serious non-fatal|1
6054502|NCT00552344|20922844|P1|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|62
6054503|NCT00552344|20922844|P1|Overall Study|AE, non-serious non-fatal|38
6054504|NCT00552344|20922844|P1|Overall Study|SAE, non-fatal|6
6054505|NCT00552344|20922844|P1|Overall Study|Withdrawal by Subject|48
6054506|NCT00552344|20922844|P1|Overall Study|Lost to Follow-up|8
6054507|NCT00552344|20922844|P1|Overall Study|Loss of efficacy|75
6054508|NCT00552344|20922844|P1|Overall Study|Lack of Efficacy|55
6054509|NCT00552305|20922853|P1|Overall Study|Other: Subject went to rehab|1
6054510|NCT00552305|20922853|P1|Overall Study|Other: Subject incarcerated|1
6054511|NCT00552305|20922853|P1|Overall Study|Other: Subject moved from area|2
6054512|NCT00552305|20922853|P1|Overall Study|Other: Health problems, not drug related|1
6054513|NCT00552305|20922853|P1|Overall Study|Other: Subject became pregnant|1
6054514|NCT00552305|20922853|P1|Overall Study|Other: Subject underwent surgery|4
6054515|NCT00552305|20922853|P1|Overall Study|Other: Unable to attend visits|1
6054516|NCT00552305|20922853|P1|Overall Study|Other: Personal problems|1
6054517|NCT00552305|20922853|P1|Overall Study|Other: Site closed|4
6054518|NCT00552305|20922853|P1|Overall Study|LoE/WD consent/Other: cannot make visits|1
6054519|NCT00552305|20922853|P1|Overall Study|AE/Other: prohibited drug required|1
6054520|NCT00552305|20922853|P1|Overall Study|Poor compliance/lost to follow-up|1
6054521|NCT00552305|20922853|P1|Overall Study|Unsatisfactory compliance|11
6054522|NCT00552305|20922853|P1|Overall Study|Adverse event (AE)/withdrew (WD) consent|2
6054523|NCT00552305|20922853|P1|Overall Study|Lack of efficacy (LoE)/adverse event|3
6054524|NCT00552305|20922853|P1|Overall Study|Lack of efficacy/withdrew consent|1
6054525|NCT00552305|20922853|P1|Overall Study|Withdrawal by Subject|44
6054526|NCT00552305|20922853|P1|Overall Study|Protocol Violation|3
6054527|NCT00552305|20922853|P1|Overall Study|Lost to Follow-up|4
6054528|NCT00552305|20922853|P1|Overall Study|Lack of Efficacy|120
6054529|NCT00552305|20922853|P1|Overall Study|Adverse Event|43
6054530|NCT00552279|20922863|P2|Overall Study|Other|1
6054531|NCT00552279|20922864|P1|Overall Study|Other|1
6054532|NCT00552279|20922863|P2|Overall Study|Lost to Follow-up|0
6054533|NCT00552279|20922864|P1|Overall Study|Lost to Follow-up|1
6054534|NCT00552279|20922863|P2|Overall Study|Withdrawal by Subject|1
6054535|NCT00552279|20922864|P1|Overall Study|Withdrawal by Subject|12
6054536|NCT00552279|20922863|P2|Overall Study|Adverse Event|1
6054537|NCT00552279|20922864|P1|Overall Study|Adverse Event|0
6054538|NCT00552240|20922890|P2|Overall Study|Other|0
6054539|NCT00552240|20922891|P1|Overall Study|Other|1
6054540|NCT00552240|20922890|P2|Overall Study|Lack of Efficacy|0
6054541|NCT00552240|20922891|P1|Overall Study|Lack of Efficacy|6
6054542|NCT00552240|20922890|P2|Overall Study|Withdrawal by Subject|2
6054543|NCT00552240|20922891|P1|Overall Study|Withdrawal by Subject|2
6054544|NCT00552240|20922890|P2|Overall Study|Lost to Follow-up|6
6054545|NCT00552240|20922891|P1|Overall Study|Lost to Follow-up|5
6054546|NCT00552240|20922890|P2|Overall Study|Protocol Violation|1
6054547|NCT00552240|20922891|P1|Overall Study|Protocol Violation|1
6054548|NCT00552240|20922890|P2|Overall Study|Adverse Event|9
6054549|NCT00552240|20922891|P1|Overall Study|Adverse Event|9
6054550|NCT00552188|20922993|P2|Overall Study|Subject returned to home country|1
6054551|NCT00552188|20922994|P1|Overall Study|Subject returned to home country|0
6054552|NCT00552188|20922993|P2|Overall Study|Withdrawal of consent|1
6054553|NCT00552188|20922994|P1|Overall Study|Withdrawal of consent|0
6054554|NCT00552188|20922993|P2|Overall Study|Lost to Follow-up|1
6054555|NCT00552188|20922994|P1|Overall Study|Lost to Follow-up|2
6054556|NCT00552188|20922993|P2|Overall Study|Adverse Event|2
6054557|NCT00552188|20922994|P1|Overall Study|Adverse Event|0
6054558|NCT00552175|20923005|P3|Overall Study|Reason Not Specified|1
6054559|NCT00552175|20923006|P2|Overall Study|Reason Not Specified|1
6054560|NCT00552175|20923007|P1|Overall Study|Reason Not Specified|3
6054561|NCT00552175|20923005|P3|Overall Study|Entry Criteria Not Met|0
6054562|NCT00552175|20923006|P2|Overall Study|Entry Criteria Not Met|1
6054563|NCT00552175|20923007|P1|Overall Study|Entry Criteria Not Met|1
6054564|NCT00552175|20923005|P3|Overall Study|Lost to Follow-up|1
6054565|NCT00552175|20923006|P2|Overall Study|Lost to Follow-up|0
6054566|NCT00552175|20923007|P1|Overall Study|Lost to Follow-up|0
6054567|NCT00552175|20923005|P3|Overall Study|Withdrawal by Subject|1
6054568|NCT00552175|20923006|P2|Overall Study|Withdrawal by Subject|2
6054569|NCT00552175|20923007|P1|Overall Study|Withdrawal by Subject|2
6054570|NCT00552175|20923005|P3|Overall Study|Adverse Event|10
6054571|NCT00552175|20923006|P2|Overall Study|Adverse Event|9
6054572|NCT00552175|20923007|P1|Overall Study|Adverse Event|9
6054573|NCT00552175|20923005|P3|Overall Study|Lack of Efficacy|1
6054574|NCT00552175|20923006|P2|Overall Study|Lack of Efficacy|0
6054575|NCT00552175|20923007|P1|Overall Study|Lack of Efficacy|2
6054576|NCT00552110|20923047|P5|Overall Study|Nonserious Adverse Event (AE)|0
6054577|NCT00552110|20923048|P4|Overall Study|Nonserious Adverse Event (AE)|1
6054578|NCT00552110|20923049|P3|Overall Study|Nonserious Adverse Event (AE)|0
6054579|NCT00552110|20923050|P2|Overall Study|Nonserious Adverse Event (AE)|0
6054580|NCT00552110|20923051|P1|Overall Study|Nonserious Adverse Event (AE)|1
6054581|NCT00552110|20923047|P5|Overall Study|Increased Blood Pressure at Visit 2|0
6054582|NCT00552110|20923048|P4|Overall Study|Increased Blood Pressure at Visit 2|1
6054583|NCT00552110|20923049|P3|Overall Study|Increased Blood Pressure at Visit 2|0
6054584|NCT00552110|20923050|P2|Overall Study|Increased Blood Pressure at Visit 2|0
6054585|NCT00552110|20923051|P1|Overall Study|Increased Blood Pressure at Visit 2|0
6054586|NCT00552110|20923047|P5|Overall Study|Delay of Study due to Relabeling|0
6054672|NCT00552032|20923131|P2|Overall Study|Protocol Violation|12
6054587|NCT00552110|20923048|P4|Overall Study|Delay of Study due to Relabeling|1
6054588|NCT00552110|20923049|P3|Overall Study|Delay of Study due to Relabeling|0
6054589|NCT00552110|20923050|P2|Overall Study|Delay of Study due to Relabeling|0
6054590|NCT00552110|20923051|P1|Overall Study|Delay of Study due to Relabeling|0
6054591|NCT00552110|20923047|P5|Overall Study|Use of Prohibited Medication|0
6054592|NCT00552110|20923048|P4|Overall Study|Use of Prohibited Medication|0
6054593|NCT00552110|20923049|P3|Overall Study|Use of Prohibited Medication|0
6054594|NCT00552110|20923050|P2|Overall Study|Use of Prohibited Medication|1
6054595|NCT00552110|20923051|P1|Overall Study|Use of Prohibited Medication|1
6054596|NCT00552110|20923047|P5|Overall Study|Withdrawn per Sponsor|1
6054597|NCT00552110|20923048|P4|Overall Study|Withdrawn per Sponsor|0
6054598|NCT00552110|20923049|P3|Overall Study|Withdrawn per Sponsor|0
6054599|NCT00552110|20923050|P2|Overall Study|Withdrawn per Sponsor|1
6054600|NCT00552110|20923051|P1|Overall Study|Withdrawn per Sponsor|0
6054601|NCT00552110|20923047|P5|Overall Study|Failed to Comply With Study Requirements|1
6054602|NCT00552110|20923048|P4|Overall Study|Failed to Comply With Study Requirements|0
6054603|NCT00552110|20923049|P3|Overall Study|Failed to Comply With Study Requirements|1
6054604|NCT00552110|20923050|P2|Overall Study|Failed to Comply With Study Requirements|1
6054605|NCT00552110|20923051|P1|Overall Study|Failed to Comply With Study Requirements|1
6054606|NCT00552110|20923047|P5|Overall Study|Lost to Follow-up|1
6054607|NCT00552110|20923048|P4|Overall Study|Lost to Follow-up|1
6054608|NCT00552110|20923049|P3|Overall Study|Lost to Follow-up|0
6054609|NCT00552110|20923050|P2|Overall Study|Lost to Follow-up|0
6054610|NCT00552110|20923051|P1|Overall Study|Lost to Follow-up|0
6054611|NCT00552110|20923047|P5|Overall Study|Withdrawal by Subject|2
6054612|NCT00552110|20923048|P4|Overall Study|Withdrawal by Subject|3
6054613|NCT00552110|20923049|P3|Overall Study|Withdrawal by Subject|0
6054614|NCT00552110|20923050|P2|Overall Study|Withdrawal by Subject|2
6054615|NCT00552110|20923051|P1|Overall Study|Withdrawal by Subject|0
6054616|NCT00552110|20923047|P5|Overall Study|Lack of Efficacy|4
6054617|NCT00552110|20923048|P4|Overall Study|Lack of Efficacy|1
6054618|NCT00552110|20923049|P3|Overall Study|Lack of Efficacy|0
6054619|NCT00552110|20923050|P2|Overall Study|Lack of Efficacy|0
6054620|NCT00552110|20923051|P1|Overall Study|Lack of Efficacy|1
6054621|NCT00552110|20923047|P5|Overall Study|Serious or Life-Threatening AE|0
6054622|NCT00552110|20923048|P4|Overall Study|Serious or Life-Threatening AE|0
6054623|NCT00552110|20923049|P3|Overall Study|Serious or Life-Threatening AE|1
6054624|NCT00552110|20923050|P2|Overall Study|Serious or Life-Threatening AE|0
6054625|NCT00552110|20923051|P1|Overall Study|Serious or Life-Threatening AE|0
6054626|NCT00552084|20923070|P2|Overall Study|change in anti-arrythmic drug|1
6054627|NCT00552084|20923071|P1|Overall Study|change in anti-arrythmic drug|1
6054628|NCT00552084|20923070|P2|Overall Study|Protocol Violation|0
6054629|NCT00552084|20923071|P1|Overall Study|Protocol Violation|1
6054630|NCT00552084|20923070|P2|Overall Study|Withdrawal by Subject|5
6054631|NCT00552084|20923071|P1|Overall Study|Withdrawal by Subject|4
6054632|NCT00552084|20923070|P2|Overall Study|Adverse Event|3
6054633|NCT00552084|20923071|P1|Overall Study|Adverse Event|2
6054634|NCT00552071|20923079|P2|Overall Study|Withdrawal by Subject|1
6054635|NCT00552071|20923080|P1|Overall Study|Withdrawal by Subject|0
6054636|NCT00552071|20923079|P2|Overall Study|Death|1
6054637|NCT00552071|20923080|P1|Overall Study|Death|0
6054638|NCT00552071|20923079|P2|Overall Study|Pregnancy|0
6054639|NCT00552071|20923080|P1|Overall Study|Pregnancy|1
6054640|NCT00552071|20923079|P2|Overall Study|Physician Decision|0
6054641|NCT00552071|20923080|P1|Overall Study|Physician Decision|1
6054642|NCT00552071|20923079|P2|Overall Study|Lack of Efficacy|0
6054643|NCT00552071|20923080|P1|Overall Study|Lack of Efficacy|1
6054644|NCT00552071|20923079|P2|Overall Study|Adverse Event|0
6054645|NCT00552071|20923080|P1|Overall Study|Adverse Event|1
6054646|NCT00552058|20923090|P2|Overall Study|Other: Early Roll Over|0
6054647|NCT00552058|20923091|P1|Overall Study|Other: Early Roll Over|1
6054648|NCT00552058|20923090|P2|Overall Study|Other: Sponsors Decision|1
6054649|NCT00552058|20923091|P1|Overall Study|Other: Sponsors Decision|0
6054650|NCT00552058|20923090|P2|Overall Study|Other: Randomized in error|1
6054651|NCT00552058|20923091|P1|Overall Study|Other: Randomized in error|0
6054652|NCT00552058|20923090|P2|Overall Study|Other: Positive Stool Result|1
6054653|NCT00552058|20923091|P1|Overall Study|Other: Positive Stool Result|0
6054654|NCT00552058|20923090|P2|Overall Study|Other: Low CDAI score, entry violation|1
6054655|NCT00552058|20923091|P1|Overall Study|Other: Low CDAI score, entry violation|0
6054656|NCT00552058|20923090|P2|Overall Study|Other: Crossed Over to a Follow-up Study|1
6054657|NCT00552058|20923091|P1|Overall Study|Other: Crossed Over to a Follow-up Study|0
6054658|NCT00552058|20923090|P2|Overall Study|Other: Non Compliance|2
6054659|NCT00552058|20923091|P1|Overall Study|Other: Non Compliance|1
6054660|NCT00552058|20923090|P2|Overall Study|Other: Protocol Violation|1
6054661|NCT00552058|20923091|P1|Overall Study|Other: Protocol Violation|0
6054662|NCT00552058|20923090|P2|Overall Study|Withdrawal by Subject|4
6054663|NCT00552058|20923091|P1|Overall Study|Withdrawal by Subject|4
6054664|NCT00552058|20923090|P2|Overall Study|Lost to Follow-up|0
6054665|NCT00552058|20923091|P1|Overall Study|Lost to Follow-up|1
6054666|NCT00552058|20923090|P2|Overall Study|Lack of Efficacy|5
6054667|NCT00552058|20923091|P1|Overall Study|Lack of Efficacy|1
6054668|NCT00552058|20923090|P2|Overall Study|Adverse Event|7
6054669|NCT00552058|20923091|P1|Overall Study|Adverse Event|8
6054670|NCT00552032|20923131|P2|Overall Study|Lost to Follow-up|5
6054671|NCT00552032|20923132|P1|Overall Study|Lost to Follow-up|8
6054673|NCT00552032|20923132|P1|Overall Study|Protocol Violation|7
6054674|NCT00552032|20923131|P2|Overall Study|Withdrawal by Subject|2
6054675|NCT00552032|20923132|P1|Overall Study|Withdrawal by Subject|2
6054676|NCT00551759|20923176|P1|Overall Study|Ineligible|1
6054677|NCT00551759|20923176|P1|Overall Study|Death|5
6054678|NCT00551759|20923176|P1|Overall Study|Adverse Event|7
6054693|NCT00551525|20923224|P1|Overall Study|Protocol Violation|5
6054694|NCT00551460|20923233|P1|Overall Study|Not analyzable (did not start treatment)|4
6054695|NCT00551460|20923233|P1|Overall Study|Ineligible|4
6054696|NCT00551460|20923233|P1|Overall Study|Death|7
6054697|NCT00551460|20923233|P1|Overall Study|Physician Decision|1
6054698|NCT00551460|20923233|P1|Overall Study|Withdrawal by Subject|1
6054699|NCT00551460|20923233|P1|Overall Study|Adverse Event|1
6054700|NCT00551421|20923239|P1|Amended Protocol (Cetuximab-refr. mCRC)|Withdrawal by Subject|1
6054701|NCT00551369|20923246|P1|Overall Study|Not treated per protocol and re|1
6054702|NCT00551369|20923246|P1|Overall Study|Withdrawal by Subject|1
6054703|NCT00551369|20923246|P1|Overall Study|Protocol Violation|5
6054704|NCT00551291|20923255|P1|Overall Study|Physician Decision|1
6054705|NCT00551213|20923263|P2|Overall Study|Not Treated|2
6054706|NCT00551213|20923264|P1|Overall Study|Not Treated|1
6054707|NCT00551213|20923263|P2|Overall Study|Withdrawal by Subject|0
6054708|NCT00551213|20923264|P1|Overall Study|Withdrawal by Subject|2
6054709|NCT00551213|20923263|P2|Overall Study|Progressive Disease|12
6054710|NCT00551213|20923264|P1|Overall Study|Progressive Disease|41
6054711|NCT00551213|20923263|P2|Overall Study|Adverse Event|3
6054712|NCT00551213|20923264|P1|Overall Study|Adverse Event|6
6054713|NCT00551161|20923308|P1|Overall Study|Withdrawal by Subject|1
6054714|NCT00551135|20923316|P4|Overall Study|Withdrawal by Subject|1
6054715|NCT00551135|20923317|P3|Overall Study|Withdrawal by Subject|3
6054716|NCT00551135|20923318|P2|Overall Study|Withdrawal by Subject|0
6054717|NCT00551135|20923319|P1|Overall Study|Withdrawal by Subject|1
6054718|NCT00551135|20923316|P4|Overall Study|Other|2
6054719|NCT00551135|20923317|P3|Overall Study|Other|1
6054720|NCT00551135|20923318|P2|Overall Study|Other|2
6054721|NCT00551135|20923319|P1|Overall Study|Other|3
6054722|NCT00551135|20923316|P4|Overall Study|Lost to Follow-up|1
6054723|NCT00551135|20923317|P3|Overall Study|Lost to Follow-up|0
6054724|NCT00551135|20923318|P2|Overall Study|Lost to Follow-up|0
6054725|NCT00551135|20923319|P1|Overall Study|Lost to Follow-up|0
6054726|NCT00551135|20923316|P4|Overall Study|Adverse Event|1
6054727|NCT00551135|20923317|P3|Overall Study|Adverse Event|1
6054728|NCT00551135|20923318|P2|Overall Study|Adverse Event|0
6054729|NCT00551135|20923319|P1|Overall Study|Adverse Event|1
6054730|NCT00551031|20923448|P5|Overall Study|Did not receive vaccine|0
6054731|NCT00551031|20923449|P4|Overall Study|Did not receive vaccine|0
6054732|NCT00551031|20923450|P3|Overall Study|Did not receive vaccine|0
6054733|NCT00551031|20923451|P2|Overall Study|Did not receive vaccine|2
6054734|NCT00551031|20923452|P1|Overall Study|Did not receive vaccine|1
6054735|NCT00551031|20923448|P5|Overall Study|Serious Adverse Event|0
6054736|NCT00551031|20923449|P4|Overall Study|Serious Adverse Event|0
6054737|NCT00551031|20923450|P3|Overall Study|Serious Adverse Event|1
6054738|NCT00551031|20923451|P2|Overall Study|Serious Adverse Event|2
6054739|NCT00551031|20923452|P1|Overall Study|Serious Adverse Event|0
6054740|NCT00551031|20923448|P5|Overall Study|Withdrawal by Subject|0
6054741|NCT00551031|20923449|P4|Overall Study|Withdrawal by Subject|2
6054742|NCT00551031|20923450|P3|Overall Study|Withdrawal by Subject|1
6054743|NCT00551031|20923451|P2|Overall Study|Withdrawal by Subject|4
6054744|NCT00551031|20923452|P1|Overall Study|Withdrawal by Subject|0
6054745|NCT00551031|20923448|P5|Overall Study|Lost to Follow-up|1
6054746|NCT00551031|20923449|P4|Overall Study|Lost to Follow-up|1
6054747|NCT00551031|20923450|P3|Overall Study|Lost to Follow-up|0
6054748|NCT00551031|20923451|P2|Overall Study|Lost to Follow-up|1
6054749|NCT00551031|20923452|P1|Overall Study|Lost to Follow-up|0
6054750|NCT00551031|20923448|P5|Overall Study|Protocol Violation|0
6054751|NCT00551031|20923449|P4|Overall Study|Protocol Violation|0
6054752|NCT00551031|20923450|P3|Overall Study|Protocol Violation|0
6054753|NCT00551031|20923451|P2|Overall Study|Protocol Violation|1
6054754|NCT00551031|20923452|P1|Overall Study|Protocol Violation|1
6054755|NCT00551031|20923448|P5|Overall Study|Adverse Event|0
6054756|NCT00551031|20923449|P4|Overall Study|Adverse Event|0
6054757|NCT00551031|20923450|P3|Overall Study|Adverse Event|0
6054758|NCT00551031|20923451|P2|Overall Study|Adverse Event|1
6054759|NCT00551031|20923452|P1|Overall Study|Adverse Event|0
6054760|NCT00550953|20923481|P2|Overall Study|Not able to visit the site|3
6054761|NCT00550953|20923482|P1|Overall Study|Not able to visit the site|2
6054762|NCT00550953|20923481|P2|Overall Study|Adverse Event|3
6054763|NCT00550953|20923482|P1|Overall Study|Adverse Event|4
6054764|NCT00550836|20923529|P2|Overall Study|Withdrawal by Subject|9
6054765|NCT00550836|20923530|P1|Overall Study|Withdrawal by Subject|3
6054766|NCT00550771|20923546|P2|Overall Study|Protocol Violation|5
6054767|NCT00550771|20923547|P1|Overall Study|Protocol Violation|4
6054768|NCT00550771|20923546|P2|Overall Study|Withdrawal by Subject|1
6054769|NCT00550771|20923547|P1|Overall Study|Withdrawal by Subject|0
6054770|NCT00550771|20923546|P2|Overall Study|Physician Decision|0
6054771|NCT00550771|20923547|P1|Overall Study|Physician Decision|2
6054772|NCT00550771|20923546|P2|Overall Study|Discontinued for study-related reasons|1
6054773|NCT00550771|20923547|P1|Overall Study|Discontinued for study-related reasons|0
6054774|NCT00550771|20923546|P2|Overall Study|Adverse Event|3
6054775|NCT00550771|20923547|P1|Overall Study|Adverse Event|11
6054776|NCT00550745|20923561|P2|Overall Study|Screen failure|0
6054777|NCT00550745|20923562|P1|Overall Study|Screen failure|1
6054778|NCT00550745|20923561|P2|Overall Study|Withdrawal by Subject|10
6054779|NCT00550745|20923562|P1|Overall Study|Withdrawal by Subject|17
6054780|NCT00550745|20923561|P2|Overall Study|Protocol Violation|2
6054781|NCT00550745|20923562|P1|Overall Study|Protocol Violation|4
6054782|NCT00550745|20923561|P2|Overall Study|Physician Decision|2
6054783|NCT00550745|20923562|P1|Overall Study|Physician Decision|0
6054784|NCT00550745|20923561|P2|Overall Study|Lost to Follow-up|30
6054785|NCT00550745|20923562|P1|Overall Study|Lost to Follow-up|45
6054786|NCT00550745|20923561|P2|Overall Study|Death|16
6054787|NCT00550745|20923562|P1|Overall Study|Death|20
6054788|NCT00550732|20923570|P1|Overall Study|Adverse Event|1
6054789|NCT00550732|20923570|P1|Overall Study|Palliative care|1
6054790|NCT00550732|20923570|P1|Overall Study|Lost to Follow-up|1
6054791|NCT00550732|20923570|P1|Overall Study|Physician Decision|2
6054792|NCT00550732|20923570|P1|Overall Study|Withdrawal by Subject|2
6054793|NCT00550732|20923570|P1|Overall Study|Death|4
6054794|NCT00550680|20923581|P1|Overall Study|Screen Failure|6
6054795|NCT00550680|20923581|P1|Overall Study|Refused Treatment|19
6054796|NCT00550680|20923581|P1|Overall Study|Protocol Violation|7
6054797|NCT00550680|20923581|P1|Overall Study|Other|10
6054798|NCT00550680|20923581|P1|Overall Study|Lack of Efficacy|1
6054799|NCT00550680|20923581|P1|Overall Study|Lost to Follow-up|3
6054800|NCT00550680|20923581|P1|Overall Study|Early Improvement|1
6054801|NCT00550680|20923581|P1|Overall Study|Death|3
6054802|NCT00550680|20923581|P1|Overall Study|Adverse Event|5
6054803|NCT00550680|20923581|P1|Overall Study|Administrative Reasons|1
6054804|NCT00550615|20923602|P4|Overall Study|Not evaluable|7
6054805|NCT00550615|20923603|P3|Overall Study|Not evaluable|2
6054806|NCT00550615|20923604|P2|Overall Study|Not evaluable|0
6054807|NCT00550615|20923605|P1|Overall Study|Not evaluable|0
6054808|NCT00550615|20923602|P4|Overall Study|Withdrawal by Subject|3
6054809|NCT00550615|20923603|P3|Overall Study|Withdrawal by Subject|2
6054810|NCT00550615|20923604|P2|Overall Study|Withdrawal by Subject|0
6054811|NCT00550615|20923605|P1|Overall Study|Withdrawal by Subject|0
6054812|NCT00550550|20923624|P2|Overall Study|Randomized But Not Treated|0
6054813|NCT00550550|20923625|P1|Overall Study|Randomized But Not Treated|1
6054814|NCT00550550|20923624|P2|Overall Study|Did Not Meet Protocol Eligibility|1
6054815|NCT00550550|20923625|P1|Overall Study|Did Not Meet Protocol Eligibility|1
6054816|NCT00550550|20923624|P2|Overall Study|Protocol Violation|14
6054817|NCT00550550|20923625|P1|Overall Study|Protocol Violation|5
6054818|NCT00550550|20923624|P2|Overall Study|Withdrawal by Subject|8
6054819|NCT00550550|20923625|P1|Overall Study|Withdrawal by Subject|10
6054820|NCT00550550|20923624|P2|Overall Study|Lost to Follow-up|0
6054821|NCT00550550|20923625|P1|Overall Study|Lost to Follow-up|4
6054822|NCT00550550|20923624|P2|Overall Study|Treatment Failure|1
6054823|NCT00550550|20923625|P1|Overall Study|Treatment Failure|0
6054824|NCT00550550|20923624|P2|Overall Study|Adverse Event|5
6054825|NCT00550550|20923625|P1|Overall Study|Adverse Event|13
6054826|NCT00550537|20923637|P1|Overall Study|Treated closer to home|4
6054827|NCT00550537|20923637|P1|Overall Study|Declining performance status|2
6054828|NCT00550537|20923637|P1|Overall Study|Other complicating ilness|3
6054829|NCT00550537|20923637|P1|Overall Study|Change in treatment plan|4
6054830|NCT00550537|20923637|P1|Overall Study|Withdrawal by Subject|7
6054831|NCT00550537|20923637|P1|Overall Study|Disease progression before|46
6054832|NCT00550537|20923637|P1|Overall Study|Adverse Event|20
6054833|NCT00550537|20923637|P1|Overall Study|Death|18
6054834|NCT00550459|20923654|P2|Overall Study|Withdrawal by Subject|1
6054835|NCT00550459|20923655|P1|Overall Study|Withdrawal by Subject|1
6054836|NCT00550459|20923654|P2|Overall Study|Adverse Event|2
6054837|NCT00550459|20923655|P1|Overall Study|Adverse Event|0
6054838|NCT00550446|20923724|P11|Post Week 12|Other|0
6054839|NCT00550446|20923725|P10|Post Week 12|Other|1
6054840|NCT00550446|20923726|P9|Post Week 12|Other|1
6054841|NCT00550446|20923727|P8|Post Week 12|Other|0
6054842|NCT00550446|20923728|P7|Post Week 12|Other|1
6054843|NCT00550446|20923729|P6|Post Week 12|Other|0
6054844|NCT00550446|20923730|P5|Post Week 12|Other|0
6054845|NCT00550446|20923731|P4|Post Week 12|Other|1
6054846|NCT00550446|20923732|P3|Post Week 12|Other|0
6054847|NCT00550446|20923733|P2|Post Week 12|Other|1
6054848|NCT00550446|20923734|P1|Post Week 12|Other|1
6054849|NCT00550446|20923724|P11|Post Week 12|Withdrawal by Subject|0
6054850|NCT00550446|20923725|P10|Post Week 12|Withdrawal by Subject|0
6054851|NCT00550446|20923726|P9|Post Week 12|Withdrawal by Subject|0
6054852|NCT00550446|20923727|P8|Post Week 12|Withdrawal by Subject|0
6054853|NCT00550446|20923728|P7|Post Week 12|Withdrawal by Subject|0
6054854|NCT00550446|20923729|P6|Post Week 12|Withdrawal by Subject|0
6054855|NCT00550446|20923730|P5|Post Week 12|Withdrawal by Subject|1
6054856|NCT00550446|20923731|P4|Post Week 12|Withdrawal by Subject|0
6054857|NCT00550446|20923732|P3|Post Week 12|Withdrawal by Subject|0
6054858|NCT00550446|20923733|P2|Post Week 12|Withdrawal by Subject|0
6054859|NCT00550446|20923734|P1|Post Week 12|Withdrawal by Subject|0
6054860|NCT00550446|20923724|P11|Post Week 12|Lost to Follow-up|0
6054861|NCT00550446|20923725|P10|Post Week 12|Lost to Follow-up|0
6054862|NCT00550446|20923726|P9|Post Week 12|Lost to Follow-up|0
6054863|NCT00550446|20923727|P8|Post Week 12|Lost to Follow-up|0
6054864|NCT00550446|20923728|P7|Post Week 12|Lost to Follow-up|1
6054865|NCT00550446|20923729|P6|Post Week 12|Lost to Follow-up|0
6054866|NCT00550446|20923730|P5|Post Week 12|Lost to Follow-up|0
6054867|NCT00550446|20923731|P4|Post Week 12|Lost to Follow-up|1
6054868|NCT00550446|20923732|P3|Post Week 12|Lost to Follow-up|1
6054869|NCT00550446|20923733|P2|Post Week 12|Lost to Follow-up|0
6054870|NCT00550446|20923734|P1|Post Week 12|Lost to Follow-up|0
6054871|NCT00550446|20923724|P11|Post Week 12|Lack of Efficacy|1
6054872|NCT00550446|20923725|P10|Post Week 12|Lack of Efficacy|2
6054873|NCT00550446|20923726|P9|Post Week 12|Lack of Efficacy|1
6054874|NCT00550446|20923727|P8|Post Week 12|Lack of Efficacy|1
6054875|NCT00550446|20923728|P7|Post Week 12|Lack of Efficacy|0
6054876|NCT00550446|20923729|P6|Post Week 12|Lack of Efficacy|0
6054877|NCT00550446|20923730|P5|Post Week 12|Lack of Efficacy|0
6054878|NCT00550446|20923731|P4|Post Week 12|Lack of Efficacy|0
6054879|NCT00550446|20923732|P3|Post Week 12|Lack of Efficacy|1
6054880|NCT00550446|20923733|P2|Post Week 12|Lack of Efficacy|0
6054881|NCT00550446|20923734|P1|Post Week 12|Lack of Efficacy|0
6054882|NCT00550446|20923724|P11|Post Week 12|Adverse Event|0
6054883|NCT00550446|20923725|P10|Post Week 12|Adverse Event|4
6054884|NCT00550446|20923726|P9|Post Week 12|Adverse Event|0
6054885|NCT00550446|20923727|P8|Post Week 12|Adverse Event|0
6054886|NCT00550446|20923728|P7|Post Week 12|Adverse Event|0
6054887|NCT00550446|20923729|P6|Post Week 12|Adverse Event|1
6054888|NCT00550446|20923730|P5|Post Week 12|Adverse Event|1
6054889|NCT00550446|20923731|P4|Post Week 12|Adverse Event|1
6054890|NCT00550446|20923732|P3|Post Week 12|Adverse Event|1
6054891|NCT00550446|20923733|P2|Post Week 12|Adverse Event|1
6054892|NCT00550446|20923734|P1|Post Week 12|Adverse Event|2
6054893|NCT00550446|20923724|P11|Up To Week 12|Randomized not treated|0
6054894|NCT00550446|20923725|P10|Up To Week 12|Randomized not treated|0
6054895|NCT00550446|20923726|P9|Up To Week 12|Randomized not treated|0
6054896|NCT00550446|20923727|P8|Up To Week 12|Randomized not treated|0
6054897|NCT00550446|20923728|P7|Up To Week 12|Randomized not treated|0
6054898|NCT00550446|20923729|P6|Up To Week 12|Randomized not treated|0
6054899|NCT00550446|20923730|P5|Up To Week 12|Randomized not treated|0
6054900|NCT00550446|20923731|P4|Up To Week 12|Randomized not treated|0
6054901|NCT00550446|20923732|P3|Up To Week 12|Randomized not treated|1
6054902|NCT00550446|20923733|P2|Up To Week 12|Randomized not treated|1
6054903|NCT00550446|20923734|P1|Up To Week 12|Randomized not treated|0
6054904|NCT00550446|20923724|P11|Up To Week 12|Other|0
6054905|NCT00550446|20923725|P10|Up To Week 12|Other|0
6054906|NCT00550446|20923726|P9|Up To Week 12|Other|0
6054907|NCT00550446|20923727|P8|Up To Week 12|Other|0
6054908|NCT00550446|20923728|P7|Up To Week 12|Other|4
6054909|NCT00550446|20923729|P6|Up To Week 12|Other|1
6054910|NCT00550446|20923730|P5|Up To Week 12|Other|0
6054911|NCT00550446|20923731|P4|Up To Week 12|Other|0
6054912|NCT00550446|20923732|P3|Up To Week 12|Other|0
6054913|NCT00550446|20923733|P2|Up To Week 12|Other|0
6054914|NCT00550446|20923734|P1|Up To Week 12|Other|3
6054915|NCT00550446|20923724|P11|Up To Week 12|Withdrawal by Subject|0
6054916|NCT00550446|20923725|P10|Up To Week 12|Withdrawal by Subject|0
6054917|NCT00550446|20923726|P9|Up To Week 12|Withdrawal by Subject|0
6054918|NCT00550446|20923727|P8|Up To Week 12|Withdrawal by Subject|0
6054919|NCT00550446|20923728|P7|Up To Week 12|Withdrawal by Subject|3
6054920|NCT00550446|20923729|P6|Up To Week 12|Withdrawal by Subject|1
6054921|NCT00550446|20923730|P5|Up To Week 12|Withdrawal by Subject|0
6054922|NCT00550446|20923731|P4|Up To Week 12|Withdrawal by Subject|2
6054923|NCT00550446|20923732|P3|Up To Week 12|Withdrawal by Subject|3
6054924|NCT00550446|20923733|P2|Up To Week 12|Withdrawal by Subject|0
6054925|NCT00550446|20923734|P1|Up To Week 12|Withdrawal by Subject|2
6054926|NCT00550446|20923724|P11|Up To Week 12|Lost to Follow-up|0
6054927|NCT00550446|20923725|P10|Up To Week 12|Lost to Follow-up|0
6054928|NCT00550446|20923726|P9|Up To Week 12|Lost to Follow-up|0
6054929|NCT00550446|20923727|P8|Up To Week 12|Lost to Follow-up|0
6054930|NCT00550446|20923728|P7|Up To Week 12|Lost to Follow-up|2
6054931|NCT00550446|20923729|P6|Up To Week 12|Lost to Follow-up|1
6054932|NCT00550446|20923730|P5|Up To Week 12|Lost to Follow-up|1
6054933|NCT00550446|20923731|P4|Up To Week 12|Lost to Follow-up|0
6054934|NCT00550446|20923732|P3|Up To Week 12|Lost to Follow-up|0
6054935|NCT00550446|20923733|P2|Up To Week 12|Lost to Follow-up|1
6054936|NCT00550446|20923734|P1|Up To Week 12|Lost to Follow-up|0
6054937|NCT00550446|20923724|P11|Up To Week 12|Lack of Efficacy|0
6054938|NCT00550446|20923725|P10|Up To Week 12|Lack of Efficacy|0
6054939|NCT00550446|20923726|P9|Up To Week 12|Lack of Efficacy|0
6054940|NCT00550446|20923727|P8|Up To Week 12|Lack of Efficacy|0
6054941|NCT00550446|20923728|P7|Up To Week 12|Lack of Efficacy|3
6054942|NCT00550446|20923729|P6|Up To Week 12|Lack of Efficacy|3
6054943|NCT00550446|20923730|P5|Up To Week 12|Lack of Efficacy|0
6054944|NCT00550446|20923731|P4|Up To Week 12|Lack of Efficacy|1
6054945|NCT00550446|20923732|P3|Up To Week 12|Lack of Efficacy|0
6054946|NCT00550446|20923733|P2|Up To Week 12|Lack of Efficacy|1
6054947|NCT00550446|20923734|P1|Up To Week 12|Lack of Efficacy|3
6054948|NCT00550446|20923724|P11|Up To Week 12|Adverse Event|0
6054949|NCT00550446|20923725|P10|Up To Week 12|Adverse Event|0
6054950|NCT00550446|20923726|P9|Up To Week 12|Adverse Event|0
6054951|NCT00550446|20923727|P8|Up To Week 12|Adverse Event|0
6054952|NCT00550446|20923728|P7|Up To Week 12|Adverse Event|1
6054953|NCT00550446|20923729|P6|Up To Week 12|Adverse Event|2
6054954|NCT00550446|20923730|P5|Up To Week 12|Adverse Event|2
6054955|NCT00550446|20923731|P4|Up To Week 12|Adverse Event|0
6054956|NCT00550446|20923732|P3|Up To Week 12|Adverse Event|0
6054957|NCT00550446|20923733|P2|Up To Week 12|Adverse Event|2
6054958|NCT00550446|20923734|P1|Up To Week 12|Adverse Event|2
6054959|NCT00550420|20924166|P1|Overall Study|Prohibited medicine|1
6054960|NCT00550420|20924166|P1|Overall Study|Exclusion criteria|1
6054961|NCT00550420|20924166|P1|Overall Study|Out of Electrocardiogram criteria|1
6054962|NCT00550420|20924166|P1|Overall Study|Caregiver's decision to withdraw|1
6054963|NCT00550420|20924166|P1|Overall Study|Unethical stop of enrollment|2
6054964|NCT00550420|20924166|P1|Overall Study|Lack of curative effect|1
6054965|NCT00550420|20924166|P1|Overall Study|Investigators opinion|1
6054966|NCT00550420|20924166|P1|Overall Study|Prolonged QT Interval Electrocardiogram|12
6054967|NCT00550420|20924166|P1|Overall Study|Missing|2
6054968|NCT00550420|20924166|P1|Overall Study|Still in study at termination|206
6054969|NCT00550420|20924166|P1|Overall Study|Withdrawal by Subject|30
6054970|NCT00550420|20924166|P1|Overall Study|Protocol Violation|11
6054971|NCT00550420|20924166|P1|Overall Study|Lost to Follow-up|8
6054972|NCT00550420|20924166|P1|Overall Study|Adverse Event|28
6054973|NCT00550407|20924189|P3|26-Week Randomized Phase|Withdrawal by Subject|3
6054974|NCT00550407|20924190|P2|26-Week Randomized Phase|Withdrawal by Subject|1
6054975|NCT00550407|20924191|P1|26-Week Randomized Phase|Withdrawal by Subject|0
6054976|NCT00550407|20924189|P3|26-Week Randomized Phase|Investigator Discretion|0
6054977|NCT00550407|20924190|P2|26-Week Randomized Phase|Investigator Discretion|1
6054978|NCT00550407|20924191|P1|26-Week Randomized Phase|Investigator Discretion|0
6054979|NCT00550407|20924189|P3|26-Week Randomized Phase|Lack of Efficacy|19
6054980|NCT00550407|20924190|P2|26-Week Randomized Phase|Lack of Efficacy|36
6054981|NCT00550407|20924191|P1|26-Week Randomized Phase|Lack of Efficacy|0
6054982|NCT00550407|20924189|P3|26-Week Randomized Phase|Adverse Event|2
6054983|NCT00550407|20924190|P2|26-Week Randomized Phase|Adverse Event|5
6054984|NCT00550407|20924191|P1|26-Week Randomized Phase|Adverse Event|0
6054985|NCT00550407|20924189|P3|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0
6054986|NCT00550407|20924190|P2|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0
6054987|NCT00550407|20924191|P1|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|1
6054988|NCT00550407|20924189|P3|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0
6054989|NCT00550407|20924190|P2|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0
6054990|NCT00550407|20924191|P1|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|6
6054991|NCT00550407|20924189|P3|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0
6054992|NCT00550407|20924190|P2|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0
6054993|NCT00550407|20924191|P1|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|8
6054994|NCT00550407|20924189|P3|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0
6054995|NCT00550407|20924190|P2|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0
6054996|NCT00550407|20924191|P1|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|1
6054997|NCT00550407|20924189|P3|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0
6054998|NCT00550407|20924190|P2|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0
6054999|NCT00550407|20924191|P1|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|1
6055000|NCT00550407|20924189|P3|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0
6055001|NCT00550407|20924190|P2|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0
6055002|NCT00550407|20924191|P1|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|1
6055003|NCT00550407|20924189|P3|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0
6055004|NCT00550407|20924190|P2|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0
6055005|NCT00550407|20924191|P1|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|39
6055006|NCT00550407|20924189|P3|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0
6055007|NCT00550407|20924190|P2|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0
6055008|NCT00550407|20924191|P1|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|55
6055009|NCT00550238|20924263|P1|Overall Study|Sponsor decision|55
6055010|NCT00550238|20924263|P1|Overall Study|Lost to Follow-up|13
6055011|NCT00550238|20924263|P1|Overall Study|Patient noncompliance|25
6055012|NCT00550238|20924263|P1|Overall Study|Physician Decision|31
6055013|NCT00550238|20924263|P1|Overall Study|Withdrawal by Subject|167
6055014|NCT00550238|20924263|P1|Overall Study|Disease progression|46
6055015|NCT00550238|20924263|P1|Overall Study|Death|34
6055016|NCT00550238|20924263|P1|Overall Study|Adverse Event|88
6055017|NCT00550173|20924270|P3|Overall Study|Lost to Follow-up|3
6055018|NCT00550173|20924271|P2|Overall Study|Lost to Follow-up|4
6055019|NCT00550173|20924272|P1|Overall Study|Lost to Follow-up|4
6055020|NCT00550173|20924270|P3|Overall Study|Sponsor Decision|1
6055021|NCT00550173|20924271|P2|Overall Study|Sponsor Decision|7
6055022|NCT00550173|20924272|P1|Overall Study|Sponsor Decision|13
6055023|NCT00550173|20924270|P3|Overall Study|Withdrawal by Subject|17
6055024|NCT00550173|20924271|P2|Overall Study|Withdrawal by Subject|12
6055025|NCT00550173|20924272|P1|Overall Study|Withdrawal by Subject|9
6055026|NCT00550173|20924270|P3|Overall Study|Physician Decision|2
6055027|NCT00550173|20924271|P2|Overall Study|Physician Decision|2
6055028|NCT00550173|20924272|P1|Overall Study|Physician Decision|1
6055029|NCT00550173|20924270|P3|Overall Study|Death|50
6055030|NCT00550173|20924271|P2|Overall Study|Death|38
6055031|NCT00550173|20924272|P1|Overall Study|Death|45
6055032|NCT00550147|20924301|P1|Quetiapine Addition Treatment Period|Moved out of state|1
6055033|NCT00550147|20924301|P1|Quetiapine Addition Treatment Period|Noncompliance|2
6055034|NCT00550147|20924301|P1|Quetiapine Addition Treatment Period|Adverse Event|3
6055035|NCT00550147|20924301|P1|OROS Methylphenidate Monotherapy|Withdrawal by Subject|2
6055036|NCT00550147|20924301|P1|OROS Methylphenidate Monotherapy|significant improvement at visit 5|4
6055037|NCT00550043|20924324|P5|Overall Study|Other Reasons- Unspecified|0
6055038|NCT00550043|20924325|P4|Overall Study|Other Reasons- Unspecified|1
6055039|NCT00550043|20924326|P3|Overall Study|Other Reasons- Unspecified|0
6055040|NCT00550043|20924327|P2|Overall Study|Other Reasons- Unspecified|1
6055041|NCT00550043|20924328|P1|Overall Study|Other Reasons- Unspecified|0
6055042|NCT00550043|20924324|P5|Overall Study|Subject Withdrew Consent|0
6055043|NCT00550043|20924325|P4|Overall Study|Subject Withdrew Consent|0
6055044|NCT00550043|20924326|P3|Overall Study|Subject Withdrew Consent|1
6055045|NCT00550043|20924327|P2|Overall Study|Subject Withdrew Consent|2
6055046|NCT00550043|20924328|P1|Overall Study|Subject Withdrew Consent|0
6055047|NCT00550043|20924324|P5|Overall Study|Adverse Event|1
6055048|NCT00550043|20924325|P4|Overall Study|Adverse Event|1
6055049|NCT00550043|20924326|P3|Overall Study|Adverse Event|0
6055050|NCT00550043|20924327|P2|Overall Study|Adverse Event|0
6055051|NCT00550043|20924328|P1|Overall Study|Adverse Event|0
6055052|NCT00549939|20924383|P3|40-week Open Label Treatment Period|Other|4
6055053|NCT00549939|20924384|P2|40-week Open Label Treatment Period|Other|1
6055054|NCT00549939|20924385|P1|40-week Open Label Treatment Period|Other|0
6055055|NCT00549939|20924383|P3|40-week Open Label Treatment Period|Protocol Violation|0
6055056|NCT00549939|20924384|P2|40-week Open Label Treatment Period|Protocol Violation|1
6055057|NCT00549939|20924385|P1|40-week Open Label Treatment Period|Protocol Violation|0
6055058|NCT00549939|20924383|P3|40-week Open Label Treatment Period|Lack of Efficacy|0
6055059|NCT00549939|20924384|P2|40-week Open Label Treatment Period|Lack of Efficacy|1
6055060|NCT00549939|20924385|P1|40-week Open Label Treatment Period|Lack of Efficacy|0
6055061|NCT00549939|20924383|P3|40-week Open Label Treatment Period|Adverse Event|1
6055062|NCT00549939|20924384|P2|40-week Open Label Treatment Period|Adverse Event|2
6055063|NCT00549939|20924385|P1|40-week Open Label Treatment Period|Adverse Event|0
6055064|NCT00549939|20924383|P3|12-week Double Blind Treatment Period|Too many blood draws|0
6055065|NCT00549939|20924384|P2|12-week Double Blind Treatment Period|Too many blood draws|1
6055066|NCT00549939|20924385|P1|12-week Double Blind Treatment Period|Too many blood draws|0
6055067|NCT00549939|20924383|P3|12-week Double Blind Treatment Period|Adverse Event|2
6055068|NCT00549939|20924384|P2|12-week Double Blind Treatment Period|Adverse Event|1
6055069|NCT00549939|20924385|P1|12-week Double Blind Treatment Period|Adverse Event|1
6055070|NCT00549900|20924412|P1|Overall Study|Adverse Event|1
6055071|NCT00549770|20924468|P8|Overall Study|Adverse Event|4
6055072|NCT00549770|20924469|P7|Overall Study|Adverse Event|5
6055073|NCT00549770|20924470|P6|Overall Study|Adverse Event|0
6055074|NCT00549770|20924471|P5|Overall Study|Adverse Event|1
6055075|NCT00549770|20924472|P4|Overall Study|Adverse Event|2
6055076|NCT00549770|20924473|P3|Overall Study|Adverse Event|1
6055077|NCT00549770|20924474|P2|Overall Study|Adverse Event|3
6055078|NCT00549770|20924475|P1|Overall Study|Adverse Event|1
6055079|NCT00549770|20924468|P8|Overall Study|Abnormal laboratory values|0
6055080|NCT00549770|20924469|P7|Overall Study|Abnormal laboratory values|0
6055081|NCT00549770|20924470|P6|Overall Study|Abnormal laboratory values|1
6055082|NCT00549770|20924471|P5|Overall Study|Abnormal laboratory values|0
6055083|NCT00549770|20924472|P4|Overall Study|Abnormal laboratory values|0
6055084|NCT00549770|20924473|P3|Overall Study|Abnormal laboratory values|0
6055085|NCT00549770|20924474|P2|Overall Study|Abnormal laboratory values|0
6055086|NCT00549770|20924475|P1|Overall Study|Abnormal laboratory values|0
6055087|NCT00549770|20924468|P8|Overall Study|Abnormal test procedure results|1
6055088|NCT00549770|20924469|P7|Overall Study|Abnormal test procedure results|1
6055089|NCT00549770|20924470|P6|Overall Study|Abnormal test procedure results|1
6055090|NCT00549770|20924471|P5|Overall Study|Abnormal test procedure results|0
6055091|NCT00549770|20924472|P4|Overall Study|Abnormal test procedure results|2
6055092|NCT00549770|20924473|P3|Overall Study|Abnormal test procedure results|0
6055093|NCT00549770|20924474|P2|Overall Study|Abnormal test procedure results|0
6055094|NCT00549770|20924475|P1|Overall Study|Abnormal test procedure results|0
6055095|NCT00549770|20924468|P8|Overall Study|Lack of Efficacy|8
6055096|NCT00549770|20924469|P7|Overall Study|Lack of Efficacy|3
6055097|NCT00549770|20924470|P6|Overall Study|Lack of Efficacy|1
6055098|NCT00549770|20924471|P5|Overall Study|Lack of Efficacy|5
6055099|NCT00549770|20924472|P4|Overall Study|Lack of Efficacy|3
6055100|NCT00549770|20924473|P3|Overall Study|Lack of Efficacy|2
6055101|NCT00549770|20924474|P2|Overall Study|Lack of Efficacy|0
6055102|NCT00549770|20924475|P1|Overall Study|Lack of Efficacy|1
6055103|NCT00549770|20924468|P8|Overall Study|Withdrawal by Subject|9
6055104|NCT00549770|20924469|P7|Overall Study|Withdrawal by Subject|4
6055105|NCT00549770|20924470|P6|Overall Study|Withdrawal by Subject|6
6055106|NCT00549770|20924471|P5|Overall Study|Withdrawal by Subject|6
6055107|NCT00549770|20924472|P4|Overall Study|Withdrawal by Subject|5
6055108|NCT00549770|20924473|P3|Overall Study|Withdrawal by Subject|4
6055109|NCT00549770|20924474|P2|Overall Study|Withdrawal by Subject|6
6055110|NCT00549770|20924475|P1|Overall Study|Withdrawal by Subject|4
6055111|NCT00549770|20924468|P8|Overall Study|Lost to Follow-up|0
6055112|NCT00549770|20924469|P7|Overall Study|Lost to Follow-up|0
6055113|NCT00549770|20924470|P6|Overall Study|Lost to Follow-up|2
6055114|NCT00549770|20924471|P5|Overall Study|Lost to Follow-up|3
6055115|NCT00549770|20924472|P4|Overall Study|Lost to Follow-up|2
6055116|NCT00549770|20924473|P3|Overall Study|Lost to Follow-up|2
6055117|NCT00549770|20924474|P2|Overall Study|Lost to Follow-up|0
6055118|NCT00549770|20924475|P1|Overall Study|Lost to Follow-up|0
6055119|NCT00549770|20924468|P8|Overall Study|Administrative problems|1
6055120|NCT00549770|20924469|P7|Overall Study|Administrative problems|0
6055121|NCT00549770|20924470|P6|Overall Study|Administrative problems|0
6055122|NCT00549770|20924471|P5|Overall Study|Administrative problems|0
6055123|NCT00549770|20924472|P4|Overall Study|Administrative problems|0
6055124|NCT00549770|20924473|P3|Overall Study|Administrative problems|0
6055125|NCT00549770|20924474|P2|Overall Study|Administrative problems|1
6055126|NCT00549770|20924475|P1|Overall Study|Administrative problems|0
6055127|NCT00549770|20924468|P8|Overall Study|Protocol deviation|2
6055128|NCT00549770|20924469|P7|Overall Study|Protocol deviation|1
6055129|NCT00549770|20924470|P6|Overall Study|Protocol deviation|2
6055130|NCT00549770|20924471|P5|Overall Study|Protocol deviation|2
6055131|NCT00549770|20924472|P4|Overall Study|Protocol deviation|2
6055132|NCT00549770|20924473|P3|Overall Study|Protocol deviation|1
6055133|NCT00549770|20924474|P2|Overall Study|Protocol deviation|1
6055134|NCT00549770|20924475|P1|Overall Study|Protocol deviation|1
6055135|NCT00549757|20924559|P2|Extension Period (in Average 9 Months)|Patient's request|436
6055136|NCT00549757|20924560|P1|Extension Period (in Average 9 Months)|Patient's request|421
6055137|NCT00549757|20924559|P2|Extension Period (in Average 9 Months)|Withdrawal by Subject|16
6055138|NCT00549757|20924560|P1|Extension Period (in Average 9 Months)|Withdrawal by Subject|9
6055139|NCT00549757|20924559|P2|Extension Period (in Average 9 Months)|Lost to Follow-up|47
6055140|NCT00549757|20924560|P1|Extension Period (in Average 9 Months)|Lost to Follow-up|52
6055141|NCT00549757|20924559|P2|Extension Period (in Average 9 Months)|Death|136
6055142|NCT00549757|20924560|P1|Extension Period (in Average 9 Months)|Death|143
6055143|NCT00549757|20924559|P2|Active Treatment Phase: Max. 50 Months|Missing data|9
6055144|NCT00549757|20924560|P1|Active Treatment Phase: Max. 50 Months|Missing data|8
6055145|NCT00549757|20924559|P2|Active Treatment Phase: Max. 50 Months|Incorrect Entry|55
6055146|NCT00549757|20924560|P1|Active Treatment Phase: Max. 50 Months|Incorrect Entry|69
6055147|NCT00549757|20924559|P2|Active Treatment Phase: Max. 50 Months|Patient's request|380
6055148|NCT00549757|20924560|P1|Active Treatment Phase: Max. 50 Months|Patient's request|353
6055149|NCT00549757|20924559|P2|Active Treatment Phase: Max. 50 Months|Death|200
6055150|NCT00549757|20924560|P1|Active Treatment Phase: Max. 50 Months|Death|188
6055151|NCT00549757|20924559|P2|Active Treatment Phase: Max. 50 Months|Administrative problems|3019
6055152|NCT00549757|20924560|P1|Active Treatment Phase: Max. 50 Months|Administrative problems|2857
6055153|NCT00549757|20924559|P2|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|29
6055154|NCT00549757|20924560|P1|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|41
6055155|NCT00549757|20924559|P2|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38
6055156|NCT00549757|20924560|P1|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38
6055157|NCT00549757|20924559|P2|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|53
6055158|NCT00549757|20924560|P1|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|47
6055159|NCT00549757|20924559|P2|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7
6055160|NCT00549757|20924560|P1|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7
6055161|NCT00549757|20924559|P2|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|58
6055162|NCT00549757|20924560|P1|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|98
6055163|NCT00549757|20924559|P2|Active Treatment Phase: Max. 50 Months|Adverse Event|462
6055164|NCT00549757|20924560|P1|Active Treatment Phase: Max. 50 Months|Adverse Event|590
6055165|NCT00549718|20924622|P4|Overall Study|Administrative|1
6055166|NCT00549718|20924623|P3|Overall Study|Administrative|2
6055167|NCT00549718|20924624|P2|Overall Study|Administrative|2
6055168|NCT00549718|20924625|P1|Overall Study|Administrative|2
6055169|NCT00549718|20924622|P4|Overall Study|Withdrawal by Subject|13
6055170|NCT00549718|20924623|P3|Overall Study|Withdrawal by Subject|12
6055171|NCT00549718|20924624|P2|Overall Study|Withdrawal by Subject|18
6055172|NCT00549718|20924625|P1|Overall Study|Withdrawal by Subject|9
6055173|NCT00549718|20924622|P4|Overall Study|Lost to Follow-up|6
6055174|NCT00549718|20924623|P3|Overall Study|Lost to Follow-up|0
6055175|NCT00549718|20924624|P2|Overall Study|Lost to Follow-up|2
6055176|NCT00549718|20924625|P1|Overall Study|Lost to Follow-up|4
6055177|NCT00549718|20924622|P4|Overall Study|Adverse Event|3
6055178|NCT00549718|20924623|P3|Overall Study|Adverse Event|7
6055179|NCT00549718|20924624|P2|Overall Study|Adverse Event|8
6055180|NCT00549718|20924625|P1|Overall Study|Adverse Event|6
6055181|NCT00549718|20924622|P4|Overall Study|Insufficient clinical response|32
6055182|NCT00549718|20924623|P3|Overall Study|Insufficient clinical response|18
6055183|NCT00549718|20924624|P2|Overall Study|Insufficient clinical response|7
6055184|NCT00549718|20924625|P1|Overall Study|Insufficient clinical response|20
6055185|NCT00549640|20924641|P2|Overall Study|Lost to Follow-up|4
6055186|NCT00549640|20924642|P1|Overall Study|Lost to Follow-up|7
6055187|NCT00549640|20924641|P2|Overall Study|Adverse Event|0
6055188|NCT00549640|20924642|P1|Overall Study|Adverse Event|5
6055189|NCT00549640|20924641|P2|Overall Study|Withdrawal by Subject|12
6055190|NCT00549640|20924642|P1|Overall Study|Withdrawal by Subject|6
6055191|NCT00549601|20924655|P3|Received Study Drug|Withdrawal by Subject|1
6055192|NCT00549601|20924656|P2|Received Study Drug|Withdrawal by Subject|0
6055193|NCT00549601|20924657|P1|Received Study Drug|Withdrawal by Subject|2
6055194|NCT00549601|20924655|P3|Received Study Drug|Protocol Violation|1
6055195|NCT00549601|20924656|P2|Received Study Drug|Protocol Violation|4
6055196|NCT00549601|20924657|P1|Received Study Drug|Protocol Violation|3
6055197|NCT00549601|20924655|P3|Received Study Drug|Lost to Follow-up|1
6055198|NCT00549601|20924656|P2|Received Study Drug|Lost to Follow-up|1
6055199|NCT00549601|20924657|P1|Received Study Drug|Lost to Follow-up|0
6055200|NCT00549601|20924655|P3|Received Study Drug|Death|0
6055201|NCT00549601|20924656|P2|Received Study Drug|Death|1
6055202|NCT00549601|20924657|P1|Received Study Drug|Death|0
6055203|NCT00549601|20924655|P3|Received Study Drug|Adverse Event|1
6055204|NCT00549601|20924656|P2|Received Study Drug|Adverse Event|5
6055205|NCT00549601|20924657|P1|Received Study Drug|Adverse Event|2
6055206|NCT00549601|20924655|P3|Randomized|Withdrawal by Subject|1
6055207|NCT00549601|20924656|P2|Randomized|Withdrawal by Subject|1
6055208|NCT00549601|20924657|P1|Randomized|Withdrawal by Subject|0
6055209|NCT00549601|20924655|P3|Randomized|Protocol Violation|1
6055210|NCT00549601|20924656|P2|Randomized|Protocol Violation|0
6055211|NCT00549601|20924657|P1|Randomized|Protocol Violation|0
6055212|NCT00549562|20924679|P1|Overall Study|Lack of Efficacy|1
6055213|NCT00549562|20924679|P1|Overall Study|Adverse Event|1
6055238|NCT00549445|20924762|P2|Overall Study|Sputum & Blood Samples Not Available|17
6055239|NCT00549445|20924763|P1|Overall Study|Sputum & Blood Samples Not Available|15
6055240|NCT00549328|20924782|P1|Overall Study|Use of Prohibited Medication|1
6055241|NCT00549328|20924782|P1|Overall Study|Death|1
6055242|NCT00549328|20924782|P1|Overall Study|Disease Progression|10
6055243|NCT00549328|20924782|P1|Overall Study|Adverse Event|2
6055244|NCT00549302|20924793|P3|Open-Label|Withdrawal by Subject|6
6055245|NCT00549302|20924794|P2|Open-Label|Withdrawal by Subject|0
6055246|NCT00549302|20924795|P1|Open-Label|Withdrawal by Subject|0
6055247|NCT00549302|20924793|P3|Open-Label|New drug pulmonary atrial hypertension|2
6055248|NCT00549302|20924794|P2|Open-Label|New drug pulmonary atrial hypertension|0
6055249|NCT00549302|20924795|P1|Open-Label|New drug pulmonary atrial hypertension|0
6055250|NCT00549302|20924793|P3|Open-Label|Other|3
6055251|NCT00549302|20924794|P2|Open-Label|Other|0
6055252|NCT00549302|20924795|P1|Open-Label|Other|0
6055253|NCT00549302|20924793|P3|Open-Label|Lost to Follow-up|2
6055254|NCT00549302|20924794|P2|Open-Label|Lost to Follow-up|0
6055255|NCT00549302|20924795|P1|Open-Label|Lost to Follow-up|0
6055256|NCT00549302|20924793|P3|Open-Label|Investigator Decision|5
6055257|NCT00549302|20924794|P2|Open-Label|Investigator Decision|0
6055258|NCT00549302|20924795|P1|Open-Label|Investigator Decision|0
6055259|NCT00549302|20924793|P3|Open-Label|Death|40
6055260|NCT00549302|20924794|P2|Open-Label|Death|0
6055261|NCT00549302|20924795|P1|Open-Label|Death|0
6055262|NCT00549302|20924793|P3|Open-Label|Adverse Event|11
6055263|NCT00549302|20924794|P2|Open-Label|Adverse Event|0
6055264|NCT00549302|20924795|P1|Open-Label|Adverse Event|0
6055265|NCT00549302|20924793|P3|Double-Blind|New condition or starts new therapy|0
6055266|NCT00549302|20924794|P2|Double-Blind|New condition or starts new therapy|2
6055267|NCT00549302|20924795|P1|Double-Blind|New condition or starts new therapy|0
6055268|NCT00549302|20924793|P3|Double-Blind|New Drug Pulmonary Atrial Hypertension|0
6055269|NCT00549302|20924794|P2|Double-Blind|New Drug Pulmonary Atrial Hypertension|10
6055270|NCT00549302|20924795|P1|Double-Blind|New Drug Pulmonary Atrial Hypertension|1
6055271|NCT00549302|20924793|P3|Double-Blind|Lost to Follow-up|0
6055272|NCT00549302|20924794|P2|Double-Blind|Lost to Follow-up|2
6055273|NCT00549302|20924795|P1|Double-Blind|Lost to Follow-up|1
6055274|NCT00549302|20924793|P3|Double-Blind|Sponsor Decision|0
6055275|NCT00549302|20924794|P2|Double-Blind|Sponsor Decision|1
6055276|NCT00549302|20924795|P1|Double-Blind|Sponsor Decision|0
6055277|NCT00549302|20924793|P3|Double-Blind|Investigator Decision|0
6055278|NCT00549302|20924794|P2|Double-Blind|Investigator Decision|5
6055279|NCT00549302|20924795|P1|Double-Blind|Investigator Decision|1
6055280|NCT00549302|20924793|P3|Double-Blind|Withdrawal by Subject|0
6055281|NCT00549302|20924794|P2|Double-Blind|Withdrawal by Subject|8
6055282|NCT00549302|20924795|P1|Double-Blind|Withdrawal by Subject|3
6055283|NCT00549302|20924793|P3|Double-Blind|Adverse Event|0
6055284|NCT00549302|20924794|P2|Double-Blind|Adverse Event|16
6055285|NCT00549302|20924795|P1|Double-Blind|Adverse Event|3
6055286|NCT00549302|20924793|P3|Double-Blind|Death|0
6055287|NCT00549302|20924794|P2|Double-Blind|Death|9
6055288|NCT00549302|20924795|P1|Double-Blind|Death|2
6055289|NCT00549198|20924807|P2|Overall Study|Not Exposed to Study Drug|4
6055290|NCT00549198|20924808|P1|Overall Study|Not Exposed to Study Drug|3
6055291|NCT00549198|20924807|P2|Overall Study|Pregnancy|3
6055292|NCT00549198|20924808|P1|Overall Study|Pregnancy|0
6055293|NCT00549198|20924807|P2|Overall Study|No scan facilities|2
6055294|NCT00549198|20924808|P1|Overall Study|No scan facilities|0
6055295|NCT00549198|20924807|P2|Overall Study|Participant overweight, no scan possible|0
6055296|NCT00549198|20924808|P1|Overall Study|Participant overweight, no scan possible|1
6055297|NCT00549198|20924807|P2|Overall Study|Participant planning pregnancy|0
6055298|NCT00549198|20924808|P1|Overall Study|Participant planning pregnancy|1
6055299|NCT00549198|20924807|P2|Overall Study|Prohibited Medication|2
6055300|NCT00549198|20924808|P1|Overall Study|Prohibited Medication|1
6055301|NCT00549198|20924807|P2|Overall Study|Participant moved.Week 96 visit, no scan|0
6055302|NCT00549198|20924808|P1|Overall Study|Participant moved.Week 96 visit, no scan|1
6055303|NCT00549198|20924807|P2|Overall Study|Participant not able to perform Week 96|0
6055304|NCT00549198|20924808|P1|Overall Study|Participant not able to perform Week 96|1
6055305|NCT00549198|20924807|P2|Overall Study|Participant Moved|0
6055306|NCT00549198|20924808|P1|Overall Study|Participant Moved|2
6055307|NCT00549198|20924807|P2|Overall Study|Disease Progression|0
6055308|NCT00549198|20924808|P1|Overall Study|Disease Progression|1
6055309|NCT00549198|20924807|P2|Overall Study|Withdrawal by Subject|7
6055310|NCT00549198|20924808|P1|Overall Study|Withdrawal by Subject|7
6055311|NCT00549198|20924807|P2|Overall Study|Investigator Decision|3
6055312|NCT00549198|20924808|P1|Overall Study|Investigator Decision|4
6055313|NCT00549198|20924807|P2|Overall Study|Protocol Violation|2
6055314|NCT00549198|20924808|P1|Overall Study|Protocol Violation|7
6055315|NCT00549198|20924807|P2|Overall Study|Treatment Eligibility Criteria Not Met|0
6055316|NCT00549198|20924808|P1|Overall Study|Treatment Eligibility Criteria Not Met|3
6055317|NCT00549198|20924807|P2|Overall Study|Lost to Follow-up|8
6055318|NCT00549198|20924808|P1|Overall Study|Lost to Follow-up|7
6055319|NCT00549198|20924807|P2|Overall Study|Non-compliance|4
6055320|NCT00549198|20924808|P1|Overall Study|Non-compliance|2
6055321|NCT00549198|20924807|P2|Overall Study|Protocol-defined Virological Failure|0
6055322|NCT00549198|20924808|P1|Overall Study|Protocol-defined Virological Failure|7
6055323|NCT00549198|20924807|P2|Overall Study|Insufficient Viral Load Response|2
6055324|NCT00549198|20924808|P1|Overall Study|Insufficient Viral Load Response|4
6055325|NCT00549198|20924807|P2|Overall Study|Adverse Event|26
6055326|NCT00549198|20924808|P1|Overall Study|Adverse Event|28
6055327|NCT00549055|20924945|P1|Overall Study|Very low visual acuity (VA)|1
6055328|NCT00549055|20924945|P1|Overall Study|Choroidal neovascularization|1
6055329|NCT00549055|20924945|P1|Overall Study|Growth choroidal neovascularisation|1
6055330|NCT00549055|20924945|P1|Overall Study|Vitreous hemorrhage|1
6055331|NCT00549055|20924945|P1|Overall Study|Active choroidal neovascula increased|1
6055332|NCT00549055|20924945|P1|Overall Study|Decrease of size|1
6055333|NCT00549055|20924945|P1|Overall Study|Progression to fibrosis|2
6055334|NCT00549055|20924945|P1|Overall Study|Stabilization|5
6055335|NCT00549055|20924945|P1|Overall Study|Lack of Efficacy|18
6055336|NCT00549055|20924945|P1|Overall Study|Adverse Event|4
6055337|NCT00548847|20924989|P1|Overall Study|Disease progression|7
6055338|NCT00548808|20924996|P2|Overall Study|Sponsor Decision|1
6055339|NCT00548808|20924997|P1|Overall Study|Sponsor Decision|1
6055340|NCT00548808|20924996|P2|Overall Study|Lack of Efficacy|0
6055341|NCT00548808|20924997|P1|Overall Study|Lack of Efficacy|2
6055342|NCT00548808|20924996|P2|Overall Study|Entry Criteria Not Met|2
6055343|NCT00548808|20924997|P1|Overall Study|Entry Criteria Not Met|2
6055344|NCT00548808|20924996|P2|Overall Study|Death|0
6055345|NCT00548808|20924997|P1|Overall Study|Death|2
6055346|NCT00548808|20924996|P2|Overall Study|Adverse Event|5
6055347|NCT00548808|20924997|P1|Overall Study|Adverse Event|4
6055348|NCT00548808|20924996|P2|Overall Study|Physician Decision|3
6055349|NCT00548808|20924997|P1|Overall Study|Physician Decision|6
6055350|NCT00548808|20924996|P2|Overall Study|Withdrawal by Subject|4
6055351|NCT00548808|20924997|P1|Overall Study|Withdrawal by Subject|8
6055352|NCT00548808|20924996|P2|Overall Study|Protocol Violation|8
6055353|NCT00548808|20924997|P1|Overall Study|Protocol Violation|8
6055354|NCT00548808|20924996|P2|Overall Study|Lost to Follow-up|3
6055355|NCT00548808|20924997|P1|Overall Study|Lost to Follow-up|9
6055356|NCT00548717|20925021|P2|Overall Study|Alternative treatment for GVHD|0
6055357|NCT00548717|20925022|P1|Overall Study|Alternative treatment for GVHD|1
6055358|NCT00548717|20925021|P2|Overall Study|Relapse|0
6055359|NCT00548717|20925022|P1|Overall Study|Relapse|3
6055360|NCT00548717|20925021|P2|Overall Study|Death|2
6055361|NCT00548717|20925022|P1|Overall Study|Death|5
6055362|NCT00548548|20925066|P2|Overall Study|Lost to Follow-up|18
6055363|NCT00548548|20925067|P1|Overall Study|Lost to Follow-up|17
6055364|NCT00548548|20925066|P2|Overall Study|Death|348
6055365|NCT00548548|20925067|P1|Overall Study|Death|345
6055366|NCT00548405|20925110|P3|Overall Study|Randomized but not treated|0
6055367|NCT00548405|20925111|P2|Overall Study|Randomized but not treated|0
6055368|NCT00548405|20925112|P1|Overall Study|Randomized but not treated|1
6055369|NCT00548405|20925110|P3|Overall Study|Sponsor decision|0
6055370|NCT00548405|20925111|P2|Overall Study|Sponsor decision|0
6055371|NCT00548405|20925112|P1|Overall Study|Sponsor decision|1
6055372|NCT00548405|20925110|P3|Overall Study|Death|1
6055373|NCT00548405|20925111|P2|Overall Study|Death|1
6055374|NCT00548405|20925112|P1|Overall Study|Death|0
6055375|NCT00548405|20925110|P3|Overall Study|Lost to Follow-up|2
6055376|NCT00548405|20925111|P2|Overall Study|Lost to Follow-up|1
6055377|NCT00548405|20925112|P1|Overall Study|Lost to Follow-up|1
6055378|NCT00548405|20925110|P3|Overall Study|Withdrawal by Subject|5
6055379|NCT00548405|20925111|P2|Overall Study|Withdrawal by Subject|12
6055380|NCT00548405|20925112|P1|Overall Study|Withdrawal by Subject|36
6055381|NCT00548405|20925110|P3|Overall Study|Protocol Violation|0
6055382|NCT00548405|20925111|P2|Overall Study|Protocol Violation|0
6055383|NCT00548405|20925112|P1|Overall Study|Protocol Violation|1
6055384|NCT00548405|20925110|P3|Overall Study|Pregnancy|0
6055385|NCT00548405|20925111|P2|Overall Study|Pregnancy|0
6055386|NCT00548405|20925112|P1|Overall Study|Pregnancy|1
6055387|NCT00548405|20925110|P3|Overall Study|Physician Decision|1
6055388|NCT00548405|20925111|P2|Overall Study|Physician Decision|4
6055389|NCT00548405|20925112|P1|Overall Study|Physician Decision|3
6055390|NCT00548405|20925110|P3|Overall Study|Lack of Efficacy|0
6055391|NCT00548405|20925111|P2|Overall Study|Lack of Efficacy|0
6055392|NCT00548405|20925112|P1|Overall Study|Lack of Efficacy|6
6055393|NCT00548405|20925110|P3|Overall Study|Adverse Event|0
6055394|NCT00548405|20925111|P2|Overall Study|Adverse Event|2
6055395|NCT00548405|20925112|P1|Overall Study|Adverse Event|6
6055396|NCT00548340|20925133|P3|Overall Study|Other|1
6055397|NCT00548340|20925134|P2|Overall Study|Other|1
6055398|NCT00548340|20925135|P1|Overall Study|Other|1
6055399|NCT00548340|20925133|P3|Overall Study|Withdrawal by Subject|3
6055400|NCT00548340|20925134|P2|Overall Study|Withdrawal by Subject|4
6055401|NCT00548340|20925135|P1|Overall Study|Withdrawal by Subject|2
6055402|NCT00548340|20925133|P3|Overall Study|Lost to Follow-up|0
6055403|NCT00548340|20925134|P2|Overall Study|Lost to Follow-up|1
6055404|NCT00548340|20925135|P1|Overall Study|Lost to Follow-up|1
6055405|NCT00548340|20925133|P3|Overall Study|Adverse Event|2
6055406|NCT00548340|20925134|P2|Overall Study|Adverse Event|2
6055407|NCT00548340|20925135|P1|Overall Study|Adverse Event|2
6055408|NCT00548340|20925133|P3|Overall Study|Protocol Violation|3
6055409|NCT00548340|20925134|P2|Overall Study|Protocol Violation|3
6055410|NCT00548340|20925135|P1|Overall Study|Protocol Violation|2
6055411|NCT00548327|20925154|P2|Overall Study|Adverse Event|1
6055412|NCT00548327|20925155|P1|Overall Study|Adverse Event|0
6055413|NCT00548262|20925173|P1|Overall Study|Withdrawal by Subject|1
6055414|NCT00548262|20925173|P1|Overall Study|Other|3
6055415|NCT00548262|20925173|P1|Overall Study|Lost to Follow-up|1
6055416|NCT00548262|20925173|P1|Overall Study|Lack of Efficacy|4
6055417|NCT00548262|20925173|P1|Overall Study|Adverse Event|2
6055418|NCT00548262|20925173|P1|Overall Study|Death|21
6055419|NCT00548249|20925203|P5|Overall Study|Sponsor's request|0
6055420|NCT00548249|20925204|P4|Overall Study|Sponsor's request|1
6055421|NCT00548249|20925205|P3|Overall Study|Sponsor's request|0
6055422|NCT00548249|20925206|P2|Overall Study|Sponsor's request|0
6055423|NCT00548249|20925207|P1|Overall Study|Sponsor's request|0
6055424|NCT00548249|20925203|P5|Overall Study|Corrected Q-wave T-wave (QTc) increase|1
6055425|NCT00548249|20925204|P4|Overall Study|Corrected Q-wave T-wave (QTc) increase|0
6055426|NCT00548249|20925205|P3|Overall Study|Corrected Q-wave T-wave (QTc) increase|0
6055427|NCT00548249|20925206|P2|Overall Study|Corrected Q-wave T-wave (QTc) increase|1
6055428|NCT00548249|20925207|P1|Overall Study|Corrected Q-wave T-wave (QTc) increase|0
6055429|NCT00548249|20925203|P5|Overall Study|Withdrawal by Subject|0
6055430|NCT00548249|20925204|P4|Overall Study|Withdrawal by Subject|0
6055431|NCT00548249|20925205|P3|Overall Study|Withdrawal by Subject|0
6055432|NCT00548249|20925206|P2|Overall Study|Withdrawal by Subject|0
6055433|NCT00548249|20925207|P1|Overall Study|Withdrawal by Subject|2
6055434|NCT00548249|20925203|P5|Overall Study|Prolonged hospitalization|0
6055435|NCT00548249|20925204|P4|Overall Study|Prolonged hospitalization|1
6055436|NCT00548249|20925205|P3|Overall Study|Prolonged hospitalization|2
6055437|NCT00548249|20925206|P2|Overall Study|Prolonged hospitalization|0
6055438|NCT00548249|20925207|P1|Overall Study|Prolonged hospitalization|0
6055439|NCT00548249|20925203|P5|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|0
6055440|NCT00548249|20925204|P4|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1
6055441|NCT00548249|20925205|P3|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1
6055442|NCT00548249|20925206|P2|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1
6055443|NCT00548249|20925207|P1|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1
6055444|NCT00548249|20925203|P5|Overall Study|Erythropoietin (ESA)Dose Change Required|2
6055445|NCT00548249|20925204|P4|Overall Study|Erythropoietin (ESA)Dose Change Required|2
6055446|NCT00548249|20925205|P3|Overall Study|Erythropoietin (ESA)Dose Change Required|1
6055447|NCT00548249|20925206|P2|Overall Study|Erythropoietin (ESA)Dose Change Required|0
6055448|NCT00548249|20925207|P1|Overall Study|Erythropoietin (ESA)Dose Change Required|0
6055449|NCT00548249|20925203|P5|Overall Study|Post-dialysis high TSAT or low UIBC|2
6055534|NCT00547521|20925473|P1|Short Term Study (4 Months)|Adverse Event|1
6055450|NCT00548249|20925204|P4|Overall Study|Post-dialysis high TSAT or low UIBC|3
6055451|NCT00548249|20925205|P3|Overall Study|Post-dialysis high TSAT or low UIBC|1
6055452|NCT00548249|20925206|P2|Overall Study|Post-dialysis high TSAT or low UIBC|0
6055453|NCT00548249|20925207|P1|Overall Study|Post-dialysis high TSAT or low UIBC|0
6055454|NCT00548249|20925203|P5|Overall Study|Adverse Event|1
6055455|NCT00548249|20925204|P4|Overall Study|Adverse Event|1
6055456|NCT00548249|20925205|P3|Overall Study|Adverse Event|0
6055457|NCT00548249|20925206|P2|Overall Study|Adverse Event|2
6055458|NCT00548249|20925207|P1|Overall Study|Adverse Event|2
6055459|NCT00548249|20925203|P5|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|4
6055460|NCT00548249|20925204|P4|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|1
6055461|NCT00548249|20925205|P3|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|2
6055462|NCT00548249|20925206|P2|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0
6055463|NCT00548249|20925207|P1|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0
6055464|NCT00548249|20925203|P5|Overall Study|Miscellaneous|2
6055465|NCT00548249|20925204|P4|Overall Study|Miscellaneous|0
6055466|NCT00548249|20925205|P3|Overall Study|Miscellaneous|2
6055467|NCT00548249|20925206|P2|Overall Study|Miscellaneous|3
6055468|NCT00548249|20925207|P1|Overall Study|Miscellaneous|2
6055469|NCT00548249|20925203|P5|Overall Study|Protocol Violation|3
6055470|NCT00548249|20925204|P4|Overall Study|Protocol Violation|0
6055471|NCT00548249|20925205|P3|Overall Study|Protocol Violation|4
6055472|NCT00548249|20925206|P2|Overall Study|Protocol Violation|1
6055473|NCT00548249|20925207|P1|Overall Study|Protocol Violation|1
6055474|NCT00548249|20925203|P5|Overall Study|Transferrin Saturation (TSAT) <20%|2
6055475|NCT00548249|20925204|P4|Overall Study|Transferrin Saturation (TSAT) <20%|1
6055476|NCT00548249|20925205|P3|Overall Study|Transferrin Saturation (TSAT) <20%|3
6055477|NCT00548249|20925206|P2|Overall Study|Transferrin Saturation (TSAT) <20%|1
6055478|NCT00548249|20925207|P1|Overall Study|Transferrin Saturation (TSAT) <20%|5
6055479|NCT00548249|20925203|P5|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4
6055480|NCT00548249|20925204|P4|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|2
6055481|NCT00548249|20925205|P3|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4
6055482|NCT00548249|20925206|P2|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4
6055483|NCT00548249|20925207|P1|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|3
6055484|NCT00548184|20925255|P1|Overall Study|Found Her2 negative|1
6055485|NCT00548184|20925255|P1|Overall Study|took other drug|1
6055486|NCT00548184|20925255|P1|Overall Study|Adverse Event|3
6055487|NCT00548145|20925303|P2|Overall Study|Physician Decision|1
6055488|NCT00548145|20925304|P1|Overall Study|Physician Decision|1
6055489|NCT00548145|20925303|P2|Overall Study|Withdrawal by Subject|2
6055490|NCT00548145|20925304|P1|Overall Study|Withdrawal by Subject|0
6055491|NCT00548145|20925303|P2|Overall Study|Death|1
6055492|NCT00548145|20925304|P1|Overall Study|Death|0
6055493|NCT00548093|20925323|P2|Overall Study|Completed post-treatment follow-up|0
6055494|NCT00548093|20925324|P1|Overall Study|Completed post-treatment follow-up|1
6055495|NCT00548093|20925323|P2|Overall Study|Withdrawal by Subject|0
6055496|NCT00548093|20925324|P1|Overall Study|Withdrawal by Subject|1
6055497|NCT00548093|20925323|P2|Overall Study|Other|1
6055498|NCT00548093|20925324|P1|Overall Study|Other|11
6055499|NCT00548093|20925323|P2|Overall Study|Objective progression or relapse|1
6055500|NCT00548093|20925324|P1|Overall Study|Objective progression or relapse|1
6055501|NCT00548093|20925323|P2|Overall Study|Lost to Follow-up|1
6055502|NCT00548093|20925324|P1|Overall Study|Lost to Follow-up|3
6055503|NCT00548093|20925323|P2|Overall Study|Death|13
6055504|NCT00548093|20925324|P1|Overall Study|Death|33
6055505|NCT00547911|20925362|P6|Overall Study|Adverse Event|0
6055506|NCT00547911|20925363|P5|Overall Study|Adverse Event|0
6055507|NCT00547911|20925364|P4|Overall Study|Adverse Event|1
6055508|NCT00547911|20925365|P3|Overall Study|Adverse Event|0
6055509|NCT00547911|20925366|P2|Overall Study|Adverse Event|0
6055510|NCT00547911|20925367|P1|Overall Study|Adverse Event|0
6055511|NCT00547703|20925417|P2|Overall Study|Lost to Follow-up|0
6055512|NCT00547703|20925418|P1|Overall Study|Lost to Follow-up|1
6055513|NCT00547534|20925464|P1|Overall Study|Disease Progression|4
6055514|NCT00547534|20925464|P1|Overall Study|Adverse Event|7
6055515|NCT00547521|20925472|P2|Long Term Extension (LTE) Study|Poor/Non-Compliance|1
6055516|NCT00547521|20925473|P1|Long Term Extension (LTE) Study|Poor/Non-Compliance|0
6055517|NCT00547521|20925472|P2|Long Term Extension (LTE) Study|Other|2
6055518|NCT00547521|20925473|P1|Long Term Extension (LTE) Study|Other|0
6055519|NCT00547521|20925472|P2|Long Term Extension (LTE) Study|Withdrawal by Subject|2
6055520|NCT00547521|20925473|P1|Long Term Extension (LTE) Study|Withdrawal by Subject|0
6055521|NCT00547521|20925472|P2|Long Term Extension (LTE) Study|Lost to Follow-up|3
6055522|NCT00547521|20925473|P1|Long Term Extension (LTE) Study|Lost to Follow-up|0
6055523|NCT00547521|20925472|P2|Long Term Extension (LTE) Study|Adverse Event|9
6055524|NCT00547521|20925473|P1|Long Term Extension (LTE) Study|Adverse Event|0
6055525|NCT00547521|20925472|P2|Long Term Extension (LTE) Study|Lack of Efficacy|14
6055526|NCT00547521|20925473|P1|Long Term Extension (LTE) Study|Lack of Efficacy|0
6055527|NCT00547521|20925472|P2|Short Term Study (4 Months)|primary endpoint evaluation not complete|1
6055528|NCT00547521|20925473|P1|Short Term Study (4 Months)|primary endpoint evaluation not complete|0
6055529|NCT00547521|20925472|P2|Short Term Study (4 Months)|Withdrawal of consent|1
6055530|NCT00547521|20925473|P1|Short Term Study (4 Months)|Withdrawal of consent|0
6055531|NCT00547521|20925472|P2|Short Term Study (4 Months)|Lack of Efficacy|2
6055532|NCT00547521|20925473|P1|Short Term Study (4 Months)|Lack of Efficacy|0
6055533|NCT00547521|20925472|P2|Short Term Study (4 Months)|Adverse Event|0
6055535|NCT00547378|20925550|P3|All Implanted Cohort|Other reasons|1
6055536|NCT00547378|20925551|P2|All Implanted Cohort|Other reasons|0
6055537|NCT00547378|20925552|P1|All Implanted Cohort|Other reasons|1
6055538|NCT00547378|20925550|P3|All Implanted Cohort|Site closure|1
6055539|NCT00547378|20925551|P2|All Implanted Cohort|Site closure|0
6055540|NCT00547378|20925552|P1|All Implanted Cohort|Site closure|2
6055541|NCT00547378|20925550|P3|All Implanted Cohort|Physician Decision|6
6055542|NCT00547378|20925551|P2|All Implanted Cohort|Physician Decision|2
6055543|NCT00547378|20925552|P1|All Implanted Cohort|Physician Decision|0
6055544|NCT00547378|20925550|P3|All Implanted Cohort|Death|4
6055545|NCT00547378|20925551|P2|All Implanted Cohort|Death|1
6055546|NCT00547378|20925552|P1|All Implanted Cohort|Death|3
6055547|NCT00547378|20925550|P3|All Implanted Cohort|Lost to Follow-up|14
6055548|NCT00547378|20925551|P2|All Implanted Cohort|Lost to Follow-up|1
6055549|NCT00547378|20925552|P1|All Implanted Cohort|Lost to Follow-up|0
6055550|NCT00547378|20925550|P3|All Implanted Cohort|Adverse Event|17
6055551|NCT00547378|20925551|P2|All Implanted Cohort|Adverse Event|10
6055552|NCT00547378|20925552|P1|All Implanted Cohort|Adverse Event|4
6055553|NCT00547378|20925550|P3|All Implanted Cohort|Withdrawal by Subject|27
6055554|NCT00547378|20925551|P2|All Implanted Cohort|Withdrawal by Subject|4
6055555|NCT00547378|20925552|P1|All Implanted Cohort|Withdrawal by Subject|5
6055556|NCT00547378|20925550|P3|Randomized Cohort|Other reasons|0
6055557|NCT00547378|20925551|P2|Randomized Cohort|Other reasons|0
6055558|NCT00547378|20925552|P1|Randomized Cohort|Other reasons|2
6055559|NCT00547378|20925550|P3|Randomized Cohort|Adverse Event|0
6055560|NCT00547378|20925551|P2|Randomized Cohort|Adverse Event|0
6055561|NCT00547378|20925552|P1|Randomized Cohort|Adverse Event|1
6055562|NCT00547378|20925550|P3|Randomized Cohort|Lost to Follow-up|0
6055563|NCT00547378|20925551|P2|Randomized Cohort|Lost to Follow-up|0
6055564|NCT00547378|20925552|P1|Randomized Cohort|Lost to Follow-up|1
6055565|NCT00547378|20925550|P3|Randomized Cohort|Death|0
6055566|NCT00547378|20925551|P2|Randomized Cohort|Death|1
6055567|NCT00547378|20925552|P1|Randomized Cohort|Death|0
6055568|NCT00547378|20925550|P3|Randomized Cohort|Withdrawal by Subject|0
6055569|NCT00547378|20925551|P2|Randomized Cohort|Withdrawal by Subject|5
6055570|NCT00547378|20925552|P1|Randomized Cohort|Withdrawal by Subject|7
6055571|NCT00547365|20925562|P1|Overall Study|death (not related to study)|4
6055572|NCT00547365|20925562|P1|Overall Study|Protocol Violation|2
6055573|NCT00547365|20925562|P1|Overall Study|Lost to Follow-up|1
6055574|NCT00547365|20925562|P1|Overall Study|Physician Decision|1
6055575|NCT00547300|20925569|P2|Overall Study|Did not Meet Entry Criteria|2
6055576|NCT00547300|20925570|P1|Overall Study|Did not Meet Entry Criteria|0
6055577|NCT00547300|20925569|P2|Overall Study|Study was Administratively Terminated|24
6055578|NCT00547300|20925570|P1|Overall Study|Study was Administratively Terminated|25
6055579|NCT00547248|20925584|P4|Overall Study|Withdrawal by Subject|1
6055580|NCT00547248|20925585|P3|Overall Study|Withdrawal by Subject|7
6055581|NCT00547248|20925586|P2|Overall Study|Withdrawal by Subject|0
6055582|NCT00547248|20925587|P1|Overall Study|Withdrawal by Subject|0
6055583|NCT00547248|20925584|P4|Overall Study|Migrated/moved from study area|0
6055584|NCT00547248|20925585|P3|Overall Study|Migrated/moved from study area|2
6055585|NCT00547248|20925586|P2|Overall Study|Migrated/moved from study area|0
6055586|NCT00547248|20925587|P1|Overall Study|Migrated/moved from study area|0
6055587|NCT00547248|20925584|P4|Overall Study|Protocol Violation|1
6055588|NCT00547248|20925585|P3|Overall Study|Protocol Violation|1
6055589|NCT00547248|20925586|P2|Overall Study|Protocol Violation|0
6055590|NCT00547248|20925587|P1|Overall Study|Protocol Violation|0
6055591|NCT00547157|20925705|P2|Overall Study|Lost to Follow-up|2
6055592|NCT00547157|20925706|P1|Overall Study|Lost to Follow-up|4
6055593|NCT00547157|20925705|P2|Overall Study|Administrative decision|2
6055594|NCT00547157|20925706|P1|Overall Study|Administrative decision|3
6055595|NCT00547157|20925705|P2|Overall Study|Withdrawal by Subject|1
6055596|NCT00547157|20925706|P1|Overall Study|Withdrawal by Subject|3
6055597|NCT00547157|20925705|P2|Overall Study|Death|18
6055598|NCT00547157|20925706|P1|Overall Study|Death|38
6055599|NCT00547157|20925705|P2|Overall Study|Other|0
6055600|NCT00547157|20925706|P1|Overall Study|Other|1
6055601|NCT00547118|20925724|P2|Overall Study|Study suspended|8
6055602|NCT00547118|20925725|P1|Overall Study|Study suspended|7
6055603|NCT00547118|20925724|P2|Overall Study|Did not qualify prior to starting drug|1
6055604|NCT00547118|20925725|P1|Overall Study|Did not qualify prior to starting drug|1
6055605|NCT00546910|20925769|P2|Overall Study|Withdrawal by Subject|0
6055606|NCT00546910|20925770|P1|Overall Study|Withdrawal by Subject|2
6055607|NCT00546910|20925769|P2|Overall Study|Physician Decision|1
6055608|NCT00546910|20925770|P1|Overall Study|Physician Decision|0
6055609|NCT00546910|20925769|P2|Overall Study|Lack of Efficacy|7
6055610|NCT00546910|20925770|P1|Overall Study|Lack of Efficacy|5
6055611|NCT00546910|20925769|P2|Overall Study|Adverse Event|3
6055612|NCT00546910|20925770|P1|Overall Study|Adverse Event|2
6055613|NCT00546871|20925836|P2|Study Extension Period|Withdrawal by Subject|1
6055614|NCT00546871|20925837|P1|Study Extension Period|Withdrawal by Subject|0
6055615|NCT00546871|20925836|P2|Study Extension Period|Protocol Violation|0
6055616|NCT00546871|20925837|P1|Study Extension Period|Protocol Violation|1
6055617|NCT00546871|20925836|P2|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|1
6055618|NCT00546871|20925837|P1|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|0
6055619|NCT00546871|20925836|P2|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|2
6055620|NCT00546871|20925837|P1|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|1
6055621|NCT00546871|20925836|P2|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|0
6055622|NCT00546871|20925837|P1|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|1
6055623|NCT00546819|20925942|P2|Overall Study|Withdrawal by Subject|2
6055624|NCT00546819|20925943|P1|Overall Study|Withdrawal by Subject|4
6055625|NCT00546819|20925942|P2|Overall Study|Lost to Follow-up|1
6055626|NCT00546819|20925943|P1|Overall Study|Lost to Follow-up|2
6055627|NCT00546819|20925942|P2|Overall Study|Adverse Event|3
6055628|NCT00546819|20925943|P1|Overall Study|Adverse Event|2
6055629|NCT00546754|20925955|P2|Overall Study|Missing|7
6055630|NCT00546754|20925956|P1|Overall Study|Missing|14
6055631|NCT00546754|20925955|P2|Overall Study|Patient's Decision|1
6055632|NCT00546754|20925956|P1|Overall Study|Patient's Decision|0
6055633|NCT00546754|20925955|P2|Overall Study|Elevated Creatinine and Potassium levels|1
6055634|NCT00546754|20925956|P1|Overall Study|Elevated Creatinine and Potassium levels|0
6055635|NCT00546754|20925955|P2|Overall Study|Missing Cooperation|0
6055636|NCT00546754|20925956|P1|Overall Study|Missing Cooperation|1
6055637|NCT00546754|20925955|P2|Overall Study|Suicide|0
6055638|NCT00546754|20925956|P1|Overall Study|Suicide|1
6055639|NCT00546754|20925955|P2|Overall Study|Hip Replacement|0
6055640|NCT00546754|20925956|P1|Overall Study|Hip Replacement|1
6055641|NCT00546754|20925955|P2|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|0
6055642|NCT00546754|20925956|P1|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|1
6055643|NCT00546754|20925955|P2|Overall Study|Dyspnea|0
6055644|NCT00546754|20925956|P1|Overall Study|Dyspnea|1
6055645|NCT00546754|20925955|P2|Overall Study|Withdrawal by Subject|7
6055646|NCT00546754|20925956|P1|Overall Study|Withdrawal by Subject|6
6055647|NCT00546754|20925955|P2|Overall Study|Protocol Violation|0
6055648|NCT00546754|20925956|P1|Overall Study|Protocol Violation|3
6055649|NCT00546754|20925955|P2|Overall Study|Lost to Follow-up|15
6055650|NCT00546754|20925956|P1|Overall Study|Lost to Follow-up|9
6055651|NCT00546754|20925955|P2|Overall Study|Lack of Efficacy|1
6055652|NCT00546754|20925956|P1|Overall Study|Lack of Efficacy|1
6055653|NCT00546754|20925955|P2|Overall Study|Adverse Event|16
6055654|NCT00546754|20925956|P1|Overall Study|Adverse Event|11
6055655|NCT00546754|20925955|P2|Overall Study|Serious Adverse Event|1
6055656|NCT00546754|20925956|P1|Overall Study|Serious Adverse Event|1
6055657|NCT00546715|20925999|P4|Overall Study|Withdrawal by Subject|0
6055658|NCT00546715|20926000|P3|Overall Study|Withdrawal by Subject|0
6055659|NCT00546715|20926001|P2|Overall Study|Withdrawal by Subject|1
6055660|NCT00546715|20926002|P1|Overall Study|Withdrawal by Subject|0
6055661|NCT00546637|20926057|P2|Overall Study|Randomized, but not treated|1
6055662|NCT00546637|20926058|P1|Overall Study|Randomized, but not treated|3
6055663|NCT00546637|20926057|P2|Overall Study|Withdrawal by Subject|9
6055664|NCT00546637|20926058|P1|Overall Study|Withdrawal by Subject|7
6055665|NCT00546637|20926057|P2|Overall Study|Other|12
6055666|NCT00546637|20926058|P1|Overall Study|Other|10
6055667|NCT00546637|20926057|P2|Overall Study|Lost to Follow-up|2
6055668|NCT00546637|20926058|P1|Overall Study|Lost to Follow-up|2
6055669|NCT00546637|20926057|P2|Overall Study|Lack of Efficacy|5
6055670|NCT00546637|20926058|P1|Overall Study|Lack of Efficacy|5
6055671|NCT00546637|20926057|P2|Overall Study|Adverse Event|20
6055672|NCT00546637|20926058|P1|Overall Study|Adverse Event|46
6055673|NCT00546572|20926132|P2|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|1
6055674|NCT00546572|20926133|P1|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|2
6055675|NCT00546572|20926132|P2|Vax 2 / Year 1|Adverse Event|0
6055676|NCT00546572|20926133|P1|Vax 2 / Year 1|Adverse Event|1
6055677|NCT00546572|20926132|P2|Vax 2 / Year 1|Other|1
6055678|NCT00546572|20926133|P1|Vax 2 / Year 1|Other|1
6055679|NCT00546572|20926132|P2|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|59
6055680|NCT00546572|20926133|P1|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|64
6055681|NCT00546572|20926132|P2|Vax 1 / Year 0|Lost to Follow-up|1
6055682|NCT00546572|20926133|P1|Vax 1 / Year 0|Lost to Follow-up|0
6055683|NCT00546572|20926132|P2|Vax 1 / Year 0|Adverse Event|1
6055684|NCT00546572|20926133|P1|Vax 1 / Year 0|Adverse Event|0
6055685|NCT00546572|20926132|P2|Vax 1 / Year 0|Death|2
6055686|NCT00546572|20926133|P1|Vax 1 / Year 0|Death|2
6055687|NCT00546572|20926132|P2|Vax 1 / Year 0|Protocol Violation|4
6055688|NCT00546572|20926133|P1|Vax 1 / Year 0|Protocol Violation|3
6055689|NCT00546572|20926132|P2|Vax 1 / Year 0|Withdrawal by Subject|2
6055690|NCT00546572|20926133|P1|Vax 1 / Year 0|Withdrawal by Subject|3
6055691|NCT00546572|20926132|P2|Vax 1 / Year 0|Randomized, not treated|1
6055692|NCT00546572|20926133|P1|Vax 1 / Year 0|Randomized, not treated|1
6055693|NCT00546481|20926177|P3|Maintenance Phase (CERA)|Other Reason|1
6055694|NCT00546481|20926178|P2|Maintenance Phase (CERA)|Other Reason|0
6055695|NCT00546481|20926179|P1|Maintenance Phase (CERA)|Other Reason|0
6055696|NCT00546481|20926177|P3|Maintenance Phase (CERA)|Kidney transplantation|1
6055697|NCT00546481|20926178|P2|Maintenance Phase (CERA)|Kidney transplantation|0
6055698|NCT00546481|20926179|P1|Maintenance Phase (CERA)|Kidney transplantation|0
6055699|NCT00546481|20926177|P3|Maintenance Phase (CERA)|Withdrawal by Subject|2
6055700|NCT00546481|20926178|P2|Maintenance Phase (CERA)|Withdrawal by Subject|0
6055701|NCT00546481|20926179|P1|Maintenance Phase (CERA)|Withdrawal by Subject|0
6055702|NCT00546481|20926177|P3|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0
6055703|NCT00546481|20926178|P2|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|1
6055704|NCT00546481|20926179|P1|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0
6055705|NCT00546481|20926177|P3|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|0
6055706|NCT00546481|20926178|P2|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1
6055707|NCT00546481|20926179|P1|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1
6055708|NCT00546481|20926177|P3|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0
6055709|NCT00546481|20926178|P2|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0
6055710|NCT00546481|20926179|P1|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|2
6055711|NCT00546481|20926177|P3|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0
6055712|NCT00546481|20926178|P2|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0
6055713|NCT00546481|20926179|P1|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|1
6055714|NCT00546481|20926177|P3|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|0
6055715|NCT00546481|20926178|P2|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|3
6055716|NCT00546481|20926179|P1|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|1
6055717|NCT00546481|20926177|P3|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0
6055718|NCT00546481|20926178|P2|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0
6055719|NCT00546481|20926179|P1|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|1
6055720|NCT00546377|20926217|P1|Overall Study|Adverse Event|6
6055721|NCT00546377|20926217|P1|Overall Study|Deemed ineligible|1
6055722|NCT00546364|20926225|P3|Overall Study|Sponsor decision|1
6055723|NCT00546364|20926226|P2|Overall Study|Sponsor decision|0
6055724|NCT00546364|20926227|P1|Overall Study|Sponsor decision|0
6055725|NCT00546364|20926225|P3|Overall Study|Physician Decision|1
6055726|NCT00546364|20926226|P2|Overall Study|Physician Decision|0
6055727|NCT00546364|20926227|P1|Overall Study|Physician Decision|0
6055728|NCT00546364|20926225|P3|Overall Study|Target lesions resected|0
6055729|NCT00546364|20926226|P2|Overall Study|Target lesions resected|0
6055730|NCT00546364|20926227|P1|Overall Study|Target lesions resected|1
6055731|NCT00546364|20926225|P3|Overall Study|Palliative treatment|1
6055732|NCT00546364|20926226|P2|Overall Study|Palliative treatment|0
6055733|NCT00546364|20926227|P1|Overall Study|Palliative treatment|1
6055734|NCT00546364|20926225|P3|Overall Study|Mixed response|0
6055735|NCT00546364|20926226|P2|Overall Study|Mixed response|0
6055736|NCT00546364|20926227|P1|Overall Study|Mixed response|1
6055737|NCT00546364|20926225|P3|Overall Study|Prior taxotere|0
6055738|NCT00546364|20926226|P2|Overall Study|Prior taxotere|0
6055739|NCT00546364|20926227|P1|Overall Study|Prior taxotere|1
6055740|NCT00546364|20926225|P3|Overall Study|Withdrawal by Subject|3
6055741|NCT00546364|20926226|P2|Overall Study|Withdrawal by Subject|6
6055742|NCT00546364|20926227|P1|Overall Study|Withdrawal by Subject|5
6055743|NCT00546364|20926225|P3|Overall Study|No longer meets study criteria|0
6055744|NCT00546364|20926226|P2|Overall Study|No longer meets study criteria|1
6055745|NCT00546364|20926227|P1|Overall Study|No longer meets study criteria|1
6055746|NCT00546364|20926225|P3|Overall Study|Poor compliance/noncompliance|1
6055747|NCT00546364|20926226|P2|Overall Study|Poor compliance/noncompliance|0
6055748|NCT00546364|20926227|P1|Overall Study|Poor compliance/noncompliance|0
6055749|NCT00546364|20926225|P3|Overall Study|Administrative reason by sponsor|0
6055750|NCT00546364|20926226|P2|Overall Study|Administrative reason by sponsor|0
6055751|NCT00546364|20926227|P1|Overall Study|Administrative reason by sponsor|1
6055752|NCT00546364|20926225|P3|Overall Study|Completed and off treatment|2
6055753|NCT00546364|20926226|P2|Overall Study|Completed and off treatment|0
6055754|NCT00546364|20926227|P1|Overall Study|Completed and off treatment|1
6055755|NCT00546364|20926225|P3|Overall Study|Disease progression|8
6055756|NCT00546364|20926226|P2|Overall Study|Disease progression|11
6055757|NCT00546364|20926227|P1|Overall Study|Disease progression|5
6055758|NCT00546351|20926262|P1|Overall Study|Other reasons for premature termination|17
6055759|NCT00546351|20926262|P1|Overall Study|Unsatisfactory compliance|9
6055760|NCT00546351|20926262|P1|Overall Study|Protocol Deviation|1
6055761|NCT00546351|20926262|P1|Overall Study|Lost to Follow-up|9
6055762|NCT00546351|20926262|P1|Overall Study|Withdrawal by Subject|109
6055763|NCT00546351|20926262|P1|Overall Study|Lack of Efficacy|15
6055764|NCT00546351|20926262|P1|Overall Study|Adverse Event|76
6055765|NCT00546260|20926308|P2|Overall Study|Drug not given pre diagnostic angiogr|2
6055766|NCT00546260|20926309|P1|Overall Study|Drug not given pre diagnostic angiogr|8
6055767|NCT00546117|20926331|P2|Overall Study|Inability to schedule follow-up visit|0
6055768|NCT00546117|20926332|P1|Overall Study|Inability to schedule follow-up visit|1
6055769|NCT00546117|20926331|P2|Overall Study|Withdrawal by Subject|0
6055770|NCT00546117|20926332|P1|Overall Study|Withdrawal by Subject|3
6055771|NCT00546078|20926357|P2|Overall Study|Other reason|1
6055772|NCT00546078|20926358|P1|Overall Study|Other reason|1
6055773|NCT00546078|20926357|P2|Overall Study|Withdrawal by Subject|3
6055774|NCT00546078|20926358|P1|Overall Study|Withdrawal by Subject|2
6055775|NCT00546078|20926357|P2|Overall Study|Lost to Follow-up|3
6055776|NCT00546078|20926358|P1|Overall Study|Lost to Follow-up|1
6055777|NCT00546052|20926396|P1|Overall Study|Non Compliance|7
6055778|NCT00546052|20926396|P1|Overall Study|Withdrawal by Subject|20
6055779|NCT00546052|20926396|P1|Overall Study|Protocol Violation|9
6055780|NCT00546052|20926396|P1|Overall Study|Lost to Follow-up|144
6055781|NCT00546052|20926396|P1|Overall Study|Adverse Event|47
6055782|NCT00546000|20926414|P1|Overall Study|Baseline HPA Axis Supression|2
6055783|NCT00546000|20926414|P1|Overall Study|Lost to Follow-up|1
6055784|NCT00546000|20926414|P1|Overall Study|Adverse Event|1
6055785|NCT00545948|20926439|P3|Overall Study|Not Treated|7
6055786|NCT00545948|20926440|P2|Overall Study|Not Treated|1
6055787|NCT00545948|20926441|P1|Overall Study|Not Treated|1
6055788|NCT00545844|20926451|P1|Overall Study|Withdrawal by Subject|2
6055789|NCT00545844|20926451|P1|Overall Study|Protocol Violation|1
6055790|NCT00545844|20926451|P1|Overall Study|Lost to Follow-up|9
6055791|NCT00545818|20926467|P2|Overall Study|Lost to Follow-up|6
6055792|NCT00545818|20926468|P1|Overall Study|Lost to Follow-up|1
6055793|NCT00545818|20926467|P2|Overall Study|Adverse Event|1
6055794|NCT00545818|20926468|P1|Overall Study|Adverse Event|1
6055795|NCT00545818|20926467|P2|Overall Study|Protocol Violation|0
6055796|NCT00545818|20926468|P1|Overall Study|Protocol Violation|1
6055797|NCT00545792|20926482|P1|Overall Study|Withdrawal by Subject|1
6055798|NCT00545779|20926487|P1|Overall Study|Failure to return|3
6055799|NCT00545779|20926487|P1|Overall Study|Adverse Event/intercurrent illness|5
6055800|NCT00545779|20926487|P1|Overall Study|Withdrawal by Subject|20
6055801|NCT00545779|20926487|P1|Overall Study|Did not cooperate|7
6055802|NCT00545779|20926487|P1|Overall Study|Other protocol violation|1
6055803|NCT00545779|20926487|P1|Overall Study|Violation of selection criteria at entry|8
6055804|NCT00545753|20926507|P3|Overall Study|Protocol Violation|4
6055805|NCT00545753|20926508|P2|Overall Study|Protocol Violation|1
6055806|NCT00545753|20926509|P1|Overall Study|Protocol Violation|3
6055807|NCT00545753|20926507|P3|Overall Study|Lost to Follow-up|12
6055808|NCT00545753|20926508|P2|Overall Study|Lost to Follow-up|3
6055809|NCT00545753|20926509|P1|Overall Study|Lost to Follow-up|13
6055810|NCT00545753|20926507|P3|Overall Study|Withdrawal by Subject|10
6055811|NCT00545753|20926508|P2|Overall Study|Withdrawal by Subject|1
6055812|NCT00545753|20926509|P1|Overall Study|Withdrawal by Subject|0
6055813|NCT00545740|20926522|P4|Overall Study|Husband against study|0
6055814|NCT00545740|20926523|P3|Overall Study|Husband against study|1
6055815|NCT00545740|20926524|P2|Overall Study|Husband against study|0
6055816|NCT00545740|20926525|P1|Overall Study|Husband against study|0
6055817|NCT00545740|20926522|P4|Overall Study|Patient difficulties|0
6055818|NCT00545740|20926523|P3|Overall Study|Patient difficulties|0
6055819|NCT00545740|20926524|P2|Overall Study|Patient difficulties|1
6055820|NCT00545740|20926525|P1|Overall Study|Patient difficulties|0
6055821|NCT00545740|20926522|P4|Overall Study|Non-adherence to visits|0
6055822|NCT00545740|20926523|P3|Overall Study|Non-adherence to visits|0
6055823|NCT00545740|20926524|P2|Overall Study|Non-adherence to visits|1
6055824|NCT00545740|20926525|P1|Overall Study|Non-adherence to visits|0
6055825|NCT00545740|20926522|P4|Overall Study|Lack of time|0
6055826|NCT00545740|20926523|P3|Overall Study|Lack of time|0
6055827|NCT00545740|20926524|P2|Overall Study|Lack of time|1
6055828|NCT00545740|20926525|P1|Overall Study|Lack of time|0
6055829|NCT00545740|20926522|P4|Overall Study|Sponsor decision|0
6055830|NCT00545740|20926523|P3|Overall Study|Sponsor decision|0
6055831|NCT00545740|20926524|P2|Overall Study|Sponsor decision|1
6055832|NCT00545740|20926525|P1|Overall Study|Sponsor decision|0
6055833|NCT00545740|20926522|P4|Overall Study|Accepted only monthly telephone calls|0
6055834|NCT00545740|20926523|P3|Overall Study|Accepted only monthly telephone calls|0
6055835|NCT00545740|20926524|P2|Overall Study|Accepted only monthly telephone calls|0
6055836|NCT00545740|20926525|P1|Overall Study|Accepted only monthly telephone calls|1
6055837|NCT00545740|20926522|P4|Overall Study|Physician Decision|0
6055838|NCT00545740|20926523|P3|Overall Study|Physician Decision|3
6055839|NCT00545740|20926524|P2|Overall Study|Physician Decision|0
6055840|NCT00545740|20926525|P1|Overall Study|Physician Decision|0
6055841|NCT00545740|20926522|P4|Overall Study|Missed visit|0
6055842|NCT00545740|20926523|P3|Overall Study|Missed visit|0
6055843|NCT00545740|20926524|P2|Overall Study|Missed visit|0
6055844|NCT00545740|20926525|P1|Overall Study|Missed visit|1
6055845|NCT00545740|20926522|P4|Overall Study|Site closure|0
6055846|NCT00545740|20926523|P3|Overall Study|Site closure|0
6055847|NCT00545740|20926524|P2|Overall Study|Site closure|0
6055848|NCT00545740|20926525|P1|Overall Study|Site closure|1
6055849|NCT00545740|20926522|P4|Overall Study|Suspected Diverticulitis Recurrence|1
6055850|NCT00545740|20926523|P3|Overall Study|Suspected Diverticulitis Recurrence|1
6055851|NCT00545740|20926524|P2|Overall Study|Suspected Diverticulitis Recurrence|1
6055852|NCT00545740|20926525|P1|Overall Study|Suspected Diverticulitis Recurrence|1
6055853|NCT00545740|20926522|P4|Overall Study|Diverticulitis attack|1
6055854|NCT00545740|20926523|P3|Overall Study|Diverticulitis attack|1
6055855|NCT00545740|20926524|P2|Overall Study|Diverticulitis attack|0
6055856|NCT00545740|20926525|P1|Overall Study|Diverticulitis attack|0
6055857|NCT00545740|20926522|P4|Overall Study|Moved|0
6055858|NCT00545740|20926523|P3|Overall Study|Moved|1
6055859|NCT00545740|20926524|P2|Overall Study|Moved|0
6055860|NCT00545740|20926525|P1|Overall Study|Moved|2
6055861|NCT00545740|20926522|P4|Overall Study|Non-compliance|0
6055862|NCT00545740|20926523|P3|Overall Study|Non-compliance|1
6055863|NCT00545740|20926524|P2|Overall Study|Non-compliance|2
6055864|NCT00545740|20926525|P1|Overall Study|Non-compliance|0
6055865|NCT00545740|20926522|P4|Overall Study|Protocol Violation|0
6055866|NCT00545740|20926523|P3|Overall Study|Protocol Violation|1
6055867|NCT00545740|20926524|P2|Overall Study|Protocol Violation|3
6055868|NCT00545740|20926525|P1|Overall Study|Protocol Violation|1
6055869|NCT00545740|20926522|P4|Overall Study|Lost to Follow-up|6
6055870|NCT00545740|20926523|P3|Overall Study|Lost to Follow-up|5
6055871|NCT00545740|20926524|P2|Overall Study|Lost to Follow-up|5
6055872|NCT00545740|20926525|P1|Overall Study|Lost to Follow-up|7
6055873|NCT00545740|20926522|P4|Overall Study|Adverse Event|9
6055874|NCT00545740|20926523|P3|Overall Study|Adverse Event|19
6055875|NCT00545740|20926524|P2|Overall Study|Adverse Event|18
6055876|NCT00545740|20926525|P1|Overall Study|Adverse Event|10
6055877|NCT00545740|20926522|P4|Overall Study|Withdrawal by Subject|18
6055878|NCT00545740|20926523|P3|Overall Study|Withdrawal by Subject|16
6055879|NCT00545740|20926524|P2|Overall Study|Withdrawal by Subject|15
6055880|NCT00545740|20926525|P1|Overall Study|Withdrawal by Subject|17
6055881|NCT00545740|20926522|P4|Overall Study|Lack of Efficacy|36
6055882|NCT00545740|20926523|P3|Overall Study|Lack of Efficacy|47
6055883|NCT00545740|20926524|P2|Overall Study|Lack of Efficacy|35
6055884|NCT00545740|20926525|P1|Overall Study|Lack of Efficacy|34
6055885|NCT00545714|20926559|P1|Maintenance Phase (36 Months)|Death|2
6055886|NCT00545714|20926559|P1|Maintenance Phase (36 Months)|Withdrawal by Subject|3
6055887|NCT00545714|20926559|P1|Maintenance Phase (36 Months)|Protocol Violation|1
6055888|NCT00545714|20926559|P1|Maintenance Phase (36 Months)|Physician Decision|1
6055889|NCT00545714|20926559|P1|Maintenance Phase (36 Months)|Disease Progression|9
6055890|NCT00545714|20926559|P1|Maintenance Phase (36 Months)|Unacceptable Toxicity|16
6055891|NCT00545714|20926559|P1|Induction Phase (6 Months)|Eligibility Criteria Violation|2
6055892|NCT00545714|20926559|P1|Induction Phase (6 Months)|Disease Progression|1
6055893|NCT00545714|20926559|P1|Induction Phase (6 Months)|Unacceptable Toxicity|6
6055894|NCT00545714|20926559|P1|Induction Phase (6 Months)|Physician Decision|3
6055895|NCT00545688|20926580|P4|Follow-Up Period|Violation of Selection Criteria at Entry|1
6055896|NCT00545688|20926581|P3|Follow-Up Period|Violation of Selection Criteria at Entry|0
6055897|NCT00545688|20926582|P2|Follow-Up Period|Violation of Selection Criteria at Entry|2
6055898|NCT00545688|20926583|P1|Follow-Up Period|Violation of Selection Criteria at Entry|0
6055899|NCT00545688|20926580|P4|Follow-Up Period|Unspecified Reason|8
6055900|NCT00545688|20926581|P3|Follow-Up Period|Unspecified Reason|6
6055901|NCT00545688|20926582|P2|Follow-Up Period|Unspecified Reason|5
6055902|NCT00545688|20926583|P1|Follow-Up Period|Unspecified Reason|2
6055903|NCT00545688|20926580|P4|Follow-Up Period|Lost to Follow-up|1
6055904|NCT00545688|20926581|P3|Follow-Up Period|Lost to Follow-up|3
6055905|NCT00545688|20926582|P2|Follow-Up Period|Lost to Follow-up|3
6055906|NCT00545688|20926583|P1|Follow-Up Period|Lost to Follow-up|3
6055907|NCT00545688|20926580|P4|Follow-Up Period|Refused Treatment|2
6055908|NCT00545688|20926581|P3|Follow-Up Period|Refused Treatment|0
6055909|NCT00545688|20926582|P2|Follow-Up Period|Refused Treatment|2
6055910|NCT00545688|20926583|P1|Follow-Up Period|Refused Treatment|6
6055911|NCT00545688|20926580|P4|Follow-Up Period|Disease Progression|9
6055912|NCT00545688|20926581|P3|Follow-Up Period|Disease Progression|9
6055913|NCT00545688|20926582|P2|Follow-Up Period|Disease Progression|5
6055914|NCT00545688|20926583|P1|Follow-Up Period|Disease Progression|6
6055915|NCT00545688|20926580|P4|Follow-Up Period|Death|6
6055916|NCT00545688|20926581|P3|Follow-Up Period|Death|2
6055917|NCT00545688|20926582|P2|Follow-Up Period|Death|2
6055918|NCT00545688|20926583|P1|Follow-Up Period|Death|4
6055919|NCT00545688|20926580|P4|Adjuvant Treatment Period|Unknown Reason|0
6055920|NCT00545688|20926581|P3|Adjuvant Treatment Period|Unknown Reason|0
6055921|NCT00545688|20926582|P2|Adjuvant Treatment Period|Unknown Reason|1
6055922|NCT00545688|20926583|P1|Adjuvant Treatment Period|Unknown Reason|0
6055923|NCT00545688|20926580|P4|Adjuvant Treatment Period|Adverse Event|2
6055924|NCT00545688|20926581|P3|Adjuvant Treatment Period|Adverse Event|2
6055925|NCT00545688|20926582|P2|Adjuvant Treatment Period|Adverse Event|3
6055926|NCT00545688|20926583|P1|Adjuvant Treatment Period|Adverse Event|0
6055927|NCT00545688|20926580|P4|Adjuvant Treatment Period|Lost to Follow-up|0
6055928|NCT00545688|20926581|P3|Adjuvant Treatment Period|Lost to Follow-up|1
6055929|NCT00545688|20926582|P2|Adjuvant Treatment Period|Lost to Follow-up|0
6055930|NCT00545688|20926583|P1|Adjuvant Treatment Period|Lost to Follow-up|1
6055931|NCT00545688|20926580|P4|Adjuvant Treatment Period|Refused Treatment|5
6055932|NCT00545688|20926581|P3|Adjuvant Treatment Period|Refused Treatment|1
6055933|NCT00545688|20926582|P2|Adjuvant Treatment Period|Refused Treatment|1
6055934|NCT00545688|20926583|P1|Adjuvant Treatment Period|Refused Treatment|1
6055935|NCT00545688|20926580|P4|Adjuvant Treatment Period|Disease Progression|7
6055936|NCT00545688|20926581|P3|Adjuvant Treatment Period|Disease Progression|0
6055937|NCT00545688|20926582|P2|Adjuvant Treatment Period|Disease Progression|3
6055938|NCT00545688|20926583|P1|Adjuvant Treatment Period|Disease Progression|3
6055939|NCT00545688|20926580|P4|Neo-Adjuvant Treatment Period|Adverse Event|2
6055940|NCT00545688|20926581|P3|Neo-Adjuvant Treatment Period|Adverse Event|2
6055941|NCT00545688|20926582|P2|Neo-Adjuvant Treatment Period|Adverse Event|0
6055942|NCT00545688|20926583|P1|Neo-Adjuvant Treatment Period|Adverse Event|0
6055943|NCT00545688|20926580|P4|Neo-Adjuvant Treatment Period|Unknown Reason|0
6055944|NCT00545688|20926581|P3|Neo-Adjuvant Treatment Period|Unknown Reason|0
6055945|NCT00545688|20926582|P2|Neo-Adjuvant Treatment Period|Unknown Reason|0
6055946|NCT00545688|20926583|P1|Neo-Adjuvant Treatment Period|Unknown Reason|1
6055947|NCT00545688|20926580|P4|Neo-Adjuvant Treatment Period|Disease Progression|2
6055948|NCT00545688|20926581|P3|Neo-Adjuvant Treatment Period|Disease Progression|7
6055949|NCT00545688|20926582|P2|Neo-Adjuvant Treatment Period|Disease Progression|1
6055950|NCT00545688|20926583|P1|Neo-Adjuvant Treatment Period|Disease Progression|0
6055951|NCT00545688|20926580|P4|Neo-Adjuvant Treatment Period|Death|0
6055952|NCT00545688|20926581|P3|Neo-Adjuvant Treatment Period|Death|0
6055953|NCT00545688|20926582|P2|Neo-Adjuvant Treatment Period|Death|1
6055954|NCT00545688|20926583|P1|Neo-Adjuvant Treatment Period|Death|0
6055955|NCT00545688|20926580|P4|Neo-Adjuvant Treatment Period|Lost to Follow-up|0
6055956|NCT00545688|20926581|P3|Neo-Adjuvant Treatment Period|Lost to Follow-up|0
6055957|NCT00545688|20926582|P2|Neo-Adjuvant Treatment Period|Lost to Follow-up|0
6055958|NCT00545688|20926583|P1|Neo-Adjuvant Treatment Period|Lost to Follow-up|1
6055959|NCT00545688|20926580|P4|Neo-Adjuvant Treatment Period|Refused Treatment|1
6055960|NCT00545688|20926581|P3|Neo-Adjuvant Treatment Period|Refused Treatment|4
6055961|NCT00545688|20926582|P2|Neo-Adjuvant Treatment Period|Refused Treatment|1
6055962|NCT00545688|20926583|P1|Neo-Adjuvant Treatment Period|Refused Treatment|1
6055963|NCT00545688|20926580|P4|Neo-Adjuvant Treatment Period|Protocol Violation|1
6055964|NCT00545688|20926581|P3|Neo-Adjuvant Treatment Period|Protocol Violation|1
6055965|NCT00545688|20926582|P2|Neo-Adjuvant Treatment Period|Protocol Violation|2
6055966|NCT00545688|20926583|P1|Neo-Adjuvant Treatment Period|Protocol Violation|1
6055967|NCT00545584|20926682|P3|Overall Study|Two or more reasons for discontinuation|8
6055968|NCT00545584|20926683|P2|Overall Study|Two or more reasons for discontinuation|19
6055969|NCT00545584|20926684|P1|Overall Study|Two or more reasons for discontinuation|17
6055970|NCT00545584|20926682|P3|Overall Study|Only one reason for discontinuation|48
6055971|NCT00545584|20926683|P2|Overall Study|Only one reason for discontinuation|61
6055972|NCT00545584|20926684|P1|Overall Study|Only one reason for discontinuation|62
6055973|NCT00545571|20926695|P1|Overall Study|Kidney Transplantation|3
6055974|NCT00545571|20926695|P1|Overall Study|Early Termination of Study|24
6055975|NCT00545571|20926695|P1|Overall Study|Transfusion|12
6055976|NCT00545571|20926695|P1|Overall Study|Screen Failure|16
6055977|NCT00545571|20926695|P1|Overall Study|Refused Treatment|1
6055978|NCT00545571|20926695|P1|Overall Study|Protocol Violation|2
6055979|NCT00545571|20926695|P1|Overall Study|Lack of Efficacy|1
6055980|NCT00545571|20926695|P1|Overall Study|Death|5
6055981|NCT00545571|20926695|P1|Overall Study|Adverse Event|2
6055982|NCT00545571|20926695|P1|Overall Study|Administrative Reasons|1
6055983|NCT00545532|20926710|P2|Overall Study|Death|1
6055984|NCT00545532|20926711|P1|Overall Study|Death|0
6055985|NCT00545532|20926710|P2|Overall Study|Lost to Follow-up|6
6055986|NCT00545532|20926711|P1|Overall Study|Lost to Follow-up|5
6055987|NCT00545532|20926710|P2|Overall Study|Withdrawal by Subject|3
6055988|NCT00545532|20926711|P1|Overall Study|Withdrawal by Subject|1
6055989|NCT00545441|20926802|P2|Overall Study|Patients were not treated|3
6055990|NCT00545441|20926803|P1|Overall Study|Patients were not treated|1
6055991|NCT00545441|20926802|P2|Overall Study|Persistence or recurrence of fistula|2
6055992|NCT00545441|20926803|P1|Overall Study|Persistence or recurrence of fistula|5
6055993|NCT00545441|20926802|P2|Overall Study|Withdrawal by Subject|1
6055994|NCT00545441|20926803|P1|Overall Study|Withdrawal by Subject|1
6055995|NCT00545441|20926802|P2|Overall Study|Technical failure|1
6055996|NCT00545441|20926803|P1|Overall Study|Technical failure|0
6055997|NCT00545441|20926802|P2|Overall Study|Lost to Follow-up|5
6055998|NCT00545441|20926803|P1|Overall Study|Lost to Follow-up|9
6055999|NCT00545441|20926802|P2|Overall Study|Fistula draining at 6 months|4
6056000|NCT00545441|20926803|P1|Overall Study|Fistula draining at 6 months|2
6056001|NCT00545402|20926811|P2|Overall Study|Reason not specified|1
6056002|NCT00545402|20926812|P1|Overall Study|Reason not specified|1
6056003|NCT00545402|20926811|P2|Overall Study|Protocol Violation|0
6056004|NCT00545402|20926812|P1|Overall Study|Protocol Violation|1
6056005|NCT00545402|20926811|P2|Overall Study|Withdrawal by Subject|1
6056006|NCT00545402|20926812|P1|Overall Study|Withdrawal by Subject|0
6056007|NCT00545402|20926811|P2|Overall Study|Graft loss|4
6056008|NCT00545402|20926812|P1|Overall Study|Graft loss|2
6056009|NCT00545402|20926811|P2|Overall Study|Death|7
6056010|NCT00545402|20926812|P1|Overall Study|Death|5
6056011|NCT00545402|20926811|P2|Overall Study|Use of unauthorized immunosuppressant|7
6056012|NCT00545402|20926812|P1|Overall Study|Use of unauthorized immunosuppressant|8
6056013|NCT00545402|20926811|P2|Overall Study|Discontinuation of treatment|9
6056014|NCT00545402|20926812|P1|Overall Study|Discontinuation of treatment|17
6056015|NCT00545363|20926830|P2|Overall Study|Other|1
6056016|NCT00545363|20926831|P1|Overall Study|Other|1
6056017|NCT00545363|20926830|P2|Overall Study|Lost to Follow-up|0
6056018|NCT00545363|20926831|P1|Overall Study|Lost to Follow-up|2
6056019|NCT00545363|20926830|P2|Overall Study|Did not meet entry criteria|1
6056020|NCT00545363|20926831|P1|Overall Study|Did not meet entry criteria|1
6056021|NCT00545363|20926830|P2|Overall Study|Non-compliance|1
6056022|NCT00545363|20926831|P1|Overall Study|Non-compliance|3
6056023|NCT00545363|20926830|P2|Overall Study|Withdrawal by Subject|5
6056024|NCT00545363|20926831|P1|Overall Study|Withdrawal by Subject|6
6056025|NCT00545363|20926830|P2|Overall Study|Adverse Event|7
6056026|NCT00545363|20926831|P1|Overall Study|Adverse Event|6
6056027|NCT00545298|20926846|P3|Overall Study|Issues with Standard of Care|1
6056028|NCT00545298|20926847|P2|Overall Study|Issues with Standard of Care|0
6056029|NCT00545298|20926848|P1|Overall Study|Issues with Standard of Care|2
6056030|NCT00545272|20926865|P6|Overall Study|Lost to Follow-up|0
6056031|NCT00545272|20926866|P5|Overall Study|Lost to Follow-up|1
6056032|NCT00545272|20926867|P4|Overall Study|Lost to Follow-up|0
6056033|NCT00545272|20926868|P3|Overall Study|Lost to Follow-up|0
6056034|NCT00545272|20926869|P2|Overall Study|Lost to Follow-up|0
6056035|NCT00545272|20926870|P1|Overall Study|Lost to Follow-up|0
6056036|NCT00545272|20926865|P6|Overall Study|Abnormal test procedure result(s)|0
6056037|NCT00545272|20926866|P5|Overall Study|Abnormal test procedure result(s)|1
6056038|NCT00545272|20926867|P4|Overall Study|Abnormal test procedure result(s)|0
6056039|NCT00545272|20926868|P3|Overall Study|Abnormal test procedure result(s)|0
6056040|NCT00545272|20926869|P2|Overall Study|Abnormal test procedure result(s)|0
6056041|NCT00545272|20926870|P1|Overall Study|Abnormal test procedure result(s)|0
6056042|NCT00545272|20926865|P6|Overall Study|Abnormal laboratory value(s)|1
6056043|NCT00545272|20926866|P5|Overall Study|Abnormal laboratory value(s)|0
6056044|NCT00545272|20926867|P4|Overall Study|Abnormal laboratory value(s)|0
6056045|NCT00545272|20926868|P3|Overall Study|Abnormal laboratory value(s)|0
6056046|NCT00545272|20926869|P2|Overall Study|Abnormal laboratory value(s)|0
6056047|NCT00545272|20926870|P1|Overall Study|Abnormal laboratory value(s)|0
6056048|NCT00545272|20926865|P6|Overall Study|Adverse Event|1
6056049|NCT00545272|20926866|P5|Overall Study|Adverse Event|0
6056050|NCT00545272|20926867|P4|Overall Study|Adverse Event|0
6056051|NCT00545272|20926868|P3|Overall Study|Adverse Event|1
6056052|NCT00545272|20926869|P2|Overall Study|Adverse Event|0
6056053|NCT00545272|20926870|P1|Overall Study|Adverse Event|0
6056054|NCT00545272|20926865|P6|Overall Study|Protocol deviation|1
6056055|NCT00545272|20926866|P5|Overall Study|Protocol deviation|0
6056056|NCT00545272|20926867|P4|Overall Study|Protocol deviation|1
6056057|NCT00545272|20926868|P3|Overall Study|Protocol deviation|0
6056058|NCT00545272|20926869|P2|Overall Study|Protocol deviation|1
6056059|NCT00545272|20926870|P1|Overall Study|Protocol deviation|0
6056060|NCT00545233|20926922|P2|Overall Study|Physician Decision|1
6056061|NCT00545233|20926923|P1|Overall Study|Physician Decision|2
6056062|NCT00545233|20926922|P2|Overall Study|Insufficient response|15
6056063|NCT00545233|20926923|P1|Overall Study|Insufficient response|14
6056064|NCT00545233|20926922|P2|Overall Study|Failure to Return|6
6056065|NCT00545233|20926923|P1|Overall Study|Failure to Return|4
6056066|NCT00545233|20926922|P2|Overall Study|Refused Treatment|7
6056067|NCT00545233|20926923|P1|Overall Study|Refused Treatment|9
6056068|NCT00545233|20926922|P2|Overall Study|Protocol Violation|0
6056069|NCT00545233|20926923|P1|Overall Study|Protocol Violation|2
6056070|NCT00545233|20926922|P2|Overall Study|Violation of Selection Criteria at Entry|1
6056071|NCT00545233|20926923|P1|Overall Study|Violation of Selection Criteria at Entry|5
6056072|NCT00545233|20926922|P2|Overall Study|Adverse Event|5
6056073|NCT00545233|20926923|P1|Overall Study|Adverse Event|10
6056074|NCT00545168|20926982|P3|Overall Study|Visit for Day 21 was not done in error|2
6056075|NCT00545168|20926983|P2|Overall Study|Visit for Day 21 was not done in error|0
6056076|NCT00545168|20926984|P1|Overall Study|Visit for Day 21 was not done in error|1
6056077|NCT00545168|20926982|P3|Overall Study|Protocol Violation|1
6056078|NCT00545168|20926983|P2|Overall Study|Protocol Violation|0
6056079|NCT00545168|20926984|P1|Overall Study|Protocol Violation|1
6056080|NCT00545168|20926982|P3|Overall Study|Withdrawal by Subject|13
6056081|NCT00545168|20926983|P2|Overall Study|Withdrawal by Subject|0
6056082|NCT00545168|20926984|P1|Overall Study|Withdrawal by Subject|9
6056083|NCT00545168|20926982|P3|Overall Study|Lost to Follow-up|5
6056084|NCT00545168|20926983|P2|Overall Study|Lost to Follow-up|5
6056085|NCT00545168|20926984|P1|Overall Study|Lost to Follow-up|5
6056086|NCT00545103|20927010|P4|Overall Study|Death|0
6056087|NCT00545103|20927011|P3|Overall Study|Death|0
6056088|NCT00545103|20927012|P2|Overall Study|Death|1
6056089|NCT00545103|20927013|P1|Overall Study|Death|0
6056090|NCT00545103|20927010|P4|Overall Study|Subject met endpoint under protocol v. 1|0
6056091|NCT00545103|20927011|P3|Overall Study|Subject met endpoint under protocol v. 1|1
6056092|NCT00545103|20927012|P2|Overall Study|Subject met endpoint under protocol v. 1|0
6056093|NCT00545103|20927013|P1|Overall Study|Subject met endpoint under protocol v. 1|0
6056094|NCT00545103|20927010|P4|Overall Study|Does not want to take study drug anymore|0
6056095|NCT00545103|20927011|P3|Overall Study|Does not want to take study drug anymore|1
6056096|NCT00545103|20927012|P2|Overall Study|Does not want to take study drug anymore|0
6056097|NCT00545103|20927013|P1|Overall Study|Does not want to take study drug anymore|1
6056098|NCT00545103|20927010|P4|Overall Study|Use of prohibited medication|0
6056099|NCT00545103|20927011|P3|Overall Study|Use of prohibited medication|1
6056100|NCT00545103|20927012|P2|Overall Study|Use of prohibited medication|0
6056101|NCT00545103|20927013|P1|Overall Study|Use of prohibited medication|0
6056102|NCT00545103|20927010|P4|Overall Study|Subject moved|0
6056103|NCT00545103|20927011|P3|Overall Study|Subject moved|0
6056104|NCT00545103|20927012|P2|Overall Study|Subject moved|1
6056105|NCT00545103|20927013|P1|Overall Study|Subject moved|0
6056106|NCT00545103|20927010|P4|Overall Study|Investigator decision|0
6056107|NCT00545103|20927011|P3|Overall Study|Investigator decision|1
6056108|NCT00545103|20927012|P2|Overall Study|Investigator decision|0
6056109|NCT00545103|20927013|P1|Overall Study|Investigator decision|0
6056110|NCT00545103|20927010|P4|Overall Study|Noncompliance|0
6056111|NCT00545103|20927011|P3|Overall Study|Noncompliance|0
6056112|NCT00545103|20927012|P2|Overall Study|Noncompliance|1
6056113|NCT00545103|20927013|P1|Overall Study|Noncompliance|0
6056114|NCT00545103|20927010|P4|Overall Study|Subject's decision|0
6056115|NCT00545103|20927011|P3|Overall Study|Subject's decision|0
6056116|NCT00545103|20927012|P2|Overall Study|Subject's decision|0
6056117|NCT00545103|20927013|P1|Overall Study|Subject's decision|1
6056118|NCT00545103|20927010|P4|Overall Study|Personal reasons|0
6056119|NCT00545103|20927011|P3|Overall Study|Personal reasons|0
6056120|NCT00545103|20927012|P2|Overall Study|Personal reasons|0
6056121|NCT00545103|20927013|P1|Overall Study|Personal reasons|1
6056122|NCT00545103|20927010|P4|Overall Study|Diverticulitis crisis|1
6056123|NCT00545103|20927011|P3|Overall Study|Diverticulitis crisis|0
6056124|NCT00545103|20927012|P2|Overall Study|Diverticulitis crisis|0
6056125|NCT00545103|20927013|P1|Overall Study|Diverticulitis crisis|0
6056126|NCT00545103|20927010|P4|Overall Study|Wish to start a family|1
6056127|NCT00545103|20927011|P3|Overall Study|Wish to start a family|0
6056128|NCT00545103|20927012|P2|Overall Study|Wish to start a family|0
6056129|NCT00545103|20927013|P1|Overall Study|Wish to start a family|0
6056130|NCT00545103|20927010|P4|Overall Study|Investigational product not taken|1
6056131|NCT00545103|20927011|P3|Overall Study|Investigational product not taken|0
6056132|NCT00545103|20927012|P2|Overall Study|Investigational product not taken|0
6056133|NCT00545103|20927013|P1|Overall Study|Investigational product not taken|1
6056134|NCT00545103|20927010|P4|Overall Study|Difficult to open package|1
6056135|NCT00545103|20927011|P3|Overall Study|Difficult to open package|0
6056136|NCT00545103|20927012|P2|Overall Study|Difficult to open package|0
6056137|NCT00545103|20927013|P1|Overall Study|Difficult to open package|0
6056138|NCT00545103|20927010|P4|Overall Study|Suspected recurrence of diverticulitis|3
6056139|NCT00545103|20927011|P3|Overall Study|Suspected recurrence of diverticulitis|0
6056140|NCT00545103|20927012|P2|Overall Study|Suspected recurrence of diverticulitis|0
6056141|NCT00545103|20927013|P1|Overall Study|Suspected recurrence of diverticulitis|1
6056142|NCT00545103|20927010|P4|Overall Study|Protocol Violation|0
6056143|NCT00545103|20927011|P3|Overall Study|Protocol Violation|3
6056144|NCT00545103|20927012|P2|Overall Study|Protocol Violation|2
6056145|NCT00545103|20927013|P1|Overall Study|Protocol Violation|1
6056146|NCT00545103|20927010|P4|Overall Study|Lost to Follow-up|4
6056147|NCT00545103|20927011|P3|Overall Study|Lost to Follow-up|3
6056148|NCT00545103|20927012|P2|Overall Study|Lost to Follow-up|6
6056149|NCT00545103|20927013|P1|Overall Study|Lost to Follow-up|4
6056150|NCT00545103|20927010|P4|Overall Study|Adverse Event|10
6056151|NCT00545103|20927011|P3|Overall Study|Adverse Event|17
6056152|NCT00545103|20927012|P2|Overall Study|Adverse Event|12
6056153|NCT00545103|20927013|P1|Overall Study|Adverse Event|11
6056154|NCT00545103|20927010|P4|Overall Study|Withdrawal by Subject|22
6056155|NCT00545103|20927011|P3|Overall Study|Withdrawal by Subject|18
6056156|NCT00545103|20927012|P2|Overall Study|Withdrawal by Subject|10
6056157|NCT00545103|20927013|P1|Overall Study|Withdrawal by Subject|6
6056158|NCT00545103|20927010|P4|Overall Study|Lack of Efficacy|27
6056159|NCT00545103|20927011|P3|Overall Study|Lack of Efficacy|31
6056160|NCT00545103|20927012|P2|Overall Study|Lack of Efficacy|45
6056161|NCT00545103|20927013|P1|Overall Study|Lack of Efficacy|48
6056162|NCT00545077|20927049|P2|Overall Study|Death|8
6056163|NCT00545077|20927050|P1|Overall Study|Death|0
6056164|NCT00545077|20927049|P2|Overall Study|Adverse Event|31
6056165|NCT00545077|20927050|P1|Overall Study|Adverse Event|0
6056166|NCT00545077|20927049|P2|Overall Study|Protocol Violation|0
6056167|NCT00545077|20927050|P1|Overall Study|Protocol Violation|1
6056168|NCT00545077|20927049|P2|Overall Study|Lost to Follow-up|0
6056169|NCT00545077|20927050|P1|Overall Study|Lost to Follow-up|2
6056170|NCT00545077|20927049|P2|Overall Study|Physician Decision|3
6056171|NCT00545077|20927050|P1|Overall Study|Physician Decision|6
6056172|NCT00545077|20927049|P2|Overall Study|Withdrawal by Subject|14
6056173|NCT00545077|20927050|P1|Overall Study|Withdrawal by Subject|3
6056174|NCT00545077|20927049|P2|Overall Study|Disease Progression|98
6056175|NCT00545077|20927050|P1|Overall Study|Disease Progression|131
6056176|NCT00545077|20927049|P2|Overall Study|Treatment not received|1
6056177|NCT00545077|20927050|P1|Overall Study|Treatment not received|5
6056178|NCT00545064|20927066|P1|Overall Study|inclement weather|1
6056179|NCT00545064|20927066|P1|Overall Study|cancel all appointments, no rebooking|1
6056180|NCT00545064|20927066|P1|Overall Study|did not complete course of treatment|1
6056181|NCT00545064|20927066|P1|Overall Study|Withdrawal by Subject|2
6056182|NCT00545064|20927066|P1|Overall Study|Lost to Follow-up|3
6056183|NCT00545051|20927077|P2|Overall Study|Administrative reasons|1
6056184|NCT00545051|20927078|P1|Overall Study|Administrative reasons|0
6056185|NCT00545051|20927077|P2|Overall Study|Withdrawal by Subject|1
6056186|NCT00545051|20927078|P1|Overall Study|Withdrawal by Subject|0
6056187|NCT00545051|20927077|P2|Overall Study|Protocol Violation|0
6056188|NCT00545051|20927078|P1|Overall Study|Protocol Violation|1
6056189|NCT00545051|20927077|P2|Overall Study|Violation of inclusion/exclusion|2
6056190|NCT00545051|20927078|P1|Overall Study|Violation of inclusion/exclusion|0
6056191|NCT00545051|20927077|P2|Overall Study|Death|0
6056192|NCT00545051|20927078|P1|Overall Study|Death|1
6056193|NCT00545051|20927077|P2|Overall Study|Adverse Event|3
6056194|NCT00545051|20927078|P1|Overall Study|Adverse Event|7
6056195|NCT00544882|20927122|P3|Cycle 3: Follow-up|Pregnancy|0
6056196|NCT00544882|20927123|P2|Cycle 3: Follow-up|Pregnancy|1
6056197|NCT00544882|20927124|P1|Cycle 3: Follow-up|Pregnancy|0
6056198|NCT00544882|20927122|P3|Cycle 3: Follow-up|Noncompliance|0
6056199|NCT00544882|20927123|P2|Cycle 3: Follow-up|Noncompliance|1
6056200|NCT00544882|20927124|P1|Cycle 3: Follow-up|Noncompliance|0
6056201|NCT00544882|20927122|P3|Cycle 2: Randomized Treatment Cycle|Noncompliance|1
6056202|NCT00544882|20927123|P2|Cycle 2: Randomized Treatment Cycle|Noncompliance|0
6056203|NCT00544882|20927124|P1|Cycle 2: Randomized Treatment Cycle|Noncompliance|0
6056204|NCT00544882|20927122|P3|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0
6056205|NCT00544882|20927123|P2|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|1
6056206|NCT00544882|20927124|P1|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0
6056207|NCT00544882|20927122|P3|Cycle 1: Run-in Cycle|Adverse Event|0
6056208|NCT00544882|20927123|P2|Cycle 1: Run-in Cycle|Adverse Event|0
6056209|NCT00544882|20927124|P1|Cycle 1: Run-in Cycle|Adverse Event|1
6056210|NCT00544882|20927122|P3|Cycle 1: Run-in Cycle|Withdrawal by Subject|0
6056211|NCT00544882|20927123|P2|Cycle 1: Run-in Cycle|Withdrawal by Subject|0
6056212|NCT00544882|20927124|P1|Cycle 1: Run-in Cycle|Withdrawal by Subject|2
6056213|NCT00544869|20927149|P3|Overall Study|Physician Decision|0
6056214|NCT00544869|20927150|P2|Overall Study|Physician Decision|0
6056215|NCT00544869|20927151|P1|Overall Study|Physician Decision|2
6056216|NCT00544869|20927149|P3|Overall Study|Lack of Efficacy|0
6056217|NCT00544869|20927150|P2|Overall Study|Lack of Efficacy|1
6056218|NCT00544869|20927151|P1|Overall Study|Lack of Efficacy|1
6056219|NCT00544869|20927149|P3|Overall Study|Adverse Event|0
6056220|NCT00544869|20927150|P2|Overall Study|Adverse Event|1
6056221|NCT00544869|20927151|P1|Overall Study|Adverse Event|6
6056222|NCT00544869|20927149|P3|Overall Study|Rsolution of congenitive symptoms|0
6056223|NCT00544869|20927150|P2|Overall Study|Rsolution of congenitive symptoms|0
6056224|NCT00544869|20927151|P1|Overall Study|Rsolution of congenitive symptoms|3
6056225|NCT00544817|20927159|P1|Follow-up Systemic Therapy|Intercurrent Illness - Pneumonia|1
6056226|NCT00544817|20927159|P1|Follow-up Systemic Therapy|Physician Decision|3
6056227|NCT00544817|20927159|P1|Follow-up Systemic Therapy|Lack of Efficacy|15
6056228|NCT00544817|20927159|P1|No Treatment Interval|Adverse Event|1
6056229|NCT00544817|20927159|P1|No Treatment Interval|Physician Decision|3
6056230|NCT00544817|20927159|P1|No Treatment Interval|Lack of Efficacy|8
6056231|NCT00544817|20927159|P1|Combined Modality|Intercurrent Illness - Pneumonia|1
6056232|NCT00544817|20927159|P1|Combined Modality|Adverse Event|2
6056233|NCT00544817|20927159|P1|Combined Modality|Worsening Neurologic Symptoms|2
6056234|NCT00544817|20927159|P1|Combined Modality|Lack of Efficacy|2
6056235|NCT00544648|20927208|P2|Overall Study|progression of disease|0
6056236|NCT00544648|20927209|P1|Overall Study|progression of disease|1
6056237|NCT00544648|20927208|P2|Overall Study|Adverse Event|1
6056238|NCT00544648|20927209|P1|Overall Study|Adverse Event|1
6056239|NCT00544648|20927208|P2|Overall Study|Withdrawal by Subject|0
6056240|NCT00544648|20927209|P1|Overall Study|Withdrawal by Subject|1
6056241|NCT00544557|20927223|P1|Overall Study|Other|98
6056242|NCT00544557|20927223|P1|Overall Study|Lack of Efficacy|196
6056243|NCT00544557|20927223|P1|Overall Study|Adverse Event|140
6056244|NCT00544544|20927254|P1|Overall Study|Lost to Follow-up|1
6056245|NCT00544544|20927254|P1|Overall Study|Adverse Event|1
6056246|NCT00544544|20927254|P1|Overall Study|Withdrawal by Subject|1
6056247|NCT00544440|20927261|P1|Overall Study|Other|5
6056248|NCT00544440|20927261|P1|Overall Study|Progressive Disease|47
6056249|NCT00544440|20927261|P1|Overall Study|Subject Non-compliance|1
6056250|NCT00544440|20927261|P1|Overall Study|Withdrawal by Subject|2
6056251|NCT00544440|20927261|P1|Overall Study|Adverse Event|1
6056252|NCT00544440|20927261|P1|Overall Study|Other|1
6056253|NCT00544167|20927268|P1|Overall Study|Physician Decision|8
6056254|NCT00544167|20927268|P1|Overall Study|Adverse Event|21
6056255|NCT00543985|20927294|P1|Overall Study|Withdrawal by Subject|4
6056256|NCT00543855|20927305|P4|Overall Study|Protocol Violation|0
6056257|NCT00543855|20927306|P3|Overall Study|Protocol Violation|0
6056258|NCT00543855|20927307|P2|Overall Study|Protocol Violation|0
6056259|NCT00543855|20927308|P1|Overall Study|Protocol Violation|1
6056260|NCT00543855|20927305|P4|Overall Study|Withdrawal by Subject|0
6056261|NCT00543855|20927306|P3|Overall Study|Withdrawal by Subject|2
6056262|NCT00543855|20927307|P2|Overall Study|Withdrawal by Subject|1
6056263|NCT00543855|20927308|P1|Overall Study|Withdrawal by Subject|0
6056264|NCT00543855|20927305|P4|Overall Study|Lost to Follow-up|0
6056265|NCT00543855|20927306|P3|Overall Study|Lost to Follow-up|1
6056266|NCT00543855|20927307|P2|Overall Study|Lost to Follow-up|0
6056267|NCT00543855|20927308|P1|Overall Study|Lost to Follow-up|0
6056268|NCT00543855|20927305|P4|Overall Study|Adverse Event|4
6056269|NCT00543855|20927306|P3|Overall Study|Adverse Event|3
6056270|NCT00543855|20927307|P2|Overall Study|Adverse Event|1
6056271|NCT00543855|20927308|P1|Overall Study|Adverse Event|3
6056272|NCT00543803|20927330|P1|Overall Study|Other|86
6056273|NCT00543803|20927330|P1|Overall Study|Lost to Follow-up|20
6056274|NCT00543803|20927330|P1|Overall Study|Lack of Efficacy|22
6056275|NCT00543803|20927330|P1|Overall Study|Adverse Event|14
6056276|NCT00543725|20927358|P2|Overall Study|Other|3
6056277|NCT00543725|20927359|P1|Overall Study|Other|3
6056278|NCT00543725|20927358|P2|Overall Study|Lost to Follow-up|11
6056279|NCT00543725|20927359|P1|Overall Study|Lost to Follow-up|15
6056280|NCT00543725|20927358|P2|Overall Study|Withdrawal by Subject|13
6056281|NCT00543725|20927359|P1|Overall Study|Withdrawal by Subject|4
6056282|NCT00543725|20927358|P2|Overall Study|Protocol Violation|1
6056283|NCT00543725|20927359|P1|Overall Study|Protocol Violation|0
6056284|NCT00543725|20927358|P2|Overall Study|Subject Reached A Virologic Endpoint|14
6056285|NCT00543725|20927359|P1|Overall Study|Subject Reached A Virologic Endpoint|22
6056286|NCT00543725|20927358|P2|Overall Study|Subject Ineligible To Continue The Trial|0
6056287|NCT00543725|20927359|P1|Overall Study|Subject Ineligible To Continue The Trial|2
6056288|NCT00543725|20927358|P2|Overall Study|Subject Non-Compliant|4
6056289|NCT00543725|20927359|P1|Overall Study|Subject Non-Compliant|4
6056290|NCT00543725|20927358|P2|Overall Study|Sponsor's Decision|1
6056291|NCT00543725|20927359|P1|Overall Study|Sponsor's Decision|0
6056292|NCT00543725|20927358|P2|Overall Study|Adverse Event|27
6056293|NCT00543725|20927359|P1|Overall Study|Adverse Event|18
6056294|NCT00543569|20927385|P4|Overall Study|Randomized but never received study drug|3
6056295|NCT00543569|20927386|P3|Overall Study|Randomized but never received study drug|5
6056296|NCT00543569|20927387|P2|Overall Study|Randomized but never received study drug|3
6056297|NCT00543569|20927388|P1|Overall Study|Randomized but never received study drug|3
6056298|NCT00543569|20927385|P4|Overall Study|Miscellaneous Reasons|4
6056299|NCT00543569|20927386|P3|Overall Study|Miscellaneous Reasons|11
6056300|NCT00543569|20927387|P2|Overall Study|Miscellaneous Reasons|3
6056301|NCT00543569|20927388|P1|Overall Study|Miscellaneous Reasons|7
6056302|NCT00543569|20927385|P4|Overall Study|Lost to Follow-up|1
6056303|NCT00543569|20927386|P3|Overall Study|Lost to Follow-up|1
6056304|NCT00543569|20927387|P2|Overall Study|Lost to Follow-up|0
6056305|NCT00543569|20927388|P1|Overall Study|Lost to Follow-up|0
6056306|NCT00543569|20927385|P4|Overall Study|Death|1
6056307|NCT00543569|20927386|P3|Overall Study|Death|3
6056308|NCT00543569|20927387|P2|Overall Study|Death|2
6056309|NCT00543569|20927388|P1|Overall Study|Death|2
6056310|NCT00543543|20927494|P4|Extension Study|Withdrawal by Subject|120
6056311|NCT00543543|20927495|P3|Extension Study|Withdrawal by Subject|0
6056312|NCT00543543|20927496|P2|Extension Study|Withdrawal by Subject|0
6056313|NCT00543543|20927497|P1|Extension Study|Withdrawal by Subject|0
6056314|NCT00543543|20927494|P4|Extension Study|Protocol Violation|11
6056315|NCT00543543|20927495|P3|Extension Study|Protocol Violation|0
6056316|NCT00543543|20927496|P2|Extension Study|Protocol Violation|0
6056317|NCT00543543|20927497|P1|Extension Study|Protocol Violation|0
6056318|NCT00543543|20927494|P4|Extension Study|Pregnancy|6
6056319|NCT00543543|20927495|P3|Extension Study|Pregnancy|0
6056320|NCT00543543|20927496|P2|Extension Study|Pregnancy|0
6056321|NCT00543543|20927497|P1|Extension Study|Pregnancy|0
6056322|NCT00543543|20927494|P4|Extension Study|Physician Decision|7
6056323|NCT00543543|20927495|P3|Extension Study|Physician Decision|0
6056324|NCT00543543|20927496|P2|Extension Study|Physician Decision|0
6056325|NCT00543543|20927497|P1|Extension Study|Physician Decision|0
6056326|NCT00543543|20927494|P4|Extension Study|Lost to Follow-up|77
6056327|NCT00543543|20927495|P3|Extension Study|Lost to Follow-up|0
6056328|NCT00543543|20927496|P2|Extension Study|Lost to Follow-up|0
6056329|NCT00543543|20927497|P1|Extension Study|Lost to Follow-up|0
6056330|NCT00543543|20927494|P4|Extension Study|Adverse Event|5
6056331|NCT00543543|20927495|P3|Extension Study|Adverse Event|0
6056332|NCT00543543|20927496|P2|Extension Study|Adverse Event|0
6056333|NCT00543543|20927497|P1|Extension Study|Adverse Event|0
6056334|NCT00543543|20927494|P4|Base Study|Withdrawal by Subject|503
6056335|NCT00543543|20927495|P3|Base Study|Withdrawal by Subject|5
6056336|NCT00543543|20927496|P2|Base Study|Withdrawal by Subject|482
6056337|NCT00543543|20927497|P1|Base Study|Withdrawal by Subject|7
6056338|NCT00543543|20927494|P4|Base Study|Protocol Violation|6
6056339|NCT00543543|20927495|P3|Base Study|Protocol Violation|0
6056340|NCT00543543|20927496|P2|Base Study|Protocol Violation|6
6056341|NCT00543543|20927497|P1|Base Study|Protocol Violation|0
6056342|NCT00543543|20927494|P4|Base Study|Physician Decision|7
6056343|NCT00543543|20927495|P3|Base Study|Physician Decision|0
6056344|NCT00543543|20927496|P2|Base Study|Physician Decision|4
6056345|NCT00543543|20927497|P1|Base Study|Physician Decision|0
6056346|NCT00543543|20927494|P4|Base Study|Lost to Follow-up|701
6056347|NCT00543543|20927495|P3|Base Study|Lost to Follow-up|9
6056348|NCT00543543|20927496|P2|Base Study|Lost to Follow-up|749
6056349|NCT00543543|20927497|P1|Base Study|Lost to Follow-up|12
6056350|NCT00543543|20927494|P4|Base Study|Adverse Event|5
6056351|NCT00543543|20927495|P3|Base Study|Adverse Event|0
6056352|NCT00543543|20927496|P2|Base Study|Adverse Event|11
6056353|NCT00543543|20927497|P1|Base Study|Adverse Event|1
6056354|NCT00543439|20927541|P3|Period 2|Adverse Event|1
6056355|NCT00543439|20927542|P2|Period 2|Adverse Event|1
6056356|NCT00543439|20927543|P1|Period 2|Adverse Event|0
6056357|NCT00543439|20927541|P3|Period 2|Protocol Violation|1
6056358|NCT00543439|20927542|P2|Period 2|Protocol Violation|0
6056359|NCT00543439|20927543|P1|Period 2|Protocol Violation|1
6056360|NCT00543439|20927541|P3|Period 1|Physician Decision|1
6056361|NCT00543439|20927542|P2|Period 1|Physician Decision|0
6056362|NCT00543439|20927543|P1|Period 1|Physician Decision|0
6056363|NCT00543439|20927541|P3|Period 1|Withdrawal by Subject|0
6056364|NCT00543439|20927542|P2|Period 1|Withdrawal by Subject|1
6056365|NCT00543439|20927543|P1|Period 1|Withdrawal by Subject|1
6056366|NCT00543439|20927541|P3|Period 1|Adverse Event|1
6056367|NCT00543439|20927542|P2|Period 1|Adverse Event|2
6056368|NCT00543439|20927543|P1|Period 1|Adverse Event|0
6056369|NCT00543387|20927612|P11|Crossover Participants|Study Terminated by Sponsor|1
6056370|NCT00543387|20927613|P10|Crossover Participants|Study Terminated by Sponsor|0
6056371|NCT00543387|20927614|P9|Crossover Participants|Study Terminated by Sponsor|0
6056372|NCT00543387|20927615|P8|Crossover Participants|Study Terminated by Sponsor|0
6056373|NCT00543387|20927616|P7|Crossover Participants|Study Terminated by Sponsor|0
6056374|NCT00543387|20927617|P6|Crossover Participants|Study Terminated by Sponsor|0
6056375|NCT00543387|20927618|P5|Crossover Participants|Study Terminated by Sponsor|0
6056376|NCT00543387|20927619|P4|Crossover Participants|Study Terminated by Sponsor|0
6056377|NCT00543387|20927620|P3|Crossover Participants|Study Terminated by Sponsor|0
6056378|NCT00543387|20927621|P2|Crossover Participants|Study Terminated by Sponsor|0
6056379|NCT00543387|20927622|P1|Crossover Participants|Study Terminated by Sponsor|0
6056380|NCT00543387|20927612|P11|Crossover Participants|Progressive Disease|2
6056381|NCT00543387|20927613|P10|Crossover Participants|Progressive Disease|1
6056382|NCT00543387|20927614|P9|Crossover Participants|Progressive Disease|0
6056383|NCT00543387|20927615|P8|Crossover Participants|Progressive Disease|0
6056384|NCT00543387|20927616|P7|Crossover Participants|Progressive Disease|0
6056385|NCT00543387|20927617|P6|Crossover Participants|Progressive Disease|0
6056386|NCT00543387|20927618|P5|Crossover Participants|Progressive Disease|0
6056387|NCT00543387|20927619|P4|Crossover Participants|Progressive Disease|0
6056388|NCT00543387|20927620|P3|Crossover Participants|Progressive Disease|0
6056389|NCT00543387|20927621|P2|Crossover Participants|Progressive Disease|0
6056390|NCT00543387|20927622|P1|Crossover Participants|Progressive Disease|0
6056391|NCT00543387|20927612|P11|Panel 1 + Panel 2|Withdrawal by Subject|0
6056392|NCT00543387|20927613|P10|Panel 1 + Panel 2|Withdrawal by Subject|0
6056393|NCT00543387|20927614|P9|Panel 1 + Panel 2|Withdrawal by Subject|0
6056394|NCT00543387|20927615|P8|Panel 1 + Panel 2|Withdrawal by Subject|0
6056395|NCT00543387|20927616|P7|Panel 1 + Panel 2|Withdrawal by Subject|1
6056396|NCT00543387|20927617|P6|Panel 1 + Panel 2|Withdrawal by Subject|0
6056397|NCT00543387|20927618|P5|Panel 1 + Panel 2|Withdrawal by Subject|0
6056398|NCT00543387|20927619|P4|Panel 1 + Panel 2|Withdrawal by Subject|0
6056399|NCT00543387|20927620|P3|Panel 1 + Panel 2|Withdrawal by Subject|0
6056400|NCT00543387|20927621|P2|Panel 1 + Panel 2|Withdrawal by Subject|0
6056401|NCT00543387|20927622|P1|Panel 1 + Panel 2|Withdrawal by Subject|0
6056402|NCT00543387|20927612|P11|Panel 1 + Panel 2|Progressive Disease (PD)|0
6056403|NCT00543387|20927613|P10|Panel 1 + Panel 2|Progressive Disease (PD)|0
6056404|NCT00543387|20927614|P9|Panel 1 + Panel 2|Progressive Disease (PD)|4
6056405|NCT00543387|20927615|P8|Panel 1 + Panel 2|Progressive Disease (PD)|4
6056406|NCT00543387|20927616|P7|Panel 1 + Panel 2|Progressive Disease (PD)|5
6056407|NCT00543387|20927617|P6|Panel 1 + Panel 2|Progressive Disease (PD)|3
6056408|NCT00543387|20927618|P5|Panel 1 + Panel 2|Progressive Disease (PD)|3
6056409|NCT00543387|20927619|P4|Panel 1 + Panel 2|Progressive Disease (PD)|3
6056410|NCT00543387|20927620|P3|Panel 1 + Panel 2|Progressive Disease (PD)|2
6056411|NCT00543387|20927621|P2|Panel 1 + Panel 2|Progressive Disease (PD)|2
6056412|NCT00543387|20927622|P1|Panel 1 + Panel 2|Progressive Disease (PD)|3
6056413|NCT00543387|20927612|P11|Panel 1 + Panel 2|Physician Decision|0
6056414|NCT00543387|20927613|P10|Panel 1 + Panel 2|Physician Decision|0
6056415|NCT00543387|20927614|P9|Panel 1 + Panel 2|Physician Decision|0
6056416|NCT00543387|20927615|P8|Panel 1 + Panel 2|Physician Decision|1
6056417|NCT00543387|20927616|P7|Panel 1 + Panel 2|Physician Decision|0
6056418|NCT00543387|20927617|P6|Panel 1 + Panel 2|Physician Decision|0
6056419|NCT00543387|20927618|P5|Panel 1 + Panel 2|Physician Decision|0
6056420|NCT00543387|20927619|P4|Panel 1 + Panel 2|Physician Decision|0
6056421|NCT00543387|20927620|P3|Panel 1 + Panel 2|Physician Decision|1
6056422|NCT00543387|20927621|P2|Panel 1 + Panel 2|Physician Decision|0
6056423|NCT00543387|20927622|P1|Panel 1 + Panel 2|Physician Decision|0
6056424|NCT00543387|20927612|P11|Panel 1 + Panel 2|Adverse Event|0
6056425|NCT00543387|20927613|P10|Panel 1 + Panel 2|Adverse Event|0
6056426|NCT00543387|20927614|P9|Panel 1 + Panel 2|Adverse Event|1
6056427|NCT00543387|20927615|P8|Panel 1 + Panel 2|Adverse Event|1
6056428|NCT00543387|20927616|P7|Panel 1 + Panel 2|Adverse Event|0
6056429|NCT00543387|20927617|P6|Panel 1 + Panel 2|Adverse Event|0
6056430|NCT00543387|20927618|P5|Panel 1 + Panel 2|Adverse Event|0
6056431|NCT00543387|20927619|P4|Panel 1 + Panel 2|Adverse Event|0
6056432|NCT00543387|20927620|P3|Panel 1 + Panel 2|Adverse Event|0
6056433|NCT00543387|20927621|P2|Panel 1 + Panel 2|Adverse Event|1
6056434|NCT00543387|20927622|P1|Panel 1 + Panel 2|Adverse Event|0
6056435|NCT00543309|20927660|P3|Overall Study|Physician Decision|0
6056436|NCT00543309|20927661|P2|Overall Study|Physician Decision|1
6056437|NCT00543309|20927662|P1|Overall Study|Physician Decision|0
6056438|NCT00543296|20927712|P1|Overall Study|Physician Decision|7
6056439|NCT00543140|20927719|P1|Overall Study|Conversion to different procedure|1
6056440|NCT00543140|20927719|P1|Overall Study|Subject moved|1
6056441|NCT00543140|20927719|P1|Overall Study|Death|1
6056442|NCT00543140|20927719|P1|Overall Study|SAE leading to explant of SAGB|3
6056443|NCT00543140|20927719|P1|Overall Study|Insufficient weight loss|10
6056444|NCT00543140|20927719|P1|Overall Study|Protocol Violation|10
6056445|NCT00543140|20927719|P1|Overall Study|Withdrawal by Subject|13
6056446|NCT00543140|20927719|P1|Overall Study|Lost to Follow-up|33
6056447|NCT00543062|20927757|P4|Overall Study|Protocol Violation|0
6056448|NCT00543062|20927758|P3|Overall Study|Protocol Violation|0
6056449|NCT00543062|20927759|P2|Overall Study|Protocol Violation|0
6056450|NCT00543062|20927760|P1|Overall Study|Protocol Violation|1
6056451|NCT00543062|20927757|P4|Overall Study|Adverse Event|1
6056452|NCT00543062|20927758|P3|Overall Study|Adverse Event|1
6056453|NCT00543062|20927759|P2|Overall Study|Adverse Event|1
6056454|NCT00543062|20927760|P1|Overall Study|Adverse Event|0
6056455|NCT00543062|20927757|P4|Overall Study|Withdrawal by Subject|0
6056456|NCT00543062|20927758|P3|Overall Study|Withdrawal by Subject|2
6056457|NCT00543062|20927759|P2|Overall Study|Withdrawal by Subject|0
6056458|NCT00543062|20927760|P1|Overall Study|Withdrawal by Subject|1
6056459|NCT00542997|20927782|P1|Efficacy Period|Adverse Event|3
6056460|NCT00542997|20927782|P1|Wash in / Wash Out Period|Adverse Event|3
6056461|NCT00542997|20927782|P1|Wash in / Wash Out Period|Withdrawal by Subject|2
6056462|NCT00542919|20927805|P3|Overall Study|Lost to Follow-up|1
6056463|NCT00542919|20927806|P2|Overall Study|Lost to Follow-up|0
6056464|NCT00542919|20927807|P1|Overall Study|Lost to Follow-up|2
6056465|NCT00542919|20927805|P3|Overall Study|Sponsor Decision|0
6056466|NCT00542919|20927806|P2|Overall Study|Sponsor Decision|0
6056467|NCT00542919|20927807|P1|Overall Study|Sponsor Decision|1
6056468|NCT00542919|20927805|P3|Overall Study|Physician Decision|1
6056469|NCT00542919|20927806|P2|Overall Study|Physician Decision|2
6056470|NCT00542919|20927807|P1|Overall Study|Physician Decision|2
6056471|NCT00542919|20927805|P3|Overall Study|Withdrawal by Subject|3
6056472|NCT00542919|20927806|P2|Overall Study|Withdrawal by Subject|0
6056473|NCT00542919|20927807|P1|Overall Study|Withdrawal by Subject|1
6056474|NCT00542919|20927805|P3|Overall Study|Adverse Event|1
6056475|NCT00542919|20927806|P2|Overall Study|Adverse Event|5
6056476|NCT00542919|20927807|P1|Overall Study|Adverse Event|1
6056477|NCT00542880|20927852|P2|Period 3|Adverse Event|2
6056478|NCT00542880|20927853|P1|Period 3|Adverse Event|0
6056479|NCT00542880|20927852|P2|Period 2|Other|1
6056480|NCT00542880|20927853|P1|Period 2|Other|0
6056481|NCT00542880|20927852|P2|Period 2|Severe non-compliance|1
6056482|NCT00542880|20927853|P1|Period 2|Severe non-compliance|0
6056483|NCT00542880|20927852|P2|Period 2|Discontinuation criteria|0
6056484|NCT00542880|20927853|P1|Period 2|Discontinuation criteria|2
6056485|NCT00542880|20927852|P2|Period 2|Eligibility not fulfilled|1
6056486|NCT00542880|20927853|P1|Period 2|Eligibility not fulfilled|0
6056487|NCT00542880|20927852|P2|Period 2|Adverse Event|7
6056488|NCT00542880|20927853|P1|Period 2|Adverse Event|5
6056489|NCT00542880|20927852|P2|Period 1|Protocol Violation|1
6056490|NCT00542880|20927853|P1|Period 1|Protocol Violation|0
6056491|NCT00542880|20927852|P2|Period 1|Withdrawal by Subject|1
6056492|NCT00542880|20927853|P1|Period 1|Withdrawal by Subject|1
6056493|NCT00542880|20927852|P2|Period 1|Development of study-specific criteria|2
6056494|NCT00542880|20927853|P1|Period 1|Development of study-specific criteria|1
6056495|NCT00542880|20927852|P2|Period 1|Adverse Event|2
6056496|NCT00542880|20927853|P1|Period 1|Adverse Event|2
6056497|NCT00542880|20927852|P2|Period 1|Eligibility criteria not fulfilled|6
6056498|NCT00542880|20927853|P1|Period 1|Eligibility criteria not fulfilled|2
6056499|NCT00542828|20927889|P1|Overall Study|Did Not Receive Thymoglobulin Treatment|2
6056500|NCT00542828|20927889|P1|Overall Study|Study Prematurely Discontinued|7
6056501|NCT00542828|20927889|P1|Overall Study|Need for Prohibited Treatment|3
6056502|NCT00542828|20927889|P1|Overall Study|Physician Decision|1
6056503|NCT00542815|20927907|P3|Overall Study|Other reasons|10
6056504|NCT00542815|20927908|P2|Overall Study|Other reasons|10
6056505|NCT00542815|20927909|P1|Overall Study|Other reasons|24
6056506|NCT00542815|20927907|P3|Overall Study|Withdrawal by Subject|8
6056507|NCT00542815|20927908|P2|Overall Study|Withdrawal by Subject|5
6056508|NCT00542815|20927909|P1|Overall Study|Withdrawal by Subject|41
6056509|NCT00542815|20927907|P3|Overall Study|Protocol Violation|2
6056510|NCT00542815|20927908|P2|Overall Study|Protocol Violation|1
6056511|NCT00542815|20927909|P1|Overall Study|Protocol Violation|1
6056512|NCT00542815|20927907|P3|Overall Study|Physician Decision|0
6056513|NCT00542815|20927908|P2|Overall Study|Physician Decision|1
6056514|NCT00542815|20927909|P1|Overall Study|Physician Decision|2
6056515|NCT00542815|20927907|P3|Overall Study|Lack of Efficacy|0
6056516|NCT00542815|20927908|P2|Overall Study|Lack of Efficacy|2
6056517|NCT00542815|20927909|P1|Overall Study|Lack of Efficacy|9
6056518|NCT00542815|20927907|P3|Overall Study|Death|3
6056519|NCT00542815|20927908|P2|Overall Study|Death|7
6056520|NCT00542815|20927909|P1|Overall Study|Death|10
6056521|NCT00542815|20927907|P3|Overall Study|Adverse Event|9
6056522|NCT00542815|20927908|P2|Overall Study|Adverse Event|6
6056523|NCT00542815|20927909|P1|Overall Study|Adverse Event|19
6056524|NCT00542789|20927922|P2|Overall Study|Recurrence of Gastric Ulcer|57
6056525|NCT00542789|20927923|P1|Overall Study|Recurrence of Gastric Ulcer|8
6056526|NCT00542789|20927922|P2|Overall Study|Protocol Violation|1
6056527|NCT00542789|20927923|P1|Overall Study|Protocol Violation|8
6056528|NCT00542789|20927922|P2|Overall Study|Withdrawal by Subject|3
6056529|NCT00542789|20927923|P1|Overall Study|Withdrawal by Subject|7
6056530|NCT00542789|20927922|P2|Overall Study|Adverse Event|17
6056531|NCT00542789|20927923|P1|Overall Study|Adverse Event|18
6056532|NCT00542425|20928023|P5|Extended 24 Weeks of Treatment|Other|1
6056533|NCT00542425|20928024|P4|Extended 24 Weeks of Treatment|Other|0
6056534|NCT00542425|20928025|P3|Extended 24 Weeks of Treatment|Other|0
6056535|NCT00542425|20928026|P2|Extended 24 Weeks of Treatment|Other|1
6056536|NCT00542425|20928027|P1|Extended 24 Weeks of Treatment|Other|1
6056537|NCT00542425|20928023|P5|Extended 24 Weeks of Treatment|Refusal of treatment|0
6056538|NCT00542425|20928024|P4|Extended 24 Weeks of Treatment|Refusal of treatment|0
6056539|NCT00542425|20928025|P3|Extended 24 Weeks of Treatment|Refusal of treatment|0
6056540|NCT00542425|20928026|P2|Extended 24 Weeks of Treatment|Refusal of treatment|1
6056541|NCT00542425|20928027|P1|Extended 24 Weeks of Treatment|Refusal of treatment|0
6056542|NCT00542425|20928023|P5|Extended 24 Weeks of Treatment|Protocol Violation|0
6056543|NCT00542425|20928024|P4|Extended 24 Weeks of Treatment|Protocol Violation|0
6056544|NCT00542425|20928025|P3|Extended 24 Weeks of Treatment|Protocol Violation|1
6056545|NCT00542425|20928026|P2|Extended 24 Weeks of Treatment|Protocol Violation|0
6056546|NCT00542425|20928027|P1|Extended 24 Weeks of Treatment|Protocol Violation|0
6056547|NCT00542425|20928023|P5|Extended 24 Weeks of Treatment|Adverse Event|0
6056548|NCT00542425|20928024|P4|Extended 24 Weeks of Treatment|Adverse Event|1
6056549|NCT00542425|20928025|P3|Extended 24 Weeks of Treatment|Adverse Event|1
6056550|NCT00542425|20928026|P2|Extended 24 Weeks of Treatment|Adverse Event|0
6056551|NCT00542425|20928027|P1|Extended 24 Weeks of Treatment|Adverse Event|0
6056552|NCT00542425|20928023|P5|Initial 24 Weeks|Other|0
6056553|NCT00542425|20928024|P4|Initial 24 Weeks|Other|0
6056554|NCT00542425|20928025|P3|Initial 24 Weeks|Other|1
6056555|NCT00542425|20928026|P2|Initial 24 Weeks|Other|2
6056556|NCT00542425|20928027|P1|Initial 24 Weeks|Other|0
6056557|NCT00542425|20928023|P5|Initial 24 Weeks|Refusal of treatment|1
6056558|NCT00542425|20928024|P4|Initial 24 Weeks|Refusal of treatment|4
6056559|NCT00542425|20928025|P3|Initial 24 Weeks|Refusal of treatment|1
6056560|NCT00542425|20928026|P2|Initial 24 Weeks|Refusal of treatment|2
6056561|NCT00542425|20928027|P1|Initial 24 Weeks|Refusal of treatment|2
6056562|NCT00542425|20928023|P5|Initial 24 Weeks|Protocol Violation|0
6056563|NCT00542425|20928024|P4|Initial 24 Weeks|Protocol Violation|1
6056564|NCT00542425|20928025|P3|Initial 24 Weeks|Protocol Violation|0
6056565|NCT00542425|20928026|P2|Initial 24 Weeks|Protocol Violation|0
6056566|NCT00542425|20928027|P1|Initial 24 Weeks|Protocol Violation|0
6056567|NCT00542425|20928023|P5|Initial 24 Weeks|Non-compliance|1
6056568|NCT00542425|20928024|P4|Initial 24 Weeks|Non-compliance|1
6056569|NCT00542425|20928025|P3|Initial 24 Weeks|Non-compliance|0
6056570|NCT00542425|20928026|P2|Initial 24 Weeks|Non-compliance|0
6056571|NCT00542425|20928027|P1|Initial 24 Weeks|Non-compliance|0
6056572|NCT00542425|20928023|P5|Initial 24 Weeks|Lost to Follow-up|0
6056573|NCT00542425|20928024|P4|Initial 24 Weeks|Lost to Follow-up|0
6056574|NCT00542425|20928025|P3|Initial 24 Weeks|Lost to Follow-up|1
6056575|NCT00542425|20928026|P2|Initial 24 Weeks|Lost to Follow-up|2
6056576|NCT00542425|20928027|P1|Initial 24 Weeks|Lost to Follow-up|2
6056577|NCT00542425|20928023|P5|Initial 24 Weeks|Inability to complete procedures|2
6056578|NCT00542425|20928024|P4|Initial 24 Weeks|Inability to complete procedures|1
6056579|NCT00542425|20928025|P3|Initial 24 Weeks|Inability to complete procedures|2
6056580|NCT00542425|20928026|P2|Initial 24 Weeks|Inability to complete procedures|3
6056581|NCT00542425|20928027|P1|Initial 24 Weeks|Inability to complete procedures|0
6056582|NCT00542425|20928023|P5|Initial 24 Weeks|Adverse Event|2
6056583|NCT00542425|20928024|P4|Initial 24 Weeks|Adverse Event|3
6056584|NCT00542425|20928025|P3|Initial 24 Weeks|Adverse Event|1
6056585|NCT00542425|20928026|P2|Initial 24 Weeks|Adverse Event|1
6056586|NCT00542425|20928027|P1|Initial 24 Weeks|Adverse Event|0
6056587|NCT00542425|20928023|P5|Initial 24 Weeks|Administrative reasons|0
6056588|NCT00542425|20928024|P4|Initial 24 Weeks|Administrative reasons|1
6056589|NCT00542425|20928025|P3|Initial 24 Weeks|Administrative reasons|1
6056590|NCT00542425|20928026|P2|Initial 24 Weeks|Administrative reasons|0
6056591|NCT00542425|20928027|P1|Initial 24 Weeks|Administrative reasons|0
6056592|NCT00542386|20928065|P6|Overall Study|Other Reasons|2
6056593|NCT00542386|20928066|P5|Overall Study|Other Reasons|4
6056594|NCT00542386|20928067|P4|Overall Study|Other Reasons|3
6056595|NCT00542386|20928068|P3|Overall Study|Other Reasons|4
6056596|NCT00542386|20928069|P2|Overall Study|Other Reasons|1
6056597|NCT00542386|20928070|P1|Overall Study|Other Reasons|4
6056598|NCT00542386|20928065|P6|Overall Study|Withdrawal by Subject|7
6056599|NCT00542386|20928066|P5|Overall Study|Withdrawal by Subject|15
6056600|NCT00542386|20928067|P4|Overall Study|Withdrawal by Subject|11
6056601|NCT00542386|20928068|P3|Overall Study|Withdrawal by Subject|10
6056602|NCT00542386|20928069|P2|Overall Study|Withdrawal by Subject|8
6056603|NCT00542386|20928070|P1|Overall Study|Withdrawal by Subject|5
6056604|NCT00542386|20928065|P6|Overall Study|Protocol Violation|4
6056605|NCT00542386|20928066|P5|Overall Study|Protocol Violation|0
6056606|NCT00542386|20928067|P4|Overall Study|Protocol Violation|0
6056607|NCT00542386|20928068|P3|Overall Study|Protocol Violation|1
6056608|NCT00542386|20928069|P2|Overall Study|Protocol Violation|0
6056609|NCT00542386|20928070|P1|Overall Study|Protocol Violation|0
6056610|NCT00542386|20928065|P6|Overall Study|Physician Decision|0
6056611|NCT00542386|20928066|P5|Overall Study|Physician Decision|0
6056612|NCT00542386|20928067|P4|Overall Study|Physician Decision|1
6056613|NCT00542386|20928068|P3|Overall Study|Physician Decision|0
6056614|NCT00542386|20928069|P2|Overall Study|Physician Decision|0
6056615|NCT00542386|20928070|P1|Overall Study|Physician Decision|1
6056616|NCT00542386|20928065|P6|Overall Study|Lack of Efficacy|31
6056617|NCT00542386|20928066|P5|Overall Study|Lack of Efficacy|7
6056618|NCT00542386|20928067|P4|Overall Study|Lack of Efficacy|13
6056619|NCT00542386|20928068|P3|Overall Study|Lack of Efficacy|10
6056620|NCT00542386|20928069|P2|Overall Study|Lack of Efficacy|12
6056621|NCT00542386|20928070|P1|Overall Study|Lack of Efficacy|32
6056622|NCT00542386|20928065|P6|Overall Study|Death|2
6056623|NCT00542386|20928066|P5|Overall Study|Death|1
6056624|NCT00542386|20928067|P4|Overall Study|Death|2
6056625|NCT00542386|20928068|P3|Overall Study|Death|1
6056626|NCT00542386|20928069|P2|Overall Study|Death|0
6056627|NCT00542386|20928070|P1|Overall Study|Death|0
6056628|NCT00542386|20928065|P6|Overall Study|Adverse Event|4
6056629|NCT00542386|20928066|P5|Overall Study|Adverse Event|13
6056630|NCT00542386|20928067|P4|Overall Study|Adverse Event|8
6056631|NCT00542386|20928068|P3|Overall Study|Adverse Event|7
6056632|NCT00542386|20928069|P2|Overall Study|Adverse Event|7
6056633|NCT00542386|20928070|P1|Overall Study|Adverse Event|1
6056634|NCT00542321|20928092|P2|Overall Study|Death|1
6056635|NCT00542321|20928093|P1|Overall Study|Death|0
6056636|NCT00542269|20928115|P3|Overall Study|Administrative problems|1
6056637|NCT00542269|20928116|P2|Overall Study|Administrative problems|1
6056638|NCT00542269|20928117|P1|Overall Study|Administrative problems|1
6056639|NCT00542269|20928115|P3|Overall Study|Withdrawal by Subject|0
6056640|NCT00542269|20928116|P2|Overall Study|Withdrawal by Subject|0
6056641|NCT00542269|20928117|P1|Overall Study|Withdrawal by Subject|1
6056642|NCT00542269|20928115|P3|Overall Study|Protocol Violation|0
6056643|NCT00542269|20928116|P2|Overall Study|Protocol Violation|1
6056644|NCT00542269|20928117|P1|Overall Study|Protocol Violation|1
6056645|NCT00542269|20928115|P3|Overall Study|Adverse Event|5
6056646|NCT00542269|20928116|P2|Overall Study|Adverse Event|4
6056647|NCT00542269|20928117|P1|Overall Study|Adverse Event|10
6056648|NCT00542191|20928146|P1|Overall Study|Death|3
6056649|NCT00542178|20928156|P8|Overall Study|did not complete year 4 follow-up|85
6056650|NCT00542178|20928157|P7|Overall Study|did not complete year 4 follow-up|87
6056651|NCT00542178|20928158|P6|Overall Study|did not complete year 4 follow-up|89
6056652|NCT00542178|20928159|P5|Overall Study|did not complete year 4 follow-up|64
6056653|NCT00542178|20928160|P4|Overall Study|did not complete year 4 follow-up|62
6056654|NCT00542178|20928161|P3|Overall Study|did not complete year 4 follow-up|74
6056655|NCT00542178|20928162|P2|Overall Study|did not complete year 4 follow-up|80
6056656|NCT00542178|20928163|P1|Overall Study|did not complete year 4 follow-up|75
6056657|NCT00541970|20928199|P4|Month 60|Protocol Violation|72
6056658|NCT00541970|20928200|P3|Month 60|Protocol Violation|82
6056659|NCT00541970|20928201|P2|Month 60|Protocol Violation|77
6056660|NCT00541970|20928202|P1|Month 60|Protocol Violation|78
6056661|NCT00541970|20928199|P4|Month 48|Lost to Follow-up|73
6056662|NCT00541970|20928200|P3|Month 48|Lost to Follow-up|68
6056663|NCT00541970|20928201|P2|Month 48|Lost to Follow-up|68
6056664|NCT00541970|20928202|P1|Month 48|Lost to Follow-up|66
6056665|NCT00541970|20928199|P4|Month 48|Other|0
6056666|NCT00541970|20928200|P3|Month 48|Other|1
6056667|NCT00541970|20928201|P2|Month 48|Other|1
6056668|NCT00541970|20928202|P1|Month 48|Other|3
6056669|NCT00541970|20928199|P4|Month 48|Withdrawal by Subject|2
6056670|NCT00541970|20928200|P3|Month 48|Withdrawal by Subject|4
6056671|NCT00541970|20928201|P2|Month 48|Withdrawal by Subject|4
6056672|NCT00541970|20928202|P1|Month 48|Withdrawal by Subject|2
6056673|NCT00541970|20928199|P4|Month 36|Protocol Violation|60
6056674|NCT00541970|20928200|P3|Month 36|Protocol Violation|66
6056675|NCT00541970|20928201|P2|Month 36|Protocol Violation|66
6056676|NCT00541970|20928202|P1|Month 36|Protocol Violation|61
6056677|NCT00541970|20928199|P4|Month 24|Protocol Violation|21
6056678|NCT00541970|20928200|P3|Month 24|Protocol Violation|31
6056679|NCT00541970|20928201|P2|Month 24|Protocol Violation|31
6056680|NCT00541970|20928202|P1|Month 24|Protocol Violation|29
6056681|NCT00541970|20928199|P4|Month 24|Adverse Event|1
6056682|NCT00541970|20928200|P3|Month 24|Adverse Event|1
6056683|NCT00541970|20928201|P2|Month 24|Adverse Event|1
6056684|NCT00541970|20928202|P1|Month 24|Adverse Event|0
6056685|NCT00541970|20928199|P4|Month 18|Protocol Violation|16
6056686|NCT00541970|20928200|P3|Month 18|Protocol Violation|24
6056687|NCT00541970|20928201|P2|Month 18|Protocol Violation|23
6056688|NCT00541970|20928202|P1|Month 18|Protocol Violation|14
6056689|NCT00541970|20928199|P4|Month 18|Adverse Event|1
6056690|NCT00541970|20928200|P3|Month 18|Adverse Event|1
6056691|NCT00541970|20928201|P2|Month 18|Adverse Event|1
6056692|NCT00541970|20928202|P1|Month 18|Adverse Event|0
6056693|NCT00541970|20928199|P4|Month 12|Protocol Violation|15
6056694|NCT00541970|20928200|P3|Month 12|Protocol Violation|20
6056695|NCT00541970|20928201|P2|Month 12|Protocol Violation|21
6056696|NCT00541970|20928202|P1|Month 12|Protocol Violation|12
6056697|NCT00541970|20928199|P4|Month 12|Adverse Event|1
6056698|NCT00541970|20928200|P3|Month 12|Adverse Event|1
6056699|NCT00541970|20928201|P2|Month 12|Adverse Event|1
6056700|NCT00541970|20928202|P1|Month 12|Adverse Event|0
6056701|NCT00541970|20928199|P4|Month 7|Protocol Violation|5
6056702|NCT00541970|20928200|P3|Month 7|Protocol Violation|11
6056703|NCT00541970|20928201|P2|Month 7|Protocol Violation|13
6056704|NCT00541970|20928202|P1|Month 7|Protocol Violation|9
6056705|NCT00541931|20928353|P2|Overall Study|Transportation Issue|1
6056706|NCT00541931|20928354|P1|Overall Study|Transportation Issue|0
6056707|NCT00541931|20928353|P2|Overall Study|Withdrawal by Subject|0
6056708|NCT00541931|20928354|P1|Overall Study|Withdrawal by Subject|1
6056709|NCT00541931|20928353|P2|Overall Study|Lost to Follow-up|3
6056710|NCT00541931|20928354|P1|Overall Study|Lost to Follow-up|3
6056711|NCT00541931|20928353|P2|Overall Study|Adverse Event|0
6056712|NCT00541931|20928354|P1|Overall Study|Adverse Event|1
6056713|NCT00541866|20928367|P5|Overall Study|Physician Decision|0
6056714|NCT00541866|20928368|P4|Overall Study|Physician Decision|1
6056715|NCT00541866|20928369|P3|Overall Study|Physician Decision|2
6056716|NCT00541866|20928370|P2|Overall Study|Physician Decision|0
6056717|NCT00541866|20928371|P1|Overall Study|Physician Decision|0
6056718|NCT00541866|20928367|P5|Overall Study|Not Reported or Other|1
6056719|NCT00541866|20928368|P4|Overall Study|Not Reported or Other|3
6056720|NCT00541866|20928369|P3|Overall Study|Not Reported or Other|3
6056721|NCT00541866|20928370|P2|Overall Study|Not Reported or Other|3
6056722|NCT00541866|20928371|P1|Overall Study|Not Reported or Other|11
6056723|NCT00541866|20928367|P5|Overall Study|Lack of Efficacy|14
6056724|NCT00541866|20928368|P4|Overall Study|Lack of Efficacy|12
6056725|NCT00541866|20928369|P3|Overall Study|Lack of Efficacy|10
6056726|NCT00541866|20928370|P2|Overall Study|Lack of Efficacy|15
6056727|NCT00541866|20928371|P1|Overall Study|Lack of Efficacy|19
6056728|NCT00541866|20928367|P5|Overall Study|Death|0
6056729|NCT00541866|20928368|P4|Overall Study|Death|0
6056730|NCT00541866|20928369|P3|Overall Study|Death|0
6056731|NCT00541866|20928370|P2|Overall Study|Death|0
6056732|NCT00541866|20928371|P1|Overall Study|Death|1
6056733|NCT00541866|20928367|P5|Overall Study|Adverse Event|0
6056734|NCT00541866|20928368|P4|Overall Study|Adverse Event|0
6056735|NCT00541866|20928369|P3|Overall Study|Adverse Event|0
6056736|NCT00541866|20928370|P2|Overall Study|Adverse Event|0
6056737|NCT00541866|20928371|P1|Overall Study|Adverse Event|3
6056738|NCT00541775|20928412|P3|Overall Study|Withdrawal by Subject and Other|2
6056739|NCT00541775|20928413|P2|Overall Study|Withdrawal by Subject and Other|0
6056740|NCT00541775|20928414|P1|Overall Study|Withdrawal by Subject and Other|5
6056741|NCT00541775|20928412|P3|Overall Study|Protocol Violation|0
6056742|NCT00541775|20928413|P2|Overall Study|Protocol Violation|0
6056743|NCT00541775|20928414|P1|Overall Study|Protocol Violation|1
6056744|NCT00541775|20928412|P3|Overall Study|Lost to Follow-up|2
6056745|NCT00541775|20928413|P2|Overall Study|Lost to Follow-up|0
6056746|NCT00541775|20928414|P1|Overall Study|Lost to Follow-up|0
6056747|NCT00541775|20928412|P3|Overall Study|Lack of Efficacy|3
6056748|NCT00541775|20928413|P2|Overall Study|Lack of Efficacy|0
6056749|NCT00541775|20928414|P1|Overall Study|Lack of Efficacy|0
6056750|NCT00541775|20928412|P3|Overall Study|Adverse Event|1
6056751|NCT00541775|20928413|P2|Overall Study|Adverse Event|2
6056752|NCT00541775|20928414|P1|Overall Study|Adverse Event|3
6056753|NCT00541658|20928440|P3|Overall Study|Took No Study Drug|0
6056754|NCT00541658|20928441|P2|Overall Study|Took No Study Drug|0
6056755|NCT00541658|20928442|P1|Overall Study|Took No Study Drug|1
6056756|NCT00541658|20928440|P3|Overall Study|Withdrawal by Subject|32
6056757|NCT00541658|20928441|P2|Overall Study|Withdrawal by Subject|32
6056758|NCT00541658|20928442|P1|Overall Study|Withdrawal by Subject|28
6056759|NCT00541658|20928440|P3|Overall Study|Protocol Violation|1
6056760|NCT00541658|20928441|P2|Overall Study|Protocol Violation|1
6056761|NCT00541658|20928442|P1|Overall Study|Protocol Violation|0
6056762|NCT00541658|20928440|P3|Overall Study|Lost to Follow-up|6
6056763|NCT00541658|20928441|P2|Overall Study|Lost to Follow-up|3
6056764|NCT00541658|20928442|P1|Overall Study|Lost to Follow-up|3
6056765|NCT00541658|20928440|P3|Overall Study|Physician Decision|4
6056766|NCT00541658|20928441|P2|Overall Study|Physician Decision|0
6056767|NCT00541658|20928442|P1|Overall Study|Physician Decision|0
6056768|NCT00541658|20928440|P3|Overall Study|Adverse Event|25
6056769|NCT00541658|20928441|P2|Overall Study|Adverse Event|37
6056770|NCT00541658|20928442|P1|Overall Study|Adverse Event|28
6056771|NCT00541450|20928605|P2|Phase B|Withdrawal by Subject|6
6056772|NCT00541450|20928606|P1|Phase B|Withdrawal by Subject|8
6056773|NCT00541450|20928605|P2|Phase B|Protocol Violation|3
6056774|NCT00541450|20928606|P1|Phase B|Protocol Violation|3
6056775|NCT00541450|20928605|P2|Phase B|Pregnancy|1
6056776|NCT00541450|20928606|P1|Phase B|Pregnancy|0
6056777|NCT00541450|20928605|P2|Phase B|Physician Decision|2
6056778|NCT00541450|20928606|P1|Phase B|Physician Decision|4
6056779|NCT00541450|20928605|P2|Phase B|Lost to Follow-up|4
6056780|NCT00541450|20928606|P1|Phase B|Lost to Follow-up|6
6056781|NCT00541450|20928605|P2|Phase B|Hyperglycemia|9
6056782|NCT00541450|20928606|P1|Phase B|Hyperglycemia|10
6056783|NCT00541450|20928605|P2|Phase B|Adverse Event|6
6056784|NCT00541450|20928606|P1|Phase B|Adverse Event|6
6056785|NCT00541450|20928605|P2|Phase A|Withdrawal by Subject|7
6056786|NCT00541450|20928606|P1|Phase A|Withdrawal by Subject|7
6056787|NCT00541450|20928605|P2|Phase A|Protocol Violation|3
6056788|NCT00541450|20928606|P1|Phase A|Protocol Violation|2
6056789|NCT00541450|20928605|P2|Phase A|Physician Decision|0
6056790|NCT00541450|20928606|P1|Phase A|Physician Decision|2
6056791|NCT00541450|20928605|P2|Phase A|Lost to Follow-up|4
6056792|NCT00541450|20928606|P1|Phase A|Lost to Follow-up|6
6056793|NCT00541450|20928605|P2|Phase A|Hyperglycemia|1
6056794|NCT00541450|20928606|P1|Phase A|Hyperglycemia|0
6056795|NCT00541450|20928605|P2|Phase A|Creatinine/CrCl -Increase in creatinine|2
6056796|NCT00541450|20928606|P1|Phase A|Creatinine/CrCl -Increase in creatinine|0
6056797|NCT00541450|20928605|P2|Phase A|Adverse Event|0
6056798|NCT00541450|20928606|P1|Phase A|Adverse Event|3
6056799|NCT00541346|20928624|P1|Follow-up|Adverse Event|1
6056800|NCT00541307|20928638|P1|Overall Study|Surgical Bypass|5
6056801|NCT00541307|20928638|P1|Overall Study|Subject returned early (outside window)|1
6056802|NCT00541307|20928638|P1|Overall Study|Lost to Follow-up|4
6056803|NCT00541307|20928638|P1|Overall Study|Withdrawal by Subject|6
6056804|NCT00541307|20928638|P1|Overall Study|Physician Decision|3
6056805|NCT00541307|20928638|P1|Overall Study|Death|5
6056806|NCT00541229|20928663|P6|Treatment Period III (Week 11)|Study Terminated by Sponsor|0
6056807|NCT00541229|20928664|P5|Treatment Period III (Week 11)|Study Terminated by Sponsor|0
6056808|NCT00541229|20928665|P4|Treatment Period III (Week 11)|Study Terminated by Sponsor|0
6056809|NCT00541229|20928666|P3|Treatment Period III (Week 11)|Study Terminated by Sponsor|1
6056810|NCT00541229|20928667|P2|Treatment Period III (Week 11)|Study Terminated by Sponsor|0
6056811|NCT00541229|20928668|P1|Treatment Period III (Week 11)|Study Terminated by Sponsor|0
6056812|NCT00541229|20928663|P6|Treatment Period III (Week 11)|Protocol Specified Criteria|1
6056813|NCT00541229|20928664|P5|Treatment Period III (Week 11)|Protocol Specified Criteria|0
6056814|NCT00541229|20928665|P4|Treatment Period III (Week 11)|Protocol Specified Criteria|0
6056815|NCT00541229|20928666|P3|Treatment Period III (Week 11)|Protocol Specified Criteria|0
6056816|NCT00541229|20928667|P2|Treatment Period III (Week 11)|Protocol Specified Criteria|0
6056817|NCT00541229|20928668|P1|Treatment Period III (Week 11)|Protocol Specified Criteria|0
6056818|NCT00541229|20928663|P6|Treatment Period III (Week 11)|Adverse Event|0
6056819|NCT00541229|20928664|P5|Treatment Period III (Week 11)|Adverse Event|1
6056820|NCT00541229|20928665|P4|Treatment Period III (Week 11)|Adverse Event|0
6056821|NCT00541229|20928666|P3|Treatment Period III (Week 11)|Adverse Event|0
6056822|NCT00541229|20928667|P2|Treatment Period III (Week 11)|Adverse Event|0
6056823|NCT00541229|20928668|P1|Treatment Period III (Week 11)|Adverse Event|0
6056824|NCT00541229|20928663|P6|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3
6056825|NCT00541229|20928664|P5|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3
6056826|NCT00541229|20928665|P4|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4
6056827|NCT00541229|20928666|P3|Washout Period II (Week 7-10)|Study Terminated by Sponsor|2
6056828|NCT00541229|20928667|P2|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4
6056829|NCT00541229|20928668|P1|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3
6056830|NCT00541229|20928663|P6|Washout Period II (Week 7-10)|Withdrawal by Subject|0
6056831|NCT00541229|20928664|P5|Washout Period II (Week 7-10)|Withdrawal by Subject|1
6056832|NCT00541229|20928665|P4|Washout Period II (Week 7-10)|Withdrawal by Subject|0
6056833|NCT00541229|20928666|P3|Washout Period II (Week 7-10)|Withdrawal by Subject|0
6056834|NCT00541229|20928667|P2|Washout Period II (Week 7-10)|Withdrawal by Subject|0
6056835|NCT00541229|20928668|P1|Washout Period II (Week 7-10)|Withdrawal by Subject|0
6056836|NCT00541229|20928663|P6|Washout Period II (Week 7-10)|Protocol Violation|0
6056837|NCT00541229|20928664|P5|Washout Period II (Week 7-10)|Protocol Violation|0
6056838|NCT00541229|20928665|P4|Washout Period II (Week 7-10)|Protocol Violation|0
6056839|NCT00541229|20928666|P3|Washout Period II (Week 7-10)|Protocol Violation|0
6056840|NCT00541229|20928667|P2|Washout Period II (Week 7-10)|Protocol Violation|0
6056841|NCT00541229|20928668|P1|Washout Period II (Week 7-10)|Protocol Violation|1
6056842|NCT00541229|20928663|P6|Treatment Period II (Week 6)|Study Terminated by Sponsor|2
6056843|NCT00541229|20928664|P5|Treatment Period II (Week 6)|Study Terminated by Sponsor|1
6056844|NCT00541229|20928665|P4|Treatment Period II (Week 6)|Study Terminated by Sponsor|1
6056845|NCT00541229|20928666|P3|Treatment Period II (Week 6)|Study Terminated by Sponsor|1
6056846|NCT00541229|20928667|P2|Treatment Period II (Week 6)|Study Terminated by Sponsor|1
6056847|NCT00541229|20928668|P1|Treatment Period II (Week 6)|Study Terminated by Sponsor|2
6056848|NCT00541229|20928663|P6|Treatment Period II (Week 6)|Protocol Violation|1
6056849|NCT00541229|20928664|P5|Treatment Period II (Week 6)|Protocol Violation|1
6056850|NCT00541229|20928665|P4|Treatment Period II (Week 6)|Protocol Violation|0
6056851|NCT00541229|20928666|P3|Treatment Period II (Week 6)|Protocol Violation|0
6056852|NCT00541229|20928667|P2|Treatment Period II (Week 6)|Protocol Violation|0
6056853|NCT00541229|20928668|P1|Treatment Period II (Week 6)|Protocol Violation|0
6056854|NCT00541229|20928663|P6|Washout Period I (Week 2-5)|Study Terminated by Sponsor|4
6056855|NCT00541229|20928664|P5|Washout Period I (Week 2-5)|Study Terminated by Sponsor|1
6056856|NCT00541229|20928665|P4|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3
6056857|NCT00541229|20928666|P3|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3
6056858|NCT00541229|20928667|P2|Washout Period I (Week 2-5)|Study Terminated by Sponsor|2
6056859|NCT00541229|20928668|P1|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3
6056860|NCT00541229|20928663|P6|Washout Period I (Week 2-5)|Protocol Violation|1
6056861|NCT00541229|20928664|P5|Washout Period I (Week 2-5)|Protocol Violation|0
6056862|NCT00541229|20928665|P4|Washout Period I (Week 2-5)|Protocol Violation|0
6056863|NCT00541229|20928666|P3|Washout Period I (Week 2-5)|Protocol Violation|0
6056864|NCT00541229|20928667|P2|Washout Period I (Week 2-5)|Protocol Violation|0
6056865|NCT00541229|20928668|P1|Washout Period I (Week 2-5)|Protocol Violation|0
6056866|NCT00541229|20928663|P6|Washout Period I (Week 2-5)|Physician Decision|0
6056867|NCT00541229|20928664|P5|Washout Period I (Week 2-5)|Physician Decision|0
6056868|NCT00541229|20928665|P4|Washout Period I (Week 2-5)|Physician Decision|1
6056869|NCT00541229|20928666|P3|Washout Period I (Week 2-5)|Physician Decision|0
6056870|NCT00541229|20928667|P2|Washout Period I (Week 2-5)|Physician Decision|0
6056871|NCT00541229|20928668|P1|Washout Period I (Week 2-5)|Physician Decision|0
6056872|NCT00541229|20928663|P6|Washout Period I (Week 2-5)|Adverse Event|0
6056873|NCT00541229|20928664|P5|Washout Period I (Week 2-5)|Adverse Event|0
6056874|NCT00541229|20928665|P4|Washout Period I (Week 2-5)|Adverse Event|0
6056875|NCT00541229|20928666|P3|Washout Period I (Week 2-5)|Adverse Event|1
6056876|NCT00541229|20928667|P2|Washout Period I (Week 2-5)|Adverse Event|0
6056877|NCT00541229|20928668|P1|Washout Period I (Week 2-5)|Adverse Event|1
6056878|NCT00541229|20928663|P6|Treatment Period I (Week 1)|Study Terminated by Sponsor|0
6056879|NCT00541229|20928664|P5|Treatment Period I (Week 1)|Study Terminated by Sponsor|0
6056880|NCT00541229|20928665|P4|Treatment Period I (Week 1)|Study Terminated by Sponsor|1
6056881|NCT00541229|20928666|P3|Treatment Period I (Week 1)|Study Terminated by Sponsor|2
6056882|NCT00541229|20928667|P2|Treatment Period I (Week 1)|Study Terminated by Sponsor|1
6056883|NCT00541229|20928668|P1|Treatment Period I (Week 1)|Study Terminated by Sponsor|0
6056884|NCT00541229|20928663|P6|Treatment Period I (Week 1)|Protocol Specified Criteria|1
6056885|NCT00541229|20928664|P5|Treatment Period I (Week 1)|Protocol Specified Criteria|0
6056886|NCT00541229|20928665|P4|Treatment Period I (Week 1)|Protocol Specified Criteria|0
6056887|NCT00541229|20928666|P3|Treatment Period I (Week 1)|Protocol Specified Criteria|0
6056888|NCT00541229|20928667|P2|Treatment Period I (Week 1)|Protocol Specified Criteria|0
6056889|NCT00541229|20928668|P1|Treatment Period I (Week 1)|Protocol Specified Criteria|0
6056890|NCT00541229|20928663|P6|Treatment Period I (Week 1)|Withdrawal by Subject|1
6056891|NCT00541229|20928664|P5|Treatment Period I (Week 1)|Withdrawal by Subject|0
6056892|NCT00541229|20928665|P4|Treatment Period I (Week 1)|Withdrawal by Subject|0
6056893|NCT00541229|20928666|P3|Treatment Period I (Week 1)|Withdrawal by Subject|0
6056894|NCT00541229|20928667|P2|Treatment Period I (Week 1)|Withdrawal by Subject|0
6056895|NCT00541229|20928668|P1|Treatment Period I (Week 1)|Withdrawal by Subject|0
6056896|NCT00541229|20928663|P6|Treatment Period I (Week 1)|Physician Decision|0
6056897|NCT00541229|20928664|P5|Treatment Period I (Week 1)|Physician Decision|0
6056898|NCT00541229|20928665|P4|Treatment Period I (Week 1)|Physician Decision|0
6056899|NCT00541229|20928666|P3|Treatment Period I (Week 1)|Physician Decision|1
6056900|NCT00541229|20928667|P2|Treatment Period I (Week 1)|Physician Decision|0
6056901|NCT00541229|20928668|P1|Treatment Period I (Week 1)|Physician Decision|0
6056902|NCT00541099|20928687|P1|Overall Study|Ineligible|3
6056903|NCT00541034|20928695|P1|Overall Study|Non-Compliance|3
6056904|NCT00540644|20928744|P2|Overall Study|Noncomplilance|0
6056905|NCT00540644|20928745|P1|Overall Study|Noncomplilance|1
6056906|NCT00540644|20928744|P2|Overall Study|Withdrawal by Subject|2
6056907|NCT00540644|20928745|P1|Overall Study|Withdrawal by Subject|2
6056908|NCT00540644|20928744|P2|Overall Study|Physician Decision|5
6056909|NCT00540644|20928745|P1|Overall Study|Physician Decision|0
6056910|NCT00540644|20928744|P2|Overall Study|Disease Progression|1
6056911|NCT00540644|20928745|P1|Overall Study|Disease Progression|3
6056912|NCT00540644|20928744|P2|Overall Study|Adverse Event|1
6056913|NCT00540644|20928745|P1|Overall Study|Adverse Event|3
6056914|NCT00540592|20928765|P10|Overall Study|Withdrawal by Subject|0
6056915|NCT00540592|20928766|P9|Overall Study|Withdrawal by Subject|0
6056916|NCT00540592|20928767|P8|Overall Study|Withdrawal by Subject|0
6056917|NCT00540592|20928768|P7|Overall Study|Withdrawal by Subject|0
6056918|NCT00540592|20928769|P6|Overall Study|Withdrawal by Subject|0
6056919|NCT00540592|20928770|P5|Overall Study|Withdrawal by Subject|0
6056920|NCT00540592|20928771|P4|Overall Study|Withdrawal by Subject|1
6056921|NCT00540592|20928772|P3|Overall Study|Withdrawal by Subject|1
6056922|NCT00540592|20928773|P2|Overall Study|Withdrawal by Subject|0
6056923|NCT00540592|20928774|P1|Overall Study|Withdrawal by Subject|0
6056924|NCT00540592|20928765|P10|Overall Study|Lost to Follow-up|0
6056925|NCT00540592|20928766|P9|Overall Study|Lost to Follow-up|0
6056926|NCT00540592|20928767|P8|Overall Study|Lost to Follow-up|0
6056927|NCT00540592|20928768|P7|Overall Study|Lost to Follow-up|0
6056928|NCT00540592|20928769|P6|Overall Study|Lost to Follow-up|0
6056929|NCT00540592|20928770|P5|Overall Study|Lost to Follow-up|0
6056930|NCT00540592|20928771|P4|Overall Study|Lost to Follow-up|0
6056931|NCT00540592|20928772|P3|Overall Study|Lost to Follow-up|0
6056932|NCT00540592|20928773|P2|Overall Study|Lost to Follow-up|0
6056933|NCT00540592|20928774|P1|Overall Study|Lost to Follow-up|2
6056934|NCT00540592|20928765|P10|Overall Study|Adverse Event|2
6056935|NCT00540592|20928766|P9|Overall Study|Adverse Event|1
6056936|NCT00540592|20928767|P8|Overall Study|Adverse Event|1
6056937|NCT00540592|20928768|P7|Overall Study|Adverse Event|0
6056938|NCT00540592|20928769|P6|Overall Study|Adverse Event|0
6056939|NCT00540592|20928770|P5|Overall Study|Adverse Event|1
6056940|NCT00540592|20928771|P4|Overall Study|Adverse Event|0
6056941|NCT00540592|20928772|P3|Overall Study|Adverse Event|0
6056942|NCT00540592|20928773|P2|Overall Study|Adverse Event|1
6056943|NCT00540592|20928774|P1|Overall Study|Adverse Event|0
6056944|NCT00540514|20929013|P2|Overall Study|Paclitaxel not available|2
6056945|NCT00540514|20929014|P1|Overall Study|Paclitaxel not available|0
6056946|NCT00540514|20929013|P2|Overall Study|Excluded prior to treatment|7
6056947|NCT00540514|20929014|P1|Overall Study|Excluded prior to treatment|7
6056948|NCT00540514|20929013|P2|Overall Study|Withdrawal by Subject|67
6056949|NCT00540514|20929014|P1|Overall Study|Withdrawal by Subject|65
6056950|NCT00540514|20929013|P2|Overall Study|Lost to Follow-up|1
6056951|NCT00540514|20929014|P1|Overall Study|Lost to Follow-up|1
6056952|NCT00540514|20929013|P2|Overall Study|Protocol Deviation|4
6056953|NCT00540514|20929014|P1|Overall Study|Protocol Deviation|3
6056954|NCT00540514|20929013|P2|Overall Study|Physician Decision|99
6056955|NCT00540514|20929014|P1|Overall Study|Physician Decision|86
6056956|NCT00540514|20929013|P2|Overall Study|Adverse Event|24
6056957|NCT00540514|20929014|P1|Overall Study|Adverse Event|20
6056958|NCT00540514|20929013|P2|Overall Study|Unacceptable Toxicity|62
6056959|NCT00540514|20929014|P1|Overall Study|Unacceptable Toxicity|61
6056960|NCT00540514|20929013|P2|Overall Study|Still on treatment|0
6056961|NCT00540514|20929014|P1|Overall Study|Still on treatment|3
6056962|NCT00540449|20929046|P2|Overall Study|Other|4
6056963|NCT00540449|20929047|P1|Overall Study|Other|1
6056964|NCT00540449|20929046|P2|Overall Study|Withdrawal by Subject|10
6056965|NCT00540449|20929047|P1|Overall Study|Withdrawal by Subject|10
6056966|NCT00540449|20929046|P2|Overall Study|Subject Reached A Virologic Endpoint|8
6056967|NCT00540449|20929047|P1|Overall Study|Subject Reached A Virologic Endpoint|32
6056968|NCT00540449|20929046|P2|Overall Study|Subject Non-Compliant|5
6056969|NCT00540449|20929047|P1|Overall Study|Subject Non-Compliant|7
6056970|NCT00540449|20929046|P2|Overall Study|Lost to Follow-up|17
6056971|NCT00540449|20929047|P1|Overall Study|Lost to Follow-up|19
6056972|NCT00540449|20929046|P2|Overall Study|Subject Ineligible To Continue The Trial|1
6056973|NCT00540449|20929047|P1|Overall Study|Subject Ineligible To Continue The Trial|2
6056974|NCT00540449|20929046|P2|Overall Study|Sponsor's Decision|1
6056975|NCT00540449|20929047|P1|Overall Study|Sponsor's Decision|1
6056976|NCT00540449|20929046|P2|Overall Study|Adverse Event|32
6056977|NCT00540449|20929047|P1|Overall Study|Adverse Event|12
6056978|NCT00540436|20929069|P1|Second 12-Week Treatment Period|Adverse Event|1
6056979|NCT00540436|20929069|P1|First 12-Week Treatment Period|Initiation of prohibited medication|1
6056980|NCT00540436|20929069|P1|First 12-Week Treatment Period|Withdrawal by Subject|1
6056981|NCT00540436|20929069|P1|First 12-Week Treatment Period|Adverse Event|1
6056982|NCT00540423|20929084|P3|Open-Label Treatment Period|Lack of Efficacy|2
6056983|NCT00540423|20929085|P2|Open-Label Treatment Period|Lack of Efficacy|0
6056984|NCT00540423|20929086|P1|Open-Label Treatment Period|Lack of Efficacy|0
6056985|NCT00540423|20929084|P3|Double-Blind Treatment Period|Adverse Event|0
6056986|NCT00540423|20929085|P2|Double-Blind Treatment Period|Adverse Event|1
6056987|NCT00540423|20929086|P1|Double-Blind Treatment Period|Adverse Event|0
6056988|NCT00540293|20929136|P1|Overall Study|Protocol violation, & subject schedule|12
6056989|NCT00540293|20929136|P1|Overall Study|Withdrawal by Subject|6
6056990|NCT00540293|20929136|P1|Overall Study|Adverse event not related to study drug|7
6056991|NCT00540293|20929136|P1|Overall Study|Adverse event related to study drug|10
6056992|NCT00540228|20929184|P5|Overall Study|Lost to Follow-up|0
6056993|NCT00540228|20929185|P4|Overall Study|Lost to Follow-up|0
6056994|NCT00540228|20929186|P3|Overall Study|Lost to Follow-up|0
6056995|NCT00540228|20929187|P2|Overall Study|Lost to Follow-up|1
6056996|NCT00540228|20929188|P1|Overall Study|Lost to Follow-up|1
6056997|NCT00540228|20929184|P5|Overall Study|Adverse Event|0
6056998|NCT00540228|20929185|P4|Overall Study|Adverse Event|0
6056999|NCT00540228|20929186|P3|Overall Study|Adverse Event|0
6057000|NCT00540228|20929187|P2|Overall Study|Adverse Event|0
6057001|NCT00540228|20929188|P1|Overall Study|Adverse Event|2
6057002|NCT00540124|20929258|P3|Overall Study|Withdrawal by Subject|0
6057003|NCT00540124|20929259|P2|Overall Study|Withdrawal by Subject|1
6057004|NCT00540124|20929260|P1|Overall Study|Withdrawal by Subject|1
6057005|NCT00540124|20929258|P3|Overall Study|Lack of Efficacy|0
6057006|NCT00540124|20929259|P2|Overall Study|Lack of Efficacy|0
6057007|NCT00540124|20929260|P1|Overall Study|Lack of Efficacy|1
6057008|NCT00540124|20929258|P3|Overall Study|Entry Criteria Not Met|0
6057009|NCT00540124|20929259|P2|Overall Study|Entry Criteria Not Met|0
6057010|NCT00540124|20929260|P1|Overall Study|Entry Criteria Not Met|2
6057011|NCT00540124|20929258|P3|Overall Study|Adverse Event|1
6057012|NCT00540124|20929259|P2|Overall Study|Adverse Event|2
6057013|NCT00540124|20929260|P1|Overall Study|Adverse Event|0
6057014|NCT00540046|20929306|P2|Overall Study|Lost to Follow-up|23
6057015|NCT00540046|20929307|P1|Overall Study|Lost to Follow-up|33
6057016|NCT00539994|20929343|P3|Overall Study|Physician Decision|1
6057017|NCT00539994|20929344|P2|Overall Study|Physician Decision|0
6057018|NCT00539994|20929345|P1|Overall Study|Physician Decision|0
6057019|NCT00539994|20929343|P3|Overall Study|Withdrawal by Subject|1
6057020|NCT00539994|20929344|P2|Overall Study|Withdrawal by Subject|0
6057021|NCT00539994|20929345|P1|Overall Study|Withdrawal by Subject|1
6057022|NCT00539994|20929343|P3|Overall Study|Lost to Follow-up|0
6057023|NCT00539994|20929344|P2|Overall Study|Lost to Follow-up|1
6057024|NCT00539994|20929345|P1|Overall Study|Lost to Follow-up|2
6057025|NCT00539864|20929395|P2|Overall Study|Withdrawal by Subject|1
6057026|NCT00539864|20929396|P1|Overall Study|Withdrawal by Subject|1
6057027|NCT00539864|20929395|P2|Overall Study|Lost to Follow-up|1
6057028|NCT00539864|20929396|P1|Overall Study|Lost to Follow-up|0
6057029|NCT00539838|20929411|P3|Overall Study|Administrative|8
6057030|NCT00539838|20929412|P2|Overall Study|Administrative|0
6057031|NCT00539838|20929413|P1|Overall Study|Administrative|4
6057032|NCT00539838|20929411|P3|Overall Study|Did not cooperate|1
6057033|NCT00539838|20929412|P2|Overall Study|Did not cooperate|0
6057034|NCT00539838|20929413|P1|Overall Study|Did not cooperate|1
6057035|NCT00539838|20929411|P3|Overall Study|Death|0
6057036|NCT00539838|20929412|P2|Overall Study|Death|2
6057037|NCT00539838|20929413|P1|Overall Study|Death|0
6057038|NCT00539838|20929411|P3|Overall Study|Withdrawal by Subject|0
6057039|NCT00539838|20929412|P2|Overall Study|Withdrawal by Subject|4
6057040|NCT00539838|20929413|P1|Overall Study|Withdrawal by Subject|0
6057041|NCT00539838|20929411|P3|Overall Study|Fail to return|0
6057042|NCT00539838|20929412|P2|Overall Study|Fail to return|0
6057043|NCT00539838|20929413|P1|Overall Study|Fail to return|2
6057044|NCT00539734|20929463|P1|Overall Study|Protocol Violation|1
6057045|NCT00539591|20929489|P3|Overall Study|Disease progression|3
6057046|NCT00539591|20929490|P2|Overall Study|Disease progression|2
6057047|NCT00539591|20929491|P1|Overall Study|Disease progression|2
6057048|NCT00539591|20929489|P3|Overall Study|Toxicity|0
6057049|NCT00539591|20929490|P2|Overall Study|Toxicity|0
6057050|NCT00539591|20929491|P1|Overall Study|Toxicity|3
6057051|NCT00539513|20929643|P2|Overall Study|Lost to Follow-up|1
6057052|NCT00539513|20929644|P1|Overall Study|Lost to Follow-up|0
6057053|NCT00539513|20929643|P2|Overall Study|Withdrawal by Subject|1
6057054|NCT00539513|20929644|P1|Overall Study|Withdrawal by Subject|2
6057055|NCT00539500|20929656|P1|Overall Study|Lost to Follow-up|2
6057056|NCT00539500|20929656|P1|Overall Study|Disease Progression|1
6057057|NCT00539305|20929664|P2|Overall Study|Withdrawal by Subject|1
6057058|NCT00539305|20929665|P1|Overall Study|Withdrawal by Subject|0
6057059|NCT00539305|20929664|P2|Overall Study|Substance Use|1
6057060|NCT00539305|20929665|P1|Overall Study|Substance Use|0
6057061|NCT00539305|20929664|P2|Overall Study|Adverse Event|0
6057062|NCT00539305|20929665|P1|Overall Study|Adverse Event|1
6057063|NCT00539279|20929679|P2|6-Month Follow-Up Assessment|Lost to Follow-up|7
6057064|NCT00539279|20929680|P1|6-Month Follow-Up Assessment|Lost to Follow-up|1
6057065|NCT00539279|20929679|P2|Post-Treatment Assessment|Lost to Follow-up|9
6057066|NCT00539279|20929680|P1|Post-Treatment Assessment|Lost to Follow-up|12
6057067|NCT00539279|20929679|P2|Treatment|Death|0
6057068|NCT00539279|20929680|P1|Treatment|Death|1
6057069|NCT00539279|20929679|P2|Treatment|Withdrawal by Subject|8
6057070|NCT00539279|20929680|P1|Treatment|Withdrawal by Subject|10
6057071|NCT00539240|20929706|P3|Overall Study|Adverse Event|10
6057072|NCT00539240|20929707|P2|Overall Study|Adverse Event|1
6057073|NCT00539240|20929708|P1|Overall Study|Adverse Event|3
6057074|NCT00539240|20929706|P3|Overall Study|Lost to Follow-up|1
6057075|NCT00539240|20929707|P2|Overall Study|Lost to Follow-up|3
6057076|NCT00539240|20929708|P1|Overall Study|Lost to Follow-up|2
6057077|NCT00539240|20929706|P3|Overall Study|Protocol Violation|4
6057078|NCT00539240|20929707|P2|Overall Study|Protocol Violation|1
6057079|NCT00539240|20929708|P1|Overall Study|Protocol Violation|1
6057080|NCT00539240|20929706|P3|Overall Study|Withdrawal by Subject|0
6057081|NCT00539240|20929707|P2|Overall Study|Withdrawal by Subject|2
6057082|NCT00539240|20929708|P1|Overall Study|Withdrawal by Subject|0
6057083|NCT00539188|20929727|P2|Overall Study|Lost to Follow-up|1
6057084|NCT00539188|20929728|P1|Overall Study|Lost to Follow-up|2
6057085|NCT00539188|20929727|P2|Overall Study|Withdrawal by Subject|0
6057086|NCT00539188|20929728|P1|Overall Study|Withdrawal by Subject|1
6057087|NCT00539032|20929751|P2|Overall Study|Withdrawal by Subject|1
6057088|NCT00539032|20929752|P1|Overall Study|Withdrawal by Subject|2
6057089|NCT00539006|20929766|P4|Treatment Period 2|Other|0
6057090|NCT00539006|20929767|P3|Treatment Period 2|Other|0
6057091|NCT00539006|20929768|P2|Treatment Period 2|Other|1
6057092|NCT00539006|20929769|P1|Treatment Period 2|Other|0
6057093|NCT00539006|20929766|P4|Treatment Period 2|Protocol Violation|0
6057094|NCT00539006|20929767|P3|Treatment Period 2|Protocol Violation|0
6057095|NCT00539006|20929768|P2|Treatment Period 2|Protocol Violation|0
6057096|NCT00539006|20929769|P1|Treatment Period 2|Protocol Violation|1
6057097|NCT00539006|20929766|P4|Washout|Other|3
6057098|NCT00539006|20929767|P3|Washout|Other|2
6057099|NCT00539006|20929768|P2|Washout|Other|1
6057100|NCT00539006|20929769|P1|Washout|Other|1
6057101|NCT00539006|20929766|P4|Washout|Failed to meet continuation criteria|6
6057102|NCT00539006|20929767|P3|Washout|Failed to meet continuation criteria|14
6057103|NCT00539006|20929768|P2|Washout|Failed to meet continuation criteria|5
6057104|NCT00539006|20929769|P1|Washout|Failed to meet continuation criteria|16
6057105|NCT00539006|20929766|P4|Washout|Withdrawal by Subject|0
6057106|NCT00539006|20929767|P3|Washout|Withdrawal by Subject|0
6057107|NCT00539006|20929768|P2|Washout|Withdrawal by Subject|2
6057108|NCT00539006|20929769|P1|Washout|Withdrawal by Subject|0
6057109|NCT00539006|20929766|P4|Washout|Protocol Violation|0
6057110|NCT00539006|20929767|P3|Washout|Protocol Violation|0
6057111|NCT00539006|20929768|P2|Washout|Protocol Violation|1
6057112|NCT00539006|20929769|P1|Washout|Protocol Violation|1
6057113|NCT00539006|20929766|P4|Washout|Adverse Event|0
6057114|NCT00539006|20929767|P3|Washout|Adverse Event|0
6057115|NCT00539006|20929768|P2|Washout|Adverse Event|1
6057116|NCT00539006|20929769|P1|Washout|Adverse Event|2
6057117|NCT00539006|20929766|P4|Treatment Period 1|Lack of Efficacy|1
6057118|NCT00539006|20929767|P3|Treatment Period 1|Lack of Efficacy|0
6057119|NCT00539006|20929768|P2|Treatment Period 1|Lack of Efficacy|0
6057120|NCT00539006|20929769|P1|Treatment Period 1|Lack of Efficacy|0
6057121|NCT00539006|20929766|P4|Treatment Period 1|Protocol Violation|0
6057122|NCT00539006|20929767|P3|Treatment Period 1|Protocol Violation|1
6057123|NCT00539006|20929768|P2|Treatment Period 1|Protocol Violation|0
6057124|NCT00539006|20929769|P1|Treatment Period 1|Protocol Violation|0
6057125|NCT00539006|20929766|P4|Treatment Period 1|Lost to Follow-up|0
6057126|NCT00539006|20929767|P3|Treatment Period 1|Lost to Follow-up|1
6057127|NCT00539006|20929768|P2|Treatment Period 1|Lost to Follow-up|0
6057128|NCT00539006|20929769|P1|Treatment Period 1|Lost to Follow-up|0
6057129|NCT00539006|20929766|P4|Pre-treatment|Other|0
6057130|NCT00539006|20929767|P3|Pre-treatment|Other|0
6057131|NCT00539006|20929768|P2|Pre-treatment|Other|1
6057132|NCT00539006|20929769|P1|Pre-treatment|Other|0
6057133|NCT00538902|20929814|P3|OL Wk 24 to End (Primary D/C Reasons)|Various|22
6057134|NCT00538902|20929815|P2|OL Wk 24 to End (Primary D/C Reasons)|Various|25
6057135|NCT00538902|20929816|P1|OL Wk 24 to End (Primary D/C Reasons)|Various|18
6057136|NCT00538902|20929814|P3|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|6
6057137|NCT00538902|20929815|P2|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|10
6057138|NCT00538902|20929816|P1|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|1
6057139|NCT00538902|20929814|P3|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|25
6057140|NCT00538902|20929815|P2|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|19
6057141|NCT00538902|20929816|P1|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|15
6057142|NCT00538902|20929814|P3|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|11
6057143|NCT00538902|20929815|P2|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|10
6057144|NCT00538902|20929816|P1|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|2
6057145|NCT00538902|20929814|P3|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0
6057146|NCT00538902|20929815|P2|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0
6057147|NCT00538902|20929816|P1|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0
6057148|NCT00538902|20929814|P3|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|1
6057149|NCT00538902|20929815|P2|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0
6057150|NCT00538902|20929816|P1|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0
6057151|NCT00538902|20929814|P3|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|1
6057152|NCT00538902|20929815|P2|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0
6057153|NCT00538902|20929816|P1|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0
6057154|NCT00538902|20929814|P3|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|3
6057155|NCT00538902|20929815|P2|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|2
6057156|NCT00538902|20929816|P1|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|1
6057157|NCT00538785|20929877|P2|Overall Study|Lost to Follow-up|0
6057158|NCT00538785|20929878|P1|Overall Study|Lost to Follow-up|1
6057159|NCT00538785|20929877|P2|Overall Study|Withdrawal of consent|7
6057160|NCT00538785|20929878|P1|Overall Study|Withdrawal of consent|9
6057161|NCT00538785|20929877|P2|Overall Study|Death|10
6057162|NCT00538785|20929878|P1|Overall Study|Death|9
6057163|NCT00538733|20929920|P1|Overall Study|still on therapy|1
6057164|NCT00538733|20929920|P1|Overall Study|declined to participate|2
6057165|NCT00538733|20929920|P1|Overall Study|Death|1
6057166|NCT00538733|20929920|P1|Overall Study|Adverse Event|8
6057167|NCT00538681|20929932|P4|Overall Study|Investigator Decision|1
6057168|NCT00538681|20929933|P3|Overall Study|Investigator Decision|0
6057169|NCT00538681|20929934|P2|Overall Study|Investigator Decision|0
6057170|NCT00538681|20929935|P1|Overall Study|Investigator Decision|0
6057171|NCT00538681|20929932|P4|Overall Study|Death|1
6057172|NCT00538681|20929933|P3|Overall Study|Death|1
6057173|NCT00538681|20929934|P2|Overall Study|Death|0
6057174|NCT00538681|20929935|P1|Overall Study|Death|0
6057175|NCT00538681|20929932|P4|Overall Study|Adverse Event|0
6057176|NCT00538681|20929933|P3|Overall Study|Adverse Event|1
6057177|NCT00538681|20929934|P2|Overall Study|Adverse Event|1
6057178|NCT00538681|20929935|P1|Overall Study|Adverse Event|1
6057179|NCT00538681|20929932|P4|Overall Study|Sponsor Decision|9
6057180|NCT00538681|20929933|P3|Overall Study|Sponsor Decision|8
6057181|NCT00538681|20929934|P2|Overall Study|Sponsor Decision|3
6057182|NCT00538681|20929935|P1|Overall Study|Sponsor Decision|1
6057183|NCT00538681|20929932|P4|Overall Study|Progressive Disease|0
6057184|NCT00538681|20929933|P3|Overall Study|Progressive Disease|1
6057185|NCT00538681|20929934|P2|Overall Study|Progressive Disease|0
6057186|NCT00538681|20929935|P1|Overall Study|Progressive Disease|7
6057187|NCT00538629|20930001|P1|Overall Study|Subject's untimely distrust of medicine|1
6057188|NCT00538629|20930001|P1|Overall Study|Lost to Follow-up|6
6057189|NCT00538629|20930001|P1|Overall Study|Lack of Efficacy|12
6057190|NCT00538629|20930001|P1|Overall Study|Adverse Event|2
6057191|NCT00538629|20930001|P1|Overall Study|At subject's request|1
6057192|NCT00538590|20930057|P2|Overall Study|Death|0
6057193|NCT00538590|20930058|P1|Overall Study|Death|1
6057194|NCT00538473|20930096|P2|Overall Study|Adverse Event|0
6057195|NCT00538473|20930097|P1|Overall Study|Adverse Event|1
6057196|NCT00538291|20930177|P1|Overall Study|Withdrawal by Subject|1
6057197|NCT00538291|20930177|P1|Overall Study|Adverse Event|2
6057198|NCT00537979|20930235|P2|Overall Study|Heart failure|1
6057199|NCT00537979|20930236|P1|Overall Study|Heart failure|0
6057200|NCT00537979|20930235|P2|Overall Study|Kidney transplant|3
6057201|NCT00537979|20930236|P1|Overall Study|Kidney transplant|0
6057202|NCT00537979|20930235|P2|Overall Study|Death|3
6057203|NCT00537979|20930236|P1|Overall Study|Death|0
6057204|NCT00537979|20930235|P2|Overall Study|Non-compliance with treatment/procedure|2
6057205|NCT00537979|20930236|P1|Overall Study|Non-compliance with treatment/procedure|2
6057206|NCT00537979|20930235|P2|Overall Study|Lack of Efficacy|1
6057207|NCT00537979|20930236|P1|Overall Study|Lack of Efficacy|0
6057208|NCT00537979|20930235|P2|Overall Study|Lost to Follow-up|4
6057209|NCT00537979|20930236|P1|Overall Study|Lost to Follow-up|1
6057210|NCT00537979|20930235|P2|Overall Study|Withdrawal by Subject|4
6057211|NCT00537979|20930236|P1|Overall Study|Withdrawal by Subject|1
6057212|NCT00537979|20930235|P2|Overall Study|Adverse Event|2
6057213|NCT00537979|20930236|P1|Overall Study|Adverse Event|2
6057214|NCT00537940|20930252|P2|Overall Study|Other|12
6057215|NCT00537940|20930253|P1|Overall Study|Other|10
6057216|NCT00537940|20930252|P2|Overall Study|Study terminated by sponsor|3
6057217|NCT00537940|20930253|P1|Overall Study|Study terminated by sponsor|2
6057218|NCT00537940|20930252|P2|Overall Study|Pregnancy|1
6057219|NCT00537940|20930253|P1|Overall Study|Pregnancy|1
6057220|NCT00537940|20930252|P2|Overall Study|Protocol Violation|4
6057221|NCT00537940|20930253|P1|Overall Study|Protocol Violation|6
6057222|NCT00537940|20930252|P2|Overall Study|Withdrawal by Subject|95
6057223|NCT00537940|20930253|P1|Overall Study|Withdrawal by Subject|113
6057224|NCT00537940|20930252|P2|Overall Study|Lost to Follow-up|29
6057225|NCT00537940|20930253|P1|Overall Study|Lost to Follow-up|23
6057226|NCT00537940|20930252|P2|Overall Study|Lack of Efficacy|16
6057227|NCT00537940|20930253|P1|Overall Study|Lack of Efficacy|8
6057228|NCT00537940|20930252|P2|Overall Study|Adverse Event|19
6057229|NCT00537940|20930253|P1|Overall Study|Adverse Event|20
6057230|NCT00537823|20930277|P2|Overall Study|Adverse Event|0
6057231|NCT00537823|20930278|P1|Overall Study|Adverse Event|2
6057232|NCT00537810|20930304|P4|Overall Study|Medically withdrawn|1
6057233|NCT00537810|20930305|P3|Overall Study|Medically withdrawn|0
6057234|NCT00537810|20930306|P2|Overall Study|Medically withdrawn|2
6057235|NCT00537810|20930307|P1|Overall Study|Medically withdrawn|2
6057236|NCT00537810|20930304|P4|Overall Study|Withdrawal by Subject|3
6057237|NCT00537810|20930305|P3|Overall Study|Withdrawal by Subject|4
6057238|NCT00537810|20930306|P2|Overall Study|Withdrawal by Subject|11
6057239|NCT00537810|20930307|P1|Overall Study|Withdrawal by Subject|4
6057240|NCT00537771|20930323|P2|Overall Study|Severe Non-Compliance to Protocol|2
6057241|NCT00537771|20930324|P1|Overall Study|Severe Non-Compliance to Protocol|4
6057242|NCT00537771|20930323|P2|Overall Study|Protocol Violation|6
6057243|NCT00537771|20930324|P1|Overall Study|Protocol Violation|2
6057244|NCT00537771|20930323|P2|Overall Study|Lost to Follow-up|15
6057245|NCT00537771|20930324|P1|Overall Study|Lost to Follow-up|9
6057246|NCT00537771|20930323|P2|Overall Study|Adverse Event|15
6057247|NCT00537771|20930324|P1|Overall Study|Adverse Event|8
6057248|NCT00537771|20930323|P2|Overall Study|Withdrawal by Subject|23
6057249|NCT00537771|20930324|P1|Overall Study|Withdrawal by Subject|6
6057250|NCT00537745|20930334|P1|Overall Study|Subject unable to provide Interlock info|1
6057251|NCT00537745|20930334|P1|Overall Study|Withdrawal by Subject|2
6057252|NCT00537745|20930334|P1|Overall Study|Did not meet eligibility criteria|2
6057253|NCT00537485|20930416|P2|Overall Study|Physician Decision|0
6057254|NCT00537485|20930417|P1|Overall Study|Physician Decision|1
6057255|NCT00537485|20930416|P2|Overall Study|Withdrawal by Subject|3
6057256|NCT00537485|20930417|P1|Overall Study|Withdrawal by Subject|1
6057257|NCT00537485|20930416|P2|Overall Study|Withdrawal by Subject|2
6057258|NCT00537485|20930417|P1|Overall Study|Withdrawal by Subject|3
6057259|NCT00537485|20930416|P2|Overall Study|Adverse Event|5
6057260|NCT00537485|20930417|P1|Overall Study|Adverse Event|10
6057261|NCT00537394|20930500|P3|2nd Year of Follow-up|Clinic site closure|0
6057262|NCT00537394|20930501|P2|2nd Year of Follow-up|Clinic site closure|0
6057263|NCT00537394|20930502|P1|2nd Year of Follow-up|Clinic site closure|1
6057264|NCT00537394|20930500|P3|2nd Year of Follow-up|Lost to Follow-up|2
6057265|NCT00537394|20930501|P2|2nd Year of Follow-up|Lost to Follow-up|7
6057266|NCT00537394|20930502|P1|2nd Year of Follow-up|Lost to Follow-up|6
6057267|NCT00537394|20930500|P3|2nd Year of Follow-up|Withdrawal by Subject|2
6057268|NCT00537394|20930501|P2|2nd Year of Follow-up|Withdrawal by Subject|1
6057269|NCT00537394|20930502|P1|2nd Year of Follow-up|Withdrawal by Subject|0
6057270|NCT00537394|20930500|P3|2nd Year of Follow-up|Death|2
6057271|NCT00537394|20930501|P2|2nd Year of Follow-up|Death|1
6057272|NCT00537394|20930502|P1|2nd Year of Follow-up|Death|4
6057273|NCT00537394|20930500|P3|First Year of Follow-up|Lost to Follow-up|1
6057274|NCT00537394|20930501|P2|First Year of Follow-up|Lost to Follow-up|5
6057275|NCT00537394|20930502|P1|First Year of Follow-up|Lost to Follow-up|1
6057276|NCT00537394|20930500|P3|First Year of Follow-up|Withdrawal by Subject|1
6057277|NCT00537394|20930501|P2|First Year of Follow-up|Withdrawal by Subject|6
6057278|NCT00537394|20930502|P1|First Year of Follow-up|Withdrawal by Subject|3
6057279|NCT00537394|20930500|P3|First Year of Follow-up|Severe debilitation|1
6057280|NCT00537394|20930501|P2|First Year of Follow-up|Severe debilitation|0
6057281|NCT00537394|20930502|P1|First Year of Follow-up|Severe debilitation|1
6057282|NCT00537394|20930500|P3|First Year of Follow-up|Death|0
6057283|NCT00537394|20930501|P2|First Year of Follow-up|Death|0
6057284|NCT00537394|20930502|P1|First Year of Follow-up|Death|7
6057285|NCT00537381|20930538|P2|Overall Study|Other|3
6057286|NCT00537381|20930539|P1|Overall Study|Other|5
6057287|NCT00537381|20930538|P2|Overall Study|Sponsor decision|9
6057288|NCT00537381|20930539|P1|Overall Study|Sponsor decision|14
6057289|NCT00537381|20930538|P2|Overall Study|Disease Progression|18
6057290|NCT00537381|20930539|P1|Overall Study|Disease Progression|9
6057291|NCT00537381|20930538|P2|Overall Study|Physician Decision|6
6057292|NCT00537381|20930539|P1|Overall Study|Physician Decision|7
6057293|NCT00537381|20930538|P2|Overall Study|Withdrawal by Subject|14
6057294|NCT00537381|20930539|P1|Overall Study|Withdrawal by Subject|5
6057295|NCT00537381|20930538|P2|Overall Study|Death|3
6057296|NCT00537381|20930539|P1|Overall Study|Death|3
6057297|NCT00537381|20930538|P2|Overall Study|Adverse Event|9
6057298|NCT00537381|20930539|P1|Overall Study|Adverse Event|13
6057299|NCT00537329|20930559|P1|Overall Study|Other|1
6057300|NCT00537329|20930559|P1|Overall Study|Withdrawal by Subject|4
6057301|NCT00537329|20930559|P1|Overall Study|Lost to Follow-up|6
6057302|NCT00537329|20930559|P1|Overall Study|Lack of Efficacy|2
6057303|NCT00537329|20930559|P1|Overall Study|Adverse Event|3
6057304|NCT00537329|20930559|P1|Overall Study|Death|10
6057305|NCT00537316|20930579|P7|Part 2|Administrative|1
6057306|NCT00537316|20930580|P6|Part 2|Administrative|4
6057307|NCT00537316|20930581|P5|Part 2|Administrative|1
6057308|NCT00537316|20930582|P4|Part 2|Administrative|3
6057309|NCT00537316|20930583|P3|Part 2|Administrative|24
6057310|NCT00537316|20930584|P2|Part 2|Administrative|8
6057311|NCT00537316|20930585|P1|Part 2|Administrative|16
6057312|NCT00537316|20930579|P7|Part 2|Withdrawal by Subject|0
6057313|NCT00537316|20930580|P6|Part 2|Withdrawal by Subject|0
6057314|NCT00537316|20930581|P5|Part 2|Withdrawal by Subject|0
6057315|NCT00537316|20930582|P4|Part 2|Withdrawal by Subject|0
6057316|NCT00537316|20930583|P3|Part 2|Withdrawal by Subject|4
6057317|NCT00537316|20930584|P2|Part 2|Withdrawal by Subject|1
6057318|NCT00537316|20930585|P1|Part 2|Withdrawal by Subject|5
6057319|NCT00537316|20930579|P7|Part 2|Lost to Follow-up|0
6057320|NCT00537316|20930580|P6|Part 2|Lost to Follow-up|0
6057321|NCT00537316|20930581|P5|Part 2|Lost to Follow-up|0
6057322|NCT00537316|20930582|P4|Part 2|Lost to Follow-up|0
6057323|NCT00537316|20930583|P3|Part 2|Lost to Follow-up|2
6057324|NCT00537316|20930584|P2|Part 2|Lost to Follow-up|0
6057325|NCT00537316|20930585|P1|Part 2|Lost to Follow-up|1
6057326|NCT00537316|20930579|P7|Part 2|Adverse Event|0
6057327|NCT00537316|20930580|P6|Part 2|Adverse Event|0
6057328|NCT00537316|20930581|P5|Part 2|Adverse Event|0
6057329|NCT00537316|20930582|P4|Part 2|Adverse Event|0
6057330|NCT00537316|20930583|P3|Part 2|Adverse Event|2
6057331|NCT00537316|20930584|P2|Part 2|Adverse Event|0
6057332|NCT00537316|20930585|P1|Part 2|Adverse Event|4
6057333|NCT00537316|20930579|P7|Part 2|Never entered follow-up|1
6057334|NCT00537316|20930580|P6|Part 2|Never entered follow-up|0
6057335|NCT00537316|20930581|P5|Part 2|Never entered follow-up|0
6057336|NCT00537316|20930582|P4|Part 2|Never entered follow-up|0
6057337|NCT00537316|20930583|P3|Part 2|Never entered follow-up|0
6057338|NCT00537316|20930584|P2|Part 2|Never entered follow-up|0
6057339|NCT00537316|20930585|P1|Part 2|Never entered follow-up|0
6057340|NCT00537316|20930579|P7|Part 1|Administrative|0
6057341|NCT00537316|20930580|P6|Part 1|Administrative|0
6057342|NCT00537316|20930581|P5|Part 1|Administrative|0
6057343|NCT00537316|20930582|P4|Part 1|Administrative|0
6057344|NCT00537316|20930583|P3|Part 1|Administrative|2
6057345|NCT00537316|20930584|P2|Part 1|Administrative|0
6057346|NCT00537316|20930585|P1|Part 1|Administrative|0
6057347|NCT00537316|20930579|P7|Part 1|Did not meet protocol eligibility|0
6057348|NCT00537316|20930580|P6|Part 1|Did not meet protocol eligibility|0
6057349|NCT00537316|20930581|P5|Part 1|Did not meet protocol eligibility|0
6057350|NCT00537316|20930582|P4|Part 1|Did not meet protocol eligibility|0
6057351|NCT00537316|20930583|P3|Part 1|Did not meet protocol eligibility|2
6057352|NCT00537316|20930584|P2|Part 1|Did not meet protocol eligibility|3
6057353|NCT00537316|20930585|P1|Part 1|Did not meet protocol eligibility|1
6057354|NCT00537316|20930579|P7|Part 1|Protocol Violation|0
6057355|NCT00537316|20930580|P6|Part 1|Protocol Violation|0
6057356|NCT00537316|20930581|P5|Part 1|Protocol Violation|0
6057357|NCT00537316|20930582|P4|Part 1|Protocol Violation|0
6057358|NCT00537316|20930583|P3|Part 1|Protocol Violation|1
6057359|NCT00537316|20930584|P2|Part 1|Protocol Violation|5
6057360|NCT00537316|20930585|P1|Part 1|Protocol Violation|1
6057361|NCT00537316|20930579|P7|Part 1|Withdrawal by Subject|0
6057362|NCT00537316|20930580|P6|Part 1|Withdrawal by Subject|0
6057363|NCT00537316|20930581|P5|Part 1|Withdrawal by Subject|0
6057364|NCT00537316|20930582|P4|Part 1|Withdrawal by Subject|0
6057365|NCT00537316|20930583|P3|Part 1|Withdrawal by Subject|4
6057366|NCT00537316|20930584|P2|Part 1|Withdrawal by Subject|8
6057367|NCT00537316|20930585|P1|Part 1|Withdrawal by Subject|3
6057368|NCT00537316|20930579|P7|Part 1|Lost to Follow-up|0
6057369|NCT00537316|20930580|P6|Part 1|Lost to Follow-up|0
6057370|NCT00537316|20930581|P5|Part 1|Lost to Follow-up|0
6057371|NCT00537316|20930582|P4|Part 1|Lost to Follow-up|0
6057372|NCT00537316|20930583|P3|Part 1|Lost to Follow-up|0
6057373|NCT00537316|20930584|P2|Part 1|Lost to Follow-up|0
6057374|NCT00537316|20930585|P1|Part 1|Lost to Follow-up|1
6057375|NCT00537316|20930579|P7|Part 1|Protocol defined clinical event|0
6057376|NCT00537316|20930580|P6|Part 1|Protocol defined clinical event|0
6057377|NCT00537316|20930581|P5|Part 1|Protocol defined clinical event|0
6057378|NCT00537316|20930582|P4|Part 1|Protocol defined clinical event|0
6057379|NCT00537316|20930583|P3|Part 1|Protocol defined clinical event|0
6057380|NCT00537316|20930584|P2|Part 1|Protocol defined clinical event|0
6057381|NCT00537316|20930585|P1|Part 1|Protocol defined clinical event|1
6057382|NCT00537316|20930579|P7|Part 1|Adverse Event|0
6057383|NCT00537316|20930580|P6|Part 1|Adverse Event|0
6057384|NCT00537316|20930581|P5|Part 1|Adverse Event|0
6057385|NCT00537316|20930582|P4|Part 1|Adverse Event|0
6057386|NCT00537316|20930583|P3|Part 1|Adverse Event|8
6057387|NCT00537316|20930584|P2|Part 1|Adverse Event|11
6057388|NCT00537316|20930585|P1|Part 1|Adverse Event|7
6057389|NCT00537303|20930612|P2|Overall Study|Unclassified|7
6057390|NCT00537303|20930613|P1|Overall Study|Unclassified|8
6057391|NCT00537303|20930612|P2|Overall Study|Withdrawal criteria|3
6057392|NCT00537303|20930613|P1|Overall Study|Withdrawal criteria|3
6057393|NCT00537303|20930612|P2|Overall Study|Protocol Violation|4
6057394|NCT00537303|20930613|P1|Overall Study|Protocol Violation|8
6057395|NCT00537303|20930612|P2|Overall Study|Lack of Efficacy|7
6057396|NCT00537303|20930613|P1|Overall Study|Lack of Efficacy|6
6057397|NCT00537303|20930612|P2|Overall Study|Adverse Event|4
6057398|NCT00537303|20930613|P1|Overall Study|Adverse Event|1
6057399|NCT00537277|20930634|P1|Overall Study|Non-compliance with trial procedures|15
6057400|NCT00537277|20930634|P1|Overall Study|Inability to tolerate trial medication|4
6057401|NCT00537277|20930634|P1|Overall Study|Unclassified|4
6057402|NCT00537277|20930634|P1|Overall Study|Protocol Violation|11
6057403|NCT00537277|20930634|P1|Overall Study|Lost to Follow-up|12
6057404|NCT00537277|20930634|P1|Overall Study|Lack of Efficacy|2
6057405|NCT00537277|20930634|P1|Overall Study|Adverse Event|1
6057406|NCT00537199|20930643|P1|Overall Study|Study Terminated|1
6057421|NCT00537082|20930665|P3|Overall Study|Discontinued before initiating treatment|0
6057422|NCT00537082|20930666|P2|Overall Study|Discontinued before initiating treatment|0
6057423|NCT00537082|20930667|P1|Overall Study|Discontinued before initiating treatment|3
6057424|NCT00537082|20930665|P3|Overall Study|Withdrawal by Subject|0
6057425|NCT00537082|20930666|P2|Overall Study|Withdrawal by Subject|1
6057426|NCT00537082|20930667|P1|Overall Study|Withdrawal by Subject|0
6057427|NCT00537082|20930665|P3|Overall Study|Lack of Efficacy|2
6057428|NCT00537082|20930666|P2|Overall Study|Lack of Efficacy|0
6057429|NCT00537082|20930667|P1|Overall Study|Lack of Efficacy|0
6057430|NCT00537082|20930665|P3|Overall Study|Protocol Violation|1
6057431|NCT00537082|20930666|P2|Overall Study|Protocol Violation|2
6057432|NCT00537082|20930667|P1|Overall Study|Protocol Violation|0
6057433|NCT00537082|20930665|P3|Overall Study|Adverse Event|3
6057434|NCT00537082|20930666|P2|Overall Study|Adverse Event|6
6057435|NCT00537082|20930667|P1|Overall Study|Adverse Event|6
6057436|NCT00537056|20930684|P1|Interim PET/CT|scheduling conflicts and/or exposure|5
6057437|NCT00537030|20930696|P1|Overall Study|Inevaluable|2
6057438|NCT00537030|20930696|P1|Overall Study|Ineligible|2
6057439|NCT00537030|20930696|P1|Overall Study|Disease progression/ relapse during Tx|1
6057440|NCT00537030|20930696|P1|Overall Study|≥ Grade 2 allergy|7
6057441|NCT00537030|20930696|P1|Overall Study|Withdrawal by Subject|2
6057442|NCT00537030|20930696|P1|Overall Study|Physician Decision|2
6057447|NCT00536991|20930714|P1|Overall Study|patient ineligible|2
6057448|NCT00536991|20930714|P1|Overall Study|Physician Decision|1
6057449|NCT00536991|20930714|P1|Overall Study|Withdrawal by Subject|10
6057450|NCT00536978|20930721|P1|Overall Study|Not eligible for Adback Infusion|22
6057451|NCT00536939|20930725|P2|Overall Study|Other Complicating Disease|0
6057452|NCT00536939|20930726|P1|Overall Study|Other Complicating Disease|1
6057453|NCT00536939|20930725|P2|Overall Study|Withdrawal by Subject|0
6057454|NCT00536939|20930726|P1|Overall Study|Withdrawal by Subject|1
6057455|NCT00536874|20930757|P1|Overall Study|Withdrawal by Subject|1
6057456|NCT00536874|20930757|P1|Overall Study|Death|2
6057457|NCT00536874|20930757|P1|Overall Study|Adverse Event|1
6057458|NCT00536809|20930767|P1|Phase II|Referred for surgical resection|1
6057459|NCT00536809|20930767|P1|Phase II|Adverse Event|1
6057460|NCT00536744|20930790|P2|Overall Study|PI tried alternative treatment|3
6057461|NCT00536744|20930791|P1|Overall Study|PI tried alternative treatment|1
6057462|NCT00536744|20930790|P2|Overall Study|Withdrawal by Subject|8
6057463|NCT00536744|20930791|P1|Overall Study|Withdrawal by Subject|7
6057464|NCT00536744|20930790|P2|Overall Study|Lost to Follow-up|5
6057465|NCT00536744|20930791|P1|Overall Study|Lost to Follow-up|3
6057466|NCT00536744|20930790|P2|Overall Study|Physician Decision|1
6057467|NCT00536744|20930791|P1|Overall Study|Physician Decision|3
6057468|NCT00536744|20930790|P2|Overall Study|Death|1
6057469|NCT00536744|20930791|P1|Overall Study|Death|2
6057470|NCT00536744|20930790|P2|Overall Study|Adverse Event|10
6057471|NCT00536744|20930791|P1|Overall Study|Adverse Event|13
6057472|NCT00536731|20930800|P3|Overall Study|Other|0
6057473|NCT00536731|20930801|P2|Overall Study|Other|1
6057474|NCT00536731|20930802|P1|Overall Study|Other|1
6057475|NCT00536731|20930800|P3|Overall Study|Safety reasons|1
6057476|NCT00536731|20930801|P2|Overall Study|Safety reasons|0
6057477|NCT00536731|20930802|P1|Overall Study|Safety reasons|0
6057478|NCT00536731|20930800|P3|Overall Study|Intake of prohibited conc. medication|1
6057479|NCT00536731|20930801|P2|Overall Study|Intake of prohibited conc. medication|0
6057480|NCT00536731|20930802|P1|Overall Study|Intake of prohibited conc. medication|0
6057481|NCT00536731|20930800|P3|Overall Study|Withdrawal by Subject|0
6057482|NCT00536731|20930801|P2|Overall Study|Withdrawal by Subject|2
6057483|NCT00536731|20930802|P1|Overall Study|Withdrawal by Subject|0
6057484|NCT00536731|20930800|P3|Overall Study|Adverse Event|3
6057485|NCT00536731|20930801|P2|Overall Study|Adverse Event|2
6057486|NCT00536731|20930802|P1|Overall Study|Adverse Event|3
6057487|NCT00536575|20930846|P1|Overall Study|Death|1
6057488|NCT00536575|20930846|P1|Overall Study|Withdrawal by Subject|1
6057489|NCT00536510|20930852|P2|Overall Study|Patient Discontinued for Other Reasons|2
6057490|NCT00536510|20930853|P1|Overall Study|Patient Discontinued for Other Reasons|2
6057491|NCT00536510|20930852|P2|Overall Study|Laboratory Adverse Event|1
6057492|NCT00536510|20930853|P1|Overall Study|Laboratory Adverse Event|2
6057493|NCT00536510|20930852|P2|Overall Study|Flushing with Product|0
6057494|NCT00536510|20930853|P1|Overall Study|Flushing with Product|20
6057495|NCT00536510|20930852|P2|Overall Study|Withdrawal by Subject|9
6057496|NCT00536510|20930853|P1|Overall Study|Withdrawal by Subject|16
6057497|NCT00536510|20930852|P2|Overall Study|Protocol Violation|5
6057498|NCT00536510|20930853|P1|Overall Study|Protocol Violation|4
6057499|NCT00536510|20930852|P2|Overall Study|Lost to Follow-up|8
6057500|NCT00536510|20930853|P1|Overall Study|Lost to Follow-up|11
6057501|NCT00536510|20930852|P2|Overall Study|Adverse Event|4
6057502|NCT00536510|20930853|P1|Overall Study|Adverse Event|27
6057503|NCT00536484|20930863|P2|Overall Study|Other|0
6057504|NCT00536484|20930864|P1|Overall Study|Other|4
6057505|NCT00536484|20930863|P2|Overall Study|Lack of Efficacy|5
6057506|NCT00536484|20930864|P1|Overall Study|Lack of Efficacy|16
6057507|NCT00536484|20930863|P2|Overall Study|Lost to Follow-up|6
6057508|NCT00536484|20930864|P1|Overall Study|Lost to Follow-up|8
6057509|NCT00536484|20930863|P2|Overall Study|Withdrawal by Subject|11
6057510|NCT00536484|20930864|P1|Overall Study|Withdrawal by Subject|11
6057511|NCT00536484|20930863|P2|Overall Study|Adverse Event|34
6057512|NCT00536484|20930864|P1|Overall Study|Adverse Event|21
6057513|NCT00536471|20930898|P4|Overall Study|Sponsor Decision|2
6057514|NCT00536471|20930899|P3|Overall Study|Sponsor Decision|3
6057515|NCT00536471|20930900|P2|Overall Study|Sponsor Decision|1
6057516|NCT00536471|20930901|P1|Overall Study|Sponsor Decision|0
6057517|NCT00536471|20930898|P4|Overall Study|Death|2
6057518|NCT00536471|20930899|P3|Overall Study|Death|1
6057519|NCT00536471|20930900|P2|Overall Study|Death|0
6057520|NCT00536471|20930901|P1|Overall Study|Death|0
6057521|NCT00536471|20930898|P4|Overall Study|Physician Decision|2
6057522|NCT00536471|20930899|P3|Overall Study|Physician Decision|3
6057523|NCT00536471|20930900|P2|Overall Study|Physician Decision|1
6057524|NCT00536471|20930901|P1|Overall Study|Physician Decision|11
6057525|NCT00536471|20930898|P4|Overall Study|Protocol Violation|3
6057526|NCT00536471|20930899|P3|Overall Study|Protocol Violation|2
6057527|NCT00536471|20930900|P2|Overall Study|Protocol Violation|1
6057528|NCT00536471|20930901|P1|Overall Study|Protocol Violation|8
6057529|NCT00536471|20930898|P4|Overall Study|Lack of Efficacy|9
6057530|NCT00536471|20930899|P3|Overall Study|Lack of Efficacy|11
6057531|NCT00536471|20930900|P2|Overall Study|Lack of Efficacy|18
6057532|NCT00536471|20930901|P1|Overall Study|Lack of Efficacy|17
6057533|NCT00536471|20930898|P4|Overall Study|Withdrawal by Subject|21
6057534|NCT00536471|20930899|P3|Overall Study|Withdrawal by Subject|43
6057535|NCT00536471|20930900|P2|Overall Study|Withdrawal by Subject|24
6057536|NCT00536471|20930901|P1|Overall Study|Withdrawal by Subject|40
6057537|NCT00536471|20930898|P4|Overall Study|Adverse Event|13
6057538|NCT00536471|20930899|P3|Overall Study|Adverse Event|28
6057539|NCT00536471|20930900|P2|Overall Study|Adverse Event|16
6057540|NCT00536471|20930901|P1|Overall Study|Adverse Event|32
6057541|NCT00536471|20930898|P4|Overall Study|Lost to Follow-up|22
6057542|NCT00536471|20930899|P3|Overall Study|Lost to Follow-up|48
6057543|NCT00536471|20930900|P2|Overall Study|Lost to Follow-up|23
6057544|NCT00536471|20930901|P1|Overall Study|Lost to Follow-up|48
6057545|NCT00536380|20931146|P3|Overall Study|Administrative|1
6057546|NCT00536380|20931147|P2|Overall Study|Administrative|0
6057547|NCT00536380|20931148|P1|Overall Study|Administrative|0
6057548|NCT00536380|20931146|P3|Overall Study|Did not meet protocol eligibility|1
6057549|NCT00536380|20931147|P2|Overall Study|Did not meet protocol eligibility|0
6057550|NCT00536380|20931148|P1|Overall Study|Did not meet protocol eligibility|0
6057551|NCT00536380|20931146|P3|Overall Study|Noncompliance with protocol|2
6057552|NCT00536380|20931147|P2|Overall Study|Noncompliance with protocol|2
6057553|NCT00536380|20931148|P1|Overall Study|Noncompliance with protocol|3
6057554|NCT00536380|20931146|P3|Overall Study|Withdrawal related to study drug|2
6057555|NCT00536380|20931147|P2|Overall Study|Withdrawal related to study drug|5
6057556|NCT00536380|20931148|P1|Overall Study|Withdrawal related to study drug|7
6057557|NCT00536380|20931146|P3|Overall Study|Withdrawal unrelated to study drug|1
6057558|NCT00536380|20931147|P2|Overall Study|Withdrawal unrelated to study drug|0
6057559|NCT00536380|20931148|P1|Overall Study|Withdrawal unrelated to study drug|2
6057560|NCT00536380|20931146|P3|Overall Study|Lost to Follow-up|1
6057561|NCT00536380|20931147|P2|Overall Study|Lost to Follow-up|0
6057562|NCT00536380|20931148|P1|Overall Study|Lost to Follow-up|0
6057563|NCT00536380|20931146|P3|Overall Study|Adverse Event|2
6057564|NCT00536380|20931147|P2|Overall Study|Adverse Event|2
6057565|NCT00536380|20931148|P1|Overall Study|Adverse Event|0
6057566|NCT00536263|20931172|P3|Overall Study|Did not meet protocol eligibility|2
6057567|NCT00536263|20931173|P2|Overall Study|Did not meet protocol eligibility|2
6057568|NCT00536263|20931174|P1|Overall Study|Did not meet protocol eligibility|1
6057569|NCT00536263|20931172|P3|Overall Study|Noncompliance with protocol|1
6057570|NCT00536263|20931173|P2|Overall Study|Noncompliance with protocol|0
6057571|NCT00536263|20931174|P1|Overall Study|Noncompliance with protocol|0
6057572|NCT00536263|20931172|P3|Overall Study|Subject withdrew - treatment related|2
6057573|NCT00536263|20931173|P2|Overall Study|Subject withdrew - treatment related|3
6057574|NCT00536263|20931174|P1|Overall Study|Subject withdrew - treatment related|0
6057575|NCT00536263|20931172|P3|Overall Study|Subject withdrew - not treatment related|5
6057576|NCT00536263|20931173|P2|Overall Study|Subject withdrew - not treatment related|0
6057577|NCT00536263|20931174|P1|Overall Study|Subject withdrew - not treatment related|2
6057578|NCT00536263|20931172|P3|Overall Study|Lost to Follow-up|4
6057579|NCT00536263|20931173|P2|Overall Study|Lost to Follow-up|4
6057580|NCT00536263|20931174|P1|Overall Study|Lost to Follow-up|3
6057581|NCT00536263|20931172|P3|Overall Study|Adverse Event|7
6057582|NCT00536263|20931173|P2|Overall Study|Adverse Event|5
6057583|NCT00536263|20931174|P1|Overall Study|Adverse Event|5
6057584|NCT00536198|20931214|P2|Overall Study|Protocol Violation|1
6057585|NCT00536198|20931215|P1|Overall Study|Protocol Violation|0
6057586|NCT00536198|20931214|P2|Overall Study|Pregnancy|1
6057587|NCT00536198|20931215|P1|Overall Study|Pregnancy|1
6057588|NCT00536198|20931214|P2|Overall Study|Rescue|9
6057589|NCT00536198|20931215|P1|Overall Study|Rescue|3
6057590|NCT00536198|20931214|P2|Overall Study|Adverse Event|2
6057591|NCT00536198|20931215|P1|Overall Study|Adverse Event|2
6057592|NCT00536198|20931214|P2|Overall Study|Withdrawal by Subject|12
6057593|NCT00536198|20931215|P1|Overall Study|Withdrawal by Subject|16
6057594|NCT00536198|20931214|P2|Overall Study|Lost to Follow-up|14
6057595|NCT00536198|20931215|P1|Overall Study|Lost to Follow-up|15
6057596|NCT00536120|20931254|P2|Overall Study|Missed Study Visit|1
6057597|NCT00536120|20931255|P1|Overall Study|Missed Study Visit|0
6057598|NCT00536120|20931254|P2|Overall Study|Steroid Use|2
6057599|NCT00536120|20931255|P1|Overall Study|Steroid Use|0
6057600|NCT00536120|20931254|P2|Overall Study|Sponsor Decision Due to Lab Values|0
6057601|NCT00536120|20931255|P1|Overall Study|Sponsor Decision Due to Lab Values|1
6057602|NCT00536120|20931254|P2|Overall Study|Non-compliance|0
6057603|NCT00536120|20931255|P1|Overall Study|Non-compliance|1
6057604|NCT00536120|20931254|P2|Overall Study|Positive for Anti-natalizumab Antibodies|0
6057605|NCT00536120|20931255|P1|Overall Study|Positive for Anti-natalizumab Antibodies|3
6057606|NCT00536120|20931254|P2|Overall Study|Lost to Follow-up|0
6057607|NCT00536120|20931255|P1|Overall Study|Lost to Follow-up|1
6057608|NCT00536107|20931269|P2|Overall Study|Study Termination|4
6057609|NCT00536107|20931270|P1|Overall Study|Study Termination|2
6057610|NCT00536107|20931269|P2|Overall Study|Withdrawal by Subject|1
6057611|NCT00536107|20931270|P1|Overall Study|Withdrawal by Subject|0
6057612|NCT00536107|20931269|P2|Overall Study|Incorrect enrolment|0
6057613|NCT00536107|20931270|P1|Overall Study|Incorrect enrolment|1
6057614|NCT00536107|20931269|P2|Overall Study|Death|1
6057615|NCT00536107|20931270|P1|Overall Study|Death|5
6057616|NCT00535847|20931335|P3|Overall Study|Protocol-defined Virologic Stopping Rule|0
6057617|NCT00535847|20931336|P2|Overall Study|Protocol-defined Virologic Stopping Rule|10
6057618|NCT00535847|20931337|P1|Overall Study|Protocol-defined Virologic Stopping Rule|16
6057619|NCT00535847|20931335|P3|Overall Study|Non compliance|0
6057620|NCT00535847|20931336|P2|Overall Study|Non compliance|1
6057621|NCT00535847|20931337|P1|Overall Study|Non compliance|1
6057622|NCT00535847|20931335|P3|Overall Study|Adverse Event|2
6057623|NCT00535847|20931336|P2|Overall Study|Adverse Event|3
6057624|NCT00535847|20931337|P1|Overall Study|Adverse Event|5
6057625|NCT00535730|20931572|P2|Overall Study|Withdrawal by Subject|4
6057626|NCT00535730|20931573|P1|Overall Study|Withdrawal by Subject|0
6057627|NCT00535730|20931572|P2|Overall Study|Protocol Violation|0
6057628|NCT00535730|20931573|P1|Overall Study|Protocol Violation|1
6057629|NCT00535730|20931572|P2|Overall Study|Physician Decision|1
6057630|NCT00535730|20931573|P1|Overall Study|Physician Decision|0
6057631|NCT00535730|20931572|P2|Overall Study|Lost to Follow-up|1
6057632|NCT00535730|20931573|P1|Overall Study|Lost to Follow-up|0
6057633|NCT00535730|20931572|P2|Overall Study|Adverse Event|1
6057634|NCT00535730|20931573|P1|Overall Study|Adverse Event|1
6057635|NCT00535626|20931594|P1|Overall Study|Unable to return|2
6057636|NCT00535626|20931594|P1|Overall Study|Subject terminated|31
6057637|NCT00535626|20931594|P1|Overall Study|Removal/revision of study component|8
6057638|NCT00535626|20931594|P1|Overall Study|Withdrawal by Subject|20
6057639|NCT00535626|20931594|P1|Overall Study|Lost to Follow-up|29
6057640|NCT00535626|20931594|P1|Overall Study|Death|15
6057641|NCT00535496|20931634|P4|Overall Study|Not treated with sugammadex|0
6057642|NCT00535496|20931635|P3|Overall Study|Not treated with sugammadex|0
6057643|NCT00535496|20931636|P2|Overall Study|Not treated with sugammadex|1
6057644|NCT00535496|20931637|P1|Overall Study|Not treated with sugammadex|0
6057645|NCT00535496|20931634|P4|Overall Study|Lost to Follow-up|0
6057646|NCT00535496|20931635|P3|Overall Study|Lost to Follow-up|0
6057647|NCT00535496|20931636|P2|Overall Study|Lost to Follow-up|1
6057648|NCT00535496|20931637|P1|Overall Study|Lost to Follow-up|0
6057649|NCT00535405|20931657|P5|Overall Study|Withdrawal by Subject|8
6057650|NCT00535405|20931658|P4|Overall Study|Withdrawal by Subject|10
6057651|NCT00535405|20931659|P3|Overall Study|Withdrawal by Subject|10
6057652|NCT00535405|20931660|P2|Overall Study|Withdrawal by Subject|11
6057653|NCT00535405|20931661|P1|Overall Study|Withdrawal by Subject|5
6057654|NCT00535405|20931657|P5|Overall Study|Protocol Violation|0
6057655|NCT00535405|20931658|P4|Overall Study|Protocol Violation|1
6057656|NCT00535405|20931659|P3|Overall Study|Protocol Violation|2
6057657|NCT00535405|20931660|P2|Overall Study|Protocol Violation|2
6057658|NCT00535405|20931661|P1|Overall Study|Protocol Violation|2
6057659|NCT00535405|20931657|P5|Overall Study|Physician Decision|1
6057660|NCT00535405|20931658|P4|Overall Study|Physician Decision|1
6057661|NCT00535405|20931659|P3|Overall Study|Physician Decision|0
6057662|NCT00535405|20931660|P2|Overall Study|Physician Decision|2
6057663|NCT00535405|20931661|P1|Overall Study|Physician Decision|3
6057664|NCT00535405|20931657|P5|Overall Study|Lost to Follow-up|1
6057665|NCT00535405|20931658|P4|Overall Study|Lost to Follow-up|2
6057666|NCT00535405|20931659|P3|Overall Study|Lost to Follow-up|3
6057667|NCT00535405|20931660|P2|Overall Study|Lost to Follow-up|3
6057668|NCT00535405|20931661|P1|Overall Study|Lost to Follow-up|1
6057669|NCT00535405|20931657|P5|Overall Study|Adverse Event|6
6057670|NCT00535405|20931658|P4|Overall Study|Adverse Event|8
6057671|NCT00535405|20931659|P3|Overall Study|Adverse Event|3
6057672|NCT00535405|20931660|P2|Overall Study|Adverse Event|8
6057673|NCT00535405|20931661|P1|Overall Study|Adverse Event|6
6057674|NCT00535288|20931722|P5|Overall Study|Other|1
6057675|NCT00535288|20931723|P4|Overall Study|Other|2
6057676|NCT00535288|20931724|P3|Overall Study|Other|1
6057677|NCT00535288|20931725|P2|Overall Study|Other|1
6057678|NCT00535288|20931726|P1|Overall Study|Other|2
6057679|NCT00535288|20931722|P5|Overall Study|Unwilling to cooperate|4
6057680|NCT00535288|20931723|P4|Overall Study|Unwilling to cooperate|3
6057681|NCT00535288|20931724|P3|Overall Study|Unwilling to cooperate|3
6057682|NCT00535288|20931725|P2|Overall Study|Unwilling to cooperate|6
6057683|NCT00535288|20931726|P1|Overall Study|Unwilling to cooperate|6
6057684|NCT00535288|20931722|P5|Overall Study|Lack of Efficacy|7
6057685|NCT00535288|20931723|P4|Overall Study|Lack of Efficacy|4
6057686|NCT00535288|20931724|P3|Overall Study|Lack of Efficacy|4
6057687|NCT00535288|20931725|P2|Overall Study|Lack of Efficacy|3
6057688|NCT00535288|20931726|P1|Overall Study|Lack of Efficacy|26
6057689|NCT00535288|20931722|P5|Overall Study|Lost to Follow-up|0
6057690|NCT00535288|20931723|P4|Overall Study|Lost to Follow-up|0
6057691|NCT00535288|20931724|P3|Overall Study|Lost to Follow-up|0
6057692|NCT00535288|20931725|P2|Overall Study|Lost to Follow-up|3
6057693|NCT00535288|20931726|P1|Overall Study|Lost to Follow-up|0
6057694|NCT00535288|20931722|P5|Overall Study|Adverse Event|30
6057695|NCT00535288|20931723|P4|Overall Study|Adverse Event|20
6057696|NCT00535288|20931724|P3|Overall Study|Adverse Event|25
6057697|NCT00535288|20931725|P2|Overall Study|Adverse Event|19
6057698|NCT00535288|20931726|P1|Overall Study|Adverse Event|20
6057699|NCT00535262|20931803|P1|Overall Study|No funding|3
6057700|NCT00535236|20931817|P10|Overall Study|Withdrawal by Subject|2
6057701|NCT00535236|20931818|P9|Overall Study|Withdrawal by Subject|4
6057702|NCT00535236|20931819|P8|Overall Study|Withdrawal by Subject|0
6057703|NCT00535236|20931820|P7|Overall Study|Withdrawal by Subject|5
6057704|NCT00535236|20931821|P6|Overall Study|Withdrawal by Subject|1
6057705|NCT00535236|20931822|P5|Overall Study|Withdrawal by Subject|6
6057706|NCT00535236|20931823|P4|Overall Study|Withdrawal by Subject|1
6057707|NCT00535236|20931824|P3|Overall Study|Withdrawal by Subject|2
6057708|NCT00535236|20931825|P2|Overall Study|Withdrawal by Subject|0
6057709|NCT00535236|20931826|P1|Overall Study|Withdrawal by Subject|3
6057710|NCT00535236|20931817|P10|Overall Study|Protocol Violation|0
6057711|NCT00535236|20931818|P9|Overall Study|Protocol Violation|1
6057712|NCT00535236|20931819|P8|Overall Study|Protocol Violation|0
6057713|NCT00535236|20931820|P7|Overall Study|Protocol Violation|0
6057714|NCT00535236|20931821|P6|Overall Study|Protocol Violation|0
6057715|NCT00535236|20931822|P5|Overall Study|Protocol Violation|0
6057716|NCT00535236|20931823|P4|Overall Study|Protocol Violation|0
6057717|NCT00535236|20931824|P3|Overall Study|Protocol Violation|1
6057718|NCT00535236|20931825|P2|Overall Study|Protocol Violation|0
6057719|NCT00535236|20931826|P1|Overall Study|Protocol Violation|2
6057720|NCT00535236|20931817|P10|Overall Study|Physician Decision|0
6057721|NCT00535236|20931818|P9|Overall Study|Physician Decision|0
6057722|NCT00535236|20931819|P8|Overall Study|Physician Decision|0
6057723|NCT00535236|20931820|P7|Overall Study|Physician Decision|1
6057724|NCT00535236|20931821|P6|Overall Study|Physician Decision|0
6057725|NCT00535236|20931822|P5|Overall Study|Physician Decision|1
6057726|NCT00535236|20931823|P4|Overall Study|Physician Decision|0
6057727|NCT00535236|20931824|P3|Overall Study|Physician Decision|0
6057728|NCT00535236|20931825|P2|Overall Study|Physician Decision|0
6057729|NCT00535236|20931826|P1|Overall Study|Physician Decision|0
6057730|NCT00535236|20931817|P10|Overall Study|Lost to Follow-up|1
6057731|NCT00535236|20931818|P9|Overall Study|Lost to Follow-up|6
6057732|NCT00535236|20931819|P8|Overall Study|Lost to Follow-up|0
6057733|NCT00535236|20931820|P7|Overall Study|Lost to Follow-up|0
6057734|NCT00535236|20931821|P6|Overall Study|Lost to Follow-up|0
6057735|NCT00535236|20931822|P5|Overall Study|Lost to Follow-up|2
6057736|NCT00535236|20931823|P4|Overall Study|Lost to Follow-up|0
6057737|NCT00535236|20931824|P3|Overall Study|Lost to Follow-up|0
6057738|NCT00535236|20931825|P2|Overall Study|Lost to Follow-up|2
6057739|NCT00535236|20931826|P1|Overall Study|Lost to Follow-up|1
6057740|NCT00535236|20931817|P10|Overall Study|Adverse Event|1
6057741|NCT00535236|20931818|P9|Overall Study|Adverse Event|2
6057742|NCT00535236|20931819|P8|Overall Study|Adverse Event|1
6057743|NCT00535236|20931820|P7|Overall Study|Adverse Event|5
6057744|NCT00535236|20931821|P6|Overall Study|Adverse Event|0
6057745|NCT00535236|20931822|P5|Overall Study|Adverse Event|3
6057746|NCT00535236|20931823|P4|Overall Study|Adverse Event|3
6057747|NCT00535236|20931824|P3|Overall Study|Adverse Event|9
6057748|NCT00535236|20931825|P2|Overall Study|Adverse Event|0
6057749|NCT00535236|20931826|P1|Overall Study|Adverse Event|1
6057750|NCT00535223|20931886|P2|Overall Study|Withdrawal by Subject|1
6057751|NCT00535223|20931887|P1|Overall Study|Withdrawal by Subject|4
6057752|NCT00535145|20931895|P1|Phase II|Subject non-compliance|2
6057753|NCT00535145|20931895|P1|Phase II|Withdrawal by Subject|5
6057754|NCT00535145|20931895|P1|Phase II|Lost to Follow-up|5
6057755|NCT00535145|20931895|P1|Phase II|Lack of Efficacy|1
6057756|NCT00535145|20931895|P1|Phase II|Adverse Event|2
6057757|NCT00535145|20931895|P1|Phase I|(diagnosis)|3
6057758|NCT00535145|20931895|P1|Phase I|(PI decision)|1
6057759|NCT00535145|20931895|P1|Phase I|(protocol violation)|1
6057760|NCT00535145|20931895|P1|Phase I|(eligibility)|8
6057761|NCT00535145|20931895|P1|Phase I|Withdrawal by Subject|6
6057762|NCT00535145|20931895|P1|Phase I|Lost to Follow-up|7
6057763|NCT00535145|20931895|P1|Phase I|Adverse Event|3
6057764|NCT00535132|20931907|P2|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3
6057765|NCT00535132|20931908|P1|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3
6057766|NCT00535132|20931907|P2|Safety Analysis Set|Did Not Receive Study Medication|2
6057767|NCT00535132|20931908|P1|Safety Analysis Set|Did Not Receive Study Medication|2
6057768|NCT00534976|20931989|P2|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|0
6057769|NCT00534976|20931990|P1|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|1
6057770|NCT00534976|20931989|P2|Period 3: Crossover Placebo/ Montelukast|Physician Decision|0
6057771|NCT00534976|20931990|P1|Period 3: Crossover Placebo/ Montelukast|Physician Decision|1
6057772|NCT00534976|20931989|P2|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|1
6057773|NCT00534976|20931990|P1|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|0
6057774|NCT00534638|20932070|P2|Overall Study|Other|902
6057775|NCT00534638|20932071|P1|Overall Study|Other|1685
6057776|NCT00534638|20932070|P2|Overall Study|Lost to follow-up, complete vaccination|10757
6057777|NCT00534638|20932071|P1|Overall Study|Lost to follow-up, complete vaccination|4707
6057778|NCT00534638|20932070|P2|Overall Study|Lost to follow-up,incomplete vaccination|117
6057779|NCT00534638|20932071|P1|Overall Study|Lost to follow-up,incomplete vaccination|83
6057780|NCT00534638|20932070|P2|Overall Study|Migrated/moved from study area|11
6057781|NCT00534638|20932071|P1|Overall Study|Migrated/moved from study area|13
6057782|NCT00534638|20932070|P2|Overall Study|Withdrawal by Subject|4
6057783|NCT00534638|20932071|P1|Overall Study|Withdrawal by Subject|3
6057784|NCT00534599|20932109|P2|Overall Study|Other|0
6057785|NCT00534599|20932110|P1|Overall Study|Other|7
6057786|NCT00534599|20932109|P2|Overall Study|Withdrawal by Subject|6
6057787|NCT00534599|20932110|P1|Overall Study|Withdrawal by Subject|4
6057788|NCT00534599|20932109|P2|Overall Study|Lost to Follow-up|14
6057789|NCT00534599|20932110|P1|Overall Study|Lost to Follow-up|11
6057790|NCT00534599|20932109|P2|Overall Study|Protocol Violation|3
6057791|NCT00534599|20932110|P1|Overall Study|Protocol Violation|1
6057792|NCT00534599|20932109|P2|Overall Study|Generalized anxiety disorder worsened|1
6057793|NCT00534599|20932110|P1|Overall Study|Generalized anxiety disorder worsened|0
6057794|NCT00534599|20932109|P2|Overall Study|Lack of Efficacy|1
6057795|NCT00534599|20932110|P1|Overall Study|Lack of Efficacy|0
6057796|NCT00534599|20932109|P2|Overall Study|Developed study-specific d/c criteria|0
6057797|NCT00534599|20932110|P1|Overall Study|Developed study-specific d/c criteria|5
6057798|NCT00534599|20932109|P2|Overall Study|Mis-randomization|2
6057799|NCT00534599|20932110|P1|Overall Study|Mis-randomization|2
6057800|NCT00534599|20932109|P2|Overall Study|Incorrect enrollment|1
6057801|NCT00534599|20932110|P1|Overall Study|Incorrect enrollment|2
6057802|NCT00534599|20932109|P2|Overall Study|Adverse Event|4
6057803|NCT00534599|20932110|P1|Overall Study|Adverse Event|25
6057804|NCT00534495|20932146|P3|Long Term Ext. Phase Week 24-month 21|non compliance|2
6057805|NCT00534495|20932147|P2|Long Term Ext. Phase Week 24-month 21|non compliance|0
6057806|NCT00534495|20932148|P1|Long Term Ext. Phase Week 24-month 21|non compliance|0
6057807|NCT00534495|20932146|P3|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|3
6057808|NCT00534495|20932147|P2|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0
6057809|NCT00534495|20932148|P1|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0
6057810|NCT00534495|20932146|P3|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|5
6057811|NCT00534495|20932147|P2|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0
6057812|NCT00534495|20932148|P1|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0
6057813|NCT00534495|20932146|P3|Long Term Ext. Phase Week 24-month 21|Adverse Event|1
6057814|NCT00534495|20932147|P2|Long Term Ext. Phase Week 24-month 21|Adverse Event|0
6057815|NCT00534495|20932148|P1|Long Term Ext. Phase Week 24-month 21|Adverse Event|0
6057816|NCT00534495|20932146|P3|All Active Treatment Phase Week 4-24|Withdrawal by Subject|0
6057817|NCT00534495|20932147|P2|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1
6057818|NCT00534495|20932148|P1|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1
6057819|NCT00534495|20932146|P3|All Active Treatment Phase Week 4-24|Lost to Follow-up|0
6057820|NCT00534495|20932147|P2|All Active Treatment Phase Week 4-24|Lost to Follow-up|1
6057821|NCT00534495|20932148|P1|All Active Treatment Phase Week 4-24|Lost to Follow-up|1
6057822|NCT00534495|20932146|P3|All Active Treatment Phase Week 4-24|Lack of Efficacy|0
6057823|NCT00534495|20932147|P2|All Active Treatment Phase Week 4-24|Lack of Efficacy|7
6057824|NCT00534495|20932148|P1|All Active Treatment Phase Week 4-24|Lack of Efficacy|1
6057825|NCT00534495|20932146|P3|All Active Treatment Phase Week 4-24|Adverse Event|0
6057826|NCT00534495|20932147|P2|All Active Treatment Phase Week 4-24|Adverse Event|0
6057827|NCT00534495|20932148|P1|All Active Treatment Phase Week 4-24|Adverse Event|1
6057828|NCT00534495|20932146|P3|Double Blind Placebo Phase Week 0-4|randomized in error|0
6057829|NCT00534495|20932147|P2|Double Blind Placebo Phase Week 0-4|randomized in error|1
6057830|NCT00534495|20932148|P1|Double Blind Placebo Phase Week 0-4|randomized in error|0
6057831|NCT00534404|20932186|P3|Overall Study|Lost to Follow-up|201
6057832|NCT00534404|20932187|P2|Overall Study|Lost to Follow-up|138
6057833|NCT00534404|20932188|P1|Overall Study|Lost to Follow-up|170
6057834|NCT00534404|20932186|P3|Overall Study|Removed by study staff|1
6057835|NCT00534404|20932187|P2|Overall Study|Removed by study staff|3
6057836|NCT00534404|20932188|P1|Overall Study|Removed by study staff|2
6057837|NCT00534404|20932186|P3|Overall Study|Withdrawal by Subject|38
6057838|NCT00534404|20932187|P2|Overall Study|Withdrawal by Subject|2
6057839|NCT00534404|20932188|P1|Overall Study|Withdrawal by Subject|8
6057840|NCT00534404|20932186|P3|Overall Study|Death|2
6057841|NCT00534404|20932187|P2|Overall Study|Death|0
6057842|NCT00534404|20932188|P1|Overall Study|Death|0
6057843|NCT00534352|20932219|P1|Optional Extension: DRV/Rtv + TDF/FTC|Pregnancy|1
6057844|NCT00534352|20932219|P1|Optional Extension: DRV/Rtv + TDF/FTC|Lost to Follow-up|2
6057845|NCT00534352|20932219|P1|Optional Extension: DRV/Rtv + TDF/FTC|Physician Decision|1
6057846|NCT00534352|20932219|P1|Treatment C: DRV/Rtv + TDF/FTC|Physician Decision|1
6057847|NCT00534352|20932219|P1|Treatment A: TMC125 + TDF/FTC|Lost to Follow-up|1
6057848|NCT00534352|20932219|P1|Treatment A: TMC125 + TDF/FTC|Physician Decision|1
6057849|NCT00534313|20932263|P4|Long-term Period|Other|2
6057850|NCT00534313|20932264|P3|Long-term Period|Other|2
6057851|NCT00534313|20932265|P2|Long-term Period|Other|2
6057852|NCT00534313|20932266|P1|Long-term Period|Other|1
6057853|NCT00534313|20932263|P4|Long-term Period|Administrative reason by sponsor|18
6057854|NCT00534313|20932264|P3|Long-term Period|Administrative reason by sponsor|26
6057855|NCT00534313|20932265|P2|Long-term Period|Administrative reason by sponsor|15
6057856|NCT00534313|20932266|P1|Long-term Period|Administrative reason by sponsor|17
6057857|NCT00534313|20932263|P4|Long-term Period|Poor compliance/noncompliance|0
6057858|NCT00534313|20932264|P3|Long-term Period|Poor compliance/noncompliance|1
6057859|NCT00534313|20932265|P2|Long-term Period|Poor compliance/noncompliance|1
6057860|NCT00534313|20932266|P1|Long-term Period|Poor compliance/noncompliance|0
6057861|NCT00534313|20932263|P4|Long-term Period|No longer meets study criteria|0
6057862|NCT00534313|20932264|P3|Long-term Period|No longer meets study criteria|0
6057863|NCT00534313|20932265|P2|Long-term Period|No longer meets study criteria|1
6057864|NCT00534313|20932266|P1|Long-term Period|No longer meets study criteria|0
6057865|NCT00534313|20932263|P4|Long-term Period|Withdrawal by Subject|0
6057866|NCT00534313|20932264|P3|Long-term Period|Withdrawal by Subject|0
6057867|NCT00534313|20932265|P2|Long-term Period|Withdrawal by Subject|2
6057868|NCT00534313|20932266|P1|Long-term Period|Withdrawal by Subject|2
6057869|NCT00534313|20932263|P4|Long-term Period|Lost to Follow-up|0
6057870|NCT00534313|20932264|P3|Long-term Period|Lost to Follow-up|0
6057871|NCT00534313|20932265|P2|Long-term Period|Lost to Follow-up|2
6057872|NCT00534313|20932266|P1|Long-term Period|Lost to Follow-up|1
6057873|NCT00534313|20932263|P4|Long-term Period|Lack of Efficacy|12
6057874|NCT00534313|20932264|P3|Long-term Period|Lack of Efficacy|14
6057875|NCT00534313|20932265|P2|Long-term Period|Lack of Efficacy|10
6057876|NCT00534313|20932266|P1|Long-term Period|Lack of Efficacy|14
6057877|NCT00534313|20932263|P4|Long-term Period|Adverse Event|1
6057878|NCT00534313|20932264|P3|Long-term Period|Adverse Event|0
6057879|NCT00534313|20932265|P2|Long-term Period|Adverse Event|1
6057880|NCT00534313|20932266|P1|Long-term Period|Adverse Event|2
6057881|NCT00534313|20932263|P4|Short-term Period|Pregnancy|0
6057882|NCT00534313|20932264|P3|Short-term Period|Pregnancy|1
6057883|NCT00534313|20932265|P2|Short-term Period|Pregnancy|0
6057884|NCT00534313|20932266|P1|Short-term Period|Pregnancy|0
6057885|NCT00534313|20932263|P4|Short-term Period|Participant withdrew consent|2
6057886|NCT00534313|20932264|P3|Short-term Period|Participant withdrew consent|0
6057887|NCT00534313|20932265|P2|Short-term Period|Participant withdrew consent|0
6057888|NCT00534313|20932266|P1|Short-term Period|Participant withdrew consent|2
6057889|NCT00534313|20932263|P4|Short-term Period|Participant not meeting study criteria|1
6057890|NCT00534313|20932264|P3|Short-term Period|Participant not meeting study criteria|0
6057891|NCT00534313|20932265|P2|Short-term Period|Participant not meeting study criteria|0
6057892|NCT00534313|20932266|P1|Short-term Period|Participant not meeting study criteria|0
6057893|NCT00534313|20932263|P4|Short-term Period|Lack of Efficacy|3
6057894|NCT00534313|20932264|P3|Short-term Period|Lack of Efficacy|0
6057895|NCT00534313|20932265|P2|Short-term Period|Lack of Efficacy|4
6057896|NCT00534313|20932266|P1|Short-term Period|Lack of Efficacy|3
6057897|NCT00534313|20932263|P4|Short-term Period|Adverse Event|3
6057898|NCT00534313|20932264|P3|Short-term Period|Adverse Event|1
6057899|NCT00534313|20932265|P2|Short-term Period|Adverse Event|2
6057900|NCT00534313|20932266|P1|Short-term Period|Adverse Event|1
6057901|NCT00534248|20932361|P2|Overall Study|Withdrawal by Subject|255
6057902|NCT00534248|20932362|P1|Overall Study|Withdrawal by Subject|263
6057903|NCT00534248|20932361|P2|Overall Study|Protocol Violation|4
6057904|NCT00534248|20932362|P1|Overall Study|Protocol Violation|3
6057905|NCT00534248|20932361|P2|Overall Study|Physician Decision|7
6057906|NCT00534248|20932362|P1|Overall Study|Physician Decision|10
6057907|NCT00534248|20932361|P2|Overall Study|Other protocol specified criteria|3
6057908|NCT00534248|20932362|P1|Overall Study|Other protocol specified criteria|13
6057909|NCT00534248|20932361|P2|Overall Study|Lost to Follow-up|375
6057910|NCT00534248|20932362|P1|Overall Study|Lost to Follow-up|353
6057911|NCT00534248|20932361|P2|Overall Study|Adverse Event|29
6057912|NCT00534248|20932362|P1|Overall Study|Adverse Event|19
6057913|NCT00534105|20932532|P2|Overall Study|Lost to Follow-up|39
6057914|NCT00534105|20932533|P1|Overall Study|Lost to Follow-up|23
6057915|NCT00534092|20932547|P2|Overall Study|personal reasons/family concerns|0
6057916|NCT00534092|20932548|P1|Overall Study|personal reasons/family concerns|1
6057917|NCT00534092|20932547|P2|Overall Study|Lost to Follow-up|0
6057918|NCT00534092|20932548|P1|Overall Study|Lost to Follow-up|1
6057919|NCT00533949|20932586|P4|Overall Study|Withdrawal by Subject|1
6057920|NCT00533949|20932587|P3|Overall Study|Withdrawal by Subject|1
6057921|NCT00533949|20932588|P2|Overall Study|Withdrawal by Subject|2
6057922|NCT00533949|20932589|P1|Overall Study|Withdrawal by Subject|3
6057923|NCT00533949|20932586|P4|Overall Study|Protocol Violation|9
6057924|NCT00533949|20932587|P3|Overall Study|Protocol Violation|9
6057925|NCT00533949|20932588|P2|Overall Study|Protocol Violation|12
6057926|NCT00533949|20932589|P1|Overall Study|Protocol Violation|12
6057927|NCT00533897|20932643|P8|Long Term Extension (LTE)|Other|6
6057928|NCT00533897|20932644|P7|Long Term Extension (LTE)|Other|1
6057929|NCT00533897|20932645|P6|Long Term Extension (LTE)|Other|0
6057930|NCT00533897|20932646|P5|Long Term Extension (LTE)|Other|0
6057931|NCT00533897|20932647|P4|Long Term Extension (LTE)|Other|0
6057932|NCT00533897|20932648|P3|Long Term Extension (LTE)|Other|0
6057933|NCT00533897|20932649|P2|Long Term Extension (LTE)|Other|0
6057934|NCT00533897|20932650|P1|Long Term Extension (LTE)|Other|0
6057935|NCT00533897|20932643|P8|Long Term Extension (LTE)|Lost to Follow-up|1
6057936|NCT00533897|20932644|P7|Long Term Extension (LTE)|Lost to Follow-up|1
6057937|NCT00533897|20932645|P6|Long Term Extension (LTE)|Lost to Follow-up|0
6057938|NCT00533897|20932646|P5|Long Term Extension (LTE)|Lost to Follow-up|0
6057939|NCT00533897|20932647|P4|Long Term Extension (LTE)|Lost to Follow-up|0
6057940|NCT00533897|20932648|P3|Long Term Extension (LTE)|Lost to Follow-up|0
6057941|NCT00533897|20932649|P2|Long Term Extension (LTE)|Lost to Follow-up|0
6057942|NCT00533897|20932650|P1|Long Term Extension (LTE)|Lost to Follow-up|0
6057943|NCT00533897|20932643|P8|Long Term Extension (LTE)|Pregnancy|2
6057944|NCT00533897|20932644|P7|Long Term Extension (LTE)|Pregnancy|0
6057945|NCT00533897|20932645|P6|Long Term Extension (LTE)|Pregnancy|0
6057946|NCT00533897|20932646|P5|Long Term Extension (LTE)|Pregnancy|0
6057947|NCT00533897|20932647|P4|Long Term Extension (LTE)|Pregnancy|0
6057948|NCT00533897|20932648|P3|Long Term Extension (LTE)|Pregnancy|0
6057949|NCT00533897|20932649|P2|Long Term Extension (LTE)|Pregnancy|0
6057950|NCT00533897|20932650|P1|Long Term Extension (LTE)|Pregnancy|0
6057951|NCT00533897|20932643|P8|Long Term Extension (LTE)|Adverse Event|5
6057952|NCT00533897|20932644|P7|Long Term Extension (LTE)|Adverse Event|2
6057953|NCT00533897|20932645|P6|Long Term Extension (LTE)|Adverse Event|0
6057954|NCT00533897|20932646|P5|Long Term Extension (LTE)|Adverse Event|0
6057955|NCT00533897|20932647|P4|Long Term Extension (LTE)|Adverse Event|0
6057956|NCT00533897|20932648|P3|Long Term Extension (LTE)|Adverse Event|0
6057957|NCT00533897|20932649|P2|Long Term Extension (LTE)|Adverse Event|0
6057958|NCT00533897|20932650|P1|Long Term Extension (LTE)|Adverse Event|0
6057959|NCT00533897|20932643|P8|Long Term Extension (LTE)|Poor/Non-compliance|0
6057960|NCT00533897|20932644|P7|Long Term Extension (LTE)|Poor/Non-compliance|1
6057961|NCT00533897|20932645|P6|Long Term Extension (LTE)|Poor/Non-compliance|0
6057962|NCT00533897|20932646|P5|Long Term Extension (LTE)|Poor/Non-compliance|0
6057963|NCT00533897|20932647|P4|Long Term Extension (LTE)|Poor/Non-compliance|0
6057964|NCT00533897|20932648|P3|Long Term Extension (LTE)|Poor/Non-compliance|0
6057965|NCT00533897|20932649|P2|Long Term Extension (LTE)|Poor/Non-compliance|0
6057966|NCT00533897|20932650|P1|Long Term Extension (LTE)|Poor/Non-compliance|0
6057967|NCT00533897|20932643|P8|Long Term Extension (LTE)|Lack of Efficacy|3
6057968|NCT00533897|20932644|P7|Long Term Extension (LTE)|Lack of Efficacy|5
6057969|NCT00533897|20932645|P6|Long Term Extension (LTE)|Lack of Efficacy|0
6057970|NCT00533897|20932646|P5|Long Term Extension (LTE)|Lack of Efficacy|0
6057971|NCT00533897|20932647|P4|Long Term Extension (LTE)|Lack of Efficacy|0
6057972|NCT00533897|20932648|P3|Long Term Extension (LTE)|Lack of Efficacy|0
6057973|NCT00533897|20932649|P2|Long Term Extension (LTE)|Lack of Efficacy|0
6057974|NCT00533897|20932650|P1|Long Term Extension (LTE)|Lack of Efficacy|0
6057975|NCT00533897|20932643|P8|Long Term Extension (LTE)|Death|3
6057976|NCT00533897|20932644|P7|Long Term Extension (LTE)|Death|1
6057977|NCT00533897|20932645|P6|Long Term Extension (LTE)|Death|0
6057978|NCT00533897|20932646|P5|Long Term Extension (LTE)|Death|0
6057979|NCT00533897|20932647|P4|Long Term Extension (LTE)|Death|0
6057980|NCT00533897|20932648|P3|Long Term Extension (LTE)|Death|0
6057981|NCT00533897|20932649|P2|Long Term Extension (LTE)|Death|0
6057982|NCT00533897|20932650|P1|Long Term Extension (LTE)|Death|0
6057983|NCT00533897|20932643|P8|Long Term Extension (LTE)|Participant Withdrew Consent|5
6057984|NCT00533897|20932644|P7|Long Term Extension (LTE)|Participant Withdrew Consent|2
6057985|NCT00533897|20932645|P6|Long Term Extension (LTE)|Participant Withdrew Consent|0
6057986|NCT00533897|20932646|P5|Long Term Extension (LTE)|Participant Withdrew Consent|0
6057987|NCT00533897|20932647|P4|Long Term Extension (LTE)|Participant Withdrew Consent|0
6057988|NCT00533897|20932648|P3|Long Term Extension (LTE)|Participant Withdrew Consent|0
6057989|NCT00533897|20932649|P2|Long Term Extension (LTE)|Participant Withdrew Consent|0
6057990|NCT00533897|20932650|P1|Long Term Extension (LTE)|Participant Withdrew Consent|0
6057991|NCT00533897|20932643|P8|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
6057992|NCT00533897|20932644|P7|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
6057993|NCT00533897|20932645|P6|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|1
6057994|NCT00533897|20932646|P5|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
6057995|NCT00533897|20932647|P4|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
6057996|NCT00533897|20932648|P3|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
6057997|NCT00533897|20932649|P2|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
6057998|NCT00533897|20932650|P1|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
6057999|NCT00533897|20932643|P8|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
6058000|NCT00533897|20932644|P7|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
6058001|NCT00533897|20932645|P6|Re-introduction (RI) Period 3|Participant Withdrew Consent|1
6058002|NCT00533897|20932646|P5|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
6058003|NCT00533897|20932647|P4|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
6058004|NCT00533897|20932648|P3|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
6058005|NCT00533897|20932649|P2|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
6058006|NCT00533897|20932650|P1|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
6058007|NCT00533897|20932643|P8|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
6058008|NCT00533897|20932644|P7|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
6058009|NCT00533897|20932645|P6|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
6058010|NCT00533897|20932646|P5|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
6058011|NCT00533897|20932647|P4|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
6058012|NCT00533897|20932648|P3|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|1
6058013|NCT00533897|20932649|P2|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
6058014|NCT00533897|20932650|P1|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
6058015|NCT00533897|20932643|P8|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
6058016|NCT00533897|20932644|P7|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
6058017|NCT00533897|20932645|P6|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
6058018|NCT00533897|20932646|P5|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
6058019|NCT00533897|20932647|P4|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
6058020|NCT00533897|20932648|P3|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|2
6058021|NCT00533897|20932649|P2|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|1
6058022|NCT00533897|20932650|P1|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
6058023|NCT00533897|20932643|P8|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
6058024|NCT00533897|20932644|P7|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
6058025|NCT00533897|20932645|P6|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
6058026|NCT00533897|20932646|P5|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
6058027|NCT00533897|20932647|P4|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
6058028|NCT00533897|20932648|P3|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
6058029|NCT00533897|20932649|P2|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
6058030|NCT00533897|20932650|P1|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|1
6058031|NCT00533897|20932643|P8|Lead-in (LI) Period 1|Lack of Efficacy|0
6058032|NCT00533897|20932644|P7|Lead-in (LI) Period 1|Lack of Efficacy|0
6058033|NCT00533897|20932645|P6|Lead-in (LI) Period 1|Lack of Efficacy|0
6058034|NCT00533897|20932646|P5|Lead-in (LI) Period 1|Lack of Efficacy|0
6058035|NCT00533897|20932647|P4|Lead-in (LI) Period 1|Lack of Efficacy|0
6058036|NCT00533897|20932648|P3|Lead-in (LI) Period 1|Lack of Efficacy|0
6058037|NCT00533897|20932649|P2|Lead-in (LI) Period 1|Lack of Efficacy|0
6058038|NCT00533897|20932650|P1|Lead-in (LI) Period 1|Lack of Efficacy|3
6058039|NCT00533897|20932643|P8|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
6058040|NCT00533897|20932644|P7|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
6058041|NCT00533897|20932645|P6|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
6058042|NCT00533897|20932646|P5|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
6058043|NCT00533897|20932647|P4|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
6058044|NCT00533897|20932648|P3|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
6058045|NCT00533897|20932649|P2|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
6058046|NCT00533897|20932650|P1|Lead-in (LI) Period 1|Administrative Reason By Sponsor|2
6058047|NCT00533897|20932643|P8|Lead-in (LI) Period 1|Lost to Follow-up|0
6058048|NCT00533897|20932644|P7|Lead-in (LI) Period 1|Lost to Follow-up|0
6058049|NCT00533897|20932645|P6|Lead-in (LI) Period 1|Lost to Follow-up|0
6058050|NCT00533897|20932646|P5|Lead-in (LI) Period 1|Lost to Follow-up|0
6058051|NCT00533897|20932647|P4|Lead-in (LI) Period 1|Lost to Follow-up|0
6058052|NCT00533897|20932648|P3|Lead-in (LI) Period 1|Lost to Follow-up|0
6058053|NCT00533897|20932649|P2|Lead-in (LI) Period 1|Lost to Follow-up|0
6058054|NCT00533897|20932650|P1|Lead-in (LI) Period 1|Lost to Follow-up|1
6058055|NCT00533897|20932643|P8|Lead-in (LI) Period 1|Participant Withdrew Consent|0
6058056|NCT00533897|20932644|P7|Lead-in (LI) Period 1|Participant Withdrew Consent|0
6058057|NCT00533897|20932645|P6|Lead-in (LI) Period 1|Participant Withdrew Consent|0
6058058|NCT00533897|20932646|P5|Lead-in (LI) Period 1|Participant Withdrew Consent|0
6058059|NCT00533897|20932647|P4|Lead-in (LI) Period 1|Participant Withdrew Consent|0
6058060|NCT00533897|20932648|P3|Lead-in (LI) Period 1|Participant Withdrew Consent|0
6058061|NCT00533897|20932649|P2|Lead-in (LI) Period 1|Participant Withdrew Consent|0
6058062|NCT00533897|20932650|P1|Lead-in (LI) Period 1|Participant Withdrew Consent|2
6058063|NCT00533897|20932643|P8|Lead-in (LI) Period 1|Adverse Event|0
6058064|NCT00533897|20932644|P7|Lead-in (LI) Period 1|Adverse Event|0
6058065|NCT00533897|20932645|P6|Lead-in (LI) Period 1|Adverse Event|0
6058066|NCT00533897|20932646|P5|Lead-in (LI) Period 1|Adverse Event|0
6058067|NCT00533897|20932647|P4|Lead-in (LI) Period 1|Adverse Event|0
6058068|NCT00533897|20932648|P3|Lead-in (LI) Period 1|Adverse Event|0
6058069|NCT00533897|20932649|P2|Lead-in (LI) Period 1|Adverse Event|0
6058070|NCT00533897|20932650|P1|Lead-in (LI) Period 1|Adverse Event|1
6058071|NCT00533845|20932790|P2|Overall Study|Physician Decision|0
6058072|NCT00533845|20932791|P1|Overall Study|Physician Decision|1
6058073|NCT00533702|20932799|P2|Overall Study|Found ineligible after randomization|1
6058074|NCT00533702|20932800|P1|Overall Study|Found ineligible after randomization|2
6058075|NCT00533702|20932799|P2|Overall Study|Withdrawal by Subject|1
6058076|NCT00533702|20932800|P1|Overall Study|Withdrawal by Subject|3
6058077|NCT00533507|20932831|P1|Overall Study|Withdrawal by Subject|1
6058078|NCT00533273|20932876|P2|Open-label|Withdrawal by Subject|0
6058079|NCT00533273|20932877|P1|Open-label|Withdrawal by Subject|6
6058080|NCT00533273|20932876|P2|Double-blind|Withdrew consent|2
6058081|NCT00533273|20932877|P1|Double-blind|Withdrew consent|0
6058082|NCT00532948|20932928|P3|Overall Study|Failure to return|0
6058083|NCT00532948|20932929|P2|Overall Study|Failure to return|1
6058084|NCT00532948|20932930|P1|Overall Study|Failure to return|0
6058085|NCT00532948|20932928|P3|Overall Study|Violation of selection criteria at entry|0
6058086|NCT00532948|20932929|P2|Overall Study|Violation of selection criteria at entry|1
6058087|NCT00532948|20932930|P1|Overall Study|Violation of selection criteria at entry|0
6058088|NCT00532948|20932928|P3|Overall Study|Death|4
6058089|NCT00532948|20932929|P2|Overall Study|Death|3
6058090|NCT00532948|20932930|P1|Overall Study|Death|3
6058091|NCT00532948|20932928|P3|Overall Study|Protocol Violation|0
6058092|NCT00532948|20932929|P2|Overall Study|Protocol Violation|0
6058093|NCT00532948|20932930|P1|Overall Study|Protocol Violation|1
6058094|NCT00532935|20932962|P2|Overall Study|Protocol Specific Criteria|15
6058095|NCT00532935|20932963|P1|Overall Study|Protocol Specific Criteria|11
6058096|NCT00532935|20932962|P2|Overall Study|Withdrawal by Subject|9
6058097|NCT00532935|20932963|P1|Overall Study|Withdrawal by Subject|10
6058098|NCT00532935|20932962|P2|Overall Study|Protocol Violation|2
6058099|NCT00532935|20932963|P1|Overall Study|Protocol Violation|4
6058100|NCT00532935|20932962|P2|Overall Study|Pregnancy|0
6058101|NCT00532935|20932963|P1|Overall Study|Pregnancy|1
6058102|NCT00532935|20932962|P2|Overall Study|Physician Decision|5
6058103|NCT00532935|20932963|P1|Overall Study|Physician Decision|4
6058104|NCT00532935|20932962|P2|Overall Study|Lost to Follow-up|6
6058105|NCT00532935|20932963|P1|Overall Study|Lost to Follow-up|10
6058106|NCT00532935|20932962|P2|Overall Study|Lack of Efficacy|3
6058107|NCT00532935|20932963|P1|Overall Study|Lack of Efficacy|0
6058108|NCT00532935|20932962|P2|Overall Study|Adverse Event|12
6058109|NCT00532935|20932963|P1|Overall Study|Adverse Event|11
6058110|NCT00532883|20932981|P4|Overall Study|Early Study Termination|4
6058111|NCT00532883|20932982|P3|Overall Study|Early Study Termination|1
6058112|NCT00532883|20932983|P2|Overall Study|Early Study Termination|4
6058113|NCT00532883|20932984|P1|Overall Study|Early Study Termination|4
6058114|NCT00532883|20932981|P4|Overall Study|Subject was Nonadherent|0
6058115|NCT00532883|20932982|P3|Overall Study|Subject was Nonadherent|1
6058116|NCT00532883|20932983|P2|Overall Study|Subject was Nonadherent|1
6058117|NCT00532883|20932984|P1|Overall Study|Subject was Nonadherent|0
6058118|NCT00532883|20932981|P4|Overall Study|Withdrawal by Subject|0
6058119|NCT00532883|20932982|P3|Overall Study|Withdrawal by Subject|1
6058120|NCT00532883|20932983|P2|Overall Study|Withdrawal by Subject|1
6058121|NCT00532883|20932984|P1|Overall Study|Withdrawal by Subject|0
6058122|NCT00532883|20932981|P4|Overall Study|Lost to Follow-up|0
6058123|NCT00532883|20932982|P3|Overall Study|Lost to Follow-up|1
6058124|NCT00532883|20932983|P2|Overall Study|Lost to Follow-up|1
6058125|NCT00532883|20932984|P1|Overall Study|Lost to Follow-up|1
6058126|NCT00532883|20932981|P4|Overall Study|Adverse Event|1
6058127|NCT00532883|20932982|P3|Overall Study|Adverse Event|0
6058128|NCT00532883|20932983|P2|Overall Study|Adverse Event|0
6058129|NCT00532883|20932984|P1|Overall Study|Adverse Event|1
6058130|NCT00532779|20932997|P3|Overall Study|Drug noncompliance, moved, other|29
6058131|NCT00532779|20932998|P2|Overall Study|Drug noncompliance, moved, other|23
6058132|NCT00532779|20932999|P1|Overall Study|Drug noncompliance, moved, other|14
6058133|NCT00532779|20932997|P3|Overall Study|Death|0
6058134|NCT00532779|20932998|P2|Overall Study|Death|1
6058135|NCT00532779|20932999|P1|Overall Study|Death|0
6058136|NCT00532779|20932997|P3|Overall Study|Pregnancy|3
6058137|NCT00532779|20932998|P2|Overall Study|Pregnancy|5
6058138|NCT00532779|20932999|P1|Overall Study|Pregnancy|2
6058139|NCT00532779|20932997|P3|Overall Study|Protocol Violation|7
6058140|NCT00532779|20932998|P2|Overall Study|Protocol Violation|9
6058141|NCT00532779|20932999|P1|Overall Study|Protocol Violation|5
6058142|NCT00532779|20932997|P3|Overall Study|Lack of Efficacy|40
6058143|NCT00532779|20932998|P2|Overall Study|Lack of Efficacy|12
6058144|NCT00532779|20932999|P1|Overall Study|Lack of Efficacy|12
6058145|NCT00532779|20932997|P3|Overall Study|Withdrawal by Subject|90
6058146|NCT00532779|20932998|P2|Overall Study|Withdrawal by Subject|60
6058147|NCT00532779|20932999|P1|Overall Study|Withdrawal by Subject|63
6058148|NCT00532779|20932997|P3|Overall Study|Lost to Follow-up|66
6058149|NCT00532779|20932998|P2|Overall Study|Lost to Follow-up|65
6058150|NCT00532779|20932999|P1|Overall Study|Lost to Follow-up|76
6058151|NCT00532779|20932997|P3|Overall Study|Adverse Event|56
6058152|NCT00532779|20932998|P2|Overall Study|Adverse Event|112
6058153|NCT00532779|20932999|P1|Overall Study|Adverse Event|122
6058154|NCT00532493|20933060|P2|Overall Study|Contraindicative Medication|0
6058155|NCT00532493|20933061|P1|Overall Study|Contraindicative Medication|1
6058156|NCT00532493|20933060|P2|Overall Study|Subject Moved Away|1
6058157|NCT00532493|20933061|P1|Overall Study|Subject Moved Away|3
6058158|NCT00532493|20933060|P2|Overall Study|Protocol Deviation|0
6058159|NCT00532493|20933061|P1|Overall Study|Protocol Deviation|1
6058160|NCT00532493|20933060|P2|Overall Study|Adverse Event|5
6058161|NCT00532493|20933061|P1|Overall Study|Adverse Event|6
6058162|NCT00532493|20933060|P2|Overall Study|Physician Decision|6
6058163|NCT00532493|20933061|P1|Overall Study|Physician Decision|1
6058164|NCT00532493|20933060|P2|Overall Study|Withdrawal by Subject|9
6058165|NCT00532493|20933061|P1|Overall Study|Withdrawal by Subject|7
6058166|NCT00532493|20933060|P2|Overall Study|Lost to Follow-up|7
6058167|NCT00532493|20933061|P1|Overall Study|Lost to Follow-up|10
6058168|NCT00532493|20933060|P2|Overall Study|Death|1
6058169|NCT00532493|20933061|P1|Overall Study|Death|1
6058170|NCT00532441|20933095|P2|Overall Study|Death|0
6058171|NCT00532441|20933096|P1|Overall Study|Death|1
6058172|NCT00532298|20933111|P6|Overall Study|Lost to Follow-up|1
6058173|NCT00532298|20933112|P5|Overall Study|Lost to Follow-up|0
6058174|NCT00532298|20933113|P4|Overall Study|Lost to Follow-up|0
6058175|NCT00532298|20933114|P3|Overall Study|Lost to Follow-up|1
6058176|NCT00532298|20933115|P2|Overall Study|Lost to Follow-up|1
6058177|NCT00532298|20933116|P1|Overall Study|Lost to Follow-up|1
6058178|NCT00532298|20933111|P6|Overall Study|Adverse Event|1
6058179|NCT00532298|20933112|P5|Overall Study|Adverse Event|1
6058180|NCT00532298|20933113|P4|Overall Study|Adverse Event|0
6058181|NCT00532298|20933114|P3|Overall Study|Adverse Event|0
6058182|NCT00532298|20933115|P2|Overall Study|Adverse Event|0
6058183|NCT00532298|20933116|P1|Overall Study|Adverse Event|1
6058184|NCT00532259|20933196|P1|Overall Study|Protocol Violation|1
6058185|NCT00532259|20933196|P1|Overall Study|Physician Decision|3
6058186|NCT00532259|20933196|P1|Overall Study|Lost to Follow-up|3
6058187|NCT00532259|20933196|P1|Overall Study|Lack of Efficacy|21
6058188|NCT00532259|20933196|P1|Overall Study|Death|1
6058189|NCT00532259|20933196|P1|Overall Study|Adverse Event|1
6058190|NCT00532259|20933196|P1|Overall Study|Withdrawal by Subject|2
6058191|NCT00532155|20933203|P2|Overall Study|Did not receive study medication|6
6058192|NCT00532155|20933204|P1|Overall Study|Did not receive study medication|2
6058193|NCT00532155|20933203|P2|Overall Study|Study termination stop further treatment|0
6058194|NCT00532155|20933204|P1|Overall Study|Study termination stop further treatment|4
6058195|NCT00532155|20933203|P2|Overall Study|Study terminated by sponsor|0
6058196|NCT00532155|20933204|P1|Overall Study|Study terminated by sponsor|1
6058197|NCT00532155|20933203|P2|Overall Study|Study stopped|0
6058198|NCT00532155|20933204|P1|Overall Study|Study stopped|1
6058199|NCT00532155|20933203|P2|Overall Study|Had brain metastasis, was mis-randomized|0
6058200|NCT00532155|20933204|P1|Overall Study|Had brain metastasis, was mis-randomized|1
6058201|NCT00532155|20933203|P2|Overall Study|Progressive disease (by incorrect scan)|1
6058202|NCT00532155|20933204|P1|Overall Study|Progressive disease (by incorrect scan)|0
6058203|NCT00532155|20933203|P2|Overall Study|Promotor ended study|0
6058204|NCT00532155|20933204|P1|Overall Study|Promotor ended study|1
6058205|NCT00532155|20933203|P2|Overall Study|Occurence of a secondary cancer|1
6058206|NCT00532155|20933204|P1|Overall Study|Occurence of a secondary cancer|0
6058207|NCT00532155|20933203|P2|Overall Study|Occurence of a second cancer|1
6058208|NCT00532155|20933204|P1|Overall Study|Occurence of a second cancer|0
6058209|NCT00532155|20933203|P2|Overall Study|Pre-existing brain metastasis (by MRI)|0
6058210|NCT00532155|20933204|P1|Overall Study|Pre-existing brain metastasis (by MRI)|1
6058211|NCT00532155|20933203|P2|Overall Study|Moved|0
6058212|NCT00532155|20933204|P1|Overall Study|Moved|1
6058213|NCT00532155|20933203|P2|Overall Study|Consent withdrawn|7
6058214|NCT00532155|20933204|P1|Overall Study|Consent withdrawn|5
6058215|NCT00532155|20933203|P2|Overall Study|Withdrawal by Subject|44
6058216|NCT00532155|20933204|P1|Overall Study|Withdrawal by Subject|23
6058217|NCT00532155|20933203|P2|Overall Study|Physician Decision|15
6058218|NCT00532155|20933204|P1|Overall Study|Physician Decision|16
6058219|NCT00532155|20933203|P2|Overall Study|Lost to Follow-up|0
6058220|NCT00532155|20933204|P1|Overall Study|Lost to Follow-up|2
6058221|NCT00532155|20933203|P2|Overall Study|Protocol Violation|3
6058222|NCT00532155|20933204|P1|Overall Study|Protocol Violation|1
6058223|NCT00532155|20933203|P2|Overall Study|Lack of Efficacy|255
6058224|NCT00532155|20933204|P1|Overall Study|Lack of Efficacy|332
6058225|NCT00532155|20933203|P2|Overall Study|Adverse Event|123
6058226|NCT00532155|20933204|P1|Overall Study|Adverse Event|66
6058227|NCT00532129|20933218|P1|Follow-up Period|Other|6
6058228|NCT00532129|20933218|P1|Follow-up Period|Lost to Follow-up|1
6058229|NCT00532129|20933218|P1|Follow-up Period|Disease progression|57
6058230|NCT00532129|20933218|P1|Follow-up Period|Adverse event/Serious adverse event|1
6058231|NCT00532129|20933218|P1|Treatment Period|Other|5
6058232|NCT00532129|20933218|P1|Treatment Period|Protocol Violation|1
6058233|NCT00532129|20933218|P1|Treatment Period|Disease progression|3
6058234|NCT00532129|20933218|P1|Treatment Period|Physician Decision|15
6058235|NCT00532129|20933218|P1|Treatment Period|Adverse event/Serious adverse event|25
6058236|NCT00531960|20933238|P2|Overall Study|Other|10
6058237|NCT00531960|20933239|P1|Overall Study|Other|4
6058238|NCT00531960|20933238|P2|Overall Study|Refused Treatment|6
6058239|NCT00531960|20933239|P1|Overall Study|Refused Treatment|5
6058240|NCT00531960|20933238|P2|Overall Study|Violation of Selection Criteria|0
6058241|NCT00531960|20933239|P1|Overall Study|Violation of Selection Criteria|2
6058242|NCT00531960|20933238|P2|Overall Study|Lack of Efficacy|41
6058243|NCT00531960|20933239|P1|Overall Study|Lack of Efficacy|42
6058244|NCT00531960|20933238|P2|Overall Study|Death|2
6058245|NCT00531960|20933239|P1|Overall Study|Death|3
6058246|NCT00531960|20933238|P2|Overall Study|Adverse Event|4
6058247|NCT00531960|20933239|P1|Overall Study|Adverse Event|5
6058248|NCT00531947|20933257|P2|Overall Study|Other (e.g., Lack of Efficacy)|5
6058249|NCT00531947|20933258|P1|Overall Study|Other (e.g., Lack of Efficacy)|5
6058250|NCT00531947|20933257|P2|Overall Study|Non-Compliance|7
6058251|NCT00531947|20933258|P1|Overall Study|Non-Compliance|4
6058252|NCT00531947|20933257|P2|Overall Study|Protocol Violation|1
6058253|NCT00531947|20933258|P1|Overall Study|Protocol Violation|2
6058254|NCT00531947|20933257|P2|Overall Study|Withdrawal by Subject|19
6058255|NCT00531947|20933258|P1|Overall Study|Withdrawal by Subject|14
6058256|NCT00531947|20933257|P2|Overall Study|Lost to Follow-up|9
6058257|NCT00531947|20933258|P1|Overall Study|Lost to Follow-up|12
6058258|NCT00531947|20933257|P2|Overall Study|Adverse Event|10
6058259|NCT00531947|20933258|P1|Overall Study|Adverse Event|5
6058260|NCT00531934|20933302|P2|Overall Study|Other|2
6058261|NCT00531934|20933303|P1|Overall Study|Other|2
6058262|NCT00531934|20933302|P2|Overall Study|Withdrawal by Subject|1
6058263|NCT00531934|20933303|P1|Overall Study|Withdrawal by Subject|1
6058264|NCT00531934|20933302|P2|Overall Study|Death|10
6058265|NCT00531934|20933303|P1|Overall Study|Death|7
6058266|NCT00531934|20933302|P2|Overall Study|Progression|42
6058267|NCT00531934|20933303|P1|Overall Study|Progression|52
6058268|NCT00531934|20933302|P2|Overall Study|Adverse Event|8
6058269|NCT00531934|20933303|P1|Overall Study|Adverse Event|4
6058270|NCT00531752|20933431|P4|Second Double-blind Intervention Period|Lost to Follow-up|1
6058271|NCT00531752|20933432|P3|Second Double-blind Intervention Period|Lost to Follow-up|0
6058272|NCT00531752|20933433|P2|Second Double-blind Intervention Period|Lost to Follow-up|0
6058273|NCT00531752|20933434|P1|Second Double-blind Intervention Period|Lost to Follow-up|0
6058274|NCT00531752|20933431|P4|Second Double-blind Intervention Period|Withdrawal by Subject|1
6058275|NCT00531752|20933432|P3|Second Double-blind Intervention Period|Withdrawal by Subject|0
6058276|NCT00531752|20933433|P2|Second Double-blind Intervention Period|Withdrawal by Subject|0
6058277|NCT00531752|20933434|P1|Second Double-blind Intervention Period|Withdrawal by Subject|0
6058278|NCT00531752|20933431|P4|Second Double-blind Intervention Period|Other|0
6058279|NCT00531752|20933432|P3|Second Double-blind Intervention Period|Other|0
6058280|NCT00531752|20933433|P2|Second Double-blind Intervention Period|Other|1
6058281|NCT00531752|20933434|P1|Second Double-blind Intervention Period|Other|1
6058282|NCT00531752|20933431|P4|Second Double-blind Intervention Period|Adverse Event|0
6058283|NCT00531752|20933432|P3|Second Double-blind Intervention Period|Adverse Event|0
6058284|NCT00531752|20933433|P2|Second Double-blind Intervention Period|Adverse Event|1
6058285|NCT00531752|20933434|P1|Second Double-blind Intervention Period|Adverse Event|1
6058286|NCT00531752|20933431|P4|First Double-blind Intervention Period|Randomized but not treated|0
6058287|NCT00531752|20933432|P3|First Double-blind Intervention Period|Randomized but not treated|0
6058288|NCT00531752|20933433|P2|First Double-blind Intervention Period|Randomized but not treated|0
6058289|NCT00531752|20933434|P1|First Double-blind Intervention Period|Randomized but not treated|1
6058290|NCT00531752|20933431|P4|First Double-blind Intervention Period|Lost to Follow-up|1
6058291|NCT00531752|20933432|P3|First Double-blind Intervention Period|Lost to Follow-up|1
6058292|NCT00531752|20933433|P2|First Double-blind Intervention Period|Lost to Follow-up|0
6058293|NCT00531752|20933434|P1|First Double-blind Intervention Period|Lost to Follow-up|0
6058294|NCT00531752|20933431|P4|First Double-blind Intervention Period|Withdrawal by Subject|1
6058295|NCT00531752|20933432|P3|First Double-blind Intervention Period|Withdrawal by Subject|1
6058296|NCT00531752|20933433|P2|First Double-blind Intervention Period|Withdrawal by Subject|0
6058297|NCT00531752|20933434|P1|First Double-blind Intervention Period|Withdrawal by Subject|2
6058298|NCT00531752|20933431|P4|First Double-blind Intervention Period|Other|0
6058299|NCT00531752|20933432|P3|First Double-blind Intervention Period|Other|4
6058300|NCT00531752|20933433|P2|First Double-blind Intervention Period|Other|4
6058301|NCT00531752|20933434|P1|First Double-blind Intervention Period|Other|1
6058302|NCT00531752|20933431|P4|First Double-blind Intervention Period|Adverse Event|1
6058303|NCT00531752|20933432|P3|First Double-blind Intervention Period|Adverse Event|1
6058304|NCT00531752|20933433|P2|First Double-blind Intervention Period|Adverse Event|0
6058305|NCT00531752|20933434|P1|First Double-blind Intervention Period|Adverse Event|2
6058306|NCT00531479|20933545|P2|Overall Study|Did not receive treatment|3
6058307|NCT00531479|20933546|P1|Overall Study|Did not receive treatment|2
6058308|NCT00531479|20933545|P2|Overall Study|Withdrawal by Subject|6
6058309|NCT00531479|20933546|P1|Overall Study|Withdrawal by Subject|6
6058310|NCT00531479|20933545|P2|Overall Study|Other|1
6058311|NCT00531479|20933546|P1|Overall Study|Other|0
6058312|NCT00531479|20933545|P2|Overall Study|Lost to Follow-up|2
6058313|NCT00531479|20933546|P1|Overall Study|Lost to Follow-up|0
6058314|NCT00531479|20933545|P2|Overall Study|Death|71
6058315|NCT00531479|20933546|P1|Overall Study|Death|68
6058316|NCT00531427|20933577|P2|Overall Study|Administrative|9
6058317|NCT00531427|20933578|P1|Overall Study|Administrative|4
6058318|NCT00531427|20933577|P2|Overall Study|Lack of Efficacy|39
6058319|NCT00531427|20933578|P1|Overall Study|Lack of Efficacy|14
6058320|NCT00531427|20933577|P2|Overall Study|Lost to Follow-up|3
6058321|NCT00531427|20933578|P1|Overall Study|Lost to Follow-up|4
6058322|NCT00531427|20933577|P2|Overall Study|Adverse Event|30
6058323|NCT00531427|20933578|P1|Overall Study|Adverse Event|44
6058324|NCT00531427|20933577|P2|Overall Study|Withdrawal by Subject|13
6058325|NCT00531427|20933578|P1|Overall Study|Withdrawal by Subject|7
6058326|NCT00531284|20933606|P17|Overall Study|Other|0
6058327|NCT00531284|20933607|P16|Overall Study|Other|0
6058328|NCT00531284|20933608|P15|Overall Study|Other|1
6058329|NCT00531284|20933609|P14|Overall Study|Other|0
6058330|NCT00531284|20933610|P13|Overall Study|Other|0
6058331|NCT00531284|20933611|P12|Overall Study|Other|2
6058332|NCT00531284|20933612|P11|Overall Study|Other|0
6058333|NCT00531284|20933613|P10|Overall Study|Other|1
6058334|NCT00531284|20933614|P9|Overall Study|Other|2
6058335|NCT00531284|20933615|P8|Overall Study|Other|0
6058336|NCT00531284|20933616|P7|Overall Study|Other|0
6058337|NCT00531284|20933617|P6|Overall Study|Other|1
6058338|NCT00531284|20933618|P5|Overall Study|Other|2
6058339|NCT00531284|20933619|P4|Overall Study|Other|10
6058340|NCT00531284|20933620|P3|Overall Study|Other|0
6058341|NCT00531284|20933621|P2|Overall Study|Other|0
6058342|NCT00531284|20933622|P1|Overall Study|Other|1
6058343|NCT00531284|20933606|P17|Overall Study|Withdrawal by Subject|1
6058344|NCT00531284|20933607|P16|Overall Study|Withdrawal by Subject|1
6058345|NCT00531284|20933608|P15|Overall Study|Withdrawal by Subject|0
6058346|NCT00531284|20933609|P14|Overall Study|Withdrawal by Subject|1
6058347|NCT00531284|20933610|P13|Overall Study|Withdrawal by Subject|0
6058348|NCT00531284|20933611|P12|Overall Study|Withdrawal by Subject|3
6058349|NCT00531284|20933612|P11|Overall Study|Withdrawal by Subject|0
6058350|NCT00531284|20933613|P10|Overall Study|Withdrawal by Subject|0
6058351|NCT00531284|20933614|P9|Overall Study|Withdrawal by Subject|0
6058352|NCT00531284|20933615|P8|Overall Study|Withdrawal by Subject|0
6058353|NCT00531284|20933616|P7|Overall Study|Withdrawal by Subject|0
6058354|NCT00531284|20933617|P6|Overall Study|Withdrawal by Subject|0
6058355|NCT00531284|20933618|P5|Overall Study|Withdrawal by Subject|0
6058356|NCT00531284|20933619|P4|Overall Study|Withdrawal by Subject|4
6058357|NCT00531284|20933620|P3|Overall Study|Withdrawal by Subject|0
6058358|NCT00531284|20933621|P2|Overall Study|Withdrawal by Subject|0
6058359|NCT00531284|20933622|P1|Overall Study|Withdrawal by Subject|1
6058360|NCT00531284|20933606|P17|Overall Study|Adverse Event|2
6058361|NCT00531284|20933607|P16|Overall Study|Adverse Event|0
6058362|NCT00531284|20933608|P15|Overall Study|Adverse Event|1
6058363|NCT00531284|20933609|P14|Overall Study|Adverse Event|1
6058364|NCT00531284|20933610|P13|Overall Study|Adverse Event|0
6058365|NCT00531284|20933611|P12|Overall Study|Adverse Event|5
6058366|NCT00531284|20933612|P11|Overall Study|Adverse Event|0
6058367|NCT00531284|20933613|P10|Overall Study|Adverse Event|0
6058368|NCT00531284|20933614|P9|Overall Study|Adverse Event|3
6058369|NCT00531284|20933615|P8|Overall Study|Adverse Event|2
6058370|NCT00531284|20933616|P7|Overall Study|Adverse Event|3
6058371|NCT00531284|20933617|P6|Overall Study|Adverse Event|2
6058372|NCT00531284|20933618|P5|Overall Study|Adverse Event|0
6058373|NCT00531284|20933619|P4|Overall Study|Adverse Event|7
6058374|NCT00531284|20933620|P3|Overall Study|Adverse Event|1
6058375|NCT00531284|20933621|P2|Overall Study|Adverse Event|1
6058376|NCT00531284|20933622|P1|Overall Study|Adverse Event|0
6058377|NCT00531284|20933606|P17|Overall Study|Progressive Disease|5
6058378|NCT00531284|20933607|P16|Overall Study|Progressive Disease|11
6058379|NCT00531284|20933608|P15|Overall Study|Progressive Disease|2
6058380|NCT00531284|20933609|P14|Overall Study|Progressive Disease|1
6058381|NCT00531284|20933610|P13|Overall Study|Progressive Disease|2
6058382|NCT00531284|20933611|P12|Overall Study|Progressive Disease|14
6058383|NCT00531284|20933612|P11|Overall Study|Progressive Disease|3
6058384|NCT00531284|20933613|P10|Overall Study|Progressive Disease|3
6058385|NCT00531284|20933614|P9|Overall Study|Progressive Disease|6
6058386|NCT00531284|20933615|P8|Overall Study|Progressive Disease|8
6058387|NCT00531284|20933616|P7|Overall Study|Progressive Disease|3
6058388|NCT00531284|20933617|P6|Overall Study|Progressive Disease|4
6058389|NCT00531284|20933618|P5|Overall Study|Progressive Disease|4
6058390|NCT00531284|20933619|P4|Overall Study|Progressive Disease|42
6058391|NCT00531284|20933620|P3|Overall Study|Progressive Disease|5
6058392|NCT00531284|20933621|P2|Overall Study|Progressive Disease|3
6058393|NCT00531284|20933622|P1|Overall Study|Progressive Disease|1
6058394|NCT00531206|20933772|P1|Overall Study|including non-related adverse events|8
6058395|NCT00531206|20933772|P1|Overall Study|Lost to Follow-up|5
6058396|NCT00531206|20933772|P1|Overall Study|Lack of Efficacy|2
6058397|NCT00531206|20933772|P1|Overall Study|Adverse Event related|5
6058398|NCT00531050|20933802|P6|Part 2: Period 3|Abnormal test procedure|1
6058399|NCT00531050|20933803|P5|Part 2: Period 3|Abnormal test procedure|0
6058400|NCT00531050|20933804|P4|Part 2: Period 3|Abnormal test procedure|0
6058401|NCT00531050|20933805|P3|Part 2: Period 3|Abnormal test procedure|0
6058402|NCT00531050|20933806|P2|Part 2: Period 3|Abnormal test procedure|0
6058403|NCT00531050|20933807|P1|Part 2: Period 3|Abnormal test procedure|1
6058404|NCT00531050|20933802|P6|Part 2: Period 1|Adverse Event|1
6058405|NCT00531050|20933803|P5|Part 2: Period 1|Adverse Event|0
6058406|NCT00531050|20933804|P4|Part 2: Period 1|Adverse Event|0
6058407|NCT00531050|20933805|P3|Part 2: Period 1|Adverse Event|0
6058408|NCT00531050|20933806|P2|Part 2: Period 1|Adverse Event|0
6058409|NCT00531050|20933807|P1|Part 2: Period 1|Adverse Event|0
6058410|NCT00531050|20933802|P6|Part 1: Period 3|Adverse Event|0
6058411|NCT00531050|20933803|P5|Part 1: Period 3|Adverse Event|0
6058412|NCT00531050|20933804|P4|Part 1: Period 3|Adverse Event|0
6058413|NCT00531050|20933805|P3|Part 1: Period 3|Adverse Event|0
6058414|NCT00531050|20933806|P2|Part 1: Period 3|Adverse Event|0
6058415|NCT00531050|20933807|P1|Part 1: Period 3|Adverse Event|1
6058416|NCT00531050|20933802|P6|Part 1: Period 1|Protocol Deviation|0
6058417|NCT00531050|20933803|P5|Part 1: Period 1|Protocol Deviation|0
6058418|NCT00531050|20933804|P4|Part 1: Period 1|Protocol Deviation|1
6058419|NCT00531050|20933805|P3|Part 1: Period 1|Protocol Deviation|0
6058420|NCT00531050|20933806|P2|Part 1: Period 1|Protocol Deviation|0
6058421|NCT00531050|20933807|P1|Part 1: Period 1|Protocol Deviation|0
6058422|NCT00531050|20933802|P6|Part 1: Period 1|Adverse Event|0
6058423|NCT00531050|20933803|P5|Part 1: Period 1|Adverse Event|0
6058424|NCT00531050|20933804|P4|Part 1: Period 1|Adverse Event|0
6058425|NCT00531050|20933805|P3|Part 1: Period 1|Adverse Event|0
6058426|NCT00531050|20933806|P2|Part 1: Period 1|Adverse Event|1
6058427|NCT00531050|20933807|P1|Part 1: Period 1|Adverse Event|0
6058428|NCT00531011|20933836|P2|Overall Study|Physician Decision|3
6058429|NCT00531011|20933837|P1|Overall Study|Physician Decision|0
6058430|NCT00531011|20933836|P2|Overall Study|Lost to Follow-up|0
6058431|NCT00531011|20933837|P1|Overall Study|Lost to Follow-up|1
6058432|NCT00531011|20933836|P2|Overall Study|Death|0
6058433|NCT00531011|20933837|P1|Overall Study|Death|1
6058434|NCT00531011|20933836|P2|Overall Study|Withdrawal by Subject|4
6058435|NCT00531011|20933837|P1|Overall Study|Withdrawal by Subject|2
6058436|NCT00530920|20933882|P3|Overall Study|Withdrawal by Subject|1
6058437|NCT00530920|20933883|P2|Overall Study|Withdrawal by Subject|0
6058438|NCT00530920|20933884|P1|Overall Study|Withdrawal by Subject|0
6058439|NCT00530920|20933882|P3|Overall Study|Adverse Event|3
6058440|NCT00530920|20933883|P2|Overall Study|Adverse Event|0
6058441|NCT00530920|20933884|P1|Overall Study|Adverse Event|0
6058442|NCT00530920|20933882|P3|Overall Study|Randomized but not treated|0
6058443|NCT00530920|20933883|P2|Overall Study|Randomized but not treated|2
6058444|NCT00530920|20933884|P1|Overall Study|Randomized but not treated|0
6058445|NCT00530894|20933944|P4|Overall Study|Alive and censored prior to 1 year|0
6058446|NCT00530894|20933945|P3|Overall Study|Alive and censored prior to 1 year|0
6058447|NCT00530894|20933946|P2|Overall Study|Alive and censored prior to 1 year|0
6058448|NCT00530894|20933947|P1|Overall Study|Alive and censored prior to 1 year|2
6058449|NCT00530894|20933944|P4|Overall Study|Withdrawal by Subject|5
6058450|NCT00530894|20933945|P3|Overall Study|Withdrawal by Subject|0
6058451|NCT00530894|20933946|P2|Overall Study|Withdrawal by Subject|23
6058452|NCT00530894|20933947|P1|Overall Study|Withdrawal by Subject|1
6058453|NCT00530894|20933944|P4|Overall Study|Lost to Follow-up|0
6058454|NCT00530894|20933945|P3|Overall Study|Lost to Follow-up|0
6058455|NCT00530894|20933946|P2|Overall Study|Lost to Follow-up|3
6058456|NCT00530894|20933947|P1|Overall Study|Lost to Follow-up|1
6058457|NCT00530894|20933944|P4|Overall Study|Death|89
6058458|NCT00530894|20933945|P3|Overall Study|Death|55
6058459|NCT00530894|20933946|P2|Overall Study|Death|89
6058460|NCT00530894|20933947|P1|Overall Study|Death|84
6058461|NCT00530855|20933975|P1|Overall Study|Other reason for premature termination|17
6058462|NCT00530855|20933975|P1|Overall Study|Lost to Follow-up|9
6058463|NCT00530855|20933975|P1|Overall Study|Unsatisfactory compliance of subject|11
6058464|NCT00530855|20933975|P1|Overall Study|Protocol Violation|3
6058465|NCT00530855|20933975|P1|Overall Study|Non Fatal Non Serious AE|12
6058466|NCT00530855|20933975|P1|Overall Study|Non Fatal Serious AE|7
6058467|NCT00530855|20933975|P1|Overall Study|Fatal Serious AE|3
6058468|NCT00530855|20933975|P1|Overall Study|Withdrawal by Subject|30
6058469|NCT00530855|20933975|P1|Overall Study|Lack of Efficacy|20
6058470|NCT00530842|20933984|P2|Period 2|Individual different reasons|0
6058471|NCT00530842|20933985|P1|Period 2|Individual different reasons|2
6058472|NCT00530842|20933984|P2|Period 2|Withdrawal by Subject|2
6058473|NCT00530842|20933985|P1|Period 2|Withdrawal by Subject|1
6058474|NCT00530842|20933984|P2|Period 2|Protocol Violation|0
6058475|NCT00530842|20933985|P1|Period 2|Protocol Violation|1
6058476|NCT00530842|20933984|P2|Period 2|Lost to Follow-up|4
6058477|NCT00530842|20933985|P1|Period 2|Lost to Follow-up|0
6058478|NCT00530842|20933984|P2|Period 2|Lack of Efficacy|0
6058479|NCT00530842|20933985|P1|Period 2|Lack of Efficacy|1
6058480|NCT00530842|20933984|P2|Period 2|Adverse Event|3
6058481|NCT00530842|20933985|P1|Period 2|Adverse Event|3
6058482|NCT00530842|20933984|P2|Period 1|Individual different reasons|3
6058483|NCT00530842|20933985|P1|Period 1|Individual different reasons|2
6058484|NCT00530842|20933984|P2|Period 1|Withdrawal by Subject|3
6058485|NCT00530842|20933985|P1|Period 1|Withdrawal by Subject|2
6058486|NCT00530842|20933984|P2|Period 1|Protocol Violation|1
6058487|NCT00530842|20933985|P1|Period 1|Protocol Violation|2
6058488|NCT00530842|20933984|P2|Period 1|Lack of Efficacy|1
6058489|NCT00530842|20933985|P1|Period 1|Lack of Efficacy|1
6058490|NCT00530842|20933984|P2|Period 1|Adverse Event|3
6058491|NCT00530842|20933985|P1|Period 1|Adverse Event|7
6058492|NCT00530842|20933984|P2|Overall Study|Individual different reasons|3
6058493|NCT00530842|20933985|P1|Overall Study|Individual different reasons|4
6058494|NCT00530842|20933984|P2|Overall Study|Withdrawal by Subject|5
6058495|NCT00530842|20933985|P1|Overall Study|Withdrawal by Subject|4
6058496|NCT00530842|20933984|P2|Overall Study|Protocol Violation|2
6058497|NCT00530842|20933985|P1|Overall Study|Protocol Violation|3
6058498|NCT00530842|20933984|P2|Overall Study|Lost to Follow-up|4
6058499|NCT00530842|20933985|P1|Overall Study|Lost to Follow-up|0
6058500|NCT00530842|20933984|P2|Overall Study|Lack of Efficacy|1
6058501|NCT00530842|20933985|P1|Overall Study|Lack of Efficacy|2
6058502|NCT00530842|20933984|P2|Overall Study|Adverse Event|6
6058503|NCT00530842|20933985|P1|Overall Study|Adverse Event|10
6058504|NCT00530816|20934112|P3|Overall Study|Withdrawal by Subject|6
6058505|NCT00530816|20934113|P2|Overall Study|Withdrawal by Subject|2
6058506|NCT00530816|20934114|P1|Overall Study|Withdrawal by Subject|1
6058507|NCT00530816|20934112|P3|Overall Study|Other|4
6058508|NCT00530816|20934113|P2|Overall Study|Other|3
6058509|NCT00530816|20934114|P1|Overall Study|Other|3
6058510|NCT00530816|20934112|P3|Overall Study|Adverse Event|7
6058511|NCT00530816|20934113|P2|Overall Study|Adverse Event|13
6058512|NCT00530816|20934114|P1|Overall Study|Adverse Event|6
6058513|NCT00530816|20934112|P3|Overall Study|Progressive Disease|24
6058514|NCT00530816|20934113|P2|Overall Study|Progressive Disease|24
6058515|NCT00530816|20934114|P1|Overall Study|Progressive Disease|16
6058516|NCT00530790|20934157|P1|Overall Study|Physician Decision|1
6058517|NCT00530790|20934157|P1|Overall Study|Withdrawal by Subject|2
6058518|NCT00530790|20934157|P1|Overall Study|Adverse Event|2
6058519|NCT00530777|20934179|P2|Overall Study|Unable to adhere to visit schedule|1
6058520|NCT00530777|20934180|P1|Overall Study|Unable to adhere to visit schedule|5
6058521|NCT00530777|20934179|P2|Overall Study|Withdrawal by Subject|1
6058522|NCT00530777|20934180|P1|Overall Study|Withdrawal by Subject|0
6058523|NCT00530777|20934179|P2|Overall Study|Physician Decision|0
6058524|NCT00530777|20934180|P1|Overall Study|Physician Decision|1
6058525|NCT00530777|20934179|P2|Overall Study|Death|2
6058526|NCT00530777|20934180|P1|Overall Study|Death|1
6058527|NCT00530777|20934179|P2|Overall Study|Lost to Follow-up|1
6058528|NCT00530777|20934180|P1|Overall Study|Lost to Follow-up|0
6058529|NCT00530712|20934237|P1|12 Month Follow-up Visit|Death|9
6058530|NCT00530712|20934237|P1|12 Month Follow-up Visit|Lost to Follow-up|7
6058531|NCT00530712|20934237|P1|12 Month Follow-up Visit|Missed Visit|3
6058532|NCT00530712|20934237|P1|12 Month Follow-up Visit|Withdrawal by Subject|5
6058533|NCT00530712|20934237|P1|6 Month Follow-up Visit|Death|2
6058534|NCT00530712|20934237|P1|6 Month Follow-up Visit|Lost to Follow-up|3
6058535|NCT00530712|20934237|P1|6 Month Follow-up Visit|Missed Visit|3
6058536|NCT00530712|20934237|P1|6 Month Follow-up Visit|Withdrawal by Subject|4
6058537|NCT00530712|20934237|P1|30 Day Follow-up Visit|Missed Visit|5
6058538|NCT00530712|20934237|P1|30 Day Follow-up Visit|Withdrawal by Subject|2
6058539|NCT00530621|20934260|P2|Overall Study|Not Treated Due to PD Prior to Dosing|0
6058540|NCT00530621|20934261|P1|Overall Study|Not Treated Due to PD Prior to Dosing|1
6058541|NCT00530621|20934260|P2|Overall Study|Death|6
6058542|NCT00530621|20934261|P1|Overall Study|Death|3
6058543|NCT00530621|20934260|P2|Overall Study|Subject Decision|7
6058544|NCT00530621|20934261|P1|Overall Study|Subject Decision|4
6058545|NCT00530621|20934260|P2|Overall Study|Sponsor Decision|15
6058546|NCT00530621|20934261|P1|Overall Study|Sponsor Decision|12
6058547|NCT00530621|20934260|P2|Overall Study|Progressive Disease (PD)|40
6058548|NCT00530621|20934261|P1|Overall Study|Progressive Disease (PD)|47
6058549|NCT00530621|20934260|P2|Overall Study|Physician Decision|4
6058550|NCT00530621|20934261|P1|Overall Study|Physician Decision|2
6058551|NCT00530621|20934260|P2|Overall Study|Adverse Event|8
6058552|NCT00530621|20934261|P1|Overall Study|Adverse Event|11
6058553|NCT00530504|20934282|P1|Overall Study|Exited study due to other reasons|33
6058554|NCT00530504|20934282|P1|Overall Study|Withdrawal by Subject|39
6058555|NCT00530504|20934282|P1|Overall Study|Lost to Follow-up|26
6058556|NCT00530504|20934282|P1|Overall Study|Death|54
6058557|NCT00530439|20934288|P2|Overall Study|Severe malformation/abortion|3
6058558|NCT00530439|20934289|P1|Overall Study|Severe malformation/abortion|0
6058559|NCT00530439|20934288|P2|Overall Study|Twin pregnancy|2
6058560|NCT00530439|20934289|P1|Overall Study|Twin pregnancy|0
6058561|NCT00530439|20934288|P2|Overall Study|Misclassification|0
6058562|NCT00530439|20934289|P1|Overall Study|Misclassification|2
6058563|NCT00530439|20934288|P2|Overall Study|Missed abortion|4
6058564|NCT00530439|20934289|P1|Overall Study|Missed abortion|1
6058565|NCT00530439|20934288|P2|Overall Study|Withdraw|14
6058566|NCT00530439|20934289|P1|Overall Study|Withdraw|18
6058567|NCT00530439|20934288|P2|Overall Study|GDM|3
6058568|NCT00530439|20934289|P1|Overall Study|GDM|9
6058569|NCT00530348|20934297|P2|Overall Study|Noncompliance with inclusion criterion 3|1
6058570|NCT00530348|20934298|P1|Overall Study|Noncompliance with inclusion criterion 3|0
6058571|NCT00530348|20934297|P2|Overall Study|Randomised in error|0
6058572|NCT00530348|20934298|P1|Overall Study|Randomised in error|1
6058573|NCT00530348|20934297|P2|Overall Study|Withdrawal by Subject|12
6058574|NCT00530348|20934298|P1|Overall Study|Withdrawal by Subject|12
6058575|NCT00530348|20934297|P2|Overall Study|Pregnancy|0
6058576|NCT00530348|20934298|P1|Overall Study|Pregnancy|1
6058577|NCT00530348|20934297|P2|Overall Study|Physician Decision|2
6058578|NCT00530348|20934298|P1|Overall Study|Physician Decision|1
6058579|NCT00530348|20934297|P2|Overall Study|Lost to Follow-up|2
6058580|NCT00530348|20934298|P1|Overall Study|Lost to Follow-up|0
6058581|NCT00530348|20934297|P2|Overall Study|Lack of Efficacy|0
6058582|NCT00530348|20934298|P1|Overall Study|Lack of Efficacy|2
6058583|NCT00530348|20934297|P2|Overall Study|Death|1
6058584|NCT00530348|20934298|P1|Overall Study|Death|0
6058585|NCT00530348|20934297|P2|Overall Study|Adverse Event|1
6058586|NCT00530348|20934298|P1|Overall Study|Adverse Event|5
6058587|NCT00530335|20934314|P1|Overall Study|Physician Decision|1
6058588|NCT00530335|20934314|P1|Overall Study|Withdrawal by Subject|1
6058589|NCT00530335|20934314|P1|Overall Study|Protocol Violation|1
6058590|NCT00530335|20934314|P1|Overall Study|Adverse Event|3
6058591|NCT00530270|20934331|P2|Overall Study|Protocol Violation|0
6058592|NCT00530270|20934332|P1|Overall Study|Protocol Violation|1
6058593|NCT00530257|20934346|P1|Overall Study|Lost to Follow-up|1
6058594|NCT00530218|20934374|P1|Overall Study|Death|12
6058595|NCT00530218|20934374|P1|Overall Study|CMV Not Detected|13
6058596|NCT00530088|20934381|P1|Overall Study|Other Not Specified|2
6058597|NCT00530088|20934381|P1|Overall Study|Physician Decision|4
6058598|NCT00530088|20934381|P1|Overall Study|Disease Progression|4
6058599|NCT00530075|20934386|P1|Overall Study|Withdrawal by Subject|1
6058600|NCT00530075|20934386|P1|Overall Study|Protocol Violation|1
6058601|NCT00530075|20934386|P1|Overall Study|Lack of Efficacy|3
6058602|NCT00530075|20934386|P1|Overall Study|Death|1
6058603|NCT00530075|20934386|P1|Overall Study|Adverse Event|1
6058604|NCT00530023|20934399|P2|Overall Study|Withdrawal by Subject|1
6058605|NCT00530023|20934400|P1|Overall Study|Withdrawal by Subject|0
6058606|NCT00529958|20934417|P3|5-Year Follow-up|Withdrawal by Subject|0
6058607|NCT00529958|20934418|P2|5-Year Follow-up|Withdrawal by Subject|0
6058608|NCT00529958|20934419|P1|5-Year Follow-up|Withdrawal by Subject|1
6058609|NCT00529958|20934417|P3|5-Year Follow-up|Lost to Follow-up|1
6058610|NCT00529958|20934418|P2|5-Year Follow-up|Lost to Follow-up|3
6058611|NCT00529958|20934419|P1|5-Year Follow-up|Lost to Follow-up|2
6058612|NCT00529958|20934417|P3|2-Year Follow-up|Withdrawal by Subject|0
6058613|NCT00529958|20934418|P2|2-Year Follow-up|Withdrawal by Subject|0
6058614|NCT00529958|20934419|P1|2-Year Follow-up|Withdrawal by Subject|3
6058615|NCT00529958|20934417|P3|2-Year Follow-up|Lost to Follow-up|2
6058616|NCT00529958|20934418|P2|2-Year Follow-up|Lost to Follow-up|2
6058617|NCT00529958|20934419|P1|2-Year Follow-up|Lost to Follow-up|1
6058618|NCT00529802|20934460|P1|Evaluable for Secondary Endpoint|Did not complete 2d FDG-PET scan|2
6058619|NCT00529802|20934460|P1|Evaluable for Primary Endpoint|Lost to Follow-up|1
6058620|NCT00529802|20934460|P1|Evaluable for Primary Endpoint|Lack of Efficacy|1
6058621|NCT00529802|20934460|P1|Evaluable for Primary Endpoint|Death|1
6058622|NCT00529802|20934460|P1|Evaluable for Primary Endpoint|Adverse Event|2
6058623|NCT00529802|20934460|P1|Evaluable for Primary Endpoint|Worsening performance status|2
6058624|NCT00529802|20934460|P1|Evaluable for Primary Endpoint|Did not complete 2d CT scan|3
6058625|NCT00529789|20934466|P1|Study Period IV|Lost to Follow-up|3
6058626|NCT00529789|20934466|P1|Study Period IV|Lack of Efficacy|1
6058627|NCT00529789|20934466|P1|Study Period IV|Adverse Event|1
6058628|NCT00529789|20934466|P1|Study Period IV|Parent/Caregiver Decision|1
6058629|NCT00529789|20934466|P1|Study Period II/III|Lost to Follow-up|3
6058630|NCT00529789|20934466|P1|Study Period II/III|Physician Decision|3
6058631|NCT00529789|20934466|P1|Study Period II/III|Protocol Violation|3
6058632|NCT00529789|20934466|P1|Study Period II/III|Withdrawal by Subject|1
6058633|NCT00529789|20934466|P1|Study Period II/III|Lack of Efficacy|2
6058634|NCT00529789|20934466|P1|Study Period II/III|Adverse Event|3
6058635|NCT00529789|20934466|P1|Study Period II/III|Parent/Caregiver Decision|9
6058636|NCT00529763|20934491|P3|Overall Study|Patient Withdrew Consent|2
6058637|NCT00529763|20934492|P2|Overall Study|Patient Withdrew Consent|3
6058638|NCT00529763|20934493|P1|Overall Study|Patient Withdrew Consent|2
6058639|NCT00529763|20934491|P3|Overall Study|Study Drug Toxicity|1
6058640|NCT00529763|20934492|P2|Overall Study|Study Drug Toxicity|6
6058641|NCT00529763|20934493|P1|Overall Study|Study Drug Toxicity|1
6058642|NCT00529763|20934491|P3|Overall Study|Stem Cell Transplant|0
6058643|NCT00529763|20934492|P2|Overall Study|Stem Cell Transplant|3
6058644|NCT00529763|20934493|P1|Overall Study|Stem Cell Transplant|0
6058645|NCT00529763|20934491|P3|Overall Study|Lost to Follow-up|1
6058646|NCT00529763|20934492|P2|Overall Study|Lost to Follow-up|1
6058647|NCT00529763|20934493|P1|Overall Study|Lost to Follow-up|0
6058648|NCT00529763|20934491|P3|Overall Study|Disease Progression|1
6058649|NCT00529763|20934492|P2|Overall Study|Disease Progression|16
6058650|NCT00529763|20934493|P1|Overall Study|Disease Progression|6
6058651|NCT00529763|20934491|P3|Overall Study|Death|1
6058652|NCT00529763|20934492|P2|Overall Study|Death|1
6058653|NCT00529763|20934493|P1|Overall Study|Death|0
6058654|NCT00529763|20934491|P3|Overall Study|Adverse Event Unrelated to Study Drug|1
6058655|NCT00529763|20934492|P2|Overall Study|Adverse Event Unrelated to Study Drug|3
6058656|NCT00529763|20934493|P1|Overall Study|Adverse Event Unrelated to Study Drug|1
6058657|NCT00529659|20934531|P2|Overall Study|Withdrawal by Subject|6
6058658|NCT00529659|20934532|P1|Overall Study|Withdrawal by Subject|1
6058659|NCT00529659|20934531|P2|Overall Study|Protocol Violation|6
6058660|NCT00529659|20934532|P1|Overall Study|Protocol Violation|2
6058661|NCT00529659|20934531|P2|Overall Study|Physician Decision|2
6058662|NCT00529659|20934532|P1|Overall Study|Physician Decision|0
6058663|NCT00529659|20934531|P2|Overall Study|Lost to Follow-up|2
6058664|NCT00529659|20934532|P1|Overall Study|Lost to Follow-up|0
6058665|NCT00529659|20934531|P2|Overall Study|Adverse Event|7
6058666|NCT00529659|20934532|P1|Overall Study|Adverse Event|8
6058667|NCT00529633|20934550|P2|Overall Study|Withdrawal by Subject|1
6058668|NCT00529633|20934551|P1|Overall Study|Withdrawal by Subject|1
6058669|NCT00529568|20934563|P3|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|19
6058670|NCT00529568|20934564|P2|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|17
6058671|NCT00529568|20934565|P1|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|0
6058672|NCT00529568|20934563|P3|Double-bilnd Antiviral Treatment Phase|Physician Decision|8
6058673|NCT00529568|20934564|P2|Double-bilnd Antiviral Treatment Phase|Physician Decision|5
6058674|NCT00529568|20934565|P1|Double-bilnd Antiviral Treatment Phase|Physician Decision|0
6058675|NCT00529568|20934563|P3|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|48
6058676|NCT00529568|20934564|P2|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|15
6058677|NCT00529568|20934565|P1|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|0
6058678|NCT00529568|20934563|P3|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0
6058679|NCT00529568|20934564|P2|Double-bilnd Antiviral Treatment Phase|Protocol Violation|1
6058680|NCT00529568|20934565|P1|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0
6058681|NCT00529568|20934563|P3|Double-bilnd Antiviral Treatment Phase|Adverse Event|27
6058682|NCT00529568|20934564|P2|Double-bilnd Antiviral Treatment Phase|Adverse Event|10
6058683|NCT00529568|20934565|P1|Double-bilnd Antiviral Treatment Phase|Adverse Event|0
6058684|NCT00529568|20934563|P3|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0
6058685|NCT00529568|20934564|P2|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0
6058686|NCT00529568|20934565|P1|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|3
6058687|NCT00529568|20934563|P3|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0
6058688|NCT00529568|20934564|P2|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0
6058689|NCT00529568|20934565|P1|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|13
6058690|NCT00529568|20934563|P3|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0
6058691|NCT00529568|20934564|P2|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0
6058692|NCT00529568|20934565|P1|Open-label Pre-Antiviral Treatment Phase|Physician Decision|8
6058693|NCT00529568|20934563|P3|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0
6058694|NCT00529568|20934564|P2|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0
6058695|NCT00529568|20934565|P1|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|5
6058696|NCT00529568|20934563|P3|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0
6058697|NCT00529568|20934564|P2|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0
6058698|NCT00529568|20934565|P1|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|12
6058699|NCT00529568|20934563|P3|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0
6058700|NCT00529568|20934564|P2|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0
6058701|NCT00529568|20934565|P1|Open-label Pre-Antiviral Treatment Phase|Adverse Event|5
6058702|NCT00529542|20934628|P2|Overall Study|Lost to Follow-up|1
6058703|NCT00529542|20934629|P1|Overall Study|Lost to Follow-up|0
6058704|NCT00529542|20934628|P2|Overall Study|Withdrawal by Subject|0
6058705|NCT00529542|20934629|P1|Overall Study|Withdrawal by Subject|1
6058706|NCT00529529|20934672|P3|Overall Study|Administrative problems|3
6058707|NCT00529529|20934673|P2|Overall Study|Administrative problems|0
6058708|NCT00529529|20934674|P1|Overall Study|Administrative problems|1
6058709|NCT00529529|20934672|P3|Overall Study|Abnormal test procedure result(s)|0
6058710|NCT00529529|20934673|P2|Overall Study|Abnormal test procedure result(s)|0
6058711|NCT00529529|20934674|P1|Overall Study|Abnormal test procedure result(s)|1
6058712|NCT00529529|20934672|P3|Overall Study|Death|0
6058713|NCT00529529|20934673|P2|Overall Study|Death|0
6058714|NCT00529529|20934674|P1|Overall Study|Death|2
6058715|NCT00529529|20934672|P3|Overall Study|Unsatisfactory therapeutic effect|2
6058716|NCT00529529|20934673|P2|Overall Study|Unsatisfactory therapeutic effect|2
6058717|NCT00529529|20934674|P1|Overall Study|Unsatisfactory therapeutic effect|2
6058718|NCT00529529|20934672|P3|Overall Study|Lost to Follow-up|1
6058719|NCT00529529|20934673|P2|Overall Study|Lost to Follow-up|3
6058720|NCT00529529|20934674|P1|Overall Study|Lost to Follow-up|5
6058721|NCT00529529|20934672|P3|Overall Study|Protocol deviation|5
6058722|NCT00529529|20934673|P2|Overall Study|Protocol deviation|12
6058723|NCT00529529|20934674|P1|Overall Study|Protocol deviation|8
6058724|NCT00529529|20934672|P3|Overall Study|Subject withdrew consent|12
6058725|NCT00529529|20934673|P2|Overall Study|Subject withdrew consent|9
6058726|NCT00529529|20934674|P1|Overall Study|Subject withdrew consent|12
6058727|NCT00529529|20934672|P3|Overall Study|Adverse Event|8
6058728|NCT00529529|20934673|P2|Overall Study|Adverse Event|17
6058729|NCT00529529|20934674|P1|Overall Study|Adverse Event|12
6058730|NCT00529516|20934733|P3|Overall Study|Lost to Follow-up|1
6058731|NCT00529516|20934734|P2|Overall Study|Lost to Follow-up|0
6058732|NCT00529516|20934735|P1|Overall Study|Lost to Follow-up|0
6058733|NCT00529516|20934733|P3|Overall Study|Withdrawal by Subject|0
6058734|NCT00529516|20934734|P2|Overall Study|Withdrawal by Subject|1
6058735|NCT00529516|20934735|P1|Overall Study|Withdrawal by Subject|1
6058736|NCT00529516|20934733|P3|Overall Study|Adverse Event|0
6058737|NCT00529516|20934734|P2|Overall Study|Adverse Event|1
6058738|NCT00529516|20934735|P1|Overall Study|Adverse Event|2
6058739|NCT00529451|20934820|P4|Overall Study|Administrative problems|2
6058740|NCT00529451|20934821|P3|Overall Study|Administrative problems|0
6058741|NCT00529451|20934822|P2|Overall Study|Administrative problems|1
6058742|NCT00529451|20934823|P1|Overall Study|Administrative problems|1
6058743|NCT00529451|20934820|P4|Overall Study|Protocol deviation|1
6058744|NCT00529451|20934821|P3|Overall Study|Protocol deviation|4
6058745|NCT00529451|20934822|P2|Overall Study|Protocol deviation|1
6058746|NCT00529451|20934823|P1|Overall Study|Protocol deviation|1
6058747|NCT00529451|20934820|P4|Overall Study|Lost to Follow-up|4
6058748|NCT00529451|20934821|P3|Overall Study|Lost to Follow-up|4
6058749|NCT00529451|20934822|P2|Overall Study|Lost to Follow-up|7
6058750|NCT00529451|20934823|P1|Overall Study|Lost to Follow-up|4
6058751|NCT00529451|20934820|P4|Overall Study|Unsatisfactory therapeutic response|4
6058752|NCT00529451|20934821|P3|Overall Study|Unsatisfactory therapeutic response|5
6058753|NCT00529451|20934822|P2|Overall Study|Unsatisfactory therapeutic response|2
6058754|NCT00529451|20934823|P1|Overall Study|Unsatisfactory therapeutic response|6
6058755|NCT00529451|20934820|P4|Overall Study|Adverse Event|8
6058756|NCT00529451|20934821|P3|Overall Study|Adverse Event|14
6058757|NCT00529451|20934822|P2|Overall Study|Adverse Event|16
6058758|NCT00529451|20934823|P1|Overall Study|Adverse Event|9
6058759|NCT00529451|20934820|P4|Overall Study|Subject withdrew consent|12
6058760|NCT00529451|20934821|P3|Overall Study|Subject withdrew consent|13
6058761|NCT00529451|20934822|P2|Overall Study|Subject withdrew consent|21
6058762|NCT00529451|20934823|P1|Overall Study|Subject withdrew consent|16
6058763|NCT00529399|20934850|P3|Overall Study|Non-compliant|0
6058764|NCT00529399|20934851|P2|Overall Study|Non-compliant|1
6058765|NCT00529399|20934852|P1|Overall Study|Non-compliant|0
6058766|NCT00529399|20934850|P3|Overall Study|Withdrawal by Subject|1
6058767|NCT00529399|20934851|P2|Overall Study|Withdrawal by Subject|0
6058768|NCT00529399|20934852|P1|Overall Study|Withdrawal by Subject|1
6058769|NCT00529399|20934850|P3|Overall Study|Lost to Follow-up|1
6058770|NCT00529399|20934851|P2|Overall Study|Lost to Follow-up|0
6058771|NCT00529399|20934852|P1|Overall Study|Lost to Follow-up|1
6058772|NCT00529386|20934860|P1|Overall Study|Lost to Follow-up|1
6058773|NCT00529373|20934866|P2|Second Extension Study|Status Missing|5
6058774|NCT00529373|20934867|P1|Second Extension Study|Status Missing|5
6058775|NCT00529373|20934866|P2|Second Extension Study|Withdrawal by Subject|75
6058776|NCT00529373|20934867|P1|Second Extension Study|Withdrawal by Subject|97
6058777|NCT00529373|20934866|P2|Second Extension Study|Protocol Violation|1
6058778|NCT00529373|20934867|P1|Second Extension Study|Protocol Violation|2
6058779|NCT00529373|20934866|P2|Second Extension Study|Physician Decision|26
6058780|NCT00529373|20934867|P1|Second Extension Study|Physician Decision|63
6058781|NCT00529373|20934866|P2|Second Extension Study|Other|12
6058782|NCT00529373|20934867|P1|Second Extension Study|Other|7
6058783|NCT00529373|20934866|P2|Second Extension Study|Lost to Follow-up|12
6058784|NCT00529373|20934867|P1|Second Extension Study|Lost to Follow-up|18
6058785|NCT00529373|20934866|P2|Second Extension Study|Lack of Efficacy|15
6058786|NCT00529373|20934867|P1|Second Extension Study|Lack of Efficacy|7
6058787|NCT00529373|20934866|P2|Second Extension Study|Adverse Event|51
6058788|NCT00529373|20934867|P1|Second Extension Study|Adverse Event|101
6058789|NCT00529373|20934866|P2|First Extension Study|Did not cont. into 2nd Ext (unknown)|25
6058790|NCT00529373|20934867|P1|First Extension Study|Did not cont. into 2nd Ext (unknown)|32
6058791|NCT00529373|20934866|P2|First Extension Study|Did not cont. into 2nd Ext (verified)|281
6058792|NCT00529373|20934867|P1|First Extension Study|Did not cont. into 2nd Ext (verified)|256
6058793|NCT00529373|20934866|P2|First Extension Study|Discontinued after 5 years completion|346
6058794|NCT00529373|20934867|P1|First Extension Study|Discontinued after 5 years completion|208
6058795|NCT00529373|20934866|P2|First Extension Study|Disposition record non-existing|1
6058796|NCT00529373|20934867|P1|First Extension Study|Disposition record non-existing|0
6058797|NCT00529373|20934866|P2|First Extension Study|Withdrawal by Subject|287
6058798|NCT00529373|20934867|P1|First Extension Study|Withdrawal by Subject|296
6058799|NCT00529373|20934866|P2|First Extension Study|Protocol Violation|13
6058800|NCT00529373|20934867|P1|First Extension Study|Protocol Violation|16
6058801|NCT00529373|20934866|P2|First Extension Study|Physician Decision|45
6058802|NCT00529373|20934867|P1|First Extension Study|Physician Decision|50
6058803|NCT00529373|20934866|P2|First Extension Study|Other|47
6058804|NCT00529373|20934867|P1|First Extension Study|Other|27
6058805|NCT00529373|20934866|P2|First Extension Study|Lost to Follow-up|37
6058806|NCT00529373|20934867|P1|First Extension Study|Lost to Follow-up|41
6058807|NCT00529373|20934866|P2|First Extension Study|Lack of Efficacy|427
6058808|NCT00529373|20934867|P1|First Extension Study|Lack of Efficacy|65
6058809|NCT00529373|20934866|P2|First Extension Study|Adverse Event|142
6058810|NCT00529373|20934867|P1|First Extension Study|Adverse Event|162
6058811|NCT00529373|20934866|P2|Base Study|Did not continue into Extension|2238
6058812|NCT00529373|20934867|P1|Base Study|Did not continue into Extension|1795
6058813|NCT00529373|20934866|P2|Base Study|Withdrawal by Subject|967
6058814|NCT00529373|20934867|P1|Base Study|Withdrawal by Subject|1062
6058815|NCT00529373|20934866|P2|Base Study|Protocol Violation|38
6058816|NCT00529373|20934867|P1|Base Study|Protocol Violation|48
6058817|NCT00529373|20934866|P2|Base Study|Physician Decision|52
6058818|NCT00529373|20934867|P1|Base Study|Physician Decision|60
6058819|NCT00529373|20934866|P2|Base Study|Other Protocol Specified Criteria|20
6058820|NCT00529373|20934867|P1|Base Study|Other Protocol Specified Criteria|19
6058821|NCT00529373|20934866|P2|Base Study|Lost to Follow-up|208
6058822|NCT00529373|20934867|P1|Base Study|Lost to Follow-up|221
6058823|NCT00529373|20934866|P2|Base Study|Lack of Efficacy|75
6058824|NCT00529373|20934867|P1|Base Study|Lack of Efficacy|16
6058825|NCT00529373|20934866|P2|Base Study|Adverse Event|470
6058826|NCT00529373|20934867|P1|Base Study|Adverse Event|525
6058827|NCT00529308|20935061|P2|Overall Study|Withdrawal by Subject|1
6058828|NCT00529308|20935062|P1|Overall Study|Withdrawal by Subject|1
6058829|NCT00529243|20935091|P1|Overall Study|Relocated|1
6058830|NCT00529243|20935091|P1|Overall Study|Death|1
6058831|NCT00529243|20935091|P1|Overall Study|Adverse Event|1
6058832|NCT00529217|20935096|P1|Overall Study|Unable to adhere to study schedule|2
6058833|NCT00529217|20935096|P1|Overall Study|Lack of Efficacy|2
6058834|NCT00529152|20935132|P1|Overall Study|Lost to Follow-up|1
6058835|NCT00529152|20935132|P1|Overall Study|Withdrawal by Subject|2
6058836|NCT00529152|20935132|P1|Overall Study|Adverse Event|2
6058837|NCT00529100|20935156|P2|Overall Study|Participant Ineligibility|1
6058838|NCT00529100|20935157|P1|Overall Study|Participant Ineligibility|0
6058839|NCT00529100|20935156|P2|Overall Study|Withdrawal by Subject|1
6058840|NCT00529100|20935157|P1|Overall Study|Withdrawal by Subject|0
6058841|NCT00529100|20935156|P2|Overall Study|Progressive Disease|1
6058842|NCT00529100|20935157|P1|Overall Study|Progressive Disease|0
6058843|NCT00529100|20935156|P2|Overall Study|Protocol Violation|1
6058844|NCT00529100|20935157|P1|Overall Study|Protocol Violation|0
6058845|NCT00529100|20935156|P2|Overall Study|Adverse Event|5
6058846|NCT00529100|20935157|P1|Overall Study|Adverse Event|0
6058847|NCT00529087|20935174|P3|Overall Study|Protocol deviation|2
6058848|NCT00529087|20935175|P2|Overall Study|Protocol deviation|1
6058849|NCT00529087|20935176|P1|Overall Study|Protocol deviation|1
6058850|NCT00529087|20935174|P3|Overall Study|Withdrawal by Subject|3
6058851|NCT00529087|20935175|P2|Overall Study|Withdrawal by Subject|3
6058852|NCT00529087|20935176|P1|Overall Study|Withdrawal by Subject|3
6058853|NCT00529087|20935174|P3|Overall Study|Protocol Violation|6
6058854|NCT00529087|20935175|P2|Overall Study|Protocol Violation|7
6058855|NCT00529087|20935176|P1|Overall Study|Protocol Violation|8
6058856|NCT00529087|20935174|P3|Overall Study|Lost to Follow-up|1
6058857|NCT00529087|20935175|P2|Overall Study|Lost to Follow-up|4
6058858|NCT00529087|20935176|P1|Overall Study|Lost to Follow-up|6
6058859|NCT00529087|20935174|P3|Overall Study|Adverse Event|4
6058860|NCT00529087|20935175|P2|Overall Study|Adverse Event|13
6058861|NCT00529087|20935176|P1|Overall Study|Adverse Event|10
6058862|NCT00529035|20935240|P1|Overall Study|Withdrawal by Subject|1
6058863|NCT00528970|20935254|P3|Overall Study|Randomized but not treated|1
6058864|NCT00528970|20935255|P2|Overall Study|Randomized but not treated|0
6058865|NCT00528970|20935256|P1|Overall Study|Randomized but not treated|0
6058866|NCT00528970|20935254|P3|Overall Study|Withdrawal by Subject|5
6058867|NCT00528970|20935255|P2|Overall Study|Withdrawal by Subject|3
6058868|NCT00528970|20935256|P1|Overall Study|Withdrawal by Subject|4
6058869|NCT00528970|20935254|P3|Overall Study|Lack of Efficacy|1
6058870|NCT00528970|20935255|P2|Overall Study|Lack of Efficacy|0
6058871|NCT00528970|20935256|P1|Overall Study|Lack of Efficacy|0
6058872|NCT00528970|20935254|P3|Overall Study|Protocol Violation|4
6058873|NCT00528970|20935255|P2|Overall Study|Protocol Violation|1
6058874|NCT00528970|20935256|P1|Overall Study|Protocol Violation|2
6058875|NCT00528970|20935254|P3|Overall Study|Other than specified|3
6058876|NCT00528970|20935255|P2|Overall Study|Other than specified|3
6058877|NCT00528970|20935256|P1|Overall Study|Other than specified|2
6058878|NCT00528970|20935254|P3|Overall Study|Lost to Follow-up|1
6058879|NCT00528970|20935255|P2|Overall Study|Lost to Follow-up|0
6058880|NCT00528970|20935256|P1|Overall Study|Lost to Follow-up|0
6058881|NCT00528970|20935254|P3|Overall Study|Adverse Event|5
6058882|NCT00528970|20935255|P2|Overall Study|Adverse Event|8
6058883|NCT00528970|20935256|P1|Overall Study|Adverse Event|6
6058884|NCT00528957|20935275|P2|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1
6058885|NCT00528957|20935276|P1|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1
6058886|NCT00528957|20935275|P2|Long-Term Extension (Week 336 and On)|Withdrew Consent|1
6058887|NCT00528957|20935276|P1|Long-Term Extension (Week 336 and On)|Withdrew Consent|2
6058888|NCT00528957|20935275|P2|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|5
6058889|NCT00528957|20935276|P1|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|3
6058890|NCT00528957|20935275|P2|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|10
6058891|NCT00528957|20935276|P1|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|4
6058892|NCT00528957|20935275|P2|Third Extension (Week 240 to Week 336)|Withdrew Consent|1
6058893|NCT00528957|20935276|P1|Third Extension (Week 240 to Week 336)|Withdrew Consent|0
6058894|NCT00528957|20935275|P2|Third Extension (Week 240 to Week 336)|Investigator's Discretion|1
6058895|NCT00528957|20935276|P1|Third Extension (Week 240 to Week 336)|Investigator's Discretion|0
6058896|NCT00528957|20935275|P2|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1
6058897|NCT00528957|20935276|P1|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1
6058898|NCT00528957|20935275|P2|Third Extension (Week 240 to Week 336)|Lost to Follow-up|3
6058899|NCT00528957|20935276|P1|Third Extension (Week 240 to Week 336)|Lost to Follow-up|0
6058900|NCT00528957|20935275|P2|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|4
6058901|NCT00528957|20935276|P1|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|5
6058902|NCT00528957|20935275|P2|Second Extension (Week 144 to Week 240)|Investigator's Discretion|0
6058903|NCT00528957|20935276|P1|Second Extension (Week 144 to Week 240)|Investigator's Discretion|3
6058904|NCT00528957|20935275|P2|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|3
6058905|NCT00528957|20935276|P1|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|4
6058906|NCT00528957|20935275|P2|First Extension (Week 48 to Week 144)|Withdrew Consent|1
6058907|NCT00528957|20935276|P1|First Extension (Week 48 to Week 144)|Withdrew Consent|0
6058908|NCT00528957|20935275|P2|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|0
6058909|NCT00528957|20935276|P1|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|1
6058910|NCT00528957|20935275|P2|First Extension (Week 48 to Week 144)|Investigator's Discretion|0
6058911|NCT00528957|20935276|P1|First Extension (Week 48 to Week 144)|Investigator's Discretion|2
6058912|NCT00528957|20935275|P2|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|0
6058913|NCT00528957|20935276|P1|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|2
6058914|NCT00528957|20935275|P2|Randomized Phase (Baseline to Week 48)|Withdrew Consent|1
6058915|NCT00528957|20935276|P1|Randomized Phase (Baseline to Week 48)|Withdrew Consent|2
6058916|NCT00528931|20935417|P1|Overall Study|Lost to Follow-up|1
6058917|NCT00528879|20935429|P4|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|0
6058918|NCT00528879|20935430|P3|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1
6058919|NCT00528879|20935431|P2|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1
6058920|NCT00528879|20935432|P1|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1
6058921|NCT00528879|20935429|P4|Long-term Period (Weeks 24 to 102)|Pregnancy|0
6058922|NCT00528879|20935430|P3|Long-term Period (Weeks 24 to 102)|Pregnancy|0
6058923|NCT00528879|20935431|P2|Long-term Period (Weeks 24 to 102)|Pregnancy|0
6058924|NCT00528879|20935432|P1|Long-term Period (Weeks 24 to 102)|Pregnancy|1
6058925|NCT00528879|20935429|P4|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|2
6058926|NCT00528879|20935430|P3|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|1
6058927|NCT00528879|20935431|P2|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|5
6058928|NCT00528879|20935432|P1|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|0
6058929|NCT00528879|20935429|P4|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|7
6058930|NCT00528879|20935430|P3|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|3
6058931|NCT00528879|20935431|P2|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|5
6058932|NCT00528879|20935432|P1|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|4
6058933|NCT00528879|20935429|P4|Long-term Period (Weeks 24 to 102)|Death|0
6058934|NCT00528879|20935430|P3|Long-term Period (Weeks 24 to 102)|Death|0
6058935|NCT00528879|20935431|P2|Long-term Period (Weeks 24 to 102)|Death|1
6058936|NCT00528879|20935432|P1|Long-term Period (Weeks 24 to 102)|Death|0
6058937|NCT00528879|20935429|P4|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4
6058938|NCT00528879|20935430|P3|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|8
6058939|NCT00528879|20935431|P2|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|6
6058940|NCT00528879|20935432|P1|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4
6058941|NCT00528879|20935429|P4|Long-term Period (Weeks 24 to 102)|Adverse Event|2
6058942|NCT00528879|20935430|P3|Long-term Period (Weeks 24 to 102)|Adverse Event|3
6058943|NCT00528879|20935431|P2|Long-term Period (Weeks 24 to 102)|Adverse Event|4
6058944|NCT00528879|20935432|P1|Long-term Period (Weeks 24 to 102)|Adverse Event|5
6058945|NCT00528879|20935429|P4|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|9
6058946|NCT00528879|20935430|P3|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|17
6058947|NCT00528879|20935431|P2|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|16
6058948|NCT00528879|20935432|P1|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|27
6058949|NCT00528879|20935429|P4|Short-term Period (Day 1 to Week 24)|Other|1
6058950|NCT00528879|20935430|P3|Short-term Period (Day 1 to Week 24)|Other|1
6058951|NCT00528879|20935431|P2|Short-term Period (Day 1 to Week 24)|Other|0
6058952|NCT00528879|20935432|P1|Short-term Period (Day 1 to Week 24)|Other|0
6058953|NCT00528879|20935429|P4|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1
6058954|NCT00528879|20935430|P3|Short-term Period (Day 1 to Week 24)|Administrative reason by author|0
6058955|NCT00528879|20935431|P2|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1
6058956|NCT00528879|20935432|P1|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1
6058957|NCT00528879|20935429|P4|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2
6058958|NCT00528879|20935430|P3|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0
6058959|NCT00528879|20935431|P2|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|3
6058960|NCT00528879|20935432|P1|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2
6058961|NCT00528879|20935429|P4|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0
6058962|NCT00528879|20935430|P3|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|2
6058963|NCT00528879|20935431|P2|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0
6058964|NCT00528879|20935432|P1|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0
6058965|NCT00528879|20935429|P4|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5
6058966|NCT00528879|20935430|P3|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4
6058967|NCT00528879|20935431|P2|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4
6058968|NCT00528879|20935432|P1|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5
6058969|NCT00528879|20935429|P4|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|3
6058970|NCT00528879|20935430|P3|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5
6058971|NCT00528879|20935431|P2|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5
6058972|NCT00528879|20935432|P1|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|7
6058973|NCT00528879|20935429|P4|Short-term Period (Day 1 to Week 24)|Adverse Event|4
6058974|NCT00528879|20935430|P3|Short-term Period (Day 1 to Week 24)|Adverse Event|2
6058975|NCT00528879|20935431|P2|Short-term Period (Day 1 to Week 24)|Adverse Event|4
6058976|NCT00528879|20935432|P1|Short-term Period (Day 1 to Week 24)|Adverse Event|4
6058977|NCT00528879|20935429|P4|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0
6058978|NCT00528879|20935430|P3|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|1
6058979|NCT00528879|20935431|P2|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0
6058980|NCT00528879|20935432|P1|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|3
6058981|NCT00528866|20935498|P1|Overall Study|Protocol Violation|6
6058982|NCT00528840|20935511|P1|Overall Study|Other|2
6058983|NCT00528840|20935511|P1|Overall Study|Administrative Reasons|1
6058984|NCT00528840|20935511|P1|Overall Study|Death|2
6058985|NCT00528840|20935511|P1|Overall Study|Withdrawal by Subject|17
6058986|NCT00528840|20935511|P1|Overall Study|Adverse Event|1
6058987|NCT00528840|20935511|P1|Overall Study|Lost to Follow-up|10
6058988|NCT00528801|20935525|P2|Overall Study|Administrative Reasons|1
6058989|NCT00528801|20935526|P1|Overall Study|Administrative Reasons|0
6058990|NCT00528801|20935525|P2|Overall Study|Lost to Follow-up|4
6058991|NCT00528801|20935526|P1|Overall Study|Lost to Follow-up|15
6058992|NCT00528801|20935525|P2|Overall Study|Protocol Violation|5
6058993|NCT00528801|20935526|P1|Overall Study|Protocol Violation|11
6058994|NCT00528801|20935525|P2|Overall Study|Withdrawal by Subject|1
6058995|NCT00528801|20935526|P1|Overall Study|Withdrawal by Subject|1
6058996|NCT00528775|20935540|P1|Overall Study|Other not specified|1
6058997|NCT00528645|20935548|P1|Overall Study|Adverse Event|3
6058998|NCT00528606|20935557|P2|Overall Study|Other|0
6058999|NCT00528606|20935558|P1|Overall Study|Other|2
6059000|NCT00528606|20935557|P2|Overall Study|Adverse Event|0
6059001|NCT00528606|20935558|P1|Overall Study|Adverse Event|3
6059002|NCT00528606|20935557|P2|Overall Study|Lost to Follow-up|1
6059003|NCT00528606|20935558|P1|Overall Study|Lost to Follow-up|4
6059004|NCT00528606|20935557|P2|Overall Study|Withdrew consent|3
6059005|NCT00528606|20935558|P1|Overall Study|Withdrew consent|4
6059006|NCT00528567|20935591|P2|Overall Study|Administrative/Other|75
6059007|NCT00528567|20935592|P1|Overall Study|Administrative/Other|22
6059008|NCT00528567|20935591|P2|Overall Study|Other Protocol Violation|21
6059009|NCT00528567|20935592|P1|Overall Study|Other Protocol Violation|5
6059010|NCT00528567|20935591|P2|Overall Study|Failure to Return|4
6059011|NCT00528567|20935592|P1|Overall Study|Failure to Return|1
6059012|NCT00528567|20935591|P2|Overall Study|Refused Treatment/Did Not Cooperate|42
6059013|NCT00528567|20935592|P1|Overall Study|Refused Treatment/Did Not Cooperate|52
6059014|NCT00528567|20935591|P2|Overall Study|Withdrew Consent|55
6059015|NCT00528567|20935592|P1|Overall Study|Withdrew Consent|59
6059016|NCT00528567|20935591|P2|Overall Study|Violation Criteria at Entry|17
6059017|NCT00528567|20935592|P1|Overall Study|Violation Criteria at Entry|3
6059018|NCT00528567|20935591|P2|Overall Study|Adverse Event/Intermittent Illness|29
6059019|NCT00528567|20935592|P1|Overall Study|Adverse Event/Intermittent Illness|255
6059020|NCT00528567|20935591|P2|Overall Study|Breast Cancer Recurrence/2nd Primary|60
6059021|NCT00528567|20935592|P1|Overall Study|Breast Cancer Recurrence/2nd Primary|30
6059022|NCT00528567|20935591|P2|Overall Study|Death|5
6059023|NCT00528567|20935592|P1|Overall Study|Death|4
6059024|NCT00528528|20935659|P4|Overall Study|Ongoing participant|0
6059025|NCT00528528|20935660|P3|Overall Study|Ongoing participant|1
6059026|NCT00528528|20935661|P2|Overall Study|Ongoing participant|0
6059027|NCT00528528|20935662|P1|Overall Study|Ongoing participant|0
6059028|NCT00528528|20935659|P4|Overall Study|Withdrawal by Subject|1
6059029|NCT00528528|20935660|P3|Overall Study|Withdrawal by Subject|1
6059030|NCT00528528|20935661|P2|Overall Study|Withdrawal by Subject|2
6059031|NCT00528528|20935662|P1|Overall Study|Withdrawal by Subject|3
6059032|NCT00528528|20935659|P4|Overall Study|Other|0
6059033|NCT00528528|20935660|P3|Overall Study|Other|0
6059034|NCT00528528|20935661|P2|Overall Study|Other|1
6059035|NCT00528528|20935662|P1|Overall Study|Other|0
6059036|NCT00528528|20935659|P4|Overall Study|Ineligible to continue the trial|1
6059037|NCT00528528|20935660|P3|Overall Study|Ineligible to continue the trial|0
6059038|NCT00528528|20935661|P2|Overall Study|Ineligible to continue the trial|0
6059039|NCT00528528|20935662|P1|Overall Study|Ineligible to continue the trial|0
6059040|NCT00528528|20935659|P4|Overall Study|Lost to Follow-up|1
6059041|NCT00528528|20935660|P3|Overall Study|Lost to Follow-up|1
6059042|NCT00528528|20935661|P2|Overall Study|Lost to Follow-up|0
6059043|NCT00528528|20935662|P1|Overall Study|Lost to Follow-up|0
6059044|NCT00528424|20935700|P1|Overall Study|Other|12
6059045|NCT00528424|20935700|P1|Overall Study|Administrative reason|2
6059046|NCT00528424|20935700|P1|Overall Study|Withdrew consent|2
6059047|NCT00528424|20935700|P1|Overall Study|Lost to Follow-up|13
6059048|NCT00528411|20935715|P3|Overall Study|Prior commitment medication|0
6059049|NCT00528411|20935716|P2|Overall Study|Prior commitment medication|1
6059050|NCT00528411|20935717|P1|Overall Study|Prior commitment medication|0
6059051|NCT00528411|20935715|P3|Overall Study|Severe non-compliance to protocol|0
6059052|NCT00528411|20935716|P2|Overall Study|Severe non-compliance to protocol|1
6059053|NCT00528411|20935717|P1|Overall Study|Severe non-compliance to protocol|0
6059054|NCT00528411|20935715|P3|Overall Study|Incorrect Enrolment|0
6059055|NCT00528411|20935716|P2|Overall Study|Incorrect Enrolment|1
6059056|NCT00528411|20935717|P1|Overall Study|Incorrect Enrolment|1
6059057|NCT00528411|20935715|P3|Overall Study|Adverse Event|1
6059058|NCT00528411|20935716|P2|Overall Study|Adverse Event|0
6059059|NCT00528411|20935717|P1|Overall Study|Adverse Event|4
6059060|NCT00528372|20935854|P9|Long-term (LT) Period (Weeks 24-102)|Other|0
6059061|NCT00528372|20935855|P8|Long-term (LT) Period (Weeks 24-102)|Other|1
6059062|NCT00528372|20935856|P7|Long-term (LT) Period (Weeks 24-102)|Other|3
6059063|NCT00528372|20935857|P6|Long-term (LT) Period (Weeks 24-102)|Other|0
6059064|NCT00528372|20935858|P5|Long-term (LT) Period (Weeks 24-102)|Other|3
6059065|NCT00528372|20935859|P4|Long-term (LT) Period (Weeks 24-102)|Other|2
6059066|NCT00528372|20935860|P3|Long-term (LT) Period (Weeks 24-102)|Other|1
6059067|NCT00528372|20935861|P2|Long-term (LT) Period (Weeks 24-102)|Other|2
6059068|NCT00528372|20935862|P1|Long-term (LT) Period (Weeks 24-102)|Other|2
6059069|NCT00528372|20935854|P9|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1
6059070|NCT00528372|20935855|P8|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
6059071|NCT00528372|20935856|P7|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1
6059072|NCT00528372|20935857|P6|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
6059073|NCT00528372|20935858|P5|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
6059074|NCT00528372|20935859|P4|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
6059075|NCT00528372|20935860|P3|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
6059076|NCT00528372|20935861|P2|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1
6059077|NCT00528372|20935862|P1|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
6059078|NCT00528372|20935854|P9|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
6059079|NCT00528372|20935855|P8|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
6059080|NCT00528372|20935856|P7|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
6059081|NCT00528372|20935857|P6|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|1
6059082|NCT00528372|20935858|P5|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|2
6059083|NCT00528372|20935859|P4|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
6059084|NCT00528372|20935860|P3|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
6059085|NCT00528372|20935861|P2|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
6059086|NCT00528372|20935862|P1|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
6059087|NCT00528372|20935854|P9|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0
6059088|NCT00528372|20935855|P8|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0
6059089|NCT00528372|20935856|P7|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1
6059090|NCT00528372|20935857|P6|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0
6059091|NCT00528372|20935858|P5|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0
6059092|NCT00528372|20935859|P4|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1
6059093|NCT00528372|20935860|P3|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1
6059094|NCT00528372|20935861|P2|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1
6059095|NCT00528372|20935862|P1|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0
6059096|NCT00528372|20935854|P9|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1
6059097|NCT00528372|20935855|P8|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3
6059098|NCT00528372|20935856|P7|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2
6059099|NCT00528372|20935857|P6|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|4
6059100|NCT00528372|20935858|P5|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|0
6059101|NCT00528372|20935859|P4|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1
6059102|NCT00528372|20935860|P3|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1
6059103|NCT00528372|20935861|P2|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2
6059104|NCT00528372|20935862|P1|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3
6059105|NCT00528372|20935854|P9|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4
6059106|NCT00528372|20935855|P8|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|2
6059107|NCT00528372|20935856|P7|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4
6059108|NCT00528372|20935857|P6|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|0
6059109|NCT00528372|20935858|P5|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|7
6059110|NCT00528372|20935859|P4|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3
6059111|NCT00528372|20935860|P3|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3
6059112|NCT00528372|20935861|P2|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6
6059113|NCT00528372|20935862|P1|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6
6059114|NCT00528372|20935854|P9|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0
6059115|NCT00528372|20935855|P8|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0
6059116|NCT00528372|20935856|P7|Long-term (LT) Period (Weeks 24-102)|Adverse Event|4
6059117|NCT00528372|20935857|P6|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3
6059118|NCT00528372|20935858|P5|Long-term (LT) Period (Weeks 24-102)|Adverse Event|2
6059119|NCT00528372|20935859|P4|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0
6059120|NCT00528372|20935860|P3|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1
6059121|NCT00528372|20935861|P2|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1
6059122|NCT00528372|20935862|P1|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3
6059123|NCT00528372|20935854|P9|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0
6059124|NCT00528372|20935855|P8|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0
6059125|NCT00528372|20935856|P7|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|2
6059126|NCT00528372|20935857|P6|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7
6059127|NCT00528372|20935858|P5|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7
6059128|NCT00528372|20935859|P4|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7
6059129|NCT00528372|20935860|P3|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|1
6059130|NCT00528372|20935861|P2|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6
6059131|NCT00528372|20935862|P1|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6
6059132|NCT00528372|20935854|P9|Short-term (ST) Period (Day 1-Week 24)|Other|0
6059133|NCT00528372|20935855|P8|Short-term (ST) Period (Day 1-Week 24)|Other|1
6059134|NCT00528372|20935856|P7|Short-term (ST) Period (Day 1-Week 24)|Other|0
6059135|NCT00528372|20935857|P6|Short-term (ST) Period (Day 1-Week 24)|Other|0
6059136|NCT00528372|20935858|P5|Short-term (ST) Period (Day 1-Week 24)|Other|0
6059137|NCT00528372|20935859|P4|Short-term (ST) Period (Day 1-Week 24)|Other|1
6059138|NCT00528372|20935860|P3|Short-term (ST) Period (Day 1-Week 24)|Other|0
6059139|NCT00528372|20935861|P2|Short-term (ST) Period (Day 1-Week 24)|Other|0
6059140|NCT00528372|20935862|P1|Short-term (ST) Period (Day 1-Week 24)|Other|3
6059141|NCT00528372|20935854|P9|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
6059142|NCT00528372|20935855|P8|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
6059143|NCT00528372|20935856|P7|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
6059144|NCT00528372|20935857|P6|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1
6059145|NCT00528372|20935858|P5|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
6059146|NCT00528372|20935859|P4|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
6059147|NCT00528372|20935860|P3|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1
6059148|NCT00528372|20935861|P2|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
6059149|NCT00528372|20935862|P1|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1
6059150|NCT00528372|20935854|P9|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
6059151|NCT00528372|20935855|P8|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
6059152|NCT00528372|20935856|P7|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
6059153|NCT00528372|20935857|P6|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|1
6059154|NCT00528372|20935858|P5|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
6059155|NCT00528372|20935859|P4|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|2
6059156|NCT00528372|20935860|P3|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
6059157|NCT00528372|20935861|P2|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
6059158|NCT00528372|20935862|P1|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
6059159|NCT00528372|20935854|P9|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1
6059160|NCT00528372|20935855|P8|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3
6059161|NCT00528372|20935856|P7|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2
6059162|NCT00528372|20935857|P6|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2
6059163|NCT00528372|20935858|P5|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3
6059164|NCT00528372|20935859|P4|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3
6059165|NCT00528372|20935860|P3|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2
6059166|NCT00528372|20935861|P2|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1
6059167|NCT00528372|20935862|P1|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|5
6059168|NCT00528372|20935854|P9|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4
6059169|NCT00528372|20935855|P8|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2
6059170|NCT00528372|20935856|P7|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6
6059171|NCT00528372|20935857|P6|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4
6059172|NCT00528372|20935858|P5|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6
6059173|NCT00528372|20935859|P4|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1
6059174|NCT00528372|20935860|P3|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|7
6059175|NCT00528372|20935861|P2|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2
6059176|NCT00528372|20935862|P1|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1
6059177|NCT00528372|20935854|P9|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0
6059178|NCT00528372|20935855|P8|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0
6059179|NCT00528372|20935856|P7|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3
6059180|NCT00528372|20935857|P6|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3
6059181|NCT00528372|20935858|P5|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0
6059182|NCT00528372|20935859|P4|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|6
6059183|NCT00528372|20935860|P3|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2
6059184|NCT00528372|20935861|P2|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2
6059185|NCT00528372|20935862|P1|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0
6059186|NCT00528372|20935854|P9|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
6059187|NCT00528372|20935855|P8|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
6059188|NCT00528372|20935856|P7|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
6059189|NCT00528372|20935857|P6|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
6059190|NCT00528372|20935858|P5|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
6059191|NCT00528372|20935859|P4|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
6059192|NCT00528372|20935860|P3|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
6059193|NCT00528372|20935861|P2|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
6059194|NCT00528372|20935862|P1|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|2
6059195|NCT00528112|20935994|P2|Extension Phase|Protocol Violation|2
6059196|NCT00528112|20935995|P1|Extension Phase|Protocol Violation|0
6059197|NCT00528112|20935994|P2|Extension Phase|Adverse Event|36
6059198|NCT00528112|20935995|P1|Extension Phase|Adverse Event|0
6059199|NCT00528112|20935994|P2|Extension Phase|Death|1
6059200|NCT00528112|20935995|P1|Extension Phase|Death|0
6059201|NCT00528112|20935994|P2|Extension Phase|Lost to Follow-up|12
6059202|NCT00528112|20935995|P1|Extension Phase|Lost to Follow-up|0
6059203|NCT00528112|20935994|P2|Extension Phase|Pregnancy|3
6059204|NCT00528112|20935995|P1|Extension Phase|Pregnancy|0
6059205|NCT00528112|20935994|P2|Extension Phase|Other reasons|100
6059206|NCT00528112|20935995|P1|Extension Phase|Other reasons|0
6059207|NCT00528112|20935994|P2|Extension Phase|Withdrawal by Subject|3
6059208|NCT00528112|20935995|P1|Extension Phase|Withdrawal by Subject|0
6059209|NCT00528112|20935994|P2|Treatment up to 3 Years|Other reasons|186
6059210|NCT00528112|20935995|P1|Treatment up to 3 Years|Other reasons|186
6059211|NCT00528112|20935994|P2|Treatment up to 3 Years|Pregnancy|10
6059212|NCT00528112|20935995|P1|Treatment up to 3 Years|Pregnancy|9
6059213|NCT00528112|20935994|P2|Treatment up to 3 Years|Lost to Follow-up|61
6059214|NCT00528112|20935995|P1|Treatment up to 3 Years|Lost to Follow-up|63
6059215|NCT00528112|20935994|P2|Treatment up to 3 Years|Death|1
6059216|NCT00528112|20935995|P1|Treatment up to 3 Years|Death|0
6059217|NCT00528112|20935994|P2|Treatment up to 3 Years|Protocol Violation|16
6059218|NCT00528112|20935995|P1|Treatment up to 3 Years|Protocol Violation|16
6059219|NCT00528112|20935994|P2|Treatment up to 3 Years|Withdrawal by Subject|31
6059220|NCT00528112|20935995|P1|Treatment up to 3 Years|Withdrawal by Subject|26
6059221|NCT00528112|20935994|P2|Treatment up to 3 Years|Adverse Event|278
6059222|NCT00528112|20935995|P1|Treatment up to 3 Years|Adverse Event|313
6059223|NCT00528021|20936053|P4|Overall Study|Lack of Efficacy|9
6059224|NCT00528021|20936054|P3|Overall Study|Lack of Efficacy|7
6059225|NCT00528021|20936055|P2|Overall Study|Lack of Efficacy|13
6059226|NCT00528021|20936056|P1|Overall Study|Lack of Efficacy|17
6059227|NCT00527982|20936068|P2|Overall Study|Physician Decision|0
6059228|NCT00527982|20936069|P1|Overall Study|Physician Decision|1
6059229|NCT00527904|20936110|P1|Overall Study|misc|22
6059230|NCT00527904|20936110|P1|Overall Study|Lost to Follow-up|8
6059231|NCT00527904|20936110|P1|Overall Study|Withdrawal by Subject|21
6059232|NCT00527904|20936110|P1|Overall Study|Adverse Event|45
6059233|NCT00527826|20936129|P2|Overall Study|Participant moved away|1
6059234|NCT00527826|20936130|P1|Overall Study|Participant moved away|0
6059235|NCT00527826|20936129|P2|Overall Study|Additional Intake of Viani forte|1
6059236|NCT00527826|20936130|P1|Overall Study|Additional Intake of Viani forte|0
6059237|NCT00527826|20936129|P2|Overall Study|Alpha-1 Antitrypsin Deficiency|1
6059238|NCT00527826|20936130|P1|Overall Study|Alpha-1 Antitrypsin Deficiency|0
6059239|NCT00527826|20936129|P2|Overall Study|Inclusion Criteria Not Met|3
6059240|NCT00527826|20936130|P1|Overall Study|Inclusion Criteria Not Met|3
6059241|NCT00527826|20936129|P2|Overall Study|Withdrawal by Subject|8
6059242|NCT00527826|20936130|P1|Overall Study|Withdrawal by Subject|5
6059243|NCT00527826|20936129|P2|Overall Study|Lost to Follow-up|2
6059244|NCT00527826|20936130|P1|Overall Study|Lost to Follow-up|3
6059245|NCT00527826|20936129|P2|Overall Study|Adverse Event|10
6059246|NCT00527826|20936130|P1|Overall Study|Adverse Event|10
6059247|NCT00527787|20936179|P2|Overall Study|misc|2
6059248|NCT00527787|20936180|P1|Overall Study|misc|5
6059249|NCT00527787|20936179|P2|Overall Study|Duodenal Ulcer|10
6059250|NCT00527787|20936180|P1|Overall Study|Duodenal Ulcer|1
6059251|NCT00527787|20936179|P2|Overall Study|Lost to Follow-up|2
6059252|NCT00527787|20936180|P1|Overall Study|Lost to Follow-up|5
6059253|NCT00527787|20936179|P2|Overall Study|Withdrawal by Subject|25
6059254|NCT00527787|20936180|P1|Overall Study|Withdrawal by Subject|13
6059255|NCT00527787|20936179|P2|Overall Study|Adverse Event|24
6059256|NCT00527787|20936180|P1|Overall Study|Adverse Event|14
6059257|NCT00527748|20936202|P1|Overall Study|Other|3
6059258|NCT00527735|20936209|P3|Overall Study|Completed treatment during maintenance|1
6059259|NCT00527735|20936210|P2|Overall Study|Completed treatment during maintenance|2
6059260|NCT00527735|20936211|P1|Overall Study|Completed treatment during maintenance|2
6059261|NCT00527735|20936209|P3|Overall Study|Poor compliance or noncompliance|1
6059262|NCT00527735|20936210|P2|Overall Study|Poor compliance or noncompliance|1
6059263|NCT00527735|20936211|P1|Overall Study|Poor compliance or noncompliance|0
6059264|NCT00527735|20936209|P3|Overall Study|Lost to Follow-up|3
6059265|NCT00527735|20936210|P2|Overall Study|Lost to Follow-up|0
6059266|NCT00527735|20936211|P1|Overall Study|Lost to Follow-up|0
6059267|NCT00527735|20936209|P3|Overall Study|No longer met study criteria|1
6059268|NCT00527735|20936210|P2|Overall Study|No longer met study criteria|2
6059269|NCT00527735|20936211|P1|Overall Study|No longer met study criteria|2
6059270|NCT00527735|20936209|P3|Overall Study|Withdrawal by Subject|3
6059271|NCT00527735|20936210|P2|Overall Study|Withdrawal by Subject|4
6059272|NCT00527735|20936211|P1|Overall Study|Withdrawal by Subject|5
6059273|NCT00527735|20936209|P3|Overall Study|Not identified|5
6059274|NCT00527735|20936210|P2|Overall Study|Not identified|5
6059275|NCT00527735|20936211|P1|Overall Study|Not identified|5
6059276|NCT00527735|20936209|P3|Overall Study|Adverse Event|7
6059277|NCT00527735|20936210|P2|Overall Study|Adverse Event|6
6059278|NCT00527735|20936211|P1|Overall Study|Adverse Event|10
6059279|NCT00527735|20936209|P3|Overall Study|Completed treatment in treatment phase|18
6059280|NCT00527735|20936210|P2|Overall Study|Completed treatment in treatment phase|13
6059281|NCT00527735|20936211|P1|Overall Study|Completed treatment in treatment phase|14
6059282|NCT00527735|20936209|P3|Overall Study|Death|15
6059283|NCT00527735|20936210|P2|Overall Study|Death|13
6059284|NCT00527735|20936211|P1|Overall Study|Death|23
6059285|NCT00527735|20936209|P3|Overall Study|Disease progression|53
6059286|NCT00527735|20936210|P2|Overall Study|Disease progression|61
6059287|NCT00527735|20936211|P1|Overall Study|Disease progression|47
6059288|NCT00527618|20936297|P2|Week 15-18 (Second Intervention)|Withdrawal by Subject|1
6059289|NCT00527618|20936298|P1|Week 15-18 (Second Intervention)|Withdrawal by Subject|0
6059290|NCT00527618|20936297|P2|Week 15-18 (Second Intervention)|Censored on initiation of HAART|1
6059291|NCT00527618|20936298|P1|Week 15-18 (Second Intervention)|Censored on initiation of HAART|0
6059292|NCT00527618|20936297|P2|Week 15-18 (Second Intervention)|Lost to Follow-up|1
6059293|NCT00527618|20936298|P1|Week 15-18 (Second Intervention)|Lost to Follow-up|0
6059294|NCT00527618|20936297|P2|Week 13-14 (Washout)|Lost to Follow-up|0
6059295|NCT00527618|20936298|P1|Week 13-14 (Washout)|Lost to Follow-up|1
6059296|NCT00527618|20936297|P2|Week 1-12 (First Intervention)|Adverse Event|1
6059297|NCT00527618|20936298|P1|Week 1-12 (First Intervention)|Adverse Event|0
6059298|NCT00527618|20936297|P2|Week 1-12 (First Intervention)|Lost to Follow-up|1
6059299|NCT00527618|20936298|P1|Week 1-12 (First Intervention)|Lost to Follow-up|3
6059300|NCT00527605|20936313|P2|Overall Study|Protocol Violation|2
6059301|NCT00527605|20936314|P1|Overall Study|Protocol Violation|1
6059302|NCT00527605|20936313|P2|Overall Study|Lost to Follow-up|2
6059303|NCT00527605|20936314|P1|Overall Study|Lost to Follow-up|6
6059304|NCT00527605|20936313|P2|Overall Study|Withdrawal by Subject|7
6059305|NCT00527605|20936314|P1|Overall Study|Withdrawal by Subject|3
6059306|NCT00527605|20936313|P2|Overall Study|Adverse Event|0
6059307|NCT00527605|20936314|P1|Overall Study|Adverse Event|3
6059308|NCT00527514|20936365|P1|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Withdrawal by Subject|1
6059309|NCT00527514|20936365|P1|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Adverse Event|1
6059310|NCT00527514|20936365|P1|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Withdrawal by Subject|1
6059311|NCT00527514|20936365|P1|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Lost to Follow-up|1
6059312|NCT00527514|20936365|P1|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Adverse Event|1
6059313|NCT00527514|20936365|P1|Weeks 4-6: Aml 5mg+Olmesartan 20 mg|Withdrawal by Subject|2
6059314|NCT00527514|20936365|P1|Weeks 1-3: Amlodipine (Aml) 5mg|Adverse Event|1
6059315|NCT00527488|20936381|P4|Overall Study|Withdrawn prior to dosing|0
6059316|NCT00527488|20936382|P3|Overall Study|Withdrawn prior to dosing|1
6059317|NCT00527488|20936383|P2|Overall Study|Withdrawn prior to dosing|1
6059318|NCT00527488|20936384|P1|Overall Study|Withdrawn prior to dosing|0
6059319|NCT00527423|20936467|P1|Overall Study|Death|9
6059320|NCT00527423|20936467|P1|Overall Study|OTHER|4
6059321|NCT00527423|20936467|P1|Overall Study|Lost to Follow-up|4
6059322|NCT00527423|20936467|P1|Overall Study|Withdrawal by Subject|10
6059323|NCT00527423|20936467|P1|Overall Study|Physician Decision|4
6059324|NCT00527423|20936467|P1|Overall Study|Adverse Event|5
6059325|NCT00527423|20936467|P1|Overall Study|Protocol Violation|1
6059326|NCT00527397|20936473|P1|Overall Study|Study terminated by sponsor|13
6059327|NCT00527397|20936473|P1|Overall Study|Withdrawal by Subject|6
6059328|NCT00527397|20936473|P1|Overall Study|Protocol Violation|1
6059329|NCT00527397|20936473|P1|Overall Study|Lack of Efficacy|1
6059330|NCT00527397|20936473|P1|Overall Study|Adverse Event|3
6059331|NCT00527332|20936499|P2|Overall Study|Withdrew consent|1
6059332|NCT00527332|20936500|P1|Overall Study|Withdrew consent|5
6059333|NCT00527332|20936499|P2|Overall Study|Protocol Violation|8
6059334|NCT00527332|20936500|P1|Overall Study|Protocol Violation|4
6059335|NCT00527319|20936509|P3|Overall Study|Adverse Event|1
6059336|NCT00527319|20936510|P2|Overall Study|Adverse Event|0
6059337|NCT00527319|20936511|P1|Overall Study|Adverse Event|0
6059338|NCT00527319|20936509|P3|Overall Study|Intercurrent Medical Illness|3
6059339|NCT00527319|20936510|P2|Overall Study|Intercurrent Medical Illness|1
6059340|NCT00527319|20936511|P1|Overall Study|Intercurrent Medical Illness|0
6059341|NCT00527319|20936509|P3|Overall Study|Death|1
6059342|NCT00527319|20936510|P2|Overall Study|Death|3
6059343|NCT00527319|20936511|P1|Overall Study|Death|0
6059344|NCT00527319|20936509|P3|Overall Study|Lost to Follow-up|0
6059345|NCT00527319|20936510|P2|Overall Study|Lost to Follow-up|0
6059346|NCT00527319|20936511|P1|Overall Study|Lost to Follow-up|1
6059347|NCT00527319|20936509|P3|Overall Study|Withdrawal by Subject|1
6059348|NCT00527319|20936510|P2|Overall Study|Withdrawal by Subject|0
6059349|NCT00527319|20936511|P1|Overall Study|Withdrawal by Subject|5
6059350|NCT00527111|20936541|P2|Overall Study|Other|2
6059351|NCT00527111|20936542|P1|Overall Study|Other|2
6059352|NCT00527111|20936541|P2|Overall Study|Patient Request|5
6059353|NCT00527111|20936542|P1|Overall Study|Patient Request|2
6059354|NCT00527111|20936541|P2|Overall Study|Investigator Request|1
6059355|NCT00527111|20936542|P1|Overall Study|Investigator Request|2
6059356|NCT00527111|20936541|P2|Overall Study|Death|1
6059357|NCT00527111|20936542|P1|Overall Study|Death|0
6059358|NCT00527111|20936541|P2|Overall Study|Adverse Event|13
6059359|NCT00527111|20936542|P1|Overall Study|Adverse Event|14
6059360|NCT00527072|20936564|P1|Overall Study|Withdrawal by Subject|7
6059361|NCT00527072|20936564|P1|Overall Study|Protocol Violation|2
6059362|NCT00527072|20936564|P1|Overall Study|Lost to Follow-up|3
6059363|NCT00527072|20936564|P1|Overall Study|Lack of Efficacy|11
6059364|NCT00527072|20936564|P1|Overall Study|Adverse Event|13
6059365|NCT00526994|20936573|P3|Overall Study|incarcerated, impaired, incomplete|3
6059366|NCT00526994|20936574|P2|Overall Study|incarcerated, impaired, incomplete|3
6059367|NCT00526994|20936575|P1|Overall Study|incarcerated, impaired, incomplete|4
6059368|NCT00526994|20936573|P3|Overall Study|Withdrawal by Subject|5
6059369|NCT00526994|20936574|P2|Overall Study|Withdrawal by Subject|7
6059370|NCT00526994|20936575|P1|Overall Study|Withdrawal by Subject|2
6059371|NCT00526994|20936573|P3|Overall Study|Death|3
6059372|NCT00526994|20936574|P2|Overall Study|Death|3
6059373|NCT00526994|20936575|P1|Overall Study|Death|4
6059374|NCT00526994|20936573|P3|Overall Study|Lost to Follow-up|96
6059375|NCT00526994|20936574|P2|Overall Study|Lost to Follow-up|108
6059376|NCT00526994|20936575|P1|Overall Study|Lost to Follow-up|98
6059377|NCT00526890|20936592|P1|Overall Study|Adverse Event|2
6059378|NCT00526799|20936604|P2|Overall Study|Intercurrent Complicating Disease|1
6059379|NCT00526799|20936605|P1|Overall Study|Intercurrent Complicating Disease|0
6059380|NCT00526799|20936604|P2|Overall Study|Withdrawal by Subject|0
6059381|NCT00526799|20936605|P1|Overall Study|Withdrawal by Subject|1
6059382|NCT00526669|20936613|P2|Combined Treatment Phase|Death|2
6059383|NCT00526669|20936614|P1|Combined Treatment Phase|Death|0
6059384|NCT00526669|20936613|P2|Combined Treatment Phase|Sponsor Terminated Study|2
6059385|NCT00526669|20936614|P1|Combined Treatment Phase|Sponsor Terminated Study|0
6059386|NCT00526669|20936613|P2|Combined Treatment Phase|Withdrawal by Subject|2
6059387|NCT00526669|20936614|P1|Combined Treatment Phase|Withdrawal by Subject|0
6059388|NCT00526669|20936613|P2|Combined Treatment Phase|Lost to Follow-up|2
6059389|NCT00526669|20936614|P1|Combined Treatment Phase|Lost to Follow-up|0
6059390|NCT00526656|20936643|P1|Overall Study|Refused surgery|1
6059391|NCT00526656|20936643|P1|Overall Study|Death|1
6059392|NCT00526630|20936649|P2|Second Intervention Period - 12 Weeks|Withdrawn|1
6059393|NCT00526630|20936650|P1|Second Intervention Period - 12 Weeks|Withdrawn|2
6059394|NCT00526630|20936649|P2|First Intervention Period - 12 Weeks|Withdrawn|3
6059395|NCT00526630|20936650|P1|First Intervention Period - 12 Weeks|Withdrawn|0
6059396|NCT00526331|20936762|P1|Overall Study|Sponsor Termination|55
6059397|NCT00526227|20936770|P1|Overall Study|Death|1
6059398|NCT00526227|20936770|P1|Overall Study|Device not implanted|1
6059399|NCT00526162|20936783|P1|Overall Study|Device not implanted|3
6059400|NCT00526110|20936816|P2|Overall Study|Poor Tolerance|5
6059401|NCT00526110|20936817|P1|Overall Study|Poor Tolerance|0
6059402|NCT00526110|20936816|P2|Overall Study|Withdrawal by Subject|2
6059403|NCT00526110|20936817|P1|Overall Study|Withdrawal by Subject|0
6059404|NCT00526110|20936816|P2|Overall Study|Maximal Response|6
6059405|NCT00526110|20936817|P1|Overall Study|Maximal Response|0
6059406|NCT00526110|20936816|P2|Overall Study|Disease Progression|19
6059407|NCT00526110|20936817|P1|Overall Study|Disease Progression|0
6059408|NCT00526110|20936816|P2|Overall Study|Adverse Event|9
6059409|NCT00526110|20936817|P1|Overall Study|Adverse Event|2
6059410|NCT00526097|20936826|P2|Overall Study|Other|1
6059411|NCT00526097|20936827|P1|Overall Study|Other|2
6059412|NCT00526097|20936826|P2|Overall Study|Withdrawal by Subject|1
6059413|NCT00526097|20936827|P1|Overall Study|Withdrawal by Subject|3
6059414|NCT00526097|20936826|P2|Overall Study|Protocol Violation|10
6059415|NCT00526097|20936827|P1|Overall Study|Protocol Violation|4
6059416|NCT00526097|20936826|P2|Overall Study|Adverse Event|44
6059417|NCT00526097|20936827|P1|Overall Study|Adverse Event|6
6059418|NCT00526071|20937003|P1|Overall Study|Lack of Response to Study Drug|4
6059419|NCT00526071|20937003|P1|Overall Study|Withdrawal by Subject|1
6059420|NCT00526071|20937003|P1|Overall Study|Adverse Event|1
6059421|NCT00525915|20937029|P2|Overall Study|Unrelated illness|0
6059422|NCT00525915|20937030|P1|Overall Study|Unrelated illness|1
6059423|NCT00525915|20937029|P2|Overall Study|Refused Surgery|2
6059424|NCT00525915|20937030|P1|Overall Study|Refused Surgery|1
6059425|NCT00525915|20937029|P2|Overall Study|Withdrawal by Subject|0
6059426|NCT00525915|20937030|P1|Overall Study|Withdrawal by Subject|1
6059427|NCT00525915|20937029|P2|Overall Study|Disease Progression|6
6059428|NCT00525915|20937030|P1|Overall Study|Disease Progression|5
6059429|NCT00525915|20937029|P2|Overall Study|Non-Compliance|1
6059430|NCT00525915|20937030|P1|Overall Study|Non-Compliance|0
6059431|NCT00525902|20937036|P1|Overall Study|Lack of Efficacy|1
6059432|NCT00525824|20937060|P4|Overall Study|Other|1
6059433|NCT00525824|20937061|P3|Overall Study|Other|3
6059434|NCT00525824|20937062|P2|Overall Study|Other|3
6059435|NCT00525824|20937063|P1|Overall Study|Other|1
6059436|NCT00525824|20937060|P4|Overall Study|Safety reasons|0
6059437|NCT00525824|20937061|P3|Overall Study|Safety reasons|1
6059438|NCT00525824|20937062|P2|Overall Study|Safety reasons|0
6059439|NCT00525824|20937063|P1|Overall Study|Safety reasons|1
6059440|NCT00525824|20937060|P4|Overall Study|Severe non-compliance|1
6059441|NCT00525824|20937061|P3|Overall Study|Severe non-compliance|1
6059442|NCT00525824|20937062|P2|Overall Study|Severe non-compliance|1
6059443|NCT00525824|20937063|P1|Overall Study|Severe non-compliance|0
6059444|NCT00525824|20937060|P4|Overall Study|Incorrect enrolment/mis-randomisation|2
6059445|NCT00525824|20937061|P3|Overall Study|Incorrect enrolment/mis-randomisation|1
6059446|NCT00525824|20937062|P2|Overall Study|Incorrect enrolment/mis-randomisation|2
6059447|NCT00525824|20937063|P1|Overall Study|Incorrect enrolment/mis-randomisation|1
6059448|NCT00525824|20937060|P4|Overall Study|Lost to Follow-up|0
6059449|NCT00525824|20937061|P3|Overall Study|Lost to Follow-up|4
6059450|NCT00525824|20937062|P2|Overall Study|Lost to Follow-up|2
6059451|NCT00525824|20937063|P1|Overall Study|Lost to Follow-up|4
6059452|NCT00525824|20937060|P4|Overall Study|Withdrawal by Subject|4
6059453|NCT00525824|20937061|P3|Overall Study|Withdrawal by Subject|3
6059454|NCT00525824|20937062|P2|Overall Study|Withdrawal by Subject|9
6059455|NCT00525824|20937063|P1|Overall Study|Withdrawal by Subject|5
6059456|NCT00525824|20937060|P4|Overall Study|Adverse Event|7
6059457|NCT00525824|20937061|P3|Overall Study|Adverse Event|6
6059458|NCT00525824|20937062|P2|Overall Study|Adverse Event|11
6059459|NCT00525824|20937063|P1|Overall Study|Adverse Event|7
6059460|NCT00525785|20937136|P1|Overall Study|Physician Decision|1
6059461|NCT00525785|20937136|P1|Overall Study|Lack of Efficacy|1
6059462|NCT00525785|20937136|P1|Overall Study|Withdrawal by Subject|1
6059463|NCT00525590|20937160|P1|Overall Study|Other|13
6059464|NCT00525590|20937160|P1|Overall Study|Death|9
6059465|NCT00525590|20937160|P1|Overall Study|Lost to Follow-up|1
6059466|NCT00525590|20937160|P1|Overall Study|Withdrawal by Subject|16
6059467|NCT00525590|20937160|P1|Overall Study|Physician Decision|3
6059468|NCT00525590|20937160|P1|Overall Study|Adverse Event|3
6059469|NCT00525512|20937188|P4|Open-Label Phase|Other reason (not specified)|5
6059470|NCT00525512|20937189|P3|Open-Label Phase|Other reason (not specified)|4
6059471|NCT00525512|20937190|P2|Open-Label Phase|Other reason (not specified)|0
6059472|NCT00525512|20937191|P1|Open-Label Phase|Other reason (not specified)|0
6059473|NCT00525512|20937188|P4|Open-Label Phase|Lost to Follow-up|0
6059474|NCT00525512|20937189|P3|Open-Label Phase|Lost to Follow-up|1
6059475|NCT00525512|20937190|P2|Open-Label Phase|Lost to Follow-up|0
6059476|NCT00525512|20937191|P1|Open-Label Phase|Lost to Follow-up|0
6059477|NCT00525512|20937188|P4|Open-Label Phase|Adverse Event|0
6059478|NCT00525512|20937189|P3|Open-Label Phase|Adverse Event|1
6059479|NCT00525512|20937190|P2|Open-Label Phase|Adverse Event|0
6059480|NCT00525512|20937191|P1|Open-Label Phase|Adverse Event|0
6059481|NCT00525512|20937188|P4|Double-Blind Phase|Other reason (not specified)|0
6059482|NCT00525512|20937189|P3|Double-Blind Phase|Other reason (not specified)|0
6059483|NCT00525512|20937190|P2|Double-Blind Phase|Other reason (not specified)|13
6059484|NCT00525512|20937191|P1|Double-Blind Phase|Other reason (not specified)|12
6059485|NCT00525512|20937188|P4|Double-Blind Phase|Lack of Efficacy|0
6059486|NCT00525512|20937189|P3|Double-Blind Phase|Lack of Efficacy|0
6059487|NCT00525512|20937190|P2|Double-Blind Phase|Lack of Efficacy|5
6059488|NCT00525512|20937191|P1|Double-Blind Phase|Lack of Efficacy|13
6059489|NCT00525512|20937188|P4|Double-Blind Phase|Withdrawal by Subject|0
6059490|NCT00525512|20937189|P3|Double-Blind Phase|Withdrawal by Subject|0
6059491|NCT00525512|20937190|P2|Double-Blind Phase|Withdrawal by Subject|12
6059492|NCT00525512|20937191|P1|Double-Blind Phase|Withdrawal by Subject|17
6059493|NCT00525512|20937188|P4|Double-Blind Phase|Lost to Follow-up|0
6059494|NCT00525512|20937189|P3|Double-Blind Phase|Lost to Follow-up|0
6059495|NCT00525512|20937190|P2|Double-Blind Phase|Lost to Follow-up|7
6059496|NCT00525512|20937191|P1|Double-Blind Phase|Lost to Follow-up|3
6059497|NCT00525512|20937188|P4|Double-Blind Phase|Protocol Violation|0
6059498|NCT00525512|20937189|P3|Double-Blind Phase|Protocol Violation|0
6059499|NCT00525512|20937190|P2|Double-Blind Phase|Protocol Violation|1
6059500|NCT00525512|20937191|P1|Double-Blind Phase|Protocol Violation|3
6059501|NCT00525512|20937188|P4|Double-Blind Phase|Adverse Event|0
6059502|NCT00525512|20937189|P3|Double-Blind Phase|Adverse Event|0
6059503|NCT00525512|20937190|P2|Double-Blind Phase|Adverse Event|28
6059504|NCT00525512|20937191|P1|Double-Blind Phase|Adverse Event|48
6059505|NCT00525499|20937333|P4|Overall Study|Protocol Violation|0
6059506|NCT00525499|20937334|P3|Overall Study|Protocol Violation|1
6059507|NCT00525499|20937335|P2|Overall Study|Protocol Violation|1
6059508|NCT00525499|20937336|P1|Overall Study|Protocol Violation|0
6059509|NCT00525499|20937333|P4|Overall Study|Withdrawal by Subject|2
6059510|NCT00525499|20937334|P3|Overall Study|Withdrawal by Subject|5
6059511|NCT00525499|20937335|P2|Overall Study|Withdrawal by Subject|1
6059512|NCT00525499|20937336|P1|Overall Study|Withdrawal by Subject|5
6059513|NCT00525499|20937333|P4|Overall Study|Adverse Event|1
6059514|NCT00525499|20937334|P3|Overall Study|Adverse Event|0
6059515|NCT00525499|20937335|P2|Overall Study|Adverse Event|1
6059516|NCT00525499|20937336|P1|Overall Study|Adverse Event|0
6059517|NCT00525499|20937333|P4|Overall Study|Lost to Follow-up|4
6059518|NCT00525499|20937334|P3|Overall Study|Lost to Follow-up|1
6059519|NCT00525499|20937335|P2|Overall Study|Lost to Follow-up|4
6059520|NCT00525499|20937336|P1|Overall Study|Lost to Follow-up|2
6059521|NCT00525265|20937363|P2|Overall Study|Protocol Violation|0
6059522|NCT00525265|20937364|P1|Overall Study|Protocol Violation|1
6059523|NCT00525161|20937421|P1|Overall Study|Adverse Event|1
6059524|NCT00525148|20937431|P4|Overall Study|Other than stated|3
6059525|NCT00525148|20937432|P3|Overall Study|Other than stated|0
6059526|NCT00525148|20937433|P2|Overall Study|Other than stated|1
6059527|NCT00525148|20937434|P1|Overall Study|Other than stated|2
6059528|NCT00525148|20937431|P4|Overall Study|Refused continuation of study medication|1
6059529|NCT00525148|20937432|P3|Overall Study|Refused continuation of study medication|0
6059530|NCT00525148|20937433|P2|Overall Study|Refused continuation of study medication|2
6059531|NCT00525148|20937434|P1|Overall Study|Refused continuation of study medication|0
6059532|NCT00525148|20937431|P4|Overall Study|Progressive disease|49
6059533|NCT00525148|20937432|P3|Overall Study|Progressive disease|6
6059534|NCT00525148|20937433|P2|Overall Study|Progressive disease|30
6059535|NCT00525148|20937434|P1|Overall Study|Progressive disease|18
6059536|NCT00525148|20937431|P4|Overall Study|Other Adverse Event|8
6059537|NCT00525148|20937432|P3|Overall Study|Other Adverse Event|1
6059538|NCT00525148|20937433|P2|Overall Study|Other Adverse Event|5
6059539|NCT00525148|20937434|P1|Overall Study|Other Adverse Event|3
6059540|NCT00525044|20937475|P2|Overall Study|Lost to Follow-up|1
6059541|NCT00525044|20937476|P1|Overall Study|Lost to Follow-up|0
6059542|NCT00525031|20937492|P2|Overall Study|Disease Progression|1
6059543|NCT00525031|20937493|P1|Overall Study|Disease Progression|1
6059544|NCT00524771|20937507|P2|Overall Study|Protocol Violation|585
6059545|NCT00524771|20937508|P1|Overall Study|Protocol Violation|220
6059546|NCT00524745|20937522|P4|Overall Study|subject withdrawal or lost to follow up|22
6059547|NCT00524745|20937523|P3|Overall Study|subject withdrawal or lost to follow up|29
6059548|NCT00524745|20937524|P2|Overall Study|subject withdrawal or lost to follow up|13
6059549|NCT00524745|20937525|P1|Overall Study|subject withdrawal or lost to follow up|34
6059550|NCT00524680|20937551|P4|Overall Study|Withdrawal by Subject|1
6059551|NCT00524680|20937552|P3|Overall Study|Withdrawal by Subject|1
6059552|NCT00524680|20937553|P2|Overall Study|Withdrawal by Subject|0
6059553|NCT00524680|20937554|P1|Overall Study|Withdrawal by Subject|1
6059554|NCT00524680|20937551|P4|Overall Study|Other|3
6059555|NCT00524680|20937552|P3|Overall Study|Other|2
6059556|NCT00524680|20937553|P2|Overall Study|Other|1
6059557|NCT00524680|20937554|P1|Overall Study|Other|0
6059558|NCT00524680|20937551|P4|Overall Study|Adverse Event|1
6059559|NCT00524680|20937552|P3|Overall Study|Adverse Event|0
6059560|NCT00524680|20937553|P2|Overall Study|Adverse Event|0
6059561|NCT00524680|20937554|P1|Overall Study|Adverse Event|2
6059562|NCT00524680|20937551|P4|Overall Study|progression|1
6059563|NCT00524680|20937552|P3|Overall Study|progression|0
6059564|NCT00524680|20937553|P2|Overall Study|progression|0
6059565|NCT00524680|20937554|P1|Overall Study|progression|0
6059566|NCT00524589|20937576|P1|Overall Study|Disease Progression|16
6059567|NCT00524589|20937576|P1|Overall Study|Withdrawal by Subject|2
6059568|NCT00524485|20937627|P1|Overall Study|Withdrawal by Subject|5
6059569|NCT00524459|20937656|P1|Overall Study|Other|1
6059570|NCT00524459|20937656|P1|Overall Study|Withdrawal by Subject|1
6059571|NCT00524420|20937666|P2|Overall Study|Lack of Efficacy|0
6059572|NCT00524420|20937667|P1|Overall Study|Lack of Efficacy|1
6059573|NCT00524368|20937685|P2|Overall Study|Other|2
6059574|NCT00524368|20937686|P1|Overall Study|Other|3
6059575|NCT00524368|20937685|P2|Overall Study|Ineligible to Continue the study|5
6059576|NCT00524368|20937686|P1|Overall Study|Ineligible to Continue the study|2
6059577|NCT00524368|20937685|P2|Overall Study|Sponsor's Decision|0
6059578|NCT00524368|20937686|P1|Overall Study|Sponsor's Decision|2
6059579|NCT00524368|20937685|P2|Overall Study|Reached a Virologic Endpoint|2
6059580|NCT00524368|20937686|P1|Overall Study|Reached a Virologic Endpoint|3
6059581|NCT00524368|20937685|P2|Overall Study|Non-compliant|9
6059582|NCT00524368|20937686|P1|Overall Study|Non-compliant|8
6059583|NCT00524368|20937685|P2|Overall Study|Withdrawal by Subject|5
6059584|NCT00524368|20937686|P1|Overall Study|Withdrawal by Subject|4
6059585|NCT00524368|20937685|P2|Overall Study|Lost to Follow-up|13
6059586|NCT00524368|20937686|P1|Overall Study|Lost to Follow-up|9
6059587|NCT00524368|20937685|P2|Overall Study|Adverse Event|12
6059588|NCT00524368|20937686|P1|Overall Study|Adverse Event|10
6059589|NCT00524316|20937720|P1|Overall Study|Disease Progression|7
6059590|NCT00524316|20937720|P1|Overall Study|Adverse Event|7
6059591|NCT00524316|20937720|P1|Overall Study|Withdrawal by Subject|2
6059592|NCT00524303|20937732|P3|Overall Study|Completed 5 years|1
6059593|NCT00524303|20937733|P2|Overall Study|Completed 5 years|0
6059594|NCT00524303|20937734|P1|Overall Study|Completed 5 years|0
6059595|NCT00524303|20937732|P3|Overall Study|Physician Decision|1
6059596|NCT00524303|20937733|P2|Overall Study|Physician Decision|0
6059597|NCT00524303|20937734|P1|Overall Study|Physician Decision|0
6059598|NCT00524303|20937732|P3|Overall Study|Sponsor Request|1
6059599|NCT00524303|20937733|P2|Overall Study|Sponsor Request|0
6059600|NCT00524303|20937734|P1|Overall Study|Sponsor Request|0
6059601|NCT00524303|20937732|P3|Overall Study|Disease Recurrence|0
6059602|NCT00524303|20937733|P2|Overall Study|Disease Recurrence|1
6059603|NCT00524303|20937734|P1|Overall Study|Disease Recurrence|0
6059604|NCT00524303|20937732|P3|Overall Study|Disease Progression|1
6059605|NCT00524303|20937733|P2|Overall Study|Disease Progression|4
6059606|NCT00524303|20937734|P1|Overall Study|Disease Progression|0
6059607|NCT00524303|20937732|P3|Overall Study|Worsening Peripheral Neuropathy|0
6059608|NCT00524303|20937733|P2|Overall Study|Worsening Peripheral Neuropathy|0
6059609|NCT00524303|20937734|P1|Overall Study|Worsening Peripheral Neuropathy|1
6059610|NCT00524303|20937732|P3|Overall Study|Did not Complete Study Dosing|0
6059611|NCT00524303|20937733|P2|Overall Study|Did not Complete Study Dosing|0
6059612|NCT00524303|20937734|P1|Overall Study|Did not Complete Study Dosing|1
6059613|NCT00524303|20937732|P3|Overall Study|Adverse Event|3
6059614|NCT00524303|20937733|P2|Overall Study|Adverse Event|2
6059615|NCT00524303|20937734|P1|Overall Study|Adverse Event|1
6059616|NCT00524303|20937732|P3|Overall Study|Death|3
6059617|NCT00524303|20937733|P2|Overall Study|Death|2
6059618|NCT00524303|20937734|P1|Overall Study|Death|0
6059619|NCT00524303|20937732|P3|Overall Study|Withdrawal by Subject|4
6059620|NCT00524303|20937733|P2|Overall Study|Withdrawal by Subject|0
6059621|NCT00524303|20937734|P1|Overall Study|Withdrawal by Subject|3
6059622|NCT00524303|20937732|P3|Overall Study|Protocol Violation|1
6059623|NCT00524303|20937733|P2|Overall Study|Protocol Violation|1
6059624|NCT00524303|20937734|P1|Overall Study|Protocol Violation|0
6059625|NCT00524303|20937732|P3|Overall Study|Lost to Follow-up|3
6059626|NCT00524303|20937733|P2|Overall Study|Lost to Follow-up|0
6059627|NCT00524303|20937734|P1|Overall Study|Lost to Follow-up|6
6059628|NCT00524173|20937786|P2|Overall Study|Had not reached endpoint at study close|1
6059629|NCT00524173|20937787|P1|Overall Study|Had not reached endpoint at study close|4
6059630|NCT00524173|20937786|P2|Overall Study|Death|0
6059631|NCT00524173|20937787|P1|Overall Study|Death|1
6059632|NCT00524173|20937786|P2|Overall Study|Lost to Follow-up|1
6059633|NCT00524173|20937787|P1|Overall Study|Lost to Follow-up|0
6059634|NCT00524134|20937799|P1|Overall Study|Physician Decision|1
6059635|NCT00524134|20937799|P1|Overall Study|Withdrawal by Subject|1
6059636|NCT00524121|20937806|P1|Overall Study|Not treated (changed mind)|1
6059637|NCT00524121|20937806|P1|Overall Study|Not treated (became ineligible)|4
6059638|NCT00524121|20937806|P1|Overall Study|Death|1
6059639|NCT00524121|20937806|P1|Overall Study|Other|1
6059640|NCT00524121|20937806|P1|Overall Study|Patient refused|2
6059641|NCT00524121|20937806|P1|Overall Study|Adverse Event|4
6059642|NCT00524121|20937806|P1|Overall Study|Disease progression|6
6059643|NCT00524043|20937826|P3|Overall Study|Various (eg, incarceration)|0
6059644|NCT00524043|20937827|P2|Overall Study|Various (eg, incarceration)|1
6059645|NCT00524043|20937828|P1|Overall Study|Various (eg, incarceration)|2
6059646|NCT00524043|20937826|P3|Overall Study|Lost to Follow-up|3
6059647|NCT00524043|20937827|P2|Overall Study|Lost to Follow-up|5
6059648|NCT00524043|20937828|P1|Overall Study|Lost to Follow-up|3
6059649|NCT00524043|20937826|P3|Overall Study|Adverse Event|7
6059650|NCT00524043|20937827|P2|Overall Study|Adverse Event|2
6059651|NCT00524043|20937828|P1|Overall Study|Adverse Event|5
6059652|NCT00524043|20937826|P3|Overall Study|Withdrawal by Subject|7
6059653|NCT00524043|20937827|P2|Overall Study|Withdrawal by Subject|7
6059654|NCT00524043|20937828|P1|Overall Study|Withdrawal by Subject|5
6059655|NCT00524043|20937826|P3|Overall Study|Lack of Efficacy|14
6059656|NCT00524043|20937827|P2|Overall Study|Lack of Efficacy|13
6059657|NCT00524043|20937828|P1|Overall Study|Lack of Efficacy|15
6059658|NCT00524030|20937850|P2|Overall Study|Death|1
6059659|NCT00524030|20937851|P1|Overall Study|Death|0
6059660|NCT00524030|20937850|P2|Overall Study|Adverse Event|21
6059661|NCT00524030|20937851|P1|Overall Study|Adverse Event|3
6059662|NCT00524030|20937850|P2|Overall Study|Pregnancy|0
6059663|NCT00524030|20937851|P1|Overall Study|Pregnancy|1
6059664|NCT00524030|20937850|P2|Overall Study|Protocol Violation|1
6059665|NCT00524030|20937851|P1|Overall Study|Protocol Violation|0
6059666|NCT00524030|20937850|P2|Overall Study|Noncompliance/Investigator discretion|2
6059667|NCT00524030|20937851|P1|Overall Study|Noncompliance/Investigator discretion|0
6059668|NCT00524030|20937850|P2|Overall Study|Withdrawal by Subject|8
6059669|NCT00524030|20937851|P1|Overall Study|Withdrawal by Subject|3
6059670|NCT00524030|20937850|P2|Overall Study|Lost to Follow-up|2
6059671|NCT00524030|20937851|P1|Overall Study|Lost to Follow-up|0
6059672|NCT00524030|20937850|P2|Overall Study|Lack of Efficacy|24
6059673|NCT00524030|20937851|P1|Overall Study|Lack of Efficacy|10
6059674|NCT00523991|20937890|P2|Overall Study|Other reason (not specified)|0
6059675|NCT00523991|20937891|P1|Overall Study|Other reason (not specified)|3
6059676|NCT00523991|20937890|P2|Overall Study|Withdrawal by Subject|17
6059677|NCT00523991|20937891|P1|Overall Study|Withdrawal by Subject|7
6059678|NCT00523991|20937890|P2|Overall Study|Lost to Follow-up|1
6059679|NCT00523991|20937891|P1|Overall Study|Lost to Follow-up|4
6059680|NCT00523991|20937890|P2|Overall Study|Protocol Violation|4
6059681|NCT00523991|20937891|P1|Overall Study|Protocol Violation|1
6059682|NCT00523991|20937890|P2|Overall Study|Adverse Event|5
6059683|NCT00523991|20937891|P1|Overall Study|Adverse Event|6
6059684|NCT00523978|20938171|P2|Overall Study|Death|0
6059685|NCT00523978|20938172|P1|Overall Study|Death|1
6059686|NCT00523978|20938171|P2|Overall Study|Screen Failures|1
6059687|NCT00523978|20938172|P1|Overall Study|Screen Failures|5
6059688|NCT00523978|20938171|P2|Overall Study|Withdrawal by Subject|7
6059689|NCT00523978|20938172|P1|Overall Study|Withdrawal by Subject|3
6059690|NCT00523848|20938194|P1|Overall Study|Other, unspecified|4
6059691|NCT00523848|20938194|P1|Overall Study|Disease Progression|5
6059692|NCT00523848|20938194|P1|Overall Study|NOT TREATED (Became ineligible)|2
6059693|NCT00523848|20938194|P1|Overall Study|Withdrawal by Subject|2
6059694|NCT00523848|20938194|P1|Overall Study|Adverse Event|11
6059695|NCT00523744|20938204|P1|Phase 2 - Amlodipine+Valsartan|Lost to Follow-up|1
6059696|NCT00523744|20938204|P1|Phase 2 - Amlodipine+Valsartan|Adverse Event|2
6059697|NCT00523744|20938204|P1|Phase 1 - Amlodipine+Olmesartan|Administrative problems|1
6059698|NCT00523744|20938204|P1|Phase 1 - Amlodipine+Olmesartan|Lost to Follow-up|2
6059699|NCT00523744|20938204|P1|Phase 1 - Amlodipine+Olmesartan|Withdrawal by Subject|1
6059700|NCT00523744|20938204|P1|Phase 1 - Amlodipine+Olmesartan|Adverse Event|2
6059701|NCT00523718|20938223|P2|Overall Study|Protocol Violation|0
6059702|NCT00523718|20938224|P1|Overall Study|Protocol Violation|2
6059703|NCT00523718|20938223|P2|Overall Study|Withdrawal by Subject|0
6059704|NCT00523718|20938224|P1|Overall Study|Withdrawal by Subject|1
6059705|NCT00523705|20938238|P2|Overall Study|No time for study.|1
6059706|NCT00523705|20938239|P1|Overall Study|No time for study.|0
6059707|NCT00523640|20938251|P1|Overall Study|Death|1
6059708|NCT00523549|20938268|P2|Overall Study|Lost to Follow-up|5
6059709|NCT00523549|20938269|P1|Overall Study|Lost to Follow-up|3
6059710|NCT00523549|20938268|P2|Overall Study|Patient withdrew consent|6
6059711|NCT00523549|20938269|P1|Overall Study|Patient withdrew consent|7
6059712|NCT00523549|20938268|P2|Overall Study|Protocol Deviation|1
6059713|NCT00523549|20938269|P1|Overall Study|Protocol Deviation|3
6059714|NCT00523549|20938268|P2|Overall Study|Unsatisfactory therapeutic effect|1
6059715|NCT00523549|20938269|P1|Overall Study|Unsatisfactory therapeutic effect|0
6059716|NCT00523549|20938268|P2|Overall Study|Adverse Event|3
6059717|NCT00523549|20938269|P1|Overall Study|Adverse Event|6
6059718|NCT00523419|20938287|P1|Overall Study|Death due to Adverse Event|2
6059719|NCT00523419|20938287|P1|Overall Study|Death due to Study Disease|4
6059720|NCT00523419|20938287|P1|Overall Study|Progressive Disease|22
6059721|NCT00523419|20938287|P1|Overall Study|Physician Decision|2
6059722|NCT00523419|20938287|P1|Overall Study|Withdrawal by Subject|1
6059723|NCT00523419|20938287|P1|Overall Study|Adverse Event|1
6059724|NCT00523367|20938297|P1|Overall Study|4 Withdrawn by PI|4
6059725|NCT00523367|20938297|P1|Overall Study|19 screen failures|19
6059726|NCT00523341|20938303|P2|Overall Study|Disease Progression|0
6059727|NCT00523341|20938304|P1|Overall Study|Disease Progression|1
6059728|NCT00523341|20938303|P2|Overall Study|Ineligibility Determined|4
6059729|NCT00523341|20938304|P1|Overall Study|Ineligibility Determined|3
6059730|NCT00523341|20938303|P2|Overall Study|Protocol Deviation|5
6059731|NCT00523341|20938304|P1|Overall Study|Protocol Deviation|6
6059732|NCT00523341|20938303|P2|Overall Study|Requirement for Alternative Therapy|14
6059733|NCT00523341|20938304|P1|Overall Study|Requirement for Alternative Therapy|4
6059734|NCT00523341|20938303|P2|Overall Study|Physician Decision|13
6059735|NCT00523341|20938304|P1|Overall Study|Physician Decision|14
6059736|NCT00523341|20938303|P2|Overall Study|Non-compliance|13
6059737|NCT00523341|20938304|P1|Overall Study|Non-compliance|20
6059738|NCT00523341|20938303|P2|Overall Study|Lost to Follow-up|61
6059739|NCT00523341|20938304|P1|Overall Study|Lost to Follow-up|73
6059740|NCT00523341|20938303|P2|Overall Study|Death|110
6059741|NCT00523341|20938304|P1|Overall Study|Death|101
6059742|NCT00523341|20938303|P2|Overall Study|Adverse Event|155
6059743|NCT00523341|20938304|P1|Overall Study|Adverse Event|122
6059744|NCT00523341|20938303|P2|Overall Study|Other|198
6059745|NCT00523341|20938304|P1|Overall Study|Other|181
6059746|NCT00523341|20938303|P2|Overall Study|Withdrawal by Subject|427
6059747|NCT00523341|20938304|P1|Overall Study|Withdrawal by Subject|399
6059748|NCT00522951|20938421|P2|Period 2|residual contrast medium|1
6059749|NCT00522951|20938422|P1|Period 2|residual contrast medium|1
6059750|NCT00522951|20938421|P2|Period 2|Withdrawal by Subject|0
6059751|NCT00522951|20938422|P1|Period 2|Withdrawal by Subject|1
6059752|NCT00522951|20938421|P2|Washout Period|Death|1
6059753|NCT00522951|20938422|P1|Washout Period|Death|0
6059754|NCT00522951|20938421|P2|Washout Period|Adverse Event|1
6059755|NCT00522951|20938422|P1|Washout Period|Adverse Event|0
6059756|NCT00522951|20938421|P2|Period 1|body motion|1
6059757|NCT00522951|20938422|P1|Period 1|body motion|0
6059758|NCT00522873|20938477|P2|Overall Study|Never Received Medication|0
6059759|NCT00522873|20938478|P1|Overall Study|Never Received Medication|1
6059760|NCT00522873|20938477|P2|Overall Study|Medication Errors|1
6059761|NCT00522873|20938478|P1|Overall Study|Medication Errors|1
6059762|NCT00522873|20938477|P2|Overall Study|Personal Reasons|1
6059763|NCT00522873|20938478|P1|Overall Study|Personal Reasons|8
6059764|NCT00522873|20938477|P2|Overall Study|Lost to Follow-up|3
6059765|NCT00522873|20938478|P1|Overall Study|Lost to Follow-up|11
6059766|NCT00522873|20938477|P2|Overall Study|Protocol Violation|4
6059767|NCT00522873|20938478|P1|Overall Study|Protocol Violation|14
6059768|NCT00522873|20938477|P2|Overall Study|Withdrawal by Subject|9
6059769|NCT00522873|20938478|P1|Overall Study|Withdrawal by Subject|20
6059770|NCT00522873|20938477|P2|Overall Study|Adverse Event|26
6059771|NCT00522873|20938478|P1|Overall Study|Adverse Event|41
6059772|NCT00522626|20938491|P1|Overall Study|Lost to Follow-up|7
6059773|NCT00522548|20938497|P2|Overall Study|Withdrawal by Subject|2
6059774|NCT00522548|20938498|P1|Overall Study|Withdrawal by Subject|0
6059775|NCT00522548|20938497|P2|Overall Study|Adverse Event|2
6059776|NCT00522548|20938498|P1|Overall Study|Adverse Event|2
6059777|NCT00522457|20938526|P1|Overall Study|Adverse Event|2
6059778|NCT00522457|20938526|P1|Overall Study|Due to disease progression|16
6059779|NCT00522431|20938532|P1|Overall Study|Other/unknown|1
6059780|NCT00522431|20938532|P1|Overall Study|Subject non-compliance|1
6059781|NCT00522431|20938532|P1|Overall Study|Withdrawal by Subject|2
6059782|NCT00522431|20938532|P1|Overall Study|Protocol Violation|2
6059783|NCT00522431|20938532|P1|Overall Study|Adverse Event|5
6059784|NCT00522418|20938539|P2|Overall Study|Lack of Efficacy|1
6059785|NCT00522418|20938540|P1|Overall Study|Lack of Efficacy|0
6059786|NCT00522418|20938539|P2|Overall Study|Consent Withdraw|2
6059787|NCT00522418|20938540|P1|Overall Study|Consent Withdraw|1
6059788|NCT00522418|20938539|P2|Overall Study|Reason Not Specified|1
6059789|NCT00522418|20938540|P1|Overall Study|Reason Not Specified|3
6059790|NCT00522418|20938539|P2|Overall Study|Noncompliance|2
6059791|NCT00522418|20938540|P1|Overall Study|Noncompliance|2
6059792|NCT00522418|20938539|P2|Overall Study|Early Study Termination|47
6059793|NCT00522418|20938540|P1|Overall Study|Early Study Termination|46
6059794|NCT00522418|20938539|P2|Overall Study|Local IRB Consent Violation|5
6059795|NCT00522418|20938540|P1|Overall Study|Local IRB Consent Violation|5
6059796|NCT00522392|20938588|P2|Overall Study|Non-compliance|1
6059797|NCT00522392|20938589|P1|Overall Study|Non-compliance|0
6059798|NCT00522392|20938588|P2|Overall Study|Physician Decision|1
6059799|NCT00522392|20938589|P1|Overall Study|Physician Decision|0
6059800|NCT00522392|20938588|P2|Overall Study|Withdrawal by Subject|1
6059801|NCT00522392|20938589|P1|Overall Study|Withdrawal by Subject|1
6059802|NCT00522392|20938588|P2|Overall Study|Adverse Event|7
6059803|NCT00522392|20938589|P1|Overall Study|Adverse Event|7
6059804|NCT00522392|20938588|P2|Overall Study|Disease progression|3
6059805|NCT00522392|20938589|P1|Overall Study|Disease progression|0
6059806|NCT00522379|20938606|P5|Overall Study|Subject Withdrawal|0
6059807|NCT00522379|20938607|P4|Overall Study|Subject Withdrawal|1
6059808|NCT00522379|20938608|P3|Overall Study|Subject Withdrawal|0
6059809|NCT00522379|20938609|P2|Overall Study|Subject Withdrawal|0
6059810|NCT00522379|20938610|P1|Overall Study|Subject Withdrawal|0
6059811|NCT00522379|20938606|P5|Overall Study|Site Closed|0
6059812|NCT00522379|20938607|P4|Overall Study|Site Closed|1
6059813|NCT00522379|20938608|P3|Overall Study|Site Closed|0
6059814|NCT00522379|20938609|P2|Overall Study|Site Closed|0
6059815|NCT00522379|20938610|P1|Overall Study|Site Closed|0
6059816|NCT00522379|20938606|P5|Overall Study|Family Problem|0
6059817|NCT00522379|20938607|P4|Overall Study|Family Problem|0
6059818|NCT00522379|20938608|P3|Overall Study|Family Problem|1
6059819|NCT00522379|20938609|P2|Overall Study|Family Problem|0
6059820|NCT00522379|20938610|P1|Overall Study|Family Problem|0
6059821|NCT00522379|20938606|P5|Overall Study|Sponsor Request|0
6059822|NCT00522379|20938607|P4|Overall Study|Sponsor Request|0
6059823|NCT00522379|20938608|P3|Overall Study|Sponsor Request|0
6059824|NCT00522379|20938609|P2|Overall Study|Sponsor Request|1
6059825|NCT00522379|20938610|P1|Overall Study|Sponsor Request|0
6059826|NCT00522379|20938606|P5|Overall Study|Subject Moved|0
6059827|NCT00522379|20938607|P4|Overall Study|Subject Moved|0
6059828|NCT00522379|20938608|P3|Overall Study|Subject Moved|0
6059829|NCT00522379|20938609|P2|Overall Study|Subject Moved|1
6059830|NCT00522379|20938610|P1|Overall Study|Subject Moved|1
6059831|NCT00522379|20938606|P5|Overall Study|Dispensing error|0
6059832|NCT00522379|20938607|P4|Overall Study|Dispensing error|1
6059833|NCT00522379|20938608|P3|Overall Study|Dispensing error|0
6059834|NCT00522379|20938609|P2|Overall Study|Dispensing error|0
6059835|NCT00522379|20938610|P1|Overall Study|Dispensing error|1
6059836|NCT00522379|20938606|P5|Overall Study|Randomization error|1
6059837|NCT00522379|20938607|P4|Overall Study|Randomization error|0
6059838|NCT00522379|20938608|P3|Overall Study|Randomization error|0
6059839|NCT00522379|20938609|P2|Overall Study|Randomization error|0
6059840|NCT00522379|20938610|P1|Overall Study|Randomization error|0
6059841|NCT00522379|20938606|P5|Overall Study|Lost to Follow-up|2
6059842|NCT00522379|20938607|P4|Overall Study|Lost to Follow-up|2
6059843|NCT00522379|20938608|P3|Overall Study|Lost to Follow-up|4
6059844|NCT00522379|20938609|P2|Overall Study|Lost to Follow-up|0
6059845|NCT00522379|20938610|P1|Overall Study|Lost to Follow-up|1
6059846|NCT00522379|20938606|P5|Overall Study|Unsatisfactory Subject Compliance|0
6059847|NCT00522379|20938607|P4|Overall Study|Unsatisfactory Subject Compliance|0
6059848|NCT00522379|20938608|P3|Overall Study|Unsatisfactory Subject Compliance|0
6059849|NCT00522379|20938609|P2|Overall Study|Unsatisfactory Subject Compliance|2
6059850|NCT00522379|20938610|P1|Overall Study|Unsatisfactory Subject Compliance|1
6059851|NCT00522379|20938606|P5|Overall Study|Protocol Violation|0
6059852|NCT00522379|20938607|P4|Overall Study|Protocol Violation|0
6059853|NCT00522379|20938608|P3|Overall Study|Protocol Violation|2
6059854|NCT00522379|20938609|P2|Overall Study|Protocol Violation|1
6059855|NCT00522379|20938610|P1|Overall Study|Protocol Violation|1
6059856|NCT00522379|20938606|P5|Overall Study|Withdrawal by Subject|0
6059857|NCT00522379|20938607|P4|Overall Study|Withdrawal by Subject|2
6059858|NCT00522379|20938608|P3|Overall Study|Withdrawal by Subject|1
6059859|NCT00522379|20938609|P2|Overall Study|Withdrawal by Subject|3
6059860|NCT00522379|20938610|P1|Overall Study|Withdrawal by Subject|2
6059861|NCT00522379|20938606|P5|Overall Study|Lack of Efficacy|7
6059862|NCT00522379|20938607|P4|Overall Study|Lack of Efficacy|2
6059863|NCT00522379|20938608|P3|Overall Study|Lack of Efficacy|2
6059864|NCT00522379|20938609|P2|Overall Study|Lack of Efficacy|0
6059865|NCT00522379|20938610|P1|Overall Study|Lack of Efficacy|3
6059866|NCT00522379|20938606|P5|Overall Study|Adverse Event|17
6059867|NCT00522379|20938607|P4|Overall Study|Adverse Event|5
6059868|NCT00522379|20938608|P3|Overall Study|Adverse Event|12
6059869|NCT00522379|20938609|P2|Overall Study|Adverse Event|15
6059870|NCT00522379|20938610|P1|Overall Study|Adverse Event|12
6059871|NCT00522301|20938712|P1|Overall Study|Adverse Event|5
6059872|NCT00522301|20938712|P1|Overall Study|Withdrawal by Subject|1
6059873|NCT00522275|20938716|P1|Overall Study|Other: Subject had surgery for epilepsy|2
6059874|NCT00522275|20938716|P1|Overall Study|Other: Subject ran out of medication|1
6059875|NCT00522275|20938716|P1|Overall Study|Other: Sponsor request|2
6059876|NCT00522275|20938716|P1|Overall Study|Other: Travel to / from site difficulty|3
6059877|NCT00522275|20938716|P1|Overall Study|Other: Site / clinic closed|4
6059878|NCT00522275|20938716|P1|Overall Study|Other: Subject arrested|1
6059879|NCT00522275|20938716|P1|Overall Study|Other: Subject relocated|2
6059880|NCT00522275|20938716|P1|Overall Study|Other: Subject is pregnant|2
6059881|NCT00522275|20938716|P1|Overall Study|Other: Subject wants to become pregnant|2
6059882|NCT00522275|20938716|P1|Overall Study|Lost to Follow-up|8
6059883|NCT00522275|20938716|P1|Overall Study|Unsatisfactory compliance|11
6059884|NCT00522275|20938716|P1|Overall Study|Protocol deviation|1
6059885|NCT00522275|20938716|P1|Overall Study|Subject withdrew consent|16
6059886|NCT00522275|20938716|P1|Overall Study|Lack of Efficacy|80
6059887|NCT00522275|20938716|P1|Overall Study|Adverse Event|35
6059888|NCT00522041|20938737|P2|Overall Study|Did not receive treatment|1
6059889|NCT00522041|20938738|P1|Overall Study|Did not receive treatment|0
6059890|NCT00522041|20938737|P2|Overall Study|Voluntary withdrawal|4
6059891|NCT00522041|20938738|P1|Overall Study|Voluntary withdrawal|5
6059892|NCT00522041|20938737|P2|Overall Study|Lost to Follow-up|4
6059893|NCT00522041|20938738|P1|Overall Study|Lost to Follow-up|1
6059894|NCT00522041|20938737|P2|Overall Study|Protocol Violation|0
6059895|NCT00522041|20938738|P1|Overall Study|Protocol Violation|2
6059896|NCT00522041|20938737|P2|Overall Study|Adverse Event|3
6059897|NCT00522041|20938738|P1|Overall Study|Adverse Event|9
6059898|NCT00521599|20938797|P3|Overall Study|Did not meet protocol eligibility|1
6059899|NCT00521599|20938798|P2|Overall Study|Did not meet protocol eligibility|2
6059900|NCT00521599|20938799|P1|Overall Study|Did not meet protocol eligibility|2
6059901|NCT00521599|20938797|P3|Overall Study|Protocol Violation|2
6059902|NCT00521599|20938798|P2|Overall Study|Protocol Violation|4
6059903|NCT00521599|20938799|P1|Overall Study|Protocol Violation|2
6059904|NCT00521599|20938797|P3|Overall Study|Withdrawal by subject treatment related|2
6059905|NCT00521599|20938798|P2|Overall Study|Withdrawal by subject treatment related|1
6059906|NCT00521599|20938799|P1|Overall Study|Withdrawal by subject treatment related|3
6059907|NCT00521599|20938797|P3|Overall Study|Withdrawal by Subject|1
6059908|NCT00521599|20938798|P2|Overall Study|Withdrawal by Subject|5
6059909|NCT00521599|20938799|P1|Overall Study|Withdrawal by Subject|3
6059910|NCT00521599|20938797|P3|Overall Study|Lost to Follow-up|2
6059911|NCT00521599|20938798|P2|Overall Study|Lost to Follow-up|1
6059912|NCT00521599|20938799|P1|Overall Study|Lost to Follow-up|2
6059913|NCT00521599|20938797|P3|Overall Study|Treatment Failure|22
6059914|NCT00521599|20938798|P2|Overall Study|Treatment Failure|9
6059915|NCT00521599|20938799|P1|Overall Study|Treatment Failure|8
6059916|NCT00521599|20938797|P3|Overall Study|Adverse Event|6
6059917|NCT00521599|20938798|P2|Overall Study|Adverse Event|7
6059918|NCT00521599|20938799|P1|Overall Study|Adverse Event|5
6059919|NCT00521586|20938810|P2|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|7
6059920|NCT00521586|20938811|P1|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|2
6059921|NCT00521586|20938810|P2|Revaccination With 13vPnC (Year 5)|Failed to return|4
6059922|NCT00521586|20938811|P1|Revaccination With 13vPnC (Year 5)|Failed to return|1
6059923|NCT00521586|20938810|P2|Revaccination With 13vPnC (Year 5)|Subject request|1
6059924|NCT00521586|20938811|P1|Revaccination With 13vPnC (Year 5)|Subject request|0
6059925|NCT00521586|20938810|P2|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|57
6059926|NCT00521586|20938811|P1|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|54
6059927|NCT00521586|20938810|P2|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|22
6059928|NCT00521586|20938811|P1|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|18
6059929|NCT00521586|20938810|P2|Follow-up (From 6-month[Year 0]-Year 5)|Other|26
6059930|NCT00521586|20938811|P1|Follow-up (From 6-month[Year 0]-Year 5)|Other|22
6059931|NCT00521586|20938810|P2|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|56
6059932|NCT00521586|20938811|P1|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|55
6059933|NCT00521586|20938810|P2|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3
6059934|NCT00521586|20938811|P1|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3
6059935|NCT00521586|20938810|P2|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|3
6059936|NCT00521586|20938811|P1|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|7
6059937|NCT00521586|20938810|P2|Follow-up (From 6-month[Year 0]-Year 5)|Death|2
6059938|NCT00521586|20938811|P1|Follow-up (From 6-month[Year 0]-Year 5)|Death|5
6059939|NCT00521586|20938810|P2|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|1
6059940|NCT00521586|20938811|P1|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|5
6059941|NCT00521586|20938810|P2|Initial Vaccination (Year 0)|Failed to return|1
6059942|NCT00521586|20938811|P1|Initial Vaccination (Year 0)|Failed to return|0
6059943|NCT00521586|20938810|P2|Initial Vaccination (Year 0)|Death|0
6059944|NCT00521586|20938811|P1|Initial Vaccination (Year 0)|Death|1
6059945|NCT00521586|20938810|P2|Initial Vaccination (Year 0)|Adverse Event|1
6059946|NCT00521586|20938811|P1|Initial Vaccination (Year 0)|Adverse Event|0
6059947|NCT00521586|20938810|P2|Initial Vaccination (Year 0)|Investigator request|0
6059948|NCT00521586|20938811|P1|Initial Vaccination (Year 0)|Investigator request|2
6059949|NCT00521586|20938810|P2|Initial Vaccination (Year 0)|Other, unspecified|1
6059950|NCT00521586|20938811|P1|Initial Vaccination (Year 0)|Other, unspecified|3
6059951|NCT00521586|20938810|P2|Initial Vaccination (Year 0)|Protocol Violation|5
6059952|NCT00521586|20938811|P1|Initial Vaccination (Year 0)|Protocol Violation|2
6059953|NCT00521586|20938810|P2|Initial Vaccination (Year 0)|Lost to Follow-up|10
6059954|NCT00521586|20938811|P1|Initial Vaccination (Year 0)|Lost to Follow-up|5
6059955|NCT00521586|20938810|P2|Initial Vaccination (Year 0)|Subject request|11
6059956|NCT00521586|20938811|P1|Initial Vaccination (Year 0)|Subject request|8
6059957|NCT00521404|20938884|P1|Overall Study|Other|7
6059958|NCT00521404|20938884|P1|Overall Study|Noncompliance or lack of cooperation|1
6059959|NCT00521404|20938884|P1|Overall Study|Withdrawal of consent|3
6059960|NCT00521404|20938884|P1|Overall Study|Investigator decision|5
6059961|NCT00521404|20938884|P1|Overall Study|Disease Progression|33
6059962|NCT00521404|20938884|P1|Overall Study|Adverse Event|13
6059963|NCT00521365|20938893|P1|Overall Study|Usage of not allowed drugs|6
6059964|NCT00521365|20938893|P1|Overall Study|Drug compliance|3
6059965|NCT00521365|20938893|P1|Overall Study|Protocol deviation|2
6059966|NCT00521365|20938893|P1|Overall Study|Lost to Follow-up|6
6059967|NCT00521365|20938893|P1|Overall Study|Adverse Event|3
6059968|NCT00521339|20938923|P3|Treatment Extension Phase|Death|1
6059969|NCT00521339|20938924|P2|Treatment Extension Phase|Death|0
6059970|NCT00521339|20938925|P1|Treatment Extension Phase|Death|0
6059971|NCT00521339|20938923|P3|Treatment Extension Phase|Withdrawal by Subject|2
6059972|NCT00521339|20938924|P2|Treatment Extension Phase|Withdrawal by Subject|0
6059973|NCT00521339|20938925|P1|Treatment Extension Phase|Withdrawal by Subject|0
6059974|NCT00521339|20938923|P3|Treatment Phase|Protocol Violation|0
6059975|NCT00521339|20938924|P2|Treatment Phase|Protocol Violation|0
6059976|NCT00521339|20938925|P1|Treatment Phase|Protocol Violation|1
6059977|NCT00521339|20938923|P3|Treatment Phase|Lost to Follow-up|0
6059978|NCT00521339|20938924|P2|Treatment Phase|Lost to Follow-up|0
6059979|NCT00521339|20938925|P1|Treatment Phase|Lost to Follow-up|1
6059980|NCT00521339|20938923|P3|Treatment Phase|Withdrawal by Subject|0
6059981|NCT00521339|20938924|P2|Treatment Phase|Withdrawal by Subject|0
6059982|NCT00521339|20938925|P1|Treatment Phase|Withdrawal by Subject|3
6059983|NCT00521339|20938923|P3|Treatment Phase|Lack of Efficacy|0
6059984|NCT00521339|20938924|P2|Treatment Phase|Lack of Efficacy|0
6059985|NCT00521339|20938925|P1|Treatment Phase|Lack of Efficacy|3
6059986|NCT00521339|20938923|P3|Treatment Phase|Intolerability to study drug|0
6059987|NCT00521339|20938924|P2|Treatment Phase|Intolerability to study drug|0
6059988|NCT00521339|20938925|P1|Treatment Phase|Intolerability to study drug|2
6059989|NCT00521339|20938923|P3|Treatment Phase|Adverse Event|0
6059990|NCT00521339|20938924|P2|Treatment Phase|Adverse Event|0
6059991|NCT00521339|20938925|P1|Treatment Phase|Adverse Event|2
6059992|NCT00521144|20938993|P5|Overall Study|Progressive Disease|6
6059993|NCT00521144|20938994|P4|Overall Study|Progressive Disease|0
6059994|NCT00521144|20938995|P3|Overall Study|Progressive Disease|2
6059995|NCT00521144|20938996|P2|Overall Study|Progressive Disease|2
6059996|NCT00521144|20938997|P1|Overall Study|Progressive Disease|4
6059997|NCT00521144|20938993|P5|Overall Study|Adverse Event|1
6059998|NCT00521144|20938994|P4|Overall Study|Adverse Event|0
6059999|NCT00521144|20938995|P3|Overall Study|Adverse Event|0
6060000|NCT00521144|20938996|P2|Overall Study|Adverse Event|1
6060001|NCT00521144|20938997|P1|Overall Study|Adverse Event|0
6060002|NCT00521144|20938993|P5|Overall Study|Not Treated|0
6060003|NCT00521144|20938994|P4|Overall Study|Not Treated|1
6060004|NCT00521144|20938995|P3|Overall Study|Not Treated|0
6060005|NCT00521144|20938996|P2|Overall Study|Not Treated|0
6060006|NCT00521144|20938997|P1|Overall Study|Not Treated|0
6060007|NCT00521079|20939011|P2|Overall Study|Withdrawal by Subject|3
6060008|NCT00521079|20939012|P1|Overall Study|Withdrawal by Subject|5
6060009|NCT00521079|20939011|P2|Overall Study|Lost to Follow-up|1
6060010|NCT00521079|20939012|P1|Overall Study|Lost to Follow-up|2
6060011|NCT00521079|20939011|P2|Overall Study|Adverse Event|1
6060012|NCT00521079|20939012|P1|Overall Study|Adverse Event|7
6060013|NCT00521053|20939022|P1|Observation Phase|Physician Decision|1
6060014|NCT00521053|20939022|P1|Observation Phase|Other non-study melanoma treatment|1
6060015|NCT00521053|20939022|P1|Observation Phase|Adverse Event|1
6060016|NCT00521053|20939022|P1|Observation Phase|Death|2
6060017|NCT00521053|20939022|P1|Observation Phase|Additional PV-10 via alternate protocol|8
6060018|NCT00521053|20939022|P1|Observation Phase|Disease Progression|55
6060019|NCT00521014|20939032|P1|Overall Study|Inevaluable, not treated|1
6060020|NCT00521001|20939036|P1|Overall Study|Ineligible|1
6060021|NCT00520975|20939045|P2|Overall Study|Not start protocol therapy|2
6060022|NCT00520975|20939046|P1|Overall Study|Not start protocol therapy|1
6060023|NCT00520975|20939045|P2|Overall Study|Other reasons|2
6060024|NCT00520975|20939046|P1|Overall Study|Other reasons|4
6060025|NCT00520975|20939045|P2|Overall Study|Other therapy|4
6060026|NCT00520975|20939046|P1|Overall Study|Other therapy|2
6060027|NCT00520975|20939045|P2|Overall Study|Withdrawal by Subject|5
6060028|NCT00520975|20939046|P1|Overall Study|Withdrawal by Subject|3
6060029|NCT00520975|20939045|P2|Overall Study|Death|2
6060030|NCT00520975|20939046|P1|Overall Study|Death|0
6060031|NCT00520975|20939045|P2|Overall Study|Adverse Event|10
6060032|NCT00520975|20939046|P1|Overall Study|Adverse Event|7
6060033|NCT00520975|20939045|P2|Overall Study|Disease progression|23
6060034|NCT00520975|20939046|P1|Overall Study|Disease progression|31
6060035|NCT00520936|20939078|P8|Overall Study|Protocol Violation|0
6060036|NCT00520936|20939079|P7|Overall Study|Protocol Violation|1
6060037|NCT00520936|20939080|P6|Overall Study|Protocol Violation|0
6060038|NCT00520936|20939081|P5|Overall Study|Protocol Violation|1
6060039|NCT00520936|20939082|P4|Overall Study|Protocol Violation|0
6060040|NCT00520936|20939083|P3|Overall Study|Protocol Violation|1
6060041|NCT00520936|20939084|P2|Overall Study|Protocol Violation|1
6060042|NCT00520936|20939085|P1|Overall Study|Protocol Violation|0
6060043|NCT00520936|20939078|P8|Overall Study|Death|0
6060044|NCT00520936|20939079|P7|Overall Study|Death|1
6060045|NCT00520936|20939080|P6|Overall Study|Death|0
6060046|NCT00520936|20939081|P5|Overall Study|Death|0
6060047|NCT00520936|20939082|P4|Overall Study|Death|0
6060048|NCT00520936|20939083|P3|Overall Study|Death|0
6060049|NCT00520936|20939084|P2|Overall Study|Death|0
6060050|NCT00520936|20939085|P1|Overall Study|Death|0
6060051|NCT00520936|20939078|P8|Overall Study|Toxicity Requiring Removal from Study|0
6060052|NCT00520936|20939079|P7|Overall Study|Toxicity Requiring Removal from Study|2
6060053|NCT00520936|20939080|P6|Overall Study|Toxicity Requiring Removal from Study|0
6060054|NCT00520936|20939081|P5|Overall Study|Toxicity Requiring Removal from Study|0
6060055|NCT00520936|20939082|P4|Overall Study|Toxicity Requiring Removal from Study|0
6060056|NCT00520936|20939083|P3|Overall Study|Toxicity Requiring Removal from Study|0
6060057|NCT00520936|20939084|P2|Overall Study|Toxicity Requiring Removal from Study|1
6060058|NCT00520936|20939085|P1|Overall Study|Toxicity Requiring Removal from Study|0
6060059|NCT00520936|20939078|P8|Overall Study|Withdrawal by Subject|1
6060060|NCT00520936|20939079|P7|Overall Study|Withdrawal by Subject|0
6060061|NCT00520936|20939080|P6|Overall Study|Withdrawal by Subject|0
6060062|NCT00520936|20939081|P5|Overall Study|Withdrawal by Subject|0
6060063|NCT00520936|20939082|P4|Overall Study|Withdrawal by Subject|0
6060064|NCT00520936|20939083|P3|Overall Study|Withdrawal by Subject|0
6060065|NCT00520936|20939084|P2|Overall Study|Withdrawal by Subject|0
6060066|NCT00520936|20939085|P1|Overall Study|Withdrawal by Subject|0
6060067|NCT00520936|20939078|P8|Overall Study|Physician Decision|0
6060068|NCT00520936|20939079|P7|Overall Study|Physician Decision|0
6060069|NCT00520936|20939080|P6|Overall Study|Physician Decision|0
6060070|NCT00520936|20939081|P5|Overall Study|Physician Decision|0
6060071|NCT00520936|20939082|P4|Overall Study|Physician Decision|0
6060072|NCT00520936|20939083|P3|Overall Study|Physician Decision|1
6060073|NCT00520936|20939084|P2|Overall Study|Physician Decision|2
6060074|NCT00520936|20939085|P1|Overall Study|Physician Decision|0
6060075|NCT00520845|20939140|P1|Overall Study|Alternative Therapy|1
6060076|NCT00520845|20939140|P1|Overall Study|Withdrawal by Subject|1
6060077|NCT00520845|20939140|P1|Overall Study|Disease Progression, relapse|13
6060078|NCT00520845|20939140|P1|Overall Study|Adverse Event|4
6060079|NCT00520845|20939140|P1|Overall Study|Death|3
6060080|NCT00520767|20939148|P1|Overall Study|Death|2
6060081|NCT00520741|20939154|P2|Overall Study|Other reasons for premature termination|6
6060082|NCT00520741|20939155|P1|Overall Study|Other reasons for premature termination|0
6060083|NCT00520741|20939154|P2|Overall Study|Lost to Follow-up|4
6060084|NCT00520741|20939155|P1|Overall Study|Lost to Follow-up|4
6060085|NCT00520741|20939154|P2|Overall Study|Unsatisfactory compliance of subject|3
6060086|NCT00520741|20939155|P1|Overall Study|Unsatisfactory compliance of subject|4
6060087|NCT00520741|20939154|P2|Overall Study|Protocol Violation|15
6060088|NCT00520741|20939155|P1|Overall Study|Protocol Violation|2
6060089|NCT00520741|20939154|P2|Overall Study|Withdrawal by Subject|11
6060090|NCT00520741|20939155|P1|Overall Study|Withdrawal by Subject|0
6060091|NCT00520741|20939154|P2|Overall Study|Lack of Efficacy|30
6060092|NCT00520741|20939155|P1|Overall Study|Lack of Efficacy|11
6060093|NCT00520741|20939154|P2|Overall Study|Adverse Event|56
6060094|NCT00520741|20939155|P1|Overall Study|Adverse Event|16
6060095|NCT00520676|20939173|P2|Overall Study|Withdrawal by Subject|11
6060096|NCT00520676|20939174|P1|Overall Study|Withdrawal by Subject|7
6060097|NCT00520676|20939173|P2|Overall Study|Physician Decision|1
6060098|NCT00520676|20939174|P1|Overall Study|Physician Decision|4
6060099|NCT00520676|20939173|P2|Overall Study|Lost to Follow-up|10
6060100|NCT00520676|20939174|P1|Overall Study|Lost to Follow-up|6
6060101|NCT00520676|20939173|P2|Overall Study|Death|81
6060102|NCT00520676|20939174|P1|Overall Study|Death|84
6060103|NCT00520572|20939200|P6|Overall Study|Did not receive Treatment|0
6060104|NCT00520572|20939201|P5|Overall Study|Did not receive Treatment|0
6060105|NCT00520572|20939202|P4|Overall Study|Did not receive Treatment|0
6060106|NCT00520572|20939203|P3|Overall Study|Did not receive Treatment|1
6060107|NCT00520572|20939204|P2|Overall Study|Did not receive Treatment|0
6060108|NCT00520572|20939205|P1|Overall Study|Did not receive Treatment|1
6060109|NCT00520572|20939200|P6|Overall Study|Long break in taking Medication|0
6060110|NCT00520572|20939201|P5|Overall Study|Long break in taking Medication|0
6060111|NCT00520572|20939202|P4|Overall Study|Long break in taking Medication|1
6060112|NCT00520572|20939203|P3|Overall Study|Long break in taking Medication|0
6060113|NCT00520572|20939204|P2|Overall Study|Long break in taking Medication|0
6060114|NCT00520572|20939205|P1|Overall Study|Long break in taking Medication|0
6060115|NCT00520572|20939200|P6|Overall Study|Oral corticotherapy for acute urticaria|0
6060116|NCT00520572|20939201|P5|Overall Study|Oral corticotherapy for acute urticaria|0
6060117|NCT00520572|20939202|P4|Overall Study|Oral corticotherapy for acute urticaria|0
6060118|NCT00520572|20939203|P3|Overall Study|Oral corticotherapy for acute urticaria|0
6060119|NCT00520572|20939204|P2|Overall Study|Oral corticotherapy for acute urticaria|1
6060120|NCT00520572|20939205|P1|Overall Study|Oral corticotherapy for acute urticaria|0
6060121|NCT00520572|20939200|P6|Overall Study|Incorrect enrollment|0
6060122|NCT00520572|20939201|P5|Overall Study|Incorrect enrollment|1
6060123|NCT00520572|20939202|P4|Overall Study|Incorrect enrollment|0
6060124|NCT00520572|20939203|P3|Overall Study|Incorrect enrollment|1
6060125|NCT00520572|20939204|P2|Overall Study|Incorrect enrollment|0
6060126|NCT00520572|20939205|P1|Overall Study|Incorrect enrollment|1
6060127|NCT00520572|20939200|P6|Overall Study|Lost to Follow-up|0
6060128|NCT00520572|20939201|P5|Overall Study|Lost to Follow-up|1
6060129|NCT00520572|20939202|P4|Overall Study|Lost to Follow-up|0
6060130|NCT00520572|20939203|P3|Overall Study|Lost to Follow-up|0
6060131|NCT00520572|20939204|P2|Overall Study|Lost to Follow-up|0
6060132|NCT00520572|20939205|P1|Overall Study|Lost to Follow-up|0
6060133|NCT00520572|20939200|P6|Overall Study|Lack of Efficacy|0
6060134|NCT00520572|20939201|P5|Overall Study|Lack of Efficacy|1
6060135|NCT00520572|20939202|P4|Overall Study|Lack of Efficacy|2
6060136|NCT00520572|20939203|P3|Overall Study|Lack of Efficacy|1
6060137|NCT00520572|20939204|P2|Overall Study|Lack of Efficacy|1
6060138|NCT00520572|20939205|P1|Overall Study|Lack of Efficacy|1
6060139|NCT00520572|20939200|P6|Overall Study|Protocol Violation|0
6060140|NCT00520572|20939201|P5|Overall Study|Protocol Violation|0
6060141|NCT00520572|20939202|P4|Overall Study|Protocol Violation|0
6060142|NCT00520572|20939203|P3|Overall Study|Protocol Violation|1
6060143|NCT00520572|20939204|P2|Overall Study|Protocol Violation|0
6060144|NCT00520572|20939205|P1|Overall Study|Protocol Violation|0
6060145|NCT00520572|20939200|P6|Overall Study|Withdrawal by Subject|0
6060146|NCT00520572|20939201|P5|Overall Study|Withdrawal by Subject|2
6060147|NCT00520572|20939202|P4|Overall Study|Withdrawal by Subject|2
6060148|NCT00520572|20939203|P3|Overall Study|Withdrawal by Subject|5
6060149|NCT00520572|20939204|P2|Overall Study|Withdrawal by Subject|9
6060150|NCT00520572|20939205|P1|Overall Study|Withdrawal by Subject|0
6060151|NCT00520572|20939200|P6|Overall Study|Adverse Event|2
6060152|NCT00520572|20939201|P5|Overall Study|Adverse Event|7
6060153|NCT00520572|20939202|P4|Overall Study|Adverse Event|9
6060154|NCT00520572|20939203|P3|Overall Study|Adverse Event|6
6060155|NCT00520572|20939204|P2|Overall Study|Adverse Event|3
6060156|NCT00520572|20939205|P1|Overall Study|Adverse Event|9
6060157|NCT00520546|20939243|P1|Overall Study|failed radiopharmaceut. synthesis of FEC|5
6060158|NCT00520546|20939243|P1|Overall Study|Withdrawal by Subject|1
6060159|NCT00520494|20939258|P1|Overall Study|Withdrawal by Subject|1
6060160|NCT00520481|20939283|P2|Overall Study|Withdrawal by Subject|0
6060161|NCT00520481|20939284|P1|Overall Study|Withdrawal by Subject|3
6060162|NCT00520481|20939283|P2|Overall Study|Adverse Event|1
6060163|NCT00520481|20939284|P1|Overall Study|Adverse Event|4
6060164|NCT00520403|20939308|P1|Bevacizumab Monotherapy|Symptomatic progression of cancer|1
6060165|NCT00520403|20939308|P1|Bevacizumab Monotherapy|Radiological progression of cancer|1
6060166|NCT00520403|20939308|P1|Bevacizumab + IFN/Vinblastine|Protocol Deviation affecting safety|1
6060167|NCT00520403|20939308|P1|Bevacizumab + IFN/Vinblastine|Discontinuation of study/background drug|1
6060168|NCT00520403|20939308|P1|Bevacizumab + IFN/Vinblastine|Death|2
6060169|NCT00520403|20939308|P1|Bevacizumab + IFN/Vinblastine|Withdrawal of consent|4
6060170|NCT00520403|20939308|P1|Bevacizumab + IFN/Vinblastine|Adverse Event|4
6060171|NCT00520403|20939308|P1|Bevacizumab + IFN/Vinblastine|Radiological progression of cancer|6
6060172|NCT00520351|20939317|P2|First Intervention|Withdrawal by Subject|1
6060173|NCT00520351|20939318|P1|First Intervention|Withdrawal by Subject|1
6060174|NCT00520299|20939333|P3|Overall Study|Progressive disease|4
6060175|NCT00520299|20939334|P2|Overall Study|Progressive disease|3
6060176|NCT00520299|20939335|P1|Overall Study|Progressive disease|0
6060177|NCT00520299|20939333|P3|Overall Study|Withdrawal by Subject|2
6060178|NCT00520299|20939334|P2|Overall Study|Withdrawal by Subject|0
6060179|NCT00520299|20939335|P1|Overall Study|Withdrawal by Subject|0
6060180|NCT00520130|20939390|P2|Overall Study|Physician Decision|1
6060181|NCT00520130|20939391|P1|Overall Study|Physician Decision|1
6060182|NCT00520130|20939390|P2|Overall Study|Disease progression on study|0
6060183|NCT00520130|20939391|P1|Overall Study|Disease progression on study|4
6060184|NCT00520039|20939433|P2|Overall Study|Exclusion criteria met at first visit|5
6060185|NCT00520039|20939434|P1|Overall Study|Exclusion criteria met at first visit|7
6060186|NCT00520013|20939447|P3|Overall Study|Physician Decision|3
6060187|NCT00520013|20939448|P2|Overall Study|Physician Decision|0
6060188|NCT00520013|20939449|P1|Overall Study|Physician Decision|0
6060189|NCT00520013|20939447|P3|Overall Study|Death|0
6060190|NCT00520013|20939448|P2|Overall Study|Death|1
6060191|NCT00520013|20939449|P1|Overall Study|Death|0
6060192|NCT00520013|20939447|P3|Overall Study|Clinical Progression|0
6060193|NCT00520013|20939448|P2|Overall Study|Clinical Progression|1
6060194|NCT00520013|20939449|P1|Overall Study|Clinical Progression|3
6060195|NCT00520013|20939447|P3|Overall Study|Progressive Disease|0
6060196|NCT00520013|20939448|P2|Overall Study|Progressive Disease|3
6060197|NCT00520013|20939449|P1|Overall Study|Progressive Disease|7
6060198|NCT00520013|20939447|P3|Overall Study|Adverse Event|7
6060199|NCT00520013|20939448|P2|Overall Study|Adverse Event|10
6060200|NCT00520013|20939449|P1|Overall Study|Adverse Event|2
6060201|NCT00520013|20939447|P3|Overall Study|Withdrawal by Subject|1
6060202|NCT00520013|20939448|P2|Overall Study|Withdrawal by Subject|0
6060203|NCT00520013|20939449|P1|Overall Study|Withdrawal by Subject|0
6060204|NCT00519896|20939459|P1|Overall Study|Adverse Event|1
6060205|NCT00519896|20939459|P1|Overall Study|Protocol Violation|1
6060206|NCT00519831|20939465|P1|Overall Study|Adverse Event|3
6060207|NCT00519779|20939482|P2|Overall Study|Withdrawal by Subject|1
6060208|NCT00519779|20939483|P1|Overall Study|Withdrawal by Subject|0
6060209|NCT00519649|20939499|P1|Overall Study|Withdrawal by Subject|1
6060210|NCT00519636|20939512|P4|Post Study Period|Subject randomized in error|1
6060211|NCT00519636|20939513|P3|Post Study Period|Subject randomized in error|0
6060212|NCT00519636|20939514|P2|Post Study Period|Subject randomized in error|0
6060213|NCT00519636|20939515|P1|Post Study Period|Subject randomized in error|0
6060214|NCT00519636|20939512|P4|Treatment Period 2|Subject misrandomized|1
6060215|NCT00519636|20939513|P3|Treatment Period 2|Subject misrandomized|0
6060216|NCT00519636|20939514|P2|Treatment Period 2|Subject misrandomized|0
6060217|NCT00519636|20939515|P1|Treatment Period 2|Subject misrandomized|0
6060218|NCT00519636|20939512|P4|Treatment Period 2|Per doctors request|0
6060219|NCT00519636|20939513|P3|Treatment Period 2|Per doctors request|1
6060220|NCT00519636|20939514|P2|Treatment Period 2|Per doctors request|0
6060221|NCT00519636|20939515|P1|Treatment Period 2|Per doctors request|0
6060222|NCT00519636|20939512|P4|Treatment Period 2|Subject randomized in error|0
6060223|NCT00519636|20939513|P3|Treatment Period 2|Subject randomized in error|0
6060224|NCT00519636|20939514|P2|Treatment Period 2|Subject randomized in error|1
6060225|NCT00519636|20939515|P1|Treatment Period 2|Subject randomized in error|0
6060226|NCT00519636|20939512|P4|Treatment Period 2|Failed To Meet Continuation Criteria|1
6060227|NCT00519636|20939513|P3|Treatment Period 2|Failed To Meet Continuation Criteria|0
6060228|NCT00519636|20939514|P2|Treatment Period 2|Failed To Meet Continuation Criteria|0
6060229|NCT00519636|20939515|P1|Treatment Period 2|Failed To Meet Continuation Criteria|0
6060230|NCT00519636|20939512|P4|Washout Period|Prohibited medications|0
6060231|NCT00519636|20939513|P3|Washout Period|Prohibited medications|1
6060232|NCT00519636|20939514|P2|Washout Period|Prohibited medications|0
6060233|NCT00519636|20939515|P1|Washout Period|Prohibited medications|0
6060234|NCT00519636|20939512|P4|Washout Period|Subject randomized in error|0
6060235|NCT00519636|20939513|P3|Washout Period|Subject randomized in error|1
6060236|NCT00519636|20939514|P2|Washout Period|Subject randomized in error|0
6060237|NCT00519636|20939515|P1|Washout Period|Subject randomized in error|0
6060238|NCT00519636|20939512|P4|Washout Period|Per doctors request|0
6060239|NCT00519636|20939513|P3|Washout Period|Per doctors request|0
6060240|NCT00519636|20939514|P2|Washout Period|Per doctors request|1
6060241|NCT00519636|20939515|P1|Washout Period|Per doctors request|0
6060242|NCT00519636|20939512|P4|Washout Period|Non-compliant|0
6060243|NCT00519636|20939513|P3|Washout Period|Non-compliant|0
6060244|NCT00519636|20939514|P2|Washout Period|Non-compliant|1
6060245|NCT00519636|20939515|P1|Washout Period|Non-compliant|0
6060246|NCT00519636|20939512|P4|Washout Period|Participating in study at another site|0
6060247|NCT00519636|20939513|P3|Washout Period|Participating in study at another site|0
6060248|NCT00519636|20939514|P2|Washout Period|Participating in study at another site|0
6060249|NCT00519636|20939515|P1|Washout Period|Participating in study at another site|1
6060250|NCT00519636|20939512|P4|Washout Period|Out of pollen area > 48 hours|0
6060251|NCT00519636|20939513|P3|Washout Period|Out of pollen area > 48 hours|0
6060252|NCT00519636|20939514|P2|Washout Period|Out of pollen area > 48 hours|0
6060253|NCT00519636|20939515|P1|Washout Period|Out of pollen area > 48 hours|1
6060254|NCT00519636|20939512|P4|Washout Period|Failed to meet continuation criteria|3
6060255|NCT00519636|20939513|P3|Washout Period|Failed to meet continuation criteria|9
6060256|NCT00519636|20939514|P2|Washout Period|Failed to meet continuation criteria|11
6060257|NCT00519636|20939515|P1|Washout Period|Failed to meet continuation criteria|14
6060258|NCT00519636|20939512|P4|Washout Period|Withdrawal by Subject|0
6060259|NCT00519636|20939513|P3|Washout Period|Withdrawal by Subject|1
6060260|NCT00519636|20939514|P2|Washout Period|Withdrawal by Subject|0
6060261|NCT00519636|20939515|P1|Washout Period|Withdrawal by Subject|1
6060262|NCT00519636|20939512|P4|Washout Period|Protocol Violation|2
6060263|NCT00519636|20939513|P3|Washout Period|Protocol Violation|1
6060264|NCT00519636|20939514|P2|Washout Period|Protocol Violation|0
6060265|NCT00519636|20939515|P1|Washout Period|Protocol Violation|0
6060266|NCT00519636|20939512|P4|Washout Period|Lost to Follow-up|0
6060267|NCT00519636|20939513|P3|Washout Period|Lost to Follow-up|0
6060268|NCT00519636|20939514|P2|Washout Period|Lost to Follow-up|0
6060269|NCT00519636|20939515|P1|Washout Period|Lost to Follow-up|1
6060270|NCT00519636|20939512|P4|Washout Period|Adverse Event|0
6060271|NCT00519636|20939513|P3|Washout Period|Adverse Event|1
6060272|NCT00519636|20939514|P2|Washout Period|Adverse Event|1
6060273|NCT00519636|20939515|P1|Washout Period|Adverse Event|2
6060274|NCT00519636|20939512|P4|Treatment Period 1|Sponsor request due to missed visit|0
6060275|NCT00519636|20939513|P3|Treatment Period 1|Sponsor request due to missed visit|0
6060276|NCT00519636|20939514|P2|Treatment Period 1|Sponsor request due to missed visit|0
6060277|NCT00519636|20939515|P1|Treatment Period 1|Sponsor request due to missed visit|1
6060278|NCT00519636|20939512|P4|Treatment Period 1|Adverse Event|0
6060279|NCT00519636|20939513|P3|Treatment Period 1|Adverse Event|1
6060280|NCT00519636|20939514|P2|Treatment Period 1|Adverse Event|0
6060281|NCT00519636|20939515|P1|Treatment Period 1|Adverse Event|1
6060282|NCT00519623|20939545|P1|Overall Study|Adverse Event|1
6060283|NCT00519532|20939579|P1|Overall Study|Lost to Follow-up|2
6060284|NCT00519532|20939579|P1|Overall Study|Withdrawal by Subject|5
6060285|NCT00519532|20939579|P1|Overall Study|Adverse Event|11
6060286|NCT00519428|20939589|P3|Overall Study|unstated|2
6060287|NCT00519428|20939590|P2|Overall Study|unstated|3
6060288|NCT00519428|20939591|P1|Overall Study|unstated|1
6060289|NCT00519428|20939589|P3|Overall Study|Withdrawal by Subject|7
6060290|NCT00519428|20939590|P2|Overall Study|Withdrawal by Subject|3
6060291|NCT00519428|20939591|P1|Overall Study|Withdrawal by Subject|8
6060292|NCT00519428|20939589|P3|Overall Study|Lost to Follow-up|6
6060293|NCT00519428|20939590|P2|Overall Study|Lost to Follow-up|7
6060294|NCT00519428|20939591|P1|Overall Study|Lost to Follow-up|7
6060295|NCT00519428|20939589|P3|Overall Study|Adverse Event|10
6060296|NCT00519428|20939590|P2|Overall Study|Adverse Event|2
6060297|NCT00519428|20939591|P1|Overall Study|Adverse Event|5
6060298|NCT00519376|20939611|P16|Treatment Period 4|Lost to Follow-up|0
6060299|NCT00519376|20939612|P15|Treatment Period 4|Lost to Follow-up|0
6060300|NCT00519376|20939613|P14|Treatment Period 4|Lost to Follow-up|0
6060301|NCT00519376|20939614|P13|Treatment Period 4|Lost to Follow-up|0
6060302|NCT00519376|20939615|P12|Treatment Period 4|Lost to Follow-up|0
6060303|NCT00519376|20939616|P11|Treatment Period 4|Lost to Follow-up|0
6060304|NCT00519376|20939617|P10|Treatment Period 4|Lost to Follow-up|0
6060305|NCT00519376|20939618|P9|Treatment Period 4|Lost to Follow-up|0
6060306|NCT00519376|20939619|P8|Treatment Period 4|Lost to Follow-up|0
6060307|NCT00519376|20939620|P7|Treatment Period 4|Lost to Follow-up|0
6060308|NCT00519376|20939621|P6|Treatment Period 4|Lost to Follow-up|0
6060309|NCT00519376|20939622|P5|Treatment Period 4|Lost to Follow-up|0
6060310|NCT00519376|20939623|P4|Treatment Period 4|Lost to Follow-up|0
6060311|NCT00519376|20939624|P3|Treatment Period 4|Lost to Follow-up|1
6060312|NCT00519376|20939625|P2|Treatment Period 4|Lost to Follow-up|0
6060313|NCT00519376|20939626|P1|Treatment Period 4|Lost to Follow-up|0
6060314|NCT00519376|20939611|P16|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
6060315|NCT00519376|20939612|P15|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
6060316|NCT00519376|20939613|P14|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
6060317|NCT00519376|20939614|P13|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|1
6060318|NCT00519376|20939615|P12|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
6060319|NCT00519376|20939616|P11|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
6060320|NCT00519376|20939617|P10|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
6060321|NCT00519376|20939618|P9|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
6060322|NCT00519376|20939619|P8|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
6060323|NCT00519376|20939620|P7|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
6060324|NCT00519376|20939621|P6|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
6060325|NCT00519376|20939622|P5|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
6060326|NCT00519376|20939623|P4|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
6060327|NCT00519376|20939624|P3|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
6060328|NCT00519376|20939625|P2|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
6060329|NCT00519376|20939626|P1|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
6060330|NCT00519285|20939750|P2|Overall Study|Treatment ongoing|2
6060331|NCT00519285|20939751|P1|Overall Study|Treatment ongoing|1
6060332|NCT00519285|20939750|P2|Overall Study|Not treated|7
6060333|NCT00519285|20939751|P1|Overall Study|Not treated|8
6060334|NCT00519285|20939750|P2|Overall Study|Reason unspecified|8
6060335|NCT00519285|20939751|P1|Overall Study|Reason unspecified|5
6060336|NCT00519285|20939750|P2|Overall Study|Poor compliance to protocol|7
6060337|NCT00519285|20939751|P1|Overall Study|Poor compliance to protocol|5
6060338|NCT00519285|20939750|P2|Overall Study|Consent withdrawn|5
6060339|NCT00519285|20939751|P1|Overall Study|Consent withdrawn|4
6060340|NCT00519285|20939750|P2|Overall Study|Participant's request|84
6060341|NCT00519285|20939751|P1|Overall Study|Participant's request|53
6060342|NCT00519285|20939750|P2|Overall Study|Physician Decision|47
6060343|NCT00519285|20939751|P1|Overall Study|Physician Decision|75
6060344|NCT00519285|20939750|P2|Overall Study|Disease progression|186
6060345|NCT00519285|20939751|P1|Overall Study|Disease progression|334
6060346|NCT00519285|20939750|P2|Overall Study|Adverse Event|266
6060347|NCT00519285|20939751|P1|Overall Study|Adverse Event|127
6060348|NCT00519194|20939777|P1|Overall Study|Lost to Follow-up|3
6060349|NCT00519194|20939777|P1|Overall Study|Death|9
6060350|NCT00519194|20939777|P1|Overall Study|Withdrawal by Subject|9
6060351|NCT00519077|20939792|P1|Overall Study|Other|2
6060352|NCT00519077|20939792|P1|Overall Study|Death|6
6060353|NCT00518986|20939799|P2|Overall Study|Non-Specific|1
6060354|NCT00518986|20939800|P1|Overall Study|Non-Specific|2
6060355|NCT00518986|20939799|P2|Overall Study|Withdrawal by Subject|4
6060356|NCT00518986|20939800|P1|Overall Study|Withdrawal by Subject|4
6060357|NCT00518986|20939799|P2|Overall Study|Protocol Violation|7
6060358|NCT00518986|20939800|P1|Overall Study|Protocol Violation|5
6060359|NCT00518986|20939799|P2|Overall Study|Physician Decision|3
6060360|NCT00518986|20939800|P1|Overall Study|Physician Decision|0
6060361|NCT00518986|20939799|P2|Overall Study|Lost to Follow-up|2
6060362|NCT00518986|20939800|P1|Overall Study|Lost to Follow-up|3
6060363|NCT00518986|20939799|P2|Overall Study|Lack of Efficacy|2
6060364|NCT00518986|20939800|P1|Overall Study|Lack of Efficacy|0
6060365|NCT00518986|20939799|P2|Overall Study|Adverse Event|7
6060366|NCT00518986|20939800|P1|Overall Study|Adverse Event|12
6060367|NCT00518973|20939926|P2|Overall Study|Withdrawal by Subject|2
6060368|NCT00518973|20939927|P1|Overall Study|Withdrawal by Subject|3
6060369|NCT00518882|20939943|P2|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|25
6060370|NCT00518882|20939944|P1|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|18
6060371|NCT00518882|20939943|P2|Open-Label Extension, Week 26-78|Subject decision|0
6060372|NCT00518882|20939944|P1|Open-Label Extension, Week 26-78|Subject decision|2
6060373|NCT00518882|20939943|P2|Open-Label Extension, Week 26-78|Exclusion criteria|0
6060374|NCT00518882|20939944|P1|Open-Label Extension, Week 26-78|Exclusion criteria|2
6060375|NCT00518882|20939943|P2|Open-Label Extension, Week 26-78|Decreased kidney function|0
6060376|NCT00518882|20939944|P1|Open-Label Extension, Week 26-78|Decreased kidney function|1
6060377|NCT00518882|20939943|P2|Open-Label Extension, Week 26-78|Creatine increased|0
6060378|NCT00518882|20939944|P1|Open-Label Extension, Week 26-78|Creatine increased|1
6060379|NCT00518882|20939943|P2|Open-Label Extension, Week 26-78|Change in treatment|1
6060380|NCT00518882|20939944|P1|Open-Label Extension, Week 26-78|Change in treatment|1
6060381|NCT00518882|20939943|P2|Open-Label Extension, Week 26-78|Consent withdrawn|1
6060382|NCT00518882|20939944|P1|Open-Label Extension, Week 26-78|Consent withdrawn|2
6060383|NCT00518882|20939943|P2|Open-Label Extension, Week 26-78|Lost to follow up|1
6060384|NCT00518882|20939944|P1|Open-Label Extension, Week 26-78|Lost to follow up|1
6060385|NCT00518882|20939943|P2|Open-Label Extension, Week 26-78|Hypoglycaemia|1
6060386|NCT00518882|20939944|P1|Open-Label Extension, Week 26-78|Hypoglycaemia|0
6060387|NCT00518882|20939943|P2|Open-Label Extension, Week 26-78|Withdrawel criteria|2
6060388|NCT00518882|20939944|P1|Open-Label Extension, Week 26-78|Withdrawel criteria|1
6060389|NCT00518882|20939943|P2|Open-Label Extension, Week 26-78|Protocol Violation|4
6060390|NCT00518882|20939944|P1|Open-Label Extension, Week 26-78|Protocol Violation|3
6060391|NCT00518882|20939943|P2|Open-Label Extension, Week 26-78|Lack of Efficacy|5
6060392|NCT00518882|20939944|P1|Open-Label Extension, Week 26-78|Lack of Efficacy|6
6060393|NCT00518882|20939943|P2|Open-Label Extension, Week 26-78|Adverse Event|9
6060394|NCT00518882|20939944|P1|Open-Label Extension, Week 26-78|Adverse Event|3
6060395|NCT00518882|20939943|P2|Double-Blind, Week 0-26|Mutual consent|1
6060396|NCT00518882|20939944|P1|Double-Blind, Week 0-26|Mutual consent|0
6060397|NCT00518882|20939943|P2|Double-Blind, Week 0-26|Hypoglycaemia|2
6060398|NCT00518882|20939944|P1|Double-Blind, Week 0-26|Hypoglycaemia|0
6060399|NCT00518882|20939943|P2|Double-Blind, Week 0-26|Fear of hypoglycaemia|1
6060400|NCT00518882|20939944|P1|Double-Blind, Week 0-26|Fear of hypoglycaemia|0
6060401|NCT00518882|20939943|P2|Double-Blind, Week 0-26|Loss of trust|1
6060402|NCT00518882|20939944|P1|Double-Blind, Week 0-26|Loss of trust|0
6060403|NCT00518882|20939943|P2|Double-Blind, Week 0-26|Withdrawal of consent|3
6060404|NCT00518882|20939944|P1|Double-Blind, Week 0-26|Withdrawal of consent|1
6060405|NCT00518882|20939943|P2|Double-Blind, Week 0-26|Subject decision|1
6060406|NCT00518882|20939944|P1|Double-Blind, Week 0-26|Subject decision|1
6060407|NCT00518882|20939943|P2|Double-Blind, Week 0-26|Lost to follow up|1
6060408|NCT00518882|20939944|P1|Double-Blind, Week 0-26|Lost to follow up|2
6060409|NCT00518882|20939943|P2|Double-Blind, Week 0-26|Withdrawal criteria|1
6060410|NCT00518882|20939944|P1|Double-Blind, Week 0-26|Withdrawal criteria|1
6060411|NCT00518882|20939943|P2|Double-Blind, Week 0-26|Protocol Violation|3
6060412|NCT00518882|20939944|P1|Double-Blind, Week 0-26|Protocol Violation|4
6060413|NCT00518882|20939943|P2|Double-Blind, Week 0-26|Lack of Efficacy|0
6060414|NCT00518882|20939944|P1|Double-Blind, Week 0-26|Lack of Efficacy|1
6060415|NCT00518882|20939943|P2|Double-Blind, Week 0-26|Adverse Event|31
6060416|NCT00518882|20939944|P1|Double-Blind, Week 0-26|Adverse Event|23
6060417|NCT00518687|20940125|P2|Overall Study|Withdrawal by Subject|110
6060418|NCT00518687|20940126|P1|Overall Study|Withdrawal by Subject|110
6060419|NCT00518687|20940125|P2|Overall Study|Study terminated by sponsor|918
6060420|NCT00518687|20940126|P1|Overall Study|Study terminated by sponsor|930
6060421|NCT00518687|20940125|P2|Overall Study|Protocol Violation|10
6060422|NCT00518687|20940126|P1|Overall Study|Protocol Violation|8
6060423|NCT00518687|20940125|P2|Overall Study|Progressive disease|2
6060424|NCT00518687|20940126|P1|Overall Study|Progressive disease|2
6060425|NCT00518687|20940125|P2|Overall Study|Physician Decision|48
6060426|NCT00518687|20940126|P1|Overall Study|Physician Decision|42
6060427|NCT00518687|20940125|P2|Overall Study|Lost to Follow-up|155
6060428|NCT00518687|20940126|P1|Overall Study|Lost to Follow-up|144
6060429|NCT00518687|20940125|P2|Overall Study|Adverse Event|177
6060430|NCT00518687|20940126|P1|Overall Study|Adverse Event|201
6060431|NCT00518622|20940146|P8|Overall Study|Study medication taken incorrectly|0
6060432|NCT00518622|20940147|P7|Overall Study|Study medication taken incorrectly|0
6060433|NCT00518622|20940148|P6|Overall Study|Study medication taken incorrectly|0
6060434|NCT00518622|20940149|P5|Overall Study|Study medication taken incorrectly|0
6060435|NCT00518622|20940150|P4|Overall Study|Study medication taken incorrectly|0
6060436|NCT00518622|20940151|P3|Overall Study|Study medication taken incorrectly|0
6060437|NCT00518622|20940152|P2|Overall Study|Study medication taken incorrectly|1
6060438|NCT00518622|20940153|P1|Overall Study|Study medication taken incorrectly|0
6060439|NCT00518622|20940146|P8|Overall Study|Lost to Follow-up|0
6060440|NCT00518622|20940147|P7|Overall Study|Lost to Follow-up|0
6060441|NCT00518622|20940148|P6|Overall Study|Lost to Follow-up|0
6060442|NCT00518622|20940149|P5|Overall Study|Lost to Follow-up|0
6060443|NCT00518622|20940150|P4|Overall Study|Lost to Follow-up|0
6060444|NCT00518622|20940151|P3|Overall Study|Lost to Follow-up|1
6060445|NCT00518622|20940152|P2|Overall Study|Lost to Follow-up|0
6060446|NCT00518622|20940153|P1|Overall Study|Lost to Follow-up|0
6060447|NCT00518531|20940181|P2|Treatment Period 2|Non-compliance|2
6060448|NCT00518531|20940182|P1|Treatment Period 2|Non-compliance|1
6060449|NCT00518531|20940181|P2|Treatment Period 2|Protocol-specified criteria|1
6060450|NCT00518531|20940182|P1|Treatment Period 2|Protocol-specified criteria|0
6060451|NCT00518531|20940181|P2|Treatment Period 2|Adverse Event|7
6060452|NCT00518531|20940182|P1|Treatment Period 2|Adverse Event|1
6060453|NCT00518531|20940181|P2|Treatment Period 2|Complete out of scheduled visit window|2
6060454|NCT00518531|20940182|P1|Treatment Period 2|Complete out of scheduled visit window|1
6060455|NCT00518531|20940181|P2|Treatment Period 2|Withdrawal by Subject|8
6060456|NCT00518531|20940182|P1|Treatment Period 2|Withdrawal by Subject|0
6060457|NCT00518531|20940181|P2|Treatment Period 1|Early crossover|3
6060458|NCT00518531|20940182|P1|Treatment Period 1|Early crossover|1
6060459|NCT00518531|20940181|P2|Treatment Period 1|Withdrawal by Subject|6
6060460|NCT00518531|20940182|P1|Treatment Period 1|Withdrawal by Subject|4
6060461|NCT00518531|20940181|P2|Treatment Period 1|Protocol Violation|0
6060462|NCT00518531|20940182|P1|Treatment Period 1|Protocol Violation|2
6060463|NCT00518531|20940181|P2|Treatment Period 1|Physician Decision|0
6060464|NCT00518531|20940182|P1|Treatment Period 1|Physician Decision|1
6060465|NCT00518531|20940181|P2|Treatment Period 1|Lost to Follow-up|3
6060466|NCT00518531|20940182|P1|Treatment Period 1|Lost to Follow-up|5
6060467|NCT00518531|20940181|P2|Treatment Period 1|Adverse Event|0
6060468|NCT00518531|20940182|P1|Treatment Period 1|Adverse Event|5
6060469|NCT00518336|20940227|P2|Year 9|Personal reasons|0
6060470|NCT00518336|20940228|P1|Year 9|Personal reasons|1
6060471|NCT00518336|20940227|P2|Year 9|Lost to Follow-up|0
6060472|NCT00518336|20940228|P1|Year 9|Lost to Follow-up|3
6060473|NCT00518336|20940227|P2|Year 9|Migrated/moved from study area|1
6060474|NCT00518336|20940228|P1|Year 9|Migrated/moved from study area|1
6060475|NCT00518336|20940227|P2|Year 8|Could not attend in time|1
6060476|NCT00518336|20940228|P1|Year 8|Could not attend in time|0
6060477|NCT00518336|20940227|P2|Year 8|Lost to Follow-up|1
6060478|NCT00518336|20940228|P1|Year 8|Lost to Follow-up|1
6060479|NCT00518336|20940227|P2|Year 7|Could not attend in time|3
6060480|NCT00518336|20940228|P1|Year 7|Could not attend in time|0
6060481|NCT00518336|20940227|P2|Year 7|Lost to Follow-up|0
6060482|NCT00518336|20940228|P1|Year 7|Lost to Follow-up|2
6060483|NCT00518323|20940394|P4|Overall Study|Prohibited medication and others|0
6060484|NCT00518323|20940395|P3|Overall Study|Prohibited medication and others|1
6060485|NCT00518323|20940396|P2|Overall Study|Prohibited medication and others|1
6060486|NCT00518323|20940397|P1|Overall Study|Prohibited medication and others|3
6060487|NCT00518323|20940394|P4|Overall Study|Adverse Event|0
6060488|NCT00518323|20940395|P3|Overall Study|Adverse Event|1
6060489|NCT00518323|20940396|P2|Overall Study|Adverse Event|1
6060490|NCT00518323|20940397|P1|Overall Study|Adverse Event|1
6060491|NCT00518323|20940394|P4|Overall Study|Lost to Follow-up|3
6060492|NCT00518323|20940395|P3|Overall Study|Lost to Follow-up|1
6060493|NCT00518323|20940396|P2|Overall Study|Lost to Follow-up|2
6060494|NCT00518323|20940397|P1|Overall Study|Lost to Follow-up|0
6060495|NCT00518323|20940394|P4|Overall Study|Withdrawal by Subject|2
6060496|NCT00518323|20940395|P3|Overall Study|Withdrawal by Subject|4
6060497|NCT00518323|20940396|P2|Overall Study|Withdrawal by Subject|2
6060498|NCT00518323|20940397|P1|Overall Study|Withdrawal by Subject|1
6060499|NCT00518323|20940394|P4|Overall Study|Lack of Efficacy|20
6060500|NCT00518323|20940395|P3|Overall Study|Lack of Efficacy|4
6060501|NCT00518323|20940396|P2|Overall Study|Lack of Efficacy|2
6060502|NCT00518323|20940397|P1|Overall Study|Lack of Efficacy|14
6060503|NCT00518284|20940427|P4|Overall Study|Study Termination|2
6060504|NCT00518284|20940428|P3|Overall Study|Study Termination|1
6060505|NCT00518284|20940429|P2|Overall Study|Study Termination|2
6060506|NCT00518284|20940430|P1|Overall Study|Study Termination|0
6060507|NCT00518284|20940427|P4|Overall Study|Adverse Event|0
6060508|NCT00518284|20940428|P3|Overall Study|Adverse Event|0
6060509|NCT00518284|20940429|P2|Overall Study|Adverse Event|1
6060510|NCT00518284|20940430|P1|Overall Study|Adverse Event|0
6060511|NCT00518206|20940486|P2|Overall Study|Completion Status Unknown|0
6060512|NCT00518206|20940487|P1|Overall Study|Completion Status Unknown|1
6060513|NCT00518206|20940486|P2|Overall Study|Reason Unknown|0
6060514|NCT00518206|20940487|P1|Overall Study|Reason Unknown|1
6060515|NCT00518206|20940486|P2|Overall Study|Drug Supply Issue|0
6060516|NCT00518206|20940487|P1|Overall Study|Drug Supply Issue|1
6060517|NCT00518206|20940486|P2|Overall Study|Withdrawal by Subject|0
6060518|NCT00518206|20940487|P1|Overall Study|Withdrawal by Subject|2
6060519|NCT00518206|20940486|P2|Overall Study|Disease Progression Requiring Therapy|6
6060520|NCT00518206|20940487|P1|Overall Study|Disease Progression Requiring Therapy|6
6060521|NCT00518180|20940504|P3|Overall Study|Adverse Event|0
6060522|NCT00518180|20940505|P2|Overall Study|Adverse Event|0
6060523|NCT00518180|20940506|P1|Overall Study|Adverse Event|1
6060524|NCT00518180|20940504|P3|Overall Study|Unable to classify|0
6060525|NCT00518180|20940505|P2|Overall Study|Unable to classify|2
6060526|NCT00518180|20940506|P1|Overall Study|Unable to classify|0
6060527|NCT00518180|20940504|P3|Overall Study|Protocol Violation|4
6060528|NCT00518180|20940505|P2|Overall Study|Protocol Violation|7
6060529|NCT00518180|20940506|P1|Overall Study|Protocol Violation|5
6060530|NCT00518180|20940504|P3|Overall Study|Administrative reason|2
6060531|NCT00518180|20940505|P2|Overall Study|Administrative reason|2
6060532|NCT00518180|20940506|P1|Overall Study|Administrative reason|0
6060533|NCT00518180|20940504|P3|Overall Study|Lost to Follow-up|34
6060534|NCT00518180|20940505|P2|Overall Study|Lost to Follow-up|28
6060535|NCT00518180|20940506|P1|Overall Study|Lost to Follow-up|30
6060536|NCT00518180|20940504|P3|Overall Study|Withdrawal by Subject|42
6060537|NCT00518180|20940505|P2|Overall Study|Withdrawal by Subject|30
6060538|NCT00518180|20940506|P1|Overall Study|Withdrawal by Subject|29
6060539|NCT00518115|20940562|P10|Overall Study|Moved Out of State|1
6060540|NCT00518115|20940563|P9|Overall Study|Moved Out of State|0
6060541|NCT00518115|20940564|P8|Overall Study|Moved Out of State|0
6060542|NCT00518115|20940565|P7|Overall Study|Moved Out of State|0
6060543|NCT00518115|20940566|P6|Overall Study|Moved Out of State|0
6060544|NCT00518115|20940567|P5|Overall Study|Moved Out of State|0
6060545|NCT00518115|20940568|P4|Overall Study|Moved Out of State|0
6060546|NCT00518115|20940569|P3|Overall Study|Moved Out of State|0
6060547|NCT00518115|20940570|P2|Overall Study|Moved Out of State|0
6060548|NCT00518115|20940571|P1|Overall Study|Moved Out of State|0
6060549|NCT00518115|20940562|P10|Overall Study|Withdrew Consent|0
6060550|NCT00518115|20940563|P9|Overall Study|Withdrew Consent|0
6060551|NCT00518115|20940564|P8|Overall Study|Withdrew Consent|0
6060552|NCT00518115|20940565|P7|Overall Study|Withdrew Consent|0
6060553|NCT00518115|20940566|P6|Overall Study|Withdrew Consent|1
6060554|NCT00518115|20940567|P5|Overall Study|Withdrew Consent|0
6060555|NCT00518115|20940568|P4|Overall Study|Withdrew Consent|0
6060556|NCT00518115|20940569|P3|Overall Study|Withdrew Consent|0
6060557|NCT00518115|20940570|P2|Overall Study|Withdrew Consent|0
6060558|NCT00518115|20940571|P1|Overall Study|Withdrew Consent|0
6060559|NCT00518115|20940562|P10|Overall Study|Family Emergency; Had to Go to England|0
6060560|NCT00518115|20940563|P9|Overall Study|Family Emergency; Had to Go to England|0
6060561|NCT00518115|20940564|P8|Overall Study|Family Emergency; Had to Go to England|0
6060562|NCT00518115|20940565|P7|Overall Study|Family Emergency; Had to Go to England|0
6060563|NCT00518115|20940566|P6|Overall Study|Family Emergency; Had to Go to England|0
6060564|NCT00518115|20940567|P5|Overall Study|Family Emergency; Had to Go to England|1
6060565|NCT00518115|20940568|P4|Overall Study|Family Emergency; Had to Go to England|0
6060566|NCT00518115|20940569|P3|Overall Study|Family Emergency; Had to Go to England|0
6060567|NCT00518115|20940570|P2|Overall Study|Family Emergency; Had to Go to England|0
6060568|NCT00518115|20940571|P1|Overall Study|Family Emergency; Had to Go to England|0
6060569|NCT00518115|20940562|P10|Overall Study|Violation of Exclusion Criteria|0
6060570|NCT00518115|20940563|P9|Overall Study|Violation of Exclusion Criteria|0
6060571|NCT00518115|20940564|P8|Overall Study|Violation of Exclusion Criteria|0
6060572|NCT00518115|20940565|P7|Overall Study|Violation of Exclusion Criteria|1
6060573|NCT00518115|20940566|P6|Overall Study|Violation of Exclusion Criteria|0
6060574|NCT00518115|20940567|P5|Overall Study|Violation of Exclusion Criteria|0
6060575|NCT00518115|20940568|P4|Overall Study|Violation of Exclusion Criteria|1
6060576|NCT00518115|20940569|P3|Overall Study|Violation of Exclusion Criteria|0
6060577|NCT00518115|20940570|P2|Overall Study|Violation of Exclusion Criteria|0
6060578|NCT00518115|20940571|P1|Overall Study|Violation of Exclusion Criteria|0
6060579|NCT00518115|20940562|P10|Overall Study|Wrong Monotherapy Administered|0
6060580|NCT00518115|20940563|P9|Overall Study|Wrong Monotherapy Administered|0
6060581|NCT00518115|20940564|P8|Overall Study|Wrong Monotherapy Administered|0
6060582|NCT00518115|20940565|P7|Overall Study|Wrong Monotherapy Administered|1
6060583|NCT00518115|20940566|P6|Overall Study|Wrong Monotherapy Administered|0
6060584|NCT00518115|20940567|P5|Overall Study|Wrong Monotherapy Administered|0
6060585|NCT00518115|20940568|P4|Overall Study|Wrong Monotherapy Administered|0
6060586|NCT00518115|20940569|P3|Overall Study|Wrong Monotherapy Administered|1
6060587|NCT00518115|20940570|P2|Overall Study|Wrong Monotherapy Administered|0
6060588|NCT00518115|20940571|P1|Overall Study|Wrong Monotherapy Administered|0
6060589|NCT00518115|20940562|P10|Overall Study|Different Monotherapy Diabetic Drug|0
6060590|NCT00518115|20940563|P9|Overall Study|Different Monotherapy Diabetic Drug|1
6060591|NCT00518115|20940564|P8|Overall Study|Different Monotherapy Diabetic Drug|0
6060592|NCT00518115|20940565|P7|Overall Study|Different Monotherapy Diabetic Drug|0
6060593|NCT00518115|20940566|P6|Overall Study|Different Monotherapy Diabetic Drug|0
6060594|NCT00518115|20940567|P5|Overall Study|Different Monotherapy Diabetic Drug|0
6060595|NCT00518115|20940568|P4|Overall Study|Different Monotherapy Diabetic Drug|0
6060596|NCT00518115|20940569|P3|Overall Study|Different Monotherapy Diabetic Drug|1
6060597|NCT00518115|20940570|P2|Overall Study|Different Monotherapy Diabetic Drug|0
6060598|NCT00518115|20940571|P1|Overall Study|Different Monotherapy Diabetic Drug|0
6060599|NCT00518115|20940562|P10|Overall Study|Physician Prescribed Antidiabetic Drug|0
6060600|NCT00518115|20940563|P9|Overall Study|Physician Prescribed Antidiabetic Drug|0
6060601|NCT00518115|20940564|P8|Overall Study|Physician Prescribed Antidiabetic Drug|0
6060602|NCT00518115|20940565|P7|Overall Study|Physician Prescribed Antidiabetic Drug|0
6060603|NCT00518115|20940566|P6|Overall Study|Physician Prescribed Antidiabetic Drug|0
6060604|NCT00518115|20940567|P5|Overall Study|Physician Prescribed Antidiabetic Drug|0
6060605|NCT00518115|20940568|P4|Overall Study|Physician Prescribed Antidiabetic Drug|0
6060606|NCT00518115|20940569|P3|Overall Study|Physician Prescribed Antidiabetic Drug|0
6060607|NCT00518115|20940570|P2|Overall Study|Physician Prescribed Antidiabetic Drug|0
6060608|NCT00518115|20940571|P1|Overall Study|Physician Prescribed Antidiabetic Drug|1
6060609|NCT00518115|20940562|P10|Overall Study|Treatment Eligibility Criteria Not Met|0
6060610|NCT00518115|20940563|P9|Overall Study|Treatment Eligibility Criteria Not Met|0
6060611|NCT00518115|20940564|P8|Overall Study|Treatment Eligibility Criteria Not Met|0
6060612|NCT00518115|20940565|P7|Overall Study|Treatment Eligibility Criteria Not Met|0
6060613|NCT00518115|20940566|P6|Overall Study|Treatment Eligibility Criteria Not Met|4
6060614|NCT00518115|20940567|P5|Overall Study|Treatment Eligibility Criteria Not Met|0
6060615|NCT00518115|20940568|P4|Overall Study|Treatment Eligibility Criteria Not Met|0
6060616|NCT00518115|20940569|P3|Overall Study|Treatment Eligibility Criteria Not Met|0
6060617|NCT00518115|20940570|P2|Overall Study|Treatment Eligibility Criteria Not Met|1
6060618|NCT00518115|20940571|P1|Overall Study|Treatment Eligibility Criteria Not Met|1
6060619|NCT00518115|20940562|P10|Overall Study|Non-Compliance|1
6060620|NCT00518115|20940563|P9|Overall Study|Non-Compliance|0
6060621|NCT00518115|20940564|P8|Overall Study|Non-Compliance|1
6060622|NCT00518115|20940565|P7|Overall Study|Non-Compliance|1
6060623|NCT00518115|20940566|P6|Overall Study|Non-Compliance|1
6060624|NCT00518115|20940567|P5|Overall Study|Non-Compliance|1
6060625|NCT00518115|20940568|P4|Overall Study|Non-Compliance|0
6060626|NCT00518115|20940569|P3|Overall Study|Non-Compliance|1
6060627|NCT00518115|20940570|P2|Overall Study|Non-Compliance|0
6060628|NCT00518115|20940571|P1|Overall Study|Non-Compliance|1
6060629|NCT00518115|20940562|P10|Overall Study|Lack of Efficacy|0
6060630|NCT00518115|20940563|P9|Overall Study|Lack of Efficacy|0
6060631|NCT00518115|20940564|P8|Overall Study|Lack of Efficacy|1
6060632|NCT00518115|20940565|P7|Overall Study|Lack of Efficacy|0
6060633|NCT00518115|20940566|P6|Overall Study|Lack of Efficacy|0
6060634|NCT00518115|20940567|P5|Overall Study|Lack of Efficacy|0
6060635|NCT00518115|20940568|P4|Overall Study|Lack of Efficacy|1
6060636|NCT00518115|20940569|P3|Overall Study|Lack of Efficacy|1
6060637|NCT00518115|20940570|P2|Overall Study|Lack of Efficacy|0
6060638|NCT00518115|20940571|P1|Overall Study|Lack of Efficacy|1
6060639|NCT00518115|20940562|P10|Overall Study|Withdrawal by Subject|3
6060640|NCT00518115|20940563|P9|Overall Study|Withdrawal by Subject|1
6060641|NCT00518115|20940564|P8|Overall Study|Withdrawal by Subject|2
6060642|NCT00518115|20940565|P7|Overall Study|Withdrawal by Subject|0
6060643|NCT00518115|20940566|P6|Overall Study|Withdrawal by Subject|1
6060644|NCT00518115|20940567|P5|Overall Study|Withdrawal by Subject|2
6060645|NCT00518115|20940568|P4|Overall Study|Withdrawal by Subject|0
6060646|NCT00518115|20940569|P3|Overall Study|Withdrawal by Subject|5
6060647|NCT00518115|20940570|P2|Overall Study|Withdrawal by Subject|1
6060648|NCT00518115|20940571|P1|Overall Study|Withdrawal by Subject|1
6060649|NCT00518115|20940562|P10|Overall Study|Protocol Violation|0
6060650|NCT00518115|20940563|P9|Overall Study|Protocol Violation|0
6060651|NCT00518115|20940564|P8|Overall Study|Protocol Violation|0
6060652|NCT00518115|20940565|P7|Overall Study|Protocol Violation|0
6060653|NCT00518115|20940566|P6|Overall Study|Protocol Violation|0
6060654|NCT00518115|20940567|P5|Overall Study|Protocol Violation|0
6060655|NCT00518115|20940568|P4|Overall Study|Protocol Violation|0
6060656|NCT00518115|20940569|P3|Overall Study|Protocol Violation|1
6060657|NCT00518115|20940570|P2|Overall Study|Protocol Violation|3
6060658|NCT00518115|20940571|P1|Overall Study|Protocol Violation|1
6060659|NCT00518115|20940562|P10|Overall Study|Lost to Follow-up|1
6060660|NCT00518115|20940563|P9|Overall Study|Lost to Follow-up|1
6060661|NCT00518115|20940564|P8|Overall Study|Lost to Follow-up|1
6060662|NCT00518115|20940565|P7|Overall Study|Lost to Follow-up|0
6060663|NCT00518115|20940566|P6|Overall Study|Lost to Follow-up|3
6060664|NCT00518115|20940567|P5|Overall Study|Lost to Follow-up|1
6060665|NCT00518115|20940568|P4|Overall Study|Lost to Follow-up|3
6060666|NCT00518115|20940569|P3|Overall Study|Lost to Follow-up|2
6060667|NCT00518115|20940570|P2|Overall Study|Lost to Follow-up|0
6060668|NCT00518115|20940571|P1|Overall Study|Lost to Follow-up|0
6060669|NCT00518115|20940562|P10|Overall Study|Adverse Event|9
6060670|NCT00518115|20940563|P9|Overall Study|Adverse Event|2
6060671|NCT00518115|20940564|P8|Overall Study|Adverse Event|10
6060672|NCT00518115|20940565|P7|Overall Study|Adverse Event|5
6060673|NCT00518115|20940566|P6|Overall Study|Adverse Event|5
6060674|NCT00518115|20940567|P5|Overall Study|Adverse Event|5
6060675|NCT00518115|20940568|P4|Overall Study|Adverse Event|6
6060676|NCT00518115|20940569|P3|Overall Study|Adverse Event|5
6060677|NCT00518115|20940570|P2|Overall Study|Adverse Event|1
6060678|NCT00518115|20940571|P1|Overall Study|Adverse Event|6
6060679|NCT00518011|20940746|P2|Overall Study|Withdrawal by Subject|0
6060680|NCT00518011|20940747|P1|Overall Study|Withdrawal by Subject|1
6060681|NCT00518011|20940746|P2|Overall Study|Other Reasons|2
6060682|NCT00518011|20940747|P1|Overall Study|Other Reasons|3
6060683|NCT00518011|20940746|P2|Overall Study|Disease Progression|2
6060684|NCT00518011|20940747|P1|Overall Study|Disease Progression|2
6060685|NCT00518011|20940746|P2|Overall Study|Adverse Event|3
6060686|NCT00518011|20940747|P1|Overall Study|Adverse Event|2
6060687|NCT00518011|20940746|P2|Overall Study|Death|1
6060688|NCT00518011|20940747|P1|Overall Study|Death|1
6060689|NCT00517933|20940769|P2|Period 2|Underwent lung transplant|2
6060690|NCT00517933|20940770|P1|Period 2|Underwent lung transplant|0
6060691|NCT00517933|20940769|P2|Period 2|Withdrawal by Subject|3
6060692|NCT00517933|20940770|P1|Period 2|Withdrawal by Subject|1
6060693|NCT00517933|20940769|P2|Period 2|Physician Decision|0
6060694|NCT00517933|20940770|P1|Period 2|Physician Decision|1
6060695|NCT00517933|20940769|P2|Period 2|Adverse Event|4
6060696|NCT00517933|20940770|P1|Period 2|Adverse Event|2
6060697|NCT00517933|20940769|P2|Period 2|Death|4
6060698|NCT00517933|20940770|P1|Period 2|Death|2
6060699|NCT00517933|20940769|P2|Period 1|Underwent lung transplant|1
6060700|NCT00517933|20940770|P1|Period 1|Underwent lung transplant|0
6060701|NCT00517933|20940769|P2|Period 1|Lost to Follow-up|0
6060702|NCT00517933|20940770|P1|Period 1|Lost to Follow-up|2
6060703|NCT00517933|20940769|P2|Period 1|Adverse Event|4
6060704|NCT00517933|20940770|P1|Period 1|Adverse Event|4
6060705|NCT00517933|20940769|P2|Period 1|Death|1
6060706|NCT00517933|20940770|P1|Period 1|Death|2
6060707|NCT00517881|20940834|P1|Overall Study|Renal transplantation|2
6060708|NCT00517881|20940834|P1|Overall Study|Adverse Event|1
6060709|NCT00517881|20940834|P1|Overall Study|Protocol Violation|2
6060710|NCT00517829|20940846|P2|Overall Study|Other|1
6060711|NCT00517829|20940847|P1|Overall Study|Other|3
6060712|NCT00517829|20940846|P2|Overall Study|Investigator Request|3
6060713|NCT00517829|20940847|P1|Overall Study|Investigator Request|5
6060714|NCT00517829|20940846|P2|Overall Study|Patient Request|5
6060715|NCT00517829|20940847|P1|Overall Study|Patient Request|6
6060716|NCT00517829|20940846|P2|Overall Study|Disease Progression|32
6060717|NCT00517829|20940847|P1|Overall Study|Disease Progression|39
6060718|NCT00517829|20940846|P2|Overall Study|Adverse Event|34
6060719|NCT00517829|20940847|P1|Overall Study|Adverse Event|22
6060720|NCT00517751|20940861|P1|Overall Study|Missing|3
6060721|NCT00517751|20940861|P1|Overall Study|Patient not due for visit|76
6060722|NCT00517751|20940861|P1|Overall Study|patient not over due|6
6060723|NCT00517751|20940861|P1|Overall Study|Lost to Follow-up|4
6060724|NCT00517751|20940861|P1|Overall Study|Withdrawal by Subject|37
6060725|NCT00517751|20940861|P1|Overall Study|Death|3
6060726|NCT00517699|20940884|P1|Overall Study|Study terminated by Sponsor|2
6060727|NCT00517699|20940884|P1|Overall Study|Administrative error|1
6060728|NCT00517699|20940884|P1|Overall Study|Lack of Efficacy|1
6060729|NCT00517699|20940884|P1|Overall Study|Withdrawal by Subject|1
6060730|NCT00517634|20940892|P6|Second Treatment Period|Withdrawal by Subject|0
6060731|NCT00517634|20940893|P5|Second Treatment Period|Withdrawal by Subject|1
6060732|NCT00517634|20940894|P4|Second Treatment Period|Withdrawal by Subject|0
6060733|NCT00517634|20940895|P3|Second Treatment Period|Withdrawal by Subject|0
6060734|NCT00517634|20940896|P2|Second Treatment Period|Withdrawal by Subject|0
6060735|NCT00517634|20940897|P1|Second Treatment Period|Withdrawal by Subject|0
6060736|NCT00517413|20940999|P1|Overall Study|Other-Reasons|23
6060737|NCT00517413|20940999|P1|Overall Study|Failure to return|1
6060738|NCT00517413|20940999|P1|Overall Study|Withdrawal by Subject|2
6060739|NCT00517413|20940999|P1|Overall Study|Protocol Violation|15
6060740|NCT00517413|20940999|P1|Overall Study|Death|13
6060741|NCT00517413|20940999|P1|Overall Study|Adverse Event|7
6060742|NCT00517361|20941020|P1|Overall Study|The study was terminated|5
6060743|NCT00517361|20941020|P1|Overall Study|Death|6
6060744|NCT00517296|20941029|P2|Overall Study|Withdrawal by Subject|0
6060745|NCT00517296|20941030|P1|Overall Study|Withdrawal by Subject|1
6060746|NCT00517192|20941042|P2|Overall Study|Early termination of the trial|18
6060747|NCT00517192|20941043|P1|Overall Study|Early termination of the trial|16
6060748|NCT00517192|20941042|P2|Overall Study|Withdrawal by Subject|0
6060749|NCT00517192|20941043|P1|Overall Study|Withdrawal by Subject|1
6060750|NCT00517192|20941042|P2|Overall Study|Lost to Follow-up|1
6060751|NCT00517192|20941043|P1|Overall Study|Lost to Follow-up|1
6060752|NCT00517192|20941042|P2|Overall Study|Adverse Event|1
6060753|NCT00517192|20941043|P1|Overall Study|Adverse Event|1
6060754|NCT00516906|20941150|P2|Overall Study|Final Dressing Removal Data not captured|2
6060755|NCT00516906|20941151|P1|Overall Study|Final Dressing Removal Data not captured|6
6060756|NCT00516893|20941161|P1|Overall Study|Received Medication From Another Study|1
6060757|NCT00516893|20941161|P1|Overall Study|Pregnancy|1
6060758|NCT00516893|20941161|P1|Overall Study|Relocated|1
6060759|NCT00516893|20941161|P1|Overall Study|Persistent Antibodies per Protocol|6
6060760|NCT00516893|20941161|P1|Overall Study|Death|1
6060761|NCT00516893|20941161|P1|Overall Study|Noncompliance|2
6060762|NCT00516893|20941161|P1|Overall Study|Withdrawal by Subject|2
6060763|NCT00516893|20941161|P1|Overall Study|Adverse Event|3
6060764|NCT00516893|20941161|P1|Overall Study|Lost to Follow-up|4
6060765|NCT00516737|20941170|P2|Overall Study|Lack of Qualifying Event|6
6060766|NCT00516737|20941171|P1|Overall Study|Lack of Qualifying Event|9
6060767|NCT00516737|20941170|P2|Overall Study|Withdrawal by Subject|1
6060768|NCT00516737|20941171|P1|Overall Study|Withdrawal by Subject|0
6060769|NCT00516737|20941170|P2|Overall Study|Physician Decision|1
6060770|NCT00516737|20941171|P1|Overall Study|Physician Decision|0
6060771|NCT00516737|20941170|P2|Overall Study|Lost to Follow-up|0
6060772|NCT00516737|20941171|P1|Overall Study|Lost to Follow-up|2
6060773|NCT00516386|20941210|P1|Overall Study|Lost to Follow-up|2
6060774|NCT00516386|20941210|P1|Overall Study|not interested in the study|4
6060775|NCT00516321|20941217|P3|Double-blind (DB) Antiviral Treatment|Physician Decision|0
6060776|NCT00516321|20941218|P2|Double-blind (DB) Antiviral Treatment|Physician Decision|2
6060777|NCT00516321|20941219|P1|Double-blind (DB) Antiviral Treatment|Physician Decision|0
6060778|NCT00516321|20941217|P3|Double-blind (DB) Antiviral Treatment|Protocol Violation|1
6060779|NCT00516321|20941218|P2|Double-blind (DB) Antiviral Treatment|Protocol Violation|0
6060780|NCT00516321|20941219|P1|Double-blind (DB) Antiviral Treatment|Protocol Violation|0
6060781|NCT00516321|20941217|P3|Double-blind (DB) Antiviral Treatment|Adverse Event|13
6060782|NCT00516321|20941218|P2|Double-blind (DB) Antiviral Treatment|Adverse Event|8
6060783|NCT00516321|20941219|P1|Double-blind (DB) Antiviral Treatment|Adverse Event|0
6060784|NCT00516321|20941217|P3|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|18
6060785|NCT00516321|20941218|P2|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|13
6060786|NCT00516321|20941219|P1|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|0
6060787|NCT00516321|20941217|P3|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|22
6060788|NCT00516321|20941218|P2|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|12
6060789|NCT00516321|20941219|P1|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|0
6060790|NCT00516321|20941217|P3|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0
6060791|NCT00516321|20941218|P2|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0
6060792|NCT00516321|20941219|P1|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|3
6060793|NCT00516321|20941217|P3|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0
6060794|NCT00516321|20941218|P2|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0
6060795|NCT00516321|20941219|P1|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|7
6060796|NCT00516321|20941217|P3|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0
6060797|NCT00516321|20941218|P2|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0
6060798|NCT00516321|20941219|P1|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|2
6060799|NCT00516321|20941217|P3|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0
6060800|NCT00516321|20941218|P2|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0
6060801|NCT00516321|20941219|P1|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|1
6060802|NCT00516321|20941217|P3|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0
6060803|NCT00516321|20941218|P2|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0
6060804|NCT00516321|20941219|P1|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|9
6060805|NCT00516321|20941217|P3|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0
6060806|NCT00516321|20941218|P2|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0
6060807|NCT00516321|20941219|P1|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|11
6060808|NCT00516295|20941270|P3|Overall Study|Ineligible|0
6060809|NCT00516295|20941271|P2|Overall Study|Ineligible|0
6060810|NCT00516295|20941272|P1|Overall Study|Ineligible|1
6060811|NCT00516295|20941270|P3|Overall Study|Lack of Efficacy|0
6060812|NCT00516295|20941271|P2|Overall Study|Lack of Efficacy|0
6060813|NCT00516295|20941272|P1|Overall Study|Lack of Efficacy|2
6060814|NCT00516269|20941285|P2|Overall Study|Protocol Violation|1
6060815|NCT00516269|20941286|P1|Overall Study|Protocol Violation|0
6060816|NCT00516269|20941285|P2|Overall Study|Lost to Follow-up|1
6060817|NCT00516269|20941286|P1|Overall Study|Lost to Follow-up|0
6060818|NCT00516269|20941285|P2|Overall Study|Adverse Event|1
6060819|NCT00516269|20941286|P1|Overall Study|Adverse Event|2
6060820|NCT00516139|20941307|P1|Overall Study|Lack of Efficacy|1
6060821|NCT00516139|20941307|P1|Overall Study|Withdrawal by Subject|8
6060822|NCT00516139|20941307|P1|Overall Study|Protocol Violation|1
6060823|NCT00516139|20941307|P1|Overall Study|Lost to Follow-up|1
6060824|NCT00516139|20941307|P1|Overall Study|Adverse Event|27
6060825|NCT00516074|20941338|P2|Overall Study|Loss of Glucose Control|0
6060826|NCT00516074|20941339|P1|Overall Study|Loss of Glucose Control|2
6060827|NCT00516074|20941338|P2|Overall Study|Subject Decision|2
6060828|NCT00516074|20941339|P1|Overall Study|Subject Decision|4
6060829|NCT00516074|20941338|P2|Overall Study|Adverse Event|1
6060830|NCT00516074|20941339|P1|Overall Study|Adverse Event|0
6060831|NCT00516048|20941357|P3|Overall Study|Subject Decision|0
6060832|NCT00516048|20941358|P2|Overall Study|Subject Decision|2
6060833|NCT00516048|20941359|P1|Overall Study|Subject Decision|0
6060834|NCT00516048|20941357|P3|Overall Study|Death|1
6060835|NCT00516048|20941358|P2|Overall Study|Death|0
6060836|NCT00516048|20941359|P1|Overall Study|Death|0
6060837|NCT00515827|20941394|P2|Second Intervention (12 Weeks)|Consent withdraw|0
6060838|NCT00515827|20941395|P1|Second Intervention (12 Weeks)|Consent withdraw|1
6060839|NCT00515827|20941394|P2|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1
6060840|NCT00515827|20941395|P1|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1
6060841|NCT00515671|20941453|P2|Overall Study|incarcerated|2
6060842|NCT00515671|20941454|P1|Overall Study|incarcerated|1
6060843|NCT00515671|20941453|P2|Overall Study|Withdrawal by Subject|5
6060844|NCT00515671|20941454|P1|Overall Study|Withdrawal by Subject|3
6060845|NCT00515671|20941453|P2|Overall Study|Lost to Follow-up|10
6060846|NCT00515671|20941454|P1|Overall Study|Lost to Follow-up|13
6060847|NCT00515619|20941462|P1|Overall Study|Other: Subject interested in other AED|1
6060848|NCT00515619|20941462|P1|Overall Study|Other: Drug available on license|1
6060849|NCT00515619|20941462|P1|Overall Study|Other: Request from sponsor|1
6060850|NCT00515619|20941462|P1|Overall Study|Other: Subject became pregnant|1
6060851|NCT00515619|20941462|P1|Overall Study|Other: Investigator decision|1
6060852|NCT00515619|20941462|P1|Overall Study|Other: Subject moved to another country|1
6060853|NCT00515619|20941462|P1|Overall Study|Other: Subject required surgery|1
6060854|NCT00515619|20941462|P1|Overall Study|Other: Subject cannot attend visits|2
6060855|NCT00515619|20941462|P1|Overall Study|Other: Site discontinuing trials|2
6060856|NCT00515619|20941462|P1|Overall Study|Unsatisfactory compliance|6
6060857|NCT00515619|20941462|P1|Overall Study|Lost to Follow-up|4
6060858|NCT00515619|20941462|P1|Overall Study|Protocol Violation|3
6060859|NCT00515619|20941462|P1|Overall Study|Withdrawal by Subject|66
6060860|NCT00515619|20941462|P1|Overall Study|Lack of Efficacy|92
6060861|NCT00515619|20941462|P1|Overall Study|Adverse Event|34
6060862|NCT00515541|20941474|P4|Overall Study|Withdrawal by Subject|2
6060863|NCT00515541|20941475|P3|Overall Study|Withdrawal by Subject|0
6060864|NCT00515541|20941476|P2|Overall Study|Withdrawal by Subject|2
6060865|NCT00515541|20941477|P1|Overall Study|Withdrawal by Subject|0
6060866|NCT00515541|20941474|P4|Overall Study|No show for appointments|2
6060867|NCT00515541|20941475|P3|Overall Study|No show for appointments|0
6060868|NCT00515541|20941476|P2|Overall Study|No show for appointments|1
6060869|NCT00515541|20941477|P1|Overall Study|No show for appointments|0
6060870|NCT00515541|20941474|P4|Overall Study|Physician Decision|1
6060871|NCT00515541|20941475|P3|Overall Study|Physician Decision|0
6060872|NCT00515541|20941476|P2|Overall Study|Physician Decision|2
6060873|NCT00515541|20941477|P1|Overall Study|Physician Decision|0
6060874|NCT00515502|20941508|P12|Treatment Period 2|Adverse Event|0
6060875|NCT00515502|20941509|P11|Treatment Period 2|Adverse Event|0
6060876|NCT00515502|20941510|P10|Treatment Period 2|Adverse Event|0
6060877|NCT00515502|20941511|P9|Treatment Period 2|Adverse Event|0
6060878|NCT00515502|20941512|P8|Treatment Period 2|Adverse Event|0
6060879|NCT00515502|20941513|P7|Treatment Period 2|Adverse Event|0
6060880|NCT00515502|20941514|P6|Treatment Period 2|Adverse Event|0
6060881|NCT00515502|20941515|P5|Treatment Period 2|Adverse Event|0
6060882|NCT00515502|20941516|P4|Treatment Period 2|Adverse Event|0
6060883|NCT00515502|20941517|P3|Treatment Period 2|Adverse Event|0
6060884|NCT00515502|20941518|P2|Treatment Period 2|Adverse Event|1
6060885|NCT00515502|20941519|P1|Treatment Period 2|Adverse Event|0
6060886|NCT00515502|20941508|P12|Treatment Period 1|Adverse Event|1
6060887|NCT00515502|20941509|P11|Treatment Period 1|Adverse Event|0
6060888|NCT00515502|20941510|P10|Treatment Period 1|Adverse Event|0
6060889|NCT00515502|20941511|P9|Treatment Period 1|Adverse Event|1
6060890|NCT00515502|20941512|P8|Treatment Period 1|Adverse Event|0
6060891|NCT00515502|20941513|P7|Treatment Period 1|Adverse Event|1
6060892|NCT00515502|20941514|P6|Treatment Period 1|Adverse Event|0
6060893|NCT00515502|20941515|P5|Treatment Period 1|Adverse Event|0
6060894|NCT00515502|20941516|P4|Treatment Period 1|Adverse Event|0
6060895|NCT00515502|20941517|P3|Treatment Period 1|Adverse Event|0
6060896|NCT00515502|20941518|P2|Treatment Period 1|Adverse Event|0
6060897|NCT00515502|20941519|P1|Treatment Period 1|Adverse Event|0
6060898|NCT00515463|20941679|P2|Overall Study|Other|1
6060899|NCT00515463|20941680|P1|Overall Study|Other|0
6060900|NCT00515463|20941679|P2|Overall Study|Lost to Follow-up|5
6060901|NCT00515463|20941680|P1|Overall Study|Lost to Follow-up|6
6060902|NCT00515463|20941679|P2|Overall Study|Withdrawal by Subject|4
6060903|NCT00515463|20941680|P1|Overall Study|Withdrawal by Subject|3
6060904|NCT00515463|20941679|P2|Overall Study|Adverse Event|2
6060905|NCT00515463|20941680|P1|Overall Study|Adverse Event|1
6060906|NCT00515463|20941679|P2|Overall Study|Physician Decision|2
6060907|NCT00515463|20941680|P1|Overall Study|Physician Decision|4
6060908|NCT00515294|20941879|P4|Overall Study|Caffeine amount inaccurate|0
6060909|NCT00515294|20941880|P3|Overall Study|Caffeine amount inaccurate|7
6060910|NCT00515294|20941881|P2|Overall Study|Caffeine amount inaccurate|0
6060911|NCT00515294|20941882|P1|Overall Study|Caffeine amount inaccurate|5
6060912|NCT00515294|20941879|P4|Overall Study|Driver simulator problems|3
6060913|NCT00515294|20941880|P3|Overall Study|Driver simulator problems|1
6060914|NCT00515294|20941881|P2|Overall Study|Driver simulator problems|1
6060915|NCT00515294|20941882|P1|Overall Study|Driver simulator problems|1
6060916|NCT00515294|20941879|P4|Overall Study|Lost to Follow-up|1
6060917|NCT00515294|20941880|P3|Overall Study|Lost to Follow-up|3
6060918|NCT00515294|20941881|P2|Overall Study|Lost to Follow-up|2
6060919|NCT00515294|20941882|P1|Overall Study|Lost to Follow-up|3
6060920|NCT00515216|20941896|P1|Overall Study|Withdrawal by Subject|1
6060921|NCT00515112|20941958|P2|Overall Study|The study was terminated|2
6060922|NCT00515112|20941959|P1|Overall Study|The study was terminated|3
6060923|NCT00515112|20941958|P2|Overall Study|Death|1
6060924|NCT00515112|20941959|P1|Overall Study|Death|0
6060925|NCT00515099|20941969|P2|Overall Study|IRB Recommendation|0
6060926|NCT00515099|20941970|P1|Overall Study|IRB Recommendation|1
6060927|NCT00515099|20941969|P2|Overall Study|Withdrawal by Subject|0
6060928|NCT00515099|20941970|P1|Overall Study|Withdrawal by Subject|2
6060929|NCT00515099|20941969|P2|Overall Study|Lost to Follow-up|4
6060930|NCT00515099|20941970|P1|Overall Study|Lost to Follow-up|0
6060931|NCT00515086|20941992|P4|Overall Study|Death|0
6060932|NCT00515086|20941993|P3|Overall Study|Death|0
6060933|NCT00515086|20941994|P2|Overall Study|Death|0
6060934|NCT00515086|20941995|P1|Overall Study|Death|2
6060935|NCT00515086|20941992|P4|Overall Study|Study drug no longer required|0
6060936|NCT00515086|20941993|P3|Overall Study|Study drug no longer required|0
6060937|NCT00515086|20941994|P2|Overall Study|Study drug no longer required|1
6060938|NCT00515086|20941995|P1|Overall Study|Study drug no longer required|0
6060939|NCT00515086|20941992|P4|Overall Study|Lost to Follow-up|0
6060940|NCT00515086|20941993|P3|Overall Study|Lost to Follow-up|0
6060941|NCT00515086|20941994|P2|Overall Study|Lost to Follow-up|0
6060942|NCT00515086|20941995|P1|Overall Study|Lost to Follow-up|1
6060943|NCT00515086|20941992|P4|Overall Study|Unsatisfactory therapeutic effect|2
6060944|NCT00515086|20941993|P3|Overall Study|Unsatisfactory therapeutic effect|3
6060945|NCT00515086|20941994|P2|Overall Study|Unsatisfactory therapeutic effect|3
6060946|NCT00515086|20941995|P1|Overall Study|Unsatisfactory therapeutic effect|18
6060947|NCT00515086|20941992|P4|Overall Study|Withdrawal by Subject|1
6060948|NCT00515086|20941993|P3|Overall Study|Withdrawal by Subject|0
6060949|NCT00515086|20941994|P2|Overall Study|Withdrawal by Subject|0
6060950|NCT00515086|20941995|P1|Overall Study|Withdrawal by Subject|1
6060951|NCT00515086|20941992|P4|Overall Study|Administrative|0
6060952|NCT00515086|20941993|P3|Overall Study|Administrative|0
6060953|NCT00515086|20941994|P2|Overall Study|Administrative|1
6060954|NCT00515086|20941995|P1|Overall Study|Administrative|1
6060955|NCT00515086|20941992|P4|Overall Study|Adverse Event|3
6060956|NCT00515086|20941993|P3|Overall Study|Adverse Event|2
6060957|NCT00515086|20941994|P2|Overall Study|Adverse Event|1
6060958|NCT00515086|20941995|P1|Overall Study|Adverse Event|1
6060959|NCT00515073|20942022|P1|Overall Study|Physician Decision|1
6060960|NCT00515073|20942022|P1|Overall Study|Withdrawal by Subject|1
6060961|NCT00515034|20942030|P4|Overall Study|Other|1
6060962|NCT00515034|20942031|P3|Overall Study|Other|2
6060963|NCT00515034|20942032|P2|Overall Study|Other|0
6060964|NCT00515034|20942033|P1|Overall Study|Other|1
6060965|NCT00515034|20942030|P4|Overall Study|Physician Decision|1
6060966|NCT00515034|20942031|P3|Overall Study|Physician Decision|1
6060967|NCT00515034|20942032|P2|Overall Study|Physician Decision|0
6060968|NCT00515034|20942033|P1|Overall Study|Physician Decision|0
6060969|NCT00515034|20942030|P4|Overall Study|Withdrawal by Subject|0
6060970|NCT00515034|20942031|P3|Overall Study|Withdrawal by Subject|3
6060971|NCT00515034|20942032|P2|Overall Study|Withdrawal by Subject|0
6060972|NCT00515034|20942033|P1|Overall Study|Withdrawal by Subject|1
6060973|NCT00515034|20942030|P4|Overall Study|Death|3
6060974|NCT00515034|20942031|P3|Overall Study|Death|1
6060975|NCT00515034|20942032|P2|Overall Study|Death|2
6060976|NCT00515034|20942033|P1|Overall Study|Death|4
6060977|NCT00515034|20942030|P4|Overall Study|Adverse Event|0
6060978|NCT00515034|20942031|P3|Overall Study|Adverse Event|1
6060979|NCT00515034|20942032|P2|Overall Study|Adverse Event|0
6060980|NCT00515034|20942033|P1|Overall Study|Adverse Event|2
6060981|NCT00515008|20942064|P2|Overall Study|Scheduling conflict|0
6060982|NCT00515008|20942065|P1|Overall Study|Scheduling conflict|1
6060983|NCT00515008|20942064|P2|Overall Study|Left the Boston Area|1
6060984|NCT00515008|20942065|P1|Overall Study|Left the Boston Area|1
6060985|NCT00515008|20942064|P2|Overall Study|Declined|3
6060986|NCT00515008|20942065|P1|Overall Study|Declined|0
6060987|NCT00515008|20942064|P2|Overall Study|Lost to Follow-up|0
6060988|NCT00515008|20942065|P1|Overall Study|Lost to Follow-up|1
6060989|NCT00514943|20942089|P2|Stage 2|Other than stated above|2
6060990|NCT00514943|20942090|P1|Stage 2|Other than stated above|0
6060991|NCT00514943|20942089|P2|Stage 2|Patient refused to continue study meds|0
6060992|NCT00514943|20942090|P1|Stage 2|Patient refused to continue study meds|2
6060993|NCT00514943|20942089|P2|Stage 2|Other Adverse Event|10
6060994|NCT00514943|20942090|P1|Stage 2|Other Adverse Event|3
6060995|NCT00514943|20942089|P2|Stage 2|Progressive disease|24
6060996|NCT00514943|20942090|P1|Stage 2|Progressive disease|27
6060997|NCT00514943|20942089|P2|Stage 1|Other than stated above|7
6060998|NCT00514943|20942090|P1|Stage 1|Other than stated above|1
6060999|NCT00514943|20942089|P2|Stage 1|Patient refused to continue study meds|3
6061000|NCT00514943|20942090|P1|Stage 1|Patient refused to continue study meds|8
6061001|NCT00514943|20942089|P2|Stage 1|Not treated|2
6061002|NCT00514943|20942090|P1|Stage 1|Not treated|1
6061003|NCT00514943|20942089|P2|Stage 1|Other Adverse Event|6
6061004|NCT00514943|20942090|P1|Stage 1|Other Adverse Event|16
6061005|NCT00514943|20942089|P2|Stage 1|Progressive disease|8
6061006|NCT00514943|20942090|P1|Stage 1|Progressive disease|4
6061007|NCT00514917|20942148|P2|Overall Study|Undefined|5
6061008|NCT00514917|20942149|P1|Overall Study|Undefined|11
6061009|NCT00514917|20942148|P2|Overall Study|Discontinued due to study closure|81
6061010|NCT00514917|20942149|P1|Overall Study|Discontinued due to study closure|88
6061011|NCT00514917|20942148|P2|Overall Study|Withdrawal by Subject|16
6061012|NCT00514917|20942149|P1|Overall Study|Withdrawal by Subject|18
6061013|NCT00514917|20942148|P2|Overall Study|Lost to Follow-up|3
6061014|NCT00514917|20942149|P1|Overall Study|Lost to Follow-up|4
6061015|NCT00514917|20942148|P2|Overall Study|Protocol Violation|0
6061016|NCT00514917|20942149|P1|Overall Study|Protocol Violation|1
6061017|NCT00514917|20942148|P2|Overall Study|Death|10
6061018|NCT00514917|20942149|P1|Overall Study|Death|4
6061019|NCT00514904|20942177|P2|Overall Study|Lost to Follow-up|3
6061020|NCT00514904|20942178|P1|Overall Study|Lost to Follow-up|21
6061021|NCT00514904|20942177|P2|Overall Study|Withdrawal by Subject|2
6061022|NCT00514904|20942178|P1|Overall Study|Withdrawal by Subject|3
6061023|NCT00514813|20942243|P4|Overall Study|Death|2
6061024|NCT00514813|20942244|P3|Overall Study|Death|3
6061025|NCT00514813|20942245|P2|Overall Study|Death|2
6061026|NCT00514813|20942246|P1|Overall Study|Death|0
6061027|NCT00514813|20942243|P4|Overall Study|Kidney transplant|0
6061028|NCT00514813|20942244|P3|Overall Study|Kidney transplant|2
6061029|NCT00514813|20942245|P2|Overall Study|Kidney transplant|6
6061030|NCT00514813|20942246|P1|Overall Study|Kidney transplant|0
6061031|NCT00514813|20942243|P4|Overall Study|Lack of Efficacy|0
6061032|NCT00514813|20942244|P3|Overall Study|Lack of Efficacy|0
6061033|NCT00514813|20942245|P2|Overall Study|Lack of Efficacy|1
6061034|NCT00514813|20942246|P1|Overall Study|Lack of Efficacy|0
6061035|NCT00514813|20942243|P4|Overall Study|Withdrawal by Subject|0
6061036|NCT00514813|20942244|P3|Overall Study|Withdrawal by Subject|0
6061037|NCT00514813|20942245|P2|Overall Study|Withdrawal by Subject|1
6061038|NCT00514813|20942246|P1|Overall Study|Withdrawal by Subject|0
6061039|NCT00514813|20942243|P4|Overall Study|Protocol Violation|0
6061040|NCT00514813|20942244|P3|Overall Study|Protocol Violation|0
6061041|NCT00514813|20942245|P2|Overall Study|Protocol Violation|0
6061042|NCT00514813|20942246|P1|Overall Study|Protocol Violation|1
6061043|NCT00514813|20942243|P4|Overall Study|Adverse Event|0
6061044|NCT00514813|20942244|P3|Overall Study|Adverse Event|2
6061045|NCT00514813|20942245|P2|Overall Study|Adverse Event|2
6061046|NCT00514813|20942246|P1|Overall Study|Adverse Event|0
6061047|NCT00514813|20942243|P4|Overall Study|Study terminated|2
6061048|NCT00514813|20942244|P3|Overall Study|Study terminated|40
6061049|NCT00514813|20942245|P2|Overall Study|Study terminated|74
6061050|NCT00514813|20942246|P1|Overall Study|Study terminated|14
6061051|NCT00514735|20942266|P2|Overall Study|Lost to Follow-up|1
6061052|NCT00514735|20942267|P1|Overall Study|Lost to Follow-up|0
6061053|NCT00514735|20942266|P2|Overall Study|Death|0
6061054|NCT00514735|20942267|P1|Overall Study|Death|1
6061055|NCT00514735|20942266|P2|Overall Study|Withdrawal by Subject|5
6061056|NCT00514735|20942267|P1|Overall Study|Withdrawal by Subject|13
6061057|NCT00514683|20942303|P5|Overall Study|Reason other than listed above|1
6061058|NCT00514683|20942304|P4|Overall Study|Reason other than listed above|0
6061059|NCT00514683|20942305|P3|Overall Study|Reason other than listed above|2
6061060|NCT00514683|20942306|P2|Overall Study|Reason other than listed above|1
6061061|NCT00514683|20942307|P1|Overall Study|Reason other than listed above|0
6061062|NCT00514683|20942303|P5|Overall Study|Withdrawal by Subject|4
6061063|NCT00514683|20942304|P4|Overall Study|Withdrawal by Subject|0
6061064|NCT00514683|20942305|P3|Overall Study|Withdrawal by Subject|1
6061065|NCT00514683|20942306|P2|Overall Study|Withdrawal by Subject|2
6061066|NCT00514683|20942307|P1|Overall Study|Withdrawal by Subject|2
6061067|NCT00514683|20942303|P5|Overall Study|Protocol Violation|0
6061068|NCT00514683|20942304|P4|Overall Study|Protocol Violation|1
6061069|NCT00514683|20942305|P3|Overall Study|Protocol Violation|0
6061070|NCT00514683|20942306|P2|Overall Study|Protocol Violation|1
6061071|NCT00514683|20942307|P1|Overall Study|Protocol Violation|1
6061072|NCT00514683|20942303|P5|Overall Study|Adverse Event|27
6061073|NCT00514683|20942304|P4|Overall Study|Adverse Event|13
6061074|NCT00514683|20942305|P3|Overall Study|Adverse Event|15
6061075|NCT00514683|20942306|P2|Overall Study|Adverse Event|20
6061076|NCT00514683|20942307|P1|Overall Study|Adverse Event|21
6061077|NCT00514683|20942303|P5|Overall Study|Not treated|1
6061078|NCT00514683|20942304|P4|Overall Study|Not treated|0
6061079|NCT00514683|20942305|P3|Overall Study|Not treated|0
6061080|NCT00514683|20942306|P2|Overall Study|Not treated|1
6061081|NCT00514683|20942307|P1|Overall Study|Not treated|2
6061082|NCT00514540|20942503|P1|Second-Line|Physician/Patient Decision|31
6061083|NCT00514540|20942503|P1|First-Line Chemo|Protocol Violation|7
6061084|NCT00514540|20942503|P1|First-Line Chemo|Withdrawal by Subject|1
6061085|NCT00514514|20942514|P3|Extension - 4 Years|Adverse Event|3
6061086|NCT00514514|20942515|P2|Extension - 4 Years|Adverse Event|6
6061087|NCT00514514|20942516|P1|Extension - 4 Years|Adverse Event|9
6061088|NCT00514514|20942514|P3|Extension - 4 Years|Death|6
6061089|NCT00514514|20942515|P2|Extension - 4 Years|Death|3
6061090|NCT00514514|20942516|P1|Extension - 4 Years|Death|8
6061091|NCT00514514|20942514|P3|Extension - 4 Years|Administrative problems|1
6061092|NCT00514514|20942515|P2|Extension - 4 Years|Administrative problems|1
6061093|NCT00514514|20942516|P1|Extension - 4 Years|Administrative problems|3
6061094|NCT00514514|20942514|P3|Extension - 4 Years|Lost to Follow-up|9
6061095|NCT00514514|20942515|P2|Extension - 4 Years|Lost to Follow-up|10
6061096|NCT00514514|20942516|P1|Extension - 4 Years|Lost to Follow-up|12
6061097|NCT00514514|20942514|P3|Extension - 4 Years|Withdrawal by Subject|2
6061098|NCT00514514|20942515|P2|Extension - 4 Years|Withdrawal by Subject|2
6061099|NCT00514514|20942516|P1|Extension - 4 Years|Withdrawal by Subject|5
6061100|NCT00514514|20942514|P3|Randomized - 9 Month|Adverse Event|27
6061101|NCT00514514|20942515|P2|Randomized - 9 Month|Adverse Event|44
6061102|NCT00514514|20942516|P1|Randomized - 9 Month|Adverse Event|25
6061103|NCT00514514|20942514|P3|Randomized - 9 Month|Abnormal laboratory values|1
6061104|NCT00514514|20942515|P2|Randomized - 9 Month|Abnormal laboratory values|3
6061105|NCT00514514|20942516|P1|Randomized - 9 Month|Abnormal laboratory values|0
6061106|NCT00514514|20942514|P3|Randomized - 9 Month|Lack of Efficacy|1
6061107|NCT00514514|20942515|P2|Randomized - 9 Month|Lack of Efficacy|3
6061108|NCT00514514|20942516|P1|Randomized - 9 Month|Lack of Efficacy|2
6061109|NCT00514514|20942514|P3|Randomized - 9 Month|Protocol Violation|0
6061110|NCT00514514|20942515|P2|Randomized - 9 Month|Protocol Violation|1
6061111|NCT00514514|20942516|P1|Randomized - 9 Month|Protocol Violation|1
6061112|NCT00514514|20942514|P3|Randomized - 9 Month|Withdrawal by Subject|5
6061113|NCT00514514|20942515|P2|Randomized - 9 Month|Withdrawal by Subject|7
6061114|NCT00514514|20942516|P1|Randomized - 9 Month|Withdrawal by Subject|7
6061115|NCT00514514|20942514|P3|Randomized - 9 Month|Administrative problems|2
6061116|NCT00514514|20942515|P2|Randomized - 9 Month|Administrative problems|1
6061117|NCT00514514|20942516|P1|Randomized - 9 Month|Administrative problems|1
6061118|NCT00514514|20942514|P3|Randomized - 9 Month|Death|2
6061119|NCT00514514|20942515|P2|Randomized - 9 Month|Death|2
6061120|NCT00514514|20942516|P1|Randomized - 9 Month|Death|3
6061121|NCT00514514|20942514|P3|Pre-phase|Withdrawal by Subject|0
6061122|NCT00514514|20942515|P2|Pre-phase|Withdrawal by Subject|0
6061123|NCT00514514|20942516|P1|Pre-phase|Withdrawal by Subject|66
6061124|NCT00514514|20942514|P3|Pre-phase|Adverse Event|0
6061125|NCT00514514|20942515|P2|Pre-phase|Adverse Event|0
6061126|NCT00514514|20942516|P1|Pre-phase|Adverse Event|137
6061127|NCT00514514|20942514|P3|Pre-phase|Lack of Efficacy|0
6061128|NCT00514514|20942515|P2|Pre-phase|Lack of Efficacy|0
6061129|NCT00514514|20942516|P1|Pre-phase|Lack of Efficacy|35
6061130|NCT00514514|20942514|P3|Pre-phase|abnormal lab values|0
6061131|NCT00514514|20942515|P2|Pre-phase|abnormal lab values|0
6061132|NCT00514514|20942516|P1|Pre-phase|abnormal lab values|23
6061133|NCT00514514|20942514|P3|Pre-phase|Lost to Follow-up|0
6061134|NCT00514514|20942515|P2|Pre-phase|Lost to Follow-up|0
6061135|NCT00514514|20942516|P1|Pre-phase|Lost to Follow-up|2
6061136|NCT00514514|20942514|P3|Pre-phase|abnormal test procedure results|0
6061137|NCT00514514|20942515|P2|Pre-phase|abnormal test procedure results|0
6061138|NCT00514514|20942516|P1|Pre-phase|abnormal test procedure results|15
6061139|NCT00514514|20942514|P3|Pre-phase|condition no longer requires study drug|0
6061140|NCT00514514|20942515|P2|Pre-phase|condition no longer requires study drug|0
6061141|NCT00514514|20942516|P1|Pre-phase|condition no longer requires study drug|7
6061142|NCT00514514|20942514|P3|Pre-phase|Protocol Violation|0
6061143|NCT00514514|20942515|P2|Pre-phase|Protocol Violation|0
6061144|NCT00514514|20942516|P1|Pre-phase|Protocol Violation|6
6061145|NCT00514514|20942514|P3|Pre-phase|administrative problems|0
6061146|NCT00514514|20942515|P2|Pre-phase|administrative problems|0
6061147|NCT00514514|20942516|P1|Pre-phase|administrative problems|2
6061148|NCT00514514|20942514|P3|Pre-phase|Death|0
6061149|NCT00514514|20942515|P2|Pre-phase|Death|0
6061150|NCT00514514|20942516|P1|Pre-phase|Death|10
6061151|NCT00514449|20942568|P2|Overall Study|Lost to Follow-up|0
6061152|NCT00514449|20942569|P1|Overall Study|Lost to Follow-up|1
6061153|NCT00514449|20942568|P2|Overall Study|Protocol Violation|2
6061154|NCT00514449|20942569|P1|Overall Study|Protocol Violation|1
6061155|NCT00514449|20942568|P2|Overall Study|Withdrawal by Subject|2
6061156|NCT00514449|20942569|P1|Overall Study|Withdrawal by Subject|1
6061157|NCT00514046|20942602|P9|Overall Study|Disease progression on study|0
6061158|NCT00514046|20942603|P8|Overall Study|Disease progression on study|0
6061159|NCT00514046|20942604|P7|Overall Study|Disease progression on study|0
6061160|NCT00514046|20942605|P6|Overall Study|Disease progression on study|1
6061161|NCT00514046|20942606|P5|Overall Study|Disease progression on study|0
6061162|NCT00514046|20942607|P4|Overall Study|Disease progression on study|0
6061163|NCT00514046|20942608|P3|Overall Study|Disease progression on study|2
6061164|NCT00514046|20942609|P2|Overall Study|Disease progression on study|0
6061165|NCT00514046|20942610|P1|Overall Study|Disease progression on study|0
6061166|NCT00514046|20942602|P9|Overall Study|Getting vandetanib via the REMS program|1
6061167|NCT00514046|20942603|P8|Overall Study|Getting vandetanib via the REMS program|1
6061168|NCT00514046|20942604|P7|Overall Study|Getting vandetanib via the REMS program|0
6061169|NCT00514046|20942605|P6|Overall Study|Getting vandetanib via the REMS program|0
6061170|NCT00514046|20942606|P5|Overall Study|Getting vandetanib via the REMS program|0
6061171|NCT00514046|20942607|P4|Overall Study|Getting vandetanib via the REMS program|0
6061172|NCT00514046|20942608|P3|Overall Study|Getting vandetanib via the REMS program|0
6061173|NCT00514046|20942609|P2|Overall Study|Getting vandetanib via the REMS program|0
6061174|NCT00514046|20942610|P1|Overall Study|Getting vandetanib via the REMS program|1
6061175|NCT00514046|20942602|P9|Overall Study|transferred to another protocol|0
6061176|NCT00514046|20942603|P8|Overall Study|transferred to another protocol|0
6061177|NCT00514046|20942604|P7|Overall Study|transferred to another protocol|0
6061178|NCT00514046|20942605|P6|Overall Study|transferred to another protocol|0
6061179|NCT00514046|20942606|P5|Overall Study|transferred to another protocol|1
6061180|NCT00514046|20942607|P4|Overall Study|transferred to another protocol|0
6061181|NCT00514046|20942608|P3|Overall Study|transferred to another protocol|3
6061182|NCT00514046|20942609|P2|Overall Study|transferred to another protocol|1
6061183|NCT00514046|20942610|P1|Overall Study|transferred to another protocol|2
6061184|NCT00514020|20942652|P1|Overall Study|"patients moved to the no tx group"|6
6061185|NCT00514020|20942652|P1|Overall Study|patient went to radiation treatment|1
6061186|NCT00514020|20942652|P1|Overall Study|other complicating disease|2
6061187|NCT00514020|20942652|P1|Overall Study|disease progression|9
6061188|NCT00514020|20942652|P1|Overall Study|Physician Decision|1
6061189|NCT00514020|20942652|P1|Overall Study|Withdrawal by Subject|3
6061190|NCT00514020|20942652|P1|Overall Study|Adverse Event|6
6061191|NCT00513708|20942706|P3|Overall Study|Lost to Follow-up|4
6061192|NCT00513708|20942707|P2|Overall Study|Lost to Follow-up|4
6061193|NCT00513708|20942708|P1|Overall Study|Lost to Follow-up|4
6061194|NCT00513695|20942722|P1|Overall Study|Progression prior to surgery|3
6061195|NCT00513695|20942722|P1|Overall Study|Discontinued therapy|2
6061196|NCT00513682|20942731|P1|Washout Phase|Adverse Event|2
6061197|NCT00513604|20942761|P5|Overall Study|Death during treatment|0
6061198|NCT00513604|20942762|P4|Overall Study|Death during treatment|0
6061199|NCT00513604|20942763|P3|Overall Study|Death during treatment|2
6061200|NCT00513604|20942764|P2|Overall Study|Death during treatment|3
6061201|NCT00513604|20942765|P1|Overall Study|Death during treatment|0
6061202|NCT00513604|20942761|P5|Overall Study|Not treated|0
6061203|NCT00513604|20942762|P4|Overall Study|Not treated|0
6061204|NCT00513604|20942763|P3|Overall Study|Not treated|1
6061205|NCT00513604|20942764|P2|Overall Study|Not treated|0
6061206|NCT00513604|20942765|P1|Overall Study|Not treated|2
6061207|NCT00513500|20942799|P2|Overall Study|Hospitalized|14
6061208|NCT00513500|20942800|P1|Overall Study|Hospitalized|4
6061209|NCT00513500|20942799|P2|Overall Study|Death|1
6061210|NCT00513500|20942800|P1|Overall Study|Death|2
6061211|NCT00513500|20942799|P2|Overall Study|Lost to Follow-up|39
6061212|NCT00513500|20942800|P1|Overall Study|Lost to Follow-up|35
6061213|NCT00513474|20942812|P2|Overall Study|Participant Withdrew Consent|0
6061214|NCT00513474|20942813|P1|Overall Study|Participant Withdrew Consent|1
6061215|NCT00513474|20942812|P2|Overall Study|Death|9
6061216|NCT00513474|20942813|P1|Overall Study|Death|6
6061217|NCT00513409|20942869|P2|Overall Study|Visit 3 not done|2
6061218|NCT00513409|20942870|P1|Overall Study|Visit 3 not done|1
6061219|NCT00513409|20942869|P2|Overall Study|Physician Decision|0
6061220|NCT00513409|20942870|P1|Overall Study|Physician Decision|1
6061221|NCT00513409|20942869|P2|Overall Study|Lost to Follow-up|1
6061222|NCT00513409|20942870|P1|Overall Study|Lost to Follow-up|0
6061223|NCT00513409|20942869|P2|Overall Study|Withdrawal by Subject|2
6061224|NCT00513409|20942870|P1|Overall Study|Withdrawal by Subject|0
6061225|NCT00513409|20942869|P2|Overall Study|Adverse Event|1
6061226|NCT00513409|20942870|P1|Overall Study|Adverse Event|0
6061227|NCT00513357|20942926|P2|Overall Study|Disease Progression|1
6061228|NCT00513357|20942927|P1|Overall Study|Disease Progression|2
6061229|NCT00513357|20942926|P2|Overall Study|Withdrawal by Subject|4
6061230|NCT00513357|20942927|P1|Overall Study|Withdrawal by Subject|5
6061231|NCT00513357|20942926|P2|Overall Study|Death|0
6061232|NCT00513357|20942927|P1|Overall Study|Death|2
6061233|NCT00513357|20942926|P2|Overall Study|Adverse Event|2
6061234|NCT00513357|20942927|P1|Overall Study|Adverse Event|4
6061235|NCT00513357|20942926|P2|Overall Study|did not receive allocated placebo|3
6061236|NCT00513357|20942927|P1|Overall Study|did not receive allocated placebo|2
6061237|NCT00513305|20942946|P2|Overall Study|Sponsor Decision|2
6061238|NCT00513305|20942947|P1|Overall Study|Sponsor Decision|0
6061239|NCT00513305|20942946|P2|Overall Study|Persistent hypocellularity|1
6061240|NCT00513305|20942947|P1|Overall Study|Persistent hypocellularity|0
6061241|NCT00513305|20942946|P2|Overall Study|Physician Decision|0
6061242|NCT00513305|20942947|P1|Overall Study|Physician Decision|1
6061243|NCT00513305|20942946|P2|Overall Study|Hematologic counts did not recover|0
6061244|NCT00513305|20942947|P1|Overall Study|Hematologic counts did not recover|1
6061245|NCT00513305|20942946|P2|Overall Study|Eligible for stem cell transplant|0
6061246|NCT00513305|20942947|P1|Overall Study|Eligible for stem cell transplant|1
6061247|NCT00513305|20942946|P2|Overall Study|Disease progression|5
6061248|NCT00513305|20942947|P1|Overall Study|Disease progression|8
6061249|NCT00513305|20942946|P2|Overall Study|Withdrawal by Subject|2
6061250|NCT00513305|20942947|P1|Overall Study|Withdrawal by Subject|1
6061251|NCT00513305|20942946|P2|Overall Study|Lack of Efficacy|13
6061252|NCT00513305|20942947|P1|Overall Study|Lack of Efficacy|8
6061253|NCT00513305|20942946|P2|Overall Study|Death (through Consolidation Treatment)|2
6061254|NCT00513305|20942947|P1|Overall Study|Death (through Consolidation Treatment)|2
6061255|NCT00513305|20942946|P2|Overall Study|Adverse Event|2
6061256|NCT00513305|20942947|P1|Overall Study|Adverse Event|6
6061257|NCT00513240|20942990|P2|Overall Study|Withdrawal by Subject|4
6061258|NCT00513240|20942991|P1|Overall Study|Withdrawal by Subject|7
6061259|NCT00513240|20942990|P2|Overall Study|Death|3
6061260|NCT00513240|20942991|P1|Overall Study|Death|3
6061261|NCT00513240|20942990|P2|Overall Study|Did not have intended surgery|0
6061262|NCT00513240|20942991|P1|Overall Study|Did not have intended surgery|3
6061263|NCT00513071|20943004|P1|Overall Study|Physician Decision|3
6061264|NCT00513071|20943004|P1|Overall Study|Withdrawal by Subject|1
6061265|NCT00513071|20943004|P1|Overall Study|Adverse Event|1
6061266|NCT00513019|20943016|P2|Overall Study|Withdrawal by Subject|5
6061267|NCT00513019|20943017|P1|Overall Study|Withdrawal by Subject|4
6061268|NCT00513019|20943016|P2|Overall Study|Adverse Event|0
6061269|NCT00513019|20943017|P1|Overall Study|Adverse Event|1
6061270|NCT00512902|20943023|P1|Overall Study|Lost to Follow-up|1
6061271|NCT00512902|20943023|P1|Overall Study|Adverse Event|7
6061272|NCT00512798|20943038|P2|Overall Study|Withdrawal by Subject|0
6061273|NCT00512798|20943039|P1|Overall Study|Withdrawal by Subject|3
6061274|NCT00512798|20943038|P2|Overall Study|Progression of disease|20
6061275|NCT00512798|20943039|P1|Overall Study|Progression of disease|14
6061276|NCT00512798|20943038|P2|Overall Study|Adverse Event|4
6061277|NCT00512798|20943039|P1|Overall Study|Adverse Event|2
6061278|NCT00512798|20943038|P2|Overall Study|Death|3
6061279|NCT00512798|20943039|P1|Overall Study|Death|0
6061280|NCT00512707|20943050|P2|Overall Study|Unable to tolerate the smell of the gel|0
6061281|NCT00512707|20943051|P1|Overall Study|Unable to tolerate the smell of the gel|1
6061282|NCT00512707|20943050|P2|Overall Study|Developed a hematocrit exceeding 0.54|0
6061283|NCT00512707|20943051|P1|Overall Study|Developed a hematocrit exceeding 0.54|2
6061284|NCT00512707|20943050|P2|Overall Study|Developed skin irritation|1
6061285|NCT00512707|20943051|P1|Overall Study|Developed skin irritation|2
6061286|NCT00512707|20943050|P2|Overall Study|Lost to Follow-up|11
6061287|NCT00512707|20943051|P1|Overall Study|Lost to Follow-up|5
6061288|NCT00512252|20943101|P3|Overall Study|Death|1
6061289|NCT00512252|20943102|P2|Overall Study|Death|0
6061290|NCT00512252|20943103|P1|Overall Study|Death|0
6061291|NCT00512252|20943101|P3|Overall Study|Protocol Violation|1
6061292|NCT00512252|20943102|P2|Overall Study|Protocol Violation|0
6061293|NCT00512252|20943103|P1|Overall Study|Protocol Violation|0
6061294|NCT00512252|20943101|P3|Overall Study|Lost to Follow-up|1
6061295|NCT00512252|20943102|P2|Overall Study|Lost to Follow-up|0
6061296|NCT00512252|20943103|P1|Overall Study|Lost to Follow-up|0
6061297|NCT00512148|20943131|P1|Primay Study Period|Withdrawal by Subject|1
6061298|NCT00512096|20943137|P1|Overall Study|Lack of Efficacy|3
6061299|NCT00512096|20943137|P1|Overall Study|Withdrawal by Subject|2
6061300|NCT00512096|20943137|P1|Overall Study|Adverse Event|2
6061301|NCT00511901|20943165|P2|Overall Study|Withdrawal by Subject|3
6061302|NCT00511901|20943166|P1|Overall Study|Withdrawal by Subject|1
6061303|NCT00511875|20943188|P2|Overall Study|Missing variables|0
6061304|NCT00511875|20943189|P1|Overall Study|Missing variables|1
6061305|NCT00511875|20943188|P2|Overall Study|Lost to Follow-up|0
6061306|NCT00511875|20943189|P1|Overall Study|Lost to Follow-up|4
6061307|NCT00511836|20943229|P2|Double-blind Period|Lost to Follow-up|0
6061308|NCT00511836|20943230|P1|Double-blind Period|Lost to Follow-up|1
6061309|NCT00511810|20943247|P2|Overall Study|Refused second scn|1
6061310|NCT00511810|20943248|P1|Overall Study|Refused second scn|0
6061311|NCT00511810|20943247|P2|Overall Study|Lack of Efficacy|2
6061312|NCT00511810|20943248|P1|Overall Study|Lack of Efficacy|0
6061313|NCT00511810|20943247|P2|Overall Study|Lost to Follow-up|2
6061314|NCT00511810|20943248|P1|Overall Study|Lost to Follow-up|1
6061315|NCT00511797|20943258|P4|Overall Study|Other (moving etc)|2
6061316|NCT00511797|20943259|P3|Overall Study|Other (moving etc)|1
6061317|NCT00511797|20943260|P2|Overall Study|Other (moving etc)|0
6061318|NCT00511797|20943261|P1|Overall Study|Other (moving etc)|1
6061319|NCT00511797|20943258|P4|Overall Study|Partially missing diary|0
6061320|NCT00511797|20943259|P3|Overall Study|Partially missing diary|1
6061321|NCT00511797|20943260|P2|Overall Study|Partially missing diary|0
6061322|NCT00511797|20943261|P1|Overall Study|Partially missing diary|0
6061323|NCT00511797|20943258|P4|Overall Study|Study drug not taken|1
6061324|NCT00511797|20943259|P3|Overall Study|Study drug not taken|0
6061325|NCT00511797|20943260|P2|Overall Study|Study drug not taken|1
6061326|NCT00511797|20943261|P1|Overall Study|Study drug not taken|0
6061327|NCT00511797|20943258|P4|Overall Study|Never dispensed|3
6061328|NCT00511797|20943259|P3|Overall Study|Never dispensed|1
6061329|NCT00511797|20943260|P2|Overall Study|Never dispensed|0
6061330|NCT00511797|20943261|P1|Overall Study|Never dispensed|1
6061331|NCT00511797|20943258|P4|Overall Study|Withdrawal by Subject|2
6061332|NCT00511797|20943259|P3|Overall Study|Withdrawal by Subject|4
6061333|NCT00511797|20943260|P2|Overall Study|Withdrawal by Subject|3
6061334|NCT00511797|20943261|P1|Overall Study|Withdrawal by Subject|3
6061335|NCT00511797|20943258|P4|Overall Study|Protocol Violation|3
6061336|NCT00511797|20943259|P3|Overall Study|Protocol Violation|2
6061337|NCT00511797|20943260|P2|Overall Study|Protocol Violation|2
6061338|NCT00511797|20943261|P1|Overall Study|Protocol Violation|0
6061339|NCT00511797|20943258|P4|Overall Study|Pregnancy|1
6061340|NCT00511797|20943259|P3|Overall Study|Pregnancy|0
6061341|NCT00511797|20943260|P2|Overall Study|Pregnancy|0
6061342|NCT00511797|20943261|P1|Overall Study|Pregnancy|0
6061343|NCT00511797|20943258|P4|Overall Study|Lost to Follow-up|1
6061344|NCT00511797|20943259|P3|Overall Study|Lost to Follow-up|0
6061345|NCT00511797|20943260|P2|Overall Study|Lost to Follow-up|0
6061346|NCT00511797|20943261|P1|Overall Study|Lost to Follow-up|1
6061347|NCT00511797|20943258|P4|Overall Study|Adverse Event|2
6061348|NCT00511797|20943259|P3|Overall Study|Adverse Event|2
6061349|NCT00511797|20943260|P2|Overall Study|Adverse Event|2
6061350|NCT00511797|20943261|P1|Overall Study|Adverse Event|1
6061351|NCT00511667|20943380|P2|Overall Study|Other|1
6061352|NCT00511667|20943381|P1|Overall Study|Other|2
6061353|NCT00511667|20943380|P2|Overall Study|Site terminated|1
6061354|NCT00511667|20943381|P1|Overall Study|Site terminated|6
6061355|NCT00511667|20943380|P2|Overall Study|Withdrawal by Subject|0
6061356|NCT00511667|20943381|P1|Overall Study|Withdrawal by Subject|2
6061357|NCT00511667|20943380|P2|Overall Study|Protocol Violation|1
6061358|NCT00511667|20943381|P1|Overall Study|Protocol Violation|1
6061359|NCT00511667|20943380|P2|Overall Study|Adverse Event|0
6061360|NCT00511667|20943381|P1|Overall Study|Adverse Event|1
6061361|NCT00511472|20943416|P2|Overall Study|Not reported|2
6061362|NCT00511472|20943417|P1|Overall Study|Not reported|2
6061363|NCT00511472|20943416|P2|Overall Study|Laboratory Adverse Event|2
6061364|NCT00511472|20943417|P1|Overall Study|Laboratory Adverse Event|0
6061365|NCT00511472|20943416|P2|Overall Study|Clinical Adverse Event|2
6061366|NCT00511472|20943417|P1|Overall Study|Clinical Adverse Event|1
6061367|NCT00511433|20943436|P2|Overall Study|Other Reason|1
6061368|NCT00511433|20943437|P1|Overall Study|Other Reason|1
6061369|NCT00511433|20943436|P2|Overall Study|Adverse Event|0
6061370|NCT00511433|20943437|P1|Overall Study|Adverse Event|5
6061371|NCT00511355|20943477|P2|Overall Study|Other reason pre-treatment|1
6061372|NCT00511355|20943478|P1|Overall Study|Other reason pre-treatment|0
6061373|NCT00511355|20943477|P2|Overall Study|Withdrawal of informed consent|1
6061374|NCT00511355|20943478|P1|Overall Study|Withdrawal of informed consent|0
6061375|NCT00511355|20943477|P2|Overall Study|Pre-treatment (serious) adverse event|1
6061376|NCT00511355|20943478|P1|Overall Study|Pre-treatment (serious) adverse event|0
6061377|NCT00511355|20943477|P2|Overall Study|Other Reason|1
6061378|NCT00511355|20943478|P1|Overall Study|Other Reason|0
6061379|NCT00511355|20943477|P2|Overall Study|Lost to Follow-up|1
6061380|NCT00511355|20943478|P1|Overall Study|Lost to Follow-up|2
6061381|NCT00511355|20943477|P2|Overall Study|Pregnancy Wish|0
6061382|NCT00511355|20943478|P1|Overall Study|Pregnancy Wish|1
6061383|NCT00511355|20943477|P2|Overall Study|Adverse Event|4
6061384|NCT00511355|20943478|P1|Overall Study|Adverse Event|4
6061385|NCT00511342|20943578|P2|Overall Study|Other Reason|2
6061386|NCT00511342|20943579|P1|Overall Study|Other Reason|2
6061387|NCT00511342|20943578|P2|Overall Study|Lost to Follow-up|5
6061388|NCT00511342|20943579|P1|Overall Study|Lost to Follow-up|1
6061389|NCT00511342|20943578|P2|Overall Study|Pregnancy wish|1
6061390|NCT00511342|20943579|P1|Overall Study|Pregnancy wish|0
6061391|NCT00511342|20943578|P2|Overall Study|Pregnancy|1
6061392|NCT00511342|20943579|P1|Overall Study|Pregnancy|0
6061393|NCT00511342|20943578|P2|Overall Study|Other Adverse Event (AE)/ Serious AE|12
6061394|NCT00511342|20943579|P1|Overall Study|Other Adverse Event (AE)/ Serious AE|8
6061395|NCT00511342|20943578|P2|Overall Study|Unacceptable vaginal bleeding|1
6061396|NCT00511342|20943579|P1|Overall Study|Unacceptable vaginal bleeding|2
6061397|NCT00511238|20943610|P2|Overall Study|various reasons|14
6061398|NCT00511238|20943611|P1|Overall Study|various reasons|4
6061399|NCT00511238|20943610|P2|Overall Study|Progressive Disease|157
6061400|NCT00511238|20943611|P1|Overall Study|Progressive Disease|23
6061401|NCT00511238|20943610|P2|Overall Study|Withdrawal by Subject|22
6061402|NCT00511238|20943611|P1|Overall Study|Withdrawal by Subject|2
6061403|NCT00511238|20943610|P2|Overall Study|Adverse Event|33
6061404|NCT00511238|20943611|P1|Overall Study|Adverse Event|13
6061405|NCT00511199|20943630|P2|Overall Study|Other Reason|37
6061406|NCT00511199|20943631|P1|Overall Study|Other Reason|78
6061407|NCT00511199|20943630|P2|Overall Study|Lost to Follow-up|17
6061408|NCT00511199|20943631|P1|Overall Study|Lost to Follow-up|40
6061409|NCT00511199|20943630|P2|Overall Study|Pregnancy Wish|8
6061410|NCT00511199|20943631|P1|Overall Study|Pregnancy Wish|16
6061411|NCT00511199|20943630|P2|Overall Study|Pregnancy|3
6061412|NCT00511199|20943631|P1|Overall Study|Pregnancy|6
6061413|NCT00511199|20943630|P2|Overall Study|Withdrawal of Informed Consent|4
6061414|NCT00511199|20943631|P1|Overall Study|Withdrawal of Informed Consent|19
6061415|NCT00511199|20943630|P2|Overall Study|Other Adverse Event (AE)/ Serious AE|52
6061416|NCT00511199|20943631|P1|Overall Study|Other Adverse Event (AE)/ Serious AE|227
6061417|NCT00511199|20943630|P2|Overall Study|Unacceptable Vaginal Bleeding|4
6061418|NCT00511199|20943631|P1|Overall Study|Unacceptable Vaginal Bleeding|63
6061419|NCT00511147|20943660|P1|Overall Study|Required platelet transfusion|1
6061420|NCT00511147|20943660|P1|Overall Study|Disease progression|5
6061421|NCT00511147|20943660|P1|Overall Study|Withdrawal by Subject|1
6061422|NCT00511134|20943669|P2|Overall Study|Withdrawal by Subject|2
6061423|NCT00511134|20943670|P1|Overall Study|Withdrawal by Subject|0
6061424|NCT00511108|20943682|P4|Overall Study|Withdrawal by Subject|2
6061425|NCT00511108|20943683|P3|Overall Study|Withdrawal by Subject|3
6061426|NCT00511108|20943684|P2|Overall Study|Withdrawal by Subject|0
6061427|NCT00511108|20943685|P1|Overall Study|Withdrawal by Subject|4
6061428|NCT00511108|20943682|P4|Overall Study|Physician Decision|1
6061429|NCT00511108|20943683|P3|Overall Study|Physician Decision|0
6061430|NCT00511108|20943684|P2|Overall Study|Physician Decision|0
6061431|NCT00511108|20943685|P1|Overall Study|Physician Decision|0
6061432|NCT00511108|20943682|P4|Overall Study|Lost to Follow-up|0
6061433|NCT00511108|20943683|P3|Overall Study|Lost to Follow-up|1
6061434|NCT00511108|20943684|P2|Overall Study|Lost to Follow-up|2
6061435|NCT00511108|20943685|P1|Overall Study|Lost to Follow-up|0
6061436|NCT00511108|20943682|P4|Overall Study|Adverse Event|2
6061437|NCT00511108|20943683|P3|Overall Study|Adverse Event|1
6061438|NCT00511108|20943684|P2|Overall Study|Adverse Event|0
6061439|NCT00511108|20943685|P1|Overall Study|Adverse Event|2
6061440|NCT00511004|20943716|P3|Overall Study|Lost to Follow-up|4
6061441|NCT00511004|20943717|P2|Overall Study|Lost to Follow-up|0
6061442|NCT00511004|20943718|P1|Overall Study|Lost to Follow-up|0
6061443|NCT00510952|20943737|P2|Overall Study|Did Not Receive Study Drug|0
6061444|NCT00510952|20943738|P1|Overall Study|Did Not Receive Study Drug|2
6061445|NCT00510952|20943737|P2|Overall Study|Withdrawal by Subject|7
6061446|NCT00510952|20943738|P1|Overall Study|Withdrawal by Subject|6
6061447|NCT00510952|20943737|P2|Overall Study|Sponsor Decision|0
6061448|NCT00510952|20943738|P1|Overall Study|Sponsor Decision|1
6061449|NCT00510952|20943737|P2|Overall Study|Protocol Violation|4
6061450|NCT00510952|20943738|P1|Overall Study|Protocol Violation|7
6061451|NCT00510952|20943737|P2|Overall Study|Physician Decision|1
6061452|NCT00510952|20943738|P1|Overall Study|Physician Decision|1
6061453|NCT00510952|20943737|P2|Overall Study|Lost to Follow-up|3
6061454|NCT00510952|20943738|P1|Overall Study|Lost to Follow-up|5
6061455|NCT00510952|20943737|P2|Overall Study|Entry Criteria Not Met|1
6061456|NCT00510952|20943738|P1|Overall Study|Entry Criteria Not Met|3
6061457|NCT00510952|20943737|P2|Overall Study|Adverse Event|0
6061458|NCT00510952|20943738|P1|Overall Study|Adverse Event|1
6061459|NCT00510887|20943764|P1|Overall Study|Lost to Follow-up|1
6061460|NCT00510874|20943780|P7|Overall Study|Lost to Follow-up|1
6061461|NCT00510874|20943781|P6|Overall Study|Lost to Follow-up|0
6061462|NCT00510874|20943782|P5|Overall Study|Lost to Follow-up|4
6061463|NCT00510874|20943783|P4|Overall Study|Lost to Follow-up|3
6061464|NCT00510874|20943784|P3|Overall Study|Lost to Follow-up|1
6061465|NCT00510874|20943785|P2|Overall Study|Lost to Follow-up|3
6061466|NCT00510874|20943786|P1|Overall Study|Lost to Follow-up|2
6061467|NCT00510874|20943780|P7|Overall Study|Withdrawal by Subject|0
6061468|NCT00510874|20943781|P6|Overall Study|Withdrawal by Subject|0
6061469|NCT00510874|20943782|P5|Overall Study|Withdrawal by Subject|3
6061470|NCT00510874|20943783|P4|Overall Study|Withdrawal by Subject|0
6061471|NCT00510874|20943784|P3|Overall Study|Withdrawal by Subject|0
6061472|NCT00510874|20943785|P2|Overall Study|Withdrawal by Subject|1
6061473|NCT00510874|20943786|P1|Overall Study|Withdrawal by Subject|1
6061474|NCT00510835|20943889|P3|Overall Study|Withdrawal by Subject|2
6061475|NCT00510835|20943890|P2|Overall Study|Withdrawal by Subject|2
6061476|NCT00510835|20943891|P1|Overall Study|Withdrawal by Subject|6
6061477|NCT00510783|20943917|P2|Overall Study|Protocol Violation|1
6061478|NCT00510783|20943918|P1|Overall Study|Protocol Violation|0
6061479|NCT00510783|20943917|P2|Overall Study|Withdrawal by Subject|3
6061480|NCT00510783|20943918|P1|Overall Study|Withdrawal by Subject|2
6061481|NCT00510783|20943917|P2|Overall Study|Lost to Follow-up|25
6061482|NCT00510783|20943918|P1|Overall Study|Lost to Follow-up|29
6061483|NCT00510718|20943935|P2|Multiple Dose Period: 12 Weeks|Other|1
6061484|NCT00510718|20943936|P1|Multiple Dose Period: 12 Weeks|Other|1
6061485|NCT00510718|20943935|P2|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|3
6061486|NCT00510718|20943936|P1|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|1
6061487|NCT00510718|20943935|P2|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|3
6061488|NCT00510718|20943936|P1|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|1
6061489|NCT00510718|20943935|P2|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|11
6061490|NCT00510718|20943936|P1|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|8
6061491|NCT00510718|20943935|P2|Multiple Dose Period: 12 Weeks|PSA Disease Progression|6
6061492|NCT00510718|20943936|P1|Multiple Dose Period: 12 Weeks|PSA Disease Progression|3
6061493|NCT00510718|20943935|P2|Multiple Dose Period: 12 Weeks|Adverse Event|8
6061494|NCT00510718|20943936|P1|Multiple Dose Period: 12 Weeks|Adverse Event|1
6061495|NCT00510692|20944062|P2|Overall Study|Withdrawal by Subject|0
6061496|NCT00510692|20944063|P1|Overall Study|Withdrawal by Subject|1
6061497|NCT00510692|20944062|P2|Overall Study|Adverse Event|3
6061498|NCT00510692|20944063|P1|Overall Study|Adverse Event|1
6061499|NCT00510653|20944077|P1|Overall Study|Monetary|3
6061500|NCT00510653|20944077|P1|Overall Study|Withdrawal by Subject|8
6061501|NCT00510510|20944084|P3|Overall Study|Protocol Violation|4
6061502|NCT00510510|20944085|P2|Overall Study|Protocol Violation|3
6061503|NCT00510510|20944086|P1|Overall Study|Protocol Violation|0
6061504|NCT00510510|20944084|P3|Overall Study|Lost to Follow-up|1
6061505|NCT00510510|20944085|P2|Overall Study|Lost to Follow-up|0
6061506|NCT00510510|20944086|P1|Overall Study|Lost to Follow-up|0
6061507|NCT00510510|20944084|P3|Overall Study|Withdrawal by Subject|3
6061508|NCT00510510|20944085|P2|Overall Study|Withdrawal by Subject|2
6061509|NCT00510510|20944086|P1|Overall Study|Withdrawal by Subject|1
6061593|NCT00510146|20944258|P2|Double-Blind Treatment|Lack of Efficacy|13
6061510|NCT00510510|20944084|P3|Overall Study|Subjects no longer requires study drug|2
6061511|NCT00510510|20944085|P2|Overall Study|Subjects no longer requires study drug|0
6061512|NCT00510510|20944086|P1|Overall Study|Subjects no longer requires study drug|0
6061513|NCT00510510|20944084|P3|Overall Study|Lack of Efficacy|1
6061514|NCT00510510|20944085|P2|Overall Study|Lack of Efficacy|1
6061515|NCT00510510|20944086|P1|Overall Study|Lack of Efficacy|0
6061516|NCT00510510|20944084|P3|Overall Study|Adverse Event|6
6061517|NCT00510510|20944085|P2|Overall Study|Adverse Event|3
6061518|NCT00510510|20944086|P1|Overall Study|Adverse Event|4
6061519|NCT00510484|20944104|P2|Wash-out Period|Adverse Event|1
6061520|NCT00510484|20944105|P1|Wash-out Period|Adverse Event|0
6061521|NCT00510458|20944125|P1|Overall Study|Revision|2
6061522|NCT00510458|20944125|P1|Overall Study|Withdrawal by Subject|3
6061523|NCT00510458|20944125|P1|Overall Study|Lost to Follow-up|6
6061524|NCT00510458|20944125|P1|Overall Study|Terminated|14
6061525|NCT00510458|20944125|P1|Overall Study|Death|1
6061526|NCT00510458|20944125|P1|Overall Study|5 year not evaluable/missed|21
6061527|NCT00510289|20944138|P1|Overall Study|Progressed prior to starting drug|2
6061528|NCT00510289|20944138|P1|Overall Study|Lost to Follow-up|1
6061529|NCT00510289|20944138|P1|Overall Study|Refused bone marrow biopsy|2
6061530|NCT00510289|20944138|P1|Overall Study|Withdrawal by Subject|7
6061531|NCT00510276|20944148|P2|Extension Open-Label Phase|Subject Decision|9
6061532|NCT00510276|20944149|P1|Extension Open-Label Phase|Subject Decision|7
6061533|NCT00510276|20944148|P2|Extension Open-Label Phase|Sponsor Decision|0
6061534|NCT00510276|20944149|P1|Extension Open-Label Phase|Sponsor Decision|1
6061535|NCT00510276|20944148|P2|Extension Open-Label Phase|Protocol Violation|1
6061536|NCT00510276|20944149|P1|Extension Open-Label Phase|Protocol Violation|0
6061537|NCT00510276|20944148|P2|Extension Open-Label Phase|Physician Decision|3
6061538|NCT00510276|20944149|P1|Extension Open-Label Phase|Physician Decision|2
6061539|NCT00510276|20944148|P2|Extension Open-Label Phase|Lost to Follow-up|10
6061540|NCT00510276|20944149|P1|Extension Open-Label Phase|Lost to Follow-up|12
6061541|NCT00510276|20944148|P2|Extension Open-Label Phase|Lack of Efficacy|7
6061542|NCT00510276|20944149|P1|Extension Open-Label Phase|Lack of Efficacy|2
6061543|NCT00510276|20944148|P2|Extension Open-Label Phase|Adverse Event|18
6061544|NCT00510276|20944149|P1|Extension Open-Label Phase|Adverse Event|9
6061545|NCT00510276|20944148|P2|Acute Double-Blind Phase|Subject Decision|28
6061546|NCT00510276|20944149|P1|Acute Double-Blind Phase|Subject Decision|26
6061547|NCT00510276|20944148|P2|Acute Double-Blind Phase|Sponsor Decision|1
6061548|NCT00510276|20944149|P1|Acute Double-Blind Phase|Sponsor Decision|2
6061549|NCT00510276|20944148|P2|Acute Double-Blind Phase|Protocol Violation|3
6061550|NCT00510276|20944149|P1|Acute Double-Blind Phase|Protocol Violation|4
6061551|NCT00510276|20944148|P2|Acute Double-Blind Phase|Physician Decision|3
6061552|NCT00510276|20944149|P1|Acute Double-Blind Phase|Physician Decision|0
6061553|NCT00510276|20944148|P2|Acute Double-Blind Phase|Lost to Follow-up|49
6061554|NCT00510276|20944149|P1|Acute Double-Blind Phase|Lost to Follow-up|48
6061555|NCT00510276|20944148|P2|Acute Double-Blind Phase|Lack of Efficacy|4
6061556|NCT00510276|20944149|P1|Acute Double-Blind Phase|Lack of Efficacy|3
6061557|NCT00510276|20944148|P2|Acute Double-Blind Phase|Entry Criteria Not Met|1
6061558|NCT00510276|20944149|P1|Acute Double-Blind Phase|Entry Criteria Not Met|1
6061559|NCT00510276|20944148|P2|Acute Double-Blind Phase|Adverse Event|6
6061560|NCT00510276|20944149|P1|Acute Double-Blind Phase|Adverse Event|21
6061561|NCT00510198|20944243|P2|Overall Study|Withdrawal by Subject|4
6061562|NCT00510198|20944244|P1|Overall Study|Withdrawal by Subject|5
6061563|NCT00510146|20944258|P2|Open-Label Treatment|Sponsor Decision|0
6061564|NCT00510146|20944259|P1|Open-Label Treatment|Sponsor Decision|2
6061565|NCT00510146|20944258|P2|Open-Label Treatment|Clinical Relapse|1
6061566|NCT00510146|20944259|P1|Open-Label Treatment|Clinical Relapse|1
6061567|NCT00510146|20944258|P2|Open-Label Treatment|Withdrawal by Subject|12
6061568|NCT00510146|20944259|P1|Open-Label Treatment|Withdrawal by Subject|24
6061569|NCT00510146|20944258|P2|Open-Label Treatment|Protocol Violation|2
6061570|NCT00510146|20944259|P1|Open-Label Treatment|Protocol Violation|4
6061571|NCT00510146|20944258|P2|Open-Label Treatment|Physician Decision|1
6061572|NCT00510146|20944259|P1|Open-Label Treatment|Physician Decision|3
6061573|NCT00510146|20944258|P2|Open-Label Treatment|Lost to Follow-up|1
6061574|NCT00510146|20944259|P1|Open-Label Treatment|Lost to Follow-up|10
6061575|NCT00510146|20944258|P2|Open-Label Treatment|Lack of Efficacy|0
6061576|NCT00510146|20944259|P1|Open-Label Treatment|Lack of Efficacy|4
6061577|NCT00510146|20944258|P2|Open-Label Treatment|Death|1
6061578|NCT00510146|20944259|P1|Open-Label Treatment|Death|1
6061579|NCT00510146|20944258|P2|Open-Label Treatment|Adverse Event|8
6061580|NCT00510146|20944259|P1|Open-Label Treatment|Adverse Event|22
6061581|NCT00510146|20944258|P2|Double-Blind Treatment|Entry Criteria Not Met|0
6061582|NCT00510146|20944259|P1|Double-Blind Treatment|Entry Criteria Not Met|3
6061583|NCT00510146|20944258|P2|Double-Blind Treatment|Clinical Relapse|1
6061584|NCT00510146|20944259|P1|Double-Blind Treatment|Clinical Relapse|0
6061585|NCT00510146|20944258|P2|Double-Blind Treatment|Withdrawal by Subject|13
6061586|NCT00510146|20944259|P1|Double-Blind Treatment|Withdrawal by Subject|27
6061587|NCT00510146|20944258|P2|Double-Blind Treatment|Protocol Violation|2
6061588|NCT00510146|20944259|P1|Double-Blind Treatment|Protocol Violation|1
6061589|NCT00510146|20944258|P2|Double-Blind Treatment|Physician Decision|0
6061590|NCT00510146|20944259|P1|Double-Blind Treatment|Physician Decision|6
6061591|NCT00510146|20944258|P2|Double-Blind Treatment|Lost to Follow-up|7
6061592|NCT00510146|20944259|P1|Double-Blind Treatment|Lost to Follow-up|3
6061594|NCT00510146|20944259|P1|Double-Blind Treatment|Lack of Efficacy|6
6061595|NCT00510146|20944258|P2|Double-Blind Treatment|Adverse Event|13
6061596|NCT00510146|20944259|P1|Double-Blind Treatment|Adverse Event|30
6061597|NCT00510068|20944348|P2|Open-label Period|Abnormal laboratory value (s)|0
6061598|NCT00510068|20944349|P1|Open-label Period|Abnormal laboratory value (s)|1
6061599|NCT00510068|20944348|P2|Open-label Period|Protocol Violation|0
6061600|NCT00510068|20944349|P1|Open-label Period|Protocol Violation|2
6061601|NCT00510068|20944348|P2|Open-label Period|New cancer therapy|0
6061602|NCT00510068|20944349|P1|Open-label Period|New cancer therapy|7
6061603|NCT00510068|20944348|P2|Open-label Period|Death|0
6061604|NCT00510068|20944349|P1|Open-label Period|Death|7
6061605|NCT00510068|20944348|P2|Open-label Period|Administrative problems|0
6061606|NCT00510068|20944349|P1|Open-label Period|Administrative problems|17
6061607|NCT00510068|20944348|P2|Open-label Period|Withdrawal by Subject|0
6061608|NCT00510068|20944349|P1|Open-label Period|Withdrawal by Subject|21
6061609|NCT00510068|20944348|P2|Open-label Period|Adverse Event|0
6061610|NCT00510068|20944349|P1|Open-label Period|Adverse Event|46
6061611|NCT00510068|20944348|P2|Open-label Period|Disease Progression|0
6061612|NCT00510068|20944349|P1|Open-label Period|Disease Progression|124
6061613|NCT00510068|20944348|P2|Double-blind Period|Protocol Violation|0
6061614|NCT00510068|20944349|P1|Double-blind Period|Protocol Violation|6
6061615|NCT00510068|20944348|P2|Double-blind Period|Lost to Follow-up|0
6061616|NCT00510068|20944349|P1|Double-blind Period|Lost to Follow-up|1
6061617|NCT00510068|20944348|P2|Double-blind Period|Abnormal test result (s)|0
6061618|NCT00510068|20944349|P1|Double-blind Period|Abnormal test result (s)|1
6061619|NCT00510068|20944348|P2|Double-blind Period|Death|3
6061620|NCT00510068|20944349|P1|Double-blind Period|Death|4
6061621|NCT00510068|20944348|P2|Double-blind Period|Withdrawal by Subject|6
6061622|NCT00510068|20944349|P1|Double-blind Period|Withdrawal by Subject|8
6061623|NCT00510068|20944348|P2|Double-blind Period|Adverse Event|7
6061624|NCT00510068|20944349|P1|Double-blind Period|Adverse Event|37
6061625|NCT00510068|20944348|P2|Double-blind Period|Final primary analysis|18
6061626|NCT00510068|20944349|P1|Double-blind Period|Final primary analysis|52
6061627|NCT00510068|20944348|P2|Double-blind Period|Disease progression|169
6061628|NCT00510068|20944349|P1|Double-blind Period|Disease progression|98
6061629|NCT00509925|20944390|P2|Overall Study|Personal reasons|1
6061630|NCT00509925|20944391|P1|Overall Study|Personal reasons|0
6061631|NCT00509899|20944439|P8|Overall Study|Lack of Efficacy|0
6061632|NCT00509899|20944440|P7|Overall Study|Lack of Efficacy|0
6061633|NCT00509899|20944441|P6|Overall Study|Lack of Efficacy|1
6061634|NCT00509899|20944442|P5|Overall Study|Lack of Efficacy|0
6061635|NCT00509899|20944443|P4|Overall Study|Lack of Efficacy|0
6061636|NCT00509899|20944444|P3|Overall Study|Lack of Efficacy|2
6061637|NCT00509899|20944445|P2|Overall Study|Lack of Efficacy|0
6061638|NCT00509899|20944446|P1|Overall Study|Lack of Efficacy|1
6061639|NCT00509899|20944439|P8|Overall Study|Death|1
6061640|NCT00509899|20944440|P7|Overall Study|Death|1
6061641|NCT00509899|20944441|P6|Overall Study|Death|1
6061642|NCT00509899|20944442|P5|Overall Study|Death|1
6061643|NCT00509899|20944443|P4|Overall Study|Death|0
6061644|NCT00509899|20944444|P3|Overall Study|Death|3
6061645|NCT00509899|20944445|P2|Overall Study|Death|2
6061646|NCT00509899|20944446|P1|Overall Study|Death|2
6061647|NCT00509899|20944439|P8|Overall Study|Intercurrent Illness|0
6061648|NCT00509899|20944440|P7|Overall Study|Intercurrent Illness|0
6061649|NCT00509899|20944441|P6|Overall Study|Intercurrent Illness|1
6061650|NCT00509899|20944442|P5|Overall Study|Intercurrent Illness|0
6061651|NCT00509899|20944443|P4|Overall Study|Intercurrent Illness|1
6061652|NCT00509899|20944444|P3|Overall Study|Intercurrent Illness|0
6061653|NCT00509899|20944445|P2|Overall Study|Intercurrent Illness|0
6061654|NCT00509899|20944446|P1|Overall Study|Intercurrent Illness|1
6061655|NCT00509899|20944439|P8|Overall Study|Physician Decision|0
6061656|NCT00509899|20944440|P7|Overall Study|Physician Decision|0
6061657|NCT00509899|20944441|P6|Overall Study|Physician Decision|4
6061658|NCT00509899|20944442|P5|Overall Study|Physician Decision|1
6061659|NCT00509899|20944443|P4|Overall Study|Physician Decision|0
6061660|NCT00509899|20944444|P3|Overall Study|Physician Decision|7
6061661|NCT00509899|20944445|P2|Overall Study|Physician Decision|2
6061662|NCT00509899|20944446|P1|Overall Study|Physician Decision|4
6061663|NCT00509899|20944439|P8|Overall Study|Withdrawal by Subject|0
6061664|NCT00509899|20944440|P7|Overall Study|Withdrawal by Subject|0
6061665|NCT00509899|20944441|P6|Overall Study|Withdrawal by Subject|2
6061666|NCT00509899|20944442|P5|Overall Study|Withdrawal by Subject|3
6061667|NCT00509899|20944443|P4|Overall Study|Withdrawal by Subject|0
6061668|NCT00509899|20944444|P3|Overall Study|Withdrawal by Subject|3
6061669|NCT00509899|20944445|P2|Overall Study|Withdrawal by Subject|2
6061670|NCT00509899|20944446|P1|Overall Study|Withdrawal by Subject|6
6061671|NCT00509899|20944439|P8|Overall Study|Unacceptable Toxicity|0
6061672|NCT00509899|20944440|P7|Overall Study|Unacceptable Toxicity|0
6061673|NCT00509899|20944441|P6|Overall Study|Unacceptable Toxicity|0
6061674|NCT00509899|20944442|P5|Overall Study|Unacceptable Toxicity|0
6061675|NCT00509899|20944443|P4|Overall Study|Unacceptable Toxicity|2
6061676|NCT00509899|20944444|P3|Overall Study|Unacceptable Toxicity|0
6061677|NCT00509899|20944445|P2|Overall Study|Unacceptable Toxicity|0
6061678|NCT00509899|20944446|P1|Overall Study|Unacceptable Toxicity|1
6061679|NCT00509899|20944439|P8|Overall Study|Progressive disease|0
6061680|NCT00509899|20944440|P7|Overall Study|Progressive disease|0
6061681|NCT00509899|20944441|P6|Overall Study|Progressive disease|1
6061682|NCT00509899|20944442|P5|Overall Study|Progressive disease|0
6061683|NCT00509899|20944443|P4|Overall Study|Progressive disease|1
6061684|NCT00509899|20944444|P3|Overall Study|Progressive disease|5
6061685|NCT00509899|20944445|P2|Overall Study|Progressive disease|3
6061686|NCT00509899|20944446|P1|Overall Study|Progressive disease|1
6061687|NCT00509821|20944503|P2|Study Period 1 (Induction)|Progressive Disease|1
6061688|NCT00509821|20944504|P1|Study Period 1 (Induction)|Progressive Disease|0
6061689|NCT00509821|20944503|P2|Study Period 1 (Induction)|Adverse Event|2
6061690|NCT00509821|20944504|P1|Study Period 1 (Induction)|Adverse Event|0
6061691|NCT00509821|20944503|P2|Study Period 1 (Induction)|Death|1
6061692|NCT00509821|20944504|P1|Study Period 1 (Induction)|Death|0
6061693|NCT00509795|20944522|P4|Overall Study|Withdrawal by Subject|8
6061694|NCT00509795|20944523|P3|Overall Study|Withdrawal by Subject|7
6061695|NCT00509795|20944524|P2|Overall Study|Withdrawal by Subject|5
6061696|NCT00509795|20944525|P1|Overall Study|Withdrawal by Subject|10
6061697|NCT00509795|20944522|P4|Overall Study|Protocol Violation|1
6061698|NCT00509795|20944523|P3|Overall Study|Protocol Violation|3
6061699|NCT00509795|20944524|P2|Overall Study|Protocol Violation|0
6061700|NCT00509795|20944525|P1|Overall Study|Protocol Violation|3
6061701|NCT00509795|20944522|P4|Overall Study|OTHER|1
6061702|NCT00509795|20944523|P3|Overall Study|OTHER|4
6061703|NCT00509795|20944524|P2|Overall Study|OTHER|0
6061704|NCT00509795|20944525|P1|Overall Study|OTHER|1
6061705|NCT00509795|20944522|P4|Overall Study|Lost to Follow-up|4
6061706|NCT00509795|20944523|P3|Overall Study|Lost to Follow-up|4
6061707|NCT00509795|20944524|P2|Overall Study|Lost to Follow-up|2
6061708|NCT00509795|20944525|P1|Overall Study|Lost to Follow-up|1
6061709|NCT00509795|20944522|P4|Overall Study|Lack of Efficacy|2
6061710|NCT00509795|20944523|P3|Overall Study|Lack of Efficacy|2
6061711|NCT00509795|20944524|P2|Overall Study|Lack of Efficacy|0
6061712|NCT00509795|20944525|P1|Overall Study|Lack of Efficacy|0
6061713|NCT00509795|20944522|P4|Overall Study|Death|7
6061714|NCT00509795|20944523|P3|Overall Study|Death|2
6061715|NCT00509795|20944524|P2|Overall Study|Death|1
6061716|NCT00509795|20944525|P1|Overall Study|Death|3
6061717|NCT00509795|20944522|P4|Overall Study|Adverse Event|4
6061718|NCT00509795|20944523|P3|Overall Study|Adverse Event|5
6061719|NCT00509795|20944524|P2|Overall Study|Adverse Event|3
6061720|NCT00509795|20944525|P1|Overall Study|Adverse Event|4
6061721|NCT00509769|20944556|P1|Overall Study|Use of prohibited therapies during study|1
6061722|NCT00509769|20944556|P1|Overall Study|Physician Decision|8
6061723|NCT00509769|20944556|P1|Overall Study|Patient's decision|1
6061724|NCT00509769|20944556|P1|Overall Study|Adverse Event|4
6061725|NCT00509769|20944556|P1|Overall Study|Progressive disease|77
6061726|NCT00509600|20944575|P1|Overall Study|Adverse Event|1
6061727|NCT00509366|20944654|P5|Overall Study|Not Treated (Screen Failure)|0
6061728|NCT00509366|20944655|P4|Overall Study|Not Treated (Screen Failure)|0
6061729|NCT00509366|20944656|P3|Overall Study|Not Treated (Screen Failure)|1
6061730|NCT00509366|20944657|P2|Overall Study|Not Treated (Screen Failure)|1
6061731|NCT00509366|20944658|P1|Overall Study|Not Treated (Screen Failure)|1
6061732|NCT00509262|20944682|P2|Overall Study|Withdrawal by Subject|11
6061733|NCT00509262|20944683|P1|Overall Study|Withdrawal by Subject|24
6061734|NCT00509262|20944682|P2|Overall Study|Protocol Violation|2
6061735|NCT00509262|20944683|P1|Overall Study|Protocol Violation|2
6061736|NCT00509262|20944682|P2|Overall Study|Physician Decision|3
6061737|NCT00509262|20944683|P1|Overall Study|Physician Decision|1
6061738|NCT00509262|20944682|P2|Overall Study|Lost to Follow-up|6
6061739|NCT00509262|20944683|P1|Overall Study|Lost to Follow-up|1
6061740|NCT00509262|20944682|P2|Overall Study|Lack of Efficacy|0
6061741|NCT00509262|20944683|P1|Overall Study|Lack of Efficacy|1
6061742|NCT00509262|20944682|P2|Overall Study|Other|2
6061743|NCT00509262|20944683|P1|Overall Study|Other|2
6061744|NCT00509262|20944682|P2|Overall Study|Adverse Event|18
6061745|NCT00509262|20944683|P1|Overall Study|Adverse Event|16
6061746|NCT00509236|20944701|P2|Overall Study|Scheduled Kidney Transplant|0
6061747|NCT00509236|20944702|P1|Overall Study|Scheduled Kidney Transplant|1
6061748|NCT00509236|20944701|P2|Overall Study|Excluded Medication|1
6061749|NCT00509236|20944702|P1|Overall Study|Excluded Medication|1
6061750|NCT00509236|20944701|P2|Overall Study|Protocol Violation|0
6061751|NCT00509236|20944702|P1|Overall Study|Protocol Violation|3
6061752|NCT00509236|20944701|P2|Overall Study|Withdrawal by Subject|10
6061753|NCT00509236|20944702|P1|Overall Study|Withdrawal by Subject|5
6061754|NCT00509236|20944701|P2|Overall Study|Adverse Event|9
6061755|NCT00509236|20944702|P1|Overall Study|Adverse Event|7
6061756|NCT00509223|20944717|P2|Overall Study|Did not meet revised inclusion criteria|62
6061757|NCT00509223|20944718|P1|Overall Study|Did not meet revised inclusion criteria|56
6061758|NCT00509223|20944717|P2|Overall Study|Including: subject change of address|2
6061759|NCT00509223|20944718|P1|Overall Study|Including: subject change of address|5
6061760|NCT00509223|20944717|P2|Overall Study|Withdrawal by Subject|6
6061761|NCT00509223|20944718|P1|Overall Study|Withdrawal by Subject|25
6061762|NCT00509223|20944717|P2|Overall Study|Adverse Event|1
6061763|NCT00509223|20944718|P1|Overall Study|Adverse Event|1
6061764|NCT00509223|20944717|P2|Overall Study|Lost to Follow-up|1
6061765|NCT00509223|20944718|P1|Overall Study|Lost to Follow-up|1
6061766|NCT00509106|20944750|P2|Overall Study|Death|6
6061767|NCT00509106|20944751|P1|Overall Study|Death|6
6061768|NCT00509106|20944750|P2|Overall Study|Other|0
6061769|NCT00509106|20944751|P1|Overall Study|Other|1
6061770|NCT00509106|20944750|P2|Overall Study|Lost to Follow-up|10
6061771|NCT00509106|20944751|P1|Overall Study|Lost to Follow-up|16
6061772|NCT00509106|20944750|P2|Overall Study|Withdrew consent|8
6061773|NCT00509106|20944751|P1|Overall Study|Withdrew consent|4
6061774|NCT00509106|20944750|P2|Overall Study|At the request of sponsor/investigator|2
6061775|NCT00509106|20944751|P1|Overall Study|At the request of sponsor/investigator|1
6061776|NCT00509106|20944750|P2|Overall Study|Noncompliance|1
6061777|NCT00509106|20944751|P1|Overall Study|Noncompliance|0
6061778|NCT00509106|20944750|P2|Overall Study|Adverse Event|2
6061779|NCT00509106|20944751|P1|Overall Study|Adverse Event|3
6061780|NCT00509093|20944757|P1|Overall Study|Physician Decision|1
6061781|NCT00509093|20944757|P1|Overall Study|Withdrawal by Subject|3
6061782|NCT00509093|20944757|P1|Overall Study|Transformed into MDS|1
6061783|NCT00509093|20944757|P1|Overall Study|Disease Progression|9
6061784|NCT00509093|20944757|P1|Overall Study|Adverse Event|10
6061785|NCT00509067|20944767|P2|Overall Study|Protocol Violation|3
6061786|NCT00509067|20944768|P1|Overall Study|Protocol Violation|0
6061787|NCT00509067|20944767|P2|Overall Study|Adverse Event|1
6061788|NCT00509067|20944768|P1|Overall Study|Adverse Event|3
6061789|NCT00509067|20944767|P2|Overall Study|Lost to Follow-up|1
6061790|NCT00509067|20944768|P1|Overall Study|Lost to Follow-up|1
6061791|NCT00509028|20944787|P2|Overall Study|Non-compliance|1
6061792|NCT00509028|20944788|P1|Overall Study|Non-compliance|2
6061793|NCT00509028|20944787|P2|Overall Study|Protocol Violation|2
6061794|NCT00509028|20944788|P1|Overall Study|Protocol Violation|4
6061795|NCT00509028|20944787|P2|Overall Study|Lost to Follow-up|1
6061796|NCT00509028|20944788|P1|Overall Study|Lost to Follow-up|0
6061797|NCT00509028|20944787|P2|Overall Study|Withdrawal by Subject|3
6061798|NCT00509028|20944788|P1|Overall Study|Withdrawal by Subject|4
6061799|NCT00509028|20944787|P2|Overall Study|Adverse Event|0
6061800|NCT00509028|20944788|P1|Overall Study|Adverse Event|2
6061801|NCT00508924|20944828|P4|Overall Study|Protocol Violation|1
6061802|NCT00508924|20944829|P3|Overall Study|Protocol Violation|1
6061803|NCT00508924|20944830|P2|Overall Study|Protocol Violation|0
6061804|NCT00508924|20944831|P1|Overall Study|Protocol Violation|0
6061805|NCT00508872|20944845|P1|Overall Study|Physician Decision|1
6061806|NCT00508872|20944845|P1|Overall Study|Lost to Follow-up|1
6061807|NCT00508820|20944851|P2|Overall Study|Protocol-specified Criteria|12
6061808|NCT00508820|20944852|P1|Overall Study|Protocol-specified Criteria|3
6061809|NCT00508820|20944851|P2|Overall Study|Requirement for alternative therapy|15
6061810|NCT00508820|20944852|P1|Overall Study|Requirement for alternative therapy|7
6061811|NCT00508820|20944851|P2|Overall Study|Noncompliance|0
6061812|NCT00508820|20944852|P1|Overall Study|Noncompliance|1
6061813|NCT00508820|20944851|P2|Overall Study|Other|2
6061814|NCT00508820|20944852|P1|Overall Study|Other|11
6061815|NCT00508820|20944851|P2|Overall Study|Withdrawal by Subject|12
6061816|NCT00508820|20944852|P1|Overall Study|Withdrawal by Subject|10
6061817|NCT00508820|20944851|P2|Overall Study|Protocol Violation|0
6061818|NCT00508820|20944852|P1|Overall Study|Protocol Violation|2
6061819|NCT00508820|20944851|P2|Overall Study|Pregnancy|2
6061820|NCT00508820|20944852|P1|Overall Study|Pregnancy|0
6061821|NCT00508820|20944851|P2|Overall Study|Physician Decision|2
6061822|NCT00508820|20944852|P1|Overall Study|Physician Decision|8
6061823|NCT00508820|20944851|P2|Overall Study|Lost to Follow-up|1
6061824|NCT00508820|20944852|P1|Overall Study|Lost to Follow-up|1
6061825|NCT00508820|20944851|P2|Overall Study|Death|8
6061826|NCT00508820|20944852|P1|Overall Study|Death|6
6061827|NCT00508820|20944851|P2|Overall Study|Adverse Event|10
6061828|NCT00508820|20944852|P1|Overall Study|Adverse Event|6
6061829|NCT00508755|20944862|P1|Overall Study|Withdrawal by Subject|1
6061830|NCT00508742|20944870|P2|Period 3: Toddler Dose|Other|4
6061831|NCT00508742|20944871|P1|Period 3: Toddler Dose|Other|5
6061832|NCT00508742|20944870|P2|Period 3: Toddler Dose|Parent/Legal Guardian Request|8
6061833|NCT00508742|20944871|P1|Period 3: Toddler Dose|Parent/Legal Guardian Request|17
6061834|NCT00508742|20944870|P2|Period 3: Toddler Dose|Lost to Follow-up|3
6061835|NCT00508742|20944871|P1|Period 3: Toddler Dose|Lost to Follow-up|2
6061836|NCT00508742|20944870|P2|Period 3: Toddler Dose|Adverse Event|0
6061837|NCT00508742|20944871|P1|Period 3: Toddler Dose|Adverse Event|1
6061838|NCT00508742|20944870|P2|Period 2: After Infant Series|Other|1
6061839|NCT00508742|20944871|P1|Period 2: After Infant Series|Other|2
6061840|NCT00508742|20944870|P2|Period 2: After Infant Series|Failed to Return|0
6061841|NCT00508742|20944871|P1|Period 2: After Infant Series|Failed to Return|1
6061842|NCT00508742|20944870|P2|Period 2: After Infant Series|Parent/Legal Guardian Request|3
6061843|NCT00508742|20944871|P1|Period 2: After Infant Series|Parent/Legal Guardian Request|0
6061844|NCT00508742|20944870|P2|Period 2: After Infant Series|Protocol Violation|0
6061845|NCT00508742|20944871|P1|Period 2: After Infant Series|Protocol Violation|1
6061846|NCT00508742|20944870|P2|Period 2: After Infant Series|Lost to Follow-up|1
6061847|NCT00508742|20944871|P1|Period 2: After Infant Series|Lost to Follow-up|1
6061848|NCT00508742|20944870|P2|Period 2: After Infant Series|Adverse Event|6
6061849|NCT00508742|20944871|P1|Period 2: After Infant Series|Adverse Event|2
6061850|NCT00508742|20944870|P2|Period 1: Infant Series|Other|1
6061851|NCT00508742|20944871|P1|Period 1: Infant Series|Other|4
6061852|NCT00508742|20944870|P2|Period 1: Infant Series|Physician Decision|0
6061853|NCT00508742|20944871|P1|Period 1: Infant Series|Physician Decision|1
6061854|NCT00508742|20944870|P2|Period 1: Infant Series|Parent/Legal Guardian Request|40
6061855|NCT00508742|20944871|P1|Period 1: Infant Series|Parent/Legal Guardian Request|31
6061856|NCT00508742|20944870|P2|Period 1: Infant Series|Protocol Violation|0
6061857|NCT00508742|20944871|P1|Period 1: Infant Series|Protocol Violation|1
6061858|NCT00508742|20944870|P2|Period 1: Infant Series|Adverse Event|4
6061859|NCT00508742|20944871|P1|Period 1: Infant Series|Adverse Event|5
6061860|NCT00508651|20944896|P2|Overall Study|Withdrawal by Subject|1
6061861|NCT00508651|20944897|P1|Overall Study|Withdrawal by Subject|1
6061862|NCT00508651|20944896|P2|Overall Study|Lost to Follow-up|1
6061863|NCT00508651|20944897|P1|Overall Study|Lost to Follow-up|3
6061864|NCT00508482|20944978|P3|at the 4th Week of Follow-up|Lost to Follow-up|1
6061865|NCT00508482|20944979|P2|at the 4th Week of Follow-up|Lost to Follow-up|6
6061866|NCT00508482|20944980|P1|at the 4th Week of Follow-up|Lost to Follow-up|20
6061867|NCT00508482|20944978|P3|Over 4 Weeks of Treatment|Lost to Follow-up|16
6061868|NCT00508482|20944979|P2|Over 4 Weeks of Treatment|Lost to Follow-up|10
6061869|NCT00508482|20944980|P1|Over 4 Weeks of Treatment|Lost to Follow-up|12
6061870|NCT00508482|20944978|P3|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|4
6061871|NCT00508482|20944979|P2|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|7
6061872|NCT00508482|20944980|P1|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|9
6061873|NCT00508404|20945024|P1|Overall Study|Other - Not Specified|3
6061874|NCT00508404|20945024|P1|Overall Study|Lost to Follow-up|2
6061875|NCT00508404|20945024|P1|Overall Study|Protocol-specified Criteria|2
6061876|NCT00508404|20945024|P1|Overall Study|Withdrawal by Subject|3
6061877|NCT00508404|20945024|P1|Overall Study|Physician Decision|2
6061878|NCT00508404|20945024|P1|Overall Study|Death|16
6061879|NCT00508404|20945024|P1|Overall Study|Adverse Event|2
6061880|NCT00508404|20945024|P1|Overall Study|Ongoing at Data Cut-off|12
6061881|NCT00508391|20945051|P2|Second Treatment|Withdrawal by Subject|0
6061882|NCT00508391|20945052|P1|Second Treatment|Withdrawal by Subject|2
6061883|NCT00508391|20945051|P2|First Treatment|Withdrawal by Subject|3
6061884|NCT00508391|20945052|P1|First Treatment|Withdrawal by Subject|6
6061885|NCT00508274|20945072|P1|Overall Study|Withdrawal by Subject|1
6061886|NCT00508274|20945072|P1|Overall Study|Adverse Event|1
6061887|NCT00508261|20945085|P4|Overall Study|Lost to Follow-up|1
6061888|NCT00508261|20945086|P3|Overall Study|Lost to Follow-up|1
6061889|NCT00508261|20945087|P2|Overall Study|Lost to Follow-up|1
6061890|NCT00508261|20945088|P1|Overall Study|Lost to Follow-up|0
6061891|NCT00508261|20945085|P4|Overall Study|Migrated/ moved from study area|0
6061892|NCT00508261|20945086|P3|Overall Study|Migrated/ moved from study area|0
6061893|NCT00508261|20945087|P2|Overall Study|Migrated/ moved from study area|1
6061894|NCT00508261|20945088|P1|Overall Study|Migrated/ moved from study area|0
6061895|NCT00508261|20945085|P4|Overall Study|Withdrawal by Subject|0
6061896|NCT00508261|20945086|P3|Overall Study|Withdrawal by Subject|4
6061897|NCT00508261|20945087|P2|Overall Study|Withdrawal by Subject|4
6061898|NCT00508261|20945088|P1|Overall Study|Withdrawal by Subject|3
6061899|NCT00508261|20945085|P4|Overall Study|Serious Adverse Event|0
6061900|NCT00508261|20945086|P3|Overall Study|Serious Adverse Event|0
6061901|NCT00508261|20945087|P2|Overall Study|Serious Adverse Event|1
6061902|NCT00508261|20945088|P1|Overall Study|Serious Adverse Event|0
6061903|NCT00508261|20945085|P4|Overall Study|Other|0
6061904|NCT00508261|20945086|P3|Overall Study|Other|1
6061905|NCT00508261|20945087|P2|Overall Study|Other|1
6061906|NCT00508261|20945088|P1|Overall Study|Other|0
6061907|NCT00508157|20945228|P2|Overall Study|Other known cause|1
6061908|NCT00508157|20945229|P1|Overall Study|Other known cause|0
6061909|NCT00508157|20945228|P2|Overall Study|Subject no longer met study criteria|1
6061910|NCT00508157|20945229|P1|Overall Study|Subject no longer met study criteria|0
6061911|NCT00508157|20945228|P2|Overall Study|Lost to Follow-up|0
6061912|NCT00508157|20945229|P1|Overall Study|Lost to Follow-up|1
6061913|NCT00508157|20945228|P2|Overall Study|Subject Withdrew Consent|0
6061914|NCT00508157|20945229|P1|Overall Study|Subject Withdrew Consent|1
6061915|NCT00508157|20945228|P2|Overall Study|Adverse Event|1
6061916|NCT00508157|20945229|P1|Overall Study|Adverse Event|0
6061917|NCT00508144|20945251|P1|Overall Study|Death|5
6061918|NCT00508144|20945251|P1|Overall Study|Not eligible|6
6061919|NCT00508027|20945290|P1|Dose Level 2|Withdrawal by Subject|2
6061920|NCT00508027|20945290|P1|Dose Level 2|Lost to Follow-up|2
6061921|NCT00508027|20945290|P1|Dose Level 1|Physician Decision|2
6061922|NCT00508027|20945290|P1|Dose Level 1|Withdrawal by Subject|2
6061923|NCT00508027|20945290|P1|Dose Level 1|Lost to Follow-up|4
6061924|NCT00508001|20945331|P3|Overall Study|Withdrawal by Subject|1
6061925|NCT00508001|20945332|P2|Overall Study|Withdrawal by Subject|4
6061926|NCT00508001|20945333|P1|Overall Study|Withdrawal by Subject|4
6061927|NCT00508001|20945331|P3|Overall Study|Death|1
6061928|NCT00508001|20945332|P2|Overall Study|Death|1
6061929|NCT00508001|20945333|P1|Overall Study|Death|0
6061930|NCT00508001|20945331|P3|Overall Study|condition under investigation worsened|1
6061931|NCT00508001|20945332|P2|Overall Study|condition under investigation worsened|7
6061932|NCT00508001|20945333|P1|Overall Study|condition under investigation worsened|13
6061933|NCT00508001|20945331|P3|Overall Study|Adverse Event|4
6061934|NCT00508001|20945332|P2|Overall Study|Adverse Event|0
6061935|NCT00508001|20945333|P1|Overall Study|Adverse Event|2
6061936|NCT00507819|20945350|P2|Washout (6 Weeks)|Withdrawal by Subject|0
6061937|NCT00507819|20945351|P1|Washout (6 Weeks)|Withdrawal by Subject|1
6061938|NCT00507689|20945370|P2|Randomized Period|Withdrawal by Subject|1
6061939|NCT00507689|20945371|P1|Randomized Period|Withdrawal by Subject|0
6061940|NCT00507689|20945370|P2|Randomized Period|Adverse Event|1
6061941|NCT00507689|20945371|P1|Randomized Period|Adverse Event|1
6061942|NCT00507689|20945370|P2|Pre-Randomization Period|Withdrawal by Subject|0
6061943|NCT00507689|20945371|P1|Pre-Randomization Period|Withdrawal by Subject|1
6061944|NCT00507689|20945370|P2|Pre-Randomization Period|Physician Decision|0
6061945|NCT00507689|20945371|P1|Pre-Randomization Period|Physician Decision|1
6061946|NCT00507689|20945370|P2|Pre-Randomization Period|Adverse Event|0
6061947|NCT00507689|20945371|P1|Pre-Randomization Period|Adverse Event|1
6061948|NCT00507546|20945403|P2|Overall Study|Physician Decision|1
6061949|NCT00507546|20945404|P1|Overall Study|Physician Decision|0
6061950|NCT00507546|20945403|P2|Overall Study|Protocol Violation|0
6061951|NCT00507546|20945404|P1|Overall Study|Protocol Violation|1
6061952|NCT00507546|20945403|P2|Overall Study|Withdrawal by Subject|0
6061953|NCT00507546|20945404|P1|Overall Study|Withdrawal by Subject|1
6061954|NCT00507507|20945414|P2|24-week Treatment-free Follow-up Period|Withdrawal by Subject|16
6061955|NCT00507507|20945415|P1|24-week Treatment-free Follow-up Period|Withdrawal by Subject|9
6061956|NCT00507507|20945414|P2|24-week Treatment-free Follow-up Period|Adverse Event|1
6061957|NCT00507507|20945415|P1|24-week Treatment-free Follow-up Period|Adverse Event|0
6061958|NCT00507507|20945414|P2|24-week Treatment-free Follow-up Period|Physician Decision|0
6061959|NCT00507507|20945415|P1|24-week Treatment-free Follow-up Period|Physician Decision|1
6061960|NCT00507507|20945414|P2|Treatment Period|Withdrawal by Subject|47
6061961|NCT00507507|20945415|P1|Treatment Period|Withdrawal by Subject|46
6061962|NCT00507507|20945414|P2|Treatment Period|Adverse Event|1
6061963|NCT00507507|20945415|P1|Treatment Period|Adverse Event|1
6061964|NCT00507507|20945414|P2|Treatment Period|Protocol Violation|2
6061965|NCT00507507|20945415|P1|Treatment Period|Protocol Violation|1
6061966|NCT00507507|20945414|P2|Treatment Period|Physician Decision|1
6061967|NCT00507507|20945415|P1|Treatment Period|Physician Decision|4
6061968|NCT00507507|20945414|P2|Treatment Period|Lost to Follow-up|2
6061969|NCT00507507|20945415|P1|Treatment Period|Lost to Follow-up|0
6061970|NCT00507455|20945450|P3|Overall Study|Other - miscellaneous reason|1
6061971|NCT00507455|20945451|P2|Overall Study|Other - miscellaneous reason|0
6061972|NCT00507455|20945452|P1|Overall Study|Other - miscellaneous reason|1
6061973|NCT00507455|20945450|P3|Overall Study|Lack of Efficacy|0
6061974|NCT00507455|20945451|P2|Overall Study|Lack of Efficacy|1
6061975|NCT00507455|20945452|P1|Overall Study|Lack of Efficacy|0
6061976|NCT00507455|20945450|P3|Overall Study|Lost to Follow-up|2
6061977|NCT00507455|20945451|P2|Overall Study|Lost to Follow-up|0
6061978|NCT00507455|20945452|P1|Overall Study|Lost to Follow-up|2
6061979|NCT00507455|20945450|P3|Overall Study|Protocol Violation|1
6061980|NCT00507455|20945451|P2|Overall Study|Protocol Violation|1
6061981|NCT00507455|20945452|P1|Overall Study|Protocol Violation|4
6061982|NCT00507455|20945450|P3|Overall Study|Withdrawal by Subject|2
6061983|NCT00507455|20945451|P2|Overall Study|Withdrawal by Subject|1
6061984|NCT00507455|20945452|P1|Overall Study|Withdrawal by Subject|2
6061985|NCT00507455|20945450|P3|Overall Study|Adverse Event|6
6061986|NCT00507455|20945451|P2|Overall Study|Adverse Event|3
6061987|NCT00507455|20945452|P1|Overall Study|Adverse Event|3
6061988|NCT00507442|20945515|P4|Overall Study|Other|2
6061989|NCT00507442|20945516|P3|Overall Study|Other|2
6061990|NCT00507442|20945517|P2|Overall Study|Other|5
6061991|NCT00507442|20945518|P1|Overall Study|Other|2
6061992|NCT00507442|20945515|P4|Overall Study|Withdrawal by Subject|1
6061993|NCT00507442|20945516|P3|Overall Study|Withdrawal by Subject|2
6061994|NCT00507442|20945517|P2|Overall Study|Withdrawal by Subject|4
6061995|NCT00507442|20945518|P1|Overall Study|Withdrawal by Subject|4
6061996|NCT00507442|20945515|P4|Overall Study|Progressive Disease|0
6061997|NCT00507442|20945516|P3|Overall Study|Progressive Disease|2
6061998|NCT00507442|20945517|P2|Overall Study|Progressive Disease|4
6061999|NCT00507442|20945518|P1|Overall Study|Progressive Disease|2
6062000|NCT00507442|20945515|P4|Overall Study|Physician Decision|1
6062001|NCT00507442|20945516|P3|Overall Study|Physician Decision|4
6062002|NCT00507442|20945517|P2|Overall Study|Physician Decision|2
6062003|NCT00507442|20945518|P1|Overall Study|Physician Decision|0
6062004|NCT00507442|20945515|P4|Overall Study|Lost to Follow-up|0
6062005|NCT00507442|20945516|P3|Overall Study|Lost to Follow-up|1
6062006|NCT00507442|20945517|P2|Overall Study|Lost to Follow-up|0
6062007|NCT00507442|20945518|P1|Overall Study|Lost to Follow-up|0
6062008|NCT00507442|20945515|P4|Overall Study|Protocol Violation|0
6062009|NCT00507442|20945516|P3|Overall Study|Protocol Violation|0
6062010|NCT00507442|20945517|P2|Overall Study|Protocol Violation|1
6062011|NCT00507442|20945518|P1|Overall Study|Protocol Violation|0
6062012|NCT00507442|20945515|P4|Overall Study|Adverse Event|1
6062013|NCT00507442|20945516|P3|Overall Study|Adverse Event|4
6062014|NCT00507442|20945517|P2|Overall Study|Adverse Event|11
6062015|NCT00507442|20945518|P1|Overall Study|Adverse Event|8
6062016|NCT00507429|20945570|P2|Maintenance Phase|Progressive Disease|0
6062017|NCT00507429|20945571|P1|Maintenance Phase|Progressive Disease|14
6062018|NCT00507429|20945570|P2|Treatment Phase|Other|3
6062019|NCT00507429|20945571|P1|Treatment Phase|Other|6
6062020|NCT00507429|20945570|P2|Treatment Phase|Physician Decision|2
6062021|NCT00507429|20945571|P1|Treatment Phase|Physician Decision|4
6062022|NCT00507429|20945570|P2|Treatment Phase|Withdrawal by Subject|3
6062023|NCT00507429|20945571|P1|Treatment Phase|Withdrawal by Subject|3
6062024|NCT00507429|20945570|P2|Treatment Phase|Adverse Event|5
6062025|NCT00507429|20945571|P1|Treatment Phase|Adverse Event|12
6062026|NCT00507429|20945570|P2|Treatment Phase|Disease Progression|5
6062027|NCT00507429|20945571|P1|Treatment Phase|Disease Progression|12
6062028|NCT00507416|20945582|P3|Overall Study|Did not Receive Study Treatment|4
6062029|NCT00507416|20945583|P2|Overall Study|Did not Receive Study Treatment|9
6062030|NCT00507416|20945584|P1|Overall Study|Did not Receive Study Treatment|3
6062031|NCT00507416|20945582|P3|Overall Study|Other|13
6062032|NCT00507416|20945583|P2|Overall Study|Other|16
6062033|NCT00507416|20945584|P1|Overall Study|Other|11
6062034|NCT00507416|20945582|P3|Overall Study|Patient declined further treatment|11
6062035|NCT00507416|20945583|P2|Overall Study|Patient declined further treatment|14
6062036|NCT00507416|20945584|P1|Overall Study|Patient declined further treatment|18
6062037|NCT00507416|20945582|P3|Overall Study|Progressive Disease|13
6062038|NCT00507416|20945583|P2|Overall Study|Progressive Disease|10
6062039|NCT00507416|20945584|P1|Overall Study|Progressive Disease|20
6062040|NCT00507416|20945582|P3|Overall Study|Lack ofEfficacy / Physician Decision|8
6062041|NCT00507416|20945583|P2|Overall Study|Lack ofEfficacy / Physician Decision|7
6062042|NCT00507416|20945584|P1|Overall Study|Lack ofEfficacy / Physician Decision|7
6062043|NCT00507416|20945582|P3|Overall Study|Protocol Violation|0
6062044|NCT00507416|20945583|P2|Overall Study|Protocol Violation|2
6062045|NCT00507416|20945584|P1|Overall Study|Protocol Violation|1
6062046|NCT00507416|20945582|P3|Overall Study|Adverse Event|65
6062047|NCT00507416|20945583|P2|Overall Study|Adverse Event|67
6062048|NCT00507416|20945584|P1|Overall Study|Adverse Event|58
6062049|NCT00507130|20945626|P4|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0
6062050|NCT00507130|20945627|P3|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0
6062051|NCT00507130|20945628|P2|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0
6062052|NCT00507130|20945629|P1|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|1
6062053|NCT00507130|20945626|P4|Overall Study|Lost to Follow-up|1
6062054|NCT00507130|20945627|P3|Overall Study|Lost to Follow-up|1
6062055|NCT00507130|20945628|P2|Overall Study|Lost to Follow-up|0
6062056|NCT00507130|20945629|P1|Overall Study|Lost to Follow-up|0
6062057|NCT00506948|20945671|P1|Overall Study|Physician Decision|1
6062058|NCT00506948|20945671|P1|Overall Study|Adverse Event|5
6062059|NCT00506948|20945671|P1|Overall Study|Death|4
6062060|NCT00506922|20945680|P5|Overall Study|Withdrawal by Subject|1
6062061|NCT00506922|20945681|P4|Overall Study|Withdrawal by Subject|0
6062062|NCT00506922|20945682|P3|Overall Study|Withdrawal by Subject|0
6062063|NCT00506922|20945683|P2|Overall Study|Withdrawal by Subject|0
6062064|NCT00506922|20945684|P1|Overall Study|Withdrawal by Subject|0
6062065|NCT00506922|20945680|P5|Overall Study|Physician Decision|0
6062066|NCT00506922|20945681|P4|Overall Study|Physician Decision|2
6062067|NCT00506922|20945682|P3|Overall Study|Physician Decision|0
6062068|NCT00506922|20945683|P2|Overall Study|Physician Decision|0
6062069|NCT00506922|20945684|P1|Overall Study|Physician Decision|0
6062070|NCT00506883|20945711|P3|Overall Study|Other|1
6062071|NCT00506883|20945712|P2|Overall Study|Other|1
6062072|NCT00506883|20945713|P1|Overall Study|Other|5
6062073|NCT00506883|20945711|P3|Overall Study|Lack of Efficacy|1
6062074|NCT00506883|20945712|P2|Overall Study|Lack of Efficacy|1
6062075|NCT00506883|20945713|P1|Overall Study|Lack of Efficacy|0
6062076|NCT00506883|20945711|P3|Overall Study|Withdrawal by Subject|1
6062077|NCT00506883|20945712|P2|Overall Study|Withdrawal by Subject|0
6062078|NCT00506883|20945713|P1|Overall Study|Withdrawal by Subject|1
6062079|NCT00506883|20945711|P3|Overall Study|Lost to Follow-up|1
6062080|NCT00506883|20945712|P2|Overall Study|Lost to Follow-up|1
6062081|NCT00506883|20945713|P1|Overall Study|Lost to Follow-up|1
6062082|NCT00506831|20945726|P1|Overall Study|Withdrawal by Subject|1
6062083|NCT00506831|20945726|P1|Overall Study|Death|1
6062084|NCT00506779|20945739|P4|Overall Study|Adverse Event|1
6062085|NCT00506779|20945740|P3|Overall Study|Adverse Event|1
6062086|NCT00506779|20945741|P2|Overall Study|Adverse Event|1
6062087|NCT00506779|20945742|P1|Overall Study|Adverse Event|0
6062088|NCT00506779|20945739|P4|Overall Study|Withdrawal by Subject|0
6062089|NCT00506779|20945740|P3|Overall Study|Withdrawal by Subject|1
6062090|NCT00506779|20945741|P2|Overall Study|Withdrawal by Subject|0
6062091|NCT00506779|20945742|P1|Overall Study|Withdrawal by Subject|1
6062092|NCT00506753|20945757|P2|Overall Study|Lost to Follow-up|15
6062093|NCT00506753|20945758|P1|Overall Study|Lost to Follow-up|21
6062094|NCT00506662|20945796|P2|Overall Study|Not recorded|6
6062095|NCT00506662|20945797|P1|Overall Study|Not recorded|4
6062096|NCT00506662|20945796|P2|Overall Study|Trial terminated|16
6062097|NCT00506662|20945797|P1|Overall Study|Trial terminated|10
6062098|NCT00506662|20945796|P2|Overall Study|Protocol Violation|4
6062099|NCT00506662|20945797|P1|Overall Study|Protocol Violation|2
6062100|NCT00506662|20945796|P2|Overall Study|Lack of Efficacy|0
6062101|NCT00506662|20945797|P1|Overall Study|Lack of Efficacy|1
6062102|NCT00506662|20945796|P2|Overall Study|Adverse Event|2
6062103|NCT00506662|20945797|P1|Overall Study|Adverse Event|0
6062104|NCT00506493|20945831|P1|Overall Study|Withdrawal by Subject|5
6062105|NCT00506493|20945831|P1|Overall Study|Death|6
6062106|NCT00506454|20945840|P2|Overall Study|Withdrawal by Subject|1
6062107|NCT00506454|20945841|P1|Overall Study|Withdrawal by Subject|1
6062108|NCT00506441|20945847|P2|Period 2; Double-blind Period|Other Reason|1
6062109|NCT00506441|20945848|P1|Period 2; Double-blind Period|Other Reason|1
6062110|NCT00506441|20945847|P2|Period 2; Double-blind Period|Withdrawal by Subject|0
6062111|NCT00506441|20945848|P1|Period 2; Double-blind Period|Withdrawal by Subject|1
6062112|NCT00506441|20945847|P2|Period 2; Double-blind Period|Physician Decision|1
6062113|NCT00506441|20945848|P1|Period 2; Double-blind Period|Physician Decision|1
6062114|NCT00506441|20945847|P2|Period 2; Double-blind Period|Lack of Efficacy|2
6062115|NCT00506441|20945848|P1|Period 2; Double-blind Period|Lack of Efficacy|0
6062116|NCT00506441|20945847|P2|Period 2; Double-blind Period|Adverse Event|1
6062117|NCT00506441|20945848|P1|Period 2; Double-blind Period|Adverse Event|0
6062118|NCT00506441|20945847|P2|Period 1; Open-label Period|Other Reasons|0
6062119|NCT00506441|20945848|P1|Period 1; Open-label Period|Other Reasons|13
6062120|NCT00506441|20945847|P2|Period 1; Open-label Period|Withdrawal by Subject|0
6062121|NCT00506441|20945848|P1|Period 1; Open-label Period|Withdrawal by Subject|13
6062122|NCT00506441|20945847|P2|Period 1; Open-label Period|Protocol Violation|0
6062123|NCT00506441|20945848|P1|Period 1; Open-label Period|Protocol Violation|9
6062124|NCT00506441|20945847|P2|Period 1; Open-label Period|Physician Decision|0
6062125|NCT00506441|20945848|P1|Period 1; Open-label Period|Physician Decision|5
6062126|NCT00506441|20945847|P2|Period 1; Open-label Period|Lost to Follow-up|0
6062127|NCT00506441|20945848|P1|Period 1; Open-label Period|Lost to Follow-up|2
6062128|NCT00506441|20945847|P2|Period 1; Open-label Period|Lack of Efficacy|0
6062129|NCT00506441|20945848|P1|Period 1; Open-label Period|Lack of Efficacy|13
6062130|NCT00506441|20945847|P2|Period 1; Open-label Period|Adverse Event|0
6062131|NCT00506441|20945848|P1|Period 1; Open-label Period|Adverse Event|21
6062132|NCT00506415|20945856|P4|Extended Open Label (Maximum 48 Weeks)|Death|7
6062133|NCT00506415|20945857|P3|Extended Open Label (Maximum 48 Weeks)|Death|0
6062134|NCT00506415|20945858|P2|Extended Open Label (Maximum 48 Weeks)|Death|0
6062135|NCT00506415|20945859|P1|Extended Open Label (Maximum 48 Weeks)|Death|0
6062136|NCT00506415|20945856|P4|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|6
6062137|NCT00506415|20945857|P3|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
6062138|NCT00506415|20945858|P2|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
6062139|NCT00506415|20945859|P1|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
6062140|NCT00506415|20945856|P4|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|5
6062141|NCT00506415|20945857|P3|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0
6062142|NCT00506415|20945858|P2|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0
6062143|NCT00506415|20945859|P1|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0
6062144|NCT00506415|20945856|P4|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|14
6062145|NCT00506415|20945857|P3|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
6062146|NCT00506415|20945858|P2|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
6062147|NCT00506415|20945859|P1|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
6062148|NCT00506415|20945856|P4|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|8
6062149|NCT00506415|20945857|P3|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
6062150|NCT00506415|20945858|P2|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
6062151|NCT00506415|20945859|P1|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
6062152|NCT00506415|20945856|P4|Extended Open Label (Maximum 48 Weeks)|Adverse Event|18
6062153|NCT00506415|20945857|P3|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0
6062154|NCT00506415|20945858|P2|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0
6062155|NCT00506415|20945859|P1|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0
6062156|NCT00506415|20945856|P4|Extended Open Label (Maximum 48 Weeks)|Administrative problems|4
6062157|NCT00506415|20945857|P3|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0
6062158|NCT00506415|20945858|P2|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0
6062159|NCT00506415|20945859|P1|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0
6062160|NCT00506415|20945856|P4|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0
6062161|NCT00506415|20945857|P3|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|1
6062162|NCT00506415|20945858|P2|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0
6062163|NCT00506415|20945859|P1|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0
6062164|NCT00506415|20945856|P4|Double Blind (Maximum 48 Weeks )|Administrative problems|0
6062165|NCT00506415|20945857|P3|Double Blind (Maximum 48 Weeks )|Administrative problems|2
6062166|NCT00506415|20945858|P2|Double Blind (Maximum 48 Weeks )|Administrative problems|3
6062167|NCT00506415|20945859|P1|Double Blind (Maximum 48 Weeks )|Administrative problems|0
6062168|NCT00506415|20945856|P4|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0
6062169|NCT00506415|20945857|P3|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|17
6062170|NCT00506415|20945858|P2|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|20
6062171|NCT00506415|20945859|P1|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0
6062172|NCT00506415|20945856|P4|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0
6062173|NCT00506415|20945857|P3|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|6
6062174|NCT00506415|20945858|P2|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|4
6062175|NCT00506415|20945859|P1|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0
6062176|NCT00506415|20945856|P4|Double Blind (Maximum 48 Weeks )|Protocol Violation|0
6062177|NCT00506415|20945857|P3|Double Blind (Maximum 48 Weeks )|Protocol Violation|3
6062178|NCT00506415|20945858|P2|Double Blind (Maximum 48 Weeks )|Protocol Violation|5
6062179|NCT00506415|20945859|P1|Double Blind (Maximum 48 Weeks )|Protocol Violation|0
6062180|NCT00506415|20945856|P4|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0
6062181|NCT00506415|20945857|P3|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13
6062182|NCT00506415|20945858|P2|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13
6062183|NCT00506415|20945859|P1|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0
6062184|NCT00506415|20945856|P4|Double Blind (Maximum 48 Weeks )|Death|0
6062185|NCT00506415|20945857|P3|Double Blind (Maximum 48 Weeks )|Death|3
6062186|NCT00506415|20945858|P2|Double Blind (Maximum 48 Weeks )|Death|5
6062187|NCT00506415|20945859|P1|Double Blind (Maximum 48 Weeks )|Death|0
6062188|NCT00506415|20945856|P4|Double Blind (Maximum 48 Weeks )|Adverse Event|0
6062189|NCT00506415|20945857|P3|Double Blind (Maximum 48 Weeks )|Adverse Event|28
6062190|NCT00506415|20945858|P2|Double Blind (Maximum 48 Weeks )|Adverse Event|33
6062191|NCT00506415|20945859|P1|Double Blind (Maximum 48 Weeks )|Adverse Event|0
6062192|NCT00506415|20945856|P4|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0
6062193|NCT00506415|20945857|P3|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0
6062194|NCT00506415|20945858|P2|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0
6062195|NCT00506415|20945859|P1|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|28
6062196|NCT00506415|20945856|P4|Initial Open Label (Maximum 48 Weeks)|Death|0
6062197|NCT00506415|20945857|P3|Initial Open Label (Maximum 48 Weeks)|Death|0
6062198|NCT00506415|20945858|P2|Initial Open Label (Maximum 48 Weeks)|Death|0
6062199|NCT00506415|20945859|P1|Initial Open Label (Maximum 48 Weeks)|Death|22
6062200|NCT00506415|20945856|P4|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0
6062201|NCT00506415|20945857|P3|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0
6062202|NCT00506415|20945858|P2|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0
6062203|NCT00506415|20945859|P1|Initial Open Label (Maximum 48 Weeks)|Administrative problem|7
6062204|NCT00506415|20945856|P4|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
6062205|NCT00506415|20945857|P3|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
6062206|NCT00506415|20945858|P2|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
6062207|NCT00506415|20945859|P1|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|22
6062208|NCT00506415|20945856|P4|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
6062209|NCT00506415|20945857|P3|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
6062210|NCT00506415|20945858|P2|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
6062211|NCT00506415|20945859|P1|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|88
6062212|NCT00506415|20945856|P4|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
6062213|NCT00506415|20945857|P3|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
6062214|NCT00506415|20945858|P2|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
6062215|NCT00506415|20945859|P1|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|58
6062216|NCT00506415|20945856|P4|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0
6062217|NCT00506415|20945857|P3|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0
6062218|NCT00506415|20945858|P2|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0
6062219|NCT00506415|20945859|P1|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|1
6062220|NCT00506415|20945856|P4|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0
6062221|NCT00506415|20945857|P3|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0
6062222|NCT00506415|20945858|P2|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0
6062223|NCT00506415|20945859|P1|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|1
6062224|NCT00506415|20945856|P4|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0
6062225|NCT00506415|20945857|P3|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0
6062226|NCT00506415|20945858|P2|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0
6062227|NCT00506415|20945859|P1|Initial Open Label (Maximum 48 Weeks)|Adverse Event|272
6062228|NCT00506389|20945884|P3|In-treatment Period|Randomized but not treated|1
6062229|NCT00506389|20945885|P2|In-treatment Period|Randomized but not treated|1
6062230|NCT00506389|20945886|P1|In-treatment Period|Randomized but not treated|4
6062231|NCT00506389|20945884|P3|In-treatment Period|Adverse Event|2
6062232|NCT00506389|20945885|P2|In-treatment Period|Adverse Event|5
6062233|NCT00506389|20945886|P1|In-treatment Period|Adverse Event|11
6062234|NCT00506389|20945884|P3|In-treatment Period|Lack of Efficacy|0
6062235|NCT00506389|20945885|P2|In-treatment Period|Lack of Efficacy|2
6062236|NCT00506389|20945886|P1|In-treatment Period|Lack of Efficacy|0
6062237|NCT00506389|20945884|P3|In-treatment Period|Withdrawal by Subject|4
6062238|NCT00506389|20945885|P2|In-treatment Period|Withdrawal by Subject|3
6062239|NCT00506389|20945886|P1|In-treatment Period|Withdrawal by Subject|3
6062240|NCT00506389|20945884|P3|In-treatment Period|Reasons not related to trial|0
6062241|NCT00506389|20945885|P2|In-treatment Period|Reasons not related to trial|1
6062242|NCT00506389|20945886|P1|In-treatment Period|Reasons not related to trial|4
6062243|NCT00506389|20945884|P3|In-treatment Period|Lack of compliance|0
6062244|NCT00506389|20945885|P2|In-treatment Period|Lack of compliance|0
6062245|NCT00506389|20945886|P1|In-treatment Period|Lack of compliance|1
6062246|NCT00506389|20945884|P3|In-treatment Period|Lost to Follow-up|1
6062247|NCT00506389|20945885|P2|In-treatment Period|Lost to Follow-up|0
6062248|NCT00506389|20945886|P1|In-treatment Period|Lost to Follow-up|0
6062249|NCT00506389|20945884|P3|In-treatment Period|Other|4
6062250|NCT00506389|20945885|P2|In-treatment Period|Other|3
6062251|NCT00506389|20945886|P1|In-treatment Period|Other|3
6062252|NCT00506350|20945912|P9|Overall Study|Other|2
6062253|NCT00506350|20945913|P8|Overall Study|Other|2
6062254|NCT00506350|20945914|P7|Overall Study|Other|0
6062255|NCT00506350|20945915|P6|Overall Study|Other|0
6062256|NCT00506350|20945916|P5|Overall Study|Other|3
6062257|NCT00506350|20945917|P4|Overall Study|Other|0
6062258|NCT00506350|20945918|P3|Overall Study|Other|3
6062259|NCT00506350|20945919|P2|Overall Study|Other|1
6062260|NCT00506350|20945920|P1|Overall Study|Other|1
6062261|NCT00506350|20945912|P9|Overall Study|Medical Reason|0
6062262|NCT00506350|20945913|P8|Overall Study|Medical Reason|0
6062263|NCT00506350|20945914|P7|Overall Study|Medical Reason|0
6062264|NCT00506350|20945915|P6|Overall Study|Medical Reason|0
6062265|NCT00506350|20945916|P5|Overall Study|Medical Reason|1
6062266|NCT00506350|20945917|P4|Overall Study|Medical Reason|0
6062267|NCT00506350|20945918|P3|Overall Study|Medical Reason|0
6062268|NCT00506350|20945919|P2|Overall Study|Medical Reason|0
6062269|NCT00506350|20945920|P1|Overall Study|Medical Reason|0
6062270|NCT00506350|20945912|P9|Overall Study|Lost to Follow-up|2
6062271|NCT00506350|20945913|P8|Overall Study|Lost to Follow-up|0
6062272|NCT00506350|20945914|P7|Overall Study|Lost to Follow-up|0
6062273|NCT00506350|20945915|P6|Overall Study|Lost to Follow-up|1
6062274|NCT00506350|20945916|P5|Overall Study|Lost to Follow-up|2
6062275|NCT00506350|20945917|P4|Overall Study|Lost to Follow-up|1
6062276|NCT00506350|20945918|P3|Overall Study|Lost to Follow-up|1
6062277|NCT00506350|20945919|P2|Overall Study|Lost to Follow-up|1
6062278|NCT00506350|20945920|P1|Overall Study|Lost to Follow-up|1
6062279|NCT00506350|20945912|P9|Overall Study|Withdrawal by Subject|0
6062280|NCT00506350|20945913|P8|Overall Study|Withdrawal by Subject|2
6062281|NCT00506350|20945914|P7|Overall Study|Withdrawal by Subject|1
6062282|NCT00506350|20945915|P6|Overall Study|Withdrawal by Subject|1
6062283|NCT00506350|20945916|P5|Overall Study|Withdrawal by Subject|4
6062284|NCT00506350|20945917|P4|Overall Study|Withdrawal by Subject|1
6062285|NCT00506350|20945918|P3|Overall Study|Withdrawal by Subject|1
6062286|NCT00506350|20945919|P2|Overall Study|Withdrawal by Subject|1
6062287|NCT00506350|20945920|P1|Overall Study|Withdrawal by Subject|0
6062288|NCT00506350|20945912|P9|Overall Study|Protocol Violation|0
6062289|NCT00506350|20945913|P8|Overall Study|Protocol Violation|0
6062290|NCT00506350|20945914|P7|Overall Study|Protocol Violation|1
6062291|NCT00506350|20945915|P6|Overall Study|Protocol Violation|0
6062292|NCT00506350|20945916|P5|Overall Study|Protocol Violation|0
6062293|NCT00506350|20945917|P4|Overall Study|Protocol Violation|0
6062294|NCT00506350|20945918|P3|Overall Study|Protocol Violation|1
6062295|NCT00506350|20945919|P2|Overall Study|Protocol Violation|0
6062296|NCT00506350|20945920|P1|Overall Study|Protocol Violation|0
6062297|NCT00506350|20945912|P9|Overall Study|Adverse Event|1
6062298|NCT00506350|20945913|P8|Overall Study|Adverse Event|1
6062299|NCT00506350|20945914|P7|Overall Study|Adverse Event|0
6062300|NCT00506350|20945915|P6|Overall Study|Adverse Event|0
6062301|NCT00506350|20945916|P5|Overall Study|Adverse Event|0
6062302|NCT00506350|20945917|P4|Overall Study|Adverse Event|0
6062303|NCT00506350|20945918|P3|Overall Study|Adverse Event|0
6062304|NCT00506350|20945919|P2|Overall Study|Adverse Event|0
6062305|NCT00506350|20945920|P1|Overall Study|Adverse Event|0
6062306|NCT00506350|20945912|P9|Overall Study|Serious Adverse Event|0
6062307|NCT00506350|20945913|P8|Overall Study|Serious Adverse Event|0
6062308|NCT00506350|20945914|P7|Overall Study|Serious Adverse Event|0
6062309|NCT00506350|20945915|P6|Overall Study|Serious Adverse Event|0
6062310|NCT00506350|20945916|P5|Overall Study|Serious Adverse Event|0
6062311|NCT00506350|20945917|P4|Overall Study|Serious Adverse Event|0
6062312|NCT00506350|20945918|P3|Overall Study|Serious Adverse Event|0
6062313|NCT00506350|20945919|P2|Overall Study|Serious Adverse Event|0
6062314|NCT00506350|20945920|P1|Overall Study|Serious Adverse Event|1
6062315|NCT00506285|20946067|P2|6-month Open Label Phase|Withdrawal by Subject|5
6062316|NCT00506285|20946068|P1|6-month Open Label Phase|Withdrawal by Subject|9
6062317|NCT00506285|20946067|P2|6-month Open Label Phase|Lost to Follow-up|7
6062318|NCT00506285|20946068|P1|6-month Open Label Phase|Lost to Follow-up|1
6062319|NCT00506285|20946067|P2|Double Blind Cross-Over Phase|Lost to Follow-up|2
6062320|NCT00506285|20946068|P1|Double Blind Cross-Over Phase|Lost to Follow-up|5
6062321|NCT00506285|20946067|P2|Double Blind Cross-Over Phase|Withdrawal by Subject|3
6062322|NCT00506285|20946068|P1|Double Blind Cross-Over Phase|Withdrawal by Subject|4
6062323|NCT00506285|20946067|P2|3 Week Screening Phase|Withdrawal by Subject|10
6062324|NCT00506285|20946068|P1|3 Week Screening Phase|Withdrawal by Subject|17
6062325|NCT00506142|20946083|P2|Overall Study|New health condition|0
6062326|NCT00506142|20946084|P1|Overall Study|New health condition|1
6062327|NCT00506142|20946083|P2|Overall Study|Physician Decision|0
6062328|NCT00506142|20946084|P1|Overall Study|Physician Decision|1
6062329|NCT00506142|20946083|P2|Overall Study|Withdrawal by Subject|5
6062330|NCT00506142|20946084|P1|Overall Study|Withdrawal by Subject|4
6062331|NCT00506142|20946083|P2|Overall Study|Lack of Efficacy|7
6062332|NCT00506142|20946084|P1|Overall Study|Lack of Efficacy|21
6062333|NCT00506142|20946083|P2|Overall Study|Adverse Event|7
6062334|NCT00506142|20946084|P1|Overall Study|Adverse Event|8
6062335|NCT00506129|20946090|P1|Overall Study|Death|7
6062336|NCT00506129|20946090|P1|Overall Study|Disease Progression/Relapse|15
6062337|NCT00506077|20946097|P2|Treatment Period 2|Withdrawal by Subject|0
6062338|NCT00506077|20946098|P1|Treatment Period 2|Withdrawal by Subject|1
6062339|NCT00506077|20946097|P2|Treatment Period 2|Adverse Event|1
6062340|NCT00506077|20946098|P1|Treatment Period 2|Adverse Event|0
6062341|NCT00506077|20946097|P2|Treatment Period 1|Withdrawal by Subject|0
6062342|NCT00506077|20946098|P1|Treatment Period 1|Withdrawal by Subject|2
6062343|NCT00506077|20946097|P2|Treatment Period 1|Lost to Follow-up|2
6062344|NCT00506077|20946098|P1|Treatment Period 1|Lost to Follow-up|0
6062345|NCT00506077|20946097|P2|Treatment Period 1|Adverse Event|1
6062346|NCT00506077|20946098|P1|Treatment Period 1|Adverse Event|2
6062347|NCT00505934|20946140|P1|Overall Study|Other: IV dose needed to be changed|1
6062348|NCT00505934|20946140|P1|Overall Study|Other: Unable to obtain IV & PK samples|1
6062349|NCT00505934|20946140|P1|Overall Study|Adverse Event|1
6062350|NCT00505921|20946146|P1|Overall Study|Failed to Mobilize|8
6062351|NCT00505921|20946146|P1|Overall Study|Ineligible|1
6062352|NCT00505778|20946163|P2|Overall Study|Took No Study Drug|2
6062353|NCT00505778|20946164|P1|Overall Study|Took No Study Drug|2
6062354|NCT00505778|20946163|P2|Overall Study|Relapse|65
6062355|NCT00505778|20946164|P1|Overall Study|Relapse|65
6062356|NCT00505778|20946163|P2|Overall Study|Withdrawal by Subject|14
6062357|NCT00505778|20946164|P1|Overall Study|Withdrawal by Subject|29
6062358|NCT00505778|20946163|P2|Overall Study|Protocol Violation|9
6062359|NCT00505778|20946164|P1|Overall Study|Protocol Violation|7
6062360|NCT00505778|20946163|P2|Overall Study|Unable to Meet Protocol Criteria|1
6062361|NCT00505778|20946164|P1|Overall Study|Unable to Meet Protocol Criteria|4
6062362|NCT00505778|20946163|P2|Overall Study|Lost to Follow-up|23
6062363|NCT00505778|20946164|P1|Overall Study|Lost to Follow-up|17
6062364|NCT00505778|20946163|P2|Overall Study|Physician Decision|14
6062365|NCT00505778|20946164|P1|Overall Study|Physician Decision|8
6062366|NCT00505778|20946163|P2|Overall Study|Adverse Event|7
6062367|NCT00505778|20946164|P1|Overall Study|Adverse Event|2
6062368|NCT00505765|20946183|P3|Overall Study|Noncompliance|3
6062369|NCT00505765|20946184|P2|Overall Study|Noncompliance|1
6062370|NCT00505765|20946185|P1|Overall Study|Noncompliance|0
6062371|NCT00505765|20946183|P3|Overall Study|Adverse Event|0
6062372|NCT00505765|20946184|P2|Overall Study|Adverse Event|2
6062373|NCT00505765|20946185|P1|Overall Study|Adverse Event|1
6062374|NCT00505765|20946183|P3|Overall Study|Withdrawal by Subject|0
6062375|NCT00505765|20946184|P2|Overall Study|Withdrawal by Subject|0
6062376|NCT00505765|20946185|P1|Overall Study|Withdrawal by Subject|1
6062377|NCT00505752|20946212|P4|Overall Study|Other|2
6062378|NCT00505752|20946213|P3|Overall Study|Other|1
6062379|NCT00505752|20946214|P2|Overall Study|Other|2
6062380|NCT00505752|20946215|P1|Overall Study|Other|1
6062381|NCT00505752|20946212|P4|Overall Study|All embryos/blastocysts discarded|1
6062382|NCT00505752|20946213|P3|Overall Study|All embryos/blastocysts discarded|1
6062383|NCT00505752|20946214|P2|Overall Study|All embryos/blastocysts discarded|0
6062384|NCT00505752|20946215|P1|Overall Study|All embryos/blastocysts discarded|0
6062385|NCT00505752|20946212|P4|Overall Study|No Fertilization|1
6062386|NCT00505752|20946213|P3|Overall Study|No Fertilization|2
6062387|NCT00505752|20946214|P2|Overall Study|No Fertilization|1
6062388|NCT00505752|20946215|P1|Overall Study|No Fertilization|1
6062389|NCT00505752|20946212|P4|Overall Study|No oocytes retrieved|1
6062390|NCT00505752|20946213|P3|Overall Study|No oocytes retrieved|0
6062391|NCT00505752|20946214|P2|Overall Study|No oocytes retrieved|2
6062392|NCT00505752|20946215|P1|Overall Study|No oocytes retrieved|0
6062393|NCT00505752|20946212|P4|Overall Study|Ovarian hyperstimulation syndrome risk|1
6062394|NCT00505752|20946213|P3|Overall Study|Ovarian hyperstimulation syndrome risk|3
6062395|NCT00505752|20946214|P2|Overall Study|Ovarian hyperstimulation syndrome risk|1
6062396|NCT00505752|20946215|P1|Overall Study|Ovarian hyperstimulation syndrome risk|1
6062397|NCT00505752|20946212|P4|Overall Study|Lack of ovarian response|0
6062398|NCT00505752|20946213|P3|Overall Study|Lack of ovarian response|0
6062399|NCT00505752|20946214|P2|Overall Study|Lack of ovarian response|3
6062400|NCT00505752|20946215|P1|Overall Study|Lack of ovarian response|1
6062401|NCT00505752|20946212|P4|Overall Study|Lost to Follow-up|0
6062402|NCT00505752|20946213|P3|Overall Study|Lost to Follow-up|0
6062403|NCT00505752|20946214|P2|Overall Study|Lost to Follow-up|0
6062404|NCT00505752|20946215|P1|Overall Study|Lost to Follow-up|1
6062405|NCT00505752|20946212|P4|Overall Study|Adverse Event|0
6062406|NCT00505752|20946213|P3|Overall Study|Adverse Event|1
6062407|NCT00505752|20946214|P2|Overall Study|Adverse Event|0
6062408|NCT00505752|20946215|P1|Overall Study|Adverse Event|1
6062409|NCT00505687|20946229|P1|Overall Study|Other: As Per Sponsor|8
6062410|NCT00505687|20946229|P1|Overall Study|Other: Disease Progression|1
6062411|NCT00505687|20946229|P1|Overall Study|Other: Neupro Given In Hospital|1
6062412|NCT00505687|20946229|P1|Overall Study|Other: Patches Would Not Stick D/T Sweat|1
6062413|NCT00505687|20946229|P1|Overall Study|Other: Prolonged Hospitalization|1
6062414|NCT00505687|20946229|P1|Overall Study|Other: Scheduled DBS Surgery|1
6062415|NCT00505687|20946229|P1|Overall Study|Other: Underwent Implantation Of DBS|1
6062416|NCT00505687|20946229|P1|Overall Study|Lost to Follow-up|1
6062417|NCT00505687|20946229|P1|Overall Study|Subject withdrew consent|15
6062418|NCT00505687|20946229|P1|Overall Study|Adverse Event|48
6062419|NCT00505687|20946229|P1|Overall Study|Lack of Efficacy|15
6062420|NCT00505687|20946229|P1|Overall Study|Important protocol violation|2
6062421|NCT00505661|20946235|P1|Overall Study|Not Eligible|4
6062422|NCT00505622|20946246|P3|Overall Study|Study termination by sponsor|90
6062423|NCT00505622|20946247|P2|Overall Study|Study termination by sponsor|98
6062424|NCT00505622|20946248|P1|Overall Study|Study termination by sponsor|115
6062425|NCT00505622|20946246|P3|Overall Study|Withdrawal by Subject|2
6062426|NCT00505622|20946247|P2|Overall Study|Withdrawal by Subject|3
6062427|NCT00505622|20946248|P1|Overall Study|Withdrawal by Subject|0
6062428|NCT00505622|20946246|P3|Overall Study|Protocol Violation|0
6062429|NCT00505622|20946247|P2|Overall Study|Protocol Violation|1
6062430|NCT00505622|20946248|P1|Overall Study|Protocol Violation|1
6062431|NCT00505622|20946246|P3|Overall Study|Adverse Event|4
6062432|NCT00505622|20946247|P2|Overall Study|Adverse Event|6
6062433|NCT00505622|20946248|P1|Overall Study|Adverse Event|5
6062434|NCT00505414|20946273|P5|Maintenance Phase|underlying disease and therapy required|0
6062435|NCT00505414|20946274|P4|Maintenance Phase|underlying disease and therapy required|0
6062436|NCT00505414|20946275|P3|Maintenance Phase|underlying disease and therapy required|2
6062437|NCT00505414|20946276|P2|Maintenance Phase|underlying disease and therapy required|2
6062438|NCT00505414|20946277|P1|Maintenance Phase|underlying disease and therapy required|0
6062439|NCT00505414|20946273|P5|Maintenance Phase|Withdrawal by Subject|0
6062440|NCT00505414|20946274|P4|Maintenance Phase|Withdrawal by Subject|0
6062441|NCT00505414|20946275|P3|Maintenance Phase|Withdrawal by Subject|1
6062442|NCT00505414|20946276|P2|Maintenance Phase|Withdrawal by Subject|0
6062443|NCT00505414|20946277|P1|Maintenance Phase|Withdrawal by Subject|0
6062444|NCT00505414|20946273|P5|Maintenance Phase|Lack of Efficacy|0
6062445|NCT00505414|20946274|P4|Maintenance Phase|Lack of Efficacy|0
6062446|NCT00505414|20946275|P3|Maintenance Phase|Lack of Efficacy|1
6062447|NCT00505414|20946276|P2|Maintenance Phase|Lack of Efficacy|1
6062448|NCT00505414|20946277|P1|Maintenance Phase|Lack of Efficacy|2
6062449|NCT00505414|20946273|P5|Maintenance Phase|Death|0
6062450|NCT00505414|20946274|P4|Maintenance Phase|Death|0
6062451|NCT00505414|20946275|P3|Maintenance Phase|Death|1
6062452|NCT00505414|20946276|P2|Maintenance Phase|Death|0
6062453|NCT00505414|20946277|P1|Maintenance Phase|Death|2
6062454|NCT00505414|20946273|P5|Maintenance Phase|Adverse Event|0
6062455|NCT00505414|20946274|P4|Maintenance Phase|Adverse Event|0
6062456|NCT00505414|20946275|P3|Maintenance Phase|Adverse Event|3
6062457|NCT00505414|20946276|P2|Maintenance Phase|Adverse Event|2
6062458|NCT00505414|20946277|P1|Maintenance Phase|Adverse Event|2
6062459|NCT00505414|20946273|P5|Titration Phase|Underlying disease and therapy required|3
6062460|NCT00505414|20946274|P4|Titration Phase|Underlying disease and therapy required|7
6062461|NCT00505414|20946275|P3|Titration Phase|Underlying disease and therapy required|0
6062462|NCT00505414|20946276|P2|Titration Phase|Underlying disease and therapy required|0
6062463|NCT00505414|20946277|P1|Titration Phase|Underlying disease and therapy required|0
6062464|NCT00505414|20946273|P5|Titration Phase|Withdrawal by Subject|4
6062465|NCT00505414|20946274|P4|Titration Phase|Withdrawal by Subject|3
6062466|NCT00505414|20946275|P3|Titration Phase|Withdrawal by Subject|0
6062467|NCT00505414|20946276|P2|Titration Phase|Withdrawal by Subject|0
6062468|NCT00505414|20946277|P1|Titration Phase|Withdrawal by Subject|0
6062469|NCT00505414|20946273|P5|Titration Phase|Protocol Violation|1
6062470|NCT00505414|20946274|P4|Titration Phase|Protocol Violation|0
6062471|NCT00505414|20946275|P3|Titration Phase|Protocol Violation|0
6062472|NCT00505414|20946276|P2|Titration Phase|Protocol Violation|0
6062473|NCT00505414|20946277|P1|Titration Phase|Protocol Violation|0
6062474|NCT00505414|20946273|P5|Titration Phase|Lack of Efficacy|1
6062475|NCT00505414|20946274|P4|Titration Phase|Lack of Efficacy|10
6062476|NCT00505414|20946275|P3|Titration Phase|Lack of Efficacy|0
6062477|NCT00505414|20946276|P2|Titration Phase|Lack of Efficacy|0
6062478|NCT00505414|20946277|P1|Titration Phase|Lack of Efficacy|0
6062479|NCT00505414|20946273|P5|Titration Phase|Death|0
6062480|NCT00505414|20946274|P4|Titration Phase|Death|2
6062481|NCT00505414|20946275|P3|Titration Phase|Death|0
6062482|NCT00505414|20946276|P2|Titration Phase|Death|0
6062483|NCT00505414|20946277|P1|Titration Phase|Death|0
6062484|NCT00505414|20946273|P5|Titration Phase|Adverse Event|3
6062485|NCT00505414|20946274|P4|Titration Phase|Adverse Event|8
6062486|NCT00505414|20946275|P3|Titration Phase|Adverse Event|0
6062487|NCT00505414|20946276|P2|Titration Phase|Adverse Event|0
6062488|NCT00505414|20946277|P1|Titration Phase|Adverse Event|0
6062489|NCT00505375|20946294|P2|Overall Study|Travel issues|1
6062490|NCT00505375|20946295|P1|Overall Study|Travel issues|0
6062491|NCT00505375|20946294|P2|Overall Study|Pregnancy|0
6062492|NCT00505375|20946295|P1|Overall Study|Pregnancy|1
6062493|NCT00505375|20946294|P2|Overall Study|Lost to Follow-up|2
6062494|NCT00505375|20946295|P1|Overall Study|Lost to Follow-up|0
6062495|NCT00505375|20946294|P2|Overall Study|Withdrawal by Subject|2
6062496|NCT00505375|20946295|P1|Overall Study|Withdrawal by Subject|2
6062497|NCT00505375|20946294|P2|Overall Study|Death|0
6062498|NCT00505375|20946295|P1|Overall Study|Death|1
6062499|NCT00505284|20946317|P5|Overall Study|Other|4
6062500|NCT00505284|20946318|P4|Overall Study|Other|4
6062501|NCT00505284|20946319|P3|Overall Study|Other|0
6062502|NCT00505284|20946320|P2|Overall Study|Other|0
6062503|NCT00505284|20946321|P1|Overall Study|Other|5
6062504|NCT00505284|20946317|P5|Overall Study|Physician Decision|0
6062505|NCT00505284|20946318|P4|Overall Study|Physician Decision|0
6062506|NCT00505284|20946319|P3|Overall Study|Physician Decision|0
6062507|NCT00505284|20946320|P2|Overall Study|Physician Decision|1
6062508|NCT00505284|20946321|P1|Overall Study|Physician Decision|0
6062509|NCT00505284|20946317|P5|Overall Study|Lack of Efficacy|1
6062510|NCT00505284|20946318|P4|Overall Study|Lack of Efficacy|1
6062511|NCT00505284|20946319|P3|Overall Study|Lack of Efficacy|1
6062512|NCT00505284|20946320|P2|Overall Study|Lack of Efficacy|1
6062513|NCT00505284|20946321|P1|Overall Study|Lack of Efficacy|0
6062514|NCT00505284|20946317|P5|Overall Study|Withdrawal by Subject|6
6062515|NCT00505284|20946318|P4|Overall Study|Withdrawal by Subject|0
6062516|NCT00505284|20946319|P3|Overall Study|Withdrawal by Subject|1
6062517|NCT00505284|20946320|P2|Overall Study|Withdrawal by Subject|6
6062518|NCT00505284|20946321|P1|Overall Study|Withdrawal by Subject|2
6062519|NCT00505284|20946317|P5|Overall Study|Protocol Violation|0
6062520|NCT00505284|20946318|P4|Overall Study|Protocol Violation|0
6062521|NCT00505284|20946319|P3|Overall Study|Protocol Violation|1
6062522|NCT00505284|20946320|P2|Overall Study|Protocol Violation|1
6062523|NCT00505284|20946321|P1|Overall Study|Protocol Violation|0
6062524|NCT00505284|20946317|P5|Overall Study|Adverse Event|22
6062525|NCT00505284|20946318|P4|Overall Study|Adverse Event|14
6062526|NCT00505284|20946319|P3|Overall Study|Adverse Event|9
6062527|NCT00505284|20946320|P2|Overall Study|Adverse Event|7
6062528|NCT00505284|20946321|P1|Overall Study|Adverse Event|3
6062529|NCT00505076|20946391|P3|Overall Study|Withdrawal by Subject|2
6062530|NCT00505076|20946392|P2|Overall Study|Withdrawal by Subject|1
6062531|NCT00505076|20946393|P1|Overall Study|Withdrawal by Subject|0
6062532|NCT00505076|20946391|P3|Overall Study|Protocol Violation|2
6062533|NCT00505076|20946392|P2|Overall Study|Protocol Violation|1
6062534|NCT00505076|20946393|P1|Overall Study|Protocol Violation|2
6062535|NCT00505076|20946391|P3|Overall Study|Adverse Event|1
6062536|NCT00505076|20946392|P2|Overall Study|Adverse Event|0
6062537|NCT00505076|20946393|P1|Overall Study|Adverse Event|1
6062538|NCT00504881|20946422|P2|Overall Study|AE of unknown type|0
6062539|NCT00504881|20946423|P1|Overall Study|AE of unknown type|1
6062540|NCT00504881|20946422|P2|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|2
6062541|NCT00504881|20946423|P1|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
6062542|NCT00504881|20946422|P2|Overall Study|AE, non-serious non-fatal|14
6062543|NCT00504881|20946423|P1|Overall Study|AE, non-serious non-fatal|4
6062544|NCT00504881|20946422|P2|Overall Study|SAE, non-fatal|6
6062545|NCT00504881|20946423|P1|Overall Study|SAE, non-fatal|2
6062546|NCT00504881|20946422|P2|Overall Study|AE, serious fatal|1
6062547|NCT00504881|20946423|P1|Overall Study|AE, serious fatal|0
6062548|NCT00504881|20946422|P2|Overall Study|Safety Visit not performed|1
6062549|NCT00504881|20946423|P1|Overall Study|Safety Visit not performed|0
6062550|NCT00504881|20946422|P2|Overall Study|No Birth Control|1
6062551|NCT00504881|20946423|P1|Overall Study|No Birth Control|0
6062552|NCT00504881|20946422|P2|Overall Study|Non-Compliance|0
6062553|NCT00504881|20946423|P1|Overall Study|Non-Compliance|1
6062554|NCT00504881|20946422|P2|Overall Study|Withdrawal by Subject|4
6062555|NCT00504881|20946423|P1|Overall Study|Withdrawal by Subject|1
6062556|NCT00504881|20946422|P2|Overall Study|Lost to Follow-up|2
6062557|NCT00504881|20946423|P1|Overall Study|Lost to Follow-up|0
6062558|NCT00504881|20946422|P2|Overall Study|Lack of Efficacy|5
6062559|NCT00504881|20946423|P1|Overall Study|Lack of Efficacy|1
6062560|NCT00504829|20946476|P3|Overall Study|Protocol Violation|10
6062561|NCT00504829|20946477|P2|Overall Study|Protocol Violation|4
6062562|NCT00504829|20946478|P1|Overall Study|Protocol Violation|6
6062563|NCT00504777|20946487|P1|Overall Study|Adverse Event|1
6062564|NCT00504725|20946500|P2|Overall Study|Protocol Violation|0
6062565|NCT00504725|20946501|P1|Overall Study|Protocol Violation|1
6062566|NCT00504595|20946524|P4|Overall Study|Other|0
6062567|NCT00504595|20946525|P3|Overall Study|Other|2
6062568|NCT00504595|20946526|P2|Overall Study|Other|0
6062569|NCT00504595|20946527|P1|Overall Study|Other|0
6062570|NCT00504595|20946524|P4|Overall Study|Lack of Efficacy|0
6062571|NCT00504595|20946525|P3|Overall Study|Lack of Efficacy|0
6062572|NCT00504595|20946526|P2|Overall Study|Lack of Efficacy|0
6062573|NCT00504595|20946527|P1|Overall Study|Lack of Efficacy|1
6062574|NCT00504556|20946544|P5|Overall Study|not in safety analysis set|1
6062575|NCT00504556|20946545|P4|Overall Study|not in safety analysis set|0
6062576|NCT00504556|20946546|P3|Overall Study|not in safety analysis set|1
6062577|NCT00504556|20946547|P2|Overall Study|not in safety analysis set|1
6062578|NCT00504556|20946548|P1|Overall Study|not in safety analysis set|0
6062579|NCT00504556|20946544|P5|Overall Study|Other|0
6062580|NCT00504556|20946545|P4|Overall Study|Other|3
6062581|NCT00504556|20946546|P3|Overall Study|Other|2
6062582|NCT00504556|20946547|P2|Overall Study|Other|2
6062583|NCT00504556|20946548|P1|Overall Study|Other|2
6062584|NCT00504556|20946544|P5|Overall Study|data monitor committee decision|0
6062585|NCT00504556|20946545|P4|Overall Study|data monitor committee decision|100
6062586|NCT00504556|20946546|P3|Overall Study|data monitor committee decision|0
6062587|NCT00504556|20946547|P2|Overall Study|data monitor committee decision|0
6062588|NCT00504556|20946548|P1|Overall Study|data monitor committee decision|0
6062589|NCT00504556|20946544|P5|Overall Study|did not meet entry criteria|0
6062590|NCT00504556|20946545|P4|Overall Study|did not meet entry criteria|1
6062591|NCT00504556|20946546|P3|Overall Study|did not meet entry criteria|1
6062592|NCT00504556|20946547|P2|Overall Study|did not meet entry criteria|0
6062593|NCT00504556|20946548|P1|Overall Study|did not meet entry criteria|2
6062594|NCT00504556|20946544|P5|Overall Study|administrative reasons|2
6062595|NCT00504556|20946545|P4|Overall Study|administrative reasons|1
6062596|NCT00504556|20946546|P3|Overall Study|administrative reasons|2
6062597|NCT00504556|20946547|P2|Overall Study|administrative reasons|2
6062598|NCT00504556|20946548|P1|Overall Study|administrative reasons|0
6062599|NCT00504556|20946544|P5|Overall Study|Withdrawal by Subject|12
6062600|NCT00504556|20946545|P4|Overall Study|Withdrawal by Subject|8
6062601|NCT00504556|20946546|P3|Overall Study|Withdrawal by Subject|7
6062602|NCT00504556|20946547|P2|Overall Study|Withdrawal by Subject|16
6062603|NCT00504556|20946548|P1|Overall Study|Withdrawal by Subject|16
6062604|NCT00504556|20946544|P5|Overall Study|Lost to Follow-up|1
6062605|NCT00504556|20946545|P4|Overall Study|Lost to Follow-up|1
6062606|NCT00504556|20946546|P3|Overall Study|Lost to Follow-up|1
6062607|NCT00504556|20946547|P2|Overall Study|Lost to Follow-up|0
6062608|NCT00504556|20946548|P1|Overall Study|Lost to Follow-up|0
6062609|NCT00504556|20946544|P5|Overall Study|Protocol Violation|2
6062610|NCT00504556|20946545|P4|Overall Study|Protocol Violation|1
6062611|NCT00504556|20946546|P3|Overall Study|Protocol Violation|2
6062612|NCT00504556|20946547|P2|Overall Study|Protocol Violation|3
6062613|NCT00504556|20946548|P1|Overall Study|Protocol Violation|1
6062614|NCT00504556|20946544|P5|Overall Study|Death|2
6062615|NCT00504556|20946545|P4|Overall Study|Death|0
6062616|NCT00504556|20946546|P3|Overall Study|Death|1
6062617|NCT00504556|20946547|P2|Overall Study|Death|3
6062618|NCT00504556|20946548|P1|Overall Study|Death|3
6062619|NCT00504556|20946544|P5|Overall Study|Adverse Event|5
6062620|NCT00504556|20946545|P4|Overall Study|Adverse Event|13
6062621|NCT00504556|20946546|P3|Overall Study|Adverse Event|14
6062622|NCT00504556|20946547|P2|Overall Study|Adverse Event|11
6062623|NCT00504556|20946548|P1|Overall Study|Adverse Event|11
6062624|NCT00504426|20946616|P4|Overall Study|Withdrawal by Subject|0
6062625|NCT00504426|20946617|P3|Overall Study|Withdrawal by Subject|0
6062626|NCT00504426|20946618|P2|Overall Study|Withdrawal by Subject|0
6062627|NCT00504426|20946619|P1|Overall Study|Withdrawal by Subject|2
6062628|NCT00504426|20946616|P4|Overall Study|Protocol Violation|0
6062629|NCT00504426|20946617|P3|Overall Study|Protocol Violation|2
6062630|NCT00504426|20946618|P2|Overall Study|Protocol Violation|1
6062631|NCT00504426|20946619|P1|Overall Study|Protocol Violation|1
6062632|NCT00504426|20946616|P4|Overall Study|Adverse Event|0
6062633|NCT00504426|20946617|P3|Overall Study|Adverse Event|2
6062634|NCT00504426|20946618|P2|Overall Study|Adverse Event|0
6062635|NCT00504426|20946619|P1|Overall Study|Adverse Event|0
6062636|NCT00504348|20946633|P1|Overall Study|Physician Decision|1
6062637|NCT00504348|20946633|P1|Overall Study|Lack of Efficacy|4
6062638|NCT00504348|20946633|P1|Overall Study|Adverse Event|3
6062639|NCT00504309|20946644|P6|Overall Study|Withdrawal by Subject|0
6062640|NCT00504309|20946645|P5|Overall Study|Withdrawal by Subject|0
6062641|NCT00504309|20946646|P4|Overall Study|Withdrawal by Subject|0
6062642|NCT00504309|20946647|P3|Overall Study|Withdrawal by Subject|1
6062643|NCT00504309|20946648|P2|Overall Study|Withdrawal by Subject|0
6062644|NCT00504309|20946649|P1|Overall Study|Withdrawal by Subject|0
6062645|NCT00504309|20946644|P6|Overall Study|Death|0
6062646|NCT00504309|20946645|P5|Overall Study|Death|1
6062647|NCT00504309|20946646|P4|Overall Study|Death|0
6062648|NCT00504309|20946647|P3|Overall Study|Death|0
6062649|NCT00504309|20946648|P2|Overall Study|Death|0
6062650|NCT00504309|20946649|P1|Overall Study|Death|0
6062651|NCT00504257|20946687|P1|Overall Study|ineligible histology|2
6062652|NCT00504257|20946687|P1|Overall Study|Withdrawal by Subject|2
6062653|NCT00504231|20946699|P4|Overall Study|Discrepant chart documentation re route|0
6062654|NCT00504231|20946700|P3|Overall Study|Discrepant chart documentation re route|1
6062655|NCT00504231|20946701|P2|Overall Study|Discrepant chart documentation re route|0
6062656|NCT00504231|20946702|P1|Overall Study|Discrepant chart documentation re route|0
6062657|NCT00504166|20946722|P2|Overall Study|Lost to Follow-up|3
6062658|NCT00504166|20946723|P1|Overall Study|Lost to Follow-up|1
6062659|NCT00504166|20946722|P2|Overall Study|Physician Decision|1
6062660|NCT00504166|20946723|P1|Overall Study|Physician Decision|1
6062661|NCT00504166|20946722|P2|Overall Study|Withdrawal by Subject|6
6062662|NCT00504166|20946723|P1|Overall Study|Withdrawal by Subject|3
6062663|NCT00504166|20946722|P2|Overall Study|Adverse Event|4
6062664|NCT00504166|20946723|P1|Overall Study|Adverse Event|1
6062665|NCT00504153|20946729|P1|Overall Study|Death|1
6062666|NCT00504153|20946729|P1|Overall Study|Adverse Event|4
6062667|NCT00504153|20946729|P1|Overall Study|Withdrawal by Subject|1
6062668|NCT00504075|20946737|P1|Overall Study|Required other therapeutic intervention|1
6062669|NCT00504075|20946737|P1|Overall Study|Withdrawal by Subject|1
6062670|NCT00504075|20946737|P1|Overall Study|Lost to Follow-up|5
6062671|NCT00504075|20946737|P1|Overall Study|Adverse Event|1
6062672|NCT00503997|20946747|P1|Overall Study|Withdrawal by Subject|1
6062673|NCT00503997|20946747|P1|Overall Study|Death|1
6062674|NCT00503997|20946747|P1|Overall Study|Adverse Event|5
6062675|NCT00503997|20946747|P1|Overall Study|disease progression|1
6062676|NCT00503984|20946753|P6|Overall Study|Death|0
6062677|NCT00503984|20946754|P5|Overall Study|Death|1
6062678|NCT00503984|20946755|P4|Overall Study|Death|0
6062679|NCT00503984|20946756|P3|Overall Study|Death|0
6062680|NCT00503984|20946757|P2|Overall Study|Death|0
6062681|NCT00503984|20946758|P1|Overall Study|Death|0
6062682|NCT00503984|20946753|P6|Overall Study|Adverse Event|0
6062683|NCT00503984|20946754|P5|Overall Study|Adverse Event|0
6062684|NCT00503984|20946755|P4|Overall Study|Adverse Event|0
6062685|NCT00503984|20946756|P3|Overall Study|Adverse Event|0
6062686|NCT00503984|20946757|P2|Overall Study|Adverse Event|1
6062687|NCT00503984|20946758|P1|Overall Study|Adverse Event|0
6062688|NCT00503984|20946753|P6|Overall Study|Protocol Violation|0
6062689|NCT00503984|20946754|P5|Overall Study|Protocol Violation|0
6062690|NCT00503984|20946755|P4|Overall Study|Protocol Violation|0
6062691|NCT00503984|20946756|P3|Overall Study|Protocol Violation|0
6062692|NCT00503984|20946757|P2|Overall Study|Protocol Violation|1
6062693|NCT00503984|20946758|P1|Overall Study|Protocol Violation|0
6062694|NCT00503906|20946784|P1|Overall Study|Withdrawal by Subject|1
6062695|NCT00503867|20946806|P1|Overall Study|Adverse Event|1
6062696|NCT00503867|20946806|P1|Overall Study|Lost to Follow-up|1
6062697|NCT00503841|20946814|P1|Overall Study|All screen failures|44
6062698|NCT00503776|20946825|P4|Overall Study|Physician Decision|1
6062699|NCT00503776|20946826|P3|Overall Study|Physician Decision|1
6062700|NCT00503776|20946827|P2|Overall Study|Physician Decision|0
6062701|NCT00503776|20946828|P1|Overall Study|Physician Decision|0
6062702|NCT00503776|20946825|P4|Overall Study|Withdrawal by Subject|1
6062703|NCT00503776|20946826|P3|Overall Study|Withdrawal by Subject|1
6062704|NCT00503776|20946827|P2|Overall Study|Withdrawal by Subject|0
6062705|NCT00503776|20946828|P1|Overall Study|Withdrawal by Subject|1
6062706|NCT00503698|20946861|P2|Overall Study|Not exposed to trial drug|6
6062707|NCT00503698|20946862|P1|Overall Study|Not exposed to trial drug|11
6062708|NCT00503698|20946861|P2|Overall Study|Unclassified|32
6062709|NCT00503698|20946862|P1|Overall Study|Unclassified|48
6062710|NCT00503698|20946861|P2|Overall Study|Critically ill|0
6062711|NCT00503698|20946862|P1|Overall Study|Critically ill|2
6062712|NCT00503698|20946861|P2|Overall Study|Move to nonparticipating dialysis center|1
6062713|NCT00503698|20946862|P1|Overall Study|Move to nonparticipating dialysis center|2
6062714|NCT00503698|20946861|P2|Overall Study|Switch to peritoneal or home dialysis|2
6062715|NCT00503698|20946862|P1|Overall Study|Switch to peritoneal or home dialysis|2
6062716|NCT00503698|20946861|P2|Overall Study|Any condition in exclusion criteria|6
6062717|NCT00503698|20946862|P1|Overall Study|Any condition in exclusion criteria|4
6062718|NCT00503698|20946861|P2|Overall Study|Pregnancy/intention to become pregnant|0
6062719|NCT00503698|20946862|P1|Overall Study|Pregnancy/intention to become pregnant|1
6062720|NCT00503698|20946861|P2|Overall Study|End hemodialysis due to renal transplant|4
6062721|NCT00503698|20946862|P1|Overall Study|End hemodialysis due to renal transplant|10
6062722|NCT00503698|20946861|P2|Overall Study|Trial terminated|253
6062723|NCT00503698|20946862|P1|Overall Study|Trial terminated|216
6062724|NCT00503698|20946861|P2|Overall Study|Lack of Efficacy|4
6062725|NCT00503698|20946862|P1|Overall Study|Lack of Efficacy|3
6062726|NCT00503698|20946861|P2|Overall Study|Death|0
6062727|NCT00503698|20946862|P1|Overall Study|Death|1
6062728|NCT00503698|20946861|P2|Overall Study|Adverse Event|41
6062729|NCT00503698|20946862|P1|Overall Study|Adverse Event|52
6062730|NCT00503698|20946861|P2|Overall Study|Protocol Violation|6
6062731|NCT00503698|20946862|P1|Overall Study|Protocol Violation|5
6062732|NCT00503685|20946879|P3|Overall Study|Eligibility Criteria Not Met|0
6062733|NCT00503685|20946880|P2|Overall Study|Eligibility Criteria Not Met|1
6062734|NCT00503685|20946881|P1|Overall Study|Eligibility Criteria Not Met|0
6062735|NCT00503685|20946879|P3|Overall Study|Protocol Violation|0
6062736|NCT00503685|20946880|P2|Overall Study|Protocol Violation|1
6062737|NCT00503685|20946881|P1|Overall Study|Protocol Violation|0
6062738|NCT00503685|20946879|P3|Overall Study|Withdrawal by Subject|0
6062739|NCT00503685|20946880|P2|Overall Study|Withdrawal by Subject|1
6062740|NCT00503685|20946881|P1|Overall Study|Withdrawal by Subject|0
6062741|NCT00503685|20946879|P3|Overall Study|Adverse Event|2
6062742|NCT00503685|20946880|P2|Overall Study|Adverse Event|0
6062743|NCT00503685|20946881|P1|Overall Study|Adverse Event|0
6062744|NCT00503581|20946926|P3|Overall Study|Study closed|2
6062745|NCT00503581|20946927|P2|Overall Study|Study closed|4
6062746|NCT00503581|20946928|P1|Overall Study|Study closed|3
6062747|NCT00503425|20946939|P1|Overall Study|Missing Data/Unknown|4
6062748|NCT00503425|20946939|P1|Overall Study|Death|3
6062749|NCT00503425|20946939|P1|Overall Study|Lost to Follow-up|3
6062750|NCT00503425|20946939|P1|Overall Study|Withdrawal by Subject|8
6062751|NCT00503425|20946939|P1|Overall Study|Lack of Efficacy|25
6062752|NCT00503425|20946939|P1|Overall Study|Adverse Event|5
6062753|NCT00503425|20946939|P1|Overall Study|Participant files lost|6
6062754|NCT00503399|20946949|P2|Overall Study|Lost to Follow-up|2
6062755|NCT00503399|20946950|P1|Overall Study|Lost to Follow-up|0
6062756|NCT00503399|20946949|P2|Overall Study|Adverse Event|3
6062757|NCT00503399|20946950|P1|Overall Study|Adverse Event|0
6062758|NCT00503399|20946949|P2|Overall Study|Withdrawal by Subject|2
6062759|NCT00503399|20946950|P1|Overall Study|Withdrawal by Subject|4
6062760|NCT00503399|20946949|P2|Overall Study|Protocol Violation|0
6062761|NCT00503399|20946950|P1|Overall Study|Protocol Violation|1
6062762|NCT00503399|20946949|P2|Overall Study|Death|1
6062763|NCT00503399|20946950|P1|Overall Study|Death|2
6062764|NCT00503308|20946974|P2|Overall Study|Protocol Violation|1
6062765|NCT00503308|20946975|P1|Overall Study|Protocol Violation|2
6062766|NCT00503139|20946981|P1|Overall Study|Protocol Violation|4
6062767|NCT00503139|20946981|P1|Overall Study|Case Report Forms were not collected|4
6062768|NCT00503009|20947029|P3|Overall Study|Physician Decision|1
6062769|NCT00503009|20947030|P2|Overall Study|Physician Decision|1
6062770|NCT00503009|20947031|P1|Overall Study|Physician Decision|0
6062771|NCT00503009|20947029|P3|Overall Study|Withdrawal by Subject|1
6062772|NCT00503009|20947030|P2|Overall Study|Withdrawal by Subject|1
6062773|NCT00503009|20947031|P1|Overall Study|Withdrawal by Subject|0
6062774|NCT00503009|20947029|P3|Overall Study|Protocol Violation|1
6062775|NCT00503009|20947030|P2|Overall Study|Protocol Violation|0
6062776|NCT00503009|20947031|P1|Overall Study|Protocol Violation|1
6062777|NCT00502996|20947048|P1|Overall Study|Adverse Event|2
6062778|NCT00502996|20947048|P1|Overall Study|Withdrawal Informed Consent|6
6062779|NCT00502996|20947048|P1|Overall Study|Treatment failure|25
6062780|NCT00502996|20947048|P1|Overall Study|Protocol Violation|2
6062781|NCT00502996|20947048|P1|Overall Study|Lost to Follow-up|9
6062782|NCT00502840|20947116|P1|Overall Study|Other|20
6062783|NCT00502840|20947116|P1|Overall Study|Administrative problems|1
6062784|NCT00502840|20947116|P1|Overall Study|Lost to Follow-up|6
6062785|NCT00502840|20947116|P1|Overall Study|Withdrawal by Subject|5
6062786|NCT00502840|20947116|P1|Overall Study|Protocol Violation|4
6062787|NCT00502840|20947116|P1|Overall Study|Lack of Efficacy|11
6062788|NCT00502840|20947116|P1|Overall Study|Additional or changed therapy|48
6062789|NCT00502840|20947116|P1|Overall Study|Adverse Event|5
6062790|NCT00502801|20947144|P1|End of Therapy to Test of Cure|OTHER|2
6062791|NCT00502801|20947144|P1|End of Therapy to Test of Cure|Death|3
6062792|NCT00502801|20947144|P1|End of Therapy to Test of Cure|Lost to Follow-up|2
6062793|NCT00502801|20947144|P1|End of Therapy to Test of Cure|Withdrawal by Subject|1
6062794|NCT00502801|20947144|P1|Treatment Period|OTHER|30
6062795|NCT00502801|20947144|P1|Treatment Period|Death|14
6062796|NCT00502801|20947144|P1|Treatment Period|Adverse Event|7
6062797|NCT00502801|20947144|P1|Treatment Period|Withdrawal by Subject|3
6062798|NCT00502775|20947152|P3|Overall Study|Subject took disallowed drug|1
6062799|NCT00502775|20947153|P2|Overall Study|Subject took disallowed drug|0
6062800|NCT00502775|20947154|P1|Overall Study|Subject took disallowed drug|0
6062801|NCT00502775|20947152|P3|Overall Study|Subject in jail|0
6062802|NCT00502775|20947153|P2|Overall Study|Subject in jail|1
6062803|NCT00502775|20947154|P1|Overall Study|Subject in jail|0
6062804|NCT00502775|20947152|P3|Overall Study|Declining pollen counts|1
6062805|NCT00502775|20947153|P2|Overall Study|Declining pollen counts|1
6062806|NCT00502775|20947154|P1|Overall Study|Declining pollen counts|0
6062807|NCT00502775|20947152|P3|Overall Study|Outside pollen area more than 48 hours|0
6062808|NCT00502775|20947153|P2|Overall Study|Outside pollen area more than 48 hours|1
6062809|NCT00502775|20947154|P1|Overall Study|Outside pollen area more than 48 hours|0
6062810|NCT00502775|20947152|P3|Overall Study|Non-compliance|2
6062811|NCT00502775|20947153|P2|Overall Study|Non-compliance|2
6062812|NCT00502775|20947154|P1|Overall Study|Non-compliance|0
6062813|NCT00502775|20947152|P3|Overall Study|Randomized in error|1
6062814|NCT00502775|20947153|P2|Overall Study|Randomized in error|1
6062815|NCT00502775|20947154|P1|Overall Study|Randomized in error|0
6062816|NCT00502775|20947152|P3|Overall Study|Logpad compliance <80%|0
6062817|NCT00502775|20947153|P2|Overall Study|Logpad compliance <80%|0
6062818|NCT00502775|20947154|P1|Overall Study|Logpad compliance <80%|1
6062819|NCT00502775|20947152|P3|Overall Study|Subject unable to swallow capsule|1
6062820|NCT00502775|20947153|P2|Overall Study|Subject unable to swallow capsule|0
6062821|NCT00502775|20947154|P1|Overall Study|Subject unable to swallow capsule|1
6062822|NCT00502775|20947152|P3|Overall Study|Non-compliance with eDiary|1
6062823|NCT00502775|20947153|P2|Overall Study|Non-compliance with eDiary|1
6062824|NCT00502775|20947154|P1|Overall Study|Non-compliance with eDiary|4
6062825|NCT00502775|20947152|P3|Overall Study|Sponsor Terminated Study|1
6062826|NCT00502775|20947153|P2|Overall Study|Sponsor Terminated Study|0
6062827|NCT00502775|20947154|P1|Overall Study|Sponsor Terminated Study|1
6062828|NCT00502775|20947152|P3|Overall Study|Withdrawal by Subject|2
6062829|NCT00502775|20947153|P2|Overall Study|Withdrawal by Subject|1
6062830|NCT00502775|20947154|P1|Overall Study|Withdrawal by Subject|1
6062831|NCT00502775|20947152|P3|Overall Study|Protocol Violation|2
6062832|NCT00502775|20947153|P2|Overall Study|Protocol Violation|5
6062833|NCT00502775|20947154|P1|Overall Study|Protocol Violation|1
6062834|NCT00502775|20947152|P3|Overall Study|Adverse Event|1
6062835|NCT00502775|20947153|P2|Overall Study|Adverse Event|2
6062836|NCT00502775|20947154|P1|Overall Study|Adverse Event|1
6062837|NCT00502697|20947197|P2|Overall Study|did not meet assignment criteria|2
6062838|NCT00502697|20947198|P1|Overall Study|did not meet assignment criteria|4
6062839|NCT00502697|20947197|P2|Overall Study|found not to meet eligibility criteria|4
6062840|NCT00502697|20947198|P1|Overall Study|found not to meet eligibility criteria|3
6062841|NCT00502697|20947197|P2|Overall Study|disenrolled due to pregnancy loss|5
6062842|NCT00502697|20947198|P1|Overall Study|disenrolled due to pregnancy loss|3
6062843|NCT00502697|20947197|P2|Overall Study|Withdrawal by Subject|1
6062844|NCT00502697|20947198|P1|Overall Study|Withdrawal by Subject|3
6062845|NCT00502671|20947206|P1|Overall Study|Adverse Event|19
6062846|NCT00502671|20947206|P1|Overall Study|Protocol Violation|16
6062847|NCT00502671|20947206|P1|Overall Study|Lost to Follow-up|7
6062848|NCT00502671|20947206|P1|Overall Study|Personal Reasons|22
6062849|NCT00502671|20947206|P1|Overall Study|Disease Progression|13
6062850|NCT00502593|20947223|P12|Overall Study|Lost to Follow-up|0
6062851|NCT00502593|20947224|P11|Overall Study|Lost to Follow-up|1
6062852|NCT00502593|20947225|P10|Overall Study|Lost to Follow-up|0
6062853|NCT00502593|20947226|P9|Overall Study|Lost to Follow-up|3
6062854|NCT00502593|20947227|P8|Overall Study|Lost to Follow-up|0
6062855|NCT00502593|20947228|P7|Overall Study|Lost to Follow-up|0
6062856|NCT00502593|20947229|P6|Overall Study|Lost to Follow-up|0
6062857|NCT00502593|20947230|P5|Overall Study|Lost to Follow-up|0
6062858|NCT00502593|20947231|P4|Overall Study|Lost to Follow-up|1
6062859|NCT00502593|20947232|P3|Overall Study|Lost to Follow-up|1
6062860|NCT00502593|20947233|P2|Overall Study|Lost to Follow-up|1
6062861|NCT00502593|20947234|P1|Overall Study|Lost to Follow-up|2
6062862|NCT00502593|20947223|P12|Overall Study|Withdrawal by Subject|0
6062863|NCT00502593|20947224|P11|Overall Study|Withdrawal by Subject|1
6062864|NCT00502593|20947225|P10|Overall Study|Withdrawal by Subject|0
6062865|NCT00502593|20947226|P9|Overall Study|Withdrawal by Subject|3
6062866|NCT00502593|20947227|P8|Overall Study|Withdrawal by Subject|0
6062867|NCT00502593|20947228|P7|Overall Study|Withdrawal by Subject|3
6062868|NCT00502593|20947229|P6|Overall Study|Withdrawal by Subject|0
6062869|NCT00502593|20947230|P5|Overall Study|Withdrawal by Subject|2
6062870|NCT00502593|20947231|P4|Overall Study|Withdrawal by Subject|2
6062871|NCT00502593|20947232|P3|Overall Study|Withdrawal by Subject|6
6062872|NCT00502593|20947233|P2|Overall Study|Withdrawal by Subject|0
6062873|NCT00502593|20947234|P1|Overall Study|Withdrawal by Subject|0
6062874|NCT00502593|20947223|P12|Overall Study|Withdrawn unspecified reason|0
6062875|NCT00502593|20947224|P11|Overall Study|Withdrawn unspecified reason|0
6062876|NCT00502593|20947225|P10|Overall Study|Withdrawn unspecified reason|0
6062877|NCT00502593|20947226|P9|Overall Study|Withdrawn unspecified reason|0
6062878|NCT00502593|20947227|P8|Overall Study|Withdrawn unspecified reason|0
6062879|NCT00502593|20947228|P7|Overall Study|Withdrawn unspecified reason|2
6062880|NCT00502593|20947229|P6|Overall Study|Withdrawn unspecified reason|0
6062881|NCT00502593|20947230|P5|Overall Study|Withdrawn unspecified reason|2
6062882|NCT00502593|20947231|P4|Overall Study|Withdrawn unspecified reason|1
6062883|NCT00502593|20947232|P3|Overall Study|Withdrawn unspecified reason|3
6062884|NCT00502593|20947233|P2|Overall Study|Withdrawn unspecified reason|1
6062885|NCT00502593|20947234|P1|Overall Study|Withdrawn unspecified reason|1
6062886|NCT00502320|20947750|P2|Overall Study|Adverse Event|5
6062887|NCT00502320|20947751|P1|Overall Study|Adverse Event|3
6062888|NCT00502320|20947750|P2|Overall Study|Screen Failure|1
6062889|NCT00502320|20947751|P1|Overall Study|Screen Failure|0
6062890|NCT00502320|20947750|P2|Overall Study|No longer met criteria|0
6062891|NCT00502320|20947751|P1|Overall Study|No longer met criteria|1
6062892|NCT00502320|20947750|P2|Overall Study|Withdrew Consent|0
6062893|NCT00502320|20947751|P1|Overall Study|Withdrew Consent|1
6062894|NCT00502320|20947750|P2|Overall Study|Lost to Follow-up|1
6062895|NCT00502320|20947751|P1|Overall Study|Lost to Follow-up|1
6062896|NCT00502307|20947761|P3|Maintenance Period|Discontinued due to other reasons|0
6062897|NCT00502307|20947762|P2|Maintenance Period|Discontinued due to other reasons|0
6062898|NCT00502307|20947763|P1|Maintenance Period|Discontinued due to other reasons|68
6062899|NCT00502307|20947761|P3|Maintenance Period|Progressive disease|0
6062900|NCT00502307|20947762|P2|Maintenance Period|Progressive disease|0
6062901|NCT00502307|20947763|P1|Maintenance Period|Progressive disease|80
6062902|NCT00502307|20947761|P3|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|7
6062903|NCT00502307|20947762|P2|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|3
6062904|NCT00502307|20947763|P1|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|0
6062905|NCT00502307|20947761|P3|Double-Blind Period (12 Weeks)|Progressive disease|2
6062906|NCT00502307|20947762|P2|Double-Blind Period (12 Weeks)|Progressive disease|23
6062907|NCT00502307|20947763|P1|Double-Blind Period (12 Weeks)|Progressive disease|0
6062908|NCT00502307|20947761|P3|Open Label Period (16 Weeks)|Discontinued due to other reasons|0
6062909|NCT00502307|20947762|P2|Open Label Period (16 Weeks)|Discontinued due to other reasons|0
6062910|NCT00502307|20947763|P1|Open Label Period (16 Weeks)|Discontinued due to other reasons|26
6062911|NCT00502307|20947761|P3|Open Label Period (16 Weeks)|Progressive disease|0
6062912|NCT00502307|20947762|P2|Open Label Period (16 Weeks)|Progressive disease|0
6062913|NCT00502307|20947763|P1|Open Label Period (16 Weeks)|Progressive disease|50
6062914|NCT00502242|20947790|P2|Overall Study|Withdrawal by Subject|7
6062915|NCT00502242|20947791|P1|Overall Study|Withdrawal by Subject|6
6062916|NCT00502242|20947790|P2|Overall Study|Protocol Violation|1
6062917|NCT00502242|20947791|P1|Overall Study|Protocol Violation|3
6062918|NCT00502242|20947790|P2|Overall Study|Other - Unspecified|14
6062919|NCT00502242|20947791|P1|Overall Study|Other - Unspecified|8
6062920|NCT00502242|20947790|P2|Overall Study|Physician Decision|3
6062921|NCT00502242|20947791|P1|Overall Study|Physician Decision|2
6062922|NCT00502242|20947790|P2|Overall Study|Adverse Event|20
6062923|NCT00502242|20947791|P1|Overall Study|Adverse Event|31
6062924|NCT00502242|20947790|P2|Overall Study|Lack of Efficacy|11
6062925|NCT00502242|20947791|P1|Overall Study|Lack of Efficacy|1
6062926|NCT00502203|20947855|P1|Overall Study|Inevaluable|1
6062927|NCT00501969|20947864|P1|Overall Study|Other: Sponsor Termination/Commercial RX|1
6062928|NCT00501969|20947864|P1|Overall Study|Other: Admin Request from the Sponsor|3
6062929|NCT00501969|20947864|P1|Overall Study|Other: As Required by Local EC|2
6062930|NCT00501969|20947864|P1|Overall Study|Other: DX Changed - Parkinsons to PSNP|1
6062931|NCT00501969|20947864|P1|Overall Study|Other: Pat Pending Surgery for PD|1
6062932|NCT00501969|20947864|P1|Overall Study|Other: Patient is Going to Have DBS|1
6062933|NCT00501969|20947864|P1|Overall Study|Other: Patients + Investigator Agreement|1
6062934|NCT00501969|20947864|P1|Overall Study|Other: Severe Dementia Unable Sign PIC|1
6062935|NCT00501969|20947864|P1|Overall Study|Other: Sponsor Stopped Study|12
6062936|NCT00501969|20947864|P1|Overall Study|Other: Sponsor Termination at Site|1
6062937|NCT00501969|20947864|P1|Overall Study|Other: Sponsors Request|10
6062938|NCT00501969|20947864|P1|Overall Study|Other: Tired Of Clinical Trial Process|1
6062939|NCT00501969|20947864|P1|Overall Study|Lost to Follow-up|4
6062940|NCT00501969|20947864|P1|Overall Study|Subject withdrew consent|51
6062941|NCT00501969|20947864|P1|Overall Study|Unsatisfactory compliance of subject|7
6062942|NCT00501969|20947864|P1|Overall Study|Adverse Event|76
6062943|NCT00501969|20947864|P1|Overall Study|Lack of Efficacy|29
6062944|NCT00501969|20947864|P1|Overall Study|Major Protocol Violation|4
6062945|NCT00501852|20947896|P1|Overall Study|Withdrawal by Subject|2
6062946|NCT00501852|20947896|P1|Overall Study|Adverse Event|3
6062947|NCT00501644|20947916|P1|Overall Study|Withdrawal by Subject|1
6062948|NCT00501644|20947916|P1|Overall Study|Adverse Event|4
6062949|NCT00501540|20947945|P1|Overall Study|Death|5
6062950|NCT00501293|20947957|P2|Maintenance Period|Application site reaction|0
6062951|NCT00501293|20947958|P1|Maintenance Period|Application site reaction|1
6062952|NCT00501293|20947957|P2|Maintenance Period|Would not wear patch|0
6062953|NCT00501293|20947958|P1|Maintenance Period|Would not wear patch|1
6062954|NCT00501293|20947957|P2|Maintenance Period|Went into rehabilitation|0
6062955|NCT00501293|20947958|P1|Maintenance Period|Went into rehabilitation|1
6062956|NCT00501293|20947957|P2|Maintenance Period|Noncompliant with study medication|0
6062957|NCT00501293|20947958|P1|Maintenance Period|Noncompliant with study medication|5
6062958|NCT00501293|20947957|P2|Maintenance Period|Lack of Efficacy|1
6062959|NCT00501293|20947958|P1|Maintenance Period|Lack of Efficacy|4
6062960|NCT00501293|20947957|P2|Maintenance Period|Protocol Violation|1
6062961|NCT00501293|20947958|P1|Maintenance Period|Protocol Violation|2
6062962|NCT00501293|20947957|P2|Maintenance Period|Adverse Event|6
6062963|NCT00501293|20947958|P1|Maintenance Period|Adverse Event|6
6062964|NCT00501293|20947957|P2|Maintenance Period|Lost to Follow-up|7
6062965|NCT00501293|20947958|P1|Maintenance Period|Lost to Follow-up|12
6062966|NCT00501293|20947957|P2|Maintenance Period|Withdrawal by Subject|13
6062967|NCT00501293|20947958|P1|Maintenance Period|Withdrawal by Subject|14
6062968|NCT00501293|20947957|P2|Optimization Period|Enrolled in error|0
6062969|NCT00501293|20947958|P1|Optimization Period|Enrolled in error|1
6062970|NCT00501228|20947985|P1|Overall Study|Withdrawal by Subject|1
6062971|NCT00501085|20947989|P1|Overall Study|Other loss to follow-up|32
6062972|NCT00501085|20947989|P1|Overall Study|Study closed by sponsor|109
6062973|NCT00501085|20947989|P1|Overall Study|Non-Compliance|24
6062974|NCT00501085|20947989|P1|Overall Study|Adverse Event|4
6062975|NCT00501085|20947989|P1|Overall Study|Explantation Surgery|26
6062976|NCT00501085|20947989|P1|Overall Study|Revision Surgery|7
6062977|NCT00501085|20947989|P1|Overall Study|Subject Decision|1
6062978|NCT00501085|20947989|P1|Overall Study|Withdrawal by Subject|34
6062979|NCT00501085|20947989|P1|Overall Study|Lost to Follow-up|195
6062980|NCT00501059|20947999|P2|Overall Study|Not treated|17
6062981|NCT00501059|20948000|P1|Overall Study|Not treated|25
6062982|NCT00501059|20947999|P2|Overall Study|Lost to Follow-up|198
6062983|NCT00501059|20948000|P1|Overall Study|Lost to Follow-up|210
6062984|NCT00501059|20947999|P2|Overall Study|Adverse Event|122
6062985|NCT00501059|20948000|P1|Overall Study|Adverse Event|129
6062986|NCT00501059|20947999|P2|Overall Study|Reason not given|1
6062987|NCT00501059|20948000|P1|Overall Study|Reason not given|3
6062988|NCT00501059|20947999|P2|Overall Study|Non-compliant with study treatment|16
6062989|NCT00501059|20948000|P1|Overall Study|Non-compliant with study treatment|23
6062990|NCT00501059|20947999|P2|Overall Study|Consent withdrawn by subject|873
6062991|NCT00501059|20948000|P1|Overall Study|Consent withdrawn by subject|817
6062992|NCT00501059|20947999|P2|Overall Study|Insufficient therapeutic effect|5
6062993|NCT00501059|20948000|P1|Overall Study|Insufficient therapeutic effect|4
6062994|NCT00501059|20947999|P2|Overall Study|Clinical endpoint reached|123
6062995|NCT00501059|20948000|P1|Overall Study|Clinical endpoint reached|110
6062996|NCT00501059|20947999|P2|Overall Study|Missing end-of-study page|92
6062997|NCT00501059|20948000|P1|Overall Study|Missing end-of-study page|91
6062998|NCT00501059|20947999|P2|Overall Study|Other|239
6062999|NCT00501059|20948000|P1|Overall Study|Other|236
6063000|NCT00501059|20947999|P2|Overall Study|Death|137
6063001|NCT00501059|20948000|P1|Overall Study|Death|140
6063002|NCT00501059|20947999|P2|Overall Study|Protocol Violation|69
6063003|NCT00501059|20948000|P1|Overall Study|Protocol Violation|80
6063004|NCT00501046|20948024|P2|Overall Study|Reaching endpoints,Noncompliance,etc|137
6063005|NCT00501046|20948025|P1|Overall Study|Reaching endpoints,Noncompliance,etc|119
6063006|NCT00501046|20948024|P2|Overall Study|Withdrawal by Subject|83
6063007|NCT00501046|20948025|P1|Overall Study|Withdrawal by Subject|84
6063008|NCT00501046|20948024|P2|Overall Study|Protocol Violation|1
6063009|NCT00501046|20948025|P1|Overall Study|Protocol Violation|2
6063010|NCT00501046|20948024|P2|Overall Study|Pregnancy|3
6063011|NCT00501046|20948025|P1|Overall Study|Pregnancy|0
6063012|NCT00501046|20948024|P2|Overall Study|Physician Decision|2
6063013|NCT00501046|20948025|P1|Overall Study|Physician Decision|7
6063014|NCT00501046|20948024|P2|Overall Study|Lost to Follow-up|13
6063015|NCT00501046|20948025|P1|Overall Study|Lost to Follow-up|14
6063016|NCT00501046|20948024|P2|Overall Study|Death|30
6063017|NCT00501046|20948025|P1|Overall Study|Death|23
6063018|NCT00501046|20948024|P2|Overall Study|Adverse Event|25
6063019|NCT00501046|20948025|P1|Overall Study|Adverse Event|21
6063020|NCT00501007|20948031|P2|Overall Study|Inclusion criteria not met.|25
6063021|NCT00501007|20948032|P1|Overall Study|Inclusion criteria not met.|29
6063022|NCT00500903|20948041|P3|Overall Study|Reason Not Specified|2
6063023|NCT00500903|20948042|P2|Overall Study|Reason Not Specified|0
6063024|NCT00500903|20948043|P1|Overall Study|Reason Not Specified|10
6063025|NCT00500903|20948041|P3|Overall Study|Symptomatic Deterioration|0
6063026|NCT00500903|20948042|P2|Overall Study|Symptomatic Deterioration|0
6063027|NCT00500903|20948043|P1|Overall Study|Symptomatic Deterioration|2
6063028|NCT00500903|20948041|P3|Overall Study|Patient Declined Further Treatment|3
6063029|NCT00500903|20948042|P2|Overall Study|Patient Declined Further Treatment|0
6063030|NCT00500903|20948043|P1|Overall Study|Patient Declined Further Treatment|0
6063031|NCT00500903|20948041|P3|Overall Study|Progressive Disease|15
6063032|NCT00500903|20948042|P2|Overall Study|Progressive Disease|2
6063033|NCT00500903|20948043|P1|Overall Study|Progressive Disease|41
6063034|NCT00500903|20948041|P3|Overall Study|Unsatisfactory Therapeutic Response|0
6063035|NCT00500903|20948042|P2|Overall Study|Unsatisfactory Therapeutic Response|0
6063036|NCT00500903|20948043|P1|Overall Study|Unsatisfactory Therapeutic Response|2
6063037|NCT00500903|20948041|P3|Overall Study|Occurrence of Adverse Event(s)|0
6063038|NCT00500903|20948042|P2|Overall Study|Occurrence of Adverse Event(s)|0
6063039|NCT00500903|20948043|P1|Overall Study|Occurrence of Adverse Event(s)|10
6063040|NCT00500760|20948239|P2|Overall Study|Other|2
6063041|NCT00500760|20948240|P1|Overall Study|Other|1
6063042|NCT00500760|20948239|P2|Overall Study|Lost to Follow-up|0
6063043|NCT00500760|20948240|P1|Overall Study|Lost to Follow-up|3
6063044|NCT00500760|20948239|P2|Overall Study|Administrative decision|0
6063045|NCT00500760|20948240|P1|Overall Study|Administrative decision|2
6063046|NCT00500760|20948239|P2|Overall Study|Withdrawal by Subject|7
6063047|NCT00500760|20948240|P1|Overall Study|Withdrawal by Subject|5
6063048|NCT00500760|20948239|P2|Overall Study|Death|15
6063049|NCT00500760|20948240|P1|Overall Study|Death|32
6063050|NCT00500682|20948260|P2|Overall Study|Reaching endpoints, Noncompliance, etc|144
6063051|NCT00500682|20948261|P1|Overall Study|Reaching endpoints, Noncompliance, etc|144
6063052|NCT00500682|20948260|P2|Overall Study|Withdrawal by Subject|74
6063053|NCT00500682|20948261|P1|Overall Study|Withdrawal by Subject|80
6063054|NCT00500682|20948260|P2|Overall Study|Protocol Violation|3
6063055|NCT00500682|20948261|P1|Overall Study|Protocol Violation|1
6063056|NCT00500682|20948260|P2|Overall Study|Pregnancy|0
6063057|NCT00500682|20948261|P1|Overall Study|Pregnancy|2
6063058|NCT00500682|20948260|P2|Overall Study|Physician Decision|10
6063059|NCT00500682|20948261|P1|Overall Study|Physician Decision|6
6063060|NCT00500682|20948260|P2|Overall Study|Lost to Follow-up|11
6063061|NCT00500682|20948261|P1|Overall Study|Lost to Follow-up|11
6063062|NCT00500682|20948260|P2|Overall Study|Death|16
6063063|NCT00500682|20948261|P1|Overall Study|Death|25
6063064|NCT00500682|20948260|P2|Overall Study|Adverse Event|29
6063065|NCT00500682|20948261|P1|Overall Study|Adverse Event|37
6063066|NCT00500539|20948295|P1|Follow-up Period (16 Weeks)|Missing|3
6063067|NCT00500539|20948295|P1|Follow-up Period (16 Weeks)|Protocol Deviation|1
6063068|NCT00500539|20948295|P1|Follow-up Period (16 Weeks)|Death|1
6063069|NCT00500539|20948295|P1|Follow-up Period (16 Weeks)|Administrative problems|1
6063070|NCT00500539|20948295|P1|Follow-up Period (16 Weeks)|Lost to Follow-up|3
6063071|NCT00500539|20948295|P1|Follow-up Period (16 Weeks)|Subject withdrew consent|2
6063072|NCT00500539|20948295|P1|Follow-up Period (16 Weeks)|Adverse Event|1
6063073|NCT00500539|20948295|P1|Treatment Period (24 Weeks)|Protocol Deviation|5
6063074|NCT00500539|20948295|P1|Treatment Period (24 Weeks)|Administrative problems|2
6063075|NCT00500539|20948295|P1|Treatment Period (24 Weeks)|Lost to Follow-up|2
6063076|NCT00500539|20948295|P1|Treatment Period (24 Weeks)|Subject withdrew consent|1
6063077|NCT00500539|20948295|P1|Treatment Period (24 Weeks)|Unsatisfactory therapeutic effect|1
6063078|NCT00500539|20948295|P1|Treatment Period (24 Weeks)|Adverse Event|4
6063079|NCT00500370|20948321|P2|Overall Study|Subject Decision|17
6063080|NCT00500370|20948322|P1|Overall Study|Subject Decision|10
6063081|NCT00500370|20948321|P2|Overall Study|Sponsor Decision|0
6063082|NCT00500370|20948322|P1|Overall Study|Sponsor Decision|2
6063083|NCT00500370|20948321|P2|Overall Study|Protocol Violation|4
6063084|NCT00500370|20948322|P1|Overall Study|Protocol Violation|2
6063085|NCT00500370|20948321|P2|Overall Study|Lost to Follow-up|10
6063086|NCT00500370|20948322|P1|Overall Study|Lost to Follow-up|10
6063087|NCT00500370|20948321|P2|Overall Study|Adverse Event|3
6063088|NCT00500370|20948322|P1|Overall Study|Adverse Event|9
6063089|NCT00500357|20948358|P1|Overall Study|Death|1
6063090|NCT00500331|20948384|P7|Overall Study|Protocol violated|0
6063091|NCT00500331|20948385|P6|Overall Study|Protocol violated|0
6063092|NCT00500331|20948386|P5|Overall Study|Protocol violated|0
6063093|NCT00500331|20948387|P4|Overall Study|Protocol violated|1
6063094|NCT00500331|20948388|P3|Overall Study|Protocol violated|0
6063095|NCT00500331|20948389|P2|Overall Study|Protocol violated|0
6063096|NCT00500331|20948390|P1|Overall Study|Protocol violated|0
6063097|NCT00500331|20948384|P7|Overall Study|State ban of biological samples export|0
6063098|NCT00500331|20948385|P6|Overall Study|State ban of biological samples export|0
6063099|NCT00500331|20948386|P5|Overall Study|State ban of biological samples export|0
6063100|NCT00500331|20948387|P4|Overall Study|State ban of biological samples export|1
6063101|NCT00500331|20948388|P3|Overall Study|State ban of biological samples export|0
6063102|NCT00500331|20948389|P2|Overall Study|State ban of biological samples export|0
6063103|NCT00500331|20948390|P1|Overall Study|State ban of biological samples export|0
6063104|NCT00500331|20948384|P7|Overall Study|Diabetologist nurse in the study|0
6063105|NCT00500331|20948385|P6|Overall Study|Diabetologist nurse in the study|0
6063106|NCT00500331|20948386|P5|Overall Study|Diabetologist nurse in the study|0
6063107|NCT00500331|20948387|P4|Overall Study|Diabetologist nurse in the study|0
6063108|NCT00500331|20948388|P3|Overall Study|Diabetologist nurse in the study|1
6063109|NCT00500331|20948389|P2|Overall Study|Diabetologist nurse in the study|0
6063110|NCT00500331|20948390|P1|Overall Study|Diabetologist nurse in the study|0
6063111|NCT00500331|20948384|P7|Overall Study|Participant was randomized by mistake|0
6063112|NCT00500331|20948385|P6|Overall Study|Participant was randomized by mistake|0
6063113|NCT00500331|20948386|P5|Overall Study|Participant was randomized by mistake|0
6063114|NCT00500331|20948387|P4|Overall Study|Participant was randomized by mistake|0
6063115|NCT00500331|20948388|P3|Overall Study|Participant was randomized by mistake|0
6063116|NCT00500331|20948389|P2|Overall Study|Participant was randomized by mistake|0
6063117|NCT00500331|20948390|P1|Overall Study|Participant was randomized by mistake|1
6063118|NCT00500331|20948384|P7|Overall Study|Sponsor decided to withdraw participant|0
6063119|NCT00500331|20948385|P6|Overall Study|Sponsor decided to withdraw participant|0
6063120|NCT00500331|20948386|P5|Overall Study|Sponsor decided to withdraw participant|0
6063121|NCT00500331|20948387|P4|Overall Study|Sponsor decided to withdraw participant|0
6063122|NCT00500331|20948388|P3|Overall Study|Sponsor decided to withdraw participant|0
6063123|NCT00500331|20948389|P2|Overall Study|Sponsor decided to withdraw participant|0
6063124|NCT00500331|20948390|P1|Overall Study|Sponsor decided to withdraw participant|1
6063125|NCT00500331|20948384|P7|Overall Study|Exclusion citeria not met on Visit 4|0
6063126|NCT00500331|20948385|P6|Overall Study|Exclusion citeria not met on Visit 4|0
6063127|NCT00500331|20948386|P5|Overall Study|Exclusion citeria not met on Visit 4|0
6063128|NCT00500331|20948387|P4|Overall Study|Exclusion citeria not met on Visit 4|0
6063129|NCT00500331|20948388|P3|Overall Study|Exclusion citeria not met on Visit 4|0
6063130|NCT00500331|20948389|P2|Overall Study|Exclusion citeria not met on Visit 4|0
6063131|NCT00500331|20948390|P1|Overall Study|Exclusion citeria not met on Visit 4|1
6063132|NCT00500331|20948384|P7|Overall Study|Didn't return for continuation of study|0
6063133|NCT00500331|20948385|P6|Overall Study|Didn't return for continuation of study|0
6063134|NCT00500331|20948386|P5|Overall Study|Didn't return for continuation of study|0
6063135|NCT00500331|20948387|P4|Overall Study|Didn't return for continuation of study|0
6063136|NCT00500331|20948388|P3|Overall Study|Didn't return for continuation of study|0
6063137|NCT00500331|20948389|P2|Overall Study|Didn't return for continuation of study|0
6063138|NCT00500331|20948390|P1|Overall Study|Didn't return for continuation of study|1
6063139|NCT00500331|20948384|P7|Overall Study|Increased serum creatinine from Baseline|0
6063140|NCT00500331|20948385|P6|Overall Study|Increased serum creatinine from Baseline|1
6063141|NCT00500331|20948386|P5|Overall Study|Increased serum creatinine from Baseline|0
6063142|NCT00500331|20948387|P4|Overall Study|Increased serum creatinine from Baseline|0
6063143|NCT00500331|20948388|P3|Overall Study|Increased serum creatinine from Baseline|0
6063144|NCT00500331|20948389|P2|Overall Study|Increased serum creatinine from Baseline|0
6063145|NCT00500331|20948390|P1|Overall Study|Increased serum creatinine from Baseline|0
6063146|NCT00500331|20948384|P7|Overall Study|Liver function test abnormality|0
6063147|NCT00500331|20948385|P6|Overall Study|Liver function test abnormality|0
6063148|NCT00500331|20948386|P5|Overall Study|Liver function test abnormality|0
6063149|NCT00500331|20948387|P4|Overall Study|Liver function test abnormality|0
6063150|NCT00500331|20948388|P3|Overall Study|Liver function test abnormality|1
6063151|NCT00500331|20948389|P2|Overall Study|Liver function test abnormality|0
6063152|NCT00500331|20948390|P1|Overall Study|Liver function test abnormality|0
6063153|NCT00500331|20948384|P7|Overall Study|Lack of Efficacy|0
6063154|NCT00500331|20948385|P6|Overall Study|Lack of Efficacy|0
6063155|NCT00500331|20948386|P5|Overall Study|Lack of Efficacy|0
6063156|NCT00500331|20948387|P4|Overall Study|Lack of Efficacy|0
6063157|NCT00500331|20948388|P3|Overall Study|Lack of Efficacy|0
6063158|NCT00500331|20948389|P2|Overall Study|Lack of Efficacy|1
6063159|NCT00500331|20948390|P1|Overall Study|Lack of Efficacy|3
6063160|NCT00500331|20948384|P7|Overall Study|Withdrawal by Subject|1
6063161|NCT00500331|20948385|P6|Overall Study|Withdrawal by Subject|1
6063162|NCT00500331|20948386|P5|Overall Study|Withdrawal by Subject|0
6063163|NCT00500331|20948387|P4|Overall Study|Withdrawal by Subject|5
6063164|NCT00500331|20948388|P3|Overall Study|Withdrawal by Subject|1
6063165|NCT00500331|20948389|P2|Overall Study|Withdrawal by Subject|0
6063166|NCT00500331|20948390|P1|Overall Study|Withdrawal by Subject|4
6063167|NCT00500331|20948384|P7|Overall Study|Protocol Violation|1
6063168|NCT00500331|20948385|P6|Overall Study|Protocol Violation|1
6063169|NCT00500331|20948386|P5|Overall Study|Protocol Violation|1
6063170|NCT00500331|20948387|P4|Overall Study|Protocol Violation|0
6063171|NCT00500331|20948388|P3|Overall Study|Protocol Violation|1
6063172|NCT00500331|20948389|P2|Overall Study|Protocol Violation|1
6063173|NCT00500331|20948390|P1|Overall Study|Protocol Violation|3
6063174|NCT00500331|20948384|P7|Overall Study|Lost to Follow-up|0
6063175|NCT00500331|20948385|P6|Overall Study|Lost to Follow-up|0
6063176|NCT00500331|20948386|P5|Overall Study|Lost to Follow-up|1
6063177|NCT00500331|20948387|P4|Overall Study|Lost to Follow-up|2
6063178|NCT00500331|20948388|P3|Overall Study|Lost to Follow-up|1
6063179|NCT00500331|20948389|P2|Overall Study|Lost to Follow-up|1
6063180|NCT00500331|20948390|P1|Overall Study|Lost to Follow-up|1
6063181|NCT00500331|20948384|P7|Overall Study|Adverse Event|0
6063182|NCT00500331|20948385|P6|Overall Study|Adverse Event|2
6063183|NCT00500331|20948386|P5|Overall Study|Adverse Event|2
6063184|NCT00500331|20948387|P4|Overall Study|Adverse Event|1
6063185|NCT00500331|20948388|P3|Overall Study|Adverse Event|0
6063186|NCT00500331|20948389|P2|Overall Study|Adverse Event|2
6063187|NCT00500331|20948390|P1|Overall Study|Adverse Event|0
6063188|NCT00500318|20948527|P2|Overall Study|Other Reason|1
6063189|NCT00500318|20948528|P1|Overall Study|Other Reason|0
6063190|NCT00500318|20948527|P2|Overall Study|Lack of Efficacy|3
6063191|NCT00500318|20948528|P1|Overall Study|Lack of Efficacy|0
6063192|NCT00500318|20948527|P2|Overall Study|Withdrawal by Subject|2
6063193|NCT00500318|20948528|P1|Overall Study|Withdrawal by Subject|1
6063194|NCT00500318|20948527|P2|Overall Study|Protocol Violation|3
6063195|NCT00500318|20948528|P1|Overall Study|Protocol Violation|1
6063196|NCT00500318|20948527|P2|Overall Study|Adverse Event|8
6063197|NCT00500318|20948528|P1|Overall Study|Adverse Event|3
6063198|NCT00500292|20948545|P3|Overall Study|Other|4
6063199|NCT00500292|20948546|P2|Overall Study|Other|1
6063200|NCT00500292|20948547|P1|Overall Study|Other|1
6063201|NCT00500292|20948545|P3|Overall Study|Withdrawal by Subject|0
6063202|NCT00500292|20948546|P2|Overall Study|Withdrawal by Subject|1
6063203|NCT00500292|20948547|P1|Overall Study|Withdrawal by Subject|0
6063204|NCT00500292|20948545|P3|Overall Study|Condition under investigation worsened|19
6063205|NCT00500292|20948546|P2|Overall Study|Condition under investigation worsened|23
6063206|NCT00500292|20948547|P1|Overall Study|Condition under investigation worsened|21
6063207|NCT00500292|20948545|P3|Overall Study|Adverse Event|4
6063208|NCT00500292|20948546|P2|Overall Study|Adverse Event|6
6063209|NCT00500292|20948547|P1|Overall Study|Adverse Event|3
6063210|NCT00500149|20948568|P2|Second Intervention (Cross-over Phase)|Lost to Follow-up|0
6063211|NCT00500149|20948569|P1|Second Intervention (Cross-over Phase)|Lost to Follow-up|2
6063212|NCT00500149|20948568|P2|First Intervention (Cross-over Phase)|Protocol Violation|0
6063213|NCT00500149|20948569|P1|First Intervention (Cross-over Phase)|Protocol Violation|1
6063214|NCT00500149|20948568|P2|First Intervention (Cross-over Phase)|Withdrawal by Subject|1
6063215|NCT00500149|20948569|P1|First Intervention (Cross-over Phase)|Withdrawal by Subject|1
6063216|NCT00500149|20948568|P2|First Intervention (Cross-over Phase)|Adverse Event|1
6063217|NCT00500149|20948569|P1|First Intervention (Cross-over Phase)|Adverse Event|0
6063218|NCT00500149|20948568|P2|Enrolled (Dose-optimization Phase)|Protocol Violation|0
6063219|NCT00500149|20948569|P1|Enrolled (Dose-optimization Phase)|Protocol Violation|1
6063220|NCT00500149|20948568|P2|Enrolled (Dose-optimization Phase)|Adverse Event|0
6063221|NCT00500149|20948569|P1|Enrolled (Dose-optimization Phase)|Adverse Event|8
6063222|NCT00500149|20948568|P2|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|0
6063223|NCT00500149|20948569|P1|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|3
6063224|NCT00500110|20948577|P1|Overall Study|Withdrawal by Subject|3
6063225|NCT00500071|20948581|P1|30-day Safety Follow-up|Lost to Follow-up|17
6063226|NCT00500071|20948581|P1|Dose-optimization and Maintenance Phase|Lack of protocol compliance|4
6063227|NCT00500071|20948581|P1|Dose-optimization and Maintenance Phase|Withdrawal by Subject|1
6063228|NCT00500071|20948581|P1|Dose-optimization and Maintenance Phase|Lack of Efficacy|2
6063229|NCT00500071|20948581|P1|Dose-optimization and Maintenance Phase|Protocol Violation|2
6063230|NCT00500071|20948581|P1|Dose-optimization and Maintenance Phase|Adverse Event|13
6063231|NCT00500071|20948581|P1|Screening and Washout Phase|Protocol Violation|1
6063232|NCT00499889|20948604|P1|Overall Study|Infection prior to treatment|1
6063233|NCT00499863|20948612|P2|Overall Study|Lost to Follow-up|1
6063234|NCT00499863|20948613|P1|Overall Study|Lost to Follow-up|1
6063235|NCT00499863|20948612|P2|Overall Study|Sponsor decision|2
6063236|NCT00499863|20948613|P1|Overall Study|Sponsor decision|2
6063237|NCT00499863|20948612|P2|Overall Study|Adverse Event|2
6063238|NCT00499863|20948613|P1|Overall Study|Adverse Event|8
6063239|NCT00499863|20948612|P2|Overall Study|Withdrawal by Subject|4
6063240|NCT00499863|20948613|P1|Overall Study|Withdrawal by Subject|6
6063241|NCT00499863|20948612|P2|Overall Study|Protocol Violation|7
6063242|NCT00499863|20948613|P1|Overall Study|Protocol Violation|12
6063243|NCT00499863|20948612|P2|Overall Study|Lack of Efficacy|27
6063244|NCT00499863|20948613|P1|Overall Study|Lack of Efficacy|21
6063245|NCT00500266|20948641|P1|Overall Study|Assigned, not treated|4
6063246|NCT00500266|20948641|P1|Overall Study|Withdrawal by Subject|3
6063247|NCT00500266|20948641|P1|Overall Study|Lost to Follow-up|3
6063248|NCT00500266|20948641|P1|Overall Study|Death|3
6063249|NCT00499746|20948648|P1|Phase 1(6-9 One Day Sessions)|Unable to determine|1
6063250|NCT00499746|20948648|P1|Phase 1(6-9 One Day Sessions)|Investigator decision|1
6063251|NCT00499746|20948648|P1|Phase 1(6-9 One Day Sessions)|Withdrawal by Subject|3
6063252|NCT00499746|20948648|P1|Phase 1(6-9 One Day Sessions)|Failed to perform study task|7
6063253|NCT00499694|20948717|P1|Overall Study|Patient never received treatment.|1
6063254|NCT00499681|20948726|P2|Overall Study|disease progression|1
6063255|NCT00499681|20948727|P1|Overall Study|disease progression|0
6063256|NCT00499681|20948726|P2|Overall Study|toxicity|1
6063257|NCT00499681|20948727|P1|Overall Study|toxicity|0
6063258|NCT00499616|20948754|P4|Overall Study|Patient/Parent Refusal|0
6063259|NCT00499616|20948755|P3|Overall Study|Patient/Parent Refusal|3
6063260|NCT00499616|20948756|P2|Overall Study|Patient/Parent Refusal|5
6063261|NCT00499616|20948757|P1|Overall Study|Patient/Parent Refusal|1
6063262|NCT00499616|20948754|P4|Overall Study|Not evaluable|41
6063263|NCT00499616|20948755|P3|Overall Study|Not evaluable|0
6063264|NCT00499616|20948756|P2|Overall Study|Not evaluable|0
6063265|NCT00499616|20948757|P1|Overall Study|Not evaluable|0
6063266|NCT00499616|20948754|P4|Overall Study|Ineligible|15
6063267|NCT00499616|20948755|P3|Overall Study|Ineligible|0
6063268|NCT00499616|20948756|P2|Overall Study|Ineligible|2
6063269|NCT00499616|20948757|P1|Overall Study|Ineligible|1
6063270|NCT00499616|20948754|P4|Overall Study|Withdrawal by Subject|0
6063271|NCT00499616|20948755|P3|Overall Study|Withdrawal by Subject|1
6063272|NCT00499616|20948756|P2|Overall Study|Withdrawal by Subject|0
6063273|NCT00499616|20948757|P1|Overall Study|Withdrawal by Subject|1
6063274|NCT00499616|20948754|P4|Overall Study|Physician Decision|0
6063275|NCT00499616|20948755|P3|Overall Study|Physician Decision|9
6063276|NCT00499616|20948756|P2|Overall Study|Physician Decision|16
6063277|NCT00499616|20948757|P1|Overall Study|Physician Decision|6
6063278|NCT00499616|20948754|P4|Overall Study|Lost to Follow-up|0
6063279|NCT00499616|20948755|P3|Overall Study|Lost to Follow-up|1
6063280|NCT00499616|20948756|P2|Overall Study|Lost to Follow-up|0
6063281|NCT00499616|20948757|P1|Overall Study|Lost to Follow-up|0
6063282|NCT00499616|20948754|P4|Overall Study|Lack of Efficacy|0
6063283|NCT00499616|20948755|P3|Overall Study|Lack of Efficacy|19
6063284|NCT00499616|20948756|P2|Overall Study|Lack of Efficacy|0
6063285|NCT00499616|20948757|P1|Overall Study|Lack of Efficacy|5
6063286|NCT00499616|20948754|P4|Overall Study|Death|1
6063287|NCT00499616|20948755|P3|Overall Study|Death|3
6063288|NCT00499616|20948756|P2|Overall Study|Death|5
6063289|NCT00499616|20948757|P1|Overall Study|Death|1
6063290|NCT00499603|20948802|P2|Overall Study|Adverse Event|1
6063291|NCT00499603|20948803|P1|Overall Study|Adverse Event|0
6063292|NCT00499590|20948816|P3|Overall Study|Not treated|1
6063293|NCT00499590|20948817|P2|Overall Study|Not treated|0
6063294|NCT00499590|20948818|P1|Overall Study|Not treated|1
6063295|NCT00499590|20948816|P3|Overall Study|Study Terminated|112
6063296|NCT00499590|20948817|P2|Overall Study|Study Terminated|112
6063297|NCT00499590|20948818|P1|Overall Study|Study Terminated|112
6063298|NCT00499486|20948829|P1|Overall Study|Withdrawal by Subject|16
6063299|NCT00499460|20948856|P2|Intervention 2 (30 Days)|Withdrawal by Subject|1
6063300|NCT00499460|20948857|P1|Intervention 2 (30 Days)|Withdrawal by Subject|0
6063301|NCT00499460|20948856|P2|Intervention 1 (30 Days)|Fainting upon Blood Draw|0
6063302|NCT00499460|20948857|P1|Intervention 1 (30 Days)|Fainting upon Blood Draw|1
6063303|NCT00499460|20948856|P2|Intervention 1 (30 Days)|Withdrawal by Subject|0
6063304|NCT00499460|20948857|P1|Intervention 1 (30 Days)|Withdrawal by Subject|1
6063305|NCT00499369|20948890|P5|Overall Study|Ineligible|0
6063306|NCT00499369|20948891|P4|Overall Study|Ineligible|1
6063307|NCT00499369|20948892|P3|Overall Study|Ineligible|1
6063308|NCT00499369|20948893|P2|Overall Study|Ineligible|2
6063309|NCT00499369|20948894|P1|Overall Study|Ineligible|2
6063310|NCT00499369|20948890|P5|Overall Study|Not protocol specified|0
6063311|NCT00499369|20948891|P4|Overall Study|Not protocol specified|1
6063312|NCT00499369|20948892|P3|Overall Study|Not protocol specified|3
6063313|NCT00499369|20948893|P2|Overall Study|Not protocol specified|0
6063314|NCT00499369|20948894|P1|Overall Study|Not protocol specified|2
6063315|NCT00499369|20948890|P5|Overall Study|Death|0
6063316|NCT00499369|20948891|P4|Overall Study|Death|0
6063317|NCT00499369|20948892|P3|Overall Study|Death|0
6063318|NCT00499369|20948893|P2|Overall Study|Death|1
6063319|NCT00499369|20948894|P1|Overall Study|Death|0
6063320|NCT00499369|20948890|P5|Overall Study|Progression|10
6063321|NCT00499369|20948891|P4|Overall Study|Progression|6
6063322|NCT00499369|20948892|P3|Overall Study|Progression|9
6063323|NCT00499369|20948893|P2|Overall Study|Progression|12
6063324|NCT00499369|20948894|P1|Overall Study|Progression|10
6063325|NCT00499369|20948890|P5|Overall Study|Withdrawal by Subject|0
6063326|NCT00499369|20948891|P4|Overall Study|Withdrawal by Subject|0
6063327|NCT00499369|20948892|P3|Overall Study|Withdrawal by Subject|1
6063328|NCT00499369|20948893|P2|Overall Study|Withdrawal by Subject|1
6063329|NCT00499369|20948894|P1|Overall Study|Withdrawal by Subject|0
6063330|NCT00499369|20948890|P5|Overall Study|Adverse Event|2
6063331|NCT00499369|20948891|P4|Overall Study|Adverse Event|1
6063332|NCT00499369|20948892|P3|Overall Study|Adverse Event|3
6063333|NCT00499369|20948893|P2|Overall Study|Adverse Event|2
6063334|NCT00499369|20948894|P1|Overall Study|Adverse Event|2
6063335|NCT00499252|20948930|P1|Overall Study|<no further label>|3
6063336|NCT00499252|20948930|P1|Overall Study|Ineligible|4
6063337|NCT00499252|20948930|P1|Overall Study|Refused further treatment|2
6063338|NCT00499252|20948930|P1|Overall Study|Adverse Event|3
6063339|NCT00499122|20948940|P1|Overall Study|Withdrawal by Subject|2
6063340|NCT00499083|20948983|P1|Overall Study|Not evaluable|3
6063341|NCT00499031|20948990|P1|Overall Study|Never treated|1
6063342|NCT00499031|20948990|P1|Overall Study|Required test not done|1
6063343|NCT00499031|20948990|P1|Overall Study|Improper pre-protocol treatment|1
6063344|NCT00498797|20949013|P2|Overall Study|Other|1
6063345|NCT00498797|20949014|P1|Overall Study|Other|3
6063346|NCT00498797|20949013|P2|Overall Study|Condition under investigation worsened|21
6063347|NCT00498797|20949014|P1|Overall Study|Condition under investigation worsened|19
6063348|NCT00498797|20949013|P2|Overall Study|Adverse Event|5
6063349|NCT00498797|20949014|P1|Overall Study|Adverse Event|12
6063350|NCT00498797|20949013|P2|Overall Study|Withdrawal by Subject|2
6063351|NCT00498797|20949014|P1|Overall Study|Withdrawal by Subject|4
6063352|NCT00498602|20949098|P7|Overall Study|Other|0
6063353|NCT00498602|20949099|P6|Overall Study|Other|3
6063354|NCT00498602|20949100|P5|Overall Study|Other|0
6063355|NCT00498602|20949101|P4|Overall Study|Other|0
6063356|NCT00498602|20949102|P3|Overall Study|Other|1
6063357|NCT00498602|20949103|P2|Overall Study|Other|3
6063358|NCT00498602|20949104|P1|Overall Study|Other|2
6063359|NCT00498602|20949098|P7|Overall Study|Subject Request|1
6063360|NCT00498602|20949099|P6|Overall Study|Subject Request|4
6063361|NCT00498602|20949100|P5|Overall Study|Subject Request|1
6063362|NCT00498602|20949101|P4|Overall Study|Subject Request|1
6063363|NCT00498602|20949102|P3|Overall Study|Subject Request|1
6063364|NCT00498602|20949103|P2|Overall Study|Subject Request|0
6063365|NCT00498602|20949104|P1|Overall Study|Subject Request|3
6063366|NCT00498602|20949098|P7|Overall Study|Investigator Request|0
6063367|NCT00498602|20949099|P6|Overall Study|Investigator Request|0
6063368|NCT00498602|20949100|P5|Overall Study|Investigator Request|0
6063369|NCT00498602|20949101|P4|Overall Study|Investigator Request|0
6063370|NCT00498602|20949102|P3|Overall Study|Investigator Request|1
6063371|NCT00498602|20949103|P2|Overall Study|Investigator Request|0
6063372|NCT00498602|20949104|P1|Overall Study|Investigator Request|0
6063373|NCT00498602|20949098|P7|Overall Study|Caregiver Request|0
6063374|NCT00498602|20949099|P6|Overall Study|Caregiver Request|2
6063375|NCT00498602|20949100|P5|Overall Study|Caregiver Request|1
6063376|NCT00498602|20949101|P4|Overall Study|Caregiver Request|0
6063377|NCT00498602|20949102|P3|Overall Study|Caregiver Request|2
6063378|NCT00498602|20949103|P2|Overall Study|Caregiver Request|2
6063379|NCT00498602|20949104|P1|Overall Study|Caregiver Request|2
6063380|NCT00498602|20949098|P7|Overall Study|AE not related to Study Drug|1
6063381|NCT00498602|20949099|P6|Overall Study|AE not related to Study Drug|2
6063382|NCT00498602|20949100|P5|Overall Study|AE not related to Study Drug|2
6063383|NCT00498602|20949101|P4|Overall Study|AE not related to Study Drug|0
6063384|NCT00498602|20949102|P3|Overall Study|AE not related to Study Drug|0
6063385|NCT00498602|20949103|P2|Overall Study|AE not related to Study Drug|3
6063386|NCT00498602|20949104|P1|Overall Study|AE not related to Study Drug|1
6063387|NCT00498602|20949098|P7|Overall Study|Adverse Event (AE) related to Study Drug|0
6063388|NCT00498602|20949099|P6|Overall Study|Adverse Event (AE) related to Study Drug|1
6063389|NCT00498602|20949100|P5|Overall Study|Adverse Event (AE) related to Study Drug|0
6063390|NCT00498602|20949101|P4|Overall Study|Adverse Event (AE) related to Study Drug|2
6063391|NCT00498602|20949102|P3|Overall Study|Adverse Event (AE) related to Study Drug|3
6063392|NCT00498602|20949103|P2|Overall Study|Adverse Event (AE) related to Study Drug|0
6063393|NCT00498602|20949104|P1|Overall Study|Adverse Event (AE) related to Study Drug|1
6063394|NCT00498602|20949098|P7|Overall Study|Lost to Follow-up|0
6063395|NCT00498602|20949099|P6|Overall Study|Lost to Follow-up|0
6063396|NCT00498602|20949100|P5|Overall Study|Lost to Follow-up|0
6063397|NCT00498602|20949101|P4|Overall Study|Lost to Follow-up|2
6063398|NCT00498602|20949102|P3|Overall Study|Lost to Follow-up|0
6063399|NCT00498602|20949103|P2|Overall Study|Lost to Follow-up|2
6063400|NCT00498602|20949104|P1|Overall Study|Lost to Follow-up|0
6063401|NCT00498602|20949098|P7|Overall Study|Lack of Efficacy|0
6063402|NCT00498602|20949099|P6|Overall Study|Lack of Efficacy|0
6063403|NCT00498602|20949100|P5|Overall Study|Lack of Efficacy|0
6063404|NCT00498602|20949101|P4|Overall Study|Lack of Efficacy|0
6063405|NCT00498602|20949102|P3|Overall Study|Lack of Efficacy|0
6063406|NCT00498602|20949103|P2|Overall Study|Lack of Efficacy|0
6063407|NCT00498602|20949104|P1|Overall Study|Lack of Efficacy|1
6063408|NCT00498602|20949098|P7|Overall Study|Death|0
6063409|NCT00498602|20949099|P6|Overall Study|Death|1
6063410|NCT00498602|20949100|P5|Overall Study|Death|0
6063411|NCT00498602|20949101|P4|Overall Study|Death|0
6063412|NCT00498602|20949102|P3|Overall Study|Death|0
6063413|NCT00498602|20949103|P2|Overall Study|Death|0
6063414|NCT00498602|20949104|P1|Overall Study|Death|0
6063415|NCT00498485|20949152|P2|Overall Study|Adverse Event|5
6063416|NCT00498485|20949153|P1|Overall Study|Adverse Event|1
6063417|NCT00498433|20949164|P3|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0
6063418|NCT00498433|20949165|P2|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0
6063419|NCT00498433|20949166|P1|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|1
6063420|NCT00498433|20949164|P3|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0
6063421|NCT00498433|20949165|P2|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0
6063422|NCT00498433|20949166|P1|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|15
6063423|NCT00498433|20949164|P3|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0
6063424|NCT00498433|20949165|P2|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0
6063425|NCT00498433|20949166|P1|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|2
6063426|NCT00498433|20949164|P3|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0
6063427|NCT00498433|20949165|P2|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0
6063428|NCT00498433|20949166|P1|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|2
6063429|NCT00498368|20949211|P2|Overall Study|Withdrawal by Subject|2
6063430|NCT00498368|20949212|P1|Overall Study|Withdrawal by Subject|3
6063431|NCT00498355|20949224|P1|Overall Study|Lost to Follow-up|1
6063432|NCT00498186|20949232|P1|Overall Study|Other|10
6063433|NCT00498186|20949232|P1|Overall Study|Lost to Follow-up|3
6063434|NCT00498186|20949232|P1|Overall Study|Withdrawal by Subject|18
6063435|NCT00498186|20949232|P1|Overall Study|Unsatisfactory compliance of subject|12
6063436|NCT00498186|20949232|P1|Overall Study|Adverse Event|89
6063437|NCT00498186|20949232|P1|Overall Study|Lack of Efficacy|31
6063438|NCT00498186|20949232|P1|Overall Study|Protocol Violation|10
6063439|NCT00498173|20949239|P3|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|0
6063440|NCT00498173|20949240|P2|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|1
6063441|NCT00498173|20949241|P1|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|2
6063452|NCT00497796|20949290|P2|Overall Study|Not applicable (randomized not treated)|4
6063453|NCT00497796|20949291|P1|Overall Study|Not applicable (randomized not treated)|0
6063454|NCT00497796|20949290|P2|Overall Study|Lost to Follow-up|1
6063455|NCT00497796|20949291|P1|Overall Study|Lost to Follow-up|0
6063456|NCT00497796|20949290|P2|Overall Study|Investigator/sponsor discretion|34
6063457|NCT00497796|20949291|P1|Overall Study|Investigator/sponsor discretion|31
6063458|NCT00497796|20949290|P2|Overall Study|Consent withdrawn|3
6063459|NCT00497796|20949291|P1|Overall Study|Consent withdrawn|10
6063460|NCT00497796|20949290|P2|Overall Study|CMV infection or disease treatment|4
6063461|NCT00497796|20949291|P1|Overall Study|CMV infection or disease treatment|30
6063462|NCT00497796|20949290|P2|Overall Study|Adverse event (related)|4
6063463|NCT00497796|20949291|P1|Overall Study|Adverse event (related)|5
6063464|NCT00497796|20949290|P2|Overall Study|Adverse event (not related)|9
6063465|NCT00497796|20949291|P1|Overall Study|Adverse event (not related)|9
6063466|NCT00497198|20949378|P2|Overall Study|Withdrawal by Subject|1
6063467|NCT00497198|20949379|P1|Overall Study|Withdrawal by Subject|0
6063468|NCT00497198|20949378|P2|Overall Study|Physician Decision|2
6063469|NCT00497198|20949379|P1|Overall Study|Physician Decision|1
6063470|NCT00497198|20949378|P2|Overall Study|Adverse Event|2
6063471|NCT00497198|20949379|P1|Overall Study|Adverse Event|4
6063472|NCT00497146|20949395|P2|Long-term Follow-up Period|Other|1
6063473|NCT00497146|20949396|P1|Long-term Follow-up Period|Other|0
6063474|NCT00497146|20949395|P2|Long-term Follow-up Period|Lost to Follow-up|1
6063475|NCT00497146|20949396|P1|Long-term Follow-up Period|Lost to Follow-up|5
6063476|NCT00497146|20949395|P2|Long-term Follow-up Period|Withdrawal by Subject|2
6063477|NCT00497146|20949396|P1|Long-term Follow-up Period|Withdrawal by Subject|8
6063478|NCT00497146|20949395|P2|Long-term Follow-up Period|Adverse Event|2
6063479|NCT00497146|20949396|P1|Long-term Follow-up Period|Adverse Event|2
6063480|NCT00497146|20949395|P2|Treatment Period|Other Reason|3
6063481|NCT00497146|20949396|P1|Treatment Period|Other Reason|2
6063482|NCT00497146|20949395|P2|Treatment Period|Unable to dose reduce per protocol|1
6063483|NCT00497146|20949396|P1|Treatment Period|Unable to dose reduce per protocol|4
6063484|NCT00497146|20949395|P2|Treatment Period|Change in RAAS inhibitor therapy|2
6063485|NCT00497146|20949396|P1|Treatment Period|Change in RAAS inhibitor therapy|5
6063486|NCT00497146|20949395|P2|Treatment Period|Required dialysis|1
6063487|NCT00497146|20949396|P1|Treatment Period|Required dialysis|4
6063488|NCT00497146|20949395|P2|Treatment Period|Lost to Follow-up|3
6063489|NCT00497146|20949396|P1|Treatment Period|Lost to Follow-up|1
6063490|NCT00497146|20949395|P2|Treatment Period|Withdrawal by Subject|9
6063491|NCT00497146|20949396|P1|Treatment Period|Withdrawal by Subject|5
6063492|NCT00497146|20949395|P2|Treatment Period|Adverse Event|2
6063493|NCT00497146|20949396|P1|Treatment Period|Adverse Event|6
6063494|NCT00496964|20949464|P2|Overall Study|Withdrawal by Subject|1
6063495|NCT00496964|20949465|P1|Overall Study|Withdrawal by Subject|0
6063496|NCT00496873|20949483|P1|Overall Study|Withdrawal by Subject|3
6063497|NCT00496873|20949483|P1|Overall Study|Death|2
6063498|NCT00496873|20949483|P1|Overall Study|Ineligible|2
6063499|NCT00496834|20949516|P2|Overall Study|Blood Pressure control failure|1
6063500|NCT00496834|20949517|P1|Overall Study|Blood Pressure control failure|2
6063501|NCT00496834|20949516|P2|Overall Study|Lost to Follow-up|0
6063502|NCT00496834|20949517|P1|Overall Study|Lost to Follow-up|2
6063503|NCT00496834|20949516|P2|Overall Study|IP administration violation|0
6063504|NCT00496834|20949517|P1|Overall Study|IP administration violation|2
6063505|NCT00496834|20949516|P2|Overall Study|Adverse Event|3
6063506|NCT00496834|20949517|P1|Overall Study|Adverse Event|5
6063507|NCT00496834|20949516|P2|Overall Study|Inclusion/exclusion criteria not met|2
6063508|NCT00496834|20949517|P1|Overall Study|Inclusion/exclusion criteria not met|3
6063509|NCT00496834|20949516|P2|Overall Study|Contraindicated medication administered|1
6063510|NCT00496834|20949517|P1|Overall Study|Contraindicated medication administered|0
6063511|NCT00496834|20949516|P2|Overall Study|Withdrawal by Subject|6
6063512|NCT00496834|20949517|P1|Overall Study|Withdrawal by Subject|4
6063513|NCT00496782|20949536|P2|Overall Study|Protocol Violation|2
6063514|NCT00496782|20949537|P1|Overall Study|Protocol Violation|1
6063515|NCT00496769|20949571|P3|Open Label|>=1 reason assigned per patient|1011
6063516|NCT00496769|20949572|P2|Open Label|>=1 reason assigned per patient|0
6063517|NCT00496769|20949573|P1|Open Label|>=1 reason assigned per patient|0
6063518|NCT00496769|20949571|P3|Double Blind|>=1 reason assigned per patient|0
6063519|NCT00496769|20949572|P2|Double Blind|>=1 reason assigned per patient|649
6063520|NCT00496769|20949573|P1|Double Blind|>=1 reason assigned per patient|558
6063521|NCT00496730|20949603|P2|Overall Study|Withdrawal by Subject|2
6063522|NCT00496730|20949604|P1|Overall Study|Withdrawal by Subject|2
6063523|NCT00496730|20949603|P2|Overall Study|Lost to Follow-up|3
6063524|NCT00496730|20949604|P1|Overall Study|Lost to Follow-up|4
6063525|NCT00496626|20949616|P2|Overall Study|Relocated|1
6063526|NCT00496626|20949617|P1|Overall Study|Relocated|0
6063527|NCT00496626|20949616|P2|Overall Study|Withdrawal by Subject|4
6063528|NCT00496626|20949617|P1|Overall Study|Withdrawal by Subject|5
6063529|NCT00496626|20949616|P2|Overall Study|Protocol Violation|0
6063530|NCT00496626|20949617|P1|Overall Study|Protocol Violation|1
6063531|NCT00496626|20949616|P2|Overall Study|Lost to Follow-up|1
6063532|NCT00496626|20949617|P1|Overall Study|Lost to Follow-up|0
6063533|NCT00496587|20949629|P1|Overall Study|Complications unrelated|2
6063534|NCT00496587|20949629|P1|Overall Study|Death|1
6063535|NCT00496587|20949629|P1|Overall Study|Withdrawal by Subject|2
6063536|NCT00496587|20949629|P1|Overall Study|Progressive Disease|24
6063537|NCT00496587|20949629|P1|Overall Study|Adverse Event|2
6063538|NCT00496483|20949635|P1|Overall Study|Lack of Efficacy|1
6063539|NCT00496483|20949635|P1|Overall Study|Adverse Event|2
6063540|NCT00496483|20949635|P1|Overall Study|Not dosed|9
6063541|NCT00496470|20949652|P2|Overall Study|Other reason|2
6063542|NCT00496470|20949653|P1|Overall Study|Other reason|0
6063543|NCT00496470|20949652|P2|Overall Study|Incorrectly enrolled|5
6063544|NCT00496470|20949653|P1|Overall Study|Incorrectly enrolled|13
6063545|NCT00496470|20949652|P2|Overall Study|Withdrawal by Subject|12
6063546|NCT00496470|20949653|P1|Overall Study|Withdrawal by Subject|5
6063547|NCT00496470|20949652|P2|Overall Study|Adverse Event|10
6063548|NCT00496470|20949653|P1|Overall Study|Adverse Event|8
6063549|NCT00496366|20949739|P1|Overall Study|Death|1
6063550|NCT00496197|20949770|P1|Overall Study|Protocol Violation|8
6063551|NCT00496197|20949770|P1|Overall Study|Other|14
6063552|NCT00496197|20949770|P1|Overall Study|Pathogen not isolated baseline specimen|4
6063553|NCT00496197|20949770|P1|Overall Study|Withdrawal by Subject|11
6063554|NCT00496197|20949770|P1|Overall Study|Lost to Follow-up|11
6063555|NCT00496197|20949770|P1|Overall Study|Insufficient bacteriological response|10
6063556|NCT00496197|20949770|P1|Overall Study|Insufficient clinical response|3
6063557|NCT00496197|20949770|P1|Overall Study|Does not meet entrance criteria|5
6063558|NCT00496197|20949770|P1|Overall Study|Adverse Event|13
6063559|NCT00496197|20949770|P1|Overall Study|Discontinued study due to death|43
6063560|NCT00496080|20949797|P1|Overall Study|Physician Decision|6
6063561|NCT00496080|20949797|P1|Overall Study|Withdrawal by Subject|5
6063562|NCT00496080|20949797|P1|Overall Study|Surgical re-intervention|7
6063563|NCT00496080|20949797|P1|Overall Study|Lost to Follow-up|9
6063564|NCT00496054|20949807|P1|Overall Study|Lost to Follow-up|7
6063565|NCT00496054|20949807|P1|Overall Study|Adverse Event|1
6063566|NCT00496015|20949839|P5|Overall Study|Other|0
6063567|NCT00496015|20949840|P4|Overall Study|Other|1
6063568|NCT00496015|20949841|P3|Overall Study|Other|0
6063569|NCT00496015|20949842|P2|Overall Study|Other|0
6063570|NCT00496015|20949843|P1|Overall Study|Other|1
6063571|NCT00495820|20949967|P2|Overall Study|Adverse Event|1
6063572|NCT00495820|20949968|P1|Overall Study|Adverse Event|1
6063573|NCT00495794|20949980|P2|Overall Study|Pharmacist did not activate patient|0
6063574|NCT00495794|20949981|P1|Overall Study|Pharmacist did not activate patient|522
6063575|NCT00495755|20949991|P1|Overall Study|Adverse Event|3
6063576|NCT00495677|20950012|P7|Stage 1 (25 Days)|Adverse Event|0
6063577|NCT00495677|20950013|P6|Stage 1 (25 Days)|Adverse Event|0
6063578|NCT00495677|20950014|P5|Stage 1 (25 Days)|Adverse Event|0
6063579|NCT00495677|20950015|P4|Stage 1 (25 Days)|Adverse Event|0
6063580|NCT00495677|20950016|P3|Stage 1 (25 Days)|Adverse Event|1
6063581|NCT00495677|20950017|P2|Stage 1 (25 Days)|Adverse Event|0
6063582|NCT00495677|20950018|P1|Stage 1 (25 Days)|Adverse Event|0
6063583|NCT00495625|20950073|P1|Overall Study|Did not complete at least 1 42 day cycle|10
6063584|NCT00495612|20950084|P2|Overall Study|Subject's Decision to Withdraw|0
6063585|NCT00495612|20950085|P1|Overall Study|Subject's Decision to Withdraw|3
6063586|NCT00495612|20950084|P2|Overall Study|Lost to Follow-up|0
6063587|NCT00495612|20950085|P1|Overall Study|Lost to Follow-up|1
6063588|NCT00495586|20950103|P2|Overall Study|Withdrawal by Subject|4
6063589|NCT00495586|20950104|P1|Overall Study|Withdrawal by Subject|4
6063590|NCT00495521|20950114|P2|Overall Study|Physician Decision|1
6063591|NCT00495521|20950115|P1|Overall Study|Physician Decision|0
6063592|NCT00495495|20950145|P1|Overall Study|Protocol Violation|99
6063593|NCT00495469|20950165|P7|Overall Study|ST depression at randomisation in ECG|0
6063594|NCT00495469|20950166|P6|Overall Study|ST depression at randomisation in ECG|0
6063595|NCT00495469|20950167|P5|Overall Study|ST depression at randomisation in ECG|0
6063596|NCT00495469|20950168|P4|Overall Study|ST depression at randomisation in ECG|0
6063597|NCT00495469|20950169|P3|Overall Study|ST depression at randomisation in ECG|0
6063598|NCT00495469|20950170|P2|Overall Study|ST depression at randomisation in ECG|1
6063599|NCT00495469|20950171|P1|Overall Study|ST depression at randomisation in ECG|0
6063600|NCT00495469|20950165|P7|Overall Study|Liver function test abnormality|0
6063601|NCT00495469|20950166|P6|Overall Study|Liver function test abnormality|0
6063602|NCT00495469|20950167|P5|Overall Study|Liver function test abnormality|0
6063603|NCT00495469|20950168|P4|Overall Study|Liver function test abnormality|0
6063604|NCT00495469|20950169|P3|Overall Study|Liver function test abnormality|0
6063605|NCT00495469|20950170|P2|Overall Study|Liver function test abnormality|1
6063606|NCT00495469|20950171|P1|Overall Study|Liver function test abnormality|0
6063607|NCT00495469|20950165|P7|Overall Study|Lack of Efficacy|1
6063608|NCT00495469|20950166|P6|Overall Study|Lack of Efficacy|0
6063609|NCT00495469|20950167|P5|Overall Study|Lack of Efficacy|0
6063610|NCT00495469|20950168|P4|Overall Study|Lack of Efficacy|0
6063611|NCT00495469|20950169|P3|Overall Study|Lack of Efficacy|0
6063612|NCT00495469|20950170|P2|Overall Study|Lack of Efficacy|0
6063613|NCT00495469|20950171|P1|Overall Study|Lack of Efficacy|0
6063614|NCT00495469|20950165|P7|Overall Study|Withdrawal by Subject|3
6063615|NCT00495469|20950166|P6|Overall Study|Withdrawal by Subject|2
6063616|NCT00495469|20950167|P5|Overall Study|Withdrawal by Subject|3
6063617|NCT00495469|20950168|P4|Overall Study|Withdrawal by Subject|3
6063618|NCT00495469|20950169|P3|Overall Study|Withdrawal by Subject|1
6063619|NCT00495469|20950170|P2|Overall Study|Withdrawal by Subject|3
6063620|NCT00495469|20950171|P1|Overall Study|Withdrawal by Subject|5
6063621|NCT00495469|20950165|P7|Overall Study|Protocol Violation|0
6063622|NCT00495469|20950166|P6|Overall Study|Protocol Violation|2
6063623|NCT00495469|20950167|P5|Overall Study|Protocol Violation|1
6063624|NCT00495469|20950168|P4|Overall Study|Protocol Violation|0
6063625|NCT00495469|20950169|P3|Overall Study|Protocol Violation|0
6063626|NCT00495469|20950170|P2|Overall Study|Protocol Violation|0
6063627|NCT00495469|20950171|P1|Overall Study|Protocol Violation|0
6063628|NCT00495469|20950165|P7|Overall Study|Lost to Follow-up|0
6063629|NCT00495469|20950166|P6|Overall Study|Lost to Follow-up|0
6063630|NCT00495469|20950167|P5|Overall Study|Lost to Follow-up|0
6063631|NCT00495469|20950168|P4|Overall Study|Lost to Follow-up|1
6063632|NCT00495469|20950169|P3|Overall Study|Lost to Follow-up|3
6063633|NCT00495469|20950170|P2|Overall Study|Lost to Follow-up|1
6063634|NCT00495469|20950171|P1|Overall Study|Lost to Follow-up|1
6063635|NCT00495469|20950165|P7|Overall Study|Adverse Event|1
6063636|NCT00495469|20950166|P6|Overall Study|Adverse Event|1
6063637|NCT00495469|20950167|P5|Overall Study|Adverse Event|1
6063638|NCT00495469|20950168|P4|Overall Study|Adverse Event|0
6063639|NCT00495469|20950169|P3|Overall Study|Adverse Event|3
6063640|NCT00495469|20950170|P2|Overall Study|Adverse Event|1
6063641|NCT00495469|20950171|P1|Overall Study|Adverse Event|0
6063642|NCT00495391|20950315|P2|Overall Study|Withdrawal by Subject|3
6063643|NCT00495391|20950316|P1|Overall Study|Withdrawal by Subject|2
6063644|NCT00495391|20950315|P2|Overall Study|Lack of Efficacy|18
6063645|NCT00495391|20950316|P1|Overall Study|Lack of Efficacy|34
6063646|NCT00495170|20950339|P1|Overall Study|Inappropriate staging|8
6063647|NCT00495170|20950339|P1|Overall Study|Withdrawal by Subject|3
6063648|NCT00495170|20950339|P1|Overall Study|Lost to Follow-up|9
6063649|NCT00495131|20950358|P2|Overall Study|Withdrawal by Subject|0
6063650|NCT00495131|20950359|P1|Overall Study|Withdrawal by Subject|1
6063651|NCT00495131|20950358|P2|Overall Study|Lost to Follow-up|2
6063652|NCT00495131|20950359|P1|Overall Study|Lost to Follow-up|0
6063653|NCT00495131|20950358|P2|Overall Study|Lack of Efficacy|2
6063654|NCT00495131|20950359|P1|Overall Study|Lack of Efficacy|0
6063655|NCT00495131|20950358|P2|Overall Study|Adverse Event|2
6063656|NCT00495131|20950359|P1|Overall Study|Adverse Event|6
6063657|NCT00495040|20950376|P1|Overall Study|Withdrawal by Subject|3
6063658|NCT00494871|20950391|P2|Follow-up (FU) Period|Clinical Endpoint Reached|2
6063659|NCT00494871|20950392|P1|Follow-up (FU) Period|Clinical Endpoint Reached|3
6063660|NCT00494871|20950391|P2|Follow-up (FU) Period|Withdrawal by Subject|5
6063661|NCT00494871|20950392|P1|Follow-up (FU) Period|Withdrawal by Subject|5
6063662|NCT00494871|20950391|P2|Follow-up (FU) Period|Protocol Violation|0
6063663|NCT00494871|20950392|P1|Follow-up (FU) Period|Protocol Violation|1
6063664|NCT00494871|20950391|P2|Follow-up (FU) Period|Physician Decision|1
6063665|NCT00494871|20950392|P1|Follow-up (FU) Period|Physician Decision|0
6063666|NCT00494871|20950391|P2|Follow-up (FU) Period|Lost to Follow-up|2
6063667|NCT00494871|20950392|P1|Follow-up (FU) Period|Lost to Follow-up|6
6063668|NCT00494871|20950391|P2|Follow-up (FU) Period|Death|12
6063669|NCT00494871|20950392|P1|Follow-up (FU) Period|Death|13
6063670|NCT00494871|20950391|P2|Follow-up (FU) Period|Adverse Event|1
6063671|NCT00494871|20950392|P1|Follow-up (FU) Period|Adverse Event|1
6063672|NCT00494871|20950391|P2|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1
6063673|NCT00494871|20950392|P1|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1
6063674|NCT00494871|20950391|P2|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1
6063675|NCT00494871|20950392|P1|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1
6063676|NCT00494871|20950391|P2|Double-blind (DB) Treatment Period|Site Closed by Investigator|2
6063677|NCT00494871|20950392|P1|Double-blind (DB) Treatment Period|Site Closed by Investigator|1
6063678|NCT00494871|20950391|P2|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|8
6063679|NCT00494871|20950392|P1|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|12
6063680|NCT00494871|20950391|P2|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|1
6063681|NCT00494871|20950392|P1|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|3
6063682|NCT00494871|20950391|P2|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|28
6063683|NCT00494871|20950392|P1|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|18
6063684|NCT00494871|20950391|P2|Double-blind (DB) Treatment Period|Protocol Violation|9
6063685|NCT00494871|20950392|P1|Double-blind (DB) Treatment Period|Protocol Violation|9
6063686|NCT00494871|20950391|P2|Double-blind (DB) Treatment Period|Lost to Follow-up|1
6063687|NCT00494871|20950392|P1|Double-blind (DB) Treatment Period|Lost to Follow-up|4
6063688|NCT00494871|20950391|P2|Double-blind (DB) Treatment Period|Physician Decision|13
6063689|NCT00494871|20950392|P1|Double-blind (DB) Treatment Period|Physician Decision|4
6063690|NCT00494871|20950391|P2|Double-blind (DB) Treatment Period|Death|3
6063691|NCT00494871|20950392|P1|Double-blind (DB) Treatment Period|Death|8
6063692|NCT00494871|20950391|P2|Double-blind (DB) Treatment Period|Withdrawal by Subject|35
6063693|NCT00494871|20950392|P1|Double-blind (DB) Treatment Period|Withdrawal by Subject|26
6063694|NCT00494871|20950391|P2|Double-blind (DB) Treatment Period|Adverse Event|70
6063695|NCT00494871|20950392|P1|Double-blind (DB) Treatment Period|Adverse Event|73
6063696|NCT00494780|20950433|P2|Overall Study|Insurance Issues|1
6063697|NCT00494780|20950434|P1|Overall Study|Insurance Issues|0
6063698|NCT00494780|20950433|P2|Overall Study|Residual Tumour Mass|1
6063699|NCT00494780|20950434|P1|Overall Study|Residual Tumour Mass|0
6063700|NCT00494780|20950433|P2|Overall Study|Non-compliance|0
6063701|NCT00494780|20950434|P1|Overall Study|Non-compliance|1
6063702|NCT00494780|20950433|P2|Overall Study|New Treatment|2
6063703|NCT00494780|20950434|P1|Overall Study|New Treatment|2
6063704|NCT00494780|20950433|P2|Overall Study|Progression of Study Disease|8
6063705|NCT00494780|20950434|P1|Overall Study|Progression of Study Disease|7
6063706|NCT00494780|20950433|P2|Overall Study|Withdrew before Dosed|1
6063707|NCT00494780|20950434|P1|Overall Study|Withdrew before Dosed|0
6063708|NCT00494780|20950433|P2|Overall Study|Adverse Event|0
6063709|NCT00494780|20950434|P1|Overall Study|Adverse Event|1
6063710|NCT00494676|20950472|P2|Second Intervention|Withdrawal by Subject|1
6063711|NCT00494676|20950473|P1|Second Intervention|Withdrawal by Subject|1
6063712|NCT00494676|20950472|P2|First Intervention|Withdrawal by Subject|3
6063713|NCT00494676|20950473|P1|First Intervention|Withdrawal by Subject|1
6063714|NCT00494676|20950472|P2|Allocation|Withdrawal by Subject|4
6063715|NCT00494676|20950473|P1|Allocation|Withdrawal by Subject|2
6063716|NCT00494507|20950488|P4|Open-Label Phase|Worsening Disease|2
6063717|NCT00494507|20950489|P3|Open-Label Phase|Worsening Disease|0
6063718|NCT00494507|20950490|P2|Open-Label Phase|Worsening Disease|0
6063719|NCT00494507|20950491|P1|Open-Label Phase|Worsening Disease|0
6063720|NCT00494507|20950488|P4|Open-Label Phase|Adverse Event|3
6063721|NCT00494507|20950489|P3|Open-Label Phase|Adverse Event|5
6063722|NCT00494507|20950490|P2|Open-Label Phase|Adverse Event|1
6063723|NCT00494507|20950491|P1|Open-Label Phase|Adverse Event|0
6063724|NCT00494507|20950488|P4|Double-Blind Phase|Negative DNA test|1
6063725|NCT00494507|20950489|P3|Double-Blind Phase|Negative DNA test|0
6063726|NCT00494507|20950490|P2|Double-Blind Phase|Negative DNA test|0
6063727|NCT00494507|20950491|P1|Double-Blind Phase|Negative DNA test|0
6063728|NCT00494507|20950488|P4|Double-Blind Phase|Subject Non-compliance|0
6063729|NCT00494507|20950489|P3|Double-Blind Phase|Subject Non-compliance|1
6063730|NCT00494507|20950490|P2|Double-Blind Phase|Subject Non-compliance|0
6063731|NCT00494507|20950491|P1|Double-Blind Phase|Subject Non-compliance|0
6063732|NCT00494507|20950488|P4|Double-Blind Phase|Withdrawal by Subject|0
6063733|NCT00494507|20950489|P3|Double-Blind Phase|Withdrawal by Subject|0
6063734|NCT00494507|20950490|P2|Double-Blind Phase|Withdrawal by Subject|0
6063735|NCT00494507|20950491|P1|Double-Blind Phase|Withdrawal by Subject|1
6063736|NCT00494507|20950488|P4|Double-Blind Phase|Adverse Event|0
6063737|NCT00494507|20950489|P3|Double-Blind Phase|Adverse Event|1
6063738|NCT00494507|20950490|P2|Double-Blind Phase|Adverse Event|0
6063739|NCT00494507|20950491|P1|Double-Blind Phase|Adverse Event|2
6063740|NCT00494481|20950558|P2|Overall Study|Never received IP|0
6063741|NCT00494481|20950559|P1|Overall Study|Never received IP|2
6063742|NCT00494481|20950558|P2|Overall Study|Other|0
6063743|NCT00494481|20950559|P1|Overall Study|Other|1
6063744|NCT00494481|20950558|P2|Overall Study|Adverse Event|11
6063745|NCT00494481|20950559|P1|Overall Study|Adverse Event|15
6063746|NCT00494481|20950558|P2|Overall Study|Condition under investigation worsened|13
6063747|NCT00494481|20950559|P1|Overall Study|Condition under investigation worsened|11
6063748|NCT00494442|20950567|P2|Overall Study|Intercurrent illness|1
6063749|NCT00494442|20950568|P1|Overall Study|Intercurrent illness|0
6063750|NCT00494442|20950567|P2|Overall Study|Non-compliance|1
6063751|NCT00494442|20950568|P1|Overall Study|Non-compliance|0
6063752|NCT00494442|20950567|P2|Overall Study|Physician Decision|1
6063753|NCT00494442|20950568|P1|Overall Study|Physician Decision|0
6063754|NCT00494442|20950567|P2|Overall Study|Adverse Event|2
6063755|NCT00494442|20950568|P1|Overall Study|Adverse Event|0
6063756|NCT00494442|20950567|P2|Overall Study|Lack of Efficacy|10
6063757|NCT00494442|20950568|P1|Overall Study|Lack of Efficacy|16
6063758|NCT00494442|20950567|P2|Overall Study|Death|1
6063759|NCT00494442|20950568|P1|Overall Study|Death|1
6063760|NCT00494299|20950584|P2|Overall Study|Protocol Driven Decision Point|22
6063761|NCT00494299|20950585|P1|Overall Study|Protocol Driven Decision Point|11
6063762|NCT00494299|20950584|P2|Overall Study|Site Closed by Sponsor|0
6063763|NCT00494299|20950585|P1|Overall Study|Site Closed by Sponsor|6
6063764|NCT00494299|20950584|P2|Overall Study|Participant Did Not Take Study Drug|2
6063765|NCT00494299|20950585|P1|Overall Study|Participant Did Not Take Study Drug|0
6063766|NCT00494299|20950584|P2|Overall Study|Disease Progression, Recurrence/Relapse|185
6063767|NCT00494299|20950585|P1|Overall Study|Disease Progression, Recurrence/Relapse|109
6063768|NCT00494299|20950584|P2|Overall Study|Withdrawal by Subject|3
6063769|NCT00494299|20950585|P1|Overall Study|Withdrawal by Subject|8
6063770|NCT00494299|20950584|P2|Overall Study|Protocol Violation|2
6063771|NCT00494299|20950585|P1|Overall Study|Protocol Violation|1
6063772|NCT00494299|20950584|P2|Overall Study|Physician Decision|2
6063773|NCT00494299|20950585|P1|Overall Study|Physician Decision|0
6063774|NCT00494299|20950584|P2|Overall Study|Lost to Follow-up|0
6063775|NCT00494299|20950585|P1|Overall Study|Lost to Follow-up|1
6063776|NCT00494299|20950584|P2|Overall Study|Adverse Event|13
6063777|NCT00494299|20950585|P1|Overall Study|Adverse Event|93
6063784|NCT00494221|20950617|P3|Overall Study|Withdrawal by Subject|0
6063785|NCT00494221|20950618|P2|Overall Study|Withdrawal by Subject|2
6063786|NCT00494221|20950619|P1|Overall Study|Withdrawal by Subject|1
6063787|NCT00494221|20950617|P3|Overall Study|Death|14
6063788|NCT00494221|20950618|P2|Overall Study|Death|9
6063789|NCT00494221|20950619|P1|Overall Study|Death|15
6063790|NCT00494091|20950660|P2|Overall Study|Withdrawal by Subject|7
6063791|NCT00494091|20950661|P1|Overall Study|Withdrawal by Subject|0
6063792|NCT00494091|20950660|P2|Overall Study|Other|11
6063793|NCT00494091|20950661|P1|Overall Study|Other|1
6063794|NCT00494091|20950660|P2|Overall Study|Lost to Follow-up|4
6063795|NCT00494091|20950661|P1|Overall Study|Lost to Follow-up|0
6063796|NCT00494091|20950660|P2|Overall Study|Death|54
6063797|NCT00494091|20950661|P1|Overall Study|Death|5
6063798|NCT00494026|20950683|P1|Overall Study|Sponsor Decision|4
6063799|NCT00494013|20950693|P2|Overall Study|Sponsor Decision|1
6063800|NCT00494013|20950694|P1|Overall Study|Sponsor Decision|0
6063801|NCT00494013|20950693|P2|Overall Study|Withdrawal by Subject|14
6063802|NCT00494013|20950694|P1|Overall Study|Withdrawal by Subject|13
6063803|NCT00494013|20950693|P2|Overall Study|Protocol Violation|5
6063804|NCT00494013|20950694|P1|Overall Study|Protocol Violation|8
6063805|NCT00494013|20950693|P2|Overall Study|Physician Decision|5
6063806|NCT00494013|20950694|P1|Overall Study|Physician Decision|3
6063807|NCT00494013|20950693|P2|Overall Study|Lost to Follow-up|6
6063808|NCT00494013|20950694|P1|Overall Study|Lost to Follow-up|5
6063809|NCT00494013|20950693|P2|Overall Study|Entry Criteria Not Met|4
6063810|NCT00494013|20950694|P1|Overall Study|Entry Criteria Not Met|1
6063811|NCT00494013|20950693|P2|Overall Study|Adverse Event|1
6063812|NCT00494013|20950694|P1|Overall Study|Adverse Event|0
6063813|NCT00493974|20950724|P2|Overall Study|Lost to Follow-up|6
6063814|NCT00493974|20950725|P1|Overall Study|Lost to Follow-up|4
6063815|NCT00493974|20950724|P2|Overall Study|Withdrawal by Subject|6
6063816|NCT00493974|20950725|P1|Overall Study|Withdrawal by Subject|8
6063817|NCT00493974|20950724|P2|Overall Study|Death|2
6063818|NCT00493974|20950725|P1|Overall Study|Death|1
6063819|NCT00493779|20950752|P1|Overall Study|Logistical issue at site|1
6063820|NCT00493649|20950759|P1|Overall Study|Other|13
6063821|NCT00493649|20950759|P1|Overall Study|Lost to Follow-up|1
6063822|NCT00493649|20950759|P1|Overall Study|Disease Progression|1
6063823|NCT00493649|20950759|P1|Overall Study|Investigator Request|2
6063824|NCT00493649|20950759|P1|Overall Study|Patient Request|21
6063825|NCT00493649|20950759|P1|Overall Study|Adverse Event|44
6063826|NCT00493636|20950772|P2|Overall Study|Mis-randomization|1
6063827|NCT00493636|20950773|P1|Overall Study|Mis-randomization|1
6063828|NCT00493636|20950772|P2|Overall Study|Disease progression/recurrence/relapse|1
6063829|NCT00493636|20950773|P1|Overall Study|Disease progression/recurrence/relapse|0
6063830|NCT00493636|20950772|P2|Overall Study|Withdrawal by Subject|0
6063831|NCT00493636|20950773|P1|Overall Study|Withdrawal by Subject|1
6063832|NCT00493467|20950787|P1|Overall Study|Death|1
6063833|NCT00493454|20950792|P1|Overall Study|Withdrawal by Subject|1
6063834|NCT00493311|20950798|P2|Overall Study|Need for rescue medication|2
6063835|NCT00493311|20950799|P1|Overall Study|Need for rescue medication|2
6063836|NCT00493285|20950819|P6|Overall Study|Lost to Follow-up|0
6063837|NCT00493285|20950820|P5|Overall Study|Lost to Follow-up|1
6063838|NCT00493285|20950821|P4|Overall Study|Lost to Follow-up|0
6063839|NCT00493285|20950822|P3|Overall Study|Lost to Follow-up|0
6063840|NCT00493285|20950823|P2|Overall Study|Lost to Follow-up|0
6063841|NCT00493285|20950824|P1|Overall Study|Lost to Follow-up|0
6063842|NCT00493246|20951056|P8|Overall Study|Lost to Follow-up|0
6063843|NCT00493246|20951057|P7|Overall Study|Lost to Follow-up|1
6063844|NCT00493246|20951058|P6|Overall Study|Lost to Follow-up|0
6063845|NCT00493246|20951059|P5|Overall Study|Lost to Follow-up|0
6063846|NCT00493246|20951060|P4|Overall Study|Lost to Follow-up|0
6063847|NCT00493246|20951061|P3|Overall Study|Lost to Follow-up|0
6063848|NCT00493246|20951062|P2|Overall Study|Lost to Follow-up|0
6063849|NCT00493246|20951063|P1|Overall Study|Lost to Follow-up|0
6063850|NCT00493246|20951056|P8|Overall Study|No access to draw blood|0
6063851|NCT00493246|20951057|P7|Overall Study|No access to draw blood|0
6063852|NCT00493246|20951058|P6|Overall Study|No access to draw blood|1
6063853|NCT00493246|20951059|P5|Overall Study|No access to draw blood|0
6063854|NCT00493246|20951060|P4|Overall Study|No access to draw blood|0
6063855|NCT00493246|20951061|P3|Overall Study|No access to draw blood|0
6063856|NCT00493246|20951062|P2|Overall Study|No access to draw blood|0
6063857|NCT00493246|20951063|P1|Overall Study|No access to draw blood|0
6063858|NCT00493246|20951056|P8|Overall Study|Withdrawal by Subject|0
6063859|NCT00493246|20951057|P7|Overall Study|Withdrawal by Subject|0
6063860|NCT00493246|20951058|P6|Overall Study|Withdrawal by Subject|0
6063861|NCT00493246|20951059|P5|Overall Study|Withdrawal by Subject|1
6063862|NCT00493246|20951060|P4|Overall Study|Withdrawal by Subject|0
6063863|NCT00493246|20951061|P3|Overall Study|Withdrawal by Subject|0
6063864|NCT00493246|20951062|P2|Overall Study|Withdrawal by Subject|0
6063865|NCT00493246|20951063|P1|Overall Study|Withdrawal by Subject|0
6063866|NCT00493220|20951127|P6|Third Intervention|Withdrawal by Subject|0
6063867|NCT00493220|20951128|P5|Third Intervention|Withdrawal by Subject|0
6063868|NCT00493220|20951129|P4|Third Intervention|Withdrawal by Subject|0
6063869|NCT00493220|20951130|P3|Third Intervention|Withdrawal by Subject|0
6063870|NCT00493220|20951131|P2|Third Intervention|Withdrawal by Subject|0
6063871|NCT00493220|20951132|P1|Third Intervention|Withdrawal by Subject|1
6063872|NCT00493038|20951160|P2|Follow-up|Lost to Follow-up|0
6063873|NCT00493038|20951161|P1|Follow-up|Lost to Follow-up|1
6063874|NCT00493038|20951160|P2|Treatment|Other|1
6063875|NCT00493038|20951161|P1|Treatment|Other|0
6063876|NCT00493038|20951160|P2|Treatment|Withdrawal by Subject|12
6063877|NCT00493038|20951161|P1|Treatment|Withdrawal by Subject|11
6063878|NCT00493038|20951160|P2|Treatment|Lost to Follow-up|3
6063879|NCT00493038|20951161|P1|Treatment|Lost to Follow-up|5
6063880|NCT00493038|20951160|P2|Treatment|Adverse Event|4
6063881|NCT00493038|20951161|P1|Treatment|Adverse Event|8
6063882|NCT00493025|20951175|P1|Overall Study|Physician Decision|19
6063883|NCT00493012|20951186|P2|Overall Study|Lost to Follow-up|17
6063884|NCT00493012|20951187|P1|Overall Study|Lost to Follow-up|18
6063885|NCT00492921|20951230|P3|Overall Study|Death|1
6063886|NCT00492921|20951231|P2|Overall Study|Death|0
6063887|NCT00492921|20951232|P1|Overall Study|Death|1
6063888|NCT00492856|20951243|P4|Post-consolidation|Observation Arm|0
6063889|NCT00492856|20951244|P3|Post-consolidation|Observation Arm|27
6063890|NCT00492856|20951245|P2|Post-consolidation|Observation Arm|0
6063891|NCT00492856|20951246|P1|Post-consolidation|Observation Arm|0
6063892|NCT00492856|20951243|P4|Post-consolidation|Lost to Follow-up|0
6063893|NCT00492856|20951244|P3|Post-consolidation|Lost to Follow-up|0
6063894|NCT00492856|20951245|P2|Post-consolidation|Lost to Follow-up|2
6063895|NCT00492856|20951246|P1|Post-consolidation|Lost to Follow-up|0
6063896|NCT00492856|20951243|P4|Post-consolidation|Not protocol specified|0
6063897|NCT00492856|20951244|P3|Post-consolidation|Not protocol specified|0
6063898|NCT00492856|20951245|P2|Post-consolidation|Not protocol specified|1
6063899|NCT00492856|20951246|P1|Post-consolidation|Not protocol specified|0
6063900|NCT00492856|20951243|P4|Post-consolidation|Death|0
6063901|NCT00492856|20951244|P3|Post-consolidation|Death|0
6063902|NCT00492856|20951245|P2|Post-consolidation|Death|1
6063903|NCT00492856|20951246|P1|Post-consolidation|Death|0
6063904|NCT00492856|20951243|P4|Post-consolidation|Withdrawal by Subject|0
6063905|NCT00492856|20951244|P3|Post-consolidation|Withdrawal by Subject|0
6063906|NCT00492856|20951245|P2|Post-consolidation|Withdrawal by Subject|4
6063907|NCT00492856|20951246|P1|Post-consolidation|Withdrawal by Subject|0
6063908|NCT00492856|20951243|P4|Post-consolidation|Adverse Event|1
6063909|NCT00492856|20951244|P3|Post-consolidation|Adverse Event|0
6063910|NCT00492856|20951245|P2|Post-consolidation|Adverse Event|4
6063911|NCT00492856|20951246|P1|Post-consolidation|Adverse Event|0
6063912|NCT00492856|20951243|P4|Consolidation|Lost to Follow-up|0
6063913|NCT00492856|20951244|P3|Consolidation|Lost to Follow-up|0
6063914|NCT00492856|20951245|P2|Consolidation|Lost to Follow-up|0
6063915|NCT00492856|20951246|P1|Consolidation|Lost to Follow-up|1
6063916|NCT00492856|20951243|P4|Consolidation|Not protocol specified|0
6063917|NCT00492856|20951244|P3|Consolidation|Not protocol specified|0
6063918|NCT00492856|20951245|P2|Consolidation|Not protocol specified|0
6063919|NCT00492856|20951246|P1|Consolidation|Not protocol specified|2
6063920|NCT00492856|20951243|P4|Consolidation|Adverse Event|0
6063921|NCT00492856|20951244|P3|Consolidation|Adverse Event|0
6063922|NCT00492856|20951245|P2|Consolidation|Adverse Event|0
6063923|NCT00492856|20951246|P1|Consolidation|Adverse Event|6
6063924|NCT00492856|20951243|P4|Induction|Death|0
6063925|NCT00492856|20951244|P3|Induction|Death|0
6063926|NCT00492856|20951245|P2|Induction|Death|0
6063927|NCT00492856|20951246|P1|Induction|Death|3
6063928|NCT00492856|20951243|P4|Induction|Withdrawal by Subject|0
6063929|NCT00492856|20951244|P3|Induction|Withdrawal by Subject|0
6063930|NCT00492856|20951245|P2|Induction|Withdrawal by Subject|0
6063931|NCT00492856|20951246|P1|Induction|Withdrawal by Subject|1
6063932|NCT00492856|20951243|P4|Induction|Adverse Event|0
6063933|NCT00492856|20951244|P3|Induction|Adverse Event|0
6063934|NCT00492856|20951245|P2|Induction|Adverse Event|0
6063935|NCT00492856|20951246|P1|Induction|Adverse Event|2
6063936|NCT00492752|20951260|P4|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0
6063937|NCT00492752|20951261|P3|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0
6063938|NCT00492752|20951262|P2|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0
6063939|NCT00492752|20951263|P1|Follow-up and/or Open Label Sorafenib|Progression measurement proven|1
6063940|NCT00492752|20951260|P4|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0
6063941|NCT00492752|20951261|P3|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0
6063942|NCT00492752|20951262|P2|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|6
6063943|NCT00492752|20951263|P1|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0
6063944|NCT00492752|20951260|P4|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|1
6063945|NCT00492752|20951261|P3|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0
6063946|NCT00492752|20951262|P2|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0
6063947|NCT00492752|20951263|P1|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0
6063948|NCT00492752|20951260|P4|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|2
6063949|NCT00492752|20951261|P3|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0
6063950|NCT00492752|20951262|P2|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|1
6063951|NCT00492752|20951263|P1|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0
6063952|NCT00492752|20951260|P4|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0
6063953|NCT00492752|20951261|P3|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0
6063954|NCT00492752|20951262|P2|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|1
6063955|NCT00492752|20951263|P1|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|2
6063956|NCT00492752|20951260|P4|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|0
6063957|NCT00492752|20951261|P3|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|2
6063958|NCT00492752|20951262|P2|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|1
6063959|NCT00492752|20951263|P1|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|8
6063960|NCT00492752|20951260|P4|Follow-up and/or Open Label Sorafenib|Death|1
6063961|NCT00492752|20951261|P3|Follow-up and/or Open Label Sorafenib|Death|45
6063962|NCT00492752|20951262|P2|Follow-up and/or Open Label Sorafenib|Death|5
6063963|NCT00492752|20951263|P1|Follow-up and/or Open Label Sorafenib|Death|75
6063964|NCT00492752|20951260|P4|Follow-up and/or Open Label Sorafenib|Adverse Event|2
6063965|NCT00492752|20951261|P3|Follow-up and/or Open Label Sorafenib|Adverse Event|0
6063966|NCT00492752|20951262|P2|Follow-up and/or Open Label Sorafenib|Adverse Event|2
6063967|NCT00492752|20951263|P1|Follow-up and/or Open Label Sorafenib|Adverse Event|0
6063968|NCT00492752|20951260|P4|Double Blind Treatment|Protocol Violation|0
6063969|NCT00492752|20951261|P3|Double Blind Treatment|Protocol Violation|1
6063970|NCT00492752|20951262|P2|Double Blind Treatment|Protocol Violation|0
6063971|NCT00492752|20951263|P1|Double Blind Treatment|Protocol Violation|0
6063972|NCT00492752|20951260|P4|Double Blind Treatment|Adverse Event|0
6063973|NCT00492752|20951261|P3|Double Blind Treatment|Adverse Event|0
6063974|NCT00492752|20951262|P2|Double Blind Treatment|Adverse Event|0
6063975|NCT00492752|20951263|P1|Double Blind Treatment|Adverse Event|1
6063976|NCT00492752|20951260|P4|Double Blind Treatment|Death|0
6063977|NCT00492752|20951261|P3|Double Blind Treatment|Death|2
6063978|NCT00492752|20951262|P2|Double Blind Treatment|Death|0
6063979|NCT00492752|20951263|P1|Double Blind Treatment|Death|13
6063980|NCT00492726|20951298|P2|Overall Study|Non compliant with study medication|3
6063981|NCT00492726|20951299|P1|Overall Study|Non compliant with study medication|0
6063982|NCT00492726|20951298|P2|Overall Study|Withdrawal by Subject|3
6063983|NCT00492726|20951299|P1|Overall Study|Withdrawal by Subject|6
6063984|NCT00492726|20951298|P2|Overall Study|Physician Decision|1
6063985|NCT00492726|20951299|P1|Overall Study|Physician Decision|0
6063986|NCT00492726|20951298|P2|Overall Study|Lost to Follow-up|19
6063987|NCT00492726|20951299|P1|Overall Study|Lost to Follow-up|27
6063988|NCT00492726|20951298|P2|Overall Study|Lack of Efficacy|2
6063989|NCT00492726|20951299|P1|Overall Study|Lack of Efficacy|0
6063990|NCT00492726|20951298|P2|Overall Study|Death|2
6063991|NCT00492726|20951299|P1|Overall Study|Death|7
6063992|NCT00492726|20951298|P2|Overall Study|Adverse Event|6
6063993|NCT00492726|20951299|P1|Overall Study|Adverse Event|10
6063994|NCT00492648|20951325|P2|Month 30 (109671 Study)|Protocol Violation|1
6063995|NCT00492648|20951326|P1|Month 30 (109671 Study)|Protocol Violation|0
6063996|NCT00492557|20951373|P2|Overall Study|Lost to Follow-up|1
6063997|NCT00492557|20951374|P1|Overall Study|Lost to Follow-up|0
6063998|NCT00492557|20951373|P2|Overall Study|Failed to return|0
6063999|NCT00492557|20951374|P1|Overall Study|Failed to return|1
6064000|NCT00492557|20951373|P2|Overall Study|Adverse Event|0
6064001|NCT00492557|20951374|P1|Overall Study|Adverse Event|1
6064002|NCT00492557|20951373|P2|Overall Study|Death|1
6064003|NCT00492557|20951374|P1|Overall Study|Death|1
6064004|NCT00492557|20951373|P2|Overall Study|Other|2
6064005|NCT00492557|20951374|P1|Overall Study|Other|2
6064006|NCT00492557|20951373|P2|Overall Study|Protocol Violation|8
6064007|NCT00492557|20951374|P1|Overall Study|Protocol Violation|7
6064008|NCT00492557|20951373|P2|Overall Study|Subject request|11
6064009|NCT00492557|20951374|P1|Overall Study|Subject request|12
6064010|NCT00492531|20951404|P2|Overall Study|Withdrawn(More than one reason selected)|23
6064011|NCT00492531|20951405|P1|Overall Study|Withdrawn(More than one reason selected)|22
6064012|NCT00492297|20951478|P1|Survival Only Follow-up|Study terminated by sponsor|12
6064013|NCT00492297|20951478|P1|Survival Only Follow-up|Lack of Efficacy|1
6064014|NCT00492297|20951478|P1|Survival Only Follow-up|Death|46
6064015|NCT00492297|20951478|P1|Active Follow-up 30(+4) Days Duration|Study terminated by sponsor|2
6064016|NCT00492297|20951478|P1|Active Follow-up 30(+4) Days Duration|Death|17
6064017|NCT00492297|20951478|P1|Treatment|Study terminated by sponsor|3
6064018|NCT00492297|20951478|P1|Treatment|Death|2
6064019|NCT00492284|20951496|P4|Overall Study|Withdrawal by Subject|2
6064020|NCT00492284|20951497|P3|Overall Study|Withdrawal by Subject|0
6064021|NCT00492284|20951498|P2|Overall Study|Withdrawal by Subject|0
6064022|NCT00492284|20951499|P1|Overall Study|Withdrawal by Subject|1
6064023|NCT00492284|20951496|P4|Overall Study|Death|5
6064024|NCT00492284|20951497|P3|Overall Study|Death|2
6064025|NCT00492284|20951498|P2|Overall Study|Death|3
6064026|NCT00492284|20951499|P1|Overall Study|Death|0
6064027|NCT00492284|20951496|P4|Overall Study|Lost to Follow-up|1
6064028|NCT00492284|20951497|P3|Overall Study|Lost to Follow-up|3
6064029|NCT00492284|20951498|P2|Overall Study|Lost to Follow-up|0
6064030|NCT00492284|20951499|P1|Overall Study|Lost to Follow-up|0
6064031|NCT00492284|20951496|P4|Overall Study|Adverse Event|2
6064032|NCT00492284|20951497|P3|Overall Study|Adverse Event|1
6064033|NCT00492284|20951498|P2|Overall Study|Adverse Event|1
6064034|NCT00492284|20951499|P1|Overall Study|Adverse Event|0
6064035|NCT00492232|20951543|P2|Open-Label Treatment|Withdrawal by Subject|0
6064036|NCT00492232|20951544|P1|Open-Label Treatment|Withdrawal by Subject|1
6064037|NCT00492232|20951543|P2|Double-Blind Treatment|Randomized not treated|0
6064038|NCT00492232|20951544|P1|Double-Blind Treatment|Randomized not treated|1
6064039|NCT00492232|20951543|P2|Double-Blind Treatment|Other|5
6064040|NCT00492232|20951544|P1|Double-Blind Treatment|Other|6
6064041|NCT00492232|20951543|P2|Double-Blind Treatment|Lack of Efficacy|0
6064042|NCT00492232|20951544|P1|Double-Blind Treatment|Lack of Efficacy|1
6064043|NCT00492232|20951543|P2|Double-Blind Treatment|Withdrawal by Subject|8
6064044|NCT00492232|20951544|P1|Double-Blind Treatment|Withdrawal by Subject|4
6064045|NCT00492232|20951543|P2|Double-Blind Treatment|Lost to Follow-up|3
6064046|NCT00492232|20951544|P1|Double-Blind Treatment|Lost to Follow-up|2
6064047|NCT00492232|20951543|P2|Double-Blind Treatment|Protocol Violation|7
6064048|NCT00492232|20951544|P1|Double-Blind Treatment|Protocol Violation|3
6064049|NCT00492232|20951543|P2|Double-Blind Treatment|Adverse Event|2
6064050|NCT00492232|20951544|P1|Double-Blind Treatment|Adverse Event|1
6064051|NCT00492232|20951543|P2|Placebo Run-in|Missing|2
6064052|NCT00492232|20951544|P1|Placebo Run-in|Missing|0
6064053|NCT00492232|20951543|P2|Placebo Run-in|Other|6
6064054|NCT00492232|20951544|P1|Placebo Run-in|Other|0
6064055|NCT00492232|20951543|P2|Placebo Run-in|Entrance criteria not met|45
6064056|NCT00492232|20951544|P1|Placebo Run-in|Entrance criteria not met|0
6064057|NCT00492232|20951543|P2|Placebo Run-in|Pregnancy|1
6064058|NCT00492232|20951544|P1|Placebo Run-in|Pregnancy|0
6064059|NCT00492232|20951543|P2|Placebo Run-in|Withdrawal by Subject|8
6064060|NCT00492232|20951544|P1|Placebo Run-in|Withdrawal by Subject|0
6064061|NCT00492232|20951543|P2|Placebo Run-in|Lost to Follow-up|3
6064062|NCT00492232|20951544|P1|Placebo Run-in|Lost to Follow-up|0
6064063|NCT00492232|20951543|P2|Placebo Run-in|Protocol Violation|3
6064064|NCT00492232|20951544|P1|Placebo Run-in|Protocol Violation|0
6064065|NCT00492232|20951543|P2|Placebo Run-in|Adverse Event|2
6064066|NCT00492232|20951544|P1|Placebo Run-in|Adverse Event|0
6064067|NCT00492115|20951585|P2|Overall Study|Withdrawal by Subject|4
6064068|NCT00492115|20951586|P1|Overall Study|Withdrawal by Subject|3
6064069|NCT00492063|20951607|P4|Overall Study|Protocol Violation|1
6064070|NCT00492063|20951608|P3|Overall Study|Protocol Violation|0
6064071|NCT00492063|20951609|P2|Overall Study|Protocol Violation|0
6064072|NCT00492063|20951610|P1|Overall Study|Protocol Violation|0
6064073|NCT00492063|20951607|P4|Overall Study|Lost to Follow-up|3
6064074|NCT00492063|20951608|P3|Overall Study|Lost to Follow-up|5
6064075|NCT00492063|20951609|P2|Overall Study|Lost to Follow-up|11
6064076|NCT00492063|20951610|P1|Overall Study|Lost to Follow-up|6
6064077|NCT00492063|20951607|P4|Overall Study|Withdrawal by Subject|4
6064078|NCT00492063|20951608|P3|Overall Study|Withdrawal by Subject|5
6064079|NCT00492063|20951609|P2|Overall Study|Withdrawal by Subject|3
6064080|NCT00492063|20951610|P1|Overall Study|Withdrawal by Subject|4
6064081|NCT00492063|20951607|P4|Overall Study|Death|2
6064082|NCT00492063|20951608|P3|Overall Study|Death|1
6064083|NCT00492063|20951609|P2|Overall Study|Death|0
6064084|NCT00492063|20951610|P1|Overall Study|Death|0
6064085|NCT00492024|20951634|P2|Follow up|Lost to Follow-up|1
6064086|NCT00492024|20951635|P1|Follow up|Lost to Follow-up|1
6064087|NCT00492024|20951634|P2|Follow up|Lack of Efficacy|1
6064088|NCT00492024|20951635|P1|Follow up|Lack of Efficacy|0
6064089|NCT00492024|20951634|P2|Treatment|Withdrawal by Subject|0
6064090|NCT00492024|20951635|P1|Treatment|Withdrawal by Subject|2
6064091|NCT00492024|20951634|P2|Treatment|Lost to Follow-up|1
6064092|NCT00492024|20951635|P1|Treatment|Lost to Follow-up|3
6064093|NCT00492024|20951634|P2|Treatment|Lack of Efficacy|20
6064094|NCT00492024|20951635|P1|Treatment|Lack of Efficacy|21
6064095|NCT00492024|20951634|P2|Treatment|Adverse Event|1
6064096|NCT00492024|20951635|P1|Treatment|Adverse Event|3
6064097|NCT00491894|20951651|P1|Overall Study|Other-Intake of prohibited medication|1
6064098|NCT00491894|20951651|P1|Overall Study|Protocol Violation|2
6064099|NCT00491894|20951651|P1|Overall Study|Physician Decision|2
6064100|NCT00491894|20951651|P1|Overall Study|Other-Failed to meet any criteria|2
6064101|NCT00491894|20951651|P1|Overall Study|Lack of Efficacy|2
6064102|NCT00491894|20951651|P1|Overall Study|Lost to Follow-up|3
6064103|NCT00491894|20951651|P1|Overall Study|Death|3
6064104|NCT00491894|20951651|P1|Overall Study|Withdrawal by Subject|5
6064105|NCT00491894|20951651|P1|Overall Study|Adverse Event|14
6064106|NCT00491764|20951678|P6|Overall Study|Administrative|0
6064107|NCT00491764|20951679|P5|Overall Study|Administrative|0
6064108|NCT00491764|20951680|P4|Overall Study|Administrative|1
6064109|NCT00491764|20951681|P3|Overall Study|Administrative|2
6064110|NCT00491764|20951682|P2|Overall Study|Administrative|0
6064111|NCT00491764|20951683|P1|Overall Study|Administrative|1
6064112|NCT00491764|20951678|P6|Overall Study|Did not Meet Protocol Eligibility|1
6064113|NCT00491764|20951679|P5|Overall Study|Did not Meet Protocol Eligibility|1
6064114|NCT00491764|20951680|P4|Overall Study|Did not Meet Protocol Eligibility|0
6064115|NCT00491764|20951681|P3|Overall Study|Did not Meet Protocol Eligibility|1
6064116|NCT00491764|20951682|P2|Overall Study|Did not Meet Protocol Eligibility|1
6064117|NCT00491764|20951683|P1|Overall Study|Did not Meet Protocol Eligibility|0
6064118|NCT00491764|20951678|P6|Overall Study|Non Compliance with the Protocol|0
6064119|NCT00491764|20951679|P5|Overall Study|Non Compliance with the Protocol|0
6064120|NCT00491764|20951680|P4|Overall Study|Non Compliance with the Protocol|0
6064121|NCT00491764|20951681|P3|Overall Study|Non Compliance with the Protocol|0
6064122|NCT00491764|20951682|P2|Overall Study|Non Compliance with the Protocol|0
6064123|NCT00491764|20951683|P1|Overall Study|Non Compliance with the Protocol|1
6064124|NCT00491764|20951678|P6|Overall Study|Withdrawal by Subject|4
6064125|NCT00491764|20951679|P5|Overall Study|Withdrawal by Subject|2
6064126|NCT00491764|20951680|P4|Overall Study|Withdrawal by Subject|2
6064127|NCT00491764|20951681|P3|Overall Study|Withdrawal by Subject|1
6064128|NCT00491764|20951682|P2|Overall Study|Withdrawal by Subject|3
6064129|NCT00491764|20951683|P1|Overall Study|Withdrawal by Subject|2
6064130|NCT00491764|20951678|P6|Overall Study|Lost to Follow-up|3
6064131|NCT00491764|20951679|P5|Overall Study|Lost to Follow-up|0
6064132|NCT00491764|20951680|P4|Overall Study|Lost to Follow-up|1
6064133|NCT00491764|20951681|P3|Overall Study|Lost to Follow-up|0
6064134|NCT00491764|20951682|P2|Overall Study|Lost to Follow-up|1
6064135|NCT00491764|20951683|P1|Overall Study|Lost to Follow-up|0
6064136|NCT00491764|20951678|P6|Overall Study|Adverse Event|1
6064137|NCT00491764|20951679|P5|Overall Study|Adverse Event|0
6064138|NCT00491764|20951680|P4|Overall Study|Adverse Event|4
6064139|NCT00491764|20951681|P3|Overall Study|Adverse Event|4
6064140|NCT00491764|20951682|P2|Overall Study|Adverse Event|2
6064141|NCT00491764|20951683|P1|Overall Study|Adverse Event|1
6064142|NCT00491608|20951731|P1|Overall Study|Withdrawal by Subject|1
6064143|NCT00491608|20951731|P1|Overall Study|Death|2
6064144|NCT00491556|20951742|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|1
6064145|NCT00491556|20951743|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|0
6064146|NCT00491556|20951742|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|1
6064147|NCT00491556|20951743|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|0
6064148|NCT00491556|20951742|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Other|0
6064149|NCT00491556|20951743|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Other|2
6064150|NCT00491556|20951742|P2|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|0
6064151|NCT00491556|20951743|P1|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|2
6064152|NCT00491556|20951742|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|0
6064153|NCT00491556|20951743|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|2
6064154|NCT00491556|20951742|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|0
6064155|NCT00491556|20951743|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|5
6064156|NCT00491556|20951742|P2|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|0
6064157|NCT00491556|20951743|P1|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|2
6064158|NCT00491556|20951742|P2|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|0
6064159|NCT00491556|20951743|P1|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|5
6064160|NCT00491556|20951742|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|1
6064245|NCT00490971|20951925|P5|Maintenance|Pregnancy|0
6064161|NCT00491556|20951743|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|2
6064162|NCT00491556|20951742|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|0
6064163|NCT00491556|20951743|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|2
6064164|NCT00491556|20951742|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2
6064165|NCT00491556|20951743|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2
6064166|NCT00491556|20951742|P2|Entry-Week (WK) 48: EXP/Standard Care|Other|0
6064167|NCT00491556|20951743|P1|Entry-Week (WK) 48: EXP/Standard Care|Other|3
6064168|NCT00491556|20951742|P2|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|0
6064169|NCT00491556|20951743|P1|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|3
6064170|NCT00491556|20951742|P2|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|0
6064171|NCT00491556|20951743|P1|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|2
6064172|NCT00491556|20951742|P2|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|0
6064173|NCT00491556|20951743|P1|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|2
6064174|NCT00491556|20951742|P2|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|0
6064175|NCT00491556|20951743|P1|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|11
6064176|NCT00491556|20951742|P2|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|0
6064177|NCT00491556|20951743|P1|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|2
6064178|NCT00491556|20951742|P2|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|0
6064179|NCT00491556|20951743|P1|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|1
6064180|NCT00491556|20951742|P2|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|0
6064181|NCT00491556|20951743|P1|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|1
6064182|NCT00491556|20951742|P2|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|0
6064183|NCT00491556|20951743|P1|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|1
6064184|NCT00491530|20951802|P3|Overall Study|Use of Prohibited Medication|1
6064185|NCT00491530|20951803|P2|Overall Study|Use of Prohibited Medication|0
6064186|NCT00491530|20951804|P1|Overall Study|Use of Prohibited Medication|0
6064187|NCT00491530|20951802|P3|Overall Study|Patient Request|0
6064188|NCT00491530|20951803|P2|Overall Study|Patient Request|1
6064189|NCT00491530|20951804|P1|Overall Study|Patient Request|0
6064190|NCT00491530|20951802|P3|Overall Study|Investigator Discretion|0
6064191|NCT00491530|20951803|P2|Overall Study|Investigator Discretion|1
6064192|NCT00491530|20951804|P1|Overall Study|Investigator Discretion|0
6064193|NCT00491530|20951802|P3|Overall Study|Lack of Efficacy|0
6064194|NCT00491530|20951803|P2|Overall Study|Lack of Efficacy|1
6064195|NCT00491530|20951804|P1|Overall Study|Lack of Efficacy|0
6064196|NCT00491530|20951802|P3|Overall Study|Lost to Follow-up|2
6064197|NCT00491530|20951803|P2|Overall Study|Lost to Follow-up|2
6064198|NCT00491530|20951804|P1|Overall Study|Lost to Follow-up|3
6064199|NCT00491530|20951802|P3|Overall Study|Withdrawal by Subject|0
6064200|NCT00491530|20951803|P2|Overall Study|Withdrawal by Subject|0
6064201|NCT00491530|20951804|P1|Overall Study|Withdrawal by Subject|3
6064202|NCT00491530|20951802|P3|Overall Study|Adverse Event|2
6064203|NCT00491530|20951803|P2|Overall Study|Adverse Event|1
6064204|NCT00491530|20951804|P1|Overall Study|Adverse Event|6
6064205|NCT00491504|20951834|P4|Overall Study|Protocol Violation|2
6064206|NCT00491504|20951835|P3|Overall Study|Protocol Violation|3
6064207|NCT00491504|20951836|P2|Overall Study|Protocol Violation|0
6064208|NCT00491504|20951837|P1|Overall Study|Protocol Violation|0
6064209|NCT00491504|20951834|P4|Overall Study|Withdrawal by Subject|2
6064210|NCT00491504|20951835|P3|Overall Study|Withdrawal by Subject|1
6064211|NCT00491504|20951836|P2|Overall Study|Withdrawal by Subject|0
6064212|NCT00491504|20951837|P1|Overall Study|Withdrawal by Subject|0
6064213|NCT00491504|20951834|P4|Overall Study|Adverse Event|0
6064214|NCT00491504|20951835|P3|Overall Study|Adverse Event|0
6064215|NCT00491504|20951836|P2|Overall Study|Adverse Event|1
6064216|NCT00491504|20951837|P1|Overall Study|Adverse Event|0
6064217|NCT00491400|20951866|P2|Overall Study|Withdrawal by Subject|4
6064218|NCT00491400|20951867|P1|Overall Study|Withdrawal by Subject|5
6064219|NCT00491387|20951875|P1|Overall Study|study terminated|20
6064220|NCT00491322|20951890|P2|Overall Study|Pregnancy|1
6064221|NCT00491322|20951891|P1|Overall Study|Pregnancy|0
6064222|NCT00491322|20951890|P2|Overall Study|Protocol Violation|0
6064223|NCT00491322|20951891|P1|Overall Study|Protocol Violation|1
6064224|NCT00491179|20951910|P2|Overall Study|Withdrawal by Subject|1
6064225|NCT00491179|20951911|P1|Overall Study|Withdrawal by Subject|2
6064226|NCT00491179|20951910|P2|Overall Study|Adverse Event|1
6064227|NCT00491179|20951911|P1|Overall Study|Adverse Event|5
6064228|NCT00491075|20951919|P1|Overall Study|Physician Decision|1
6064229|NCT00491075|20951919|P1|Overall Study|Withdrawal by Subject|1
6064230|NCT00490971|20951925|P5|Maintenance|Other|3
6064231|NCT00490971|20951926|P4|Maintenance|Other|9
6064232|NCT00490971|20951927|P3|Maintenance|Other|11
6064233|NCT00490971|20951928|P2|Maintenance|Other|0
6064234|NCT00490971|20951929|P1|Maintenance|Other|0
6064235|NCT00490971|20951925|P5|Maintenance|Withdrawal by Subject|18
6064236|NCT00490971|20951926|P4|Maintenance|Withdrawal by Subject|28
6064237|NCT00490971|20951927|P3|Maintenance|Withdrawal by Subject|26
6064238|NCT00490971|20951928|P2|Maintenance|Withdrawal by Subject|0
6064239|NCT00490971|20951929|P1|Maintenance|Withdrawal by Subject|0
6064240|NCT00490971|20951925|P5|Maintenance|Protocol Violation|1
6064241|NCT00490971|20951926|P4|Maintenance|Protocol Violation|1
6064242|NCT00490971|20951927|P3|Maintenance|Protocol Violation|4
6064243|NCT00490971|20951928|P2|Maintenance|Protocol Violation|0
6064244|NCT00490971|20951929|P1|Maintenance|Protocol Violation|0
6064246|NCT00490971|20951926|P4|Maintenance|Pregnancy|0
6064247|NCT00490971|20951927|P3|Maintenance|Pregnancy|1
6064248|NCT00490971|20951928|P2|Maintenance|Pregnancy|0
6064249|NCT00490971|20951929|P1|Maintenance|Pregnancy|0
6064250|NCT00490971|20951925|P5|Maintenance|Lost to Follow-up|10
6064251|NCT00490971|20951926|P4|Maintenance|Lost to Follow-up|8
6064252|NCT00490971|20951927|P3|Maintenance|Lost to Follow-up|5
6064253|NCT00490971|20951928|P2|Maintenance|Lost to Follow-up|0
6064254|NCT00490971|20951929|P1|Maintenance|Lost to Follow-up|0
6064255|NCT00490971|20951925|P5|Maintenance|Death|0
6064256|NCT00490971|20951926|P4|Maintenance|Death|2
6064257|NCT00490971|20951927|P3|Maintenance|Death|0
6064258|NCT00490971|20951928|P2|Maintenance|Death|0
6064259|NCT00490971|20951929|P1|Maintenance|Death|0
6064260|NCT00490971|20951925|P5|Maintenance|Adverse Event|7
6064261|NCT00490971|20951926|P4|Maintenance|Adverse Event|5
6064262|NCT00490971|20951927|P3|Maintenance|Adverse Event|4
6064263|NCT00490971|20951928|P2|Maintenance|Adverse Event|0
6064264|NCT00490971|20951929|P1|Maintenance|Adverse Event|0
6064265|NCT00490971|20951925|P5|Acute/Continuation|Other|0
6064266|NCT00490971|20951926|P4|Acute/Continuation|Other|0
6064267|NCT00490971|20951927|P3|Acute/Continuation|Other|0
6064268|NCT00490971|20951928|P2|Acute/Continuation|Other|4
6064269|NCT00490971|20951929|P1|Acute/Continuation|Other|11
6064270|NCT00490971|20951925|P5|Acute/Continuation|Withdrawal by Subject|0
6064271|NCT00490971|20951926|P4|Acute/Continuation|Withdrawal by Subject|0
6064272|NCT00490971|20951927|P3|Acute/Continuation|Withdrawal by Subject|0
6064273|NCT00490971|20951928|P2|Acute/Continuation|Withdrawal by Subject|24
6064274|NCT00490971|20951929|P1|Acute/Continuation|Withdrawal by Subject|92
6064275|NCT00490971|20951925|P5|Acute/Continuation|Protocol Violation|0
6064276|NCT00490971|20951926|P4|Acute/Continuation|Protocol Violation|0
6064277|NCT00490971|20951927|P3|Acute/Continuation|Protocol Violation|0
6064278|NCT00490971|20951928|P2|Acute/Continuation|Protocol Violation|2
6064279|NCT00490971|20951929|P1|Acute/Continuation|Protocol Violation|10
6064280|NCT00490971|20951925|P5|Acute/Continuation|Lost to Follow-up|0
6064281|NCT00490971|20951926|P4|Acute/Continuation|Lost to Follow-up|0
6064282|NCT00490971|20951927|P3|Acute/Continuation|Lost to Follow-up|0
6064283|NCT00490971|20951928|P2|Acute/Continuation|Lost to Follow-up|7
6064284|NCT00490971|20951929|P1|Acute/Continuation|Lost to Follow-up|23
6064285|NCT00490971|20951925|P5|Acute/Continuation|Lack of Efficacy|0
6064286|NCT00490971|20951926|P4|Acute/Continuation|Lack of Efficacy|0
6064287|NCT00490971|20951927|P3|Acute/Continuation|Lack of Efficacy|0
6064288|NCT00490971|20951928|P2|Acute/Continuation|Lack of Efficacy|12
6064289|NCT00490971|20951929|P1|Acute/Continuation|Lack of Efficacy|106
6064290|NCT00490971|20951925|P5|Acute/Continuation|Death|0
6064291|NCT00490971|20951926|P4|Acute/Continuation|Death|0
6064292|NCT00490971|20951927|P3|Acute/Continuation|Death|0
6064293|NCT00490971|20951928|P2|Acute/Continuation|Death|0
6064294|NCT00490971|20951929|P1|Acute/Continuation|Death|2
6064295|NCT00490971|20951925|P5|Acute/Continuation|Adverse Event|0
6064296|NCT00490971|20951926|P4|Acute/Continuation|Adverse Event|0
6064297|NCT00490971|20951927|P3|Acute/Continuation|Adverse Event|0
6064298|NCT00490971|20951928|P2|Acute/Continuation|Adverse Event|13
6064299|NCT00490971|20951929|P1|Acute/Continuation|Adverse Event|62
6064300|NCT00490945|20951976|P5|Overall Study|Adverse Event|0
6064301|NCT00490945|20951977|P4|Overall Study|Adverse Event|0
6064302|NCT00490945|20951978|P3|Overall Study|Adverse Event|0
6064303|NCT00490945|20951979|P2|Overall Study|Adverse Event|1
6064304|NCT00490945|20951980|P1|Overall Study|Adverse Event|0
6064305|NCT00490919|20952016|P3|Double-blind Phase|Administrative|6
6064306|NCT00490919|20952017|P2|Double-blind Phase|Administrative|6
6064307|NCT00490919|20952018|P1|Double-blind Phase|Administrative|0
6064308|NCT00490919|20952016|P3|Double-blind Phase|Lack of Efficacy|36
6064309|NCT00490919|20952017|P2|Double-blind Phase|Lack of Efficacy|22
6064310|NCT00490919|20952018|P1|Double-blind Phase|Lack of Efficacy|0
6064311|NCT00490919|20952016|P3|Double-blind Phase|Lost to Follow-up|11
6064312|NCT00490919|20952017|P2|Double-blind Phase|Lost to Follow-up|8
6064313|NCT00490919|20952018|P1|Double-blind Phase|Lost to Follow-up|0
6064314|NCT00490919|20952016|P3|Double-blind Phase|Withdrawal by Subject|11
6064315|NCT00490919|20952017|P2|Double-blind Phase|Withdrawal by Subject|10
6064316|NCT00490919|20952018|P1|Double-blind Phase|Withdrawal by Subject|0
6064317|NCT00490919|20952016|P3|Double-blind Phase|Adverse Event|20
6064318|NCT00490919|20952017|P2|Double-blind Phase|Adverse Event|40
6064319|NCT00490919|20952018|P1|Double-blind Phase|Adverse Event|0
6064320|NCT00490919|20952016|P3|Open-label Run-in Period|Confirmed or suspected diversion|0
6064321|NCT00490919|20952017|P2|Open-label Run-in Period|Confirmed or suspected diversion|0
6064322|NCT00490919|20952018|P1|Open-label Run-in Period|Confirmed or suspected diversion|3
6064323|NCT00490919|20952016|P3|Open-label Run-in Period|Administrative|0
6064324|NCT00490919|20952017|P2|Open-label Run-in Period|Administrative|0
6064325|NCT00490919|20952018|P1|Open-label Run-in Period|Administrative|40
6064326|NCT00490919|20952016|P3|Open-label Run-in Period|Lack of Efficacy|0
6064327|NCT00490919|20952017|P2|Open-label Run-in Period|Lack of Efficacy|0
6064328|NCT00490919|20952018|P1|Open-label Run-in Period|Lack of Efficacy|143
6064329|NCT00490919|20952016|P3|Open-label Run-in Period|Lost to Follow-up|0
6064330|NCT00490919|20952017|P2|Open-label Run-in Period|Lost to Follow-up|0
6064331|NCT00490919|20952018|P1|Open-label Run-in Period|Lost to Follow-up|21
6064332|NCT00490919|20952016|P3|Open-label Run-in Period|Withdrawal by Subject|0
6064333|NCT00490919|20952017|P2|Open-label Run-in Period|Withdrawal by Subject|0
6064334|NCT00490919|20952018|P1|Open-label Run-in Period|Withdrawal by Subject|37
6064335|NCT00490919|20952016|P3|Open-label Run-in Period|Adverse Event|0
6064336|NCT00490919|20952017|P2|Open-label Run-in Period|Adverse Event|0
6064337|NCT00490919|20952018|P1|Open-label Run-in Period|Adverse Event|239
6064338|NCT00490841|20952029|P1|Overall Study|30 day f/u, only non-study stent used|3
6064339|NCT00490841|20952029|P1|Overall Study|Lost to Follow-up|1
6064340|NCT00490841|20952029|P1|Overall Study|Withdrawal by Subject|4
6064341|NCT00490841|20952029|P1|Overall Study|Death|5
6064342|NCT00490815|20952051|P2|Overall Study|Death|3
6064343|NCT00490815|20952052|P1|Overall Study|Death|1
6064344|NCT00490815|20952051|P2|Overall Study|Lost to Follow-up|3
6064345|NCT00490815|20952052|P1|Overall Study|Lost to Follow-up|1
6064346|NCT00490815|20952051|P2|Overall Study|Withdrawal by Subject|0
6064347|NCT00490815|20952052|P1|Overall Study|Withdrawal by Subject|4
6064348|NCT00490815|20952051|P2|Overall Study|Adverse Event|3
6064349|NCT00490815|20952052|P1|Overall Study|Adverse Event|2
6064350|NCT00490724|20952080|P3|Period II|Treatment Discontinuation|3
6064351|NCT00490724|20952081|P2|Period II|Treatment Discontinuation|1
6064352|NCT00490724|20952082|P1|Period II|Treatment Discontinuation|3
6064353|NCT00490724|20952080|P3|Period I|Physician Decision|1
6064354|NCT00490724|20952081|P2|Period I|Physician Decision|0
6064355|NCT00490724|20952082|P1|Period I|Physician Decision|0
6064356|NCT00490698|20952147|P1|Overall Study|Physician Decision|2
6064357|NCT00490698|20952147|P1|Overall Study|Disease Progression|7
6064358|NCT00490698|20952147|P1|Overall Study|Withdrawal by Subject|1
6064359|NCT00490646|20952153|P2|Overall Study|Never Treated (withdrew consent)|1
6064360|NCT00490646|20952154|P1|Overall Study|Never Treated (withdrew consent)|0
6064361|NCT00490646|20952153|P2|Overall Study|Never Treated (had an adverse event)|0
6064362|NCT00490646|20952154|P1|Overall Study|Never Treated (had an adverse event)|1
6064363|NCT00490646|20952153|P2|Overall Study|Still on trastuzumab monotherapy|1
6064364|NCT00490646|20952154|P1|Overall Study|Still on trastuzumab monotherapy|1
6064365|NCT00490568|20952174|P1|Overall Study|Participant withdrawal due to surgery|1
6064366|NCT00490568|20952174|P1|Overall Study|Participant died|1
6064367|NCT00490568|20952174|P1|Overall Study|Efficacy related|3
6064368|NCT00490568|20952174|P1|Overall Study|Non-Compliance|7
6064369|NCT00490568|20952174|P1|Overall Study|Investigator decision|3
6064370|NCT00490568|20952174|P1|Overall Study|Unmet inclusion-exclusion criteria|5
6064371|NCT00490568|20952174|P1|Overall Study|Disease progression|4
6064372|NCT00490568|20952174|P1|Overall Study|Legal representative withdrew consent|1
6064373|NCT00490568|20952174|P1|Overall Study|Participant refused follow-up|9
6064374|NCT00490568|20952174|P1|Overall Study|Abnormal ECG|25
6064375|NCT00490568|20952174|P1|Overall Study|Caregiver related|20
6064376|NCT00490568|20952174|P1|Overall Study|Exclusion criteria met|1
6064377|NCT00490568|20952174|P1|Overall Study|Other|1
6064378|NCT00490568|20952174|P1|Overall Study|Still in the study at termination|974
6064379|NCT00490568|20952174|P1|Overall Study|Withdrawal by Subject|135
6064380|NCT00490568|20952174|P1|Overall Study|Protocol Violation|45
6064381|NCT00490568|20952174|P1|Overall Study|Lost to Follow-up|13
6064382|NCT00490568|20952174|P1|Overall Study|Adverse Event|116
6064383|NCT00490555|20952198|P4|Overall Study|noncompliant with drug administration|0
6064384|NCT00490555|20952199|P3|Overall Study|noncompliant with drug administration|2
6064385|NCT00490555|20952200|P2|Overall Study|noncompliant with drug administration|0
6064386|NCT00490555|20952201|P1|Overall Study|noncompliant with drug administration|0
6064387|NCT00490542|20952229|P2|Overall Study|Lack of Efficacy|1
6064388|NCT00490542|20952230|P1|Overall Study|Lack of Efficacy|1
6064389|NCT00490542|20952229|P2|Overall Study|Adverse Event|3
6064390|NCT00490542|20952230|P1|Overall Study|Adverse Event|3
6064391|NCT00490542|20952229|P2|Overall Study|Lost to Follow-up|0
6064392|NCT00490542|20952230|P1|Overall Study|Lost to Follow-up|3
6064393|NCT00490529|20952236|P1|Treatment With CpG-MCL Vaccine|Received vaccine, did not receive AHCT|1
6064394|NCT00490529|20952236|P1|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal due to insurance refusal|1
6064395|NCT00490529|20952236|P1|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, chemo not suitable treatment|1
6064396|NCT00490529|20952236|P1|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, AHCT not suitable treatment|1
6064397|NCT00490529|20952236|P1|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal by Subject|4
6064398|NCT00490529|20952236|P1|Completed Pre-CpG-MCL Vaccine Procedures|Death|4
6064399|NCT00490490|20952244|P1|Completed Assessment for TTP|Lost to Follow-up|2
6064400|NCT00490490|20952244|P1|Completed Assessment for TTP|Withdrawal by Subject|1
6064401|NCT00490451|20952261|P2|Overall Study|Progressive Disease|34
6064402|NCT00490451|20952262|P1|Overall Study|Progressive Disease|53
6064403|NCT00490451|20952261|P2|Overall Study|Protocol Violation|0
6064404|NCT00490451|20952262|P1|Overall Study|Protocol Violation|1
6064405|NCT00490451|20952261|P2|Overall Study|Investigator Decision|0
6064406|NCT00490451|20952262|P1|Overall Study|Investigator Decision|1
6064407|NCT00490451|20952261|P2|Overall Study|Withdrawal by Subject|0
6064408|NCT00490451|20952262|P1|Overall Study|Withdrawal by Subject|2
6064409|NCT00490451|20952261|P2|Overall Study|Death|1
6064410|NCT00490451|20952262|P1|Overall Study|Death|3
6064411|NCT00490451|20952261|P2|Overall Study|Adverse Event|3
6064412|NCT00490451|20952262|P1|Overall Study|Adverse Event|3
6064413|NCT00490282|20952282|P1|Overall Study|Withdrawal by Subject|3
6064414|NCT00490139|20952310|P4|Overall Study|Participant Withdrew Consent|116
6064415|NCT00490139|20952311|P3|Overall Study|Participant Withdrew Consent|208
6064416|NCT00490139|20952312|P2|Overall Study|Participant Withdrew Consent|110
6064417|NCT00490139|20952313|P1|Overall Study|Participant Withdrew Consent|146
6064418|NCT00490139|20952310|P4|Overall Study|Lost to Follow-up|56
6064419|NCT00490139|20952311|P3|Overall Study|Lost to Follow-up|58
6064420|NCT00490139|20952312|P2|Overall Study|Lost to Follow-up|46
6064421|NCT00490139|20952313|P1|Overall Study|Lost to Follow-up|56
6064422|NCT00490139|20952310|P4|Overall Study|Death|135
6064423|NCT00490139|20952311|P3|Overall Study|Death|168
6064424|NCT00490139|20952312|P2|Overall Study|Death|119
6064425|NCT00490139|20952313|P1|Overall Study|Death|106
6064426|NCT00490061|20952348|P1|Overall Study|Physician Decision|1
6064427|NCT00490035|20952357|P4|Overall Study|AE of unknown type|0
6064428|NCT00490035|20952358|P3|Overall Study|AE of unknown type|2
6064429|NCT00490035|20952359|P2|Overall Study|AE of unknown type|0
6064430|NCT00490035|20952360|P1|Overall Study|AE of unknown type|0
6064431|NCT00490035|20952357|P4|Overall Study|Serious adverse event (SAE), non-fatal|0
6064432|NCT00490035|20952358|P3|Overall Study|Serious adverse event (SAE), non-fatal|1
6064433|NCT00490035|20952359|P2|Overall Study|Serious adverse event (SAE), non-fatal|0
6064434|NCT00490035|20952360|P1|Overall Study|Serious adverse event (SAE), non-fatal|0
6064435|NCT00490035|20952357|P4|Overall Study|AE, serious fatal|0
6064436|NCT00490035|20952358|P3|Overall Study|AE, serious fatal|0
6064437|NCT00490035|20952359|P2|Overall Study|AE, serious fatal|0
6064438|NCT00490035|20952360|P1|Overall Study|AE, serious fatal|1
6064439|NCT00490035|20952357|P4|Overall Study|Other reason|1
6064440|NCT00490035|20952358|P3|Overall Study|Other reason|3
6064441|NCT00490035|20952359|P2|Overall Study|Other reason|1
6064442|NCT00490035|20952360|P1|Overall Study|Other reason|0
6064443|NCT00490035|20952357|P4|Overall Study|Withdrawal by Subject|0
6064444|NCT00490035|20952358|P3|Overall Study|Withdrawal by Subject|1
6064445|NCT00490035|20952359|P2|Overall Study|Withdrawal by Subject|1
6064446|NCT00490035|20952360|P1|Overall Study|Withdrawal by Subject|2
6064447|NCT00490035|20952357|P4|Overall Study|Lost to Follow-up|0
6064448|NCT00490035|20952358|P3|Overall Study|Lost to Follow-up|1
6064449|NCT00490035|20952359|P2|Overall Study|Lost to Follow-up|0
6064450|NCT00490035|20952360|P1|Overall Study|Lost to Follow-up|2
6064451|NCT00490035|20952357|P4|Overall Study|AE, non-serious non-fatal|5
6064452|NCT00490035|20952358|P3|Overall Study|AE, non-serious non-fatal|4
6064453|NCT00490035|20952359|P2|Overall Study|AE, non-serious non-fatal|4
6064454|NCT00490035|20952360|P1|Overall Study|AE, non-serious non-fatal|3
6064455|NCT00490022|20952460|P2|Overall Study|Subject failed to disclose concommitant|1
6064456|NCT00490022|20952461|P1|Overall Study|Subject failed to disclose concommitant|0
6064457|NCT00490022|20952460|P2|Overall Study|Withdrawal by Subject|0
6064458|NCT00490022|20952461|P1|Overall Study|Withdrawal by Subject|1
6064459|NCT00490022|20952460|P2|Overall Study|Adverse Event|2
6064460|NCT00490022|20952461|P1|Overall Study|Adverse Event|0
6064461|NCT00489970|20952478|P3|Persistence Year 9|Other|2
6064462|NCT00489970|20952479|P2|Persistence Year 9|Other|0
6064463|NCT00489970|20952480|P1|Persistence Year 9|Other|1
6064464|NCT00489970|20952478|P3|Persistence Year 9|Lost to Follow-up|3
6064465|NCT00489970|20952479|P2|Persistence Year 9|Lost to Follow-up|2
6064466|NCT00489970|20952480|P1|Persistence Year 9|Lost to Follow-up|2
6064467|NCT00489918|20952584|P5|Overall Study|Physician Decision|0
6064468|NCT00489918|20952585|P4|Overall Study|Physician Decision|0
6064469|NCT00489918|20952586|P3|Overall Study|Physician Decision|1
6064470|NCT00489918|20952587|P2|Overall Study|Physician Decision|0
6064471|NCT00489918|20952588|P1|Overall Study|Physician Decision|0
6064472|NCT00489918|20952584|P5|Overall Study|Lost to Follow-up|0
6064473|NCT00489918|20952585|P4|Overall Study|Lost to Follow-up|1
6064474|NCT00489918|20952586|P3|Overall Study|Lost to Follow-up|1
6064475|NCT00489918|20952587|P2|Overall Study|Lost to Follow-up|0
6064476|NCT00489918|20952588|P1|Overall Study|Lost to Follow-up|0
6064477|NCT00489918|20952584|P5|Overall Study|Adverse Event|0
6064478|NCT00489918|20952585|P4|Overall Study|Adverse Event|0
6064479|NCT00489918|20952586|P3|Overall Study|Adverse Event|1
6064480|NCT00489918|20952587|P2|Overall Study|Adverse Event|1
6064481|NCT00489918|20952588|P1|Overall Study|Adverse Event|0
6064482|NCT00489918|20952584|P5|Overall Study|Withdrawal by Subject|1
6064483|NCT00489918|20952585|P4|Overall Study|Withdrawal by Subject|0
6064484|NCT00489918|20952586|P3|Overall Study|Withdrawal by Subject|1
6064485|NCT00489918|20952587|P2|Overall Study|Withdrawal by Subject|1
6064486|NCT00489918|20952588|P1|Overall Study|Withdrawal by Subject|2
6064487|NCT00489853|20952637|P3|Treatment Period 3|Study specific discontinuation criteria|0
6064488|NCT00489853|20952638|P2|Treatment Period 3|Study specific discontinuation criteria|1
6064489|NCT00489853|20952639|P1|Treatment Period 3|Study specific discontinuation criteria|0
6064490|NCT00489853|20952637|P3|Wash-out Period 2|Study specific discontinuation criteria|2
6064491|NCT00489853|20952638|P2|Wash-out Period 2|Study specific discontinuation criteria|2
6064492|NCT00489853|20952639|P1|Wash-out Period 2|Study specific discontinuation criteria|3
6064493|NCT00489853|20952637|P3|Wash-out Period 2|Adverse Event|0
6064494|NCT00489853|20952638|P2|Wash-out Period 2|Adverse Event|1
6064495|NCT00489853|20952639|P1|Wash-out Period 2|Adverse Event|1
6064496|NCT00489853|20952637|P3|Wash-out Period 1|Study-specific discontinuation criteria|4
6064497|NCT00489853|20952638|P2|Wash-out Period 1|Study-specific discontinuation criteria|1
6064498|NCT00489853|20952639|P1|Wash-out Period 1|Study-specific discontinuation criteria|0
6064499|NCT00489853|20952637|P3|Wash-out Period 1|Protocol Violation|1
6064500|NCT00489853|20952638|P2|Wash-out Period 1|Protocol Violation|1
6064501|NCT00489853|20952639|P1|Wash-out Period 1|Protocol Violation|0
6064502|NCT00489853|20952637|P3|Wash-out Period 1|Adverse Event|1
6064503|NCT00489853|20952638|P2|Wash-out Period 1|Adverse Event|1
6064504|NCT00489853|20952639|P1|Wash-out Period 1|Adverse Event|0
6064505|NCT00489853|20952637|P3|Wash-out Period 1|Withdrawal by Subject|0
6064506|NCT00489853|20952638|P2|Wash-out Period 1|Withdrawal by Subject|0
6064507|NCT00489853|20952639|P1|Wash-out Period 1|Withdrawal by Subject|1
6064508|NCT00489827|20952736|P2|Overall Study|Intraoperative exclusion criteria|1
6064509|NCT00489827|20952737|P1|Overall Study|Intraoperative exclusion criteria|1
6064510|NCT00489827|20952736|P2|Overall Study|Intraoperative exclusion criteria|1
6064511|NCT00489827|20952737|P1|Overall Study|Intraoperative exclusion criteria|1
6064512|NCT00489736|20952761|P2|Overall Study|Not coded/ Not pre-specified|8
6064513|NCT00489736|20952762|P1|Overall Study|Not coded/ Not pre-specified|5
6064514|NCT00489736|20952761|P2|Overall Study|Poor compliance|2
6064515|NCT00489736|20952762|P1|Overall Study|Poor compliance|6
6064516|NCT00489736|20952761|P2|Overall Study|Adverse Event|45
6064517|NCT00489736|20952762|P1|Overall Study|Adverse Event|32
6064518|NCT00489736|20952761|P2|Overall Study|Lack of Efficacy|14
6064519|NCT00489736|20952762|P1|Overall Study|Lack of Efficacy|53
6064520|NCT00489554|20952772|P1|Overall Study|Lost to Follow-up|1
6064521|NCT00489554|20952772|P1|Overall Study|Withdrawal by Subject|1
6064522|NCT00489554|20952772|P1|Overall Study|Adverse Event|2
6064523|NCT00489541|20952792|P2|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|5
6064524|NCT00489541|20952793|P1|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|4
6064525|NCT00489541|20952792|P2|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|12
6064526|NCT00489541|20952793|P1|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|23
6064527|NCT00489541|20952792|P2|12-Month Clinical Follow-up|Death|2
6064528|NCT00489541|20952793|P1|12-Month Clinical Follow-up|Death|3
6064529|NCT00489541|20952792|P2|12-Month Clinical Follow-up|Missed 12-Month Visit|0
6064530|NCT00489541|20952793|P1|12-Month Clinical Follow-up|Missed 12-Month Visit|2
6064531|NCT00489541|20952792|P2|12-Month Clinical Follow-up|Lost to Follow-up|0
6064532|NCT00489541|20952793|P1|12-Month Clinical Follow-up|Lost to Follow-up|2
6064533|NCT00489541|20952792|P2|12-Month Clinical Follow-up|Withdrawal by Subject|3
6064534|NCT00489541|20952793|P1|12-Month Clinical Follow-up|Withdrawal by Subject|2
6064535|NCT00489489|20952804|P3|Overall Study|Other than above|0
6064536|NCT00489489|20952805|P2|Overall Study|Other than above|1
6064537|NCT00489489|20952806|P1|Overall Study|Other than above|0
6064538|NCT00489489|20952804|P3|Overall Study|Participant did not wish to continue|0
6064539|NCT00489489|20952805|P2|Overall Study|Participant did not wish to continue|1
6064540|NCT00489489|20952806|P1|Overall Study|Participant did not wish to continue|1
6064541|NCT00489489|20952804|P3|Overall Study|Progressive disease|0
6064542|NCT00489489|20952805|P2|Overall Study|Progressive disease|1
6064543|NCT00489489|20952806|P1|Overall Study|Progressive disease|0
6064544|NCT00489489|20952804|P3|Overall Study|Protocol Violation|1
6064545|NCT00489489|20952805|P2|Overall Study|Protocol Violation|0
6064546|NCT00489489|20952806|P1|Overall Study|Protocol Violation|1
6064547|NCT00489489|20952804|P3|Overall Study|Adverse Event|1
6064548|NCT00489489|20952805|P2|Overall Study|Adverse Event|1
6064549|NCT00489489|20952806|P1|Overall Study|Adverse Event|1
6064550|NCT00489489|20952804|P3|Overall Study|Not treated due to protocol violation|1
6064551|NCT00489489|20952805|P2|Overall Study|Not treated due to protocol violation|1
6064552|NCT00489489|20952806|P1|Overall Study|Not treated due to protocol violation|0
6064553|NCT00489476|20952838|P4|Overall Study|Lost to Follow-up|0
6064554|NCT00489476|20952839|P3|Overall Study|Lost to Follow-up|0
6064555|NCT00489476|20952840|P2|Overall Study|Lost to Follow-up|1
6064556|NCT00489476|20952841|P1|Overall Study|Lost to Follow-up|0
6064557|NCT00489424|20952862|P3|Overall Study|Administrative problems|1
6064558|NCT00489424|20952863|P2|Overall Study|Administrative problems|2
6064559|NCT00489424|20952864|P1|Overall Study|Administrative problems|0
6064560|NCT00489424|20952862|P3|Overall Study|Lack of Efficacy|0
6064561|NCT00489424|20952863|P2|Overall Study|Lack of Efficacy|0
6064562|NCT00489424|20952864|P1|Overall Study|Lack of Efficacy|1
6064563|NCT00489424|20952862|P3|Overall Study|Adverse Event|4
6064564|NCT00489424|20952863|P2|Overall Study|Adverse Event|3
6064565|NCT00489424|20952864|P1|Overall Study|Adverse Event|3
6064566|NCT00489411|20952895|P2|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7
6064567|NCT00489411|20952896|P1|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7
6064568|NCT00489411|20952895|P2|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|12
6064569|NCT00489411|20952896|P1|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|11
6064570|NCT00489411|20952895|P2|Initial Treatment Period (Weeks 1-5)|Incomplete data|5
6064571|NCT00489411|20952896|P1|Initial Treatment Period (Weeks 1-5)|Incomplete data|1
6064572|NCT00489411|20952895|P2|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|12
6064573|NCT00489411|20952896|P1|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|21
6064574|NCT00489411|20952895|P2|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|5
6064575|NCT00489411|20952896|P1|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|6
6064576|NCT00489359|20952910|P2|Overall Study|Adverse Event|16
6064577|NCT00489359|20952911|P1|Overall Study|Adverse Event|0
6064578|NCT00489359|20952910|P2|Overall Study|Withdrawal by Subject|5
6064579|NCT00489359|20952911|P1|Overall Study|Withdrawal by Subject|1
6064580|NCT00489359|20952910|P2|Overall Study|Lost to Follow-up|0
6064581|NCT00489359|20952911|P1|Overall Study|Lost to Follow-up|1
6064582|NCT00489359|20952910|P2|Overall Study|Progressive Disease|6
6064583|NCT00489359|20952911|P1|Overall Study|Progressive Disease|5
6064584|NCT00489359|20952910|P2|Overall Study|Death|2
6064585|NCT00489359|20952911|P1|Overall Study|Death|0
6064586|NCT00489255|20952987|P2|Period 3: Days 57 to 84|Lost to Follow-up|1
6064587|NCT00489255|20952988|P1|Period 3: Days 57 to 84|Lost to Follow-up|0
6064588|NCT00489255|20952987|P2|Period 3: Days 57 to 84|Withdrawal by Subject|0
6064589|NCT00489255|20952988|P1|Period 3: Days 57 to 84|Withdrawal by Subject|1
6064590|NCT00489255|20952987|P2|Period 3: Days 57 to 84|Adverse Event|3
6064591|NCT00489255|20952988|P1|Period 3: Days 57 to 84|Adverse Event|3
6064592|NCT00489255|20952987|P2|Period 2: Days 29 to 56|Withdrawal by Subject|3
6064593|NCT00489255|20952988|P1|Period 2: Days 29 to 56|Withdrawal by Subject|0
6064594|NCT00489255|20952987|P2|Period 2: Days 29 to 56|Adverse Event|1
6064595|NCT00489255|20952988|P1|Period 2: Days 29 to 56|Adverse Event|3
6064596|NCT00489255|20952987|P2|Period 1: Days 1 to 28|Noncompliance|0
6064597|NCT00489255|20952988|P1|Period 1: Days 1 to 28|Noncompliance|2
6064598|NCT00489255|20952987|P2|Period 1: Days 1 to 28|Physician Decision|4
6064599|NCT00489255|20952988|P1|Period 1: Days 1 to 28|Physician Decision|1
6064600|NCT00489255|20952987|P2|Period 1: Days 1 to 28|Withdrawal by Subject|0
6064601|NCT00489255|20952988|P1|Period 1: Days 1 to 28|Withdrawal by Subject|5
6064602|NCT00489255|20952987|P2|Period 1: Days 1 to 28|Adverse Event|8
6064603|NCT00489255|20952988|P1|Period 1: Days 1 to 28|Adverse Event|21
6064604|NCT00489255|20952987|P2|Screening and Initial Randomization|Discontinued prior to taking study drug|3
6064605|NCT00489255|20952988|P1|Screening and Initial Randomization|Discontinued prior to taking study drug|9
6064606|NCT00489216|20953036|P1|Overall Study|Adverse Event|1
6064607|NCT00488982|20953053|P3|Course 1|Adverse Event|6
6064608|NCT00488982|20953054|P2|Course 1|Adverse Event|0
6064609|NCT00488982|20953055|P1|Course 1|Adverse Event|0
6064610|NCT00488982|20953053|P3|Course 1|nonprotocol therapy|2
6064611|NCT00488982|20953054|P2|Course 1|nonprotocol therapy|2
6064612|NCT00488982|20953055|P1|Course 1|nonprotocol therapy|0
6064613|NCT00488982|20953053|P3|Course 1|Withdrawal by Subject|2
6064614|NCT00488982|20953054|P2|Course 1|Withdrawal by Subject|8
6064615|NCT00488982|20953055|P1|Course 1|Withdrawal by Subject|0
6064616|NCT00488982|20953053|P3|Course 1|Physician Decision|4
6064617|NCT00488982|20953054|P2|Course 1|Physician Decision|2
6064618|NCT00488982|20953055|P1|Course 1|Physician Decision|0
6064619|NCT00488826|20953078|P3|Overall Study|Protocol Deviations|1
6064620|NCT00488826|20953079|P2|Overall Study|Protocol Deviations|1
6064621|NCT00488826|20953080|P1|Overall Study|Protocol Deviations|2
6064622|NCT00488826|20953078|P3|Overall Study|Lost to Follow-up|0
6064623|NCT00488826|20953079|P2|Overall Study|Lost to Follow-up|1
6064624|NCT00488826|20953080|P1|Overall Study|Lost to Follow-up|5
6064625|NCT00488826|20953078|P3|Overall Study|Adverse Event|4
6064626|NCT00488826|20953079|P2|Overall Study|Adverse Event|15
6064627|NCT00488826|20953080|P1|Overall Study|Adverse Event|9
6064628|NCT00488826|20953078|P3|Overall Study|Protocol Violation|2
6064629|NCT00488826|20953079|P2|Overall Study|Protocol Violation|0
6064630|NCT00488826|20953080|P1|Overall Study|Protocol Violation|0
6064631|NCT00488826|20953078|P3|Overall Study|Withdrawal by Subject|19
6064632|NCT00488826|20953079|P2|Overall Study|Withdrawal by Subject|35
6064633|NCT00488826|20953080|P1|Overall Study|Withdrawal by Subject|40
6064634|NCT00488774|20953095|P4|Overall Study|Lost to Follow-up|1
6064635|NCT00488774|20953096|P3|Overall Study|Lost to Follow-up|1
6064636|NCT00488774|20953097|P2|Overall Study|Lost to Follow-up|0
6064637|NCT00488774|20953098|P1|Overall Study|Lost to Follow-up|0
6064638|NCT00488774|20953095|P4|Overall Study|Other|2
6064639|NCT00488774|20953096|P3|Overall Study|Other|2
6064640|NCT00488774|20953097|P2|Overall Study|Other|3
6064641|NCT00488774|20953098|P1|Overall Study|Other|6
6064642|NCT00488774|20953095|P4|Overall Study|Withdrawal of consent|0
6064643|NCT00488774|20953096|P3|Overall Study|Withdrawal of consent|2
6064644|NCT00488774|20953097|P2|Overall Study|Withdrawal of consent|2
6064645|NCT00488774|20953098|P1|Overall Study|Withdrawal of consent|2
6064646|NCT00488683|20953115|P3|Overall Study|Unable to Classify|0
6064647|NCT00488683|20953116|P2|Overall Study|Unable to Classify|0
6064648|NCT00488683|20953117|P1|Overall Study|Unable to Classify|1
6064649|NCT00488683|20953115|P3|Overall Study|Protocol Violation|0
6064650|NCT00488683|20953116|P2|Overall Study|Protocol Violation|1
6064651|NCT00488683|20953117|P1|Overall Study|Protocol Violation|5
6064652|NCT00488683|20953115|P3|Overall Study|Lost to Follow-up|0
6064653|NCT00488683|20953116|P2|Overall Study|Lost to Follow-up|3
6064654|NCT00488683|20953117|P1|Overall Study|Lost to Follow-up|5
6064655|NCT00488683|20953115|P3|Overall Study|Withdrawal by Subject|2
6064656|NCT00488683|20953116|P2|Overall Study|Withdrawal by Subject|2
6064657|NCT00488683|20953117|P1|Overall Study|Withdrawal by Subject|1
6064658|NCT00488644|20953176|P1|Overall Study|Not Evaluable|1
6064659|NCT00488644|20953176|P1|Overall Study|Not Eligible|1
6064660|NCT00488631|20953186|P10|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
6064661|NCT00488631|20953187|P9|Open Label Study Extension (Week 54-228)|Unspecified reasons|87
6064662|NCT00488631|20953188|P8|Open Label Study Extension (Week 54-228)|Unspecified reasons|14
6064663|NCT00488631|20953189|P7|Open Label Study Extension (Week 54-228)|Unspecified reasons|63
6064664|NCT00488631|20953190|P6|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
6064665|NCT00488631|20953191|P5|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
6064666|NCT00488631|20953192|P4|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
6064667|NCT00488631|20953193|P3|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
6064668|NCT00488631|20953194|P2|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
6064669|NCT00488631|20953195|P1|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
6064670|NCT00488631|20953186|P10|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
6064671|NCT00488631|20953187|P9|Open Label Study Extension (Week 54-228)|Lost to Follow-up|6
6064672|NCT00488631|20953188|P8|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
6064673|NCT00488631|20953189|P7|Open Label Study Extension (Week 54-228)|Lost to Follow-up|2
6064674|NCT00488631|20953190|P6|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
6064675|NCT00488631|20953191|P5|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
6064676|NCT00488631|20953192|P4|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
6064677|NCT00488631|20953193|P3|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
6064678|NCT00488631|20953194|P2|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
6064679|NCT00488631|20953195|P1|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
6064680|NCT00488631|20953186|P10|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|3
6064681|NCT00488631|20953187|P9|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|34
6064682|NCT00488631|20953188|P8|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5
6064683|NCT00488631|20953189|P7|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5
6064684|NCT00488631|20953190|P6|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
6064685|NCT00488631|20953191|P5|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
6064686|NCT00488631|20953192|P4|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
6064687|NCT00488631|20953193|P3|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
6064688|NCT00488631|20953194|P2|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
6064689|NCT00488631|20953195|P1|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
6064690|NCT00488631|20953186|P10|Open Label Study Extension (Week 54-228)|Death|0
6064691|NCT00488631|20953187|P9|Open Label Study Extension (Week 54-228)|Death|1
6064692|NCT00488631|20953188|P8|Open Label Study Extension (Week 54-228)|Death|0
6064693|NCT00488631|20953189|P7|Open Label Study Extension (Week 54-228)|Death|0
6064694|NCT00488631|20953190|P6|Open Label Study Extension (Week 54-228)|Death|0
6064695|NCT00488631|20953191|P5|Open Label Study Extension (Week 54-228)|Death|0
6064696|NCT00488631|20953192|P4|Open Label Study Extension (Week 54-228)|Death|0
6064697|NCT00488631|20953193|P3|Open Label Study Extension (Week 54-228)|Death|0
6064698|NCT00488631|20953194|P2|Open Label Study Extension (Week 54-228)|Death|0
6064699|NCT00488631|20953195|P1|Open Label Study Extension (Week 54-228)|Death|0
6064700|NCT00488631|20953186|P10|Open Label Study Extension (Week 54-228)|Adverse Event|0
6064701|NCT00488631|20953187|P9|Open Label Study Extension (Week 54-228)|Adverse Event|54
6064702|NCT00488631|20953188|P8|Open Label Study Extension (Week 54-228)|Adverse Event|8
6064703|NCT00488631|20953189|P7|Open Label Study Extension (Week 54-228)|Adverse Event|10
6064704|NCT00488631|20953190|P6|Open Label Study Extension (Week 54-228)|Adverse Event|0
6064705|NCT00488631|20953191|P5|Open Label Study Extension (Week 54-228)|Adverse Event|0
6064706|NCT00488631|20953192|P4|Open Label Study Extension (Week 54-228)|Adverse Event|0
6064707|NCT00488631|20953193|P3|Open Label Study Extension (Week 54-228)|Adverse Event|0
6064708|NCT00488631|20953194|P2|Open Label Study Extension (Week 54-228)|Adverse Event|0
6064709|NCT00488631|20953195|P1|Open Label Study Extension (Week 54-228)|Adverse Event|0
6064710|NCT00488631|20953186|P10|Double Blind Period (Week 0-54)|Other|0
6064711|NCT00488631|20953187|P9|Double Blind Period (Week 0-54)|Other|0
6064712|NCT00488631|20953188|P8|Double Blind Period (Week 0-54)|Other|0
6064713|NCT00488631|20953189|P7|Double Blind Period (Week 0-54)|Other|0
6064714|NCT00488631|20953190|P6|Double Blind Period (Week 0-54)|Other|34
6064715|NCT00488631|20953191|P5|Double Blind Period (Week 0-54)|Other|14
6064716|NCT00488631|20953192|P4|Double Blind Period (Week 0-54)|Other|11
6064717|NCT00488631|20953193|P3|Double Blind Period (Week 0-54)|Other|10
6064718|NCT00488631|20953194|P2|Double Blind Period (Week 0-54)|Other|12
6064719|NCT00488631|20953195|P1|Double Blind Period (Week 0-54)|Other|6
6064720|NCT00488631|20953186|P10|Double Blind Period (Week 0-54)|Lost to Follow-up|0
6064721|NCT00488631|20953187|P9|Double Blind Period (Week 0-54)|Lost to Follow-up|0
6064722|NCT00488631|20953188|P8|Double Blind Period (Week 0-54)|Lost to Follow-up|0
6064723|NCT00488631|20953189|P7|Double Blind Period (Week 0-54)|Lost to Follow-up|0
6064724|NCT00488631|20953190|P6|Double Blind Period (Week 0-54)|Lost to Follow-up|7
6064725|NCT00488631|20953191|P5|Double Blind Period (Week 0-54)|Lost to Follow-up|3
6064726|NCT00488631|20953192|P4|Double Blind Period (Week 0-54)|Lost to Follow-up|0
6064727|NCT00488631|20953193|P3|Double Blind Period (Week 0-54)|Lost to Follow-up|1
6064728|NCT00488631|20953194|P2|Double Blind Period (Week 0-54)|Lost to Follow-up|2
6064729|NCT00488631|20953195|P1|Double Blind Period (Week 0-54)|Lost to Follow-up|1
6064730|NCT00488631|20953186|P10|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0
6064731|NCT00488631|20953187|P9|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0
6064732|NCT00488631|20953188|P8|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0
6064733|NCT00488631|20953189|P7|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0
6064734|NCT00488631|20953190|P6|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|124
6064735|NCT00488631|20953191|P5|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|56
6064736|NCT00488631|20953192|P4|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|18
6064737|NCT00488631|20953193|P3|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|22
6064738|NCT00488631|20953194|P2|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|17
6064739|NCT00488631|20953195|P1|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|19
6064740|NCT00488631|20953186|P10|Double Blind Period (Week 0-54)|Death|0
6064741|NCT00488631|20953187|P9|Double Blind Period (Week 0-54)|Death|0
6064742|NCT00488631|20953188|P8|Double Blind Period (Week 0-54)|Death|0
6064743|NCT00488631|20953189|P7|Double Blind Period (Week 0-54)|Death|0
6064744|NCT00488631|20953190|P6|Double Blind Period (Week 0-54)|Death|1
6064745|NCT00488631|20953191|P5|Double Blind Period (Week 0-54)|Death|0
6064746|NCT00488631|20953192|P4|Double Blind Period (Week 0-54)|Death|0
6064747|NCT00488631|20953193|P3|Double Blind Period (Week 0-54)|Death|0
6064748|NCT00488631|20953194|P2|Double Blind Period (Week 0-54)|Death|0
6064749|NCT00488631|20953195|P1|Double Blind Period (Week 0-54)|Death|0
6064750|NCT00488631|20953186|P10|Double Blind Period (Week 0-54)|Adverse Event|0
6064751|NCT00488631|20953187|P9|Double Blind Period (Week 0-54)|Adverse Event|0
6064752|NCT00488631|20953188|P8|Double Blind Period (Week 0-54)|Adverse Event|0
6064753|NCT00488631|20953189|P7|Double Blind Period (Week 0-54)|Adverse Event|0
6064754|NCT00488631|20953190|P6|Double Blind Period (Week 0-54)|Adverse Event|50
6064755|NCT00488631|20953191|P5|Double Blind Period (Week 0-54)|Adverse Event|30
6064756|NCT00488631|20953192|P4|Double Blind Period (Week 0-54)|Adverse Event|12
6064757|NCT00488631|20953193|P3|Double Blind Period (Week 0-54)|Adverse Event|12
6064758|NCT00488631|20953194|P2|Double Blind Period (Week 0-54)|Adverse Event|12
6064759|NCT00488631|20953195|P1|Double Blind Period (Week 0-54)|Adverse Event|17
6064760|NCT00488618|20953232|P2|Overall Study|Lost to Follow-up|0
6064761|NCT00488618|20953233|P1|Overall Study|Lost to Follow-up|1
6064762|NCT00488618|20953232|P2|Overall Study|Withdrawal of Consent|13
6064763|NCT00488618|20953233|P1|Overall Study|Withdrawal of Consent|15
6064764|NCT00488618|20953232|P2|Overall Study|Protocol Violation|2
6064765|NCT00488618|20953233|P1|Overall Study|Protocol Violation|0
6064766|NCT00488618|20953232|P2|Overall Study|Insufficient Therapeutic Response|11
6064767|NCT00488618|20953233|P1|Overall Study|Insufficient Therapeutic Response|18
6064768|NCT00488618|20953232|P2|Overall Study|Adverse Event|17
6064769|NCT00488618|20953233|P1|Overall Study|Adverse Event|13
6064770|NCT00488592|20953241|P1|Overall Study|Enrolled but not treated|1
6064771|NCT00488592|20953241|P1|Overall Study|Disease progression|1
6064772|NCT00488592|20953241|P1|Overall Study|Withdrawal by Subject|1
6064773|NCT00488514|20953245|P1|Overall Study|Increased use of concomitant medication|1
6064774|NCT00488514|20953245|P1|Overall Study|Increase in number of migraines|2
6064775|NCT00488514|20953245|P1|Overall Study|Participant had too few migraines|5
6064776|NCT00488514|20953245|P1|Overall Study|Investigator decision|1
6064777|NCT00488514|20953245|P1|Overall Study|Withdrawn per medical monitor decision|2
6064778|NCT00488514|20953245|P1|Overall Study|Postive drug screen|1
6064779|NCT00488514|20953245|P1|Overall Study|Did not meet criteria for treatment|30
6064780|NCT00488514|20953245|P1|Overall Study|Lack of Efficacy|28
6064781|NCT00488514|20953245|P1|Overall Study|Withdrawal by Subject|106
6064782|NCT00488514|20953245|P1|Overall Study|Protocol Violation|32
6064783|NCT00488514|20953245|P1|Overall Study|Lost to Follow-up|44
6064784|NCT00488514|20953245|P1|Overall Study|Adverse Event|41
6064785|NCT00488475|20953333|P1|Overall Study|Other|1754
6064786|NCT00488345|20953362|P3|Overall Study|Parent/legal guardian request|1
6064787|NCT00488345|20953363|P2|Overall Study|Parent/legal guardian request|1
6064788|NCT00488345|20953364|P1|Overall Study|Parent/legal guardian request|0
6064789|NCT00488345|20953362|P3|Overall Study|Surgical team recommendation|0
6064790|NCT00488345|20953363|P2|Overall Study|Surgical team recommendation|1
6064791|NCT00488345|20953364|P1|Overall Study|Surgical team recommendation|0
6064792|NCT00488345|20953362|P3|Overall Study|Institutional Review Board review|1
6064793|NCT00488345|20953363|P2|Overall Study|Institutional Review Board review|0
6064794|NCT00488345|20953364|P1|Overall Study|Institutional Review Board review|0
6064795|NCT00488345|20953362|P3|Overall Study|Unable to administer antibiotics at home|0
6064796|NCT00488345|20953363|P2|Overall Study|Unable to administer antibiotics at home|1
6064797|NCT00488345|20953364|P1|Overall Study|Unable to administer antibiotics at home|0
6064798|NCT00488345|20953362|P3|Overall Study|Adverse Event|1
6064799|NCT00488345|20953363|P2|Overall Study|Adverse Event|1
6064800|NCT00488345|20953364|P1|Overall Study|Adverse Event|0
6064801|NCT00488319|20953390|P3|Overall Study|Other reasons for withdrawal|12
6064802|NCT00488319|20953391|P2|Overall Study|Other reasons for withdrawal|4
6064803|NCT00488319|20953392|P1|Overall Study|Other reasons for withdrawal|0
6064804|NCT00488319|20953390|P3|Overall Study|Withdrawal by Subject|44
6064805|NCT00488319|20953391|P2|Overall Study|Withdrawal by Subject|20
6064806|NCT00488319|20953392|P1|Overall Study|Withdrawal by Subject|5
6064807|NCT00488319|20953390|P3|Overall Study|Lost to Follow-up|16
6064808|NCT00488319|20953391|P2|Overall Study|Lost to Follow-up|5
6064809|NCT00488319|20953392|P1|Overall Study|Lost to Follow-up|3
6064810|NCT00488319|20953390|P3|Overall Study|Lack of Efficacy|27
6064811|NCT00488319|20953391|P2|Overall Study|Lack of Efficacy|12
6064812|NCT00488319|20953392|P1|Overall Study|Lack of Efficacy|6
6064813|NCT00488319|20953390|P3|Overall Study|Adverse Event|23
6064814|NCT00488319|20953391|P2|Overall Study|Adverse Event|2
6064815|NCT00488319|20953392|P1|Overall Study|Adverse Event|1
6064816|NCT00488293|20953479|P2|Overall Study|Misrandomization/Other Unspecified|1
6064817|NCT00488293|20953480|P1|Overall Study|Misrandomization/Other Unspecified|1
6064818|NCT00488293|20953479|P2|Overall Study|Death|1
6064819|NCT00488293|20953480|P1|Overall Study|Death|2
6064820|NCT00488293|20953479|P2|Overall Study|Withdrawal by Subject|3
6064821|NCT00488293|20953480|P1|Overall Study|Withdrawal by Subject|5
6064822|NCT00488293|20953479|P2|Overall Study|Lost to Follow-up|25
6064823|NCT00488293|20953480|P1|Overall Study|Lost to Follow-up|28
6064824|NCT00488033|20953525|P2|Overall Study|Withdrawal by Subject|0
6064825|NCT00488033|20953526|P1|Overall Study|Withdrawal by Subject|1
6064826|NCT00487981|20953542|P1|Overall Study|Hypothyroidism diagnosis|1
6064827|NCT00487942|20953550|P4|Overall Study|Withdrawal by Subject|0
6064828|NCT00487942|20953551|P3|Overall Study|Withdrawal by Subject|2
6064829|NCT00487942|20953552|P2|Overall Study|Withdrawal by Subject|1
6064830|NCT00487942|20953553|P1|Overall Study|Withdrawal by Subject|0
6064831|NCT00487942|20953550|P4|Overall Study|Protocol Violation|0
6064832|NCT00487942|20953551|P3|Overall Study|Protocol Violation|0
6064833|NCT00487942|20953552|P2|Overall Study|Protocol Violation|1
6064834|NCT00487942|20953553|P1|Overall Study|Protocol Violation|1
6064835|NCT00487942|20953550|P4|Overall Study|Lost to Follow-up|1
6064836|NCT00487942|20953551|P3|Overall Study|Lost to Follow-up|0
6064837|NCT00487942|20953552|P2|Overall Study|Lost to Follow-up|0
6064838|NCT00487942|20953553|P1|Overall Study|Lost to Follow-up|1
6064839|NCT00487942|20953550|P4|Overall Study|Adverse Event|1
6064840|NCT00487942|20953551|P3|Overall Study|Adverse Event|1
6064841|NCT00487942|20953552|P2|Overall Study|Adverse Event|1
6064842|NCT00487942|20953553|P1|Overall Study|Adverse Event|1
6064843|NCT00487825|20953937|P2|Overall Study|Other|2
6064844|NCT00487825|20953938|P1|Overall Study|Other|3
6064845|NCT00487825|20953937|P2|Overall Study|Lack of Efficacy|1
6064846|NCT00487825|20953938|P1|Overall Study|Lack of Efficacy|1
6064847|NCT00487825|20953937|P2|Overall Study|Adverse Event|2
6064848|NCT00487825|20953938|P1|Overall Study|Adverse Event|2
6064849|NCT00487747|20953950|P1|Overall Study|Lack of Efficacy|1
6064850|NCT00487747|20953950|P1|Overall Study|Lost to Follow-up|9
6064851|NCT00487747|20953950|P1|Overall Study|Adverse Event|1
6064852|NCT00487695|20953967|P2|Second Procedure|Withdrawal by Subject|2
6064853|NCT00487695|20953968|P1|Second Procedure|Withdrawal by Subject|1
6064854|NCT00487695|20953967|P2|Second Procedure|active wheezing|1
6064855|NCT00487695|20953968|P1|Second Procedure|active wheezing|0
6064856|NCT00487695|20953967|P2|First Procedure|esophageal stricture found (excl crit)|0
6064857|NCT00487695|20953968|P1|First Procedure|esophageal stricture found (excl crit)|1
6064858|NCT00487695|20953967|P2|First Procedure|active wheezing (did not have procedure)|0
6064859|NCT00487695|20953968|P1|First Procedure|active wheezing (did not have procedure)|1
6064860|NCT00487695|20953967|P2|First Procedure|invasive cancer on EGD (excl criteria)|0
6064861|NCT00487695|20953968|P1|First Procedure|invasive cancer on EGD (excl criteria)|1
6064862|NCT00487578|20953996|P2|Overall Study|Lost to Follow-up|1
6064863|NCT00487578|20953997|P1|Overall Study|Lost to Follow-up|0
6064864|NCT00487578|20953996|P2|Overall Study|Lack of Efficacy|1
6064865|NCT00487578|20953997|P1|Overall Study|Lack of Efficacy|0
6064866|NCT00487578|20953996|P2|Overall Study|Adverse Event|2
6064867|NCT00487578|20953997|P1|Overall Study|Adverse Event|1
6064868|NCT00487552|20954017|P1|Overall Study|Stent not placed|1
6064869|NCT00487552|20954017|P1|Overall Study|Death due to progressive malignancy|2
6064870|NCT00487552|20954017|P1|Overall Study|Unsuccessful magnet placements|3
6064871|NCT00487539|20954026|P4|Overall Study|Other|2
6064872|NCT00487539|20954027|P3|Overall Study|Other|2
6064873|NCT00487539|20954028|P2|Overall Study|Other|1
6064874|NCT00487539|20954029|P1|Overall Study|Other|3
6064875|NCT00487539|20954026|P4|Overall Study|Unsatisfactory therapeutic effect|1
6064876|NCT00487539|20954027|P3|Overall Study|Unsatisfactory therapeutic effect|0
6064877|NCT00487539|20954028|P2|Overall Study|Unsatisfactory therapeutic effect|0
6064878|NCT00487539|20954029|P1|Overall Study|Unsatisfactory therapeutic effect|1
6064879|NCT00487539|20954026|P4|Overall Study|Adverse Event|1
6064880|NCT00487539|20954027|P3|Overall Study|Adverse Event|1
6064881|NCT00487539|20954028|P2|Overall Study|Adverse Event|2
6064882|NCT00487539|20954029|P1|Overall Study|Adverse Event|3
6064883|NCT00487435|20954063|P1|Overall Study|Other|83
6064884|NCT00487435|20954063|P1|Overall Study|Study Medication Non-Compliant|32
6064885|NCT00487435|20954063|P1|Overall Study|Resolution Of Pain|1
6064886|NCT00487435|20954063|P1|Overall Study|Withdrawal by Subject|132
6064887|NCT00487435|20954063|P1|Overall Study|Pregnancy|2
6064888|NCT00487435|20954063|P1|Overall Study|Lost to Follow-up|54
6064889|NCT00487435|20954063|P1|Overall Study|Lack of Efficacy|33
6064890|NCT00487435|20954063|P1|Overall Study|Death|2
6064891|NCT00487435|20954063|P1|Overall Study|Adverse Event|146
6064892|NCT00487279|20954079|P2|Overall Study|Withdrawal by Subject|2
6064893|NCT00487279|20954080|P1|Overall Study|Withdrawal by Subject|0
6064894|NCT00487279|20954079|P2|Overall Study|Death|0
6064895|NCT00487279|20954080|P1|Overall Study|Death|1
6064896|NCT00487240|20954090|P2|Overall Study|Physician Decision|0
6064897|NCT00487240|20954091|P1|Overall Study|Physician Decision|2
6064898|NCT00487240|20954090|P2|Overall Study|Sponsor Decision|1
6064899|NCT00487240|20954091|P1|Overall Study|Sponsor Decision|2
6064900|NCT00487240|20954090|P2|Overall Study|Entry Criteria Not Met|4
6064901|NCT00487240|20954091|P1|Overall Study|Entry Criteria Not Met|3
6064902|NCT00487240|20954090|P2|Overall Study|Protocol Violation|5
6064903|NCT00487240|20954091|P1|Overall Study|Protocol Violation|5
6064904|NCT00487240|20954090|P2|Overall Study|Adverse Event|4
6064905|NCT00487240|20954091|P1|Overall Study|Adverse Event|0
6064906|NCT00487240|20954090|P2|Overall Study|Lost to Follow-up|6
6064907|NCT00487240|20954091|P1|Overall Study|Lost to Follow-up|7
6064908|NCT00487240|20954090|P2|Overall Study|Withdrawal by Subject|6
6064909|NCT00487240|20954091|P1|Overall Study|Withdrawal by Subject|12
6064910|NCT00487188|20954119|P3|Maintenance Phase|Administrative|1
6064911|NCT00487188|20954120|P2|Maintenance Phase|Administrative|0
6064912|NCT00487188|20954121|P1|Maintenance Phase|Administrative|0
6064913|NCT00487188|20954119|P3|Maintenance Phase|Lost to Follow-up|0
6064914|NCT00487188|20954120|P2|Maintenance Phase|Lost to Follow-up|0
6064915|NCT00487188|20954121|P1|Maintenance Phase|Lost to Follow-up|1
6064916|NCT00487188|20954119|P3|Maintenance Phase|Death|0
6064917|NCT00487188|20954120|P2|Maintenance Phase|Death|0
6064918|NCT00487188|20954121|P1|Maintenance Phase|Death|1
6064919|NCT00487188|20954119|P3|Maintenance Phase|Adverse Event|0
6064920|NCT00487188|20954120|P2|Maintenance Phase|Adverse Event|0
6064921|NCT00487188|20954121|P1|Maintenance Phase|Adverse Event|1
6064922|NCT00487188|20954119|P3|Induction Phase|Administrative|0
6064923|NCT00487188|20954120|P2|Induction Phase|Administrative|1
6064924|NCT00487188|20954121|P1|Induction Phase|Administrative|0
6064925|NCT00487188|20954119|P3|Induction Phase|Lost to Follow-up|0
6064926|NCT00487188|20954120|P2|Induction Phase|Lost to Follow-up|2
6064927|NCT00487188|20954121|P1|Induction Phase|Lost to Follow-up|2
6064928|NCT00487188|20954119|P3|Induction Phase|Refused Treatment|0
6064929|NCT00487188|20954120|P2|Induction Phase|Refused Treatment|2
6064930|NCT00487188|20954121|P1|Induction Phase|Refused Treatment|1
6064931|NCT00487188|20954119|P3|Induction Phase|Protocol Violation|0
6064932|NCT00487188|20954120|P2|Induction Phase|Protocol Violation|0
6064933|NCT00487188|20954121|P1|Induction Phase|Protocol Violation|1
6064934|NCT00487188|20954119|P3|Induction Phase|Lack of Efficacy|0
6064935|NCT00487188|20954120|P2|Induction Phase|Lack of Efficacy|1
6064936|NCT00487188|20954121|P1|Induction Phase|Lack of Efficacy|0
6064937|NCT00487188|20954119|P3|Induction Phase|Adverse Event|0
6064938|NCT00487188|20954120|P2|Induction Phase|Adverse Event|0
6064939|NCT00487188|20954121|P1|Induction Phase|Adverse Event|5
6064940|NCT00487188|20954119|P3|Induction Phase|Abnormality of Laboratory Test|0
6064941|NCT00487188|20954120|P2|Induction Phase|Abnormality of Laboratory Test|1
6064942|NCT00487188|20954121|P1|Induction Phase|Abnormality of Laboratory Test|0
6064943|NCT00487162|20954160|P2|Overall Study|Withdrawal by Subject|3
6064944|NCT00487162|20954161|P1|Overall Study|Withdrawal by Subject|2
6064945|NCT00487162|20954160|P2|Overall Study|Physician Decision|1
6064946|NCT00487162|20954161|P1|Overall Study|Physician Decision|0
6064947|NCT00487162|20954160|P2|Overall Study|Adverse Event|1
6064948|NCT00487162|20954161|P1|Overall Study|Adverse Event|0
6064949|NCT00487084|20954172|P3|Overall Study|Did not receive intervention|5
6064950|NCT00487084|20954173|P2|Overall Study|Did not receive intervention|3
6064951|NCT00487084|20954174|P1|Overall Study|Did not receive intervention|4
6064952|NCT00486954|20954195|P5|Randomized Part|Sponsor Terminated Study|13
6064953|NCT00486954|20954196|P4|Randomized Part|Sponsor Terminated Study|19
6064954|NCT00486954|20954197|P3|Randomized Part|Sponsor Terminated Study|0
6064955|NCT00486954|20954198|P2|Randomized Part|Sponsor Terminated Study|0
6064956|NCT00486954|20954199|P1|Randomized Part|Sponsor Terminated Study|0
6064957|NCT00486954|20954195|P5|Randomized Part|Withdrawal by Subject|0
6064958|NCT00486954|20954196|P4|Randomized Part|Withdrawal by Subject|1
6064959|NCT00486954|20954197|P3|Randomized Part|Withdrawal by Subject|0
6064960|NCT00486954|20954198|P2|Randomized Part|Withdrawal by Subject|0
6064961|NCT00486954|20954199|P1|Randomized Part|Withdrawal by Subject|0
6064962|NCT00486954|20954195|P5|Randomized Part|Lost to Follow-up|1
6064963|NCT00486954|20954196|P4|Randomized Part|Lost to Follow-up|0
6064964|NCT00486954|20954197|P3|Randomized Part|Lost to Follow-up|0
6064965|NCT00486954|20954198|P2|Randomized Part|Lost to Follow-up|0
6064966|NCT00486954|20954199|P1|Randomized Part|Lost to Follow-up|0
6064967|NCT00486954|20954195|P5|Pilot Part|Disease Progression|0
6064968|NCT00486954|20954196|P4|Pilot Part|Disease Progression|0
6064969|NCT00486954|20954197|P3|Pilot Part|Disease Progression|1
6064970|NCT00486954|20954198|P2|Pilot Part|Disease Progression|0
6064971|NCT00486954|20954199|P1|Pilot Part|Disease Progression|2
6064972|NCT00486954|20954195|P5|Pilot Part|Adverse Event|0
6064973|NCT00486954|20954196|P4|Pilot Part|Adverse Event|0
6064974|NCT00486954|20954197|P3|Pilot Part|Adverse Event|5
6064975|NCT00486954|20954198|P2|Pilot Part|Adverse Event|0
6064976|NCT00486954|20954199|P1|Pilot Part|Adverse Event|4
6064977|NCT00486902|20954297|P2|Overall Study|No toradol due to hemmorhage or allergy|1
6064978|NCT00486902|20954298|P1|Overall Study|No toradol due to hemmorhage or allergy|3
6064979|NCT00486902|20954297|P2|Overall Study|Did not meet inclusion criteria|0
6064980|NCT00486902|20954298|P1|Overall Study|Did not meet inclusion criteria|1
6064981|NCT00486902|20954297|P2|Overall Study|spinal anesthetic protocal violation|1
6064982|NCT00486902|20954298|P1|Overall Study|spinal anesthetic protocal violation|1
6064983|NCT00486902|20954297|P2|Overall Study|decision for postpartum tubal ligation|1
6064984|NCT00486902|20954298|P1|Overall Study|decision for postpartum tubal ligation|3
6064985|NCT00486902|20954297|P2|Overall Study|Withdrawal by Subject|2
6064986|NCT00486902|20954298|P1|Overall Study|Withdrawal by Subject|1
6064987|NCT00486837|20954365|P2|Overall Study|No sputum, devise issues, exacerbation|4
6064988|NCT00486837|20954366|P1|Overall Study|No sputum, devise issues, exacerbation|3
6064989|NCT00486837|20954365|P2|Overall Study|Protocol Violation|2
6064990|NCT00486837|20954366|P1|Overall Study|Protocol Violation|4
6064991|NCT00486837|20954365|P2|Overall Study|Adverse Event|1
6064992|NCT00486837|20954366|P1|Overall Study|Adverse Event|1
6064993|NCT00486837|20954365|P2|Overall Study|Withdrawal by Subject|0
6064994|NCT00486837|20954366|P1|Overall Study|Withdrawal by Subject|1
6064995|NCT00486811|20954406|P3|Overall Study|All other|7
6064996|NCT00486811|20954407|P2|Overall Study|All other|11
6064997|NCT00486811|20954408|P1|Overall Study|All other|18
6064998|NCT00486811|20954406|P3|Overall Study|Study drug non-compliant|3
6064999|NCT00486811|20954407|P2|Overall Study|Study drug non-compliant|6
6065000|NCT00486811|20954408|P1|Overall Study|Study drug non-compliant|5
6065001|NCT00486811|20954406|P3|Overall Study|Withdrawal by Subject|58
6065002|NCT00486811|20954407|P2|Overall Study|Withdrawal by Subject|44
6065003|NCT00486811|20954408|P1|Overall Study|Withdrawal by Subject|33
6065004|NCT00486811|20954406|P3|Overall Study|Lost to Follow-up|4
6065005|NCT00486811|20954407|P2|Overall Study|Lost to Follow-up|6
6065006|NCT00486811|20954408|P1|Overall Study|Lost to Follow-up|4
6065007|NCT00486811|20954406|P3|Overall Study|Lack of Efficacy|7
6065008|NCT00486811|20954407|P2|Overall Study|Lack of Efficacy|14
6065009|NCT00486811|20954408|P1|Overall Study|Lack of Efficacy|34
6065010|NCT00486811|20954406|P3|Overall Study|Adverse Event|135
6065011|NCT00486811|20954407|P2|Overall Study|Adverse Event|60
6065012|NCT00486811|20954408|P1|Overall Study|Adverse Event|28
6065013|NCT00486759|20954451|P2|Safety Follow-up|Adverse event/intercurrent illness|0
6065014|NCT00486759|20954452|P1|Safety Follow-up|Adverse event/intercurrent illness|4
6065015|NCT00486759|20954451|P2|Safety Follow-up|Refused treatment/did not cooperate|4
6065016|NCT00486759|20954452|P1|Safety Follow-up|Refused treatment/did not cooperate|6
6065017|NCT00486759|20954451|P2|Safety Follow-up|Administrative/not specified|6
6065018|NCT00486759|20954452|P1|Safety Follow-up|Administrative/not specified|8
6065019|NCT00486759|20954451|P2|Safety Follow-up|Failure to return|6
6065020|NCT00486759|20954452|P1|Safety Follow-up|Failure to return|9
6065021|NCT00486759|20954451|P2|Safety Follow-up|Withdrew consent|23
6065022|NCT00486759|20954452|P1|Safety Follow-up|Withdrew consent|32
6065023|NCT00486759|20954451|P2|Safety Follow-up|Death|29
6065024|NCT00486759|20954452|P1|Safety Follow-up|Death|40
6065025|NCT00486759|20954451|P2|Safety Follow-up|Insufficient therapeutic response|50
6065026|NCT00486759|20954452|P1|Safety Follow-up|Insufficient therapeutic response|40
6065027|NCT00486759|20954451|P2|Treatment|Failure to return|1
6065028|NCT00486759|20954452|P1|Treatment|Failure to return|1
6065029|NCT00486759|20954451|P2|Treatment|Other protocol violation|5
6065030|NCT00486759|20954452|P1|Treatment|Other protocol violation|1
6065031|NCT00486759|20954451|P2|Treatment|Violation of selection criteria at entry|3
6065032|NCT00486759|20954452|P1|Treatment|Violation of selection criteria at entry|3
6065033|NCT00486759|20954451|P2|Treatment|Refused treatment|7
6065034|NCT00486759|20954452|P1|Treatment|Refused treatment|10
6065035|NCT00486759|20954451|P2|Treatment|Administrative/reason not specified|21
6065036|NCT00486759|20954452|P1|Treatment|Administrative/reason not specified|17
6065037|NCT00486759|20954451|P2|Treatment|Withdrew consent|12
6065038|NCT00486759|20954452|P1|Treatment|Withdrew consent|15
6065039|NCT00486759|20954451|P2|Treatment|Death|10
6065040|NCT00486759|20954452|P1|Treatment|Death|17
6065041|NCT00486759|20954451|P2|Treatment|Insufficient therapeutic response|39
6065042|NCT00486759|20954452|P1|Treatment|Insufficient therapeutic response|37
6065043|NCT00486759|20954451|P2|Treatment|Adverse event/intercurrent illness|39
6065044|NCT00486759|20954452|P1|Treatment|Adverse event/intercurrent illness|86
6065045|NCT00486720|20954464|P2|Overall Study|Progressive Disease|1
6065046|NCT00486720|20954465|P1|Overall Study|Progressive Disease|0
6065047|NCT00486720|20954464|P2|Overall Study|Withdrawal by Subject|1
6065048|NCT00486720|20954465|P1|Overall Study|Withdrawal by Subject|3
6065049|NCT00486720|20954464|P2|Overall Study|Protocol Violation|0
6065050|NCT00486720|20954465|P1|Overall Study|Protocol Violation|1
6065051|NCT00486720|20954464|P2|Overall Study|Physician Decision|2
6065052|NCT00486720|20954465|P1|Overall Study|Physician Decision|1
6065053|NCT00486720|20954464|P2|Overall Study|Lack of Efficacy|6
6065054|NCT00486720|20954465|P1|Overall Study|Lack of Efficacy|4
6065055|NCT00486720|20954464|P2|Overall Study|Adverse Event|2
6065056|NCT00486720|20954465|P1|Overall Study|Adverse Event|1
6065057|NCT00486603|20954500|P5|Overall Study|Physician Decision|0
6065058|NCT00486603|20954501|P4|Overall Study|Physician Decision|0
6065059|NCT00486603|20954502|P3|Overall Study|Physician Decision|0
6065060|NCT00486603|20954503|P2|Overall Study|Physician Decision|1
6065061|NCT00486603|20954504|P1|Overall Study|Physician Decision|0
6065062|NCT00486603|20954500|P5|Overall Study|Withdrawal by Subject|0
6065063|NCT00486603|20954501|P4|Overall Study|Withdrawal by Subject|0
6065064|NCT00486603|20954502|P3|Overall Study|Withdrawal by Subject|0
6065065|NCT00486603|20954503|P2|Overall Study|Withdrawal by Subject|0
6065066|NCT00486603|20954504|P1|Overall Study|Withdrawal by Subject|1
6065067|NCT00486434|20954552|P2|Overall Study|Personal reasons|6
6065068|NCT00486434|20954553|P1|Overall Study|Personal reasons|5
6065069|NCT00486434|20954552|P2|Overall Study|Death|2
6065070|NCT00486434|20954553|P1|Overall Study|Death|1
6065071|NCT00486434|20954552|P2|Overall Study|Lost to Follow-up|3
6065072|NCT00486434|20954553|P1|Overall Study|Lost to Follow-up|2
6065073|NCT00486434|20954552|P2|Overall Study|Lack of Efficacy|19
6065074|NCT00486434|20954553|P1|Overall Study|Lack of Efficacy|12
6065075|NCT00486434|20954552|P2|Overall Study|Protocol Violation|21
6065076|NCT00486434|20954553|P1|Overall Study|Protocol Violation|22
6065077|NCT00486434|20954552|P2|Overall Study|Adverse Event|44
6065078|NCT00486434|20954553|P1|Overall Study|Adverse Event|118
6065079|NCT00486434|20954552|P2|Overall Study|Withdrawal by Subject|39
6065080|NCT00486434|20954553|P1|Overall Study|Withdrawal by Subject|34
6065081|NCT00486330|20954572|P1|Overall Study|Adverse Event|2
6065082|NCT00486291|20954578|P2|Overall Study|requirement for restricted medication|3
6065083|NCT00486291|20954579|P1|Overall Study|requirement for restricted medication|0
6065084|NCT00486291|20954578|P2|Overall Study|protocol non-compliance|15
6065085|NCT00486291|20954579|P1|Overall Study|protocol non-compliance|10
6065086|NCT00486291|20954578|P2|Overall Study|Lost to Follow-up|7
6065087|NCT00486291|20954579|P1|Overall Study|Lost to Follow-up|3
6065088|NCT00486291|20954578|P2|Overall Study|Adverse Event|4
6065089|NCT00486291|20954579|P1|Overall Study|Adverse Event|3
6065090|NCT00486278|20954587|P1|Overall Study|Physician Decision|2
6065091|NCT00486278|20954587|P1|Overall Study|Withdrawal by Subject|2
6065092|NCT00486278|20954587|P1|Overall Study|Adverse Event|5
6065093|NCT00486265|20954721|P1|Overall Study|Lack of Efficacy|8
6065094|NCT00486265|20954721|P1|Overall Study|Adverse Event|1
6065099|NCT00486226|20954740|P1|Overall Study|Lost to Follow-up|8
6065100|NCT00486226|20954740|P1|Overall Study|Withdrawal by Subject|1
6065101|NCT00486226|20954740|P1|Overall Study|Adverse Event|1
6065102|NCT00486226|20954740|P1|Overall Study|Death|3
6065103|NCT00486044|20954750|P2|Overall Study|Lost to Follow-up|1
6065104|NCT00486044|20954751|P1|Overall Study|Lost to Follow-up|0
6065105|NCT00486044|20954750|P2|Overall Study|Adverse Event|1
6065106|NCT00486044|20954751|P1|Overall Study|Adverse Event|0
6065107|NCT00486044|20954750|P2|Overall Study|Withdrawal by Subject|1
6065108|NCT00486044|20954751|P1|Overall Study|Withdrawal by Subject|2
6065109|NCT00485758|20954845|P2|Overall Study|Study Terminated by Sponsor|0
6065110|NCT00485758|20954846|P1|Overall Study|Study Terminated by Sponsor|3
6065111|NCT00485758|20954845|P2|Overall Study|Withdrawal by Subject|27
6065112|NCT00485758|20954846|P1|Overall Study|Withdrawal by Subject|32
6065113|NCT00485758|20954845|P2|Overall Study|Protocol Violation|2
6065114|NCT00485758|20954846|P1|Overall Study|Protocol Violation|11
6065115|NCT00485758|20954845|P2|Overall Study|Physician Decision|3
6065116|NCT00485758|20954846|P1|Overall Study|Physician Decision|3
6065117|NCT00485758|20954845|P2|Overall Study|Lost to Follow-up|1
6065118|NCT00485758|20954846|P1|Overall Study|Lost to Follow-up|5
6065119|NCT00485758|20954845|P2|Overall Study|Death|1
6065120|NCT00485758|20954846|P1|Overall Study|Death|0
6065121|NCT00485758|20954845|P2|Overall Study|Adverse Event|31
6065122|NCT00485758|20954846|P1|Overall Study|Adverse Event|102
6065123|NCT00485732|20954858|P2|Overall Study|Lost to Follow-up|2
6065124|NCT00485732|20954859|P1|Overall Study|Lost to Follow-up|2
6065125|NCT00485732|20954858|P2|Overall Study|Withdrawal by Subject|4
6065126|NCT00485732|20954859|P1|Overall Study|Withdrawal by Subject|5
6065127|NCT00485732|20954858|P2|Overall Study|Protocol Violation|3
6065128|NCT00485732|20954859|P1|Overall Study|Protocol Violation|1
6065129|NCT00485589|20954894|P3|Overall Study|Adverse Event|10
6065130|NCT00485589|20954895|P2|Overall Study|Adverse Event|3
6065131|NCT00485589|20954896|P1|Overall Study|Adverse Event|3
6065132|NCT00485589|20954894|P3|Overall Study|Withdrawal by Subject|2
6065133|NCT00485589|20954895|P2|Overall Study|Withdrawal by Subject|2
6065134|NCT00485589|20954896|P1|Overall Study|Withdrawal by Subject|3
6065135|NCT00485589|20954894|P3|Overall Study|Refused treatment/did not cooperate|2
6065136|NCT00485589|20954895|P2|Overall Study|Refused treatment/did not cooperate|0
6065137|NCT00485589|20954896|P1|Overall Study|Refused treatment/did not cooperate|1
6065138|NCT00485589|20954894|P3|Overall Study|Insufficient therapeutic response|1
6065139|NCT00485589|20954895|P2|Overall Study|Insufficient therapeutic response|3
6065140|NCT00485589|20954896|P1|Overall Study|Insufficient therapeutic response|10
6065141|NCT00485589|20954894|P3|Overall Study|Administrative/Other|1
6065142|NCT00485589|20954895|P2|Overall Study|Administrative/Other|2
6065143|NCT00485589|20954896|P1|Overall Study|Administrative/Other|1
6065144|NCT00485589|20954894|P3|Overall Study|Violation of selection criteria at entry|1
6065145|NCT00485589|20954895|P2|Overall Study|Violation of selection criteria at entry|3
6065146|NCT00485589|20954896|P1|Overall Study|Violation of selection criteria at entry|0
6065147|NCT00485589|20954894|P3|Overall Study|Protocol Violation|0
6065148|NCT00485589|20954895|P2|Overall Study|Protocol Violation|0
6065149|NCT00485589|20954896|P1|Overall Study|Protocol Violation|1
6065150|NCT00485589|20954894|P3|Overall Study|Failure to return|1
6065151|NCT00485589|20954895|P2|Overall Study|Failure to return|5
6065152|NCT00485589|20954896|P1|Overall Study|Failure to return|6
6065153|NCT00485589|20954894|P3|Overall Study|Death|0
6065154|NCT00485589|20954895|P2|Overall Study|Death|2
6065155|NCT00485589|20954896|P1|Overall Study|Death|2
6065156|NCT00485472|20954928|P2|Overall Study|Lost to Follow-up|1
6065157|NCT00485472|20954929|P1|Overall Study|Lost to Follow-up|0
6065158|NCT00485472|20954928|P2|Overall Study|Other|1
6065159|NCT00485472|20954929|P1|Overall Study|Other|2
6065160|NCT00485472|20954928|P2|Overall Study|Protocol Violation|1
6065161|NCT00485472|20954929|P1|Overall Study|Protocol Violation|0
6065162|NCT00485472|20954928|P2|Overall Study|Withdrawal by Subject|0
6065163|NCT00485472|20954929|P1|Overall Study|Withdrawal by Subject|1
6065164|NCT00485472|20954928|P2|Overall Study|Lack of Efficacy|4
6065165|NCT00485472|20954929|P1|Overall Study|Lack of Efficacy|5
6065166|NCT00485472|20954928|P2|Overall Study|Adverse Event|5
6065167|NCT00485472|20954929|P1|Overall Study|Adverse Event|8
6065168|NCT00485303|20954966|P1|Overall Study|Treatment ongoing at cutoff date|2
6065169|NCT00485303|20954966|P1|Overall Study|Initiation of new anti-cancer treatment|2
6065170|NCT00485303|20954966|P1|Overall Study|Other|3
6065171|NCT00485303|20954966|P1|Overall Study|Progressive Disease|44
6065172|NCT00485303|20954966|P1|Overall Study|Adverse Event|5
6065173|NCT00485264|20954984|P6|Overall Study|Other Reason|0
6065174|NCT00485264|20954985|P5|Overall Study|Other Reason|0
6065175|NCT00485264|20954986|P4|Overall Study|Other Reason|0
6065176|NCT00485264|20954987|P3|Overall Study|Other Reason|0
6065177|NCT00485264|20954988|P2|Overall Study|Other Reason|0
6065178|NCT00485264|20954989|P1|Overall Study|Other Reason|3
6065179|NCT00485264|20954984|P6|Overall Study|Lost to Follow-up|1
6065180|NCT00485264|20954985|P5|Overall Study|Lost to Follow-up|0
6065181|NCT00485264|20954986|P4|Overall Study|Lost to Follow-up|0
6065182|NCT00485264|20954987|P3|Overall Study|Lost to Follow-up|1
6065183|NCT00485264|20954988|P2|Overall Study|Lost to Follow-up|1
6065184|NCT00485264|20954989|P1|Overall Study|Lost to Follow-up|2
6065185|NCT00485264|20954984|P6|Overall Study|Non-Compliant|0
6065186|NCT00485264|20954985|P5|Overall Study|Non-Compliant|1
6065187|NCT00485264|20954986|P4|Overall Study|Non-Compliant|0
6065188|NCT00485264|20954987|P3|Overall Study|Non-Compliant|1
6065189|NCT00485264|20954988|P2|Overall Study|Non-Compliant|2
6065190|NCT00485264|20954989|P1|Overall Study|Non-Compliant|17
6065191|NCT00485264|20954984|P6|Overall Study|Not Able to Attend Clinic|2
6065192|NCT00485264|20954985|P5|Overall Study|Not Able to Attend Clinic|1
6065193|NCT00485264|20954986|P4|Overall Study|Not Able to Attend Clinic|1
6065194|NCT00485264|20954987|P3|Overall Study|Not Able to Attend Clinic|0
6065195|NCT00485264|20954988|P2|Overall Study|Not Able to Attend Clinic|0
6065196|NCT00485264|20954989|P1|Overall Study|Not Able to Attend Clinic|5
6065197|NCT00485264|20954984|P6|Overall Study|Intolerance/Unable to Tolerate Dose|0
6065198|NCT00485264|20954985|P5|Overall Study|Intolerance/Unable to Tolerate Dose|0
6065199|NCT00485264|20954986|P4|Overall Study|Intolerance/Unable to Tolerate Dose|0
6065200|NCT00485264|20954987|P3|Overall Study|Intolerance/Unable to Tolerate Dose|1
6065201|NCT00485264|20954988|P2|Overall Study|Intolerance/Unable to Tolerate Dose|0
6065202|NCT00485264|20954989|P1|Overall Study|Intolerance/Unable to Tolerate Dose|0
6065203|NCT00485264|20954984|P6|Overall Study|Physician Decision|0
6065204|NCT00485264|20954985|P5|Overall Study|Physician Decision|0
6065205|NCT00485264|20954986|P4|Overall Study|Physician Decision|0
6065206|NCT00485264|20954987|P3|Overall Study|Physician Decision|0
6065207|NCT00485264|20954988|P2|Overall Study|Physician Decision|2
6065208|NCT00485264|20954989|P1|Overall Study|Physician Decision|0
6065209|NCT00485264|20954984|P6|Overall Study|Guardian Consent Withdrawn|0
6065210|NCT00485264|20954985|P5|Overall Study|Guardian Consent Withdrawn|1
6065211|NCT00485264|20954986|P4|Overall Study|Guardian Consent Withdrawn|0
6065212|NCT00485264|20954987|P3|Overall Study|Guardian Consent Withdrawn|0
6065213|NCT00485264|20954988|P2|Overall Study|Guardian Consent Withdrawn|0
6065214|NCT00485264|20954989|P1|Overall Study|Guardian Consent Withdrawn|1
6065215|NCT00485264|20954984|P6|Overall Study|Lack of Efficacy|0
6065216|NCT00485264|20954985|P5|Overall Study|Lack of Efficacy|0
6065217|NCT00485264|20954986|P4|Overall Study|Lack of Efficacy|0
6065218|NCT00485264|20954987|P3|Overall Study|Lack of Efficacy|0
6065219|NCT00485264|20954988|P2|Overall Study|Lack of Efficacy|1
6065220|NCT00485264|20954989|P1|Overall Study|Lack of Efficacy|0
6065221|NCT00485264|20954984|P6|Overall Study|Number/Volume/Timing of Study Meds|0
6065222|NCT00485264|20954985|P5|Overall Study|Number/Volume/Timing of Study Meds|0
6065223|NCT00485264|20954986|P4|Overall Study|Number/Volume/Timing of Study Meds|0
6065224|NCT00485264|20954987|P3|Overall Study|Number/Volume/Timing of Study Meds|1
6065225|NCT00485264|20954988|P2|Overall Study|Number/Volume/Timing of Study Meds|1
6065226|NCT00485264|20954989|P1|Overall Study|Number/Volume/Timing of Study Meds|2
6065227|NCT00485264|20954984|P6|Overall Study|Disallowed Medication|1
6065228|NCT00485264|20954985|P5|Overall Study|Disallowed Medication|0
6065229|NCT00485264|20954986|P4|Overall Study|Disallowed Medication|0
6065230|NCT00485264|20954987|P3|Overall Study|Disallowed Medication|0
6065231|NCT00485264|20954988|P2|Overall Study|Disallowed Medication|0
6065232|NCT00485264|20954989|P1|Overall Study|Disallowed Medication|0
6065233|NCT00485264|20954984|P6|Overall Study|Pregnancy|0
6065234|NCT00485264|20954985|P5|Overall Study|Pregnancy|0
6065235|NCT00485264|20954986|P4|Overall Study|Pregnancy|0
6065236|NCT00485264|20954987|P3|Overall Study|Pregnancy|0
6065237|NCT00485264|20954988|P2|Overall Study|Pregnancy|0
6065238|NCT00485264|20954989|P1|Overall Study|Pregnancy|4
6065239|NCT00485264|20954984|P6|Overall Study|Adverse Event|3
6065240|NCT00485264|20954985|P5|Overall Study|Adverse Event|1
6065241|NCT00485264|20954986|P4|Overall Study|Adverse Event|3
6065242|NCT00485264|20954987|P3|Overall Study|Adverse Event|2
6065243|NCT00485264|20954988|P2|Overall Study|Adverse Event|0
6065244|NCT00485264|20954989|P1|Overall Study|Adverse Event|1
6065245|NCT00485264|20954984|P6|Overall Study|Death|0
6065246|NCT00485264|20954985|P5|Overall Study|Death|1
6065247|NCT00485264|20954986|P4|Overall Study|Death|0
6065248|NCT00485264|20954987|P3|Overall Study|Death|0
6065249|NCT00485264|20954988|P2|Overall Study|Death|0
6065250|NCT00485264|20954989|P1|Overall Study|Death|1
6065251|NCT00485264|20954984|P6|Overall Study|Enrolled But Not Given Treatment|0
6065252|NCT00485264|20954985|P5|Overall Study|Enrolled But Not Given Treatment|1
6065253|NCT00485264|20954986|P4|Overall Study|Enrolled But Not Given Treatment|0
6065254|NCT00485264|20954987|P3|Overall Study|Enrolled But Not Given Treatment|0
6065255|NCT00485264|20954988|P2|Overall Study|Enrolled But Not Given Treatment|0
6065256|NCT00485264|20954989|P1|Overall Study|Enrolled But Not Given Treatment|0
6065257|NCT00485173|20955077|P2|Overall Study|Lost to Follow-up|61
6065258|NCT00485173|20955078|P1|Overall Study|Lost to Follow-up|32
6065259|NCT00485173|20955077|P2|Overall Study|Death|3
6065260|NCT00485173|20955078|P1|Overall Study|Death|4
6065261|NCT00485134|20955126|P8|Overall Study|Pregnancy|0
6065262|NCT00485134|20955127|P7|Overall Study|Pregnancy|1
6065263|NCT00485134|20955128|P6|Overall Study|Pregnancy|0
6065264|NCT00485134|20955129|P5|Overall Study|Pregnancy|0
6065265|NCT00485134|20955130|P4|Overall Study|Pregnancy|0
6065266|NCT00485134|20955131|P3|Overall Study|Pregnancy|0
6065267|NCT00485134|20955132|P2|Overall Study|Pregnancy|0
6065268|NCT00485134|20955133|P1|Overall Study|Pregnancy|0
6065269|NCT00485134|20955126|P8|Overall Study|Unable to comply with study schedule|1
6065270|NCT00485134|20955127|P7|Overall Study|Unable to comply with study schedule|0
6065271|NCT00485134|20955128|P6|Overall Study|Unable to comply with study schedule|0
6065272|NCT00485134|20955129|P5|Overall Study|Unable to comply with study schedule|0
6065273|NCT00485134|20955130|P4|Overall Study|Unable to comply with study schedule|0
6065274|NCT00485134|20955131|P3|Overall Study|Unable to comply with study schedule|0
6065275|NCT00485134|20955132|P2|Overall Study|Unable to comply with study schedule|0
6065276|NCT00485134|20955133|P1|Overall Study|Unable to comply with study schedule|0
6065277|NCT00485134|20955126|P8|Overall Study|Non-compliance|0
6065278|NCT00485134|20955127|P7|Overall Study|Non-compliance|2
6065279|NCT00485134|20955128|P6|Overall Study|Non-compliance|2
6065280|NCT00485134|20955129|P5|Overall Study|Non-compliance|1
6065281|NCT00485134|20955130|P4|Overall Study|Non-compliance|0
6065282|NCT00485134|20955131|P3|Overall Study|Non-compliance|0
6065283|NCT00485134|20955132|P2|Overall Study|Non-compliance|0
6065284|NCT00485134|20955133|P1|Overall Study|Non-compliance|0
6065285|NCT00485134|20955126|P8|Overall Study|Positive drug test|0
6065286|NCT00485134|20955127|P7|Overall Study|Positive drug test|0
6065287|NCT00485134|20955128|P6|Overall Study|Positive drug test|1
6065288|NCT00485134|20955129|P5|Overall Study|Positive drug test|2
6065289|NCT00485134|20955130|P4|Overall Study|Positive drug test|0
6065290|NCT00485134|20955131|P3|Overall Study|Positive drug test|0
6065291|NCT00485134|20955132|P2|Overall Study|Positive drug test|0
6065292|NCT00485134|20955133|P1|Overall Study|Positive drug test|0
6065293|NCT00485134|20955126|P8|Overall Study|Withdrew for adverse event|0
6065294|NCT00485134|20955127|P7|Overall Study|Withdrew for adverse event|0
6065295|NCT00485134|20955128|P6|Overall Study|Withdrew for adverse event|0
6065296|NCT00485134|20955129|P5|Overall Study|Withdrew for adverse event|0
6065297|NCT00485134|20955130|P4|Overall Study|Withdrew for adverse event|0
6065298|NCT00485134|20955131|P3|Overall Study|Withdrew for adverse event|1
6065299|NCT00485134|20955132|P2|Overall Study|Withdrew for adverse event|0
6065300|NCT00485134|20955133|P1|Overall Study|Withdrew for adverse event|0
6065301|NCT00485134|20955126|P8|Overall Study|Change in health status|0
6065302|NCT00485134|20955127|P7|Overall Study|Change in health status|0
6065303|NCT00485134|20955128|P6|Overall Study|Change in health status|1
6065304|NCT00485134|20955129|P5|Overall Study|Change in health status|0
6065305|NCT00485134|20955130|P4|Overall Study|Change in health status|1
6065306|NCT00485134|20955131|P3|Overall Study|Change in health status|2
6065307|NCT00485134|20955132|P2|Overall Study|Change in health status|1
6065308|NCT00485134|20955133|P1|Overall Study|Change in health status|0
6065309|NCT00485134|20955126|P8|Overall Study|Withdrawal by Subject|0
6065310|NCT00485134|20955127|P7|Overall Study|Withdrawal by Subject|0
6065311|NCT00485134|20955128|P6|Overall Study|Withdrawal by Subject|0
6065312|NCT00485134|20955129|P5|Overall Study|Withdrawal by Subject|0
6065313|NCT00485134|20955130|P4|Overall Study|Withdrawal by Subject|0
6065314|NCT00485134|20955131|P3|Overall Study|Withdrawal by Subject|0
6065315|NCT00485134|20955132|P2|Overall Study|Withdrawal by Subject|1
6065316|NCT00485134|20955133|P1|Overall Study|Withdrawal by Subject|0
6065317|NCT00485134|20955126|P8|Overall Study|Lost to Follow-up|0
6065318|NCT00485134|20955127|P7|Overall Study|Lost to Follow-up|0
6065319|NCT00485134|20955128|P6|Overall Study|Lost to Follow-up|0
6065320|NCT00485134|20955129|P5|Overall Study|Lost to Follow-up|0
6065321|NCT00485134|20955130|P4|Overall Study|Lost to Follow-up|0
6065322|NCT00485134|20955131|P3|Overall Study|Lost to Follow-up|0
6065323|NCT00485134|20955132|P2|Overall Study|Lost to Follow-up|0
6065324|NCT00485134|20955133|P1|Overall Study|Lost to Follow-up|1
6065325|NCT00485069|20955155|P2|Overall Study|Withdrawal by Subject|6
6065326|NCT00485069|20955156|P1|Overall Study|Withdrawal by Subject|6
6065327|NCT00485069|20955155|P2|Overall Study|Protocol Violation|1
6065328|NCT00485069|20955156|P1|Overall Study|Protocol Violation|0
6065329|NCT00485069|20955155|P2|Overall Study|Lack of Efficacy|1
6065330|NCT00485069|20955156|P1|Overall Study|Lack of Efficacy|2
6065331|NCT00485069|20955155|P2|Overall Study|Adverse Event|4
6065332|NCT00485069|20955156|P1|Overall Study|Adverse Event|10
6065333|NCT00484939|20955201|P2|Overall Study|Reason Not Specified|6
6065334|NCT00484939|20955202|P1|Overall Study|Reason Not Specified|11
6065335|NCT00484939|20955201|P2|Overall Study|Screen Failure|2
6065336|NCT00484939|20955202|P1|Overall Study|Screen Failure|2
6065337|NCT00484939|20955201|P2|Overall Study|Disease progression|88
6065338|NCT00484939|20955202|P1|Overall Study|Disease progression|67
6065339|NCT00484939|20955201|P2|Overall Study|Discretion of Investigator or Sponsor|3
6065340|NCT00484939|20955202|P1|Overall Study|Discretion of Investigator or Sponsor|7
6065341|NCT00484939|20955201|P2|Overall Study|Lost to Follow-up|3
6065342|NCT00484939|20955202|P1|Overall Study|Lost to Follow-up|0
6065343|NCT00484939|20955201|P2|Overall Study|Protocol Violation|3
6065344|NCT00484939|20955202|P1|Overall Study|Protocol Violation|3
6065345|NCT00484939|20955201|P2|Overall Study|Patient Withdrew Consent|10
6065346|NCT00484939|20955202|P1|Overall Study|Patient Withdrew Consent|19
6065347|NCT00484939|20955201|P2|Overall Study|Adverse Event|12
6065348|NCT00484939|20955202|P1|Overall Study|Adverse Event|22
6065349|NCT00484939|20955201|P2|Overall Study|Death|13
6065350|NCT00484939|20955202|P1|Overall Study|Death|9
6065351|NCT00484679|20955229|P1|Overall Study|Withdrawal by Subject|3
6065352|NCT00484419|20955236|P3|Overall Study|sponsor decision, randomized in error|2
6065353|NCT00484419|20955237|P2|Overall Study|sponsor decision, randomized in error|0
6065354|NCT00484419|20955238|P1|Overall Study|sponsor decision, randomized in error|0
6065355|NCT00484419|20955236|P3|Overall Study|subject relocated|0
6065356|NCT00484419|20955237|P2|Overall Study|subject relocated|1
6065357|NCT00484419|20955238|P1|Overall Study|subject relocated|0
6065358|NCT00484419|20955236|P3|Overall Study|subject unable to receive medication|0
6065359|NCT00484419|20955237|P2|Overall Study|subject unable to receive medication|0
6065360|NCT00484419|20955238|P1|Overall Study|subject unable to receive medication|1
6065361|NCT00484419|20955236|P3|Overall Study|Physician Decision|1
6065362|NCT00484419|20955237|P2|Overall Study|Physician Decision|1
6065363|NCT00484419|20955238|P1|Overall Study|Physician Decision|1
6065364|NCT00484419|20955236|P3|Overall Study|required restricted medication|1
6065365|NCT00484419|20955237|P2|Overall Study|required restricted medication|0
6065366|NCT00484419|20955238|P1|Overall Study|required restricted medication|1
6065367|NCT00484419|20955236|P3|Overall Study|subject met discontinuation criteria|4
6065368|NCT00484419|20955237|P2|Overall Study|subject met discontinuation criteria|2
6065369|NCT00484419|20955238|P1|Overall Study|subject met discontinuation criteria|2
6065370|NCT00484419|20955236|P3|Overall Study|Withdrawal by Subject|1
6065371|NCT00484419|20955237|P2|Overall Study|Withdrawal by Subject|1
6065372|NCT00484419|20955238|P1|Overall Study|Withdrawal by Subject|3
6065373|NCT00484419|20955236|P3|Overall Study|Lost to Follow-up|2
6065374|NCT00484419|20955237|P2|Overall Study|Lost to Follow-up|0
6065375|NCT00484419|20955238|P1|Overall Study|Lost to Follow-up|1
6065376|NCT00484419|20955236|P3|Overall Study|Adverse Event|0
6065377|NCT00484419|20955237|P2|Overall Study|Adverse Event|0
6065378|NCT00484419|20955238|P1|Overall Study|Adverse Event|3
6065379|NCT00484315|20955322|P2|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|2
6065380|NCT00484315|20955323|P1|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|3
6065381|NCT00484315|20955322|P2|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|11
6065382|NCT00484315|20955323|P1|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|25
6065383|NCT00484315|20955322|P2|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|2
6065384|NCT00484315|20955323|P1|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|3
6065385|NCT00484315|20955322|P2|12-Month Clinical Follow-up|Missed 12-Month Visit|4
6065386|NCT00484315|20955323|P1|12-Month Clinical Follow-up|Missed 12-Month Visit|13
6065387|NCT00484315|20955322|P2|12-Month Clinical Follow-up|Lost to Follow-up|1
6065388|NCT00484315|20955323|P1|12-Month Clinical Follow-up|Lost to Follow-up|2
6065389|NCT00484315|20955322|P2|12-Month Clinical Follow-up|Withdrawal by Subject|0
6065390|NCT00484315|20955323|P1|12-Month Clinical Follow-up|Withdrawal by Subject|4
6065391|NCT00484315|20955322|P2|12-Month Clinical Follow-up|Death|2
6065392|NCT00484315|20955323|P1|12-Month Clinical Follow-up|Death|6
6065393|NCT00484289|20955334|P3|Post Marketing Phase|Adverse Event|0
6065394|NCT00484289|20955335|P2|Post Marketing Phase|Adverse Event|1
6065395|NCT00484289|20955336|P1|Post Marketing Phase|Adverse Event|0
6065396|NCT00484289|20955334|P3|Long Term Phase|Other Reason|1
6065397|NCT00484289|20955335|P2|Long Term Phase|Other Reason|5
6065398|NCT00484289|20955336|P1|Long Term Phase|Other Reason|0
6065399|NCT00484289|20955334|P3|Long Term Phase|Inadequate response|4
6065400|NCT00484289|20955335|P2|Long Term Phase|Inadequate response|7
6065401|NCT00484289|20955336|P1|Long Term Phase|Inadequate response|2
6065402|NCT00484289|20955334|P3|Long Term Phase|Withdrawal by Subject|6
6065403|NCT00484289|20955335|P2|Long Term Phase|Withdrawal by Subject|7
6065404|NCT00484289|20955336|P1|Long Term Phase|Withdrawal by Subject|0
6065405|NCT00484289|20955334|P3|Long Term Phase|Adverse Event|5
6065406|NCT00484289|20955335|P2|Long Term Phase|Adverse Event|17
6065407|NCT00484289|20955336|P1|Long Term Phase|Adverse Event|1
6065408|NCT00484185|20955408|P1|Overall Study|Death|2
6065409|NCT00484185|20955408|P1|Overall Study|Randomized but not treated|5
6065410|NCT00484185|20955408|P1|Overall Study|Other|20
6065411|NCT00484185|20955408|P1|Overall Study|Lost to Follow-up|44
6065412|NCT00484159|20955430|P3|Overall Study|Lost to Follow-up|0
6065413|NCT00484159|20955431|P2|Overall Study|Lost to Follow-up|1
6065414|NCT00484159|20955432|P1|Overall Study|Lost to Follow-up|1
6065415|NCT00484094|20955443|P1|Overall Study|Other|3
6065416|NCT00484094|20955443|P1|Overall Study|Discontinued|39
6065417|NCT00483938|20955459|P7|Overall Study|Other|32
6065418|NCT00483938|20955460|P6|Overall Study|Other|4
6065419|NCT00483938|20955461|P5|Overall Study|Other|0
6065420|NCT00483938|20955462|P4|Overall Study|Other|4
6065421|NCT00483938|20955463|P3|Overall Study|Other|0
6065422|NCT00483938|20955464|P2|Overall Study|Other|9
6065423|NCT00483938|20955465|P1|Overall Study|Other|3
6065424|NCT00483938|20955459|P7|Overall Study|Death|0
6065425|NCT00483938|20955460|P6|Overall Study|Death|0
6065426|NCT00483938|20955461|P5|Overall Study|Death|0
6065427|NCT00483938|20955462|P4|Overall Study|Death|0
6065428|NCT00483938|20955463|P3|Overall Study|Death|0
6065429|NCT00483938|20955464|P2|Overall Study|Death|2
6065430|NCT00483938|20955465|P1|Overall Study|Death|0
6065431|NCT00483938|20955459|P7|Overall Study|Lost to Follow-up|3
6065432|NCT00483938|20955460|P6|Overall Study|Lost to Follow-up|1
6065433|NCT00483938|20955461|P5|Overall Study|Lost to Follow-up|1
6065434|NCT00483938|20955462|P4|Overall Study|Lost to Follow-up|2
6065435|NCT00483938|20955463|P3|Overall Study|Lost to Follow-up|0
6065436|NCT00483938|20955464|P2|Overall Study|Lost to Follow-up|2
6065437|NCT00483938|20955465|P1|Overall Study|Lost to Follow-up|1
6065438|NCT00483938|20955459|P7|Overall Study|Withdrawal by Subject|2
6065439|NCT00483938|20955460|P6|Overall Study|Withdrawal by Subject|3
6065440|NCT00483938|20955461|P5|Overall Study|Withdrawal by Subject|1
6065441|NCT00483938|20955462|P4|Overall Study|Withdrawal by Subject|0
6065442|NCT00483938|20955463|P3|Overall Study|Withdrawal by Subject|0
6065443|NCT00483938|20955464|P2|Overall Study|Withdrawal by Subject|6
6065444|NCT00483938|20955465|P1|Overall Study|Withdrawal by Subject|1
6065445|NCT00483938|20955459|P7|Overall Study|Protocol Violation|3
6065446|NCT00483938|20955460|P6|Overall Study|Protocol Violation|0
6065447|NCT00483938|20955461|P5|Overall Study|Protocol Violation|0
6065448|NCT00483938|20955462|P4|Overall Study|Protocol Violation|0
6065449|NCT00483938|20955463|P3|Overall Study|Protocol Violation|0
6065450|NCT00483938|20955464|P2|Overall Study|Protocol Violation|0
6065451|NCT00483938|20955465|P1|Overall Study|Protocol Violation|0
6065452|NCT00483756|20955489|P3|Overall Study|Randomized, Not Treated|4
6065453|NCT00483756|20955490|P2|Overall Study|Randomized, Not Treated|4
6065454|NCT00483756|20955491|P1|Overall Study|Randomized, Not Treated|1
6065455|NCT00483756|20955489|P3|Overall Study|Other|3
6065456|NCT00483756|20955490|P2|Overall Study|Other|4
6065457|NCT00483756|20955491|P1|Overall Study|Other|2
6065458|NCT00483756|20955489|P3|Overall Study|Withdrawal by Subject|4
6065459|NCT00483756|20955490|P2|Overall Study|Withdrawal by Subject|3
6065460|NCT00483756|20955491|P1|Overall Study|Withdrawal by Subject|5
6065461|NCT00483756|20955489|P3|Overall Study|Lost to Follow-up|0
6065462|NCT00483756|20955490|P2|Overall Study|Lost to Follow-up|1
6065463|NCT00483756|20955491|P1|Overall Study|Lost to Follow-up|3
6065464|NCT00483756|20955489|P3|Overall Study|Lack of Efficacy|0
6065465|NCT00483756|20955490|P2|Overall Study|Lack of Efficacy|0
6065466|NCT00483756|20955491|P1|Overall Study|Lack of Efficacy|1
6065467|NCT00483756|20955489|P3|Overall Study|Adverse Event|40
6065468|NCT00483756|20955490|P2|Overall Study|Adverse Event|38
6065469|NCT00483756|20955491|P1|Overall Study|Adverse Event|19
6065470|NCT00483756|20955489|P3|Overall Study|Death|1
6065471|NCT00483756|20955490|P2|Overall Study|Death|0
6065472|NCT00483756|20955491|P1|Overall Study|Death|2
6065473|NCT00483717|20955555|P2|Overall Study|Withdrawal by Subject|0
6065474|NCT00483717|20955556|P1|Overall Study|Withdrawal by Subject|1
6065475|NCT00483717|20955555|P2|Overall Study|Lost to Follow-up|0
6065476|NCT00483717|20955556|P1|Overall Study|Lost to Follow-up|1
6065477|NCT00483717|20955555|P2|Overall Study|No treatment for migraine|13
6065478|NCT00483717|20955556|P1|Overall Study|No treatment for migraine|16
6065479|NCT00483717|20955555|P2|Overall Study|Time of dosing missing|1
6065480|NCT00483717|20955556|P1|Overall Study|Time of dosing missing|1
6065481|NCT00483717|20955555|P2|Overall Study|Protocol Violation|7
6065482|NCT00483717|20955556|P1|Overall Study|Protocol Violation|5
6065483|NCT00483704|20955579|P3|Treatment|Physician Decision|4
6065484|NCT00483704|20955580|P2|Treatment|Physician Decision|1
6065485|NCT00483704|20955581|P1|Treatment|Physician Decision|0
6065486|NCT00483704|20955579|P3|Treatment|Pregnancy|0
6065487|NCT00483704|20955580|P2|Treatment|Pregnancy|1
6065488|NCT00483704|20955581|P1|Treatment|Pregnancy|0
6065489|NCT00483704|20955579|P3|Treatment|Lack of Efficacy|1
6065490|NCT00483704|20955580|P2|Treatment|Lack of Efficacy|1
6065491|NCT00483704|20955581|P1|Treatment|Lack of Efficacy|1
6065492|NCT00483704|20955579|P3|Treatment|Lost to Follow-up|5
6065493|NCT00483704|20955580|P2|Treatment|Lost to Follow-up|7
6065494|NCT00483704|20955581|P1|Treatment|Lost to Follow-up|2
6065495|NCT00483704|20955579|P3|Treatment|Protocol Violation|5
6065496|NCT00483704|20955580|P2|Treatment|Protocol Violation|3
6065497|NCT00483704|20955581|P1|Treatment|Protocol Violation|6
6065498|NCT00483704|20955579|P3|Treatment|Withdrawal by Subject|21
6065499|NCT00483704|20955580|P2|Treatment|Withdrawal by Subject|12
6065500|NCT00483704|20955581|P1|Treatment|Withdrawal by Subject|16
6065501|NCT00483704|20955579|P3|Treatment|Adverse Event|4
6065502|NCT00483704|20955580|P2|Treatment|Adverse Event|5
6065503|NCT00483704|20955581|P1|Treatment|Adverse Event|3
6065504|NCT00483704|20955579|P3|Treatment|Lack of qualifying migraines|116
6065505|NCT00483704|20955580|P2|Treatment|Lack of qualifying migraines|99
6065506|NCT00483704|20955581|P1|Treatment|Lack of qualifying migraines|101
6065507|NCT00483704|20955579|P3|Randomization|Lack of qualifying migraines|31
6065508|NCT00483704|20955580|P2|Randomization|Lack of qualifying migraines|25
6065509|NCT00483704|20955581|P1|Randomization|Lack of qualifying migraines|21
6065510|NCT00483704|20955579|P3|Randomization|Progressive disease|1
6065511|NCT00483704|20955580|P2|Randomization|Progressive disease|0
6065512|NCT00483704|20955581|P1|Randomization|Progressive disease|0
6065513|NCT00483704|20955579|P3|Randomization|Physician Decision|0
6065514|NCT00483704|20955580|P2|Randomization|Physician Decision|4
6065515|NCT00483704|20955581|P1|Randomization|Physician Decision|2
6065516|NCT00483704|20955579|P3|Randomization|Pregnancy|0
6065517|NCT00483704|20955580|P2|Randomization|Pregnancy|0
6065518|NCT00483704|20955581|P1|Randomization|Pregnancy|1
6065519|NCT00483704|20955579|P3|Randomization|Lost to Follow-up|19
6065520|NCT00483704|20955580|P2|Randomization|Lost to Follow-up|14
6065521|NCT00483704|20955581|P1|Randomization|Lost to Follow-up|14
6065522|NCT00483704|20955579|P3|Randomization|Protocol Violation|22
6065523|NCT00483704|20955580|P2|Randomization|Protocol Violation|25
6065524|NCT00483704|20955581|P1|Randomization|Protocol Violation|14
6065525|NCT00483704|20955579|P3|Randomization|Withdrawal by Subject|18
6065526|NCT00483704|20955580|P2|Randomization|Withdrawal by Subject|28
6065527|NCT00483704|20955581|P1|Randomization|Withdrawal by Subject|19
6065528|NCT00483652|20955627|P2|Double-blind Treatment Period|Withdrawal due to AE before study began|0
6065529|NCT00483652|20955628|P1|Double-blind Treatment Period|Withdrawal due to AE before study began|1
6065530|NCT00483652|20955627|P2|Double-blind Treatment Period|Protocol inclusion deviation|0
6065531|NCT00483652|20955628|P1|Double-blind Treatment Period|Protocol inclusion deviation|1
6065532|NCT00483652|20955627|P2|Double-blind Treatment Period|Adverse Event|4
6065533|NCT00483652|20955628|P1|Double-blind Treatment Period|Adverse Event|3
6065534|NCT00483652|20955627|P2|Double-blind Treatment Period|Protocol Violation|1
6065535|NCT00483652|20955628|P1|Double-blind Treatment Period|Protocol Violation|2
6065536|NCT00483574|20955638|P2|Overall Study|Withdrawal by Subject|0
6065537|NCT00483574|20955639|P1|Overall Study|Withdrawal by Subject|52
6065538|NCT00483574|20955638|P2|Overall Study|Lost to Follow-up|4
6065539|NCT00483574|20955639|P1|Overall Study|Lost to Follow-up|16
6065540|NCT00483574|20955638|P2|Overall Study|Protocol Violation|9
6065541|NCT00483574|20955639|P1|Overall Study|Protocol Violation|28
6065542|NCT00483574|20955638|P2|Overall Study|Adverse Event|0
6065543|NCT00483574|20955639|P1|Overall Study|Adverse Event|6
6065544|NCT00483548|20955654|P2|Overall Study|Withdrawal by Subject|2
6065545|NCT00483548|20955655|P1|Overall Study|Withdrawal by Subject|5
6065546|NCT00483548|20955654|P2|Overall Study|Lost to Follow-up|4
6065547|NCT00483548|20955655|P1|Overall Study|Lost to Follow-up|3
6065548|NCT00483548|20955654|P2|Overall Study|Non-compliance with medication|0
6065549|NCT00483548|20955655|P1|Overall Study|Non-compliance with medication|2
6065550|NCT00483548|20955654|P2|Overall Study|Unable to comply with protocol schedule|0
6065551|NCT00483548|20955655|P1|Overall Study|Unable to comply with protocol schedule|1
6065552|NCT00483548|20955654|P2|Overall Study|Protocol required discontinuation|6
6065553|NCT00483548|20955655|P1|Overall Study|Protocol required discontinuation|6
6065554|NCT00483548|20955654|P2|Overall Study|Pregnancy|0
6065555|NCT00483548|20955655|P1|Overall Study|Pregnancy|1
6065556|NCT00483548|20955654|P2|Overall Study|Protocol Violation|7
6065557|NCT00483548|20955655|P1|Overall Study|Protocol Violation|11
6065558|NCT00483548|20955654|P2|Overall Study|Lack of Efficacy|8
6065559|NCT00483548|20955655|P1|Overall Study|Lack of Efficacy|4
6065560|NCT00483548|20955654|P2|Overall Study|Laboratory abnormality|2
6065561|NCT00483548|20955655|P1|Overall Study|Laboratory abnormality|1
6065562|NCT00483548|20955654|P2|Overall Study|Adverse Event|14
6065563|NCT00483548|20955655|P1|Overall Study|Adverse Event|25
6065564|NCT00483548|20955654|P2|Overall Study|Randomized; not treated with study drug|3
6065565|NCT00483548|20955655|P1|Overall Study|Randomized; not treated with study drug|1
6065566|NCT00483405|20955713|P1|Overall Study|Other complicating disease|1
6065567|NCT00483405|20955713|P1|Overall Study|Withdrawal by Subject|2
6065568|NCT00483405|20955713|P1|Overall Study|Death|3
6065569|NCT00483405|20955713|P1|Overall Study|Lack of Efficacy|14
6065570|NCT00483405|20955713|P1|Overall Study|Adverse Event|8
6065571|NCT00483379|20955722|P2|Treatment Period|Withdrawal by Subject|0
6065572|NCT00483379|20955723|P1|Treatment Period|Withdrawal by Subject|1
6065573|NCT00483379|20955722|P2|Treatment Period|Adverse Event|0
6065574|NCT00483379|20955723|P1|Treatment Period|Adverse Event|1
6065575|NCT00483327|20955759|P1|Overall Study|Patient Non Compliance|2
6065576|NCT00483327|20955759|P1|Overall Study|Lost to Follow-up|4
6065577|NCT00483327|20955759|P1|Overall Study|Withdrawal by Subject|3
6065578|NCT00483327|20955759|P1|Overall Study|Adverse Event|1
6065579|NCT00483184|20955791|P3|Overall Study|Protocol Violation|1
6065580|NCT00483184|20955792|P2|Overall Study|Protocol Violation|0
6065581|NCT00483184|20955793|P1|Overall Study|Protocol Violation|1
6065582|NCT00483184|20955791|P3|Overall Study|Adverse Event|2
6065583|NCT00483184|20955792|P2|Overall Study|Adverse Event|2
6065584|NCT00483184|20955793|P1|Overall Study|Adverse Event|1
6065585|NCT00483184|20955791|P3|Overall Study|Lost to Follow-up|0
6065586|NCT00483184|20955792|P2|Overall Study|Lost to Follow-up|0
6065587|NCT00483184|20955793|P1|Overall Study|Lost to Follow-up|1
6065588|NCT00483184|20955791|P3|Overall Study|Withdrawal by Subject|0
6065589|NCT00483184|20955792|P2|Overall Study|Withdrawal by Subject|2
6065590|NCT00483184|20955793|P1|Overall Study|Withdrawal by Subject|2
6065591|NCT00483119|20955803|P2|Overall Study|Physician Decision|0
6065592|NCT00483119|20955804|P1|Overall Study|Physician Decision|1
6065593|NCT00483119|20955803|P2|Overall Study|Adverse Event|1
6065594|NCT00483119|20955804|P1|Overall Study|Adverse Event|0
6065595|NCT00483041|20955818|P2|Overall Study|ABNORMAL LAB DATA AT SCREENING|1
6065596|NCT00483041|20955819|P1|Overall Study|ABNORMAL LAB DATA AT SCREENING|0
6065597|NCT00483002|20955849|P1|Overall Study|Other|967
6065598|NCT00483002|20955849|P1|Overall Study|Other|2
6065599|NCT00483002|20955849|P1|Overall Study|Lost to Follow-up|962
6065600|NCT00483002|20955849|P1|Overall Study|Lack of Efficacy|555
6065601|NCT00483002|20955849|P1|Overall Study|Adverse Event|68
6065602|NCT00482729|20955874|P2|Overall Study|Withdrawal by Subject|69
6065603|NCT00482729|20955875|P1|Overall Study|Withdrawal by Subject|67
6065604|NCT00482729|20955874|P2|Overall Study|Protocol Violation|18
6065605|NCT00482729|20955875|P1|Overall Study|Protocol Violation|10
6065606|NCT00482729|20955874|P2|Overall Study|Pregnancy|2
6065607|NCT00482729|20955875|P1|Overall Study|Pregnancy|4
6065608|NCT00482729|20955874|P2|Overall Study|Physician Decision|7
6065609|NCT00482729|20955875|P1|Overall Study|Physician Decision|10
6065610|NCT00482729|20955874|P2|Overall Study|Lost to Follow-up|66
6065611|NCT00482729|20955875|P1|Overall Study|Lost to Follow-up|86
6065612|NCT00482729|20955874|P2|Overall Study|Lack of Efficacy|16
6065613|NCT00482729|20955875|P1|Overall Study|Lack of Efficacy|4
6065614|NCT00482729|20955874|P2|Overall Study|Hyperglycemia Criteria|5
6065615|NCT00482729|20955875|P1|Overall Study|Hyperglycemia Criteria|7
6065616|NCT00482729|20955874|P2|Overall Study|Creatinine/Creatinine Clearance Criteria|2
6065617|NCT00482729|20955875|P1|Overall Study|Creatinine/Creatinine Clearance Criteria|0
6065618|NCT00482729|20955874|P2|Overall Study|Adverse Event|33
6065619|NCT00482729|20955875|P1|Overall Study|Adverse Event|29
6065620|NCT00482703|20955891|P2|Overall Study|Poor compliance|0
6065621|NCT00482703|20955892|P1|Overall Study|Poor compliance|1
6065622|NCT00482612|20955963|P4|Follow-up Period|Reasons not related to trial|3
6065623|NCT00482612|20955964|P3|Follow-up Period|Reasons not related to trial|1
6065624|NCT00482612|20955965|P2|Follow-up Period|Reasons not related to trial|0
6065625|NCT00482612|20955966|P1|Follow-up Period|Reasons not related to trial|1
6065626|NCT00482612|20955963|P4|Follow-up Period|Withdrawal by Subject|2
6065627|NCT00482612|20955964|P3|Follow-up Period|Withdrawal by Subject|7
6065628|NCT00482612|20955965|P2|Follow-up Period|Withdrawal by Subject|5
6065629|NCT00482612|20955966|P1|Follow-up Period|Withdrawal by Subject|3
6065630|NCT00482612|20955963|P4|Follow-up Period|Lack of Efficacy|0
6065631|NCT00482612|20955964|P3|Follow-up Period|Lack of Efficacy|1
6065632|NCT00482612|20955965|P2|Follow-up Period|Lack of Efficacy|0
6065633|NCT00482612|20955966|P1|Follow-up Period|Lack of Efficacy|2
6065634|NCT00482612|20955963|P4|Follow-up Period|Adverse Event|0
6065635|NCT00482612|20955964|P3|Follow-up Period|Adverse Event|9
6065636|NCT00482612|20955965|P2|Follow-up Period|Adverse Event|7
6065637|NCT00482612|20955966|P1|Follow-up Period|Adverse Event|4
6065638|NCT00482612|20955963|P4|Follow-up Period|Lost to Follow-up|1
6065639|NCT00482612|20955964|P3|Follow-up Period|Lost to Follow-up|2
6065640|NCT00482612|20955965|P2|Follow-up Period|Lost to Follow-up|4
6065641|NCT00482612|20955966|P1|Follow-up Period|Lost to Follow-up|0
6065642|NCT00482612|20955963|P4|Follow-up Period|Lack of compliance|0
6065643|NCT00482612|20955964|P3|Follow-up Period|Lack of compliance|1
6065644|NCT00482612|20955965|P2|Follow-up Period|Lack of compliance|0
6065645|NCT00482612|20955966|P1|Follow-up Period|Lack of compliance|0
6065646|NCT00482612|20955963|P4|Follow-up Period|Other|2
6065647|NCT00482612|20955964|P3|Follow-up Period|Other|1
6065648|NCT00482612|20955965|P2|Follow-up Period|Other|2
6065649|NCT00482612|20955966|P1|Follow-up Period|Other|4
6065650|NCT00482612|20955963|P4|In-treatment Period|No study medication administered|0
6065651|NCT00482612|20955964|P3|In-treatment Period|No study medication administered|1
6065652|NCT00482612|20955965|P2|In-treatment Period|No study medication administered|0
6065653|NCT00482612|20955966|P1|In-treatment Period|No study medication administered|0
6065654|NCT00482391|20956015|P1|Overall Study|Death|1
6065655|NCT00482391|20956015|P1|Overall Study|Adverse Event|1
6065656|NCT00482391|20956015|P1|Overall Study|Withdrawal by Subject|1
6065657|NCT00482274|20956020|P1|Overall Study|Adverse Event|1
6065658|NCT00482170|20956030|P2|Overall Study|Unspecified reason|2
6065659|NCT00482170|20956031|P1|Overall Study|Unspecified reason|0
6065660|NCT00482170|20956030|P2|Overall Study|Lost to Follow-up|0
6065661|NCT00482170|20956031|P1|Overall Study|Lost to Follow-up|2
6065662|NCT00482170|20956030|P2|Overall Study|Protocol Violation|3
6065663|NCT00482170|20956031|P1|Overall Study|Protocol Violation|2
6065664|NCT00482170|20956030|P2|Overall Study|Withdrawal by Subject|1
6065665|NCT00482170|20956031|P1|Overall Study|Withdrawal by Subject|6
6065666|NCT00482170|20956030|P2|Overall Study|Adverse Event|14
6065667|NCT00482170|20956031|P1|Overall Study|Adverse Event|5
6065668|NCT00482053|20956149|P1|Inter-treatment Period|Disease progression|1
6065669|NCT00482014|20956163|P4|Overall Study|Sponsor Decision|1
6065670|NCT00482014|20956164|P3|Overall Study|Sponsor Decision|1
6065671|NCT00482014|20956165|P2|Overall Study|Sponsor Decision|2
6065672|NCT00482014|20956166|P1|Overall Study|Sponsor Decision|1
6065673|NCT00482014|20956163|P4|Overall Study|Lack of Efficacy|6
6065674|NCT00482014|20956164|P3|Overall Study|Lack of Efficacy|4
6065675|NCT00482014|20956165|P2|Overall Study|Lack of Efficacy|0
6065676|NCT00482014|20956166|P1|Overall Study|Lack of Efficacy|1
6065677|NCT00482014|20956163|P4|Overall Study|Death|4
6065678|NCT00482014|20956164|P3|Overall Study|Death|1
6065679|NCT00482014|20956165|P2|Overall Study|Death|2
6065680|NCT00482014|20956166|P1|Overall Study|Death|1
6065681|NCT00482014|20956163|P4|Overall Study|Adverse Event|8
6065682|NCT00482014|20956164|P3|Overall Study|Adverse Event|2
6065683|NCT00482014|20956165|P2|Overall Study|Adverse Event|0
6065684|NCT00482014|20956166|P1|Overall Study|Adverse Event|3
6065685|NCT00482014|20956163|P4|Overall Study|Withdrawal by Subject|4
6065686|NCT00482014|20956164|P3|Overall Study|Withdrawal by Subject|3
6065687|NCT00482014|20956165|P2|Overall Study|Withdrawal by Subject|2
6065688|NCT00482014|20956166|P1|Overall Study|Withdrawal by Subject|1
6065689|NCT00482001|20956190|P2|Overall Study|Protocol Violation|1
6065690|NCT00482001|20956191|P1|Overall Study|Protocol Violation|1
6065691|NCT00481988|20956211|P2|Overall Study|Withdrawal by Subject|1
6065692|NCT00481988|20956212|P1|Overall Study|Withdrawal by Subject|1
6065693|NCT00481871|20956225|P5|Overall Study|Progressive Disease - pt withdrew|0
6065694|NCT00481871|20956226|P4|Overall Study|Progressive Disease - pt withdrew|0
6065695|NCT00481871|20956227|P3|Overall Study|Progressive Disease - pt withdrew|1
6065696|NCT00481871|20956228|P2|Overall Study|Progressive Disease - pt withdrew|0
6065697|NCT00481871|20956229|P1|Overall Study|Progressive Disease - pt withdrew|0
6065698|NCT00481832|20956254|P1|Inter-transplant Period|Lack of allogeneic donor|5
6065699|NCT00481832|20956254|P1|Inter-transplant Period|Disease relapse|11
6065700|NCT00481832|20956254|P1|Inter-transplant Period|Physician Decision|4
6065701|NCT00481832|20956254|P1|Inter-transplant Period|Death|3
6065702|NCT00481832|20956254|P1|Inter-transplant Period|Adverse Event|4
6065703|NCT00481832|20956254|P1|Enrollment|Unable to collect enough stem cells|2
6065704|NCT00481832|20956254|P1|Enrollment|Physician Decision|8
6065705|NCT00481767|20956269|P2|Overall Study|Lost to Follow-up|10
6065706|NCT00481767|20956270|P1|Overall Study|Lost to Follow-up|16
6065707|NCT00481767|20956269|P2|Overall Study|Withdrawal by Subject|11
6065708|NCT00481767|20956270|P1|Overall Study|Withdrawal by Subject|16
6065709|NCT00481676|20956304|P2|Overall Study|Administrative problem|0
6065710|NCT00481676|20956305|P1|Overall Study|Administrative problem|1
6065711|NCT00481676|20956304|P2|Overall Study|Unsatisfactory therapeutic effect|4
6065712|NCT00481676|20956305|P1|Overall Study|Unsatisfactory therapeutic effect|1
6065713|NCT00481676|20956304|P2|Overall Study|Adverse Event|1
6065714|NCT00481676|20956305|P1|Overall Study|Adverse Event|0
6065715|NCT00481247|20956357|P2|Overall Study|Did not receive treatment|2
6065716|NCT00481247|20956358|P1|Overall Study|Did not receive treatment|1
6065717|NCT00481247|20956357|P2|Overall Study|Varied|15
6065718|NCT00481247|20956358|P1|Overall Study|Varied|6
6065719|NCT00481247|20956357|P2|Overall Study|Administrative reason by sponsor|162
6065720|NCT00481247|20956358|P1|Overall Study|Administrative reason by sponsor|157
6065721|NCT00481247|20956357|P2|Overall Study|Poor compliance/noncompliance|7
6065722|NCT00481247|20956358|P1|Overall Study|Poor compliance/noncompliance|1
6065723|NCT00481247|20956357|P2|Overall Study|Lost to Follow-up|2
6065724|NCT00481247|20956358|P1|Overall Study|Lost to Follow-up|1
6065725|NCT00481247|20956357|P2|Overall Study|Pregnancy|1
6065726|NCT00481247|20956358|P1|Overall Study|Pregnancy|2
6065727|NCT00481247|20956357|P2|Overall Study|Withdrawal by Subject|13
6065728|NCT00481247|20956358|P1|Overall Study|Withdrawal by Subject|8
6065729|NCT00481247|20956357|P2|Overall Study|AE unrelated to study drug|4
6065730|NCT00481247|20956358|P1|Overall Study|AE unrelated to study drug|13
6065731|NCT00481247|20956357|P2|Overall Study|Treatment failure|14
6065732|NCT00481247|20956358|P1|Overall Study|Treatment failure|10
6065733|NCT00481247|20956357|P2|Overall Study|Intolerance|17
6065734|NCT00481247|20956358|P1|Overall Study|Intolerance|42
6065735|NCT00481247|20956357|P2|Overall Study|Disease progression|22
6065736|NCT00481247|20956358|P1|Overall Study|Disease progression|18
6065737|NCT00481247|20956357|P2|Overall Study|Death|1
6065738|NCT00481247|20956358|P1|Overall Study|Death|0
6065739|NCT00481195|20956382|P2|Overall Study|Miscellaneous|2
6065740|NCT00481195|20956383|P1|Overall Study|Miscellaneous|2
6065741|NCT00481195|20956382|P2|Overall Study|Withdrawal by Subject|9
6065742|NCT00481195|20956383|P1|Overall Study|Withdrawal by Subject|3
6065743|NCT00481195|20956382|P2|Overall Study|Protocol Violation|7
6065744|NCT00481195|20956383|P1|Overall Study|Protocol Violation|10
6065745|NCT00481195|20956382|P2|Overall Study|Physician Decision|1
6065746|NCT00481195|20956383|P1|Overall Study|Physician Decision|3
6065747|NCT00481195|20956382|P2|Overall Study|Lost to Follow-up|6
6065748|NCT00481195|20956383|P1|Overall Study|Lost to Follow-up|4
6065749|NCT00481195|20956382|P2|Overall Study|Lack of Efficacy|3
6065750|NCT00481195|20956383|P1|Overall Study|Lack of Efficacy|1
6065751|NCT00481195|20956382|P2|Overall Study|Adverse Event|11
6065752|NCT00481195|20956383|P1|Overall Study|Adverse Event|16
6065753|NCT00481078|20956469|P2|Overall Study|Brain metastasis|1
6065754|NCT00481078|20956470|P1|Overall Study|Brain metastasis|0
6065755|NCT00481078|20956469|P2|Overall Study|Received other treatment|1
6065756|NCT00481078|20956470|P1|Overall Study|Received other treatment|2
6065757|NCT00481078|20956469|P2|Overall Study|Information not available|0
6065758|NCT00481078|20956470|P1|Overall Study|Information not available|1
6065759|NCT00481078|20956469|P2|Overall Study|Withdrawal by Subject|1
6065760|NCT00481078|20956470|P1|Overall Study|Withdrawal by Subject|7
6065761|NCT00481078|20956469|P2|Overall Study|Intercurrent illness|0
6065762|NCT00481078|20956470|P1|Overall Study|Intercurrent illness|1
6065763|NCT00481078|20956469|P2|Overall Study|Death|3
6065764|NCT00481078|20956470|P1|Overall Study|Death|5
6065765|NCT00481078|20956469|P2|Overall Study|Adverse Event|3
6065766|NCT00481078|20956470|P1|Overall Study|Adverse Event|15
6065767|NCT00481078|20956469|P2|Overall Study|Progression of disease|11
6065768|NCT00481078|20956470|P1|Overall Study|Progression of disease|11
6065769|NCT00481065|20956488|P8|Overall Study|Unable to classify|0
6065770|NCT00481065|20956489|P7|Overall Study|Unable to classify|0
6065771|NCT00481065|20956490|P6|Overall Study|Unable to classify|0
6065772|NCT00481065|20956491|P5|Overall Study|Unable to classify|1
6065773|NCT00481065|20956492|P4|Overall Study|Unable to classify|0
6065774|NCT00481065|20956493|P3|Overall Study|Unable to classify|2
6065775|NCT00481065|20956494|P2|Overall Study|Unable to classify|1
6065776|NCT00481065|20956495|P1|Overall Study|Unable to classify|0
6065777|NCT00481065|20956488|P8|Overall Study|Protocol Violation|2
6065778|NCT00481065|20956489|P7|Overall Study|Protocol Violation|3
6065779|NCT00481065|20956490|P6|Overall Study|Protocol Violation|6
6065780|NCT00481065|20956491|P5|Overall Study|Protocol Violation|2
6065781|NCT00481065|20956492|P4|Overall Study|Protocol Violation|1
6065782|NCT00481065|20956493|P3|Overall Study|Protocol Violation|1
6065783|NCT00481065|20956494|P2|Overall Study|Protocol Violation|1
6065784|NCT00481065|20956495|P1|Overall Study|Protocol Violation|2
6065785|NCT00481065|20956488|P8|Overall Study|Administrative reason|0
6065786|NCT00481065|20956489|P7|Overall Study|Administrative reason|1
6065787|NCT00481065|20956490|P6|Overall Study|Administrative reason|2
6065788|NCT00481065|20956491|P5|Overall Study|Administrative reason|0
6065789|NCT00481065|20956492|P4|Overall Study|Administrative reason|0
6065790|NCT00481065|20956493|P3|Overall Study|Administrative reason|0
6065791|NCT00481065|20956494|P2|Overall Study|Administrative reason|0
6065792|NCT00481065|20956495|P1|Overall Study|Administrative reason|0
6065793|NCT00481065|20956488|P8|Overall Study|Inappropriate enrollment|1
6065794|NCT00481065|20956489|P7|Overall Study|Inappropriate enrollment|0
6065795|NCT00481065|20956490|P6|Overall Study|Inappropriate enrollment|1
6065796|NCT00481065|20956491|P5|Overall Study|Inappropriate enrollment|2
6065797|NCT00481065|20956492|P4|Overall Study|Inappropriate enrollment|0
6065798|NCT00481065|20956493|P3|Overall Study|Inappropriate enrollment|2
6065799|NCT00481065|20956494|P2|Overall Study|Inappropriate enrollment|0
6065800|NCT00481065|20956495|P1|Overall Study|Inappropriate enrollment|4
6065801|NCT00481065|20956488|P8|Overall Study|Lost to Follow-up|5
6065802|NCT00481065|20956489|P7|Overall Study|Lost to Follow-up|2
6065803|NCT00481065|20956490|P6|Overall Study|Lost to Follow-up|3
6065804|NCT00481065|20956491|P5|Overall Study|Lost to Follow-up|3
6065805|NCT00481065|20956492|P4|Overall Study|Lost to Follow-up|3
6065806|NCT00481065|20956493|P3|Overall Study|Lost to Follow-up|4
6065807|NCT00481065|20956494|P2|Overall Study|Lost to Follow-up|2
6065808|NCT00481065|20956495|P1|Overall Study|Lost to Follow-up|4
6065809|NCT00481065|20956488|P8|Overall Study|Withdrawal by Subject|10
6065810|NCT00481065|20956489|P7|Overall Study|Withdrawal by Subject|9
6065811|NCT00481065|20956490|P6|Overall Study|Withdrawal by Subject|12
6065812|NCT00481065|20956491|P5|Overall Study|Withdrawal by Subject|13
6065813|NCT00481065|20956492|P4|Overall Study|Withdrawal by Subject|11
6065814|NCT00481065|20956493|P3|Overall Study|Withdrawal by Subject|7
6065815|NCT00481065|20956494|P2|Overall Study|Withdrawal by Subject|12
6065816|NCT00481065|20956495|P1|Overall Study|Withdrawal by Subject|11
6065817|NCT00481065|20956488|P8|Overall Study|Adverse event or death|1
6065818|NCT00481065|20956489|P7|Overall Study|Adverse event or death|1
6065819|NCT00481065|20956490|P6|Overall Study|Adverse event or death|0
6065820|NCT00481065|20956491|P5|Overall Study|Adverse event or death|2
6065821|NCT00481065|20956492|P4|Overall Study|Adverse event or death|0
6065822|NCT00481065|20956493|P3|Overall Study|Adverse event or death|3
6065823|NCT00481065|20956494|P2|Overall Study|Adverse event or death|1
6065824|NCT00481065|20956495|P1|Overall Study|Adverse event or death|1
6065825|NCT00480857|20956585|P1|Overall Study|Lack of Efficacy|2
6065826|NCT00480779|20956595|P2|Overall Study|Job and Health-related|3
6065827|NCT00480779|20956596|P1|Overall Study|Job and Health-related|0
6065828|NCT00480779|20956595|P2|Overall Study|Other|0
6065829|NCT00480779|20956596|P1|Overall Study|Other|2
6065830|NCT00480636|20956633|P1|Overall Study|Lost to follow-up; subsequently died|1
6065831|NCT00480636|20956633|P1|Overall Study|Other|2
6065832|NCT00480636|20956633|P1|Overall Study|Lost to Follow-up|4
6065833|NCT00480636|20956633|P1|Overall Study|Death|12
6065834|NCT00480532|20956645|P4|Overall Study|Protocol Violation|0
6065835|NCT00480532|20956646|P3|Overall Study|Protocol Violation|1
6065836|NCT00480532|20956647|P2|Overall Study|Protocol Violation|0
6065837|NCT00480532|20956648|P1|Overall Study|Protocol Violation|0
6065838|NCT00480532|20956645|P4|Overall Study|Withdrawal by Subject|1
6065839|NCT00480532|20956646|P3|Overall Study|Withdrawal by Subject|3
6065840|NCT00480532|20956647|P2|Overall Study|Withdrawal by Subject|4
6065841|NCT00480532|20956648|P1|Overall Study|Withdrawal by Subject|2
6065842|NCT00480493|20956668|P2|Overall Study|moved|7
6065843|NCT00480493|20956669|P1|Overall Study|moved|2
6065844|NCT00480441|20956681|P3|Randomization|Lost to Follow-up|2
6065845|NCT00480441|20956682|P2|Randomization|Lost to Follow-up|7
6065846|NCT00480441|20956683|P1|Randomization|Lost to Follow-up|0
6065847|NCT00480441|20956681|P3|Baseline Functional MRI|physical contraindication|0
6065848|NCT00480441|20956682|P2|Baseline Functional MRI|physical contraindication|0
6065849|NCT00480441|20956683|P1|Baseline Functional MRI|physical contraindication|4
6065850|NCT00480441|20956681|P3|Baseline Functional MRI|Lost to Follow-up|0
6065851|NCT00480441|20956682|P2|Baseline Functional MRI|Lost to Follow-up|0
6065852|NCT00480441|20956683|P1|Baseline Functional MRI|Lost to Follow-up|4
6065853|NCT00480441|20956681|P3|Baseline Functional MRI|Functional MRI data not usable|0
6065854|NCT00480441|20956682|P2|Baseline Functional MRI|Functional MRI data not usable|0
6065855|NCT00480441|20956683|P1|Baseline Functional MRI|Functional MRI data not usable|4
6065856|NCT00480441|20956681|P3|Screening|Not Eligible|0
6065857|NCT00480441|20956682|P2|Screening|Not Eligible|0
6065858|NCT00480441|20956683|P1|Screening|Not Eligible|37
6065859|NCT00480324|20956692|P2|Overall Study|Subject's mother pregnant|1
6065860|NCT00480324|20956693|P1|Overall Study|Subject's mother pregnant|0
6065861|NCT00480324|20956692|P2|Overall Study|Lost to Follow-up|8
6065862|NCT00480324|20956693|P1|Overall Study|Lost to Follow-up|17
6065863|NCT00480324|20956692|P2|Overall Study|Withdrawal by Subject|5
6065864|NCT00480324|20956693|P1|Overall Study|Withdrawal by Subject|14
6065865|NCT00480324|20956692|P2|Overall Study|Protocol Violation|1
6065866|NCT00480324|20956693|P1|Overall Study|Protocol Violation|0
6065867|NCT00480324|20956692|P2|Overall Study|Adverse Event|1
6065868|NCT00480324|20956693|P1|Overall Study|Adverse Event|1
6065869|NCT00480077|20956721|P2|Overall Study|early exit|11
6065870|NCT00480077|20956722|P1|Overall Study|early exit|12
6065871|NCT00480077|20956721|P2|Overall Study|Death|15
6065872|NCT00480077|20956722|P1|Overall Study|Death|19
6065873|NCT00480025|20956730|P2|Overall Study|SAE including intercurrent illness|42
6065874|NCT00480025|20956731|P1|Overall Study|SAE including intercurrent illness|76
6065875|NCT00480025|20956730|P2|Overall Study|Other|29
6065876|NCT00480025|20956731|P1|Overall Study|Other|70
6065877|NCT00480025|20956730|P2|Overall Study|Adverse Event|12
6065878|NCT00480025|20956731|P1|Overall Study|Adverse Event|44
6065879|NCT00480025|20956730|P2|Overall Study|Disease Progression / Recurrence|224
6065880|NCT00480025|20956731|P1|Overall Study|Disease Progression / Recurrence|449
6065881|NCT00480025|20956730|P2|Overall Study|Patients remaining ongoing at Data Lock|55
6065882|NCT00480025|20956731|P1|Overall Study|Patients remaining ongoing at Data Lock|101
6065883|NCT00480025|20956730|P2|Overall Study|Protocol Violation|7
6065884|NCT00480025|20956731|P1|Overall Study|Protocol Violation|12
6065885|NCT00479882|20956803|P4|Crossover: Period III (Weeks 13-20)|Protocol Violation|0
6065886|NCT00479882|20956804|P3|Crossover: Period III (Weeks 13-20)|Protocol Violation|1
6065887|NCT00479882|20956805|P2|Crossover: Period III (Weeks 13-20)|Protocol Violation|0
6065888|NCT00479882|20956806|P1|Crossover: Period III (Weeks 13-20)|Protocol Violation|0
6065889|NCT00479882|20956803|P4|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3
6065890|NCT00479882|20956804|P3|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|1
6065891|NCT00479882|20956805|P2|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3
6065892|NCT00479882|20956806|P1|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3
6065893|NCT00479882|20956803|P4|Crossover: Period III (Weeks 13-20)|Participant moved|0
6065894|NCT00479882|20956804|P3|Crossover: Period III (Weeks 13-20)|Participant moved|1
6065895|NCT00479882|20956805|P2|Crossover: Period III (Weeks 13-20)|Participant moved|2
6065896|NCT00479882|20956806|P1|Crossover: Period III (Weeks 13-20)|Participant moved|1
6065897|NCT00479882|20956803|P4|Crossover: Period III (Weeks 13-20)|Other|2
6065898|NCT00479882|20956804|P3|Crossover: Period III (Weeks 13-20)|Other|2
6065899|NCT00479882|20956805|P2|Crossover: Period III (Weeks 13-20)|Other|0
6065900|NCT00479882|20956806|P1|Crossover: Period III (Weeks 13-20)|Other|5
6065901|NCT00479882|20956803|P4|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1
6065902|NCT00479882|20956804|P3|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1
6065903|NCT00479882|20956805|P2|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|2
6065904|NCT00479882|20956806|P1|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1
6065905|NCT00479882|20956803|P4|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2
6065906|NCT00479882|20956804|P3|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2
6065907|NCT00479882|20956805|P2|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|1
6065908|NCT00479882|20956806|P1|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|3
6065909|NCT00479882|20956803|P4|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|10
6065910|NCT00479882|20956804|P3|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12
6065911|NCT00479882|20956805|P2|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|13
6065912|NCT00479882|20956806|P1|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12
6065913|NCT00479882|20956803|P4|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7
6065914|NCT00479882|20956804|P3|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|5
6065915|NCT00479882|20956805|P2|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7
6065916|NCT00479882|20956806|P1|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|2
6065917|NCT00479882|20956803|P4|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|25
6065918|NCT00479882|20956804|P3|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|30
6065919|NCT00479882|20956805|P2|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|33
6065920|NCT00479882|20956806|P1|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|24
6065921|NCT00479882|20956803|P4|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|1
6065922|NCT00479882|20956804|P3|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|2
6065923|NCT00479882|20956805|P2|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|4
6065924|NCT00479882|20956806|P1|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|0
6065925|NCT00479882|20956803|P4|Precrossover: Periods I/II (Weeks 1-12)|Other|5
6065926|NCT00479882|20956804|P3|Precrossover: Periods I/II (Weeks 1-12)|Other|9
6065927|NCT00479882|20956805|P2|Precrossover: Periods I/II (Weeks 1-12)|Other|6
6065928|NCT00479882|20956806|P1|Precrossover: Periods I/II (Weeks 1-12)|Other|4
6065929|NCT00479882|20956803|P4|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|11
6065930|NCT00479882|20956804|P3|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9
6065931|NCT00479882|20956805|P2|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9
6065932|NCT00479882|20956806|P1|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|12
6065933|NCT00479882|20956803|P4|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4
6065934|NCT00479882|20956804|P3|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4
6065935|NCT00479882|20956805|P2|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4
6065936|NCT00479882|20956806|P1|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|0
6065937|NCT00479882|20956803|P4|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|87
6065938|NCT00479882|20956804|P3|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|98
6065939|NCT00479882|20956805|P2|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|99
6065940|NCT00479882|20956806|P1|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|96
6065941|NCT00479856|20956936|P1|Overall Study|Physician Decision|1
6065942|NCT00479856|20956936|P1|Overall Study|Withdrawal by Subject|1
6065943|NCT00479856|20956936|P1|Overall Study|Adverse Event|1
6065944|NCT00479765|20956945|P1|Overall Study|study terminated|4
6065945|NCT00479713|20956951|P2|Overall Study|Withdrawal by Subject|1
6065946|NCT00479713|20956952|P1|Overall Study|Withdrawal by Subject|4
6065947|NCT00479713|20956951|P2|Overall Study|Protocol Violation|1
6065948|NCT00479713|20956952|P1|Overall Study|Protocol Violation|0
6065949|NCT00479713|20956951|P2|Overall Study|Lost to Follow-up|1
6065950|NCT00479713|20956952|P1|Overall Study|Lost to Follow-up|0
6065951|NCT00479713|20956951|P2|Overall Study|Death|0
6065952|NCT00479713|20956952|P1|Overall Study|Death|1
6065953|NCT00479713|20956951|P2|Overall Study|Adverse Event|6
6065954|NCT00479713|20956952|P1|Overall Study|Adverse Event|8
6065955|NCT00479674|20956976|P1|Overall Study|none provided|3
6065956|NCT00479674|20956976|P1|Overall Study|Physician Decision|14
6065957|NCT00479674|20956976|P1|Overall Study|Withdrawal by Subject|6
6065958|NCT00479674|20956976|P1|Overall Study|Adverse Event|18
6065959|NCT00479557|20956991|P7|Overall Study|Other|0
6065960|NCT00479557|20956992|P6|Overall Study|Other|3
6065961|NCT00479557|20956993|P5|Overall Study|Other|0
6065962|NCT00479557|20956994|P4|Overall Study|Other|0
6065963|NCT00479557|20956995|P3|Overall Study|Other|1
6065964|NCT00479557|20956996|P2|Overall Study|Other|3
6065965|NCT00479557|20956997|P1|Overall Study|Other|2
6065966|NCT00479557|20956991|P7|Overall Study|Subject Request|1
6065967|NCT00479557|20956992|P6|Overall Study|Subject Request|4
6065968|NCT00479557|20956993|P5|Overall Study|Subject Request|1
6065969|NCT00479557|20956994|P4|Overall Study|Subject Request|1
6065970|NCT00479557|20956995|P3|Overall Study|Subject Request|1
6065971|NCT00479557|20956996|P2|Overall Study|Subject Request|0
6065972|NCT00479557|20956997|P1|Overall Study|Subject Request|3
6065973|NCT00479557|20956991|P7|Overall Study|Investigator Request|0
6065974|NCT00479557|20956992|P6|Overall Study|Investigator Request|0
6065975|NCT00479557|20956993|P5|Overall Study|Investigator Request|0
6065976|NCT00479557|20956994|P4|Overall Study|Investigator Request|0
6065977|NCT00479557|20956995|P3|Overall Study|Investigator Request|1
6065978|NCT00479557|20956996|P2|Overall Study|Investigator Request|0
6065979|NCT00479557|20956997|P1|Overall Study|Investigator Request|0
6065980|NCT00479557|20956991|P7|Overall Study|Caregiver Request|0
6065981|NCT00479557|20956992|P6|Overall Study|Caregiver Request|2
6065982|NCT00479557|20956993|P5|Overall Study|Caregiver Request|1
6065983|NCT00479557|20956994|P4|Overall Study|Caregiver Request|0
6065984|NCT00479557|20956995|P3|Overall Study|Caregiver Request|2
6065985|NCT00479557|20956996|P2|Overall Study|Caregiver Request|2
6065986|NCT00479557|20956997|P1|Overall Study|Caregiver Request|2
6065987|NCT00479557|20956991|P7|Overall Study|AE not related to Study Drug|1
6065988|NCT00479557|20956992|P6|Overall Study|AE not related to Study Drug|2
6065989|NCT00479557|20956993|P5|Overall Study|AE not related to Study Drug|2
6065990|NCT00479557|20956994|P4|Overall Study|AE not related to Study Drug|0
6065991|NCT00479557|20956995|P3|Overall Study|AE not related to Study Drug|0
6065992|NCT00479557|20956996|P2|Overall Study|AE not related to Study Drug|3
6065993|NCT00479557|20956997|P1|Overall Study|AE not related to Study Drug|1
6065994|NCT00479557|20956991|P7|Overall Study|Adverse Event (AE) related to Study Drug|0
6065995|NCT00479557|20956992|P6|Overall Study|Adverse Event (AE) related to Study Drug|1
6065996|NCT00479557|20956993|P5|Overall Study|Adverse Event (AE) related to Study Drug|0
6065997|NCT00479557|20956994|P4|Overall Study|Adverse Event (AE) related to Study Drug|2
6065998|NCT00479557|20956995|P3|Overall Study|Adverse Event (AE) related to Study Drug|3
6065999|NCT00479557|20956996|P2|Overall Study|Adverse Event (AE) related to Study Drug|0
6066000|NCT00479557|20956997|P1|Overall Study|Adverse Event (AE) related to Study Drug|1
6066001|NCT00479557|20956991|P7|Overall Study|Lost to Follow-up|0
6066002|NCT00479557|20956992|P6|Overall Study|Lost to Follow-up|0
6066003|NCT00479557|20956993|P5|Overall Study|Lost to Follow-up|0
6066004|NCT00479557|20956994|P4|Overall Study|Lost to Follow-up|2
6066005|NCT00479557|20956995|P3|Overall Study|Lost to Follow-up|0
6066006|NCT00479557|20956996|P2|Overall Study|Lost to Follow-up|2
6066007|NCT00479557|20956997|P1|Overall Study|Lost to Follow-up|0
6066008|NCT00479557|20956991|P7|Overall Study|Lack of Efficacy|0
6066009|NCT00479557|20956992|P6|Overall Study|Lack of Efficacy|0
6066010|NCT00479557|20956993|P5|Overall Study|Lack of Efficacy|0
6066011|NCT00479557|20956994|P4|Overall Study|Lack of Efficacy|0
6066012|NCT00479557|20956995|P3|Overall Study|Lack of Efficacy|0
6066013|NCT00479557|20956996|P2|Overall Study|Lack of Efficacy|0
6066014|NCT00479557|20956997|P1|Overall Study|Lack of Efficacy|1
6066015|NCT00479557|20956991|P7|Overall Study|Death|0
6066016|NCT00479557|20956992|P6|Overall Study|Death|1
6066017|NCT00479557|20956993|P5|Overall Study|Death|0
6066018|NCT00479557|20956994|P4|Overall Study|Death|0
6066019|NCT00479557|20956995|P3|Overall Study|Death|0
6066020|NCT00479557|20956996|P2|Overall Study|Death|0
6066021|NCT00479557|20956997|P1|Overall Study|Death|0
6066022|NCT00479466|20957040|P6|Overall Study|Withdrawal by Subject|1
6066023|NCT00479466|20957041|P5|Overall Study|Withdrawal by Subject|3
6066024|NCT00479466|20957042|P4|Overall Study|Withdrawal by Subject|2
6066025|NCT00479466|20957043|P3|Overall Study|Withdrawal by Subject|0
6066026|NCT00479466|20957044|P2|Overall Study|Withdrawal by Subject|5
6066027|NCT00479466|20957045|P1|Overall Study|Withdrawal by Subject|3
6066028|NCT00479466|20957040|P6|Overall Study|Protocol Violation|0
6066029|NCT00479466|20957041|P5|Overall Study|Protocol Violation|0
6066030|NCT00479466|20957042|P4|Overall Study|Protocol Violation|0
6066031|NCT00479466|20957043|P3|Overall Study|Protocol Violation|0
6066032|NCT00479466|20957044|P2|Overall Study|Protocol Violation|0
6066033|NCT00479466|20957045|P1|Overall Study|Protocol Violation|1
6066034|NCT00479466|20957040|P6|Overall Study|Pregnancy|0
6066035|NCT00479466|20957041|P5|Overall Study|Pregnancy|1
6066036|NCT00479466|20957042|P4|Overall Study|Pregnancy|0
6066037|NCT00479466|20957043|P3|Overall Study|Pregnancy|0
6066038|NCT00479466|20957044|P2|Overall Study|Pregnancy|0
6066039|NCT00479466|20957045|P1|Overall Study|Pregnancy|0
6066040|NCT00479466|20957040|P6|Overall Study|Physician Decision|0
6066041|NCT00479466|20957041|P5|Overall Study|Physician Decision|0
6066042|NCT00479466|20957042|P4|Overall Study|Physician Decision|0
6066043|NCT00479466|20957043|P3|Overall Study|Physician Decision|1
6066044|NCT00479466|20957044|P2|Overall Study|Physician Decision|1
6066045|NCT00479466|20957045|P1|Overall Study|Physician Decision|2
6066046|NCT00479466|20957040|P6|Overall Study|Lost to Follow-up|2
6066047|NCT00479466|20957041|P5|Overall Study|Lost to Follow-up|2
6066048|NCT00479466|20957042|P4|Overall Study|Lost to Follow-up|0
6066049|NCT00479466|20957043|P3|Overall Study|Lost to Follow-up|1
6066050|NCT00479466|20957044|P2|Overall Study|Lost to Follow-up|1
6066051|NCT00479466|20957045|P1|Overall Study|Lost to Follow-up|0
6066052|NCT00479466|20957040|P6|Overall Study|Lack of Efficacy|0
6066053|NCT00479466|20957041|P5|Overall Study|Lack of Efficacy|0
6066054|NCT00479466|20957042|P4|Overall Study|Lack of Efficacy|0
6066055|NCT00479466|20957043|P3|Overall Study|Lack of Efficacy|1
6066056|NCT00479466|20957044|P2|Overall Study|Lack of Efficacy|0
6066057|NCT00479466|20957045|P1|Overall Study|Lack of Efficacy|2
6066058|NCT00479466|20957040|P6|Overall Study|Hyperglycemia|1
6066059|NCT00479466|20957041|P5|Overall Study|Hyperglycemia|0
6066060|NCT00479466|20957042|P4|Overall Study|Hyperglycemia|0
6066061|NCT00479466|20957043|P3|Overall Study|Hyperglycemia|0
6066062|NCT00479466|20957044|P2|Overall Study|Hyperglycemia|0
6066063|NCT00479466|20957045|P1|Overall Study|Hyperglycemia|0
6066064|NCT00479466|20957040|P6|Overall Study|Adverse Event|0
6066065|NCT00479466|20957041|P5|Overall Study|Adverse Event|2
6066066|NCT00479466|20957042|P4|Overall Study|Adverse Event|1
6066067|NCT00479466|20957043|P3|Overall Study|Adverse Event|0
6066068|NCT00479466|20957044|P2|Overall Study|Adverse Event|1
6066069|NCT00479466|20957045|P1|Overall Study|Adverse Event|5
6066070|NCT00479401|20957074|P3|Overall Study|Exclusion criteria, relocation|0
6066071|NCT00479401|20957075|P2|Overall Study|Exclusion criteria, relocation|3
6066072|NCT00479401|20957076|P1|Overall Study|Exclusion criteria, relocation|4
6066073|NCT00479401|20957074|P3|Overall Study|Withdrawal by Subject|2
6066074|NCT00479401|20957075|P2|Overall Study|Withdrawal by Subject|10
6066075|NCT00479401|20957076|P1|Overall Study|Withdrawal by Subject|16
6066076|NCT00479401|20957074|P3|Overall Study|Lost to Follow-up|1
6066077|NCT00479401|20957075|P2|Overall Study|Lost to Follow-up|1
6066078|NCT00479401|20957076|P1|Overall Study|Lost to Follow-up|1
6066079|NCT00479401|20957074|P3|Overall Study|Protocol Violation|1
6066080|NCT00479401|20957075|P2|Overall Study|Protocol Violation|1
6066081|NCT00479401|20957076|P1|Overall Study|Protocol Violation|2
6066082|NCT00479401|20957074|P3|Overall Study|Lack of Efficacy|4
6066083|NCT00479401|20957075|P2|Overall Study|Lack of Efficacy|2
6066084|NCT00479401|20957076|P1|Overall Study|Lack of Efficacy|2
6066085|NCT00479401|20957074|P3|Overall Study|Adverse Event|4
6066086|NCT00479401|20957075|P2|Overall Study|Adverse Event|20
6066087|NCT00479401|20957076|P1|Overall Study|Adverse Event|24
6066088|NCT00479388|20957131|P2|Overall Study|Withdrawal by Subject|17
6066089|NCT00479388|20957132|P1|Overall Study|Withdrawal by Subject|32
6066090|NCT00479388|20957131|P2|Overall Study|Protocol Violation|9
6066091|NCT00479388|20957132|P1|Overall Study|Protocol Violation|10
6066092|NCT00479388|20957131|P2|Overall Study|Lost to Follow-up|2
6066093|NCT00479388|20957132|P1|Overall Study|Lost to Follow-up|0
6066094|NCT00479388|20957131|P2|Overall Study|Adverse Event|45
6066095|NCT00479388|20957132|P1|Overall Study|Adverse Event|90
6066096|NCT00479336|20957146|P4|Overall Study|Resolution of all hepatic edema findings|0
6066097|NCT00479336|20957147|P3|Overall Study|Resolution of all hepatic edema findings|0
6066098|NCT00479336|20957148|P2|Overall Study|Resolution of all hepatic edema findings|1
6066099|NCT00479336|20957149|P1|Overall Study|Resolution of all hepatic edema findings|1
6066100|NCT00479336|20957146|P4|Overall Study|Physician Decision|2
6066101|NCT00479336|20957147|P3|Overall Study|Physician Decision|0
6066102|NCT00479336|20957148|P2|Overall Study|Physician Decision|1
6066103|NCT00479336|20957149|P1|Overall Study|Physician Decision|0
6066104|NCT00479336|20957146|P4|Overall Study|Withdrawal by Subject|0
6066105|NCT00479336|20957147|P3|Overall Study|Withdrawal by Subject|0
6066106|NCT00479336|20957148|P2|Overall Study|Withdrawal by Subject|2
6066107|NCT00479336|20957149|P1|Overall Study|Withdrawal by Subject|1
6066108|NCT00479336|20957146|P4|Overall Study|Protocol Violation|0
6066109|NCT00479336|20957147|P3|Overall Study|Protocol Violation|0
6066110|NCT00479336|20957148|P2|Overall Study|Protocol Violation|1
6066111|NCT00479336|20957149|P1|Overall Study|Protocol Violation|0
6066112|NCT00479336|20957146|P4|Overall Study|Lack of Efficacy|0
6066113|NCT00479336|20957147|P3|Overall Study|Lack of Efficacy|0
6066114|NCT00479336|20957148|P2|Overall Study|Lack of Efficacy|0
6066115|NCT00479336|20957149|P1|Overall Study|Lack of Efficacy|1
6066116|NCT00479336|20957146|P4|Overall Study|Adverse Event|3
6066117|NCT00479336|20957147|P3|Overall Study|Adverse Event|1
6066118|NCT00479336|20957148|P2|Overall Study|Adverse Event|1
6066119|NCT00479336|20957149|P1|Overall Study|Adverse Event|1
6066120|NCT00479232|20957172|P6|Overall Study|Withdrew Consent|3
6066121|NCT00479232|20957173|P5|Overall Study|Withdrew Consent|1
6066122|NCT00479232|20957174|P4|Overall Study|Withdrew Consent|0
6066123|NCT00479232|20957175|P3|Overall Study|Withdrew Consent|6
6066124|NCT00479232|20957176|P2|Overall Study|Withdrew Consent|2
6066125|NCT00479232|20957177|P1|Overall Study|Withdrew Consent|0
6066126|NCT00479232|20957172|P6|Overall Study|Progressive Disease|12
6066127|NCT00479232|20957173|P5|Overall Study|Progressive Disease|3
6066128|NCT00479232|20957174|P4|Overall Study|Progressive Disease|3
6066129|NCT00479232|20957175|P3|Overall Study|Progressive Disease|12
6066130|NCT00479232|20957176|P2|Overall Study|Progressive Disease|1
6066131|NCT00479232|20957177|P1|Overall Study|Progressive Disease|3
6066132|NCT00479232|20957172|P6|Overall Study|Physician Decision|1
6066133|NCT00479232|20957173|P5|Overall Study|Physician Decision|0
6066134|NCT00479232|20957174|P4|Overall Study|Physician Decision|0
6066135|NCT00479232|20957175|P3|Overall Study|Physician Decision|2
6066136|NCT00479232|20957176|P2|Overall Study|Physician Decision|0
6066137|NCT00479232|20957177|P1|Overall Study|Physician Decision|0
6066138|NCT00479232|20957172|P6|Overall Study|Lack of Efficacy|4
6066139|NCT00479232|20957173|P5|Overall Study|Lack of Efficacy|0
6066140|NCT00479232|20957174|P4|Overall Study|Lack of Efficacy|0
6066141|NCT00479232|20957175|P3|Overall Study|Lack of Efficacy|2
6066142|NCT00479232|20957176|P2|Overall Study|Lack of Efficacy|0
6066143|NCT00479232|20957177|P1|Overall Study|Lack of Efficacy|0
6066144|NCT00479232|20957172|P6|Overall Study|Deviation from Protocol|0
6066145|NCT00479232|20957173|P5|Overall Study|Deviation from Protocol|0
6066146|NCT00479232|20957174|P4|Overall Study|Deviation from Protocol|0
6066147|NCT00479232|20957175|P3|Overall Study|Deviation from Protocol|1
6066148|NCT00479232|20957176|P2|Overall Study|Deviation from Protocol|0
6066149|NCT00479232|20957177|P1|Overall Study|Deviation from Protocol|0
6066150|NCT00479232|20957172|P6|Overall Study|Adverse Event|10
6066151|NCT00479232|20957173|P5|Overall Study|Adverse Event|0
6066152|NCT00479232|20957174|P4|Overall Study|Adverse Event|0
6066153|NCT00479232|20957175|P3|Overall Study|Adverse Event|5
6066154|NCT00479232|20957176|P2|Overall Study|Adverse Event|0
6066155|NCT00479232|20957177|P1|Overall Study|Adverse Event|0
6066156|NCT00478933|20957239|P1|Overall Study|Inadequate data available|53
6066157|NCT00478933|20957239|P1|Overall Study|Informed consent not verified|3
6066158|NCT00478933|20957239|P1|Overall Study|Protocol Violation|22
6066159|NCT00478881|20957265|P2|Overall Study|Non-Compliance with Study Medication|2
6066160|NCT00478881|20957266|P1|Overall Study|Non-Compliance with Study Medication|0
6066161|NCT00478881|20957265|P2|Overall Study|Withdrawal by Subject|2
6066162|NCT00478881|20957266|P1|Overall Study|Withdrawal by Subject|6
6066163|NCT00478881|20957265|P2|Overall Study|Protocol Violation|2
6066164|NCT00478881|20957266|P1|Overall Study|Protocol Violation|2
6066165|NCT00478881|20957265|P2|Overall Study|Lost to Follow-up|1
6066166|NCT00478881|20957266|P1|Overall Study|Lost to Follow-up|0
6066167|NCT00478881|20957265|P2|Overall Study|Lack of Efficacy|3
6066168|NCT00478881|20957266|P1|Overall Study|Lack of Efficacy|0
6066169|NCT00478881|20957265|P2|Overall Study|Adverse Event|12
6066170|NCT00478881|20957266|P1|Overall Study|Adverse Event|31
6066171|NCT00478777|20957290|P1|Overall Study|Not treated with lenalidomide|6
6066172|NCT00478777|20957290|P1|Overall Study|End of therapy|2
6066173|NCT00478777|20957290|P1|Overall Study|Lymphocytes infusion|1
6066174|NCT00478777|20957290|P1|Overall Study|Lack of compliance|1
6066175|NCT00478777|20957290|P1|Overall Study|Intolerance of therapy|1
6066176|NCT00478777|20957290|P1|Overall Study|Physician Decision|1
6066177|NCT00478777|20957290|P1|Overall Study|Lost to Follow-up|3
6066178|NCT00478777|20957290|P1|Overall Study|Protocol Violation|3
6066179|NCT00478777|20957290|P1|Overall Study|Death|3
6066180|NCT00478777|20957290|P1|Overall Study|Withdrawal by Subject|4
6066181|NCT00478777|20957290|P1|Overall Study|Lack of Efficacy|23
6066182|NCT00478777|20957290|P1|Overall Study|Adverse Event|29
6066183|NCT00478673|20957297|P1|12-Months Post-Procedure|Visit Not Required by Protocol|6
6066184|NCT00478673|20957297|P1|12-Months Post-Procedure|Missed Visit|25
6066185|NCT00478673|20957297|P1|12-Months Post-Procedure|Withdrawal by Subject|6
6066186|NCT00478673|20957297|P1|12-Months Post-Procedure|Lost to Follow-up|4
6066187|NCT00478673|20957297|P1|12-Months Post-Procedure|Death|23
6066188|NCT00478673|20957297|P1|30-Days Post-Procedure|Missed Visit|7
6066189|NCT00478673|20957297|P1|30-Days Post-Procedure|Withdrawal by Subject|1
6066190|NCT00478673|20957297|P1|30-Days Post-Procedure|Death|2
6066191|NCT00478647|20957302|P1|Overall Study|Withdrawal by Subject|1
6066192|NCT00478647|20957302|P1|Overall Study|Adverse Event|1
6066193|NCT00478608|20957310|P1|Overall Study|Protocol Violation|3
6066194|NCT00478608|20957310|P1|Overall Study|Withdrawal by Subject|2
6066195|NCT00478608|20957310|P1|Overall Study|Serious Adverse Event|14
6066196|NCT00478608|20957310|P1|Overall Study|Adverse Event|1
6066197|NCT00478426|20957343|P1|Overall Study|Withdrawal by Subject|1
6066198|NCT00478257|20957368|P2|Overall Study|Withdrawal by Subject|3
6066199|NCT00478257|20957369|P1|Overall Study|Withdrawal by Subject|8
6066200|NCT00478244|20957375|P1|Overall Study|Did not receive transplant|1
6066201|NCT00478231|20957388|P1|Overall Study|Randomized, not treated|3
6066202|NCT00478231|20957388|P1|Overall Study|Adverse Event|5
6066203|NCT00478231|20957388|P1|Overall Study|Other|9
6066204|NCT00478231|20957388|P1|Overall Study|Withdrawal by Subject|6
6066205|NCT00478231|20957388|P1|Overall Study|Lost to Follow-up|7
6066206|NCT00478231|20957388|P1|Overall Study|Lack of Efficacy|47
6066207|NCT00478231|20957388|P1|Overall Study|Death|7
6066208|NCT00478205|20957424|P2|Overall Study|Other|12
6066209|NCT00478205|20957425|P1|Overall Study|Other|24
6066210|NCT00478205|20957424|P2|Overall Study|Lack of Efficacy|0
6066211|NCT00478205|20957425|P1|Overall Study|Lack of Efficacy|1
6066212|NCT00478205|20957424|P2|Overall Study|Withdrawal by Subject|22
6066213|NCT00478205|20957425|P1|Overall Study|Withdrawal by Subject|61
6066214|NCT00478205|20957424|P2|Overall Study|Request of Investigator or Sponsor|5
6066215|NCT00478205|20957425|P1|Overall Study|Request of Investigator or Sponsor|4
6066216|NCT00478205|20957424|P2|Overall Study|Protocol Violation|5
6066217|NCT00478205|20957425|P1|Overall Study|Protocol Violation|15
6066218|NCT00478205|20957424|P2|Overall Study|Medication Non-compliance|4
6066219|NCT00478205|20957425|P1|Overall Study|Medication Non-compliance|9
6066220|NCT00478205|20957424|P2|Overall Study|Adverse Event|39
6066221|NCT00478205|20957425|P1|Overall Study|Adverse Event|182
6066222|NCT00478140|20957469|P1|Overall Study|Clinical Disease Progression|1
6066223|NCT00478023|20957501|P5|Overall Study|Lack of pain, Technical difficulties|3
6066224|NCT00478023|20957502|P4|Overall Study|Lack of pain, Technical difficulties|6
6066225|NCT00478023|20957503|P3|Overall Study|Lack of pain, Technical difficulties|5
6066226|NCT00478023|20957504|P2|Overall Study|Lack of pain, Technical difficulties|3
6066227|NCT00478023|20957505|P1|Overall Study|Lack of pain, Technical difficulties|7
6066228|NCT00478023|20957501|P5|Overall Study|Withdrawal by Subject|5
6066229|NCT00478023|20957502|P4|Overall Study|Withdrawal by Subject|4
6066230|NCT00478023|20957503|P3|Overall Study|Withdrawal by Subject|2
6066231|NCT00478023|20957504|P2|Overall Study|Withdrawal by Subject|3
6066232|NCT00478023|20957505|P1|Overall Study|Withdrawal by Subject|2
6066233|NCT00478023|20957501|P5|Overall Study|Lost to Follow-up|0
6066234|NCT00478023|20957502|P4|Overall Study|Lost to Follow-up|1
6066235|NCT00478023|20957503|P3|Overall Study|Lost to Follow-up|1
6066236|NCT00478023|20957504|P2|Overall Study|Lost to Follow-up|1
6066237|NCT00478023|20957505|P1|Overall Study|Lost to Follow-up|3
6066238|NCT00478023|20957501|P5|Overall Study|Lack of Efficacy|41
6066239|NCT00478023|20957502|P4|Overall Study|Lack of Efficacy|5
6066240|NCT00478023|20957503|P3|Overall Study|Lack of Efficacy|4
6066241|NCT00478023|20957504|P2|Overall Study|Lack of Efficacy|10
6066242|NCT00478023|20957505|P1|Overall Study|Lack of Efficacy|11
6066243|NCT00478023|20957501|P5|Overall Study|Death|0
6066244|NCT00478023|20957502|P4|Overall Study|Death|0
6066245|NCT00478023|20957503|P3|Overall Study|Death|0
6066246|NCT00478023|20957504|P2|Overall Study|Death|0
6066247|NCT00478023|20957505|P1|Overall Study|Death|1
6066248|NCT00478023|20957501|P5|Overall Study|Adverse Event|6
6066249|NCT00478023|20957502|P4|Overall Study|Adverse Event|14
6066250|NCT00478023|20957503|P3|Overall Study|Adverse Event|8
6066251|NCT00478023|20957504|P2|Overall Study|Adverse Event|7
6066252|NCT00478023|20957505|P1|Overall Study|Adverse Event|11
6066253|NCT00477971|20957524|P2|Overall Study|Alternative treatment|1
6066254|NCT00477971|20957525|P1|Overall Study|Alternative treatment|3
6066255|NCT00477971|20957524|P2|Overall Study|Death|4
6066256|NCT00477971|20957525|P1|Overall Study|Death|2
6066257|NCT00477971|20957524|P2|Overall Study|Adverse Event|0
6066258|NCT00477971|20957525|P1|Overall Study|Adverse Event|3
6066259|NCT00477971|20957524|P2|Overall Study|Withdrawal by Subject|1
6066260|NCT00477971|20957525|P1|Overall Study|Withdrawal by Subject|3
6066261|NCT00477971|20957524|P2|Overall Study|Disease progression|0
6066262|NCT00477971|20957525|P1|Overall Study|Disease progression|6
6066263|NCT00477750|20957537|P1|Overall Study|Currently Receiving Treatment|11
6066264|NCT00477672|20957553|P3|Overall Study|Discretion of Sponsor|0
6066265|NCT00477672|20957554|P2|Overall Study|Discretion of Sponsor|2
6066266|NCT00477672|20957555|P1|Overall Study|Discretion of Sponsor|1
6066267|NCT00477672|20957553|P3|Overall Study|Consent withdrawn|10
6066268|NCT00477672|20957554|P2|Overall Study|Consent withdrawn|5
6066269|NCT00477672|20957555|P1|Overall Study|Consent withdrawn|2
6066270|NCT00477672|20957553|P3|Overall Study|Protocol noncompliance|0
6066271|NCT00477672|20957554|P2|Overall Study|Protocol noncompliance|2
6066272|NCT00477672|20957555|P1|Overall Study|Protocol noncompliance|0
6066273|NCT00477672|20957553|P3|Overall Study|Physician Decision|0
6066274|NCT00477672|20957554|P2|Overall Study|Physician Decision|0
6066275|NCT00477672|20957555|P1|Overall Study|Physician Decision|1
6066276|NCT00477672|20957553|P3|Overall Study|Disease progression|0
6066277|NCT00477672|20957554|P2|Overall Study|Disease progression|1
6066278|NCT00477672|20957555|P1|Overall Study|Disease progression|0
6066279|NCT00477672|20957553|P3|Overall Study|Death|0
6066280|NCT00477672|20957554|P2|Overall Study|Death|1
6066281|NCT00477672|20957555|P1|Overall Study|Death|0
6066282|NCT00477672|20957553|P3|Overall Study|Adverse Event|6
6066283|NCT00477672|20957554|P2|Overall Study|Adverse Event|5
6066284|NCT00477672|20957555|P1|Overall Study|Adverse Event|3
6066285|NCT00477633|20957566|P1|Overall Study|Various (Moving, Enrollment closed)|75
6066286|NCT00477633|20957566|P1|Overall Study|Protocol Violation|25
6066287|NCT00477633|20957566|P1|Overall Study|Withdrawal by Subject|149
6066288|NCT00477633|20957566|P1|Overall Study|Lost to Follow-up|271
6066289|NCT00477633|20957566|P1|Overall Study|Pregnancy|23
6066290|NCT00477633|20957566|P1|Overall Study|Adverse Event|143
6066291|NCT00477633|20957566|P1|Overall Study|Did not receive treatment|23
6066292|NCT00477607|20957574|P2|Overall Study|Lost to Follow-up|7
6066293|NCT00477607|20957575|P1|Overall Study|Lost to Follow-up|7
6066294|NCT00477594|20957587|P2|Follow-up Period|Other|0
6066295|NCT00477594|20957588|P1|Follow-up Period|Other|1
6066296|NCT00477594|20957587|P2|Follow-up Period|Withdrawal by Subject|1
6066297|NCT00477594|20957588|P1|Follow-up Period|Withdrawal by Subject|2
6066298|NCT00477594|20957587|P2|Year 3|Withdrawal by Subject|0
6066299|NCT00477594|20957588|P1|Year 3|Withdrawal by Subject|1
6066300|NCT00477594|20957587|P2|Year 3|Adverse Event|0
6066301|NCT00477594|20957588|P1|Year 3|Adverse Event|1
6066302|NCT00477594|20957587|P2|Year 1 and Year 2|Other|0
6066303|NCT00477594|20957588|P1|Year 1 and Year 2|Other|1
6066304|NCT00477594|20957587|P2|Year 1 and Year 2|Withdrawal by Subject|1
6066305|NCT00477594|20957588|P1|Year 1 and Year 2|Withdrawal by Subject|2
6066306|NCT00477594|20957587|P2|Year 1 and Year 2|Physician Decision|1
6066307|NCT00477594|20957588|P1|Year 1 and Year 2|Physician Decision|2
6066308|NCT00477594|20957587|P2|Year 1 and Year 2|Adverse Event|2
6066309|NCT00477594|20957588|P1|Year 1 and Year 2|Adverse Event|4
6066310|NCT00477490|20957649|P9|Part II: Extension Week 5 up to Day 169|Not reported|0
6066311|NCT00477490|20957650|P8|Part II: Extension Week 5 up to Day 169|Not reported|0
6066312|NCT00477490|20957651|P7|Part II: Extension Week 5 up to Day 169|Not reported|0
6066313|NCT00477490|20957652|P6|Part II: Extension Week 5 up to Day 169|Not reported|0
6066314|NCT00477490|20957653|P5|Part II: Extension Week 5 up to Day 169|Not reported|1
6066315|NCT00477490|20957654|P4|Part II: Extension Week 5 up to Day 169|Not reported|0
6066316|NCT00477490|20957655|P3|Part II: Extension Week 5 up to Day 169|Not reported|1
6066317|NCT00477490|20957656|P2|Part II: Extension Week 5 up to Day 169|Not reported|3
6066318|NCT00477490|20957657|P1|Part II: Extension Week 5 up to Day 169|Not reported|0
6066319|NCT00477490|20957649|P9|Part II: Extension Week 5 up to Day 169|Other, not specified|1
6066320|NCT00477490|20957650|P8|Part II: Extension Week 5 up to Day 169|Other, not specified|0
6066321|NCT00477490|20957651|P7|Part II: Extension Week 5 up to Day 169|Other, not specified|1
6066322|NCT00477490|20957652|P6|Part II: Extension Week 5 up to Day 169|Other, not specified|1
6066323|NCT00477490|20957653|P5|Part II: Extension Week 5 up to Day 169|Other, not specified|2
6066324|NCT00477490|20957654|P4|Part II: Extension Week 5 up to Day 169|Other, not specified|4
6066325|NCT00477490|20957655|P3|Part II: Extension Week 5 up to Day 169|Other, not specified|2
6066326|NCT00477490|20957656|P2|Part II: Extension Week 5 up to Day 169|Other, not specified|4
6066327|NCT00477490|20957657|P1|Part II: Extension Week 5 up to Day 169|Other, not specified|0
6066328|NCT00477490|20957649|P9|Part II: Extension Week 5 up to Day 169|Excluded medication|0
6066329|NCT00477490|20957650|P8|Part II: Extension Week 5 up to Day 169|Excluded medication|0
6066330|NCT00477490|20957651|P7|Part II: Extension Week 5 up to Day 169|Excluded medication|0
6066331|NCT00477490|20957652|P6|Part II: Extension Week 5 up to Day 169|Excluded medication|0
6066332|NCT00477490|20957653|P5|Part II: Extension Week 5 up to Day 169|Excluded medication|0
6066333|NCT00477490|20957654|P4|Part II: Extension Week 5 up to Day 169|Excluded medication|0
6066334|NCT00477490|20957655|P3|Part II: Extension Week 5 up to Day 169|Excluded medication|0
6066335|NCT00477490|20957656|P2|Part II: Extension Week 5 up to Day 169|Excluded medication|1
6066336|NCT00477490|20957657|P1|Part II: Extension Week 5 up to Day 169|Excluded medication|0
6066337|NCT00477490|20957649|P9|Part II: Extension Week 5 up to Day 169|Decreased sodium|1
6066338|NCT00477490|20957650|P8|Part II: Extension Week 5 up to Day 169|Decreased sodium|1
6066339|NCT00477490|20957651|P7|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
6066340|NCT00477490|20957652|P6|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
6066341|NCT00477490|20957653|P5|Part II: Extension Week 5 up to Day 169|Decreased sodium|1
6066342|NCT00477490|20957654|P4|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
6066343|NCT00477490|20957655|P3|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
6066344|NCT00477490|20957656|P2|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
6066345|NCT00477490|20957657|P1|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
6066346|NCT00477490|20957649|P9|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0
6066347|NCT00477490|20957650|P8|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0
6066348|NCT00477490|20957651|P7|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|1
6066349|NCT00477490|20957652|P6|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0
6066350|NCT00477490|20957653|P5|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|5
6066351|NCT00477490|20957654|P4|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0
6066352|NCT00477490|20957655|P3|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|2
6066353|NCT00477490|20957656|P2|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|3
6066354|NCT00477490|20957657|P1|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0
6066355|NCT00477490|20957649|P9|Part II: Extension Week 5 up to Day 169|Adverse Event|4
6066356|NCT00477490|20957650|P8|Part II: Extension Week 5 up to Day 169|Adverse Event|1
6066357|NCT00477490|20957651|P7|Part II: Extension Week 5 up to Day 169|Adverse Event|1
6066358|NCT00477490|20957652|P6|Part II: Extension Week 5 up to Day 169|Adverse Event|1
6066359|NCT00477490|20957653|P5|Part II: Extension Week 5 up to Day 169|Adverse Event|1
6066360|NCT00477490|20957654|P4|Part II: Extension Week 5 up to Day 169|Adverse Event|1
6066361|NCT00477490|20957655|P3|Part II: Extension Week 5 up to Day 169|Adverse Event|3
6066362|NCT00477490|20957656|P2|Part II: Extension Week 5 up to Day 169|Adverse Event|2
6066363|NCT00477490|20957657|P1|Part II: Extension Week 5 up to Day 169|Adverse Event|0
6066364|NCT00477490|20957649|P9|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2
6066365|NCT00477490|20957650|P8|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|3
6066366|NCT00477490|20957651|P7|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2
6066367|NCT00477490|20957652|P6|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|4
6066368|NCT00477490|20957653|P5|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|10
6066369|NCT00477490|20957654|P4|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7
6066370|NCT00477490|20957655|P3|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7
6066371|NCT00477490|20957656|P2|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|15
6066372|NCT00477490|20957657|P1|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|0
6066373|NCT00477490|20957649|P9|Part I: 4 Week Efficacy|Not Reported|0
6066374|NCT00477490|20957650|P8|Part I: 4 Week Efficacy|Not Reported|0
6066375|NCT00477490|20957651|P7|Part I: 4 Week Efficacy|Not Reported|0
6066376|NCT00477490|20957652|P6|Part I: 4 Week Efficacy|Not Reported|0
6066377|NCT00477490|20957653|P5|Part I: 4 Week Efficacy|Not Reported|1
6066378|NCT00477490|20957654|P4|Part I: 4 Week Efficacy|Not Reported|0
6066379|NCT00477490|20957655|P3|Part I: 4 Week Efficacy|Not Reported|3
6066380|NCT00477490|20957656|P2|Part I: 4 Week Efficacy|Not Reported|2
6066381|NCT00477490|20957657|P1|Part I: 4 Week Efficacy|Not Reported|1
6066382|NCT00477490|20957649|P9|Part I: 4 Week Efficacy|Other, not specified|0
6066383|NCT00477490|20957650|P8|Part I: 4 Week Efficacy|Other, not specified|0
6066384|NCT00477490|20957651|P7|Part I: 4 Week Efficacy|Other, not specified|0
6066385|NCT00477490|20957652|P6|Part I: 4 Week Efficacy|Other, not specified|0
6066386|NCT00477490|20957653|P5|Part I: 4 Week Efficacy|Other, not specified|1
6066387|NCT00477490|20957654|P4|Part I: 4 Week Efficacy|Other, not specified|1
6066388|NCT00477490|20957655|P3|Part I: 4 Week Efficacy|Other, not specified|0
6066389|NCT00477490|20957656|P2|Part I: 4 Week Efficacy|Other, not specified|4
6066390|NCT00477490|20957657|P1|Part I: 4 Week Efficacy|Other, not specified|2
6066391|NCT00477490|20957649|P9|Part I: 4 Week Efficacy|Lost to Follow-up|0
6066392|NCT00477490|20957650|P8|Part I: 4 Week Efficacy|Lost to Follow-up|0
6066393|NCT00477490|20957651|P7|Part I: 4 Week Efficacy|Lost to Follow-up|0
6066394|NCT00477490|20957652|P6|Part I: 4 Week Efficacy|Lost to Follow-up|0
6066395|NCT00477490|20957653|P5|Part I: 4 Week Efficacy|Lost to Follow-up|3
6066396|NCT00477490|20957654|P4|Part I: 4 Week Efficacy|Lost to Follow-up|5
6066397|NCT00477490|20957655|P3|Part I: 4 Week Efficacy|Lost to Follow-up|1
6066398|NCT00477490|20957656|P2|Part I: 4 Week Efficacy|Lost to Follow-up|4
6066399|NCT00477490|20957657|P1|Part I: 4 Week Efficacy|Lost to Follow-up|2
6066400|NCT00477490|20957649|P9|Part I: 4 Week Efficacy|Withdrawal by Subject|0
6066401|NCT00477490|20957650|P8|Part I: 4 Week Efficacy|Withdrawal by Subject|0
6066402|NCT00477490|20957651|P7|Part I: 4 Week Efficacy|Withdrawal by Subject|0
6066403|NCT00477490|20957652|P6|Part I: 4 Week Efficacy|Withdrawal by Subject|0
6066404|NCT00477490|20957653|P5|Part I: 4 Week Efficacy|Withdrawal by Subject|9
6066405|NCT00477490|20957654|P4|Part I: 4 Week Efficacy|Withdrawal by Subject|4
6066406|NCT00477490|20957655|P3|Part I: 4 Week Efficacy|Withdrawal by Subject|6
6066407|NCT00477490|20957656|P2|Part I: 4 Week Efficacy|Withdrawal by Subject|5
6066408|NCT00477490|20957657|P1|Part I: 4 Week Efficacy|Withdrawal by Subject|6
6066409|NCT00477490|20957649|P9|Part I: 4 Week Efficacy|Protocol Violation|0
6066410|NCT00477490|20957650|P8|Part I: 4 Week Efficacy|Protocol Violation|0
6066411|NCT00477490|20957651|P7|Part I: 4 Week Efficacy|Protocol Violation|0
6066412|NCT00477490|20957652|P6|Part I: 4 Week Efficacy|Protocol Violation|0
6066413|NCT00477490|20957653|P5|Part I: 4 Week Efficacy|Protocol Violation|1
6066414|NCT00477490|20957654|P4|Part I: 4 Week Efficacy|Protocol Violation|0
6066415|NCT00477490|20957655|P3|Part I: 4 Week Efficacy|Protocol Violation|0
6066416|NCT00477490|20957656|P2|Part I: 4 Week Efficacy|Protocol Violation|0
6066417|NCT00477490|20957657|P1|Part I: 4 Week Efficacy|Protocol Violation|2
6066418|NCT00477490|20957649|P9|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
6066419|NCT00477490|20957650|P8|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
6066420|NCT00477490|20957651|P7|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
6066421|NCT00477490|20957652|P6|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
6066422|NCT00477490|20957653|P5|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|4
6066423|NCT00477490|20957654|P4|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|5
6066424|NCT00477490|20957655|P3|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
6066425|NCT00477490|20957656|P2|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
6066426|NCT00477490|20957657|P1|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|1
6066427|NCT00477490|20957649|P9|Part I: 4 Week Efficacy|Adverse Event|0
6066428|NCT00477490|20957650|P8|Part I: 4 Week Efficacy|Adverse Event|0
6066429|NCT00477490|20957651|P7|Part I: 4 Week Efficacy|Adverse Event|0
6066430|NCT00477490|20957652|P6|Part I: 4 Week Efficacy|Adverse Event|0
6066431|NCT00477490|20957653|P5|Part I: 4 Week Efficacy|Adverse Event|6
6066432|NCT00477490|20957654|P4|Part I: 4 Week Efficacy|Adverse Event|5
6066433|NCT00477490|20957655|P3|Part I: 4 Week Efficacy|Adverse Event|0
6066434|NCT00477490|20957656|P2|Part I: 4 Week Efficacy|Adverse Event|4
6066435|NCT00477490|20957657|P1|Part I: 4 Week Efficacy|Adverse Event|1
6066436|NCT00477464|20957741|P1|Overall Study|Completion of protocol-defined follow-up|14
6066437|NCT00477464|20957741|P1|Overall Study|Death|36
6066438|NCT00477464|20957741|P1|Overall Study|Lost to Follow-up|1
6066439|NCT00477386|20957785|P2|Overall Study|Withdrawal by Subject|0
6066440|NCT00477386|20957786|P1|Overall Study|Withdrawal by Subject|1
6066441|NCT00477386|20957785|P2|Overall Study|Physician Decision|0
6066442|NCT00477386|20957786|P1|Overall Study|Physician Decision|1
6066443|NCT00477386|20957785|P2|Overall Study|Other|2
6066444|NCT00477386|20957786|P1|Overall Study|Other|1
6066445|NCT00477386|20957785|P2|Overall Study|Disease progression, refractory|3
6066446|NCT00477386|20957786|P1|Overall Study|Disease progression, refractory|1
6066447|NCT00477386|20957785|P2|Overall Study|Disease progression, relapse|4
6066448|NCT00477386|20957786|P1|Overall Study|Disease progression, relapse|3
6066449|NCT00477386|20957785|P2|Overall Study|Adverse Event|8
6066450|NCT00477386|20957786|P1|Overall Study|Adverse Event|4
6066451|NCT00477334|20957796|P2|Overall Study|Protocol Violation|1
6066452|NCT00477334|20957797|P1|Overall Study|Protocol Violation|7
6066453|NCT00477334|20957796|P2|Overall Study|Administrative Problems|15
6066454|NCT00477334|20957797|P1|Overall Study|Administrative Problems|39
6066455|NCT00477334|20957796|P2|Overall Study|Lost to Follow-up|4
6066456|NCT00477334|20957797|P1|Overall Study|Lost to Follow-up|15
6066457|NCT00477334|20957796|P2|Overall Study|Withdrawal by Subject|1
6066458|NCT00477334|20957797|P1|Overall Study|Withdrawal by Subject|2
6066459|NCT00477334|20957796|P2|Overall Study|Adverse Event|2
6066460|NCT00477334|20957797|P1|Overall Study|Adverse Event|1
6066461|NCT00477334|20957796|P2|Overall Study|Discontinued prior to taking study drug|53
6066462|NCT00477334|20957797|P1|Overall Study|Discontinued prior to taking study drug|106
6066463|NCT00477295|20957823|P2|Overall Study|Other|3
6066464|NCT00477295|20957824|P1|Overall Study|Other|4
6066465|NCT00477295|20957823|P2|Overall Study|Lost to Follow-up|11
6066466|NCT00477295|20957824|P1|Overall Study|Lost to Follow-up|21
6066467|NCT00477295|20957823|P2|Overall Study|Physician Decision|5
6066468|NCT00477295|20957824|P1|Overall Study|Physician Decision|4
6066469|NCT00477295|20957823|P2|Overall Study|Protocol Violation|8
6066470|NCT00477295|20957824|P1|Overall Study|Protocol Violation|3
6066471|NCT00477295|20957823|P2|Overall Study|Lack of Efficacy|23
6066472|NCT00477295|20957824|P1|Overall Study|Lack of Efficacy|23
6066473|NCT00477295|20957823|P2|Overall Study|Withdrawal by Subject|24
6066474|NCT00477295|20957824|P1|Overall Study|Withdrawal by Subject|35
6066475|NCT00477295|20957823|P2|Overall Study|Adverse Event|35
6066476|NCT00477295|20957824|P1|Overall Study|Adverse Event|31
6066477|NCT00477269|20957852|P3|Open Label Extension|Death|4
6066478|NCT00477269|20957853|P2|Open Label Extension|Death|0
6066479|NCT00477269|20957854|P1|Open Label Extension|Death|0
6066480|NCT00477269|20957852|P3|Open Label Extension|Adminiatrative problems|2
6066481|NCT00477269|20957853|P2|Open Label Extension|Adminiatrative problems|0
6066482|NCT00477269|20957854|P1|Open Label Extension|Adminiatrative problems|0
6066483|NCT00477269|20957852|P3|Open Label Extension|unsatisfactory therapeutic effects|2
6066484|NCT00477269|20957853|P2|Open Label Extension|unsatisfactory therapeutic effects|0
6066485|NCT00477269|20957854|P1|Open Label Extension|unsatisfactory therapeutic effects|0
6066486|NCT00477269|20957852|P3|Open Label Extension|Abnormal laboratory values|1
6066487|NCT00477269|20957853|P2|Open Label Extension|Abnormal laboratory values|0
6066488|NCT00477269|20957854|P1|Open Label Extension|Abnormal laboratory values|0
6066489|NCT00477269|20957852|P3|Open Label Extension|Adverse Event|4
6066490|NCT00477269|20957853|P2|Open Label Extension|Adverse Event|0
6066491|NCT00477269|20957854|P1|Open Label Extension|Adverse Event|0
6066492|NCT00477269|20957852|P3|Core Study|Withdrawn Consent|0
6066493|NCT00477269|20957853|P2|Core Study|Withdrawn Consent|1
6066494|NCT00477269|20957854|P1|Core Study|Withdrawn Consent|0
6066495|NCT00477269|20957852|P3|Core Study|Death|0
6066496|NCT00477269|20957853|P2|Core Study|Death|3
6066497|NCT00477269|20957854|P1|Core Study|Death|3
6066498|NCT00477269|20957852|P3|Core Study|Adverse Event|0
6066499|NCT00477269|20957853|P2|Core Study|Adverse Event|4
6066500|NCT00477269|20957854|P1|Core Study|Adverse Event|6
6066501|NCT00477165|20957933|P2|Overall Study|Adverse Event|2
6066502|NCT00477165|20957934|P1|Overall Study|Adverse Event|7
6066503|NCT00477152|20957946|P1|Overall Study|Adverse Event|1
6066504|NCT00477152|20957946|P1|Overall Study|Parent withdrew consent|2
6066505|NCT00476996|20957962|P4|OLE Phase (From Week 48)|Early termination of the study|578
6066506|NCT00476996|20957963|P3|OLE Phase (From Week 48)|Early termination of the study|0
6066507|NCT00476996|20957964|P2|OLE Phase (From Week 48)|Early termination of the study|0
6066508|NCT00476996|20957965|P1|OLE Phase (From Week 48)|Early termination of the study|0
6066509|NCT00476996|20957962|P4|OLE Phase (From Week 48)|Non-Compliance with Study Drug|4
6066510|NCT00476996|20957963|P3|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0
6066511|NCT00476996|20957964|P2|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0
6066512|NCT00476996|20957965|P1|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0
6066513|NCT00476996|20957962|P4|OLE Phase (From Week 48)|Lost to Follow-up|4
6066514|NCT00476996|20957963|P3|OLE Phase (From Week 48)|Lost to Follow-up|0
6066515|NCT00476996|20957964|P2|OLE Phase (From Week 48)|Lost to Follow-up|0
6066516|NCT00476996|20957965|P1|OLE Phase (From Week 48)|Lost to Follow-up|0
6066517|NCT00476996|20957962|P4|OLE Phase (From Week 48)|Lack of Efficacy|13
6066518|NCT00476996|20957963|P3|OLE Phase (From Week 48)|Lack of Efficacy|0
6066519|NCT00476996|20957964|P2|OLE Phase (From Week 48)|Lack of Efficacy|0
6066520|NCT00476996|20957965|P1|OLE Phase (From Week 48)|Lack of Efficacy|0
6066521|NCT00476996|20957962|P4|OLE Phase (From Week 48)|Death|7
6066522|NCT00476996|20957963|P3|OLE Phase (From Week 48)|Death|0
6066523|NCT00476996|20957964|P2|OLE Phase (From Week 48)|Death|0
6066524|NCT00476996|20957965|P1|OLE Phase (From Week 48)|Death|0
6066525|NCT00476996|20957962|P4|OLE Phase (From Week 48)|Adverse Event|8
6066526|NCT00476996|20957963|P3|OLE Phase (From Week 48)|Adverse Event|0
6066527|NCT00476996|20957964|P2|OLE Phase (From Week 48)|Adverse Event|0
6066528|NCT00476996|20957965|P1|OLE Phase (From Week 48)|Adverse Event|0
6066529|NCT00476996|20957962|P4|OLE Phase (From Week 48)|Withdrawal by Subject|50
6066530|NCT00476996|20957963|P3|OLE Phase (From Week 48)|Withdrawal by Subject|0
6066531|NCT00476996|20957964|P2|OLE Phase (From Week 48)|Withdrawal by Subject|0
6066532|NCT00476996|20957965|P1|OLE Phase (From Week 48)|Withdrawal by Subject|0
6066533|NCT00476996|20957962|P4|Blinded Treatment Phase (up to Week 48)|Adverse Event|0
6066534|NCT00476996|20957963|P3|Blinded Treatment Phase (up to Week 48)|Adverse Event|7
6066535|NCT00476996|20957964|P2|Blinded Treatment Phase (up to Week 48)|Adverse Event|13
6066536|NCT00476996|20957965|P1|Blinded Treatment Phase (up to Week 48)|Adverse Event|11
6066537|NCT00476996|20957962|P4|Blinded Treatment Phase (up to Week 48)|Death|0
6066538|NCT00476996|20957963|P3|Blinded Treatment Phase (up to Week 48)|Death|1
6066539|NCT00476996|20957964|P2|Blinded Treatment Phase (up to Week 48)|Death|1
6066540|NCT00476996|20957965|P1|Blinded Treatment Phase (up to Week 48)|Death|2
6066541|NCT00476996|20957962|P4|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|0
6066542|NCT00476996|20957963|P3|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|6
6066543|NCT00476996|20957964|P2|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|5
6066544|NCT00476996|20957965|P1|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|22
6066545|NCT00476996|20957962|P4|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0
6066546|NCT00476996|20957963|P3|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|3
6066547|NCT00476996|20957964|P2|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|4
6066548|NCT00476996|20957965|P1|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0
6066549|NCT00476996|20957962|P4|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0
6066550|NCT00476996|20957963|P3|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0
6066551|NCT00476996|20957964|P2|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|2
6066552|NCT00476996|20957965|P1|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0
6066553|NCT00476996|20957962|P4|Blinded Treatment Phase (up to Week 48)|Early termination of the study|0
6066554|NCT00476996|20957963|P3|Blinded Treatment Phase (up to Week 48)|Early termination of the study|21
6066555|NCT00476996|20957964|P2|Blinded Treatment Phase (up to Week 48)|Early termination of the study|20
6066556|NCT00476996|20957965|P1|Blinded Treatment Phase (up to Week 48)|Early termination of the study|24
6066557|NCT00476996|20957962|P4|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0
6066558|NCT00476996|20957963|P3|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0
6066559|NCT00476996|20957964|P2|Blinded Treatment Phase (up to Week 48)|Protocol Violation|3
6066560|NCT00476996|20957965|P1|Blinded Treatment Phase (up to Week 48)|Protocol Violation|1
6066561|NCT00476996|20957962|P4|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|0
6066562|NCT00476996|20957963|P3|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7
6066563|NCT00476996|20957964|P2|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7
6066564|NCT00476996|20957965|P1|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|12
6066565|NCT00476957|20957997|P2|Overall Study|Lost to Follow-up|193
6066566|NCT00476957|20957998|P1|Overall Study|Lost to Follow-up|176
6066567|NCT00476593|20958062|P4|Overall Study|Lost to Follow-up|22
6066568|NCT00476593|20958063|P3|Overall Study|Lost to Follow-up|8
6066569|NCT00476593|20958064|P2|Overall Study|Lost to Follow-up|2
6066570|NCT00476593|20958065|P1|Overall Study|Lost to Follow-up|10
6066571|NCT00476476|20958077|P2|Overall Study|Progressive Disease|17
6066572|NCT00476476|20958078|P1|Overall Study|Progressive Disease|0
6066573|NCT00476476|20958077|P2|Overall Study|Adverse Event|7
6066574|NCT00476476|20958078|P1|Overall Study|Adverse Event|2
6066575|NCT00476229|20958096|P1|Overall Study|Progressive shortness of breath|1
6066576|NCT00476151|20958102|P2|Overall Study|Physician Decision|2
6066577|NCT00476151|20958103|P1|Overall Study|Physician Decision|0
6066578|NCT00476151|20958102|P2|Overall Study|Withdrawal by Subject|0
6066579|NCT00476151|20958103|P1|Overall Study|Withdrawal by Subject|2
6066580|NCT00476151|20958102|P2|Overall Study|Protocol Violation|3
6066581|NCT00476151|20958103|P1|Overall Study|Protocol Violation|1
6066582|NCT00476151|20958102|P2|Overall Study|Adverse Event|2
6066583|NCT00476151|20958103|P1|Overall Study|Adverse Event|0
6066584|NCT00476086|20958109|P1|Overall Study|Progressive Disease|4
6066585|NCT00476086|20958109|P1|Overall Study|Alternative therapy|1
6066586|NCT00476047|20958115|P1|Overall Study|Lost to Follow-up|1
6066587|NCT00476008|20958141|P2|Overall Study|Death|0
6066588|NCT00476008|20958142|P1|Overall Study|Death|1
6066589|NCT00476008|20958141|P2|Overall Study|Withdrawal by Subject|1
6066590|NCT00476008|20958142|P1|Overall Study|Withdrawal by Subject|0
6066591|NCT00476008|20958141|P2|Overall Study|Physician Decision: Medication Noncompli|1
6066592|NCT00476008|20958142|P1|Overall Study|Physician Decision: Medication Noncompli|2
6066593|NCT00476008|20958141|P2|Overall Study|Placebo concerns|2
6066594|NCT00476008|20958142|P1|Overall Study|Placebo concerns|2
6066595|NCT00476008|20958141|P2|Overall Study|Adverse Event|4
6066596|NCT00476008|20958142|P1|Overall Study|Adverse Event|4
6066597|NCT00475982|20958168|P2|Overall Study|surgery rescheduled|3
6066598|NCT00475982|20958169|P1|Overall Study|surgery rescheduled|7
6066599|NCT00475865|20958217|P3|Overall Study|Other than above|0
6066600|NCT00475865|20958218|P2|Overall Study|Other than above|1
6066601|NCT00475865|20958219|P1|Overall Study|Other than above|0
6066602|NCT00475865|20958217|P3|Overall Study|Participant did not wish to continue|0
6066603|NCT00475865|20958218|P2|Overall Study|Participant did not wish to continue|0
6066604|NCT00475865|20958219|P1|Overall Study|Participant did not wish to continue|1
6066605|NCT00475865|20958217|P3|Overall Study|Progressive disease|2
6066606|NCT00475865|20958218|P2|Overall Study|Progressive disease|1
6066607|NCT00475865|20958219|P1|Overall Study|Progressive disease|0
6066608|NCT00475865|20958217|P3|Overall Study|Lack of Efficacy|0
6066609|NCT00475865|20958218|P2|Overall Study|Lack of Efficacy|0
6066610|NCT00475865|20958219|P1|Overall Study|Lack of Efficacy|1
6066611|NCT00475865|20958217|P3|Overall Study|Adverse Event|4
6066612|NCT00475865|20958218|P2|Overall Study|Adverse Event|3
6066613|NCT00475865|20958219|P1|Overall Study|Adverse Event|0
6066614|NCT00475852|20958249|P2|Overall Study|Lost to Follow-up|68
6066615|NCT00475852|20958250|P1|Overall Study|Lost to Follow-up|54
6066616|NCT00475852|20958249|P2|Overall Study|Withdrawal by Subject|24
6066617|NCT00475852|20958250|P1|Overall Study|Withdrawal by Subject|19
6066618|NCT00475852|20958249|P2|Overall Study|Death|456
6066619|NCT00475852|20958250|P1|Overall Study|Death|444
6066620|NCT00475735|20958301|P6|Treatment Period 2|Withdrawal by Subject|0
6066621|NCT00475735|20958302|P5|Treatment Period 2|Withdrawal by Subject|1
6066622|NCT00475735|20958303|P4|Treatment Period 2|Withdrawal by Subject|0
6066623|NCT00475735|20958304|P3|Treatment Period 2|Withdrawal by Subject|0
6066624|NCT00475735|20958305|P2|Treatment Period 2|Withdrawal by Subject|0
6066625|NCT00475735|20958306|P1|Treatment Period 2|Withdrawal by Subject|0
6066626|NCT00475735|20958301|P6|Treatment Period 2|Lack of Efficacy|1
6066627|NCT00475735|20958302|P5|Treatment Period 2|Lack of Efficacy|0
6066628|NCT00475735|20958303|P4|Treatment Period 2|Lack of Efficacy|0
6066629|NCT00475735|20958304|P3|Treatment Period 2|Lack of Efficacy|0
6066630|NCT00475735|20958305|P2|Treatment Period 2|Lack of Efficacy|0
6066631|NCT00475735|20958306|P1|Treatment Period 2|Lack of Efficacy|0
6066632|NCT00475735|20958301|P6|Treatment Period 2|Adverse Event|0
6066633|NCT00475735|20958302|P5|Treatment Period 2|Adverse Event|0
6066634|NCT00475735|20958303|P4|Treatment Period 2|Adverse Event|2
6066635|NCT00475735|20958304|P3|Treatment Period 2|Adverse Event|0
6066636|NCT00475735|20958305|P2|Treatment Period 2|Adverse Event|1
6066637|NCT00475735|20958306|P1|Treatment Period 2|Adverse Event|0
6066638|NCT00475735|20958301|P6|Treatment Washout|Protocol Violation|0
6066639|NCT00475735|20958302|P5|Treatment Washout|Protocol Violation|0
6066640|NCT00475735|20958303|P4|Treatment Washout|Protocol Violation|0
6066641|NCT00475735|20958304|P3|Treatment Washout|Protocol Violation|0
6066642|NCT00475735|20958305|P2|Treatment Washout|Protocol Violation|1
6066643|NCT00475735|20958306|P1|Treatment Washout|Protocol Violation|0
6066644|NCT00475735|20958301|P6|Treatment Washout|Lost to Follow-up|0
6066645|NCT00475735|20958302|P5|Treatment Washout|Lost to Follow-up|0
6066646|NCT00475735|20958303|P4|Treatment Washout|Lost to Follow-up|0
6066647|NCT00475735|20958304|P3|Treatment Washout|Lost to Follow-up|0
6066648|NCT00475735|20958305|P2|Treatment Washout|Lost to Follow-up|1
6066649|NCT00475735|20958306|P1|Treatment Washout|Lost to Follow-up|0
6066650|NCT00475735|20958301|P6|Treatment Period 1|DC due to no efficacy but Continuing|0
6066651|NCT00475735|20958302|P5|Treatment Period 1|DC due to no efficacy but Continuing|0
6066652|NCT00475735|20958303|P4|Treatment Period 1|DC due to no efficacy but Continuing|0
6066653|NCT00475735|20958304|P3|Treatment Period 1|DC due to no efficacy but Continuing|0
6066654|NCT00475735|20958305|P2|Treatment Period 1|DC due to no efficacy but Continuing|1
6066655|NCT00475735|20958306|P1|Treatment Period 1|DC due to no efficacy but Continuing|0
6066656|NCT00475735|20958301|P6|Treatment Period 1|DC due to AE but continuing|2
6066657|NCT00475735|20958302|P5|Treatment Period 1|DC due to AE but continuing|2
6066658|NCT00475735|20958303|P4|Treatment Period 1|DC due to AE but continuing|1
6066659|NCT00475735|20958304|P3|Treatment Period 1|DC due to AE but continuing|0
6066660|NCT00475735|20958305|P2|Treatment Period 1|DC due to AE but continuing|0
6066661|NCT00475735|20958306|P1|Treatment Period 1|DC due to AE but continuing|0
6066662|NCT00475735|20958301|P6|Treatment Period 1|Withdrawal by Subject|0
6066663|NCT00475735|20958302|P5|Treatment Period 1|Withdrawal by Subject|0
6066664|NCT00475735|20958303|P4|Treatment Period 1|Withdrawal by Subject|0
6066665|NCT00475735|20958304|P3|Treatment Period 1|Withdrawal by Subject|0
6066666|NCT00475735|20958305|P2|Treatment Period 1|Withdrawal by Subject|1
6066667|NCT00475735|20958306|P1|Treatment Period 1|Withdrawal by Subject|1
6066668|NCT00475735|20958301|P6|Treatment Period 1|Protocol Violation|0
6066669|NCT00475735|20958302|P5|Treatment Period 1|Protocol Violation|0
6066670|NCT00475735|20958303|P4|Treatment Period 1|Protocol Violation|1
6066671|NCT00475735|20958304|P3|Treatment Period 1|Protocol Violation|0
6066672|NCT00475735|20958305|P2|Treatment Period 1|Protocol Violation|0
6066673|NCT00475735|20958306|P1|Treatment Period 1|Protocol Violation|0
6066674|NCT00475735|20958301|P6|Treatment Period 1|Lost to Follow-up|1
6066675|NCT00475735|20958302|P5|Treatment Period 1|Lost to Follow-up|0
6066676|NCT00475735|20958303|P4|Treatment Period 1|Lost to Follow-up|0
6066677|NCT00475735|20958304|P3|Treatment Period 1|Lost to Follow-up|0
6066678|NCT00475735|20958305|P2|Treatment Period 1|Lost to Follow-up|0
6066679|NCT00475735|20958306|P1|Treatment Period 1|Lost to Follow-up|0
6066680|NCT00475735|20958301|P6|Treatment Period 1|Lack of Efficacy|0
6066681|NCT00475735|20958302|P5|Treatment Period 1|Lack of Efficacy|0
6066682|NCT00475735|20958303|P4|Treatment Period 1|Lack of Efficacy|0
6066683|NCT00475735|20958304|P3|Treatment Period 1|Lack of Efficacy|0
6066684|NCT00475735|20958305|P2|Treatment Period 1|Lack of Efficacy|0
6066685|NCT00475735|20958306|P1|Treatment Period 1|Lack of Efficacy|1
6066686|NCT00475735|20958301|P6|Treatment Period 1|Adverse Event|0
6066687|NCT00475735|20958302|P5|Treatment Period 1|Adverse Event|0
6066688|NCT00475735|20958303|P4|Treatment Period 1|Adverse Event|0
6066689|NCT00475735|20958304|P3|Treatment Period 1|Adverse Event|0
6066690|NCT00475735|20958305|P2|Treatment Period 1|Adverse Event|0
6066691|NCT00475735|20958306|P1|Treatment Period 1|Adverse Event|2
6066692|NCT00475722|20958319|P2|Overall Study|Protocol Violation|0
6066693|NCT00475722|20958320|P1|Overall Study|Protocol Violation|3
6066694|NCT00475722|20958319|P2|Overall Study|Withdrawal by Subject|12
6066695|NCT00475722|20958320|P1|Overall Study|Withdrawal by Subject|12
6066696|NCT00475709|20958326|P1|Overall Study|Lost to Follow-up|21
6066697|NCT00475709|20958326|P1|Overall Study|Device Explant|6
6066698|NCT00475709|20958326|P1|Overall Study|Death|41
6066699|NCT00475709|20958326|P1|Overall Study|Did not meet eligibility criteria|8
6066700|NCT00475670|20958334|P2|Overall Study|Other|3
6066701|NCT00475670|20958335|P1|Overall Study|Other|0
6066702|NCT00475670|20958334|P2|Overall Study|Failure to Return|1
6066703|NCT00475670|20958335|P1|Overall Study|Failure to Return|0
6066704|NCT00475670|20958334|P2|Overall Study|Refused treatment|2
6066705|NCT00475670|20958335|P1|Overall Study|Refused treatment|0
6066706|NCT00475670|20958334|P2|Overall Study|Lack of Efficacy|34
6066707|NCT00475670|20958335|P1|Overall Study|Lack of Efficacy|3
6066708|NCT00475670|20958334|P2|Overall Study|Death|1
6066709|NCT00475670|20958335|P1|Overall Study|Death|0
6066710|NCT00475657|20958359|P1|Overall Study|Sponsor's Decision|3
6066711|NCT00475657|20958359|P1|Overall Study|Death|1
6066712|NCT00475644|20958367|P1|Overall Study|Protocol Violation|13
6066713|NCT00475423|20958432|P1|Overall Study|Lost to Follow-up|7
6066714|NCT00475423|20958432|P1|Overall Study|Reason not specified|1
6066715|NCT00475423|20958432|P1|Overall Study|Death|1
6066716|NCT00475423|20958432|P1|Overall Study|Lack of Efficacy|8
6066717|NCT00475423|20958432|P1|Overall Study|Withdrawal by Subject|6
6066718|NCT00475423|20958432|P1|Overall Study|Adverse Event|4
6066719|NCT00475423|20958432|P1|Overall Study|Protocol Violation|5
6066720|NCT00475306|20958478|P4|Overall Study|Protocol Violation|1
6066721|NCT00475306|20958479|P3|Overall Study|Protocol Violation|0
6066722|NCT00475306|20958480|P2|Overall Study|Protocol Violation|1
6066723|NCT00475306|20958481|P1|Overall Study|Protocol Violation|1
6066724|NCT00475228|20958512|P2|Overall Study|Lost to Follow-up|17
6066725|NCT00475228|20958513|P1|Overall Study|Lost to Follow-up|17
6066726|NCT00475176|20958552|P1|Overall Study|Protocol Violation|1
6066727|NCT00475176|20958552|P1|Overall Study|Withdrawal by Subject|1
6066728|NCT00475176|20958552|P1|Overall Study|Adverse Event|2
6066729|NCT00475033|20958592|P2|Toddler Dose|Lost to Follow-up|0
6066730|NCT00475033|20958593|P1|Toddler Dose|Lost to Follow-up|1
6066731|NCT00475033|20958592|P2|Toddler Dose|Failed to return|0
6066732|NCT00475033|20958593|P1|Toddler Dose|Failed to return|1
6066733|NCT00475033|20958592|P2|Toddler Dose|Parent or legal guardian request|0
6066734|NCT00475033|20958593|P1|Toddler Dose|Parent or legal guardian request|2
6066735|NCT00475033|20958592|P2|After the Infant Series|Other|1
6066736|NCT00475033|20958593|P1|After the Infant Series|Other|0
6066737|NCT00475033|20958592|P2|After the Infant Series|Lost to Follow-up|0
6066738|NCT00475033|20958593|P1|After the Infant Series|Lost to Follow-up|1
6066739|NCT00475033|20958592|P2|After the Infant Series|Protocol Violation|0
6066740|NCT00475033|20958593|P1|After the Infant Series|Protocol Violation|1
6066741|NCT00475033|20958592|P2|After the Infant Series|Failed to return|1
6066742|NCT00475033|20958593|P1|After the Infant Series|Failed to return|2
6066743|NCT00475033|20958592|P2|After the Infant Series|Parent or legal guardian request|2
6066744|NCT00475033|20958593|P1|After the Infant Series|Parent or legal guardian request|2
6066745|NCT00475033|20958592|P2|After the Infant Series|Adverse Event|4
6066746|NCT00475033|20958593|P1|After the Infant Series|Adverse Event|0
6066747|NCT00475033|20958592|P2|Infant Series|Adverse Event|2
6066748|NCT00475033|20958593|P1|Infant Series|Adverse Event|0
6066749|NCT00475033|20958592|P2|Infant Series|Lost to Follow-up|0
6066750|NCT00475033|20958593|P1|Infant Series|Lost to Follow-up|2
6066751|NCT00475033|20958592|P2|Infant Series|Protocol Violation|2
6066752|NCT00475033|20958593|P1|Infant Series|Protocol Violation|1
6066753|NCT00475033|20958592|P2|Infant Series|Parent or legal guardian request|5
6066754|NCT00475033|20958593|P1|Infant Series|Parent or legal guardian request|1
6066755|NCT00475033|20958592|P2|Infant Series|Failed to return|4
6066756|NCT00475033|20958593|P1|Infant Series|Failed to return|3
6066757|NCT00475020|20958641|P1|Overall Study|Donor not able to donate the last minute|1
6066758|NCT00475020|20958641|P1|Overall Study|Insurance Denial|1
6066759|NCT00475020|20958641|P1|Overall Study|Physician Decision|3
6066760|NCT00474994|20958646|P1|Overall Study|Patient found to be ineligible|1
6066761|NCT00474994|20958646|P1|Overall Study|Patient evaluable for toxicity only|3
6066762|NCT00474994|20958646|P1|Overall Study|Patient Not treated|1
6066763|NCT00474968|20958652|P2|Overall Study|Sample not collected|1
6066764|NCT00474968|20958653|P1|Overall Study|Sample not collected|1
6066765|NCT00474968|20958652|P2|Overall Study|Protocol Violation|8
6066766|NCT00474968|20958653|P1|Overall Study|Protocol Violation|9
6066767|NCT00474968|20958652|P2|Overall Study|Withdrawal by Subject|7
6066768|NCT00474968|20958653|P1|Overall Study|Withdrawal by Subject|8
6066769|NCT00474955|20958663|P1|Overall Study|Personal reasons|5
6066770|NCT00474955|20958663|P1|Overall Study|Drug unavailability|1
6066771|NCT00474955|20958663|P1|Overall Study|Adverse Event|2
6066772|NCT00474929|20958679|P5|Overall Study|Physician Decision|0
6066773|NCT00474929|20958680|P4|Overall Study|Physician Decision|2
6066774|NCT00474929|20958681|P3|Overall Study|Physician Decision|1
6066775|NCT00474929|20958682|P2|Overall Study|Physician Decision|0
6066776|NCT00474929|20958683|P1|Overall Study|Physician Decision|0
6066777|NCT00474929|20958679|P5|Overall Study|Unrelated medical condition|0
6066778|NCT00474929|20958680|P4|Overall Study|Unrelated medical condition|0
6066779|NCT00474929|20958681|P3|Overall Study|Unrelated medical condition|1
6066780|NCT00474929|20958682|P2|Overall Study|Unrelated medical condition|0
6066781|NCT00474929|20958683|P1|Overall Study|Unrelated medical condition|0
6066782|NCT00474929|20958679|P5|Overall Study|Withdrawal by Subject|0
6066783|NCT00474929|20958680|P4|Overall Study|Withdrawal by Subject|0
6066784|NCT00474929|20958681|P3|Overall Study|Withdrawal by Subject|0
6066785|NCT00474929|20958682|P2|Overall Study|Withdrawal by Subject|1
6066786|NCT00474929|20958683|P1|Overall Study|Withdrawal by Subject|0
6066787|NCT00474903|20958700|P3|Overall Study|Protocol Violation|2
6066788|NCT00474903|20958701|P2|Overall Study|Protocol Violation|5
6066789|NCT00474903|20958702|P1|Overall Study|Protocol Violation|1
6066790|NCT00474812|20958724|P1|Overall Study|No Initiation of treatment|2
6066791|NCT00474812|20958724|P1|Overall Study|Withdrawal by Subject|5
6066792|NCT00474786|20958734|P2|Overall Study|Other|0
6066793|NCT00474786|20958735|P1|Overall Study|Other|5
6066794|NCT00474786|20958734|P2|Overall Study|Withdrawal by Subject|15
6066795|NCT00474786|20958735|P1|Overall Study|Withdrawal by Subject|15
6066796|NCT00474786|20958734|P2|Overall Study|Protocol Violation|0
6066797|NCT00474786|20958735|P1|Overall Study|Protocol Violation|2
6066798|NCT00474786|20958734|P2|Overall Study|Lost to Follow-up|7
6066799|NCT00474786|20958735|P1|Overall Study|Lost to Follow-up|4
6066800|NCT00474786|20958734|P2|Overall Study|Discontinuation of Study by Sponsor|59
6066801|NCT00474786|20958735|P1|Overall Study|Discontinuation of Study by Sponsor|42
6066802|NCT00474786|20958734|P2|Overall Study|Death|170
6066803|NCT00474786|20958735|P1|Overall Study|Death|189
6066804|NCT00474786|20958734|P2|Overall Study|Investigator Request|1
6066805|NCT00474786|20958735|P1|Overall Study|Investigator Request|2
6066806|NCT00474786|20958734|P2|Overall Study|Not Meeting Study Criteria|1
6066807|NCT00474786|20958735|P1|Overall Study|Not Meeting Study Criteria|0
6066808|NCT00474760|20958760|P7|Overall Study|Terminated by sponsor|2
6066809|NCT00474760|20958761|P6|Overall Study|Terminated by sponsor|0
6066810|NCT00474760|20958762|P5|Overall Study|Terminated by sponsor|0
6066811|NCT00474760|20958763|P4|Overall Study|Terminated by sponsor|0
6066812|NCT00474760|20958764|P3|Overall Study|Terminated by sponsor|0
6066813|NCT00474760|20958765|P2|Overall Study|Terminated by sponsor|0
6066814|NCT00474760|20958766|P1|Overall Study|Terminated by sponsor|0
6066815|NCT00474760|20958760|P7|Overall Study|Progressive disease|7
6066816|NCT00474760|20958761|P6|Overall Study|Progressive disease|20
6066817|NCT00474760|20958762|P5|Overall Study|Progressive disease|8
6066818|NCT00474760|20958763|P4|Overall Study|Progressive disease|2
6066819|NCT00474760|20958764|P3|Overall Study|Progressive disease|3
6066820|NCT00474760|20958765|P2|Overall Study|Progressive disease|2
6066821|NCT00474760|20958766|P1|Overall Study|Progressive disease|3
6066822|NCT00474760|20958760|P7|Overall Study|Other|0
6066823|NCT00474760|20958761|P6|Overall Study|Other|0
6066824|NCT00474760|20958762|P5|Overall Study|Other|1
6066825|NCT00474760|20958763|P4|Overall Study|Other|0
6066826|NCT00474760|20958764|P3|Overall Study|Other|0
6066827|NCT00474760|20958765|P2|Overall Study|Other|1
6066828|NCT00474760|20958766|P1|Overall Study|Other|0
6066829|NCT00474760|20958760|P7|Overall Study|Withdrawal by Subject|1
6066830|NCT00474760|20958761|P6|Overall Study|Withdrawal by Subject|1
6066831|NCT00474760|20958762|P5|Overall Study|Withdrawal by Subject|0
6066832|NCT00474760|20958763|P4|Overall Study|Withdrawal by Subject|1
6066833|NCT00474760|20958764|P3|Overall Study|Withdrawal by Subject|0
6066834|NCT00474760|20958765|P2|Overall Study|Withdrawal by Subject|0
6066835|NCT00474760|20958766|P1|Overall Study|Withdrawal by Subject|0
6066836|NCT00474760|20958760|P7|Overall Study|Laboratory abnormality|0
6066837|NCT00474760|20958761|P6|Overall Study|Laboratory abnormality|1
6066838|NCT00474760|20958762|P5|Overall Study|Laboratory abnormality|0
6066839|NCT00474760|20958763|P4|Overall Study|Laboratory abnormality|0
6066840|NCT00474760|20958764|P3|Overall Study|Laboratory abnormality|0
6066841|NCT00474760|20958765|P2|Overall Study|Laboratory abnormality|0
6066842|NCT00474760|20958766|P1|Overall Study|Laboratory abnormality|0
6066843|NCT00474760|20958760|P7|Overall Study|Adverse Event|0
6066844|NCT00474760|20958761|P6|Overall Study|Adverse Event|7
6066845|NCT00474760|20958762|P5|Overall Study|Adverse Event|1
6066846|NCT00474760|20958763|P4|Overall Study|Adverse Event|0
6066847|NCT00474760|20958764|P3|Overall Study|Adverse Event|0
6066848|NCT00474760|20958765|P2|Overall Study|Adverse Event|0
6066849|NCT00474760|20958766|P1|Overall Study|Adverse Event|0
6066850|NCT00474760|20958760|P7|Overall Study|Death|0
6066851|NCT00474760|20958761|P6|Overall Study|Death|0
6066852|NCT00474760|20958762|P5|Overall Study|Death|2
6066853|NCT00474760|20958763|P4|Overall Study|Death|0
6066854|NCT00474760|20958764|P3|Overall Study|Death|0
6066855|NCT00474760|20958765|P2|Overall Study|Death|0
6066856|NCT00474760|20958766|P1|Overall Study|Death|0
6066857|NCT00474708|20958873|P2|Overall Study|Physician Decision|6
6066858|NCT00474708|20958874|P1|Overall Study|Physician Decision|9
6066859|NCT00474708|20958873|P2|Overall Study|Lost to Follow-up|9
6066860|NCT00474708|20958874|P1|Overall Study|Lost to Follow-up|18
6066861|NCT00474708|20958873|P2|Overall Study|Lack of compliance|4
6066862|NCT00474708|20958874|P1|Overall Study|Lack of compliance|12
6066863|NCT00474708|20958873|P2|Overall Study|Withdrawal by Subject|0
6066864|NCT00474708|20958874|P1|Overall Study|Withdrawal by Subject|7
6066865|NCT00474708|20958873|P2|Overall Study|Suicide ideation/behavior|1
6066866|NCT00474708|20958874|P1|Overall Study|Suicide ideation/behavior|0
6066867|NCT00474708|20958873|P2|Overall Study|Lack of Efficacy|5
6066868|NCT00474708|20958874|P1|Overall Study|Lack of Efficacy|11
6066869|NCT00474630|20958884|P2|Overall Study|Drug noncompliance, other|4
6066870|NCT00474630|20958885|P1|Overall Study|Drug noncompliance, other|11
6066871|NCT00474630|20958884|P2|Overall Study|Lack of Efficacy|6
6066872|NCT00474630|20958885|P1|Overall Study|Lack of Efficacy|5
6066873|NCT00474630|20958884|P2|Overall Study|Protocol Violation|4
6066874|NCT00474630|20958885|P1|Overall Study|Protocol Violation|3
6066875|NCT00474630|20958884|P2|Overall Study|Withdrawal by Subject|15
6066876|NCT00474630|20958885|P1|Overall Study|Withdrawal by Subject|21
6066877|NCT00474630|20958884|P2|Overall Study|Lost to Follow-up|15
6066878|NCT00474630|20958885|P1|Overall Study|Lost to Follow-up|22
6066879|NCT00474630|20958884|P2|Overall Study|Adverse Event|26
6066880|NCT00474630|20958885|P1|Overall Study|Adverse Event|98
6066881|NCT00474539|20958978|P2|Toddler Dose|Protocol Violation|0
6066882|NCT00474539|20958979|P1|Toddler Dose|Protocol Violation|1
6066883|NCT00474539|20958978|P2|After Infant Series|Withdrawal by Subject|0
6066884|NCT00474539|20958979|P1|After Infant Series|Withdrawal by Subject|1
6066885|NCT00474539|20958978|P2|After Infant Series|Lost to Follow-up|0
6066886|NCT00474539|20958979|P1|After Infant Series|Lost to Follow-up|3
6066887|NCT00474539|20958978|P2|Infant Series|Protocol Violation|1
6066888|NCT00474539|20958979|P1|Infant Series|Protocol Violation|0
6066889|NCT00474539|20958978|P2|Infant Series|Lost to Follow-up|1
6066890|NCT00474539|20958979|P1|Infant Series|Lost to Follow-up|2
6066891|NCT00474539|20958978|P2|Infant Series|Randomization error|0
6066892|NCT00474539|20958979|P1|Infant Series|Randomization error|5
6066893|NCT00474539|20958978|P2|Infant Series|Withdrawal by Subject|4
6066894|NCT00474539|20958979|P1|Infant Series|Withdrawal by Subject|3
6066895|NCT00474526|20959044|P17|Overall Study|Withdrawal by Subject|1
6066896|NCT00474526|20959045|P16|Overall Study|Withdrawal by Subject|1
6066897|NCT00474526|20959046|P15|Overall Study|Withdrawal by Subject|22
6066898|NCT00474526|20959047|P14|Overall Study|Withdrawal by Subject|37
6066899|NCT00474526|20959048|P13|Overall Study|Withdrawal by Subject|4
6066900|NCT00474526|20959049|P12|Overall Study|Withdrawal by Subject|4
6066901|NCT00474526|20959050|P11|Overall Study|Withdrawal by Subject|5
6066902|NCT00474526|20959051|P10|Overall Study|Withdrawal by Subject|13
6066903|NCT00474526|20959052|P9|Overall Study|Withdrawal by Subject|4
6066904|NCT00474526|20959053|P8|Overall Study|Withdrawal by Subject|4
6066905|NCT00474526|20959054|P7|Overall Study|Withdrawal by Subject|12
6066906|NCT00474526|20959055|P6|Overall Study|Withdrawal by Subject|6
6066907|NCT00474526|20959056|P5|Overall Study|Withdrawal by Subject|38
6066908|NCT00474526|20959057|P4|Overall Study|Withdrawal by Subject|52
6066909|NCT00474526|20959058|P3|Overall Study|Withdrawal by Subject|21
6066910|NCT00474526|20959059|P2|Overall Study|Withdrawal by Subject|24
6066911|NCT00474526|20959060|P1|Overall Study|Withdrawal by Subject|9
6066912|NCT00474526|20959044|P17|Overall Study|UNABLE TO CLASSIFY|1
6066913|NCT00474526|20959045|P16|Overall Study|UNABLE TO CLASSIFY|6
6066914|NCT00474526|20959046|P15|Overall Study|UNABLE TO CLASSIFY|12
6066915|NCT00474526|20959047|P14|Overall Study|UNABLE TO CLASSIFY|20
6066916|NCT00474526|20959048|P13|Overall Study|UNABLE TO CLASSIFY|0
6066917|NCT00474526|20959049|P12|Overall Study|UNABLE TO CLASSIFY|0
6066918|NCT00474526|20959050|P11|Overall Study|UNABLE TO CLASSIFY|0
6066919|NCT00474526|20959051|P10|Overall Study|UNABLE TO CLASSIFY|3
6066920|NCT00474526|20959052|P9|Overall Study|UNABLE TO CLASSIFY|0
6066921|NCT00474526|20959053|P8|Overall Study|UNABLE TO CLASSIFY|1
6066922|NCT00474526|20959054|P7|Overall Study|UNABLE TO CLASSIFY|0
6066923|NCT00474526|20959055|P6|Overall Study|UNABLE TO CLASSIFY|2
6066924|NCT00474526|20959056|P5|Overall Study|UNABLE TO CLASSIFY|3
6066925|NCT00474526|20959057|P4|Overall Study|UNABLE TO CLASSIFY|1
6066926|NCT00474526|20959058|P3|Overall Study|UNABLE TO CLASSIFY|0
6066927|NCT00474526|20959059|P2|Overall Study|UNABLE TO CLASSIFY|0
6066928|NCT00474526|20959060|P1|Overall Study|UNABLE TO CLASSIFY|1
6066929|NCT00474526|20959044|P17|Overall Study|Protocol Violation|2
6066930|NCT00474526|20959045|P16|Overall Study|Protocol Violation|6
6066931|NCT00474526|20959046|P15|Overall Study|Protocol Violation|9
6066932|NCT00474526|20959047|P14|Overall Study|Protocol Violation|19
6066933|NCT00474526|20959048|P13|Overall Study|Protocol Violation|4
6066934|NCT00474526|20959049|P12|Overall Study|Protocol Violation|2
6066935|NCT00474526|20959050|P11|Overall Study|Protocol Violation|2
6066936|NCT00474526|20959051|P10|Overall Study|Protocol Violation|4
6066937|NCT00474526|20959052|P9|Overall Study|Protocol Violation|0
6066938|NCT00474526|20959053|P8|Overall Study|Protocol Violation|0
6066939|NCT00474526|20959054|P7|Overall Study|Protocol Violation|3
6066940|NCT00474526|20959055|P6|Overall Study|Protocol Violation|1
6066941|NCT00474526|20959056|P5|Overall Study|Protocol Violation|3
6066942|NCT00474526|20959057|P4|Overall Study|Protocol Violation|12
6066943|NCT00474526|20959058|P3|Overall Study|Protocol Violation|4
6066944|NCT00474526|20959059|P2|Overall Study|Protocol Violation|6
6066945|NCT00474526|20959060|P1|Overall Study|Protocol Violation|2
6066946|NCT00474526|20959044|P17|Overall Study|Lost to Follow-up|5
6066947|NCT00474526|20959045|P16|Overall Study|Lost to Follow-up|4
6066948|NCT00474526|20959046|P15|Overall Study|Lost to Follow-up|29
6066949|NCT00474526|20959047|P14|Overall Study|Lost to Follow-up|74
6066950|NCT00474526|20959048|P13|Overall Study|Lost to Follow-up|6
6066951|NCT00474526|20959049|P12|Overall Study|Lost to Follow-up|4
6066952|NCT00474526|20959050|P11|Overall Study|Lost to Follow-up|2
6066953|NCT00474526|20959051|P10|Overall Study|Lost to Follow-up|6
6066954|NCT00474526|20959052|P9|Overall Study|Lost to Follow-up|0
6066955|NCT00474526|20959053|P8|Overall Study|Lost to Follow-up|1
6066956|NCT00474526|20959054|P7|Overall Study|Lost to Follow-up|8
6066957|NCT00474526|20959055|P6|Overall Study|Lost to Follow-up|5
6066958|NCT00474526|20959056|P5|Overall Study|Lost to Follow-up|11
6066959|NCT00474526|20959057|P4|Overall Study|Lost to Follow-up|29
6066960|NCT00474526|20959058|P3|Overall Study|Lost to Follow-up|13
6066961|NCT00474526|20959059|P2|Overall Study|Lost to Follow-up|6
6066962|NCT00474526|20959060|P1|Overall Study|Lost to Follow-up|8
6066963|NCT00474526|20959044|P17|Overall Study|INAPPROPRIATE ENROLLMENT|0
6066964|NCT00474526|20959045|P16|Overall Study|INAPPROPRIATE ENROLLMENT|0
6066965|NCT00474526|20959046|P15|Overall Study|INAPPROPRIATE ENROLLMENT|2
6066966|NCT00474526|20959047|P14|Overall Study|INAPPROPRIATE ENROLLMENT|2
6066967|NCT00474526|20959048|P13|Overall Study|INAPPROPRIATE ENROLLMENT|0
6066968|NCT00474526|20959049|P12|Overall Study|INAPPROPRIATE ENROLLMENT|0
6066969|NCT00474526|20959050|P11|Overall Study|INAPPROPRIATE ENROLLMENT|0
6066970|NCT00474526|20959051|P10|Overall Study|INAPPROPRIATE ENROLLMENT|0
6066971|NCT00474526|20959052|P9|Overall Study|INAPPROPRIATE ENROLLMENT|0
6066972|NCT00474526|20959053|P8|Overall Study|INAPPROPRIATE ENROLLMENT|0
6066973|NCT00474526|20959054|P7|Overall Study|INAPPROPRIATE ENROLLMENT|0
6066974|NCT00474526|20959055|P6|Overall Study|INAPPROPRIATE ENROLLMENT|0
6066975|NCT00474526|20959056|P5|Overall Study|INAPPROPRIATE ENROLLMENT|2
6066976|NCT00474526|20959057|P4|Overall Study|INAPPROPRIATE ENROLLMENT|1
6066977|NCT00474526|20959058|P3|Overall Study|INAPPROPRIATE ENROLLMENT|0
6066978|NCT00474526|20959059|P2|Overall Study|INAPPROPRIATE ENROLLMENT|1
6066979|NCT00474526|20959060|P1|Overall Study|INAPPROPRIATE ENROLLMENT|0
6066980|NCT00474526|20959044|P17|Overall Study|Death|0
6066981|NCT00474526|20959045|P16|Overall Study|Death|0
6066982|NCT00474526|20959046|P15|Overall Study|Death|0
6066983|NCT00474526|20959047|P14|Overall Study|Death|3
6066984|NCT00474526|20959048|P13|Overall Study|Death|0
6066985|NCT00474526|20959049|P12|Overall Study|Death|0
6066986|NCT00474526|20959050|P11|Overall Study|Death|0
6066987|NCT00474526|20959051|P10|Overall Study|Death|0
6066988|NCT00474526|20959052|P9|Overall Study|Death|0
6066989|NCT00474526|20959053|P8|Overall Study|Death|0
6066990|NCT00474526|20959054|P7|Overall Study|Death|0
6066991|NCT00474526|20959055|P6|Overall Study|Death|0
6066992|NCT00474526|20959056|P5|Overall Study|Death|0
6066993|NCT00474526|20959057|P4|Overall Study|Death|0
6066994|NCT00474526|20959058|P3|Overall Study|Death|0
6066995|NCT00474526|20959059|P2|Overall Study|Death|0
6066996|NCT00474526|20959060|P1|Overall Study|Death|0
6066997|NCT00474526|20959044|P17|Overall Study|Adverse Event|0
6066998|NCT00474526|20959045|P16|Overall Study|Adverse Event|1
6066999|NCT00474526|20959046|P15|Overall Study|Adverse Event|1
6067000|NCT00474526|20959047|P14|Overall Study|Adverse Event|0
6067001|NCT00474526|20959048|P13|Overall Study|Adverse Event|0
6067002|NCT00474526|20959049|P12|Overall Study|Adverse Event|0
6067003|NCT00474526|20959050|P11|Overall Study|Adverse Event|0
6067004|NCT00474526|20959051|P10|Overall Study|Adverse Event|0
6067005|NCT00474526|20959052|P9|Overall Study|Adverse Event|0
6067006|NCT00474526|20959053|P8|Overall Study|Adverse Event|0
6067007|NCT00474526|20959054|P7|Overall Study|Adverse Event|1
6067008|NCT00474526|20959055|P6|Overall Study|Adverse Event|1
6067009|NCT00474526|20959056|P5|Overall Study|Adverse Event|2
6067010|NCT00474526|20959057|P4|Overall Study|Adverse Event|4
6067011|NCT00474526|20959058|P3|Overall Study|Adverse Event|2
6067012|NCT00474526|20959059|P2|Overall Study|Adverse Event|0
6067013|NCT00474526|20959060|P1|Overall Study|Adverse Event|2
6067014|NCT00474526|20959044|P17|Overall Study|ADMINISTRATIVE REASON|0
6067015|NCT00474526|20959045|P16|Overall Study|ADMINISTRATIVE REASON|0
6067016|NCT00474526|20959046|P15|Overall Study|ADMINISTRATIVE REASON|2
6067017|NCT00474526|20959047|P14|Overall Study|ADMINISTRATIVE REASON|1
6067018|NCT00474526|20959048|P13|Overall Study|ADMINISTRATIVE REASON|1
6067019|NCT00474526|20959049|P12|Overall Study|ADMINISTRATIVE REASON|1
6067020|NCT00474526|20959050|P11|Overall Study|ADMINISTRATIVE REASON|1
6067021|NCT00474526|20959051|P10|Overall Study|ADMINISTRATIVE REASON|1
6067022|NCT00474526|20959052|P9|Overall Study|ADMINISTRATIVE REASON|2
6067023|NCT00474526|20959053|P8|Overall Study|ADMINISTRATIVE REASON|0
6067024|NCT00474526|20959054|P7|Overall Study|ADMINISTRATIVE REASON|1
6067025|NCT00474526|20959055|P6|Overall Study|ADMINISTRATIVE REASON|1
6067026|NCT00474526|20959056|P5|Overall Study|ADMINISTRATIVE REASON|9
6067027|NCT00474526|20959057|P4|Overall Study|ADMINISTRATIVE REASON|20
6067028|NCT00474526|20959058|P3|Overall Study|ADMINISTRATIVE REASON|9
6067029|NCT00474526|20959059|P2|Overall Study|ADMINISTRATIVE REASON|9
6067030|NCT00474526|20959060|P1|Overall Study|ADMINISTRATIVE REASON|11
6067031|NCT00474487|20959225|P4|Overall Study|Death|0
6067032|NCT00474487|20959226|P3|Overall Study|Death|0
6067033|NCT00474487|20959227|P2|Overall Study|Death|1
6067034|NCT00474487|20959228|P1|Overall Study|Death|0
6067035|NCT00474487|20959225|P4|Overall Study|Inappropriate enrollment|0
6067036|NCT00474487|20959226|P3|Overall Study|Inappropriate enrollment|7
6067037|NCT00474487|20959227|P2|Overall Study|Inappropriate enrollment|0
6067038|NCT00474487|20959228|P1|Overall Study|Inappropriate enrollment|4
6067039|NCT00474487|20959225|P4|Overall Study|Lost to Follow-up|0
6067040|NCT00474487|20959226|P3|Overall Study|Lost to Follow-up|7
6067041|NCT00474487|20959227|P2|Overall Study|Lost to Follow-up|1
6067042|NCT00474487|20959228|P1|Overall Study|Lost to Follow-up|20
6067043|NCT00474487|20959225|P4|Overall Study|Withdrawal by Subject|0
6067044|NCT00474487|20959226|P3|Overall Study|Withdrawal by Subject|0
6067045|NCT00474487|20959227|P2|Overall Study|Withdrawal by Subject|0
6067046|NCT00474487|20959228|P1|Overall Study|Withdrawal by Subject|6
6067047|NCT00474383|20959248|P2|Extension|Progressive Disease|5
6067048|NCT00474383|20959249|P1|Extension|Progressive Disease|0
6067049|NCT00474383|20959248|P2|Between Main Study and Extension|Did Not Enter Extension Phase|0
6067050|NCT00474383|20959249|P1|Between Main Study and Extension|Did Not Enter Extension Phase|6
6067051|NCT00474383|20959248|P2|Main Study|Other|0
6067052|NCT00474383|20959249|P1|Main Study|Other|1
6067053|NCT00474383|20959248|P2|Main Study|Progressive Disease|0
6067054|NCT00474383|20959249|P1|Main Study|Progressive Disease|23
6067055|NCT00474383|20959248|P2|Main Study|Symptomatic Deterioration|0
6067056|NCT00474383|20959249|P1|Main Study|Symptomatic Deterioration|1
6067057|NCT00474383|20959248|P2|Main Study|Adverse Event|0
6067058|NCT00474383|20959249|P1|Main Study|Adverse Event|11
6067059|NCT00474266|20959264|P4|Overall Study|Withdrawal by Subject|7
6067060|NCT00474266|20959265|P3|Overall Study|Withdrawal by Subject|4
6067061|NCT00474266|20959266|P2|Overall Study|Withdrawal by Subject|20
6067062|NCT00474266|20959267|P1|Overall Study|Withdrawal by Subject|7
6067063|NCT00474253|20959371|P2|Overall Study|Discharged prior to study completion|1
6067064|NCT00474253|20959372|P1|Overall Study|Discharged prior to study completion|0
6067065|NCT00474253|20959371|P2|Overall Study|Lost to Follow-up|0
6067066|NCT00474253|20959372|P1|Overall Study|Lost to Follow-up|1
6067067|NCT00474253|20959371|P2|Overall Study|Withdrew due to surgery-related issues|3
6067068|NCT00474253|20959372|P1|Overall Study|Withdrew due to surgery-related issues|0
6067069|NCT00474253|20959371|P2|Overall Study|Withdrew consent|0
6067070|NCT00474253|20959372|P1|Overall Study|Withdrew consent|2
6067071|NCT00474240|20959396|P6|Overall Study|Removed due to lab value|1
6067072|NCT00474240|20959397|P5|Overall Study|Removed due to lab value|0
6067073|NCT00474240|20959398|P4|Overall Study|Removed due to lab value|0
6067074|NCT00474240|20959399|P3|Overall Study|Removed due to lab value|0
6067075|NCT00474240|20959400|P2|Overall Study|Removed due to lab value|0
6067076|NCT00474240|20959401|P1|Overall Study|Removed due to lab value|0
6067077|NCT00474240|20959396|P6|Overall Study|Adverse Event|16
6067078|NCT00474240|20959397|P5|Overall Study|Adverse Event|5
6067079|NCT00474240|20959398|P4|Overall Study|Adverse Event|14
6067080|NCT00474240|20959399|P3|Overall Study|Adverse Event|9
6067081|NCT00474240|20959400|P2|Overall Study|Adverse Event|0
6067082|NCT00474240|20959401|P1|Overall Study|Adverse Event|0
6067083|NCT00474240|20959396|P6|Overall Study|Withdrawal by Subject|1
6067084|NCT00474240|20959397|P5|Overall Study|Withdrawal by Subject|3
6067085|NCT00474240|20959398|P4|Overall Study|Withdrawal by Subject|2
6067086|NCT00474240|20959399|P3|Overall Study|Withdrawal by Subject|0
6067087|NCT00474240|20959400|P2|Overall Study|Withdrawal by Subject|1
6067088|NCT00474240|20959401|P1|Overall Study|Withdrawal by Subject|1
6067089|NCT00474188|20959426|P1|Overall Study|Study discontinued by sponsor|5
6067090|NCT00474188|20959426|P1|Overall Study|Withdrawal by Subject|1
6067091|NCT00474175|20959436|P3|Overall Study|Administrative|0
6067092|NCT00474175|20959437|P2|Overall Study|Administrative|1
6067093|NCT00474175|20959438|P1|Overall Study|Administrative|0
6067094|NCT00474175|20959436|P3|Overall Study|Protocol Violation|1
6067095|NCT00474175|20959437|P2|Overall Study|Protocol Violation|2
6067096|NCT00474175|20959438|P1|Overall Study|Protocol Violation|0
6067097|NCT00474175|20959436|P3|Overall Study|Ineligible|1
6067098|NCT00474175|20959437|P2|Overall Study|Ineligible|3
6067099|NCT00474175|20959438|P1|Overall Study|Ineligible|1
6067100|NCT00474175|20959436|P3|Overall Study|Withdrawal by Subject|1
6067101|NCT00474175|20959437|P2|Overall Study|Withdrawal by Subject|1
6067102|NCT00474175|20959438|P1|Overall Study|Withdrawal by Subject|0
6067103|NCT00474175|20959436|P3|Overall Study|Lack of Efficacy|1
6067104|NCT00474175|20959437|P2|Overall Study|Lack of Efficacy|0
6067105|NCT00474175|20959438|P1|Overall Study|Lack of Efficacy|0
6067106|NCT00474058|20959502|P2|Overall Study|Other|0
6067107|NCT00474058|20959503|P1|Overall Study|Other|2
6067108|NCT00474058|20959502|P2|Overall Study|Withdrawal by Subject|7
6067109|NCT00474058|20959503|P1|Overall Study|Withdrawal by Subject|11
6067110|NCT00474058|20959502|P2|Overall Study|Lack of Efficacy|4
6067111|NCT00474058|20959503|P1|Overall Study|Lack of Efficacy|0
6067112|NCT00474058|20959502|P2|Overall Study|Adverse Event|6
6067113|NCT00474058|20959503|P1|Overall Study|Adverse Event|11
6067114|NCT00474045|20959517|P2|Overall Study|Withdrawal criteria|50
6067115|NCT00474045|20959518|P1|Overall Study|Withdrawal criteria|60
6067116|NCT00474045|20959517|P2|Overall Study|Withdrawal by Subject|18
6067117|NCT00474045|20959518|P1|Overall Study|Withdrawal by Subject|16
6067118|NCT00474045|20959517|P2|Overall Study|Protocol Violation|12
6067119|NCT00474045|20959518|P1|Overall Study|Protocol Violation|10
6067120|NCT00474045|20959517|P2|Overall Study|Lost to Follow-up|1
6067121|NCT00474045|20959518|P1|Overall Study|Lost to Follow-up|1
6067122|NCT00474045|20959517|P2|Overall Study|Lack of Efficacy|9
6067123|NCT00474045|20959518|P1|Overall Study|Lack of Efficacy|0
6067124|NCT00474045|20959517|P2|Overall Study|Unclassified|3
6067125|NCT00474045|20959518|P1|Overall Study|Unclassified|1
6067126|NCT00474045|20959517|P2|Overall Study|Adverse Event|8
6067127|NCT00474045|20959518|P1|Overall Study|Adverse Event|18
6067128|NCT00473889|20959618|P2|Overall Study|Withdrawal by Subject|0
6067129|NCT00473889|20959619|P1|Overall Study|Withdrawal by Subject|5
6067130|NCT00473889|20959618|P2|Overall Study|Trial Terminated|6
6067131|NCT00473889|20959619|P1|Overall Study|Trial Terminated|3
6067132|NCT00473889|20959618|P2|Overall Study|Physician Decision|5
6067133|NCT00473889|20959619|P1|Overall Study|Physician Decision|10
6067134|NCT00473889|20959618|P2|Overall Study|Lost to Follow-up|1
6067135|NCT00473889|20959619|P1|Overall Study|Lost to Follow-up|2
6067136|NCT00473889|20959618|P2|Overall Study|Lack of Efficacy|29
6067137|NCT00473889|20959619|P1|Overall Study|Lack of Efficacy|28
6067138|NCT00473889|20959618|P2|Overall Study|Protocol Violation|2
6067139|NCT00473889|20959619|P1|Overall Study|Protocol Violation|4
6067140|NCT00473889|20959618|P2|Overall Study|Adverse Event|17
6067141|NCT00473889|20959619|P1|Overall Study|Adverse Event|30
6067142|NCT00473889|20959618|P2|Overall Study|Did not receive study medication|4
6067143|NCT00473889|20959619|P1|Overall Study|Did not receive study medication|1
6067144|NCT00473876|20959631|P2|Overall Study|Lost to Follow-up|1
6067145|NCT00473876|20959632|P1|Overall Study|Lost to Follow-up|3
6067146|NCT00473824|20959651|P2|Overall Study|Withdrawal by physician|0
6067147|NCT00473824|20959652|P1|Overall Study|Withdrawal by physician|1
6067148|NCT00473824|20959651|P2|Overall Study|Lost to Follow-up|0
6067149|NCT00473824|20959652|P1|Overall Study|Lost to Follow-up|1
6067150|NCT00473824|20959651|P2|Overall Study|Death|0
6067151|NCT00473824|20959652|P1|Overall Study|Death|1
6067152|NCT00473824|20959651|P2|Overall Study|Adverse Event|0
6067153|NCT00473824|20959652|P1|Overall Study|Adverse Event|1
6067154|NCT00473824|20959651|P2|Overall Study|Virologic Breakthrough|0
6067155|NCT00473824|20959652|P1|Overall Study|Virologic Breakthrough|1
6067156|NCT00473746|20959663|P5|Period 2 (Phase 2)|Reason not specified|3
6067157|NCT00473746|20959664|P4|Period 2 (Phase 2)|Reason not specified|0
6067158|NCT00473746|20959665|P3|Period 2 (Phase 2)|Reason not specified|0
6067159|NCT00473746|20959666|P2|Period 2 (Phase 2)|Reason not specified|0
6067160|NCT00473746|20959667|P1|Period 2 (Phase 2)|Reason not specified|0
6067161|NCT00473746|20959663|P5|Period 2 (Phase 2)|Progressive Disease|20
6067162|NCT00473746|20959664|P4|Period 2 (Phase 2)|Progressive Disease|0
6067163|NCT00473746|20959665|P3|Period 2 (Phase 2)|Progressive Disease|0
6067164|NCT00473746|20959666|P2|Period 2 (Phase 2)|Progressive Disease|0
6067165|NCT00473746|20959667|P1|Period 2 (Phase 2)|Progressive Disease|0
6067166|NCT00473746|20959663|P5|Period 2 (Phase 2)|Death|1
6067167|NCT00473746|20959664|P4|Period 2 (Phase 2)|Death|0
6067168|NCT00473746|20959665|P3|Period 2 (Phase 2)|Death|0
6067169|NCT00473746|20959666|P2|Period 2 (Phase 2)|Death|0
6067170|NCT00473746|20959667|P1|Period 2 (Phase 2)|Death|0
6067171|NCT00473746|20959663|P5|Period 2 (Phase 2)|Adverse Event|3
6067172|NCT00473746|20959664|P4|Period 2 (Phase 2)|Adverse Event|0
6067173|NCT00473746|20959665|P3|Period 2 (Phase 2)|Adverse Event|0
6067174|NCT00473746|20959666|P2|Period 2 (Phase 2)|Adverse Event|0
6067175|NCT00473746|20959667|P1|Period 2 (Phase 2)|Adverse Event|0
6067176|NCT00473746|20959663|P5|Period 1 (Phase 1)|Reason not specified|0
6067177|NCT00473746|20959664|P4|Period 1 (Phase 1)|Reason not specified|0
6067178|NCT00473746|20959665|P3|Period 1 (Phase 1)|Reason not specified|0
6067179|NCT00473746|20959666|P2|Period 1 (Phase 1)|Reason not specified|1
6067180|NCT00473746|20959667|P1|Period 1 (Phase 1)|Reason not specified|0
6067181|NCT00473746|20959663|P5|Period 1 (Phase 1)|Symptomatic Deterioration|0
6067182|NCT00473746|20959664|P4|Period 1 (Phase 1)|Symptomatic Deterioration|0
6067183|NCT00473746|20959665|P3|Period 1 (Phase 1)|Symptomatic Deterioration|0
6067184|NCT00473746|20959666|P2|Period 1 (Phase 1)|Symptomatic Deterioration|1
6067185|NCT00473746|20959667|P1|Period 1 (Phase 1)|Symptomatic Deterioration|0
6067186|NCT00473746|20959663|P5|Period 1 (Phase 1)|Progressive Disease|0
6067187|NCT00473746|20959664|P4|Period 1 (Phase 1)|Progressive Disease|10
6067188|NCT00473746|20959665|P3|Period 1 (Phase 1)|Progressive Disease|6
6067189|NCT00473746|20959666|P2|Period 1 (Phase 1)|Progressive Disease|6
6067190|NCT00473746|20959667|P1|Period 1 (Phase 1)|Progressive Disease|5
6067191|NCT00473746|20959663|P5|Period 1 (Phase 1)|Withdrawal by Subject|0
6067192|NCT00473746|20959664|P4|Period 1 (Phase 1)|Withdrawal by Subject|0
6067193|NCT00473746|20959665|P3|Period 1 (Phase 1)|Withdrawal by Subject|0
6067194|NCT00473746|20959666|P2|Period 1 (Phase 1)|Withdrawal by Subject|1
6067195|NCT00473746|20959667|P1|Period 1 (Phase 1)|Withdrawal by Subject|0
6067196|NCT00473746|20959663|P5|Period 1 (Phase 1)|Adverse Event|0
6067197|NCT00473746|20959664|P4|Period 1 (Phase 1)|Adverse Event|0
6067198|NCT00473746|20959665|P3|Period 1 (Phase 1)|Adverse Event|0
6067199|NCT00473746|20959666|P2|Period 1 (Phase 1)|Adverse Event|0
6067200|NCT00473746|20959667|P1|Period 1 (Phase 1)|Adverse Event|1
6067201|NCT00473694|20959716|P4|Overall Study|Lost to Follow-up|1
6067202|NCT00473694|20959717|P3|Overall Study|Lost to Follow-up|0
6067203|NCT00473694|20959718|P2|Overall Study|Lost to Follow-up|0
6067204|NCT00473694|20959719|P1|Overall Study|Lost to Follow-up|0
6067205|NCT00473694|20959716|P4|Overall Study|Participants did not receive treatment|6
6067206|NCT00473694|20959717|P3|Overall Study|Participants did not receive treatment|5
6067207|NCT00473694|20959718|P2|Overall Study|Participants did not receive treatment|3
6067208|NCT00473694|20959719|P1|Overall Study|Participants did not receive treatment|11
6067209|NCT00473694|20959716|P4|Overall Study|Adverse Event|0
6067210|NCT00473694|20959717|P3|Overall Study|Adverse Event|0
6067211|NCT00473694|20959718|P2|Overall Study|Adverse Event|1
6067212|NCT00473694|20959719|P1|Overall Study|Adverse Event|0
6067213|NCT00473668|20959760|P3|Overall Study|Other|4
6067214|NCT00473668|20959761|P2|Overall Study|Other|3
6067215|NCT00473668|20959762|P1|Overall Study|Other|2
6067216|NCT00473668|20959760|P3|Overall Study|Lost to Follow-up|6
6067217|NCT00473668|20959761|P2|Overall Study|Lost to Follow-up|4
6067218|NCT00473668|20959762|P1|Overall Study|Lost to Follow-up|0
6067219|NCT00473668|20959760|P3|Overall Study|Migrated/moved from study area|0
6067220|NCT00473668|20959761|P2|Overall Study|Migrated/moved from study area|2
6067221|NCT00473668|20959762|P1|Overall Study|Migrated/moved from study area|3
6067222|NCT00473668|20959760|P3|Overall Study|Withdrawal by Subject|0
6067223|NCT00473668|20959761|P2|Overall Study|Withdrawal by Subject|2
6067224|NCT00473668|20959762|P1|Overall Study|Withdrawal by Subject|0
6067225|NCT00473655|20959815|P3|Overall Study|Lost to Follow-up|8
6067226|NCT00473655|20959816|P2|Overall Study|Lost to Follow-up|5
6067227|NCT00473655|20959817|P1|Overall Study|Lost to Follow-up|9
6067228|NCT00473590|20959878|P2|Overall Study|Other|1
6067229|NCT00473590|20959879|P1|Overall Study|Other|0
6067230|NCT00473590|20959878|P2|Overall Study|Withdrawal by Subject|3
6067231|NCT00473590|20959879|P1|Overall Study|Withdrawal by Subject|5
6067232|NCT00473590|20959878|P2|Overall Study|Physician Decision|4
6067233|NCT00473590|20959879|P1|Overall Study|Physician Decision|2
6067234|NCT00473590|20959878|P2|Overall Study|Non-protocol-specified therapy|5
6067235|NCT00473590|20959879|P1|Overall Study|Non-protocol-specified therapy|7
6067236|NCT00473590|20959878|P2|Overall Study|Progression not resulting in death|20
6067237|NCT00473590|20959879|P1|Overall Study|Progression not resulting in death|24
6067238|NCT00473590|20959878|P2|Overall Study|Death|2
6067239|NCT00473590|20959879|P1|Overall Study|Death|4
6067240|NCT00473590|20959878|P2|Overall Study|Adverse Event|3
6067241|NCT00473590|20959879|P1|Overall Study|Adverse Event|3
6067242|NCT00473564|20959895|P1|Overall Study|robot surgery aborted in OR|23
6067243|NCT00473512|20959905|P5|Period 2 (Phase 2)|Other|0
6067244|NCT00473512|20959906|P4|Period 2 (Phase 2)|Other|3
6067245|NCT00473512|20959907|P3|Period 2 (Phase 2)|Other|0
6067246|NCT00473512|20959908|P2|Period 2 (Phase 2)|Other|0
6067247|NCT00473512|20959909|P1|Period 2 (Phase 2)|Other|1
6067248|NCT00473512|20959905|P5|Period 2 (Phase 2)|Symptomatic Deterioration|0
6067249|NCT00473512|20959906|P4|Period 2 (Phase 2)|Symptomatic Deterioration|1
6067250|NCT00473512|20959907|P3|Period 2 (Phase 2)|Symptomatic Deterioration|0
6067251|NCT00473512|20959908|P2|Period 2 (Phase 2)|Symptomatic Deterioration|0
6067252|NCT00473512|20959909|P1|Period 2 (Phase 2)|Symptomatic Deterioration|0
6067253|NCT00473512|20959905|P5|Period 2 (Phase 2)|Disease Progression|1
6067254|NCT00473512|20959906|P4|Period 2 (Phase 2)|Disease Progression|17
6067255|NCT00473512|20959907|P3|Period 2 (Phase 2)|Disease Progression|2
6067256|NCT00473512|20959908|P2|Period 2 (Phase 2)|Disease Progression|2
6067257|NCT00473512|20959909|P1|Period 2 (Phase 2)|Disease Progression|0
6067258|NCT00473512|20959905|P5|Period 2 (Phase 2)|Death|1
6067259|NCT00473512|20959906|P4|Period 2 (Phase 2)|Death|1
6067260|NCT00473512|20959907|P3|Period 2 (Phase 2)|Death|0
6067261|NCT00473512|20959908|P2|Period 2 (Phase 2)|Death|0
6067262|NCT00473512|20959909|P1|Period 2 (Phase 2)|Death|0
6067263|NCT00473512|20959905|P5|Period 2 (Phase 2)|Adverse Event|0
6067264|NCT00473512|20959906|P4|Period 2 (Phase 2)|Adverse Event|1
6067265|NCT00473512|20959907|P3|Period 2 (Phase 2)|Adverse Event|0
6067266|NCT00473512|20959908|P2|Period 2 (Phase 2)|Adverse Event|0
6067267|NCT00473512|20959909|P1|Period 2 (Phase 2)|Adverse Event|0
6067268|NCT00473512|20959905|P5|Period 1 (Phase 1)|Other|0
6067269|NCT00473512|20959906|P4|Period 1 (Phase 1)|Other|1
6067270|NCT00473512|20959907|P3|Period 1 (Phase 1)|Other|0
6067271|NCT00473512|20959908|P2|Period 1 (Phase 1)|Other|0
6067272|NCT00473512|20959909|P1|Period 1 (Phase 1)|Other|0
6067273|NCT00473512|20959905|P5|Period 1 (Phase 1)|Disease Progression|1
6067274|NCT00473512|20959906|P4|Period 1 (Phase 1)|Disease Progression|10
6067275|NCT00473512|20959907|P3|Period 1 (Phase 1)|Disease Progression|0
6067276|NCT00473512|20959908|P2|Period 1 (Phase 1)|Disease Progression|1
6067277|NCT00473512|20959909|P1|Period 1 (Phase 1)|Disease Progression|1
6067278|NCT00473512|20959905|P5|Period 1 (Phase 1)|Death|0
6067279|NCT00473512|20959906|P4|Period 1 (Phase 1)|Death|1
6067280|NCT00473512|20959907|P3|Period 1 (Phase 1)|Death|0
6067281|NCT00473512|20959908|P2|Period 1 (Phase 1)|Death|0
6067282|NCT00473512|20959909|P1|Period 1 (Phase 1)|Death|0
6067283|NCT00473512|20959905|P5|Period 1 (Phase 1)|Adverse Event|0
6067284|NCT00473512|20959906|P4|Period 1 (Phase 1)|Adverse Event|5
6067285|NCT00473512|20959907|P3|Period 1 (Phase 1)|Adverse Event|0
6067286|NCT00473512|20959908|P2|Period 1 (Phase 1)|Adverse Event|0
6067287|NCT00473512|20959909|P1|Period 1 (Phase 1)|Adverse Event|0
6067288|NCT00473434|20959967|P1|Overall Study|No longer required|1
6067289|NCT00473434|20959967|P1|Overall Study|Switching to trial medication|1
6067290|NCT00473434|20959967|P1|Overall Study|Ceased in favor of Paliperidone|1
6067291|NCT00473434|20959967|P1|Overall Study|Reason not specified|6
6067292|NCT00473434|20959967|P1|Overall Study|Safety evaluation|1
6067293|NCT00473434|20959967|P1|Overall Study|Patient was selling medication to others|1
6067294|NCT00473434|20959967|P1|Overall Study|Adverse Event|3
6067295|NCT00473434|20959967|P1|Overall Study|Lack of Efficacy|3
6067296|NCT00473434|20959967|P1|Overall Study|Compliance|3
6067297|NCT00473434|20959967|P1|Overall Study|Withdrawal by Subject|9
6067298|NCT00473434|20959967|P1|Overall Study|Physician Decision|3
6067299|NCT00473382|20960032|P3|Open-label Extension Through Month 60|Subject Required Other Intervention|0
6067300|NCT00473382|20960033|P2|Open-label Extension Through Month 60|Subject Required Other Intervention|1
6067301|NCT00473382|20960034|P1|Open-label Extension Through Month 60|Subject Required Other Intervention|2
6067302|NCT00473382|20960032|P3|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|69
6067303|NCT00473382|20960033|P2|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|70
6067304|NCT00473382|20960034|P1|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|75
6067305|NCT00473382|20960032|P3|Open-label Extension Through Month 60|Subject's Decision|6
6067306|NCT00473382|20960033|P2|Open-label Extension Through Month 60|Subject's Decision|1
6067307|NCT00473382|20960034|P1|Open-label Extension Through Month 60|Subject's Decision|7
6067308|NCT00473382|20960032|P3|Open-label Extension Through Month 60|Lost to Follow-up|1
6067309|NCT00473382|20960033|P2|Open-label Extension Through Month 60|Lost to Follow-up|3
6067310|NCT00473382|20960034|P1|Open-label Extension Through Month 60|Lost to Follow-up|1
6067311|NCT00473382|20960032|P3|Open-label Extension Through Month 60|Death|4
6067312|NCT00473382|20960033|P2|Open-label Extension Through Month 60|Death|7
6067313|NCT00473382|20960034|P1|Open-label Extension Through Month 60|Death|1
6067314|NCT00473382|20960032|P3|Open-label Extension Through Month 60|Adverse Event|2
6067315|NCT00473382|20960033|P2|Open-label Extension Through Month 60|Adverse Event|0
6067316|NCT00473382|20960034|P1|Open-label Extension Through Month 60|Adverse Event|0
6067317|NCT00473382|20960032|P3|Open-label Extension Through Month 48|Subject Required Other Intervention|0
6067318|NCT00473382|20960033|P2|Open-label Extension Through Month 48|Subject Required Other Intervention|1
6067319|NCT00473382|20960034|P1|Open-label Extension Through Month 48|Subject Required Other Intervention|2
6067320|NCT00473382|20960032|P3|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|36
6067321|NCT00473382|20960033|P2|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|34
6067322|NCT00473382|20960034|P1|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|41
6067323|NCT00473382|20960032|P3|Open-label Extension Through Month 48|Subject's Decision|6
6067324|NCT00473382|20960033|P2|Open-label Extension Through Month 48|Subject's Decision|1
6067325|NCT00473382|20960034|P1|Open-label Extension Through Month 48|Subject's Decision|5
6067326|NCT00473382|20960032|P3|Open-label Extension Through Month 48|Lost to Follow-up|1
6067327|NCT00473382|20960033|P2|Open-label Extension Through Month 48|Lost to Follow-up|2
6067328|NCT00473382|20960034|P1|Open-label Extension Through Month 48|Lost to Follow-up|1
6067329|NCT00473382|20960032|P3|Open-label Extension Through Month 48|Death|3
6067330|NCT00473382|20960033|P2|Open-label Extension Through Month 48|Death|3
6067331|NCT00473382|20960034|P1|Open-label Extension Through Month 48|Death|1
6067332|NCT00473382|20960032|P3|Open-label Extension Through Month 48|Adverse Event|1
6067333|NCT00473382|20960033|P2|Open-label Extension Through Month 48|Adverse Event|0
6067334|NCT00473382|20960034|P1|Open-label Extension Through Month 48|Adverse Event|0
6067335|NCT00473382|20960032|P3|Core Study|Subject's decision|10
6067336|NCT00473382|20960033|P2|Core Study|Subject's decision|11
6067337|NCT00473382|20960034|P1|Core Study|Subject's decision|12
6067338|NCT00473382|20960032|P3|Core Study|Subject needed other treatment|2
6067339|NCT00473382|20960033|P2|Core Study|Subject needed other treatment|3
6067340|NCT00473382|20960034|P1|Core Study|Subject needed other treatment|1
6067341|NCT00473382|20960032|P3|Core Study|Subject non-compliance|1
6067342|NCT00473382|20960033|P2|Core Study|Subject non-compliance|2
6067343|NCT00473382|20960034|P1|Core Study|Subject non-compliance|5
6067344|NCT00473382|20960032|P3|Core Study|Physician Decision|2
6067345|NCT00473382|20960033|P2|Core Study|Physician Decision|2
6067346|NCT00473382|20960034|P1|Core Study|Physician Decision|1
6067347|NCT00473382|20960032|P3|Core Study|Lost to Follow-up|3
6067348|NCT00473382|20960033|P2|Core Study|Lost to Follow-up|3
6067349|NCT00473382|20960034|P1|Core Study|Lost to Follow-up|3
6067350|NCT00473382|20960032|P3|Core Study|Death|10
6067351|NCT00473382|20960033|P2|Core Study|Death|5
6067352|NCT00473382|20960034|P1|Core Study|Death|3
6067353|NCT00473382|20960032|P3|Core Study|Adverse Event|1
6067354|NCT00473382|20960033|P2|Core Study|Adverse Event|1
6067355|NCT00473382|20960034|P1|Core Study|Adverse Event|3
6067356|NCT00473330|20960092|P3|Open-label Extension Through Month 60|Subject Required Other Therapy|1
6067357|NCT00473330|20960093|P2|Open-label Extension Through Month 60|Subject Required Other Therapy|0
6067358|NCT00473330|20960094|P1|Open-label Extension Through Month 60|Subject Required Other Therapy|1
6067359|NCT00473330|20960092|P3|Open-label Extension Through Month 60|Subject Non-compliance|0
6067360|NCT00473330|20960093|P2|Open-label Extension Through Month 60|Subject Non-compliance|1
6067361|NCT00473330|20960094|P1|Open-label Extension Through Month 60|Subject Non-compliance|2
6067362|NCT00473330|20960092|P3|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|62
6067363|NCT00473330|20960093|P2|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|71
6067364|NCT00473330|20960094|P1|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|77
6067365|NCT00473330|20960092|P3|Open-label Extension Through Month 60|Subject's Decision|4
6067366|NCT00473330|20960093|P2|Open-label Extension Through Month 60|Subject's Decision|3
6067367|NCT00473330|20960094|P1|Open-label Extension Through Month 60|Subject's Decision|1
6067368|NCT00473330|20960092|P3|Open-label Extension Through Month 60|Physician's Decision|3
6067369|NCT00473330|20960093|P2|Open-label Extension Through Month 60|Physician's Decision|1
6067370|NCT00473330|20960094|P1|Open-label Extension Through Month 60|Physician's Decision|2
6067371|NCT00473330|20960092|P3|Open-label Extension Through Month 60|Lost to Follow-up|4
6067372|NCT00473330|20960093|P2|Open-label Extension Through Month 60|Lost to Follow-up|0
6067373|NCT00473330|20960094|P1|Open-label Extension Through Month 60|Lost to Follow-up|3
6067374|NCT00473330|20960092|P3|Open-label Extension Through Month 60|Death|1
6067375|NCT00473330|20960093|P2|Open-label Extension Through Month 60|Death|2
6067376|NCT00473330|20960094|P1|Open-label Extension Through Month 60|Death|2
6067377|NCT00473330|20960092|P3|Open-label Extension Through Month 60|Adverse Event|2
6067378|NCT00473330|20960093|P2|Open-label Extension Through Month 60|Adverse Event|0
6067379|NCT00473330|20960094|P1|Open-label Extension Through Month 60|Adverse Event|0
6067380|NCT00473330|20960092|P3|Open-label Extension Through Month 48|Subject Required Other Therapy|1
6067381|NCT00473330|20960093|P2|Open-label Extension Through Month 48|Subject Required Other Therapy|0
6067382|NCT00473330|20960094|P1|Open-label Extension Through Month 48|Subject Required Other Therapy|0
6067383|NCT00473330|20960092|P3|Open-label Extension Through Month 48|Subject Non-compliance|0
6067384|NCT00473330|20960093|P2|Open-label Extension Through Month 48|Subject Non-compliance|1
6067385|NCT00473330|20960094|P1|Open-label Extension Through Month 48|Subject Non-compliance|2
6067386|NCT00473330|20960092|P3|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|16
6067387|NCT00473330|20960093|P2|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|15
6067388|NCT00473330|20960094|P1|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|18
6067389|NCT00473330|20960092|P3|Open-label Extension Through Month 48|Subject's Decision|3
6067390|NCT00473330|20960093|P2|Open-label Extension Through Month 48|Subject's Decision|3
6067391|NCT00473330|20960094|P1|Open-label Extension Through Month 48|Subject's Decision|1
6067392|NCT00473330|20960092|P3|Open-label Extension Through Month 48|Physician's Decision|3
6067393|NCT00473330|20960093|P2|Open-label Extension Through Month 48|Physician's Decision|1
6067394|NCT00473330|20960094|P1|Open-label Extension Through Month 48|Physician's Decision|2
6067395|NCT00473330|20960092|P3|Open-label Extension Through Month 48|Lost to Follow-up|2
6067396|NCT00473330|20960093|P2|Open-label Extension Through Month 48|Lost to Follow-up|0
6067397|NCT00473330|20960094|P1|Open-label Extension Through Month 48|Lost to Follow-up|1
6067398|NCT00473330|20960092|P3|Open-label Extension Through Month 48|Death|0
6067399|NCT00473330|20960093|P2|Open-label Extension Through Month 48|Death|0
6067400|NCT00473330|20960094|P1|Open-label Extension Through Month 48|Death|2
6067401|NCT00473330|20960092|P3|Open-label Extension Through Month 48|Adverse Event|2
6067402|NCT00473330|20960093|P2|Open-label Extension Through Month 48|Adverse Event|0
6067403|NCT00473330|20960094|P1|Open-label Extension Through Month 48|Adverse Event|0
6067404|NCT00473330|20960092|P3|Core Study|Subject's Decision|19
6067405|NCT00473330|20960093|P2|Core Study|Subject's Decision|8
6067406|NCT00473330|20960094|P1|Core Study|Subject's Decision|9
6067407|NCT00473330|20960092|P3|Core Study|Subject Required Other Therapy|3
6067408|NCT00473330|20960093|P2|Core Study|Subject Required Other Therapy|1
6067409|NCT00473330|20960094|P1|Core Study|Subject Required Other Therapy|0
6067410|NCT00473330|20960092|P3|Core Study|Subject Non-compliance|1
6067411|NCT00473330|20960093|P2|Core Study|Subject Non-compliance|2
6067412|NCT00473330|20960094|P1|Core Study|Subject Non-compliance|1
6067413|NCT00473330|20960092|P3|Core Study|Physician Decision|3
6067414|NCT00473330|20960093|P2|Core Study|Physician Decision|1
6067415|NCT00473330|20960094|P1|Core Study|Physician Decision|2
6067416|NCT00473330|20960092|P3|Core Study|Lost to Follow-up|10
6067417|NCT00473330|20960093|P2|Core Study|Lost to Follow-up|5
6067418|NCT00473330|20960094|P1|Core Study|Lost to Follow-up|5
6067419|NCT00473330|20960092|P3|Core Study|Death|4
6067420|NCT00473330|20960093|P2|Core Study|Death|4
6067421|NCT00473330|20960094|P1|Core Study|Death|6
6067422|NCT00473330|20960092|P3|Core Study|Adverse Event|1
6067423|NCT00473330|20960093|P2|Core Study|Adverse Event|4
6067424|NCT00473330|20960094|P1|Core Study|Adverse Event|4
6067425|NCT00473265|20960149|P1|Overall Study|Off treatment early|15
6067426|NCT00473265|20960149|P1|Overall Study|Unrelated adverse event|5
6067427|NCT00473083|20960161|P3|Overall Study|Adverse Event|0
6067428|NCT00473083|20960162|P2|Overall Study|Adverse Event|0
6067429|NCT00473083|20960163|P1|Overall Study|Adverse Event|1
6067430|NCT00472641|20960238|P1|Overall Study|Lost to Follow-up|1
6067431|NCT00472641|20960238|P1|Overall Study|Adverse Event|3
6067432|NCT00472641|20960238|P1|Overall Study|Lack of Efficacy|3
6067433|NCT00472446|20960258|P4|Overall Study|Questionnaires not returned|4
6067434|NCT00472446|20960259|P3|Overall Study|Questionnaires not returned|6
6067435|NCT00472446|20960260|P2|Overall Study|Questionnaires not returned|6
6067436|NCT00472446|20960261|P1|Overall Study|Questionnaires not returned|5
6067437|NCT00472446|20960258|P4|Overall Study|Reintervention|1
6067438|NCT00472446|20960259|P3|Overall Study|Reintervention|1
6067439|NCT00472446|20960260|P2|Overall Study|Reintervention|0
6067440|NCT00472446|20960261|P1|Overall Study|Reintervention|0
6067441|NCT00472446|20960258|P4|Overall Study|Protocol Violation|1
6067442|NCT00472446|20960259|P3|Overall Study|Protocol Violation|0
6067443|NCT00472446|20960260|P2|Overall Study|Protocol Violation|0
6067444|NCT00472446|20960261|P1|Overall Study|Protocol Violation|0
6067445|NCT00472420|20960291|P1|Follow-up Period|Protocol Violation|1
6067446|NCT00472420|20960291|P1|Follow-up Period|Lost to Follow-up|2
6067447|NCT00472420|20960291|P1|Follow-up Period|Physician Decision|9
6067448|NCT00472420|20960291|P1|Follow-up Period|Death|5
6067449|NCT00472420|20960291|P1|Induction Treatment Period|Death|3
6067450|NCT00472420|20960291|P1|Induction Treatment Period|Non-compliance|1
6067451|NCT00472420|20960291|P1|Induction Treatment Period|Adverse Event|3
6067452|NCT00472420|20960291|P1|Induction Treatment Period|Physician Decision|9
6067453|NCT00472303|20960299|P3|Maintenance Phase|Other|0
6067454|NCT00472303|20960300|P2|Maintenance Phase|Other|1
6067455|NCT00472303|20960301|P1|Maintenance Phase|Other|1
6067456|NCT00472303|20960299|P3|Maintenance Phase|Resolution of pain|1
6067457|NCT00472303|20960300|P2|Maintenance Phase|Resolution of pain|0
6067458|NCT00472303|20960301|P1|Maintenance Phase|Resolution of pain|0
6067459|NCT00472303|20960299|P3|Maintenance Phase|Trial medication non-compliant|1
6067460|NCT00472303|20960300|P2|Maintenance Phase|Trial medication non-compliant|0
6067461|NCT00472303|20960301|P1|Maintenance Phase|Trial medication non-compliant|0
6067462|NCT00472303|20960299|P3|Maintenance Phase|Withdrawal by Subject|3
6067463|NCT00472303|20960300|P2|Maintenance Phase|Withdrawal by Subject|7
6067464|NCT00472303|20960301|P1|Maintenance Phase|Withdrawal by Subject|6
6067465|NCT00472303|20960299|P3|Maintenance Phase|Lack of Efficacy|4
6067466|NCT00472303|20960300|P2|Maintenance Phase|Lack of Efficacy|2
6067467|NCT00472303|20960301|P1|Maintenance Phase|Lack of Efficacy|2
6067468|NCT00472303|20960299|P3|Maintenance Phase|Death|2
6067469|NCT00472303|20960300|P2|Maintenance Phase|Death|0
6067470|NCT00472303|20960301|P1|Maintenance Phase|Death|3
6067471|NCT00472303|20960299|P3|Maintenance Phase|Adverse Event|6
6067472|NCT00472303|20960300|P2|Maintenance Phase|Adverse Event|6
6067473|NCT00472303|20960301|P1|Maintenance Phase|Adverse Event|5
6067474|NCT00472303|20960299|P3|Discontinuations After Titration Phase|Other|0
6067475|NCT00472303|20960300|P2|Discontinuations After Titration Phase|Other|0
6067476|NCT00472303|20960301|P1|Discontinuations After Titration Phase|Other|5
6067477|NCT00472303|20960299|P3|Discontinuations After Titration Phase|Trial Medication non-compliant|0
6067478|NCT00472303|20960300|P2|Discontinuations After Titration Phase|Trial Medication non-compliant|1
6067479|NCT00472303|20960301|P1|Discontinuations After Titration Phase|Trial Medication non-compliant|0
6067480|NCT00472303|20960299|P3|Discontinuations After Titration Phase|Withdrawal by Subject|0
6067481|NCT00472303|20960300|P2|Discontinuations After Titration Phase|Withdrawal by Subject|2
6067730|NCT00471237|20960723|P2|Overall Study|Withdrawal by Subject|6
6067482|NCT00472303|20960301|P1|Discontinuations After Titration Phase|Withdrawal by Subject|2
6067483|NCT00472303|20960299|P3|Discontinuations After Titration Phase|Lack of Efficacy|0
6067484|NCT00472303|20960300|P2|Discontinuations After Titration Phase|Lack of Efficacy|17
6067485|NCT00472303|20960301|P1|Discontinuations After Titration Phase|Lack of Efficacy|48
6067486|NCT00472303|20960299|P3|Discontinuations After Titration Phase|Adverse Event|0
6067487|NCT00472303|20960300|P2|Discontinuations After Titration Phase|Adverse Event|0
6067488|NCT00472303|20960301|P1|Discontinuations After Titration Phase|Adverse Event|6
6067489|NCT00472303|20960299|P3|Titration Phase|Other|0
6067490|NCT00472303|20960300|P2|Titration Phase|Other|1
6067491|NCT00472303|20960301|P1|Titration Phase|Other|3
6067492|NCT00472303|20960299|P3|Titration Phase|Trial Medication non-compliant|0
6067493|NCT00472303|20960300|P2|Titration Phase|Trial Medication non-compliant|1
6067494|NCT00472303|20960301|P1|Titration Phase|Trial Medication non-compliant|4
6067495|NCT00472303|20960299|P3|Titration Phase|Withdrawal by Subject|0
6067496|NCT00472303|20960300|P2|Titration Phase|Withdrawal by Subject|13
6067497|NCT00472303|20960301|P1|Titration Phase|Withdrawal by Subject|16
6067498|NCT00472303|20960299|P3|Titration Phase|Lack of Efficacy|0
6067499|NCT00472303|20960300|P2|Titration Phase|Lack of Efficacy|0
6067500|NCT00472303|20960301|P1|Titration Phase|Lack of Efficacy|10
6067501|NCT00472303|20960299|P3|Titration Phase|Death|0
6067502|NCT00472303|20960300|P2|Titration Phase|Death|2
6067503|NCT00472303|20960301|P1|Titration Phase|Death|4
6067504|NCT00472303|20960299|P3|Titration Phase|Adverse Event|0
6067505|NCT00472303|20960300|P2|Titration Phase|Adverse Event|12
6067506|NCT00472303|20960301|P1|Titration Phase|Adverse Event|22
6067507|NCT00472290|20960364|P1|Overall Study|Requirement for alternative therapy|7
6067508|NCT00472290|20960364|P1|Overall Study|Adverse Event|6
6067509|NCT00472290|20960364|P1|Overall Study|Withdrawal by Subject|5
6067510|NCT00472290|20960364|P1|Overall Study|Disease Progression|4
6067511|NCT00472290|20960364|P1|Overall Study|Lack of Efficacy|1
6067512|NCT00472290|20960364|P1|Overall Study|Lost to Follow-up|1
6067513|NCT00472290|20960364|P1|Overall Study|Death|3
6067514|NCT00472290|20960364|P1|Overall Study|Administrative Decision|37
6067515|NCT00472290|20960364|P1|Overall Study|Protocol Specified Criteria|7
6067516|NCT00472290|20960364|P1|Overall Study|Progression of Therapy-Related MDS|1
6067517|NCT00472199|20960376|P2|Overall Study|patient was asymptomatic|0
6067518|NCT00472199|20960377|P1|Overall Study|patient was asymptomatic|1
6067519|NCT00472199|20960376|P2|Overall Study|personal reason|1
6067520|NCT00472199|20960377|P1|Overall Study|personal reason|0
6067521|NCT00472199|20960376|P2|Overall Study|Withdrawal by Subject|5
6067522|NCT00472199|20960377|P1|Overall Study|Withdrawal by Subject|6
6067523|NCT00472199|20960376|P2|Overall Study|Protocol Violation|2
6067524|NCT00472199|20960377|P1|Overall Study|Protocol Violation|3
6067525|NCT00472199|20960376|P2|Overall Study|Lost to Follow-up|4
6067526|NCT00472199|20960377|P1|Overall Study|Lost to Follow-up|2
6067527|NCT00472199|20960376|P2|Overall Study|Lack of Efficacy|25
6067528|NCT00472199|20960377|P1|Overall Study|Lack of Efficacy|4
6067529|NCT00472199|20960376|P2|Overall Study|Adverse Event|23
6067530|NCT00472199|20960377|P1|Overall Study|Adverse Event|19
6067531|NCT00472082|20960443|P1|Overall Study|Study prematurely terminated|5
6067532|NCT00472030|20960465|P2|Overall Study|Physician Decision|0
6067533|NCT00472030|20960466|P1|Overall Study|Physician Decision|1
6067534|NCT00471887|20960482|P1|Overall Study|Adverse Event|9
6067535|NCT00471822|20960491|P1|Overall Study|Protocol Violation|2
6067536|NCT00471718|20960499|P1|Overall Study|Withdrawal by Subject|1
6067537|NCT00471718|20960499|P1|Overall Study|disease progression|22
6067538|NCT00471718|20960499|P1|Overall Study|other complicating disease|1
6067539|NCT00471718|20960499|P1|Overall Study|Adverse Event|3
6067540|NCT00471536|20960527|P1|Overall Study|Withdrawal by Subject|1
6067541|NCT00471497|20960539|P3|Extension Phase|Protocol Violation|0
6067542|NCT00471497|20960540|P2|Extension Phase|Protocol Violation|2
6067543|NCT00471497|20960541|P1|Extension Phase|Protocol Violation|2
6067544|NCT00471497|20960539|P3|Extension Phase|Disease progression|0
6067545|NCT00471497|20960540|P2|Extension Phase|Disease progression|0
6067546|NCT00471497|20960541|P1|Extension Phase|Disease progression|2
6067547|NCT00471497|20960539|P3|Extension Phase|Death|0
6067548|NCT00471497|20960540|P2|Extension Phase|Death|0
6067549|NCT00471497|20960541|P1|Extension Phase|Death|1
6067550|NCT00471497|20960539|P3|Extension Phase|Lost to Follow-up|0
6067551|NCT00471497|20960540|P2|Extension Phase|Lost to Follow-up|0
6067552|NCT00471497|20960541|P1|Extension Phase|Lost to Follow-up|2
6067553|NCT00471497|20960539|P3|Extension Phase|Withdrawal by Subject|0
6067554|NCT00471497|20960540|P2|Extension Phase|Withdrawal by Subject|1
6067555|NCT00471497|20960541|P1|Extension Phase|Withdrawal by Subject|3
6067556|NCT00471497|20960539|P3|Extension Phase|Unsatisfactory therapeutic effect|0
6067557|NCT00471497|20960540|P2|Extension Phase|Unsatisfactory therapeutic effect|6
6067558|NCT00471497|20960541|P1|Extension Phase|Unsatisfactory therapeutic effect|8
6067559|NCT00471497|20960539|P3|Extension Phase|Adverse Event|1
6067560|NCT00471497|20960540|P2|Extension Phase|Adverse Event|5
6067561|NCT00471497|20960541|P1|Extension Phase|Adverse Event|9
6067562|NCT00471497|20960539|P3|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|3
6067563|NCT00471497|20960540|P2|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|26
6067564|NCT00471497|20960541|P1|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|46
6067565|NCT00471497|20960539|P3|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|0
6067731|NCT00471237|20960724|P1|Overall Study|Withdrawal by Subject|8
6067566|NCT00471497|20960540|P2|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|0
6067567|NCT00471497|20960541|P1|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|2
6067568|NCT00471497|20960539|P3|Core Treatment Phase|Adverse Event|89
6067569|NCT00471497|20960540|P2|Core Treatment Phase|Adverse Event|53
6067570|NCT00471497|20960541|P1|Core Treatment Phase|Adverse Event|43
6067571|NCT00471497|20960539|P3|Core Treatment Phase|Administrative problems|12
6067572|NCT00471497|20960540|P2|Core Treatment Phase|Administrative problems|14
6067573|NCT00471497|20960541|P1|Core Treatment Phase|Administrative problems|14
6067574|NCT00471497|20960539|P3|Core Treatment Phase|Sub optimal response or treat. failure|13
6067575|NCT00471497|20960540|P2|Core Treatment Phase|Sub optimal response or treat. failure|11
6067576|NCT00471497|20960541|P1|Core Treatment Phase|Sub optimal response or treat. failure|19
6067577|NCT00471497|20960539|P3|Core Treatment Phase|Protocol Violation|11
6067578|NCT00471497|20960540|P2|Core Treatment Phase|Protocol Violation|15
6067579|NCT00471497|20960541|P1|Core Treatment Phase|Protocol Violation|6
6067580|NCT00471497|20960539|P3|Core Treatment Phase|Disease Progression|4
6067581|NCT00471497|20960540|P2|Core Treatment Phase|Disease Progression|2
6067582|NCT00471497|20960541|P1|Core Treatment Phase|Disease Progression|10
6067583|NCT00471497|20960539|P3|Core Treatment Phase|Death|3
6067584|NCT00471497|20960540|P2|Core Treatment Phase|Death|9
6067585|NCT00471497|20960541|P1|Core Treatment Phase|Death|3
6067586|NCT00471497|20960539|P3|Core Treatment Phase|Lost to Follow-up|3
6067587|NCT00471497|20960540|P2|Core Treatment Phase|Lost to Follow-up|6
6067588|NCT00471497|20960541|P1|Core Treatment Phase|Lost to Follow-up|6
6067589|NCT00471497|20960539|P3|Core Treatment Phase|Withdrawal by Subject|34
6067590|NCT00471497|20960540|P2|Core Treatment Phase|Withdrawal by Subject|29
6067591|NCT00471497|20960541|P1|Core Treatment Phase|Withdrawal by Subject|31
6067592|NCT00471497|20960539|P3|Core Treatment Phase|Condition no longer requires study drug|0
6067593|NCT00471497|20960540|P2|Core Treatment Phase|Condition no longer requires study drug|1
6067594|NCT00471497|20960541|P1|Core Treatment Phase|Condition no longer requires study drug|0
6067595|NCT00471497|20960539|P3|Core Treatment Phase|Abnormal Test Procedures|1
6067596|NCT00471497|20960540|P2|Core Treatment Phase|Abnormal Test Procedures|0
6067597|NCT00471497|20960541|P1|Core Treatment Phase|Abnormal Test Procedures|1
6067598|NCT00471497|20960539|P3|Core Treatment Phase|Abnormal Laboratory Values|9
6067599|NCT00471497|20960540|P2|Core Treatment Phase|Abnormal Laboratory Values|9
6067600|NCT00471497|20960541|P1|Core Treatment Phase|Abnormal Laboratory Values|3
6067601|NCT00471445|20960637|P2|Overall Study|Protocol Violation|1
6067602|NCT00471445|20960638|P1|Overall Study|Protocol Violation|0
6067603|NCT00471445|20960637|P2|Overall Study|Ineligible|0
6067604|NCT00471445|20960638|P1|Overall Study|Ineligible|1
6067605|NCT00471445|20960637|P2|Overall Study|Withdrawal by Subject|1
6067606|NCT00471445|20960638|P1|Overall Study|Withdrawal by Subject|1
6067607|NCT00471354|20960651|P1|Overall Study|Patient/Caregiver Decision|12
6067608|NCT00471354|20960651|P1|Overall Study|Lack of Efficacy|5
6067609|NCT00471354|20960651|P1|Overall Study|Lost to Follow-up|3
6067610|NCT00471354|20960651|P1|Overall Study|Sponsor Decision|1
6067611|NCT00471354|20960651|P1|Overall Study|Physician Decision|4
6067612|NCT00471354|20960651|P1|Overall Study|Withdrawal by Subject|1
6067613|NCT00471354|20960651|P1|Overall Study|Protocol Violation|12
6067614|NCT00471354|20960651|P1|Overall Study|Adverse Event|13
6067615|NCT00471354|20960651|P1|Overall Study|Protocol Entry Criteria Not Met|1
6067616|NCT00471328|20960663|P2|Extension Phase|Administrative Problem|0
6067617|NCT00471328|20960664|P1|Extension Phase|Administrative Problem|1
6067618|NCT00471328|20960663|P2|Extension Phase|New cancer Therapy|0
6067619|NCT00471328|20960664|P1|Extension Phase|New cancer Therapy|1
6067620|NCT00471328|20960663|P2|Extension Phase|Disease Progression|44
6067621|NCT00471328|20960664|P1|Extension Phase|Disease Progression|32
6067622|NCT00471328|20960663|P2|Extension Phase|Treatment duration as per protocol|1
6067623|NCT00471328|20960664|P1|Extension Phase|Treatment duration as per protocol|0
6067624|NCT00471328|20960663|P2|Extension Phase|Protocol Deviation|1
6067625|NCT00471328|20960664|P1|Extension Phase|Protocol Deviation|3
6067626|NCT00471328|20960663|P2|Extension Phase|Death|7
6067627|NCT00471328|20960664|P1|Extension Phase|Death|1
6067628|NCT00471328|20960663|P2|Extension Phase|Withdrawal by Subject|2
6067629|NCT00471328|20960664|P1|Extension Phase|Withdrawal by Subject|0
6067630|NCT00471328|20960663|P2|Extension Phase|Adverse Event|12
6067631|NCT00471328|20960664|P1|Extension Phase|Adverse Event|3
6067632|NCT00471328|20960663|P2|Core Phase|Protocol Deviation|1
6067633|NCT00471328|20960664|P1|Core Phase|Protocol Deviation|0
6067634|NCT00471328|20960663|P2|Core Phase|Administrative Problem|1
6067635|NCT00471328|20960664|P1|Core Phase|Administrative Problem|0
6067636|NCT00471328|20960663|P2|Core Phase|Disease Progression|53
6067637|NCT00471328|20960664|P1|Core Phase|Disease Progression|78
6067638|NCT00471328|20960663|P2|Core Phase|Abnormal laboratory value|0
6067639|NCT00471328|20960664|P1|Core Phase|Abnormal laboratory value|1
6067640|NCT00471328|20960663|P2|Core Phase|Withdrawal by Subject|2
6067641|NCT00471328|20960664|P1|Core Phase|Withdrawal by Subject|2
6067642|NCT00471328|20960663|P2|Core Phase|Death|4
6067643|NCT00471328|20960664|P1|Core Phase|Death|8
6067644|NCT00471328|20960663|P2|Core Phase|Adverse Event|6
6067645|NCT00471328|20960664|P1|Core Phase|Adverse Event|18
6067646|NCT00471315|20960683|P1|Overall Study|Withdrawal by Subject|1
6067647|NCT00471315|20960683|P1|Overall Study|Adverse Event|7
6067648|NCT00471276|20960688|P1|Overall Study|Refused treatment|6
6067649|NCT00471276|20960688|P1|Overall Study|Other|3
6067650|NCT00471276|20960688|P1|Overall Study|Global deterioration of health status|1
6067651|NCT00471276|20960688|P1|Overall Study|Objective progression or relapse|54
6067652|NCT00471276|20960688|P1|Overall Study|Protocol Violation|1
6067653|NCT00471276|20960688|P1|Overall Study|Adverse Event|16
6067654|NCT00471276|20960688|P1|Overall Study|Death|2
6067655|NCT00471237|20960718|P7|Overall Study|Participant's decision|0
6067656|NCT00471237|20960719|P6|Overall Study|Participant's decision|1
6067657|NCT00471237|20960720|P5|Overall Study|Participant's decision|0
6067658|NCT00471237|20960721|P4|Overall Study|Participant's decision|0
6067659|NCT00471237|20960722|P3|Overall Study|Participant's decision|0
6067660|NCT00471237|20960723|P2|Overall Study|Participant's decision|0
6067661|NCT00471237|20960724|P1|Overall Study|Participant's decision|0
6067662|NCT00471237|20960718|P7|Overall Study|Participant shifted residence|0
6067663|NCT00471237|20960719|P6|Overall Study|Participant shifted residence|0
6067664|NCT00471237|20960720|P5|Overall Study|Participant shifted residence|1
6067665|NCT00471237|20960721|P4|Overall Study|Participant shifted residence|0
6067666|NCT00471237|20960722|P3|Overall Study|Participant shifted residence|0
6067667|NCT00471237|20960723|P2|Overall Study|Participant shifted residence|0
6067668|NCT00471237|20960724|P1|Overall Study|Participant shifted residence|0
6067669|NCT00471237|20960718|P7|Overall Study|Administration of prohibited medicine|0
6067670|NCT00471237|20960719|P6|Overall Study|Administration of prohibited medicine|0
6067671|NCT00471237|20960720|P5|Overall Study|Administration of prohibited medicine|1
6067672|NCT00471237|20960721|P4|Overall Study|Administration of prohibited medicine|0
6067673|NCT00471237|20960722|P3|Overall Study|Administration of prohibited medicine|0
6067674|NCT00471237|20960723|P2|Overall Study|Administration of prohibited medicine|0
6067675|NCT00471237|20960724|P1|Overall Study|Administration of prohibited medicine|0
6067676|NCT00471237|20960718|P7|Overall Study|Participant lost medication|0
6067677|NCT00471237|20960719|P6|Overall Study|Participant lost medication|0
6067678|NCT00471237|20960720|P5|Overall Study|Participant lost medication|1
6067679|NCT00471237|20960721|P4|Overall Study|Participant lost medication|0
6067680|NCT00471237|20960722|P3|Overall Study|Participant lost medication|0
6067681|NCT00471237|20960723|P2|Overall Study|Participant lost medication|0
6067682|NCT00471237|20960724|P1|Overall Study|Participant lost medication|0
6067683|NCT00471237|20960718|P7|Overall Study|High parathyroid hormone|0
6067684|NCT00471237|20960719|P6|Overall Study|High parathyroid hormone|0
6067685|NCT00471237|20960720|P5|Overall Study|High parathyroid hormone|0
6067686|NCT00471237|20960721|P4|Overall Study|High parathyroid hormone|0
6067687|NCT00471237|20960722|P3|Overall Study|High parathyroid hormone|1
6067688|NCT00471237|20960723|P2|Overall Study|High parathyroid hormone|0
6067689|NCT00471237|20960724|P1|Overall Study|High parathyroid hormone|0
6067690|NCT00471237|20960718|P7|Overall Study|Participant planned to travel to abraod|0
6067691|NCT00471237|20960719|P6|Overall Study|Participant planned to travel to abraod|1
6067692|NCT00471237|20960720|P5|Overall Study|Participant planned to travel to abraod|0
6067693|NCT00471237|20960721|P4|Overall Study|Participant planned to travel to abraod|0
6067694|NCT00471237|20960722|P3|Overall Study|Participant planned to travel to abraod|0
6067695|NCT00471237|20960723|P2|Overall Study|Participant planned to travel to abraod|0
6067696|NCT00471237|20960724|P1|Overall Study|Participant planned to travel to abraod|1
6067697|NCT00471237|20960718|P7|Overall Study|Early stopping due to non-efficacy|0
6067698|NCT00471237|20960719|P6|Overall Study|Early stopping due to non-efficacy|0
6067699|NCT00471237|20960720|P5|Overall Study|Early stopping due to non-efficacy|1
6067700|NCT00471237|20960721|P4|Overall Study|Early stopping due to non-efficacy|0
6067701|NCT00471237|20960722|P3|Overall Study|Early stopping due to non-efficacy|0
6067702|NCT00471237|20960723|P2|Overall Study|Early stopping due to non-efficacy|0
6067703|NCT00471237|20960724|P1|Overall Study|Early stopping due to non-efficacy|1
6067704|NCT00471237|20960718|P7|Overall Study|Met serum creatinine withdrawal criteria|0
6067705|NCT00471237|20960719|P6|Overall Study|Met serum creatinine withdrawal criteria|0
6067706|NCT00471237|20960720|P5|Overall Study|Met serum creatinine withdrawal criteria|0
6067707|NCT00471237|20960721|P4|Overall Study|Met serum creatinine withdrawal criteria|2
6067708|NCT00471237|20960722|P3|Overall Study|Met serum creatinine withdrawal criteria|2
6067709|NCT00471237|20960723|P2|Overall Study|Met serum creatinine withdrawal criteria|0
6067710|NCT00471237|20960724|P1|Overall Study|Met serum creatinine withdrawal criteria|1
6067711|NCT00471237|20960718|P7|Overall Study|Non-compliance|0
6067712|NCT00471237|20960719|P6|Overall Study|Non-compliance|0
6067713|NCT00471237|20960720|P5|Overall Study|Non-compliance|0
6067714|NCT00471237|20960721|P4|Overall Study|Non-compliance|1
6067715|NCT00471237|20960722|P3|Overall Study|Non-compliance|0
6067716|NCT00471237|20960723|P2|Overall Study|Non-compliance|1
6067717|NCT00471237|20960724|P1|Overall Study|Non-compliance|0
6067718|NCT00471237|20960718|P7|Overall Study|Sponsor terminated study|0
6067719|NCT00471237|20960719|P6|Overall Study|Sponsor terminated study|24
6067720|NCT00471237|20960720|P5|Overall Study|Sponsor terminated study|18
6067721|NCT00471237|20960721|P4|Overall Study|Sponsor terminated study|22
6067722|NCT00471237|20960722|P3|Overall Study|Sponsor terminated study|19
6067723|NCT00471237|20960723|P2|Overall Study|Sponsor terminated study|23
6067724|NCT00471237|20960724|P1|Overall Study|Sponsor terminated study|20
6067725|NCT00471237|20960718|P7|Overall Study|Withdrawal by Subject|2
6067726|NCT00471237|20960719|P6|Overall Study|Withdrawal by Subject|4
6067727|NCT00471237|20960720|P5|Overall Study|Withdrawal by Subject|7
6067728|NCT00471237|20960721|P4|Overall Study|Withdrawal by Subject|8
6067729|NCT00471237|20960722|P3|Overall Study|Withdrawal by Subject|5
6067732|NCT00471237|20960718|P7|Overall Study|Protocol Violation|1
6067733|NCT00471237|20960719|P6|Overall Study|Protocol Violation|4
6067734|NCT00471237|20960720|P5|Overall Study|Protocol Violation|2
6067735|NCT00471237|20960721|P4|Overall Study|Protocol Violation|2
6067736|NCT00471237|20960722|P3|Overall Study|Protocol Violation|3
6067737|NCT00471237|20960723|P2|Overall Study|Protocol Violation|6
6067738|NCT00471237|20960724|P1|Overall Study|Protocol Violation|3
6067739|NCT00471237|20960718|P7|Overall Study|Lost to Follow-up|0
6067740|NCT00471237|20960719|P6|Overall Study|Lost to Follow-up|0
6067741|NCT00471237|20960720|P5|Overall Study|Lost to Follow-up|3
6067742|NCT00471237|20960721|P4|Overall Study|Lost to Follow-up|2
6067743|NCT00471237|20960722|P3|Overall Study|Lost to Follow-up|0
6067744|NCT00471237|20960723|P2|Overall Study|Lost to Follow-up|1
6067745|NCT00471237|20960724|P1|Overall Study|Lost to Follow-up|1
6067746|NCT00471237|20960718|P7|Overall Study|Adverse Event|0
6067747|NCT00471237|20960719|P6|Overall Study|Adverse Event|5
6067748|NCT00471237|20960720|P5|Overall Study|Adverse Event|7
6067749|NCT00471237|20960721|P4|Overall Study|Adverse Event|8
6067750|NCT00471237|20960722|P3|Overall Study|Adverse Event|4
6067751|NCT00471237|20960723|P2|Overall Study|Adverse Event|5
6067752|NCT00471237|20960724|P1|Overall Study|Adverse Event|6
6067753|NCT00471146|20960874|P2|Overall Study|Other|5
6067754|NCT00471146|20960875|P1|Overall Study|Other|4
6067755|NCT00471146|20960874|P2|Overall Study|Randomized but not treated|8
6067756|NCT00471146|20960875|P1|Overall Study|Randomized but not treated|9
6067757|NCT00471146|20960874|P2|Overall Study|Global deterioration of health status|14
6067758|NCT00471146|20960875|P1|Overall Study|Global deterioration of health status|12
6067759|NCT00471146|20960874|P2|Overall Study|Objective progression or relapse|87
6067760|NCT00471146|20960875|P1|Overall Study|Objective progression or relapse|84
6067761|NCT00471146|20960874|P2|Overall Study|Protocol Violation|2
6067762|NCT00471146|20960875|P1|Overall Study|Protocol Violation|2
6067763|NCT00471146|20960874|P2|Overall Study|Lost to Follow-up|2
6067764|NCT00471146|20960875|P1|Overall Study|Lost to Follow-up|4
6067765|NCT00471146|20960874|P2|Overall Study|Death|12
6067766|NCT00471146|20960875|P1|Overall Study|Death|11
6067767|NCT00471146|20960874|P2|Overall Study|Withdrawal by Subject|11
6067768|NCT00471146|20960875|P1|Overall Study|Withdrawal by Subject|14
6067769|NCT00471146|20960874|P2|Overall Study|Adverse Event|33
6067770|NCT00471146|20960875|P1|Overall Study|Adverse Event|32
6067771|NCT00471107|20960900|P3|Overall Study|Technical problems/data loss|3
6067772|NCT00471107|20960901|P2|Overall Study|Technical problems/data loss|1
6067773|NCT00471107|20960902|P1|Overall Study|Technical problems/data loss|3
6067774|NCT00471081|20960912|P2|Extended Safety Follow-Up|Missing confirmed|1
6067775|NCT00471081|20960913|P1|Extended Safety Follow-Up|Missing confirmed|0
6067776|NCT00471081|20960912|P2|Extended Safety Follow-Up|Lost to Follow-up|8
6067777|NCT00471081|20960913|P1|Extended Safety Follow-Up|Lost to Follow-up|1
6067778|NCT00471081|20960912|P2|Extended Safety Follow-Up|Withdrawal by Subject|4
6067779|NCT00471081|20960913|P1|Extended Safety Follow-Up|Withdrawal by Subject|1
6067780|NCT00471081|20960912|P2|Active Phase|Lost health plan/insurance|8
6067781|NCT00471081|20960913|P1|Active Phase|Lost health plan/insurance|1
6067782|NCT00471081|20960912|P2|Active Phase|Lost to Follow-up|1
6067783|NCT00471081|20960913|P1|Active Phase|Lost to Follow-up|0
6067784|NCT00471081|20960912|P2|Active Phase|Withdrawal by Subject|3
6067785|NCT00471081|20960913|P1|Active Phase|Withdrawal by Subject|0
6067786|NCT00471081|20960912|P2|Active Phase|Protocol Violation|1
6067787|NCT00471081|20960913|P1|Active Phase|Protocol Violation|1
6067788|NCT00470847|20960959|P1|Overall Study|Pt still receiving treatment|1
6067789|NCT00470834|20960972|P2|Extension Period (24 Months)|Disease Progression|1
6067790|NCT00470834|20960973|P1|Extension Period (24 Months)|Disease Progression|0
6067791|NCT00470834|20960972|P2|Extension Period (24 Months)|Non-compliance|1
6067792|NCT00470834|20960973|P1|Extension Period (24 Months)|Non-compliance|0
6067793|NCT00470834|20960972|P2|Extension Period (24 Months)|Lost to Follow-up|1
6067794|NCT00470834|20960973|P1|Extension Period (24 Months)|Lost to Follow-up|0
6067795|NCT00470834|20960972|P2|Extension Period (24 Months)|Sponsor Terminated Study|1
6067796|NCT00470834|20960973|P1|Extension Period (24 Months)|Sponsor Terminated Study|0
6067797|NCT00470834|20960972|P2|Extension Period (24 Months)|Physician Decision|3
6067798|NCT00470834|20960973|P1|Extension Period (24 Months)|Physician Decision|4
6067799|NCT00470834|20960972|P2|Extension Period (24 Months)|Withdrawal by Subject|5
6067800|NCT00470834|20960973|P1|Extension Period (24 Months)|Withdrawal by Subject|2
6067801|NCT00470834|20960972|P2|Extension Period (24 Months)|Adverse Event|4
6067802|NCT00470834|20960973|P1|Extension Period (24 Months)|Adverse Event|3
6067803|NCT00470834|20960972|P2|Extension Period (24 Months)|Protocol-defined Stopping Criteria|7
6067804|NCT00470834|20960973|P1|Extension Period (24 Months)|Protocol-defined Stopping Criteria|6
6067805|NCT00470834|20960972|P2|Treatment Period (18 Months)|Lack of Efficacy|0
6067806|NCT00470834|20960973|P1|Treatment Period (18 Months)|Lack of Efficacy|1
6067807|NCT00470834|20960972|P2|Treatment Period (18 Months)|Non-compliance|0
6067808|NCT00470834|20960973|P1|Treatment Period (18 Months)|Non-compliance|1
6067809|NCT00470834|20960972|P2|Treatment Period (18 Months)|Lost to Follow-up|0
6067810|NCT00470834|20960973|P1|Treatment Period (18 Months)|Lost to Follow-up|1
6067811|NCT00470834|20960972|P2|Treatment Period (18 Months)|Sponsor Terminated Study|1
6067812|NCT00470834|20960973|P1|Treatment Period (18 Months)|Sponsor Terminated Study|1
6067813|NCT00470834|20960972|P2|Treatment Period (18 Months)|Protocol Violation|1
6067814|NCT00470834|20960973|P1|Treatment Period (18 Months)|Protocol Violation|3
6067815|NCT00470834|20960972|P2|Treatment Period (18 Months)|Physician Decision|4
6067816|NCT00470834|20960973|P1|Treatment Period (18 Months)|Physician Decision|4
6067817|NCT00470834|20960972|P2|Treatment Period (18 Months)|Withdrawal by Subject|5
6067818|NCT00470834|20960973|P1|Treatment Period (18 Months)|Withdrawal by Subject|4
6067819|NCT00470834|20960972|P2|Treatment Period (18 Months)|Adverse Event|6
6067820|NCT00470834|20960973|P1|Treatment Period (18 Months)|Adverse Event|7
6067821|NCT00470834|20960972|P2|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|14
6067822|NCT00470834|20960973|P1|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|16
6067823|NCT00470626|20960987|P1|Overall Study|Withdrawal by Subject|7
6067824|NCT00470626|20960987|P1|Overall Study|Lost to Follow-up|10
6067825|NCT00470535|20961035|P1|Overall Study|Other|2
6067826|NCT00470535|20961035|P1|Overall Study|Death|1
6067827|NCT00470535|20961035|P1|Overall Study|Adverse Event|1
6067828|NCT00470535|20961035|P1|Overall Study|Withdrawal by Subject|1
6067829|NCT00470535|20961035|P1|Overall Study|Disease Progression|13
6067830|NCT00470470|20961044|P1|Overall Study|Not treated|1
6067831|NCT00470470|20961044|P1|Overall Study|Death|2
6067832|NCT00470470|20961044|P1|Overall Study|Adverse Event|2
6067833|NCT00470418|20961051|P2|Overall Study|Withdrawal by Subject|0
6067834|NCT00470418|20961052|P1|Overall Study|Withdrawal by Subject|1
6067835|NCT00470366|20961073|P1|Overall Study|Poor compliance|1
6067836|NCT00470366|20961073|P1|Overall Study|Adverse Event|3
6067837|NCT00470275|20961084|P1|Overall Study|Withdrawal by Subject|2
6067838|NCT00470275|20961084|P1|Overall Study|Lack of Efficacy|7
6067839|NCT00470275|20961084|P1|Overall Study|Death|1
6067840|NCT00470262|20961090|P2|Overall Study|Withdrawal by Subject|0
6067841|NCT00470262|20961091|P1|Overall Study|Withdrawal by Subject|2
6067842|NCT00470184|20961099|P1|Overall Study|recurrence|1
6067843|NCT00470184|20961099|P1|Overall Study|other|5
6067844|NCT00470184|20961099|P1|Overall Study|Withdrawal by Subject|4
6067845|NCT00470184|20961099|P1|Overall Study|Adverse Event|3
6067846|NCT00470184|20961099|P1|Overall Study|disease Progression|4
6067847|NCT00470184|20961099|P1|Overall Study|Not treated (other)|1
6067848|NCT00470184|20961099|P1|Overall Study|Not Treated(became ineligible)|4
6067849|NCT00470158|20961111|P5|Overall Study|Protocol Violation|0
6067850|NCT00470158|20961112|P4|Overall Study|Protocol Violation|0
6067851|NCT00470158|20961113|P3|Overall Study|Protocol Violation|0
6067852|NCT00470158|20961114|P2|Overall Study|Protocol Violation|0
6067853|NCT00470158|20961115|P1|Overall Study|Protocol Violation|1
6067854|NCT00470158|20961111|P5|Overall Study|Lost to Follow-up|4
6067855|NCT00470158|20961112|P4|Overall Study|Lost to Follow-up|5
6067856|NCT00470158|20961113|P3|Overall Study|Lost to Follow-up|8
6067857|NCT00470158|20961114|P2|Overall Study|Lost to Follow-up|8
6067858|NCT00470158|20961115|P1|Overall Study|Lost to Follow-up|7
6067859|NCT00470158|20961111|P5|Overall Study|Death|2
6067860|NCT00470158|20961112|P4|Overall Study|Death|0
6067861|NCT00470158|20961113|P3|Overall Study|Death|0
6067862|NCT00470158|20961114|P2|Overall Study|Death|0
6067863|NCT00470158|20961115|P1|Overall Study|Death|0
6067864|NCT00470093|20961148|P1|Overall Study|Adverse Event|2
6067865|NCT00470067|20961155|P1|Overall Study|Disease Progression|6
6067866|NCT00470067|20961155|P1|Overall Study|Death|1
6067867|NCT00470054|20961159|P1|Overall Study|Ineligible|1
6067868|NCT00469898|20961175|P1|Overall Study|Decreased performance status|1
6067869|NCT00469898|20961175|P1|Overall Study|Disease progression|9
6067870|NCT00469898|20961175|P1|Overall Study|Death|4
6067871|NCT00469898|20961175|P1|Overall Study|Withdrawal by Subject|4
6067872|NCT00469898|20961175|P1|Overall Study|Adverse Event|7
6067873|NCT00469859|20961184|P2|Overall Study|Inevaluable|2
6067874|NCT00469859|20961185|P1|Overall Study|Inevaluable|0
6067875|NCT00469833|20961193|P1|Overall Study|No IV access|2
6067876|NCT00469612|20961205|P2|Overall Study|Study terminated before data collected|0
6067877|NCT00469612|20961206|P1|Overall Study|Study terminated before data collected|2
6067878|NCT00469456|20961233|P2|Overall Study|Withdrawal by Subject|1
6067879|NCT00469456|20961234|P1|Overall Study|Withdrawal by Subject|4
6067880|NCT00469456|20961233|P2|Overall Study|Protocol Violation|0
6067881|NCT00469456|20961234|P1|Overall Study|Protocol Violation|1
6067882|NCT00469456|20961233|P2|Overall Study|Adverse Event|3
6067883|NCT00469456|20961234|P1|Overall Study|Adverse Event|4
6067884|NCT00469209|20961263|P3|Overall Study|Adverse Event|1
6067885|NCT00469209|20961264|P2|Overall Study|Adverse Event|0
6067886|NCT00469209|20961265|P1|Overall Study|Adverse Event|1
6067887|NCT00469144|20961275|P2|Overall Study|Progressive Disease|0
6067888|NCT00469144|20961276|P1|Overall Study|Progressive Disease|1
6067889|NCT00469144|20961275|P2|Overall Study|No Response|5
6067890|NCT00469144|20961276|P1|Overall Study|No Response|5
6067891|NCT00469144|20961275|P2|Overall Study|Death|1
6067892|NCT00469144|20961276|P1|Overall Study|Death|0
6067893|NCT00469092|20961288|P2|Overall Study|Use of Corticosteroid|0
6067894|NCT00469092|20961289|P1|Overall Study|Use of Corticosteroid|1
6067895|NCT00469092|20961288|P2|Overall Study|Abnormal lab value|0
6067896|NCT00469092|20961289|P1|Overall Study|Abnormal lab value|1
6067897|NCT00469092|20961288|P2|Overall Study|Hypoglycaemic Episodes|1
6067898|NCT00469092|20961289|P1|Overall Study|Hypoglycaemic Episodes|1
6067899|NCT00469092|20961288|P2|Overall Study|Use of lipid lowering drug|0
6067900|NCT00469092|20961289|P1|Overall Study|Use of lipid lowering drug|1
6067901|NCT00469092|20961288|P2|Overall Study|Contraindication metformin/glimepiride|0
6067902|NCT00469092|20961289|P1|Overall Study|Contraindication metformin/glimepiride|1
6067903|NCT00469092|20961288|P2|Overall Study|Incorrectly Randomised|3
6067904|NCT00469092|20961289|P1|Overall Study|Incorrectly Randomised|4
6067905|NCT00469092|20961288|P2|Overall Study|Withdrawal Criteria|4
6067906|NCT00469092|20961289|P1|Overall Study|Withdrawal Criteria|3
6067907|NCT00469092|20961288|P2|Overall Study|Withdrawal by Subject|4
6067908|NCT00469092|20961289|P1|Overall Study|Withdrawal by Subject|4
6067909|NCT00469092|20961288|P2|Overall Study|Protocol Violation|3
6067910|NCT00469092|20961289|P1|Overall Study|Protocol Violation|3
6067911|NCT00469092|20961288|P2|Overall Study|Lost to Follow-up|2
6067912|NCT00469092|20961289|P1|Overall Study|Lost to Follow-up|1
6067913|NCT00469092|20961288|P2|Overall Study|Lack of Efficacy|0
6067914|NCT00469092|20961289|P1|Overall Study|Lack of Efficacy|1
6067915|NCT00469092|20961288|P2|Overall Study|Adverse Event|4
6067916|NCT00469092|20961289|P1|Overall Study|Adverse Event|5
6067917|NCT00469079|20961308|P3|Overall Study|Ineligible|0
6067918|NCT00469079|20961309|P2|Overall Study|Ineligible|1
6067919|NCT00469079|20961310|P1|Overall Study|Ineligible|0
6067920|NCT00469079|20961308|P3|Overall Study|Withdrawal by Subject|2
6067921|NCT00469079|20961309|P2|Overall Study|Withdrawal by Subject|2
6067922|NCT00469079|20961310|P1|Overall Study|Withdrawal by Subject|1
6067923|NCT00469079|20961308|P3|Overall Study|Lost to Follow-up|10
6067924|NCT00469079|20961309|P2|Overall Study|Lost to Follow-up|8
6067925|NCT00469079|20961310|P1|Overall Study|Lost to Follow-up|4
6067926|NCT00469079|20961308|P3|Overall Study|Adverse Event|2
6067927|NCT00469079|20961309|P2|Overall Study|Adverse Event|3
6067928|NCT00469079|20961310|P1|Overall Study|Adverse Event|1
6067929|NCT00469079|20961308|P3|Overall Study|Lack of Efficacy|5
6067930|NCT00469079|20961309|P2|Overall Study|Lack of Efficacy|8
6067931|NCT00469079|20961310|P1|Overall Study|Lack of Efficacy|3
6067932|NCT00469014|20961331|P4|Adaptive Randomization|Death|0
6067933|NCT00469014|20961332|P3|Adaptive Randomization|Death|1
6067934|NCT00469014|20961333|P2|Adaptive Randomization|Death|0
6067935|NCT00469014|20961334|P1|Adaptive Randomization|Death|0
6067936|NCT00469014|20961331|P4|Adaptive Randomization|No Response|0
6067937|NCT00469014|20961332|P3|Adaptive Randomization|No Response|0
6067938|NCT00469014|20961333|P2|Adaptive Randomization|No Response|1
6067939|NCT00469014|20961334|P1|Adaptive Randomization|No Response|0
6067940|NCT00469014|20961331|P4|Adaptive Randomization|Not Evaluable|1
6067941|NCT00469014|20961332|P3|Adaptive Randomization|Not Evaluable|0
6067942|NCT00469014|20961333|P2|Adaptive Randomization|Not Evaluable|0
6067943|NCT00469014|20961334|P1|Adaptive Randomization|Not Evaluable|1
6067944|NCT00469014|20961331|P4|Initial Phase Randomization|No Response|1
6067945|NCT00469014|20961332|P3|Initial Phase Randomization|No Response|0
6067946|NCT00469014|20961333|P2|Initial Phase Randomization|No Response|0
6067947|NCT00469014|20961334|P1|Initial Phase Randomization|No Response|1
6067948|NCT00469014|20961331|P4|Initial Phase Randomization|Disease Progression|0
6067949|NCT00469014|20961332|P3|Initial Phase Randomization|Disease Progression|1
6067950|NCT00469014|20961333|P2|Initial Phase Randomization|Disease Progression|1
6067951|NCT00469014|20961334|P1|Initial Phase Randomization|Disease Progression|0
6067952|NCT00468910|20961346|P2|Overall Study|Medical Contraindication|1
6067953|NCT00468910|20961347|P1|Overall Study|Medical Contraindication|0
6067954|NCT00468910|20961346|P2|Overall Study|Withdrawal by Subject|1
6067955|NCT00468910|20961347|P1|Overall Study|Withdrawal by Subject|2
6067956|NCT00468910|20961346|P2|Overall Study|Lost to Follow-up|1
6067957|NCT00468910|20961347|P1|Overall Study|Lost to Follow-up|2
6067958|NCT00468858|20961366|P3|Overall Study|Other|1
6067959|NCT00468858|20961367|P2|Overall Study|Other|0
6067960|NCT00468858|20961368|P1|Overall Study|Other|0
6067961|NCT00468858|20961366|P3|Overall Study|Lost to Follow-up|5
6067962|NCT00468858|20961367|P2|Overall Study|Lost to Follow-up|2
6067963|NCT00468858|20961368|P1|Overall Study|Lost to Follow-up|1
6067964|NCT00468858|20961366|P3|Overall Study|Relocation|3
6067965|NCT00468858|20961367|P2|Overall Study|Relocation|3
6067966|NCT00468858|20961368|P1|Overall Study|Relocation|1
6067967|NCT00468858|20961366|P3|Overall Study|Withdrawal by Subject|5
6067968|NCT00468858|20961367|P2|Overall Study|Withdrawal by Subject|4
6067969|NCT00468858|20961368|P1|Overall Study|Withdrawal by Subject|7
6067970|NCT00468858|20961366|P3|Overall Study|Adverse Event|0
6067971|NCT00468858|20961367|P2|Overall Study|Adverse Event|1
6067972|NCT00468858|20961368|P1|Overall Study|Adverse Event|0
6067988|NCT00468819|20961628|P3|Overall Study|Drop-outs (Treatment never received)|0
6067989|NCT00468819|20961629|P2|Overall Study|Drop-outs (Treatment never received)|0
6067990|NCT00468819|20961630|P1|Overall Study|Drop-outs (Treatment never received)|2
6067991|NCT00468819|20961628|P3|Overall Study|Lost to Follow-up|1
6067992|NCT00468819|20961629|P2|Overall Study|Lost to Follow-up|0
6067993|NCT00468819|20961630|P1|Overall Study|Lost to Follow-up|0
6067994|NCT00468819|20961628|P3|Overall Study|Withdrawal by Subject|1
6067995|NCT00468819|20961629|P2|Overall Study|Withdrawal by Subject|0
6067996|NCT00468819|20961630|P1|Overall Study|Withdrawal by Subject|4
6067997|NCT00468728|20961710|P2|Follow-up|mITT failure|31
6067998|NCT00468728|20961711|P1|Follow-up|mITT failure|34
6067999|NCT00468728|20961710|P2|Treatment|criteria for mITT population|11
6068000|NCT00468728|20961711|P1|Treatment|criteria for mITT population|4
6068001|NCT00468676|20961723|P2|Overall Study|Death|1
6068002|NCT00468676|20961724|P1|Overall Study|Death|2
6068003|NCT00468676|20961723|P2|Overall Study|Lost to Follow-up|11
6068004|NCT00468676|20961724|P1|Overall Study|Lost to Follow-up|14
6068008|NCT00468585|20961789|P4|Overall Study|Withdrawal by Subject|1
6068009|NCT00468585|20961790|P3|Overall Study|Withdrawal by Subject|2
6068010|NCT00468585|20961791|P2|Overall Study|Withdrawal by Subject|0
6068011|NCT00468585|20961792|P1|Overall Study|Withdrawal by Subject|0
6068012|NCT00468585|20961789|P4|Overall Study|Adverse Event|0
6068013|NCT00468585|20961790|P3|Overall Study|Adverse Event|1
6068014|NCT00468585|20961791|P2|Overall Study|Adverse Event|0
6068015|NCT00468585|20961792|P1|Overall Study|Adverse Event|0
6068016|NCT00468585|20961789|P4|Overall Study|Patient found to be ineligible|0
6068017|NCT00468585|20961790|P3|Overall Study|Patient found to be ineligible|1
6068018|NCT00468585|20961791|P2|Overall Study|Patient found to be ineligible|0
6068019|NCT00468585|20961792|P1|Overall Study|Patient found to be ineligible|0
6068020|NCT00468585|20961789|P4|Overall Study|Patient not treated|0
6068021|NCT00468585|20961790|P3|Overall Study|Patient not treated|1
6068022|NCT00468585|20961791|P2|Overall Study|Patient not treated|0
6068023|NCT00468585|20961792|P1|Overall Study|Patient not treated|1
6068024|NCT00468559|20961804|P3|Double-blind, Treatment-withdrawal Phase|Adverse Event|0
6068025|NCT00468559|20961805|P2|Double-blind, Treatment-withdrawal Phase|Adverse Event|2
6068026|NCT00468559|20961806|P1|Double-blind, Treatment-withdrawal Phase|Adverse Event|0
6068027|NCT00468559|20961804|P3|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|17
6068028|NCT00468559|20961805|P2|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|8
6068029|NCT00468559|20961806|P1|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|0
6068030|NCT00468559|20961804|P3|Open-label Treatment Phase|Withdrawal by Subject|0
6068031|NCT00468559|20961805|P2|Open-label Treatment Phase|Withdrawal by Subject|0
6068032|NCT00468559|20961806|P1|Open-label Treatment Phase|Withdrawal by Subject|4
6068033|NCT00468559|20961804|P3|Open-label Treatment Phase|Lack of Efficacy|0
6068034|NCT00468559|20961805|P2|Open-label Treatment Phase|Lack of Efficacy|0
6068035|NCT00468559|20961806|P1|Open-label Treatment Phase|Lack of Efficacy|9
6068036|NCT00468559|20961804|P3|Open-label Treatment Phase|Adverse Event|0
6068037|NCT00468559|20961805|P2|Open-label Treatment Phase|Adverse Event|0
6068038|NCT00468559|20961806|P1|Open-label Treatment Phase|Adverse Event|5
6068039|NCT00468546|20961834|P2|Week 24 to Week 104 Analysis|Other|14
6068040|NCT00468546|20961835|P1|Week 24 to Week 104 Analysis|Other|17
6068041|NCT00468546|20961834|P2|Week 24 to Week 104 Analysis|Movement into re-treatment study|183
6068042|NCT00468546|20961835|P1|Week 24 to Week 104 Analysis|Movement into re-treatment study|77
6068043|NCT00468546|20961834|P2|Week 24 to Week 104 Analysis|Failure to return|2
6068044|NCT00468546|20961835|P1|Week 24 to Week 104 Analysis|Failure to return|1
6068045|NCT00468546|20961834|P2|Week 24 to Week 104 Analysis|Refused treatment|7
6068046|NCT00468546|20961835|P1|Week 24 to Week 104 Analysis|Refused treatment|4
6068047|NCT00468546|20961834|P2|Week 24 to Week 104 Analysis|Protocol Violation|2
6068048|NCT00468546|20961835|P1|Week 24 to Week 104 Analysis|Protocol Violation|0
6068049|NCT00468546|20961834|P2|Week 24 to Week 104 Analysis|Lack of Efficacy|12
6068050|NCT00468546|20961835|P1|Week 24 to Week 104 Analysis|Lack of Efficacy|3
6068051|NCT00468546|20961834|P2|Week 24 to Week 104 Analysis|Death|0
6068052|NCT00468546|20961835|P1|Week 24 to Week 104 Analysis|Death|1
6068053|NCT00468546|20961834|P2|Week 24 to Week 104 Analysis|Adverse Event|5
6068054|NCT00468546|20961835|P1|Week 24 to Week 104 Analysis|Adverse Event|2
6068055|NCT00468546|20961834|P2|Week 24 Analysis|Participant unblinded (clinical hold)|0
6068056|NCT00468546|20961835|P1|Week 24 Analysis|Participant unblinded (clinical hold)|1
6068057|NCT00468546|20961834|P2|Week 24 Analysis|Went onto rescue therapy|0
6068058|NCT00468546|20961835|P1|Week 24 Analysis|Went onto rescue therapy|1
6068059|NCT00468546|20961834|P2|Week 24 Analysis|Due to clinical hold|0
6068060|NCT00468546|20961835|P1|Week 24 Analysis|Due to clinical hold|1
6068061|NCT00468546|20961834|P2|Week 24 Analysis|Incorrect diagnosis and treatment|1
6068062|NCT00468546|20961835|P1|Week 24 Analysis|Incorrect diagnosis and treatment|0
6068063|NCT00468546|20961834|P2|Week 24 Analysis|Rescue therapy|0
6068064|NCT00468546|20961835|P1|Week 24 Analysis|Rescue therapy|2
6068065|NCT00468546|20961834|P2|Week 24 Analysis|Failure to return|4
6068066|NCT00468546|20961835|P1|Week 24 Analysis|Failure to return|3
6068067|NCT00468546|20961834|P2|Week 24 Analysis|Adverse Event|8
6068068|NCT00468546|20961835|P1|Week 24 Analysis|Adverse Event|1
6068069|NCT00468546|20961834|P2|Week 24 Analysis|Refused treatment|5
6068070|NCT00468546|20961835|P1|Week 24 Analysis|Refused treatment|5
6068071|NCT00468546|20961834|P2|Week 24 Analysis|Lack of Efficacy|37
6068072|NCT00468546|20961835|P1|Week 24 Analysis|Lack of Efficacy|83
6068073|NCT00468481|20961865|P2|Overall Study|Other|0
6068074|NCT00468481|20961866|P1|Overall Study|Other|6
6068075|NCT00468481|20961865|P2|Overall Study|Non-Compliance|0
6068076|NCT00468481|20961866|P1|Overall Study|Non-Compliance|5
6068077|NCT00468481|20961865|P2|Overall Study|Moved out of area|1
6068078|NCT00468481|20961866|P1|Overall Study|Moved out of area|4
6068079|NCT00468481|20961865|P2|Overall Study|Egg Donor|0
6068080|NCT00468481|20961866|P1|Overall Study|Egg Donor|1
6068081|NCT00468481|20961865|P2|Overall Study|Prohibited Medication|1
6068082|NCT00468481|20961866|P1|Overall Study|Prohibited Medication|1
6068083|NCT00468481|20961865|P2|Overall Study|susp/diag malignant/premalignant disease|0
6068084|NCT00468481|20961866|P1|Overall Study|susp/diag malignant/premalignant disease|1
6068085|NCT00468481|20961865|P2|Overall Study|Withdrawal by Subject|3
6068086|NCT00468481|20961866|P1|Overall Study|Withdrawal by Subject|12
6068087|NCT00468481|20961865|P2|Overall Study|Protocol Violation|8
6068088|NCT00468481|20961866|P1|Overall Study|Protocol Violation|18
6068089|NCT00468481|20961865|P2|Overall Study|Pregnancy|0
6068090|NCT00468481|20961866|P1|Overall Study|Pregnancy|2
6068091|NCT00468481|20961865|P2|Overall Study|Lost to Follow-up|8
6068092|NCT00468481|20961866|P1|Overall Study|Lost to Follow-up|25
6068093|NCT00468481|20961865|P2|Overall Study|Adverse Event|3
6068094|NCT00468481|20961866|P1|Overall Study|Adverse Event|13
6068095|NCT00468312|20961966|P2|Overall Study|Did not meet protocol eligibility|1
6068096|NCT00468312|20961967|P1|Overall Study|Did not meet protocol eligibility|0
6068097|NCT00468312|20961966|P2|Overall Study|Protocol Violation|1
6068098|NCT00468312|20961967|P1|Overall Study|Protocol Violation|2
6068099|NCT00468312|20961966|P2|Overall Study|Withdrawal by Subject|1
6068100|NCT00468312|20961967|P1|Overall Study|Withdrawal by Subject|0
6068101|NCT00468312|20961966|P2|Overall Study|Lack of Efficacy|1
6068102|NCT00468312|20961967|P1|Overall Study|Lack of Efficacy|0
6068103|NCT00468312|20961966|P2|Overall Study|Adverse Event|1
6068104|NCT00468312|20961967|P1|Overall Study|Adverse Event|2
6068105|NCT00468299|20961983|P2|Overall Study|Withdrawal by Subject|1
6068106|NCT00468299|20961984|P1|Overall Study|Withdrawal by Subject|0
6068107|NCT00468286|20961994|P2|Overall Study|Physician Decision|1
6068108|NCT00468286|20961995|P1|Overall Study|Physician Decision|0
6068109|NCT00468286|20961994|P2|Overall Study|Withdrawal by Subject|3
6068110|NCT00468286|20961995|P1|Overall Study|Withdrawal by Subject|4
6068111|NCT00468286|20961994|P2|Overall Study|Protocol Violation|2
6068112|NCT00468286|20961995|P1|Overall Study|Protocol Violation|2
6068113|NCT00468286|20961994|P2|Overall Study|Adverse Event|6
6068114|NCT00468286|20961995|P1|Overall Study|Adverse Event|1
6068115|NCT00468169|20962027|P2|Overall Study|Withdrawal by Subject|0
6068116|NCT00468169|20962028|P1|Overall Study|Withdrawal by Subject|1
6068117|NCT00468143|20962044|P2|Second Intervention (3 Weeks)|Withdrawal by Subject|3
6068118|NCT00468143|20962045|P1|Second Intervention (3 Weeks)|Withdrawal by Subject|3
6068119|NCT00468143|20962044|P2|First Intervention (3 Weeks)|Withdrawal by Subject|4
6068120|NCT00468143|20962045|P1|First Intervention (3 Weeks)|Withdrawal by Subject|3
6068121|NCT00468104|20962059|P2|Second Intervention|discarded for malposition of chest tube|2
6068122|NCT00468104|20962060|P1|Second Intervention|discarded for malposition of chest tube|0
6068123|NCT00468104|20962059|P2|Second Intervention|Withdrawal by Subject|2
6068124|NCT00468104|20962060|P1|Second Intervention|Withdrawal by Subject|5
6068125|NCT00468104|20962059|P2|First Intervention|trapped lung|0
6068126|NCT00468104|20962060|P1|First Intervention|trapped lung|1
6068127|NCT00468104|20962059|P2|First Intervention|associated prolonged pneumothorax|0
6068128|NCT00468104|20962060|P1|First Intervention|associated prolonged pneumothorax|1
6068129|NCT00468104|20962059|P2|First Intervention|large lung mass with minimal effusion|0
6068130|NCT00468104|20962060|P1|First Intervention|large lung mass with minimal effusion|1
6068131|NCT00468104|20962059|P2|First Intervention|malposition/blocked chest tube tube|0
6068132|NCT00468104|20962060|P1|First Intervention|malposition/blocked chest tube tube|2
6068133|NCT00468104|20962059|P2|First Intervention|died within 3 weeks|0
6068134|NCT00468104|20962060|P1|First Intervention|died within 3 weeks|1
6068135|NCT00468104|20962059|P2|First Intervention|bleeding at chest tube site--first dose|0
6068136|NCT00468104|20962060|P1|First Intervention|bleeding at chest tube site--first dose|1
6068137|NCT00468104|20962059|P2|First Intervention|Protocol Violation|1
6068138|NCT00468104|20962060|P1|First Intervention|Protocol Violation|2
6068139|NCT00468052|20962077|P2|Overall Study|Protocol Violation|8
6068140|NCT00468052|20962078|P1|Overall Study|Protocol Violation|7
6068141|NCT00467961|20962096|P1|Overall Study|Disease Progression|2
6068142|NCT00467961|20962096|P1|Overall Study|Technical Failures|5
6068143|NCT00467896|20962100|P1|Overall Study|Patient had no improvement|1
6068144|NCT00467896|20962100|P1|Overall Study|Started inhaled Remodulin|1
6068145|NCT00467896|20962100|P1|Overall Study|Started intravenous prostacyclin|1
6068146|NCT00467896|20962100|P1|Overall Study|Mainly used Prodose not I-neb® device|1
6068147|NCT00467896|20962100|P1|Overall Study|Patient weaned off iloprost|1
6068148|NCT00467896|20962100|P1|Overall Study|Patient had atrial septostomy|1
6068149|NCT00467896|20962100|P1|Overall Study|Patient received transplant|2
6068150|NCT00467896|20962100|P1|Overall Study|Changed therapy|2
6068151|NCT00467896|20962100|P1|Overall Study|Non-compliance|3
6068152|NCT00467896|20962100|P1|Overall Study|Serious Adverse Event|13
6068153|NCT00467896|20962100|P1|Overall Study|Adverse Event|7
6068154|NCT00467896|20962100|P1|Overall Study|Consent Withdrawal|18
6068155|NCT00467870|20962126|P6|Overall Study|Other/Unknown|0
6068156|NCT00467870|20962127|P5|Overall Study|Other/Unknown|4
6068157|NCT00467870|20962128|P4|Overall Study|Other/Unknown|5
6068158|NCT00467870|20962129|P3|Overall Study|Other/Unknown|1
6068159|NCT00467870|20962130|P2|Overall Study|Other/Unknown|5
6068160|NCT00467870|20962131|P1|Overall Study|Other/Unknown|8
6068161|NCT00467870|20962126|P6|Overall Study|Subject Non-compliance|0
6068162|NCT00467870|20962127|P5|Overall Study|Subject Non-compliance|5
6068163|NCT00467870|20962128|P4|Overall Study|Subject Non-compliance|1
6068164|NCT00467870|20962129|P3|Overall Study|Subject Non-compliance|0
6068165|NCT00467870|20962130|P2|Overall Study|Subject Non-compliance|4
6068166|NCT00467870|20962131|P1|Overall Study|Subject Non-compliance|3
6068167|NCT00467870|20962126|P6|Overall Study|Lost to Follow-up|0
6068168|NCT00467870|20962127|P5|Overall Study|Lost to Follow-up|3
6068169|NCT00467870|20962128|P4|Overall Study|Lost to Follow-up|1
6068170|NCT00467870|20962129|P3|Overall Study|Lost to Follow-up|1
6068171|NCT00467870|20962130|P2|Overall Study|Lost to Follow-up|3
6068172|NCT00467870|20962131|P1|Overall Study|Lost to Follow-up|5
6068173|NCT00467870|20962126|P6|Overall Study|Withdrawal by Subject|1
6068174|NCT00467870|20962127|P5|Overall Study|Withdrawal by Subject|10
6068175|NCT00467870|20962128|P4|Overall Study|Withdrawal by Subject|9
6068176|NCT00467870|20962129|P3|Overall Study|Withdrawal by Subject|0
6068177|NCT00467870|20962130|P2|Overall Study|Withdrawal by Subject|21
6068178|NCT00467870|20962131|P1|Overall Study|Withdrawal by Subject|14
6068179|NCT00467870|20962126|P6|Overall Study|Protocol Violation|0
6068180|NCT00467870|20962127|P5|Overall Study|Protocol Violation|0
6068181|NCT00467870|20962128|P4|Overall Study|Protocol Violation|2
6068182|NCT00467870|20962129|P3|Overall Study|Protocol Violation|1
6068183|NCT00467870|20962130|P2|Overall Study|Protocol Violation|1
6068184|NCT00467870|20962131|P1|Overall Study|Protocol Violation|2
6068185|NCT00467870|20962126|P6|Overall Study|Adverse Event|1
6068186|NCT00467870|20962127|P5|Overall Study|Adverse Event|15
6068187|NCT00467870|20962128|P4|Overall Study|Adverse Event|15
6068188|NCT00467870|20962129|P3|Overall Study|Adverse Event|1
6068189|NCT00467870|20962130|P2|Overall Study|Adverse Event|9
6068190|NCT00467870|20962131|P1|Overall Study|Adverse Event|13
6068191|NCT00467857|20962174|P2|Overall Study|Discontinuation reason missing|3
6068192|NCT00467857|20962175|P1|Overall Study|Discontinuation reason missing|0
6068193|NCT00467857|20962174|P2|Overall Study|Did not meet inclusion/exclusion criteri|2
6068194|NCT00467857|20962175|P1|Overall Study|Did not meet inclusion/exclusion criteri|0
6068195|NCT00467857|20962174|P2|Overall Study|Emergency care required|1
6068196|NCT00467857|20962175|P1|Overall Study|Emergency care required|0
6068197|NCT00467857|20962174|P2|Overall Study|Discharged from court service|1
6068198|NCT00467857|20962175|P1|Overall Study|Discharged from court service|0
6068199|NCT00467857|20962174|P2|Overall Study|Death|1
6068200|NCT00467857|20962175|P1|Overall Study|Death|0
6068201|NCT00467857|20962174|P2|Overall Study|Withdrew consent|0
6068202|NCT00467857|20962175|P1|Overall Study|Withdrew consent|2
6068203|NCT00467857|20962174|P2|Overall Study|Adverse Event|0
6068204|NCT00467857|20962175|P1|Overall Study|Adverse Event|1
6068205|NCT00467831|20962223|P1|Overall Study|Withdrawal by Subject|1
6068206|NCT00467831|20962223|P1|Overall Study|Death|2
6068207|NCT00467818|20962229|P2|Overall Study|Lost to Follow-up|2
6068208|NCT00467818|20962230|P1|Overall Study|Lost to Follow-up|2
6068209|NCT00467818|20962229|P2|Overall Study|Adverse Event|0
6068210|NCT00467818|20962230|P1|Overall Study|Adverse Event|1
6068211|NCT00467779|20962259|P15|Stage 3|Unspecified Reason|5
6068212|NCT00467779|20962260|P14|Stage 3|Unspecified Reason|0
6068213|NCT00467779|20962261|P13|Stage 3|Unspecified Reason|0
6068214|NCT00467779|20962262|P12|Stage 3|Unspecified Reason|0
6068215|NCT00467779|20962263|P11|Stage 3|Unspecified Reason|0
6068216|NCT00467779|20962264|P10|Stage 3|Unspecified Reason|0
6068217|NCT00467779|20962265|P9|Stage 3|Unspecified Reason|0
6068218|NCT00467779|20962266|P8|Stage 3|Unspecified Reason|0
6068219|NCT00467779|20962267|P7|Stage 3|Unspecified Reason|0
6068220|NCT00467779|20962268|P6|Stage 3|Unspecified Reason|0
6068221|NCT00467779|20962269|P5|Stage 3|Unspecified Reason|0
6068222|NCT00467779|20962270|P4|Stage 3|Unspecified Reason|0
6068223|NCT00467779|20962271|P3|Stage 3|Unspecified Reason|0
6068224|NCT00467779|20962272|P2|Stage 3|Unspecified Reason|0
6068225|NCT00467779|20962273|P1|Stage 3|Unspecified Reason|0
6068226|NCT00467779|20962259|P15|Stage 3|Disease Progression|9
6068227|NCT00467779|20962260|P14|Stage 3|Disease Progression|0
6068228|NCT00467779|20962261|P13|Stage 3|Disease Progression|0
6068229|NCT00467779|20962262|P12|Stage 3|Disease Progression|0
6068230|NCT00467779|20962263|P11|Stage 3|Disease Progression|0
6068231|NCT00467779|20962264|P10|Stage 3|Disease Progression|0
6068232|NCT00467779|20962265|P9|Stage 3|Disease Progression|0
6068233|NCT00467779|20962266|P8|Stage 3|Disease Progression|0
6068234|NCT00467779|20962267|P7|Stage 3|Disease Progression|0
6068235|NCT00467779|20962268|P6|Stage 3|Disease Progression|0
6068236|NCT00467779|20962269|P5|Stage 3|Disease Progression|0
6068237|NCT00467779|20962270|P4|Stage 3|Disease Progression|0
6068238|NCT00467779|20962271|P3|Stage 3|Disease Progression|0
6068239|NCT00467779|20962272|P2|Stage 3|Disease Progression|0
6068240|NCT00467779|20962273|P1|Stage 3|Disease Progression|0
6068241|NCT00467779|20962259|P15|Stage 3|Death|1
6068242|NCT00467779|20962260|P14|Stage 3|Death|0
6068243|NCT00467779|20962261|P13|Stage 3|Death|0
6068244|NCT00467779|20962262|P12|Stage 3|Death|0
6068245|NCT00467779|20962263|P11|Stage 3|Death|0
6068246|NCT00467779|20962264|P10|Stage 3|Death|0
6068247|NCT00467779|20962265|P9|Stage 3|Death|0
6068248|NCT00467779|20962266|P8|Stage 3|Death|0
6068249|NCT00467779|20962267|P7|Stage 3|Death|0
6068250|NCT00467779|20962268|P6|Stage 3|Death|0
6068251|NCT00467779|20962269|P5|Stage 3|Death|0
6068252|NCT00467779|20962270|P4|Stage 3|Death|0
6068253|NCT00467779|20962271|P3|Stage 3|Death|0
6068254|NCT00467779|20962272|P2|Stage 3|Death|0
6068255|NCT00467779|20962273|P1|Stage 3|Death|0
6068256|NCT00467779|20962259|P15|Stage 3|Adverse Event|2
6068257|NCT00467779|20962260|P14|Stage 3|Adverse Event|0
6068258|NCT00467779|20962261|P13|Stage 3|Adverse Event|0
6068259|NCT00467779|20962262|P12|Stage 3|Adverse Event|0
6068260|NCT00467779|20962263|P11|Stage 3|Adverse Event|0
6068261|NCT00467779|20962264|P10|Stage 3|Adverse Event|0
6068262|NCT00467779|20962265|P9|Stage 3|Adverse Event|0
6068263|NCT00467779|20962266|P8|Stage 3|Adverse Event|0
6068264|NCT00467779|20962267|P7|Stage 3|Adverse Event|0
6068265|NCT00467779|20962268|P6|Stage 3|Adverse Event|0
6068266|NCT00467779|20962269|P5|Stage 3|Adverse Event|0
6068267|NCT00467779|20962270|P4|Stage 3|Adverse Event|0
6068268|NCT00467779|20962271|P3|Stage 3|Adverse Event|0
6068269|NCT00467779|20962272|P2|Stage 3|Adverse Event|0
6068270|NCT00467779|20962273|P1|Stage 3|Adverse Event|0
6068271|NCT00467779|20962259|P15|Stage 2A|Withdrawal by Subject|0
6068272|NCT00467779|20962260|P14|Stage 2A|Withdrawal by Subject|1
6068273|NCT00467779|20962261|P13|Stage 2A|Withdrawal by Subject|0
6068274|NCT00467779|20962262|P12|Stage 2A|Withdrawal by Subject|0
6068275|NCT00467779|20962263|P11|Stage 2A|Withdrawal by Subject|0
6068276|NCT00467779|20962264|P10|Stage 2A|Withdrawal by Subject|0
6068277|NCT00467779|20962265|P9|Stage 2A|Withdrawal by Subject|0
6068278|NCT00467779|20962266|P8|Stage 2A|Withdrawal by Subject|0
6068279|NCT00467779|20962267|P7|Stage 2A|Withdrawal by Subject|0
6068280|NCT00467779|20962268|P6|Stage 2A|Withdrawal by Subject|0
6068281|NCT00467779|20962269|P5|Stage 2A|Withdrawal by Subject|0
6068282|NCT00467779|20962270|P4|Stage 2A|Withdrawal by Subject|0
6068283|NCT00467779|20962271|P3|Stage 2A|Withdrawal by Subject|0
6068284|NCT00467779|20962272|P2|Stage 2A|Withdrawal by Subject|0
6068285|NCT00467779|20962273|P1|Stage 2A|Withdrawal by Subject|0
6068286|NCT00467779|20962259|P15|Stage 2A|Unspecified Reason|0
6068287|NCT00467779|20962260|P14|Stage 2A|Unspecified Reason|7
6068288|NCT00467779|20962261|P13|Stage 2A|Unspecified Reason|0
6068289|NCT00467779|20962262|P12|Stage 2A|Unspecified Reason|0
6068290|NCT00467779|20962263|P11|Stage 2A|Unspecified Reason|0
6068291|NCT00467779|20962264|P10|Stage 2A|Unspecified Reason|0
6068292|NCT00467779|20962265|P9|Stage 2A|Unspecified Reason|0
6068293|NCT00467779|20962266|P8|Stage 2A|Unspecified Reason|0
6068294|NCT00467779|20962267|P7|Stage 2A|Unspecified Reason|0
6068295|NCT00467779|20962268|P6|Stage 2A|Unspecified Reason|0
6068296|NCT00467779|20962269|P5|Stage 2A|Unspecified Reason|0
6068297|NCT00467779|20962270|P4|Stage 2A|Unspecified Reason|0
6068298|NCT00467779|20962271|P3|Stage 2A|Unspecified Reason|0
6068299|NCT00467779|20962272|P2|Stage 2A|Unspecified Reason|0
6068300|NCT00467779|20962273|P1|Stage 2A|Unspecified Reason|0
6068301|NCT00467779|20962259|P15|Stage 2A|Disease Progression|0
6068302|NCT00467779|20962260|P14|Stage 2A|Disease Progression|10
6068303|NCT00467779|20962261|P13|Stage 2A|Disease Progression|0
6068304|NCT00467779|20962262|P12|Stage 2A|Disease Progression|0
6068305|NCT00467779|20962263|P11|Stage 2A|Disease Progression|0
6068306|NCT00467779|20962264|P10|Stage 2A|Disease Progression|0
6068307|NCT00467779|20962265|P9|Stage 2A|Disease Progression|0
6068308|NCT00467779|20962266|P8|Stage 2A|Disease Progression|0
6068309|NCT00467779|20962267|P7|Stage 2A|Disease Progression|0
6068310|NCT00467779|20962268|P6|Stage 2A|Disease Progression|0
6068311|NCT00467779|20962269|P5|Stage 2A|Disease Progression|0
6068312|NCT00467779|20962270|P4|Stage 2A|Disease Progression|0
6068313|NCT00467779|20962271|P3|Stage 2A|Disease Progression|0
6068314|NCT00467779|20962272|P2|Stage 2A|Disease Progression|0
6068315|NCT00467779|20962273|P1|Stage 2A|Disease Progression|0
6068316|NCT00467779|20962259|P15|Stage 2A|Death|0
6068317|NCT00467779|20962260|P14|Stage 2A|Death|1
6068318|NCT00467779|20962261|P13|Stage 2A|Death|0
6068319|NCT00467779|20962262|P12|Stage 2A|Death|0
6068320|NCT00467779|20962263|P11|Stage 2A|Death|0
6068321|NCT00467779|20962264|P10|Stage 2A|Death|0
6068322|NCT00467779|20962265|P9|Stage 2A|Death|0
6068323|NCT00467779|20962266|P8|Stage 2A|Death|0
6068324|NCT00467779|20962267|P7|Stage 2A|Death|0
6068325|NCT00467779|20962268|P6|Stage 2A|Death|0
6068326|NCT00467779|20962269|P5|Stage 2A|Death|0
6068327|NCT00467779|20962270|P4|Stage 2A|Death|0
6068328|NCT00467779|20962271|P3|Stage 2A|Death|0
6068329|NCT00467779|20962272|P2|Stage 2A|Death|0
6068330|NCT00467779|20962273|P1|Stage 2A|Death|0
6068331|NCT00467779|20962259|P15|Stage 2A|Adverse Event|0
6068332|NCT00467779|20962260|P14|Stage 2A|Adverse Event|2
6068333|NCT00467779|20962261|P13|Stage 2A|Adverse Event|0
6068334|NCT00467779|20962262|P12|Stage 2A|Adverse Event|0
6068335|NCT00467779|20962263|P11|Stage 2A|Adverse Event|0
6068336|NCT00467779|20962264|P10|Stage 2A|Adverse Event|0
6068337|NCT00467779|20962265|P9|Stage 2A|Adverse Event|0
6068338|NCT00467779|20962266|P8|Stage 2A|Adverse Event|0
6068339|NCT00467779|20962267|P7|Stage 2A|Adverse Event|0
6068340|NCT00467779|20962268|P6|Stage 2A|Adverse Event|0
6068341|NCT00467779|20962269|P5|Stage 2A|Adverse Event|0
6068342|NCT00467779|20962270|P4|Stage 2A|Adverse Event|0
6068343|NCT00467779|20962271|P3|Stage 2A|Adverse Event|0
6068344|NCT00467779|20962272|P2|Stage 2A|Adverse Event|0
6068345|NCT00467779|20962273|P1|Stage 2A|Adverse Event|0
6068346|NCT00467779|20962259|P15|Stage 2|Unspecified Reason|0
6068347|NCT00467779|20962260|P14|Stage 2|Unspecified Reason|0
6068348|NCT00467779|20962261|P13|Stage 2|Unspecified Reason|0
6068349|NCT00467779|20962262|P12|Stage 2|Unspecified Reason|0
6068350|NCT00467779|20962263|P11|Stage 2|Unspecified Reason|0
6068351|NCT00467779|20962264|P10|Stage 2|Unspecified Reason|0
6068352|NCT00467779|20962265|P9|Stage 2|Unspecified Reason|3
6068353|NCT00467779|20962266|P8|Stage 2|Unspecified Reason|0
6068354|NCT00467779|20962267|P7|Stage 2|Unspecified Reason|0
6068355|NCT00467779|20962268|P6|Stage 2|Unspecified Reason|0
6068356|NCT00467779|20962269|P5|Stage 2|Unspecified Reason|0
6068357|NCT00467779|20962270|P4|Stage 2|Unspecified Reason|0
6068358|NCT00467779|20962271|P3|Stage 2|Unspecified Reason|0
6068359|NCT00467779|20962272|P2|Stage 2|Unspecified Reason|0
6068360|NCT00467779|20962273|P1|Stage 2|Unspecified Reason|0
6068361|NCT00467779|20962259|P15|Stage 2|Disease Progression|0
6068362|NCT00467779|20962260|P14|Stage 2|Disease Progression|0
6068363|NCT00467779|20962261|P13|Stage 2|Disease Progression|0
6068364|NCT00467779|20962262|P12|Stage 2|Disease Progression|0
6068365|NCT00467779|20962263|P11|Stage 2|Disease Progression|0
6068366|NCT00467779|20962264|P10|Stage 2|Disease Progression|0
6068367|NCT00467779|20962265|P9|Stage 2|Disease Progression|16
6068368|NCT00467779|20962266|P8|Stage 2|Disease Progression|0
6068369|NCT00467779|20962267|P7|Stage 2|Disease Progression|0
6068370|NCT00467779|20962268|P6|Stage 2|Disease Progression|0
6068371|NCT00467779|20962269|P5|Stage 2|Disease Progression|0
6068372|NCT00467779|20962270|P4|Stage 2|Disease Progression|0
6068373|NCT00467779|20962271|P3|Stage 2|Disease Progression|0
6068374|NCT00467779|20962272|P2|Stage 2|Disease Progression|0
6068375|NCT00467779|20962273|P1|Stage 2|Disease Progression|0
6068376|NCT00467779|20962259|P15|Stage 2|Death|0
6068377|NCT00467779|20962260|P14|Stage 2|Death|0
6068378|NCT00467779|20962261|P13|Stage 2|Death|0
6068379|NCT00467779|20962262|P12|Stage 2|Death|0
6068380|NCT00467779|20962263|P11|Stage 2|Death|0
6068381|NCT00467779|20962264|P10|Stage 2|Death|0
6068382|NCT00467779|20962265|P9|Stage 2|Death|1
6068383|NCT00467779|20962266|P8|Stage 2|Death|0
6068384|NCT00467779|20962267|P7|Stage 2|Death|0
6068385|NCT00467779|20962268|P6|Stage 2|Death|0
6068386|NCT00467779|20962269|P5|Stage 2|Death|0
6068387|NCT00467779|20962270|P4|Stage 2|Death|0
6068388|NCT00467779|20962271|P3|Stage 2|Death|0
6068389|NCT00467779|20962272|P2|Stage 2|Death|0
6068390|NCT00467779|20962273|P1|Stage 2|Death|0
6068391|NCT00467779|20962259|P15|Stage 2|Adverse Event|0
6068392|NCT00467779|20962260|P14|Stage 2|Adverse Event|0
6068393|NCT00467779|20962261|P13|Stage 2|Adverse Event|0
6068394|NCT00467779|20962262|P12|Stage 2|Adverse Event|0
6068395|NCT00467779|20962263|P11|Stage 2|Adverse Event|0
6068396|NCT00467779|20962264|P10|Stage 2|Adverse Event|0
6068397|NCT00467779|20962265|P9|Stage 2|Adverse Event|1
6068398|NCT00467779|20962266|P8|Stage 2|Adverse Event|0
6068399|NCT00467779|20962267|P7|Stage 2|Adverse Event|0
6068400|NCT00467779|20962268|P6|Stage 2|Adverse Event|0
6068401|NCT00467779|20962269|P5|Stage 2|Adverse Event|0
6068402|NCT00467779|20962270|P4|Stage 2|Adverse Event|0
6068403|NCT00467779|20962271|P3|Stage 2|Adverse Event|0
6068404|NCT00467779|20962272|P2|Stage 2|Adverse Event|0
6068405|NCT00467779|20962273|P1|Stage 2|Adverse Event|0
6068406|NCT00467779|20962259|P15|Stage 1A|Unspecified Reason|0
6068407|NCT00467779|20962260|P14|Stage 1A|Unspecified Reason|0
6068408|NCT00467779|20962261|P13|Stage 1A|Unspecified Reason|1
6068409|NCT00467779|20962262|P12|Stage 1A|Unspecified Reason|1
6068410|NCT00467779|20962263|P11|Stage 1A|Unspecified Reason|0
6068411|NCT00467779|20962264|P10|Stage 1A|Unspecified Reason|0
6068412|NCT00467779|20962265|P9|Stage 1A|Unspecified Reason|0
6068413|NCT00467779|20962266|P8|Stage 1A|Unspecified Reason|0
6068414|NCT00467779|20962267|P7|Stage 1A|Unspecified Reason|0
6068415|NCT00467779|20962268|P6|Stage 1A|Unspecified Reason|0
6068416|NCT00467779|20962269|P5|Stage 1A|Unspecified Reason|0
6068417|NCT00467779|20962270|P4|Stage 1A|Unspecified Reason|0
6068418|NCT00467779|20962271|P3|Stage 1A|Unspecified Reason|0
6068419|NCT00467779|20962272|P2|Stage 1A|Unspecified Reason|0
6068420|NCT00467779|20962273|P1|Stage 1A|Unspecified Reason|0
6068421|NCT00467779|20962259|P15|Stage 1A|Withdrawal by Subject|0
6068422|NCT00467779|20962260|P14|Stage 1A|Withdrawal by Subject|0
6068423|NCT00467779|20962261|P13|Stage 1A|Withdrawal by Subject|1
6068424|NCT00467779|20962262|P12|Stage 1A|Withdrawal by Subject|1
6068425|NCT00467779|20962263|P11|Stage 1A|Withdrawal by Subject|1
6068426|NCT00467779|20962264|P10|Stage 1A|Withdrawal by Subject|0
6068427|NCT00467779|20962265|P9|Stage 1A|Withdrawal by Subject|0
6068428|NCT00467779|20962266|P8|Stage 1A|Withdrawal by Subject|0
6068429|NCT00467779|20962267|P7|Stage 1A|Withdrawal by Subject|0
6068430|NCT00467779|20962268|P6|Stage 1A|Withdrawal by Subject|0
6068431|NCT00467779|20962269|P5|Stage 1A|Withdrawal by Subject|0
6068432|NCT00467779|20962270|P4|Stage 1A|Withdrawal by Subject|0
6068433|NCT00467779|20962271|P3|Stage 1A|Withdrawal by Subject|0
6068434|NCT00467779|20962272|P2|Stage 1A|Withdrawal by Subject|0
6068435|NCT00467779|20962273|P1|Stage 1A|Withdrawal by Subject|0
6068436|NCT00467779|20962259|P15|Stage 1A|Physician Decision|0
6068437|NCT00467779|20962260|P14|Stage 1A|Physician Decision|0
6068438|NCT00467779|20962261|P13|Stage 1A|Physician Decision|0
6068439|NCT00467779|20962262|P12|Stage 1A|Physician Decision|0
6068440|NCT00467779|20962263|P11|Stage 1A|Physician Decision|0
6068441|NCT00467779|20962264|P10|Stage 1A|Physician Decision|1
6068442|NCT00467779|20962265|P9|Stage 1A|Physician Decision|0
6068443|NCT00467779|20962266|P8|Stage 1A|Physician Decision|0
6068444|NCT00467779|20962267|P7|Stage 1A|Physician Decision|0
6068445|NCT00467779|20962268|P6|Stage 1A|Physician Decision|0
6068446|NCT00467779|20962269|P5|Stage 1A|Physician Decision|0
6068447|NCT00467779|20962270|P4|Stage 1A|Physician Decision|0
6068448|NCT00467779|20962271|P3|Stage 1A|Physician Decision|0
6068449|NCT00467779|20962272|P2|Stage 1A|Physician Decision|0
6068450|NCT00467779|20962273|P1|Stage 1A|Physician Decision|0
6068451|NCT00467779|20962259|P15|Stage 1A|Disease Progression|0
6068452|NCT00467779|20962260|P14|Stage 1A|Disease Progression|0
6068453|NCT00467779|20962261|P13|Stage 1A|Disease Progression|2
6068454|NCT00467779|20962262|P12|Stage 1A|Disease Progression|5
6068455|NCT00467779|20962263|P11|Stage 1A|Disease Progression|2
6068456|NCT00467779|20962264|P10|Stage 1A|Disease Progression|2
6068457|NCT00467779|20962265|P9|Stage 1A|Disease Progression|0
6068458|NCT00467779|20962266|P8|Stage 1A|Disease Progression|0
6068459|NCT00467779|20962267|P7|Stage 1A|Disease Progression|0
6068460|NCT00467779|20962268|P6|Stage 1A|Disease Progression|0
6068461|NCT00467779|20962269|P5|Stage 1A|Disease Progression|0
6068462|NCT00467779|20962270|P4|Stage 1A|Disease Progression|0
6068463|NCT00467779|20962271|P3|Stage 1A|Disease Progression|0
6068464|NCT00467779|20962272|P2|Stage 1A|Disease Progression|0
6068465|NCT00467779|20962273|P1|Stage 1A|Disease Progression|0
6068466|NCT00467779|20962259|P15|Stage 1A|Death|0
6068467|NCT00467779|20962260|P14|Stage 1A|Death|0
6068468|NCT00467779|20962261|P13|Stage 1A|Death|1
6068469|NCT00467779|20962262|P12|Stage 1A|Death|1
6068470|NCT00467779|20962263|P11|Stage 1A|Death|0
6068471|NCT00467779|20962264|P10|Stage 1A|Death|0
6068472|NCT00467779|20962265|P9|Stage 1A|Death|0
6068473|NCT00467779|20962266|P8|Stage 1A|Death|0
6068474|NCT00467779|20962267|P7|Stage 1A|Death|0
6068475|NCT00467779|20962268|P6|Stage 1A|Death|0
6068476|NCT00467779|20962269|P5|Stage 1A|Death|0
6068477|NCT00467779|20962270|P4|Stage 1A|Death|0
6068478|NCT00467779|20962271|P3|Stage 1A|Death|0
6068479|NCT00467779|20962272|P2|Stage 1A|Death|0
6068480|NCT00467779|20962273|P1|Stage 1A|Death|0
6068481|NCT00467779|20962259|P15|Stage 1A|Adverse Event|0
6068482|NCT00467779|20962260|P14|Stage 1A|Adverse Event|0
6068483|NCT00467779|20962261|P13|Stage 1A|Adverse Event|1
6068484|NCT00467779|20962262|P12|Stage 1A|Adverse Event|0
6068485|NCT00467779|20962263|P11|Stage 1A|Adverse Event|0
6068486|NCT00467779|20962264|P10|Stage 1A|Adverse Event|0
6068487|NCT00467779|20962265|P9|Stage 1A|Adverse Event|0
6068488|NCT00467779|20962266|P8|Stage 1A|Adverse Event|0
6068489|NCT00467779|20962267|P7|Stage 1A|Adverse Event|0
6068490|NCT00467779|20962268|P6|Stage 1A|Adverse Event|0
6068491|NCT00467779|20962269|P5|Stage 1A|Adverse Event|0
6068492|NCT00467779|20962270|P4|Stage 1A|Adverse Event|0
6068493|NCT00467779|20962271|P3|Stage 1A|Adverse Event|0
6068494|NCT00467779|20962272|P2|Stage 1A|Adverse Event|0
6068495|NCT00467779|20962273|P1|Stage 1A|Adverse Event|0
6068496|NCT00467779|20962259|P15|Stage 1|Withdrawal by Subject|0
6068497|NCT00467779|20962260|P14|Stage 1|Withdrawal by Subject|0
6068498|NCT00467779|20962261|P13|Stage 1|Withdrawal by Subject|0
6068499|NCT00467779|20962262|P12|Stage 1|Withdrawal by Subject|0
6068500|NCT00467779|20962263|P11|Stage 1|Withdrawal by Subject|0
6068501|NCT00467779|20962264|P10|Stage 1|Withdrawal by Subject|0
6068502|NCT00467779|20962265|P9|Stage 1|Withdrawal by Subject|0
6068503|NCT00467779|20962266|P8|Stage 1|Withdrawal by Subject|1
6068504|NCT00467779|20962267|P7|Stage 1|Withdrawal by Subject|1
6068505|NCT00467779|20962268|P6|Stage 1|Withdrawal by Subject|0
6068506|NCT00467779|20962269|P5|Stage 1|Withdrawal by Subject|0
6068507|NCT00467779|20962270|P4|Stage 1|Withdrawal by Subject|0
6068508|NCT00467779|20962271|P3|Stage 1|Withdrawal by Subject|0
6068509|NCT00467779|20962272|P2|Stage 1|Withdrawal by Subject|0
6068510|NCT00467779|20962273|P1|Stage 1|Withdrawal by Subject|0
6068511|NCT00467779|20962259|P15|Stage 1|Physician Decision|0
6068512|NCT00467779|20962260|P14|Stage 1|Physician Decision|0
6068513|NCT00467779|20962261|P13|Stage 1|Physician Decision|0
6068514|NCT00467779|20962262|P12|Stage 1|Physician Decision|0
6068515|NCT00467779|20962263|P11|Stage 1|Physician Decision|0
6068516|NCT00467779|20962264|P10|Stage 1|Physician Decision|0
6068517|NCT00467779|20962265|P9|Stage 1|Physician Decision|0
6068518|NCT00467779|20962266|P8|Stage 1|Physician Decision|0
6068519|NCT00467779|20962267|P7|Stage 1|Physician Decision|0
6068520|NCT00467779|20962268|P6|Stage 1|Physician Decision|0
6068521|NCT00467779|20962269|P5|Stage 1|Physician Decision|0
6068522|NCT00467779|20962270|P4|Stage 1|Physician Decision|0
6068523|NCT00467779|20962271|P3|Stage 1|Physician Decision|0
6068524|NCT00467779|20962272|P2|Stage 1|Physician Decision|1
6068525|NCT00467779|20962273|P1|Stage 1|Physician Decision|0
6068526|NCT00467779|20962259|P15|Stage 1|Unspecified Reason|0
6068527|NCT00467779|20962260|P14|Stage 1|Unspecified Reason|0
6068528|NCT00467779|20962261|P13|Stage 1|Unspecified Reason|0
6068529|NCT00467779|20962262|P12|Stage 1|Unspecified Reason|0
6068530|NCT00467779|20962263|P11|Stage 1|Unspecified Reason|0
6068531|NCT00467779|20962264|P10|Stage 1|Unspecified Reason|0
6068532|NCT00467779|20962265|P9|Stage 1|Unspecified Reason|0
6068533|NCT00467779|20962266|P8|Stage 1|Unspecified Reason|0
6068534|NCT00467779|20962267|P7|Stage 1|Unspecified Reason|0
6068535|NCT00467779|20962268|P6|Stage 1|Unspecified Reason|2
6068536|NCT00467779|20962269|P5|Stage 1|Unspecified Reason|1
6068537|NCT00467779|20962270|P4|Stage 1|Unspecified Reason|0
6068538|NCT00467779|20962271|P3|Stage 1|Unspecified Reason|1
6068539|NCT00467779|20962272|P2|Stage 1|Unspecified Reason|0
6068540|NCT00467779|20962273|P1|Stage 1|Unspecified Reason|1
6068541|NCT00467779|20962259|P15|Stage 1|Disease Progression|0
6068542|NCT00467779|20962260|P14|Stage 1|Disease Progression|0
6068543|NCT00467779|20962261|P13|Stage 1|Disease Progression|0
6068544|NCT00467779|20962262|P12|Stage 1|Disease Progression|0
6068545|NCT00467779|20962263|P11|Stage 1|Disease Progression|0
6068546|NCT00467779|20962264|P10|Stage 1|Disease Progression|0
6068547|NCT00467779|20962265|P9|Stage 1|Disease Progression|0
6068548|NCT00467779|20962266|P8|Stage 1|Disease Progression|5
6068549|NCT00467779|20962267|P7|Stage 1|Disease Progression|4
6068550|NCT00467779|20962268|P6|Stage 1|Disease Progression|2
6068551|NCT00467779|20962269|P5|Stage 1|Disease Progression|2
6068552|NCT00467779|20962270|P4|Stage 1|Disease Progression|3
6068553|NCT00467779|20962271|P3|Stage 1|Disease Progression|2
6068554|NCT00467779|20962272|P2|Stage 1|Disease Progression|2
6068555|NCT00467779|20962273|P1|Stage 1|Disease Progression|2
6068556|NCT00467779|20962259|P15|Stage 1|Adverse Event|0
6068557|NCT00467779|20962260|P14|Stage 1|Adverse Event|0
6068558|NCT00467779|20962261|P13|Stage 1|Adverse Event|0
6068559|NCT00467779|20962262|P12|Stage 1|Adverse Event|0
6068560|NCT00467779|20962263|P11|Stage 1|Adverse Event|0
6068561|NCT00467779|20962264|P10|Stage 1|Adverse Event|0
6068562|NCT00467779|20962265|P9|Stage 1|Adverse Event|0
6068563|NCT00467779|20962266|P8|Stage 1|Adverse Event|1
6068564|NCT00467779|20962267|P7|Stage 1|Adverse Event|2
6068565|NCT00467779|20962268|P6|Stage 1|Adverse Event|1
6068566|NCT00467779|20962269|P5|Stage 1|Adverse Event|0
6068567|NCT00467779|20962270|P4|Stage 1|Adverse Event|0
6068568|NCT00467779|20962271|P3|Stage 1|Adverse Event|0
6068569|NCT00467779|20962272|P2|Stage 1|Adverse Event|0
6068570|NCT00467779|20962273|P1|Stage 1|Adverse Event|1
6068571|NCT00467753|20962447|P2|Overall Study|Adverse Event|0
6068572|NCT00467753|20962448|P1|Overall Study|Adverse Event|2
6068573|NCT00467753|20962447|P2|Overall Study|Lost to Follow-up|2
6068574|NCT00467753|20962448|P1|Overall Study|Lost to Follow-up|1
6068575|NCT00467740|20962465|P5|Overall Study|Lack of Efficacy|0
6068576|NCT00467740|20962466|P4|Overall Study|Lack of Efficacy|0
6068577|NCT00467740|20962467|P3|Overall Study|Lack of Efficacy|0
6068578|NCT00467740|20962468|P2|Overall Study|Lack of Efficacy|1
6068579|NCT00467740|20962469|P1|Overall Study|Lack of Efficacy|0
6068580|NCT00467740|20962465|P5|Overall Study|Withdrawal by Subject|0
6068581|NCT00467740|20962466|P4|Overall Study|Withdrawal by Subject|1
6068582|NCT00467740|20962467|P3|Overall Study|Withdrawal by Subject|0
6068583|NCT00467740|20962468|P2|Overall Study|Withdrawal by Subject|1
6068584|NCT00467740|20962469|P1|Overall Study|Withdrawal by Subject|1
6068585|NCT00467740|20962465|P5|Overall Study|Lost to Follow-up|0
6068586|NCT00467740|20962466|P4|Overall Study|Lost to Follow-up|0
6068587|NCT00467740|20962467|P3|Overall Study|Lost to Follow-up|0
6068588|NCT00467740|20962468|P2|Overall Study|Lost to Follow-up|1
6068589|NCT00467740|20962469|P1|Overall Study|Lost to Follow-up|0
6068590|NCT00467740|20962465|P5|Overall Study|Protocol Violation|0
6068591|NCT00467740|20962466|P4|Overall Study|Protocol Violation|0
6068592|NCT00467740|20962467|P3|Overall Study|Protocol Violation|1
6068593|NCT00467740|20962468|P2|Overall Study|Protocol Violation|0
6068594|NCT00467740|20962469|P1|Overall Study|Protocol Violation|0
6068595|NCT00467740|20962465|P5|Overall Study|Adverse Event|0
6068596|NCT00467740|20962466|P4|Overall Study|Adverse Event|0
6068597|NCT00467740|20962467|P3|Overall Study|Adverse Event|1
6068598|NCT00467740|20962468|P2|Overall Study|Adverse Event|0
6068599|NCT00467740|20962469|P1|Overall Study|Adverse Event|0
6068600|NCT00467649|20962658|P6|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|1
6068601|NCT00467649|20962659|P5|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0
6068602|NCT00467649|20962660|P4|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0
6068603|NCT00467649|20962661|P3|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0
6068604|NCT00467649|20962662|P2|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0
6068605|NCT00467649|20962663|P1|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0
6068606|NCT00467649|20962658|P6|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0
6068607|NCT00467649|20962659|P5|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0
6068608|NCT00467649|20962660|P4|Phase 2 (Intent-to-Treat Population)|Protocol Violation|1
6068609|NCT00467649|20962661|P3|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0
6068610|NCT00467649|20962662|P2|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0
6068611|NCT00467649|20962663|P1|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0
6068612|NCT00467649|20962658|P6|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0
6068613|NCT00467649|20962659|P5|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0
6068614|NCT00467649|20962660|P4|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|1
6068615|NCT00467649|20962661|P3|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0
6068616|NCT00467649|20962662|P2|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0
6068617|NCT00467649|20962663|P1|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0
6068618|NCT00467649|20962658|P6|Phase 1 (Randomized Population)|Withdrawal of Consent|0
6068619|NCT00467649|20962659|P5|Phase 1 (Randomized Population)|Withdrawal of Consent|0
6068620|NCT00467649|20962660|P4|Phase 1 (Randomized Population)|Withdrawal of Consent|0
6068621|NCT00467649|20962661|P3|Phase 1 (Randomized Population)|Withdrawal of Consent|0
6068622|NCT00467649|20962662|P2|Phase 1 (Randomized Population)|Withdrawal of Consent|2
6068623|NCT00467649|20962663|P1|Phase 1 (Randomized Population)|Withdrawal of Consent|4
6068624|NCT00467649|20962658|P6|Phase 1 (Randomized Population)|Lost to Follow-up|0
6068625|NCT00467649|20962659|P5|Phase 1 (Randomized Population)|Lost to Follow-up|0
6068626|NCT00467649|20962660|P4|Phase 1 (Randomized Population)|Lost to Follow-up|0
6068627|NCT00467649|20962661|P3|Phase 1 (Randomized Population)|Lost to Follow-up|0
6068628|NCT00467649|20962662|P2|Phase 1 (Randomized Population)|Lost to Follow-up|4
6068629|NCT00467649|20962663|P1|Phase 1 (Randomized Population)|Lost to Follow-up|2
6068630|NCT00467649|20962658|P6|Phase 1 (Randomized Population)|Investigator Decision|0
6068631|NCT00467649|20962659|P5|Phase 1 (Randomized Population)|Investigator Decision|0
6068632|NCT00467649|20962660|P4|Phase 1 (Randomized Population)|Investigator Decision|0
6068633|NCT00467649|20962661|P3|Phase 1 (Randomized Population)|Investigator Decision|0
6068634|NCT00467649|20962662|P2|Phase 1 (Randomized Population)|Investigator Decision|0
6068635|NCT00467649|20962663|P1|Phase 1 (Randomized Population)|Investigator Decision|1
6068636|NCT00467649|20962658|P6|Phase 1 (Randomized Population)|Adverse Event|0
6068637|NCT00467649|20962659|P5|Phase 1 (Randomized Population)|Adverse Event|0
6068638|NCT00467649|20962660|P4|Phase 1 (Randomized Population)|Adverse Event|0
6068639|NCT00467649|20962661|P3|Phase 1 (Randomized Population)|Adverse Event|0
6068640|NCT00467649|20962662|P2|Phase 1 (Randomized Population)|Adverse Event|0
6068641|NCT00467649|20962663|P1|Phase 1 (Randomized Population)|Adverse Event|2
6068642|NCT00467610|20962703|P1|Overall Study|Withdrawal by Subject|1
6068643|NCT00467597|20962714|P2|Overall Study|Withdrawal by Subject|0
6068644|NCT00467597|20962715|P1|Overall Study|Withdrawal by Subject|2
6068645|NCT00467584|20962728|P3|Overall Study|Withdrawal by Subject|1
6068646|NCT00467584|20962729|P2|Overall Study|Withdrawal by Subject|5
6068647|NCT00467584|20962730|P1|Overall Study|Withdrawal by Subject|4
6068648|NCT00467558|20962740|P2|Overall Study|Lost to Follow-up|0
6068649|NCT00467558|20962741|P1|Overall Study|Lost to Follow-up|2
6068650|NCT00467519|20962751|P2|Overall Study|Withdrawal by Subject|10
6068651|NCT00467519|20962752|P1|Overall Study|Withdrawal by Subject|4
6068652|NCT00467519|20962751|P2|Overall Study|Lost to Follow-up|9
6068653|NCT00467519|20962752|P1|Overall Study|Lost to Follow-up|2
6068654|NCT00467519|20962751|P2|Overall Study|Protocol Violation|4
6068655|NCT00467519|20962752|P1|Overall Study|Protocol Violation|8
6068656|NCT00467363|20962781|P2|Overall Study|Lost to Follow-up|70
6068657|NCT00467363|20962782|P1|Overall Study|Lost to Follow-up|80
6068658|NCT00467285|20962838|P2|Overall Study|Lost to Follow-up|4
6068659|NCT00467285|20962839|P1|Overall Study|Lost to Follow-up|4
6068660|NCT00467259|20962859|P2|Overall Study|Site Closed|1
6068661|NCT00467259|20962860|P1|Overall Study|Site Closed|2
6068662|NCT00467259|20962859|P2|Overall Study|Lost to Follow-up|34
6068663|NCT00467259|20962860|P1|Overall Study|Lost to Follow-up|14
6068664|NCT00467259|20962859|P2|Overall Study|Physician Decision|2
6068665|NCT00467259|20962860|P1|Overall Study|Physician Decision|0
6068666|NCT00467259|20962859|P2|Overall Study|Withdrawal by Subject|108
6068667|NCT00467259|20962860|P1|Overall Study|Withdrawal by Subject|34
6068668|NCT00467259|20962859|P2|Overall Study|Protocol Violation|7
6068669|NCT00467259|20962860|P1|Overall Study|Protocol Violation|1
6068670|NCT00467259|20962859|P2|Overall Study|Adverse Event|90
6068671|NCT00467259|20962860|P1|Overall Study|Adverse Event|24
6068672|NCT00467051|20962877|P1|Overall Study|Adverse Event|2
6068673|NCT00466947|20962904|P2|Study End Analysis Period|Other - Unconformity in team's treatment|1
6068674|NCT00466947|20962905|P1|Study End Analysis Period|Other - Unconformity in team's treatment|0
6068675|NCT00466947|20962904|P2|Study End Analysis Period|Other - Subject without a legal guardian|0
6068676|NCT00466947|20962905|P1|Study End Analysis Period|Other - Subject without a legal guardian|1
6068677|NCT00466947|20962904|P2|Study End Analysis Period|Other - Forbidden vaccination|10
6068678|NCT00466947|20962905|P1|Study End Analysis Period|Other - Forbidden vaccination|21
6068679|NCT00466947|20962904|P2|Study End Analysis Period|Withdrawal by Subject|1267
6068680|NCT00466947|20962905|P1|Study End Analysis Period|Withdrawal by Subject|1264
6068681|NCT00466947|20962904|P2|Study End Analysis Period|Protocol Violation|17
6068682|NCT00466947|20962905|P1|Study End Analysis Period|Protocol Violation|9
6068683|NCT00466947|20962904|P2|Study End Analysis Period|Physician Decision|29
6068684|NCT00466947|20962905|P1|Study End Analysis Period|Physician Decision|29
6068685|NCT00466947|20962904|P2|Study End Analysis Period|Lost to Follow-up|1167
6068686|NCT00466947|20962905|P1|Study End Analysis Period|Lost to Follow-up|1137
6068687|NCT00466947|20962904|P2|Study End Analysis Period|Adverse Event|43
6068688|NCT00466947|20962905|P1|Study End Analysis Period|Adverse Event|35
6068689|NCT00466947|20962904|P2|Primary Outcome Analysis Period|Other: study still ongoing|11863
6068690|NCT00466947|20962905|P1|Primary Outcome Analysis Period|Other: study still ongoing|11875
6068691|NCT00466921|20963027|P1|Follow up for a Minimum of 1 Year|Death|6
6068692|NCT00466921|20963027|P1|Completed 4 Cycles/Reached 1st Response|Other|1
6068693|NCT00466921|20963027|P1|Completed 4 Cycles/Reached 1st Response|Progressive Disease|2
6068694|NCT00466921|20963027|P1|Completed 4 Cycles/Reached 1st Response|Withdrawal by Subject|2
6068695|NCT00466921|20963027|P1|First 3 Cycles of Treatment|Withdrawal by Subject|5
6068696|NCT00466921|20963027|P1|First 3 Cycles of Treatment|Adverse Event|2
6068697|NCT00466726|20963103|P1|Overall Study|Not evaluable for response|14
6068698|NCT00466687|20963109|P1|Overall Study|Disease progression|29
6068699|NCT00466687|20963109|P1|Overall Study|Withdrawal by Subject|1
6068700|NCT00466687|20963109|P1|Overall Study|Other complicating illness|3
6068701|NCT00466687|20963109|P1|Overall Study|Adverse Event|1
6068702|NCT00466505|20963141|P1|Overall Study|Adverse Event|4
6068703|NCT00466505|20963141|P1|Overall Study|disease progression|13
6068704|NCT00466440|20963156|P3|Overall Study|Sponsor decision|1
6068705|NCT00466440|20963157|P2|Overall Study|Sponsor decision|0
6068706|NCT00466440|20963158|P1|Overall Study|Sponsor decision|0
6068707|NCT00466440|20963156|P3|Overall Study|Withdrawal by Subject|0
6068708|NCT00466440|20963157|P2|Overall Study|Withdrawal by Subject|1
6068709|NCT00466440|20963158|P1|Overall Study|Withdrawal by Subject|0
6068710|NCT00466440|20963156|P3|Overall Study|Protocol entry criteria not met|4
6068711|NCT00466440|20963157|P2|Overall Study|Protocol entry criteria not met|0
6068712|NCT00466440|20963158|P1|Overall Study|Protocol entry criteria not met|0
6068713|NCT00466440|20963156|P3|Overall Study|Physician Decision|2
6068714|NCT00466440|20963157|P2|Overall Study|Physician Decision|1
6068715|NCT00466440|20963158|P1|Overall Study|Physician Decision|0
6068716|NCT00466440|20963156|P3|Overall Study|Lost to Follow-up|0
6068717|NCT00466440|20963157|P2|Overall Study|Lost to Follow-up|1
6068718|NCT00466440|20963158|P1|Overall Study|Lost to Follow-up|0
6068719|NCT00466440|20963156|P3|Overall Study|Progressive disease|4
6068720|NCT00466440|20963157|P2|Overall Study|Progressive disease|5
6068721|NCT00466440|20963158|P1|Overall Study|Progressive disease|13
6068722|NCT00466440|20963156|P3|Overall Study|Death|0
6068723|NCT00466440|20963157|P2|Overall Study|Death|1
6068724|NCT00466440|20963158|P1|Overall Study|Death|1
6068725|NCT00466440|20963156|P3|Overall Study|Adverse Event|1
6068726|NCT00466440|20963157|P2|Overall Study|Adverse Event|3
6068727|NCT00466440|20963158|P1|Overall Study|Adverse Event|0
6068728|NCT00466193|20963233|P2|Overall Study|Patient refused Visit 4 procedures|0
6068729|NCT00466193|20963234|P1|Overall Study|Patient refused Visit 4 procedures|1
6068730|NCT00466193|20963233|P2|Overall Study|Withdrawal by Subject|2
6068731|NCT00466193|20963234|P1|Overall Study|Withdrawal by Subject|7
6068732|NCT00466193|20963233|P2|Overall Study|Protocol Violation|1
6068733|NCT00466193|20963234|P1|Overall Study|Protocol Violation|1
6068734|NCT00466193|20963233|P2|Overall Study|Physician Decision|0
6068735|NCT00466193|20963234|P1|Overall Study|Physician Decision|1
6068736|NCT00466193|20963233|P2|Overall Study|Lost to Follow-up|4
6068737|NCT00466193|20963234|P1|Overall Study|Lost to Follow-up|2
6068738|NCT00466193|20963233|P2|Overall Study|Adverse Event|1
6068739|NCT00466193|20963234|P1|Overall Study|Adverse Event|0
6068740|NCT00466167|20963261|P3|Overall Study|Not treated|0
6068741|NCT00466167|20963262|P2|Overall Study|Not treated|0
6068742|NCT00466167|20963263|P1|Overall Study|Not treated|1
6068743|NCT00466167|20963261|P3|Overall Study|patient did not meet inclusion criteria|1
6068744|NCT00466167|20963262|P2|Overall Study|patient did not meet inclusion criteria|0
6068745|NCT00466167|20963263|P1|Overall Study|patient did not meet inclusion criteria|1
6068746|NCT00466167|20963261|P3|Overall Study|Withdrawal by Subject|6
6068747|NCT00466167|20963262|P2|Overall Study|Withdrawal by Subject|1
6068748|NCT00466167|20963263|P1|Overall Study|Withdrawal by Subject|4
6068749|NCT00466167|20963261|P3|Overall Study|Lost to Follow-up|2
6068750|NCT00466167|20963262|P2|Overall Study|Lost to Follow-up|2
6068751|NCT00466167|20963263|P1|Overall Study|Lost to Follow-up|3
6068752|NCT00466167|20963261|P3|Overall Study|Protocol Violation|2
6068753|NCT00466167|20963262|P2|Overall Study|Protocol Violation|1
6068754|NCT00466167|20963263|P1|Overall Study|Protocol Violation|1
6068755|NCT00466167|20963261|P3|Overall Study|Lack of Efficacy|3
6068756|NCT00466167|20963262|P2|Overall Study|Lack of Efficacy|0
6068757|NCT00466167|20963263|P1|Overall Study|Lack of Efficacy|2
6068758|NCT00466167|20963261|P3|Overall Study|Adverse Event|7
6068759|NCT00466167|20963262|P2|Overall Study|Adverse Event|8
6068760|NCT00466167|20963263|P1|Overall Study|Adverse Event|8
6068761|NCT00465985|20963324|P2|Part III - Open-label Treatment Period|Adverse Event|0
6068762|NCT00465985|20963325|P1|Part III - Open-label Treatment Period|Adverse Event|1
6068763|NCT00465985|20963324|P2|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|0
6068764|NCT00465985|20963325|P1|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|1
6068765|NCT00465985|20963324|P2|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|12
6068766|NCT00465985|20963325|P1|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|0
6068767|NCT00465985|20963324|P2|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|0
6068768|NCT00465985|20963325|P1|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|4
6068769|NCT00465972|20963348|P2|Overall Study|Withdrawal by Subject|1
6068770|NCT00465972|20963349|P1|Overall Study|Withdrawal by Subject|2
6068771|NCT00465894|20963359|P2|Treatment For 12 Weeks|Withdrawal by Subject|1
6068772|NCT00465894|20963360|P1|Treatment For 12 Weeks|Withdrawal by Subject|0
6068773|NCT00465894|20963359|P2|Treatment For 12 Weeks|Family Issues|1
6068774|NCT00465894|20963360|P1|Treatment For 12 Weeks|Family Issues|1
6068775|NCT00465894|20963359|P2|Treatment For 12 Weeks|Lost to Follow-up|1
6068776|NCT00465894|20963360|P1|Treatment For 12 Weeks|Lost to Follow-up|4
6068777|NCT00465816|20963393|P3|Overall Study|Lost to Follow-up|2
6068778|NCT00465816|20963394|P2|Overall Study|Lost to Follow-up|0
6068779|NCT00465816|20963395|P1|Overall Study|Lost to Follow-up|0
6068780|NCT00465738|20963458|P2|Overall Study|Other|5
6068781|NCT00465738|20963459|P1|Overall Study|Other|2
6068782|NCT00465738|20963458|P2|Overall Study|Withdrawal by Subject|0
6068783|NCT00465738|20963459|P1|Overall Study|Withdrawal by Subject|2
6068784|NCT00465738|20963458|P2|Overall Study|Adverse Event|1
6068785|NCT00465738|20963459|P1|Overall Study|Adverse Event|0
6068786|NCT00465738|20963458|P2|Overall Study|Lost to Follow-up|0
6068787|NCT00465738|20963459|P1|Overall Study|Lost to Follow-up|2
6068788|NCT00465647|20963553|P4|Overall Study|"The other reasons included loss of IV"|2
6068789|NCT00465647|20963554|P3|Overall Study|"The other reasons included loss of IV"|3
6068790|NCT00465647|20963555|P2|Overall Study|"The other reasons included loss of IV"|4
6068791|NCT00465647|20963556|P1|Overall Study|"The other reasons included loss of IV"|8
6068792|NCT00465647|20963553|P4|Overall Study|Withdrawal by Subject|7
6068793|NCT00465647|20963554|P3|Overall Study|Withdrawal by Subject|2
6068794|NCT00465647|20963555|P2|Overall Study|Withdrawal by Subject|2
6068795|NCT00465647|20963556|P1|Overall Study|Withdrawal by Subject|1
6068796|NCT00465647|20963553|P4|Overall Study|Adverse Event|2
6068797|NCT00465647|20963554|P3|Overall Study|Adverse Event|3
6068798|NCT00465647|20963555|P2|Overall Study|Adverse Event|0
6068799|NCT00465647|20963556|P1|Overall Study|Adverse Event|2
6068800|NCT00465647|20963553|P4|Overall Study|Administrative|2
6068801|NCT00465647|20963554|P3|Overall Study|Administrative|3
6068802|NCT00465647|20963555|P2|Overall Study|Administrative|2
6068803|NCT00465647|20963556|P1|Overall Study|Administrative|2
6068804|NCT00465569|20963604|P2|Overall Study|persistent eczema during dose escalation|0
6068805|NCT00465569|20963605|P1|Overall Study|persistent eczema during dose escalation|1
6068806|NCT00465361|20963628|P1|Baseline Assessment|Personal Issues/Scheduling|4
6068807|NCT00465270|20963634|P2|Overall Study|Investigator request|4
6068808|NCT00465270|20963635|P1|Overall Study|Investigator request|3
6068809|NCT00465270|20963634|P2|Overall Study|Lost to Follow-up|67
6068810|NCT00465270|20963635|P1|Overall Study|Lost to Follow-up|60
6068811|NCT00465270|20963634|P2|Overall Study|Withdrawal by Subject|78
6068812|NCT00465270|20963635|P1|Overall Study|Withdrawal by Subject|34
6068813|NCT00465270|20963634|P2|Overall Study|Death|11
6068814|NCT00465270|20963635|P1|Overall Study|Death|7
6068815|NCT00465179|20963644|P1|Overall Study|Progression of Disease|47
6068816|NCT00465179|20963644|P1|Overall Study|Withdrawal by Subject|2
6068817|NCT00465179|20963644|P1|Overall Study|Adverse Event|4
6068818|NCT00465101|20963650|P1|Overall Study|Withdrew consent prior to procedure|3
6068819|NCT00465101|20963650|P1|Overall Study|Physician Decision|1
6068820|NCT00465101|20963650|P1|Overall Study|Withdrawal by Subject|25
6068821|NCT00465101|20963650|P1|Overall Study|Death|3
6068822|NCT00465101|20963650|P1|Overall Study|Unable to obtain IRB approval|1
6068823|NCT00465101|20963650|P1|Overall Study|Site closed due to IRB expiration|1
6068824|NCT00465101|20963650|P1|Overall Study|Patient postponed procedure|1
6068825|NCT00465101|20963650|P1|Overall Study|Pt. Insurance not accepted at center|2
6068826|NCT00465101|20963650|P1|Overall Study|Other|6
6068827|NCT00465101|20963650|P1|Overall Study|Lost to Follow-up|5
6068828|NCT00465101|20963650|P1|Overall Study|Did not meet study criteria|4
6068829|NCT00465101|20963650|P1|Overall Study|Change in health precluded follow up|4
6068830|NCT00465101|20963650|P1|Overall Study|Aborted Proc./Treatment Not Attempted|3
6068831|NCT00464945|20963720|P2|Toddler Dose|Lost to Follow-up|1
6068832|NCT00464945|20963721|P1|Toddler Dose|Lost to Follow-up|0
6068833|NCT00464945|20963720|P2|After Infant Series|Withdrawal by Subject|2
6068834|NCT00464945|20963721|P1|After Infant Series|Withdrawal by Subject|0
6068835|NCT00464945|20963720|P2|Infant Series|Lost to Follow-up|0
6068836|NCT00464945|20963721|P1|Infant Series|Lost to Follow-up|1
6068837|NCT00464945|20963720|P2|Infant Series|Protocol Violation|0
6068838|NCT00464945|20963721|P1|Infant Series|Protocol Violation|1
6068839|NCT00464945|20963720|P2|Infant Series|Withdrawal by parent/guardian request|1
6068840|NCT00464945|20963721|P1|Infant Series|Withdrawal by parent/guardian request|2
6068841|NCT00464815|20963751|P2|Overall Study|Withdrawal by Subject|3
6068842|NCT00464815|20963752|P1|Overall Study|Withdrawal by Subject|6
6068843|NCT00464737|20963785|P3|Overall Study|Other: Subject's disability per sponsor|1
6068844|NCT00464737|20963786|P2|Overall Study|Other: Subject's disability per sponsor|0
6068845|NCT00464737|20963787|P1|Overall Study|Other: Subject's disability per sponsor|0
6068846|NCT00464737|20963785|P3|Overall Study|Other: Personal family reasons|1
6068847|NCT00464737|20963786|P2|Overall Study|Other: Personal family reasons|0
6068848|NCT00464737|20963787|P1|Overall Study|Other: Personal family reasons|0
6068849|NCT00464737|20963785|P3|Overall Study|Other: Study demands too great|0
6068850|NCT00464737|20963786|P2|Overall Study|Other: Study demands too great|1
6068851|NCT00464737|20963787|P1|Overall Study|Other: Study demands too great|0
6068852|NCT00464737|20963785|P3|Overall Study|Other: Subject left town; family illness|0
6068853|NCT00464737|20963786|P2|Overall Study|Other: Subject left town; family illness|0
6068854|NCT00464737|20963787|P1|Overall Study|Other: Subject left town; family illness|1
6068855|NCT00464737|20963785|P3|Overall Study|Other: Subject's schedule doesn't permit|0
6068856|NCT00464737|20963786|P2|Overall Study|Other: Subject's schedule doesn't permit|0
6068857|NCT00464737|20963787|P1|Overall Study|Other: Subject's schedule doesn't permit|1
6068858|NCT00464737|20963785|P3|Overall Study|Lost to Follow-up|5
6068859|NCT00464737|20963786|P2|Overall Study|Lost to Follow-up|2
6068860|NCT00464737|20963787|P1|Overall Study|Lost to Follow-up|5
6068861|NCT00464737|20963785|P3|Overall Study|Non-compliance|1
6068862|NCT00464737|20963786|P2|Overall Study|Non-compliance|1
6068863|NCT00464737|20963787|P1|Overall Study|Non-compliance|0
6068864|NCT00464737|20963785|P3|Overall Study|Protocol Violation|5
6068865|NCT00464737|20963786|P2|Overall Study|Protocol Violation|1
6068866|NCT00464737|20963787|P1|Overall Study|Protocol Violation|1
6068867|NCT00464737|20963785|P3|Overall Study|Withdrawal by Subject|5
6068868|NCT00464737|20963786|P2|Overall Study|Withdrawal by Subject|3
6068869|NCT00464737|20963787|P1|Overall Study|Withdrawal by Subject|5
6068870|NCT00464737|20963785|P3|Overall Study|Lack of Efficacy|4
6068871|NCT00464737|20963786|P2|Overall Study|Lack of Efficacy|7
6068872|NCT00464737|20963787|P1|Overall Study|Lack of Efficacy|7
6068873|NCT00464737|20963785|P3|Overall Study|Adverse Event|33
6068874|NCT00464737|20963786|P2|Overall Study|Adverse Event|17
6068875|NCT00464737|20963787|P1|Overall Study|Adverse Event|12
6068876|NCT00464672|20963867|P6|Overall Study|Lost to Follow-up|0
6068877|NCT00464672|20963868|P5|Overall Study|Lost to Follow-up|1
6068878|NCT00464672|20963869|P4|Overall Study|Lost to Follow-up|0
6068879|NCT00464672|20963870|P3|Overall Study|Lost to Follow-up|0
6068880|NCT00464672|20963871|P2|Overall Study|Lost to Follow-up|10
6068881|NCT00464672|20963872|P1|Overall Study|Lost to Follow-up|25
6068882|NCT00464672|20963867|P6|Overall Study|withdrawal of consent|4
6068883|NCT00464672|20963868|P5|Overall Study|withdrawal of consent|9
6068884|NCT00464672|20963869|P4|Overall Study|withdrawal of consent|1
6068885|NCT00464672|20963870|P3|Overall Study|withdrawal of consent|0
6068886|NCT00464672|20963871|P2|Overall Study|withdrawal of consent|0
6068887|NCT00464672|20963872|P1|Overall Study|withdrawal of consent|0
6068888|NCT00464620|20963951|P3|Overall Study|Use of prohibited concomitant medication|2
6068889|NCT00464620|20963952|P2|Overall Study|Use of prohibited concomitant medication|0
6068890|NCT00464620|20963953|P1|Overall Study|Use of prohibited concomitant medication|0
6068891|NCT00464620|20963951|P3|Overall Study|Ineligible sarcoma subtype|2
6068892|NCT00464620|20963952|P2|Overall Study|Ineligible sarcoma subtype|2
6068893|NCT00464620|20963953|P1|Overall Study|Ineligible sarcoma subtype|0
6068894|NCT00464620|20963951|P3|Overall Study|Withdrawal by Subject|3
6068895|NCT00464620|20963952|P2|Overall Study|Withdrawal by Subject|0
6068896|NCT00464620|20963953|P1|Overall Study|Withdrawal by Subject|1
6068897|NCT00464620|20963951|P3|Overall Study|Physician Decision|0
6068898|NCT00464620|20963952|P2|Overall Study|Physician Decision|0
6068899|NCT00464620|20963953|P1|Overall Study|Physician Decision|1
6068900|NCT00464568|20963980|P1|Overall Study|Adverse Event|2
6068901|NCT00464542|20964053|P1|Pre-treatment|Withdrawal by Subject|2
6068902|NCT00464490|20964060|P2|Overall Study|Physician Decision|11
6068903|NCT00464490|20964061|P1|Overall Study|Physician Decision|11
6068904|NCT00464334|20964108|P11|Overall Study|Withdrawal by Subject|0
6068905|NCT00464334|20964109|P10|Overall Study|Withdrawal by Subject|0
6068906|NCT00464334|20964110|P9|Overall Study|Withdrawal by Subject|3
6068907|NCT00464334|20964111|P8|Overall Study|Withdrawal by Subject|1
6068908|NCT00464334|20964112|P7|Overall Study|Withdrawal by Subject|2
6068909|NCT00464334|20964113|P6|Overall Study|Withdrawal by Subject|2
6068910|NCT00464334|20964114|P5|Overall Study|Withdrawal by Subject|2
6068911|NCT00464334|20964115|P4|Overall Study|Withdrawal by Subject|2
6068912|NCT00464334|20964116|P3|Overall Study|Withdrawal by Subject|4
6068913|NCT00464334|20964117|P2|Overall Study|Withdrawal by Subject|7
6068914|NCT00464334|20964118|P1|Overall Study|Withdrawal by Subject|1
6068915|NCT00464334|20964108|P11|Overall Study|Study Terminated by Sponsor|0
6068916|NCT00464334|20964109|P10|Overall Study|Study Terminated by Sponsor|0
6068917|NCT00464334|20964110|P9|Overall Study|Study Terminated by Sponsor|0
6068918|NCT00464334|20964111|P8|Overall Study|Study Terminated by Sponsor|0
6068919|NCT00464334|20964112|P7|Overall Study|Study Terminated by Sponsor|0
6068920|NCT00464334|20964113|P6|Overall Study|Study Terminated by Sponsor|0
6068921|NCT00464334|20964114|P5|Overall Study|Study Terminated by Sponsor|0
6068922|NCT00464334|20964115|P4|Overall Study|Study Terminated by Sponsor|1
6068923|NCT00464334|20964116|P3|Overall Study|Study Terminated by Sponsor|0
6068924|NCT00464334|20964117|P2|Overall Study|Study Terminated by Sponsor|0
6068925|NCT00464334|20964118|P1|Overall Study|Study Terminated by Sponsor|0
6068926|NCT00464334|20964108|P11|Overall Study|Progressive Disease|0
6068927|NCT00464334|20964109|P10|Overall Study|Progressive Disease|0
6068928|NCT00464334|20964110|P9|Overall Study|Progressive Disease|1
6068929|NCT00464334|20964111|P8|Overall Study|Progressive Disease|0
6068930|NCT00464334|20964112|P7|Overall Study|Progressive Disease|0
6068931|NCT00464334|20964113|P6|Overall Study|Progressive Disease|1
6068932|NCT00464334|20964114|P5|Overall Study|Progressive Disease|0
6068933|NCT00464334|20964115|P4|Overall Study|Progressive Disease|0
6068934|NCT00464334|20964116|P3|Overall Study|Progressive Disease|0
6068935|NCT00464334|20964117|P2|Overall Study|Progressive Disease|0
6068936|NCT00464334|20964118|P1|Overall Study|Progressive Disease|0
6068937|NCT00464334|20964108|P11|Overall Study|Lost to Follow-up|2
6068938|NCT00464334|20964109|P10|Overall Study|Lost to Follow-up|0
6068939|NCT00464334|20964110|P9|Overall Study|Lost to Follow-up|0
6068940|NCT00464334|20964111|P8|Overall Study|Lost to Follow-up|0
6068941|NCT00464334|20964112|P7|Overall Study|Lost to Follow-up|1
6068942|NCT00464334|20964113|P6|Overall Study|Lost to Follow-up|0
6068943|NCT00464334|20964114|P5|Overall Study|Lost to Follow-up|1
6068944|NCT00464334|20964115|P4|Overall Study|Lost to Follow-up|0
6068945|NCT00464334|20964116|P3|Overall Study|Lost to Follow-up|1
6068946|NCT00464334|20964117|P2|Overall Study|Lost to Follow-up|0
6068947|NCT00464334|20964118|P1|Overall Study|Lost to Follow-up|0
6068948|NCT00464334|20964108|P11|Overall Study|Lack of Efficacy|0
6068949|NCT00464334|20964109|P10|Overall Study|Lack of Efficacy|0
6068950|NCT00464334|20964110|P9|Overall Study|Lack of Efficacy|0
6068951|NCT00464334|20964111|P8|Overall Study|Lack of Efficacy|0
6068952|NCT00464334|20964112|P7|Overall Study|Lack of Efficacy|0
6068953|NCT00464334|20964113|P6|Overall Study|Lack of Efficacy|0
6068954|NCT00464334|20964114|P5|Overall Study|Lack of Efficacy|0
6068955|NCT00464334|20964115|P4|Overall Study|Lack of Efficacy|0
6068956|NCT00464334|20964116|P3|Overall Study|Lack of Efficacy|0
6068957|NCT00464334|20964117|P2|Overall Study|Lack of Efficacy|1
6068958|NCT00464334|20964118|P1|Overall Study|Lack of Efficacy|0
6068959|NCT00464334|20964108|P11|Overall Study|Adverse Event|2
6068960|NCT00464334|20964109|P10|Overall Study|Adverse Event|1
6068961|NCT00464334|20964110|P9|Overall Study|Adverse Event|2
6068962|NCT00464334|20964111|P8|Overall Study|Adverse Event|0
6068963|NCT00464334|20964112|P7|Overall Study|Adverse Event|0
6068964|NCT00464334|20964113|P6|Overall Study|Adverse Event|1
6068965|NCT00464334|20964114|P5|Overall Study|Adverse Event|1
6068966|NCT00464334|20964115|P4|Overall Study|Adverse Event|1
6068967|NCT00464334|20964116|P3|Overall Study|Adverse Event|0
6068968|NCT00464334|20964117|P2|Overall Study|Adverse Event|0
6068969|NCT00464334|20964118|P1|Overall Study|Adverse Event|0
6068970|NCT00464308|20964178|P3|Overall Study|Physician Decision|0
6068971|NCT00464308|20964179|P2|Overall Study|Physician Decision|0
6068972|NCT00464308|20964180|P1|Overall Study|Physician Decision|1
6068973|NCT00464308|20964178|P3|Overall Study|Patient discontinued and other reasons|23
6068974|NCT00464308|20964179|P2|Overall Study|Patient discontinued and other reasons|17
6068975|NCT00464308|20964180|P1|Overall Study|Patient discontinued and other reasons|17
6068976|NCT00464308|20964178|P3|Overall Study|Lost to Follow-up|20
6068977|NCT00464308|20964179|P2|Overall Study|Lost to Follow-up|19
6068978|NCT00464308|20964180|P1|Overall Study|Lost to Follow-up|29
6068979|NCT00464308|20964178|P3|Overall Study|Adverse Event|16
6068980|NCT00464308|20964179|P2|Overall Study|Adverse Event|27
6068981|NCT00464308|20964180|P1|Overall Study|Adverse Event|22
6068982|NCT00464269|20964210|P4|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
6068983|NCT00464269|20964211|P3|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1
6068984|NCT00464269|20964212|P2|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
6068985|NCT00464269|20964213|P1|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
6068986|NCT00464269|20964210|P4|Overall Study|AE, non-serious non-fatal|4
6068987|NCT00464269|20964211|P3|Overall Study|AE, non-serious non-fatal|3
6068988|NCT00464269|20964212|P2|Overall Study|AE, non-serious non-fatal|8
6068989|NCT00464269|20964213|P1|Overall Study|AE, non-serious non-fatal|2
6068990|NCT00464269|20964210|P4|Overall Study|SAE, non-fatal|1
6068991|NCT00464269|20964211|P3|Overall Study|SAE, non-fatal|0
6068992|NCT00464269|20964212|P2|Overall Study|SAE, non-fatal|0
6068993|NCT00464269|20964213|P1|Overall Study|SAE, non-fatal|0
6068994|NCT00464269|20964210|P4|Overall Study|AE, serious fatal|1
6068995|NCT00464269|20964211|P3|Overall Study|AE, serious fatal|1
6068996|NCT00464269|20964212|P2|Overall Study|AE, serious fatal|0
6068997|NCT00464269|20964213|P1|Overall Study|AE, serious fatal|0
6068998|NCT00464269|20964210|P4|Overall Study|Other reason|1
6068999|NCT00464269|20964211|P3|Overall Study|Other reason|1
6069000|NCT00464269|20964212|P2|Overall Study|Other reason|3
6069001|NCT00464269|20964213|P1|Overall Study|Other reason|3
6069002|NCT00464269|20964210|P4|Overall Study|Withdrawal by Subject|1
6069003|NCT00464269|20964211|P3|Overall Study|Withdrawal by Subject|1
6069004|NCT00464269|20964212|P2|Overall Study|Withdrawal by Subject|2
6069005|NCT00464269|20964213|P1|Overall Study|Withdrawal by Subject|0
6069006|NCT00464269|20964210|P4|Overall Study|Lost to Follow-up|1
6069007|NCT00464269|20964211|P3|Overall Study|Lost to Follow-up|0
6069008|NCT00464269|20964212|P2|Overall Study|Lost to Follow-up|4
6069009|NCT00464269|20964213|P1|Overall Study|Lost to Follow-up|0
6069010|NCT00464269|20964210|P4|Overall Study|Lack of Efficacy|0
6069011|NCT00464269|20964211|P3|Overall Study|Lack of Efficacy|0
6069012|NCT00464269|20964212|P2|Overall Study|Lack of Efficacy|0
6069013|NCT00464269|20964213|P1|Overall Study|Lack of Efficacy|1
6069014|NCT00464087|20964351|P3|Overall Study|No PCI per inclusion criteria|29
6069015|NCT00464087|20964352|P2|Overall Study|No PCI per inclusion criteria|0
6069016|NCT00464087|20964353|P1|Overall Study|No PCI per inclusion criteria|0
6069017|NCT00463866|20964371|P2|Overall Study|Other|22
6069018|NCT00463866|20964372|P1|Overall Study|Other|22
6069019|NCT00463866|20964371|P2|Overall Study|Mis-Randomization of subject|1
6069020|NCT00463866|20964372|P1|Overall Study|Mis-Randomization of subject|0
6069021|NCT00463866|20964371|P2|Overall Study|Safety Reason|3
6069022|NCT00463866|20964372|P1|Overall Study|Safety Reason|1
6069023|NCT00463866|20964371|P2|Overall Study|Severe Non-Compliance to Protocol|21
6069024|NCT00463866|20964372|P1|Overall Study|Severe Non-Compliance to Protocol|25
6069025|NCT00463866|20964371|P2|Overall Study|Incorrect Enrolment|66
6069026|NCT00463866|20964372|P1|Overall Study|Incorrect Enrolment|64
6069027|NCT00463866|20964371|P2|Overall Study|Lost to Follow-up|55
6069028|NCT00463866|20964372|P1|Overall Study|Lost to Follow-up|46
6069029|NCT00463866|20964371|P2|Overall Study|Withdrawal by Subject|79
6069030|NCT00463866|20964372|P1|Overall Study|Withdrawal by Subject|81
6069031|NCT00463866|20964371|P2|Overall Study|Adverse Event|93
6069032|NCT00463866|20964372|P1|Overall Study|Adverse Event|70
6069033|NCT00463840|20964392|P1|Overall Study|Adverse Event|3
6069034|NCT00463840|20964392|P1|Overall Study|Withdrawal by Subject|2
6069035|NCT00463840|20964392|P1|Overall Study|Disease progression|7
6069036|NCT00463801|20964397|P1|Overall Study|No longer require therapy|1
6069037|NCT00463801|20964397|P1|Overall Study|Lost to Follow-up|5
6069038|NCT00463801|20964397|P1|Overall Study|Adverse Event|4
6069039|NCT00463801|20964397|P1|Overall Study|Lack of Efficacy|2
6069040|NCT00463801|20964397|P1|Overall Study|Protocol Violation|1
6069041|NCT00463788|20964403|P2|Overall Study|Randomized but not treated|1
6069042|NCT00463788|20964404|P1|Overall Study|Randomized but not treated|1
6069043|NCT00463788|20964403|P2|Overall Study|Other|0
6069044|NCT00463788|20964404|P1|Overall Study|Other|3
6069045|NCT00463788|20964403|P2|Overall Study|Protocol Violation|1
6069046|NCT00463788|20964404|P1|Overall Study|Protocol Violation|0
6069047|NCT00463788|20964403|P2|Overall Study|Lost to Follow-up|0
6069048|NCT00463788|20964404|P1|Overall Study|Lost to Follow-up|1
6069049|NCT00463788|20964403|P2|Overall Study|Symptomatic Deterioration|3
6069050|NCT00463788|20964404|P1|Overall Study|Symptomatic Deterioration|2
6069051|NCT00463788|20964403|P2|Overall Study|Death|3
6069052|NCT00463788|20964404|P1|Overall Study|Death|4
6069053|NCT00463788|20964403|P2|Overall Study|Withdrawal by Subject|2
6069054|NCT00463788|20964404|P1|Overall Study|Withdrawal by Subject|6
6069055|NCT00463788|20964403|P2|Overall Study|Adverse Event|2
6069056|NCT00463788|20964404|P1|Overall Study|Adverse Event|6
6069057|NCT00463788|20964403|P2|Overall Study|Progressive Disease|42
6069058|NCT00463788|20964404|P1|Overall Study|Progressive Disease|86
6069059|NCT00463684|20964419|P1|Overall Study|Lost to Follow-up|3
6069060|NCT00463684|20964419|P1|Overall Study|Withdrawal by Subject|1
6069061|NCT00463606|20964437|P3|Overall Study|Protocol Violation|1
6069062|NCT00463606|20964438|P2|Overall Study|Protocol Violation|0
6069063|NCT00463606|20964439|P1|Overall Study|Protocol Violation|0
6069064|NCT00463606|20964437|P3|Overall Study|Participation in another ABT-335 trial|0
6069065|NCT00463606|20964438|P2|Overall Study|Participation in another ABT-335 trial|0
6069066|NCT00463606|20964439|P1|Overall Study|Participation in another ABT-335 trial|1
6069067|NCT00463606|20964437|P3|Overall Study|Patient randomized in error|0
6069068|NCT00463606|20964438|P2|Overall Study|Patient randomized in error|0
6069069|NCT00463606|20964439|P1|Overall Study|Patient randomized in error|1
6069070|NCT00463606|20964437|P3|Overall Study|Coordinator error|0
6069071|NCT00463606|20964438|P2|Overall Study|Coordinator error|0
6069072|NCT00463606|20964439|P1|Overall Study|Coordinator error|1
6069073|NCT00463606|20964437|P3|Overall Study|Exclusion criteria violation|0
6069074|NCT00463606|20964438|P2|Overall Study|Exclusion criteria violation|0
6069075|NCT00463606|20964439|P1|Overall Study|Exclusion criteria violation|2
6069076|NCT00463606|20964437|P3|Overall Study|Sponsor request|0
6069077|NCT00463606|20964438|P2|Overall Study|Sponsor request|1
6069078|NCT00463606|20964439|P1|Overall Study|Sponsor request|0
6069079|NCT00463606|20964437|P3|Overall Study|Physician Decision|0
6069080|NCT00463606|20964438|P2|Overall Study|Physician Decision|1
6069081|NCT00463606|20964439|P1|Overall Study|Physician Decision|0
6069082|NCT00463606|20964437|P3|Overall Study|Subject moved out of town|0
6069083|NCT00463606|20964438|P2|Overall Study|Subject moved out of town|0
6069084|NCT00463606|20964439|P1|Overall Study|Subject moved out of town|1
6069085|NCT00463606|20964437|P3|Overall Study|Subject noncompliance|0
6069086|NCT00463606|20964438|P2|Overall Study|Subject noncompliance|1
6069087|NCT00463606|20964439|P1|Overall Study|Subject noncompliance|1
6069088|NCT00463606|20964437|P3|Overall Study|Lost to Follow-up|3
6069089|NCT00463606|20964438|P2|Overall Study|Lost to Follow-up|2
6069090|NCT00463606|20964439|P1|Overall Study|Lost to Follow-up|2
6069091|NCT00463606|20964437|P3|Overall Study|Withdrawal by Subject|5
6069092|NCT00463606|20964438|P2|Overall Study|Withdrawal by Subject|11
6069093|NCT00463606|20964439|P1|Overall Study|Withdrawal by Subject|11
6069094|NCT00463606|20964437|P3|Overall Study|Adverse Event|11
6069095|NCT00463606|20964438|P2|Overall Study|Adverse Event|18
6069096|NCT00463606|20964439|P1|Overall Study|Adverse Event|21
6069097|NCT00463580|20964464|P2|Overall Study|Medical/psychiatric complications|2
6069098|NCT00463580|20964465|P1|Overall Study|Medical/psychiatric complications|0
6069099|NCT00463580|20964464|P2|Overall Study|Schedule conflict|0
6069100|NCT00463580|20964465|P1|Overall Study|Schedule conflict|2
6069101|NCT00463580|20964464|P2|Overall Study|Lost to Follow-up|0
6069102|NCT00463580|20964465|P1|Overall Study|Lost to Follow-up|1
6069103|NCT00463567|20964498|P7|Overall Study|Death|0
6069104|NCT00463567|20964499|P6|Overall Study|Death|0
6069105|NCT00463567|20964500|P5|Overall Study|Death|0
6069106|NCT00463567|20964501|P4|Overall Study|Death|0
6069107|NCT00463567|20964502|P3|Overall Study|Death|2
6069108|NCT00463567|20964503|P2|Overall Study|Death|0
6069109|NCT00463567|20964504|P1|Overall Study|Death|1
6069110|NCT00463567|20964498|P7|Overall Study|Abnormal test procedure result(s)|0
6069111|NCT00463567|20964499|P6|Overall Study|Abnormal test procedure result(s)|2
6069112|NCT00463567|20964500|P5|Overall Study|Abnormal test procedure result(s)|0
6069113|NCT00463567|20964501|P4|Overall Study|Abnormal test procedure result(s)|2
6069114|NCT00463567|20964502|P3|Overall Study|Abnormal test procedure result(s)|6
6069115|NCT00463567|20964503|P2|Overall Study|Abnormal test procedure result(s)|1
6069116|NCT00463567|20964504|P1|Overall Study|Abnormal test procedure result(s)|1
6069117|NCT00463567|20964498|P7|Overall Study|Abnormal lab value(s)|0
6069118|NCT00463567|20964499|P6|Overall Study|Abnormal lab value(s)|0
6069119|NCT00463567|20964500|P5|Overall Study|Abnormal lab value(s)|1
6069120|NCT00463567|20964501|P4|Overall Study|Abnormal lab value(s)|1
6069121|NCT00463567|20964502|P3|Overall Study|Abnormal lab value(s)|2
6069122|NCT00463567|20964503|P2|Overall Study|Abnormal lab value(s)|1
6069123|NCT00463567|20964504|P1|Overall Study|Abnormal lab value(s)|1
6069124|NCT00463567|20964498|P7|Overall Study|Lack of Efficacy|1
6069125|NCT00463567|20964499|P6|Overall Study|Lack of Efficacy|0
6069126|NCT00463567|20964500|P5|Overall Study|Lack of Efficacy|1
6069127|NCT00463567|20964501|P4|Overall Study|Lack of Efficacy|17
6069128|NCT00463567|20964502|P3|Overall Study|Lack of Efficacy|9
6069129|NCT00463567|20964503|P2|Overall Study|Lack of Efficacy|9
6069130|NCT00463567|20964504|P1|Overall Study|Lack of Efficacy|4
6069131|NCT00463567|20964498|P7|Overall Study|Administrative problems|2
6069132|NCT00463567|20964499|P6|Overall Study|Administrative problems|2
6069133|NCT00463567|20964500|P5|Overall Study|Administrative problems|3
6069134|NCT00463567|20964501|P4|Overall Study|Administrative problems|9
6069135|NCT00463567|20964502|P3|Overall Study|Administrative problems|6
6069136|NCT00463567|20964503|P2|Overall Study|Administrative problems|3
6069137|NCT00463567|20964504|P1|Overall Study|Administrative problems|5
6069138|NCT00463567|20964498|P7|Overall Study|Lost to Follow-up|1
6069139|NCT00463567|20964499|P6|Overall Study|Lost to Follow-up|1
6069140|NCT00463567|20964500|P5|Overall Study|Lost to Follow-up|1
6069141|NCT00463567|20964501|P4|Overall Study|Lost to Follow-up|8
6069142|NCT00463567|20964502|P3|Overall Study|Lost to Follow-up|13
6069143|NCT00463567|20964503|P2|Overall Study|Lost to Follow-up|6
6069144|NCT00463567|20964504|P1|Overall Study|Lost to Follow-up|12
6069145|NCT00463567|20964498|P7|Overall Study|Protocol Deviation|2
6069146|NCT00463567|20964499|P6|Overall Study|Protocol Deviation|1
6069147|NCT00463567|20964500|P5|Overall Study|Protocol Deviation|1
6069148|NCT00463567|20964501|P4|Overall Study|Protocol Deviation|11
6069149|NCT00463567|20964502|P3|Overall Study|Protocol Deviation|14
6069150|NCT00463567|20964503|P2|Overall Study|Protocol Deviation|9
6069151|NCT00463567|20964504|P1|Overall Study|Protocol Deviation|13
6069152|NCT00463567|20964498|P7|Overall Study|Withdrawal by Subject|1
6069153|NCT00463567|20964499|P6|Overall Study|Withdrawal by Subject|5
6069154|NCT00463567|20964500|P5|Overall Study|Withdrawal by Subject|6
6069155|NCT00463567|20964501|P4|Overall Study|Withdrawal by Subject|37
6069156|NCT00463567|20964502|P3|Overall Study|Withdrawal by Subject|20
6069157|NCT00463567|20964503|P2|Overall Study|Withdrawal by Subject|22
6069158|NCT00463567|20964504|P1|Overall Study|Withdrawal by Subject|29
6069159|NCT00463567|20964498|P7|Overall Study|Adverse Event|4
6069160|NCT00463567|20964499|P6|Overall Study|Adverse Event|10
6069161|NCT00463567|20964500|P5|Overall Study|Adverse Event|10
6069162|NCT00463567|20964501|P4|Overall Study|Adverse Event|46
6069163|NCT00463567|20964502|P3|Overall Study|Adverse Event|17
6069164|NCT00463567|20964503|P2|Overall Study|Adverse Event|26
6069165|NCT00463567|20964504|P1|Overall Study|Adverse Event|29
6069166|NCT00463476|20964537|P2|Overall Study|Lost to Follow-up|1
6069167|NCT00463476|20964538|P1|Overall Study|Lost to Follow-up|1
6069168|NCT00463476|20964537|P2|Overall Study|Withdrawal by Subject|2
6069169|NCT00463476|20964538|P1|Overall Study|Withdrawal by Subject|1
6069170|NCT00463385|20964627|P4|Overall Study|1 participant received commercial drug|0
6069171|NCT00463385|20964628|P3|Overall Study|1 participant received commercial drug|0
6069172|NCT00463385|20964629|P2|Overall Study|1 participant received commercial drug|1
6069173|NCT00463385|20964630|P1|Overall Study|1 participant received commercial drug|0
6069174|NCT00463385|20964627|P4|Overall Study|Missing|2
6069175|NCT00463385|20964628|P3|Overall Study|Missing|0
6069176|NCT00463385|20964629|P2|Overall Study|Missing|0
6069177|NCT00463385|20964630|P1|Overall Study|Missing|2
6069178|NCT00463385|20964627|P4|Overall Study|Death|0
6069179|NCT00463385|20964628|P3|Overall Study|Death|2
6069180|NCT00463385|20964629|P2|Overall Study|Death|1
6069181|NCT00463385|20964630|P1|Overall Study|Death|2
6069182|NCT00463385|20964627|P4|Overall Study|Lost to Follow-up|1
6069183|NCT00463385|20964628|P3|Overall Study|Lost to Follow-up|0
6069184|NCT00463385|20964629|P2|Overall Study|Lost to Follow-up|0
6069185|NCT00463385|20964630|P1|Overall Study|Lost to Follow-up|0
6069186|NCT00463385|20964627|P4|Overall Study|Withdrawal by Subject|4
6069187|NCT00463385|20964628|P3|Overall Study|Withdrawal by Subject|3
6069188|NCT00463385|20964629|P2|Overall Study|Withdrawal by Subject|3
6069189|NCT00463385|20964630|P1|Overall Study|Withdrawal by Subject|3
6069190|NCT00463385|20964627|P4|Overall Study|Lack of Efficacy|9
6069191|NCT00463385|20964628|P3|Overall Study|Lack of Efficacy|7
6069192|NCT00463385|20964629|P2|Overall Study|Lack of Efficacy|6
6069193|NCT00463385|20964630|P1|Overall Study|Lack of Efficacy|6
6069194|NCT00463385|20964627|P4|Overall Study|Adverse Event|2
6069195|NCT00463385|20964628|P3|Overall Study|Adverse Event|4
6069196|NCT00463385|20964629|P2|Overall Study|Adverse Event|8
6069197|NCT00463385|20964630|P1|Overall Study|Adverse Event|5
6069198|NCT00463385|20964627|P4|Overall Study|Other|4
6069199|NCT00463385|20964628|P3|Overall Study|Other|6
6069200|NCT00463385|20964629|P2|Overall Study|Other|3
6069201|NCT00463385|20964630|P1|Overall Study|Other|4
6069202|NCT00463346|20964682|P2|Overall Study|Withdrawal by Subject|3
6069203|NCT00463346|20964683|P1|Overall Study|Withdrawal by Subject|3
6069204|NCT00463229|20964693|P2|Overall Study|Death|3
6069205|NCT00463229|20964694|P1|Overall Study|Death|4
6069206|NCT00463229|20964693|P2|Overall Study|Lost to Follow-up|7
6069207|NCT00463229|20964694|P1|Overall Study|Lost to Follow-up|5
6069208|NCT00463060|20964714|P1|Phase 2-Radiation 50Gy +Sunitinib 37.5mg|Withdrawal by Subject|1
6069209|NCT00463060|20964714|P1|Phase 1-Radiation 50Gy +Sunitinib 50mg|acute toxicity|5
6069210|NCT00463047|20964728|P2|Double-Blind Treatment Period 2|Non-compliance with procedures|0
6069211|NCT00463047|20964729|P1|Double-Blind Treatment Period 2|Non-compliance with procedures|1
6069212|NCT00463047|20964728|P2|Double-Blind Treatment Period 2|Withdrawal by Subject|1
6069213|NCT00463047|20964729|P1|Double-Blind Treatment Period 2|Withdrawal by Subject|0
6069214|NCT00463047|20964728|P2|Double-Blind Treatment Period 2|Adverse Event|1
6069215|NCT00463047|20964729|P1|Double-Blind Treatment Period 2|Adverse Event|0
6069216|NCT00463047|20964728|P2|Double-Blind Treatment Period 1|Other|0
6069217|NCT00463047|20964729|P1|Double-Blind Treatment Period 1|Other|1
6069218|NCT00463047|20964728|P2|Double-Blind Treatment Period 1|Non-compliance with procedures|0
6069219|NCT00463047|20964729|P1|Double-Blind Treatment Period 1|Non-compliance with procedures|1
6069220|NCT00463047|20964728|P2|Double-Blind Treatment Period 1|Protocol Violation|2
6069221|NCT00463047|20964729|P1|Double-Blind Treatment Period 1|Protocol Violation|1
6069222|NCT00463047|20964728|P2|Double-Blind Treatment Period 1|Adverse Event|2
6069223|NCT00463047|20964729|P1|Double-Blind Treatment Period 1|Adverse Event|0
6069224|NCT00463047|20964728|P2|Titration Period 2|Other|2
6069225|NCT00463047|20964729|P1|Titration Period 2|Other|3
6069226|NCT00463047|20964728|P2|Titration Period 2|Non-compliance procedures|1
6069227|NCT00463047|20964729|P1|Titration Period 2|Non-compliance procedures|4
6069228|NCT00463047|20964728|P2|Titration Period 2|Non-compliance study medication|2
6069229|NCT00463047|20964729|P1|Titration Period 2|Non-compliance study medication|4
6069230|NCT00463047|20964728|P2|Titration Period 2|Lost to Follow-up|2
6069231|NCT00463047|20964729|P1|Titration Period 2|Lost to Follow-up|1
6069232|NCT00463047|20964728|P2|Titration Period 2|Protocol Violation|3
6069233|NCT00463047|20964729|P1|Titration Period 2|Protocol Violation|2
6069234|NCT00463047|20964728|P2|Titration Period 2|Withdrawal by Subject|0
6069235|NCT00463047|20964729|P1|Titration Period 2|Withdrawal by Subject|1
6069236|NCT00463047|20964728|P2|Titration Period 2|Lack of Efficacy|4
6069237|NCT00463047|20964729|P1|Titration Period 2|Lack of Efficacy|6
6069238|NCT00463047|20964728|P2|Titration Period 2|Adverse Event|9
6069239|NCT00463047|20964729|P1|Titration Period 2|Adverse Event|9
6069240|NCT00463047|20964728|P2|Titration Period 1|Other|2
6069241|NCT00463047|20964729|P1|Titration Period 1|Other|0
6069242|NCT00463047|20964728|P2|Titration Period 1|Non-compliance procedures|10
6069243|NCT00463047|20964729|P1|Titration Period 1|Non-compliance procedures|4
6069244|NCT00463047|20964728|P2|Titration Period 1|Withdrawal by Subject|5
6069245|NCT00463047|20964729|P1|Titration Period 1|Withdrawal by Subject|3
6069246|NCT00463047|20964728|P2|Titration Period 1|Protocol Violation|5
6069247|NCT00463047|20964729|P1|Titration Period 1|Protocol Violation|5
6069248|NCT00463047|20964728|P2|Titration Period 1|Non-compliance with study medication|5
6069249|NCT00463047|20964729|P1|Titration Period 1|Non-compliance with study medication|3
6069250|NCT00463047|20964728|P2|Titration Period 1|Lost to Follow-up|0
6069251|NCT00463047|20964729|P1|Titration Period 1|Lost to Follow-up|2
6069252|NCT00463047|20964728|P2|Titration Period 1|Lack of Efficacy|4
6069253|NCT00463047|20964729|P1|Titration Period 1|Lack of Efficacy|10
6069254|NCT00463047|20964728|P2|Titration Period 1|Adverse Event|8
6069255|NCT00463047|20964729|P1|Titration Period 1|Adverse Event|10
6069256|NCT00462982|20964814|P1|Overall Study|Patient Not Treated|2
6069257|NCT00462982|20964814|P1|Overall Study|Adverse Event|1
6069258|NCT00462943|20964821|P3|Overall Study|Withdrawal by Subject|0
6069259|NCT00462943|20964822|P2|Overall Study|Withdrawal by Subject|1
6069260|NCT00462943|20964823|P1|Overall Study|Withdrawal by Subject|0
6069261|NCT00462943|20964821|P3|Overall Study|Physician Decision|0
6069262|NCT00462943|20964822|P2|Overall Study|Physician Decision|0
6069263|NCT00462943|20964823|P1|Overall Study|Physician Decision|1
6069264|NCT00462943|20964821|P3|Overall Study|Transplant - not specified|1
6069265|NCT00462943|20964822|P2|Overall Study|Transplant - not specified|0
6069266|NCT00462943|20964823|P1|Overall Study|Transplant - not specified|1
6069267|NCT00462943|20964821|P3|Overall Study|Required Lymphocyte Infusion|0
6069268|NCT00462943|20964822|P2|Overall Study|Required Lymphocyte Infusion|0
6069269|NCT00462943|20964823|P1|Overall Study|Required Lymphocyte Infusion|1
6069270|NCT00462943|20964821|P3|Overall Study|Bone Marrow Transplant|0
6069271|NCT00462943|20964822|P2|Overall Study|Bone Marrow Transplant|0
6069272|NCT00462943|20964823|P1|Overall Study|Bone Marrow Transplant|1
6069273|NCT00462943|20964821|P3|Overall Study|Stem Cell Transplant|0
6069274|NCT00462943|20964822|P2|Overall Study|Stem Cell Transplant|1
6069275|NCT00462943|20964823|P1|Overall Study|Stem Cell Transplant|1
6069276|NCT00462943|20964821|P3|Overall Study|Death|7
6069277|NCT00462943|20964822|P2|Overall Study|Death|2
6069278|NCT00462943|20964823|P1|Overall Study|Death|5
6069279|NCT00462943|20964821|P3|Overall Study|Disease Progression|9
6069280|NCT00462943|20964822|P2|Overall Study|Disease Progression|15
6069281|NCT00462943|20964823|P1|Overall Study|Disease Progression|15
6069282|NCT00462943|20964821|P3|Overall Study|Request of Patient, PI, Sponsor or RA|4
6069283|NCT00462943|20964822|P2|Overall Study|Request of Patient, PI, Sponsor or RA|2
6069284|NCT00462943|20964823|P1|Overall Study|Request of Patient, PI, Sponsor or RA|8
6069285|NCT00462943|20964821|P3|Overall Study|Protocol Violation|0
6069286|NCT00462943|20964822|P2|Overall Study|Protocol Violation|0
6069287|NCT00462943|20964823|P1|Overall Study|Protocol Violation|1
6069288|NCT00462943|20964821|P3|Overall Study|Adverse Event|1
6069289|NCT00462943|20964822|P2|Overall Study|Adverse Event|4
6069290|NCT00462943|20964823|P1|Overall Study|Adverse Event|6
6069291|NCT00462943|20964821|P3|Overall Study|Failure to achieve a response|1
6069292|NCT00462943|20964822|P2|Overall Study|Failure to achieve a response|5
6069293|NCT00462943|20964823|P1|Overall Study|Failure to achieve a response|5
6069294|NCT00462904|20964915|P1|Overall Study|Lost to Follow-up|1
6069295|NCT00462865|20964920|P1|Overall Study|Adverse Event|1
6069296|NCT00462826|20964940|P1|Overall Study|Never treated|1
6069297|NCT00462826|20964940|P1|Overall Study|Ineligible - wrong primary|2
6069298|NCT00462826|20964940|P1|Overall Study|Ineligible - wrong cell type|1
6069299|NCT00462826|20964940|P1|Overall Study|Ineligible - second primary|1
6069300|NCT00462761|20964953|P1|Overall Study|Other|1
6069301|NCT00462761|20964953|P1|Overall Study|Death|12
6069302|NCT00462761|20964953|P1|Overall Study|Disease progression|43
6069303|NCT00462761|20964953|P1|Overall Study|Physician Decision|5
6069304|NCT00462761|20964953|P1|Overall Study|Withdrawal by Subject|9
6069305|NCT00462761|20964953|P1|Overall Study|Adverse Event|6
6069306|NCT00462748|20965028|P3|Overall Study|Discontinued after 41 days Rx|0
6069307|NCT00462748|20965029|P2|Overall Study|Discontinued after 41 days Rx|0
6069308|NCT00462748|20965030|P1|Overall Study|Discontinued after 41 days Rx|1
6069309|NCT00462748|20965028|P3|Overall Study|Lost to Follow-up|1
6069310|NCT00462748|20965029|P2|Overall Study|Lost to Follow-up|1
6069311|NCT00462748|20965030|P1|Overall Study|Lost to Follow-up|1
6069312|NCT00462748|20965028|P3|Overall Study|Withdrew consent|0
6069313|NCT00462748|20965029|P2|Overall Study|Withdrew consent|3
6069314|NCT00462748|20965030|P1|Overall Study|Withdrew consent|3
6069315|NCT00462748|20965028|P3|Overall Study|Protocol Violation|1
6069316|NCT00462748|20965029|P2|Overall Study|Protocol Violation|2
6069317|NCT00462748|20965030|P1|Overall Study|Protocol Violation|0
6069318|NCT00462748|20965028|P3|Overall Study|Adverse Event|9
6069319|NCT00462748|20965029|P2|Overall Study|Adverse Event|5
6069320|NCT00462748|20965030|P1|Overall Study|Adverse Event|7
6069321|NCT00462709|20965083|P1|Overall Study|Withdrew to start treatment with Cetor|1
6069322|NCT00462709|20965083|P1|Overall Study|Physician Decision|1
6069323|NCT00462709|20965083|P1|Overall Study|Logistical reasons|2
6069324|NCT00462709|20965083|P1|Overall Study|Death|2
6069325|NCT00462709|20965083|P1|Overall Study|Transferred to LEVP2006-1 (NCT00438815)|3
6069326|NCT00462709|20965083|P1|Overall Study|Withdrawal by Subject|8
6069327|NCT00462709|20965083|P1|Overall Study|Lost to Follow-up|10
6069328|NCT00462709|20965083|P1|Overall Study|Transitioned to commercial C1INH-nf|40
6069329|NCT00462670|20965092|P2|Overall Study|Resolution of signs and symptoms|2
6069330|NCT00462670|20965093|P1|Overall Study|Resolution of signs and symptoms|0
6069331|NCT00462670|20965092|P2|Overall Study|Protocol Violation|0
6069332|NCT00462670|20965093|P1|Overall Study|Protocol Violation|1
6069333|NCT00462670|20965092|P2|Overall Study|Lack of Efficacy|0
6069334|NCT00462670|20965093|P1|Overall Study|Lack of Efficacy|1
6069335|NCT00462670|20965092|P2|Overall Study|Adverse Event|5
6069336|NCT00462670|20965093|P1|Overall Study|Adverse Event|3
6069337|NCT00462501|20965130|P1|Overall Study|Adverse Event|2
6069338|NCT00462501|20965130|P1|Overall Study|Not treated|3
6069339|NCT00462488|20965136|P2|Overall Study|Lack of Efficacy|17
6069340|NCT00462488|20965137|P1|Overall Study|Lack of Efficacy|19
6069341|NCT00462488|20965136|P2|Overall Study|Protocol Violation|0
6069342|NCT00462488|20965137|P1|Overall Study|Protocol Violation|1
6069343|NCT00462462|20965145|P2|Overall Study|Physician Decision|1
6069344|NCT00462462|20965146|P1|Overall Study|Physician Decision|0
6069345|NCT00462384|20965174|P1|Overall Study|Other|4
6069346|NCT00462384|20965174|P1|Overall Study|Withdrawal by Subject|1
6069347|NCT00462384|20965174|P1|Overall Study|Death|2
6069348|NCT00462384|20965174|P1|Overall Study|Adverse Event|2
6069349|NCT00462345|20965182|P1|Overall Study|Did not complete second course|1
6069350|NCT00462345|20965182|P1|Overall Study|Withdrawal by Subject|2
6069351|NCT00462306|20965217|P2|Overall Study|insufficient data|13
6069352|NCT00462306|20965218|P1|Overall Study|insufficient data|0
6069353|NCT00461981|20965349|P2|Overall Study|Withdrawal by Subject|3
6069354|NCT00461981|20965350|P1|Overall Study|Withdrawal by Subject|2
6069355|NCT00461981|20965349|P2|Overall Study|Lost to Follow-up|6
6069356|NCT00461981|20965350|P1|Overall Study|Lost to Follow-up|9
6069357|NCT00461812|20965466|P1|Overall Study|study terminated|10
6069358|NCT00461786|20965471|P1|Overall Study|Inevaluable (Never Treated)|1
6069359|NCT00461786|20965471|P1|Overall Study|Entry Criteria Not Met|2
6069360|NCT00461708|20965516|P2|Overall Study|Death|1
6069361|NCT00461708|20965517|P1|Overall Study|Death|8
6069362|NCT00461708|20965516|P2|Overall Study|Other|4
6069363|NCT00461708|20965517|P1|Overall Study|Other|4
6069364|NCT00461708|20965516|P2|Overall Study|Withdrawal by Subject|2
6069365|NCT00461708|20965517|P1|Overall Study|Withdrawal by Subject|8
6069366|NCT00461708|20965516|P2|Overall Study|Physician Decision|4
6069367|NCT00461708|20965517|P1|Overall Study|Physician Decision|10
6069368|NCT00461708|20965516|P2|Overall Study|Lack of Efficacy|20
6069369|NCT00461708|20965517|P1|Overall Study|Lack of Efficacy|68
6069370|NCT00461708|20965516|P2|Overall Study|Adverse Event|7
6069371|NCT00461708|20965517|P1|Overall Study|Adverse Event|17
6069372|NCT00461682|20965543|P1|Overall Study|Protocol Violation|1
6069373|NCT00461630|20965571|P2|Overall Study|Lost to Follow-up|95
6069374|NCT00461630|20965572|P1|Overall Study|Lost to Follow-up|108
6069375|NCT00461630|20965571|P2|Overall Study|Death|732
6069376|NCT00461630|20965572|P1|Overall Study|Death|798
6069377|NCT00461552|20965611|P2|Overall Study|Drug Dispensing error|2
6069378|NCT00461552|20965612|P1|Overall Study|Drug Dispensing error|0
6069379|NCT00461500|20965635|P2|Overall Study|Lost to Follow-up|2
6069380|NCT00461500|20965636|P1|Overall Study|Lost to Follow-up|2
6069381|NCT00461500|20965635|P2|Overall Study|No Longer Willing to Take Part in Study|0
6069382|NCT00461500|20965636|P1|Overall Study|No Longer Willing to Take Part in Study|1
6069383|NCT00461500|20965635|P2|Overall Study|Drug Treatment Misuse|0
6069384|NCT00461500|20965636|P1|Overall Study|Drug Treatment Misuse|1
6069385|NCT00461500|20965635|P2|Overall Study|Study Stopped|2
6069386|NCT00461500|20965636|P1|Overall Study|Study Stopped|1
6069387|NCT00461500|20965635|P2|Overall Study|Expired Drug Treatment|1
6069388|NCT00461500|20965636|P1|Overall Study|Expired Drug Treatment|1
6069389|NCT00461500|20965635|P2|Overall Study|Lack of Efficacy|1
6069390|NCT00461500|20965636|P1|Overall Study|Lack of Efficacy|0
6069391|NCT00461500|20965635|P2|Overall Study|Adverse Event|0
6069392|NCT00461500|20965636|P1|Overall Study|Adverse Event|1
6069393|NCT00461305|20965679|P2|Continued Treatment|Other (missing drug etc)|0
6069394|NCT00461305|20965680|P1|Continued Treatment|Other (missing drug etc)|2
6069395|NCT00461305|20965679|P2|Continued Treatment|Partially missing diary|0
6069396|NCT00461305|20965680|P1|Continued Treatment|Partially missing diary|2
6069397|NCT00461305|20965679|P2|Continued Treatment|Withdrawal by Subject|0
6069398|NCT00461305|20965680|P1|Continued Treatment|Withdrawal by Subject|48
6069399|NCT00461305|20965679|P2|Continued Treatment|Protocol Violation|0
6069400|NCT00461305|20965680|P1|Continued Treatment|Protocol Violation|13
6069401|NCT00461305|20965679|P2|Continued Treatment|Lost to Follow-up|0
6069402|NCT00461305|20965680|P1|Continued Treatment|Lost to Follow-up|4
6069403|NCT00461305|20965679|P2|Continued Treatment|Adverse Event|0
6069404|NCT00461305|20965680|P1|Continued Treatment|Adverse Event|26
6069405|NCT00461305|20965679|P2|Treatment|Other (missing drug etc)|0
6069406|NCT00461305|20965680|P1|Treatment|Other (missing drug etc)|2
6069407|NCT00461305|20965679|P2|Treatment|Partially missing diary|0
6069408|NCT00461305|20965680|P1|Treatment|Partially missing diary|2
6069409|NCT00461305|20965679|P2|Treatment|Study drug not taken|0
6069410|NCT00461305|20965680|P1|Treatment|Study drug not taken|1
6069411|NCT00461305|20965679|P2|Treatment|Never dispensed|0
6069412|NCT00461305|20965680|P1|Treatment|Never dispensed|5
6069413|NCT00461305|20965679|P2|Treatment|Withdrawal by Subject|2
6069414|NCT00461305|20965680|P1|Treatment|Withdrawal by Subject|48
6069415|NCT00461305|20965679|P2|Treatment|Protocol Violation|2
6069416|NCT00461305|20965680|P1|Treatment|Protocol Violation|13
6069417|NCT00461305|20965679|P2|Treatment|Lost to Follow-up|2
6069418|NCT00461305|20965680|P1|Treatment|Lost to Follow-up|4
6069419|NCT00461305|20965679|P2|Treatment|Adverse Event|3
6069420|NCT00461305|20965680|P1|Treatment|Adverse Event|26
6069421|NCT00461253|20965764|P2|Overall Study|administrative|7773
6069422|NCT00461253|20965765|P1|Overall Study|administrative|773
6069423|NCT00461253|20965764|P2|Overall Study|no response|11789
6069424|NCT00461253|20965765|P1|Overall Study|no response|2609
6069425|NCT00461253|20965764|P2|Overall Study|Protocol Violation|236
6069426|NCT00461253|20965765|P1|Overall Study|Protocol Violation|613
6069427|NCT00461253|20965764|P2|Overall Study|Death|0
6069428|NCT00461253|20965765|P1|Overall Study|Death|985
6069429|NCT00461175|20965773|P2|Overall Study|Protocol Violation|365
6069430|NCT00461175|20965774|P1|Overall Study|Protocol Violation|522
6069431|NCT00461123|20965784|P2|Overall Study|Withdrawal by Subject|3
6069432|NCT00461123|20965785|P1|Overall Study|Withdrawal by Subject|1
6069433|NCT00461123|20965784|P2|Overall Study|Protocol Violation|2
6069434|NCT00461123|20965785|P1|Overall Study|Protocol Violation|3
6069435|NCT00461123|20965784|P2|Overall Study|Lost to Follow-up|1
6069436|NCT00461123|20965785|P1|Overall Study|Lost to Follow-up|1
6069437|NCT00461123|20965784|P2|Overall Study|Adverse Event|0
6069438|NCT00461123|20965785|P1|Overall Study|Adverse Event|1
6069439|NCT00461032|20965830|P2|Overall Study|Other|5
6069440|NCT00461032|20965831|P1|Overall Study|Other|7
6069441|NCT00461032|20965830|P2|Overall Study|Patient Moved or Relocated|1
6069442|NCT00461032|20965831|P1|Overall Study|Patient Moved or Relocated|2
6069443|NCT00461032|20965830|P2|Overall Study|Withdrawal by Subject|15
6069444|NCT00461032|20965831|P1|Overall Study|Withdrawal by Subject|7
6069445|NCT00461032|20965830|P2|Overall Study|Protocol Violation|4
6069446|NCT00461032|20965831|P1|Overall Study|Protocol Violation|4
6069447|NCT00461032|20965830|P2|Overall Study|Lost to Follow-up|12
6069448|NCT00461032|20965831|P1|Overall Study|Lost to Follow-up|7
6069449|NCT00461032|20965830|P2|Overall Study|Lack of Efficacy|1
6069450|NCT00461032|20965831|P1|Overall Study|Lack of Efficacy|5
6069451|NCT00461032|20965830|P2|Overall Study|Adverse Event|6
6069452|NCT00461032|20965831|P1|Overall Study|Adverse Event|5
6069453|NCT00460811|20965857|P5|Overall Study|Lost to Follow-up|6
6069454|NCT00460811|20965858|P4|Overall Study|Lost to Follow-up|3
6069455|NCT00460811|20965859|P3|Overall Study|Lost to Follow-up|5
6069456|NCT00460811|20965860|P2|Overall Study|Lost to Follow-up|2
6069457|NCT00460811|20965861|P1|Overall Study|Lost to Follow-up|3
6069458|NCT00460811|20965857|P5|Overall Study|Physician Decision|0
6069459|NCT00460811|20965858|P4|Overall Study|Physician Decision|0
6069460|NCT00460811|20965859|P3|Overall Study|Physician Decision|0
6069461|NCT00460811|20965860|P2|Overall Study|Physician Decision|0
6069462|NCT00460811|20965861|P1|Overall Study|Physician Decision|1
6069463|NCT00460811|20965857|P5|Overall Study|Withdrawal by Subject|11
6069464|NCT00460811|20965858|P4|Overall Study|Withdrawal by Subject|3
6069465|NCT00460811|20965859|P3|Overall Study|Withdrawal by Subject|6
6069466|NCT00460811|20965860|P2|Overall Study|Withdrawal by Subject|7
6069467|NCT00460811|20965861|P1|Overall Study|Withdrawal by Subject|7
6069468|NCT00460811|20965857|P5|Overall Study|Noncompliance|1
6069469|NCT00460811|20965858|P4|Overall Study|Noncompliance|2
6069470|NCT00460811|20965859|P3|Overall Study|Noncompliance|0
6069471|NCT00460811|20965860|P2|Overall Study|Noncompliance|0
6069472|NCT00460811|20965861|P1|Overall Study|Noncompliance|1
6069473|NCT00460811|20965857|P5|Overall Study|Adverse Event|2
6069474|NCT00460811|20965858|P4|Overall Study|Adverse Event|10
6069475|NCT00460811|20965859|P3|Overall Study|Adverse Event|3
6069476|NCT00460811|20965860|P2|Overall Study|Adverse Event|6
6069477|NCT00460811|20965861|P1|Overall Study|Adverse Event|4
6069478|NCT00460798|20965903|P1|Overall Study|Missing/Incomplete Dosing Information|27
6069479|NCT00460798|20965903|P1|Overall Study|Ongoing at Date of Cut-Off|82
6069480|NCT00460798|20965903|P1|Overall Study|Other|27
6069481|NCT00460798|20965903|P1|Overall Study|Progressive Disease|99
6069482|NCT00460798|20965903|P1|Overall Study|Lost to Follow-up|19
6069483|NCT00460798|20965903|P1|Overall Study|Adverse Event|27
6069484|NCT00460798|20965903|P1|Overall Study|Death|59
6069485|NCT00460746|20965911|P1|Overall Study|Lost to Follow-up|1
6069486|NCT00460746|20965911|P1|Overall Study|Adverse Event|1
6069487|NCT00460655|20965926|P4|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|1
6069488|NCT00460655|20965927|P3|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0
6069489|NCT00460655|20965928|P2|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0
6069490|NCT00460655|20965929|P1|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0
6069491|NCT00460655|20965926|P4|Open-Label Phase (36 Weeks)|Withdrawal by Subject|2
6069492|NCT00460655|20965927|P3|Open-Label Phase (36 Weeks)|Withdrawal by Subject|6
6069493|NCT00460655|20965928|P2|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
6069494|NCT00460655|20965929|P1|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
6069495|NCT00460655|20965926|P4|Open-Label Phase (36 Weeks)|Adverse Event|6
6069496|NCT00460655|20965927|P3|Open-Label Phase (36 Weeks)|Adverse Event|1
6069497|NCT00460655|20965928|P2|Open-Label Phase (36 Weeks)|Adverse Event|0
6069498|NCT00460655|20965929|P1|Open-Label Phase (36 Weeks)|Adverse Event|0
6069499|NCT00460655|20965926|P4|Double-Blind Phase (12 Weeks)|Protocol Violation|0
6069500|NCT00460655|20965927|P3|Double-Blind Phase (12 Weeks)|Protocol Violation|0
6069501|NCT00460655|20965928|P2|Double-Blind Phase (12 Weeks)|Protocol Violation|1
6069502|NCT00460655|20965929|P1|Double-Blind Phase (12 Weeks)|Protocol Violation|0
6069503|NCT00460655|20965926|P4|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
6069504|NCT00460655|20965927|P3|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
6069505|NCT00460655|20965928|P2|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
6069506|NCT00460655|20965929|P1|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|3
6069507|NCT00460655|20965926|P4|Double-Blind Phase (12 Weeks)|Adverse Event|0
6069508|NCT00460655|20965927|P3|Double-Blind Phase (12 Weeks)|Adverse Event|0
6069509|NCT00460655|20965928|P2|Double-Blind Phase (12 Weeks)|Adverse Event|0
6069510|NCT00460655|20965929|P1|Double-Blind Phase (12 Weeks)|Adverse Event|3
6069511|NCT00460603|20965973|P12|Phase 2|Randomized, but not treated|0
6069512|NCT00460603|20965974|P11|Phase 2|Randomized, but not treated|0
6069513|NCT00460603|20965975|P10|Phase 2|Randomized, but not treated|3
6069514|NCT00460603|20965976|P9|Phase 2|Randomized, but not treated|0
6069515|NCT00460603|20965977|P8|Phase 2|Randomized, but not treated|0
6069516|NCT00460603|20965978|P7|Phase 2|Randomized, but not treated|0
6069517|NCT00460603|20965979|P6|Phase 2|Randomized, but not treated|0
6069518|NCT00460603|20965980|P5|Phase 2|Randomized, but not treated|0
6069519|NCT00460603|20965981|P4|Phase 2|Randomized, but not treated|0
6069520|NCT00460603|20965982|P3|Phase 2|Randomized, but not treated|0
6069521|NCT00460603|20965983|P2|Phase 2|Randomized, but not treated|0
6069522|NCT00460603|20965984|P1|Phase 2|Randomized, but not treated|0
6069523|NCT00460603|20965973|P12|Phase 2|Withdrawal by Subject|5
6069524|NCT00460603|20965974|P11|Phase 2|Withdrawal by Subject|4
6069525|NCT00460603|20965975|P10|Phase 2|Withdrawal by Subject|5
6069526|NCT00460603|20965976|P9|Phase 2|Withdrawal by Subject|0
6069527|NCT00460603|20965977|P8|Phase 2|Withdrawal by Subject|0
6069528|NCT00460603|20965978|P7|Phase 2|Withdrawal by Subject|0
6069529|NCT00460603|20965979|P6|Phase 2|Withdrawal by Subject|0
6069530|NCT00460603|20965980|P5|Phase 2|Withdrawal by Subject|0
6069531|NCT00460603|20965981|P4|Phase 2|Withdrawal by Subject|0
6069532|NCT00460603|20965982|P3|Phase 2|Withdrawal by Subject|0
6069533|NCT00460603|20965983|P2|Phase 2|Withdrawal by Subject|0
6069534|NCT00460603|20965984|P1|Phase 2|Withdrawal by Subject|0
6069535|NCT00460603|20965973|P12|Phase 2|Global Deterioration of Health Status|0
6069536|NCT00460603|20965974|P11|Phase 2|Global Deterioration of Health Status|1
6069537|NCT00460603|20965975|P10|Phase 2|Global Deterioration of Health Status|0
6069538|NCT00460603|20965976|P9|Phase 2|Global Deterioration of Health Status|0
6069539|NCT00460603|20965977|P8|Phase 2|Global Deterioration of Health Status|0
6069540|NCT00460603|20965978|P7|Phase 2|Global Deterioration of Health Status|0
6069541|NCT00460603|20965979|P6|Phase 2|Global Deterioration of Health Status|0
6069542|NCT00460603|20965980|P5|Phase 2|Global Deterioration of Health Status|0
6069543|NCT00460603|20965981|P4|Phase 2|Global Deterioration of Health Status|0
6069544|NCT00460603|20965982|P3|Phase 2|Global Deterioration of Health Status|0
6069545|NCT00460603|20965983|P2|Phase 2|Global Deterioration of Health Status|0
6069546|NCT00460603|20965984|P1|Phase 2|Global Deterioration of Health Status|0
6069547|NCT00460603|20965973|P12|Phase 2|Objective Progression or Relapse|17
6069548|NCT00460603|20965974|P11|Phase 2|Objective Progression or Relapse|10
6069549|NCT00460603|20965975|P10|Phase 2|Objective Progression or Relapse|9
6069550|NCT00460603|20965976|P9|Phase 2|Objective Progression or Relapse|0
6069551|NCT00460603|20965977|P8|Phase 2|Objective Progression or Relapse|0
6069552|NCT00460603|20965978|P7|Phase 2|Objective Progression or Relapse|0
6069553|NCT00460603|20965979|P6|Phase 2|Objective Progression or Relapse|0
6069554|NCT00460603|20965980|P5|Phase 2|Objective Progression or Relapse|0
6069555|NCT00460603|20965981|P4|Phase 2|Objective Progression or Relapse|0
6069556|NCT00460603|20965982|P3|Phase 2|Objective Progression or Relapse|0
6069557|NCT00460603|20965983|P2|Phase 2|Objective Progression or Relapse|0
6069558|NCT00460603|20965984|P1|Phase 2|Objective Progression or Relapse|0
6069559|NCT00460603|20965973|P12|Phase 2|Other|7
6069560|NCT00460603|20965974|P11|Phase 2|Other|16
6069561|NCT00460603|20965975|P10|Phase 2|Other|6
6069562|NCT00460603|20965976|P9|Phase 2|Other|0
6069563|NCT00460603|20965977|P8|Phase 2|Other|0
6069564|NCT00460603|20965978|P7|Phase 2|Other|0
6069565|NCT00460603|20965979|P6|Phase 2|Other|0
6069566|NCT00460603|20965980|P5|Phase 2|Other|0
6069567|NCT00460603|20965981|P4|Phase 2|Other|0
6069568|NCT00460603|20965982|P3|Phase 2|Other|0
6069569|NCT00460603|20965983|P2|Phase 2|Other|0
6069570|NCT00460603|20965984|P1|Phase 2|Other|0
6069571|NCT00460603|20965973|P12|Phase 2|Lost to Follow-up|0
6069572|NCT00460603|20965974|P11|Phase 2|Lost to Follow-up|0
6069573|NCT00460603|20965975|P10|Phase 2|Lost to Follow-up|1
6069574|NCT00460603|20965976|P9|Phase 2|Lost to Follow-up|0
6069575|NCT00460603|20965977|P8|Phase 2|Lost to Follow-up|0
6069576|NCT00460603|20965978|P7|Phase 2|Lost to Follow-up|0
6069577|NCT00460603|20965979|P6|Phase 2|Lost to Follow-up|0
6069578|NCT00460603|20965980|P5|Phase 2|Lost to Follow-up|0
6069579|NCT00460603|20965981|P4|Phase 2|Lost to Follow-up|0
6069580|NCT00460603|20965982|P3|Phase 2|Lost to Follow-up|0
6069581|NCT00460603|20965983|P2|Phase 2|Lost to Follow-up|0
6069582|NCT00460603|20965984|P1|Phase 2|Lost to Follow-up|0
6069583|NCT00460603|20965973|P12|Phase 2|Protocol Violation|0
6069584|NCT00460603|20965974|P11|Phase 2|Protocol Violation|1
6069585|NCT00460603|20965975|P10|Phase 2|Protocol Violation|1
6069586|NCT00460603|20965976|P9|Phase 2|Protocol Violation|0
6069587|NCT00460603|20965977|P8|Phase 2|Protocol Violation|0
6069588|NCT00460603|20965978|P7|Phase 2|Protocol Violation|0
6069589|NCT00460603|20965979|P6|Phase 2|Protocol Violation|0
6069590|NCT00460603|20965980|P5|Phase 2|Protocol Violation|0
6069591|NCT00460603|20965981|P4|Phase 2|Protocol Violation|0
6069592|NCT00460603|20965982|P3|Phase 2|Protocol Violation|0
6069593|NCT00460603|20965983|P2|Phase 2|Protocol Violation|0
6069594|NCT00460603|20965984|P1|Phase 2|Protocol Violation|0
6069595|NCT00460603|20965973|P12|Phase 2|Death|2
6069596|NCT00460603|20965974|P11|Phase 2|Death|2
6069597|NCT00460603|20965975|P10|Phase 2|Death|4
6069598|NCT00460603|20965976|P9|Phase 2|Death|0
6069599|NCT00460603|20965977|P8|Phase 2|Death|0
6069600|NCT00460603|20965978|P7|Phase 2|Death|0
6069601|NCT00460603|20965979|P6|Phase 2|Death|0
6069602|NCT00460603|20965980|P5|Phase 2|Death|0
6069603|NCT00460603|20965981|P4|Phase 2|Death|0
6069604|NCT00460603|20965982|P3|Phase 2|Death|0
6069605|NCT00460603|20965983|P2|Phase 2|Death|0
6069606|NCT00460603|20965984|P1|Phase 2|Death|0
6069607|NCT00460603|20965973|P12|Phase 2|Adverse Event|10
6069608|NCT00460603|20965974|P11|Phase 2|Adverse Event|9
6069609|NCT00460603|20965975|P10|Phase 2|Adverse Event|12
6069610|NCT00460603|20965976|P9|Phase 2|Adverse Event|0
6069611|NCT00460603|20965977|P8|Phase 2|Adverse Event|0
6069612|NCT00460603|20965978|P7|Phase 2|Adverse Event|0
6069613|NCT00460603|20965979|P6|Phase 2|Adverse Event|0
6069614|NCT00460603|20965980|P5|Phase 2|Adverse Event|0
6069615|NCT00460603|20965981|P4|Phase 2|Adverse Event|0
6069616|NCT00460603|20965982|P3|Phase 2|Adverse Event|0
6069617|NCT00460603|20965983|P2|Phase 2|Adverse Event|0
6069618|NCT00460603|20965984|P1|Phase 2|Adverse Event|0
6069619|NCT00460603|20965973|P12|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
6069620|NCT00460603|20965974|P11|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
6069621|NCT00460603|20965975|P10|Phase 2|Ongoing in study A4061008 (NCT00828919)|1
6069622|NCT00460603|20965976|P9|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
6069623|NCT00460603|20965977|P8|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
6069624|NCT00460603|20965978|P7|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
6069625|NCT00460603|20965979|P6|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
6069626|NCT00460603|20965980|P5|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
6069627|NCT00460603|20965981|P4|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
6069628|NCT00460603|20965982|P3|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
6069629|NCT00460603|20965983|P2|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
6069630|NCT00460603|20965984|P1|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
6069631|NCT00460603|20965973|P12|Phase 1|Other|0
6069632|NCT00460603|20965974|P11|Phase 1|Other|0
6069633|NCT00460603|20965975|P10|Phase 1|Other|0
6069634|NCT00460603|20965976|P9|Phase 1|Other|0
6069635|NCT00460603|20965977|P8|Phase 1|Other|1
6069636|NCT00460603|20965978|P7|Phase 1|Other|0
6069637|NCT00460603|20965979|P6|Phase 1|Other|2
6069638|NCT00460603|20965980|P5|Phase 1|Other|1
6069639|NCT00460603|20965981|P4|Phase 1|Other|1
6069640|NCT00460603|20965982|P3|Phase 1|Other|1
6069641|NCT00460603|20965983|P2|Phase 1|Other|3
6069642|NCT00460603|20965984|P1|Phase 1|Other|0
6069643|NCT00460603|20965973|P12|Phase 1|Withdrawal by Subject|0
6069644|NCT00460603|20965974|P11|Phase 1|Withdrawal by Subject|0
6069645|NCT00460603|20965975|P10|Phase 1|Withdrawal by Subject|0
6069646|NCT00460603|20965976|P9|Phase 1|Withdrawal by Subject|2
6069647|NCT00460603|20965977|P8|Phase 1|Withdrawal by Subject|0
6069648|NCT00460603|20965978|P7|Phase 1|Withdrawal by Subject|1
6069649|NCT00460603|20965979|P6|Phase 1|Withdrawal by Subject|0
6069650|NCT00460603|20965980|P5|Phase 1|Withdrawal by Subject|3
6069651|NCT00460603|20965981|P4|Phase 1|Withdrawal by Subject|1
6069652|NCT00460603|20965982|P3|Phase 1|Withdrawal by Subject|1
6069653|NCT00460603|20965983|P2|Phase 1|Withdrawal by Subject|2
6069654|NCT00460603|20965984|P1|Phase 1|Withdrawal by Subject|1
6069655|NCT00460603|20965973|P12|Phase 1|Lack of Efficacy|0
6069656|NCT00460603|20965974|P11|Phase 1|Lack of Efficacy|0
6069657|NCT00460603|20965975|P10|Phase 1|Lack of Efficacy|0
6069658|NCT00460603|20965976|P9|Phase 1|Lack of Efficacy|11
6069659|NCT00460603|20965977|P8|Phase 1|Lack of Efficacy|2
6069660|NCT00460603|20965978|P7|Phase 1|Lack of Efficacy|2
6069661|NCT00460603|20965979|P6|Phase 1|Lack of Efficacy|2
6069662|NCT00460603|20965980|P5|Phase 1|Lack of Efficacy|2
6069663|NCT00460603|20965981|P4|Phase 1|Lack of Efficacy|2
6069664|NCT00460603|20965982|P3|Phase 1|Lack of Efficacy|1
6069665|NCT00460603|20965983|P2|Phase 1|Lack of Efficacy|0
6069666|NCT00460603|20965984|P1|Phase 1|Lack of Efficacy|1
6069667|NCT00460603|20965973|P12|Phase 1|Adverse Event|0
6069668|NCT00460603|20965974|P11|Phase 1|Adverse Event|0
6069669|NCT00460603|20965975|P10|Phase 1|Adverse Event|0
6069670|NCT00460603|20965976|P9|Phase 1|Adverse Event|4
6069671|NCT00460603|20965977|P8|Phase 1|Adverse Event|0
6069672|NCT00460603|20965978|P7|Phase 1|Adverse Event|3
6069673|NCT00460603|20965979|P6|Phase 1|Adverse Event|0
6069674|NCT00460603|20965980|P5|Phase 1|Adverse Event|0
6069675|NCT00460603|20965981|P4|Phase 1|Adverse Event|2
6069676|NCT00460603|20965982|P3|Phase 1|Adverse Event|1
6069677|NCT00460603|20965983|P2|Phase 1|Adverse Event|1
6069678|NCT00460603|20965984|P1|Phase 1|Adverse Event|3
6069679|NCT00460603|20965973|P12|Phase 1|Death|0
6069680|NCT00460603|20965974|P11|Phase 1|Death|0
6069681|NCT00460603|20965975|P10|Phase 1|Death|0
6069682|NCT00460603|20965976|P9|Phase 1|Death|1
6069683|NCT00460603|20965977|P8|Phase 1|Death|0
6069684|NCT00460603|20965978|P7|Phase 1|Death|0
6069685|NCT00460603|20965979|P6|Phase 1|Death|0
6069686|NCT00460603|20965980|P5|Phase 1|Death|0
6069687|NCT00460603|20965981|P4|Phase 1|Death|2
6069688|NCT00460603|20965982|P3|Phase 1|Death|0
6069689|NCT00460603|20965983|P2|Phase 1|Death|0
6069690|NCT00460603|20965984|P1|Phase 1|Death|1
6069691|NCT00460577|20966078|P2|Overall Study|Protocol Violation|6
6069692|NCT00460577|20966079|P1|Overall Study|Protocol Violation|2
6069693|NCT00460564|20966097|P8|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
6069694|NCT00460564|20966098|P7|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
6069695|NCT00460564|20966099|P6|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
6069696|NCT00460564|20966100|P5|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|1
6069697|NCT00460564|20966101|P4|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
6069698|NCT00460564|20966102|P3|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
6069699|NCT00460564|20966103|P2|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
6069700|NCT00460564|20966104|P1|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
6069701|NCT00460564|20966097|P8|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
6069702|NCT00460564|20966098|P7|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
6069703|NCT00460564|20966099|P6|Open-Label Phase (36 Weeks)|Withdrawal by Subject|1
6069704|NCT00460564|20966100|P5|Open-Label Phase (36 Weeks)|Withdrawal by Subject|5
6069705|NCT00460564|20966101|P4|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
6069706|NCT00460564|20966102|P3|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
6069707|NCT00460564|20966103|P2|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
6069708|NCT00460564|20966104|P1|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
6069709|NCT00460564|20966097|P8|Open-Label Phase (36 Weeks)|Adverse Event|0
6069710|NCT00460564|20966098|P7|Open-Label Phase (36 Weeks)|Adverse Event|2
6069711|NCT00460564|20966099|P6|Open-Label Phase (36 Weeks)|Adverse Event|5
6069712|NCT00460564|20966100|P5|Open-Label Phase (36 Weeks)|Adverse Event|3
6069713|NCT00460564|20966101|P4|Open-Label Phase (36 Weeks)|Adverse Event|0
6069714|NCT00460564|20966102|P3|Open-Label Phase (36 Weeks)|Adverse Event|0
6069715|NCT00460564|20966103|P2|Open-Label Phase (36 Weeks)|Adverse Event|0
6069716|NCT00460564|20966104|P1|Open-Label Phase (36 Weeks)|Adverse Event|0
6069717|NCT00460564|20966097|P8|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
6069718|NCT00460564|20966098|P7|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
6069719|NCT00460564|20966099|P6|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
6069720|NCT00460564|20966100|P5|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
6069721|NCT00460564|20966101|P4|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
6069722|NCT00460564|20966102|P3|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
6069723|NCT00460564|20966103|P2|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
6069724|NCT00460564|20966104|P1|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|1
6069725|NCT00460564|20966097|P8|Double-Blind Phase (12 Weeks)|Adverse Event|0
6069726|NCT00460564|20966098|P7|Double-Blind Phase (12 Weeks)|Adverse Event|0
6069727|NCT00460564|20966099|P6|Double-Blind Phase (12 Weeks)|Adverse Event|0
6069728|NCT00460564|20966100|P5|Double-Blind Phase (12 Weeks)|Adverse Event|0
6069729|NCT00460564|20966101|P4|Double-Blind Phase (12 Weeks)|Adverse Event|0
6069730|NCT00460564|20966102|P3|Double-Blind Phase (12 Weeks)|Adverse Event|0
6069731|NCT00460564|20966103|P2|Double-Blind Phase (12 Weeks)|Adverse Event|1
6069732|NCT00460564|20966104|P1|Double-Blind Phase (12 Weeks)|Adverse Event|3
6069733|NCT00460434|20966248|P2|Overall Study|Lost to Follow-up|7
6069734|NCT00460434|20966249|P1|Overall Study|Lost to Follow-up|3
6069735|NCT00460408|20966328|P4|Overall Study|Other|0
6069736|NCT00460408|20966329|P3|Overall Study|Other|0
6069737|NCT00460408|20966330|P2|Overall Study|Other|2
6069738|NCT00460408|20966331|P1|Overall Study|Other|12
6069739|NCT00460408|20966328|P4|Overall Study|Insufficient clinical response|0
6069740|NCT00460408|20966329|P3|Overall Study|Insufficient clinical response|5
6069741|NCT00460408|20966330|P2|Overall Study|Insufficient clinical response|1
6069742|NCT00460408|20966331|P1|Overall Study|Insufficient clinical response|5
6069743|NCT00460408|20966328|P4|Overall Study|Withdrawal by Subject|0
6069744|NCT00460408|20966329|P3|Overall Study|Withdrawal by Subject|0
6069745|NCT00460408|20966330|P2|Overall Study|Withdrawal by Subject|0
6069746|NCT00460408|20966331|P1|Overall Study|Withdrawal by Subject|31
6069747|NCT00460408|20966328|P4|Overall Study|Lost to Follow-up|0
6069748|NCT00460408|20966329|P3|Overall Study|Lost to Follow-up|1
6069749|NCT00460408|20966330|P2|Overall Study|Lost to Follow-up|0
6069750|NCT00460408|20966331|P1|Overall Study|Lost to Follow-up|11
6069751|NCT00460408|20966328|P4|Overall Study|Death|0
6069752|NCT00460408|20966329|P3|Overall Study|Death|0
6069753|NCT00460408|20966330|P2|Overall Study|Death|0
6069754|NCT00460408|20966331|P1|Overall Study|Death|7
6069755|NCT00460408|20966328|P4|Overall Study|Adverse Event|0
6069756|NCT00460408|20966329|P3|Overall Study|Adverse Event|0
6069757|NCT00460408|20966330|P2|Overall Study|Adverse Event|0
6069758|NCT00460408|20966331|P1|Overall Study|Adverse Event|1
6069759|NCT00460265|20966368|P2|Overall Study|Ongoing|47
6069760|NCT00460265|20966369|P1|Overall Study|Ongoing|60
6069761|NCT00460265|20966368|P2|Overall Study|Withdrawal by Subject|25
6069762|NCT00460265|20966369|P1|Overall Study|Withdrawal by Subject|10
6069763|NCT00460265|20966368|P2|Overall Study|Physician Decision|2
6069764|NCT00460265|20966369|P1|Overall Study|Physician Decision|1
6069765|NCT00460265|20966368|P2|Overall Study|Lost to Follow-up|15
6069766|NCT00460265|20966369|P1|Overall Study|Lost to Follow-up|14
6069767|NCT00460239|20966385|P9|Overall Study|Withdrawal by Subject|0
6069768|NCT00460239|20966386|P8|Overall Study|Withdrawal by Subject|0
6069769|NCT00460239|20966387|P7|Overall Study|Withdrawal by Subject|0
6069770|NCT00460239|20966388|P6|Overall Study|Withdrawal by Subject|1
6069771|NCT00460239|20966389|P5|Overall Study|Withdrawal by Subject|0
6069772|NCT00460239|20966390|P4|Overall Study|Withdrawal by Subject|0
6069773|NCT00460239|20966391|P3|Overall Study|Withdrawal by Subject|0
6069774|NCT00460239|20966392|P2|Overall Study|Withdrawal by Subject|0
6069775|NCT00460239|20966393|P1|Overall Study|Withdrawal by Subject|0
6069776|NCT00460239|20966385|P9|Overall Study|Physician Decision|0
6069777|NCT00460239|20966386|P8|Overall Study|Physician Decision|0
6069778|NCT00460239|20966387|P7|Overall Study|Physician Decision|0
6069779|NCT00460239|20966388|P6|Overall Study|Physician Decision|2
6069780|NCT00460239|20966389|P5|Overall Study|Physician Decision|0
6069781|NCT00460239|20966390|P4|Overall Study|Physician Decision|0
6069782|NCT00460239|20966391|P3|Overall Study|Physician Decision|0
6069783|NCT00460239|20966392|P2|Overall Study|Physician Decision|1
6069784|NCT00460239|20966393|P1|Overall Study|Physician Decision|0
6069785|NCT00460109|20966462|P1|Overall Study|Death|1
6069786|NCT00460031|20966470|P1|Overall Study|Death|1
6069787|NCT00460031|20966470|P1|Overall Study|Withdrawal by Subject|5
6069788|NCT00460031|20966470|P1|Overall Study|Adverse Event|5
6069789|NCT00459979|20966478|P1|Overall Study|Protocol Violation|1
6069790|NCT00459979|20966478|P1|Overall Study|Withdrawal by Subject|1
6069791|NCT00459953|20966490|P2|Overall Study|not analyzed-household member in study|1
6069792|NCT00459953|20966491|P1|Overall Study|not analyzed-household member in study|1
6069793|NCT00459875|20966497|P1|Overall Study|Adverse Event|2
6069794|NCT00459875|20966497|P1|Overall Study|Ineligible participant|1
6069795|NCT00459706|20966533|P2|Overall Study|Other|1
6069796|NCT00459706|20966534|P1|Overall Study|Other|0
6069797|NCT00459706|20966533|P2|Overall Study|Failed to Return|0
6069798|NCT00459706|20966534|P1|Overall Study|Failed to Return|1
6069799|NCT00459706|20966533|P2|Overall Study|Protocol Violation|1
6069800|NCT00459706|20966534|P1|Overall Study|Protocol Violation|2
6069801|NCT00459706|20966533|P2|Overall Study|Discontinuation of Study by Sponsor|0
6069802|NCT00459706|20966534|P1|Overall Study|Discontinuation of Study by Sponsor|1
6069803|NCT00459706|20966533|P2|Overall Study|Physician Decision|0
6069804|NCT00459706|20966534|P1|Overall Study|Physician Decision|2
6069805|NCT00459706|20966533|P2|Overall Study|Withdrawal by Subject|6
6069806|NCT00459706|20966534|P1|Overall Study|Withdrawal by Subject|1
6069807|NCT00459706|20966533|P2|Overall Study|Adverse Event|13
6069808|NCT00459706|20966534|P1|Overall Study|Adverse Event|19
6069809|NCT00459667|20966677|P3|Overall Study|No treatment administered|1
6069810|NCT00459667|20966678|P2|Overall Study|No treatment administered|3
6069811|NCT00459667|20966679|P1|Overall Study|No treatment administered|6
6069812|NCT00459667|20966677|P3|Overall Study|Other reason (incl. 2 missing subjects)|1
6069813|NCT00459667|20966678|P2|Overall Study|Other reason (incl. 2 missing subjects)|15
6069814|NCT00459667|20966679|P1|Overall Study|Other reason (incl. 2 missing subjects)|12
6069815|NCT00459667|20966677|P3|Overall Study|Other disease modifying treatment|1
6069816|NCT00459667|20966678|P2|Overall Study|Other disease modifying treatment|2
6069817|NCT00459667|20966679|P1|Overall Study|Other disease modifying treatment|1
6069818|NCT00459667|20966677|P3|Overall Study|Withdrawal by Subject|5
6069819|NCT00459667|20966678|P2|Overall Study|Withdrawal by Subject|5
6069820|NCT00459667|20966679|P1|Overall Study|Withdrawal by Subject|3
6069821|NCT00459667|20966677|P3|Overall Study|Protocol Violation|0
6069822|NCT00459667|20966678|P2|Overall Study|Protocol Violation|0
6069823|NCT00459667|20966679|P1|Overall Study|Protocol Violation|1
6069824|NCT00459667|20966677|P3|Overall Study|Pregnancy|1
6069825|NCT00459667|20966678|P2|Overall Study|Pregnancy|1
6069826|NCT00459667|20966679|P1|Overall Study|Pregnancy|1
6069827|NCT00459667|20966677|P3|Overall Study|Lost to Follow-up|3
6069828|NCT00459667|20966678|P2|Overall Study|Lost to Follow-up|9
6069829|NCT00459667|20966679|P1|Overall Study|Lost to Follow-up|5
6069830|NCT00459667|20966677|P3|Overall Study|Adverse Event|8
6069831|NCT00459667|20966678|P2|Overall Study|Adverse Event|12
6069832|NCT00459667|20966679|P1|Overall Study|Adverse Event|9
6069833|NCT00459537|20966701|P2|Overall Study|Missing|0
6069834|NCT00459537|20966702|P1|Overall Study|Missing|1
6069835|NCT00459537|20966701|P2|Overall Study|Protocol Violation|3
6069836|NCT00459537|20966702|P1|Overall Study|Protocol Violation|4
6069837|NCT00459537|20966701|P2|Overall Study|Administrative problems|0
6069838|NCT00459537|20966702|P1|Overall Study|Administrative problems|3
6069839|NCT00459537|20966701|P2|Overall Study|Lost to Follow-up|30
6069840|NCT00459537|20966702|P1|Overall Study|Lost to Follow-up|27
6069841|NCT00459537|20966701|P2|Overall Study|Withdrawal by Subject|26
6069842|NCT00459537|20966702|P1|Overall Study|Withdrawal by Subject|20
6069843|NCT00459537|20966701|P2|Overall Study|Lack of Efficacy|11
6069844|NCT00459537|20966702|P1|Overall Study|Lack of Efficacy|10
6069845|NCT00459537|20966701|P2|Overall Study|Adverse Event|6
6069846|NCT00459537|20966702|P1|Overall Study|Adverse Event|1
6069847|NCT00459355|20966737|P2|Overall Study|Subject no longer met inc criteria|18
6069848|NCT00459355|20966738|P1|Overall Study|Subject no longer met inc criteria|20
6069849|NCT00459342|20966750|P1|Overall Study|Not eligible|1
6069850|NCT00459316|20966763|P3|Step 3|Withdrawal by Subject|1
6069851|NCT00459316|20966764|P2|Step 3|Withdrawal by Subject|0
6069852|NCT00459316|20966765|P1|Step 3|Withdrawal by Subject|3
6069853|NCT00459316|20966763|P3|Steps 1 & 2|Lost to Follow-up|2
6069854|NCT00459316|20966764|P2|Steps 1 & 2|Lost to Follow-up|0
6069855|NCT00459316|20966765|P1|Steps 1 & 2|Lost to Follow-up|5
6069856|NCT00459316|20966763|P3|Steps 1 & 2|Not willing to adhere to regulations|0
6069857|NCT00459316|20966764|P2|Steps 1 & 2|Not willing to adhere to regulations|0
6069858|NCT00459316|20966765|P1|Steps 1 & 2|Not willing to adhere to regulations|1
6069859|NCT00459316|20966763|P3|Steps 1 & 2|Withdrawal by Subject|0
6069860|NCT00459316|20966764|P2|Steps 1 & 2|Withdrawal by Subject|1
6069861|NCT00459316|20966765|P1|Steps 1 & 2|Withdrawal by Subject|6
6069862|NCT00459316|20966763|P3|Steps 1 & 2|Not able to get to clinic|0
6069863|NCT00459316|20966764|P2|Steps 1 & 2|Not able to get to clinic|4
6069864|NCT00459316|20966765|P1|Steps 1 & 2|Not able to get to clinic|7
6069865|NCT00459316|20966763|P3|Steps 1 & 2|Death|0
6069866|NCT00459316|20966764|P2|Steps 1 & 2|Death|1
6069867|NCT00459316|20966765|P1|Steps 1 & 2|Death|1
6069868|NCT00459316|20966763|P3|Steps 1 & 2|Other eligibility failure|0
6069869|NCT00459316|20966764|P2|Steps 1 & 2|Other eligibility failure|1
6069870|NCT00459316|20966765|P1|Steps 1 & 2|Other eligibility failure|1
6069871|NCT00459290|20966830|P1|Overall Study|Ineligible|2
6069872|NCT00459290|20966830|P1|Overall Study|Adverse Event|3
6069873|NCT00459186|20966845|P1|PET Imaging and Assessment|Adverse Event|3
6069874|NCT00459186|20966845|P1|Single Agent RAD001|Withdrawal by Subject|1
6069875|NCT00459134|20966852|P2|Overall Study|Multiple Reasons|3
6069876|NCT00459134|20966853|P1|Overall Study|Multiple Reasons|2
6069877|NCT00459134|20966852|P2|Overall Study|Progression|0
6069878|NCT00459134|20966853|P1|Overall Study|Progression|1
6069879|NCT00459134|20966852|P2|Overall Study|Toxicity|5
6069880|NCT00459134|20966853|P1|Overall Study|Toxicity|4
6069881|NCT00459134|20966852|P2|Overall Study|Surgery|2
6069882|NCT00459134|20966853|P1|Overall Study|Surgery|1
6069883|NCT00459134|20966852|P2|Overall Study|Lost to Follow-up|7
6069884|NCT00459134|20966853|P1|Overall Study|Lost to Follow-up|6
6069885|NCT00459134|20966852|P2|Overall Study|Withdrawal by Subject|7
6069886|NCT00459134|20966853|P1|Overall Study|Withdrawal by Subject|8
6069887|NCT00459134|20966852|P2|Overall Study|Physician Decision|1
6069888|NCT00459134|20966853|P1|Overall Study|Physician Decision|1
6069889|NCT00459108|20966869|P1|Overall Study|Progression|1
6069890|NCT00459108|20966869|P1|Overall Study|Death|2
6069891|NCT00459108|20966869|P1|Overall Study|Adverse Event|3
6069892|NCT00459108|20966869|P1|Overall Study|Withdrawal by Subject|5
6069893|NCT00459056|20966879|P2|First Intervention (First Three Months)|Lost to Follow-up|1
6069894|NCT00459056|20966880|P1|First Intervention (First Three Months)|Lost to Follow-up|1
6069895|NCT00459043|20966888|P2|Overall Study|Withdrawal by Subject|0
6069896|NCT00459043|20966889|P1|Overall Study|Withdrawal by Subject|1
6069897|NCT00458705|20966916|P1|Overall Study|Not Treated|1
6069898|NCT00458705|20966916|P1|Overall Study|Adverse Event|4
6069899|NCT00458536|20966920|P1|Overall Study|Progressive disease during treatment|2
6069900|NCT00458536|20966920|P1|Overall Study|Withdrawal by Subject|1
6069901|NCT00458536|20966920|P1|Overall Study|Ineligible due to toxicity|1
6069902|NCT00458536|20966920|P1|Overall Study|Patient did not have surgery|1
6069903|NCT00458536|20966920|P1|Overall Study|Did not have renal cell carcinoma|2
6069904|NCT00458536|20966920|P1|Overall Study|No measurable disease after surgery|2
6069905|NCT00458536|20966920|P1|Overall Study|Unable to make vaccine|3
6069906|NCT00458536|20966920|P1|Overall Study|Disease progression prior to treatment|7
6069907|NCT00458484|20966931|P7|Overall Study|Not eligible b/c prior radiation history|0
6069908|NCT00458484|20966932|P6|Overall Study|Not eligible b/c prior radiation history|1
6069909|NCT00458484|20966933|P5|Overall Study|Not eligible b/c prior radiation history|0
6069910|NCT00458484|20966934|P4|Overall Study|Not eligible b/c prior radiation history|0
6069911|NCT00458484|20966935|P3|Overall Study|Not eligible b/c prior radiation history|0
6069912|NCT00458484|20966936|P2|Overall Study|Not eligible b/c prior radiation history|0
6069913|NCT00458484|20966937|P1|Overall Study|Not eligible b/c prior radiation history|0
6069914|NCT00458393|20967003|P2|Overall Study|Sites marked other on the form.|20
6069915|NCT00458393|20967004|P1|Overall Study|Sites marked other on the form.|19
6069916|NCT00458393|20967003|P2|Overall Study|Lost to Follow-up|92
6069917|NCT00458393|20967004|P1|Overall Study|Lost to Follow-up|115
6069918|NCT00458393|20967003|P2|Overall Study|Relocated|81
6069919|NCT00458393|20967004|P1|Overall Study|Relocated|77
6069920|NCT00458393|20967003|P2|Overall Study|Physician Decision|22
6069921|NCT00458393|20967004|P1|Overall Study|Physician Decision|31
6069922|NCT00458393|20967003|P2|Overall Study|Withdrawal by Subject|80
6069923|NCT00458393|20967004|P1|Overall Study|Withdrawal by Subject|67
6069924|NCT00458341|20967052|P2|Cycle 1|Adverse Event|0
6069925|NCT00458341|20967053|P1|Cycle 1|Adverse Event|1
6069926|NCT00458302|20967093|P2|Overall Study|Other|2
6069927|NCT00458302|20967094|P1|Overall Study|Other|4
6069928|NCT00458302|20967093|P2|Overall Study|Lost to Follow-up|0
6069929|NCT00458302|20967094|P1|Overall Study|Lost to Follow-up|2
6069930|NCT00458302|20967093|P2|Overall Study|Study Termination By Sponsor|0
6069931|NCT00458302|20967094|P1|Overall Study|Study Termination By Sponsor|1
6069932|NCT00458302|20967093|P2|Overall Study|Inc/Exc Criteria Not Met|1
6069933|NCT00458302|20967094|P1|Overall Study|Inc/Exc Criteria Not Met|1
6069934|NCT00458302|20967093|P2|Overall Study|Withdrawal by Subject|4
6069935|NCT00458302|20967094|P1|Overall Study|Withdrawal by Subject|6
6069936|NCT00458302|20967093|P2|Overall Study|Protocol Violation|2
6069937|NCT00458302|20967094|P1|Overall Study|Protocol Violation|0
6069938|NCT00458302|20967093|P2|Overall Study|Pregnancy|1
6069939|NCT00458302|20967094|P1|Overall Study|Pregnancy|2
6069940|NCT00458302|20967093|P2|Overall Study|Adverse Event|14
6069941|NCT00458302|20967094|P1|Overall Study|Adverse Event|4
6069942|NCT00458211|20967139|P1|Overall Study|Protocol Violation|2
6069943|NCT00458211|20967139|P1|Overall Study|Withdrawal by Subject|2
6069944|NCT00458211|20967139|P1|Overall Study|Lack of Efficacy|12
6069945|NCT00457821|20967189|P8|Part 2|Withdrawal by Subject|1
6069946|NCT00457821|20967190|P7|Part 2|Withdrawal by Subject|0
6069947|NCT00457821|20967191|P6|Part 2|Withdrawal by Subject|0
6069948|NCT00457821|20967192|P5|Part 2|Withdrawal by Subject|0
6069949|NCT00457821|20967193|P4|Part 2|Withdrawal by Subject|0
6069950|NCT00457821|20967194|P3|Part 2|Withdrawal by Subject|0
6069951|NCT00457821|20967195|P2|Part 2|Withdrawal by Subject|0
6069952|NCT00457821|20967196|P1|Part 2|Withdrawal by Subject|0
6069953|NCT00457743|20967235|P3|Overall Study|Lack of Efficacy|3
6069954|NCT00457743|20967236|P2|Overall Study|Lack of Efficacy|23
6069955|NCT00457743|20967237|P1|Overall Study|Lack of Efficacy|3
6069956|NCT00457743|20967235|P3|Overall Study|Adverse Event|0
6069957|NCT00457743|20967236|P2|Overall Study|Adverse Event|4
6069958|NCT00457743|20967237|P1|Overall Study|Adverse Event|0
6069959|NCT00457691|20967294|P2|Overall Study|Disease progression, study terminated|196
6069960|NCT00457691|20967295|P1|Overall Study|Disease progression, study terminated|180
6069961|NCT00457691|20967294|P2|Overall Study|Subject refused (reason other than AE)|19
6069962|NCT00457691|20967295|P1|Overall Study|Subject refused (reason other than AE)|14
6069963|NCT00457691|20967294|P2|Overall Study|Study terminated by Sponsor|1
6069964|NCT00457691|20967295|P1|Overall Study|Study terminated by Sponsor|1
6069965|NCT00457691|20967294|P2|Overall Study|Lost to Follow-up|14
6069966|NCT00457691|20967295|P1|Overall Study|Lost to Follow-up|23
6069967|NCT00457691|20967294|P2|Overall Study|Protocol Violation|3
6069968|NCT00457691|20967295|P1|Overall Study|Protocol Violation|1
6069969|NCT00457691|20967294|P2|Overall Study|Death|148
6069970|NCT00457691|20967295|P1|Overall Study|Death|163
6069971|NCT00457691|20967294|P2|Overall Study|Adverse Event|1
6069972|NCT00457691|20967295|P1|Overall Study|Adverse Event|4
6069973|NCT00457665|20967317|P2|24 Months|Abnormal liver function tests|5
6069974|NCT00457665|20967318|P1|24 Months|Abnormal liver function tests|1
6069975|NCT00457665|20967317|P2|24 Months|Lipodystrophy|1
6069976|NCT00457665|20967318|P1|24 Months|Lipodystrophy|1
6069977|NCT00457665|20967317|P2|24 Months|Withdrawal by Subject|2
6069978|NCT00457665|20967318|P1|24 Months|Withdrawal by Subject|3
6069979|NCT00457665|20967317|P2|12 Months|Abnormal Liver function tests|5
6069980|NCT00457665|20967318|P1|12 Months|Abnormal Liver function tests|0
6069981|NCT00457665|20967317|P2|12 Months|Withdrawal by Subject|2
6069982|NCT00457665|20967318|P1|12 Months|Withdrawal by Subject|0
6069983|NCT00457665|20967317|P2|12 Months|Lipodystrophy|0
6069984|NCT00457665|20967318|P1|12 Months|Lipodystrophy|2
6069985|NCT00457665|20967317|P2|12 Months|High HIV viral load|1
6069986|NCT00457665|20967318|P1|12 Months|High HIV viral load|5
6069987|NCT00457665|20967317|P2|12 Months|Drug allergy|1
6069988|NCT00457665|20967318|P1|12 Months|Drug allergy|1
6069989|NCT00457639|20967324|P2|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|1
6069990|NCT00457639|20967325|P1|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|0
6069991|NCT00457639|20967324|P2|Intervention 1 (6 Months)|unrelated illness|2
6069992|NCT00457639|20967325|P1|Intervention 1 (6 Months)|unrelated illness|0
6069993|NCT00457639|20967324|P2|Intervention 1 (6 Months)|Lost to Follow-up|0
6069994|NCT00457639|20967325|P1|Intervention 1 (6 Months)|Lost to Follow-up|3
6069995|NCT00457418|20967333|P1|Post PK Maintenance|Lost to Follow-up|1
6069996|NCT00457418|20967333|P1|Post PK Maintenance|Withdrawal by Subject|11
6069997|NCT00457418|20967333|P1|Post PK Maintenance|Progression of Disease|6
6069998|NCT00457418|20967333|P1|Post PK Maintenance|Adverse Event|10
6069999|NCT00457418|20967333|P1|Pharmacokinetic (PK) Sampling Phase|Non-compliance with protocol|2
6070000|NCT00457418|20967333|P1|Pharmacokinetic (PK) Sampling Phase|Progression of Disease|1
6070001|NCT00457418|20967333|P1|Pharmacokinetic (PK) Sampling Phase|Adverse Event|2
6070002|NCT00457392|20967345|P2|Overall Study|Randomized, Not Treated|3
6070003|NCT00457392|20967346|P1|Overall Study|Randomized, Not Treated|7
6070004|NCT00457392|20967345|P2|Overall Study|Study Terminated by Sponsor|4
6070005|NCT00457392|20967346|P1|Overall Study|Study Terminated by Sponsor|1
6070006|NCT00457392|20967345|P2|Overall Study|Other|4
6070007|NCT00457392|20967346|P1|Overall Study|Other|7
6070008|NCT00457392|20967345|P2|Overall Study|Protocol Violation|3
6070009|NCT00457392|20967346|P1|Overall Study|Protocol Violation|4
6070010|NCT00457392|20967345|P2|Overall Study|Lost to Follow-up|7
6070011|NCT00457392|20967346|P1|Overall Study|Lost to Follow-up|6
6070012|NCT00457392|20967345|P2|Overall Study|Withdrawal by Subject|8
6070013|NCT00457392|20967346|P1|Overall Study|Withdrawal by Subject|14
6070014|NCT00457392|20967345|P2|Overall Study|Global Deterioration of Health Status|8
6070015|NCT00457392|20967346|P1|Overall Study|Global Deterioration of Health Status|22
6070016|NCT00457392|20967345|P2|Overall Study|Adverse Event|41
6070017|NCT00457392|20967346|P1|Overall Study|Adverse Event|84
6070018|NCT00457392|20967345|P2|Overall Study|Death|106
6070019|NCT00457392|20967346|P1|Overall Study|Death|106
6070020|NCT00457392|20967345|P2|Overall Study|Objective Progression or Relapse|296
6070021|NCT00457392|20967346|P1|Overall Study|Objective Progression or Relapse|229
6070022|NCT00457301|20967373|P2|Overall Study|Death|7
6070023|NCT00457301|20967374|P1|Overall Study|Death|5
6070024|NCT00457301|20967373|P2|Overall Study|Censored out of the study|14
6070025|NCT00457301|20967374|P1|Overall Study|Censored out of the study|15
6070026|NCT00457301|20967373|P2|Overall Study|Withdrawal by Subject|3
6070027|NCT00457301|20967374|P1|Overall Study|Withdrawal by Subject|3
6070028|NCT00457249|20967388|P2|Overall Study|Serious Adverse Events|0
6070029|NCT00457249|20967389|P1|Overall Study|Serious Adverse Events|2
6070030|NCT00457249|20967388|P2|Overall Study|Withdrawal by Subject|1
6070031|NCT00457249|20967389|P1|Overall Study|Withdrawal by Subject|3
6070032|NCT00457249|20967388|P2|Overall Study|Protocol Violation|1
6070033|NCT00457249|20967389|P1|Overall Study|Protocol Violation|4
6070034|NCT00457249|20967388|P2|Overall Study|Lost to Follow-up|0
6070035|NCT00457249|20967389|P1|Overall Study|Lost to Follow-up|3
6070036|NCT00457015|20967428|P2|Overall Study|Left study site against medical advice|1
6070037|NCT00457015|20967429|P1|Overall Study|Left study site against medical advice|0
6070038|NCT00457002|20967445|P2|Overall Study|treated for 1 day; missing status/reason|0
6070039|NCT00457002|20967446|P1|Overall Study|treated for 1 day; missing status/reason|1
6070040|NCT00457002|20967445|P2|Overall Study|non-specified|38
6070041|NCT00457002|20967446|P1|Overall Study|non-specified|29
6070042|NCT00457002|20967445|P2|Overall Study|Administrative reason by Sponsor|0
6070043|NCT00457002|20967446|P1|Overall Study|Administrative reason by Sponsor|1
6070044|NCT00457002|20967445|P2|Overall Study|No longer met criteria|37
6070045|NCT00457002|20967446|P1|Overall Study|No longer met criteria|41
6070046|NCT00457002|20967445|P2|Overall Study|Poor/Non-compliance|33
6070047|NCT00457002|20967446|P1|Overall Study|Poor/Non-compliance|46
6070048|NCT00457002|20967445|P2|Overall Study|Lost to Follow-up|71
6070049|NCT00457002|20967446|P1|Overall Study|Lost to Follow-up|72
6070050|NCT00457002|20967445|P2|Overall Study|Withdrawal by Subject|271
6070051|NCT00457002|20967446|P1|Overall Study|Withdrawal by Subject|299
6070052|NCT00457002|20967445|P2|Overall Study|Adverse Event|260
6070053|NCT00457002|20967446|P1|Overall Study|Adverse Event|284
6070054|NCT00457002|20967445|P2|Overall Study|Death|47
6070055|NCT00457002|20967446|P1|Overall Study|Death|40
6070056|NCT00456846|20967551|P2|Overall Study|Other|2
6070057|NCT00456846|20967552|P1|Overall Study|Other|0
6070058|NCT00456846|20967551|P2|Overall Study|Participant Discretion|5
6070059|NCT00456846|20967552|P1|Overall Study|Participant Discretion|1
6070060|NCT00456846|20967551|P2|Overall Study|Protocol Deviation|0
6070061|NCT00456846|20967552|P1|Overall Study|Protocol Deviation|2
6070062|NCT00456846|20967551|P2|Overall Study|Physician Decision|6
6070063|NCT00456846|20967552|P1|Overall Study|Physician Decision|11
6070064|NCT00456846|20967551|P2|Overall Study|Adverse Event|15
6070065|NCT00456846|20967552|P1|Overall Study|Adverse Event|2
6070066|NCT00456755|20967593|P2|Overall Study|Lost to Follow-up|1
6070067|NCT00456755|20967594|P1|Overall Study|Lost to Follow-up|2
6070068|NCT00456612|20967608|P1|Overall Study|Withdrawal by Subject|3
6070069|NCT00456599|20967613|P1|Overall Study|Withdrawal by Subject|2
6070070|NCT00456599|20967613|P1|Overall Study|Non-compliance|1
6070071|NCT00456521|20967636|P2|Overall Study|Drug non-compliance, moved, other|11
6070072|NCT00456521|20967637|P1|Overall Study|Drug non-compliance, moved, other|26
6070073|NCT00456521|20967636|P2|Overall Study|Pregnancy|1
6070074|NCT00456521|20967637|P1|Overall Study|Pregnancy|1
6070075|NCT00456521|20967636|P2|Overall Study|Protocol Violation|0
6070076|NCT00456521|20967637|P1|Overall Study|Protocol Violation|4
6070077|NCT00456521|20967636|P2|Overall Study|Lack of Efficacy|6
6070078|NCT00456521|20967637|P1|Overall Study|Lack of Efficacy|3
6070079|NCT00456521|20967636|P2|Overall Study|Lost to Follow-up|17
6070080|NCT00456521|20967637|P1|Overall Study|Lost to Follow-up|22
6070081|NCT00456521|20967636|P2|Overall Study|Withdrawal by Subject|24
6070082|NCT00456521|20967637|P1|Overall Study|Withdrawal by Subject|43
6070083|NCT00456521|20967636|P2|Overall Study|Adverse Event|25
6070084|NCT00456521|20967637|P1|Overall Study|Adverse Event|150
6070085|NCT00456495|20967683|P1|Overall Study|Physician Decision|2
6070086|NCT00456365|20967690|P2|Overall Study|oncologic diagnosis|1
6070087|NCT00456365|20967691|P1|Overall Study|oncologic diagnosis|1
6070088|NCT00456365|20967690|P2|Overall Study|Pregnancy|1
6070089|NCT00456365|20967691|P1|Overall Study|Pregnancy|1
6070090|NCT00456365|20967690|P2|Overall Study|Withdrawal by Subject|7
6070091|NCT00456365|20967691|P1|Overall Study|Withdrawal by Subject|4
6070092|NCT00456365|20967690|P2|Overall Study|Lost to Follow-up|3
6070093|NCT00456365|20967691|P1|Overall Study|Lost to Follow-up|1
6070094|NCT00456300|20967703|P2|Overall Study|Adverse Event|0
6070095|NCT00456300|20967704|P1|Overall Study|Adverse Event|1
6070096|NCT00456092|20967728|P5|Treatment Phase (12 Weeks)|Other|0
6070097|NCT00456092|20967729|P4|Treatment Phase (12 Weeks)|Other|0
6070098|NCT00456092|20967730|P3|Treatment Phase (12 Weeks)|Other|1
6070099|NCT00456092|20967731|P2|Treatment Phase (12 Weeks)|Other|0
6070100|NCT00456092|20967732|P1|Treatment Phase (12 Weeks)|Other|1
6070101|NCT00456092|20967728|P5|Treatment Phase (12 Weeks)|Lost to Follow-up|0
6070102|NCT00456092|20967729|P4|Treatment Phase (12 Weeks)|Lost to Follow-up|0
6070103|NCT00456092|20967730|P3|Treatment Phase (12 Weeks)|Lost to Follow-up|1
6070104|NCT00456092|20967731|P2|Treatment Phase (12 Weeks)|Lost to Follow-up|1
6070105|NCT00456092|20967732|P1|Treatment Phase (12 Weeks)|Lost to Follow-up|0
6070106|NCT00456092|20967728|P5|Treatment Phase (12 Weeks)|Withdrew Consent|0
6070107|NCT00456092|20967729|P4|Treatment Phase (12 Weeks)|Withdrew Consent|0
6070108|NCT00456092|20967730|P3|Treatment Phase (12 Weeks)|Withdrew Consent|2
6070109|NCT00456092|20967731|P2|Treatment Phase (12 Weeks)|Withdrew Consent|1
6070110|NCT00456092|20967732|P1|Treatment Phase (12 Weeks)|Withdrew Consent|0
6070111|NCT00456092|20967728|P5|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0
6070112|NCT00456092|20967729|P4|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0
6070113|NCT00456092|20967730|P3|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|7
6070114|NCT00456092|20967731|P2|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|2
6070115|NCT00456092|20967732|P1|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0
6070116|NCT00456092|20967728|P5|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0
6070117|NCT00456092|20967729|P4|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0
6070118|NCT00456092|20967730|P3|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3
6070119|NCT00456092|20967731|P2|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3
6070120|NCT00456092|20967732|P1|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0
6070121|NCT00456092|20967728|P5|Treatment Phase (12 Weeks)|Flare of Psoriasis|0
6070122|NCT00456092|20967729|P4|Treatment Phase (12 Weeks)|Flare of Psoriasis|0
6070123|NCT00456092|20967730|P3|Treatment Phase (12 Weeks)|Flare of Psoriasis|2
6070124|NCT00456092|20967731|P2|Treatment Phase (12 Weeks)|Flare of Psoriasis|1
6070125|NCT00456092|20967732|P1|Treatment Phase (12 Weeks)|Flare of Psoriasis|0
6070126|NCT00456092|20967728|P5|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0
6070127|NCT00456092|20967729|P4|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0
6070128|NCT00456092|20967730|P3|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0
6070129|NCT00456092|20967731|P2|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0
6070130|NCT00456092|20967732|P1|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|2
6070131|NCT00456092|20967728|P5|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0
6070132|NCT00456092|20967729|P4|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0
6070133|NCT00456092|20967730|P3|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0
6070134|NCT00456092|20967731|P2|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|2
6070135|NCT00456092|20967732|P1|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|1
6070136|NCT00456092|20967728|P5|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0
6070137|NCT00456092|20967729|P4|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0
6070138|NCT00456092|20967730|P3|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|2
6070139|NCT00456092|20967731|P2|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|4
6070140|NCT00456092|20967732|P1|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|3
6070141|NCT00456092|20967728|P5|Extension Phase|Other|1
6070142|NCT00456092|20967729|P4|Extension Phase|Other|1
6070143|NCT00456092|20967730|P3|Extension Phase|Other|0
6070144|NCT00456092|20967731|P2|Extension Phase|Other|0
6070145|NCT00456092|20967732|P1|Extension Phase|Other|2
6070146|NCT00456092|20967728|P5|Extension Phase|Lost to Follow-up|1
6070147|NCT00456092|20967729|P4|Extension Phase|Lost to Follow-up|0
6070148|NCT00456092|20967730|P3|Extension Phase|Lost to Follow-up|0
6070149|NCT00456092|20967731|P2|Extension Phase|Lost to Follow-up|1
6070150|NCT00456092|20967732|P1|Extension Phase|Lost to Follow-up|1
6070151|NCT00456092|20967728|P5|Extension Phase|Withdrew Consent|0
6070152|NCT00456092|20967729|P4|Extension Phase|Withdrew Consent|0
6070153|NCT00456092|20967730|P3|Extension Phase|Withdrew Consent|0
6070154|NCT00456092|20967731|P2|Extension Phase|Withdrew Consent|0
6070155|NCT00456092|20967732|P1|Extension Phase|Withdrew Consent|2
6070156|NCT00456092|20967728|P5|Extension Phase|Worsening / Not Responding to Study Drug|2
6070157|NCT00456092|20967729|P4|Extension Phase|Worsening / Not Responding to Study Drug|0
6070158|NCT00456092|20967730|P3|Extension Phase|Worsening / Not Responding to Study Drug|0
6070159|NCT00456092|20967731|P2|Extension Phase|Worsening / Not Responding to Study Drug|1
6070160|NCT00456092|20967732|P1|Extension Phase|Worsening / Not Responding to Study Drug|3
6070161|NCT00456092|20967728|P5|Extension Phase|Flare of Psoriatic Arthritis|1
6070162|NCT00456092|20967729|P4|Extension Phase|Flare of Psoriatic Arthritis|0
6070163|NCT00456092|20967730|P3|Extension Phase|Flare of Psoriatic Arthritis|0
6070164|NCT00456092|20967731|P2|Extension Phase|Flare of Psoriatic Arthritis|0
6070165|NCT00456092|20967732|P1|Extension Phase|Flare of Psoriatic Arthritis|1
6070166|NCT00456092|20967728|P5|Extension Phase|Grade 2 or Greater AE|2
6070167|NCT00456092|20967729|P4|Extension Phase|Grade 2 or Greater AE|0
6070168|NCT00456092|20967730|P3|Extension Phase|Grade 2 or Greater AE|0
6070169|NCT00456092|20967731|P2|Extension Phase|Grade 2 or Greater AE|2
6070170|NCT00456092|20967732|P1|Extension Phase|Grade 2 or Greater AE|2
6070171|NCT00455923|20967914|P2|Overall Study|Other|1
6070172|NCT00455923|20967915|P1|Overall Study|Other|3
6070173|NCT00455923|20967914|P2|Overall Study|Pregnancy|2
6070174|NCT00455923|20967915|P1|Overall Study|Pregnancy|0
6070175|NCT00455858|20967931|P1|Overall Study|Withdrawal|1
6070176|NCT00455858|20967931|P1|Overall Study|Well controlled FPG without insulin|1
6070177|NCT00455858|20967931|P1|Overall Study|Lack of Efficacy|1
6070178|NCT00455858|20967931|P1|Overall Study|Protocol Violation|1
6070179|NCT00455858|20967931|P1|Overall Study|Lost to Follow-up|2
6070180|NCT00455741|20967941|P2|Overall Study|Physician Decision|1
6070181|NCT00455741|20967942|P1|Overall Study|Physician Decision|0
6070182|NCT00455533|20968038|P3|Period Two: Randomized Period|Subject Withdrew Consent|1
6070256|NCT00455429|20968128|P3|Overall Study|Other|0
6070183|NCT00455533|20968039|P2|Period Two: Randomized Period|Subject Withdrew Consent|2
6070184|NCT00455533|20968040|P1|Period Two: Randomized Period|Subject Withdrew Consent|0
6070185|NCT00455533|20968038|P3|Period Two: Randomized Period|Study Drug Toxicity|0
6070186|NCT00455533|20968039|P2|Period Two: Randomized Period|Study Drug Toxicity|2
6070187|NCT00455533|20968040|P1|Period Two: Randomized Period|Study Drug Toxicity|0
6070188|NCT00455533|20968038|P3|Period Two: Randomized Period|Other - need reasons|0
6070189|NCT00455533|20968039|P2|Period Two: Randomized Period|Other - need reasons|1
6070190|NCT00455533|20968040|P1|Period Two: Randomized Period|Other - need reasons|0
6070191|NCT00455533|20968038|P3|Period Two: Randomized Period|Lost to Follow-up|1
6070192|NCT00455533|20968039|P2|Period Two: Randomized Period|Lost to Follow-up|0
6070193|NCT00455533|20968040|P1|Period Two: Randomized Period|Lost to Follow-up|0
6070194|NCT00455533|20968038|P3|Period Two: Randomized Period|Disease Progression|1
6070195|NCT00455533|20968039|P2|Period Two: Randomized Period|Disease Progression|1
6070196|NCT00455533|20968040|P1|Period Two: Randomized Period|Disease Progression|0
6070197|NCT00455533|20968038|P3|Period Two: Randomized Period|Death|3
6070198|NCT00455533|20968039|P2|Period Two: Randomized Period|Death|0
6070199|NCT00455533|20968040|P1|Period Two: Randomized Period|Death|0
6070200|NCT00455533|20968038|P3|Period One: Initial Chemotherapy|Subject Withdrew Consent|0
6070201|NCT00455533|20968039|P2|Period One: Initial Chemotherapy|Subject Withdrew Consent|0
6070202|NCT00455533|20968040|P1|Period One: Initial Chemotherapy|Subject Withdrew Consent|2
6070203|NCT00455533|20968038|P3|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0
6070204|NCT00455533|20968039|P2|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0
6070205|NCT00455533|20968040|P1|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|2
6070206|NCT00455533|20968038|P3|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0
6070207|NCT00455533|20968039|P2|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0
6070208|NCT00455533|20968040|P1|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|1
6070209|NCT00455533|20968038|P3|Period One: Initial Chemotherapy|Study Drug Toxicity|0
6070210|NCT00455533|20968039|P2|Period One: Initial Chemotherapy|Study Drug Toxicity|0
6070211|NCT00455533|20968040|P1|Period One: Initial Chemotherapy|Study Drug Toxicity|2
6070212|NCT00455533|20968038|P3|Period One: Initial Chemotherapy|Other--Need Reasons|0
6070213|NCT00455533|20968039|P2|Period One: Initial Chemotherapy|Other--Need Reasons|0
6070214|NCT00455533|20968040|P1|Period One: Initial Chemotherapy|Other--Need Reasons|2
6070215|NCT00455533|20968038|P3|Period One: Initial Chemotherapy|Not Reported|0
6070216|NCT00455533|20968039|P2|Period One: Initial Chemotherapy|Not Reported|0
6070217|NCT00455533|20968040|P1|Period One: Initial Chemotherapy|Not Reported|1
6070218|NCT00455533|20968038|P3|Period One: Initial Chemotherapy|Lost to Follow-up|0
6070219|NCT00455533|20968039|P2|Period One: Initial Chemotherapy|Lost to Follow-up|0
6070220|NCT00455533|20968040|P1|Period One: Initial Chemotherapy|Lost to Follow-up|2
6070221|NCT00455533|20968038|P3|Period One: Initial Chemotherapy|Disease Progression|0
6070222|NCT00455533|20968039|P2|Period One: Initial Chemotherapy|Disease Progression|0
6070223|NCT00455533|20968040|P1|Period One: Initial Chemotherapy|Disease Progression|5
6070224|NCT00455533|20968038|P3|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0
6070225|NCT00455533|20968039|P2|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0
6070226|NCT00455533|20968040|P1|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|1
6070227|NCT00455520|20968089|P2|Double Blind Tapentadol ER vs Placebo|All other|6
6070228|NCT00455520|20968090|P1|Double Blind Tapentadol ER vs Placebo|All other|4
6070229|NCT00455520|20968089|P2|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|2
6070230|NCT00455520|20968090|P1|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|4
6070231|NCT00455520|20968089|P2|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3
6070232|NCT00455520|20968090|P1|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3
6070233|NCT00455520|20968089|P2|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|7
6070234|NCT00455520|20968090|P1|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|15
6070235|NCT00455520|20968089|P2|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|29
6070236|NCT00455520|20968090|P1|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|8
6070237|NCT00455520|20968089|P2|Double Blind Tapentadol ER vs Placebo|Adverse Event|15
6070238|NCT00455520|20968090|P1|Double Blind Tapentadol ER vs Placebo|Adverse Event|29
6070239|NCT00455520|20968089|P2|Open Label Tapentadol Extended Release|All other|0
6070240|NCT00455520|20968090|P1|Open Label Tapentadol Extended Release|All other|33
6070241|NCT00455520|20968089|P2|Open Label Tapentadol Extended Release|Study drug non-compliant|0
6070242|NCT00455520|20968090|P1|Open Label Tapentadol Extended Release|Study drug non-compliant|13
6070243|NCT00455520|20968089|P2|Open Label Tapentadol Extended Release|Lack of Efficacy|0
6070244|NCT00455520|20968090|P1|Open Label Tapentadol Extended Release|Lack of Efficacy|23
6070245|NCT00455520|20968089|P2|Open Label Tapentadol Extended Release|Adverse Event|0
6070246|NCT00455520|20968090|P1|Open Label Tapentadol Extended Release|Adverse Event|100
6070247|NCT00455520|20968089|P2|Open Label Tapentadol Extended Release|Lost to Follow-up|0
6070248|NCT00455520|20968090|P1|Open Label Tapentadol Extended Release|Lost to Follow-up|3
6070249|NCT00455520|20968089|P2|Open Label Tapentadol Extended Release|Withdrawal by Subject|0
6070250|NCT00455520|20968090|P1|Open Label Tapentadol Extended Release|Withdrawal by Subject|24
6070251|NCT00455455|20968106|P2|Washout|Withdrawal by Subject|0
6070252|NCT00455455|20968107|P1|Washout|Withdrawal by Subject|1
6070253|NCT00455455|20968106|P2|Washout|Withdrawal by Subject|1
6070254|NCT00455455|20968107|P1|Washout|Withdrawal by Subject|0
6070255|NCT00455429|20968127|P4|Overall Study|Other|1
6070257|NCT00455429|20968129|P2|Overall Study|Other|2
6070258|NCT00455429|20968130|P1|Overall Study|Other|0
6070259|NCT00455429|20968127|P4|Overall Study|Non-compliance|1
6070260|NCT00455429|20968128|P3|Overall Study|Non-compliance|0
6070261|NCT00455429|20968129|P2|Overall Study|Non-compliance|0
6070262|NCT00455429|20968130|P1|Overall Study|Non-compliance|0
6070263|NCT00455429|20968127|P4|Overall Study|Personal Reason|0
6070264|NCT00455429|20968128|P3|Overall Study|Personal Reason|0
6070265|NCT00455429|20968129|P2|Overall Study|Personal Reason|0
6070266|NCT00455429|20968130|P1|Overall Study|Personal Reason|1
6070267|NCT00455429|20968127|P4|Overall Study|Randomly assigned but not treated|2
6070268|NCT00455429|20968128|P3|Overall Study|Randomly assigned but not treated|0
6070269|NCT00455429|20968129|P2|Overall Study|Randomly assigned but not treated|0
6070270|NCT00455429|20968130|P1|Overall Study|Randomly assigned but not treated|0
6070271|NCT00455429|20968127|P4|Overall Study|Adverse Event|3
6070272|NCT00455429|20968128|P3|Overall Study|Adverse Event|0
6070273|NCT00455429|20968129|P2|Overall Study|Adverse Event|1
6070274|NCT00455429|20968130|P1|Overall Study|Adverse Event|0
6070275|NCT00455429|20968127|P4|Overall Study|Lack of Efficacy|1
6070276|NCT00455429|20968128|P3|Overall Study|Lack of Efficacy|0
6070277|NCT00455429|20968129|P2|Overall Study|Lack of Efficacy|1
6070278|NCT00455429|20968130|P1|Overall Study|Lack of Efficacy|0
6070279|NCT00455429|20968127|P4|Overall Study|Withdrawal by Subject|0
6070280|NCT00455429|20968128|P3|Overall Study|Withdrawal by Subject|1
6070281|NCT00455429|20968129|P2|Overall Study|Withdrawal by Subject|1
6070282|NCT00455429|20968130|P1|Overall Study|Withdrawal by Subject|0
6070283|NCT00455429|20968127|P4|Overall Study|Lost to Follow-up|3
6070284|NCT00455429|20968128|P3|Overall Study|Lost to Follow-up|0
6070285|NCT00455429|20968129|P2|Overall Study|Lost to Follow-up|0
6070286|NCT00455429|20968130|P1|Overall Study|Lost to Follow-up|1
6070287|NCT00455429|20968127|P4|Overall Study|Study Terminated by Sponsor|3
6070288|NCT00455429|20968128|P3|Overall Study|Study Terminated by Sponsor|0
6070289|NCT00455429|20968129|P2|Overall Study|Study Terminated by Sponsor|0
6070290|NCT00455429|20968130|P1|Overall Study|Study Terminated by Sponsor|0
6070291|NCT00455312|20968189|P2|Overall Study|Death|1
6070292|NCT00455312|20968190|P1|Overall Study|Death|0
6070293|NCT00455195|20968216|P2|Double-blind Study AGLU02704|Unable to commit time to study|1
6070294|NCT00455195|20968217|P1|Double-blind Study AGLU02704|Unable to commit time to study|0
6070295|NCT00455195|20968216|P2|Double-blind Study AGLU02704|Withdrawal by Subject|2
6070296|NCT00455195|20968217|P1|Double-blind Study AGLU02704|Withdrawal by Subject|2
6070297|NCT00455195|20968216|P2|Double-blind Study AGLU02704|Death|0
6070298|NCT00455195|20968217|P1|Double-blind Study AGLU02704|Death|1
6070299|NCT00455195|20968216|P2|Double-blind Study AGLU02704|Adverse Event|1
6070300|NCT00455195|20968217|P1|Double-blind Study AGLU02704|Adverse Event|2
6070301|NCT00455143|20968231|P1|Overall Study|Surgical time, staff not available|1
6070302|NCT00455143|20968231|P1|Overall Study|No longer met Inclusion Criteria|1
6070303|NCT00455143|20968231|P1|Overall Study|Staff was not avail to follow patient|2
6070304|NCT00455143|20968231|P1|Overall Study|Withdrawal by Subject|1
6070305|NCT00455143|20968231|P1|Overall Study|Physician Decision|1
6070306|NCT00455013|20968255|P3|Long Term Extension (LTE)|non-specified|1
6070307|NCT00455013|20968256|P2|Long Term Extension (LTE)|non-specified|0
6070308|NCT00455013|20968257|P1|Long Term Extension (LTE)|non-specified|0
6070309|NCT00455013|20968255|P3|Long Term Extension (LTE)|Poor non-compliance|0
6070310|NCT00455013|20968256|P2|Long Term Extension (LTE)|Poor non-compliance|1
6070311|NCT00455013|20968257|P1|Long Term Extension (LTE)|Poor non-compliance|0
6070312|NCT00455013|20968255|P3|Long Term Extension (LTE)|Subject Request or refused|3
6070313|NCT00455013|20968256|P2|Long Term Extension (LTE)|Subject Request or refused|0
6070314|NCT00455013|20968257|P1|Long Term Extension (LTE)|Subject Request or refused|0
6070315|NCT00455013|20968255|P3|Long Term Extension (LTE)|No longer met criteria|1
6070316|NCT00455013|20968256|P2|Long Term Extension (LTE)|No longer met criteria|0
6070317|NCT00455013|20968257|P1|Long Term Extension (LTE)|No longer met criteria|0
6070318|NCT00455013|20968255|P3|Long Term Extension (LTE)|Death|0
6070319|NCT00455013|20968256|P2|Long Term Extension (LTE)|Death|1
6070320|NCT00455013|20968257|P1|Long Term Extension (LTE)|Death|1
6070321|NCT00455013|20968255|P3|Long Term Extension (LTE)|Withdrawal by Subject|1
6070322|NCT00455013|20968256|P2|Long Term Extension (LTE)|Withdrawal by Subject|0
6070323|NCT00455013|20968257|P1|Long Term Extension (LTE)|Withdrawal by Subject|1
6070324|NCT00455013|20968255|P3|Long Term Extension (LTE)|Adverse Event|1
6070325|NCT00455013|20968256|P2|Long Term Extension (LTE)|Adverse Event|1
6070326|NCT00455013|20968257|P1|Long Term Extension (LTE)|Adverse Event|0
6070327|NCT00455013|20968255|P3|Short Term Period|Other|1
6070328|NCT00455013|20968256|P2|Short Term Period|Other|0
6070329|NCT00455013|20968257|P1|Short Term Period|Other|0
6070330|NCT00455013|20968255|P3|Short Term Period|Lack of Efficacy|0
6070331|NCT00455013|20968256|P2|Short Term Period|Lack of Efficacy|0
6070332|NCT00455013|20968257|P1|Short Term Period|Lack of Efficacy|4
6070333|NCT00455013|20968255|P3|Short Term Period|Withdrawal by Subject|1
6070334|NCT00455013|20968256|P2|Short Term Period|Withdrawal by Subject|0
6070335|NCT00455013|20968257|P1|Short Term Period|Withdrawal by Subject|0
6070336|NCT00455013|20968255|P3|Short Term Period|Adverse Event|0
6070337|NCT00455013|20968256|P2|Short Term Period|Adverse Event|5
6070338|NCT00455013|20968257|P1|Short Term Period|Adverse Event|2
6070339|NCT00454987|20968325|P3|Booster Period (NCT00258700)|Lost to Follow-up|0
6070340|NCT00454987|20968326|P2|Booster Period (NCT00258700)|Lost to Follow-up|0
6070341|NCT00454987|20968327|P1|Booster Period (NCT00258700)|Lost to Follow-up|1
6070342|NCT00454987|20968325|P3|Booster Period (NCT00258700)|Withdrawal by Subject|0
6070343|NCT00454987|20968326|P2|Booster Period (NCT00258700)|Withdrawal by Subject|1
6070344|NCT00454987|20968327|P1|Booster Period (NCT00258700)|Withdrawal by Subject|0
6070345|NCT00454987|20968325|P3|Booster Period (NCT00258700)|Adverse Event|0
6070346|NCT00454987|20968326|P2|Booster Period (NCT00258700)|Adverse Event|0
6070347|NCT00454987|20968327|P1|Booster Period (NCT00258700)|Adverse Event|1
6070348|NCT00454909|20968401|P3|Overall Study|Others|0
6070349|NCT00454909|20968402|P2|Overall Study|Others|0
6070350|NCT00454909|20968403|P1|Overall Study|Others|1
6070351|NCT00454909|20968401|P3|Overall Study|Lost to follow-up (complete vaccination)|1
6070352|NCT00454909|20968402|P2|Overall Study|Lost to follow-up (complete vaccination)|3
6070353|NCT00454909|20968403|P1|Overall Study|Lost to follow-up (complete vaccination)|5
6070354|NCT00454909|20968401|P3|Overall Study|Migrated/moved from study area|1
6070355|NCT00454909|20968402|P2|Overall Study|Migrated/moved from study area|0
6070356|NCT00454909|20968403|P1|Overall Study|Migrated/moved from study area|0
6070357|NCT00454909|20968401|P3|Overall Study|Withdrawal by Subject|0
6070358|NCT00454909|20968402|P2|Overall Study|Withdrawal by Subject|0
6070359|NCT00454909|20968403|P1|Overall Study|Withdrawal by Subject|1
6070360|NCT00454857|20968441|P1|Overall Study|Reason unknown|1
6070361|NCT00454857|20968441|P1|Overall Study|Other|11
6070362|NCT00454857|20968441|P1|Overall Study|Death|5
6070363|NCT00454857|20968441|P1|Overall Study|Noncompliance|6
6070364|NCT00454857|20968441|P1|Overall Study|Lost to Follow-up|16
6070365|NCT00454857|20968441|P1|Overall Study|Withdrawal by Subject|15
6070366|NCT00454818|20968466|P5|Phase 2: Randomized Double-blind|Received left ventricular assist device|2
6070367|NCT00454818|20968467|P4|Phase 2: Randomized Double-blind|Received left ventricular assist device|0
6070368|NCT00454818|20968468|P3|Phase 2: Randomized Double-blind|Received left ventricular assist device|1
6070369|NCT00454818|20968469|P2|Phase 2: Randomized Double-blind|Received left ventricular assist device|0
6070370|NCT00454818|20968470|P1|Phase 2: Randomized Double-blind|Received left ventricular assist device|0
6070371|NCT00454818|20968466|P5|Phase 2: Randomized Double-blind|Received a heart transplant|1
6070372|NCT00454818|20968467|P4|Phase 2: Randomized Double-blind|Received a heart transplant|0
6070373|NCT00454818|20968468|P3|Phase 2: Randomized Double-blind|Received a heart transplant|2
6070374|NCT00454818|20968469|P2|Phase 2: Randomized Double-blind|Received a heart transplant|0
6070375|NCT00454818|20968470|P1|Phase 2: Randomized Double-blind|Received a heart transplant|0
6070376|NCT00454818|20968466|P5|Phase 2: Randomized Double-blind|Death|1
6070377|NCT00454818|20968467|P4|Phase 2: Randomized Double-blind|Death|0
6070378|NCT00454818|20968468|P3|Phase 2: Randomized Double-blind|Death|0
6070379|NCT00454818|20968469|P2|Phase 2: Randomized Double-blind|Death|1
6070380|NCT00454818|20968470|P1|Phase 2: Randomized Double-blind|Death|0
6070381|NCT00454818|20968466|P5|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0
6070382|NCT00454818|20968467|P4|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1
6070383|NCT00454818|20968468|P3|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0
6070384|NCT00454818|20968469|P2|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1
6070385|NCT00454818|20968470|P1|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0
6070386|NCT00454818|20968466|P5|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0
6070387|NCT00454818|20968467|P4|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1
6070388|NCT00454818|20968468|P3|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1
6070389|NCT00454818|20968469|P2|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0
6070390|NCT00454818|20968470|P1|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0
6070391|NCT00454818|20968466|P5|Phase I: Open-label Dose-escalation|Death|0
6070392|NCT00454818|20968467|P4|Phase I: Open-label Dose-escalation|Death|0
6070393|NCT00454818|20968468|P3|Phase I: Open-label Dose-escalation|Death|0
6070394|NCT00454818|20968469|P2|Phase I: Open-label Dose-escalation|Death|1
6070395|NCT00454818|20968470|P1|Phase I: Open-label Dose-escalation|Death|0
6070396|NCT00454818|20968466|P5|Phase I: Open-label Dose-escalation|Received heart transplant|0
6070397|NCT00454818|20968467|P4|Phase I: Open-label Dose-escalation|Received heart transplant|0
6070398|NCT00454818|20968468|P3|Phase I: Open-label Dose-escalation|Received heart transplant|0
6070399|NCT00454818|20968469|P2|Phase I: Open-label Dose-escalation|Received heart transplant|0
6070400|NCT00454818|20968470|P1|Phase I: Open-label Dose-escalation|Received heart transplant|1
6070401|NCT00454805|20968549|P2|Overall Study|In order to begin radiotherapy|0
6070402|NCT00454805|20968550|P1|Overall Study|In order to begin radiotherapy|1
6070403|NCT00454805|20968549|P2|Overall Study|Disease progression|19
6070404|NCT00454805|20968550|P1|Overall Study|Disease progression|16
6070405|NCT00454805|20968549|P2|Overall Study|Death|2
6070406|NCT00454805|20968550|P1|Overall Study|Death|0
6070407|NCT00454805|20968549|P2|Overall Study|Withdrawal by Subject|2
6070408|NCT00454805|20968550|P1|Overall Study|Withdrawal by Subject|9
6070409|NCT00454779|20968566|P2|Second-line Treatment Phase|Ongoing|1
6070410|NCT00454779|20968567|P1|Second-line Treatment Phase|Ongoing|0
6070411|NCT00454779|20968566|P2|Second-line Treatment Phase|Ended follow-up prior to analysis|1
6070412|NCT00454779|20968567|P1|Second-line Treatment Phase|Ended follow-up prior to analysis|0
6070413|NCT00454779|20968566|P2|Second-line Treatment Phase|Withdrawal by Subject|1
6070414|NCT00454779|20968567|P1|Second-line Treatment Phase|Withdrawal by Subject|0
6070415|NCT00454779|20968566|P2|First-line Treatment Phase|Ongoing|0
6070416|NCT00454779|20968567|P1|First-line Treatment Phase|Ongoing|1
6070417|NCT00454779|20968566|P2|First-line Treatment Phase|Ended follow-up prior to analysis|1
6070418|NCT00454779|20968567|P1|First-line Treatment Phase|Ended follow-up prior to analysis|1
6070419|NCT00454779|20968566|P2|First-line Treatment Phase|Protocol Violation|1
6070420|NCT00454779|20968567|P1|First-line Treatment Phase|Protocol Violation|0
6070421|NCT00454779|20968566|P2|First-line Treatment Phase|Lost to Follow-up|0
6070422|NCT00454779|20968567|P1|First-line Treatment Phase|Lost to Follow-up|1
6070423|NCT00454779|20968566|P2|First-line Treatment Phase|Withdrawal by Subject|4
6070424|NCT00454779|20968567|P1|First-line Treatment Phase|Withdrawal by Subject|2
6070425|NCT00454779|20968566|P2|First-line Treatment Phase|Lack of Efficacy|2
6070426|NCT00454779|20968567|P1|First-line Treatment Phase|Lack of Efficacy|0
6070427|NCT00454649|20968605|P10|Overall Study|Withdrawal by Subject|0
6070428|NCT00454649|20968606|P9|Overall Study|Withdrawal by Subject|1
6070429|NCT00454649|20968607|P8|Overall Study|Withdrawal by Subject|2
6070430|NCT00454649|20968608|P7|Overall Study|Withdrawal by Subject|0
6070431|NCT00454649|20968609|P6|Overall Study|Withdrawal by Subject|1
6070432|NCT00454649|20968610|P5|Overall Study|Withdrawal by Subject|0
6070433|NCT00454649|20968611|P4|Overall Study|Withdrawal by Subject|0
6070434|NCT00454649|20968612|P3|Overall Study|Withdrawal by Subject|0
6070435|NCT00454649|20968613|P2|Overall Study|Withdrawal by Subject|0
6070436|NCT00454649|20968614|P1|Overall Study|Withdrawal by Subject|0
6070437|NCT00454649|20968605|P10|Overall Study|Other|1
6070438|NCT00454649|20968606|P9|Overall Study|Other|3
6070439|NCT00454649|20968607|P8|Overall Study|Other|0
6070440|NCT00454649|20968608|P7|Overall Study|Other|0
6070441|NCT00454649|20968609|P6|Overall Study|Other|0
6070442|NCT00454649|20968610|P5|Overall Study|Other|0
6070443|NCT00454649|20968611|P4|Overall Study|Other|3
6070444|NCT00454649|20968612|P3|Overall Study|Other|5
6070445|NCT00454649|20968613|P2|Overall Study|Other|1
6070446|NCT00454649|20968614|P1|Overall Study|Other|1
6070447|NCT00454649|20968605|P10|Overall Study|Lost to Follow-up|0
6070448|NCT00454649|20968606|P9|Overall Study|Lost to Follow-up|0
6070449|NCT00454649|20968607|P8|Overall Study|Lost to Follow-up|0
6070450|NCT00454649|20968608|P7|Overall Study|Lost to Follow-up|1
6070451|NCT00454649|20968609|P6|Overall Study|Lost to Follow-up|0
6070452|NCT00454649|20968610|P5|Overall Study|Lost to Follow-up|0
6070453|NCT00454649|20968611|P4|Overall Study|Lost to Follow-up|0
6070454|NCT00454649|20968612|P3|Overall Study|Lost to Follow-up|1
6070455|NCT00454649|20968613|P2|Overall Study|Lost to Follow-up|0
6070456|NCT00454649|20968614|P1|Overall Study|Lost to Follow-up|0
6070457|NCT00454649|20968605|P10|Overall Study|Adverse Event|2
6070458|NCT00454649|20968606|P9|Overall Study|Adverse Event|6
6070459|NCT00454649|20968607|P8|Overall Study|Adverse Event|4
6070460|NCT00454649|20968608|P7|Overall Study|Adverse Event|3
6070461|NCT00454649|20968609|P6|Overall Study|Adverse Event|2
6070462|NCT00454649|20968610|P5|Overall Study|Adverse Event|1
6070463|NCT00454649|20968611|P4|Overall Study|Adverse Event|0
6070464|NCT00454649|20968612|P3|Overall Study|Adverse Event|3
6070465|NCT00454649|20968613|P2|Overall Study|Adverse Event|1
6070466|NCT00454649|20968614|P1|Overall Study|Adverse Event|0
6070467|NCT00454649|20968605|P10|Overall Study|Lack of Efficacy|2
6070468|NCT00454649|20968606|P9|Overall Study|Lack of Efficacy|10
6070469|NCT00454649|20968607|P8|Overall Study|Lack of Efficacy|13
6070470|NCT00454649|20968608|P7|Overall Study|Lack of Efficacy|5
6070471|NCT00454649|20968609|P6|Overall Study|Lack of Efficacy|4
6070472|NCT00454649|20968610|P5|Overall Study|Lack of Efficacy|0
6070473|NCT00454649|20968611|P4|Overall Study|Lack of Efficacy|3
6070474|NCT00454649|20968612|P3|Overall Study|Lack of Efficacy|10
6070475|NCT00454649|20968613|P2|Overall Study|Lack of Efficacy|2
6070476|NCT00454649|20968614|P1|Overall Study|Lack of Efficacy|2
6070477|NCT00454636|20968743|P4|Overall Study|Lost to Follow-up|0
6070478|NCT00454636|20968744|P3|Overall Study|Lost to Follow-up|0
6070479|NCT00454636|20968745|P2|Overall Study|Lost to Follow-up|1
6070480|NCT00454636|20968746|P1|Overall Study|Lost to Follow-up|0
6070481|NCT00454636|20968743|P4|Overall Study|Patient refusal|2
6070482|NCT00454636|20968744|P3|Overall Study|Patient refusal|3
6070483|NCT00454636|20968745|P2|Overall Study|Patient refusal|1
6070484|NCT00454636|20968746|P1|Overall Study|Patient refusal|1
6070485|NCT00454636|20968743|P4|Overall Study|Death|1
6070486|NCT00454636|20968744|P3|Overall Study|Death|1
6070487|NCT00454636|20968745|P2|Overall Study|Death|1
6070488|NCT00454636|20968746|P1|Overall Study|Death|6
6070489|NCT00454636|20968743|P4|Overall Study|Protocol Violation|3
6070490|NCT00454636|20968744|P3|Overall Study|Protocol Violation|3
6070491|NCT00454636|20968745|P2|Overall Study|Protocol Violation|2
6070492|NCT00454636|20968746|P1|Overall Study|Protocol Violation|3
6070493|NCT00454636|20968743|P4|Overall Study|Disease Progression|11
6070494|NCT00454636|20968744|P3|Overall Study|Disease Progression|4
6070495|NCT00454636|20968745|P2|Overall Study|Disease Progression|12
6070496|NCT00454636|20968746|P1|Overall Study|Disease Progression|11
6070497|NCT00454636|20968743|P4|Overall Study|Adverse Event|15
6070498|NCT00454636|20968744|P3|Overall Study|Adverse Event|9
6070499|NCT00454636|20968745|P2|Overall Study|Adverse Event|6
6070500|NCT00454636|20968746|P1|Overall Study|Adverse Event|10
6070501|NCT00454584|20968779|P6|After Controlled Period|Other|17
6070502|NCT00454584|20968780|P5|After Controlled Period|Other|5
6070503|NCT00454584|20968781|P4|After Controlled Period|Other|13
6070504|NCT00454584|20968782|P3|After Controlled Period|Other|0
6070505|NCT00454584|20968783|P2|After Controlled Period|Other|0
6070506|NCT00454584|20968784|P1|After Controlled Period|Other|0
6070507|NCT00454584|20968779|P6|After Controlled Period|Other|0
6070508|NCT00454584|20968780|P5|After Controlled Period|Other|0
6070509|NCT00454584|20968781|P4|After Controlled Period|Other|1
6070510|NCT00454584|20968782|P3|After Controlled Period|Other|0
6070511|NCT00454584|20968783|P2|After Controlled Period|Other|0
6070512|NCT00454584|20968784|P1|After Controlled Period|Other|0
6070513|NCT00454584|20968779|P6|After Controlled Period|Lost to Follow-up|6
6070514|NCT00454584|20968780|P5|After Controlled Period|Lost to Follow-up|4
6070515|NCT00454584|20968781|P4|After Controlled Period|Lost to Follow-up|2
6070516|NCT00454584|20968782|P3|After Controlled Period|Lost to Follow-up|0
6070517|NCT00454584|20968783|P2|After Controlled Period|Lost to Follow-up|0
6070518|NCT00454584|20968784|P1|After Controlled Period|Lost to Follow-up|0
6070519|NCT00454584|20968779|P6|After Controlled Period|Lack of Efficacy|0
6070520|NCT00454584|20968780|P5|After Controlled Period|Lack of Efficacy|0
6070521|NCT00454584|20968781|P4|After Controlled Period|Lack of Efficacy|1
6070522|NCT00454584|20968782|P3|After Controlled Period|Lack of Efficacy|0
6070523|NCT00454584|20968783|P2|After Controlled Period|Lack of Efficacy|0
6070524|NCT00454584|20968784|P1|After Controlled Period|Lack of Efficacy|0
6070525|NCT00454584|20968779|P6|After Controlled Period|Adverse Event|9
6070526|NCT00454584|20968780|P5|After Controlled Period|Adverse Event|3
6070527|NCT00454584|20968781|P4|After Controlled Period|Adverse Event|9
6070528|NCT00454584|20968782|P3|After Controlled Period|Adverse Event|0
6070529|NCT00454584|20968783|P2|After Controlled Period|Adverse Event|0
6070530|NCT00454584|20968784|P1|After Controlled Period|Adverse Event|0
6070531|NCT00454584|20968779|P6|Controlled Period|Other|0
6070532|NCT00454584|20968780|P5|Controlled Period|Other|0
6070533|NCT00454584|20968781|P4|Controlled Period|Other|0
6070534|NCT00454584|20968782|P3|Controlled Period|Other|2
6070535|NCT00454584|20968783|P2|Controlled Period|Other|4
6070536|NCT00454584|20968784|P1|Controlled Period|Other|5
6070537|NCT00454584|20968779|P6|Controlled Period|Lost to Follow-up|0
6070538|NCT00454584|20968780|P5|Controlled Period|Lost to Follow-up|0
6070539|NCT00454584|20968781|P4|Controlled Period|Lost to Follow-up|0
6070540|NCT00454584|20968782|P3|Controlled Period|Lost to Follow-up|2
6070541|NCT00454584|20968783|P2|Controlled Period|Lost to Follow-up|2
6070542|NCT00454584|20968784|P1|Controlled Period|Lost to Follow-up|1
6070543|NCT00454584|20968779|P6|Controlled Period|Adverse Event|0
6070544|NCT00454584|20968780|P5|Controlled Period|Adverse Event|0
6070545|NCT00454584|20968781|P4|Controlled Period|Adverse Event|0
6070546|NCT00454584|20968782|P3|Controlled Period|Adverse Event|1
6070547|NCT00454584|20968783|P2|Controlled Period|Adverse Event|2
6070548|NCT00454584|20968784|P1|Controlled Period|Adverse Event|5
6070549|NCT00454571|20968806|P2|Overall Study|Withdrawal by Subject|5
6070550|NCT00454571|20968807|P1|Overall Study|Withdrawal by Subject|10
6070551|NCT00454571|20968806|P2|Overall Study|Protocol Violation|0
6070552|NCT00454571|20968807|P1|Overall Study|Protocol Violation|1
6070553|NCT00454571|20968806|P2|Overall Study|Physician Decision|1
6070554|NCT00454571|20968807|P1|Overall Study|Physician Decision|0
6070555|NCT00454571|20968806|P2|Overall Study|Adverse Event|0
6070556|NCT00454571|20968807|P1|Overall Study|Adverse Event|2
6070557|NCT00454363|20968842|P2|Overall Study|Withdrawal prior to 12 weeks treatment|0
6070558|NCT00454363|20968843|P1|Overall Study|Withdrawal prior to 12 weeks treatment|4
6070559|NCT00454363|20968842|P2|Overall Study|Adverse Event|2
6070560|NCT00454363|20968843|P1|Overall Study|Adverse Event|1
6070561|NCT00454246|20968872|P3|Overall Study|Early termination of study|9
6070562|NCT00454246|20968873|P2|Overall Study|Early termination of study|26
6070563|NCT00454246|20968874|P1|Overall Study|Early termination of study|62
6070564|NCT00454246|20968872|P3|Overall Study|Failure to return|0
6070565|NCT00454246|20968873|P2|Overall Study|Failure to return|0
6070566|NCT00454246|20968874|P1|Overall Study|Failure to return|1
6070567|NCT00454246|20968872|P3|Overall Study|Refused Treatment|0
6070568|NCT00454246|20968873|P2|Overall Study|Refused Treatment|1
6070569|NCT00454246|20968874|P1|Overall Study|Refused Treatment|1
6070570|NCT00454246|20968872|P3|Overall Study|Protocol Violation|0
6070571|NCT00454246|20968873|P2|Overall Study|Protocol Violation|0
6070572|NCT00454246|20968874|P1|Overall Study|Protocol Violation|1
6070573|NCT00454246|20968872|P3|Overall Study|Violation of selection criteria at entry|0
6070574|NCT00454246|20968873|P2|Overall Study|Violation of selection criteria at entry|0
6070575|NCT00454246|20968874|P1|Overall Study|Violation of selection criteria at entry|6
6070576|NCT00454246|20968872|P3|Overall Study|Adverse Event|0
6070577|NCT00454246|20968873|P2|Overall Study|Adverse Event|2
6070578|NCT00454246|20968874|P1|Overall Study|Adverse Event|2
6070585|NCT00454194|20968936|P2|Overall Study|Other Unspecified Reason|2
6070586|NCT00454194|20968937|P1|Overall Study|Other Unspecified Reason|2
6070587|NCT00454194|20968936|P2|Overall Study|Other Medical Problems|2
6070588|NCT00454194|20968937|P1|Overall Study|Other Medical Problems|1
6070589|NCT00454194|20968936|P2|Overall Study|Withdrawal by Subject|8
6070590|NCT00454194|20968937|P1|Overall Study|Withdrawal by Subject|12
6070591|NCT00454194|20968936|P2|Overall Study|Adverse Event|2
6070592|NCT00454194|20968937|P1|Overall Study|Adverse Event|7
6070593|NCT00454181|20968955|P2|Overall Study|Withdrawal by Subject|0
6070594|NCT00454181|20968956|P1|Overall Study|Withdrawal by Subject|2
6070595|NCT00454181|20968955|P2|Overall Study|Protocol Violation|1
6070596|NCT00454181|20968956|P1|Overall Study|Protocol Violation|1
6070597|NCT00454181|20968955|P2|Overall Study|Lost to Follow-up|1
6070598|NCT00454181|20968956|P1|Overall Study|Lost to Follow-up|11
6070599|NCT00454181|20968955|P2|Overall Study|Adverse Event|1
6070600|NCT00454181|20968956|P1|Overall Study|Adverse Event|1
6070601|NCT00454142|20968972|P1|Overall Study|Withdrawal by Subject|1
6070602|NCT00454116|20968990|P3|Overall Study|Other|0
6070603|NCT00454116|20968991|P2|Overall Study|Other|2
6070604|NCT00454116|20968992|P1|Overall Study|Other|2
6070605|NCT00454116|20968990|P3|Overall Study|Withdrawal by Subject|1
6070606|NCT00454116|20968991|P2|Overall Study|Withdrawal by Subject|3
6070607|NCT00454116|20968992|P1|Overall Study|Withdrawal by Subject|3
6070608|NCT00454116|20968990|P3|Overall Study|Condition under investigation worsened|18
6070609|NCT00454116|20968991|P2|Overall Study|Condition under investigation worsened|13
6070610|NCT00454116|20968992|P1|Overall Study|Condition under investigation worsened|17
6070611|NCT00454116|20968990|P3|Overall Study|Adverse Event|9
6070612|NCT00454116|20968991|P2|Overall Study|Adverse Event|11
6070613|NCT00454116|20968992|P1|Overall Study|Adverse Event|5
6070614|NCT00454051|20969002|P2|Overall Study|Protocol Violation|1
6070615|NCT00454051|20969003|P1|Overall Study|Protocol Violation|1
6070616|NCT00454051|20969002|P2|Overall Study|Withdrawal by Subject|0
6070617|NCT00454051|20969003|P1|Overall Study|Withdrawal by Subject|1
6070618|NCT00454051|20969002|P2|Overall Study|Adverse Event|2
6070619|NCT00454051|20969003|P1|Overall Study|Adverse Event|1
6070620|NCT00453999|20969036|P3|Overall Study|Subject Request|0
6070621|NCT00453999|20969037|P2|Overall Study|Subject Request|1
6070622|NCT00453999|20969038|P1|Overall Study|Subject Request|2
6070623|NCT00453999|20969036|P3|Overall Study|Withdrawal by Subject|1
6070624|NCT00453999|20969037|P2|Overall Study|Withdrawal by Subject|1
6070625|NCT00453999|20969038|P1|Overall Study|Withdrawal by Subject|2
6070626|NCT00453999|20969036|P3|Overall Study|Lost to Follow-up|1
6070627|NCT00453999|20969037|P2|Overall Study|Lost to Follow-up|1
6070628|NCT00453999|20969038|P1|Overall Study|Lost to Follow-up|0
6070629|NCT00453999|20969036|P3|Overall Study|Adverse Event|1
6070630|NCT00453999|20969037|P2|Overall Study|Adverse Event|2
6070631|NCT00453999|20969038|P1|Overall Study|Adverse Event|1
6070632|NCT00453986|20969066|P5|Overall Study|Lost to Follow-up|0
6070633|NCT00453986|20969067|P4|Overall Study|Lost to Follow-up|2
6070634|NCT00453986|20969068|P3|Overall Study|Lost to Follow-up|6
6070635|NCT00453986|20969069|P2|Overall Study|Lost to Follow-up|5
6070636|NCT00453986|20969070|P1|Overall Study|Lost to Follow-up|6
6070637|NCT00453973|20969163|P2|Overall Study|Sponsor Decision to Terminate Study|30
6070638|NCT00453973|20969164|P1|Overall Study|Sponsor Decision to Terminate Study|35
6070639|NCT00453973|20969163|P2|Overall Study|Site closed by sponsor|0
6070640|NCT00453973|20969164|P1|Overall Study|Site closed by sponsor|3
6070641|NCT00453973|20969163|P2|Overall Study|Renal transplant|1
6070642|NCT00453973|20969164|P1|Overall Study|Renal transplant|1
6070643|NCT00453973|20969163|P2|Overall Study|Relocation|0
6070644|NCT00453973|20969164|P1|Overall Study|Relocation|1
6070645|NCT00453973|20969163|P2|Overall Study|PI Decision|2
6070646|NCT00453973|20969164|P1|Overall Study|PI Decision|0
6070647|NCT00453973|20969163|P2|Overall Study|Withdrawal by Subject|6
6070648|NCT00453973|20969164|P1|Overall Study|Withdrawal by Subject|7
6070649|NCT00453973|20969163|P2|Overall Study|Adverse Event|9
6070650|NCT00453973|20969164|P1|Overall Study|Adverse Event|4
6070651|NCT00453921|20969174|P4|Overall Study|Lost to Follow-up|0
6070652|NCT00453921|20969175|P3|Overall Study|Lost to Follow-up|1
6070653|NCT00453921|20969176|P2|Overall Study|Lost to Follow-up|0
6070654|NCT00453921|20969177|P1|Overall Study|Lost to Follow-up|0
6070655|NCT00453921|20969174|P4|Overall Study|Withdrawal by Subject|1
6070656|NCT00453921|20969175|P3|Overall Study|Withdrawal by Subject|1
6070657|NCT00453921|20969176|P2|Overall Study|Withdrawal by Subject|1
6070658|NCT00453921|20969177|P1|Overall Study|Withdrawal by Subject|1
6070659|NCT00453362|20969324|P1|Overall Study|Screening Failure|14
6070660|NCT00453362|20969324|P1|Overall Study|Progression of disease|56
6070661|NCT00453362|20969324|P1|Overall Study|Withdrawal by Subject|3
6070662|NCT00453362|20969324|P1|Overall Study|Physician Decision|2
6070663|NCT00453362|20969324|P1|Overall Study|Death|7
6070664|NCT00453362|20969324|P1|Overall Study|Adverse Event|5
6070665|NCT00453349|20969350|P2|Completed Study|Lost to follow up after study treatment|11
6070666|NCT00453349|20969351|P1|Completed Study|Lost to follow up after study treatment|2
6070667|NCT00453349|20969350|P2|Completed Study|Withdrawal by Subject|5
6070668|NCT00453349|20969351|P1|Completed Study|Withdrawal by Subject|3
6070669|NCT00453349|20969350|P2|Completed Study|Protocol Violation|1
6070670|NCT00453349|20969351|P1|Completed Study|Protocol Violation|1
6070671|NCT00453349|20969350|P2|Completed Study|Lost to Follow-up|5
6070672|NCT00453349|20969351|P1|Completed Study|Lost to Follow-up|7
6070673|NCT00453349|20969350|P2|Completed Study|Lack of Efficacy|1
6070674|NCT00453349|20969351|P1|Completed Study|Lack of Efficacy|2
6070675|NCT00453349|20969350|P2|Completed Study|Adverse Event|11
6070676|NCT00453349|20969351|P1|Completed Study|Adverse Event|12
6070677|NCT00453349|20969350|P2|Reaching of Primary Endpoint (TOC)|Missing information|11
6070678|NCT00453349|20969351|P1|Reaching of Primary Endpoint (TOC)|Missing information|10
6070679|NCT00453349|20969350|P2|Randomized|Withdrawal by Subject|5
6070680|NCT00453349|20969351|P1|Randomized|Withdrawal by Subject|3
6070681|NCT00453349|20969350|P2|Randomized|Protocol Violation|1
6070682|NCT00453349|20969351|P1|Randomized|Protocol Violation|1
6070683|NCT00453349|20969350|P2|Randomized|Lost to Follow-up|5
6070684|NCT00453349|20969351|P1|Randomized|Lost to Follow-up|7
6070685|NCT00453349|20969350|P2|Randomized|Lack of Efficacy|1
6070686|NCT00453349|20969351|P1|Randomized|Lack of Efficacy|2
6070687|NCT00453349|20969350|P2|Randomized|Adverse Event|11
6070688|NCT00453349|20969351|P1|Randomized|Adverse Event|12
6070689|NCT00453310|20969382|P1|Overall Study|Progression of Disease|10
6070690|NCT00453206|20969386|P1|Overall Study|Death|1
6070691|NCT00453180|20969396|P2|Overall Study|Adverse Event|2
6070692|NCT00453180|20969397|P1|Overall Study|Adverse Event|1
6070693|NCT00453180|20969396|P2|Overall Study|Lost to Follow-up|1
6070694|NCT00453180|20969397|P1|Overall Study|Lost to Follow-up|2
6070695|NCT00453154|20969416|P4|Double BIind Maintenance|Randomized, did not receive therapy|5
6070696|NCT00453154|20969417|P3|Double BIind Maintenance|Randomized, did not receive therapy|5
6070697|NCT00453154|20969418|P2|Double BIind Maintenance|Randomized, did not receive therapy|0
6070698|NCT00453154|20969419|P1|Double BIind Maintenance|Randomized, did not receive therapy|0
6070699|NCT00453154|20969416|P4|Double BIind Maintenance|Medical Issues|1
6070700|NCT00453154|20969417|P3|Double BIind Maintenance|Medical Issues|3
6070701|NCT00453154|20969418|P2|Double BIind Maintenance|Medical Issues|0
6070702|NCT00453154|20969419|P1|Double BIind Maintenance|Medical Issues|0
6070703|NCT00453154|20969416|P4|Double BIind Maintenance|Progression|26
6070704|NCT00453154|20969417|P3|Double BIind Maintenance|Progression|29
6070705|NCT00453154|20969418|P2|Double BIind Maintenance|Progression|0
6070706|NCT00453154|20969419|P1|Double BIind Maintenance|Progression|0
6070707|NCT00453154|20969416|P4|Double BIind Maintenance|Withdrawal by Subject|4
6070708|NCT00453154|20969417|P3|Double BIind Maintenance|Withdrawal by Subject|4
6070709|NCT00453154|20969418|P2|Double BIind Maintenance|Withdrawal by Subject|0
6070710|NCT00453154|20969419|P1|Double BIind Maintenance|Withdrawal by Subject|0
6070711|NCT00453154|20969416|P4|Double BIind Maintenance|Death|1
6070712|NCT00453154|20969417|P3|Double BIind Maintenance|Death|2
6070713|NCT00453154|20969418|P2|Double BIind Maintenance|Death|0
6070714|NCT00453154|20969419|P1|Double BIind Maintenance|Death|0
6070715|NCT00453154|20969416|P4|Double BIind Maintenance|Adverse Event|12
6070716|NCT00453154|20969417|P3|Double BIind Maintenance|Adverse Event|3
6070717|NCT00453154|20969418|P2|Double BIind Maintenance|Adverse Event|0
6070718|NCT00453154|20969419|P1|Double BIind Maintenance|Adverse Event|0
6070719|NCT00453102|20969432|P1|Overall Study|Withdrawal by Subject|2
6070720|NCT00453063|20969443|P2|Overall Study|Protocol Violation|0
6070721|NCT00453063|20969444|P1|Overall Study|Protocol Violation|1
6070722|NCT00453063|20969443|P2|Overall Study|Withdrawal by Subject|1
6070723|NCT00453063|20969444|P1|Overall Study|Withdrawal by Subject|1
6070724|NCT00453063|20969443|P2|Overall Study|Adverse Event|2
6070725|NCT00453063|20969444|P1|Overall Study|Adverse Event|1
6070726|NCT00452790|20969464|P2|Toddler Dose|Parent/legal guardian request|1
6070727|NCT00452790|20969465|P1|Toddler Dose|Parent/legal guardian request|0
6070728|NCT00452790|20969464|P2|Toddler Dose|Failed to return|1
6070729|NCT00452790|20969465|P1|Toddler Dose|Failed to return|0
6070730|NCT00452790|20969464|P2|After Infant Series|Other reasons|0
6070731|NCT00452790|20969465|P1|After Infant Series|Other reasons|1
6070732|NCT00452790|20969464|P2|After Infant Series|Failed to return|0
6070733|NCT00452790|20969465|P1|After Infant Series|Failed to return|1
6070734|NCT00452790|20969464|P2|After Infant Series|Lost to Follow-up|0
6070735|NCT00452790|20969465|P1|After Infant Series|Lost to Follow-up|4
6070736|NCT00452790|20969464|P2|After Infant Series|Parent/legal guardian request|3
6070737|NCT00452790|20969465|P1|After Infant Series|Parent/legal guardian request|1
6070738|NCT00452790|20969464|P2|After Infant Series|Adverse Event|1
6070739|NCT00452790|20969465|P1|After Infant Series|Adverse Event|4
6070740|NCT00452790|20969464|P2|After Infant Series|Investigator request|10
6070741|NCT00452790|20969465|P1|After Infant Series|Investigator request|10
6070742|NCT00452790|20969464|P2|Infant Series|Death|1
6070743|NCT00452790|20969465|P1|Infant Series|Death|0
6070744|NCT00452790|20969464|P2|Infant Series|Investigator request|1
6070745|NCT00452790|20969465|P1|Infant Series|Investigator request|0
6070746|NCT00452790|20969464|P2|Infant Series|Other reasons|2
6070747|NCT00452790|20969465|P1|Infant Series|Other reasons|1
6070748|NCT00452790|20969464|P2|Infant Series|Adverse Event|2
6070749|NCT00452790|20969465|P1|Infant Series|Adverse Event|1
6070750|NCT00452790|20969464|P2|Infant Series|Lost to Follow-up|2
6070751|NCT00452790|20969465|P1|Infant Series|Lost to Follow-up|2
6070752|NCT00452790|20969464|P2|Infant Series|Protocol Violation|3
6070753|NCT00452790|20969465|P1|Infant Series|Protocol Violation|1
6070754|NCT00452790|20969464|P2|Infant Series|Failed to return|1
6070755|NCT00452790|20969465|P1|Infant Series|Failed to return|4
6070756|NCT00452790|20969464|P2|Infant Series|Parent/legal guardian request|6
6070757|NCT00452790|20969465|P1|Infant Series|Parent/legal guardian request|8
6070758|NCT00452790|20969464|P2|Infant Series|Clinical hold - consent withdrawn|123
6070759|NCT00452790|20969465|P1|Infant Series|Clinical hold - consent withdrawn|118
6070760|NCT00452699|20969501|P2|Overall Study|Other|7
6070761|NCT00452699|20969502|P1|Overall Study|Other|12
6070762|NCT00452699|20969501|P2|Overall Study|Withdrawal by Subject|25
6070763|NCT00452699|20969502|P1|Overall Study|Withdrawal by Subject|26
6070764|NCT00452699|20969501|P2|Overall Study|Protocol Violation|25
6070765|NCT00452699|20969502|P1|Overall Study|Protocol Violation|21
6070766|NCT00452699|20969501|P2|Overall Study|Lost to Follow-up|9
6070767|NCT00452699|20969502|P1|Overall Study|Lost to Follow-up|6
6070768|NCT00452699|20969501|P2|Overall Study|Lack of Efficacy|4
6070769|NCT00452699|20969502|P1|Overall Study|Lack of Efficacy|6
6070770|NCT00452699|20969501|P2|Overall Study|Adverse Event|3
6070771|NCT00452699|20969502|P1|Overall Study|Adverse Event|10
6070772|NCT00452673|20969518|P5|Dose Expansion Period|Other|2
6070773|NCT00452673|20969519|P4|Dose Expansion Period|Other|0
6070774|NCT00452673|20969520|P3|Dose Expansion Period|Other|0
6070775|NCT00452673|20969521|P2|Dose Expansion Period|Other|0
6070776|NCT00452673|20969522|P1|Dose Expansion Period|Other|0
6070777|NCT00452673|20969518|P5|Dose Expansion Period|Disease Progression|19
6070778|NCT00452673|20969519|P4|Dose Expansion Period|Disease Progression|0
6070779|NCT00452673|20969520|P3|Dose Expansion Period|Disease Progression|0
6070780|NCT00452673|20969521|P2|Dose Expansion Period|Disease Progression|0
6070781|NCT00452673|20969522|P1|Dose Expansion Period|Disease Progression|0
6070782|NCT00452673|20969518|P5|Dose Escalation Period|Withdrawal by Subject|0
6070783|NCT00452673|20969519|P4|Dose Escalation Period|Withdrawal by Subject|1
6070784|NCT00452673|20969520|P3|Dose Escalation Period|Withdrawal by Subject|0
6070785|NCT00452673|20969521|P2|Dose Escalation Period|Withdrawal by Subject|0
6070786|NCT00452673|20969522|P1|Dose Escalation Period|Withdrawal by Subject|0
6070787|NCT00452673|20969518|P5|Dose Escalation Period|Adverse Event|0
6070788|NCT00452673|20969519|P4|Dose Escalation Period|Adverse Event|1
6070789|NCT00452673|20969520|P3|Dose Escalation Period|Adverse Event|0
6070790|NCT00452673|20969521|P2|Dose Escalation Period|Adverse Event|0
6070791|NCT00452673|20969522|P1|Dose Escalation Period|Adverse Event|0
6070792|NCT00452673|20969518|P5|Dose Escalation Period|Other|0
6070793|NCT00452673|20969519|P4|Dose Escalation Period|Other|0
6070794|NCT00452673|20969520|P3|Dose Escalation Period|Other|1
6070795|NCT00452673|20969521|P2|Dose Escalation Period|Other|0
6070796|NCT00452673|20969522|P1|Dose Escalation Period|Other|0
6070797|NCT00452673|20969518|P5|Dose Escalation Period|study drug toxicity|0
6070798|NCT00452673|20969519|P4|Dose Escalation Period|study drug toxicity|1
6070799|NCT00452673|20969520|P3|Dose Escalation Period|study drug toxicity|3
6070800|NCT00452673|20969521|P2|Dose Escalation Period|study drug toxicity|3
6070801|NCT00452673|20969522|P1|Dose Escalation Period|study drug toxicity|1
6070802|NCT00452673|20969518|P5|Dose Escalation Period|Disease Progression|0
6070803|NCT00452673|20969519|P4|Dose Escalation Period|Disease Progression|6
6070804|NCT00452673|20969520|P3|Dose Escalation Period|Disease Progression|2
6070805|NCT00452673|20969521|P2|Dose Escalation Period|Disease Progression|6
6070806|NCT00452673|20969522|P1|Dose Escalation Period|Disease Progression|6
6070807|NCT00452530|20969569|P2|Overall Study|Other|11
6070808|NCT00452530|20969570|P1|Overall Study|Other|7
6070809|NCT00452530|20969569|P2|Overall Study|No longer met study criteria|22
6070810|NCT00452530|20969570|P1|Overall Study|No longer met study criteria|18
6070811|NCT00452530|20969569|P2|Overall Study|Poor compliance/noncompliance|2
6070812|NCT00452530|20969570|P1|Overall Study|Poor compliance/noncompliance|1
6070813|NCT00452530|20969569|P2|Overall Study|Lost to Follow-up|0
6070814|NCT00452530|20969570|P1|Overall Study|Lost to Follow-up|1
6070815|NCT00452530|20969569|P2|Overall Study|Withdrawal by Subject|57
6070816|NCT00452530|20969570|P1|Overall Study|Withdrawal by Subject|68
6070817|NCT00452530|20969569|P2|Overall Study|Adverse Event|44
6070818|NCT00452530|20969570|P1|Overall Study|Adverse Event|40
6070819|NCT00452530|20969569|P2|Overall Study|Death|0
6070820|NCT00452530|20969570|P1|Overall Study|Death|1
6070821|NCT00452452|20969591|P3|Overall Study|Lost to Follow-up|0
6070822|NCT00452452|20969592|P2|Overall Study|Lost to Follow-up|0
6070823|NCT00452452|20969593|P1|Overall Study|Lost to Follow-up|1
6070824|NCT00452452|20969591|P3|Overall Study|Withdrawal by Subject|0
6070825|NCT00452452|20969592|P2|Overall Study|Withdrawal by Subject|0
6070826|NCT00452452|20969593|P1|Overall Study|Withdrawal by Subject|1
6070827|NCT00452452|20969591|P3|Overall Study|Protocol Violation|1
6070828|NCT00452452|20969592|P2|Overall Study|Protocol Violation|0
6070829|NCT00452452|20969593|P1|Overall Study|Protocol Violation|0
6070830|NCT00452439|20969618|P2|Overall Study|Fracture|0
6070831|NCT00452439|20969619|P1|Overall Study|Fracture|1
6070832|NCT00452439|20969618|P2|Overall Study|Relapse|0
6070833|NCT00452439|20969619|P1|Overall Study|Relapse|3
6070834|NCT00452439|20969618|P2|Overall Study|Failed to achieve complete response|0
6070835|NCT00452439|20969619|P1|Overall Study|Failed to achieve complete response|2
6070836|NCT00452439|20969618|P2|Overall Study|Too Ill to Continue|1
6070837|NCT00452439|20969619|P1|Overall Study|Too Ill to Continue|0
6070838|NCT00452439|20969618|P2|Overall Study|Bone Marrow Transplant|1
6070839|NCT00452439|20969619|P1|Overall Study|Bone Marrow Transplant|0
6070840|NCT00452439|20969618|P2|Overall Study|Death|1
6070841|NCT00452439|20969619|P1|Overall Study|Death|3
6070842|NCT00452439|20969618|P2|Overall Study|Refused Treatment|3
6070843|NCT00452439|20969619|P1|Overall Study|Refused Treatment|4
6070844|NCT00452439|20969618|P2|Overall Study|Lost to Follow-up|1
6070845|NCT00452439|20969619|P1|Overall Study|Lost to Follow-up|1
6070846|NCT00452400|20969649|P5|Overall Study|Other reasons not listed above|1
6070847|NCT00452400|20969650|P4|Overall Study|Other reasons not listed above|1
6070848|NCT00452400|20969651|P3|Overall Study|Other reasons not listed above|0
6070849|NCT00452400|20969652|P2|Overall Study|Other reasons not listed above|0
6070850|NCT00452400|20969653|P1|Overall Study|Other reasons not listed above|0
6070851|NCT00452400|20969649|P5|Overall Study|Lack of Efficacy|0
6070852|NCT00452400|20969650|P4|Overall Study|Lack of Efficacy|0
6070853|NCT00452400|20969651|P3|Overall Study|Lack of Efficacy|0
6070854|NCT00452400|20969652|P2|Overall Study|Lack of Efficacy|0
6070855|NCT00452400|20969653|P1|Overall Study|Lack of Efficacy|2
6070856|NCT00452400|20969649|P5|Overall Study|Withdrawal by Subject|0
6070857|NCT00452400|20969650|P4|Overall Study|Withdrawal by Subject|0
6070858|NCT00452400|20969651|P3|Overall Study|Withdrawal by Subject|1
6070859|NCT00452400|20969652|P2|Overall Study|Withdrawal by Subject|0
6070860|NCT00452400|20969653|P1|Overall Study|Withdrawal by Subject|1
6070861|NCT00452400|20969649|P5|Overall Study|Lost to Follow-up|0
6070862|NCT00452400|20969650|P4|Overall Study|Lost to Follow-up|0
6070863|NCT00452400|20969651|P3|Overall Study|Lost to Follow-up|0
6070864|NCT00452400|20969652|P2|Overall Study|Lost to Follow-up|0
6070865|NCT00452400|20969653|P1|Overall Study|Lost to Follow-up|1
6070866|NCT00452400|20969649|P5|Overall Study|Protocol Violation|0
6070867|NCT00452400|20969650|P4|Overall Study|Protocol Violation|0
6070868|NCT00452400|20969651|P3|Overall Study|Protocol Violation|1
6070869|NCT00452400|20969652|P2|Overall Study|Protocol Violation|0
6070870|NCT00452400|20969653|P1|Overall Study|Protocol Violation|0
6070871|NCT00452400|20969649|P5|Overall Study|Adverse Event|2
6070872|NCT00452400|20969650|P4|Overall Study|Adverse Event|0
6070873|NCT00452400|20969651|P3|Overall Study|Adverse Event|5
6070874|NCT00452400|20969652|P2|Overall Study|Adverse Event|1
6070875|NCT00452400|20969653|P1|Overall Study|Adverse Event|1
6070876|NCT00452361|20969840|P2|Overall Study|Premature termination|9
6070877|NCT00452361|20969841|P1|Overall Study|Premature termination|13
6070878|NCT00452361|20969840|P2|Overall Study|Withdrawal by Subject|1
6070879|NCT00452361|20969841|P1|Overall Study|Withdrawal by Subject|0
6070880|NCT00452361|20969840|P2|Overall Study|Adverse Event|0
6070881|NCT00452361|20969841|P1|Overall Study|Adverse Event|8
6070882|NCT00452348|20969885|P2|Overall Study|Other|9
6070883|NCT00452348|20969886|P1|Overall Study|Other|9
6070884|NCT00452348|20969885|P2|Overall Study|Withdrawal by Subject|21
6070885|NCT00452348|20969886|P1|Overall Study|Withdrawal by Subject|18
6070886|NCT00452348|20969885|P2|Overall Study|Protocol Violation|28
6070887|NCT00452348|20969886|P1|Overall Study|Protocol Violation|22
6070888|NCT00452348|20969885|P2|Overall Study|Lost to Follow-up|8
6070889|NCT00452348|20969886|P1|Overall Study|Lost to Follow-up|14
6070890|NCT00452348|20969885|P2|Overall Study|Lack of Efficacy|9
6070891|NCT00452348|20969886|P1|Overall Study|Lack of Efficacy|10
6070892|NCT00452348|20969885|P2|Overall Study|Adverse Event|9
6070893|NCT00452348|20969886|P1|Overall Study|Adverse Event|6
6070894|NCT00452114|20969940|P2|Overall Study|Physician Decision|3
6070895|NCT00452114|20969941|P1|Overall Study|Physician Decision|3
6070896|NCT00451958|20969957|P5|CS21A (NCT00451958)|Miscellaneous reasons|0
6070897|NCT00451958|20969958|P4|CS21A (NCT00451958)|Miscellaneous reasons|14
6070898|NCT00451958|20969959|P3|CS21A (NCT00451958)|Miscellaneous reasons|17
6070899|NCT00451958|20969960|P2|CS21A (NCT00451958)|Miscellaneous reasons|27
6070900|NCT00451958|20969961|P1|CS21A (NCT00451958)|Miscellaneous reasons|28
6070901|NCT00451958|20969957|P5|CS21A (NCT00451958)|Withdrawal by Subject|0
6070902|NCT00451958|20969958|P4|CS21A (NCT00451958)|Withdrawal by Subject|3
6070903|NCT00451958|20969959|P3|CS21A (NCT00451958)|Withdrawal by Subject|4
6070904|NCT00451958|20969960|P2|CS21A (NCT00451958)|Withdrawal by Subject|4
6070905|NCT00451958|20969961|P1|CS21A (NCT00451958)|Withdrawal by Subject|7
6070906|NCT00451958|20969957|P5|CS21A (NCT00451958)|Physician Decision|0
6070907|NCT00451958|20969958|P4|CS21A (NCT00451958)|Physician Decision|4
6070908|NCT00451958|20969959|P3|CS21A (NCT00451958)|Physician Decision|4
6070909|NCT00451958|20969960|P2|CS21A (NCT00451958)|Physician Decision|4
6070910|NCT00451958|20969961|P1|CS21A (NCT00451958)|Physician Decision|2
6070911|NCT00451958|20969957|P5|CS21A (NCT00451958)|Protocol Violation|0
6070912|NCT00451958|20969958|P4|CS21A (NCT00451958)|Protocol Violation|0
6070913|NCT00451958|20969959|P3|CS21A (NCT00451958)|Protocol Violation|2
6070914|NCT00451958|20969960|P2|CS21A (NCT00451958)|Protocol Violation|3
6070915|NCT00451958|20969961|P1|CS21A (NCT00451958)|Protocol Violation|1
6070916|NCT00451958|20969957|P5|CS21A (NCT00451958)|Lost to Follow-up|0
6070917|NCT00451958|20969958|P4|CS21A (NCT00451958)|Lost to Follow-up|1
6070918|NCT00451958|20969959|P3|CS21A (NCT00451958)|Lost to Follow-up|1
6070919|NCT00451958|20969960|P2|CS21A (NCT00451958)|Lost to Follow-up|5
6070920|NCT00451958|20969961|P1|CS21A (NCT00451958)|Lost to Follow-up|6
6070921|NCT00451958|20969957|P5|CS21A (NCT00451958)|Adverse Event|0
6070922|NCT00451958|20969958|P4|CS21A (NCT00451958)|Adverse Event|17
6070923|NCT00451958|20969959|P3|CS21A (NCT00451958)|Adverse Event|14
6070924|NCT00451958|20969960|P2|CS21A (NCT00451958)|Adverse Event|34
6070925|NCT00451958|20969961|P1|CS21A (NCT00451958)|Adverse Event|21
6070926|NCT00451906|20969991|P1|Overall Study|Did not complete final visit|4
6070927|NCT00451906|20969991|P1|Overall Study|Other Reasons|121
6070928|NCT00451906|20969991|P1|Overall Study|Termination of the study|108
6070929|NCT00451906|20969991|P1|Overall Study|Progressive disease|1328
6070930|NCT00451906|20969991|P1|Overall Study|Protocol Violation|21
6070931|NCT00451906|20969991|P1|Overall Study|Withdrawal by Subject|111
6070932|NCT00451906|20969991|P1|Overall Study|Lost to Follow-up|31
6070933|NCT00451906|20969991|P1|Overall Study|Adverse Event|515
6070934|NCT00451555|20970019|P2|Overall Study|Physician Decision|1
6070935|NCT00451555|20970020|P1|Overall Study|Physician Decision|2
6070936|NCT00451555|20970019|P2|Overall Study|Withdrawal by Subject|0
6070937|NCT00451555|20970020|P1|Overall Study|Withdrawal by Subject|6
6070938|NCT00451555|20970019|P2|Overall Study|Adverse Event|1
6070939|NCT00451555|20970020|P1|Overall Study|Adverse Event|3
6070940|NCT00451555|20970019|P2|Overall Study|Protocol Violation|2
6070941|NCT00451555|20970020|P1|Overall Study|Protocol Violation|2
6070942|NCT00451451|20970054|P4|Overall Study|Other Reasons for Not Completing Study|14
6070943|NCT00451451|20970055|P3|Overall Study|Other Reasons for Not Completing Study|17
6070944|NCT00451451|20970056|P2|Overall Study|Other Reasons for Not Completing Study|30
6070945|NCT00451451|20970057|P1|Overall Study|Other Reasons for Not Completing Study|34
6070946|NCT00451451|20970054|P4|Overall Study|Death|1
6070947|NCT00451451|20970055|P3|Overall Study|Death|0
6070948|NCT00451451|20970056|P2|Overall Study|Death|0
6070949|NCT00451451|20970057|P1|Overall Study|Death|1
6070950|NCT00451451|20970054|P4|Overall Study|Subject Non-Compliance|3
6070951|NCT00451451|20970055|P3|Overall Study|Subject Non-Compliance|3
6070952|NCT00451451|20970056|P2|Overall Study|Subject Non-Compliance|4
6070953|NCT00451451|20970057|P1|Overall Study|Subject Non-Compliance|8
6070954|NCT00451451|20970054|P4|Overall Study|Investigator Decision|2
6070955|NCT00451451|20970055|P3|Overall Study|Investigator Decision|1
6070956|NCT00451451|20970056|P2|Overall Study|Investigator Decision|2
6070957|NCT00451451|20970057|P1|Overall Study|Investigator Decision|6
6070958|NCT00451451|20970054|P4|Overall Study|Consent Withdrawn|17
6070959|NCT00451451|20970055|P3|Overall Study|Consent Withdrawn|17
6070960|NCT00451451|20970056|P2|Overall Study|Consent Withdrawn|9
6070961|NCT00451451|20970057|P1|Overall Study|Consent Withdrawn|14
6070962|NCT00451451|20970054|P4|Overall Study|Lost to Follow-up|11
6070963|NCT00451451|20970055|P3|Overall Study|Lost to Follow-up|8
6070964|NCT00451451|20970056|P2|Overall Study|Lost to Follow-up|9
6070965|NCT00451451|20970057|P1|Overall Study|Lost to Follow-up|11
6070966|NCT00451451|20970054|P4|Overall Study|Adverse Event|10
6070967|NCT00451451|20970055|P3|Overall Study|Adverse Event|26
6070968|NCT00451451|20970056|P2|Overall Study|Adverse Event|21
6070969|NCT00451451|20970057|P1|Overall Study|Adverse Event|11
6070970|NCT00451321|20970092|P8|Overall Study|Sponsor decision to amend protocol|3
6070971|NCT00451321|20970093|P7|Overall Study|Sponsor decision to amend protocol|1
6070972|NCT00451321|20970094|P6|Overall Study|Sponsor decision to amend protocol|1
6070973|NCT00451321|20970095|P5|Overall Study|Sponsor decision to amend protocol|0
6070974|NCT00451321|20970096|P4|Overall Study|Sponsor decision to amend protocol|0
6070975|NCT00451321|20970097|P3|Overall Study|Sponsor decision to amend protocol|0
6070976|NCT00451321|20970098|P2|Overall Study|Sponsor decision to amend protocol|0
6070977|NCT00451321|20970099|P1|Overall Study|Sponsor decision to amend protocol|0
6070978|NCT00451321|20970092|P8|Overall Study|Study closed/terminated|3
6070979|NCT00451321|20970093|P7|Overall Study|Study closed/terminated|5
6070980|NCT00451321|20970094|P6|Overall Study|Study closed/terminated|7
6070981|NCT00451321|20970095|P5|Overall Study|Study closed/terminated|7
6070982|NCT00451321|20970096|P4|Overall Study|Study closed/terminated|5
6070983|NCT00451321|20970097|P3|Overall Study|Study closed/terminated|17
6070984|NCT00451321|20970098|P2|Overall Study|Study closed/terminated|1
6070985|NCT00451321|20970099|P1|Overall Study|Study closed/terminated|1
6070986|NCT00451321|20970092|P8|Overall Study|Withdrawal by Subject|0
6070987|NCT00451321|20970093|P7|Overall Study|Withdrawal by Subject|0
6070988|NCT00451321|20970094|P6|Overall Study|Withdrawal by Subject|0
6070989|NCT00451321|20970095|P5|Overall Study|Withdrawal by Subject|0
6070990|NCT00451321|20970096|P4|Overall Study|Withdrawal by Subject|4
6070991|NCT00451321|20970097|P3|Overall Study|Withdrawal by Subject|0
6070992|NCT00451321|20970098|P2|Overall Study|Withdrawal by Subject|1
6070993|NCT00451321|20970099|P1|Overall Study|Withdrawal by Subject|3
6070994|NCT00451321|20970092|P8|Overall Study|Lost to Follow-up|0
6070995|NCT00451321|20970093|P7|Overall Study|Lost to Follow-up|0
6070996|NCT00451321|20970094|P6|Overall Study|Lost to Follow-up|1
6070997|NCT00451321|20970095|P5|Overall Study|Lost to Follow-up|0
6070998|NCT00451321|20970096|P4|Overall Study|Lost to Follow-up|3
6070999|NCT00451321|20970097|P3|Overall Study|Lost to Follow-up|1
6071000|NCT00451321|20970098|P2|Overall Study|Lost to Follow-up|3
6071001|NCT00451321|20970099|P1|Overall Study|Lost to Follow-up|3
6071002|NCT00451282|20970271|P2|Overall Study|Lost to Follow-up|5
6071003|NCT00451282|20970272|P1|Overall Study|Lost to Follow-up|6
6071004|NCT00451217|20970288|P4|Overall Study|Not Treated|4
6071005|NCT00451217|20970289|P3|Overall Study|Not Treated|3
6071006|NCT00451217|20970290|P2|Overall Study|Not Treated|1
6071007|NCT00451217|20970291|P1|Overall Study|Not Treated|1
6071008|NCT00451217|20970288|P4|Overall Study|Withdrawal by Subject|0
6071009|NCT00451217|20970289|P3|Overall Study|Withdrawal by Subject|0
6071010|NCT00451217|20970290|P2|Overall Study|Withdrawal by Subject|0
6071011|NCT00451217|20970291|P1|Overall Study|Withdrawal by Subject|1
6071012|NCT00451217|20970288|P4|Overall Study|Lost to Follow-up|1
6071013|NCT00451217|20970289|P3|Overall Study|Lost to Follow-up|1
6071014|NCT00451217|20970290|P2|Overall Study|Lost to Follow-up|1
6071015|NCT00451217|20970291|P1|Overall Study|Lost to Follow-up|0
6071016|NCT00451204|20970319|P2|Overall Study|Other|2
6071017|NCT00451204|20970320|P1|Overall Study|Other|1
6071018|NCT00451204|20970319|P2|Overall Study|Patient refusal|4
6071019|NCT00451204|20970320|P1|Overall Study|Patient refusal|8
6071020|NCT00451204|20970319|P2|Overall Study|Protocol Violation|0
6071021|NCT00451204|20970320|P1|Overall Study|Protocol Violation|1
6071022|NCT00451204|20970319|P2|Overall Study|Lost to Follow-up|4
6071023|NCT00451204|20970320|P1|Overall Study|Lost to Follow-up|4
6071024|NCT00451204|20970319|P2|Overall Study|Lack of Efficacy|4
6071025|NCT00451204|20970320|P1|Overall Study|Lack of Efficacy|4
6071026|NCT00451204|20970319|P2|Overall Study|Adverse Event|6
6071027|NCT00451204|20970320|P1|Overall Study|Adverse Event|4
6071028|NCT00451191|20970338|P2|Overall Study|withdrawal or received alternate tx|11
6071029|NCT00451191|20970339|P1|Overall Study|withdrawal or received alternate tx|15
6071030|NCT00451178|20970347|P2|Long-Term Follow-Up (Up to 2 Years)|Continuing Follow-Up|26
6071031|NCT00451178|20970348|P1|Long-Term Follow-Up (Up to 2 Years)|Continuing Follow-Up|6
6071032|NCT00451178|20970347|P2|Maintenance Therapy (up to 3 Years)|Continuing Maintenance|0
6071033|NCT00451178|20970348|P1|Maintenance Therapy (up to 3 Years)|Continuing Maintenance|9
6071034|NCT00451178|20970347|P2|Maintenance Therapy (up to 3 Years)|PD|0
6071035|NCT00451178|20970348|P1|Maintenance Therapy (up to 3 Years)|PD|10
6071036|NCT00451178|20970347|P2|Maintenance Therapy (up to 3 Years)|Death|0
6071037|NCT00451178|20970348|P1|Maintenance Therapy (up to 3 Years)|Death|1
6071038|NCT00451178|20970347|P2|Maintenance Therapy (up to 3 Years)|Physician Decision|0
6071039|NCT00451178|20970348|P1|Maintenance Therapy (up to 3 Years)|Physician Decision|1
6071040|NCT00451178|20970347|P2|Maintenance Therapy (up to 3 Years)|Withdrawal by Subject|0
6071041|NCT00451178|20970348|P1|Maintenance Therapy (up to 3 Years)|Withdrawal by Subject|5
6071042|NCT00451178|20970347|P2|Maintenance Therapy (up to 3 Years)|Adverse Event|0
6071043|NCT00451178|20970348|P1|Maintenance Therapy (up to 3 Years)|Adverse Event|4
6071044|NCT00451178|20970347|P2|Prior to Maintenance Therapy|PD|0
6071045|NCT00451178|20970348|P1|Prior to Maintenance Therapy|PD|2
6071046|NCT00451178|20970347|P2|Prior to Maintenance Therapy|Physician Decision|0
6071047|NCT00451178|20970348|P1|Prior to Maintenance Therapy|Physician Decision|2
6071048|NCT00451178|20970347|P2|Chemotherapy (Up To Six 21-Day Cycles)|Progressive Disease (PD)|2
6071049|NCT00451178|20970348|P1|Chemotherapy (Up To Six 21-Day Cycles)|Progressive Disease (PD)|1
6071050|NCT00451178|20970347|P2|Chemotherapy (Up To Six 21-Day Cycles)|Death|3
6071051|NCT00451178|20970348|P1|Chemotherapy (Up To Six 21-Day Cycles)|Death|4
6071052|NCT00451178|20970347|P2|Chemotherapy (Up To Six 21-Day Cycles)|Physician Decision|2
6071053|NCT00451178|20970348|P1|Chemotherapy (Up To Six 21-Day Cycles)|Physician Decision|1
6071054|NCT00451178|20970347|P2|Chemotherapy (Up To Six 21-Day Cycles)|Protocol Violation|1
6071055|NCT00451178|20970348|P1|Chemotherapy (Up To Six 21-Day Cycles)|Protocol Violation|2
6071056|NCT00451178|20970347|P2|Chemotherapy (Up To Six 21-Day Cycles)|Withdrawal by Subject|3
6071057|NCT00451178|20970348|P1|Chemotherapy (Up To Six 21-Day Cycles)|Withdrawal by Subject|4
6071058|NCT00451178|20970347|P2|Chemotherapy (Up To Six 21-Day Cycles)|Adverse Event|6
6071059|NCT00451178|20970348|P1|Chemotherapy (Up To Six 21-Day Cycles)|Adverse Event|6
6071060|NCT00450866|20970395|P2|Overall Study|Physician Decision|0
6071061|NCT00450866|20970396|P1|Overall Study|Physician Decision|1
6071062|NCT00450866|20970395|P2|Overall Study|Death|0
6071063|NCT00450866|20970396|P1|Overall Study|Death|1
6071064|NCT00450866|20970395|P2|Overall Study|Withdrawal by Subject|2
6071065|NCT00450866|20970396|P1|Overall Study|Withdrawal by Subject|5
6071066|NCT00450866|20970395|P2|Overall Study|Adverse Event|1
6071067|NCT00450866|20970396|P1|Overall Study|Adverse Event|0
6071068|NCT00450814|20970416|P11|Overall Study|Patient withdrawal prior to treatment|0
6071069|NCT00450814|20970417|P10|Overall Study|Patient withdrawal prior to treatment|1
6071070|NCT00450814|20970418|P9|Overall Study|Patient withdrawal prior to treatment|0
6071071|NCT00450814|20970419|P8|Overall Study|Patient withdrawal prior to treatment|0
6071072|NCT00450814|20970420|P7|Overall Study|Patient withdrawal prior to treatment|0
6071073|NCT00450814|20970421|P6|Overall Study|Patient withdrawal prior to treatment|0
6071074|NCT00450814|20970422|P5|Overall Study|Patient withdrawal prior to treatment|0
6071075|NCT00450814|20970423|P4|Overall Study|Patient withdrawal prior to treatment|0
6071076|NCT00450814|20970424|P3|Overall Study|Patient withdrawal prior to treatment|0
6071077|NCT00450814|20970425|P2|Overall Study|Patient withdrawal prior to treatment|0
6071078|NCT00450814|20970426|P1|Overall Study|Patient withdrawal prior to treatment|0
6071079|NCT00450814|20970416|P11|Overall Study|Failed to complete the initial therapy|0
6071080|NCT00450814|20970417|P10|Overall Study|Failed to complete the initial therapy|0
6071081|NCT00450814|20970418|P9|Overall Study|Failed to complete the initial therapy|0
6071082|NCT00450814|20970419|P8|Overall Study|Failed to complete the initial therapy|0
6071083|NCT00450814|20970420|P7|Overall Study|Failed to complete the initial therapy|0
6071084|NCT00450814|20970421|P6|Overall Study|Failed to complete the initial therapy|1
6071085|NCT00450814|20970422|P5|Overall Study|Failed to complete the initial therapy|1
6071086|NCT00450814|20970423|P4|Overall Study|Failed to complete the initial therapy|1
6071087|NCT00450814|20970424|P3|Overall Study|Failed to complete the initial therapy|0
6071088|NCT00450814|20970425|P2|Overall Study|Failed to complete the initial therapy|0
6071089|NCT00450814|20970426|P1|Overall Study|Failed to complete the initial therapy|0
6071090|NCT00450801|20970460|P1|Overall Study|Death|1
6071091|NCT00450749|20970474|P3|Overall Study|Noncompliant|0
6071092|NCT00450749|20970475|P2|Overall Study|Noncompliant|1
6071093|NCT00450749|20970476|P1|Overall Study|Noncompliant|0
6071094|NCT00450749|20970474|P3|Overall Study|Withdrawal by Subject|2
6071095|NCT00450749|20970475|P2|Overall Study|Withdrawal by Subject|0
6071096|NCT00450749|20970476|P1|Overall Study|Withdrawal by Subject|0
6071097|NCT00450723|20970514|P1|Overall Study|Physician Decision|5
6071098|NCT00450658|20970522|P2|Overall Study|misc|10
6071099|NCT00450658|20970523|P1|Overall Study|misc|21
6071100|NCT00450658|20970522|P2|Overall Study|UGI ulcer|34
6071101|NCT00450658|20970523|P1|Overall Study|UGI ulcer|33
6071102|NCT00450658|20970522|P2|Overall Study|Lost to Follow-up|5
6071103|NCT00450658|20970523|P1|Overall Study|Lost to Follow-up|22
6071104|NCT00450658|20970522|P2|Overall Study|Withdrawal by Subject|26
6071105|NCT00450658|20970523|P1|Overall Study|Withdrawal by Subject|43
6071106|NCT00450658|20970522|P2|Overall Study|Adverse Event|15
6071107|NCT00450658|20970523|P1|Overall Study|Adverse Event|24
6071108|NCT00450619|20970537|P2|Overall Study|Adverse Event|0
6071109|NCT00450619|20970538|P1|Overall Study|Adverse Event|1
6071110|NCT00450619|20970537|P2|Overall Study|did not progress; refused further trmt|1
6071111|NCT00450619|20970538|P1|Overall Study|did not progress; refused further trmt|1
6071112|NCT00450619|20970537|P2|Overall Study|refused treatment after randomization|0
6071113|NCT00450619|20970538|P1|Overall Study|refused treatment after randomization|2
6071114|NCT00450580|20970564|P2|Overall Study|Withdrawal due to pregnancy|1
6071115|NCT00450580|20970565|P1|Overall Study|Withdrawal due to pregnancy|0
6071116|NCT00450580|20970564|P2|Overall Study|Patient could not swallow Norvir|0
6071117|NCT00450580|20970565|P1|Overall Study|Patient could not swallow Norvir|1
6071118|NCT00450580|20970564|P2|Overall Study|Patient went to Brazil|0
6071119|NCT00450580|20970565|P1|Overall Study|Patient went to Brazil|1
6071120|NCT00450580|20970564|P2|Overall Study|Could not comply with scheduled visits|0
6071121|NCT00450580|20970565|P1|Overall Study|Could not comply with scheduled visits|1
6071122|NCT00450580|20970564|P2|Overall Study|Protocol-defined virologic failure|0
6071123|NCT00450580|20970565|P1|Overall Study|Protocol-defined virologic failure|1
6071124|NCT00450580|20970564|P2|Overall Study|Protocol Violation|1
6071125|NCT00450580|20970565|P1|Overall Study|Protocol Violation|1
6071126|NCT00450580|20970564|P2|Overall Study|Withdrawal by Subject|2
6071127|NCT00450580|20970565|P1|Overall Study|Withdrawal by Subject|2
6071128|NCT00450580|20970564|P2|Overall Study|Lost to Follow-up|5
6071129|NCT00450580|20970565|P1|Overall Study|Lost to Follow-up|4
6071130|NCT00450580|20970564|P2|Overall Study|Adverse Event|7
6071131|NCT00450580|20970565|P1|Overall Study|Adverse Event|5
6071132|NCT00450450|20970602|P2|Overall Study|Missing Data|0
6071133|NCT00450450|20970603|P1|Overall Study|Missing Data|2
6071134|NCT00450450|20970602|P2|Overall Study|Relapse|0
6071135|NCT00450450|20970603|P1|Overall Study|Relapse|2
6071136|NCT00450450|20970602|P2|Overall Study|Death|3
6071137|NCT00450450|20970603|P1|Overall Study|Death|1
6071138|NCT00450437|20970627|P4|Overall Study|Unable to Classify|0
6071139|NCT00450437|20970628|P3|Overall Study|Unable to Classify|1
6071140|NCT00450437|20970629|P2|Overall Study|Unable to Classify|0
6071141|NCT00450437|20970630|P1|Overall Study|Unable to Classify|1
6071142|NCT00450437|20970627|P4|Overall Study|Administrative reason|0
6071143|NCT00450437|20970628|P3|Overall Study|Administrative reason|1
6071144|NCT00450437|20970629|P2|Overall Study|Administrative reason|0
6071145|NCT00450437|20970630|P1|Overall Study|Administrative reason|0
6071146|NCT00450437|20970627|P4|Overall Study|Inappropriate enrollment|0
6071147|NCT00450437|20970628|P3|Overall Study|Inappropriate enrollment|3
6071148|NCT00450437|20970629|P2|Overall Study|Inappropriate enrollment|1
6071149|NCT00450437|20970630|P1|Overall Study|Inappropriate enrollment|4
6071150|NCT00450437|20970627|P4|Overall Study|Protocol Violation|1
6071151|NCT00450437|20970628|P3|Overall Study|Protocol Violation|0
6071152|NCT00450437|20970629|P2|Overall Study|Protocol Violation|1
6071153|NCT00450437|20970630|P1|Overall Study|Protocol Violation|0
6071154|NCT00450437|20970627|P4|Overall Study|Lost to Follow-up|9
6071155|NCT00450437|20970628|P3|Overall Study|Lost to Follow-up|19
6071156|NCT00450437|20970629|P2|Overall Study|Lost to Follow-up|12
6071157|NCT00450437|20970630|P1|Overall Study|Lost to Follow-up|31
6071158|NCT00450437|20970627|P4|Overall Study|Withdrawal by Subject|1
6071159|NCT00450437|20970628|P3|Overall Study|Withdrawal by Subject|0
6071160|NCT00450437|20970629|P2|Overall Study|Withdrawal by Subject|2
6071161|NCT00450437|20970630|P1|Overall Study|Withdrawal by Subject|10
6071162|NCT00450411|20970661|P1|Overall Study|No protocol treatment|2
6071163|NCT00450411|20970661|P1|Overall Study|Protocol Violation|6
6071164|NCT00450385|20970666|P1|Overall Study|Other|3
6071165|NCT00450385|20970666|P1|Overall Study|Physician Decision|1
6071166|NCT00450385|20970666|P1|Overall Study|Adverse Event|1
6071167|NCT00450385|20970666|P1|Overall Study|Lack of Efficacy|2
6071168|NCT00450385|20970666|P1|Overall Study|Withdrawal by Subject|2
6071169|NCT00450385|20970666|P1|Overall Study|Protocol Violation|1
6071170|NCT00450385|20970666|P1|Overall Study|Death|3
6071171|NCT00450372|20970675|P1|Overall Study|Physician Decision|1
6071172|NCT00450333|20970688|P4|Overall Study|Death|2
6071173|NCT00450333|20970689|P3|Overall Study|Death|2
6071174|NCT00450333|20970690|P2|Overall Study|Death|2
6071175|NCT00450333|20970691|P1|Overall Study|Death|3
6071176|NCT00450333|20970688|P4|Overall Study|Kidney transplant|3
6071177|NCT00450333|20970689|P3|Overall Study|Kidney transplant|1
6071178|NCT00450333|20970690|P2|Overall Study|Kidney transplant|0
6071179|NCT00450333|20970691|P1|Overall Study|Kidney transplant|1
6071180|NCT00450333|20970688|P4|Overall Study|Withdrawal by Subject|0
6071181|NCT00450333|20970689|P3|Overall Study|Withdrawal by Subject|3
6071182|NCT00450333|20970690|P2|Overall Study|Withdrawal by Subject|0
6071183|NCT00450333|20970691|P1|Overall Study|Withdrawal by Subject|1
6071184|NCT00450333|20970688|P4|Overall Study|Protocol Violation|0
6071185|NCT00450333|20970689|P3|Overall Study|Protocol Violation|1
6071186|NCT00450333|20970690|P2|Overall Study|Protocol Violation|0
6071187|NCT00450333|20970691|P1|Overall Study|Protocol Violation|1
6071188|NCT00450333|20970688|P4|Overall Study|Adverse Event|2
6071189|NCT00450333|20970689|P3|Overall Study|Adverse Event|2
6071190|NCT00450333|20970690|P2|Overall Study|Adverse Event|7
6071191|NCT00450333|20970691|P1|Overall Study|Adverse Event|1
6071192|NCT00450333|20970688|P4|Overall Study|Study terminated|21
6071193|NCT00450333|20970689|P3|Overall Study|Study terminated|16
6071194|NCT00450333|20970690|P2|Overall Study|Study terminated|54
6071195|NCT00450333|20970691|P1|Overall Study|Study terminated|47
6071196|NCT00450255|20970714|P1|Overall Study|Prior RFA ablation of liver|1
6071197|NCT00450216|20970739|P2|Overall Study|misc|20
6071198|NCT00450216|20970740|P1|Overall Study|misc|21
6071199|NCT00450216|20970739|P2|Overall Study|upper gastrointestinal (UGI) ulcer|51
6071200|NCT00450216|20970740|P1|Overall Study|upper gastrointestinal (UGI) ulcer|51
6071201|NCT00450216|20970739|P2|Overall Study|Lost to Follow-up|9
6071202|NCT00450216|20970740|P1|Overall Study|Lost to Follow-up|16
6071203|NCT00450216|20970739|P2|Overall Study|Withdrawal by Subject|26
6071204|NCT00450216|20970740|P1|Overall Study|Withdrawal by Subject|48
6071205|NCT00450216|20970739|P2|Overall Study|Adverse Event|23
6071206|NCT00450216|20970740|P1|Overall Study|Adverse Event|38
6071207|NCT00450190|20970752|P1|Overall Study|Withdrawal by Subject|2
6071208|NCT00450177|20970762|P2|Overall Study|Withdrawal by Primary Team|1
6071209|NCT00450177|20970763|P1|Overall Study|Withdrawal by Primary Team|1
6071210|NCT00450177|20970762|P2|Overall Study|Withdrawal by Subject|6
6071211|NCT00450177|20970763|P1|Overall Study|Withdrawal by Subject|1
6071212|NCT00450177|20970762|P2|Overall Study|Adverse Event|4
6071213|NCT00450177|20970763|P1|Overall Study|Adverse Event|7
6071214|NCT00450112|20970789|P2|Overall Study|Others|3
6071215|NCT00450112|20970790|P1|Overall Study|Others|2
6071216|NCT00450112|20970789|P2|Overall Study|Lost to Follow-up|1
6071217|NCT00450112|20970790|P1|Overall Study|Lost to Follow-up|2
6071218|NCT00450112|20970789|P2|Overall Study|Withdrawal by Subject|1
6071219|NCT00450112|20970790|P1|Overall Study|Withdrawal by Subject|4
6071220|NCT00450112|20970789|P2|Overall Study|Other Treatment Required|1
6071221|NCT00450112|20970790|P1|Overall Study|Other Treatment Required|5
6071222|NCT00449956|20970828|P3|Overall Study|Physician Decision|1
6071223|NCT00449956|20970829|P2|Overall Study|Physician Decision|1
6071224|NCT00449956|20970830|P1|Overall Study|Physician Decision|2
6071225|NCT00449956|20970828|P3|Overall Study|Withdrawal by Subject|0
6071226|NCT00449956|20970829|P2|Overall Study|Withdrawal by Subject|1
6071227|NCT00449956|20970830|P1|Overall Study|Withdrawal by Subject|0
6071228|NCT00449956|20970828|P3|Overall Study|Protocol Violation|1
6071229|NCT00449956|20970829|P2|Overall Study|Protocol Violation|1
6071230|NCT00449956|20970830|P1|Overall Study|Protocol Violation|1
6071231|NCT00449956|20970828|P3|Overall Study|Lack of Efficacy|1
6071232|NCT00449956|20970829|P2|Overall Study|Lack of Efficacy|0
6071233|NCT00449956|20970830|P1|Overall Study|Lack of Efficacy|0
6071234|NCT00449956|20970828|P3|Overall Study|Adverse Event|6
6071235|NCT00449956|20970829|P2|Overall Study|Adverse Event|1
6071236|NCT00449956|20970830|P1|Overall Study|Adverse Event|7
6071237|NCT00449930|20970846|P2|Overall Study|Glycemic discontinuation criteria|1
6071238|NCT00449930|20970847|P1|Overall Study|Glycemic discontinuation criteria|1
6071239|NCT00449930|20970846|P2|Overall Study|Withdrawal by Subject|23
6071240|NCT00449930|20970847|P1|Overall Study|Withdrawal by Subject|16
6071241|NCT00449930|20970846|P2|Overall Study|Protocol Violation|15
6071242|NCT00449930|20970847|P1|Overall Study|Protocol Violation|14
6071243|NCT00449930|20970846|P2|Overall Study|Physician Decision|2
6071244|NCT00449930|20970847|P1|Overall Study|Physician Decision|1
6071245|NCT00449930|20970846|P2|Overall Study|Lost to Follow-up|14
6071246|NCT00449930|20970847|P1|Overall Study|Lost to Follow-up|9
6071247|NCT00449930|20970846|P2|Overall Study|Lack of Efficacy|1
6071248|NCT00449930|20970847|P1|Overall Study|Lack of Efficacy|10
6071249|NCT00449930|20970846|P2|Overall Study|Trial Terminated ( Site Closed)|0
6071250|NCT00449930|20970847|P1|Overall Study|Trial Terminated ( Site Closed)|1
6071251|NCT00449930|20970846|P2|Overall Study|Adverse Event|19
6071252|NCT00449930|20970847|P1|Overall Study|Adverse Event|9
6071253|NCT00449865|20970863|P2|Overall Study|Study was stopped|328
6071254|NCT00449865|20970864|P1|Overall Study|Study was stopped|324
6071255|NCT00449865|20970863|P2|Overall Study|Protocol Violation|7
6071256|NCT00449865|20970864|P1|Overall Study|Protocol Violation|8
6071257|NCT00449865|20970863|P2|Overall Study|Death|40
6071258|NCT00449865|20970864|P1|Overall Study|Death|31
6071259|NCT00449865|20970863|P2|Overall Study|Physician Decision|12
6071260|NCT00449865|20970864|P1|Overall Study|Physician Decision|13
6071261|NCT00449865|20970863|P2|Overall Study|Lost to Follow-up|37
6071262|NCT00449865|20970864|P1|Overall Study|Lost to Follow-up|36
6071263|NCT00449865|20970863|P2|Overall Study|Withdrawal by Subject|110
6071264|NCT00449865|20970864|P1|Overall Study|Withdrawal by Subject|110
6071265|NCT00449787|20970872|P2|Overall Study|Did not require medication|92
6071266|NCT00449787|20970873|P1|Overall Study|Did not require medication|95
6071267|NCT00449787|20970872|P2|Overall Study|Lost to Follow-up|8
6071268|NCT00449787|20970873|P1|Overall Study|Lost to Follow-up|10
6071269|NCT00449696|20970889|P2|Overall Study|Others|0
6071270|NCT00449696|20970890|P1|Overall Study|Others|7
6071271|NCT00449696|20970889|P2|Overall Study|Lost to Follow-up|3
6071272|NCT00449696|20970890|P1|Overall Study|Lost to Follow-up|2
6071273|NCT00449696|20970889|P2|Overall Study|Withdrawal by Subject|5
6071274|NCT00449696|20970890|P1|Overall Study|Withdrawal by Subject|5
6071275|NCT00449696|20970889|P2|Overall Study|Other Treatment Required|1
6071276|NCT00449696|20970890|P1|Overall Study|Other Treatment Required|6
6071277|NCT00449670|20970914|P2|Booster Phase (Study no.109873)|Other|2
6071278|NCT00449670|20970915|P1|Booster Phase (Study no.109873)|Other|0
6071279|NCT00449670|20970914|P2|Booster Phase (Study no.109873)|Migrated/moved from study area|1
6071280|NCT00449670|20970915|P1|Booster Phase (Study no.109873)|Migrated/moved from study area|0
6071281|NCT00449670|20970914|P2|Primary Phase (Study no.109630)|Lost to Follow-up|1
6071282|NCT00449670|20970915|P1|Primary Phase (Study no.109630)|Lost to Follow-up|5
6071283|NCT00449670|20970914|P2|Primary Phase (Study no.109630)|Withdrawal by Subject|1
6071284|NCT00449670|20970915|P1|Primary Phase (Study no.109630)|Withdrawal by Subject|4
6071285|NCT00449670|20970914|P2|Primary Phase (Study no.109630)|Non-serious adverse event|0
6071286|NCT00449670|20970915|P1|Primary Phase (Study no.109630)|Non-serious adverse event|4
6071287|NCT00449670|20970914|P2|Primary Phase (Study no.109630)|Serious Adverse Event|0
6071288|NCT00449670|20970915|P1|Primary Phase (Study no.109630)|Serious Adverse Event|1
6071289|NCT00449644|20971028|P4|Overall Study|Rolled-over to treatment with TMC207|1
6071290|NCT00449644|20971029|P3|Overall Study|Rolled-over to treatment with TMC207|0
6071291|NCT00449644|20971030|P2|Overall Study|Rolled-over to treatment with TMC207|0
6071292|NCT00449644|20971031|P1|Overall Study|Rolled-over to treatment with TMC207|0
6071293|NCT00449644|20971028|P4|Overall Study|Other|0
6071294|NCT00449644|20971029|P3|Overall Study|Other|1
6071295|NCT00449644|20971030|P2|Overall Study|Other|4
6071296|NCT00449644|20971031|P1|Overall Study|Other|1
6071297|NCT00449644|20971028|P4|Overall Study|Inclusion/exclusion criteria not met|6
6071298|NCT00449644|20971029|P3|Overall Study|Inclusion/exclusion criteria not met|2
6071299|NCT00449644|20971030|P2|Overall Study|Inclusion/exclusion criteria not met|0
6071300|NCT00449644|20971031|P1|Overall Study|Inclusion/exclusion criteria not met|0
6071301|NCT00449644|20971028|P4|Overall Study|Withdrawal by Subject|7
6071302|NCT00449644|20971029|P3|Overall Study|Withdrawal by Subject|6
6071303|NCT00449644|20971030|P2|Overall Study|Withdrawal by Subject|4
6071304|NCT00449644|20971031|P1|Overall Study|Withdrawal by Subject|3
6071305|NCT00449644|20971028|P4|Overall Study|Protocol Violation|7
6071306|NCT00449644|20971029|P3|Overall Study|Protocol Violation|3
6071307|NCT00449644|20971030|P2|Overall Study|Protocol Violation|4
6071308|NCT00449644|20971031|P1|Overall Study|Protocol Violation|4
6071309|NCT00449644|20971028|P4|Overall Study|Pregnancy|2
6071310|NCT00449644|20971029|P3|Overall Study|Pregnancy|3
6071311|NCT00449644|20971030|P2|Overall Study|Pregnancy|0
6071312|NCT00449644|20971031|P1|Overall Study|Pregnancy|0
6071313|NCT00449644|20971028|P4|Overall Study|Lost to Follow-up|3
6071314|NCT00449644|20971029|P3|Overall Study|Lost to Follow-up|5
6071315|NCT00449644|20971030|P2|Overall Study|Lost to Follow-up|1
6071316|NCT00449644|20971031|P1|Overall Study|Lost to Follow-up|1
6071317|NCT00449644|20971028|P4|Overall Study|Death|1
6071318|NCT00449644|20971029|P3|Overall Study|Death|6
6071319|NCT00449644|20971030|P2|Overall Study|Death|0
6071320|NCT00449644|20971031|P1|Overall Study|Death|1
6071321|NCT00449644|20971028|P4|Overall Study|Adverse Event|5
6071322|NCT00449644|20971029|P3|Overall Study|Adverse Event|3
6071323|NCT00449644|20971030|P2|Overall Study|Adverse Event|0
6071324|NCT00449644|20971031|P1|Overall Study|Adverse Event|0
6071325|NCT00449540|20971051|P3|Treatment Phase|did not experience or treat migraine|17
6071326|NCT00449540|20971052|P2|Treatment Phase|did not experience or treat migraine|20
6071327|NCT00449540|20971053|P1|Treatment Phase|did not experience or treat migraine|0
6071328|NCT00449540|20971051|P3|Pretreatment Phase|No migraine experienced|0
6071329|NCT00449540|20971052|P2|Pretreatment Phase|No migraine experienced|0
6071330|NCT00449540|20971053|P1|Pretreatment Phase|No migraine experienced|66
6071331|NCT00449176|20971070|P3|Overall Study|all other|20
6071332|NCT00449176|20971071|P2|Overall Study|all other|19
6071333|NCT00449176|20971072|P1|Overall Study|all other|22
6071334|NCT00449176|20971070|P3|Overall Study|Study drug non-compliant|11
6071335|NCT00449176|20971071|P2|Overall Study|Study drug non-compliant|11
6071336|NCT00449176|20971072|P1|Overall Study|Study drug non-compliant|14
6071337|NCT00449176|20971070|P3|Overall Study|Lack of Efficacy|50
6071338|NCT00449176|20971071|P2|Overall Study|Lack of Efficacy|7
6071339|NCT00449176|20971072|P1|Overall Study|Lack of Efficacy|13
6071340|NCT00449176|20971070|P3|Overall Study|Adverse Event|15
6071341|NCT00449176|20971071|P2|Overall Study|Adverse Event|107
6071342|NCT00449176|20971072|P1|Overall Study|Adverse Event|51
6071343|NCT00449176|20971070|P3|Overall Study|Lost to Follow-up|12
6071344|NCT00449176|20971071|P2|Overall Study|Lost to Follow-up|8
6071345|NCT00449176|20971072|P1|Overall Study|Lost to Follow-up|13
6071346|NCT00449176|20971070|P3|Overall Study|Withdrawal by Subject|59
6071347|NCT00449176|20971071|P2|Overall Study|Withdrawal by Subject|43
6071348|NCT00449176|20971072|P1|Overall Study|Withdrawal by Subject|39
6071349|NCT00449163|20971098|P1|Overall Study|Physician Decision|3
6071350|NCT00449150|20971108|P3|Overall Study|Protocol Violation|1
6071351|NCT00449150|20971109|P2|Overall Study|Protocol Violation|2
6071352|NCT00449150|20971110|P1|Overall Study|Protocol Violation|1
6071353|NCT00449150|20971108|P3|Overall Study|Withdrawal by Subject|21
6071354|NCT00449150|20971109|P2|Overall Study|Withdrawal by Subject|18
6071355|NCT00449150|20971110|P1|Overall Study|Withdrawal by Subject|17
6071356|NCT00449150|20971108|P3|Overall Study|Other|14
6071357|NCT00449150|20971109|P2|Overall Study|Other|13
6071358|NCT00449150|20971110|P1|Overall Study|Other|16
6071359|NCT00449150|20971108|P3|Overall Study|Lack of Efficacy|2
6071360|NCT00449150|20971109|P2|Overall Study|Lack of Efficacy|2
6071361|NCT00449150|20971110|P1|Overall Study|Lack of Efficacy|1
6071362|NCT00449150|20971108|P3|Overall Study|Adverse Event|9
6071363|NCT00449150|20971109|P2|Overall Study|Adverse Event|18
6071364|NCT00449150|20971110|P1|Overall Study|Adverse Event|11
6071365|NCT00449072|20971123|P2|Overall Study|Relocation|2
6071366|NCT00449072|20971124|P1|Overall Study|Relocation|3
6071367|NCT00449072|20971123|P2|Overall Study|Sponsor decision|3
6071368|NCT00449072|20971124|P1|Overall Study|Sponsor decision|1
6071369|NCT00449072|20971123|P2|Overall Study|Non-compliance|5
6071370|NCT00449072|20971124|P1|Overall Study|Non-compliance|2
6071371|NCT00449072|20971123|P2|Overall Study|Excluded medication|2
6071372|NCT00449072|20971124|P1|Overall Study|Excluded medication|0
6071373|NCT00449072|20971123|P2|Overall Study|Not treated|1
6071374|NCT00449072|20971124|P1|Overall Study|Not treated|0
6071375|NCT00449072|20971123|P2|Overall Study|Physician Decision|0
6071376|NCT00449072|20971124|P1|Overall Study|Physician Decision|1
6071377|NCT00449072|20971123|P2|Overall Study|Lack of Efficacy|1
6071378|NCT00449072|20971124|P1|Overall Study|Lack of Efficacy|1
6071379|NCT00449072|20971123|P2|Overall Study|Withdrawal by Subject|8
6071380|NCT00449072|20971124|P1|Overall Study|Withdrawal by Subject|11
6071381|NCT00449072|20971123|P2|Overall Study|Lost to Follow-up|7
6071382|NCT00449072|20971124|P1|Overall Study|Lost to Follow-up|5
6071383|NCT00449072|20971123|P2|Overall Study|Protocol Violation|12
6071384|NCT00449072|20971124|P1|Overall Study|Protocol Violation|14
6071385|NCT00449072|20971123|P2|Overall Study|Adverse Event|1
6071386|NCT00449072|20971124|P1|Overall Study|Adverse Event|3
6071387|NCT00449033|20971161|P2|Follow-up Period|Reason Missing|113
6071388|NCT00449033|20971162|P1|Follow-up Period|Reason Missing|120
6071389|NCT00449033|20971161|P2|Follow-up Period|Lost to Follow-up|10
6071390|NCT00449033|20971162|P1|Follow-up Period|Lost to Follow-up|6
6071391|NCT00449033|20971161|P2|Follow-up Period|Death|311
6071392|NCT00449033|20971162|P1|Follow-up Period|Death|299
6071393|NCT00449033|20971161|P2|Treatment Period|Treatment Ongoing|4
6071394|NCT00449033|20971162|P1|Treatment Period|Treatment Ongoing|6
6071395|NCT00449033|20971161|P2|Treatment Period|Reason Missing|4
6071396|NCT00449033|20971162|P1|Treatment Period|Reason Missing|0
6071397|NCT00449033|20971161|P2|Treatment Period|Second Malignancy|1
6071398|NCT00449033|20971162|P1|Treatment Period|Second Malignancy|0
6071399|NCT00449033|20971161|P2|Treatment Period|Non-compliance|8
6071400|NCT00449033|20971162|P1|Treatment Period|Non-compliance|7
6071401|NCT00449033|20971161|P2|Treatment Period|Amended Protocol Criteria|18
6071402|NCT00449033|20971162|P1|Treatment Period|Amended Protocol Criteria|22
6071403|NCT00449033|20971161|P2|Treatment Period|Consent Withdrawn|20
6071404|NCT00449033|20971162|P1|Treatment Period|Consent Withdrawn|36
6071405|NCT00449033|20971161|P2|Treatment Period|Disease Progression|288
6071406|NCT00449033|20971162|P1|Treatment Period|Disease Progression|231
6071407|NCT00449033|20971161|P2|Treatment Period|Protocol Violation|7
6071408|NCT00449033|20971162|P1|Treatment Period|Protocol Violation|8
6071409|NCT00449033|20971161|P2|Treatment Period|Physician Decision|5
6071410|NCT00449033|20971162|P1|Treatment Period|Physician Decision|4
6071411|NCT00449033|20971161|P2|Treatment Period|Lost to Follow-up|2
6071412|NCT00449033|20971162|P1|Treatment Period|Lost to Follow-up|0
6071413|NCT00449033|20971161|P2|Treatment Period|Death|12
6071414|NCT00449033|20971162|P1|Treatment Period|Death|21
6071415|NCT00449033|20971161|P2|Treatment Period|Adverse Event|83
6071416|NCT00449033|20971162|P1|Treatment Period|Adverse Event|117
6071417|NCT00448916|20971200|P4|Overall Study|Protocol Violation|1
6071418|NCT00448916|20971201|P3|Overall Study|Protocol Violation|0
6071419|NCT00448916|20971202|P2|Overall Study|Protocol Violation|0
6071420|NCT00448916|20971203|P1|Overall Study|Protocol Violation|0
6071421|NCT00448916|20971200|P4|Overall Study|Lost to Follow-up|1
6071422|NCT00448916|20971201|P3|Overall Study|Lost to Follow-up|0
6071423|NCT00448916|20971202|P2|Overall Study|Lost to Follow-up|1
6071424|NCT00448916|20971203|P1|Overall Study|Lost to Follow-up|0
6071425|NCT00448916|20971200|P4|Overall Study|Other|0
6071426|NCT00448916|20971201|P3|Overall Study|Other|0
6071427|NCT00448916|20971202|P2|Overall Study|Other|0
6071428|NCT00448916|20971203|P1|Overall Study|Other|1
6071429|NCT00448916|20971200|P4|Overall Study|Withdrawal by Subject|1
6071430|NCT00448916|20971201|P3|Overall Study|Withdrawal by Subject|1
6071431|NCT00448916|20971202|P2|Overall Study|Withdrawal by Subject|3
6071432|NCT00448916|20971203|P1|Overall Study|Withdrawal by Subject|3
6071433|NCT00448916|20971200|P4|Overall Study|Lack of Efficacy|1
6071434|NCT00448916|20971201|P3|Overall Study|Lack of Efficacy|2
6071435|NCT00448916|20971202|P2|Overall Study|Lack of Efficacy|0
6071436|NCT00448916|20971203|P1|Overall Study|Lack of Efficacy|1
6071437|NCT00448916|20971200|P4|Overall Study|Adverse Event|2
6071438|NCT00448916|20971201|P3|Overall Study|Adverse Event|3
6071439|NCT00448916|20971202|P2|Overall Study|Adverse Event|2
6071440|NCT00448916|20971203|P1|Overall Study|Adverse Event|2
6071441|NCT00448864|20971277|P3|Overall Study|Protocol Violation|0
6071442|NCT00448864|20971278|P2|Overall Study|Protocol Violation|2
6071443|NCT00448864|20971279|P1|Overall Study|Protocol Violation|0
6071444|NCT00448864|20971277|P3|Overall Study|Withdrawal by Subject|0
6071445|NCT00448864|20971278|P2|Overall Study|Withdrawal by Subject|2
6071446|NCT00448864|20971279|P1|Overall Study|Withdrawal by Subject|0
6071447|NCT00448864|20971277|P3|Overall Study|Physician Decision|1
6071448|NCT00448864|20971278|P2|Overall Study|Physician Decision|0
6071449|NCT00448864|20971279|P1|Overall Study|Physician Decision|1
6071450|NCT00448864|20971277|P3|Overall Study|Lost to Follow-up|0
6071451|NCT00448864|20971278|P2|Overall Study|Lost to Follow-up|1
6071452|NCT00448864|20971279|P1|Overall Study|Lost to Follow-up|3
6071453|NCT00448864|20971277|P3|Overall Study|Death|0
6071454|NCT00448864|20971278|P2|Overall Study|Death|0
6071455|NCT00448864|20971279|P1|Overall Study|Death|1
6071456|NCT00448760|20971295|P1|Overall Study|Death|3
6071457|NCT00448747|20971304|P2|Overall Study|collapsed veins|0
6071458|NCT00448747|20971305|P1|Overall Study|collapsed veins|1
6071459|NCT00448708|20971323|P2|Overall Study|not listed|2
6071460|NCT00448708|20971324|P1|Overall Study|not listed|0
6071461|NCT00448708|20971323|P2|Overall Study|Lost to Follow-up|8
6071462|NCT00448708|20971324|P1|Overall Study|Lost to Follow-up|6
6071463|NCT00448708|20971323|P2|Overall Study|Withdrawal by Subject|4
6071464|NCT00448708|20971324|P1|Overall Study|Withdrawal by Subject|8
6071465|NCT00448708|20971323|P2|Overall Study|Death|17
6071466|NCT00448708|20971324|P1|Overall Study|Death|21
6071467|NCT00448669|20971340|P2|Overall Study|Never started drug|7
6071468|NCT00448669|20971341|P1|Overall Study|Never started drug|9
6071469|NCT00448669|20971340|P2|Overall Study|HIV-infected at enrollment|2
6071470|NCT00448669|20971341|P1|Overall Study|HIV-infected at enrollment|1
6071471|NCT00448669|20971340|P2|Overall Study|Had other reasons|6
6071472|NCT00448669|20971341|P1|Overall Study|Had other reasons|5
6071473|NCT00448669|20971340|P2|Overall Study|Death|4
6071474|NCT00448669|20971341|P1|Overall Study|Death|2
6071475|NCT00448669|20971340|P2|Overall Study|Were withdrawn by investigator|6
6071476|NCT00448669|20971341|P1|Overall Study|Were withdrawn by investigator|10
6071477|NCT00448669|20971340|P2|Overall Study|Relocated|36
6071478|NCT00448669|20971341|P1|Overall Study|Relocated|49
6071479|NCT00448669|20971340|P2|Overall Study|Withdrawal by Subject|74
6071480|NCT00448669|20971341|P1|Overall Study|Withdrawal by Subject|90
6071481|NCT00448669|20971340|P2|Overall Study|Lost to Follow-up|63
6071482|NCT00448669|20971341|P1|Overall Study|Lost to Follow-up|52
6071483|NCT00448591|20971402|P1|Overall Study|Termination of Study|70
6071484|NCT00448591|20971402|P1|Overall Study|Other|154
6071485|NCT00448591|20971402|P1|Overall Study|Treatment Regimen Completed|70
6071486|NCT00448591|20971402|P1|Overall Study|Lost to Follow-up|19
6071487|NCT00448591|20971402|P1|Overall Study|Protocol Violation|41
6071488|NCT00448591|20971402|P1|Overall Study|Adverse Event|382
6071489|NCT00448591|20971402|P1|Overall Study|Progressive Disease|1382
6071490|NCT00448591|20971402|P1|Overall Study|Withdrawal by Subject|178
6071491|NCT00448539|20971413|P2|Overall Study|Lost to Follow-up|3
6071492|NCT00448539|20971414|P1|Overall Study|Lost to Follow-up|1
6071493|NCT00448539|20971413|P2|Overall Study|Change of meds|3
6071494|NCT00448539|20971414|P1|Overall Study|Change of meds|2
6071495|NCT00448539|20971413|P2|Overall Study|Miscellaneous|1
6071496|NCT00448539|20971414|P1|Overall Study|Miscellaneous|2
6071497|NCT00448539|20971413|P2|Overall Study|Lack of Efficacy|40
6071498|NCT00448539|20971414|P1|Overall Study|Lack of Efficacy|27
6071499|NCT00448539|20971413|P2|Overall Study|Adverse Event|26
6071500|NCT00448539|20971414|P1|Overall Study|Adverse Event|9
6071501|NCT00448539|20971413|P2|Overall Study|Diary non-compliance|0
6071502|NCT00448539|20971414|P1|Overall Study|Diary non-compliance|1
6071503|NCT00448539|20971413|P2|Overall Study|Withdrawal by Subject|24
6071504|NCT00448539|20971414|P1|Overall Study|Withdrawal by Subject|20
6071505|NCT00448539|20971413|P2|Overall Study|Request of the investigator or sponsor|54
6071506|NCT00448539|20971414|P1|Overall Study|Request of the investigator or sponsor|67
6071507|NCT00448539|20971413|P2|Overall Study|Protocol Violation|0
6071508|NCT00448539|20971414|P1|Overall Study|Protocol Violation|1
6071509|NCT00448539|20971413|P2|Overall Study|Medication non-compliance|1
6071510|NCT00448539|20971414|P1|Overall Study|Medication non-compliance|4
6071511|NCT00448448|20971422|P2|Overall Study|Signed consent lost|1
6071512|NCT00448448|20971423|P1|Overall Study|Signed consent lost|0
6071513|NCT00448448|20971422|P2|Overall Study|Wrong diagnosis (n=3) or other|1
6071514|NCT00448448|20971423|P1|Overall Study|Wrong diagnosis (n=3) or other|2
6071515|NCT00448448|20971422|P2|Overall Study|Lost to Follow-up|1
6071516|NCT00448448|20971423|P1|Overall Study|Lost to Follow-up|2
6071517|NCT00448448|20971422|P2|Overall Study|On protocol when study ended|36
6071518|NCT00448448|20971423|P1|Overall Study|On protocol when study ended|83
6071519|NCT00448448|20971422|P2|Overall Study|Withdrawal by Subject|2
6071520|NCT00448448|20971423|P1|Overall Study|Withdrawal by Subject|13
6071521|NCT00448435|20971429|P2|Washout Period - 2 Weeks|Withdrawal by Subject|0
6071522|NCT00448435|20971430|P1|Washout Period - 2 Weeks|Withdrawal by Subject|1
6071523|NCT00448344|20971481|P2|Overall Study|Physician Decision|2
6071524|NCT00448344|20971482|P1|Overall Study|Physician Decision|1
6071525|NCT00448344|20971481|P2|Overall Study|Death|4
6071526|NCT00448344|20971482|P1|Overall Study|Death|3
6071527|NCT00448344|20971481|P2|Overall Study|Withdrawal by Subject|8
6071528|NCT00448344|20971482|P1|Overall Study|Withdrawal by Subject|6
6071529|NCT00448344|20971481|P2|Overall Study|Lost to Follow-up|22
6071530|NCT00448344|20971482|P1|Overall Study|Lost to Follow-up|20
6071531|NCT00448279|20971492|P2|Overall Study|Protocol Violation|1
6071532|NCT00448279|20971493|P1|Overall Study|Protocol Violation|0
6071533|NCT00448279|20971492|P2|Overall Study|Other|4
6071534|NCT00448279|20971493|P1|Overall Study|Other|6
6071535|NCT00448279|20971492|P2|Overall Study|Withdrawal by Subject|3
6071536|NCT00448279|20971493|P1|Overall Study|Withdrawal by Subject|4
6071537|NCT00448279|20971492|P2|Overall Study|Disease progression|18
6071538|NCT00448279|20971493|P1|Overall Study|Disease progression|16
6071539|NCT00448279|20971492|P2|Overall Study|Adverse Event|1
6071540|NCT00448279|20971493|P1|Overall Study|Adverse Event|1
6071541|NCT00448279|20971492|P2|Overall Study|Lost to Follow-up|2
6071542|NCT00448279|20971493|P1|Overall Study|Lost to Follow-up|2
6071543|NCT00448136|20971556|P2|Overall Study|Investigator's decision (progression)|0
6071544|NCT00448136|20971557|P1|Overall Study|Investigator's decision (progression)|1
6071545|NCT00448136|20971556|P2|Overall Study|Death|8
6071546|NCT00448136|20971557|P1|Overall Study|Death|3
6071547|NCT00448123|20971595|P2|Overall Study|Physician Decision|6
6071548|NCT00448123|20971596|P1|Overall Study|Physician Decision|6
6071549|NCT00448123|20971595|P2|Overall Study|Lost to Follow-up|6
6071550|NCT00448123|20971596|P1|Overall Study|Lost to Follow-up|9
6071551|NCT00448019|20971606|P1|Overall Study|Insurance Issues|1
6071552|NCT00448019|20971606|P1|Overall Study|Death|2
6071553|NCT00448019|20971606|P1|Overall Study|Disease progression|1
6071554|NCT00448019|20971606|P1|Overall Study|Withdrawal by Subject|3
6071555|NCT00447902|20971614|P2|Overall Study|Lack of Efficacy|1
6071556|NCT00447902|20971615|P1|Overall Study|Lack of Efficacy|2
6071557|NCT00447902|20971614|P2|Overall Study|included patients who discontinued|1
6071558|NCT00447902|20971615|P1|Overall Study|included patients who discontinued|1
6071559|NCT00447902|20971614|P2|Overall Study|Withdrawal by Subject|1
6071560|NCT00447902|20971615|P1|Overall Study|Withdrawal by Subject|0
6071561|NCT00447902|20971614|P2|Overall Study|Protocol Violation|0
6071562|NCT00447902|20971615|P1|Overall Study|Protocol Violation|1
6071563|NCT00447902|20971614|P2|Overall Study|Adverse Event|3
6071564|NCT00447902|20971615|P1|Overall Study|Adverse Event|0
6071565|NCT00447876|20971657|P2|Overall Study|Deterioration of symptomology|0
6071566|NCT00447876|20971658|P1|Overall Study|Deterioration of symptomology|1
6071567|NCT00447876|20971657|P2|Overall Study|Lost to Follow-up|0
6071568|NCT00447876|20971658|P1|Overall Study|Lost to Follow-up|1
6071569|NCT00447876|20971657|P2|Overall Study|Withdrawal by Subject|4
6071570|NCT00447876|20971658|P1|Overall Study|Withdrawal by Subject|1
6071571|NCT00447772|20971688|P1|Overall Study|Premature re-injection required|1
6071572|NCT00447772|20971688|P1|Overall Study|Chemotherapy for lung cancer|1
6071573|NCT00447772|20971688|P1|Overall Study|Incomplete documentation at visit 1|1
6071574|NCT00447772|20971688|P1|Overall Study|Patient relocated|1
6071575|NCT00447772|20971688|P1|Overall Study|Adverse Event|1
6071576|NCT00447772|20971688|P1|Overall Study|Unable to attend all study visits|2
6071577|NCT00447772|20971688|P1|Overall Study|Withdrawal by Subject|1
6071578|NCT00447772|20971688|P1|Overall Study|Lost to Follow-up|9
6071579|NCT00447772|20971688|P1|Overall Study|Discontinuation of drug therapy|1
6071580|NCT00447772|20971688|P1|Overall Study|Insufficient compliance|6
6071581|NCT00447772|20971688|P1|Overall Study|Lack of Efficacy|3
6071582|NCT00447603|20971708|P3|Filter Period|Study terminated by Sponsor|10
6071583|NCT00447603|20971709|P2|Filter Period|Study terminated by Sponsor|1
6071584|NCT00447603|20971710|P1|Filter Period|Study terminated by Sponsor|0
6071585|NCT00447603|20971708|P3|Filter Period|Screen Failure|4
6071586|NCT00447603|20971709|P2|Filter Period|Screen Failure|3
6071587|NCT00447603|20971710|P1|Filter Period|Screen Failure|0
6071588|NCT00447603|20971708|P3|Filter Period|Adverse Event|1
6071589|NCT00447603|20971709|P2|Filter Period|Adverse Event|0
6071590|NCT00447603|20971710|P1|Filter Period|Adverse Event|0
6071591|NCT00447603|20971708|P3|Screening|Study Terminated by Sponsor|0
6071592|NCT00447603|20971709|P2|Screening|Study Terminated by Sponsor|0
6071593|NCT00447603|20971710|P1|Screening|Study Terminated by Sponsor|15
6071594|NCT00447603|20971708|P3|Screening|Screen Failure|0
6071595|NCT00447603|20971709|P2|Screening|Screen Failure|0
6071596|NCT00447603|20971710|P1|Screening|Screen Failure|4
6071597|NCT00447603|20971708|P3|Screening|Protocol Violation|0
6071598|NCT00447603|20971709|P2|Screening|Protocol Violation|0
6071599|NCT00447603|20971710|P1|Screening|Protocol Violation|1
6071600|NCT00447603|20971708|P3|Screening|Withdrawal by Subject|0
6071601|NCT00447603|20971709|P2|Screening|Withdrawal by Subject|0
6071602|NCT00447603|20971710|P1|Screening|Withdrawal by Subject|1
6071603|NCT00447590|20971730|P1|Overall Study|Band Removed/Eroded/Other Follow-Up Loss|10
6071604|NCT00447590|20971730|P1|Overall Study|Lost to Follow-up|24
6071605|NCT00447590|20971730|P1|Overall Study|Withdrawal by Subject|26
6071606|NCT00447499|20971739|P1|Overall Study|Physician Decision|1
6071607|NCT00447499|20971739|P1|Overall Study|Sponsor Decision|1
6071608|NCT00447499|20971739|P1|Overall Study|Patient Decision|4
6071609|NCT00447499|20971739|P1|Overall Study|Adverse Event|1
6071610|NCT00447421|20971749|P1|Overall Study|Sponsor Decision|2
6071611|NCT00447421|20971749|P1|Overall Study|Adverse Event|3
6071612|NCT00447421|20971749|P1|Overall Study|Lack of Efficacy|1
6071613|NCT00447382|20971761|P2|Overall Study|Unclassified|5
6071614|NCT00447382|20971762|P1|Overall Study|Unclassified|2
6071615|NCT00447382|20971761|P2|Overall Study|Protocol Violation|0
6071616|NCT00447382|20971762|P1|Overall Study|Protocol Violation|2
6071617|NCT00447382|20971761|P2|Overall Study|Lack of Efficacy|0
6071618|NCT00447382|20971762|P1|Overall Study|Lack of Efficacy|1
6071619|NCT00447382|20971761|P2|Overall Study|Adverse Event|1
6071620|NCT00447382|20971762|P1|Overall Study|Adverse Event|1
6071621|NCT00447278|20971823|P2|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|8
6071622|NCT00447278|20971824|P1|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|11
6071623|NCT00447278|20971823|P2|Period III (Optional 6 Month Extension)|Lack of Efficacy|0
6071624|NCT00447278|20971824|P1|Period III (Optional 6 Month Extension)|Lack of Efficacy|4
6071625|NCT00447278|20971823|P2|Period III (Optional 6 Month Extension)|Physician Decision|1
6071626|NCT00447278|20971824|P1|Period III (Optional 6 Month Extension)|Physician Decision|1
6071627|NCT00447278|20971823|P2|Period III (Optional 6 Month Extension)|Withdrawal by Subject|1
6071628|NCT00447278|20971824|P1|Period III (Optional 6 Month Extension)|Withdrawal by Subject|4
6071629|NCT00447278|20971823|P2|Period III (Optional 6 Month Extension)|Protocol Violation|1
6071630|NCT00447278|20971824|P1|Period III (Optional 6 Month Extension)|Protocol Violation|6
6071631|NCT00447278|20971823|P2|Period III (Optional 6 Month Extension)|Lost to Follow-up|2
6071632|NCT00447278|20971824|P1|Period III (Optional 6 Month Extension)|Lost to Follow-up|2
6071633|NCT00447278|20971823|P2|Period III (Optional 6 Month Extension)|Adverse Event|2
6071634|NCT00447278|20971824|P1|Period III (Optional 6 Month Extension)|Adverse Event|2
6071635|NCT00447278|20971823|P2|Period II (6 Month Open-Label)|Parent/Guardian Decision|10
6071636|NCT00447278|20971824|P1|Period II (6 Month Open-Label)|Parent/Guardian Decision|9
6071637|NCT00447278|20971823|P2|Period II (6 Month Open-Label)|Lack of Efficacy|1
6071638|NCT00447278|20971824|P1|Period II (6 Month Open-Label)|Lack of Efficacy|11
6071639|NCT00447278|20971823|P2|Period II (6 Month Open-Label)|Physician Decision|1
6071640|NCT00447278|20971824|P1|Period II (6 Month Open-Label)|Physician Decision|4
6071641|NCT00447278|20971823|P2|Period II (6 Month Open-Label)|Withdrawal by Subject|3
6071642|NCT00447278|20971824|P1|Period II (6 Month Open-Label)|Withdrawal by Subject|1
6071643|NCT00447278|20971823|P2|Period II (6 Month Open-Label)|Protocol Violation|7
6071644|NCT00447278|20971824|P1|Period II (6 Month Open-Label)|Protocol Violation|10
6071645|NCT00447278|20971823|P2|Period II (6 Month Open-Label)|Lost to Follow-up|4
6071646|NCT00447278|20971824|P1|Period II (6 Month Open-Label)|Lost to Follow-up|0
6071647|NCT00447278|20971823|P2|Period II (6 Month Open-Label)|Adverse Event|3
6071648|NCT00447278|20971824|P1|Period II (6 Month Open-Label)|Adverse Event|7
6071649|NCT00447265|20971845|P2|Overall Study|Physician Decision|0
6071650|NCT00447265|20971846|P1|Overall Study|Physician Decision|1
6071651|NCT00447226|20971859|P2|Double-blind Phase|Disease Progression|3
6071652|NCT00447226|20971860|P1|Double-blind Phase|Disease Progression|4
6071653|NCT00447226|20971859|P2|12-Week Open-label Phase|Physician Decision|1
6071654|NCT00447226|20971860|P1|12-Week Open-label Phase|Physician Decision|0
6071655|NCT00447226|20971859|P2|12-Week Open-label Phase|Disease Progression|20
6071656|NCT00447226|20971860|P1|12-Week Open-label Phase|Disease Progression|0
6071657|NCT00447226|20971859|P2|12-Week Open-label Phase|Protocol Violation|1
6071658|NCT00447226|20971860|P1|12-Week Open-label Phase|Protocol Violation|0
6071659|NCT00447226|20971859|P2|12-Week Open-label Phase|Adverse Event|3
6071660|NCT00447226|20971860|P1|12-Week Open-label Phase|Adverse Event|0
6071661|NCT00447057|20971903|P4|Overall Study|Death, study drug related|0
6071662|NCT00447057|20971904|P3|Overall Study|Death, study drug related|0
6071663|NCT00447057|20971905|P2|Overall Study|Death, study drug related|1
6071664|NCT00447057|20971906|P1|Overall Study|Death, study drug related|0
6071665|NCT00447057|20971903|P4|Overall Study|Death due to adverse event|2
6071666|NCT00447057|20971904|P3|Overall Study|Death due to adverse event|1
6071667|NCT00447057|20971905|P2|Overall Study|Death due to adverse event|0
6071668|NCT00447057|20971906|P1|Overall Study|Death due to adverse event|0
6071669|NCT00447057|20971903|P4|Overall Study|Progressive disease|18
6071670|NCT00447057|20971904|P3|Overall Study|Progressive disease|13
6071671|NCT00447057|20971905|P2|Overall Study|Progressive disease|43
6071672|NCT00447057|20971906|P1|Overall Study|Progressive disease|58
6071673|NCT00447057|20971903|P4|Overall Study|Sponsor decision|0
6071674|NCT00447057|20971904|P3|Overall Study|Sponsor decision|0
6071675|NCT00447057|20971905|P2|Overall Study|Sponsor decision|1
6071676|NCT00447057|20971906|P1|Overall Study|Sponsor decision|1
6071677|NCT00447057|20971903|P4|Overall Study|Physician Decision|1
6071678|NCT00447057|20971904|P3|Overall Study|Physician Decision|3
6071679|NCT00447057|20971905|P2|Overall Study|Physician Decision|6
6071680|NCT00447057|20971906|P1|Overall Study|Physician Decision|9
6071681|NCT00447057|20971903|P4|Overall Study|Withdrawal by Subject|1
6071682|NCT00447057|20971904|P3|Overall Study|Withdrawal by Subject|1
6071683|NCT00447057|20971905|P2|Overall Study|Withdrawal by Subject|5
6071684|NCT00447057|20971906|P1|Overall Study|Withdrawal by Subject|4
6071685|NCT00447057|20971903|P4|Overall Study|Protocol Violation|0
6071686|NCT00447057|20971904|P3|Overall Study|Protocol Violation|0
6071687|NCT00447057|20971905|P2|Overall Study|Protocol Violation|1
6071688|NCT00447057|20971906|P1|Overall Study|Protocol Violation|0
6071689|NCT00447057|20971903|P4|Overall Study|Entry criteria not met|0
6071690|NCT00447057|20971904|P3|Overall Study|Entry criteria not met|0
6071691|NCT00447057|20971905|P2|Overall Study|Entry criteria not met|1
6071692|NCT00447057|20971906|P1|Overall Study|Entry criteria not met|1
6071693|NCT00447057|20971903|P4|Overall Study|Lost to Follow-up|0
6071694|NCT00447057|20971904|P3|Overall Study|Lost to Follow-up|0
6071695|NCT00447057|20971905|P2|Overall Study|Lost to Follow-up|1
6071696|NCT00447057|20971906|P1|Overall Study|Lost to Follow-up|0
6071697|NCT00447057|20971903|P4|Overall Study|Death due to study disease|1
6071698|NCT00447057|20971904|P3|Overall Study|Death due to study disease|1
6071699|NCT00447057|20971905|P2|Overall Study|Death due to study disease|4
6071700|NCT00447057|20971906|P1|Overall Study|Death due to study disease|6
6071701|NCT00447057|20971903|P4|Overall Study|Adverse Event|3
6071702|NCT00447057|20971904|P3|Overall Study|Adverse Event|0
6071703|NCT00447057|20971905|P2|Overall Study|Adverse Event|10
6071704|NCT00447057|20971906|P1|Overall Study|Adverse Event|4
6071705|NCT00447005|20971924|P1|Overall Study|Lack of Efficacy|11
6071706|NCT00447005|20971924|P1|Overall Study|Adverse Event|1
6071707|NCT00446992|20971938|P1|Overall Study|Lost to Follow-up|5
6071708|NCT00446992|20971938|P1|Overall Study|Adverse Event|11
6071709|NCT00446966|20971952|P2|Overall Study|Lost to Follow-up|7
6071710|NCT00446966|20971953|P1|Overall Study|Lost to Follow-up|10
6071711|NCT00446849|20971959|P1|Maintenance Phase|concomitant medication use|1
6071712|NCT00446849|20971959|P1|Maintenance Phase|hydrocodone use|1
6071713|NCT00446849|20971959|P1|Maintenance Phase|study closure|1
6071714|NCT00446849|20971959|P1|Maintenance Phase|antibiotic use|1
6071715|NCT00446849|20971959|P1|Maintenance Phase|prohibited medication use|2
6071716|NCT00446849|20971959|P1|Maintenance Phase|noncompliance|2
6071717|NCT00446849|20971959|P1|Maintenance Phase|Pregnancy|1
6071718|NCT00446849|20971959|P1|Maintenance Phase|Lost to Follow-up|3
6071719|NCT00446849|20971959|P1|Maintenance Phase|Consent withdrawn|5
6071720|NCT00446849|20971959|P1|Maintenance Phase|Adverse Event|6
6071721|NCT00446849|20971959|P1|Maintenance Phase|Protocol Violation|7
6071722|NCT00446849|20971959|P1|Maintenance Phase|Lack of Efficacy|40
6071723|NCT00446849|20971959|P1|Acute Phase|noncompliance|1
6071724|NCT00446849|20971959|P1|Acute Phase|Physician Decision|1
6071725|NCT00446849|20971959|P1|Acute Phase|Lost to Follow-up|2
6071726|NCT00446849|20971959|P1|Acute Phase|Consent withdrawn|4
6071727|NCT00446849|20971959|P1|Acute Phase|Protocol Violation|10
6071728|NCT00446849|20971959|P1|Acute Phase|Lack of Efficacy|64
6071741|NCT00446654|20972018|P2|Overall Study|Adverse Event|0
6071742|NCT00446654|20972019|P1|Overall Study|Adverse Event|1
6071743|NCT00446654|20972018|P2|Overall Study|Withdrawal by Subject|0
6071744|NCT00446654|20972019|P1|Overall Study|Withdrawal by Subject|1
6071745|NCT00446641|20972027|P2|Overall Study|Lost to Follow-up|1
6071746|NCT00446641|20972028|P1|Overall Study|Lost to Follow-up|1
6071747|NCT00446641|20972027|P2|Overall Study|poor compliance|6
6071748|NCT00446641|20972028|P1|Overall Study|poor compliance|8
6071749|NCT00446641|20972027|P2|Overall Study|Withdrawal by Subject|3
6071750|NCT00446641|20972028|P1|Overall Study|Withdrawal by Subject|8
6071751|NCT00446563|20972048|P2|Overall Study|Administrative problems|1
6071752|NCT00446563|20972049|P1|Overall Study|Administrative problems|0
6071753|NCT00446563|20972048|P2|Overall Study|Withdrawal by Subject|1
6071754|NCT00446563|20972049|P1|Overall Study|Withdrawal by Subject|2
6071755|NCT00446563|20972048|P2|Overall Study|Unsatisfactory therapeutic effect|3
6071756|NCT00446563|20972049|P1|Overall Study|Unsatisfactory therapeutic effect|0
6071757|NCT00446563|20972048|P2|Overall Study|Abnormal test procedure result(s)|0
6071758|NCT00446563|20972049|P1|Overall Study|Abnormal test procedure result(s)|1
6071759|NCT00446563|20972048|P2|Overall Study|Abnormal laboratory value(s)|1
6071760|NCT00446563|20972049|P1|Overall Study|Abnormal laboratory value(s)|0
6071761|NCT00446563|20972048|P2|Overall Study|Adverse Event|3
6071762|NCT00446563|20972049|P1|Overall Study|Adverse Event|4
6071763|NCT00446550|20972085|P2|Overall Study|Adverse Event|0
6071764|NCT00446550|20972086|P1|Overall Study|Adverse Event|1
6071765|NCT00446511|20972098|P4|Overall Study|Administrative Problems|1
6071766|NCT00446511|20972099|P3|Overall Study|Administrative Problems|4
6071767|NCT00446511|20972100|P2|Overall Study|Administrative Problems|0
6071768|NCT00446511|20972101|P1|Overall Study|Administrative Problems|3
6071769|NCT00446511|20972098|P4|Overall Study|Withdrawal by Subject|3
6071770|NCT00446511|20972099|P3|Overall Study|Withdrawal by Subject|0
6071771|NCT00446511|20972100|P2|Overall Study|Withdrawal by Subject|0
6071772|NCT00446511|20972101|P1|Overall Study|Withdrawal by Subject|0
6071773|NCT00446511|20972098|P4|Overall Study|Protocol Violation|1
6071774|NCT00446511|20972099|P3|Overall Study|Protocol Violation|0
6071775|NCT00446511|20972100|P2|Overall Study|Protocol Violation|0
6071776|NCT00446511|20972101|P1|Overall Study|Protocol Violation|0
6071777|NCT00446511|20972098|P4|Overall Study|Adverse Event|1
6071778|NCT00446511|20972099|P3|Overall Study|Adverse Event|3
6071779|NCT00446511|20972100|P2|Overall Study|Adverse Event|2
6071780|NCT00446511|20972101|P1|Overall Study|Adverse Event|7
6071781|NCT00446459|20972125|P1|12 Months|14 subjects to MMF + Rituximab Study|14
6071782|NCT00446459|20972125|P1|12 Months|Protocol Violation|4
6071783|NCT00446459|20972125|P1|8 Months|Protocol Violation|12
6071784|NCT00446446|20972133|P1|Overall Study|On Treatment at Time of Data Cut-off|1
6071785|NCT00446446|20972133|P1|Overall Study|Adverse Event|1
6071786|NCT00446446|20972133|P1|Overall Study|Disease Progession|2
6071787|NCT00446446|20972133|P1|Overall Study|Other|4
6071788|NCT00446446|20972133|P1|Overall Study|Withdrawal by Subject|6
6071789|NCT00446446|20972133|P1|Overall Study|Death|10
6071790|NCT00446251|20972157|P1|Overall Study|Lost to Follow-up|1
6071791|NCT00446251|20972157|P1|Overall Study|Rituximab Infusion Reaction|2
6071792|NCT00446251|20972157|P1|Overall Study|On-study Transplants|2
6071793|NCT00446199|20972167|P4|Overall Study|Move|0
6071794|NCT00446199|20972168|P3|Overall Study|Move|0
6071795|NCT00446199|20972169|P2|Overall Study|Move|1
6071796|NCT00446199|20972170|P1|Overall Study|Move|0
6071797|NCT00446199|20972167|P4|Overall Study|In-/Exclusion criterion violated|1
6071798|NCT00446199|20972168|P3|Overall Study|In-/Exclusion criterion violated|2
6071799|NCT00446199|20972169|P2|Overall Study|In-/Exclusion criterion violated|1
6071800|NCT00446199|20972170|P1|Overall Study|In-/Exclusion criterion violated|2
6071801|NCT00446199|20972167|P4|Overall Study|Lost interest in study participation|0
6071802|NCT00446199|20972168|P3|Overall Study|Lost interest in study participation|0
6071803|NCT00446199|20972169|P2|Overall Study|Lost interest in study participation|1
6071804|NCT00446199|20972170|P1|Overall Study|Lost interest in study participation|0
6071805|NCT00446199|20972167|P4|Overall Study|Hormone fear|1
6071806|NCT00446199|20972168|P3|Overall Study|Hormone fear|0
6071807|NCT00446199|20972169|P2|Overall Study|Hormone fear|0
6071808|NCT00446199|20972170|P1|Overall Study|Hormone fear|0
6071809|NCT00446199|20972167|P4|Overall Study|Non-compliant with visit schedule|2
6071810|NCT00446199|20972168|P3|Overall Study|Non-compliant with visit schedule|1
6071811|NCT00446199|20972169|P2|Overall Study|Non-compliant with visit schedule|1
6071812|NCT00446199|20972170|P1|Overall Study|Non-compliant with visit schedule|1
6071813|NCT00446199|20972167|P4|Overall Study|Non-compliant with study drug|0
6071814|NCT00446199|20972168|P3|Overall Study|Non-compliant with study drug|5
6071815|NCT00446199|20972169|P2|Overall Study|Non-compliant with study drug|0
6071816|NCT00446199|20972170|P1|Overall Study|Non-compliant with study drug|1
6071817|NCT00446199|20972167|P4|Overall Study|Lack of Efficacy|1
6071818|NCT00446199|20972168|P3|Overall Study|Lack of Efficacy|0
6071819|NCT00446199|20972169|P2|Overall Study|Lack of Efficacy|0
6071820|NCT00446199|20972170|P1|Overall Study|Lack of Efficacy|1
6071821|NCT00446199|20972167|P4|Overall Study|Randomization in Error|1
6071822|NCT00446199|20972168|P3|Overall Study|Randomization in Error|1
6071823|NCT00446199|20972169|P2|Overall Study|Randomization in Error|0
6071824|NCT00446199|20972170|P1|Overall Study|Randomization in Error|2
6071825|NCT00446199|20972167|P4|Overall Study|Site termination|1
6071826|NCT00446199|20972168|P3|Overall Study|Site termination|0
6071827|NCT00446199|20972169|P2|Overall Study|Site termination|0
6071828|NCT00446199|20972170|P1|Overall Study|Site termination|2
6071829|NCT00446199|20972167|P4|Overall Study|Withdrawal by Subject|10
6071830|NCT00446199|20972168|P3|Overall Study|Withdrawal by Subject|9
6071831|NCT00446199|20972169|P2|Overall Study|Withdrawal by Subject|5
6071832|NCT00446199|20972170|P1|Overall Study|Withdrawal by Subject|2
6071833|NCT00446199|20972167|P4|Overall Study|Protocol Violation|3
6071834|NCT00446199|20972168|P3|Overall Study|Protocol Violation|1
6071835|NCT00446199|20972169|P2|Overall Study|Protocol Violation|2
6071836|NCT00446199|20972170|P1|Overall Study|Protocol Violation|1
6071837|NCT00446199|20972167|P4|Overall Study|Lost to Follow-up|6
6071838|NCT00446199|20972168|P3|Overall Study|Lost to Follow-up|2
6071839|NCT00446199|20972169|P2|Overall Study|Lost to Follow-up|5
6071840|NCT00446199|20972170|P1|Overall Study|Lost to Follow-up|4
6071841|NCT00446199|20972167|P4|Overall Study|Adverse Event|4
6071842|NCT00446199|20972168|P3|Overall Study|Adverse Event|6
6071843|NCT00446199|20972169|P2|Overall Study|Adverse Event|4
6071844|NCT00446199|20972170|P1|Overall Study|Adverse Event|7
6071845|NCT00446134|20972263|P4|Overall Study|Reason Not Completed|2
6071846|NCT00446134|20972264|P3|Overall Study|Reason Not Completed|1
6071847|NCT00446134|20972265|P2|Overall Study|Reason Not Completed|0
6071848|NCT00446134|20972266|P1|Overall Study|Reason Not Completed|3
6071849|NCT00446134|20972263|P4|Overall Study|Adverse Event-Diarrhea|0
6071850|NCT00446134|20972264|P3|Overall Study|Adverse Event-Diarrhea|2
6071851|NCT00446134|20972265|P2|Overall Study|Adverse Event-Diarrhea|1
6071852|NCT00446134|20972266|P1|Overall Study|Adverse Event-Diarrhea|1
6071853|NCT00446134|20972263|P4|Overall Study|Physician Decision|2
6071854|NCT00446134|20972264|P3|Overall Study|Physician Decision|0
6071855|NCT00446134|20972265|P2|Overall Study|Physician Decision|0
6071856|NCT00446134|20972266|P1|Overall Study|Physician Decision|0
6071857|NCT00446134|20972263|P4|Overall Study|Withdrawal by Subject|3
6071858|NCT00446134|20972264|P3|Overall Study|Withdrawal by Subject|1
6071859|NCT00446134|20972265|P2|Overall Study|Withdrawal by Subject|3
6071860|NCT00446134|20972266|P1|Overall Study|Withdrawal by Subject|3
6071861|NCT00446134|20972263|P4|Overall Study|Lost to Follow-up|1
6071862|NCT00446134|20972264|P3|Overall Study|Lost to Follow-up|1
6071863|NCT00446134|20972265|P2|Overall Study|Lost to Follow-up|3
6071864|NCT00446134|20972266|P1|Overall Study|Lost to Follow-up|1
6071865|NCT00446134|20972263|P4|Overall Study|Protocol Violation|0
6071866|NCT00446134|20972264|P3|Overall Study|Protocol Violation|1
6071867|NCT00446134|20972265|P2|Overall Study|Protocol Violation|2
6071868|NCT00446134|20972266|P1|Overall Study|Protocol Violation|0
6071869|NCT00446134|20972263|P4|Overall Study|Lack of Efficacy|19
6071870|NCT00446134|20972264|P3|Overall Study|Lack of Efficacy|24
6071871|NCT00446134|20972265|P2|Overall Study|Lack of Efficacy|19
6071872|NCT00446134|20972266|P1|Overall Study|Lack of Efficacy|19
6071873|NCT00446134|20972263|P4|Overall Study|Adverse Event|18
6071874|NCT00446134|20972264|P3|Overall Study|Adverse Event|13
6071875|NCT00446134|20972265|P2|Overall Study|Adverse Event|17
6071876|NCT00446134|20972266|P1|Overall Study|Adverse Event|7
6071877|NCT00446095|20972293|P5|Phase I (28 Days)|Lack of Efficacy|3
6071878|NCT00446095|20972294|P4|Phase I (28 Days)|Lack of Efficacy|0
6071879|NCT00446095|20972295|P3|Phase I (28 Days)|Lack of Efficacy|0
6071880|NCT00446095|20972296|P2|Phase I (28 Days)|Lack of Efficacy|0
6071881|NCT00446095|20972297|P1|Phase I (28 Days)|Lack of Efficacy|0
6071882|NCT00446095|20972293|P5|Phase I (28 Days)|Adverse Event|0
6071883|NCT00446095|20972294|P4|Phase I (28 Days)|Adverse Event|1
6071884|NCT00446095|20972295|P3|Phase I (28 Days)|Adverse Event|0
6071885|NCT00446095|20972296|P2|Phase I (28 Days)|Adverse Event|0
6071886|NCT00446095|20972297|P1|Phase I (28 Days)|Adverse Event|0
6071887|NCT00446095|20972293|P5|Phase II (8 Weeks)|Ongoing|0
6071888|NCT00446095|20972294|P4|Phase II (8 Weeks)|Ongoing|0
6071889|NCT00446095|20972295|P3|Phase II (8 Weeks)|Ongoing|1
6071890|NCT00446095|20972296|P2|Phase II (8 Weeks)|Ongoing|0
6071891|NCT00446095|20972297|P1|Phase II (8 Weeks)|Ongoing|0
6071892|NCT00446095|20972293|P5|Phase II (8 Weeks)|Lack of Efficacy|0
6071893|NCT00446095|20972294|P4|Phase II (8 Weeks)|Lack of Efficacy|0
6071894|NCT00446095|20972295|P3|Phase II (8 Weeks)|Lack of Efficacy|1
6071895|NCT00446095|20972296|P2|Phase II (8 Weeks)|Lack of Efficacy|2
6071896|NCT00446095|20972297|P1|Phase II (8 Weeks)|Lack of Efficacy|9
6071897|NCT00446095|20972293|P5|Phase II (8 Weeks)|Physician Decision|0
6071898|NCT00446095|20972294|P4|Phase II (8 Weeks)|Physician Decision|0
6071899|NCT00446095|20972295|P3|Phase II (8 Weeks)|Physician Decision|0
6071900|NCT00446095|20972296|P2|Phase II (8 Weeks)|Physician Decision|0
6071901|NCT00446095|20972297|P1|Phase II (8 Weeks)|Physician Decision|1
6071902|NCT00446095|20972293|P5|Phase II (8 Weeks)|Withdrawal by Subject|0
6071903|NCT00446095|20972294|P4|Phase II (8 Weeks)|Withdrawal by Subject|0
6071904|NCT00446095|20972295|P3|Phase II (8 Weeks)|Withdrawal by Subject|0
6071905|NCT00446095|20972296|P2|Phase II (8 Weeks)|Withdrawal by Subject|0
6071906|NCT00446095|20972297|P1|Phase II (8 Weeks)|Withdrawal by Subject|1
6071907|NCT00446095|20972293|P5|Phase II (8 Weeks)|Adverse Event|0
6071908|NCT00446095|20972294|P4|Phase II (8 Weeks)|Adverse Event|0
6071909|NCT00446095|20972295|P3|Phase II (8 Weeks)|Adverse Event|1
6071910|NCT00446095|20972296|P2|Phase II (8 Weeks)|Adverse Event|1
6071911|NCT00446095|20972297|P1|Phase II (8 Weeks)|Adverse Event|0
6071912|NCT00446095|20972293|P5|Phase II (8 Weeks)|Lost to Follow-up|0
6071913|NCT00446095|20972294|P4|Phase II (8 Weeks)|Lost to Follow-up|0
6071914|NCT00446095|20972295|P3|Phase II (8 Weeks)|Lost to Follow-up|0
6071915|NCT00446095|20972296|P2|Phase II (8 Weeks)|Lost to Follow-up|0
6071916|NCT00446095|20972297|P1|Phase II (8 Weeks)|Lost to Follow-up|1
6071917|NCT00446030|20972320|P2|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|1
6071918|NCT00446030|20972321|P1|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|0
6071919|NCT00446030|20972320|P2|FOLLOW-UP (up to 2-years)|Right axilla wound|0
6071920|NCT00446030|20972321|P1|FOLLOW-UP (up to 2-years)|Right axilla wound|1
6071921|NCT00446030|20972320|P2|FOLLOW-UP (up to 2-years)|Patient concern|0
6071922|NCT00446030|20972321|P1|FOLLOW-UP (up to 2-years)|Patient concern|1
6071923|NCT00446030|20972320|P2|FOLLOW-UP (up to 2-years)|Protocol Violation|0
6071924|NCT00446030|20972321|P1|FOLLOW-UP (up to 2-years)|Protocol Violation|1
6071925|NCT00446030|20972320|P2|FOLLOW-UP (up to 2-years)|Per physician discretion|0
6071926|NCT00446030|20972321|P1|FOLLOW-UP (up to 2-years)|Per physician discretion|2
6071927|NCT00446030|20972320|P2|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|0
6071928|NCT00446030|20972321|P1|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|2
6071929|NCT00446030|20972320|P2|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|2
6071930|NCT00446030|20972321|P1|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|3
6071931|NCT00446030|20972320|P2|FOLLOW-UP (up to 2-years)|Death|2
6071932|NCT00446030|20972321|P1|FOLLOW-UP (up to 2-years)|Death|2
6071933|NCT00446030|20972320|P2|FOLLOW-UP (up to 2-years)|Lost to Follow-up|0
6071934|NCT00446030|20972321|P1|FOLLOW-UP (up to 2-years)|Lost to Follow-up|4
6071935|NCT00446030|20972320|P2|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|0
6071936|NCT00446030|20972321|P1|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|5
6071937|NCT00446030|20972320|P2|FOLLOW-UP (up to 2-years)|Subject's request|4
6071938|NCT00446030|20972321|P1|FOLLOW-UP (up to 2-years)|Subject's request|9
6071939|NCT00446030|20972320|P2|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|0
6071940|NCT00446030|20972321|P1|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|1
6071941|NCT00446030|20972320|P2|TREATMENT (up to 52 Weeks)|Patient concern|0
6071942|NCT00446030|20972321|P1|TREATMENT (up to 52 Weeks)|Patient concern|1
6071943|NCT00446030|20972320|P2|TREATMENT (up to 52 Weeks)|Physician Decision|0
6071944|NCT00446030|20972321|P1|TREATMENT (up to 52 Weeks)|Physician Decision|1
6071945|NCT00446030|20972320|P2|TREATMENT (up to 52 Weeks)|Protocol Violation|0
6071946|NCT00446030|20972321|P1|TREATMENT (up to 52 Weeks)|Protocol Violation|1
6071947|NCT00446030|20972320|P2|TREATMENT (up to 52 Weeks)|Suspicious meningioma|0
6071948|NCT00446030|20972321|P1|TREATMENT (up to 52 Weeks)|Suspicious meningioma|1
6071949|NCT00446030|20972320|P2|TREATMENT (up to 52 Weeks)|Poor compliance|0
6071950|NCT00446030|20972321|P1|TREATMENT (up to 52 Weeks)|Poor compliance|1
6071951|NCT00446030|20972320|P2|TREATMENT (up to 52 Weeks)|Subject Request|1
6071952|NCT00446030|20972321|P1|TREATMENT (up to 52 Weeks)|Subject Request|9
6071953|NCT00446030|20972320|P2|TREATMENT (up to 52 Weeks)|Adverse Event|8
6071954|NCT00446030|20972321|P1|TREATMENT (up to 52 Weeks)|Adverse Event|29
6071955|NCT00445939|20972332|P4|Period B - Week 4 - Week 8|Adverse Event|1
6071956|NCT00445939|20972333|P3|Period B - Week 4 - Week 8|Adverse Event|0
6071957|NCT00445939|20972334|P2|Period B - Week 4 - Week 8|Adverse Event|0
6071958|NCT00445939|20972335|P1|Period B - Week 4 - Week 8|Adverse Event|2
6071959|NCT00445939|20972332|P4|Period A - Week 0 - Week 4|Adverse Event|0
6071960|NCT00445939|20972333|P3|Period A - Week 0 - Week 4|Adverse Event|0
6071961|NCT00445939|20972334|P2|Period A - Week 0 - Week 4|Adverse Event|2
6071962|NCT00445939|20972335|P1|Period A - Week 0 - Week 4|Adverse Event|1
6071963|NCT00445848|20972383|P1|Overall Study|Other-Not protocol specified|5
6071964|NCT00445848|20972383|P1|Overall Study|Progression|62
6071965|NCT00445848|20972383|P1|Overall Study|Withdrawal by Subject|4
6071966|NCT00445848|20972383|P1|Overall Study|Adverse Event|14
6071967|NCT00445770|20972393|P3|Overall Study|Other|6
6071968|NCT00445770|20972394|P2|Overall Study|Other|5
6071969|NCT00445770|20972395|P1|Overall Study|Other|6
6071970|NCT00445770|20972393|P3|Overall Study|Lost to Follow-up|0
6071971|NCT00445770|20972394|P2|Overall Study|Lost to Follow-up|2
6071972|NCT00445770|20972395|P1|Overall Study|Lost to Follow-up|0
6071973|NCT00445770|20972393|P3|Overall Study|Lack of Efficacy|6
6071974|NCT00445770|20972394|P2|Overall Study|Lack of Efficacy|13
6071975|NCT00445770|20972395|P1|Overall Study|Lack of Efficacy|38
6071976|NCT00445770|20972393|P3|Overall Study|Adverse Event|19
6071977|NCT00445770|20972394|P2|Overall Study|Adverse Event|15
6071978|NCT00445770|20972395|P1|Overall Study|Adverse Event|9
6071979|NCT00445692|20972496|P1|Overall Study|Lack of Efficacy|5
6071980|NCT00445692|20972496|P1|Overall Study|Adverse Event|11
6071981|NCT00445679|20972506|P4|Overall Study|Lack of Efficacy|0
6071982|NCT00445679|20972507|P3|Overall Study|Lack of Efficacy|2
6071983|NCT00445679|20972508|P2|Overall Study|Lack of Efficacy|6
6071984|NCT00445679|20972509|P1|Overall Study|Lack of Efficacy|2
6071985|NCT00445679|20972506|P4|Overall Study|Withdrawal by Subject|18
6071986|NCT00445679|20972507|P3|Overall Study|Withdrawal by Subject|20
6071987|NCT00445679|20972508|P2|Overall Study|Withdrawal by Subject|14
6071988|NCT00445679|20972509|P1|Overall Study|Withdrawal by Subject|8
6071989|NCT00445679|20972506|P4|Overall Study|Protocol Violation|1
6071990|NCT00445679|20972507|P3|Overall Study|Protocol Violation|3
6071991|NCT00445679|20972508|P2|Overall Study|Protocol Violation|3
6071992|NCT00445679|20972509|P1|Overall Study|Protocol Violation|2
6071993|NCT00445679|20972506|P4|Overall Study|Withdrawal of Informed Consent|0
6071994|NCT00445679|20972507|P3|Overall Study|Withdrawal of Informed Consent|1
6071995|NCT00445679|20972508|P2|Overall Study|Withdrawal of Informed Consent|0
6071996|NCT00445679|20972509|P1|Overall Study|Withdrawal of Informed Consent|0
6071997|NCT00445679|20972506|P4|Overall Study|Compliance|2
6071998|NCT00445679|20972507|P3|Overall Study|Compliance|1
6071999|NCT00445679|20972508|P2|Overall Study|Compliance|2
6072000|NCT00445679|20972509|P1|Overall Study|Compliance|3
6072001|NCT00445679|20972506|P4|Overall Study|Lost to Follow-up|5
6072002|NCT00445679|20972507|P3|Overall Study|Lost to Follow-up|6
6072003|NCT00445679|20972508|P2|Overall Study|Lost to Follow-up|6
6072004|NCT00445679|20972509|P1|Overall Study|Lost to Follow-up|10
6072005|NCT00445679|20972506|P4|Overall Study|Physician Decision|0
6072006|NCT00445679|20972507|P3|Overall Study|Physician Decision|1
6072007|NCT00445679|20972508|P2|Overall Study|Physician Decision|0
6072008|NCT00445679|20972509|P1|Overall Study|Physician Decision|0
6072009|NCT00445679|20972506|P4|Overall Study|Failed to return|2
6072010|NCT00445679|20972507|P3|Overall Study|Failed to return|2
6072011|NCT00445679|20972508|P2|Overall Study|Failed to return|3
6072012|NCT00445679|20972509|P1|Overall Study|Failed to return|1
6072013|NCT00445679|20972506|P4|Overall Study|Adverse Event|19
6072014|NCT00445679|20972507|P3|Overall Study|Adverse Event|30
6072015|NCT00445679|20972508|P2|Overall Study|Adverse Event|12
6072016|NCT00445679|20972509|P1|Overall Study|Adverse Event|22
6072017|NCT00445601|20972545|P2|Overall Study|Death prior to TURBT|1
6072018|NCT00445601|20972546|P1|Overall Study|Death prior to TURBT|0
6072019|NCT00445601|20972545|P2|Overall Study|Adverse Event|0
6072020|NCT00445601|20972546|P1|Overall Study|Adverse Event|2
6072021|NCT00445601|20972545|P2|Overall Study|Drug Delivery Issue|2
6072022|NCT00445601|20972546|P1|Overall Study|Drug Delivery Issue|2
6072023|NCT00445601|20972545|P2|Overall Study|Incorrect Disease Status|6
6072024|NCT00445601|20972546|P1|Overall Study|Incorrect Disease Status|6
6072025|NCT00445601|20972545|P2|Overall Study|TURBT Complication|8
6072026|NCT00445601|20972546|P1|Overall Study|TURBT Complication|12
6072027|NCT00445601|20972545|P2|Overall Study|Withdrawal by Subject|11
6072028|NCT00445601|20972546|P1|Overall Study|Withdrawal by Subject|11
6072029|NCT00445549|20972563|P1|Overall Study|progressive disease|12
6072030|NCT00445458|20972587|P4|Overall Study|Surgery|0
6072031|NCT00445458|20972588|P3|Overall Study|Surgery|1
6072032|NCT00445458|20972589|P2|Overall Study|Surgery|0
6072033|NCT00445458|20972590|P1|Overall Study|Surgery|0
6072034|NCT00445458|20972587|P4|Overall Study|Physician Decision|1
6072035|NCT00445458|20972588|P3|Overall Study|Physician Decision|1
6072036|NCT00445458|20972589|P2|Overall Study|Physician Decision|0
6072037|NCT00445458|20972590|P1|Overall Study|Physician Decision|0
6072038|NCT00445458|20972587|P4|Overall Study|Death|0
6072039|NCT00445458|20972588|P3|Overall Study|Death|2
6072040|NCT00445458|20972589|P2|Overall Study|Death|1
6072041|NCT00445458|20972590|P1|Overall Study|Death|0
6072042|NCT00445458|20972587|P4|Overall Study|Adverse Event|0
6072043|NCT00445458|20972588|P3|Overall Study|Adverse Event|3
6072044|NCT00445458|20972589|P2|Overall Study|Adverse Event|0
6072045|NCT00445458|20972590|P1|Overall Study|Adverse Event|0
6072046|NCT00445458|20972587|P4|Overall Study|Withdrawal by Subject|0
6072047|NCT00445458|20972588|P3|Overall Study|Withdrawal by Subject|7
6072048|NCT00445458|20972589|P2|Overall Study|Withdrawal by Subject|0
6072049|NCT00445458|20972590|P1|Overall Study|Withdrawal by Subject|0
6072050|NCT00445458|20972587|P4|Overall Study|Disease Progression|27
6072051|NCT00445458|20972588|P3|Overall Study|Disease Progression|54
6072052|NCT00445458|20972589|P2|Overall Study|Disease Progression|4
6072053|NCT00445458|20972590|P1|Overall Study|Disease Progression|3
6072054|NCT00445432|20972608|P4|148 Weeks of Adalimumab Treatment|Other|9
6072055|NCT00445432|20972609|P3|148 Weeks of Adalimumab Treatment|Other|0
6072056|NCT00445432|20972610|P2|148 Weeks of Adalimumab Treatment|Other|0
6072057|NCT00445432|20972611|P1|148 Weeks of Adalimumab Treatment|Other|0
6072058|NCT00445432|20972608|P4|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|3
6072059|NCT00445432|20972609|P3|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0
6072060|NCT00445432|20972610|P2|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0
6072061|NCT00445432|20972611|P1|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0
6072062|NCT00445432|20972608|P4|148 Weeks of Adalimumab Treatment|Adverse Event|32
6072063|NCT00445432|20972609|P3|148 Weeks of Adalimumab Treatment|Adverse Event|0
6072064|NCT00445432|20972610|P2|148 Weeks of Adalimumab Treatment|Adverse Event|0
6072065|NCT00445432|20972611|P1|148 Weeks of Adalimumab Treatment|Adverse Event|0
6072066|NCT00445432|20972608|P4|Through Week 52 of NCT00445432 (M06-837)|Other|0
6072067|NCT00445432|20972609|P3|Through Week 52 of NCT00445432 (M06-837)|Other|2
6072068|NCT00445432|20972610|P2|Through Week 52 of NCT00445432 (M06-837)|Other|1
6072069|NCT00445432|20972611|P1|Through Week 52 of NCT00445432 (M06-837)|Other|0
6072070|NCT00445432|20972608|P4|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0
6072071|NCT00445432|20972609|P3|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0
6072072|NCT00445432|20972610|P2|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|20
6072073|NCT00445432|20972611|P1|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|14
6072074|NCT00445432|20972608|P4|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0
6072075|NCT00445432|20972609|P3|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|2
6072076|NCT00445432|20972610|P2|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0
6072077|NCT00445432|20972611|P1|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0
6072078|NCT00445432|20972608|P4|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|0
6072079|NCT00445432|20972609|P3|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|7
6072080|NCT00445432|20972610|P2|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|2
6072081|NCT00445432|20972611|P1|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|1
6072082|NCT00445341|20972644|P1|Overall Study|taken off treatment too early|1
6072083|NCT00445341|20972644|P1|Overall Study|refused further treatment|1
6072084|NCT00445328|20972651|P2|Overall Study|Protocol Violation|0
6072085|NCT00445328|20972652|P1|Overall Study|Protocol Violation|1
6072086|NCT00445328|20972651|P2|Overall Study|Withdrawal by Subject|0
6072087|NCT00445328|20972652|P1|Overall Study|Withdrawal by Subject|2
6072088|NCT00445328|20972651|P2|Overall Study|Other|2
6072089|NCT00445328|20972652|P1|Overall Study|Other|0
6072090|NCT00445328|20972651|P2|Overall Study|Adverse Event|3
6072091|NCT00445328|20972652|P1|Overall Study|Adverse Event|0
6072092|NCT00445328|20972651|P2|Overall Study|Death|1
6072093|NCT00445328|20972652|P1|Overall Study|Death|0
6072094|NCT00445224|20972813|P2|Specific Exercises|Withdrawal by Subject|0
6072095|NCT00445224|20972814|P1|Specific Exercises|Withdrawal by Subject|1
6072096|NCT00445224|20972813|P2|Specific Exercises|Withdrawal by Subject|3
6072097|NCT00445224|20972814|P1|Specific Exercises|Withdrawal by Subject|3
6072098|NCT00445146|20972841|P1|Overall Study|Pregnancy|1
6072099|NCT00445146|20972841|P1|Overall Study|Protocol Violation|4
6072100|NCT00445146|20972841|P1|Overall Study|Death|9
6072101|NCT00445146|20972841|P1|Overall Study|Lost to Follow-up|13
6072102|NCT00445146|20972841|P1|Overall Study|Adverse Event|13
6072103|NCT00445146|20972841|P1|Overall Study|Investigator's Discretion|22
6072104|NCT00445146|20972841|P1|Overall Study|Lack of Efficacy|28
6072105|NCT00445146|20972841|P1|Overall Study|Withdrew Consent|29
6072106|NCT00445003|20972863|P3|Overall Study|Dropped|2
6072107|NCT00445003|20972864|P2|Overall Study|Dropped|3
6072108|NCT00445003|20972865|P1|Overall Study|Dropped|1
6072109|NCT00445003|20972863|P3|Overall Study|Missed Visit|1
6072110|NCT00445003|20972864|P2|Overall Study|Missed Visit|5
6072111|NCT00445003|20972865|P1|Overall Study|Missed Visit|3
6072112|NCT00445003|20972863|P3|Overall Study|Death|1
6072113|NCT00445003|20972864|P2|Overall Study|Death|2
6072114|NCT00445003|20972865|P1|Overall Study|Death|1
6072115|NCT00444951|20972903|P3|Overall Study|Withdrawal by Subject|3
6072116|NCT00444951|20972904|P2|Overall Study|Withdrawal by Subject|5
6072117|NCT00444951|20972905|P1|Overall Study|Withdrawal by Subject|4
6072118|NCT00444951|20972903|P3|Overall Study|Lost to Follow-up|0
6072119|NCT00444951|20972904|P2|Overall Study|Lost to Follow-up|1
6072120|NCT00444951|20972905|P1|Overall Study|Lost to Follow-up|1
6072121|NCT00444925|20972922|P3|Double-blind Treatment Period|Other|12
6072122|NCT00444925|20972923|P2|Double-blind Treatment Period|Other|7
6072123|NCT00444925|20972924|P1|Double-blind Treatment Period|Other|7
6072124|NCT00444925|20972922|P3|Double-blind Treatment Period|Withdrawal by Subject|7
6072125|NCT00444925|20972923|P2|Double-blind Treatment Period|Withdrawal by Subject|8
6072126|NCT00444925|20972924|P1|Double-blind Treatment Period|Withdrawal by Subject|6
6072127|NCT00444925|20972922|P3|Double-blind Treatment Period|Lost to Follow-up|5
6072128|NCT00444925|20972923|P2|Double-blind Treatment Period|Lost to Follow-up|8
6072129|NCT00444925|20972924|P1|Double-blind Treatment Period|Lost to Follow-up|4
6072130|NCT00444925|20972922|P3|Double-blind Treatment Period|Lack of Efficacy|13
6072131|NCT00444925|20972923|P2|Double-blind Treatment Period|Lack of Efficacy|5
6072132|NCT00444925|20972924|P1|Double-blind Treatment Period|Lack of Efficacy|5
6072133|NCT00444925|20972922|P3|Double-blind Treatment Period|Adverse Event|44
6072134|NCT00444925|20972923|P2|Double-blind Treatment Period|Adverse Event|28
6072135|NCT00444925|20972924|P1|Double-blind Treatment Period|Adverse Event|6
6072136|NCT00444925|20972922|P3|Double-blind Treatment Period|Death|0
6072137|NCT00444925|20972923|P2|Double-blind Treatment Period|Death|0
6072138|NCT00444925|20972924|P1|Double-blind Treatment Period|Death|2
6072139|NCT00444925|20972922|P3|Randomized to Double-blind Treatment|Never returned after randomization|6
6072140|NCT00444925|20972923|P2|Randomized to Double-blind Treatment|Never returned after randomization|6
6072141|NCT00444925|20972924|P1|Randomized to Double-blind Treatment|Never returned after randomization|3
6072142|NCT00444912|20972988|P2|Overall Study|Participant Failed Mobilization|0
6072143|NCT00444912|20972989|P1|Overall Study|Participant Failed Mobilization|1
6072144|NCT00444912|20972988|P2|Overall Study|Lost to Follow-up|0
6072145|NCT00444912|20972989|P1|Overall Study|Lost to Follow-up|1
6072146|NCT00444912|20972988|P2|Overall Study|Death|2
6072147|NCT00444912|20972989|P1|Overall Study|Death|1
6072148|NCT00444795|20973030|P1|Overall Study|Treated Prior to the Contract Date|2
6072149|NCT00444795|20973030|P1|Overall Study|Not Treated|1
6072150|NCT00444678|20973035|P1|Overall Study|Withdrawal by Subject|2
6072151|NCT00444678|20973035|P1|Overall Study|Physician Decision|3
6072152|NCT00444678|20973035|P1|Overall Study|Death|3
6072153|NCT00444678|20973035|P1|Overall Study|Disease Progression|12
6072154|NCT00444678|20973035|P1|Overall Study|Toxicity|11
6072155|NCT00444626|20973042|P1|Initial Treatment Period|Lost to Follow-up|9
6072156|NCT00444626|20973042|P1|Initial Treatment Period|Adverse Event|1
6072157|NCT00444626|20973042|P1|Initial Treatment Period|Withdrawal by Subject|2
6072158|NCT00444600|20973072|P4|Overall Study|Missed visit|1
6072159|NCT00444600|20973073|P3|Overall Study|Missed visit|0
6072160|NCT00444600|20973074|P2|Overall Study|Missed visit|0
6072161|NCT00444600|20973075|P1|Overall Study|Missed visit|1
6072162|NCT00444600|20973072|P4|Overall Study|Dropped|7
6072163|NCT00444600|20973073|P3|Overall Study|Dropped|7
6072164|NCT00444600|20973074|P2|Overall Study|Dropped|11
6072165|NCT00444600|20973075|P1|Overall Study|Dropped|11
6072166|NCT00444600|20973072|P4|Overall Study|Death|2
6072167|NCT00444600|20973073|P3|Overall Study|Death|3
6072168|NCT00444600|20973074|P2|Overall Study|Death|5
6072169|NCT00444600|20973075|P1|Overall Study|Death|7
6072170|NCT00444587|20973167|P2|Overall Study|Missing|5
6072171|NCT00444587|20973168|P1|Overall Study|Missing|0
6072172|NCT00444587|20973167|P2|Overall Study|Protocol Violation|0
6072173|NCT00444587|20973168|P1|Overall Study|Protocol Violation|1
6072174|NCT00444587|20973167|P2|Overall Study|Investigator decision|0
6072175|NCT00444587|20973168|P1|Overall Study|Investigator decision|3
6072176|NCT00444587|20973167|P2|Overall Study|Refused treatment/did not cooperate|1
6072177|NCT00444587|20973168|P1|Overall Study|Refused treatment/did not cooperate|4
6072178|NCT00444587|20973167|P2|Overall Study|Progression of the disease|8
6072179|NCT00444587|20973168|P1|Overall Study|Progression of the disease|73
6072180|NCT00444587|20973167|P2|Overall Study|Death|1
6072181|NCT00444587|20973168|P1|Overall Study|Death|2
6072182|NCT00444535|20973189|P1|Overall Study|Adverse Event|3
6072183|NCT00444535|20973189|P1|Overall Study|Investigator decision|2
6072184|NCT00444535|20973189|P1|Overall Study|Withdrawal by Subject|3
6072185|NCT00444535|20973189|P1|Overall Study|Treatment is ongoing|16
6072186|NCT00444457|20973200|P4|Toddler Dose|Protocol Violation|1
6072187|NCT00444457|20973201|P3|Toddler Dose|Protocol Violation|0
6072188|NCT00444457|20973202|P2|Toddler Dose|Protocol Violation|0
6072189|NCT00444457|20973203|P1|Toddler Dose|Protocol Violation|1
6072190|NCT00444457|20973200|P4|Toddler Dose|Parent or legal guardian request|1
6072191|NCT00444457|20973201|P3|Toddler Dose|Parent or legal guardian request|2
6072192|NCT00444457|20973202|P2|Toddler Dose|Parent or legal guardian request|3
6072193|NCT00444457|20973203|P1|Toddler Dose|Parent or legal guardian request|0
6072194|NCT00444457|20973200|P4|Toddler Dose|Failed to return|3
6072195|NCT00444457|20973201|P3|Toddler Dose|Failed to return|1
6072196|NCT00444457|20973202|P2|Toddler Dose|Failed to return|2
6072197|NCT00444457|20973203|P1|Toddler Dose|Failed to return|2
6072198|NCT00444457|20973200|P4|Toddler Dose|Lost to Follow-up|3
6072199|NCT00444457|20973201|P3|Toddler Dose|Lost to Follow-up|1
6072200|NCT00444457|20973202|P2|Toddler Dose|Lost to Follow-up|1
6072201|NCT00444457|20973203|P1|Toddler Dose|Lost to Follow-up|4
6072202|NCT00444457|20973200|P4|After Infant Series|Other|0
6072203|NCT00444457|20973201|P3|After Infant Series|Other|0
6072204|NCT00444457|20973202|P2|After Infant Series|Other|1
6072205|NCT00444457|20973203|P1|After Infant Series|Other|0
6072206|NCT00444457|20973200|P4|After Infant Series|Investigator request|1
6072207|NCT00444457|20973201|P3|After Infant Series|Investigator request|0
6072208|NCT00444457|20973202|P2|After Infant Series|Investigator request|0
6072209|NCT00444457|20973203|P1|After Infant Series|Investigator request|0
6072210|NCT00444457|20973200|P4|After Infant Series|Adverse Event|0
6072211|NCT00444457|20973201|P3|After Infant Series|Adverse Event|0
6072212|NCT00444457|20973202|P2|After Infant Series|Adverse Event|2
6072213|NCT00444457|20973203|P1|After Infant Series|Adverse Event|2
6072214|NCT00444457|20973200|P4|After Infant Series|Protocol Violation|2
6072215|NCT00444457|20973201|P3|After Infant Series|Protocol Violation|2
6072216|NCT00444457|20973202|P2|After Infant Series|Protocol Violation|4
6072217|NCT00444457|20973203|P1|After Infant Series|Protocol Violation|2
6072218|NCT00444457|20973200|P4|After Infant Series|Lost to Follow-up|2
6072219|NCT00444457|20973201|P3|After Infant Series|Lost to Follow-up|5
6072220|NCT00444457|20973202|P2|After Infant Series|Lost to Follow-up|5
6072221|NCT00444457|20973203|P1|After Infant Series|Lost to Follow-up|5
6072222|NCT00444457|20973200|P4|After Infant Series|Failed to return|1
6072223|NCT00444457|20973201|P3|After Infant Series|Failed to return|5
6072224|NCT00444457|20973202|P2|After Infant Series|Failed to return|6
6072225|NCT00444457|20973203|P1|After Infant Series|Failed to return|7
6072226|NCT00444457|20973200|P4|After Infant Series|Parent or legal guardian request|3
6072227|NCT00444457|20973201|P3|After Infant Series|Parent or legal guardian request|6
6072228|NCT00444457|20973202|P2|After Infant Series|Parent or legal guardian request|11
6072229|NCT00444457|20973203|P1|After Infant Series|Parent or legal guardian request|4
6072230|NCT00444457|20973200|P4|After Infant Series|Other|1
6072231|NCT00444457|20973201|P3|After Infant Series|Other|1
6072232|NCT00444457|20973202|P2|After Infant Series|Other|1
6072233|NCT00444457|20973203|P1|After Infant Series|Other|0
6072234|NCT00444457|20973200|P4|Infant Series|Death|1
6072235|NCT00444457|20973201|P3|Infant Series|Death|1
6072236|NCT00444457|20973202|P2|Infant Series|Death|1
6072237|NCT00444457|20973203|P1|Infant Series|Death|0
6072238|NCT00444457|20973200|P4|Infant Series|Adverse Event|0
6072239|NCT00444457|20973201|P3|Infant Series|Adverse Event|2
6072240|NCT00444457|20973202|P2|Infant Series|Adverse Event|2
6072241|NCT00444457|20973203|P1|Infant Series|Adverse Event|1
6072242|NCT00444457|20973200|P4|Infant Series|Other|0
6072243|NCT00444457|20973201|P3|Infant Series|Other|4
6072244|NCT00444457|20973202|P2|Infant Series|Other|2
6072245|NCT00444457|20973203|P1|Infant Series|Other|0
6072246|NCT00444457|20973200|P4|Infant Series|Investigator request|2
6072247|NCT00444457|20973201|P3|Infant Series|Investigator request|3
6072248|NCT00444457|20973202|P2|Infant Series|Investigator request|3
6072249|NCT00444457|20973203|P1|Infant Series|Investigator request|4
6072250|NCT00444457|20973200|P4|Infant Series|Failed to return|2
6072251|NCT00444457|20973201|P3|Infant Series|Failed to return|4
6072252|NCT00444457|20973202|P2|Infant Series|Failed to return|4
6072253|NCT00444457|20973203|P1|Infant Series|Failed to return|5
6072254|NCT00444457|20973200|P4|Infant Series|Protocol Violation|3
6072255|NCT00444457|20973201|P3|Infant Series|Protocol Violation|6
6072256|NCT00444457|20973202|P2|Infant Series|Protocol Violation|8
6072257|NCT00444457|20973203|P1|Infant Series|Protocol Violation|16
6072258|NCT00444457|20973200|P4|Infant Series|Lost to Follow-up|6
6072259|NCT00444457|20973201|P3|Infant Series|Lost to Follow-up|7
6072260|NCT00444457|20973202|P2|Infant Series|Lost to Follow-up|11
6072261|NCT00444457|20973203|P1|Infant Series|Lost to Follow-up|10
6072262|NCT00444457|20973200|P4|Infant Series|Parent or legal guardian request|14
6072263|NCT00444457|20973201|P3|Infant Series|Parent or legal guardian request|34
6072264|NCT00444457|20973202|P2|Infant Series|Parent or legal guardian request|29
6072265|NCT00444457|20973203|P1|Infant Series|Parent or legal guardian request|18
6072266|NCT00444457|20973200|P4|Infant Series|Other|0
6072267|NCT00444457|20973201|P3|Infant Series|Other|0
6072268|NCT00444457|20973202|P2|Infant Series|Other|1
6072269|NCT00444457|20973203|P1|Infant Series|Other|0
6072270|NCT00444275|20973268|P5|Maintenance Treatment Phase|Ineffectiveness|14
6072271|NCT00444275|20973269|P4|Maintenance Treatment Phase|Ineffectiveness|3
6072272|NCT00444275|20973270|P3|Maintenance Treatment Phase|Ineffectiveness|5
6072273|NCT00444275|20973271|P2|Maintenance Treatment Phase|Ineffectiveness|0
6072274|NCT00444275|20973272|P1|Maintenance Treatment Phase|Ineffectiveness|0
6072275|NCT00444275|20973268|P5|Maintenance Treatment Phase|Protocol Violation|87
6072276|NCT00444275|20973269|P4|Maintenance Treatment Phase|Protocol Violation|88
6072277|NCT00444275|20973270|P3|Maintenance Treatment Phase|Protocol Violation|103
6072278|NCT00444275|20973271|P2|Maintenance Treatment Phase|Protocol Violation|0
6072279|NCT00444275|20973272|P1|Maintenance Treatment Phase|Protocol Violation|0
6072280|NCT00444275|20973268|P5|Maintenance Treatment Phase|Patient's wish|20
6072281|NCT00444275|20973269|P4|Maintenance Treatment Phase|Patient's wish|9
6072282|NCT00444275|20973270|P3|Maintenance Treatment Phase|Patient's wish|19
6072283|NCT00444275|20973271|P2|Maintenance Treatment Phase|Patient's wish|0
6072284|NCT00444275|20973272|P1|Maintenance Treatment Phase|Patient's wish|0
6072285|NCT00444275|20973268|P5|Maintenance Treatment Phase|Protocol specific criteria's development|6
6072286|NCT00444275|20973269|P4|Maintenance Treatment Phase|Protocol specific criteria's development|0
6072287|NCT00444275|20973270|P3|Maintenance Treatment Phase|Protocol specific criteria's development|1
6072288|NCT00444275|20973271|P2|Maintenance Treatment Phase|Protocol specific criteria's development|0
6072289|NCT00444275|20973272|P1|Maintenance Treatment Phase|Protocol specific criteria's development|0
6072290|NCT00444275|20973268|P5|Maintenance Treatment Phase|Adverse Event|13
6072291|NCT00444275|20973269|P4|Maintenance Treatment Phase|Adverse Event|2
6072292|NCT00444275|20973270|P3|Maintenance Treatment Phase|Adverse Event|3
6072293|NCT00444275|20973271|P2|Maintenance Treatment Phase|Adverse Event|0
6072294|NCT00444275|20973272|P1|Maintenance Treatment Phase|Adverse Event|0
6072295|NCT00444275|20973268|P5|Maintenance Treatment Phase|Lost to Follow-up|10
6072296|NCT00444275|20973269|P4|Maintenance Treatment Phase|Lost to Follow-up|14
6072297|NCT00444275|20973270|P3|Maintenance Treatment Phase|Lost to Follow-up|8
6072298|NCT00444275|20973271|P2|Maintenance Treatment Phase|Lost to Follow-up|0
6072299|NCT00444275|20973272|P1|Maintenance Treatment Phase|Lost to Follow-up|0
6072300|NCT00444275|20973268|P5|Maintenance Treatment Phase|Didn'r receive the treatment|29
6072301|NCT00444275|20973269|P4|Maintenance Treatment Phase|Didn'r receive the treatment|17
6072302|NCT00444275|20973270|P3|Maintenance Treatment Phase|Didn'r receive the treatment|22
6072303|NCT00444275|20973271|P2|Maintenance Treatment Phase|Didn'r receive the treatment|0
6072304|NCT00444275|20973272|P1|Maintenance Treatment Phase|Didn'r receive the treatment|0
6072305|NCT00444145|20973322|P1|Overall Study|Screen Failures|5
6072306|NCT00444145|20973322|P1|Overall Study|non-compliant|11
6072307|NCT00444145|20973322|P1|Overall Study|Lost to Follow-up|1
6072308|NCT00444145|20973322|P1|Overall Study|Withdrawal by Subject|2
6072309|NCT00444106|20973329|P3|Overall Study|Abnormal Test Procedure Results|1
6072310|NCT00444106|20973330|P2|Overall Study|Abnormal Test Procedure Results|0
6072311|NCT00444106|20973331|P1|Overall Study|Abnormal Test Procedure Results|0
6072312|NCT00444106|20973329|P3|Overall Study|Lost to Follow-up|0
6072313|NCT00444106|20973330|P2|Overall Study|Lost to Follow-up|1
6072314|NCT00444106|20973331|P1|Overall Study|Lost to Follow-up|2
6072315|NCT00444067|20973363|P2|Overall Study|Lost to Follow-up|1
6072316|NCT00444067|20973364|P1|Overall Study|Lost to Follow-up|0
6072317|NCT00443898|20973427|P4|Overall Study|Death|0
6072318|NCT00443898|20973428|P3|Overall Study|Death|0
6072319|NCT00443898|20973429|P2|Overall Study|Death|1
6072320|NCT00443898|20973430|P1|Overall Study|Death|0
6072321|NCT00443898|20973427|P4|Overall Study|Lost to Follow-up|10
6072322|NCT00443898|20973428|P3|Overall Study|Lost to Follow-up|14
6072323|NCT00443898|20973429|P2|Overall Study|Lost to Follow-up|10
6072324|NCT00443898|20973430|P1|Overall Study|Lost to Follow-up|10
6072325|NCT00443898|20973427|P4|Overall Study|Withdrawal by Subject|6
6072326|NCT00443898|20973428|P3|Overall Study|Withdrawal by Subject|10
6072327|NCT00443898|20973429|P2|Overall Study|Withdrawal by Subject|10
6072328|NCT00443898|20973430|P1|Overall Study|Withdrawal by Subject|11
6072329|NCT00443898|20973427|P4|Overall Study|Protocol Violation|0
6072330|NCT00443898|20973428|P3|Overall Study|Protocol Violation|1
6072331|NCT00443898|20973429|P2|Overall Study|Protocol Violation|1
6072332|NCT00443898|20973430|P1|Overall Study|Protocol Violation|1
6072333|NCT00443898|20973427|P4|Overall Study|Lack of Efficacy|1
6072334|NCT00443898|20973428|P3|Overall Study|Lack of Efficacy|3
6072335|NCT00443898|20973429|P2|Overall Study|Lack of Efficacy|3
6072336|NCT00443898|20973430|P1|Overall Study|Lack of Efficacy|2
6072337|NCT00443898|20973427|P4|Overall Study|Adverse Event|1
6072338|NCT00443898|20973428|P3|Overall Study|Adverse Event|1
6072339|NCT00443898|20973429|P2|Overall Study|Adverse Event|0
6072340|NCT00443898|20973430|P1|Overall Study|Adverse Event|0
6072341|NCT00443872|20973452|P1|Overall Study|Adverse Event|8
6072342|NCT00443872|20973452|P1|Overall Study|Lost to Follow-up|2
6072343|NCT00443872|20973452|P1|Overall Study|Protocol Violation|7
6072344|NCT00443846|20973467|P2|Overall Study|Lost to Follow-up|2
6072345|NCT00443846|20973468|P1|Overall Study|Lost to Follow-up|1
6072346|NCT00443846|20973467|P2|Overall Study|Personal reason|3
6072347|NCT00443846|20973468|P1|Overall Study|Personal reason|8
6072348|NCT00443846|20973467|P2|Overall Study|Adverse Event|1
6072349|NCT00443846|20973468|P1|Overall Study|Adverse Event|0
6072350|NCT00443846|20973467|P2|Overall Study|Not vaccinated, no blood sample drawn|0
6072351|NCT00443846|20973468|P1|Overall Study|Not vaccinated, no blood sample drawn|1
6072352|NCT00443846|20973467|P2|Overall Study|Withdrawn due to intercurrent disease|0
6072353|NCT00443846|20973468|P1|Overall Study|Withdrawn due to intercurrent disease|1
6072354|NCT00443820|20973478|P4|Overall Study|Death|0
6072355|NCT00443820|20973479|P3|Overall Study|Death|1
6072356|NCT00443820|20973480|P2|Overall Study|Death|0
6072357|NCT00443820|20973481|P1|Overall Study|Death|0
6072358|NCT00443820|20973478|P4|Overall Study|Administrative problems|1
6072359|NCT00443820|20973479|P3|Overall Study|Administrative problems|0
6072360|NCT00443820|20973480|P2|Overall Study|Administrative problems|0
6072361|NCT00443820|20973481|P1|Overall Study|Administrative problems|0
6072362|NCT00443820|20973478|P4|Overall Study|Lost to Follow-up|5
6072363|NCT00443820|20973479|P3|Overall Study|Lost to Follow-up|6
6072364|NCT00443820|20973480|P2|Overall Study|Lost to Follow-up|8
6072365|NCT00443820|20973481|P1|Overall Study|Lost to Follow-up|9
6072366|NCT00443820|20973478|P4|Overall Study|Withdrawal by Subject|9
6072367|NCT00443820|20973479|P3|Overall Study|Withdrawal by Subject|8
6072368|NCT00443820|20973480|P2|Overall Study|Withdrawal by Subject|7
6072369|NCT00443820|20973481|P1|Overall Study|Withdrawal by Subject|6
6072370|NCT00443820|20973478|P4|Overall Study|Protocol Violation|1
6072371|NCT00443820|20973479|P3|Overall Study|Protocol Violation|2
6072372|NCT00443820|20973480|P2|Overall Study|Protocol Violation|1
6072373|NCT00443820|20973481|P1|Overall Study|Protocol Violation|2
6072374|NCT00443820|20973478|P4|Overall Study|Lack of Efficacy|1
6072375|NCT00443820|20973479|P3|Overall Study|Lack of Efficacy|1
6072376|NCT00443820|20973480|P2|Overall Study|Lack of Efficacy|2
6072377|NCT00443820|20973481|P1|Overall Study|Lack of Efficacy|3
6072378|NCT00443820|20973478|P4|Overall Study|Adverse Event|0
6072379|NCT00443820|20973479|P3|Overall Study|Adverse Event|0
6072380|NCT00443820|20973480|P2|Overall Study|Adverse Event|1
6072381|NCT00443820|20973481|P1|Overall Study|Adverse Event|1
6072382|NCT00443781|20973503|P1|Overall Study|PD/FAD not done|1
6072383|NCT00443781|20973503|P1|Overall Study|Insurance not covered|2
6072384|NCT00443781|20973503|P1|Overall Study|Investigator terminated participation|1
6072385|NCT00443781|20973503|P1|Overall Study|Unable to comply with study follow up|2
6072386|NCT00443781|20973503|P1|Overall Study|Withdrawal by Subject|6
6072387|NCT00443781|20973503|P1|Overall Study|Protocol Violation|1
6072388|NCT00443781|20973503|P1|Overall Study|Physician Decision|2
6072389|NCT00443781|20973503|P1|Overall Study|Lost to Follow-up|10
6072390|NCT00443755|20973509|P2|Overall Study|Withdrawal by Subject|1
6072391|NCT00443755|20973510|P1|Overall Study|Withdrawal by Subject|2
6072392|NCT00443729|20973544|P2|Overall Study|Withdrawal by Subject|1
6072393|NCT00443729|20973545|P1|Overall Study|Withdrawal by Subject|3
6072394|NCT00443729|20973544|P2|Overall Study|Protocol Violation|1
6072395|NCT00443729|20973545|P1|Overall Study|Protocol Violation|1
6072396|NCT00443729|20973544|P2|Overall Study|Physician Decision|1
6072397|NCT00443729|20973545|P1|Overall Study|Physician Decision|2
6072398|NCT00443729|20973544|P2|Overall Study|Lost to Follow-up|1
6072399|NCT00443729|20973545|P1|Overall Study|Lost to Follow-up|0
6072400|NCT00443729|20973544|P2|Overall Study|Lack of Efficacy|2
6072401|NCT00443729|20973545|P1|Overall Study|Lack of Efficacy|4
6072402|NCT00443729|20973544|P2|Overall Study|Never Treated|1
6072403|NCT00443729|20973545|P1|Overall Study|Never Treated|0
6072404|NCT00443703|20973593|P2|Overall Study|Progressive Disease|0
6072405|NCT00443703|20973594|P1|Overall Study|Progressive Disease|1
6072406|NCT00443703|20973593|P2|Overall Study|Withdrawal by Subject|6
6072407|NCT00443703|20973594|P1|Overall Study|Withdrawal by Subject|9
6072408|NCT00443703|20973593|P2|Overall Study|Protocol Violation|1
6072409|NCT00443703|20973594|P1|Overall Study|Protocol Violation|1
6072410|NCT00443703|20973593|P2|Overall Study|Physician Decision|2
6072411|NCT00443703|20973594|P1|Overall Study|Physician Decision|4
6072412|NCT00443703|20973593|P2|Overall Study|Lost to Follow-up|4
6072413|NCT00443703|20973594|P1|Overall Study|Lost to Follow-up|0
6072414|NCT00443703|20973593|P2|Overall Study|Lack of Efficacy|1
6072415|NCT00443703|20973594|P1|Overall Study|Lack of Efficacy|3
6072416|NCT00443703|20973593|P2|Overall Study|Adverse Event|3
6072417|NCT00443703|20973594|P1|Overall Study|Adverse Event|7
6072418|NCT00443703|20973593|P2|Overall Study|Never Treated|1
6072419|NCT00443703|20973594|P1|Overall Study|Never Treated|3
6072420|NCT00443651|20973646|P2|Overall Study|Pregnancy|1
6072421|NCT00443651|20973647|P1|Overall Study|Pregnancy|0
6072422|NCT00443651|20973646|P2|Overall Study|Physician Decision|4
6072423|NCT00443651|20973647|P1|Overall Study|Physician Decision|13
6072424|NCT00443651|20973646|P2|Overall Study|Patient's/Guardian's Decision|30
6072425|NCT00443651|20973647|P1|Overall Study|Patient's/Guardian's Decision|58
6072426|NCT00443651|20973646|P2|Overall Study|Lost to Follow-up|12
6072427|NCT00443651|20973647|P1|Overall Study|Lost to Follow-up|18
6072428|NCT00443651|20973646|P2|Overall Study|Adverse Event|6
6072429|NCT00443651|20973647|P1|Overall Study|Adverse Event|5
6072430|NCT00443651|20973646|P2|Overall Study|Death|5
6072431|NCT00443651|20973647|P1|Overall Study|Death|1
6072438|NCT00443560|20973702|P2|Overall Study|Multiple pregnancies or fetal demise|4
6072439|NCT00443560|20973703|P1|Overall Study|Multiple pregnancies or fetal demise|2
6072440|NCT00443560|20973702|P2|Overall Study|No intrathecal dose|26
6072441|NCT00443560|20973703|P1|Overall Study|No intrathecal dose|58
6072442|NCT00443534|20973738|P1|Overall Study|Enrolled, Not Treated|1
6072443|NCT00443534|20973738|P1|Overall Study|Other|10
6072444|NCT00443534|20973738|P1|Overall Study|Study Terminated by Sponsor|12
6072445|NCT00443534|20973738|P1|Overall Study|Withdrawal by Subject|8
6072446|NCT00443534|20973738|P1|Overall Study|Death|9
6072447|NCT00443534|20973738|P1|Overall Study|Adverse Event|16
6072448|NCT00443534|20973738|P1|Overall Study|Lack of Efficacy|67
6072449|NCT00443456|20973745|P1|Overall Study|Withdrawal by Subject|1
6072450|NCT00443456|20973745|P1|Overall Study|Move|1
6072451|NCT00443456|20973745|P1|Overall Study|Adverse Event|16
6072452|NCT00443430|20973780|P2|Overall Study|Adverse Event|1
6072453|NCT00443430|20973781|P1|Overall Study|Adverse Event|1
6072454|NCT00443430|20973780|P2|Overall Study|Lack of Efficacy|3
6072455|NCT00443430|20973781|P1|Overall Study|Lack of Efficacy|3
6072456|NCT00443261|20973795|P1|Overall Study|Death|1
6072457|NCT00443209|20973801|P2|Months 13 to 18 Treatment Period|Withdrawal by Subject|2
6072458|NCT00443209|20973802|P1|Months 13 to 18 Treatment Period|Withdrawal by Subject|7
6072459|NCT00443209|20973801|P2|Months 13 to 18 Treatment Period|Trial Terminated|43
6072460|NCT00443209|20973802|P1|Months 13 to 18 Treatment Period|Trial Terminated|87
6072461|NCT00443209|20973801|P2|Months 13 to 18 Treatment Period|Lost to Follow-up|2
6072462|NCT00443209|20973802|P1|Months 13 to 18 Treatment Period|Lost to Follow-up|2
6072463|NCT00443209|20973801|P2|Months 13 to 18 Treatment Period|Lack of Efficacy|0
6072464|NCT00443209|20973802|P1|Months 13 to 18 Treatment Period|Lack of Efficacy|1
6072465|NCT00443209|20973801|P2|Months 13 to 18 Treatment Period|Protocol Violation|0
6072466|NCT00443209|20973802|P1|Months 13 to 18 Treatment Period|Protocol Violation|1
6072467|NCT00443209|20973801|P2|Months 13 to 18 Treatment Period|Adverse Event|0
6072468|NCT00443209|20973802|P1|Months 13 to 18 Treatment Period|Adverse Event|1
6072469|NCT00443209|20973801|P2|Months 1 to 12 Treatment Period|Not Treated|43
6072470|NCT00443209|20973802|P1|Months 1 to 12 Treatment Period|Not Treated|71
6072471|NCT00443209|20973801|P2|Months 1 to 12 Treatment Period|Missing|1
6072472|NCT00443209|20973802|P1|Months 1 to 12 Treatment Period|Missing|2
6072473|NCT00443209|20973801|P2|Months 1 to 12 Treatment Period|Withdrawal by Subject|34
6072474|NCT00443209|20973802|P1|Months 1 to 12 Treatment Period|Withdrawal by Subject|95
6072475|NCT00443209|20973801|P2|Months 1 to 12 Treatment Period|Trial Terminated|23
6072476|NCT00443209|20973802|P1|Months 1 to 12 Treatment Period|Trial Terminated|43
6072477|NCT00443209|20973801|P2|Months 1 to 12 Treatment Period|Pregnancy|4
6072478|NCT00443209|20973802|P1|Months 1 to 12 Treatment Period|Pregnancy|3
6072479|NCT00443209|20973801|P2|Months 1 to 12 Treatment Period|Physician Decision|4
6072480|NCT00443209|20973802|P1|Months 1 to 12 Treatment Period|Physician Decision|8
6072481|NCT00443209|20973801|P2|Months 1 to 12 Treatment Period|Lost to Follow-up|15
6072482|NCT00443209|20973802|P1|Months 1 to 12 Treatment Period|Lost to Follow-up|36
6072483|NCT00443209|20973801|P2|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1
6072484|NCT00443209|20973802|P1|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1
6072485|NCT00443209|20973801|P2|Months 1 to 12 Treatment Period|Lack of Efficacy|11
6072486|NCT00443209|20973802|P1|Months 1 to 12 Treatment Period|Lack of Efficacy|50
6072487|NCT00443209|20973801|P2|Months 1 to 12 Treatment Period|Protocol Violation|7
6072488|NCT00443209|20973802|P1|Months 1 to 12 Treatment Period|Protocol Violation|14
6072489|NCT00443209|20973801|P2|Months 1 to 12 Treatment Period|Adverse Event|11
6072490|NCT00443209|20973802|P1|Months 1 to 12 Treatment Period|Adverse Event|22
6072491|NCT00443118|20973819|P3|Overall Study|Withdrawal by Subject|0
6072492|NCT00443118|20973820|P2|Overall Study|Withdrawal by Subject|0
6072493|NCT00443118|20973821|P1|Overall Study|Withdrawal by Subject|1
6072494|NCT00443118|20973819|P3|Overall Study|unknown primary outcome|0
6072495|NCT00443118|20973820|P2|Overall Study|unknown primary outcome|1
6072496|NCT00443118|20973821|P1|Overall Study|unknown primary outcome|3
6072497|NCT00443053|20973870|P2|Overall Study|Physician Decision|4
6072498|NCT00443053|20973871|P1|Overall Study|Physician Decision|0
6072499|NCT00443053|20973870|P2|Overall Study|Other|4
6072500|NCT00443053|20973871|P1|Overall Study|Other|3
6072501|NCT00443053|20973870|P2|Overall Study|Noncompliance|1
6072502|NCT00443053|20973871|P1|Overall Study|Noncompliance|2
6072503|NCT00443053|20973870|P2|Overall Study|Did Not Meet Eligibility Criteria|0
6072504|NCT00443053|20973871|P1|Overall Study|Did Not Meet Eligibility Criteria|1
6072505|NCT00443053|20973870|P2|Overall Study|Lost to Follow-up|5
6072506|NCT00443053|20973871|P1|Overall Study|Lost to Follow-up|4
6072507|NCT00443053|20973870|P2|Overall Study|Withdrawal by Subject|18
6072508|NCT00443053|20973871|P1|Overall Study|Withdrawal by Subject|9
6072509|NCT00443053|20973870|P2|Overall Study|Adverse Event|1
6072510|NCT00443053|20973871|P1|Overall Study|Adverse Event|2
6072511|NCT00443040|20973892|P3|Overall Study|Converted to an open laparotomy|1
6072512|NCT00443040|20973893|P2|Overall Study|Converted to an open laparotomy|0
6072513|NCT00443040|20973894|P1|Overall Study|Converted to an open laparotomy|3
6072514|NCT00443040|20973892|P3|Overall Study|Withdrawal by Subject|0
6072515|NCT00443040|20973893|P2|Overall Study|Withdrawal by Subject|0
6072516|NCT00443040|20973894|P1|Overall Study|Withdrawal by Subject|1
6072517|NCT00442962|20973902|P1|Overall Study|Lost to Follow-up|7
6072518|NCT00442962|20973902|P1|Overall Study|Pregnancy|1
6072519|NCT00442936|20973920|P4|Overall Study|Protocol Violation|1
6072520|NCT00442936|20973921|P3|Overall Study|Protocol Violation|1
6072521|NCT00442936|20973922|P2|Overall Study|Protocol Violation|0
6072522|NCT00442936|20973923|P1|Overall Study|Protocol Violation|1
6072523|NCT00442897|20973971|P2|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|3
6072524|NCT00442897|20973972|P1|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|1
6072525|NCT00442897|20973971|P2|24 Weeks Follow-up (3 Centers)|Protocol Violation|1
6072526|NCT00442897|20973972|P1|24 Weeks Follow-up (3 Centers)|Protocol Violation|2
6072527|NCT00442897|20973971|P2|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2
6072528|NCT00442897|20973972|P1|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2
6072529|NCT00442897|20973971|P2|24 Weeks Follow-up (3 Centers)|Adverse Event|0
6072530|NCT00442897|20973972|P1|24 Weeks Follow-up (3 Centers)|Adverse Event|1
6072531|NCT00442897|20973971|P2|Base Study (12 Week Follow-up)|Withdrawal by Subject|8
6072532|NCT00442897|20973972|P1|Base Study (12 Week Follow-up)|Withdrawal by Subject|9
6072533|NCT00442897|20973971|P2|Base Study (12 Week Follow-up)|Protocol Violation|3
6072534|NCT00442897|20973972|P1|Base Study (12 Week Follow-up)|Protocol Violation|7
6072535|NCT00442897|20973971|P2|Base Study (12 Week Follow-up)|Death|1
6072536|NCT00442897|20973972|P1|Base Study (12 Week Follow-up)|Death|0
6072537|NCT00442897|20973971|P2|Base Study (12 Week Follow-up)|Adverse Event|0
6072538|NCT00442897|20973972|P1|Base Study (12 Week Follow-up)|Adverse Event|1
6072539|NCT00442702|20973990|P2|Evaluation Period|Site closure|1
6072540|NCT00442702|20973991|P1|Evaluation Period|Site closure|0
6072541|NCT00442702|20973990|P2|Evaluation Period|Failure to return|0
6072542|NCT00442702|20973991|P1|Evaluation Period|Failure to return|1
6072543|NCT00442702|20973990|P2|Evaluation Period|Renal transplant|1
6072544|NCT00442702|20973991|P1|Evaluation Period|Renal transplant|0
6072545|NCT00442702|20973990|P2|Evaluation Period|Refused treatment|1
6072546|NCT00442702|20973991|P1|Evaluation Period|Refused treatment|1
6072547|NCT00442702|20973990|P2|Evaluation Period|Insufficient Therapeutic Response|0
6072548|NCT00442702|20973991|P1|Evaluation Period|Insufficient Therapeutic Response|1
6072549|NCT00442702|20973990|P2|Evaluation Period|Death|1
6072550|NCT00442702|20973991|P1|Evaluation Period|Death|1
6072551|NCT00442702|20973990|P2|Evaluation Period|Adverse Event|0
6072552|NCT00442702|20973991|P1|Evaluation Period|Adverse Event|1
6072553|NCT00442702|20973990|P2|Titration Period|Hospitalized in another hospital|0
6072554|NCT00442702|20973991|P1|Titration Period|Hospitalized in another hospital|1
6072555|NCT00442702|20973990|P2|Titration Period|Failure to return|0
6072556|NCT00442702|20973991|P1|Titration Period|Failure to return|1
6072557|NCT00442702|20973990|P2|Titration Period|Refused Treatment|1
6072558|NCT00442702|20973991|P1|Titration Period|Refused Treatment|4
6072559|NCT00442702|20973990|P2|Titration Period|Insufficient Therapeutic Response|0
6072560|NCT00442702|20973991|P1|Titration Period|Insufficient Therapeutic Response|1
6072561|NCT00442702|20973990|P2|Titration Period|Death|2
6072562|NCT00442702|20973991|P1|Titration Period|Death|3
6072563|NCT00442702|20973990|P2|Titration Period|Adverse Event|0
6072564|NCT00442702|20973991|P1|Titration Period|Adverse Event|2
6072565|NCT00442598|20974056|P3|Overall Study|Death|0
6072566|NCT00442598|20974057|P2|Overall Study|Death|1
6072567|NCT00442598|20974058|P1|Overall Study|Death|0
6072568|NCT00442598|20974056|P3|Overall Study|Reduced creatinine clearance|0
6072569|NCT00442598|20974057|P2|Overall Study|Reduced creatinine clearance|0
6072570|NCT00442598|20974058|P1|Overall Study|Reduced creatinine clearance|1
6072571|NCT00442598|20974056|P3|Overall Study|CA125 progression|0
6072572|NCT00442598|20974057|P2|Overall Study|CA125 progression|1
6072573|NCT00442598|20974058|P1|Overall Study|CA125 progression|0
6072574|NCT00442598|20974056|P3|Overall Study|Clinical deterioration|0
6072575|NCT00442598|20974057|P2|Overall Study|Clinical deterioration|2
6072576|NCT00442598|20974058|P1|Overall Study|Clinical deterioration|1
6072577|NCT00442598|20974056|P3|Overall Study|Tumor progression|0
6072578|NCT00442598|20974057|P2|Overall Study|Tumor progression|4
6072579|NCT00442598|20974058|P1|Overall Study|Tumor progression|3
6072580|NCT00442598|20974056|P3|Overall Study|Adverse Event|0
6072581|NCT00442598|20974057|P2|Overall Study|Adverse Event|0
6072582|NCT00442598|20974058|P1|Overall Study|Adverse Event|1
6072583|NCT00442572|20974076|P2|Overall Study|Withdrawal by Subject|1
6072584|NCT00442572|20974077|P1|Overall Study|Withdrawal by Subject|0
6072585|NCT00442572|20974076|P2|Overall Study|Lost to Follow-up|1
6072586|NCT00442572|20974077|P1|Overall Study|Lost to Follow-up|0
6072587|NCT00442572|20974076|P2|Overall Study|Relapse|1
6072588|NCT00442572|20974077|P1|Overall Study|Relapse|8
6072589|NCT00442559|20974117|P2|Overall Study|Withdrawal by Subject|0
6072590|NCT00442559|20974118|P1|Overall Study|Withdrawal by Subject|1
6072591|NCT00442559|20974117|P2|Overall Study|Protocol Violation|1
6072592|NCT00442559|20974118|P1|Overall Study|Protocol Violation|1
6072593|NCT00442559|20974117|P2|Overall Study|Lost to Follow-up|34
6072594|NCT00442559|20974118|P1|Overall Study|Lost to Follow-up|32
6072595|NCT00442546|20974133|P3|Overall Study|Randomized But Not Treated|6
6072596|NCT00442546|20974134|P2|Overall Study|Randomized But Not Treated|4
6072597|NCT00442546|20974135|P1|Overall Study|Randomized But Not Treated|5
6072598|NCT00442546|20974133|P3|Overall Study|Withdrawal by Subject|7
6072599|NCT00442546|20974134|P2|Overall Study|Withdrawal by Subject|5
6072600|NCT00442546|20974135|P1|Overall Study|Withdrawal by Subject|5
6072601|NCT00442546|20974133|P3|Overall Study|Other|6
6072602|NCT00442546|20974134|P2|Overall Study|Other|9
6072603|NCT00442546|20974135|P1|Overall Study|Other|4
6072604|NCT00442546|20974133|P3|Overall Study|Lost to Follow-up|1
6072605|NCT00442546|20974134|P2|Overall Study|Lost to Follow-up|2
6072606|NCT00442546|20974135|P1|Overall Study|Lost to Follow-up|1
6072607|NCT00442546|20974133|P3|Overall Study|Adverse Event|13
6072608|NCT00442546|20974134|P2|Overall Study|Adverse Event|17
6072609|NCT00442546|20974135|P1|Overall Study|Adverse Event|11
6072610|NCT00442468|20974264|P1|Overall Study|Did not complete all study procedures|88
6072611|NCT00442468|20974264|P1|Overall Study|Withdrawal by Subject|91
6072612|NCT00442468|20974264|P1|Overall Study|Adverse Event|4
6072613|NCT00442416|20974294|P2|Overall Study|Administrative/Other|33
6072614|NCT00442416|20974295|P1|Overall Study|Administrative/Other|27
6072615|NCT00442416|20974294|P2|Overall Study|Withdrew consent|2
6072616|NCT00442416|20974295|P1|Overall Study|Withdrew consent|1
6072617|NCT00442416|20974294|P2|Overall Study|Protocol Violation|3
6072618|NCT00442416|20974295|P1|Overall Study|Protocol Violation|2
6072619|NCT00442416|20974294|P2|Overall Study|Lack of Efficacy|0
6072620|NCT00442416|20974295|P1|Overall Study|Lack of Efficacy|2
6072621|NCT00442416|20974294|P2|Overall Study|Death|0
6072622|NCT00442416|20974295|P1|Overall Study|Death|1
6072623|NCT00442416|20974294|P2|Overall Study|Adverse Event|1
6072624|NCT00442416|20974295|P1|Overall Study|Adverse Event|4
6072625|NCT00442351|20974334|P2|Overall Study|Other|1
6072626|NCT00442351|20974335|P1|Overall Study|Other|0
6072627|NCT00442351|20974334|P2|Overall Study|Did not meet protocol eligibility|0
6072628|NCT00442351|20974335|P1|Overall Study|Did not meet protocol eligibility|1
6072629|NCT00442351|20974334|P2|Overall Study|Administrative|5
6072630|NCT00442351|20974335|P1|Overall Study|Administrative|6
6072631|NCT00442286|20974357|P2|Overall Study|Patient Injury|0
6072632|NCT00442286|20974358|P1|Overall Study|Patient Injury|1
6072633|NCT00442286|20974357|P2|Overall Study|System explanted|0
6072634|NCT00442286|20974358|P1|Overall Study|System explanted|1
6072635|NCT00442286|20974357|P2|Overall Study|Withdrawal by Subject|0
6072636|NCT00442286|20974358|P1|Overall Study|Withdrawal by Subject|2
6072637|NCT00442286|20974357|P2|Overall Study|Lost to Follow-up|0
6072638|NCT00442286|20974358|P1|Overall Study|Lost to Follow-up|1
6072639|NCT00442286|20974357|P2|Overall Study|Death|2
6072640|NCT00442286|20974358|P1|Overall Study|Death|2
6072641|NCT00442117|20974424|P2|Overall Study|Met Withdrawal Criteria|1
6072642|NCT00442117|20974425|P1|Overall Study|Met Withdrawal Criteria|2
6072643|NCT00442117|20974424|P2|Overall Study|Non compliance with protocol|5
6072644|NCT00442117|20974425|P1|Overall Study|Non compliance with protocol|3
6072645|NCT00442117|20974424|P2|Overall Study|Major Deviation|20
6072646|NCT00442117|20974425|P1|Overall Study|Major Deviation|25
6072647|NCT00442117|20974424|P2|Overall Study|Withdrawal by Subject|2
6072648|NCT00442117|20974425|P1|Overall Study|Withdrawal by Subject|2
6072649|NCT00442117|20974424|P2|Overall Study|Lost to Follow-up|2
6072650|NCT00442117|20974425|P1|Overall Study|Lost to Follow-up|1
6072651|NCT00442117|20974424|P2|Overall Study|Lack of Efficacy|6
6072652|NCT00442117|20974425|P1|Overall Study|Lack of Efficacy|2
6072653|NCT00442117|20974424|P2|Overall Study|Adverse Event|2
6072654|NCT00442117|20974425|P1|Overall Study|Adverse Event|3
6072655|NCT00441974|20974456|P1|Overall Study|Protocol Violation|7
6072656|NCT00441974|20974456|P1|Overall Study|Lost to Follow-up|80
6072657|NCT00441974|20974456|P1|Overall Study|Consent Withdrawn|35
6072658|NCT00441974|20974456|P1|Overall Study|Adverse Event|6
6072659|NCT00441792|20974503|P2|Overall Study|Lost to Follow-up|2
6072660|NCT00441792|20974504|P1|Overall Study|Lost to Follow-up|0
6072661|NCT00441727|20974544|P3|Overall Study|Various reason specified|5
6072662|NCT00441727|20974545|P2|Overall Study|Various reason specified|8
6072663|NCT00441727|20974546|P1|Overall Study|Various reason specified|6
6072664|NCT00441727|20974544|P3|Overall Study|Safety Reasons|3
6072665|NCT00441727|20974545|P2|Overall Study|Safety Reasons|1
6072666|NCT00441727|20974546|P1|Overall Study|Safety Reasons|3
6072667|NCT00441727|20974544|P3|Overall Study|Lost to Follow-up|5
6072668|NCT00441727|20974545|P2|Overall Study|Lost to Follow-up|6
6072669|NCT00441727|20974546|P1|Overall Study|Lost to Follow-up|5
6072670|NCT00441727|20974544|P3|Overall Study|Withdrawal by Subject|47
6072671|NCT00441727|20974545|P2|Overall Study|Withdrawal by Subject|34
6072672|NCT00441727|20974546|P1|Overall Study|Withdrawal by Subject|40
6072673|NCT00441727|20974544|P3|Overall Study|Lack of Efficacy|48
6072674|NCT00441727|20974545|P2|Overall Study|Lack of Efficacy|8
6072675|NCT00441727|20974546|P1|Overall Study|Lack of Efficacy|7
6072676|NCT00441727|20974544|P3|Overall Study|Adverse Event|28
6072677|NCT00441727|20974545|P2|Overall Study|Adverse Event|33
6072678|NCT00441727|20974546|P1|Overall Study|Adverse Event|26
6072679|NCT00441727|20974544|P3|Overall Study|Protocol Violation|32
6072680|NCT00441727|20974545|P2|Overall Study|Protocol Violation|28
6072681|NCT00441727|20974546|P1|Overall Study|Protocol Violation|19
6072682|NCT00441701|20974579|P10|Overall Study|Withdrawal by Subject|0
6072683|NCT00441701|20974580|P9|Overall Study|Withdrawal by Subject|0
6072684|NCT00441701|20974581|P8|Overall Study|Withdrawal by Subject|0
6072685|NCT00441701|20974582|P7|Overall Study|Withdrawal by Subject|0
6072686|NCT00441701|20974583|P6|Overall Study|Withdrawal by Subject|0
6072687|NCT00441701|20974584|P5|Overall Study|Withdrawal by Subject|0
6072688|NCT00441701|20974585|P4|Overall Study|Withdrawal by Subject|1
6072689|NCT00441701|20974586|P3|Overall Study|Withdrawal by Subject|1
6072690|NCT00441701|20974587|P2|Overall Study|Withdrawal by Subject|2
6072691|NCT00441701|20974588|P1|Overall Study|Withdrawal by Subject|0
6072692|NCT00441701|20974579|P10|Overall Study|Lack of Efficacy|0
6072693|NCT00441701|20974580|P9|Overall Study|Lack of Efficacy|0
6072694|NCT00441701|20974581|P8|Overall Study|Lack of Efficacy|0
6072695|NCT00441701|20974582|P7|Overall Study|Lack of Efficacy|0
6072696|NCT00441701|20974583|P6|Overall Study|Lack of Efficacy|1
6072697|NCT00441701|20974584|P5|Overall Study|Lack of Efficacy|0
6072698|NCT00441701|20974585|P4|Overall Study|Lack of Efficacy|2
6072699|NCT00441701|20974586|P3|Overall Study|Lack of Efficacy|2
6072700|NCT00441701|20974587|P2|Overall Study|Lack of Efficacy|0
6072701|NCT00441701|20974588|P1|Overall Study|Lack of Efficacy|2
6072702|NCT00441701|20974579|P10|Overall Study|Adverse Event|0
6072703|NCT00441701|20974580|P9|Overall Study|Adverse Event|0
6072704|NCT00441701|20974581|P8|Overall Study|Adverse Event|0
6072705|NCT00441701|20974582|P7|Overall Study|Adverse Event|0
6072706|NCT00441701|20974583|P6|Overall Study|Adverse Event|2
6072707|NCT00441701|20974584|P5|Overall Study|Adverse Event|2
6072708|NCT00441701|20974585|P4|Overall Study|Adverse Event|0
6072709|NCT00441701|20974586|P3|Overall Study|Adverse Event|1
6072710|NCT00441701|20974587|P2|Overall Study|Adverse Event|2
6072711|NCT00441701|20974588|P1|Overall Study|Adverse Event|3
6072712|NCT00441584|20974670|P1|Overall Study|Failure to meet eligibility criteria|3
6072713|NCT00441584|20974670|P1|Overall Study|Lost to Follow-up|4
6072714|NCT00441584|20974670|P1|Overall Study|Protocol Violation|5
6072715|NCT00441584|20974670|P1|Overall Study|Adverse Event|6
6072716|NCT00441584|20974670|P1|Overall Study|Withdrawal by Subject|8
6072717|NCT00441584|20974670|P1|Overall Study|Lack of Efficacy|79
6072718|NCT00441545|20974678|P2|Second Intervention|Subject moved|1
6072719|NCT00441545|20974679|P1|Second Intervention|Subject moved|0
6072720|NCT00441545|20974678|P2|Second Intervention|Subject exceeded safety criteria|0
6072721|NCT00441545|20974679|P1|Second Intervention|Subject exceeded safety criteria|1
6072722|NCT00441545|20974678|P2|Second Intervention|Lack of Efficacy|1
6072723|NCT00441545|20974679|P1|Second Intervention|Lack of Efficacy|0
6072724|NCT00441545|20974678|P2|Second Intervention|Kidney Transplant|1
6072725|NCT00441545|20974679|P1|Second Intervention|Kidney Transplant|1
6072726|NCT00441545|20974678|P2|Second Intervention|Withdrawal by Subject|1
6072727|NCT00441545|20974679|P1|Second Intervention|Withdrawal by Subject|1
6072728|NCT00441545|20974678|P2|Second Intervention|Protocol Violation|1
6072729|NCT00441545|20974679|P1|Second Intervention|Protocol Violation|4
6072730|NCT00441545|20974678|P2|Second Intervention|Adverse Event|2
6072731|NCT00441545|20974679|P1|Second Intervention|Adverse Event|5
6072732|NCT00441545|20974678|P2|First Intervention|Sponsor's request|0
6072733|NCT00441545|20974679|P1|First Intervention|Sponsor's request|1
6072734|NCT00441545|20974678|P2|First Intervention|Site error|0
6072735|NCT00441545|20974679|P1|First Intervention|Site error|1
6072736|NCT00441545|20974678|P2|First Intervention|Extended hospitalization|0
6072737|NCT00441545|20974679|P1|First Intervention|Extended hospitalization|1
6072738|NCT00441545|20974678|P2|First Intervention|Subject met an exclusionary criteria|0
6072739|NCT00441545|20974679|P1|First Intervention|Subject met an exclusionary criteria|1
6072740|NCT00441545|20974678|P2|First Intervention|Subject exceeded safety criteria|1
6072741|NCT00441545|20974679|P1|First Intervention|Subject exceeded safety criteria|0
6072742|NCT00441545|20974678|P2|First Intervention|Lack of Efficacy|0
6072743|NCT00441545|20974679|P1|First Intervention|Lack of Efficacy|2
6072744|NCT00441545|20974678|P2|First Intervention|Kidney transplant|1
6072745|NCT00441545|20974679|P1|First Intervention|Kidney transplant|1
6072746|NCT00441545|20974678|P2|First Intervention|Withdrawal by Subject|3
6072747|NCT00441545|20974679|P1|First Intervention|Withdrawal by Subject|3
6072748|NCT00441545|20974678|P2|First Intervention|Protocol Violation|2
6072749|NCT00441545|20974679|P1|First Intervention|Protocol Violation|2
6072750|NCT00441545|20974678|P2|First Intervention|Adverse Event|5
6072751|NCT00441545|20974679|P1|First Intervention|Adverse Event|6
6072752|NCT00441480|20974693|P2|Overall Study|Withdrawal by Subject|3
6072753|NCT00441480|20974694|P1|Overall Study|Withdrawal by Subject|2
6072754|NCT00441480|20974693|P2|Overall Study|Protocol Violation|1
6072755|NCT00441480|20974694|P1|Overall Study|Protocol Violation|1
6072756|NCT00441467|20974726|P1|Overall Study|Progressive disease|9
6072757|NCT00441467|20974726|P1|Overall Study|Withdrawal by Subject|3
6072758|NCT00441467|20974726|P1|Overall Study|Adverse Event|6
6072759|NCT00441441|20974734|P2|Overall Study|Other|3
6072760|NCT00441441|20974735|P1|Overall Study|Other|3
6072761|NCT00441441|20974734|P2|Overall Study|Withdrawal by Subject|2
6072762|NCT00441441|20974735|P1|Overall Study|Withdrawal by Subject|1
6072763|NCT00441441|20974734|P2|Overall Study|Exacerbation of asthma|2
6072764|NCT00441441|20974735|P1|Overall Study|Exacerbation of asthma|1
6072765|NCT00441441|20974734|P2|Overall Study|Protocol Violation|6
6072766|NCT00441441|20974735|P1|Overall Study|Protocol Violation|4
6072767|NCT00441441|20974734|P2|Overall Study|Adverse Event|1
6072768|NCT00441441|20974735|P1|Overall Study|Adverse Event|2
6072769|NCT00441363|20974795|P2|Overall Study|Other|0
6072770|NCT00441363|20974796|P1|Overall Study|Other|2
6072771|NCT00441363|20974795|P2|Overall Study|Lost to Follow-up|2
6072772|NCT00441363|20974796|P1|Overall Study|Lost to Follow-up|2
6072773|NCT00441363|20974795|P2|Overall Study|Physician Decision|7
6072774|NCT00441363|20974796|P1|Overall Study|Physician Decision|6
6072775|NCT00441363|20974795|P2|Overall Study|Withdrawal by Subject|4
6072776|NCT00441363|20974796|P1|Overall Study|Withdrawal by Subject|3
6072777|NCT00441363|20974795|P2|Overall Study|Adverse Event|2
6072778|NCT00441363|20974796|P1|Overall Study|Adverse Event|4
6072779|NCT00441337|20974808|P4|Overall Study|Did not meet inclusion criteria|0
6072780|NCT00441337|20974809|P3|Overall Study|Did not meet inclusion criteria|1
6072781|NCT00441337|20974810|P2|Overall Study|Did not meet inclusion criteria|0
6072782|NCT00441337|20974811|P1|Overall Study|Did not meet inclusion criteria|0
6072783|NCT00441337|20974808|P4|Overall Study|Sponsor Decision|2
6072784|NCT00441337|20974809|P3|Overall Study|Sponsor Decision|1
6072785|NCT00441337|20974810|P2|Overall Study|Sponsor Decision|0
6072786|NCT00441337|20974811|P1|Overall Study|Sponsor Decision|0
6072787|NCT00441337|20974808|P4|Overall Study|Lost to Follow-up|1
6072788|NCT00441337|20974809|P3|Overall Study|Lost to Follow-up|0
6072789|NCT00441337|20974810|P2|Overall Study|Lost to Follow-up|0
6072790|NCT00441337|20974811|P1|Overall Study|Lost to Follow-up|0
6072791|NCT00441337|20974808|P4|Overall Study|Disease Progression|18
6072792|NCT00441337|20974809|P3|Overall Study|Disease Progression|4
6072793|NCT00441337|20974810|P2|Overall Study|Disease Progression|6
6072794|NCT00441337|20974811|P1|Overall Study|Disease Progression|6
6072795|NCT00441272|20974924|P2|Overall Study|Study terminated prior to enrollment|25
6072796|NCT00441272|20974925|P1|Overall Study|Study terminated prior to enrollment|25
6072797|NCT00441168|20974952|P2|Follow-up Period|Other|3
6072798|NCT00441168|20974953|P1|Follow-up Period|Other|1
6072799|NCT00441168|20974952|P2|Follow-up Period|Withdrawal by Subject|0
6072800|NCT00441168|20974953|P1|Follow-up Period|Withdrawal by Subject|3
6072801|NCT00441168|20974952|P2|Follow-up Period|Lost to Follow-up|6
6072802|NCT00441168|20974953|P1|Follow-up Period|Lost to Follow-up|5
6072803|NCT00441168|20974952|P2|Follow-up Period|Death|0
6072804|NCT00441168|20974953|P1|Follow-up Period|Death|3
6072805|NCT00441168|20974952|P2|Treatment Period|refractory disease|0
6072806|NCT00441168|20974953|P1|Treatment Period|refractory disease|1
6072807|NCT00441168|20974952|P2|Treatment Period|qualified for stem-cell transplantation|0
6072808|NCT00441168|20974953|P1|Treatment Period|qualified for stem-cell transplantation|3
6072809|NCT00441168|20974952|P2|Treatment Period|Withdrawal by Subject|0
6072810|NCT00441168|20974953|P1|Treatment Period|Withdrawal by Subject|3
6072811|NCT00441168|20974952|P2|Treatment Period|Lost to Follow-up|1
6072812|NCT00441168|20974953|P1|Treatment Period|Lost to Follow-up|0
6072813|NCT00441168|20974952|P2|Treatment Period|Protocol Violation|1
6072814|NCT00441168|20974953|P1|Treatment Period|Protocol Violation|0
6072815|NCT00441168|20974952|P2|Treatment Period|Progressive Disease|2
6072816|NCT00441168|20974953|P1|Treatment Period|Progressive Disease|0
6072817|NCT00441168|20974952|P2|Treatment Period|Adverse Event|2
6072818|NCT00441168|20974953|P1|Treatment Period|Adverse Event|1
6072819|NCT00441168|20974952|P2|Treatment Period|Death|0
6072820|NCT00441168|20974953|P1|Treatment Period|Death|3
6072821|NCT00441142|20974967|P4|Overall Study|Death|1
6072822|NCT00441142|20974968|P3|Overall Study|Death|0
6072823|NCT00441142|20974969|P2|Overall Study|Death|0
6072824|NCT00441142|20974970|P1|Overall Study|Death|0
6072825|NCT00441142|20974967|P4|Overall Study|Physician Decision|1
6072826|NCT00441142|20974968|P3|Overall Study|Physician Decision|0
6072827|NCT00441142|20974969|P2|Overall Study|Physician Decision|1
6072828|NCT00441142|20974970|P1|Overall Study|Physician Decision|0
6072829|NCT00441142|20974967|P4|Overall Study|Patient still receiving active study tx|2
6072830|NCT00441142|20974968|P3|Overall Study|Patient still receiving active study tx|0
6072831|NCT00441142|20974969|P2|Overall Study|Patient still receiving active study tx|0
6072832|NCT00441142|20974970|P1|Overall Study|Patient still receiving active study tx|1
6072833|NCT00441142|20974967|P4|Overall Study|Withdrawal by Subject|10
6072834|NCT00441142|20974968|P3|Overall Study|Withdrawal by Subject|2
6072835|NCT00441142|20974969|P2|Overall Study|Withdrawal by Subject|0
6072836|NCT00441142|20974970|P1|Overall Study|Withdrawal by Subject|0
6072837|NCT00441142|20974967|P4|Overall Study|Lack of Efficacy|32
6072838|NCT00441142|20974968|P3|Overall Study|Lack of Efficacy|17
6072839|NCT00441142|20974969|P2|Overall Study|Lack of Efficacy|3
6072840|NCT00441142|20974970|P1|Overall Study|Lack of Efficacy|3
6072841|NCT00441142|20974967|P4|Overall Study|Adverse Event|22
6072842|NCT00441142|20974968|P3|Overall Study|Adverse Event|3
6072843|NCT00441142|20974969|P2|Overall Study|Adverse Event|3
6072844|NCT00441142|20974970|P1|Overall Study|Adverse Event|2
6072845|NCT00441129|20974992|P2|Overall Study|Withdrawal by Subject|14
6072846|NCT00441129|20974993|P1|Overall Study|Withdrawal by Subject|6
6072847|NCT00441116|20975005|P2|Overall Study|Did not meet Eligibility Criteria|1
6072848|NCT00441116|20975006|P1|Overall Study|Did not meet Eligibility Criteria|1
6072849|NCT00441116|20975005|P2|Overall Study|Withdrawal by Subject|0
6072850|NCT00441116|20975006|P1|Overall Study|Withdrawal by Subject|1
6072851|NCT00441116|20975005|P2|Overall Study|Adverse Event|1
6072852|NCT00441116|20975006|P1|Overall Study|Adverse Event|1
6072853|NCT00441103|20975074|P2|Overall Study|Participant decided to stop|1
6072854|NCT00441103|20975075|P1|Overall Study|Participant decided to stop|0
6072855|NCT00441103|20975074|P2|Overall Study|Participant's reason|1
6072856|NCT00441103|20975075|P1|Overall Study|Participant's reason|0
6072857|NCT00441103|20975074|P2|Overall Study|Participant decided to withdraw|0
6072858|NCT00441103|20975075|P1|Overall Study|Participant decided to withdraw|1
6072859|NCT00441103|20975074|P2|Overall Study|Non-compliant|1
6072860|NCT00441103|20975075|P1|Overall Study|Non-compliant|0
6072861|NCT00441103|20975074|P2|Overall Study|Inclusion criteria absent|0
6072862|NCT00441103|20975075|P1|Overall Study|Inclusion criteria absent|1
6072863|NCT00441103|20975074|P2|Overall Study|Participant refused MRI|0
6072864|NCT00441103|20975075|P1|Overall Study|Participant refused MRI|1
6072865|NCT00441103|20975074|P2|Overall Study|Participant unable to use Rebiject II|0
6072866|NCT00441103|20975075|P1|Overall Study|Participant unable to use Rebiject II|1
6072867|NCT00441103|20975074|P2|Overall Study|Protocol Violation|0
6072868|NCT00441103|20975075|P1|Overall Study|Protocol Violation|1
6072869|NCT00441103|20975074|P2|Overall Study|Lost to Follow-up|0
6072870|NCT00441103|20975075|P1|Overall Study|Lost to Follow-up|1
6072871|NCT00441103|20975074|P2|Overall Study|Disease Progression|0
6072872|NCT00441103|20975075|P1|Overall Study|Disease Progression|2
6072873|NCT00441103|20975074|P2|Overall Study|Death|0
6072874|NCT00441103|20975075|P1|Overall Study|Death|1
6072875|NCT00441103|20975074|P2|Overall Study|Adverse Event|1
6072876|NCT00441103|20975075|P1|Overall Study|Adverse Event|2
6072877|NCT00441090|20975091|P5|Overall Study|Lack of Efficacy|0
6072878|NCT00441090|20975092|P4|Overall Study|Lack of Efficacy|0
6072879|NCT00441090|20975093|P3|Overall Study|Lack of Efficacy|0
6072880|NCT00441090|20975094|P2|Overall Study|Lack of Efficacy|0
6072881|NCT00441090|20975095|P1|Overall Study|Lack of Efficacy|1
6072882|NCT00441090|20975091|P5|Overall Study|Withdrawal by Subject|0
6072883|NCT00441090|20975092|P4|Overall Study|Withdrawal by Subject|0
6072884|NCT00441090|20975093|P3|Overall Study|Withdrawal by Subject|1
6072885|NCT00441090|20975094|P2|Overall Study|Withdrawal by Subject|0
6072886|NCT00441090|20975095|P1|Overall Study|Withdrawal by Subject|1
6072887|NCT00441090|20975091|P5|Overall Study|Platelet increase;more than 500,000 mm^3|0
6072888|NCT00441090|20975092|P4|Overall Study|Platelet increase;more than 500,000 mm^3|2
6072889|NCT00441090|20975093|P3|Overall Study|Platelet increase;more than 500,000 mm^3|0
6072890|NCT00441090|20975094|P2|Overall Study|Platelet increase;more than 500,000 mm^3|0
6072891|NCT00441090|20975095|P1|Overall Study|Platelet increase;more than 500,000 mm^3|0
6072892|NCT00441090|20975091|P5|Overall Study|Adverse Event|0
6072893|NCT00441090|20975092|P4|Overall Study|Adverse Event|0
6072894|NCT00441090|20975093|P3|Overall Study|Adverse Event|1
6072895|NCT00441090|20975094|P2|Overall Study|Adverse Event|1
6072896|NCT00441090|20975095|P1|Overall Study|Adverse Event|0
6072897|NCT00441064|20975139|P2|Overall Study|Patient withdrew consent|2
6072898|NCT00441064|20975140|P1|Overall Study|Patient withdrew consent|5
6072899|NCT00441064|20975139|P2|Overall Study|Protocol Deviation|2
6072900|NCT00441064|20975140|P1|Overall Study|Protocol Deviation|3
6072901|NCT00441064|20975139|P2|Overall Study|Unsatisfactory therapeutic effect|0
6072902|NCT00441064|20975140|P1|Overall Study|Unsatisfactory therapeutic effect|1
6072903|NCT00441064|20975139|P2|Overall Study|Abnormal test procedure results|1
6072904|NCT00441064|20975140|P1|Overall Study|Abnormal test procedure results|0
6072905|NCT00441064|20975139|P2|Overall Study|Abnormal laboratory values|2
6072906|NCT00441064|20975140|P1|Overall Study|Abnormal laboratory values|0
6072907|NCT00441064|20975139|P2|Overall Study|Adverse Event|0
6072908|NCT00441064|20975140|P1|Overall Study|Adverse Event|1
6072909|NCT00441012|20975152|P2|Overall Study|Subject Randomized but Not Vaccinated|0
6072910|NCT00441012|20975153|P1|Overall Study|Subject Randomized but Not Vaccinated|1
6072911|NCT00441012|20975152|P2|Overall Study|Withdrawal by Subject|0
6072912|NCT00441012|20975153|P1|Overall Study|Withdrawal by Subject|4
6072913|NCT00441012|20975152|P2|Overall Study|Protocol Violation|9
6072914|NCT00441012|20975153|P1|Overall Study|Protocol Violation|10
6072915|NCT00441012|20975152|P2|Overall Study|Lost to Follow-up|3
6072916|NCT00441012|20975153|P1|Overall Study|Lost to Follow-up|3
6072917|NCT00441012|20975152|P2|Overall Study|Adverse Event|1
6072918|NCT00441012|20975153|P1|Overall Study|Adverse Event|0
6072919|NCT00440947|20975167|P5|Optional 60-Week Extension Phase|Participant Remained in Cuba|1
6072920|NCT00440947|20975168|P4|Optional 60-Week Extension Phase|Participant Remained in Cuba|0
6072921|NCT00440947|20975169|P3|Optional 60-Week Extension Phase|Participant Remained in Cuba|0
6072922|NCT00440947|20975170|P2|Optional 60-Week Extension Phase|Participant Remained in Cuba|0
6072923|NCT00440947|20975171|P1|Optional 60-Week Extension Phase|Participant Remained in Cuba|0
6072924|NCT00440947|20975167|P5|Optional 60-Week Extension Phase|Physician Decision|1
6072925|NCT00440947|20975168|P4|Optional 60-Week Extension Phase|Physician Decision|0
6072926|NCT00440947|20975169|P3|Optional 60-Week Extension Phase|Physician Decision|0
6072927|NCT00440947|20975170|P2|Optional 60-Week Extension Phase|Physician Decision|0
6072928|NCT00440947|20975171|P1|Optional 60-Week Extension Phase|Physician Decision|0
6072929|NCT00440947|20975167|P5|Optional 60-Week Extension Phase|Other|0
6072930|NCT00440947|20975168|P4|Optional 60-Week Extension Phase|Other|1
6072931|NCT00440947|20975169|P3|Optional 60-Week Extension Phase|Other|0
6072932|NCT00440947|20975170|P2|Optional 60-Week Extension Phase|Other|0
6072933|NCT00440947|20975171|P1|Optional 60-Week Extension Phase|Other|0
6072934|NCT00440947|20975167|P5|Optional 60-Week Extension Phase|Sponsor Terminated Site|3
6072935|NCT00440947|20975168|P4|Optional 60-Week Extension Phase|Sponsor Terminated Site|3
6072936|NCT00440947|20975169|P3|Optional 60-Week Extension Phase|Sponsor Terminated Site|0
6072937|NCT00440947|20975170|P2|Optional 60-Week Extension Phase|Sponsor Terminated Site|0
6072938|NCT00440947|20975171|P1|Optional 60-Week Extension Phase|Sponsor Terminated Site|0
6072939|NCT00440947|20975167|P5|Optional 60-Week Extension Phase|Sponsor Request|1
6072940|NCT00440947|20975168|P4|Optional 60-Week Extension Phase|Sponsor Request|1
6072941|NCT00440947|20975169|P3|Optional 60-Week Extension Phase|Sponsor Request|0
6072942|NCT00440947|20975170|P2|Optional 60-Week Extension Phase|Sponsor Request|0
6072943|NCT00440947|20975171|P1|Optional 60-Week Extension Phase|Sponsor Request|0
6072944|NCT00440947|20975167|P5|Optional 60-Week Extension Phase|Participant Moved|1
6072945|NCT00440947|20975168|P4|Optional 60-Week Extension Phase|Participant Moved|1
6072946|NCT00440947|20975169|P3|Optional 60-Week Extension Phase|Participant Moved|0
6072947|NCT00440947|20975170|P2|Optional 60-Week Extension Phase|Participant Moved|0
6072948|NCT00440947|20975171|P1|Optional 60-Week Extension Phase|Participant Moved|0
6072949|NCT00440947|20975167|P5|Optional 60-Week Extension Phase|Pregnancy|0
6072950|NCT00440947|20975168|P4|Optional 60-Week Extension Phase|Pregnancy|3
6072951|NCT00440947|20975169|P3|Optional 60-Week Extension Phase|Pregnancy|0
6072952|NCT00440947|20975170|P2|Optional 60-Week Extension Phase|Pregnancy|0
6072953|NCT00440947|20975171|P1|Optional 60-Week Extension Phase|Pregnancy|0
6072954|NCT00440947|20975167|P5|Optional 60-Week Extension Phase|Withdrawal by Subject|3
6072955|NCT00440947|20975168|P4|Optional 60-Week Extension Phase|Withdrawal by Subject|4
6072956|NCT00440947|20975169|P3|Optional 60-Week Extension Phase|Withdrawal by Subject|0
6072957|NCT00440947|20975170|P2|Optional 60-Week Extension Phase|Withdrawal by Subject|0
6072958|NCT00440947|20975171|P1|Optional 60-Week Extension Phase|Withdrawal by Subject|0
6072959|NCT00440947|20975167|P5|Optional 60-Week Extension Phase|Protocol Violation|0
6072960|NCT00440947|20975168|P4|Optional 60-Week Extension Phase|Protocol Violation|1
6072961|NCT00440947|20975169|P3|Optional 60-Week Extension Phase|Protocol Violation|0
6072962|NCT00440947|20975170|P2|Optional 60-Week Extension Phase|Protocol Violation|0
6072963|NCT00440947|20975171|P1|Optional 60-Week Extension Phase|Protocol Violation|0
6072964|NCT00440947|20975167|P5|Optional 60-Week Extension Phase|Lost to Follow-up|9
6072965|NCT00440947|20975168|P4|Optional 60-Week Extension Phase|Lost to Follow-up|9
6072966|NCT00440947|20975169|P3|Optional 60-Week Extension Phase|Lost to Follow-up|0
6072967|NCT00440947|20975170|P2|Optional 60-Week Extension Phase|Lost to Follow-up|0
6072968|NCT00440947|20975171|P1|Optional 60-Week Extension Phase|Lost to Follow-up|0
6072969|NCT00440947|20975167|P5|Optional 60-Week Extension Phase|Non-compliance|1
6072970|NCT00440947|20975168|P4|Optional 60-Week Extension Phase|Non-compliance|1
6072971|NCT00440947|20975169|P3|Optional 60-Week Extension Phase|Non-compliance|0
6072972|NCT00440947|20975170|P2|Optional 60-Week Extension Phase|Non-compliance|0
6072973|NCT00440947|20975171|P1|Optional 60-Week Extension Phase|Non-compliance|0
6072974|NCT00440947|20975167|P5|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|2
6072975|NCT00440947|20975168|P4|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|3
6072976|NCT00440947|20975169|P3|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0
6072977|NCT00440947|20975170|P2|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0
6072978|NCT00440947|20975171|P1|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0
6072979|NCT00440947|20975167|P5|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1
6072980|NCT00440947|20975168|P4|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1
6072981|NCT00440947|20975169|P3|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0
6072982|NCT00440947|20975170|P2|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0
6072983|NCT00440947|20975171|P1|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0
6072984|NCT00440947|20975167|P5|Optional 60-Week Extension Phase|Adverse Event|3
6072985|NCT00440947|20975168|P4|Optional 60-Week Extension Phase|Adverse Event|1
6072986|NCT00440947|20975169|P3|Optional 60-Week Extension Phase|Adverse Event|0
6072987|NCT00440947|20975170|P2|Optional 60-Week Extension Phase|Adverse Event|0
6072988|NCT00440947|20975171|P1|Optional 60-Week Extension Phase|Adverse Event|0
6072989|NCT00440947|20975167|P5|48-Week Randomization Phase|Physician Decision|0
6072990|NCT00440947|20975168|P4|48-Week Randomization Phase|Physician Decision|0
6072991|NCT00440947|20975169|P3|48-Week Randomization Phase|Physician Decision|0
6072992|NCT00440947|20975170|P2|48-Week Randomization Phase|Physician Decision|2
6072993|NCT00440947|20975171|P1|48-Week Randomization Phase|Physician Decision|0
6072994|NCT00440947|20975167|P5|48-Week Randomization Phase|Trying to Get Pregnant|0
6072995|NCT00440947|20975168|P4|48-Week Randomization Phase|Trying to Get Pregnant|0
6072996|NCT00440947|20975169|P3|48-Week Randomization Phase|Trying to Get Pregnant|0
6072997|NCT00440947|20975170|P2|48-Week Randomization Phase|Trying to Get Pregnant|1
6072998|NCT00440947|20975171|P1|48-Week Randomization Phase|Trying to Get Pregnant|0
6072999|NCT00440947|20975167|P5|48-Week Randomization Phase|Incarceration|0
6073000|NCT00440947|20975168|P4|48-Week Randomization Phase|Incarceration|0
6073001|NCT00440947|20975169|P3|48-Week Randomization Phase|Incarceration|0
6073002|NCT00440947|20975170|P2|48-Week Randomization Phase|Incarceration|3
6073003|NCT00440947|20975171|P1|48-Week Randomization Phase|Incarceration|0
6073004|NCT00440947|20975167|P5|48-Week Randomization Phase|Pregnancy|0
6073005|NCT00440947|20975168|P4|48-Week Randomization Phase|Pregnancy|0
6073006|NCT00440947|20975169|P3|48-Week Randomization Phase|Pregnancy|1
6073007|NCT00440947|20975170|P2|48-Week Randomization Phase|Pregnancy|0
6073008|NCT00440947|20975171|P1|48-Week Randomization Phase|Pregnancy|0
6073009|NCT00440947|20975167|P5|48-Week Randomization Phase|Withdrawal by Subject|0
6073010|NCT00440947|20975168|P4|48-Week Randomization Phase|Withdrawal by Subject|0
6073011|NCT00440947|20975169|P3|48-Week Randomization Phase|Withdrawal by Subject|4
6073012|NCT00440947|20975170|P2|48-Week Randomization Phase|Withdrawal by Subject|2
6073013|NCT00440947|20975171|P1|48-Week Randomization Phase|Withdrawal by Subject|0
6073014|NCT00440947|20975167|P5|48-Week Randomization Phase|Protocol Violation|0
6073015|NCT00440947|20975168|P4|48-Week Randomization Phase|Protocol Violation|0
6073016|NCT00440947|20975169|P3|48-Week Randomization Phase|Protocol Violation|1
6073017|NCT00440947|20975170|P2|48-Week Randomization Phase|Protocol Violation|0
6073018|NCT00440947|20975171|P1|48-Week Randomization Phase|Protocol Violation|0
6073019|NCT00440947|20975167|P5|48-Week Randomization Phase|Lost to Follow-up|0
6073020|NCT00440947|20975168|P4|48-Week Randomization Phase|Lost to Follow-up|0
6073021|NCT00440947|20975169|P3|48-Week Randomization Phase|Lost to Follow-up|8
6073022|NCT00440947|20975170|P2|48-Week Randomization Phase|Lost to Follow-up|2
6073023|NCT00440947|20975171|P1|48-Week Randomization Phase|Lost to Follow-up|0
6073024|NCT00440947|20975167|P5|48-Week Randomization Phase|Non-compliance|0
6073025|NCT00440947|20975168|P4|48-Week Randomization Phase|Non-compliance|0
6073026|NCT00440947|20975169|P3|48-Week Randomization Phase|Non-compliance|4
6073027|NCT00440947|20975170|P2|48-Week Randomization Phase|Non-compliance|3
6073028|NCT00440947|20975171|P1|48-Week Randomization Phase|Non-compliance|0
6073029|NCT00440947|20975167|P5|48-Week Randomization Phase|Protocol-defined Virologic Failure|0
6073030|NCT00440947|20975168|P4|48-Week Randomization Phase|Protocol-defined Virologic Failure|0
6073031|NCT00440947|20975169|P3|48-Week Randomization Phase|Protocol-defined Virologic Failure|1
6073032|NCT00440947|20975170|P2|48-Week Randomization Phase|Protocol-defined Virologic Failure|1
6073033|NCT00440947|20975171|P1|48-Week Randomization Phase|Protocol-defined Virologic Failure|0
6073034|NCT00440947|20975167|P5|48-Week Randomization Phase|Adverse Event|0
6073035|NCT00440947|20975168|P4|48-Week Randomization Phase|Adverse Event|0
6073036|NCT00440947|20975169|P3|48-Week Randomization Phase|Adverse Event|5
6073037|NCT00440947|20975170|P2|48-Week Randomization Phase|Adverse Event|2
6073038|NCT00440947|20975171|P1|48-Week Randomization Phase|Adverse Event|0
6073039|NCT00440947|20975167|P5|36-Week Induction Phase|Pregnancy|0
6073040|NCT00440947|20975168|P4|36-Week Induction Phase|Pregnancy|0
6073041|NCT00440947|20975169|P3|36-Week Induction Phase|Pregnancy|0
6073042|NCT00440947|20975170|P2|36-Week Induction Phase|Pregnancy|0
6073043|NCT00440947|20975171|P1|36-Week Induction Phase|Pregnancy|1
6073044|NCT00440947|20975167|P5|36-Week Induction Phase|Incarceration|0
6073045|NCT00440947|20975168|P4|36-Week Induction Phase|Incarceration|0
6073046|NCT00440947|20975169|P3|36-Week Induction Phase|Incarceration|0
6073047|NCT00440947|20975170|P2|36-Week Induction Phase|Incarceration|0
6073048|NCT00440947|20975171|P1|36-Week Induction Phase|Incarceration|3
6073049|NCT00440947|20975167|P5|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0
6073050|NCT00440947|20975168|P4|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0
6073051|NCT00440947|20975169|P3|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0
6073052|NCT00440947|20975170|P2|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0
6073053|NCT00440947|20975171|P1|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|1
6073054|NCT00440947|20975167|P5|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0
6073055|NCT00440947|20975168|P4|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0
6073056|NCT00440947|20975169|P3|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0
6073057|NCT00440947|20975170|P2|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0
6073058|NCT00440947|20975171|P1|36-Week Induction Phase|Genotype Had Exclusionary Mutations|1
6073059|NCT00440947|20975167|P5|36-Week Induction Phase|Took Exclusionary Medications|0
6073060|NCT00440947|20975168|P4|36-Week Induction Phase|Took Exclusionary Medications|0
6073061|NCT00440947|20975169|P3|36-Week Induction Phase|Took Exclusionary Medications|0
6073062|NCT00440947|20975170|P2|36-Week Induction Phase|Took Exclusionary Medications|0
6073063|NCT00440947|20975171|P1|36-Week Induction Phase|Took Exclusionary Medications|1
6073064|NCT00440947|20975167|P5|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0
6073065|NCT00440947|20975168|P4|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0
6073066|NCT00440947|20975169|P3|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0
6073067|NCT00440947|20975170|P2|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0
6073068|NCT00440947|20975171|P1|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|1
6073069|NCT00440947|20975167|P5|36-Week Induction Phase|Withdrawal by Subject|0
6073070|NCT00440947|20975168|P4|36-Week Induction Phase|Withdrawal by Subject|0
6073071|NCT00440947|20975169|P3|36-Week Induction Phase|Withdrawal by Subject|0
6073072|NCT00440947|20975170|P2|36-Week Induction Phase|Withdrawal by Subject|0
6073073|NCT00440947|20975171|P1|36-Week Induction Phase|Withdrawal by Subject|7
6073074|NCT00440947|20975167|P5|36-Week Induction Phase|Lost to Follow-up|0
6073075|NCT00440947|20975168|P4|36-Week Induction Phase|Lost to Follow-up|0
6073076|NCT00440947|20975169|P3|36-Week Induction Phase|Lost to Follow-up|0
6073077|NCT00440947|20975170|P2|36-Week Induction Phase|Lost to Follow-up|0
6073078|NCT00440947|20975171|P1|36-Week Induction Phase|Lost to Follow-up|16
6073079|NCT00440947|20975167|P5|36-Week Induction Phase|Non-compliance|0
6073080|NCT00440947|20975168|P4|36-Week Induction Phase|Non-compliance|0
6073081|NCT00440947|20975169|P3|36-Week Induction Phase|Non-compliance|0
6073082|NCT00440947|20975170|P2|36-Week Induction Phase|Non-compliance|0
6073083|NCT00440947|20975171|P1|36-Week Induction Phase|Non-compliance|10
6073084|NCT00440947|20975167|P5|36-Week Induction Phase|Protocol-defined Virologic Failure|0
6073085|NCT00440947|20975168|P4|36-Week Induction Phase|Protocol-defined Virologic Failure|0
6073086|NCT00440947|20975169|P3|36-Week Induction Phase|Protocol-defined Virologic Failure|0
6073087|NCT00440947|20975170|P2|36-Week Induction Phase|Protocol-defined Virologic Failure|0
6073088|NCT00440947|20975171|P1|36-Week Induction Phase|Protocol-defined Virologic Failure|5
6073089|NCT00440947|20975167|P5|36-Week Induction Phase|Insufficient Viral Load Response|0
6073090|NCT00440947|20975168|P4|36-Week Induction Phase|Insufficient Viral Load Response|0
6073091|NCT00440947|20975169|P3|36-Week Induction Phase|Insufficient Viral Load Response|0
6073092|NCT00440947|20975170|P2|36-Week Induction Phase|Insufficient Viral Load Response|0
6073093|NCT00440947|20975171|P1|36-Week Induction Phase|Insufficient Viral Load Response|11
6073094|NCT00440947|20975167|P5|36-Week Induction Phase|Adverse Event|0
6073095|NCT00440947|20975168|P4|36-Week Induction Phase|Adverse Event|0
6073096|NCT00440947|20975169|P3|36-Week Induction Phase|Adverse Event|0
6073097|NCT00440947|20975170|P2|36-Week Induction Phase|Adverse Event|0
6073098|NCT00440947|20975171|P1|36-Week Induction Phase|Adverse Event|16
6073099|NCT00440726|20975246|P3|Phase 2|Adverse Event|1
6073100|NCT00440726|20975247|P2|Phase 2|Adverse Event|0
6073101|NCT00440726|20975248|P1|Phase 2|Adverse Event|0
6073102|NCT00440726|20975246|P3|Phase 2|Death|1
6073103|NCT00440726|20975247|P2|Phase 2|Death|0
6073104|NCT00440726|20975248|P1|Phase 2|Death|0
6073105|NCT00440726|20975246|P3|Phase 1|Physician Decision|0
6073106|NCT00440726|20975247|P2|Phase 1|Physician Decision|0
6073107|NCT00440726|20975248|P1|Phase 1|Physician Decision|1
6073108|NCT00440726|20975246|P3|Phase 1|Dose-Limiting Toxicity|0
6073109|NCT00440726|20975247|P2|Phase 1|Dose-Limiting Toxicity|1
6073110|NCT00440726|20975248|P1|Phase 1|Dose-Limiting Toxicity|0
6073111|NCT00440700|20975262|P3|Overall Study|Withdrawal by Subject|4
6073112|NCT00440700|20975263|P2|Overall Study|Withdrawal by Subject|8
6073113|NCT00440700|20975264|P1|Overall Study|Withdrawal by Subject|8
6073114|NCT00440557|20975298|P3|Overall Study|Patient had surgery|0
6073115|NCT00440557|20975299|P2|Overall Study|Patient had surgery|0
6073116|NCT00440557|20975300|P1|Overall Study|Patient had surgery|1
6073117|NCT00440557|20975298|P3|Overall Study|Patient transferred to nursing home|0
6073118|NCT00440557|20975299|P2|Overall Study|Patient transferred to nursing home|1
6073119|NCT00440557|20975300|P1|Overall Study|Patient transferred to nursing home|0
6073120|NCT00440557|20975298|P3|Overall Study|Principal Investigator's office closed|4
6073121|NCT00440557|20975299|P2|Overall Study|Principal Investigator's office closed|6
6073122|NCT00440557|20975300|P1|Overall Study|Principal Investigator's office closed|3
6073123|NCT00440557|20975298|P3|Overall Study|Patient moved|1
6073124|NCT00440557|20975299|P2|Overall Study|Patient moved|2
6073125|NCT00440557|20975300|P1|Overall Study|Patient moved|1
6073126|NCT00440557|20975298|P3|Overall Study|Principal Investigator decision|1
6073127|NCT00440557|20975299|P2|Overall Study|Principal Investigator decision|3
6073128|NCT00440557|20975300|P1|Overall Study|Principal Investigator decision|0
6073129|NCT00440557|20975298|P3|Overall Study|Began Dialysis|4
6073130|NCT00440557|20975299|P2|Overall Study|Began Dialysis|1
6073131|NCT00440557|20975300|P1|Overall Study|Began Dialysis|4
6073132|NCT00440557|20975298|P3|Overall Study|Death|3
6073133|NCT00440557|20975299|P2|Overall Study|Death|6
6073134|NCT00440557|20975300|P1|Overall Study|Death|2
6073135|NCT00440557|20975298|P3|Overall Study|Adverse Event|5
6073136|NCT00440557|20975299|P2|Overall Study|Adverse Event|3
6073137|NCT00440557|20975300|P1|Overall Study|Adverse Event|3
6073138|NCT00440557|20975298|P3|Overall Study|Lost to Follow-up|6
6073139|NCT00440557|20975299|P2|Overall Study|Lost to Follow-up|2
6073140|NCT00440557|20975300|P1|Overall Study|Lost to Follow-up|1
6073141|NCT00440557|20975298|P3|Overall Study|Withdrawal by Subject|11
6073142|NCT00440557|20975299|P2|Overall Study|Withdrawal by Subject|5
6073143|NCT00440557|20975300|P1|Overall Study|Withdrawal by Subject|10
6073144|NCT00440531|20975332|P3|Overall Study|see pre-assignment details|0
6073145|NCT00440531|20975333|P2|Overall Study|see pre-assignment details|0
6073146|NCT00440531|20975334|P1|Overall Study|see pre-assignment details|2
6073147|NCT00440531|20975332|P3|Overall Study|Lost to Follow-up|5
6073148|NCT00440531|20975333|P2|Overall Study|Lost to Follow-up|3
6073149|NCT00440531|20975334|P1|Overall Study|Lost to Follow-up|4
6073150|NCT00440531|20975332|P3|Overall Study|Protocol Violation|0
6073151|NCT00440531|20975333|P2|Overall Study|Protocol Violation|2
6073152|NCT00440531|20975334|P1|Overall Study|Protocol Violation|1
6073153|NCT00440531|20975332|P3|Overall Study|Withdrawal by Subject|0
6073154|NCT00440531|20975333|P2|Overall Study|Withdrawal by Subject|0
6073155|NCT00440531|20975334|P1|Overall Study|Withdrawal by Subject|2
6073156|NCT00440531|20975332|P3|Overall Study|Adverse Event|2
6073157|NCT00440531|20975333|P2|Overall Study|Adverse Event|0
6073158|NCT00440531|20975334|P1|Overall Study|Adverse Event|1
6073159|NCT00440518|20975351|P3|Maintenance and Safety Follow-up Periods|Lost to Follow-up|0
6073160|NCT00440518|20975352|P2|Maintenance and Safety Follow-up Periods|Lost to Follow-up|2
6073161|NCT00440518|20975353|P1|Maintenance and Safety Follow-up Periods|Lost to Follow-up|1
6073162|NCT00440518|20975351|P3|Maintenance and Safety Follow-up Periods|Other|2
6073163|NCT00440518|20975352|P2|Maintenance and Safety Follow-up Periods|Other|0
6073164|NCT00440518|20975353|P1|Maintenance and Safety Follow-up Periods|Other|0
6073165|NCT00440518|20975351|P3|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|6
6073166|NCT00440518|20975352|P2|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|3
6073167|NCT00440518|20975353|P1|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|0
6073168|NCT00440518|20975351|P3|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|4
6073169|NCT00440518|20975352|P2|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|2
6073170|NCT00440518|20975353|P1|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|3
6073171|NCT00440518|20975351|P3|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1
6073172|NCT00440518|20975352|P2|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1
6073173|NCT00440518|20975353|P1|Maintenance and Safety Follow-up Periods|Lack of Efficacy|0
6073174|NCT00440518|20975351|P3|Maintenance and Safety Follow-up Periods|Adverse Event|2
6073175|NCT00440518|20975352|P2|Maintenance and Safety Follow-up Periods|Adverse Event|4
6073176|NCT00440518|20975353|P1|Maintenance and Safety Follow-up Periods|Adverse Event|3
6073177|NCT00440518|20975351|P3|Randomized /Titration Period|Adverse Event|0
6073178|NCT00440518|20975352|P2|Randomized /Titration Period|Adverse Event|3
6073179|NCT00440518|20975353|P1|Randomized /Titration Period|Adverse Event|2
6073180|NCT00440518|20975351|P3|Randomized /Titration Period|Lost to Follow-up|1
6073181|NCT00440518|20975352|P2|Randomized /Titration Period|Lost to Follow-up|2
6073182|NCT00440518|20975353|P1|Randomized /Titration Period|Lost to Follow-up|2
6073183|NCT00440518|20975351|P3|Randomized /Titration Period|Other|0
6073184|NCT00440518|20975352|P2|Randomized /Titration Period|Other|0
6073185|NCT00440518|20975353|P1|Randomized /Titration Period|Other|1
6073186|NCT00440518|20975351|P3|Randomized /Titration Period|Unsatisfactory Compliance|2
6073187|NCT00440518|20975352|P2|Randomized /Titration Period|Unsatisfactory Compliance|3
6073188|NCT00440518|20975353|P1|Randomized /Titration Period|Unsatisfactory Compliance|2
6073189|NCT00440518|20975351|P3|Randomized /Titration Period|Protocol Deviation|0
6073190|NCT00440518|20975352|P2|Randomized /Titration Period|Protocol Deviation|0
6073191|NCT00440518|20975353|P1|Randomized /Titration Period|Protocol Deviation|1
6073192|NCT00440518|20975351|P3|Randomized /Titration Period|Subject Withdrew Consent|0
6073193|NCT00440518|20975352|P2|Randomized /Titration Period|Subject Withdrew Consent|1
6073194|NCT00440518|20975353|P1|Randomized /Titration Period|Subject Withdrew Consent|4
6073195|NCT00440518|20975351|P3|Randomized /Titration Period|Lack of Efficacy|1
6073196|NCT00440518|20975352|P2|Randomized /Titration Period|Lack of Efficacy|0
6073197|NCT00440518|20975353|P1|Randomized /Titration Period|Lack of Efficacy|1
6073198|NCT00440466|20975398|P3|Overall Study|Met Hemoglobin Withdrawal Criteria|4
6073199|NCT00440466|20975399|P2|Overall Study|Met Hemoglobin Withdrawal Criteria|4
6073200|NCT00440466|20975400|P1|Overall Study|Met Hemoglobin Withdrawal Criteria|0
6073201|NCT00440466|20975398|P3|Overall Study|Began Dialysis|1
6073202|NCT00440466|20975399|P2|Overall Study|Began Dialysis|0
6073203|NCT00440466|20975400|P1|Overall Study|Began Dialysis|0
6073204|NCT00440466|20975398|P3|Overall Study|Withdrawal by Subject|9
6073205|NCT00440466|20975399|P2|Overall Study|Withdrawal by Subject|5
6073206|NCT00440466|20975400|P1|Overall Study|Withdrawal by Subject|2
6073207|NCT00440466|20975398|P3|Overall Study|Protocol Violation|4
6073208|NCT00440466|20975399|P2|Overall Study|Protocol Violation|0
6073209|NCT00440466|20975400|P1|Overall Study|Protocol Violation|2
6073210|NCT00440466|20975398|P3|Overall Study|Physician Decision|1
6073211|NCT00440466|20975399|P2|Overall Study|Physician Decision|0
6073212|NCT00440466|20975400|P1|Overall Study|Physician Decision|2
6073213|NCT00440466|20975398|P3|Overall Study|Lost to Follow-up|2
6073214|NCT00440466|20975399|P2|Overall Study|Lost to Follow-up|0
6073215|NCT00440466|20975400|P1|Overall Study|Lost to Follow-up|1
6073216|NCT00440466|20975398|P3|Overall Study|Adverse Event|11
6073217|NCT00440466|20975399|P2|Overall Study|Adverse Event|4
6073218|NCT00440466|20975400|P1|Overall Study|Adverse Event|3
6073219|NCT00440466|20975398|P3|Overall Study|Death|9
6073220|NCT00440466|20975399|P2|Overall Study|Death|2
6073221|NCT00440466|20975400|P1|Overall Study|Death|3
6073222|NCT00440401|20975434|P2|Overall Study|Other|5
6073223|NCT00440401|20975435|P1|Overall Study|Other|2
6073224|NCT00440401|20975434|P2|Overall Study|Adverse Event|1
6073225|NCT00440401|20975435|P1|Overall Study|Adverse Event|2
6073226|NCT00440310|20975445|P2|Overall Study|Status Unknown|3
6073227|NCT00440310|20975446|P1|Overall Study|Status Unknown|1
6073228|NCT00440310|20975445|P2|Overall Study|Other|0
6073229|NCT00440310|20975446|P1|Overall Study|Other|1
6073230|NCT00440310|20975445|P2|Overall Study|No Reply at EOS|7
6073231|NCT00440310|20975446|P1|Overall Study|No Reply at EOS|7
6073232|NCT00440310|20975445|P2|Overall Study|Withdrawal by Subject|14
6073233|NCT00440310|20975446|P1|Overall Study|Withdrawal by Subject|15
6073234|NCT00440310|20975445|P2|Overall Study|Protocol Violation|1
6073235|NCT00440310|20975446|P1|Overall Study|Protocol Violation|0
6073236|NCT00440310|20975445|P2|Overall Study|Lost to Follow-up|5
6073237|NCT00440310|20975446|P1|Overall Study|Lost to Follow-up|4
6073238|NCT00440297|20975454|P2|Overall Study|Randomized by mistake|0
6073239|NCT00440297|20975455|P1|Overall Study|Randomized by mistake|1
6073240|NCT00440297|20975454|P2|Overall Study|Withdrawal by Subject|6
6073241|NCT00440297|20975455|P1|Overall Study|Withdrawal by Subject|1
6073242|NCT00440297|20975454|P2|Overall Study|Protocol Violation|7
6073243|NCT00440297|20975455|P1|Overall Study|Protocol Violation|11
6073244|NCT00440297|20975454|P2|Overall Study|Physician Decision|0
6073245|NCT00440297|20975455|P1|Overall Study|Physician Decision|1
6073246|NCT00440297|20975454|P2|Overall Study|Lost to Follow-up|0
6073247|NCT00440297|20975455|P1|Overall Study|Lost to Follow-up|1
6073248|NCT00440297|20975454|P2|Overall Study|Adverse Event|5
6073249|NCT00440297|20975455|P1|Overall Study|Adverse Event|8
6073250|NCT00440271|20975471|P2|Overall Study|Other|0
6073251|NCT00440271|20975472|P1|Overall Study|Other|2
6073252|NCT00440271|20975471|P2|Overall Study|Due to closure of trial|10
6073253|NCT00440271|20975472|P1|Overall Study|Due to closure of trial|8
6073254|NCT00440271|20975471|P2|Overall Study|Lack of Efficacy|1
6073255|NCT00440271|20975472|P1|Overall Study|Lack of Efficacy|0
6073256|NCT00440271|20975471|P2|Overall Study|Withdrawal by Subject|2
6073257|NCT00440271|20975472|P1|Overall Study|Withdrawal by Subject|0
6073258|NCT00440271|20975471|P2|Overall Study|Lost to Follow-up|0
6073259|NCT00440271|20975472|P1|Overall Study|Lost to Follow-up|1
6073260|NCT00440271|20975471|P2|Overall Study|Adverse Event|1
6073261|NCT00440271|20975472|P1|Overall Study|Adverse Event|0
6073262|NCT00440271|20975471|P2|Overall Study|Protocol Violation|1
6073263|NCT00440271|20975472|P1|Overall Study|Protocol Violation|1
6073264|NCT00440232|20975506|P2|Overall Study|Onset of headache within 4 hours of fast|2
6073265|NCT00440232|20975507|P1|Overall Study|Onset of headache within 4 hours of fast|2
6073266|NCT00440232|20975506|P2|Overall Study|Unable to treat within allowed time|1
6073267|NCT00440232|20975507|P1|Overall Study|Unable to treat within allowed time|0
6073268|NCT00440232|20975506|P2|Overall Study|Lost to Follow-up|1
6073269|NCT00440232|20975507|P1|Overall Study|Lost to Follow-up|1
6073270|NCT00440193|20975517|P2|Observational Period|Participant convenience|0
6073271|NCT00440193|20975518|P1|Observational Period|Participant convenience|2
6073272|NCT00440193|20975517|P2|Observational Period|Clinical endpoint reached|0
6073273|NCT00440193|20975518|P1|Observational Period|Clinical endpoint reached|1
6073274|NCT00440193|20975517|P2|Observational Period|Physician Decision|0
6073275|NCT00440193|20975518|P1|Observational Period|Physician Decision|1
6073276|NCT00440193|20975517|P2|Observational Period|Withdrawal by Subject|8
6073277|NCT00440193|20975518|P1|Observational Period|Withdrawal by Subject|11
6073278|NCT00440193|20975517|P2|Observational Period|Protocol Violation|0
6073279|NCT00440193|20975518|P1|Observational Period|Protocol Violation|1
6073280|NCT00440193|20975517|P2|Observational Period|Lost to Follow-up|8
6073281|NCT00440193|20975518|P1|Observational Period|Lost to Follow-up|12
6073282|NCT00440193|20975517|P2|Observational Period|Death|20
6073283|NCT00440193|20975518|P1|Observational Period|Death|15
6073284|NCT00440193|20975517|P2|Observational Period|Adverse Event|2
6073285|NCT00440193|20975518|P1|Observational Period|Adverse Event|2
6073286|NCT00440193|20975517|P2|Treatment Period|Site closed by investigator|2
6073287|NCT00440193|20975518|P1|Treatment Period|Site closed by investigator|0
6073288|NCT00440193|20975517|P2|Treatment Period|Participant did not receive treatment|13
6073289|NCT00440193|20975518|P1|Treatment Period|Participant did not receive treatment|7
6073290|NCT00440193|20975517|P2|Treatment Period|Participant convenience|2
6073291|NCT00440193|20975518|P1|Treatment Period|Participant convenience|5
6073292|NCT00440193|20975517|P2|Treatment Period|Technical problems|1
6073293|NCT00440193|20975518|P1|Treatment Period|Technical problems|1
6073294|NCT00440193|20975517|P2|Treatment Period|Switch to commercial drug|2
6073295|NCT00440193|20975518|P1|Treatment Period|Switch to commercial drug|0
6073296|NCT00440193|20975517|P2|Treatment Period|Protocol driven decision point|2
6073297|NCT00440193|20975518|P1|Treatment Period|Protocol driven decision point|2
6073298|NCT00440193|20975517|P2|Treatment Period|Study terminated by sponsor|94
6073299|NCT00440193|20975518|P1|Treatment Period|Study terminated by sponsor|102
6073300|NCT00440193|20975517|P2|Treatment Period|Clinical endpoint reached|25
6073301|NCT00440193|20975518|P1|Treatment Period|Clinical endpoint reached|28
6073302|NCT00440193|20975517|P2|Treatment Period|Withdrawal by Subject|77
6073303|NCT00440193|20975518|P1|Treatment Period|Withdrawal by Subject|36
6073304|NCT00440193|20975517|P2|Treatment Period|Protocol Violation|19
6073305|NCT00440193|20975518|P1|Treatment Period|Protocol Violation|16
6073306|NCT00440193|20975517|P2|Treatment Period|Physician Decision|6
6073307|NCT00440193|20975518|P1|Treatment Period|Physician Decision|3
6073308|NCT00440193|20975517|P2|Treatment Period|Lost to Follow-up|18
6073309|NCT00440193|20975518|P1|Treatment Period|Lost to Follow-up|12
6073310|NCT00440193|20975517|P2|Treatment Period|Lack of Efficacy|1
6073311|NCT00440193|20975518|P1|Treatment Period|Lack of Efficacy|0
6073312|NCT00440193|20975517|P2|Treatment Period|Death|22
6073313|NCT00440193|20975518|P1|Treatment Period|Death|19
6073314|NCT00440193|20975517|P2|Treatment Period|Adverse Event|67
6073315|NCT00440193|20975518|P1|Treatment Period|Adverse Event|74
6073316|NCT00440115|20975564|P3|Overall Study|Incarceration|1
6073317|NCT00440115|20975565|P2|Overall Study|Incarceration|2
6073318|NCT00440115|20975566|P1|Overall Study|Incarceration|0
6073319|NCT00440115|20975564|P3|Overall Study|Death|5
6073320|NCT00440115|20975565|P2|Overall Study|Death|9
6073321|NCT00440115|20975566|P1|Overall Study|Death|7
6073322|NCT00440037|20975595|P1|Overall Study|Administrative decision|3
6073323|NCT00440037|20975595|P1|Overall Study|Withdrawal by Subject|6
6073324|NCT00440011|20975605|P2|Overall Study|Withdrawal by Subject|0
6073325|NCT00440011|20975606|P1|Overall Study|Withdrawal by Subject|1
6073326|NCT00440011|20975605|P2|Overall Study|Protocol Violation|1
6073327|NCT00440011|20975606|P1|Overall Study|Protocol Violation|1
6073328|NCT00440011|20975605|P2|Overall Study|Lost to Follow-up|2
6073329|NCT00440011|20975606|P1|Overall Study|Lost to Follow-up|0
6073330|NCT00440011|20975605|P2|Overall Study|Adverse Event|0
6073331|NCT00440011|20975606|P1|Overall Study|Adverse Event|2
6073332|NCT00439777|20975633|P2|Observational Period|Technical problems|1
6073333|NCT00439777|20975634|P1|Observational Period|Technical problems|0
6073334|NCT00439777|20975633|P2|Observational Period|Lack of Efficacy|0
6073335|NCT00439777|20975634|P1|Observational Period|Lack of Efficacy|1
6073336|NCT00439777|20975633|P2|Observational Period|Protocol driven decision point|1
6073337|NCT00439777|20975634|P1|Observational Period|Protocol driven decision point|0
6073338|NCT00439777|20975633|P2|Observational Period|Study terminated by sponsor|1
6073339|NCT00439777|20975634|P1|Observational Period|Study terminated by sponsor|3
6073340|NCT00439777|20975633|P2|Observational Period|Death|20
6073341|NCT00439777|20975634|P1|Observational Period|Death|27
6073342|NCT00439777|20975633|P2|Observational Period|Lost to Follow-up|11
6073343|NCT00439777|20975634|P1|Observational Period|Lost to Follow-up|1
6073344|NCT00439777|20975633|P2|Observational Period|Withdrawal by Subject|5
6073345|NCT00439777|20975634|P1|Observational Period|Withdrawal by Subject|9
6073346|NCT00439777|20975633|P2|Observational Period|Protocol Violation|2
6073347|NCT00439777|20975634|P1|Observational Period|Protocol Violation|0
6073348|NCT00439777|20975633|P2|Treatment Period|Participant convenience|8
6073349|NCT00439777|20975634|P1|Treatment Period|Participant convenience|12
6073350|NCT00439777|20975633|P2|Treatment Period|Technical problems|1
6073351|NCT00439777|20975634|P1|Treatment Period|Technical problems|3
6073352|NCT00439777|20975633|P2|Treatment Period|Clinical endpoint reached|13
6073353|NCT00439777|20975634|P1|Treatment Period|Clinical endpoint reached|26
6073354|NCT00439777|20975633|P2|Treatment Period|Physician Decision|18
6073355|NCT00439777|20975634|P1|Treatment Period|Physician Decision|7
6073356|NCT00439777|20975633|P2|Treatment Period|Protocol driven decision point|3
6073357|NCT00439777|20975634|P1|Treatment Period|Protocol driven decision point|1
6073358|NCT00439777|20975633|P2|Treatment Period|Lost to Follow-up|10
6073359|NCT00439777|20975634|P1|Treatment Period|Lost to Follow-up|8
6073360|NCT00439777|20975633|P2|Treatment Period|Lack of Efficacy|4
6073361|NCT00439777|20975634|P1|Treatment Period|Lack of Efficacy|1
6073362|NCT00439777|20975633|P2|Treatment Period|Withdrawal by Subject|118
6073363|NCT00439777|20975634|P1|Treatment Period|Withdrawal by Subject|66
6073364|NCT00439777|20975633|P2|Treatment Period|Protocol Violation|30
6073365|NCT00439777|20975634|P1|Treatment Period|Protocol Violation|23
6073366|NCT00439777|20975633|P2|Treatment Period|Adverse Event|92
6073367|NCT00439777|20975634|P1|Treatment Period|Adverse Event|111
6073368|NCT00439777|20975633|P2|Treatment Period|Did not take study treatment|8
6073369|NCT00439777|20975634|P1|Treatment Period|Did not take study treatment|7
6073370|NCT00439777|20975633|P2|Treatment Period|Site closed by investigator|1
6073371|NCT00439777|20975634|P1|Treatment Period|Site closed by investigator|0
6073372|NCT00439777|20975633|P2|Treatment Period|Study terminated by sponsor|132
6073373|NCT00439777|20975634|P1|Treatment Period|Study terminated by sponsor|125
6073374|NCT00439777|20975633|P2|Treatment Period|Death|21
6073375|NCT00439777|20975634|P1|Treatment Period|Death|29
6073376|NCT00439738|20975672|P2|Overall Study|Abnormal Lab Values|0
6073377|NCT00439738|20975673|P1|Overall Study|Abnormal Lab Values|1
6073378|NCT00439738|20975672|P2|Overall Study|Lack of Efficacy|2
6073379|NCT00439738|20975673|P1|Overall Study|Lack of Efficacy|2
6073380|NCT00439738|20975672|P2|Overall Study|Protocol Violation|3
6073381|NCT00439738|20975673|P1|Overall Study|Protocol Violation|6
6073382|NCT00439738|20975672|P2|Overall Study|Lost to Follow-up|6
6073383|NCT00439738|20975673|P1|Overall Study|Lost to Follow-up|5
6073384|NCT00439738|20975672|P2|Overall Study|Adverse Event|4
6073385|NCT00439738|20975673|P1|Overall Study|Adverse Event|6
6073386|NCT00439738|20975672|P2|Overall Study|Withdrawal by Subject|13
6073387|NCT00439738|20975673|P1|Overall Study|Withdrawal by Subject|16
6073388|NCT00439725|20975691|P2|Observational Period|Participant convenience|0
6073389|NCT00439725|20975692|P1|Observational Period|Participant convenience|1
6073390|NCT00439725|20975691|P2|Observational Period|Technical problems|0
6073391|NCT00439725|20975692|P1|Observational Period|Technical problems|1
6073392|NCT00439725|20975691|P2|Observational Period|Clinical endpoint reached|1
6073393|NCT00439725|20975692|P1|Observational Period|Clinical endpoint reached|3
6073394|NCT00439725|20975691|P2|Observational Period|Study termination by sponsor|1
6073395|NCT00439725|20975692|P1|Observational Period|Study termination by sponsor|1
6073396|NCT00439725|20975691|P2|Observational Period|Death|2
6073397|NCT00439725|20975692|P1|Observational Period|Death|0
6073398|NCT00439725|20975691|P2|Observational Period|Lost to Follow-up|1
6073399|NCT00439725|20975692|P1|Observational Period|Lost to Follow-up|0
6073400|NCT00439725|20975691|P2|Observational Period|Withdrawal by Subject|2
6073401|NCT00439725|20975692|P1|Observational Period|Withdrawal by Subject|2
6073402|NCT00439725|20975691|P2|Treatment Period|Participant did not receive treatment|4
6073403|NCT00439725|20975692|P1|Treatment Period|Participant did not receive treatment|4
6073404|NCT00439725|20975691|P2|Treatment Period|Death|1
6073405|NCT00439725|20975692|P1|Treatment Period|Death|1
6073406|NCT00439725|20975691|P2|Treatment Period|Protocol driven decision point|1
6073407|NCT00439725|20975692|P1|Treatment Period|Protocol driven decision point|1
6073408|NCT00439725|20975691|P2|Treatment Period|Participant convenience|0
6073409|NCT00439725|20975692|P1|Treatment Period|Participant convenience|1
6073410|NCT00439725|20975691|P2|Treatment Period|Lost to Follow-up|1
6073411|NCT00439725|20975692|P1|Treatment Period|Lost to Follow-up|1
6073412|NCT00439725|20975691|P2|Treatment Period|Technical problems|0
6073413|NCT00439725|20975692|P1|Treatment Period|Technical problems|1
6073414|NCT00439725|20975691|P2|Treatment Period|Clinical endpoint reached|50
6073415|NCT00439725|20975692|P1|Treatment Period|Clinical endpoint reached|6
6073416|NCT00439725|20975691|P2|Treatment Period|Protocol Violation|1
6073417|NCT00439725|20975692|P1|Treatment Period|Protocol Violation|2
6073418|NCT00439725|20975691|P2|Treatment Period|Physician Decision|1
6073419|NCT00439725|20975692|P1|Treatment Period|Physician Decision|1
6073420|NCT00439725|20975691|P2|Treatment Period|Adverse Event|18
6073421|NCT00439725|20975692|P1|Treatment Period|Adverse Event|39
6073422|NCT00439725|20975691|P2|Treatment Period|Site closed by investigator|2
6073423|NCT00439725|20975692|P1|Treatment Period|Site closed by investigator|1
6073424|NCT00439725|20975691|P2|Treatment Period|Study terminated by sponsor|148
6073425|NCT00439725|20975692|P1|Treatment Period|Study terminated by sponsor|156
6073426|NCT00439725|20975691|P2|Treatment Period|Withdrawal by Subject|19
6073427|NCT00439725|20975692|P1|Treatment Period|Withdrawal by Subject|22
6073428|NCT00439647|20975743|P2|Overall Study|Lack of Efficacy|4
6073429|NCT00439647|20975744|P1|Overall Study|Lack of Efficacy|0
6073430|NCT00439647|20975743|P2|Overall Study|Protocol Violation|4
6073431|NCT00439647|20975744|P1|Overall Study|Protocol Violation|3
6073432|NCT00439647|20975743|P2|Overall Study|Lost to Follow-up|12
6073433|NCT00439647|20975744|P1|Overall Study|Lost to Follow-up|4
6073434|NCT00439647|20975743|P2|Overall Study|Adverse Event|11
6073435|NCT00439647|20975744|P1|Overall Study|Adverse Event|11
6073436|NCT00439647|20975743|P2|Overall Study|Death|18
6073437|NCT00439647|20975744|P1|Overall Study|Death|15
6073438|NCT00439647|20975743|P2|Overall Study|Withdrawal by Subject|22
6073439|NCT00439647|20975744|P1|Overall Study|Withdrawal by Subject|25
6073440|NCT00439569|20975781|P1|Cohort 2 (500 mg/kg/Day)|Less than 80% study drug compliance|1
6073441|NCT00439569|20975781|P1|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|3
6073442|NCT00439569|20975781|P1|Cohort 1 (500 mg/kg/Day)|Allergic reaction|1
6073443|NCT00439556|20975795|P3|Overall Study|Patient was taken off study for non-comp|0
6073444|NCT00439556|20975796|P2|Overall Study|Patient was taken off study for non-comp|1
6073445|NCT00439556|20975797|P1|Overall Study|Patient was taken off study for non-comp|0
6073446|NCT00439517|20975810|P2|Overall Study|Subject in survival follow-up|0
6073447|NCT00439517|20975811|P1|Overall Study|Subject in survival follow-up|1
6073448|NCT00439517|20975810|P2|Overall Study|Subject on treatment|0
6073449|NCT00439517|20975811|P1|Overall Study|Subject on treatment|1
6073450|NCT00439309|20975950|P2|Follow-Up|Late response by subject|1
6073451|NCT00439309|20975951|P1|Follow-Up|Late response by subject|0
6073452|NCT00439309|20975950|P2|Follow-Up|Withdrawal by Subject|1
6073453|NCT00439309|20975951|P1|Follow-Up|Withdrawal by Subject|0
6073454|NCT00439309|20975950|P2|Follow-Up|Lost to Follow-up|0
6073455|NCT00439309|20975951|P1|Follow-Up|Lost to Follow-up|2
6073456|NCT00439309|20975950|P2|Follow-Up|Death|0
6073457|NCT00439309|20975951|P1|Follow-Up|Death|1
6073458|NCT00439270|20975983|P5|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0
6073459|NCT00439270|20975984|P4|Phase 2 (51.6 Months)|Insurance no longer covered patient care|1
6073460|NCT00439270|20975985|P3|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0
6073461|NCT00439270|20975986|P2|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0
6073462|NCT00439270|20975987|P1|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0
6073463|NCT00439270|20975983|P5|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0
6073464|NCT00439270|20975984|P4|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|2
6073465|NCT00439270|20975985|P3|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0
6073466|NCT00439270|20975986|P2|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0
6073467|NCT00439270|20975987|P1|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0
6073468|NCT00439270|20975983|P5|Phase 2 (51.6 Months)|Withdrawal by Subject|0
6073469|NCT00439270|20975984|P4|Phase 2 (51.6 Months)|Withdrawal by Subject|2
6073470|NCT00439270|20975985|P3|Phase 2 (51.6 Months)|Withdrawal by Subject|0
6073471|NCT00439270|20975986|P2|Phase 2 (51.6 Months)|Withdrawal by Subject|0
6073472|NCT00439270|20975987|P1|Phase 2 (51.6 Months)|Withdrawal by Subject|0
6073473|NCT00439270|20975983|P5|Phase 2 (51.6 Months)|No longer meets study criteria|0
6073474|NCT00439270|20975984|P4|Phase 2 (51.6 Months)|No longer meets study criteria|1
6073475|NCT00439270|20975985|P3|Phase 2 (51.6 Months)|No longer meets study criteria|0
6073476|NCT00439270|20975986|P2|Phase 2 (51.6 Months)|No longer meets study criteria|0
6073477|NCT00439270|20975987|P1|Phase 2 (51.6 Months)|No longer meets study criteria|0
6073478|NCT00439270|20975983|P5|Phase 2 (51.6 Months)|Maximum clinical benefit|0
6073479|NCT00439270|20975984|P4|Phase 2 (51.6 Months)|Maximum clinical benefit|3
6073480|NCT00439270|20975985|P3|Phase 2 (51.6 Months)|Maximum clinical benefit|0
6073481|NCT00439270|20975986|P2|Phase 2 (51.6 Months)|Maximum clinical benefit|0
6073482|NCT00439270|20975987|P1|Phase 2 (51.6 Months)|Maximum clinical benefit|0
6073483|NCT00439270|20975983|P5|Phase 2 (51.6 Months)|Study drug toxicity|0
6073484|NCT00439270|20975984|P4|Phase 2 (51.6 Months)|Study drug toxicity|6
6073485|NCT00439270|20975985|P3|Phase 2 (51.6 Months)|Study drug toxicity|0
6073486|NCT00439270|20975986|P2|Phase 2 (51.6 Months)|Study drug toxicity|0
6073487|NCT00439270|20975987|P1|Phase 2 (51.6 Months)|Study drug toxicity|0
6073488|NCT00439270|20975983|P5|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0
6073489|NCT00439270|20975984|P4|Phase 2 (51.6 Months)|Poor compliance/noncompliance|1
6073490|NCT00439270|20975985|P3|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0
6073491|NCT00439270|20975986|P2|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0
6073492|NCT00439270|20975987|P1|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0
6073493|NCT00439270|20975983|P5|Phase 2 (51.6 Months)|Disease progression|0
6073494|NCT00439270|20975984|P4|Phase 2 (51.6 Months)|Disease progression|18
6073495|NCT00439270|20975985|P3|Phase 2 (51.6 Months)|Disease progression|0
6073496|NCT00439270|20975986|P2|Phase 2 (51.6 Months)|Disease progression|0
6073497|NCT00439270|20975987|P1|Phase 2 (51.6 Months)|Disease progression|0
6073498|NCT00439270|20975983|P5|Phase 1 (18.1 Months)|Study drug toxicity|0
6073499|NCT00439270|20975984|P4|Phase 1 (18.1 Months)|Study drug toxicity|0
6073500|NCT00439270|20975985|P3|Phase 1 (18.1 Months)|Study drug toxicity|0
6073501|NCT00439270|20975986|P2|Phase 1 (18.1 Months)|Study drug toxicity|1
6073502|NCT00439270|20975987|P1|Phase 1 (18.1 Months)|Study drug toxicity|0
6073503|NCT00439270|20975983|P5|Phase 1 (18.1 Months)|Disease progression|3
6073504|NCT00439270|20975984|P4|Phase 1 (18.1 Months)|Disease progression|0
6073505|NCT00439270|20975985|P3|Phase 1 (18.1 Months)|Disease progression|3
6073506|NCT00439270|20975986|P2|Phase 1 (18.1 Months)|Disease progression|2
6073507|NCT00439270|20975987|P1|Phase 1 (18.1 Months)|Disease progression|3
6073508|NCT00439244|20976029|P3|Overall Study|Administrative problems|0
6073509|NCT00439244|20976030|P2|Overall Study|Administrative problems|0
6073510|NCT00439244|20976031|P1|Overall Study|Administrative problems|1
6073511|NCT00439244|20976029|P3|Overall Study|Protocol Violation|0
6073512|NCT00439244|20976030|P2|Overall Study|Protocol Violation|1
6073513|NCT00439244|20976031|P1|Overall Study|Protocol Violation|0
6073514|NCT00439244|20976029|P3|Overall Study|Death|0
6073515|NCT00439244|20976030|P2|Overall Study|Death|1
6073516|NCT00439244|20976031|P1|Overall Study|Death|0
6073517|NCT00439244|20976029|P3|Overall Study|Lost to Follow-up|2
6073518|NCT00439244|20976030|P2|Overall Study|Lost to Follow-up|1
6073519|NCT00439244|20976031|P1|Overall Study|Lost to Follow-up|2
6073520|NCT00439244|20976029|P3|Overall Study|Withdrawal by Subject|2
6073521|NCT00439244|20976030|P2|Overall Study|Withdrawal by Subject|1
6073522|NCT00439244|20976031|P1|Overall Study|Withdrawal by Subject|3
6073523|NCT00439244|20976029|P3|Overall Study|Adverse Event|3
6073524|NCT00439244|20976030|P2|Overall Study|Adverse Event|2
6073525|NCT00439244|20976031|P1|Overall Study|Adverse Event|5
6073526|NCT00439231|20976051|P1|Overall Study|Lack of Efficacy|28
6073527|NCT00439218|20976055|P1|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|1
6073528|NCT00439179|20976070|P4|Overall Study|* 1 pt inelig, 1 pt numb not used|0
6073529|NCT00439179|20976071|P3|Overall Study|* 1 pt inelig, 1 pt numb not used|0
6073530|NCT00439179|20976072|P2|Overall Study|* 1 pt inelig, 1 pt numb not used|2
6073531|NCT00439179|20976073|P1|Overall Study|* 1 pt inelig, 1 pt numb not used|0
6073532|NCT00439140|20976090|P3|Treatment Cycle 2|Lost to Follow-up|0
6073533|NCT00439140|20976091|P2|Treatment Cycle 2|Lost to Follow-up|1
6073534|NCT00439140|20976092|P1|Treatment Cycle 2|Lost to Follow-up|1
6073535|NCT00439140|20976090|P3|Treatment Cycle 2|Withdrawal by Subject|0
6073536|NCT00439140|20976091|P2|Treatment Cycle 2|Withdrawal by Subject|0
6073537|NCT00439140|20976092|P1|Treatment Cycle 2|Withdrawal by Subject|1
6073538|NCT00439140|20976090|P3|Treatment Cycle 1|Withdrawal by Subject|0
6073539|NCT00439140|20976091|P2|Treatment Cycle 1|Withdrawal by Subject|1
6073540|NCT00439140|20976092|P1|Treatment Cycle 1|Withdrawal by Subject|0
6073541|NCT00439140|20976090|P3|Treatment Cycle 1|Personal reasons|0
6073542|NCT00439140|20976091|P2|Treatment Cycle 1|Personal reasons|2
6073543|NCT00439140|20976092|P1|Treatment Cycle 1|Personal reasons|0
6073544|NCT00439140|20976090|P3|Treatment Cycle 1|Lost to Follow-up|1
6073545|NCT00439140|20976091|P2|Treatment Cycle 1|Lost to Follow-up|1
6073546|NCT00439140|20976092|P1|Treatment Cycle 1|Lost to Follow-up|1
6073547|NCT00438815|20976175|P1|Overall Study|Death|1
6073548|NCT00438815|20976175|P1|Overall Study|Withdrawal by Subject|6
6073549|NCT00438815|20976175|P1|Overall Study|Lost to Follow-up|6
6073550|NCT00438815|20976175|P1|Overall Study|Transitioned to commercial C1INH-nf|6
6073551|NCT00438815|20976175|P1|Overall Study|Noncompliance with protocol requirements|9
6073552|NCT00438815|20976175|P1|Overall Study|3-month follow-up no longer required|12
6073553|NCT00438815|20976175|P1|Overall Study|Transferred to LEVP2006-4 (NCT00462709)|30
6073554|NCT00438672|20976225|P2|Overall Study|Lost to Follow-up|9
6073555|NCT00438672|20976226|P1|Overall Study|Lost to Follow-up|7
6073556|NCT00438659|20976236|P2|Overall Study|Cancel|2
6073557|NCT00438659|20976237|P1|Overall Study|Cancel|5
6073558|NCT00438659|20976236|P2|Overall Study|Discontinued Mometasone/Placebo|2
6073559|NCT00438659|20976237|P1|Overall Study|Discontinued Mometasone/Placebo|1
6073560|NCT00438633|20976261|P2|Overall Study|Lost to Follow-up|17
6073561|NCT00438633|20976262|P1|Overall Study|Lost to Follow-up|15
6073562|NCT00438633|20976261|P2|Overall Study|Withdrawal by Subject|0
6073563|NCT00438633|20976262|P1|Overall Study|Withdrawal by Subject|1
6073564|NCT00438464|20976293|P2|Overall Study|Incomplete data submission|2
6073565|NCT00438464|20976294|P1|Overall Study|Incomplete data submission|0
6073566|NCT00438464|20976293|P2|Overall Study|Terminated Early|5
6073567|NCT00438464|20976294|P1|Overall Study|Terminated Early|14
6073610|NCT00438360|20976411|P2|Overall Study|Other|15
6073611|NCT00438360|20976412|P1|Overall Study|Other|24
6073612|NCT00438360|20976411|P2|Overall Study|Lack of Efficacy|27
6073613|NCT00438360|20976412|P1|Overall Study|Lack of Efficacy|42
6073614|NCT00438360|20976411|P2|Overall Study|Adverse Event|1
6073615|NCT00438360|20976412|P1|Overall Study|Adverse Event|6
6073616|NCT00438256|20976426|P4|Overall Study|Excluded final Diagnosis|2
6073617|NCT00438256|20976427|P3|Overall Study|Excluded final Diagnosis|0
6073618|NCT00438256|20976428|P2|Overall Study|Excluded final Diagnosis|0
6073619|NCT00438256|20976429|P1|Overall Study|Excluded final Diagnosis|0
6073620|NCT00438256|20976426|P4|Overall Study|Ineligible for Resection|7
6073621|NCT00438256|20976427|P3|Overall Study|Ineligible for Resection|1
6073622|NCT00438256|20976428|P2|Overall Study|Ineligible for Resection|1
6073623|NCT00438256|20976429|P1|Overall Study|Ineligible for Resection|2
6073624|NCT00437983|20976479|P2|Overall Study|Withdrawal by Subject|6
6073625|NCT00437983|20976480|P1|Overall Study|Withdrawal by Subject|5
6073626|NCT00437983|20976479|P2|Overall Study|Protocol Violation|1
6073627|NCT00437983|20976480|P1|Overall Study|Protocol Violation|2
6073628|NCT00437983|20976479|P2|Overall Study|Adverse Event|6
6073629|NCT00437983|20976480|P1|Overall Study|Adverse Event|6
6073630|NCT00437658|20976493|P3|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|1
6073631|NCT00437658|20976494|P2|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|0
6073632|NCT00437658|20976495|P1|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|3
6073633|NCT00437658|20976493|P3|Post-treatment Period (24 Weeks)|Lost to Follow-up|1
6073634|NCT00437658|20976494|P2|Post-treatment Period (24 Weeks)|Lost to Follow-up|0
6073635|NCT00437658|20976495|P1|Post-treatment Period (24 Weeks)|Lost to Follow-up|5
6073636|NCT00437658|20976493|P3|Post-treatment Period (24 Weeks)|Lack of Efficacy|2
6073637|NCT00437658|20976494|P2|Post-treatment Period (24 Weeks)|Lack of Efficacy|2
6073638|NCT00437658|20976495|P1|Post-treatment Period (24 Weeks)|Lack of Efficacy|0
6073639|NCT00437658|20976493|P3|Post-treatment Period (24 Weeks)|Withdrawal by Subject|8
6073640|NCT00437658|20976494|P2|Post-treatment Period (24 Weeks)|Withdrawal by Subject|6
6073641|NCT00437658|20976495|P1|Post-treatment Period (24 Weeks)|Withdrawal by Subject|12
6073642|NCT00437658|20976493|P3|Post-treatment Period (24 Weeks)|Non-compliance|1
6073643|NCT00437658|20976494|P2|Post-treatment Period (24 Weeks)|Non-compliance|0
6073644|NCT00437658|20976495|P1|Post-treatment Period (24 Weeks)|Non-compliance|3
6073645|NCT00437658|20976493|P3|Post-treatment Period (24 Weeks)|Adverse Event|1
6073646|NCT00437658|20976494|P2|Post-treatment Period (24 Weeks)|Adverse Event|0
6073647|NCT00437658|20976495|P1|Post-treatment Period (24 Weeks)|Adverse Event|1
6073648|NCT00437658|20976493|P3|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|0
6073649|NCT00437658|20976494|P2|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|1
6073650|NCT00437658|20976495|P1|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|5
6073651|NCT00437658|20976493|P3|Treatment Period (24 Weeks)|Lost to Follow-up|5
6073652|NCT00437658|20976494|P2|Treatment Period (24 Weeks)|Lost to Follow-up|4
6073653|NCT00437658|20976495|P1|Treatment Period (24 Weeks)|Lost to Follow-up|5
6073654|NCT00437658|20976493|P3|Treatment Period (24 Weeks)|Lack of Efficacy|3
6073655|NCT00437658|20976494|P2|Treatment Period (24 Weeks)|Lack of Efficacy|2
6073656|NCT00437658|20976495|P1|Treatment Period (24 Weeks)|Lack of Efficacy|4
6073657|NCT00437658|20976493|P3|Treatment Period (24 Weeks)|Withdrawal by Subject|7
6073658|NCT00437658|20976494|P2|Treatment Period (24 Weeks)|Withdrawal by Subject|7
6073659|NCT00437658|20976495|P1|Treatment Period (24 Weeks)|Withdrawal by Subject|9
6073660|NCT00437658|20976493|P3|Treatment Period (24 Weeks)|Non-compliance|4
6073661|NCT00437658|20976494|P2|Treatment Period (24 Weeks)|Non-compliance|1
6073662|NCT00437658|20976495|P1|Treatment Period (24 Weeks)|Non-compliance|1
6073663|NCT00437658|20976493|P3|Treatment Period (24 Weeks)|Adverse Event|14
6073664|NCT00437658|20976494|P2|Treatment Period (24 Weeks)|Adverse Event|7
6073665|NCT00437658|20976495|P1|Treatment Period (24 Weeks)|Adverse Event|4
6073666|NCT00437645|20976589|P2|Overall Study|Condition no longer requires study drug|1
6073667|NCT00437645|20976590|P1|Overall Study|Condition no longer requires study drug|1
6073668|NCT00437645|20976589|P2|Overall Study|Lack of Efficacy|1
6073669|NCT00437645|20976590|P1|Overall Study|Lack of Efficacy|2
6073670|NCT00437645|20976589|P2|Overall Study|Administrative problems|1
6073671|NCT00437645|20976590|P1|Overall Study|Administrative problems|2
6073672|NCT00437645|20976589|P2|Overall Study|Lost to Follow-up|3
6073673|NCT00437645|20976590|P1|Overall Study|Lost to Follow-up|2
6073674|NCT00437645|20976589|P2|Overall Study|Protocol Violation|3
6073675|NCT00437645|20976590|P1|Overall Study|Protocol Violation|3
6073676|NCT00437645|20976589|P2|Overall Study|Withdrawal by Subject|22
6073677|NCT00437645|20976590|P1|Overall Study|Withdrawal by Subject|10
6073678|NCT00437645|20976589|P2|Overall Study|Adverse Event|84
6073679|NCT00437645|20976590|P1|Overall Study|Adverse Event|15
6073680|NCT00437489|20976606|P2|Overall Study|Lost to Follow-up|1
6073681|NCT00437489|20976607|P1|Overall Study|Lost to Follow-up|0
6073682|NCT00437489|20976606|P2|Overall Study|Study terminated by sponsor|21
6073683|NCT00437489|20976607|P1|Overall Study|Study terminated by sponsor|23
6073684|NCT00437294|20976626|P2|Overall Study|Entry criteria not met|1
6073685|NCT00437294|20976627|P1|Overall Study|Entry criteria not met|1
6073686|NCT00437294|20976626|P2|Overall Study|Protocol Violation|1
6073687|NCT00437294|20976627|P1|Overall Study|Protocol Violation|0
6073688|NCT00437294|20976626|P2|Overall Study|Sponsor Decision|9
6073689|NCT00437294|20976627|P1|Overall Study|Sponsor Decision|8
6073690|NCT00437294|20976626|P2|Overall Study|Progressive Disease|23
6073691|NCT00437294|20976627|P1|Overall Study|Progressive Disease|19
6073692|NCT00437294|20976626|P2|Overall Study|Withdrawal by Subject|0
6073693|NCT00437294|20976627|P1|Overall Study|Withdrawal by Subject|5
6073694|NCT00437294|20976626|P2|Overall Study|Physician Decision|3
6073695|NCT00437294|20976627|P1|Overall Study|Physician Decision|0
6073696|NCT00437294|20976626|P2|Overall Study|Death|2
6073697|NCT00437294|20976627|P1|Overall Study|Death|5
6073698|NCT00437294|20976626|P2|Overall Study|Adverse Event|4
6073699|NCT00437294|20976627|P1|Overall Study|Adverse Event|5
6073740|NCT00437268|20976983|P2|Overall Study|Death|1
6073741|NCT00437268|20976984|P1|Overall Study|Death|0
6073742|NCT00437268|20976983|P2|Overall Study|Physician Decision|0
6073743|NCT00437268|20976984|P1|Overall Study|Physician Decision|1
6073744|NCT00437268|20976983|P2|Overall Study|Progressive disease|9
6073745|NCT00437268|20976984|P1|Overall Study|Progressive disease|9
6073746|NCT00437268|20976983|P2|Overall Study|Withdrawal by Subject|2
6073747|NCT00437268|20976984|P1|Overall Study|Withdrawal by Subject|2
6073748|NCT00437268|20976983|P2|Overall Study|Adverse Event|1
6073749|NCT00437268|20976984|P1|Overall Study|Adverse Event|1
6073750|NCT00437203|20977010|P10|Overall Study|Other|0
6073751|NCT00437203|20977011|P9|Overall Study|Other|0
6073752|NCT00437203|20977012|P8|Overall Study|Other|0
6073753|NCT00437203|20977013|P7|Overall Study|Other|1
6073754|NCT00437203|20977014|P6|Overall Study|Other|0
6073755|NCT00437203|20977015|P5|Overall Study|Other|0
6073756|NCT00437203|20977016|P4|Overall Study|Other|0
6073757|NCT00437203|20977017|P3|Overall Study|Other|0
6073758|NCT00437203|20977018|P2|Overall Study|Other|1
6073759|NCT00437203|20977019|P1|Overall Study|Other|0
6073760|NCT00437203|20977010|P10|Overall Study|Objective progression or relapse|2
6073761|NCT00437203|20977011|P9|Overall Study|Objective progression or relapse|2
6073762|NCT00437203|20977012|P8|Overall Study|Objective progression or relapse|1
6073763|NCT00437203|20977013|P7|Overall Study|Objective progression or relapse|6
6073764|NCT00437203|20977014|P6|Overall Study|Objective progression or relapse|3
6073765|NCT00437203|20977015|P5|Overall Study|Objective progression or relapse|3
6073766|NCT00437203|20977016|P4|Overall Study|Objective progression or relapse|3
6073767|NCT00437203|20977017|P3|Overall Study|Objective progression or relapse|2
6073768|NCT00437203|20977018|P2|Overall Study|Objective progression or relapse|6
6073769|NCT00437203|20977019|P1|Overall Study|Objective progression or relapse|5
6073770|NCT00437203|20977010|P10|Overall Study|Study terminated by sponsor|0
6073771|NCT00437203|20977011|P9|Overall Study|Study terminated by sponsor|1
6073772|NCT00437203|20977012|P8|Overall Study|Study terminated by sponsor|0
6073773|NCT00437203|20977013|P7|Overall Study|Study terminated by sponsor|0
6073774|NCT00437203|20977014|P6|Overall Study|Study terminated by sponsor|0
6073775|NCT00437203|20977015|P5|Overall Study|Study terminated by sponsor|0
6073776|NCT00437203|20977016|P4|Overall Study|Study terminated by sponsor|0
6073777|NCT00437203|20977017|P3|Overall Study|Study terminated by sponsor|0
6073778|NCT00437203|20977018|P2|Overall Study|Study terminated by sponsor|0
6073779|NCT00437203|20977019|P1|Overall Study|Study terminated by sponsor|0
6073780|NCT00437203|20977010|P10|Overall Study|Adverse Event|1
6073781|NCT00437203|20977011|P9|Overall Study|Adverse Event|0
6073782|NCT00437203|20977012|P8|Overall Study|Adverse Event|1
6073783|NCT00437203|20977013|P7|Overall Study|Adverse Event|0
6073784|NCT00437203|20977014|P6|Overall Study|Adverse Event|0
6073785|NCT00437203|20977015|P5|Overall Study|Adverse Event|0
6073786|NCT00437203|20977016|P4|Overall Study|Adverse Event|0
6073787|NCT00437203|20977017|P3|Overall Study|Adverse Event|0
6073788|NCT00437203|20977018|P2|Overall Study|Adverse Event|1
6073789|NCT00437203|20977019|P1|Overall Study|Adverse Event|1
6073790|NCT00437203|20977010|P10|Overall Study|Death|1
6073791|NCT00437203|20977011|P9|Overall Study|Death|0
6073792|NCT00437203|20977012|P8|Overall Study|Death|1
6073793|NCT00437203|20977013|P7|Overall Study|Death|0
6073794|NCT00437203|20977014|P6|Overall Study|Death|0
6073795|NCT00437203|20977015|P5|Overall Study|Death|0
6073796|NCT00437203|20977016|P4|Overall Study|Death|0
6073797|NCT00437203|20977017|P3|Overall Study|Death|1
6073798|NCT00437203|20977018|P2|Overall Study|Death|0
6073799|NCT00437203|20977019|P1|Overall Study|Death|0
6073800|NCT00437125|20977123|P1|Overall Study|Physician Decision|1
6073801|NCT00437125|20977123|P1|Overall Study|Withdrawal by Caregiver|2
6073802|NCT00437125|20977123|P1|Overall Study|Withdrawal by Subject|13
6073803|NCT00437125|20977123|P1|Overall Study|Lost to Follow-up|1
6073804|NCT00437125|20977123|P1|Overall Study|Lack of Efficacy|1
6073805|NCT00437125|20977123|P1|Overall Study|Clinical Relapse|1
6073806|NCT00437125|20977123|P1|Overall Study|Death|1
6073807|NCT00437125|20977123|P1|Overall Study|Adverse Event|12
6073808|NCT00437073|20977144|P2|Overall Study|Physician Decision|1
6073809|NCT00437073|20977145|P1|Overall Study|Physician Decision|0
6073810|NCT00437073|20977144|P2|Overall Study|Sponsor Terminated Study|0
6073811|NCT00437073|20977145|P1|Overall Study|Sponsor Terminated Study|1
6073814|NCT00436982|20977179|P2|Overall Study|no RSA data|2
6073815|NCT00436982|20977180|P1|Overall Study|no RSA data|1
6073816|NCT00436982|20977179|P2|Overall Study|Did not receive allocated intervention|1
6073817|NCT00436982|20977180|P1|Overall Study|Did not receive allocated intervention|0
6073818|NCT00436982|20977179|P2|Overall Study|Withdrawal by Subject|1
6073819|NCT00436982|20977180|P1|Overall Study|Withdrawal by Subject|3
6073820|NCT00436956|20977251|P2|Overall Study|Not evaluable|0
6073821|NCT00436956|20977252|P1|Overall Study|Not evaluable|1
6073822|NCT00436917|20977266|P1|Overall Study|Personal conflicts of patient|1
6073823|NCT00436917|20977266|P1|Overall Study|Increased creatinine|1
6073824|NCT00436917|20977266|P1|Overall Study|Treatment for polymyalgia rheumatic|1
6073825|NCT00436917|20977266|P1|Overall Study|Lost to Follow-up|1
6073826|NCT00436917|20977266|P1|Overall Study|Death|1
6073827|NCT00436917|20977266|P1|Overall Study|Physician Decision|1
6073828|NCT00436917|20977266|P1|Overall Study|Adverse Event|2
6073829|NCT00436917|20977266|P1|Overall Study|Withdrawal by Subject|13
6073830|NCT00436852|20977292|P2|Overall Study|Ineligible|0
6073831|NCT00436852|20977293|P1|Overall Study|Ineligible|1
6073832|NCT00436852|20977292|P2|Overall Study|Withdrawal by Subject|4
6073833|NCT00436852|20977293|P1|Overall Study|Withdrawal by Subject|2
6073834|NCT00436852|20977292|P2|Overall Study|Lack of Efficacy|7
6073835|NCT00436852|20977293|P1|Overall Study|Lack of Efficacy|9
6073836|NCT00436852|20977292|P2|Overall Study|Death|34
6073837|NCT00436852|20977293|P1|Overall Study|Death|23
6073838|NCT00436826|20977312|P6|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|7
6073839|NCT00436826|20977313|P5|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|51
6073840|NCT00436826|20977314|P4|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0
6073925|NCT00436553|20977493|P1|Overall Study|Death|3
6073841|NCT00436826|20977315|P3|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0
6073842|NCT00436826|20977316|P2|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0
6073843|NCT00436826|20977317|P1|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0
6073844|NCT00436826|20977312|P6|Ext. Period (With Cladribine Treatment)|Other un-specified|0
6073845|NCT00436826|20977313|P5|Ext. Period (With Cladribine Treatment)|Other un-specified|0
6073846|NCT00436826|20977314|P4|Ext. Period (With Cladribine Treatment)|Other un-specified|25
6073847|NCT00436826|20977315|P3|Ext. Period (With Cladribine Treatment)|Other un-specified|46
6073848|NCT00436826|20977316|P2|Ext. Period (With Cladribine Treatment)|Other un-specified|0
6073849|NCT00436826|20977317|P1|Ext. Period (With Cladribine Treatment)|Other un-specified|0
6073850|NCT00436826|20977312|P6|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0
6073851|NCT00436826|20977313|P5|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0
6073852|NCT00436826|20977314|P4|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|1
6073853|NCT00436826|20977315|P3|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0
6073854|NCT00436826|20977316|P2|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0
6073855|NCT00436826|20977317|P1|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0
6073856|NCT00436826|20977312|P6|Double Blind Period (DBP)|Other|0
6073857|NCT00436826|20977313|P5|Double Blind Period (DBP)|Other|0
6073858|NCT00436826|20977314|P4|Double Blind Period (DBP)|Other|0
6073859|NCT00436826|20977315|P3|Double Blind Period (DBP)|Other|0
6073860|NCT00436826|20977316|P2|Double Blind Period (DBP)|Other|11
6073861|NCT00436826|20977317|P1|Double Blind Period (DBP)|Other|10
6073862|NCT00436826|20977312|P6|Double Blind Period (DBP)|Protocol Violation|0
6073863|NCT00436826|20977313|P5|Double Blind Period (DBP)|Protocol Violation|0
6073864|NCT00436826|20977314|P4|Double Blind Period (DBP)|Protocol Violation|0
6073865|NCT00436826|20977315|P3|Double Blind Period (DBP)|Protocol Violation|0
6073866|NCT00436826|20977316|P2|Double Blind Period (DBP)|Protocol Violation|0
6073867|NCT00436826|20977317|P1|Double Blind Period (DBP)|Protocol Violation|1
6073868|NCT00436826|20977312|P6|Double Blind Period (DBP)|Adverse Event|0
6073869|NCT00436826|20977313|P5|Double Blind Period (DBP)|Adverse Event|0
6073870|NCT00436826|20977314|P4|Double Blind Period (DBP)|Adverse Event|0
6073871|NCT00436826|20977315|P3|Double Blind Period (DBP)|Adverse Event|0
6073872|NCT00436826|20977316|P2|Double Blind Period (DBP)|Adverse Event|0
6073873|NCT00436826|20977317|P1|Double Blind Period (DBP)|Adverse Event|2
6073874|NCT00436748|20977415|P2|Overall Study|Other|0
6073875|NCT00436748|20977416|P1|Overall Study|Other|3
6073876|NCT00436748|20977415|P2|Overall Study|Protocol-specified Criteria|4
6073877|NCT00436748|20977416|P1|Overall Study|Protocol-specified Criteria|5
6073878|NCT00436748|20977415|P2|Overall Study|Lost to Follow-up|1
6073879|NCT00436748|20977416|P1|Overall Study|Lost to Follow-up|0
6073880|NCT00436748|20977415|P2|Overall Study|Administrative Decision|0
6073881|NCT00436748|20977416|P1|Overall Study|Administrative Decision|1
6073882|NCT00436748|20977415|P2|Overall Study|Consent Withdrawn|4
6073883|NCT00436748|20977416|P1|Overall Study|Consent Withdrawn|1
6073884|NCT00436748|20977415|P2|Overall Study|Adverse Event|2
6073885|NCT00436748|20977416|P1|Overall Study|Adverse Event|0
6073886|NCT00436748|20977415|P2|Overall Study|Ineligibility Determined|1
6073887|NCT00436748|20977416|P1|Overall Study|Ineligibility Determined|1
6073888|NCT00436644|20977450|P1|Overall Study|Death|1
6073889|NCT00436644|20977450|P1|Overall Study|Adverse Event|2
6073890|NCT00436618|20977460|P3|Overall Study|Still on treatment|7
6073891|NCT00436618|20977461|P2|Overall Study|Still on treatment|2
6073892|NCT00436618|20977462|P1|Overall Study|Still on treatment|1
6073893|NCT00436618|20977460|P3|Overall Study|New Primary or Other Reasons|12
6073894|NCT00436618|20977461|P2|Overall Study|New Primary or Other Reasons|2
6073895|NCT00436618|20977462|P1|Overall Study|New Primary or Other Reasons|6
6073896|NCT00436618|20977460|P3|Overall Study|Death|3
6073897|NCT00436618|20977461|P2|Overall Study|Death|2
6073898|NCT00436618|20977462|P1|Overall Study|Death|4
6073899|NCT00436618|20977460|P3|Overall Study|Other Medical Problems|7
6073900|NCT00436618|20977461|P2|Overall Study|Other Medical Problems|1
6073901|NCT00436618|20977462|P1|Overall Study|Other Medical Problems|3
6073902|NCT00436618|20977460|P3|Overall Study|Alternate Treatment|12
6073903|NCT00436618|20977461|P2|Overall Study|Alternate Treatment|4
6073904|NCT00436618|20977462|P1|Overall Study|Alternate Treatment|3
6073905|NCT00436618|20977460|P3|Overall Study|Adverse Event|9
6073906|NCT00436618|20977461|P2|Overall Study|Adverse Event|8
6073907|NCT00436618|20977462|P1|Overall Study|Adverse Event|8
6073908|NCT00436618|20977460|P3|Overall Study|Withdrawal by Subject|11
6073909|NCT00436618|20977461|P2|Overall Study|Withdrawal by Subject|8
6073910|NCT00436618|20977462|P1|Overall Study|Withdrawal by Subject|5
6073911|NCT00436605|20977479|P1|Overall Study|Protocol Violation|3
6073912|NCT00436566|20977484|P1|Overall Study|Protocol Violation|1
6073913|NCT00436566|20977484|P1|Overall Study|Withdrawal by Subject|2
6073914|NCT00436553|20977491|P3|Overall Study|Withdrawal by Subject|3
6073915|NCT00436553|20977492|P2|Overall Study|Withdrawal by Subject|6
6073916|NCT00436553|20977493|P1|Overall Study|Withdrawal by Subject|5
6073917|NCT00436553|20977491|P3|Overall Study|Protocol Violation|0
6073918|NCT00436553|20977492|P2|Overall Study|Protocol Violation|0
6073919|NCT00436553|20977493|P1|Overall Study|Protocol Violation|1
6073920|NCT00436553|20977491|P3|Overall Study|Lost to Follow-up|0
6073921|NCT00436553|20977492|P2|Overall Study|Lost to Follow-up|2
6073922|NCT00436553|20977493|P1|Overall Study|Lost to Follow-up|0
6073923|NCT00436553|20977491|P3|Overall Study|Death|3
6073924|NCT00436553|20977492|P2|Overall Study|Death|1
6073926|NCT00436553|20977491|P3|Overall Study|Adverse Event|4
6073927|NCT00436553|20977492|P2|Overall Study|Adverse Event|3
6073928|NCT00436553|20977493|P1|Overall Study|Adverse Event|4
6073929|NCT00436501|20977514|P2|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|1
6073930|NCT00436501|20977515|P1|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|0
6073931|NCT00436501|20977514|P2|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|2
6073932|NCT00436501|20977515|P1|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|0
6073933|NCT00436436|20977551|P1|Overall Study|Death|6
6073934|NCT00436436|20977551|P1|Overall Study|Adverse Event|2
6073935|NCT00436436|20977551|P1|Overall Study|Progression|4
6073936|NCT00436345|20977562|P2|Overall Study|ICU resident beyond follow-up period|0
6073937|NCT00436345|20977563|P1|Overall Study|ICU resident beyond follow-up period|3
6073938|NCT00436332|20977616|P1|Overall Study|Never Received Treatment|3
6073939|NCT00436332|20977616|P1|Overall Study|Ineligible|2
6073940|NCT00436332|20977616|P1|Overall Study|Not Protocol Specified|6
6073941|NCT00436332|20977616|P1|Overall Study|Death|2
6073942|NCT00436332|20977616|P1|Overall Study|Progression|59
6073943|NCT00436332|20977616|P1|Overall Study|Withdrawal by Subject|2
6073944|NCT00436332|20977616|P1|Overall Study|Adverse Event|9
6073945|NCT00436280|20977623|P1|Period 3: Maintenance|Progressive Disease|12
6073946|NCT00436280|20977623|P1|Period 3: Maintenance|Adverse Event|6
6073947|NCT00436280|20977623|P1|Period 2: Consolidation|Death|1
6073948|NCT00436280|20977623|P1|Period 2: Consolidation|Withdrawal by Subject|2
6073949|NCT00436280|20977623|P1|Period 2: Consolidation|Physician Decision|2
6073950|NCT00436280|20977623|P1|Period 2: Consolidation|Stable Disease|1
6073951|NCT00436280|20977623|P1|Period 2: Consolidation|Progressive Disease|10
6073952|NCT00436280|20977623|P1|Period 2: Consolidation|Adverse Event|1
6073953|NCT00436280|20977623|P1|Period 1: Induction|Death|1
6073954|NCT00436280|20977623|P1|Period 1: Induction|Withdrawal by Subject|1
6073955|NCT00436280|20977623|P1|Period 1: Induction|Stable Disease|6
6073956|NCT00436280|20977623|P1|Period 1: Induction|Progressive Disease|12
6073957|NCT00436280|20977623|P1|Period 1: Induction|Adverse Event|8
6073958|NCT00436215|20977637|P1|Overall Study|Small bowel obstruction|1
6073959|NCT00436215|20977637|P1|Overall Study|Refused further treatment|3
6073960|NCT00436163|20977643|P1|Overall Study|Adverse Event|1
6073961|NCT00436163|20977643|P1|Overall Study|Lost to Follow-up|2
6073962|NCT00436007|20977691|P3|Overall Study|Other|1
6073963|NCT00436007|20977692|P2|Overall Study|Other|0
6073964|NCT00436007|20977693|P1|Overall Study|Other|0
6073965|NCT00436007|20977691|P3|Overall Study|Death|3
6073966|NCT00436007|20977692|P2|Overall Study|Death|1
6073967|NCT00436007|20977693|P1|Overall Study|Death|0
6073968|NCT00436007|20977691|P3|Overall Study|Physician Decision|2
6073969|NCT00436007|20977692|P2|Overall Study|Physician Decision|0
6073970|NCT00436007|20977693|P1|Overall Study|Physician Decision|0
6073971|NCT00436007|20977691|P3|Overall Study|Lost to Follow-up|13
6073972|NCT00436007|20977692|P2|Overall Study|Lost to Follow-up|10
6073973|NCT00436007|20977693|P1|Overall Study|Lost to Follow-up|14
6073974|NCT00436007|20977691|P3|Overall Study|Withdrawal by Subject|4
6073975|NCT00436007|20977692|P2|Overall Study|Withdrawal by Subject|3
6073976|NCT00436007|20977693|P1|Overall Study|Withdrawal by Subject|5
6073977|NCT00435994|20977741|P3|Overall Study|Lost to Follow-up|0
6073978|NCT00435994|20977742|P2|Overall Study|Lost to Follow-up|0
6073979|NCT00435994|20977743|P1|Overall Study|Lost to Follow-up|7
6073980|NCT00435942|20977754|P2|Overall Study|Other|1
6073981|NCT00435942|20977755|P1|Overall Study|Other|0
6073982|NCT00435942|20977754|P2|Overall Study|Technical Failure|0
6073983|NCT00435942|20977755|P1|Overall Study|Technical Failure|3
6073984|NCT00435942|20977754|P2|Overall Study|Conversion to Open Repair|0
6073985|NCT00435942|20977755|P1|Overall Study|Conversion to Open Repair|1
6073986|NCT00435942|20977754|P2|Overall Study|Lost to Follow-up|16
6073987|NCT00435942|20977755|P1|Overall Study|Lost to Follow-up|0
6073988|NCT00435942|20977754|P2|Overall Study|Withdrawal by Subject|0
6073989|NCT00435942|20977755|P1|Overall Study|Withdrawal by Subject|2
6073990|NCT00435942|20977754|P2|Overall Study|Death|10
6073991|NCT00435942|20977755|P1|Overall Study|Death|17
6073992|NCT00435825|20977795|P4|Overall Study|Did not complete full follow-up period|5
6073993|NCT00435825|20977796|P3|Overall Study|Did not complete full follow-up period|4
6073994|NCT00435825|20977797|P2|Overall Study|Did not complete full follow-up period|6
6073995|NCT00435825|20977798|P1|Overall Study|Did not complete full follow-up period|6
6073996|NCT00435825|20977795|P4|Overall Study|Did not enter follow-up|3
6073997|NCT00435825|20977796|P3|Overall Study|Did not enter follow-up|1
6073998|NCT00435825|20977797|P2|Overall Study|Did not enter follow-up|4
6073999|NCT00435825|20977798|P1|Overall Study|Did not enter follow-up|0
6074000|NCT00435825|20977795|P4|Overall Study|Did not receive study drug|0
6074001|NCT00435825|20977796|P3|Overall Study|Did not receive study drug|2
6074002|NCT00435825|20977797|P2|Overall Study|Did not receive study drug|0
6074003|NCT00435825|20977798|P1|Overall Study|Did not receive study drug|1
6074004|NCT00435825|20977795|P4|Overall Study|Failure to return|0
6074005|NCT00435825|20977796|P3|Overall Study|Failure to return|4
6074006|NCT00435825|20977797|P2|Overall Study|Failure to return|0
6074007|NCT00435825|20977798|P1|Overall Study|Failure to return|5
6074008|NCT00435825|20977795|P4|Overall Study|Refused treatment|5
6074009|NCT00435825|20977796|P3|Overall Study|Refused treatment|0
6074010|NCT00435825|20977797|P2|Overall Study|Refused treatment|0
6074011|NCT00435825|20977798|P1|Overall Study|Refused treatment|2
6074012|NCT00435825|20977795|P4|Overall Study|Other Protocol Violation|0
6074013|NCT00435825|20977796|P3|Overall Study|Other Protocol Violation|0
6074014|NCT00435825|20977797|P2|Overall Study|Other Protocol Violation|0
6074015|NCT00435825|20977798|P1|Overall Study|Other Protocol Violation|1
6074016|NCT00435825|20977795|P4|Overall Study|Insufficient Therapeutic Response|3
6074017|NCT00435825|20977796|P3|Overall Study|Insufficient Therapeutic Response|0
6074018|NCT00435825|20977797|P2|Overall Study|Insufficient Therapeutic Response|1
6074019|NCT00435825|20977798|P1|Overall Study|Insufficient Therapeutic Response|3
6074020|NCT00435825|20977795|P4|Overall Study|Abnormality of Laboratory Test|0
6074021|NCT00435825|20977796|P3|Overall Study|Abnormality of Laboratory Test|0
6074022|NCT00435825|20977797|P2|Overall Study|Abnormality of Laboratory Test|1
6074023|NCT00435825|20977798|P1|Overall Study|Abnormality of Laboratory Test|0
6074024|NCT00435487|20977921|P2|Overall Study|Received Drug in Other Treatment Group|1
6074025|NCT00435487|20977922|P1|Overall Study|Received Drug in Other Treatment Group|0
6074026|NCT00435487|20977921|P2|Overall Study|Withdrawal by Subject Prior to Treatment|2
6074027|NCT00435487|20977922|P1|Overall Study|Withdrawal by Subject Prior to Treatment|0
6074028|NCT00435487|20977921|P2|Overall Study|Withdrawal by Subject|1
6074029|NCT00435487|20977922|P1|Overall Study|Withdrawal by Subject|2
6074030|NCT00435487|20977921|P2|Overall Study|Other|2
6074031|NCT00435487|20977922|P1|Overall Study|Other|5
6074032|NCT00435487|20977921|P2|Overall Study|Lost to Follow-up|2
6074033|NCT00435487|20977922|P1|Overall Study|Lost to Follow-up|2
6074034|NCT00435487|20977921|P2|Overall Study|Adverse Event|3
6074035|NCT00435487|20977922|P1|Overall Study|Adverse Event|0
6074036|NCT00435487|20977921|P2|Overall Study|Death|4
6074037|NCT00435487|20977922|P1|Overall Study|Death|3
6074038|NCT00435461|20977941|P3|Overall Study|Lost to Follow-up|2
6074039|NCT00435461|20977942|P2|Overall Study|Lost to Follow-up|1
6074040|NCT00435461|20977943|P1|Overall Study|Lost to Follow-up|1
6074041|NCT00435461|20977941|P3|Overall Study|Non-Compliance of diary|1
6074042|NCT00435461|20977942|P2|Overall Study|Non-Compliance of diary|0
6074043|NCT00435461|20977943|P1|Overall Study|Non-Compliance of diary|2
6074044|NCT00435461|20977941|P3|Overall Study|Adverse Event|6
6074045|NCT00435461|20977942|P2|Overall Study|Adverse Event|2
6074046|NCT00435461|20977943|P1|Overall Study|Adverse Event|1
6074047|NCT00435461|20977941|P3|Overall Study|Noncompliance with study requirements|1
6074048|NCT00435461|20977942|P2|Overall Study|Noncompliance with study requirements|1
6074049|NCT00435461|20977943|P1|Overall Study|Noncompliance with study requirements|1
6074050|NCT00435461|20977941|P3|Overall Study|Participant ended study one day early|0
6074051|NCT00435461|20977942|P2|Overall Study|Participant ended study one day early|0
6074052|NCT00435461|20977943|P1|Overall Study|Participant ended study one day early|1
6074053|NCT00435461|20977941|P3|Overall Study|Participant moved eDiary,studymedication|0
6074054|NCT00435461|20977942|P2|Overall Study|Participant moved eDiary,studymedication|0
6074055|NCT00435461|20977943|P1|Overall Study|Participant moved eDiary,studymedication|1
6074056|NCT00435461|20977941|P3|Overall Study|Pregnancy|0
6074057|NCT00435461|20977942|P2|Overall Study|Pregnancy|0
6074058|NCT00435461|20977943|P1|Overall Study|Pregnancy|2
6074059|NCT00435461|20977941|P3|Overall Study|Participant could not swallow capsule|1
6074060|NCT00435461|20977942|P2|Overall Study|Participant could not swallow capsule|0
6074061|NCT00435461|20977943|P1|Overall Study|Participant could not swallow capsule|0
6074062|NCT00435461|20977941|P3|Overall Study|Participant could not tolerate symptoms|1
6074063|NCT00435461|20977942|P2|Overall Study|Participant could not tolerate symptoms|0
6074064|NCT00435461|20977943|P1|Overall Study|Participant could not tolerate symptoms|0
6074065|NCT00435461|20977941|P3|Overall Study|Randomized in error|0
6074066|NCT00435461|20977942|P2|Overall Study|Randomized in error|0
6074067|NCT00435461|20977943|P1|Overall Study|Randomized in error|1
6074068|NCT00435461|20977941|P3|Overall Study|Withdrawal by Subject|2
6074069|NCT00435461|20977942|P2|Overall Study|Withdrawal by Subject|0
6074070|NCT00435461|20977943|P1|Overall Study|Withdrawal by Subject|1
6074071|NCT00435461|20977941|P3|Overall Study|Lack of Efficacy|0
6074072|NCT00435461|20977942|P2|Overall Study|Lack of Efficacy|1
6074073|NCT00435461|20977943|P1|Overall Study|Lack of Efficacy|2
6074074|NCT00435461|20977941|P3|Overall Study|In error, two study medications switched|0
6074075|NCT00435461|20977942|P2|Overall Study|In error, two study medications switched|0
6074076|NCT00435461|20977943|P1|Overall Study|In error, two study medications switched|1
6074077|NCT00435461|20977941|P3|Overall Study|Compliance less than 80 percent|0
6074078|NCT00435461|20977942|P2|Overall Study|Compliance less than 80 percent|0
6074079|NCT00435461|20977943|P1|Overall Study|Compliance less than 80 percent|1
6074080|NCT00435461|20977941|P3|Overall Study|Participant randomized(inadequate score)|0
6074081|NCT00435461|20977942|P2|Overall Study|Participant randomized(inadequate score)|0
6074082|NCT00435461|20977943|P1|Overall Study|Participant randomized(inadequate score)|1
6074083|NCT00435461|20977941|P3|Overall Study|Protocol Violation|10
6074084|NCT00435461|20977942|P2|Overall Study|Protocol Violation|9
6074085|NCT00435461|20977943|P1|Overall Study|Protocol Violation|6
6074086|NCT00435461|20977941|P3|Overall Study|Visit changed to EarlyWithdrawn Visit|0
6074087|NCT00435461|20977942|P2|Overall Study|Visit changed to EarlyWithdrawn Visit|0
6074088|NCT00435461|20977943|P1|Overall Study|Visit changed to EarlyWithdrawn Visit|1
6074089|NCT00435409|20977980|P3|Overall Study|Sponsor decision|0
6074090|NCT00435409|20977981|P2|Overall Study|Sponsor decision|3
6074091|NCT00435409|20977982|P1|Overall Study|Sponsor decision|0
6074092|NCT00435409|20977980|P3|Overall Study|Adverse Event|8
6074093|NCT00435409|20977981|P2|Overall Study|Adverse Event|0
6074094|NCT00435409|20977982|P1|Overall Study|Adverse Event|0
6074095|NCT00435409|20977980|P3|Overall Study|Other|1
6074096|NCT00435409|20977981|P2|Overall Study|Other|30
6074097|NCT00435409|20977982|P1|Overall Study|Other|45
6074098|NCT00435409|20977980|P3|Overall Study|Withdrawal by Subject|1
6074099|NCT00435409|20977981|P2|Overall Study|Withdrawal by Subject|7
6074100|NCT00435409|20977982|P1|Overall Study|Withdrawal by Subject|8
6074101|NCT00435409|20977980|P3|Overall Study|Global deterioration of health status|4
6074102|NCT00435409|20977981|P2|Overall Study|Global deterioration of health status|0
6074103|NCT00435409|20977982|P1|Overall Study|Global deterioration of health status|0
6074104|NCT00435409|20977980|P3|Overall Study|Objective progression or relapse|58
6074105|NCT00435409|20977981|P2|Overall Study|Objective progression or relapse|93
6074106|NCT00435409|20977982|P1|Overall Study|Objective progression or relapse|158
6074107|NCT00435409|20977980|P3|Overall Study|Death|6
6074108|NCT00435409|20977981|P2|Overall Study|Death|6
6074109|NCT00435409|20977982|P1|Overall Study|Death|8
6074110|NCT00435409|20977980|P3|Overall Study|Lost to Follow-up|0
6074111|NCT00435409|20977981|P2|Overall Study|Lost to Follow-up|2
6074112|NCT00435409|20977982|P1|Overall Study|Lost to Follow-up|1
6074113|NCT00435409|20977980|P3|Overall Study|Protocol Violation|0
6074114|NCT00435409|20977981|P2|Overall Study|Protocol Violation|2
6074115|NCT00435409|20977982|P1|Overall Study|Protocol Violation|1
6074116|NCT00435370|20978004|P2|Overall Study|Antipsychotic medication changed|2
6074117|NCT00435370|20978005|P1|Overall Study|Antipsychotic medication changed|4
6074118|NCT00435370|20978004|P2|Overall Study|Withdrawal by Subject|10
6074119|NCT00435370|20978005|P1|Overall Study|Withdrawal by Subject|10
6074120|NCT00435370|20978004|P2|Overall Study|Adverse Event|8
6074121|NCT00435370|20978005|P1|Overall Study|Adverse Event|8
6074122|NCT00435188|20978013|P2|Overall Study|Lost to Follow-up|6
6074123|NCT00435188|20978014|P1|Overall Study|Lost to Follow-up|5
6074124|NCT00435188|20978013|P2|Overall Study|Withdrawal by Subject|11
6074125|NCT00435188|20978014|P1|Overall Study|Withdrawal by Subject|16
6074126|NCT00435188|20978013|P2|Overall Study|Death|6
6074127|NCT00435188|20978014|P1|Overall Study|Death|1
6074128|NCT00435162|20978057|P6|Period 2 (2 Weeks)|Adverse Event|0
6074129|NCT00435162|20978058|P5|Period 2 (2 Weeks)|Adverse Event|0
6074130|NCT00435162|20978059|P4|Period 2 (2 Weeks)|Adverse Event|0
6074131|NCT00435162|20978060|P3|Period 2 (2 Weeks)|Adverse Event|0
6074132|NCT00435162|20978061|P2|Period 2 (2 Weeks)|Adverse Event|1
6074133|NCT00435162|20978062|P1|Period 2 (2 Weeks)|Adverse Event|0
6074134|NCT00435045|20978082|P2|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|0
6074135|NCT00435045|20978083|P1|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|1
6074136|NCT00435045|20978082|P2|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|0
6074137|NCT00435045|20978083|P1|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|1
6074138|NCT00435045|20978082|P2|Weeks 13-16 / 40mg Dose Level|Adverse Event|2
6074139|NCT00435045|20978083|P1|Weeks 13-16 / 40mg Dose Level|Adverse Event|3
6074140|NCT00435045|20978082|P2|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|1
6074141|NCT00435045|20978083|P1|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|0
6074142|NCT00435045|20978082|P2|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1
6074143|NCT00435045|20978083|P1|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1
6074144|NCT00435045|20978082|P2|Weeks 9-12 / 20mg Dose Level|Adverse Event|3
6074145|NCT00435045|20978083|P1|Weeks 9-12 / 20mg Dose Level|Adverse Event|4
6074146|NCT00435045|20978082|P2|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|1
6074147|NCT00435045|20978083|P1|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|0
6074148|NCT00435045|20978082|P2|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|0
6074149|NCT00435045|20978083|P1|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|1
6074150|NCT00435045|20978082|P2|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|1
6074151|NCT00435045|20978083|P1|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|2
6074152|NCT00435045|20978082|P2|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1
6074153|NCT00435045|20978083|P1|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1
6074154|NCT00435045|20978082|P2|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1
6074155|NCT00435045|20978083|P1|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1
6074156|NCT00435019|20978139|P2|Overall Study|Personal reasons for withdrawal|7
6074157|NCT00435019|20978140|P1|Overall Study|Personal reasons for withdrawal|8
6074158|NCT00435019|20978139|P2|Overall Study|Protocol Violation|1
6074159|NCT00435019|20978140|P1|Overall Study|Protocol Violation|3
6074160|NCT00435019|20978139|P2|Overall Study|Lack of Efficacy|2
6074161|NCT00435019|20978140|P1|Overall Study|Lack of Efficacy|1
6074162|NCT00435019|20978139|P2|Overall Study|Adverse Event|0
6074163|NCT00435019|20978140|P1|Overall Study|Adverse Event|1
6074164|NCT00434967|20978181|P4|Overall Study|Patient Disposition Challenges|3
6074165|NCT00434967|20978182|P3|Overall Study|Patient Disposition Challenges|0
6074166|NCT00434967|20978183|P2|Overall Study|Patient Disposition Challenges|0
6074167|NCT00434967|20978184|P1|Overall Study|Patient Disposition Challenges|2
6074168|NCT00434967|20978181|P4|Overall Study|Physician Decision|0
6074169|NCT00434967|20978182|P3|Overall Study|Physician Decision|1
6074170|NCT00434967|20978183|P2|Overall Study|Physician Decision|1
6074171|NCT00434967|20978184|P1|Overall Study|Physician Decision|1
6074172|NCT00434967|20978181|P4|Overall Study|Protocol Violation|1
6074173|NCT00434967|20978182|P3|Overall Study|Protocol Violation|0
6074174|NCT00434967|20978183|P2|Overall Study|Protocol Violation|1
6074175|NCT00434967|20978184|P1|Overall Study|Protocol Violation|0
6074176|NCT00434967|20978181|P4|Overall Study|Randomized in error|1
6074177|NCT00434967|20978182|P3|Overall Study|Randomized in error|0
6074178|NCT00434967|20978183|P2|Overall Study|Randomized in error|0
6074179|NCT00434967|20978184|P1|Overall Study|Randomized in error|0
6074180|NCT00434967|20978181|P4|Overall Study|Withdrawal by Subject|6
6074181|NCT00434967|20978182|P3|Overall Study|Withdrawal by Subject|4
6074182|NCT00434967|20978183|P2|Overall Study|Withdrawal by Subject|2
6074183|NCT00434967|20978184|P1|Overall Study|Withdrawal by Subject|2
6074184|NCT00434967|20978181|P4|Overall Study|Lost to Follow-up|0
6074185|NCT00434967|20978182|P3|Overall Study|Lost to Follow-up|1
6074186|NCT00434967|20978183|P2|Overall Study|Lost to Follow-up|0
6074187|NCT00434967|20978184|P1|Overall Study|Lost to Follow-up|0
6074188|NCT00434967|20978181|P4|Overall Study|Adverse Event|3
6074189|NCT00434967|20978182|P3|Overall Study|Adverse Event|3
6074190|NCT00434967|20978183|P2|Overall Study|Adverse Event|4
6074191|NCT00434967|20978184|P1|Overall Study|Adverse Event|2
6074192|NCT00434954|20978204|P2|Overall Study|Subject decision|22
6074193|NCT00434954|20978205|P1|Overall Study|Subject decision|8
6074194|NCT00434954|20978204|P2|Overall Study|Sponsor decision|0
6074195|NCT00434954|20978205|P1|Overall Study|Sponsor decision|1
6074196|NCT00434954|20978204|P2|Overall Study|Protocol Violation|27
6074197|NCT00434954|20978205|P1|Overall Study|Protocol Violation|36
6074198|NCT00434954|20978204|P2|Overall Study|Physician Decision|3
6074199|NCT00434954|20978205|P1|Overall Study|Physician Decision|6
6074200|NCT00434954|20978204|P2|Overall Study|Lost to Follow-up|1
6074201|NCT00434954|20978205|P1|Overall Study|Lost to Follow-up|0
6074202|NCT00434954|20978204|P2|Overall Study|Entry criteria not met|16
6074203|NCT00434954|20978205|P1|Overall Study|Entry criteria not met|14
6074204|NCT00434954|20978204|P2|Overall Study|Adverse Event|2
6074205|NCT00434954|20978205|P1|Overall Study|Adverse Event|17
6074206|NCT00434876|20978235|P2|Overall Study|Lost to Follow-up|1
6074207|NCT00434876|20978236|P1|Overall Study|Lost to Follow-up|1
6074208|NCT00434759|20978250|P2|Overall Study|family affairs|0
6074209|NCT00434759|20978251|P1|Overall Study|family affairs|2
6074210|NCT00434759|20978250|P2|Overall Study|Withdrawal by Subject|1
6074211|NCT00434759|20978251|P1|Overall Study|Withdrawal by Subject|17
6074212|NCT00434759|20978250|P2|Overall Study|Lack of Efficacy|4
6074213|NCT00434759|20978251|P1|Overall Study|Lack of Efficacy|5
6074214|NCT00434642|20978267|P2|Open-label Treatment Phase|Disease Progression Per RECIST|6
6074215|NCT00434642|20978268|P1|Open-label Treatment Phase|Disease Progression Per RECIST|0
6074216|NCT00434642|20978267|P2|Open-label Treatment Phase|Adverse Event|5
6074217|NCT00434642|20978268|P1|Open-label Treatment Phase|Adverse Event|0
6074218|NCT00434642|20978267|P2|Blinded Treatment Phase|Did not Receive Treatment|1
6074219|NCT00434642|20978268|P1|Blinded Treatment Phase|Did not Receive Treatment|4
6074220|NCT00434642|20978267|P2|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|29
6074221|NCT00434642|20978268|P1|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|32
6074222|NCT00434642|20978267|P2|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|0
6074223|NCT00434642|20978268|P1|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|3
6074224|NCT00434642|20978267|P2|Blinded Treatment Phase|Physician Decision|27
6074225|NCT00434642|20978268|P1|Blinded Treatment Phase|Physician Decision|19
6074226|NCT00434642|20978267|P2|Blinded Treatment Phase|Disease Progression Per RECIST|109
6074227|NCT00434642|20978268|P1|Blinded Treatment Phase|Disease Progression Per RECIST|168
6074228|NCT00434642|20978267|P2|Blinded Treatment Phase|Clinical Disease Progression|5
6074229|NCT00434642|20978268|P1|Blinded Treatment Phase|Clinical Disease Progression|4
6074230|NCT00434642|20978267|P2|Blinded Treatment Phase|Adverse Event|58
6074231|NCT00434642|20978268|P1|Blinded Treatment Phase|Adverse Event|12
6074232|NCT00434590|20978286|P2|Overall Study|Administrative problems|5
6074233|NCT00434590|20978287|P1|Overall Study|Administrative problems|5
6074234|NCT00434577|20978298|P5|Months 0-3|Withdrawal by Subject|1
6074235|NCT00434577|20978299|P4|Months 0-3|Withdrawal by Subject|1
6074236|NCT00434577|20978300|P3|Months 0-3|Withdrawal by Subject|1
6074237|NCT00434577|20978301|P2|Months 0-3|Withdrawal by Subject|1
6074238|NCT00434577|20978302|P1|Months 0-3|Withdrawal by Subject|2
6074239|NCT00434577|20978298|P5|Months 0-3|Protocol Violation|0
6074240|NCT00434577|20978299|P4|Months 0-3|Protocol Violation|0
6074241|NCT00434577|20978300|P3|Months 0-3|Protocol Violation|1
6074242|NCT00434577|20978301|P2|Months 0-3|Protocol Violation|0
6074243|NCT00434577|20978302|P1|Months 0-3|Protocol Violation|1
6074244|NCT00434577|20978298|P5|Months 0-3|Lost to Follow-up|2
6074245|NCT00434577|20978299|P4|Months 0-3|Lost to Follow-up|0
6074246|NCT00434577|20978300|P3|Months 0-3|Lost to Follow-up|0
6074247|NCT00434577|20978301|P2|Months 0-3|Lost to Follow-up|0
6074248|NCT00434577|20978302|P1|Months 0-3|Lost to Follow-up|0
6074249|NCT00434577|20978298|P5|Months 0-3|Adverse Event|0
6074250|NCT00434577|20978299|P4|Months 0-3|Adverse Event|0
6074251|NCT00434577|20978300|P3|Months 0-3|Adverse Event|1
6074252|NCT00434577|20978301|P2|Months 0-3|Adverse Event|1
6074253|NCT00434577|20978302|P1|Months 0-3|Adverse Event|0
6074254|NCT00434577|20978298|P5|Months 0-3|Serious Adverse Event|0
6074255|NCT00434577|20978299|P4|Months 0-3|Serious Adverse Event|0
6074256|NCT00434577|20978300|P3|Months 0-3|Serious Adverse Event|1
6074257|NCT00434577|20978301|P2|Months 0-3|Serious Adverse Event|0
6074258|NCT00434577|20978302|P1|Months 0-3|Serious Adverse Event|0
6074259|NCT00434512|20978480|P6|Overall Study|Other|0
6074260|NCT00434512|20978481|P5|Overall Study|Other|0
6074261|NCT00434512|20978482|P4|Overall Study|Other|0
6074262|NCT00434512|20978483|P3|Overall Study|Other|0
6074263|NCT00434512|20978484|P2|Overall Study|Other|1
6074264|NCT00434512|20978485|P1|Overall Study|Other|0
6074265|NCT00434512|20978480|P6|Overall Study|Migrated/moved from study area|1
6074266|NCT00434512|20978481|P5|Overall Study|Migrated/moved from study area|1
6074267|NCT00434512|20978482|P4|Overall Study|Migrated/moved from study area|1
6074268|NCT00434512|20978483|P3|Overall Study|Migrated/moved from study area|0
6074269|NCT00434512|20978484|P2|Overall Study|Migrated/moved from study area|0
6074270|NCT00434512|20978485|P1|Overall Study|Migrated/moved from study area|0
6074271|NCT00434421|20978599|P1|Overall Study|Non-compliance with study treatment|1
6074272|NCT00434421|20978599|P1|Overall Study|Withdrawal by Subject|1
6074273|NCT00434330|20978627|P6|Overall Study|Subject Not Compliant With Study|0
6074274|NCT00434330|20978628|P5|Overall Study|Subject Not Compliant With Study|0
6074275|NCT00434330|20978629|P4|Overall Study|Subject Not Compliant With Study|0
6074276|NCT00434330|20978630|P3|Overall Study|Subject Not Compliant With Study|1
6074277|NCT00434330|20978631|P2|Overall Study|Subject Not Compliant With Study|0
6074278|NCT00434330|20978632|P1|Overall Study|Subject Not Compliant With Study|0
6074279|NCT00434330|20978627|P6|Overall Study|Renal transplant|0
6074280|NCT00434330|20978628|P5|Overall Study|Renal transplant|0
6074281|NCT00434330|20978629|P4|Overall Study|Renal transplant|1
6074282|NCT00434330|20978630|P3|Overall Study|Renal transplant|0
6074283|NCT00434330|20978631|P2|Overall Study|Renal transplant|0
6074284|NCT00434330|20978632|P1|Overall Study|Renal transplant|0
6074285|NCT00434330|20978627|P6|Overall Study|Withdrawal by Subject|0
6074286|NCT00434330|20978628|P5|Overall Study|Withdrawal by Subject|0
6074287|NCT00434330|20978629|P4|Overall Study|Withdrawal by Subject|1
6074288|NCT00434330|20978630|P3|Overall Study|Withdrawal by Subject|1
6074289|NCT00434330|20978631|P2|Overall Study|Withdrawal by Subject|0
6074290|NCT00434330|20978632|P1|Overall Study|Withdrawal by Subject|0
6074291|NCT00434330|20978627|P6|Overall Study|Death|1
6074292|NCT00434330|20978628|P5|Overall Study|Death|1
6074293|NCT00434330|20978629|P4|Overall Study|Death|0
6074294|NCT00434330|20978630|P3|Overall Study|Death|0
6074295|NCT00434330|20978631|P2|Overall Study|Death|0
6074296|NCT00434330|20978632|P1|Overall Study|Death|1
6074297|NCT00434330|20978627|P6|Overall Study|Adverse Event|0
6074298|NCT00434330|20978628|P5|Overall Study|Adverse Event|0
6074299|NCT00434330|20978629|P4|Overall Study|Adverse Event|0
6074300|NCT00434330|20978630|P3|Overall Study|Adverse Event|1
6074301|NCT00434330|20978631|P2|Overall Study|Adverse Event|0
6074302|NCT00434330|20978632|P1|Overall Study|Adverse Event|0
6074303|NCT00434304|20978664|P1|Overall Study|Withdrawal by Subject|4
6074304|NCT00434304|20978664|P1|Overall Study|Lack of Efficacy|2
6074305|NCT00434304|20978664|P1|Overall Study|Adverse Event|14
6074306|NCT00434252|20978713|P2|Overall Study|Withdrawal by Subject|7
6074307|NCT00434252|20978714|P1|Overall Study|Withdrawal by Subject|3
6074308|NCT00434252|20978713|P2|Overall Study|Physician Decision|8
6074309|NCT00434252|20978714|P1|Overall Study|Physician Decision|4
6074310|NCT00434252|20978713|P2|Overall Study|Lost to Follow-up|1
6074311|NCT00434252|20978714|P1|Overall Study|Lost to Follow-up|0
6074312|NCT00434252|20978713|P2|Overall Study|Death|2
6074313|NCT00434252|20978714|P1|Overall Study|Death|1
6074314|NCT00434252|20978713|P2|Overall Study|Adverse Event|13
6074315|NCT00434252|20978714|P1|Overall Study|Adverse Event|6
6074316|NCT00434252|20978713|P2|Overall Study|Lack of Efficacy|100
6074317|NCT00434252|20978714|P1|Overall Study|Lack of Efficacy|50
6074318|NCT00434213|20978748|P1|Overall Study|Non-compliant to study schedule|1
6074319|NCT00434213|20978748|P1|Overall Study|Application site reaction|1
6074320|NCT00434213|20978748|P1|Overall Study|Unable to comply with study visit window|2
6074321|NCT00434213|20978748|P1|Overall Study|Protocol Violation|3
6074322|NCT00434213|20978748|P1|Overall Study|Withdrawal by Subject|7
6074323|NCT00434213|20978748|P1|Overall Study|Lost to Follow-up|14
6074324|NCT00434213|20978748|P1|Overall Study|Lack of Efficacy|9
6074325|NCT00434213|20978748|P1|Overall Study|Adverse Event|12
6074326|NCT00434161|20978756|P3|Overall Study|Logistical error study assessments|3
6074327|NCT00434161|20978757|P2|Overall Study|Logistical error study assessments|0
6074328|NCT00434161|20978758|P1|Overall Study|Logistical error study assessments|1
6074329|NCT00434161|20978756|P3|Overall Study|Withdrawal by Subject|3
6074330|NCT00434161|20978757|P2|Overall Study|Withdrawal by Subject|0
6074331|NCT00434161|20978758|P1|Overall Study|Withdrawal by Subject|2
6074332|NCT00434161|20978756|P3|Overall Study|Non-Compliance|0
6074333|NCT00434161|20978757|P2|Overall Study|Non-Compliance|1
6074334|NCT00434161|20978758|P1|Overall Study|Non-Compliance|1
6074335|NCT00434161|20978756|P3|Overall Study|Death|1
6074336|NCT00434161|20978757|P2|Overall Study|Death|0
6074337|NCT00434161|20978758|P1|Overall Study|Death|1
6074338|NCT00434161|20978756|P3|Overall Study|Lost to Follow-up|0
6074339|NCT00434161|20978757|P2|Overall Study|Lost to Follow-up|1
6074340|NCT00434161|20978758|P1|Overall Study|Lost to Follow-up|0
6074341|NCT00434161|20978756|P3|Overall Study|Adverse Event|4
6074342|NCT00434161|20978757|P2|Overall Study|Adverse Event|1
6074343|NCT00434161|20978758|P1|Overall Study|Adverse Event|5
6074344|NCT00434148|20978802|P2|Overall Study|Abnormal test procedure result|1
6074345|NCT00434148|20978803|P1|Overall Study|Abnormal test procedure result|0
6074346|NCT00434148|20978802|P2|Overall Study|Condition no longer requires study drug|0
6074347|NCT00434148|20978803|P1|Overall Study|Condition no longer requires study drug|1
6074348|NCT00434148|20978802|P2|Overall Study|Lost to Follow-up|1
6074349|NCT00434148|20978803|P1|Overall Study|Lost to Follow-up|0
6074350|NCT00434148|20978802|P2|Overall Study|Administrative problems|10
6074351|NCT00434148|20978803|P1|Overall Study|Administrative problems|6
6074352|NCT00434148|20978802|P2|Overall Study|Protocol Violation|0
6074353|NCT00434148|20978803|P1|Overall Study|Protocol Violation|4
6074354|NCT00434148|20978802|P2|Overall Study|Withdrawal by Subject|15
6074355|NCT00434148|20978803|P1|Overall Study|Withdrawal by Subject|15
6074356|NCT00434148|20978802|P2|Overall Study|Lack of Efficacy|28
6074357|NCT00434148|20978803|P1|Overall Study|Lack of Efficacy|25
6074358|NCT00434148|20978802|P2|Overall Study|Adverse Event|18
6074359|NCT00434148|20978803|P1|Overall Study|Adverse Event|18
6074360|NCT00434122|20978839|P2|Overall Study|Travelling of subject.|0
6074361|NCT00434122|20978840|P1|Overall Study|Travelling of subject.|1
6074362|NCT00434122|20978839|P2|Overall Study|Low follicular response.|2
6074363|NCT00434122|20978840|P1|Overall Study|Low follicular response.|1
6074364|NCT00434122|20978839|P2|Overall Study|Large follicle size|2
6074365|NCT00434122|20978840|P1|Overall Study|Large follicle size|2
6074366|NCT00434122|20978839|P2|Overall Study|Personal reasons|1
6074367|NCT00434122|20978840|P1|Overall Study|Personal reasons|1
6074368|NCT00434122|20978839|P2|Overall Study|loss of subject contact|1
6074369|NCT00434122|20978840|P1|Overall Study|loss of subject contact|1
6074370|NCT00434122|20978839|P2|Overall Study|Non-compliance with protocol|1
6074371|NCT00434122|20978840|P1|Overall Study|Non-compliance with protocol|0
6074372|NCT00434109|20978849|P1|Overall Study|had embolism, did not receive sunitinib|3
6074373|NCT00434109|20978849|P1|Overall Study|Protocol Violation|1
6074374|NCT00434109|20978849|P1|Overall Study|Adverse Event|5
6074375|NCT00434109|20978849|P1|Overall Study|Physician Decision|9
6074376|NCT00434057|20978858|P1|Overall Study|Withdrawal by Subject|1
6074377|NCT00433966|20978896|P4|Stent Intervention/Randomization|Lost to Follow-up|47
6074378|NCT00433966|20978897|P3|Stent Intervention/Randomization|Lost to Follow-up|113
6074379|NCT00433966|20978898|P2|Stent Intervention/Randomization|Lost to Follow-up|0
6074380|NCT00433966|20978899|P1|Stent Intervention/Randomization|Lost to Follow-up|0
6074381|NCT00433966|20978896|P4|Stent Intervention/Randomization|Withdrawal by Subject|15
6074382|NCT00433966|20978897|P3|Stent Intervention/Randomization|Withdrawal by Subject|41
6074383|NCT00433966|20978898|P2|Stent Intervention/Randomization|Withdrawal by Subject|0
6074384|NCT00433966|20978899|P1|Stent Intervention/Randomization|Withdrawal by Subject|0
6074385|NCT00433966|20978896|P4|Pharmacology Intervention/Randomization|Not true myocardial infarction|0
6074386|NCT00433966|20978897|P3|Pharmacology Intervention/Randomization|Not true myocardial infarction|0
6074387|NCT00433966|20978898|P2|Pharmacology Intervention/Randomization|Not true myocardial infarction|28
6074388|NCT00433966|20978899|P1|Pharmacology Intervention/Randomization|Not true myocardial infarction|29
6074389|NCT00433966|20978896|P4|Pharmacology Intervention/Randomization|Lost to Follow-up|0
6074390|NCT00433966|20978897|P3|Pharmacology Intervention/Randomization|Lost to Follow-up|0
6074391|NCT00433966|20978898|P2|Pharmacology Intervention/Randomization|Lost to Follow-up|103
6074392|NCT00433966|20978899|P1|Pharmacology Intervention/Randomization|Lost to Follow-up|97
6074393|NCT00433966|20978896|P4|Pharmacology Intervention/Randomization|Withdrawal by Subject|0
6074394|NCT00433966|20978897|P3|Pharmacology Intervention/Randomization|Withdrawal by Subject|0
6074395|NCT00433966|20978898|P2|Pharmacology Intervention/Randomization|Withdrawal by Subject|43
6074396|NCT00433966|20978899|P1|Pharmacology Intervention/Randomization|Withdrawal by Subject|40
6074397|NCT00433914|20978921|P2|Overall Study|Lost to Follow-up|1
6074398|NCT00433914|20978922|P1|Overall Study|Lost to Follow-up|0
6074399|NCT00433914|20978921|P2|Overall Study|Withdrawal by Subject|2
6074400|NCT00433914|20978922|P1|Overall Study|Withdrawal by Subject|0
6074401|NCT00433836|20978942|P2|Overall Study|Abnormal laboratory values|1
6074402|NCT00433836|20978943|P1|Overall Study|Abnormal laboratory values|0
6074403|NCT00433836|20978942|P2|Overall Study|Condition no longer requires study drug|1
6074404|NCT00433836|20978943|P1|Overall Study|Condition no longer requires study drug|0
6074405|NCT00433836|20978942|P2|Overall Study|Protocol Violation|2
6074406|NCT00433836|20978943|P1|Overall Study|Protocol Violation|0
6074407|NCT00433836|20978942|P2|Overall Study|Unsatisfactory therapeutic effect|1
6074408|NCT00433836|20978943|P1|Overall Study|Unsatisfactory therapeutic effect|1
6074409|NCT00433836|20978942|P2|Overall Study|Withdrawal by Subject|1
6074410|NCT00433836|20978943|P1|Overall Study|Withdrawal by Subject|2
6074411|NCT00433836|20978942|P2|Overall Study|Lost to Follow-up|0
6074412|NCT00433836|20978943|P1|Overall Study|Lost to Follow-up|3
6074413|NCT00433836|20978942|P2|Overall Study|Adverse Event|0
6074414|NCT00433836|20978943|P1|Overall Study|Adverse Event|7
6074415|NCT00433771|20978955|P1|Overall Study|Failure to deploy stent|1
6074416|NCT00433771|20978955|P1|Overall Study|Death|2
6074417|NCT00433771|20978955|P1|Overall Study|Treated and later found to be ineligible|2
6074418|NCT00433771|20978955|P1|Overall Study|screen fail|14
6074419|NCT00433654|20978978|P2|Overall Study|Withdrawal by Subject|2
6074420|NCT00433654|20978979|P1|Overall Study|Withdrawal by Subject|1
6074421|NCT00433654|20978978|P2|Overall Study|Subject not yet due for visit|0
6074422|NCT00433654|20978979|P1|Overall Study|Subject not yet due for visit|4
6074423|NCT00433654|20978978|P2|Overall Study|Missed visit|3
6074424|NCT00433654|20978979|P1|Overall Study|Missed visit|6
6074425|NCT00433654|20978978|P2|Overall Study|Death|0
6074426|NCT00433654|20978979|P1|Overall Study|Death|4
6074427|NCT00433537|20979025|P3|Step 2 - Maintenance Rituximab or ASCT|Other|0
6074428|NCT00433537|20979026|P2|Step 2 - Maintenance Rituximab or ASCT|Other|0
6074429|NCT00433537|20979027|P1|Step 2 - Maintenance Rituximab or ASCT|Other|1
6074430|NCT00433537|20979025|P3|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0
6074431|NCT00433537|20979026|P2|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0
6074432|NCT00433537|20979027|P1|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|4
6074433|NCT00433537|20979025|P3|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0
6074434|NCT00433537|20979026|P2|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0
6074435|NCT00433537|20979027|P1|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|2
6074436|NCT00433537|20979025|P3|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0
6074437|NCT00433537|20979026|P2|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0
6074438|NCT00433537|20979027|P1|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|8
6074439|NCT00433537|20979025|P3|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0
6074440|NCT00433537|20979026|P2|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0
6074441|NCT00433537|20979027|P1|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|1
6074442|NCT00433537|20979025|P3|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|2
6074443|NCT00433537|20979026|P2|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0
6074444|NCT00433537|20979027|P1|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0
6074445|NCT00433537|20979025|P3|Step 1 - VcR-CVAD Induction|Adverse Event|4
6074446|NCT00433537|20979026|P2|Step 1 - VcR-CVAD Induction|Adverse Event|0
6074447|NCT00433537|20979027|P1|Step 1 - VcR-CVAD Induction|Adverse Event|0
6074448|NCT00433537|20979025|P3|Step 1 - VcR-CVAD Induction|Lack of Efficacy|2
6074449|NCT00433537|20979026|P2|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0
6074450|NCT00433537|20979027|P1|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0
6074451|NCT00433537|20979025|P3|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1
6074452|NCT00433537|20979026|P2|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|0
6074453|NCT00433537|20979027|P1|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1
6074454|NCT00433511|20979039|P3|Step 2 (Arm D)|Unknown (Missing off treatment form)|1
6074455|NCT00433511|20979040|P2|Step 2 (Arm D)|Unknown (Missing off treatment form)|0
6074456|NCT00433511|20979041|P1|Step 2 (Arm D)|Unknown (Missing off treatment form)|0
6074457|NCT00433511|20979039|P3|Step 2 (Arm D)|Insurance/drug distribution issues|4
6074458|NCT00433511|20979040|P2|Step 2 (Arm D)|Insurance/drug distribution issues|0
6074459|NCT00433511|20979041|P1|Step 2 (Arm D)|Insurance/drug distribution issues|0
6074460|NCT00433511|20979039|P3|Step 2 (Arm D)|Suspected recurrence|1
6074461|NCT00433511|20979040|P2|Step 2 (Arm D)|Suspected recurrence|0
6074462|NCT00433511|20979041|P1|Step 2 (Arm D)|Suspected recurrence|0
6074463|NCT00433511|20979039|P3|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|2
6074464|NCT00433511|20979040|P2|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0
6074465|NCT00433511|20979041|P1|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0
6074466|NCT00433511|20979039|P3|Step 2 (Arm D)|Other complicating disease|3
6074467|NCT00433511|20979040|P2|Step 2 (Arm D)|Other complicating disease|0
6074468|NCT00433511|20979041|P1|Step 2 (Arm D)|Other complicating disease|0
6074469|NCT00433511|20979039|P3|Step 2 (Arm D)|Disease progression, relapse|7
6074470|NCT00433511|20979040|P2|Step 2 (Arm D)|Disease progression, relapse|0
6074471|NCT00433511|20979041|P1|Step 2 (Arm D)|Disease progression, relapse|0
6074472|NCT00433511|20979039|P3|Step 2 (Arm D)|Physician Decision|9
6074473|NCT00433511|20979040|P2|Step 2 (Arm D)|Physician Decision|0
6074474|NCT00433511|20979041|P1|Step 2 (Arm D)|Physician Decision|0
6074475|NCT00433511|20979039|P3|Step 2 (Arm D)|Never started protocol therapy|148
6074476|NCT00433511|20979040|P2|Step 2 (Arm D)|Never started protocol therapy|0
6074477|NCT00433511|20979041|P1|Step 2 (Arm D)|Never started protocol therapy|0
6074478|NCT00433511|20979039|P3|Step 2 (Arm D)|Withdrawal by Subject|181
6074479|NCT00433511|20979040|P2|Step 2 (Arm D)|Withdrawal by Subject|0
6074480|NCT00433511|20979041|P1|Step 2 (Arm D)|Withdrawal by Subject|0
6074481|NCT00433511|20979039|P3|Step 2 (Arm D)|Adverse Event|135
6074482|NCT00433511|20979040|P2|Step 2 (Arm D)|Adverse Event|0
6074483|NCT00433511|20979041|P1|Step 2 (Arm D)|Adverse Event|0
6074484|NCT00433511|20979039|P3|Step 1|Patient moved|1
6074485|NCT00433511|20979040|P2|Step 1|Patient moved|0
6074486|NCT00433511|20979041|P1|Step 1|Patient moved|0
6074487|NCT00433511|20979039|P3|Step 1|Insurance/drug distribution issues|2
6074488|NCT00433511|20979040|P2|Step 1|Insurance/drug distribution issues|1
6074489|NCT00433511|20979041|P1|Step 1|Insurance/drug distribution issues|0
6074490|NCT00433511|20979039|P3|Step 1|Suspected recurrence|0
6074491|NCT00433511|20979040|P2|Step 1|Suspected recurrence|1
6074492|NCT00433511|20979041|P1|Step 1|Suspected recurrence|0
6074493|NCT00433511|20979039|P3|Step 1|Non-breast cancer surgery/wound issues|1
6074494|NCT00433511|20979040|P2|Step 1|Non-breast cancer surgery/wound issues|4
6074495|NCT00433511|20979041|P1|Step 1|Non-breast cancer surgery/wound issues|0
6074496|NCT00433511|20979039|P3|Step 1|Other complicating disease|3
6074497|NCT00433511|20979040|P2|Step 1|Other complicating disease|6
6074498|NCT00433511|20979041|P1|Step 1|Other complicating disease|2
6074499|NCT00433511|20979039|P3|Step 1|Disease progression, relapse|3
6074500|NCT00433511|20979040|P2|Step 1|Disease progression, relapse|3
6074501|NCT00433511|20979041|P1|Step 1|Disease progression, relapse|5
6074502|NCT00433511|20979039|P3|Step 1|Alternative therapy|3
6074503|NCT00433511|20979040|P2|Step 1|Alternative therapy|1
6074504|NCT00433511|20979041|P1|Step 1|Alternative therapy|2
6074505|NCT00433511|20979039|P3|Step 1|Never started protocol therapy|66
6074506|NCT00433511|20979040|P2|Step 1|Never started protocol therapy|64
6074507|NCT00433511|20979041|P1|Step 1|Never started protocol therapy|28
6074508|NCT00433511|20979039|P3|Step 1|Physician Decision|3
6074509|NCT00433511|20979040|P2|Step 1|Physician Decision|4
6074510|NCT00433511|20979041|P1|Step 1|Physician Decision|1
6074511|NCT00433511|20979039|P3|Step 1|Death|1
6074512|NCT00433511|20979040|P2|Step 1|Death|1
6074513|NCT00433511|20979041|P1|Step 1|Death|3
6074514|NCT00433511|20979039|P3|Step 1|Withdrawal by Subject|154
6074515|NCT00433511|20979040|P2|Step 1|Withdrawal by Subject|143
6074516|NCT00433511|20979041|P1|Step 1|Withdrawal by Subject|45
6074517|NCT00433511|20979039|P3|Step 1|Adverse Event|153
6074518|NCT00433511|20979040|P2|Step 1|Adverse Event|157
6074519|NCT00433511|20979041|P1|Step 1|Adverse Event|50
6074520|NCT00433446|20979055|P1|Overall Study|Ineligible|9
6074521|NCT00433446|20979055|P1|Overall Study|Other - Not Protocol specified|3
6074522|NCT00433446|20979055|P1|Overall Study|Progression|44
6074523|NCT00433446|20979055|P1|Overall Study|Refusal Unrelated to Adverse Event|1
6074524|NCT00433446|20979055|P1|Overall Study|Adverse Event|4
6074525|NCT00433381|20979065|P2|Overall Study|Ineligible / no protocol treatment|3
6074526|NCT00433381|20979066|P1|Overall Study|Ineligible / no protocol treatment|3
6074527|NCT00433329|20979085|P1|Overall Study|Physician Decision|1
6074528|NCT00433329|20979085|P1|Overall Study|Lost to Follow-up|1
6074529|NCT00433329|20979085|P1|Overall Study|Moved out of state|1
6074530|NCT00433329|20979085|P1|Overall Study|Discontinued sildenafil|2
6074531|NCT00433329|20979085|P1|Overall Study|Withdrew consent|3
6074532|NCT00433329|20979085|P1|Overall Study|Death|4
6074533|NCT00433329|20979085|P1|Overall Study|Adverse Event|9
6074534|NCT00433290|20979091|P2|Overall Study|Lost to Follow-up|0
6074535|NCT00433290|20979092|P1|Overall Study|Lost to Follow-up|1
6074536|NCT00433290|20979091|P2|Overall Study|Entry Criteria Not Met|1
6074537|NCT00433290|20979092|P1|Overall Study|Entry Criteria Not Met|0
6074538|NCT00433290|20979091|P2|Overall Study|Physician Decision|0
6074539|NCT00433290|20979092|P1|Overall Study|Physician Decision|2
6074540|NCT00433290|20979091|P2|Overall Study|Protocol Violation|2
6074541|NCT00433290|20979092|P1|Overall Study|Protocol Violation|3
6074542|NCT00433290|20979091|P2|Overall Study|Withdrawal by Subject|2
6074543|NCT00433290|20979092|P1|Overall Study|Withdrawal by Subject|4
6074544|NCT00433290|20979091|P2|Overall Study|Lack of Efficacy|5
6074545|NCT00433290|20979092|P1|Overall Study|Lack of Efficacy|1
6074546|NCT00433290|20979091|P2|Overall Study|Adverse Event|7
6074547|NCT00433290|20979092|P1|Overall Study|Adverse Event|24
6074548|NCT00433199|20979161|P2|Open-Label Period|Administrative|1
6074549|NCT00433199|20979162|P1|Open-Label Period|Administrative|0
6074550|NCT00433199|20979161|P2|Open-Label Period|Protocol Violation|2
6074551|NCT00433199|20979162|P1|Open-Label Period|Protocol Violation|0
6074552|NCT00433199|20979161|P2|Open-Label Period|Withdrawal by Subject|7
6074553|NCT00433199|20979162|P1|Open-Label Period|Withdrawal by Subject|0
6074554|NCT00433199|20979161|P2|Open-Label Period|Lost to Follow-up|3
6074555|NCT00433199|20979162|P1|Open-Label Period|Lost to Follow-up|0
6074556|NCT00433199|20979161|P2|Open-Label Period|Lack of Efficacy|2
6074557|NCT00433199|20979162|P1|Open-Label Period|Lack of Efficacy|0
6074558|NCT00433199|20979161|P2|Open-Label Period|Adverse Event|19
6074559|NCT00433199|20979162|P1|Open-Label Period|Adverse Event|0
6074560|NCT00433199|20979161|P2|Double-Blind Period|Administrative|5
6074561|NCT00433199|20979162|P1|Double-Blind Period|Administrative|1
6074562|NCT00433199|20979161|P2|Double-Blind Period|Protocol Violation|10
6074563|NCT00433199|20979162|P1|Double-Blind Period|Protocol Violation|1
6074564|NCT00433199|20979161|P2|Double-Blind Period|Withdrawal by Subject|19
6074565|NCT00433199|20979162|P1|Double-Blind Period|Withdrawal by Subject|8
6074566|NCT00433199|20979161|P2|Double-Blind Period|Lost to Follow-up|5
6074567|NCT00433199|20979162|P1|Double-Blind Period|Lost to Follow-up|2
6074568|NCT00433199|20979161|P2|Double-Blind Period|Lack of Efficacy|2
6074569|NCT00433199|20979162|P1|Double-Blind Period|Lack of Efficacy|0
6074570|NCT00433199|20979161|P2|Double-Blind Period|Adverse Event|25
6074571|NCT00433199|20979162|P1|Double-Blind Period|Adverse Event|0
6074572|NCT00433160|20979182|P2|104 Weeks, 28-Week OL Period|Physician Decision|1
6074573|NCT00433160|20979183|P1|104 Weeks, 28-Week OL Period|Physician Decision|0
6074574|NCT00433160|20979182|P2|104 Weeks, 28-Week OL Period|Withdrawal by Subject|2
6074575|NCT00433160|20979183|P1|104 Weeks, 28-Week OL Period|Withdrawal by Subject|8
6074576|NCT00433160|20979182|P2|104 Weeks, 28-Week OL Period|Adverse Event|0
6074577|NCT00433160|20979183|P1|104 Weeks, 28-Week OL Period|Adverse Event|2
6074578|NCT00433160|20979182|P2|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|1
6074579|NCT00433160|20979183|P1|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|0
6074580|NCT00433160|20979182|P2|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|0
6074581|NCT00433160|20979183|P1|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|2
6074582|NCT00433160|20979182|P2|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|2
6074583|NCT00433160|20979183|P1|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|1
6074584|NCT00433160|20979182|P2|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|1
6074585|NCT00433160|20979183|P1|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|3
6074586|NCT00433160|20979182|P2|52-Week Double-Blind (DB) Period|Lack of Efficacy|2
6074587|NCT00433160|20979183|P1|52-Week Double-Blind (DB) Period|Lack of Efficacy|1
6074588|NCT00433160|20979182|P2|52-Week Double-Blind (DB) Period|Sponsor Decision|0
6074589|NCT00433160|20979183|P1|52-Week Double-Blind (DB) Period|Sponsor Decision|0
6074590|NCT00433160|20979182|P2|52-Week Double-Blind (DB) Period|Physician Decision|2
6074591|NCT00433160|20979183|P1|52-Week Double-Blind (DB) Period|Physician Decision|4
6074592|NCT00433160|20979182|P2|52-Week Double-Blind (DB) Period|Withdrawal by Subject|1
6074593|NCT00433160|20979183|P1|52-Week Double-Blind (DB) Period|Withdrawal by Subject|6
6074594|NCT00433160|20979182|P2|52-Week Double-Blind (DB) Period|Protocol Violation|2
6074595|NCT00433160|20979183|P1|52-Week Double-Blind (DB) Period|Protocol Violation|0
6074596|NCT00433160|20979182|P2|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|1
6074597|NCT00433160|20979183|P1|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|0
6074598|NCT00433160|20979182|P2|52-Week Double-Blind (DB) Period|Lost to Follow-up|0
6074599|NCT00433160|20979183|P1|52-Week Double-Blind (DB) Period|Lost to Follow-up|0
6074600|NCT00433160|20979182|P2|52-Week Double-Blind (DB) Period|Death|0
6074601|NCT00433160|20979183|P1|52-Week Double-Blind (DB) Period|Death|0
6074602|NCT00433160|20979182|P2|52-Week Double-Blind (DB) Period|Adverse Event|2
6074603|NCT00433160|20979183|P1|52-Week Double-Blind (DB) Period|Adverse Event|6
6074604|NCT00433147|20979235|P4|Overall Study|Adverse Event|0
6074605|NCT00433147|20979236|P3|Overall Study|Adverse Event|0
6074606|NCT00433147|20979237|P2|Overall Study|Adverse Event|1
6074607|NCT00433147|20979238|P1|Overall Study|Adverse Event|0
6074608|NCT00433017|20979254|P2|Overall Study|Subject no longer requires study drug|1
6074609|NCT00433017|20979255|P1|Overall Study|Subject no longer requires study drug|1
6074610|NCT00433017|20979254|P2|Overall Study|Death|2
6074611|NCT00433017|20979255|P1|Overall Study|Death|2
6074612|NCT00433017|20979254|P2|Overall Study|Protocol Violation|0
6074613|NCT00433017|20979255|P1|Overall Study|Protocol Violation|1
6074614|NCT00433017|20979254|P2|Overall Study|Administrative problems|86
6074615|NCT00433017|20979255|P1|Overall Study|Administrative problems|80
6074616|NCT00433017|20979254|P2|Overall Study|Lost to Follow-up|4
6074617|NCT00433017|20979255|P1|Overall Study|Lost to Follow-up|3
6074618|NCT00433017|20979254|P2|Overall Study|Withdrawal by Subject|5
6074619|NCT00433017|20979255|P1|Overall Study|Withdrawal by Subject|4
6074620|NCT00433017|20979254|P2|Overall Study|Adverse Event|3
6074621|NCT00433017|20979255|P1|Overall Study|Adverse Event|5
6074622|NCT00433004|20979271|P2|Overall Study|Lost to Follow-up|7
6074623|NCT00433004|20979272|P1|Overall Study|Lost to Follow-up|5
6074624|NCT00432991|20979284|P2|Overall Study|Protocol Violation|12
6074625|NCT00432991|20979285|P1|Overall Study|Protocol Violation|7
6074626|NCT00432965|20979297|P2|Overall Study|Incomplete Data|3
6074627|NCT00432965|20979298|P1|Overall Study|Incomplete Data|4
6074628|NCT00432965|20979297|P2|Overall Study|Exclusionary Methods|2
6074629|NCT00432965|20979298|P1|Overall Study|Exclusionary Methods|1
6074630|NCT00432965|20979297|P2|Overall Study|Death|4
6074631|NCT00432965|20979298|P1|Overall Study|Death|3
6074632|NCT00432965|20979297|P2|Overall Study|Adverse Event|19
6074633|NCT00432965|20979298|P1|Overall Study|Adverse Event|22
6074634|NCT00432965|20979297|P2|Overall Study|Non-compliance|0
6074635|NCT00432965|20979298|P1|Overall Study|Non-compliance|7
6074636|NCT00432965|20979297|P2|Overall Study|Lack of Efficacy|13
6074637|NCT00432965|20979298|P1|Overall Study|Lack of Efficacy|8
6074638|NCT00432965|20979297|P2|Overall Study|Physician Decision|13
6074639|NCT00432965|20979298|P1|Overall Study|Physician Decision|14
6074640|NCT00432965|20979297|P2|Overall Study|Withdrawal by Subject|13
6074641|NCT00432965|20979298|P1|Overall Study|Withdrawal by Subject|13
6074642|NCT00432965|20979297|P2|Overall Study|Lost to Follow-up|19
6074643|NCT00432965|20979298|P1|Overall Study|Lost to Follow-up|22
6074644|NCT00432835|20979306|P2|Overall Study|Adverse event: lead dislodgement.|7
6074645|NCT00432835|20979307|P1|Overall Study|Adverse event: lead dislodgement.|6
6074646|NCT00432809|20979320|P3|1 Year Follow-up|Withdrawal by Subject|1
6074647|NCT00432809|20979321|P2|1 Year Follow-up|Withdrawal by Subject|0
6074648|NCT00432809|20979322|P1|1 Year Follow-up|Withdrawal by Subject|7
6074649|NCT00432809|20979320|P3|1 Year Follow-up|Misses 9 and 12 month visit|0
6074650|NCT00432809|20979321|P2|1 Year Follow-up|Misses 9 and 12 month visit|0
6074651|NCT00432809|20979322|P1|1 Year Follow-up|Misses 9 and 12 month visit|2
6074652|NCT00432744|20979395|P2|Months 7 - 12|Too disabled to score|1
6074653|NCT00432744|20979396|P1|Months 7 - 12|Too disabled to score|0
6074654|NCT00432744|20979395|P2|Months 7 - 12|Withdrawal by Subject|0
6074655|NCT00432744|20979396|P1|Months 7 - 12|Withdrawal by Subject|1
6074656|NCT00432744|20979395|P2|Months 0-6|Too disabled to score|0
6074657|NCT00432744|20979396|P1|Months 0-6|Too disabled to score|1
6074658|NCT00432744|20979395|P2|Months 0-6|Withdrawal by Subject|4
6074659|NCT00432744|20979396|P1|Months 0-6|Withdrawal by Subject|4
6074660|NCT00432679|20979408|P2|Overall Study|Withdrawal by Subject|2
6074661|NCT00432679|20979409|P1|Overall Study|Withdrawal by Subject|3
6074662|NCT00432679|20979408|P2|Overall Study|Adverse Event|1
6074663|NCT00432679|20979409|P1|Overall Study|Adverse Event|2
6074664|NCT00432666|20979433|P2|Open-Label Extension Period|Physician Decision|0
6074665|NCT00432666|20979434|P1|Open-Label Extension Period|Physician Decision|3
6074666|NCT00432666|20979433|P2|Open-Label Extension Period|Consent withdrawn|0
6074667|NCT00432666|20979434|P1|Open-Label Extension Period|Consent withdrawn|10
6074668|NCT00432666|20979433|P2|Open-Label Extension Period|Adverse Event|0
6074669|NCT00432666|20979434|P1|Open-Label Extension Period|Adverse Event|5
6074670|NCT00432666|20979433|P2|Open-Label Extension Period|Lack of Efficacy|0
6074671|NCT00432666|20979434|P1|Open-Label Extension Period|Lack of Efficacy|6
6074672|NCT00432666|20979433|P2|Open-Label Extension Period|Withdrawal Criteria Occurred|0
6074673|NCT00432666|20979434|P1|Open-Label Extension Period|Withdrawal Criteria Occurred|1
6074674|NCT00432666|20979433|P2|Main Period|Consent Withdrawn|0
6074675|NCT00432666|20979434|P1|Main Period|Consent Withdrawn|1
6074676|NCT00432666|20979433|P2|Main Period|Adverse Event|1
6074677|NCT00432666|20979434|P1|Main Period|Adverse Event|1
6074678|NCT00432562|20979607|P2|Overall Study|Death|0
6074679|NCT00432562|20979608|P1|Overall Study|Death|3
6074680|NCT00432380|20979660|P3|Overall Study|Adverse Event|0
6074681|NCT00432380|20979661|P2|Overall Study|Adverse Event|0
6074682|NCT00432380|20979662|P1|Overall Study|Adverse Event|1
6074683|NCT00432380|20979660|P3|Overall Study|Migrated/moved from study area|1
6074684|NCT00432380|20979661|P2|Overall Study|Migrated/moved from study area|4
6074685|NCT00432380|20979662|P1|Overall Study|Migrated/moved from study area|3
6074686|NCT00432276|20979715|P2|Overall Study|Other|3
6074687|NCT00432276|20979716|P1|Overall Study|Other|2
6074688|NCT00432276|20979715|P2|Overall Study|Physician Decision|8
6074689|NCT00432276|20979716|P1|Overall Study|Physician Decision|6
6074690|NCT00432276|20979715|P2|Overall Study|Withdrawal by Subject|20
6074691|NCT00432276|20979716|P1|Overall Study|Withdrawal by Subject|25
6074692|NCT00432276|20979715|P2|Overall Study|Lost to Follow-up|2
6074693|NCT00432276|20979716|P1|Overall Study|Lost to Follow-up|6
6074694|NCT00432276|20979715|P2|Overall Study|Protocol Violation|20
6074695|NCT00432276|20979716|P1|Overall Study|Protocol Violation|25
6074696|NCT00432276|20979715|P2|Overall Study|Adverse Event|16
6074697|NCT00432276|20979716|P1|Overall Study|Adverse Event|13
6074698|NCT00432276|20979715|P2|Overall Study|Hyperglycemic Rescue|87
6074699|NCT00432276|20979716|P1|Overall Study|Hyperglycemic Rescue|44
6074700|NCT00432237|20979806|P4|Overall Study|Lack of Qualifying Event|84
6074701|NCT00432237|20979807|P3|Overall Study|Lack of Qualifying Event|69
6074702|NCT00432237|20979808|P2|Overall Study|Lack of Qualifying Event|71
6074703|NCT00432237|20979809|P1|Overall Study|Lack of Qualifying Event|38
6074704|NCT00432237|20979806|P4|Overall Study|Withdrawal by Subject|11
6074705|NCT00432237|20979807|P3|Overall Study|Withdrawal by Subject|9
6074706|NCT00432237|20979808|P2|Overall Study|Withdrawal by Subject|6
6074707|NCT00432237|20979809|P1|Overall Study|Withdrawal by Subject|5
6074708|NCT00432237|20979806|P4|Overall Study|Protocol Violation|8
6074709|NCT00432237|20979807|P3|Overall Study|Protocol Violation|11
6074710|NCT00432237|20979808|P2|Overall Study|Protocol Violation|10
6074711|NCT00432237|20979809|P1|Overall Study|Protocol Violation|13
6074712|NCT00432237|20979806|P4|Overall Study|Pregnancy|0
6074713|NCT00432237|20979807|P3|Overall Study|Pregnancy|0
6074714|NCT00432237|20979808|P2|Overall Study|Pregnancy|1
6074715|NCT00432237|20979809|P1|Overall Study|Pregnancy|0
6074716|NCT00432237|20979806|P4|Overall Study|Physician Decision|1
6074717|NCT00432237|20979807|P3|Overall Study|Physician Decision|2
6074718|NCT00432237|20979808|P2|Overall Study|Physician Decision|3
6074719|NCT00432237|20979809|P1|Overall Study|Physician Decision|1
6074720|NCT00432237|20979806|P4|Overall Study|Lost to Follow-up|18
6074721|NCT00432237|20979807|P3|Overall Study|Lost to Follow-up|18
6074722|NCT00432237|20979808|P2|Overall Study|Lost to Follow-up|10
6074723|NCT00432237|20979809|P1|Overall Study|Lost to Follow-up|10
6074724|NCT00432237|20979806|P4|Overall Study|Lack of Efficacy|1
6074725|NCT00432237|20979807|P3|Overall Study|Lack of Efficacy|0
6074726|NCT00432237|20979808|P2|Overall Study|Lack of Efficacy|0
6074727|NCT00432237|20979809|P1|Overall Study|Lack of Efficacy|0
6074728|NCT00432237|20979806|P4|Overall Study|Adverse Event|1
6074729|NCT00432237|20979807|P3|Overall Study|Adverse Event|0
6074730|NCT00432237|20979808|P2|Overall Study|Adverse Event|0
6074731|NCT00432237|20979809|P1|Overall Study|Adverse Event|0
6074732|NCT00432172|20979851|P4|Overall Study|No treatment received|1
6074733|NCT00432172|20979852|P3|Overall Study|No treatment received|0
6074734|NCT00432172|20979853|P2|Overall Study|No treatment received|2
6074735|NCT00432172|20979854|P1|Overall Study|No treatment received|2
6074736|NCT00432172|20979851|P4|Overall Study|Withdrawal by Subject|2
6074737|NCT00432172|20979852|P3|Overall Study|Withdrawal by Subject|0
6074738|NCT00432172|20979853|P2|Overall Study|Withdrawal by Subject|1
6074739|NCT00432172|20979854|P1|Overall Study|Withdrawal by Subject|0
6074740|NCT00432172|20979851|P4|Overall Study|Disease progression|1
6074741|NCT00432172|20979852|P3|Overall Study|Disease progression|5
6074742|NCT00432172|20979853|P2|Overall Study|Disease progression|2
6074743|NCT00432172|20979854|P1|Overall Study|Disease progression|0
6074744|NCT00432172|20979851|P4|Overall Study|Adverse Event|3
6074745|NCT00432172|20979852|P3|Overall Study|Adverse Event|4
6074746|NCT00432172|20979853|P2|Overall Study|Adverse Event|2
6074747|NCT00432172|20979854|P1|Overall Study|Adverse Event|4
6074748|NCT00432172|20979851|P4|Overall Study|Physician Decision|0
6074749|NCT00432172|20979852|P3|Overall Study|Physician Decision|2
6074750|NCT00432172|20979853|P2|Overall Study|Physician Decision|0
6074751|NCT00432172|20979854|P1|Overall Study|Physician Decision|0
6074752|NCT00432159|20979879|P5|Overall Study|Missing NDI and/or neuro. assessment|7
6074753|NCT00432159|20979880|P4|Overall Study|Missing NDI and/or neuro. assessment|3
6074754|NCT00432159|20979881|P3|Overall Study|Missing NDI and/or neuro. assessment|1
6074755|NCT00432159|20979882|P2|Overall Study|Missing NDI and/or neuro. assessment|24
6074756|NCT00432159|20979883|P1|Overall Study|Missing NDI and/or neuro. assessment|13
6074757|NCT00432159|20979879|P5|Overall Study|Failure|3
6074758|NCT00432159|20979880|P4|Overall Study|Failure|2
6074759|NCT00432159|20979881|P3|Overall Study|Failure|3
6074760|NCT00432159|20979882|P2|Overall Study|Failure|5
6074761|NCT00432159|20979883|P1|Overall Study|Failure|9
6074762|NCT00432159|20979879|P5|Overall Study|Death|0
6074763|NCT00432159|20979880|P4|Overall Study|Death|0
6074764|NCT00432159|20979881|P3|Overall Study|Death|0
6074765|NCT00432159|20979882|P2|Overall Study|Death|1
6074766|NCT00432159|20979883|P1|Overall Study|Death|0
6074767|NCT00432042|20979990|P3|Overall Study|Lost to Follow-up|0
6074768|NCT00432042|20979991|P2|Overall Study|Lost to Follow-up|1
6074769|NCT00432042|20979992|P1|Overall Study|Lost to Follow-up|5
6074770|NCT00432042|20979990|P3|Overall Study|Withdrawal by Subject|2
6074771|NCT00432042|20979991|P2|Overall Study|Withdrawal by Subject|0
6074772|NCT00432042|20979992|P1|Overall Study|Withdrawal by Subject|0
6074773|NCT00432042|20979990|P3|Overall Study|Protocol Violation|0
6074774|NCT00432042|20979991|P2|Overall Study|Protocol Violation|0
6074775|NCT00432042|20979992|P1|Overall Study|Protocol Violation|2
6074776|NCT00431964|20980005|P2|Overall Study|Due to Unstable Health|1
6074777|NCT00431964|20980006|P1|Overall Study|Due to Unstable Health|0
6074778|NCT00431964|20980005|P2|Overall Study|Parental Consent Withdrawn|2
6074779|NCT00431964|20980006|P1|Overall Study|Parental Consent Withdrawn|0
6074780|NCT00431964|20980005|P2|Overall Study|Withdrawal by Subject|1
6074781|NCT00431964|20980006|P1|Overall Study|Withdrawal by Subject|2
6074782|NCT00431964|20980005|P2|Overall Study|Physician Decision|2
6074783|NCT00431964|20980006|P1|Overall Study|Physician Decision|2
6074784|NCT00431964|20980005|P2|Overall Study|Lost to Follow-up|2
6074785|NCT00431964|20980006|P1|Overall Study|Lost to Follow-up|1
6074786|NCT00431964|20980005|P2|Overall Study|Adverse Event|0
6074787|NCT00431964|20980006|P1|Overall Study|Adverse Event|1
6074788|NCT00431951|20980016|P4|Overall Study|Adverse Event|0
6074789|NCT00431951|20980017|P3|Overall Study|Adverse Event|1
6074790|NCT00431951|20980018|P2|Overall Study|Adverse Event|0
6074791|NCT00431951|20980019|P1|Overall Study|Adverse Event|0
6074792|NCT00431951|20980016|P4|Overall Study|Withdrawal by Subject|0
6074793|NCT00431951|20980017|P3|Overall Study|Withdrawal by Subject|0
6074794|NCT00431951|20980018|P2|Overall Study|Withdrawal by Subject|1
6074795|NCT00431951|20980019|P1|Overall Study|Withdrawal by Subject|0
6074796|NCT00431951|20980016|P4|Overall Study|Lost to Follow-up|0
6074797|NCT00431951|20980017|P3|Overall Study|Lost to Follow-up|0
6074798|NCT00431951|20980018|P2|Overall Study|Lost to Follow-up|1
6074799|NCT00431951|20980019|P1|Overall Study|Lost to Follow-up|0
6074800|NCT00431951|20980016|P4|Overall Study|Inability to follow study procedures|2
6074801|NCT00431951|20980017|P3|Overall Study|Inability to follow study procedures|1
6074802|NCT00431951|20980018|P2|Overall Study|Inability to follow study procedures|0
6074803|NCT00431951|20980019|P1|Overall Study|Inability to follow study procedures|1
6074804|NCT00431847|20980081|P5|Overall Study|Protocol Violation|1
6074805|NCT00431847|20980082|P4|Overall Study|Protocol Violation|0
6074806|NCT00431847|20980083|P3|Overall Study|Protocol Violation|0
6074807|NCT00431847|20980084|P2|Overall Study|Protocol Violation|0
6074808|NCT00431847|20980085|P1|Overall Study|Protocol Violation|0
6074809|NCT00431847|20980081|P5|Overall Study|completion of less than two study visits|0
6074810|NCT00431847|20980082|P4|Overall Study|completion of less than two study visits|14
6074811|NCT00431847|20980083|P3|Overall Study|completion of less than two study visits|4
6074812|NCT00431847|20980084|P2|Overall Study|completion of less than two study visits|3
6074813|NCT00431847|20980085|P1|Overall Study|completion of less than two study visits|6
6074814|NCT00431834|20980159|P1|Overall Study|Lost to Follow-up|1
6074815|NCT00431834|20980159|P1|Overall Study|Missed Endpoint Visit|2
6074816|NCT00431834|20980159|P1|Overall Study|Death|3
6074817|NCT00431834|20980159|P1|Overall Study|Withdrawal by Subject|7
6074818|NCT00431496|20980175|P1|Overall Study|Protocol-specified criteria|5
6074819|NCT00431496|20980175|P1|Overall Study|Withdrawal by Subject|2
6074820|NCT00431496|20980175|P1|Overall Study|Lost to Follow-up|1
6074821|NCT00431496|20980175|P1|Overall Study|Adverse Event|3
6074822|NCT00431444|20980186|P2|Overall Study|Administrative Problems|1
6074823|NCT00431444|20980187|P1|Overall Study|Administrative Problems|0
6074824|NCT00431444|20980186|P2|Overall Study|Lost to Follow-up|0
6074825|NCT00431444|20980187|P1|Overall Study|Lost to Follow-up|1
6074826|NCT00431444|20980186|P2|Overall Study|Withdrawal by Subject|1
6074827|NCT00431444|20980187|P1|Overall Study|Withdrawal by Subject|1
6074828|NCT00431444|20980186|P2|Overall Study|Adverse Event|1
6074829|NCT00431444|20980187|P1|Overall Study|Adverse Event|2
6074830|NCT00431444|20980186|P2|Overall Study|Protocol Violation|4
6074831|NCT00431444|20980187|P1|Overall Study|Protocol Violation|1
6074832|NCT00431067|20980227|P1|Overall Study|Non-compliance,lost to follow-up|2
6074833|NCT00431067|20980227|P1|Overall Study|Progressive disease|30
6074834|NCT00431067|20980227|P1|Overall Study|Other Adverse Event|9
6074835|NCT00430989|20980252|P2|Overall Study|Not eligible|6
6074836|NCT00430989|20980253|P1|Overall Study|Not eligible|13
6074837|NCT00430989|20980252|P2|Overall Study|Protocol Violation|37
6074838|NCT00430989|20980253|P1|Overall Study|Protocol Violation|30
6074839|NCT00430989|20980252|P2|Overall Study|Withdrawal by Subject|14
6074840|NCT00430989|20980253|P1|Overall Study|Withdrawal by Subject|15
6074841|NCT00430989|20980252|P2|Overall Study|Lost to Follow-up|3
6074842|NCT00430989|20980253|P1|Overall Study|Lost to Follow-up|2
6074843|NCT00430950|20980273|P2|Overall Study|concomitant medication,etc.|7
6074844|NCT00430950|20980274|P1|Overall Study|concomitant medication,etc.|5
6074845|NCT00430950|20980273|P2|Overall Study|Withdrawal by Subject|0
6074846|NCT00430950|20980274|P1|Overall Study|Withdrawal by Subject|1
6074847|NCT00430950|20980273|P2|Overall Study|Adverse Event|6
6074848|NCT00430950|20980274|P1|Overall Study|Adverse Event|7
6074849|NCT00430937|20980288|P2|Overall Study|Unable to classify|1
6074850|NCT00430937|20980289|P1|Overall Study|Unable to classify|0
6074851|NCT00430937|20980288|P2|Overall Study|Protocol discontinuation criteria met|2
6074852|NCT00430937|20980289|P1|Overall Study|Protocol discontinuation criteria met|1
6074853|NCT00430937|20980288|P2|Overall Study|Administrative reasons|0
6074854|NCT00430937|20980289|P1|Overall Study|Administrative reasons|1
6074855|NCT00430937|20980288|P2|Overall Study|Inappropriate enrollment|1
6074856|NCT00430937|20980289|P1|Overall Study|Inappropriate enrollment|2
6074857|NCT00430937|20980288|P2|Overall Study|Lack of Efficacy|5
6074858|NCT00430937|20980289|P1|Overall Study|Lack of Efficacy|6
6074859|NCT00430937|20980288|P2|Overall Study|Protocol Violation|2
6074860|NCT00430937|20980289|P1|Overall Study|Protocol Violation|3
6074861|NCT00430937|20980288|P2|Overall Study|Withdrawal by Subject|2
6074862|NCT00430937|20980289|P1|Overall Study|Withdrawal by Subject|5
6074863|NCT00430937|20980288|P2|Overall Study|Lost to Follow-up|6
6074864|NCT00430937|20980289|P1|Overall Study|Lost to Follow-up|6
6074865|NCT00430937|20980288|P2|Overall Study|Death|1
6074866|NCT00430937|20980289|P1|Overall Study|Death|0
6074867|NCT00430937|20980288|P2|Overall Study|Adverse Event|8
6074868|NCT00430937|20980289|P1|Overall Study|Adverse Event|3
6074869|NCT00430781|20980300|P3|End-of-Study Analysis; 28 July 2011|Other|0
6074870|NCT00430781|20980301|P2|End-of-Study Analysis; 28 July 2011|Other|1
6074871|NCT00430781|20980302|P1|End-of-Study Analysis; 28 July 2011|Other|4
6074872|NCT00430781|20980300|P3|End-of-Study Analysis; 28 July 2011|Physician Decision|6
6074873|NCT00430781|20980301|P2|End-of-Study Analysis; 28 July 2011|Physician Decision|6
6074874|NCT00430781|20980302|P1|End-of-Study Analysis; 28 July 2011|Physician Decision|4
6074875|NCT00430781|20980300|P3|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4
6074876|NCT00430781|20980301|P2|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|5
6074877|NCT00430781|20980302|P1|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4
6074878|NCT00430781|20980300|P3|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7
6074879|NCT00430781|20980301|P2|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|2
6074880|NCT00430781|20980302|P1|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7
6074881|NCT00430781|20980300|P3|End-of-Study Analysis; 28 July 2011|Protocol Violation|0
6074882|NCT00430781|20980301|P2|End-of-Study Analysis; 28 July 2011|Protocol Violation|1
6074883|NCT00430781|20980302|P1|End-of-Study Analysis; 28 July 2011|Protocol Violation|0
6074884|NCT00430781|20980300|P3|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3
6074885|NCT00430781|20980301|P2|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3
6074886|NCT00430781|20980302|P1|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|5
6074887|NCT00430781|20980300|P3|Final Analysis; 31 July 2008|Ongoing|32
6074888|NCT00430781|20980301|P2|Final Analysis; 31 July 2008|Ongoing|29
6074889|NCT00430781|20980302|P1|Final Analysis; 31 July 2008|Ongoing|0
6074890|NCT00430781|20980300|P3|Final Analysis; 31 July 2008|Other|0
6074891|NCT00430781|20980301|P2|Final Analysis; 31 July 2008|Other|1
6074892|NCT00430781|20980302|P1|Final Analysis; 31 July 2008|Other|0
6074893|NCT00430781|20980300|P3|Final Analysis; 31 July 2008|Physician Decision|6
6074894|NCT00430781|20980301|P2|Final Analysis; 31 July 2008|Physician Decision|6
6074895|NCT00430781|20980302|P1|Final Analysis; 31 July 2008|Physician Decision|0
6074896|NCT00430781|20980300|P3|Final Analysis; 31 July 2008|Withdrawal by Subject|7
6074897|NCT00430781|20980301|P2|Final Analysis; 31 July 2008|Withdrawal by Subject|2
6074898|NCT00430781|20980302|P1|Final Analysis; 31 July 2008|Withdrawal by Subject|0
6074899|NCT00430781|20980300|P3|Final Analysis; 31 July 2008|Protocol Violation|0
6074900|NCT00430781|20980301|P2|Final Analysis; 31 July 2008|Protocol Violation|1
6074901|NCT00430781|20980302|P1|Final Analysis; 31 July 2008|Protocol Violation|0
6074902|NCT00430781|20980300|P3|Final Analysis; 31 July 2008|Lost to Follow-up|3
6074903|NCT00430781|20980301|P2|Final Analysis; 31 July 2008|Lost to Follow-up|0
6074904|NCT00430781|20980302|P1|Final Analysis; 31 July 2008|Lost to Follow-up|0
6074905|NCT00430781|20980300|P3|Interim Analysis; 11 February 2008|Ongoing|25
6074906|NCT00430781|20980301|P2|Interim Analysis; 11 February 2008|Ongoing|20
6074907|NCT00430781|20980302|P1|Interim Analysis; 11 February 2008|Ongoing|23
6074908|NCT00430781|20980300|P3|Interim Analysis; 11 February 2008|Physician Decision|3
6074909|NCT00430781|20980301|P2|Interim Analysis; 11 February 2008|Physician Decision|3
6074910|NCT00430781|20980302|P1|Interim Analysis; 11 February 2008|Physician Decision|2
6074911|NCT00430781|20980300|P3|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0
6074912|NCT00430781|20980301|P2|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0
6074913|NCT00430781|20980302|P1|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|2
6074914|NCT00430781|20980300|P3|Interim Analysis; 11 February 2008|Death|0
6074915|NCT00430781|20980301|P2|Interim Analysis; 11 February 2008|Death|1
6074916|NCT00430781|20980302|P1|Interim Analysis; 11 February 2008|Death|0
6074917|NCT00430781|20980300|P3|Interim Analysis; 11 February 2008|Disease Progression|22
6074918|NCT00430781|20980301|P2|Interim Analysis; 11 February 2008|Disease Progression|30
6074919|NCT00430781|20980302|P1|Interim Analysis; 11 February 2008|Disease Progression|16
6074920|NCT00430781|20980300|P3|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0
6074921|NCT00430781|20980301|P2|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0
6074922|NCT00430781|20980302|P1|Interim Analysis; 11 February 2008|Sponsor Terminated Study|1
6074923|NCT00430781|20980300|P3|Interim Analysis; 11 February 2008|Withdrawal by Subject|2
6074924|NCT00430781|20980301|P2|Interim Analysis; 11 February 2008|Withdrawal by Subject|0
6074925|NCT00430781|20980302|P1|Interim Analysis; 11 February 2008|Withdrawal by Subject|4
6074926|NCT00430781|20980300|P3|Interim Analysis; 11 February 2008|Protocol Violation|0
6074927|NCT00430781|20980301|P2|Interim Analysis; 11 February 2008|Protocol Violation|1
6074928|NCT00430781|20980302|P1|Interim Analysis; 11 February 2008|Protocol Violation|0
6074929|NCT00430781|20980300|P3|Interim Analysis; 11 February 2008|Lost to Follow-up|1
6074930|NCT00430781|20980301|P2|Interim Analysis; 11 February 2008|Lost to Follow-up|0
6074931|NCT00430781|20980302|P1|Interim Analysis; 11 February 2008|Lost to Follow-up|1
6074932|NCT00430781|20980300|P3|Interim Analysis; 11 February 2008|Adverse Event|7
6074933|NCT00430781|20980301|P2|Interim Analysis; 11 February 2008|Adverse Event|3
6074934|NCT00430781|20980302|P1|Interim Analysis; 11 February 2008|Adverse Event|10
6074935|NCT00430755|20980344|P1|Overall Study|Withdrawal by Subject|53
6074936|NCT00430716|20980351|P3|Open Label Phase|Study terminated by sponsor|4
6074937|NCT00430716|20980352|P2|Open Label Phase|Study terminated by sponsor|5
6074938|NCT00430716|20980353|P1|Open Label Phase|Study terminated by sponsor|4
6074939|NCT00430716|20980351|P3|Open Label Phase|Protocol Violation|0
6074940|NCT00430716|20980352|P2|Open Label Phase|Protocol Violation|0
6074941|NCT00430716|20980353|P1|Open Label Phase|Protocol Violation|1
6074942|NCT00430716|20980351|P3|Open Label Phase|Other|1
6074943|NCT00430716|20980352|P2|Open Label Phase|Other|1
6074944|NCT00430716|20980353|P1|Open Label Phase|Other|3
6074945|NCT00430716|20980351|P3|Open Label Phase|No longer willing to participate|1
6074946|NCT00430716|20980352|P2|Open Label Phase|No longer willing to participate|1
6074947|NCT00430716|20980353|P1|Open Label Phase|No longer willing to participate|0
6074948|NCT00430716|20980351|P3|Open Label Phase|Lost to Follow-up|1
6074949|NCT00430716|20980352|P2|Open Label Phase|Lost to Follow-up|0
6074950|NCT00430716|20980353|P1|Open Label Phase|Lost to Follow-up|1
6074951|NCT00430716|20980351|P3|Double Blind Phase|Not treated|0
6074952|NCT00430716|20980352|P2|Double Blind Phase|Not treated|0
6074953|NCT00430716|20980353|P1|Double Blind Phase|Not treated|1
6074954|NCT00430716|20980351|P3|Double Blind Phase|Adverse Event|3
6074955|NCT00430716|20980352|P2|Double Blind Phase|Adverse Event|1
6074956|NCT00430716|20980353|P1|Double Blind Phase|Adverse Event|1
6074957|NCT00430716|20980351|P3|Double Blind Phase|Study terminated by sponsor|2
6074958|NCT00430716|20980352|P2|Double Blind Phase|Study terminated by sponsor|1
6074959|NCT00430716|20980353|P1|Double Blind Phase|Study terminated by sponsor|1
6074960|NCT00430716|20980351|P3|Double Blind Phase|Other|0
6074961|NCT00430716|20980352|P2|Double Blind Phase|Other|2
6074962|NCT00430716|20980353|P1|Double Blind Phase|Other|0
6074963|NCT00430716|20980351|P3|Double Blind Phase|No longer willing to participate|1
6074964|NCT00430716|20980352|P2|Double Blind Phase|No longer willing to participate|1
6074965|NCT00430716|20980353|P1|Double Blind Phase|No longer willing to participate|2
6074966|NCT00430716|20980351|P3|Double Blind Phase|Death|0
6074967|NCT00430716|20980352|P2|Double Blind Phase|Death|0
6074968|NCT00430716|20980353|P1|Double Blind Phase|Death|1
6074969|NCT00430677|20980385|P3|Long-term Extension Period|Poor compliance/noncompliance|0
6074970|NCT00430677|20980386|P2|Long-term Extension Period|Poor compliance/noncompliance|0
6074971|NCT00430677|20980387|P1|Long-term Extension Period|Poor compliance/noncompliance|1
6074972|NCT00430677|20980385|P3|Long-term Extension Period|Other|1
6074973|NCT00430677|20980386|P2|Long-term Extension Period|Other|1
6074974|NCT00430677|20980387|P1|Long-term Extension Period|Other|2
6074975|NCT00430677|20980385|P3|Long-term Extension Period|Administrative reason by sponsor|46
6074976|NCT00430677|20980386|P2|Long-term Extension Period|Administrative reason by sponsor|49
6074977|NCT00430677|20980387|P1|Long-term Extension Period|Administrative reason by sponsor|41
6074978|NCT00430677|20980385|P3|Long-term Extension Period|Pregnancy|0
6074979|NCT00430677|20980386|P2|Long-term Extension Period|Pregnancy|1
6074980|NCT00430677|20980387|P1|Long-term Extension Period|Pregnancy|1
6074981|NCT00430677|20980385|P3|Long-term Extension Period|Withdrawal by Subject|2
6074982|NCT00430677|20980386|P2|Long-term Extension Period|Withdrawal by Subject|1
6074983|NCT00430677|20980387|P1|Long-term Extension Period|Withdrawal by Subject|5
6074984|NCT00430677|20980385|P3|Long-term Extension Period|Lost to Follow-up|1
6074985|NCT00430677|20980386|P2|Long-term Extension Period|Lost to Follow-up|1
6074986|NCT00430677|20980387|P1|Long-term Extension Period|Lost to Follow-up|1
6074987|NCT00430677|20980385|P3|Long-term Extension Period|Lack of Efficacy|8
6074988|NCT00430677|20980386|P2|Long-term Extension Period|Lack of Efficacy|3
6074989|NCT00430677|20980387|P1|Long-term Extension Period|Lack of Efficacy|5
6074990|NCT00430677|20980385|P3|Long-term Extension Period|Adverse Event|5
6074991|NCT00430677|20980386|P2|Long-term Extension Period|Adverse Event|2
6074992|NCT00430677|20980387|P1|Long-term Extension Period|Adverse Event|3
6074993|NCT00430677|20980385|P3|Long-term Extension Period|Death|0
6074994|NCT00430677|20980386|P2|Long-term Extension Period|Death|0
6074995|NCT00430677|20980387|P1|Long-term Extension Period|Death|1
6074996|NCT00430677|20980385|P3|Short-term Period|Pregnancy|0
6074997|NCT00430677|20980386|P2|Short-term Period|Pregnancy|2
6074998|NCT00430677|20980387|P1|Short-term Period|Pregnancy|0
6074999|NCT00430677|20980385|P3|Short-term Period|Poor compliance/ noncompliance|0
6075000|NCT00430677|20980386|P2|Short-term Period|Poor compliance/ noncompliance|1
6075001|NCT00430677|20980387|P1|Short-term Period|Poor compliance/ noncompliance|0
6075002|NCT00430677|20980385|P3|Short-term Period|Participant no longer met study criteria|2
6075003|NCT00430677|20980386|P2|Short-term Period|Participant no longer met study criteria|1
6075004|NCT00430677|20980387|P1|Short-term Period|Participant no longer met study criteria|1
6075005|NCT00430677|20980385|P3|Short-term Period|Withdrawal by Subject|2
6075006|NCT00430677|20980386|P2|Short-term Period|Withdrawal by Subject|1
6075007|NCT00430677|20980387|P1|Short-term Period|Withdrawal by Subject|1
6075008|NCT00430677|20980385|P3|Short-term Period|Lack of Efficacy|4
6075009|NCT00430677|20980386|P2|Short-term Period|Lack of Efficacy|6
6075010|NCT00430677|20980387|P1|Short-term Period|Lack of Efficacy|5
6075011|NCT00430677|20980385|P3|Short-term Period|Adverse Event|9
6075012|NCT00430677|20980386|P2|Short-term Period|Adverse Event|13
6075013|NCT00430677|20980387|P1|Short-term Period|Adverse Event|15
6075014|NCT00430677|20980385|P3|Short-term Period|Death|5
6075015|NCT00430677|20980386|P2|Short-term Period|Death|1
6075016|NCT00430677|20980387|P1|Short-term Period|Death|1
6075017|NCT00430638|20980510|P2|Overall Study|Other|2
6075018|NCT00430638|20980511|P1|Overall Study|Other|2
6075019|NCT00430638|20980510|P2|Overall Study|Non-compliant|1
6075020|NCT00430638|20980511|P1|Overall Study|Non-compliant|2
6075021|NCT00430638|20980510|P2|Overall Study|Withdrawal by Subject|6
6075022|NCT00430638|20980511|P1|Overall Study|Withdrawal by Subject|4
6075023|NCT00430638|20980510|P2|Overall Study|Protocol Violation|4
6075024|NCT00430638|20980511|P1|Overall Study|Protocol Violation|6
6075025|NCT00430638|20980510|P2|Overall Study|Lost to Follow-up|7
6075026|NCT00430638|20980511|P1|Overall Study|Lost to Follow-up|1
6075027|NCT00430638|20980510|P2|Overall Study|Uncontrolled blood pressure|13
6075028|NCT00430638|20980511|P1|Overall Study|Uncontrolled blood pressure|48
6075029|NCT00430638|20980510|P2|Overall Study|Adverse Event|15
6075030|NCT00430638|20980511|P1|Overall Study|Adverse Event|15
6075031|NCT00430573|20980546|P1|Overall Study|Withdrawal by Subject|5
6075032|NCT00430521|20980559|P8|Overall Study|Withdrawal by Subject|2
6075033|NCT00430521|20980560|P7|Overall Study|Withdrawal by Subject|0
6075034|NCT00430521|20980561|P6|Overall Study|Withdrawal by Subject|0
6075035|NCT00430521|20980562|P5|Overall Study|Withdrawal by Subject|0
6075036|NCT00430521|20980563|P4|Overall Study|Withdrawal by Subject|3
6075037|NCT00430521|20980564|P3|Overall Study|Withdrawal by Subject|0
6075038|NCT00430521|20980565|P2|Overall Study|Withdrawal by Subject|1
6075039|NCT00430521|20980566|P1|Overall Study|Withdrawal by Subject|3
6075040|NCT00430521|20980559|P8|Overall Study|Protocol Violation|0
6075041|NCT00430521|20980560|P7|Overall Study|Protocol Violation|0
6075042|NCT00430521|20980561|P6|Overall Study|Protocol Violation|0
6075043|NCT00430521|20980562|P5|Overall Study|Protocol Violation|0
6075044|NCT00430521|20980563|P4|Overall Study|Protocol Violation|0
6075045|NCT00430521|20980564|P3|Overall Study|Protocol Violation|0
6075046|NCT00430521|20980565|P2|Overall Study|Protocol Violation|0
6075047|NCT00430521|20980566|P1|Overall Study|Protocol Violation|1
6075048|NCT00430521|20980559|P8|Overall Study|Vaccine Expired|0
6075049|NCT00430521|20980560|P7|Overall Study|Vaccine Expired|0
6075050|NCT00430521|20980561|P6|Overall Study|Vaccine Expired|1
6075051|NCT00430521|20980562|P5|Overall Study|Vaccine Expired|0
6075052|NCT00430521|20980563|P4|Overall Study|Vaccine Expired|0
6075053|NCT00430521|20980564|P3|Overall Study|Vaccine Expired|0
6075054|NCT00430521|20980565|P2|Overall Study|Vaccine Expired|0
6075055|NCT00430521|20980566|P1|Overall Study|Vaccine Expired|0
6075056|NCT00430521|20980559|P8|Overall Study|Pregnancy|0
6075057|NCT00430521|20980560|P7|Overall Study|Pregnancy|1
6075058|NCT00430521|20980561|P6|Overall Study|Pregnancy|0
6075059|NCT00430521|20980562|P5|Overall Study|Pregnancy|0
6075060|NCT00430521|20980563|P4|Overall Study|Pregnancy|0
6075061|NCT00430521|20980564|P3|Overall Study|Pregnancy|0
6075062|NCT00430521|20980565|P2|Overall Study|Pregnancy|0
6075063|NCT00430521|20980566|P1|Overall Study|Pregnancy|0
6075064|NCT00430521|20980559|P8|Overall Study|Lost to Follow-up|10
6075065|NCT00430521|20980560|P7|Overall Study|Lost to Follow-up|8
6075066|NCT00430521|20980561|P6|Overall Study|Lost to Follow-up|2
6075067|NCT00430521|20980562|P5|Overall Study|Lost to Follow-up|5
6075068|NCT00430521|20980563|P4|Overall Study|Lost to Follow-up|5
6075069|NCT00430521|20980564|P3|Overall Study|Lost to Follow-up|3
6075070|NCT00430521|20980565|P2|Overall Study|Lost to Follow-up|8
6075071|NCT00430521|20980566|P1|Overall Study|Lost to Follow-up|7
6075072|NCT00430521|20980559|P8|Overall Study|Adverse Event|0
6075073|NCT00430521|20980560|P7|Overall Study|Adverse Event|1
6075074|NCT00430521|20980561|P6|Overall Study|Adverse Event|2
6075075|NCT00430521|20980562|P5|Overall Study|Adverse Event|0
6075076|NCT00430521|20980563|P4|Overall Study|Adverse Event|0
6075077|NCT00430521|20980564|P3|Overall Study|Adverse Event|0
6075078|NCT00430521|20980565|P2|Overall Study|Adverse Event|0
6075079|NCT00430521|20980566|P1|Overall Study|Adverse Event|0
6075080|NCT00430508|20980808|P4|Overall Study|Other|0
6075081|NCT00430508|20980809|P3|Overall Study|Other|3
6075082|NCT00430508|20980810|P2|Overall Study|Other|1
6075083|NCT00430508|20980811|P1|Overall Study|Other|1
6075084|NCT00430508|20980808|P4|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1
6075085|NCT00430508|20980809|P3|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|2
6075086|NCT00430508|20980810|P2|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1
6075087|NCT00430508|20980811|P1|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|0
6075088|NCT00430508|20980808|P4|Overall Study|responder at visit 4|0
6075089|NCT00430508|20980809|P3|Overall Study|responder at visit 4|2
6075090|NCT00430508|20980810|P2|Overall Study|responder at visit 4|0
6075091|NCT00430508|20980811|P1|Overall Study|responder at visit 4|0
6075092|NCT00430508|20980808|P4|Overall Study|Withdrawal by Subject|1
6075093|NCT00430508|20980809|P3|Overall Study|Withdrawal by Subject|1
6075094|NCT00430508|20980810|P2|Overall Study|Withdrawal by Subject|1
6075095|NCT00430508|20980811|P1|Overall Study|Withdrawal by Subject|0
6075096|NCT00430508|20980808|P4|Overall Study|Adverse Event|3
6075097|NCT00430508|20980809|P3|Overall Study|Adverse Event|5
6075098|NCT00430508|20980810|P2|Overall Study|Adverse Event|3
6075099|NCT00430508|20980811|P1|Overall Study|Adverse Event|2
6075100|NCT00430495|20980849|P4|Overall Study|Randomized but not Treated|0
6075101|NCT00430495|20980850|P3|Overall Study|Randomized but not Treated|0
6075102|NCT00430495|20980851|P2|Overall Study|Randomized but not Treated|0
6075103|NCT00430495|20980852|P1|Overall Study|Randomized but not Treated|2
6075104|NCT00430495|20980849|P4|Overall Study|Other|4
6075105|NCT00430495|20980850|P3|Overall Study|Other|5
6075106|NCT00430495|20980851|P2|Overall Study|Other|2
6075107|NCT00430495|20980852|P1|Overall Study|Other|8
6075108|NCT00430495|20980849|P4|Overall Study|Disease Progression|0
6075109|NCT00430495|20980850|P3|Overall Study|Disease Progression|0
6075110|NCT00430495|20980851|P2|Overall Study|Disease Progression|1
6075111|NCT00430495|20980852|P1|Overall Study|Disease Progression|1
6075112|NCT00430495|20980849|P4|Overall Study|Protocol Violation|0
6075113|NCT00430495|20980850|P3|Overall Study|Protocol Violation|1
6075114|NCT00430495|20980851|P2|Overall Study|Protocol Violation|0
6075115|NCT00430495|20980852|P1|Overall Study|Protocol Violation|1
6075116|NCT00430495|20980849|P4|Overall Study|Lost to Follow-up|0
6075117|NCT00430495|20980850|P3|Overall Study|Lost to Follow-up|4
6075118|NCT00430495|20980851|P2|Overall Study|Lost to Follow-up|1
6075119|NCT00430495|20980852|P1|Overall Study|Lost to Follow-up|0
6075120|NCT00430495|20980849|P4|Overall Study|Death|0
6075121|NCT00430495|20980850|P3|Overall Study|Death|1
6075122|NCT00430495|20980851|P2|Overall Study|Death|0
6075123|NCT00430495|20980852|P1|Overall Study|Death|0
6075124|NCT00430495|20980849|P4|Overall Study|Adverse Event|0
6075125|NCT00430495|20980850|P3|Overall Study|Adverse Event|2
6075126|NCT00430495|20980851|P2|Overall Study|Adverse Event|3
6075127|NCT00430495|20980852|P1|Overall Study|Adverse Event|2
6075128|NCT00430482|20980892|P2|Completed Treatment|Insufficient Treatment|11
6075129|NCT00430482|20980893|P1|Completed Treatment|Insufficient Treatment|7
6075130|NCT00430352|20980901|P1|Overall Study|Other|48
6075131|NCT00430352|20980901|P1|Overall Study|Death|5
6075132|NCT00430352|20980901|P1|Overall Study|Adverse Event|16
6075133|NCT00430352|20980901|P1|Overall Study|Withdrawal by Subject|11
6075134|NCT00430352|20980901|P1|Overall Study|Disease progression|58
6075135|NCT00430300|20980919|P4|Overall Study|Other|1
6075136|NCT00430300|20980920|P3|Overall Study|Other|0
6075137|NCT00430300|20980921|P2|Overall Study|Other|0
6075138|NCT00430300|20980922|P1|Overall Study|Other|0
6075139|NCT00430300|20980919|P4|Overall Study|Laboratory abnormality|0
6075140|NCT00430300|20980920|P3|Overall Study|Laboratory abnormality|0
6075141|NCT00430300|20980921|P2|Overall Study|Laboratory abnormality|0
6075142|NCT00430300|20980922|P1|Overall Study|Laboratory abnormality|1
6075143|NCT00430300|20980919|P4|Overall Study|Withdrawal by Subject|0
6075144|NCT00430300|20980920|P3|Overall Study|Withdrawal by Subject|5
6075145|NCT00430300|20980921|P2|Overall Study|Withdrawal by Subject|0
6075146|NCT00430300|20980922|P1|Overall Study|Withdrawal by Subject|1
6075147|NCT00430300|20980919|P4|Overall Study|Adverse Event|1
6075148|NCT00430300|20980920|P3|Overall Study|Adverse Event|1
6075149|NCT00430300|20980921|P2|Overall Study|Adverse Event|2
6075150|NCT00430300|20980922|P1|Overall Study|Adverse Event|0
6075151|NCT00430248|20981027|P3|Overall Study|Reason Not Specified|11
6075152|NCT00430248|20981028|P2|Overall Study|Reason Not Specified|8
6075153|NCT00430248|20981029|P1|Overall Study|Reason Not Specified|8
6075154|NCT00430248|20981027|P3|Overall Study|Gout Flare|2
6075155|NCT00430248|20981028|P2|Overall Study|Gout Flare|7
6075156|NCT00430248|20981029|P1|Overall Study|Gout Flare|3
6075157|NCT00430248|20981027|P3|Overall Study|Inclusion/Exclusion Criteria Not Met|0
6075158|NCT00430248|20981028|P2|Overall Study|Inclusion/Exclusion Criteria Not Met|2
6075159|NCT00430248|20981029|P1|Overall Study|Inclusion/Exclusion Criteria Not Met|0
6075160|NCT00430248|20981027|P3|Overall Study|Withdrawal by Subject|16
6075161|NCT00430248|20981028|P2|Overall Study|Withdrawal by Subject|20
6075162|NCT00430248|20981029|P1|Overall Study|Withdrawal by Subject|14
6075163|NCT00430248|20981027|P3|Overall Study|Therapeutic Failure|1
6075164|NCT00430248|20981028|P2|Overall Study|Therapeutic Failure|1
6075165|NCT00430248|20981029|P1|Overall Study|Therapeutic Failure|1
6075166|NCT00430248|20981027|P3|Overall Study|Lost to Follow-up|28
6075167|NCT00430248|20981028|P2|Overall Study|Lost to Follow-up|33
6075168|NCT00430248|20981029|P1|Overall Study|Lost to Follow-up|28
6075169|NCT00430248|20981027|P3|Overall Study|Personal Reasons|9
6075170|NCT00430248|20981028|P2|Overall Study|Personal Reasons|24
6075171|NCT00430248|20981029|P1|Overall Study|Personal Reasons|12
6075172|NCT00430248|20981027|P3|Overall Study|Protocol Violation|4
6075173|NCT00430248|20981028|P2|Overall Study|Protocol Violation|2
6075174|NCT00430248|20981029|P1|Overall Study|Protocol Violation|10
6075175|NCT00430248|20981027|P3|Overall Study|Adverse Event|64
6075176|NCT00430248|20981028|P2|Overall Study|Adverse Event|61
6075177|NCT00430248|20981029|P1|Overall Study|Adverse Event|49
6075178|NCT00430092|20981097|P3|Overall Study|Withdrawal by Subject|1
6075179|NCT00430092|20981098|P2|Overall Study|Withdrawal by Subject|1
6075180|NCT00430092|20981099|P1|Overall Study|Withdrawal by Subject|0
6075181|NCT00430092|20981097|P3|Overall Study|Protocol Violation|1
6075182|NCT00430092|20981098|P2|Overall Study|Protocol Violation|1
6075183|NCT00430092|20981099|P1|Overall Study|Protocol Violation|0
6075184|NCT00430092|20981097|P3|Overall Study|Lost to Follow-up|0
6075185|NCT00430092|20981098|P2|Overall Study|Lost to Follow-up|0
6075186|NCT00430092|20981099|P1|Overall Study|Lost to Follow-up|1
6075187|NCT00430092|20981097|P3|Overall Study|Lack of Efficacy|54
6075188|NCT00430092|20981098|P2|Overall Study|Lack of Efficacy|2
6075189|NCT00430092|20981099|P1|Overall Study|Lack of Efficacy|5
6075190|NCT00430092|20981097|P3|Overall Study|Adverse Event|1
6075191|NCT00430092|20981098|P2|Overall Study|Adverse Event|0
6075192|NCT00430092|20981099|P1|Overall Study|Adverse Event|0
6075193|NCT00430027|20981104|P1|Overall Study|Study terminated|8
6075194|NCT00429923|20981121|P3|Overall Study|Early Termination|0
6075195|NCT00429923|20981122|P2|Overall Study|Early Termination|1
6075196|NCT00429923|20981123|P1|Overall Study|Early Termination|0
6075197|NCT00429923|20981121|P3|Overall Study|Withdrew Consent|1
6075198|NCT00429923|20981122|P2|Overall Study|Withdrew Consent|0
6075199|NCT00429923|20981123|P1|Overall Study|Withdrew Consent|1
6075200|NCT00429923|20981121|P3|Overall Study|Lost to Follow-up|2
6075201|NCT00429923|20981122|P2|Overall Study|Lost to Follow-up|0
6075202|NCT00429923|20981123|P1|Overall Study|Lost to Follow-up|0
6075203|NCT00429923|20981121|P3|Overall Study|Lack of Efficacy|33
6075204|NCT00429923|20981122|P2|Overall Study|Lack of Efficacy|1
6075205|NCT00429923|20981123|P1|Overall Study|Lack of Efficacy|4
6075206|NCT00429923|20981121|P3|Overall Study|Adverse Event|3
6075207|NCT00429923|20981122|P2|Overall Study|Adverse Event|2
6075208|NCT00429923|20981123|P1|Overall Study|Adverse Event|0
6075209|NCT00429858|20981128|P1|Overall Study|Study Termination|1
6075210|NCT00429858|20981128|P1|Overall Study|Withdrawal by Subject|1
6075211|NCT00429793|20981139|P1|Overall Study|Non-measurable|1
6075212|NCT00429793|20981139|P1|Overall Study|Never treated|1
6075213|NCT00429793|20981139|P1|Overall Study|Required test not done|1
6075214|NCT00429793|20981139|P1|Overall Study|Improper pre-protocol treatment|3
6075215|NCT00429663|20981166|P2|Overall Study|Death|0
6075216|NCT00429663|20981167|P1|Overall Study|Death|4
6075217|NCT00429663|20981166|P2|Overall Study|Withdrawal by Subject|5
6075218|NCT00429663|20981167|P1|Overall Study|Withdrawal by Subject|2
6075219|NCT00429663|20981166|P2|Overall Study|Physician Decision|3
6075220|NCT00429663|20981167|P1|Overall Study|Physician Decision|6
6075221|NCT00429663|20981166|P2|Overall Study|Lost to Follow-up|31
6075222|NCT00429663|20981167|P1|Overall Study|Lost to Follow-up|24
6075223|NCT00429572|20981181|P1|Overall Study|Disease progression|1
6075224|NCT00429494|20981193|P1|Overall Study|Death|6
6075225|NCT00429494|20981193|P1|Overall Study|Withdrawal by Subject|9
6075226|NCT00429416|20981197|P1|Overall Study|Death|1
6075227|NCT00429364|20981216|P2|Overall Study|Pregnancy|1
6075228|NCT00429364|20981217|P1|Overall Study|Pregnancy|0
6075229|NCT00429364|20981216|P2|Overall Study|Underwent aortic root surgery|18
6075230|NCT00429364|20981217|P1|Overall Study|Underwent aortic root surgery|10
6075231|NCT00429364|20981216|P2|Overall Study|Death|1
6075232|NCT00429364|20981217|P1|Overall Study|Death|0
6075233|NCT00429364|20981216|P2|Overall Study|Lost to Follow-up|6
6075234|NCT00429364|20981217|P1|Overall Study|Lost to Follow-up|7
6075235|NCT00429364|20981216|P2|Overall Study|Physician Decision|2
6075236|NCT00429364|20981217|P1|Overall Study|Physician Decision|4
6075237|NCT00429364|20981216|P2|Overall Study|Withdrawal by Subject|5
6075238|NCT00429364|20981217|P1|Overall Study|Withdrawal by Subject|11
6075239|NCT00429299|20981276|P3|Overall Study|Withdrawal by Subject|3
6075240|NCT00429299|20981277|P2|Overall Study|Withdrawal by Subject|1
6075241|NCT00429299|20981278|P1|Overall Study|Withdrawal by Subject|0
6075242|NCT00429299|20981276|P3|Overall Study|Protocol Violation|0
6075243|NCT00429299|20981277|P2|Overall Study|Protocol Violation|0
6075244|NCT00429299|20981278|P1|Overall Study|Protocol Violation|1
6075245|NCT00429299|20981276|P3|Overall Study|Adverse Event|1
6075246|NCT00429299|20981277|P2|Overall Study|Adverse Event|5
6075247|NCT00429299|20981278|P1|Overall Study|Adverse Event|2
6075248|NCT00429299|20981276|P3|Overall Study|Disease Progression|0
6075249|NCT00429299|20981277|P2|Overall Study|Disease Progression|1
6075250|NCT00429299|20981278|P1|Overall Study|Disease Progression|1
6075251|NCT00429273|20981310|P3|Overall Study|Adverse Event|2
6075252|NCT00429273|20981311|P2|Overall Study|Adverse Event|1
6075253|NCT00429273|20981312|P1|Overall Study|Adverse Event|1
6075254|NCT00429273|20981310|P3|Overall Study|Physician Decision|5
6075255|NCT00429273|20981311|P2|Overall Study|Physician Decision|5
6075256|NCT00429273|20981312|P1|Overall Study|Physician Decision|6
6075257|NCT00429273|20981310|P3|Overall Study|Lost to Follow-up|2
6075258|NCT00429273|20981311|P2|Overall Study|Lost to Follow-up|2
6075259|NCT00429273|20981312|P1|Overall Study|Lost to Follow-up|1
6075260|NCT00429182|20981320|P1|Overall Study|Not eligible|5
6075261|NCT00429182|20981320|P1|Overall Study|Not evaluable, Disease Progression|2
6075262|NCT00429169|20981327|P2|Overall Study|Ineligibility discovered after entry|1
6075263|NCT00429169|20981328|P1|Overall Study|Ineligibility discovered after entry|2
6075264|NCT00429169|20981327|P2|Overall Study|Lost to Follow-up|1
6075265|NCT00429169|20981328|P1|Overall Study|Lost to Follow-up|0
6075266|NCT00429104|20981348|P1|Overall Study|Protocol Violation|1
6075267|NCT00429026|20981353|P1|Overall Study|Inevaluable for response.|40
6075268|NCT00428948|20981380|P2|Overall Study|Protocol Deviation|1
6075269|NCT00428948|20981381|P1|Overall Study|Protocol Deviation|1
6075270|NCT00428948|20981380|P2|Overall Study|Subject Withdrew Consent|30
6075271|NCT00428948|20981381|P1|Overall Study|Subject Withdrew Consent|50
6075272|NCT00428948|20981380|P2|Overall Study|Investigator Withdrew Subject|4
6075273|NCT00428948|20981381|P1|Overall Study|Investigator Withdrew Subject|3
6075274|NCT00428948|20981380|P2|Overall Study|Subject Met Withdrawal Criteria|0
6075275|NCT00428948|20981381|P1|Overall Study|Subject Met Withdrawal Criteria|4
6075276|NCT00428948|20981380|P2|Overall Study|Adverse Event|24
6075277|NCT00428948|20981381|P1|Overall Study|Adverse Event|148
6075278|NCT00428948|20981380|P2|Overall Study|Lost to Follow-up|8
6075279|NCT00428948|20981381|P1|Overall Study|Lost to Follow-up|15
6075280|NCT00428844|20981409|P3|Completed Test of Cure (TOC) Visit|Microbiologic failure|0
6075281|NCT00428844|20981410|P2|Completed Test of Cure (TOC) Visit|Microbiologic failure|1
6075282|NCT00428844|20981411|P1|Completed Test of Cure (TOC) Visit|Microbiologic failure|0
6075283|NCT00428844|20981409|P3|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0
6075284|NCT00428844|20981410|P2|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0
6075285|NCT00428844|20981411|P1|Completed Test of Cure (TOC) Visit|Lack of Efficacy|2
6075286|NCT00428844|20981409|P3|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0
6075287|NCT00428844|20981410|P2|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0
6075288|NCT00428844|20981411|P1|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|1
6075289|NCT00428844|20981409|P3|Completed Test of Cure (TOC) Visit|Protocol Violation|1
6075290|NCT00428844|20981410|P2|Completed Test of Cure (TOC) Visit|Protocol Violation|0
6075291|NCT00428844|20981411|P1|Completed Test of Cure (TOC) Visit|Protocol Violation|0
6075292|NCT00428844|20981409|P3|Completed Test of Cure (TOC) Visit|Adverse Event|1
6075293|NCT00428844|20981410|P2|Completed Test of Cure (TOC) Visit|Adverse Event|1
6075294|NCT00428844|20981411|P1|Completed Test of Cure (TOC) Visit|Adverse Event|0
6075295|NCT00428844|20981409|P3|Completed Study Drug Treatment|Randomized Not Treated|1
6075296|NCT00428844|20981410|P2|Completed Study Drug Treatment|Randomized Not Treated|0
6075297|NCT00428844|20981411|P1|Completed Study Drug Treatment|Randomized Not Treated|0
6075298|NCT00428844|20981409|P3|Completed Study Drug Treatment|Withdrawal by Subject|1
6075299|NCT00428844|20981410|P2|Completed Study Drug Treatment|Withdrawal by Subject|1
6075300|NCT00428844|20981411|P1|Completed Study Drug Treatment|Withdrawal by Subject|0
6075301|NCT00428844|20981409|P3|Completed Study Drug Treatment|Protocol Violation|1
6075302|NCT00428844|20981410|P2|Completed Study Drug Treatment|Protocol Violation|1
6075303|NCT00428844|20981411|P1|Completed Study Drug Treatment|Protocol Violation|0
6075304|NCT00428844|20981409|P3|Completed Study Drug Treatment|Adverse Event|4
6075305|NCT00428844|20981410|P2|Completed Study Drug Treatment|Adverse Event|4
6075306|NCT00428844|20981411|P1|Completed Study Drug Treatment|Adverse Event|2
6075307|NCT00428792|20981434|P2|Overall Study|Lost to Follow-up|1
6075308|NCT00428792|20981435|P1|Overall Study|Lost to Follow-up|0
6075309|NCT00428792|20981434|P2|Overall Study|Lack of Efficacy|3
6075310|NCT00428792|20981435|P1|Overall Study|Lack of Efficacy|1
6075311|NCT00428714|20981461|P2|Overall Study|Death due to other then PD|0
6075312|NCT00428714|20981462|P1|Overall Study|Death due to other then PD|1
6075313|NCT00428714|20981461|P2|Overall Study|Death due to Progressive Disease (PD)|0
6075314|NCT00428714|20981462|P1|Overall Study|Death due to Progressive Disease (PD)|1
6075315|NCT00428714|20981461|P2|Overall Study|Physician Decision|1
6075316|NCT00428714|20981462|P1|Overall Study|Physician Decision|1
6075317|NCT00428714|20981461|P2|Overall Study|Adverse Event|2
6075318|NCT00428714|20981462|P1|Overall Study|Adverse Event|0
6075319|NCT00428714|20981461|P2|Overall Study|Withdrawal by Subject|3
6075320|NCT00428714|20981462|P1|Overall Study|Withdrawal by Subject|0
6075321|NCT00428714|20981461|P2|Overall Study|Progressive Disease|36
6075322|NCT00428714|20981462|P1|Overall Study|Progressive Disease|28
6075323|NCT00428610|20981481|P3|Overall Study|Withdrawal by Subject|0
6075324|NCT00428610|20981482|P2|Overall Study|Withdrawal by Subject|0
6075325|NCT00428610|20981483|P1|Overall Study|Withdrawal by Subject|4
6075326|NCT00428610|20981481|P3|Overall Study|Progressive Disease|22
6075327|NCT00428610|20981482|P2|Overall Study|Progressive Disease|14
6075328|NCT00428610|20981483|P1|Overall Study|Progressive Disease|42
6075329|NCT00428610|20981481|P3|Overall Study|Investigator Decision|1
6075330|NCT00428610|20981482|P2|Overall Study|Investigator Decision|1
6075331|NCT00428610|20981483|P1|Overall Study|Investigator Decision|2
6075332|NCT00428610|20981481|P3|Overall Study|Adverse Event|2
6075333|NCT00428610|20981482|P2|Overall Study|Adverse Event|3
6075334|NCT00428610|20981483|P1|Overall Study|Adverse Event|2
6075335|NCT00428610|20981481|P3|Overall Study|Death Due to Progressive Disease|2
6075336|NCT00428610|20981482|P2|Overall Study|Death Due to Progressive Disease|0
6075337|NCT00428610|20981483|P1|Overall Study|Death Due to Progressive Disease|0
6075338|NCT00428610|20981481|P3|Overall Study|Death Due to Adverse Event|5
6075339|NCT00428610|20981482|P2|Overall Study|Death Due to Adverse Event|0
6075340|NCT00428610|20981483|P1|Overall Study|Death Due to Adverse Event|3
6075341|NCT00428597|20981517|P2|Overall Study|Death|3
6075342|NCT00428597|20981518|P1|Overall Study|Death|1
6075343|NCT00428597|20981517|P2|Overall Study|Pregnancy|0
6075344|NCT00428597|20981518|P1|Overall Study|Pregnancy|1
6075345|NCT00428597|20981517|P2|Overall Study|Lost to Follow-up|1
6075346|NCT00428597|20981518|P1|Overall Study|Lost to Follow-up|0
6075347|NCT00428597|20981517|P2|Overall Study|Other|1
6075348|NCT00428597|20981518|P1|Overall Study|Other|1
6075349|NCT00428597|20981517|P2|Overall Study|Withdrawal by Subject|1
6075350|NCT00428597|20981518|P1|Overall Study|Withdrawal by Subject|2
6075351|NCT00428597|20981517|P2|Overall Study|Protocol Violation|1
6075352|NCT00428597|20981518|P1|Overall Study|Protocol Violation|2
6075353|NCT00428597|20981517|P2|Overall Study|Global Deterioration of Health Status|5
6075354|NCT00428597|20981518|P1|Overall Study|Global Deterioration of Health Status|1
6075355|NCT00428597|20981517|P2|Overall Study|Adverse Event|7
6075356|NCT00428597|20981518|P1|Overall Study|Adverse Event|15
6075357|NCT00428597|20981517|P2|Overall Study|Study Terminated by Sponsor|16
6075358|NCT00428597|20981518|P1|Overall Study|Study Terminated by Sponsor|41
6075359|NCT00428597|20981517|P2|Overall Study|Objective Progression or Relapse|47
6075360|NCT00428597|20981518|P1|Overall Study|Objective Progression or Relapse|19
6075361|NCT00428597|20981517|P2|Overall Study|Randomized but not treated|3
6075362|NCT00428597|20981518|P1|Overall Study|Randomized but not treated|3
6075363|NCT00428441|20981585|P1|Overall Study|Lost to Follow-up|1
6075364|NCT00428389|20981591|P2|Extension Phase|Administrative problems|1
6075365|NCT00428389|20981592|P1|Extension Phase|Administrative problems|1
6075366|NCT00428389|20981591|P2|Extension Phase|Protocol Violation|2
6075367|NCT00428389|20981592|P1|Extension Phase|Protocol Violation|3
6075368|NCT00428389|20981591|P2|Extension Phase|Death|0
6075369|NCT00428389|20981592|P1|Extension Phase|Death|1
6075370|NCT00428389|20981591|P2|Extension Phase|Lost to Follow-up|3
6075371|NCT00428389|20981592|P1|Extension Phase|Lost to Follow-up|0
6075372|NCT00428389|20981591|P2|Extension Phase|Withdrawal by Subject|6
6075373|NCT00428389|20981592|P1|Extension Phase|Withdrawal by Subject|6
6075374|NCT00428389|20981591|P2|Extension Phase|Lack of Efficacy|3
6075375|NCT00428389|20981592|P1|Extension Phase|Lack of Efficacy|4
6075376|NCT00428389|20981591|P2|Extension Phase|Adverse Event|11
6075377|NCT00428389|20981592|P1|Extension Phase|Adverse Event|17
6075378|NCT00428389|20981591|P2|Core Phase|Protocol deviation|2
6075379|NCT00428389|20981592|P1|Core Phase|Protocol deviation|0
6075380|NCT00428389|20981591|P2|Core Phase|Withdrawal by Subject|4
6075381|NCT00428389|20981592|P1|Core Phase|Withdrawal by Subject|3
6075382|NCT00428389|20981591|P2|Core Phase|Abnormal test procedure result(s)|1
6075383|NCT00428389|20981592|P1|Core Phase|Abnormal test procedure result(s)|0
6075384|NCT00428389|20981591|P2|Core Phase|Lack of Efficacy|0
6075385|NCT00428389|20981592|P1|Core Phase|Lack of Efficacy|2
6075386|NCT00428389|20981591|P2|Core Phase|Adverse Event|4
6075387|NCT00428389|20981592|P1|Core Phase|Adverse Event|6
6075388|NCT00428246|20981626|P3|Overall Study|Adverse Event|0
6075389|NCT00428246|20981627|P2|Overall Study|Adverse Event|0
6075390|NCT00428246|20981628|P1|Overall Study|Adverse Event|1
6075391|NCT00428246|20981626|P3|Overall Study|Withdrawal by Subject|1
6075392|NCT00428246|20981627|P2|Overall Study|Withdrawal by Subject|0
6075393|NCT00428246|20981628|P1|Overall Study|Withdrawal by Subject|0
6075394|NCT00428220|20981636|P1|Overall Study|Other|23
6075395|NCT00428220|20981636|P1|Overall Study|Adverse Event|51
6075396|NCT00428220|20981636|P1|Overall Study|Participant refused continued treatment|7
6075397|NCT00428220|20981636|P1|Overall Study|Objective progression or relapse|123
6075398|NCT00428220|20981636|P1|Overall Study|Lost to Follow-up|4
6075399|NCT00428220|20981636|P1|Overall Study|Global deterioration of health status|7
6075400|NCT00428220|20981636|P1|Overall Study|Participant died|8
6075401|NCT00428116|20981661|P2|Overall Study|Lost to Follow-up|0
6075402|NCT00428116|20981662|P1|Overall Study|Lost to Follow-up|1
6075403|NCT00428116|20981661|P2|Overall Study|Withdrawal by Subject|0
6075404|NCT00428116|20981662|P1|Overall Study|Withdrawal by Subject|1
6075405|NCT00428116|20981661|P2|Overall Study|Death|0
6075406|NCT00428116|20981662|P1|Overall Study|Death|1
6075407|NCT00428090|20981674|P4|Overall Study|Raised Creatinine Value|1
6075408|NCT00428090|20981675|P3|Overall Study|Raised Creatinine Value|0
6075409|NCT00428090|20981676|P2|Overall Study|Raised Creatinine Value|0
6075410|NCT00428090|20981677|P1|Overall Study|Raised Creatinine Value|0
6075411|NCT00428090|20981674|P4|Overall Study|Excluded for heart insufficiency|0
6075412|NCT00428090|20981675|P3|Overall Study|Excluded for heart insufficiency|1
6075413|NCT00428090|20981676|P2|Overall Study|Excluded for heart insufficiency|0
6075414|NCT00428090|20981677|P1|Overall Study|Excluded for heart insufficiency|0
6075415|NCT00428090|20981674|P4|Overall Study|Serious adverse event|0
6075416|NCT00428090|20981675|P3|Overall Study|Serious adverse event|1
6075417|NCT00428090|20981676|P2|Overall Study|Serious adverse event|0
6075418|NCT00428090|20981677|P1|Overall Study|Serious adverse event|0
6075419|NCT00428090|20981674|P4|Overall Study|Deterioration of cognitive status|0
6075420|NCT00428090|20981675|P3|Overall Study|Deterioration of cognitive status|1
6075421|NCT00428090|20981676|P2|Overall Study|Deterioration of cognitive status|0
6075422|NCT00428090|20981677|P1|Overall Study|Deterioration of cognitive status|0
6075423|NCT00428090|20981674|P4|Overall Study|High MMSE scores|0
6075424|NCT00428090|20981675|P3|Overall Study|High MMSE scores|1
6075425|NCT00428090|20981676|P2|Overall Study|High MMSE scores|0
6075426|NCT00428090|20981677|P1|Overall Study|High MMSE scores|0
6075427|NCT00428090|20981674|P4|Overall Study|Insufficient AD documentation|0
6075428|NCT00428090|20981675|P3|Overall Study|Insufficient AD documentation|1
6075429|NCT00428090|20981676|P2|Overall Study|Insufficient AD documentation|0
6075430|NCT00428090|20981677|P1|Overall Study|Insufficient AD documentation|0
6075431|NCT00428090|20981674|P4|Overall Study|Excluded for concerning QTc value|0
6075432|NCT00428090|20981675|P3|Overall Study|Excluded for concerning QTc value|1
6075433|NCT00428090|20981676|P2|Overall Study|Excluded for concerning QTc value|0
6075434|NCT00428090|20981677|P1|Overall Study|Excluded for concerning QTc value|0
6075435|NCT00428090|20981674|P4|Overall Study|Worsening of AD|0
6075436|NCT00428090|20981675|P3|Overall Study|Worsening of AD|1
6075437|NCT00428090|20981676|P2|Overall Study|Worsening of AD|0
6075438|NCT00428090|20981677|P1|Overall Study|Worsening of AD|0
6075439|NCT00428090|20981674|P4|Overall Study|Mental status of par. was|0
6075440|NCT00428090|20981675|P3|Overall Study|Mental status of par. was|0
6075441|NCT00428090|20981676|P2|Overall Study|Mental status of par. was|1
6075442|NCT00428090|20981677|P1|Overall Study|Mental status of par. was|0
6075443|NCT00428090|20981674|P4|Overall Study|Medical monitor terminated par.|0
6075444|NCT00428090|20981675|P3|Overall Study|Medical monitor terminated par.|0
6075445|NCT00428090|20981676|P2|Overall Study|Medical monitor terminated par.|1
6075446|NCT00428090|20981677|P1|Overall Study|Medical monitor terminated par.|0
6075447|NCT00428090|20981674|P4|Overall Study|Visit 7 exceed the visit window|0
6075448|NCT00428090|20981675|P3|Overall Study|Visit 7 exceed the visit window|0
6075449|NCT00428090|20981676|P2|Overall Study|Visit 7 exceed the visit window|1
6075450|NCT00428090|20981677|P1|Overall Study|Visit 7 exceed the visit window|0
6075451|NCT00428090|20981674|P4|Overall Study|Death of par.|0
6075452|NCT00428090|20981675|P3|Overall Study|Death of par.|1
6075453|NCT00428090|20981676|P2|Overall Study|Death of par.|0
6075454|NCT00428090|20981677|P1|Overall Study|Death of par.|1
6075455|NCT00428090|20981674|P4|Overall Study|Prohibited medication used for SAE|0
6075456|NCT00428090|20981675|P3|Overall Study|Prohibited medication used for SAE|0
6075457|NCT00428090|20981676|P2|Overall Study|Prohibited medication used for SAE|0
6075458|NCT00428090|20981677|P1|Overall Study|Prohibited medication used for SAE|1
6075459|NCT00428090|20981674|P4|Overall Study|Follow-Up visit not possible|0
6075460|NCT00428090|20981675|P3|Overall Study|Follow-Up visit not possible|0
6075461|NCT00428090|20981676|P2|Overall Study|Follow-Up visit not possible|0
6075462|NCT00428090|20981677|P1|Overall Study|Follow-Up visit not possible|1
6075463|NCT00428090|20981674|P4|Overall Study|Par. did not returned to visit|1
6075464|NCT00428090|20981675|P3|Overall Study|Par. did not returned to visit|0
6075465|NCT00428090|20981676|P2|Overall Study|Par. did not returned to visit|0
6075466|NCT00428090|20981677|P1|Overall Study|Par. did not returned to visit|1
6075467|NCT00428090|20981674|P4|Overall Study|Non-compliance|3
6075468|NCT00428090|20981675|P3|Overall Study|Non-compliance|1
6075469|NCT00428090|20981676|P2|Overall Study|Non-compliance|0
6075470|NCT00428090|20981677|P1|Overall Study|Non-compliance|4
6075471|NCT00428090|20981674|P4|Overall Study|Sponsor terminated study|0
6075472|NCT00428090|20981675|P3|Overall Study|Sponsor terminated study|0
6075473|NCT00428090|20981676|P2|Overall Study|Sponsor terminated study|1
6075474|NCT00428090|20981677|P1|Overall Study|Sponsor terminated study|0
6075475|NCT00428090|20981674|P4|Overall Study|Withdrawal by Subject|5
6075476|NCT00428090|20981675|P3|Overall Study|Withdrawal by Subject|15
6075477|NCT00428090|20981676|P2|Overall Study|Withdrawal by Subject|12
6075478|NCT00428090|20981677|P1|Overall Study|Withdrawal by Subject|10
6075479|NCT00428090|20981674|P4|Overall Study|Protocol Violation|3
6075480|NCT00428090|20981675|P3|Overall Study|Protocol Violation|3
6075481|NCT00428090|20981676|P2|Overall Study|Protocol Violation|1
6075482|NCT00428090|20981677|P1|Overall Study|Protocol Violation|3
6075483|NCT00428090|20981674|P4|Overall Study|Lost to Follow-up|4
6075484|NCT00428090|20981675|P3|Overall Study|Lost to Follow-up|1
6075485|NCT00428090|20981676|P2|Overall Study|Lost to Follow-up|6
6075486|NCT00428090|20981677|P1|Overall Study|Lost to Follow-up|3
6075487|NCT00428090|20981674|P4|Overall Study|Adverse Event|11
6075488|NCT00428090|20981675|P3|Overall Study|Adverse Event|10
6075489|NCT00428090|20981676|P2|Overall Study|Adverse Event|8
6075490|NCT00428090|20981677|P1|Overall Study|Adverse Event|10
6075491|NCT00427999|20981795|P1|Overall Study|Death|1
6075492|NCT00427999|20981795|P1|Overall Study|Withdrawal by Subject|9
6075493|NCT00427999|20981795|P1|Overall Study|Protocol Violation|2
6075494|NCT00427999|20981795|P1|Overall Study|Unsatisfactory therapeutic effect|13
6075495|NCT00427999|20981795|P1|Overall Study|Abnormal laboratory values|1
6075496|NCT00427999|20981795|P1|Overall Study|Adverse Event|6
6075497|NCT00427960|20981813|P2|Overall Study|Other|1
6075498|NCT00427960|20981814|P1|Overall Study|Other|0
6075499|NCT00427960|20981813|P2|Overall Study|Withdrawal by Subject|3
6075500|NCT00427960|20981814|P1|Overall Study|Withdrawal by Subject|0
6075501|NCT00427960|20981813|P2|Overall Study|Adverse Event|0
6075502|NCT00427960|20981814|P1|Overall Study|Adverse Event|2
6075503|NCT00427934|20981852|P4|Overall Study|Withdrawal by Subject|3
6075504|NCT00427934|20981853|P3|Overall Study|Withdrawal by Subject|1
6075505|NCT00427934|20981854|P2|Overall Study|Withdrawal by Subject|0
6075506|NCT00427934|20981855|P1|Overall Study|Withdrawal by Subject|0
6075507|NCT00427934|20981852|P4|Overall Study|Other|5
6075508|NCT00427934|20981853|P3|Overall Study|Other|11
6075509|NCT00427934|20981854|P2|Overall Study|Other|0
6075510|NCT00427934|20981855|P1|Overall Study|Other|0
6075511|NCT00427934|20981852|P4|Overall Study|Randomized But Did Not Receive Treatment|1
6075512|NCT00427934|20981853|P3|Overall Study|Randomized But Did Not Receive Treatment|1
6075513|NCT00427934|20981854|P2|Overall Study|Randomized But Did Not Receive Treatment|0
6075514|NCT00427934|20981855|P1|Overall Study|Randomized But Did Not Receive Treatment|0
6075515|NCT00427934|20981852|P4|Overall Study|Lack of Efficacy|2
6075516|NCT00427934|20981853|P3|Overall Study|Lack of Efficacy|5
6075517|NCT00427934|20981854|P2|Overall Study|Lack of Efficacy|0
6075518|NCT00427934|20981855|P1|Overall Study|Lack of Efficacy|0
6075519|NCT00427934|20981852|P4|Overall Study|Adverse Event|4
6075520|NCT00427934|20981853|P3|Overall Study|Adverse Event|5
6075521|NCT00427934|20981854|P2|Overall Study|Adverse Event|0
6075522|NCT00427934|20981855|P1|Overall Study|Adverse Event|1
6075523|NCT00427921|20981923|P1|Overall Study|Withdrew Consent + Lack of Efficacy|1
6075524|NCT00427921|20981923|P1|Overall Study|Adverse Event + Withdrawn from Study|1
6075525|NCT00427921|20981923|P1|Overall Study|Adverse Event + Lost Response|1
6075526|NCT00427921|20981923|P1|Overall Study|Adverse Event + No Therapeutic Benefit|1
6075527|NCT00427921|20981923|P1|Overall Study|Adverse Event + Worsening of CD|1
6075528|NCT00427921|20981923|P1|Overall Study|Adverse Event + No Response|1
6075529|NCT00427921|20981923|P1|Overall Study|Adverse Event + Withdrew Consent|1
6075530|NCT00427921|20981923|P1|Overall Study|Adverse Event + Hospitalization|1
6075531|NCT00427921|20981923|P1|Overall Study|Other reason not specified|10
6075532|NCT00427921|20981923|P1|Overall Study|Lost to Follow-up|2
6075533|NCT00427921|20981923|P1|Overall Study|Withdrawal by Subject|4
6075534|NCT00427921|20981923|P1|Overall Study|Adverse Event|26
6075535|NCT00427908|20981946|P4|Primary Phase|Adverse Event|0
6075536|NCT00427908|20981947|P3|Primary Phase|Adverse Event|0
6075537|NCT00427908|20981948|P2|Primary Phase|Adverse Event|1
6075538|NCT00427908|20981949|P1|Primary Phase|Adverse Event|0
6075539|NCT00427908|20981946|P4|Primary Phase|Withdrawal by Subject|0
6075540|NCT00427908|20981947|P3|Primary Phase|Withdrawal by Subject|1
6075541|NCT00427908|20981948|P2|Primary Phase|Withdrawal by Subject|2
6075542|NCT00427908|20981949|P1|Primary Phase|Withdrawal by Subject|1
6075543|NCT00427908|20981946|P4|Primary Phase|Lost to Follow-up|0
6075544|NCT00427908|20981947|P3|Primary Phase|Lost to Follow-up|2
6075545|NCT00427908|20981948|P2|Primary Phase|Lost to Follow-up|0
6075546|NCT00427908|20981949|P1|Primary Phase|Lost to Follow-up|4
6075547|NCT00427895|20982149|P8|Vax 2/Year 3 to 4|Failed to Return|0
6075548|NCT00427895|20982150|P7|Vax 2/Year 3 to 4|Failed to Return|0
6075549|NCT00427895|20982151|P6|Vax 2/Year 3 to 4|Failed to Return|0
6075550|NCT00427895|20982152|P5|Vax 2/Year 3 to 4|Failed to Return|1
6075551|NCT00427895|20982153|P4|Vax 2/Year 3 to 4|Failed to Return|0
6075552|NCT00427895|20982154|P3|Vax 2/Year 3 to 4|Failed to Return|0
6075553|NCT00427895|20982155|P2|Vax 2/Year 3 to 4|Failed to Return|0
6075554|NCT00427895|20982156|P1|Vax 2/Year 3 to 4|Failed to Return|0
6075555|NCT00427895|20982149|P8|Vax 2/Year 3 to 4|Protocol Violation|1
6075556|NCT00427895|20982150|P7|Vax 2/Year 3 to 4|Protocol Violation|0
6075557|NCT00427895|20982151|P6|Vax 2/Year 3 to 4|Protocol Violation|0
6075558|NCT00427895|20982152|P5|Vax 2/Year 3 to 4|Protocol Violation|0
6075559|NCT00427895|20982153|P4|Vax 2/Year 3 to 4|Protocol Violation|0
6075560|NCT00427895|20982154|P3|Vax 2/Year 3 to 4|Protocol Violation|0
6075561|NCT00427895|20982155|P2|Vax 2/Year 3 to 4|Protocol Violation|0
6075562|NCT00427895|20982156|P1|Vax 2/Year 3 to 4|Protocol Violation|0
6075563|NCT00427895|20982149|P8|Vax 2/Year 3 to 4|Lost to Follow-up|1
6075564|NCT00427895|20982150|P7|Vax 2/Year 3 to 4|Lost to Follow-up|0
6075565|NCT00427895|20982151|P6|Vax 2/Year 3 to 4|Lost to Follow-up|0
6075566|NCT00427895|20982152|P5|Vax 2/Year 3 to 4|Lost to Follow-up|0
6075567|NCT00427895|20982153|P4|Vax 2/Year 3 to 4|Lost to Follow-up|0
6075568|NCT00427895|20982154|P3|Vax 2/Year 3 to 4|Lost to Follow-up|0
6075569|NCT00427895|20982155|P2|Vax 2/Year 3 to 4|Lost to Follow-up|0
6075570|NCT00427895|20982156|P1|Vax 2/Year 3 to 4|Lost to Follow-up|0
6075571|NCT00427895|20982149|P8|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0
6075572|NCT00427895|20982150|P7|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0
6075573|NCT00427895|20982151|P6|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0
6075574|NCT00427895|20982152|P5|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0
6075575|NCT00427895|20982153|P4|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|469
6075576|NCT00427895|20982154|P3|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|159
6075577|NCT00427895|20982155|P2|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|207
6075578|NCT00427895|20982156|P1|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|188
6075579|NCT00427895|20982149|P8|Vax 1/Year 1 Follow-up|Other|0
6075580|NCT00427895|20982150|P7|Vax 1/Year 1 Follow-up|Other|0
6075581|NCT00427895|20982151|P6|Vax 1/Year 1 Follow-up|Other|0
6075582|NCT00427895|20982152|P5|Vax 1/Year 1 Follow-up|Other|0
6075583|NCT00427895|20982153|P4|Vax 1/Year 1 Follow-up|Other|2
6075584|NCT00427895|20982154|P3|Vax 1/Year 1 Follow-up|Other|0
6075585|NCT00427895|20982155|P2|Vax 1/Year 1 Follow-up|Other|0
6075586|NCT00427895|20982156|P1|Vax 1/Year 1 Follow-up|Other|0
6075587|NCT00427895|20982149|P8|Vax 1/Year 1 Follow-up|Failed to Return|0
6075588|NCT00427895|20982150|P7|Vax 1/Year 1 Follow-up|Failed to Return|0
6075589|NCT00427895|20982151|P6|Vax 1/Year 1 Follow-up|Failed to Return|0
6075590|NCT00427895|20982152|P5|Vax 1/Year 1 Follow-up|Failed to Return|0
6075591|NCT00427895|20982153|P4|Vax 1/Year 1 Follow-up|Failed to Return|5
6075592|NCT00427895|20982154|P3|Vax 1/Year 1 Follow-up|Failed to Return|12
6075593|NCT00427895|20982155|P2|Vax 1/Year 1 Follow-up|Failed to Return|0
6075594|NCT00427895|20982156|P1|Vax 1/Year 1 Follow-up|Failed to Return|0
6075595|NCT00427895|20982149|P8|Vax 1/Year 1 Follow-up|Death|0
6075596|NCT00427895|20982150|P7|Vax 1/Year 1 Follow-up|Death|0
6075597|NCT00427895|20982151|P6|Vax 1/Year 1 Follow-up|Death|0
6075598|NCT00427895|20982152|P5|Vax 1/Year 1 Follow-up|Death|0
6075599|NCT00427895|20982153|P4|Vax 1/Year 1 Follow-up|Death|0
6075600|NCT00427895|20982154|P3|Vax 1/Year 1 Follow-up|Death|0
6075601|NCT00427895|20982155|P2|Vax 1/Year 1 Follow-up|Death|0
6075602|NCT00427895|20982156|P1|Vax 1/Year 1 Follow-up|Death|1
6075603|NCT00427895|20982149|P8|Vax 1/Year 1 Follow-up|Adverse Event|0
6075604|NCT00427895|20982150|P7|Vax 1/Year 1 Follow-up|Adverse Event|0
6075605|NCT00427895|20982151|P6|Vax 1/Year 1 Follow-up|Adverse Event|0
6075606|NCT00427895|20982152|P5|Vax 1/Year 1 Follow-up|Adverse Event|0
6075607|NCT00427895|20982153|P4|Vax 1/Year 1 Follow-up|Adverse Event|0
6075608|NCT00427895|20982154|P3|Vax 1/Year 1 Follow-up|Adverse Event|0
6075609|NCT00427895|20982155|P2|Vax 1/Year 1 Follow-up|Adverse Event|1
6075610|NCT00427895|20982156|P1|Vax 1/Year 1 Follow-up|Adverse Event|0
6075611|NCT00427895|20982149|P8|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0
6075612|NCT00427895|20982150|P7|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0
6075613|NCT00427895|20982151|P6|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0
6075614|NCT00427895|20982152|P5|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0
6075615|NCT00427895|20982153|P4|Vax 1/Year 1 Follow-up|Withdrawal by Subject|4
6075616|NCT00427895|20982154|P3|Vax 1/Year 1 Follow-up|Withdrawal by Subject|5
6075617|NCT00427895|20982155|P2|Vax 1/Year 1 Follow-up|Withdrawal by Subject|6
6075618|NCT00427895|20982156|P1|Vax 1/Year 1 Follow-up|Withdrawal by Subject|3
6075619|NCT00427895|20982149|P8|Vax 1/Year 1 Follow-up|Protocol Violation|0
6075620|NCT00427895|20982150|P7|Vax 1/Year 1 Follow-up|Protocol Violation|0
6075621|NCT00427895|20982151|P6|Vax 1/Year 1 Follow-up|Protocol Violation|0
6075622|NCT00427895|20982152|P5|Vax 1/Year 1 Follow-up|Protocol Violation|0
6075623|NCT00427895|20982153|P4|Vax 1/Year 1 Follow-up|Protocol Violation|1
6075624|NCT00427895|20982154|P3|Vax 1/Year 1 Follow-up|Protocol Violation|0
6075625|NCT00427895|20982155|P2|Vax 1/Year 1 Follow-up|Protocol Violation|3
6075626|NCT00427895|20982156|P1|Vax 1/Year 1 Follow-up|Protocol Violation|3
6075627|NCT00427895|20982149|P8|Vax 1/Year 1 Follow-up|Lost to Follow-up|0
6075628|NCT00427895|20982150|P7|Vax 1/Year 1 Follow-up|Lost to Follow-up|0
6075629|NCT00427895|20982151|P6|Vax 1/Year 1 Follow-up|Lost to Follow-up|0
6075630|NCT00427895|20982152|P5|Vax 1/Year 1 Follow-up|Lost to Follow-up|0
6075631|NCT00427895|20982153|P4|Vax 1/Year 1 Follow-up|Lost to Follow-up|21
6075632|NCT00427895|20982154|P3|Vax 1/Year 1 Follow-up|Lost to Follow-up|2
6075633|NCT00427895|20982155|P2|Vax 1/Year 1 Follow-up|Lost to Follow-up|5
6075634|NCT00427895|20982156|P1|Vax 1/Year 1 Follow-up|Lost to Follow-up|0
6075635|NCT00427895|20982149|P8|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
6075636|NCT00427895|20982150|P7|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
6075637|NCT00427895|20982151|P6|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
6075638|NCT00427895|20982152|P5|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
6075639|NCT00427895|20982153|P4|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|352
6075640|NCT00427895|20982154|P3|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
6075641|NCT00427895|20982155|P2|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
6075642|NCT00427895|20982156|P1|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
6075643|NCT00427895|20982149|P8|Vax 1 Baseline/6-Month Follow-up|Other|0
6075644|NCT00427895|20982150|P7|Vax 1 Baseline/6-Month Follow-up|Other|0
6075645|NCT00427895|20982151|P6|Vax 1 Baseline/6-Month Follow-up|Other|0
6075646|NCT00427895|20982152|P5|Vax 1 Baseline/6-Month Follow-up|Other|0
6075647|NCT00427895|20982153|P4|Vax 1 Baseline/6-Month Follow-up|Other|2
6075648|NCT00427895|20982154|P3|Vax 1 Baseline/6-Month Follow-up|Other|1
6075649|NCT00427895|20982155|P2|Vax 1 Baseline/6-Month Follow-up|Other|0
6075650|NCT00427895|20982156|P1|Vax 1 Baseline/6-Month Follow-up|Other|0
6075651|NCT00427895|20982149|P8|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0
6075652|NCT00427895|20982150|P7|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0
6075653|NCT00427895|20982151|P6|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0
6075654|NCT00427895|20982152|P5|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0
6075655|NCT00427895|20982153|P4|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1
6075656|NCT00427895|20982154|P3|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|2
6075657|NCT00427895|20982155|P2|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|3
6075658|NCT00427895|20982156|P1|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1
6075659|NCT00427895|20982149|P8|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
6075660|NCT00427895|20982150|P7|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
6075661|NCT00427895|20982151|P6|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
6075662|NCT00427895|20982152|P5|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
6075663|NCT00427895|20982153|P4|Vax 1 Baseline/6-Month Follow-up|Failed to Return|2
6075664|NCT00427895|20982154|P3|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
6075665|NCT00427895|20982155|P2|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
6075666|NCT00427895|20982156|P1|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
6075667|NCT00427895|20982149|P8|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0
6075668|NCT00427895|20982150|P7|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0
6075669|NCT00427895|20982151|P6|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0
6075670|NCT00427895|20982152|P5|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0
6075671|NCT00427895|20982153|P4|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|7
6075672|NCT00427895|20982154|P3|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|4
6075673|NCT00427895|20982155|P2|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1
6075674|NCT00427895|20982156|P1|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1
6075675|NCT00427895|20982149|P8|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
6075676|NCT00427895|20982150|P7|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
6075677|NCT00427895|20982151|P6|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
6075678|NCT00427895|20982152|P5|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
6075679|NCT00427895|20982153|P4|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
6075680|NCT00427895|20982154|P3|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
6075681|NCT00427895|20982155|P2|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1
6075682|NCT00427895|20982156|P1|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1
6075683|NCT00427895|20982149|P8|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0
6075684|NCT00427895|20982150|P7|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0
6075685|NCT00427895|20982151|P6|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0
6075686|NCT00427895|20982152|P5|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0
6075687|NCT00427895|20982153|P4|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|2
6075688|NCT00427895|20982154|P3|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|3
6075689|NCT00427895|20982155|P2|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0
6075690|NCT00427895|20982156|P1|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|4
6075691|NCT00427895|20982149|P8|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0
6075692|NCT00427895|20982150|P7|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0
6075693|NCT00427895|20982151|P6|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0
6075694|NCT00427895|20982152|P5|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0
6075695|NCT00427895|20982153|P4|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|32
6075696|NCT00427895|20982154|P3|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|4
6075697|NCT00427895|20982155|P2|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|1
6075698|NCT00427895|20982156|P1|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0
6075699|NCT00427778|20982231|P2|First Intervention (4 Weeks)|anxious about using ring|0
6075700|NCT00427778|20982232|P1|First Intervention (4 Weeks)|anxious about using ring|1
6075701|NCT00427778|20982231|P2|First Intervention (4 Weeks)|unable to manipulate ring due to OA|1
6075702|NCT00427778|20982232|P1|First Intervention (4 Weeks)|unable to manipulate ring due to OA|0
6075703|NCT00427778|20982231|P2|First Intervention (4 Weeks)|Not successfully fitted with ring|0
6075704|NCT00427778|20982232|P1|First Intervention (4 Weeks)|Not successfully fitted with ring|2
6075705|NCT00427778|20982231|P2|First Intervention (4 Weeks)|no longer interested|0
6075706|NCT00427778|20982232|P1|First Intervention (4 Weeks)|no longer interested|1
6075707|NCT00427700|20982257|P2|Overall Study|Pregnancy|2
6075708|NCT00427700|20982258|P1|Overall Study|Pregnancy|0
6075709|NCT00427700|20982257|P2|Overall Study|no induction of menses|4
6075710|NCT00427700|20982258|P1|Overall Study|no induction of menses|1
6075711|NCT00427700|20982257|P2|Overall Study|Lost to Follow-up|5
6075712|NCT00427700|20982258|P1|Overall Study|Lost to Follow-up|2
6075713|NCT00427648|20982274|P2|Overall Study|Adverse Event|1
6075714|NCT00427648|20982275|P1|Overall Study|Adverse Event|0
6075715|NCT00427648|20982274|P2|Overall Study|Protocol Violation|2
6075716|NCT00427648|20982275|P1|Overall Study|Protocol Violation|1
6075717|NCT00427635|20982295|P2|Study Completion to Safety Follow-up|Lost to Follow-up|1
6075718|NCT00427635|20982296|P1|Study Completion to Safety Follow-up|Lost to Follow-up|0
6075719|NCT00427635|20982295|P2|Treatment Phase|Withdrawal by Subject|0
6075720|NCT00427635|20982296|P1|Treatment Phase|Withdrawal by Subject|1
6075721|NCT00427349|20982328|P1|Overall Study|Never started therapy|1
6075722|NCT00427349|20982328|P1|Overall Study|Ineligible|1
6075723|NCT00427349|20982328|P1|Overall Study|Other|2
6075724|NCT00427349|20982328|P1|Overall Study|Alternative therapy|1
6075725|NCT00427349|20982328|P1|Overall Study|Withdrawal by Subject|3
6075726|NCT00427349|20982328|P1|Overall Study|Death|1
6075727|NCT00427349|20982328|P1|Overall Study|Adverse Event|14
6075728|NCT00427349|20982328|P1|Overall Study|Lack of Efficacy|23
6075729|NCT00427011|20982385|P1|Overall Study|Other|12
6075730|NCT00427011|20982385|P1|Overall Study|Lack of Efficacy|2
6075731|NCT00427011|20982385|P1|Overall Study|Withdrawal by Subject|1
6075732|NCT00427011|20982385|P1|Overall Study|Adverse Event|10
6075733|NCT00426842|20982400|P1|Overall Study|Lost to Follow-up|1
6075734|NCT00426764|20982406|P1|Overall Study|Other Reasons (Miscellaneous)|10
6075735|NCT00426764|20982406|P1|Overall Study|Death|1
6075736|NCT00426764|20982406|P1|Overall Study|Other|1
6075737|NCT00426764|20982406|P1|Overall Study|Adverse Event|24
6075738|NCT00426764|20982406|P1|Overall Study|Progressive Disease|83
6075739|NCT00426764|20982406|P1|Overall Study|Compassionate Use|1
6075740|NCT00426764|20982406|P1|Overall Study|Physician Decision|6
6075741|NCT00426764|20982406|P1|Overall Study|Withdrawal by Subject|4
6075742|NCT00426764|20982406|P1|Overall Study|Protocol Violation|1
6075743|NCT00426751|20982423|P2|Overall Study|Other Reasons|12
6075744|NCT00426751|20982424|P1|Overall Study|Other Reasons|7
6075745|NCT00426751|20982423|P2|Overall Study|Consent Withdrawn|1
6075746|NCT00426751|20982424|P1|Overall Study|Consent Withdrawn|0
6075747|NCT00426751|20982423|P2|Overall Study|Lost to Follow-up|6
6075748|NCT00426751|20982424|P1|Overall Study|Lost to Follow-up|7
6075749|NCT00426751|20982423|P2|Overall Study|Adverse Event|1
6075750|NCT00426751|20982424|P1|Overall Study|Adverse Event|8
6075751|NCT00426660|20982468|P1|Overall Study|Enrolled Not Treated|15
6075752|NCT00426660|20982468|P1|Overall Study|Protocol Violation|1
6075753|NCT00426660|20982468|P1|Overall Study|Withdrawal by Subject|18
6075754|NCT00426660|20982468|P1|Overall Study|Other|23
6075755|NCT00426660|20982468|P1|Overall Study|Lost to Follow-up|15
6075756|NCT00426660|20982468|P1|Overall Study|Insufficient Clinical Response|22
6075757|NCT00426660|20982468|P1|Overall Study|Adverse Event|23
6075758|NCT00426660|20982468|P1|Overall Study|Death|14
6075759|NCT00426556|20982499|P4|Phase II - Extension Phase|Adverse Event|2
6075760|NCT00426556|20982500|P3|Phase II - Extension Phase|Adverse Event|0
6075761|NCT00426556|20982501|P2|Phase II - Extension Phase|Adverse Event|0
6075762|NCT00426556|20982502|P1|Phase II - Extension Phase|Adverse Event|0
6075763|NCT00426556|20982499|P4|Phase II - Extension Phase|Disease Progression|21
6075764|NCT00426556|20982500|P3|Phase II - Extension Phase|Disease Progression|0
6075765|NCT00426556|20982501|P2|Phase II - Extension Phase|Disease Progression|0
6075766|NCT00426556|20982502|P1|Phase II - Extension Phase|Disease Progression|0
6075767|NCT00426556|20982499|P4|Phase II - Core Phase|Adverse Event|8
6075768|NCT00426556|20982500|P3|Phase II - Core Phase|Adverse Event|0
6075769|NCT00426556|20982501|P2|Phase II - Core Phase|Adverse Event|0
6075770|NCT00426556|20982502|P1|Phase II - Core Phase|Adverse Event|0
6075771|NCT00426556|20982499|P4|Phase II - Core Phase|Disease Progression|16
6075772|NCT00426556|20982500|P3|Phase II - Core Phase|Disease Progression|0
6075773|NCT00426556|20982501|P2|Phase II - Core Phase|Disease Progression|0
6075774|NCT00426556|20982502|P1|Phase II - Core Phase|Disease Progression|0
6075775|NCT00426556|20982499|P4|Phase II - Core Phase|Withdrawal by Subject|3
6075776|NCT00426556|20982500|P3|Phase II - Core Phase|Withdrawal by Subject|0
6075777|NCT00426556|20982501|P2|Phase II - Core Phase|Withdrawal by Subject|0
6075778|NCT00426556|20982502|P1|Phase II - Core Phase|Withdrawal by Subject|0
6075779|NCT00426556|20982499|P4|Phase I - Extension Phase|Disease Progression|0
6075780|NCT00426556|20982500|P3|Phase I - Extension Phase|Disease Progression|6
6075781|NCT00426556|20982501|P2|Phase I - Extension Phase|Disease Progression|5
6075782|NCT00426556|20982502|P1|Phase I - Extension Phase|Disease Progression|5
6075783|NCT00426556|20982499|P4|Phase I - Extension Phase|Adverse Event|0
6075784|NCT00426556|20982500|P3|Phase I - Extension Phase|Adverse Event|1
6075785|NCT00426556|20982501|P2|Phase I - Extension Phase|Adverse Event|1
6075786|NCT00426556|20982502|P1|Phase I - Extension Phase|Adverse Event|0
6075787|NCT00426556|20982499|P4|Phase I - Core Phase|Death|0
6075788|NCT00426556|20982500|P3|Phase I - Core Phase|Death|0
6075789|NCT00426556|20982501|P2|Phase I - Core Phase|Death|1
6075790|NCT00426556|20982502|P1|Phase I - Core Phase|Death|0
6075791|NCT00426556|20982499|P4|Phase I - Core Phase|Adverse Event|0
6075792|NCT00426556|20982500|P3|Phase I - Core Phase|Adverse Event|1
6075793|NCT00426556|20982501|P2|Phase I - Core Phase|Adverse Event|3
6075794|NCT00426556|20982502|P1|Phase I - Core Phase|Adverse Event|1
6075795|NCT00426556|20982499|P4|Phase I - Core Phase|Disease Progression|0
6075796|NCT00426556|20982500|P3|Phase I - Core Phase|Disease Progression|2
6075797|NCT00426556|20982501|P2|Phase I - Core Phase|Disease Progression|6
6075798|NCT00426556|20982502|P1|Phase I - Core Phase|Disease Progression|0
6075799|NCT00426361|20982527|P3|Overall Study|Withdrawal by Subject|0
6075800|NCT00426361|20982528|P2|Overall Study|Withdrawal by Subject|3
6075801|NCT00426361|20982529|P1|Overall Study|Withdrawal by Subject|1
6075802|NCT00426361|20982527|P3|Overall Study|Lost to Follow-up|5
6075803|NCT00426361|20982528|P2|Overall Study|Lost to Follow-up|2
6075804|NCT00426361|20982529|P1|Overall Study|Lost to Follow-up|3
6075805|NCT00426270|20982596|P1|Overall Study|Adverse Event|5
6075806|NCT00426270|20982596|P1|Overall Study|Incorrectly Enrolled in the Study|1
6075807|NCT00426231|20982606|P2|Overall Study|Withdrawal by Subject|12
6075808|NCT00426231|20982607|P1|Overall Study|Withdrawal by Subject|9
6075809|NCT00426127|20982630|P1|Overall Study|Removed due to disease progression|1
6075810|NCT00426127|20982630|P1|Overall Study|Adverse Event|1
6075811|NCT00425945|20982638|P2|Overall Study|Moved from area|1
6075812|NCT00425945|20982639|P1|Overall Study|Moved from area|0
6075813|NCT00425945|20982638|P2|Overall Study|Began cancer treatments|0
6075814|NCT00425945|20982639|P1|Overall Study|Began cancer treatments|1
6075815|NCT00425945|20982638|P2|Overall Study|Began hypertension medication|0
6075816|NCT00425945|20982639|P1|Overall Study|Began hypertension medication|1
6075817|NCT00425945|20982638|P2|Overall Study|Lost to Follow-up|2
6075818|NCT00425945|20982639|P1|Overall Study|Lost to Follow-up|0
6075819|NCT00425945|20982638|P2|Overall Study|Inconvenience|2
6075820|NCT00425945|20982639|P1|Overall Study|Inconvenience|0
6075821|NCT00425945|20982638|P2|Overall Study|Concern about Supplement|0
6075822|NCT00425945|20982639|P1|Overall Study|Concern about Supplement|2
6075823|NCT00425854|20982677|P2|Overall Study|Other Adverse Event|2
6075824|NCT00425854|20982678|P1|Overall Study|Other Adverse Event|2
6075825|NCT00425854|20982677|P2|Overall Study|Dose reduction toxicity AE|7
6075826|NCT00425854|20982678|P1|Overall Study|Dose reduction toxicity AE|8
6075827|NCT00425854|20982677|P2|Overall Study|Progressive Disease|12
6075828|NCT00425854|20982678|P1|Overall Study|Progressive Disease|19
6075829|NCT00425750|20982711|P1|Overall Study|Progression of disease|18
6075830|NCT00425750|20982711|P1|Overall Study|Adverse Event|3
6075831|NCT00425750|20982711|P1|Overall Study|Withdrawal by Subject|3
6075832|NCT00425750|20982711|P1|Overall Study|Death|1
6075833|NCT00425698|20982719|P2|Overall Study|Withdrawal by Subject|1
6075834|NCT00425698|20982720|P1|Overall Study|Withdrawal by Subject|0
6075835|NCT00425698|20982719|P2|Overall Study|Adverse Event|1
6075836|NCT00425698|20982720|P1|Overall Study|Adverse Event|3
6075837|NCT00425607|20982735|P1|Overall Study|Withdrawal by Subject|1
6075838|NCT00425607|20982735|P1|Overall Study|Death|1
6075839|NCT00425503|20982739|P1|Overall Study|Protocol Violation|1
6075840|NCT00425503|20982739|P1|Overall Study|Adverse Event|2
6075841|NCT00425438|20982751|P2|Overall Study|Termination by Sponsor|27
6075842|NCT00425438|20982752|P1|Overall Study|Termination by Sponsor|25
6075843|NCT00425373|20982786|P9|Overall Study|Lack of Efficacy|5
6075844|NCT00425373|20982787|P8|Overall Study|Lack of Efficacy|0
6075845|NCT00425373|20982788|P7|Overall Study|Lack of Efficacy|3
6075846|NCT00425373|20982789|P6|Overall Study|Lack of Efficacy|3
6075847|NCT00425373|20982790|P5|Overall Study|Lack of Efficacy|1
6075848|NCT00425373|20982791|P4|Overall Study|Lack of Efficacy|0
6075849|NCT00425373|20982792|P3|Overall Study|Lack of Efficacy|0
6075850|NCT00425373|20982793|P2|Overall Study|Lack of Efficacy|0
6075851|NCT00425373|20982794|P1|Overall Study|Lack of Efficacy|0
6075852|NCT00425373|20982786|P9|Overall Study|Withdrawal by Subject|2
6075853|NCT00425373|20982787|P8|Overall Study|Withdrawal by Subject|2
6075854|NCT00425373|20982788|P7|Overall Study|Withdrawal by Subject|2
6075855|NCT00425373|20982789|P6|Overall Study|Withdrawal by Subject|0
6075856|NCT00425373|20982790|P5|Overall Study|Withdrawal by Subject|4
6075857|NCT00425373|20982791|P4|Overall Study|Withdrawal by Subject|1
6075858|NCT00425373|20982792|P3|Overall Study|Withdrawal by Subject|2
6075859|NCT00425373|20982793|P2|Overall Study|Withdrawal by Subject|0
6075860|NCT00425373|20982794|P1|Overall Study|Withdrawal by Subject|2
6075861|NCT00425373|20982786|P9|Overall Study|Protocol Violation|3
6075862|NCT00425373|20982787|P8|Overall Study|Protocol Violation|5
6075863|NCT00425373|20982788|P7|Overall Study|Protocol Violation|0
6075864|NCT00425373|20982789|P6|Overall Study|Protocol Violation|0
6075865|NCT00425373|20982790|P5|Overall Study|Protocol Violation|0
6075866|NCT00425373|20982791|P4|Overall Study|Protocol Violation|0
6075867|NCT00425373|20982792|P3|Overall Study|Protocol Violation|1
6075868|NCT00425373|20982793|P2|Overall Study|Protocol Violation|0
6075869|NCT00425373|20982794|P1|Overall Study|Protocol Violation|1
6075870|NCT00425373|20982786|P9|Overall Study|Lost to Follow-up|0
6075871|NCT00425373|20982787|P8|Overall Study|Lost to Follow-up|0
6075872|NCT00425373|20982788|P7|Overall Study|Lost to Follow-up|0
6075873|NCT00425373|20982789|P6|Overall Study|Lost to Follow-up|0
6075874|NCT00425373|20982790|P5|Overall Study|Lost to Follow-up|1
6075875|NCT00425373|20982791|P4|Overall Study|Lost to Follow-up|0
6075876|NCT00425373|20982792|P3|Overall Study|Lost to Follow-up|0
6075877|NCT00425373|20982793|P2|Overall Study|Lost to Follow-up|1
6075878|NCT00425373|20982794|P1|Overall Study|Lost to Follow-up|0
6075879|NCT00425373|20982786|P9|Overall Study|Adverse Event|8
6075880|NCT00425373|20982787|P8|Overall Study|Adverse Event|3
6075881|NCT00425373|20982788|P7|Overall Study|Adverse Event|2
6075882|NCT00425373|20982789|P6|Overall Study|Adverse Event|6
6075883|NCT00425373|20982790|P5|Overall Study|Adverse Event|4
6075884|NCT00425373|20982791|P4|Overall Study|Adverse Event|1
6075885|NCT00425373|20982792|P3|Overall Study|Adverse Event|0
6075886|NCT00425373|20982793|P2|Overall Study|Adverse Event|2
6075887|NCT00425373|20982794|P1|Overall Study|Adverse Event|2
6075888|NCT00425308|20982852|P2|Overall Study|Death|0
6075889|NCT00425308|20982853|P1|Overall Study|Death|1
6075890|NCT00425308|20982852|P2|Overall Study|Withdrawal by Subject|0
6075891|NCT00425308|20982853|P1|Overall Study|Withdrawal by Subject|1
6075892|NCT00425308|20982852|P2|Overall Study|Adverse Event|1
6075893|NCT00425308|20982853|P1|Overall Study|Adverse Event|2
6075894|NCT00425269|20982883|P2|Overall Study|moved or medical reason|4
6075895|NCT00425269|20982884|P1|Overall Study|moved or medical reason|5
6075896|NCT00425269|20982883|P2|Overall Study|Lost to Follow-up|9
6075897|NCT00425269|20982884|P1|Overall Study|Lost to Follow-up|9
6075898|NCT00425269|20982883|P2|Overall Study|Pregnancy|7
6075899|NCT00425269|20982884|P1|Overall Study|Pregnancy|5
6075900|NCT00425113|20982962|P2|Overall Study|Withdrawal by Subject|0
6075901|NCT00425113|20982963|P1|Overall Study|Withdrawal by Subject|1
6075902|NCT00425113|20982962|P2|Overall Study|missing study drug more than 14 days|1
6075903|NCT00425113|20982963|P1|Overall Study|missing study drug more than 14 days|0
6075904|NCT00425113|20982962|P2|Overall Study|diagnosis of abdominal TB|1
6075905|NCT00425113|20982963|P1|Overall Study|diagnosis of abdominal TB|0
6075906|NCT00425113|20982962|P2|Overall Study|uncontrolled diabetes mellitus|0
6075907|NCT00425113|20982963|P1|Overall Study|uncontrolled diabetes mellitus|1
6075908|NCT00425100|20982971|P1|Overall Study|Withdrawal by Subject|7
6075909|NCT00425100|20982971|P1|Overall Study|Protocol Violation|4
6075910|NCT00425100|20982971|P1|Overall Study|Lost to Follow-up|2
6075911|NCT00425100|20982971|P1|Overall Study|Lack of Efficacy|4
6075912|NCT00425100|20982971|P1|Overall Study|Adverse Event|36
6075913|NCT00425061|20983015|P7|Overall Study|Other|1
6075914|NCT00425061|20983016|P6|Overall Study|Other|0
6075915|NCT00425061|20983017|P5|Overall Study|Other|3
6075916|NCT00425061|20983018|P4|Overall Study|Other|0
6075917|NCT00425061|20983019|P3|Overall Study|Other|0
6075918|NCT00425061|20983020|P2|Overall Study|Other|0
6075919|NCT00425061|20983021|P1|Overall Study|Other|0
6075920|NCT00425061|20983015|P7|Overall Study|Physician Decision|0
6075921|NCT00425061|20983016|P6|Overall Study|Physician Decision|0
6075922|NCT00425061|20983017|P5|Overall Study|Physician Decision|1
6075923|NCT00425061|20983018|P4|Overall Study|Physician Decision|0
6075924|NCT00425061|20983019|P3|Overall Study|Physician Decision|0
6075925|NCT00425061|20983020|P2|Overall Study|Physician Decision|0
6075926|NCT00425061|20983021|P1|Overall Study|Physician Decision|0
6075927|NCT00425061|20983015|P7|Overall Study|Sponsor's request|15
6075928|NCT00425061|20983016|P6|Overall Study|Sponsor's request|4
6075929|NCT00425061|20983017|P5|Overall Study|Sponsor's request|19
6075930|NCT00425061|20983018|P4|Overall Study|Sponsor's request|0
6075931|NCT00425061|20983019|P3|Overall Study|Sponsor's request|0
6075932|NCT00425061|20983020|P2|Overall Study|Sponsor's request|0
6075933|NCT00425061|20983021|P1|Overall Study|Sponsor's request|0
6075934|NCT00425061|20983015|P7|Overall Study|Withdrawal by Subject|3
6075935|NCT00425061|20983016|P6|Overall Study|Withdrawal by Subject|0
6075936|NCT00425061|20983017|P5|Overall Study|Withdrawal by Subject|1
6075937|NCT00425061|20983018|P4|Overall Study|Withdrawal by Subject|0
6075938|NCT00425061|20983019|P3|Overall Study|Withdrawal by Subject|0
6075939|NCT00425061|20983020|P2|Overall Study|Withdrawal by Subject|1
6075940|NCT00425061|20983021|P1|Overall Study|Withdrawal by Subject|0
6075941|NCT00425061|20983015|P7|Overall Study|Protocol Violation|0
6075942|NCT00425061|20983016|P6|Overall Study|Protocol Violation|0
6075943|NCT00425061|20983017|P5|Overall Study|Protocol Violation|0
6075944|NCT00425061|20983018|P4|Overall Study|Protocol Violation|0
6075945|NCT00425061|20983019|P3|Overall Study|Protocol Violation|0
6075946|NCT00425061|20983020|P2|Overall Study|Protocol Violation|0
6075947|NCT00425061|20983021|P1|Overall Study|Protocol Violation|1
6075948|NCT00425061|20983015|P7|Overall Study|Lost to Follow-up|0
6075949|NCT00425061|20983016|P6|Overall Study|Lost to Follow-up|0
6075950|NCT00425061|20983017|P5|Overall Study|Lost to Follow-up|0
6075951|NCT00425061|20983018|P4|Overall Study|Lost to Follow-up|0
6075952|NCT00425061|20983019|P3|Overall Study|Lost to Follow-up|0
6075953|NCT00425061|20983020|P2|Overall Study|Lost to Follow-up|1
6075954|NCT00425061|20983021|P1|Overall Study|Lost to Follow-up|0
6075955|NCT00425061|20983015|P7|Overall Study|Adverse Event|0
6075956|NCT00425061|20983016|P6|Overall Study|Adverse Event|0
6075957|NCT00425061|20983017|P5|Overall Study|Adverse Event|2
6075958|NCT00425061|20983018|P4|Overall Study|Adverse Event|2
6075959|NCT00425061|20983019|P3|Overall Study|Adverse Event|0
6075960|NCT00425061|20983020|P2|Overall Study|Adverse Event|0
6075961|NCT00425061|20983021|P1|Overall Study|Adverse Event|1
6075962|NCT00424827|20983145|P1|Overall Study|Adverse Event|1
6075963|NCT00424775|20983153|P2|Overall Study|Lack of Efficacy|0
6075964|NCT00424775|20983154|P1|Overall Study|Lack of Efficacy|1
6075965|NCT00424775|20983153|P2|Overall Study|Adverse Event|0
6075966|NCT00424775|20983154|P1|Overall Study|Adverse Event|2
6075967|NCT00424762|20983164|P2|Overall Study|Lost to Follow-up|3
6075968|NCT00424762|20983165|P1|Overall Study|Lost to Follow-up|2
6075969|NCT00424762|20983164|P2|Overall Study|Withdrawal by Subject|19
6075970|NCT00424762|20983165|P1|Overall Study|Withdrawal by Subject|18
6075971|NCT00424749|20983175|P1|Overall Study|Withdrawal by Subject|1
6075972|NCT00424645|20983182|P2|Overall Study|Death|0
6075973|NCT00424645|20983183|P1|Overall Study|Death|1
6075974|NCT00424632|20983191|P10|Overall Study|Other|0
6075975|NCT00424632|20983192|P9|Overall Study|Other|1
6075976|NCT00424632|20983193|P8|Overall Study|Other|0
6075977|NCT00424632|20983194|P7|Overall Study|Other|0
6075978|NCT00424632|20983195|P6|Overall Study|Other|0
6075979|NCT00424632|20983196|P5|Overall Study|Other|0
6075980|NCT00424632|20983197|P4|Overall Study|Other|1
6075981|NCT00424632|20983198|P3|Overall Study|Other|0
6075982|NCT00424632|20983199|P2|Overall Study|Other|0
6075983|NCT00424632|20983200|P1|Overall Study|Other|0
6075984|NCT00424632|20983191|P10|Overall Study|Objective progression or relapse|4
6075985|NCT00424632|20983192|P9|Overall Study|Objective progression or relapse|12
6075986|NCT00424632|20983193|P8|Overall Study|Objective progression or relapse|3
6075987|NCT00424632|20983194|P7|Overall Study|Objective progression or relapse|7
6075988|NCT00424632|20983195|P6|Overall Study|Objective progression or relapse|13
6075989|NCT00424632|20983196|P5|Overall Study|Objective progression or relapse|2
6075990|NCT00424632|20983197|P4|Overall Study|Objective progression or relapse|2
6075991|NCT00424632|20983198|P3|Overall Study|Objective progression or relapse|1
6075992|NCT00424632|20983199|P2|Overall Study|Objective progression or relapse|1
6075993|NCT00424632|20983200|P1|Overall Study|Objective progression or relapse|1
6075994|NCT00424632|20983191|P10|Overall Study|Global deterioration of health status|0
6075995|NCT00424632|20983192|P9|Overall Study|Global deterioration of health status|0
6075996|NCT00424632|20983193|P8|Overall Study|Global deterioration of health status|0
6075997|NCT00424632|20983194|P7|Overall Study|Global deterioration of health status|0
6075998|NCT00424632|20983195|P6|Overall Study|Global deterioration of health status|0
6075999|NCT00424632|20983196|P5|Overall Study|Global deterioration of health status|1
6076000|NCT00424632|20983197|P4|Overall Study|Global deterioration of health status|1
6076001|NCT00424632|20983198|P3|Overall Study|Global deterioration of health status|0
6076002|NCT00424632|20983199|P2|Overall Study|Global deterioration of health status|0
6076003|NCT00424632|20983200|P1|Overall Study|Global deterioration of health status|0
6076004|NCT00424632|20983191|P10|Overall Study|Adverse Event|2
6076005|NCT00424632|20983192|P9|Overall Study|Adverse Event|3
6076006|NCT00424632|20983193|P8|Overall Study|Adverse Event|0
6076007|NCT00424632|20983194|P7|Overall Study|Adverse Event|0
6076008|NCT00424632|20983195|P6|Overall Study|Adverse Event|0
6076009|NCT00424632|20983196|P5|Overall Study|Adverse Event|0
6076010|NCT00424632|20983197|P4|Overall Study|Adverse Event|0
6076011|NCT00424632|20983198|P3|Overall Study|Adverse Event|0
6076012|NCT00424632|20983199|P2|Overall Study|Adverse Event|0
6076013|NCT00424632|20983200|P1|Overall Study|Adverse Event|0
6076014|NCT00424632|20983191|P10|Overall Study|Death|0
6076015|NCT00424632|20983192|P9|Overall Study|Death|0
6076016|NCT00424632|20983193|P8|Overall Study|Death|0
6076017|NCT00424632|20983194|P7|Overall Study|Death|0
6076018|NCT00424632|20983195|P6|Overall Study|Death|2
6076019|NCT00424632|20983196|P5|Overall Study|Death|0
6076020|NCT00424632|20983197|P4|Overall Study|Death|0
6076021|NCT00424632|20983198|P3|Overall Study|Death|0
6076022|NCT00424632|20983199|P2|Overall Study|Death|0
6076023|NCT00424632|20983200|P1|Overall Study|Death|0
6076024|NCT00424593|20983370|P2|Dose-Blind Extension Period|Physician Decision|0
6076025|NCT00424593|20983371|P1|Dose-Blind Extension Period|Physician Decision|3
6076026|NCT00424593|20983370|P2|Dose-Blind Extension Period|Lost to Follow-up|0
6076027|NCT00424593|20983371|P1|Dose-Blind Extension Period|Lost to Follow-up|6
6076028|NCT00424593|20983370|P2|Dose-Blind Extension Period|Protocol Violation|0
6076029|NCT00424593|20983371|P1|Dose-Blind Extension Period|Protocol Violation|9
6076030|NCT00424593|20983370|P2|Dose-Blind Extension Period|Lack of Efficacy|0
6076031|NCT00424593|20983371|P1|Dose-Blind Extension Period|Lack of Efficacy|9
6076032|NCT00424593|20983370|P2|Dose-Blind Extension Period|Adverse Event|0
6076033|NCT00424593|20983371|P1|Dose-Blind Extension Period|Adverse Event|18
6076034|NCT00424593|20983370|P2|Dose-Blind Extension Period|Withdrawal by Subject|0
6076035|NCT00424593|20983371|P1|Dose-Blind Extension Period|Withdrawal by Subject|19
6076036|NCT00424593|20983370|P2|Acute Double-Blind Period|Lack of Efficacy|1
6076037|NCT00424593|20983371|P1|Acute Double-Blind Period|Lack of Efficacy|0
6076038|NCT00424593|20983370|P2|Acute Double-Blind Period|Lost to Follow-up|1
6076039|NCT00424593|20983371|P1|Acute Double-Blind Period|Lost to Follow-up|1
6076040|NCT00424593|20983370|P2|Acute Double-Blind Period|Physician Decision|2
6076041|NCT00424593|20983371|P1|Acute Double-Blind Period|Physician Decision|1
6076042|NCT00424593|20983370|P2|Acute Double-Blind Period|Protocol Violation|2
6076043|NCT00424593|20983371|P1|Acute Double-Blind Period|Protocol Violation|2
6076044|NCT00424593|20983370|P2|Acute Double-Blind Period|Withdrawal by Subject|10
6076045|NCT00424593|20983371|P1|Acute Double-Blind Period|Withdrawal by Subject|11
6076046|NCT00424593|20983370|P2|Acute Double-Blind Period|Adverse Event|7
6076047|NCT00424593|20983371|P1|Acute Double-Blind Period|Adverse Event|16
6076048|NCT00424528|20983435|P3|Overall Study|noncompliance with study requirements|2
6076049|NCT00424528|20983436|P2|Overall Study|noncompliance with study requirements|1
6076050|NCT00424528|20983437|P1|Overall Study|noncompliance with study requirements|2
6076051|NCT00424528|20983435|P3|Overall Study|Lost to Follow-up|0
6076052|NCT00424528|20983436|P2|Overall Study|Lost to Follow-up|1
6076053|NCT00424528|20983437|P1|Overall Study|Lost to Follow-up|0
6076054|NCT00424528|20983435|P3|Overall Study|Protocol Violation|0
6076055|NCT00424528|20983436|P2|Overall Study|Protocol Violation|1
6076056|NCT00424528|20983437|P1|Overall Study|Protocol Violation|1
6076057|NCT00424528|20983435|P3|Overall Study|Adverse Event|2
6076058|NCT00424528|20983436|P2|Overall Study|Adverse Event|1
6076059|NCT00424528|20983437|P1|Overall Study|Adverse Event|2
6076060|NCT00424515|20983492|P2|Overall Study|Withdrawal by Subject|0
6076061|NCT00424515|20983493|P1|Overall Study|Withdrawal by Subject|1
6076062|NCT00424515|20983492|P2|Overall Study|Intercurrent Illness|1
6076063|NCT00424515|20983493|P1|Overall Study|Intercurrent Illness|0
6076064|NCT00424515|20983492|P2|Overall Study|Adverse Event|1
6076065|NCT00424515|20983493|P1|Overall Study|Adverse Event|0
6076066|NCT00424515|20983492|P2|Overall Study|Progressive Disease|11
6076067|NCT00424515|20983493|P1|Overall Study|Progressive Disease|10
6076068|NCT00424489|20983512|P1|Overall Study|Death|3
6076069|NCT00424476|20983519|P3|Overall Study|Other|9
6076070|NCT00424476|20983520|P2|Overall Study|Other|3
6076071|NCT00424476|20983521|P1|Overall Study|Other|4
6076072|NCT00424476|20983519|P3|Overall Study|Physician Decision|3
6076073|NCT00424476|20983520|P2|Overall Study|Physician Decision|2
6076074|NCT00424476|20983521|P1|Overall Study|Physician Decision|3
6076075|NCT00424476|20983519|P3|Overall Study|Protocol Violation|3
6076076|NCT00424476|20983520|P2|Overall Study|Protocol Violation|2
6076077|NCT00424476|20983521|P1|Overall Study|Protocol Violation|7
6076078|NCT00424476|20983519|P3|Overall Study|Lost to Follow-up|3
6076079|NCT00424476|20983520|P2|Overall Study|Lost to Follow-up|6
6076080|NCT00424476|20983521|P1|Overall Study|Lost to Follow-up|4
6076081|NCT00424476|20983519|P3|Overall Study|Lack of Compliance|1
6076082|NCT00424476|20983520|P2|Overall Study|Lack of Compliance|1
6076083|NCT00424476|20983521|P1|Overall Study|Lack of Compliance|1
6076084|NCT00424476|20983519|P3|Overall Study|Lack of Efficacy|12
6076085|NCT00424476|20983520|P2|Overall Study|Lack of Efficacy|12
6076086|NCT00424476|20983521|P1|Overall Study|Lack of Efficacy|16
6076087|NCT00424476|20983519|P3|Overall Study|Adverse Event|15
6076088|NCT00424476|20983520|P2|Overall Study|Adverse Event|16
6076089|NCT00424476|20983521|P1|Overall Study|Adverse Event|19
6076090|NCT00424476|20983519|P3|Overall Study|Withdrawal by Subject|3
6076091|NCT00424476|20983520|P2|Overall Study|Withdrawal by Subject|6
6076092|NCT00424476|20983521|P1|Overall Study|Withdrawal by Subject|7
6076093|NCT00424463|20983547|P3|Overall Study|Patient's convenience|1
6076094|NCT00424463|20983548|P2|Overall Study|Patient's convenience|0
6076095|NCT00424463|20983549|P1|Overall Study|Patient's convenience|0
6076096|NCT00424463|20983547|P3|Overall Study|Tracheotomy due to worsening of ALS|6
6076097|NCT00424463|20983548|P2|Overall Study|Tracheotomy due to worsening of ALS|7
6076098|NCT00424463|20983549|P1|Overall Study|Tracheotomy due to worsening of ALS|1
6076099|NCT00424463|20983547|P3|Overall Study|Withdrawal by Subject|5
6076100|NCT00424463|20983548|P2|Overall Study|Withdrawal by Subject|2
6076101|NCT00424463|20983549|P1|Overall Study|Withdrawal by Subject|4
6076102|NCT00424463|20983547|P3|Overall Study|Physician Decision|2
6076103|NCT00424463|20983548|P2|Overall Study|Physician Decision|2
6076104|NCT00424463|20983549|P1|Overall Study|Physician Decision|0
6076105|NCT00424463|20983547|P3|Overall Study|Adverse Event|2
6076106|NCT00424463|20983548|P2|Overall Study|Adverse Event|3
6076107|NCT00424463|20983549|P1|Overall Study|Adverse Event|2
6076108|NCT00424398|20983578|P3|Overall Study|Subject met exclusion criteria|0
6076109|NCT00424398|20983579|P2|Overall Study|Subject met exclusion criteria|0
6076110|NCT00424398|20983580|P1|Overall Study|Subject met exclusion criteria|1
6076111|NCT00424398|20983578|P3|Overall Study|Withdrawal by Subject|0
6076112|NCT00424398|20983579|P2|Overall Study|Withdrawal by Subject|1
6076113|NCT00424398|20983580|P1|Overall Study|Withdrawal by Subject|2
6076114|NCT00424385|20983624|P1|Cohort 1|Withdrawal by Subject|1
6076115|NCT00424385|20983624|P1|Cohort 0|Physician Decision|1
6076116|NCT00424385|20983624|P1|Cohort 0|Withdrawal by Subject|5
6076117|NCT00424372|20983631|P1|Overall Study|Lack of Efficacy|6
6076118|NCT00424372|20983631|P1|Overall Study|Protocol Violation|1
6076119|NCT00424372|20983631|P1|Overall Study|Withdrawal by Subject|4
6076120|NCT00424372|20983631|P1|Overall Study|Health deterioration|1
6076121|NCT00424372|20983631|P1|Overall Study|Adverse Event|18
6076122|NCT00424372|20983631|P1|Overall Study|Death|1
6076123|NCT00424346|20983643|P4|Extension Phase|Protocol Violation|0
6076124|NCT00424346|20983644|P3|Extension Phase|Protocol Violation|1
6076125|NCT00424346|20983645|P2|Extension Phase|Protocol Violation|1
6076126|NCT00424346|20983646|P1|Extension Phase|Protocol Violation|0
6076127|NCT00424346|20983643|P4|Extension Phase|Death|1
6076128|NCT00424346|20983644|P3|Extension Phase|Death|0
6076129|NCT00424346|20983645|P2|Extension Phase|Death|0
6076130|NCT00424346|20983646|P1|Extension Phase|Death|0
6076131|NCT00424346|20983643|P4|Extension Phase|Administrative Problems|35
6076132|NCT00424346|20983644|P3|Extension Phase|Administrative Problems|32
6076133|NCT00424346|20983645|P2|Extension Phase|Administrative Problems|69
6076134|NCT00424346|20983646|P1|Extension Phase|Administrative Problems|0
6076135|NCT00424346|20983643|P4|Extension Phase|Lost to Follow-up|0
6076136|NCT00424346|20983644|P3|Extension Phase|Lost to Follow-up|0
6076137|NCT00424346|20983645|P2|Extension Phase|Lost to Follow-up|2
6076138|NCT00424346|20983646|P1|Extension Phase|Lost to Follow-up|0
6076139|NCT00424346|20983643|P4|Extension Phase|Withdrawal by Subject|4
6076140|NCT00424346|20983644|P3|Extension Phase|Withdrawal by Subject|3
6076141|NCT00424346|20983645|P2|Extension Phase|Withdrawal by Subject|5
6076142|NCT00424346|20983646|P1|Extension Phase|Withdrawal by Subject|0
6076143|NCT00424346|20983643|P4|Extension Phase|Lack of Efficacy|11
6076144|NCT00424346|20983644|P3|Extension Phase|Lack of Efficacy|14
6076145|NCT00424346|20983645|P2|Extension Phase|Lack of Efficacy|16
6076146|NCT00424346|20983646|P1|Extension Phase|Lack of Efficacy|0
6076147|NCT00424346|20983643|P4|Extension Phase|Adverse Event|4
6076148|NCT00424346|20983644|P3|Extension Phase|Adverse Event|5
6076149|NCT00424346|20983645|P2|Extension Phase|Adverse Event|9
6076150|NCT00424346|20983646|P1|Extension Phase|Adverse Event|0
6076151|NCT00424346|20983643|P4|Core Study|Protocol Violation|0
6076152|NCT00424346|20983644|P3|Core Study|Protocol Violation|2
6076153|NCT00424346|20983645|P2|Core Study|Protocol Violation|0
6076154|NCT00424346|20983646|P1|Core Study|Protocol Violation|0
6076155|NCT00424346|20983643|P4|Core Study|Administrative Problems|0
6076156|NCT00424346|20983644|P3|Core Study|Administrative Problems|1
6076157|NCT00424346|20983645|P2|Core Study|Administrative Problems|0
6076158|NCT00424346|20983646|P1|Core Study|Administrative Problems|1
6076159|NCT00424346|20983643|P4|Core Study|Lost to Follow-up|0
6076160|NCT00424346|20983644|P3|Core Study|Lost to Follow-up|0
6076161|NCT00424346|20983645|P2|Core Study|Lost to Follow-up|1
6076162|NCT00424346|20983646|P1|Core Study|Lost to Follow-up|1
6076163|NCT00424346|20983643|P4|Core Study|Withdrawal by Subject|2
6076164|NCT00424346|20983644|P3|Core Study|Withdrawal by Subject|0
6076165|NCT00424346|20983645|P2|Core Study|Withdrawal by Subject|0
6076166|NCT00424346|20983646|P1|Core Study|Withdrawal by Subject|1
6076167|NCT00424346|20983643|P4|Core Study|Lack of Efficacy|4
6076168|NCT00424346|20983644|P3|Core Study|Lack of Efficacy|0
6076169|NCT00424346|20983645|P2|Core Study|Lack of Efficacy|3
6076170|NCT00424346|20983646|P1|Core Study|Lack of Efficacy|1
6076171|NCT00424346|20983643|P4|Core Study|Abnormal Laboratory Values|0
6076172|NCT00424346|20983644|P3|Core Study|Abnormal Laboratory Values|0
6076173|NCT00424346|20983645|P2|Core Study|Abnormal Laboratory Values|1
6076174|NCT00424346|20983646|P1|Core Study|Abnormal Laboratory Values|0
6076175|NCT00424346|20983643|P4|Core Study|Adverse Event|1
6076176|NCT00424346|20983644|P3|Core Study|Adverse Event|1
6076177|NCT00424346|20983645|P2|Core Study|Adverse Event|3
6076178|NCT00424346|20983646|P1|Core Study|Adverse Event|5
6076179|NCT00424294|20983761|P2|Overall Study|Randomized but not Treated|0
6076180|NCT00424294|20983762|P1|Overall Study|Randomized but not Treated|1
6076181|NCT00424294|20983761|P2|Overall Study|Other|2
6076182|NCT00424294|20983762|P1|Overall Study|Other|0
6076183|NCT00424294|20983761|P2|Overall Study|Withdrawal by Subject|2
6076184|NCT00424294|20983762|P1|Overall Study|Withdrawal by Subject|1
6076185|NCT00424294|20983761|P2|Overall Study|Lack of Efficacy|1
6076186|NCT00424294|20983762|P1|Overall Study|Lack of Efficacy|2
6076187|NCT00424294|20983761|P2|Overall Study|Adverse Event|10
6076188|NCT00424294|20983762|P1|Overall Study|Adverse Event|4
6076189|NCT00424255|20983829|P2|Overall Study|Sponsor Terminated Study|167
6076190|NCT00424255|20983830|P1|Overall Study|Sponsor Terminated Study|161
6076191|NCT00424255|20983829|P2|Overall Study|Disease Progression|2
6076192|NCT00424255|20983830|P1|Overall Study|Disease Progression|0
6076193|NCT00424255|20983829|P2|Overall Study|Fatigue|0
6076194|NCT00424255|20983830|P1|Overall Study|Fatigue|1
6076195|NCT00424255|20983829|P2|Overall Study|Non-compliance by Participants|0
6076196|NCT00424255|20983830|P1|Overall Study|Non-compliance by Participants|1
6076197|NCT00424255|20983829|P2|Overall Study|Cognitive Disturbance|0
6076198|NCT00424255|20983830|P1|Overall Study|Cognitive Disturbance|1
6076199|NCT00424255|20983829|P2|Overall Study|Physician Decision|7
6076200|NCT00424255|20983830|P1|Overall Study|Physician Decision|3
6076201|NCT00424255|20983829|P2|Overall Study|Withdrawal by Subject|38
6076202|NCT00424255|20983830|P1|Overall Study|Withdrawal by Subject|34
6076203|NCT00424255|20983829|P2|Overall Study|Protocol Violation|1
6076204|NCT00424255|20983830|P1|Overall Study|Protocol Violation|0
6076205|NCT00424255|20983829|P2|Overall Study|Lost to Follow-up|20
6076206|NCT00424255|20983830|P1|Overall Study|Lost to Follow-up|26
6076207|NCT00424255|20983829|P2|Overall Study|Death|111
6076208|NCT00424255|20983830|P1|Overall Study|Death|115
6076209|NCT00424190|20983878|P2|Overall Study|Other|21
6076210|NCT00424190|20983879|P1|Overall Study|Other|15
6076211|NCT00424190|20983878|P2|Overall Study|Diagnosis of osteomyelitis|1
6076212|NCT00424190|20983879|P1|Overall Study|Diagnosis of osteomyelitis|0
6076213|NCT00424190|20983878|P2|Overall Study|Request of sponsor or investigator|2
6076214|NCT00424190|20983879|P1|Overall Study|Request of sponsor or investigator|0
6076215|NCT00424190|20983878|P2|Overall Study|Noncompliance|2
6076216|NCT00424190|20983879|P1|Overall Study|Noncompliance|1
6076217|NCT00424190|20983878|P2|Overall Study|Death|0
6076218|NCT00424190|20983879|P1|Overall Study|Death|3
6076219|NCT00424190|20983878|P2|Overall Study|Withdrew consent|4
6076220|NCT00424190|20983879|P1|Overall Study|Withdrew consent|3
6076221|NCT00424177|20983885|P1|Cycle 3: Eltrombopag 50 or 75 mg|Physician Decision|1
6076222|NCT00424177|20983885|P1|Cycle 3: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1
6076223|NCT00424177|20983885|P1|Cycle 3: Eltrombopag 50 or 75 mg|Lack of Efficacy|1
6076224|NCT00424177|20983885|P1|Cycle 2: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1
6076225|NCT00424177|20983885|P1|Cycle 2: Eltrombopag 50 or 75 mg|Prolonged Response|1
6076226|NCT00424177|20983885|P1|Cycle 2: Eltrombopag 50 or 75 mg|Lack of Efficacy|2
6076227|NCT00424177|20983885|P1|Cycle 1: Eltrombopag 50 mg Starting Dose|Relocation|1
6076228|NCT00424177|20983885|P1|Cycle 1: Eltrombopag 50 mg Starting Dose|Prolonged Response|1
6076229|NCT00424177|20983885|P1|Cycle 1: Eltrombopag 50 mg Starting Dose|Adverse Event|1
6076230|NCT00424177|20983885|P1|Cycle 1: Eltrombopag 50 mg Starting Dose|Lack of Efficacy|8
6076231|NCT00424047|20983914|P2|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|0
6076232|NCT00424047|20983915|P1|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|1
6076233|NCT00424047|20983914|P2|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|3
6076234|NCT00424047|20983915|P1|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|7
6076235|NCT00424047|20983914|P2|Long Term Extension (Up to 25 Jun 2013)|Other|4
6076236|NCT00424047|20983915|P1|Long Term Extension (Up to 25 Jun 2013)|Other|12
6076237|NCT00424047|20983914|P2|Long Term Extension (Up to 25 Jun 2013)|Death|1
6076238|NCT00424047|20983915|P1|Long Term Extension (Up to 25 Jun 2013)|Death|0
6076239|NCT00424047|20983914|P2|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|0
6076240|NCT00424047|20983915|P1|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|1
6076241|NCT00424047|20983914|P2|On Study at Time of Unblinding|Other|4
6076242|NCT00424047|20983915|P1|On Study at Time of Unblinding|Other|5
6076243|NCT00424047|20983914|P2|On Study at Time of Unblinding|Death|11
6076244|NCT00424047|20983915|P1|On Study at Time of Unblinding|Death|11
6076245|NCT00424047|20983914|P2|On Study at Time of Unblinding|Withdrawal by Subject|9
6076246|NCT00424047|20983915|P1|On Study at Time of Unblinding|Withdrawal by Subject|24
6076247|NCT00424047|20983914|P2|On Study at Time of Unblinding|Lack of Efficacy|3
6076248|NCT00424047|20983915|P1|On Study at Time of Unblinding|Lack of Efficacy|1
6076249|NCT00424047|20983914|P2|On Study at Time of Unblinding|Progression of disease|128
6076250|NCT00424047|20983915|P1|On Study at Time of Unblinding|Progression of disease|92
6076251|NCT00424047|20983914|P2|On Study at Time of Unblinding|Adverse Event|12
6076252|NCT00424047|20983915|P1|On Study at Time of Unblinding|Adverse Event|22
6076253|NCT00424047|20983914|P2|Blinded Treatment (Up to 03 Aug 2005)|Other|1
6076254|NCT00424047|20983915|P1|Blinded Treatment (Up to 03 Aug 2005)|Other|2
6076255|NCT00424047|20983914|P2|Blinded Treatment (Up to 03 Aug 2005)|Death|10
6076256|NCT00424047|20983915|P1|Blinded Treatment (Up to 03 Aug 2005)|Death|11
6076257|NCT00424047|20983914|P2|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|8
6076258|NCT00424047|20983915|P1|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|23
6076259|NCT00424047|20983914|P2|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|3
6076260|NCT00424047|20983915|P1|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|1
6076261|NCT00424047|20983914|P2|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|122
6076262|NCT00424047|20983915|P1|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|67
6076263|NCT00424047|20983914|P2|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|12
6076264|NCT00424047|20983915|P1|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|18
6076265|NCT00424021|20983947|P4|AMB-220-E Study Period|Physician Decision|1
6076266|NCT00424021|20983948|P3|AMB-220-E Study Period|Physician Decision|0
6076267|NCT00424021|20983949|P2|AMB-220-E Study Period|Physician Decision|0
6076268|NCT00424021|20983950|P1|AMB-220-E Study Period|Physician Decision|0
6076269|NCT00424021|20983947|P4|AMB-220-E Study Period|Lost to Follow-up|1
6076270|NCT00424021|20983948|P3|AMB-220-E Study Period|Lost to Follow-up|1
6076271|NCT00424021|20983949|P2|AMB-220-E Study Period|Lost to Follow-up|1
6076272|NCT00424021|20983950|P1|AMB-220-E Study Period|Lost to Follow-up|0
6076273|NCT00424021|20983947|P4|AMB-220-E Study Period|Death|1
6076274|NCT00424021|20983948|P3|AMB-220-E Study Period|Death|1
6076275|NCT00424021|20983949|P2|AMB-220-E Study Period|Death|0
6076276|NCT00424021|20983950|P1|AMB-220-E Study Period|Death|0
6076277|NCT00424021|20983947|P4|AMB-220-E Study Period|Adverse Event|7
6076278|NCT00424021|20983948|P3|AMB-220-E Study Period|Adverse Event|3
6076279|NCT00424021|20983949|P2|AMB-220-E Study Period|Adverse Event|1
6076280|NCT00424021|20983950|P1|AMB-220-E Study Period|Adverse Event|1
6076281|NCT00424021|20983947|P4|NCT00046319 Study Period|Lost to Follow-up|0
6076282|NCT00424021|20983948|P3|NCT00046319 Study Period|Lost to Follow-up|0
6076283|NCT00424021|20983949|P2|NCT00046319 Study Period|Lost to Follow-up|1
6076284|NCT00424021|20983950|P1|NCT00046319 Study Period|Lost to Follow-up|0
6076285|NCT00424021|20983947|P4|NCT00046319 Study Period|Sponsor discretion|0
6076286|NCT00424021|20983948|P3|NCT00046319 Study Period|Sponsor discretion|0
6076287|NCT00424021|20983949|P2|NCT00046319 Study Period|Sponsor discretion|1
6076288|NCT00424021|20983950|P1|NCT00046319 Study Period|Sponsor discretion|0
6076289|NCT00424021|20983947|P4|NCT00046319 Study Period|Withdrawal by Subject|0
6076290|NCT00424021|20983948|P3|NCT00046319 Study Period|Withdrawal by Subject|0
6076291|NCT00424021|20983949|P2|NCT00046319 Study Period|Withdrawal by Subject|1
6076292|NCT00424021|20983950|P1|NCT00046319 Study Period|Withdrawal by Subject|0
6076293|NCT00424021|20983947|P4|NCT00046319 Study Period|Adverse Event|1
6076294|NCT00424021|20983948|P3|NCT00046319 Study Period|Adverse Event|1
6076295|NCT00424021|20983949|P2|NCT00046319 Study Period|Adverse Event|0
6076296|NCT00424021|20983950|P1|NCT00046319 Study Period|Adverse Event|1
6076297|NCT00424008|20983993|P2|Overall Study|Administrative|257
6076298|NCT00424008|20983994|P1|Overall Study|Administrative|266
6076299|NCT00424008|20983993|P2|Overall Study|Did not meet protocol eligibility|21
6076300|NCT00424008|20983994|P1|Overall Study|Did not meet protocol eligibility|16
6076301|NCT00424008|20983993|P2|Overall Study|Noncompliance with protocol|7
6076302|NCT00424008|20983994|P1|Overall Study|Noncompliance with protocol|13
6076303|NCT00424008|20983993|P2|Overall Study|Withdrawal by Subject|8
6076304|NCT00424008|20983994|P1|Overall Study|Withdrawal by Subject|5
6076305|NCT00424008|20983993|P2|Overall Study|Lost to Follow-up|2
6076306|NCT00424008|20983994|P1|Overall Study|Lost to Follow-up|1
6076307|NCT00424008|20983993|P2|Overall Study|Lack of Efficacy|34
6076308|NCT00424008|20983994|P1|Overall Study|Lack of Efficacy|40
6076309|NCT00424008|20983993|P2|Overall Study|Adverse Event|6
6076310|NCT00424008|20983994|P1|Overall Study|Adverse Event|8
6076311|NCT00423943|20984009|P2|Overall Study|Withdrawal by Subject|1
6076312|NCT00423943|20984010|P1|Overall Study|Withdrawal by Subject|3
6076313|NCT00423930|20984024|P1|Overall Study|Withdrawal by Subject|2
6076314|NCT00423917|20984029|P1|Overall Study|Ineligible|1
6076315|NCT00423917|20984029|P1|Overall Study|Cancel|2
6076316|NCT00423891|20984042|P3|Post-Dosing Follow Up|Lost to Follow-up|0
6076317|NCT00423891|20984043|P2|Post-Dosing Follow Up|Lost to Follow-up|0
6076318|NCT00423891|20984044|P1|Post-Dosing Follow Up|Lost to Follow-up|2
6076319|NCT00423891|20984042|P3|Post-Dosing Follow Up|Withdrawal by Subject|2
6076320|NCT00423891|20984043|P2|Post-Dosing Follow Up|Withdrawal by Subject|3
6076321|NCT00423891|20984044|P1|Post-Dosing Follow Up|Withdrawal by Subject|0
6076322|NCT00423891|20984042|P3|Treatment|Lost to Follow-up|0
6076323|NCT00423891|20984043|P2|Treatment|Lost to Follow-up|0
6076324|NCT00423891|20984044|P1|Treatment|Lost to Follow-up|1
6076325|NCT00423891|20984042|P3|Treatment|Withdrawal by Subject|0
6076326|NCT00423891|20984043|P2|Treatment|Withdrawal by Subject|0
6076327|NCT00423891|20984044|P1|Treatment|Withdrawal by Subject|1
6076328|NCT00423891|20984042|P3|Enrolled|No longer met criteria|1
6076329|NCT00423891|20984043|P2|Enrolled|No longer met criteria|2
6076330|NCT00423891|20984044|P1|Enrolled|No longer met criteria|11
6076331|NCT00423891|20984042|P3|Enrolled|Lost to Follow-up|1
6076332|NCT00423891|20984043|P2|Enrolled|Lost to Follow-up|0
6076333|NCT00423891|20984044|P1|Enrolled|Lost to Follow-up|0
6076334|NCT00423891|20984042|P3|Enrolled|Withdrawal by Subject|1
6076335|NCT00423891|20984043|P2|Enrolled|Withdrawal by Subject|0
6076336|NCT00423891|20984044|P1|Enrolled|Withdrawal by Subject|0
6076337|NCT00423852|20984122|P1|Overall Study|Removed pior to the high-dose portion|3
6076338|NCT00423813|20984130|P3|Overall Study|Undergoing tests for Cushings Syndrome|1
6076339|NCT00423813|20984131|P2|Overall Study|Undergoing tests for Cushings Syndrome|0
6076340|NCT00423813|20984132|P1|Overall Study|Undergoing tests for Cushings Syndrome|0
6076341|NCT00423813|20984130|P3|Overall Study|Will start exclusionary medications|0
6076342|NCT00423813|20984131|P2|Overall Study|Will start exclusionary medications|1
6076343|NCT00423813|20984132|P1|Overall Study|Will start exclusionary medications|0
6076344|NCT00423813|20984130|P3|Overall Study|Subject started night shift work|0
6076345|NCT00423813|20984131|P2|Overall Study|Subject started night shift work|0
6076346|NCT00423813|20984132|P1|Overall Study|Subject started night shift work|1
6076347|NCT00423813|20984130|P3|Overall Study|Pregnancy|1
6076348|NCT00423813|20984131|P2|Overall Study|Pregnancy|0
6076349|NCT00423813|20984132|P1|Overall Study|Pregnancy|0
6076350|NCT00423813|20984130|P3|Overall Study|Protocol Violation|4
6076351|NCT00423813|20984131|P2|Overall Study|Protocol Violation|4
6076352|NCT00423813|20984132|P1|Overall Study|Protocol Violation|9
6076353|NCT00423813|20984130|P3|Overall Study|Sponsor Decision|0
6076354|NCT00423813|20984131|P2|Overall Study|Sponsor Decision|1
6076355|NCT00423813|20984132|P1|Overall Study|Sponsor Decision|0
6076356|NCT00423813|20984130|P3|Overall Study|Physician Decision|0
6076357|NCT00423813|20984131|P2|Overall Study|Physician Decision|0
6076358|NCT00423813|20984132|P1|Overall Study|Physician Decision|2
6076359|NCT00423813|20984130|P3|Overall Study|Lack of Efficacy|19
6076360|NCT00423813|20984131|P2|Overall Study|Lack of Efficacy|18
6076361|NCT00423813|20984132|P1|Overall Study|Lack of Efficacy|23
6076362|NCT00423813|20984130|P3|Overall Study|Lost to Follow-up|4
6076363|NCT00423813|20984131|P2|Overall Study|Lost to Follow-up|4
6076364|NCT00423813|20984132|P1|Overall Study|Lost to Follow-up|5
6076365|NCT00423813|20984130|P3|Overall Study|Withdrawal by Subject|5
6076366|NCT00423813|20984131|P2|Overall Study|Withdrawal by Subject|8
6076367|NCT00423813|20984132|P1|Overall Study|Withdrawal by Subject|6
6076368|NCT00423813|20984130|P3|Overall Study|Adverse Event|40
6076369|NCT00423813|20984131|P2|Overall Study|Adverse Event|30
6076370|NCT00423813|20984132|P1|Overall Study|Adverse Event|11
6076371|NCT00423800|20984142|P2|Overall Study|Protocol Violation|1
6076372|NCT00423800|20984143|P1|Overall Study|Protocol Violation|0
6076373|NCT00423735|20984155|P3|Overall Study|Ineligible / No protocol treatment|0
6076374|NCT00423735|20984156|P2|Overall Study|Ineligible / No protocol treatment|6
6076375|NCT00423735|20984157|P1|Overall Study|Ineligible / No protocol treatment|8
6076376|NCT00423722|20984180|P2|Overall Study|Withdrawal by Subject|2
6076377|NCT00423722|20984181|P1|Overall Study|Withdrawal by Subject|4
6076378|NCT00423722|20984180|P2|Overall Study|Unable to complete questionnaires|4
6076379|NCT00423722|20984181|P1|Overall Study|Unable to complete questionnaires|4
6076380|NCT00423722|20984180|P2|Overall Study|Declined to participate|3
6076381|NCT00423722|20984181|P1|Overall Study|Declined to participate|2
6076382|NCT00423722|20984180|P2|Overall Study|Death|4
6076383|NCT00423722|20984181|P1|Overall Study|Death|4
6076384|NCT00423670|20984223|P8|Follow-up Period|Non-compliance with protocol|2
6076385|NCT00423670|20984224|P7|Follow-up Period|Non-compliance with protocol|3
6076386|NCT00423670|20984225|P6|Follow-up Period|Non-compliance with protocol|0
6076387|NCT00423670|20984226|P5|Follow-up Period|Non-compliance with protocol|0
6076388|NCT00423670|20984227|P4|Follow-up Period|Non-compliance with protocol|1
6076389|NCT00423670|20984228|P3|Follow-up Period|Non-compliance with protocol|1
6076390|NCT00423670|20984229|P2|Follow-up Period|Non-compliance with protocol|0
6076391|NCT00423670|20984230|P1|Follow-up Period|Non-compliance with protocol|2
6076392|NCT00423670|20984223|P8|Follow-up Period|Subject withdrew (not treatment related)|1
6076393|NCT00423670|20984224|P7|Follow-up Period|Subject withdrew (not treatment related)|1
6076394|NCT00423670|20984225|P6|Follow-up Period|Subject withdrew (not treatment related)|0
6076395|NCT00423670|20984226|P5|Follow-up Period|Subject withdrew (not treatment related)|1
6076396|NCT00423670|20984227|P4|Follow-up Period|Subject withdrew (not treatment related)|1
6076397|NCT00423670|20984228|P3|Follow-up Period|Subject withdrew (not treatment related)|2
6076398|NCT00423670|20984229|P2|Follow-up Period|Subject withdrew (not treatment related)|4
6076399|NCT00423670|20984230|P1|Follow-up Period|Subject withdrew (not treatment related)|1
6076400|NCT00423670|20984223|P8|Follow-up Period|Lost to Follow-up|0
6076401|NCT00423670|20984224|P7|Follow-up Period|Lost to Follow-up|5
6076402|NCT00423670|20984225|P6|Follow-up Period|Lost to Follow-up|0
6076403|NCT00423670|20984226|P5|Follow-up Period|Lost to Follow-up|1
6076404|NCT00423670|20984227|P4|Follow-up Period|Lost to Follow-up|3
6076405|NCT00423670|20984228|P3|Follow-up Period|Lost to Follow-up|8
6076406|NCT00423670|20984229|P2|Follow-up Period|Lost to Follow-up|12
6076407|NCT00423670|20984230|P1|Follow-up Period|Lost to Follow-up|0
6076408|NCT00423670|20984223|P8|Treatment Period|Non-compliance with protocol|2
6076409|NCT00423670|20984224|P7|Treatment Period|Non-compliance with protocol|2
6076410|NCT00423670|20984225|P6|Treatment Period|Non-compliance with protocol|0
6076411|NCT00423670|20984226|P5|Treatment Period|Non-compliance with protocol|2
6076412|NCT00423670|20984227|P4|Treatment Period|Non-compliance with protocol|3
6076413|NCT00423670|20984228|P3|Treatment Period|Non-compliance with protocol|1
6076414|NCT00423670|20984229|P2|Treatment Period|Non-compliance with protocol|1
6076415|NCT00423670|20984230|P1|Treatment Period|Non-compliance with protocol|3
6076416|NCT00423670|20984223|P8|Treatment Period|Investigator decision|1
6076417|NCT00423670|20984224|P7|Treatment Period|Investigator decision|0
6076418|NCT00423670|20984225|P6|Treatment Period|Investigator decision|0
6076419|NCT00423670|20984226|P5|Treatment Period|Investigator decision|0
6076420|NCT00423670|20984227|P4|Treatment Period|Investigator decision|0
6076421|NCT00423670|20984228|P3|Treatment Period|Investigator decision|0
6076422|NCT00423670|20984229|P2|Treatment Period|Investigator decision|0
6076423|NCT00423670|20984230|P1|Treatment Period|Investigator decision|0
6076424|NCT00423670|20984223|P8|Treatment Period|Subject withdrew (not treatment related)|0
6076425|NCT00423670|20984224|P7|Treatment Period|Subject withdrew (not treatment related)|3
6076426|NCT00423670|20984225|P6|Treatment Period|Subject withdrew (not treatment related)|0
6076427|NCT00423670|20984226|P5|Treatment Period|Subject withdrew (not treatment related)|5
6076428|NCT00423670|20984227|P4|Treatment Period|Subject withdrew (not treatment related)|4
6076429|NCT00423670|20984228|P3|Treatment Period|Subject withdrew (not treatment related)|4
6076430|NCT00423670|20984229|P2|Treatment Period|Subject withdrew (not treatment related)|9
6076431|NCT00423670|20984230|P1|Treatment Period|Subject withdrew (not treatment related)|3
6076432|NCT00423670|20984223|P8|Treatment Period|Lost to Follow-up|1
6076433|NCT00423670|20984224|P7|Treatment Period|Lost to Follow-up|3
6076434|NCT00423670|20984225|P6|Treatment Period|Lost to Follow-up|0
6076435|NCT00423670|20984226|P5|Treatment Period|Lost to Follow-up|6
6076436|NCT00423670|20984227|P4|Treatment Period|Lost to Follow-up|1
6076437|NCT00423670|20984228|P3|Treatment Period|Lost to Follow-up|3
6076438|NCT00423670|20984229|P2|Treatment Period|Lost to Follow-up|1
6076439|NCT00423670|20984230|P1|Treatment Period|Lost to Follow-up|2
6076440|NCT00423670|20984223|P8|Treatment Period|Protocol-defined clinical event|15
6076441|NCT00423670|20984224|P7|Treatment Period|Protocol-defined clinical event|16
6076442|NCT00423670|20984225|P6|Treatment Period|Protocol-defined clinical event|4
6076443|NCT00423670|20984226|P5|Treatment Period|Protocol-defined clinical event|5
6076444|NCT00423670|20984227|P4|Treatment Period|Protocol-defined clinical event|12
6076445|NCT00423670|20984228|P3|Treatment Period|Protocol-defined clinical event|4
6076446|NCT00423670|20984229|P2|Treatment Period|Protocol-defined clinical event|7
6076447|NCT00423670|20984230|P1|Treatment Period|Protocol-defined clinical event|0
6076448|NCT00423670|20984223|P8|Treatment Period|Adverse Event|2
6076449|NCT00423670|20984224|P7|Treatment Period|Adverse Event|7
6076450|NCT00423670|20984225|P6|Treatment Period|Adverse Event|4
6076451|NCT00423670|20984226|P5|Treatment Period|Adverse Event|9
6076452|NCT00423670|20984227|P4|Treatment Period|Adverse Event|20
6076453|NCT00423670|20984228|P3|Treatment Period|Adverse Event|15
6076454|NCT00423670|20984229|P2|Treatment Period|Adverse Event|12
6076455|NCT00423670|20984230|P1|Treatment Period|Adverse Event|8
6076456|NCT00423670|20984223|P8|Treatment Period|Switched to Arm 8 at TW 24|0
6076457|NCT00423670|20984224|P7|Treatment Period|Switched to Arm 8 at TW 24|0
6076458|NCT00423670|20984225|P6|Treatment Period|Switched to Arm 8 at TW 24|0
6076459|NCT00423670|20984226|P5|Treatment Period|Switched to Arm 8 at TW 24|0
6076460|NCT00423670|20984227|P4|Treatment Period|Switched to Arm 8 at TW 24|0
6076461|NCT00423670|20984228|P3|Treatment Period|Switched to Arm 8 at TW 24|0
6076462|NCT00423670|20984229|P2|Treatment Period|Switched to Arm 8 at TW 24|0
6076463|NCT00423670|20984230|P1|Treatment Period|Switched to Arm 8 at TW 24|36
6076464|NCT00423657|20984288|P2|Overall Study|Request of sponsor/investigator|0
6076465|NCT00423657|20984289|P1|Overall Study|Request of sponsor/investigator|1
6076466|NCT00423657|20984288|P2|Overall Study|Other|16
6076467|NCT00423657|20984289|P1|Overall Study|Other|15
6076468|NCT00423657|20984288|P2|Overall Study|Non-compliance|1
6076469|NCT00423657|20984289|P1|Overall Study|Non-compliance|0
6076470|NCT00423657|20984288|P2|Overall Study|Withdrew consent|8
6076471|NCT00423657|20984289|P1|Overall Study|Withdrew consent|10
6076472|NCT00423605|20984295|P1|Overall Study|Not one of the pre-specified options|5
6076473|NCT00423605|20984295|P1|Overall Study|Protocol Violation|7
6076474|NCT00423605|20984295|P1|Overall Study|Physician Decision|8
6076475|NCT00423605|20984295|P1|Overall Study|Sponsor Decision|3
6076476|NCT00423605|20984295|P1|Overall Study|Lack of Efficacy|38
6076477|NCT00423605|20984295|P1|Overall Study|Lost to Follow-up|15
6076478|NCT00423605|20984295|P1|Overall Study|Withdrawal by Subject|36
6076479|NCT00423605|20984295|P1|Overall Study|Adverse Event|129
6076480|NCT00423592|20984299|P1|Overall Study|Adverse Event (post Week 12)|5
6076481|NCT00423592|20984299|P1|Overall Study|Adverse Event (through Week 12)|2
6076482|NCT00423579|20984320|P2|Overall Study|Diagnosis of diabetes|1
6076483|NCT00423579|20984321|P1|Overall Study|Diagnosis of diabetes|0
6076484|NCT00423579|20984320|P2|Overall Study|Protocol Violation|3
6076485|NCT00423579|20984321|P1|Overall Study|Protocol Violation|1
6076486|NCT00423579|20984320|P2|Overall Study|Lost to Follow-up|0
6076487|NCT00423579|20984321|P1|Overall Study|Lost to Follow-up|3
6076488|NCT00423488|20984329|P2|Overall Study|No post baseline data|0
6076489|NCT00423488|20984330|P1|Overall Study|No post baseline data|3
6076490|NCT00423488|20984329|P2|Overall Study|No evidence of study drug intake|1
6076491|NCT00423488|20984330|P1|Overall Study|No evidence of study drug intake|2
6076492|NCT00423449|20984336|P5|Overall Study|Protocol Violation|0
6076493|NCT00423449|20984337|P4|Overall Study|Protocol Violation|1
6076494|NCT00423449|20984338|P3|Overall Study|Protocol Violation|2
6076495|NCT00423449|20984339|P2|Overall Study|Protocol Violation|0
6076496|NCT00423449|20984340|P1|Overall Study|Protocol Violation|0
6076497|NCT00423449|20984336|P5|Overall Study|Other|0
6076498|NCT00423449|20984337|P4|Overall Study|Other|1
6076499|NCT00423449|20984338|P3|Overall Study|Other|0
6076500|NCT00423449|20984339|P2|Overall Study|Other|0
6076501|NCT00423449|20984340|P1|Overall Study|Other|0
6076502|NCT00423449|20984336|P5|Overall Study|Laboratory Adverse Event|0
6076503|NCT00423449|20984337|P4|Overall Study|Laboratory Adverse Event|0
6076504|NCT00423449|20984338|P3|Overall Study|Laboratory Adverse Event|2
6076505|NCT00423449|20984339|P2|Overall Study|Laboratory Adverse Event|1
6076506|NCT00423449|20984340|P1|Overall Study|Laboratory Adverse Event|0
6076507|NCT00423449|20984336|P5|Overall Study|Progressive Disease|4
6076508|NCT00423449|20984337|P4|Overall Study|Progressive Disease|11
6076509|NCT00423449|20984338|P3|Overall Study|Progressive Disease|8
6076510|NCT00423449|20984339|P2|Overall Study|Progressive Disease|3
6076511|NCT00423449|20984340|P1|Overall Study|Progressive Disease|1
6076512|NCT00423449|20984336|P5|Overall Study|Death|1
6076513|NCT00423449|20984337|P4|Overall Study|Death|1
6076514|NCT00423449|20984338|P3|Overall Study|Death|2
6076515|NCT00423449|20984339|P2|Overall Study|Death|0
6076516|NCT00423449|20984340|P1|Overall Study|Death|1
6076517|NCT00423449|20984336|P5|Overall Study|Clinical Adverse Event|2
6076518|NCT00423449|20984337|P4|Overall Study|Clinical Adverse Event|8
6076519|NCT00423449|20984338|P3|Overall Study|Clinical Adverse Event|1
6076520|NCT00423449|20984339|P2|Overall Study|Clinical Adverse Event|0
6076521|NCT00423449|20984340|P1|Overall Study|Clinical Adverse Event|1
6076522|NCT00423332|20984387|P2|Overall Study|Unblinded before 12 weeks|3
6076523|NCT00423332|20984388|P1|Overall Study|Unblinded before 12 weeks|1
6076524|NCT00423332|20984387|P2|Overall Study|Progressive at Week 6|1
6076525|NCT00423332|20984388|P1|Overall Study|Progressive at Week 6|0
6076526|NCT00423332|20984387|P2|Overall Study|Condition under investigation worsened|1
6076527|NCT00423332|20984388|P1|Overall Study|Condition under investigation worsened|1
6076528|NCT00423332|20984387|P2|Overall Study|Withdrawal by Subject|0
6076529|NCT00423332|20984388|P1|Overall Study|Withdrawal by Subject|1
6076530|NCT00423332|20984387|P2|Overall Study|Adverse Event|2
6076531|NCT00423332|20984388|P1|Overall Study|Adverse Event|6
6076532|NCT00423319|20984407|P2|Overall Study|Other|22
6076533|NCT00423319|20984408|P1|Overall Study|Other|23
6076534|NCT00423319|20984407|P2|Overall Study|No longer meets study criteria|15
6076535|NCT00423319|20984408|P1|Overall Study|No longer meets study criteria|15
6076536|NCT00423319|20984407|P2|Overall Study|Poor compliance or noncompliance|1
6076537|NCT00423319|20984408|P1|Overall Study|Poor compliance or noncompliance|1
6076538|NCT00423319|20984407|P2|Overall Study|Lost to Follow-up|3
6076539|NCT00423319|20984408|P1|Overall Study|Lost to Follow-up|4
6076540|NCT00423319|20984407|P2|Overall Study|Withdrawal by Subject|99
6076541|NCT00423319|20984408|P1|Overall Study|Withdrawal by Subject|86
6076542|NCT00423319|20984407|P2|Overall Study|Adverse Event|112
6076543|NCT00423319|20984408|P1|Overall Study|Adverse Event|93
6076544|NCT00423319|20984407|P2|Overall Study|Death|0
6076545|NCT00423319|20984408|P1|Overall Study|Death|2
6076546|NCT00423293|20984440|P1|Overall Study|Ineligible / No protocol treatment|11
6076547|NCT00423267|20984457|P2|Period A|Administrative|0
6076548|NCT00423267|20984458|P1|Period A|Administrative|1
6076549|NCT00423267|20984457|P2|Period A|Non-compliance with protocol|0
6076550|NCT00423267|20984458|P1|Period A|Non-compliance with protocol|1
6076551|NCT00423267|20984457|P2|Period A|Withdrawal by Subject|1
6076552|NCT00423267|20984458|P1|Period A|Withdrawal by Subject|0
6076553|NCT00423189|20984478|P3|Overall Study|Death|0
6076554|NCT00423189|20984479|P2|Overall Study|Death|1
6076555|NCT00423189|20984480|P1|Overall Study|Death|0
6076556|NCT00423176|20984502|P2|Overall Study|Did not meet protocol eligibility|4
6076557|NCT00423176|20984503|P1|Overall Study|Did not meet protocol eligibility|2
6076558|NCT00423176|20984502|P2|Overall Study|Protocol Violation|3
6076559|NCT00423176|20984503|P1|Overall Study|Protocol Violation|1
6076560|NCT00423176|20984502|P2|Overall Study|Withdrawal by Subject|3
6076561|NCT00423176|20984503|P1|Overall Study|Withdrawal by Subject|4
6076562|NCT00423176|20984502|P2|Overall Study|Lost to Follow-up|7
6076563|NCT00423176|20984503|P1|Overall Study|Lost to Follow-up|4
6076564|NCT00423176|20984502|P2|Overall Study|Treatment Failure|6
6076565|NCT00423176|20984503|P1|Overall Study|Treatment Failure|1
6076566|NCT00423176|20984502|P2|Overall Study|Adverse Event|6
6076567|NCT00423176|20984503|P1|Overall Study|Adverse Event|4
6076568|NCT00423150|20984511|P1|Overall Study|Administrative|4
6076569|NCT00423150|20984511|P1|Overall Study|Non-compliance with protocol|1
6076570|NCT00423150|20984511|P1|Overall Study|Withdrawal by Subject|1
6076571|NCT00423150|20984511|P1|Overall Study|Progression of disease being studied|69
6076572|NCT00423150|20984511|P1|Overall Study|Adverse Event|11
6076573|NCT00423098|20984517|P2|Overall Study|Death|0
6076574|NCT00423098|20984518|P1|Overall Study|Death|2
6076575|NCT00423098|20984517|P2|Overall Study|Administrative problems|1
6076576|NCT00423098|20984518|P1|Overall Study|Administrative problems|0
6076577|NCT00423098|20984517|P2|Overall Study|Unsatisfactory therapeutic effect|1
6076578|NCT00423098|20984518|P1|Overall Study|Unsatisfactory therapeutic effect|0
6076579|NCT00423098|20984517|P2|Overall Study|Adverse Event|2
6076580|NCT00423098|20984518|P1|Overall Study|Adverse Event|1
6076581|NCT00423085|20984545|P4|52-Week Open-Label Extension Phase|Death|2
6076582|NCT00423085|20984546|P3|52-Week Open-Label Extension Phase|Death|0
6076583|NCT00423085|20984547|P2|52-Week Open-Label Extension Phase|Death|0
6076584|NCT00423085|20984548|P1|52-Week Open-Label Extension Phase|Death|0
6076585|NCT00423085|20984545|P4|52-Week Open-Label Extension Phase|Protocol deviation|9
6076586|NCT00423085|20984546|P3|52-Week Open-Label Extension Phase|Protocol deviation|0
6076587|NCT00423085|20984547|P2|52-Week Open-Label Extension Phase|Protocol deviation|0
6076588|NCT00423085|20984548|P1|52-Week Open-Label Extension Phase|Protocol deviation|0
6076589|NCT00423085|20984545|P4|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|18
6076590|NCT00423085|20984546|P3|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0
6076591|NCT00423085|20984547|P2|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0
6076592|NCT00423085|20984548|P1|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0
6076593|NCT00423085|20984545|P4|52-Week Open-Label Extension Phase|Withdrawal by Subject|37
6076594|NCT00423085|20984546|P3|52-Week Open-Label Extension Phase|Withdrawal by Subject|0
6076595|NCT00423085|20984547|P2|52-Week Open-Label Extension Phase|Withdrawal by Subject|0
6076596|NCT00423085|20984548|P1|52-Week Open-Label Extension Phase|Withdrawal by Subject|0
6076597|NCT00423085|20984545|P4|52-Week Open-Label Extension Phase|Adverse Event|97
6076598|NCT00423085|20984546|P3|52-Week Open-Label Extension Phase|Adverse Event|0
6076599|NCT00423085|20984547|P2|52-Week Open-Label Extension Phase|Adverse Event|0
6076600|NCT00423085|20984548|P1|52-Week Open-Label Extension Phase|Adverse Event|0
6076601|NCT00423085|20984545|P4|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0
6076602|NCT00423085|20984546|P3|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0
6076603|NCT00423085|20984547|P2|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0
6076604|NCT00423085|20984548|P1|24-Week Double-Blind Treatment Phase|Lost to Follow-up|1
6076605|NCT00423085|20984545|P4|24-Week Double-Blind Treatment Phase|Death|0
6076606|NCT00423085|20984546|P3|24-Week Double-Blind Treatment Phase|Death|0
6076607|NCT00423085|20984547|P2|24-Week Double-Blind Treatment Phase|Death|1
6076608|NCT00423085|20984548|P1|24-Week Double-Blind Treatment Phase|Death|1
6076609|NCT00423085|20984545|P4|24-Week Double-Blind Treatment Phase|Protocol Violation|0
6076610|NCT00423085|20984546|P3|24-Week Double-Blind Treatment Phase|Protocol Violation|7
6076611|NCT00423085|20984547|P2|24-Week Double-Blind Treatment Phase|Protocol Violation|3
6076612|NCT00423085|20984548|P1|24-Week Double-Blind Treatment Phase|Protocol Violation|8
6076613|NCT00423085|20984545|P4|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0
6076614|NCT00423085|20984546|P3|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7
6076615|NCT00423085|20984547|P2|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|6
6076616|NCT00423085|20984548|P1|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7
6076617|NCT00423085|20984545|P4|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|0
6076618|NCT00423085|20984546|P3|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|11
6076619|NCT00423085|20984547|P2|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|16
6076620|NCT00423085|20984548|P1|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|8
6076621|NCT00423085|20984545|P4|24-Week Double-Blind Treatment Phase|Adverse Event|0
6076622|NCT00423085|20984546|P3|24-Week Double-Blind Treatment Phase|Adverse Event|34
6076623|NCT00423085|20984547|P2|24-Week Double-Blind Treatment Phase|Adverse Event|38
6076624|NCT00423085|20984548|P1|24-Week Double-Blind Treatment Phase|Adverse Event|21
6076625|NCT00423046|20984577|P2|Overall Study|Other|345
6076626|NCT00423046|20984578|P1|Overall Study|Other|340
6076627|NCT00422942|20984644|P1|Overall Study|Study terminated by Sponsor|3
6076628|NCT00422903|20984663|P2|Overall Study|Informed Consent Withdrawn|2
6076629|NCT00422903|20984664|P1|Overall Study|Informed Consent Withdrawn|1
6076630|NCT00422903|20984663|P2|Overall Study|Adverse Event|2
6076631|NCT00422903|20984664|P1|Overall Study|Adverse Event|0
6076632|NCT00422903|20984663|P2|Overall Study|Disease Progression|1
6076633|NCT00422903|20984664|P1|Overall Study|Disease Progression|3
6076634|NCT00422799|20984713|P1|Overall Study|Adverse Event|7
6076635|NCT00422799|20984713|P1|Overall Study|Withdrawal by Subject|6
6076636|NCT00422734|20984722|P2|Overall Study|Partner Decision|3
6076637|NCT00422734|20984723|P1|Overall Study|Partner Decision|0
6076638|NCT00422734|20984722|P2|Overall Study|Adverse Event|3
6076639|NCT00422734|20984723|P1|Overall Study|Adverse Event|0
6076640|NCT00422734|20984722|P2|Overall Study|Withdrawal by Subject|8
6076641|NCT00422734|20984723|P1|Overall Study|Withdrawal by Subject|12
6076642|NCT00422734|20984722|P2|Overall Study|Protocol Violation|6
6076643|NCT00422734|20984723|P1|Overall Study|Protocol Violation|1
6076644|NCT00422734|20984722|P2|Overall Study|Physician Decision|1
6076645|NCT00422734|20984723|P1|Overall Study|Physician Decision|1
6076646|NCT00422669|20984769|P3|Overall Study|The study was terminated early.|7
6076647|NCT00422669|20984770|P2|Overall Study|The study was terminated early.|100
6076648|NCT00422669|20984771|P1|Overall Study|The study was terminated early.|98
6076649|NCT00422591|20984799|P1|Overall Study|Withdrawal by Subject|2
6076650|NCT00422591|20984799|P1|Overall Study|Physician Decision|4
6076651|NCT00422513|20984807|P2|Overall Study|Death|7
6076652|NCT00422513|20984808|P1|Overall Study|Death|3
6076653|NCT00422513|20984807|P2|Overall Study|Adverse Event|4
6076654|NCT00422513|20984808|P1|Overall Study|Adverse Event|4
6076655|NCT00422513|20984807|P2|Overall Study|early termination of the study|80
6076656|NCT00422513|20984808|P1|Overall Study|early termination of the study|67
6076657|NCT00422513|20984807|P2|Overall Study|Withdrawal by Subject|1
6076658|NCT00422513|20984808|P1|Overall Study|Withdrawal by Subject|2
6076659|NCT00422513|20984807|P2|Overall Study|Refused Treatment|2
6076660|NCT00422513|20984808|P1|Overall Study|Refused Treatment|4
6076661|NCT00422513|20984807|P2|Overall Study|Protocol Violation|7
6076662|NCT00422513|20984808|P1|Overall Study|Protocol Violation|23
6076663|NCT00422513|20984807|P2|Overall Study|Lack of Efficacy|5
6076664|NCT00422513|20984808|P1|Overall Study|Lack of Efficacy|4
6076665|NCT00422422|20984825|P1|Overall Study|AE, non-serious non-fatal|5
6076666|NCT00422422|20984825|P1|Overall Study|SAE, non-fatal|1
6076667|NCT00422422|20984825|P1|Overall Study|Withdrawal by Subject|2
6076668|NCT00422422|20984825|P1|Overall Study|Protocol Violation|1
6076669|NCT00422422|20984825|P1|Overall Study|Lack of Efficacy|1
6076670|NCT00422383|20984842|P5|Overall Study|Withdrawal by Subject|1
6076671|NCT00422383|20984843|P4|Overall Study|Withdrawal by Subject|0
6076672|NCT00422383|20984844|P3|Overall Study|Withdrawal by Subject|0
6076673|NCT00422383|20984845|P2|Overall Study|Withdrawal by Subject|5
6076674|NCT00422383|20984846|P1|Overall Study|Withdrawal by Subject|5
6076675|NCT00422383|20984842|P5|Overall Study|Protocol Violation|0
6076676|NCT00422383|20984843|P4|Overall Study|Protocol Violation|0
6076677|NCT00422383|20984844|P3|Overall Study|Protocol Violation|1
6076678|NCT00422383|20984845|P2|Overall Study|Protocol Violation|1
6076679|NCT00422383|20984846|P1|Overall Study|Protocol Violation|1
6076680|NCT00422383|20984842|P5|Overall Study|Lost to Follow-up|1
6076681|NCT00422383|20984843|P4|Overall Study|Lost to Follow-up|0
6076682|NCT00422383|20984844|P3|Overall Study|Lost to Follow-up|0
6076683|NCT00422383|20984845|P2|Overall Study|Lost to Follow-up|1
6076684|NCT00422383|20984846|P1|Overall Study|Lost to Follow-up|0
6076685|NCT00422383|20984842|P5|Overall Study|Lack of Efficacy|1
6076686|NCT00422383|20984843|P4|Overall Study|Lack of Efficacy|1
6076687|NCT00422383|20984844|P3|Overall Study|Lack of Efficacy|2
6076688|NCT00422383|20984845|P2|Overall Study|Lack of Efficacy|4
6076689|NCT00422383|20984846|P1|Overall Study|Lack of Efficacy|4
6076690|NCT00422383|20984842|P5|Overall Study|Adverse Event|0
6076691|NCT00422383|20984843|P4|Overall Study|Adverse Event|1
6076692|NCT00422383|20984844|P3|Overall Study|Adverse Event|1
6076693|NCT00422383|20984845|P2|Overall Study|Adverse Event|3
6076694|NCT00422383|20984846|P1|Overall Study|Adverse Event|5
6076695|NCT00422292|20984989|P4|Overall Study|Withdrawal by Subject|13
6076696|NCT00422292|20984990|P3|Overall Study|Withdrawal by Subject|7
6076697|NCT00422292|20984991|P2|Overall Study|Withdrawal by Subject|25
6076698|NCT00422292|20984992|P1|Overall Study|Withdrawal by Subject|6
6076699|NCT00422292|20984989|P4|Overall Study|Lost to Follow-up|6
6076700|NCT00422292|20984990|P3|Overall Study|Lost to Follow-up|6
6076701|NCT00422292|20984991|P2|Overall Study|Lost to Follow-up|12
6076702|NCT00422292|20984992|P1|Overall Study|Lost to Follow-up|6
6076703|NCT00422292|20984989|P4|Overall Study|Protocol Violation|5
6076704|NCT00422292|20984990|P3|Overall Study|Protocol Violation|8
6076705|NCT00422292|20984991|P2|Overall Study|Protocol Violation|25
6076706|NCT00422292|20984992|P1|Overall Study|Protocol Violation|4
6076707|NCT00422292|20984989|P4|Overall Study|Adverse Event|0
6076708|NCT00422292|20984990|P3|Overall Study|Adverse Event|1
6076709|NCT00422292|20984991|P2|Overall Study|Adverse Event|0
6076710|NCT00422292|20984992|P1|Overall Study|Adverse Event|1
6076711|NCT00422292|20984989|P4|Overall Study|Serious adverse events|0
6076712|NCT00422292|20984990|P3|Overall Study|Serious adverse events|0
6076713|NCT00422292|20984991|P2|Overall Study|Serious adverse events|4
6076714|NCT00422292|20984992|P1|Overall Study|Serious adverse events|1
6076715|NCT00422227|20985031|P2|Overall Study|Withdrawal by Subject|4
6076716|NCT00422227|20985032|P1|Overall Study|Withdrawal by Subject|0
6076717|NCT00422227|20985031|P2|Overall Study|Lost to Follow-up|3
6076718|NCT00422227|20985032|P1|Overall Study|Lost to Follow-up|1
6076719|NCT00422227|20985031|P2|Overall Study|Adverse Event|8
6076720|NCT00422227|20985032|P1|Overall Study|Adverse Event|3
6076721|NCT00422162|20985063|P2|Overall Study|Didn't Receive Treatment|1
6076722|NCT00422162|20985064|P1|Overall Study|Didn't Receive Treatment|0
6076723|NCT00422162|20985063|P2|Overall Study|Other|1
6076724|NCT00422162|20985064|P1|Overall Study|Other|0
6076725|NCT00422162|20985063|P2|Overall Study|Non-Compliant with Protocol|1
6076726|NCT00422162|20985064|P1|Overall Study|Non-Compliant with Protocol|1
6076727|NCT00422162|20985063|P2|Overall Study|Lost to Follow-up|2
6076728|NCT00422162|20985064|P1|Overall Study|Lost to Follow-up|1
6076729|NCT00422162|20985063|P2|Overall Study|Withdrawal by Subject|6
6076730|NCT00422162|20985064|P1|Overall Study|Withdrawal by Subject|7
6076731|NCT00422162|20985063|P2|Overall Study|Lack of Efficacy|10
6076732|NCT00422162|20985064|P1|Overall Study|Lack of Efficacy|4
6076733|NCT00422162|20985063|P2|Overall Study|Adverse Event|9
6076734|NCT00422162|20985064|P1|Overall Study|Adverse Event|11
6076735|NCT00422097|20985124|P8|Dose Level 2|Still on treatment|0
6076736|NCT00422097|20985125|P7|Dose Level 2|Still on treatment|0
6076737|NCT00422097|20985126|P6|Dose Level 2|Still on treatment|0
6076738|NCT00422097|20985127|P5|Dose Level 2|Still on treatment|0
6076739|NCT00422097|20985128|P4|Dose Level 2|Still on treatment|0
6076740|NCT00422097|20985129|P3|Dose Level 2|Still on treatment|0
6076741|NCT00422097|20985130|P2|Dose Level 2|Still on treatment|1
6076742|NCT00422097|20985131|P1|Dose Level 2|Still on treatment|0
6076743|NCT00422058|20985196|P6|Open-Label Extension, Week 20-104|Other|18
6076744|NCT00422058|20985197|P5|Open-Label Extension, Week 20-104|Other|16
6076745|NCT00422058|20985198|P4|Open-Label Extension, Week 20-104|Other|13
6076746|NCT00422058|20985199|P3|Open-Label Extension, Week 20-104|Other|6
6076747|NCT00422058|20985200|P2|Open-Label Extension, Week 20-104|Other|14
6076748|NCT00422058|20985201|P1|Open-Label Extension, Week 20-104|Other|13
6076749|NCT00422058|20985196|P6|Open-Label Extension, Week 20-104|Lack of Efficacy|1
6076750|NCT00422058|20985197|P5|Open-Label Extension, Week 20-104|Lack of Efficacy|0
6076751|NCT00422058|20985198|P4|Open-Label Extension, Week 20-104|Lack of Efficacy|2
6076752|NCT00422058|20985199|P3|Open-Label Extension, Week 20-104|Lack of Efficacy|5
6076753|NCT00422058|20985200|P2|Open-Label Extension, Week 20-104|Lack of Efficacy|2
6076754|NCT00422058|20985201|P1|Open-Label Extension, Week 20-104|Lack of Efficacy|3
6076755|NCT00422058|20985196|P6|Open-Label Extension, Week 20-104|Protocol Violation|3
6076756|NCT00422058|20985197|P5|Open-Label Extension, Week 20-104|Protocol Violation|5
6076757|NCT00422058|20985198|P4|Open-Label Extension, Week 20-104|Protocol Violation|1
6076758|NCT00422058|20985199|P3|Open-Label Extension, Week 20-104|Protocol Violation|3
6076759|NCT00422058|20985200|P2|Open-Label Extension, Week 20-104|Protocol Violation|2
6076760|NCT00422058|20985201|P1|Open-Label Extension, Week 20-104|Protocol Violation|1
6076761|NCT00422058|20985196|P6|Open-Label Extension, Week 20-104|Adverse Event|0
6076762|NCT00422058|20985197|P5|Open-Label Extension, Week 20-104|Adverse Event|4
6076763|NCT00422058|20985198|P4|Open-Label Extension, Week 20-104|Adverse Event|4
6076764|NCT00422058|20985199|P3|Open-Label Extension, Week 20-104|Adverse Event|7
6076765|NCT00422058|20985200|P2|Open-Label Extension, Week 20-104|Adverse Event|4
6076766|NCT00422058|20985201|P1|Open-Label Extension, Week 20-104|Adverse Event|3
6076767|NCT00422058|20985196|P6|Open-Label Extension, Week 20-104|Not giving consent for extension|12
6076768|NCT00422058|20985197|P5|Open-Label Extension, Week 20-104|Not giving consent for extension|10
6076769|NCT00422058|20985198|P4|Open-Label Extension, Week 20-104|Not giving consent for extension|8
6076770|NCT00422058|20985199|P3|Open-Label Extension, Week 20-104|Not giving consent for extension|15
6076771|NCT00422058|20985200|P2|Open-Label Extension, Week 20-104|Not giving consent for extension|17
6076772|NCT00422058|20985201|P1|Open-Label Extension, Week 20-104|Not giving consent for extension|12
6076773|NCT00422058|20985196|P6|Double-Blind, Week 0-20|Other|10
6076774|NCT00422058|20985197|P5|Double-Blind, Week 0-20|Other|4
6076775|NCT00422058|20985198|P4|Double-Blind, Week 0-20|Other|8
6076776|NCT00422058|20985199|P3|Double-Blind, Week 0-20|Other|8
6076777|NCT00422058|20985200|P2|Double-Blind, Week 0-20|Other|3
6076778|NCT00422058|20985201|P1|Double-Blind, Week 0-20|Other|11
6076779|NCT00422058|20985196|P6|Double-Blind, Week 0-20|Lack of Efficacy|1
6076780|NCT00422058|20985197|P5|Double-Blind, Week 0-20|Lack of Efficacy|0
6076781|NCT00422058|20985198|P4|Double-Blind, Week 0-20|Lack of Efficacy|0
6076782|NCT00422058|20985199|P3|Double-Blind, Week 0-20|Lack of Efficacy|1
6076783|NCT00422058|20985200|P2|Double-Blind, Week 0-20|Lack of Efficacy|1
6076784|NCT00422058|20985201|P1|Double-Blind, Week 0-20|Lack of Efficacy|2
6076785|NCT00422058|20985196|P6|Double-Blind, Week 0-20|Protocol Violation|2
6076786|NCT00422058|20985197|P5|Double-Blind, Week 0-20|Protocol Violation|2
6076787|NCT00422058|20985198|P4|Double-Blind, Week 0-20|Protocol Violation|3
6076788|NCT00422058|20985199|P3|Double-Blind, Week 0-20|Protocol Violation|2
6076789|NCT00422058|20985200|P2|Double-Blind, Week 0-20|Protocol Violation|2
6076790|NCT00422058|20985201|P1|Double-Blind, Week 0-20|Protocol Violation|3
6076791|NCT00422058|20985196|P6|Double-Blind, Week 0-20|Adverse Event|3
6076792|NCT00422058|20985197|P5|Double-Blind, Week 0-20|Adverse Event|5
6076793|NCT00422058|20985198|P4|Double-Blind, Week 0-20|Adverse Event|9
6076794|NCT00422058|20985199|P3|Double-Blind, Week 0-20|Adverse Event|5
6076795|NCT00422058|20985200|P2|Double-Blind, Week 0-20|Adverse Event|4
6076796|NCT00422058|20985201|P1|Double-Blind, Week 0-20|Adverse Event|3
6076825|NCT00421928|20985382|P3|Overall Study|Death|0
6076826|NCT00421928|20985383|P2|Overall Study|Death|1
6076827|NCT00421928|20985384|P1|Overall Study|Death|0
6076828|NCT00421928|20985382|P3|Overall Study|All other|27
6076829|NCT00421928|20985383|P2|Overall Study|All other|21
6076830|NCT00421928|20985384|P1|Overall Study|All other|26
6076831|NCT00421928|20985382|P3|Overall Study|Study drug non-compliant|4
6076832|NCT00421928|20985383|P2|Overall Study|Study drug non-compliant|7
6076833|NCT00421928|20985384|P1|Overall Study|Study drug non-compliant|6
6076834|NCT00421928|20985382|P3|Overall Study|Lack of Efficacy|35
6076835|NCT00421928|20985383|P2|Overall Study|Lack of Efficacy|7
6076836|NCT00421928|20985384|P1|Overall Study|Lack of Efficacy|15
6076837|NCT00421928|20985382|P3|Overall Study|Withdrawal by Subject|43
6076838|NCT00421928|20985383|P2|Overall Study|Withdrawal by Subject|48
6076839|NCT00421928|20985384|P1|Overall Study|Withdrawal by Subject|50
6076840|NCT00421928|20985382|P3|Overall Study|Lost to Follow-up|3
6076841|NCT00421928|20985383|P2|Overall Study|Lost to Follow-up|0
6076842|NCT00421928|20985384|P1|Overall Study|Lost to Follow-up|5
6076843|NCT00421928|20985382|P3|Overall Study|Adverse Event|22
6076844|NCT00421928|20985383|P2|Overall Study|Adverse Event|140
6076845|NCT00421928|20985384|P1|Overall Study|Adverse Event|61
6076846|NCT00421889|20985419|P9|Overall Study|Lost to Follow-up|1
6076847|NCT00421889|20985420|P8|Overall Study|Lost to Follow-up|0
6076848|NCT00421889|20985421|P7|Overall Study|Lost to Follow-up|0
6076849|NCT00421889|20985422|P6|Overall Study|Lost to Follow-up|0
6076850|NCT00421889|20985423|P5|Overall Study|Lost to Follow-up|0
6076851|NCT00421889|20985424|P4|Overall Study|Lost to Follow-up|0
6076852|NCT00421889|20985425|P3|Overall Study|Lost to Follow-up|0
6076853|NCT00421889|20985426|P2|Overall Study|Lost to Follow-up|0
6076854|NCT00421889|20985427|P1|Overall Study|Lost to Follow-up|0
6076855|NCT00421889|20985419|P9|Overall Study|Patient/Investigator request|3
6076856|NCT00421889|20985420|P8|Overall Study|Patient/Investigator request|1
6076857|NCT00421889|20985421|P7|Overall Study|Patient/Investigator request|0
6076858|NCT00421889|20985422|P6|Overall Study|Patient/Investigator request|9
6076859|NCT00421889|20985423|P5|Overall Study|Patient/Investigator request|0
6076860|NCT00421889|20985424|P4|Overall Study|Patient/Investigator request|0
6076861|NCT00421889|20985425|P3|Overall Study|Patient/Investigator request|0
6076862|NCT00421889|20985426|P2|Overall Study|Patient/Investigator request|0
6076863|NCT00421889|20985427|P1|Overall Study|Patient/Investigator request|0
6076864|NCT00421889|20985419|P9|Overall Study|Progressive disease|5
6076865|NCT00421889|20985420|P8|Overall Study|Progressive disease|1
6076866|NCT00421889|20985421|P7|Overall Study|Progressive disease|3
6076867|NCT00421889|20985422|P6|Overall Study|Progressive disease|21
6076868|NCT00421889|20985423|P5|Overall Study|Progressive disease|2
6076869|NCT00421889|20985424|P4|Overall Study|Progressive disease|3
6076870|NCT00421889|20985425|P3|Overall Study|Progressive disease|2
6076871|NCT00421889|20985426|P2|Overall Study|Progressive disease|2
6076872|NCT00421889|20985427|P1|Overall Study|Progressive disease|3
6076873|NCT00421889|20985419|P9|Overall Study|Death|0
6076874|NCT00421889|20985420|P8|Overall Study|Death|0
6076875|NCT00421889|20985421|P7|Overall Study|Death|0
6076876|NCT00421889|20985422|P6|Overall Study|Death|1
6076877|NCT00421889|20985423|P5|Overall Study|Death|1
6076878|NCT00421889|20985424|P4|Overall Study|Death|0
6076879|NCT00421889|20985425|P3|Overall Study|Death|0
6076880|NCT00421889|20985426|P2|Overall Study|Death|0
6076881|NCT00421889|20985427|P1|Overall Study|Death|0
6076882|NCT00421889|20985419|P9|Overall Study|Withdrawal by Subject|0
6076883|NCT00421889|20985420|P8|Overall Study|Withdrawal by Subject|0
6076884|NCT00421889|20985421|P7|Overall Study|Withdrawal by Subject|0
6076885|NCT00421889|20985422|P6|Overall Study|Withdrawal by Subject|0
6076886|NCT00421889|20985423|P5|Overall Study|Withdrawal by Subject|2
6076887|NCT00421889|20985424|P4|Overall Study|Withdrawal by Subject|0
6076888|NCT00421889|20985425|P3|Overall Study|Withdrawal by Subject|0
6076889|NCT00421889|20985426|P2|Overall Study|Withdrawal by Subject|3
6076890|NCT00421889|20985427|P1|Overall Study|Withdrawal by Subject|1
6076891|NCT00421889|20985419|P9|Overall Study|Adverse Event|2
6076892|NCT00421889|20985420|P8|Overall Study|Adverse Event|0
6076893|NCT00421889|20985421|P7|Overall Study|Adverse Event|1
6076894|NCT00421889|20985422|P6|Overall Study|Adverse Event|4
6076895|NCT00421889|20985423|P5|Overall Study|Adverse Event|1
6076896|NCT00421889|20985424|P4|Overall Study|Adverse Event|1
6076897|NCT00421889|20985425|P3|Overall Study|Adverse Event|1
6076898|NCT00421889|20985426|P2|Overall Study|Adverse Event|0
6076899|NCT00421889|20985427|P1|Overall Study|Adverse Event|1
6076900|NCT00421733|20985472|P3|Overall Study|Protocol deviation|2
6076901|NCT00421733|20985473|P2|Overall Study|Protocol deviation|7
6076902|NCT00421733|20985474|P1|Overall Study|Protocol deviation|4
6076903|NCT00421733|20985472|P3|Overall Study|Sponsor request|3
6076904|NCT00421733|20985473|P2|Overall Study|Sponsor request|0
6076905|NCT00421733|20985474|P1|Overall Study|Sponsor request|1
6076906|NCT00421733|20985472|P3|Overall Study|Did not satisfy entry criteria|2
6076907|NCT00421733|20985473|P2|Overall Study|Did not satisfy entry criteria|3
6076908|NCT00421733|20985474|P1|Overall Study|Did not satisfy entry criteria|1
6076909|NCT00421733|20985472|P3|Overall Study|Administrative|0
6076910|NCT00421733|20985473|P2|Overall Study|Administrative|0
6076911|NCT00421733|20985474|P1|Overall Study|Administrative|2
6076912|NCT00421733|20985472|P3|Overall Study|Required dialysis|0
6076913|NCT00421733|20985473|P2|Overall Study|Required dialysis|0
6076914|NCT00421733|20985474|P1|Overall Study|Required dialysis|1
6076915|NCT00421733|20985472|P3|Overall Study|Death|0
6076916|NCT00421733|20985473|P2|Overall Study|Death|3
6076917|NCT00421733|20985474|P1|Overall Study|Death|0
6076918|NCT00421733|20985472|P3|Overall Study|Withdrawal by Subject|7
6076919|NCT00421733|20985473|P2|Overall Study|Withdrawal by Subject|2
6076920|NCT00421733|20985474|P1|Overall Study|Withdrawal by Subject|1
6076921|NCT00421733|20985472|P3|Overall Study|Lost to Follow-up|4
6076922|NCT00421733|20985473|P2|Overall Study|Lost to Follow-up|2
6076923|NCT00421733|20985474|P1|Overall Study|Lost to Follow-up|1
6076924|NCT00421733|20985472|P3|Overall Study|Adverse Event|2
6076925|NCT00421733|20985473|P2|Overall Study|Adverse Event|9
6076926|NCT00421733|20985474|P1|Overall Study|Adverse Event|4
6076927|NCT00421707|20985494|P2|Period 3:Treatment Period 2|Adverse Event|2
6076928|NCT00421707|20985495|P1|Period 3:Treatment Period 2|Adverse Event|0
6076929|NCT00421707|20985494|P2|Period 3:Treatment Period 2|Protocol Violation|0
6076930|NCT00421707|20985495|P1|Period 3:Treatment Period 2|Protocol Violation|1
6076931|NCT00421707|20985494|P2|Period 3:Treatment Period 2|Withdrawal by Subject|1
6076932|NCT00421707|20985495|P1|Period 3:Treatment Period 2|Withdrawal by Subject|1
6076933|NCT00421707|20985494|P2|Period 2: Washout|Other: Pregnancy|1
6076934|NCT00421707|20985495|P1|Period 2: Washout|Other: Pregnancy|0
6076935|NCT00421707|20985494|P2|Period 2: Washout|Lost to Follow-up|1
6076936|NCT00421707|20985495|P1|Period 2: Washout|Lost to Follow-up|0
6076937|NCT00421707|20985494|P2|Period 2: Washout|Withdrawal by Subject|1
6076938|NCT00421707|20985495|P1|Period 2: Washout|Withdrawal by Subject|0
6076939|NCT00421707|20985494|P2|Period 2: Washout|Adverse Event|1
6076940|NCT00421707|20985495|P1|Period 2: Washout|Adverse Event|1
6076941|NCT00421707|20985494|P2|Period 1: Treatment Period 1|Protocol Violation|0
6076942|NCT00421707|20985495|P1|Period 1: Treatment Period 1|Protocol Violation|1
6076943|NCT00421707|20985494|P2|Period 1: Treatment Period 1|Lost to Follow-up|2
6076944|NCT00421707|20985495|P1|Period 1: Treatment Period 1|Lost to Follow-up|2
6076945|NCT00421707|20985494|P2|Period 1: Treatment Period 1|Adverse Event|2
6076946|NCT00421707|20985495|P1|Period 1: Treatment Period 1|Adverse Event|7
6076947|NCT00421707|20985494|P2|Period 1: Treatment Period 1|Withdrawal by Subject|5
6076948|NCT00421707|20985495|P1|Period 1: Treatment Period 1|Withdrawal by Subject|1
6076949|NCT00421408|20985546|P2|Overall Study|Discountinued from treatment/ f/u cont.|25
6076950|NCT00421408|20985547|P1|Overall Study|Discountinued from treatment/ f/u cont.|12
6076951|NCT00421408|20985546|P2|Overall Study|Lost to Follow-up|20
6076952|NCT00421408|20985547|P1|Overall Study|Lost to Follow-up|30
6076953|NCT00421343|20985565|P1|Overall Study|Lost to Follow-up|3
6076954|NCT00421343|20985565|P1|Overall Study|Withdrawal by Subject|2
6076955|NCT00421343|20985565|P1|Overall Study|Death|1
6076956|NCT00421174|20985571|P2|Overall Study|Ineligible due to infection|0
6076957|NCT00421174|20985572|P1|Overall Study|Ineligible due to infection|2
6076958|NCT00421174|20985571|P2|Overall Study|Withdrawal by Subject|1
6076959|NCT00421174|20985572|P1|Overall Study|Withdrawal by Subject|0
6076960|NCT00421148|20985620|P20|Overall Study|Protocol Violation|0
6076961|NCT00421148|20985621|P19|Overall Study|Protocol Violation|1
6076962|NCT00421148|20985622|P18|Overall Study|Protocol Violation|0
6076963|NCT00421148|20985623|P17|Overall Study|Protocol Violation|0
6076964|NCT00421148|20985624|P16|Overall Study|Protocol Violation|0
6076965|NCT00421148|20985625|P15|Overall Study|Protocol Violation|0
6076966|NCT00421148|20985626|P14|Overall Study|Protocol Violation|0
6076967|NCT00421148|20985627|P13|Overall Study|Protocol Violation|0
6076968|NCT00421148|20985628|P12|Overall Study|Protocol Violation|0
6076969|NCT00421148|20985629|P11|Overall Study|Protocol Violation|0
6076970|NCT00421148|20985630|P10|Overall Study|Protocol Violation|0
6076971|NCT00421148|20985631|P9|Overall Study|Protocol Violation|0
6076972|NCT00421148|20985632|P8|Overall Study|Protocol Violation|0
6076973|NCT00421148|20985633|P7|Overall Study|Protocol Violation|0
6076974|NCT00421148|20985634|P6|Overall Study|Protocol Violation|1
6076975|NCT00421148|20985635|P5|Overall Study|Protocol Violation|0
6076976|NCT00421148|20985636|P4|Overall Study|Protocol Violation|0
6076977|NCT00421148|20985637|P3|Overall Study|Protocol Violation|0
6076978|NCT00421148|20985638|P2|Overall Study|Protocol Violation|0
6076979|NCT00421148|20985639|P1|Overall Study|Protocol Violation|0
6076980|NCT00421148|20985620|P20|Overall Study|Withdrawal by Subject|0
6076981|NCT00421148|20985621|P19|Overall Study|Withdrawal by Subject|0
6076982|NCT00421148|20985622|P18|Overall Study|Withdrawal by Subject|1
6076983|NCT00421148|20985623|P17|Overall Study|Withdrawal by Subject|0
6076984|NCT00421148|20985624|P16|Overall Study|Withdrawal by Subject|0
6076985|NCT00421148|20985625|P15|Overall Study|Withdrawal by Subject|0
6076986|NCT00421148|20985626|P14|Overall Study|Withdrawal by Subject|0
6076987|NCT00421148|20985627|P13|Overall Study|Withdrawal by Subject|0
6076988|NCT00421148|20985628|P12|Overall Study|Withdrawal by Subject|0
6076989|NCT00421148|20985629|P11|Overall Study|Withdrawal by Subject|0
6076990|NCT00421148|20985630|P10|Overall Study|Withdrawal by Subject|0
6076991|NCT00421148|20985631|P9|Overall Study|Withdrawal by Subject|0
6076992|NCT00421148|20985632|P8|Overall Study|Withdrawal by Subject|0
6076993|NCT00421148|20985633|P7|Overall Study|Withdrawal by Subject|0
6076994|NCT00421148|20985634|P6|Overall Study|Withdrawal by Subject|0
6076995|NCT00421148|20985635|P5|Overall Study|Withdrawal by Subject|0
6076996|NCT00421148|20985636|P4|Overall Study|Withdrawal by Subject|0
6076997|NCT00421148|20985637|P3|Overall Study|Withdrawal by Subject|0
6076998|NCT00421148|20985638|P2|Overall Study|Withdrawal by Subject|0
6076999|NCT00421148|20985639|P1|Overall Study|Withdrawal by Subject|0
6077000|NCT00421148|20985620|P20|Overall Study|Lost to Follow-up|0
6077001|NCT00421148|20985621|P19|Overall Study|Lost to Follow-up|0
6077002|NCT00421148|20985622|P18|Overall Study|Lost to Follow-up|1
6077003|NCT00421148|20985623|P17|Overall Study|Lost to Follow-up|0
6077004|NCT00421148|20985624|P16|Overall Study|Lost to Follow-up|0
6077005|NCT00421148|20985625|P15|Overall Study|Lost to Follow-up|0
6077006|NCT00421148|20985626|P14|Overall Study|Lost to Follow-up|0
6077007|NCT00421148|20985627|P13|Overall Study|Lost to Follow-up|0
6077008|NCT00421148|20985628|P12|Overall Study|Lost to Follow-up|0
6077009|NCT00421148|20985629|P11|Overall Study|Lost to Follow-up|0
6077010|NCT00421148|20985630|P10|Overall Study|Lost to Follow-up|0
6077011|NCT00421148|20985631|P9|Overall Study|Lost to Follow-up|0
6077012|NCT00421148|20985632|P8|Overall Study|Lost to Follow-up|0
6077013|NCT00421148|20985633|P7|Overall Study|Lost to Follow-up|0
6077014|NCT00421148|20985634|P6|Overall Study|Lost to Follow-up|0
6077015|NCT00421148|20985635|P5|Overall Study|Lost to Follow-up|0
6077016|NCT00421148|20985636|P4|Overall Study|Lost to Follow-up|0
6077017|NCT00421148|20985637|P3|Overall Study|Lost to Follow-up|0
6077018|NCT00421148|20985638|P2|Overall Study|Lost to Follow-up|0
6077019|NCT00421148|20985639|P1|Overall Study|Lost to Follow-up|0
6077020|NCT00420927|20985738|P7|Period 2|Took prohibited medication|0
6077021|NCT00420927|20985739|P6|Period 2|Took prohibited medication|0
6077022|NCT00420927|20985740|P5|Period 2|Took prohibited medication|1
6077023|NCT00420927|20985741|P4|Period 2|Took prohibited medication|0
6077024|NCT00420927|20985742|P3|Period 2|Took prohibited medication|0
6077025|NCT00420927|20985743|P2|Period 2|Took prohibited medication|0
6077026|NCT00420927|20985744|P1|Period 2|Took prohibited medication|0
6077027|NCT00420927|20985738|P7|Period 2|Methotrexate intolerance|1
6077028|NCT00420927|20985739|P6|Period 2|Methotrexate intolerance|0
6077029|NCT00420927|20985740|P5|Period 2|Methotrexate intolerance|0
6077030|NCT00420927|20985741|P4|Period 2|Methotrexate intolerance|0
6077031|NCT00420927|20985742|P3|Period 2|Methotrexate intolerance|0
6077032|NCT00420927|20985743|P2|Period 2|Methotrexate intolerance|0
6077033|NCT00420927|20985744|P1|Period 2|Methotrexate intolerance|0
6077034|NCT00420927|20985738|P7|Period 2|Noncompliant with study drug|2
6077035|NCT00420927|20985739|P6|Period 2|Noncompliant with study drug|0
6077036|NCT00420927|20985740|P5|Period 2|Noncompliant with study drug|0
6077037|NCT00420927|20985741|P4|Period 2|Noncompliant with study drug|1
6077038|NCT00420927|20985742|P3|Period 2|Noncompliant with study drug|0
6077039|NCT00420927|20985743|P2|Period 2|Noncompliant with study drug|0
6077040|NCT00420927|20985744|P1|Period 2|Noncompliant with study drug|0
6077041|NCT00420927|20985738|P7|Period 2|Randomization error|0
6077042|NCT00420927|20985739|P6|Period 2|Randomization error|1
6077043|NCT00420927|20985740|P5|Period 2|Randomization error|1
6077044|NCT00420927|20985741|P4|Period 2|Randomization error|0
6077045|NCT00420927|20985742|P3|Period 2|Randomization error|0
6077046|NCT00420927|20985743|P2|Period 2|Randomization error|0
6077047|NCT00420927|20985744|P1|Period 2|Randomization error|0
6077048|NCT00420927|20985738|P7|Period 2|Sponsor decision|1
6077049|NCT00420927|20985739|P6|Period 2|Sponsor decision|0
6077050|NCT00420927|20985740|P5|Period 2|Sponsor decision|0
6077051|NCT00420927|20985741|P4|Period 2|Sponsor decision|0
6077052|NCT00420927|20985742|P3|Period 2|Sponsor decision|1
6077053|NCT00420927|20985743|P2|Period 2|Sponsor decision|0
6077054|NCT00420927|20985744|P1|Period 2|Sponsor decision|0
6077055|NCT00420927|20985738|P7|Period 2|Physician Decision|0
6077056|NCT00420927|20985739|P6|Period 2|Physician Decision|1
6077057|NCT00420927|20985740|P5|Period 2|Physician Decision|1
6077058|NCT00420927|20985741|P4|Period 2|Physician Decision|0
6077059|NCT00420927|20985742|P3|Period 2|Physician Decision|0
6077060|NCT00420927|20985743|P2|Period 2|Physician Decision|0
6077061|NCT00420927|20985744|P1|Period 2|Physician Decision|0
6077062|NCT00420927|20985738|P7|Period 2|Subject unable to find transportation|1
6077063|NCT00420927|20985739|P6|Period 2|Subject unable to find transportation|0
6077064|NCT00420927|20985740|P5|Period 2|Subject unable to find transportation|0
6077065|NCT00420927|20985741|P4|Period 2|Subject unable to find transportation|0
6077066|NCT00420927|20985742|P3|Period 2|Subject unable to find transportation|0
6077067|NCT00420927|20985743|P2|Period 2|Subject unable to find transportation|0
6077068|NCT00420927|20985744|P1|Period 2|Subject unable to find transportation|0
6077069|NCT00420927|20985738|P7|Period 2|Received wrong treatment/incorrect dose|1
6077070|NCT00420927|20985739|P6|Period 2|Received wrong treatment/incorrect dose|0
6077071|NCT00420927|20985740|P5|Period 2|Received wrong treatment/incorrect dose|0
6077072|NCT00420927|20985741|P4|Period 2|Received wrong treatment/incorrect dose|0
6077073|NCT00420927|20985742|P3|Period 2|Received wrong treatment/incorrect dose|0
6077074|NCT00420927|20985743|P2|Period 2|Received wrong treatment/incorrect dose|0
6077075|NCT00420927|20985744|P1|Period 2|Received wrong treatment/incorrect dose|0
6077076|NCT00420927|20985738|P7|Period 2|Lack of efficacy/Loss of efficacy|6
6077077|NCT00420927|20985739|P6|Period 2|Lack of efficacy/Loss of efficacy|2
6077078|NCT00420927|20985740|P5|Period 2|Lack of efficacy/Loss of efficacy|6
6077079|NCT00420927|20985741|P4|Period 2|Lack of efficacy/Loss of efficacy|1
6077080|NCT00420927|20985742|P3|Period 2|Lack of efficacy/Loss of efficacy|2
6077081|NCT00420927|20985743|P2|Period 2|Lack of efficacy/Loss of efficacy|0
6077082|NCT00420927|20985744|P1|Period 2|Lack of efficacy/Loss of efficacy|0
6077083|NCT00420927|20985738|P7|Period 2|Lost to Follow-up|9
6077084|NCT00420927|20985739|P6|Period 2|Lost to Follow-up|3
6077085|NCT00420927|20985740|P5|Period 2|Lost to Follow-up|6
6077086|NCT00420927|20985741|P4|Period 2|Lost to Follow-up|2
6077087|NCT00420927|20985742|P3|Period 2|Lost to Follow-up|2
6077088|NCT00420927|20985743|P2|Period 2|Lost to Follow-up|0
6077089|NCT00420927|20985744|P1|Period 2|Lost to Follow-up|0
6077090|NCT00420927|20985738|P7|Period 2|Withdrawal by Subject|12
6077091|NCT00420927|20985739|P6|Period 2|Withdrawal by Subject|2
6077092|NCT00420927|20985740|P5|Period 2|Withdrawal by Subject|11
6077093|NCT00420927|20985741|P4|Period 2|Withdrawal by Subject|3
6077094|NCT00420927|20985742|P3|Period 2|Withdrawal by Subject|1
6077095|NCT00420927|20985743|P2|Period 2|Withdrawal by Subject|0
6077096|NCT00420927|20985744|P1|Period 2|Withdrawal by Subject|0
6077097|NCT00420927|20985738|P7|Period 2|Adverse Event|20
6077098|NCT00420927|20985739|P6|Period 2|Adverse Event|6
6077099|NCT00420927|20985740|P5|Period 2|Adverse Event|17
6077100|NCT00420927|20985741|P4|Period 2|Adverse Event|3
6077101|NCT00420927|20985742|P3|Period 2|Adverse Event|7
6077102|NCT00420927|20985743|P2|Period 2|Adverse Event|0
6077103|NCT00420927|20985744|P1|Period 2|Adverse Event|0
6077104|NCT00420927|20985738|P7|Period 1|Took prohibited medication|0
6077105|NCT00420927|20985739|P6|Period 1|Took prohibited medication|0
6077106|NCT00420927|20985740|P5|Period 1|Took prohibited medication|0
6077107|NCT00420927|20985741|P4|Period 1|Took prohibited medication|0
6077108|NCT00420927|20985742|P3|Period 1|Took prohibited medication|0
6077109|NCT00420927|20985743|P2|Period 1|Took prohibited medication|3
6077110|NCT00420927|20985744|P1|Period 1|Took prohibited medication|1
6077111|NCT00420927|20985738|P7|Period 1|Failed to meet entry criteria|0
6077112|NCT00420927|20985739|P6|Period 1|Failed to meet entry criteria|0
6077113|NCT00420927|20985740|P5|Period 1|Failed to meet entry criteria|0
6077114|NCT00420927|20985741|P4|Period 1|Failed to meet entry criteria|0
6077115|NCT00420927|20985742|P3|Period 1|Failed to meet entry criteria|0
6077116|NCT00420927|20985743|P2|Period 1|Failed to meet entry criteria|7
6077117|NCT00420927|20985744|P1|Period 1|Failed to meet entry criteria|8
6077118|NCT00420927|20985738|P7|Period 1|Received wrong treatment/incorrect dose|0
6077119|NCT00420927|20985739|P6|Period 1|Received wrong treatment/incorrect dose|0
6077120|NCT00420927|20985740|P5|Period 1|Received wrong treatment/incorrect dose|0
6077121|NCT00420927|20985741|P4|Period 1|Received wrong treatment/incorrect dose|0
6077122|NCT00420927|20985742|P3|Period 1|Received wrong treatment/incorrect dose|0
6077123|NCT00420927|20985743|P2|Period 1|Received wrong treatment/incorrect dose|1
6077124|NCT00420927|20985744|P1|Period 1|Received wrong treatment/incorrect dose|0
6077125|NCT00420927|20985738|P7|Period 1|Subject received new diagnosis|0
6077126|NCT00420927|20985739|P6|Period 1|Subject received new diagnosis|0
6077127|NCT00420927|20985740|P5|Period 1|Subject received new diagnosis|0
6077128|NCT00420927|20985741|P4|Period 1|Subject received new diagnosis|0
6077129|NCT00420927|20985742|P3|Period 1|Subject received new diagnosis|0
6077130|NCT00420927|20985743|P2|Period 1|Subject received new diagnosis|2
6077131|NCT00420927|20985744|P1|Period 1|Subject received new diagnosis|0
6077132|NCT00420927|20985738|P7|Period 1|Study site closure|0
6077133|NCT00420927|20985739|P6|Period 1|Study site closure|0
6077134|NCT00420927|20985740|P5|Period 1|Study site closure|0
6077135|NCT00420927|20985741|P4|Period 1|Study site closure|0
6077136|NCT00420927|20985742|P3|Period 1|Study site closure|0
6077137|NCT00420927|20985743|P2|Period 1|Study site closure|1
6077138|NCT00420927|20985744|P1|Period 1|Study site closure|0
6077139|NCT00420927|20985738|P7|Period 1|Suspected tuberculosis/positive test|0
6077140|NCT00420927|20985739|P6|Period 1|Suspected tuberculosis/positive test|0
6077141|NCT00420927|20985740|P5|Period 1|Suspected tuberculosis/positive test|0
6077142|NCT00420927|20985741|P4|Period 1|Suspected tuberculosis/positive test|0
6077143|NCT00420927|20985742|P3|Period 1|Suspected tuberculosis/positive test|0
6077144|NCT00420927|20985743|P2|Period 1|Suspected tuberculosis/positive test|1
6077145|NCT00420927|20985744|P1|Period 1|Suspected tuberculosis/positive test|1
6077146|NCT00420927|20985738|P7|Period 1|Randomization error|0
6077147|NCT00420927|20985739|P6|Period 1|Randomization error|0
6077148|NCT00420927|20985740|P5|Period 1|Randomization error|0
6077149|NCT00420927|20985741|P4|Period 1|Randomization error|0
6077150|NCT00420927|20985742|P3|Period 1|Randomization error|0
6077151|NCT00420927|20985743|P2|Period 1|Randomization error|0
6077152|NCT00420927|20985744|P1|Period 1|Randomization error|1
6077153|NCT00420927|20985738|P7|Period 1|Noncompliant with study drug|0
6077154|NCT00420927|20985739|P6|Period 1|Noncompliant with study drug|0
6077155|NCT00420927|20985740|P5|Period 1|Noncompliant with study drug|0
6077156|NCT00420927|20985741|P4|Period 1|Noncompliant with study drug|0
6077157|NCT00420927|20985742|P3|Period 1|Noncompliant with study drug|0
6077158|NCT00420927|20985743|P2|Period 1|Noncompliant with study drug|1
6077159|NCT00420927|20985744|P1|Period 1|Noncompliant with study drug|1
6077160|NCT00420927|20985738|P7|Period 1|Subject moved/relocated|0
6077161|NCT00420927|20985739|P6|Period 1|Subject moved/relocated|0
6077162|NCT00420927|20985740|P5|Period 1|Subject moved/relocated|0
6077163|NCT00420927|20985741|P4|Period 1|Subject moved/relocated|0
6077164|NCT00420927|20985742|P3|Period 1|Subject moved/relocated|0
6077165|NCT00420927|20985743|P2|Period 1|Subject moved/relocated|2
6077166|NCT00420927|20985744|P1|Period 1|Subject moved/relocated|0
6077167|NCT00420927|20985738|P7|Period 1|Death|0
6077168|NCT00420927|20985739|P6|Period 1|Death|0
6077169|NCT00420927|20985740|P5|Period 1|Death|0
6077170|NCT00420927|20985741|P4|Period 1|Death|0
6077171|NCT00420927|20985742|P3|Period 1|Death|0
6077172|NCT00420927|20985743|P2|Period 1|Death|0
6077173|NCT00420927|20985744|P1|Period 1|Death|2
6077174|NCT00420927|20985738|P7|Period 1|Lack of efficacy/Loss of efficacy|0
6077175|NCT00420927|20985739|P6|Period 1|Lack of efficacy/Loss of efficacy|0
6077176|NCT00420927|20985740|P5|Period 1|Lack of efficacy/Loss of efficacy|0
6077177|NCT00420927|20985741|P4|Period 1|Lack of efficacy/Loss of efficacy|0
6077178|NCT00420927|20985742|P3|Period 1|Lack of efficacy/Loss of efficacy|0
6077179|NCT00420927|20985743|P2|Period 1|Lack of efficacy/Loss of efficacy|6
6077180|NCT00420927|20985744|P1|Period 1|Lack of efficacy/Loss of efficacy|1
6077181|NCT00420927|20985738|P7|Period 1|Lost to Follow-up|0
6077182|NCT00420927|20985739|P6|Period 1|Lost to Follow-up|0
6077183|NCT00420927|20985740|P5|Period 1|Lost to Follow-up|0
6077184|NCT00420927|20985741|P4|Period 1|Lost to Follow-up|0
6077185|NCT00420927|20985742|P3|Period 1|Lost to Follow-up|0
6077186|NCT00420927|20985743|P2|Period 1|Lost to Follow-up|6
6077187|NCT00420927|20985744|P1|Period 1|Lost to Follow-up|8
6077188|NCT00420927|20985738|P7|Period 1|Withdrawal by Subject|0
6077189|NCT00420927|20985739|P6|Period 1|Withdrawal by Subject|0
6077190|NCT00420927|20985740|P5|Period 1|Withdrawal by Subject|0
6077191|NCT00420927|20985741|P4|Period 1|Withdrawal by Subject|0
6077192|NCT00420927|20985742|P3|Period 1|Withdrawal by Subject|0
6077193|NCT00420927|20985743|P2|Period 1|Withdrawal by Subject|12
6077194|NCT00420927|20985744|P1|Period 1|Withdrawal by Subject|7
6077195|NCT00420927|20985738|P7|Period 1|Adverse Event|0
6077196|NCT00420927|20985739|P6|Period 1|Adverse Event|0
6077197|NCT00420927|20985740|P5|Period 1|Adverse Event|0
6077198|NCT00420927|20985741|P4|Period 1|Adverse Event|0
6077199|NCT00420927|20985742|P3|Period 1|Adverse Event|0
6077200|NCT00420927|20985743|P2|Period 1|Adverse Event|15
6077201|NCT00420927|20985744|P1|Period 1|Adverse Event|19
6077202|NCT00420849|20985848|P1|Overall Study|Lost to Follow-up|1
6077203|NCT00420849|20985848|P1|Overall Study|Protocol Violation|1
6077204|NCT00420849|20985848|P1|Overall Study|Transplant|8
6077205|NCT00420849|20985848|P1|Overall Study|Other|14
6077206|NCT00420849|20985848|P1|Overall Study|Death|18
6077207|NCT00420849|20985848|P1|Overall Study|Withdrawal by Subject|28
6077208|NCT00420849|20985848|P1|Overall Study|Adverse Event|107
6077209|NCT00420849|20985848|P1|Overall Study|Lack of Efficacy|154
6077210|NCT00420784|20985917|P4|Overall Study|Other|5
6077211|NCT00420784|20985918|P3|Overall Study|Other|0
6077212|NCT00420784|20985919|P2|Overall Study|Other|2
6077213|NCT00420784|20985920|P1|Overall Study|Other|1
6077214|NCT00420784|20985917|P4|Overall Study|Virologic Stopping Rule|67
6077215|NCT00420784|20985918|P3|Overall Study|Virologic Stopping Rule|41
6077216|NCT00420784|20985919|P2|Overall Study|Virologic Stopping Rule|26
6077217|NCT00420784|20985920|P1|Overall Study|Virologic Stopping Rule|17
6077218|NCT00420784|20985917|P4|Overall Study|Lost to Follow-up|1
6077219|NCT00420784|20985918|P3|Overall Study|Lost to Follow-up|2
6077220|NCT00420784|20985919|P2|Overall Study|Lost to Follow-up|0
6077221|NCT00420784|20985920|P1|Overall Study|Lost to Follow-up|0
6077222|NCT00420784|20985917|P4|Overall Study|Withdrawal by Subject|0
6077223|NCT00420784|20985918|P3|Overall Study|Withdrawal by Subject|0
6077224|NCT00420784|20985919|P2|Overall Study|Withdrawal by Subject|1
6077225|NCT00420784|20985920|P1|Overall Study|Withdrawal by Subject|0
6077226|NCT00420784|20985917|P4|Overall Study|Adverse Event|5
6077227|NCT00420784|20985918|P3|Overall Study|Adverse Event|10
6077228|NCT00420784|20985919|P2|Overall Study|Adverse Event|29
6077229|NCT00420784|20985920|P1|Overall Study|Adverse Event|11
6077230|NCT00420745|20985958|P2|Overall Study|Age limit exceeded for Dose 2|0
6077231|NCT00420745|20985959|P1|Overall Study|Age limit exceeded for Dose 2|1
6077232|NCT00420745|20985958|P2|Overall Study|Recurrent pneumonia & bronchitis|1
6077233|NCT00420745|20985959|P1|Overall Study|Recurrent pneumonia & bronchitis|0
6077234|NCT00420745|20985958|P2|Overall Study|Physician Decision|1
6077235|NCT00420745|20985959|P1|Overall Study|Physician Decision|1
6077236|NCT00420745|20985958|P2|Overall Study|Protocol Violation|0
6077237|NCT00420745|20985959|P1|Overall Study|Protocol Violation|1
6077238|NCT00420745|20985958|P2|Overall Study|Lost to Follow-up|2
6077239|NCT00420745|20985959|P1|Overall Study|Lost to Follow-up|10
6077240|NCT00420745|20985958|P2|Overall Study|Adverse Event|2
6077241|NCT00420745|20985959|P1|Overall Study|Adverse Event|2
6077242|NCT00420641|20985978|P3|Overall Study|Other|3
6077243|NCT00420641|20985979|P2|Overall Study|Other|4
6077244|NCT00420641|20985980|P1|Overall Study|Other|4
6077245|NCT00420641|20985978|P3|Overall Study|Non-compliance|4
6077246|NCT00420641|20985979|P2|Overall Study|Non-compliance|5
6077247|NCT00420641|20985980|P1|Overall Study|Non-compliance|7
6077248|NCT00420641|20985978|P3|Overall Study|Lack of Efficacy|4
6077249|NCT00420641|20985979|P2|Overall Study|Lack of Efficacy|5
6077250|NCT00420641|20985980|P1|Overall Study|Lack of Efficacy|6
6077251|NCT00420641|20985978|P3|Overall Study|Withdrawal by Subject|14
6077252|NCT00420641|20985979|P2|Overall Study|Withdrawal by Subject|21
6077253|NCT00420641|20985980|P1|Overall Study|Withdrawal by Subject|15
6077254|NCT00420641|20985978|P3|Overall Study|Protocol Violation|7
6077255|NCT00420641|20985979|P2|Overall Study|Protocol Violation|8
6077256|NCT00420641|20985980|P1|Overall Study|Protocol Violation|8
6077257|NCT00420641|20985978|P3|Overall Study|Lost to Follow-up|2
6077258|NCT00420641|20985979|P2|Overall Study|Lost to Follow-up|4
6077259|NCT00420641|20985980|P1|Overall Study|Lost to Follow-up|2
6077260|NCT00420641|20985978|P3|Overall Study|Adverse Event|10
6077261|NCT00420641|20985979|P2|Overall Study|Adverse Event|25
6077262|NCT00420641|20985980|P1|Overall Study|Adverse Event|3
6077263|NCT00420628|20986056|P2|Overall Study|Adverse Event|0
6077264|NCT00420628|20986057|P1|Overall Study|Adverse Event|1
6077265|NCT00420628|20986056|P2|Overall Study|Lost to Follow-up|2
6077266|NCT00420628|20986057|P1|Overall Study|Lost to Follow-up|3
6077267|NCT00420628|20986056|P2|Overall Study|Withdrawn by parent or gaurdian|2
6077268|NCT00420628|20986057|P1|Overall Study|Withdrawn by parent or gaurdian|5
6077269|NCT00420511|20986073|P2|Overall Study|Lost to Follow-up|0
6077270|NCT00420511|20986074|P1|Overall Study|Lost to Follow-up|1
6077271|NCT00420511|20986073|P2|Overall Study|Adverse Event|1
6077272|NCT00420511|20986074|P1|Overall Study|Adverse Event|1
6077273|NCT00420420|20986095|P2|Overall Study|sponsor decision (abnormal ECG @ screen)|0
6077274|NCT00420420|20986096|P1|Overall Study|sponsor decision (abnormal ECG @ screen)|1
6077275|NCT00420420|20986095|P2|Overall Study|Withdrawal by Subject|0
6077276|NCT00420420|20986096|P1|Overall Study|Withdrawal by Subject|1
6077277|NCT00420420|20986095|P2|Overall Study|Protocol Violation|1
6077278|NCT00420420|20986096|P1|Overall Study|Protocol Violation|1
6077279|NCT00420420|20986095|P2|Overall Study|Adverse Event|3
6077280|NCT00420420|20986096|P1|Overall Study|Adverse Event|5
6077281|NCT00420407|20986114|P2|Overall Study|Withdrawal by Subject|2
6077282|NCT00420407|20986115|P1|Overall Study|Withdrawal by Subject|0
6077283|NCT00420407|20986114|P2|Overall Study|subject identified as Jehovah's witness|0
6077284|NCT00420407|20986115|P1|Overall Study|subject identified as Jehovah's witness|1
6077285|NCT00420407|20986114|P2|Overall Study|subject identified as detainee|0
6077286|NCT00420407|20986115|P1|Overall Study|subject identified as detainee|1
6077287|NCT00420407|20986114|P2|Overall Study|Physician Decision|1
6077288|NCT00420407|20986115|P1|Overall Study|Physician Decision|2
6077289|NCT00420407|20986114|P2|Overall Study|Lost to Follow-up|3
6077290|NCT00420407|20986115|P1|Overall Study|Lost to Follow-up|0
6077291|NCT00420381|20986122|P1|Overall Study|Protocol Violation|1
6077292|NCT00420342|20986134|P3|Overall Study|Withdrawal by Subject|0
6077293|NCT00420342|20986135|P2|Overall Study|Withdrawal by Subject|2
6077294|NCT00420342|20986136|P1|Overall Study|Withdrawal by Subject|0
6077295|NCT00420342|20986134|P3|Overall Study|Lost to Follow-up|1
6077296|NCT00420342|20986135|P2|Overall Study|Lost to Follow-up|0
6077297|NCT00420342|20986136|P1|Overall Study|Lost to Follow-up|1
6077298|NCT00420316|20986179|P2|Overall Study|Lost to Follow-up|8
6077299|NCT00420316|20986180|P1|Overall Study|Lost to Follow-up|12
6077300|NCT00420316|20986179|P2|Overall Study|Withdrawal by Subject|1
6077301|NCT00420316|20986180|P1|Overall Study|Withdrawal by Subject|0
6077302|NCT00420303|20986204|P2|Overall Study|Physician Decision|1
6077303|NCT00420303|20986205|P1|Overall Study|Physician Decision|0
6077304|NCT00420303|20986204|P2|Overall Study|Lack of Efficacy|3
6077305|NCT00420303|20986205|P1|Overall Study|Lack of Efficacy|0
6077306|NCT00420303|20986204|P2|Overall Study|Serious Adverse Event|0
6077307|NCT00420303|20986205|P1|Overall Study|Serious Adverse Event|1
6077308|NCT00420290|20986217|P2|Overall Study|did not meet inclusion/exclusion|1
6077309|NCT00420290|20986218|P1|Overall Study|did not meet inclusion/exclusion|1
6077310|NCT00420290|20986217|P2|Overall Study|Withdrawal by Subject|2
6077311|NCT00420290|20986218|P1|Overall Study|Withdrawal by Subject|0
6077312|NCT00420290|20986217|P2|Overall Study|Adverse Event|1
6077313|NCT00420290|20986218|P1|Overall Study|Adverse Event|3
6077314|NCT00420238|20986234|P2|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1
6077315|NCT00420238|20986235|P1|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1
6077316|NCT00420238|20986234|P2|12 Week Open-Label Treatment Period 2|Lost to Follow-up|0
6077317|NCT00420238|20986235|P1|12 Week Open-Label Treatment Period 2|Lost to Follow-up|1
6077318|NCT00420238|20986234|P2|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|1
6077319|NCT00420238|20986235|P1|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|0
6077320|NCT00420238|20986234|P2|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|1
6077321|NCT00420238|20986235|P1|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|0
6077322|NCT00420238|20986234|P2|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|2
6077323|NCT00420238|20986235|P1|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|0
6077324|NCT00420238|20986234|P2|12 Week Double-Blind Treatment Period 1|Adverse Event|0
6077325|NCT00420238|20986235|P1|12 Week Double-Blind Treatment Period 1|Adverse Event|1
6077326|NCT00420212|20986374|P3|Overall Study|Other-Unspecified|18
6077327|NCT00420212|20986375|P2|Overall Study|Other-Unspecified|14
6077328|NCT00420212|20986376|P1|Overall Study|Other-Unspecified|21
6077329|NCT00420212|20986374|P3|Overall Study|Death|1
6077330|NCT00420212|20986375|P2|Overall Study|Death|0
6077331|NCT00420212|20986376|P1|Overall Study|Death|0
6077332|NCT00420212|20986374|P3|Overall Study|Protocol Violation|8
6077333|NCT00420212|20986375|P2|Overall Study|Protocol Violation|4
6077334|NCT00420212|20986376|P1|Overall Study|Protocol Violation|4
6077335|NCT00420212|20986374|P3|Overall Study|Physician Decision|3
6077336|NCT00420212|20986375|P2|Overall Study|Physician Decision|4
6077337|NCT00420212|20986376|P1|Overall Study|Physician Decision|4
6077338|NCT00420212|20986374|P3|Overall Study|Withdrawal by Subject|19
6077339|NCT00420212|20986375|P2|Overall Study|Withdrawal by Subject|22
6077340|NCT00420212|20986376|P1|Overall Study|Withdrawal by Subject|31
6077341|NCT00420212|20986374|P3|Overall Study|Lost to Follow-up|11
6077342|NCT00420212|20986375|P2|Overall Study|Lost to Follow-up|11
6077343|NCT00420212|20986376|P1|Overall Study|Lost to Follow-up|9
6077344|NCT00420212|20986374|P3|Overall Study|Adverse Event|36
6077345|NCT00420212|20986375|P2|Overall Study|Adverse Event|40
6077346|NCT00420212|20986376|P1|Overall Study|Adverse Event|22
6077347|NCT00420199|20986402|P2|Overall Study|Participant no longer met study criteria|0
6077348|NCT00420199|20986403|P1|Overall Study|Participant no longer met study criteria|1
6077349|NCT00420095|20986469|P2|Overall Study|Lost to Follow-up|0
6077350|NCT00420095|20986470|P1|Overall Study|Lost to Follow-up|1
6077351|NCT00420095|20986469|P2|Overall Study|Protocol Violation|1
6077352|NCT00420095|20986470|P1|Overall Study|Protocol Violation|1
6077353|NCT00420095|20986469|P2|Overall Study|Adverse Event|0
6077354|NCT00420095|20986470|P1|Overall Study|Adverse Event|1
6077355|NCT00420056|20986488|P1|Overall Study|Objective progression or relapse|17
6077356|NCT00420004|20986528|P3|Overall Study|Sponsor Decision|1
6077357|NCT00420004|20986529|P2|Overall Study|Sponsor Decision|3
6077358|NCT00420004|20986530|P1|Overall Study|Sponsor Decision|3
6077359|NCT00420004|20986528|P3|Overall Study|Withdrawal by Subject|14
6077360|NCT00420004|20986529|P2|Overall Study|Withdrawal by Subject|42
6077361|NCT00420004|20986530|P1|Overall Study|Withdrawal by Subject|67
6077362|NCT00420004|20986528|P3|Overall Study|Protocol Violation|3
6077363|NCT00420004|20986529|P2|Overall Study|Protocol Violation|4
6077364|NCT00420004|20986530|P1|Overall Study|Protocol Violation|5
6077365|NCT00420004|20986528|P3|Overall Study|Physician Decision|2
6077366|NCT00420004|20986529|P2|Overall Study|Physician Decision|4
6077367|NCT00420004|20986530|P1|Overall Study|Physician Decision|14
6077368|NCT00420004|20986528|P3|Overall Study|Entry Criteria Not Met|0
6077369|NCT00420004|20986529|P2|Overall Study|Entry Criteria Not Met|1
6077370|NCT00420004|20986530|P1|Overall Study|Entry Criteria Not Met|0
6077371|NCT00420004|20986528|P3|Overall Study|Lost to Follow-up|10
6077372|NCT00420004|20986529|P2|Overall Study|Lost to Follow-up|12
6077373|NCT00420004|20986530|P1|Overall Study|Lost to Follow-up|31
6077374|NCT00420004|20986528|P3|Overall Study|Lack of Efficacy|1
6077375|NCT00420004|20986529|P2|Overall Study|Lack of Efficacy|4
6077376|NCT00420004|20986530|P1|Overall Study|Lack of Efficacy|5
6077377|NCT00420004|20986528|P3|Overall Study|Adverse Event|1
6077378|NCT00420004|20986529|P2|Overall Study|Adverse Event|1
6077379|NCT00420004|20986530|P1|Overall Study|Adverse Event|4
6077380|NCT00419952|20986595|P2|Overall Study|Abnormal ECG|0
6077381|NCT00419952|20986596|P1|Overall Study|Abnormal ECG|1
6077382|NCT00419952|20986595|P2|Overall Study|Diary or medication non-compliance|4
6077383|NCT00419952|20986596|P1|Overall Study|Diary or medication non-compliance|2
6077384|NCT00419952|20986595|P2|Overall Study|Occurence of 2 or more exacerbations|0
6077385|NCT00419952|20986596|P1|Overall Study|Occurence of 2 or more exacerbations|2
6077386|NCT00419952|20986595|P2|Overall Study|Intake of prohibited medication|2
6077387|NCT00419952|20986596|P1|Overall Study|Intake of prohibited medication|2
6077388|NCT00419952|20986595|P2|Overall Study|Incorrectly enrolled|3
6077389|NCT00419952|20986596|P1|Overall Study|Incorrectly enrolled|10
6077390|NCT00419952|20986595|P2|Overall Study|Physician Decision|3
6077391|NCT00419952|20986596|P1|Overall Study|Physician Decision|1
6077392|NCT00419952|20986595|P2|Overall Study|Pregnancy|2
6077393|NCT00419952|20986596|P1|Overall Study|Pregnancy|4
6077394|NCT00419952|20986595|P2|Overall Study|Protocol Violation|24
6077395|NCT00419952|20986596|P1|Overall Study|Protocol Violation|32
6077396|NCT00419952|20986595|P2|Overall Study|Lost to Follow-up|34
6077397|NCT00419952|20986596|P1|Overall Study|Lost to Follow-up|43
6077398|NCT00419952|20986595|P2|Overall Study|Withdrawal by Subject|43
6077399|NCT00419952|20986596|P1|Overall Study|Withdrawal by Subject|44
6077400|NCT00419952|20986595|P2|Overall Study|Adverse Event|10
6077401|NCT00419952|20986596|P1|Overall Study|Adverse Event|8
6077402|NCT00419926|20986630|P2|Overall Study|Death|1
6077403|NCT00419926|20986631|P1|Overall Study|Death|2
6077404|NCT00419926|20986630|P2|Overall Study|Lost to Follow-up|2
6077405|NCT00419926|20986631|P1|Overall Study|Lost to Follow-up|1
6077406|NCT00419926|20986630|P2|Overall Study|Administrative Problem|4
6077407|NCT00419926|20986631|P1|Overall Study|Administrative Problem|4
6077408|NCT00419926|20986630|P2|Overall Study|Withdrawal by Subject|3
6077409|NCT00419926|20986631|P1|Overall Study|Withdrawal by Subject|7
6077410|NCT00419770|20986647|P2|Overall Study|Withdrawal by Subject|1
6077411|NCT00419770|20986648|P1|Overall Study|Withdrawal by Subject|5
6077412|NCT00419757|20986656|P2|Overall Study|Multiple reasons|1
6077413|NCT00419757|20986657|P1|Overall Study|Multiple reasons|3
6077414|NCT00419757|20986656|P2|Overall Study|Study specific discontinuation criteria|8
6077415|NCT00419757|20986657|P1|Overall Study|Study specific discontinuation criteria|4
6077416|NCT00419757|20986656|P2|Overall Study|Protocol Violation|3
6077417|NCT00419757|20986657|P1|Overall Study|Protocol Violation|2
6077418|NCT00419757|20986656|P2|Overall Study|Withdrawal by Subject|1
6077419|NCT00419757|20986657|P1|Overall Study|Withdrawal by Subject|7
6077420|NCT00419757|20986656|P2|Overall Study|Lost to Follow-up|4
6077421|NCT00419757|20986657|P1|Overall Study|Lost to Follow-up|1
6077422|NCT00419757|20986656|P2|Overall Study|Adverse Event|4
6077423|NCT00419757|20986657|P1|Overall Study|Adverse Event|1
6077424|NCT00419744|20986696|P3|Overall Study|Incorrect medication kit dispensed|1
6077425|NCT00419744|20986697|P2|Overall Study|Incorrect medication kit dispensed|0
6077426|NCT00419744|20986698|P1|Overall Study|Incorrect medication kit dispensed|0
6077427|NCT00419744|20986696|P3|Overall Study|Spirometry mouthpiece issues|2
6077428|NCT00419744|20986697|P2|Overall Study|Spirometry mouthpiece issues|1
6077429|NCT00419744|20986698|P1|Overall Study|Spirometry mouthpiece issues|0
6077430|NCT00419744|20986696|P3|Overall Study|Physician Decision|6
6077431|NCT00419744|20986697|P2|Overall Study|Physician Decision|5
6077432|NCT00419744|20986698|P1|Overall Study|Physician Decision|10
6077433|NCT00419744|20986696|P3|Overall Study|Moving out of state|1
6077434|NCT00419744|20986697|P2|Overall Study|Moving out of state|0
6077435|NCT00419744|20986698|P1|Overall Study|Moving out of state|2
6077436|NCT00419744|20986696|P3|Overall Study|Randomized in error|7
6077437|NCT00419744|20986697|P2|Overall Study|Randomized in error|6
6077438|NCT00419744|20986698|P1|Overall Study|Randomized in error|9
6077439|NCT00419744|20986696|P3|Overall Study|Protocol Violation|8
6077440|NCT00419744|20986697|P2|Overall Study|Protocol Violation|7
6077441|NCT00419744|20986698|P1|Overall Study|Protocol Violation|4
6077442|NCT00419744|20986696|P3|Overall Study|Lost to Follow-up|6
6077443|NCT00419744|20986697|P2|Overall Study|Lost to Follow-up|10
6077444|NCT00419744|20986698|P1|Overall Study|Lost to Follow-up|8
6077445|NCT00419744|20986696|P3|Overall Study|Withdrawal by Subject|52
6077446|NCT00419744|20986697|P2|Overall Study|Withdrawal by Subject|49
6077447|NCT00419744|20986698|P1|Overall Study|Withdrawal by Subject|45
6077448|NCT00419744|20986696|P3|Overall Study|Adverse Event|50
6077449|NCT00419744|20986697|P2|Overall Study|Adverse Event|40
6077450|NCT00419744|20986698|P1|Overall Study|Adverse Event|39
6077451|NCT00419562|20986741|P2|Overall Study|Participant Institutionalized|0
6077452|NCT00419562|20986742|P1|Overall Study|Participant Institutionalized|1
6077453|NCT00419562|20986741|P2|Overall Study|Withdrawal by Subject|18
6077454|NCT00419562|20986742|P1|Overall Study|Withdrawal by Subject|20
6077455|NCT00419562|20986741|P2|Overall Study|Lost to Follow-up|13
6077456|NCT00419562|20986742|P1|Overall Study|Lost to Follow-up|12
6077457|NCT00419393|20986765|P1|Overall Study|Other: Investigator decision|1
6077458|NCT00419393|20986765|P1|Overall Study|Other: Other health problems|1
6077459|NCT00419393|20986765|P1|Overall Study|Other: Site closure|1
6077460|NCT00419393|20986765|P1|Overall Study|Other: Subject had temporal lobectomy|1
6077461|NCT00419393|20986765|P1|Overall Study|Other: Sponsor request|3
6077462|NCT00419393|20986765|P1|Overall Study|Withdrawal by Subject|7
6077463|NCT00419393|20986765|P1|Overall Study|Protocol Violation|5
6077464|NCT00419393|20986765|P1|Overall Study|Adverse Event|5
6077465|NCT00419380|20986775|P2|Overall Study|Withdrawal by Subject|1
6077466|NCT00419380|20986776|P1|Overall Study|Withdrawal by Subject|0
6077467|NCT00419380|20986775|P2|Overall Study|Lost to Follow-up|1
6077468|NCT00419380|20986776|P1|Overall Study|Lost to Follow-up|0
6077469|NCT00419380|20986775|P2|Overall Study|Physician Decision|1
6077470|NCT00419380|20986776|P1|Overall Study|Physician Decision|0
6077471|NCT00419380|20986775|P2|Overall Study|Lack of Efficacy|7
6077472|NCT00419380|20986776|P1|Overall Study|Lack of Efficacy|1
6077473|NCT00419341|20986784|P1|Efficacy Period|Termination of study site|1
6077474|NCT00419341|20986784|P1|Efficacy Period|Non-compliance|1
6077475|NCT00419341|20986784|P1|Efficacy Period|Lost to Follow-up|1
6077476|NCT00419341|20986784|P1|Efficacy Period|Protocol Violation|1
6077477|NCT00419341|20986784|P1|Efficacy Period|Withdrawal by Subject|6
6077478|NCT00419341|20986784|P1|Wash in/Wash Out Period|Disqualifying laboratory results|1
6077479|NCT00419341|20986784|P1|Wash in/Wash Out Period|Adverse Event|2
6077480|NCT00419341|20986784|P1|Wash in/Wash Out Period|Withdrawal by Subject|8
6077481|NCT00419263|20986819|P3|Overall Study|Withdrawal by Subject|1
6077482|NCT00419263|20986820|P2|Overall Study|Withdrawal by Subject|0
6077483|NCT00419263|20986821|P1|Overall Study|Withdrawal by Subject|0
6077484|NCT00419263|20986819|P3|Overall Study|Adverse Event|1
6077485|NCT00419263|20986820|P2|Overall Study|Adverse Event|0
6077486|NCT00419263|20986821|P1|Overall Study|Adverse Event|0
6077487|NCT00419263|20986819|P3|Overall Study|Randomized in Error, Not Treated|0
6077488|NCT00419263|20986820|P2|Overall Study|Randomized in Error, Not Treated|1
6077489|NCT00419263|20986821|P1|Overall Study|Randomized in Error, Not Treated|1
6077490|NCT00419263|20986819|P3|Overall Study|Lost to Follow-up|1
6077491|NCT00419263|20986820|P2|Overall Study|Lost to Follow-up|1
6077492|NCT00419263|20986821|P1|Overall Study|Lost to Follow-up|2
6077493|NCT00419159|20986850|P2|Overall Study|Disease progression|76
6077494|NCT00419159|20986851|P1|Overall Study|Disease progression|79
6077495|NCT00419159|20986850|P2|Overall Study|Death|2
6077496|NCT00419159|20986851|P1|Overall Study|Death|2
6077497|NCT00419159|20986850|P2|Overall Study|Lost to Follow-up|1
6077498|NCT00419159|20986851|P1|Overall Study|Lost to Follow-up|0
6077499|NCT00419159|20986850|P2|Overall Study|Withdrawal by Subject|3
6077500|NCT00419159|20986851|P1|Overall Study|Withdrawal by Subject|10
6077501|NCT00419159|20986850|P2|Overall Study|Protocol Violation|0
6077502|NCT00419159|20986851|P1|Overall Study|Protocol Violation|1
6077503|NCT00419159|20986850|P2|Overall Study|Subject's no longer requires study drug|1
6077504|NCT00419159|20986851|P1|Overall Study|Subject's no longer requires study drug|0
6077505|NCT00419159|20986850|P2|Overall Study|Abnormal laboratory value(s)|2
6077506|NCT00419159|20986851|P1|Overall Study|Abnormal laboratory value(s)|0
6077507|NCT00419159|20986850|P2|Overall Study|Adverse Event|15
6077508|NCT00419159|20986851|P1|Overall Study|Adverse Event|7
6077509|NCT00419120|20986881|P1|Long Term Follow up Period|study ongoing|10
6077510|NCT00419094|20986888|P2|Overall Study|Other: No contact for extended period|1
6077511|NCT00419094|20986889|P1|Overall Study|Other: No contact for extended period|0
6077512|NCT00419094|20986888|P2|Overall Study|Other: Patient non-compliant|1
6077513|NCT00419094|20986889|P1|Overall Study|Other: Patient non-compliant|0
6077514|NCT00419094|20986888|P2|Overall Study|Other: Error determining exit criteria|0
6077515|NCT00419094|20986889|P1|Overall Study|Other: Error determining exit criteria|1
6077516|NCT00419094|20986888|P2|Overall Study|Withdrawal of consent|5
6077517|NCT00419094|20986889|P1|Overall Study|Withdrawal of consent|1
6077518|NCT00419094|20986888|P2|Overall Study|Protocol Violation|14
6077519|NCT00419094|20986889|P1|Overall Study|Protocol Violation|1
6077520|NCT00419094|20986888|P2|Overall Study|Lost to Follow-up|2
6077521|NCT00419094|20986889|P1|Overall Study|Lost to Follow-up|0
6077522|NCT00419094|20986888|P2|Overall Study|Lack of Efficacy|0
6077523|NCT00419094|20986889|P1|Overall Study|Lack of Efficacy|1
6077524|NCT00419094|20986888|P2|Overall Study|Adverse Event|7
6077525|NCT00419094|20986889|P1|Overall Study|Adverse Event|3
6077526|NCT00419003|20986903|P2|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|0
6077527|NCT00419003|20986904|P1|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|1
6077528|NCT00419003|20986903|P2|Phase I, Ketamine Infusion|Lack of Efficacy|6
6077529|NCT00419003|20986904|P1|Phase I, Ketamine Infusion|Lack of Efficacy|6
6077530|NCT00418938|20986958|P2|Overall Study|Ineligibility Determined|0
6077531|NCT00418938|20986959|P1|Overall Study|Ineligibility Determined|1
6077532|NCT00418938|20986958|P2|Overall Study|On-going|1
6077533|NCT00418938|20986959|P1|Overall Study|On-going|1
6077534|NCT00418938|20986958|P2|Overall Study|Adverse Event|1
6077535|NCT00418938|20986959|P1|Overall Study|Adverse Event|1
6077536|NCT00418938|20986958|P2|Overall Study|Lost to Follow-up|3
6077537|NCT00418938|20986959|P1|Overall Study|Lost to Follow-up|1
6077538|NCT00418938|20986958|P2|Overall Study|Withdrawal by Subject|15
6077539|NCT00418938|20986959|P1|Overall Study|Withdrawal by Subject|16
6077540|NCT00418938|20986958|P2|Overall Study|Administrative decision|3
6077541|NCT00418938|20986959|P1|Overall Study|Administrative decision|3
6077542|NCT00418938|20986958|P2|Overall Study|Reimbursement|0
6077543|NCT00418938|20986959|P1|Overall Study|Reimbursement|1
6077544|NCT00418886|20986979|P2|Overall Study|randomised but no treatment received|1
6077545|NCT00418886|20986980|P1|Overall Study|randomised but no treatment received|0
6077546|NCT00418886|20986979|P2|Overall Study|withdrawn due to other reason|0
6077547|NCT00418886|20986980|P1|Overall Study|withdrawn due to other reason|1
6077548|NCT00418886|20986979|P2|Overall Study|Lost to Follow-up|6
6077549|NCT00418886|20986980|P1|Overall Study|Lost to Follow-up|4
6077550|NCT00418886|20986979|P2|Overall Study|Withdrawal by Subject|10
6077551|NCT00418886|20986980|P1|Overall Study|Withdrawal by Subject|9
6077552|NCT00418886|20986979|P2|Overall Study|Death|147
6077553|NCT00418886|20986980|P1|Overall Study|Death|122
6077554|NCT00418886|20986979|P2|Overall Study|discontinue treatment survival follow up|91
6077555|NCT00418886|20986980|P1|Overall Study|discontinue treatment survival follow up|90
6077556|NCT00418834|20987006|P2|Overall Study|Withdrawal by Subject|7
6077557|NCT00418834|20987007|P1|Overall Study|Withdrawal by Subject|3
6077558|NCT00418834|20987006|P2|Overall Study|Protocol Violation|3
6077559|NCT00418834|20987007|P1|Overall Study|Protocol Violation|4
6077560|NCT00418834|20987006|P2|Overall Study|Lost to Follow-up|1
6077561|NCT00418834|20987007|P1|Overall Study|Lost to Follow-up|0
6077562|NCT00418834|20987006|P2|Overall Study|Adverse Event|9
6077563|NCT00418834|20987007|P1|Overall Study|Adverse Event|16
6077564|NCT00418717|20987067|P1|Treatment Period B - Weeks 5-12|Adverse Event|2
6077565|NCT00418717|20987067|P1|Treatment Period A - Weeks 1-4|Protocol Violation|1
6077566|NCT00418691|20987075|P3|Overall Study|Progressive Disease|1
6077567|NCT00418691|20987076|P2|Overall Study|Progressive Disease|0
6077568|NCT00418691|20987077|P1|Overall Study|Progressive Disease|1
6077569|NCT00418691|20987075|P3|Overall Study|Started new medication voiding entry|1
6077570|NCT00418691|20987076|P2|Overall Study|Started new medication voiding entry|0
6077571|NCT00418691|20987077|P1|Overall Study|Started new medication voiding entry|0
6077572|NCT00418691|20987075|P3|Overall Study|Lost to Follow-up|3
6077573|NCT00418691|20987076|P2|Overall Study|Lost to Follow-up|2
6077574|NCT00418691|20987077|P1|Overall Study|Lost to Follow-up|1
6077575|NCT00418665|20987088|P3|Treatment Extension|Death|1
6077576|NCT00418665|20987089|P2|Treatment Extension|Death|0
6077577|NCT00418665|20987090|P1|Treatment Extension|Death|0
6077578|NCT00418665|20987088|P3|Treatment Extension|Physician Decision|1
6077579|NCT00418665|20987089|P2|Treatment Extension|Physician Decision|2
6077580|NCT00418665|20987090|P1|Treatment Extension|Physician Decision|2
6077581|NCT00418665|20987088|P3|Treatment Extension|Requirement for alternative therapy|0
6077582|NCT00418665|20987089|P2|Treatment Extension|Requirement for alternative therapy|2
6077583|NCT00418665|20987090|P1|Treatment Extension|Requirement for alternative therapy|2
6077584|NCT00418665|20987088|P3|Treatment Extension|Withdrawal by Subject|0
6077585|NCT00418665|20987089|P2|Treatment Extension|Withdrawal by Subject|0
6077586|NCT00418665|20987090|P1|Treatment Extension|Withdrawal by Subject|1
6077587|NCT00418665|20987088|P3|Treatment Extension|Adverse Event|0
6077588|NCT00418665|20987089|P2|Treatment Extension|Adverse Event|0
6077589|NCT00418665|20987090|P1|Treatment Extension|Adverse Event|1
6077590|NCT00418665|20987088|P3|Treatment Period|Physician Decision|3
6077591|NCT00418665|20987089|P2|Treatment Period|Physician Decision|0
6077592|NCT00418665|20987090|P1|Treatment Period|Physician Decision|1
6077593|NCT00418665|20987088|P3|Treatment Period|Requirement for alternative therapy|0
6077594|NCT00418665|20987089|P2|Treatment Period|Requirement for alternative therapy|0
6077595|NCT00418665|20987090|P1|Treatment Period|Requirement for alternative therapy|1
6077596|NCT00418665|20987088|P3|Treatment Period|Withdrawal by Subject|1
6077597|NCT00418665|20987089|P2|Treatment Period|Withdrawal by Subject|3
6077598|NCT00418665|20987090|P1|Treatment Period|Withdrawal by Subject|0
6077599|NCT00418665|20987088|P3|Treatment Period|Adverse Event|0
6077600|NCT00418665|20987089|P2|Treatment Period|Adverse Event|2
6077601|NCT00418665|20987090|P1|Treatment Period|Adverse Event|2
6077602|NCT00418665|20987088|P3|Treatment Period|Ineligibility determined|0
6077603|NCT00418665|20987089|P2|Treatment Period|Ineligibility determined|1
6077604|NCT00418665|20987090|P1|Treatment Period|Ineligibility determined|1
6077605|NCT00418561|20987124|P3|Overall Study|Participant's (guardian's) decision|0
6077606|NCT00418561|20987125|P2|Overall Study|Participant's (guardian's) decision|1
6077607|NCT00418561|20987126|P1|Overall Study|Participant's (guardian's) decision|0
6077608|NCT00418522|20987196|P2|Overall Study|Randomized but did not receive treatment|4
6077609|NCT00418522|20987197|P1|Overall Study|Randomized but did not receive treatment|7
6077610|NCT00418522|20987196|P2|Overall Study|Other|23
6077611|NCT00418522|20987197|P1|Overall Study|Other|27
6077612|NCT00418522|20987196|P2|Overall Study|Withdrawal by Subject|7
6077613|NCT00418522|20987197|P1|Overall Study|Withdrawal by Subject|31
6077614|NCT00418522|20987196|P2|Overall Study|Lost to Follow-up|4
6077615|NCT00418522|20987197|P1|Overall Study|Lost to Follow-up|10
6077616|NCT00418522|20987196|P2|Overall Study|Lack of Efficacy|3
6077617|NCT00418522|20987197|P1|Overall Study|Lack of Efficacy|1
6077618|NCT00418522|20987196|P2|Overall Study|Adverse Event|1
6077619|NCT00418522|20987197|P1|Overall Study|Adverse Event|7
6077620|NCT00418379|20987261|P3|Year 5|Any other reason not above-mentioned|3
6077621|NCT00418379|20987262|P2|Year 5|Any other reason not above-mentioned|4
6077622|NCT00418379|20987263|P1|Year 5|Any other reason not above-mentioned|2
6077623|NCT00418379|20987261|P3|Year 5|Adverse Event|0
6077624|NCT00418379|20987262|P2|Year 5|Adverse Event|1
6077625|NCT00418379|20987263|P1|Year 5|Adverse Event|0
6077626|NCT00418379|20987261|P3|Year 4|Any other reason not above-mentioned|0
6077627|NCT00418379|20987262|P2|Year 4|Any other reason not above-mentioned|1
6077628|NCT00418379|20987263|P1|Year 4|Any other reason not above-mentioned|1
6077629|NCT00418379|20987261|P3|Year 4|Withdrawal by Subject|2
6077630|NCT00418379|20987262|P2|Year 4|Withdrawal by Subject|3
6077631|NCT00418379|20987263|P1|Year 4|Withdrawal by Subject|2
6077632|NCT00418379|20987261|P3|Year 4|Adverse Event|0
6077633|NCT00418379|20987262|P2|Year 4|Adverse Event|1
6077634|NCT00418379|20987263|P1|Year 4|Adverse Event|0
6077635|NCT00418379|20987261|P3|Year 3|Any other reason not above-mentioned|1
6077636|NCT00418379|20987262|P2|Year 3|Any other reason not above-mentioned|1
6077637|NCT00418379|20987263|P1|Year 3|Any other reason not above-mentioned|2
6077638|NCT00418379|20987261|P3|Year 3|Withdrawal by Subject|2
6077639|NCT00418379|20987262|P2|Year 3|Withdrawal by Subject|1
6077640|NCT00418379|20987263|P1|Year 3|Withdrawal by Subject|1
6077641|NCT00418379|20987261|P3|Year 2|Any other reason not above-mentioned|6
6077642|NCT00418379|20987262|P2|Year 2|Any other reason not above-mentioned|1
6077643|NCT00418379|20987263|P1|Year 2|Any other reason not above-mentioned|2
6077644|NCT00418379|20987261|P3|Year 2|Withdrawal by Subject|3
6077645|NCT00418379|20987262|P2|Year 2|Withdrawal by Subject|1
6077646|NCT00418379|20987263|P1|Year 2|Withdrawal by Subject|1
6077647|NCT00418379|20987261|P3|Year 2|Adverse Event|1
6077648|NCT00418379|20987262|P2|Year 2|Adverse Event|2
6077649|NCT00418379|20987263|P1|Year 2|Adverse Event|5
6077650|NCT00418379|20987261|P3|Year 1|Any other reason not above-mentioned|7
6077651|NCT00418379|20987262|P2|Year 1|Any other reason not above-mentioned|5
6077652|NCT00418379|20987263|P1|Year 1|Any other reason not above-mentioned|2
6077653|NCT00418379|20987261|P3|Year 1|Withdrawal by Subject|5
6077654|NCT00418379|20987262|P2|Year 1|Withdrawal by Subject|8
6077655|NCT00418379|20987263|P1|Year 1|Withdrawal by Subject|7
6077656|NCT00418379|20987261|P3|Year 1|Adverse Event|3
6077657|NCT00418379|20987262|P2|Year 1|Adverse Event|15
6077658|NCT00418379|20987263|P1|Year 1|Adverse Event|9
6077659|NCT00418314|20987273|P2|Overall Study|Withdrawal by Subject|2
6077660|NCT00418314|20987274|P1|Overall Study|Withdrawal by Subject|1
6077661|NCT00418184|20987304|P2|Double-blind Phase|Poor compliance|1
6077662|NCT00418184|20987305|P1|Double-blind Phase|Poor compliance|3
6077663|NCT00418184|20987304|P2|Double-blind Phase|Adverse Event|1
6077664|NCT00418184|20987305|P1|Double-blind Phase|Adverse Event|2
6077665|NCT00418184|20987304|P2|Double-blind Phase|Withdrawal by Subject|9
6077666|NCT00418184|20987305|P1|Double-blind Phase|Withdrawal by Subject|22
6077667|NCT00418145|20987313|P1|Overall Study|study terminated|6
6077668|NCT00417989|20987388|P2|Overall Study|Physician Decision|2
6077669|NCT00417989|20987389|P1|Overall Study|Physician Decision|5
6077670|NCT00417989|20987388|P2|Overall Study|Death|1
6077671|NCT00417989|20987389|P1|Overall Study|Death|0
6077672|NCT00417989|20987388|P2|Overall Study|Protocol Violation|0
6077673|NCT00417989|20987389|P1|Overall Study|Protocol Violation|1
6077674|NCT00417989|20987388|P2|Overall Study|Lost to Follow-up|6
6077675|NCT00417989|20987389|P1|Overall Study|Lost to Follow-up|1
6077676|NCT00417989|20987388|P2|Overall Study|Withdrawal by Subject|13
6077677|NCT00417989|20987389|P1|Overall Study|Withdrawal by Subject|13
6077678|NCT00417976|20987411|P1|Overall Study|Treatment -related toxicity|2
6077679|NCT00417976|20987411|P1|Overall Study|Non compliance unrelated to toxicity|1
6077680|NCT00417963|20987416|P1|Overall Study|Study device could not be deployed|3
6077681|NCT00417963|20987416|P1|Overall Study|Death|17
6077682|NCT00417963|20987416|P1|Overall Study|Withdrawal by Subject|18
6077683|NCT00417963|20987416|P1|Overall Study|Lost to Follow-up|3
6077684|NCT00417885|20987433|P1|Overall Study|Transferred to Another Sunitinib Study|2
6077685|NCT00417885|20987433|P1|Overall Study|Objective Progression or Relapse|3
6077686|NCT00417885|20987433|P1|Overall Study|Adverse Event|1
6077687|NCT00417612|20987459|P2|Overall Study|Lost to Follow-up|0
6077688|NCT00417612|20987460|P1|Overall Study|Lost to Follow-up|1
6077689|NCT00417612|20987459|P2|Overall Study|Protocol Violation|2
6077690|NCT00417612|20987460|P1|Overall Study|Protocol Violation|0
6077691|NCT00417612|20987459|P2|Overall Study|Adverse Event|0
6077692|NCT00417612|20987460|P1|Overall Study|Adverse Event|2
6077693|NCT00417612|20987459|P2|Overall Study|Errant diagnosis|1
6077694|NCT00417612|20987460|P1|Overall Study|Errant diagnosis|0
6077695|NCT00417482|20987486|P3|Phase B 2nd 16 Weeks|Death|0
6077696|NCT00417482|20987487|P2|Phase B 2nd 16 Weeks|Death|1
6077697|NCT00417482|20987488|P1|Phase B 2nd 16 Weeks|Death|1
6077698|NCT00417482|20987486|P3|Phase B 2nd 16 Weeks|Moved; unclear reason|0
6077699|NCT00417482|20987487|P2|Phase B 2nd 16 Weeks|Moved; unclear reason|0
6077700|NCT00417482|20987488|P1|Phase B 2nd 16 Weeks|Moved; unclear reason|1
6077701|NCT00417482|20987486|P3|Phase B 2nd 16 Weeks|Adverse Event|1
6077702|NCT00417482|20987487|P2|Phase B 2nd 16 Weeks|Adverse Event|0
6077703|NCT00417482|20987488|P1|Phase B 2nd 16 Weeks|Adverse Event|0
6077704|NCT00417482|20987486|P3|Phase B 2nd 16 Weeks|Lack of Efficacy|2
6077705|NCT00417482|20987487|P2|Phase B 2nd 16 Weeks|Lack of Efficacy|12
6077706|NCT00417482|20987488|P1|Phase B 2nd 16 Weeks|Lack of Efficacy|1
6077707|NCT00417482|20987486|P3|Phase B 1st 16 Weeks|Death|0
6077708|NCT00417482|20987487|P2|Phase B 1st 16 Weeks|Death|0
6077709|NCT00417482|20987488|P1|Phase B 1st 16 Weeks|Death|1
6077710|NCT00417482|20987486|P3|Phase B 1st 16 Weeks|Moved, Unclear reasons|2
6077711|NCT00417482|20987487|P2|Phase B 1st 16 Weeks|Moved, Unclear reasons|3
6077712|NCT00417482|20987488|P1|Phase B 1st 16 Weeks|Moved, Unclear reasons|2
6077713|NCT00417482|20987486|P3|Phase B 1st 16 Weeks|Adverse Event|1
6077714|NCT00417482|20987487|P2|Phase B 1st 16 Weeks|Adverse Event|0
6077715|NCT00417482|20987488|P1|Phase B 1st 16 Weeks|Adverse Event|2
6077716|NCT00417482|20987486|P3|Phase B 1st 16 Weeks|Lack of Efficacy|24
6077717|NCT00417482|20987487|P2|Phase B 1st 16 Weeks|Lack of Efficacy|8
6077718|NCT00417482|20987488|P1|Phase B 1st 16 Weeks|Lack of Efficacy|14
6077719|NCT00417248|20987527|P1|Overall Study|Lack of Efficacy|1
6077720|NCT00417248|20987527|P1|Overall Study|Death|1
6077721|NCT00417248|20987527|P1|Overall Study|Study Terminated|6
6077722|NCT00417170|20987534|P2|Overall Study|Lost to Follow-up|1
6077723|NCT00417170|20987535|P1|Overall Study|Lost to Follow-up|0
6077724|NCT00417170|20987534|P2|Overall Study|Withdrawal by Subject|1
6077725|NCT00417170|20987535|P1|Overall Study|Withdrawal by Subject|1
6077726|NCT00417170|20987534|P2|Overall Study|Adverse Event|1
6077727|NCT00417170|20987535|P1|Overall Study|Adverse Event|1
6077728|NCT00417079|20987551|P2|Overall Study|abnormal liver function tests|1
6077729|NCT00417079|20987552|P1|Overall Study|abnormal liver function tests|0
6077730|NCT00417079|20987551|P2|Overall Study|Patient unable to come to the clinic|1
6077731|NCT00417079|20987552|P1|Overall Study|Patient unable to come to the clinic|0
6077732|NCT00417079|20987551|P2|Overall Study|Withdrawal by subject's family|1
6077733|NCT00417079|20987552|P1|Overall Study|Withdrawal by subject's family|0
6077734|NCT00417079|20987551|P2|Overall Study|Screening error|1
6077735|NCT00417079|20987552|P1|Overall Study|Screening error|2
6077736|NCT00417079|20987551|P2|Overall Study|Clinical deterioration|0
6077737|NCT00417079|20987552|P1|Overall Study|Clinical deterioration|1
6077738|NCT00417079|20987551|P2|Overall Study|Non-confirmed Disease progression|1
6077739|NCT00417079|20987552|P1|Overall Study|Non-confirmed Disease progression|1
6077740|NCT00417079|20987551|P2|Overall Study|Investigator's decision|4
6077741|NCT00417079|20987552|P1|Overall Study|Investigator's decision|1
6077742|NCT00417079|20987551|P2|Overall Study|Screened failure|1
6077743|NCT00417079|20987552|P1|Overall Study|Screened failure|2
6077744|NCT00417079|20987551|P2|Overall Study|Not treated|7
6077745|NCT00417079|20987552|P1|Overall Study|Not treated|6
6077746|NCT00417079|20987551|P2|Overall Study|Withdrawal by Subject|8
6077747|NCT00417079|20987552|P1|Overall Study|Withdrawal by Subject|17
6077748|NCT00417079|20987551|P2|Overall Study|Lost to Follow-up|0
6077749|NCT00417079|20987552|P1|Overall Study|Lost to Follow-up|2
6077750|NCT00417079|20987551|P2|Overall Study|Non-compliance to protocol|1
6077751|NCT00417079|20987552|P1|Overall Study|Non-compliance to protocol|0
6077752|NCT00417079|20987551|P2|Overall Study|Adverse Event|67
6077753|NCT00417079|20987552|P1|Overall Study|Adverse Event|32
6077754|NCT00417079|20987551|P2|Overall Study|Disease progression|180
6077755|NCT00417079|20987552|P1|Overall Study|Disease progression|267
6077756|NCT00417027|20987575|P3|Overall Study|Protocol Violation|5
6077757|NCT00417027|20987576|P2|Overall Study|Protocol Violation|5
6077758|NCT00417027|20987577|P1|Overall Study|Protocol Violation|0
6077759|NCT00416949|20987603|P1|Overall Study|Patients refused to participate|5
6077760|NCT00416884|20987607|P1|Overall Study|Study terminated due to low accrual|1
6077761|NCT00416715|20987616|P1|Overall Study|Vitamin D levels not evaluable|8
6077762|NCT00416715|20987616|P1|Overall Study|Not evaluable for joint aches|7
6077763|NCT00416624|20987627|P4|Overall Study|Cancel|0
6077764|NCT00416624|20987628|P3|Overall Study|Cancel|0
6077765|NCT00416624|20987629|P2|Overall Study|Cancel|0
6077766|NCT00416624|20987630|P1|Overall Study|Cancel|1
6077767|NCT00416624|20987627|P4|Overall Study|Other|5
6077768|NCT00416624|20987628|P3|Overall Study|Other|5
6077769|NCT00416624|20987629|P2|Overall Study|Other|11
6077770|NCT00416624|20987630|P1|Overall Study|Other|8
6077771|NCT00416624|20987627|P4|Overall Study|Adverse Event|2
6077772|NCT00416624|20987628|P3|Overall Study|Adverse Event|2
6077773|NCT00416624|20987629|P2|Overall Study|Adverse Event|3
6077774|NCT00416624|20987630|P1|Overall Study|Adverse Event|8
6077775|NCT00416624|20987627|P4|Overall Study|Death|1
6077776|NCT00416624|20987628|P3|Overall Study|Death|7
6077777|NCT00416624|20987629|P2|Overall Study|Death|7
6077778|NCT00416624|20987630|P1|Overall Study|Death|4
6077779|NCT00416624|20987627|P4|Overall Study|Withdrawal by Subject|9
6077780|NCT00416624|20987628|P3|Overall Study|Withdrawal by Subject|4
6077781|NCT00416624|20987629|P2|Overall Study|Withdrawal by Subject|6
6077782|NCT00416624|20987630|P1|Overall Study|Withdrawal by Subject|1
6077783|NCT00416598|20987684|P1|Decitabine Maintenance|Physician discretion/other medical issue|9
6077784|NCT00416598|20987684|P1|Decitabine Maintenance|Alternative treatment|2
6077785|NCT00416598|20987684|P1|Decitabine Maintenance|Progression/relapse|38
6077786|NCT00416598|20987684|P1|Decitabine Maintenance|Withdrawal by Subject|18
6077787|NCT00416598|20987684|P1|Decitabine Maintenance|Adverse Event|5
6077788|NCT00416598|20987684|P1|Induction & Intensification|Failed induction|87
6077789|NCT00416598|20987684|P1|Induction & Intensification|Relapse/progression|29
6077790|NCT00416598|20987684|P1|Induction & Intensification|Physician discretion/other medical issue|45
6077791|NCT00416598|20987684|P1|Induction & Intensification|Alternative Treatment|135
6077792|NCT00416598|20987684|P1|Induction & Intensification|Withdrawal by Subject|46
6077793|NCT00416598|20987684|P1|Induction & Intensification|Death|32
6077794|NCT00416598|20987684|P1|Induction & Intensification|Adverse Event|38
6077795|NCT00416520|20987710|P4|Placebo-controlled Withdrawal Period|Protocol Violation|1
6077796|NCT00416520|20987711|P3|Placebo-controlled Withdrawal Period|Protocol Violation|1
6077797|NCT00416520|20987712|P2|Placebo-controlled Withdrawal Period|Protocol Violation|0
6077798|NCT00416520|20987713|P1|Placebo-controlled Withdrawal Period|Protocol Violation|0
6077799|NCT00416520|20987710|P4|Placebo-controlled Withdrawal Period|Lack of Efficacy|3
6077800|NCT00416520|20987711|P3|Placebo-controlled Withdrawal Period|Lack of Efficacy|0
6077801|NCT00416520|20987712|P2|Placebo-controlled Withdrawal Period|Lack of Efficacy|0
6077802|NCT00416520|20987713|P1|Placebo-controlled Withdrawal Period|Lack of Efficacy|0
6077803|NCT00416520|20987710|P4|Placebo-controlled Withdrawal Period|Adverse Event|1
6077804|NCT00416520|20987711|P3|Placebo-controlled Withdrawal Period|Adverse Event|0
6077805|NCT00416520|20987712|P2|Placebo-controlled Withdrawal Period|Adverse Event|0
6077806|NCT00416520|20987713|P1|Placebo-controlled Withdrawal Period|Adverse Event|0
6077807|NCT00416520|20987710|P4|Open-label Period|Other Reasons|0
6077808|NCT00416520|20987711|P3|Open-label Period|Other Reasons|0
6077809|NCT00416520|20987712|P2|Open-label Period|Other Reasons|12
6077810|NCT00416520|20987713|P1|Open-label Period|Other Reasons|3
6077811|NCT00416520|20987710|P4|Open-label Period|Withdrawal by Subject|0
6077812|NCT00416520|20987711|P3|Open-label Period|Withdrawal by Subject|0
6077813|NCT00416520|20987712|P2|Open-label Period|Withdrawal by Subject|5
6077814|NCT00416520|20987713|P1|Open-label Period|Withdrawal by Subject|16
6077815|NCT00416520|20987710|P4|Open-label Period|Protocol Violation|0
6077816|NCT00416520|20987711|P3|Open-label Period|Protocol Violation|0
6077817|NCT00416520|20987712|P2|Open-label Period|Protocol Violation|3
6077818|NCT00416520|20987713|P1|Open-label Period|Protocol Violation|3
6077819|NCT00416520|20987710|P4|Open-label Period|Lack of Efficacy|0
6077820|NCT00416520|20987711|P3|Open-label Period|Lack of Efficacy|0
6077821|NCT00416520|20987712|P2|Open-label Period|Lack of Efficacy|1
6077822|NCT00416520|20987713|P1|Open-label Period|Lack of Efficacy|8
6077823|NCT00416520|20987710|P4|Open-label Period|Death|0
6077824|NCT00416520|20987711|P3|Open-label Period|Death|0
6077825|NCT00416520|20987712|P2|Open-label Period|Death|1
6077826|NCT00416520|20987713|P1|Open-label Period|Death|2
6077827|NCT00416520|20987710|P4|Open-label Period|Adverse Event|0
6077828|NCT00416520|20987711|P3|Open-label Period|Adverse Event|0
6077829|NCT00416520|20987712|P2|Open-label Period|Adverse Event|10
6077830|NCT00416520|20987713|P1|Open-label Period|Adverse Event|28
6077831|NCT00416455|20987742|P2|Overall Study|Inadequate pathology|2
6077832|NCT00416455|20987743|P1|Overall Study|Inadequate pathology|11
6077833|NCT00416455|20987742|P2|Overall Study|PET / CT poor quality|1
6077834|NCT00416455|20987743|P1|Overall Study|PET / CT poor quality|2
6077835|NCT00416455|20987742|P2|Overall Study|PET / CT not done|5
6077836|NCT00416455|20987743|P1|Overall Study|PET / CT not done|3
6077837|NCT00416312|20987778|P1|Overall Study|tumors not visible on imaging|2
6077838|NCT00416195|20987784|P2|Overall Study|Other|1
6077839|NCT00416195|20987785|P1|Overall Study|Other|0
6077840|NCT00416195|20987784|P2|Overall Study|Protocol Violation|1
6077841|NCT00416195|20987785|P1|Overall Study|Protocol Violation|1
6077842|NCT00416195|20987784|P2|Overall Study|Adverse Event|2
6077843|NCT00416195|20987785|P1|Overall Study|Adverse Event|1
6077844|NCT00416078|20987810|P2|Overall Study|Lost to Follow-up|2
6077845|NCT00416078|20987811|P1|Overall Study|Lost to Follow-up|4
6077846|NCT00416078|20987810|P2|Overall Study|Physician Decision|0
6077847|NCT00416078|20987811|P1|Overall Study|Physician Decision|1
6077848|NCT00416078|20987810|P2|Overall Study|Withdrawal by Subject|2
6077849|NCT00416078|20987811|P1|Overall Study|Withdrawal by Subject|3
6077850|NCT00416078|20987810|P2|Overall Study|Death|4
6077851|NCT00416078|20987811|P1|Overall Study|Death|3
6077852|NCT00415909|20987827|P1|Overall Study|Death|1
6077853|NCT00415909|20987827|P1|Overall Study|Withdrawal by Subject|2
6077854|NCT00415636|20987861|P6|Overall Study|Disease progression|1
6077855|NCT00415636|20987862|P5|Overall Study|Disease progression|0
6077856|NCT00415636|20987863|P4|Overall Study|Disease progression|3
6077857|NCT00415636|20987864|P3|Overall Study|Disease progression|0
6077858|NCT00415636|20987865|P2|Overall Study|Disease progression|0
6077859|NCT00415636|20987866|P1|Overall Study|Disease progression|0
6077860|NCT00415636|20987861|P6|Overall Study|Withdrawal by Subject|0
6077861|NCT00415636|20987862|P5|Overall Study|Withdrawal by Subject|1
6077862|NCT00415636|20987863|P4|Overall Study|Withdrawal by Subject|0
6077863|NCT00415636|20987864|P3|Overall Study|Withdrawal by Subject|0
6077864|NCT00415636|20987865|P2|Overall Study|Withdrawal by Subject|0
6077865|NCT00415636|20987866|P1|Overall Study|Withdrawal by Subject|0
6077866|NCT00415636|20987861|P6|Overall Study|Adverse Event|0
6077867|NCT00415636|20987862|P5|Overall Study|Adverse Event|1
6077868|NCT00415636|20987863|P4|Overall Study|Adverse Event|1
6077869|NCT00415636|20987864|P3|Overall Study|Adverse Event|0
6077870|NCT00415636|20987865|P2|Overall Study|Adverse Event|0
6077871|NCT00415636|20987866|P1|Overall Study|Adverse Event|0
6077872|NCT00415636|20987861|P6|Overall Study|Symptomatic deterioration|1
6077873|NCT00415636|20987862|P5|Overall Study|Symptomatic deterioration|0
6077874|NCT00415636|20987863|P4|Overall Study|Symptomatic deterioration|2
6077875|NCT00415636|20987864|P3|Overall Study|Symptomatic deterioration|1
6077876|NCT00415636|20987865|P2|Overall Study|Symptomatic deterioration|0
6077877|NCT00415636|20987866|P1|Overall Study|Symptomatic deterioration|1
6077884|NCT00415610|20987928|P3|Overall Study|Death|5
6077885|NCT00415610|20987929|P2|Overall Study|Death|2
6077886|NCT00415610|20987930|P1|Overall Study|Death|3
6077887|NCT00415597|20987950|P1|Treatment|Multiple Reasons|1
6077888|NCT00415597|20987950|P1|Treatment|Sponsor Decision|1
6077889|NCT00415597|20987950|P1|Treatment|Administrative|3
6077890|NCT00415597|20987950|P1|Treatment|Drug Screen|2
6077891|NCT00415597|20987950|P1|Treatment|Lost to Follow-up|28
6077892|NCT00415597|20987950|P1|Treatment|Withdrawal by Subject|51
6077893|NCT00415597|20987950|P1|Treatment|Physician Decision|3
6077894|NCT00415597|20987950|P1|Treatment|Protocol Violation|67
6077895|NCT00415597|20987950|P1|Treatment|Lack of Efficacy|39
6077896|NCT00415597|20987950|P1|Treatment|Adverse Event|110
6077897|NCT00415597|20987950|P1|Enrollment|Protocol Violation|1
6077898|NCT00415597|20987950|P1|Enrollment|Withdrawal by Subject|1
6077899|NCT00415532|20987958|P2|Safety Follow Up Period|Requirement for alternative therapy|1
6077900|NCT00415532|20987959|P1|Safety Follow Up Period|Requirement for alternative therapy|0
6077901|NCT00415532|20987958|P2|Safety Follow Up Period|Noncompliance|0
6077902|NCT00415532|20987959|P1|Safety Follow Up Period|Noncompliance|1
6077903|NCT00415532|20987958|P2|Safety Follow Up Period|Ineligibility determined|1
6077904|NCT00415532|20987959|P1|Safety Follow Up Period|Ineligibility determined|1
6077905|NCT00415532|20987958|P2|Safety Follow Up Period|Other|4
6077906|NCT00415532|20987959|P1|Safety Follow Up Period|Other|1
6077907|NCT00415532|20987958|P2|Safety Follow Up Period|Withdrawal by Subject|3
6077908|NCT00415532|20987959|P1|Safety Follow Up Period|Withdrawal by Subject|2
6077909|NCT00415532|20987958|P2|Safety Follow Up Period|Death|0
6077910|NCT00415532|20987959|P1|Safety Follow Up Period|Death|3
6077911|NCT00415532|20987958|P2|Safety Follow Up Period|Adverse Event|3
6077912|NCT00415532|20987959|P1|Safety Follow Up Period|Adverse Event|1
6077913|NCT00415532|20987958|P2|Treatment Period|Requirement for alternative therapy|0
6077914|NCT00415532|20987959|P1|Treatment Period|Requirement for alternative therapy|1
6077915|NCT00415532|20987958|P2|Treatment Period|Noncompliance|1
6077916|NCT00415532|20987959|P1|Treatment Period|Noncompliance|1
6077917|NCT00415532|20987958|P2|Treatment Period|Ineligibility determined|1
6077918|NCT00415532|20987959|P1|Treatment Period|Ineligibility determined|1
6077919|NCT00415532|20987958|P2|Treatment Period|Other|2
6077920|NCT00415532|20987959|P1|Treatment Period|Other|2
6077921|NCT00415532|20987958|P2|Treatment Period|Withdrawal by Subject|6
6077922|NCT00415532|20987959|P1|Treatment Period|Withdrawal by Subject|6
6077923|NCT00415532|20987958|P2|Treatment Period|Protocol Violation|0
6077924|NCT00415532|20987959|P1|Treatment Period|Protocol Violation|1
6077925|NCT00415532|20987958|P2|Treatment Period|Lost to Follow-up|1
6077926|NCT00415532|20987959|P1|Treatment Period|Lost to Follow-up|1
6077927|NCT00415532|20987958|P2|Treatment Period|Death|1
6077928|NCT00415532|20987959|P1|Treatment Period|Death|2
6077929|NCT00415532|20987958|P2|Treatment Period|Adverse Event|3
6077930|NCT00415532|20987959|P1|Treatment Period|Adverse Event|2
6077931|NCT00415519|20987981|P2|Overall Study|Patient's convenience|0
6077932|NCT00415519|20987982|P1|Overall Study|Patient's convenience|1
6077933|NCT00415519|20987981|P2|Overall Study|Withdrawal by Subject|0
6077934|NCT00415519|20987982|P1|Overall Study|Withdrawal by Subject|2
6077935|NCT00415519|20987981|P2|Overall Study|Adverse Event|0
6077936|NCT00415519|20987982|P1|Overall Study|Adverse Event|1
6077937|NCT00415363|20988022|P2|Overall Study|Progressive disease|32
6077938|NCT00415363|20988023|P1|Overall Study|Progressive disease|26
6077939|NCT00415363|20988022|P2|Overall Study|Death|12
6077940|NCT00415363|20988023|P1|Overall Study|Death|16
6077941|NCT00415363|20988022|P2|Overall Study|Physician Decision|1
6077942|NCT00415363|20988023|P1|Overall Study|Physician Decision|3
6077943|NCT00415363|20988022|P2|Overall Study|Lost to Follow-up|1
6077944|NCT00415363|20988023|P1|Overall Study|Lost to Follow-up|2
6077945|NCT00415363|20988022|P2|Overall Study|Adverse Event|4
6077946|NCT00415363|20988023|P1|Overall Study|Adverse Event|4
6077947|NCT00415363|20988022|P2|Overall Study|Withdrawal by Subject|4
6077948|NCT00415363|20988023|P1|Overall Study|Withdrawal by Subject|4
6077949|NCT00415194|20988053|P2|Overall Study|Death Due to AE (Other Causes)|15
6077950|NCT00415194|20988054|P1|Overall Study|Death Due to AE (Other Causes)|27
6077951|NCT00415194|20988053|P2|Overall Study|Death Due to Procedural Related AE|1
6077952|NCT00415194|20988054|P1|Overall Study|Death Due to Procedural Related AE|0
6077953|NCT00415194|20988053|P2|Overall Study|Death Due to Study Drug Related AE|1
6077954|NCT00415194|20988054|P1|Overall Study|Death Due to Study Drug Related AE|11
6077955|NCT00415194|20988053|P2|Overall Study|Death Due to Study Disease|29
6077956|NCT00415194|20988054|P1|Overall Study|Death Due to Study Disease|26
6077957|NCT00415194|20988053|P2|Overall Study|Withdrawal by Subject|21
6077958|NCT00415194|20988054|P1|Overall Study|Withdrawal by Subject|28
6077959|NCT00415194|20988053|P2|Overall Study|Protocol Violation|2
6077960|NCT00415194|20988054|P1|Overall Study|Protocol Violation|4
6077961|NCT00415194|20988053|P2|Overall Study|Progressive Disease|217
6077962|NCT00415194|20988054|P1|Overall Study|Progressive Disease|180
6077963|NCT00415194|20988053|P2|Overall Study|Physician Decision|16
6077964|NCT00415194|20988054|P1|Overall Study|Physician Decision|10
6077965|NCT00415194|20988053|P2|Overall Study|Lost to Follow-up|0
6077966|NCT00415194|20988054|P1|Overall Study|Lost to Follow-up|1
6077967|NCT00415194|20988053|P2|Overall Study|Entry Criteria Not Met|8
6077968|NCT00415194|20988054|P1|Overall Study|Entry Criteria Not Met|4
6077969|NCT00415194|20988053|P2|Overall Study|Adverse Event|32
6077970|NCT00415194|20988054|P1|Overall Study|Adverse Event|37
6077971|NCT00415168|20988070|P1|Overall Study|Withdrawal by Subject|6
6077972|NCT00415168|20988070|P1|Overall Study|Sponsor Decision|4
6077973|NCT00415168|20988070|P1|Overall Study|Physician Decision|13
6077974|NCT00415168|20988070|P1|Overall Study|Lost to Follow-up|3
6077975|NCT00415168|20988070|P1|Overall Study|Death|26
6077976|NCT00415051|20988080|P1|Overall Study|Protocol Violation|1
6077977|NCT00414973|20988091|P4|Overall Study|Death|0
6077978|NCT00414973|20988092|P3|Overall Study|Death|1
6077979|NCT00414973|20988093|P2|Overall Study|Death|0
6077980|NCT00414973|20988094|P1|Overall Study|Death|0
6077981|NCT00414973|20988091|P4|Overall Study|Sponsor Decision|0
6077982|NCT00414973|20988092|P3|Overall Study|Sponsor Decision|0
6077983|NCT00414973|20988093|P2|Overall Study|Sponsor Decision|0
6077984|NCT00414973|20988094|P1|Overall Study|Sponsor Decision|1
6077985|NCT00414973|20988091|P4|Overall Study|Lost to Follow-up|0
6077986|NCT00414973|20988092|P3|Overall Study|Lost to Follow-up|0
6077987|NCT00414973|20988093|P2|Overall Study|Lost to Follow-up|2
6077988|NCT00414973|20988094|P1|Overall Study|Lost to Follow-up|0
6077989|NCT00414973|20988091|P4|Overall Study|Protocol Violation|0
6077990|NCT00414973|20988092|P3|Overall Study|Protocol Violation|0
6077991|NCT00414973|20988093|P2|Overall Study|Protocol Violation|4
6077992|NCT00414973|20988094|P1|Overall Study|Protocol Violation|3
6077993|NCT00414973|20988091|P4|Overall Study|Adverse Event|0
6077994|NCT00414973|20988092|P3|Overall Study|Adverse Event|1
6077995|NCT00414973|20988093|P2|Overall Study|Adverse Event|0
6077996|NCT00414973|20988094|P1|Overall Study|Adverse Event|10
6077997|NCT00414973|20988091|P4|Overall Study|Withdrawal by Subject|0
6077998|NCT00414973|20988092|P3|Overall Study|Withdrawal by Subject|1
6077999|NCT00414973|20988093|P2|Overall Study|Withdrawal by Subject|4
6078000|NCT00414973|20988094|P1|Overall Study|Withdrawal by Subject|14
6078001|NCT00414960|20988114|P2|Overall Study|Physician Decision|1
6078002|NCT00414960|20988115|P1|Overall Study|Physician Decision|0
6078003|NCT00414960|20988114|P2|Overall Study|Withdrawal by Subject|0
6078004|NCT00414960|20988115|P1|Overall Study|Withdrawal by Subject|3
6078005|NCT00414960|20988114|P2|Overall Study|Adverse Event|0
6078006|NCT00414960|20988115|P1|Overall Study|Adverse Event|4
6078007|NCT00414908|20988125|P2|Overall Study|Protocol Violation|1
6078008|NCT00414908|20988126|P1|Overall Study|Protocol Violation|1
6078009|NCT00414726|20988163|P2|Overall Study|Withdrawal by Subject|1
6078010|NCT00414726|20988164|P1|Overall Study|Withdrawal by Subject|0
6078011|NCT00414661|20988199|P4|Overall Study|Other|0
6078012|NCT00414661|20988200|P3|Overall Study|Other|0
6078013|NCT00414661|20988201|P2|Overall Study|Other|3
6078014|NCT00414661|20988202|P1|Overall Study|Other|6
6078015|NCT00414661|20988199|P4|Overall Study|Withdrawal by Subject|2
6078016|NCT00414661|20988200|P3|Overall Study|Withdrawal by Subject|2
6078017|NCT00414661|20988201|P2|Overall Study|Withdrawal by Subject|2
6078018|NCT00414661|20988202|P1|Overall Study|Withdrawal by Subject|5
6078019|NCT00414661|20988199|P4|Overall Study|Lost to Follow-up|1
6078020|NCT00414661|20988200|P3|Overall Study|Lost to Follow-up|0
6078021|NCT00414661|20988201|P2|Overall Study|Lost to Follow-up|4
6078022|NCT00414661|20988202|P1|Overall Study|Lost to Follow-up|1
6078023|NCT00414661|20988199|P4|Overall Study|Death|0
6078024|NCT00414661|20988200|P3|Overall Study|Death|0
6078025|NCT00414661|20988201|P2|Overall Study|Death|5
6078026|NCT00414661|20988202|P1|Overall Study|Death|2
6078027|NCT00414609|20988247|P3|Extension Study|Death|17
6078028|NCT00414609|20988248|P2|Extension Study|Death|0
6078029|NCT00414609|20988249|P1|Extension Study|Death|0
6078030|NCT00414609|20988247|P3|Extension Study|Administrative problems|1
6078031|NCT00414609|20988248|P2|Extension Study|Administrative problems|0
6078032|NCT00414609|20988249|P1|Extension Study|Administrative problems|0
6078033|NCT00414609|20988247|P3|Extension Study|Lost to Follow-up|10
6078034|NCT00414609|20988248|P2|Extension Study|Lost to Follow-up|0
6078035|NCT00414609|20988249|P1|Extension Study|Lost to Follow-up|0
6078036|NCT00414609|20988247|P3|Extension Study|Withdrawal by Subject|13
6078037|NCT00414609|20988248|P2|Extension Study|Withdrawal by Subject|0
6078038|NCT00414609|20988249|P1|Extension Study|Withdrawal by Subject|0
6078039|NCT00414609|20988247|P3|Extension Study|Unsatisfactory therapeutic effect|2
6078040|NCT00414609|20988248|P2|Extension Study|Unsatisfactory therapeutic effect|0
6078041|NCT00414609|20988249|P1|Extension Study|Unsatisfactory therapeutic effect|0
6078042|NCT00414609|20988247|P3|Extension Study|Adverse Event|14
6078043|NCT00414609|20988248|P2|Extension Study|Adverse Event|0
6078044|NCT00414609|20988249|P1|Extension Study|Adverse Event|0
6078045|NCT00414609|20988247|P3|Core Study|Death|0
6078046|NCT00414609|20988248|P2|Core Study|Death|14
6078047|NCT00414609|20988249|P1|Core Study|Death|7
6078048|NCT00414609|20988247|P3|Core Study|Administrative problems|0
6078049|NCT00414609|20988248|P2|Core Study|Administrative problems|2
6078050|NCT00414609|20988249|P1|Core Study|Administrative problems|0
6078051|NCT00414609|20988247|P3|Core Study|Lost to Follow-up|0
6078052|NCT00414609|20988248|P2|Core Study|Lost to Follow-up|4
6078053|NCT00414609|20988249|P1|Core Study|Lost to Follow-up|7
6078054|NCT00414609|20988247|P3|Core Study|Patient withdrew consent|0
6078055|NCT00414609|20988248|P2|Core Study|Patient withdrew consent|11
6078056|NCT00414609|20988249|P1|Core Study|Patient withdrew consent|10
6078057|NCT00414609|20988247|P3|Core Study|Protocol deviation|0
6078058|NCT00414609|20988248|P2|Core Study|Protocol deviation|1
6078059|NCT00414609|20988249|P1|Core Study|Protocol deviation|0
6078060|NCT00414609|20988247|P3|Core Study|Abnormal test procedure results|0
6078061|NCT00414609|20988248|P2|Core Study|Abnormal test procedure results|1
6078062|NCT00414609|20988249|P1|Core Study|Abnormal test procedure results|1
6078063|NCT00414609|20988247|P3|Core Study|Abnormal laboratory values|0
6078064|NCT00414609|20988248|P2|Core Study|Abnormal laboratory values|1
6078065|NCT00414609|20988249|P1|Core Study|Abnormal laboratory values|0
6078066|NCT00414609|20988247|P3|Core Study|Adverse Event|0
6078067|NCT00414609|20988248|P2|Core Study|Adverse Event|11
6078068|NCT00414609|20988249|P1|Core Study|Adverse Event|9
6078069|NCT00414596|20988272|P1|Overall Study|Protocol Violation|2
6078070|NCT00414544|20988281|P1|Overall Study|Lost to Follow-up|14
6078071|NCT00414466|20988304|P4|Overall Study|Withdrawn by Sponsor|0
6078072|NCT00414466|20988305|P3|Overall Study|Withdrawn by Sponsor|0
6078073|NCT00414466|20988306|P2|Overall Study|Withdrawn by Sponsor|0
6078074|NCT00414466|20988307|P1|Overall Study|Withdrawn by Sponsor|1
6078075|NCT00414466|20988304|P4|Overall Study|Lack of Efficacy|0
6078076|NCT00414466|20988305|P3|Overall Study|Lack of Efficacy|0
6078077|NCT00414466|20988306|P2|Overall Study|Lack of Efficacy|0
6078078|NCT00414466|20988307|P1|Overall Study|Lack of Efficacy|1
6078079|NCT00414466|20988304|P4|Overall Study|Adverse Event|1
6078080|NCT00414466|20988305|P3|Overall Study|Adverse Event|1
6078081|NCT00414466|20988306|P2|Overall Study|Adverse Event|0
6078082|NCT00414466|20988307|P1|Overall Study|Adverse Event|0
6078083|NCT00414453|20988325|P1|Overall Study|Abnormal lab work|16
6078084|NCT00414440|20988373|P2|Extension Period|Not included in follow up period|8
6078085|NCT00414440|20988374|P1|Extension Period|Not included in follow up period|18
6078086|NCT00414440|20988373|P2|Extension Period|Withdrawal by Subject|7
6078087|NCT00414440|20988374|P1|Extension Period|Withdrawal by Subject|9
6078088|NCT00414440|20988373|P2|Extension Period|Death|2
6078089|NCT00414440|20988374|P1|Extension Period|Death|1
6078090|NCT00414440|20988373|P2|Extension Period|Administrative|16
6078091|NCT00414440|20988374|P1|Extension Period|Administrative|16
6078092|NCT00414440|20988373|P2|Extension Period|Other|1
6078093|NCT00414440|20988374|P1|Extension Period|Other|1
6078094|NCT00414440|20988373|P2|Extension Period|Did not consent to continue follow up|54
6078095|NCT00414440|20988374|P1|Extension Period|Did not consent to continue follow up|61
6078096|NCT00414440|20988373|P2|Extension Period|Lost to Follow-up|52
6078097|NCT00414440|20988374|P1|Extension Period|Lost to Follow-up|44
6078098|NCT00414440|20988373|P2|Core Period|Withdrawal by Subject|32
6078099|NCT00414440|20988374|P1|Core Period|Withdrawal by Subject|70
6078100|NCT00414388|20988388|P1|Overall Study|Adverse Event|1
6078101|NCT00414310|20988396|P2|Overall Study|Not treated|0
6078102|NCT00414310|20988397|P1|Overall Study|Not treated|1
6078103|NCT00414076|20988441|P2|Overall Study|Adverse Event|0
6078104|NCT00414076|20988442|P1|Overall Study|Adverse Event|1
6078105|NCT00414076|20988441|P2|Overall Study|Withdrawal by Subject|3
6078106|NCT00414076|20988442|P1|Overall Study|Withdrawal by Subject|1
6078107|NCT00414076|20988441|P2|Overall Study|Progression|2
6078108|NCT00414076|20988442|P1|Overall Study|Progression|1
6078109|NCT00414050|20988452|P4|Overall Study|Subject Moved|1
6078110|NCT00414050|20988453|P3|Overall Study|Subject Moved|0
6078111|NCT00414050|20988454|P2|Overall Study|Subject Moved|0
6078112|NCT00414050|20988455|P1|Overall Study|Subject Moved|0
6078113|NCT00414050|20988452|P4|Overall Study|Subject discontinued for other reason|1
6078114|NCT00414050|20988453|P3|Overall Study|Subject discontinued for other reason|2
6078115|NCT00414050|20988454|P2|Overall Study|Subject discontinued for other reason|2
6078116|NCT00414050|20988455|P1|Overall Study|Subject discontinued for other reason|1
6078117|NCT00414050|20988452|P4|Overall Study|Withdrawal by Subject|4
6078118|NCT00414050|20988453|P3|Overall Study|Withdrawal by Subject|2
6078119|NCT00414050|20988454|P2|Overall Study|Withdrawal by Subject|3
6078120|NCT00414050|20988455|P1|Overall Study|Withdrawal by Subject|5
6078121|NCT00414050|20988452|P4|Overall Study|Lost to Follow-up|1
6078122|NCT00414050|20988453|P3|Overall Study|Lost to Follow-up|1
6078123|NCT00414050|20988454|P2|Overall Study|Lost to Follow-up|2
6078124|NCT00414050|20988455|P1|Overall Study|Lost to Follow-up|2
6078125|NCT00414050|20988452|P4|Overall Study|Adverse Event|1
6078126|NCT00414050|20988453|P3|Overall Study|Adverse Event|1
6078127|NCT00414050|20988454|P2|Overall Study|Adverse Event|1
6078128|NCT00414050|20988455|P1|Overall Study|Adverse Event|1
6078129|NCT00414011|20988469|P1|Overall Study|Withdrawal by Subject|2
6078130|NCT00414011|20988469|P1|Overall Study|Physician Decision|3
6078131|NCT00413972|20988478|P4|Overall Study|Other|1
6078132|NCT00413972|20988479|P3|Overall Study|Other|0
6078133|NCT00413972|20988480|P2|Overall Study|Other|0
6078134|NCT00413972|20988481|P1|Overall Study|Other|0
6078135|NCT00413972|20988478|P4|Overall Study|Protocol Violation|0
6078136|NCT00413972|20988479|P3|Overall Study|Protocol Violation|2
6078137|NCT00413972|20988480|P2|Overall Study|Protocol Violation|0
6078138|NCT00413972|20988481|P1|Overall Study|Protocol Violation|0
6078139|NCT00413972|20988478|P4|Overall Study|Withdrawal by Subject|2
6078140|NCT00413972|20988479|P3|Overall Study|Withdrawal by Subject|7
6078141|NCT00413972|20988480|P2|Overall Study|Withdrawal by Subject|5
6078142|NCT00413972|20988481|P1|Overall Study|Withdrawal by Subject|4
6078143|NCT00413972|20988478|P4|Overall Study|Lost to Follow-up|0
6078144|NCT00413972|20988479|P3|Overall Study|Lost to Follow-up|1
6078145|NCT00413972|20988480|P2|Overall Study|Lost to Follow-up|2
6078146|NCT00413972|20988481|P1|Overall Study|Lost to Follow-up|1
6078147|NCT00413972|20988478|P4|Overall Study|Adverse Event|0
6078148|NCT00413972|20988479|P3|Overall Study|Adverse Event|0
6078149|NCT00413972|20988480|P2|Overall Study|Adverse Event|1
6078150|NCT00413972|20988481|P1|Overall Study|Adverse Event|2
6078151|NCT00413959|20988491|P1|Overall Study|Pt had only one cycle.|1
6078152|NCT00413920|20988498|P2|Overall Study|Graft Loss|3
6078153|NCT00413920|20988499|P1|Overall Study|Graft Loss|5
6078154|NCT00413920|20988498|P2|Overall Study|Death|5
6078155|NCT00413920|20988499|P1|Overall Study|Death|3
6078156|NCT00413920|20988498|P2|Overall Study|Lack of Efficacy|9
6078157|NCT00413920|20988499|P1|Overall Study|Lack of Efficacy|11
6078158|NCT00413920|20988498|P2|Overall Study|Adverse Event|11
6078159|NCT00413920|20988499|P1|Overall Study|Adverse Event|9
6078160|NCT00413894|20988514|P1|Overall Study|Other|18
6078161|NCT00413894|20988514|P1|Overall Study|Protocol Violation|11
6078162|NCT00413894|20988514|P1|Overall Study|Adverse Event|28
6078163|NCT00413894|20988514|P1|Overall Study|Hb <10 grams/deciliter|12
6078164|NCT00413894|20988514|P1|Overall Study|Administrative Reasons|1
6078165|NCT00413894|20988514|P1|Overall Study|Withdrawal by Subject|10
6078166|NCT00413777|20988531|P2|Fixed-dose Period|Withdrew Consent|1
6078167|NCT00413777|20988532|P1|Fixed-dose Period|Withdrew Consent|0
6078168|NCT00413777|20988531|P2|Fixed-dose Period|Met Withdrawal Criteria|0
6078169|NCT00413777|20988532|P1|Fixed-dose Period|Met Withdrawal Criteria|1
6078170|NCT00413777|20988531|P2|Fixed-dose Period|Adverse Event|1
6078171|NCT00413777|20988532|P1|Fixed-dose Period|Adverse Event|2
6078172|NCT00413777|20988531|P2|Fixed-dose Period|Lost to Follow-up|1
6078173|NCT00413777|20988532|P1|Fixed-dose Period|Lost to Follow-up|1
6078174|NCT00413699|20988580|P3|Extension Period|Adverse Event|2
6078175|NCT00413699|20988581|P2|Extension Period|Adverse Event|0
6078176|NCT00413699|20988582|P1|Extension Period|Adverse Event|0
6078177|NCT00413699|20988580|P3|Extension Period|Protocol Violation|1
6078178|NCT00413699|20988581|P2|Extension Period|Protocol Violation|0
6078179|NCT00413699|20988582|P1|Extension Period|Protocol Violation|0
6078180|NCT00413699|20988580|P3|Extension Period|No Longer Willing to Participate|2
6078181|NCT00413699|20988581|P2|Extension Period|No Longer Willing to Participate|0
6078182|NCT00413699|20988582|P1|Extension Period|No Longer Willing to Participate|0
6078183|NCT00413699|20988580|P3|Initial Period|No longer willing to participate|0
6078184|NCT00413699|20988581|P2|Initial Period|No longer willing to participate|368
6078185|NCT00413699|20988582|P1|Initial Period|No longer willing to participate|116
6078186|NCT00413699|20988580|P3|Initial Period|Missing end of study page|0
6078187|NCT00413699|20988581|P2|Initial Period|Missing end of study page|4
6078188|NCT00413699|20988582|P1|Initial Period|Missing end of study page|0
6078189|NCT00413699|20988580|P3|Initial Period|Adverse event not related to study drug|0
6078190|NCT00413699|20988581|P2|Initial Period|Adverse event not related to study drug|248
6078191|NCT00413699|20988582|P1|Initial Period|Adverse event not related to study drug|113
6078192|NCT00413699|20988580|P3|Initial Period|Adverse event related to study drug|0
6078193|NCT00413699|20988581|P2|Initial Period|Adverse event related to study drug|527
6078194|NCT00413699|20988582|P1|Initial Period|Adverse event related to study drug|178
6078195|NCT00413699|20988580|P3|Initial Period|Other|0
6078196|NCT00413699|20988581|P2|Initial Period|Other|211
6078197|NCT00413699|20988582|P1|Initial Period|Other|67
6078198|NCT00413699|20988580|P3|Initial Period|Study terminated by Sponsor|0
6078199|NCT00413699|20988581|P2|Initial Period|Study terminated by Sponsor|1
6078200|NCT00413699|20988582|P1|Initial Period|Study terminated by Sponsor|0
6078201|NCT00413699|20988580|P3|Initial Period|Medication error without adverse event|0
6078202|NCT00413699|20988581|P2|Initial Period|Medication error without adverse event|1
6078203|NCT00413699|20988582|P1|Initial Period|Medication error without adverse event|0
6078204|NCT00413699|20988580|P3|Initial Period|Did not meet entrance criteria|0
6078205|NCT00413699|20988581|P2|Initial Period|Did not meet entrance criteria|2
6078206|NCT00413699|20988582|P1|Initial Period|Did not meet entrance criteria|2
6078207|NCT00413699|20988580|P3|Initial Period|Pregnancy|0
6078208|NCT00413699|20988581|P2|Initial Period|Pregnancy|8
6078209|NCT00413699|20988582|P1|Initial Period|Pregnancy|10
6078210|NCT00413699|20988580|P3|Initial Period|Protocol Violation|0
6078211|NCT00413699|20988581|P2|Initial Period|Protocol Violation|89
6078212|NCT00413699|20988582|P1|Initial Period|Protocol Violation|38
6078213|NCT00413699|20988580|P3|Initial Period|Lost to Follow-up|0
6078214|NCT00413699|20988581|P2|Initial Period|Lost to Follow-up|101
6078215|NCT00413699|20988582|P1|Initial Period|Lost to Follow-up|31
6078216|NCT00413699|20988580|P3|Initial Period|Lack of Efficacy|0
6078217|NCT00413699|20988581|P2|Initial Period|Lack of Efficacy|115
6078218|NCT00413699|20988582|P1|Initial Period|Lack of Efficacy|59
6078219|NCT00413699|20988580|P3|Initial Period|Death|0
6078220|NCT00413699|20988581|P2|Initial Period|Death|30
6078221|NCT00413699|20988582|P1|Initial Period|Death|25
6078222|NCT00413660|20988664|P11|Post Week 12|Other|0
6078223|NCT00413660|20988665|P10|Post Week 12|Other|0
6078224|NCT00413660|20988666|P9|Post Week 12|Other|0
6078225|NCT00413660|20988667|P8|Post Week 12|Other|0
6078226|NCT00413660|20988668|P7|Post Week 12|Other|1
6078227|NCT00413660|20988669|P6|Post Week 12|Other|1
6078228|NCT00413660|20988670|P5|Post Week 12|Other|1
6078229|NCT00413660|20988671|P4|Post Week 12|Other|0
6078230|NCT00413660|20988672|P3|Post Week 12|Other|3
6078231|NCT00413660|20988673|P2|Post Week 12|Other|2
6078232|NCT00413660|20988674|P1|Post Week 12|Other|1
6078233|NCT00413660|20988664|P11|Post Week 12|Withdrawal by Subject|1
6078234|NCT00413660|20988665|P10|Post Week 12|Withdrawal by Subject|0
6078235|NCT00413660|20988666|P9|Post Week 12|Withdrawal by Subject|0
6078236|NCT00413660|20988667|P8|Post Week 12|Withdrawal by Subject|0
6078237|NCT00413660|20988668|P7|Post Week 12|Withdrawal by Subject|0
6078238|NCT00413660|20988669|P6|Post Week 12|Withdrawal by Subject|0
6078239|NCT00413660|20988670|P5|Post Week 12|Withdrawal by Subject|1
6078240|NCT00413660|20988671|P4|Post Week 12|Withdrawal by Subject|0
6078241|NCT00413660|20988672|P3|Post Week 12|Withdrawal by Subject|1
6078242|NCT00413660|20988673|P2|Post Week 12|Withdrawal by Subject|1
6078243|NCT00413660|20988674|P1|Post Week 12|Withdrawal by Subject|0
6078244|NCT00413660|20988664|P11|Post Week 12|Lost to Follow-up|0
6078245|NCT00413660|20988665|P10|Post Week 12|Lost to Follow-up|0
6078246|NCT00413660|20988666|P9|Post Week 12|Lost to Follow-up|0
6078247|NCT00413660|20988667|P8|Post Week 12|Lost to Follow-up|0
6078248|NCT00413660|20988668|P7|Post Week 12|Lost to Follow-up|0
6078249|NCT00413660|20988669|P6|Post Week 12|Lost to Follow-up|0
6078250|NCT00413660|20988670|P5|Post Week 12|Lost to Follow-up|0
6078251|NCT00413660|20988671|P4|Post Week 12|Lost to Follow-up|0
6078252|NCT00413660|20988672|P3|Post Week 12|Lost to Follow-up|1
6078253|NCT00413660|20988673|P2|Post Week 12|Lost to Follow-up|1
6078254|NCT00413660|20988674|P1|Post Week 12|Lost to Follow-up|0
6078255|NCT00413660|20988664|P11|Post Week 12|Lack of Efficacy|0
6078256|NCT00413660|20988665|P10|Post Week 12|Lack of Efficacy|1
6078257|NCT00413660|20988666|P9|Post Week 12|Lack of Efficacy|0
6078258|NCT00413660|20988667|P8|Post Week 12|Lack of Efficacy|0
6078259|NCT00413660|20988668|P7|Post Week 12|Lack of Efficacy|0
6078260|NCT00413660|20988669|P6|Post Week 12|Lack of Efficacy|0
6078261|NCT00413660|20988670|P5|Post Week 12|Lack of Efficacy|0
6078262|NCT00413660|20988671|P4|Post Week 12|Lack of Efficacy|0
6078263|NCT00413660|20988672|P3|Post Week 12|Lack of Efficacy|1
6078264|NCT00413660|20988673|P2|Post Week 12|Lack of Efficacy|0
6078265|NCT00413660|20988674|P1|Post Week 12|Lack of Efficacy|0
6078266|NCT00413660|20988664|P11|Post Week 12|Adverse Event|0
6078267|NCT00413660|20988665|P10|Post Week 12|Adverse Event|0
6078268|NCT00413660|20988666|P9|Post Week 12|Adverse Event|0
6078269|NCT00413660|20988667|P8|Post Week 12|Adverse Event|0
6078270|NCT00413660|20988668|P7|Post Week 12|Adverse Event|2
6078271|NCT00413660|20988669|P6|Post Week 12|Adverse Event|2
6078272|NCT00413660|20988670|P5|Post Week 12|Adverse Event|4
6078273|NCT00413660|20988671|P4|Post Week 12|Adverse Event|1
6078274|NCT00413660|20988672|P3|Post Week 12|Adverse Event|2
6078275|NCT00413660|20988673|P2|Post Week 12|Adverse Event|0
6078276|NCT00413660|20988674|P1|Post Week 12|Adverse Event|2
6078277|NCT00413660|20988664|P11|Up To Week 12|Other|0
6078278|NCT00413660|20988665|P10|Up To Week 12|Other|0
6078279|NCT00413660|20988666|P9|Up To Week 12|Other|0
6078280|NCT00413660|20988667|P8|Up To Week 12|Other|0
6078281|NCT00413660|20988668|P7|Up To Week 12|Other|3
6078282|NCT00413660|20988669|P6|Up To Week 12|Other|4
6078283|NCT00413660|20988670|P5|Up To Week 12|Other|2
6078284|NCT00413660|20988671|P4|Up To Week 12|Other|1
6078285|NCT00413660|20988672|P3|Up To Week 12|Other|6
6078286|NCT00413660|20988673|P2|Up To Week 12|Other|1
6078287|NCT00413660|20988674|P1|Up To Week 12|Other|3
6078288|NCT00413660|20988664|P11|Up To Week 12|Randomized, Not Treated|0
6078289|NCT00413660|20988665|P10|Up To Week 12|Randomized, Not Treated|0
6078290|NCT00413660|20988666|P9|Up To Week 12|Randomized, Not Treated|0
6078291|NCT00413660|20988667|P8|Up To Week 12|Randomized, Not Treated|0
6078292|NCT00413660|20988668|P7|Up To Week 12|Randomized, Not Treated|0
6078293|NCT00413660|20988669|P6|Up To Week 12|Randomized, Not Treated|0
6078294|NCT00413660|20988670|P5|Up To Week 12|Randomized, Not Treated|0
6078295|NCT00413660|20988671|P4|Up To Week 12|Randomized, Not Treated|1
6078296|NCT00413660|20988672|P3|Up To Week 12|Randomized, Not Treated|0
6078297|NCT00413660|20988673|P2|Up To Week 12|Randomized, Not Treated|0
6078298|NCT00413660|20988674|P1|Up To Week 12|Randomized, Not Treated|1
6078299|NCT00413660|20988664|P11|Up To Week 12|Withdrawal by Subject|0
6078300|NCT00413660|20988665|P10|Up To Week 12|Withdrawal by Subject|0
6078301|NCT00413660|20988666|P9|Up To Week 12|Withdrawal by Subject|0
6078302|NCT00413660|20988667|P8|Up To Week 12|Withdrawal by Subject|0
6078303|NCT00413660|20988668|P7|Up To Week 12|Withdrawal by Subject|2
6078304|NCT00413660|20988669|P6|Up To Week 12|Withdrawal by Subject|2
6078305|NCT00413660|20988670|P5|Up To Week 12|Withdrawal by Subject|0
6078306|NCT00413660|20988671|P4|Up To Week 12|Withdrawal by Subject|2
6078307|NCT00413660|20988672|P3|Up To Week 12|Withdrawal by Subject|0
6078308|NCT00413660|20988673|P2|Up To Week 12|Withdrawal by Subject|2
6078309|NCT00413660|20988674|P1|Up To Week 12|Withdrawal by Subject|0
6078310|NCT00413660|20988664|P11|Up To Week 12|Lost to Follow-up|0
6078311|NCT00413660|20988665|P10|Up To Week 12|Lost to Follow-up|0
6078312|NCT00413660|20988666|P9|Up To Week 12|Lost to Follow-up|0
6078313|NCT00413660|20988667|P8|Up To Week 12|Lost to Follow-up|0
6078314|NCT00413660|20988668|P7|Up To Week 12|Lost to Follow-up|0
6078315|NCT00413660|20988669|P6|Up To Week 12|Lost to Follow-up|0
6078316|NCT00413660|20988670|P5|Up To Week 12|Lost to Follow-up|1
6078317|NCT00413660|20988671|P4|Up To Week 12|Lost to Follow-up|0
6078318|NCT00413660|20988672|P3|Up To Week 12|Lost to Follow-up|0
6078319|NCT00413660|20988673|P2|Up To Week 12|Lost to Follow-up|1
6078320|NCT00413660|20988674|P1|Up To Week 12|Lost to Follow-up|0
6078321|NCT00413660|20988664|P11|Up To Week 12|Lack of Efficacy|0
6078322|NCT00413660|20988665|P10|Up To Week 12|Lack of Efficacy|0
6078323|NCT00413660|20988666|P9|Up To Week 12|Lack of Efficacy|0
6078324|NCT00413660|20988667|P8|Up To Week 12|Lack of Efficacy|0
6078325|NCT00413660|20988668|P7|Up To Week 12|Lack of Efficacy|5
6078326|NCT00413660|20988669|P6|Up To Week 12|Lack of Efficacy|0
6078327|NCT00413660|20988670|P5|Up To Week 12|Lack of Efficacy|0
6078328|NCT00413660|20988671|P4|Up To Week 12|Lack of Efficacy|0
6078329|NCT00413660|20988672|P3|Up To Week 12|Lack of Efficacy|0
6078330|NCT00413660|20988673|P2|Up To Week 12|Lack of Efficacy|0
6078331|NCT00413660|20988674|P1|Up To Week 12|Lack of Efficacy|2
6078332|NCT00413660|20988664|P11|Up To Week 12|Adverse Event|0
6078333|NCT00413660|20988665|P10|Up To Week 12|Adverse Event|0
6078334|NCT00413660|20988666|P9|Up To Week 12|Adverse Event|0
6078335|NCT00413660|20988667|P8|Up To Week 12|Adverse Event|0
6078336|NCT00413660|20988668|P7|Up To Week 12|Adverse Event|1
6078337|NCT00413660|20988669|P6|Up To Week 12|Adverse Event|4
6078338|NCT00413660|20988670|P5|Up To Week 12|Adverse Event|6
6078339|NCT00413660|20988671|P4|Up To Week 12|Adverse Event|4
6078340|NCT00413660|20988672|P3|Up To Week 12|Adverse Event|1
6078341|NCT00413660|20988673|P2|Up To Week 12|Adverse Event|3
6078342|NCT00413660|20988674|P1|Up To Week 12|Adverse Event|1
6078343|NCT00413413|20989077|P3|Double-Blind|Lost to Follow-up|2
6078344|NCT00413413|20989078|P2|Double-Blind|Lost to Follow-up|4
6078345|NCT00413413|20989079|P1|Double-Blind|Lost to Follow-up|3
6078346|NCT00413413|20989077|P3|Double-Blind|Subject withdrew consent|9
6078347|NCT00413413|20989078|P2|Double-Blind|Subject withdrew consent|6
6078348|NCT00413413|20989079|P1|Double-Blind|Subject withdrew consent|4
6078349|NCT00413413|20989077|P3|Double-Blind|Protocol deviation|1
6078350|NCT00413413|20989078|P2|Double-Blind|Protocol deviation|2
6078351|NCT00413413|20989079|P1|Double-Blind|Protocol deviation|1
6078352|NCT00413413|20989077|P3|Double-Blind|Unsatisfactory therapeutic effect|1
6078353|NCT00413413|20989078|P2|Double-Blind|Unsatisfactory therapeutic effect|2
6078354|NCT00413413|20989079|P1|Double-Blind|Unsatisfactory therapeutic effect|1
6078355|NCT00413413|20989077|P3|Double-Blind|Adverse Event|5
6078356|NCT00413413|20989078|P2|Double-Blind|Adverse Event|0
6078357|NCT00413413|20989079|P1|Double-Blind|Adverse Event|6
6078358|NCT00413413|20989077|P3|Single-Blind|Lost to Follow-up|0
6078359|NCT00413413|20989078|P2|Single-Blind|Lost to Follow-up|8
6078360|NCT00413413|20989079|P1|Single-Blind|Lost to Follow-up|0
6078361|NCT00413413|20989077|P3|Single-Blind|Withdrawal by Subject|0
6078362|NCT00413413|20989078|P2|Single-Blind|Withdrawal by Subject|27
6078363|NCT00413413|20989079|P1|Single-Blind|Withdrawal by Subject|0
6078364|NCT00413413|20989077|P3|Single-Blind|Protocol Violation|0
6078365|NCT00413413|20989078|P2|Single-Blind|Protocol Violation|16
6078366|NCT00413413|20989079|P1|Single-Blind|Protocol Violation|0
6078367|NCT00413413|20989077|P3|Single-Blind|Subject no longer requires study drug|0
6078368|NCT00413413|20989078|P2|Single-Blind|Subject no longer requires study drug|151
6078369|NCT00413413|20989079|P1|Single-Blind|Subject no longer requires study drug|0
6078370|NCT00413413|20989077|P3|Single-Blind|Lack of Efficacy|0
6078371|NCT00413413|20989078|P2|Single-Blind|Lack of Efficacy|5
6078372|NCT00413413|20989079|P1|Single-Blind|Lack of Efficacy|0
6078373|NCT00413413|20989077|P3|Single-Blind|Adverse Event|0
6078374|NCT00413413|20989078|P2|Single-Blind|Adverse Event|9
6078375|NCT00413413|20989079|P1|Single-Blind|Adverse Event|0
6078376|NCT00413374|20989132|P2|Overall Study|Surgery|0
6078377|NCT00413374|20989133|P1|Overall Study|Surgery|1
6078378|NCT00413374|20989132|P2|Overall Study|Lost to Follow-up|0
6078379|NCT00413374|20989133|P1|Overall Study|Lost to Follow-up|1
6078380|NCT00413374|20989132|P2|Overall Study|Adverse Event|0
6078381|NCT00413374|20989133|P1|Overall Study|Adverse Event|1
6078382|NCT00413374|20989132|P2|Overall Study|Ineligible due to screening criteria.|0
6078383|NCT00413374|20989133|P1|Overall Study|Ineligible due to screening criteria.|3
6078384|NCT00413283|20989164|P4|Overall Study|Other|0
6078385|NCT00413283|20989165|P3|Overall Study|Other|1
6078386|NCT00413283|20989166|P2|Overall Study|Other|0
6078387|NCT00413283|20989167|P1|Overall Study|Other|0
6078388|NCT00413283|20989164|P4|Overall Study|Requirement for alternative therapy|0
6078389|NCT00413283|20989165|P3|Overall Study|Requirement for alternative therapy|0
6078390|NCT00413283|20989166|P2|Overall Study|Requirement for alternative therapy|2
6078391|NCT00413283|20989167|P1|Overall Study|Requirement for alternative therapy|0
6078392|NCT00413283|20989164|P4|Overall Study|Protocol deviation|0
6078393|NCT00413283|20989165|P3|Overall Study|Protocol deviation|0
6078394|NCT00413283|20989166|P2|Overall Study|Protocol deviation|1
6078395|NCT00413283|20989167|P1|Overall Study|Protocol deviation|0
6078396|NCT00413283|20989164|P4|Overall Study|Ineligibility determined|1
6078397|NCT00413283|20989165|P3|Overall Study|Ineligibility determined|0
6078398|NCT00413283|20989166|P2|Overall Study|Ineligibility determined|0
6078399|NCT00413283|20989167|P1|Overall Study|Ineligibility determined|0
6078400|NCT00413283|20989164|P4|Overall Study|Adverse Event|1
6078401|NCT00413283|20989165|P3|Overall Study|Adverse Event|0
6078402|NCT00413283|20989166|P2|Overall Study|Adverse Event|0
6078403|NCT00413283|20989167|P1|Overall Study|Adverse Event|0
6078404|NCT00413283|20989164|P4|Overall Study|Death|1
6078405|NCT00413283|20989165|P3|Overall Study|Death|1
6078406|NCT00413283|20989166|P2|Overall Study|Death|0
6078407|NCT00413283|20989167|P1|Overall Study|Death|0
6078408|NCT00413283|20989164|P4|Overall Study|Withdrawal by Subject|1
6078409|NCT00413283|20989165|P3|Overall Study|Withdrawal by Subject|0
6078410|NCT00413283|20989166|P2|Overall Study|Withdrawal by Subject|0
6078411|NCT00413283|20989167|P1|Overall Study|Withdrawal by Subject|1
6078412|NCT00413244|20989199|P2|Overall Study|Withdrawal by Subject|1
6078413|NCT00413244|20989200|P1|Overall Study|Withdrawal by Subject|10
6078414|NCT00413231|20989228|P1|365-day to 60-month Post Treatment|Exited after surgical conversion|1
6078415|NCT00413231|20989228|P1|365-day to 60-month Post Treatment|Lost to Follow-up|4
6078416|NCT00413231|20989228|P1|365-day to 60-month Post Treatment|Withdrawal by Subject|5
6078417|NCT00413231|20989228|P1|365-day to 60-month Post Treatment|Death|36
6078418|NCT00413231|20989228|P1|30-day to 365-day Post Treatment|Death|13
6078419|NCT00413231|20989228|P1|0 to 30-day Post Treatment|Intend to treat, but not implanted|3
6078420|NCT00413231|20989228|P1|0 to 30-day Post Treatment|Death|5
6078421|NCT00413218|20989260|P2|Overall Study|Withdrawal by Subject|1
6078422|NCT00413218|20989261|P1|Overall Study|Withdrawal by Subject|9
6078423|NCT00413218|20989260|P2|Overall Study|Missing|0
6078424|NCT00413218|20989261|P1|Overall Study|Missing|1
6078425|NCT00413218|20989260|P2|Overall Study|Admin|14
6078426|NCT00413218|20989261|P1|Overall Study|Admin|20
6078427|NCT00413218|20989260|P2|Overall Study|Lost to Follow-up|17
6078428|NCT00413218|20989261|P1|Overall Study|Lost to Follow-up|14
6078429|NCT00413218|20989260|P2|Overall Study|Death|56
6078430|NCT00413218|20989261|P1|Overall Study|Death|57
6078431|NCT00413218|20989260|P2|Overall Study|Randomized but didn't receive study drug|8
6078432|NCT00413218|20989261|P1|Overall Study|Randomized but didn't receive study drug|2
6078433|NCT00413192|20989287|P4|Overall Study|Not treated|1
6078434|NCT00413192|20989288|P3|Overall Study|Not treated|0
6078435|NCT00413192|20989289|P2|Overall Study|Not treated|0
6078436|NCT00413192|20989290|P1|Overall Study|Not treated|0
6078437|NCT00413192|20989287|P4|Overall Study|Other|2
6078438|NCT00413192|20989288|P3|Overall Study|Other|1
6078439|NCT00413192|20989289|P2|Overall Study|Other|1
6078440|NCT00413192|20989290|P1|Overall Study|Other|5
6078441|NCT00413192|20989287|P4|Overall Study|Intercurrent death|0
6078442|NCT00413192|20989288|P3|Overall Study|Intercurrent death|0
6078443|NCT00413192|20989289|P2|Overall Study|Intercurrent death|1
6078444|NCT00413192|20989290|P1|Overall Study|Intercurrent death|0
6078445|NCT00413192|20989287|P4|Overall Study|Intercurrent illness|1
6078446|NCT00413192|20989288|P3|Overall Study|Intercurrent illness|0
6078447|NCT00413192|20989289|P2|Overall Study|Intercurrent illness|0
6078448|NCT00413192|20989290|P1|Overall Study|Intercurrent illness|0
6078449|NCT00413192|20989287|P4|Overall Study|Withdrawal by Subject|1
6078450|NCT00413192|20989288|P3|Overall Study|Withdrawal by Subject|0
6078451|NCT00413192|20989289|P2|Overall Study|Withdrawal by Subject|5
6078452|NCT00413192|20989290|P1|Overall Study|Withdrawal by Subject|3
6078453|NCT00413192|20989287|P4|Overall Study|Toxicity|2
6078454|NCT00413192|20989288|P3|Overall Study|Toxicity|2
6078455|NCT00413192|20989289|P2|Overall Study|Toxicity|2
6078456|NCT00413192|20989290|P1|Overall Study|Toxicity|3
6078457|NCT00413192|20989287|P4|Overall Study|Disease progression|25
6078458|NCT00413192|20989288|P3|Overall Study|Disease progression|16
6078459|NCT00413192|20989289|P2|Overall Study|Disease progression|31
6078460|NCT00413192|20989290|P1|Overall Study|Disease progression|26
6078461|NCT00413153|20989343|P2|Overall Study|Adverse Event|0
6078462|NCT00413153|20989344|P1|Overall Study|Adverse Event|1
6078463|NCT00413153|20989343|P2|Overall Study|Withdrawal by Subject|1
6078464|NCT00413153|20989344|P1|Overall Study|Withdrawal by Subject|1
6078465|NCT00413062|20989368|P2|Overall Study|Other reason|34
6078466|NCT00413062|20989369|P1|Overall Study|Other reason|70
6078467|NCT00413062|20989368|P2|Overall Study|Lost to Follow-up|73
6078468|NCT00413062|20989369|P1|Overall Study|Lost to Follow-up|175
6078469|NCT00413062|20989368|P2|Overall Study|Pregnancy wish|6
6078470|NCT00413062|20989369|P1|Overall Study|Pregnancy wish|17
6078471|NCT00413062|20989368|P2|Overall Study|Pregnancy|5
6078472|NCT00413062|20989369|P1|Overall Study|Pregnancy|15
6078473|NCT00413062|20989368|P2|Overall Study|Withdrawal of informed consent|36
6078474|NCT00413062|20989369|P1|Overall Study|Withdrawal of informed consent|111
6078475|NCT00413062|20989368|P2|Overall Study|Pre-treatment (serious) adverse event|0
6078476|NCT00413062|20989369|P1|Overall Study|Pre-treatment (serious) adverse event|1
6078477|NCT00413062|20989368|P2|Overall Study|Adverse event/serious adverse event|56
6078478|NCT00413062|20989369|P1|Overall Study|Adverse event/serious adverse event|289
6078479|NCT00413049|20989395|P2|Overall Study|Lack of Efficacy|0
6078480|NCT00413049|20989396|P1|Overall Study|Lack of Efficacy|1
6078481|NCT00413049|20989395|P2|Overall Study|Abnormal laboratory value(s)|0
6078482|NCT00413049|20989396|P1|Overall Study|Abnormal laboratory value(s)|1
6078483|NCT00413049|20989395|P2|Overall Study|Subject no longer requires study drug|1
6078484|NCT00413049|20989396|P1|Overall Study|Subject no longer requires study drug|0
6078485|NCT00413049|20989395|P2|Overall Study|Protocol Violation|1
6078486|NCT00413049|20989396|P1|Overall Study|Protocol Violation|3
6078487|NCT00413049|20989395|P2|Overall Study|Lost to Follow-up|3
6078488|NCT00413049|20989396|P1|Overall Study|Lost to Follow-up|2
6078489|NCT00413049|20989395|P2|Overall Study|Withdrawal by Subject|5
6078490|NCT00413049|20989396|P1|Overall Study|Withdrawal by Subject|7
6078491|NCT00413049|20989395|P2|Overall Study|Adverse Event|8
6078492|NCT00413049|20989396|P1|Overall Study|Adverse Event|10
6078493|NCT00413036|20989412|P1|Overall Study|Missing|2
6078494|NCT00413036|20989412|P1|Overall Study|Other|26
6078495|NCT00413036|20989412|P1|Overall Study|Death|9
6078496|NCT00413036|20989412|P1|Overall Study|Withdrawal by Subject|7
6078497|NCT00413036|20989412|P1|Overall Study|Lack of Efficacy|129
6078498|NCT00413036|20989412|P1|Overall Study|Adverse Event|44
6078511|NCT00412984|20989445|P2|Overall Study|Not Reported|12
6078512|NCT00412984|20989446|P1|Overall Study|Not Reported|11
6078513|NCT00412984|20989445|P2|Overall Study|Other Reason|92
6078514|NCT00412984|20989446|P1|Overall Study|Other Reason|80
6078515|NCT00412984|20989445|P2|Overall Study|Physician Refused to Continue Treatment|89
6078516|NCT00412984|20989446|P1|Overall Study|Physician Refused to Continue Treatment|81
6078517|NCT00412984|20989445|P2|Overall Study|Administrative Reason by Sponsor|8
6078518|NCT00412984|20989446|P1|Overall Study|Administrative Reason by Sponsor|11
6078519|NCT00412984|20989445|P2|Overall Study|Subject No Longer Meets Study Criteria|100
6078520|NCT00412984|20989446|P1|Overall Study|Subject No Longer Meets Study Criteria|87
6078521|NCT00412984|20989445|P2|Overall Study|Pregnancy|0
6078522|NCT00412984|20989446|P1|Overall Study|Pregnancy|1
6078523|NCT00412984|20989445|P2|Overall Study|Poor/Noncompliance|77
6078524|NCT00412984|20989446|P1|Overall Study|Poor/Noncompliance|57
6078525|NCT00412984|20989445|P2|Overall Study|Lost to Follow-up|39
6078526|NCT00412984|20989446|P1|Overall Study|Lost to Follow-up|51
6078527|NCT00412984|20989445|P2|Overall Study|Withdrawal by Subject|989
6078528|NCT00412984|20989446|P1|Overall Study|Withdrawal by Subject|921
6078529|NCT00412984|20989445|P2|Overall Study|Adverse Event|738
6078530|NCT00412984|20989446|P1|Overall Study|Adverse Event|679
6078531|NCT00412984|20989445|P2|Overall Study|Death|349
6078532|NCT00412984|20989446|P1|Overall Study|Death|331
6078533|NCT00412971|20989490|P2|Overall Study|Protocol Violation|1
6078534|NCT00412971|20989491|P1|Overall Study|Protocol Violation|13
6078535|NCT00412971|20989490|P2|Overall Study|Lost to Follow-up|9
6078536|NCT00412971|20989491|P1|Overall Study|Lost to Follow-up|17
6078537|NCT00412958|20989504|P4|Overall Study|Transport issue|0
6078538|NCT00412958|20989505|P3|Overall Study|Transport issue|0
6078539|NCT00412958|20989506|P2|Overall Study|Transport issue|1
6078540|NCT00412958|20989507|P1|Overall Study|Transport issue|0
6078541|NCT00412958|20989504|P4|Overall Study|Death|0
6078542|NCT00412958|20989505|P3|Overall Study|Death|0
6078543|NCT00412958|20989506|P2|Overall Study|Death|1
6078544|NCT00412958|20989507|P1|Overall Study|Death|0
6078545|NCT00412958|20989504|P4|Overall Study|Lost to Follow-up|0
6078546|NCT00412958|20989505|P3|Overall Study|Lost to Follow-up|0
6078547|NCT00412958|20989506|P2|Overall Study|Lost to Follow-up|1
6078548|NCT00412958|20989507|P1|Overall Study|Lost to Follow-up|0
6078549|NCT00412958|20989504|P4|Overall Study|Adverse Event|0
6078550|NCT00412958|20989505|P3|Overall Study|Adverse Event|0
6078551|NCT00412958|20989506|P2|Overall Study|Adverse Event|1
6078552|NCT00412958|20989507|P1|Overall Study|Adverse Event|0
6078553|NCT00412958|20989504|P4|Overall Study|Withdrawal by Subject|1
6078554|NCT00412958|20989505|P3|Overall Study|Withdrawal by Subject|0
6078555|NCT00412958|20989506|P2|Overall Study|Withdrawal by Subject|0
6078556|NCT00412958|20989507|P1|Overall Study|Withdrawal by Subject|3
6078557|NCT00412932|20989517|P1|Olm+ Hydrochlorothiazide 25 mg|Lost to Follow-up|1
6078558|NCT00412932|20989517|P1|Olm+ Hydrochlorothiazide 25 mg|Adverse Event|1
6078559|NCT00412932|20989517|P1|Olm+Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|3
6078560|NCT00412932|20989517|P1|Olm+Hydrochlorothiazide 12.5 mg|Adverse Event|3
6078561|NCT00412932|20989517|P1|Olmesartan 40 mg|Withdrawal by Subject|1
6078562|NCT00412932|20989517|P1|Olmesartan 40 mg|Lack of Efficacy|3
6078563|NCT00412932|20989517|P1|Olmesartan 40 mg|Adverse Event|4
6078564|NCT00412932|20989517|P1|Olmesartan (Olm) 20 mg|Other|1
6078565|NCT00412932|20989517|P1|Olmesartan (Olm) 20 mg|Withdrawal by Subject|2
6078566|NCT00412932|20989517|P1|Olmesartan (Olm) 20 mg|Protocol Violation|1
6078567|NCT00412932|20989517|P1|Olmesartan (Olm) 20 mg|Lack of Efficacy|2
6078568|NCT00412932|20989517|P1|Olmesartan (Olm) 20 mg|Adverse Event|1
6078569|NCT00412893|20989528|P2|Overall Study|Randomized but Never Received Study Drug|6
6078570|NCT00412893|20989529|P1|Overall Study|Randomized but Never Received Study Drug|5
6078571|NCT00412893|20989528|P2|Overall Study|Administrative Reason|15
6078572|NCT00412893|20989529|P1|Overall Study|Administrative Reason|12
6078573|NCT00412893|20989528|P2|Overall Study|Did Not Cooperate|9
6078574|NCT00412893|20989529|P1|Overall Study|Did Not Cooperate|12
6078575|NCT00412893|20989528|P2|Overall Study|Other Protocol Violation|6
6078576|NCT00412893|20989529|P1|Overall Study|Other Protocol Violation|10
6078577|NCT00412893|20989528|P2|Overall Study|Violation of Selection at Entry|10
6078578|NCT00412893|20989529|P1|Overall Study|Violation of Selection at Entry|17
6078579|NCT00412893|20989528|P2|Overall Study|Lost to Follow-up|1
6078580|NCT00412893|20989529|P1|Overall Study|Lost to Follow-up|2
6078581|NCT00412893|20989528|P2|Overall Study|Insufficient Therapeutic Response|23
6078582|NCT00412893|20989529|P1|Overall Study|Insufficient Therapeutic Response|39
6078583|NCT00412893|20989528|P2|Overall Study|Death|21
6078584|NCT00412893|20989529|P1|Overall Study|Death|17
6078585|NCT00412893|20989528|P2|Overall Study|Adverse Event|53
6078586|NCT00412893|20989529|P1|Overall Study|Adverse Event|31
6078587|NCT00412854|20989567|P2|Overall Study|Withdrawn for other reasons|11
6078588|NCT00412854|20989568|P1|Overall Study|Withdrawn for other reasons|13
6078589|NCT00412854|20989567|P2|Overall Study|Withdrawn due to adverse events|5
6078590|NCT00412854|20989568|P1|Overall Study|Withdrawn due to adverse events|1
6078591|NCT00412750|20989612|P3|Overall Study|Lack of Efficacy|3
6078592|NCT00412750|20989613|P2|Overall Study|Lack of Efficacy|0
6078593|NCT00412750|20989614|P1|Overall Study|Lack of Efficacy|0
6078594|NCT00412750|20989612|P3|Overall Study|Withdrawal by Subject|2
6078595|NCT00412750|20989613|P2|Overall Study|Withdrawal by Subject|1
6078596|NCT00412750|20989614|P1|Overall Study|Withdrawal by Subject|0
6078597|NCT00412750|20989612|P3|Overall Study|Lost to Follow-up|1
6078598|NCT00412750|20989613|P2|Overall Study|Lost to Follow-up|0
6078599|NCT00412750|20989614|P1|Overall Study|Lost to Follow-up|1
6078600|NCT00412750|20989612|P3|Overall Study|Adverse Event|3
6078601|NCT00412750|20989613|P2|Overall Study|Adverse Event|3
6078602|NCT00412750|20989614|P1|Overall Study|Adverse Event|8
6078603|NCT00412750|20989612|P3|Overall Study|Administrative problems|14
6078604|NCT00412750|20989613|P2|Overall Study|Administrative problems|17
6078605|NCT00412750|20989614|P1|Overall Study|Administrative problems|21
6078606|NCT00412750|20989612|P3|Overall Study|Abnormal laboratory value(s)|0
6078607|NCT00412750|20989613|P2|Overall Study|Abnormal laboratory value(s)|0
6078608|NCT00412750|20989614|P1|Overall Study|Abnormal laboratory value(s)|1
6078609|NCT00412737|20989639|P2|Overall Study|Failure to Return|2
6078610|NCT00412737|20989640|P1|Overall Study|Failure to Return|6
6078611|NCT00412737|20989639|P2|Overall Study|Refused Treatment|2
6078612|NCT00412737|20989640|P1|Overall Study|Refused Treatment|6
6078613|NCT00412737|20989639|P2|Overall Study|Adverse Event|2
6078614|NCT00412737|20989640|P1|Overall Study|Adverse Event|3
6078615|NCT00412737|20989639|P2|Overall Study|Death|0
6078616|NCT00412737|20989640|P1|Overall Study|Death|1
6078617|NCT00412607|20989658|P1|Overall Study|Not meet inclusion/exclusion Criteria|15
6078618|NCT00412607|20989658|P1|Overall Study|Death|61
6078619|NCT00412607|20989658|P1|Overall Study|Lost to Follow-up|19
6078620|NCT00412607|20989658|P1|Overall Study|Withdrawal by Subject|9
6078621|NCT00412542|20989671|P2|Overall Study|Not Eligible|1
6078622|NCT00412542|20989672|P1|Overall Study|Not Eligible|0
6078623|NCT00412542|20989671|P2|Overall Study|Withdrawal by Subject|2
6078624|NCT00412542|20989672|P1|Overall Study|Withdrawal by Subject|0
6078625|NCT00412373|20989757|P2|Overall Study|Other|2
6078626|NCT00412373|20989758|P1|Overall Study|Other|2
6078627|NCT00412373|20989757|P2|Overall Study|Withdrawal by Subject|27
6078628|NCT00412373|20989758|P1|Overall Study|Withdrawal by Subject|8
6078629|NCT00412373|20989757|P2|Overall Study|Lost to Follow-up|13
6078630|NCT00412373|20989758|P1|Overall Study|Lost to Follow-up|7
6078631|NCT00412373|20989757|P2|Overall Study|Lack of Efficacy|22
6078632|NCT00412373|20989758|P1|Overall Study|Lack of Efficacy|16
6078633|NCT00412373|20989757|P2|Overall Study|Adverse Event|13
6078634|NCT00412373|20989758|P1|Overall Study|Adverse Event|8
6078635|NCT00412360|20989800|P2|Overall Study|Not Transplanted|2
6078636|NCT00412360|20989801|P1|Overall Study|Not Transplanted|1
6078637|NCT00412360|20989800|P2|Overall Study|Lost to Follow-up|1
6078638|NCT00412360|20989801|P1|Overall Study|Lost to Follow-up|0
6078639|NCT00412217|20989831|P2|Overall Study|Other|1
6078640|NCT00412217|20989832|P1|Overall Study|Other|1
6078641|NCT00412217|20989831|P2|Overall Study|Study Terminated by Sponsor|33
6078642|NCT00412217|20989832|P1|Overall Study|Study Terminated by Sponsor|26
6078643|NCT00412217|20989831|P2|Overall Study|Lost to Follow-up|4
6078644|NCT00412217|20989832|P1|Overall Study|Lost to Follow-up|1
6078645|NCT00412217|20989831|P2|Overall Study|Withdrawal by Subject|0
6078646|NCT00412217|20989832|P1|Overall Study|Withdrawal by Subject|2
6078647|NCT00412217|20989831|P2|Overall Study|Investigator Decision|0
6078648|NCT00412217|20989832|P1|Overall Study|Investigator Decision|1
6078649|NCT00412217|20989831|P2|Overall Study|Disease Progression|3
6078650|NCT00412217|20989832|P1|Overall Study|Disease Progression|2
6078651|NCT00412217|20989831|P2|Overall Study|Death|4
6078652|NCT00412217|20989832|P1|Overall Study|Death|5
6078653|NCT00412217|20989831|P2|Overall Study|Insufficient Data Available|3
6078654|NCT00412217|20989832|P1|Overall Study|Insufficient Data Available|8
6078659|NCT00412061|20989931|P2|Open Label Phase|New Cancer Therapy|1
6078660|NCT00412061|20989932|P1|Open Label Phase|New Cancer Therapy|0
6078661|NCT00412061|20989931|P2|Open Label Phase|Lost to Follow-up|2
6078662|NCT00412061|20989932|P1|Open Label Phase|Lost to Follow-up|0
6078663|NCT00412061|20989931|P2|Open Label Phase|Death|7
6078664|NCT00412061|20989932|P1|Open Label Phase|Death|0
6078665|NCT00412061|20989931|P2|Open Label Phase|Administrative Problems|13
6078666|NCT00412061|20989932|P1|Open Label Phase|Administrative Problems|0
6078667|NCT00412061|20989931|P2|Open Label Phase|Withdrawal by Subject|15
6078668|NCT00412061|20989932|P1|Open Label Phase|Withdrawal by Subject|0
6078669|NCT00412061|20989931|P2|Open Label Phase|Adverse Event|46
6078670|NCT00412061|20989932|P1|Open Label Phase|Adverse Event|0
6078671|NCT00412061|20989931|P2|Open Label Phase|Disease Progression|86
6078672|NCT00412061|20989932|P1|Open Label Phase|Disease Progression|0
6078673|NCT00412061|20989931|P2|Double Blind Phase|Lost to Follow-up|1
6078674|NCT00412061|20989932|P1|Double Blind Phase|Lost to Follow-up|0
6078675|NCT00412061|20989931|P2|Double Blind Phase|New Cander Therapy|1
6078676|NCT00412061|20989932|P1|Double Blind Phase|New Cander Therapy|1
6078677|NCT00412061|20989931|P2|Double Blind Phase|Protocol Violation|4
6078678|NCT00412061|20989932|P1|Double Blind Phase|Protocol Violation|3
6078679|NCT00412061|20989931|P2|Double Blind Phase|Death|3
6078680|NCT00412061|20989932|P1|Double Blind Phase|Death|6
6078681|NCT00412061|20989931|P2|Double Blind Phase|Withdrawal by Subject|20
6078682|NCT00412061|20989932|P1|Double Blind Phase|Withdrawal by Subject|18
6078683|NCT00412061|20989931|P2|Double Blind Phase|Final Primary Analysis|14
6078684|NCT00412061|20989932|P1|Double Blind Phase|Final Primary Analysis|26
6078685|NCT00412061|20989931|P2|Double Blind Phase|Adverse Event|16
6078686|NCT00412061|20989932|P1|Double Blind Phase|Adverse Event|61
6078687|NCT00412061|20989931|P2|Double Blind Phase|Disease Progression|154
6078688|NCT00412061|20989932|P1|Double Blind Phase|Disease Progression|101
6078689|NCT00411788|20989950|P1|Overall Study|Adverse Event|1
6078690|NCT00411788|20989950|P1|Overall Study|Protocol Violation|1
6078691|NCT00411762|20989959|P1|Overall Study|Withdrawal by Subject|5
6078692|NCT00411671|20989983|P1|Overall Study|Lost to Follow-up|3
6078693|NCT00411671|20989983|P1|Overall Study|Death|2
6078694|NCT00411671|20989983|P1|Overall Study|Adverse Event|15
6078695|NCT00411645|20989991|P2|Overall Study|Lost to Follow-up|0
6078696|NCT00411645|20989992|P1|Overall Study|Lost to Follow-up|2
6078697|NCT00411645|20989991|P2|Overall Study|Investigator/Sponsor Decision|7
6078698|NCT00411645|20989992|P1|Overall Study|Investigator/Sponsor Decision|10
6078699|NCT00411645|20989991|P2|Overall Study|Death|135
6078700|NCT00411645|20989992|P1|Overall Study|Death|56
6078701|NCT00411645|20989991|P2|Overall Study|Consent Withdrawn|22
6078702|NCT00411645|20989992|P1|Overall Study|Consent Withdrawn|13
6078703|NCT00411632|20990016|P1|Overall Study|Death|1
6078704|NCT00411554|20990027|P2|Overall Study|Patient Moved|0
6078705|NCT00411554|20990028|P1|Overall Study|Patient Moved|1
6078706|NCT00411554|20990027|P2|Overall Study|Withdrawal by Subject|0
6078707|NCT00411554|20990028|P1|Overall Study|Withdrawal by Subject|3
6078708|NCT00411554|20990027|P2|Overall Study|Lack of Efficacy|5
6078709|NCT00411554|20990028|P1|Overall Study|Lack of Efficacy|2
6078710|NCT00411554|20990027|P2|Overall Study|Adverse Event|4
6078711|NCT00411554|20990028|P1|Overall Study|Adverse Event|2
6078712|NCT00411450|20990054|P1|Overall Study|Ongoing at time of data cut-off.|3
6078713|NCT00411216|20990097|P2|Overall Study|Ten participants were entered into the c|2
6078714|NCT00411216|20990098|P1|Overall Study|Ten participants were entered into the c|0
6078715|NCT00411151|20990104|P1|Overall Study|Trial prematurely closed|4
6078716|NCT00411151|20990104|P1|Overall Study|Protocol Violation|1
6078717|NCT00411151|20990104|P1|Overall Study|Lost to Follow-up|2
6078718|NCT00411151|20990104|P1|Overall Study|Withdrawal by Subject|2
6078719|NCT00411151|20990104|P1|Overall Study|Death|38
6078720|NCT00410813|20990148|P2|Overall Study|Death|2
6078721|NCT00410813|20990149|P1|Overall Study|Death|0
6078722|NCT00410813|20990148|P2|Overall Study|Ineligible|4
6078723|NCT00410813|20990149|P1|Overall Study|Ineligible|2
6078724|NCT00410813|20990148|P2|Overall Study|Not protocol specified|4
6078725|NCT00410813|20990149|P1|Overall Study|Not protocol specified|3
6078726|NCT00410813|20990148|P2|Overall Study|Progression|21
6078727|NCT00410813|20990149|P1|Overall Study|Progression|32
6078728|NCT00410813|20990148|P2|Overall Study|Adverse Event|11
6078729|NCT00410813|20990149|P1|Overall Study|Adverse Event|6
6078730|NCT00410761|20990186|P2|Overall Study|Never received randomised treatment|1
6078731|NCT00410761|20990187|P1|Overall Study|Never received randomised treatment|0
6078732|NCT00410761|20990186|P2|Overall Study|Other|9
6078733|NCT00410761|20990187|P1|Overall Study|Other|12
6078734|NCT00410761|20990186|P2|Overall Study|Withdrawal by Subject|4
6078735|NCT00410761|20990187|P1|Overall Study|Withdrawal by Subject|8
6078736|NCT00410761|20990186|P2|Overall Study|objective disease progression|55
6078737|NCT00410761|20990187|P1|Overall Study|objective disease progression|71
6078738|NCT00410761|20990186|P2|Overall Study|Adverse Event|3
6078739|NCT00410761|20990187|P1|Overall Study|Adverse Event|29
6078740|NCT00410605|20990207|P1|Overall Study|Transferred to another Institution|1
6078741|NCT00410605|20990207|P1|Overall Study|Stopped treatmen to collect stem cells|1
6078742|NCT00410605|20990207|P1|Overall Study|Started Non-Protocol Therapy|3
6078743|NCT00410605|20990207|P1|Overall Study|Withdrawal by Subject|5
6078744|NCT00410605|20990207|P1|Overall Study|Physician Decision|3
6078745|NCT00410605|20990207|P1|Overall Study|Adverse Event|12
6078746|NCT00410514|20990219|P3|Overall Study|Non-compliant with study procedures|2
6078747|NCT00410514|20990220|P2|Overall Study|Non-compliant with study procedures|0
6078748|NCT00410514|20990221|P1|Overall Study|Non-compliant with study procedures|0
6078749|NCT00410514|20990219|P3|Overall Study|Lost to Follow-up|2
6078750|NCT00410514|20990220|P2|Overall Study|Lost to Follow-up|0
6078751|NCT00410514|20990221|P1|Overall Study|Lost to Follow-up|0
6078752|NCT00410514|20990219|P3|Overall Study|Protocol Violation|1
6078753|NCT00410514|20990220|P2|Overall Study|Protocol Violation|1
6078754|NCT00410514|20990221|P1|Overall Study|Protocol Violation|0
6078755|NCT00410514|20990219|P3|Overall Study|Adverse Event|2
6078756|NCT00410514|20990220|P2|Overall Study|Adverse Event|2
6078757|NCT00410514|20990221|P1|Overall Study|Adverse Event|2
6078758|NCT00410410|20990304|P9|Open-Label Period (OL)|Other|7
6078759|NCT00410410|20990305|P8|Open-Label Period (OL)|Other|0
6078760|NCT00410410|20990306|P7|Open-Label Period (OL)|Other|0
6078761|NCT00410410|20990307|P6|Open-Label Period (OL)|Other|0
6078762|NCT00410410|20990308|P5|Open-Label Period (OL)|Other|0
6078763|NCT00410410|20990309|P4|Open-Label Period (OL)|Other|0
6078764|NCT00410410|20990310|P3|Open-Label Period (OL)|Other|0
6078765|NCT00410410|20990311|P2|Open-Label Period (OL)|Other|0
6078766|NCT00410410|20990312|P1|Open-Label Period (OL)|Other|0
6078767|NCT00410410|20990304|P9|Open-Label Period (OL)|Administrative Reason By Sponsor|145
6078768|NCT00410410|20990305|P8|Open-Label Period (OL)|Administrative Reason By Sponsor|0
6078769|NCT00410410|20990306|P7|Open-Label Period (OL)|Administrative Reason By Sponsor|0
6078770|NCT00410410|20990307|P6|Open-Label Period (OL)|Administrative Reason By Sponsor|0
6078771|NCT00410410|20990308|P5|Open-Label Period (OL)|Administrative Reason By Sponsor|0
6078772|NCT00410410|20990309|P4|Open-Label Period (OL)|Administrative Reason By Sponsor|0
6078773|NCT00410410|20990310|P3|Open-Label Period (OL)|Administrative Reason By Sponsor|0
6078774|NCT00410410|20990311|P2|Open-Label Period (OL)|Administrative Reason By Sponsor|0
6078775|NCT00410410|20990312|P1|Open-Label Period (OL)|Administrative Reason By Sponsor|0
6078776|NCT00410410|20990304|P9|Open-Label Period (OL)|Pregnancy|1
6078777|NCT00410410|20990305|P8|Open-Label Period (OL)|Pregnancy|0
6078778|NCT00410410|20990306|P7|Open-Label Period (OL)|Pregnancy|0
6078779|NCT00410410|20990307|P6|Open-Label Period (OL)|Pregnancy|0
6078780|NCT00410410|20990308|P5|Open-Label Period (OL)|Pregnancy|0
6078781|NCT00410410|20990309|P4|Open-Label Period (OL)|Pregnancy|0
6078782|NCT00410410|20990310|P3|Open-Label Period (OL)|Pregnancy|0
6078783|NCT00410410|20990311|P2|Open-Label Period (OL)|Pregnancy|0
6078784|NCT00410410|20990312|P1|Open-Label Period (OL)|Pregnancy|0
6078785|NCT00410410|20990304|P9|Open-Label Period (OL)|Withdrawal by Subject|20
6078786|NCT00410410|20990305|P8|Open-Label Period (OL)|Withdrawal by Subject|0
6078787|NCT00410410|20990306|P7|Open-Label Period (OL)|Withdrawal by Subject|0
6078788|NCT00410410|20990307|P6|Open-Label Period (OL)|Withdrawal by Subject|0
6078789|NCT00410410|20990308|P5|Open-Label Period (OL)|Withdrawal by Subject|0
6078790|NCT00410410|20990309|P4|Open-Label Period (OL)|Withdrawal by Subject|0
6078791|NCT00410410|20990310|P3|Open-Label Period (OL)|Withdrawal by Subject|0
6078792|NCT00410410|20990311|P2|Open-Label Period (OL)|Withdrawal by Subject|0
6078793|NCT00410410|20990312|P1|Open-Label Period (OL)|Withdrawal by Subject|0
6078794|NCT00410410|20990304|P9|Open-Label Period (OL)|Lost to Follow-up|4
6078795|NCT00410410|20990305|P8|Open-Label Period (OL)|Lost to Follow-up|0
6078796|NCT00410410|20990306|P7|Open-Label Period (OL)|Lost to Follow-up|0
6078797|NCT00410410|20990307|P6|Open-Label Period (OL)|Lost to Follow-up|0
6078798|NCT00410410|20990308|P5|Open-Label Period (OL)|Lost to Follow-up|0
6078799|NCT00410410|20990309|P4|Open-Label Period (OL)|Lost to Follow-up|0
6078800|NCT00410410|20990310|P3|Open-Label Period (OL)|Lost to Follow-up|0
6078801|NCT00410410|20990311|P2|Open-Label Period (OL)|Lost to Follow-up|0
6078802|NCT00410410|20990312|P1|Open-Label Period (OL)|Lost to Follow-up|0
6078803|NCT00410410|20990304|P9|Open-Label Period (OL)|Lack of Efficacy|161
6078804|NCT00410410|20990305|P8|Open-Label Period (OL)|Lack of Efficacy|0
6078805|NCT00410410|20990306|P7|Open-Label Period (OL)|Lack of Efficacy|0
6078806|NCT00410410|20990307|P6|Open-Label Period (OL)|Lack of Efficacy|0
6078807|NCT00410410|20990308|P5|Open-Label Period (OL)|Lack of Efficacy|0
6078808|NCT00410410|20990309|P4|Open-Label Period (OL)|Lack of Efficacy|0
6078809|NCT00410410|20990310|P3|Open-Label Period (OL)|Lack of Efficacy|0
6078810|NCT00410410|20990311|P2|Open-Label Period (OL)|Lack of Efficacy|0
6078811|NCT00410410|20990312|P1|Open-Label Period (OL)|Lack of Efficacy|0
6078812|NCT00410410|20990304|P9|Open-Label Period (OL)|Adverse Event|10
6078813|NCT00410410|20990305|P8|Open-Label Period (OL)|Adverse Event|0
6078814|NCT00410410|20990306|P7|Open-Label Period (OL)|Adverse Event|0
6078815|NCT00410410|20990307|P6|Open-Label Period (OL)|Adverse Event|0
6078816|NCT00410410|20990308|P5|Open-Label Period (OL)|Adverse Event|0
6078817|NCT00410410|20990309|P4|Open-Label Period (OL)|Adverse Event|0
6078818|NCT00410410|20990310|P3|Open-Label Period (OL)|Adverse Event|0
6078819|NCT00410410|20990311|P2|Open-Label Period (OL)|Adverse Event|0
6078820|NCT00410410|20990312|P1|Open-Label Period (OL)|Adverse Event|0
6078821|NCT00410410|20990304|P9|Open-Label Period (OL)|Death|1
6078822|NCT00410410|20990305|P8|Open-Label Period (OL)|Death|0
6078823|NCT00410410|20990306|P7|Open-Label Period (OL)|Death|0
6078824|NCT00410410|20990307|P6|Open-Label Period (OL)|Death|0
6078825|NCT00410410|20990308|P5|Open-Label Period (OL)|Death|0
6078826|NCT00410410|20990309|P4|Open-Label Period (OL)|Death|0
6078827|NCT00410410|20990310|P3|Open-Label Period (OL)|Death|0
6078828|NCT00410410|20990311|P2|Open-Label Period (OL)|Death|0
6078829|NCT00410410|20990312|P1|Open-Label Period (OL)|Death|0
6078830|NCT00410410|20990304|P9|Maintenance Period (MP)|Administrative Reason By Sponsor|0
6078831|NCT00410410|20990305|P8|Maintenance Period (MP)|Administrative Reason By Sponsor|25
6078832|NCT00410410|20990306|P7|Maintenance Period (MP)|Administrative Reason By Sponsor|21
6078833|NCT00410410|20990307|P6|Maintenance Period (MP)|Administrative Reason By Sponsor|0
6078834|NCT00410410|20990308|P5|Maintenance Period (MP)|Administrative Reason By Sponsor|0
6078835|NCT00410410|20990309|P4|Maintenance Period (MP)|Administrative Reason By Sponsor|0
6078836|NCT00410410|20990310|P3|Maintenance Period (MP)|Administrative Reason By Sponsor|0
6078837|NCT00410410|20990311|P2|Maintenance Period (MP)|Administrative Reason By Sponsor|0
6078838|NCT00410410|20990312|P1|Maintenance Period (MP)|Administrative Reason By Sponsor|0
6078839|NCT00410410|20990304|P9|Maintenance Period (MP)|Withdrawal by Subject|0
6078840|NCT00410410|20990305|P8|Maintenance Period (MP)|Withdrawal by Subject|1
6078841|NCT00410410|20990306|P7|Maintenance Period (MP)|Withdrawal by Subject|1
6078842|NCT00410410|20990307|P6|Maintenance Period (MP)|Withdrawal by Subject|0
6078843|NCT00410410|20990308|P5|Maintenance Period (MP)|Withdrawal by Subject|0
6078844|NCT00410410|20990309|P4|Maintenance Period (MP)|Withdrawal by Subject|0
6078845|NCT00410410|20990310|P3|Maintenance Period (MP)|Withdrawal by Subject|0
6078846|NCT00410410|20990311|P2|Maintenance Period (MP)|Withdrawal by Subject|0
6078847|NCT00410410|20990312|P1|Maintenance Period (MP)|Withdrawal by Subject|0
6078848|NCT00410410|20990304|P9|Maintenance Period (MP)|Lost to Follow-up|0
6078849|NCT00410410|20990305|P8|Maintenance Period (MP)|Lost to Follow-up|2
6078850|NCT00410410|20990306|P7|Maintenance Period (MP)|Lost to Follow-up|1
6078851|NCT00410410|20990307|P6|Maintenance Period (MP)|Lost to Follow-up|0
6078852|NCT00410410|20990308|P5|Maintenance Period (MP)|Lost to Follow-up|0
6078853|NCT00410410|20990309|P4|Maintenance Period (MP)|Lost to Follow-up|0
6078854|NCT00410410|20990310|P3|Maintenance Period (MP)|Lost to Follow-up|0
6078855|NCT00410410|20990311|P2|Maintenance Period (MP)|Lost to Follow-up|0
6078856|NCT00410410|20990312|P1|Maintenance Period (MP)|Lost to Follow-up|0
6078857|NCT00410410|20990304|P9|Maintenance Period (MP)|Lack of Efficacy|0
6078858|NCT00410410|20990305|P8|Maintenance Period (MP)|Lack of Efficacy|24
6078859|NCT00410410|20990306|P7|Maintenance Period (MP)|Lack of Efficacy|25
6078860|NCT00410410|20990307|P6|Maintenance Period (MP)|Lack of Efficacy|0
6078861|NCT00410410|20990308|P5|Maintenance Period (MP)|Lack of Efficacy|0
6078862|NCT00410410|20990309|P4|Maintenance Period (MP)|Lack of Efficacy|0
6078863|NCT00410410|20990310|P3|Maintenance Period (MP)|Lack of Efficacy|0
6078864|NCT00410410|20990311|P2|Maintenance Period (MP)|Lack of Efficacy|0
6078865|NCT00410410|20990312|P1|Maintenance Period (MP)|Lack of Efficacy|0
6078866|NCT00410410|20990304|P9|Maintenance Period (MP)|Adverse Event|0
6078867|NCT00410410|20990305|P8|Maintenance Period (MP)|Adverse Event|3
6078868|NCT00410410|20990306|P7|Maintenance Period (MP)|Adverse Event|1
6078869|NCT00410410|20990307|P6|Maintenance Period (MP)|Adverse Event|0
6078870|NCT00410410|20990308|P5|Maintenance Period (MP)|Adverse Event|0
6078871|NCT00410410|20990309|P4|Maintenance Period (MP)|Adverse Event|0
6078872|NCT00410410|20990310|P3|Maintenance Period (MP)|Adverse Event|0
6078873|NCT00410410|20990311|P2|Maintenance Period (MP)|Adverse Event|0
6078874|NCT00410410|20990312|P1|Maintenance Period (MP)|Adverse Event|0
6078875|NCT00410410|20990304|P9|Maintenance Period (MP)|Death|0
6078876|NCT00410410|20990305|P8|Maintenance Period (MP)|Death|0
6078877|NCT00410410|20990306|P7|Maintenance Period (MP)|Death|1
6078878|NCT00410410|20990307|P6|Maintenance Period (MP)|Death|0
6078879|NCT00410410|20990308|P5|Maintenance Period (MP)|Death|0
6078880|NCT00410410|20990309|P4|Maintenance Period (MP)|Death|0
6078881|NCT00410410|20990310|P3|Maintenance Period (MP)|Death|0
6078882|NCT00410410|20990311|P2|Maintenance Period (MP)|Death|0
6078883|NCT00410410|20990312|P1|Maintenance Period (MP)|Death|0
6078884|NCT00410410|20990304|P9|Induction Period (IP)|Other|0
6078885|NCT00410410|20990305|P8|Induction Period (IP)|Other|0
6078886|NCT00410410|20990306|P7|Induction Period (IP)|Other|0
6078887|NCT00410410|20990307|P6|Induction Period (IP)|Other|0
6078888|NCT00410410|20990308|P5|Induction Period (IP)|Other|0
6078889|NCT00410410|20990309|P4|Induction Period (IP)|Other|0
6078890|NCT00410410|20990310|P3|Induction Period (IP)|Other|1
6078891|NCT00410410|20990311|P2|Induction Period (IP)|Other|0
6078892|NCT00410410|20990312|P1|Induction Period (IP)|Other|0
6078893|NCT00410410|20990304|P9|Induction Period (IP)|Administrative Reason By Sponsor|0
6078894|NCT00410410|20990305|P8|Induction Period (IP)|Administrative Reason By Sponsor|0
6078895|NCT00410410|20990306|P7|Induction Period (IP)|Administrative Reason By Sponsor|0
6078896|NCT00410410|20990307|P6|Induction Period (IP)|Administrative Reason By Sponsor|21
6078897|NCT00410410|20990308|P5|Induction Period (IP)|Administrative Reason By Sponsor|22
6078898|NCT00410410|20990309|P4|Induction Period (IP)|Administrative Reason By Sponsor|0
6078899|NCT00410410|20990310|P3|Induction Period (IP)|Administrative Reason By Sponsor|0
6078900|NCT00410410|20990311|P2|Induction Period (IP)|Administrative Reason By Sponsor|0
6078901|NCT00410410|20990312|P1|Induction Period (IP)|Administrative Reason By Sponsor|0
6078902|NCT00410410|20990304|P9|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
6078903|NCT00410410|20990305|P8|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
6078904|NCT00410410|20990306|P7|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
6078905|NCT00410410|20990307|P6|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
6078906|NCT00410410|20990308|P5|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
6078907|NCT00410410|20990309|P4|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
6078908|NCT00410410|20990310|P3|Induction Period (IP)|Subject No Longer Meets Study Criteria|1
6078909|NCT00410410|20990311|P2|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
6078910|NCT00410410|20990312|P1|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
6078911|NCT00410410|20990304|P9|Induction Period (IP)|Withdrawal by Subject|0
6078912|NCT00410410|20990305|P8|Induction Period (IP)|Withdrawal by Subject|0
6078913|NCT00410410|20990306|P7|Induction Period (IP)|Withdrawal by Subject|0
6078914|NCT00410410|20990307|P6|Induction Period (IP)|Withdrawal by Subject|0
6078915|NCT00410410|20990308|P5|Induction Period (IP)|Withdrawal by Subject|2
6078916|NCT00410410|20990309|P4|Induction Period (IP)|Withdrawal by Subject|5
6078917|NCT00410410|20990310|P3|Induction Period (IP)|Withdrawal by Subject|3
6078918|NCT00410410|20990311|P2|Induction Period (IP)|Withdrawal by Subject|5
6078919|NCT00410410|20990312|P1|Induction Period (IP)|Withdrawal by Subject|3
6078920|NCT00410410|20990304|P9|Induction Period (IP)|Lost to Follow-up|0
6078921|NCT00410410|20990305|P8|Induction Period (IP)|Lost to Follow-up|0
6078922|NCT00410410|20990306|P7|Induction Period (IP)|Lost to Follow-up|0
6078923|NCT00410410|20990307|P6|Induction Period (IP)|Lost to Follow-up|1
6078924|NCT00410410|20990308|P5|Induction Period (IP)|Lost to Follow-up|0
6078925|NCT00410410|20990309|P4|Induction Period (IP)|Lost to Follow-up|3
6078926|NCT00410410|20990310|P3|Induction Period (IP)|Lost to Follow-up|2
6078927|NCT00410410|20990311|P2|Induction Period (IP)|Lost to Follow-up|2
6078928|NCT00410410|20990312|P1|Induction Period (IP)|Lost to Follow-up|2
6078929|NCT00410410|20990304|P9|Induction Period (IP)|Lack of Efficacy|0
6078930|NCT00410410|20990305|P8|Induction Period (IP)|Lack of Efficacy|0
6078931|NCT00410410|20990306|P7|Induction Period (IP)|Lack of Efficacy|0
6078932|NCT00410410|20990307|P6|Induction Period (IP)|Lack of Efficacy|7
6078933|NCT00410410|20990308|P5|Induction Period (IP)|Lack of Efficacy|7
6078934|NCT00410410|20990309|P4|Induction Period (IP)|Lack of Efficacy|8
6078935|NCT00410410|20990310|P3|Induction Period (IP)|Lack of Efficacy|8
6078936|NCT00410410|20990311|P2|Induction Period (IP)|Lack of Efficacy|24
6078937|NCT00410410|20990312|P1|Induction Period (IP)|Lack of Efficacy|26
6078938|NCT00410410|20990304|P9|Induction Period (IP)|Adverse Event|0
6078939|NCT00410410|20990305|P8|Induction Period (IP)|Adverse Event|0
6078940|NCT00410410|20990306|P7|Induction Period (IP)|Adverse Event|0
6078941|NCT00410410|20990307|P6|Induction Period (IP)|Adverse Event|0
6078942|NCT00410410|20990308|P5|Induction Period (IP)|Adverse Event|1
6078943|NCT00410410|20990309|P4|Induction Period (IP)|Adverse Event|4
6078944|NCT00410410|20990310|P3|Induction Period (IP)|Adverse Event|2
6078945|NCT00410410|20990311|P2|Induction Period (IP)|Adverse Event|4
6078946|NCT00410410|20990312|P1|Induction Period (IP)|Adverse Event|3
6078947|NCT00410410|20990304|P9|Induction Period (IP)|Death|0
6078948|NCT00410410|20990305|P8|Induction Period (IP)|Death|0
6078949|NCT00410410|20990306|P7|Induction Period (IP)|Death|0
6078950|NCT00410410|20990307|P6|Induction Period (IP)|Death|0
6078951|NCT00410410|20990308|P5|Induction Period (IP)|Death|0
6078952|NCT00410410|20990309|P4|Induction Period (IP)|Death|0
6078953|NCT00410410|20990310|P3|Induction Period (IP)|Death|0
6078954|NCT00410410|20990311|P2|Induction Period (IP)|Death|0
6078955|NCT00410410|20990312|P1|Induction Period (IP)|Death|1
6078956|NCT00410384|20990473|P3|Overall Study|Other|4
6078957|NCT00410384|20990474|P2|Overall Study|Other|8
6078958|NCT00410384|20990475|P1|Overall Study|Other|3
6078959|NCT00410384|20990473|P3|Overall Study|Physician Decision|4
6078960|NCT00410384|20990474|P2|Overall Study|Physician Decision|3
6078961|NCT00410384|20990475|P1|Overall Study|Physician Decision|3
6078962|NCT00410384|20990473|P3|Overall Study|Protocol Violation|6
6078963|NCT00410384|20990474|P2|Overall Study|Protocol Violation|6
6078964|NCT00410384|20990475|P1|Overall Study|Protocol Violation|6
6078965|NCT00410384|20990473|P3|Overall Study|Lost to Follow-up|6
6078966|NCT00410384|20990474|P2|Overall Study|Lost to Follow-up|6
6078967|NCT00410384|20990475|P1|Overall Study|Lost to Follow-up|4
6078968|NCT00410384|20990473|P3|Overall Study|Lack of Compliance|2
6078969|NCT00410384|20990474|P2|Overall Study|Lack of Compliance|2
6078970|NCT00410384|20990475|P1|Overall Study|Lack of Compliance|2
6078971|NCT00410384|20990473|P3|Overall Study|Lack of Efficacy|17
6078972|NCT00410384|20990474|P2|Overall Study|Lack of Efficacy|12
6078973|NCT00410384|20990475|P1|Overall Study|Lack of Efficacy|20
6078974|NCT00410384|20990473|P3|Overall Study|Adverse Event|23
6078975|NCT00410384|20990474|P2|Overall Study|Adverse Event|18
6078976|NCT00410384|20990475|P1|Overall Study|Adverse Event|23
6078977|NCT00410384|20990473|P3|Overall Study|Withdrawal by Subject|20
6078978|NCT00410384|20990474|P2|Overall Study|Withdrawal by Subject|17
6078979|NCT00410384|20990475|P1|Overall Study|Withdrawal by Subject|28
6078980|NCT00410202|20990548|P3|Off-treatment Follow up|Lost to Follow-up|0
6078981|NCT00410202|20990549|P2|Off-treatment Follow up|Lost to Follow-up|0
6078982|NCT00410202|20990550|P1|Off-treatment Follow up|Lost to Follow-up|1
6078983|NCT00410202|20990548|P3|Off-treatment Follow up|Follow up not required per protocol|1
6078984|NCT00410202|20990549|P2|Off-treatment Follow up|Follow up not required per protocol|0
6078985|NCT00410202|20990550|P1|Off-treatment Follow up|Follow up not required per protocol|3
6078986|NCT00410202|20990548|P3|Off-treatment Follow up|Continuing off-treatment follow up|11
6078987|NCT00410202|20990549|P2|Off-treatment Follow up|Continuing off-treatment follow up|8
6078988|NCT00410202|20990550|P1|Off-treatment Follow up|Continuing off-treatment follow up|10
6078989|NCT00410202|20990548|P3|On-Treatment|Other Reason|1
6078990|NCT00410202|20990549|P2|On-Treatment|Other Reason|0
6078991|NCT00410202|20990550|P1|On-Treatment|Other Reason|0
6078992|NCT00410202|20990548|P3|On-Treatment|Withdrawal by Subject|1
6078993|NCT00410202|20990549|P2|On-Treatment|Withdrawal by Subject|1
6078994|NCT00410202|20990550|P1|On-Treatment|Withdrawal by Subject|2
6078995|NCT00410202|20990548|P3|On-Treatment|Lack of Efficacy|0
6078996|NCT00410202|20990549|P2|On-Treatment|Lack of Efficacy|4
6078997|NCT00410202|20990550|P1|On-Treatment|Lack of Efficacy|1
6078998|NCT00410202|20990548|P3|On-Treatment|Lost to Follow-up|1
6078999|NCT00410202|20990549|P2|On-Treatment|Lost to Follow-up|0
6079000|NCT00410202|20990550|P1|On-Treatment|Lost to Follow-up|1
6079001|NCT00410202|20990548|P3|On-Treatment|Death|0
6079002|NCT00410202|20990549|P2|On-Treatment|Death|0
6079003|NCT00410202|20990550|P1|On-Treatment|Death|1
6079004|NCT00410202|20990548|P3|On-Treatment|Adverse Event|2
6079005|NCT00410202|20990549|P2|On-Treatment|Adverse Event|3
6079006|NCT00410202|20990550|P1|On-Treatment|Adverse Event|1
6079007|NCT00410202|20990548|P3|On-Treatment|Continuing treatment|66
6079008|NCT00410202|20990549|P2|On-Treatment|Continuing treatment|71
6079009|NCT00410202|20990550|P1|On-Treatment|Continuing treatment|69
6079010|NCT00410163|20990637|P2|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|0
6079011|NCT00410163|20990638|P1|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|1
6079012|NCT00410163|20990637|P2|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|8
6079013|NCT00410163|20990638|P1|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|4
6079014|NCT00410163|20990637|P2|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|0
6079015|NCT00410163|20990638|P1|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|1
6079016|NCT00410163|20990637|P2|Extended Follow-up (FU) Phase (2-5 Years|Death|1
6079017|NCT00410163|20990638|P1|Extended Follow-up (FU) Phase (2-5 Years|Death|1
6079018|NCT00410163|20990637|P2|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|1
6079019|NCT00410163|20990638|P1|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|3
6079020|NCT00410163|20990637|P2|Treatment and Follow-up Phase (2 Years)|Investigator Decision|1
6079021|NCT00410163|20990638|P1|Treatment and Follow-up Phase (2 Years)|Investigator Decision|0
6079022|NCT00410163|20990637|P2|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|0
6079023|NCT00410163|20990638|P1|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|1
6079024|NCT00410163|20990637|P2|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1
6079025|NCT00410163|20990638|P1|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1
6079026|NCT00410163|20990637|P2|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|0
6079027|NCT00410163|20990638|P1|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|1
6079028|NCT00410163|20990637|P2|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|1
6079029|NCT00410163|20990638|P1|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|2
6079030|NCT00410163|20990637|P2|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|4
6079031|NCT00410163|20990638|P1|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|0
6079032|NCT00410163|20990637|P2|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|1
6079033|NCT00410163|20990638|P1|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|2
6079034|NCT00410163|20990637|P2|Treatment and Follow-up Phase (2 Years)|Death|1
6079035|NCT00410163|20990638|P1|Treatment and Follow-up Phase (2 Years)|Death|1
6079036|NCT00410163|20990637|P2|Treatment and Follow-up Phase (2 Years)|Adverse Event|2
6079037|NCT00410163|20990638|P1|Treatment and Follow-up Phase (2 Years)|Adverse Event|4
6079038|NCT00410124|20990691|P2|Extension Phase - Open Label (45 Months)|Final Primary Analysis|1
6079039|NCT00410124|20990692|P1|Extension Phase - Open Label (45 Months)|Final Primary Analysis|0
6079040|NCT00410124|20990691|P2|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|0
6079041|NCT00410124|20990692|P1|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|1
6079042|NCT00410124|20990691|P2|Extension Phase - Open Label (45 Months)|Disease Progression|78
6079043|NCT00410124|20990692|P1|Extension Phase - Open Label (45 Months)|Disease Progression|56
6079044|NCT00410124|20990691|P2|Extension Phase - Open Label (45 Months)|Death|10
6079045|NCT00410124|20990692|P1|Extension Phase - Open Label (45 Months)|Death|2
6079046|NCT00410124|20990691|P2|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1
6079047|NCT00410124|20990692|P1|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1
6079048|NCT00410124|20990691|P2|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|1
6079049|NCT00410124|20990692|P1|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|0
6079050|NCT00410124|20990691|P2|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|1
6079051|NCT00410124|20990692|P1|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|0
6079052|NCT00410124|20990691|P2|Extension Phase - Open Label (45 Months)|Adverse Event|19
6079053|NCT00410124|20990692|P1|Extension Phase - Open Label (45 Months)|Adverse Event|7
6079054|NCT00410124|20990691|P2|Core Phase Double Blind (15 Months)|Disease Progression|124
6079055|NCT00410124|20990692|P1|Core Phase Double Blind (15 Months)|Disease Progression|137
6079056|NCT00410124|20990691|P2|Core Phase Double Blind (15 Months)|Death|4
6079057|NCT00410124|20990692|P1|Core Phase Double Blind (15 Months)|Death|7
6079058|NCT00410124|20990691|P2|Core Phase Double Blind (15 Months)|Administrative Problems|0
6079059|NCT00410124|20990692|P1|Core Phase Double Blind (15 Months)|Administrative Problems|2
6079060|NCT00410124|20990691|P2|Core Phase Double Blind (15 Months)|Lost to Follow-up|0
6079061|NCT00410124|20990692|P1|Core Phase Double Blind (15 Months)|Lost to Follow-up|4
6079062|NCT00410124|20990691|P2|Core Phase Double Blind (15 Months)|Withdrawal by Subject|2
6079063|NCT00410124|20990692|P1|Core Phase Double Blind (15 Months)|Withdrawal by Subject|13
6079064|NCT00410124|20990691|P2|Core Phase Double Blind (15 Months)|Protocol Violation|1
6079065|NCT00410124|20990692|P1|Core Phase Double Blind (15 Months)|Protocol Violation|2
6079066|NCT00410124|20990691|P2|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|0
6079067|NCT00410124|20990692|P1|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|1
6079068|NCT00410124|20990691|P2|Core Phase Double Blind (15 Months)|Adverse Event|2
6079069|NCT00410124|20990692|P1|Core Phase Double Blind (15 Months)|Adverse Event|36
6079070|NCT00410072|20990723|P2|After Week 48 to Week 96|Withdrawal by Subject|1
6079071|NCT00410072|20990724|P1|After Week 48 to Week 96|Withdrawal by Subject|0
6079072|NCT00410072|20990723|P2|After Week 48 to Week 96|Pregnancy|2
6079073|NCT00410072|20990724|P1|After Week 48 to Week 96|Pregnancy|0
6079074|NCT00410072|20990723|P2|After Week 48 to Week 96|Poor compliance/noncompliance|1
6079075|NCT00410072|20990724|P1|After Week 48 to Week 96|Poor compliance/noncompliance|0
6079076|NCT00410072|20990723|P2|After Week 48 to Week 96|Other|0
6079077|NCT00410072|20990724|P1|After Week 48 to Week 96|Other|2
6079078|NCT00410072|20990723|P2|After Week 48 to Week 96|Lost to Follow-up|4
6079079|NCT00410072|20990724|P1|After Week 48 to Week 96|Lost to Follow-up|2
6079080|NCT00410072|20990723|P2|After Week 48 to Week 96|Lack of Efficacy|0
6079081|NCT00410072|20990724|P1|After Week 48 to Week 96|Lack of Efficacy|1
6079082|NCT00410072|20990723|P2|After Week 48 to Week 96|Death|1
6079083|NCT00410072|20990724|P1|After Week 48 to Week 96|Death|0
6079084|NCT00410072|20990723|P2|After Week 48 to Week 96|Adverse Event|2
6079085|NCT00410072|20990724|P1|After Week 48 to Week 96|Adverse Event|1
6079086|NCT00410072|20990723|P2|Day 1 to Week 48|Withdrawal by Subject|2
6079087|NCT00410072|20990724|P1|Day 1 to Week 48|Withdrawal by Subject|0
6079088|NCT00410072|20990723|P2|Day 1 to Week 48|Pregnancy|2
6079089|NCT00410072|20990724|P1|Day 1 to Week 48|Pregnancy|0
6079090|NCT00410072|20990723|P2|Day 1 to Week 48|poor compliance/noncompliance|3
6079091|NCT00410072|20990724|P1|Day 1 to Week 48|poor compliance/noncompliance|0
6079092|NCT00410072|20990723|P2|Day 1 to Week 48|Other|1
6079093|NCT00410072|20990724|P1|Day 1 to Week 48|Other|0
6079094|NCT00410072|20990723|P2|Day 1 to Week 48|Lost to Follow-up|2
6079095|NCT00410072|20990724|P1|Day 1 to Week 48|Lost to Follow-up|5
6079096|NCT00410072|20990723|P2|Day 1 to Week 48|Adverse Event|2
6079097|NCT00410072|20990724|P1|Day 1 to Week 48|Adverse Event|1
6079098|NCT00410046|20990764|P1|Overall Study|Lost to Follow-up|1
6079099|NCT00410046|20990764|P1|Overall Study|Withdrawal by Subject|1
6079100|NCT00410046|20990764|P1|Overall Study|Adverse Event|3
6079101|NCT00409838|20990795|P2|Long-term Extension Period|Pregnancy|0
6079102|NCT00409838|20990796|P1|Long-term Extension Period|Pregnancy|1
6079103|NCT00409838|20990795|P2|Long-term Extension Period|Poor compliance/noncompliance|0
6079104|NCT00409838|20990796|P1|Long-term Extension Period|Poor compliance/noncompliance|1
6079105|NCT00409838|20990795|P2|Long-term Extension Period|Withdrawal by Subject|0
6079106|NCT00409838|20990796|P1|Long-term Extension Period|Withdrawal by Subject|3
6079107|NCT00409838|20990795|P2|Long-term Extension Period|Lack of Efficacy|0
6079108|NCT00409838|20990796|P1|Long-term Extension Period|Lack of Efficacy|2
6079109|NCT00409838|20990795|P2|Long-term Extension Period|Death|0
6079110|NCT00409838|20990796|P1|Long-term Extension Period|Death|1
6079111|NCT00409838|20990795|P2|Long-term Extension Period|Adverse Event|0
6079112|NCT00409838|20990796|P1|Long-term Extension Period|Adverse Event|10
6079113|NCT00409838|20990795|P2|Short-term Period|Never Treated|0
6079114|NCT00409838|20990796|P1|Short-term Period|Never Treated|1
6079115|NCT00409838|20990795|P2|Short-term Period|Withdrawal by Subject|3
6079116|NCT00409838|20990796|P1|Short-term Period|Withdrawal by Subject|2
6079117|NCT00409838|20990795|P2|Short-term Period|Lost to Follow-up|1
6079118|NCT00409838|20990796|P1|Short-term Period|Lost to Follow-up|0
6079119|NCT00409838|20990795|P2|Short-term Period|Adverse Event|1
6079120|NCT00409838|20990796|P1|Short-term Period|Adverse Event|0
6079121|NCT00409786|20990861|P1|Overall Study|Withdrawal by Subject|3
6079122|NCT00409773|20990870|P5|Overall Study|Lack of Eligibility|1
6079123|NCT00409773|20990871|P4|Overall Study|Lack of Eligibility|0
6079124|NCT00409773|20990872|P3|Overall Study|Lack of Eligibility|0
6079125|NCT00409773|20990873|P2|Overall Study|Lack of Eligibility|0
6079126|NCT00409773|20990874|P1|Overall Study|Lack of Eligibility|0
6079127|NCT00409773|20990870|P5|Overall Study|Withdrawal by Subject|1
6079128|NCT00409773|20990871|P4|Overall Study|Withdrawal by Subject|2
6079129|NCT00409773|20990872|P3|Overall Study|Withdrawal by Subject|0
6079130|NCT00409773|20990873|P2|Overall Study|Withdrawal by Subject|0
6079131|NCT00409773|20990874|P1|Overall Study|Withdrawal by Subject|0
6079132|NCT00409773|20990870|P5|Overall Study|Protocol Violation|1
6079133|NCT00409773|20990871|P4|Overall Study|Protocol Violation|3
6079134|NCT00409773|20990872|P3|Overall Study|Protocol Violation|3
6079135|NCT00409773|20990873|P2|Overall Study|Protocol Violation|2
6079136|NCT00409773|20990874|P1|Overall Study|Protocol Violation|0
6079137|NCT00409773|20990870|P5|Overall Study|Physician Decision|0
6079138|NCT00409773|20990871|P4|Overall Study|Physician Decision|2
6079139|NCT00409773|20990872|P3|Overall Study|Physician Decision|0
6079140|NCT00409773|20990873|P2|Overall Study|Physician Decision|0
6079141|NCT00409773|20990874|P1|Overall Study|Physician Decision|0
6079142|NCT00409773|20990870|P5|Overall Study|Lost to Follow-up|1
6079143|NCT00409773|20990871|P4|Overall Study|Lost to Follow-up|3
6079144|NCT00409773|20990872|P3|Overall Study|Lost to Follow-up|2
6079145|NCT00409773|20990873|P2|Overall Study|Lost to Follow-up|1
6079146|NCT00409773|20990874|P1|Overall Study|Lost to Follow-up|6
6079147|NCT00409773|20990870|P5|Overall Study|Adverse Event|6
6079148|NCT00409773|20990871|P4|Overall Study|Adverse Event|2
6079149|NCT00409773|20990872|P3|Overall Study|Adverse Event|4
6079150|NCT00409773|20990873|P2|Overall Study|Adverse Event|4
6079151|NCT00409773|20990874|P1|Overall Study|Adverse Event|3
6079152|NCT00409747|20990956|P1|Overall Study|Withdrawal by Subject|1
6079153|NCT00409708|20990963|P2|Washout|Lost to Follow-up|3
6079154|NCT00409708|20990964|P1|Washout|Lost to Follow-up|1
6079155|NCT00409708|20990963|P2|Washout|Withdrawal by Subject|5
6079156|NCT00409708|20990964|P1|Washout|Withdrawal by Subject|11
6079157|NCT00409708|20990963|P2|Washout|Protocol Violation|1
6079158|NCT00409708|20990964|P1|Washout|Protocol Violation|0
6079159|NCT00409708|20990963|P2|Washout|Lack of Efficacy|1
6079160|NCT00409708|20990964|P1|Washout|Lack of Efficacy|9
6079161|NCT00409708|20990963|P2|Treatment|Administrative problems|0
6079162|NCT00409708|20990964|P1|Treatment|Administrative problems|5
6079163|NCT00409708|20990963|P2|Treatment|Lost to Follow-up|6
6079164|NCT00409708|20990964|P1|Treatment|Lost to Follow-up|0
6079165|NCT00409708|20990963|P2|Treatment|Withdrawal by Subject|8
6079166|NCT00409708|20990964|P1|Treatment|Withdrawal by Subject|3
6079167|NCT00409708|20990963|P2|Treatment|Protocol Violation|2
6079168|NCT00409708|20990964|P1|Treatment|Protocol Violation|6
6079169|NCT00409708|20990963|P2|Treatment|Lack of Efficacy|1
6079170|NCT00409708|20990964|P1|Treatment|Lack of Efficacy|0
6079171|NCT00409708|20990963|P2|Treatment|Abnormal test procedure result(s)|0
6079172|NCT00409708|20990964|P1|Treatment|Abnormal test procedure result(s)|1
6079173|NCT00409682|20990985|P3|EOW Double-blind Maintenance Period|Non-compliance|1
6079174|NCT00409682|20990986|P2|EOW Double-blind Maintenance Period|Non-compliance|0
6079175|NCT00409682|20990987|P1|EOW Double-blind Maintenance Period|Non-compliance|0
6079176|NCT00409682|20990985|P3|EOW Double-blind Maintenance Period|Protocol Violation|1
6079177|NCT00409682|20990986|P2|EOW Double-blind Maintenance Period|Protocol Violation|4
6079178|NCT00409682|20990987|P1|EOW Double-blind Maintenance Period|Protocol Violation|0
6079179|NCT00409682|20990985|P3|EOW Double-blind Maintenance Period|Withdrawal by Subject|2
6079180|NCT00409682|20990986|P2|EOW Double-blind Maintenance Period|Withdrawal by Subject|4
6079181|NCT00409682|20990987|P1|EOW Double-blind Maintenance Period|Withdrawal by Subject|0
6079182|NCT00409682|20990985|P3|EOW Double-blind Maintenance Period|Lost to Follow-up|0
6079183|NCT00409682|20990986|P2|EOW Double-blind Maintenance Period|Lost to Follow-up|1
6079184|NCT00409682|20990987|P1|EOW Double-blind Maintenance Period|Lost to Follow-up|0
6079185|NCT00409682|20990985|P3|EOW Double-blind Maintenance Period|Lack of Efficacy|11
6079186|NCT00409682|20990986|P2|EOW Double-blind Maintenance Period|Lack of Efficacy|18
6079187|NCT00409682|20990987|P1|EOW Double-blind Maintenance Period|Lack of Efficacy|0
6079188|NCT00409682|20990985|P3|EOW Double-blind Maintenance Period|Adverse Event|12
6079189|NCT00409682|20990986|P2|EOW Double-blind Maintenance Period|Adverse Event|10
6079190|NCT00409682|20990987|P1|EOW Double-blind Maintenance Period|Adverse Event|0
6079191|NCT00409682|20990985|P3|Open-label Induction Period|Subject did not satisfy entry criteria|0
6079192|NCT00409682|20990986|P2|Open-label Induction Period|Subject did not satisfy entry criteria|0
6079193|NCT00409682|20990987|P1|Open-label Induction Period|Subject did not satisfy entry criteria|1
6079194|NCT00409682|20990985|P3|Open-label Induction Period|Protocol Violation|0
6079195|NCT00409682|20990986|P2|Open-label Induction Period|Protocol Violation|0
6079196|NCT00409682|20990987|P1|Open-label Induction Period|Protocol Violation|1
6079197|NCT00409682|20990985|P3|Open-label Induction Period|Lack of Efficacy|0
6079198|NCT00409682|20990986|P2|Open-label Induction Period|Lack of Efficacy|0
6079199|NCT00409682|20990987|P1|Open-label Induction Period|Lack of Efficacy|1
6079200|NCT00409682|20990985|P3|Open-label Induction Period|Adverse Event|0
6079201|NCT00409682|20990986|P2|Open-label Induction Period|Adverse Event|0
6079202|NCT00409682|20990987|P1|Open-label Induction Period|Adverse Event|1
6079203|NCT00409617|20991004|P1|Overall Study|Not described|14
6079204|NCT00409617|20991004|P1|Overall Study|Administrative reasons|1
6079205|NCT00409617|20991004|P1|Overall Study|Withdrawal by Subject|8
6079206|NCT00409617|20991004|P1|Overall Study|Protocol Violation|24
6079207|NCT00409617|20991004|P1|Overall Study|Lost to Follow-up|2
6079208|NCT00409617|20991004|P1|Overall Study|Lack of Efficacy|54
6079209|NCT00409617|20991004|P1|Overall Study|Adverse Event|57
6079210|NCT00409578|20991020|P4|Overall Study|Missing|1
6079211|NCT00409578|20991021|P3|Overall Study|Missing|0
6079212|NCT00409578|20991022|P2|Overall Study|Missing|1
6079213|NCT00409578|20991023|P1|Overall Study|Missing|0
6079214|NCT00409578|20991020|P4|Overall Study|Protocol Violation|1
6079215|NCT00409578|20991021|P3|Overall Study|Protocol Violation|3
6079216|NCT00409578|20991022|P2|Overall Study|Protocol Violation|2
6079217|NCT00409578|20991023|P1|Overall Study|Protocol Violation|3
6079218|NCT00409578|20991020|P4|Overall Study|Death|2
6079219|NCT00409578|20991021|P3|Overall Study|Death|4
6079220|NCT00409578|20991022|P2|Overall Study|Death|4
6079221|NCT00409578|20991023|P1|Overall Study|Death|2
6079222|NCT00409578|20991020|P4|Overall Study|Administrative problems|4
6079223|NCT00409578|20991021|P3|Overall Study|Administrative problems|2
6079224|NCT00409578|20991022|P2|Overall Study|Administrative problems|9
6079225|NCT00409578|20991023|P1|Overall Study|Administrative problems|8
6079226|NCT00409578|20991020|P4|Overall Study|Lost to Follow-up|2
6079227|NCT00409578|20991021|P3|Overall Study|Lost to Follow-up|2
6079228|NCT00409578|20991022|P2|Overall Study|Lost to Follow-up|0
6079229|NCT00409578|20991023|P1|Overall Study|Lost to Follow-up|2
6079230|NCT00409578|20991020|P4|Overall Study|Withdrawal by Subject|17
6079231|NCT00409578|20991021|P3|Overall Study|Withdrawal by Subject|16
6079232|NCT00409578|20991022|P2|Overall Study|Withdrawal by Subject|15
6079233|NCT00409578|20991023|P1|Overall Study|Withdrawal by Subject|8
6079234|NCT00409578|20991020|P4|Overall Study|Subject no longer requires study drug|1
6079235|NCT00409578|20991021|P3|Overall Study|Subject no longer requires study drug|0
6079236|NCT00409578|20991022|P2|Overall Study|Subject no longer requires study drug|0
6079237|NCT00409578|20991023|P1|Overall Study|Subject no longer requires study drug|0
6079238|NCT00409578|20991020|P4|Overall Study|Lack of Efficacy|2
6079239|NCT00409578|20991021|P3|Overall Study|Lack of Efficacy|0
6079240|NCT00409578|20991022|P2|Overall Study|Lack of Efficacy|0
6079241|NCT00409578|20991023|P1|Overall Study|Lack of Efficacy|0
6079242|NCT00409578|20991020|P4|Overall Study|Abnormal laboratory value(s)|4
6079243|NCT00409578|20991021|P3|Overall Study|Abnormal laboratory value(s)|2
6079244|NCT00409578|20991022|P2|Overall Study|Abnormal laboratory value(s)|2
6079245|NCT00409578|20991023|P1|Overall Study|Abnormal laboratory value(s)|2
6079246|NCT00409578|20991020|P4|Overall Study|Adverse Event|33
6079247|NCT00409578|20991021|P3|Overall Study|Adverse Event|25
6079248|NCT00409578|20991022|P2|Overall Study|Adverse Event|37
6079249|NCT00409578|20991023|P1|Overall Study|Adverse Event|27
6079250|NCT00409409|20991081|P2|Overall Study|Any other reason not above-mentioned|1
6079251|NCT00409409|20991082|P1|Overall Study|Any other reason not above-mentioned|0
6079252|NCT00409409|20991081|P2|Overall Study|Withdrawal by Subject|1
6079253|NCT00409409|20991082|P1|Overall Study|Withdrawal by Subject|1
6079254|NCT00409409|20991081|P2|Overall Study|Adverse Event|2
6079255|NCT00409409|20991082|P1|Overall Study|Adverse Event|7
6079256|NCT00409344|20991090|P2|Overall Study|no enrollment|0
6079257|NCT00409344|20991091|P1|Overall Study|no enrollment|0
6079258|NCT00409331|20991109|P1|Overall Study|Physician Decision|1
6079259|NCT00409188|20991131|P2|Overall Study|Ongoing at data cut-off|175
6079260|NCT00409188|20991132|P1|Overall Study|Ongoing at data cut-off|383
6079261|NCT00409175|20991148|P2|Overall Study|Liver transplantation|13
6079262|NCT00409175|20991149|P1|Overall Study|Liver transplantation|13
6079263|NCT00409175|20991148|P2|Overall Study|Negative genotype|1
6079264|NCT00409175|20991149|P1|Overall Study|Negative genotype|0
6079265|NCT00409175|20991148|P2|Overall Study|Withdrawal by Subject|2
6079266|NCT00409175|20991149|P1|Overall Study|Withdrawal by Subject|1
6079267|NCT00409175|20991148|P2|Overall Study|Adverse Event|3
6079268|NCT00409175|20991149|P1|Overall Study|Adverse Event|4
6079269|NCT00409006|20991175|P2|Overall Study|Physician Decision|2
6079270|NCT00409006|20991176|P1|Overall Study|Physician Decision|1
6079271|NCT00409006|20991175|P2|Overall Study|Withdrawal by Subject|2
6079272|NCT00409006|20991176|P1|Overall Study|Withdrawal by Subject|3
6079273|NCT00409006|20991175|P2|Overall Study|Lost to Follow-up|2
6079274|NCT00409006|20991176|P1|Overall Study|Lost to Follow-up|1
6079275|NCT00409006|20991175|P2|Overall Study|Death|6
6079276|NCT00409006|20991176|P1|Overall Study|Death|15
6079277|NCT00408993|20991192|P2|Overall Study|Withdrawal by Subject|3
6079278|NCT00408993|20991193|P1|Overall Study|Withdrawal by Subject|2
6079279|NCT00408993|20991192|P2|Overall Study|Lack of Efficacy|4
6079280|NCT00408993|20991193|P1|Overall Study|Lack of Efficacy|1
6079281|NCT00408993|20991192|P2|Overall Study|Protocol Violation|6
6079282|NCT00408993|20991193|P1|Overall Study|Protocol Violation|1
6079283|NCT00408993|20991192|P2|Overall Study|Adverse Event|4
6079284|NCT00408993|20991193|P1|Overall Study|Adverse Event|15
6079285|NCT00408928|20991225|P1|Overall Study|Infection indistinguishable from GVHD|1
6079286|NCT00408928|20991225|P1|Overall Study|Death|1
6079287|NCT00408928|20991225|P1|Overall Study|Withdrawal by Subject|1
6079288|NCT00408902|20991230|P1|Overall Study|Adverse Event|3
6079289|NCT00408902|20991230|P1|Overall Study|Lack of Efficacy|7
6079290|NCT00408876|20991240|P4|Overall Study|Physician Decision|0
6079291|NCT00408876|20991241|P3|Overall Study|Physician Decision|3
6079292|NCT00408876|20991242|P2|Overall Study|Physician Decision|0
6079293|NCT00408876|20991243|P1|Overall Study|Physician Decision|1
6079294|NCT00408876|20991240|P4|Overall Study|Protocol Violation|3
6079295|NCT00408876|20991241|P3|Overall Study|Protocol Violation|4
6079296|NCT00408876|20991242|P2|Overall Study|Protocol Violation|3
6079297|NCT00408876|20991243|P1|Overall Study|Protocol Violation|0
6079298|NCT00408876|20991240|P4|Overall Study|Lost to Follow-up|2
6079299|NCT00408876|20991241|P3|Overall Study|Lost to Follow-up|5
6079300|NCT00408876|20991242|P2|Overall Study|Lost to Follow-up|6
6079301|NCT00408876|20991243|P1|Overall Study|Lost to Follow-up|1
6079302|NCT00408876|20991240|P4|Overall Study|Lack of Efficacy|6
6079303|NCT00408876|20991241|P3|Overall Study|Lack of Efficacy|5
6079304|NCT00408876|20991242|P2|Overall Study|Lack of Efficacy|4
6079305|NCT00408876|20991243|P1|Overall Study|Lack of Efficacy|2
6079306|NCT00408876|20991240|P4|Overall Study|Withdrawal by Subject|14
6079307|NCT00408876|20991241|P3|Overall Study|Withdrawal by Subject|6
6079308|NCT00408876|20991242|P2|Overall Study|Withdrawal by Subject|6
6079309|NCT00408876|20991243|P1|Overall Study|Withdrawal by Subject|3
6079310|NCT00408876|20991240|P4|Overall Study|Adverse Event|10
6079311|NCT00408876|20991241|P3|Overall Study|Adverse Event|27
6079312|NCT00408876|20991242|P2|Overall Study|Adverse Event|17
6079313|NCT00408876|20991243|P1|Overall Study|Adverse Event|9
6079314|NCT00408694|20991493|P1|Overall Study|No protocol treatment|1
6079315|NCT00408694|20991493|P1|Overall Study|Ineligible|1
6079316|NCT00408681|20991505|P1|Overall Study|Adverse Event|7
6079317|NCT00408681|20991505|P1|Overall Study|Lack of Efficacy|2
6079318|NCT00408629|20991524|P2|Overall Study|Miscellaneous|15
6079319|NCT00408629|20991525|P1|Overall Study|Miscellaneous|11
6079320|NCT00408629|20991524|P2|Overall Study|Protocol Violation|5
6079321|NCT00408629|20991525|P1|Overall Study|Protocol Violation|1
6079322|NCT00408629|20991524|P2|Overall Study|Lack of Efficacy|73
6079323|NCT00408629|20991525|P1|Overall Study|Lack of Efficacy|63
6079324|NCT00408629|20991524|P2|Overall Study|Lost to Follow-up|1
6079325|NCT00408629|20991525|P1|Overall Study|Lost to Follow-up|1
6079326|NCT00408629|20991524|P2|Overall Study|Withdrawal by Subject|4
6079327|NCT00408629|20991525|P1|Overall Study|Withdrawal by Subject|8
6079328|NCT00408629|20991524|P2|Overall Study|Adverse Event|27
6079329|NCT00408629|20991525|P1|Overall Study|Adverse Event|13
6079330|NCT00408499|20991621|P5|Phase II- MTD Expansion|treatment delay|3
6079331|NCT00408499|20991622|P4|Phase II- MTD Expansion|treatment delay|0
6079332|NCT00408499|20991623|P3|Phase II- MTD Expansion|treatment delay|0
6079333|NCT00408499|20991624|P2|Phase II- MTD Expansion|treatment delay|0
6079334|NCT00408499|20991625|P1|Phase II- MTD Expansion|treatment delay|0
6079335|NCT00408499|20991621|P5|Phase II- MTD Expansion|Withdrawal by Subject|5
6079336|NCT00408499|20991622|P4|Phase II- MTD Expansion|Withdrawal by Subject|0
6079337|NCT00408499|20991623|P3|Phase II- MTD Expansion|Withdrawal by Subject|0
6079338|NCT00408499|20991624|P2|Phase II- MTD Expansion|Withdrawal by Subject|0
6079339|NCT00408499|20991625|P1|Phase II- MTD Expansion|Withdrawal by Subject|0
6079340|NCT00408499|20991621|P5|Phase II- MTD Expansion|Physician Decision|1
6079341|NCT00408499|20991622|P4|Phase II- MTD Expansion|Physician Decision|0
6079342|NCT00408499|20991623|P3|Phase II- MTD Expansion|Physician Decision|0
6079343|NCT00408499|20991624|P2|Phase II- MTD Expansion|Physician Decision|0
6079344|NCT00408499|20991625|P1|Phase II- MTD Expansion|Physician Decision|0
6079345|NCT00408499|20991621|P5|Phase II- MTD Expansion|Death|2
6079346|NCT00408499|20991622|P4|Phase II- MTD Expansion|Death|0
6079347|NCT00408499|20991623|P3|Phase II- MTD Expansion|Death|0
6079348|NCT00408499|20991624|P2|Phase II- MTD Expansion|Death|0
6079349|NCT00408499|20991625|P1|Phase II- MTD Expansion|Death|0
6079350|NCT00408499|20991621|P5|Phase II- MTD Expansion|Adverse Event|9
6079351|NCT00408499|20991622|P4|Phase II- MTD Expansion|Adverse Event|0
6079352|NCT00408499|20991623|P3|Phase II- MTD Expansion|Adverse Event|0
6079353|NCT00408499|20991624|P2|Phase II- MTD Expansion|Adverse Event|0
6079354|NCT00408499|20991625|P1|Phase II- MTD Expansion|Adverse Event|0
6079355|NCT00408499|20991621|P5|Phase 1: Dose Levels 1-4|Physician Decision|0
6079356|NCT00408499|20991622|P4|Phase 1: Dose Levels 1-4|Physician Decision|0
6079357|NCT00408499|20991623|P3|Phase 1: Dose Levels 1-4|Physician Decision|0
6079358|NCT00408499|20991624|P2|Phase 1: Dose Levels 1-4|Physician Decision|1
6079359|NCT00408499|20991625|P1|Phase 1: Dose Levels 1-4|Physician Decision|1
6079360|NCT00408499|20991621|P5|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0
6079361|NCT00408499|20991622|P4|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0
6079362|NCT00408499|20991623|P3|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0
6079363|NCT00408499|20991624|P2|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1
6079364|NCT00408499|20991625|P1|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1
6079365|NCT00408499|20991621|P5|Phase 1: Dose Levels 1-4|Adverse Event|0
6079366|NCT00408499|20991622|P4|Phase 1: Dose Levels 1-4|Adverse Event|0
6079367|NCT00408499|20991623|P3|Phase 1: Dose Levels 1-4|Adverse Event|1
6079368|NCT00408499|20991624|P2|Phase 1: Dose Levels 1-4|Adverse Event|0
6079369|NCT00408499|20991625|P1|Phase 1: Dose Levels 1-4|Adverse Event|0
6079370|NCT00408434|20991647|P7|Overall Study|Terminated by Investigator|0
6079371|NCT00408434|20991648|P6|Overall Study|Terminated by Investigator|1
6079372|NCT00408434|20991649|P5|Overall Study|Terminated by Investigator|1
6079373|NCT00408434|20991650|P4|Overall Study|Terminated by Investigator|0
6079374|NCT00408434|20991651|P3|Overall Study|Terminated by Investigator|0
6079375|NCT00408434|20991652|P2|Overall Study|Terminated by Investigator|0
6079376|NCT00408434|20991653|P1|Overall Study|Terminated by Investigator|0
6079377|NCT00408434|20991647|P7|Overall Study|Other|0
6079378|NCT00408434|20991648|P6|Overall Study|Other|1
6079379|NCT00408434|20991649|P5|Overall Study|Other|2
6079380|NCT00408434|20991650|P4|Overall Study|Other|0
6079381|NCT00408434|20991651|P3|Overall Study|Other|1
6079382|NCT00408434|20991652|P2|Overall Study|Other|0
6079383|NCT00408434|20991653|P1|Overall Study|Other|0
6079384|NCT00408434|20991647|P7|Overall Study|Progressive disease|4
6079385|NCT00408434|20991648|P6|Overall Study|Progressive disease|1
6079386|NCT00408434|20991649|P5|Overall Study|Progressive disease|3
6079387|NCT00408434|20991650|P4|Overall Study|Progressive disease|3
6079388|NCT00408434|20991651|P3|Overall Study|Progressive disease|4
6079389|NCT00408434|20991652|P2|Overall Study|Progressive disease|3
6079390|NCT00408434|20991653|P1|Overall Study|Progressive disease|6
6079391|NCT00408434|20991647|P7|Overall Study|Adverse Event|0
6079392|NCT00408434|20991648|P6|Overall Study|Adverse Event|0
6079393|NCT00408434|20991649|P5|Overall Study|Adverse Event|0
6079394|NCT00408434|20991650|P4|Overall Study|Adverse Event|0
6079395|NCT00408434|20991651|P3|Overall Study|Adverse Event|1
6079396|NCT00408434|20991652|P2|Overall Study|Adverse Event|0
6079397|NCT00408434|20991653|P1|Overall Study|Adverse Event|0
6079398|NCT00408421|20991700|P3|Treatment Re-Randomization|Withdrawal by Subject|0
6079399|NCT00408421|20991701|P2|Treatment Re-Randomization|Withdrawal by Subject|1
6079400|NCT00408421|20991702|P1|Treatment Re-Randomization|Withdrawal by Subject|2
6079401|NCT00408421|20991700|P3|Treatment Re-Randomization|Protocol Violation|0
6079402|NCT00408421|20991701|P2|Treatment Re-Randomization|Protocol Violation|1
6079403|NCT00408421|20991702|P1|Treatment Re-Randomization|Protocol Violation|1
6079404|NCT00408421|20991700|P3|Treatment Re-Randomization|Physician Decision|0
6079405|NCT00408421|20991701|P2|Treatment Re-Randomization|Physician Decision|3
6079406|NCT00408421|20991702|P1|Treatment Re-Randomization|Physician Decision|1
6079407|NCT00408421|20991700|P3|Treatment Re-Randomization|Lost to Follow-up|1
6079408|NCT00408421|20991701|P2|Treatment Re-Randomization|Lost to Follow-up|0
6079409|NCT00408421|20991702|P1|Treatment Re-Randomization|Lost to Follow-up|0
6079410|NCT00408421|20991700|P3|Treatment Re-Randomization|Lack of Efficacy|0
6079411|NCT00408421|20991701|P2|Treatment Re-Randomization|Lack of Efficacy|0
6079412|NCT00408421|20991702|P1|Treatment Re-Randomization|Lack of Efficacy|1
6079413|NCT00408421|20991700|P3|Treatment Re-Randomization|Adverse Event|4
6079414|NCT00408421|20991701|P2|Treatment Re-Randomization|Adverse Event|2
6079415|NCT00408421|20991702|P1|Treatment Re-Randomization|Adverse Event|2
6079416|NCT00408421|20991700|P3|Treatment Initial Randomization|Sponsor Decision|0
6079417|NCT00408421|20991701|P2|Treatment Initial Randomization|Sponsor Decision|0
6079418|NCT00408421|20991702|P1|Treatment Initial Randomization|Sponsor Decision|1
6079419|NCT00408421|20991700|P3|Treatment Initial Randomization|Entry Criteria Not Met|0
6079420|NCT00408421|20991701|P2|Treatment Initial Randomization|Entry Criteria Not Met|0
6079421|NCT00408421|20991702|P1|Treatment Initial Randomization|Entry Criteria Not Met|1
6079422|NCT00408421|20991700|P3|Treatment Initial Randomization|Withdrawal by Subject|0
6079423|NCT00408421|20991701|P2|Treatment Initial Randomization|Withdrawal by Subject|7
6079424|NCT00408421|20991702|P1|Treatment Initial Randomization|Withdrawal by Subject|7
6079425|NCT00408421|20991700|P3|Treatment Initial Randomization|Protocol Violation|0
6079426|NCT00408421|20991701|P2|Treatment Initial Randomization|Protocol Violation|1
6079427|NCT00408421|20991702|P1|Treatment Initial Randomization|Protocol Violation|0
6079428|NCT00408421|20991700|P3|Treatment Initial Randomization|Physician Decision|0
6079429|NCT00408421|20991701|P2|Treatment Initial Randomization|Physician Decision|0
6079430|NCT00408421|20991702|P1|Treatment Initial Randomization|Physician Decision|1
6079431|NCT00408421|20991700|P3|Treatment Initial Randomization|Lost to Follow-up|0
6079432|NCT00408421|20991701|P2|Treatment Initial Randomization|Lost to Follow-up|3
6079433|NCT00408421|20991702|P1|Treatment Initial Randomization|Lost to Follow-up|0
6079434|NCT00408421|20991700|P3|Treatment Initial Randomization|Lack of Efficacy|0
6079435|NCT00408421|20991701|P2|Treatment Initial Randomization|Lack of Efficacy|2
6079436|NCT00408421|20991702|P1|Treatment Initial Randomization|Lack of Efficacy|2
6079437|NCT00408421|20991700|P3|Treatment Initial Randomization|Adverse Event|0
6079438|NCT00408421|20991701|P2|Treatment Initial Randomization|Adverse Event|9
6079439|NCT00408421|20991702|P1|Treatment Initial Randomization|Adverse Event|5
6079440|NCT00408408|20991782|P6|Overall Study|No follow up data|3
6079441|NCT00408408|20991783|P5|Overall Study|No follow up data|5
6079442|NCT00408408|20991784|P4|Overall Study|No follow up data|7
6079443|NCT00408408|20991785|P3|Overall Study|No follow up data|0
6079444|NCT00408408|20991786|P2|Overall Study|No follow up data|3
6079445|NCT00408408|20991787|P1|Overall Study|No follow up data|2
6079446|NCT00408317|20991849|P2|Second Intervention Period|Withdrawal of consent|1
6079447|NCT00408317|20991850|P1|Second Intervention Period|Withdrawal of consent|0
6079448|NCT00408317|20991849|P2|Second Intervention Period|Protocol Violation|1
6079449|NCT00408317|20991850|P1|Second Intervention Period|Protocol Violation|0
6079450|NCT00408317|20991849|P2|Second Intervention Period|Adverse Event|0
6079451|NCT00408317|20991850|P1|Second Intervention Period|Adverse Event|2
6079452|NCT00408317|20991849|P2|First Intervention Period|Adverse Event|1
6079453|NCT00408317|20991850|P1|First Intervention Period|Adverse Event|0
6079686|NCT00407797|20991932|P1|Overall Study|Withdrawal by Subject|3
6079687|NCT00407797|20991932|P1|Overall Study|Other|7
6079688|NCT00407797|20991932|P1|Overall Study|Adverse Event|6
6079689|NCT00407797|20991932|P1|Overall Study|Lost to Follow-up|2
6079690|NCT00407758|20991947|P1|Overall Study|ineligible -improper prior treatment|1
6079691|NCT00407745|20991960|P2|Overall Study|Randomized, unknown if treated|1
6079692|NCT00407745|20991961|P1|Overall Study|Randomized, unknown if treated|0
6079693|NCT00407745|20991960|P2|Overall Study|Other|0
6079694|NCT00407745|20991961|P1|Overall Study|Other|2
6079695|NCT00407745|20991960|P2|Overall Study|Adverse Event|8
6079696|NCT00407745|20991961|P1|Overall Study|Adverse Event|8
6079697|NCT00407745|20991960|P2|Overall Study|Protocol Violation|3
6079698|NCT00407745|20991961|P1|Overall Study|Protocol Violation|5
6079699|NCT00407745|20991960|P2|Overall Study|Withdrawal by Subject|3
6079700|NCT00407745|20991961|P1|Overall Study|Withdrawal by Subject|3
6079701|NCT00407745|20991960|P2|Overall Study|Lack of Efficacy|2
6079702|NCT00407745|20991961|P1|Overall Study|Lack of Efficacy|1
6079703|NCT00407563|20992047|P1|Overall Study|Patient continues on treatment|1
6079704|NCT00407550|20992057|P2|Overall Study|Insurance or Other medical condition|1
6079705|NCT00407550|20992058|P1|Overall Study|Insurance or Other medical condition|2
6079706|NCT00407550|20992057|P2|Overall Study|Death|0
6079707|NCT00407550|20992058|P1|Overall Study|Death|1
6079708|NCT00407550|20992057|P2|Overall Study|Withdrawal by Subject|2
6079709|NCT00407550|20992058|P1|Overall Study|Withdrawal by Subject|0
6079710|NCT00407550|20992057|P2|Overall Study|Adverse Event|1
6079711|NCT00407550|20992058|P1|Overall Study|Adverse Event|0
6079716|NCT00407030|20992131|P3|Extension Period - up to 68 Weeks|Physician Decision|0
6079717|NCT00407030|20992132|P2|Extension Period - up to 68 Weeks|Physician Decision|2
6079718|NCT00407030|20992133|P1|Extension Period - up to 68 Weeks|Physician Decision|1
6079719|NCT00407030|20992131|P3|Extension Period - up to 68 Weeks|Patient Decision|0
6079720|NCT00407030|20992132|P2|Extension Period - up to 68 Weeks|Patient Decision|2
6079721|NCT00407030|20992133|P1|Extension Period - up to 68 Weeks|Patient Decision|1
6079722|NCT00407030|20992131|P3|Extension Period - up to 68 Weeks|Lost to Follow-up|0
6079723|NCT00407030|20992132|P2|Extension Period - up to 68 Weeks|Lost to Follow-up|5
6079724|NCT00407030|20992133|P1|Extension Period - up to 68 Weeks|Lost to Follow-up|5
6079725|NCT00407030|20992131|P3|Extension Period - up to 68 Weeks|Consent Withdrawn|0
6079726|NCT00407030|20992132|P2|Extension Period - up to 68 Weeks|Consent Withdrawn|4
6079727|NCT00407030|20992133|P1|Extension Period - up to 68 Weeks|Consent Withdrawn|4
6079728|NCT00407030|20992131|P3|Extension Period - up to 68 Weeks|Adverse Event|0
6079729|NCT00407030|20992132|P2|Extension Period - up to 68 Weeks|Adverse Event|0
6079730|NCT00407030|20992133|P1|Extension Period - up to 68 Weeks|Adverse Event|1
6079731|NCT00407030|20992131|P3|Extension Period - up to 68 Weeks|Lack of Efficacy|0
6079732|NCT00407030|20992132|P2|Extension Period - up to 68 Weeks|Lack of Efficacy|11
6079733|NCT00407030|20992133|P1|Extension Period - up to 68 Weeks|Lack of Efficacy|11
6079734|NCT00407030|20992131|P3|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|0
6079735|NCT00407030|20992132|P2|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|5
6079736|NCT00407030|20992133|P1|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|4
6079737|NCT00407030|20992131|P3|Main Period - 8 to 20 Weeks|Patient Decision|0
6079738|NCT00407030|20992132|P2|Main Period - 8 to 20 Weeks|Patient Decision|0
6079739|NCT00407030|20992133|P1|Main Period - 8 to 20 Weeks|Patient Decision|1
6079740|NCT00407030|20992131|P3|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|1
6079741|NCT00407030|20992132|P2|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0
6079742|NCT00407030|20992133|P1|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0
6079743|NCT00407030|20992131|P3|Main Period - 8 to 20 Weeks|Consent Withdrawn|1
6079744|NCT00407030|20992132|P2|Main Period - 8 to 20 Weeks|Consent Withdrawn|1
6079745|NCT00407030|20992133|P1|Main Period - 8 to 20 Weeks|Consent Withdrawn|1
6079746|NCT00407030|20992131|P3|Main Period - 8 to 20 Weeks|Lost to Follow-up|1
6079747|NCT00407030|20992132|P2|Main Period - 8 to 20 Weeks|Lost to Follow-up|1
6079748|NCT00407030|20992133|P1|Main Period - 8 to 20 Weeks|Lost to Follow-up|1
6079749|NCT00407030|20992131|P3|Main Period - 8 to 20 Weeks|Lack of Efficacy|3
6079750|NCT00407030|20992132|P2|Main Period - 8 to 20 Weeks|Lack of Efficacy|0
6079751|NCT00407030|20992133|P1|Main Period - 8 to 20 Weeks|Lack of Efficacy|0
6079752|NCT00407030|20992131|P3|Main Period - 8 to 20 Weeks|Adverse Event|0
6079753|NCT00407030|20992132|P2|Main Period - 8 to 20 Weeks|Adverse Event|1
6079754|NCT00407030|20992133|P1|Main Period - 8 to 20 Weeks|Adverse Event|2
6079755|NCT00406848|20992161|P2|Overall Study|Sponsor Decision|1
6079756|NCT00406848|20992162|P1|Overall Study|Sponsor Decision|1
6079757|NCT00406848|20992161|P2|Overall Study|Physician Decision|2
6079758|NCT00406848|20992162|P1|Overall Study|Physician Decision|2
6079759|NCT00406848|20992161|P2|Overall Study|Lost to Follow-up|2
6079760|NCT00406848|20992162|P1|Overall Study|Lost to Follow-up|6
6079761|NCT00406848|20992161|P2|Overall Study|Protocol Violation|6
6079762|NCT00406848|20992162|P1|Overall Study|Protocol Violation|10
6079763|NCT00406848|20992161|P2|Overall Study|Lack of Efficacy|14
6079764|NCT00406848|20992162|P1|Overall Study|Lack of Efficacy|9
6079765|NCT00406848|20992161|P2|Overall Study|Adverse Event|7
6079766|NCT00406848|20992162|P1|Overall Study|Adverse Event|38
6079767|NCT00406848|20992161|P2|Overall Study|Withdrawal by Subject|22
6079768|NCT00406848|20992162|P1|Overall Study|Withdrawal by Subject|27
6079769|NCT00406783|20992226|P2|Overall Study|Protocol Violation|4
6079770|NCT00406783|20992227|P1|Overall Study|Protocol Violation|4
6079771|NCT00406783|20992226|P2|Overall Study|Withdrawal by Subject|4
6079772|NCT00406783|20992227|P1|Overall Study|Withdrawal by Subject|1
6079773|NCT00406783|20992226|P2|Overall Study|Lost to Follow-up|0
6079774|NCT00406783|20992227|P1|Overall Study|Lost to Follow-up|3
6079775|NCT00406783|20992226|P2|Overall Study|Treatment Failure|3
6079776|NCT00406783|20992227|P1|Overall Study|Treatment Failure|2
6079777|NCT00406783|20992226|P2|Overall Study|Adverse Event|4
6079778|NCT00406783|20992227|P1|Overall Study|Adverse Event|4
6079779|NCT00406718|20992242|P3|Overall Study|Lost to Follow-up|4
6079780|NCT00406718|20992243|P2|Overall Study|Lost to Follow-up|5
6079781|NCT00406718|20992244|P1|Overall Study|Lost to Follow-up|2
6079782|NCT00406718|20992242|P3|Overall Study|Withdrawal by Subject|4
6079783|NCT00406718|20992243|P2|Overall Study|Withdrawal by Subject|9
6079784|NCT00406718|20992244|P1|Overall Study|Withdrawal by Subject|2
6079785|NCT00406692|20992258|P1|Overall Study|Lack of Efficacy|1
6079786|NCT00406692|20992258|P1|Overall Study|Adverse Event|1
6079787|NCT00406692|20992258|P1|Overall Study|Physician Decision|1
6079788|NCT00406692|20992258|P1|Overall Study|Withdrawal by Subject|4
6079789|NCT00406653|20992268|P7|Open-Label Period|Refused followup|1
6079790|NCT00406653|20992269|P6|Open-Label Period|Refused followup|0
6079791|NCT00406653|20992270|P5|Open-Label Period|Refused followup|0
6079792|NCT00406653|20992271|P4|Open-Label Period|Refused followup|0
6079793|NCT00406653|20992272|P3|Open-Label Period|Refused followup|0
6079794|NCT00406653|20992273|P2|Open-Label Period|Refused followup|0
6079795|NCT00406653|20992274|P1|Open-Label Period|Refused followup|0
6079796|NCT00406653|20992268|P7|Open-Label Period|Discontinued by Sponsor|1
6079797|NCT00406653|20992269|P6|Open-Label Period|Discontinued by Sponsor|0
6079798|NCT00406653|20992270|P5|Open-Label Period|Discontinued by Sponsor|0
6079799|NCT00406653|20992271|P4|Open-Label Period|Discontinued by Sponsor|0
6079800|NCT00406653|20992272|P3|Open-Label Period|Discontinued by Sponsor|0
6079801|NCT00406653|20992273|P2|Open-Label Period|Discontinued by Sponsor|0
6079802|NCT00406653|20992274|P1|Open-Label Period|Discontinued by Sponsor|0
6079803|NCT00406653|20992268|P7|Open-Label Period|Declined participation but followup done|8
6079804|NCT00406653|20992269|P6|Open-Label Period|Declined participation but followup done|0
6079805|NCT00406653|20992270|P5|Open-Label Period|Declined participation but followup done|0
6079806|NCT00406653|20992271|P4|Open-Label Period|Declined participation but followup done|0
6079807|NCT00406653|20992272|P3|Open-Label Period|Declined participation but followup done|0
6079808|NCT00406653|20992273|P2|Open-Label Period|Declined participation but followup done|0
6079809|NCT00406653|20992274|P1|Open-Label Period|Declined participation but followup done|0
6079810|NCT00406653|20992268|P7|Open-Label Period|Administrative Reason By Sponsor|115
6079811|NCT00406653|20992269|P6|Open-Label Period|Administrative Reason By Sponsor|0
6079812|NCT00406653|20992270|P5|Open-Label Period|Administrative Reason By Sponsor|0
6079813|NCT00406653|20992271|P4|Open-Label Period|Administrative Reason By Sponsor|0
6079814|NCT00406653|20992272|P3|Open-Label Period|Administrative Reason By Sponsor|0
6079815|NCT00406653|20992273|P2|Open-Label Period|Administrative Reason By Sponsor|0
6079816|NCT00406653|20992274|P1|Open-Label Period|Administrative Reason By Sponsor|0
6079817|NCT00406653|20992268|P7|Open-Label Period|Pregnancy|2
6079818|NCT00406653|20992269|P6|Open-Label Period|Pregnancy|0
6079819|NCT00406653|20992270|P5|Open-Label Period|Pregnancy|0
6079820|NCT00406653|20992271|P4|Open-Label Period|Pregnancy|0
6079821|NCT00406653|20992272|P3|Open-Label Period|Pregnancy|0
6079822|NCT00406653|20992273|P2|Open-Label Period|Pregnancy|0
6079823|NCT00406653|20992274|P1|Open-Label Period|Pregnancy|0
6079824|NCT00406653|20992268|P7|Open-Label Period|Subject No Longer Meets Study Criteria|1
6079825|NCT00406653|20992269|P6|Open-Label Period|Subject No Longer Meets Study Criteria|0
6079826|NCT00406653|20992270|P5|Open-Label Period|Subject No Longer Meets Study Criteria|0
6079827|NCT00406653|20992271|P4|Open-Label Period|Subject No Longer Meets Study Criteria|0
6079828|NCT00406653|20992272|P3|Open-Label Period|Subject No Longer Meets Study Criteria|0
6079829|NCT00406653|20992273|P2|Open-Label Period|Subject No Longer Meets Study Criteria|0
6079830|NCT00406653|20992274|P1|Open-Label Period|Subject No Longer Meets Study Criteria|0
6079831|NCT00406653|20992268|P7|Open-Label Period|Withdrawal of Consent|11
6079832|NCT00406653|20992269|P6|Open-Label Period|Withdrawal of Consent|0
6079833|NCT00406653|20992270|P5|Open-Label Period|Withdrawal of Consent|0
6079834|NCT00406653|20992271|P4|Open-Label Period|Withdrawal of Consent|0
6079835|NCT00406653|20992272|P3|Open-Label Period|Withdrawal of Consent|0
6079836|NCT00406653|20992273|P2|Open-Label Period|Withdrawal of Consent|0
6079837|NCT00406653|20992274|P1|Open-Label Period|Withdrawal of Consent|0
6079838|NCT00406653|20992268|P7|Open-Label Period|Lost to Follow-up|6
6079839|NCT00406653|20992269|P6|Open-Label Period|Lost to Follow-up|0
6079840|NCT00406653|20992270|P5|Open-Label Period|Lost to Follow-up|0
6079841|NCT00406653|20992271|P4|Open-Label Period|Lost to Follow-up|0
6079842|NCT00406653|20992272|P3|Open-Label Period|Lost to Follow-up|0
6079843|NCT00406653|20992273|P2|Open-Label Period|Lost to Follow-up|0
6079844|NCT00406653|20992274|P1|Open-Label Period|Lost to Follow-up|0
6079845|NCT00406653|20992268|P7|Open-Label Period|Lack of Efficacy|160
6079846|NCT00406653|20992269|P6|Open-Label Period|Lack of Efficacy|0
6079847|NCT00406653|20992270|P5|Open-Label Period|Lack of Efficacy|0
6079848|NCT00406653|20992271|P4|Open-Label Period|Lack of Efficacy|0
6079849|NCT00406653|20992272|P3|Open-Label Period|Lack of Efficacy|0
6079850|NCT00406653|20992273|P2|Open-Label Period|Lack of Efficacy|0
6079851|NCT00406653|20992274|P1|Open-Label Period|Lack of Efficacy|0
6079852|NCT00406653|20992268|P7|Open-Label Period|Adverse Event|18
6079853|NCT00406653|20992269|P6|Open-Label Period|Adverse Event|0
6079854|NCT00406653|20992270|P5|Open-Label Period|Adverse Event|0
6079855|NCT00406653|20992271|P4|Open-Label Period|Adverse Event|0
6079856|NCT00406653|20992272|P3|Open-Label Period|Adverse Event|0
6079857|NCT00406653|20992273|P2|Open-Label Period|Adverse Event|0
6079858|NCT00406653|20992274|P1|Open-Label Period|Adverse Event|0
6079859|NCT00406653|20992268|P7|Open-Label Period|Death|1
6079860|NCT00406653|20992269|P6|Open-Label Period|Death|0
6079861|NCT00406653|20992270|P5|Open-Label Period|Death|0
6079862|NCT00406653|20992271|P4|Open-Label Period|Death|0
6079863|NCT00406653|20992272|P3|Open-Label Period|Death|0
6079864|NCT00406653|20992273|P2|Open-Label Period|Death|0
6079865|NCT00406653|20992274|P1|Open-Label Period|Death|0
6079866|NCT00406653|20992268|P7|Maintenance Period|Error in disease score evaluation|0
6079867|NCT00406653|20992269|P6|Maintenance Period|Error in disease score evaluation|0
6079868|NCT00406653|20992270|P5|Maintenance Period|Error in disease score evaluation|1
6079869|NCT00406653|20992271|P4|Maintenance Period|Error in disease score evaluation|0
6079870|NCT00406653|20992272|P3|Maintenance Period|Error in disease score evaluation|0
6079871|NCT00406653|20992273|P2|Maintenance Period|Error in disease score evaluation|0
6079872|NCT00406653|20992274|P1|Maintenance Period|Error in disease score evaluation|0
6079873|NCT00406653|20992268|P7|Maintenance Period|Administrative Reason By Sponsor|0
6079874|NCT00406653|20992269|P6|Maintenance Period|Administrative Reason By Sponsor|7
6079875|NCT00406653|20992270|P5|Maintenance Period|Administrative Reason By Sponsor|4
6079876|NCT00406653|20992271|P4|Maintenance Period|Administrative Reason By Sponsor|0
6079877|NCT00406653|20992272|P3|Maintenance Period|Administrative Reason By Sponsor|0
6079878|NCT00406653|20992273|P2|Maintenance Period|Administrative Reason By Sponsor|0
6079879|NCT00406653|20992274|P1|Maintenance Period|Administrative Reason By Sponsor|0
6079880|NCT00406653|20992268|P7|Maintenance Period|Pregnancy|0
6079881|NCT00406653|20992269|P6|Maintenance Period|Pregnancy|1
6079882|NCT00406653|20992270|P5|Maintenance Period|Pregnancy|0
6079883|NCT00406653|20992271|P4|Maintenance Period|Pregnancy|0
6079884|NCT00406653|20992272|P3|Maintenance Period|Pregnancy|0
6079885|NCT00406653|20992273|P2|Maintenance Period|Pregnancy|0
6079886|NCT00406653|20992274|P1|Maintenance Period|Pregnancy|0
6079887|NCT00406653|20992268|P7|Maintenance Period|Withdrawal of Consent|0
6079888|NCT00406653|20992269|P6|Maintenance Period|Withdrawal of Consent|0
6079889|NCT00406653|20992270|P5|Maintenance Period|Withdrawal of Consent|2
6079890|NCT00406653|20992271|P4|Maintenance Period|Withdrawal of Consent|0
6079891|NCT00406653|20992272|P3|Maintenance Period|Withdrawal of Consent|0
6079892|NCT00406653|20992273|P2|Maintenance Period|Withdrawal of Consent|0
6079893|NCT00406653|20992274|P1|Maintenance Period|Withdrawal of Consent|0
6079894|NCT00406653|20992268|P7|Maintenance Period|Lost to Follow-up|0
6079895|NCT00406653|20992269|P6|Maintenance Period|Lost to Follow-up|1
6079896|NCT00406653|20992270|P5|Maintenance Period|Lost to Follow-up|2
6079897|NCT00406653|20992271|P4|Maintenance Period|Lost to Follow-up|0
6079898|NCT00406653|20992272|P3|Maintenance Period|Lost to Follow-up|0
6079899|NCT00406653|20992273|P2|Maintenance Period|Lost to Follow-up|0
6079900|NCT00406653|20992274|P1|Maintenance Period|Lost to Follow-up|0
6079901|NCT00406653|20992268|P7|Maintenance Period|Lack of Efficacy|0
6079902|NCT00406653|20992269|P6|Maintenance Period|Lack of Efficacy|26
6079903|NCT00406653|20992270|P5|Maintenance Period|Lack of Efficacy|20
6079904|NCT00406653|20992271|P4|Maintenance Period|Lack of Efficacy|0
6079905|NCT00406653|20992272|P3|Maintenance Period|Lack of Efficacy|0
6079906|NCT00406653|20992273|P2|Maintenance Period|Lack of Efficacy|0
6079907|NCT00406653|20992274|P1|Maintenance Period|Lack of Efficacy|0
6079908|NCT00406653|20992268|P7|Maintenance Period|Adverse Event|0
6079909|NCT00406653|20992269|P6|Maintenance Period|Adverse Event|1
6079910|NCT00406653|20992270|P5|Maintenance Period|Adverse Event|1
6079911|NCT00406653|20992271|P4|Maintenance Period|Adverse Event|0
6079912|NCT00406653|20992272|P3|Maintenance Period|Adverse Event|0
6079913|NCT00406653|20992273|P2|Maintenance Period|Adverse Event|0
6079914|NCT00406653|20992274|P1|Maintenance Period|Adverse Event|0
6079915|NCT00406653|20992268|P7|Induction Period|Patient relocated|0
6079916|NCT00406653|20992269|P6|Induction Period|Patient relocated|0
6079917|NCT00406653|20992270|P5|Induction Period|Patient relocated|0
6079918|NCT00406653|20992271|P4|Induction Period|Patient relocated|0
6079919|NCT00406653|20992272|P3|Induction Period|Patient relocated|1
6079920|NCT00406653|20992273|P2|Induction Period|Patient relocated|0
6079921|NCT00406653|20992274|P1|Induction Period|Patient relocated|0
6079922|NCT00406653|20992268|P7|Induction Period|Incarcerated|0
6079923|NCT00406653|20992269|P6|Induction Period|Incarcerated|0
6079924|NCT00406653|20992270|P5|Induction Period|Incarcerated|0
6079925|NCT00406653|20992271|P4|Induction Period|Incarcerated|0
6079926|NCT00406653|20992272|P3|Induction Period|Incarcerated|1
6079927|NCT00406653|20992273|P2|Induction Period|Incarcerated|0
6079928|NCT00406653|20992274|P1|Induction Period|Incarcerated|0
6079929|NCT00406653|20992268|P7|Induction Period|Given prohibited drug|0
6079930|NCT00406653|20992269|P6|Induction Period|Given prohibited drug|0
6079931|NCT00406653|20992270|P5|Induction Period|Given prohibited drug|0
6079932|NCT00406653|20992271|P4|Induction Period|Given prohibited drug|0
6079933|NCT00406653|20992272|P3|Induction Period|Given prohibited drug|2
6079934|NCT00406653|20992273|P2|Induction Period|Given prohibited drug|1
6079935|NCT00406653|20992274|P1|Induction Period|Given prohibited drug|0
6079936|NCT00406653|20992268|P7|Induction Period|Declined participation but followup done|0
6079937|NCT00406653|20992269|P6|Induction Period|Declined participation but followup done|0
6079938|NCT00406653|20992270|P5|Induction Period|Declined participation but followup done|0
6079939|NCT00406653|20992271|P4|Induction Period|Declined participation but followup done|1
6079940|NCT00406653|20992272|P3|Induction Period|Declined participation but followup done|1
6079941|NCT00406653|20992273|P2|Induction Period|Declined participation but followup done|2
6079942|NCT00406653|20992274|P1|Induction Period|Declined participation but followup done|0
6079943|NCT00406653|20992268|P7|Induction Period|Pregnancy|0
6079944|NCT00406653|20992269|P6|Induction Period|Pregnancy|0
6079945|NCT00406653|20992270|P5|Induction Period|Pregnancy|0
6079946|NCT00406653|20992271|P4|Induction Period|Pregnancy|0
6079947|NCT00406653|20992272|P3|Induction Period|Pregnancy|0
6079948|NCT00406653|20992273|P2|Induction Period|Pregnancy|0
6079949|NCT00406653|20992274|P1|Induction Period|Pregnancy|1
6079950|NCT00406653|20992268|P7|Induction Period|Subject No Longer Meets Study Criteria|0
6079951|NCT00406653|20992269|P6|Induction Period|Subject No Longer Meets Study Criteria|0
6079952|NCT00406653|20992270|P5|Induction Period|Subject No Longer Meets Study Criteria|0
6079953|NCT00406653|20992271|P4|Induction Period|Subject No Longer Meets Study Criteria|2
6079954|NCT00406653|20992272|P3|Induction Period|Subject No Longer Meets Study Criteria|0
6079955|NCT00406653|20992273|P2|Induction Period|Subject No Longer Meets Study Criteria|0
6079956|NCT00406653|20992274|P1|Induction Period|Subject No Longer Meets Study Criteria|0
6079957|NCT00406653|20992268|P7|Induction Period|Withdrawal of Consent|0
6079958|NCT00406653|20992269|P6|Induction Period|Withdrawal of Consent|0
6079959|NCT00406653|20992270|P5|Induction Period|Withdrawal of Consent|0
6079960|NCT00406653|20992271|P4|Induction Period|Withdrawal of Consent|2
6079961|NCT00406653|20992272|P3|Induction Period|Withdrawal of Consent|1
6079962|NCT00406653|20992273|P2|Induction Period|Withdrawal of Consent|5
6079963|NCT00406653|20992274|P1|Induction Period|Withdrawal of Consent|2
6079964|NCT00406653|20992268|P7|Induction Period|Lost to Follow-up|0
6079965|NCT00406653|20992269|P6|Induction Period|Lost to Follow-up|0
6079966|NCT00406653|20992270|P5|Induction Period|Lost to Follow-up|0
6079967|NCT00406653|20992271|P4|Induction Period|Lost to Follow-up|0
6079968|NCT00406653|20992272|P3|Induction Period|Lost to Follow-up|0
6079969|NCT00406653|20992273|P2|Induction Period|Lost to Follow-up|2
6079970|NCT00406653|20992274|P1|Induction Period|Lost to Follow-up|0
6079971|NCT00406653|20992268|P7|Induction Period|Lack of Efficacy|0
6079972|NCT00406653|20992269|P6|Induction Period|Lack of Efficacy|0
6079973|NCT00406653|20992270|P5|Induction Period|Lack of Efficacy|0
6079974|NCT00406653|20992271|P4|Induction Period|Lack of Efficacy|10
6079975|NCT00406653|20992272|P3|Induction Period|Lack of Efficacy|8
6079976|NCT00406653|20992273|P2|Induction Period|Lack of Efficacy|14
6079977|NCT00406653|20992274|P1|Induction Period|Lack of Efficacy|11
6079978|NCT00406653|20992268|P7|Induction Period|Adverse Event|0
6079979|NCT00406653|20992269|P6|Induction Period|Adverse Event|0
6079980|NCT00406653|20992270|P5|Induction Period|Adverse Event|0
6079981|NCT00406653|20992271|P4|Induction Period|Adverse Event|11
6079982|NCT00406653|20992272|P3|Induction Period|Adverse Event|4
6079983|NCT00406653|20992273|P2|Induction Period|Adverse Event|10
6079984|NCT00406653|20992274|P1|Induction Period|Adverse Event|1
6079985|NCT00406640|20992355|P2|OL Extension Phase for Non-Responders|Lack of Efficacy|7
6079986|NCT00406640|20992356|P1|OL Extension Phase for Non-Responders|Lack of Efficacy|6
6079987|NCT00406640|20992355|P2|OL Extension Phase for Non-Responders|Withdrawal by Subject|6
6079988|NCT00406640|20992356|P1|OL Extension Phase for Non-Responders|Withdrawal by Subject|3
6079989|NCT00406640|20992355|P2|OL Extension Phase for Non-Responders|non-compliance|2
6079990|NCT00406640|20992356|P1|OL Extension Phase for Non-Responders|non-compliance|3
6079991|NCT00406640|20992355|P2|OL Extension Phase for Non-Responders|Lost to Follow-up|3
6079992|NCT00406640|20992356|P1|OL Extension Phase for Non-Responders|Lost to Follow-up|2
6079993|NCT00406640|20992355|P2|OL Extension Phase for Non-Responders|Physician Decision|0
6079994|NCT00406640|20992356|P1|OL Extension Phase for Non-Responders|Physician Decision|1
6079995|NCT00406640|20992355|P2|OL Extension Phase for Non-Responders|Failed to Return|0
6079996|NCT00406640|20992356|P1|OL Extension Phase for Non-Responders|Failed to Return|1
6079997|NCT00406640|20992355|P2|OL Extension Phase for Non-Responders|Adverse Event|6
6079998|NCT00406640|20992356|P1|OL Extension Phase for Non-Responders|Adverse Event|6
6079999|NCT00406640|20992355|P2|DB Continuation Phase for Responders|Lack of Efficacy|1
6080000|NCT00406640|20992356|P1|DB Continuation Phase for Responders|Lack of Efficacy|1
6080001|NCT00406640|20992355|P2|DB Continuation Phase for Responders|Withdrawal by Subject|6
6080002|NCT00406640|20992356|P1|DB Continuation Phase for Responders|Withdrawal by Subject|8
6080003|NCT00406640|20992355|P2|DB Continuation Phase for Responders|Protocol Violation|2
6080004|NCT00406640|20992356|P1|DB Continuation Phase for Responders|Protocol Violation|2
6080005|NCT00406640|20992355|P2|DB Continuation Phase for Responders|non-compliance|5
6080006|NCT00406640|20992356|P1|DB Continuation Phase for Responders|non-compliance|7
6080007|NCT00406640|20992355|P2|DB Continuation Phase for Responders|Lost to Follow-up|7
6080008|NCT00406640|20992356|P1|DB Continuation Phase for Responders|Lost to Follow-up|1
6080009|NCT00406640|20992355|P2|DB Continuation Phase for Responders|Physician Decision|3
6080010|NCT00406640|20992356|P1|DB Continuation Phase for Responders|Physician Decision|2
6080011|NCT00406640|20992355|P2|DB Continuation Phase for Responders|Failed to Return|2
6080012|NCT00406640|20992356|P1|DB Continuation Phase for Responders|Failed to Return|0
6080013|NCT00406640|20992355|P2|DB Continuation Phase for Responders|Death|0
6080014|NCT00406640|20992356|P1|DB Continuation Phase for Responders|Death|1
6080015|NCT00406640|20992355|P2|DB Continuation Phase for Responders|Adverse Event|11
6080016|NCT00406640|20992356|P1|DB Continuation Phase for Responders|Adverse Event|11
6080017|NCT00406640|20992355|P2|Acute Phase|Lack of Efficacy|3
6080018|NCT00406640|20992356|P1|Acute Phase|Lack of Efficacy|3
6080019|NCT00406640|20992355|P2|Acute Phase|Withdrawal by Subject|9
6080020|NCT00406640|20992356|P1|Acute Phase|Withdrawal by Subject|11
6080021|NCT00406640|20992355|P2|Acute Phase|Protocol Violation|2
6080022|NCT00406640|20992356|P1|Acute Phase|Protocol Violation|3
6080023|NCT00406640|20992355|P2|Acute Phase|Protocol deviation|10
6080024|NCT00406640|20992356|P1|Acute Phase|Protocol deviation|4
6080025|NCT00406640|20992355|P2|Acute Phase|Lost to Follow-up|4
6080026|NCT00406640|20992356|P1|Acute Phase|Lost to Follow-up|7
6080027|NCT00406640|20992355|P2|Acute Phase|Physician Decision|1
6080028|NCT00406640|20992356|P1|Acute Phase|Physician Decision|0
6080029|NCT00406640|20992355|P2|Acute Phase|Failed to Return|1
6080030|NCT00406640|20992356|P1|Acute Phase|Failed to Return|5
6080031|NCT00406640|20992355|P2|Acute Phase|Adverse Event|13
6080032|NCT00406640|20992356|P1|Acute Phase|Adverse Event|18
6080033|NCT00406419|20992389|P3|Overall Study|Lost to Follow-up|5
6080034|NCT00406419|20992390|P2|Overall Study|Lost to Follow-up|10
6080035|NCT00406419|20992391|P1|Overall Study|Lost to Follow-up|11
6080036|NCT00406419|20992389|P3|Overall Study|Adverse Event|16
6080037|NCT00406419|20992390|P2|Overall Study|Adverse Event|12
6080038|NCT00406419|20992391|P1|Overall Study|Adverse Event|10
6080039|NCT00406419|20992389|P3|Overall Study|Non-Compliance with Study Drug|3
6080040|NCT00406419|20992390|P2|Overall Study|Non-Compliance with Study Drug|6
6080041|NCT00406419|20992391|P1|Overall Study|Non-Compliance with Study Drug|5
6080042|NCT00406419|20992389|P3|Overall Study|Lack of Efficacy|6
6080043|NCT00406419|20992390|P2|Overall Study|Lack of Efficacy|1
6080044|NCT00406419|20992391|P1|Overall Study|Lack of Efficacy|12
6080045|NCT00406419|20992389|P3|Overall Study|Withdrawal by Subject|26
6080046|NCT00406419|20992390|P2|Overall Study|Withdrawal by Subject|24
6080047|NCT00406419|20992391|P1|Overall Study|Withdrawal by Subject|17
6080048|NCT00406419|20992389|P3|Overall Study|Study Terminated by Sponsor|282
6080049|NCT00406419|20992390|P2|Overall Study|Study Terminated by Sponsor|288
6080050|NCT00406419|20992391|P1|Overall Study|Study Terminated by Sponsor|260
6080051|NCT00406419|20992389|P3|Overall Study|Protocol Violation|5
6080052|NCT00406419|20992390|P2|Overall Study|Protocol Violation|2
6080053|NCT00406419|20992391|P1|Overall Study|Protocol Violation|6
6080054|NCT00406419|20992389|P3|Overall Study|Death|4
6080055|NCT00406419|20992390|P2|Overall Study|Death|1
6080056|NCT00406419|20992391|P1|Overall Study|Death|3
6080057|NCT00406393|20992476|P2|Overall Study|Did not undergo transplantation|1
6080058|NCT00406393|20992477|P1|Overall Study|Did not undergo transplantation|2
6080059|NCT00406367|20992507|P2|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|0
6080060|NCT00406367|20992508|P1|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|1
6080061|NCT00406367|20992507|P2|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|0
6080062|NCT00406367|20992508|P1|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|1
6080063|NCT00406367|20992507|P2|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|0
6080064|NCT00406367|20992508|P1|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|1
6080065|NCT00406367|20992507|P2|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|0
6080066|NCT00406367|20992508|P1|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|1
6080067|NCT00406367|20992507|P2|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|0
6080068|NCT00406367|20992508|P1|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|4
6080069|NCT00406367|20992507|P2|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|0
6080070|NCT00406367|20992508|P1|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|4
6080071|NCT00406367|20992507|P2|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|0
6080072|NCT00406367|20992508|P1|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|6
6080073|NCT00406367|20992507|P2|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|0
6080074|NCT00406367|20992508|P1|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|2
6080075|NCT00406367|20992507|P2|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|1
6080076|NCT00406367|20992508|P1|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|0
6080077|NCT00406367|20992507|P2|Main Period - 6 to 20 Weeks|Lost to Follow-up|1
6080078|NCT00406367|20992508|P1|Main Period - 6 to 20 Weeks|Lost to Follow-up|0
6080079|NCT00406367|20992507|P2|Main Period - 6 to 20 Weeks|Consent Withdrawn|0
6080080|NCT00406367|20992508|P1|Main Period - 6 to 20 Weeks|Consent Withdrawn|1
6080081|NCT00406367|20992507|P2|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|0
6080082|NCT00406367|20992508|P1|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|4
6080083|NCT00406354|20992523|P3|All Randomized and Treated Patients|Physician Decision|1
6080084|NCT00406354|20992524|P2|All Randomized and Treated Patients|Physician Decision|0
6080085|NCT00406354|20992525|P1|All Randomized and Treated Patients|Physician Decision|0
6080086|NCT00406354|20992523|P3|All Randomized and Treated Patients|Withdrawal by Subject|2
6080087|NCT00406354|20992524|P2|All Randomized and Treated Patients|Withdrawal by Subject|1
6080088|NCT00406354|20992525|P1|All Randomized and Treated Patients|Withdrawal by Subject|1
6080089|NCT00406354|20992523|P3|All Randomized and Treated Patients|Parent/Caregiver Decision|1
6080090|NCT00406354|20992524|P2|All Randomized and Treated Patients|Parent/Caregiver Decision|6
6080091|NCT00406354|20992525|P1|All Randomized and Treated Patients|Parent/Caregiver Decision|2
6080092|NCT00406354|20992523|P3|All Randomized and Treated Patients|Adverse Event|1
6080093|NCT00406354|20992524|P2|All Randomized and Treated Patients|Adverse Event|2
6080094|NCT00406354|20992525|P1|All Randomized and Treated Patients|Adverse Event|6
6080095|NCT00406354|20992523|P3|All Randomized and Treated Patients|Lack of Efficacy|17
6080096|NCT00406354|20992524|P2|All Randomized and Treated Patients|Lack of Efficacy|4
6080097|NCT00406354|20992525|P1|All Randomized and Treated Patients|Lack of Efficacy|7
6080098|NCT00406354|20992523|P3|All Randomized Patients|Protocol Violation|1
6080099|NCT00406354|20992524|P2|All Randomized Patients|Protocol Violation|0
6080100|NCT00406354|20992525|P1|All Randomized Patients|Protocol Violation|0
6080101|NCT00406315|20992596|P1|Overall Study|Withdrawal by Subject|30
6080102|NCT00406315|20992596|P1|Overall Study|Lost to Follow-up|21
6080103|NCT00406315|20992596|P1|Overall Study|Other|33
6080104|NCT00406315|20992596|P1|Overall Study|Lack of Efficacy|13
6080105|NCT00406315|20992596|P1|Overall Study|Laboratory Abnormality|4
6080106|NCT00406315|20992596|P1|Overall Study|Adverse Event|39
6080107|NCT00406315|20992596|P1|Overall Study|Death|1
6080108|NCT00406029|20992706|P5|Overall Study|Randomized in Error|1
6080109|NCT00406029|20992707|P4|Overall Study|Randomized in Error|3
6080110|NCT00406029|20992708|P3|Overall Study|Randomized in Error|2
6080111|NCT00406029|20992709|P2|Overall Study|Randomized in Error|0
6080112|NCT00406029|20992710|P1|Overall Study|Randomized in Error|0
6080113|NCT00406029|20992706|P5|Overall Study|Did Not Meet Eligibility Criteria|0
6080114|NCT00406029|20992707|P4|Overall Study|Did Not Meet Eligibility Criteria|0
6080115|NCT00406029|20992708|P3|Overall Study|Did Not Meet Eligibility Criteria|1
6080116|NCT00406029|20992709|P2|Overall Study|Did Not Meet Eligibility Criteria|0
6080117|NCT00406029|20992710|P1|Overall Study|Did Not Meet Eligibility Criteria|0
6080118|NCT00406029|20992706|P5|Overall Study|Protocol Violation|0
6080119|NCT00406029|20992707|P4|Overall Study|Protocol Violation|2
6080120|NCT00406029|20992708|P3|Overall Study|Protocol Violation|0
6080121|NCT00406029|20992709|P2|Overall Study|Protocol Violation|2
6080122|NCT00406029|20992710|P1|Overall Study|Protocol Violation|1
6080123|NCT00406029|20992706|P5|Overall Study|Withdrawal by Subject|0
6080124|NCT00406029|20992707|P4|Overall Study|Withdrawal by Subject|2
6080125|NCT00406029|20992708|P3|Overall Study|Withdrawal by Subject|2
6080126|NCT00406029|20992709|P2|Overall Study|Withdrawal by Subject|4
6080127|NCT00406029|20992710|P1|Overall Study|Withdrawal by Subject|3
6080128|NCT00406029|20992706|P5|Overall Study|Adverse Event|7
6080129|NCT00406029|20992707|P4|Overall Study|Adverse Event|10
6080130|NCT00406029|20992708|P3|Overall Study|Adverse Event|5
6080131|NCT00406029|20992709|P2|Overall Study|Adverse Event|2
6080132|NCT00406029|20992710|P1|Overall Study|Adverse Event|12
6080133|NCT00405964|20992814|P2|Overall Study|Protocol Violation|6
6080134|NCT00405964|20992815|P1|Overall Study|Protocol Violation|11
6080135|NCT00405964|20992814|P2|Overall Study|Withdrawal by Subject|23
6080136|NCT00405964|20992815|P1|Overall Study|Withdrawal by Subject|19
6080137|NCT00405964|20992814|P2|Overall Study|Lost to Follow-up|5
6080138|NCT00405964|20992815|P1|Overall Study|Lost to Follow-up|5
6080139|NCT00405964|20992814|P2|Overall Study|Adverse Event|16
6080140|NCT00405964|20992815|P1|Overall Study|Adverse Event|7
6080141|NCT00405964|20992814|P2|Overall Study|Treatment Failure|45
6080142|NCT00405964|20992815|P1|Overall Study|Treatment Failure|17
6080143|NCT00405912|20992837|P3|Overall Study|Lost to Follow-up|4
6080144|NCT00405912|20992838|P2|Overall Study|Lost to Follow-up|8
6080145|NCT00405912|20992839|P1|Overall Study|Lost to Follow-up|4
6080146|NCT00405912|20992837|P3|Overall Study|Withdrawal by Subject|12
6080147|NCT00405912|20992838|P2|Overall Study|Withdrawal by Subject|11
6080148|NCT00405912|20992839|P1|Overall Study|Withdrawal by Subject|12
6080149|NCT00405821|20992852|P2|Overall Study|initiated ART|8
6080150|NCT00405821|20992853|P1|Overall Study|initiated ART|9
6080151|NCT00405821|20992852|P2|Overall Study|Protocol Violation|0
6080152|NCT00405821|20992853|P1|Overall Study|Protocol Violation|1
6080153|NCT00405821|20992852|P2|Overall Study|Lost to Follow-up|7
6080154|NCT00405821|20992853|P1|Overall Study|Lost to Follow-up|7
6080155|NCT00405821|20992852|P2|Overall Study|Death|7
6080156|NCT00405821|20992853|P1|Overall Study|Death|5
6080157|NCT00405756|20992866|P3|Follow-up|Lost to Follow-up|4
6080158|NCT00405756|20992867|P2|Follow-up|Lost to Follow-up|8
6080159|NCT00405756|20992868|P1|Follow-up|Lost to Follow-up|2
6080160|NCT00405756|20992866|P3|Follow-up|Death|24
6080161|NCT00405756|20992867|P2|Follow-up|Death|31
6080162|NCT00405756|20992868|P1|Follow-up|Death|21
6080163|NCT00405756|20992866|P3|Follow-up|Ongoing in Follow-up Period|60
6080164|NCT00405756|20992867|P2|Follow-up|Ongoing in Follow-up Period|51
6080165|NCT00405756|20992868|P1|Follow-up|Ongoing in Follow-up Period|52
6080166|NCT00405756|20992866|P3|Open-label Extension|Other|7
6080167|NCT00405756|20992867|P2|Open-label Extension|Other|1
6080168|NCT00405756|20992868|P1|Open-label Extension|Other|0
6080169|NCT00405756|20992866|P3|Open-label Extension|Death|4
6080170|NCT00405756|20992867|P2|Open-label Extension|Death|2
6080171|NCT00405756|20992868|P1|Open-label Extension|Death|1
6080172|NCT00405756|20992866|P3|Open-label Extension|Withdrawal by Subject|3
6080173|NCT00405756|20992867|P2|Open-label Extension|Withdrawal by Subject|3
6080174|NCT00405756|20992868|P1|Open-label Extension|Withdrawal by Subject|2
6080175|NCT00405756|20992866|P3|Open-label Extension|Disease Progression|26
6080176|NCT00405756|20992867|P2|Open-label Extension|Disease Progression|23
6080177|NCT00405756|20992868|P1|Open-label Extension|Disease Progression|8
6080178|NCT00405756|20992866|P3|Open-label Extension|Adverse Event|7
6080179|NCT00405756|20992867|P2|Open-label Extension|Adverse Event|3
6080180|NCT00405756|20992868|P1|Open-label Extension|Adverse Event|1
6080181|NCT00405756|20992866|P3|Open-label Extension|Ongoing in Open Label Period|25
6080182|NCT00405756|20992867|P2|Open-label Extension|Ongoing in Open Label Period|15
6080183|NCT00405756|20992868|P1|Open-label Extension|Ongoing in Open Label Period|7
6080184|NCT00405756|20992866|P3|Double-blind Treatment|Other|4
6080185|NCT00405756|20992867|P2|Double-blind Treatment|Other|4
6080186|NCT00405756|20992868|P1|Double-blind Treatment|Other|7
6080187|NCT00405756|20992866|P3|Double-blind Treatment|Protocol Violation|2
6080188|NCT00405756|20992867|P2|Double-blind Treatment|Protocol Violation|0
6080189|NCT00405756|20992868|P1|Double-blind Treatment|Protocol Violation|1
6080190|NCT00405756|20992866|P3|Double-blind Treatment|Death|4
6080191|NCT00405756|20992867|P2|Double-blind Treatment|Death|4
6080192|NCT00405756|20992868|P1|Double-blind Treatment|Death|4
6080193|NCT00405756|20992866|P3|Double-blind Treatment|Lost to Follow-up|0
6080194|NCT00405756|20992867|P2|Double-blind Treatment|Lost to Follow-up|0
6080195|NCT00405756|20992868|P1|Double-blind Treatment|Lost to Follow-up|1
6080196|NCT00405756|20992866|P3|Double-blind Treatment|Withdrawal by Subject|10
6080197|NCT00405756|20992867|P2|Double-blind Treatment|Withdrawal by Subject|9
6080198|NCT00405756|20992868|P1|Double-blind Treatment|Withdrawal by Subject|15
6080199|NCT00405756|20992866|P3|Double-blind Treatment|Lack of Efficacy|2
6080200|NCT00405756|20992867|P2|Double-blind Treatment|Lack of Efficacy|4
6080201|NCT00405756|20992868|P1|Double-blind Treatment|Lack of Efficacy|1
6080202|NCT00405756|20992866|P3|Double-blind Treatment|Disease Progression|102
6080203|NCT00405756|20992867|P2|Double-blind Treatment|Disease Progression|81
6080204|NCT00405756|20992868|P1|Double-blind Treatment|Disease Progression|47
6080205|NCT00405756|20992866|P3|Double-blind Treatment|Adverse Event|12
6080206|NCT00405756|20992867|P2|Double-blind Treatment|Adverse Event|27
6080207|NCT00405756|20992868|P1|Double-blind Treatment|Adverse Event|31
6080208|NCT00405756|20992866|P3|Double-blind Treatment|Ongoing in Double-blind Treatment|18
6080209|NCT00405756|20992867|P2|Double-blind Treatment|Ongoing in Double-blind Treatment|24
6080210|NCT00405756|20992868|P1|Double-blind Treatment|Ongoing in Double-blind Treatment|45
6080211|NCT00405652|20992979|P1|Overall Study|Adverse Event|4
6080212|NCT00405639|20992986|P2|Overall Study|Seizure prior to receiving BNP|0
6080213|NCT00405639|20992987|P1|Overall Study|Seizure prior to receiving BNP|1
6080214|NCT00405639|20992986|P2|Overall Study|Adverse Event|0
6080215|NCT00405639|20992987|P1|Overall Study|Adverse Event|1
6080216|NCT00405639|20992986|P2|Overall Study|Withdrawal by Subject|0
6080217|NCT00405639|20992987|P1|Overall Study|Withdrawal by Subject|1
6080218|NCT00405587|20993003|P4|Overall Study|Participant not dosed|0
6080219|NCT00405587|20993004|P3|Overall Study|Participant not dosed|0
6080220|NCT00405587|20993005|P2|Overall Study|Participant not dosed|1
6080221|NCT00405587|20993006|P1|Overall Study|Participant not dosed|0
6080222|NCT00405587|20993003|P4|Overall Study|Withdrawal by Subject|2
6080223|NCT00405587|20993004|P3|Overall Study|Withdrawal by Subject|0
6080224|NCT00405587|20993005|P2|Overall Study|Withdrawal by Subject|0
6080225|NCT00405587|20993006|P1|Overall Study|Withdrawal by Subject|0
6080226|NCT00405587|20993003|P4|Overall Study|Radiation induced necrosis|0
6080227|NCT00405587|20993004|P3|Overall Study|Radiation induced necrosis|0
6080228|NCT00405587|20993005|P2|Overall Study|Radiation induced necrosis|1
6080229|NCT00405587|20993006|P1|Overall Study|Radiation induced necrosis|0
6080230|NCT00405587|20993003|P4|Overall Study|Lost to Follow-up|0
6080231|NCT00405587|20993004|P3|Overall Study|Lost to Follow-up|1
6080232|NCT00405587|20993005|P2|Overall Study|Lost to Follow-up|1
6080233|NCT00405587|20993006|P1|Overall Study|Lost to Follow-up|0
6080234|NCT00405587|20993003|P4|Overall Study|Adverse Event|0
6080235|NCT00405587|20993004|P3|Overall Study|Adverse Event|0
6080236|NCT00405587|20993005|P2|Overall Study|Adverse Event|0
6080237|NCT00405587|20993006|P1|Overall Study|Adverse Event|1
6080238|NCT00405587|20993003|P4|Overall Study|Physician Decision|0
6080239|NCT00405587|20993004|P3|Overall Study|Physician Decision|0
6080240|NCT00405587|20993005|P2|Overall Study|Physician Decision|2
6080241|NCT00405587|20993006|P1|Overall Study|Physician Decision|3
6080242|NCT00405587|20993003|P4|Overall Study|Disease Progression|17
6080243|NCT00405587|20993004|P3|Overall Study|Disease Progression|21
6080244|NCT00405587|20993005|P2|Overall Study|Disease Progression|23
6080245|NCT00405587|20993006|P1|Overall Study|Disease Progression|22
6080246|NCT00405587|20993003|P4|Overall Study|Death|1
6080247|NCT00405587|20993004|P3|Overall Study|Death|0
6080248|NCT00405587|20993005|P2|Overall Study|Death|0
6080249|NCT00405587|20993006|P1|Overall Study|Death|0
6080250|NCT00405548|20993124|P2|Overall Study|Withdrawal by Subject|0
6080251|NCT00405548|20993125|P1|Overall Study|Withdrawal by Subject|1
6080252|NCT00405548|20993124|P2|Overall Study|Venous access failed during study day|0
6080253|NCT00405548|20993125|P1|Overall Study|Venous access failed during study day|1
6080254|NCT00405548|20993124|P2|Overall Study|Unable to self-administer shots|0
6080255|NCT00405548|20993125|P1|Overall Study|Unable to self-administer shots|1
6080256|NCT00405548|20993124|P2|Overall Study|Amyloidosis on study echo-exclusionary|1
6080257|NCT00405548|20993125|P1|Overall Study|Amyloidosis on study echo-exclusionary|0
6080258|NCT00405548|20993124|P2|Overall Study|Cognitive Memory problems on study day|0
6080259|NCT00405548|20993125|P1|Overall Study|Cognitive Memory problems on study day|1
6080260|NCT00405392|20993169|P2|Overall Study|Other|5
6080261|NCT00405392|20993170|P1|Overall Study|Other|1
6080262|NCT00405392|20993169|P2|Overall Study|Non-compliance|1
6080263|NCT00405392|20993170|P1|Overall Study|Non-compliance|0
6080264|NCT00405392|20993169|P2|Overall Study|Data missing|0
6080265|NCT00405392|20993170|P1|Overall Study|Data missing|2
6080266|NCT00405392|20993169|P2|Overall Study|Lost to Follow-up|2
6080267|NCT00405392|20993170|P1|Overall Study|Lost to Follow-up|1
6080268|NCT00405392|20993169|P2|Overall Study|Withdrawal by Subject|3
6080269|NCT00405392|20993170|P1|Overall Study|Withdrawal by Subject|4
6080270|NCT00405392|20993169|P2|Overall Study|Did not meet Eligibility criteria|2
6080271|NCT00405392|20993170|P1|Overall Study|Did not meet Eligibility criteria|7
6080272|NCT00405392|20993169|P2|Overall Study|Adverse Event|14
6080273|NCT00405392|20993170|P1|Overall Study|Adverse Event|15
6080274|NCT00405275|20993217|P2|Overall Study|Unwilling to continue|9
6080275|NCT00405275|20993218|P1|Overall Study|Unwilling to continue|10
6080276|NCT00405275|20993217|P2|Overall Study|Withdrawal by Subject|9
6080277|NCT00405275|20993218|P1|Overall Study|Withdrawal by Subject|7
6080278|NCT00405275|20993217|P2|Overall Study|Lost to Follow-up|1
6080279|NCT00405275|20993218|P1|Overall Study|Lost to Follow-up|5
6080280|NCT00405275|20993217|P2|Overall Study|Death|0
6080281|NCT00405275|20993218|P1|Overall Study|Death|1
6080282|NCT00405067|20993227|P3|Overall Study|Lost to Follow-up|1
6080283|NCT00405067|20993228|P2|Overall Study|Lost to Follow-up|0
6080284|NCT00405067|20993229|P1|Overall Study|Lost to Follow-up|0
6080285|NCT00405067|20993227|P3|Overall Study|Adverse Event|4
6080286|NCT00405067|20993228|P2|Overall Study|Adverse Event|9
6080287|NCT00405067|20993229|P1|Overall Study|Adverse Event|4
6080288|NCT00404924|20993266|P2|Overall Study|Randomised but not received treatment|1
6080289|NCT00404924|20993267|P1|Overall Study|Randomised but not received treatment|1
6080290|NCT00404924|20993266|P2|Overall Study|Other|11
6080291|NCT00404924|20993267|P1|Overall Study|Other|25
6080292|NCT00404924|20993266|P2|Overall Study|Withdrawal by Subject|13
6080293|NCT00404924|20993267|P1|Overall Study|Withdrawal by Subject|26
6080294|NCT00404924|20993266|P2|Overall Study|Lost to Follow-up|1
6080295|NCT00404924|20993267|P1|Overall Study|Lost to Follow-up|1
6080296|NCT00404924|20993266|P2|Overall Study|Condition under investigation worsened|264
6080297|NCT00404924|20993267|P1|Overall Study|Condition under investigation worsened|475
6080298|NCT00404924|20993266|P2|Overall Study|Adverse Event|16
6080299|NCT00404924|20993267|P1|Overall Study|Adverse Event|75
6080300|NCT00404820|20993285|P2|Overall Study|Other|2
6080301|NCT00404820|20993286|P1|Overall Study|Other|0
6080302|NCT00404820|20993285|P2|Overall Study|Death|0
6080303|NCT00404820|20993286|P1|Overall Study|Death|1
6080304|NCT00404820|20993285|P2|Overall Study|Administrative problems|0
6080305|NCT00404820|20993286|P1|Overall Study|Administrative problems|2
6080306|NCT00404820|20993285|P2|Overall Study|Lost to Follow-up|3
6080307|NCT00404820|20993286|P1|Overall Study|Lost to Follow-up|7
6080308|NCT00404820|20993285|P2|Overall Study|Withdrawal by Subject|3
6080309|NCT00404820|20993286|P1|Overall Study|Withdrawal by Subject|5
6080310|NCT00404820|20993285|P2|Overall Study|Adverse Event|16
6080311|NCT00404820|20993286|P1|Overall Study|Adverse Event|4
6080312|NCT00404768|20993308|P4|Part C|Researcher suspended study medication|1
6080313|NCT00404768|20993309|P3|Part C|Researcher suspended study medication|0
6080314|NCT00404768|20993310|P2|Part C|Researcher suspended study medication|0
6080315|NCT00404768|20993311|P1|Part C|Researcher suspended study medication|0
6080316|NCT00404768|20993308|P4|Part C|Investigator discretion|1
6080317|NCT00404768|20993309|P3|Part C|Investigator discretion|0
6080318|NCT00404768|20993310|P2|Part C|Investigator discretion|0
6080319|NCT00404768|20993311|P1|Part C|Investigator discretion|0
6080320|NCT00404768|20993308|P4|Part C|Treatment failure|1
6080321|NCT00404768|20993309|P3|Part C|Treatment failure|0
6080322|NCT00404768|20993310|P2|Part C|Treatment failure|0
6080323|NCT00404768|20993311|P1|Part C|Treatment failure|0
6080324|NCT00404768|20993308|P4|Part C|Lack of Efficacy|2
6080325|NCT00404768|20993309|P3|Part C|Lack of Efficacy|0
6080326|NCT00404768|20993310|P2|Part C|Lack of Efficacy|0
6080327|NCT00404768|20993311|P1|Part C|Lack of Efficacy|0
6080328|NCT00404768|20993308|P4|Part C|Active labor|1
6080329|NCT00404768|20993309|P3|Part C|Active labor|0
6080330|NCT00404768|20993310|P2|Part C|Active labor|0
6080331|NCT00404768|20993311|P1|Part C|Active labor|0
6080332|NCT00404768|20993308|P4|Part C|Unsatisfactory uterine response to IP|1
6080333|NCT00404768|20993309|P3|Part C|Unsatisfactory uterine response to IP|0
6080334|NCT00404768|20993310|P2|Part C|Unsatisfactory uterine response to IP|0
6080335|NCT00404768|20993311|P1|Part C|Unsatisfactory uterine response to IP|0
6080336|NCT00404768|20993308|P4|Part C|Participant delivered baby|1
6080337|NCT00404768|20993309|P3|Part C|Participant delivered baby|0
6080338|NCT00404768|20993310|P2|Part C|Participant delivered baby|0
6080339|NCT00404768|20993311|P1|Part C|Participant delivered baby|0
6080340|NCT00404768|20993308|P4|Part C|Physician withdrew the study medication|0
6080341|NCT00404768|20993309|P3|Part C|Physician withdrew the study medication|1
6080342|NCT00404768|20993310|P2|Part C|Physician withdrew the study medication|0
6080343|NCT00404768|20993311|P1|Part C|Physician withdrew the study medication|0
6080344|NCT00404768|20993308|P4|Part C|Participant did not respond to therapy|1
6080345|NCT00404768|20993309|P3|Part C|Participant did not respond to therapy|1
6080346|NCT00404768|20993310|P2|Part C|Participant did not respond to therapy|0
6080347|NCT00404768|20993311|P1|Part C|Participant did not respond to therapy|0
6080348|NCT00404768|20993308|P4|Part C|Early withdrawal from study medication|0
6080349|NCT00404768|20993309|P3|Part C|Early withdrawal from study medication|1
6080350|NCT00404768|20993310|P2|Part C|Early withdrawal from study medication|0
6080351|NCT00404768|20993311|P1|Part C|Early withdrawal from study medication|0
6080352|NCT00404768|20993308|P4|Part C|Withdrawal by Subject|1
6080353|NCT00404768|20993309|P3|Part C|Withdrawal by Subject|2
6080354|NCT00404768|20993310|P2|Part C|Withdrawal by Subject|0
6080355|NCT00404768|20993311|P1|Part C|Withdrawal by Subject|0
6080356|NCT00404768|20993308|P4|Part C|Lost to Follow-up|1
6080357|NCT00404768|20993309|P3|Part C|Lost to Follow-up|3
6080358|NCT00404768|20993310|P2|Part C|Lost to Follow-up|0
6080359|NCT00404768|20993311|P1|Part C|Lost to Follow-up|0
6080360|NCT00404768|20993308|P4|Part C|Adverse Event|3
6080361|NCT00404768|20993309|P3|Part C|Adverse Event|0
6080362|NCT00404768|20993310|P2|Part C|Adverse Event|0
6080363|NCT00404768|20993311|P1|Part C|Adverse Event|0
6080364|NCT00404768|20993308|P4|Part A and B|Withdrawn as delivery imminemnt|0
6080365|NCT00404768|20993309|P3|Part A and B|Withdrawn as delivery imminemnt|0
6080366|NCT00404768|20993310|P2|Part A and B|Withdrawn as delivery imminemnt|1
6080367|NCT00404768|20993311|P1|Part A and B|Withdrawn as delivery imminemnt|0
6080368|NCT00404768|20993308|P4|Part A and B|Withdrawn due to labor progression|0
6080369|NCT00404768|20993309|P3|Part A and B|Withdrawn due to labor progression|0
6080370|NCT00404768|20993310|P2|Part A and B|Withdrawn due to labor progression|0
6080371|NCT00404768|20993311|P1|Part A and B|Withdrawn due to labor progression|1
6080372|NCT00404755|20993372|P1|Phase II (Escitalopram)|Lost to Follow-up|2
6080373|NCT00404755|20993372|P1|Phase I (Bupropion)|Other|1
6080374|NCT00404755|20993372|P1|Phase I (Bupropion)|Adverse Event|3
6080375|NCT00404651|20993387|P4|Overall Study|Withdrawal by Subject|6
6080376|NCT00404651|20993388|P3|Overall Study|Withdrawal by Subject|16
6080377|NCT00404651|20993389|P2|Overall Study|Withdrawal by Subject|12
6080378|NCT00404651|20993390|P1|Overall Study|Withdrawal by Subject|14
6080379|NCT00404651|20993387|P4|Overall Study|Lost to Follow-up|10
6080380|NCT00404651|20993388|P3|Overall Study|Lost to Follow-up|13
6080381|NCT00404651|20993389|P2|Overall Study|Lost to Follow-up|11
6080382|NCT00404651|20993390|P1|Overall Study|Lost to Follow-up|15
6080383|NCT00404651|20993387|P4|Overall Study|Protocol Violation|5
6080384|NCT00404651|20993388|P3|Overall Study|Protocol Violation|14
6080385|NCT00404651|20993389|P2|Overall Study|Protocol Violation|5
6080386|NCT00404651|20993390|P1|Overall Study|Protocol Violation|10
6080387|NCT00404651|20993387|P4|Overall Study|Serious Adverse Event|0
6080388|NCT00404651|20993388|P3|Overall Study|Serious Adverse Event|2
6080389|NCT00404651|20993389|P2|Overall Study|Serious Adverse Event|0
6080390|NCT00404651|20993390|P1|Overall Study|Serious Adverse Event|0
6080391|NCT00404547|20993418|P2|Overall Study|Reason not stated|6
6080392|NCT00404547|20993419|P1|Overall Study|Reason not stated|3
6080393|NCT00404547|20993418|P2|Overall Study|Other|0
6080394|NCT00404547|20993419|P1|Overall Study|Other|4
6080395|NCT00404547|20993418|P2|Overall Study|Lack of compliance|1
6080396|NCT00404547|20993419|P1|Overall Study|Lack of compliance|5
6080397|NCT00404547|20993418|P2|Overall Study|Lost to Follow-up|9
6080398|NCT00404547|20993419|P1|Overall Study|Lost to Follow-up|20
6080399|NCT00404547|20993418|P2|Overall Study|Protocol Violation|1
6080400|NCT00404547|20993419|P1|Overall Study|Protocol Violation|0
6080401|NCT00404547|20993418|P2|Overall Study|Withdrawal by Subject|2
6080402|NCT00404547|20993419|P1|Overall Study|Withdrawal by Subject|19
6080403|NCT00404547|20993418|P2|Overall Study|Adverse Event|6
6080404|NCT00404547|20993419|P1|Overall Study|Adverse Event|39
6080405|NCT00404495|20993429|P2|Overall Study|Withdrawal by Subject|0
6080406|NCT00404495|20993430|P1|Overall Study|Withdrawal by Subject|1
6080407|NCT00404495|20993429|P2|Overall Study|Other|0
6080408|NCT00404495|20993430|P1|Overall Study|Other|1
6080409|NCT00404495|20993429|P2|Overall Study|Lost to Follow-up|0
6080410|NCT00404495|20993430|P1|Overall Study|Lost to Follow-up|5
6080411|NCT00404495|20993429|P2|Overall Study|Death|11
6080412|NCT00404495|20993430|P1|Overall Study|Death|37
6080413|NCT00404352|20993449|P9|Open Label Extension (up to 36 Months)|Other|2
6080414|NCT00404352|20993450|P8|Open Label Extension (up to 36 Months)|Other|0
6080415|NCT00404352|20993451|P7|Open Label Extension (up to 36 Months)|Other|0
6080416|NCT00404352|20993452|P6|Open Label Extension (up to 36 Months)|Other|0
6080417|NCT00404352|20993453|P5|Open Label Extension (up to 36 Months)|Other|0
6080418|NCT00404352|20993454|P4|Open Label Extension (up to 36 Months)|Other|0
6080419|NCT00404352|20993455|P3|Open Label Extension (up to 36 Months)|Other|0
6080420|NCT00404352|20993456|P2|Open Label Extension (up to 36 Months)|Other|0
6080421|NCT00404352|20993457|P1|Open Label Extension (up to 36 Months)|Other|0
6080422|NCT00404352|20993449|P9|Open Label Extension (up to 36 Months)|Adverse Event|0
6080423|NCT00404352|20993450|P8|Open Label Extension (up to 36 Months)|Adverse Event|1
6080424|NCT00404352|20993451|P7|Open Label Extension (up to 36 Months)|Adverse Event|1
6080425|NCT00404352|20993452|P6|Open Label Extension (up to 36 Months)|Adverse Event|0
6080426|NCT00404352|20993453|P5|Open Label Extension (up to 36 Months)|Adverse Event|0
6080427|NCT00404352|20993454|P4|Open Label Extension (up to 36 Months)|Adverse Event|0
6080428|NCT00404352|20993455|P3|Open Label Extension (up to 36 Months)|Adverse Event|0
6080429|NCT00404352|20993456|P2|Open Label Extension (up to 36 Months)|Adverse Event|0
6080430|NCT00404352|20993457|P1|Open Label Extension (up to 36 Months)|Adverse Event|0
6080431|NCT00404352|20993449|P9|Open Label (up to 24 Month)|Disease progression|0
6080432|NCT00404352|20993450|P8|Open Label (up to 24 Month)|Disease progression|0
6080433|NCT00404352|20993451|P7|Open Label (up to 24 Month)|Disease progression|0
6080434|NCT00404352|20993452|P6|Open Label (up to 24 Month)|Disease progression|0
6080435|NCT00404352|20993453|P5|Open Label (up to 24 Month)|Disease progression|0
6080436|NCT00404352|20993454|P4|Open Label (up to 24 Month)|Disease progression|1
6080437|NCT00404352|20993455|P3|Open Label (up to 24 Month)|Disease progression|0
6080438|NCT00404352|20993456|P2|Open Label (up to 24 Month)|Disease progression|0
6080439|NCT00404352|20993457|P1|Open Label (up to 24 Month)|Disease progression|0
6080440|NCT00404352|20993449|P9|Open Label (up to 24 Month)|Withdrawal by Subject|0
6080441|NCT00404352|20993450|P8|Open Label (up to 24 Month)|Withdrawal by Subject|0
6080442|NCT00404352|20993451|P7|Open Label (up to 24 Month)|Withdrawal by Subject|0
6080443|NCT00404352|20993452|P6|Open Label (up to 24 Month)|Withdrawal by Subject|5
6080444|NCT00404352|20993453|P5|Open Label (up to 24 Month)|Withdrawal by Subject|0
6080445|NCT00404352|20993454|P4|Open Label (up to 24 Month)|Withdrawal by Subject|0
6080446|NCT00404352|20993455|P3|Open Label (up to 24 Month)|Withdrawal by Subject|0
6080447|NCT00404352|20993456|P2|Open Label (up to 24 Month)|Withdrawal by Subject|0
6080448|NCT00404352|20993457|P1|Open Label (up to 24 Month)|Withdrawal by Subject|0
6080449|NCT00404352|20993449|P9|Open Label (up to 24 Month)|Lost to Follow-up|0
6080450|NCT00404352|20993450|P8|Open Label (up to 24 Month)|Lost to Follow-up|0
6080451|NCT00404352|20993451|P7|Open Label (up to 24 Month)|Lost to Follow-up|0
6080452|NCT00404352|20993452|P6|Open Label (up to 24 Month)|Lost to Follow-up|0
6080453|NCT00404352|20993453|P5|Open Label (up to 24 Month)|Lost to Follow-up|1
6080454|NCT00404352|20993454|P4|Open Label (up to 24 Month)|Lost to Follow-up|0
6080455|NCT00404352|20993455|P3|Open Label (up to 24 Month)|Lost to Follow-up|0
6080456|NCT00404352|20993456|P2|Open Label (up to 24 Month)|Lost to Follow-up|0
6080457|NCT00404352|20993457|P1|Open Label (up to 24 Month)|Lost to Follow-up|0
6080458|NCT00404352|20993449|P9|Open Label (up to 24 Month)|Pregnancy|0
6080459|NCT00404352|20993450|P8|Open Label (up to 24 Month)|Pregnancy|0
6080460|NCT00404352|20993451|P7|Open Label (up to 24 Month)|Pregnancy|0
6080461|NCT00404352|20993452|P6|Open Label (up to 24 Month)|Pregnancy|1
6080462|NCT00404352|20993453|P5|Open Label (up to 24 Month)|Pregnancy|0
6080463|NCT00404352|20993454|P4|Open Label (up to 24 Month)|Pregnancy|0
6080464|NCT00404352|20993455|P3|Open Label (up to 24 Month)|Pregnancy|0
6080465|NCT00404352|20993456|P2|Open Label (up to 24 Month)|Pregnancy|0
6080466|NCT00404352|20993457|P1|Open Label (up to 24 Month)|Pregnancy|0
6080467|NCT00404352|20993449|P9|Open Label (up to 24 Month)|Adverse Event|0
6080468|NCT00404352|20993450|P8|Open Label (up to 24 Month)|Adverse Event|0
6080469|NCT00404352|20993451|P7|Open Label (up to 24 Month)|Adverse Event|0
6080470|NCT00404352|20993452|P6|Open Label (up to 24 Month)|Adverse Event|1
6080471|NCT00404352|20993453|P5|Open Label (up to 24 Month)|Adverse Event|1
6080472|NCT00404352|20993454|P4|Open Label (up to 24 Month)|Adverse Event|2
6080473|NCT00404352|20993455|P3|Open Label (up to 24 Month)|Adverse Event|0
6080474|NCT00404352|20993456|P2|Open Label (up to 24 Month)|Adverse Event|0
6080475|NCT00404352|20993457|P1|Open Label (up to 24 Month)|Adverse Event|0
6080476|NCT00404352|20993449|P9|Double Blind (up to 24 Month)|Other|0
6080477|NCT00404352|20993450|P8|Double Blind (up to 24 Month)|Other|0
6080478|NCT00404352|20993451|P7|Double Blind (up to 24 Month)|Other|0
6080479|NCT00404352|20993452|P6|Double Blind (up to 24 Month)|Other|0
6080480|NCT00404352|20993453|P5|Double Blind (up to 24 Month)|Other|0
6080481|NCT00404352|20993454|P4|Double Blind (up to 24 Month)|Other|0
6080482|NCT00404352|20993455|P3|Double Blind (up to 24 Month)|Other|0
6080483|NCT00404352|20993456|P2|Double Blind (up to 24 Month)|Other|1
6080484|NCT00404352|20993457|P1|Double Blind (up to 24 Month)|Other|0
6080485|NCT00404352|20993449|P9|Double Blind (up to 24 Month)|Physician Decision|0
6080486|NCT00404352|20993450|P8|Double Blind (up to 24 Month)|Physician Decision|0
6080487|NCT00404352|20993451|P7|Double Blind (up to 24 Month)|Physician Decision|0
6080488|NCT00404352|20993452|P6|Double Blind (up to 24 Month)|Physician Decision|0
6080489|NCT00404352|20993453|P5|Double Blind (up to 24 Month)|Physician Decision|0
6080490|NCT00404352|20993454|P4|Double Blind (up to 24 Month)|Physician Decision|0
6080491|NCT00404352|20993455|P3|Double Blind (up to 24 Month)|Physician Decision|1
6080492|NCT00404352|20993456|P2|Double Blind (up to 24 Month)|Physician Decision|0
6080493|NCT00404352|20993457|P1|Double Blind (up to 24 Month)|Physician Decision|0
6080494|NCT00404352|20993449|P9|Double Blind (up to 24 Month)|Randomized but not treated|0
6080495|NCT00404352|20993450|P8|Double Blind (up to 24 Month)|Randomized but not treated|0
6080496|NCT00404352|20993451|P7|Double Blind (up to 24 Month)|Randomized but not treated|0
6080497|NCT00404352|20993452|P6|Double Blind (up to 24 Month)|Randomized but not treated|0
6080498|NCT00404352|20993453|P5|Double Blind (up to 24 Month)|Randomized but not treated|0
6080499|NCT00404352|20993454|P4|Double Blind (up to 24 Month)|Randomized but not treated|0
6080500|NCT00404352|20993455|P3|Double Blind (up to 24 Month)|Randomized but not treated|0
6080501|NCT00404352|20993456|P2|Double Blind (up to 24 Month)|Randomized but not treated|2
6080502|NCT00404352|20993457|P1|Double Blind (up to 24 Month)|Randomized but not treated|0
6080503|NCT00404352|20993449|P9|Double Blind (up to 24 Month)|Switched to open label phase|0
6080504|NCT00404352|20993450|P8|Double Blind (up to 24 Month)|Switched to open label phase|0
6080505|NCT00404352|20993451|P7|Double Blind (up to 24 Month)|Switched to open label phase|0
6080506|NCT00404352|20993452|P6|Double Blind (up to 24 Month)|Switched to open label phase|0
6080507|NCT00404352|20993453|P5|Double Blind (up to 24 Month)|Switched to open label phase|0
6080508|NCT00404352|20993454|P4|Double Blind (up to 24 Month)|Switched to open label phase|0
6080509|NCT00404352|20993455|P3|Double Blind (up to 24 Month)|Switched to open label phase|59
6080510|NCT00404352|20993456|P2|Double Blind (up to 24 Month)|Switched to open label phase|30
6080511|NCT00404352|20993457|P1|Double Blind (up to 24 Month)|Switched to open label phase|31
6080512|NCT00404352|20993449|P9|Double Blind (up to 24 Month)|Poor compliance|0
6080513|NCT00404352|20993450|P8|Double Blind (up to 24 Month)|Poor compliance|0
6080514|NCT00404352|20993451|P7|Double Blind (up to 24 Month)|Poor compliance|0
6080515|NCT00404352|20993452|P6|Double Blind (up to 24 Month)|Poor compliance|0
6080516|NCT00404352|20993453|P5|Double Blind (up to 24 Month)|Poor compliance|0
6080517|NCT00404352|20993454|P4|Double Blind (up to 24 Month)|Poor compliance|0
6080518|NCT00404352|20993455|P3|Double Blind (up to 24 Month)|Poor compliance|0
6080519|NCT00404352|20993456|P2|Double Blind (up to 24 Month)|Poor compliance|0
6080520|NCT00404352|20993457|P1|Double Blind (up to 24 Month)|Poor compliance|1
6080521|NCT00404352|20993449|P9|Double Blind (up to 24 Month)|Disease progression|0
6080522|NCT00404352|20993450|P8|Double Blind (up to 24 Month)|Disease progression|0
6080523|NCT00404352|20993451|P7|Double Blind (up to 24 Month)|Disease progression|0
6080524|NCT00404352|20993452|P6|Double Blind (up to 24 Month)|Disease progression|0
6080525|NCT00404352|20993453|P5|Double Blind (up to 24 Month)|Disease progression|0
6080526|NCT00404352|20993454|P4|Double Blind (up to 24 Month)|Disease progression|0
6080527|NCT00404352|20993455|P3|Double Blind (up to 24 Month)|Disease progression|2
6080528|NCT00404352|20993456|P2|Double Blind (up to 24 Month)|Disease progression|0
6080529|NCT00404352|20993457|P1|Double Blind (up to 24 Month)|Disease progression|3
6080530|NCT00404352|20993449|P9|Double Blind (up to 24 Month)|Withdrawal by Subject|0
6080531|NCT00404352|20993450|P8|Double Blind (up to 24 Month)|Withdrawal by Subject|0
6080532|NCT00404352|20993451|P7|Double Blind (up to 24 Month)|Withdrawal by Subject|0
6080533|NCT00404352|20993452|P6|Double Blind (up to 24 Month)|Withdrawal by Subject|0
6080534|NCT00404352|20993453|P5|Double Blind (up to 24 Month)|Withdrawal by Subject|0
6080535|NCT00404352|20993454|P4|Double Blind (up to 24 Month)|Withdrawal by Subject|0
6080536|NCT00404352|20993455|P3|Double Blind (up to 24 Month)|Withdrawal by Subject|7
6080537|NCT00404352|20993456|P2|Double Blind (up to 24 Month)|Withdrawal by Subject|8
6080538|NCT00404352|20993457|P1|Double Blind (up to 24 Month)|Withdrawal by Subject|11
6080539|NCT00404352|20993449|P9|Double Blind (up to 24 Month)|Lost to Follow-up|0
6080540|NCT00404352|20993450|P8|Double Blind (up to 24 Month)|Lost to Follow-up|0
6080541|NCT00404352|20993451|P7|Double Blind (up to 24 Month)|Lost to Follow-up|0
6080542|NCT00404352|20993452|P6|Double Blind (up to 24 Month)|Lost to Follow-up|0
6080543|NCT00404352|20993453|P5|Double Blind (up to 24 Month)|Lost to Follow-up|0
6080544|NCT00404352|20993454|P4|Double Blind (up to 24 Month)|Lost to Follow-up|0
6080545|NCT00404352|20993455|P3|Double Blind (up to 24 Month)|Lost to Follow-up|1
6080546|NCT00404352|20993456|P2|Double Blind (up to 24 Month)|Lost to Follow-up|2
6080631|NCT00403767|20993611|P1|Overall Study|Consent withdrawn|671
6080547|NCT00404352|20993457|P1|Double Blind (up to 24 Month)|Lost to Follow-up|1
6080548|NCT00404352|20993449|P9|Double Blind (up to 24 Month)|Death|0
6080549|NCT00404352|20993450|P8|Double Blind (up to 24 Month)|Death|0
6080550|NCT00404352|20993451|P7|Double Blind (up to 24 Month)|Death|0
6080551|NCT00404352|20993452|P6|Double Blind (up to 24 Month)|Death|0
6080552|NCT00404352|20993453|P5|Double Blind (up to 24 Month)|Death|0
6080553|NCT00404352|20993454|P4|Double Blind (up to 24 Month)|Death|0
6080554|NCT00404352|20993455|P3|Double Blind (up to 24 Month)|Death|1
6080555|NCT00404352|20993456|P2|Double Blind (up to 24 Month)|Death|0
6080556|NCT00404352|20993457|P1|Double Blind (up to 24 Month)|Death|0
6080557|NCT00404352|20993449|P9|Double Blind (up to 24 Month)|Pregnancy|0
6080558|NCT00404352|20993450|P8|Double Blind (up to 24 Month)|Pregnancy|0
6080559|NCT00404352|20993451|P7|Double Blind (up to 24 Month)|Pregnancy|0
6080560|NCT00404352|20993452|P6|Double Blind (up to 24 Month)|Pregnancy|0
6080561|NCT00404352|20993453|P5|Double Blind (up to 24 Month)|Pregnancy|0
6080562|NCT00404352|20993454|P4|Double Blind (up to 24 Month)|Pregnancy|0
6080563|NCT00404352|20993455|P3|Double Blind (up to 24 Month)|Pregnancy|2
6080564|NCT00404352|20993456|P2|Double Blind (up to 24 Month)|Pregnancy|0
6080565|NCT00404352|20993457|P1|Double Blind (up to 24 Month)|Pregnancy|0
6080566|NCT00404352|20993449|P9|Double Blind (up to 24 Month)|Adverse Event|0
6080567|NCT00404352|20993450|P8|Double Blind (up to 24 Month)|Adverse Event|0
6080568|NCT00404352|20993451|P7|Double Blind (up to 24 Month)|Adverse Event|0
6080569|NCT00404352|20993452|P6|Double Blind (up to 24 Month)|Adverse Event|0
6080570|NCT00404352|20993453|P5|Double Blind (up to 24 Month)|Adverse Event|0
6080571|NCT00404352|20993454|P4|Double Blind (up to 24 Month)|Adverse Event|0
6080572|NCT00404352|20993455|P3|Double Blind (up to 24 Month)|Adverse Event|6
6080573|NCT00404352|20993456|P2|Double Blind (up to 24 Month)|Adverse Event|4
6080574|NCT00404352|20993457|P1|Double Blind (up to 24 Month)|Adverse Event|5
6080575|NCT00404248|20993492|P9|Overall Study|pts declining status|0
6080576|NCT00404248|20993493|P8|Overall Study|pts declining status|0
6080577|NCT00404248|20993494|P7|Overall Study|pts declining status|0
6080578|NCT00404248|20993495|P6|Overall Study|pts declining status|0
6080579|NCT00404248|20993496|P5|Overall Study|pts declining status|0
6080580|NCT00404248|20993497|P4|Overall Study|pts declining status|0
6080581|NCT00404248|20993498|P3|Overall Study|pts declining status|0
6080582|NCT00404248|20993499|P2|Overall Study|pts declining status|1
6080583|NCT00404248|20993500|P1|Overall Study|pts declining status|0
6080584|NCT00404235|20993533|P2|Overall Study|Withdrawal by Subject|2
6080585|NCT00404235|20993534|P1|Overall Study|Withdrawal by Subject|1
6080586|NCT00404092|20993552|P4|Overall Study|Adverse Event|0
6080587|NCT00404092|20993553|P3|Overall Study|Adverse Event|1
6080588|NCT00404092|20993554|P2|Overall Study|Adverse Event|0
6080589|NCT00404092|20993555|P1|Overall Study|Adverse Event|0
6080590|NCT00404092|20993552|P4|Overall Study|Death|0
6080591|NCT00404092|20993553|P3|Overall Study|Death|0
6080592|NCT00404092|20993554|P2|Overall Study|Death|0
6080593|NCT00404092|20993555|P1|Overall Study|Death|1
6080594|NCT00404079|20993571|P2|Overall Study|Lost to follow up, adverse event etc|20
6080595|NCT00404079|20993572|P1|Overall Study|Lost to follow up, adverse event etc|22
6080596|NCT00404066|20993578|P1|Overall Study|Withdrawal by Subject - Adverse event|2
6080597|NCT00404066|20993578|P1|Overall Study|Withdrawal by Subject - Pre-treatment|1
6080598|NCT00403845|20993583|P4|Treatment Period 3|Adverse Event|1
6080599|NCT00403845|20993584|P3|Treatment Period 3|Adverse Event|0
6080600|NCT00403845|20993585|P2|Treatment Period 3|Adverse Event|0
6080601|NCT00403845|20993586|P1|Treatment Period 3|Adverse Event|0
6080602|NCT00403845|20993583|P4|Treatment Period 3|Subject withdrew consent|1
6080603|NCT00403845|20993584|P3|Treatment Period 3|Subject withdrew consent|0
6080604|NCT00403845|20993585|P2|Treatment Period 3|Subject withdrew consent|0
6080605|NCT00403845|20993586|P1|Treatment Period 3|Subject withdrew consent|0
6080606|NCT00403845|20993583|P4|Treatment Period 2|Subject withdrew consent|0
6080607|NCT00403845|20993584|P3|Treatment Period 2|Subject withdrew consent|0
6080608|NCT00403845|20993585|P2|Treatment Period 2|Subject withdrew consent|0
6080609|NCT00403845|20993586|P1|Treatment Period 2|Subject withdrew consent|1
6080610|NCT00403845|20993583|P4|Treatment Period 1|Subject no longer needs study drug|1
6080611|NCT00403845|20993584|P3|Treatment Period 1|Subject no longer needs study drug|0
6080612|NCT00403845|20993585|P2|Treatment Period 1|Subject no longer needs study drug|0
6080613|NCT00403845|20993586|P1|Treatment Period 1|Subject no longer needs study drug|0
6080614|NCT00403845|20993583|P4|Treatment Period 1|Subject withdrew consent|0
6080615|NCT00403845|20993584|P3|Treatment Period 1|Subject withdrew consent|0
6080616|NCT00403845|20993585|P2|Treatment Period 1|Subject withdrew consent|0
6080617|NCT00403845|20993586|P1|Treatment Period 1|Subject withdrew consent|1
6080618|NCT00403767|20993610|P2|Overall Study|Missing/incomplete data|1
6080619|NCT00403767|20993611|P1|Overall Study|Missing/incomplete data|1
6080620|NCT00403767|20993610|P2|Overall Study|Study terminated by sponsor|69
6080621|NCT00403767|20993611|P1|Overall Study|Study terminated by sponsor|82
6080622|NCT00403767|20993610|P2|Overall Study|Clinical efficacy endpoint reached|332
6080623|NCT00403767|20993611|P1|Overall Study|Clinical efficacy endpoint reached|300
6080624|NCT00403767|20993610|P2|Overall Study|Protocol Violation|124
6080625|NCT00403767|20993611|P1|Overall Study|Protocol Violation|142
6080626|NCT00403767|20993610|P2|Overall Study|Lost to Follow-up|8
6080627|NCT00403767|20993611|P1|Overall Study|Lost to Follow-up|6
6080628|NCT00403767|20993610|P2|Overall Study|Investigator dec./not protocol-related|178
6080629|NCT00403767|20993611|P1|Overall Study|Investigator dec./not protocol-related|191
6080630|NCT00403767|20993610|P2|Overall Study|Consent withdrawn|673
6080632|NCT00403767|20993610|P2|Overall Study|Non-compliant with study medication|164
6080633|NCT00403767|20993611|P1|Overall Study|Non-compliant with study medication|134
6080634|NCT00403767|20993610|P2|Overall Study|Adverse Event|919
6080635|NCT00403767|20993611|P1|Overall Study|Adverse Event|993
6080636|NCT00403754|20993635|P4|Core Treatment Period 2|Lack of Efficacy|0
6080637|NCT00403754|20993636|P3|Core Treatment Period 2|Lack of Efficacy|1
6080638|NCT00403754|20993637|P2|Core Treatment Period 2|Lack of Efficacy|0
6080639|NCT00403754|20993638|P1|Core Treatment Period 2|Lack of Efficacy|0
6080640|NCT00403754|20993635|P4|Core Treatment Period 1|Withdrawal by Subject|0
6080641|NCT00403754|20993636|P3|Core Treatment Period 1|Withdrawal by Subject|0
6080642|NCT00403754|20993637|P2|Core Treatment Period 1|Withdrawal by Subject|1
6080643|NCT00403754|20993638|P1|Core Treatment Period 1|Withdrawal by Subject|0
6080644|NCT00403585|20993665|P1|Open-Label Phase; Extension Study|HBV DNA Mutation Positive|4
6080645|NCT00403585|20993665|P1|Open-Label Phase; Extension Study|Withdrawal by Subject|2
6080646|NCT00403585|20993665|P1|Initial Treatment Phase|Lost to Follow-up|2
6080647|NCT00403546|20993676|P3|Randomized Trial|Early Terminations|16
6080648|NCT00403546|20993677|P2|Randomized Trial|Early Terminations|17
6080649|NCT00403546|20993678|P1|Randomized Trial|Early Terminations|0
6080650|NCT00403546|20993676|P3|Screening Phase|Terminated Prior to Randomization|0
6080651|NCT00403546|20993677|P2|Screening Phase|Terminated Prior to Randomization|0
6080652|NCT00403546|20993678|P1|Screening Phase|Terminated Prior to Randomization|5
6080653|NCT00403546|20993676|P3|Screening Phase|Adverse Event|0
6080654|NCT00403546|20993677|P2|Screening Phase|Adverse Event|0
6080655|NCT00403546|20993678|P1|Screening Phase|Adverse Event|1
6080656|NCT00403546|20993676|P3|Screening Phase|Screening Failure|0
6080657|NCT00403546|20993677|P2|Screening Phase|Screening Failure|0
6080658|NCT00403546|20993678|P1|Screening Phase|Screening Failure|22
6080659|NCT00403546|20993676|P3|Signed Informed Consent/Open-Label|Adverse Event|0
6080660|NCT00403546|20993677|P2|Signed Informed Consent/Open-Label|Adverse Event|0
6080661|NCT00403546|20993678|P1|Signed Informed Consent/Open-Label|Adverse Event|5
6080662|NCT00403546|20993676|P3|Signed Informed Consent/Open-Label|Terminated by Investigator|0
6080663|NCT00403546|20993677|P2|Signed Informed Consent/Open-Label|Terminated by Investigator|0
6080664|NCT00403546|20993678|P1|Signed Informed Consent/Open-Label|Terminated by Investigator|9
6080665|NCT00403546|20993676|P3|Signed Informed Consent/Open-Label|Early Termination|0
6080666|NCT00403546|20993677|P2|Signed Informed Consent/Open-Label|Early Termination|0
6080667|NCT00403546|20993678|P1|Signed Informed Consent/Open-Label|Early Termination|8
6080668|NCT00403546|20993676|P3|Signed Informed Consent/Open-Label|Withdrew Consent|0
6080669|NCT00403546|20993677|P2|Signed Informed Consent/Open-Label|Withdrew Consent|0
6080670|NCT00403546|20993678|P1|Signed Informed Consent/Open-Label|Withdrew Consent|6
6080671|NCT00403494|20993720|P2|Overall Study|Sponsor Request|0
6080672|NCT00403494|20993721|P1|Overall Study|Sponsor Request|1
6080673|NCT00403494|20993720|P2|Overall Study|Death|0
6080674|NCT00403494|20993721|P1|Overall Study|Death|1
6080675|NCT00403494|20993720|P2|Overall Study|Protocol noncompliance|1
6080676|NCT00403494|20993721|P1|Overall Study|Protocol noncompliance|0
6080677|NCT00403494|20993720|P2|Overall Study|Lost to Follow-up|2
6080678|NCT00403494|20993721|P1|Overall Study|Lost to Follow-up|0
6080679|NCT00403494|20993720|P2|Overall Study|Inappropriately enrolled|1
6080680|NCT00403494|20993721|P1|Overall Study|Inappropriately enrolled|0
6080681|NCT00403494|20993720|P2|Overall Study|Withdrew Consent|2
6080682|NCT00403494|20993721|P1|Overall Study|Withdrew Consent|3
6080683|NCT00403494|20993720|P2|Overall Study|Adverse Event|8
6080684|NCT00403494|20993721|P1|Overall Study|Adverse Event|10
6080685|NCT00403481|20993733|P1|Olm 40 mg + Hydrochlorothiazide 25 mg|Lost to Follow-up|1
6080686|NCT00403481|20993733|P1|Olm 40 mg + Hydrochlorothiazide 25 mg|Withdrawal by Subject|1
6080687|NCT00403481|20993733|P1|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Other|1
6080688|NCT00403481|20993733|P1|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|1
6080689|NCT00403481|20993733|P1|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Protocol Violation|1
6080690|NCT00403481|20993733|P1|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Adverse Event|2
6080691|NCT00403481|20993733|P1|Olm 40 mg|Other|1
6080692|NCT00403481|20993733|P1|Olm 40 mg|Withdrawal by Subject|1
6080693|NCT00403481|20993733|P1|Olm 40 mg|Protocol Violation|1
6080694|NCT00403481|20993733|P1|Olm 40 mg|Adverse Event|2
6080695|NCT00403481|20993733|P1|Olmesartan Medoxomil (Olm) 20 mg|Withdrawal by Subject|1
6080696|NCT00403481|20993733|P1|Olmesartan Medoxomil (Olm) 20 mg|Protocol Violation|3
6080697|NCT00403481|20993733|P1|Olmesartan Medoxomil (Olm) 20 mg|Physician Decision|1
6080698|NCT00403481|20993733|P1|Olmesartan Medoxomil (Olm) 20 mg|Adverse Event|1
6080699|NCT00403455|20993748|P1|Overall Study|Withdrawal by Subject|1
6080700|NCT00403390|20993771|P2|Overall Study|non-compliant|0
6080701|NCT00403390|20993772|P1|Overall Study|non-compliant|1
6080702|NCT00403390|20993771|P2|Overall Study|samples lost|0
6080703|NCT00403390|20993772|P1|Overall Study|samples lost|1
6080704|NCT00403390|20993771|P2|Overall Study|Withdrawal by Subject|0
6080705|NCT00403390|20993772|P1|Overall Study|Withdrawal by Subject|1
6080706|NCT00403273|20993780|P2|Overall Study|pt. wanted to have a surgical procedure|1
6080707|NCT00403273|20993781|P1|Overall Study|pt. wanted to have a surgical procedure|0
6080708|NCT00403273|20993780|P2|Overall Study|Physician Decision|1
6080709|NCT00403273|20993781|P1|Overall Study|Physician Decision|0
6080710|NCT00403273|20993780|P2|Overall Study|Lost to Follow-up|2
6080711|NCT00403273|20993781|P1|Overall Study|Lost to Follow-up|3
6080712|NCT00403234|20993823|P4|Overall Study|Adverse Event|0
6080713|NCT00403234|20993824|P3|Overall Study|Adverse Event|1
6080714|NCT00403234|20993825|P2|Overall Study|Adverse Event|0
6080715|NCT00403234|20993826|P1|Overall Study|Adverse Event|1
6080716|NCT00403234|20993823|P4|Overall Study|Withdrawal by Subject|0
6080717|NCT00403234|20993824|P3|Overall Study|Withdrawal by Subject|0
6080718|NCT00403234|20993825|P2|Overall Study|Withdrawal by Subject|1
6080719|NCT00403234|20993826|P1|Overall Study|Withdrawal by Subject|0
6080720|NCT00403130|20993836|P1|Survival Follow-up up to 6 Years|Lost to Follow-up|10
6080721|NCT00403130|20993836|P1|2 Years From Start of Treatment|Withdrawal by Subject|1
6080722|NCT00403130|20993836|P1|2 Years From Start of Treatment|Lost to Follow up|1
6080723|NCT00403130|20993836|P1|2 Years From Start of Treatment|Not Eligible|3
6080724|NCT00402987|20993889|P4|Overall Study|Lack of Efficacy|0
6080725|NCT00402987|20993890|P3|Overall Study|Lack of Efficacy|1
6080726|NCT00402987|20993891|P2|Overall Study|Lack of Efficacy|0
6080727|NCT00402987|20993892|P1|Overall Study|Lack of Efficacy|0
6080728|NCT00402831|20994064|P2|Overall Study|Non-compliance with protocol|1
6080729|NCT00402831|20994065|P1|Overall Study|Non-compliance with protocol|0
6080730|NCT00402831|20994064|P2|Overall Study|Lost to Follow-up|2
6080731|NCT00402831|20994065|P1|Overall Study|Lost to Follow-up|1
6080732|NCT00402779|20994099|P2|Overall Study|Screen Failure|76
6080733|NCT00402779|20994100|P1|Overall Study|Screen Failure|77
6080734|NCT00402740|20994106|P1|Overall Study|Subject disposition unknown.|1
6080735|NCT00402740|20994106|P1|Overall Study|No stent. Completed FU at 30 days.|5
6080736|NCT00402740|20994106|P1|Overall Study|Lost to Follow-up|6
6080737|NCT00402740|20994106|P1|Overall Study|Death|50
6080738|NCT00402740|20994106|P1|Overall Study|Withdrawal by Subject|18
6080739|NCT00402727|20994118|P2|Overall Study|non-compliance|1
6080740|NCT00402727|20994119|P1|Overall Study|non-compliance|0
6080741|NCT00402727|20994118|P2|Overall Study|supply problems|1
6080742|NCT00402727|20994119|P1|Overall Study|supply problems|2
6080743|NCT00402727|20994118|P2|Overall Study|Withdrawal by Subject|7
6080744|NCT00402727|20994119|P1|Overall Study|Withdrawal by Subject|3
6080745|NCT00402727|20994118|P2|Overall Study|Protocol Violation|4
6080746|NCT00402727|20994119|P1|Overall Study|Protocol Violation|0
6080747|NCT00402727|20994118|P2|Overall Study|Physician Decision|1
6080748|NCT00402727|20994119|P1|Overall Study|Physician Decision|1
6080749|NCT00402727|20994118|P2|Overall Study|Lost to Follow-up|11
6080750|NCT00402727|20994119|P1|Overall Study|Lost to Follow-up|24
6080751|NCT00402727|20994118|P2|Overall Study|Lack of Efficacy|3
6080752|NCT00402727|20994119|P1|Overall Study|Lack of Efficacy|1
6080753|NCT00402727|20994118|P2|Overall Study|Death|0
6080754|NCT00402727|20994119|P1|Overall Study|Death|1
6080755|NCT00402727|20994118|P2|Overall Study|Adverse Event|6
6080756|NCT00402727|20994119|P1|Overall Study|Adverse Event|10
6080757|NCT00402688|20994161|P3|Overall Study|Patient Left Town and Forgot Medication|1
6080758|NCT00402688|20994162|P2|Overall Study|Patient Left Town and Forgot Medication|0
6080759|NCT00402688|20994163|P1|Overall Study|Patient Left Town and Forgot Medication|0
6080760|NCT00402688|20994161|P3|Overall Study|Urine Cult. Yield Resistant to Levaquin|1
6080761|NCT00402688|20994162|P2|Overall Study|Urine Cult. Yield Resistant to Levaquin|0
6080762|NCT00402688|20994163|P1|Overall Study|Urine Cult. Yield Resistant to Levaquin|0
6080763|NCT00402688|20994161|P3|Overall Study|Culture Show Fluoroquinolone Resistance|0
6080764|NCT00402688|20994162|P2|Overall Study|Culture Show Fluoroquinolone Resistance|1
6080765|NCT00402688|20994163|P1|Overall Study|Culture Show Fluoroquinolone Resistance|0
6080766|NCT00402688|20994161|P3|Overall Study|Lost to Follow-up|2
6080767|NCT00402688|20994162|P2|Overall Study|Lost to Follow-up|0
6080768|NCT00402688|20994163|P1|Overall Study|Lost to Follow-up|1
6080769|NCT00402688|20994161|P3|Overall Study|Protocol Violation|1
6080770|NCT00402688|20994162|P2|Overall Study|Protocol Violation|1
6080771|NCT00402688|20994163|P1|Overall Study|Protocol Violation|1
6080772|NCT00402688|20994161|P3|Overall Study|Lack of Efficacy|5
6080773|NCT00402688|20994162|P2|Overall Study|Lack of Efficacy|4
6080774|NCT00402688|20994163|P1|Overall Study|Lack of Efficacy|4
6080775|NCT00402688|20994161|P3|Overall Study|Physician Decision|1
6080776|NCT00402688|20994162|P2|Overall Study|Physician Decision|0
6080777|NCT00402688|20994163|P1|Overall Study|Physician Decision|0
6080778|NCT00402688|20994161|P3|Overall Study|Withdrawal by Subject|1
6080779|NCT00402688|20994162|P2|Overall Study|Withdrawal by Subject|1
6080780|NCT00402688|20994163|P1|Overall Study|Withdrawal by Subject|3
6080781|NCT00402688|20994161|P3|Overall Study|Adverse Event|3
6080782|NCT00402688|20994162|P2|Overall Study|Adverse Event|9
6080783|NCT00402688|20994163|P1|Overall Study|Adverse Event|12
6080784|NCT00402649|20994186|P1|Overall Study|Withdrawal by Subject|1
6080785|NCT00402649|20994186|P1|Overall Study|Lost to Follow-up|1
6080786|NCT00402597|20994201|P5|Overall Study|reason not specified|20
6080787|NCT00402597|20994202|P4|Overall Study|reason not specified|14
6080788|NCT00402597|20994203|P3|Overall Study|reason not specified|27
6080789|NCT00402597|20994204|P2|Overall Study|reason not specified|4
6080790|NCT00402597|20994205|P1|Overall Study|reason not specified|30
6080791|NCT00402597|20994201|P5|Overall Study|Withdrawal by Subject|24
6080792|NCT00402597|20994202|P4|Overall Study|Withdrawal by Subject|15
6080793|NCT00402597|20994203|P3|Overall Study|Withdrawal by Subject|65
6080794|NCT00402597|20994204|P2|Overall Study|Withdrawal by Subject|16
6080795|NCT00402597|20994205|P1|Overall Study|Withdrawal by Subject|57
6080796|NCT00402597|20994201|P5|Overall Study|Lost to Follow-up|3
6080797|NCT00402597|20994202|P4|Overall Study|Lost to Follow-up|2
6080798|NCT00402597|20994203|P3|Overall Study|Lost to Follow-up|8
6080799|NCT00402597|20994204|P2|Overall Study|Lost to Follow-up|1
6080800|NCT00402597|20994205|P1|Overall Study|Lost to Follow-up|8
6080801|NCT00402597|20994201|P5|Overall Study|Adverse Event|71
6080802|NCT00402597|20994202|P4|Overall Study|Adverse Event|39
6080803|NCT00402597|20994203|P3|Overall Study|Adverse Event|106
6080804|NCT00402597|20994204|P2|Overall Study|Adverse Event|18
6080805|NCT00402597|20994205|P1|Overall Study|Adverse Event|81
6080806|NCT00402597|20994201|P5|Overall Study|Death|6
6080807|NCT00402597|20994202|P4|Overall Study|Death|4
6080808|NCT00402597|20994203|P3|Overall Study|Death|6
6080809|NCT00402597|20994204|P2|Overall Study|Death|7
6080810|NCT00402597|20994205|P1|Overall Study|Death|15
6080811|NCT00402363|20994246|P4|Overall Study|"Captured as Other"|2
6080812|NCT00402363|20994247|P3|Overall Study|"Captured as Other"|2
6080813|NCT00402363|20994248|P2|Overall Study|"Captured as Other"|2
6080814|NCT00402363|20994249|P1|Overall Study|"Captured as Other"|6
6080815|NCT00402363|20994246|P4|Overall Study|Lost to Follow-up|2
6080816|NCT00402363|20994247|P3|Overall Study|Lost to Follow-up|0
6080817|NCT00402363|20994248|P2|Overall Study|Lost to Follow-up|4
6080818|NCT00402363|20994249|P1|Overall Study|Lost to Follow-up|5
6080819|NCT00402363|20994246|P4|Overall Study|Protocol Violation|3
6080820|NCT00402363|20994247|P3|Overall Study|Protocol Violation|0
6080821|NCT00402363|20994248|P2|Overall Study|Protocol Violation|5
6080822|NCT00402363|20994249|P1|Overall Study|Protocol Violation|3
6080823|NCT00402363|20994246|P4|Overall Study|Withdrew Consent|1
6080824|NCT00402363|20994247|P3|Overall Study|Withdrew Consent|2
6080825|NCT00402363|20994248|P2|Overall Study|Withdrew Consent|5
6080826|NCT00402363|20994249|P1|Overall Study|Withdrew Consent|10
6080827|NCT00402363|20994246|P4|Overall Study|Adverse Event|2
6080828|NCT00402363|20994247|P3|Overall Study|Adverse Event|2
6080829|NCT00402363|20994248|P2|Overall Study|Adverse Event|14
6080830|NCT00402363|20994249|P1|Overall Study|Adverse Event|9
6080831|NCT00402337|20994312|P5|Overall Study|Other Reason|0
6080832|NCT00402337|20994313|P4|Overall Study|Other Reason|0
6080833|NCT00402337|20994314|P3|Overall Study|Other Reason|0
6080834|NCT00402337|20994315|P2|Overall Study|Other Reason|1
6080835|NCT00402337|20994316|P1|Overall Study|Other Reason|0
6080836|NCT00402337|20994312|P5|Overall Study|Physician Decision|0
6080837|NCT00402337|20994313|P4|Overall Study|Physician Decision|1
6080838|NCT00402337|20994314|P3|Overall Study|Physician Decision|0
6080839|NCT00402337|20994315|P2|Overall Study|Physician Decision|0
6080840|NCT00402337|20994316|P1|Overall Study|Physician Decision|0
6080841|NCT00402337|20994312|P5|Overall Study|Lost to Follow-up|0
6080842|NCT00402337|20994313|P4|Overall Study|Lost to Follow-up|2
6080843|NCT00402337|20994314|P3|Overall Study|Lost to Follow-up|1
6080844|NCT00402337|20994315|P2|Overall Study|Lost to Follow-up|0
6080845|NCT00402337|20994316|P1|Overall Study|Lost to Follow-up|0
6080846|NCT00402337|20994312|P5|Overall Study|Withdrawal by Subject|4
6080847|NCT00402337|20994313|P4|Overall Study|Withdrawal by Subject|6
6080848|NCT00402337|20994314|P3|Overall Study|Withdrawal by Subject|1
6080849|NCT00402337|20994315|P2|Overall Study|Withdrawal by Subject|3
6080850|NCT00402337|20994316|P1|Overall Study|Withdrawal by Subject|5
6080851|NCT00402337|20994312|P5|Overall Study|Noncompliance|2
6080852|NCT00402337|20994313|P4|Overall Study|Noncompliance|0
6080853|NCT00402337|20994314|P3|Overall Study|Noncompliance|0
6080854|NCT00402337|20994315|P2|Overall Study|Noncompliance|0
6080855|NCT00402337|20994316|P1|Overall Study|Noncompliance|0
6080856|NCT00402337|20994312|P5|Overall Study|Adverse Event|2
6080857|NCT00402337|20994313|P4|Overall Study|Adverse Event|3
6080858|NCT00402337|20994314|P3|Overall Study|Adverse Event|2
6080859|NCT00402337|20994315|P2|Overall Study|Adverse Event|2
6080860|NCT00402337|20994316|P1|Overall Study|Adverse Event|0
6080861|NCT00402324|20994355|P2|Overall Study|Death|0
6080862|NCT00402324|20994356|P1|Overall Study|Death|1
6080863|NCT00402324|20994355|P2|Overall Study|Adverse Event|4
6080864|NCT00402324|20994356|P1|Overall Study|Adverse Event|6
6080865|NCT00402324|20994355|P2|Overall Study|Lack of Efficacy|4
6080866|NCT00402324|20994356|P1|Overall Study|Lack of Efficacy|1
6080867|NCT00402324|20994355|P2|Overall Study|Sponsor Decision|5
6080868|NCT00402324|20994356|P1|Overall Study|Sponsor Decision|4
6080869|NCT00402324|20994355|P2|Overall Study|Physician Decision|4
6080870|NCT00402324|20994356|P1|Overall Study|Physician Decision|2
6080871|NCT00402324|20994355|P2|Overall Study|Withdrawal by Subject|2
6080872|NCT00402324|20994356|P1|Overall Study|Withdrawal by Subject|5
6080873|NCT00402324|20994355|P2|Overall Study|Protocol Violation|7
6080874|NCT00402324|20994356|P1|Overall Study|Protocol Violation|8
6080875|NCT00402324|20994355|P2|Overall Study|Protocol Entry Criteria Not Met|4
6080876|NCT00402324|20994356|P1|Overall Study|Protocol Entry Criteria Not Met|5
6080877|NCT00402324|20994355|P2|Overall Study|Lost to Follow-up|11
6080878|NCT00402324|20994356|P1|Overall Study|Lost to Follow-up|11
6080879|NCT00402285|20994389|P3|Overall Study|insufficient RNA quality|2
6080880|NCT00402285|20994390|P2|Overall Study|insufficient RNA quality|6
6080881|NCT00402285|20994391|P1|Overall Study|insufficient RNA quality|7
6080882|NCT00402246|20994399|P2|Overall Study|Deterioriating Condition|2
6080883|NCT00402246|20994400|P1|Overall Study|Deterioriating Condition|3
6080884|NCT00402246|20994399|P2|Overall Study|Center Closure|3
6080885|NCT00402246|20994400|P1|Overall Study|Center Closure|5
6080886|NCT00402246|20994399|P2|Overall Study|Patient's device explanted|2
6080887|NCT00402246|20994400|P1|Overall Study|Patient's device explanted|6
6080888|NCT00402246|20994399|P2|Overall Study|Heart Transplant|1
6080889|NCT00402246|20994400|P1|Overall Study|Heart Transplant|0
6080890|NCT00402246|20994399|P2|Overall Study|Insurance Issues|1
6080891|NCT00402246|20994400|P1|Overall Study|Insurance Issues|2
6080892|NCT00402246|20994399|P2|Overall Study|Missed Final Visit|2
6080893|NCT00402246|20994400|P1|Overall Study|Missed Final Visit|1
6080894|NCT00402246|20994399|P2|Overall Study|Protocol Violation|24
6080895|NCT00402246|20994400|P1|Overall Study|Protocol Violation|25
6080896|NCT00402246|20994399|P2|Overall Study|Physician Decision|26
6080897|NCT00402246|20994400|P1|Overall Study|Physician Decision|24
6080898|NCT00402246|20994399|P2|Overall Study|Withdrawal by Subject|87
6080899|NCT00402246|20994400|P1|Overall Study|Withdrawal by Subject|72
6080900|NCT00402246|20994399|P2|Overall Study|Lost to Follow-up|28
6080901|NCT00402246|20994400|P1|Overall Study|Lost to Follow-up|20
6080902|NCT00402246|20994399|P2|Overall Study|Death|58
6080903|NCT00402246|20994400|P1|Overall Study|Death|62
6080904|NCT00402233|20994434|P4|Overall Study|Worsening of other pre-existing disease|0
6080905|NCT00402233|20994435|P3|Overall Study|Worsening of other pre-existing disease|0
6080906|NCT00402233|20994436|P2|Overall Study|Worsening of other pre-existing disease|1
6080907|NCT00402233|20994437|P1|Overall Study|Worsening of other pre-existing disease|0
6080908|NCT00402233|20994434|P4|Overall Study|Worsening of disease under study|0
6080909|NCT00402233|20994435|P3|Overall Study|Worsening of disease under study|0
6080910|NCT00402233|20994436|P2|Overall Study|Worsening of disease under study|0
6080911|NCT00402233|20994437|P1|Overall Study|Worsening of disease under study|2
6080912|NCT00402233|20994434|P4|Overall Study|Withdrawal by Subject|2
6080913|NCT00402233|20994435|P3|Overall Study|Withdrawal by Subject|2
6080914|NCT00402233|20994436|P2|Overall Study|Withdrawal by Subject|1
6080915|NCT00402233|20994437|P1|Overall Study|Withdrawal by Subject|2
6080916|NCT00402233|20994434|P4|Overall Study|Protocol Violation|0
6080917|NCT00402233|20994435|P3|Overall Study|Protocol Violation|0
6080918|NCT00402233|20994436|P2|Overall Study|Protocol Violation|1
6080919|NCT00402233|20994437|P1|Overall Study|Protocol Violation|0
6080920|NCT00402233|20994434|P4|Overall Study|Adverse Event|9
6080921|NCT00402233|20994435|P3|Overall Study|Adverse Event|9
6080922|NCT00402233|20994436|P2|Overall Study|Adverse Event|7
6080923|NCT00402233|20994437|P1|Overall Study|Adverse Event|1
6080924|NCT00402168|20994472|P2|Switched From CNI to Belatacept in LT|Adverse Event|0
6080925|NCT00402168|20994473|P1|Switched From CNI to Belatacept in LT|Adverse Event|4
6080926|NCT00402168|20994472|P2|Switched From CNI to Belatacept in LT|Withdrawal by Subject|0
6080927|NCT00402168|20994473|P1|Switched From CNI to Belatacept in LT|Withdrawal by Subject|2
6080928|NCT00402168|20994472|P2|Long Term (LT)|non-specified|2
6080929|NCT00402168|20994473|P1|Long Term (LT)|non-specified|1
6080930|NCT00402168|20994472|P2|Long Term (LT)|Lack of Efficacy|2
6080931|NCT00402168|20994473|P1|Long Term (LT)|Lack of Efficacy|0
6080932|NCT00402168|20994472|P2|Long Term (LT)|Death|0
6080933|NCT00402168|20994473|P1|Long Term (LT)|Death|4
6080934|NCT00402168|20994472|P2|Long Term (LT)|Lost to Follow-up|0
6080935|NCT00402168|20994473|P1|Long Term (LT)|Lost to Follow-up|1
6080936|NCT00402168|20994472|P2|Long Term (LT)|Pregnancy|1
6080937|NCT00402168|20994473|P1|Long Term (LT)|Pregnancy|0
6080938|NCT00402168|20994472|P2|Long Term (LT)|Withdrawal by Subject|7
6080939|NCT00402168|20994473|P1|Long Term (LT)|Withdrawal by Subject|4
6080940|NCT00402168|20994472|P2|Long Term (LT)|Adverse Event|5
6080941|NCT00402168|20994473|P1|Long Term (LT)|Adverse Event|1
6080942|NCT00402168|20994472|P2|Treatment (up to 12 Months)|non-specified|1
6080943|NCT00402168|20994473|P1|Treatment (up to 12 Months)|non-specified|0
6080944|NCT00402168|20994472|P2|Treatment (up to 12 Months)|Lack of Efficacy|0
6080945|NCT00402168|20994473|P1|Treatment (up to 12 Months)|Lack of Efficacy|2
6080946|NCT00402168|20994472|P2|Treatment (up to 12 Months)|Death|1
6080947|NCT00402168|20994473|P1|Treatment (up to 12 Months)|Death|0
6080948|NCT00402168|20994472|P2|Randomized|Withdrawal by Subject|1
6080949|NCT00402168|20994473|P1|Randomized|Withdrawal by Subject|0
6080950|NCT00402168|20994472|P2|Randomized|Lost to Follow-up|0
6080951|NCT00402168|20994473|P1|Randomized|Lost to Follow-up|1
6080952|NCT00402116|20994531|P3|Overall Study|Adverse Event|6
6080953|NCT00402116|20994532|P2|Overall Study|Adverse Event|1
6080954|NCT00402116|20994533|P1|Overall Study|Adverse Event|0
6080955|NCT00402116|20994531|P3|Overall Study|decline related hyponatremia/tumor|1
6080956|NCT00402116|20994532|P2|Overall Study|decline related hyponatremia/tumor|0
6080957|NCT00402116|20994533|P1|Overall Study|decline related hyponatremia/tumor|0
6080958|NCT00402116|20994531|P3|Overall Study|mistaken thrombocytopenia|1
6080959|NCT00402116|20994532|P2|Overall Study|mistaken thrombocytopenia|0
6080960|NCT00402116|20994533|P1|Overall Study|mistaken thrombocytopenia|0
6080961|NCT00402116|20994531|P3|Overall Study|Disease Progression|38
6080962|NCT00402116|20994532|P2|Overall Study|Disease Progression|4
6080963|NCT00402116|20994533|P1|Overall Study|Disease Progression|0
6080964|NCT00402116|20994531|P3|Overall Study|other complicating disease|2
6080965|NCT00402116|20994532|P2|Overall Study|other complicating disease|0
6080966|NCT00402116|20994533|P1|Overall Study|other complicating disease|0
6080967|NCT00402116|20994531|P3|Overall Study|Treatment completed per protocol|2
6080968|NCT00402116|20994532|P2|Overall Study|Treatment completed per protocol|1
6080969|NCT00402116|20994533|P1|Overall Study|Treatment completed per protocol|1
6080970|NCT00402116|20994531|P3|Overall Study|Withdrawal by Subject|5
6080971|NCT00402116|20994532|P2|Overall Study|Withdrawal by Subject|0
6080972|NCT00402116|20994533|P1|Overall Study|Withdrawal by Subject|1
6080973|NCT00402116|20994531|P3|Overall Study|Jaw infection after surgery-other|0
6080974|NCT00402116|20994532|P2|Overall Study|Jaw infection after surgery-other|0
6080975|NCT00402116|20994533|P1|Overall Study|Jaw infection after surgery-other|1
6080976|NCT00402103|20994563|P2|Overall Study|Administrative problems|0
6080977|NCT00402103|20994564|P1|Overall Study|Administrative problems|2
6080978|NCT00402103|20994563|P2|Overall Study|Lost to Follow-up|3
6080979|NCT00402103|20994564|P1|Overall Study|Lost to Follow-up|6
6080980|NCT00402103|20994563|P2|Overall Study|Patient withdrew consent|1
6080981|NCT00402103|20994564|P1|Overall Study|Patient withdrew consent|12
6080982|NCT00402103|20994563|P2|Overall Study|Protocol Deviation|0
6080983|NCT00402103|20994564|P1|Overall Study|Protocol Deviation|8
6080984|NCT00402103|20994563|P2|Overall Study|Condition no longer requires study drug|0
6080985|NCT00402103|20994564|P1|Overall Study|Condition no longer requires study drug|2
6080986|NCT00402103|20994563|P2|Overall Study|Unsatisfactory therapeutic effect|2
6080987|NCT00402103|20994564|P1|Overall Study|Unsatisfactory therapeutic effect|1
6080988|NCT00402103|20994563|P2|Overall Study|Adverse Event|7
6080989|NCT00402103|20994564|P1|Overall Study|Adverse Event|60
6080990|NCT00402051|20994580|P2|Overall Study|Lost to Follow-up|0
6080991|NCT00402051|20994581|P1|Overall Study|Lost to Follow-up|1
6080992|NCT00402051|20994580|P2|Overall Study|Death Due to Adverse Event|2
6080993|NCT00402051|20994581|P1|Overall Study|Death Due to Adverse Event|0
6080994|NCT00402051|20994580|P2|Overall Study|Death Due to Study Disease|1
6080995|NCT00402051|20994581|P1|Overall Study|Death Due to Study Disease|2
6080996|NCT00402051|20994580|P2|Overall Study|Death - Related to Study Drug|2
6080997|NCT00402051|20994581|P1|Overall Study|Death - Related to Study Drug|1
6080998|NCT00402051|20994580|P2|Overall Study|Withdrawal by Subject|3
6080999|NCT00402051|20994581|P1|Overall Study|Withdrawal by Subject|3
6081000|NCT00402051|20994580|P2|Overall Study|Physician Decision|3
6081001|NCT00402051|20994581|P1|Overall Study|Physician Decision|7
6081002|NCT00402051|20994580|P2|Overall Study|Adverse Event|4
6081003|NCT00402051|20994581|P1|Overall Study|Adverse Event|11
6081004|NCT00402051|20994580|P2|Overall Study|Progressive Disease|20
6081005|NCT00402051|20994581|P1|Overall Study|Progressive Disease|13
6081006|NCT00402025|20994598|P3|Overall Study|Participant Decision|1
6081007|NCT00402025|20994599|P2|Overall Study|Participant Decision|0
6081008|NCT00402025|20994600|P1|Overall Study|Participant Decision|0
6081009|NCT00402025|20994598|P3|Overall Study|Physician Decision|0
6081010|NCT00402025|20994599|P2|Overall Study|Physician Decision|1
6081011|NCT00402025|20994600|P1|Overall Study|Physician Decision|1
6081012|NCT00402025|20994598|P3|Overall Study|Disease Progression|2
6081013|NCT00402025|20994599|P2|Overall Study|Disease Progression|1
6081014|NCT00402025|20994600|P1|Overall Study|Disease Progression|1
6081015|NCT00402025|20994598|P3|Overall Study|Death|5
6081016|NCT00402025|20994599|P2|Overall Study|Death|1
6081017|NCT00402025|20994600|P1|Overall Study|Death|0
6081018|NCT00402025|20994598|P3|Overall Study|Adverse Event|2
6081019|NCT00402025|20994599|P2|Overall Study|Adverse Event|0
6081020|NCT00402025|20994600|P1|Overall Study|Adverse Event|0
6081021|NCT00401973|20994626|P3|Overall Study|Withdrawal by Subject|9
6081022|NCT00401973|20994627|P2|Overall Study|Withdrawal by Subject|12
6081023|NCT00401973|20994628|P1|Overall Study|Withdrawal by Subject|4
6081024|NCT00401973|20994626|P3|Overall Study|Sponsor Decision|0
6081025|NCT00401973|20994627|P2|Overall Study|Sponsor Decision|1
6081026|NCT00401973|20994628|P1|Overall Study|Sponsor Decision|0
6081027|NCT00401973|20994626|P3|Overall Study|Protocol Violation|3
6081028|NCT00401973|20994627|P2|Overall Study|Protocol Violation|2
6081029|NCT00401973|20994628|P1|Overall Study|Protocol Violation|1
6081030|NCT00401973|20994626|P3|Overall Study|Physician Decision|1
6081031|NCT00401973|20994627|P2|Overall Study|Physician Decision|0
6081032|NCT00401973|20994628|P1|Overall Study|Physician Decision|2
6081033|NCT00401973|20994626|P3|Overall Study|Lost to Follow-up|2
6081034|NCT00401973|20994627|P2|Overall Study|Lost to Follow-up|2
6081035|NCT00401973|20994628|P1|Overall Study|Lost to Follow-up|2
6081036|NCT00401973|20994626|P3|Overall Study|Lack of Efficacy|3
6081037|NCT00401973|20994627|P2|Overall Study|Lack of Efficacy|0
6081038|NCT00401973|20994628|P1|Overall Study|Lack of Efficacy|0
6081039|NCT00401973|20994626|P3|Overall Study|Clinical Relapse|1
6081040|NCT00401973|20994627|P2|Overall Study|Clinical Relapse|1
6081041|NCT00401973|20994628|P1|Overall Study|Clinical Relapse|0
6081042|NCT00401973|20994626|P3|Overall Study|Adverse Event|4
6081043|NCT00401973|20994627|P2|Overall Study|Adverse Event|8
6081044|NCT00401973|20994628|P1|Overall Study|Adverse Event|2
6081045|NCT00401960|20994667|P2|Overall Study|Death|0
6081046|NCT00401960|20994668|P1|Overall Study|Death|2
6081047|NCT00401960|20994667|P2|Overall Study|Lost to Follow-up|0
6081048|NCT00401960|20994668|P1|Overall Study|Lost to Follow-up|3
6081049|NCT00401843|20994698|P3|Overall Study|Received incorrect treatment|0
6081050|NCT00401843|20994699|P2|Overall Study|Received incorrect treatment|3
6081051|NCT00401843|20994700|P1|Overall Study|Received incorrect treatment|0
6081052|NCT00401843|20994698|P3|Overall Study|Randomized but not Treated|3
6081053|NCT00401843|20994699|P2|Overall Study|Randomized but not Treated|2
6081054|NCT00401843|20994700|P1|Overall Study|Randomized but not Treated|0
6081055|NCT00401843|20994698|P3|Overall Study|Withdrawal of consent to study agent|17
6081056|NCT00401843|20994699|P2|Overall Study|Withdrawal of consent to study agent|15
6081057|NCT00401843|20994700|P1|Overall Study|Withdrawal of consent to study agent|1
6081058|NCT00401843|20994698|P3|Overall Study|Withdrawal by Subject|5
6081059|NCT00401843|20994699|P2|Overall Study|Withdrawal by Subject|5
6081060|NCT00401843|20994700|P1|Overall Study|Withdrawal by Subject|1
6081061|NCT00401843|20994698|P3|Overall Study|Protocol Violation|1
6081062|NCT00401843|20994699|P2|Overall Study|Protocol Violation|0
6081063|NCT00401843|20994700|P1|Overall Study|Protocol Violation|0
6081064|NCT00401843|20994698|P3|Overall Study|Physician Decision|10
6081065|NCT00401843|20994699|P2|Overall Study|Physician Decision|16
6081066|NCT00401843|20994700|P1|Overall Study|Physician Decision|0
6081067|NCT00401843|20994698|P3|Overall Study|Other Unspecified|5
6081068|NCT00401843|20994699|P2|Overall Study|Other Unspecified|3
6081069|NCT00401843|20994700|P1|Overall Study|Other Unspecified|0
6081070|NCT00401843|20994698|P3|Overall Study|Lost to Follow-up|2
6081071|NCT00401843|20994699|P2|Overall Study|Lost to Follow-up|0
6081072|NCT00401843|20994700|P1|Overall Study|Lost to Follow-up|0
6081073|NCT00401843|20994698|P3|Overall Study|End of Study|2
6081074|NCT00401843|20994699|P2|Overall Study|End of Study|1
6081075|NCT00401843|20994700|P1|Overall Study|End of Study|1
6081076|NCT00401843|20994698|P3|Overall Study|Disease progression|49
6081077|NCT00401843|20994699|P2|Overall Study|Disease progression|60
6081078|NCT00401843|20994700|P1|Overall Study|Disease progression|10
6081079|NCT00401843|20994698|P3|Overall Study|Death|10
6081080|NCT00401843|20994699|P2|Overall Study|Death|8
6081081|NCT00401843|20994700|P1|Overall Study|Death|0
6081082|NCT00401843|20994698|P3|Overall Study|Adverse Event|27
6081083|NCT00401843|20994699|P2|Overall Study|Adverse Event|26
6081084|NCT00401843|20994700|P1|Overall Study|Adverse Event|7
6081085|NCT00401843|20994698|P3|Overall Study|Achieved Complete Response|11
6081086|NCT00401843|20994699|P2|Overall Study|Achieved Complete Response|5
6081087|NCT00401843|20994700|P1|Overall Study|Achieved Complete Response|1
6081088|NCT00401830|20994718|P2|Overall Study|Other: Personal / Family problems|0
6081089|NCT00401830|20994719|P1|Overall Study|Other: Personal / Family problems|1
6081090|NCT00401830|20994718|P2|Overall Study|Lost to Follow-up|3
6081091|NCT00401830|20994719|P1|Overall Study|Lost to Follow-up|1
6081092|NCT00401830|20994718|P2|Overall Study|Non-compliance with drug study|0
6081093|NCT00401830|20994719|P1|Overall Study|Non-compliance with drug study|1
6081094|NCT00401830|20994718|P2|Overall Study|Protocol Violation|3
6081095|NCT00401830|20994719|P1|Overall Study|Protocol Violation|3
6081096|NCT00401830|20994718|P2|Overall Study|Withdrawal by Subject|3
6081097|NCT00401830|20994719|P1|Overall Study|Withdrawal by Subject|4
6081098|NCT00401830|20994718|P2|Overall Study|Lack of Efficacy|5
6081099|NCT00401830|20994719|P1|Overall Study|Lack of Efficacy|11
6081100|NCT00401830|20994718|P2|Overall Study|Adverse Event|18
6081101|NCT00401830|20994719|P1|Overall Study|Adverse Event|10
6081102|NCT00401752|20994777|P2|Overall Study|Physician Decision|1
6081103|NCT00401752|20994778|P1|Overall Study|Physician Decision|1
6081104|NCT00401752|20994777|P2|Overall Study|Development of any exclusion criteria|2
6081105|NCT00401752|20994778|P1|Overall Study|Development of any exclusion criteria|4
6081106|NCT00401752|20994777|P2|Overall Study|Lost to Follow-up|4
6081107|NCT00401752|20994778|P1|Overall Study|Lost to Follow-up|1
6081108|NCT00401752|20994777|P2|Overall Study|Withdrawal by Subject|6
6081109|NCT00401752|20994778|P1|Overall Study|Withdrawal by Subject|2
6081110|NCT00401752|20994777|P2|Overall Study|Adverse Event|5
6081111|NCT00401752|20994778|P1|Overall Study|Adverse Event|2
6081112|NCT00401726|20994796|P2|Overall Study|Protocol Deviation|4
6081113|NCT00401726|20994797|P1|Overall Study|Protocol Deviation|9
6081114|NCT00401726|20994796|P2|Overall Study|Lack of Efficacy|6
6081115|NCT00401726|20994797|P1|Overall Study|Lack of Efficacy|4
6081116|NCT00401726|20994796|P2|Overall Study|Withdrawal by Subject|24
6081117|NCT00401726|20994797|P1|Overall Study|Withdrawal by Subject|18
6081118|NCT00401726|20994796|P2|Overall Study|Protocol Violation|3
6081119|NCT00401726|20994797|P1|Overall Study|Protocol Violation|6
6081120|NCT00401726|20994796|P2|Overall Study|Lost to Follow-up|20
6081121|NCT00401726|20994797|P1|Overall Study|Lost to Follow-up|23
6081122|NCT00401726|20994796|P2|Overall Study|Physician Decision|6
6081123|NCT00401726|20994797|P1|Overall Study|Physician Decision|3
6081124|NCT00401726|20994796|P2|Overall Study|Sponsor Request|1
6081125|NCT00401726|20994797|P1|Overall Study|Sponsor Request|0
6081126|NCT00401726|20994796|P2|Overall Study|Death|3
6081127|NCT00401726|20994797|P1|Overall Study|Death|0
6081128|NCT00401726|20994796|P2|Overall Study|Adverse Event|45
6081129|NCT00401726|20994797|P1|Overall Study|Adverse Event|34
6081130|NCT00401544|20994832|P4|Overall Study|Other|2
6081131|NCT00401544|20994833|P3|Overall Study|Other|2
6081132|NCT00401544|20994834|P2|Overall Study|Other|0
6081133|NCT00401544|20994835|P1|Overall Study|Other|0
6081134|NCT00401544|20994832|P4|Overall Study|Disease progression|0
6081135|NCT00401544|20994833|P3|Overall Study|Disease progression|0
6081136|NCT00401544|20994834|P2|Overall Study|Disease progression|1
6081137|NCT00401544|20994835|P1|Overall Study|Disease progression|0
6081138|NCT00401544|20994832|P4|Overall Study|Ineligibility determined|2
6081139|NCT00401544|20994833|P3|Overall Study|Ineligibility determined|0
6081140|NCT00401544|20994834|P2|Overall Study|Ineligibility determined|1
6081141|NCT00401544|20994835|P1|Overall Study|Ineligibility determined|0
6081142|NCT00401544|20994832|P4|Overall Study|Physician Decision|0
6081143|NCT00401544|20994833|P3|Overall Study|Physician Decision|0
6081144|NCT00401544|20994834|P2|Overall Study|Physician Decision|3
6081145|NCT00401544|20994835|P1|Overall Study|Physician Decision|1
6081146|NCT00401544|20994832|P4|Overall Study|Withdrawal by Subject|5
6081147|NCT00401544|20994833|P3|Overall Study|Withdrawal by Subject|6
6081148|NCT00401544|20994834|P2|Overall Study|Withdrawal by Subject|6
6081149|NCT00401544|20994835|P1|Overall Study|Withdrawal by Subject|7
6081150|NCT00401544|20994832|P4|Overall Study|Lost to Follow-up|1
6081151|NCT00401544|20994833|P3|Overall Study|Lost to Follow-up|1
6081152|NCT00401544|20994834|P2|Overall Study|Lost to Follow-up|0
6081153|NCT00401544|20994835|P1|Overall Study|Lost to Follow-up|2
6081154|NCT00401544|20994832|P4|Overall Study|Death|5
6081155|NCT00401544|20994833|P3|Overall Study|Death|2
6081156|NCT00401544|20994834|P2|Overall Study|Death|6
6081157|NCT00401544|20994835|P1|Overall Study|Death|3
6081158|NCT00401544|20994832|P4|Overall Study|Adverse Event|1
6081159|NCT00401544|20994833|P3|Overall Study|Adverse Event|1
6081160|NCT00401544|20994834|P2|Overall Study|Adverse Event|1
6081161|NCT00401544|20994835|P1|Overall Study|Adverse Event|5
6081162|NCT00401531|20994875|P2|Overall Study|Withdrawal by Subject|2
6081163|NCT00401531|20994876|P1|Overall Study|Withdrawal by Subject|3
6081164|NCT00401531|20994875|P2|Overall Study|Lost to Follow-up|1
6081165|NCT00401531|20994876|P1|Overall Study|Lost to Follow-up|1
6081166|NCT00401531|20994875|P2|Overall Study|Protocol Violation|7
6081167|NCT00401531|20994876|P1|Overall Study|Protocol Violation|3
6081168|NCT00401531|20994875|P2|Overall Study|Adverse Event|0
6081169|NCT00401531|20994876|P1|Overall Study|Adverse Event|2
6081170|NCT00401375|20994980|P3|Overall Study|Randomized but not treated|3
6081171|NCT00401375|20994981|P2|Overall Study|Randomized but not treated|3
6081172|NCT00401375|20994982|P1|Overall Study|Randomized but not treated|3
6081173|NCT00401375|20994980|P3|Overall Study|Other than specified|3
6081174|NCT00401375|20994981|P2|Overall Study|Other than specified|1
6081175|NCT00401375|20994982|P1|Overall Study|Other than specified|2
6081176|NCT00401375|20994980|P3|Overall Study|Lost to Follow-up|1
6081177|NCT00401375|20994981|P2|Overall Study|Lost to Follow-up|1
6081178|NCT00401375|20994982|P1|Overall Study|Lost to Follow-up|0
6081179|NCT00401375|20994980|P3|Overall Study|Withdrawal by Subject|7
6081180|NCT00401375|20994981|P2|Overall Study|Withdrawal by Subject|7
6081181|NCT00401375|20994982|P1|Overall Study|Withdrawal by Subject|9
6081182|NCT00401375|20994980|P3|Overall Study|Adverse Event|10
6081183|NCT00401375|20994981|P2|Overall Study|Adverse Event|11
6081184|NCT00401375|20994982|P1|Overall Study|Adverse Event|6
6081185|NCT00401375|20994980|P3|Overall Study|Protocol Violation|1
6081186|NCT00401375|20994981|P2|Overall Study|Protocol Violation|2
6081187|NCT00401375|20994982|P1|Overall Study|Protocol Violation|2
6081188|NCT00401258|20994999|P1|Overall Study|Adverse Event|7
6081189|NCT00401245|20995014|P8|Double Blind Tapering Phase|Lack of Efficacy|0
6081190|NCT00401245|20995015|P7|Double Blind Tapering Phase|Lack of Efficacy|0
6081191|NCT00401245|20995016|P6|Double Blind Tapering Phase|Lack of Efficacy|1
6081192|NCT00401245|20995017|P5|Double Blind Tapering Phase|Lack of Efficacy|0
6081193|NCT00401245|20995018|P4|Double Blind Tapering Phase|Lack of Efficacy|0
6081194|NCT00401245|20995019|P3|Double Blind Tapering Phase|Lack of Efficacy|0
6081195|NCT00401245|20995020|P2|Double Blind Tapering Phase|Lack of Efficacy|0
6081196|NCT00401245|20995021|P1|Double Blind Tapering Phase|Lack of Efficacy|0
6081197|NCT00401245|20995014|P8|Double Blind Tapering Phase|Withdrawal by Subject|0
6081198|NCT00401245|20995015|P7|Double Blind Tapering Phase|Withdrawal by Subject|3
6081199|NCT00401245|20995016|P6|Double Blind Tapering Phase|Withdrawal by Subject|2
6081200|NCT00401245|20995017|P5|Double Blind Tapering Phase|Withdrawal by Subject|2
6081201|NCT00401245|20995018|P4|Double Blind Tapering Phase|Withdrawal by Subject|0
6081202|NCT00401245|20995019|P3|Double Blind Tapering Phase|Withdrawal by Subject|0
6081203|NCT00401245|20995020|P2|Double Blind Tapering Phase|Withdrawal by Subject|0
6081204|NCT00401245|20995021|P1|Double Blind Tapering Phase|Withdrawal by Subject|0
6081205|NCT00401245|20995014|P8|Double Blind Tapering Phase|Other|2
6081206|NCT00401245|20995015|P7|Double Blind Tapering Phase|Other|2
6081207|NCT00401245|20995016|P6|Double Blind Tapering Phase|Other|0
6081208|NCT00401245|20995017|P5|Double Blind Tapering Phase|Other|1
6081209|NCT00401245|20995018|P4|Double Blind Tapering Phase|Other|0
6081210|NCT00401245|20995019|P3|Double Blind Tapering Phase|Other|0
6081211|NCT00401245|20995020|P2|Double Blind Tapering Phase|Other|0
6081212|NCT00401245|20995021|P1|Double Blind Tapering Phase|Other|0
6081213|NCT00401245|20995014|P8|Double Blind Tapering Phase|Investigator request|1
6081214|NCT00401245|20995015|P7|Double Blind Tapering Phase|Investigator request|0
6081215|NCT00401245|20995016|P6|Double Blind Tapering Phase|Investigator request|0
6081216|NCT00401245|20995017|P5|Double Blind Tapering Phase|Investigator request|0
6081217|NCT00401245|20995018|P4|Double Blind Tapering Phase|Investigator request|0
6081218|NCT00401245|20995019|P3|Double Blind Tapering Phase|Investigator request|0
6081219|NCT00401245|20995020|P2|Double Blind Tapering Phase|Investigator request|0
6081220|NCT00401245|20995021|P1|Double Blind Tapering Phase|Investigator request|0
6081221|NCT00401245|20995014|P8|Double Blind Tapering Phase|Adverse Event|4
6081222|NCT00401245|20995015|P7|Double Blind Tapering Phase|Adverse Event|2
6081223|NCT00401245|20995016|P6|Double Blind Tapering Phase|Adverse Event|1
6081224|NCT00401245|20995017|P5|Double Blind Tapering Phase|Adverse Event|1
6081225|NCT00401245|20995018|P4|Double Blind Tapering Phase|Adverse Event|0
6081226|NCT00401245|20995019|P3|Double Blind Tapering Phase|Adverse Event|0
6081227|NCT00401245|20995020|P2|Double Blind Tapering Phase|Adverse Event|0
6081228|NCT00401245|20995021|P1|Double Blind Tapering Phase|Adverse Event|0
6081229|NCT00401245|20995014|P8|Open Label Phase|Lack of Efficacy|0
6081230|NCT00401245|20995015|P7|Open Label Phase|Lack of Efficacy|0
6081231|NCT00401245|20995016|P6|Open Label Phase|Lack of Efficacy|0
6081232|NCT00401245|20995017|P5|Open Label Phase|Lack of Efficacy|0
6081233|NCT00401245|20995018|P4|Open Label Phase|Lack of Efficacy|0
6081234|NCT00401245|20995019|P3|Open Label Phase|Lack of Efficacy|3
6081235|NCT00401245|20995020|P2|Open Label Phase|Lack of Efficacy|2
6081236|NCT00401245|20995021|P1|Open Label Phase|Lack of Efficacy|4
6081237|NCT00401245|20995014|P8|Open Label Phase|Withdrawal by Subject|0
6081238|NCT00401245|20995015|P7|Open Label Phase|Withdrawal by Subject|0
6081239|NCT00401245|20995016|P6|Open Label Phase|Withdrawal by Subject|0
6081240|NCT00401245|20995017|P5|Open Label Phase|Withdrawal by Subject|0
6081241|NCT00401245|20995018|P4|Open Label Phase|Withdrawal by Subject|1
6081242|NCT00401245|20995019|P3|Open Label Phase|Withdrawal by Subject|2
6081243|NCT00401245|20995020|P2|Open Label Phase|Withdrawal by Subject|3
6081244|NCT00401245|20995021|P1|Open Label Phase|Withdrawal by Subject|3
6081245|NCT00401245|20995014|P8|Open Label Phase|Protocol Violation|0
6081246|NCT00401245|20995015|P7|Open Label Phase|Protocol Violation|0
6081247|NCT00401245|20995016|P6|Open Label Phase|Protocol Violation|0
6081248|NCT00401245|20995017|P5|Open Label Phase|Protocol Violation|0
6081249|NCT00401245|20995018|P4|Open Label Phase|Protocol Violation|1
6081250|NCT00401245|20995019|P3|Open Label Phase|Protocol Violation|0
6081251|NCT00401245|20995020|P2|Open Label Phase|Protocol Violation|1
6081252|NCT00401245|20995021|P1|Open Label Phase|Protocol Violation|0
6081253|NCT00401245|20995014|P8|Open Label Phase|Other|0
6081254|NCT00401245|20995015|P7|Open Label Phase|Other|0
6081255|NCT00401245|20995016|P6|Open Label Phase|Other|0
6081256|NCT00401245|20995017|P5|Open Label Phase|Other|0
6081257|NCT00401245|20995018|P4|Open Label Phase|Other|8
6081258|NCT00401245|20995019|P3|Open Label Phase|Other|7
6081259|NCT00401245|20995020|P2|Open Label Phase|Other|8
6081260|NCT00401245|20995021|P1|Open Label Phase|Other|4
6081261|NCT00401245|20995014|P8|Open Label Phase|Lost to Follow-up|0
6081262|NCT00401245|20995015|P7|Open Label Phase|Lost to Follow-up|0
6081263|NCT00401245|20995016|P6|Open Label Phase|Lost to Follow-up|0
6081264|NCT00401245|20995017|P5|Open Label Phase|Lost to Follow-up|0
6081265|NCT00401245|20995018|P4|Open Label Phase|Lost to Follow-up|4
6081266|NCT00401245|20995019|P3|Open Label Phase|Lost to Follow-up|5
6081267|NCT00401245|20995020|P2|Open Label Phase|Lost to Follow-up|7
6081268|NCT00401245|20995021|P1|Open Label Phase|Lost to Follow-up|5
6081269|NCT00401245|20995014|P8|Open Label Phase|Adverse Event|0
6081270|NCT00401245|20995015|P7|Open Label Phase|Adverse Event|0
6081271|NCT00401245|20995016|P6|Open Label Phase|Adverse Event|0
6081272|NCT00401245|20995017|P5|Open Label Phase|Adverse Event|0
6081273|NCT00401245|20995018|P4|Open Label Phase|Adverse Event|7
6081274|NCT00401245|20995019|P3|Open Label Phase|Adverse Event|6
6081275|NCT00401245|20995020|P2|Open Label Phase|Adverse Event|14
6081276|NCT00401245|20995021|P1|Open Label Phase|Adverse Event|5
6081277|NCT00401245|20995014|P8|Between Titration and Open Label Phase|Did not enter the open label phase|0
6081278|NCT00401245|20995015|P7|Between Titration and Open Label Phase|Did not enter the open label phase|0
6081279|NCT00401245|20995016|P6|Between Titration and Open Label Phase|Did not enter the open label phase|0
6081280|NCT00401245|20995017|P5|Between Titration and Open Label Phase|Did not enter the open label phase|0
6081281|NCT00401245|20995018|P4|Between Titration and Open Label Phase|Did not enter the open label phase|2
6081282|NCT00401245|20995019|P3|Between Titration and Open Label Phase|Did not enter the open label phase|0
6081283|NCT00401245|20995020|P2|Between Titration and Open Label Phase|Did not enter the open label phase|2
6081284|NCT00401245|20995021|P1|Between Titration and Open Label Phase|Did not enter the open label phase|0
6081285|NCT00401245|20995014|P8|Double Blind Titration Phase|Withdrawal by Subject|0
6081286|NCT00401245|20995015|P7|Double Blind Titration Phase|Withdrawal by Subject|0
6081287|NCT00401245|20995016|P6|Double Blind Titration Phase|Withdrawal by Subject|0
6081288|NCT00401245|20995017|P5|Double Blind Titration Phase|Withdrawal by Subject|0
6081289|NCT00401245|20995018|P4|Double Blind Titration Phase|Withdrawal by Subject|2
6081290|NCT00401245|20995019|P3|Double Blind Titration Phase|Withdrawal by Subject|0
6081291|NCT00401245|20995020|P2|Double Blind Titration Phase|Withdrawal by Subject|1
6081292|NCT00401245|20995021|P1|Double Blind Titration Phase|Withdrawal by Subject|1
6081293|NCT00401245|20995014|P8|Double Blind Titration Phase|Protocol Violation|0
6081294|NCT00401245|20995015|P7|Double Blind Titration Phase|Protocol Violation|0
6081295|NCT00401245|20995016|P6|Double Blind Titration Phase|Protocol Violation|0
6081296|NCT00401245|20995017|P5|Double Blind Titration Phase|Protocol Violation|0
6081297|NCT00401245|20995018|P4|Double Blind Titration Phase|Protocol Violation|1
6081298|NCT00401245|20995019|P3|Double Blind Titration Phase|Protocol Violation|0
6081299|NCT00401245|20995020|P2|Double Blind Titration Phase|Protocol Violation|0
6081300|NCT00401245|20995021|P1|Double Blind Titration Phase|Protocol Violation|0
6081301|NCT00401245|20995014|P8|Double Blind Titration Phase|Other|0
6081302|NCT00401245|20995015|P7|Double Blind Titration Phase|Other|0
6081303|NCT00401245|20995016|P6|Double Blind Titration Phase|Other|0
6081304|NCT00401245|20995017|P5|Double Blind Titration Phase|Other|0
6081305|NCT00401245|20995018|P4|Double Blind Titration Phase|Other|0
6081306|NCT00401245|20995019|P3|Double Blind Titration Phase|Other|1
6081307|NCT00401245|20995020|P2|Double Blind Titration Phase|Other|0
6081308|NCT00401245|20995021|P1|Double Blind Titration Phase|Other|0
6081309|NCT00401245|20995014|P8|Double Blind Titration Phase|Adverse Event|0
6081310|NCT00401245|20995015|P7|Double Blind Titration Phase|Adverse Event|0
6081311|NCT00401245|20995016|P6|Double Blind Titration Phase|Adverse Event|0
6081312|NCT00401245|20995017|P5|Double Blind Titration Phase|Adverse Event|0
6081313|NCT00401245|20995018|P4|Double Blind Titration Phase|Adverse Event|12
6081314|NCT00401245|20995019|P3|Double Blind Titration Phase|Adverse Event|5
6081315|NCT00401245|20995020|P2|Double Blind Titration Phase|Adverse Event|2
6081316|NCT00401245|20995021|P1|Double Blind Titration Phase|Adverse Event|3
6081317|NCT00401193|20995089|P3|Overall Study|Other Event|2
6081318|NCT00401193|20995090|P2|Overall Study|Other Event|2
6081319|NCT00401193|20995091|P1|Overall Study|Other Event|3
6081320|NCT00401193|20995089|P3|Overall Study|Withdrawal by Subject|1
6081321|NCT00401193|20995090|P2|Overall Study|Withdrawal by Subject|0
6081322|NCT00401193|20995091|P1|Overall Study|Withdrawal by Subject|2
6081323|NCT00401193|20995089|P3|Overall Study|Lost to Follow-up|1
6081324|NCT00401193|20995090|P2|Overall Study|Lost to Follow-up|5
6081325|NCT00401193|20995091|P1|Overall Study|Lost to Follow-up|6
6081326|NCT00401193|20995089|P3|Overall Study|Protocol Violation|1
6081327|NCT00401193|20995090|P2|Overall Study|Protocol Violation|1
6081328|NCT00401193|20995091|P1|Overall Study|Protocol Violation|3
6081329|NCT00401193|20995089|P3|Overall Study|Adverse Event|1
6081330|NCT00401193|20995090|P2|Overall Study|Adverse Event|3
6081331|NCT00401193|20995091|P1|Overall Study|Adverse Event|1
6081332|NCT00400985|20995109|P1|Overall Study|Lost to Follow-up|9
6081333|NCT00400985|20995109|P1|Overall Study|Death|30
6081334|NCT00400985|20995109|P1|Overall Study|system modification|8
6081335|NCT00400985|20995109|P1|Overall Study|Withdrawal by Subject|5
6081336|NCT00400946|20995118|P5|Overall Study|Other|1
6081337|NCT00400946|20995119|P4|Overall Study|Other|0
6081338|NCT00400946|20995120|P3|Overall Study|Other|0
6081339|NCT00400946|20995121|P2|Overall Study|Other|0
6081340|NCT00400946|20995122|P1|Overall Study|Other|0
6081341|NCT00400946|20995118|P5|Overall Study|Clinical|9
6081342|NCT00400946|20995119|P4|Overall Study|Clinical|2
6081343|NCT00400946|20995120|P3|Overall Study|Clinical|0
6081344|NCT00400946|20995121|P2|Overall Study|Clinical|2
6081345|NCT00400946|20995122|P1|Overall Study|Clinical|1
6081346|NCT00400946|20995118|P5|Overall Study|Withdrawal by Subject|8
6081347|NCT00400946|20995119|P4|Overall Study|Withdrawal by Subject|5
6081348|NCT00400946|20995120|P3|Overall Study|Withdrawal by Subject|1
6081349|NCT00400946|20995121|P2|Overall Study|Withdrawal by Subject|5
6081350|NCT00400946|20995122|P1|Overall Study|Withdrawal by Subject|2
6081351|NCT00400946|20995118|P5|Overall Study|Transplant in CR1|1
6081352|NCT00400946|20995119|P4|Overall Study|Transplant in CR1|10
6081353|NCT00400946|20995120|P3|Overall Study|Transplant in CR1|0
6081354|NCT00400946|20995121|P2|Overall Study|Transplant in CR1|0
6081355|NCT00400946|20995122|P1|Overall Study|Transplant in CR1|0
6081356|NCT00400946|20995118|P5|Overall Study|Relapse|5
6081357|NCT00400946|20995119|P4|Overall Study|Relapse|1
6081358|NCT00400946|20995120|P3|Overall Study|Relapse|1
6081359|NCT00400946|20995121|P2|Overall Study|Relapse|2
6081360|NCT00400946|20995122|P1|Overall Study|Relapse|9
6081361|NCT00400946|20995118|P5|Overall Study|Remission Death|1
6081362|NCT00400946|20995119|P4|Overall Study|Remission Death|0
6081363|NCT00400946|20995120|P3|Overall Study|Remission Death|0
6081364|NCT00400946|20995121|P2|Overall Study|Remission Death|1
6081365|NCT00400946|20995122|P1|Overall Study|Remission Death|1
6081366|NCT00400946|20995118|P5|Overall Study|Lost to Follow-up|1
6081367|NCT00400946|20995119|P4|Overall Study|Lost to Follow-up|0
6081368|NCT00400946|20995120|P3|Overall Study|Lost to Follow-up|0
6081369|NCT00400946|20995121|P2|Overall Study|Lost to Follow-up|1
6081370|NCT00400946|20995122|P1|Overall Study|Lost to Follow-up|1
6081371|NCT00400946|20995118|P5|Overall Study|Induction Death|3
6081372|NCT00400946|20995119|P4|Overall Study|Induction Death|13
6081373|NCT00400946|20995120|P3|Overall Study|Induction Death|0
6081374|NCT00400946|20995121|P2|Overall Study|Induction Death|0
6081375|NCT00400946|20995122|P1|Overall Study|Induction Death|0
6081376|NCT00400946|20995118|P5|Overall Study|Induction Failure|8
6081377|NCT00400946|20995119|P4|Overall Study|Induction Failure|11
6081378|NCT00400946|20995120|P3|Overall Study|Induction Failure|0
6081379|NCT00400946|20995121|P2|Overall Study|Induction Failure|0
6081380|NCT00400946|20995122|P1|Overall Study|Induction Failure|0
6081381|NCT00400946|20995118|P5|Overall Study|Ineligible|1
6081382|NCT00400946|20995119|P4|Overall Study|Ineligible|5
6081383|NCT00400946|20995120|P3|Overall Study|Ineligible|0
6081384|NCT00400946|20995121|P2|Overall Study|Ineligible|0
6081385|NCT00400946|20995122|P1|Overall Study|Ineligible|0
6081386|NCT00400764|20995181|P5|Phase II|Withdrawal by Subject|0
6081387|NCT00400764|20995182|P4|Phase II|Withdrawal by Subject|1
6081388|NCT00400764|20995183|P3|Phase II|Withdrawal by Subject|1
6081389|NCT00400764|20995184|P2|Phase II|Withdrawal by Subject|0
6081390|NCT00400764|20995185|P1|Phase II|Withdrawal by Subject|0
6081391|NCT00400764|20995181|P5|Phase II|Patient began new, non-protocol, therapy|0
6081392|NCT00400764|20995182|P4|Phase II|Patient began new, non-protocol, therapy|0
6081393|NCT00400764|20995183|P3|Phase II|Patient began new, non-protocol, therapy|1
6081394|NCT00400764|20995184|P2|Phase II|Patient began new, non-protocol, therapy|0
6081395|NCT00400764|20995185|P1|Phase II|Patient began new, non-protocol, therapy|0
6081396|NCT00400764|20995181|P5|Phase II|Sponsor's decision to terminate|11
6081397|NCT00400764|20995182|P4|Phase II|Sponsor's decision to terminate|22
6081398|NCT00400764|20995183|P3|Phase II|Sponsor's decision to terminate|18
6081399|NCT00400764|20995184|P2|Phase II|Sponsor's decision to terminate|0
6081400|NCT00400764|20995185|P1|Phase II|Sponsor's decision to terminate|0
6081401|NCT00400764|20995181|P5|Phase II|Physician Decision|0
6081402|NCT00400764|20995182|P4|Phase II|Physician Decision|1
6081403|NCT00400764|20995183|P3|Phase II|Physician Decision|1
6081404|NCT00400764|20995184|P2|Phase II|Physician Decision|0
6081405|NCT00400764|20995185|P1|Phase II|Physician Decision|0
6081406|NCT00400764|20995181|P5|Phase II|Lost to Follow-up|0
6081407|NCT00400764|20995182|P4|Phase II|Lost to Follow-up|0
6081408|NCT00400764|20995183|P3|Phase II|Lost to Follow-up|1
6081409|NCT00400764|20995184|P2|Phase II|Lost to Follow-up|0
6081410|NCT00400764|20995185|P1|Phase II|Lost to Follow-up|0
6081411|NCT00400764|20995181|P5|Phase II|Death|0
6081412|NCT00400764|20995182|P4|Phase II|Death|2
6081413|NCT00400764|20995183|P3|Phase II|Death|1
6081414|NCT00400764|20995184|P2|Phase II|Death|0
6081415|NCT00400764|20995185|P1|Phase II|Death|0
6081416|NCT00400764|20995181|P5|Phase Ib|Disease Progression|0
6081417|NCT00400764|20995182|P4|Phase Ib|Disease Progression|0
6081418|NCT00400764|20995183|P3|Phase Ib|Disease Progression|0
6081419|NCT00400764|20995184|P2|Phase Ib|Disease Progression|4
6081420|NCT00400764|20995185|P1|Phase Ib|Disease Progression|4
6081421|NCT00400764|20995181|P5|Phase Ib|Death|0
6081422|NCT00400764|20995182|P4|Phase Ib|Death|0
6081423|NCT00400764|20995183|P3|Phase Ib|Death|0
6081424|NCT00400764|20995184|P2|Phase Ib|Death|0
6081425|NCT00400764|20995185|P1|Phase Ib|Death|1
6081426|NCT00400764|20995181|P5|Phase Ib|Adverse Event|0
6081427|NCT00400764|20995182|P4|Phase Ib|Adverse Event|0
6081428|NCT00400764|20995183|P3|Phase Ib|Adverse Event|0
6081429|NCT00400764|20995184|P2|Phase Ib|Adverse Event|0
6081430|NCT00400764|20995185|P1|Phase Ib|Adverse Event|1
6081431|NCT00400712|20995238|P2|Overall Study|Physician Decision|4
6081432|NCT00400712|20995239|P1|Overall Study|Physician Decision|5
6081433|NCT00400712|20995238|P2|Overall Study|Withdrawal by Subject|12
6081434|NCT00400712|20995239|P1|Overall Study|Withdrawal by Subject|11
6081435|NCT00400712|20995238|P2|Overall Study|Death|0
6081436|NCT00400712|20995239|P1|Overall Study|Death|1
6081437|NCT00400569|20995274|P1|Overall Study|Death|1
6081438|NCT00400517|20995285|P1|Overall Study|Physician Decision|1
6081439|NCT00400517|20995285|P1|Overall Study|Withdrawal by Subject|1
6081440|NCT00400400|20995305|P2|Overall Study|Did not receive study drug|3
6081441|NCT00400400|20995306|P1|Overall Study|Did not receive study drug|1
6081442|NCT00400400|20995305|P2|Overall Study|Lost to Follow-up|1
6081443|NCT00400400|20995306|P1|Overall Study|Lost to Follow-up|0
6081444|NCT00400400|20995305|P2|Overall Study|Administrative Problem|0
6081445|NCT00400400|20995306|P1|Overall Study|Administrative Problem|1
6081446|NCT00400400|20995305|P2|Overall Study|Withdrawal by Subject|3
6081447|NCT00400400|20995306|P1|Overall Study|Withdrawal by Subject|1
6081448|NCT00400400|20995305|P2|Overall Study|Protocol Violation|0
6081449|NCT00400400|20995306|P1|Overall Study|Protocol Violation|2
6081450|NCT00400400|20995305|P2|Overall Study|Adverse Event|8
6081451|NCT00400400|20995306|P1|Overall Study|Adverse Event|9
6081452|NCT00400179|20995331|P2|Overall Study|Randomization error/patient ineligible|6
6081453|NCT00400179|20995332|P1|Overall Study|Randomization error/patient ineligible|1
6081454|NCT00400179|20995331|P2|Overall Study|Investigator judgment|1
6081455|NCT00400179|20995332|P1|Overall Study|Investigator judgment|0
6081456|NCT00400179|20995331|P2|Overall Study|Intercurrent illness|1
6081457|NCT00400179|20995332|P1|Overall Study|Intercurrent illness|0
6081458|NCT00400179|20995331|P2|Overall Study|Disease progression|1
6081459|NCT00400179|20995332|P1|Overall Study|Disease progression|1
6081460|NCT00400179|20995331|P2|Overall Study|Withdrew Consent|5
6081461|NCT00400179|20995332|P1|Overall Study|Withdrew Consent|1
6081462|NCT00400179|20995331|P2|Overall Study|Death|2
6081463|NCT00400179|20995332|P1|Overall Study|Death|1
6081464|NCT00400179|20995331|P2|Overall Study|Adverse Event|2
6081465|NCT00400179|20995332|P1|Overall Study|Adverse Event|2
6081466|NCT00400153|20995349|P3|Overall Study|Other reasons - not mentioned above|3
6081467|NCT00400153|20995350|P2|Overall Study|Other reasons - not mentioned above|5
6081468|NCT00400153|20995351|P1|Overall Study|Other reasons - not mentioned above|8
6081469|NCT00400153|20995349|P3|Overall Study|Withdrawal by Subject|10
6081470|NCT00400153|20995350|P2|Overall Study|Withdrawal by Subject|11
6081471|NCT00400153|20995351|P1|Overall Study|Withdrawal by Subject|12
6081472|NCT00400153|20995349|P3|Overall Study|Lost to Follow-up|4
6081473|NCT00400153|20995350|P2|Overall Study|Lost to Follow-up|1
6081474|NCT00400153|20995351|P1|Overall Study|Lost to Follow-up|2
6081475|NCT00400153|20995349|P3|Overall Study|Protocol Violation|9
6081476|NCT00400153|20995350|P2|Overall Study|Protocol Violation|4
6081477|NCT00400153|20995351|P1|Overall Study|Protocol Violation|7
6081478|NCT00400153|20995349|P3|Overall Study|AE due to other condition|15
6081479|NCT00400153|20995350|P2|Overall Study|AE due to other condition|14
6081480|NCT00400153|20995351|P1|Overall Study|AE due to other condition|3
6081481|NCT00400153|20995349|P3|Overall Study|AE due to other disease worsening|0
6081482|NCT00400153|20995350|P2|Overall Study|AE due to other disease worsening|1
6081483|NCT00400153|20995351|P1|Overall Study|AE due to other disease worsening|2
6081484|NCT00400153|20995349|P3|Overall Study|AE due to study disease worsening|20
6081485|NCT00400153|20995350|P2|Overall Study|AE due to study disease worsening|19
6081486|NCT00400153|20995351|P1|Overall Study|AE due to study disease worsening|14
6081487|NCT00399893|20995598|P2|Overall Study|Withdrawal by Subject|0
6081488|NCT00399893|20995599|P1|Overall Study|Withdrawal by Subject|1
6081489|NCT00399802|20995645|P2|Overall Study|Participant discontinued by mistake|1
6081490|NCT00399802|20995646|P1|Overall Study|Participant discontinued by mistake|0
6081491|NCT00399802|20995645|P2|Overall Study|Adverse Event|2
6081492|NCT00399802|20995646|P1|Overall Study|Adverse Event|0
6081493|NCT00399763|20995660|P2|Overall Study|Lost to Follow-up|3
6081494|NCT00399763|20995661|P1|Overall Study|Lost to Follow-up|2
6081495|NCT00399568|20995673|P2|Overall Study|Lost to Follow-up|2
6081496|NCT00399568|20995674|P1|Overall Study|Lost to Follow-up|2
6081497|NCT00399568|20995673|P2|Overall Study|Protocol non-compliance|2
6081498|NCT00399568|20995674|P1|Overall Study|Protocol non-compliance|2
6081499|NCT00399568|20995673|P2|Overall Study|Withdrawal by Subject|3
6081500|NCT00399568|20995674|P1|Overall Study|Withdrawal by Subject|7
6081501|NCT00399568|20995673|P2|Overall Study|Adverse Event|2
6081502|NCT00399568|20995674|P1|Overall Study|Adverse Event|1
6081503|NCT00399542|20995688|P2|Overall Study|Physician Decision|1
6081504|NCT00399542|20995689|P1|Overall Study|Physician Decision|0
6081505|NCT00399542|20995688|P2|Overall Study|Other|0
6081506|NCT00399542|20995689|P1|Overall Study|Other|1
6081507|NCT00399542|20995688|P2|Overall Study|Lost to Follow-up|6
6081508|NCT00399542|20995689|P1|Overall Study|Lost to Follow-up|6
6081509|NCT00399542|20995688|P2|Overall Study|Lack of Efficacy|8
6081510|NCT00399542|20995689|P1|Overall Study|Lack of Efficacy|18
6081511|NCT00399542|20995688|P2|Overall Study|Withdrawal by Subject|10
6081512|NCT00399542|20995689|P1|Overall Study|Withdrawal by Subject|28
6081513|NCT00399542|20995688|P2|Overall Study|Protocol Violation|3
6081514|NCT00399542|20995689|P1|Overall Study|Protocol Violation|13
6081515|NCT00399542|20995688|P2|Overall Study|Adverse Event|15
6081516|NCT00399542|20995689|P1|Overall Study|Adverse Event|18
6081517|NCT00399529|20995751|P1|Overall Study|Off Study Prior to Treatment|2
6081518|NCT00399516|20995757|P1|Overall Study|Lost to Follow-up|2
6081519|NCT00399360|20995765|P4|Overall Study|Withdrawal by Subject|2
6081520|NCT00399360|20995766|P3|Overall Study|Withdrawal by Subject|0
6081521|NCT00399360|20995767|P2|Overall Study|Withdrawal by Subject|2
6081522|NCT00399360|20995768|P1|Overall Study|Withdrawal by Subject|0
6081523|NCT00399360|20995765|P4|Overall Study|Adverse Event|0
6081524|NCT00399360|20995766|P3|Overall Study|Adverse Event|1
6081525|NCT00399360|20995767|P2|Overall Study|Adverse Event|0
6081526|NCT00399360|20995768|P1|Overall Study|Adverse Event|0
6081527|NCT00399360|20995765|P4|Overall Study|Lost to Follow-up|4
6081528|NCT00399360|20995766|P3|Overall Study|Lost to Follow-up|2
6081529|NCT00399360|20995767|P2|Overall Study|Lost to Follow-up|1
6081530|NCT00399360|20995768|P1|Overall Study|Lost to Follow-up|2
6081531|NCT00399035|20995839|P3|Overall Study|Severe non-compliance with protocol|0
6081532|NCT00399035|20995840|P2|Overall Study|Severe non-compliance with protocol|1
6081533|NCT00399035|20995841|P1|Overall Study|Severe non-compliance with protocol|2
6081534|NCT00399035|20995839|P3|Overall Study|Incorrect enrolment/eligib not fulfilled|1
6081535|NCT00399035|20995840|P2|Overall Study|Incorrect enrolment/eligib not fulfilled|0
6081536|NCT00399035|20995841|P1|Overall Study|Incorrect enrolment/eligib not fulfilled|1
6081537|NCT00399035|20995839|P3|Overall Study|Withdrawal by Subject|12
6081538|NCT00399035|20995840|P2|Overall Study|Withdrawal by Subject|15
6081539|NCT00399035|20995841|P1|Overall Study|Withdrawal by Subject|19
6081540|NCT00399035|20995839|P3|Overall Study|Lost to Follow-up|5
6081541|NCT00399035|20995840|P2|Overall Study|Lost to Follow-up|1
6081542|NCT00399035|20995841|P1|Overall Study|Lost to Follow-up|2
6081543|NCT00399035|20995839|P3|Overall Study|Death|234
6081544|NCT00399035|20995840|P2|Overall Study|Death|141
6081545|NCT00399035|20995841|P1|Overall Study|Death|289
6081546|NCT00398866|20995877|P3|Overall Study|Unable to complete requirements of study|1
6081547|NCT00398866|20995878|P2|Overall Study|Unable to complete requirements of study|1
6081548|NCT00398866|20995879|P1|Overall Study|Unable to complete requirements of study|1
6081549|NCT00398866|20995877|P3|Overall Study|Withdrawal by Subject|2
6081550|NCT00398866|20995878|P2|Overall Study|Withdrawal by Subject|1
6081551|NCT00398866|20995879|P1|Overall Study|Withdrawal by Subject|5
6081552|NCT00398866|20995877|P3|Overall Study|Lost to Follow-up|4
6081553|NCT00398866|20995878|P2|Overall Study|Lost to Follow-up|6
6081554|NCT00398866|20995879|P1|Overall Study|Lost to Follow-up|7
6081555|NCT00398866|20995877|P3|Overall Study|Lack of Efficacy|1
6081556|NCT00398866|20995878|P2|Overall Study|Lack of Efficacy|0
6081557|NCT00398866|20995879|P1|Overall Study|Lack of Efficacy|0
6081558|NCT00398866|20995877|P3|Overall Study|Adverse Event|0
6081559|NCT00398866|20995878|P2|Overall Study|Adverse Event|0
6081560|NCT00398866|20995879|P1|Overall Study|Adverse Event|1
6081561|NCT00398632|20995890|P1|Overall Study|Lack of Efficacy|1
6081562|NCT00398632|20995890|P1|Overall Study|Withdrawal by Subject|1
6081563|NCT00398567|20995898|P3|Overall Study|Protocol Violation|1
6081564|NCT00398567|20995899|P2|Overall Study|Protocol Violation|0
6081565|NCT00398567|20995900|P1|Overall Study|Protocol Violation|0
6081566|NCT00398567|20995898|P3|Overall Study|Adverse Event|2
6081567|NCT00398567|20995899|P2|Overall Study|Adverse Event|0
6081568|NCT00398567|20995900|P1|Overall Study|Adverse Event|0
6081569|NCT00398567|20995898|P3|Overall Study|Withdrawal by Subject|4
6081570|NCT00398567|20995899|P2|Overall Study|Withdrawal by Subject|0
6081571|NCT00398567|20995900|P1|Overall Study|Withdrawal by Subject|1
6081572|NCT00398567|20995898|P3|Overall Study|Disease Progression|27
6081573|NCT00398567|20995899|P2|Overall Study|Disease Progression|4
6081574|NCT00398567|20995900|P1|Overall Study|Disease Progression|3
6081575|NCT00398411|20995954|P2|Overall Study|Death|1
6081576|NCT00398411|20995955|P1|Overall Study|Death|0
6081577|NCT00398320|20995978|P1|Overall Study|Physician Decision|1
6081578|NCT00398320|20995978|P1|Overall Study|Adverse Event|4
6081579|NCT00398320|20995978|P1|Overall Study|Death|1
6081580|NCT00398216|20995991|P5|Overall Study|entrance criteria|2
6081581|NCT00398216|20995992|P4|Overall Study|entrance criteria|0
6081582|NCT00398216|20995993|P3|Overall Study|entrance criteria|0
6081583|NCT00398216|20995994|P2|Overall Study|entrance criteria|0
6081584|NCT00398216|20995995|P1|Overall Study|entrance criteria|0
6081585|NCT00398216|20995991|P5|Overall Study|administrative reasons|3
6081586|NCT00398216|20995992|P4|Overall Study|administrative reasons|3
6081587|NCT00398216|20995993|P3|Overall Study|administrative reasons|4
6081588|NCT00398216|20995994|P2|Overall Study|administrative reasons|4
6081589|NCT00398216|20995995|P1|Overall Study|administrative reasons|3
6081590|NCT00398216|20995991|P5|Overall Study|Withdrawal by Subject|2
6081591|NCT00398216|20995992|P4|Overall Study|Withdrawal by Subject|1
6081592|NCT00398216|20995993|P3|Overall Study|Withdrawal by Subject|3
6081593|NCT00398216|20995994|P2|Overall Study|Withdrawal by Subject|0
6081594|NCT00398216|20995995|P1|Overall Study|Withdrawal by Subject|1
6081595|NCT00398216|20995991|P5|Overall Study|Death|0
6081596|NCT00398216|20995992|P4|Overall Study|Death|0
6081597|NCT00398216|20995993|P3|Overall Study|Death|0
6081598|NCT00398216|20995994|P2|Overall Study|Death|3
6081599|NCT00398216|20995995|P1|Overall Study|Death|0
6081600|NCT00398216|20995991|P5|Overall Study|Lost to Follow-up|1
6081601|NCT00398216|20995992|P4|Overall Study|Lost to Follow-up|4
6081602|NCT00398216|20995993|P3|Overall Study|Lost to Follow-up|4
6081603|NCT00398216|20995994|P2|Overall Study|Lost to Follow-up|6
6081604|NCT00398216|20995995|P1|Overall Study|Lost to Follow-up|1
6081605|NCT00398216|20995991|P5|Overall Study|Protocol Violation|5
6081606|NCT00398216|20995992|P4|Overall Study|Protocol Violation|7
6081607|NCT00398216|20995993|P3|Overall Study|Protocol Violation|5
6081608|NCT00398216|20995994|P2|Overall Study|Protocol Violation|4
6081609|NCT00398216|20995995|P1|Overall Study|Protocol Violation|2
6081610|NCT00398216|20995991|P5|Overall Study|Adverse Event|2
6081611|NCT00398216|20995992|P4|Overall Study|Adverse Event|7
6081612|NCT00398216|20995993|P3|Overall Study|Adverse Event|5
6081613|NCT00398216|20995994|P2|Overall Study|Adverse Event|2
6081614|NCT00398216|20995995|P1|Overall Study|Adverse Event|4
6081615|NCT00398138|20996022|P1|Overall Study|Adverse Event|2
6081616|NCT00398112|20996027|P1|Overall Study|Death|1
6081617|NCT00398112|20996027|P1|Overall Study|Withdrawal by Subject|3
6081618|NCT00398112|20996027|P1|Overall Study|Alternative treatment|1
6081619|NCT00398112|20996027|P1|Overall Study|Disease progression|9
6081620|NCT00398112|20996027|P1|Overall Study|Adverse Event|4
6081621|NCT00398086|20996038|P3|Overall Study|Withdrawal by Subject|0
6081622|NCT00398086|20996039|P2|Overall Study|Withdrawal by Subject|7
6081623|NCT00398086|20996040|P1|Overall Study|Withdrawal by Subject|5
6081624|NCT00398086|20996038|P3|Overall Study|Physician Decision|0
6081625|NCT00398086|20996039|P2|Overall Study|Physician Decision|4
6081626|NCT00398086|20996040|P1|Overall Study|Physician Decision|1
6081627|NCT00398086|20996038|P3|Overall Study|Adverse Event|0
6081628|NCT00398086|20996039|P2|Overall Study|Adverse Event|4
6081629|NCT00398086|20996040|P1|Overall Study|Adverse Event|1
6081630|NCT00398086|20996038|P3|Overall Study|Unacceptable Toxicity|2
6081631|NCT00398086|20996039|P2|Overall Study|Unacceptable Toxicity|8
6081632|NCT00398086|20996040|P1|Overall Study|Unacceptable Toxicity|2
6081633|NCT00398073|20996074|P2|Overall Study|Withdrawal by Subject|0
6081634|NCT00398073|20996075|P1|Overall Study|Withdrawal by Subject|1
6081635|NCT00398047|20996085|P1|Overall Study|all patient progressed before completion|3
6081636|NCT00397982|20996095|P1|Overall Study|Unrelated health issues|1
6081637|NCT00397982|20996095|P1|Overall Study|noncompliance|1
6081638|NCT00397982|20996095|P1|Overall Study|Adverse Event|1
6081639|NCT00397982|20996095|P1|Overall Study|Withdrawal by Subject|1
6081640|NCT00397943|20996109|P5|Overall Study|Unspecified reasons|0
6081641|NCT00397943|20996110|P4|Overall Study|Unspecified reasons|0
6081642|NCT00397943|20996111|P3|Overall Study|Unspecified reasons|0
6081643|NCT00397943|20996112|P2|Overall Study|Unspecified reasons|9
6081644|NCT00397943|20996113|P1|Overall Study|Unspecified reasons|12
6081645|NCT00397930|20996269|P2|Overall Study|Missing data|4
6081646|NCT00397930|20996270|P1|Overall Study|Missing data|0
6081647|NCT00397930|20996269|P2|Overall Study|Withdrawal by Subject|8
6081648|NCT00397930|20996270|P1|Overall Study|Withdrawal by Subject|0
6081649|NCT00397930|20996269|P2|Overall Study|Did not want to be in control group|1
6081650|NCT00397930|20996270|P1|Overall Study|Did not want to be in control group|0
6081651|NCT00397930|20996269|P2|Overall Study|Started own yoga program|1
6081652|NCT00397930|20996270|P1|Overall Study|Started own yoga program|1
6081653|NCT00397930|20996269|P2|Overall Study|Too time-consuming|9
6081654|NCT00397930|20996270|P1|Overall Study|Too time-consuming|2
6081655|NCT00397930|20996269|P2|Overall Study|Noncompliant|2
6081656|NCT00397930|20996270|P1|Overall Study|Noncompliant|3
6081657|NCT00397930|20996269|P2|Overall Study|Unknown reasons|14
6081658|NCT00397930|20996270|P1|Overall Study|Unknown reasons|9
6081659|NCT00397930|20996269|P2|Overall Study|Other medical|4
6081660|NCT00397930|20996270|P1|Overall Study|Other medical|9
6081661|NCT00397930|20996269|P2|Overall Study|Personal reasons|8
6081662|NCT00397930|20996270|P1|Overall Study|Personal reasons|14
6081663|NCT00397891|20996285|P5|Overall Study|Withdrawal by Subject|1
6081664|NCT00397891|20996286|P4|Overall Study|Withdrawal by Subject|0
6081665|NCT00397891|20996287|P3|Overall Study|Withdrawal by Subject|0
6081666|NCT00397891|20996288|P2|Overall Study|Withdrawal by Subject|0
6081667|NCT00397891|20996289|P1|Overall Study|Withdrawal by Subject|1
6081668|NCT00397631|20996462|P2|Overall Study|protocol discontinuation criteria|4
6081669|NCT00397631|20996463|P1|Overall Study|protocol discontinuation criteria|1
6081670|NCT00397631|20996462|P2|Overall Study|Withdrawal by Subject|14
6081671|NCT00397631|20996463|P1|Overall Study|Withdrawal by Subject|7
6081672|NCT00397631|20996462|P2|Overall Study|Protocol Violation|1
6081673|NCT00397631|20996463|P1|Overall Study|Protocol Violation|0
6081674|NCT00397631|20996462|P2|Overall Study|Physician Decision|0
6081675|NCT00397631|20996463|P1|Overall Study|Physician Decision|2
6081676|NCT00397631|20996462|P2|Overall Study|Lost to Follow-up|9
6081677|NCT00397631|20996463|P1|Overall Study|Lost to Follow-up|8
6081678|NCT00397631|20996462|P2|Overall Study|Lack of Efficacy|10
6081679|NCT00397631|20996463|P1|Overall Study|Lack of Efficacy|7
6081680|NCT00397631|20996462|P2|Overall Study|Adverse Event|6
6081681|NCT00397631|20996463|P1|Overall Study|Adverse Event|5
6081682|NCT00397540|20996479|P2|Overall Study|short follow-up duration < 12 months|0
6081683|NCT00397540|20996480|P1|Overall Study|short follow-up duration < 12 months|1
6081684|NCT00397514|20996488|P1|Overall Study|poor echocardiographic windows|1
6081685|NCT00397514|20996488|P1|Overall Study|early extubation|2
6081686|NCT00397514|20996488|P1|Overall Study|Not able to capture & pace LV intraoper.|4
6081687|NCT00397514|20996488|P1|Overall Study|Pacing wire malfunction|1
6081688|NCT00397514|20996488|P1|Overall Study|Withdrawal by Subject|1
6081689|NCT00397488|20996498|P1|Overall Study|Death|1
6081690|NCT00397488|20996498|P1|Overall Study|Adverse Event|3
6081691|NCT00397488|20996498|P1|Overall Study|Withdrawal by Subject|3
6081692|NCT00397254|20996518|P2|Overall Study|Lost to Follow-up|2
6081693|NCT00397254|20996519|P1|Overall Study|Lost to Follow-up|2
6081694|NCT00397215|20996541|P4|Month 6 (Day 180)|Other|0
6081695|NCT00397215|20996542|P3|Month 6 (Day 180)|Other|3
6081696|NCT00397215|20996543|P2|Month 6 (Day 180)|Other|0
6081697|NCT00397215|20996544|P1|Month 6 (Day 180)|Other|2
6081698|NCT00397215|20996541|P4|Month 6 (Day 180)|Adverse Event|0
6081699|NCT00397215|20996542|P3|Month 6 (Day 180)|Adverse Event|2
6081700|NCT00397215|20996543|P2|Month 6 (Day 180)|Adverse Event|3
6081701|NCT00397215|20996544|P1|Month 6 (Day 180)|Adverse Event|0
6081702|NCT00397215|20996541|P4|Month 0 (Day 0)|Other|3
6081703|NCT00397215|20996542|P3|Month 0 (Day 0)|Other|3
6081704|NCT00397215|20996543|P2|Month 0 (Day 0)|Other|1
6081705|NCT00397215|20996544|P1|Month 0 (Day 0)|Other|4
6081706|NCT00397215|20996541|P4|Month 0 (Day 0)|Withdrawal by Subject|1
6081707|NCT00397215|20996542|P3|Month 0 (Day 0)|Withdrawal by Subject|3
6081708|NCT00397215|20996543|P2|Month 0 (Day 0)|Withdrawal by Subject|3
6081709|NCT00397215|20996544|P1|Month 0 (Day 0)|Withdrawal by Subject|3
6081710|NCT00397215|20996541|P4|Month 0 (Day 0)|Adverse Event|0
6081711|NCT00397215|20996542|P3|Month 0 (Day 0)|Adverse Event|0
6081712|NCT00397215|20996543|P2|Month 0 (Day 0)|Adverse Event|1
6081713|NCT00397215|20996544|P1|Month 0 (Day 0)|Adverse Event|0
6081714|NCT00397189|20996680|P2|3 Weeks Period|Other|2
6081715|NCT00397189|20996681|P1|3 Weeks Period|Other|0
6081716|NCT00397189|20996680|P2|3 Weeks Period|Protocol Violation|3
6081717|NCT00397189|20996681|P1|3 Weeks Period|Protocol Violation|0
6081718|NCT00397189|20996680|P2|3 Weeks Period|Physician Decision|2
6081719|NCT00397189|20996681|P1|3 Weeks Period|Physician Decision|0
6081720|NCT00397189|20996680|P2|3 Weeks Period|Withdrawal by Subject|9
6081721|NCT00397189|20996681|P1|3 Weeks Period|Withdrawal by Subject|13
6081722|NCT00397189|20996680|P2|3 Weeks Period|Adverse Event|2
6081723|NCT00397189|20996681|P1|3 Weeks Period|Adverse Event|3
6081724|NCT00397189|20996680|P2|3 Weeks Period|Lost to Follow-up|4
6081725|NCT00397189|20996681|P1|3 Weeks Period|Lost to Follow-up|5
6081726|NCT00397046|20996708|P4|Overall Study|Disease Progression|5
6081727|NCT00397046|20996709|P3|Overall Study|Disease Progression|10
6081728|NCT00397046|20996710|P2|Overall Study|Disease Progression|3
6081729|NCT00397046|20996711|P1|Overall Study|Disease Progression|3
6081730|NCT00397033|20996733|P3|Overall Study|Other|2
6081731|NCT00397033|20996734|P2|Overall Study|Other|5
6081732|NCT00397033|20996735|P1|Overall Study|Other|0
6081733|NCT00397033|20996733|P3|Overall Study|Withdrawal by Subject|5
6081734|NCT00397033|20996734|P2|Overall Study|Withdrawal by Subject|7
6081735|NCT00397033|20996735|P1|Overall Study|Withdrawal by Subject|12
6081736|NCT00397033|20996733|P3|Overall Study|Lost to Follow-up|3
6081737|NCT00397033|20996734|P2|Overall Study|Lost to Follow-up|3
6081738|NCT00397033|20996735|P1|Overall Study|Lost to Follow-up|3
6081739|NCT00397033|20996733|P3|Overall Study|Lack of Efficacy|9
6081740|NCT00397033|20996734|P2|Overall Study|Lack of Efficacy|12
6081741|NCT00397033|20996735|P1|Overall Study|Lack of Efficacy|22
6081742|NCT00397033|20996733|P3|Overall Study|Adverse Event|4
6081743|NCT00397033|20996734|P2|Overall Study|Adverse Event|10
6081744|NCT00397033|20996735|P1|Overall Study|Adverse Event|7
6081745|NCT00396877|20996826|P2|Overall Study|Parent(s)/guardian(s)'s request|7
6081746|NCT00396877|20996827|P1|Overall Study|Parent(s)/guardian(s)'s request|4
6081747|NCT00396877|20996826|P2|Overall Study|Lost to Follow-up|1
6081748|NCT00396877|20996827|P1|Overall Study|Lost to Follow-up|2
6081749|NCT00396812|20996837|P1|Overall Study|Physician Decision|1
6081750|NCT00396656|20996849|P2|Second Treatment Period|Adverse Event|1
6081751|NCT00396656|20996850|P1|Second Treatment Period|Adverse Event|0
6081752|NCT00396656|20996849|P2|First Treatment Period|Withdrawal by Subject|2
6081753|NCT00396656|20996850|P1|First Treatment Period|Withdrawal by Subject|0
6081754|NCT00396630|20996868|P2|Overall Study|Not vaccinated at Visit 3|3
6081755|NCT00396630|20996869|P1|Overall Study|Not vaccinated at Visit 3|3
6081756|NCT00396630|20996868|P2|Overall Study|Withdrawal by Subject|1
6081757|NCT00396630|20996869|P1|Overall Study|Withdrawal by Subject|1
6081758|NCT00396630|20996868|P2|Overall Study|Lost to Follow-up|1
6081759|NCT00396630|20996869|P1|Overall Study|Lost to Follow-up|1
6081760|NCT00396591|20996889|P1|Overall Study|Participant request|1
6081761|NCT00396591|20996889|P1|Overall Study|Adverse Event|2
6081762|NCT00396591|20996889|P1|Overall Study|Disease Progression|13
6081763|NCT00396565|20996902|P3|Overall Study|Lack of Efficacy|11
6081764|NCT00396565|20996903|P2|Overall Study|Lack of Efficacy|64
6081765|NCT00396565|20996904|P1|Overall Study|Lack of Efficacy|32
6081766|NCT00396565|20996902|P3|Overall Study|Withdrawal by Subject|1
6081767|NCT00396565|20996903|P2|Overall Study|Withdrawal by Subject|13
6081768|NCT00396565|20996904|P1|Overall Study|Withdrawal by Subject|8
6081769|NCT00396565|20996902|P3|Overall Study|Adverse Event|3
6081770|NCT00396565|20996903|P2|Overall Study|Adverse Event|13
6081771|NCT00396565|20996904|P1|Overall Study|Adverse Event|5
6081772|NCT00396565|20996902|P3|Overall Study|Physician Decision|2
6081773|NCT00396565|20996903|P2|Overall Study|Physician Decision|1
6081774|NCT00396565|20996904|P1|Overall Study|Physician Decision|3
6081775|NCT00396409|20996929|P2|Period 2 - 2008|Lost to Follow-up|1
6081776|NCT00396409|20996930|P1|Period 2 - 2008|Lost to Follow-up|3
6081777|NCT00396409|20996929|P2|Period 2 - 2008|Withdrawal by Subject|1
6081778|NCT00396409|20996930|P1|Period 2 - 2008|Withdrawal by Subject|3
6081779|NCT00396409|20996929|P2|Period 2 - 2008|Protocol Violation|0
6081780|NCT00396409|20996930|P1|Period 2 - 2008|Protocol Violation|1
6081781|NCT00396409|20996929|P2|Between Period 1 and Period 2|Withdrawal by Subject|2
6081782|NCT00396409|20996930|P1|Between Period 1 and Period 2|Withdrawal by Subject|3
6081783|NCT00396409|20996929|P2|Period 1 - 2007|Lost to Follow-up|3
6081784|NCT00396409|20996930|P1|Period 1 - 2007|Lost to Follow-up|2
6081785|NCT00396409|20996929|P2|Period 1 - 2007|Withdrawal by Subject|1
6081786|NCT00396409|20996930|P1|Period 1 - 2007|Withdrawal by Subject|1
6081787|NCT00396409|20996929|P2|Period 1 - 2007|Lack of Efficacy|1
6081788|NCT00396409|20996930|P1|Period 1 - 2007|Lack of Efficacy|0
6081789|NCT00396409|20996929|P2|Period 1 - 2007|Adverse Event|1
6081790|NCT00396409|20996930|P1|Period 1 - 2007|Adverse Event|0
6081791|NCT00396383|20996960|P1|Overall Study|Lost to Follow-up|1
6081792|NCT00396383|20996960|P1|Overall Study|Death|2
6081793|NCT00396331|20996973|P1|Overall Study|Death|16
6081794|NCT00396331|20996973|P1|Overall Study|Lost to Follow-up|3
6081795|NCT00396331|20996973|P1|Overall Study|Did not go on to transplant|5
6081796|NCT00396331|20996973|P1|Overall Study|Failed to mobilize - no transplant|8
6081797|NCT00396318|20997026|P1|At Least One Dose of Tenecteplase (MITT)|Subject withdrew consent|5
6081798|NCT00396279|20997046|P1|Overall Study|Physician Decision|1
6081799|NCT00396279|20997046|P1|Overall Study|Withdrawal by Subject|1
6081800|NCT00396279|20997046|P1|Overall Study|Disease progression|2
6081801|NCT00396279|20997046|P1|Overall Study|Ongoing in study|26
6081802|NCT00396253|20997079|P1|Overall Study|Change in eligibility status|1
6081803|NCT00396253|20997079|P1|Overall Study|Physician Decision|1
6081804|NCT00396253|20997079|P1|Overall Study|Death|3
6081805|NCT00396253|20997079|P1|Overall Study|Withdrawal by Subject|7
6081806|NCT00396253|20997079|P1|Overall Study|Protocol Violation|1
6081807|NCT00396162|20997110|P2|Overall Study|Withdrawal by Subject|3
6081808|NCT00396162|20997111|P1|Overall Study|Withdrawal by Subject|2
6081809|NCT00396136|20997123|P1|Overall Study|Study device explanted|8
6081810|NCT00396136|20997123|P1|Overall Study|Lost to Follow-up|15
6081811|NCT00396136|20997123|P1|Overall Study|Withdrawal by Subject|59
6081812|NCT00396136|20997123|P1|Overall Study|Death|43
6081813|NCT00396097|20997130|P2|Overall Study|Insufficient Clinical Response|4
6081814|NCT00396097|20997131|P1|Overall Study|Insufficient Clinical Response|1
6081815|NCT00396097|20997130|P2|Overall Study|Adverse Event|5
6081816|NCT00396097|20997131|P1|Overall Study|Adverse Event|1
6081817|NCT00396097|20997130|P2|Overall Study|Protocol Violation|6
6081818|NCT00396097|20997131|P1|Overall Study|Protocol Violation|0
6081819|NCT00396097|20997130|P2|Overall Study|Other|5
6081820|NCT00396097|20997131|P1|Overall Study|Other|3
6081821|NCT00396097|20997130|P2|Overall Study|Lost to Follow-up|9
6081822|NCT00396097|20997131|P1|Overall Study|Lost to Follow-up|4
6081823|NCT00396097|20997130|P2|Overall Study|Withdrawal by Subject|17
6081824|NCT00396097|20997131|P1|Overall Study|Withdrawal by Subject|17
6081825|NCT00396084|20997159|P6|Overall Study|Withdrawal by Subject|0
6081826|NCT00396084|20997160|P5|Overall Study|Withdrawal by Subject|0
6081827|NCT00396084|20997161|P4|Overall Study|Withdrawal by Subject|1
6081828|NCT00396084|20997162|P3|Overall Study|Withdrawal by Subject|0
6081829|NCT00396084|20997163|P2|Overall Study|Withdrawal by Subject|0
6081830|NCT00396084|20997164|P1|Overall Study|Withdrawal by Subject|0
6081831|NCT00396084|20997159|P6|Overall Study|Adverse Event|2
6081832|NCT00396084|20997160|P5|Overall Study|Adverse Event|1
6081833|NCT00396084|20997161|P4|Overall Study|Adverse Event|0
6081834|NCT00396084|20997162|P3|Overall Study|Adverse Event|0
6081835|NCT00396084|20997163|P2|Overall Study|Adverse Event|0
6081836|NCT00396084|20997164|P1|Overall Study|Adverse Event|0
6081837|NCT00395967|20997293|P1|Follow-up Period|Lost to Follow-up|1
6081838|NCT00395967|20997293|P1|Follow-up Period|Death|1
6081839|NCT00395967|20997293|P1|Treatment Period|Failed Mobilization|1
6081840|NCT00395863|20997333|P2|Overall Study|Patients did not complete both exams|3
6081841|NCT00395863|20997334|P1|Overall Study|Patients did not complete both exams|2
6081842|NCT00395850|20997369|P4|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0
6081843|NCT00395850|20997370|P3|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0
6081844|NCT00395850|20997371|P2|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0
6081845|NCT00395850|20997372|P1|Randomization to Disulfiram/ Pre-admin|work schedule conflict|1
6081846|NCT00395850|20997369|P4|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0
6081847|NCT00395850|20997370|P3|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0
6081848|NCT00395850|20997371|P2|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0
6081849|NCT00395850|20997372|P1|Randomization to Disulfiram/ Pre-admin|suicidal ideation|1
6081850|NCT00395850|20997369|P4|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0
6081851|NCT00395850|20997370|P3|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0
6081852|NCT00395850|20997371|P2|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0
6081853|NCT00395850|20997372|P1|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|1
6081854|NCT00395850|20997369|P4|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|4
6081855|NCT00395850|20997370|P3|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|6
6081856|NCT00395850|20997371|P2|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2
6081857|NCT00395850|20997372|P1|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2
6081858|NCT00395850|20997369|P4|Pre-randomization Baseline/Induction|Inconsistent attendance|0
6081859|NCT00395850|20997370|P3|Pre-randomization Baseline/Induction|Inconsistent attendance|0
6081860|NCT00395850|20997371|P2|Pre-randomization Baseline/Induction|Inconsistent attendance|0
6081861|NCT00395850|20997372|P1|Pre-randomization Baseline/Induction|Inconsistent attendance|1
6081862|NCT00395850|20997369|P4|Pre-randomization Baseline/Induction|Withdrawal by Subject|0
6081863|NCT00395850|20997370|P3|Pre-randomization Baseline/Induction|Withdrawal by Subject|0
6081864|NCT00395850|20997371|P2|Pre-randomization Baseline/Induction|Withdrawal by Subject|0
6081865|NCT00395850|20997372|P1|Pre-randomization Baseline/Induction|Withdrawal by Subject|4
6081866|NCT00395850|20997369|P4|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0
6081867|NCT00395850|20997370|P3|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0
6081868|NCT00395850|20997371|P2|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0
6081869|NCT00395850|20997372|P1|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|6
6081870|NCT00395746|20997389|P3|Overall Study|Unable to visit site on schedule|0
6081871|NCT00395746|20997390|P2|Overall Study|Unable to visit site on schedule|0
6081872|NCT00395746|20997391|P1|Overall Study|Unable to visit site on schedule|1
6081873|NCT00395746|20997389|P3|Overall Study|Difficultulty in use of device|1
6081874|NCT00395746|20997390|P2|Overall Study|Difficultulty in use of device|0
6081875|NCT00395746|20997391|P1|Overall Study|Difficultulty in use of device|0
6081876|NCT00395746|20997389|P3|Overall Study|Withdrawal of consent|1
6081877|NCT00395746|20997390|P2|Overall Study|Withdrawal of consent|0
6081878|NCT00395746|20997391|P1|Overall Study|Withdrawal of consent|0
6081879|NCT00395746|20997389|P3|Overall Study|Subject decision|1
6081880|NCT00395746|20997390|P2|Overall Study|Subject decision|0
6081881|NCT00395746|20997391|P1|Overall Study|Subject decision|0
6081882|NCT00395746|20997389|P3|Overall Study|Hypoglycaemia|0
6081883|NCT00395746|20997390|P2|Overall Study|Hypoglycaemia|1
6081884|NCT00395746|20997391|P1|Overall Study|Hypoglycaemia|2
6081885|NCT00395746|20997389|P3|Overall Study|Lack of Efficacy|17
6081886|NCT00395746|20997390|P2|Overall Study|Lack of Efficacy|0
6081887|NCT00395746|20997391|P1|Overall Study|Lack of Efficacy|2
6081888|NCT00395746|20997389|P3|Overall Study|Protocol Violation|0
6081889|NCT00395746|20997390|P2|Overall Study|Protocol Violation|1
6081890|NCT00395746|20997391|P1|Overall Study|Protocol Violation|0
6081891|NCT00395746|20997389|P3|Overall Study|Adverse Event|2
6081892|NCT00395746|20997390|P2|Overall Study|Adverse Event|2
6081893|NCT00395746|20997391|P1|Overall Study|Adverse Event|5
6081894|NCT00395733|20997437|P2|Period 2|Technical problems|0
6081895|NCT00395733|20997438|P1|Period 2|Technical problems|1
6081896|NCT00395733|20997437|P2|Period 2|Adverse Event|2
6081897|NCT00395733|20997438|P1|Period 2|Adverse Event|0
6081898|NCT00395733|20997437|P2|Period 2|Protocol Violation|1
6081899|NCT00395733|20997438|P1|Period 2|Protocol Violation|0
6081900|NCT00395733|20997437|P2|Period 2|Withdrawal by Subject|2
6081901|NCT00395733|20997438|P1|Period 2|Withdrawal by Subject|1
6081902|NCT00395694|20997462|P2|Continuation Phase|Withdrawal by Subject|2
6081903|NCT00395694|20997463|P1|Continuation Phase|Withdrawal by Subject|0
6081904|NCT00395694|20997462|P2|Continuation Phase|Poor Compliance|0
6081905|NCT00395694|20997463|P1|Continuation Phase|Poor Compliance|1
6081906|NCT00395694|20997462|P2|Continuation Phase|Withdrawal Due to Wishes of Family|0
6081907|NCT00395694|20997463|P1|Continuation Phase|Withdrawal Due to Wishes of Family|1
6081908|NCT00395694|20997462|P2|Continuation Phase|Lack of Efficacy|11
6081909|NCT00395694|20997463|P1|Continuation Phase|Lack of Efficacy|12
6081910|NCT00395694|20997462|P2|Continuation Phase|Adverse Event|0
6081911|NCT00395694|20997463|P1|Continuation Phase|Adverse Event|1
6081912|NCT00395694|20997462|P2|Escalation Phase + Maintenance Phase|Adverse Event|2
6081913|NCT00395694|20997463|P1|Escalation Phase + Maintenance Phase|Adverse Event|1
6081914|NCT00395642|20997494|P1|Overall Study|Withdrawal by Subject|1
6081915|NCT00395642|20997494|P1|Overall Study|Physician Decision|7
6081916|NCT00395642|20997494|P1|Overall Study|Lost to Follow-up|1
6081917|NCT00395642|20997494|P1|Overall Study|Death|4
6081918|NCT00395629|20997501|P3|Extension Study|Administrative problems|1
6081919|NCT00395629|20997502|P2|Extension Study|Administrative problems|0
6081920|NCT00395629|20997503|P1|Extension Study|Administrative problems|0
6081921|NCT00395629|20997501|P3|Extension Study|Adverse Event|2
6081922|NCT00395629|20997502|P2|Extension Study|Adverse Event|0
6081923|NCT00395629|20997503|P1|Extension Study|Adverse Event|0
6081924|NCT00395629|20997501|P3|Core Study|Lost to Follow-up|1
6081925|NCT00395629|20997502|P2|Core Study|Lost to Follow-up|0
6081926|NCT00395629|20997503|P1|Core Study|Lost to Follow-up|0
6081927|NCT00395629|20997501|P3|Core Study|Withdrawal by Subject|1
6081928|NCT00395629|20997502|P2|Core Study|Withdrawal by Subject|1
6081929|NCT00395629|20997503|P1|Core Study|Withdrawal by Subject|0
6081930|NCT00395629|20997501|P3|Core Study|Protocol Violation|0
6081931|NCT00395629|20997502|P2|Core Study|Protocol Violation|0
6081932|NCT00395629|20997503|P1|Core Study|Protocol Violation|1
6081933|NCT00395629|20997501|P3|Core Study|Abnormal laboratory value(s)|1
6081934|NCT00395629|20997502|P2|Core Study|Abnormal laboratory value(s)|0
6081935|NCT00395629|20997503|P1|Core Study|Abnormal laboratory value(s)|0
6081936|NCT00395629|20997501|P3|Core Study|Adverse Event|4
6081937|NCT00395629|20997502|P2|Core Study|Adverse Event|3
6081938|NCT00395629|20997503|P1|Core Study|Adverse Event|0
6081939|NCT00395538|20997520|P3|Overall Study|Participant elected to discontinue|1
6081940|NCT00395538|20997521|P2|Overall Study|Participant elected to discontinue|0
6081941|NCT00395538|20997522|P1|Overall Study|Participant elected to discontinue|0
6081942|NCT00395538|20997520|P3|Overall Study|Partial recovery of parathyroid function|1
6081943|NCT00395538|20997521|P2|Overall Study|Partial recovery of parathyroid function|0
6081944|NCT00395538|20997522|P1|Overall Study|Partial recovery of parathyroid function|0
6081945|NCT00395538|20997520|P3|Overall Study|Pregnancy|0
6081946|NCT00395538|20997521|P2|Overall Study|Pregnancy|0
6081947|NCT00395538|20997522|P1|Overall Study|Pregnancy|1
6081948|NCT00395538|20997520|P3|Overall Study|PTH resistance|1
6081949|NCT00395538|20997521|P2|Overall Study|PTH resistance|0
6081950|NCT00395538|20997522|P1|Overall Study|PTH resistance|0
6081951|NCT00395538|20997520|P3|Overall Study|Non-compliance with study protocol|0
6081952|NCT00395538|20997521|P2|Overall Study|Non-compliance with study protocol|1
6081953|NCT00395538|20997522|P1|Overall Study|Non-compliance with study protocol|0
6081954|NCT00395538|20997520|P3|Overall Study|DXA or QCT z-score or t-score<-2|0
6081955|NCT00395538|20997521|P2|Overall Study|DXA or QCT z-score or t-score<-2|2
6081956|NCT00395538|20997522|P1|Overall Study|DXA or QCT z-score or t-score<-2|0
6081957|NCT00395538|20997520|P3|Overall Study|Adverse Event|2
6081958|NCT00395538|20997521|P2|Overall Study|Adverse Event|0
6081959|NCT00395538|20997522|P1|Overall Study|Adverse Event|1
6081960|NCT00395538|20997520|P3|Overall Study|Switch to Natpara|3
6081961|NCT00395538|20997521|P2|Overall Study|Switch to Natpara|0
6081962|NCT00395538|20997522|P1|Overall Study|Switch to Natpara|0
6081963|NCT00395538|20997520|P3|Overall Study|Failed screening|4
6081964|NCT00395538|20997521|P2|Overall Study|Failed screening|0
6081965|NCT00395538|20997522|P1|Overall Study|Failed screening|0
6081966|NCT00395538|20997520|P3|Overall Study|FDA partial hold on PTH|11
6081967|NCT00395538|20997521|P2|Overall Study|FDA partial hold on PTH|0
6081968|NCT00395538|20997522|P1|Overall Study|FDA partial hold on PTH|0
6081969|NCT00395538|20997520|P3|Overall Study|Did not re-consent to revised protocol|0
6081970|NCT00395538|20997521|P2|Overall Study|Did not re-consent to revised protocol|10
6081971|NCT00395538|20997522|P1|Overall Study|Did not re-consent to revised protocol|1
6081972|NCT00395512|20997595|P4|Overall Study|Hyperglycemic Rescue|6
6081973|NCT00395512|20997596|P3|Overall Study|Hyperglycemic Rescue|4
6081974|NCT00395512|20997597|P2|Overall Study|Hyperglycemic Rescue|10
6081975|NCT00395512|20997598|P1|Overall Study|Hyperglycemic Rescue|18
6081976|NCT00395512|20997595|P4|Overall Study|Other|0
6081977|NCT00395512|20997596|P3|Overall Study|Other|0
6081978|NCT00395512|20997597|P2|Overall Study|Other|1
6081979|NCT00395512|20997598|P1|Overall Study|Other|1
6081980|NCT00395512|20997595|P4|Overall Study|Physician Decision|2
6081981|NCT00395512|20997596|P3|Overall Study|Physician Decision|2
6081982|NCT00395512|20997597|P2|Overall Study|Physician Decision|4
6081983|NCT00395512|20997598|P1|Overall Study|Physician Decision|6
6081984|NCT00395512|20997595|P4|Overall Study|Withdrawal by Subject|12
6081985|NCT00395512|20997596|P3|Overall Study|Withdrawal by Subject|5
6081986|NCT00395512|20997597|P2|Overall Study|Withdrawal by Subject|5
6081987|NCT00395512|20997598|P1|Overall Study|Withdrawal by Subject|6
6081988|NCT00395512|20997595|P4|Overall Study|Lost to Follow-up|5
6081989|NCT00395512|20997596|P3|Overall Study|Lost to Follow-up|5
6081990|NCT00395512|20997597|P2|Overall Study|Lost to Follow-up|6
6081991|NCT00395512|20997598|P1|Overall Study|Lost to Follow-up|2
6081992|NCT00395512|20997595|P4|Overall Study|Protocol Violation|7
6081993|NCT00395512|20997596|P3|Overall Study|Protocol Violation|6
6081994|NCT00395512|20997597|P2|Overall Study|Protocol Violation|3
6081995|NCT00395512|20997598|P1|Overall Study|Protocol Violation|2
6081996|NCT00395512|20997595|P4|Overall Study|Adverse Event|6
6081997|NCT00395512|20997596|P3|Overall Study|Adverse Event|6
6081998|NCT00395512|20997597|P2|Overall Study|Adverse Event|8
6081999|NCT00395512|20997598|P1|Overall Study|Adverse Event|3
6082000|NCT00395486|20997770|P2|Overall Study|Lost to Follow-up|1
6082001|NCT00395486|20997771|P1|Overall Study|Lost to Follow-up|0
6082002|NCT00395486|20997770|P2|Overall Study|Withdrawal by Subject|2
6082003|NCT00395486|20997771|P1|Overall Study|Withdrawal by Subject|5
6082004|NCT00395486|20997770|P2|Overall Study|Adverse Event|2
6082005|NCT00395486|20997771|P1|Overall Study|Adverse Event|1
6082006|NCT00395460|20997801|P2|Overall Study|Withdrawal by Subject|0
6082007|NCT00395460|20997802|P1|Overall Study|Withdrawal by Subject|1
6082008|NCT00395447|20997826|P2|Overall Study|Withdrawl - Other (not subject)|17
6082009|NCT00395447|20997827|P1|Overall Study|Withdrawl - Other (not subject)|8
6082010|NCT00395447|20997826|P2|Overall Study|Withdrawal by Subject|19
6082011|NCT00395447|20997827|P1|Overall Study|Withdrawal by Subject|24
6082012|NCT00395447|20997826|P2|Overall Study|Lost to Follow-up|43
6082013|NCT00395447|20997827|P1|Overall Study|Lost to Follow-up|52
6082014|NCT00395447|20997826|P2|Overall Study|Death|32
6082015|NCT00395447|20997827|P1|Overall Study|Death|37
6082016|NCT00395343|20997835|P2|Overall Study|Other|2
6082017|NCT00395343|20997836|P1|Overall Study|Other|5
6082018|NCT00395343|20997835|P2|Overall Study|Withdrawal by Subject|12
6082019|NCT00395343|20997836|P1|Overall Study|Withdrawal by Subject|11
6082020|NCT00395343|20997835|P2|Overall Study|Protocol Violation|8
6082021|NCT00395343|20997836|P1|Overall Study|Protocol Violation|6
6082022|NCT00395343|20997835|P2|Overall Study|Physician Decision|4
6082023|NCT00395343|20997836|P1|Overall Study|Physician Decision|2
6082024|NCT00395343|20997835|P2|Overall Study|Lost to Follow-up|4
6082025|NCT00395343|20997836|P1|Overall Study|Lost to Follow-up|4
6082026|NCT00395343|20997835|P2|Overall Study|Lack of Efficacy|1
6082027|NCT00395343|20997836|P1|Overall Study|Lack of Efficacy|0
6082028|NCT00395343|20997835|P2|Overall Study|Adverse Event|5
6082029|NCT00395343|20997836|P1|Overall Study|Adverse Event|13
6082030|NCT00395304|20997854|P6|Treatment Period 3|Other|0
6082031|NCT00395304|20997855|P5|Treatment Period 3|Other|0
6082032|NCT00395304|20997856|P4|Treatment Period 3|Other|1
6082033|NCT00395304|20997857|P3|Treatment Period 3|Other|0
6082034|NCT00395304|20997858|P2|Treatment Period 3|Other|0
6082035|NCT00395304|20997859|P1|Treatment Period 3|Other|0
6082036|NCT00395304|20997854|P6|Treatment Period 3|Physician Decision|0
6082037|NCT00395304|20997855|P5|Treatment Period 3|Physician Decision|0
6082038|NCT00395304|20997856|P4|Treatment Period 3|Physician Decision|0
6082039|NCT00395304|20997857|P3|Treatment Period 3|Physician Decision|0
6082040|NCT00395304|20997858|P2|Treatment Period 3|Physician Decision|1
6082041|NCT00395304|20997859|P1|Treatment Period 3|Physician Decision|0
6082042|NCT00395304|20997854|P6|Treatment Period 3|Lost to Follow-up|0
6082043|NCT00395304|20997855|P5|Treatment Period 3|Lost to Follow-up|0
6082044|NCT00395304|20997856|P4|Treatment Period 3|Lost to Follow-up|0
6082045|NCT00395304|20997857|P3|Treatment Period 3|Lost to Follow-up|0
6082046|NCT00395304|20997858|P2|Treatment Period 3|Lost to Follow-up|1
6082047|NCT00395304|20997859|P1|Treatment Period 3|Lost to Follow-up|1
6082048|NCT00395304|20997854|P6|Treatment Period 3|Withdrawal by Subject|1
6082049|NCT00395304|20997855|P5|Treatment Period 3|Withdrawal by Subject|0
6082050|NCT00395304|20997856|P4|Treatment Period 3|Withdrawal by Subject|1
6082051|NCT00395304|20997857|P3|Treatment Period 3|Withdrawal by Subject|0
6082052|NCT00395304|20997858|P2|Treatment Period 3|Withdrawal by Subject|0
6082053|NCT00395304|20997859|P1|Treatment Period 3|Withdrawal by Subject|0
6082054|NCT00395304|20997854|P6|Treatment Period 2|Other|0
6082055|NCT00395304|20997855|P5|Treatment Period 2|Other|0
6082056|NCT00395304|20997856|P4|Treatment Period 2|Other|0
6082057|NCT00395304|20997857|P3|Treatment Period 2|Other|0
6082058|NCT00395304|20997858|P2|Treatment Period 2|Other|1
6082059|NCT00395304|20997859|P1|Treatment Period 2|Other|0
6082060|NCT00395304|20997854|P6|Treatment Period 2|Physician Decision|0
6082061|NCT00395304|20997855|P5|Treatment Period 2|Physician Decision|0
6082062|NCT00395304|20997856|P4|Treatment Period 2|Physician Decision|0
6082063|NCT00395304|20997857|P3|Treatment Period 2|Physician Decision|1
6082064|NCT00395304|20997858|P2|Treatment Period 2|Physician Decision|0
6082065|NCT00395304|20997859|P1|Treatment Period 2|Physician Decision|0
6082066|NCT00395304|20997854|P6|Treatment Period 2|Lost to Follow-up|0
6082067|NCT00395304|20997855|P5|Treatment Period 2|Lost to Follow-up|0
6082068|NCT00395304|20997856|P4|Treatment Period 2|Lost to Follow-up|0
6082069|NCT00395304|20997857|P3|Treatment Period 2|Lost to Follow-up|0
6082070|NCT00395304|20997858|P2|Treatment Period 2|Lost to Follow-up|3
6082071|NCT00395304|20997859|P1|Treatment Period 2|Lost to Follow-up|0
6082072|NCT00395304|20997854|P6|Treatment Period 2|Withdrawal by Subject|2
6082073|NCT00395304|20997855|P5|Treatment Period 2|Withdrawal by Subject|0
6082074|NCT00395304|20997856|P4|Treatment Period 2|Withdrawal by Subject|1
6082075|NCT00395304|20997857|P3|Treatment Period 2|Withdrawal by Subject|0
6082076|NCT00395304|20997858|P2|Treatment Period 2|Withdrawal by Subject|0
6082077|NCT00395304|20997859|P1|Treatment Period 2|Withdrawal by Subject|0
6082078|NCT00395304|20997854|P6|Treatment Period 1|Physician Decision|0
6082079|NCT00395304|20997855|P5|Treatment Period 1|Physician Decision|0
6082080|NCT00395304|20997856|P4|Treatment Period 1|Physician Decision|0
6082081|NCT00395304|20997857|P3|Treatment Period 1|Physician Decision|0
6082082|NCT00395304|20997858|P2|Treatment Period 1|Physician Decision|1
6082083|NCT00395304|20997859|P1|Treatment Period 1|Physician Decision|0
6082084|NCT00395304|20997854|P6|Treatment Period 1|Lost to Follow-up|1
6082085|NCT00395304|20997855|P5|Treatment Period 1|Lost to Follow-up|0
6082086|NCT00395304|20997856|P4|Treatment Period 1|Lost to Follow-up|1
6082087|NCT00395304|20997857|P3|Treatment Period 1|Lost to Follow-up|0
6082088|NCT00395304|20997858|P2|Treatment Period 1|Lost to Follow-up|0
6082089|NCT00395304|20997859|P1|Treatment Period 1|Lost to Follow-up|1
6082090|NCT00395304|20997854|P6|Treatment Period 1|Withdrawal by Subject|1
6082091|NCT00395304|20997855|P5|Treatment Period 1|Withdrawal by Subject|1
6082092|NCT00395304|20997856|P4|Treatment Period 1|Withdrawal by Subject|2
6082093|NCT00395304|20997857|P3|Treatment Period 1|Withdrawal by Subject|0
6082094|NCT00395304|20997858|P2|Treatment Period 1|Withdrawal by Subject|3
6082095|NCT00395304|20997859|P1|Treatment Period 1|Withdrawal by Subject|0
6082096|NCT00395226|20997935|P2|Overall Study|Lost to Follow-up|1
6082097|NCT00395226|20997936|P1|Overall Study|Lost to Follow-up|0
6082098|NCT00395226|20997935|P2|Overall Study|Withdrawal by Subject|1
6082099|NCT00395226|20997936|P1|Overall Study|Withdrawal by Subject|0
6082100|NCT00395226|20997935|P2|Overall Study|Adverse Event|3
6082101|NCT00395226|20997936|P1|Overall Study|Adverse Event|4
6082102|NCT00395083|20997983|P2|Overall Study|Developed another disease|3
6082103|NCT00395083|20997984|P1|Overall Study|Developed another disease|4
6082104|NCT00395083|20997983|P2|Overall Study|Withdrawal by Subject|5
6082105|NCT00395083|20997984|P1|Overall Study|Withdrawal by Subject|6
6082106|NCT00395018|20998050|P1|Off-Treatment Follow-up|Poor/non-compliance|1
6082107|NCT00395018|20998050|P1|Off-Treatment Follow-up|Lost to Follow-up|2
6082108|NCT00395018|20998050|P1|Off-Treatment Follow-up|Followup no longer required per protocol|1
6082109|NCT00395018|20998050|P1|On-Treatment|Subject no longer meets study criteria|2
6082110|NCT00395018|20998050|P1|On-Treatment|Poor/non-compliance|2
6082111|NCT00395018|20998050|P1|On-Treatment|Other Reason|2
6082112|NCT00395018|20998050|P1|On-Treatment|Death|4
6082113|NCT00394953|20998071|P2|Second Treatment Period|Not defined|8
6082114|NCT00394953|20998072|P1|Second Treatment Period|Not defined|3
6082115|NCT00394953|20998071|P2|Second Treatment Period|Renal transplant|6
6082116|NCT00394953|20998072|P1|Second Treatment Period|Renal transplant|4
6082117|NCT00394953|20998071|P2|Second Treatment Period|Lost to Follow-up|1
6082118|NCT00394953|20998072|P1|Second Treatment Period|Lost to Follow-up|0
6082119|NCT00394953|20998071|P2|Second Treatment Period|Withdrawal by Subject|3
6082120|NCT00394953|20998072|P1|Second Treatment Period|Withdrawal by Subject|3
6082121|NCT00394953|20998071|P2|Second Treatment Period|Lack of Efficacy|47
6082122|NCT00394953|20998072|P1|Second Treatment Period|Lack of Efficacy|9
6082123|NCT00394953|20998071|P2|Second Treatment Period|Death|4
6082124|NCT00394953|20998072|P1|Second Treatment Period|Death|8
6082125|NCT00394953|20998071|P2|Second Treatment Period|Adverse Event|5
6082126|NCT00394953|20998072|P1|Second Treatment Period|Adverse Event|2
6082127|NCT00394953|20998071|P2|First Treatment Period|Not defined|1
6082128|NCT00394953|20998072|P1|First Treatment Period|Not defined|4
6082129|NCT00394953|20998071|P2|First Treatment Period|Renal transplant|7
6082130|NCT00394953|20998072|P1|First Treatment Period|Renal transplant|11
6082131|NCT00394953|20998071|P2|First Treatment Period|Lost to Follow-up|1
6082132|NCT00394953|20998072|P1|First Treatment Period|Lost to Follow-up|0
6082133|NCT00394953|20998071|P2|First Treatment Period|Withdrawal by Subject|3
6082134|NCT00394953|20998072|P1|First Treatment Period|Withdrawal by Subject|6
6082135|NCT00394953|20998071|P2|First Treatment Period|Lack of Efficacy|1
6082136|NCT00394953|20998072|P1|First Treatment Period|Lack of Efficacy|1
6082137|NCT00394953|20998071|P2|First Treatment Period|Death|7
6082138|NCT00394953|20998072|P1|First Treatment Period|Death|6
6082139|NCT00394953|20998071|P2|First Treatment Period|Adverse Event|2
6082140|NCT00394953|20998072|P1|First Treatment Period|Adverse Event|1
6082141|NCT00394914|20998090|P3|Treatment Period|Did not meet protocol eligibility|1
6082142|NCT00394914|20998091|P2|Treatment Period|Did not meet protocol eligibility|1
6082143|NCT00394914|20998092|P1|Treatment Period|Did not meet protocol eligibility|0
6082144|NCT00394914|20998090|P3|Treatment Period|Noncompliance with protocol|2
6082145|NCT00394914|20998091|P2|Treatment Period|Noncompliance with protocol|3
6082146|NCT00394914|20998092|P1|Treatment Period|Noncompliance with protocol|0
6082147|NCT00394914|20998090|P3|Treatment Period|Withdrawal by Subject|2
6082148|NCT00394914|20998091|P2|Treatment Period|Withdrawal by Subject|2
6082149|NCT00394914|20998092|P1|Treatment Period|Withdrawal by Subject|0
6082150|NCT00394914|20998090|P3|Treatment Period|Lost to Follow-up|0
6082151|NCT00394914|20998091|P2|Treatment Period|Lost to Follow-up|1
6082152|NCT00394914|20998092|P1|Treatment Period|Lost to Follow-up|0
6082153|NCT00394914|20998090|P3|Treatment Period|Adverse Event|1
6082154|NCT00394914|20998091|P2|Treatment Period|Adverse Event|3
6082155|NCT00394914|20998092|P1|Treatment Period|Adverse Event|0
6082200|NCT00394836|20998366|P2|Extended Follow-up Phase (2-5 Years)|Medical Reasons|10
6082201|NCT00394836|20998367|P1|Extended Follow-up Phase (2-5 Years)|Medical Reasons|7
6082202|NCT00394836|20998366|P2|Extended Follow-up Phase (2-5 Years)|Alternative treatment|41
6082203|NCT00394836|20998367|P1|Extended Follow-up Phase (2-5 Years)|Alternative treatment|13
6082204|NCT00394836|20998366|P2|Extended Follow-up Phase (2-5 Years)|Death|1
6082205|NCT00394836|20998367|P1|Extended Follow-up Phase (2-5 Years)|Death|0
6082206|NCT00394836|20998366|P2|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|1
6082207|NCT00394836|20998367|P1|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|0
6082208|NCT00394836|20998366|P2|Teatment or Follow-up Phase|Non compliance|1
6082209|NCT00394836|20998367|P1|Teatment or Follow-up Phase|Non compliance|0
6082210|NCT00394836|20998366|P2|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|1
6082211|NCT00394836|20998367|P1|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|0
6082212|NCT00394836|20998366|P2|Teatment or Follow-up Phase|Physician Decision|1
6082213|NCT00394836|20998367|P1|Teatment or Follow-up Phase|Physician Decision|0
6082214|NCT00394836|20998366|P2|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|1
6082215|NCT00394836|20998367|P1|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|0
6082216|NCT00394836|20998366|P2|Teatment or Follow-up Phase|Started alternative treatment|6
6082217|NCT00394836|20998367|P1|Teatment or Follow-up Phase|Started alternative treatment|0
6082218|NCT00394836|20998366|P2|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|1
6082219|NCT00394836|20998367|P1|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|0
6082220|NCT00394836|20998366|P2|Teatment or Follow-up Phase|Death|1
6082221|NCT00394836|20998367|P1|Teatment or Follow-up Phase|Death|0
6082222|NCT00394836|20998366|P2|Teatment or Follow-up Phase|Patient Refusal|2
6082223|NCT00394836|20998367|P1|Teatment or Follow-up Phase|Patient Refusal|1
6082224|NCT00394836|20998366|P2|Teatment or Follow-up Phase|Disease Progression|60
6082225|NCT00394836|20998367|P1|Teatment or Follow-up Phase|Disease Progression|27
6082226|NCT00394836|20998366|P2|Teatment or Follow-up Phase|Protocol Violation|2
6082227|NCT00394836|20998367|P1|Teatment or Follow-up Phase|Protocol Violation|0
6082228|NCT00394836|20998366|P2|Teatment or Follow-up Phase|Adverse Event|2
6082229|NCT00394836|20998367|P1|Teatment or Follow-up Phase|Adverse Event|0
6082230|NCT00394771|20998413|P4|Overall Study|Other|0
6082231|NCT00394771|20998414|P3|Overall Study|Other|1
6082232|NCT00394771|20998415|P2|Overall Study|Other|3
6082233|NCT00394771|20998416|P1|Overall Study|Other|3
6082234|NCT00394771|20998413|P4|Overall Study|Lost to Follow-up|10
6082235|NCT00394771|20998414|P3|Overall Study|Lost to Follow-up|13
6082236|NCT00394771|20998415|P2|Overall Study|Lost to Follow-up|15
6082237|NCT00394771|20998416|P1|Overall Study|Lost to Follow-up|15
6082238|NCT00394771|20998413|P4|Overall Study|Participant pregnant|2
6082239|NCT00394771|20998414|P3|Overall Study|Participant pregnant|2
6082240|NCT00394771|20998415|P2|Overall Study|Participant pregnant|1
6082241|NCT00394771|20998416|P1|Overall Study|Participant pregnant|0
6082242|NCT00394771|20998413|P4|Overall Study|Adverse Event|8
6082243|NCT00394771|20998414|P3|Overall Study|Adverse Event|12
6082244|NCT00394771|20998415|P2|Overall Study|Adverse Event|5
6082245|NCT00394771|20998416|P1|Overall Study|Adverse Event|10
6082246|NCT00394771|20998413|P4|Overall Study|Withdrawal by Subject|12
6082247|NCT00394771|20998414|P3|Overall Study|Withdrawal by Subject|8
6082248|NCT00394771|20998415|P2|Overall Study|Withdrawal by Subject|6
6082249|NCT00394771|20998416|P1|Overall Study|Withdrawal by Subject|10
6082250|NCT00394771|20998413|P4|Overall Study|Protocol Violation|7
6082251|NCT00394771|20998414|P3|Overall Study|Protocol Violation|9
6082252|NCT00394771|20998415|P2|Overall Study|Protocol Violation|4
6082253|NCT00394771|20998416|P1|Overall Study|Protocol Violation|2
6082254|NCT00394771|20998413|P4|Overall Study|Did not meet protocol requirements|0
6082255|NCT00394771|20998414|P3|Overall Study|Did not meet protocol requirements|2
6082256|NCT00394771|20998415|P2|Overall Study|Did not meet protocol requirements|0
6082257|NCT00394771|20998416|P1|Overall Study|Did not meet protocol requirements|1
6082258|NCT00394706|20998486|P8|Overall Study|Lost to Follow-up|0
6082259|NCT00394706|20998487|P7|Overall Study|Lost to Follow-up|2
6082260|NCT00394706|20998488|P6|Overall Study|Lost to Follow-up|5
6082261|NCT00394706|20998489|P5|Overall Study|Lost to Follow-up|2
6082262|NCT00394706|20998490|P4|Overall Study|Lost to Follow-up|1
6082263|NCT00394706|20998491|P3|Overall Study|Lost to Follow-up|8
6082264|NCT00394706|20998492|P2|Overall Study|Lost to Follow-up|2
6082265|NCT00394706|20998493|P1|Overall Study|Lost to Follow-up|2
6082266|NCT00394706|20998486|P8|Overall Study|Withdrawal by Subject|0
6082267|NCT00394706|20998487|P7|Overall Study|Withdrawal by Subject|1
6082268|NCT00394706|20998488|P6|Overall Study|Withdrawal by Subject|2
6082269|NCT00394706|20998489|P5|Overall Study|Withdrawal by Subject|0
6082270|NCT00394706|20998490|P4|Overall Study|Withdrawal by Subject|0
6082271|NCT00394706|20998491|P3|Overall Study|Withdrawal by Subject|1
6082272|NCT00394706|20998492|P2|Overall Study|Withdrawal by Subject|0
6082273|NCT00394706|20998493|P1|Overall Study|Withdrawal by Subject|2
6082274|NCT00394654|20998525|P2|Overall Study|PARTICIPANT LEFT STDUY REGION|0
6082275|NCT00394654|20998526|P1|Overall Study|PARTICIPANT LEFT STDUY REGION|1
6082276|NCT00394654|20998525|P2|Overall Study|Lost to Follow-up|0
6082277|NCT00394654|20998526|P1|Overall Study|Lost to Follow-up|1
6082278|NCT00394589|20998591|P3|Overall Study|Protocol Violation|2
6082279|NCT00394589|20998592|P2|Overall Study|Protocol Violation|0
6082280|NCT00394589|20998593|P1|Overall Study|Protocol Violation|4
6082281|NCT00394589|20998591|P3|Overall Study|Lack of Efficacy|3
6082282|NCT00394589|20998592|P2|Overall Study|Lack of Efficacy|2
6082283|NCT00394589|20998593|P1|Overall Study|Lack of Efficacy|2
6082284|NCT00394589|20998591|P3|Overall Study|Adverse Event|2
6082285|NCT00394589|20998592|P2|Overall Study|Adverse Event|1
6082286|NCT00394589|20998593|P1|Overall Study|Adverse Event|2
6082287|NCT00394524|20998603|P2|Overall Study|Withdrawal by Subject|1
6082288|NCT00394524|20998604|P1|Overall Study|Withdrawal by Subject|0
6082289|NCT00394524|20998603|P2|Overall Study|Death|0
6082290|NCT00394524|20998604|P1|Overall Study|Death|1
6082291|NCT00394524|20998603|P2|Overall Study|Protocol Violation|3
6082292|NCT00394524|20998604|P1|Overall Study|Protocol Violation|2
6082293|NCT00394472|20998618|P2|Overall Study|Lost to Follow-up|1
6082294|NCT00394472|20998619|P1|Overall Study|Lost to Follow-up|0
6082295|NCT00394472|20998618|P2|Overall Study|Physician Decision|1
6082296|NCT00394472|20998619|P1|Overall Study|Physician Decision|0
6082297|NCT00394472|20998618|P2|Overall Study|Withdrawal by Subject|2
6082298|NCT00394472|20998619|P1|Overall Study|Withdrawal by Subject|0
6082299|NCT00394472|20998618|P2|Overall Study|Adverse Event|2
6082300|NCT00394472|20998619|P1|Overall Study|Adverse Event|4
6082301|NCT00394472|20998618|P2|Overall Study|incorrect enrolment|2
6082302|NCT00394472|20998619|P1|Overall Study|incorrect enrolment|4
6082303|NCT00394472|20998618|P2|Overall Study|Protocol Violation|3
6082304|NCT00394472|20998619|P1|Overall Study|Protocol Violation|1
6082305|NCT00394433|20998627|P1|Overall Study|Alternative Therapy|1
6082306|NCT00394433|20998627|P1|Overall Study|Adverse Event|2
6082307|NCT00394355|20998638|P4|Overall Study|Lack of Efficacy|3
6082308|NCT00394355|20998639|P3|Overall Study|Lack of Efficacy|2
6082309|NCT00394355|20998640|P2|Overall Study|Lack of Efficacy|0
6082310|NCT00394355|20998641|P1|Overall Study|Lack of Efficacy|0
6082311|NCT00394355|20998638|P4|Overall Study|Administrative|1
6082312|NCT00394355|20998639|P3|Overall Study|Administrative|1
6082313|NCT00394355|20998640|P2|Overall Study|Administrative|1
6082314|NCT00394355|20998641|P1|Overall Study|Administrative|0
6082315|NCT00394355|20998638|P4|Overall Study|Noncompliance with protocol|8
6082316|NCT00394355|20998639|P3|Overall Study|Noncompliance with protocol|10
6082317|NCT00394355|20998640|P2|Overall Study|Noncompliance with protocol|3
6082318|NCT00394355|20998641|P1|Overall Study|Noncompliance with protocol|4
6082319|NCT00394355|20998638|P4|Overall Study|Lost to Follow-up|3
6082320|NCT00394355|20998639|P3|Overall Study|Lost to Follow-up|4
6082321|NCT00394355|20998640|P2|Overall Study|Lost to Follow-up|5
6082322|NCT00394355|20998641|P1|Overall Study|Lost to Follow-up|7
6082323|NCT00394355|20998638|P4|Overall Study|Subject withdrawal - related to drug|0
6082324|NCT00394355|20998639|P3|Overall Study|Subject withdrawal - related to drug|0
6082325|NCT00394355|20998640|P2|Overall Study|Subject withdrawal - related to drug|0
6082326|NCT00394355|20998641|P1|Overall Study|Subject withdrawal - related to drug|1
6082327|NCT00394355|20998638|P4|Overall Study|Subject withdrawal - unrelated to drug|6
6082328|NCT00394355|20998639|P3|Overall Study|Subject withdrawal - unrelated to drug|10
6082329|NCT00394355|20998640|P2|Overall Study|Subject withdrawal - unrelated to drug|14
6082330|NCT00394355|20998641|P1|Overall Study|Subject withdrawal - unrelated to drug|12
6082331|NCT00394355|20998638|P4|Overall Study|Did not meet protocol eligibility|2
6082332|NCT00394355|20998639|P3|Overall Study|Did not meet protocol eligibility|4
6082333|NCT00394355|20998640|P2|Overall Study|Did not meet protocol eligibility|5
6082334|NCT00394355|20998641|P1|Overall Study|Did not meet protocol eligibility|1
6082335|NCT00394355|20998638|P4|Overall Study|Adverse Event|8
6082336|NCT00394355|20998639|P3|Overall Study|Adverse Event|7
6082337|NCT00394355|20998640|P2|Overall Study|Adverse Event|6
6082338|NCT00394355|20998641|P1|Overall Study|Adverse Event|10
6082339|NCT00394251|20998747|P2|Overall Study|Non-compliance, pt moved, pt/inv agree|2
6082340|NCT00394251|20998748|P1|Overall Study|Non-compliance, pt moved, pt/inv agree|2
6082341|NCT00394251|20998747|P2|Overall Study|Withdrawal by Subject|11
6082342|NCT00394251|20998748|P1|Overall Study|Withdrawal by Subject|7
6082343|NCT00394251|20998747|P2|Overall Study|Protocol Violation|1
6082344|NCT00394251|20998748|P1|Overall Study|Protocol Violation|0
6082345|NCT00394251|20998747|P2|Overall Study|Physician Decision|1
6082346|NCT00394251|20998748|P1|Overall Study|Physician Decision|1
6082347|NCT00394251|20998747|P2|Overall Study|Unacceptable Toxicity|18
6082348|NCT00394251|20998748|P1|Overall Study|Unacceptable Toxicity|20
6082349|NCT00394251|20998747|P2|Overall Study|Adverse Event|5
6082350|NCT00394251|20998748|P1|Overall Study|Adverse Event|7
6082351|NCT00394212|20998776|P2|Overall Study|Withdrawal by Subject|1
6082352|NCT00394212|20998777|P1|Overall Study|Withdrawal by Subject|4
6082353|NCT00394212|20998776|P2|Overall Study|Lost to Follow-up|0
6082354|NCT00394212|20998777|P1|Overall Study|Lost to Follow-up|3
6082355|NCT00394095|20998791|P2|Overall Study|Adverse Event|0
6082356|NCT00394095|20998792|P1|Overall Study|Adverse Event|1
6082357|NCT00394082|20998800|P1|Overall Study|Other|1
6082358|NCT00394082|20998800|P1|Overall Study|Withdrawal by Subject|2
6082359|NCT00394082|20998800|P1|Overall Study|Physician Decision|4
6082360|NCT00394082|20998800|P1|Overall Study|Adverse Event|4
6082361|NCT00394082|20998800|P1|Overall Study|Unacceptable toxicity|15
6082362|NCT00393939|20998822|P2|Overall Study|Other|45
6082363|NCT00393939|20998823|P1|Overall Study|Other|37
6082364|NCT00393939|20998822|P2|Overall Study|Withdrawal by Subject|7
6082365|NCT00393939|20998823|P1|Overall Study|Withdrawal by Subject|2
6082366|NCT00393939|20998822|P2|Overall Study|Objective progression or relapse|223
6082367|NCT00393939|20998823|P1|Overall Study|Objective progression or relapse|239
6082368|NCT00393939|20998822|P2|Overall Study|Sponsor|13
6082369|NCT00393939|20998823|P1|Overall Study|Sponsor|5
6082370|NCT00393939|20998822|P2|Overall Study|Death|4
6082371|NCT00393939|20998823|P1|Overall Study|Death|10
6082372|NCT00393939|20998822|P2|Overall Study|Lost to Follow-up|4
6082373|NCT00393939|20998823|P1|Overall Study|Lost to Follow-up|2
6082374|NCT00393939|20998822|P2|Overall Study|Protocol Violation|1
6082375|NCT00393939|20998823|P1|Overall Study|Protocol Violation|1
6082376|NCT00393913|20998841|P1|CPAP|TEchnical problem with CPAP|3
6082377|NCT00393913|20998841|P1|CPAP|Physician Decision|1
6082378|NCT00393913|20998841|P1|CPAP|Withdrawal by Subject|3
6082379|NCT00393913|20998841|P1|Initial Assessment|Withdrawal by Subject|16
6082380|NCT00393913|20998841|P1|Initial Assessment|diagnosed with other sleep disorder|21
6082381|NCT00393887|20998849|P2|Overall Study|Lost to Follow-up|9
6082382|NCT00393887|20998850|P1|Overall Study|Lost to Follow-up|11
6082383|NCT00393887|20998849|P2|Overall Study|Physician Decision|0
6082384|NCT00393887|20998850|P1|Overall Study|Physician Decision|5
6082385|NCT00393861|20998878|P1|Overall Study|Disease Progression|24
6082386|NCT00393861|20998878|P1|Overall Study|Adverse Event|2
6082387|NCT00393848|20998889|P4|Overall Study|Personal reasons|0
6082388|NCT00393848|20998890|P3|Overall Study|Personal reasons|2
6082389|NCT00393848|20998891|P2|Overall Study|Personal reasons|0
6082390|NCT00393848|20998892|P1|Overall Study|Personal reasons|0
6082391|NCT00393848|20998889|P4|Overall Study|Surgical schedule|1
6082392|NCT00393848|20998890|P3|Overall Study|Surgical schedule|0
6082393|NCT00393848|20998891|P2|Overall Study|Surgical schedule|0
6082394|NCT00393848|20998892|P1|Overall Study|Surgical schedule|0
6082395|NCT00393718|20998915|P2|Overall Study|Move|0
6082396|NCT00393718|20998916|P1|Overall Study|Move|1
6082397|NCT00393718|20998915|P2|Overall Study|Missed measurement|0
6082398|NCT00393718|20998916|P1|Overall Study|Missed measurement|1
6082399|NCT00393718|20998915|P2|Overall Study|Withdrawal of consent|1
6082400|NCT00393718|20998916|P1|Overall Study|Withdrawal of consent|2
6082401|NCT00393718|20998915|P2|Overall Study|Subject decision|0
6082402|NCT00393718|20998916|P1|Overall Study|Subject decision|5
6082403|NCT00393718|20998915|P2|Overall Study|Hypoglycaemia|2
6082404|NCT00393718|20998916|P1|Overall Study|Hypoglycaemia|3
6082405|NCT00393718|20998915|P2|Overall Study|Lack of Efficacy|9
6082406|NCT00393718|20998916|P1|Overall Study|Lack of Efficacy|10
6082407|NCT00393718|20998915|P2|Overall Study|Protocol Violation|2
6082408|NCT00393718|20998916|P1|Overall Study|Protocol Violation|1
6082409|NCT00393718|20998915|P2|Overall Study|Adverse Event|8
6082410|NCT00393718|20998916|P1|Overall Study|Adverse Event|20
6082411|NCT00393705|20998948|P2|Overall Study|Physician Decision|2
6082412|NCT00393705|20998949|P1|Overall Study|Physician Decision|2
6082413|NCT00393705|20998948|P2|Overall Study|Withdrawal by Subject|3
6082414|NCT00393705|20998949|P1|Overall Study|Withdrawal by Subject|5
6082415|NCT00393705|20998948|P2|Overall Study|Protocol Violation|3
6082416|NCT00393705|20998949|P1|Overall Study|Protocol Violation|4
6082417|NCT00393705|20998948|P2|Overall Study|Entry Criteria Not Met|10
6082418|NCT00393705|20998949|P1|Overall Study|Entry Criteria Not Met|10
6082419|NCT00393705|20998948|P2|Overall Study|Lost to Follow-up|2
6082420|NCT00393705|20998949|P1|Overall Study|Lost to Follow-up|2
6082421|NCT00393705|20998948|P2|Overall Study|Death|1
6082422|NCT00393705|20998949|P1|Overall Study|Death|0
6082423|NCT00393705|20998948|P2|Overall Study|Adverse Event|2
6082424|NCT00393705|20998949|P1|Overall Study|Adverse Event|0
6082425|NCT00393523|20998978|P5|Overall Study|Vaccine supply issue|0
6082426|NCT00393523|20998979|P4|Overall Study|Vaccine supply issue|0
6082427|NCT00393523|20998980|P3|Overall Study|Vaccine supply issue|1
6082428|NCT00393523|20998981|P2|Overall Study|Vaccine supply issue|0
6082429|NCT00393523|20998982|P1|Overall Study|Vaccine supply issue|0
6082430|NCT00393523|20998978|P5|Overall Study|Difficulties in specimen collection|0
6082431|NCT00393523|20998979|P4|Overall Study|Difficulties in specimen collection|0
6082432|NCT00393523|20998980|P3|Overall Study|Difficulties in specimen collection|1
6082433|NCT00393523|20998981|P2|Overall Study|Difficulties in specimen collection|0
6082434|NCT00393523|20998982|P1|Overall Study|Difficulties in specimen collection|0
6082435|NCT00393523|20998978|P5|Overall Study|Withdrawal by Subject|0
6082436|NCT00393523|20998979|P4|Overall Study|Withdrawal by Subject|3
6082437|NCT00393523|20998980|P3|Overall Study|Withdrawal by Subject|2
6082438|NCT00393523|20998981|P2|Overall Study|Withdrawal by Subject|7
6082439|NCT00393523|20998982|P1|Overall Study|Withdrawal by Subject|6
6082440|NCT00393523|20998978|P5|Overall Study|Protocol Violation|0
6082441|NCT00393523|20998979|P4|Overall Study|Protocol Violation|1
6082442|NCT00393523|20998980|P3|Overall Study|Protocol Violation|0
6082443|NCT00393523|20998981|P2|Overall Study|Protocol Violation|2
6082444|NCT00393523|20998982|P1|Overall Study|Protocol Violation|6
6082445|NCT00393523|20998978|P5|Overall Study|Lost to Follow-up|1
6082446|NCT00393523|20998979|P4|Overall Study|Lost to Follow-up|2
6082447|NCT00393523|20998980|P3|Overall Study|Lost to Follow-up|0
6082448|NCT00393523|20998981|P2|Overall Study|Lost to Follow-up|0
6082449|NCT00393523|20998982|P1|Overall Study|Lost to Follow-up|0
6082450|NCT00393510|20998999|P2|Overall Study|Physician Decision|9
6082451|NCT00393510|20999000|P1|Overall Study|Physician Decision|3
6082452|NCT00393484|20999012|P2|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|18
6082453|NCT00393484|20999013|P1|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|0
6082454|NCT00393484|20999012|P2|Open-label Period (Weeks 96 to 240)|Noncompliance|2
6082455|NCT00393484|20999013|P1|Open-label Period (Weeks 96 to 240)|Noncompliance|2
6082456|NCT00393484|20999012|P2|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|2
6082457|NCT00393484|20999013|P1|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|1
6082458|NCT00393484|20999012|P2|Open-label Period (Weeks 96 to 240)|Death|0
6082459|NCT00393484|20999013|P1|Open-label Period (Weeks 96 to 240)|Death|1
6082460|NCT00393484|20999012|P2|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|1
6082461|NCT00393484|20999013|P1|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|4
6082462|NCT00393484|20999012|P2|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|2
6082463|NCT00393484|20999013|P1|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|0
6082464|NCT00393484|20999012|P2|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|6
6082465|NCT00393484|20999013|P1|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|0
6082466|NCT00393484|20999012|P2|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|3
6082467|NCT00393484|20999013|P1|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|0
6082468|NCT00393484|20999012|P2|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|0
6082469|NCT00393484|20999013|P1|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|2
6082470|NCT00393484|20999012|P2|Double-blind Period (Day 1 to Week 96)|Adverse Event|1
6082471|NCT00393484|20999013|P1|Double-blind Period (Day 1 to Week 96)|Adverse Event|0
6082472|NCT00393458|20999049|P4|Overall Study|Subject no longer requires study drug|0
6082473|NCT00393458|20999050|P3|Overall Study|Subject no longer requires study drug|0
6082474|NCT00393458|20999051|P2|Overall Study|Subject no longer requires study drug|1
6082475|NCT00393458|20999052|P1|Overall Study|Subject no longer requires study drug|0
6082476|NCT00393458|20999049|P4|Overall Study|Abnormal test procedure result(s)|2
6082477|NCT00393458|20999050|P3|Overall Study|Abnormal test procedure result(s)|1
6082478|NCT00393458|20999051|P2|Overall Study|Abnormal test procedure result(s)|1
6082479|NCT00393458|20999052|P1|Overall Study|Abnormal test procedure result(s)|0
6082480|NCT00393458|20999049|P4|Overall Study|Death|5
6082481|NCT00393458|20999050|P3|Overall Study|Death|5
6082482|NCT00393458|20999051|P2|Overall Study|Death|1
6082483|NCT00393458|20999052|P1|Overall Study|Death|1
6082484|NCT00393458|20999049|P4|Overall Study|Abnormal laboratory value(s)|0
6082485|NCT00393458|20999050|P3|Overall Study|Abnormal laboratory value(s)|0
6082486|NCT00393458|20999051|P2|Overall Study|Abnormal laboratory value(s)|1
6082487|NCT00393458|20999052|P1|Overall Study|Abnormal laboratory value(s)|1
6082488|NCT00393458|20999049|P4|Overall Study|Lost to Follow-up|3
6082489|NCT00393458|20999050|P3|Overall Study|Lost to Follow-up|5
6082490|NCT00393458|20999051|P2|Overall Study|Lost to Follow-up|6
6082491|NCT00393458|20999052|P1|Overall Study|Lost to Follow-up|5
6082492|NCT00393458|20999049|P4|Overall Study|Administrative problems|2
6082493|NCT00393458|20999050|P3|Overall Study|Administrative problems|5
6082494|NCT00393458|20999051|P2|Overall Study|Administrative problems|8
6082495|NCT00393458|20999052|P1|Overall Study|Administrative problems|7
6082496|NCT00393458|20999049|P4|Overall Study|Protocol deviation|10
6082497|NCT00393458|20999050|P3|Overall Study|Protocol deviation|11
6082498|NCT00393458|20999051|P2|Overall Study|Protocol deviation|11
6082499|NCT00393458|20999052|P1|Overall Study|Protocol deviation|11
6082500|NCT00393458|20999049|P4|Overall Study|Unsatisfactory therapeutic effect|30
6082501|NCT00393458|20999050|P3|Overall Study|Unsatisfactory therapeutic effect|12
6082502|NCT00393458|20999051|P2|Overall Study|Unsatisfactory therapeutic effect|9
6082503|NCT00393458|20999052|P1|Overall Study|Unsatisfactory therapeutic effect|12
6082504|NCT00393458|20999049|P4|Overall Study|Subject withdrew consent|50
6082505|NCT00393458|20999050|P3|Overall Study|Subject withdrew consent|33
6082506|NCT00393458|20999051|P2|Overall Study|Subject withdrew consent|40
6082507|NCT00393458|20999052|P1|Overall Study|Subject withdrew consent|27
6082508|NCT00393458|20999049|P4|Overall Study|Adverse Event|35
6082509|NCT00393458|20999050|P3|Overall Study|Adverse Event|40
6082510|NCT00393458|20999051|P2|Overall Study|Adverse Event|24
6082511|NCT00393458|20999052|P1|Overall Study|Adverse Event|35
6082512|NCT00393367|20999079|P2|Overall Study|Withdrawal by Subject|2
6082513|NCT00393367|20999080|P1|Overall Study|Withdrawal by Subject|0
6082514|NCT00393367|20999079|P2|Overall Study|Protocol Violation|5
6082515|NCT00393367|20999080|P1|Overall Study|Protocol Violation|2
6082516|NCT00393094|20999108|P1|Disease Progression After Trtmt: Onstudy|Refused further treatment|1
6082517|NCT00393094|20999108|P1|Period1Bevacizumab & Irinotecan Patients|Disease progression before treatment|1
6082518|NCT00393042|20999119|P2|Second Intervetion|Protocol Violation|1
6082519|NCT00393042|20999120|P1|Second Intervetion|Protocol Violation|1
6082520|NCT00393042|20999119|P2|Second Intervetion|Lost to Follow-up|2
6082521|NCT00393042|20999120|P1|Second Intervetion|Lost to Follow-up|0
6082522|NCT00393042|20999119|P2|Second Intervetion|Lack of Efficacy|0
6082523|NCT00393042|20999120|P1|Second Intervetion|Lack of Efficacy|1
6082524|NCT00393042|20999119|P2|Second Intervetion|Withdrawal by Subject|2
6082525|NCT00393042|20999120|P1|Second Intervetion|Withdrawal by Subject|0
6082526|NCT00393042|20999119|P2|Second Intervetion|Adverse Event|3
6082527|NCT00393042|20999120|P1|Second Intervetion|Adverse Event|0
6082528|NCT00393042|20999119|P2|First Intervention|Adverse Event|1
6082529|NCT00393042|20999120|P1|First Intervention|Adverse Event|0
6082530|NCT00393042|20999119|P2|First Intervention|Protocol Violation|0
6082531|NCT00393042|20999120|P1|First Intervention|Protocol Violation|1
6082532|NCT00393042|20999119|P2|First Intervention|Lost to Follow-up|3
6082533|NCT00393042|20999120|P1|First Intervention|Lost to Follow-up|3
6082534|NCT00393042|20999119|P2|First Intervention|Withdrawal by Subject|2
6082535|NCT00393042|20999120|P1|First Intervention|Withdrawal by Subject|1
6082536|NCT00393029|20999192|P2|Overall Study|Not treated|1
6082537|NCT00393029|20999193|P1|Overall Study|Not treated|0
6082538|NCT00392990|20999204|P2|Follow up for 2 Years|Death|0
6082539|NCT00392990|20999205|P1|Follow up for 2 Years|Death|4
6082540|NCT00392990|20999204|P2|Treatment on Study|Adverse Event|1
6082541|NCT00392990|20999205|P1|Treatment on Study|Adverse Event|3
6082542|NCT00392925|20999229|P4|Randomization to Treatment Group Period|Lost to Follow-up|4
6082543|NCT00392925|20999230|P3|Randomization to Treatment Group Period|Lost to Follow-up|8
6082544|NCT00392925|20999231|P2|Randomization to Treatment Group Period|Lost to Follow-up|3
6082545|NCT00392925|20999232|P1|Randomization to Treatment Group Period|Lost to Follow-up|0
6082546|NCT00392925|20999229|P4|Randomization to Treatment Group Period|Protocol Violation|1
6082547|NCT00392925|20999230|P3|Randomization to Treatment Group Period|Protocol Violation|2
6082548|NCT00392925|20999231|P2|Randomization to Treatment Group Period|Protocol Violation|0
6082549|NCT00392925|20999232|P1|Randomization to Treatment Group Period|Protocol Violation|0
6082550|NCT00392925|20999229|P4|Randomization to Treatment Group Period|Adverse Event|5
6082551|NCT00392925|20999230|P3|Randomization to Treatment Group Period|Adverse Event|3
6082552|NCT00392925|20999231|P2|Randomization to Treatment Group Period|Adverse Event|3
6082553|NCT00392925|20999232|P1|Randomization to Treatment Group Period|Adverse Event|0
6082554|NCT00392925|20999229|P4|Randomization to Treatment Group Period|Withdrawal by Subject|8
6082555|NCT00392925|20999230|P3|Randomization to Treatment Group Period|Withdrawal by Subject|6
6082556|NCT00392925|20999231|P2|Randomization to Treatment Group Period|Withdrawal by Subject|2
6082557|NCT00392925|20999232|P1|Randomization to Treatment Group Period|Withdrawal by Subject|0
6082558|NCT00392925|20999229|P4|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0
6082559|NCT00392925|20999230|P3|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0
6082560|NCT00392925|20999231|P2|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0
6082561|NCT00392925|20999232|P1|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|16
6082562|NCT00392925|20999229|P4|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0
6082563|NCT00392925|20999230|P3|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0
6082564|NCT00392925|20999231|P2|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0
6082565|NCT00392925|20999232|P1|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|5
6082566|NCT00392925|20999229|P4|4 Week Lead-In Period - Non-Randomized|Physician Decision|0
6082567|NCT00392925|20999230|P3|4 Week Lead-In Period - Non-Randomized|Physician Decision|0
6082568|NCT00392925|20999231|P2|4 Week Lead-In Period - Non-Randomized|Physician Decision|0
6082569|NCT00392925|20999232|P1|4 Week Lead-In Period - Non-Randomized|Physician Decision|1
6082570|NCT00392925|20999229|P4|4 Week Lead-In Period - Non-Randomized|Adverse Event|0
6082571|NCT00392925|20999230|P3|4 Week Lead-In Period - Non-Randomized|Adverse Event|0
6082572|NCT00392925|20999231|P2|4 Week Lead-In Period - Non-Randomized|Adverse Event|0
6082573|NCT00392925|20999232|P1|4 Week Lead-In Period - Non-Randomized|Adverse Event|5
6082574|NCT00392925|20999229|P4|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0
6082575|NCT00392925|20999230|P3|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0
6082576|NCT00392925|20999231|P2|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0
6082577|NCT00392925|20999232|P1|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|11
6082578|NCT00392808|20999346|P4|Overall Study|Unable to withdraw blood|2
6082579|NCT00392808|20999347|P3|Overall Study|Unable to withdraw blood|1
6082580|NCT00392808|20999348|P2|Overall Study|Unable to withdraw blood|1
6082581|NCT00392808|20999349|P1|Overall Study|Unable to withdraw blood|3
6082582|NCT00392808|20999346|P4|Overall Study|Lost to Follow-up|2
6082583|NCT00392808|20999347|P3|Overall Study|Lost to Follow-up|1
6082584|NCT00392808|20999348|P2|Overall Study|Lost to Follow-up|2
6082585|NCT00392808|20999349|P1|Overall Study|Lost to Follow-up|3
6082586|NCT00392769|20999373|P1|Overall Study|Adverse Event|1
6082587|NCT00392769|20999373|P1|Overall Study|Clinical Deterioration|9
6082588|NCT00392665|20999425|P2|Overall Study|Lost to Follow-up|1
6082589|NCT00392665|20999426|P1|Overall Study|Lost to Follow-up|1
6082590|NCT00392665|20999425|P2|Overall Study|Death|14
6082591|NCT00392665|20999426|P1|Overall Study|Death|16
6082592|NCT00392379|20999452|P2|Overall Study|Adverse Event|1
6082593|NCT00392379|20999453|P1|Overall Study|Adverse Event|1
6082594|NCT00392379|20999452|P2|Overall Study|Lost to Follow-up|9
6082595|NCT00392379|20999453|P1|Overall Study|Lost to Follow-up|4
6082596|NCT00392379|20999452|P2|Overall Study|Withdrawal by Subject|28
6082597|NCT00392379|20999453|P1|Overall Study|Withdrawal by Subject|17
6082598|NCT00392327|20999471|P8|Overall Study|Ineligible|0
6082599|NCT00392327|20999472|P7|Overall Study|Ineligible|0
6082600|NCT00392327|20999473|P6|Overall Study|Ineligible|0
6082601|NCT00392327|20999474|P5|Overall Study|Ineligible|0
6082602|NCT00392327|20999475|P4|Overall Study|Ineligible|2
6082603|NCT00392327|20999476|P3|Overall Study|Ineligible|3
6082604|NCT00392327|20999477|P2|Overall Study|Ineligible|4
6082605|NCT00392327|20999478|P1|Overall Study|Ineligible|0
6082606|NCT00392327|20999471|P8|Overall Study|Withdrawal by Subject|5
6082607|NCT00392327|20999472|P7|Overall Study|Withdrawal by Subject|1
6082608|NCT00392327|20999473|P6|Overall Study|Withdrawal by Subject|1
6082609|NCT00392327|20999474|P5|Overall Study|Withdrawal by Subject|0
6082610|NCT00392327|20999475|P4|Overall Study|Withdrawal by Subject|6
6082611|NCT00392327|20999476|P3|Overall Study|Withdrawal by Subject|4
6082612|NCT00392327|20999477|P2|Overall Study|Withdrawal by Subject|2
6082613|NCT00392327|20999478|P1|Overall Study|Withdrawal by Subject|3
6082614|NCT00392327|20999471|P8|Overall Study|Protocol Violation|0
6082615|NCT00392327|20999472|P7|Overall Study|Protocol Violation|0
6082616|NCT00392327|20999473|P6|Overall Study|Protocol Violation|0
6082617|NCT00392327|20999474|P5|Overall Study|Protocol Violation|0
6082618|NCT00392327|20999475|P4|Overall Study|Protocol Violation|0
6082619|NCT00392327|20999476|P3|Overall Study|Protocol Violation|1
6082620|NCT00392327|20999477|P2|Overall Study|Protocol Violation|0
6082621|NCT00392327|20999478|P1|Overall Study|Protocol Violation|0
6082622|NCT00392327|20999471|P8|Overall Study|Physician Decision|3
6082623|NCT00392327|20999472|P7|Overall Study|Physician Decision|5
6082624|NCT00392327|20999473|P6|Overall Study|Physician Decision|1
6082625|NCT00392327|20999474|P5|Overall Study|Physician Decision|0
6082626|NCT00392327|20999475|P4|Overall Study|Physician Decision|2
6082627|NCT00392327|20999476|P3|Overall Study|Physician Decision|2
6082628|NCT00392327|20999477|P2|Overall Study|Physician Decision|5
6082629|NCT00392327|20999478|P1|Overall Study|Physician Decision|3
6082630|NCT00392327|20999471|P8|Overall Study|Lack of Efficacy|3
6082631|NCT00392327|20999472|P7|Overall Study|Lack of Efficacy|3
6082632|NCT00392327|20999473|P6|Overall Study|Lack of Efficacy|3
6082633|NCT00392327|20999474|P5|Overall Study|Lack of Efficacy|3
6082634|NCT00392327|20999475|P4|Overall Study|Lack of Efficacy|6
6082635|NCT00392327|20999476|P3|Overall Study|Lack of Efficacy|9
6082636|NCT00392327|20999477|P2|Overall Study|Lack of Efficacy|8
6082637|NCT00392327|20999478|P1|Overall Study|Lack of Efficacy|8
6082638|NCT00392327|20999471|P8|Overall Study|Death|0
6082639|NCT00392327|20999472|P7|Overall Study|Death|0
6082640|NCT00392327|20999473|P6|Overall Study|Death|0
6082641|NCT00392327|20999474|P5|Overall Study|Death|0
6082642|NCT00392327|20999475|P4|Overall Study|Death|0
6082643|NCT00392327|20999476|P3|Overall Study|Death|1
6082644|NCT00392327|20999477|P2|Overall Study|Death|0
6082645|NCT00392327|20999478|P1|Overall Study|Death|1
6082646|NCT00392288|20999547|P3|Overall Study|Other|1
6082647|NCT00392288|20999548|P2|Overall Study|Other|4
6082648|NCT00392288|20999549|P1|Overall Study|Other|3
6082649|NCT00392288|20999547|P3|Overall Study|Parent/legal guardian withdrawal|1
6082650|NCT00392288|20999548|P2|Overall Study|Parent/legal guardian withdrawal|2
6082651|NCT00392288|20999549|P1|Overall Study|Parent/legal guardian withdrawal|1
6082652|NCT00392288|20999547|P3|Overall Study|Withdrawal by Subject|2
6082653|NCT00392288|20999548|P2|Overall Study|Withdrawal by Subject|0
6082654|NCT00392288|20999549|P1|Overall Study|Withdrawal by Subject|1
6082655|NCT00392288|20999547|P3|Overall Study|Lost to Follow-up|1
6082656|NCT00392288|20999548|P2|Overall Study|Lost to Follow-up|1
6082657|NCT00392288|20999549|P1|Overall Study|Lost to Follow-up|1
6082658|NCT00392288|20999547|P3|Overall Study|Protocol Violation|1
6082659|NCT00392288|20999548|P2|Overall Study|Protocol Violation|3
6082660|NCT00392288|20999549|P1|Overall Study|Protocol Violation|1
6082661|NCT00392288|20999547|P3|Overall Study|Lack of Efficacy|3
6082662|NCT00392288|20999548|P2|Overall Study|Lack of Efficacy|5
6082663|NCT00392288|20999549|P1|Overall Study|Lack of Efficacy|8
6082664|NCT00392288|20999547|P3|Overall Study|Adverse Event|8
6082665|NCT00392288|20999548|P2|Overall Study|Adverse Event|7
6082666|NCT00392288|20999549|P1|Overall Study|Adverse Event|17
6082667|NCT00392223|20999574|P2|Overall Study|Withdrawal by Subject|2
6082668|NCT00392223|20999575|P1|Overall Study|Withdrawal by Subject|3
6082669|NCT00392223|20999574|P2|Overall Study|Protocol Violation|3
6082670|NCT00392223|20999575|P1|Overall Study|Protocol Violation|0
6082671|NCT00392223|20999574|P2|Overall Study|Lost to Follow-up|4
6082672|NCT00392223|20999575|P1|Overall Study|Lost to Follow-up|1
6082673|NCT00392223|20999574|P2|Overall Study|Adverse Event|4
6082674|NCT00392223|20999575|P1|Overall Study|Adverse Event|5
6082675|NCT00392210|20999593|P2|First Voiding Trial|Physician Decision|2
6082676|NCT00392210|20999594|P1|First Voiding Trial|Physician Decision|2
6082677|NCT00392197|20999602|P2|Overall Study|Withdrawal by Subject|6
6082678|NCT00392197|20999603|P1|Overall Study|Withdrawal by Subject|4
6082679|NCT00392197|20999602|P2|Overall Study|Protocol Violation|5
6082680|NCT00392197|20999603|P1|Overall Study|Protocol Violation|7
6082681|NCT00392197|20999602|P2|Overall Study|Physician Decision|2
6082682|NCT00392197|20999603|P1|Overall Study|Physician Decision|3
6082683|NCT00392197|20999602|P2|Overall Study|Lost to Follow-up|1
6082684|NCT00392197|20999603|P1|Overall Study|Lost to Follow-up|0
6082685|NCT00392197|20999602|P2|Overall Study|Lack of Efficacy|4
6082686|NCT00392197|20999603|P1|Overall Study|Lack of Efficacy|3
6082687|NCT00392197|20999602|P2|Overall Study|Adverse Event|12
6082688|NCT00392197|20999603|P1|Overall Study|Adverse Event|4
6082689|NCT00392171|20999611|P1|Overall Study|Disease progression|101
6082690|NCT00392171|20999611|P1|Overall Study|Did not meet inclusion criteria|4
6082691|NCT00391976|20999662|P3|Overall Study|Positive P. aeruginosa antibody test|31
6082692|NCT00391976|20999663|P2|Overall Study|Positive P. aeruginosa antibody test|0
6082693|NCT00391976|20999664|P1|Overall Study|Positive P. aeruginosa antibody test|0
6082694|NCT00391976|20999662|P3|Overall Study|Unable to classify|1
6082695|NCT00391976|20999663|P2|Overall Study|Unable to classify|0
6082696|NCT00391976|20999664|P1|Overall Study|Unable to classify|0
6082697|NCT00391976|20999662|P3|Overall Study|Recurrence/no eradication of infection|0
6082698|NCT00391976|20999663|P2|Overall Study|Recurrence/no eradication of infection|19
6082699|NCT00391976|20999664|P1|Overall Study|Recurrence/no eradication of infection|21
6082700|NCT00391976|20999662|P3|Overall Study|Protocol deviation/violation|1
6082701|NCT00391976|20999663|P2|Overall Study|Protocol deviation/violation|2
6082702|NCT00391976|20999664|P1|Overall Study|Protocol deviation/violation|4
6082703|NCT00391976|20999662|P3|Overall Study|Inappropriate enrollment|0
6082704|NCT00391976|20999663|P2|Overall Study|Inappropriate enrollment|1
6082705|NCT00391976|20999664|P1|Overall Study|Inappropriate enrollment|1
6082706|NCT00391976|20999662|P3|Overall Study|Lost to Follow-up|0
6082707|NCT00391976|20999663|P2|Overall Study|Lost to Follow-up|2
6082708|NCT00391976|20999664|P1|Overall Study|Lost to Follow-up|1
6082709|NCT00391976|20999662|P3|Overall Study|Withdrawal of consent|1
6082710|NCT00391976|20999663|P2|Overall Study|Withdrawal of consent|1
6082711|NCT00391976|20999664|P1|Overall Study|Withdrawal of consent|0
6082712|NCT00391976|20999662|P3|Overall Study|Adverse Event|1
6082713|NCT00391976|20999663|P2|Overall Study|Adverse Event|0
6082714|NCT00391976|20999664|P1|Overall Study|Adverse Event|0
6082715|NCT00391898|20999688|P2|Overall Study|Other|10
6082716|NCT00391898|20999689|P1|Overall Study|Other|8
6082717|NCT00391898|20999688|P2|Overall Study|Adverse Event|0
6082718|NCT00391898|20999689|P1|Overall Study|Adverse Event|3
6082719|NCT00391872|20999709|P2|Overall Study|Lost to Follow-up|0
6082720|NCT00391872|20999710|P1|Overall Study|Lost to Follow-up|2
6082721|NCT00391872|20999709|P2|Overall Study|Reason unknown|4
6082722|NCT00391872|20999710|P1|Overall Study|Reason unknown|2
6082723|NCT00391872|20999709|P2|Overall Study|Withdrawal by Subject|249
6082724|NCT00391872|20999710|P1|Overall Study|Withdrawal by Subject|296
6082725|NCT00391872|20999709|P2|Overall Study|Protocol Violation|2
6082726|NCT00391872|20999710|P1|Overall Study|Protocol Violation|7
6082727|NCT00391846|20999748|P2|Overall Study|Developed study specific DC criteria|1
6082728|NCT00391846|20999749|P1|Overall Study|Developed study specific DC criteria|0
6082729|NCT00391846|20999748|P2|Overall Study|Withdrawal by Subject|3
6082730|NCT00391846|20999749|P1|Overall Study|Withdrawal by Subject|2
6082731|NCT00391846|20999748|P2|Overall Study|Did not meet the required elig. crit|2
6082732|NCT00391846|20999749|P1|Overall Study|Did not meet the required elig. crit|2
6082733|NCT00391846|20999748|P2|Overall Study|Adverse Event|1
6082734|NCT00391846|20999749|P1|Overall Study|Adverse Event|4
6082735|NCT00391807|20999769|P1|Overall Study|Various|96
6082736|NCT00391807|20999769|P1|Overall Study|Protocol Violation|20
6082737|NCT00391807|20999769|P1|Overall Study|Withdrawal by Subject|147
6082738|NCT00391807|20999769|P1|Overall Study|Lost to Follow-up|227
6082739|NCT00391807|20999769|P1|Overall Study|Pregnancy|25
6082740|NCT00391807|20999769|P1|Overall Study|Adverse Event|177
6082741|NCT00391807|20999769|P1|Overall Study|Did not receive study medication|23
6082742|NCT00391768|20999796|P7|Overall Study|Lost to Follow-up|3
6082743|NCT00391768|20999797|P6|Overall Study|Lost to Follow-up|2
6082744|NCT00391768|20999798|P5|Overall Study|Lost to Follow-up|2
6082745|NCT00391768|20999799|P4|Overall Study|Lost to Follow-up|1
6082746|NCT00391768|20999800|P3|Overall Study|Lost to Follow-up|0
6082747|NCT00391768|20999801|P2|Overall Study|Lost to Follow-up|0
6082748|NCT00391768|20999802|P1|Overall Study|Lost to Follow-up|0
6082749|NCT00391768|20999796|P7|Overall Study|Withdrawal by Subject|1
6082750|NCT00391768|20999797|P6|Overall Study|Withdrawal by Subject|1
6082751|NCT00391768|20999798|P5|Overall Study|Withdrawal by Subject|0
6082752|NCT00391768|20999799|P4|Overall Study|Withdrawal by Subject|0
6082753|NCT00391768|20999800|P3|Overall Study|Withdrawal by Subject|1
6082754|NCT00391768|20999801|P2|Overall Study|Withdrawal by Subject|0
6082755|NCT00391768|20999802|P1|Overall Study|Withdrawal by Subject|0
6082756|NCT00391625|20999889|P1|Month 50|Physician Decision|1
6082757|NCT00391625|20999889|P1|Month 14|Withdrawal by Subject|1
6082758|NCT00391586|20999942|P1|Overall Study|Death|4
6082759|NCT00391586|20999942|P1|Overall Study|Physician Decision|2
6082760|NCT00391586|20999942|P1|Overall Study|Adverse Event|5
6082761|NCT00391586|20999942|P1|Overall Study|Progressive disease|13
6082762|NCT00391391|20999979|P4|Overall Study|Withdrawal by Subject|7
6082763|NCT00391391|20999980|P3|Overall Study|Withdrawal by Subject|10
6082764|NCT00391391|20999981|P2|Overall Study|Withdrawal by Subject|4
6082765|NCT00391391|20999982|P1|Overall Study|Withdrawal by Subject|6
6082766|NCT00391391|20999979|P4|Overall Study|Protocol Violation|7
6082767|NCT00391391|20999980|P3|Overall Study|Protocol Violation|6
6082768|NCT00391391|20999981|P2|Overall Study|Protocol Violation|3
6082769|NCT00391391|20999982|P1|Overall Study|Protocol Violation|2
6082770|NCT00391391|20999979|P4|Overall Study|Lost to Follow-up|4
6082771|NCT00391391|20999980|P3|Overall Study|Lost to Follow-up|7
6082772|NCT00391391|20999981|P2|Overall Study|Lost to Follow-up|3
6082773|NCT00391391|20999982|P1|Overall Study|Lost to Follow-up|1
6082774|NCT00391391|20999979|P4|Overall Study|Adverse Event|1
6082775|NCT00391391|20999980|P3|Overall Study|Adverse Event|0
6082776|NCT00391391|20999981|P2|Overall Study|Adverse Event|0
6082777|NCT00391391|20999982|P1|Overall Study|Adverse Event|0
6082778|NCT00391274|21000027|P2|Overall Study|Death Not Study Related|1
6082779|NCT00391274|21000028|P1|Overall Study|Death Not Study Related|0
6082780|NCT00391274|21000027|P2|Overall Study|Death Due to Indeterminate Cause|0
6082781|NCT00391274|21000028|P1|Overall Study|Death Due to Indeterminate Cause|1
6082782|NCT00391274|21000027|P2|Overall Study|Death Due to Adverse Event|3
6082783|NCT00391274|21000028|P1|Overall Study|Death Due to Adverse Event|1
6082784|NCT00391274|21000027|P2|Overall Study|Withdrawal by Subject|3
6082785|NCT00391274|21000028|P1|Overall Study|Withdrawal by Subject|0
6082786|NCT00391274|21000027|P2|Overall Study|Physician Decision|2
6082787|NCT00391274|21000028|P1|Overall Study|Physician Decision|4
6082788|NCT00391274|21000027|P2|Overall Study|Lost to Follow-up|3
6082789|NCT00391274|21000028|P1|Overall Study|Lost to Follow-up|0
6082790|NCT00391274|21000027|P2|Overall Study|Death Due to Study Disease|45
6082791|NCT00391274|21000028|P1|Overall Study|Death Due to Study Disease|55
6082792|NCT00391222|21000047|P4|Period III (Double-Blind Treatment)|Other|0
6082793|NCT00391222|21000048|P3|Period III (Double-Blind Treatment)|Other|6
6082794|NCT00391222|21000049|P2|Period III (Double-Blind Treatment)|Other|1
6082795|NCT00391222|21000050|P1|Period III (Double-Blind Treatment)|Other|6
6082796|NCT00391222|21000047|P4|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0
6082797|NCT00391222|21000048|P3|Period III (Double-Blind Treatment)|Study Medication Non-compliant|3
6082798|NCT00391222|21000049|P2|Period III (Double-Blind Treatment)|Study Medication Non-compliant|1
6082799|NCT00391222|21000050|P1|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0
6082800|NCT00391222|21000047|P4|Period III (Double-Blind Treatment)|Pregnancy|0
6082801|NCT00391222|21000048|P3|Period III (Double-Blind Treatment)|Pregnancy|0
6082802|NCT00391222|21000049|P2|Period III (Double-Blind Treatment)|Pregnancy|2
6082803|NCT00391222|21000050|P1|Period III (Double-Blind Treatment)|Pregnancy|0
6082804|NCT00391222|21000047|P4|Period III (Double-Blind Treatment)|Adverse Event|0
6082805|NCT00391222|21000048|P3|Period III (Double-Blind Treatment)|Adverse Event|4
6082806|NCT00391222|21000049|P2|Period III (Double-Blind Treatment)|Adverse Event|2
6082807|NCT00391222|21000050|P1|Period III (Double-Blind Treatment)|Adverse Event|5
6082808|NCT00391222|21000047|P4|Period III (Double-Blind Treatment)|Lost to Follow-up|0
6082809|NCT00391222|21000048|P3|Period III (Double-Blind Treatment)|Lost to Follow-up|4
6082810|NCT00391222|21000049|P2|Period III (Double-Blind Treatment)|Lost to Follow-up|4
6082811|NCT00391222|21000050|P1|Period III (Double-Blind Treatment)|Lost to Follow-up|2
6082812|NCT00391222|21000047|P4|Period III (Double-Blind Treatment)|Withdrawal by Subject|0
6082813|NCT00391222|21000048|P3|Period III (Double-Blind Treatment)|Withdrawal by Subject|6
6082814|NCT00391222|21000049|P2|Period III (Double-Blind Treatment)|Withdrawal by Subject|12
6082815|NCT00391222|21000050|P1|Period III (Double-Blind Treatment)|Withdrawal by Subject|15
6082816|NCT00391222|21000047|P4|Period II (Open-label Risperidone LAI)|Other|24
6082817|NCT00391222|21000048|P3|Period II (Open-label Risperidone LAI)|Other|0
6082818|NCT00391222|21000049|P2|Period II (Open-label Risperidone LAI)|Other|0
6082819|NCT00391222|21000050|P1|Period II (Open-label Risperidone LAI)|Other|0
6082820|NCT00391222|21000047|P4|Period II (Open-label Risperidone LAI)|Non-responder|97
6082821|NCT00391222|21000048|P3|Period II (Open-label Risperidone LAI)|Non-responder|0
6082822|NCT00391222|21000049|P2|Period II (Open-label Risperidone LAI)|Non-responder|0
6082823|NCT00391222|21000050|P1|Period II (Open-label Risperidone LAI)|Non-responder|0
6082824|NCT00391222|21000047|P4|Period II (Open-label Risperidone LAI)|Adverse Event|10
6082825|NCT00391222|21000048|P3|Period II (Open-label Risperidone LAI)|Adverse Event|0
6082826|NCT00391222|21000049|P2|Period II (Open-label Risperidone LAI)|Adverse Event|0
6082827|NCT00391222|21000050|P1|Period II (Open-label Risperidone LAI)|Adverse Event|0
6082828|NCT00391222|21000047|P4|Period II (Open-label Risperidone LAI)|Lost to Follow-up|5
6082829|NCT00391222|21000048|P3|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0
6082830|NCT00391222|21000049|P2|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0
6082831|NCT00391222|21000050|P1|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0
6082832|NCT00391222|21000047|P4|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|26
6082833|NCT00391222|21000048|P3|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0
6082834|NCT00391222|21000049|P2|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0
6082835|NCT00391222|21000050|P1|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0
6082836|NCT00391118|21000077|P3|Overall Study|Protocol Violation|0
6082837|NCT00391118|21000078|P2|Overall Study|Protocol Violation|0
6082838|NCT00391118|21000079|P1|Overall Study|Protocol Violation|1
6082839|NCT00391118|21000077|P3|Overall Study|Sponsor Decision|3
6082840|NCT00391118|21000078|P2|Overall Study|Sponsor Decision|1
6082841|NCT00391118|21000079|P1|Overall Study|Sponsor Decision|0
6082842|NCT00391118|21000077|P3|Overall Study|Progressive Disease|43
6082843|NCT00391118|21000078|P2|Overall Study|Progressive Disease|26
6082844|NCT00391118|21000079|P1|Overall Study|Progressive Disease|7
6082845|NCT00391118|21000077|P3|Overall Study|Protocol Entry Criteria Not Met|1
6082846|NCT00391118|21000078|P2|Overall Study|Protocol Entry Criteria Not Met|3
6082847|NCT00391118|21000079|P1|Overall Study|Protocol Entry Criteria Not Met|0
6082848|NCT00391118|21000077|P3|Overall Study|Physician Decision|0
6082849|NCT00391118|21000078|P2|Overall Study|Physician Decision|3
6082850|NCT00391118|21000079|P1|Overall Study|Physician Decision|0
6082851|NCT00391118|21000077|P3|Overall Study|Death|0
6082852|NCT00391118|21000078|P2|Overall Study|Death|1
6082853|NCT00391118|21000079|P1|Overall Study|Death|0
6082854|NCT00391118|21000077|P3|Overall Study|Withdrawal by Subject|1
6082855|NCT00391118|21000078|P2|Overall Study|Withdrawal by Subject|9
6082856|NCT00391118|21000079|P1|Overall Study|Withdrawal by Subject|0
6082857|NCT00391118|21000077|P3|Overall Study|Lost to Follow-up|3
6082858|NCT00391118|21000078|P2|Overall Study|Lost to Follow-up|2
6082859|NCT00391118|21000079|P1|Overall Study|Lost to Follow-up|0
6082860|NCT00391118|21000077|P3|Overall Study|Adverse Event|7
6082861|NCT00391118|21000078|P2|Overall Study|Adverse Event|10
6082862|NCT00391118|21000079|P1|Overall Study|Adverse Event|3
6082863|NCT00391092|21000105|P2|Overall Study|Alive in follow-up|84
6082864|NCT00391092|21000106|P1|Overall Study|Alive in follow-up|88
6082865|NCT00391092|21000105|P2|Overall Study|Alive on treatment|33
6082866|NCT00391092|21000106|P1|Overall Study|Alive on treatment|29
6082867|NCT00391092|21000105|P2|Overall Study|Lost to Follow-up|18
6082868|NCT00391092|21000106|P1|Overall Study|Lost to Follow-up|13
6082869|NCT00391092|21000105|P2|Overall Study|Death|81
6082870|NCT00391092|21000106|P1|Overall Study|Death|78
6082871|NCT00391053|21000149|P4|Overall Study|Withdrawal by Subject|1
6082872|NCT00391053|21000150|P3|Overall Study|Withdrawal by Subject|1
6082873|NCT00391053|21000151|P2|Overall Study|Withdrawal by Subject|1
6082874|NCT00391053|21000152|P1|Overall Study|Withdrawal by Subject|5
6082875|NCT00391053|21000149|P4|Overall Study|Lost to Follow-up|5
6082876|NCT00391053|21000150|P3|Overall Study|Lost to Follow-up|0
6082877|NCT00391053|21000151|P2|Overall Study|Lost to Follow-up|0
6082878|NCT00391053|21000152|P1|Overall Study|Lost to Follow-up|1
6082879|NCT00391053|21000149|P4|Overall Study|Protocol Violation|0
6082880|NCT00391053|21000150|P3|Overall Study|Protocol Violation|0
6082881|NCT00391053|21000151|P2|Overall Study|Protocol Violation|0
6082882|NCT00391053|21000152|P1|Overall Study|Protocol Violation|2
6082883|NCT00391053|21000149|P4|Overall Study|Serious Adverse Events|4
6082884|NCT00391053|21000150|P3|Overall Study|Serious Adverse Events|1
6082885|NCT00391053|21000151|P2|Overall Study|Serious Adverse Events|0
6082886|NCT00391053|21000152|P1|Overall Study|Serious Adverse Events|1
6082887|NCT00391027|21000176|P2|Overall Study|Other|3
6082888|NCT00391027|21000177|P1|Overall Study|Other|4
6082889|NCT00391027|21000176|P2|Overall Study|Withdrawal by Subject|1
6082890|NCT00391027|21000177|P1|Overall Study|Withdrawal by Subject|10
6082891|NCT00391027|21000176|P2|Overall Study|Lack of Efficacy|0
6082892|NCT00391027|21000177|P1|Overall Study|Lack of Efficacy|3
6082893|NCT00391027|21000176|P2|Overall Study|Adverse Event|8
6082894|NCT00391027|21000177|P1|Overall Study|Adverse Event|8
6082895|NCT00390910|21000227|P3|Overall Study|Migrated/moved from study area|3
6082896|NCT00390910|21000228|P2|Overall Study|Migrated/moved from study area|0
6082897|NCT00390910|21000229|P1|Overall Study|Migrated/moved from study area|0
6082898|NCT00390910|21000227|P3|Overall Study|Withdrawal by Subject|2
6082899|NCT00390910|21000228|P2|Overall Study|Withdrawal by Subject|3
6082900|NCT00390910|21000229|P1|Overall Study|Withdrawal by Subject|1
6082901|NCT00390910|21000227|P3|Overall Study|Lost to Follow-up|5
6082902|NCT00390910|21000228|P2|Overall Study|Lost to Follow-up|1
6082903|NCT00390910|21000229|P1|Overall Study|Lost to Follow-up|0
6082904|NCT00390910|21000227|P3|Overall Study|Adverse Event|0
6082905|NCT00390910|21000228|P2|Overall Study|Adverse Event|0
6082906|NCT00390910|21000229|P1|Overall Study|Adverse Event|1
6082907|NCT00390884|21000317|P2|Overall Study|Withdrawal by Subject|2
6082908|NCT00390884|21000318|P1|Overall Study|Withdrawal by Subject|2
6082909|NCT00390858|21000330|P2|Overall Study|Withdrawal by Subject|4
6082910|NCT00390858|21000331|P1|Overall Study|Withdrawal by Subject|3
6082911|NCT00390858|21000330|P2|Overall Study|Lack of Efficacy|1
6082912|NCT00390858|21000331|P1|Overall Study|Lack of Efficacy|0
6082913|NCT00390858|21000330|P2|Overall Study|Adverse Event|2
6082914|NCT00390858|21000331|P1|Overall Study|Adverse Event|6
6082915|NCT00390806|21000345|P2|Overall Study|Ongoing|2
6082916|NCT00390806|21000346|P1|Overall Study|Ongoing|4
6082917|NCT00390806|21000345|P2|Overall Study|Physician Decision|1
6082918|NCT00390806|21000346|P1|Overall Study|Physician Decision|0
6082919|NCT00390806|21000345|P2|Overall Study|Death|0
6082920|NCT00390806|21000346|P1|Overall Study|Death|1
6082921|NCT00390806|21000345|P2|Overall Study|Investigator Decision|6
6082922|NCT00390806|21000346|P1|Overall Study|Investigator Decision|4
6082923|NCT00390806|21000345|P2|Overall Study|Withdrawal by Subject|15
6082924|NCT00390806|21000346|P1|Overall Study|Withdrawal by Subject|12
6082925|NCT00390806|21000345|P2|Overall Study|Protocol Violation|2
6082926|NCT00390806|21000346|P1|Overall Study|Protocol Violation|2
6082927|NCT00390806|21000345|P2|Overall Study|Lost to Follow-up|6
6082928|NCT00390806|21000346|P1|Overall Study|Lost to Follow-up|7
6082929|NCT00390780|21000414|P2|Overall Study|SAE, death|1
6082930|NCT00390780|21000415|P1|Overall Study|SAE, death|0
6082931|NCT00390780|21000414|P2|Overall Study|Investigator decision, SAE, other reason|1
6082932|NCT00390780|21000415|P1|Overall Study|Investigator decision, SAE, other reason|0
6082933|NCT00390780|21000414|P2|Overall Study|Lost to follow up and other reasons|1
6082934|NCT00390780|21000415|P1|Overall Study|Lost to follow up and other reasons|0
6082935|NCT00390780|21000414|P2|Overall Study|Inclusion criteria not satisfied|2
6082936|NCT00390780|21000415|P1|Overall Study|Inclusion criteria not satisfied|0
6082937|NCT00390780|21000414|P2|Overall Study|Withdrawal by Subject|2
6082938|NCT00390780|21000415|P1|Overall Study|Withdrawal by Subject|1
6082939|NCT00390780|21000414|P2|Overall Study|Death|3
6082940|NCT00390780|21000415|P1|Overall Study|Death|1
6082941|NCT00390780|21000414|P2|Overall Study|Adverse Event|3
6082942|NCT00390780|21000415|P1|Overall Study|Adverse Event|2
6082943|NCT00390780|21000414|P2|Overall Study|Lost to Follow-up|6
6082944|NCT00390780|21000415|P1|Overall Study|Lost to Follow-up|3
6082945|NCT00390780|21000414|P2|Overall Study|Protocol Violation|4
6082946|NCT00390780|21000415|P1|Overall Study|Protocol Violation|6
6082947|NCT00390780|21000414|P2|Overall Study|Not completed|4
6082948|NCT00390780|21000415|P1|Overall Study|Not completed|10
6082949|NCT00390689|21000448|P3|Overall Study|Investigator's judgement|0
6082950|NCT00390689|21000449|P2|Overall Study|Investigator's judgement|0
6082951|NCT00390689|21000450|P1|Overall Study|Investigator's judgement|2
6082952|NCT00390689|21000448|P3|Overall Study|Protocol Violation|0
6082953|NCT00390689|21000449|P2|Overall Study|Protocol Violation|0
6082954|NCT00390689|21000450|P1|Overall Study|Protocol Violation|1
6082955|NCT00390689|21000448|P3|Overall Study|Lack of Efficacy|1
6082956|NCT00390689|21000449|P2|Overall Study|Lack of Efficacy|0
6082957|NCT00390689|21000450|P1|Overall Study|Lack of Efficacy|0
6082958|NCT00390689|21000448|P3|Overall Study|Adverse Event|2
6082959|NCT00390689|21000449|P2|Overall Study|Adverse Event|5
6082960|NCT00390689|21000450|P1|Overall Study|Adverse Event|2
6082961|NCT00390572|21000525|P2|Overall Study|health condition|1
6082962|NCT00390572|21000526|P1|Overall Study|health condition|0
6082963|NCT00390572|21000525|P2|Overall Study|Lost to Follow-up|4
6082964|NCT00390572|21000526|P1|Overall Study|Lost to Follow-up|8
6082965|NCT00390546|21000552|P2|Overall Study|Physician Decision|5
6082966|NCT00390546|21000553|P1|Overall Study|Physician Decision|5
6082967|NCT00390546|21000552|P2|Overall Study|Renal impairment|0
6082968|NCT00390546|21000553|P1|Overall Study|Renal impairment|1
6082969|NCT00390468|21000563|P1|Overall Study|Lack of Efficacy|1
6082970|NCT00390468|21000563|P1|Overall Study|Protocol Violation|2
6082971|NCT00390455|21000569|P2|Overall Study|Other Medical Reasons|11
6082972|NCT00390455|21000570|P1|Overall Study|Other Medical Reasons|7
6082973|NCT00390455|21000569|P2|Overall Study|Alternate Treatment|1
6082974|NCT00390455|21000570|P1|Overall Study|Alternate Treatment|0
6082975|NCT00390455|21000569|P2|Overall Study|Withdrawal by Subject|8
6082976|NCT00390455|21000570|P1|Overall Study|Withdrawal by Subject|8
6082977|NCT00390455|21000569|P2|Overall Study|Adverse Event|3
6082978|NCT00390455|21000570|P1|Overall Study|Adverse Event|17
6082979|NCT00390416|21000615|P1|Overall Study|Not treated|3
6082980|NCT00390416|21000615|P1|Overall Study|Withdrawal by Subject|1
6082981|NCT00390299|21000653|P5|Overall Study|Cancellation|0
6082982|NCT00390299|21000654|P4|Overall Study|Cancellation|0
6082983|NCT00390299|21000655|P3|Overall Study|Cancellation|0
6082984|NCT00390299|21000656|P2|Overall Study|Cancellation|0
6082985|NCT00390299|21000657|P1|Overall Study|Cancellation|1
6082986|NCT00390221|21000688|P3|Overall Study|Other|2
6082987|NCT00390221|21000689|P2|Overall Study|Other|4
6082988|NCT00390221|21000690|P1|Overall Study|Other|3
6082989|NCT00390221|21000688|P3|Overall Study|Subject Non-compliance|2
6082990|NCT00390221|21000689|P2|Overall Study|Subject Non-compliance|0
6082991|NCT00390221|21000690|P1|Overall Study|Subject Non-compliance|1
6082992|NCT00390221|21000688|P3|Overall Study|Withdrawal by Subject|7
6082993|NCT00390221|21000689|P2|Overall Study|Withdrawal by Subject|9
6082994|NCT00390221|21000690|P1|Overall Study|Withdrawal by Subject|13
6082995|NCT00390221|21000688|P3|Overall Study|Investigator Decision|1
6082996|NCT00390221|21000689|P2|Overall Study|Investigator Decision|0
6082997|NCT00390221|21000690|P1|Overall Study|Investigator Decision|0
6082998|NCT00390221|21000688|P3|Overall Study|Adverse Event|3
6082999|NCT00390221|21000689|P2|Overall Study|Adverse Event|4
6083000|NCT00390221|21000690|P1|Overall Study|Adverse Event|1
6083001|NCT00390221|21000688|P3|Overall Study|Lost to Follow-up|0
6083002|NCT00390221|21000689|P2|Overall Study|Lost to Follow-up|3
6083003|NCT00390221|21000690|P1|Overall Study|Lost to Follow-up|0
6083004|NCT00390013|21000720|P4|Phase 2 First Treatment|Withdrawal by Subject|0
6083005|NCT00390013|21000721|P3|Phase 2 First Treatment|Withdrawal by Subject|0
6083006|NCT00390013|21000722|P2|Phase 2 First Treatment|Withdrawal by Subject|1
6083007|NCT00390013|21000723|P1|Phase 2 First Treatment|Withdrawal by Subject|0
6083008|NCT00390013|21000720|P4|Phase 2 First Treatment|tired|0
6083009|NCT00390013|21000721|P3|Phase 2 First Treatment|tired|0
6083010|NCT00390013|21000722|P2|Phase 2 First Treatment|tired|0
6083011|NCT00390013|21000723|P1|Phase 2 First Treatment|tired|1
6083012|NCT00390013|21000720|P4|Phase 1|tired|1
6083013|NCT00390013|21000721|P3|Phase 1|tired|0
6083014|NCT00390013|21000722|P2|Phase 1|tired|0
6083015|NCT00390013|21000723|P1|Phase 1|tired|0
6083016|NCT00389831|21000748|P2|Overall Study|Lost to Follow-up|1
6083017|NCT00389831|21000749|P1|Overall Study|Lost to Follow-up|0
6083018|NCT00389831|21000748|P2|Overall Study|Other reasons|2
6083019|NCT00389831|21000749|P1|Overall Study|Other reasons|0
6083020|NCT00389831|21000748|P2|Overall Study|Did not receive treatment.|2
6083021|NCT00389831|21000749|P1|Overall Study|Did not receive treatment.|0
6083022|NCT00389831|21000748|P2|Overall Study|Lack of Efficacy|2
6083023|NCT00389831|21000749|P1|Overall Study|Lack of Efficacy|0
6083024|NCT00389597|21000812|P4|Overall Study|Lost to Follow-up|6
6083025|NCT00389597|21000813|P3|Overall Study|Lost to Follow-up|4
6083026|NCT00389597|21000814|P2|Overall Study|Lost to Follow-up|6
6083027|NCT00389597|21000815|P1|Overall Study|Lost to Follow-up|8
6083028|NCT00389519|21000840|P4|Treated|Reason not specified|2
6083029|NCT00389519|21000841|P3|Treated|Reason not specified|0
6083030|NCT00389519|21000842|P2|Treated|Reason not specified|1
6083031|NCT00389519|21000843|P1|Treated|Reason not specified|1
6083032|NCT00389519|21000840|P4|Treated|Adverse Event|2
6083033|NCT00389519|21000841|P3|Treated|Adverse Event|0
6083034|NCT00389519|21000842|P2|Treated|Adverse Event|0
6083035|NCT00389519|21000843|P1|Treated|Adverse Event|1
6083036|NCT00389519|21000840|P4|Randomized|Did not receive study drug|0
6083037|NCT00389519|21000841|P3|Randomized|Did not receive study drug|0
6083038|NCT00389519|21000842|P2|Randomized|Did not receive study drug|0
6083039|NCT00389519|21000843|P1|Randomized|Did not receive study drug|2
6083040|NCT00389519|21000840|P4|Placebo Run-In|Reason not specified|0
6083041|NCT00389519|21000841|P3|Placebo Run-In|Reason not specified|0
6083042|NCT00389519|21000842|P2|Placebo Run-In|Reason not specified|0
6083043|NCT00389519|21000843|P1|Placebo Run-In|Reason not specified|40
6083044|NCT00389519|21000840|P4|Placebo Run-In|Withdrawal by Subject|0
6083045|NCT00389519|21000841|P3|Placebo Run-In|Withdrawal by Subject|0
6083046|NCT00389519|21000842|P2|Placebo Run-In|Withdrawal by Subject|0
6083047|NCT00389519|21000843|P1|Placebo Run-In|Withdrawal by Subject|19
6083048|NCT00389519|21000840|P4|Placebo Run-In|Did not meet blood pressure criteria|0
6083049|NCT00389519|21000841|P3|Placebo Run-In|Did not meet blood pressure criteria|0
6083050|NCT00389519|21000842|P2|Placebo Run-In|Did not meet blood pressure criteria|0
6083051|NCT00389519|21000843|P1|Placebo Run-In|Did not meet blood pressure criteria|119
6083052|NCT00389441|21000920|P1|Overall Study|Clinical progression|1
6083053|NCT00389441|21000920|P1|Overall Study|Ongoing in study A4061008 (NCT00828919)|2
6083054|NCT00389441|21000920|P1|Overall Study|Objective progression or relapse|26
6083055|NCT00389441|21000920|P1|Overall Study|Global deterioration of health status|4
6083056|NCT00389441|21000920|P1|Overall Study|Protocol Violation|1
6083057|NCT00389441|21000920|P1|Overall Study|Physician Decision|1
6083058|NCT00389441|21000920|P1|Overall Study|Withdrawal by Subject|4
6083059|NCT00389441|21000920|P1|Overall Study|Lost to Follow-up|2
6083060|NCT00389441|21000920|P1|Overall Study|Death|4
6083061|NCT00389441|21000920|P1|Overall Study|Adverse Event|7
6083062|NCT00389324|21000929|P1|Subcutaneous Phase|Lost to Follow-up|1
6083063|NCT00389324|21000929|P1|Subcutaneous Phase|Withdrawal by Subject|2
6083064|NCT00389324|21000929|P1|Subcutaneous Phase|Non-compliance with study medication|2
6083065|NCT00389324|21000929|P1|Subcutaneous Phase|Adverse Event|2
6083066|NCT00389324|21000929|P1|Run-In Phase|Withdrawal by Subject|1
6083067|NCT00389324|21000929|P1|Run-In Phase|Lost to Follow-up|1
6083068|NCT00389324|21000929|P1|Run-In Phase|Adverse Event|1
6083069|NCT00389207|21000939|P3|Overall Study|Other|9
6083070|NCT00389207|21000940|P2|Overall Study|Other|23
6083071|NCT00389207|21000941|P1|Overall Study|Other|17
6083072|NCT00389207|21000939|P3|Overall Study|Withdrawal by Subject|11
6083073|NCT00389207|21000940|P2|Overall Study|Withdrawal by Subject|7
6083074|NCT00389207|21000941|P1|Overall Study|Withdrawal by Subject|5
6083075|NCT00389207|21000939|P3|Overall Study|Lost to Follow-up|7
6083076|NCT00389207|21000940|P2|Overall Study|Lost to Follow-up|9
6083077|NCT00389207|21000941|P1|Overall Study|Lost to Follow-up|12
6083078|NCT00389207|21000939|P3|Overall Study|Protocol Violation|4
6083079|NCT00389207|21000940|P2|Overall Study|Protocol Violation|1
6083080|NCT00389207|21000941|P1|Overall Study|Protocol Violation|3
6083081|NCT00389207|21000939|P3|Overall Study|Adverse Event|10
6083082|NCT00389207|21000940|P2|Overall Study|Adverse Event|32
6083083|NCT00389207|21000941|P1|Overall Study|Adverse Event|26
6083084|NCT00389064|21001064|P2|Overall Study|Multiple Reasons|11
6083085|NCT00389064|21001065|P1|Overall Study|Multiple Reasons|9
6083086|NCT00389064|21001064|P2|Overall Study|Protocol Violation|0
6083087|NCT00389064|21001065|P1|Overall Study|Protocol Violation|2
6083088|NCT00389064|21001064|P2|Overall Study|Lost to Follow-up|2
6083089|NCT00389064|21001065|P1|Overall Study|Lost to Follow-up|1
6083090|NCT00389064|21001064|P2|Overall Study|Physician Decision|2
6083091|NCT00389064|21001065|P1|Overall Study|Physician Decision|2
6083092|NCT00389064|21001064|P2|Overall Study|Withdrawal by Subject|27
6083093|NCT00389064|21001065|P1|Overall Study|Withdrawal by Subject|17
6083094|NCT00389064|21001064|P2|Overall Study|Lack of Efficacy|14
6083095|NCT00389064|21001065|P1|Overall Study|Lack of Efficacy|3
6083096|NCT00389064|21001064|P2|Overall Study|Adverse Event|3
6083097|NCT00389064|21001065|P1|Overall Study|Adverse Event|11
6083098|NCT00388973|21001093|P2|Overall Study|Did not complete 2-week follow-up visit|17
6083099|NCT00388973|21001094|P1|Overall Study|Did not complete 2-week follow-up visit|17
6083100|NCT00388973|21001093|P2|Overall Study|Left region|1
6083101|NCT00388973|21001094|P1|Overall Study|Left region|0
6083102|NCT00388973|21001093|P2|Overall Study|Did not complete 61 days of treatment|4
6083103|NCT00388973|21001094|P1|Overall Study|Did not complete 61 days of treatment|5
6083104|NCT00388973|21001093|P2|Overall Study|Study specific Discontinuation Criteria|1
6083105|NCT00388973|21001094|P1|Overall Study|Study specific Discontinuation Criteria|0
6083106|NCT00388973|21001093|P2|Overall Study|Withdrawal by Subject|17
6083107|NCT00388973|21001094|P1|Overall Study|Withdrawal by Subject|14
6083108|NCT00388973|21001093|P2|Overall Study|Protocol Violation|0
6083109|NCT00388973|21001094|P1|Overall Study|Protocol Violation|3
6083110|NCT00388973|21001093|P2|Overall Study|Lack of Efficacy|12
6083111|NCT00388973|21001094|P1|Overall Study|Lack of Efficacy|1
6083112|NCT00388973|21001093|P2|Overall Study|Adverse Event|6
6083113|NCT00388973|21001094|P1|Overall Study|Adverse Event|16
6083114|NCT00388947|21001114|P1|Overall Study|Protocol Violation|47
6083115|NCT00388726|21001130|P2|Overall Study|Death|2
6083116|NCT00388726|21001131|P1|Overall Study|Death|3
6083117|NCT00388726|21001130|P2|Overall Study|Physician Decision|13
6083118|NCT00388726|21001131|P1|Overall Study|Physician Decision|18
6083119|NCT00388726|21001130|P2|Overall Study|Administrative|9
6083120|NCT00388726|21001131|P1|Overall Study|Administrative|6
6083121|NCT00388726|21001130|P2|Overall Study|Withdrawal by Subject|7
6083122|NCT00388726|21001131|P1|Overall Study|Withdrawal by Subject|10
6083123|NCT00388726|21001130|P2|Overall Study|Clinical Progression|36
6083124|NCT00388726|21001131|P1|Overall Study|Clinical Progression|61
6083125|NCT00388726|21001130|P2|Overall Study|Progressive Disease|153
6083126|NCT00388726|21001131|P1|Overall Study|Progressive Disease|336
6083127|NCT00388726|21001130|P2|Overall Study|Adverse Event|24
6083128|NCT00388726|21001131|P1|Overall Study|Adverse Event|50
6083129|NCT00388674|21001147|P2|End of Study|Not Reported|1
6083130|NCT00388674|21001148|P1|End of Study|Not Reported|0
6083131|NCT00388674|21001147|P2|End of Study|No Off-Treatment Status Data|30
6083132|NCT00388674|21001148|P1|End of Study|No Off-Treatment Status Data|22
6083133|NCT00388674|21001147|P2|End of Study|Participant Withdrew Consent|673
6083134|NCT00388674|21001148|P1|End of Study|Participant Withdrew Consent|437
6083135|NCT00388674|21001147|P2|End of Study|Not Defined|214
6083136|NCT00388674|21001148|P1|End of Study|Not Defined|135
6083137|NCT00388674|21001147|P2|End of Study|Non-Study Related Comorbidities|4
6083138|NCT00388674|21001148|P1|End of Study|Non-Study Related Comorbidities|3
6083139|NCT00388674|21001147|P2|End of Study|Malignancy (Non-HCC)|1
6083140|NCT00388674|21001148|P1|End of Study|Malignancy (Non-HCC)|1
6083141|NCT00388674|21001147|P2|End of Study|Lost to Follow-up|715
6083142|NCT00388674|21001148|P1|End of Study|Lost to Follow-up|587
6083143|NCT00388674|21001147|P2|End of Study|HCC|7
6083144|NCT00388674|21001148|P1|End of Study|HCC|8
6083145|NCT00388674|21001147|P2|End of Study|HBV Disease Progression (Non-HCC)|9
6083146|NCT00388674|21001148|P1|End of Study|HBV Disease Progression (Non-HCC)|3
6083147|NCT00388674|21001147|P2|End of Study|Death|262
6083148|NCT00388674|21001148|P1|End of Study|Death|239
6083149|NCT00388674|21001147|P2|End of Study|Administrative Reason By Sponsor|253
6083150|NCT00388674|21001148|P1|End of Study|Administrative Reason By Sponsor|299
6083151|NCT00388674|21001147|P2|Initial Treatment|Not Reported|12
6083152|NCT00388674|21001148|P1|Initial Treatment|Not Reported|10
6083153|NCT00388674|21001147|P2|Initial Treatment|No Off-Treatment Status Data|13
6083154|NCT00388674|21001148|P1|Initial Treatment|No Off-Treatment Status Data|11
6083155|NCT00388674|21001147|P2|Initial Treatment|Participant Request|673
6083156|NCT00388674|21001148|P1|Initial Treatment|Participant Request|501
6083157|NCT00388674|21001147|P2|Initial Treatment|Study Drug Toxicity|92
6083158|NCT00388674|21001148|P1|Initial Treatment|Study Drug Toxicity|5
6083159|NCT00388674|21001147|P2|Initial Treatment|Pregnancy|16
6083160|NCT00388674|21001148|P1|Initial Treatment|Pregnancy|26
6083161|NCT00388674|21001147|P2|Initial Treatment|Partial or inadequate Treatment|472
6083162|NCT00388674|21001148|P1|Initial Treatment|Partial or inadequate Treatment|112
6083163|NCT00388674|21001147|P2|Initial Treatment|Not Defined|172
6083164|NCT00388674|21001148|P1|Initial Treatment|Not Defined|125
6083165|NCT00388674|21001147|P2|Initial Treatment|Non-Study related Comorbidities|4
6083166|NCT00388674|21001148|P1|Initial Treatment|Non-Study related Comorbidities|3
6083167|NCT00388674|21001147|P2|Initial Treatment|Never Treated with Study Medication|7
6083168|NCT00388674|21001148|P1|Initial Treatment|Never Treated with Study Medication|1
6083169|NCT00388674|21001147|P2|Initial Treatment|Malignancy (Non-HCC)|3
6083170|NCT00388674|21001148|P1|Initial Treatment|Malignancy (Non-HCC)|7
6083171|NCT00388674|21001147|P2|Initial Treatment|Lost to Follow-up|624
6083172|NCT00388674|21001148|P1|Initial Treatment|Lost to Follow-up|526
6083173|NCT00388674|21001147|P2|Initial Treatment|HCC|20
6083174|NCT00388674|21001148|P1|Initial Treatment|HCC|12
6083175|NCT00388674|21001147|P2|Initial Treatment|Non-HCC HBV Disease Progression|17
6083176|NCT00388674|21001148|P1|Initial Treatment|Non-HCC HBV Disease Progression|11
6083177|NCT00388674|21001147|P2|Initial Treatment|Death|216
6083178|NCT00388674|21001148|P1|Initial Treatment|Death|215
6083179|NCT00388674|21001147|P2|Initial Treatment|Adverse Event|87
6083180|NCT00388674|21001148|P1|Initial Treatment|Adverse Event|22
6083181|NCT00388674|21001147|P2|Initial Treatment|Administrative Reason by Sponsor|158
6083182|NCT00388674|21001148|P1|Initial Treatment|Administrative Reason by Sponsor|241
6083183|NCT00388583|21001166|P2|Overall Study|Did not receive vaccine|1
6083184|NCT00388583|21001167|P1|Overall Study|Did not receive vaccine|0
6083185|NCT00388583|21001166|P2|Overall Study|Serious Adverse Event|0
6083186|NCT00388583|21001167|P1|Overall Study|Serious Adverse Event|2
6083187|NCT00388583|21001166|P2|Overall Study|Withdrawal by Subject|3
6083188|NCT00388583|21001167|P1|Overall Study|Withdrawal by Subject|3
6083189|NCT00388583|21001166|P2|Overall Study|Protocol Violation|0
6083190|NCT00388583|21001167|P1|Overall Study|Protocol Violation|1
6083191|NCT00388505|21001181|P2|Overall Study|Unable to classify|3
6083192|NCT00388505|21001182|P1|Overall Study|Unable to classify|4
6083193|NCT00388505|21001181|P2|Overall Study|Protocol Violation|5
6083194|NCT00388505|21001182|P1|Overall Study|Protocol Violation|6
6083195|NCT00388505|21001181|P2|Overall Study|Administrative Reason|0
6083196|NCT00388505|21001182|P1|Overall Study|Administrative Reason|1
6083197|NCT00388505|21001181|P2|Overall Study|Inappropriate Enrollment|1
6083198|NCT00388505|21001182|P1|Overall Study|Inappropriate Enrollment|0
6083199|NCT00388505|21001181|P2|Overall Study|Lost to Follow-up|3
6083200|NCT00388505|21001182|P1|Overall Study|Lost to Follow-up|5
6083201|NCT00388505|21001181|P2|Overall Study|Withdrawal by Subject|9
6083202|NCT00388505|21001182|P1|Overall Study|Withdrawal by Subject|24
6083203|NCT00388505|21001181|P2|Overall Study|Adverse Event or Death|17
6083204|NCT00388505|21001182|P1|Overall Study|Adverse Event or Death|43
6083205|NCT00388362|21001237|P1|Remained on Study Median of 514 Days|Death|2
6083206|NCT00388362|21001237|P1|Enrolled|Withdrawal by Subject|1
6083207|NCT00388362|21001237|P1|Enrolled|Loss insurance|1
6083208|NCT00388362|21001237|P1|Enrolled|Death|1
6083209|NCT00388362|21001237|P1|Enrolled|Adverse Event|9
6083210|NCT00388362|21001237|P1|Enrolled|Ineligible|1
6083211|NCT00388349|21001242|P2|Phase I Dose Escalation|Dose reduction due to DLT|3
6083212|NCT00388349|21001243|P1|Phase I Dose Escalation|Dose reduction due to DLT|0
6083213|NCT00388297|21001256|P4|Overall Study|Lost to Follow-up|8
6083214|NCT00388297|21001257|P3|Overall Study|Lost to Follow-up|11
6083215|NCT00388297|21001258|P2|Overall Study|Lost to Follow-up|12
6083216|NCT00388297|21001259|P1|Overall Study|Lost to Follow-up|16
6083217|NCT00388154|21001369|P1|Overall Study|Withdrawal by Subject|1
6083218|NCT00388037|21001374|P1|Overall Study|Protocol Violation|1
6083219|NCT00387894|21001382|P1|Overall Study|Withdrawal by Subject|1
6083220|NCT00387881|21001389|P2|Overall Study|Not otherwise specified|7
6083221|NCT00387881|21001390|P1|Overall Study|Not otherwise specified|11
6083222|NCT00387881|21001389|P2|Overall Study|No opportunity to treat headache|34
6083223|NCT00387881|21001390|P1|Overall Study|No opportunity to treat headache|32
6083224|NCT00387881|21001389|P2|Overall Study|Not eligible|7
6083225|NCT00387881|21001390|P1|Overall Study|Not eligible|6
6083226|NCT00387881|21001389|P2|Overall Study|Sponsor terminated Study|1
6083227|NCT00387881|21001390|P1|Overall Study|Sponsor terminated Study|0
6083228|NCT00387881|21001389|P2|Overall Study|Withdrawal by Subject|18
6083229|NCT00387881|21001390|P1|Overall Study|Withdrawal by Subject|15
6083230|NCT00387881|21001389|P2|Overall Study|Protocol Violation|12
6083231|NCT00387881|21001390|P1|Overall Study|Protocol Violation|2
6083232|NCT00387881|21001389|P2|Overall Study|Lost to Follow-up|23
6083233|NCT00387881|21001390|P1|Overall Study|Lost to Follow-up|23
6083234|NCT00387790|21001423|P1|Overall Study|Ineligible for study|2
6083235|NCT00387790|21001423|P1|Overall Study|Withdrawal by Subject|3
6083236|NCT00387790|21001423|P1|Overall Study|Physician Decision|2
6083237|NCT00387790|21001423|P1|Overall Study|Lack of Efficacy|2
6083238|NCT00387790|21001423|P1|Overall Study|Adverse Event|5
6083239|NCT00387764|21001429|P1|Overall Study|Death|7
6083240|NCT00387764|21001429|P1|Overall Study|Other|2
6083241|NCT00387764|21001429|P1|Overall Study|Physician Decision|1
6083242|NCT00387764|21001429|P1|Overall Study|Sponsor Terminated Study|1
6083243|NCT00387764|21001429|P1|Overall Study|Withdrawal by Subject|8
6083244|NCT00387764|21001429|P1|Overall Study|Adverse Event|12
6083245|NCT00387725|21001457|P4|Overall Study|Parent/legal guardian request|1
6083246|NCT00387725|21001458|P3|Overall Study|Parent/legal guardian request|1
6083247|NCT00387725|21001459|P2|Overall Study|Parent/legal guardian request|0
6083248|NCT00387725|21001460|P1|Overall Study|Parent/legal guardian request|0
6083249|NCT00387725|21001457|P4|Overall Study|Withdrawal by Subject|0
6083250|NCT00387725|21001458|P3|Overall Study|Withdrawal by Subject|1
6083251|NCT00387725|21001459|P2|Overall Study|Withdrawal by Subject|0
6083252|NCT00387725|21001460|P1|Overall Study|Withdrawal by Subject|1
6083253|NCT00387725|21001457|P4|Overall Study|Protocol Violation|0
6083254|NCT00387725|21001458|P3|Overall Study|Protocol Violation|0
6083255|NCT00387725|21001459|P2|Overall Study|Protocol Violation|1
6083256|NCT00387725|21001460|P1|Overall Study|Protocol Violation|0
6083257|NCT00387725|21001457|P4|Overall Study|Adverse Event|1
6083258|NCT00387725|21001458|P3|Overall Study|Adverse Event|0
6083259|NCT00387725|21001459|P2|Overall Study|Adverse Event|0
6083260|NCT00387725|21001460|P1|Overall Study|Adverse Event|0
6083261|NCT00387712|21001480|P2|Overall Study|Withdrawal by Subject|12
6083262|NCT00387712|21001481|P1|Overall Study|Withdrawal by Subject|6
6083263|NCT00387712|21001480|P2|Overall Study|Lost to Follow-up|20
6083264|NCT00387712|21001481|P1|Overall Study|Lost to Follow-up|17
6083265|NCT00387712|21001480|P2|Overall Study|Physician Decision|4
6083266|NCT00387712|21001481|P1|Overall Study|Physician Decision|6
6083267|NCT00387647|21001512|P1|Overall Study|Death|18
6083268|NCT00387465|21001555|P3|Overall Study|Withdrawal by Subject|0
6083269|NCT00387465|21001556|P2|Overall Study|Withdrawal by Subject|1
6083270|NCT00387465|21001557|P1|Overall Study|Withdrawal by Subject|0
6083271|NCT00387426|21001574|P1|Overall Study|Disease Progression|3
6083272|NCT00387426|21001574|P1|Overall Study|Toxicities|4
6083273|NCT00387426|21001574|P1|Overall Study|Lack of Response|7
6083274|NCT00387348|21001581|P3|Overall Study|Adverse Event|1
6083275|NCT00387348|21001582|P2|Overall Study|Adverse Event|0
6083276|NCT00387348|21001583|P1|Overall Study|Adverse Event|1
6083277|NCT00387348|21001581|P3|Overall Study|Withdrawal by Subject|2
6083278|NCT00387348|21001582|P2|Overall Study|Withdrawal by Subject|2
6083279|NCT00387348|21001583|P1|Overall Study|Withdrawal by Subject|0
6083280|NCT00387348|21001581|P3|Overall Study|Physician Decision|1
6083281|NCT00387348|21001582|P2|Overall Study|Physician Decision|0
6083282|NCT00387348|21001583|P1|Overall Study|Physician Decision|1
6083283|NCT00387348|21001581|P3|Overall Study|Death|0
6083284|NCT00387348|21001582|P2|Overall Study|Death|1
6083285|NCT00387348|21001583|P1|Overall Study|Death|1
6083286|NCT00387153|21001616|P1|Overall Study|Lack of Response|4
6083287|NCT00387153|21001616|P1|Overall Study|Disease Progression|3
6083288|NCT00387153|21001616|P1|Overall Study|Adverse Event|1
6083289|NCT00387127|21001622|P2|Overall Study|Sponsor Unblinded|0
6083290|NCT00387127|21001623|P1|Overall Study|Sponsor Unblinded|1
6083291|NCT00387127|21001622|P2|Overall Study|Serious Adverse Event|1
6083292|NCT00387127|21001623|P1|Overall Study|Serious Adverse Event|1
6083293|NCT00387127|21001622|P2|Overall Study|Required by Protocol Amendment #4|10
6083294|NCT00387127|21001623|P1|Overall Study|Required by Protocol Amendment #4|12
6083295|NCT00387127|21001622|P2|Overall Study|Withdrawal by Subject|2
6083296|NCT00387127|21001623|P1|Overall Study|Withdrawal by Subject|3
6083297|NCT00387127|21001622|P2|Overall Study|Physician Decision|1
6083298|NCT00387127|21001623|P1|Overall Study|Physician Decision|0
6083299|NCT00387127|21001622|P2|Overall Study|Death|16
6083300|NCT00387127|21001623|P1|Overall Study|Death|16
6083301|NCT00387127|21001622|P2|Overall Study|Lost to Follow-up|4
6083302|NCT00387127|21001623|P1|Overall Study|Lost to Follow-up|0
6083303|NCT00387088|21001665|P2|Overall Study|Other|52
6083304|NCT00387088|21001666|P1|Overall Study|Other|58
6083305|NCT00387088|21001665|P2|Overall Study|Lost to Follow-up|28
6083306|NCT00387088|21001666|P1|Overall Study|Lost to Follow-up|22
6083307|NCT00387088|21001665|P2|Overall Study|Lack of Efficacy|67
6083308|NCT00387088|21001666|P1|Overall Study|Lack of Efficacy|28
6083309|NCT00387088|21001665|P2|Overall Study|Withdrawal by Subject|35
6083310|NCT00387088|21001666|P1|Overall Study|Withdrawal by Subject|20
6083311|NCT00387088|21001665|P2|Overall Study|Protocol Violation|35
6083312|NCT00387088|21001666|P1|Overall Study|Protocol Violation|47
6083313|NCT00387088|21001665|P2|Overall Study|Adverse Event|156
6083314|NCT00387088|21001666|P1|Overall Study|Adverse Event|143
6083315|NCT00387010|21001723|P1|Treatment Period|Participant reported study drug stolen|1
6083316|NCT00387010|21001723|P1|Treatment Period|Noncompliance with study procedures|3
6083317|NCT00387010|21001723|P1|Treatment Period|Noncompliance with study medication|2
6083318|NCT00387010|21001723|P1|Treatment Period|Withdrawal by Subject|1
6083319|NCT00387010|21001723|P1|Treatment Period|Adverse Event|4
6083320|NCT00387010|21001723|P1|Dose Titration Period|Noncompliance with study procedures|7
6083321|NCT00387010|21001723|P1|Dose Titration Period|Noncompliance with study medication|8
6083322|NCT00387010|21001723|P1|Dose Titration Period|Lost to Follow-up|2
6083323|NCT00387010|21001723|P1|Dose Titration Period|Protocol Violation|1
6083324|NCT00387010|21001723|P1|Dose Titration Period|Withdrawal by Subject|3
6083325|NCT00387010|21001723|P1|Dose Titration Period|Lack of Efficacy|5
6083326|NCT00387010|21001723|P1|Dose Titration Period|Adverse Event|12
6083327|NCT00386776|21001750|P1|Overall Study|Withdrawal by Subject|8
6083328|NCT00386607|21001764|P2|Extension|Unsatisfactory therapeutic effect|1
6083329|NCT00386607|21001765|P1|Extension|Unsatisfactory therapeutic effect|0
6083330|NCT00386607|21001764|P2|Extension|Patient withdrew consent|5
6083331|NCT00386607|21001765|P1|Extension|Patient withdrew consent|0
6083332|NCT00386607|21001764|P2|Extension|Lost to Follow-up|3
6083333|NCT00386607|21001765|P1|Extension|Lost to Follow-up|0
6083334|NCT00386607|21001764|P2|Extension|Administrative problems|1
6083335|NCT00386607|21001765|P1|Extension|Administrative problems|0
6083336|NCT00386607|21001764|P2|Extension|Abnormal laboratory value(s)|1
6083337|NCT00386607|21001765|P1|Extension|Abnormal laboratory value(s)|0
6083338|NCT00386607|21001764|P2|Extension|Adverse Event|6
6083339|NCT00386607|21001765|P1|Extension|Adverse Event|0
6083340|NCT00386607|21001764|P2|Core|Protocol Deviation|0
6083341|NCT00386607|21001765|P1|Core|Protocol Deviation|6
6083342|NCT00386607|21001764|P2|Core|Administrative problems|0
6083343|NCT00386607|21001765|P1|Core|Administrative problems|1
6083344|NCT00386607|21001764|P2|Core|Lost to Follow-up|0
6083345|NCT00386607|21001765|P1|Core|Lost to Follow-up|23
6083346|NCT00386607|21001764|P2|Core|Patient withdrew consent|0
6083347|NCT00386607|21001765|P1|Core|Patient withdrew consent|15
6083348|NCT00386607|21001764|P2|Core|Condition no longer requires study drug|0
6083349|NCT00386607|21001765|P1|Core|Condition no longer requires study drug|4
6083350|NCT00386607|21001764|P2|Core|Unsatisfactory therapeutic effect|0
6083351|NCT00386607|21001765|P1|Core|Unsatisfactory therapeutic effect|23
6083352|NCT00386607|21001764|P2|Core|Abnormal laboratory value(s)|0
6083353|NCT00386607|21001765|P1|Core|Abnormal laboratory value(s)|3
6083354|NCT00386607|21001764|P2|Core|Adverse Event|0
6083355|NCT00386607|21001765|P1|Core|Adverse Event|40
6083356|NCT00386425|21001793|P3|Overall Study|Withdrawal by Subject|0
6083357|NCT00386425|21001794|P2|Overall Study|Withdrawal by Subject|1
6083358|NCT00386425|21001795|P1|Overall Study|Withdrawal by Subject|0
6083359|NCT00386425|21001793|P3|Overall Study|Physician Decision|0
6083360|NCT00386425|21001794|P2|Overall Study|Physician Decision|0
6083361|NCT00386425|21001795|P1|Overall Study|Physician Decision|3
6083362|NCT00386360|21001821|P2|Overall Study|Did not take any study medication|2
6083363|NCT00386360|21001822|P1|Overall Study|Did not take any study medication|0
6083364|NCT00386360|21001821|P2|Overall Study|Withdrawal by Subject|6
6083365|NCT00386360|21001822|P1|Overall Study|Withdrawal by Subject|3
6083366|NCT00386360|21001821|P2|Overall Study|Protocol Violation|3
6083367|NCT00386360|21001822|P1|Overall Study|Protocol Violation|0
6083368|NCT00386360|21001821|P2|Overall Study|Lost to Follow-up|2
6083369|NCT00386360|21001822|P1|Overall Study|Lost to Follow-up|0
6083370|NCT00386360|21001821|P2|Overall Study|Physician Decision|2
6083371|NCT00386360|21001822|P1|Overall Study|Physician Decision|2
6083372|NCT00386360|21001821|P2|Overall Study|Adverse Event|2
6083373|NCT00386360|21001822|P1|Overall Study|Adverse Event|4
6083374|NCT00386334|21001856|P2|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|1
6083375|NCT00386334|21001857|P1|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|3
6083376|NCT00386334|21001856|P2|Double Blind Period|Other|3
6083377|NCT00386334|21001857|P1|Double Blind Period|Other|3
6083378|NCT00386334|21001856|P2|Double Blind Period|Didnt Meet Entry/Randomization Criteria|5
6083379|NCT00386334|21001857|P1|Double Blind Period|Didnt Meet Entry/Randomization Criteria|4
6083380|NCT00386334|21001856|P2|Double Blind Period|Lack of Efficacy|11
6083381|NCT00386334|21001857|P1|Double Blind Period|Lack of Efficacy|20
6083382|NCT00386334|21001856|P2|Double Blind Period|Withdrawal by Subject|13
6083383|NCT00386334|21001857|P1|Double Blind Period|Withdrawal by Subject|9
6083384|NCT00386334|21001856|P2|Double Blind Period|Protocol Violation|1
6083385|NCT00386334|21001857|P1|Double Blind Period|Protocol Violation|1
6083386|NCT00386334|21001856|P2|Double Blind Period|Adverse Event|14
6083387|NCT00386334|21001857|P1|Double Blind Period|Adverse Event|9
6083388|NCT00386308|21002001|P2|Overall Study|Other Event|1
6083389|NCT00386308|21002002|P1|Overall Study|Other Event|8
6083390|NCT00386308|21002001|P2|Overall Study|Withdrawal by Subject|2
6083391|NCT00386308|21002002|P1|Overall Study|Withdrawal by Subject|6
6083392|NCT00386308|21002001|P2|Overall Study|Lost to Follow-up|6
6083393|NCT00386308|21002002|P1|Overall Study|Lost to Follow-up|10
6083394|NCT00386308|21002001|P2|Overall Study|Lack of Efficacy|2
6083395|NCT00386308|21002002|P1|Overall Study|Lack of Efficacy|0
6083396|NCT00386308|21002001|P2|Overall Study|Protocol Violation|5
6083397|NCT00386308|21002002|P1|Overall Study|Protocol Violation|2
6083398|NCT00386308|21002001|P2|Overall Study|Adverse Event|3
6083399|NCT00386308|21002002|P1|Overall Study|Adverse Event|3
6083400|NCT00386152|21002059|P3|Overall Study|Withdrawal by Subject|10
6083401|NCT00386152|21002060|P2|Overall Study|Withdrawal by Subject|6
6083402|NCT00386152|21002061|P1|Overall Study|Withdrawal by Subject|3
6083403|NCT00386152|21002059|P3|Overall Study|Protocol Violation|2
6083404|NCT00386152|21002060|P2|Overall Study|Protocol Violation|5
6083405|NCT00386152|21002061|P1|Overall Study|Protocol Violation|3
6083406|NCT00386152|21002059|P3|Overall Study|Completed chemotherapy|1
6083407|NCT00386152|21002060|P2|Overall Study|Completed chemotherapy|5
6083408|NCT00386152|21002061|P1|Overall Study|Completed chemotherapy|4
6083409|NCT00386152|21002059|P3|Overall Study|Lost to Follow-up|0
6083410|NCT00386152|21002060|P2|Overall Study|Lost to Follow-up|0
6083411|NCT00386152|21002061|P1|Overall Study|Lost to Follow-up|1
6083412|NCT00386152|21002059|P3|Overall Study|Physician Decision|4
6083413|NCT00386152|21002060|P2|Overall Study|Physician Decision|10
6083414|NCT00386152|21002061|P1|Overall Study|Physician Decision|13
6083415|NCT00386152|21002059|P3|Overall Study|Disease progression|5
6083416|NCT00386152|21002060|P2|Overall Study|Disease progression|4
6083417|NCT00386152|21002061|P1|Overall Study|Disease progression|7
6083418|NCT00386152|21002059|P3|Overall Study|Death|1
6083419|NCT00386152|21002060|P2|Overall Study|Death|0
6083420|NCT00386152|21002061|P1|Overall Study|Death|3
6083421|NCT00386152|21002059|P3|Overall Study|Chang from original chemo stratification|6
6083422|NCT00386152|21002060|P2|Overall Study|Chang from original chemo stratification|5
6083423|NCT00386152|21002061|P1|Overall Study|Chang from original chemo stratification|4
6083424|NCT00386152|21002059|P3|Overall Study|Adverse Event|4
6083425|NCT00386152|21002060|P2|Overall Study|Adverse Event|5
6083426|NCT00386152|21002061|P1|Overall Study|Adverse Event|6
6083427|NCT00386100|21002080|P2|Overall Study|Participant randomized in error|0
6083428|NCT00386100|21002081|P1|Overall Study|Participant randomized in error|1
6083429|NCT00386100|21002080|P2|Overall Study|Hb1Ac >8%|1
6083430|NCT00386100|21002081|P1|Overall Study|Hb1Ac >8%|0
6083431|NCT00386100|21002080|P2|Overall Study|Out of country for 5 months|0
6083432|NCT00386100|21002081|P1|Overall Study|Out of country for 5 months|1
6083433|NCT00386100|21002080|P2|Overall Study|Positive pregnancy test|3
6083434|NCT00386100|21002081|P1|Overall Study|Positive pregnancy test|1
6083435|NCT00386100|21002080|P2|Overall Study|Osteoporosis|1
6083436|NCT00386100|21002081|P1|Overall Study|Osteoporosis|0
6083437|NCT00386100|21002080|P2|Overall Study|7.6% bone loss|0
6083438|NCT00386100|21002081|P1|Overall Study|7.6% bone loss|1
6083439|NCT00386100|21002080|P2|Overall Study|DBP 93 mmHg at randomization|0
6083440|NCT00386100|21002081|P1|Overall Study|DBP 93 mmHg at randomization|1
6083441|NCT00386100|21002080|P2|Overall Study|Bone loss by DXA bone scan|0
6083442|NCT00386100|21002081|P1|Overall Study|Bone loss by DXA bone scan|1
6083443|NCT00386100|21002080|P2|Overall Study|Bad metabolic control & patient security|0
6083444|NCT00386100|21002081|P1|Overall Study|Bad metabolic control & patient security|1
6083445|NCT00386100|21002080|P2|Overall Study|Osteoporosis findings on Visit 2 DXA|1
6083446|NCT00386100|21002081|P1|Overall Study|Osteoporosis findings on Visit 2 DXA|0
6083447|NCT00386100|21002080|P2|Overall Study|Participant's PCP wanted to stop drug|0
6083448|NCT00386100|21002081|P1|Overall Study|Participant's PCP wanted to stop drug|1
6083449|NCT00386100|21002080|P2|Overall Study|Didn't meet entry criteria|1
6083450|NCT00386100|21002081|P1|Overall Study|Didn't meet entry criteria|1
6083451|NCT00386100|21002080|P2|Overall Study|Excessive bone loss vs. baseline value|1
6083452|NCT00386100|21002081|P1|Overall Study|Excessive bone loss vs. baseline value|0
6083453|NCT00386100|21002080|P2|Overall Study|Participant moving out of state|0
6083454|NCT00386100|21002081|P1|Overall Study|Participant moving out of state|2
6083455|NCT00386100|21002080|P2|Overall Study|Participant's concern due to CPK levels|0
6083456|NCT00386100|21002081|P1|Overall Study|Participant's concern due to CPK levels|1
6083457|NCT00386100|21002080|P2|Overall Study|Laboratory findings|0
6083458|NCT00386100|21002081|P1|Overall Study|Laboratory findings|1
6083459|NCT00386100|21002080|P2|Overall Study|Visit 11 DXA showed excessive bone loss|1
6083460|NCT00386100|21002081|P1|Overall Study|Visit 11 DXA showed excessive bone loss|0
6083461|NCT00386100|21002080|P2|Overall Study|Consecutive elevated Hba1C|0
6083462|NCT00386100|21002081|P1|Overall Study|Consecutive elevated Hba1C|1
6083463|NCT00386100|21002080|P2|Overall Study|BMD <2.5|0
6083464|NCT00386100|21002081|P1|Overall Study|BMD <2.5|1
6083465|NCT00386100|21002080|P2|Overall Study|Bone mass density (BMD) loss >6%|4
6083466|NCT00386100|21002081|P1|Overall Study|Bone mass density (BMD) loss >6%|4
6083467|NCT00386100|21002080|P2|Overall Study|Withdrawal by Subject|31
6083468|NCT00386100|21002081|P1|Overall Study|Withdrawal by Subject|32
6083469|NCT00386100|21002080|P2|Overall Study|Protocol Violation|3
6083470|NCT00386100|21002081|P1|Overall Study|Protocol Violation|5
6083471|NCT00386100|21002080|P2|Overall Study|Non-compliance|19
6083472|NCT00386100|21002081|P1|Overall Study|Non-compliance|18
6083473|NCT00386100|21002080|P2|Overall Study|Lost to Follow-up|29
6083474|NCT00386100|21002081|P1|Overall Study|Lost to Follow-up|29
6083475|NCT00386100|21002080|P2|Overall Study|Insufficient therapeutic effect|6
6083476|NCT00386100|21002081|P1|Overall Study|Insufficient therapeutic effect|30
6083477|NCT00386100|21002080|P2|Overall Study|Death|1
6083478|NCT00386100|21002081|P1|Overall Study|Death|0
6083479|NCT00386100|21002080|P2|Overall Study|Adverse Event|25
6083480|NCT00386100|21002081|P1|Overall Study|Adverse Event|15
6083481|NCT00386100|21002080|P2|Overall Study|Did not receive study medication|4
6083482|NCT00386100|21002081|P1|Overall Study|Did not receive study medication|6
6083483|NCT00386022|21002145|P2|Plus Estrogen|Adverse Event|1
6083484|NCT00386022|21002146|P1|Plus Estrogen|Adverse Event|0
6083485|NCT00386022|21002145|P2|Plus Estrogen|Lost to Follow-up|0
6083486|NCT00386022|21002146|P1|Plus Estrogen|Lost to Follow-up|2
6083487|NCT00386009|21002156|P2|Overall Study|Withdrawal by Subject|4
6083488|NCT00386009|21002157|P1|Overall Study|Withdrawal by Subject|5
6083489|NCT00386009|21002156|P2|Overall Study|Sponsor Decision|1
6083490|NCT00386009|21002157|P1|Overall Study|Sponsor Decision|1
6083491|NCT00386009|21002156|P2|Overall Study|Protocol Violation|0
6083492|NCT00386009|21002157|P1|Overall Study|Protocol Violation|1
6083493|NCT00386009|21002156|P2|Overall Study|Lost to Follow-up|1
6083494|NCT00386009|21002157|P1|Overall Study|Lost to Follow-up|1
6083495|NCT00386009|21002156|P2|Overall Study|Entry Criteria Not Met|2
6083496|NCT00386009|21002157|P1|Overall Study|Entry Criteria Not Met|0
6083497|NCT00386009|21002156|P2|Overall Study|Death|0
6083498|NCT00386009|21002157|P1|Overall Study|Death|1
6083499|NCT00386009|21002156|P2|Overall Study|Adverse Event|2
6083500|NCT00386009|21002157|P1|Overall Study|Adverse Event|0
6083501|NCT00385944|21002204|P3|2nd Maintenance Dose Period|Invalid PD Data|0
6083502|NCT00385944|21002205|P2|2nd Maintenance Dose Period|Invalid PD Data|3
6083503|NCT00385944|21002206|P1|2nd Maintenance Dose Period|Invalid PD Data|2
6083504|NCT00385944|21002204|P3|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0
6083505|NCT00385944|21002205|P2|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0
6083506|NCT00385944|21002206|P1|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|3
6083507|NCT00385944|21002204|P3|1st Maintenance Dose Period|Entry Criteria Exclusion|0
6083508|NCT00385944|21002205|P2|1st Maintenance Dose Period|Entry Criteria Exclusion|1
6083509|NCT00385944|21002206|P1|1st Maintenance Dose Period|Entry Criteria Exclusion|0
6083510|NCT00385944|21002204|P3|1st Maintenance Dose Period|Physician Decision|0
6083511|NCT00385944|21002205|P2|1st Maintenance Dose Period|Physician Decision|0
6083512|NCT00385944|21002206|P1|1st Maintenance Dose Period|Physician Decision|1
6083513|NCT00385918|21002249|P3|Intervention Phase After Randomization|Lost to Follow-up|0
6083514|NCT00385918|21002250|P2|Intervention Phase After Randomization|Lost to Follow-up|0
6083515|NCT00385918|21002251|P1|Intervention Phase After Randomization|Lost to Follow-up|1
6083516|NCT00385918|21002249|P3|Intervention Phase After Randomization|Physician Decision|0
6083517|NCT00385918|21002250|P2|Intervention Phase After Randomization|Physician Decision|0
6083518|NCT00385918|21002251|P1|Intervention Phase After Randomization|Physician Decision|1
6083519|NCT00385918|21002249|P3|Intervention Phase After Randomization|Withdrawal by Subject|0
6083520|NCT00385918|21002250|P2|Intervention Phase After Randomization|Withdrawal by Subject|0
6083521|NCT00385918|21002251|P1|Intervention Phase After Randomization|Withdrawal by Subject|1
6083522|NCT00385918|21002249|P3|Feasibility & Baseline Measurement Phase|Physician Decision|1
6083523|NCT00385918|21002250|P2|Feasibility & Baseline Measurement Phase|Physician Decision|0
6083524|NCT00385918|21002251|P1|Feasibility & Baseline Measurement Phase|Physician Decision|0
6083525|NCT00385918|21002249|P3|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|5
6083526|NCT00385918|21002250|P2|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0
6083527|NCT00385918|21002251|P1|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0
6083528|NCT00385918|21002249|P3|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|8
6083529|NCT00385918|21002250|P2|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0
6083530|NCT00385918|21002251|P1|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0
6083531|NCT00385840|21002275|P2|Overall Study|Lost to Follow-up|13
6083532|NCT00385840|21002276|P1|Overall Study|Lost to Follow-up|3
6083533|NCT00385840|21002275|P2|Overall Study|Adverse Event|1
6083534|NCT00385840|21002276|P1|Overall Study|Adverse Event|1
6083535|NCT00385827|21002299|P3|Part 2|Other|21
6083536|NCT00385827|21002300|P2|Part 2|Other|11
6083537|NCT00385827|21002301|P1|Part 2|Other|0
6083538|NCT00385827|21002299|P3|Part 2|Randomized but not treated|2
6083539|NCT00385827|21002300|P2|Part 2|Randomized but not treated|2
6083540|NCT00385827|21002301|P1|Part 2|Randomized but not treated|0
6083541|NCT00385827|21002299|P3|Part 2|Lack of Efficacy|13
6083542|NCT00385827|21002300|P2|Part 2|Lack of Efficacy|14
6083543|NCT00385827|21002301|P1|Part 2|Lack of Efficacy|0
6083544|NCT00385827|21002299|P3|Part 2|Death|2
6083545|NCT00385827|21002300|P2|Part 2|Death|0
6083546|NCT00385827|21002301|P1|Part 2|Death|0
6083547|NCT00385827|21002299|P3|Part 2|Adverse Event|10
6083548|NCT00385827|21002300|P2|Part 2|Adverse Event|6
6083549|NCT00385827|21002301|P1|Part 2|Adverse Event|0
6083550|NCT00385827|21002299|P3|Part 1|Other|0
6083551|NCT00385827|21002300|P2|Part 1|Other|0
6083552|NCT00385827|21002301|P1|Part 1|Other|1
6083553|NCT00385827|21002299|P3|Part 1|Lack of Efficacy|0
6083554|NCT00385827|21002300|P2|Part 1|Lack of Efficacy|0
6083555|NCT00385827|21002301|P1|Part 1|Lack of Efficacy|5
6083556|NCT00385827|21002299|P3|Part 1|Death|0
6083557|NCT00385827|21002300|P2|Part 1|Death|0
6083558|NCT00385827|21002301|P1|Part 1|Death|2
6083559|NCT00385827|21002299|P3|Part 1|Adverse Event|0
6083560|NCT00385827|21002300|P2|Part 1|Adverse Event|0
6083561|NCT00385827|21002301|P1|Part 1|Adverse Event|1
6083562|NCT00385762|21002345|P1|Overall Study|Lost to Follow-up|1
6083563|NCT00385762|21002345|P1|Overall Study|Adverse Event|1
6083564|NCT00385736|21002355|P3|Safety Analysis Set|Other|4
6083565|NCT00385736|21002356|P2|Safety Analysis Set|Other|4
6083566|NCT00385736|21002357|P1|Safety Analysis Set|Other|1
6083567|NCT00385736|21002355|P3|Safety Analysis Set|Protocol Violation|6
6083568|NCT00385736|21002356|P2|Safety Analysis Set|Protocol Violation|1
6083569|NCT00385736|21002357|P1|Safety Analysis Set|Protocol Violation|2
6083570|NCT00385736|21002355|P3|Safety Analysis Set|Lack of Efficacy|31
6083571|NCT00385736|21002356|P2|Safety Analysis Set|Lack of Efficacy|16
6083572|NCT00385736|21002357|P1|Safety Analysis Set|Lack of Efficacy|38
6083573|NCT00385736|21002355|P3|Safety Analysis Set|Lost to Follow-up|2
6083574|NCT00385736|21002356|P2|Safety Analysis Set|Lost to Follow-up|2
6083575|NCT00385736|21002357|P1|Safety Analysis Set|Lost to Follow-up|0
6083576|NCT00385736|21002355|P3|Safety Analysis Set|Withdrawal by Subject|14
6083577|NCT00385736|21002356|P2|Safety Analysis Set|Withdrawal by Subject|6
6083578|NCT00385736|21002357|P1|Safety Analysis Set|Withdrawal by Subject|6
6083579|NCT00385736|21002355|P3|Safety Analysis Set|Adverse Event|23
6083580|NCT00385736|21002356|P2|Safety Analysis Set|Adverse Event|15
6083581|NCT00385736|21002357|P1|Safety Analysis Set|Adverse Event|23
6083582|NCT00385736|21002355|P3|Efficacy Analysis Set - Maintenance|Other|4
6083583|NCT00385736|21002356|P2|Efficacy Analysis Set - Maintenance|Other|4
6083584|NCT00385736|21002357|P1|Efficacy Analysis Set - Maintenance|Other|0
6083585|NCT00385736|21002355|P3|Efficacy Analysis Set - Maintenance|Protocol Violation|6
6083586|NCT00385736|21002356|P2|Efficacy Analysis Set - Maintenance|Protocol Violation|1
6083587|NCT00385736|21002357|P1|Efficacy Analysis Set - Maintenance|Protocol Violation|2
6083588|NCT00385736|21002355|P3|Efficacy Analysis Set - Maintenance|Lack of Efficacy|31
6083589|NCT00385736|21002356|P2|Efficacy Analysis Set - Maintenance|Lack of Efficacy|16
6083590|NCT00385736|21002357|P1|Efficacy Analysis Set - Maintenance|Lack of Efficacy|38
6083591|NCT00385736|21002355|P3|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2
6083592|NCT00385736|21002356|P2|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2
6083593|NCT00385736|21002357|P1|Efficacy Analysis Set - Maintenance|Lost to Follow-up|0
6083594|NCT00385736|21002355|P3|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|14
6083595|NCT00385736|21002356|P2|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6
6083596|NCT00385736|21002357|P1|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6
6083597|NCT00385736|21002355|P3|Efficacy Analysis Set - Maintenance|Adverse Event|23
6083598|NCT00385736|21002356|P2|Efficacy Analysis Set - Maintenance|Adverse Event|15
6083599|NCT00385736|21002357|P1|Efficacy Analysis Set - Maintenance|Adverse Event|23
6083600|NCT00385736|21002355|P3|Efficacy Analysis Set - Induction|Other|1
6083601|NCT00385736|21002356|P2|Efficacy Analysis Set - Induction|Other|0
6083602|NCT00385736|21002357|P1|Efficacy Analysis Set - Induction|Other|0
6083603|NCT00385736|21002355|P3|Efficacy Analysis Set - Induction|Protocol Violation|2
6083604|NCT00385736|21002356|P2|Efficacy Analysis Set - Induction|Protocol Violation|0
6083605|NCT00385736|21002357|P1|Efficacy Analysis Set - Induction|Protocol Violation|0
6083606|NCT00385736|21002355|P3|Efficacy Analysis Set - Induction|Lack of Efficacy|1
6083607|NCT00385736|21002356|P2|Efficacy Analysis Set - Induction|Lack of Efficacy|2
6083608|NCT00385736|21002357|P1|Efficacy Analysis Set - Induction|Lack of Efficacy|4
6083609|NCT00385736|21002355|P3|Efficacy Analysis Set - Induction|Lost to Follow-up|0
6083610|NCT00385736|21002356|P2|Efficacy Analysis Set - Induction|Lost to Follow-up|2
6083611|NCT00385736|21002357|P1|Efficacy Analysis Set - Induction|Lost to Follow-up|0
6083612|NCT00385736|21002355|P3|Efficacy Analysis Set - Induction|Withdrawal by Subject|1
6083613|NCT00385736|21002356|P2|Efficacy Analysis Set - Induction|Withdrawal by Subject|2
6083614|NCT00385736|21002357|P1|Efficacy Analysis Set - Induction|Withdrawal by Subject|0
6083615|NCT00385736|21002355|P3|Efficacy Analysis Set - Induction|Adverse Event|4
6083616|NCT00385736|21002356|P2|Efficacy Analysis Set - Induction|Adverse Event|6
6083617|NCT00385736|21002357|P1|Efficacy Analysis Set - Induction|Adverse Event|5
6083618|NCT00385723|21002402|P3|Overall Study|Withdrawal by Subject|2
6083619|NCT00385723|21002403|P2|Overall Study|Withdrawal by Subject|0
6083620|NCT00385723|21002404|P1|Overall Study|Withdrawal by Subject|1
6083621|NCT00385723|21002402|P3|Overall Study|Lost to Follow-up|0
6083622|NCT00385723|21002403|P2|Overall Study|Lost to Follow-up|1
6083623|NCT00385723|21002404|P1|Overall Study|Lost to Follow-up|1
6083624|NCT00385684|21002418|P2|SECOND INTERVENTION OF PHASE A|study drug recall|1
6083625|NCT00385684|21002419|P1|SECOND INTERVENTION OF PHASE A|study drug recall|0
6083626|NCT00385684|21002418|P2|SECOND INTERVENTION OF PHASE A|Adverse Event|1
6083627|NCT00385684|21002419|P1|SECOND INTERVENTION OF PHASE A|Adverse Event|0
6083628|NCT00385684|21002418|P2|FIRST INTERVENTION OF PHASE A|Death|0
6083629|NCT00385684|21002419|P1|FIRST INTERVENTION OF PHASE A|Death|1
6083630|NCT00385671|21002428|P3|Overall Study|Withdrawal by Subject|4
6083631|NCT00385671|21002429|P2|Overall Study|Withdrawal by Subject|4
6083632|NCT00385671|21002430|P1|Overall Study|Withdrawal by Subject|4
6083633|NCT00385671|21002428|P3|Overall Study|Sponsor Decision|1
6083634|NCT00385671|21002429|P2|Overall Study|Sponsor Decision|2
6083635|NCT00385671|21002430|P1|Overall Study|Sponsor Decision|2
6083636|NCT00385671|21002428|P3|Overall Study|Protocol Violation|1
6083637|NCT00385671|21002429|P2|Overall Study|Protocol Violation|2
6083638|NCT00385671|21002430|P1|Overall Study|Protocol Violation|5
6083639|NCT00385671|21002428|P3|Overall Study|Physician Decision|2
6083640|NCT00385671|21002429|P2|Overall Study|Physician Decision|1
6083641|NCT00385671|21002430|P1|Overall Study|Physician Decision|2
6083642|NCT00385671|21002428|P3|Overall Study|Lost to Follow-up|5
6083643|NCT00385671|21002429|P2|Overall Study|Lost to Follow-up|6
6083644|NCT00385671|21002430|P1|Overall Study|Lost to Follow-up|6
6083645|NCT00385671|21002428|P3|Overall Study|Lack of Efficacy|5
6083646|NCT00385671|21002429|P2|Overall Study|Lack of Efficacy|9
6083647|NCT00385671|21002430|P1|Overall Study|Lack of Efficacy|5
6083648|NCT00385671|21002428|P3|Overall Study|Adverse Event|18
6083649|NCT00385671|21002429|P2|Overall Study|Adverse Event|27
6083650|NCT00385671|21002430|P1|Overall Study|Adverse Event|14
6083651|NCT00385593|21002586|P2|Overall Study|Incorrect randomization|1
6083652|NCT00385593|21002587|P1|Overall Study|Incorrect randomization|0
6083653|NCT00385593|21002586|P2|Overall Study|Incorrect inclusion|0
6083654|NCT00385593|21002587|P1|Overall Study|Incorrect inclusion|2
6083655|NCT00385593|21002586|P2|Overall Study|Several reasons|15
6083656|NCT00385593|21002587|P1|Overall Study|Several reasons|17
6083657|NCT00385593|21002586|P2|Overall Study|Protocol Violation|4
6083658|NCT00385593|21002587|P1|Overall Study|Protocol Violation|7
6083659|NCT00385593|21002586|P2|Overall Study|Lost to Follow-up|8
6083660|NCT00385593|21002587|P1|Overall Study|Lost to Follow-up|12
6083661|NCT00385593|21002586|P2|Overall Study|Withdrawal by Subject|7
6083662|NCT00385593|21002587|P1|Overall Study|Withdrawal by Subject|17
6083663|NCT00385593|21002586|P2|Overall Study|Adverse Event|2
6083664|NCT00385593|21002587|P1|Overall Study|Adverse Event|3
6083665|NCT00385541|21002697|P2|Overall Study|severe pain, clinician requested unblind|1
6083666|NCT00385541|21002698|P1|Overall Study|severe pain, clinician requested unblind|0
6083667|NCT00385255|21002732|P2|Overall Study|Lost to Follow-up|58
6083668|NCT00385255|21002733|P1|Overall Study|Lost to Follow-up|20
6083669|NCT00385255|21002732|P2|Overall Study|Migrated/moved from study area|1
6083670|NCT00385255|21002733|P1|Overall Study|Migrated/moved from study area|0
6083671|NCT00385255|21002732|P2|Overall Study|Withdrawal by Subject|8
6083672|NCT00385255|21002733|P1|Overall Study|Withdrawal by Subject|0
6083673|NCT00385255|21002732|P2|Overall Study|Protocol Violation|4
6083674|NCT00385255|21002733|P1|Overall Study|Protocol Violation|0
6083675|NCT00385255|21002732|P2|Overall Study|Serious Adverse Event|2
6083676|NCT00385255|21002733|P1|Overall Study|Serious Adverse Event|1
6083677|NCT00385203|21002812|P2|Overall Study|Incorrect enrollment|0
6083678|NCT00385203|21002813|P1|Overall Study|Incorrect enrollment|2
6083679|NCT00385203|21002812|P2|Overall Study|Condition under investigation worsened|3
6083680|NCT00385203|21002813|P1|Overall Study|Condition under investigation worsened|18
6083681|NCT00385203|21002812|P2|Overall Study|Death|0
6083682|NCT00385203|21002813|P1|Overall Study|Death|1
6083683|NCT00385203|21002812|P2|Overall Study|Adverse Event|4
6083684|NCT00385203|21002813|P1|Overall Study|Adverse Event|5
6083685|NCT00384956|21002901|P1|Overall Study|Ineligible (acute myeloid leukemia)|3
6083686|NCT00384930|21002918|P5|Overall Study|Didn't Receive Double-Blind Study Drug|0
6083687|NCT00384930|21002919|P4|Overall Study|Didn't Receive Double-Blind Study Drug|0
6083688|NCT00384930|21002920|P3|Overall Study|Didn't Receive Double-Blind Study Drug|0
6083689|NCT00384930|21002921|P2|Overall Study|Didn't Receive Double-Blind Study Drug|1
6083690|NCT00384930|21002922|P1|Overall Study|Didn't Receive Double-Blind Study Drug|1
6083691|NCT00384930|21002918|P5|Overall Study|Withdrawal by Subject|16
6083692|NCT00384930|21002919|P4|Overall Study|Withdrawal by Subject|6
6083693|NCT00384930|21002920|P3|Overall Study|Withdrawal by Subject|7
6083694|NCT00384930|21002921|P2|Overall Study|Withdrawal by Subject|7
6083695|NCT00384930|21002922|P1|Overall Study|Withdrawal by Subject|9
6083696|NCT00384930|21002918|P5|Overall Study|Sponsor Decision|0
6083697|NCT00384930|21002919|P4|Overall Study|Sponsor Decision|5
6083698|NCT00384930|21002920|P3|Overall Study|Sponsor Decision|0
6083699|NCT00384930|21002921|P2|Overall Study|Sponsor Decision|4
6083700|NCT00384930|21002922|P1|Overall Study|Sponsor Decision|3
6083701|NCT00384930|21002918|P5|Overall Study|Protocol Violation|4
6083702|NCT00384930|21002919|P4|Overall Study|Protocol Violation|6
6083703|NCT00384930|21002920|P3|Overall Study|Protocol Violation|1
6083704|NCT00384930|21002921|P2|Overall Study|Protocol Violation|0
6083705|NCT00384930|21002922|P1|Overall Study|Protocol Violation|1
6083706|NCT00384930|21002918|P5|Overall Study|Physician Decision|1
6083707|NCT00384930|21002919|P4|Overall Study|Physician Decision|0
6083708|NCT00384930|21002920|P3|Overall Study|Physician Decision|1
6083709|NCT00384930|21002921|P2|Overall Study|Physician Decision|1
6083710|NCT00384930|21002922|P1|Overall Study|Physician Decision|0
6083711|NCT00384930|21002918|P5|Overall Study|Lost to Follow-up|6
6083712|NCT00384930|21002919|P4|Overall Study|Lost to Follow-up|4
6083713|NCT00384930|21002920|P3|Overall Study|Lost to Follow-up|0
6083714|NCT00384930|21002921|P2|Overall Study|Lost to Follow-up|3
6083715|NCT00384930|21002922|P1|Overall Study|Lost to Follow-up|5
6083716|NCT00384930|21002918|P5|Overall Study|Lack of Efficacy|2
6083717|NCT00384930|21002919|P4|Overall Study|Lack of Efficacy|1
6083718|NCT00384930|21002920|P3|Overall Study|Lack of Efficacy|2
6083719|NCT00384930|21002921|P2|Overall Study|Lack of Efficacy|1
6083720|NCT00384930|21002922|P1|Overall Study|Lack of Efficacy|1
6083721|NCT00384930|21002918|P5|Overall Study|Entry Criteria Not Met|4
6083722|NCT00384930|21002919|P4|Overall Study|Entry Criteria Not Met|8
6083723|NCT00384930|21002920|P3|Overall Study|Entry Criteria Not Met|7
6083724|NCT00384930|21002921|P2|Overall Study|Entry Criteria Not Met|6
6083725|NCT00384930|21002922|P1|Overall Study|Entry Criteria Not Met|2
6083726|NCT00384930|21002918|P5|Overall Study|Adverse Event|14
6083727|NCT00384930|21002919|P4|Overall Study|Adverse Event|11
6083728|NCT00384930|21002920|P3|Overall Study|Adverse Event|12
6083729|NCT00384930|21002921|P2|Overall Study|Adverse Event|4
6083730|NCT00384930|21002922|P1|Overall Study|Adverse Event|5
6083731|NCT00384839|21003001|P1|Overall Study|Ineligible|2
6083732|NCT00384839|21003001|P1|Overall Study|Patient Request|1
6083733|NCT00384839|21003001|P1|Overall Study|Investigator Request|1
6083734|NCT00384839|21003001|P1|Overall Study|Adverse Event|4
6083735|NCT00384397|21003134|P3|Overall Study|Withdrawal by Subject|15
6083736|NCT00384397|21003135|P2|Overall Study|Withdrawal by Subject|17
6083737|NCT00384397|21003136|P1|Overall Study|Withdrawal by Subject|14
6083738|NCT00384397|21003134|P3|Overall Study|Lost to Follow-up|3
6083739|NCT00384397|21003135|P2|Overall Study|Lost to Follow-up|13
6083740|NCT00384397|21003136|P1|Overall Study|Lost to Follow-up|11
6083741|NCT00384397|21003134|P3|Overall Study|Protocol Violation|13
6083742|NCT00384397|21003135|P2|Overall Study|Protocol Violation|15
6083743|NCT00384397|21003136|P1|Overall Study|Protocol Violation|7
6083744|NCT00384397|21003134|P3|Overall Study|Adverse Event|2
6083745|NCT00384397|21003135|P2|Overall Study|Adverse Event|1
6083746|NCT00384397|21003136|P1|Overall Study|Adverse Event|0
6083747|NCT00384332|21003155|P2|Overall Study|Lost to Follow-up|0
6083748|NCT00384332|21003156|P1|Overall Study|Lost to Follow-up|4
6083749|NCT00384293|21003166|P3|Post-randomization Period|Patient Randomized in Error|1
6083750|NCT00384293|21003167|P2|Post-randomization Period|Patient Randomized in Error|0
6083751|NCT00384293|21003168|P1|Post-randomization Period|Patient Randomized in Error|0
6083752|NCT00384293|21003166|P3|Post-randomization Period|Trial Termination|204
6083753|NCT00384293|21003167|P2|Post-randomization Period|Trial Termination|180
6083754|NCT00384293|21003168|P1|Post-randomization Period|Trial Termination|0
6083755|NCT00384293|21003166|P3|Post-randomization Period|Withdrawal by Subject|6
6083756|NCT00384293|21003167|P2|Post-randomization Period|Withdrawal by Subject|8
6083757|NCT00384293|21003168|P1|Post-randomization Period|Withdrawal by Subject|0
6083758|NCT00384293|21003166|P3|Post-randomization Period|Protocol Violation|0
6083759|NCT00384293|21003167|P2|Post-randomization Period|Protocol Violation|1
6083760|NCT00384293|21003168|P1|Post-randomization Period|Protocol Violation|0
6083761|NCT00384293|21003166|P3|Post-randomization Period|Lost to Follow-up|1
6083762|NCT00384293|21003167|P2|Post-randomization Period|Lost to Follow-up|2
6083763|NCT00384293|21003168|P1|Post-randomization Period|Lost to Follow-up|0
6083764|NCT00384293|21003166|P3|Post-randomization Period|Adverse Event|7
6083765|NCT00384293|21003167|P2|Post-randomization Period|Adverse Event|23
6083766|NCT00384293|21003168|P1|Post-randomization Period|Adverse Event|0
6083767|NCT00384293|21003166|P3|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0
6083768|NCT00384293|21003167|P2|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0
6083769|NCT00384293|21003168|P1|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|1
6083770|NCT00384293|21003166|P3|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0
6083771|NCT00384293|21003167|P2|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0
6083772|NCT00384293|21003168|P1|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|2
6083773|NCT00384293|21003166|P3|MK0524A Active Run-In, Pre-randomization|Trial Termination|0
6083774|NCT00384293|21003167|P2|MK0524A Active Run-In, Pre-randomization|Trial Termination|0
6083775|NCT00384293|21003168|P1|MK0524A Active Run-In, Pre-randomization|Trial Termination|16
6083776|NCT00384293|21003166|P3|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0
6083777|NCT00384293|21003167|P2|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0
6083778|NCT00384293|21003168|P1|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|340
6083779|NCT00384293|21003166|P3|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0
6083780|NCT00384293|21003167|P2|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0
6083781|NCT00384293|21003168|P1|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|24
6083782|NCT00384293|21003166|P3|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0
6083783|NCT00384293|21003167|P2|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0
6083784|NCT00384293|21003168|P1|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|1
6083785|NCT00384293|21003166|P3|MK0524A Active Run-In, Pre-randomization|Adverse Event|0
6083786|NCT00384293|21003167|P2|MK0524A Active Run-In, Pre-randomization|Adverse Event|0
6083787|NCT00384293|21003168|P1|MK0524A Active Run-In, Pre-randomization|Adverse Event|120
6083788|NCT00384189|21003192|P4|Overall Study|Reason Not Specified|40
6083789|NCT00384189|21003193|P3|Overall Study|Reason Not Specified|58
6083790|NCT00384189|21003194|P2|Overall Study|Reason Not Specified|57
6083791|NCT00384189|21003195|P1|Overall Study|Reason Not Specified|50
6083792|NCT00384176|21003256|P3|Overall Study|Liver metastases, colon resec. planned|0
6083793|NCT00384176|21003257|P2|Overall Study|Liver metastases, colon resec. planned|0
6083794|NCT00384176|21003258|P1|Overall Study|Liver metastases, colon resec. planned|1
6083795|NCT00384176|21003256|P3|Overall Study|Physician Decision|0
6083796|NCT00384176|21003257|P2|Overall Study|Physician Decision|2
6083797|NCT00384176|21003258|P1|Overall Study|Physician Decision|0
6083798|NCT00384176|21003256|P3|Overall Study|Did not receive study treatment|1
6083799|NCT00384176|21003257|P2|Overall Study|Did not receive study treatment|1
6083800|NCT00384176|21003258|P1|Overall Study|Did not receive study treatment|0
6083801|NCT00384176|21003256|P3|Overall Study|Toxicity of treatment|0
6083802|NCT00384176|21003257|P2|Overall Study|Toxicity of treatment|0
6083803|NCT00384176|21003258|P1|Overall Study|Toxicity of treatment|1
6083804|NCT00384176|21003256|P3|Overall Study|Longer QTC as Visit 1|0
6083805|NCT00384176|21003257|P2|Overall Study|Longer QTC as Visit 1|0
6083806|NCT00384176|21003258|P1|Overall Study|Longer QTC as Visit 1|1
6083807|NCT00384176|21003256|P3|Overall Study|Incorrect enrol/elig crit not fulfilled|0
6083808|NCT00384176|21003257|P2|Overall Study|Incorrect enrol/elig crit not fulfilled|3
6083809|NCT00384176|21003258|P1|Overall Study|Incorrect enrol/elig crit not fulfilled|2
6083810|NCT00384176|21003256|P3|Overall Study|Lost to Follow-up|4
6083811|NCT00384176|21003257|P2|Overall Study|Lost to Follow-up|18
6083812|NCT00384176|21003258|P1|Overall Study|Lost to Follow-up|16
6083813|NCT00384176|21003256|P3|Overall Study|Withdrawal by Subject|22
6083814|NCT00384176|21003257|P2|Overall Study|Withdrawal by Subject|48
6083815|NCT00384176|21003258|P1|Overall Study|Withdrawal by Subject|52
6083816|NCT00384176|21003256|P3|Overall Study|Death|105
6083817|NCT00384176|21003257|P2|Overall Study|Death|247
6083818|NCT00384176|21003258|P1|Overall Study|Death|239
6083819|NCT00384085|21003284|P3|Overall Study|Patient required surgery|0
6083820|NCT00384085|21003285|P2|Overall Study|Patient required surgery|1
6083821|NCT00384085|21003286|P1|Overall Study|Patient required surgery|0
6083822|NCT00384085|21003284|P3|Overall Study|Patient moved|1
6083823|NCT00384085|21003285|P2|Overall Study|Patient moved|0
6083824|NCT00384085|21003286|P1|Overall Study|Patient moved|1
6083825|NCT00384085|21003284|P3|Overall Study|Sponsor decision|1
6083826|NCT00384085|21003285|P2|Overall Study|Sponsor decision|2
6083827|NCT00384085|21003286|P1|Overall Study|Sponsor decision|1
6083828|NCT00384085|21003284|P3|Overall Study|Loss of site personnel|1
6083829|NCT00384085|21003285|P2|Overall Study|Loss of site personnel|0
6083830|NCT00384085|21003286|P1|Overall Study|Loss of site personnel|1
6083831|NCT00384085|21003284|P3|Overall Study|Physician Decision|0
6083832|NCT00384085|21003285|P2|Overall Study|Physician Decision|0
6083833|NCT00384085|21003286|P1|Overall Study|Physician Decision|1
6083834|NCT00384085|21003284|P3|Overall Study|Patient non-compliant|5
6083835|NCT00384085|21003285|P2|Overall Study|Patient non-compliant|4
6083836|NCT00384085|21003286|P1|Overall Study|Patient non-compliant|4
6083837|NCT00384085|21003284|P3|Overall Study|Withdrawal by Subject|29
6083838|NCT00384085|21003285|P2|Overall Study|Withdrawal by Subject|19
6083839|NCT00384085|21003286|P1|Overall Study|Withdrawal by Subject|14
6083840|NCT00384085|21003284|P3|Overall Study|Progressive Disease|0
6083841|NCT00384085|21003285|P2|Overall Study|Progressive Disease|1
6083842|NCT00384085|21003286|P1|Overall Study|Progressive Disease|0
6083843|NCT00384085|21003284|P3|Overall Study|Lost to Follow-up|10
6083844|NCT00384085|21003285|P2|Overall Study|Lost to Follow-up|9
6083845|NCT00384085|21003286|P1|Overall Study|Lost to Follow-up|9
6083846|NCT00384085|21003284|P3|Overall Study|Protocol Violation|2
6083847|NCT00384085|21003285|P2|Overall Study|Protocol Violation|2
6083848|NCT00384085|21003286|P1|Overall Study|Protocol Violation|2
6083849|NCT00384085|21003284|P3|Overall Study|No longer Requires Study Treatment|1
6083850|NCT00384085|21003285|P2|Overall Study|No longer Requires Study Treatment|0
6083851|NCT00384085|21003286|P1|Overall Study|No longer Requires Study Treatment|1
6083852|NCT00384085|21003284|P3|Overall Study|Lack of Efficacy|2
6083853|NCT00384085|21003285|P2|Overall Study|Lack of Efficacy|3
6083854|NCT00384085|21003286|P1|Overall Study|Lack of Efficacy|0
6083855|NCT00384085|21003284|P3|Overall Study|Adverse Event|4
6083856|NCT00384085|21003285|P2|Overall Study|Adverse Event|5
6083857|NCT00384085|21003286|P1|Overall Study|Adverse Event|5
6083858|NCT00384059|21003312|P2|Toddler Dose|Failed to return|1
6083859|NCT00384059|21003313|P1|Toddler Dose|Failed to return|0
6083860|NCT00384059|21003312|P2|Toddler Dose|Lost to Follow-up|1
6083861|NCT00384059|21003313|P1|Toddler Dose|Lost to Follow-up|1
6083862|NCT00384059|21003312|P2|After Infant Series|Lost to Follow-up|1
6083863|NCT00384059|21003313|P1|After Infant Series|Lost to Follow-up|0
6083864|NCT00384059|21003312|P2|After Infant Series|Physician Decision|1
6083865|NCT00384059|21003313|P1|After Infant Series|Physician Decision|0
6083866|NCT00384059|21003312|P2|After Infant Series|Adverse Event|1
6083867|NCT00384059|21003313|P1|After Infant Series|Adverse Event|0
6083868|NCT00384059|21003312|P2|After Infant Series|Failed to Return|2
6083869|NCT00384059|21003313|P1|After Infant Series|Failed to Return|0
6083870|NCT00384059|21003312|P2|After Infant Series|Withdrawal by Subject|2
6083871|NCT00384059|21003313|P1|After Infant Series|Withdrawal by Subject|2
6083872|NCT00384059|21003312|P2|After Infant Series|Protocol Violation|3
6083873|NCT00384059|21003313|P1|After Infant Series|Protocol Violation|2
6083874|NCT00384059|21003312|P2|Infant Series|Lost to Follow-up|1
6083875|NCT00384059|21003313|P1|Infant Series|Lost to Follow-up|0
6083876|NCT00384059|21003312|P2|Infant Series|Protocol Violation|2
6083877|NCT00384059|21003313|P1|Infant Series|Protocol Violation|1
6083878|NCT00384059|21003312|P2|Infant Series|Adverse Event|2
6083879|NCT00384059|21003313|P1|Infant Series|Adverse Event|1
6083880|NCT00384059|21003312|P2|Infant Series|Withdrawal by Subject|2
6083881|NCT00384059|21003313|P1|Infant Series|Withdrawal by Subject|2
6083882|NCT00384059|21003312|P2|Infant Series|Not consented|6
6083883|NCT00384059|21003313|P1|Infant Series|Not consented|2
6083884|NCT00384033|21003363|P4|Overall Study|Randomized but not treated|2
6083885|NCT00384033|21003364|P3|Overall Study|Randomized but not treated|10
6083886|NCT00384033|21003365|P2|Overall Study|Randomized but not treated|7
6083887|NCT00384033|21003366|P1|Overall Study|Randomized but not treated|3
6083888|NCT00384033|21003363|P4|Overall Study|Lack of Efficacy|1
6083889|NCT00384033|21003364|P3|Overall Study|Lack of Efficacy|3
6083890|NCT00384033|21003365|P2|Overall Study|Lack of Efficacy|3
6083891|NCT00384033|21003366|P1|Overall Study|Lack of Efficacy|7
6083892|NCT00384033|21003363|P4|Overall Study|Withdrawal by Subject|2
6083893|NCT00384033|21003364|P3|Overall Study|Withdrawal by Subject|5
6083894|NCT00384033|21003365|P2|Overall Study|Withdrawal by Subject|2
6083895|NCT00384033|21003366|P1|Overall Study|Withdrawal by Subject|6
6083896|NCT00384033|21003363|P4|Overall Study|Protocol Violation|6
6083897|NCT00384033|21003364|P3|Overall Study|Protocol Violation|5
6083898|NCT00384033|21003365|P2|Overall Study|Protocol Violation|0
6083899|NCT00384033|21003366|P1|Overall Study|Protocol Violation|5
6083900|NCT00384033|21003363|P4|Overall Study|Other|0
6083901|NCT00384033|21003364|P3|Overall Study|Other|0
6083902|NCT00384033|21003365|P2|Overall Study|Other|0
6083903|NCT00384033|21003366|P1|Overall Study|Other|2
6083904|NCT00384033|21003363|P4|Overall Study|Lost to Follow-up|7
6083905|NCT00384033|21003364|P3|Overall Study|Lost to Follow-up|7
6083906|NCT00384033|21003365|P2|Overall Study|Lost to Follow-up|12
6083907|NCT00384033|21003366|P1|Overall Study|Lost to Follow-up|6
6083908|NCT00384033|21003363|P4|Overall Study|Physician Decision|0
6083909|NCT00384033|21003364|P3|Overall Study|Physician Decision|0
6083910|NCT00384033|21003365|P2|Overall Study|Physician Decision|0
6083911|NCT00384033|21003366|P1|Overall Study|Physician Decision|1
6083912|NCT00384033|21003363|P4|Overall Study|Failed to return|2
6083913|NCT00384033|21003364|P3|Overall Study|Failed to return|2
6083914|NCT00384033|21003365|P2|Overall Study|Failed to return|3
6083915|NCT00384033|21003366|P1|Overall Study|Failed to return|1
6083916|NCT00384033|21003363|P4|Overall Study|Adverse Event|20
6083917|NCT00384033|21003364|P3|Overall Study|Adverse Event|11
6083918|NCT00384033|21003365|P2|Overall Study|Adverse Event|8
6083919|NCT00384033|21003366|P1|Overall Study|Adverse Event|10
6083920|NCT00383786|21003419|P2|Overall Study|Physician Decision|1
6083921|NCT00383786|21003420|P1|Overall Study|Physician Decision|0
6083922|NCT00383786|21003419|P2|Overall Study|Withdrawal by Subject|5
6083923|NCT00383786|21003420|P1|Overall Study|Withdrawal by Subject|2
6083924|NCT00383786|21003419|P2|Overall Study|Protocol Violation|6
6083925|NCT00383786|21003420|P1|Overall Study|Protocol Violation|2
6083926|NCT00383721|21003470|P5|26-Week Treatment Safety Extension|Administrative|0
6083927|NCT00383721|21003471|P4|26-Week Treatment Safety Extension|Administrative|1
6083928|NCT00383721|21003472|P3|26-Week Treatment Safety Extension|Administrative|3
6083929|NCT00383721|21003473|P2|26-Week Treatment Safety Extension|Administrative|2
6083930|NCT00383721|21003474|P1|26-Week Treatment Safety Extension|Administrative|1
6083931|NCT00383721|21003470|P5|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0
6083932|NCT00383721|21003471|P4|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1
6083933|NCT00383721|21003472|P3|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1
6083934|NCT00383721|21003473|P2|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0
6083935|NCT00383721|21003474|P1|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1
6083936|NCT00383721|21003470|P5|26-Week Treatment Safety Extension|Non-compliance with protocol|0
6083937|NCT00383721|21003471|P4|26-Week Treatment Safety Extension|Non-compliance with protocol|4
6083938|NCT00383721|21003472|P3|26-Week Treatment Safety Extension|Non-compliance with protocol|1
6083939|NCT00383721|21003473|P2|26-Week Treatment Safety Extension|Non-compliance with protocol|1
6083940|NCT00383721|21003474|P1|26-Week Treatment Safety Extension|Non-compliance with protocol|2
6083941|NCT00383721|21003470|P5|26-Week Treatment Safety Extension|Participant withdrawal related|0
6083942|NCT00383721|21003471|P4|26-Week Treatment Safety Extension|Participant withdrawal related|1
6083943|NCT00383721|21003472|P3|26-Week Treatment Safety Extension|Participant withdrawal related|1
6083944|NCT00383721|21003473|P2|26-Week Treatment Safety Extension|Participant withdrawal related|1
6083945|NCT00383721|21003474|P1|26-Week Treatment Safety Extension|Participant withdrawal related|1
6083946|NCT00383721|21003470|P5|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0
6083947|NCT00383721|21003471|P4|26-Week Treatment Safety Extension|Participant withdrawal unrelated|7
6083948|NCT00383721|21003472|P3|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2
6083949|NCT00383721|21003473|P2|26-Week Treatment Safety Extension|Participant withdrawal unrelated|4
6083950|NCT00383721|21003474|P1|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6
6083951|NCT00383721|21003470|P5|26-Week Treatment Safety Extension|Lost to Follow-up|0
6083952|NCT00383721|21003471|P4|26-Week Treatment Safety Extension|Lost to Follow-up|1
6083953|NCT00383721|21003472|P3|26-Week Treatment Safety Extension|Lost to Follow-up|1
6083954|NCT00383721|21003473|P2|26-Week Treatment Safety Extension|Lost to Follow-up|0
6083955|NCT00383721|21003474|P1|26-Week Treatment Safety Extension|Lost to Follow-up|2
6083956|NCT00383721|21003470|P5|26-Week Treatment Safety Extension|Lack of Efficacy|0
6083957|NCT00383721|21003471|P4|26-Week Treatment Safety Extension|Lack of Efficacy|1
6083958|NCT00383721|21003472|P3|26-Week Treatment Safety Extension|Lack of Efficacy|4
6083959|NCT00383721|21003473|P2|26-Week Treatment Safety Extension|Lack of Efficacy|2
6083960|NCT00383721|21003474|P1|26-Week Treatment Safety Extension|Lack of Efficacy|0
6083961|NCT00383721|21003470|P5|26-Week Treatment Safety Extension|Adverse Event|0
6083962|NCT00383721|21003471|P4|26-Week Treatment Safety Extension|Adverse Event|1
6083963|NCT00383721|21003472|P3|26-Week Treatment Safety Extension|Adverse Event|10
6083964|NCT00383721|21003473|P2|26-Week Treatment Safety Extension|Adverse Event|7
6083965|NCT00383721|21003474|P1|26-Week Treatment Safety Extension|Adverse Event|6
6083966|NCT00383721|21003470|P5|26-Week Double-Blind Treatment Period|Ongoing|0
6083967|NCT00383721|21003471|P4|26-Week Double-Blind Treatment Period|Ongoing|0
6083968|NCT00383721|21003472|P3|26-Week Double-Blind Treatment Period|Ongoing|0
6083969|NCT00383721|21003473|P2|26-Week Double-Blind Treatment Period|Ongoing|0
6083970|NCT00383721|21003474|P1|26-Week Double-Blind Treatment Period|Ongoing|1
6083971|NCT00383721|21003470|P5|26-Week Double-Blind Treatment Period|Administrative|3
6083972|NCT00383721|21003471|P4|26-Week Double-Blind Treatment Period|Administrative|3
6083973|NCT00383721|21003472|P3|26-Week Double-Blind Treatment Period|Administrative|3
6083974|NCT00383721|21003473|P2|26-Week Double-Blind Treatment Period|Administrative|3
6083975|NCT00383721|21003474|P1|26-Week Double-Blind Treatment Period|Administrative|1
6083976|NCT00383721|21003470|P5|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|13
6083977|NCT00383721|21003471|P4|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|4
6083978|NCT00383721|21003472|P3|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|11
6083979|NCT00383721|21003473|P2|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6
6083980|NCT00383721|21003474|P1|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5
6083981|NCT00383721|21003470|P5|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6
6083982|NCT00383721|21003471|P4|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6
6083983|NCT00383721|21003472|P3|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4
6083984|NCT00383721|21003473|P2|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5
6083985|NCT00383721|21003474|P1|26-Week Double-Blind Treatment Period|Non-compliance with protocol|7
6083986|NCT00383721|21003470|P5|26-Week Double-Blind Treatment Period|Participant withdrawal related|9
6083987|NCT00383721|21003471|P4|26-Week Double-Blind Treatment Period|Participant withdrawal related|8
6083988|NCT00383721|21003472|P3|26-Week Double-Blind Treatment Period|Participant withdrawal related|6
6083989|NCT00383721|21003473|P2|26-Week Double-Blind Treatment Period|Participant withdrawal related|3
6083990|NCT00383721|21003474|P1|26-Week Double-Blind Treatment Period|Participant withdrawal related|5
6083991|NCT00383721|21003470|P5|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|11
6083992|NCT00383721|21003471|P4|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10
6083993|NCT00383721|21003472|P3|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|15
6083994|NCT00383721|21003473|P2|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12
6083995|NCT00383721|21003474|P1|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|4
6083996|NCT00383721|21003470|P5|26-Week Double-Blind Treatment Period|Lost to Follow-up|4
6083997|NCT00383721|21003471|P4|26-Week Double-Blind Treatment Period|Lost to Follow-up|1
6083998|NCT00383721|21003472|P3|26-Week Double-Blind Treatment Period|Lost to Follow-up|2
6083999|NCT00383721|21003473|P2|26-Week Double-Blind Treatment Period|Lost to Follow-up|0
6084000|NCT00383721|21003474|P1|26-Week Double-Blind Treatment Period|Lost to Follow-up|0
6084001|NCT00383721|21003470|P5|26-Week Double-Blind Treatment Period|Lack of Efficacy|8
6084002|NCT00383721|21003471|P4|26-Week Double-Blind Treatment Period|Lack of Efficacy|4
6084003|NCT00383721|21003472|P3|26-Week Double-Blind Treatment Period|Lack of Efficacy|3
6084004|NCT00383721|21003473|P2|26-Week Double-Blind Treatment Period|Lack of Efficacy|3
6084005|NCT00383721|21003474|P1|26-Week Double-Blind Treatment Period|Lack of Efficacy|1
6084006|NCT00383721|21003470|P5|26-Week Double-Blind Treatment Period|Adverse Event|13
6084007|NCT00383721|21003471|P4|26-Week Double-Blind Treatment Period|Adverse Event|14
6084008|NCT00383721|21003472|P3|26-Week Double-Blind Treatment Period|Adverse Event|7
6084009|NCT00383721|21003473|P2|26-Week Double-Blind Treatment Period|Adverse Event|5
6084010|NCT00383721|21003474|P1|26-Week Double-Blind Treatment Period|Adverse Event|11
6084011|NCT00383708|21003511|P1|Co-administration Period|Adverse Event|5
6084012|NCT00383708|21003511|P1|Run-in Period|Claustrophobia|1
6084013|NCT00383708|21003511|P1|Run-in Period|Adverse Event|2
6084014|NCT00383708|21003511|P1|Run-in Period|Protocol Violation|4
6084015|NCT00383708|21003511|P1|Enrolment Through Start Treatment|Did not meet entry criteria|32
6084016|NCT00383708|21003511|P1|Enrolment Through Start Treatment|Withdrawal by Subject|1
6084017|NCT00383552|21003586|P4|Overall Study|Administrative|1
6084018|NCT00383552|21003587|P3|Overall Study|Administrative|1
6084019|NCT00383552|21003588|P2|Overall Study|Administrative|0
6084020|NCT00383552|21003589|P1|Overall Study|Administrative|1
6084021|NCT00383552|21003586|P4|Overall Study|Did not meet protocol eligibility|3
6084022|NCT00383552|21003587|P3|Overall Study|Did not meet protocol eligibility|2
6084023|NCT00383552|21003588|P2|Overall Study|Did not meet protocol eligibility|6
6084024|NCT00383552|21003589|P1|Overall Study|Did not meet protocol eligibility|8
6084025|NCT00383552|21003586|P4|Overall Study|Noncompliance with the protocol|10
6084026|NCT00383552|21003587|P3|Overall Study|Noncompliance with the protocol|8
6084027|NCT00383552|21003588|P2|Overall Study|Noncompliance with the protocol|6
6084028|NCT00383552|21003589|P1|Overall Study|Noncompliance with the protocol|11
6084029|NCT00383552|21003586|P4|Overall Study|Did not wish to continue (related)|3
6084030|NCT00383552|21003587|P3|Overall Study|Did not wish to continue (related)|2
6084031|NCT00383552|21003588|P2|Overall Study|Did not wish to continue (related)|0
6084032|NCT00383552|21003589|P1|Overall Study|Did not wish to continue (related)|1
6084033|NCT00383552|21003586|P4|Overall Study|Did not wish to continue (unrelated)|6
6084034|NCT00383552|21003587|P3|Overall Study|Did not wish to continue (unrelated)|5
6084035|NCT00383552|21003588|P2|Overall Study|Did not wish to continue (unrelated)|9
6084036|NCT00383552|21003589|P1|Overall Study|Did not wish to continue (unrelated)|4
6084037|NCT00383552|21003586|P4|Overall Study|Lost to Follow-up|1
6084038|NCT00383552|21003587|P3|Overall Study|Lost to Follow-up|5
6084039|NCT00383552|21003588|P2|Overall Study|Lost to Follow-up|1
6084040|NCT00383552|21003589|P1|Overall Study|Lost to Follow-up|0
6084041|NCT00383552|21003586|P4|Overall Study|Lack of Efficacy|42
6084042|NCT00383552|21003587|P3|Overall Study|Lack of Efficacy|29
6084043|NCT00383552|21003588|P2|Overall Study|Lack of Efficacy|13
6084044|NCT00383552|21003589|P1|Overall Study|Lack of Efficacy|4
6084045|NCT00383552|21003586|P4|Overall Study|Adverse Event|6
6084046|NCT00383552|21003587|P3|Overall Study|Adverse Event|9
6084047|NCT00383552|21003588|P2|Overall Study|Adverse Event|6
6084048|NCT00383552|21003589|P1|Overall Study|Adverse Event|7
6084049|NCT00383500|21003631|P3|Overall Study|Lost to Follow-up|2
6084050|NCT00383500|21003632|P2|Overall Study|Lost to Follow-up|0
6084051|NCT00383500|21003633|P1|Overall Study|Lost to Follow-up|0
6084052|NCT00383500|21003631|P3|Overall Study|Withdrawal by Subject|0
6084053|NCT00383500|21003632|P2|Overall Study|Withdrawal by Subject|3
6084054|NCT00383500|21003633|P1|Overall Study|Withdrawal by Subject|8
6084055|NCT00383435|21003657|P5|26-Week Treatment Safety Extension|Administrative|0
6084056|NCT00383435|21003658|P4|26-Week Treatment Safety Extension|Administrative|1
6084057|NCT00383435|21003659|P3|26-Week Treatment Safety Extension|Administrative|0
6084058|NCT00383435|21003660|P2|26-Week Treatment Safety Extension|Administrative|1
6084059|NCT00383435|21003661|P1|26-Week Treatment Safety Extension|Administrative|1
6084060|NCT00383435|21003657|P5|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0
6084061|NCT00383435|21003658|P4|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1
6084062|NCT00383435|21003659|P3|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0
6084063|NCT00383435|21003660|P2|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0
6084064|NCT00383435|21003661|P1|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1
6084065|NCT00383435|21003657|P5|26-Week Treatment Safety Extension|Non-compliance with protocol|0
6084066|NCT00383435|21003658|P4|26-Week Treatment Safety Extension|Non-compliance with protocol|1
6084067|NCT00383435|21003659|P3|26-Week Treatment Safety Extension|Non-compliance with protocol|1
6084068|NCT00383435|21003660|P2|26-Week Treatment Safety Extension|Non-compliance with protocol|1
6084069|NCT00383435|21003661|P1|26-Week Treatment Safety Extension|Non-compliance with protocol|4
6084070|NCT00383435|21003657|P5|26-Week Treatment Safety Extension|Participant withdrawal related|1
6084071|NCT00383435|21003658|P4|26-Week Treatment Safety Extension|Participant withdrawal related|0
6084072|NCT00383435|21003659|P3|26-Week Treatment Safety Extension|Participant withdrawal related|2
6084073|NCT00383435|21003660|P2|26-Week Treatment Safety Extension|Participant withdrawal related|0
6084074|NCT00383435|21003661|P1|26-Week Treatment Safety Extension|Participant withdrawal related|1
6084075|NCT00383435|21003657|P5|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0
6084076|NCT00383435|21003658|P4|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6
6084077|NCT00383435|21003659|P3|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6
6084078|NCT00383435|21003660|P2|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2
6084079|NCT00383435|21003661|P1|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2
6084080|NCT00383435|21003657|P5|26-Week Treatment Safety Extension|Lost to Follow-up|1
6084081|NCT00383435|21003658|P4|26-Week Treatment Safety Extension|Lost to Follow-up|0
6084082|NCT00383435|21003659|P3|26-Week Treatment Safety Extension|Lost to Follow-up|1
6084083|NCT00383435|21003660|P2|26-Week Treatment Safety Extension|Lost to Follow-up|2
6084084|NCT00383435|21003661|P1|26-Week Treatment Safety Extension|Lost to Follow-up|0
6084085|NCT00383435|21003657|P5|26-Week Treatment Safety Extension|Lack of Efficacy|0
6084086|NCT00383435|21003658|P4|26-Week Treatment Safety Extension|Lack of Efficacy|1
6084087|NCT00383435|21003659|P3|26-Week Treatment Safety Extension|Lack of Efficacy|1
6084088|NCT00383435|21003660|P2|26-Week Treatment Safety Extension|Lack of Efficacy|1
6084089|NCT00383435|21003661|P1|26-Week Treatment Safety Extension|Lack of Efficacy|1
6084090|NCT00383435|21003657|P5|26-Week Treatment Safety Extension|Adverse Event|1
6084091|NCT00383435|21003658|P4|26-Week Treatment Safety Extension|Adverse Event|5
6084092|NCT00383435|21003659|P3|26-Week Treatment Safety Extension|Adverse Event|5
6084093|NCT00383435|21003660|P2|26-Week Treatment Safety Extension|Adverse Event|2
6084094|NCT00383435|21003661|P1|26-Week Treatment Safety Extension|Adverse Event|4
6084095|NCT00383435|21003657|P5|26-Week Double-Blind Treatment Period|Administrative|1
6084096|NCT00383435|21003658|P4|26-Week Double-Blind Treatment Period|Administrative|1
6084097|NCT00383435|21003659|P3|26-Week Double-Blind Treatment Period|Administrative|1
6084098|NCT00383435|21003660|P2|26-Week Double-Blind Treatment Period|Administrative|3
6084099|NCT00383435|21003661|P1|26-Week Double-Blind Treatment Period|Administrative|5
6084100|NCT00383435|21003657|P5|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6
6084101|NCT00383435|21003658|P4|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5
6084102|NCT00383435|21003659|P3|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|9
6084103|NCT00383435|21003660|P2|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|8
6084104|NCT00383435|21003661|P1|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|10
6084105|NCT00383435|21003657|P5|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4
6084106|NCT00383435|21003658|P4|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5
6084107|NCT00383435|21003659|P3|26-Week Double-Blind Treatment Period|Non-compliance with protocol|3
6084108|NCT00383435|21003660|P2|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5
6084109|NCT00383435|21003661|P1|26-Week Double-Blind Treatment Period|Non-compliance with protocol|1
6084110|NCT00383435|21003657|P5|26-Week Double-Blind Treatment Period|Participant withdrawal related|7
6084111|NCT00383435|21003658|P4|26-Week Double-Blind Treatment Period|Participant withdrawal related|3
6084112|NCT00383435|21003659|P3|26-Week Double-Blind Treatment Period|Participant withdrawal related|7
6084113|NCT00383435|21003660|P2|26-Week Double-Blind Treatment Period|Participant withdrawal related|3
6084114|NCT00383435|21003661|P1|26-Week Double-Blind Treatment Period|Participant withdrawal related|2
6084115|NCT00383435|21003657|P5|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|17
6084116|NCT00383435|21003658|P4|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10
6084278|NCT00382720|21004138|P2|Overall Study|Withdrawal by Subject|20
6084117|NCT00383435|21003659|P3|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|14
6084118|NCT00383435|21003660|P2|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12
6084119|NCT00383435|21003661|P1|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|7
6084120|NCT00383435|21003657|P5|26-Week Double-Blind Treatment Period|Lost to Follow-up|2
6084121|NCT00383435|21003658|P4|26-Week Double-Blind Treatment Period|Lost to Follow-up|2
6084122|NCT00383435|21003659|P3|26-Week Double-Blind Treatment Period|Lost to Follow-up|1
6084123|NCT00383435|21003660|P2|26-Week Double-Blind Treatment Period|Lost to Follow-up|3
6084124|NCT00383435|21003661|P1|26-Week Double-Blind Treatment Period|Lost to Follow-up|3
6084125|NCT00383435|21003657|P5|26-Week Double-Blind Treatment Period|Lack of Efficacy|8
6084126|NCT00383435|21003658|P4|26-Week Double-Blind Treatment Period|Lack of Efficacy|5
6084127|NCT00383435|21003659|P3|26-Week Double-Blind Treatment Period|Lack of Efficacy|3
6084128|NCT00383435|21003660|P2|26-Week Double-Blind Treatment Period|Lack of Efficacy|2
6084129|NCT00383435|21003661|P1|26-Week Double-Blind Treatment Period|Lack of Efficacy|3
6084130|NCT00383435|21003657|P5|26-Week Double-Blind Treatment Period|Adverse Event|8
6084131|NCT00383435|21003658|P4|26-Week Double-Blind Treatment Period|Adverse Event|6
6084132|NCT00383435|21003659|P3|26-Week Double-Blind Treatment Period|Adverse Event|8
6084133|NCT00383435|21003660|P2|26-Week Double-Blind Treatment Period|Adverse Event|2
6084134|NCT00383435|21003661|P1|26-Week Double-Blind Treatment Period|Adverse Event|10
6084135|NCT00383331|21003700|P2|Overall Study|Protocol Violation|1
6084136|NCT00383331|21003701|P1|Overall Study|Protocol Violation|0
6084137|NCT00383292|21003720|P3|Overall Study|Other|0
6084138|NCT00383292|21003721|P2|Overall Study|Other|0
6084139|NCT00383292|21003722|P1|Overall Study|Other|1
6084140|NCT00383292|21003720|P3|Overall Study|Withdrawal by Subject|2
6084141|NCT00383292|21003721|P2|Overall Study|Withdrawal by Subject|2
6084142|NCT00383292|21003722|P1|Overall Study|Withdrawal by Subject|3
6084143|NCT00383292|21003720|P3|Overall Study|Physician Decision|1
6084144|NCT00383292|21003721|P2|Overall Study|Physician Decision|0
6084145|NCT00383292|21003722|P1|Overall Study|Physician Decision|4
6084146|NCT00383292|21003720|P3|Overall Study|Death|3
6084147|NCT00383292|21003721|P2|Overall Study|Death|3
6084148|NCT00383292|21003722|P1|Overall Study|Death|3
6084149|NCT00383292|21003720|P3|Overall Study|Adverse Event|2
6084150|NCT00383292|21003721|P2|Overall Study|Adverse Event|1
6084151|NCT00383292|21003722|P1|Overall Study|Adverse Event|4
6084152|NCT00383240|21003763|P4|Overall Study|Administrative|0
6084153|NCT00383240|21003764|P3|Overall Study|Administrative|0
6084154|NCT00383240|21003765|P2|Overall Study|Administrative|1
6084155|NCT00383240|21003766|P1|Overall Study|Administrative|1
6084156|NCT00383240|21003763|P4|Overall Study|Did not meet protocol eligibility|3
6084157|NCT00383240|21003764|P3|Overall Study|Did not meet protocol eligibility|9
6084158|NCT00383240|21003765|P2|Overall Study|Did not meet protocol eligibility|4
6084159|NCT00383240|21003766|P1|Overall Study|Did not meet protocol eligibility|9
6084160|NCT00383240|21003763|P4|Overall Study|Protocol Violation|6
6084161|NCT00383240|21003764|P3|Overall Study|Protocol Violation|9
6084162|NCT00383240|21003765|P2|Overall Study|Protocol Violation|5
6084163|NCT00383240|21003766|P1|Overall Study|Protocol Violation|4
6084164|NCT00383240|21003763|P4|Overall Study|Withdrawal by subjects, reasons related|5
6084165|NCT00383240|21003764|P3|Overall Study|Withdrawal by subjects, reasons related|3
6084166|NCT00383240|21003765|P2|Overall Study|Withdrawal by subjects, reasons related|1
6084167|NCT00383240|21003766|P1|Overall Study|Withdrawal by subjects, reasons related|0
6084168|NCT00383240|21003763|P4|Overall Study|Withdrawal by subject, reasons unrelated|8
6084169|NCT00383240|21003764|P3|Overall Study|Withdrawal by subject, reasons unrelated|8
6084170|NCT00383240|21003765|P2|Overall Study|Withdrawal by subject, reasons unrelated|3
6084171|NCT00383240|21003766|P1|Overall Study|Withdrawal by subject, reasons unrelated|6
6084172|NCT00383240|21003763|P4|Overall Study|Lost to Follow-up|2
6084173|NCT00383240|21003764|P3|Overall Study|Lost to Follow-up|0
6084174|NCT00383240|21003765|P2|Overall Study|Lost to Follow-up|0
6084175|NCT00383240|21003766|P1|Overall Study|Lost to Follow-up|3
6084176|NCT00383240|21003763|P4|Overall Study|Treatment Failure|46
6084177|NCT00383240|21003764|P3|Overall Study|Treatment Failure|47
6084178|NCT00383240|21003765|P2|Overall Study|Treatment Failure|13
6084179|NCT00383240|21003766|P1|Overall Study|Treatment Failure|8
6084180|NCT00383240|21003763|P4|Overall Study|Adverse Event|7
6084181|NCT00383240|21003764|P3|Overall Study|Adverse Event|9
6084182|NCT00383240|21003765|P2|Overall Study|Adverse Event|6
6084183|NCT00383240|21003766|P1|Overall Study|Adverse Event|4
6084184|NCT00383162|21003797|P2|Migraine Attack 2 (Period 2)|Unknown reason|3
6084185|NCT00383162|21003798|P1|Migraine Attack 2 (Period 2)|Unknown reason|0
6084186|NCT00383162|21003797|P2|Migraine Attack 2 (Period 2)|Adverse Event|0
6084187|NCT00383162|21003798|P1|Migraine Attack 2 (Period 2)|Adverse Event|1
6084188|NCT00383162|21003797|P2|Migraine Attack 2 (Period 2)|Lost to Follow-up|1
6084189|NCT00383162|21003798|P1|Migraine Attack 2 (Period 2)|Lost to Follow-up|0
6084190|NCT00383162|21003797|P2|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|3
6084191|NCT00383162|21003798|P1|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|1
6084192|NCT00383162|21003797|P2|Migraine Attack 1 (Period 1)|Non-compliant|0
6084193|NCT00383162|21003798|P1|Migraine Attack 1 (Period 1)|Non-compliant|3
6084194|NCT00383162|21003797|P2|Migraine Attack 1 (Period 1)|Withdrawal by Subject|0
6084195|NCT00383162|21003798|P1|Migraine Attack 1 (Period 1)|Withdrawal by Subject|2
6084196|NCT00383162|21003797|P2|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|2
6084197|NCT00383162|21003798|P1|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|4
6084198|NCT00383162|21003797|P2|Migraine Attack 1 (Period 1)|Lost to Follow-up|7
6084199|NCT00383162|21003798|P1|Migraine Attack 1 (Period 1)|Lost to Follow-up|8
6084200|NCT00383162|21003797|P2|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|4
6084201|NCT00383162|21003798|P1|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|3
6084202|NCT00383149|21003840|P1|Overall Study|Participant Withdrew Consent|1
6084203|NCT00383149|21003840|P1|Overall Study|Request to Discontinue Treatment|4
6084204|NCT00383149|21003840|P1|Overall Study|Study Drug Toxicity|4
6084205|NCT00383149|21003840|P1|Overall Study|Other|1
6084206|NCT00383149|21003840|P1|Overall Study|Lost to Follow-up|1
6084207|NCT00383149|21003840|P1|Overall Study|Disease Progression|38
6084208|NCT00383149|21003840|P1|Overall Study|Death|2
6084209|NCT00383149|21003840|P1|Overall Study|Adverse Event not Related to Study Drug|3
6084210|NCT00383123|21003859|P2|Overall Study|Other reason|6
6084211|NCT00383123|21003860|P1|Overall Study|Other reason|10
6084212|NCT00383123|21003859|P2|Overall Study|Withdrawal by Subject|18
6084213|NCT00383123|21003860|P1|Overall Study|Withdrawal by Subject|27
6084214|NCT00383123|21003859|P2|Overall Study|Protocol Violation|1
6084215|NCT00383123|21003860|P1|Overall Study|Protocol Violation|5
6084216|NCT00383123|21003859|P2|Overall Study|Lost to Follow-up|61
6084217|NCT00383123|21003860|P1|Overall Study|Lost to Follow-up|68
6084218|NCT00383123|21003859|P2|Overall Study|Adverse Event|0
6084219|NCT00383123|21003860|P1|Overall Study|Adverse Event|1
6084220|NCT00383084|21003901|P2|Overall Study|Withdrawal by Subject|10
6084221|NCT00383084|21003902|P1|Overall Study|Withdrawal by Subject|12
6084222|NCT00383019|21003933|P2|Overall Study|Withdrawal by Subject|1
6084223|NCT00383019|21003934|P1|Overall Study|Withdrawal by Subject|0
6084224|NCT00383019|21003933|P2|Overall Study|Adverse Event|1
6084225|NCT00383019|21003934|P1|Overall Study|Adverse Event|5
6084226|NCT00382993|21003956|P2|Migraine Attack 2 (Period 2)|Other (no additional data present)|1
6084227|NCT00382993|21003957|P1|Migraine Attack 2 (Period 2)|Other (no additional data present)|1
6084228|NCT00382993|21003956|P2|Migraine Attack 2 (Period 2)|Protocol Violation|1
6084229|NCT00382993|21003957|P1|Migraine Attack 2 (Period 2)|Protocol Violation|0
6084230|NCT00382993|21003956|P2|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|1
6084231|NCT00382993|21003957|P1|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|0
6084232|NCT00382993|21003956|P2|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|1
6084233|NCT00382993|21003957|P1|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|0
6084234|NCT00382993|21003956|P2|Migraine Attack 2 (Period 2)|Lost to Follow-up|0
6084235|NCT00382993|21003957|P1|Migraine Attack 2 (Period 2)|Lost to Follow-up|1
6084236|NCT00382993|21003956|P2|Migraine Attack 1 (Period 1)|Other (no additional data present)|5
6084237|NCT00382993|21003957|P1|Migraine Attack 1 (Period 1)|Other (no additional data present)|3
6084238|NCT00382993|21003956|P2|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3
6084239|NCT00382993|21003957|P1|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3
6084240|NCT00382993|21003956|P2|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|5
6084241|NCT00382993|21003957|P1|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|0
6084242|NCT00382993|21003956|P2|Migraine Attack 1 (Period 1)|Withdrawal by Subject|3
6084243|NCT00382993|21003957|P1|Migraine Attack 1 (Period 1)|Withdrawal by Subject|1
6084244|NCT00382993|21003956|P2|Migraine Attack 1 (Period 1)|Lost to Follow-up|2
6084245|NCT00382993|21003957|P1|Migraine Attack 1 (Period 1)|Lost to Follow-up|7
6084246|NCT00382967|21004001|P2|Overall Study|Protocol Violation|1
6084247|NCT00382967|21004002|P1|Overall Study|Protocol Violation|1
6084248|NCT00382863|21004027|P2|Overall Study|Withdrawal by Subject|25
6084249|NCT00382863|21004028|P1|Overall Study|Withdrawal by Subject|5
6084250|NCT00382863|21004027|P2|Overall Study|Lost to Follow-up|2
6084251|NCT00382863|21004028|P1|Overall Study|Lost to Follow-up|1
6084252|NCT00382863|21004027|P2|Overall Study|Death|9
6084253|NCT00382863|21004028|P1|Overall Study|Death|9
6084254|NCT00382733|21004112|P5|Overall Study|Withdrawal by Subject|0
6084255|NCT00382733|21004113|P4|Overall Study|Withdrawal by Subject|0
6084256|NCT00382733|21004114|P3|Overall Study|Withdrawal by Subject|0
6084257|NCT00382733|21004115|P2|Overall Study|Withdrawal by Subject|1
6084258|NCT00382733|21004116|P1|Overall Study|Withdrawal by Subject|0
6084259|NCT00382720|21004137|P3|Overall Study|Discontinued at end of study|2
6084260|NCT00382720|21004138|P2|Overall Study|Discontinued at end of study|1
6084261|NCT00382720|21004139|P1|Overall Study|Discontinued at end of study|0
6084262|NCT00382720|21004137|P3|Overall Study|Investigator/Clinical decision|6
6084263|NCT00382720|21004138|P2|Overall Study|Investigator/Clinical decision|6
6084264|NCT00382720|21004139|P1|Overall Study|Investigator/Clinical decision|5
6084265|NCT00382720|21004137|P3|Overall Study|Good prognosis|0
6084266|NCT00382720|21004138|P2|Overall Study|Good prognosis|1
6084267|NCT00382720|21004139|P1|Overall Study|Good prognosis|0
6084268|NCT00382720|21004137|P3|Overall Study|Clinically progressive disease|0
6084269|NCT00382720|21004138|P2|Overall Study|Clinically progressive disease|1
6084270|NCT00382720|21004139|P1|Overall Study|Clinically progressive disease|0
6084271|NCT00382720|21004137|P3|Overall Study|Patient did not receive study medication|4
6084272|NCT00382720|21004138|P2|Overall Study|Patient did not receive study medication|1
6084273|NCT00382720|21004139|P1|Overall Study|Patient did not receive study medication|1
6084274|NCT00382720|21004137|P3|Overall Study|Surgery|4
6084275|NCT00382720|21004138|P2|Overall Study|Surgery|1
6084276|NCT00382720|21004139|P1|Overall Study|Surgery|1
6084277|NCT00382720|21004137|P3|Overall Study|Withdrawal by Subject|12
6084279|NCT00382720|21004139|P1|Overall Study|Withdrawal by Subject|11
6084280|NCT00382720|21004137|P3|Overall Study|Withdrew consent|2
6084281|NCT00382720|21004138|P2|Overall Study|Withdrew consent|1
6084282|NCT00382720|21004139|P1|Overall Study|Withdrew consent|1
6084283|NCT00382720|21004137|P3|Overall Study|Progressive disease|38
6084284|NCT00382720|21004138|P2|Overall Study|Progressive disease|28
6084285|NCT00382720|21004139|P1|Overall Study|Progressive disease|37
6084286|NCT00382720|21004137|P3|Overall Study|Death|2
6084287|NCT00382720|21004138|P2|Overall Study|Death|1
6084288|NCT00382720|21004139|P1|Overall Study|Death|0
6084289|NCT00382720|21004137|P3|Overall Study|Protocol Violation|1
6084290|NCT00382720|21004138|P2|Overall Study|Protocol Violation|5
6084291|NCT00382720|21004139|P1|Overall Study|Protocol Violation|2
6084292|NCT00382720|21004137|P3|Overall Study|Adverse Event|15
6084293|NCT00382720|21004138|P2|Overall Study|Adverse Event|23
6084294|NCT00382720|21004139|P1|Overall Study|Adverse Event|21
6084295|NCT00382408|21004164|P2|Overall Study|Other|35
6084296|NCT00382408|21004165|P1|Overall Study|Other|100
6084297|NCT00382408|21004164|P2|Overall Study|Lost to Follow-up|8
6084298|NCT00382408|21004165|P1|Overall Study|Lost to Follow-up|19
6084299|NCT00382408|21004164|P2|Overall Study|Pregnancy|0
6084300|NCT00382408|21004165|P1|Overall Study|Pregnancy|2
6084301|NCT00382408|21004164|P2|Overall Study|Withdrawal by Subject|6
6084302|NCT00382408|21004165|P1|Overall Study|Withdrawal by Subject|17
6084303|NCT00382408|21004164|P2|Overall Study|Physician Decision|0
6084304|NCT00382408|21004165|P1|Overall Study|Physician Decision|1
6084305|NCT00382408|21004164|P2|Overall Study|Protocol Violation|2
6084306|NCT00382408|21004165|P1|Overall Study|Protocol Violation|2
6084307|NCT00382408|21004164|P2|Overall Study|Did not meet protocol requirement|3
6084308|NCT00382408|21004165|P1|Overall Study|Did not meet protocol requirement|3
6084309|NCT00382291|21004192|P3|Overall Study|Lack of Efficacy|1
6084310|NCT00382291|21004193|P2|Overall Study|Lack of Efficacy|0
6084311|NCT00382291|21004194|P1|Overall Study|Lack of Efficacy|0
6084312|NCT00382291|21004192|P3|Overall Study|Physician Decision|0
6084313|NCT00382291|21004193|P2|Overall Study|Physician Decision|1
6084314|NCT00382291|21004194|P1|Overall Study|Physician Decision|0
6084315|NCT00382291|21004192|P3|Overall Study|Withdrawal by Subject|0
6084316|NCT00382291|21004193|P2|Overall Study|Withdrawal by Subject|2
6084317|NCT00382291|21004194|P1|Overall Study|Withdrawal by Subject|0
6084318|NCT00382291|21004192|P3|Overall Study|Temporary study suspension|5
6084319|NCT00382291|21004193|P2|Overall Study|Temporary study suspension|2
6084320|NCT00382291|21004194|P1|Overall Study|Temporary study suspension|2
6084321|NCT00382291|21004192|P3|Overall Study|Protocol Violation|0
6084322|NCT00382291|21004193|P2|Overall Study|Protocol Violation|0
6084323|NCT00382291|21004194|P1|Overall Study|Protocol Violation|1
6084324|NCT00382291|21004192|P3|Overall Study|Adverse Event|2
6084325|NCT00382291|21004193|P2|Overall Study|Adverse Event|2
6084326|NCT00382291|21004194|P1|Overall Study|Adverse Event|1
6084327|NCT00382174|21004226|P3|Overall Study|Wounds merged|2
6084328|NCT00382174|21004227|P2|Overall Study|Wounds merged|2
6084329|NCT00382174|21004228|P1|Overall Study|Wounds merged|0
6084330|NCT00382174|21004226|P3|Overall Study|Failed to meet criteria|1
6084331|NCT00382174|21004227|P2|Overall Study|Failed to meet criteria|1
6084332|NCT00382174|21004228|P1|Overall Study|Failed to meet criteria|0
6084333|NCT00382174|21004226|P3|Overall Study|Physician Decision|2
6084334|NCT00382174|21004227|P2|Overall Study|Physician Decision|2
6084335|NCT00382174|21004228|P1|Overall Study|Physician Decision|0
6084336|NCT00382174|21004226|P3|Overall Study|Non compliance|1
6084337|NCT00382174|21004227|P2|Overall Study|Non compliance|0
6084338|NCT00382174|21004228|P1|Overall Study|Non compliance|1
6084339|NCT00382174|21004226|P3|Overall Study|Withdrawal by Subject|5
6084340|NCT00382174|21004227|P2|Overall Study|Withdrawal by Subject|4
6084341|NCT00382174|21004228|P1|Overall Study|Withdrawal by Subject|1
6084342|NCT00382174|21004226|P3|Overall Study|Adverse Event|5
6084343|NCT00382174|21004227|P2|Overall Study|Adverse Event|4
6084344|NCT00382174|21004228|P1|Overall Study|Adverse Event|1
6084345|NCT00382174|21004226|P3|Overall Study|Lost to Follow-up|5
6084346|NCT00382174|21004227|P2|Overall Study|Lost to Follow-up|4
6084347|NCT00382174|21004228|P1|Overall Study|Lost to Follow-up|1
6084348|NCT00382109|21004256|P2|Overall Study|consent withdrawal|1
6084349|NCT00382109|21004257|P1|Overall Study|consent withdrawal|0
6084350|NCT00382109|21004256|P2|Overall Study|Other|2
6084351|NCT00382109|21004257|P1|Overall Study|Other|0
6084352|NCT00382109|21004256|P2|Overall Study|ineligible|0
6084353|NCT00382109|21004257|P1|Overall Study|ineligible|2
6084354|NCT00382109|21004256|P2|Overall Study|Withdrawal by Subject|0
6084355|NCT00382109|21004257|P1|Overall Study|Withdrawal by Subject|1
6084356|NCT00382109|21004256|P2|Overall Study|Physician Decision|1
6084357|NCT00382109|21004257|P1|Overall Study|Physician Decision|6
6084358|NCT00382109|21004256|P2|Overall Study|Adverse Event|0
6084359|NCT00382109|21004257|P1|Overall Study|Adverse Event|3
6084360|NCT00382018|21004296|P4|Overall Study|Other, not protocol specified|1
6084361|NCT00382018|21004297|P3|Overall Study|Other, not protocol specified|3
6084362|NCT00382018|21004298|P2|Overall Study|Other, not protocol specified|16
6084363|NCT00382018|21004299|P1|Overall Study|Other, not protocol specified|0
6084364|NCT00382018|21004296|P4|Overall Study|Withdrawal by Subject|4
6084365|NCT00382018|21004297|P3|Overall Study|Withdrawal by Subject|3
6084366|NCT00382018|21004298|P2|Overall Study|Withdrawal by Subject|4
6084367|NCT00382018|21004299|P1|Overall Study|Withdrawal by Subject|0
6084368|NCT00382018|21004296|P4|Overall Study|Death|11
6084369|NCT00382018|21004297|P3|Overall Study|Death|7
6084370|NCT00382018|21004298|P2|Overall Study|Death|9
6084371|NCT00382018|21004299|P1|Overall Study|Death|0
6084372|NCT00382018|21004296|P4|Overall Study|Progression|43
6084373|NCT00382018|21004297|P3|Overall Study|Progression|51
6084374|NCT00382018|21004298|P2|Overall Study|Progression|136
6084375|NCT00382018|21004299|P1|Overall Study|Progression|0
6084376|NCT00381888|21004322|P1|Overall Study|Adverse Event|1
6084377|NCT00381888|21004322|P1|Overall Study|Surgery was cancelled|2
6084378|NCT00381888|21004322|P1|Overall Study|Had laparoscopic surgery|2
6084379|NCT00381888|21004322|P1|Overall Study|Protocol Violation|9
6084380|NCT00381888|21004322|P1|Overall Study|Physician Decision|1
6084381|NCT00381888|21004322|P1|Overall Study|Withdrawal by Subject|1
6084382|NCT00381888|21004322|P1|Overall Study|Death|1
6084383|NCT00381849|21004333|P2|Wash Out|Withdrawal by Subject|1
6084384|NCT00381849|21004334|P1|Wash Out|Withdrawal by Subject|0
6084385|NCT00381797|21004361|P5|Overall Study|Ineligible|0
6084386|NCT00381797|21004362|P4|Overall Study|Ineligible|1
6084387|NCT00381797|21004363|P3|Overall Study|Ineligible|0
6084388|NCT00381797|21004364|P2|Overall Study|Ineligible|0
6084389|NCT00381797|21004365|P1|Overall Study|Ineligible|0
6084390|NCT00381797|21004361|P5|Overall Study|Withdrawal by Subject|2
6084391|NCT00381797|21004362|P4|Overall Study|Withdrawal by Subject|0
6084392|NCT00381797|21004363|P3|Overall Study|Withdrawal by Subject|0
6084393|NCT00381797|21004364|P2|Overall Study|Withdrawal by Subject|1
6084394|NCT00381797|21004365|P1|Overall Study|Withdrawal by Subject|1
6084395|NCT00381706|21004440|P3|Overall Study|Never treated|1
6084396|NCT00381706|21004441|P2|Overall Study|Never treated|2
6084397|NCT00381706|21004442|P1|Overall Study|Never treated|7
6084398|NCT00381693|21004465|P1|Overall Study|Progression|2
6084399|NCT00381693|21004465|P1|Overall Study|Patient Choice|1
6084400|NCT00381693|21004465|P1|Overall Study|Adverse Event|4
6084401|NCT00381693|21004465|P1|Overall Study|Death|1
6084402|NCT00381680|21004474|P2|Overall Study|Ineligible|1
6084403|NCT00381680|21004475|P1|Overall Study|Ineligible|3
6084404|NCT00381680|21004474|P2|Overall Study|Other not otherwise specified|2
6084405|NCT00381680|21004475|P1|Overall Study|Other not otherwise specified|7
6084406|NCT00381680|21004474|P2|Overall Study|Progression|1
6084407|NCT00381680|21004475|P1|Overall Study|Progression|1
6084408|NCT00381680|21004474|P2|Overall Study|Induction Failure|1
6084409|NCT00381680|21004475|P1|Overall Study|Induction Failure|4
6084410|NCT00381680|21004474|P2|Overall Study|Relapse|9
6084411|NCT00381680|21004475|P1|Overall Study|Relapse|18
6084412|NCT00381680|21004474|P2|Overall Study|Stem Cell Transplant|10
6084413|NCT00381680|21004475|P1|Overall Study|Stem Cell Transplant|26
6084414|NCT00381680|21004474|P2|Overall Study|Delay initiation|0
6084415|NCT00381680|21004475|P1|Overall Study|Delay initiation|1
6084416|NCT00381680|21004474|P2|Overall Study|Secondary Malignancy|0
6084417|NCT00381680|21004475|P1|Overall Study|Secondary Malignancy|3
6084418|NCT00381680|21004474|P2|Overall Study|Alternative Therapy|5
6084419|NCT00381680|21004475|P1|Overall Study|Alternative Therapy|11
6084420|NCT00381680|21004474|P2|Overall Study|Entry onto another COG Trial|2
6084421|NCT00381680|21004475|P1|Overall Study|Entry onto another COG Trial|1
6084422|NCT00381680|21004474|P2|Overall Study|Withdrawal by Subject|1
6084423|NCT00381680|21004475|P1|Overall Study|Withdrawal by Subject|3
6084424|NCT00381680|21004474|P2|Overall Study|Physician Decision|6
6084425|NCT00381680|21004475|P1|Overall Study|Physician Decision|25
6084426|NCT00381680|21004474|P2|Overall Study|Lost to Follow-up|2
6084427|NCT00381680|21004475|P1|Overall Study|Lost to Follow-up|3
6084428|NCT00381680|21004474|P2|Overall Study|Death|7
6084429|NCT00381680|21004475|P1|Overall Study|Death|10
6084430|NCT00381680|21004474|P2|Overall Study|Adverse Event|3
6084431|NCT00381680|21004475|P1|Overall Study|Adverse Event|9
6084432|NCT00381641|21004492|P2|Overall Study|Withdrawal by Subject|2
6084433|NCT00381641|21004493|P1|Overall Study|Withdrawal by Subject|0
6084434|NCT00381615|21004526|P4|Overall Study|Protocol Violation|0
6084435|NCT00381615|21004527|P3|Overall Study|Protocol Violation|1
6084436|NCT00381615|21004528|P2|Overall Study|Protocol Violation|0
6084437|NCT00381615|21004529|P1|Overall Study|Protocol Violation|0
6084438|NCT00381615|21004526|P4|Overall Study|Lost to Follow-up|1
6084439|NCT00381615|21004527|P3|Overall Study|Lost to Follow-up|0
6084440|NCT00381615|21004528|P2|Overall Study|Lost to Follow-up|2
6084441|NCT00381615|21004529|P1|Overall Study|Lost to Follow-up|3
6084442|NCT00381615|21004526|P4|Overall Study|Withdrawal by Subject|1
6084443|NCT00381615|21004527|P3|Overall Study|Withdrawal by Subject|0
6084444|NCT00381615|21004528|P2|Overall Study|Withdrawal by Subject|3
6084445|NCT00381615|21004529|P1|Overall Study|Withdrawal by Subject|1
6084446|NCT00381563|21004581|P2|Overall Study|Protocol Violation|1
6084447|NCT00381563|21004582|P1|Overall Study|Protocol Violation|0
6084448|NCT00381563|21004581|P2|Overall Study|Lost to Follow-up|0
6084449|NCT00381563|21004582|P1|Overall Study|Lost to Follow-up|2
6084450|NCT00381563|21004581|P2|Overall Study|Withdrawal by Subject|5
6084451|NCT00381563|21004582|P1|Overall Study|Withdrawal by Subject|5
6084452|NCT00381485|21004597|P4|Double-Blind Treatment Period|Administrative|1
6084453|NCT00381485|21004598|P3|Double-Blind Treatment Period|Administrative|0
6084454|NCT00381485|21004599|P2|Double-Blind Treatment Period|Administrative|1
6084455|NCT00381485|21004600|P1|Double-Blind Treatment Period|Administrative|0
6084456|NCT00381485|21004597|P4|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|1
6084457|NCT00381485|21004598|P3|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0
6084458|NCT00381485|21004599|P2|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0
6084459|NCT00381485|21004600|P1|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0
6084460|NCT00381485|21004597|P4|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|4
6084461|NCT00381485|21004598|P3|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|1
6084462|NCT00381485|21004599|P2|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|2
6084463|NCT00381485|21004600|P1|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|0
6084464|NCT00381485|21004597|P4|Double-Blind Treatment Period|Did not meet protocol eligibility|5
6084465|NCT00381485|21004598|P3|Double-Blind Treatment Period|Did not meet protocol eligibility|7
6084466|NCT00381485|21004599|P2|Double-Blind Treatment Period|Did not meet protocol eligibility|5
6084467|NCT00381485|21004600|P1|Double-Blind Treatment Period|Did not meet protocol eligibility|0
6084468|NCT00381485|21004597|P4|Double-Blind Treatment Period|Noncompliance with protocol|3
6084469|NCT00381485|21004598|P3|Double-Blind Treatment Period|Noncompliance with protocol|3
6084470|NCT00381485|21004599|P2|Double-Blind Treatment Period|Noncompliance with protocol|9
6084471|NCT00381485|21004600|P1|Double-Blind Treatment Period|Noncompliance with protocol|0
6084472|NCT00381485|21004597|P4|Double-Blind Treatment Period|Lost to Follow-up|1
6084473|NCT00381485|21004598|P3|Double-Blind Treatment Period|Lost to Follow-up|1
6084474|NCT00381485|21004599|P2|Double-Blind Treatment Period|Lost to Follow-up|0
6084475|NCT00381485|21004600|P1|Double-Blind Treatment Period|Lost to Follow-up|0
6084476|NCT00381485|21004597|P4|Double-Blind Treatment Period|Lack of Efficacy|13
6084477|NCT00381485|21004598|P3|Double-Blind Treatment Period|Lack of Efficacy|11
6084478|NCT00381485|21004599|P2|Double-Blind Treatment Period|Lack of Efficacy|8
6084479|NCT00381485|21004600|P1|Double-Blind Treatment Period|Lack of Efficacy|0
6084480|NCT00381485|21004597|P4|Double-Blind Treatment Period|Adverse Event|5
6084481|NCT00381485|21004598|P3|Double-Blind Treatment Period|Adverse Event|2
6084482|NCT00381485|21004599|P2|Double-Blind Treatment Period|Adverse Event|2
6084483|NCT00381485|21004600|P1|Double-Blind Treatment Period|Adverse Event|0
6084484|NCT00381485|21004597|P4|Open-Label Run-In Period|Treatment failure|0
6084485|NCT00381485|21004598|P3|Open-Label Run-In Period|Treatment failure|0
6084486|NCT00381485|21004599|P2|Open-Label Run-In Period|Treatment failure|0
6084487|NCT00381485|21004600|P1|Open-Label Run-In Period|Treatment failure|1
6084488|NCT00381485|21004597|P4|Open-Label Run-In Period|Lost to Follow-up|0
6084489|NCT00381485|21004598|P3|Open-Label Run-In Period|Lost to Follow-up|0
6084490|NCT00381485|21004599|P2|Open-Label Run-In Period|Lost to Follow-up|0
6084491|NCT00381485|21004600|P1|Open-Label Run-In Period|Lost to Follow-up|3
6084492|NCT00381485|21004597|P4|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0
6084493|NCT00381485|21004598|P3|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0
6084494|NCT00381485|21004599|P2|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0
6084495|NCT00381485|21004600|P1|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|1
6084496|NCT00381485|21004597|P4|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0
6084497|NCT00381485|21004598|P3|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0
6084498|NCT00381485|21004599|P2|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0
6084499|NCT00381485|21004600|P1|Open-Label Run-In Period|Withdrawal by Subject-reasons related|16
6084500|NCT00381485|21004597|P4|Open-Label Run-In Period|Did not meet protocol eligibility|0
6084501|NCT00381485|21004598|P3|Open-Label Run-In Period|Did not meet protocol eligibility|0
6084502|NCT00381485|21004599|P2|Open-Label Run-In Period|Did not meet protocol eligibility|0
6084503|NCT00381485|21004600|P1|Open-Label Run-In Period|Did not meet protocol eligibility|76
6084504|NCT00381485|21004597|P4|Open-Label Run-In Period|Adverse Event|0
6084505|NCT00381485|21004598|P3|Open-Label Run-In Period|Adverse Event|0
6084506|NCT00381485|21004599|P2|Open-Label Run-In Period|Adverse Event|0
6084507|NCT00381485|21004600|P1|Open-Label Run-In Period|Adverse Event|9
6084508|NCT00381381|21004618|P1|Overall Study|Withdrawal by Subject|9
6084509|NCT00381381|21004618|P1|Overall Study|Lost to Follow-up|52
6084510|NCT00381381|21004618|P1|Overall Study|Adverse Event|3
6084511|NCT00381303|21004627|P2|Overall Study|Subject primary physician's decision|0
6084512|NCT00381303|21004628|P1|Overall Study|Subject primary physician's decision|1
6084513|NCT00381303|21004627|P2|Overall Study|Subject did not continue visits|0
6084514|NCT00381303|21004628|P1|Overall Study|Subject did not continue visits|1
6084515|NCT00381303|21004627|P2|Overall Study|Subject was too busy for appointments|0
6084516|NCT00381303|21004628|P1|Overall Study|Subject was too busy for appointments|1
6084517|NCT00381303|21004627|P2|Overall Study|No virologic response by week 12|0
6084518|NCT00381303|21004628|P1|Overall Study|No virologic response by week 12|1
6084519|NCT00381303|21004627|P2|Overall Study|Subject taking too many different meds|0
6084520|NCT00381303|21004628|P1|Overall Study|Subject taking too many different meds|1
6084521|NCT00381303|21004627|P2|Overall Study|Subject moved out of state|0
6084522|NCT00381303|21004628|P1|Overall Study|Subject moved out of state|2
6084523|NCT00381303|21004627|P2|Overall Study|Physician's decision to close the site|1
6084524|NCT00381303|21004628|P1|Overall Study|Physician's decision to close the site|3
6084525|NCT00381303|21004627|P2|Overall Study|Physician Decision|0
6084526|NCT00381303|21004628|P1|Overall Study|Physician Decision|1
6084527|NCT00381303|21004627|P2|Overall Study|Pregnancy|0
6084528|NCT00381303|21004628|P1|Overall Study|Pregnancy|2
6084529|NCT00381303|21004627|P2|Overall Study|Ineligible to continue the trial|1
6084530|NCT00381303|21004628|P1|Overall Study|Ineligible to continue the trial|2
6084531|NCT00381303|21004627|P2|Overall Study|Virologic failure|4
6084532|NCT00381303|21004628|P1|Overall Study|Virologic failure|6
6084533|NCT00381303|21004627|P2|Overall Study|Withdrawal by Subject|6
6084534|NCT00381303|21004628|P1|Overall Study|Withdrawal by Subject|13
6084535|NCT00381303|21004627|P2|Overall Study|Non-Adherence|6
6084536|NCT00381303|21004628|P1|Overall Study|Non-Adherence|13
6084537|NCT00381303|21004627|P2|Overall Study|AE/HIV-related event|6
6084538|NCT00381303|21004628|P1|Overall Study|AE/HIV-related event|22
6084539|NCT00381303|21004627|P2|Overall Study|Lost to Follow-up|9
6084540|NCT00381303|21004628|P1|Overall Study|Lost to Follow-up|25
6084541|NCT00381238|21004688|P1|Overall Study|Disease progression|1
6084542|NCT00381238|21004688|P1|Overall Study|Withdrew by physician|1
6084543|NCT00381238|21004688|P1|Overall Study|Lack of Efficacy|2
6084544|NCT00381238|21004688|P1|Overall Study|Withdrawal by Subject|4
6084545|NCT00381238|21004688|P1|Overall Study|Protocol Violation|1
6084546|NCT00381238|21004688|P1|Overall Study|Adverse Event|3
6084547|NCT00381095|21004704|P2|Overall Study|Adverse Event|7
6084548|NCT00381095|21004705|P1|Overall Study|Adverse Event|2
6084549|NCT00381095|21004704|P2|Overall Study|Withdrawal by Subject|3
6084550|NCT00381095|21004705|P1|Overall Study|Withdrawal by Subject|3
6084551|NCT00381095|21004704|P2|Overall Study|Protocol Violation|1
6084552|NCT00381095|21004705|P1|Overall Study|Protocol Violation|1
6084553|NCT00381095|21004704|P2|Overall Study|Other|2
6084554|NCT00381095|21004705|P1|Overall Study|Other|2
6084555|NCT00381095|21004704|P2|Overall Study|Lack of Efficacy|4
6084556|NCT00381095|21004705|P1|Overall Study|Lack of Efficacy|2
6084557|NCT00381095|21004704|P2|Overall Study|Death|4
6084558|NCT00381095|21004705|P1|Overall Study|Death|3
6084559|NCT00381043|21004737|P2|Overall Study|incarcerated|0
6084560|NCT00381043|21004738|P1|Overall Study|incarcerated|1
6084561|NCT00381043|21004737|P2|Overall Study|wanted more care|1
6084562|NCT00381043|21004738|P1|Overall Study|wanted more care|0
6084563|NCT00381043|21004737|P2|Overall Study|Withdrawal by Subject|1
6084564|NCT00381043|21004738|P1|Overall Study|Withdrawal by Subject|3
6084565|NCT00381043|21004737|P2|Overall Study|Lost to Follow-up|6
6084566|NCT00381043|21004738|P1|Overall Study|Lost to Follow-up|8
6084567|NCT00380978|21004764|P2|Overall Study|Parous patient|0
6084568|NCT00380978|21004765|P1|Overall Study|Parous patient|1
6084569|NCT00380978|21004764|P2|Overall Study|Allocation prior to analgesia request|2
6084570|NCT00380978|21004765|P1|Overall Study|Allocation prior to analgesia request|1
6084571|NCT00380978|21004764|P2|Overall Study|Wrong study envelope|2
6084572|NCT00380978|21004765|P1|Overall Study|Wrong study envelope|0
6084573|NCT00380978|21004764|P2|Overall Study|Refused allocated intervention|6
6084574|NCT00380978|21004765|P1|Overall Study|Refused allocated intervention|0
6084583|NCT00380744|21004820|P7|Overall Study|Withdrawal by Subject|0
6084584|NCT00380744|21004821|P6|Overall Study|Withdrawal by Subject|0
6084585|NCT00380744|21004822|P5|Overall Study|Withdrawal by Subject|0
6084586|NCT00380744|21004823|P4|Overall Study|Withdrawal by Subject|0
6084587|NCT00380744|21004824|P3|Overall Study|Withdrawal by Subject|0
6084588|NCT00380744|21004825|P2|Overall Study|Withdrawal by Subject|0
6084589|NCT00380744|21004826|P1|Overall Study|Withdrawal by Subject|1
6084590|NCT00380744|21004820|P7|Overall Study|Death|1
6084591|NCT00380744|21004821|P6|Overall Study|Death|0
6084592|NCT00380744|21004822|P5|Overall Study|Death|0
6084593|NCT00380744|21004823|P4|Overall Study|Death|0
6084594|NCT00380744|21004824|P3|Overall Study|Death|0
6084595|NCT00380744|21004825|P2|Overall Study|Death|0
6084596|NCT00380744|21004826|P1|Overall Study|Death|0
6084597|NCT00380718|21004876|P1|Overall Study|Death after 30-day post-therapy followup|17
6084598|NCT00380718|21004876|P1|Overall Study|Adverse Event|1
6084599|NCT00380692|21004888|P2|Study Period III - Open Label|Parent/Caregiver Decision|1
6084600|NCT00380692|21004889|P1|Study Period III - Open Label|Parent/Caregiver Decision|1
6084601|NCT00380692|21004888|P2|Study Period III - Open Label|Lack of Efficacy|4
6084602|NCT00380692|21004889|P1|Study Period III - Open Label|Lack of Efficacy|0
6084603|NCT00380692|21004888|P2|Study Period III - Open Label|Physician Decision|3
6084604|NCT00380692|21004889|P1|Study Period III - Open Label|Physician Decision|0
6084605|NCT00380692|21004888|P2|Study Period III - Open Label|Withdrawal by Subject|1
6084606|NCT00380692|21004889|P1|Study Period III - Open Label|Withdrawal by Subject|0
6084607|NCT00380692|21004888|P2|Study Period III - Open Label|Protocol Violation|0
6084608|NCT00380692|21004889|P1|Study Period III - Open Label|Protocol Violation|0
6084609|NCT00380692|21004888|P2|Study Period III - Open Label|Adverse Event|3
6084610|NCT00380692|21004889|P1|Study Period III - Open Label|Adverse Event|5
6084611|NCT00380692|21004888|P2|Study Period II - Double Blind|Parent/Caregiver Decision|0
6084612|NCT00380692|21004889|P1|Study Period II - Double Blind|Parent/Caregiver Decision|1
6084613|NCT00380692|21004888|P2|Study Period II - Double Blind|Lack of Efficacy|0
6084614|NCT00380692|21004889|P1|Study Period II - Double Blind|Lack of Efficacy|1
6084615|NCT00380692|21004888|P2|Study Period II - Double Blind|Physician Decision|1
6084616|NCT00380692|21004889|P1|Study Period II - Double Blind|Physician Decision|0
6084617|NCT00380692|21004888|P2|Study Period II - Double Blind|Withdrawal by Subject|0
6084618|NCT00380692|21004889|P1|Study Period II - Double Blind|Withdrawal by Subject|0
6084619|NCT00380692|21004888|P2|Study Period II - Double Blind|Protocol Violation|2
6084620|NCT00380692|21004889|P1|Study Period II - Double Blind|Protocol Violation|2
6084621|NCT00380692|21004888|P2|Study Period II - Double Blind|Adverse Event|0
6084622|NCT00380692|21004889|P1|Study Period II - Double Blind|Adverse Event|1
6084623|NCT00380588|21004937|P2|Overall Study|Physician Decision|0
6084624|NCT00380588|21004938|P1|Overall Study|Physician Decision|2
6084625|NCT00380588|21004937|P2|Overall Study|Withdrawal by Subject|3
6084626|NCT00380588|21004938|P1|Overall Study|Withdrawal by Subject|1
6084627|NCT00380588|21004937|P2|Overall Study|Adverse Event|3
6084628|NCT00380588|21004938|P1|Overall Study|Adverse Event|7
6084629|NCT00380588|21004937|P2|Overall Study|Next Cycle Not Started|0
6084630|NCT00380588|21004938|P1|Overall Study|Next Cycle Not Started|4
6084631|NCT00380588|21004937|P2|Overall Study|Unequivocal Disease Progression|34
6084632|NCT00380588|21004938|P1|Overall Study|Unequivocal Disease Progression|25
6084633|NCT00380393|21004952|P2|Month 14|Others|6
6084634|NCT00380393|21004953|P1|Month 14|Others|6
6084635|NCT00380393|21004952|P2|Month 14|Protocol Violation|0
6084636|NCT00380393|21004953|P1|Month 14|Protocol Violation|2
6084637|NCT00380393|21004952|P2|Month 14|Migrated/moved from study area|42
6084638|NCT00380393|21004953|P1|Month 14|Migrated/moved from study area|39
6084639|NCT00380393|21004952|P2|Month 14|Lost to Follow-up|1
6084640|NCT00380393|21004953|P1|Month 14|Lost to Follow-up|0
6084641|NCT00380393|21004952|P2|Month 14|Death|0
6084642|NCT00380393|21004953|P1|Month 14|Death|1
6084643|NCT00380393|21004952|P2|Month 14|Withdrawal by Subject|7
6084644|NCT00380393|21004953|P1|Month 14|Withdrawal by Subject|9
6084645|NCT00380393|21004952|P2|Month 8 (Cross-sectional Visit)|Others|4
6084646|NCT00380393|21004953|P1|Month 8 (Cross-sectional Visit)|Others|5
6084647|NCT00380393|21004952|P2|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1
6084648|NCT00380393|21004953|P1|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1
6084649|NCT00380393|21004952|P2|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|29
6084650|NCT00380393|21004953|P1|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|37
6084651|NCT00380393|21004952|P2|Month 8 (Cross-sectional Visit)|Lost to Follow-up|1
6084652|NCT00380393|21004953|P1|Month 8 (Cross-sectional Visit)|Lost to Follow-up|0
6084653|NCT00380393|21004952|P2|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|5
6084654|NCT00380393|21004953|P1|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|6
6084655|NCT00380367|21005001|P1|Overall Study|Withdrawal by Subject|1
6084656|NCT00380367|21005001|P1|Overall Study|Lost to Follow-up|1
6084657|NCT00380250|21005008|P2|Overall Study|Physician Decision|0
6084658|NCT00380250|21005009|P1|Overall Study|Physician Decision|1
6084659|NCT00380250|21005008|P2|Overall Study|Lost to Follow-up|5
6084660|NCT00380250|21005009|P1|Overall Study|Lost to Follow-up|14
6084661|NCT00380250|21005008|P2|Overall Study|Protocol Violation|5
6084662|NCT00380250|21005009|P1|Overall Study|Protocol Violation|15
6084663|NCT00380250|21005008|P2|Overall Study|Lack of Efficacy|8
6084664|NCT00380250|21005009|P1|Overall Study|Lack of Efficacy|10
6084665|NCT00380250|21005008|P2|Overall Study|Adverse Event|9
6084666|NCT00380250|21005009|P1|Overall Study|Adverse Event|20
6084667|NCT00380250|21005008|P2|Overall Study|Withdrawal by Subject|28
6084668|NCT00380250|21005009|P1|Overall Study|Withdrawal by Subject|39
6084669|NCT00380081|21005077|P6|Overall Study|Family Emergency|1
6084670|NCT00380081|21005078|P5|Overall Study|Family Emergency|0
6084671|NCT00380081|21005079|P4|Overall Study|Family Emergency|0
6084672|NCT00380081|21005080|P3|Overall Study|Family Emergency|0
6084673|NCT00380081|21005081|P2|Overall Study|Family Emergency|0
6084674|NCT00380081|21005082|P1|Overall Study|Family Emergency|0
6084675|NCT00380081|21005077|P6|Overall Study|Withdrawal by Subject|0
6084676|NCT00380081|21005078|P5|Overall Study|Withdrawal by Subject|1
6084677|NCT00380081|21005079|P4|Overall Study|Withdrawal by Subject|0
6084678|NCT00380081|21005080|P3|Overall Study|Withdrawal by Subject|0
6084679|NCT00380081|21005081|P2|Overall Study|Withdrawal by Subject|0
6084680|NCT00380081|21005082|P1|Overall Study|Withdrawal by Subject|0
6084681|NCT00380068|21005132|P1|Overall Study|Lack of Efficacy|5
6084682|NCT00380068|21005132|P1|Overall Study|Partipant moved away|1
6084683|NCT00380068|21005132|P1|Overall Study|Physician Decision|2
6084684|NCT00380068|21005132|P1|Overall Study|Lung transplant|3
6084685|NCT00380068|21005132|P1|Overall Study|Addition of other PAH therapeutic agent|1
6084686|NCT00380068|21005132|P1|Overall Study|Lost to Follow-up|1
6084687|NCT00380068|21005132|P1|Overall Study|Not compliant|6
6084688|NCT00380068|21005132|P1|Overall Study|Withdrawal by Subject|10
6084689|NCT00380068|21005132|P1|Overall Study|Adverse Event|40
6084690|NCT00379912|21005164|P2|Overall Study|Lack of Efficacy|0
6084691|NCT00379912|21005165|P1|Overall Study|Lack of Efficacy|1
6084692|NCT00379899|21005187|P2|Overall Study|Other|1
6084693|NCT00379899|21005188|P1|Overall Study|Other|3
6084694|NCT00379899|21005187|P2|Overall Study|Other protocol-specified criteria|4
6084695|NCT00379899|21005188|P1|Overall Study|Other protocol-specified criteria|3
6084696|NCT00379899|21005187|P2|Overall Study|Coronary artery bypass graft|1
6084697|NCT00379899|21005188|P1|Overall Study|Coronary artery bypass graft|1
6084698|NCT00379899|21005187|P2|Overall Study|Renal transplantation|4
6084699|NCT00379899|21005188|P1|Overall Study|Renal transplantation|5
6084700|NCT00379899|21005187|P2|Overall Study|Parathyroidectomy|2
6084701|NCT00379899|21005188|P1|Overall Study|Parathyroidectomy|0
6084702|NCT00379899|21005187|P2|Overall Study|Noncompliance|1
6084703|NCT00379899|21005188|P1|Overall Study|Noncompliance|1
6084704|NCT00379899|21005187|P2|Overall Study|Ineligibility determined|1
6084705|NCT00379899|21005188|P1|Overall Study|Ineligibility determined|0
6084706|NCT00379899|21005187|P2|Overall Study|Withdrawal by Subject|5
6084707|NCT00379899|21005188|P1|Overall Study|Withdrawal by Subject|5
6084708|NCT00379899|21005187|P2|Overall Study|Physician Decision|4
6084709|NCT00379899|21005188|P1|Overall Study|Physician Decision|3
6084710|NCT00379899|21005187|P2|Overall Study|Lost to Follow-up|4
6084711|NCT00379899|21005188|P1|Overall Study|Lost to Follow-up|2
6084712|NCT00379899|21005187|P2|Overall Study|Death|10
6084713|NCT00379899|21005188|P1|Overall Study|Death|10
6084714|NCT00379899|21005187|P2|Overall Study|Adverse Event|3
6084715|NCT00379899|21005188|P1|Overall Study|Adverse Event|7
6084716|NCT00379834|21005216|P1|Overall Study|Time constraints|2
6084717|NCT00379808|21005368|P2|Intervention Period 2 (4 Weeks)|Lost to Follow-up|1
6084718|NCT00379808|21005369|P1|Intervention Period 2 (4 Weeks)|Lost to Follow-up|0
6084719|NCT00379795|21005390|P5|Overall Study|Sponsor's decision|10
6084720|NCT00379795|21005391|P4|Overall Study|Sponsor's decision|47
6084721|NCT00379795|21005392|P3|Overall Study|Sponsor's decision|54
6084722|NCT00379795|21005393|P2|Overall Study|Sponsor's decision|17
6084723|NCT00379795|21005394|P1|Overall Study|Sponsor's decision|257
6084724|NCT00379795|21005390|P5|Overall Study|Subjects condition mandated intervention|7
6084725|NCT00379795|21005391|P4|Overall Study|Subjects condition mandated intervention|5
6084726|NCT00379795|21005392|P3|Overall Study|Subjects condition mandated intervention|7
6084727|NCT00379795|21005393|P2|Overall Study|Subjects condition mandated intervention|9
6084728|NCT00379795|21005394|P1|Overall Study|Subjects condition mandated intervention|34
6084729|NCT00379795|21005390|P5|Overall Study|Verteporfin photodynamic therapy in eye|0
6084730|NCT00379795|21005391|P4|Overall Study|Verteporfin photodynamic therapy in eye|1
6084731|NCT00379795|21005392|P3|Overall Study|Verteporfin photodynamic therapy in eye|0
6084732|NCT00379795|21005393|P2|Overall Study|Verteporfin photodynamic therapy in eye|0
6084733|NCT00379795|21005394|P1|Overall Study|Verteporfin photodynamic therapy in eye|3
6084734|NCT00379795|21005390|P5|Overall Study|Subject non-compliance|1
6084735|NCT00379795|21005391|P4|Overall Study|Subject non-compliance|0
6084736|NCT00379795|21005392|P3|Overall Study|Subject non-compliance|0
6084737|NCT00379795|21005393|P2|Overall Study|Subject non-compliance|2
6084738|NCT00379795|21005394|P1|Overall Study|Subject non-compliance|7
6084739|NCT00379795|21005390|P5|Overall Study|Withdrawal by Subject|14
6084740|NCT00379795|21005391|P4|Overall Study|Withdrawal by Subject|7
6084741|NCT00379795|21005392|P3|Overall Study|Withdrawal by Subject|19
6084742|NCT00379795|21005393|P2|Overall Study|Withdrawal by Subject|11
6084743|NCT00379795|21005394|P1|Overall Study|Withdrawal by Subject|94
6084744|NCT00379795|21005390|P5|Overall Study|Physician Decision|2
6084745|NCT00379795|21005391|P4|Overall Study|Physician Decision|2
6084746|NCT00379795|21005392|P3|Overall Study|Physician Decision|2
6084747|NCT00379795|21005393|P2|Overall Study|Physician Decision|0
6084748|NCT00379795|21005394|P1|Overall Study|Physician Decision|25
6084749|NCT00379795|21005390|P5|Overall Study|Lost to Follow-up|4
6084750|NCT00379795|21005391|P4|Overall Study|Lost to Follow-up|1
6084751|NCT00379795|21005392|P3|Overall Study|Lost to Follow-up|2
6084752|NCT00379795|21005393|P2|Overall Study|Lost to Follow-up|1
6084753|NCT00379795|21005394|P1|Overall Study|Lost to Follow-up|8
6084754|NCT00379795|21005390|P5|Overall Study|Adverse Event|4
6084755|NCT00379795|21005391|P4|Overall Study|Adverse Event|1
6084756|NCT00379795|21005392|P3|Overall Study|Adverse Event|3
6084757|NCT00379795|21005393|P2|Overall Study|Adverse Event|3
6084758|NCT00379795|21005394|P1|Overall Study|Adverse Event|17
6084759|NCT00379795|21005390|P5|Overall Study|Death|7
6084760|NCT00379795|21005391|P4|Overall Study|Death|4
6084761|NCT00379795|21005392|P3|Overall Study|Death|6
6084762|NCT00379795|21005393|P2|Overall Study|Death|8
6084763|NCT00379795|21005394|P1|Overall Study|Death|31
6084764|NCT00379769|21005424|P6|Observational Follow-up|Unknown; Reason Not Provided|1
6084765|NCT00379769|21005425|P5|Observational Follow-up|Unknown; Reason Not Provided|1
6084766|NCT00379769|21005426|P4|Observational Follow-up|Unknown; Reason Not Provided|0
6084767|NCT00379769|21005427|P3|Observational Follow-up|Unknown; Reason Not Provided|0
6084768|NCT00379769|21005428|P2|Observational Follow-up|Unknown; Reason Not Provided|0
6084769|NCT00379769|21005429|P1|Observational Follow-up|Unknown; Reason Not Provided|0
6084770|NCT00379769|21005424|P6|Observational Follow-up|Participant Moved|1
6084771|NCT00379769|21005425|P5|Observational Follow-up|Participant Moved|0
6084772|NCT00379769|21005426|P4|Observational Follow-up|Participant Moved|0
6084773|NCT00379769|21005427|P3|Observational Follow-up|Participant Moved|0
6084774|NCT00379769|21005428|P2|Observational Follow-up|Participant Moved|0
6084775|NCT00379769|21005429|P1|Observational Follow-up|Participant Moved|0
6084776|NCT00379769|21005424|P6|Observational Follow-up|Site Closed Early|7
6084777|NCT00379769|21005425|P5|Observational Follow-up|Site Closed Early|6
6084778|NCT00379769|21005426|P4|Observational Follow-up|Site Closed Early|0
6084779|NCT00379769|21005427|P3|Observational Follow-up|Site Closed Early|0
6084780|NCT00379769|21005428|P2|Observational Follow-up|Site Closed Early|0
6084781|NCT00379769|21005429|P1|Observational Follow-up|Site Closed Early|0
6084782|NCT00379769|21005424|P6|Observational Follow-up|Physician Decision|8
6084783|NCT00379769|21005425|P5|Observational Follow-up|Physician Decision|8
6084784|NCT00379769|21005426|P4|Observational Follow-up|Physician Decision|0
6084785|NCT00379769|21005427|P3|Observational Follow-up|Physician Decision|0
6084786|NCT00379769|21005428|P2|Observational Follow-up|Physician Decision|0
6084787|NCT00379769|21005429|P1|Observational Follow-up|Physician Decision|0
6084788|NCT00379769|21005424|P6|Observational Follow-up|Entered into Another Clinical Trial|22
6084789|NCT00379769|21005425|P5|Observational Follow-up|Entered into Another Clinical Trial|18
6084790|NCT00379769|21005426|P4|Observational Follow-up|Entered into Another Clinical Trial|0
6084791|NCT00379769|21005427|P3|Observational Follow-up|Entered into Another Clinical Trial|0
6084792|NCT00379769|21005428|P2|Observational Follow-up|Entered into Another Clinical Trial|0
6084793|NCT00379769|21005429|P1|Observational Follow-up|Entered into Another Clinical Trial|0
6084794|NCT00379769|21005424|P6|Observational Follow-up|Withdrawal by Subject|12
6084795|NCT00379769|21005425|P5|Observational Follow-up|Withdrawal by Subject|12
6084796|NCT00379769|21005426|P4|Observational Follow-up|Withdrawal by Subject|0
6084797|NCT00379769|21005427|P3|Observational Follow-up|Withdrawal by Subject|0
6084798|NCT00379769|21005428|P2|Observational Follow-up|Withdrawal by Subject|0
6084799|NCT00379769|21005429|P1|Observational Follow-up|Withdrawal by Subject|0
6084800|NCT00379769|21005424|P6|Observational Follow-up|Lost to Follow-up|27
6084801|NCT00379769|21005425|P5|Observational Follow-up|Lost to Follow-up|25
6084802|NCT00379769|21005426|P4|Observational Follow-up|Lost to Follow-up|0
6084803|NCT00379769|21005427|P3|Observational Follow-up|Lost to Follow-up|0
6084804|NCT00379769|21005428|P2|Observational Follow-up|Lost to Follow-up|0
6084805|NCT00379769|21005429|P1|Observational Follow-up|Lost to Follow-up|0
6084806|NCT00379769|21005424|P6|Observational Follow-up|Adverse Event|0
6084807|NCT00379769|21005425|P5|Observational Follow-up|Adverse Event|1
6084808|NCT00379769|21005426|P4|Observational Follow-up|Adverse Event|0
6084809|NCT00379769|21005427|P3|Observational Follow-up|Adverse Event|0
6084810|NCT00379769|21005428|P2|Observational Follow-up|Adverse Event|0
6084811|NCT00379769|21005429|P1|Observational Follow-up|Adverse Event|0
6084812|NCT00379769|21005424|P6|Observational Follow-up|Death|70
6084813|NCT00379769|21005425|P5|Observational Follow-up|Death|78
6084814|NCT00379769|21005426|P4|Observational Follow-up|Death|0
6084815|NCT00379769|21005427|P3|Observational Follow-up|Death|0
6084816|NCT00379769|21005428|P2|Observational Follow-up|Death|0
6084817|NCT00379769|21005429|P1|Observational Follow-up|Death|0
6084818|NCT00379769|21005424|P6|Main Study|Reason unspecified|0
6084819|NCT00379769|21005425|P5|Main Study|Reason unspecified|0
6084820|NCT00379769|21005426|P4|Main Study|Reason unspecified|0
6084821|NCT00379769|21005427|P3|Main Study|Reason unspecified|1
6084822|NCT00379769|21005428|P2|Main Study|Reason unspecified|0
6084823|NCT00379769|21005429|P1|Main Study|Reason unspecified|0
6084824|NCT00379769|21005424|P6|Main Study|Investigator refused to log temperature|0
6084825|NCT00379769|21005425|P5|Main Study|Investigator refused to log temperature|0
6084826|NCT00379769|21005426|P4|Main Study|Investigator refused to log temperature|0
6084827|NCT00379769|21005427|P3|Main Study|Investigator refused to log temperature|1
6084828|NCT00379769|21005428|P2|Main Study|Investigator refused to log temperature|0
6084829|NCT00379769|21005429|P1|Main Study|Investigator refused to log temperature|0
6084830|NCT00379769|21005424|P6|Main Study|Risk of heart failure|0
6084831|NCT00379769|21005425|P5|Main Study|Risk of heart failure|0
6084832|NCT00379769|21005426|P4|Main Study|Risk of heart failure|0
6084833|NCT00379769|21005427|P3|Main Study|Risk of heart failure|0
6084834|NCT00379769|21005428|P2|Main Study|Risk of heart failure|1
6084835|NCT00379769|21005429|P1|Main Study|Risk of heart failure|0
6084836|NCT00379769|21005424|P6|Main Study|Personal reasons|0
6084837|NCT00379769|21005425|P5|Main Study|Personal reasons|0
6084838|NCT00379769|21005426|P4|Main Study|Personal reasons|0
6084839|NCT00379769|21005427|P3|Main Study|Personal reasons|0
6084840|NCT00379769|21005428|P2|Main Study|Personal reasons|0
6084841|NCT00379769|21005429|P1|Main Study|Personal reasons|1
6084842|NCT00379769|21005424|P6|Main Study|Participant completed study at visit 27|0
6084843|NCT00379769|21005425|P5|Main Study|Participant completed study at visit 27|0
6084844|NCT00379769|21005426|P4|Main Study|Participant completed study at visit 27|0
6084845|NCT00379769|21005427|P3|Main Study|Participant completed study at visit 27|0
6084846|NCT00379769|21005428|P2|Main Study|Participant completed study at visit 27|0
6084847|NCT00379769|21005429|P1|Main Study|Participant completed study at visit 27|1
6084848|NCT00379769|21005424|P6|Main Study|Physician Decision|0
6084849|NCT00379769|21005425|P5|Main Study|Physician Decision|0
6084850|NCT00379769|21005426|P4|Main Study|Physician Decision|1
6084851|NCT00379769|21005427|P3|Main Study|Physician Decision|1
6084852|NCT00379769|21005428|P2|Main Study|Physician Decision|2
6084853|NCT00379769|21005429|P1|Main Study|Physician Decision|2
6084854|NCT00379769|21005424|P6|Main Study|Participant did not take study drug|0
6084855|NCT00379769|21005425|P5|Main Study|Participant did not take study drug|0
6084856|NCT00379769|21005426|P4|Main Study|Participant did not take study drug|0
6084857|NCT00379769|21005427|P3|Main Study|Participant did not take study drug|1
6084858|NCT00379769|21005428|P2|Main Study|Participant did not take study drug|0
6084859|NCT00379769|21005429|P1|Main Study|Participant did not take study drug|0
6084860|NCT00379769|21005424|P6|Main Study|Entry criteria violation|0
6084861|NCT00379769|21005425|P5|Main Study|Entry criteria violation|0
6084862|NCT00379769|21005426|P4|Main Study|Entry criteria violation|1
6084863|NCT00379769|21005427|P3|Main Study|Entry criteria violation|1
6084864|NCT00379769|21005428|P2|Main Study|Entry criteria violation|0
6084865|NCT00379769|21005429|P1|Main Study|Entry criteria violation|0
6084866|NCT00379769|21005424|P6|Main Study|Site closed|0
6084867|NCT00379769|21005425|P5|Main Study|Site closed|0
6084868|NCT00379769|21005426|P4|Main Study|Site closed|8
6084869|NCT00379769|21005427|P3|Main Study|Site closed|4
6084870|NCT00379769|21005428|P2|Main Study|Site closed|4
6084871|NCT00379769|21005429|P1|Main Study|Site closed|4
6084872|NCT00379769|21005424|P6|Main Study|Prohibited glucose lowering medication|0
6084873|NCT00379769|21005425|P5|Main Study|Prohibited glucose lowering medication|0
6084874|NCT00379769|21005426|P4|Main Study|Prohibited glucose lowering medication|1
6084875|NCT00379769|21005427|P3|Main Study|Prohibited glucose lowering medication|0
6084876|NCT00379769|21005428|P2|Main Study|Prohibited glucose lowering medication|3
6084877|NCT00379769|21005429|P1|Main Study|Prohibited glucose lowering medication|0
6084878|NCT00379769|21005424|P6|Main Study|Poor compliance|0
6084879|NCT00379769|21005425|P5|Main Study|Poor compliance|0
6084880|NCT00379769|21005426|P4|Main Study|Poor compliance|1
6084881|NCT00379769|21005427|P3|Main Study|Poor compliance|2
6084882|NCT00379769|21005428|P2|Main Study|Poor compliance|2
6084883|NCT00379769|21005429|P1|Main Study|Poor compliance|3
6084884|NCT00379769|21005424|P6|Main Study|Participant moved|0
6084885|NCT00379769|21005425|P5|Main Study|Participant moved|0
6084886|NCT00379769|21005426|P4|Main Study|Participant moved|3
6084887|NCT00379769|21005427|P3|Main Study|Participant moved|3
6084888|NCT00379769|21005428|P2|Main Study|Participant moved|2
6084889|NCT00379769|21005429|P1|Main Study|Participant moved|3
6084890|NCT00379769|21005424|P6|Main Study|Moved to survival status follow-up only|0
6084891|NCT00379769|21005425|P5|Main Study|Moved to survival status follow-up only|0
6084892|NCT00379769|21005426|P4|Main Study|Moved to survival status follow-up only|36
6084893|NCT00379769|21005427|P3|Main Study|Moved to survival status follow-up only|32
6084894|NCT00379769|21005428|P2|Main Study|Moved to survival status follow-up only|25
6084895|NCT00379769|21005429|P1|Main Study|Moved to survival status follow-up only|27
6084896|NCT00379769|21005424|P6|Main Study|Withdrawal by Subject|0
6084897|NCT00379769|21005425|P5|Main Study|Withdrawal by Subject|0
6084898|NCT00379769|21005426|P4|Main Study|Withdrawal by Subject|70
6084899|NCT00379769|21005427|P3|Main Study|Withdrawal by Subject|72
6084900|NCT00379769|21005428|P2|Main Study|Withdrawal by Subject|56
6084901|NCT00379769|21005429|P1|Main Study|Withdrawal by Subject|46
6084902|NCT00379769|21005424|P6|Main Study|Lost to Follow-up|0
6084903|NCT00379769|21005425|P5|Main Study|Lost to Follow-up|0
6084904|NCT00379769|21005426|P4|Main Study|Lost to Follow-up|26
6084905|NCT00379769|21005427|P3|Main Study|Lost to Follow-up|25
6084906|NCT00379769|21005428|P2|Main Study|Lost to Follow-up|29
6084907|NCT00379769|21005429|P1|Main Study|Lost to Follow-up|29
6084908|NCT00379769|21005424|P6|Main Study|Adverse Event|0
6084909|NCT00379769|21005425|P5|Main Study|Adverse Event|0
6084910|NCT00379769|21005426|P4|Main Study|Adverse Event|11
6084911|NCT00379769|21005427|P3|Main Study|Adverse Event|10
6084912|NCT00379769|21005428|P2|Main Study|Adverse Event|8
6084913|NCT00379769|21005429|P1|Main Study|Adverse Event|5
6084914|NCT00379769|21005424|P6|Main Study|Death|0
6084915|NCT00379769|21005425|P5|Main Study|Death|0
6084916|NCT00379769|21005426|P4|Main Study|Death|72
6084917|NCT00379769|21005427|P3|Main Study|Death|54
6084918|NCT00379769|21005428|P2|Main Study|Death|67
6084919|NCT00379769|21005429|P1|Main Study|Death|57
6084920|NCT00379639|21005588|P5|Overall Study|Other|0
6084921|NCT00379639|21005589|P4|Overall Study|Other|0
6084922|NCT00379639|21005590|P3|Overall Study|Other|3
6084923|NCT00379639|21005591|P2|Overall Study|Other|0
6084924|NCT00379639|21005592|P1|Overall Study|Other|0
6084925|NCT00379639|21005588|P5|Overall Study|Lost to Follow-up|0
6084926|NCT00379639|21005589|P4|Overall Study|Lost to Follow-up|1
6084927|NCT00379639|21005590|P3|Overall Study|Lost to Follow-up|0
6084928|NCT00379639|21005591|P2|Overall Study|Lost to Follow-up|0
6084929|NCT00379639|21005592|P1|Overall Study|Lost to Follow-up|0
6084930|NCT00379639|21005588|P5|Overall Study|Adverse Event|1
6084931|NCT00379639|21005589|P4|Overall Study|Adverse Event|0
6084932|NCT00379639|21005590|P3|Overall Study|Adverse Event|1
6084933|NCT00379639|21005591|P2|Overall Study|Adverse Event|0
6084934|NCT00379639|21005592|P1|Overall Study|Adverse Event|0
6084935|NCT00379639|21005588|P5|Overall Study|Symptomatic Deterioration|1
6084936|NCT00379639|21005589|P4|Overall Study|Symptomatic Deterioration|0
6084937|NCT00379639|21005590|P3|Overall Study|Symptomatic Deterioration|1
6084938|NCT00379639|21005591|P2|Overall Study|Symptomatic Deterioration|0
6084939|NCT00379639|21005592|P1|Overall Study|Symptomatic Deterioration|0
6084940|NCT00379639|21005588|P5|Overall Study|Physician Decision|0
6084941|NCT00379639|21005589|P4|Overall Study|Physician Decision|1
6084942|NCT00379639|21005590|P3|Overall Study|Physician Decision|1
6084943|NCT00379639|21005591|P2|Overall Study|Physician Decision|2
6084944|NCT00379639|21005592|P1|Overall Study|Physician Decision|0
6084945|NCT00379639|21005588|P5|Overall Study|Disease Progression|4
6084946|NCT00379639|21005589|P4|Overall Study|Disease Progression|4
6084947|NCT00379639|21005590|P3|Overall Study|Disease Progression|3
6084948|NCT00379639|21005591|P2|Overall Study|Disease Progression|3
6084949|NCT00379639|21005592|P1|Overall Study|Disease Progression|3
6084950|NCT00379587|21005614|P1|Overall Study|Lost to Follow-up|2
6084951|NCT00379353|21005628|P2|Overall Study|Conflicting drug treatment|1
6084952|NCT00379353|21005629|P1|Overall Study|Conflicting drug treatment|0
6084953|NCT00379353|21005628|P2|Overall Study|Non-compliance|0
6084954|NCT00379353|21005629|P1|Overall Study|Non-compliance|1
6084955|NCT00379353|21005628|P2|Overall Study|Cardiac Tamponade|0
6084956|NCT00379353|21005629|P1|Overall Study|Cardiac Tamponade|1
6084957|NCT00379353|21005628|P2|Overall Study|Death|0
6084958|NCT00379353|21005629|P1|Overall Study|Death|1
6084959|NCT00379353|21005628|P2|Overall Study|Withdrawal by Subject|2
6084960|NCT00379353|21005629|P1|Overall Study|Withdrawal by Subject|5
6084961|NCT00379353|21005628|P2|Overall Study|Hospitalization|3
6084962|NCT00379353|21005629|P1|Overall Study|Hospitalization|3
6084963|NCT00379340|21005664|P5|Overall Study|Delayed nephrectomy and anaplasia|1
6084964|NCT00379340|21005665|P4|Overall Study|Delayed nephrectomy and anaplasia|1
6084965|NCT00379340|21005666|P3|Overall Study|Delayed nephrectomy and anaplasia|0
6084966|NCT00379340|21005667|P2|Overall Study|Delayed nephrectomy and anaplasia|0
6084967|NCT00379340|21005668|P1|Overall Study|Delayed nephrectomy and anaplasia|0
6084968|NCT00379340|21005664|P5|Overall Study|On more than 1 tumor therapeutic study|0
6084969|NCT00379340|21005665|P4|Overall Study|On more than 1 tumor therapeutic study|2
6084970|NCT00379340|21005666|P3|Overall Study|On more than 1 tumor therapeutic study|0
6084971|NCT00379340|21005667|P2|Overall Study|On more than 1 tumor therapeutic study|0
6084972|NCT00379340|21005668|P1|Overall Study|On more than 1 tumor therapeutic study|0
6084973|NCT00379340|21005664|P5|Overall Study|Refusal of further protocol therapy|7
6084974|NCT00379340|21005665|P4|Overall Study|Refusal of further protocol therapy|1
6084975|NCT00379340|21005666|P3|Overall Study|Refusal of further protocol therapy|1
6084976|NCT00379340|21005667|P2|Overall Study|Refusal of further protocol therapy|0
6084977|NCT00379340|21005668|P1|Overall Study|Refusal of further protocol therapy|1
6084978|NCT00379340|21005664|P5|Overall Study|Withdrawal by Subject|0
6084979|NCT00379340|21005665|P4|Overall Study|Withdrawal by Subject|1
6084980|NCT00379340|21005666|P3|Overall Study|Withdrawal by Subject|0
6084981|NCT00379340|21005667|P2|Overall Study|Withdrawal by Subject|0
6084982|NCT00379340|21005668|P1|Overall Study|Withdrawal by Subject|0
6084983|NCT00379340|21005664|P5|Overall Study|Physician Decision|3
6084984|NCT00379340|21005665|P4|Overall Study|Physician Decision|2
6084985|NCT00379340|21005666|P3|Overall Study|Physician Decision|1
6084986|NCT00379340|21005667|P2|Overall Study|Physician Decision|2
6084987|NCT00379340|21005668|P1|Overall Study|Physician Decision|6
6084988|NCT00379340|21005664|P5|Overall Study|Lack of Efficacy|3
6084989|NCT00379340|21005665|P4|Overall Study|Lack of Efficacy|4
6084990|NCT00379340|21005666|P3|Overall Study|Lack of Efficacy|0
6084991|NCT00379340|21005667|P2|Overall Study|Lack of Efficacy|1
6084992|NCT00379340|21005668|P1|Overall Study|Lack of Efficacy|6
6084993|NCT00379340|21005664|P5|Overall Study|Death|0
6084994|NCT00379340|21005665|P4|Overall Study|Death|2
6084995|NCT00379340|21005666|P3|Overall Study|Death|0
6084996|NCT00379340|21005667|P2|Overall Study|Death|0
6084997|NCT00379340|21005668|P1|Overall Study|Death|0
6084998|NCT00379288|21005685|P4|Overall Study|Administrative|1
6084999|NCT00379288|21005686|P3|Overall Study|Administrative|0
6085000|NCT00379288|21005687|P2|Overall Study|Administrative|2
6085001|NCT00379288|21005688|P1|Overall Study|Administrative|2
6085002|NCT00379288|21005685|P4|Overall Study|Did not meet protocol eligibility|2
6085003|NCT00379288|21005686|P3|Overall Study|Did not meet protocol eligibility|0
6085004|NCT00379288|21005687|P2|Overall Study|Did not meet protocol eligibility|1
6085005|NCT00379288|21005688|P1|Overall Study|Did not meet protocol eligibility|0
6085006|NCT00379288|21005685|P4|Overall Study|Noncompliance with protocol|1
6085007|NCT00379288|21005686|P3|Overall Study|Noncompliance with protocol|2
6085008|NCT00379288|21005687|P2|Overall Study|Noncompliance with protocol|6
6085009|NCT00379288|21005688|P1|Overall Study|Noncompliance with protocol|8
6085010|NCT00379288|21005685|P4|Overall Study|Subject withdrew-related to study drug|1
6085011|NCT00379288|21005686|P3|Overall Study|Subject withdrew-related to study drug|0
6085012|NCT00379288|21005687|P2|Overall Study|Subject withdrew-related to study drug|0
6085013|NCT00379288|21005688|P1|Overall Study|Subject withdrew-related to study drug|1
6085014|NCT00379288|21005685|P4|Overall Study|Subject withdrew-unrelated to study drug|2
6085015|NCT00379288|21005686|P3|Overall Study|Subject withdrew-unrelated to study drug|4
6085016|NCT00379288|21005687|P2|Overall Study|Subject withdrew-unrelated to study drug|3
6085017|NCT00379288|21005688|P1|Overall Study|Subject withdrew-unrelated to study drug|0
6085018|NCT00379288|21005685|P4|Overall Study|Lost to Follow-up|0
6085019|NCT00379288|21005686|P3|Overall Study|Lost to Follow-up|2
6085020|NCT00379288|21005687|P2|Overall Study|Lost to Follow-up|3
6085021|NCT00379288|21005688|P1|Overall Study|Lost to Follow-up|3
6085022|NCT00379288|21005685|P4|Overall Study|Treatment Failure|1
6085023|NCT00379288|21005686|P3|Overall Study|Treatment Failure|0
6085024|NCT00379288|21005687|P2|Overall Study|Treatment Failure|1
6085025|NCT00379288|21005688|P1|Overall Study|Treatment Failure|0
6085026|NCT00379288|21005685|P4|Overall Study|Adverse Event|0
6085027|NCT00379288|21005686|P3|Overall Study|Adverse Event|2
6085028|NCT00379288|21005687|P2|Overall Study|Adverse Event|6
6085029|NCT00379288|21005688|P1|Overall Study|Adverse Event|5
6085030|NCT00379236|21005700|P3|Open-label Extension|Other|7
6085031|NCT00379236|21005701|P2|Open-label Extension|Other|0
6085032|NCT00379236|21005702|P1|Open-label Extension|Other|0
6085033|NCT00379236|21005700|P3|Open-label Extension|Use of exclusionary medication|3
6085034|NCT00379236|21005701|P2|Open-label Extension|Use of exclusionary medication|0
6085035|NCT00379236|21005702|P1|Open-label Extension|Use of exclusionary medication|0
6085036|NCT00379236|21005700|P3|Open-label Extension|Lost to Follow-up|12
6085037|NCT00379236|21005701|P2|Open-label Extension|Lost to Follow-up|0
6085038|NCT00379236|21005702|P1|Open-label Extension|Lost to Follow-up|0
6085039|NCT00379236|21005700|P3|Open-label Extension|Withdrawal by Subject|13
6085040|NCT00379236|21005701|P2|Open-label Extension|Withdrawal by Subject|0
6085041|NCT00379236|21005702|P1|Open-label Extension|Withdrawal by Subject|0
6085042|NCT00379236|21005700|P3|Open-label Extension|Protocol Violation|7
6085043|NCT00379236|21005701|P2|Open-label Extension|Protocol Violation|0
6085044|NCT00379236|21005702|P1|Open-label Extension|Protocol Violation|0
6085045|NCT00379236|21005700|P3|Open-label Extension|Adverse Event|13
6085046|NCT00379236|21005701|P2|Open-label Extension|Adverse Event|0
6085047|NCT00379236|21005702|P1|Open-label Extension|Adverse Event|0
6085048|NCT00379236|21005700|P3|Double-blind|Data could not be retrieved|0
6085049|NCT00379236|21005701|P2|Double-blind|Data could not be retrieved|2
6085050|NCT00379236|21005702|P1|Double-blind|Data could not be retrieved|2
6085051|NCT00379236|21005700|P3|Double-blind|Other|0
6085052|NCT00379236|21005701|P2|Double-blind|Other|7
6085053|NCT00379236|21005702|P1|Double-blind|Other|3
6085054|NCT00379236|21005700|P3|Double-blind|Use of exclusionary medication|0
6085055|NCT00379236|21005701|P2|Double-blind|Use of exclusionary medication|2
6085056|NCT00379236|21005702|P1|Double-blind|Use of exclusionary medication|1
6085057|NCT00379236|21005700|P3|Double-blind|Lost to Follow-up|0
6085058|NCT00379236|21005701|P2|Double-blind|Lost to Follow-up|3
6085059|NCT00379236|21005702|P1|Double-blind|Lost to Follow-up|4
6085060|NCT00379236|21005700|P3|Double-blind|Withdrawal by Subject|0
6085061|NCT00379236|21005701|P2|Double-blind|Withdrawal by Subject|13
6085062|NCT00379236|21005702|P1|Double-blind|Withdrawal by Subject|12
6085063|NCT00379236|21005700|P3|Double-blind|Protocol Violation|0
6085064|NCT00379236|21005701|P2|Double-blind|Protocol Violation|3
6085065|NCT00379236|21005702|P1|Double-blind|Protocol Violation|3
6085066|NCT00379236|21005700|P3|Double-blind|Adverse Event|0
6085067|NCT00379236|21005701|P2|Double-blind|Adverse Event|6
6085068|NCT00379236|21005702|P1|Double-blind|Adverse Event|11
6085069|NCT00379210|21005747|P2|Overall Study|Withdrawal by Subject|7
6085070|NCT00379210|21005748|P1|Overall Study|Withdrawal by Subject|10
6085071|NCT00379080|21005771|P3|Overall Study|Withdrawal by Subject|0
6085072|NCT00379080|21005772|P2|Overall Study|Withdrawal by Subject|4
6085073|NCT00379080|21005773|P1|Overall Study|Withdrawal by Subject|0
6085074|NCT00378898|21005818|P2|Overall Study|Protocol Violation|1
6085075|NCT00378898|21005819|P1|Overall Study|Protocol Violation|1
6085076|NCT00378898|21005818|P2|Overall Study|Withdrawal by Subject|5
6085077|NCT00378898|21005819|P1|Overall Study|Withdrawal by Subject|10
6085078|NCT00378703|21005831|P4|Overall Study|Other|3
6085079|NCT00378703|21005832|P3|Overall Study|Other|2
6085080|NCT00378703|21005833|P2|Overall Study|Other|1
6085081|NCT00378703|21005834|P1|Overall Study|Other|1
6085082|NCT00378703|21005831|P4|Overall Study|Never started treatment|0
6085083|NCT00378703|21005832|P3|Overall Study|Never started treatment|0
6085084|NCT00378703|21005833|P2|Overall Study|Never started treatment|4
6085085|NCT00378703|21005834|P1|Overall Study|Never started treatment|1
6085086|NCT00378703|21005831|P4|Overall Study|Ineligible|7
6085087|NCT00378703|21005832|P3|Overall Study|Ineligible|7
6085088|NCT00378703|21005833|P2|Overall Study|Ineligible|7
6085089|NCT00378703|21005834|P1|Overall Study|Ineligible|4
6085090|NCT00378703|21005831|P4|Overall Study|Relocation|0
6085091|NCT00378703|21005832|P3|Overall Study|Relocation|1
6085092|NCT00378703|21005833|P2|Overall Study|Relocation|0
6085093|NCT00378703|21005834|P1|Overall Study|Relocation|0
6085094|NCT00378703|21005831|P4|Overall Study|Adverse events and progressive disease|1
6085095|NCT00378703|21005832|P3|Overall Study|Adverse events and progressive disease|0
6085096|NCT00378703|21005833|P2|Overall Study|Adverse events and progressive disease|0
6085097|NCT00378703|21005834|P1|Overall Study|Adverse events and progressive disease|0
6085098|NCT00378703|21005831|P4|Overall Study|Joint decision of physician and patient|0
6085099|NCT00378703|21005832|P3|Overall Study|Joint decision of physician and patient|0
6085100|NCT00378703|21005833|P2|Overall Study|Joint decision of physician and patient|0
6085101|NCT00378703|21005834|P1|Overall Study|Joint decision of physician and patient|1
6085102|NCT00378703|21005831|P4|Overall Study|Surgery|1
6085103|NCT00378703|21005832|P3|Overall Study|Surgery|0
6085104|NCT00378703|21005833|P2|Overall Study|Surgery|0
6085105|NCT00378703|21005834|P1|Overall Study|Surgery|1
6085106|NCT00378703|21005831|P4|Overall Study|Symptomatic deterioration|2
6085107|NCT00378703|21005832|P3|Overall Study|Symptomatic deterioration|0
6085108|NCT00378703|21005833|P2|Overall Study|Symptomatic deterioration|1
6085109|NCT00378703|21005834|P1|Overall Study|Symptomatic deterioration|0
6085110|NCT00378703|21005831|P4|Overall Study|Other complicated disease|0
6085111|NCT00378703|21005832|P3|Overall Study|Other complicated disease|2
6085112|NCT00378703|21005833|P2|Overall Study|Other complicated disease|2
6085113|NCT00378703|21005834|P1|Overall Study|Other complicated disease|0
6085114|NCT00378703|21005831|P4|Overall Study|Alternative therapy|0
6085115|NCT00378703|21005832|P3|Overall Study|Alternative therapy|0
6085116|NCT00378703|21005833|P2|Overall Study|Alternative therapy|2
6085117|NCT00378703|21005834|P1|Overall Study|Alternative therapy|4
6085118|NCT00378703|21005831|P4|Overall Study|Physician Decision|0
6085119|NCT00378703|21005832|P3|Overall Study|Physician Decision|1
6085120|NCT00378703|21005833|P2|Overall Study|Physician Decision|4
6085121|NCT00378703|21005834|P1|Overall Study|Physician Decision|1
6085122|NCT00378703|21005831|P4|Overall Study|Withdrawal by Subject|7
6085123|NCT00378703|21005832|P3|Overall Study|Withdrawal by Subject|5
6085124|NCT00378703|21005833|P2|Overall Study|Withdrawal by Subject|8
6085125|NCT00378703|21005834|P1|Overall Study|Withdrawal by Subject|4
6085126|NCT00378703|21005831|P4|Overall Study|Death|3
6085127|NCT00378703|21005832|P3|Overall Study|Death|4
6085128|NCT00378703|21005833|P2|Overall Study|Death|2
6085129|NCT00378703|21005834|P1|Overall Study|Death|2
6085130|NCT00378703|21005831|P4|Overall Study|Adverse Event|18
6085131|NCT00378703|21005832|P3|Overall Study|Adverse Event|20
6085132|NCT00378703|21005833|P2|Overall Study|Adverse Event|17
6085133|NCT00378703|21005834|P1|Overall Study|Adverse Event|11
6085134|NCT00378703|21005831|P4|Overall Study|Disease progression|49
6085135|NCT00378703|21005832|P3|Overall Study|Disease progression|48
6085136|NCT00378703|21005833|P2|Overall Study|Disease progression|43
6085137|NCT00378703|21005834|P1|Overall Study|Disease progression|59
6085138|NCT00378599|21005856|P1|Overall Study|Withdrawal by Subject|5
6085139|NCT00378599|21005856|P1|Overall Study|Treatment failure|7
6085140|NCT00378599|21005856|P1|Overall Study|Protocol Violation|2
6085141|NCT00378599|21005856|P1|Overall Study|Adverse Event|38
6085142|NCT00378573|21005860|P1|Follow-up|Withdrawal by Subject|1
6085143|NCT00378573|21005860|P1|Follow-up|Lost to Follow-up|1
6085144|NCT00378573|21005860|P1|Follow-up|Death|12
6085145|NCT00378573|21005860|P1|Treatment Period|Sponsor decision to close study|1
6085146|NCT00378573|21005860|P1|Treatment Period|Disease Progression|4
6085147|NCT00378573|21005860|P1|Treatment Period|Withdrawal by Subject|2
6085148|NCT00378573|21005860|P1|Treatment Period|Physician Decision|1
6085149|NCT00378573|21005860|P1|Treatment Period|Adverse Event|9
6085150|NCT00378560|21005868|P2|Overall Study|Laboratory test values abnormal|0
6085151|NCT00378560|21005869|P1|Overall Study|Laboratory test values abnormal|1
6085152|NCT00378560|21005868|P2|Overall Study|Pregnancy|5
6085153|NCT00378560|21005869|P1|Overall Study|Pregnancy|7
6085154|NCT00378560|21005868|P2|Overall Study|Moved|3
6085155|NCT00378560|21005869|P1|Overall Study|Moved|4
6085156|NCT00378560|21005868|P2|Overall Study|Withdrawal by Subject|21
6085157|NCT00378560|21005869|P1|Overall Study|Withdrawal by Subject|17
6085158|NCT00378560|21005868|P2|Overall Study|Protocol Violation|0
6085159|NCT00378560|21005869|P1|Overall Study|Protocol Violation|2
6085160|NCT00378560|21005868|P2|Overall Study|Lost to Follow-up|29
6085161|NCT00378560|21005869|P1|Overall Study|Lost to Follow-up|24
6085162|NCT00378560|21005868|P2|Overall Study|Adverse Event|0
6085163|NCT00378560|21005869|P1|Overall Study|Adverse Event|1
6085164|NCT00378534|21005883|P1|Overall Study|Subjects did not receive a transplant|3
6085165|NCT00378534|21005883|P1|Overall Study|Donors|57
6085166|NCT00378508|21005889|P2|Overall Study|Lost to Follow-up|0
6085167|NCT00378508|21005890|P1|Overall Study|Lost to Follow-up|1
6085168|NCT00378508|21005889|P2|Overall Study|Withdrawal by Subject|3
6085169|NCT00378508|21005890|P1|Overall Study|Withdrawal by Subject|1
6085170|NCT00378378|21005909|P3|Overall Study|Non-compliance with protocol|1
6085171|NCT00378378|21005910|P2|Overall Study|Non-compliance with protocol|0
6085172|NCT00378378|21005911|P1|Overall Study|Non-compliance with protocol|0
6085173|NCT00378378|21005909|P3|Overall Study|Treatment Failure|1
6085174|NCT00378378|21005910|P2|Overall Study|Treatment Failure|0
6085175|NCT00378378|21005911|P1|Overall Study|Treatment Failure|0
6085176|NCT00378378|21005909|P3|Overall Study|Withdrawal by Subject|0
6085177|NCT00378378|21005910|P2|Overall Study|Withdrawal by Subject|1
6085178|NCT00378378|21005911|P1|Overall Study|Withdrawal by Subject|0
6085179|NCT00378209|21005957|P1|Overall Study|Treatment delay|1
6085180|NCT00378209|21005957|P1|Overall Study|Death|1
6085181|NCT00378209|21005957|P1|Overall Study|Physician Decision|3
6085182|NCT00378209|21005957|P1|Overall Study|Initiation of non-protocol therapy|3
6085183|NCT00378209|21005957|P1|Overall Study|Adverse Event|3
6085184|NCT00378209|21005957|P1|Overall Study|Progressive disease|11
6085203|NCT00378079|21005980|P3|Overall Study|Lost to Follow-up|0
6085204|NCT00378079|21005981|P2|Overall Study|Lost to Follow-up|1
6085205|NCT00378079|21005982|P1|Overall Study|Lost to Follow-up|6
6085206|NCT00378014|21006004|P2|Extension (Month 12 to Month 59)|Lack of Efficacy|1
6085207|NCT00378014|21006005|P1|Extension (Month 12 to Month 59)|Lack of Efficacy|3
6085208|NCT00378014|21006004|P2|Extension (Month 12 to Month 59)|Withdrawal by Subject|3
6085209|NCT00378014|21006005|P1|Extension (Month 12 to Month 59)|Withdrawal by Subject|0
6085210|NCT00378014|21006004|P2|Extension (Month 12 to Month 59)|Lost to Follow-up|1
6085211|NCT00378014|21006005|P1|Extension (Month 12 to Month 59)|Lost to Follow-up|1
6085212|NCT00378014|21006004|P2|Extension (Month 12 to Month 59)|Administrative problems|0
6085213|NCT00378014|21006005|P1|Extension (Month 12 to Month 59)|Administrative problems|1
6085214|NCT00378014|21006004|P2|Extension (Month 12 to Month 59)|Death|2
6085215|NCT00378014|21006005|P1|Extension (Month 12 to Month 59)|Death|1
6085216|NCT00378014|21006004|P2|Extension (Month 12 to Month 59)|Adverse Event|7
6085217|NCT00378014|21006005|P1|Extension (Month 12 to Month 59)|Adverse Event|8
6085218|NCT00378014|21006004|P2|Core (Randomization to Month 11)|Lack of Efficacy|1
6085219|NCT00378014|21006005|P1|Core (Randomization to Month 11)|Lack of Efficacy|0
6085220|NCT00378014|21006004|P2|Core (Randomization to Month 11)|Protocol deviation|1
6085221|NCT00378014|21006005|P1|Core (Randomization to Month 11)|Protocol deviation|0
6085222|NCT00378014|21006004|P2|Core (Randomization to Month 11)|Withdrawal by Subject|2
6085223|NCT00378014|21006005|P1|Core (Randomization to Month 11)|Withdrawal by Subject|5
6085224|NCT00378014|21006004|P2|Core (Randomization to Month 11)|Lost to Follow-up|1
6085225|NCT00378014|21006005|P1|Core (Randomization to Month 11)|Lost to Follow-up|0
6085226|NCT00378014|21006004|P2|Core (Randomization to Month 11)|Administrative Problems|2
6085227|NCT00378014|21006005|P1|Core (Randomization to Month 11)|Administrative Problems|2
6085228|NCT00378014|21006004|P2|Core (Randomization to Month 11)|Death|3
6085229|NCT00378014|21006005|P1|Core (Randomization to Month 11)|Death|5
6085230|NCT00378014|21006004|P2|Core (Randomization to Month 11)|Graft loss|2
6085231|NCT00378014|21006005|P1|Core (Randomization to Month 11)|Graft loss|1
6085232|NCT00378014|21006004|P2|Core (Randomization to Month 11)|Adverse Event|0
6085233|NCT00378014|21006005|P1|Core (Randomization to Month 11)|Adverse Event|1
6085234|NCT00377962|21006031|P2|Extension Study: 12-24 Months|Unspecified reason|3
6085235|NCT00377962|21006032|P1|Extension Study: 12-24 Months|Unspecified reason|0
6085236|NCT00377962|21006031|P2|Extension Study: 12-24 Months|Abnormal laboratory value|0
6085237|NCT00377962|21006032|P1|Extension Study: 12-24 Months|Abnormal laboratory value|1
6085238|NCT00377962|21006031|P2|Extension Study: 12-24 Months|Adverse Event|0
6085239|NCT00377962|21006032|P1|Extension Study: 12-24 Months|Adverse Event|8
6085240|NCT00377962|21006031|P2|Extension Study: 12-24 Months|Death|1
6085241|NCT00377962|21006032|P1|Extension Study: 12-24 Months|Death|1
6085242|NCT00377962|21006031|P2|Core Study: 0-12 Months|Unspecified reasons|4
6085243|NCT00377962|21006032|P1|Core Study: 0-12 Months|Unspecified reasons|1
6085244|NCT00377962|21006031|P2|Core Study: 0-12 Months|Administrative Reason|1
6085245|NCT00377962|21006032|P1|Core Study: 0-12 Months|Administrative Reason|1
6085246|NCT00377962|21006031|P2|Core Study: 0-12 Months|Withdrew Consent|2
6085247|NCT00377962|21006032|P1|Core Study: 0-12 Months|Withdrew Consent|5
6085248|NCT00377962|21006031|P2|Core Study: 0-12 Months|Death|0
6085249|NCT00377962|21006032|P1|Core Study: 0-12 Months|Death|3
6085250|NCT00377962|21006031|P2|Core Study: 0-12 Months|Adverse Event|2
6085251|NCT00377962|21006032|P1|Core Study: 0-12 Months|Adverse Event|18
6085252|NCT00377858|21006068|P2|Overall Study|Death|3
6085253|NCT00377858|21006069|P1|Overall Study|Death|0
6085254|NCT00377858|21006068|P2|Overall Study|Sponsor Decision|2
6085255|NCT00377858|21006069|P1|Overall Study|Sponsor Decision|1
6085256|NCT00377858|21006068|P2|Overall Study|Entry Criteria Not Met|0
6085257|NCT00377858|21006069|P1|Overall Study|Entry Criteria Not Met|2
6085258|NCT00377858|21006068|P2|Overall Study|Adverse Event|1
6085259|NCT00377858|21006069|P1|Overall Study|Adverse Event|2
6085260|NCT00377858|21006068|P2|Overall Study|Protocol Violation|4
6085261|NCT00377858|21006069|P1|Overall Study|Protocol Violation|3
6085262|NCT00377858|21006068|P2|Overall Study|Physician Decision|5
6085263|NCT00377858|21006069|P1|Overall Study|Physician Decision|5
6085264|NCT00377858|21006068|P2|Overall Study|Lost to Follow-up|1
6085265|NCT00377858|21006069|P1|Overall Study|Lost to Follow-up|6
6085266|NCT00377858|21006068|P2|Overall Study|Withdrawal by Subject|11
6085267|NCT00377858|21006069|P1|Overall Study|Withdrawal by Subject|12
6085268|NCT00377819|21006122|P2|Overall Study|Protocol Violation|1
6085269|NCT00377819|21006123|P1|Overall Study|Protocol Violation|1
6085270|NCT00377819|21006122|P2|Overall Study|Lost to Follow-up|1
6085271|NCT00377819|21006123|P1|Overall Study|Lost to Follow-up|0
6085272|NCT00377819|21006122|P2|Overall Study|Death|1
6085273|NCT00377819|21006123|P1|Overall Study|Death|0
6085274|NCT00377819|21006122|P2|Overall Study|Withdrawal by Subject|4
6085275|NCT00377819|21006123|P1|Overall Study|Withdrawal by Subject|10
6085276|NCT00377819|21006122|P2|Overall Study|Adverse Event|3
6085277|NCT00377819|21006123|P1|Overall Study|Adverse Event|2
6085278|NCT00377676|21006152|P2|Overall Study|Other|58
6085279|NCT00377676|21006153|P1|Overall Study|Other|118
6085280|NCT00377676|21006152|P2|Overall Study|Lost to Follow-up|56
6085281|NCT00377676|21006153|P1|Overall Study|Lost to Follow-up|120
6085282|NCT00377676|21006152|P2|Overall Study|Withdrawal by Subject|72
6085283|NCT00377676|21006153|P1|Overall Study|Withdrawal by Subject|187
6085284|NCT00377676|21006152|P2|Overall Study|Death|2
6085285|NCT00377676|21006153|P1|Overall Study|Death|5
6085286|NCT00377676|21006152|P2|Overall Study|Protocol Violation|27
6085287|NCT00377676|21006153|P1|Overall Study|Protocol Violation|33
6085288|NCT00377676|21006152|P2|Overall Study|Adverse Event|107
6085289|NCT00377676|21006153|P1|Overall Study|Adverse Event|498
6085290|NCT00377637|21006169|P4|Maintenance Phase|Death|1
6085291|NCT00377637|21006170|P3|Maintenance Phase|Death|0
6085292|NCT00377637|21006171|P2|Maintenance Phase|Death|0
6085293|NCT00377637|21006172|P1|Maintenance Phase|Death|0
6085294|NCT00377637|21006169|P4|Maintenance Phase|Study medication stopped > 14 days|1
6085295|NCT00377637|21006170|P3|Maintenance Phase|Study medication stopped > 14 days|0
6085296|NCT00377637|21006171|P2|Maintenance Phase|Study medication stopped > 14 days|0
6085297|NCT00377637|21006172|P1|Maintenance Phase|Study medication stopped > 14 days|0
6085298|NCT00377637|21006169|P4|Maintenance Phase|Non-compliance|1
6085299|NCT00377637|21006170|P3|Maintenance Phase|Non-compliance|1
6085300|NCT00377637|21006171|P2|Maintenance Phase|Non-compliance|0
6085301|NCT00377637|21006172|P1|Maintenance Phase|Non-compliance|0
6085302|NCT00377637|21006169|P4|Maintenance Phase|Sponsor decision|3
6085303|NCT00377637|21006170|P3|Maintenance Phase|Sponsor decision|2
6085304|NCT00377637|21006171|P2|Maintenance Phase|Sponsor decision|0
6085305|NCT00377637|21006172|P1|Maintenance Phase|Sponsor decision|0
6085306|NCT00377637|21006169|P4|Maintenance Phase|Withdrawal by Subject|3
6085307|NCT00377637|21006170|P3|Maintenance Phase|Withdrawal by Subject|3
6085308|NCT00377637|21006171|P2|Maintenance Phase|Withdrawal by Subject|0
6085309|NCT00377637|21006172|P1|Maintenance Phase|Withdrawal by Subject|0
6085310|NCT00377637|21006169|P4|Maintenance Phase|Lost to Follow-up|1
6085311|NCT00377637|21006170|P3|Maintenance Phase|Lost to Follow-up|3
6085312|NCT00377637|21006171|P2|Maintenance Phase|Lost to Follow-up|0
6085313|NCT00377637|21006172|P1|Maintenance Phase|Lost to Follow-up|0
6085314|NCT00377637|21006169|P4|Maintenance Phase|Physician Decision|4
6085315|NCT00377637|21006170|P3|Maintenance Phase|Physician Decision|5
6085316|NCT00377637|21006171|P2|Maintenance Phase|Physician Decision|0
6085317|NCT00377637|21006172|P1|Maintenance Phase|Physician Decision|0
6085318|NCT00377637|21006169|P4|Maintenance Phase|Adverse Event|43
6085319|NCT00377637|21006170|P3|Maintenance Phase|Adverse Event|29
6085320|NCT00377637|21006171|P2|Maintenance Phase|Adverse Event|0
6085321|NCT00377637|21006172|P1|Maintenance Phase|Adverse Event|0
6085322|NCT00377637|21006169|P4|Induction Phase|Reason for withdrawal is not noted|0
6085323|NCT00377637|21006170|P3|Induction Phase|Reason for withdrawal is not noted|0
6085324|NCT00377637|21006171|P2|Induction Phase|Reason for withdrawal is not noted|0
6085325|NCT00377637|21006172|P1|Induction Phase|Reason for withdrawal is not noted|2
6085326|NCT00377637|21006169|P4|Induction Phase|Non-Compliance|0
6085327|NCT00377637|21006170|P3|Induction Phase|Non-Compliance|0
6085328|NCT00377637|21006171|P2|Induction Phase|Non-Compliance|0
6085329|NCT00377637|21006172|P1|Induction Phase|Non-Compliance|1
6085330|NCT00377637|21006169|P4|Induction Phase|Sponsor decision|0
6085331|NCT00377637|21006170|P3|Induction Phase|Sponsor decision|0
6085332|NCT00377637|21006171|P2|Induction Phase|Sponsor decision|2
6085333|NCT00377637|21006172|P1|Induction Phase|Sponsor decision|1
6085334|NCT00377637|21006169|P4|Induction Phase|Physician Decision|0
6085335|NCT00377637|21006170|P3|Induction Phase|Physician Decision|0
6085336|NCT00377637|21006171|P2|Induction Phase|Physician Decision|1
6085337|NCT00377637|21006172|P1|Induction Phase|Physician Decision|3
6085338|NCT00377637|21006169|P4|Induction Phase|Withdrawal by Subject|0
6085339|NCT00377637|21006170|P3|Induction Phase|Withdrawal by Subject|0
6085340|NCT00377637|21006171|P2|Induction Phase|Withdrawal by Subject|6
6085341|NCT00377637|21006172|P1|Induction Phase|Withdrawal by Subject|5
6085342|NCT00377637|21006169|P4|Induction Phase|Death|0
6085343|NCT00377637|21006170|P3|Induction Phase|Death|0
6085344|NCT00377637|21006171|P2|Induction Phase|Death|3
6085345|NCT00377637|21006172|P1|Induction Phase|Death|1
6085346|NCT00377637|21006169|P4|Induction Phase|Lost to Follow-up|0
6085347|NCT00377637|21006170|P3|Induction Phase|Lost to Follow-up|0
6085348|NCT00377637|21006171|P2|Induction Phase|Lost to Follow-up|1
6085349|NCT00377637|21006172|P1|Induction Phase|Lost to Follow-up|2
6085350|NCT00377637|21006169|P4|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0
6085351|NCT00377637|21006170|P3|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0
6085352|NCT00377637|21006171|P2|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|1
6085353|NCT00377637|21006172|P1|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0
6085354|NCT00377637|21006169|P4|Induction Phase|Deterioration/serum creatinine|0
6085355|NCT00377637|21006170|P3|Induction Phase|Deterioration/serum creatinine|0
6085356|NCT00377637|21006171|P2|Induction Phase|Deterioration/serum creatinine|0
6085357|NCT00377637|21006172|P1|Induction Phase|Deterioration/serum creatinine|2
6085358|NCT00377637|21006169|P4|Induction Phase|Adverse Event|0
6085359|NCT00377637|21006170|P3|Induction Phase|Adverse Event|0
6085360|NCT00377637|21006171|P2|Induction Phase|Adverse Event|21
6085361|NCT00377637|21006172|P1|Induction Phase|Adverse Event|12
6085362|NCT00377611|21006208|P2|Overall Study|Other|3
6085363|NCT00377611|21006209|P1|Overall Study|Other|0
6085364|NCT00377611|21006208|P2|Overall Study|Lost to Follow-up|16
6085365|NCT00377611|21006209|P1|Overall Study|Lost to Follow-up|18
6085366|NCT00377611|21006208|P2|Overall Study|Withdrawal by Subject|5
6085367|NCT00377611|21006209|P1|Overall Study|Withdrawal by Subject|0
6085368|NCT00377611|21006208|P2|Overall Study|Protocol Violation|0
6085369|NCT00377611|21006209|P1|Overall Study|Protocol Violation|2
6085370|NCT00377611|21006208|P2|Overall Study|Adverse Event|9
6085371|NCT00377611|21006209|P1|Overall Study|Adverse Event|2
6085372|NCT00377520|21006311|P1|Overall Study|Ineligible (Prior radiation)|1
6085373|NCT00377455|21006316|P1|Overall Study|Withdrawal by Subject|1
6085374|NCT00377429|21006324|P1|Overall Study|Patient non-compliance|1
6085375|NCT00377429|21006324|P1|Overall Study|Physician Decision|1
6085376|NCT00377429|21006324|P1|Overall Study|Adverse Event|8
6085377|NCT00377429|21006324|P1|Overall Study|Withdrawal by Subject|5
6085378|NCT00377403|21006335|P2|Overall Study|Unable to contact for telephone intervie|7
6085379|NCT00377403|21006336|P1|Overall Study|Unable to contact for telephone intervie|4
6085380|NCT00377364|21006344|P2|Overall Study|Withdrawal by Subject|0
6085381|NCT00377364|21006345|P1|Overall Study|Withdrawal by Subject|1
6085382|NCT00377364|21006344|P2|Overall Study|Lost to Follow-up|0
6085383|NCT00377364|21006345|P1|Overall Study|Lost to Follow-up|1
6085384|NCT00377312|21006371|P2|Overall Study|Adverse Event|1
6085385|NCT00377312|21006372|P1|Overall Study|Adverse Event|1
6085386|NCT00377299|21006404|P2|Overall Study|Withdrawal by Subject|4
6085387|NCT00377299|21006405|P1|Overall Study|Withdrawal by Subject|5
6085388|NCT00377299|21006404|P2|Overall Study|Adverse Event|1
6085389|NCT00377299|21006405|P1|Overall Study|Adverse Event|0
6085390|NCT00377299|21006404|P2|Overall Study|Lost to Follow-up|19
6085391|NCT00377299|21006405|P1|Overall Study|Lost to Follow-up|14
6085392|NCT00377260|21006421|P2|Overall Study|Withdrawal by Subject|4
6085393|NCT00377260|21006422|P1|Overall Study|Withdrawal by Subject|2
6085394|NCT00377260|21006421|P2|Overall Study|Lost to Follow-up|1
6085395|NCT00377260|21006422|P1|Overall Study|Lost to Follow-up|0
6085396|NCT00377234|21006476|P2|Overall Study|Not assigned|2
6085397|NCT00377234|21006477|P1|Overall Study|Not assigned|3
6085398|NCT00377234|21006476|P2|Overall Study|Administrative|1
6085399|NCT00377234|21006477|P1|Overall Study|Administrative|2
6085400|NCT00377234|21006476|P2|Overall Study|Lost to Follow-up|2
6085401|NCT00377234|21006477|P1|Overall Study|Lost to Follow-up|4
6085402|NCT00377234|21006476|P2|Overall Study|Withdrawal by Subject|9
6085403|NCT00377234|21006477|P1|Overall Study|Withdrawal by Subject|11
6085404|NCT00377234|21006476|P2|Overall Study|Adverse Event|17
6085405|NCT00377234|21006477|P1|Overall Study|Adverse Event|14
6085406|NCT00377156|21006495|P2|Overall Study|Other|2
6085407|NCT00377156|21006496|P1|Overall Study|Other|5
6085408|NCT00377156|21006495|P2|Overall Study|Disability or language problem|1
6085409|NCT00377156|21006496|P1|Overall Study|Disability or language problem|0
6085410|NCT00377156|21006495|P2|Overall Study|Ineligible|1
6085411|NCT00377156|21006496|P1|Overall Study|Ineligible|0
6085412|NCT00377156|21006495|P2|Overall Study|Refused testing|1
6085413|NCT00377156|21006496|P1|Overall Study|Refused testing|0
6085414|NCT00377156|21006495|P2|Overall Study|Cancellation|0
6085415|NCT00377156|21006496|P1|Overall Study|Cancellation|1
6085416|NCT00377156|21006495|P2|Overall Study|Had follow-up <90 d|6
6085417|NCT00377156|21006496|P1|Overall Study|Had follow-up <90 d|3
6085418|NCT00377156|21006495|P2|Overall Study|Withdrawal by Subject|24
6085419|NCT00377156|21006496|P1|Overall Study|Withdrawal by Subject|16
6085420|NCT00377156|21006495|P2|Overall Study|Death|19
6085421|NCT00377156|21006496|P1|Overall Study|Death|23
6085422|NCT00376961|21006510|P2|Maintenance|Ineligible|3
6085423|NCT00376961|21006511|P1|Maintenance|Ineligible|0
6085424|NCT00376961|21006510|P2|Maintenance|Progression/relapse|18
6085425|NCT00376961|21006511|P1|Maintenance|Progression/relapse|0
6085426|NCT00376961|21006510|P2|Maintenance|Refusal Unrelated to Adverse Event|1
6085427|NCT00376961|21006511|P1|Maintenance|Refusal Unrelated to Adverse Event|0
6085428|NCT00376961|21006510|P2|Maintenance|Adverse Event|1
6085429|NCT00376961|21006511|P1|Maintenance|Adverse Event|0
6085430|NCT00376961|21006510|P2|Initial Registration|Ineligible|0
6085431|NCT00376961|21006511|P1|Initial Registration|Ineligible|3
6085432|NCT00376961|21006510|P2|Initial Registration|Progression/relapse|0
6085433|NCT00376961|21006511|P1|Initial Registration|Progression/relapse|1
6085434|NCT00376961|21006510|P2|Initial Registration|Refusal Unrelated to Adverse Event|0
6085435|NCT00376961|21006511|P1|Initial Registration|Refusal Unrelated to Adverse Event|2
6085436|NCT00376961|21006510|P2|Initial Registration|Adverse Event|0
6085437|NCT00376961|21006511|P1|Initial Registration|Adverse Event|1
6085438|NCT00376688|21006577|P1|Overall Study|Death|1
6085439|NCT00376688|21006577|P1|Overall Study|Adverse Event|3
6085440|NCT00376675|21006583|P2|Overall Study|Other Reason|7
6085441|NCT00376675|21006584|P1|Overall Study|Other Reason|1
6085442|NCT00376675|21006583|P2|Overall Study|Adverse Event|5
6085443|NCT00376675|21006584|P1|Overall Study|Adverse Event|10
6085444|NCT00376675|21006583|P2|Overall Study|Withdrawal by Subject|2
6085445|NCT00376675|21006584|P1|Overall Study|Withdrawal by Subject|9
6085446|NCT00376532|21006633|P2|Overall Study|Lack sufficient blood sample|6
6085447|NCT00376532|21006634|P1|Overall Study|Lack sufficient blood sample|6
6085448|NCT00376506|21006644|P2|Overall Study|Death|2
6085449|NCT00376506|21006645|P1|Overall Study|Death|0
6085450|NCT00376259|21006676|P2|Overall Study|Patient request|0
6085451|NCT00376259|21006677|P1|Overall Study|Patient request|1
6085452|NCT00376259|21006676|P2|Overall Study|Sponsor request - study termination|21
6085453|NCT00376259|21006677|P1|Overall Study|Sponsor request - study termination|21
6085454|NCT00376246|21006689|P2|First Intervention (2 Weeks)|Lost to Follow-up|0
6085455|NCT00376246|21006690|P1|First Intervention (2 Weeks)|Lost to Follow-up|1
6085456|NCT00376246|21006689|P2|First Intervention (2 Weeks)|Withdrawal by Subject|2
6085457|NCT00376246|21006690|P1|First Intervention (2 Weeks)|Withdrawal by Subject|1
6085458|NCT00376246|21006689|P2|First Intervention (2 Weeks)|Adverse Event|0
6085459|NCT00376246|21006690|P1|First Intervention (2 Weeks)|Adverse Event|2
6085460|NCT00376220|21006700|P2|Overall Study|Withdrawal by Subject|2
6085461|NCT00376220|21006701|P1|Overall Study|Withdrawal by Subject|3
6085462|NCT00376220|21006700|P2|Overall Study|Lost to Follow-up|10
6085463|NCT00376220|21006701|P1|Overall Study|Lost to Follow-up|7
6085464|NCT00376168|21006709|P2|Overall Study|Pregnancy|0
6085465|NCT00376168|21006710|P1|Overall Study|Pregnancy|1
6085466|NCT00376168|21006709|P2|Overall Study|Adverse Event|1
6085467|NCT00376168|21006710|P1|Overall Study|Adverse Event|1
6085468|NCT00375934|21006751|P2|Overall Study|Physician Decision|1
6085469|NCT00375934|21006752|P1|Overall Study|Physician Decision|0
6085470|NCT00375934|21006751|P2|Overall Study|Lack of Efficacy|2
6085471|NCT00375934|21006752|P1|Overall Study|Lack of Efficacy|0
6085472|NCT00375934|21006751|P2|Overall Study|Withdrawal by Subject|2
6085473|NCT00375934|21006752|P1|Overall Study|Withdrawal by Subject|2
6085474|NCT00375934|21006751|P2|Overall Study|Adverse Event|1
6085475|NCT00375934|21006752|P1|Overall Study|Adverse Event|1
6085476|NCT00375752|21006810|P2|Overall Study|Administrative Problems|1
6085477|NCT00375752|21006811|P1|Overall Study|Administrative Problems|0
6085478|NCT00375752|21006810|P2|Overall Study|Protocol Violation|2
6085479|NCT00375752|21006811|P1|Overall Study|Protocol Violation|0
6085480|NCT00375752|21006810|P2|Overall Study|Abnormal Laboratory Value(s)|1
6085481|NCT00375752|21006811|P1|Overall Study|Abnormal Laboratory Value(s)|1
6085482|NCT00375752|21006810|P2|Overall Study|Withdrawal by Subject|1
6085483|NCT00375752|21006811|P1|Overall Study|Withdrawal by Subject|6
6085484|NCT00375752|21006810|P2|Overall Study|Adverse Event|6
6085485|NCT00375752|21006811|P1|Overall Study|Adverse Event|1
6085486|NCT00375752|21006810|P2|Overall Study|Lack of Efficacy|4
6085487|NCT00375752|21006811|P1|Overall Study|Lack of Efficacy|4
6085488|NCT00375674|21006842|P2|Overall Study|Enrolled but not treated|2
6085489|NCT00375674|21006843|P1|Overall Study|Enrolled but not treated|3
6085490|NCT00375674|21006842|P2|Overall Study|Lost to Follow-up|15
6085491|NCT00375674|21006843|P1|Overall Study|Lost to Follow-up|17
6085492|NCT00375674|21006842|P2|Overall Study|Participants refused further follow-up|30
6085493|NCT00375674|21006843|P1|Overall Study|Participants refused further follow-up|31
6085494|NCT00375674|21006842|P2|Overall Study|Death|76
6085495|NCT00375674|21006843|P1|Overall Study|Death|67
6085496|NCT00375674|21006842|P2|Overall Study|Other|18
6085497|NCT00375674|21006843|P1|Overall Study|Other|26
6085498|NCT00375609|21006872|P3|Overall Study|Neurologist Wanted Pt to start Plavix|0
6085499|NCT00375609|21006873|P2|Overall Study|Neurologist Wanted Pt to start Plavix|0
6085500|NCT00375609|21006874|P1|Overall Study|Neurologist Wanted Pt to start Plavix|1
6085501|NCT00375609|21006872|P3|Overall Study|Withdrawal by Subject|0
6085502|NCT00375609|21006873|P2|Overall Study|Withdrawal by Subject|4
6085503|NCT00375609|21006874|P1|Overall Study|Withdrawal by Subject|1
6085504|NCT00375609|21006872|P3|Overall Study|Physician Decision|1
6085505|NCT00375609|21006873|P2|Overall Study|Physician Decision|0
6085506|NCT00375609|21006874|P1|Overall Study|Physician Decision|0
6085507|NCT00375609|21006872|P3|Overall Study|Lost to Follow-up|0
6085508|NCT00375609|21006873|P2|Overall Study|Lost to Follow-up|0
6085509|NCT00375609|21006874|P1|Overall Study|Lost to Follow-up|1
6085510|NCT00375609|21006872|P3|Overall Study|Adverse Event|0
6085511|NCT00375609|21006873|P2|Overall Study|Adverse Event|3
6085512|NCT00375609|21006874|P1|Overall Study|Adverse Event|0
6085513|NCT00375609|21006872|P3|Overall Study|Did not receive treatment|0
6085514|NCT00375609|21006873|P2|Overall Study|Did not receive treatment|0
6085515|NCT00375609|21006874|P1|Overall Study|Did not receive treatment|1
6085516|NCT00375518|21006890|P2|Overall Study|Death|1
6085517|NCT00375518|21006891|P1|Overall Study|Death|0
6085518|NCT00375518|21006890|P2|Overall Study|Patient Not Treated|6
6085519|NCT00375518|21006891|P1|Overall Study|Patient Not Treated|6
6085520|NCT00375518|21006890|P2|Overall Study|Withdrawal by Subject|10
6085521|NCT00375518|21006891|P1|Overall Study|Withdrawal by Subject|2
6085522|NCT00375505|21006899|P2|Overall Study|Adverse Event|2
6085523|NCT00375505|21006900|P1|Overall Study|Adverse Event|1
6085524|NCT00375492|21006944|P2|Overall Study|Withdrawal by Subject|6
6085525|NCT00375492|21006945|P1|Overall Study|Withdrawal by Subject|6
6085526|NCT00375492|21006944|P2|Overall Study|Sponsor Decision|1
6085527|NCT00375492|21006945|P1|Overall Study|Sponsor Decision|0
6085528|NCT00375492|21006944|P2|Overall Study|Protocol Violation|3
6085529|NCT00375492|21006945|P1|Overall Study|Protocol Violation|6
6085530|NCT00375492|21006944|P2|Overall Study|Physician Decision|4
6085531|NCT00375492|21006945|P1|Overall Study|Physician Decision|0
6085532|NCT00375492|21006944|P2|Overall Study|Lost to Follow-up|5
6085533|NCT00375492|21006945|P1|Overall Study|Lost to Follow-up|10
6085534|NCT00375492|21006944|P2|Overall Study|Loss of Glucose Control|1
6085535|NCT00375492|21006945|P1|Overall Study|Loss of Glucose Control|0
6085536|NCT00375492|21006944|P2|Overall Study|Entry Criteria Not Met|1
6085537|NCT00375492|21006945|P1|Overall Study|Entry Criteria Not Met|0
6085538|NCT00375492|21006944|P2|Overall Study|Adverse Event|5
6085539|NCT00375492|21006945|P1|Overall Study|Adverse Event|4
6085540|NCT00375427|21006975|P2|Overall Study|Death|10
6085541|NCT00375427|21006976|P1|Overall Study|Death|11
6085542|NCT00375427|21006975|P2|Overall Study|Administrative reasons|1
6085543|NCT00375427|21006976|P1|Overall Study|Administrative reasons|0
6085544|NCT00375427|21006975|P2|Overall Study|Lost to Follow-up|1
6085545|NCT00375427|21006976|P1|Overall Study|Lost to Follow-up|1
6085546|NCT00375427|21006975|P2|Overall Study|Withdrawal by Subject|13
6085547|NCT00375427|21006976|P1|Overall Study|Withdrawal by Subject|9
6085548|NCT00375427|21006975|P2|Overall Study|Protocol Violation|8
6085549|NCT00375427|21006976|P1|Overall Study|Protocol Violation|10
6085550|NCT00375427|21006975|P2|Overall Study|Patient no longer requires study drug|7
6085551|NCT00375427|21006976|P1|Overall Study|Patient no longer requires study drug|3
6085552|NCT00375427|21006975|P2|Overall Study|Unsatisfactory therapeutic effect|4
6085553|NCT00375427|21006976|P1|Overall Study|Unsatisfactory therapeutic effect|4
6085554|NCT00375427|21006975|P2|Overall Study|Abnormal laboratory value(s)|2
6085555|NCT00375427|21006976|P1|Overall Study|Abnormal laboratory value(s)|1
6085556|NCT00375427|21006975|P2|Overall Study|Abnormal test procedure result(s)|1
6085557|NCT00375427|21006976|P1|Overall Study|Abnormal test procedure result(s)|0
6085558|NCT00375427|21006975|P2|Overall Study|Adverse Event|27
6085559|NCT00375427|21006976|P1|Overall Study|Adverse Event|21
6085560|NCT00375219|21007001|P3|Overall Study|Withdrawal by Subject|0
6085561|NCT00375219|21007002|P2|Overall Study|Withdrawal by Subject|0
6085562|NCT00375219|21007003|P1|Overall Study|Withdrawal by Subject|1
6085563|NCT00375219|21007001|P3|Overall Study|Cord blood transplantation|0
6085564|NCT00375219|21007002|P2|Overall Study|Cord blood transplantation|0
6085565|NCT00375219|21007003|P1|Overall Study|Cord blood transplantation|1
6085566|NCT00375219|21007001|P3|Overall Study|Allograft|0
6085567|NCT00375219|21007002|P2|Overall Study|Allograft|0
6085568|NCT00375219|21007003|P1|Overall Study|Allograft|2
6085569|NCT00375219|21007001|P3|Overall Study|Specific tyrosine kinase inhibitor avail|0
6085570|NCT00375219|21007002|P2|Overall Study|Specific tyrosine kinase inhibitor avail|0
6085571|NCT00375219|21007003|P1|Overall Study|Specific tyrosine kinase inhibitor avail|1
6085572|NCT00375219|21007001|P3|Overall Study|Hematologic resistance|0
6085573|NCT00375219|21007002|P2|Overall Study|Hematologic resistance|0
6085574|NCT00375219|21007003|P1|Overall Study|Hematologic resistance|1
6085575|NCT00375219|21007001|P3|Overall Study|Death|7
6085576|NCT00375219|21007002|P2|Overall Study|Death|3
6085577|NCT00375219|21007003|P1|Overall Study|Death|4
6085578|NCT00375219|21007001|P3|Overall Study|Disease progression|12
6085579|NCT00375219|21007002|P2|Overall Study|Disease progression|9
6085580|NCT00375219|21007003|P1|Overall Study|Disease progression|18
6085581|NCT00375219|21007001|P3|Overall Study|Lost to Follow-up|0
6085582|NCT00375219|21007002|P2|Overall Study|Lost to Follow-up|1
6085583|NCT00375219|21007003|P1|Overall Study|Lost to Follow-up|1
6085584|NCT00375219|21007001|P3|Overall Study|Request of Patient, PI, Sponsor or RA|0
6085585|NCT00375219|21007002|P2|Overall Study|Request of Patient, PI, Sponsor or RA|3
6085586|NCT00375219|21007003|P1|Overall Study|Request of Patient, PI, Sponsor or RA|5
6085587|NCT00375219|21007001|P3|Overall Study|Protocol Violation|1
6085588|NCT00375219|21007002|P2|Overall Study|Protocol Violation|0
6085589|NCT00375219|21007003|P1|Overall Study|Protocol Violation|1
6085590|NCT00375219|21007001|P3|Overall Study|Adverse Event|1
6085591|NCT00375219|21007002|P2|Overall Study|Adverse Event|2
6085592|NCT00375219|21007003|P1|Overall Study|Adverse Event|8
6085593|NCT00375219|21007001|P3|Overall Study|Failure to achieve a response|0
6085594|NCT00375219|21007002|P2|Overall Study|Failure to achieve a response|2
6085595|NCT00375219|21007003|P1|Overall Study|Failure to achieve a response|16
6085596|NCT00374907|21007086|P2|116-Week Short-term + Long-term Period|Lost to Follow-up|1
6085597|NCT00374907|21007087|P1|116-Week Short-term + Long-term Period|Lost to Follow-up|1
6085598|NCT00374907|21007086|P2|116-Week Short-term + Long-term Period|Adverse Event|2
6085599|NCT00374907|21007087|P1|116-Week Short-term + Long-term Period|Adverse Event|0
6085600|NCT00374907|21007086|P2|116-Week Short-term + Long-term Period|Lack of Efficacy|2
6085601|NCT00374907|21007087|P1|116-Week Short-term + Long-term Period|Lack of Efficacy|4
6085602|NCT00374907|21007086|P2|116-Week Short-term + Long-term Period|Subject Withdrew Consent|9
6085603|NCT00374907|21007087|P1|116-Week Short-term + Long-term Period|Subject Withdrew Consent|8
6085604|NCT00374907|21007086|P2|12-Week Short-term Period|Subject Withdrew Consent|1
6085605|NCT00374907|21007087|P1|12-Week Short-term Period|Subject Withdrew Consent|3
6085606|NCT00374868|21007099|P1|Overall Study|Other - Not Specified|1
6085607|NCT00374868|21007099|P1|Overall Study|Death|2
6085608|NCT00374868|21007099|P1|Overall Study|Lost to Follow-up|1
6085609|NCT00374868|21007099|P1|Overall Study|Physician Decision|13
6085610|NCT00374868|21007099|P1|Overall Study|Progressive Disease|7
6085611|NCT00374868|21007099|P1|Overall Study|Adverse Event|12
6085612|NCT00374556|21007163|P2|Overall Study|Removed at baseline due to medical cond|1
6085613|NCT00374556|21007164|P1|Overall Study|Removed at baseline due to medical cond|0
6085614|NCT00374556|21007163|P2|Overall Study|Lost to Follow-up|0
6085615|NCT00374556|21007164|P1|Overall Study|Lost to Follow-up|1
6085616|NCT00374452|21007225|P2|Overall Study|Withdrawal by Subject|2
6085617|NCT00374452|21007226|P1|Overall Study|Withdrawal by Subject|0
6085618|NCT00374452|21007225|P2|Overall Study|Left clinic after intervention started|1
6085619|NCT00374452|21007226|P1|Overall Study|Left clinic after intervention started|1
6085620|NCT00374452|21007225|P2|Overall Study|Change in job role before intervention|1
6085621|NCT00374452|21007226|P1|Overall Study|Change in job role before intervention|0
6085622|NCT00374452|21007225|P2|Overall Study|Left clinic before intervention started|1
6085623|NCT00374452|21007226|P1|Overall Study|Left clinic before intervention started|4
6085624|NCT00374322|21007239|P2|Overall Study|Did Not Receive Study Medication|6
6085625|NCT00374322|21007240|P1|Overall Study|Did Not Receive Study Medication|8
6085626|NCT00374322|21007239|P2|Overall Study|Withdrew Consent During Follow-up|5
6085627|NCT00374322|21007240|P1|Overall Study|Withdrew Consent During Follow-up|0
6085628|NCT00374322|21007239|P2|Overall Study|Noncompliance with Study Requirements|1
6085629|NCT00374322|21007240|P1|Overall Study|Noncompliance with Study Requirements|0
6085630|NCT00374322|21007239|P2|Overall Study|Started Another Chemotherapy Regimen|1
6085631|NCT00374322|21007240|P1|Overall Study|Started Another Chemotherapy Regimen|0
6085632|NCT00374322|21007239|P2|Overall Study|Participant Changed Physician|0
6085633|NCT00374322|21007240|P1|Overall Study|Participant Changed Physician|1
6085634|NCT00374322|21007239|P2|Overall Study|Site Closed|2
6085635|NCT00374322|21007240|P1|Overall Study|Site Closed|2
6085636|NCT00374322|21007239|P2|Overall Study|Severe Toxicity|0
6085637|NCT00374322|21007240|P1|Overall Study|Severe Toxicity|1
6085638|NCT00374322|21007239|P2|Overall Study|Seen in FU by a Non-Primary Investigator|0
6085639|NCT00374322|21007240|P1|Overall Study|Seen in FU by a Non-Primary Investigator|1
6085640|NCT00374322|21007239|P2|Overall Study|FU by a Non-Principal Investigator (PI)|3
6085641|NCT00374322|21007240|P1|Overall Study|FU by a Non-Principal Investigator (PI)|2
6085642|NCT00374322|21007239|P2|Overall Study|Sponsor Decision|3
6085643|NCT00374322|21007240|P1|Overall Study|Sponsor Decision|2
6085644|NCT00374322|21007239|P2|Overall Study|Par. Consented to Survival FU Only|1
6085645|NCT00374322|21007240|P1|Overall Study|Par. Consented to Survival FU Only|3
6085646|NCT00374322|21007239|P2|Overall Study|Physician Decision|32
6085647|NCT00374322|21007240|P1|Overall Study|Physician Decision|36
6085648|NCT00374322|21007239|P2|Overall Study|Sponsor Terminated Study|990
6085649|NCT00374322|21007240|P1|Overall Study|Sponsor Terminated Study|866
6085650|NCT00374322|21007239|P2|Overall Study|Withdrawal by Subject|167
6085651|NCT00374322|21007240|P1|Overall Study|Withdrawal by Subject|235
6085652|NCT00374322|21007239|P2|Overall Study|Protocol Violation|3
6085653|NCT00374322|21007240|P1|Overall Study|Protocol Violation|8
6085654|NCT00374322|21007239|P2|Overall Study|Lost to Follow-up|90
6085655|NCT00374322|21007240|P1|Overall Study|Lost to Follow-up|92
6085656|NCT00374140|21007331|P1|Overall Study|Protocol Violation|1
6085657|NCT00374140|21007331|P1|Overall Study|Lost to Follow-up|1
6085658|NCT00374127|21007338|P1|Overall Study|Pregnancy|1
6085659|NCT00374127|21007338|P1|Overall Study|Protocol Violation|5
6085660|NCT00374127|21007338|P1|Overall Study|Blood could not be drawn.|2
6085661|NCT00374127|21007338|P1|Overall Study|Did not inhale during smoking procedure.|3
6085662|NCT00373958|21007387|P2|Toddler Dose|Withdrawn after infant series|25
6085663|NCT00373958|21007388|P1|Toddler Dose|Withdrawn after infant series|22
6085664|NCT00373958|21007387|P2|Toddler Dose|Protocol Violation|1
6085665|NCT00373958|21007388|P1|Toddler Dose|Protocol Violation|0
6085666|NCT00373958|21007387|P2|Toddler Dose|Failed to return|2
6085667|NCT00373958|21007388|P1|Toddler Dose|Failed to return|1
6085668|NCT00373958|21007387|P2|Toddler Dose|Withdrawal by Subject|2
6085669|NCT00373958|21007388|P1|Toddler Dose|Withdrawal by Subject|2
6085670|NCT00373958|21007387|P2|Toddler Dose|Lost to Follow-up|8
6085671|NCT00373958|21007388|P1|Toddler Dose|Lost to Follow-up|5
6085672|NCT00373958|21007387|P2|Infant Series|Physician Decision|1
6085673|NCT00373958|21007388|P1|Infant Series|Physician Decision|1
6085674|NCT00373958|21007387|P2|Infant Series|Adverse Event|1
6085675|NCT00373958|21007388|P1|Infant Series|Adverse Event|3
6085676|NCT00373958|21007387|P2|Infant Series|Consent was not received|0
6085677|NCT00373958|21007388|P1|Infant Series|Consent was not received|1
6085678|NCT00373958|21007387|P2|Infant Series|Child relocated|0
6085679|NCT00373958|21007388|P1|Infant Series|Child relocated|1
6085680|NCT00373958|21007387|P2|Infant Series|Lost Kaiser coverage|0
6085681|NCT00373958|21007388|P1|Infant Series|Lost Kaiser coverage|4
6085682|NCT00373958|21007387|P2|Infant Series|Protocol Violation|7
6085683|NCT00373958|21007388|P1|Infant Series|Protocol Violation|3
6085684|NCT00373958|21007387|P2|Infant Series|Lost to Follow-up|5
6085685|NCT00373958|21007388|P1|Infant Series|Lost to Follow-up|6
6085686|NCT00373958|21007387|P2|Infant Series|Failed to return|13
6085687|NCT00373958|21007388|P1|Infant Series|Failed to return|8
6085688|NCT00373958|21007387|P2|Infant Series|Withdrawal by Subject|15
6085689|NCT00373958|21007388|P1|Infant Series|Withdrawal by Subject|13
6085690|NCT00373880|21007436|P1|Overall Study|Protocol Violation|14
6085691|NCT00373880|21007436|P1|Overall Study|Arrested|1
6085692|NCT00373880|21007436|P1|Overall Study|Physician Decision|3
6085693|NCT00373685|21007481|P2|Overall Study|Randomized, not treated|77
6085694|NCT00373685|21007482|P1|Overall Study|Randomized, not treated|51
6085695|NCT00373685|21007481|P2|Overall Study|Final Status Unknown|4
6085696|NCT00373685|21007482|P1|Overall Study|Final Status Unknown|12
6085697|NCT00373685|21007481|P2|Overall Study|Protocol Violation|182
6085698|NCT00373685|21007482|P1|Overall Study|Protocol Violation|191
6085699|NCT00373685|21007481|P2|Overall Study|Other|146
6085700|NCT00373685|21007482|P1|Overall Study|Other|149
6085701|NCT00373685|21007481|P2|Overall Study|No longer willing to participate|352
6085702|NCT00373685|21007482|P1|Overall Study|No longer willing to participate|337
6085703|NCT00373685|21007481|P2|Overall Study|Lost to follow up|103
6085704|NCT00373685|21007482|P1|Overall Study|Lost to follow up|83
6085705|NCT00373685|21007481|P2|Overall Study|Did not meet entrance criteria|184
6085706|NCT00373685|21007482|P1|Overall Study|Did not meet entrance criteria|167
6085707|NCT00373685|21007481|P2|Overall Study|Insufficient clinical response|119
6085708|NCT00373685|21007482|P1|Overall Study|Insufficient clinical response|169
6085709|NCT00373685|21007481|P2|Overall Study|Adverse Event|253
6085710|NCT00373685|21007482|P1|Overall Study|Adverse Event|278
6085711|NCT00373685|21007481|P2|Overall Study|Death|1
6085712|NCT00373685|21007482|P1|Overall Study|Death|2
6085713|NCT00373529|21007516|P1|Overall Study|Consent violation|1
6085714|NCT00373529|21007516|P1|Overall Study|Failed independent confirmation of AML|3
6085715|NCT00373529|21007516|P1|Overall Study|Other|8
6085716|NCT00373529|21007516|P1|Overall Study|Need for treatment prohibited by study|1
6085717|NCT00373529|21007516|P1|Overall Study|Death|16
6085718|NCT00373529|21007516|P1|Overall Study|Disease recurrence|10
6085719|NCT00373529|21007516|P1|Overall Study|Treatment failure|36
6085720|NCT00373529|21007516|P1|Overall Study|Adverse Event|7
6085721|NCT00373529|21007516|P1|Overall Study|Withdrawal by Subject|7
6085722|NCT00373529|21007516|P1|Overall Study|Physician Decision|19
6085723|NCT00373490|21007528|P2|Overall Study|Withdrawal by Subject|1
6085724|NCT00373490|21007529|P1|Overall Study|Withdrawal by Subject|0
6085725|NCT00373490|21007528|P2|Overall Study|Lack of Efficacy|4
6085726|NCT00373490|21007529|P1|Overall Study|Lack of Efficacy|9
6085727|NCT00373490|21007528|P2|Overall Study|Adverse Event|1
6085728|NCT00373490|21007529|P1|Overall Study|Adverse Event|0
6085729|NCT00373425|21007552|P5|Overall Study|Death|0
6085730|NCT00373425|21007553|P4|Overall Study|Death|1
6085731|NCT00373425|21007554|P3|Overall Study|Death|3
6085732|NCT00373425|21007555|P2|Overall Study|Death|0
6085733|NCT00373425|21007556|P1|Overall Study|Death|7
6085734|NCT00373425|21007552|P5|Overall Study|Medical/ethical/noncompliance reason|5
6085735|NCT00373425|21007553|P4|Overall Study|Medical/ethical/noncompliance reason|2
6085736|NCT00373425|21007554|P3|Overall Study|Medical/ethical/noncompliance reason|10
6085737|NCT00373425|21007555|P2|Overall Study|Medical/ethical/noncompliance reason|9
6085738|NCT00373425|21007556|P1|Overall Study|Medical/ethical/noncompliance reason|21
6085739|NCT00373425|21007552|P5|Overall Study|Patient request|7
6085740|NCT00373425|21007553|P4|Overall Study|Patient request|6
6085741|NCT00373425|21007554|P3|Overall Study|Patient request|43
6085742|NCT00373425|21007555|P2|Overall Study|Patient request|18
6085743|NCT00373425|21007556|P1|Overall Study|Patient request|35
6085744|NCT00373425|21007552|P5|Overall Study|Adverse Event|34
6085745|NCT00373425|21007553|P4|Overall Study|Adverse Event|0
6085746|NCT00373425|21007554|P3|Overall Study|Adverse Event|59
6085747|NCT00373425|21007555|P2|Overall Study|Adverse Event|22
6085748|NCT00373425|21007556|P1|Overall Study|Adverse Event|191
6085749|NCT00373425|21007552|P5|Overall Study|Relapse of NSCLC|26
6085750|NCT00373425|21007553|P4|Overall Study|Relapse of NSCLC|2
6085751|NCT00373425|21007554|P3|Overall Study|Relapse of NSCLC|19
6085752|NCT00373425|21007555|P2|Overall Study|Relapse of NSCLC|104
6085753|NCT00373425|21007556|P1|Overall Study|Relapse of NSCLC|116
6085754|NCT00373295|21007651|P6|Intervention 1 (8 Days)|Withdrawal by Subject|0
6085755|NCT00373295|21007652|P5|Intervention 1 (8 Days)|Withdrawal by Subject|1
6085756|NCT00373295|21007653|P4|Intervention 1 (8 Days)|Withdrawal by Subject|0
6085757|NCT00373295|21007654|P3|Intervention 1 (8 Days)|Withdrawal by Subject|0
6085758|NCT00373295|21007655|P2|Intervention 1 (8 Days)|Withdrawal by Subject|2
6085759|NCT00373295|21007656|P1|Intervention 1 (8 Days)|Withdrawal by Subject|0
6085760|NCT00373256|21007677|P2|Overall Study|Study Terminated by Sponsor|13
6085761|NCT00373256|21007678|P1|Overall Study|Study Terminated by Sponsor|41
6085762|NCT00373256|21007677|P2|Overall Study|Protocol Violation|2
6085763|NCT00373256|21007678|P1|Overall Study|Protocol Violation|0
6085764|NCT00373256|21007677|P2|Overall Study|Other|107
6085765|NCT00373256|21007678|P1|Overall Study|Other|73
6085766|NCT00373256|21007677|P2|Overall Study|Refused Treatment-Reason Other Than AE|7
6085767|NCT00373256|21007678|P1|Overall Study|Refused Treatment-Reason Other Than AE|4
6085768|NCT00373256|21007677|P2|Overall Study|Objective Progression or Relapse|104
6085769|NCT00373256|21007678|P1|Overall Study|Objective Progression or Relapse|111
6085770|NCT00373256|21007677|P2|Overall Study|Death|8
6085771|NCT00373256|21007678|P1|Overall Study|Death|9
6085772|NCT00373256|21007677|P2|Overall Study|Lost to Follow-up|1
6085773|NCT00373256|21007678|P1|Overall Study|Lost to Follow-up|2
6085774|NCT00373256|21007677|P2|Overall Study|Adverse Event (AE)|5
6085775|NCT00373256|21007678|P1|Overall Study|Adverse Event (AE)|1
6085776|NCT00373113|21007704|P2|Overall Study|Withdrawal by Subject|15
6085777|NCT00373113|21007705|P1|Overall Study|Withdrawal by Subject|10
6085778|NCT00373113|21007704|P2|Overall Study|Protocol Violation|1
6085779|NCT00373113|21007705|P1|Overall Study|Protocol Violation|5
6085780|NCT00373113|21007704|P2|Overall Study|Other|17
6085781|NCT00373113|21007705|P1|Overall Study|Other|14
6085782|NCT00373113|21007704|P2|Overall Study|Objective progression or relapse|169
6085783|NCT00373113|21007705|P1|Overall Study|Objective progression or relapse|150
6085784|NCT00373113|21007704|P2|Overall Study|Lost to Follow-up|3
6085785|NCT00373113|21007705|P1|Overall Study|Lost to Follow-up|1
6085786|NCT00373113|21007704|P2|Overall Study|Global deterioration of health status|7
6085787|NCT00373113|21007705|P1|Overall Study|Global deterioration of health status|10
6085788|NCT00373113|21007704|P2|Overall Study|Study terminated by sponsor|1
6085789|NCT00373113|21007705|P1|Overall Study|Study terminated by sponsor|9
6085790|NCT00373113|21007704|P2|Overall Study|Adverse Event|24
6085791|NCT00373113|21007705|P1|Overall Study|Adverse Event|38
6085792|NCT00373113|21007704|P2|Overall Study|Death|7
6085793|NCT00373113|21007705|P1|Overall Study|Death|1
6085794|NCT00372996|21007727|P4|Overall Study|Other|7
6085795|NCT00372996|21007728|P3|Overall Study|Other|7
6085796|NCT00372996|21007729|P2|Overall Study|Other|2
6085797|NCT00372996|21007730|P1|Overall Study|Other|10
6085798|NCT00372996|21007727|P4|Overall Study|Study Terminated by Sponsor|0
6085799|NCT00372996|21007728|P3|Overall Study|Study Terminated by Sponsor|4
6085800|NCT00372996|21007729|P2|Overall Study|Study Terminated by Sponsor|0
6085801|NCT00372996|21007730|P1|Overall Study|Study Terminated by Sponsor|4
6085802|NCT00372996|21007727|P4|Overall Study|Withdrawal by Subject|5
6085803|NCT00372996|21007728|P3|Overall Study|Withdrawal by Subject|9
6085804|NCT00372996|21007729|P2|Overall Study|Withdrawal by Subject|6
6085805|NCT00372996|21007730|P1|Overall Study|Withdrawal by Subject|12
6085806|NCT00372996|21007727|P4|Overall Study|Lost to Follow-up|1
6085807|NCT00372996|21007728|P3|Overall Study|Lost to Follow-up|0
6085808|NCT00372996|21007729|P2|Overall Study|Lost to Follow-up|2
6085809|NCT00372996|21007730|P1|Overall Study|Lost to Follow-up|0
6085810|NCT00372996|21007727|P4|Overall Study|Death|7
6085811|NCT00372996|21007728|P3|Overall Study|Death|8
6085812|NCT00372996|21007729|P2|Overall Study|Death|4
6085813|NCT00372996|21007730|P1|Overall Study|Death|11
6085814|NCT00372905|21007815|P4|Follow up Until Relapse or Progression|Other|0
6085815|NCT00372905|21007816|P3|Follow up Until Relapse or Progression|Other|0
6085816|NCT00372905|21007817|P2|Follow up Until Relapse or Progression|Other|1
6085817|NCT00372905|21007818|P1|Follow up Until Relapse or Progression|Other|0
6085818|NCT00372905|21007815|P4|Follow up Until Relapse or Progression|Study closed|3
6085819|NCT00372905|21007816|P3|Follow up Until Relapse or Progression|Study closed|0
6085820|NCT00372905|21007817|P2|Follow up Until Relapse or Progression|Study closed|0
6085821|NCT00372905|21007818|P1|Follow up Until Relapse or Progression|Study closed|0
6085822|NCT00372905|21007815|P4|Expansion Phase at Dose 1.3mg/m2|Adverse Event|2
6085823|NCT00372905|21007816|P3|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0
6085824|NCT00372905|21007817|P2|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0
6085825|NCT00372905|21007818|P1|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0
6085826|NCT00372905|21007815|P4|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0
6085827|NCT00372905|21007816|P3|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|1
6085828|NCT00372905|21007817|P2|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0
6085829|NCT00372905|21007818|P1|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0
6085830|NCT00372905|21007815|P4|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0
6085831|NCT00372905|21007816|P3|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|2
6085832|NCT00372905|21007817|P2|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0
6085833|NCT00372905|21007818|P1|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0
6085834|NCT00372905|21007815|P4|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0
6085835|NCT00372905|21007816|P3|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0
6085836|NCT00372905|21007817|P2|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0
6085837|NCT00372905|21007818|P1|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|2
6085838|NCT00372775|21007830|P1|Overall Study|Not Treated|2
6085839|NCT00372775|21007830|P1|Overall Study|Other|1
6085840|NCT00372775|21007830|P1|Overall Study|Withdrawal by Subject|1
6085841|NCT00372775|21007830|P1|Overall Study|Global deterioration of health status|6
6085842|NCT00372775|21007830|P1|Overall Study|Objective progression or relapse|30
6085843|NCT00372775|21007830|P1|Overall Study|Death|15
6085844|NCT00372775|21007830|P1|Overall Study|Adverse Event|8
6085845|NCT00372697|21007852|P2|Overall Study|Protocol Violation|1
6085846|NCT00372697|21007853|P1|Overall Study|Protocol Violation|1
6085847|NCT00372619|21007878|P7|Overall Study|Inevaluable|0
6085848|NCT00372619|21007879|P6|Overall Study|Inevaluable|1
6085849|NCT00372619|21007880|P5|Overall Study|Inevaluable|0
6085850|NCT00372619|21007881|P4|Overall Study|Inevaluable|0
6085851|NCT00372619|21007882|P3|Overall Study|Inevaluable|0
6085852|NCT00372619|21007883|P2|Overall Study|Inevaluable|0
6085853|NCT00372619|21007884|P1|Overall Study|Inevaluable|0
6085854|NCT00372619|21007878|P7|Overall Study|Ineligible|0
6085855|NCT00372619|21007879|P6|Overall Study|Ineligible|2
6085856|NCT00372619|21007880|P5|Overall Study|Ineligible|0
6085857|NCT00372619|21007881|P4|Overall Study|Ineligible|0
6085858|NCT00372619|21007882|P3|Overall Study|Ineligible|0
6085859|NCT00372619|21007883|P2|Overall Study|Ineligible|0
6085860|NCT00372619|21007884|P1|Overall Study|Ineligible|0
6085861|NCT00372593|21007917|P3|Overall Study|Ineligible|1
6085862|NCT00372593|21007918|P2|Overall Study|Ineligible|21
6085863|NCT00372593|21007919|P1|Overall Study|Ineligible|20
6085864|NCT00372593|21007917|P3|Overall Study|Physician Decision|0
6085865|NCT00372593|21007918|P2|Overall Study|Physician Decision|41
6085866|NCT00372593|21007919|P1|Overall Study|Physician Decision|42
6085867|NCT00372593|21007917|P3|Overall Study|Lost to Follow-up|0
6085868|NCT00372593|21007918|P2|Overall Study|Lost to Follow-up|0
6085869|NCT00372593|21007919|P1|Overall Study|Lost to Follow-up|1
6085870|NCT00372593|21007917|P3|Overall Study|Lack of Efficacy|2
6085871|NCT00372593|21007918|P2|Overall Study|Lack of Efficacy|71
6085872|NCT00372593|21007919|P1|Overall Study|Lack of Efficacy|82
6085873|NCT00372593|21007917|P3|Overall Study|Death|1
6085874|NCT00372593|21007918|P2|Overall Study|Death|20
6085875|NCT00372593|21007919|P1|Overall Study|Death|16
6085876|NCT00372593|21007917|P3|Overall Study|Adverse Event|0
6085877|NCT00372593|21007918|P2|Overall Study|Adverse Event|45
6085878|NCT00372593|21007919|P1|Overall Study|Adverse Event|43
6085879|NCT00372567|21007948|P3|Phase 3 Study|study terminated by sponsor|5
6085880|NCT00372567|21007949|P2|Phase 3 Study|study terminated by sponsor|8
6085881|NCT00372567|21007950|P1|Phase 3 Study|study terminated by sponsor|13
6085882|NCT00372567|21007948|P3|Phase 3 Study|Other|1
6085883|NCT00372567|21007949|P2|Phase 3 Study|Other|2
6085884|NCT00372567|21007950|P1|Phase 3 Study|Other|2
6085885|NCT00372567|21007948|P3|Phase 3 Study|Global deterioration of health status|0
6085886|NCT00372567|21007949|P2|Phase 3 Study|Global deterioration of health status|1
6085887|NCT00372567|21007950|P1|Phase 3 Study|Global deterioration of health status|0
6085888|NCT00372567|21007948|P3|Phase 3 Study|Objective progression or relapse|4
6085889|NCT00372567|21007949|P2|Phase 3 Study|Objective progression or relapse|13
6085890|NCT00372567|21007950|P1|Phase 3 Study|Objective progression or relapse|10
6085891|NCT00372567|21007948|P3|Phase 3 Study|Protocol Violation|1
6085892|NCT00372567|21007949|P2|Phase 3 Study|Protocol Violation|0
6085893|NCT00372567|21007950|P1|Phase 3 Study|Protocol Violation|0
6085894|NCT00372567|21007948|P3|Phase 3 Study|Death|0
6085895|NCT00372567|21007949|P2|Phase 3 Study|Death|1
6085896|NCT00372567|21007950|P1|Phase 3 Study|Death|1
6085897|NCT00372567|21007948|P3|Phase 3 Study|Adverse Event|1
6085898|NCT00372567|21007949|P2|Phase 3 Study|Adverse Event|1
6085899|NCT00372567|21007950|P1|Phase 3 Study|Adverse Event|5
6085900|NCT00372528|21007978|P1|Overall Study|Other|1
6085901|NCT00372528|21007978|P1|Overall Study|Study Terminated by Sponsor|18
6085902|NCT00372528|21007978|P1|Overall Study|Adverse Event|1
6085903|NCT00372528|21007978|P1|Overall Study|Lack of Efficacy|1
6085904|NCT00372489|21007983|P1|Overall Study|Sponsor Decision to Terminate Study|41
6085905|NCT00372489|21007983|P1|Overall Study|Renal transplant|6
6085906|NCT00372489|21007983|P1|Overall Study|Patient Relocation|2
6085907|NCT00372489|21007983|P1|Overall Study|Withdrawal by Subject|5
6085908|NCT00372489|21007983|P1|Overall Study|Physician Decision|3
6085909|NCT00372489|21007983|P1|Overall Study|Lost to Follow-up|3
6085910|NCT00372489|21007983|P1|Overall Study|Lack of Efficacy|1
6085911|NCT00372489|21007983|P1|Overall Study|Adverse Event|18
6085912|NCT00372424|21007987|P1|Overall Study|Enrolled, Not Treated|1
6085913|NCT00372424|21007987|P1|Overall Study|Other|7
6085914|NCT00372424|21007987|P1|Overall Study|Objective Progression or Relapse|14
6085915|NCT00372424|21007987|P1|Overall Study|Death|1
6085916|NCT00372424|21007987|P1|Overall Study|Withdrawal by Subject|1
6085917|NCT00372424|21007987|P1|Overall Study|Adverse Event|2
6085918|NCT00372411|21008001|P3|Overall Study|Adverse Event|0
6085919|NCT00372411|21008002|P2|Overall Study|Adverse Event|1
6085920|NCT00372411|21008003|P1|Overall Study|Adverse Event|1
6085921|NCT00372411|21008001|P3|Overall Study|Lost to Follow-up|1
6085922|NCT00372411|21008002|P2|Overall Study|Lost to Follow-up|1
6085923|NCT00372411|21008003|P1|Overall Study|Lost to Follow-up|1
6085924|NCT00372411|21008001|P3|Overall Study|Death|1
6085925|NCT00372411|21008002|P2|Overall Study|Death|2
6085926|NCT00372411|21008003|P1|Overall Study|Death|0
6085927|NCT00372411|21008001|P3|Overall Study|Withdrawal by Subject|1
6085928|NCT00372411|21008002|P2|Overall Study|Withdrawal by Subject|4
6085929|NCT00372411|21008003|P1|Overall Study|Withdrawal by Subject|3
6085930|NCT00372385|21008027|P4|Overall Study|Virologic Stopping Rule|0
6085931|NCT00372385|21008028|P3|Overall Study|Virologic Stopping Rule|0
6085932|NCT00372385|21008029|P2|Overall Study|Virologic Stopping Rule|0
6085933|NCT00372385|21008030|P1|Overall Study|Virologic Stopping Rule|17
6085934|NCT00372385|21008027|P4|Overall Study|Ineligibility due to Exclusion Criterion|0
6085935|NCT00372385|21008028|P3|Overall Study|Ineligibility due to Exclusion Criterion|0
6085936|NCT00372385|21008029|P2|Overall Study|Ineligibility due to Exclusion Criterion|0
6085937|NCT00372385|21008030|P1|Overall Study|Ineligibility due to Exclusion Criterion|1
6085938|NCT00372385|21008027|P4|Overall Study|No Response|0
6085939|NCT00372385|21008028|P3|Overall Study|No Response|0
6085940|NCT00372385|21008029|P2|Overall Study|No Response|1
6085941|NCT00372385|21008030|P1|Overall Study|No Response|1
6085942|NCT00372385|21008027|P4|Overall Study|Refusal of Treatment|0
6085943|NCT00372385|21008028|P3|Overall Study|Refusal of Treatment|0
6085944|NCT00372385|21008029|P2|Overall Study|Refusal of Treatment|6
6085945|NCT00372385|21008030|P1|Overall Study|Refusal of Treatment|3
6085946|NCT00372385|21008027|P4|Overall Study|Withdrawal by Subject|0
6085947|NCT00372385|21008028|P3|Overall Study|Withdrawal by Subject|0
6085948|NCT00372385|21008029|P2|Overall Study|Withdrawal by Subject|1
6085949|NCT00372385|21008030|P1|Overall Study|Withdrawal by Subject|2
6085950|NCT00372385|21008027|P4|Overall Study|Lost to Follow-up|0
6085951|NCT00372385|21008028|P3|Overall Study|Lost to Follow-up|0
6085952|NCT00372385|21008029|P2|Overall Study|Lost to Follow-up|0
6085953|NCT00372385|21008030|P1|Overall Study|Lost to Follow-up|2
6085954|NCT00372385|21008027|P4|Overall Study|Physician Decision|0
6085955|NCT00372385|21008028|P3|Overall Study|Physician Decision|0
6085956|NCT00372385|21008029|P2|Overall Study|Physician Decision|0
6085957|NCT00372385|21008030|P1|Overall Study|Physician Decision|1
6085958|NCT00372385|21008027|P4|Overall Study|Noncompliance|1
6085959|NCT00372385|21008028|P3|Overall Study|Noncompliance|1
6085960|NCT00372385|21008029|P2|Overall Study|Noncompliance|1
6085961|NCT00372385|21008030|P1|Overall Study|Noncompliance|0
6085962|NCT00372385|21008027|P4|Overall Study|Adverse Event|7
6085963|NCT00372385|21008028|P3|Overall Study|Adverse Event|9
6085964|NCT00372385|21008029|P2|Overall Study|Adverse Event|11
6085965|NCT00372385|21008030|P1|Overall Study|Adverse Event|6
6085966|NCT00372255|21008059|P2|Overall Study|Withdrawn for other reasons|1
6085967|NCT00372255|21008060|P1|Overall Study|Withdrawn for other reasons|2
6085968|NCT00372229|21008082|P2|Follow-Up Phase|Lost to Follow-up|10
6085969|NCT00372229|21008083|P1|Follow-Up Phase|Lost to Follow-up|12
6085970|NCT00372229|21008082|P2|Follow-Up Phase|Reason not specified|3
6085971|NCT00372229|21008083|P1|Follow-Up Phase|Reason not specified|2
6085972|NCT00372229|21008082|P2|Follow-Up Phase|Administrative|0
6085973|NCT00372229|21008083|P1|Follow-Up Phase|Administrative|1
6085974|NCT00372229|21008082|P2|Follow-Up Phase|Death|12
6085975|NCT00372229|21008083|P1|Follow-Up Phase|Death|9
6085976|NCT00372229|21008082|P2|Follow-Up Phase|Adverse event/intercurrent illness|0
6085977|NCT00372229|21008083|P1|Follow-Up Phase|Adverse event/intercurrent illness|1
6085978|NCT00372229|21008082|P2|Follow-Up Phase|Refused treatment/did not cooperate|1
6085979|NCT00372229|21008083|P1|Follow-Up Phase|Refused treatment/did not cooperate|0
6085980|NCT00372229|21008082|P2|Follow-Up Phase|Consent withdrawn|19
6085981|NCT00372229|21008083|P1|Follow-Up Phase|Consent withdrawn|13
6085982|NCT00372229|21008082|P2|Follow-Up Phase|Graft loss|7
6085983|NCT00372229|21008083|P1|Follow-Up Phase|Graft loss|8
6085984|NCT00372229|21008082|P2|Study Phase|Lost to Follow-up|3
6085985|NCT00372229|21008083|P1|Study Phase|Lost to Follow-up|3
6085986|NCT00372229|21008082|P2|Study Phase|Reason not specified|2
6085987|NCT00372229|21008083|P1|Study Phase|Reason not specified|3
6085988|NCT00372229|21008082|P2|Study Phase|Death|2
6085989|NCT00372229|21008083|P1|Study Phase|Death|3
6085990|NCT00372229|21008082|P2|Study Phase|Refused treatment/did not cooperate|1
6085991|NCT00372229|21008083|P1|Study Phase|Refused treatment/did not cooperate|3
6085992|NCT00372229|21008082|P2|Study Phase|Consent withdrawn|14
6085993|NCT00372229|21008083|P1|Study Phase|Consent withdrawn|16
6085994|NCT00372229|21008082|P2|Study Phase|Protocol Violation|4
6085995|NCT00372229|21008083|P1|Study Phase|Protocol Violation|3
6085996|NCT00372229|21008082|P2|Study Phase|Graft loss|3
6085997|NCT00372229|21008083|P1|Study Phase|Graft loss|0
6085998|NCT00372190|21008173|P2|Overall Study|Lost to Follow-up|1
6085999|NCT00372190|21008174|P1|Overall Study|Lost to Follow-up|3
6086000|NCT00372112|21008190|P4|Overall Study|Other-protocol violation|0
6086001|NCT00372112|21008191|P3|Overall Study|Other-protocol violation|1
6086002|NCT00372112|21008192|P2|Overall Study|Other-protocol violation|0
6086003|NCT00372112|21008193|P1|Overall Study|Other-protocol violation|0
6086004|NCT00372112|21008190|P4|Overall Study|Hepatitis B|0
6086005|NCT00372112|21008191|P3|Overall Study|Hepatitis B|0
6086006|NCT00372112|21008192|P2|Overall Study|Hepatitis B|0
6086007|NCT00372112|21008193|P1|Overall Study|Hepatitis B|1
6086008|NCT00372112|21008190|P4|Overall Study|PR >240 at Visit 3|1
6086009|NCT00372112|21008191|P3|Overall Study|PR >240 at Visit 3|0
6086010|NCT00372112|21008192|P2|Overall Study|PR >240 at Visit 3|0
6086011|NCT00372112|21008193|P1|Overall Study|PR >240 at Visit 3|0
6086012|NCT00372112|21008190|P4|Overall Study|Exacerbation|1
6086013|NCT00372112|21008191|P3|Overall Study|Exacerbation|0
6086014|NCT00372112|21008192|P2|Overall Study|Exacerbation|0
6086015|NCT00372112|21008193|P1|Overall Study|Exacerbation|0
6086016|NCT00372112|21008190|P4|Overall Study|Withdrawal by Subject|1
6086017|NCT00372112|21008191|P3|Overall Study|Withdrawal by Subject|2
6086018|NCT00372112|21008192|P2|Overall Study|Withdrawal by Subject|0
6086019|NCT00372112|21008193|P1|Overall Study|Withdrawal by Subject|0
6086020|NCT00372112|21008190|P4|Overall Study|Adverse Event|1
6086021|NCT00372112|21008191|P3|Overall Study|Adverse Event|1
6086022|NCT00372112|21008192|P2|Overall Study|Adverse Event|1
6086023|NCT00372112|21008193|P1|Overall Study|Adverse Event|0
6086024|NCT00372060|21008324|P2|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|0
6086025|NCT00372060|21008325|P1|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|2
6086026|NCT00372060|21008324|P2|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|8
6086027|NCT00372060|21008325|P1|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|9
6086028|NCT00372060|21008324|P2|Period II - Open-label (Weeks 12-52)|Adverse Event|0
6086029|NCT00372060|21008325|P1|Period II - Open-label (Weeks 12-52)|Adverse Event|3
6086030|NCT00372060|21008324|P2|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|0
6086031|NCT00372060|21008325|P1|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|1
6086032|NCT00372060|21008324|P2|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|1
6086033|NCT00372060|21008325|P1|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|0
6086034|NCT00372060|21008324|P2|Period I - Double-blind (Weeks 0-12)|Adverse Event|0
6086035|NCT00372060|21008325|P1|Period I - Double-blind (Weeks 0-12)|Adverse Event|2
6086036|NCT00371865|21008340|P2|Overall Study|Withdrawal by Subject|10
6086037|NCT00371865|21008341|P1|Overall Study|Withdrawal by Subject|12
6086038|NCT00371865|21008340|P2|Overall Study|Protocol Violation|2
6086039|NCT00371865|21008341|P1|Overall Study|Protocol Violation|3
6086040|NCT00371865|21008340|P2|Overall Study|Lack of Efficacy|2
6086041|NCT00371865|21008341|P1|Overall Study|Lack of Efficacy|0
6086042|NCT00371839|21008358|P3|Overall Study|Lost to Follow-up|2
6086043|NCT00371839|21008359|P2|Overall Study|Lost to Follow-up|3
6086044|NCT00371839|21008360|P1|Overall Study|Lost to Follow-up|6
6086045|NCT00371839|21008358|P3|Overall Study|Withdrawal by Subject|0
6086046|NCT00371839|21008359|P2|Overall Study|Withdrawal by Subject|4
6086047|NCT00371839|21008360|P1|Overall Study|Withdrawal by Subject|7
6086048|NCT00371839|21008358|P3|Overall Study|Death|0
6086049|NCT00371839|21008359|P2|Overall Study|Death|0
6086050|NCT00371839|21008360|P1|Overall Study|Death|4
6086051|NCT00371826|21008369|P3|Extension Phase (24 Months)|Administrative problems|2
6086052|NCT00371826|21008370|P2|Extension Phase (24 Months)|Administrative problems|0
6086053|NCT00371826|21008371|P1|Extension Phase (24 Months)|Administrative problems|0
6086054|NCT00371826|21008369|P3|Extension Phase (24 Months)|Subject withdrew consent|0
6086055|NCT00371826|21008370|P2|Extension Phase (24 Months)|Subject withdrew consent|2
6086056|NCT00371826|21008371|P1|Extension Phase (24 Months)|Subject withdrew consent|1
6086057|NCT00371826|21008369|P3|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0
6086058|NCT00371826|21008370|P2|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|2
6086059|NCT00371826|21008371|P1|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0
6086060|NCT00371826|21008369|P3|Extension Phase (24 Months)|Abnormal test procedure result(s)|0
6086061|NCT00371826|21008370|P2|Extension Phase (24 Months)|Abnormal test procedure result(s)|1
6086062|NCT00371826|21008371|P1|Extension Phase (24 Months)|Abnormal test procedure result(s)|0
6086063|NCT00371826|21008369|P3|Extension Phase (24 Months)|Adverse Event|0
6086064|NCT00371826|21008370|P2|Extension Phase (24 Months)|Adverse Event|5
6086065|NCT00371826|21008371|P1|Extension Phase (24 Months)|Adverse Event|4
6086066|NCT00371826|21008369|P3|Core Phase (12 Months)|Graft Loss|0
6086067|NCT00371826|21008370|P2|Core Phase (12 Months)|Graft Loss|1
6086068|NCT00371826|21008371|P1|Core Phase (12 Months)|Graft Loss|0
6086069|NCT00371826|21008369|P3|Core Phase (12 Months)|Administrative problems|8
6086070|NCT00371826|21008370|P2|Core Phase (12 Months)|Administrative problems|0
6086071|NCT00371826|21008371|P1|Core Phase (12 Months)|Administrative problems|1
6086072|NCT00371826|21008369|P3|Core Phase (12 Months)|Subject withdrew consent|3
6086073|NCT00371826|21008370|P2|Core Phase (12 Months)|Subject withdrew consent|0
6086074|NCT00371826|21008371|P1|Core Phase (12 Months)|Subject withdrew consent|0
6086075|NCT00371826|21008369|P3|Core Phase (12 Months)|Protocol Violation|1
6086076|NCT00371826|21008370|P2|Core Phase (12 Months)|Protocol Violation|0
6086077|NCT00371826|21008371|P1|Core Phase (12 Months)|Protocol Violation|1
6086078|NCT00371826|21008369|P3|Core Phase (12 Months)|Unsatisfactory therapeutic effect|2
6086079|NCT00371826|21008370|P2|Core Phase (12 Months)|Unsatisfactory therapeutic effect|3
6086080|NCT00371826|21008371|P1|Core Phase (12 Months)|Unsatisfactory therapeutic effect|6
6086081|NCT00371826|21008369|P3|Core Phase (12 Months)|Abnormal test procedure result(s)|1
6086082|NCT00371826|21008370|P2|Core Phase (12 Months)|Abnormal test procedure result(s)|0
6086083|NCT00371826|21008371|P1|Core Phase (12 Months)|Abnormal test procedure result(s)|1
6086084|NCT00371826|21008369|P3|Core Phase (12 Months)|Adverse Event|9
6086085|NCT00371826|21008370|P2|Core Phase (12 Months)|Adverse Event|4
6086086|NCT00371826|21008371|P1|Core Phase (12 Months)|Adverse Event|15
6086087|NCT00371787|21008495|P2|Overall Study|Withdrawal by Subject|1
6086088|NCT00371787|21008496|P1|Overall Study|Withdrawal by Subject|3
6086089|NCT00371761|21008510|P2|Overall Study|Study termination|3
6086090|NCT00371761|21008511|P1|Overall Study|Study termination|4
6086091|NCT00371761|21008510|P2|Overall Study|Investigator Judgment|3
6086092|NCT00371761|21008511|P1|Overall Study|Investigator Judgment|2
6086093|NCT00371761|21008510|P2|Overall Study|Withdrawal by Subject|3
6086094|NCT00371761|21008511|P1|Overall Study|Withdrawal by Subject|1
6086095|NCT00371761|21008510|P2|Overall Study|Adverse Event|1
6086096|NCT00371761|21008511|P1|Overall Study|Adverse Event|1
6086097|NCT00371683|21008519|P2|Follow-Up Period - Randomized Patients|non-specified|12
6086098|NCT00371683|21008520|P1|Follow-Up Period - Randomized Patients|non-specified|6
6086099|NCT00371683|21008519|P2|Follow-Up Period - Randomized Patients|Lost to Follow-up|39
6086100|NCT00371683|21008520|P1|Follow-Up Period - Randomized Patients|Lost to Follow-up|38
6086101|NCT00371683|21008519|P2|Follow-Up Period - Randomized Patients|Death|2
6086102|NCT00371683|21008520|P1|Follow-Up Period - Randomized Patients|Death|0
6086103|NCT00371683|21008519|P2|Follow-Up Period - Randomized Patients|Withdrawal by Subject|19
6086104|NCT00371683|21008520|P1|Follow-Up Period - Randomized Patients|Withdrawal by Subject|17
6086105|NCT00371683|21008519|P2|DB Treatment Period-Randomized Patients|non-specified|8
6086106|NCT00371683|21008520|P1|DB Treatment Period-Randomized Patients|non-specified|9
6086107|NCT00371683|21008519|P2|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|0
6086108|NCT00371683|21008520|P1|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|1
6086109|NCT00371683|21008519|P2|DB Treatment Period-Randomized Patients|No longer meets study criteria|2
6086110|NCT00371683|21008520|P1|DB Treatment Period-Randomized Patients|No longer meets study criteria|1
6086111|NCT00371683|21008519|P2|DB Treatment Period-Randomized Patients|Lost to Follow-up|1
6086112|NCT00371683|21008520|P1|DB Treatment Period-Randomized Patients|Lost to Follow-up|0
6086113|NCT00371683|21008519|P2|DB Treatment Period-Randomized Patients|Withdrawal by Subject|37
6086114|NCT00371683|21008520|P1|DB Treatment Period-Randomized Patients|Withdrawal by Subject|18
6086115|NCT00371683|21008519|P2|DB Treatment Period-Randomized Patients|Adverse Event|58
6086116|NCT00371683|21008520|P1|DB Treatment Period-Randomized Patients|Adverse Event|60
6086117|NCT00371683|21008519|P2|DB Treatment Period-Randomized Patients|Death|1
6086118|NCT00371683|21008520|P1|DB Treatment Period-Randomized Patients|Death|1
6086119|NCT00371566|21008588|P2|Follow Up Phase|Lost to Follow-up|0
6086120|NCT00371566|21008589|P1|Follow Up Phase|Lost to Follow-up|1
6086121|NCT00371566|21008588|P2|Follow Up Phase|Physician Decision|1
6086122|NCT00371566|21008589|P1|Follow Up Phase|Physician Decision|1
6086123|NCT00371566|21008588|P2|Follow Up Phase|Withdrawal by Subject|1
6086124|NCT00371566|21008589|P1|Follow Up Phase|Withdrawal by Subject|0
6086125|NCT00371566|21008588|P2|Follow Up Phase|Disease progression|0
6086126|NCT00371566|21008589|P1|Follow Up Phase|Disease progression|1
6086127|NCT00371566|21008588|P2|Follow Up Phase|Death|5
6086128|NCT00371566|21008589|P1|Follow Up Phase|Death|0
6086129|NCT00371566|21008588|P2|Chemoradiation Phase|Death|0
6086130|NCT00371566|21008589|P1|Chemoradiation Phase|Death|2
6086131|NCT00371566|21008588|P2|Chemoradiation Phase|Progressive Disease|1
6086132|NCT00371566|21008589|P1|Chemoradiation Phase|Progressive Disease|1
6086133|NCT00371566|21008588|P2|Chemoradiation Phase|Non compliant|1
6086134|NCT00371566|21008589|P1|Chemoradiation Phase|Non compliant|0
6086135|NCT00371566|21008588|P2|Chemoradiation Phase|Withdrawal by Subject|1
6086136|NCT00371566|21008589|P1|Chemoradiation Phase|Withdrawal by Subject|0
6086137|NCT00371566|21008588|P2|Chemoradiation Phase|Physician Decision|0
6086138|NCT00371566|21008589|P1|Chemoradiation Phase|Physician Decision|2
6086139|NCT00371566|21008588|P2|Treatment Phase|Protocol Violation|1
6086140|NCT00371566|21008589|P1|Treatment Phase|Protocol Violation|0
6086141|NCT00371566|21008588|P2|Treatment Phase|Adverse Event|1
6086142|NCT00371566|21008589|P1|Treatment Phase|Adverse Event|0
6086143|NCT00371566|21008588|P2|Treatment Phase|Withdrawal by Subject|1
6086144|NCT00371566|21008589|P1|Treatment Phase|Withdrawal by Subject|0
6086145|NCT00371462|21008674|P2|Overall Study|Other|8
6086146|NCT00371462|21008675|P1|Overall Study|Other|7
6086147|NCT00371462|21008674|P2|Overall Study|Withdrawal by Subject|0
6086148|NCT00371462|21008675|P1|Overall Study|Withdrawal by Subject|1
6086149|NCT00371397|21008699|P12|Session 1|Withdrawal by Subject|0
6086150|NCT00371397|21008700|P11|Session 1|Withdrawal by Subject|0
6086151|NCT00371397|21008701|P10|Session 1|Withdrawal by Subject|0
6086152|NCT00371397|21008702|P9|Session 1|Withdrawal by Subject|0
6086153|NCT00371397|21008703|P8|Session 1|Withdrawal by Subject|1
6086154|NCT00371397|21008704|P7|Session 1|Withdrawal by Subject|0
6086155|NCT00371397|21008705|P6|Session 1|Withdrawal by Subject|0
6086156|NCT00371397|21008706|P5|Session 1|Withdrawal by Subject|0
6086157|NCT00371397|21008707|P4|Session 1|Withdrawal by Subject|0
6086158|NCT00371397|21008708|P3|Session 1|Withdrawal by Subject|0
6086159|NCT00371397|21008709|P2|Session 1|Withdrawal by Subject|0
6086160|NCT00371397|21008710|P1|Session 1|Withdrawal by Subject|1
6086161|NCT00371345|21008718|P2|Overall Study|Participant Withdrew Consent|1
6086162|NCT00371345|21008719|P1|Overall Study|Participant Withdrew Consent|0
6086163|NCT00371345|21008718|P2|Overall Study|Participant Request|1
6086164|NCT00371345|21008719|P1|Overall Study|Participant Request|1
6086165|NCT00371345|21008718|P2|Overall Study|Adverse event(AE Unrelated to Study Drug|2
6086166|NCT00371345|21008719|P1|Overall Study|Adverse event(AE Unrelated to Study Drug|1
6086167|NCT00371345|21008718|P2|Overall Study|Study Drug Toxicity|7
6086168|NCT00371345|21008719|P1|Overall Study|Study Drug Toxicity|1
6086169|NCT00371345|21008718|P2|Overall Study|Disease Progression|35
6086170|NCT00371345|21008719|P1|Overall Study|Disease Progression|21
6086171|NCT00371254|21008820|P2|Overall Study|Withdrawal by Subject|1
6086172|NCT00371254|21008821|P1|Overall Study|Withdrawal by Subject|0
6086173|NCT00371254|21008820|P2|Overall Study|Lost to Follow-up|1
6086174|NCT00371254|21008821|P1|Overall Study|Lost to Follow-up|0
6086175|NCT00371254|21008820|P2|Overall Study|Adverse event unrelated to study drug|1
6086176|NCT00371254|21008821|P1|Overall Study|Adverse event unrelated to study drug|0
6086177|NCT00371254|21008820|P2|Overall Study|Investigator Decision|0
6086178|NCT00371254|21008821|P1|Overall Study|Investigator Decision|2
6086179|NCT00371254|21008820|P2|Overall Study|Subject request|0
6086180|NCT00371254|21008821|P1|Overall Study|Subject request|5
6086181|NCT00371254|21008820|P2|Overall Study|Study drug toxicity|5
6086182|NCT00371254|21008821|P1|Overall Study|Study drug toxicity|3
6086183|NCT00371254|21008820|P2|Overall Study|Disease progression|13
6086184|NCT00371254|21008821|P1|Overall Study|Disease progression|13
6086185|NCT00371150|21008904|P2|Overall Study|Lost to Follow-up|2
6086186|NCT00371150|21008905|P1|Overall Study|Lost to Follow-up|3
6086187|NCT00371137|21008940|P3|Overall Study|Protocol Violation|1
6086188|NCT00371137|21008941|P2|Overall Study|Protocol Violation|1
6086189|NCT00371137|21008942|P1|Overall Study|Protocol Violation|2
6086190|NCT00371137|21008940|P3|Overall Study|Physician Decision|1
6086191|NCT00371137|21008941|P2|Overall Study|Physician Decision|1
6086192|NCT00371137|21008942|P1|Overall Study|Physician Decision|1
6086193|NCT00371137|21008940|P3|Overall Study|Sponsor Decision|2
6086194|NCT00371137|21008941|P2|Overall Study|Sponsor Decision|1
6086195|NCT00371137|21008942|P1|Overall Study|Sponsor Decision|2
6086196|NCT00371137|21008940|P3|Overall Study|Lack of Efficacy|13
6086197|NCT00371137|21008941|P2|Overall Study|Lack of Efficacy|12
6086198|NCT00371137|21008942|P1|Overall Study|Lack of Efficacy|30
6086199|NCT00371137|21008940|P3|Overall Study|Lost to Follow-up|5
6086200|NCT00371137|21008941|P2|Overall Study|Lost to Follow-up|3
6086201|NCT00371137|21008942|P1|Overall Study|Lost to Follow-up|6
6086202|NCT00371137|21008940|P3|Overall Study|Withdrawal by Subject|15
6086203|NCT00371137|21008941|P2|Overall Study|Withdrawal by Subject|10
6086204|NCT00371137|21008942|P1|Overall Study|Withdrawal by Subject|11
6086205|NCT00371137|21008940|P3|Overall Study|Adverse Event|42
6086206|NCT00371137|21008941|P2|Overall Study|Adverse Event|35
6086207|NCT00371137|21008942|P1|Overall Study|Adverse Event|20
6086208|NCT00370682|21008989|P3|Overall Study|Lost to Follow-up|1
6086209|NCT00370682|21008990|P2|Overall Study|Lost to Follow-up|1
6086210|NCT00370682|21008991|P1|Overall Study|Lost to Follow-up|0
6086211|NCT00370682|21008989|P3|Overall Study|Moved from area|0
6086212|NCT00370682|21008990|P2|Overall Study|Moved from area|2
6086213|NCT00370682|21008991|P1|Overall Study|Moved from area|0
6086214|NCT00370552|21009033|P3|Overall Study|Planned radiation for palliation|0
6086215|NCT00370552|21009034|P2|Overall Study|Planned radiation for palliation|1
6086216|NCT00370552|21009035|P1|Overall Study|Planned radiation for palliation|0
6086217|NCT00370552|21009033|P3|Overall Study|High risk of allergic reaction|0
6086218|NCT00370552|21009034|P2|Overall Study|High risk of allergic reaction|1
6086219|NCT00370552|21009035|P1|Overall Study|High risk of allergic reaction|0
6086220|NCT00370552|21009033|P3|Overall Study|Investigator decision|0
6086221|NCT00370552|21009034|P2|Overall Study|Investigator decision|1
6086222|NCT00370552|21009035|P1|Overall Study|Investigator decision|2
6086223|NCT00370552|21009033|P3|Overall Study|Physician Decision|0
6086224|NCT00370552|21009034|P2|Overall Study|Physician Decision|1
6086225|NCT00370552|21009035|P1|Overall Study|Physician Decision|1
6086226|NCT00370552|21009033|P3|Overall Study|Never treated|0
6086227|NCT00370552|21009034|P2|Overall Study|Never treated|0
6086228|NCT00370552|21009035|P1|Overall Study|Never treated|1
6086229|NCT00370552|21009033|P3|Overall Study|Still on treatment|2
6086230|NCT00370552|21009034|P2|Overall Study|Still on treatment|3
6086231|NCT00370552|21009035|P1|Overall Study|Still on treatment|1
6086232|NCT00370552|21009033|P3|Overall Study|Withdrawal by Subject|1
6086233|NCT00370552|21009034|P2|Overall Study|Withdrawal by Subject|0
6086234|NCT00370552|21009035|P1|Overall Study|Withdrawal by Subject|2
6086235|NCT00370552|21009033|P3|Overall Study|Study drug toxicity|6
6086236|NCT00370552|21009034|P2|Overall Study|Study drug toxicity|8
6086237|NCT00370552|21009035|P1|Overall Study|Study drug toxicity|11
6086238|NCT00370552|21009033|P3|Overall Study|Poor or noncompliance|1
6086239|NCT00370552|21009034|P2|Overall Study|Poor or noncompliance|0
6086240|NCT00370552|21009035|P1|Overall Study|Poor or noncompliance|0
6086241|NCT00370552|21009033|P3|Overall Study|Maximum clinical benefit|5
6086242|NCT00370552|21009034|P2|Overall Study|Maximum clinical benefit|5
6086243|NCT00370552|21009035|P1|Overall Study|Maximum clinical benefit|3
6086244|NCT00370552|21009033|P3|Overall Study|Disease progression|15
6086245|NCT00370552|21009034|P2|Overall Study|Disease progression|23
6086246|NCT00370552|21009035|P1|Overall Study|Disease progression|23
6086247|NCT00370552|21009033|P3|Overall Study|Adverse Event|2
6086248|NCT00370552|21009034|P2|Overall Study|Adverse Event|2
6086249|NCT00370552|21009035|P1|Overall Study|Adverse Event|2
6086250|NCT00370396|21009076|P3|Overall Study|Lost to Follow-up|0
6086251|NCT00370396|21009077|P2|Overall Study|Lost to Follow-up|1
6086252|NCT00370396|21009078|P1|Overall Study|Lost to Follow-up|11
6086253|NCT00370396|21009076|P3|Overall Study|Withdrawal by Subject|1
6086254|NCT00370396|21009077|P2|Overall Study|Withdrawal by Subject|0
6086255|NCT00370396|21009078|P1|Overall Study|Withdrawal by Subject|0
6086256|NCT00370331|21009132|P2|Overall Study|Protocol Violation|1
6086257|NCT00370331|21009133|P1|Overall Study|Protocol Violation|1
6086258|NCT00370331|21009132|P2|Overall Study|Non-compliance|1
6086259|NCT00370331|21009133|P1|Overall Study|Non-compliance|0
6086260|NCT00370331|21009132|P2|Overall Study|Lack of Efficacy|1
6086261|NCT00370331|21009133|P1|Overall Study|Lack of Efficacy|0
6086262|NCT00370331|21009132|P2|Overall Study|Lost to Follow-up|3
6086263|NCT00370331|21009133|P1|Overall Study|Lost to Follow-up|0
6086264|NCT00370331|21009132|P2|Overall Study|Withdrawal by Subject|4
6086265|NCT00370331|21009133|P1|Overall Study|Withdrawal by Subject|2
6086266|NCT00370331|21009132|P2|Overall Study|Adverse Event|13
6086267|NCT00370331|21009133|P1|Overall Study|Adverse Event|4
6086268|NCT00370292|21009159|P1|Overall Study|Physician Decision|2
6086269|NCT00370292|21009159|P1|Overall Study|Adverse Event|7
6086270|NCT00370292|21009159|P1|Overall Study|Disease Progression|4
6086271|NCT00370149|21009172|P2|Overall Study|Antibiotic coated dressing placed|1
6086272|NCT00370149|21009173|P1|Overall Study|Antibiotic coated dressing placed|0
6086273|NCT00370149|21009172|P2|Overall Study|Pre-existing infection|1
6086274|NCT00370149|21009173|P1|Overall Study|Pre-existing infection|0
6086275|NCT00370149|21009172|P2|Overall Study|Catheter inserted in wrong vessel-|1
6086276|NCT00370149|21009173|P1|Overall Study|Catheter inserted in wrong vessel-|2
6086277|NCT00370149|21009172|P2|Overall Study|Protocol Violation|0
6086278|NCT00370149|21009173|P1|Overall Study|Protocol Violation|1
6086279|NCT00370149|21009172|P2|Overall Study|Physician Decision|16
6086280|NCT00370149|21009173|P1|Overall Study|Physician Decision|16
6086281|NCT00370071|21009183|P1|Overall Study|Withdrawal by Subject|2
6086282|NCT00370032|21009200|P2|Follow-up Period|Withdrawal by Subject|0
6086283|NCT00370032|21009201|P1|Follow-up Period|Withdrawal by Subject|1
6086284|NCT00370032|21009200|P2|Washout Period|Adverse Event|0
6086285|NCT00370032|21009201|P1|Washout Period|Adverse Event|1
6086286|NCT00370032|21009200|P2|Washout Period|Lost to Follow-up|1
6086287|NCT00370032|21009201|P1|Washout Period|Lost to Follow-up|0
6086288|NCT00370032|21009200|P2|Washout Period|Withdrawal by Subject|1
6086289|NCT00370032|21009201|P1|Washout Period|Withdrawal by Subject|0
6086290|NCT00370032|21009200|P2|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|1
6086291|NCT00370032|21009201|P1|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|0
6086292|NCT00369967|21009221|P2|Overall Study|Lost to Follow-up|12
6086293|NCT00369967|21009222|P1|Overall Study|Lost to Follow-up|23
6086294|NCT00369941|21009240|P2|Overall Study|Miscellaneous|3
6086295|NCT00369941|21009241|P1|Overall Study|Miscellaneous|3
6086296|NCT00369941|21009240|P2|Overall Study|Study Site Terminated|0
6086297|NCT00369941|21009241|P1|Overall Study|Study Site Terminated|2
6086298|NCT00369941|21009240|P2|Overall Study|Employment Interfered with Study Visits|0
6086299|NCT00369941|21009241|P1|Overall Study|Employment Interfered with Study Visits|1
6086300|NCT00369941|21009240|P2|Overall Study|Treatment with Prohibited Medication|1
6086301|NCT00369941|21009241|P1|Overall Study|Treatment with Prohibited Medication|3
6086302|NCT00369941|21009240|P2|Overall Study|Moved|5
6086303|NCT00369941|21009241|P1|Overall Study|Moved|11
6086304|NCT00369941|21009240|P2|Overall Study|Completed, Did Not Enter Extension|6
6086305|NCT00369941|21009241|P1|Overall Study|Completed, Did Not Enter Extension|5
6086306|NCT00369941|21009240|P2|Overall Study|Pregnancy|2
6086307|NCT00369941|21009241|P1|Overall Study|Pregnancy|4
6086308|NCT00369941|21009240|P2|Overall Study|Withdrawal by Subject|18
6086309|NCT00369941|21009241|P1|Overall Study|Withdrawal by Subject|5
6086310|NCT00369941|21009240|P2|Overall Study|Protocol Violation|3
6086311|NCT00369941|21009241|P1|Overall Study|Protocol Violation|5
6086312|NCT00369941|21009240|P2|Overall Study|Lost to Follow-up|22
6086313|NCT00369941|21009241|P1|Overall Study|Lost to Follow-up|12
6086314|NCT00369941|21009240|P2|Overall Study|Lack of Efficacy|10
6086315|NCT00369941|21009241|P1|Overall Study|Lack of Efficacy|6
6086316|NCT00369941|21009240|P2|Overall Study|Adverse Event|28
6086317|NCT00369941|21009241|P1|Overall Study|Adverse Event|14
6086318|NCT00369941|21009240|P2|Overall Study|Never Treated|2
6086319|NCT00369941|21009241|P1|Overall Study|Never Treated|1
6086320|NCT00369915|21009406|P2|Overall Study|W/drawl by investigators|1
6086321|NCT00369915|21009407|P1|Overall Study|W/drawl by investigators|0
6086322|NCT00369915|21009406|P2|Overall Study|Withdrawal by Subject|1
6086323|NCT00369915|21009407|P1|Overall Study|Withdrawal by Subject|4
6086324|NCT00369915|21009406|P2|Overall Study|expected side effects|1
6086325|NCT00369915|21009407|P1|Overall Study|expected side effects|2
6086326|NCT00369824|21009421|P6|Overall Study|Other|3
6086327|NCT00369824|21009422|P5|Overall Study|Other|1
6086328|NCT00369824|21009423|P4|Overall Study|Other|2
6086329|NCT00369824|21009424|P3|Overall Study|Other|0
6086330|NCT00369824|21009425|P2|Overall Study|Other|0
6086331|NCT00369824|21009426|P1|Overall Study|Other|0
6086332|NCT00369824|21009421|P6|Overall Study|Lost to Follow-up|6
6086333|NCT00369824|21009422|P5|Overall Study|Lost to Follow-up|9
6086334|NCT00369824|21009423|P4|Overall Study|Lost to Follow-up|8
6086335|NCT00369824|21009424|P3|Overall Study|Lost to Follow-up|7
6086336|NCT00369824|21009425|P2|Overall Study|Lost to Follow-up|11
6086337|NCT00369824|21009426|P1|Overall Study|Lost to Follow-up|6
6086338|NCT00369824|21009421|P6|Overall Study|Withdrawal by Subject|2
6086339|NCT00369824|21009422|P5|Overall Study|Withdrawal by Subject|6
6086340|NCT00369824|21009423|P4|Overall Study|Withdrawal by Subject|4
6086341|NCT00369824|21009424|P3|Overall Study|Withdrawal by Subject|5
6086342|NCT00369824|21009425|P2|Overall Study|Withdrawal by Subject|5
6086343|NCT00369824|21009426|P1|Overall Study|Withdrawal by Subject|9
6086344|NCT00369824|21009421|P6|Overall Study|Protocol Violation|0
6086345|NCT00369824|21009422|P5|Overall Study|Protocol Violation|1
6086346|NCT00369824|21009423|P4|Overall Study|Protocol Violation|1
6086347|NCT00369824|21009424|P3|Overall Study|Protocol Violation|0
6086348|NCT00369824|21009425|P2|Overall Study|Protocol Violation|1
6086349|NCT00369824|21009426|P1|Overall Study|Protocol Violation|0
6086350|NCT00369824|21009421|P6|Overall Study|Adverse Event|0
6086351|NCT00369824|21009422|P5|Overall Study|Adverse Event|1
6086352|NCT00369824|21009423|P4|Overall Study|Adverse Event|0
6086353|NCT00369824|21009424|P3|Overall Study|Adverse Event|0
6086354|NCT00369824|21009425|P2|Overall Study|Adverse Event|2
6086355|NCT00369824|21009426|P1|Overall Study|Adverse Event|0
6086356|NCT00369785|21009526|P2|Overall Study|Multiple reasons|5
6086357|NCT00369785|21009527|P1|Overall Study|Multiple reasons|6
6086358|NCT00369785|21009526|P2|Overall Study|Progression|4
6086359|NCT00369785|21009527|P1|Overall Study|Progression|4
6086360|NCT00369785|21009526|P2|Overall Study|Never started|2
6086361|NCT00369785|21009527|P1|Overall Study|Never started|0
6086362|NCT00369785|21009526|P2|Overall Study|Toxicity|4
6086363|NCT00369785|21009527|P1|Overall Study|Toxicity|6
6086364|NCT00369785|21009526|P2|Overall Study|Withdrawal by Subject|6
6086365|NCT00369785|21009527|P1|Overall Study|Withdrawal by Subject|7
6086366|NCT00369785|21009526|P2|Overall Study|Death|2
6086367|NCT00369785|21009527|P1|Overall Study|Death|1
6086368|NCT00369785|21009526|P2|Overall Study|Physician Decision|2
6086369|NCT00369785|21009527|P1|Overall Study|Physician Decision|3
6086370|NCT00369707|21009548|P1|Follow up for 2 Years After Treatment|Other|2
6086371|NCT00369707|21009548|P1|Follow up for 2 Years After Treatment|Death|1
6086372|NCT00369707|21009548|P1|Maintenance Period (up to 4 Cycles)|Progressive disease|4
6086373|NCT00369707|21009548|P1|Maintenance Period (up to 4 Cycles)|inadequate response/MD decision|2
6086374|NCT00369707|21009548|P1|Maintenance Period (up to 4 Cycles)|Withdrawal by Subject|2
6086375|NCT00369707|21009548|P1|Induction Part B (2 Cycles)|Progressive disease|1
6086376|NCT00369707|21009548|P1|Induction Part B (2 Cycles)|Inadequate response/MD decision|1
6086377|NCT00369707|21009548|P1|Induction Part B (2 Cycles)|Withdrawal by Subject|2
6086378|NCT00369707|21009548|P1|Induction Part B (2 Cycles)|Adverse Event|3
6086379|NCT00369681|21009561|P1|Overall Study|Death|1
6086380|NCT00369668|21009571|P3|Overall Study|Lack of Efficacy|7
6086381|NCT00369668|21009572|P2|Overall Study|Lack of Efficacy|5
6086382|NCT00369668|21009573|P1|Overall Study|Lack of Efficacy|4
6086383|NCT00369655|21009587|P1|Overall Study|Refusal of further treatment|2
6086384|NCT00369629|21009596|P4|Follow up for 1 Year|stopped being followed as study closed|0
6086385|NCT00369629|21009597|P3|Follow up for 1 Year|stopped being followed as study closed|2
6086386|NCT00369629|21009598|P2|Follow up for 1 Year|stopped being followed as study closed|0
6086387|NCT00369629|21009599|P1|Follow up for 1 Year|stopped being followed as study closed|0
6086388|NCT00369629|21009596|P4|Follow up for 1 Year|Lost to Follow-up|0
6086389|NCT00369629|21009597|P3|Follow up for 1 Year|Lost to Follow-up|0
6086390|NCT00369629|21009598|P2|Follow up for 1 Year|Lost to Follow-up|1
6086391|NCT00369629|21009599|P1|Follow up for 1 Year|Lost to Follow-up|0
6086392|NCT00369629|21009596|P4|Follow up for 1 Year|Death|0
6086393|NCT00369629|21009597|P3|Follow up for 1 Year|Death|1
6086394|NCT00369629|21009598|P2|Follow up for 1 Year|Death|1
6086395|NCT00369629|21009599|P1|Follow up for 1 Year|Death|2
6086396|NCT00369629|21009596|P4|Completed 4 More Cycles|Progressive disease|0
6086397|NCT00369629|21009597|P3|Completed 4 More Cycles|Progressive disease|2
6086398|NCT00369629|21009598|P2|Completed 4 More Cycles|Progressive disease|1
6086399|NCT00369629|21009599|P1|Completed 4 More Cycles|Progressive disease|2
6086400|NCT00369629|21009596|P4|Completed 4 More Cycles|Withdrawal by Subject|0
6086401|NCT00369629|21009597|P3|Completed 4 More Cycles|Withdrawal by Subject|0
6086402|NCT00369629|21009598|P2|Completed 4 More Cycles|Withdrawal by Subject|1
6086403|NCT00369629|21009599|P1|Completed 4 More Cycles|Withdrawal by Subject|2
6086404|NCT00369629|21009596|P4|Moved on to 4 More Cycles|Progressive Disease|0
6086405|NCT00369629|21009597|P3|Moved on to 4 More Cycles|Progressive Disease|1
6086406|NCT00369629|21009598|P2|Moved on to 4 More Cycles|Progressive Disease|0
6086407|NCT00369629|21009599|P1|Moved on to 4 More Cycles|Progressive Disease|0
6086408|NCT00369629|21009596|P4|Treated 2 Cycles/Reached First Response|Progressive disease|0
6086409|NCT00369629|21009597|P3|Treated 2 Cycles/Reached First Response|Progressive disease|0
6086410|NCT00369629|21009598|P2|Treated 2 Cycles/Reached First Response|Progressive disease|0
6086411|NCT00369629|21009599|P1|Treated 2 Cycles/Reached First Response|Progressive disease|2
6086412|NCT00369629|21009596|P4|Treated 2 Cycles/Reached First Response|Adverse Event|0
6086413|NCT00369629|21009597|P3|Treated 2 Cycles/Reached First Response|Adverse Event|1
6086414|NCT00369629|21009598|P2|Treated 2 Cycles/Reached First Response|Adverse Event|0
6086415|NCT00369629|21009599|P1|Treated 2 Cycles/Reached First Response|Adverse Event|0
6086416|NCT00369629|21009596|P4|Treated 2 Cycles/Reached First Response|Physician Decision|0
6086417|NCT00369629|21009597|P3|Treated 2 Cycles/Reached First Response|Physician Decision|1
6086418|NCT00369629|21009598|P2|Treated 2 Cycles/Reached First Response|Physician Decision|1
6086419|NCT00369629|21009599|P1|Treated 2 Cycles/Reached First Response|Physician Decision|0
6086420|NCT00369577|21009630|P3|Overall Study|Withdrawal by Subject|1
6086421|NCT00369577|21009631|P2|Overall Study|Withdrawal by Subject|0
6086422|NCT00369577|21009632|P1|Overall Study|Withdrawal by Subject|0
6086423|NCT00369486|21009669|P5|34-Week Visit|Dropped|3
6086424|NCT00369486|21009670|P4|34-Week Visit|Dropped|3
6086425|NCT00369486|21009671|P3|34-Week Visit|Dropped|1
6086426|NCT00369486|21009672|P2|34-Week Visit|Dropped|1
6086427|NCT00369486|21009673|P1|34-Week Visit|Dropped|0
6086428|NCT00369486|21009669|P5|17-Week Visit|Missed visit|1
6086429|NCT00369486|21009670|P4|17-Week Visit|Missed visit|1
6086430|NCT00369486|21009671|P3|17-Week Visit|Missed visit|1
6086431|NCT00369486|21009672|P2|17-Week Visit|Missed visit|0
6086432|NCT00369486|21009673|P1|17-Week Visit|Missed visit|0
6086433|NCT00369486|21009669|P5|8-Week Visit|Dropped|0
6086434|NCT00369486|21009670|P4|8-Week Visit|Dropped|1
6086435|NCT00369486|21009671|P3|8-Week Visit|Dropped|0
6086436|NCT00369486|21009672|P2|8-Week Visit|Dropped|0
6086437|NCT00369486|21009673|P1|8-Week Visit|Dropped|0
6086438|NCT00369486|21009669|P5|8-Week Visit|Missed visit|1
6086439|NCT00369486|21009670|P4|8-Week Visit|Missed visit|0
6086440|NCT00369486|21009671|P3|8-Week Visit|Missed visit|0
6086441|NCT00369486|21009672|P2|8-Week Visit|Missed visit|1
6086442|NCT00369486|21009673|P1|8-Week Visit|Missed visit|0
6086443|NCT00369486|21009669|P5|4-Week Visit|Dropped|0
6086444|NCT00369486|21009670|P4|4-Week Visit|Dropped|0
6086445|NCT00369486|21009671|P3|4-Week Visit|Dropped|1
6086446|NCT00369486|21009672|P2|4-Week Visit|Dropped|0
6086447|NCT00369486|21009673|P1|4-Week Visit|Dropped|0
6086448|NCT00369486|21009669|P5|4-Week Visit|Missed visit|1
6086449|NCT00369486|21009670|P4|4-Week Visit|Missed visit|2
6086450|NCT00369486|21009671|P3|4-Week Visit|Missed visit|0
6086451|NCT00369486|21009672|P2|4-Week Visit|Missed visit|2
6086452|NCT00369486|21009673|P1|4-Week Visit|Missed visit|2
6086453|NCT00369382|21009712|P2|Overall Study|Other|0
6086454|NCT00369382|21009713|P1|Overall Study|Other|1
6086455|NCT00369382|21009712|P2|Overall Study|Randomized, not treated|0
6086456|NCT00369382|21009713|P1|Overall Study|Randomized, not treated|2
6086457|NCT00369382|21009712|P2|Overall Study|Withdrawal by Subject|0
6086458|NCT00369382|21009713|P1|Overall Study|Withdrawal by Subject|5
6086459|NCT00369382|21009712|P2|Overall Study|Physician Decision|1
6086460|NCT00369382|21009713|P1|Overall Study|Physician Decision|2
6086461|NCT00369382|21009712|P2|Overall Study|Death|2
6086462|NCT00369382|21009713|P1|Overall Study|Death|0
6086463|NCT00369343|21009746|P2|Open-label Phase|did not take study drug|2
6086464|NCT00369343|21009747|P1|Open-label Phase|did not take study drug|1
6086465|NCT00369343|21009746|P2|Open-label Phase|Lack of continuance tolerability|4
6086466|NCT00369343|21009747|P1|Open-label Phase|Lack of continuance tolerability|3
6086467|NCT00369343|21009746|P2|Open-label Phase|Lack of Efficacy|3
6086468|NCT00369343|21009747|P1|Open-label Phase|Lack of Efficacy|4
6086469|NCT00369343|21009746|P2|Open-label Phase|Withdrawal by Subject|6
6086470|NCT00369343|21009747|P1|Open-label Phase|Withdrawal by Subject|15
6086471|NCT00369343|21009746|P2|Open-label Phase|Protocol Violation|3
6086472|NCT00369343|21009747|P1|Open-label Phase|Protocol Violation|1
6086473|NCT00369343|21009746|P2|Open-label Phase|inadvertently reported study completers|2
6086474|NCT00369343|21009747|P1|Open-label Phase|inadvertently reported study completers|3
6086475|NCT00369343|21009746|P2|Open-label Phase|Lost to Follow-up|3
6086476|NCT00369343|21009747|P1|Open-label Phase|Lost to Follow-up|5
6086477|NCT00369343|21009746|P2|Open-label Phase|Physician Decision|0
6086478|NCT00369343|21009747|P1|Open-label Phase|Physician Decision|2
6086479|NCT00369343|21009746|P2|Open-label Phase|Failed to return|0
6086480|NCT00369343|21009747|P1|Open-label Phase|Failed to return|4
6086481|NCT00369343|21009746|P2|Open-label Phase|Adverse Event|7
6086482|NCT00369343|21009747|P1|Open-label Phase|Adverse Event|19
6086483|NCT00369343|21009746|P2|Double-blind Phase|Protocol deviation|0
6086484|NCT00369343|21009747|P1|Double-blind Phase|Protocol deviation|4
6086485|NCT00369343|21009746|P2|Double-blind Phase|Lack of Efficacy|4
6086486|NCT00369343|21009747|P1|Double-blind Phase|Lack of Efficacy|0
6086487|NCT00369343|21009746|P2|Double-blind Phase|Withdrawal by Subject|6
6086488|NCT00369343|21009747|P1|Double-blind Phase|Withdrawal by Subject|8
6086489|NCT00369343|21009746|P2|Double-blind Phase|Protocol Violation|0
6086490|NCT00369343|21009747|P1|Double-blind Phase|Protocol Violation|2
6086491|NCT00369343|21009746|P2|Double-blind Phase|Lost to Follow-up|2
6086492|NCT00369343|21009747|P1|Double-blind Phase|Lost to Follow-up|9
6086493|NCT00369343|21009746|P2|Double-blind Phase|Failed to return|0
6086494|NCT00369343|21009747|P1|Double-blind Phase|Failed to return|2
6086495|NCT00369343|21009746|P2|Double-blind Phase|Adverse Event|4
6086496|NCT00369343|21009747|P1|Double-blind Phase|Adverse Event|19
6086497|NCT00369317|21009780|P1|Overall Study|Ineligible|1
6086498|NCT00369317|21009780|P1|Overall Study|Withdrawal by Subject|8
6086499|NCT00369317|21009780|P1|Overall Study|Physician Decision|2
6086500|NCT00369317|21009780|P1|Overall Study|Lack of Efficacy|5
6086501|NCT00369317|21009780|P1|Overall Study|Death|1
6086502|NCT00369317|21009780|P1|Overall Study|Adverse Event|3
6086503|NCT00369278|21009796|P2|Overall Study|Graft loss|2
6086504|NCT00369278|21009797|P1|Overall Study|Graft loss|1
6086505|NCT00369278|21009796|P2|Overall Study|Lost to Follow-up|0
6086506|NCT00369278|21009797|P1|Overall Study|Lost to Follow-up|1
6086507|NCT00369278|21009796|P2|Overall Study|Withdrawal by Subject|2
6086508|NCT00369278|21009797|P1|Overall Study|Withdrawal by Subject|2
6086509|NCT00369278|21009796|P2|Overall Study|Protocol Violation|1
6086510|NCT00369278|21009797|P1|Overall Study|Protocol Violation|2
6086511|NCT00369278|21009796|P2|Overall Study|Unsatisfactory therapeutic effect|5
6086512|NCT00369278|21009797|P1|Overall Study|Unsatisfactory therapeutic effect|4
6086513|NCT00369278|21009796|P2|Overall Study|Adverse Event|11
6086514|NCT00369278|21009797|P1|Overall Study|Adverse Event|14
6086515|NCT00369265|21009813|P2|Overall Study|Study terminated|7
6086516|NCT00369265|21009814|P1|Overall Study|Study terminated|4
6086517|NCT00369161|21009835|P2|Overall Study|Administrative Problem|2
6086518|NCT00369161|21009836|P1|Overall Study|Administrative Problem|2
6086519|NCT00369161|21009835|P2|Overall Study|Graft loss|0
6086520|NCT00369161|21009836|P1|Overall Study|Graft loss|4
6086521|NCT00369161|21009835|P2|Overall Study|Death|2
6086522|NCT00369161|21009836|P1|Overall Study|Death|1
6086523|NCT00369161|21009835|P2|Overall Study|Withdrawal by Subject|3
6086524|NCT00369161|21009836|P1|Overall Study|Withdrawal by Subject|2
6086525|NCT00369161|21009835|P2|Overall Study|Protocol Violation|2
6086526|NCT00369161|21009836|P1|Overall Study|Protocol Violation|0
6086527|NCT00369161|21009835|P2|Overall Study|Lack of Efficacy|1
6086528|NCT00369161|21009836|P1|Overall Study|Lack of Efficacy|3
6086529|NCT00369161|21009835|P2|Overall Study|Abnormal laboratory value|1
6086530|NCT00369161|21009836|P1|Overall Study|Abnormal laboratory value|0
6086531|NCT00369161|21009835|P2|Overall Study|Adverse Event|13
6086532|NCT00369161|21009836|P1|Overall Study|Adverse Event|15
6086533|NCT00369122|21009846|P1|Overall Study|No protocol treatment|1
6086534|NCT00369122|21009846|P1|Overall Study|Ineligible|10
6086535|NCT00368992|21009853|P1|Overall Study|Other|9
6086536|NCT00368992|21009853|P1|Overall Study|Death|4
6086537|NCT00368992|21009853|P1|Overall Study|Adverse Event|26
6086538|NCT00368992|21009853|P1|Overall Study|Lack of Efficacy|63
6086539|NCT00368992|21009853|P1|Overall Study|Refused treatment|3
6086540|NCT00368992|21009853|P1|Overall Study|Ineligible|5
6086541|NCT00368979|21009862|P2|Overall Study|Withdrawal by Subject|9
6086542|NCT00368979|21009863|P1|Overall Study|Withdrawal by Subject|5
6086543|NCT00368979|21009862|P2|Overall Study|Protocol Violation|1
6086544|NCT00368979|21009863|P1|Overall Study|Protocol Violation|2
6086545|NCT00368979|21009862|P2|Overall Study|Lost to Follow-up|0
6086546|NCT00368979|21009863|P1|Overall Study|Lost to Follow-up|1
6086547|NCT00368979|21009862|P2|Overall Study|Other|1
6086548|NCT00368979|21009863|P1|Overall Study|Other|3
6086549|NCT00368979|21009862|P2|Overall Study|Lack of Efficacy|3
6086550|NCT00368979|21009863|P1|Overall Study|Lack of Efficacy|5
6086551|NCT00368979|21009862|P2|Overall Study|Adverse Event|16
6086552|NCT00368979|21009863|P1|Overall Study|Adverse Event|9
6086553|NCT00368966|21009879|P2|Toddler Dose|Lost to Follow-up|2
6086554|NCT00368966|21009880|P1|Toddler Dose|Lost to Follow-up|0
6086555|NCT00368966|21009879|P2|Toddler Dose|Withdrawal by Subject|1
6086556|NCT00368966|21009880|P1|Toddler Dose|Withdrawal by Subject|1
6086557|NCT00368966|21009879|P2|After Infant|Lost to Follow-up|1
6086558|NCT00368966|21009880|P1|After Infant|Lost to Follow-up|0
6086559|NCT00368966|21009879|P2|After Infant|Death|0
6086560|NCT00368966|21009880|P1|After Infant|Death|1
6086561|NCT00368966|21009879|P2|After Infant|Withdrawal by Subject|1
6086562|NCT00368966|21009880|P1|After Infant|Withdrawal by Subject|1
6086563|NCT00368966|21009879|P2|After Infant|Adverse Event|2
6086564|NCT00368966|21009880|P1|After Infant|Adverse Event|1
6086565|NCT00368966|21009879|P2|After Infant|Failed to return|1
6086566|NCT00368966|21009880|P1|After Infant|Failed to return|3
6086567|NCT00368966|21009879|P2|Infant Series|Failed to return|0
6086568|NCT00368966|21009880|P1|Infant Series|Failed to return|1
6086569|NCT00368966|21009879|P2|Infant Series|Adverse Event|1
6086570|NCT00368966|21009880|P1|Infant Series|Adverse Event|0
6086571|NCT00368966|21009879|P2|Infant Series|Failed to meet eligibility criteria|1
6086572|NCT00368966|21009880|P1|Infant Series|Failed to meet eligibility criteria|0
6086573|NCT00368966|21009879|P2|Infant Series|Randomization error|1
6086574|NCT00368966|21009880|P1|Infant Series|Randomization error|0
6086575|NCT00368966|21009879|P2|Infant Series|Lost to Follow-up|0
6086576|NCT00368966|21009880|P1|Infant Series|Lost to Follow-up|2
6086577|NCT00368966|21009879|P2|Infant Series|Protocol Violation|1
6086578|NCT00368966|21009880|P1|Infant Series|Protocol Violation|2
6086579|NCT00368966|21009879|P2|Infant Series|Withdrawal by Subject|6
6086580|NCT00368966|21009880|P1|Infant Series|Withdrawal by Subject|11
6086581|NCT00368927|21009951|P2|Overall Study|Physician Decision|0
6086582|NCT00368927|21009952|P1|Overall Study|Physician Decision|1
6086583|NCT00368927|21009951|P2|Overall Study|Withdrawal by Subject|2
6086584|NCT00368927|21009952|P1|Overall Study|Withdrawal by Subject|1
6086585|NCT00368927|21009951|P2|Overall Study|Adverse Event|1
6086586|NCT00368927|21009952|P1|Overall Study|Adverse Event|1
6086587|NCT00368927|21009951|P2|Overall Study|Lost to Follow-up|0
6086588|NCT00368927|21009952|P1|Overall Study|Lost to Follow-up|2
6086589|NCT00368875|21009960|P2|Overall Study|Alternative Therapy|1
6086590|NCT00368875|21009961|P1|Overall Study|Alternative Therapy|1
6086591|NCT00368875|21009960|P2|Overall Study|Other Reason|2
6086592|NCT00368875|21009961|P1|Overall Study|Other Reason|0
6086593|NCT00368875|21009960|P2|Overall Study|Withdrawal by Subject|6
6086594|NCT00368875|21009961|P1|Overall Study|Withdrawal by Subject|2
6086595|NCT00368875|21009960|P2|Overall Study|Progressive disease|27
6086596|NCT00368875|21009961|P1|Overall Study|Progressive disease|3
6086597|NCT00368875|21009960|P2|Overall Study|Adverse Event|12
6086598|NCT00368875|21009961|P1|Overall Study|Adverse Event|0
6086599|NCT00368849|21009969|P2|Overall Study|Physician Decision|1
6086600|NCT00368849|21009970|P1|Overall Study|Physician Decision|0
6086601|NCT00368849|21009969|P2|Overall Study|Withdrawal by Subject|1
6086602|NCT00368849|21009970|P1|Overall Study|Withdrawal by Subject|0
6086694|NCT00368108|21010195|P2|Overall Study|Adverse Event|26
6086613|NCT00368641|21010040|P2|Overall Study|Sponsor decision to terminate study|5
6086614|NCT00368641|21010041|P1|Overall Study|Sponsor decision to terminate study|2
6086615|NCT00368641|21010040|P2|Overall Study|Withdrawal by Subject|0
6086616|NCT00368641|21010041|P1|Overall Study|Withdrawal by Subject|1
6086617|NCT00368641|21010040|P2|Overall Study|Death|0
6086618|NCT00368641|21010041|P1|Overall Study|Death|1
6086619|NCT00368641|21010040|P2|Overall Study|Adverse Event|1
6086620|NCT00368641|21010041|P1|Overall Study|Adverse Event|2
6086621|NCT00368550|21010049|P2|Overall Study|Withdrawal by Subject|10
6086622|NCT00368550|21010050|P1|Overall Study|Withdrawal by Subject|17
6086623|NCT00368550|21010049|P2|Overall Study|Lack of Efficacy|9
6086624|NCT00368550|21010050|P1|Overall Study|Lack of Efficacy|4
6086625|NCT00368550|21010049|P2|Overall Study|Adverse Event|4
6086626|NCT00368550|21010050|P1|Overall Study|Adverse Event|7
6086627|NCT00368537|21010062|P2|Baseline Participants|Patient uncompliant|1
6086628|NCT00368537|21010063|P1|Baseline Participants|Patient uncompliant|0
6086629|NCT00368537|21010062|P2|Baseline Participants|No susceptibility|0
6086630|NCT00368537|21010063|P1|Baseline Participants|No susceptibility|1
6086631|NCT00368537|21010062|P2|Baseline Participants|Death|2
6086632|NCT00368537|21010063|P1|Baseline Participants|Death|1
6086633|NCT00368537|21010062|P2|Baseline Participants|Withdrawal by Subject|4
6086634|NCT00368537|21010063|P1|Baseline Participants|Withdrawal by Subject|6
6086635|NCT00368537|21010062|P2|Baseline Participants|Lost to Follow-up|17
6086636|NCT00368537|21010063|P1|Baseline Participants|Lost to Follow-up|16
6086637|NCT00368537|21010062|P2|Randomization|No study drug dosed|6
6086638|NCT00368537|21010063|P1|Randomization|No study drug dosed|13
6086639|NCT00368472|21010077|P1|Overall Study|Missing Final Disposition Date|1
6086640|NCT00368472|21010077|P1|Overall Study|Other|32
6086641|NCT00368472|21010077|P1|Overall Study|Diary non-compliance|1
6086642|NCT00368472|21010077|P1|Overall Study|Withdrawal by Subject|40
6086643|NCT00368472|21010077|P1|Overall Study|Request of Investigator or Sponsor|3
6086644|NCT00368472|21010077|P1|Overall Study|Protocol Violation|2
6086645|NCT00368472|21010077|P1|Overall Study|Medication non-compliance|4
6086646|NCT00368472|21010077|P1|Overall Study|Adverse Event|22
6086647|NCT00368355|21010112|P2|Overall Study|Treatment - hematopoietic cell product|0
6086648|NCT00368355|21010113|P1|Overall Study|Treatment - hematopoietic cell product|2
6086649|NCT00368355|21010112|P2|Overall Study|Subsequent transplant|3
6086650|NCT00368355|21010113|P1|Overall Study|Subsequent transplant|0
6086651|NCT00368355|21010112|P2|Overall Study|Relapse|10
6086652|NCT00368355|21010113|P1|Overall Study|Relapse|6
6086653|NCT00368355|21010112|P2|Overall Study|Death|4
6086654|NCT00368355|21010113|P1|Overall Study|Death|2
6086655|NCT00368355|21010112|P2|Overall Study|Adverse Event|0
6086656|NCT00368355|21010113|P1|Overall Study|Adverse Event|1
6086657|NCT00368277|21010153|P2|Overall Study|Lost to Follow-up|6
6086658|NCT00368277|21010154|P1|Overall Study|Lost to Follow-up|8
6086659|NCT00368277|21010153|P2|Overall Study|Patient withdrew consent|28
6086660|NCT00368277|21010154|P1|Overall Study|Patient withdrew consent|32
6086661|NCT00368277|21010153|P2|Overall Study|Protocol deviation|0
6086662|NCT00368277|21010154|P1|Overall Study|Protocol deviation|7
6086663|NCT00368277|21010153|P2|Overall Study|Unsatisfactory therapeutic effect|24
6086664|NCT00368277|21010154|P1|Overall Study|Unsatisfactory therapeutic effect|31
6086665|NCT00368277|21010153|P2|Overall Study|Death|1
6086666|NCT00368277|21010154|P1|Overall Study|Death|2
6086667|NCT00368277|21010153|P2|Overall Study|Adverse Event|49
6086668|NCT00368277|21010154|P1|Overall Study|Adverse Event|33
6086669|NCT00368251|21010169|P3|Overall Study|AE, non-serious non-fatal|1
6086670|NCT00368251|21010170|P2|Overall Study|AE, non-serious non-fatal|0
6086671|NCT00368251|21010171|P1|Overall Study|AE, non-serious non-fatal|0
6086672|NCT00368251|21010169|P3|Overall Study|SAE, non-fatal|0
6086673|NCT00368251|21010170|P2|Overall Study|SAE, non-fatal|0
6086674|NCT00368251|21010171|P1|Overall Study|SAE, non-fatal|1
6086675|NCT00368108|21010194|P3|Overall Study|Other|1
6086676|NCT00368108|21010195|P2|Overall Study|Other|7
6086677|NCT00368108|21010196|P1|Overall Study|Other|3
6086678|NCT00368108|21010194|P3|Overall Study|Physician Decision|1
6086679|NCT00368108|21010195|P2|Overall Study|Physician Decision|0
6086680|NCT00368108|21010196|P1|Overall Study|Physician Decision|2
6086681|NCT00368108|21010194|P3|Overall Study|Lack of Efficacy|5
6086682|NCT00368108|21010195|P2|Overall Study|Lack of Efficacy|8
6086683|NCT00368108|21010196|P1|Overall Study|Lack of Efficacy|7
6086684|NCT00368108|21010194|P3|Overall Study|Withdrawal by Subject|5
6086685|NCT00368108|21010195|P2|Overall Study|Withdrawal by Subject|3
6086686|NCT00368108|21010196|P1|Overall Study|Withdrawal by Subject|9
6086687|NCT00368108|21010194|P3|Overall Study|Protocol Violation|9
6086688|NCT00368108|21010195|P2|Overall Study|Protocol Violation|9
6086689|NCT00368108|21010196|P1|Overall Study|Protocol Violation|5
6086690|NCT00368108|21010194|P3|Overall Study|Abnormal Laboratory Value|3
6086691|NCT00368108|21010195|P2|Overall Study|Abnormal Laboratory Value|0
6086692|NCT00368108|21010196|P1|Overall Study|Abnormal Laboratory Value|0
6086693|NCT00368108|21010194|P3|Overall Study|Adverse Event|44
6086695|NCT00368108|21010196|P1|Overall Study|Adverse Event|38
6086696|NCT00368069|21010215|P2|Overall Study|no blood sampling possible|1
6086697|NCT00368069|21010216|P1|Overall Study|no blood sampling possible|0
6086698|NCT00368069|21010215|P2|Overall Study|Withdrawal of Consent|1
6086699|NCT00368069|21010216|P1|Overall Study|Withdrawal of Consent|2
6086700|NCT00368069|21010215|P2|Overall Study|Protocol Violation|2
6086701|NCT00368069|21010216|P1|Overall Study|Protocol Violation|0
6086702|NCT00368069|21010215|P2|Overall Study|Lost to Follow-up|0
6086703|NCT00368069|21010216|P1|Overall Study|Lost to Follow-up|1
6086704|NCT00368069|21010215|P2|Overall Study|Lack of Efficacy|1
6086705|NCT00368069|21010216|P1|Overall Study|Lack of Efficacy|0
6086706|NCT00368069|21010215|P2|Overall Study|Adverse Event|2
6086707|NCT00368069|21010216|P1|Overall Study|Adverse Event|5
6086708|NCT00367991|21010234|P2|Overall Study|Adverse Event|1
6086709|NCT00367991|21010235|P1|Overall Study|Adverse Event|1
6086710|NCT00367991|21010234|P2|Overall Study|Withdrawal by Subject|1
6086711|NCT00367991|21010235|P1|Overall Study|Withdrawal by Subject|1
6086712|NCT00367835|21010253|P2|Overall Study|History of lead poisoning|1
6086713|NCT00367835|21010254|P1|Overall Study|History of lead poisoning|0
6086714|NCT00367835|21010253|P2|Overall Study|Did not respond to calls|0
6086715|NCT00367835|21010254|P1|Overall Study|Did not respond to calls|1
6086716|NCT00367835|21010253|P2|Overall Study|refused blood collection|0
6086717|NCT00367835|21010254|P1|Overall Study|refused blood collection|1
6086718|NCT00367835|21010253|P2|Overall Study|Subject in juvenile detention center|0
6086719|NCT00367835|21010254|P1|Overall Study|Subject in juvenile detention center|1
6086720|NCT00367835|21010253|P2|Overall Study|Lack of Efficacy|12
6086721|NCT00367835|21010254|P1|Overall Study|Lack of Efficacy|3
6086722|NCT00367835|21010253|P2|Overall Study|Lost to Follow-up|4
6086723|NCT00367835|21010254|P1|Overall Study|Lost to Follow-up|1
6086724|NCT00367835|21010253|P2|Overall Study|Withdrawal by Subject|6
6086725|NCT00367835|21010254|P1|Overall Study|Withdrawal by Subject|7
6086726|NCT00367835|21010253|P2|Overall Study|Protocol Violation|7
6086727|NCT00367835|21010254|P1|Overall Study|Protocol Violation|1
6086728|NCT00367835|21010253|P2|Overall Study|Adverse Event|1
6086729|NCT00367835|21010254|P1|Overall Study|Adverse Event|14
6086730|NCT00367770|21010280|P1|Overall Study|Withdrawal by Subject|1
6086731|NCT00367770|21010280|P1|Overall Study|Adverse Event|1
6086732|NCT00367744|21010288|P2|Overall Study|Lost to Follow-up|5
6086733|NCT00367744|21010289|P1|Overall Study|Lost to Follow-up|4
6086734|NCT00367640|21010318|P4|Overall Study|Any other reason not above-mentioned|4
6086735|NCT00367640|21010319|P3|Overall Study|Any other reason not above-mentioned|3
6086736|NCT00367640|21010320|P2|Overall Study|Any other reason not above-mentioned|5
6086737|NCT00367640|21010321|P1|Overall Study|Any other reason not above-mentioned|7
6086738|NCT00367640|21010318|P4|Overall Study|Withdrawal by Subject|6
6086739|NCT00367640|21010319|P3|Overall Study|Withdrawal by Subject|8
6086740|NCT00367640|21010320|P2|Overall Study|Withdrawal by Subject|11
6086741|NCT00367640|21010321|P1|Overall Study|Withdrawal by Subject|8
6086742|NCT00367640|21010318|P4|Overall Study|Adverse Event|0
6086743|NCT00367640|21010319|P3|Overall Study|Adverse Event|8
6086744|NCT00367640|21010320|P2|Overall Study|Adverse Event|6
6086745|NCT00367640|21010321|P1|Overall Study|Adverse Event|3
6086746|NCT00367484|21010337|P1|Overall Study|Lack of Efficacy|1
6086747|NCT00367484|21010337|P1|Overall Study|The choice of the patient|1
6086748|NCT00367484|21010337|P1|Overall Study|Protocol Violation|1
6086749|NCT00367484|21010337|P1|Overall Study|Lost to Follow-up|1
6086750|NCT00367484|21010337|P1|Overall Study|Travel to USA|1
6086751|NCT00367484|21010337|P1|Overall Study|Withdrew informed consent|5
6086752|NCT00367484|21010337|P1|Overall Study|Adverse Event|7
6086753|NCT00367458|21010343|P2|First Intervention - 8 Weeks|Adverse Event|0
6086754|NCT00367458|21010344|P1|First Intervention - 8 Weeks|Adverse Event|2
6086755|NCT00367432|21010358|P2|Second Period (up to 54 Months)|Other Reason|2
6086756|NCT00367432|21010359|P1|Second Period (up to 54 Months)|Other Reason|6
6086757|NCT00367432|21010358|P2|Second Period (up to 54 Months)|Withdrawal by Subject|5
6086758|NCT00367432|21010359|P1|Second Period (up to 54 Months)|Withdrawal by Subject|8
6086759|NCT00367432|21010358|P2|Second Period (up to 54 Months)|Lost to Follow-up|1
6086760|NCT00367432|21010359|P1|Second Period (up to 54 Months)|Lost to Follow-up|0
6086761|NCT00367432|21010358|P2|Second Period (up to 54 Months)|Lack of Efficacy|5
6086762|NCT00367432|21010359|P1|Second Period (up to 54 Months)|Lack of Efficacy|59
6086763|NCT00367432|21010358|P2|Second Period (up to 54 Months)|Adverse Event|3
6086764|NCT00367432|21010359|P1|Second Period (up to 54 Months)|Adverse Event|14
6086765|NCT00367432|21010358|P2|First Period (16 Weeks)|Other Reason|0
6086766|NCT00367432|21010359|P1|First Period (16 Weeks)|Other Reason|2
6086767|NCT00367432|21010358|P2|First Period (16 Weeks)|Withdrawal by Subject|0
6086768|NCT00367432|21010359|P1|First Period (16 Weeks)|Withdrawal by Subject|6
6086769|NCT00367432|21010358|P2|First Period (16 Weeks)|Lack of Efficacy|0
6086770|NCT00367432|21010359|P1|First Period (16 Weeks)|Lack of Efficacy|24
6086771|NCT00367432|21010358|P2|First Period (16 Weeks)|Adverse Event|0
6086772|NCT00367432|21010359|P1|First Period (16 Weeks)|Adverse Event|6
6086773|NCT00367341|21010386|P2|Overall Study|Protocol Violation|0
6086774|NCT00367341|21010387|P1|Overall Study|Protocol Violation|1
6086775|NCT00367341|21010386|P2|Overall Study|Physician Decision|0
6086776|NCT00367341|21010387|P1|Overall Study|Physician Decision|1
6086777|NCT00367237|21010397|P2|Overall Study|Protocol Violation|5
6086778|NCT00367237|21010398|P1|Overall Study|Protocol Violation|2
6086779|NCT00367237|21010397|P2|Overall Study|Withdrawal by Subject|4
6086780|NCT00367237|21010398|P1|Overall Study|Withdrawal by Subject|0
6086781|NCT00367237|21010397|P2|Overall Study|Lost to Follow-up|0
6086782|NCT00367237|21010398|P1|Overall Study|Lost to Follow-up|1
6086783|NCT00367237|21010397|P2|Overall Study|Adverse Event|2
6086784|NCT00367237|21010398|P1|Overall Study|Adverse Event|7
6086785|NCT00367133|21010407|P3|2 Years|Missed visit|4
6086786|NCT00367133|21010408|P2|2 Years|Missed visit|5
6086787|NCT00367133|21010409|P1|2 Years|Missed visit|4
6086788|NCT00367133|21010407|P3|2 Years|Dropped|33
6086789|NCT00367133|21010408|P2|2 Years|Dropped|19
6086790|NCT00367133|21010409|P1|2 Years|Dropped|34
6086791|NCT00367133|21010407|P3|2 Years|Death|12
6086792|NCT00367133|21010408|P2|2 Years|Death|12
6086793|NCT00367133|21010409|P1|2 Years|Death|20
6086794|NCT00367055|21010461|P2|Overall Study|Participant Living too Far from Hospital|1
6086795|NCT00367055|21010462|P1|Overall Study|Participant Living too Far from Hospital|0
6086796|NCT00367055|21010461|P2|Overall Study|Stopping Criterion Met|1
6086797|NCT00367055|21010462|P1|Overall Study|Stopping Criterion Met|0
6086798|NCT00367055|21010461|P2|Overall Study|Protocol Violation|1
6086799|NCT00367055|21010462|P1|Overall Study|Protocol Violation|0
6086800|NCT00367055|21010461|P2|Overall Study|Lost to Follow-up|1
6086801|NCT00367055|21010462|P1|Overall Study|Lost to Follow-up|1
6086802|NCT00367055|21010461|P2|Overall Study|Lack of Efficacy|2
6086803|NCT00367055|21010462|P1|Overall Study|Lack of Efficacy|1
6086804|NCT00367055|21010461|P2|Overall Study|Patient's Willing|2
6086805|NCT00367055|21010462|P1|Overall Study|Patient's Willing|3
6086806|NCT00367055|21010461|P2|Overall Study|Adverse Event|3
6086807|NCT00367055|21010462|P1|Overall Study|Adverse Event|6
6086808|NCT00366899|21010482|P2|Toddler Dose|Protocol Violation|0
6086809|NCT00366899|21010483|P1|Toddler Dose|Protocol Violation|1
6086810|NCT00366899|21010482|P2|Toddler Dose|Withdrawal by Subject|1
6086811|NCT00366899|21010483|P1|Toddler Dose|Withdrawal by Subject|1
6086812|NCT00366899|21010482|P2|After Infant Series|Protocol Violation|0
6086813|NCT00366899|21010483|P1|After Infant Series|Protocol Violation|1
6086814|NCT00366899|21010482|P2|After Infant Series|Adverse Event|2
6086815|NCT00366899|21010483|P1|After Infant Series|Adverse Event|1
6086816|NCT00366899|21010482|P2|After Infant Series|Withdrawal by Subject|4
6086817|NCT00366899|21010483|P1|After Infant Series|Withdrawal by Subject|1
6086818|NCT00366899|21010482|P2|After Infant Series|Lost to Follow-up|3
6086819|NCT00366899|21010483|P1|After Infant Series|Lost to Follow-up|4
6086820|NCT00366899|21010482|P2|Infant Series|Randomized but not consented|0
6086821|NCT00366899|21010483|P1|Infant Series|Randomized but not consented|1
6086822|NCT00366899|21010482|P2|Infant Series|Physician Decision|0
6086823|NCT00366899|21010483|P1|Infant Series|Physician Decision|1
6086824|NCT00366899|21010482|P2|Infant Series|Adverse Event|1
6086825|NCT00366899|21010483|P1|Infant Series|Adverse Event|0
6086826|NCT00366899|21010482|P2|Infant Series|Lost to Follow-up|2
6086827|NCT00366899|21010483|P1|Infant Series|Lost to Follow-up|0
6086828|NCT00366899|21010482|P2|Infant Series|Failed to return|1
6086829|NCT00366899|21010483|P1|Infant Series|Failed to return|1
6086830|NCT00366899|21010482|P2|Infant Series|Protocol Violation|1
6086831|NCT00366899|21010483|P1|Infant Series|Protocol Violation|2
6086832|NCT00366899|21010482|P2|Infant Series|Withdrawal by Subject|7
6086833|NCT00366899|21010483|P1|Infant Series|Withdrawal by Subject|4
6086834|NCT00366678|21010543|P3|Toddler Dose|protocol deviation|0
6086835|NCT00366678|21010544|P2|Toddler Dose|protocol deviation|0
6086836|NCT00366678|21010545|P1|Toddler Dose|protocol deviation|1
6086837|NCT00366678|21010543|P3|Toddler Dose|Withdrawal by Subject|0
6086838|NCT00366678|21010544|P2|Toddler Dose|Withdrawal by Subject|0
6086839|NCT00366678|21010545|P1|Toddler Dose|Withdrawal by Subject|1
6086840|NCT00366678|21010543|P3|Toddler Dose|Failed to return|0
6086841|NCT00366678|21010544|P2|Toddler Dose|Failed to return|0
6086842|NCT00366678|21010545|P1|Toddler Dose|Failed to return|1
6086843|NCT00366678|21010543|P3|Toddler Dose|Protocol Violation|0
6086844|NCT00366678|21010544|P2|Toddler Dose|Protocol Violation|1
6086845|NCT00366678|21010545|P1|Toddler Dose|Protocol Violation|2
6086846|NCT00366678|21010543|P3|After Infant|Protocol Violation|0
6086847|NCT00366678|21010544|P2|After Infant|Protocol Violation|0
6086848|NCT00366678|21010545|P1|After Infant|Protocol Violation|1
6086849|NCT00366678|21010543|P3|After Infant|Adverse Event|0
6086850|NCT00366678|21010544|P2|After Infant|Adverse Event|0
6086851|NCT00366678|21010545|P1|After Infant|Adverse Event|1
6086852|NCT00366678|21010543|P3|After Infant|Failed to return|0
6086853|NCT00366678|21010544|P2|After Infant|Failed to return|5
6086854|NCT00366678|21010545|P1|After Infant|Failed to return|5
6086855|NCT00366678|21010543|P3|After Infant|Lost to Follow-up|0
6086856|NCT00366678|21010544|P2|After Infant|Lost to Follow-up|1
6086857|NCT00366678|21010545|P1|After Infant|Lost to Follow-up|2
6086858|NCT00366678|21010543|P3|After Infant|Withdrawal by Subject|0
6086859|NCT00366678|21010544|P2|After Infant|Withdrawal by Subject|4
6086860|NCT00366678|21010545|P1|After Infant|Withdrawal by Subject|8
6086861|NCT00366678|21010543|P3|Infant Series|Adverse Event|0
6086862|NCT00366678|21010544|P2|Infant Series|Adverse Event|0
6086863|NCT00366678|21010545|P1|Infant Series|Adverse Event|1
6086864|NCT00366678|21010543|P3|Infant Series|Failed to return|0
6086865|NCT00366678|21010544|P2|Infant Series|Failed to return|1
6086866|NCT00366678|21010545|P1|Infant Series|Failed to return|1
6086867|NCT00366678|21010543|P3|Infant Series|Protocol Violation|0
6086868|NCT00366678|21010544|P2|Infant Series|Protocol Violation|3
6086869|NCT00366678|21010545|P1|Infant Series|Protocol Violation|4
6086870|NCT00366678|21010543|P3|Infant Series|Withdrawal by Subject|0
6086871|NCT00366678|21010544|P2|Infant Series|Withdrawal by Subject|6
6086872|NCT00366678|21010545|P1|Infant Series|Withdrawal by Subject|8
6086873|NCT00366548|21010627|P2|After Infant Series|Lost to Follow-up|0
6086874|NCT00366548|21010628|P1|After Infant Series|Lost to Follow-up|1
6086875|NCT00366548|21010627|P2|After Infant Series|Adverse Event|0
6086876|NCT00366548|21010628|P1|After Infant Series|Adverse Event|2
6086877|NCT00366548|21010627|P2|After Infant Series|Withdrawal by Subject|1
6086878|NCT00366548|21010628|P1|After Infant Series|Withdrawal by Subject|3
6086879|NCT00366548|21010627|P2|Infant Series|Withdrawal by Subject|1
6086880|NCT00366548|21010628|P1|Infant Series|Withdrawal by Subject|3
6086881|NCT00366548|21010627|P2|Infant Series|Protocol Violation|1
6086882|NCT00366548|21010628|P1|Infant Series|Protocol Violation|0
6086883|NCT00366548|21010627|P2|Infant Series|Adverse Event|3
6086884|NCT00366548|21010628|P1|Infant Series|Adverse Event|1
6086885|NCT00366535|21010664|P2|Second Phase: 12 Weeks|Withdrawal by Subject|2
6086886|NCT00366535|21010665|P1|Second Phase: 12 Weeks|Withdrawal by Subject|2
6086887|NCT00366535|21010664|P2|Second Phase: 12 Weeks|Adverse Event|1
6086888|NCT00366535|21010665|P1|Second Phase: 12 Weeks|Adverse Event|1
6086889|NCT00366535|21010664|P2|First Phase: 12 Weeks|Withdrawal by Subject|5
6086890|NCT00366535|21010665|P1|First Phase: 12 Weeks|Withdrawal by Subject|2
6086891|NCT00366535|21010664|P2|First Phase: 12 Weeks|Adverse Event|3
6086892|NCT00366535|21010665|P1|First Phase: 12 Weeks|Adverse Event|1
6086893|NCT00366457|21010679|P1|Overall Study|never began study therapy|2
6086894|NCT00366444|21010688|P2|Overall Study|Lack of Efficacy|1
6086895|NCT00366444|21010689|P1|Overall Study|Lack of Efficacy|0
6086896|NCT00366444|21010688|P2|Overall Study|Withdrawal by Subject|1
6086897|NCT00366444|21010689|P1|Overall Study|Withdrawal by Subject|1
6086898|NCT00366340|21010717|P2|Toddler Dose|Parent/legal guardian request|1
6086899|NCT00366340|21010718|P1|Toddler Dose|Parent/legal guardian request|0
6086900|NCT00366340|21010717|P2|Toddler Dose|Failed to return|0
6086901|NCT00366340|21010718|P1|Toddler Dose|Failed to return|1
6086902|NCT00366340|21010717|P2|After the Infant Series|Lost to Follow-up|1
6086903|NCT00366340|21010718|P1|After the Infant Series|Lost to Follow-up|0
6086904|NCT00366340|21010717|P2|After the Infant Series|Adverse Event|1
6086905|NCT00366340|21010718|P1|After the Infant Series|Adverse Event|0
6086906|NCT00366340|21010717|P2|After the Infant Series|Protocol Violation|2
6086907|NCT00366340|21010718|P1|After the Infant Series|Protocol Violation|2
6086908|NCT00366340|21010717|P2|After the Infant Series|Failed to return|1
6086909|NCT00366340|21010718|P1|After the Infant Series|Failed to return|0
6086910|NCT00366340|21010717|P2|After the Infant Series|Parent/legal guardian request|1
6086911|NCT00366340|21010718|P1|After the Infant Series|Parent/legal guardian request|1
6086912|NCT00366340|21010717|P2|Infant Series|Failure to return|0
6086913|NCT00366340|21010718|P1|Infant Series|Failure to return|1
6086914|NCT00366340|21010717|P2|Infant Series|Lost to Follow-up|1
6086915|NCT00366340|21010718|P1|Infant Series|Lost to Follow-up|1
6086916|NCT00366340|21010717|P2|Infant Series|Adverse Event|2
6086917|NCT00366340|21010718|P1|Infant Series|Adverse Event|0
6086918|NCT00366340|21010717|P2|Infant Series|Withdrawal by Subject|3
6086919|NCT00366340|21010718|P1|Infant Series|Withdrawal by Subject|3
6086920|NCT00366340|21010717|P2|Infant Series|Protocol Violation|4
6086921|NCT00366340|21010718|P1|Infant Series|Protocol Violation|3
6086922|NCT00366301|21010776|P4|Overall Study|Withdrawal by Subject|1
6086923|NCT00366301|21010777|P3|Overall Study|Withdrawal by Subject|1
6086924|NCT00366301|21010778|P2|Overall Study|Withdrawal by Subject|2
6086925|NCT00366301|21010779|P1|Overall Study|Withdrawal by Subject|4
6086926|NCT00366301|21010776|P4|Overall Study|Lost to Follow-up|7
6086927|NCT00366301|21010777|P3|Overall Study|Lost to Follow-up|3
6086928|NCT00366301|21010778|P2|Overall Study|Lost to Follow-up|4
6086929|NCT00366301|21010779|P1|Overall Study|Lost to Follow-up|4
6086930|NCT00366249|21010795|P2|Overall Study|Most due to osteomylitis status|20
6086931|NCT00366249|21010796|P1|Overall Study|Most due to osteomylitis status|31
6086932|NCT00366249|21010795|P2|Overall Study|Lack of Efficacy|21
6086933|NCT00366249|21010796|P1|Overall Study|Lack of Efficacy|21
6086934|NCT00366249|21010795|P2|Overall Study|Withdrawal by Subject|4
6086935|NCT00366249|21010796|P1|Overall Study|Withdrawal by Subject|18
6086936|NCT00366249|21010795|P2|Overall Study|Protocol Violation|2
6086937|NCT00366249|21010796|P1|Overall Study|Protocol Violation|1
6086938|NCT00366249|21010795|P2|Overall Study|Lost to Follow-up|0
6086939|NCT00366249|21010796|P1|Overall Study|Lost to Follow-up|2
6086940|NCT00366249|21010795|P2|Overall Study|Physician Decision|2
6086941|NCT00366249|21010796|P1|Overall Study|Physician Decision|5
6086942|NCT00366249|21010795|P2|Overall Study|Death|1
6086943|NCT00366249|21010796|P1|Overall Study|Death|0
6086944|NCT00366249|21010795|P2|Overall Study|Adverse Event|28
6086945|NCT00366249|21010796|P1|Overall Study|Adverse Event|53
6086946|NCT00365989|21010828|P1|Overall Study|Non-compliance|1
6086947|NCT00365989|21010828|P1|Overall Study|Withdrawal by Subject|1
6086948|NCT00365976|21010836|P2|Overall Study|Withdrawal by Subject|5
6086949|NCT00365976|21010837|P1|Overall Study|Withdrawal by Subject|1
6086950|NCT00365846|21010975|P1|Overall Study|Lost to Follow-up|1
6086951|NCT00365794|21010984|P1|Overall Study|Withdrawal by Subject|2
6086952|NCT00365716|21011013|P7|Extension 2|Withdrawal by Subject|5
6086953|NCT00365716|21011014|P6|Extension 2|Withdrawal by Subject|0
6086954|NCT00365716|21011015|P5|Extension 2|Withdrawal by Subject|0
6086955|NCT00365716|21011016|P4|Extension 2|Withdrawal by Subject|0
6086956|NCT00365716|21011017|P3|Extension 2|Withdrawal by Subject|0
6086957|NCT00365716|21011018|P2|Extension 2|Withdrawal by Subject|0
6086958|NCT00365716|21011019|P1|Extension 2|Withdrawal by Subject|0
6086959|NCT00365716|21011013|P7|Extension 2|Other|3
6086960|NCT00365716|21011014|P6|Extension 2|Other|0
6086961|NCT00365716|21011015|P5|Extension 2|Other|0
6086962|NCT00365716|21011016|P4|Extension 2|Other|0
6086963|NCT00365716|21011017|P3|Extension 2|Other|0
6086964|NCT00365716|21011018|P2|Extension 2|Other|0
6086965|NCT00365716|21011019|P1|Extension 2|Other|0
6086966|NCT00365716|21011013|P7|Extension 2|Lost to Follow-up|2
6086967|NCT00365716|21011014|P6|Extension 2|Lost to Follow-up|0
6086968|NCT00365716|21011015|P5|Extension 2|Lost to Follow-up|0
6086969|NCT00365716|21011016|P4|Extension 2|Lost to Follow-up|0
6086970|NCT00365716|21011017|P3|Extension 2|Lost to Follow-up|0
6086971|NCT00365716|21011018|P2|Extension 2|Lost to Follow-up|0
6086972|NCT00365716|21011019|P1|Extension 2|Lost to Follow-up|0
6086973|NCT00365716|21011013|P7|Extension 1|Protocol Violation|0
6086974|NCT00365716|21011014|P6|Extension 1|Protocol Violation|1
6086975|NCT00365716|21011015|P5|Extension 1|Protocol Violation|0
6086976|NCT00365716|21011016|P4|Extension 1|Protocol Violation|0
6086977|NCT00365716|21011017|P3|Extension 1|Protocol Violation|0
6086978|NCT00365716|21011018|P2|Extension 1|Protocol Violation|0
6086979|NCT00365716|21011019|P1|Extension 1|Protocol Violation|0
6086980|NCT00365716|21011013|P7|Extension 1|Pregnancy|0
6086981|NCT00365716|21011014|P6|Extension 1|Pregnancy|4
6086982|NCT00365716|21011015|P5|Extension 1|Pregnancy|0
6086983|NCT00365716|21011016|P4|Extension 1|Pregnancy|0
6086984|NCT00365716|21011017|P3|Extension 1|Pregnancy|0
6086985|NCT00365716|21011018|P2|Extension 1|Pregnancy|0
6086986|NCT00365716|21011019|P1|Extension 1|Pregnancy|0
6086987|NCT00365716|21011013|P7|Extension 1|Withdrawal by Subject|0
6086988|NCT00365716|21011014|P6|Extension 1|Withdrawal by Subject|3
6086989|NCT00365716|21011015|P5|Extension 1|Withdrawal by Subject|0
6086990|NCT00365716|21011016|P4|Extension 1|Withdrawal by Subject|0
6086991|NCT00365716|21011017|P3|Extension 1|Withdrawal by Subject|0
6086992|NCT00365716|21011018|P2|Extension 1|Withdrawal by Subject|0
6086993|NCT00365716|21011019|P1|Extension 1|Withdrawal by Subject|0
6086994|NCT00365716|21011013|P7|Extension 1|Moved|0
6086995|NCT00365716|21011014|P6|Extension 1|Moved|4
6086996|NCT00365716|21011015|P5|Extension 1|Moved|0
6086997|NCT00365716|21011016|P4|Extension 1|Moved|0
6086998|NCT00365716|21011017|P3|Extension 1|Moved|0
6086999|NCT00365716|21011018|P2|Extension 1|Moved|0
6087000|NCT00365716|21011019|P1|Extension 1|Moved|0
6087001|NCT00365716|21011013|P7|Extension 1|Other|0
6087002|NCT00365716|21011014|P6|Extension 1|Other|9
6087003|NCT00365716|21011015|P5|Extension 1|Other|0
6087004|NCT00365716|21011016|P4|Extension 1|Other|0
6087005|NCT00365716|21011017|P3|Extension 1|Other|0
6087006|NCT00365716|21011018|P2|Extension 1|Other|0
6087007|NCT00365716|21011019|P1|Extension 1|Other|0
6087008|NCT00365716|21011013|P7|Extension 1|Lost to Follow-up|0
6087009|NCT00365716|21011014|P6|Extension 1|Lost to Follow-up|1
6087010|NCT00365716|21011015|P5|Extension 1|Lost to Follow-up|0
6087011|NCT00365716|21011016|P4|Extension 1|Lost to Follow-up|0
6087012|NCT00365716|21011017|P3|Extension 1|Lost to Follow-up|0
6087013|NCT00365716|21011018|P2|Extension 1|Lost to Follow-up|0
6087014|NCT00365716|21011019|P1|Extension 1|Lost to Follow-up|0
6087015|NCT00365716|21011013|P7|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0
6087016|NCT00365716|21011014|P6|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0
6087017|NCT00365716|21011015|P5|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|3
6087018|NCT00365716|21011016|P4|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4
6087019|NCT00365716|21011017|P3|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|13
6087020|NCT00365716|21011018|P2|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4
6087021|NCT00365716|21011019|P1|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|7
6087022|NCT00365716|21011013|P7|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0
6087023|NCT00365716|21011014|P6|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0
6087024|NCT00365716|21011015|P5|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0
6087025|NCT00365716|21011016|P4|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0
6087026|NCT00365716|21011017|P3|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1
6087027|NCT00365716|21011018|P2|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1
6087028|NCT00365716|21011019|P1|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0
6087029|NCT00365716|21011013|P7|Long Term Follow-up (Month 7 toMonth 36)|Other|0
6087030|NCT00365716|21011014|P6|Long Term Follow-up (Month 7 toMonth 36)|Other|0
6087031|NCT00365716|21011015|P5|Long Term Follow-up (Month 7 toMonth 36)|Other|1
6087032|NCT00365716|21011016|P4|Long Term Follow-up (Month 7 toMonth 36)|Other|0
6087033|NCT00365716|21011017|P3|Long Term Follow-up (Month 7 toMonth 36)|Other|0
6087034|NCT00365716|21011018|P2|Long Term Follow-up (Month 7 toMonth 36)|Other|0
6087035|NCT00365716|21011019|P1|Long Term Follow-up (Month 7 toMonth 36)|Other|2
6087036|NCT00365716|21011013|P7|Long Term Follow-up (Month 7 toMonth 36)|Moved|0
6087037|NCT00365716|21011014|P6|Long Term Follow-up (Month 7 toMonth 36)|Moved|0
6087038|NCT00365716|21011015|P5|Long Term Follow-up (Month 7 toMonth 36)|Moved|0
6087039|NCT00365716|21011016|P4|Long Term Follow-up (Month 7 toMonth 36)|Moved|2
6087040|NCT00365716|21011017|P3|Long Term Follow-up (Month 7 toMonth 36)|Moved|1
6087041|NCT00365716|21011018|P2|Long Term Follow-up (Month 7 toMonth 36)|Moved|2
6087042|NCT00365716|21011019|P1|Long Term Follow-up (Month 7 toMonth 36)|Moved|3
6087043|NCT00365716|21011013|P7|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0
6087044|NCT00365716|21011014|P6|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0
6087045|NCT00365716|21011015|P5|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|3
6087046|NCT00365716|21011016|P4|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|4
6087047|NCT00365716|21011017|P3|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|5
6087048|NCT00365716|21011018|P2|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|8
6087049|NCT00365716|21011019|P1|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|6
6087050|NCT00365716|21011013|P7|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0
6087051|NCT00365716|21011014|P6|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0
6087052|NCT00365716|21011015|P5|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|75
6087053|NCT00365716|21011016|P4|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|69
6087054|NCT00365716|21011017|P3|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0
6087055|NCT00365716|21011018|P2|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0
6087056|NCT00365716|21011019|P1|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|114
6087057|NCT00365716|21011013|P7|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0
6087058|NCT00365716|21011014|P6|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0
6087059|NCT00365716|21011015|P5|Base Study (Day 1 to Month 7)|Withdrawal by Subject|3
6087060|NCT00365716|21011016|P4|Base Study (Day 1 to Month 7)|Withdrawal by Subject|4
6087061|NCT00365716|21011017|P3|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12
6087062|NCT00365716|21011018|P2|Base Study (Day 1 to Month 7)|Withdrawal by Subject|9
6087063|NCT00365716|21011019|P1|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12
6087064|NCT00365716|21011013|P7|Base Study (Day 1 to Month 7)|Protocol Violation|0
6087065|NCT00365716|21011014|P6|Base Study (Day 1 to Month 7)|Protocol Violation|0
6087066|NCT00365716|21011015|P5|Base Study (Day 1 to Month 7)|Protocol Violation|2
6087067|NCT00365716|21011016|P4|Base Study (Day 1 to Month 7)|Protocol Violation|1
6087068|NCT00365716|21011017|P3|Base Study (Day 1 to Month 7)|Protocol Violation|0
6087069|NCT00365716|21011018|P2|Base Study (Day 1 to Month 7)|Protocol Violation|2
6087070|NCT00365716|21011019|P1|Base Study (Day 1 to Month 7)|Protocol Violation|1
6087071|NCT00365716|21011013|P7|Base Study (Day 1 to Month 7)|Pregnancy|0
6087072|NCT00365716|21011014|P6|Base Study (Day 1 to Month 7)|Pregnancy|0
6087073|NCT00365716|21011015|P5|Base Study (Day 1 to Month 7)|Pregnancy|1
6087074|NCT00365716|21011016|P4|Base Study (Day 1 to Month 7)|Pregnancy|1
6087075|NCT00365716|21011017|P3|Base Study (Day 1 to Month 7)|Pregnancy|3
6087076|NCT00365716|21011018|P2|Base Study (Day 1 to Month 7)|Pregnancy|2
6087077|NCT00365716|21011019|P1|Base Study (Day 1 to Month 7)|Pregnancy|3
6087078|NCT00365716|21011013|P7|Base Study (Day 1 to Month 7)|Other|0
6087079|NCT00365716|21011014|P6|Base Study (Day 1 to Month 7)|Other|0
6087080|NCT00365716|21011015|P5|Base Study (Day 1 to Month 7)|Other|0
6087081|NCT00365716|21011016|P4|Base Study (Day 1 to Month 7)|Other|0
6087082|NCT00365716|21011017|P3|Base Study (Day 1 to Month 7)|Other|0
6087083|NCT00365716|21011018|P2|Base Study (Day 1 to Month 7)|Other|1
6087084|NCT00365716|21011019|P1|Base Study (Day 1 to Month 7)|Other|0
6087085|NCT00365716|21011013|P7|Base Study (Day 1 to Month 7)|Lost to Follow-up|0
6087086|NCT00365716|21011014|P6|Base Study (Day 1 to Month 7)|Lost to Follow-up|0
6087087|NCT00365716|21011015|P5|Base Study (Day 1 to Month 7)|Lost to Follow-up|0
6087088|NCT00365716|21011016|P4|Base Study (Day 1 to Month 7)|Lost to Follow-up|4
6087089|NCT00365716|21011017|P3|Base Study (Day 1 to Month 7)|Lost to Follow-up|6
6087090|NCT00365716|21011018|P2|Base Study (Day 1 to Month 7)|Lost to Follow-up|6
6087091|NCT00365716|21011019|P1|Base Study (Day 1 to Month 7)|Lost to Follow-up|4
6087092|NCT00365716|21011013|P7|Base Study (Day 1 to Month 7)|Adverse Event|0
6087093|NCT00365716|21011014|P6|Base Study (Day 1 to Month 7)|Adverse Event|0
6087094|NCT00365716|21011015|P5|Base Study (Day 1 to Month 7)|Adverse Event|1
6087095|NCT00365716|21011016|P4|Base Study (Day 1 to Month 7)|Adverse Event|0
6087096|NCT00365716|21011017|P3|Base Study (Day 1 to Month 7)|Adverse Event|0
6087097|NCT00365716|21011018|P2|Base Study (Day 1 to Month 7)|Adverse Event|2
6087098|NCT00365716|21011019|P1|Base Study (Day 1 to Month 7)|Adverse Event|0
6087099|NCT00365716|21011013|P7|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0
6087100|NCT00365716|21011014|P6|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0
6087101|NCT00365716|21011015|P5|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0
6087102|NCT00365716|21011016|P4|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0
6087103|NCT00365716|21011017|P3|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0
6087104|NCT00365716|21011018|P2|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|2
6087105|NCT00365716|21011019|P1|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|1
6087106|NCT00365547|21011040|P1|Overall Study|Withdrawal by Subject|1
6087107|NCT00365547|21011040|P1|Overall Study|Screen failure|1
6087108|NCT00365547|21011040|P1|Overall Study|Insurance did not cover Avastin|1
6087109|NCT00365508|21011050|P2|Overall Study|Lost to Follow-up|154
6087110|NCT00365508|21011051|P1|Overall Study|Lost to Follow-up|139
6087111|NCT00365456|21011059|P2|Trial Period III (12 Months)|Other|1
6087112|NCT00365456|21011060|P1|Trial Period III (12 Months)|Other|1
6087113|NCT00365456|21011059|P2|Trial Period III (12 Months)|Withdrawal by Subject|1
6087114|NCT00365456|21011060|P1|Trial Period III (12 Months)|Withdrawal by Subject|4
6087115|NCT00365456|21011059|P2|Trial Period III (12 Months)|Adverse Event|3
6087116|NCT00365456|21011060|P1|Trial Period III (12 Months)|Adverse Event|13
6087117|NCT00365456|21011059|P2|Trial Period II (12 Months)|Other|1
6087118|NCT00365456|21011060|P1|Trial Period II (12 Months)|Other|0
6087119|NCT00365456|21011059|P2|Trial Period II (12 Months)|Withdrawal by Subject|5
6087120|NCT00365456|21011060|P1|Trial Period II (12 Months)|Withdrawal by Subject|0
6087121|NCT00365456|21011059|P2|Trial Period II (12 Months)|Non-compliance|2
6087122|NCT00365456|21011060|P1|Trial Period II (12 Months)|Non-compliance|0
6087123|NCT00365456|21011059|P2|Trial Period II (12 Months)|Adverse Event|6
6087124|NCT00365456|21011060|P1|Trial Period II (12 Months)|Adverse Event|0
6087125|NCT00365456|21011059|P2|Trial Period I (12 Months)|Other|0
6087126|NCT00365456|21011060|P1|Trial Period I (12 Months)|Other|11
6087127|NCT00365456|21011059|P2|Trial Period I (12 Months)|Withdrawal by Subject|0
6087128|NCT00365456|21011060|P1|Trial Period I (12 Months)|Withdrawal by Subject|27
6087129|NCT00365456|21011059|P2|Trial Period I (12 Months)|Non-compliance|0
6087130|NCT00365456|21011060|P1|Trial Period I (12 Months)|Non-compliance|3
6087131|NCT00365456|21011059|P2|Trial Period I (12 Months)|Adverse Event|0
6087132|NCT00365456|21011060|P1|Trial Period I (12 Months)|Adverse Event|84
6087133|NCT00365378|21011087|P3|Extension|Other|31
6087134|NCT00365378|21011088|P2|Extension|Other|0
6087135|NCT00365378|21011089|P1|Extension|Other|0
6087136|NCT00365378|21011087|P3|Extension|Withdrawal by Subject|98
6087137|NCT00365378|21011088|P2|Extension|Withdrawal by Subject|0
6087138|NCT00365378|21011089|P1|Extension|Withdrawal by Subject|0
6087139|NCT00365378|21011087|P3|Extension|Protocol Violation|2
6087140|NCT00365378|21011088|P2|Extension|Protocol Violation|0
6087141|NCT00365378|21011089|P1|Extension|Protocol Violation|0
6087142|NCT00365378|21011087|P3|Extension|Lost to Follow-up|57
6087143|NCT00365378|21011088|P2|Extension|Lost to Follow-up|0
6087144|NCT00365378|21011089|P1|Extension|Lost to Follow-up|0
6087145|NCT00365378|21011087|P3|Extension|Moved|8
6087146|NCT00365378|21011088|P2|Extension|Moved|0
6087147|NCT00365378|21011089|P1|Extension|Moved|0
6087148|NCT00365378|21011087|P3|Extension|Adverse Event|1
6087149|NCT00365378|21011088|P2|Extension|Adverse Event|0
6087150|NCT00365378|21011089|P1|Extension|Adverse Event|0
6087151|NCT00365378|21011087|P3|Follow-up (Month 7 Though Month 48)|Other|0
6087152|NCT00365378|21011088|P2|Follow-up (Month 7 Though Month 48)|Other|21
6087153|NCT00365378|21011089|P1|Follow-up (Month 7 Though Month 48)|Other|11
6087154|NCT00365378|21011087|P3|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|0
6087155|NCT00365378|21011088|P2|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|104
6087156|NCT00365378|21011089|P1|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|73
6087157|NCT00365378|21011087|P3|Follow-up (Month 7 Though Month 48)|Protocol Violation|0
6087158|NCT00365378|21011088|P2|Follow-up (Month 7 Though Month 48)|Protocol Violation|2
6087159|NCT00365378|21011089|P1|Follow-up (Month 7 Though Month 48)|Protocol Violation|1
6087160|NCT00365378|21011087|P3|Follow-up (Month 7 Though Month 48)|Pregnancy|0
6087161|NCT00365378|21011088|P2|Follow-up (Month 7 Though Month 48)|Pregnancy|1
6087162|NCT00365378|21011089|P1|Follow-up (Month 7 Though Month 48)|Pregnancy|0
6087163|NCT00365378|21011087|P3|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|0
6087164|NCT00365378|21011088|P2|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|69
6087165|NCT00365378|21011089|P1|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|67
6087166|NCT00365378|21011087|P3|Follow-up (Month 7 Though Month 48)|Moved|0
6087167|NCT00365378|21011088|P2|Follow-up (Month 7 Though Month 48)|Moved|5
6087168|NCT00365378|21011089|P1|Follow-up (Month 7 Though Month 48)|Moved|6
6087169|NCT00365378|21011087|P3|Vaccination (Day 1 to Month 7)|Other|0
6087170|NCT00365378|21011088|P2|Vaccination (Day 1 to Month 7)|Other|9
6087171|NCT00365378|21011089|P1|Vaccination (Day 1 to Month 7)|Other|17
6087172|NCT00365378|21011087|P3|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|0
6087173|NCT00365378|21011088|P2|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|44
6087174|NCT00365378|21011089|P1|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|50
6087175|NCT00365378|21011087|P3|Vaccination (Day 1 to Month 7)|Protocol Violation|0
6087176|NCT00365378|21011088|P2|Vaccination (Day 1 to Month 7)|Protocol Violation|13
6087177|NCT00365378|21011089|P1|Vaccination (Day 1 to Month 7)|Protocol Violation|22
6087178|NCT00365378|21011087|P3|Vaccination (Day 1 to Month 7)|Pregnancy|0
6087179|NCT00365378|21011088|P2|Vaccination (Day 1 to Month 7)|Pregnancy|14
6087180|NCT00365378|21011089|P1|Vaccination (Day 1 to Month 7)|Pregnancy|19
6087181|NCT00365378|21011087|P3|Vaccination (Day 1 to Month 7)|Lost to Follow-up|0
6087182|NCT00365378|21011088|P2|Vaccination (Day 1 to Month 7)|Lost to Follow-up|75
6087183|NCT00365378|21011089|P1|Vaccination (Day 1 to Month 7)|Lost to Follow-up|88
6087184|NCT00365378|21011087|P3|Vaccination (Day 1 to Month 7)|Adverse Event|0
6087185|NCT00365378|21011088|P2|Vaccination (Day 1 to Month 7)|Adverse Event|5
6087186|NCT00365378|21011089|P1|Vaccination (Day 1 to Month 7)|Adverse Event|4
6087187|NCT00365378|21011087|P3|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|0
6087188|NCT00365378|21011088|P2|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|7
6087189|NCT00365378|21011089|P1|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|11
6087190|NCT00365365|21011103|P3|Overall Study|Patient/physician decision|1
6087191|NCT00365365|21011104|P2|Overall Study|Patient/physician decision|0
6087192|NCT00365365|21011105|P1|Overall Study|Patient/physician decision|0
6087193|NCT00365365|21011103|P3|Overall Study|Second malignancy|0
6087194|NCT00365365|21011104|P2|Overall Study|Second malignancy|1
6087195|NCT00365365|21011105|P1|Overall Study|Second malignancy|0
6087196|NCT00365365|21011103|P3|Overall Study|Withdrew consent|0
6087197|NCT00365365|21011104|P2|Overall Study|Withdrew consent|1
6087198|NCT00365365|21011105|P1|Overall Study|Withdrew consent|1
6087199|NCT00365365|21011103|P3|Overall Study|New cancer|0
6087200|NCT00365365|21011104|P2|Overall Study|New cancer|0
6087201|NCT00365365|21011105|P1|Overall Study|New cancer|1
6087202|NCT00365365|21011103|P3|Overall Study|Moved|0
6087203|NCT00365365|21011104|P2|Overall Study|Moved|0
6087204|NCT00365365|21011105|P1|Overall Study|Moved|2
6087205|NCT00365365|21011103|P3|Overall Study|Adverse Event|3
6087206|NCT00365365|21011104|P2|Overall Study|Adverse Event|6
6087207|NCT00365365|21011105|P1|Overall Study|Adverse Event|6
6087208|NCT00365365|21011103|P3|Overall Study|Disease progression/relapse|7
6087209|NCT00365365|21011104|P2|Overall Study|Disease progression/relapse|6
6087210|NCT00365365|21011105|P1|Overall Study|Disease progression/relapse|9
6087211|NCT00365365|21011103|P3|Overall Study|Subject's request|1
6087212|NCT00365365|21011104|P2|Overall Study|Subject's request|13
6087213|NCT00365365|21011105|P1|Overall Study|Subject's request|11
6087214|NCT00365365|21011103|P3|Overall Study|Death|0
6087215|NCT00365365|21011104|P2|Overall Study|Death|3
6087216|NCT00365365|21011105|P1|Overall Study|Death|1
6087217|NCT00365365|21011103|P3|Overall Study|Lost to Follow-up|3
6087218|NCT00365365|21011104|P2|Overall Study|Lost to Follow-up|3
6087219|NCT00365365|21011105|P1|Overall Study|Lost to Follow-up|3
6087220|NCT00365365|21011103|P3|Overall Study|Poor compliance to protocol|0
6087221|NCT00365365|21011104|P2|Overall Study|Poor compliance to protocol|1
6087222|NCT00365365|21011105|P1|Overall Study|Poor compliance to protocol|0
6087223|NCT00365365|21011103|P3|Overall Study|Randomized but not treated|0
6087224|NCT00365365|21011104|P2|Overall Study|Randomized but not treated|2
6087225|NCT00365365|21011105|P1|Overall Study|Randomized but not treated|0
6087226|NCT00365352|21011122|P3|Overall Study|Withdrawal of Participant by Sponsor|0
6087227|NCT00365352|21011123|P2|Overall Study|Withdrawal of Participant by Sponsor|0
6087228|NCT00365352|21011124|P1|Overall Study|Withdrawal of Participant by Sponsor|1
6087229|NCT00365352|21011122|P3|Overall Study|Lost to Follow-up|0
6087230|NCT00365352|21011123|P2|Overall Study|Lost to Follow-up|1
6087231|NCT00365352|21011124|P1|Overall Study|Lost to Follow-up|1
6087232|NCT00365352|21011122|P3|Overall Study|Non-Compliance (after Randomization)|1
6087233|NCT00365352|21011123|P2|Overall Study|Non-Compliance (after Randomization)|0
6087234|NCT00365352|21011124|P1|Overall Study|Non-Compliance (after Randomization)|1
6087235|NCT00365352|21011122|P3|Overall Study|Ineligible (Did Not Meet Entry Criteria)|2
6087236|NCT00365352|21011123|P2|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0
6087237|NCT00365352|21011124|P1|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0
6087238|NCT00365352|21011122|P3|Overall Study|Lack of Efficacy|0
6087239|NCT00365352|21011123|P2|Overall Study|Lack of Efficacy|0
6087240|NCT00365352|21011124|P1|Overall Study|Lack of Efficacy|3
6087241|NCT00365352|21011122|P3|Overall Study|Participant Withdrew Consent|4
6087242|NCT00365352|21011123|P2|Overall Study|Participant Withdrew Consent|3
6087243|NCT00365352|21011124|P1|Overall Study|Participant Withdrew Consent|8
6087244|NCT00365352|21011122|P3|Overall Study|Adverse Event|8
6087245|NCT00365352|21011123|P2|Overall Study|Adverse Event|7
6087246|NCT00365352|21011124|P1|Overall Study|Adverse Event|6
6087247|NCT00365300|21011208|P2|Double-blind Phase|Lack of Efficacy|6
6087248|NCT00365300|21011209|P1|Double-blind Phase|Lack of Efficacy|6
6087249|NCT00365300|21011208|P2|Double-blind Phase|Protocol Violation|1
6087250|NCT00365300|21011209|P1|Double-blind Phase|Protocol Violation|3
6087251|NCT00365300|21011208|P2|Double-blind Phase|Withdrawal by Subject|1
6087252|NCT00365300|21011209|P1|Double-blind Phase|Withdrawal by Subject|0
6087253|NCT00365300|21011208|P2|Double-blind Phase|Noncompliance|1
6087254|NCT00365300|21011209|P1|Double-blind Phase|Noncompliance|1
6087255|NCT00365300|21011208|P2|Double-blind Phase|Failed to return|0
6087256|NCT00365300|21011209|P1|Double-blind Phase|Failed to return|1
6087257|NCT00365300|21011208|P2|Open-label Phase|Patient skipped open label phase|0
6087258|NCT00365300|21011209|P1|Open-label Phase|Patient skipped open label phase|1
6087259|NCT00365300|21011208|P2|Open-label Phase|Lack of Efficacy|0
6087260|NCT00365300|21011209|P1|Open-label Phase|Lack of Efficacy|1
6087261|NCT00365300|21011208|P2|Open-label Phase|Protocol Violation|0
6087262|NCT00365300|21011209|P1|Open-label Phase|Protocol Violation|1
6087263|NCT00365300|21011208|P2|Open-label Phase|Parent/Legal Guardian Request|0
6087264|NCT00365300|21011209|P1|Open-label Phase|Parent/Legal Guardian Request|4
6087265|NCT00365300|21011208|P2|Open-label Phase|Noncompliance|0
6087266|NCT00365300|21011209|P1|Open-label Phase|Noncompliance|9
6087267|NCT00365300|21011208|P2|Open-label Phase|Physician Decision|0
6087268|NCT00365300|21011209|P1|Open-label Phase|Physician Decision|1
6087269|NCT00365300|21011208|P2|Open-label Phase|Failed to Return|0
6087270|NCT00365300|21011209|P1|Open-label Phase|Failed to Return|1
6087271|NCT00365300|21011208|P2|Open-label Phase|Adverse Event|0
6087272|NCT00365300|21011209|P1|Open-label Phase|Adverse Event|4
6087273|NCT00365105|21011274|P2|Overall Study|Protocol Violation|8
6087274|NCT00365105|21011275|P1|Overall Study|Protocol Violation|5
6087275|NCT00364923|21011321|P1|Survival Follow-up, After Pralatrexate|Pts still in follow-up at data cutoff|24
6087276|NCT00364923|21011321|P1|Treatment With Pralatrexate|Treatment with pralatrexate ongoing|4
6087277|NCT00364858|21011330|P2|Overall Study|Clinical baseline issue|1
6087278|NCT00364858|21011331|P1|Overall Study|Clinical baseline issue|0
6087279|NCT00364858|21011330|P2|Overall Study|Return to Q2 regimen|1
6087280|NCT00364858|21011331|P1|Overall Study|Return to Q2 regimen|0
6087281|NCT00364858|21011330|P2|Overall Study|Non-compliant|0
6087282|NCT00364858|21011331|P1|Overall Study|Non-compliant|1
6087283|NCT00364858|21011330|P2|Overall Study|Discontinuation at baseline|0
6087284|NCT00364858|21011331|P1|Overall Study|Discontinuation at baseline|1
6087285|NCT00364858|21011330|P2|Overall Study|Clinical failure|13
6087286|NCT00364858|21011331|P1|Overall Study|Clinical failure|2
6087287|NCT00364858|21011330|P2|Overall Study|Pregnancy|1
6087288|NCT00364858|21011331|P1|Overall Study|Pregnancy|1
6087289|NCT00364858|21011330|P2|Overall Study|Withdrawal by Subject|1
6087290|NCT00364858|21011331|P1|Overall Study|Withdrawal by Subject|1
6087291|NCT00364858|21011330|P2|Overall Study|Adverse Event|5
6087292|NCT00364858|21011331|P1|Overall Study|Adverse Event|1
6087293|NCT00364845|21011346|P2|Overall Study|Death|1
6087294|NCT00364845|21011347|P1|Overall Study|Death|0
6087295|NCT00364845|21011346|P2|Overall Study|Lost to Follow-up|1
6087296|NCT00364845|21011347|P1|Overall Study|Lost to Follow-up|0
6087297|NCT00364845|21011346|P2|Overall Study|Physician Decision|8
6087298|NCT00364845|21011347|P1|Overall Study|Physician Decision|8
6087299|NCT00364845|21011346|P2|Overall Study|Withdrawal by Subject|1
6087300|NCT00364845|21011347|P1|Overall Study|Withdrawal by Subject|2
6087301|NCT00364845|21011346|P2|Overall Study|Adverse Event|0
6087302|NCT00364845|21011347|P1|Overall Study|Adverse Event|1
6087303|NCT00364832|21011368|P12|Extension Year 2|Early Withdrawals|3
6087304|NCT00364832|21011369|P11|Extension Year 2|Early Withdrawals|5
6087305|NCT00364832|21011370|P10|Extension Year 2|Early Withdrawals|5
6087306|NCT00364832|21011371|P9|Extension Year 2|Early Withdrawals|0
6087307|NCT00364832|21011372|P8|Extension Year 2|Early Withdrawals|0
6087308|NCT00364832|21011373|P7|Extension Year 2|Early Withdrawals|0
6087309|NCT00364832|21011374|P6|Extension Year 2|Early Withdrawals|0
6087310|NCT00364832|21011375|P5|Extension Year 2|Early Withdrawals|0
6087311|NCT00364832|21011376|P4|Extension Year 2|Early Withdrawals|0
6087312|NCT00364832|21011377|P3|Extension Year 2|Early Withdrawals|0
6087313|NCT00364832|21011378|P2|Extension Year 2|Early Withdrawals|0
6087314|NCT00364832|21011379|P1|Extension Year 2|Early Withdrawals|0
6087315|NCT00364832|21011368|P12|Extension Year 1|Early Withdrawals|10
6087316|NCT00364832|21011369|P11|Extension Year 1|Early Withdrawals|2
6087317|NCT00364832|21011370|P10|Extension Year 1|Early Withdrawals|4
6087318|NCT00364832|21011371|P9|Extension Year 1|Early Withdrawals|0
6087319|NCT00364832|21011372|P8|Extension Year 1|Early Withdrawals|0
6087320|NCT00364832|21011373|P7|Extension Year 1|Early Withdrawals|0
6087321|NCT00364832|21011374|P6|Extension Year 1|Early Withdrawals|0
6087322|NCT00364832|21011375|P5|Extension Year 1|Early Withdrawals|0
6087323|NCT00364832|21011376|P4|Extension Year 1|Early Withdrawals|0
6087324|NCT00364832|21011377|P3|Extension Year 1|Early Withdrawals|0
6087325|NCT00364832|21011378|P2|Extension Year 1|Early Withdrawals|0
6087326|NCT00364832|21011379|P1|Extension Year 1|Early Withdrawals|0
6087327|NCT00364832|21011368|P12|Core Period|Early Withdrawals|0
6087328|NCT00364832|21011369|P11|Core Period|Early Withdrawals|0
6087329|NCT00364832|21011370|P10|Core Period|Early Withdrawals|0
6087330|NCT00364832|21011371|P9|Core Period|Early Withdrawals|0
6087331|NCT00364832|21011372|P8|Core Period|Early Withdrawals|1
6087332|NCT00364832|21011373|P7|Core Period|Early Withdrawals|4
6087333|NCT00364832|21011374|P6|Core Period|Early Withdrawals|0
6087334|NCT00364832|21011375|P5|Core Period|Early Withdrawals|0
6087335|NCT00364832|21011376|P4|Core Period|Early Withdrawals|1
6087336|NCT00364832|21011377|P3|Core Period|Early Withdrawals|1
6087337|NCT00364832|21011378|P2|Core Period|Early Withdrawals|2
6087338|NCT00364832|21011379|P1|Core Period|Early Withdrawals|2
6087339|NCT00364793|21011444|P4|Overall Study|Withdrawal by Subject|0
6087340|NCT00364793|21011445|P3|Overall Study|Withdrawal by Subject|0
6087341|NCT00364793|21011446|P2|Overall Study|Withdrawal by Subject|1
6087342|NCT00364793|21011447|P1|Overall Study|Withdrawal by Subject|0
6087343|NCT00364793|21011444|P4|Overall Study|No longer meets criteria|1
6087344|NCT00364793|21011445|P3|Overall Study|No longer meets criteria|0
6087345|NCT00364793|21011446|P2|Overall Study|No longer meets criteria|0
6087346|NCT00364793|21011447|P1|Overall Study|No longer meets criteria|0
6087347|NCT00364793|21011444|P4|Overall Study|Poor or non-compliance|1
6087348|NCT00364793|21011445|P3|Overall Study|Poor or non-compliance|0
6087349|NCT00364793|21011446|P2|Overall Study|Poor or non-compliance|1
6087350|NCT00364793|21011447|P1|Overall Study|Poor or non-compliance|1
6087351|NCT00364793|21011444|P4|Overall Study|Lost to Follow-up|0
6087352|NCT00364793|21011445|P3|Overall Study|Lost to Follow-up|2
6087353|NCT00364793|21011446|P2|Overall Study|Lost to Follow-up|0
6087354|NCT00364793|21011447|P1|Overall Study|Lost to Follow-up|1
6087355|NCT00364793|21011444|P4|Overall Study|Lack of Efficacy|1
6087356|NCT00364793|21011445|P3|Overall Study|Lack of Efficacy|1
6087357|NCT00364793|21011446|P2|Overall Study|Lack of Efficacy|3
6087358|NCT00364793|21011447|P1|Overall Study|Lack of Efficacy|3
6087359|NCT00364793|21011444|P4|Overall Study|Death|0
6087360|NCT00364793|21011445|P3|Overall Study|Death|1
6087361|NCT00364793|21011446|P2|Overall Study|Death|0
6087362|NCT00364793|21011447|P1|Overall Study|Death|1
6087363|NCT00364793|21011444|P4|Overall Study|Adverse Event|0
6087364|NCT00364793|21011445|P3|Overall Study|Adverse Event|0
6087365|NCT00364793|21011446|P2|Overall Study|Adverse Event|0
6087366|NCT00364793|21011447|P1|Overall Study|Adverse Event|2
6087367|NCT00364689|21011584|P1|Overall Study|Lost to Follow-up|1
6087368|NCT00364611|21011604|P2|Overall Study|Receiving Liver Ablation|1
6087369|NCT00364611|21011605|P1|Overall Study|Receiving Liver Ablation|0
6087370|NCT00364611|21011604|P2|Overall Study|Presumed CR on Study|1
6087371|NCT00364611|21011605|P1|Overall Study|Presumed CR on Study|0
6087372|NCT00364611|21011604|P2|Overall Study|Found Ineligible|0
6087373|NCT00364611|21011605|P1|Overall Study|Found Ineligible|1
6087374|NCT00364611|21011604|P2|Overall Study|Investigator decision|2
6087375|NCT00364611|21011605|P1|Overall Study|Investigator decision|2
6087376|NCT00364611|21011604|P2|Overall Study|Disease Progression|8
6087377|NCT00364611|21011605|P1|Overall Study|Disease Progression|38
6087378|NCT00364611|21011604|P2|Overall Study|Participant's Request|4
6087379|NCT00364611|21011605|P1|Overall Study|Participant's Request|3
6087380|NCT00364611|21011604|P2|Overall Study|Adverse Event|4
6087381|NCT00364611|21011605|P1|Overall Study|Adverse Event|7
6087382|NCT00364611|21011604|P2|Overall Study|Did not receive study medication|1
6087383|NCT00364611|21011605|P1|Overall Study|Did not receive study medication|0
6087384|NCT00364533|21011628|P5|Overall Study|Protocol Violation|0
6087385|NCT00364533|21011629|P4|Overall Study|Protocol Violation|0
6087386|NCT00364533|21011630|P3|Overall Study|Protocol Violation|0
6087387|NCT00364533|21011631|P2|Overall Study|Protocol Violation|1
6087388|NCT00364533|21011632|P1|Overall Study|Protocol Violation|1
6087389|NCT00364533|21011628|P5|Overall Study|Non-compliance|0
6087390|NCT00364533|21011629|P4|Overall Study|Non-compliance|0
6087391|NCT00364533|21011630|P3|Overall Study|Non-compliance|0
6087392|NCT00364533|21011631|P2|Overall Study|Non-compliance|0
6087393|NCT00364533|21011632|P1|Overall Study|Non-compliance|1
6087394|NCT00364533|21011628|P5|Overall Study|Variations in drug compliance|0
6087395|NCT00364533|21011629|P4|Overall Study|Variations in drug compliance|0
6087396|NCT00364533|21011630|P3|Overall Study|Variations in drug compliance|1
6087397|NCT00364533|21011631|P2|Overall Study|Variations in drug compliance|1
6087398|NCT00364533|21011632|P1|Overall Study|Variations in drug compliance|2
6087399|NCT00364533|21011628|P5|Overall Study|Subject discharged from hospital|1
6087400|NCT00364533|21011629|P4|Overall Study|Subject discharged from hospital|3
6087401|NCT00364533|21011630|P3|Overall Study|Subject discharged from hospital|2
6087402|NCT00364533|21011631|P2|Overall Study|Subject discharged from hospital|1
6087403|NCT00364533|21011632|P1|Overall Study|Subject discharged from hospital|4
6087404|NCT00364533|21011628|P5|Overall Study|Lack of Efficacy|42
6087405|NCT00364533|21011629|P4|Overall Study|Lack of Efficacy|17
6087406|NCT00364533|21011630|P3|Overall Study|Lack of Efficacy|21
6087407|NCT00364533|21011631|P2|Overall Study|Lack of Efficacy|22
6087408|NCT00364533|21011632|P1|Overall Study|Lack of Efficacy|22
6087409|NCT00364533|21011628|P5|Overall Study|Withdrawal by Subject|6
6087410|NCT00364533|21011629|P4|Overall Study|Withdrawal by Subject|6
6087411|NCT00364533|21011630|P3|Overall Study|Withdrawal by Subject|6
6087412|NCT00364533|21011631|P2|Overall Study|Withdrawal by Subject|8
6087413|NCT00364533|21011632|P1|Overall Study|Withdrawal by Subject|4
6087414|NCT00364533|21011628|P5|Overall Study|Adverse Event|2
6087415|NCT00364533|21011629|P4|Overall Study|Adverse Event|5
6087416|NCT00364533|21011630|P3|Overall Study|Adverse Event|15
6087417|NCT00364533|21011631|P2|Overall Study|Adverse Event|7
6087418|NCT00364533|21011632|P1|Overall Study|Adverse Event|8
6087419|NCT00364351|21011665|P2|Overall Study|Randomised treatment not started|3
6087420|NCT00364351|21011666|P1|Overall Study|Randomised treatment not started|0
6087421|NCT00364351|21011665|P2|Overall Study|Patient could not travel to site|1
6087422|NCT00364351|21011666|P1|Overall Study|Patient could not travel to site|0
6087423|NCT00364351|21011665|P2|Overall Study|Investigator error|2
6087424|NCT00364351|21011666|P1|Overall Study|Investigator error|0
6087425|NCT00364351|21011665|P2|Overall Study|Poor treatment compliance|3
6087426|NCT00364351|21011666|P1|Overall Study|Poor treatment compliance|0
6087427|NCT00364351|21011665|P2|Overall Study|Sponsor decision|0
6087428|NCT00364351|21011666|P1|Overall Study|Sponsor decision|1
6087429|NCT00364351|21011665|P2|Overall Study|Incorrect enrollment|1
6087430|NCT00364351|21011666|P1|Overall Study|Incorrect enrollment|1
6087431|NCT00364351|21011665|P2|Overall Study|Withdrawal by Subject|29
6087432|NCT00364351|21011666|P1|Overall Study|Withdrawal by Subject|30
6087433|NCT00364351|21011665|P2|Overall Study|Lost to Follow-up|1
6087434|NCT00364351|21011666|P1|Overall Study|Lost to Follow-up|1
6087435|NCT00364351|21011665|P2|Overall Study|Prohibited concomitant medication|2
6087436|NCT00364351|21011666|P1|Overall Study|Prohibited concomitant medication|0
6087437|NCT00364351|21011665|P2|Overall Study|Condition under investigation worsened|497
6087438|NCT00364351|21011666|P1|Overall Study|Condition under investigation worsened|469
6087439|NCT00364351|21011665|P2|Overall Study|Adverse Event|44
6087440|NCT00364351|21011666|P1|Overall Study|Adverse Event|90
6087441|NCT00364286|21011684|P1|Overall Study|Adverse Event|2
6087442|NCT00364286|21011684|P1|Overall Study|Withdrawal by Subject|1
6087443|NCT00364182|21011691|P3|Third Intervention|Lost to Follow-up|1
6087444|NCT00364182|21011692|P2|Third Intervention|Lost to Follow-up|0
6087445|NCT00364182|21011693|P1|Third Intervention|Lost to Follow-up|0
6087446|NCT00364182|21011691|P3|Third Intervention|non-compliance|0
6087447|NCT00364182|21011692|P2|Third Intervention|non-compliance|1
6087448|NCT00364182|21011693|P1|Third Intervention|non-compliance|0
6087449|NCT00364182|21011691|P3|Second Intervention|Adverse Event|1
6087450|NCT00364182|21011692|P2|Second Intervention|Adverse Event|0
6087451|NCT00364182|21011693|P1|Second Intervention|Adverse Event|0
6087452|NCT00364182|21011691|P3|Second Intervention|Protocol Violation|0
6087453|NCT00364182|21011692|P2|Second Intervention|Protocol Violation|1
6087454|NCT00364182|21011693|P1|Second Intervention|Protocol Violation|0
6087455|NCT00364182|21011691|P3|Second Intervention|non-compliance|1
6087456|NCT00364182|21011692|P2|Second Intervention|non-compliance|1
6087457|NCT00364182|21011693|P1|Second Intervention|non-compliance|0
6087458|NCT00364182|21011691|P3|First Intervention|Withdrawal by Subject|0
6087459|NCT00364182|21011692|P2|First Intervention|Withdrawal by Subject|0
6087460|NCT00364182|21011693|P1|First Intervention|Withdrawal by Subject|2
6087461|NCT00364182|21011691|P3|First Intervention|Secondary prophylaxis|0
6087462|NCT00364182|21011692|P2|First Intervention|Secondary prophylaxis|0
6087463|NCT00364182|21011693|P1|First Intervention|Secondary prophylaxis|1
6087464|NCT00364156|21011727|P2|Overall Study|Protocol Violation|1
6087465|NCT00364156|21011728|P1|Overall Study|Protocol Violation|6
6087466|NCT00364156|21011727|P2|Overall Study|Withdrawal by Subject|80
6087467|NCT00364156|21011728|P1|Overall Study|Withdrawal by Subject|73
6087468|NCT00364130|21011736|P2|Post Intervention Follow-up Period|Lost to Follow-up|11
6087469|NCT00364130|21011737|P1|Post Intervention Follow-up Period|Lost to Follow-up|5
6087470|NCT00364130|21011736|P2|Intervention Period|Withdrawal by Subject|5
6087471|NCT00364130|21011737|P1|Intervention Period|Withdrawal by Subject|4
6087472|NCT00364130|21011736|P2|Intervention Period|Pregnancy|0
6087473|NCT00364130|21011737|P1|Intervention Period|Pregnancy|1
6087474|NCT00364130|21011736|P2|Intervention Period|Lost to Follow-up|3
6087475|NCT00364130|21011737|P1|Intervention Period|Lost to Follow-up|4
6087476|NCT00364013|21011759|P2|Overall Study|Ongoing|13
6087477|NCT00364013|21011760|P1|Overall Study|Ongoing|20
6087478|NCT00364013|21011759|P2|Overall Study|Other|47
6087479|NCT00364013|21011760|P1|Overall Study|Other|41
6087480|NCT00364013|21011759|P2|Overall Study|Protocol-specified criteria|6
6087481|NCT00364013|21011760|P1|Overall Study|Protocol-specified criteria|6
6087482|NCT00364013|21011759|P2|Overall Study|Lost to Follow-up|3
6087483|NCT00364013|21011760|P1|Overall Study|Lost to Follow-up|10
6087484|NCT00364013|21011759|P2|Overall Study|Physician Decision|3
6087485|NCT00364013|21011760|P1|Overall Study|Physician Decision|3
6087486|NCT00364013|21011759|P2|Overall Study|Withdrawal by Subject|18
6087487|NCT00364013|21011760|P1|Overall Study|Withdrawal by Subject|13
6087488|NCT00364013|21011759|P2|Overall Study|Adverse Event|3
6087489|NCT00364013|21011760|P1|Overall Study|Adverse Event|4
6087490|NCT00364013|21011759|P2|Overall Study|Ineligibility determined|2
6087491|NCT00364013|21011760|P1|Overall Study|Ineligibility determined|4
6087492|NCT00363896|21011788|P2|Overall Study|Other|2
6087493|NCT00363896|21011789|P1|Overall Study|Other|1
6087494|NCT00363896|21011788|P2|Overall Study|Non-fulfilment of entry criteria|0
6087495|NCT00363896|21011789|P1|Overall Study|Non-fulfilment of entry criteria|1
6087496|NCT00363896|21011788|P2|Overall Study|Lost to Follow-up|0
6087497|NCT00363896|21011789|P1|Overall Study|Lost to Follow-up|3
6087498|NCT00363896|21011788|P2|Overall Study|Protocol Violation|1
6087499|NCT00363896|21011789|P1|Overall Study|Protocol Violation|6
6087500|NCT00363896|21011788|P2|Overall Study|Lack of Efficacy|8
6087501|NCT00363896|21011789|P1|Overall Study|Lack of Efficacy|12
6087502|NCT00363896|21011788|P2|Overall Study|COPD exacerbation|7
6087503|NCT00363896|21011789|P1|Overall Study|COPD exacerbation|13
6087504|NCT00363896|21011788|P2|Overall Study|Adverse Event|13
6087505|NCT00363896|21011789|P1|Overall Study|Adverse Event|24
6087506|NCT00363896|21011788|P2|Overall Study|Withdrawal by Subject|16
6087507|NCT00363896|21011789|P1|Overall Study|Withdrawal by Subject|29
6087508|NCT00363766|21011830|P2|Overall Study|Physician Decision|2
6087509|NCT00363766|21011831|P1|Overall Study|Physician Decision|1
6087510|NCT00363766|21011830|P2|Overall Study|Withdrawal by Subject|0
6087511|NCT00363766|21011831|P1|Overall Study|Withdrawal by Subject|2
6087512|NCT00363766|21011830|P2|Overall Study|Not Disease Related Death|4
6087513|NCT00363766|21011831|P1|Overall Study|Not Disease Related Death|3
6087514|NCT00363766|21011830|P2|Overall Study|Disease Related Death|3
6087515|NCT00363766|21011831|P1|Overall Study|Disease Related Death|1
6087516|NCT00363766|21011830|P2|Overall Study|Adverse Event|2
6087517|NCT00363766|21011831|P1|Overall Study|Adverse Event|10
6087518|NCT00363766|21011830|P2|Overall Study|Progressive Disease|9
6087519|NCT00363766|21011831|P1|Overall Study|Progressive Disease|15
6087520|NCT00363649|21011860|P2|Overall Study|Adverse Event|0
6087521|NCT00363649|21011861|P1|Overall Study|Adverse Event|6
6087522|NCT00363649|21011860|P2|Overall Study|Withdrawal by Subject|1
6087523|NCT00363649|21011861|P1|Overall Study|Withdrawal by Subject|1
6087524|NCT00363545|21011877|P2|Overall Study|Others|0
6087525|NCT00363545|21011878|P1|Overall Study|Others|1
6087526|NCT00363545|21011877|P2|Overall Study|Lost to follow-up (complete vaccination)|17
6087527|NCT00363545|21011878|P1|Overall Study|Lost to follow-up (complete vaccination)|14
6087528|NCT00363545|21011877|P2|Overall Study|Lost to follow-up (incompl. vaccination)|18
6087529|NCT00363545|21011878|P1|Overall Study|Lost to follow-up (incompl. vaccination)|14
6087530|NCT00363545|21011877|P2|Overall Study|Migrated/moved from study area|6
6087531|NCT00363545|21011878|P1|Overall Study|Migrated/moved from study area|3
6087532|NCT00363545|21011877|P2|Overall Study|Withdrawal by Subject|15
6087533|NCT00363545|21011878|P1|Overall Study|Withdrawal by Subject|12
6087534|NCT00363545|21011877|P2|Overall Study|Serious Adverse Event|1
6087535|NCT00363545|21011878|P1|Overall Study|Serious Adverse Event|0
6087536|NCT00363480|21011896|P1|Overall Study|Participant discontinued on its own|1
6087537|NCT00363480|21011896|P1|Overall Study|Non-compliance of subject|1
6087538|NCT00363480|21011896|P1|Overall Study|Withdrawal by Subject|5
6087539|NCT00363480|21011896|P1|Overall Study|Lost to Follow-up|5
6087540|NCT00363480|21011896|P1|Overall Study|Adverse Event|4
6087541|NCT00363480|21011896|P1|Overall Study|Criteria for treatment period not fulfil|1
6087542|NCT00363467|21011916|P1|Overall Study|Physician Decision|1
6087543|NCT00363415|21011926|P2|Overall Study|Protocol Violation|4
6087544|NCT00363415|21011927|P1|Overall Study|Protocol Violation|1
6087545|NCT00363415|21011926|P2|Overall Study|Lost to Follow-up|3
6087546|NCT00363415|21011927|P1|Overall Study|Lost to Follow-up|3
6087547|NCT00363415|21011926|P2|Overall Study|Withdrawal by Subject|15
6087548|NCT00363415|21011927|P1|Overall Study|Withdrawal by Subject|9
6087549|NCT00363415|21011926|P2|Overall Study|Entry Criteria Not Met|10
6087550|NCT00363415|21011927|P1|Overall Study|Entry Criteria Not Met|11
6087551|NCT00363415|21011926|P2|Overall Study|Physician Decision|35
6087552|NCT00363415|21011927|P1|Overall Study|Physician Decision|18
6087553|NCT00363415|21011926|P2|Overall Study|Adverse Event|15
6087554|NCT00363415|21011927|P1|Overall Study|Adverse Event|24
6087555|NCT00363415|21011926|P2|Overall Study|Death|29
6087556|NCT00363415|21011927|P1|Overall Study|Death|32
6087557|NCT00363415|21011926|P2|Overall Study|Sponsor Decision|31
6087558|NCT00363415|21011927|P1|Overall Study|Sponsor Decision|67
6087559|NCT00363415|21011926|P2|Overall Study|Progressive Disease|107
6087560|NCT00363415|21011927|P1|Overall Study|Progressive Disease|196
6087561|NCT00363311|21011945|P2|Overall Study|Participant Moved to Louisiana|1
6087562|NCT00363311|21011946|P1|Overall Study|Participant Moved to Louisiana|0
6087563|NCT00363311|21011945|P2|Overall Study|Withdrawn per Instructions of Monitor|1
6087564|NCT00363311|21011946|P1|Overall Study|Withdrawn per Instructions of Monitor|0
6087565|NCT00363311|21011945|P2|Overall Study|Participant Withdrew Waiting for Surgery|1
6087566|NCT00363311|21011946|P1|Overall Study|Participant Withdrew Waiting for Surgery|0
6087567|NCT00363311|21011945|P2|Overall Study|Participant Moved to Another Country|0
6087568|NCT00363311|21011946|P1|Overall Study|Participant Moved to Another Country|1
6087569|NCT00363311|21011945|P2|Overall Study|Participant Opted for Treatment|0
6087570|NCT00363311|21011946|P1|Overall Study|Participant Opted for Treatment|1
6087571|NCT00363311|21011945|P2|Overall Study|Prostate Volume/PSA Doubled|0
6087572|NCT00363311|21011946|P1|Overall Study|Prostate Volume/PSA Doubled|1
6087573|NCT00363311|21011945|P2|Overall Study|Participant Refused Biopsy|0
6087574|NCT00363311|21011946|P1|Overall Study|Participant Refused Biopsy|1
6087575|NCT00363311|21011945|P2|Overall Study|Non-Compliance|1
6087576|NCT00363311|21011946|P1|Overall Study|Non-Compliance|1
6087577|NCT00363311|21011945|P2|Overall Study|Disease Progression|26
6087578|NCT00363311|21011946|P1|Overall Study|Disease Progression|46
6087579|NCT00363311|21011945|P2|Overall Study|Sponsor Terminated Study|2
6087580|NCT00363311|21011946|P1|Overall Study|Sponsor Terminated Study|2
6087581|NCT00363311|21011945|P2|Overall Study|Physician Decision|1
6087582|NCT00363311|21011946|P1|Overall Study|Physician Decision|1
6087583|NCT00363311|21011945|P2|Overall Study|Withdrawal by Subject|6
6087584|NCT00363311|21011946|P1|Overall Study|Withdrawal by Subject|12
6087585|NCT00363311|21011945|P2|Overall Study|Protocol Violation|2
6087586|NCT00363311|21011946|P1|Overall Study|Protocol Violation|1
6087587|NCT00363311|21011945|P2|Overall Study|Lost to Follow-up|0
6087588|NCT00363311|21011946|P1|Overall Study|Lost to Follow-up|3
6087589|NCT00363311|21011945|P2|Overall Study|Adverse Event|4
6087590|NCT00363311|21011946|P1|Overall Study|Adverse Event|6
6087591|NCT00363298|21012012|P2|4-week Study Continuation Phase|Lack of Efficacy|0
6087592|NCT00363298|21012013|P1|4-week Study Continuation Phase|Lack of Efficacy|1
6087593|NCT00363298|21012012|P2|First Study Week|Lack of Efficacy|5
6087594|NCT00363298|21012013|P1|First Study Week|Lack of Efficacy|6
6087595|NCT00363246|21012021|P1|Overall Study|Eligibility changed due to Hospice move|5
6087596|NCT00363246|21012021|P1|Overall Study|Subject expressed security concerns|2
6087597|NCT00363246|21012021|P1|Overall Study|Stopped using wheelchair|11
6087598|NCT00363246|21012021|P1|Overall Study|Bad health|6
6087599|NCT00363246|21012021|P1|Overall Study|Lost to Follow-up|14
6087600|NCT00363246|21012021|P1|Overall Study|Withdrawal by Subject|19
6087601|NCT00363246|21012021|P1|Overall Study|Death|40
6087602|NCT00363142|21012039|P2|Overall Study|Withdrawal by Subject|1
6087603|NCT00363142|21012040|P1|Overall Study|Withdrawal by Subject|3
6087604|NCT00363142|21012039|P2|Overall Study|Non-compliance|1
6087605|NCT00363142|21012040|P1|Overall Study|Non-compliance|1
6087606|NCT00363142|21012039|P2|Overall Study|Lost to Follow-up|0
6087607|NCT00363142|21012040|P1|Overall Study|Lost to Follow-up|1
6087608|NCT00363142|21012039|P2|Overall Study|Lack of Efficacy|1
6087609|NCT00363142|21012040|P1|Overall Study|Lack of Efficacy|0
6087610|NCT00363142|21012039|P2|Overall Study|Adverse Event|0
6087611|NCT00363142|21012040|P1|Overall Study|Adverse Event|2
6087612|NCT00363129|21012069|P2|Overall Study|Other Reasons|3
6087613|NCT00363129|21012070|P1|Overall Study|Other Reasons|6
6087614|NCT00363129|21012069|P2|Overall Study|Death|1
6087615|NCT00363129|21012070|P1|Overall Study|Death|0
6087616|NCT00363129|21012069|P2|Overall Study|Other Medical Problems|4
6087617|NCT00363129|21012070|P1|Overall Study|Other Medical Problems|2
6087618|NCT00363129|21012069|P2|Overall Study|Alternate Treatment|4
6087619|NCT00363129|21012070|P1|Overall Study|Alternate Treatment|2
6087620|NCT00363129|21012069|P2|Overall Study|Adverse Event|3
6087621|NCT00363129|21012070|P1|Overall Study|Adverse Event|8
6087622|NCT00363129|21012069|P2|Overall Study|Withdrawal by Subject|18
6087623|NCT00363129|21012070|P1|Overall Study|Withdrawal by Subject|11
6087624|NCT00363051|21012113|P2|Overall Study|Death|2
6087625|NCT00363051|21012114|P1|Overall Study|Death|3
6087626|NCT00363051|21012113|P2|Overall Study|Protocol Violation|2
6087627|NCT00363051|21012114|P1|Overall Study|Protocol Violation|0
6087628|NCT00363051|21012113|P2|Overall Study|Lost to Follow-up|1
6087629|NCT00363051|21012114|P1|Overall Study|Lost to Follow-up|0
6087630|NCT00363051|21012113|P2|Overall Study|Withdrawal by Subject|3
6087631|NCT00363051|21012114|P1|Overall Study|Withdrawal by Subject|11
6087632|NCT00363051|21012113|P2|Overall Study|New Cancer Therapy|1
6087633|NCT00363051|21012114|P1|Overall Study|New Cancer Therapy|2
6087634|NCT00363051|21012113|P2|Overall Study|Adverse Event|12
6087635|NCT00363051|21012114|P1|Overall Study|Adverse Event|21
6087636|NCT00363051|21012113|P2|Overall Study|Adminstrative problems|1
6087637|NCT00363051|21012114|P1|Overall Study|Adminstrative problems|1
6087638|NCT00362648|21012163|P4|Overall Study|Withdrawal by Subject|6
6087639|NCT00362648|21012164|P3|Overall Study|Withdrawal by Subject|2
6087640|NCT00362648|21012165|P2|Overall Study|Withdrawal by Subject|42
6087641|NCT00362648|21012166|P1|Overall Study|Withdrawal by Subject|48
6087642|NCT00362648|21012163|P4|Overall Study|Protocol Violation|2
6087643|NCT00362648|21012164|P3|Overall Study|Protocol Violation|2
6087644|NCT00362648|21012165|P2|Overall Study|Protocol Violation|2
6087645|NCT00362648|21012166|P1|Overall Study|Protocol Violation|4
6087646|NCT00362648|21012163|P4|Overall Study|Lost to Follow-up|3
6087647|NCT00362648|21012164|P3|Overall Study|Lost to Follow-up|4
6087648|NCT00362648|21012165|P2|Overall Study|Lost to Follow-up|69
6087649|NCT00362648|21012166|P1|Overall Study|Lost to Follow-up|62
6087650|NCT00362648|21012163|P4|Overall Study|Adverse Event|0
6087651|NCT00362648|21012164|P3|Overall Study|Adverse Event|1
6087652|NCT00362648|21012165|P2|Overall Study|Adverse Event|21
6087653|NCT00362648|21012166|P1|Overall Study|Adverse Event|12
6087654|NCT00362609|21012184|P2|Overall Study|Protocol Violation|1
6087655|NCT00362609|21012185|P1|Overall Study|Protocol Violation|0
6087656|NCT00362609|21012184|P2|Overall Study|Withdrawal by Subject|1
6087657|NCT00362609|21012185|P1|Overall Study|Withdrawal by Subject|0
6087658|NCT00362414|21012266|P1|Overall Study|Adverse Event|1
6087659|NCT00362414|21012266|P1|Overall Study|Death|2
6087660|NCT00362375|21012295|P2|Overall Study|Lost to Follow-up|35
6087661|NCT00362375|21012296|P1|Overall Study|Lost to Follow-up|40
6087662|NCT00362336|21012313|P3|Overall Study|Withdrawal by Subject|1
6087663|NCT00362336|21012314|P2|Overall Study|Withdrawal by Subject|3
6087664|NCT00362336|21012315|P1|Overall Study|Withdrawal by Subject|3
6087665|NCT00362336|21012313|P3|Overall Study|Lost to Follow-up|0
6087666|NCT00362336|21012314|P2|Overall Study|Lost to Follow-up|4
6087667|NCT00362336|21012315|P1|Overall Study|Lost to Follow-up|6
6087668|NCT00362336|21012313|P3|Overall Study|Protocol Violation|1
6087669|NCT00362336|21012314|P2|Overall Study|Protocol Violation|0
6087670|NCT00362336|21012315|P1|Overall Study|Protocol Violation|0
6087671|NCT00362336|21012313|P3|Overall Study|Serious Adverse Event|1
6087672|NCT00362336|21012314|P2|Overall Study|Serious Adverse Event|0
6087673|NCT00362336|21012315|P1|Overall Study|Serious Adverse Event|1
6087674|NCT00362297|21012343|P2|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|4
6087675|NCT00362297|21012344|P1|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|0
6087676|NCT00362232|21012352|P2|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|7
6087677|NCT00362232|21012353|P1|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|8
6087678|NCT00362232|21012352|P2|Follow-up (30 (+ 5) Days)|Lost to Follow-up|28
6087679|NCT00362232|21012353|P1|Follow-up (30 (+ 5) Days)|Lost to Follow-up|27
6087680|NCT00362232|21012352|P2|Follow-up (30 (+ 5) Days)|Death|1
6087681|NCT00362232|21012353|P1|Follow-up (30 (+ 5) Days)|Death|1
6087682|NCT00362232|21012352|P2|Follow-up (30 (+ 5) Days)|Adverse Event|3
6087683|NCT00362232|21012353|P1|Follow-up (30 (+ 5) Days)|Adverse Event|2
6087684|NCT00362232|21012352|P2|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|18
6087685|NCT00362232|21012353|P1|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|10
6087686|NCT00362232|21012352|P2|Treatment (12 +/- 2 Days)|Technical Problems|0
6087687|NCT00362232|21012353|P1|Treatment (12 +/- 2 Days)|Technical Problems|1
6087688|NCT00362232|21012352|P2|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|0
6087689|NCT00362232|21012353|P1|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|9
6087690|NCT00362232|21012352|P2|Treatment (12 +/- 2 Days)|Withdrawal by Subject|47
6087691|NCT00362232|21012353|P1|Treatment (12 +/- 2 Days)|Withdrawal by Subject|49
6087692|NCT00362232|21012352|P2|Treatment (12 +/- 2 Days)|Protocol Violation|21
6087693|NCT00362232|21012353|P1|Treatment (12 +/- 2 Days)|Protocol Violation|22
6087694|NCT00362232|21012352|P2|Treatment (12 +/- 2 Days)|Physician Decision|5
6087695|NCT00362232|21012353|P1|Treatment (12 +/- 2 Days)|Physician Decision|2
6087696|NCT00362232|21012352|P2|Treatment (12 +/- 2 Days)|Lost to Follow-up|1
6087697|NCT00362232|21012353|P1|Treatment (12 +/- 2 Days)|Lost to Follow-up|3
6087698|NCT00362232|21012352|P2|Treatment (12 +/- 2 Days)|Death|3
6087699|NCT00362232|21012353|P1|Treatment (12 +/- 2 Days)|Death|1
6087700|NCT00362232|21012352|P2|Treatment (12 +/- 2 Days)|Adverse Event|56
6087701|NCT00362232|21012353|P1|Treatment (12 +/- 2 Days)|Adverse Event|62
6087702|NCT00362180|21012398|P9|Treated Period|Adverse Event|0
6087703|NCT00362180|21012399|P8|Treated Period|Adverse Event|1
6087704|NCT00362180|21012400|P7|Treated Period|Adverse Event|0
6087705|NCT00362180|21012401|P6|Treated Period|Adverse Event|1
6087706|NCT00362180|21012402|P5|Treated Period|Adverse Event|0
6087707|NCT00362180|21012403|P4|Treated Period|Adverse Event|0
6087708|NCT00362180|21012404|P3|Treated Period|Adverse Event|0
6087709|NCT00362180|21012405|P2|Treated Period|Adverse Event|0
6087710|NCT00362180|21012406|P1|Treated Period|Adverse Event|0
6087711|NCT00362180|21012398|P9|Treated Period|Withdrawal by Subject|0
6087712|NCT00362180|21012399|P8|Treated Period|Withdrawal by Subject|0
6087713|NCT00362180|21012400|P7|Treated Period|Withdrawal by Subject|0
6087714|NCT00362180|21012401|P6|Treated Period|Withdrawal by Subject|0
6087715|NCT00362180|21012402|P5|Treated Period|Withdrawal by Subject|0
6087716|NCT00362180|21012403|P4|Treated Period|Withdrawal by Subject|0
6087717|NCT00362180|21012404|P3|Treated Period|Withdrawal by Subject|0
6087718|NCT00362180|21012405|P2|Treated Period|Withdrawal by Subject|0
6087719|NCT00362180|21012406|P1|Treated Period|Withdrawal by Subject|1
6087720|NCT00362115|21012478|P7|Overall Study|Other|0
6087721|NCT00362115|21012479|P6|Overall Study|Other|1
6087722|NCT00362115|21012480|P5|Overall Study|Other|0
6087723|NCT00362115|21012481|P4|Overall Study|Other|1
6087724|NCT00362115|21012482|P3|Overall Study|Other|0
6087725|NCT00362115|21012483|P2|Overall Study|Other|1
6087726|NCT00362115|21012484|P1|Overall Study|Other|0
6087727|NCT00362115|21012478|P7|Overall Study|Physician Decision|3
6087728|NCT00362115|21012479|P6|Overall Study|Physician Decision|0
6087729|NCT00362115|21012480|P5|Overall Study|Physician Decision|0
6087730|NCT00362115|21012481|P4|Overall Study|Physician Decision|0
6087731|NCT00362115|21012482|P3|Overall Study|Physician Decision|0
6087732|NCT00362115|21012483|P2|Overall Study|Physician Decision|0
6087733|NCT00362115|21012484|P1|Overall Study|Physician Decision|0
6087734|NCT00362115|21012478|P7|Overall Study|Lack of Efficacy|3
6087735|NCT00362115|21012479|P6|Overall Study|Lack of Efficacy|0
6087736|NCT00362115|21012480|P5|Overall Study|Lack of Efficacy|2
6087737|NCT00362115|21012481|P4|Overall Study|Lack of Efficacy|2
6087738|NCT00362115|21012482|P3|Overall Study|Lack of Efficacy|5
6087739|NCT00362115|21012483|P2|Overall Study|Lack of Efficacy|0
6087740|NCT00362115|21012484|P1|Overall Study|Lack of Efficacy|1
6087741|NCT00362115|21012478|P7|Overall Study|Withdrawal by Subject|4
6087742|NCT00362115|21012479|P6|Overall Study|Withdrawal by Subject|3
6087743|NCT00362115|21012480|P5|Overall Study|Withdrawal by Subject|1
6087744|NCT00362115|21012481|P4|Overall Study|Withdrawal by Subject|0
6087745|NCT00362115|21012482|P3|Overall Study|Withdrawal by Subject|1
6087746|NCT00362115|21012483|P2|Overall Study|Withdrawal by Subject|3
6087747|NCT00362115|21012484|P1|Overall Study|Withdrawal by Subject|1
6087748|NCT00362115|21012478|P7|Overall Study|Lost to Follow-up|1
6087749|NCT00362115|21012479|P6|Overall Study|Lost to Follow-up|0
6087750|NCT00362115|21012480|P5|Overall Study|Lost to Follow-up|2
6087751|NCT00362115|21012481|P4|Overall Study|Lost to Follow-up|0
6087752|NCT00362115|21012482|P3|Overall Study|Lost to Follow-up|0
6087753|NCT00362115|21012483|P2|Overall Study|Lost to Follow-up|1
6087754|NCT00362115|21012484|P1|Overall Study|Lost to Follow-up|0
6087755|NCT00362115|21012478|P7|Overall Study|Protocol Violation|0
6087756|NCT00362115|21012479|P6|Overall Study|Protocol Violation|1
6087757|NCT00362115|21012480|P5|Overall Study|Protocol Violation|0
6087758|NCT00362115|21012481|P4|Overall Study|Protocol Violation|0
6087759|NCT00362115|21012482|P3|Overall Study|Protocol Violation|0
6087760|NCT00362115|21012483|P2|Overall Study|Protocol Violation|0
6087761|NCT00362115|21012484|P1|Overall Study|Protocol Violation|0
6087762|NCT00362115|21012478|P7|Overall Study|Adverse Event|1
6087763|NCT00362115|21012479|P6|Overall Study|Adverse Event|2
6087764|NCT00362115|21012480|P5|Overall Study|Adverse Event|2
6087765|NCT00362115|21012481|P4|Overall Study|Adverse Event|1
6087766|NCT00362115|21012482|P3|Overall Study|Adverse Event|1
6087767|NCT00362115|21012483|P2|Overall Study|Adverse Event|1
6087768|NCT00362115|21012484|P1|Overall Study|Adverse Event|0
6087769|NCT00361634|21012657|P1|Overall Study|Withdrawal by Subject|1
6087770|NCT00361634|21012657|P1|Overall Study|Lost to Follow-up|1
6087771|NCT00361569|21012686|P4|Overall Study|Not specified by investigator|1
6087772|NCT00361569|21012687|P3|Overall Study|Not specified by investigator|0
6087773|NCT00361569|21012688|P2|Overall Study|Not specified by investigator|0
6087774|NCT00361569|21012689|P1|Overall Study|Not specified by investigator|2
6087775|NCT00361569|21012686|P4|Overall Study|Lost to Follow-up|2
6087776|NCT00361569|21012687|P3|Overall Study|Lost to Follow-up|3
6087777|NCT00361569|21012688|P2|Overall Study|Lost to Follow-up|3
6087778|NCT00361569|21012689|P1|Overall Study|Lost to Follow-up|2
6087779|NCT00361569|21012686|P4|Overall Study|Adverse Event|2
6087780|NCT00361569|21012687|P3|Overall Study|Adverse Event|2
6087781|NCT00361569|21012688|P2|Overall Study|Adverse Event|5
6087782|NCT00361569|21012689|P1|Overall Study|Adverse Event|3
6087783|NCT00361569|21012686|P4|Overall Study|Withdrawal by Subject|14
6087784|NCT00361569|21012687|P3|Overall Study|Withdrawal by Subject|9
6087785|NCT00361569|21012688|P2|Overall Study|Withdrawal by Subject|1
6087786|NCT00361569|21012689|P1|Overall Study|Withdrawal by Subject|2
6087787|NCT00361569|21012686|P4|Overall Study|Protocol Violation|2
6087788|NCT00361569|21012687|P3|Overall Study|Protocol Violation|4
6087789|NCT00361569|21012688|P2|Overall Study|Protocol Violation|2
6087790|NCT00361569|21012689|P1|Overall Study|Protocol Violation|3
6087791|NCT00361504|21012713|P2|Overall Study|All other|3
6087792|NCT00361504|21012714|P1|Overall Study|All other|28
6087793|NCT00361504|21012713|P2|Overall Study|Study medication non compliant|15
6087794|NCT00361504|21012714|P1|Overall Study|Study medication non compliant|42
6087795|NCT00361504|21012713|P2|Overall Study|Resolution of Pain|0
6087796|NCT00361504|21012714|P1|Overall Study|Resolution of Pain|2
6087797|NCT00361504|21012713|P2|Overall Study|Lack of Efficacy|7
6087798|NCT00361504|21012714|P1|Overall Study|Lack of Efficacy|72
6087799|NCT00361504|21012713|P2|Overall Study|Adverse Event|82
6087800|NCT00361504|21012714|P1|Overall Study|Adverse Event|203
6087801|NCT00361504|21012713|P2|Overall Study|Lost to Follow-up|7
6087802|NCT00361504|21012714|P1|Overall Study|Lost to Follow-up|40
6087803|NCT00361504|21012713|P2|Overall Study|Withdrawal by Subject|31
6087804|NCT00361504|21012714|P1|Overall Study|Withdrawal by Subject|94
6087805|NCT00361335|21012755|P7|SC Period: Week E0 to Week E24|Lack of Efficacy|3
6087806|NCT00361335|21012756|P6|SC Period: Week E0 to Week E24|Lack of Efficacy|0
6087807|NCT00361335|21012757|P5|SC Period: Week E0 to Week E24|Lack of Efficacy|0
6087808|NCT00361335|21012758|P4|SC Period: Week E0 to Week E24|Lack of Efficacy|0
6087809|NCT00361335|21012759|P3|SC Period: Week E0 to Week E24|Lack of Efficacy|2
6087810|NCT00361335|21012760|P2|SC Period: Week E0 to Week E24|Lack of Efficacy|0
6087811|NCT00361335|21012761|P1|SC Period: Week E0 to Week E24|Lack of Efficacy|0
6087812|NCT00361335|21012755|P7|SC Period: Week E0 to Week E24|Other|2
6087813|NCT00361335|21012756|P6|SC Period: Week E0 to Week E24|Other|1
6087814|NCT00361335|21012757|P5|SC Period: Week E0 to Week E24|Other|0
6087815|NCT00361335|21012758|P4|SC Period: Week E0 to Week E24|Other|1
6087816|NCT00361335|21012759|P3|SC Period: Week E0 to Week E24|Other|0
6087817|NCT00361335|21012760|P2|SC Period: Week E0 to Week E24|Other|0
6087818|NCT00361335|21012761|P1|SC Period: Week E0 to Week E24|Other|1
6087819|NCT00361335|21012755|P7|SC Period: Week E0 to Week E24|Worsening of RA|0
6087820|NCT00361335|21012756|P6|SC Period: Week E0 to Week E24|Worsening of RA|0
6087821|NCT00361335|21012757|P5|SC Period: Week E0 to Week E24|Worsening of RA|0
6087822|NCT00361335|21012758|P4|SC Period: Week E0 to Week E24|Worsening of RA|1
6087823|NCT00361335|21012759|P3|SC Period: Week E0 to Week E24|Worsening of RA|1
6087824|NCT00361335|21012760|P2|SC Period: Week E0 to Week E24|Worsening of RA|1
6087825|NCT00361335|21012761|P1|SC Period: Week E0 to Week E24|Worsening of RA|0
6087826|NCT00361335|21012755|P7|SC Period: Week E0 to Week E24|Death|1
6087827|NCT00361335|21012756|P6|SC Period: Week E0 to Week E24|Death|0
6087828|NCT00361335|21012757|P5|SC Period: Week E0 to Week E24|Death|0
6087829|NCT00361335|21012758|P4|SC Period: Week E0 to Week E24|Death|0
6087830|NCT00361335|21012759|P3|SC Period: Week E0 to Week E24|Death|0
6087831|NCT00361335|21012760|P2|SC Period: Week E0 to Week E24|Death|0
6087832|NCT00361335|21012761|P1|SC Period: Week E0 to Week E24|Death|0
6087833|NCT00361335|21012755|P7|SC Period: Week E0 to Week E24|Lost to Follow-up|1
6087834|NCT00361335|21012756|P6|SC Period: Week E0 to Week E24|Lost to Follow-up|0
6087835|NCT00361335|21012757|P5|SC Period: Week E0 to Week E24|Lost to Follow-up|0
6087836|NCT00361335|21012758|P4|SC Period: Week E0 to Week E24|Lost to Follow-up|0
6087837|NCT00361335|21012759|P3|SC Period: Week E0 to Week E24|Lost to Follow-up|1
6087838|NCT00361335|21012760|P2|SC Period: Week E0 to Week E24|Lost to Follow-up|0
6087839|NCT00361335|21012761|P1|SC Period: Week E0 to Week E24|Lost to Follow-up|1
6087840|NCT00361335|21012755|P7|SC Period: Week E0 to Week E24|Adverse Event|2
6087841|NCT00361335|21012756|P6|SC Period: Week E0 to Week E24|Adverse Event|0
6087842|NCT00361335|21012757|P5|SC Period: Week E0 to Week E24|Adverse Event|0
6087843|NCT00361335|21012758|P4|SC Period: Week E0 to Week E24|Adverse Event|2
6087844|NCT00361335|21012759|P3|SC Period: Week E0 to Week E24|Adverse Event|1
6087845|NCT00361335|21012760|P2|SC Period: Week E0 to Week E24|Adverse Event|2
6087846|NCT00361335|21012761|P1|SC Period: Week E0 to Week E24|Adverse Event|0
6087847|NCT00361335|21012755|P7|IV Period: Baseline to E0|Lack of Efficacy|0
6087848|NCT00361335|21012756|P6|IV Period: Baseline to E0|Lack of Efficacy|0
6087849|NCT00361335|21012757|P5|IV Period: Baseline to E0|Lack of Efficacy|8
6087850|NCT00361335|21012758|P4|IV Period: Baseline to E0|Lack of Efficacy|7
6087851|NCT00361335|21012759|P3|IV Period: Baseline to E0|Lack of Efficacy|3
6087852|NCT00361335|21012760|P2|IV Period: Baseline to E0|Lack of Efficacy|9
6087853|NCT00361335|21012761|P1|IV Period: Baseline to E0|Lack of Efficacy|5
6087854|NCT00361335|21012755|P7|IV Period: Baseline to E0|Other|0
6087855|NCT00361335|21012756|P6|IV Period: Baseline to E0|Other|0
6087856|NCT00361335|21012757|P5|IV Period: Baseline to E0|Other|2
6087857|NCT00361335|21012758|P4|IV Period: Baseline to E0|Other|3
6087858|NCT00361335|21012759|P3|IV Period: Baseline to E0|Other|9
6087859|NCT00361335|21012760|P2|IV Period: Baseline to E0|Other|9
6087860|NCT00361335|21012761|P1|IV Period: Baseline to E0|Other|2
6087861|NCT00361335|21012755|P7|IV Period: Baseline to E0|Worsening of RA|0
6087862|NCT00361335|21012756|P6|IV Period: Baseline to E0|Worsening of RA|0
6087863|NCT00361335|21012757|P5|IV Period: Baseline to E0|Worsening of RA|2
6087864|NCT00361335|21012758|P4|IV Period: Baseline to E0|Worsening of RA|4
6087865|NCT00361335|21012759|P3|IV Period: Baseline to E0|Worsening of RA|1
6087866|NCT00361335|21012760|P2|IV Period: Baseline to E0|Worsening of RA|5
6087867|NCT00361335|21012761|P1|IV Period: Baseline to E0|Worsening of RA|0
6087868|NCT00361335|21012755|P7|IV Period: Baseline to E0|Protocol-prohibited medications|0
6087869|NCT00361335|21012756|P6|IV Period: Baseline to E0|Protocol-prohibited medications|0
6087870|NCT00361335|21012757|P5|IV Period: Baseline to E0|Protocol-prohibited medications|0
6087871|NCT00361335|21012758|P4|IV Period: Baseline to E0|Protocol-prohibited medications|0
6087872|NCT00361335|21012759|P3|IV Period: Baseline to E0|Protocol-prohibited medications|1
6087873|NCT00361335|21012760|P2|IV Period: Baseline to E0|Protocol-prohibited medications|0
6087874|NCT00361335|21012761|P1|IV Period: Baseline to E0|Protocol-prohibited medications|0
6087875|NCT00361335|21012755|P7|IV Period: Baseline to E0|Discontinued oral study agent|0
6087876|NCT00361335|21012756|P6|IV Period: Baseline to E0|Discontinued oral study agent|0
6087877|NCT00361335|21012757|P5|IV Period: Baseline to E0|Discontinued oral study agent|2
6087878|NCT00361335|21012758|P4|IV Period: Baseline to E0|Discontinued oral study agent|1
6087879|NCT00361335|21012759|P3|IV Period: Baseline to E0|Discontinued oral study agent|1
6087880|NCT00361335|21012760|P2|IV Period: Baseline to E0|Discontinued oral study agent|1
6087881|NCT00361335|21012761|P1|IV Period: Baseline to E0|Discontinued oral study agent|2
6087882|NCT00361335|21012755|P7|IV Period: Baseline to E0|Death|0
6087883|NCT00361335|21012756|P6|IV Period: Baseline to E0|Death|0
6087884|NCT00361335|21012757|P5|IV Period: Baseline to E0|Death|0
6087885|NCT00361335|21012758|P4|IV Period: Baseline to E0|Death|1
6087886|NCT00361335|21012759|P3|IV Period: Baseline to E0|Death|1
6087887|NCT00361335|21012760|P2|IV Period: Baseline to E0|Death|1
6087888|NCT00361335|21012761|P1|IV Period: Baseline to E0|Death|1
6087889|NCT00361335|21012755|P7|IV Period: Baseline to E0|Lost to Follow-up|0
6087890|NCT00361335|21012756|P6|IV Period: Baseline to E0|Lost to Follow-up|0
6087891|NCT00361335|21012757|P5|IV Period: Baseline to E0|Lost to Follow-up|2
6087892|NCT00361335|21012758|P4|IV Period: Baseline to E0|Lost to Follow-up|2
6087893|NCT00361335|21012759|P3|IV Period: Baseline to E0|Lost to Follow-up|0
6087894|NCT00361335|21012760|P2|IV Period: Baseline to E0|Lost to Follow-up|0
6087895|NCT00361335|21012761|P1|IV Period: Baseline to E0|Lost to Follow-up|1
6087896|NCT00361335|21012755|P7|IV Period: Baseline to E0|Adverse Event|0
6087897|NCT00361335|21012756|P6|IV Period: Baseline to E0|Adverse Event|0
6087898|NCT00361335|21012757|P5|IV Period: Baseline to E0|Adverse Event|8
6087899|NCT00361335|21012758|P4|IV Period: Baseline to E0|Adverse Event|9
6087900|NCT00361335|21012759|P3|IV Period: Baseline to E0|Adverse Event|5
6087901|NCT00361335|21012760|P2|IV Period: Baseline to E0|Adverse Event|4
6087902|NCT00361335|21012761|P1|IV Period: Baseline to E0|Adverse Event|9
6087903|NCT00361296|21012805|P1|Overall Study|Lack of Efficacy|2
6087904|NCT00361296|21012805|P1|Overall Study|Physician Decision|1
6087905|NCT00361283|21012812|P1|Overall Study|Lost to Follow-up|27
6087906|NCT00361270|21012820|P4|Overall Study|Adverse Event|0
6087907|NCT00361270|21012821|P3|Overall Study|Adverse Event|1
6087908|NCT00361270|21012822|P2|Overall Study|Adverse Event|1
6087909|NCT00361270|21012823|P1|Overall Study|Adverse Event|0
6087910|NCT00361270|21012820|P4|Overall Study|Problems with Transportation|0
6087911|NCT00361270|21012821|P3|Overall Study|Problems with Transportation|0
6087912|NCT00361270|21012822|P2|Overall Study|Problems with Transportation|0
6087913|NCT00361270|21012823|P1|Overall Study|Problems with Transportation|4
6087914|NCT00361270|21012820|P4|Overall Study|Afraid of Hypnosis|0
6087915|NCT00361270|21012821|P3|Overall Study|Afraid of Hypnosis|0
6087916|NCT00361270|21012822|P2|Overall Study|Afraid of Hypnosis|2
6087917|NCT00361270|21012823|P1|Overall Study|Afraid of Hypnosis|1
6087918|NCT00361270|21012820|P4|Overall Study|Withdrawal by Subject|7
6087919|NCT00361270|21012821|P3|Overall Study|Withdrawal by Subject|3
6087920|NCT00361270|21012822|P2|Overall Study|Withdrawal by Subject|6
6087921|NCT00361270|21012823|P1|Overall Study|Withdrawal by Subject|6
6087922|NCT00361270|21012820|P4|Overall Study|Protocol Violation|4
6087923|NCT00361270|21012821|P3|Overall Study|Protocol Violation|5
6087924|NCT00361270|21012822|P2|Overall Study|Protocol Violation|4
6087925|NCT00361270|21012823|P1|Overall Study|Protocol Violation|9
6087926|NCT00361270|21012820|P4|Overall Study|Physician Decision|0
6087927|NCT00361270|21012821|P3|Overall Study|Physician Decision|1
6087928|NCT00361270|21012822|P2|Overall Study|Physician Decision|0
6087929|NCT00361270|21012823|P1|Overall Study|Physician Decision|0
6087930|NCT00361270|21012820|P4|Overall Study|Lost to Follow-up|0
6087931|NCT00361270|21012821|P3|Overall Study|Lost to Follow-up|0
6087932|NCT00361270|21012822|P2|Overall Study|Lost to Follow-up|1
6087933|NCT00361270|21012823|P1|Overall Study|Lost to Follow-up|4
6087934|NCT00361270|21012820|P4|Overall Study|Death|2
6087935|NCT00361270|21012821|P3|Overall Study|Death|0
6087936|NCT00361270|21012822|P2|Overall Study|Death|0
6087937|NCT00361270|21012823|P1|Overall Study|Death|0
6087938|NCT00361231|21012896|P1|Overall Study|Adverse Event|6
6087939|NCT00361231|21012896|P1|Overall Study|Withdrawal by Subject|4
6087940|NCT00361231|21012896|P1|Overall Study|Radiographic disease progression|16
6087941|NCT00361231|21012896|P1|Overall Study|Symptomatic deterioration|5
6087942|NCT00361231|21012896|P1|Overall Study|Physician Decision|3
6087943|NCT00361218|21012901|P1|Overall Study|terminated / withdrawn due to toxicity /|5
6087944|NCT00361218|21012901|P1|Overall Study|Personal Reasons|7
6087945|NCT00361218|21012901|P1|Overall Study|Lost to Follow-up|11
6087946|NCT00360698|21012980|P2|Treatment Period|Early termination by error|1
6087947|NCT00360698|21012981|P1|Treatment Period|Early termination by error|0
6087948|NCT00360698|21012980|P2|Treatment Period|Non compliance with treatment procedure|0
6087949|NCT00360698|21012981|P1|Treatment Period|Non compliance with treatment procedure|1
6087950|NCT00360698|21012980|P2|Run-In|Need of insulin with meals|1
6087951|NCT00360698|21012981|P1|Run-In|Need of insulin with meals|0
6087952|NCT00360698|21012980|P2|Run-In|Patient personal reasons|2
6087953|NCT00360698|21012981|P1|Run-In|Patient personal reasons|0
6087954|NCT00360698|21012980|P2|Run-In|Patient did not meet inclusion criteria|1
6087955|NCT00360698|21012981|P1|Run-In|Patient did not meet inclusion criteria|0
6087956|NCT00360698|21012980|P2|Run-In|Sponsor request|2
6087957|NCT00360698|21012981|P1|Run-In|Sponsor request|0
6087958|NCT00360698|21012980|P2|Run-In|Non compliance with treatment procedure|1
6087959|NCT00360698|21012981|P1|Run-In|Non compliance with treatment procedure|0
6087960|NCT00360698|21012980|P2|Run-In|Withdrawal by Subject|2
6087961|NCT00360698|21012981|P1|Run-In|Withdrawal by Subject|0
6087962|NCT00360698|21012980|P2|Run-In|Physician Decision|1
6087963|NCT00360698|21012981|P1|Run-In|Physician Decision|0
6087964|NCT00360568|21013026|P2|Overall Study|Withdrawal by Subject|3
6087965|NCT00360568|21013027|P1|Overall Study|Withdrawal by Subject|0
6087966|NCT00360568|21013026|P2|Overall Study|Lack of Efficacy|0
6087967|NCT00360568|21013027|P1|Overall Study|Lack of Efficacy|1
6087968|NCT00360568|21013026|P2|Overall Study|Adverse Event|2
6087969|NCT00360568|21013027|P1|Overall Study|Adverse Event|1
6087970|NCT00360529|21013158|P3|Overall Study|Reason discontinued not explained above|11
6087971|NCT00360529|21013159|P2|Overall Study|Reason discontinued not explained above|9
6087972|NCT00360529|21013160|P1|Overall Study|Reason discontinued not explained above|4
6087973|NCT00360529|21013158|P3|Overall Study|Lack of Efficacy|5
6087974|NCT00360529|21013159|P2|Overall Study|Lack of Efficacy|6
6087975|NCT00360529|21013160|P1|Overall Study|Lack of Efficacy|8
6087976|NCT00360529|21013158|P3|Overall Study|Withdrawal by Subject|18
6087977|NCT00360529|21013159|P2|Overall Study|Withdrawal by Subject|14
6087978|NCT00360529|21013160|P1|Overall Study|Withdrawal by Subject|22
6087979|NCT00360529|21013158|P3|Overall Study|Lost to Follow-up|13
6087980|NCT00360529|21013159|P2|Overall Study|Lost to Follow-up|10
6087981|NCT00360529|21013160|P1|Overall Study|Lost to Follow-up|14
6087982|NCT00360529|21013158|P3|Overall Study|Protocol Violation|11
6087983|NCT00360529|21013159|P2|Overall Study|Protocol Violation|3
6087984|NCT00360529|21013160|P1|Overall Study|Protocol Violation|3
6087985|NCT00360529|21013158|P3|Overall Study|Adverse Event|33
6087986|NCT00360529|21013159|P2|Overall Study|Adverse Event|23
6087987|NCT00360529|21013160|P1|Overall Study|Adverse Event|10
6087988|NCT00360490|21013188|P2|Overall Study|Withdrawal by Subject|3
6087989|NCT00360490|21013189|P1|Overall Study|Withdrawal by Subject|1
6087990|NCT00360490|21013188|P2|Overall Study|Protocol Violation|4
6087991|NCT00360490|21013189|P1|Overall Study|Protocol Violation|0
6087992|NCT00360490|21013188|P2|Overall Study|Physician Decision|1
6087993|NCT00360490|21013189|P1|Overall Study|Physician Decision|2
6087994|NCT00360490|21013188|P2|Overall Study|Lost to Follow-up|1
6087995|NCT00360490|21013189|P1|Overall Study|Lost to Follow-up|2
6087996|NCT00360490|21013188|P2|Overall Study|Adverse Event|2
6087997|NCT00360490|21013189|P1|Overall Study|Adverse Event|4
6087998|NCT00360412|21013224|P2|Overall Study|Study termination by Sponsor|469
6087999|NCT00360412|21013225|P1|Overall Study|Study termination by Sponsor|214
6088000|NCT00360412|21013224|P2|Overall Study|Other|6
6088001|NCT00360412|21013225|P1|Overall Study|Other|5
6088002|NCT00360412|21013224|P2|Overall Study|Physician Decision|4
6088003|NCT00360412|21013225|P1|Overall Study|Physician Decision|2
6088004|NCT00360412|21013224|P2|Overall Study|Lack of therapeutic efficacy|61
6088005|NCT00360412|21013225|P1|Overall Study|Lack of therapeutic efficacy|46
6088006|NCT00360412|21013224|P2|Overall Study|Patient withdrew consent|52
6088007|NCT00360412|21013225|P1|Overall Study|Patient withdrew consent|27
6088008|NCT00360412|21013224|P2|Overall Study|Protocol Violation|5
6088009|NCT00360412|21013225|P1|Overall Study|Protocol Violation|2
6088010|NCT00360412|21013224|P2|Overall Study|Adverse Event|65
6088011|NCT00360412|21013225|P1|Overall Study|Adverse Event|37
6088012|NCT00360334|21013272|P2|Overall Study|Subject decision|2
6088013|NCT00360334|21013273|P1|Overall Study|Subject decision|8
6088014|NCT00360334|21013272|P2|Overall Study|Entry criterion not met|2
6088015|NCT00360334|21013273|P1|Overall Study|Entry criterion not met|1
6088016|NCT00360334|21013272|P2|Overall Study|Lack of Efficacy|1
6088017|NCT00360334|21013273|P1|Overall Study|Lack of Efficacy|0
6088018|NCT00360334|21013272|P2|Overall Study|Physician Decision|3
6088019|NCT00360334|21013273|P1|Overall Study|Physician Decision|2
6088020|NCT00360334|21013272|P2|Overall Study|Protocol Violation|1
6088021|NCT00360334|21013273|P1|Overall Study|Protocol Violation|1
6088022|NCT00360334|21013272|P2|Overall Study|Adverse Event|4
6088023|NCT00360334|21013273|P1|Overall Study|Adverse Event|7
6088024|NCT00360308|21013336|P3|Overall Study|Study termination by sponsor|44
6088025|NCT00360308|21013337|P2|Overall Study|Study termination by sponsor|55
6088026|NCT00360308|21013338|P1|Overall Study|Study termination by sponsor|43
6088027|NCT00360308|21013336|P3|Overall Study|Other|1
6088028|NCT00360308|21013337|P2|Overall Study|Other|1
6088029|NCT00360308|21013338|P1|Overall Study|Other|2
6088030|NCT00360308|21013336|P3|Overall Study|Lack of Efficacy|2
6088031|NCT00360308|21013337|P2|Overall Study|Lack of Efficacy|0
6088032|NCT00360308|21013338|P1|Overall Study|Lack of Efficacy|3
6088033|NCT00360308|21013336|P3|Overall Study|Withdrawal by Subject|14
6088034|NCT00360308|21013337|P2|Overall Study|Withdrawal by Subject|7
6088035|NCT00360308|21013338|P1|Overall Study|Withdrawal by Subject|11
6088036|NCT00360308|21013336|P3|Overall Study|Protocol Violation|2
6088037|NCT00360308|21013337|P2|Overall Study|Protocol Violation|1
6088038|NCT00360308|21013338|P1|Overall Study|Protocol Violation|2
6088039|NCT00360308|21013336|P3|Overall Study|Abnormal Laboratory Value(s)|0
6088040|NCT00360308|21013337|P2|Overall Study|Abnormal Laboratory Value(s)|1
6088041|NCT00360308|21013338|P1|Overall Study|Abnormal Laboratory Value(s)|0
6088042|NCT00360308|21013336|P3|Overall Study|Adverse Event|25
6088043|NCT00360308|21013337|P2|Overall Study|Adverse Event|14
6088044|NCT00360308|21013338|P1|Overall Study|Adverse Event|15
6088045|NCT00360282|21013355|P4|Second Intervention|Adverse Event|0
6088046|NCT00360282|21013356|P3|Second Intervention|Adverse Event|0
6088047|NCT00360282|21013357|P2|Second Intervention|Adverse Event|1
6088048|NCT00360282|21013358|P1|Second Intervention|Adverse Event|0
6088049|NCT00360282|21013355|P4|Washout 1-3 Weeks|Lost to Follow-up|0
6088050|NCT00360282|21013356|P3|Washout 1-3 Weeks|Lost to Follow-up|1
6088051|NCT00360282|21013357|P2|Washout 1-3 Weeks|Lost to Follow-up|0
6088052|NCT00360282|21013358|P1|Washout 1-3 Weeks|Lost to Follow-up|0
6088053|NCT00360269|21013370|P2|Overall Study|Withdrawal by Subject|1
6088054|NCT00360269|21013371|P1|Overall Study|Withdrawal by Subject|1
6088055|NCT00360269|21013370|P2|Overall Study|Adverse Event|0
6088056|NCT00360269|21013371|P1|Overall Study|Adverse Event|1
6088057|NCT00360269|21013370|P2|Overall Study|Physician Decision|2
6088058|NCT00360269|21013371|P1|Overall Study|Physician Decision|1
6088059|NCT00360269|21013370|P2|Overall Study|Lost to Follow-up|9
6088060|NCT00360269|21013371|P1|Overall Study|Lost to Follow-up|7
6088061|NCT00360230|21013413|P7|Overall Study|Death|1
6088062|NCT00360230|21013414|P6|Overall Study|Death|1
6088063|NCT00360230|21013415|P5|Overall Study|Death|0
6088064|NCT00360230|21013416|P4|Overall Study|Death|0
6088065|NCT00360230|21013417|P3|Overall Study|Death|0
6088066|NCT00360230|21013418|P2|Overall Study|Death|1
6088067|NCT00360230|21013419|P1|Overall Study|Death|0
6088068|NCT00360230|21013413|P7|Overall Study|Protocol Violation|0
6088069|NCT00360230|21013414|P6|Overall Study|Protocol Violation|1
6088070|NCT00360230|21013415|P5|Overall Study|Protocol Violation|0
6088071|NCT00360230|21013416|P4|Overall Study|Protocol Violation|0
6088072|NCT00360230|21013417|P3|Overall Study|Protocol Violation|0
6088073|NCT00360230|21013418|P2|Overall Study|Protocol Violation|0
6088074|NCT00360230|21013419|P1|Overall Study|Protocol Violation|0
6088075|NCT00360230|21013413|P7|Overall Study|Other|0
6088076|NCT00360230|21013414|P6|Overall Study|Other|0
6088077|NCT00360230|21013415|P5|Overall Study|Other|0
6088078|NCT00360230|21013416|P4|Overall Study|Other|0
6088079|NCT00360230|21013417|P3|Overall Study|Other|0
6088080|NCT00360230|21013418|P2|Overall Study|Other|0
6088081|NCT00360230|21013419|P1|Overall Study|Other|1
6088082|NCT00360230|21013413|P7|Overall Study|Migrated|1
6088083|NCT00360230|21013414|P6|Overall Study|Migrated|1
6088084|NCT00360230|21013415|P5|Overall Study|Migrated|4
6088085|NCT00360230|21013416|P4|Overall Study|Migrated|1
6088086|NCT00360230|21013417|P3|Overall Study|Migrated|3
6088087|NCT00360230|21013418|P2|Overall Study|Migrated|1
6088088|NCT00360230|21013419|P1|Overall Study|Migrated|4
6088089|NCT00360230|21013413|P7|Overall Study|Withdrawal by Subject|0
6088090|NCT00360230|21013414|P6|Overall Study|Withdrawal by Subject|1
6088091|NCT00360230|21013415|P5|Overall Study|Withdrawal by Subject|1
6088092|NCT00360230|21013416|P4|Overall Study|Withdrawal by Subject|1
6088093|NCT00360230|21013417|P3|Overall Study|Withdrawal by Subject|0
6088094|NCT00360230|21013418|P2|Overall Study|Withdrawal by Subject|1
6088095|NCT00360230|21013419|P1|Overall Study|Withdrawal by Subject|1
6088096|NCT00359801|21013575|P2|Overall Study|Sponsor Decision|16
6088097|NCT00359801|21013576|P1|Overall Study|Sponsor Decision|17
6088098|NCT00359801|21013575|P2|Overall Study|Final Status Unknown: missing data|4
6088099|NCT00359801|21013576|P1|Overall Study|Final Status Unknown: missing data|7
6088100|NCT00359801|21013575|P2|Overall Study|Other|46
6088101|NCT00359801|21013576|P1|Overall Study|Other|66
6088102|NCT00359801|21013575|P2|Overall Study|Withdrawal by Subject|96
6088103|NCT00359801|21013576|P1|Overall Study|Withdrawal by Subject|143
6088104|NCT00359801|21013575|P2|Overall Study|Lost to Follow-up|58
6088105|NCT00359801|21013576|P1|Overall Study|Lost to Follow-up|72
6088106|NCT00359788|21013610|P2|Overall Study|Protocol Violation|2
6088107|NCT00359788|21013611|P1|Overall Study|Protocol Violation|4
6088108|NCT00359788|21013610|P2|Overall Study|Withdrawal by Subject|1
6088109|NCT00359788|21013611|P1|Overall Study|Withdrawal by Subject|4
6088110|NCT00359788|21013610|P2|Overall Study|Lost to Follow-up|2
6088111|NCT00359788|21013611|P1|Overall Study|Lost to Follow-up|3
6088112|NCT00359788|21013610|P2|Overall Study|Lack of Efficacy|2
6088113|NCT00359788|21013611|P1|Overall Study|Lack of Efficacy|1
6088114|NCT00359788|21013610|P2|Overall Study|Adverse Event|10
6088115|NCT00359788|21013611|P1|Overall Study|Adverse Event|11
6088116|NCT00359762|21013845|P5|Period III|Subject Decision|0
6088117|NCT00359762|21013846|P4|Period III|Subject Decision|20
6088118|NCT00359762|21013847|P3|Period III|Subject Decision|8
6088119|NCT00359762|21013848|P2|Period III|Subject Decision|7
6088120|NCT00359762|21013849|P1|Period III|Subject Decision|0
6088121|NCT00359762|21013845|P5|Period III|Entry Criteria Not Met|0
6088122|NCT00359762|21013846|P4|Period III|Entry Criteria Not Met|1
6088123|NCT00359762|21013847|P3|Period III|Entry Criteria Not Met|0
6088124|NCT00359762|21013848|P2|Period III|Entry Criteria Not Met|1
6088125|NCT00359762|21013849|P1|Period III|Entry Criteria Not Met|0
6088126|NCT00359762|21013845|P5|Period III|Lost to follow up|0
6088127|NCT00359762|21013846|P4|Period III|Lost to follow up|2
6088128|NCT00359762|21013847|P3|Period III|Lost to follow up|1
6088129|NCT00359762|21013848|P2|Period III|Lost to follow up|1
6088130|NCT00359762|21013849|P1|Period III|Lost to follow up|0
6088131|NCT00359762|21013845|P5|Period III|Lack of Efficacy|0
6088132|NCT00359762|21013846|P4|Period III|Lack of Efficacy|9
6088133|NCT00359762|21013847|P3|Period III|Lack of Efficacy|5
6088134|NCT00359762|21013848|P2|Period III|Lack of Efficacy|7
6088135|NCT00359762|21013849|P1|Period III|Lack of Efficacy|0
6088136|NCT00359762|21013845|P5|Period III|Physician Decision|0
6088137|NCT00359762|21013846|P4|Period III|Physician Decision|15
6088138|NCT00359762|21013847|P3|Period III|Physician Decision|9
6088139|NCT00359762|21013848|P2|Period III|Physician Decision|5
6088140|NCT00359762|21013849|P1|Period III|Physician Decision|0
6088141|NCT00359762|21013845|P5|Period III|Adverse Event|0
6088142|NCT00359762|21013846|P4|Period III|Adverse Event|10
6088143|NCT00359762|21013847|P3|Period III|Adverse Event|4
6088144|NCT00359762|21013848|P2|Period III|Adverse Event|3
6088145|NCT00359762|21013849|P1|Period III|Adverse Event|0
6088146|NCT00359762|21013845|P5|Period III|Protocol Violation|0
6088147|NCT00359762|21013846|P4|Period III|Protocol Violation|8
6088148|NCT00359762|21013847|P3|Period III|Protocol Violation|3
6088149|NCT00359762|21013848|P2|Period III|Protocol Violation|5
6088150|NCT00359762|21013849|P1|Period III|Protocol Violation|0
6088151|NCT00359762|21013845|P5|Period II|Subject Decision|70
6088152|NCT00359762|21013846|P4|Period II|Subject Decision|0
6088153|NCT00359762|21013847|P3|Period II|Subject Decision|0
6088154|NCT00359762|21013848|P2|Period II|Subject Decision|0
6088155|NCT00359762|21013849|P1|Period II|Subject Decision|50
6088156|NCT00359762|21013845|P5|Period II|Entry Criteria Not Met|4
6088157|NCT00359762|21013846|P4|Period II|Entry Criteria Not Met|0
6088158|NCT00359762|21013847|P3|Period II|Entry Criteria Not Met|0
6088159|NCT00359762|21013848|P2|Period II|Entry Criteria Not Met|0
6088160|NCT00359762|21013849|P1|Period II|Entry Criteria Not Met|8
6088161|NCT00359762|21013845|P5|Period II|Lost to follow up|5
6088162|NCT00359762|21013846|P4|Period II|Lost to follow up|0
6088163|NCT00359762|21013847|P3|Period II|Lost to follow up|0
6088164|NCT00359762|21013848|P2|Period II|Lost to follow up|0
6088165|NCT00359762|21013849|P1|Period II|Lost to follow up|5
6088166|NCT00359762|21013845|P5|Period II|Lack of Efficacy|8
6088167|NCT00359762|21013846|P4|Period II|Lack of Efficacy|0
6088168|NCT00359762|21013847|P3|Period II|Lack of Efficacy|0
6088169|NCT00359762|21013848|P2|Period II|Lack of Efficacy|0
6088170|NCT00359762|21013849|P1|Period II|Lack of Efficacy|11
6088171|NCT00359762|21013845|P5|Period II|Death|4
6088172|NCT00359762|21013846|P4|Period II|Death|0
6088173|NCT00359762|21013847|P3|Period II|Death|0
6088174|NCT00359762|21013848|P2|Period II|Death|0
6088175|NCT00359762|21013849|P1|Period II|Death|2
6088176|NCT00359762|21013845|P5|Period II|Physician Decision|23
6088177|NCT00359762|21013846|P4|Period II|Physician Decision|0
6088178|NCT00359762|21013847|P3|Period II|Physician Decision|0
6088179|NCT00359762|21013848|P2|Period II|Physician Decision|0
6088180|NCT00359762|21013849|P1|Period II|Physician Decision|17
6088181|NCT00359762|21013845|P5|Period II|Protocol Violation|11
6088182|NCT00359762|21013846|P4|Period II|Protocol Violation|0
6088183|NCT00359762|21013847|P3|Period II|Protocol Violation|0
6088184|NCT00359762|21013848|P2|Period II|Protocol Violation|0
6088185|NCT00359762|21013849|P1|Period II|Protocol Violation|18
6088186|NCT00359762|21013845|P5|Period II|Adverse Event|49
6088187|NCT00359762|21013846|P4|Period II|Adverse Event|0
6088188|NCT00359762|21013847|P3|Period II|Adverse Event|0
6088189|NCT00359762|21013848|P2|Period II|Adverse Event|0
6088190|NCT00359762|21013849|P1|Period II|Adverse Event|17
6088191|NCT00359632|21013923|P2|Overall Study|Non-compliance with visit schedule|0
6088192|NCT00359632|21013924|P1|Overall Study|Non-compliance with visit schedule|1
6088193|NCT00359632|21013923|P2|Overall Study|Adverse Event|0
6088194|NCT00359632|21013924|P1|Overall Study|Adverse Event|1
6088195|NCT00359632|21013923|P2|Overall Study|Death|0
6088196|NCT00359632|21013924|P1|Overall Study|Death|2
6088197|NCT00359619|21013938|P7|Overall Study|Lost to Follow-up|0
6088198|NCT00359619|21013939|P6|Overall Study|Lost to Follow-up|5
6088199|NCT00359619|21013940|P5|Overall Study|Lost to Follow-up|1
6088200|NCT00359619|21013941|P4|Overall Study|Lost to Follow-up|1
6088201|NCT00359619|21013942|P3|Overall Study|Lost to Follow-up|2
6088202|NCT00359619|21013943|P2|Overall Study|Lost to Follow-up|4
6088203|NCT00359619|21013944|P1|Overall Study|Lost to Follow-up|4
6088204|NCT00359619|21013938|P7|Overall Study|Other|0
6088205|NCT00359619|21013939|P6|Overall Study|Other|0
6088206|NCT00359619|21013940|P5|Overall Study|Other|0
6088207|NCT00359619|21013941|P4|Overall Study|Other|0
6088208|NCT00359619|21013942|P3|Overall Study|Other|0
6088209|NCT00359619|21013943|P2|Overall Study|Other|0
6088210|NCT00359619|21013944|P1|Overall Study|Other|1
6088211|NCT00359619|21013938|P7|Overall Study|Withdrawal by Subject|3
6088212|NCT00359619|21013939|P6|Overall Study|Withdrawal by Subject|0
6088213|NCT00359619|21013940|P5|Overall Study|Withdrawal by Subject|2
6088214|NCT00359619|21013941|P4|Overall Study|Withdrawal by Subject|2
6088215|NCT00359619|21013942|P3|Overall Study|Withdrawal by Subject|4
6088216|NCT00359619|21013943|P2|Overall Study|Withdrawal by Subject|1
6088217|NCT00359619|21013944|P1|Overall Study|Withdrawal by Subject|3
6088218|NCT00359619|21013938|P7|Overall Study|Adverse Event|1
6088219|NCT00359619|21013939|P6|Overall Study|Adverse Event|0
6088220|NCT00359619|21013940|P5|Overall Study|Adverse Event|0
6088221|NCT00359619|21013941|P4|Overall Study|Adverse Event|0
6088222|NCT00359619|21013942|P3|Overall Study|Adverse Event|1
6088223|NCT00359619|21013943|P2|Overall Study|Adverse Event|0
6088224|NCT00359619|21013944|P1|Overall Study|Adverse Event|0
6088225|NCT00359424|21014074|P2|Overall Study|follow up not conducted|0
6088226|NCT00359424|21014075|P1|Overall Study|follow up not conducted|2
6088227|NCT00359424|21014074|P2|Overall Study|Withdrawal by Subject|2
6088228|NCT00359424|21014075|P1|Overall Study|Withdrawal by Subject|10
6088229|NCT00359424|21014074|P2|Overall Study|Lost to Follow-up|7
6088230|NCT00359424|21014075|P1|Overall Study|Lost to Follow-up|19
6088231|NCT00359424|21014074|P2|Overall Study|Death|58
6088232|NCT00359424|21014075|P1|Overall Study|Death|99
6088233|NCT00359281|21014114|P9|Overall Study|Withdrawal by Subject|0
6088234|NCT00359281|21014115|P8|Overall Study|Withdrawal by Subject|0
6088235|NCT00359281|21014116|P7|Overall Study|Withdrawal by Subject|1
6088236|NCT00359281|21014117|P6|Overall Study|Withdrawal by Subject|0
6088237|NCT00359281|21014118|P5|Overall Study|Withdrawal by Subject|0
6088238|NCT00359281|21014119|P4|Overall Study|Withdrawal by Subject|0
6088239|NCT00359281|21014120|P3|Overall Study|Withdrawal by Subject|0
6088240|NCT00359281|21014121|P2|Overall Study|Withdrawal by Subject|0
6088241|NCT00359281|21014122|P1|Overall Study|Withdrawal by Subject|0
6088242|NCT00359281|21014114|P9|Overall Study|Adverse Event|0
6088243|NCT00359281|21014115|P8|Overall Study|Adverse Event|0
6088244|NCT00359281|21014116|P7|Overall Study|Adverse Event|1
6088245|NCT00359281|21014117|P6|Overall Study|Adverse Event|0
6088246|NCT00359281|21014118|P5|Overall Study|Adverse Event|0
6088247|NCT00359281|21014119|P4|Overall Study|Adverse Event|0
6088248|NCT00359281|21014120|P3|Overall Study|Adverse Event|0
6088249|NCT00359281|21014121|P2|Overall Study|Adverse Event|0
6088250|NCT00359281|21014122|P1|Overall Study|Adverse Event|1
6088251|NCT00359073|21014185|P2|Overall Study|developed RV16 antibody|1
6088252|NCT00359073|21014186|P1|Overall Study|developed RV16 antibody|0
6088253|NCT00359073|21014185|P2|Overall Study|Eligibility criteria no longer met|0
6088254|NCT00359073|21014186|P1|Overall Study|Eligibility criteria no longer met|3
6088255|NCT00359073|21014185|P2|Overall Study|Withdrawal by Subject|1
6088256|NCT00359073|21014186|P1|Overall Study|Withdrawal by Subject|1
6088257|NCT00359021|21014198|P2|Overall Study|Pregnancy|0
6088258|NCT00359021|21014199|P1|Overall Study|Pregnancy|1
6088259|NCT00359021|21014198|P2|Overall Study|Other|1
6088260|NCT00359021|21014199|P1|Overall Study|Other|4
6088261|NCT00359021|21014198|P2|Overall Study|Lost to Follow-up|0
6088262|NCT00359021|21014199|P1|Overall Study|Lost to Follow-up|1
6088263|NCT00359021|21014198|P2|Overall Study|Withdrawal by Subject|9
6088264|NCT00359021|21014199|P1|Overall Study|Withdrawal by Subject|2
6088265|NCT00359021|21014198|P2|Overall Study|Subject Reached A Virologic Endpoint|32
6088266|NCT00359021|21014199|P1|Overall Study|Subject Reached A Virologic Endpoint|45
6088267|NCT00359021|21014198|P2|Overall Study|Subject Ineligible To Continue The Trial|0
6088268|NCT00359021|21014199|P1|Overall Study|Subject Ineligible To Continue The Trial|1
6088269|NCT00359021|21014198|P2|Overall Study|Subject Non-Compliant|2
6088270|NCT00359021|21014199|P1|Overall Study|Subject Non-Compliant|1
6088271|NCT00359021|21014198|P2|Overall Study|Adverse Event|8
6088272|NCT00359021|21014199|P1|Overall Study|Adverse Event|26
6088273|NCT00358956|21014211|P1|Overall Study|Withdrawal by Subject|1
6088274|NCT00358956|21014211|P1|Overall Study|condition under investigation worsened|4
6088275|NCT00358956|21014211|P1|Overall Study|Adverse Event|3
6088276|NCT00358917|21014223|P2|Overall Study|Unable to Continue Participation|2
6088277|NCT00358917|21014224|P1|Overall Study|Unable to Continue Participation|2
6088278|NCT00358917|21014223|P2|Overall Study|Virologic failure|8
6088279|NCT00358917|21014224|P1|Overall Study|Virologic failure|11
6088280|NCT00358917|21014223|P2|Overall Study|Death|3
6088281|NCT00358917|21014224|P1|Overall Study|Death|2
6088282|NCT00358917|21014223|P2|Overall Study|Noncompliance|11
6088283|NCT00358917|21014224|P1|Overall Study|Noncompliance|12
6088284|NCT00358917|21014223|P2|Overall Study|Lost to Follow-up|17
6088285|NCT00358917|21014224|P1|Overall Study|Lost to Follow-up|20
6088286|NCT00358917|21014223|P2|Overall Study|Withdrawal by Subject|7
6088287|NCT00358917|21014224|P1|Overall Study|Withdrawal by Subject|5
6088288|NCT00358917|21014223|P2|Overall Study|Adverse Event|21
6088289|NCT00358917|21014224|P1|Overall Study|Adverse Event|14
6088290|NCT00358826|21014242|P8|MDCT Substudy|Withdrawal by Subject|0
6088291|NCT00358826|21014243|P7|MDCT Substudy|Withdrawal by Subject|0
6088292|NCT00358826|21014244|P6|MDCT Substudy|Withdrawal by Subject|1
6088293|NCT00358826|21014245|P5|MDCT Substudy|Withdrawal by Subject|0
6088294|NCT00358826|21014246|P4|MDCT Substudy|Withdrawal by Subject|0
6088295|NCT00358826|21014247|P3|MDCT Substudy|Withdrawal by Subject|0
6088296|NCT00358826|21014248|P2|MDCT Substudy|Withdrawal by Subject|0
6088297|NCT00358826|21014249|P1|MDCT Substudy|Withdrawal by Subject|0
6088298|NCT00358826|21014242|P8|MDCT Substudy|Lost to Follow-up|0
6088299|NCT00358826|21014243|P7|MDCT Substudy|Lost to Follow-up|0
6088300|NCT00358826|21014244|P6|MDCT Substudy|Lost to Follow-up|1
6088301|NCT00358826|21014245|P5|MDCT Substudy|Lost to Follow-up|0
6088302|NCT00358826|21014246|P4|MDCT Substudy|Lost to Follow-up|0
6088303|NCT00358826|21014247|P3|MDCT Substudy|Lost to Follow-up|0
6088304|NCT00358826|21014248|P2|MDCT Substudy|Lost to Follow-up|0
6088305|NCT00358826|21014249|P1|MDCT Substudy|Lost to Follow-up|0
6088306|NCT00358826|21014242|P8|MDCT Substudy|Adverse Event|0
6088307|NCT00358826|21014243|P7|MDCT Substudy|Adverse Event|0
6088308|NCT00358826|21014244|P6|MDCT Substudy|Adverse Event|0
6088309|NCT00358826|21014245|P5|MDCT Substudy|Adverse Event|1
6088310|NCT00358826|21014246|P4|MDCT Substudy|Adverse Event|0
6088311|NCT00358826|21014247|P3|MDCT Substudy|Adverse Event|0
6088312|NCT00358826|21014248|P2|MDCT Substudy|Adverse Event|0
6088313|NCT00358826|21014249|P1|MDCT Substudy|Adverse Event|0
6088314|NCT00358826|21014242|P8|Core Study|Physician Decision|0
6088315|NCT00358826|21014243|P7|Core Study|Physician Decision|0
6088316|NCT00358826|21014244|P6|Core Study|Physician Decision|0
6088317|NCT00358826|21014245|P5|Core Study|Physician Decision|0
6088318|NCT00358826|21014246|P4|Core Study|Physician Decision|0
6088319|NCT00358826|21014247|P3|Core Study|Physician Decision|1
6088320|NCT00358826|21014248|P2|Core Study|Physician Decision|0
6088321|NCT00358826|21014249|P1|Core Study|Physician Decision|0
6088322|NCT00358826|21014242|P8|Core Study|Lost to Follow-up|0
6088323|NCT00358826|21014243|P7|Core Study|Lost to Follow-up|0
6088324|NCT00358826|21014244|P6|Core Study|Lost to Follow-up|0
6088325|NCT00358826|21014245|P5|Core Study|Lost to Follow-up|0
6088326|NCT00358826|21014246|P4|Core Study|Lost to Follow-up|1
6088327|NCT00358826|21014247|P3|Core Study|Lost to Follow-up|0
6088328|NCT00358826|21014248|P2|Core Study|Lost to Follow-up|0
6088329|NCT00358826|21014249|P1|Core Study|Lost to Follow-up|0
6088330|NCT00358826|21014242|P8|Core Study|Withdrawal by Subject|0
6088331|NCT00358826|21014243|P7|Core Study|Withdrawal by Subject|0
6088332|NCT00358826|21014244|P6|Core Study|Withdrawal by Subject|0
6088333|NCT00358826|21014245|P5|Core Study|Withdrawal by Subject|0
6088334|NCT00358826|21014246|P4|Core Study|Withdrawal by Subject|0
6088335|NCT00358826|21014247|P3|Core Study|Withdrawal by Subject|0
6088336|NCT00358826|21014248|P2|Core Study|Withdrawal by Subject|2
6088337|NCT00358826|21014249|P1|Core Study|Withdrawal by Subject|2
6088338|NCT00358826|21014242|P8|Core Study|Adverse Event|0
6088339|NCT00358826|21014243|P7|Core Study|Adverse Event|0
6088340|NCT00358826|21014244|P6|Core Study|Adverse Event|0
6088341|NCT00358826|21014245|P5|Core Study|Adverse Event|0
6088342|NCT00358826|21014246|P4|Core Study|Adverse Event|1
6088343|NCT00358826|21014247|P3|Core Study|Adverse Event|1
6088344|NCT00358826|21014248|P2|Core Study|Adverse Event|3
6088345|NCT00358826|21014249|P1|Core Study|Adverse Event|1
6088346|NCT00358670|21014316|P2|Overall Study|Administrative|125
6088347|NCT00358670|21014317|P1|Overall Study|Administrative|153
6088348|NCT00358670|21014316|P2|Overall Study|Did Not Meet Protocol Eligibility|3
6088349|NCT00358670|21014317|P1|Overall Study|Did Not Meet Protocol Eligibility|0
6088350|NCT00358670|21014316|P2|Overall Study|Protocol Defined Clinical Event|1
6088351|NCT00358670|21014317|P1|Overall Study|Protocol Defined Clinical Event|0
6088352|NCT00358670|21014316|P2|Overall Study|Withdrawal by Subject|24
6088353|NCT00358670|21014317|P1|Overall Study|Withdrawal by Subject|13
6088354|NCT00358670|21014316|P2|Overall Study|Lost to Follow-up|5
6088355|NCT00358670|21014317|P1|Overall Study|Lost to Follow-up|4
6088356|NCT00358670|21014316|P2|Overall Study|Protocol Violation|9
6088357|NCT00358670|21014317|P1|Overall Study|Protocol Violation|6
6088358|NCT00358670|21014316|P2|Overall Study|Lack of Efficacy|23
6088359|NCT00358670|21014317|P1|Overall Study|Lack of Efficacy|20
6088360|NCT00358670|21014316|P2|Overall Study|Adverse Event|29
6088361|NCT00358670|21014317|P1|Overall Study|Adverse Event|26
6088362|NCT00358644|21014343|P1|Overall Study|Patient not eligible for study|1
6088363|NCT00358644|21014343|P1|Overall Study|Physician Decision|6
6088364|NCT00358644|21014343|P1|Overall Study|Withdrawal by Subject|4
6088365|NCT00358644|21014343|P1|Overall Study|Death|11
6088366|NCT00358644|21014343|P1|Overall Study|Adverse Event|7
6088367|NCT00358644|21014343|P1|Overall Study|Progressive Disease|21
6088368|NCT00358527|21014366|P2|Overall Study|Administrative|1
6088369|NCT00358527|21014367|P1|Overall Study|Administrative|2
6088370|NCT00358527|21014366|P2|Overall Study|Non-compliance with protocol|1
6088371|NCT00358527|21014367|P1|Overall Study|Non-compliance with protocol|6
6088372|NCT00358527|21014366|P2|Overall Study|Withdrawal by Subject|1
6088373|NCT00358527|21014367|P1|Overall Study|Withdrawal by Subject|1
6088374|NCT00358527|21014366|P2|Overall Study|Adverse Event|0
6088375|NCT00358527|21014367|P1|Overall Study|Adverse Event|4
6088376|NCT00358449|21014417|P3|Overall Study|Steriod Inhaler was Increased|1
6088377|NCT00358449|21014418|P2|Overall Study|Steriod Inhaler was Increased|0
6088378|NCT00358449|21014419|P1|Overall Study|Steriod Inhaler was Increased|0
6088379|NCT00358449|21014417|P3|Overall Study|Lack of Efficacy|0
6088380|NCT00358449|21014418|P2|Overall Study|Lack of Efficacy|1
6088381|NCT00358449|21014419|P1|Overall Study|Lack of Efficacy|0
6088382|NCT00358449|21014417|P3|Overall Study|Withdrawal by Subject|0
6088383|NCT00358449|21014418|P2|Overall Study|Withdrawal by Subject|0
6088384|NCT00358449|21014419|P1|Overall Study|Withdrawal by Subject|2
6088385|NCT00358449|21014417|P3|Overall Study|Lost to Follow-up|0
6088386|NCT00358449|21014418|P2|Overall Study|Lost to Follow-up|0
6088387|NCT00358449|21014419|P1|Overall Study|Lost to Follow-up|1
6088388|NCT00358449|21014417|P3|Overall Study|Adverse Event|1
6088389|NCT00358449|21014418|P2|Overall Study|Adverse Event|0
6088390|NCT00358449|21014419|P1|Overall Study|Adverse Event|1
6088391|NCT00358436|21014522|P2|Overall Study|Other|1
6088392|NCT00358436|21014523|P1|Overall Study|Other|6
6088393|NCT00358436|21014522|P2|Overall Study|COPD exacerbation|10
6088394|NCT00358436|21014523|P1|Overall Study|COPD exacerbation|22
6088395|NCT00358436|21014522|P2|Overall Study|Non-fulfilment of inclusion/exclusion|0
6088396|NCT00358436|21014523|P1|Overall Study|Non-fulfilment of inclusion/exclusion|4
6088397|NCT00358436|21014522|P2|Overall Study|Withdrawal by Subject|17
6088398|NCT00358436|21014523|P1|Overall Study|Withdrawal by Subject|40
6088399|NCT00358436|21014522|P2|Overall Study|Protocol Violation|3
6088400|NCT00358436|21014523|P1|Overall Study|Protocol Violation|8
6088401|NCT00358436|21014522|P2|Overall Study|Lost to Follow-up|6
6088402|NCT00358436|21014523|P1|Overall Study|Lost to Follow-up|11
6088403|NCT00358436|21014522|P2|Overall Study|Lack of Efficacy|36
6088404|NCT00358436|21014523|P1|Overall Study|Lack of Efficacy|34
6088405|NCT00358436|21014522|P2|Overall Study|Adverse Event|13
6088406|NCT00358436|21014523|P1|Overall Study|Adverse Event|29
6088407|NCT00358215|21014594|P2|Overall Study|Did not receive investigational product|3
6088408|NCT00358215|21014595|P1|Overall Study|Did not receive investigational product|2
6088409|NCT00358215|21014594|P2|Overall Study|Other|14
6088410|NCT00358215|21014595|P1|Overall Study|Other|21
6088411|NCT00358215|21014594|P2|Overall Study|Pregnancy|0
6088412|NCT00358215|21014595|P1|Overall Study|Pregnancy|1
6088413|NCT00358215|21014594|P2|Overall Study|Protocol Violation|59
6088414|NCT00358215|21014595|P1|Overall Study|Protocol Violation|64
6088415|NCT00358215|21014594|P2|Overall Study|Death|281
6088416|NCT00358215|21014595|P1|Overall Study|Death|265
6088417|NCT00358215|21014594|P2|Overall Study|Lost to Follow-up|22
6088418|NCT00358215|21014595|P1|Overall Study|Lost to Follow-up|16
6088419|NCT00358215|21014594|P2|Overall Study|Physician Decision|39
6088420|NCT00358215|21014595|P1|Overall Study|Physician Decision|47
6088421|NCT00358215|21014594|P2|Overall Study|Participant request|64
6088422|NCT00358215|21014595|P1|Overall Study|Participant request|65
6088423|NCT00358215|21014594|P2|Overall Study|Withdrawal by Subject|102
6088424|NCT00358215|21014595|P1|Overall Study|Withdrawal by Subject|111
6088425|NCT00358215|21014594|P2|Overall Study|Adverse Event|65
6088426|NCT00358215|21014595|P1|Overall Study|Adverse Event|83
6088427|NCT00358215|21014594|P2|Overall Study|Ineligibility determined|3
6088428|NCT00358215|21014595|P1|Overall Study|Ineligibility determined|4
6088429|NCT00358150|21014609|P1|Overall Study|Undefined|3
6088430|NCT00358150|21014609|P1|Overall Study|Withdrawal by Subject|1
6088431|NCT00358150|21014609|P1|Overall Study|Adverse Event|3
6088432|NCT00357994|21014638|P2|Overall Study|Protocol Violation|0
6088433|NCT00357994|21014639|P1|Overall Study|Protocol Violation|1
6088434|NCT00357994|21014638|P2|Overall Study|Lack of Efficacy|1
6088435|NCT00357994|21014639|P1|Overall Study|Lack of Efficacy|0
6088436|NCT00357994|21014638|P2|Overall Study|Adverse Event|2
6088437|NCT00357994|21014639|P1|Overall Study|Adverse Event|1
6088438|NCT00357968|21014693|P2|First Maintenance Dose Phase|Withdrawal by Subject|2
6088439|NCT00357968|21014694|P1|First Maintenance Dose Phase|Withdrawal by Subject|1
6088440|NCT00357968|21014693|P2|First Maintenance Dose Phase|Not a PCI patient|42
6088441|NCT00357968|21014694|P1|First Maintenance Dose Phase|Not a PCI patient|47
6088442|NCT00357903|21014747|P2|Overall Study|Other|10
6088443|NCT00357903|21014748|P1|Overall Study|Other|49
6088444|NCT00357903|21014747|P2|Overall Study|Response status|9
6088445|NCT00357903|21014748|P1|Overall Study|Response status|61
6088446|NCT00357903|21014747|P2|Overall Study|Protocol issues|3
6088447|NCT00357903|21014748|P1|Overall Study|Protocol issues|14
6088448|NCT00357903|21014747|P2|Overall Study|Completed month 12 only|1
6088449|NCT00357903|21014748|P1|Overall Study|Completed month 12 only|0
6088450|NCT00357903|21014747|P2|Overall Study|Withdrawal by Subject|7
6088451|NCT00357903|21014748|P1|Overall Study|Withdrawal by Subject|57
6088452|NCT00357903|21014747|P2|Overall Study|Physician Decision|5
6088453|NCT00357903|21014748|P1|Overall Study|Physician Decision|39
6088454|NCT00357903|21014747|P2|Overall Study|Lost to Follow-up|4
6088455|NCT00357903|21014748|P1|Overall Study|Lost to Follow-up|23
6088456|NCT00357903|21014747|P2|Overall Study|Death|0
6088457|NCT00357903|21014748|P1|Overall Study|Death|33
6088458|NCT00357903|21014747|P2|Overall Study|Adverse Event|4
6088459|NCT00357903|21014748|P1|Overall Study|Adverse Event|87
6088460|NCT00357877|21014788|P2|Overall Study|Other|2
6088461|NCT00357877|21014789|P1|Overall Study|Other|0
6088462|NCT00357877|21014788|P2|Overall Study|Administrative withdrawal|1
6088463|NCT00357877|21014789|P1|Overall Study|Administrative withdrawal|1
6088464|NCT00357877|21014788|P2|Overall Study|Withdrawal by Subject|3
6088465|NCT00357877|21014789|P1|Overall Study|Withdrawal by Subject|3
6088466|NCT00357877|21014788|P2|Overall Study|Lost to Follow-up|23
6088467|NCT00357877|21014789|P1|Overall Study|Lost to Follow-up|20
6088468|NCT00357877|21014788|P2|Overall Study|Death|1
6088469|NCT00357877|21014789|P1|Overall Study|Death|2
6088470|NCT00357760|21014803|P2|Overall Study|To receive hospice care|1
6088471|NCT00357760|21014804|P1|Overall Study|To receive hospice care|0
6088472|NCT00357760|21014803|P2|Overall Study|Protocol Violation|1
6088473|NCT00357760|21014804|P1|Overall Study|Protocol Violation|0
6088474|NCT00357760|21014803|P2|Overall Study|Physician Decision|1
6088475|NCT00357760|21014804|P1|Overall Study|Physician Decision|2
6088476|NCT00357760|21014803|P2|Overall Study|Ineligible|2
6088477|NCT00357760|21014804|P1|Overall Study|Ineligible|0
6088478|NCT00357760|21014803|P2|Overall Study|Never started treatment|1
6088479|NCT00357760|21014804|P1|Overall Study|Never started treatment|2
6088480|NCT00357760|21014803|P2|Overall Study|Withdrawal by Subject|2
6088481|NCT00357760|21014804|P1|Overall Study|Withdrawal by Subject|0
6088482|NCT00357760|21014803|P2|Overall Study|Alternative therapy|0
6088483|NCT00357760|21014804|P1|Overall Study|Alternative therapy|1
6088484|NCT00357760|21014803|P2|Overall Study|Death|3
6088485|NCT00357760|21014804|P1|Overall Study|Death|0
6088486|NCT00357760|21014803|P2|Overall Study|Adverse Event|7
6088487|NCT00357760|21014804|P1|Overall Study|Adverse Event|10
6088488|NCT00357760|21014803|P2|Overall Study|Disease progression|17
6088489|NCT00357760|21014804|P1|Overall Study|Disease progression|44
6088490|NCT00357656|21014825|P2|Overall Study|Other, No surgery performed|3
6088491|NCT00357656|21014826|P1|Overall Study|Other, No surgery performed|0
6088492|NCT00357552|21014877|P1|Weeks 24 to 104|Not able to get to clinic|2
6088493|NCT00357552|21014877|P1|Weeks 24 to 104|Death|3
6088494|NCT00357552|21014877|P1|Weeks 0 to 24|Death|1
6088495|NCT00357552|21014877|P1|Screening|Did not meet eligibility criteria|84
6088496|NCT00357500|21014892|P1|Overall Study|Not Started Protocol Therapy|4
6088497|NCT00357500|21014892|P1|Overall Study|Progressive Disease|65
6088498|NCT00357500|21014892|P1|Overall Study|Withdrawal by Subject|5
6088499|NCT00357500|21014892|P1|Overall Study|Adverse Event|3
6088500|NCT00357396|21014901|P2|Overall Study|Adverse Event|0
6088501|NCT00357396|21014902|P1|Overall Study|Adverse Event|1
6088502|NCT00357370|21014910|P3|Cohort 2|Withdrawal by Subject|0
6088503|NCT00357370|21014911|P2|Cohort 2|Withdrawal by Subject|2
6088504|NCT00357370|21014912|P1|Cohort 2|Withdrawal by Subject|0
6088505|NCT00357370|21014910|P3|Cohort 2|non-compliance, not met criteria, etc|0
6088506|NCT00357370|21014911|P2|Cohort 2|non-compliance, not met criteria, etc|1
6088507|NCT00357370|21014912|P1|Cohort 2|non-compliance, not met criteria, etc|1
6088508|NCT00357370|21014910|P3|Cohort 2|Lost to Follow-up|0
6088509|NCT00357370|21014911|P2|Cohort 2|Lost to Follow-up|1
6088510|NCT00357370|21014912|P1|Cohort 2|Lost to Follow-up|0
6088511|NCT00357370|21014910|P3|Cohort 2|Adverse Event|1
6088512|NCT00357370|21014911|P2|Cohort 2|Adverse Event|1
6088513|NCT00357370|21014912|P1|Cohort 2|Adverse Event|1
6088514|NCT00357370|21014910|P3|Cohort 2|Lack of Efficacy|1
6088515|NCT00357370|21014911|P2|Cohort 2|Lack of Efficacy|2
6088516|NCT00357370|21014912|P1|Cohort 2|Lack of Efficacy|0
6088517|NCT00357110|21014975|P2|Overall Study|Early study termination|5
6088518|NCT00357110|21014976|P1|Overall Study|Early study termination|5
6088519|NCT00357097|21014984|P2|Overall Study|Increase of RLS Symptoms|1
6088520|NCT00357097|21014985|P1|Overall Study|Increase of RLS Symptoms|0
6088521|NCT00357097|21014984|P2|Overall Study|Other|1
6088522|NCT00357097|21014985|P1|Overall Study|Other|1
6088523|NCT00357097|21014984|P2|Overall Study|Met Exclusion Criteria|1
6088524|NCT00357097|21014985|P1|Overall Study|Met Exclusion Criteria|3
6088525|NCT00357097|21014984|P2|Overall Study|Lack of Efficacy|8
6088526|NCT00357097|21014985|P1|Overall Study|Lack of Efficacy|2
6088527|NCT00357097|21014984|P2|Overall Study|Non-compliance|2
6088528|NCT00357097|21014985|P1|Overall Study|Non-compliance|1
6088529|NCT00357097|21014984|P2|Overall Study|Withdrawal by Subject|7
6088530|NCT00357097|21014985|P1|Overall Study|Withdrawal by Subject|8
6088531|NCT00357097|21014984|P2|Overall Study|Adverse Event|6
6088532|NCT00357097|21014985|P1|Overall Study|Adverse Event|34
6088533|NCT00357097|21014984|P2|Overall Study|Did not meet inclusion criteria|3
6088534|NCT00357097|21014985|P1|Overall Study|Did not meet inclusion criteria|5
6088535|NCT00357006|21015039|P3|Overall Study|Withdrawal by Subject|2
6088536|NCT00357006|21015040|P2|Overall Study|Withdrawal by Subject|3
6088537|NCT00357006|21015041|P1|Overall Study|Withdrawal by Subject|1
6088538|NCT00357006|21015039|P3|Overall Study|Lost to Follow-up|1
6088539|NCT00357006|21015040|P2|Overall Study|Lost to Follow-up|2
6088540|NCT00357006|21015041|P1|Overall Study|Lost to Follow-up|1
6088541|NCT00356915|21015056|P3|Overall Study|Miscellaneous reasons|3
6088542|NCT00356915|21015057|P2|Overall Study|Miscellaneous reasons|8
6088543|NCT00356915|21015058|P1|Overall Study|Miscellaneous reasons|11
6088544|NCT00356915|21015056|P3|Overall Study|Adverse Event|8
6088545|NCT00356915|21015057|P2|Overall Study|Adverse Event|31
6088546|NCT00356915|21015058|P1|Overall Study|Adverse Event|21
6088547|NCT00356915|21015056|P3|Overall Study|Physician Decision|0
6088548|NCT00356915|21015057|P2|Overall Study|Physician Decision|2
6088549|NCT00356915|21015058|P1|Overall Study|Physician Decision|0
6088550|NCT00356915|21015056|P3|Overall Study|Administrative Decision|1
6088551|NCT00356915|21015057|P2|Overall Study|Administrative Decision|0
6088552|NCT00356915|21015058|P1|Overall Study|Administrative Decision|0
6088553|NCT00356915|21015056|P3|Overall Study|Lost to Follow-up|14
6088554|NCT00356915|21015057|P2|Overall Study|Lost to Follow-up|34
6088555|NCT00356915|21015058|P1|Overall Study|Lost to Follow-up|27
6088556|NCT00356915|21015056|P3|Overall Study|Lack of Efficacy|3
6088557|NCT00356915|21015057|P2|Overall Study|Lack of Efficacy|0
6088558|NCT00356915|21015058|P1|Overall Study|Lack of Efficacy|0
6088559|NCT00356915|21015056|P3|Overall Study|Withdrawal by Subject|10
6088560|NCT00356915|21015057|P2|Overall Study|Withdrawal by Subject|14
6088561|NCT00356915|21015058|P1|Overall Study|Withdrawal by Subject|14
6088562|NCT00356915|21015056|P3|Overall Study|Protocol Violation|2
6088563|NCT00356915|21015057|P2|Overall Study|Protocol Violation|3
6088564|NCT00356915|21015058|P1|Overall Study|Protocol Violation|2
6088565|NCT00356915|21015056|P3|Overall Study|Non compliance|1
6088566|NCT00356915|21015057|P2|Overall Study|Non compliance|2
6088567|NCT00356915|21015058|P1|Overall Study|Non compliance|1
6088568|NCT00356889|21015075|P1|Overall Study|Adverse Event|1
6088569|NCT00356889|21015075|P1|Overall Study|Protocol Violation|2
6088570|NCT00356863|21015084|P2|Overall Study|Lost to Follow-up|43
6088571|NCT00356863|21015085|P1|Overall Study|Lost to Follow-up|76
6088572|NCT00356863|21015084|P2|Overall Study|Death|32
6088573|NCT00356863|21015085|P1|Overall Study|Death|16
6088574|NCT00356811|21015111|P1|Overall Study|Site Closed during Follow-up|2
6088575|NCT00356811|21015111|P1|Overall Study|Study Is Terminating|3
6088576|NCT00356811|21015111|P1|Overall Study|Participant Could Not Make a Checkup|1
6088577|NCT00356811|21015111|P1|Overall Study|Withdrawal by Subject|6
6088578|NCT00356811|21015111|P1|Overall Study|Lost to Follow-up|2
6088579|NCT00356811|21015111|P1|Overall Study|Death|35
6088580|NCT00356759|21015126|P2|Overall Study|Intercurrent disease or persistent extre|2
6088581|NCT00356759|21015127|P1|Overall Study|Intercurrent disease or persistent extre|5
6088582|NCT00356759|21015126|P2|Overall Study|Lost to Follow-up|1
6088583|NCT00356759|21015127|P1|Overall Study|Lost to Follow-up|1
6088584|NCT00356759|21015126|P2|Overall Study|Adverse Event|3
6088585|NCT00356759|21015127|P1|Overall Study|Adverse Event|1
6088586|NCT00356759|21015126|P2|Overall Study|Withdrawal by Subject|2
6088587|NCT00356759|21015127|P1|Overall Study|Withdrawal by Subject|2
6088588|NCT00356759|21015126|P2|Overall Study|Death|2
6088589|NCT00356759|21015127|P1|Overall Study|Death|5
6088590|NCT00356603|21015145|P2|Overall Study|Other|3
6088591|NCT00356603|21015146|P1|Overall Study|Other|6
6088592|NCT00356590|21015160|P1|Overall Study|Other|52
6088593|NCT00356590|21015160|P1|Overall Study|Response status|28
6088594|NCT00356590|21015160|P1|Overall Study|Protocol issues|6
6088595|NCT00356590|21015160|P1|Overall Study|Completed month 12 only|2
6088596|NCT00356590|21015160|P1|Overall Study|Withdrawal by Subject|41
6088597|NCT00356590|21015160|P1|Overall Study|Physician Decision|46
6088598|NCT00356590|21015160|P1|Overall Study|Lost to Follow-up|35
6088599|NCT00356590|21015160|P1|Overall Study|Death|10
6088600|NCT00356590|21015160|P1|Overall Study|Adverse Event|54
6088601|NCT00356525|21015196|P4|Overall Study|Sponsor Decision|1
6088602|NCT00356525|21015197|P3|Overall Study|Sponsor Decision|0
6088603|NCT00356525|21015198|P2|Overall Study|Sponsor Decision|0
6088604|NCT00356525|21015199|P1|Overall Study|Sponsor Decision|0
6088605|NCT00356525|21015196|P4|Overall Study|Death|1
6088606|NCT00356525|21015197|P3|Overall Study|Death|0
6088607|NCT00356525|21015198|P2|Overall Study|Death|0
6088608|NCT00356525|21015199|P1|Overall Study|Death|0
6088609|NCT00356525|21015196|P4|Overall Study|Withdrawal by Subject|3
6088610|NCT00356525|21015197|P3|Overall Study|Withdrawal by Subject|0
6088611|NCT00356525|21015198|P2|Overall Study|Withdrawal by Subject|1
6088612|NCT00356525|21015199|P1|Overall Study|Withdrawal by Subject|1
6088613|NCT00356525|21015196|P4|Overall Study|Protocol Entry Criteria Not Met|0
6088614|NCT00356525|21015197|P3|Overall Study|Protocol Entry Criteria Not Met|0
6088615|NCT00356525|21015198|P2|Overall Study|Protocol Entry Criteria Not Met|0
6088616|NCT00356525|21015199|P1|Overall Study|Protocol Entry Criteria Not Met|1
6088617|NCT00356525|21015196|P4|Overall Study|Physician Decision|1
6088618|NCT00356525|21015197|P3|Overall Study|Physician Decision|2
6088619|NCT00356525|21015198|P2|Overall Study|Physician Decision|2
6088620|NCT00356525|21015199|P1|Overall Study|Physician Decision|2
6088621|NCT00356525|21015196|P4|Overall Study|Lost to Follow-up|0
6088622|NCT00356525|21015197|P3|Overall Study|Lost to Follow-up|0
6088623|NCT00356525|21015198|P2|Overall Study|Lost to Follow-up|0
6088624|NCT00356525|21015199|P1|Overall Study|Lost to Follow-up|1
6088625|NCT00356525|21015196|P4|Overall Study|Adverse Event|1
6088626|NCT00356525|21015197|P3|Overall Study|Adverse Event|1
6088627|NCT00356525|21015198|P2|Overall Study|Adverse Event|3
6088628|NCT00356525|21015199|P1|Overall Study|Adverse Event|1
6088629|NCT00356525|21015196|P4|Overall Study|Progressive Disease|2
6088630|NCT00356525|21015197|P3|Overall Study|Progressive Disease|4
6088631|NCT00356525|21015198|P2|Overall Study|Progressive Disease|5
6088632|NCT00356525|21015199|P1|Overall Study|Progressive Disease|8
6088633|NCT00356421|21015240|P2|Overall Study|Not related to study drug|3
6088634|NCT00356421|21015241|P1|Overall Study|Not related to study drug|5
6088635|NCT00356421|21015240|P2|Overall Study|Related to study drug|12
6088636|NCT00356421|21015241|P1|Overall Study|Related to study drug|15
6088637|NCT00356421|21015240|P2|Overall Study|Withdrawal by Subject|2
6088638|NCT00356421|21015241|P1|Overall Study|Withdrawal by Subject|9
6088639|NCT00356421|21015240|P2|Overall Study|Lack of Efficacy|0
6088640|NCT00356421|21015241|P1|Overall Study|Lack of Efficacy|3
6088641|NCT00356408|21015281|P1|Overall Study|Other: Subject chose commerical dosing|1
6088642|NCT00356408|21015281|P1|Overall Study|Other: Failed to meet Inc/Exc criteria|1
6088643|NCT00356408|21015281|P1|Overall Study|Other: Azathioprine stopped|1
6088644|NCT00356408|21015281|P1|Overall Study|Other: Sponsor request|1
6088645|NCT00356408|21015281|P1|Overall Study|Other: Principal investigator discretion|3
6088646|NCT00356408|21015281|P1|Overall Study|Withdrawal by Subject|6
6088647|NCT00356408|21015281|P1|Overall Study|Lost to Follow-up|2
6088648|NCT00356408|21015281|P1|Overall Study|Lack of Efficacy|36
6088649|NCT00356408|21015281|P1|Overall Study|Adverse Event|9
6088650|NCT00356369|21015298|P2|Active Phase|Withdrawal by Subject|1
6088651|NCT00356369|21015299|P1|Active Phase|Withdrawal by Subject|2
6088652|NCT00356278|21015381|P3|Overall Study|Withdrawal by Subject|19
6088653|NCT00356278|21015382|P2|Overall Study|Withdrawal by Subject|15
6088654|NCT00356278|21015383|P1|Overall Study|Withdrawal by Subject|25
6088655|NCT00356265|21015421|P3|Overall Study|Withdrawal by Subject|1
6088656|NCT00356265|21015422|P2|Overall Study|Withdrawal by Subject|0
6088657|NCT00356265|21015423|P1|Overall Study|Withdrawal by Subject|0
6088658|NCT00356200|21015435|P2|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|2
6088659|NCT00356200|21015436|P1|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|0
6088660|NCT00356200|21015435|P2|Cohort 1: 10 ug/ml|Lack of Efficacy|0
6088661|NCT00356200|21015436|P1|Cohort 1: 10 ug/ml|Lack of Efficacy|1
6088662|NCT00356148|21015465|P2|Overall Study|Reoperation within 30 days|1
6088663|NCT00356148|21015466|P1|Overall Study|Reoperation within 30 days|2
6088664|NCT00356135|21015477|P3|Overall Study|Subject non-compliance|3
6088665|NCT00356135|21015478|P2|Overall Study|Subject non-compliance|1
6088666|NCT00356135|21015479|P1|Overall Study|Subject non-compliance|1
6088667|NCT00356135|21015477|P3|Overall Study|Physician Decision|1
6088668|NCT00356135|21015478|P2|Overall Study|Physician Decision|1
6088669|NCT00356135|21015479|P1|Overall Study|Physician Decision|1
6088670|NCT00356135|21015477|P3|Overall Study|Lost to Follow-up|1
6088671|NCT00356135|21015478|P2|Overall Study|Lost to Follow-up|0
6088672|NCT00356135|21015479|P1|Overall Study|Lost to Follow-up|0
6088673|NCT00356135|21015477|P3|Overall Study|Adverse Event|0
6088674|NCT00356135|21015478|P2|Overall Study|Adverse Event|0
6088675|NCT00356135|21015479|P1|Overall Study|Adverse Event|1
6088676|NCT00356135|21015477|P3|Overall Study|Protocol Violation|0
6088677|NCT00356135|21015478|P2|Overall Study|Protocol Violation|0
6088678|NCT00356135|21015479|P1|Overall Study|Protocol Violation|1
6088679|NCT00356122|21015501|P1|FOLLOW-UP|Other|2
6088680|NCT00356122|21015501|P1|FOLLOW-UP|Lost to Follow-up|2
6088681|NCT00356122|21015501|P1|FOLLOW-UP|Death|37
6088682|NCT00356122|21015501|P1|TREATMENT|Did not receive study medication|1
6088683|NCT00356122|21015501|P1|TREATMENT|Other|4
6088684|NCT00356122|21015501|P1|TREATMENT|Subject's request|4
6088685|NCT00356122|21015501|P1|TREATMENT|Adverse Event|10
6088686|NCT00356122|21015501|P1|TREATMENT|Lack of Efficacy|26
6088687|NCT00355784|21015609|P3|Overall Study|Withdrawal by Subject|2
6088688|NCT00355784|21015610|P2|Overall Study|Withdrawal by Subject|0
6088689|NCT00355784|21015611|P1|Overall Study|Withdrawal by Subject|0
6088690|NCT00355615|21015660|P5|40-week Rosuvastatin Open Label Period|investigational site closed|1
6088691|NCT00355615|21015661|P4|40-week Rosuvastatin Open Label Period|investigational site closed|0
6088692|NCT00355615|21015662|P3|40-week Rosuvastatin Open Label Period|investigational site closed|0
6088693|NCT00355615|21015663|P2|40-week Rosuvastatin Open Label Period|investigational site closed|0
6088694|NCT00355615|21015664|P1|40-week Rosuvastatin Open Label Period|investigational site closed|0
6088695|NCT00355615|21015660|P5|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|3
6088696|NCT00355615|21015661|P4|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0
6088697|NCT00355615|21015662|P3|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0
6088698|NCT00355615|21015663|P2|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0
6088699|NCT00355615|21015664|P1|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0
6088700|NCT00355615|21015660|P5|40-week Rosuvastatin Open Label Period|Protocol Violation|1
6088701|NCT00355615|21015661|P4|40-week Rosuvastatin Open Label Period|Protocol Violation|0
6088702|NCT00355615|21015662|P3|40-week Rosuvastatin Open Label Period|Protocol Violation|0
6088703|NCT00355615|21015663|P2|40-week Rosuvastatin Open Label Period|Protocol Violation|0
6088704|NCT00355615|21015664|P1|40-week Rosuvastatin Open Label Period|Protocol Violation|0
6088705|NCT00355615|21015660|P5|40-week Rosuvastatin Open Label Period|Adverse Event|4
6088706|NCT00355615|21015661|P4|40-week Rosuvastatin Open Label Period|Adverse Event|0
6088707|NCT00355615|21015662|P3|40-week Rosuvastatin Open Label Period|Adverse Event|0
6088708|NCT00355615|21015663|P2|40-week Rosuvastatin Open Label Period|Adverse Event|0
6088709|NCT00355615|21015664|P1|40-week Rosuvastatin Open Label Period|Adverse Event|0
6088710|NCT00355615|21015660|P5|Randomized Double Blind Period|Protocol Violation|0
6088711|NCT00355615|21015661|P4|Randomized Double Blind Period|Protocol Violation|1
6088712|NCT00355615|21015662|P3|Randomized Double Blind Period|Protocol Violation|1
6088713|NCT00355615|21015663|P2|Randomized Double Blind Period|Protocol Violation|0
6088714|NCT00355615|21015664|P1|Randomized Double Blind Period|Protocol Violation|0
6088715|NCT00355615|21015660|P5|Randomized Double Blind Period|Adverse Event|0
6088716|NCT00355615|21015661|P4|Randomized Double Blind Period|Adverse Event|0
6088717|NCT00355615|21015662|P3|Randomized Double Blind Period|Adverse Event|0
6088718|NCT00355615|21015663|P2|Randomized Double Blind Period|Adverse Event|0
6088719|NCT00355615|21015664|P1|Randomized Double Blind Period|Adverse Event|1
6088720|NCT00355472|21015723|P1|Overall Study|Physician Decision|1
6088721|NCT00355368|21015769|P2|Overall Study|cardiac arrest prior to intubation|2
6088722|NCT00355368|21015770|P1|Overall Study|cardiac arrest prior to intubation|2
6088723|NCT00355368|21015769|P2|Overall Study|Protocol Violation|7
6088724|NCT00355368|21015770|P1|Overall Study|Protocol Violation|8
6088725|NCT00355342|21015784|P2|Overall Study|Use of protocol excluded medication|1
6088726|NCT00355342|21015785|P1|Overall Study|Use of protocol excluded medication|0
6088727|NCT00355342|21015784|P2|Overall Study|Protocol Violation|1
6088728|NCT00355342|21015785|P1|Overall Study|Protocol Violation|0
6088729|NCT00355342|21015784|P2|Overall Study|Study management|1
6088730|NCT00355342|21015785|P1|Overall Study|Study management|0
6088731|NCT00355342|21015784|P2|Overall Study|Participant discontinued study drug|1
6088732|NCT00355342|21015785|P1|Overall Study|Participant discontinued study drug|0
6088733|NCT00355342|21015784|P2|Overall Study|Participant relocated|1
6088734|NCT00355342|21015785|P1|Overall Study|Participant relocated|0
6088735|NCT00355342|21015784|P2|Overall Study|Withdrawal by participant and physician|0
6088736|NCT00355342|21015785|P1|Overall Study|Withdrawal by participant and physician|1
6088737|NCT00355342|21015784|P2|Overall Study|Non-compliance with Dexa scans|0
6088738|NCT00355342|21015785|P1|Overall Study|Non-compliance with Dexa scans|1
6088739|NCT00355342|21015784|P2|Overall Study|Dispensed wrong study drug kit|0
6088740|NCT00355342|21015785|P1|Overall Study|Dispensed wrong study drug kit|1
6088741|NCT00355342|21015784|P2|Overall Study|COPD exacerbation|1
6088742|NCT00355342|21015785|P1|Overall Study|COPD exacerbation|1
6088743|NCT00355342|21015784|P2|Overall Study|Use of prohibited medication|0
6088744|NCT00355342|21015785|P1|Overall Study|Use of prohibited medication|1
6088745|NCT00355342|21015784|P2|Overall Study|Overcompliant-PI discretion|0
6088746|NCT00355342|21015785|P1|Overall Study|Overcompliant-PI discretion|1
6088747|NCT00355342|21015784|P2|Overall Study|Sponsor terminated study|2
6088748|NCT00355342|21015785|P1|Overall Study|Sponsor terminated study|2
6088749|NCT00355342|21015784|P2|Overall Study|Withdrawal by Subject|11
6088750|NCT00355342|21015785|P1|Overall Study|Withdrawal by Subject|14
6088751|NCT00355342|21015784|P2|Overall Study|Lost to Follow-up|2
6088752|NCT00355342|21015785|P1|Overall Study|Lost to Follow-up|4
6088753|NCT00355342|21015784|P2|Overall Study|Adverse Event|15
6088754|NCT00355342|21015785|P1|Overall Study|Adverse Event|13
6088755|NCT00355264|21015793|P1|Extension (Variable Duration)|Withdrew Consent|1
6088756|NCT00355264|21015793|P1|Extension (Variable Duration)|Adverse Event|1
6088757|NCT00355147|21015821|P2|Overall Study|Withdrawal by Subject|12
6088758|NCT00355147|21015822|P1|Overall Study|Withdrawal by Subject|8
6088759|NCT00355147|21015821|P2|Overall Study|Lost to Follow-up|8
6088760|NCT00355147|21015822|P1|Overall Study|Lost to Follow-up|10
6088761|NCT00355134|21015841|P5|Extension Phase|Protocol Violation|0
6088762|NCT00355134|21015842|P4|Extension Phase|Protocol Violation|1
6088763|NCT00355134|21015843|P3|Extension Phase|Protocol Violation|0
6088764|NCT00355134|21015844|P2|Extension Phase|Protocol Violation|0
6088765|NCT00355134|21015845|P1|Extension Phase|Protocol Violation|0
6088766|NCT00355134|21015841|P5|Extension Phase|Abnormal test procedure result(s)|1
6088767|NCT00355134|21015842|P4|Extension Phase|Abnormal test procedure result(s)|0
6088768|NCT00355134|21015843|P3|Extension Phase|Abnormal test procedure result(s)|0
6088769|NCT00355134|21015844|P2|Extension Phase|Abnormal test procedure result(s)|1
6088770|NCT00355134|21015845|P1|Extension Phase|Abnormal test procedure result(s)|0
6088771|NCT00355134|21015841|P5|Extension Phase|Unsatisfactory therapeutic effect|1
6088772|NCT00355134|21015842|P4|Extension Phase|Unsatisfactory therapeutic effect|0
6088773|NCT00355134|21015843|P3|Extension Phase|Unsatisfactory therapeutic effect|0
6088774|NCT00355134|21015844|P2|Extension Phase|Unsatisfactory therapeutic effect|4
6088775|NCT00355134|21015845|P1|Extension Phase|Unsatisfactory therapeutic effect|3
6088776|NCT00355134|21015841|P5|Extension Phase|Administrative problems|1
6088777|NCT00355134|21015842|P4|Extension Phase|Administrative problems|1
6088778|NCT00355134|21015843|P3|Extension Phase|Administrative problems|0
6088779|NCT00355134|21015844|P2|Extension Phase|Administrative problems|4
6088780|NCT00355134|21015845|P1|Extension Phase|Administrative problems|2
6088781|NCT00355134|21015841|P5|Extension Phase|Abnormal laboratory value(s)|2
6088782|NCT00355134|21015842|P4|Extension Phase|Abnormal laboratory value(s)|2
6088783|NCT00355134|21015843|P3|Extension Phase|Abnormal laboratory value(s)|0
6088784|NCT00355134|21015844|P2|Extension Phase|Abnormal laboratory value(s)|2
6088785|NCT00355134|21015845|P1|Extension Phase|Abnormal laboratory value(s)|4
6088786|NCT00355134|21015841|P5|Extension Phase|Lost to Follow-up|4
6088787|NCT00355134|21015842|P4|Extension Phase|Lost to Follow-up|2
6088788|NCT00355134|21015843|P3|Extension Phase|Lost to Follow-up|0
6088789|NCT00355134|21015844|P2|Extension Phase|Lost to Follow-up|6
6088790|NCT00355134|21015845|P1|Extension Phase|Lost to Follow-up|2
6088791|NCT00355134|21015841|P5|Extension Phase|Adverse Event|5
6088792|NCT00355134|21015842|P4|Extension Phase|Adverse Event|3
6088793|NCT00355134|21015843|P3|Extension Phase|Adverse Event|0
6088794|NCT00355134|21015844|P2|Extension Phase|Adverse Event|9
6088795|NCT00355134|21015845|P1|Extension Phase|Adverse Event|13
6088796|NCT00355134|21015841|P5|Extension Phase|Withdrawal by Subject|5
6088797|NCT00355134|21015842|P4|Extension Phase|Withdrawal by Subject|7
6088798|NCT00355134|21015843|P3|Extension Phase|Withdrawal by Subject|0
6088799|NCT00355134|21015844|P2|Extension Phase|Withdrawal by Subject|11
6088800|NCT00355134|21015845|P1|Extension Phase|Withdrawal by Subject|7
6088801|NCT00355134|21015841|P5|Core Phase|Condition no longer requires study drug|0
6088802|NCT00355134|21015842|P4|Core Phase|Condition no longer requires study drug|0
6088803|NCT00355134|21015843|P3|Core Phase|Condition no longer requires study drug|1
6088804|NCT00355134|21015844|P2|Core Phase|Condition no longer requires study drug|0
6088805|NCT00355134|21015845|P1|Core Phase|Condition no longer requires study drug|1
6088806|NCT00355134|21015841|P5|Core Phase|Abnormal test procedure result(s)|0
6088807|NCT00355134|21015842|P4|Core Phase|Abnormal test procedure result(s)|0
6088808|NCT00355134|21015843|P3|Core Phase|Abnormal test procedure result(s)|1
6088809|NCT00355134|21015844|P2|Core Phase|Abnormal test procedure result(s)|2
6088810|NCT00355134|21015845|P1|Core Phase|Abnormal test procedure result(s)|1
6088811|NCT00355134|21015841|P5|Core Phase|Protocol Violation|0
6088812|NCT00355134|21015842|P4|Core Phase|Protocol Violation|0
6088813|NCT00355134|21015843|P3|Core Phase|Protocol Violation|2
6088814|NCT00355134|21015844|P2|Core Phase|Protocol Violation|2
6088815|NCT00355134|21015845|P1|Core Phase|Protocol Violation|3
6088816|NCT00355134|21015841|P5|Core Phase|Administrative problems|0
6088817|NCT00355134|21015842|P4|Core Phase|Administrative problems|0
6088818|NCT00355134|21015843|P3|Core Phase|Administrative problems|5
6088819|NCT00355134|21015844|P2|Core Phase|Administrative problems|3
6088820|NCT00355134|21015845|P1|Core Phase|Administrative problems|5
6088821|NCT00355134|21015841|P5|Core Phase|Unsatisfactory therapeutic effect|0
6088822|NCT00355134|21015842|P4|Core Phase|Unsatisfactory therapeutic effect|0
6088823|NCT00355134|21015843|P3|Core Phase|Unsatisfactory therapeutic effect|17
6088824|NCT00355134|21015844|P2|Core Phase|Unsatisfactory therapeutic effect|6
6088825|NCT00355134|21015845|P1|Core Phase|Unsatisfactory therapeutic effect|10
6088826|NCT00355134|21015841|P5|Core Phase|Abnormal laboratory value(s)|0
6088827|NCT00355134|21015842|P4|Core Phase|Abnormal laboratory value(s)|0
6088828|NCT00355134|21015843|P3|Core Phase|Abnormal laboratory value(s)|2
6088829|NCT00355134|21015844|P2|Core Phase|Abnormal laboratory value(s)|14
6088830|NCT00355134|21015845|P1|Core Phase|Abnormal laboratory value(s)|19
6088831|NCT00355134|21015841|P5|Core Phase|Lost to Follow-up|0
6088832|NCT00355134|21015842|P4|Core Phase|Lost to Follow-up|0
6088833|NCT00355134|21015843|P3|Core Phase|Lost to Follow-up|21
6088834|NCT00355134|21015844|P2|Core Phase|Lost to Follow-up|13
6088835|NCT00355134|21015845|P1|Core Phase|Lost to Follow-up|17
6088836|NCT00355134|21015841|P5|Core Phase|Adverse Event|0
6088837|NCT00355134|21015842|P4|Core Phase|Adverse Event|0
6088838|NCT00355134|21015843|P3|Core Phase|Adverse Event|16
6088839|NCT00355134|21015844|P2|Core Phase|Adverse Event|22
6088840|NCT00355134|21015845|P1|Core Phase|Adverse Event|28
6088841|NCT00355134|21015841|P5|Core Phase|Withdrawal by Subject|0
6088842|NCT00355134|21015842|P4|Core Phase|Withdrawal by Subject|0
6088843|NCT00355134|21015843|P3|Core Phase|Withdrawal by Subject|35
6088844|NCT00355134|21015844|P2|Core Phase|Withdrawal by Subject|24
6088845|NCT00355134|21015845|P1|Core Phase|Withdrawal by Subject|35
6088846|NCT00355121|21015888|P3|Overall Study|Serious adverse events|0
6088847|NCT00355121|21015889|P2|Overall Study|Serious adverse events|2
6088848|NCT00355121|21015890|P1|Overall Study|Serious adverse events|0
6088849|NCT00355121|21015888|P3|Overall Study|Withdrawal by Subject|2
6088850|NCT00355121|21015889|P2|Overall Study|Withdrawal by Subject|10
6088851|NCT00355121|21015890|P1|Overall Study|Withdrawal by Subject|9
6088852|NCT00355121|21015888|P3|Overall Study|Lost to Follow-up|1
6088853|NCT00355121|21015889|P2|Overall Study|Lost to Follow-up|7
6088854|NCT00355121|21015890|P1|Overall Study|Lost to Follow-up|4
6088855|NCT00355121|21015888|P3|Overall Study|Protocol Violation|1
6088856|NCT00355121|21015889|P2|Overall Study|Protocol Violation|9
6088857|NCT00355121|21015890|P1|Overall Study|Protocol Violation|7
6088858|NCT00355121|21015888|P3|Overall Study|Adverse Event|0
6088859|NCT00355121|21015889|P2|Overall Study|Adverse Event|1
6088860|NCT00355121|21015890|P1|Overall Study|Adverse Event|0
6088861|NCT00355121|21015888|P3|Overall Study|Did not receive study vaccine|1
6088862|NCT00355121|21015889|P2|Overall Study|Did not receive study vaccine|0
6088863|NCT00355121|21015890|P1|Overall Study|Did not receive study vaccine|1
6088864|NCT00355082|21015921|P3|Continuation Phase|Ran Out of Drug Due to Travel|0
6088865|NCT00355082|21015922|P2|Continuation Phase|Ran Out of Drug Due to Travel|0
6088866|NCT00355082|21015923|P1|Continuation Phase|Ran Out of Drug Due to Travel|1
6088867|NCT00355082|21015921|P3|Continuation Phase|Scheduling Error|0
6088868|NCT00355082|21015922|P2|Continuation Phase|Scheduling Error|0
6088869|NCT00355082|21015923|P1|Continuation Phase|Scheduling Error|1
6088870|NCT00355082|21015921|P3|Continuation Phase|Site Closed by Sponsor|0
6088871|NCT00355082|21015922|P2|Continuation Phase|Site Closed by Sponsor|0
6088872|NCT00355082|21015923|P1|Continuation Phase|Site Closed by Sponsor|8
6088873|NCT00355082|21015921|P3|Continuation Phase|Lack of Efficacy|0
6088874|NCT00355082|21015922|P2|Continuation Phase|Lack of Efficacy|0
6088875|NCT00355082|21015923|P1|Continuation Phase|Lack of Efficacy|5
6088876|NCT00355082|21015921|P3|Continuation Phase|Withdrawal by Subject|0
6088877|NCT00355082|21015922|P2|Continuation Phase|Withdrawal by Subject|0
6088878|NCT00355082|21015923|P1|Continuation Phase|Withdrawal by Subject|4
6088879|NCT00355082|21015921|P3|Continuation Phase|Protocol Violation|1
6088880|NCT00355082|21015922|P2|Continuation Phase|Protocol Violation|0
6088881|NCT00355082|21015923|P1|Continuation Phase|Protocol Violation|1
6088882|NCT00355082|21015921|P3|Continuation Phase|Lost to Follow-up|1
6088883|NCT00355082|21015922|P2|Continuation Phase|Lost to Follow-up|0
6088884|NCT00355082|21015923|P1|Continuation Phase|Lost to Follow-up|2
6088885|NCT00355082|21015921|P3|Continuation Phase|Adverse Event|1
6088886|NCT00355082|21015922|P2|Continuation Phase|Adverse Event|0
6088887|NCT00355082|21015923|P1|Continuation Phase|Adverse Event|2
6088888|NCT00355082|21015921|P3|Double-Blind (DB) Treatment Phase|Pregnancy|0
6088889|NCT00355082|21015922|P2|Double-Blind (DB) Treatment Phase|Pregnancy|1
6088890|NCT00355082|21015923|P1|Double-Blind (DB) Treatment Phase|Pregnancy|0
6088891|NCT00355082|21015921|P3|Double-Blind (DB) Treatment Phase|Protocol Violation|0
6088892|NCT00355082|21015922|P2|Double-Blind (DB) Treatment Phase|Protocol Violation|4
6088893|NCT00355082|21015923|P1|Double-Blind (DB) Treatment Phase|Protocol Violation|0
6088894|NCT00355082|21015921|P3|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0
6088895|NCT00355082|21015922|P2|Double-Blind (DB) Treatment Phase|Lost to Follow-up|4
6088896|NCT00355082|21015923|P1|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0
6088897|NCT00355082|21015921|P3|Double-Blind (DB) Treatment Phase|Lack of Efficacy|0
6088898|NCT00355082|21015922|P2|Double-Blind (DB) Treatment Phase|Lack of Efficacy|7
6088899|NCT00355082|21015923|P1|Double-Blind (DB) Treatment Phase|Lack of Efficacy|6
6088900|NCT00355082|21015921|P3|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|0
6088901|NCT00355082|21015922|P2|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|8
6088902|NCT00355082|21015923|P1|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|9
6088903|NCT00355082|21015921|P3|Double-Blind (DB) Treatment Phase|Adverse Event|0
6088904|NCT00355082|21015922|P2|Double-Blind (DB) Treatment Phase|Adverse Event|10
6088905|NCT00355082|21015923|P1|Double-Blind (DB) Treatment Phase|Adverse Event|4
6088906|NCT00355056|21015945|P2|Randomization Period|Early Termination|6
6088907|NCT00355056|21015946|P1|Randomization Period|Early Termination|4
6088908|NCT00355030|21015976|P2|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1
6088909|NCT00355030|21015977|P1|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1
6088910|NCT00355030|21015976|P2|Study Period 2 Long Term Follow-Up|Lost to Follow-up|1
6088911|NCT00355030|21015977|P1|Study Period 2 Long Term Follow-Up|Lost to Follow-up|0
6088912|NCT00355030|21015976|P2|Study Period 1 Treatment|Other|6
6088913|NCT00355030|21015977|P1|Study Period 1 Treatment|Other|2
6088914|NCT00355030|21015976|P2|Study Period 1 Treatment|Protocol Entry Criterion Not Met|1
6088915|NCT00355030|21015977|P1|Study Period 1 Treatment|Protocol Entry Criterion Not Met|0
6088916|NCT00355030|21015976|P2|Study Period 1 Treatment|Sponsor Decision|32
6088917|NCT00355030|21015977|P1|Study Period 1 Treatment|Sponsor Decision|34
6088918|NCT00355030|21015976|P2|Study Period 1 Treatment|Physician Decision|1
6088919|NCT00355030|21015977|P1|Study Period 1 Treatment|Physician Decision|0
6088920|NCT00355030|21015976|P2|Study Period 1 Treatment|Parent/Caregiver Decision|2
6088921|NCT00355030|21015977|P1|Study Period 1 Treatment|Parent/Caregiver Decision|1
6088922|NCT00355030|21015976|P2|Study Period 1 Treatment|Withdrawal by Subject|1
6088923|NCT00355030|21015977|P1|Study Period 1 Treatment|Withdrawal by Subject|4
6088924|NCT00355030|21015976|P2|Study Period 1 Treatment|Lost to Follow-up|0
6088925|NCT00355030|21015977|P1|Study Period 1 Treatment|Lost to Follow-up|3
6088926|NCT00355030|21015976|P2|Study Period 1 Treatment|Adverse Event|1
6088927|NCT00355030|21015977|P1|Study Period 1 Treatment|Adverse Event|1
6088928|NCT00354835|21016016|P2|Overall Study|Refusal of further therapy|8
6088929|NCT00354835|21016017|P1|Overall Study|Refusal of further therapy|3
6088930|NCT00354835|21016016|P2|Overall Study|Adverse Event|0
6088931|NCT00354835|21016017|P1|Overall Study|Adverse Event|6
6088932|NCT00354835|21016016|P2|Overall Study|Disease progression or relapse|22
6088933|NCT00354835|21016017|P1|Overall Study|Disease progression or relapse|15
6088934|NCT00354835|21016016|P2|Overall Study|Ineligible|16
6088935|NCT00354835|21016017|P1|Overall Study|Ineligible|17
6088936|NCT00354835|21016016|P2|Overall Study|Withdrawal by Subject|1
6088937|NCT00354835|21016017|P1|Overall Study|Withdrawal by Subject|2
6088938|NCT00354835|21016016|P2|Overall Study|Physician Decision|13
6088939|NCT00354835|21016017|P1|Overall Study|Physician Decision|8
6088940|NCT00354835|21016016|P2|Overall Study|Death|1
6088941|NCT00354835|21016017|P1|Overall Study|Death|1
6088942|NCT00354744|21016056|P1|Overall Study|Withdrawal by Subject|14
6088943|NCT00354744|21016056|P1|Overall Study|Physician Decision|11
6088944|NCT00354744|21016056|P1|Overall Study|Lost to Follow-up|2
6088945|NCT00354744|21016056|P1|Overall Study|Lack of Efficacy|11
6088946|NCT00354744|21016056|P1|Overall Study|Death|2
6088947|NCT00354744|21016056|P1|Overall Study|Adverse Event|2
6088948|NCT00354679|21016062|P1|Overall Study|Patient Not Treated|1
6088949|NCT00354614|21016071|P1|Overall Study|Lack of Efficacy|28
6088950|NCT00354601|21016075|P1|Overall Study|progression|1
6088951|NCT00354601|21016075|P1|Overall Study|Protocol Violation|1
6088952|NCT00354432|21016095|P4|Overall Study|Off/Toxicity|5
6088953|NCT00354432|21016096|P3|Overall Study|Off/Toxicity|5
6088954|NCT00354432|21016097|P2|Overall Study|Off/Toxicity|7
6088955|NCT00354432|21016098|P1|Overall Study|Off/Toxicity|3
6088956|NCT00354432|21016095|P4|Overall Study|Adverse Event|5
6088957|NCT00354432|21016096|P3|Overall Study|Adverse Event|5
6088958|NCT00354432|21016097|P2|Overall Study|Adverse Event|1
6088959|NCT00354432|21016098|P1|Overall Study|Adverse Event|3
6088960|NCT00354341|21016114|P2|Overall Study|Other|2
6088961|NCT00354341|21016115|P1|Overall Study|Other|1
6088962|NCT00354341|21016114|P2|Overall Study|Failure to return|1
6088963|NCT00354341|21016115|P1|Overall Study|Failure to return|0
6088964|NCT00354341|21016114|P2|Overall Study|Refused treatment|2
6088965|NCT00354341|21016115|P1|Overall Study|Refused treatment|1
6088966|NCT00354341|21016114|P2|Overall Study|Death|2
6088967|NCT00354341|21016115|P1|Overall Study|Death|0
6088968|NCT00354341|21016114|P2|Overall Study|Adverse Event|0
6088969|NCT00354341|21016115|P1|Overall Study|Adverse Event|1
6088970|NCT00354172|21016137|P1|Overall Study|Did not receive transplant|1
6088971|NCT00354159|21016157|P2|Long-term Follow-up|Study Closed|34
6088972|NCT00354159|21016158|P1|Long-term Follow-up|Study Closed|29
6088973|NCT00354159|21016157|P2|Long-term Follow-up|Death|11
6088974|NCT00354159|21016158|P1|Long-term Follow-up|Death|14
6088975|NCT00354159|21016157|P2|Long-term Follow-up|Lost to Follow-up|0
6088976|NCT00354159|21016158|P1|Long-term Follow-up|Lost to Follow-up|1
6088977|NCT00354159|21016157|P2|Long-term Follow-up|Physician Decision|122
6088978|NCT00354159|21016158|P1|Long-term Follow-up|Physician Decision|127
6088979|NCT00354159|21016157|P2|Long-term Follow-up|Withdrawal by Subject|9
6088980|NCT00354159|21016158|P1|Long-term Follow-up|Withdrawal by Subject|9
6088981|NCT00354159|21016157|P2|Randomized Study Period|Death|9
6088982|NCT00354159|21016158|P1|Randomized Study Period|Death|7
6088983|NCT00354159|21016157|P2|Randomized Study Period|Lost to Follow-up|0
6088984|NCT00354159|21016158|P1|Randomized Study Period|Lost to Follow-up|4
6088985|NCT00354159|21016157|P2|Randomized Study Period|Physician Decision|10
6088986|NCT00354159|21016158|P1|Randomized Study Period|Physician Decision|6
6088987|NCT00354159|21016157|P2|Randomized Study Period|Withdrawal by Subject|3
6088988|NCT00354159|21016158|P1|Randomized Study Period|Withdrawal by Subject|5
6088989|NCT00354107|21016201|P1|Overall Study|Withdrawal by Subject|1
6088990|NCT00354107|21016201|P1|Overall Study|Physician Decision|2
6088991|NCT00354107|21016201|P1|Overall Study|Adverse Event|2
6088992|NCT00354029|21016211|P2|Overall Study|Protocol Violation|2
6088993|NCT00354029|21016212|P1|Overall Study|Protocol Violation|4
6088994|NCT00353873|21016224|P2|Overall Study|Withdrawal by Subject|1
6088995|NCT00353873|21016225|P1|Overall Study|Withdrawal by Subject|1
6088996|NCT00353873|21016224|P2|Overall Study|Physician Decision|0
6088997|NCT00353873|21016225|P1|Overall Study|Physician Decision|2
6088998|NCT00353873|21016224|P2|Overall Study|Adverse Event|0
6088999|NCT00353873|21016225|P1|Overall Study|Adverse Event|1
6089000|NCT00353873|21016224|P2|Overall Study|Exacerbation|0
6089001|NCT00353873|21016225|P1|Overall Study|Exacerbation|1
6089002|NCT00353873|21016224|P2|Overall Study|Protocol Violation|2
6089003|NCT00353873|21016225|P1|Overall Study|Protocol Violation|1
6089004|NCT00353704|21016254|P2|Overall Study|Protocol Violation|1
6089005|NCT00353704|21016255|P1|Overall Study|Protocol Violation|3
6089006|NCT00353496|21016325|P2|Overall Study|Not otherwise specified|2
6089007|NCT00353496|21016326|P1|Overall Study|Not otherwise specified|4
6089008|NCT00353496|21016325|P2|Overall Study|Physician Decision|9
6089009|NCT00353496|21016326|P1|Overall Study|Physician Decision|6
6089010|NCT00353496|21016325|P2|Overall Study|Withdrawal by Subject|4
6089011|NCT00353496|21016326|P1|Overall Study|Withdrawal by Subject|3
6089012|NCT00353496|21016325|P2|Overall Study|Protocol Violation|2
6089013|NCT00353496|21016326|P1|Overall Study|Protocol Violation|2
6089014|NCT00353496|21016325|P2|Overall Study|Adverse Event|0
6089015|NCT00353496|21016326|P1|Overall Study|Adverse Event|1
6089016|NCT00353366|21016379|P1|Overall Study|Other|135
6089017|NCT00353366|21016379|P1|Overall Study|Adverse Event|8
6089018|NCT00353262|21016406|P1|Overall Study|Break from Chemotherapy|1
6089019|NCT00353262|21016406|P1|Overall Study|Surgery|4
6089020|NCT00353262|21016406|P1|Overall Study|Progression|1
6089021|NCT00353262|21016406|P1|Overall Study|Insufficient Therapeutic Response|13
6089022|NCT00353262|21016406|P1|Overall Study|Withdrawal by Subject|2
6089023|NCT00353262|21016406|P1|Overall Study|Adverse Event|8
6089024|NCT00352885|21016447|P2|Overall Study|Side effects of IL-2 administration|0
6089025|NCT00352885|21016448|P1|Overall Study|Side effects of IL-2 administration|1
6089026|NCT00352885|21016447|P2|Overall Study|Progression of metastatic melanoma|3
6089027|NCT00352885|21016448|P1|Overall Study|Progression of metastatic melanoma|5
6089028|NCT00352885|21016447|P2|Overall Study|Development of major depression|1
6089029|NCT00352885|21016448|P1|Overall Study|Development of major depression|0
6089030|NCT00352885|21016447|P2|Overall Study|Withdrawal by Subject|3
6089031|NCT00352885|21016448|P1|Overall Study|Withdrawal by Subject|0
6089032|NCT00352846|21016466|P2|Overall Study|Death|1
6089033|NCT00352846|21016467|P1|Overall Study|Death|0
6089034|NCT00352846|21016466|P2|Overall Study|Non-compliance|0
6089035|NCT00352846|21016467|P1|Overall Study|Non-compliance|2
6089036|NCT00352846|21016466|P2|Overall Study|Ineligible|2
6089037|NCT00352846|21016467|P1|Overall Study|Ineligible|3
6089038|NCT00352846|21016466|P2|Overall Study|Withdrawal by Subject|8
6089039|NCT00352846|21016467|P1|Overall Study|Withdrawal by Subject|3
6089040|NCT00352846|21016466|P2|Overall Study|Disease progression|2
6089041|NCT00352846|21016467|P1|Overall Study|Disease progression|0
6089042|NCT00352755|21016482|P1|Overall Study|Adverse Event|1
6089043|NCT00352755|21016482|P1|Overall Study|Physician Decision|1
6089044|NCT00352690|21016492|P2|Overall Study|Determined to be ineligible|0
6089045|NCT00352690|21016493|P1|Overall Study|Determined to be ineligible|2
6089046|NCT00352664|21016513|P2|Overall Study|Withdrawal by Subject|0
6089047|NCT00352664|21016514|P1|Overall Study|Withdrawal by Subject|7
6089048|NCT00352534|21016531|P7|Final Risk Group Assignment|Death|0
6089049|NCT00352534|21016532|P6|Final Risk Group Assignment|Death|2
6089050|NCT00352534|21016533|P5|Final Risk Group Assignment|Death|0
6089051|NCT00352534|21016534|P4|Final Risk Group Assignment|Death|0
6089052|NCT00352534|21016535|P3|Final Risk Group Assignment|Death|0
6089053|NCT00352534|21016536|P2|Final Risk Group Assignment|Death|0
6089054|NCT00352534|21016537|P1|Final Risk Group Assignment|Death|0
6089055|NCT00352534|21016531|P7|Final Risk Group Assignment|Stage III Wilms tumor with LOH|11
6089056|NCT00352534|21016532|P6|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
6089057|NCT00352534|21016533|P5|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
6089058|NCT00352534|21016534|P4|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
6089059|NCT00352534|21016535|P3|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
6089060|NCT00352534|21016536|P2|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
6089061|NCT00352534|21016537|P1|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
6089062|NCT00352534|21016531|P7|Final Risk Group Assignment|Enrollment onto another COG study|28
6089063|NCT00352534|21016532|P6|Final Risk Group Assignment|Enrollment onto another COG study|0
6089064|NCT00352534|21016533|P5|Final Risk Group Assignment|Enrollment onto another COG study|0
6089065|NCT00352534|21016534|P4|Final Risk Group Assignment|Enrollment onto another COG study|0
6089066|NCT00352534|21016535|P3|Final Risk Group Assignment|Enrollment onto another COG study|0
6089067|NCT00352534|21016536|P2|Final Risk Group Assignment|Enrollment onto another COG study|0
6089068|NCT00352534|21016537|P1|Final Risk Group Assignment|Enrollment onto another COG study|0
6089069|NCT00352534|21016531|P7|Final Risk Group Assignment|Ineligible|0
6089070|NCT00352534|21016532|P6|Final Risk Group Assignment|Ineligible|13
6089071|NCT00352534|21016533|P5|Final Risk Group Assignment|Ineligible|0
6089072|NCT00352534|21016534|P4|Final Risk Group Assignment|Ineligible|1
6089073|NCT00352534|21016535|P3|Final Risk Group Assignment|Ineligible|3
6089074|NCT00352534|21016536|P2|Final Risk Group Assignment|Ineligible|0
6089075|NCT00352534|21016537|P1|Final Risk Group Assignment|Ineligible|0
6089076|NCT00352534|21016531|P7|Final Risk Group Assignment|Withdrawal by Subject|0
6089077|NCT00352534|21016532|P6|Final Risk Group Assignment|Withdrawal by Subject|3
6089078|NCT00352534|21016533|P5|Final Risk Group Assignment|Withdrawal by Subject|0
6089079|NCT00352534|21016534|P4|Final Risk Group Assignment|Withdrawal by Subject|0
6089080|NCT00352534|21016535|P3|Final Risk Group Assignment|Withdrawal by Subject|0
6089081|NCT00352534|21016536|P2|Final Risk Group Assignment|Withdrawal by Subject|0
6089082|NCT00352534|21016537|P1|Final Risk Group Assignment|Withdrawal by Subject|0
6089083|NCT00352534|21016531|P7|Final Risk Group Assignment|Physician Decision|0
6089084|NCT00352534|21016532|P6|Final Risk Group Assignment|Physician Decision|8
6089085|NCT00352534|21016533|P5|Final Risk Group Assignment|Physician Decision|0
6089086|NCT00352534|21016534|P4|Final Risk Group Assignment|Physician Decision|0
6089087|NCT00352534|21016535|P3|Final Risk Group Assignment|Physician Decision|0
6089088|NCT00352534|21016536|P2|Final Risk Group Assignment|Physician Decision|0
6089089|NCT00352534|21016537|P1|Final Risk Group Assignment|Physician Decision|0
6089090|NCT00352534|21016531|P7|Final Risk Group Assignment|Lack of Efficacy|0
6089091|NCT00352534|21016532|P6|Final Risk Group Assignment|Lack of Efficacy|19
6089092|NCT00352534|21016533|P5|Final Risk Group Assignment|Lack of Efficacy|1
6089093|NCT00352534|21016534|P4|Final Risk Group Assignment|Lack of Efficacy|2
6089094|NCT00352534|21016535|P3|Final Risk Group Assignment|Lack of Efficacy|0
6089095|NCT00352534|21016536|P2|Final Risk Group Assignment|Lack of Efficacy|0
6089096|NCT00352534|21016537|P1|Final Risk Group Assignment|Lack of Efficacy|0
6089097|NCT00352534|21016531|P7|Initial Staging|Ineligible|0
6089098|NCT00352534|21016532|P6|Initial Staging|Ineligible|0
6089099|NCT00352534|21016533|P5|Initial Staging|Ineligible|0
6089100|NCT00352534|21016534|P4|Initial Staging|Ineligible|0
6089101|NCT00352534|21016535|P3|Initial Staging|Ineligible|0
6089102|NCT00352534|21016536|P2|Initial Staging|Ineligible|9
6089103|NCT00352534|21016537|P1|Initial Staging|Ineligible|8
6089104|NCT00352417|21016554|P2|Overall Study|Schedule Change|1
6089105|NCT00352417|21016555|P1|Overall Study|Schedule Change|2
6089106|NCT00352417|21016554|P2|Overall Study|Lost to Follow-up|0
6089107|NCT00352417|21016555|P1|Overall Study|Lost to Follow-up|1
6089108|NCT00352417|21016554|P2|Overall Study|Withdrawal by Subject|2
6089109|NCT00352417|21016555|P1|Overall Study|Withdrawal by Subject|1
6089110|NCT00352417|21016554|P2|Overall Study|Protocol Violation|2
6089111|NCT00352417|21016555|P1|Overall Study|Protocol Violation|0
6089112|NCT00352417|21016554|P2|Overall Study|Adverse Event|0
6089113|NCT00352417|21016555|P1|Overall Study|Adverse Event|1
6089114|NCT00352365|21016569|P1|Maintenance Therapy|Not eligible|4
6089115|NCT00352365|21016569|P1|Maintenance Therapy|Not protocol specified|3
6089116|NCT00352365|21016569|P1|Maintenance Therapy|Death|2
6089117|NCT00352365|21016569|P1|Maintenance Therapy|Progression/Relapse|3
6089118|NCT00352365|21016569|P1|Induction Therapy|Death before starting protocol therapy|1
6089119|NCT00352365|21016569|P1|Induction Therapy|Not eligible|3
6089120|NCT00352365|21016569|P1|Induction Therapy|Not protocol specified|1
6089121|NCT00352365|21016569|P1|Induction Therapy|Death|7
6089122|NCT00352365|21016569|P1|Induction Therapy|Progression/Relapse|8
6089123|NCT00352365|21016569|P1|Induction Therapy|Adverse Event|7
6089124|NCT00352118|21016579|P1|Overall Study|Physician Decision|4
6089125|NCT00352105|21016589|P1|Overall Study|Protocol Violation|2
6089126|NCT00352105|21016589|P1|Overall Study|Adverse Event|19
6089127|NCT00352105|21016589|P1|Overall Study|Lack of Efficacy|9
6089128|NCT00352105|21016589|P1|Overall Study|Withdrawal by Subject|5
6089129|NCT00352105|21016589|P1|Overall Study|Death|5
6089130|NCT00352053|21016600|P2|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|1
6089131|NCT00352053|21016601|P1|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|0
6089132|NCT00352053|21016600|P2|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1
6089133|NCT00352053|21016601|P1|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1
6089134|NCT00352053|21016600|P2|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1
6089135|NCT00352053|21016601|P1|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1
6089136|NCT00352053|21016600|P2|Second Extension Phase (Weeks 144-240)|Physician Decision|4
6089137|NCT00352053|21016601|P1|Second Extension Phase (Weeks 144-240)|Physician Decision|4
6089138|NCT00352053|21016600|P2|First Extension Phase (Weeks 48-144)|Lost to Follow-up|0
6089139|NCT00352053|21016601|P1|First Extension Phase (Weeks 48-144)|Lost to Follow-up|1
6089140|NCT00352053|21016600|P2|First Extension Phase (Weeks 48-144)|Pregnancy|0
6089141|NCT00352053|21016601|P1|First Extension Phase (Weeks 48-144)|Pregnancy|1
6089142|NCT00352053|21016600|P2|First Extension Phase (Weeks 48-144)|Lack of Efficacy|4
6089143|NCT00352053|21016601|P1|First Extension Phase (Weeks 48-144)|Lack of Efficacy|1
6089144|NCT00352053|21016600|P2|First Extension Phase (Weeks 48-144)|Physician Decision|13
6089145|NCT00352053|21016601|P1|First Extension Phase (Weeks 48-144)|Physician Decision|9
6089146|NCT00352053|21016600|P2|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|0
6089147|NCT00352053|21016601|P1|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|1
6089148|NCT00352053|21016600|P2|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|1
6089149|NCT00352053|21016601|P1|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|0
6089150|NCT00352053|21016600|P2|Double-Blind Phase (Through Week 48)|Adverse Event|0
6089151|NCT00352053|21016601|P1|Double-Blind Phase (Through Week 48)|Adverse Event|1
6089152|NCT00352053|21016600|P2|Double-Blind Phase (Through Week 48)|Physician Decision|2
6089153|NCT00352053|21016601|P1|Double-Blind Phase (Through Week 48)|Physician Decision|2
6089154|NCT00352053|21016600|P2|Double-Blind Phase (Through Week 48)|Virologic Failure|10
6089155|NCT00352053|21016601|P1|Double-Blind Phase (Through Week 48)|Virologic Failure|14
6089157|NCT00351819|21017067|P2|Overall Study|Enrolled in another trial|1
6089158|NCT00351819|21017068|P1|Overall Study|Enrolled in another trial|0
6089159|NCT00351819|21017067|P2|Overall Study|Incarcerated|1
6089160|NCT00351819|21017068|P1|Overall Study|Incarcerated|0
6089161|NCT00351819|21017067|P2|Overall Study|Non-compliance|1
6089162|NCT00351819|21017068|P1|Overall Study|Non-compliance|0
6089163|NCT00351819|21017067|P2|Overall Study|Unprofessional behavior|0
6089164|NCT00351819|21017068|P1|Overall Study|Unprofessional behavior|1
6089165|NCT00351819|21017067|P2|Overall Study|Traumatic ankle fracture|0
6089166|NCT00351819|21017068|P1|Overall Study|Traumatic ankle fracture|1
6089167|NCT00351819|21017067|P2|Overall Study|Elevated PSA|1
6089168|NCT00351819|21017068|P1|Overall Study|Elevated PSA|1
6089169|NCT00351819|21017067|P2|Overall Study|Withdrawal by Subject|4
6089170|NCT00351819|21017068|P1|Overall Study|Withdrawal by Subject|0
6089171|NCT00351819|21017067|P2|Overall Study|Lost to Follow-up|4
6089172|NCT00351819|21017068|P1|Overall Study|Lost to Follow-up|4
6089173|NCT00351533|21017139|P2|Overall Study|Withdrawal by Subject|1
6089174|NCT00351533|21017140|P1|Overall Study|Withdrawal by Subject|0
6089175|NCT00351533|21017139|P2|Overall Study|Physician Decision|1
6089176|NCT00351533|21017140|P1|Overall Study|Physician Decision|0
6089177|NCT00351533|21017139|P2|Overall Study|Lost to Follow-up|3
6089178|NCT00351533|21017140|P1|Overall Study|Lost to Follow-up|1
6089179|NCT00351533|21017139|P2|Overall Study|Extubated before first BAL|0
6089180|NCT00351533|21017140|P1|Overall Study|Extubated before first BAL|1
6089181|NCT00351468|21017200|P1|Overall Study|Protocol Violation|3
6089182|NCT00351468|21017200|P1|Overall Study|Lost to Follow-up|4
6089183|NCT00351468|21017200|P1|Overall Study|Non-compliance|8
6089184|NCT00351468|21017200|P1|Overall Study|Lack of Efficacy|32
6089185|NCT00351468|21017200|P1|Overall Study|Various -follow up w clinical team|39
6089186|NCT00351468|21017200|P1|Overall Study|Withdrawal by Subject|39
6089187|NCT00351468|21017200|P1|Overall Study|Adverse Event|42
6089188|NCT00351377|21017224|P1|Overall Study|Unsatisfactory therapeutic effect|1
6089189|NCT00351377|21017224|P1|Overall Study|Death|1
6089190|NCT00351377|21017224|P1|Overall Study|Adverse Event|5
6089191|NCT00351351|21017238|P2|Overall Study|surgical access pbs; device issues|4
6089192|NCT00351351|21017239|P1|Overall Study|surgical access pbs; device issues|9
6089193|NCT00351273|21017265|P3|Overall Study|Lost to Follow-up|5
6089194|NCT00351273|21017266|P2|Overall Study|Lost to Follow-up|2
6089195|NCT00351273|21017267|P1|Overall Study|Lost to Follow-up|1
6089196|NCT00350870|21017310|P4|Overall Study|Physician Decision|1
6089197|NCT00350870|21017311|P3|Overall Study|Physician Decision|1
6089198|NCT00350870|21017312|P2|Overall Study|Physician Decision|0
6089199|NCT00350870|21017313|P1|Overall Study|Physician Decision|1
6089200|NCT00350870|21017310|P4|Overall Study|Withdrawal by Subject|14
6089201|NCT00350870|21017311|P3|Overall Study|Withdrawal by Subject|15
6089202|NCT00350870|21017312|P2|Overall Study|Withdrawal by Subject|17
6089203|NCT00350870|21017313|P1|Overall Study|Withdrawal by Subject|21
6089204|NCT00350844|21017327|P1|Overall Study|Lost to Follow-up|1
6089205|NCT00350792|21017331|P1|Overall Study|Lack of Efficacy|11
6089206|NCT00350792|21017331|P1|Overall Study|Physician Decision|2
6089207|NCT00350792|21017331|P1|Overall Study|Withdrawal by Subject|4
6089208|NCT00350792|21017331|P1|Overall Study|Protocol Violation|1
6089209|NCT00350792|21017331|P1|Overall Study|Death Not Study Drug Related|2
6089210|NCT00350792|21017331|P1|Overall Study|Death from Study Drug Toxicity|1
6089211|NCT00350792|21017331|P1|Overall Study|Death from Study Disease|1
6089212|NCT00350792|21017331|P1|Overall Study|Adverse Event|11
6089213|NCT00350779|21017341|P2|Overall Study|Non-compliance with study procedures|1
6089214|NCT00350779|21017342|P1|Overall Study|Non-compliance with study procedures|0
6089215|NCT00350779|21017341|P2|Overall Study|Patient Moved|1
6089216|NCT00350779|21017342|P1|Overall Study|Patient Moved|2
6089217|NCT00350779|21017341|P2|Overall Study|Withdrawal by Subject|8
6089218|NCT00350779|21017342|P1|Overall Study|Withdrawal by Subject|9
6089219|NCT00350779|21017341|P2|Overall Study|Protocol Violation|1
6089220|NCT00350779|21017342|P1|Overall Study|Protocol Violation|3
6089221|NCT00350779|21017341|P2|Overall Study|Physician Decision|4
6089222|NCT00350779|21017342|P1|Overall Study|Physician Decision|2
6089223|NCT00350779|21017341|P2|Overall Study|Lost to Follow-up|0
6089224|NCT00350779|21017342|P1|Overall Study|Lost to Follow-up|2
6089225|NCT00350779|21017341|P2|Overall Study|Lack of Efficacy|4
6089226|NCT00350779|21017342|P1|Overall Study|Lack of Efficacy|0
6089227|NCT00350779|21017341|P2|Overall Study|Adverse Event|2
6089228|NCT00350779|21017342|P1|Overall Study|Adverse Event|4
6089229|NCT00350727|21017363|P3|Phase II|Enrolled in Rollover Study|1
6089230|NCT00350727|21017364|P2|Phase II|Enrolled in Rollover Study|0
6089231|NCT00350727|21017365|P1|Phase II|Enrolled in Rollover Study|0
6089232|NCT00350727|21017363|P3|Phase II|Sponsor Terminated Study|1
6089233|NCT00350727|21017364|P2|Phase II|Sponsor Terminated Study|0
6089234|NCT00350727|21017365|P1|Phase II|Sponsor Terminated Study|0
6089235|NCT00350727|21017363|P3|Phase II|Death|2
6089236|NCT00350727|21017364|P2|Phase II|Death|0
6089237|NCT00350727|21017365|P1|Phase II|Death|0
6089238|NCT00350727|21017363|P3|Phase II|Adverse Event|1
6089239|NCT00350727|21017364|P2|Phase II|Adverse Event|1
6089240|NCT00350727|21017365|P1|Phase II|Adverse Event|0
6089241|NCT00350727|21017363|P3|Phase II|Withdrawal by Subject|1
6089242|NCT00350727|21017364|P2|Phase II|Withdrawal by Subject|2
6089243|NCT00350727|21017365|P1|Phase II|Withdrawal by Subject|0
6089244|NCT00350727|21017363|P3|Phase II|Clinical Deterioration|0
6089245|NCT00350727|21017364|P2|Phase II|Clinical Deterioration|1
6089246|NCT00350727|21017365|P1|Phase II|Clinical Deterioration|0
6089247|NCT00350727|21017363|P3|Phase II|Disease Progression|16
6089248|NCT00350727|21017364|P2|Phase II|Disease Progression|15
6089249|NCT00350727|21017365|P1|Phase II|Disease Progression|0
6089250|NCT00350727|21017363|P3|Phase I: Dose Escalation|Transition to Extension Phase|0
6089251|NCT00350727|21017364|P2|Phase I: Dose Escalation|Transition to Extension Phase|0
6089252|NCT00350727|21017365|P1|Phase I: Dose Escalation|Transition to Extension Phase|3
6089253|NCT00350727|21017363|P3|Phase I: Dose Escalation|Physician Decision|0
6089254|NCT00350727|21017364|P2|Phase I: Dose Escalation|Physician Decision|0
6089255|NCT00350727|21017365|P1|Phase I: Dose Escalation|Physician Decision|1
6089256|NCT00350727|21017363|P3|Phase I: Dose Escalation|Death|0
6089257|NCT00350727|21017364|P2|Phase I: Dose Escalation|Death|0
6089258|NCT00350727|21017365|P1|Phase I: Dose Escalation|Death|1
6089259|NCT00350727|21017363|P3|Phase I: Dose Escalation|Lack of Efficacy|0
6089260|NCT00350727|21017364|P2|Phase I: Dose Escalation|Lack of Efficacy|0
6089261|NCT00350727|21017365|P1|Phase I: Dose Escalation|Lack of Efficacy|25
6089262|NCT00350727|21017363|P3|Phase I: Dose Escalation|Adverse Event|0
6089263|NCT00350727|21017364|P2|Phase I: Dose Escalation|Adverse Event|0
6089264|NCT00350727|21017365|P1|Phase I: Dose Escalation|Adverse Event|4
6089265|NCT00350636|21017509|P2|Overall Study|Other|2
6089266|NCT00350636|21017510|P1|Overall Study|Other|1
6089267|NCT00350636|21017509|P2|Overall Study|Physician Decision|2
6089268|NCT00350636|21017510|P1|Overall Study|Physician Decision|0
6089269|NCT00350636|21017509|P2|Overall Study|Lost to Follow-up|8
6089270|NCT00350636|21017510|P1|Overall Study|Lost to Follow-up|9
6089271|NCT00350636|21017509|P2|Overall Study|Withdrawal by Subject|17
6089272|NCT00350636|21017510|P1|Overall Study|Withdrawal by Subject|13
6089273|NCT00350636|21017509|P2|Overall Study|Protocol Violation|3
6089274|NCT00350636|21017510|P1|Overall Study|Protocol Violation|1
6089275|NCT00350636|21017509|P2|Overall Study|Adverse Event|13
6089276|NCT00350636|21017510|P1|Overall Study|Adverse Event|19
6089277|NCT00350623|21017529|P3|Overall Study|patient traveling outside the country|1
6089278|NCT00350623|21017530|P2|Overall Study|patient traveling outside the country|0
6089279|NCT00350623|21017531|P1|Overall Study|patient traveling outside the country|0
6089280|NCT00350623|21017529|P3|Overall Study|Withdrawal by Subject|1
6089281|NCT00350623|21017530|P2|Overall Study|Withdrawal by Subject|1
6089282|NCT00350623|21017531|P1|Overall Study|Withdrawal by Subject|0
6089283|NCT00350623|21017529|P3|Overall Study|Lost to Follow-up|4
6089284|NCT00350623|21017530|P2|Overall Study|Lost to Follow-up|3
6089285|NCT00350623|21017531|P1|Overall Study|Lost to Follow-up|8
6089286|NCT00350545|21017539|P1|Overall Study|Withdrawal by Subject|2
6089287|NCT00350519|21017558|P2|Overall Study|Withdrawal by Subject|2
6089288|NCT00350519|21017559|P1|Overall Study|Withdrawal by Subject|3
6089289|NCT00350519|21017558|P2|Overall Study|Protocol Violation|2
6089290|NCT00350519|21017559|P1|Overall Study|Protocol Violation|1
6089291|NCT00350519|21017558|P2|Overall Study|Physician Decision|1
6089292|NCT00350519|21017559|P1|Overall Study|Physician Decision|0
6089293|NCT00350519|21017558|P2|Overall Study|Death|1
6089294|NCT00350519|21017559|P1|Overall Study|Death|0
6089295|NCT00350402|21017573|P2|Overall Study|Lost to Follow-up|1
6089296|NCT00350402|21017574|P1|Overall Study|Lost to Follow-up|1
6089297|NCT00350272|21017647|P2|Open-Label 84 Week Treatment|Sponsor decision|1
6089298|NCT00350272|21017648|P1|Open-Label 84 Week Treatment|Sponsor decision|2
6089299|NCT00350272|21017647|P2|Open-Label 84 Week Treatment|Physician Decision|2
6089300|NCT00350272|21017648|P1|Open-Label 84 Week Treatment|Physician Decision|1
6089301|NCT00350272|21017647|P2|Open-Label 84 Week Treatment|Withdrawal by Subject|2
6089302|NCT00350272|21017648|P1|Open-Label 84 Week Treatment|Withdrawal by Subject|1
6089303|NCT00350272|21017647|P2|Open-Label 84 Week Treatment|Lost to Follow-up|2
6089304|NCT00350272|21017648|P1|Open-Label 84 Week Treatment|Lost to Follow-up|3
6089305|NCT00350272|21017647|P2|Open-Label 84 Week Treatment|Adverse Event|1
6089306|NCT00350272|21017648|P1|Open-Label 84 Week Treatment|Adverse Event|2
6089307|NCT00350272|21017647|P2|Blinded 12 Week Treatment|Sponsor decision|1
6089308|NCT00350272|21017648|P1|Blinded 12 Week Treatment|Sponsor decision|0
6089309|NCT00350272|21017647|P2|Blinded 12 Week Treatment|Physician Decision|1
6089310|NCT00350272|21017648|P1|Blinded 12 Week Treatment|Physician Decision|2
6089311|NCT00350272|21017647|P2|Blinded 12 Week Treatment|Withdrawal by Subject|0
6089312|NCT00350272|21017648|P1|Blinded 12 Week Treatment|Withdrawal by Subject|3
6089313|NCT00350272|21017647|P2|Blinded 12 Week Treatment|Lost to Follow-up|0
6089314|NCT00350272|21017648|P1|Blinded 12 Week Treatment|Lost to Follow-up|2
6089315|NCT00350272|21017647|P2|Blinded 12 Week Treatment|Death|0
6089316|NCT00350272|21017648|P1|Blinded 12 Week Treatment|Death|1
6089317|NCT00350272|21017647|P2|Blinded 12 Week Treatment|Adverse Event|0
6089318|NCT00350272|21017648|P1|Blinded 12 Week Treatment|Adverse Event|1
6089319|NCT00350207|21017670|P3|Overall Study|Other|1
6089320|NCT00350207|21017671|P2|Overall Study|Other|3
6089321|NCT00350207|21017672|P1|Overall Study|Other|1
6089322|NCT00350207|21017670|P3|Overall Study|Withdrawal by Subject|1
6089323|NCT00350207|21017671|P2|Overall Study|Withdrawal by Subject|1
6089324|NCT00350207|21017672|P1|Overall Study|Withdrawal by Subject|0
6089325|NCT00350207|21017670|P3|Overall Study|Lost to Follow-up|1
6089326|NCT00350207|21017671|P2|Overall Study|Lost to Follow-up|0
6089327|NCT00350207|21017672|P1|Overall Study|Lost to Follow-up|1
6089328|NCT00350207|21017670|P3|Overall Study|Lack of Efficacy|2
6089329|NCT00350207|21017671|P2|Overall Study|Lack of Efficacy|0
6089330|NCT00350207|21017672|P1|Overall Study|Lack of Efficacy|1
6089331|NCT00350207|21017670|P3|Overall Study|Adverse Event|2
6089332|NCT00350207|21017671|P2|Overall Study|Adverse Event|2
6089333|NCT00350207|21017672|P1|Overall Study|Adverse Event|5
6089334|NCT00349973|21017884|P2|Overall Study|Withdrawal by Subject|0
6089335|NCT00349973|21017885|P1|Overall Study|Withdrawal by Subject|1
6089336|NCT00349973|21017884|P2|Overall Study|Adverse Event|3
6089337|NCT00349973|21017885|P1|Overall Study|Adverse Event|3
6089338|NCT00349921|21017899|P4|First Spinal Injection|Adverse Event|0
6089339|NCT00349921|21017900|P3|First Spinal Injection|Adverse Event|1
6089340|NCT00349921|21017901|P2|First Spinal Injection|Adverse Event|0
6089341|NCT00349921|21017902|P1|First Spinal Injection|Adverse Event|0
6089342|NCT00349921|21017899|P4|First Spinal Injection|Physician Decision|0
6089343|NCT00349921|21017900|P3|First Spinal Injection|Physician Decision|0
6089344|NCT00349921|21017901|P2|First Spinal Injection|Physician Decision|0
6089345|NCT00349921|21017902|P1|First Spinal Injection|Physician Decision|1
6089346|NCT00349908|21017913|P2|Overall Study|Withdrawal by Subject|4
6089347|NCT00349908|21017914|P1|Overall Study|Withdrawal by Subject|0
6089348|NCT00349752|21017940|P2|Overall Study|Other:History of squamous cell carcinoma|0
6089349|NCT00349752|21017941|P1|Overall Study|Other:History of squamous cell carcinoma|1
6089350|NCT00349752|21017940|P2|Overall Study|Other: Inadvertently unblinded|0
6089351|NCT00349752|21017941|P1|Overall Study|Other: Inadvertently unblinded|1
6089352|NCT00349752|21017940|P2|Overall Study|Other: Ineligible|0
6089353|NCT00349752|21017941|P1|Overall Study|Other: Ineligible|1
6089354|NCT00349752|21017940|P2|Overall Study|Other: Patient's steroid use|0
6089355|NCT00349752|21017941|P1|Overall Study|Other: Patient's steroid use|1
6089356|NCT00349752|21017940|P2|Overall Study|Other: Patient stopped steroids|1
6089357|NCT00349752|21017941|P1|Overall Study|Other: Patient stopped steroids|0
6089358|NCT00349752|21017940|P2|Overall Study|Other: Non compliance|1
6089359|NCT00349752|21017941|P1|Overall Study|Other: Non compliance|0
6089360|NCT00349752|21017940|P2|Overall Study|Other: Required exclusionary medication|1
6089361|NCT00349752|21017941|P1|Overall Study|Other: Required exclusionary medication|0
6089362|NCT00349752|21017940|P2|Overall Study|Personal reasons|5
6089363|NCT00349752|21017941|P1|Overall Study|Personal reasons|6
6089364|NCT00349752|21017940|P2|Overall Study|Lost to Follow-up|2
6089365|NCT00349752|21017941|P1|Overall Study|Lost to Follow-up|4
6089366|NCT00349752|21017940|P2|Overall Study|Lack of Efficacy|42
6089367|NCT00349752|21017941|P1|Overall Study|Lack of Efficacy|37
6089368|NCT00349752|21017940|P2|Overall Study|Adverse Event|12
6089369|NCT00349752|21017941|P1|Overall Study|Adverse Event|8
6089370|NCT00349622|21017994|P2|Overall Study|Withdrawal by Subject|9
6089371|NCT00349622|21017995|P1|Overall Study|Withdrawal by Subject|5
6089372|NCT00349622|21017994|P2|Overall Study|Lost to Follow-up|1
6089373|NCT00349622|21017995|P1|Overall Study|Lost to Follow-up|5
6089374|NCT00349622|21017994|P2|Overall Study|Death|86
6089375|NCT00349622|21017995|P1|Overall Study|Death|168
6089376|NCT00349349|21018034|P3|Overall Study|New Malignancy (Bladder Cancer)|0
6089377|NCT00349349|21018035|P2|Overall Study|New Malignancy (Bladder Cancer)|1
6089378|NCT00349349|21018036|P1|Overall Study|New Malignancy (Bladder Cancer)|0
6089379|NCT00349349|21018034|P3|Overall Study|No Response|0
6089380|NCT00349349|21018035|P2|Overall Study|No Response|3
6089381|NCT00349349|21018036|P1|Overall Study|No Response|0
6089382|NCT00349349|21018034|P3|Overall Study|Physician Decision|1
6089383|NCT00349349|21018035|P2|Overall Study|Physician Decision|2
6089384|NCT00349349|21018036|P1|Overall Study|Physician Decision|1
6089385|NCT00349349|21018034|P3|Overall Study|Participant Reduced General Condition|0
6089386|NCT00349349|21018035|P2|Overall Study|Participant Reduced General Condition|1
6089387|NCT00349349|21018036|P1|Overall Study|Participant Reduced General Condition|0
6089388|NCT00349349|21018034|P3|Overall Study|Other Treatment Selected|0
6089389|NCT00349349|21018035|P2|Overall Study|Other Treatment Selected|0
6089390|NCT00349349|21018036|P1|Overall Study|Other Treatment Selected|2
6089391|NCT00349349|21018034|P3|Overall Study|Death|1
6089392|NCT00349349|21018035|P2|Overall Study|Death|10
6089393|NCT00349349|21018036|P1|Overall Study|Death|13
6089394|NCT00349349|21018034|P3|Overall Study|Withdrawn due to Disease Progression|1
6089395|NCT00349349|21018035|P2|Overall Study|Withdrawn due to Disease Progression|37
6089396|NCT00349349|21018036|P1|Overall Study|Withdrawn due to Disease Progression|27
6089397|NCT00349349|21018034|P3|Overall Study|Withdrawal by Subject|1
6089398|NCT00349349|21018035|P2|Overall Study|Withdrawal by Subject|2
6089399|NCT00349349|21018036|P1|Overall Study|Withdrawal by Subject|5
6089400|NCT00349349|21018034|P3|Overall Study|Adverse Event|2
6089401|NCT00349349|21018035|P2|Overall Study|Adverse Event|6
6089402|NCT00349349|21018036|P1|Overall Study|Adverse Event|5
6089403|NCT00348933|21018125|P1|Overall Study|Adverse Event|7
6089404|NCT00348933|21018125|P1|Overall Study|Protocol Violation|2
6089405|NCT00348933|21018125|P1|Overall Study|Lost to Follow-up|6
6089406|NCT00348933|21018125|P1|Overall Study|Withdrawal by Subject|10
6089407|NCT00348881|21018133|P2|Overall Study|Serious Adverse Event|2
6089408|NCT00348881|21018134|P1|Overall Study|Serious Adverse Event|0
6089409|NCT00348881|21018133|P2|Overall Study|Adverse Event|0
6089410|NCT00348881|21018134|P1|Overall Study|Adverse Event|2
6089411|NCT00348881|21018133|P2|Overall Study|Withdrawal by Subject|4
6089412|NCT00348881|21018134|P1|Overall Study|Withdrawal by Subject|3
6089413|NCT00348881|21018133|P2|Overall Study|Lost to Follow-up|6
6089414|NCT00348881|21018134|P1|Overall Study|Lost to Follow-up|12
6089415|NCT00348816|21018146|P1|Overall Study|Noncompliance with radiation treatment|1
6089416|NCT00348790|21018153|P1|Completed Treatment|Unable to travel to study site|1
6089417|NCT00348790|21018153|P1|Completed Treatment|Required surgery|2
6089418|NCT00348790|21018153|P1|Completed Treatment|Adverse Event|4
6089419|NCT00348790|21018153|P1|Completed Treatment|Disease progression|14
6089420|NCT00348790|21018153|P1|Completed Treatment|Withdrawal by Subject|4
6089421|NCT00348686|21018165|P1|Overall Study|Multiple Reasons|8
6089422|NCT00348686|21018165|P1|Overall Study|Lost to Follow-up|2
6089423|NCT00348686|21018165|P1|Overall Study|Protocol Violation|6
6089424|NCT00348686|21018165|P1|Overall Study|Adverse Event|5
6089425|NCT00348686|21018165|P1|Overall Study|Withdrawal by Subject|45
6089426|NCT00348673|21018182|P9|Stage 1|Randomized but not Treated|0
6089427|NCT00348673|21018183|P8|Stage 1|Randomized but not Treated|0
6089428|NCT00348673|21018184|P7|Stage 1|Randomized but not Treated|0
6089429|NCT00348673|21018185|P6|Stage 1|Randomized but not Treated|0
6089430|NCT00348673|21018186|P5|Stage 1|Randomized but not Treated|0
6089431|NCT00348673|21018187|P4|Stage 1|Randomized but not Treated|0
6089432|NCT00348673|21018188|P3|Stage 1|Randomized but not Treated|1
6089433|NCT00348673|21018189|P2|Stage 1|Randomized but not Treated|0
6089434|NCT00348673|21018190|P1|Stage 1|Randomized but not Treated|0
6089435|NCT00348595|21018239|P2|Overall Study|Adverse Event|8
6089436|NCT00348595|21018240|P1|Overall Study|Adverse Event|5
6089437|NCT00348556|21018252|P1|Overall Study|Adverse Event|1
6089438|NCT00348374|21018259|P2|Overall Study|randomized but did not receive treatment|7
6089439|NCT00348374|21018260|P1|Overall Study|randomized but did not receive treatment|0
6089440|NCT00348374|21018259|P2|Overall Study|ongoing at date of cutoff|1
6089441|NCT00348374|21018260|P1|Overall Study|ongoing at date of cutoff|1
6089442|NCT00348374|21018259|P2|Overall Study|Other|12
6089443|NCT00348374|21018260|P1|Overall Study|Other|11
6089444|NCT00348374|21018259|P2|Overall Study|Withdrawal by Subject|5
6089445|NCT00348374|21018260|P1|Overall Study|Withdrawal by Subject|5
6089446|NCT00348374|21018259|P2|Overall Study|Lost to Follow-up|3
6089447|NCT00348374|21018260|P1|Overall Study|Lost to Follow-up|1
6089448|NCT00348374|21018259|P2|Overall Study|Adverse Event|4
6089449|NCT00348374|21018260|P1|Overall Study|Adverse Event|1
6089450|NCT00348348|21018307|P2|Overall Study|Adverse event probably related to study|0
6089451|NCT00348348|21018308|P1|Overall Study|Adverse event probably related to study|1
6089452|NCT00348348|21018307|P2|Overall Study|Worsening of BC - Unlikely related|2
6089453|NCT00348348|21018308|P1|Overall Study|Worsening of BC - Unlikely related|1
6089454|NCT00348348|21018307|P2|Overall Study|Worsening of BC - Unrelated to study|3
6089455|NCT00348348|21018308|P1|Overall Study|Worsening of BC - Unrelated to study|0
6089456|NCT00348348|21018307|P2|Overall Study|Dissallowed Meds - possibly releated|1
6089457|NCT00348348|21018308|P1|Overall Study|Dissallowed Meds - possibly releated|1
6089458|NCT00348348|21018307|P2|Overall Study|Dissallowed Meds - unlikley related|1
6089459|NCT00348348|21018308|P1|Overall Study|Dissallowed Meds - unlikley related|1
6089460|NCT00348348|21018307|P2|Overall Study|Dissallowed Meds - unrelated to study|3
6089461|NCT00348348|21018308|P1|Overall Study|Dissallowed Meds - unrelated to study|1
6089462|NCT00348348|21018307|P2|Overall Study|Other|4
6089463|NCT00348348|21018308|P1|Overall Study|Other|7
6089464|NCT00348348|21018307|P2|Overall Study|Withdrawal by Subject|1
6089465|NCT00348348|21018308|P1|Overall Study|Withdrawal by Subject|4
6089466|NCT00348348|21018307|P2|Overall Study|Lost to Follow-up|10
6089467|NCT00348348|21018308|P1|Overall Study|Lost to Follow-up|8
6089468|NCT00348348|21018307|P2|Overall Study|Lack of Efficacy|1
6089469|NCT00348348|21018308|P1|Overall Study|Lack of Efficacy|1
6089470|NCT00348348|21018307|P2|Overall Study|Adverse event - unrelated to study drug|1
6089471|NCT00348348|21018308|P1|Overall Study|Adverse event - unrelated to study drug|0
6089472|NCT00348309|21018323|P3|Overall Study|HCV career|1
6089473|NCT00348309|21018324|P2|Overall Study|HCV career|0
6089474|NCT00348309|21018325|P1|Overall Study|HCV career|0
6089475|NCT00348309|21018323|P3|Overall Study|Cardiologist recommendations|1
6089476|NCT00348309|21018324|P2|Overall Study|Cardiologist recommendations|0
6089477|NCT00348309|21018325|P1|Overall Study|Cardiologist recommendations|0
6089478|NCT00348309|21018323|P3|Overall Study|ECG abnormal|2
6089479|NCT00348309|21018324|P2|Overall Study|ECG abnormal|0
6089480|NCT00348309|21018325|P1|Overall Study|ECG abnormal|0
6089481|NCT00348309|21018323|P3|Overall Study|Adverse event not attended|1
6089482|NCT00348309|21018324|P2|Overall Study|Adverse event not attended|0
6089483|NCT00348309|21018325|P1|Overall Study|Adverse event not attended|0
6089484|NCT00348309|21018323|P3|Overall Study|Site closure|1
6089485|NCT00348309|21018324|P2|Overall Study|Site closure|0
6089486|NCT00348309|21018325|P1|Overall Study|Site closure|0
6089487|NCT00348309|21018323|P3|Overall Study|Increased dose of Aricept|1
6089488|NCT00348309|21018324|P2|Overall Study|Increased dose of Aricept|0
6089489|NCT00348309|21018325|P1|Overall Study|Increased dose of Aricept|0
6089490|NCT00348309|21018323|P3|Overall Study|Medical Monitor decision|1
6089491|NCT00348309|21018324|P2|Overall Study|Medical Monitor decision|0
6089492|NCT00348309|21018325|P1|Overall Study|Medical Monitor decision|0
6089493|NCT00348309|21018323|P3|Overall Study|Forgot often medication|0
6089494|NCT00348309|21018324|P2|Overall Study|Forgot often medication|1
6089495|NCT00348309|21018325|P1|Overall Study|Forgot often medication|0
6089496|NCT00348309|21018323|P3|Overall Study|Sponsor refuseal|1
6089497|NCT00348309|21018324|P2|Overall Study|Sponsor refuseal|1
6089498|NCT00348309|21018325|P1|Overall Study|Sponsor refuseal|0
6089499|NCT00348309|21018323|P3|Overall Study|Participant was hospitalized|0
6089500|NCT00348309|21018324|P2|Overall Study|Participant was hospitalized|1
6089501|NCT00348309|21018325|P1|Overall Study|Participant was hospitalized|0
6089502|NCT00348309|21018323|P3|Overall Study|A foul of exclusion criteria|0
6089503|NCT00348309|21018324|P2|Overall Study|A foul of exclusion criteria|1
6089504|NCT00348309|21018325|P1|Overall Study|A foul of exclusion criteria|0
6089505|NCT00348309|21018323|P3|Overall Study|Ineffectiveness of treatment|0
6089506|NCT00348309|21018324|P2|Overall Study|Ineffectiveness of treatment|1
6089507|NCT00348309|21018325|P1|Overall Study|Ineffectiveness of treatment|0
6089508|NCT00348309|21018323|P3|Overall Study|Decision of sponsor|0
6089509|NCT00348309|21018324|P2|Overall Study|Decision of sponsor|0
6089510|NCT00348309|21018325|P1|Overall Study|Decision of sponsor|1
6089511|NCT00348309|21018323|P3|Overall Study|Participant died|1
6089512|NCT00348309|21018324|P2|Overall Study|Participant died|1
6089513|NCT00348309|21018325|P1|Overall Study|Participant died|2
6089514|NCT00348309|21018323|P3|Overall Study|Did not appear in time for Visit 3|0
6089515|NCT00348309|21018324|P2|Overall Study|Did not appear in time for Visit 3|0
6089516|NCT00348309|21018325|P1|Overall Study|Did not appear in time for Visit 3|1
6089517|NCT00348309|21018323|P3|Overall Study|Worsening of alzheimer|1
6089518|NCT00348309|21018324|P2|Overall Study|Worsening of alzheimer|0
6089519|NCT00348309|21018325|P1|Overall Study|Worsening of alzheimer|1
6089520|NCT00348309|21018323|P3|Overall Study|Cognitive and behaviour worsening|0
6089521|NCT00348309|21018324|P2|Overall Study|Cognitive and behaviour worsening|0
6089522|NCT00348309|21018325|P1|Overall Study|Cognitive and behaviour worsening|2
6089523|NCT00348309|21018323|P3|Overall Study|Worsened neurodegenerative disease|0
6089524|NCT00348309|21018324|P2|Overall Study|Worsened neurodegenerative disease|0
6089525|NCT00348309|21018325|P1|Overall Study|Worsened neurodegenerative disease|1
6089526|NCT00348309|21018323|P3|Overall Study|No disponibility of medication|0
6089527|NCT00348309|21018324|P2|Overall Study|No disponibility of medication|0
6089528|NCT00348309|21018325|P1|Overall Study|No disponibility of medication|1
6089529|NCT00348309|21018323|P3|Overall Study|Principal investigator's decision|0
6089530|NCT00348309|21018324|P2|Overall Study|Principal investigator's decision|0
6089531|NCT00348309|21018325|P1|Overall Study|Principal investigator's decision|1
6089532|NCT00348309|21018323|P3|Overall Study|PI closing medical practice|0
6089533|NCT00348309|21018324|P2|Overall Study|PI closing medical practice|0
6089534|NCT00348309|21018325|P1|Overall Study|PI closing medical practice|1
6089535|NCT00348309|21018323|P3|Overall Study|Unable to complete ET visit|0
6089536|NCT00348309|21018324|P2|Overall Study|Unable to complete ET visit|0
6089537|NCT00348309|21018325|P1|Overall Study|Unable to complete ET visit|1
6089538|NCT00348309|21018323|P3|Overall Study|Caregiver withdrawal|7
6089539|NCT00348309|21018324|P2|Overall Study|Caregiver withdrawal|0
6089540|NCT00348309|21018325|P1|Overall Study|Caregiver withdrawal|3
6089541|NCT00348309|21018323|P3|Overall Study|Use of prohibited medication|2
6089542|NCT00348309|21018324|P2|Overall Study|Use of prohibited medication|2
6089543|NCT00348309|21018325|P1|Overall Study|Use of prohibited medication|5
6089544|NCT00348309|21018323|P3|Overall Study|Caregiver sick|0
6089545|NCT00348309|21018324|P2|Overall Study|Caregiver sick|0
6089546|NCT00348309|21018325|P1|Overall Study|Caregiver sick|1
6089547|NCT00348309|21018323|P3|Overall Study|Wrong bottle allocated|0
6089548|NCT00348309|21018324|P2|Overall Study|Wrong bottle allocated|0
6089549|NCT00348309|21018325|P1|Overall Study|Wrong bottle allocated|1
6089550|NCT00348309|21018323|P3|Overall Study|Lack of insight, dementia|0
6089551|NCT00348309|21018324|P2|Overall Study|Lack of insight, dementia|0
6089552|NCT00348309|21018325|P1|Overall Study|Lack of insight, dementia|1
6089553|NCT00348309|21018323|P3|Overall Study|Death of caregiver|1
6089554|NCT00348309|21018324|P2|Overall Study|Death of caregiver|0
6089555|NCT00348309|21018325|P1|Overall Study|Death of caregiver|1
6089556|NCT00348309|21018323|P3|Overall Study|Non-compliance|8
6089557|NCT00348309|21018324|P2|Overall Study|Non-compliance|6
6089558|NCT00348309|21018325|P1|Overall Study|Non-compliance|8
6089559|NCT00348309|21018323|P3|Overall Study|Withdrawal by Subject|40
6089560|NCT00348309|21018324|P2|Overall Study|Withdrawal by Subject|37
6089561|NCT00348309|21018325|P1|Overall Study|Withdrawal by Subject|33
6089562|NCT00348309|21018323|P3|Overall Study|Protocol Violation|7
6089563|NCT00348309|21018324|P2|Overall Study|Protocol Violation|12
6089564|NCT00348309|21018325|P1|Overall Study|Protocol Violation|7
6089565|NCT00348309|21018323|P3|Overall Study|Lost to Follow-up|4
6089566|NCT00348309|21018324|P2|Overall Study|Lost to Follow-up|7
6089567|NCT00348309|21018325|P1|Overall Study|Lost to Follow-up|6
6089568|NCT00348309|21018323|P3|Overall Study|Adverse Event|63
6089569|NCT00348309|21018324|P2|Overall Study|Adverse Event|28
6089570|NCT00348309|21018325|P1|Overall Study|Adverse Event|56
6089571|NCT00348283|21018398|P2|Open Label|Sponsor decision|1
6089572|NCT00348283|21018399|P1|Open Label|Sponsor decision|0
6089573|NCT00348283|21018398|P2|Open Label|Pregnancy|1
6089574|NCT00348283|21018399|P1|Open Label|Pregnancy|0
6089575|NCT00348283|21018398|P2|Open Label|Subject moved to the United States|1
6089576|NCT00348283|21018399|P1|Open Label|Subject moved to the United States|0
6089577|NCT00348283|21018398|P2|Open Label|Administrative reasons|5
6089578|NCT00348283|21018399|P1|Open Label|Administrative reasons|0
6089579|NCT00348283|21018398|P2|Open Label|Lack of Efficacy|13
6089580|NCT00348283|21018399|P1|Open Label|Lack of Efficacy|0
6089581|NCT00348283|21018398|P2|Open Label|Lost to Follow-up|1
6089582|NCT00348283|21018399|P1|Open Label|Lost to Follow-up|0
6089583|NCT00348283|21018398|P2|Open Label|Withdrawal by Subject|4
6089584|NCT00348283|21018399|P1|Open Label|Withdrawal by Subject|0
6089585|NCT00348283|21018398|P2|Open Label|Adverse Event|8
6089586|NCT00348283|21018399|P1|Open Label|Adverse Event|0
6089587|NCT00348283|21018398|P2|Double Blind|Pregnancy|1
6089588|NCT00348283|21018399|P1|Double Blind|Pregnancy|0
6089589|NCT00348283|21018398|P2|Double Blind|Lack of Efficacy|2
6089590|NCT00348283|21018399|P1|Double Blind|Lack of Efficacy|2
6089591|NCT00348283|21018398|P2|Double Blind|Protocol Violation|1
6089592|NCT00348283|21018399|P1|Double Blind|Protocol Violation|0
6089593|NCT00348283|21018398|P2|Double Blind|Withdrawal by Subject|1
6089594|NCT00348283|21018399|P1|Double Blind|Withdrawal by Subject|1
6089595|NCT00348283|21018398|P2|Double Blind|Adverse Event|5
6089596|NCT00348283|21018399|P1|Double Blind|Adverse Event|2
6089597|NCT00348283|21018398|P2|Induction|Protocol Violation|4
6089598|NCT00348283|21018399|P1|Induction|Protocol Violation|0
6089599|NCT00348283|21018398|P2|Induction|Adverse Event|2
6089600|NCT00348283|21018399|P1|Induction|Adverse Event|0
6089601|NCT00348140|21018428|P3|Overall Study|Memory declined|1
6089602|NCT00348140|21018429|P2|Overall Study|Memory declined|0
6089603|NCT00348140|21018430|P1|Overall Study|Memory declined|0
6089604|NCT00348140|21018428|P3|Overall Study|Exclusion criteria met|1
6089605|NCT00348140|21018429|P2|Overall Study|Exclusion criteria met|0
6089606|NCT00348140|21018430|P1|Overall Study|Exclusion criteria met|0
6089607|NCT00348140|21018428|P3|Overall Study|Participant died|0
6089608|NCT00348140|21018429|P2|Overall Study|Participant died|1
6089609|NCT00348140|21018430|P1|Overall Study|Participant died|0
6089610|NCT00348140|21018428|P3|Overall Study|Abnormal ECG|3
6089611|NCT00348140|21018429|P2|Overall Study|Abnormal ECG|1
6089612|NCT00348140|21018430|P1|Overall Study|Abnormal ECG|0
6089613|NCT00348140|21018428|P3|Overall Study|Serious adverse event|0
6089614|NCT00348140|21018429|P2|Overall Study|Serious adverse event|1
6089615|NCT00348140|21018430|P1|Overall Study|Serious adverse event|0
6089616|NCT00348140|21018428|P3|Overall Study|Increased risk of cardiac infarction|0
6089617|NCT00348140|21018429|P2|Overall Study|Increased risk of cardiac infarction|1
6089618|NCT00348140|21018430|P1|Overall Study|Increased risk of cardiac infarction|0
6089619|NCT00348140|21018428|P3|Overall Study|Disease progression|5
6089620|NCT00348140|21018429|P2|Overall Study|Disease progression|2
6089621|NCT00348140|21018430|P1|Overall Study|Disease progression|1
6089622|NCT00348140|21018428|P3|Overall Study|Use of prohibited drug|2
6089623|NCT00348140|21018429|P2|Overall Study|Use of prohibited drug|0
6089624|NCT00348140|21018430|P1|Overall Study|Use of prohibited drug|1
6089625|NCT00348140|21018428|P3|Overall Study|Decided to discontinue on their own|1
6089626|NCT00348140|21018429|P2|Overall Study|Decided to discontinue on their own|4
6089627|NCT00348140|21018430|P1|Overall Study|Decided to discontinue on their own|1
6089628|NCT00348140|21018428|P3|Overall Study|Investigator decided to discontinue|4
6089629|NCT00348140|21018429|P2|Overall Study|Investigator decided to discontinue|1
6089630|NCT00348140|21018430|P1|Overall Study|Investigator decided to discontinue|4
6089631|NCT00348140|21018428|P3|Overall Study|Screen failure|0
6089632|NCT00348140|21018429|P2|Overall Study|Screen failure|0
6089633|NCT00348140|21018430|P1|Overall Study|Screen failure|1
6089634|NCT00348140|21018428|P3|Overall Study|Participant unwell|0
6089635|NCT00348140|21018429|P2|Overall Study|Participant unwell|0
6089636|NCT00348140|21018430|P1|Overall Study|Participant unwell|1
6089637|NCT00348140|21018428|P3|Overall Study|Unmet inclusion-exclusion criteria|1
6089638|NCT00348140|21018429|P2|Overall Study|Unmet inclusion-exclusion criteria|0
6089639|NCT00348140|21018430|P1|Overall Study|Unmet inclusion-exclusion criteria|1
6089640|NCT00348140|21018428|P3|Overall Study|Administration related|1
6089641|NCT00348140|21018429|P2|Overall Study|Administration related|1
6089642|NCT00348140|21018430|P1|Overall Study|Administration related|3
6089643|NCT00348140|21018428|P3|Overall Study|Efficacy related|0
6089644|NCT00348140|21018429|P2|Overall Study|Efficacy related|1
6089645|NCT00348140|21018430|P1|Overall Study|Efficacy related|1
6089646|NCT00348140|21018428|P3|Overall Study|Participant hospitalised|0
6089647|NCT00348140|21018429|P2|Overall Study|Participant hospitalised|0
6089648|NCT00348140|21018430|P1|Overall Study|Participant hospitalised|3
6089649|NCT00348140|21018428|P3|Overall Study|Caregiver related|3
6089650|NCT00348140|21018429|P2|Overall Study|Caregiver related|7
6089651|NCT00348140|21018430|P1|Overall Study|Caregiver related|4
6089652|NCT00348140|21018428|P3|Overall Study|Conditional medication increased dose|0
6089653|NCT00348140|21018429|P2|Overall Study|Conditional medication increased dose|0
6089654|NCT00348140|21018430|P1|Overall Study|Conditional medication increased dose|1
6089655|NCT00348140|21018428|P3|Overall Study|Participant at risk due to study drug|0
6089656|NCT00348140|21018429|P2|Overall Study|Participant at risk due to study drug|0
6089657|NCT00348140|21018430|P1|Overall Study|Participant at risk due to study drug|2
6089658|NCT00348140|21018428|P3|Overall Study|Non-compliance|5
6089659|NCT00348140|21018429|P2|Overall Study|Non-compliance|13
6089660|NCT00348140|21018430|P1|Overall Study|Non-compliance|8
6089661|NCT00348140|21018428|P3|Overall Study|Withdrawal by Subject|40
6089662|NCT00348140|21018429|P2|Overall Study|Withdrawal by Subject|40
6089663|NCT00348140|21018430|P1|Overall Study|Withdrawal by Subject|32
6089664|NCT00348140|21018428|P3|Overall Study|Protocol Violation|14
6089665|NCT00348140|21018429|P2|Overall Study|Protocol Violation|13
6089666|NCT00348140|21018430|P1|Overall Study|Protocol Violation|12
6089667|NCT00348140|21018428|P3|Overall Study|Lost to Follow-up|4
6089668|NCT00348140|21018429|P2|Overall Study|Lost to Follow-up|4
6089669|NCT00348140|21018430|P1|Overall Study|Lost to Follow-up|4
6089670|NCT00348140|21018428|P3|Overall Study|Adverse Event|78
6089671|NCT00348140|21018429|P2|Overall Study|Adverse Event|49
6089672|NCT00348140|21018430|P1|Overall Study|Adverse Event|46
6089673|NCT00347958|21018528|P1|Overall Study|Withdrawal by Subject|1
6089674|NCT00347958|21018528|P1|Overall Study|Protocol Violation|2
6089675|NCT00347958|21018528|P1|Overall Study|Adverse Event|1
6089676|NCT00347932|21018537|P2|Overall Study|Did not meet inclusion criteria|8
6089677|NCT00347932|21018538|P1|Overall Study|Did not meet inclusion criteria|4
6089678|NCT00347932|21018537|P2|Overall Study|Withdrawal by Subject|16
6089679|NCT00347932|21018538|P1|Overall Study|Withdrawal by Subject|10
6089680|NCT00347932|21018537|P2|Overall Study|Lost to Follow-up|9
6089681|NCT00347932|21018538|P1|Overall Study|Lost to Follow-up|10
6089682|NCT00347932|21018537|P2|Overall Study|Lack of Efficacy|14
6089683|NCT00347932|21018538|P1|Overall Study|Lack of Efficacy|3
6089684|NCT00347932|21018537|P2|Overall Study|Adverse Event|5
6089685|NCT00347932|21018538|P1|Overall Study|Adverse Event|4
6089686|NCT00347919|21018553|P3|Overall Study|Missing|2
6089687|NCT00347919|21018554|P2|Overall Study|Missing|1
6089688|NCT00347919|21018555|P1|Overall Study|Missing|2
6089689|NCT00347919|21018553|P3|Overall Study|Par. Started Other Treatment|1
6089690|NCT00347919|21018554|P2|Overall Study|Par. Started Other Treatment|1
6089691|NCT00347919|21018555|P1|Overall Study|Par. Started Other Treatment|1
6089692|NCT00347919|21018553|P3|Overall Study|Death|19
6089693|NCT00347919|21018554|P2|Overall Study|Death|42
6089694|NCT00347919|21018555|P1|Overall Study|Death|35
6089695|NCT00347919|21018553|P3|Overall Study|Sponsor terminated study|16
6089696|NCT00347919|21018554|P2|Overall Study|Sponsor terminated study|10
6089697|NCT00347919|21018555|P1|Overall Study|Sponsor terminated study|15
6089698|NCT00347919|21018553|P3|Overall Study|Physician Decision|0
6089699|NCT00347919|21018554|P2|Overall Study|Physician Decision|1
6089700|NCT00347919|21018555|P1|Overall Study|Physician Decision|1
6089701|NCT00347919|21018553|P3|Overall Study|Withdrawal by Subject|0
6089702|NCT00347919|21018554|P2|Overall Study|Withdrawal by Subject|8
6089703|NCT00347919|21018555|P1|Overall Study|Withdrawal by Subject|6
6089704|NCT00347919|21018553|P3|Overall Study|Lost to Follow-up|0
6089705|NCT00347919|21018554|P2|Overall Study|Lost to Follow-up|13
6089706|NCT00347919|21018555|P1|Overall Study|Lost to Follow-up|11
6089707|NCT00347776|21018578|P3|12 Month Follow-up|Reached endpoint|9
6089708|NCT00347776|21018579|P2|12 Month Follow-up|Reached endpoint|6
6089709|NCT00347776|21018580|P1|12 Month Follow-up|Reached endpoint|13
6089710|NCT00347776|21018578|P3|12 Month Follow-up|Death|4
6089711|NCT00347776|21018579|P2|12 Month Follow-up|Death|4
6089712|NCT00347776|21018580|P1|12 Month Follow-up|Death|3
6089713|NCT00347776|21018578|P3|12 Month Follow-up|Lost to Follow-up|6
6089714|NCT00347776|21018579|P2|12 Month Follow-up|Lost to Follow-up|6
6089715|NCT00347776|21018580|P1|12 Month Follow-up|Lost to Follow-up|7
6089716|NCT00347776|21018578|P3|6 Month Follow-up|reached endpont|15
6089717|NCT00347776|21018579|P2|6 Month Follow-up|reached endpont|12
6089718|NCT00347776|21018580|P1|6 Month Follow-up|reached endpont|20
6089719|NCT00347776|21018578|P3|6 Month Follow-up|Death|3
6089720|NCT00347776|21018579|P2|6 Month Follow-up|Death|1
6089721|NCT00347776|21018580|P1|6 Month Follow-up|Death|2
6089722|NCT00347776|21018578|P3|1.5 Month Follow-up|reached the endpoint|12
6089723|NCT00347776|21018579|P2|1.5 Month Follow-up|reached the endpoint|8
6089724|NCT00347776|21018580|P1|1.5 Month Follow-up|reached the endpoint|12
6089725|NCT00347776|21018578|P3|1.5 Month Follow-up|Death|0
6089726|NCT00347776|21018579|P2|1.5 Month Follow-up|Death|0
6089727|NCT00347776|21018580|P1|1.5 Month Follow-up|Death|2
6089728|NCT00347438|21018592|P1|Overall Study|Physician Decision|1
6089729|NCT00347438|21018592|P1|Overall Study|Withdrawal by Subject|1
6089730|NCT00347360|21018614|P15|Overall Study|Visits conflicted with new job|0
6089731|NCT00347360|21018615|P14|Overall Study|Visits conflicted with new job|0
6089732|NCT00347360|21018616|P13|Overall Study|Visits conflicted with new job|0
6089733|NCT00347360|21018617|P12|Overall Study|Visits conflicted with new job|0
6089734|NCT00347360|21018618|P11|Overall Study|Visits conflicted with new job|0
6089735|NCT00347360|21018619|P10|Overall Study|Visits conflicted with new job|0
6089736|NCT00347360|21018620|P9|Overall Study|Visits conflicted with new job|0
6089737|NCT00347360|21018621|P8|Overall Study|Visits conflicted with new job|0
6089738|NCT00347360|21018622|P7|Overall Study|Visits conflicted with new job|1
6089739|NCT00347360|21018623|P6|Overall Study|Visits conflicted with new job|0
6089740|NCT00347360|21018624|P5|Overall Study|Visits conflicted with new job|0
6089741|NCT00347360|21018625|P4|Overall Study|Visits conflicted with new job|0
6089742|NCT00347360|21018626|P3|Overall Study|Visits conflicted with new job|0
6089743|NCT00347360|21018627|P2|Overall Study|Visits conflicted with new job|0
6089744|NCT00347360|21018628|P1|Overall Study|Visits conflicted with new job|0
6089745|NCT00347360|21018614|P15|Overall Study|Subject refuse to sign updated consent|1
6089746|NCT00347360|21018615|P14|Overall Study|Subject refuse to sign updated consent|0
6089747|NCT00347360|21018616|P13|Overall Study|Subject refuse to sign updated consent|0
6089748|NCT00347360|21018617|P12|Overall Study|Subject refuse to sign updated consent|0
6089749|NCT00347360|21018618|P11|Overall Study|Subject refuse to sign updated consent|0
6089750|NCT00347360|21018619|P10|Overall Study|Subject refuse to sign updated consent|0
6089751|NCT00347360|21018620|P9|Overall Study|Subject refuse to sign updated consent|0
6089752|NCT00347360|21018621|P8|Overall Study|Subject refuse to sign updated consent|0
6089753|NCT00347360|21018622|P7|Overall Study|Subject refuse to sign updated consent|0
6089754|NCT00347360|21018623|P6|Overall Study|Subject refuse to sign updated consent|0
6089755|NCT00347360|21018624|P5|Overall Study|Subject refuse to sign updated consent|0
6089756|NCT00347360|21018625|P4|Overall Study|Subject refuse to sign updated consent|0
6089757|NCT00347360|21018626|P3|Overall Study|Subject refuse to sign updated consent|0
6089758|NCT00347360|21018627|P2|Overall Study|Subject refuse to sign updated consent|0
6089759|NCT00347360|21018628|P1|Overall Study|Subject refuse to sign updated consent|0
6089760|NCT00347360|21018614|P15|Overall Study|Subject left town, ran out of study drug|0
6089761|NCT00347360|21018615|P14|Overall Study|Subject left town, ran out of study drug|1
6089762|NCT00347360|21018616|P13|Overall Study|Subject left town, ran out of study drug|0
6089763|NCT00347360|21018617|P12|Overall Study|Subject left town, ran out of study drug|0
6089764|NCT00347360|21018618|P11|Overall Study|Subject left town, ran out of study drug|0
6089765|NCT00347360|21018619|P10|Overall Study|Subject left town, ran out of study drug|0
6089766|NCT00347360|21018620|P9|Overall Study|Subject left town, ran out of study drug|0
6089767|NCT00347360|21018621|P8|Overall Study|Subject left town, ran out of study drug|0
6089768|NCT00347360|21018622|P7|Overall Study|Subject left town, ran out of study drug|0
6089769|NCT00347360|21018623|P6|Overall Study|Subject left town, ran out of study drug|0
6089770|NCT00347360|21018624|P5|Overall Study|Subject left town, ran out of study drug|0
6089771|NCT00347360|21018625|P4|Overall Study|Subject left town, ran out of study drug|0
6089772|NCT00347360|21018626|P3|Overall Study|Subject left town, ran out of study drug|0
6089773|NCT00347360|21018627|P2|Overall Study|Subject left town, ran out of study drug|0
6089774|NCT00347360|21018628|P1|Overall Study|Subject left town, ran out of study drug|0
6089775|NCT00347360|21018614|P15|Overall Study|Prolonged duration between visits|0
6089776|NCT00347360|21018615|P14|Overall Study|Prolonged duration between visits|0
6089777|NCT00347360|21018616|P13|Overall Study|Prolonged duration between visits|1
6089778|NCT00347360|21018617|P12|Overall Study|Prolonged duration between visits|0
6089779|NCT00347360|21018618|P11|Overall Study|Prolonged duration between visits|0
6089780|NCT00347360|21018619|P10|Overall Study|Prolonged duration between visits|0
6089781|NCT00347360|21018620|P9|Overall Study|Prolonged duration between visits|0
6089782|NCT00347360|21018621|P8|Overall Study|Prolonged duration between visits|0
6089783|NCT00347360|21018622|P7|Overall Study|Prolonged duration between visits|0
6089784|NCT00347360|21018623|P6|Overall Study|Prolonged duration between visits|0
6089785|NCT00347360|21018624|P5|Overall Study|Prolonged duration between visits|0
6089786|NCT00347360|21018625|P4|Overall Study|Prolonged duration between visits|0
6089787|NCT00347360|21018626|P3|Overall Study|Prolonged duration between visits|0
6089788|NCT00347360|21018627|P2|Overall Study|Prolonged duration between visits|0
6089789|NCT00347360|21018628|P1|Overall Study|Prolonged duration between visits|0
6089790|NCT00347360|21018614|P15|Overall Study|Failed inclusion criteria #4|0
6089791|NCT00347360|21018615|P14|Overall Study|Failed inclusion criteria #4|0
6089792|NCT00347360|21018616|P13|Overall Study|Failed inclusion criteria #4|0
6089793|NCT00347360|21018617|P12|Overall Study|Failed inclusion criteria #4|1
6089794|NCT00347360|21018618|P11|Overall Study|Failed inclusion criteria #4|0
6089795|NCT00347360|21018619|P10|Overall Study|Failed inclusion criteria #4|0
6089796|NCT00347360|21018620|P9|Overall Study|Failed inclusion criteria #4|0
6089797|NCT00347360|21018621|P8|Overall Study|Failed inclusion criteria #4|0
6089798|NCT00347360|21018622|P7|Overall Study|Failed inclusion criteria #4|0
6089799|NCT00347360|21018623|P6|Overall Study|Failed inclusion criteria #4|0
6089800|NCT00347360|21018624|P5|Overall Study|Failed inclusion criteria #4|0
6089801|NCT00347360|21018625|P4|Overall Study|Failed inclusion criteria #4|0
6089802|NCT00347360|21018626|P3|Overall Study|Failed inclusion criteria #4|0
6089803|NCT00347360|21018627|P2|Overall Study|Failed inclusion criteria #4|0
6089804|NCT00347360|21018628|P1|Overall Study|Failed inclusion criteria #4|0
6089805|NCT00347360|21018614|P15|Overall Study|Randomized in error|0
6089806|NCT00347360|21018615|P14|Overall Study|Randomized in error|0
6089807|NCT00347360|21018616|P13|Overall Study|Randomized in error|0
6089808|NCT00347360|21018617|P12|Overall Study|Randomized in error|1
6089809|NCT00347360|21018618|P11|Overall Study|Randomized in error|0
6089810|NCT00347360|21018619|P10|Overall Study|Randomized in error|0
6089811|NCT00347360|21018620|P9|Overall Study|Randomized in error|0
6089812|NCT00347360|21018621|P8|Overall Study|Randomized in error|0
6089813|NCT00347360|21018622|P7|Overall Study|Randomized in error|0
6089814|NCT00347360|21018623|P6|Overall Study|Randomized in error|0
6089815|NCT00347360|21018624|P5|Overall Study|Randomized in error|0
6089816|NCT00347360|21018625|P4|Overall Study|Randomized in error|0
6089817|NCT00347360|21018626|P3|Overall Study|Randomized in error|0
6089818|NCT00347360|21018627|P2|Overall Study|Randomized in error|0
6089819|NCT00347360|21018628|P1|Overall Study|Randomized in error|0
6089820|NCT00347360|21018614|P15|Overall Study|Did not meet criteria before ABPM|0
6089821|NCT00347360|21018615|P14|Overall Study|Did not meet criteria before ABPM|0
6089822|NCT00347360|21018616|P13|Overall Study|Did not meet criteria before ABPM|0
6089823|NCT00347360|21018617|P12|Overall Study|Did not meet criteria before ABPM|0
6089824|NCT00347360|21018618|P11|Overall Study|Did not meet criteria before ABPM|1
6089825|NCT00347360|21018619|P10|Overall Study|Did not meet criteria before ABPM|0
6089826|NCT00347360|21018620|P9|Overall Study|Did not meet criteria before ABPM|0
6089827|NCT00347360|21018621|P8|Overall Study|Did not meet criteria before ABPM|0
6089828|NCT00347360|21018622|P7|Overall Study|Did not meet criteria before ABPM|0
6089829|NCT00347360|21018623|P6|Overall Study|Did not meet criteria before ABPM|0
6089830|NCT00347360|21018624|P5|Overall Study|Did not meet criteria before ABPM|0
6089831|NCT00347360|21018625|P4|Overall Study|Did not meet criteria before ABPM|0
6089832|NCT00347360|21018626|P3|Overall Study|Did not meet criteria before ABPM|0
6089833|NCT00347360|21018627|P2|Overall Study|Did not meet criteria before ABPM|0
6089834|NCT00347360|21018628|P1|Overall Study|Did not meet criteria before ABPM|0
6089835|NCT00347360|21018614|P15|Overall Study|PI recommended early withdrawal|0
6089836|NCT00347360|21018615|P14|Overall Study|PI recommended early withdrawal|0
6089837|NCT00347360|21018616|P13|Overall Study|PI recommended early withdrawal|0
6089838|NCT00347360|21018617|P12|Overall Study|PI recommended early withdrawal|0
6089839|NCT00347360|21018618|P11|Overall Study|PI recommended early withdrawal|0
6089840|NCT00347360|21018619|P10|Overall Study|PI recommended early withdrawal|1
6089841|NCT00347360|21018620|P9|Overall Study|PI recommended early withdrawal|0
6089842|NCT00347360|21018621|P8|Overall Study|PI recommended early withdrawal|0
6089843|NCT00347360|21018622|P7|Overall Study|PI recommended early withdrawal|0
6089844|NCT00347360|21018623|P6|Overall Study|PI recommended early withdrawal|0
6089845|NCT00347360|21018624|P5|Overall Study|PI recommended early withdrawal|0
6089846|NCT00347360|21018625|P4|Overall Study|PI recommended early withdrawal|0
6089847|NCT00347360|21018626|P3|Overall Study|PI recommended early withdrawal|0
6089848|NCT00347360|21018627|P2|Overall Study|PI recommended early withdrawal|0
6089849|NCT00347360|21018628|P1|Overall Study|PI recommended early withdrawal|0
6089850|NCT00347360|21018614|P15|Overall Study|Abnormal lab values|0
6089851|NCT00347360|21018615|P14|Overall Study|Abnormal lab values|0
6089852|NCT00347360|21018616|P13|Overall Study|Abnormal lab values|0
6089853|NCT00347360|21018617|P12|Overall Study|Abnormal lab values|0
6089854|NCT00347360|21018618|P11|Overall Study|Abnormal lab values|0
6089855|NCT00347360|21018619|P10|Overall Study|Abnormal lab values|0
6089856|NCT00347360|21018620|P9|Overall Study|Abnormal lab values|0
6089857|NCT00347360|21018621|P8|Overall Study|Abnormal lab values|0
6089858|NCT00347360|21018622|P7|Overall Study|Abnormal lab values|1
6089859|NCT00347360|21018623|P6|Overall Study|Abnormal lab values|0
6089860|NCT00347360|21018624|P5|Overall Study|Abnormal lab values|0
6089861|NCT00347360|21018625|P4|Overall Study|Abnormal lab values|0
6089862|NCT00347360|21018626|P3|Overall Study|Abnormal lab values|0
6089863|NCT00347360|21018627|P2|Overall Study|Abnormal lab values|0
6089864|NCT00347360|21018628|P1|Overall Study|Abnormal lab values|0
6089865|NCT00347360|21018614|P15|Overall Study|Subject did not meet end of study ABPM|0
6089866|NCT00347360|21018615|P14|Overall Study|Subject did not meet end of study ABPM|1
6089867|NCT00347360|21018616|P13|Overall Study|Subject did not meet end of study ABPM|1
6089868|NCT00347360|21018617|P12|Overall Study|Subject did not meet end of study ABPM|0
6089869|NCT00347360|21018618|P11|Overall Study|Subject did not meet end of study ABPM|1
6089870|NCT00347360|21018619|P10|Overall Study|Subject did not meet end of study ABPM|0
6089871|NCT00347360|21018620|P9|Overall Study|Subject did not meet end of study ABPM|0
6089872|NCT00347360|21018621|P8|Overall Study|Subject did not meet end of study ABPM|0
6089873|NCT00347360|21018622|P7|Overall Study|Subject did not meet end of study ABPM|1
6089874|NCT00347360|21018623|P6|Overall Study|Subject did not meet end of study ABPM|0
6089875|NCT00347360|21018624|P5|Overall Study|Subject did not meet end of study ABPM|0
6089876|NCT00347360|21018625|P4|Overall Study|Subject did not meet end of study ABPM|0
6089877|NCT00347360|21018626|P3|Overall Study|Subject did not meet end of study ABPM|0
6089878|NCT00347360|21018627|P2|Overall Study|Subject did not meet end of study ABPM|0
6089879|NCT00347360|21018628|P1|Overall Study|Subject did not meet end of study ABPM|0
6089880|NCT00347360|21018614|P15|Overall Study|P.I. recommended due to blood pressure|0
6089881|NCT00347360|21018615|P14|Overall Study|P.I. recommended due to blood pressure|0
6089882|NCT00347360|21018616|P13|Overall Study|P.I. recommended due to blood pressure|0
6089883|NCT00347360|21018617|P12|Overall Study|P.I. recommended due to blood pressure|0
6089884|NCT00347360|21018618|P11|Overall Study|P.I. recommended due to blood pressure|0
6089885|NCT00347360|21018619|P10|Overall Study|P.I. recommended due to blood pressure|0
6089886|NCT00347360|21018620|P9|Overall Study|P.I. recommended due to blood pressure|0
6089887|NCT00347360|21018621|P8|Overall Study|P.I. recommended due to blood pressure|0
6089888|NCT00347360|21018622|P7|Overall Study|P.I. recommended due to blood pressure|0
6089889|NCT00347360|21018623|P6|Overall Study|P.I. recommended due to blood pressure|0
6089890|NCT00347360|21018624|P5|Overall Study|P.I. recommended due to blood pressure|1
6089891|NCT00347360|21018625|P4|Overall Study|P.I. recommended due to blood pressure|0
6089892|NCT00347360|21018626|P3|Overall Study|P.I. recommended due to blood pressure|0
6089893|NCT00347360|21018627|P2|Overall Study|P.I. recommended due to blood pressure|0
6089894|NCT00347360|21018628|P1|Overall Study|P.I. recommended due to blood pressure|0
6089895|NCT00347360|21018614|P15|Overall Study|Per sponsors instruction|0
6089896|NCT00347360|21018615|P14|Overall Study|Per sponsors instruction|0
6089897|NCT00347360|21018616|P13|Overall Study|Per sponsors instruction|0
6089898|NCT00347360|21018617|P12|Overall Study|Per sponsors instruction|0
6089899|NCT00347360|21018618|P11|Overall Study|Per sponsors instruction|0
6089900|NCT00347360|21018619|P10|Overall Study|Per sponsors instruction|0
6089901|NCT00347360|21018620|P9|Overall Study|Per sponsors instruction|0
6089902|NCT00347360|21018621|P8|Overall Study|Per sponsors instruction|0
6089903|NCT00347360|21018622|P7|Overall Study|Per sponsors instruction|0
6089904|NCT00347360|21018623|P6|Overall Study|Per sponsors instruction|0
6089905|NCT00347360|21018624|P5|Overall Study|Per sponsors instruction|0
6089906|NCT00347360|21018625|P4|Overall Study|Per sponsors instruction|0
6089907|NCT00347360|21018626|P3|Overall Study|Per sponsors instruction|0
6089908|NCT00347360|21018627|P2|Overall Study|Per sponsors instruction|1
6089909|NCT00347360|21018628|P1|Overall Study|Per sponsors instruction|0
6089910|NCT00347360|21018614|P15|Overall Study|Reason not listed/blank|0
6089911|NCT00347360|21018615|P14|Overall Study|Reason not listed/blank|1
6089912|NCT00347360|21018616|P13|Overall Study|Reason not listed/blank|0
6089913|NCT00347360|21018617|P12|Overall Study|Reason not listed/blank|0
6089914|NCT00347360|21018618|P11|Overall Study|Reason not listed/blank|0
6089915|NCT00347360|21018619|P10|Overall Study|Reason not listed/blank|0
6089916|NCT00347360|21018620|P9|Overall Study|Reason not listed/blank|0
6089917|NCT00347360|21018621|P8|Overall Study|Reason not listed/blank|0
6089918|NCT00347360|21018622|P7|Overall Study|Reason not listed/blank|1
6089919|NCT00347360|21018623|P6|Overall Study|Reason not listed/blank|0
6089920|NCT00347360|21018624|P5|Overall Study|Reason not listed/blank|0
6089921|NCT00347360|21018625|P4|Overall Study|Reason not listed/blank|0
6089922|NCT00347360|21018626|P3|Overall Study|Reason not listed/blank|0
6089923|NCT00347360|21018627|P2|Overall Study|Reason not listed/blank|0
6089924|NCT00347360|21018628|P1|Overall Study|Reason not listed/blank|1
6089925|NCT00347360|21018614|P15|Overall Study|Lack of Efficacy|0
6089926|NCT00347360|21018615|P14|Overall Study|Lack of Efficacy|0
6089927|NCT00347360|21018616|P13|Overall Study|Lack of Efficacy|0
6089928|NCT00347360|21018617|P12|Overall Study|Lack of Efficacy|0
6089929|NCT00347360|21018618|P11|Overall Study|Lack of Efficacy|0
6089930|NCT00347360|21018619|P10|Overall Study|Lack of Efficacy|0
6089931|NCT00347360|21018620|P9|Overall Study|Lack of Efficacy|1
6089932|NCT00347360|21018621|P8|Overall Study|Lack of Efficacy|1
6089933|NCT00347360|21018622|P7|Overall Study|Lack of Efficacy|0
6089934|NCT00347360|21018623|P6|Overall Study|Lack of Efficacy|1
6089935|NCT00347360|21018624|P5|Overall Study|Lack of Efficacy|0
6089936|NCT00347360|21018625|P4|Overall Study|Lack of Efficacy|1
6089937|NCT00347360|21018626|P3|Overall Study|Lack of Efficacy|3
6089938|NCT00347360|21018627|P2|Overall Study|Lack of Efficacy|1
6089939|NCT00347360|21018628|P1|Overall Study|Lack of Efficacy|1
6089940|NCT00347360|21018614|P15|Overall Study|Withdrawal by Subject|1
6089941|NCT00347360|21018615|P14|Overall Study|Withdrawal by Subject|2
6089942|NCT00347360|21018616|P13|Overall Study|Withdrawal by Subject|4
6089943|NCT00347360|21018617|P12|Overall Study|Withdrawal by Subject|3
6089944|NCT00347360|21018618|P11|Overall Study|Withdrawal by Subject|0
6089945|NCT00347360|21018619|P10|Overall Study|Withdrawal by Subject|1
6089946|NCT00347360|21018620|P9|Overall Study|Withdrawal by Subject|1
6089947|NCT00347360|21018621|P8|Overall Study|Withdrawal by Subject|1
6089948|NCT00347360|21018622|P7|Overall Study|Withdrawal by Subject|1
6089949|NCT00347360|21018623|P6|Overall Study|Withdrawal by Subject|2
6089950|NCT00347360|21018624|P5|Overall Study|Withdrawal by Subject|1
6089951|NCT00347360|21018625|P4|Overall Study|Withdrawal by Subject|4
6089952|NCT00347360|21018626|P3|Overall Study|Withdrawal by Subject|2
6089953|NCT00347360|21018627|P2|Overall Study|Withdrawal by Subject|1
6089954|NCT00347360|21018628|P1|Overall Study|Withdrawal by Subject|0
6089955|NCT00347360|21018614|P15|Overall Study|Protocol Violation|0
6089956|NCT00347360|21018615|P14|Overall Study|Protocol Violation|1
6089957|NCT00347360|21018616|P13|Overall Study|Protocol Violation|0
6089958|NCT00347360|21018617|P12|Overall Study|Protocol Violation|0
6089959|NCT00347360|21018618|P11|Overall Study|Protocol Violation|0
6089960|NCT00347360|21018619|P10|Overall Study|Protocol Violation|2
6089961|NCT00347360|21018620|P9|Overall Study|Protocol Violation|1
6089962|NCT00347360|21018621|P8|Overall Study|Protocol Violation|0
6089963|NCT00347360|21018622|P7|Overall Study|Protocol Violation|0
6089964|NCT00347360|21018623|P6|Overall Study|Protocol Violation|2
6089965|NCT00347360|21018624|P5|Overall Study|Protocol Violation|1
6089966|NCT00347360|21018625|P4|Overall Study|Protocol Violation|2
6089967|NCT00347360|21018626|P3|Overall Study|Protocol Violation|1
6089968|NCT00347360|21018627|P2|Overall Study|Protocol Violation|3
6089969|NCT00347360|21018628|P1|Overall Study|Protocol Violation|2
6089970|NCT00347360|21018614|P15|Overall Study|Lost to Follow-up|0
6089971|NCT00347360|21018615|P14|Overall Study|Lost to Follow-up|0
6089972|NCT00347360|21018616|P13|Overall Study|Lost to Follow-up|1
6089973|NCT00347360|21018617|P12|Overall Study|Lost to Follow-up|0
6089974|NCT00347360|21018618|P11|Overall Study|Lost to Follow-up|0
6089975|NCT00347360|21018619|P10|Overall Study|Lost to Follow-up|2
6089976|NCT00347360|21018620|P9|Overall Study|Lost to Follow-up|1
6089977|NCT00347360|21018621|P8|Overall Study|Lost to Follow-up|1
6089978|NCT00347360|21018622|P7|Overall Study|Lost to Follow-up|0
6089979|NCT00347360|21018623|P6|Overall Study|Lost to Follow-up|1
6089980|NCT00347360|21018624|P5|Overall Study|Lost to Follow-up|1
6089981|NCT00347360|21018625|P4|Overall Study|Lost to Follow-up|2
6089982|NCT00347360|21018626|P3|Overall Study|Lost to Follow-up|0
6089983|NCT00347360|21018627|P2|Overall Study|Lost to Follow-up|0
6089984|NCT00347360|21018628|P1|Overall Study|Lost to Follow-up|0
6089985|NCT00347360|21018614|P15|Overall Study|Adverse Event|2
6089986|NCT00347360|21018615|P14|Overall Study|Adverse Event|2
6089987|NCT00347360|21018616|P13|Overall Study|Adverse Event|3
6089988|NCT00347360|21018617|P12|Overall Study|Adverse Event|1
6089989|NCT00347360|21018618|P11|Overall Study|Adverse Event|3
6089990|NCT00347360|21018619|P10|Overall Study|Adverse Event|3
6089991|NCT00347360|21018620|P9|Overall Study|Adverse Event|2
6089992|NCT00347360|21018621|P8|Overall Study|Adverse Event|0
6089993|NCT00347360|21018622|P7|Overall Study|Adverse Event|2
6089994|NCT00347360|21018623|P6|Overall Study|Adverse Event|2
6089995|NCT00347360|21018624|P5|Overall Study|Adverse Event|1
6089996|NCT00347360|21018625|P4|Overall Study|Adverse Event|4
6089997|NCT00347360|21018626|P3|Overall Study|Adverse Event|0
6089998|NCT00347360|21018627|P2|Overall Study|Adverse Event|2
6089999|NCT00347360|21018628|P1|Overall Study|Adverse Event|1
6090000|NCT00347269|21018816|P2|Overall Study|Death|3
6090001|NCT00347269|21018817|P1|Overall Study|Death|2
6090002|NCT00347269|21018816|P2|Overall Study|Withdrawal by Subject|38
6090003|NCT00347269|21018817|P1|Overall Study|Withdrawal by Subject|18
6090004|NCT00347269|21018816|P2|Overall Study|Lost to Follow-up|65
6090005|NCT00347269|21018817|P1|Overall Study|Lost to Follow-up|74
6090006|NCT00347009|21018832|P1|Overall Study|Serious Adverse Event|1
6090007|NCT00347009|21018832|P1|Overall Study|Increased ALT/HBV DNA|1
6090008|NCT00347009|21018832|P1|Overall Study|Insufficient Viral Suppression|3
6090009|NCT00347009|21018832|P1|Overall Study|Adverse Laboratory Experience|1
6090010|NCT00347009|21018832|P1|Overall Study|Protocol Violation|2
6090011|NCT00347009|21018832|P1|Overall Study|Lost to Follow-up|4
6090012|NCT00347009|21018832|P1|Overall Study|Physician Decision|5
6090013|NCT00347009|21018832|P1|Overall Study|Withdrawal by Subject|3
6090014|NCT00347009|21018832|P1|Overall Study|Adverse Event|6
6090015|NCT00347009|21018832|P1|Overall Study|Death|1
6090016|NCT00346775|21018853|P2|Period 1: Intervention Period 1|Participant had nasal congestion score<2|0
6090017|NCT00346775|21018854|P1|Period 1: Intervention Period 1|Participant had nasal congestion score<2|1
6090018|NCT00346775|21018853|P2|Period 1: Intervention Period 1|Protocol Violation|2
6090019|NCT00346775|21018854|P1|Period 1: Intervention Period 1|Protocol Violation|3
6090020|NCT00346775|21018853|P2|Period 1: Intervention Period 1|Lost to Follow-up|1
6090021|NCT00346775|21018854|P1|Period 1: Intervention Period 1|Lost to Follow-up|1
6090022|NCT00346697|21018866|P2|Overall Study|Lost to Follow-up|1
6090023|NCT00346697|21018867|P1|Overall Study|Lost to Follow-up|0
6090024|NCT00346632|21018903|P10|Overall Study|Not Stated|1
6090025|NCT00346632|21018904|P9|Overall Study|Not Stated|2
6090026|NCT00346632|21018905|P8|Overall Study|Not Stated|2
6090027|NCT00346632|21018906|P7|Overall Study|Not Stated|0
6090028|NCT00346632|21018907|P6|Overall Study|Not Stated|0
6090029|NCT00346632|21018908|P5|Overall Study|Not Stated|0
6090030|NCT00346632|21018909|P4|Overall Study|Not Stated|0
6090031|NCT00346632|21018910|P3|Overall Study|Not Stated|0
6090032|NCT00346632|21018911|P2|Overall Study|Not Stated|1
6090033|NCT00346632|21018912|P1|Overall Study|Not Stated|1
6090034|NCT00346632|21018903|P10|Overall Study|Switched to alternative treatment|0
6090035|NCT00346632|21018904|P9|Overall Study|Switched to alternative treatment|0
6090036|NCT00346632|21018905|P8|Overall Study|Switched to alternative treatment|0
6090037|NCT00346632|21018906|P7|Overall Study|Switched to alternative treatment|0
6090038|NCT00346632|21018907|P6|Overall Study|Switched to alternative treatment|0
6090039|NCT00346632|21018908|P5|Overall Study|Switched to alternative treatment|0
6090040|NCT00346632|21018909|P4|Overall Study|Switched to alternative treatment|0
6090041|NCT00346632|21018910|P3|Overall Study|Switched to alternative treatment|1
6090042|NCT00346632|21018911|P2|Overall Study|Switched to alternative treatment|0
6090043|NCT00346632|21018912|P1|Overall Study|Switched to alternative treatment|0
6090044|NCT00346632|21018903|P10|Overall Study|Withdrawal by Subject|0
6090045|NCT00346632|21018904|P9|Overall Study|Withdrawal by Subject|0
6090046|NCT00346632|21018905|P8|Overall Study|Withdrawal by Subject|0
6090047|NCT00346632|21018906|P7|Overall Study|Withdrawal by Subject|1
6090048|NCT00346632|21018907|P6|Overall Study|Withdrawal by Subject|0
6090049|NCT00346632|21018908|P5|Overall Study|Withdrawal by Subject|0
6090050|NCT00346632|21018909|P4|Overall Study|Withdrawal by Subject|0
6090051|NCT00346632|21018910|P3|Overall Study|Withdrawal by Subject|0
6090052|NCT00346632|21018911|P2|Overall Study|Withdrawal by Subject|0
6090053|NCT00346632|21018912|P1|Overall Study|Withdrawal by Subject|0
6090054|NCT00346632|21018903|P10|Overall Study|Protocol Violation|0
6090055|NCT00346632|21018904|P9|Overall Study|Protocol Violation|0
6090056|NCT00346632|21018905|P8|Overall Study|Protocol Violation|0
6090057|NCT00346632|21018906|P7|Overall Study|Protocol Violation|1
6090058|NCT00346632|21018907|P6|Overall Study|Protocol Violation|0
6090059|NCT00346632|21018908|P5|Overall Study|Protocol Violation|0
6090060|NCT00346632|21018909|P4|Overall Study|Protocol Violation|0
6090061|NCT00346632|21018910|P3|Overall Study|Protocol Violation|0
6090062|NCT00346632|21018911|P2|Overall Study|Protocol Violation|0
6090063|NCT00346632|21018912|P1|Overall Study|Protocol Violation|0
6090064|NCT00346632|21018903|P10|Overall Study|Death|0
6090065|NCT00346632|21018904|P9|Overall Study|Death|0
6090066|NCT00346632|21018905|P8|Overall Study|Death|0
6090067|NCT00346632|21018906|P7|Overall Study|Death|0
6090068|NCT00346632|21018907|P6|Overall Study|Death|0
6090069|NCT00346632|21018908|P5|Overall Study|Death|0
6090070|NCT00346632|21018909|P4|Overall Study|Death|0
6090071|NCT00346632|21018910|P3|Overall Study|Death|1
6090072|NCT00346632|21018911|P2|Overall Study|Death|0
6090073|NCT00346632|21018912|P1|Overall Study|Death|0
6090074|NCT00346632|21018903|P10|Overall Study|Adverse Event|0
6090075|NCT00346632|21018904|P9|Overall Study|Adverse Event|0
6090076|NCT00346632|21018905|P8|Overall Study|Adverse Event|0
6090077|NCT00346632|21018906|P7|Overall Study|Adverse Event|1
6090078|NCT00346632|21018907|P6|Overall Study|Adverse Event|1
6090079|NCT00346632|21018908|P5|Overall Study|Adverse Event|1
6090080|NCT00346632|21018909|P4|Overall Study|Adverse Event|0
6090081|NCT00346632|21018910|P3|Overall Study|Adverse Event|0
6090082|NCT00346632|21018911|P2|Overall Study|Adverse Event|0
6090083|NCT00346632|21018912|P1|Overall Study|Adverse Event|0
6090084|NCT00346632|21018903|P10|Overall Study|Progressive Disease|2
6090085|NCT00346632|21018904|P9|Overall Study|Progressive Disease|2
6090086|NCT00346632|21018905|P8|Overall Study|Progressive Disease|2
6090087|NCT00346632|21018906|P7|Overall Study|Progressive Disease|2
6090088|NCT00346632|21018907|P6|Overall Study|Progressive Disease|1
6090089|NCT00346632|21018908|P5|Overall Study|Progressive Disease|3
6090090|NCT00346632|21018909|P4|Overall Study|Progressive Disease|3
6090091|NCT00346632|21018910|P3|Overall Study|Progressive Disease|4
6090092|NCT00346632|21018911|P2|Overall Study|Progressive Disease|2
6090093|NCT00346632|21018912|P1|Overall Study|Progressive Disease|2
6090094|NCT00346398|21019062|P2|Overall Study|Withdrawal by Subject|2
6090095|NCT00346398|21019063|P1|Overall Study|Withdrawal by Subject|0
6090096|NCT00346398|21019062|P2|Overall Study|Lost to Follow-up|0
6090097|NCT00346398|21019063|P1|Overall Study|Lost to Follow-up|3
6090098|NCT00346333|21019075|P2|Overall Study|unwilling or unable to continue|8
6090099|NCT00346333|21019076|P1|Overall Study|unwilling or unable to continue|4
6090100|NCT00346333|21019075|P2|Overall Study|Death|0
6090101|NCT00346333|21019076|P1|Overall Study|Death|1
6090102|NCT00346268|21019092|P2|Overall Study|Participant refused|3
6090103|NCT00346268|21019093|P1|Overall Study|Participant refused|0
6090104|NCT00346268|21019092|P2|Overall Study|Protocol Violation|0
6090105|NCT00346268|21019093|P1|Overall Study|Protocol Violation|1
6090106|NCT00346268|21019092|P2|Overall Study|Adverse Event|0
6090107|NCT00346268|21019093|P1|Overall Study|Adverse Event|1
6090108|NCT00346216|21019128|P3|Overall Study|Missing Subject Summary Status|62
6090109|NCT00346216|21019129|P2|Overall Study|Missing Subject Summary Status|61
6090110|NCT00346216|21019130|P1|Overall Study|Missing Subject Summary Status|62
6090111|NCT00346216|21019128|P3|Overall Study|Study terminated by sponsor|8
6090112|NCT00346216|21019129|P2|Overall Study|Study terminated by sponsor|4
6090113|NCT00346216|21019130|P1|Overall Study|Study terminated by sponsor|11
6090114|NCT00346216|21019128|P3|Overall Study|Death|228
6090115|NCT00346216|21019129|P2|Overall Study|Death|192
6090116|NCT00346216|21019130|P1|Overall Study|Death|189
6090117|NCT00346216|21019128|P3|Overall Study|Does not meet entrance criteria|8
6090118|NCT00346216|21019129|P2|Overall Study|Does not meet entrance criteria|10
6090119|NCT00346216|21019130|P1|Overall Study|Does not meet entrance criteria|13
6090120|NCT00346216|21019128|P3|Overall Study|Physician Decision|59
6090121|NCT00346216|21019129|P2|Overall Study|Physician Decision|76
6090122|NCT00346216|21019130|P1|Overall Study|Physician Decision|80
6090123|NCT00346216|21019128|P3|Overall Study|Lost to Follow-up|542
6090124|NCT00346216|21019129|P2|Overall Study|Lost to Follow-up|588
6090125|NCT00346216|21019130|P1|Overall Study|Lost to Follow-up|611
6090126|NCT00346216|21019128|P3|Overall Study|Withdrawal by Subject|651
6090127|NCT00346216|21019129|P2|Overall Study|Withdrawal by Subject|692
6090128|NCT00346216|21019130|P1|Overall Study|Withdrawal by Subject|661
6090129|NCT00346216|21019128|P3|Overall Study|No longer willing to participate|585
6090130|NCT00346216|21019129|P2|Overall Study|No longer willing to participate|606
6090131|NCT00346216|21019130|P1|Overall Study|No longer willing to participate|600
6090132|NCT00346216|21019128|P3|Overall Study|Other|205
6090133|NCT00346216|21019129|P2|Overall Study|Other|231
6090134|NCT00346216|21019130|P1|Overall Study|Other|181
6090135|NCT00346164|21019151|P4|Overall Study|Inability to start week 16 tx on time|11
6090136|NCT00346164|21019152|P3|Overall Study|Inability to start week 16 tx on time|0
6090137|NCT00346164|21019153|P2|Overall Study|Inability to start week 16 tx on time|0
6090138|NCT00346164|21019154|P1|Overall Study|Inability to start week 16 tx on time|0
6090139|NCT00346164|21019151|P4|Overall Study|Refusal of further protocol therapy|15
6090140|NCT00346164|21019152|P3|Overall Study|Refusal of further protocol therapy|3
6090141|NCT00346164|21019153|P2|Overall Study|Refusal of further protocol therapy|1
6090142|NCT00346164|21019154|P1|Overall Study|Refusal of further protocol therapy|0
6090143|NCT00346164|21019151|P4|Overall Study|Ineligible|23
6090144|NCT00346164|21019152|P3|Overall Study|Ineligible|2
6090145|NCT00346164|21019153|P2|Overall Study|Ineligible|2
6090146|NCT00346164|21019154|P1|Overall Study|Ineligible|11
6090147|NCT00346164|21019151|P4|Overall Study|Withdrawal by Subject|0
6090148|NCT00346164|21019152|P3|Overall Study|Withdrawal by Subject|2
6090149|NCT00346164|21019153|P2|Overall Study|Withdrawal by Subject|0
6090150|NCT00346164|21019154|P1|Overall Study|Withdrawal by Subject|0
6090151|NCT00346164|21019151|P4|Overall Study|Protocol Violation|4
6090152|NCT00346164|21019152|P3|Overall Study|Protocol Violation|10
6090153|NCT00346164|21019153|P2|Overall Study|Protocol Violation|2
6090154|NCT00346164|21019154|P1|Overall Study|Protocol Violation|6
6090155|NCT00346164|21019151|P4|Overall Study|Physician Decision|27
6090156|NCT00346164|21019152|P3|Overall Study|Physician Decision|2
6090157|NCT00346164|21019153|P2|Overall Study|Physician Decision|1
6090158|NCT00346164|21019154|P1|Overall Study|Physician Decision|0
6090159|NCT00346164|21019151|P4|Overall Study|Lack of Efficacy|25
6090160|NCT00346164|21019152|P3|Overall Study|Lack of Efficacy|7
6090161|NCT00346164|21019153|P2|Overall Study|Lack of Efficacy|1
6090162|NCT00346164|21019154|P1|Overall Study|Lack of Efficacy|0
6090163|NCT00346164|21019151|P4|Overall Study|Adverse Event|1
6090164|NCT00346164|21019152|P3|Overall Study|Adverse Event|0
6090165|NCT00346164|21019153|P2|Overall Study|Adverse Event|0
6090166|NCT00346164|21019154|P1|Overall Study|Adverse Event|0
6090167|NCT00346151|21019189|P1|Overall Study|Withdrawal by Subject|3
6090168|NCT00346073|21019209|P2|Overall Study|Lost to Follow-up|24
6090169|NCT00346073|21019210|P1|Overall Study|Lost to Follow-up|39
6090170|NCT00346073|21019209|P2|Overall Study|Serious Adverse Event|0
6090171|NCT00346073|21019210|P1|Overall Study|Serious Adverse Event|2
6090172|NCT00346034|21019244|P1|Overall Study|Not Willing to Follow Dosing Regimen|1
6090173|NCT00346034|21019244|P1|Overall Study|Patient Stopped Taking Study Drug|1
6090174|NCT00346034|21019244|P1|Overall Study|Withdrawal by Subject|13
6090175|NCT00346034|21019244|P1|Overall Study|Lack of Efficacy|8
6090176|NCT00346034|21019244|P1|Overall Study|Adverse Event|34
6090177|NCT00345878|21019284|P2|Overall Study|Other|0
6090178|NCT00345878|21019285|P1|Overall Study|Other|1
6090179|NCT00345878|21019284|P2|Overall Study|Lost to Follow-up|1
6090180|NCT00345878|21019285|P1|Overall Study|Lost to Follow-up|2
6090181|NCT00345878|21019284|P2|Overall Study|Adverse Event|0
6090182|NCT00345878|21019285|P1|Overall Study|Adverse Event|1
6090183|NCT00345839|21019344|P2|Overall Study|Lost to Follow-up|61
6090184|NCT00345839|21019345|P1|Overall Study|Lost to Follow-up|58
6090185|NCT00345839|21019344|P2|Overall Study|Withdrawal by Subject|98
6090186|NCT00345839|21019345|P1|Overall Study|Withdrawal by Subject|91
6090187|NCT00345683|21019371|P2|Overall Study|Other|2
6090188|NCT00345683|21019372|P1|Overall Study|Other|6
6090189|NCT00345683|21019371|P2|Overall Study|Lost to Follow-up|7
6090190|NCT00345683|21019372|P1|Overall Study|Lost to Follow-up|19
6090191|NCT00345631|21019395|P3|Overall Study|Other reasons|1
6090192|NCT00345631|21019396|P2|Overall Study|Other reasons|0
6090193|NCT00345631|21019397|P1|Overall Study|Other reasons|0
6090194|NCT00345631|21019395|P3|Overall Study|Lost to Follow-up|4
6090195|NCT00345631|21019396|P2|Overall Study|Lost to Follow-up|7
6090196|NCT00345631|21019397|P1|Overall Study|Lost to Follow-up|3
6090197|NCT00345631|21019395|P3|Overall Study|Adverse Event|0
6090198|NCT00345631|21019396|P2|Overall Study|Adverse Event|1
6090199|NCT00345631|21019397|P1|Overall Study|Adverse Event|0
6090200|NCT00345631|21019395|P3|Overall Study|Withdrawal by Subject|1
6090201|NCT00345631|21019396|P2|Overall Study|Withdrawal by Subject|0
6090202|NCT00345631|21019397|P1|Overall Study|Withdrawal by Subject|1
6090203|NCT00345605|21019429|P2|Arm 2, Opposite Treatment|Adverse Event|0
6090204|NCT00345605|21019430|P1|Arm 2, Opposite Treatment|Adverse Event|1
6090205|NCT00345605|21019429|P2|Arm 1|Adverse Event|1
6090206|NCT00345605|21019430|P1|Arm 1|Adverse Event|0
6090207|NCT00345592|21019450|P2|Overall Study|Withdrawal by Subject|8
6090208|NCT00345592|21019451|P1|Overall Study|Withdrawal by Subject|11
6090209|NCT00345592|21019450|P2|Overall Study|Death|16
6090210|NCT00345592|21019451|P1|Overall Study|Death|14
6090211|NCT00345579|21019459|P2|Overall Study|Other|1
6090212|NCT00345579|21019460|P1|Overall Study|Other|9
6090213|NCT00345579|21019459|P2|Overall Study|Lost to Follow-up|36
6090214|NCT00345579|21019460|P1|Overall Study|Lost to Follow-up|82
6090215|NCT00345579|21019459|P2|Overall Study|Withdrawal by Subject|17
6090216|NCT00345579|21019460|P1|Overall Study|Withdrawal by Subject|50
6090217|NCT00345579|21019459|P2|Overall Study|Protocol Violation|5
6090218|NCT00345579|21019460|P1|Overall Study|Protocol Violation|14
6090219|NCT00345579|21019459|P2|Overall Study|Adverse Event|6
6090220|NCT00345579|21019460|P1|Overall Study|Adverse Event|9
6090221|NCT00345540|21019480|P1|Overall Study|Withdrawal by Subject|1
6090222|NCT00345397|21019486|P1|Overall Study|Death|1
6090223|NCT00345358|21019517|P4|Booster Vaccination Phase|Lost to Follow-up|0
6090224|NCT00345358|21019518|P3|Booster Vaccination Phase|Lost to Follow-up|0
6090225|NCT00345358|21019519|P2|Booster Vaccination Phase|Lost to Follow-up|0
6090226|NCT00345358|21019520|P1|Booster Vaccination Phase|Lost to Follow-up|3
6090227|NCT00345358|21019517|P4|Booster Vaccination Phase|Withdrawal by Subject|0
6090228|NCT00345358|21019518|P3|Booster Vaccination Phase|Withdrawal by Subject|0
6090229|NCT00345358|21019519|P2|Booster Vaccination Phase|Withdrawal by Subject|0
6090230|NCT00345358|21019520|P1|Booster Vaccination Phase|Withdrawal by Subject|1
6090231|NCT00345358|21019517|P4|Primary Vaccination Phase|Lost to Follow-up|2
6090232|NCT00345358|21019518|P3|Primary Vaccination Phase|Lost to Follow-up|2
6090233|NCT00345358|21019519|P2|Primary Vaccination Phase|Lost to Follow-up|0
6090234|NCT00345358|21019520|P1|Primary Vaccination Phase|Lost to Follow-up|1
6090235|NCT00345358|21019517|P4|Primary Vaccination Phase|Withdrawal by Subject|0
6090236|NCT00345358|21019518|P3|Primary Vaccination Phase|Withdrawal by Subject|4
6090237|NCT00345358|21019519|P2|Primary Vaccination Phase|Withdrawal by Subject|2
6090238|NCT00345358|21019520|P1|Primary Vaccination Phase|Withdrawal by Subject|1
6090239|NCT00345358|21019517|P4|Primary Vaccination Phase|Adverse event, non-fatal|0
6090240|NCT00345358|21019518|P3|Primary Vaccination Phase|Adverse event, non-fatal|1
6090241|NCT00345358|21019519|P2|Primary Vaccination Phase|Adverse event, non-fatal|1
6090242|NCT00345358|21019520|P1|Primary Vaccination Phase|Adverse event, non-fatal|3
6090243|NCT00345358|21019517|P4|Primary Vaccination Phase|Other|0
6090244|NCT00345358|21019518|P3|Primary Vaccination Phase|Other|1
6090245|NCT00345358|21019519|P2|Primary Vaccination Phase|Other|1
6090246|NCT00345358|21019520|P1|Primary Vaccination Phase|Other|0
6090247|NCT00345293|21019610|P2|Overall Study|Withdrawal by Subject|0
6090248|NCT00345293|21019611|P1|Overall Study|Withdrawal by Subject|1
6090249|NCT00345293|21019610|P2|Overall Study|Unable to access line for sample|0
6090250|NCT00345293|21019611|P1|Overall Study|Unable to access line for sample|1
6090251|NCT00345046|21019657|P3|Overall Study|Protocol Violation|2
6090252|NCT00345046|21019658|P2|Overall Study|Protocol Violation|1
6090253|NCT00345046|21019659|P1|Overall Study|Protocol Violation|1
6090254|NCT00344968|21019689|P3|Overall Study|Other|0
6090255|NCT00344968|21019690|P2|Overall Study|Other|1
6090256|NCT00344968|21019691|P1|Overall Study|Other|0
6090257|NCT00344968|21019689|P3|Overall Study|Death|31
6090258|NCT00344968|21019690|P2|Overall Study|Death|27
6090259|NCT00344968|21019691|P1|Overall Study|Death|11
6090260|NCT00344968|21019689|P3|Overall Study|Lost to Follow-up|37
6090261|NCT00344968|21019690|P2|Overall Study|Lost to Follow-up|37
6090262|NCT00344968|21019691|P1|Overall Study|Lost to Follow-up|24
6090263|NCT00344968|21019689|P3|Overall Study|Withdrawal by Subject|27
6090264|NCT00344968|21019690|P2|Overall Study|Withdrawal by Subject|31
6090265|NCT00344968|21019691|P1|Overall Study|Withdrawal by Subject|14
6090266|NCT00344968|21019689|P3|Overall Study|Protocol Violation|5
6090267|NCT00344968|21019690|P2|Overall Study|Protocol Violation|2
6090268|NCT00344968|21019691|P1|Overall Study|Protocol Violation|2
6090269|NCT00344968|21019689|P3|Overall Study|Unsatisfactory Therapeutic Effect|1
6090270|NCT00344968|21019690|P2|Overall Study|Unsatisfactory Therapeutic Effect|0
6090271|NCT00344968|21019691|P1|Overall Study|Unsatisfactory Therapeutic Effect|3
6090272|NCT00344968|21019689|P3|Overall Study|Adverse Event|15
6090273|NCT00344968|21019690|P2|Overall Study|Adverse Event|4
6090274|NCT00344968|21019691|P1|Overall Study|Adverse Event|5
6090275|NCT00344773|21019702|P1|Overall Study|Not Eligible for the study|2
6090276|NCT00344773|21019702|P1|Overall Study|Withdrawal by Subject|1
6090277|NCT00344773|21019702|P1|Overall Study|Objective Disease Progression|16
6090278|NCT00344773|21019702|P1|Overall Study|Adverse Event|2
6090279|NCT00344500|21019725|P3|Overall Study|Not Noted|0
6090280|NCT00344500|21019726|P2|Overall Study|Not Noted|3
6090281|NCT00344500|21019727|P1|Overall Study|Not Noted|1
6090282|NCT00344500|21019725|P3|Overall Study|Protocol Violation|1
6090283|NCT00344500|21019726|P2|Overall Study|Protocol Violation|7
6090284|NCT00344500|21019727|P1|Overall Study|Protocol Violation|4
6090285|NCT00344500|21019725|P3|Overall Study|Withdrawal by Subject|0
6090286|NCT00344500|21019726|P2|Overall Study|Withdrawal by Subject|10
6090287|NCT00344500|21019727|P1|Overall Study|Withdrawal by Subject|7
6090288|NCT00344500|21019725|P3|Overall Study|Lost to Follow-up|1
6090289|NCT00344500|21019726|P2|Overall Study|Lost to Follow-up|13
6090290|NCT00344500|21019727|P1|Overall Study|Lost to Follow-up|5
6090291|NCT00344500|21019725|P3|Overall Study|Adverse Event|0
6090292|NCT00344500|21019726|P2|Overall Study|Adverse Event|2
6090293|NCT00344500|21019727|P1|Overall Study|Adverse Event|6
6090294|NCT00344487|21019738|P1|Overall Study|immunologic failure|1
6090295|NCT00344461|21019742|P1|Overall Study|Withdrawal by Subject|2
6090296|NCT00344461|21019742|P1|Overall Study|Protocol Violation|6
6090297|NCT00344461|21019742|P1|Overall Study|Physician Decision|2
6090298|NCT00344461|21019742|P1|Overall Study|Lost to Follow-up|2
6090299|NCT00344461|21019742|P1|Overall Study|Lack of Efficacy|2
6090300|NCT00344461|21019742|P1|Overall Study|Death|1
6090301|NCT00344461|21019742|P1|Overall Study|Adverse Event|6
6090302|NCT00344448|21019753|P2|Open Label|Study terminated|0
6090303|NCT00344448|21019754|P1|Open Label|Study terminated|1
6090304|NCT00344448|21019753|P2|Open Label|Withdrawal by Subject|1
6090305|NCT00344448|21019754|P1|Open Label|Withdrawal by Subject|1
6090306|NCT00344448|21019753|P2|Double Blind, Placebo Controlled|Study terminated|0
6090307|NCT00344448|21019754|P1|Double Blind, Placebo Controlled|Study terminated|1
6090308|NCT00344448|21019753|P2|Double Blind, Placebo Controlled|Withdrawal by Subject|0
6090309|NCT00344448|21019754|P1|Double Blind, Placebo Controlled|Withdrawal by Subject|1
6090310|NCT00344448|21019753|P2|Screening|Withdrawal by Subject|1
6090311|NCT00344448|21019754|P1|Screening|Withdrawal by Subject|0
6090312|NCT00344318|21019775|P4|Overall Study|Lost to Follow-up|0
6090313|NCT00344318|21019776|P3|Overall Study|Lost to Follow-up|1
6090314|NCT00344318|21019777|P2|Overall Study|Lost to Follow-up|0
6090315|NCT00344318|21019778|P1|Overall Study|Lost to Follow-up|2
6090316|NCT00344318|21019775|P4|Overall Study|Withdrawal by Subject|2
6090317|NCT00344318|21019776|P3|Overall Study|Withdrawal by Subject|0
6090318|NCT00344318|21019777|P2|Overall Study|Withdrawal by Subject|2
6090319|NCT00344318|21019778|P1|Overall Study|Withdrawal by Subject|2
6090320|NCT00344318|21019775|P4|Overall Study|Adverse Event|1
6090321|NCT00344318|21019776|P3|Overall Study|Adverse Event|0
6090322|NCT00344318|21019777|P2|Overall Study|Adverse Event|3
6090323|NCT00344318|21019778|P1|Overall Study|Adverse Event|0
6090324|NCT00344305|21019900|P2|Overall Study|Participant was not contacted in window|1
6090325|NCT00344305|21019901|P1|Overall Study|Participant was not contacted in window|0
6090326|NCT00344305|21019900|P2|Overall Study|Lost to Follow-up|0
6090327|NCT00344305|21019901|P1|Overall Study|Lost to Follow-up|2
6090328|NCT00344032|21019951|P2|Overall Study|Physician Decision|1
6090329|NCT00344032|21019952|P1|Overall Study|Physician Decision|4
6090330|NCT00344032|21019951|P2|Overall Study|Lost to Follow-up|6
6090331|NCT00344032|21019952|P1|Overall Study|Lost to Follow-up|4
6090332|NCT00344032|21019951|P2|Overall Study|Withdrawal by Subject|2
6090333|NCT00344032|21019952|P1|Overall Study|Withdrawal by Subject|6
6090334|NCT00344032|21019951|P2|Overall Study|Adverse Event|1
6090335|NCT00344032|21019952|P1|Overall Study|Adverse Event|0
6090336|NCT00344019|21019971|P3|Overall Study|did not meet final inclusion criteria|74
6090337|NCT00344019|21019972|P2|Overall Study|did not meet final inclusion criteria|0
6090338|NCT00344019|21019973|P1|Overall Study|did not meet final inclusion criteria|0
6090339|NCT00343915|21019991|P2|Primary Study|Other|0
6090340|NCT00343915|21019992|P1|Primary Study|Other|1
6090341|NCT00343915|21019991|P2|Primary Study|Lost to Follow-up|3
6090342|NCT00343915|21019992|P1|Primary Study|Lost to Follow-up|2
6090343|NCT00343915|21019991|P2|Primary Study|Withdrawal by Subject|0
6090344|NCT00343915|21019992|P1|Primary Study|Withdrawal by Subject|1
6090345|NCT00343889|21020018|P2|Overall Study|Protocol Violation|0
6090346|NCT00343889|21020019|P1|Overall Study|Protocol Violation|1
6090347|NCT00343889|21020018|P2|Overall Study|Withdrawal by Subject|1
6090348|NCT00343889|21020019|P1|Overall Study|Withdrawal by Subject|0
6090349|NCT00343889|21020018|P2|Overall Study|Lost to Follow-up|0
6090350|NCT00343889|21020019|P1|Overall Study|Lost to Follow-up|2
6090351|NCT00343512|21020183|P1|Overall Study|Withdrawal by Subject|2
6090352|NCT00343382|21020271|P3|Overall Study|Other Reason Not Specified|4
6090353|NCT00343382|21020272|P2|Overall Study|Other Reason Not Specified|2
6090354|NCT00343382|21020273|P1|Overall Study|Other Reason Not Specified|1
6090355|NCT00343382|21020271|P3|Overall Study|Withdrawal by Subject|6
6090356|NCT00343382|21020272|P2|Overall Study|Withdrawal by Subject|2
6090357|NCT00343382|21020273|P1|Overall Study|Withdrawal by Subject|1
6090358|NCT00343382|21020271|P3|Overall Study|Adverse Event|7
6090359|NCT00343382|21020272|P2|Overall Study|Adverse Event|10
6090360|NCT00343382|21020273|P1|Overall Study|Adverse Event|2
6090361|NCT00343291|21020292|P2|Overall Study|Other|5
6090362|NCT00343291|21020293|P1|Overall Study|Other|8
6090363|NCT00343291|21020292|P2|Overall Study|Withdrawal by Subject|2
6090364|NCT00343291|21020293|P1|Overall Study|Withdrawal by Subject|0
6090365|NCT00343291|21020292|P2|Overall Study|Progressive disease|34
6090366|NCT00343291|21020293|P1|Overall Study|Progressive disease|33
6090367|NCT00343291|21020292|P2|Overall Study|Death|2
6090368|NCT00343291|21020293|P1|Overall Study|Death|3
6090369|NCT00343291|21020292|P2|Overall Study|Adverse Event|13
6090370|NCT00343291|21020293|P1|Overall Study|Adverse Event|13
6090371|NCT00343252|21020309|P2|18 Months (All Treated Participants)|Withdrawal by Subject|20
6090372|NCT00343252|21020310|P1|18 Months (All Treated Participants)|Withdrawal by Subject|36
6090373|NCT00343252|21020309|P2|18 Months (All Treated Participants)|Sponsor Decision|5
6090374|NCT00343252|21020310|P1|18 Months (All Treated Participants)|Sponsor Decision|8
6090375|NCT00343252|21020309|P2|18 Months (All Treated Participants)|Protocol Violation|3
6090376|NCT00343252|21020310|P1|18 Months (All Treated Participants)|Protocol Violation|3
6090377|NCT00343252|21020309|P2|18 Months (All Treated Participants)|Physician Decision|7
6090378|NCT00343252|21020310|P1|18 Months (All Treated Participants)|Physician Decision|4
6090379|NCT00343252|21020309|P2|18 Months (All Treated Participants)|Lost to Follow-up|7
6090380|NCT00343252|21020310|P1|18 Months (All Treated Participants)|Lost to Follow-up|3
6090381|NCT00343252|21020309|P2|18 Months (All Treated Participants)|Lack of Efficacy|1
6090382|NCT00343252|21020310|P1|18 Months (All Treated Participants)|Lack of Efficacy|1
6090383|NCT00343252|21020309|P2|18 Months (All Treated Participants)|Entry Criteria Not Met|10
6090384|NCT00343252|21020310|P1|18 Months (All Treated Participants)|Entry Criteria Not Met|11
6090385|NCT00343252|21020309|P2|18 Months (All Treated Participants)|Death|5
6090386|NCT00343252|21020310|P1|18 Months (All Treated Participants)|Death|4
6090387|NCT00343252|21020309|P2|18 Months (All Treated Participants)|Adverse Event|23
6090388|NCT00343252|21020310|P1|18 Months (All Treated Participants)|Adverse Event|31
6090389|NCT00343252|21020309|P2|12 Months (All Treated Participants)|Withdrawal by Subject|17
6090390|NCT00343252|21020310|P1|12 Months (All Treated Participants)|Withdrawal by Subject|33
6090391|NCT00343252|21020309|P2|12 Months (All Treated Participants)|Sponsor Decision|6
6090392|NCT00343252|21020310|P1|12 Months (All Treated Participants)|Sponsor Decision|9
6090393|NCT00343252|21020309|P2|12 Months (All Treated Participants)|Protocol Violation|2
6090394|NCT00343252|21020310|P1|12 Months (All Treated Participants)|Protocol Violation|3
6090395|NCT00343252|21020309|P2|12 Months (All Treated Participants)|Physician Decision|5
6090396|NCT00343252|21020310|P1|12 Months (All Treated Participants)|Physician Decision|4
6090397|NCT00343252|21020309|P2|12 Months (All Treated Participants)|Lost to Follow-up|5
6090398|NCT00343252|21020310|P1|12 Months (All Treated Participants)|Lost to Follow-up|1
6090399|NCT00343252|21020309|P2|12 Months (All Treated Participants)|Lack of Efficacy|1
6090400|NCT00343252|21020310|P1|12 Months (All Treated Participants)|Lack of Efficacy|1
6090401|NCT00343252|21020309|P2|12 Months (All Treated Participants)|Entry Criteria Not Met|10
6090402|NCT00343252|21020310|P1|12 Months (All Treated Participants)|Entry Criteria Not Met|10
6090403|NCT00343252|21020309|P2|12 Months (All Treated Participants)|Death|3
6090404|NCT00343252|21020310|P1|12 Months (All Treated Participants)|Death|3
6090405|NCT00343252|21020309|P2|12 Months (All Treated Participants)|Adverse Event|20
6090406|NCT00343252|21020310|P1|12 Months (All Treated Participants)|Adverse Event|22
6090407|NCT00343252|21020309|P2|6 Months (All Treated Participants)|Withdrawal by Subject|9
6090408|NCT00343252|21020310|P1|6 Months (All Treated Participants)|Withdrawal by Subject|19
6090409|NCT00343252|21020309|P2|6 Months (All Treated Participants)|Sponsor Decision|4
6090410|NCT00343252|21020310|P1|6 Months (All Treated Participants)|Sponsor Decision|7
6090411|NCT00343252|21020309|P2|6 Months (All Treated Participants)|Protocol Violation|2
6090412|NCT00343252|21020310|P1|6 Months (All Treated Participants)|Protocol Violation|2
6090413|NCT00343252|21020309|P2|6 Months (All Treated Participants)|Physician Decision|3
6090414|NCT00343252|21020310|P1|6 Months (All Treated Participants)|Physician Decision|1
6090415|NCT00343252|21020309|P2|6 Months (All Treated Participants)|Lost to Follow-up|4
6090416|NCT00343252|21020310|P1|6 Months (All Treated Participants)|Lost to Follow-up|0
6090417|NCT00343252|21020309|P2|6 Months (All Treated Participants)|Lack of Efficacy|1
6090418|NCT00343252|21020310|P1|6 Months (All Treated Participants)|Lack of Efficacy|0
6090419|NCT00343252|21020309|P2|6 Months (All Treated Participants)|Entry Criteria Not Met|8
6090420|NCT00343252|21020310|P1|6 Months (All Treated Participants)|Entry Criteria Not Met|10
6090421|NCT00343252|21020309|P2|6 Months (All Treated Participants)|Death|2
6090422|NCT00343252|21020310|P1|6 Months (All Treated Participants)|Death|0
6090423|NCT00343252|21020309|P2|6 Months (All Treated Participants)|Adverse Event|11
6090424|NCT00343252|21020310|P1|6 Months (All Treated Participants)|Adverse Event|17
6090425|NCT00342628|21020375|P3|Overall Study|moved residence|1
6090426|NCT00342628|21020376|P2|Overall Study|moved residence|1
6090427|NCT00342628|21020377|P1|Overall Study|moved residence|0
6090428|NCT00342628|21020375|P3|Overall Study|Death|0
6090429|NCT00342628|21020376|P2|Overall Study|Death|1
6090430|NCT00342628|21020377|P1|Overall Study|Death|1
6090431|NCT00342628|21020375|P3|Overall Study|Withdrawal by Subject|18
6090432|NCT00342628|21020376|P2|Overall Study|Withdrawal by Subject|19
6090433|NCT00342628|21020377|P1|Overall Study|Withdrawal by Subject|19
6090434|NCT00340834|21020443|P5|Extension Phase of Study|Death|1
6090435|NCT00340834|21020444|P4|Extension Phase of Study|Death|0
6090436|NCT00340834|21020445|P3|Extension Phase of Study|Death|0
6090437|NCT00340834|21020446|P2|Extension Phase of Study|Death|0
6090438|NCT00340834|21020447|P1|Extension Phase of Study|Death|0
6090439|NCT00340834|21020443|P5|Extension Phase of Study|Protocol Violation|0
6090440|NCT00340834|21020444|P4|Extension Phase of Study|Protocol Violation|0
6090441|NCT00340834|21020445|P3|Extension Phase of Study|Protocol Violation|0
6090442|NCT00340834|21020446|P2|Extension Phase of Study|Protocol Violation|0
6090443|NCT00340834|21020447|P1|Extension Phase of Study|Protocol Violation|3
6090444|NCT00340834|21020443|P5|Extension Phase of Study|Abnormal test procedure result(s)|2
6090445|NCT00340834|21020444|P4|Extension Phase of Study|Abnormal test procedure result(s)|0
6090446|NCT00340834|21020445|P3|Extension Phase of Study|Abnormal test procedure result(s)|0
6090447|NCT00340834|21020446|P2|Extension Phase of Study|Abnormal test procedure result(s)|1
6090448|NCT00340834|21020447|P1|Extension Phase of Study|Abnormal test procedure result(s)|0
6090449|NCT00340834|21020443|P5|Extension Phase of Study|Administrative problems|1
6090450|NCT00340834|21020444|P4|Extension Phase of Study|Administrative problems|1
6090451|NCT00340834|21020445|P3|Extension Phase of Study|Administrative problems|0
6090452|NCT00340834|21020446|P2|Extension Phase of Study|Administrative problems|0
6090453|NCT00340834|21020447|P1|Extension Phase of Study|Administrative problems|3
6090454|NCT00340834|21020443|P5|Extension Phase of Study|Subject no longer requires study drug|2
6090455|NCT00340834|21020444|P4|Extension Phase of Study|Subject no longer requires study drug|0
6090456|NCT00340834|21020445|P3|Extension Phase of Study|Subject no longer requires study drug|0
6090457|NCT00340834|21020446|P2|Extension Phase of Study|Subject no longer requires study drug|0
6090458|NCT00340834|21020447|P1|Extension Phase of Study|Subject no longer requires study drug|4
6090459|NCT00340834|21020443|P5|Extension Phase of Study|Lost to Follow-up|3
6090460|NCT00340834|21020444|P4|Extension Phase of Study|Lost to Follow-up|2
6090461|NCT00340834|21020445|P3|Extension Phase of Study|Lost to Follow-up|0
6090462|NCT00340834|21020446|P2|Extension Phase of Study|Lost to Follow-up|1
6090463|NCT00340834|21020447|P1|Extension Phase of Study|Lost to Follow-up|1
6090464|NCT00340834|21020443|P5|Extension Phase of Study|Unsatisfactory therapeutic effect|9
6090465|NCT00340834|21020444|P4|Extension Phase of Study|Unsatisfactory therapeutic effect|4
6090466|NCT00340834|21020445|P3|Extension Phase of Study|Unsatisfactory therapeutic effect|0
6090467|NCT00340834|21020446|P2|Extension Phase of Study|Unsatisfactory therapeutic effect|7
6090468|NCT00340834|21020447|P1|Extension Phase of Study|Unsatisfactory therapeutic effect|13
6090469|NCT00340834|21020443|P5|Extension Phase of Study|Abnormal laboratory value(s)|4
6090470|NCT00340834|21020444|P4|Extension Phase of Study|Abnormal laboratory value(s)|13
6090471|NCT00340834|21020445|P3|Extension Phase of Study|Abnormal laboratory value(s)|0
6090472|NCT00340834|21020446|P2|Extension Phase of Study|Abnormal laboratory value(s)|13
6090473|NCT00340834|21020447|P1|Extension Phase of Study|Abnormal laboratory value(s)|14
6090474|NCT00340834|21020443|P5|Extension Phase of Study|Adverse Event|7
6090475|NCT00340834|21020444|P4|Extension Phase of Study|Adverse Event|19
6090476|NCT00340834|21020445|P3|Extension Phase of Study|Adverse Event|0
6090477|NCT00340834|21020446|P2|Extension Phase of Study|Adverse Event|22
6090478|NCT00340834|21020447|P1|Extension Phase of Study|Adverse Event|21
6090479|NCT00340834|21020443|P5|Extension Phase of Study|Subject withdrew consent|15
6090480|NCT00340834|21020444|P4|Extension Phase of Study|Subject withdrew consent|12
6090481|NCT00340834|21020445|P3|Extension Phase of Study|Subject withdrew consent|0
6090482|NCT00340834|21020446|P2|Extension Phase of Study|Subject withdrew consent|31
6090483|NCT00340834|21020447|P1|Extension Phase of Study|Subject withdrew consent|26
6090484|NCT00340834|21020443|P5|Extension Phase of Study|Subject did not receive study drug|0
6090485|NCT00340834|21020444|P4|Extension Phase of Study|Subject did not receive study drug|2
6090486|NCT00340834|21020445|P3|Extension Phase of Study|Subject did not receive study drug|0
6090487|NCT00340834|21020446|P2|Extension Phase of Study|Subject did not receive study drug|1
6090488|NCT00340834|21020447|P1|Extension Phase of Study|Subject did not receive study drug|0
6090489|NCT00340834|21020443|P5|Core Phase of Study|Protocol Violation|0
6090490|NCT00340834|21020444|P4|Core Phase of Study|Protocol Violation|0
6090491|NCT00340834|21020445|P3|Core Phase of Study|Protocol Violation|2
6090492|NCT00340834|21020446|P2|Core Phase of Study|Protocol Violation|0
6090493|NCT00340834|21020447|P1|Core Phase of Study|Protocol Violation|0
6090494|NCT00340834|21020443|P5|Core Phase of Study|Death|0
6090495|NCT00340834|21020444|P4|Core Phase of Study|Death|0
6090496|NCT00340834|21020445|P3|Core Phase of Study|Death|0
6090497|NCT00340834|21020446|P2|Core Phase of Study|Death|0
6090498|NCT00340834|21020447|P1|Core Phase of Study|Death|2
6090499|NCT00340834|21020443|P5|Core Phase of Study|Lost to Follow-up|0
6090500|NCT00340834|21020444|P4|Core Phase of Study|Lost to Follow-up|0
6090501|NCT00340834|21020445|P3|Core Phase of Study|Lost to Follow-up|4
6090502|NCT00340834|21020446|P2|Core Phase of Study|Lost to Follow-up|1
6090503|NCT00340834|21020447|P1|Core Phase of Study|Lost to Follow-up|1
6090504|NCT00340834|21020443|P5|Core Phase of Study|Abnormal test procedure result(s)|0
6090505|NCT00340834|21020444|P4|Core Phase of Study|Abnormal test procedure result(s)|0
6090506|NCT00340834|21020445|P3|Core Phase of Study|Abnormal test procedure result(s)|3
6090507|NCT00340834|21020446|P2|Core Phase of Study|Abnormal test procedure result(s)|3
6090508|NCT00340834|21020447|P1|Core Phase of Study|Abnormal test procedure result(s)|4
6090509|NCT00340834|21020443|P5|Core Phase of Study|Abnormal laboratory value(s)|0
6090510|NCT00340834|21020444|P4|Core Phase of Study|Abnormal laboratory value(s)|0
6090511|NCT00340834|21020445|P3|Core Phase of Study|Abnormal laboratory value(s)|1
6090512|NCT00340834|21020446|P2|Core Phase of Study|Abnormal laboratory value(s)|6
6090513|NCT00340834|21020447|P1|Core Phase of Study|Abnormal laboratory value(s)|4
6090514|NCT00340834|21020443|P5|Core Phase of Study|Lack of Efficacy|0
6090515|NCT00340834|21020444|P4|Core Phase of Study|Lack of Efficacy|0
6090516|NCT00340834|21020445|P3|Core Phase of Study|Lack of Efficacy|7
6090517|NCT00340834|21020446|P2|Core Phase of Study|Lack of Efficacy|3
6090518|NCT00340834|21020447|P1|Core Phase of Study|Lack of Efficacy|3
6090519|NCT00340834|21020443|P5|Core Phase of Study|Administrative Problems|0
6090520|NCT00340834|21020444|P4|Core Phase of Study|Administrative Problems|0
6090521|NCT00340834|21020445|P3|Core Phase of Study|Administrative Problems|7
6090522|NCT00340834|21020446|P2|Core Phase of Study|Administrative Problems|2
6090523|NCT00340834|21020447|P1|Core Phase of Study|Administrative Problems|6
6090524|NCT00340834|21020443|P5|Core Phase of Study|Withdrawal by Subject|0
6090525|NCT00340834|21020444|P4|Core Phase of Study|Withdrawal by Subject|0
6090526|NCT00340834|21020445|P3|Core Phase of Study|Withdrawal by Subject|16
6090527|NCT00340834|21020446|P2|Core Phase of Study|Withdrawal by Subject|9
6090528|NCT00340834|21020447|P1|Core Phase of Study|Withdrawal by Subject|11
6090529|NCT00340834|21020443|P5|Core Phase of Study|Adverse Event|0
6090530|NCT00340834|21020444|P4|Core Phase of Study|Adverse Event|0
6090531|NCT00340834|21020445|P3|Core Phase of Study|Adverse Event|9
6090532|NCT00340834|21020446|P2|Core Phase of Study|Adverse Event|9
6090533|NCT00340834|21020447|P1|Core Phase of Study|Adverse Event|26
6090534|NCT00340704|21020481|P9|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|28
6090535|NCT00340704|21020482|P8|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|11
6090536|NCT00340704|21020483|P7|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|53
6090537|NCT00340704|21020484|P6|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|3
6090538|NCT00340704|21020485|P5|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0
6090539|NCT00340704|21020486|P4|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0
6090540|NCT00340704|21020487|P3|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0
6090541|NCT00340704|21020488|P2|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0
6090542|NCT00340704|21020489|P1|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0
6090543|NCT00340704|21020481|P9|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
6090544|NCT00340704|21020482|P8|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
6090545|NCT00340704|21020483|P7|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
6090546|NCT00340704|21020484|P6|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|3
6090547|NCT00340704|21020485|P5|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|1
6090548|NCT00340704|21020486|P4|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
6090549|NCT00340704|21020487|P3|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
6090550|NCT00340704|21020488|P2|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
6090551|NCT00340704|21020489|P1|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
6090552|NCT00340704|21020481|P9|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
6090553|NCT00340704|21020482|P8|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
6090554|NCT00340704|21020483|P7|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
6090555|NCT00340704|21020484|P6|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|1
6090556|NCT00340704|21020485|P5|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
6090557|NCT00340704|21020486|P4|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
6090558|NCT00340704|21020487|P3|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
6090559|NCT00340704|21020488|P2|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
6090560|NCT00340704|21020489|P1|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
6090561|NCT00340704|21020481|P9|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1
6090562|NCT00340704|21020482|P8|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1
6090563|NCT00340704|21020483|P7|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0
6090564|NCT00340704|21020484|P6|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0
6090565|NCT00340704|21020485|P5|Group D- Denovo & 527.51 Rollover Study|Adverse Event|4
6090566|NCT00340704|21020486|P4|Group D- Denovo & 527.51 Rollover Study|Adverse Event|2
6090567|NCT00340704|21020487|P3|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0
6090568|NCT00340704|21020488|P2|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0
6090569|NCT00340704|21020489|P1|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0
6090570|NCT00340704|21020481|P9|PK Study|Not treated|0
6090571|NCT00340704|21020482|P8|PK Study|Not treated|0
6090572|NCT00340704|21020483|P7|PK Study|Not treated|0
6090573|NCT00340704|21020484|P6|PK Study|Not treated|0
6090574|NCT00340704|21020485|P5|PK Study|Not treated|0
6090575|NCT00340704|21020486|P4|PK Study|Not treated|0
6090576|NCT00340704|21020487|P3|PK Study|Not treated|1
6090577|NCT00340704|21020488|P2|PK Study|Not treated|0
6090578|NCT00340704|21020489|P1|PK Study|Not treated|0
6090579|NCT00340704|21020481|P9|PK Study|Adverse Event|0
6090580|NCT00340704|21020482|P8|PK Study|Adverse Event|0
6090581|NCT00340704|21020483|P7|PK Study|Adverse Event|0
6090582|NCT00340704|21020484|P6|PK Study|Adverse Event|0
6090583|NCT00340704|21020485|P5|PK Study|Adverse Event|0
6090584|NCT00340704|21020486|P4|PK Study|Adverse Event|0
6090585|NCT00340704|21020487|P3|PK Study|Adverse Event|0
6090586|NCT00340704|21020488|P2|PK Study|Adverse Event|1
6090587|NCT00340704|21020489|P1|PK Study|Adverse Event|0
6090588|NCT00340678|21020595|P4|Overall Study|Lost to Follow-up|0
6090589|NCT00340678|21020596|P3|Overall Study|Lost to Follow-up|0
6090590|NCT00340678|21020597|P2|Overall Study|Lost to Follow-up|0
6090591|NCT00340678|21020598|P1|Overall Study|Lost to Follow-up|1
6090592|NCT00339833|21020625|P2|Overall Study|Error in data records|0
6090593|NCT00339833|21020626|P1|Overall Study|Error in data records|1
6090594|NCT00339833|21020625|P2|Overall Study|anaemia or excess drop in glycaemia|0
6090595|NCT00339833|21020626|P1|Overall Study|anaemia or excess drop in glycaemia|2
6090596|NCT00339833|21020625|P2|Overall Study|Poor venous access|2
6090597|NCT00339833|21020626|P1|Overall Study|Poor venous access|2
6090598|NCT00339833|21020625|P2|Overall Study|minor infection|1
6090599|NCT00339833|21020626|P1|Overall Study|minor infection|0
6090600|NCT00339833|21020625|P2|Overall Study|Chest pain|1
6090601|NCT00339833|21020626|P1|Overall Study|Chest pain|0
6090602|NCT00339833|21020625|P2|Overall Study|indigestion|1
6090603|NCT00339833|21020626|P1|Overall Study|indigestion|0
6090604|NCT00339833|21020625|P2|Overall Study|toothache|1
6090605|NCT00339833|21020626|P1|Overall Study|toothache|0
6090606|NCT00339833|21020625|P2|Overall Study|Withdrawal by Subject|2
6090607|NCT00339833|21020626|P1|Overall Study|Withdrawal by Subject|1
6090608|NCT00339183|21020636|P2|Overall Study|Ongoing|13
6090609|NCT00339183|21020637|P1|Overall Study|Ongoing|20
6090610|NCT00339183|21020636|P2|Overall Study|Other|40
6090611|NCT00339183|21020637|P1|Overall Study|Other|46
6090612|NCT00339183|21020636|P2|Overall Study|Missing reason|1
6090613|NCT00339183|21020637|P1|Overall Study|Missing reason|3
6090614|NCT00339183|21020636|P2|Overall Study|Protocol-specified criteria|8
6090615|NCT00339183|21020637|P1|Overall Study|Protocol-specified criteria|12
6090616|NCT00339183|21020636|P2|Overall Study|Lost to Follow-up|17
6090617|NCT00339183|21020637|P1|Overall Study|Lost to Follow-up|17
6090618|NCT00339183|21020636|P2|Overall Study|Physician Decision|4
6090619|NCT00339183|21020637|P1|Overall Study|Physician Decision|2
6090620|NCT00339183|21020636|P2|Overall Study|Withdrawal by Subject|19
6090621|NCT00339183|21020637|P1|Overall Study|Withdrawal by Subject|16
6090622|NCT00339183|21020636|P2|Overall Study|Adverse Event|3
6090623|NCT00339183|21020637|P1|Overall Study|Adverse Event|5
6090624|NCT00339144|21020666|P3|Overall Study|Participant's request to discontinuation|1
6090625|NCT00339144|21020667|P2|Overall Study|Participant's request to discontinuation|0
6090626|NCT00339144|21020668|P1|Overall Study|Participant's request to discontinuation|1
6090627|NCT00339144|21020666|P3|Overall Study|Study drug toxicity|1
6090628|NCT00339144|21020667|P2|Overall Study|Study drug toxicity|1
6090629|NCT00339144|21020668|P1|Overall Study|Study drug toxicity|3
6090630|NCT00339144|21020666|P3|Overall Study|Disease progression|2
6090631|NCT00339144|21020667|P2|Overall Study|Disease progression|2
6090632|NCT00339144|21020668|P1|Overall Study|Disease progression|5
6090633|NCT00339040|21020773|P2|Stage II|Site closing|0
6090634|NCT00339040|21020774|P1|Stage II|Site closing|2
6090635|NCT00339040|21020773|P2|Stage II|Not able to attend clinic|0
6090636|NCT00339040|21020774|P1|Stage II|Not able to attend clinic|1
6090637|NCT00339040|21020773|P2|Stage II|Protocol Violation|0
6090638|NCT00339040|21020774|P1|Stage II|Protocol Violation|3
6090639|NCT00339040|21020773|P2|Stage II|Withdrawal by Subject|2
6090640|NCT00339040|21020774|P1|Stage II|Withdrawal by Subject|1
6090641|NCT00339040|21020773|P2|Stage II|Lost to Follow-up|0
6090642|NCT00339040|21020774|P1|Stage II|Lost to Follow-up|3
6090643|NCT00339040|21020773|P2|Stage I|Protocol Violation|1
6090644|NCT00339040|21020774|P1|Stage I|Protocol Violation|1
6090645|NCT00339040|21020773|P2|Stage I|Not able to attend clinic|0
6090646|NCT00339040|21020774|P1|Stage I|Not able to attend clinic|1
6090647|NCT00338962|21020801|P4|Overall Study|Poor Compliance|0
6090648|NCT00338962|21020802|P3|Overall Study|Poor Compliance|2
6090649|NCT00338962|21020803|P2|Overall Study|Poor Compliance|0
6090650|NCT00338962|21020804|P1|Overall Study|Poor Compliance|0
6090651|NCT00338962|21020801|P4|Overall Study|Adverse Event|0
6090652|NCT00338962|21020802|P3|Overall Study|Adverse Event|2
6090653|NCT00338962|21020803|P2|Overall Study|Adverse Event|0
6090654|NCT00338962|21020804|P1|Overall Study|Adverse Event|0
6090655|NCT00338962|21020801|P4|Overall Study|Moved|0
6090656|NCT00338962|21020802|P3|Overall Study|Moved|0
6090657|NCT00338962|21020803|P2|Overall Study|Moved|1
6090658|NCT00338962|21020804|P1|Overall Study|Moved|0
6090659|NCT00338962|21020801|P4|Overall Study|Time Constraint|0
6090660|NCT00338962|21020802|P3|Overall Study|Time Constraint|0
6090661|NCT00338962|21020803|P2|Overall Study|Time Constraint|0
6090662|NCT00338962|21020804|P1|Overall Study|Time Constraint|2
6090663|NCT00338962|21020801|P4|Overall Study|No Transportation|0
6090664|NCT00338962|21020802|P3|Overall Study|No Transportation|0
6090665|NCT00338962|21020803|P2|Overall Study|No Transportation|0
6090666|NCT00338962|21020804|P1|Overall Study|No Transportation|2
6090667|NCT00338962|21020801|P4|Overall Study|Withdrawal by Subject|0
6090668|NCT00338962|21020802|P3|Overall Study|Withdrawal by Subject|0
6090669|NCT00338962|21020803|P2|Overall Study|Withdrawal by Subject|0
6090670|NCT00338962|21020804|P1|Overall Study|Withdrawal by Subject|1
6090671|NCT00338962|21020801|P4|Overall Study|Lost to Follow-up|3
6090672|NCT00338962|21020802|P3|Overall Study|Lost to Follow-up|2
6090673|NCT00338962|21020803|P2|Overall Study|Lost to Follow-up|3
6090674|NCT00338962|21020804|P1|Overall Study|Lost to Follow-up|3
6090675|NCT00338949|21020828|P2|Randomization|Adverse Event|5
6090676|NCT00338949|21020829|P1|Randomization|Adverse Event|0
6090677|NCT00338949|21020828|P2|Randomization|Withdrawal by Subject|0
6090678|NCT00338949|21020829|P1|Randomization|Withdrawal by Subject|1
6090679|NCT00338949|21020828|P2|Subject Screening|Screen failures|11
6090680|NCT00338949|21020829|P1|Subject Screening|Screen failures|11
6090681|NCT00338884|21020837|P1|Overall Study|Randomized But Did Not Receive Treatment|1
6090682|NCT00338884|21020837|P1|Overall Study|Lost to Follow-up|1
6090683|NCT00338884|21020837|P1|Overall Study|Withdrawal by Subject|3
6090684|NCT00338884|21020837|P1|Overall Study|Global Deterioration of Health Status|3
6090685|NCT00338884|21020837|P1|Overall Study|Other|4
6090686|NCT00338884|21020837|P1|Overall Study|Death|8
6090687|NCT00338884|21020837|P1|Overall Study|Adverse Event|14
6090688|NCT00338884|21020837|P1|Overall Study|Objective Disease Progression or Relapse|44
6090689|NCT00338806|21020871|P2|Follow-up|Lost to Follow-up|3
6090690|NCT00338806|21020872|P1|Follow-up|Lost to Follow-up|1
6090691|NCT00338806|21020871|P2|Acute Phase|Withdrawal by Subject|1
6090692|NCT00338806|21020872|P1|Acute Phase|Withdrawal by Subject|0
6090693|NCT00338741|21020934|P2|Overall Study|Lost to Follow-up|0
6090694|NCT00338741|21020935|P1|Overall Study|Lost to Follow-up|2
6090695|NCT00338728|21020943|P1|Overall Study|Screen Failure|14
6090696|NCT00338455|21020971|P2|Overall Study|Physician Decision|0
6090697|NCT00338455|21020972|P1|Overall Study|Physician Decision|1
6090698|NCT00338455|21020971|P2|Overall Study|Death|1
6090699|NCT00338455|21020972|P1|Overall Study|Death|2
6090700|NCT00338286|21020986|P2|Overall Study|Other|93
6090701|NCT00338286|21020987|P1|Overall Study|Other|103
6090702|NCT00338286|21020986|P2|Overall Study|Lost to Follow-up|66
6090703|NCT00338286|21020987|P1|Overall Study|Lost to Follow-up|80
6090704|NCT00338286|21020986|P2|Overall Study|Withdrawal by Subject|54
6090705|NCT00338286|21020987|P1|Overall Study|Withdrawal by Subject|50
6090706|NCT00338104|21021004|P3|Overall Study|Protocol Violation|3
6090707|NCT00338104|21021005|P2|Overall Study|Protocol Violation|1
6090708|NCT00338104|21021006|P1|Overall Study|Protocol Violation|2
6090709|NCT00337935|21021029|P2|Overall Study|Lack of Efficacy|1
6090710|NCT00337935|21021030|P1|Overall Study|Lack of Efficacy|0
6090711|NCT00337935|21021029|P2|Overall Study|Other|1
6090712|NCT00337935|21021030|P1|Overall Study|Other|0
6090713|NCT00337935|21021029|P2|Overall Study|Withdrawal by Subject|7
6090714|NCT00337935|21021030|P1|Overall Study|Withdrawal by Subject|1
6090715|NCT00337935|21021029|P2|Overall Study|Protocol Violation|3
6090716|NCT00337935|21021030|P1|Overall Study|Protocol Violation|4
6090717|NCT00337935|21021029|P2|Overall Study|Lost to Follow-up|1
6090718|NCT00337935|21021030|P1|Overall Study|Lost to Follow-up|0
6090719|NCT00337935|21021029|P2|Overall Study|Physician Decision|1
6090720|NCT00337935|21021030|P1|Overall Study|Physician Decision|1
6090721|NCT00337935|21021029|P2|Overall Study|Death|8
6090722|NCT00337935|21021030|P1|Overall Study|Death|2
6090723|NCT00337935|21021029|P2|Overall Study|Adverse Event|5
6090724|NCT00337935|21021030|P1|Overall Study|Adverse Event|2
6090725|NCT00337818|21021043|P3|Overall Study|Lost to Follow-up|107
6090726|NCT00337818|21021044|P2|Overall Study|Lost to Follow-up|91
6090727|NCT00337818|21021045|P1|Overall Study|Lost to Follow-up|289
6090728|NCT00337779|21021067|P2|Overall Study|Death|1
6090729|NCT00337779|21021068|P1|Overall Study|Death|0
6090730|NCT00337779|21021067|P2|Overall Study|Pregnancy|2
6090731|NCT00337779|21021068|P1|Overall Study|Pregnancy|3
6090732|NCT00337779|21021067|P2|Overall Study|Adverse Event|51
6090733|NCT00337779|21021068|P1|Overall Study|Adverse Event|28
6090734|NCT00337779|21021067|P2|Overall Study|Lost to Follow-up|5
6090735|NCT00337779|21021068|P1|Overall Study|Lost to Follow-up|6
6090736|NCT00337779|21021067|P2|Overall Study|Protocol Violation|1
6090737|NCT00337779|21021068|P1|Overall Study|Protocol Violation|1
6090738|NCT00337779|21021067|P2|Overall Study|Physician Decision|6
6090739|NCT00337779|21021068|P1|Overall Study|Physician Decision|3
6090740|NCT00337779|21021067|P2|Overall Study|Sponsor decision|1
6090741|NCT00337779|21021068|P1|Overall Study|Sponsor decision|1
6090742|NCT00337779|21021067|P2|Overall Study|Withdrawal by Subject|12
6090743|NCT00337779|21021068|P1|Overall Study|Withdrawal by Subject|10
6090744|NCT00337727|21021080|P2|Overall Study|Withdrawal by Subject|5
6090745|NCT00337727|21021081|P1|Overall Study|Withdrawal by Subject|3
6090746|NCT00337727|21021080|P2|Overall Study|Protocol Violation|0
6090747|NCT00337727|21021081|P1|Overall Study|Protocol Violation|4
6090748|NCT00337727|21021080|P2|Overall Study|Physician Decision|0
6090749|NCT00337727|21021081|P1|Overall Study|Physician Decision|1
6090750|NCT00337727|21021080|P2|Overall Study|Lost to Follow-up|4
6090751|NCT00337727|21021081|P1|Overall Study|Lost to Follow-up|5
6090752|NCT00337727|21021080|P2|Overall Study|Adverse Event|3
6090753|NCT00337727|21021081|P1|Overall Study|Adverse Event|5
6090754|NCT00337675|21021092|P3|Overall Study|Trial Terminated|2
6090755|NCT00337675|21021093|P2|Overall Study|Trial Terminated|0
6090756|NCT00337675|21021094|P1|Overall Study|Trial Terminated|0
6090757|NCT00337675|21021092|P3|Overall Study|Progressive Disease|0
6090758|NCT00337675|21021093|P2|Overall Study|Progressive Disease|2
6090759|NCT00337675|21021094|P1|Overall Study|Progressive Disease|0
6090760|NCT00337675|21021092|P3|Overall Study|Withdrawal by Subject|19
6090761|NCT00337675|21021093|P2|Overall Study|Withdrawal by Subject|25
6090762|NCT00337675|21021094|P1|Overall Study|Withdrawal by Subject|25
6090763|NCT00337675|21021092|P3|Overall Study|Protocol Violation|19
6090764|NCT00337675|21021093|P2|Overall Study|Protocol Violation|24
6090765|NCT00337675|21021094|P1|Overall Study|Protocol Violation|21
6090766|NCT00337675|21021092|P3|Overall Study|Physician Decision|14
6090767|NCT00337675|21021093|P2|Overall Study|Physician Decision|17
6090768|NCT00337675|21021094|P1|Overall Study|Physician Decision|9
6090769|NCT00337675|21021092|P3|Overall Study|Lost to Follow-up|17
6090770|NCT00337675|21021093|P2|Overall Study|Lost to Follow-up|19
6090771|NCT00337675|21021094|P1|Overall Study|Lost to Follow-up|22
6090772|NCT00337675|21021092|P3|Overall Study|Lack of Efficacy|9
6090773|NCT00337675|21021093|P2|Overall Study|Lack of Efficacy|7
6090774|NCT00337675|21021094|P1|Overall Study|Lack of Efficacy|10
6090775|NCT00337675|21021092|P3|Overall Study|Adverse Event|19
6090776|NCT00337675|21021093|P2|Overall Study|Adverse Event|9
6090777|NCT00337675|21021094|P1|Overall Study|Adverse Event|10
6090778|NCT00337662|21021111|P4|Study Period III|Clinical Relapse|0
6090779|NCT00337662|21021112|P3|Study Period III|Clinical Relapse|0
6090780|NCT00337662|21021113|P2|Study Period III|Clinical Relapse|0
6090781|NCT00337662|21021114|P1|Study Period III|Clinical Relapse|1
6090782|NCT00337662|21021111|P4|Study Period III|Sponsor Decision|0
6090783|NCT00337662|21021112|P3|Study Period III|Sponsor Decision|1
6090784|NCT00337662|21021113|P2|Study Period III|Sponsor Decision|0
6090785|NCT00337662|21021114|P1|Study Period III|Sponsor Decision|1
6090786|NCT00337662|21021111|P4|Study Period III|Parent/Caregiver Decision|0
6090787|NCT00337662|21021112|P3|Study Period III|Parent/Caregiver Decision|2
6090788|NCT00337662|21021113|P2|Study Period III|Parent/Caregiver Decision|0
6090789|NCT00337662|21021114|P1|Study Period III|Parent/Caregiver Decision|0
6090790|NCT00337662|21021111|P4|Study Period III|Lack of Efficacy|0
6090791|NCT00337662|21021112|P3|Study Period III|Lack of Efficacy|2
6090792|NCT00337662|21021113|P2|Study Period III|Lack of Efficacy|4
6090793|NCT00337662|21021114|P1|Study Period III|Lack of Efficacy|4
6090794|NCT00337662|21021111|P4|Study Period III|Entry Criteria Not Met|0
6090795|NCT00337662|21021112|P3|Study Period III|Entry Criteria Not Met|3
6090796|NCT00337662|21021113|P2|Study Period III|Entry Criteria Not Met|1
6090797|NCT00337662|21021114|P1|Study Period III|Entry Criteria Not Met|4
6090798|NCT00337662|21021111|P4|Study Period III|Physician Decision|0
6090799|NCT00337662|21021112|P3|Study Period III|Physician Decision|0
6090800|NCT00337662|21021113|P2|Study Period III|Physician Decision|5
6090801|NCT00337662|21021114|P1|Study Period III|Physician Decision|6
6090802|NCT00337662|21021111|P4|Study Period III|Protocol Violation|0
6090803|NCT00337662|21021112|P3|Study Period III|Protocol Violation|2
6090804|NCT00337662|21021113|P2|Study Period III|Protocol Violation|8
6090805|NCT00337662|21021114|P1|Study Period III|Protocol Violation|3
6090806|NCT00337662|21021111|P4|Study Period III|Adverse Event|0
6090807|NCT00337662|21021112|P3|Study Period III|Adverse Event|8
6090808|NCT00337662|21021113|P2|Study Period III|Adverse Event|10
6090809|NCT00337662|21021114|P1|Study Period III|Adverse Event|9
6090810|NCT00337662|21021111|P4|Study Period III|Withdrawal by Subject|0
6090811|NCT00337662|21021112|P3|Study Period III|Withdrawal by Subject|12
6090812|NCT00337662|21021113|P2|Study Period III|Withdrawal by Subject|14
6090813|NCT00337662|21021114|P1|Study Period III|Withdrawal by Subject|18
6090814|NCT00337662|21021111|P4|Study Period III|Lost to Follow-up|0
6090815|NCT00337662|21021112|P3|Study Period III|Lost to Follow-up|14
6090816|NCT00337662|21021113|P2|Study Period III|Lost to Follow-up|16
6090817|NCT00337662|21021114|P1|Study Period III|Lost to Follow-up|14
6090818|NCT00337662|21021111|P4|Study Period II|Parent/Caregiver Decision|1
6090819|NCT00337662|21021112|P3|Study Period II|Parent/Caregiver Decision|0
6090820|NCT00337662|21021113|P2|Study Period II|Parent/Caregiver Decision|0
6090821|NCT00337662|21021114|P1|Study Period II|Parent/Caregiver Decision|0
6090822|NCT00337662|21021111|P4|Study Period II|Sponsor Decision|2
6090823|NCT00337662|21021112|P3|Study Period II|Sponsor Decision|0
6090824|NCT00337662|21021113|P2|Study Period II|Sponsor Decision|0
6090825|NCT00337662|21021114|P1|Study Period II|Sponsor Decision|0
6090826|NCT00337662|21021111|P4|Study Period II|Lack of Efficacy|7
6090827|NCT00337662|21021112|P3|Study Period II|Lack of Efficacy|0
6090828|NCT00337662|21021113|P2|Study Period II|Lack of Efficacy|0
6090829|NCT00337662|21021114|P1|Study Period II|Lack of Efficacy|0
6090830|NCT00337662|21021111|P4|Study Period II|Protocol Violation|6
6090831|NCT00337662|21021112|P3|Study Period II|Protocol Violation|0
6090832|NCT00337662|21021113|P2|Study Period II|Protocol Violation|0
6090833|NCT00337662|21021114|P1|Study Period II|Protocol Violation|0
6090834|NCT00337662|21021111|P4|Study Period II|Entry Criteria Not Met|6
6090835|NCT00337662|21021112|P3|Study Period II|Entry Criteria Not Met|0
6090836|NCT00337662|21021113|P2|Study Period II|Entry Criteria Not Met|0
6090837|NCT00337662|21021114|P1|Study Period II|Entry Criteria Not Met|0
6090838|NCT00337662|21021111|P4|Study Period II|Physician Decision|13
6090839|NCT00337662|21021112|P3|Study Period II|Physician Decision|0
6090840|NCT00337662|21021113|P2|Study Period II|Physician Decision|0
6090841|NCT00337662|21021114|P1|Study Period II|Physician Decision|0
6090842|NCT00337662|21021111|P4|Study Period II|Adverse Event|16
6090843|NCT00337662|21021112|P3|Study Period II|Adverse Event|0
6090844|NCT00337662|21021113|P2|Study Period II|Adverse Event|0
6090845|NCT00337662|21021114|P1|Study Period II|Adverse Event|0
6090846|NCT00337662|21021111|P4|Study Period II|Withdrawal by Subject|20
6090847|NCT00337662|21021112|P3|Study Period II|Withdrawal by Subject|0
6090848|NCT00337662|21021113|P2|Study Period II|Withdrawal by Subject|0
6090849|NCT00337662|21021114|P1|Study Period II|Withdrawal by Subject|0
6090850|NCT00337662|21021111|P4|Study Period II|Lost to Follow-up|35
6090851|NCT00337662|21021112|P3|Study Period II|Lost to Follow-up|0
6090852|NCT00337662|21021113|P2|Study Period II|Lost to Follow-up|0
6090853|NCT00337662|21021114|P1|Study Period II|Lost to Follow-up|0
6090854|NCT00337610|21021168|P2|Overall Study|Withdrawal by Subject|5
6090855|NCT00337610|21021169|P1|Overall Study|Withdrawal by Subject|6
6090856|NCT00337610|21021168|P2|Overall Study|Lost to Follow-up|3
6090857|NCT00337610|21021169|P1|Overall Study|Lost to Follow-up|3
6090858|NCT00337610|21021168|P2|Overall Study|Lack of Efficacy|3
6090859|NCT00337610|21021169|P1|Overall Study|Lack of Efficacy|6
6090860|NCT00337610|21021168|P2|Overall Study|Death|1
6090861|NCT00337610|21021169|P1|Overall Study|Death|0
6090862|NCT00337610|21021168|P2|Overall Study|Adverse Event|2
6090863|NCT00337610|21021169|P1|Overall Study|Adverse Event|2
6090864|NCT00337571|21021185|P4|Overall Study|High Potassium level|1
6090865|NCT00337571|21021186|P3|Overall Study|High Potassium level|0
6090866|NCT00337571|21021187|P2|Overall Study|High Potassium level|0
6090867|NCT00337571|21021188|P1|Overall Study|High Potassium level|0
6090868|NCT00337571|21021185|P4|Overall Study|No longer met study criteria|0
6090869|NCT00337571|21021186|P3|Overall Study|No longer met study criteria|0
6090870|NCT00337571|21021187|P2|Overall Study|No longer met study criteria|0
6090871|NCT00337571|21021188|P1|Overall Study|No longer met study criteria|1
6090872|NCT00337571|21021185|P4|Overall Study|Poor/noncompliance|1
6090873|NCT00337571|21021186|P3|Overall Study|Poor/noncompliance|1
6090874|NCT00337571|21021187|P2|Overall Study|Poor/noncompliance|1
6090875|NCT00337571|21021188|P1|Overall Study|Poor/noncompliance|1
6090876|NCT00337571|21021185|P4|Overall Study|Lost to Follow-up|1
6090877|NCT00337571|21021186|P3|Overall Study|Lost to Follow-up|0
6090878|NCT00337571|21021187|P2|Overall Study|Lost to Follow-up|1
6090879|NCT00337571|21021188|P1|Overall Study|Lost to Follow-up|3
6090880|NCT00337571|21021185|P4|Overall Study|Withdrawal by Subject|0
6090881|NCT00337571|21021186|P3|Overall Study|Withdrawal by Subject|1
6090882|NCT00337571|21021187|P2|Overall Study|Withdrawal by Subject|2
6090883|NCT00337571|21021188|P1|Overall Study|Withdrawal by Subject|2
6090884|NCT00337571|21021185|P4|Overall Study|Adverse Event|4
6090885|NCT00337571|21021186|P3|Overall Study|Adverse Event|8
6090886|NCT00337571|21021187|P2|Overall Study|Adverse Event|5
6090887|NCT00337571|21021188|P1|Overall Study|Adverse Event|4
6090888|NCT00337571|21021185|P4|Overall Study|Lack of Efficacy|0
6090889|NCT00337571|21021186|P3|Overall Study|Lack of Efficacy|0
6090890|NCT00337571|21021187|P2|Overall Study|Lack of Efficacy|0
6090891|NCT00337571|21021188|P1|Overall Study|Lack of Efficacy|3
6090892|NCT00337467|21021226|P1|Overall Study|Subject No Longer Met Study Criteria|2
6090893|NCT00337467|21021226|P1|Overall Study|Lost to Follow-up|2
6090894|NCT00337467|21021226|P1|Overall Study|Pregnancy|1
6090895|NCT00337467|21021226|P1|Overall Study|Subject Withdrew Consent|2
6090896|NCT00337467|21021226|P1|Overall Study|Adverse Event|3
6090897|NCT00337428|21021245|P2|Overall Study|Anorexia|0
6090898|NCT00337428|21021246|P1|Overall Study|Anorexia|1
6090899|NCT00337428|21021245|P2|Overall Study|Unwilling to Continue|0
6090900|NCT00337428|21021246|P1|Overall Study|Unwilling to Continue|1
6090901|NCT00337428|21021245|P2|Overall Study|Lack of Time|1
6090902|NCT00337428|21021246|P1|Overall Study|Lack of Time|1
6090903|NCT00337428|21021245|P2|Overall Study|Withdrawal by Subject|2
6090904|NCT00337428|21021246|P1|Overall Study|Withdrawal by Subject|1
6090905|NCT00337285|21021297|P1|Overall Study|Lack of protocol compliance|7
6090906|NCT00337285|21021297|P1|Overall Study|Physician Decision|1
6090907|NCT00337285|21021297|P1|Overall Study|Death|1
6090908|NCT00337285|21021297|P1|Overall Study|Lack of Efficacy|11
6090909|NCT00337285|21021297|P1|Overall Study|Protocol Violation|27
6090910|NCT00337285|21021297|P1|Overall Study|Adverse Event|28
6090911|NCT00337285|21021297|P1|Overall Study|Lost to Follow-up|41
6090912|NCT00337285|21021297|P1|Overall Study|Withdrawal by Subject|42
6090913|NCT00337272|21021305|P2|Withdrawal Period|Non-compliance|1
6090914|NCT00337272|21021306|P1|Withdrawal Period|Non-compliance|0
6090915|NCT00337272|21021305|P2|Treatment Period|Withdrawal by Subject|1
6090916|NCT00337272|21021306|P1|Treatment Period|Withdrawal by Subject|0
6090917|NCT00337272|21021305|P2|Treatment Period|Non-compliance|1
6090918|NCT00337272|21021306|P1|Treatment Period|Non-compliance|1
6090919|NCT00337272|21021305|P2|Screening Period (Pre-randomization)|Screen failure|0
6090920|NCT00337272|21021306|P1|Screening Period (Pre-randomization)|Screen failure|3
6090921|NCT00337272|21021305|P2|Screening Period (Pre-randomization)|Non-compliance|0
6090922|NCT00337272|21021306|P1|Screening Period (Pre-randomization)|Non-compliance|1
6090923|NCT00337272|21021305|P2|Screening Period (Pre-randomization)|Withdrawal by Subject|0
6090924|NCT00337272|21021306|P1|Screening Period (Pre-randomization)|Withdrawal by Subject|2
6090925|NCT00337207|21021326|P1|Overall Study|Withdrawal by Subject|3
6090926|NCT00337194|21021334|P2|Overall Study|Subsequent non-protocol therapy|1
6090927|NCT00337194|21021335|P1|Overall Study|Subsequent non-protocol therapy|3
6090928|NCT00337194|21021334|P2|Overall Study|Disease progression|2
6090929|NCT00337194|21021335|P1|Overall Study|Disease progression|1
6090930|NCT00337194|21021334|P2|Overall Study|Withdrawal by Subject|0
6090931|NCT00337194|21021335|P1|Overall Study|Withdrawal by Subject|1
6090932|NCT00337194|21021334|P2|Overall Study|Death|0
6090933|NCT00337194|21021335|P1|Overall Study|Death|2
6090934|NCT00337194|21021334|P2|Overall Study|Adverse Event|1
6090935|NCT00337194|21021335|P1|Overall Study|Adverse Event|5
6090936|NCT00337168|21021359|P1|Overall Study|Did not start therapy|1
6090937|NCT00337168|21021359|P1|Overall Study|Not protocol specified|2
6090938|NCT00337168|21021359|P1|Overall Study|Death|5
6090939|NCT00337129|21021366|P1|Overall Study|not protocol specified|1
6090940|NCT00337129|21021366|P1|Overall Study|Death|2
6090941|NCT00337129|21021366|P1|Overall Study|Lack of Efficacy|32
6090942|NCT00337129|21021366|P1|Overall Study|Withdrawal by Subject|1
6090943|NCT00337129|21021366|P1|Overall Study|Adverse Event|4
6090944|NCT00337103|21021375|P2|Overall Study|Death|0
6090945|NCT00337103|21021376|P1|Overall Study|Death|1
6090946|NCT00337103|21021375|P2|Overall Study|Lost to Follow-up|2
6090947|NCT00337103|21021376|P1|Overall Study|Lost to Follow-up|1
6090948|NCT00337103|21021375|P2|Overall Study|Entry Criteria Not Met|1
6090949|NCT00337103|21021376|P1|Overall Study|Entry Criteria Not Met|4
6090950|NCT00337103|21021375|P2|Overall Study|Other|6
6090951|NCT00337103|21021376|P1|Overall Study|Other|5
6090952|NCT00337103|21021375|P2|Overall Study|Withdrawal by Subject|5
6090953|NCT00337103|21021376|P1|Overall Study|Withdrawal by Subject|8
6090954|NCT00337103|21021375|P2|Overall Study|Physician Decision|14
6090955|NCT00337103|21021376|P1|Overall Study|Physician Decision|15
6090956|NCT00337103|21021375|P2|Overall Study|Clinical Progression|24
6090957|NCT00337103|21021376|P1|Overall Study|Clinical Progression|27
6090958|NCT00337103|21021375|P2|Overall Study|Subject Choice|27
6090959|NCT00337103|21021376|P1|Overall Study|Subject Choice|34
6090960|NCT00337103|21021375|P2|Overall Study|Adverse Event|59
6090961|NCT00337103|21021376|P1|Overall Study|Adverse Event|45
6090962|NCT00337103|21021375|P2|Overall Study|Progressive Disease|410
6090963|NCT00337103|21021376|P1|Overall Study|Progressive Disease|414
6090964|NCT00337077|21021410|P3|Overall Study|Ineligible|1
6090965|NCT00337077|21021411|P2|Overall Study|Ineligible|1
6090966|NCT00337077|21021412|P1|Overall Study|Ineligible|1
6090967|NCT00337077|21021410|P3|Overall Study|Never started treatment|0
6090968|NCT00337077|21021411|P2|Overall Study|Never started treatment|1
6090969|NCT00337077|21021412|P1|Overall Study|Never started treatment|1
6090970|NCT00337077|21021410|P3|Overall Study|Physician Decision|2
6090971|NCT00337077|21021411|P2|Overall Study|Physician Decision|4
6090972|NCT00337077|21021412|P1|Overall Study|Physician Decision|1
6090973|NCT00337077|21021410|P3|Overall Study|Alternative therapy|0
6090974|NCT00337077|21021411|P2|Overall Study|Alternative therapy|0
6090975|NCT00337077|21021412|P1|Overall Study|Alternative therapy|1
6090976|NCT00337077|21021410|P3|Overall Study|Withdrawal by Subject|2
6090977|NCT00337077|21021411|P2|Overall Study|Withdrawal by Subject|2
6090978|NCT00337077|21021412|P1|Overall Study|Withdrawal by Subject|7
6090979|NCT00337077|21021410|P3|Overall Study|Death|0
6090980|NCT00337077|21021411|P2|Overall Study|Death|1
6090981|NCT00337077|21021412|P1|Overall Study|Death|0
6090982|NCT00337077|21021410|P3|Overall Study|Adverse Event|1
6090983|NCT00337077|21021411|P2|Overall Study|Adverse Event|7
6090984|NCT00337077|21021412|P1|Overall Study|Adverse Event|7
6090985|NCT00337077|21021410|P3|Overall Study|Progressive disease|19
6090986|NCT00337077|21021411|P2|Overall Study|Progressive disease|37
6090987|NCT00337077|21021412|P1|Overall Study|Progressive disease|25
6090988|NCT00336895|21021427|P1|Overall Study|screen failed|1
6090989|NCT00336895|21021427|P1|Overall Study|Physician Decision|1
6090990|NCT00336895|21021427|P1|Overall Study|nausea and upset stomach|1
6090991|NCT00336895|21021427|P1|Overall Study|diarrhea|1
6090992|NCT00336856|21021433|P1|Overall Study|Found ineligible at time of analysis|1
6090993|NCT00336856|21021433|P1|Overall Study|Withdrawal by Subject|3
6090994|NCT00336583|21021481|P1|Overall Study|Death|1
6090995|NCT00336583|21021481|P1|Overall Study|Lost to Follow-up|1
6090996|NCT00336544|21021488|P2|Overall Study|Other|5
6090997|NCT00336544|21021489|P1|Overall Study|Other|3
6090998|NCT00336544|21021488|P2|Overall Study|Withdrawal by Subject|3
6090999|NCT00336544|21021489|P1|Overall Study|Withdrawal by Subject|4
6091000|NCT00336544|21021488|P2|Overall Study|Adverse Event|9
6091001|NCT00336544|21021489|P1|Overall Study|Adverse Event|4
6091002|NCT00336544|21021488|P2|Overall Study|Lack of Efficacy|5
6091003|NCT00336544|21021489|P1|Overall Study|Lack of Efficacy|8
6091004|NCT00336505|21021503|P2|Overall Study|Other|7
6091005|NCT00336505|21021504|P1|Overall Study|Other|7
6091006|NCT00336505|21021503|P2|Overall Study|Withdrawal by Subject|3
6091007|NCT00336505|21021504|P1|Overall Study|Withdrawal by Subject|5
6091008|NCT00336505|21021503|P2|Overall Study|Lost to Follow-up|4
6091009|NCT00336505|21021504|P1|Overall Study|Lost to Follow-up|7
6091010|NCT00336505|21021503|P2|Overall Study|Lack of Efficacy|4
6091011|NCT00336505|21021504|P1|Overall Study|Lack of Efficacy|8
6091012|NCT00336505|21021503|P2|Overall Study|Adverse Event|9
6091013|NCT00336505|21021504|P1|Overall Study|Adverse Event|10
6091014|NCT00336492|21021519|P3|Overall Study|Other|1
6091015|NCT00336492|21021520|P2|Overall Study|Other|0
6091016|NCT00336492|21021521|P1|Overall Study|Other|5
6091017|NCT00336492|21021519|P3|Overall Study|Lack of Efficacy|4
6091018|NCT00336492|21021520|P2|Overall Study|Lack of Efficacy|1
6091019|NCT00336492|21021521|P1|Overall Study|Lack of Efficacy|6
6091020|NCT00336492|21021519|P3|Overall Study|Adverse Event|6
6091021|NCT00336492|21021520|P2|Overall Study|Adverse Event|3
6091022|NCT00336492|21021521|P1|Overall Study|Adverse Event|4
6091023|NCT00336479|21021533|P4|Overall Study|Virologic Stopping Rule|0
6091024|NCT00336479|21021534|P3|Overall Study|Virologic Stopping Rule|0
6091025|NCT00336479|21021535|P2|Overall Study|Virologic Stopping Rule|0
6091026|NCT00336479|21021536|P1|Overall Study|Virologic Stopping Rule|20
6091027|NCT00336479|21021533|P4|Overall Study|Other|0
6091028|NCT00336479|21021534|P3|Overall Study|Other|1
6091029|NCT00336479|21021535|P2|Overall Study|Other|0
6091030|NCT00336479|21021536|P1|Overall Study|Other|0
6091031|NCT00336479|21021533|P4|Overall Study|Withdrawal by Subject|0
6091032|NCT00336479|21021534|P3|Overall Study|Withdrawal by Subject|3
6091033|NCT00336479|21021535|P2|Overall Study|Withdrawal by Subject|2
6091034|NCT00336479|21021536|P1|Overall Study|Withdrawal by Subject|3
6091035|NCT00336479|21021533|P4|Overall Study|Lost to Follow-up|0
6091036|NCT00336479|21021534|P3|Overall Study|Lost to Follow-up|0
6091037|NCT00336479|21021535|P2|Overall Study|Lost to Follow-up|2
6091038|NCT00336479|21021536|P1|Overall Study|Lost to Follow-up|3
6091039|NCT00336479|21021533|P4|Overall Study|Physician Decision|0
6091040|NCT00336479|21021534|P3|Overall Study|Physician Decision|1
6091041|NCT00336479|21021535|P2|Overall Study|Physician Decision|3
6091042|NCT00336479|21021536|P1|Overall Study|Physician Decision|2
6091043|NCT00336479|21021533|P4|Overall Study|Noncompliant|0
6091044|NCT00336479|21021534|P3|Overall Study|Noncompliant|3
6091045|NCT00336479|21021535|P2|Overall Study|Noncompliant|7
6091046|NCT00336479|21021536|P1|Overall Study|Noncompliant|1
6091047|NCT00336479|21021533|P4|Overall Study|Adverse Event|4
6091048|NCT00336479|21021534|P3|Overall Study|Adverse Event|18
6091049|NCT00336479|21021535|P2|Overall Study|Adverse Event|11
6091050|NCT00336479|21021536|P1|Overall Study|Adverse Event|8
6091051|NCT00336284|21021625|P2|Overall Study|Withdrawal by Physician or Subject|64
6091052|NCT00336284|21021626|P1|Overall Study|Withdrawal by Physician or Subject|102
6091053|NCT00336284|21021625|P2|Overall Study|Lost to Follow-up|61
6091054|NCT00336284|21021626|P1|Overall Study|Lost to Follow-up|82
6091055|NCT00336284|21021625|P2|Overall Study|Death|26
6091056|NCT00336284|21021626|P1|Overall Study|Death|52
6091057|NCT00336024|21021644|P2|Overall Study|Ineligible|7
6091058|NCT00336024|21021645|P1|Overall Study|Ineligible|7
6091059|NCT00336024|21021644|P2|Overall Study|Progressive Disease|7
6091060|NCT00336024|21021645|P1|Overall Study|Progressive Disease|4
6091061|NCT00336024|21021644|P2|Overall Study|Failure to fulfill consolidation|1
6091062|NCT00336024|21021645|P1|Overall Study|Failure to fulfill consolidation|1
6091063|NCT00336024|21021644|P2|Overall Study|Withdrawal by Subject|2
6091064|NCT00336024|21021645|P1|Overall Study|Withdrawal by Subject|1
6091065|NCT00336024|21021644|P2|Overall Study|Protocol Violation|0
6091066|NCT00336024|21021645|P1|Overall Study|Protocol Violation|1
6091067|NCT00336024|21021644|P2|Overall Study|Physician Decision|1
6091068|NCT00336024|21021645|P1|Overall Study|Physician Decision|4
6091069|NCT00336024|21021644|P2|Overall Study|Death|1
6091070|NCT00336024|21021645|P1|Overall Study|Death|2
6091071|NCT00335972|21021681|P2|Overall Study|not given treatments|3
6091072|NCT00335972|21021682|P1|Overall Study|not given treatments|0
6091073|NCT00335959|21021692|P1|Overall Study|Ineligible|1
6091074|NCT00335959|21021692|P1|Overall Study|Adverse Event|2
6091075|NCT00335829|21021697|P1|Overall Study|Adverse Event|1
6091076|NCT00335829|21021697|P1|Overall Study|Lost to Follow-up|1
6091077|NCT00335829|21021697|P1|Overall Study|Withdrawal by Subject|1
6091078|NCT00335777|21021711|P1|Treated 2 Headaches Per Protocol|Treated 1 early and 1 late out of protoc|12
6091079|NCT00335777|21021711|P1|Treated 2 Headaches Per Protocol|Treated 2 early or 2 late headaches|1
6091080|NCT00335777|21021711|P1|Enrolled and Dispensed Study Medication|Treated only 1 or no headaches|18
6091081|NCT00335777|21021711|P1|Enrolled and Dispensed Study Medication|Withdrawal by Subject|6
6091082|NCT00335777|21021711|P1|Enrolled and Dispensed Study Medication|Lost to Follow-up|5
6091083|NCT00335764|21021721|P5|Overall Study|wrong histology|1
6091084|NCT00335764|21021722|P4|Overall Study|wrong histology|0
6091085|NCT00335764|21021723|P3|Overall Study|wrong histology|0
6091086|NCT00335764|21021724|P2|Overall Study|wrong histology|0
6091087|NCT00335764|21021725|P1|Overall Study|wrong histology|1
6091094|NCT00335556|21021807|P6|Overall Study|Refusal of further protocol therapy|0
6091095|NCT00335556|21021808|P5|Overall Study|Refusal of further protocol therapy|0
6091096|NCT00335556|21021809|P4|Overall Study|Refusal of further protocol therapy|1
6091097|NCT00335556|21021810|P3|Overall Study|Refusal of further protocol therapy|0
6091098|NCT00335556|21021811|P2|Overall Study|Refusal of further protocol therapy|4
6091099|NCT00335556|21021812|P1|Overall Study|Refusal of further protocol therapy|0
6091100|NCT00335556|21021807|P6|Overall Study|Ineligible|0
6091101|NCT00335556|21021808|P5|Overall Study|Ineligible|0
6091102|NCT00335556|21021809|P4|Overall Study|Ineligible|0
6091103|NCT00335556|21021810|P3|Overall Study|Ineligible|0
6091104|NCT00335556|21021811|P2|Overall Study|Ineligible|0
6091105|NCT00335556|21021812|P1|Overall Study|Ineligible|2
6091106|NCT00335556|21021807|P6|Overall Study|Physician Decision|0
6091107|NCT00335556|21021808|P5|Overall Study|Physician Decision|0
6091108|NCT00335556|21021809|P4|Overall Study|Physician Decision|1
6091109|NCT00335556|21021810|P3|Overall Study|Physician Decision|2
6091110|NCT00335556|21021811|P2|Overall Study|Physician Decision|6
6091111|NCT00335556|21021812|P1|Overall Study|Physician Decision|0
6091112|NCT00335556|21021807|P6|Overall Study|Lack of Efficacy|1
6091113|NCT00335556|21021808|P5|Overall Study|Lack of Efficacy|0
6091114|NCT00335556|21021809|P4|Overall Study|Lack of Efficacy|3
6091115|NCT00335556|21021810|P3|Overall Study|Lack of Efficacy|3
6091116|NCT00335556|21021811|P2|Overall Study|Lack of Efficacy|19
6091117|NCT00335556|21021812|P1|Overall Study|Lack of Efficacy|0
6091118|NCT00335556|21021807|P6|Overall Study|Death|0
6091119|NCT00335556|21021808|P5|Overall Study|Death|1
6091120|NCT00335556|21021809|P4|Overall Study|Death|0
6091121|NCT00335556|21021810|P3|Overall Study|Death|0
6091122|NCT00335556|21021811|P2|Overall Study|Death|5
6091123|NCT00335556|21021812|P1|Overall Study|Death|0
6091124|NCT00335452|21021874|P4|Overall Study|Lost to Follow-up|2
6091125|NCT00335452|21021875|P3|Overall Study|Lost to Follow-up|1
6091126|NCT00335452|21021876|P2|Overall Study|Lost to Follow-up|3
6091127|NCT00335452|21021877|P1|Overall Study|Lost to Follow-up|2
6091128|NCT00335452|21021874|P4|Overall Study|Death|129
6091129|NCT00335452|21021875|P3|Overall Study|Death|158
6091130|NCT00335452|21021876|P2|Overall Study|Death|144
6091131|NCT00335452|21021877|P1|Overall Study|Death|156
6091132|NCT00335322|21021902|P3|Overall Study|Randomised but withdrew prior to ART sta|2
6091133|NCT00335322|21021903|P2|Overall Study|Randomised but withdrew prior to ART sta|2
6091134|NCT00335322|21021904|P1|Overall Study|Randomised but withdrew prior to ART sta|1
6091135|NCT00335153|21021952|P1|Post-PEG-J Long-Term Treatment Period|Protocol Violation|2
6091136|NCT00335153|21021952|P1|Post-PEG-J Long-Term Treatment Period|Administrative|13
6091137|NCT00335153|21021952|P1|Post-PEG-J Long-Term Treatment Period|Withdrawal by Subject|13
6091138|NCT00335153|21021952|P1|Post-PEG-J Long-Term Treatment Period|Lack of Efficacy|2
6091139|NCT00335153|21021952|P1|Post-PEG-J Long-Term Treatment Period|Adverse Event|22
6091140|NCT00335153|21021952|P1|Nasojejunal (NJ) Test Period|Protocol Violation|7
6091141|NCT00335153|21021952|P1|Nasojejunal (NJ) Test Period|Administrative|1
6091142|NCT00335153|21021952|P1|Nasojejunal (NJ) Test Period|Withdrawal by Subject|12
6091143|NCT00335153|21021952|P1|Nasojejunal (NJ) Test Period|Lack of Efficacy|5
6091144|NCT00335153|21021952|P1|Nasojejunal (NJ) Test Period|Adverse Event|5
6091145|NCT00335140|21021989|P1|Overall Study|Ineligible|1
6091146|NCT00334958|21021995|P2|Overall Study|Other|2
6091147|NCT00334958|21021996|P1|Overall Study|Other|1
6091148|NCT00334958|21021995|P2|Overall Study|Adverse Event|12
6091149|NCT00334958|21021996|P1|Overall Study|Adverse Event|27
6091150|NCT00334958|21021995|P2|Overall Study|Withdrawal by Subject|4
6091151|NCT00334958|21021996|P1|Overall Study|Withdrawal by Subject|7
6091152|NCT00334958|21021995|P2|Overall Study|Request of the investigator or sponsor|1
6091153|NCT00334958|21021996|P1|Overall Study|Request of the investigator or sponsor|0
6091154|NCT00334958|21021995|P2|Overall Study|Protocol Violation|2
6091155|NCT00334958|21021996|P1|Overall Study|Protocol Violation|2
6091156|NCT00334958|21021995|P2|Overall Study|Medication Noncompliance|3
6091157|NCT00334958|21021996|P1|Overall Study|Medication Noncompliance|0
6091158|NCT00334893|21022010|P2|Overall Study|Not Treated|0
6091159|NCT00334893|21022011|P1|Overall Study|Not Treated|1
6091172|NCT00334802|21022036|P2|Overall Study|Criteria for Starting Next Cycle Not Met|1
6091173|NCT00334802|21022037|P1|Overall Study|Criteria for Starting Next Cycle Not Met|0
6091174|NCT00334802|21022036|P2|Overall Study|Adverse Event|3
6091175|NCT00334802|21022037|P1|Overall Study|Adverse Event|0
6091176|NCT00334802|21022036|P2|Overall Study|Withdrawal by Subject|4
6091177|NCT00334802|21022037|P1|Overall Study|Withdrawal by Subject|0
6091178|NCT00334802|21022036|P2|Overall Study|Physician Decision|0
6091179|NCT00334802|21022037|P1|Overall Study|Physician Decision|1
6091180|NCT00334802|21022036|P2|Overall Study|Patient Condition Aggrevated|0
6091181|NCT00334802|21022037|P1|Overall Study|Patient Condition Aggrevated|1
6091182|NCT00334802|21022036|P2|Overall Study|Lack of Efficacy|3
6091183|NCT00334802|21022037|P1|Overall Study|Lack of Efficacy|1
6091184|NCT00334802|21022036|P2|Overall Study|Toxicity|5
6091185|NCT00334802|21022037|P1|Overall Study|Toxicity|1
6091186|NCT00334802|21022036|P2|Overall Study|Progressive Disease|24
6091187|NCT00334802|21022037|P1|Overall Study|Progressive Disease|2
6091188|NCT00334737|21022057|P3|Follow up Phase|Lost to Follow-up|6
6091189|NCT00334737|21022058|P2|Follow up Phase|Lost to Follow-up|3
6091190|NCT00334737|21022059|P1|Follow up Phase|Lost to Follow-up|5
6091191|NCT00334737|21022057|P3|Hospital Phase|Did not receive study drug|0
6091192|NCT00334737|21022058|P2|Hospital Phase|Did not receive study drug|0
6091193|NCT00334737|21022059|P1|Hospital Phase|Did not receive study drug|1
6091194|NCT00334737|21022057|P3|Hospital Phase|Withdrawal by Subject|1
6091195|NCT00334737|21022058|P2|Hospital Phase|Withdrawal by Subject|0
6091196|NCT00334737|21022059|P1|Hospital Phase|Withdrawal by Subject|0
6091197|NCT00334737|21022057|P3|Hospital Phase|Death|3
6091198|NCT00334737|21022058|P2|Hospital Phase|Death|2
6091199|NCT00334737|21022059|P1|Hospital Phase|Death|1
6091200|NCT00334542|21022107|P1|Overall Study|New cancer diagnosis|1
6091201|NCT00334542|21022107|P1|Overall Study|Withdrawal by Subject|1
6091202|NCT00334542|21022107|P1|Overall Study|Adverse Event|3
6091203|NCT00334295|21022114|P1|Overall Study|Patients received fewer than 3 injection|5
6091204|NCT00334282|21022124|P2|Overall Study|Death|100
6091205|NCT00334282|21022125|P1|Overall Study|Death|194
6091206|NCT00334282|21022124|P2|Overall Study|Withdrawal by Subject|3
6091207|NCT00334282|21022125|P1|Overall Study|Withdrawal by Subject|17
6091208|NCT00334282|21022124|P2|Overall Study|Lost to Follow-up|5
6091209|NCT00334282|21022125|P1|Overall Study|Lost to Follow-up|11
6091210|NCT00334113|21022156|P2|Overall Study|Withdrawal by Subject|1
6091211|NCT00334113|21022157|P1|Overall Study|Withdrawal by Subject|0
6091212|NCT00334113|21022156|P2|Overall Study|Lost to Follow-up|2
6091213|NCT00334113|21022157|P1|Overall Study|Lost to Follow-up|2
6091214|NCT00333983|21022180|P3|Overall Study|Withdrawal by Subject|1
6091215|NCT00333983|21022181|P2|Overall Study|Withdrawal by Subject|3
6091216|NCT00333983|21022182|P1|Overall Study|Withdrawal by Subject|0
6091217|NCT00333983|21022180|P3|Overall Study|Adverse Event|1
6091218|NCT00333983|21022181|P2|Overall Study|Adverse Event|1
6091219|NCT00333983|21022182|P1|Overall Study|Adverse Event|1
6091220|NCT00333983|21022180|P3|Overall Study|Lost to Follow-up|0
6091221|NCT00333983|21022181|P2|Overall Study|Lost to Follow-up|1
6091222|NCT00333983|21022182|P1|Overall Study|Lost to Follow-up|2
6091223|NCT00333970|21022192|P2|Overall Study|Withdrawal by Subject|7
6091224|NCT00333970|21022193|P1|Overall Study|Withdrawal by Subject|13
6091249|NCT00333840|21022271|P4|Second-line Treatment Period|Death|9
6091250|NCT00333840|21022272|P3|Second-line Treatment Period|Death|0
6091251|NCT00333840|21022273|P2|Second-line Treatment Period|Death|0
6091252|NCT00333840|21022274|P1|Second-line Treatment Period|Death|0
6091253|NCT00333840|21022271|P4|Second-line Treatment Period|Administrative problems|7
6091254|NCT00333840|21022272|P3|Second-line Treatment Period|Administrative problems|0
6091255|NCT00333840|21022273|P2|Second-line Treatment Period|Administrative problems|0
6091256|NCT00333840|21022274|P1|Second-line Treatment Period|Administrative problems|0
6091257|NCT00333840|21022271|P4|Second-line Treatment Period|Lost to Follow-up|6
6091258|NCT00333840|21022272|P3|Second-line Treatment Period|Lost to Follow-up|0
6091259|NCT00333840|21022273|P2|Second-line Treatment Period|Lost to Follow-up|0
6091260|NCT00333840|21022274|P1|Second-line Treatment Period|Lost to Follow-up|0
6091261|NCT00333840|21022271|P4|Second-line Treatment Period|Subject withdrew consent|34
6091262|NCT00333840|21022272|P3|Second-line Treatment Period|Subject withdrew consent|0
6091263|NCT00333840|21022273|P2|Second-line Treatment Period|Subject withdrew consent|0
6091264|NCT00333840|21022274|P1|Second-line Treatment Period|Subject withdrew consent|0
6091265|NCT00333840|21022271|P4|Second-line Treatment Period|Protocol Violation|10
6091266|NCT00333840|21022272|P3|Second-line Treatment Period|Protocol Violation|1
6091267|NCT00333840|21022273|P2|Second-line Treatment Period|Protocol Violation|0
6091268|NCT00333840|21022274|P1|Second-line Treatment Period|Protocol Violation|0
6091269|NCT00333840|21022271|P4|Second-line Treatment Period|No longer required study drug|14
6091270|NCT00333840|21022272|P3|Second-line Treatment Period|No longer required study drug|1
6091271|NCT00333840|21022273|P2|Second-line Treatment Period|No longer required study drug|0
6091272|NCT00333840|21022274|P1|Second-line Treatment Period|No longer required study drug|0
6091273|NCT00333840|21022271|P4|Second-line Treatment Period|Unsatisfactory therapeutic effect|70
6091274|NCT00333840|21022272|P3|Second-line Treatment Period|Unsatisfactory therapeutic effect|9
6091275|NCT00333840|21022273|P2|Second-line Treatment Period|Unsatisfactory therapeutic effect|0
6091276|NCT00333840|21022274|P1|Second-line Treatment Period|Unsatisfactory therapeutic effect|0
6091277|NCT00333840|21022271|P4|Second-line Treatment Period|Abnormal procedure|1
6091278|NCT00333840|21022272|P3|Second-line Treatment Period|Abnormal procedure|0
6091279|NCT00333840|21022273|P2|Second-line Treatment Period|Abnormal procedure|0
6091280|NCT00333840|21022274|P1|Second-line Treatment Period|Abnormal procedure|0
6091281|NCT00333840|21022271|P4|Second-line Treatment Period|Abnormal Laboratory Values|3
6091282|NCT00333840|21022272|P3|Second-line Treatment Period|Abnormal Laboratory Values|0
6091283|NCT00333840|21022273|P2|Second-line Treatment Period|Abnormal Laboratory Values|0
6091284|NCT00333840|21022274|P1|Second-line Treatment Period|Abnormal Laboratory Values|0
6091285|NCT00333840|21022271|P4|Second-line Treatment Period|Adverse Event|34
6091286|NCT00333840|21022272|P3|Second-line Treatment Period|Adverse Event|3
6091287|NCT00333840|21022273|P2|Second-line Treatment Period|Adverse Event|0
6091288|NCT00333840|21022274|P1|Second-line Treatment Period|Adverse Event|0
6091289|NCT00333840|21022271|P4|First-line Treatment Period|Crossed over to other treatment arm|0
6091290|NCT00333840|21022272|P3|First-line Treatment Period|Crossed over to other treatment arm|0
6091291|NCT00333840|21022273|P2|First-line Treatment Period|Crossed over to other treatment arm|363
6091292|NCT00333840|21022274|P1|First-line Treatment Period|Crossed over to other treatment arm|14
6091293|NCT00333840|21022271|P4|First-line Treatment Period|Death|0
6091294|NCT00333840|21022272|P3|First-line Treatment Period|Death|0
6091295|NCT00333840|21022273|P2|First-line Treatment Period|Death|2
6091296|NCT00333840|21022274|P1|First-line Treatment Period|Death|19
6091297|NCT00333840|21022271|P4|First-line Treatment Period|Administrative problems|0
6091298|NCT00333840|21022272|P3|First-line Treatment Period|Administrative problems|0
6091299|NCT00333840|21022273|P2|First-line Treatment Period|Administrative problems|6
6091300|NCT00333840|21022274|P1|First-line Treatment Period|Administrative problems|12
6091301|NCT00333840|21022271|P4|First-line Treatment Period|Lost to Follow-up|0
6091302|NCT00333840|21022272|P3|First-line Treatment Period|Lost to Follow-up|0
6091303|NCT00333840|21022273|P2|First-line Treatment Period|Lost to Follow-up|6
6091304|NCT00333840|21022274|P1|First-line Treatment Period|Lost to Follow-up|15
6091305|NCT00333840|21022271|P4|First-line Treatment Period|Subject withdrew consent|0
6091306|NCT00333840|21022272|P3|First-line Treatment Period|Subject withdrew consent|0
6091307|NCT00333840|21022273|P2|First-line Treatment Period|Subject withdrew consent|77
6091308|NCT00333840|21022274|P1|First-line Treatment Period|Subject withdrew consent|57
6091309|NCT00333840|21022271|P4|First-line Treatment Period|Protocol Violation|0
6091310|NCT00333840|21022272|P3|First-line Treatment Period|Protocol Violation|0
6091311|NCT00333840|21022273|P2|First-line Treatment Period|Protocol Violation|17
6091312|NCT00333840|21022274|P1|First-line Treatment Period|Protocol Violation|17
6091313|NCT00333840|21022271|P4|First-line Treatment Period|No longer required study drug|0
6091314|NCT00333840|21022272|P3|First-line Treatment Period|No longer required study drug|0
6091315|NCT00333840|21022273|P2|First-line Treatment Period|No longer required study drug|8
6091316|NCT00333840|21022274|P1|First-line Treatment Period|No longer required study drug|21
6091317|NCT00333840|21022271|P4|First-line Treatment Period|Unsatisfactory therapeutic effect|0
6091318|NCT00333840|21022272|P3|First-line Treatment Period|Unsatisfactory therapeutic effect|0
6091319|NCT00333840|21022273|P2|First-line Treatment Period|Unsatisfactory therapeutic effect|29
6091320|NCT00333840|21022274|P1|First-line Treatment Period|Unsatisfactory therapeutic effect|88
6091321|NCT00333840|21022271|P4|First-line Treatment Period|Abnormal procedure|0
6091322|NCT00333840|21022272|P3|First-line Treatment Period|Abnormal procedure|0
6091323|NCT00333840|21022273|P2|First-line Treatment Period|Abnormal procedure|0
6091324|NCT00333840|21022274|P1|First-line Treatment Period|Abnormal procedure|2
6091325|NCT00333840|21022271|P4|First-line Treatment Period|Abnormal laboratory values|0
6091326|NCT00333840|21022272|P3|First-line Treatment Period|Abnormal laboratory values|0
6091327|NCT00333840|21022273|P2|First-line Treatment Period|Abnormal laboratory values|1
6091328|NCT00333840|21022274|P1|First-line Treatment Period|Abnormal laboratory values|3
6091329|NCT00333840|21022271|P4|First-line Treatment Period|Adverse Event|0
6091330|NCT00333840|21022272|P3|First-line Treatment Period|Adverse Event|0
6091331|NCT00333840|21022273|P2|First-line Treatment Period|Adverse Event|37
6091332|NCT00333840|21022274|P1|First-line Treatment Period|Adverse Event|38
6091333|NCT00333801|21022320|P2|Overall Study|Withdrawal by Subject|1
6091334|NCT00333801|21022321|P1|Overall Study|Withdrawal by Subject|0
6091335|NCT00333801|21022320|P2|Overall Study|Incarcerated|2
6091336|NCT00333801|21022321|P1|Overall Study|Incarcerated|1
6091337|NCT00333801|21022320|P2|Overall Study|Lost to Follow-up|0
6091338|NCT00333801|21022321|P1|Overall Study|Lost to Follow-up|2
6091339|NCT00333801|21022320|P2|Overall Study|Moved to another state|3
6091340|NCT00333801|21022321|P1|Overall Study|Moved to another state|5
6091341|NCT00333788|21022339|P1|Overall Study|Other: Signed consent for another study|1
6091342|NCT00333788|21022339|P1|Overall Study|Other: Physician decision|1
6091343|NCT00333788|21022339|P1|Overall Study|Other: Medical monitor decision|1
6091344|NCT00333788|21022339|P1|Overall Study|Other: Subject in need of an Entocort|1
6091345|NCT00333788|21022339|P1|Overall Study|Other: Sponsor decision|1
6091346|NCT00333788|21022339|P1|Overall Study|Other: Quality of life concern|1
6091347|NCT00333788|21022339|P1|Overall Study|Other: Investigator decision|1
6091348|NCT00333788|21022339|P1|Overall Study|Other: Recurrent squamaous cell cancer|1
6091349|NCT00333788|21022339|P1|Overall Study|Other: Moved|2
6091350|NCT00333788|21022339|P1|Overall Study|Other: Non-compliance|2
6091351|NCT00333788|21022339|P1|Overall Study|Withdrawal by Subject|24
6091352|NCT00333788|21022339|P1|Overall Study|Lost to Follow-up|2
6091353|NCT00333788|21022339|P1|Overall Study|Lack of Efficacy|80
6091354|NCT00333788|21022339|P1|Overall Study|Adverse Event|44
6091355|NCT00333775|21022369|P3|Overall Study|Lost to Follow-up|8
6091356|NCT00333775|21022370|P2|Overall Study|Lost to Follow-up|7
6091357|NCT00333775|21022371|P1|Overall Study|Lost to Follow-up|10
6091358|NCT00333775|21022369|P3|Overall Study|In Follow-up When Study Stopped|96
6091359|NCT00333775|21022370|P2|Overall Study|In Follow-up When Study Stopped|92
6091360|NCT00333775|21022371|P1|Overall Study|In Follow-up When Study Stopped|87
6091361|NCT00333775|21022369|P3|Overall Study|Death|143
6091362|NCT00333775|21022370|P2|Overall Study|Death|149
6091363|NCT00333775|21022371|P1|Overall Study|Death|144
6091364|NCT00333619|21022410|P2|Overall Study|Lost to Follow-up|3
6091365|NCT00333619|21022411|P1|Overall Study|Lost to Follow-up|3
6091366|NCT00333619|21022410|P2|Overall Study|Withdrawal by Subject|1
6091367|NCT00333619|21022411|P1|Overall Study|Withdrawal by Subject|6
6091368|NCT00333619|21022410|P2|Overall Study|Death|6
6091369|NCT00333619|21022411|P1|Overall Study|Death|12
6091370|NCT00333359|21022440|P2|Overall Study|Withdrew before Receiving One Dose|6
6091371|NCT00333359|21022441|P1|Overall Study|Withdrew before Receiving One Dose|2
6091372|NCT00333359|21022440|P2|Overall Study|Treatment Failure|8
6091373|NCT00333359|21022441|P1|Overall Study|Treatment Failure|3
6091374|NCT00333359|21022440|P2|Overall Study|Termination or Withdrawal by Sponsor|1
6091375|NCT00333359|21022441|P1|Overall Study|Termination or Withdrawal by Sponsor|1
6091376|NCT00333359|21022440|P2|Overall Study|Lost to Follow-up|25
6091377|NCT00333359|21022441|P1|Overall Study|Lost to Follow-up|15
6091378|NCT00333359|21022440|P2|Overall Study|Protocol Non-compliance|8
6091379|NCT00333359|21022441|P1|Overall Study|Protocol Non-compliance|2
6091380|NCT00333359|21022440|P2|Overall Study|Physician Decision|2
6091381|NCT00333359|21022441|P1|Overall Study|Physician Decision|2
6091382|NCT00333359|21022440|P2|Overall Study|Withdrawal by Subject|37
6091383|NCT00333359|21022441|P1|Overall Study|Withdrawal by Subject|19
6091384|NCT00333359|21022440|P2|Overall Study|Adverse Event|35
6091385|NCT00333359|21022441|P1|Overall Study|Adverse Event|29
6091386|NCT00333229|21022484|P2|Overall Study|Lack of Efficacy|1
6091387|NCT00333229|21022485|P1|Overall Study|Lack of Efficacy|0
6091388|NCT00333138|21022555|P3|Extension Study (Month6 to End of Study)|Death|0
6091389|NCT00333138|21022556|P2|Extension Study (Month6 to End of Study)|Death|1
6091390|NCT00333138|21022557|P1|Extension Study (Month6 to End of Study)|Death|0
6091391|NCT00333138|21022555|P3|Extension Study (Month6 to End of Study)|Lost to Follow-up|0
6091392|NCT00333138|21022556|P2|Extension Study (Month6 to End of Study)|Lost to Follow-up|1
6091393|NCT00333138|21022557|P1|Extension Study (Month6 to End of Study)|Lost to Follow-up|1
6091394|NCT00333138|21022555|P3|Extension Study (Month6 to End of Study)|Patient no longer required study drug|0
6091395|NCT00333138|21022556|P2|Extension Study (Month6 to End of Study)|Patient no longer required study drug|1
6091396|NCT00333138|21022557|P1|Extension Study (Month6 to End of Study)|Patient no longer required study drug|2
6091397|NCT00333138|21022555|P3|Extension Study (Month6 to End of Study)|Lack of Efficacy|7
6091398|NCT00333138|21022556|P2|Extension Study (Month6 to End of Study)|Lack of Efficacy|4
6091399|NCT00333138|21022557|P1|Extension Study (Month6 to End of Study)|Lack of Efficacy|7
6091400|NCT00333138|21022555|P3|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14
6091401|NCT00333138|21022556|P2|Extension Study (Month6 to End of Study)|Withdrawal by Subject|13
6091402|NCT00333138|21022557|P1|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14
6091403|NCT00333138|21022555|P3|Extension Study (Month6 to End of Study)|Protocol Violation|3
6091404|NCT00333138|21022556|P2|Extension Study (Month6 to End of Study)|Protocol Violation|0
6091405|NCT00333138|21022557|P1|Extension Study (Month6 to End of Study)|Protocol Violation|0
6091406|NCT00333138|21022555|P3|Extension Study (Month6 to End of Study)|Adverse Event|15
6091407|NCT00333138|21022556|P2|Extension Study (Month6 to End of Study)|Adverse Event|19
6091408|NCT00333138|21022557|P1|Extension Study (Month6 to End of Study)|Adverse Event|15
6091409|NCT00333138|21022555|P3|Extension Study (Month6 to End of Study)|Administrative problems|2
6091410|NCT00333138|21022556|P2|Extension Study (Month6 to End of Study)|Administrative problems|1
6091411|NCT00333138|21022557|P1|Extension Study (Month6 to End of Study)|Administrative problems|1
6091412|NCT00333138|21022555|P3|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2
6091413|NCT00333138|21022556|P2|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2
6091414|NCT00333138|21022557|P1|Extension Study (Month6 to End of Study)|Abnormal laboratory value|3
6091415|NCT00333138|21022555|P3|Core Study (6 Months)|Laboratory abnormality|1
6091416|NCT00333138|21022556|P2|Core Study (6 Months)|Laboratory abnormality|0
6091417|NCT00333138|21022557|P1|Core Study (6 Months)|Laboratory abnormality|0
6091418|NCT00333138|21022555|P3|Core Study (6 Months)|Protocol Violation|1
6091419|NCT00333138|21022556|P2|Core Study (6 Months)|Protocol Violation|0
6091420|NCT00333138|21022557|P1|Core Study (6 Months)|Protocol Violation|1
6091421|NCT00333138|21022555|P3|Core Study (6 Months)|Lack of Efficacy|0
6091422|NCT00333138|21022556|P2|Core Study (6 Months)|Lack of Efficacy|0
6091423|NCT00333138|21022557|P1|Core Study (6 Months)|Lack of Efficacy|1
6091424|NCT00333138|21022555|P3|Core Study (6 Months)|Withdrawal by Subject|2
6091425|NCT00333138|21022556|P2|Core Study (6 Months)|Withdrawal by Subject|1
6091426|NCT00333138|21022557|P1|Core Study (6 Months)|Withdrawal by Subject|1
6091427|NCT00333138|21022555|P3|Core Study (6 Months)|Adverse Event|8
6091428|NCT00333138|21022556|P2|Core Study (6 Months)|Adverse Event|5
6091429|NCT00333138|21022557|P1|Core Study (6 Months)|Adverse Event|4
6091430|NCT00332839|21022596|P2|Follow-up (Months 12 - 60)|Death|1
6091431|NCT00332839|21022597|P1|Follow-up (Months 12 - 60)|Death|1
6091432|NCT00332839|21022596|P2|Follow-up (Months 12 - 60)|Lost to Follow-up|1
6091433|NCT00332839|21022597|P1|Follow-up (Months 12 - 60)|Lost to Follow-up|2
6091434|NCT00332839|21022596|P2|Follow-up (Months 12 - 60)|Withdrawal by Subject|1
6091435|NCT00332839|21022597|P1|Follow-up (Months 12 - 60)|Withdrawal by Subject|1
6091436|NCT00332839|21022596|P2|Core (Months 0 - 12)|Adverse Event|15
6091437|NCT00332839|21022597|P1|Core (Months 0 - 12)|Adverse Event|5
6091438|NCT00332839|21022596|P2|Core (Months 0 - 12)|Protocol deviation|1
6091439|NCT00332839|21022597|P1|Core (Months 0 - 12)|Protocol deviation|1
6091440|NCT00332839|21022596|P2|Core (Months 0 - 12)|Withdrawal by Subject|1
6091441|NCT00332839|21022597|P1|Core (Months 0 - 12)|Withdrawal by Subject|3
6091442|NCT00332839|21022596|P2|Core (Months 0 - 12)|Administrative problems|1
6091443|NCT00332839|21022597|P1|Core (Months 0 - 12)|Administrative problems|1
6091444|NCT00332709|21022628|P2|Overall Study|Abnormal test procedure result|0
6091445|NCT00332709|21022629|P1|Overall Study|Abnormal test procedure result|1
6091446|NCT00332709|21022628|P2|Overall Study|Administrative Problems|3
6091447|NCT00332709|21022629|P1|Overall Study|Administrative Problems|0
6091448|NCT00332709|21022628|P2|Overall Study|Lost to Follow-up|0
6091449|NCT00332709|21022629|P1|Overall Study|Lost to Follow-up|2
6091450|NCT00332709|21022628|P2|Overall Study|Withdrawal by Subject|3
6091451|NCT00332709|21022629|P1|Overall Study|Withdrawal by Subject|2
6091452|NCT00332709|21022628|P2|Overall Study|Adverse Event|14
6091453|NCT00332709|21022629|P1|Overall Study|Adverse Event|11
6091454|NCT00332696|21022653|P2|Overall Study|Withdrawal by Subject|0
6091455|NCT00332696|21022654|P1|Overall Study|Withdrawal by Subject|1
6091456|NCT00332696|21022653|P2|Overall Study|Lost to Follow-up|1
6091457|NCT00332696|21022654|P1|Overall Study|Lost to Follow-up|0
6091458|NCT00332696|21022653|P2|Overall Study|Condition does not justify treatment|2
6091459|NCT00332696|21022654|P1|Overall Study|Condition does not justify treatment|0
6091460|NCT00332696|21022653|P2|Overall Study|Adverse Event|2
6091461|NCT00332696|21022654|P1|Overall Study|Adverse Event|1
6091462|NCT00332696|21022653|P2|Overall Study|Insufficient therapeutic effect|11
6091463|NCT00332696|21022654|P1|Overall Study|Insufficient therapeutic effect|4
6091464|NCT00332696|21022653|P2|Overall Study|Death|14
6091465|NCT00332696|21022654|P1|Overall Study|Death|24
6091466|NCT00332488|21022730|P3|Transfer Treatment Phase (Weeks 12 - 24)|Various|5
6091467|NCT00332488|21022731|P2|Transfer Treatment Phase (Weeks 12 - 24)|Various|0
6091468|NCT00332488|21022732|P1|Transfer Treatment Phase (Weeks 12 - 24)|Various|0
6091469|NCT00332488|21022730|P3|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|8
6091470|NCT00332488|21022731|P2|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|2
6091471|NCT00332488|21022732|P1|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|2
6091472|NCT00332488|21022730|P3|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|1
6091473|NCT00332488|21022731|P2|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|0
6091474|NCT00332488|21022732|P1|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|0
6091475|NCT00332488|21022730|P3|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|3
6091476|NCT00332488|21022731|P2|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|0
6091477|NCT00332488|21022732|P1|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|0
6091478|NCT00332488|21022730|P3|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|1
6091479|NCT00332488|21022731|P2|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|0
6091480|NCT00332488|21022732|P1|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|0
6091481|NCT00332488|21022730|P3|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|3
6091482|NCT00332488|21022731|P2|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|0
6091483|NCT00332488|21022732|P1|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|0
6091484|NCT00332488|21022730|P3|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|0
6091485|NCT00332488|21022731|P2|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|1
6091486|NCT00332488|21022732|P1|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|3
6091487|NCT00332488|21022730|P3|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|0
6091488|NCT00332488|21022731|P2|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|3
6091489|NCT00332488|21022732|P1|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|1
6091490|NCT00332488|21022730|P3|Initial Treatment Phase (Weeks 0 - 12)|Various|20
6091491|NCT00332488|21022731|P2|Initial Treatment Phase (Weeks 0 - 12)|Various|0
6091492|NCT00332488|21022732|P1|Initial Treatment Phase (Weeks 0 - 12)|Various|4
6091493|NCT00332488|21022730|P3|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|20
6091494|NCT00332488|21022731|P2|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|10
6091495|NCT00332488|21022732|P1|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|21
6091496|NCT00332488|21022730|P3|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|10
6091497|NCT00332488|21022731|P2|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|2
6091498|NCT00332488|21022732|P1|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|13
6091499|NCT00332488|21022730|P3|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|6
6091500|NCT00332488|21022731|P2|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|2
6091501|NCT00332488|21022732|P1|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|8
6091502|NCT00332462|21022744|P1|Overall Study|Graft Loss|2
6091503|NCT00332462|21022744|P1|Overall Study|Death|3
6091504|NCT00332462|21022744|P1|Overall Study|no longer requires study drug|1
6091505|NCT00332462|21022744|P1|Overall Study|Unsatisfactory therapeutic effect|4
6091506|NCT00332462|21022744|P1|Overall Study|Abnormal Lab Value|1
6091507|NCT00332462|21022744|P1|Overall Study|Adverse Event|5
6091508|NCT00332332|21022751|P1|Overall Study|Did not receive study treatment|16
6091509|NCT00332332|21022751|P1|Overall Study|Other|18
6091510|NCT00332332|21022751|P1|Overall Study|Disease progression|2
6091511|NCT00332332|21022751|P1|Overall Study|Noncompliance|2
6091512|NCT00332332|21022751|P1|Overall Study|Protocol deviation|4
6091513|NCT00332332|21022751|P1|Overall Study|Lost to Follow-up|3
6091514|NCT00332332|21022751|P1|Overall Study|Physician Decision|1
6091515|NCT00332332|21022751|P1|Overall Study|Withdrawal by Subject|8
6091516|NCT00332332|21022751|P1|Overall Study|Death|1
6091517|NCT00332332|21022751|P1|Overall Study|Adverse Event|13
6091518|NCT00332241|21022760|P2|Overall Study|Lost to Follow-up|1
6091519|NCT00332241|21022761|P1|Overall Study|Lost to Follow-up|4
6091520|NCT00332241|21022760|P2|Overall Study|Withdrawal by Subject|1
6091521|NCT00332241|21022761|P1|Overall Study|Withdrawal by Subject|2
6091522|NCT00332241|21022760|P2|Overall Study|Adverse Event|5
6091523|NCT00332241|21022761|P1|Overall Study|Adverse Event|3
6091524|NCT00332241|21022760|P2|Overall Study|Lack of Efficacy|1
6091525|NCT00332241|21022761|P1|Overall Study|Lack of Efficacy|6
6091526|NCT00332202|21022783|P2|Overall Study|Death|2
6091527|NCT00332202|21022784|P1|Overall Study|Death|5
6091528|NCT00332202|21022783|P2|Overall Study|Progressive Disease|60
6091529|NCT00332202|21022784|P1|Overall Study|Progressive Disease|106
6091530|NCT00332202|21022783|P2|Overall Study|Withdrawal by Subject|17
6091531|NCT00332202|21022784|P1|Overall Study|Withdrawal by Subject|36
6091532|NCT00332202|21022783|P2|Overall Study|Sponsor Decision|2
6091533|NCT00332202|21022784|P1|Overall Study|Sponsor Decision|1
6091534|NCT00332202|21022783|P2|Overall Study|Protocol Violation|2
6091535|NCT00332202|21022784|P1|Overall Study|Protocol Violation|7
6091536|NCT00332202|21022783|P2|Overall Study|Protocol Entry Criteria Not Met|5
6091537|NCT00332202|21022784|P1|Overall Study|Protocol Entry Criteria Not Met|6
6091538|NCT00332202|21022783|P2|Overall Study|Physician Decision|8
6091539|NCT00332202|21022784|P1|Overall Study|Physician Decision|6
6091540|NCT00332202|21022783|P2|Overall Study|Lost to Follow-up|1
6091541|NCT00332202|21022784|P1|Overall Study|Lost to Follow-up|2
6091542|NCT00332202|21022783|P2|Overall Study|Adverse Event|28
6091543|NCT00332202|21022784|P1|Overall Study|Adverse Event|72
6091544|NCT00332189|21022813|P1|Overall Study|Moved out of country|2
6091545|NCT00332189|21022813|P1|Overall Study|Lack of Efficacy|4
6091546|NCT00332189|21022813|P1|Overall Study|Withdrawal by Subject|9
6091547|NCT00332189|21022813|P1|Overall Study|Uncooperative/Noncompliant|3
6091548|NCT00332189|21022813|P1|Overall Study|Adverse Event|3
6091549|NCT00331864|21022855|P2|Overall Study|Death|0
6091550|NCT00331864|21022856|P1|Overall Study|Death|6
6091551|NCT00331864|21022855|P2|Overall Study|Administrative Problems|0
6091552|NCT00331864|21022856|P1|Overall Study|Administrative Problems|1
6091553|NCT00331864|21022855|P2|Overall Study|Lost to Follow-up|3
6091554|NCT00331864|21022856|P1|Overall Study|Lost to Follow-up|4
6091555|NCT00331864|21022855|P2|Overall Study|Withdrawal by Subject|0
6091556|NCT00331864|21022856|P1|Overall Study|Withdrawal by Subject|10
6091557|NCT00331864|21022855|P2|Overall Study|Protocol Violation|0
6091558|NCT00331864|21022856|P1|Overall Study|Protocol Violation|3
6091559|NCT00331864|21022855|P2|Overall Study|Lack of Efficacy|0
6091560|NCT00331864|21022856|P1|Overall Study|Lack of Efficacy|4
6091561|NCT00331864|21022855|P2|Overall Study|Adverse Event|1
6091562|NCT00331864|21022856|P1|Overall Study|Adverse Event|30
6091563|NCT00331799|21022875|P1|Overall Study|Sedation|1
6091564|NCT00331799|21022875|P1|Overall Study|Withdrawal by Subject|2
6091565|NCT00331773|21022881|P2|Overall Study|Protocol Violation|3
6091566|NCT00331773|21022882|P1|Overall Study|Protocol Violation|10
6091567|NCT00331773|21022881|P2|Overall Study|Withdrawal by Subject|4
6091568|NCT00331773|21022882|P1|Overall Study|Withdrawal by Subject|6
6091569|NCT00331760|21022912|P2|Overall Study|Ineligible / no protocol treatment|8
6091570|NCT00331760|21022913|P1|Overall Study|Ineligible / no protocol treatment|15
6091571|NCT00331682|21022934|P1|Overall Study|Adverse Event|1
6091572|NCT00331630|21022940|P1|Follow up for 5 Years|Data collection was stopped|24
6091573|NCT00331630|21022940|P1|Follow up for 5 Years|Death|5
6091574|NCT00331630|21022940|P1|Evaluated for and Completed SOC Surgery|Lost to Follow-up|1
6091575|NCT00331630|21022940|P1|Evaluated for and Completed SOC Surgery|Progressive Disease|1
6091576|NCT00331552|21022952|P2|Period 3: Phase II|Severe Nausea|0
6091577|NCT00331552|21022953|P1|Period 3: Phase II|Severe Nausea|1
6091578|NCT00331552|21022952|P2|Period 3: Phase II|Neurological Symptoms|0
6091579|NCT00331552|21022953|P1|Period 3: Phase II|Neurological Symptoms|1
6091580|NCT00331422|21022967|P1|Overall Study|Did not receive entire study regimen|5
6091581|NCT00331409|21022976|P1|Overall Study|Lack of Efficacy|4
6091582|NCT00331344|21022984|P9|Phase II|Death|4
6091583|NCT00331344|21022985|P8|Phase II|Death|0
6091584|NCT00331344|21022986|P7|Phase II|Death|0
6091585|NCT00331344|21022987|P6|Phase II|Death|0
6091586|NCT00331344|21022988|P5|Phase II|Death|0
6091587|NCT00331344|21022989|P4|Phase II|Death|0
6091588|NCT00331344|21022990|P3|Phase II|Death|0
6091589|NCT00331344|21022991|P2|Phase II|Death|0
6091590|NCT00331344|21022992|P1|Phase II|Death|0
6091591|NCT00331344|21022984|P9|Phase I|Adverse Event|0
6091592|NCT00331344|21022985|P8|Phase I|Adverse Event|1
6091593|NCT00331344|21022986|P7|Phase I|Adverse Event|0
6091594|NCT00331344|21022987|P6|Phase I|Adverse Event|2
6091595|NCT00331344|21022988|P5|Phase I|Adverse Event|2
6091596|NCT00331344|21022989|P4|Phase I|Adverse Event|1
6091597|NCT00331344|21022990|P3|Phase I|Adverse Event|0
6091598|NCT00331344|21022991|P2|Phase I|Adverse Event|0
6091599|NCT00331344|21022992|P1|Phase I|Adverse Event|0
6091600|NCT00331006|21023029|P1|Follow-Up Phase II|Lost to Follow-up|3
6091601|NCT00331006|21023029|P1|Follow-Up Phase I|Lost to Follow-up|1
6091602|NCT00331006|21023029|P1|Treatment Phase|Withdrawal by Subject|1
6091603|NCT00331006|21023029|P1|Screening Phase|Ineligible for treatment phase|4
6091604|NCT00331006|21023029|P1|Screening Phase|Lost to Follow-up|1
6091605|NCT00331006|21023029|P1|Screening Phase|enrollment halted|1
6091606|NCT00331006|21023029|P1|Screening Phase|Withdrawal by Subject|1
6091607|NCT00330967|21023042|P2|Overall Study|Physician Decision|9
6091608|NCT00330967|21023043|P1|Overall Study|Physician Decision|0
6091609|NCT00330967|21023042|P2|Overall Study|Withdrawal by Subject|5
6091610|NCT00330967|21023043|P1|Overall Study|Withdrawal by Subject|0
6091611|NCT00330928|21023054|P1|Overall Study|IVUS could not be performed.|1
6091612|NCT00330928|21023054|P1|Overall Study|Death|1
6091613|NCT00330928|21023054|P1|Overall Study|Physician Decision|9
6091614|NCT00330928|21023054|P1|Overall Study|Lost to Follow-up|6
6091615|NCT00330759|21023096|P2|Overall Study|Other|44
6091616|NCT00330759|21023097|P1|Overall Study|Other|36
6091617|NCT00330759|21023096|P2|Overall Study|Ineligibility determined|1
6091618|NCT00330759|21023097|P1|Overall Study|Ineligibility determined|2
6091619|NCT00330759|21023096|P2|Overall Study|Protocol deviation|2
6091620|NCT00330759|21023097|P1|Overall Study|Protocol deviation|0
6091621|NCT00330759|21023096|P2|Overall Study|Physician Decision|2
6091622|NCT00330759|21023097|P1|Overall Study|Physician Decision|1
6091623|NCT00330759|21023096|P2|Overall Study|Noncompliance|17
6091624|NCT00330759|21023097|P1|Overall Study|Noncompliance|15
6091625|NCT00330759|21023096|P2|Overall Study|Lost to Follow-up|22
6091626|NCT00330759|21023097|P1|Overall Study|Lost to Follow-up|16
6091627|NCT00330759|21023096|P2|Overall Study|Participant request|22
6091628|NCT00330759|21023097|P1|Overall Study|Participant request|31
6091629|NCT00330759|21023096|P2|Overall Study|Adverse Event|36
6091630|NCT00330759|21023097|P1|Overall Study|Adverse Event|48
6091631|NCT00330759|21023096|P2|Overall Study|Withdrawal by Subject|124
6091632|NCT00330759|21023097|P1|Overall Study|Withdrawal by Subject|143
6091633|NCT00330759|21023096|P2|Overall Study|Disease progression|126
6091634|NCT00330759|21023097|P1|Overall Study|Disease progression|104
6091635|NCT00330759|21023096|P2|Overall Study|Death|310
6091636|NCT00330759|21023097|P1|Overall Study|Death|316
6091637|NCT00330681|21023130|P2|Overall Study|Tracheotomy due to worsening of ALS|2
6091638|NCT00330681|21023131|P1|Overall Study|Tracheotomy due to worsening of ALS|1
6091639|NCT00330681|21023130|P2|Overall Study|Withdrawal by Subject|5
6091640|NCT00330681|21023131|P1|Overall Study|Withdrawal by Subject|5
6091641|NCT00330681|21023130|P2|Overall Study|Protocol Violation|1
6091642|NCT00330681|21023131|P1|Overall Study|Protocol Violation|0
6091643|NCT00330681|21023130|P2|Overall Study|Adverse Event|6
6091644|NCT00330681|21023131|P1|Overall Study|Adverse Event|3
6091645|NCT00330668|21023153|P1|QD Dosing Period|Lost to Follow-up|2
6091646|NCT00330668|21023153|P1|QD Dosing Period|Withdrawal by Subject|1
6091647|NCT00330668|21023153|P1|QD Dosing Period|Other|1
6091648|NCT00330668|21023153|P1|QD Dosing Period|Sponsor decision to terminate study|74
6091649|NCT00330668|21023153|P1|BID Dosing Period|Other|3
6091650|NCT00330668|21023153|P1|BID Dosing Period|Sponsor's decision|1
6091651|NCT00330668|21023153|P1|BID Dosing Period|Withdrawal by Subject|19
6091652|NCT00330668|21023153|P1|BID Dosing Period|Non-Compliance|5
6091653|NCT00330668|21023153|P1|BID Dosing Period|Lost to Follow-up|7
6091654|NCT00330668|21023153|P1|BID Dosing Period|Adverse Event|1
6091655|NCT00330616|21023161|P1|Overall Study|Other|1
6091656|NCT00330616|21023161|P1|Overall Study|Withdrawal by Subject|4
6091657|NCT00330616|21023161|P1|Overall Study|Lost to Follow-up|2
6091658|NCT00330616|21023161|P1|Overall Study|Lack of Efficacy|1
6091659|NCT00330616|21023161|P1|Overall Study|Adverse Event|13
6091660|NCT00330460|21023212|P2|Overall Study|Other|0
6091661|NCT00330460|21023213|P1|Overall Study|Other|1
6091662|NCT00330460|21023212|P2|Overall Study|Noncompliance|1
6091663|NCT00330460|21023213|P1|Overall Study|Noncompliance|2
6091664|NCT00330460|21023212|P2|Overall Study|Lost to Follow-up|3
6091665|NCT00330460|21023213|P1|Overall Study|Lost to Follow-up|8
6091666|NCT00330460|21023212|P2|Overall Study|Ineligibility determined|3
6091667|NCT00330460|21023213|P1|Overall Study|Ineligibility determined|1
6091668|NCT00330460|21023212|P2|Overall Study|Death|1
6091669|NCT00330460|21023213|P1|Overall Study|Death|1
6091670|NCT00330460|21023212|P2|Overall Study|Withdrawal by Subject|17
6091671|NCT00330460|21023213|P1|Overall Study|Withdrawal by Subject|18
6091672|NCT00330460|21023212|P2|Overall Study|Adverse Event|8
6091673|NCT00330460|21023213|P1|Overall Study|Adverse Event|10
6091674|NCT00330460|21023212|P2|Overall Study|Physician Decision|0
6091675|NCT00330460|21023213|P1|Overall Study|Physician Decision|1
6091676|NCT00330343|21023256|P1|Overall Study|Lost to Follow-up|5
6091677|NCT00330187|21023264|P4|Overall Study|Withdrawal by Subject|4
6091678|NCT00330187|21023265|P3|Overall Study|Withdrawal by Subject|4
6091679|NCT00330187|21023266|P2|Overall Study|Withdrawal by Subject|5
6091680|NCT00330187|21023267|P1|Overall Study|Withdrawal by Subject|8
6091681|NCT00330187|21023264|P4|Overall Study|Lost to Follow-up|10
6091682|NCT00330187|21023265|P3|Overall Study|Lost to Follow-up|14
6091683|NCT00330187|21023266|P2|Overall Study|Lost to Follow-up|13
6091684|NCT00330187|21023267|P1|Overall Study|Lost to Follow-up|12
6091685|NCT00330174|21023279|P2|Overall Study|Miscellaneous reasons|1
6091686|NCT00330174|21023280|P1|Overall Study|Miscellaneous reasons|7
6091687|NCT00330174|21023279|P2|Overall Study|Excessive missed visits|8
6091688|NCT00330174|21023280|P1|Overall Study|Excessive missed visits|3
6091689|NCT00330174|21023279|P2|Overall Study|Clinical deterioration|2
6091690|NCT00330174|21023280|P1|Overall Study|Clinical deterioration|1
6091691|NCT00330174|21023279|P2|Overall Study|Lost to Follow-up|1
6091692|NCT00330174|21023280|P1|Overall Study|Lost to Follow-up|4
6091693|NCT00330174|21023279|P2|Overall Study|Withdrawal by Subject|7
6091694|NCT00330174|21023280|P1|Overall Study|Withdrawal by Subject|7
6091695|NCT00329901|21023304|P3|Overall Study|Unable to classify|0
6091696|NCT00329901|21023305|P2|Overall Study|Unable to classify|2
6091697|NCT00329901|21023306|P1|Overall Study|Unable to classify|2
6091698|NCT00329901|21023304|P3|Overall Study|Protocol Violation|1
6091699|NCT00329901|21023305|P2|Overall Study|Protocol Violation|0
6091700|NCT00329901|21023306|P1|Overall Study|Protocol Violation|1
6091701|NCT00329901|21023304|P3|Overall Study|Lost to Follow-up|1
6091702|NCT00329901|21023305|P2|Overall Study|Lost to Follow-up|0
6091703|NCT00329901|21023306|P1|Overall Study|Lost to Follow-up|2
6091704|NCT00329901|21023304|P3|Overall Study|Withdrawal by Subject|2
6091705|NCT00329901|21023305|P2|Overall Study|Withdrawal by Subject|3
6091706|NCT00329901|21023306|P1|Overall Study|Withdrawal by Subject|4
6091707|NCT00329849|21023336|P2|Overall Study|Withdrawal by Subject|4
6091708|NCT00329849|21023337|P1|Overall Study|Withdrawal by Subject|6
6091709|NCT00329797|21023363|P2|Overall Study|Withdrawal by Subject|6
6091710|NCT00329797|21023364|P1|Overall Study|Withdrawal by Subject|6
6091711|NCT00329797|21023363|P2|Overall Study|Protocol Violation|0
6091712|NCT00329797|21023364|P1|Overall Study|Protocol Violation|1
6091713|NCT00329784|21023380|P4|Overall Study|Other|0
6091714|NCT00329784|21023381|P3|Overall Study|Other|0
6091715|NCT00329784|21023382|P2|Overall Study|Other|2
6091716|NCT00329784|21023383|P1|Overall Study|Other|1
6091717|NCT00329784|21023380|P4|Overall Study|Withdrawal by Subject|0
6091718|NCT00329784|21023381|P3|Overall Study|Withdrawal by Subject|0
6091719|NCT00329784|21023382|P2|Overall Study|Withdrawal by Subject|2
6091720|NCT00329784|21023383|P1|Overall Study|Withdrawal by Subject|4
6091721|NCT00329784|21023380|P4|Overall Study|Lost to Follow-up|0
6091722|NCT00329784|21023381|P3|Overall Study|Lost to Follow-up|0
6091723|NCT00329784|21023382|P2|Overall Study|Lost to Follow-up|1
6091724|NCT00329784|21023383|P1|Overall Study|Lost to Follow-up|0
6091725|NCT00329745|21023411|P2|Overall Study|Lost to Follow-up|101
6091726|NCT00329745|21023412|P1|Overall Study|Lost to Follow-up|86
6091727|NCT00329745|21023411|P2|Overall Study|Withdrawal by Subject|1
6091728|NCT00329745|21023412|P1|Overall Study|Withdrawal by Subject|0
6091729|NCT00329745|21023411|P2|Overall Study|Protocol Violation|0
6091730|NCT00329745|21023412|P1|Overall Study|Protocol Violation|1
6091731|NCT00329719|21023432|P4|Overall Study|Lost to Follow-up|1
6091732|NCT00329719|21023433|P3|Overall Study|Lost to Follow-up|0
6091733|NCT00329719|21023434|P2|Overall Study|Lost to Follow-up|0
6091734|NCT00329719|21023435|P1|Overall Study|Lost to Follow-up|0
6091735|NCT00329641|21023457|P1|Overall Study|Other reason, not protocol specified|1
6091736|NCT00329641|21023457|P1|Overall Study|Adverse Event|3
6091737|NCT00329641|21023457|P1|Overall Study|Not eligible|1
6091738|NCT00329641|21023457|P1|Overall Study|Did not start treatment|1
6091739|NCT00329602|21023466|P3|40-Week Open-Label Treatment Phase|Captured as Other|4
6091740|NCT00329602|21023467|P2|40-Week Open-Label Treatment Phase|Captured as Other|0
6091741|NCT00329602|21023468|P1|40-Week Open-Label Treatment Phase|Captured as Other|0
6091742|NCT00329602|21023466|P3|40-Week Open-Label Treatment Phase|Lack of Efficacy|9
6091743|NCT00329602|21023467|P2|40-Week Open-Label Treatment Phase|Lack of Efficacy|0
6091744|NCT00329602|21023468|P1|40-Week Open-Label Treatment Phase|Lack of Efficacy|0
6091745|NCT00329602|21023466|P3|40-Week Open-Label Treatment Phase|Protocol Violation|2
6091746|NCT00329602|21023467|P2|40-Week Open-Label Treatment Phase|Protocol Violation|0
6091747|NCT00329602|21023468|P1|40-Week Open-Label Treatment Phase|Protocol Violation|0
6091748|NCT00329602|21023466|P3|40-Week Open-Label Treatment Phase|Lost to Follow-up|1
6091749|NCT00329602|21023467|P2|40-Week Open-Label Treatment Phase|Lost to Follow-up|0
6091750|NCT00329602|21023468|P1|40-Week Open-Label Treatment Phase|Lost to Follow-up|0
6091751|NCT00329602|21023466|P3|40-Week Open-Label Treatment Phase|Adverse Event|20
6091752|NCT00329602|21023467|P2|40-Week Open-Label Treatment Phase|Adverse Event|0
6091753|NCT00329602|21023468|P1|40-Week Open-Label Treatment Phase|Adverse Event|0
6091754|NCT00329602|21023466|P3|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|0
6091755|NCT00329602|21023467|P2|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|99
6091756|NCT00329602|21023468|P1|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|119
6091757|NCT00329550|21023506|P3|Overall Study|Due to Relocation|1
6091758|NCT00329550|21023507|P2|Overall Study|Due to Relocation|0
6091759|NCT00329550|21023508|P1|Overall Study|Due to Relocation|0
6091760|NCT00329550|21023506|P3|Overall Study|Withdrawal of Consent|1
6091761|NCT00329550|21023507|P2|Overall Study|Withdrawal of Consent|0
6091762|NCT00329550|21023508|P1|Overall Study|Withdrawal of Consent|1
6091763|NCT00329550|21023506|P3|Overall Study|Adverse Event|2
6091764|NCT00329550|21023507|P2|Overall Study|Adverse Event|4
6091765|NCT00329550|21023508|P1|Overall Study|Adverse Event|3
6091766|NCT00329420|21023777|P3|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0
6091767|NCT00329420|21023778|P2|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0
6091768|NCT00329420|21023779|P1|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|1
6091769|NCT00329420|21023777|P3|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|0
6091770|NCT00329420|21023778|P2|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1
6091771|NCT00329420|21023779|P1|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1
6091772|NCT00329420|21023777|P3|4-weekly Dosing Phase (Responders Only)|Adverse Event|1
6091773|NCT00329420|21023778|P2|4-weekly Dosing Phase (Responders Only)|Adverse Event|1
6091774|NCT00329420|21023779|P1|4-weekly Dosing Phase (Responders Only)|Adverse Event|2
6091775|NCT00329420|21023777|P3|Re-induction Phase|Did not respond to re-induction|7
6091776|NCT00329420|21023778|P2|Re-induction Phase|Did not respond to re-induction|5
6091777|NCT00329420|21023779|P1|Re-induction Phase|Did not respond to re-induction|6
6091778|NCT00329420|21023777|P3|Re-induction Phase|Withdrawal of Consent|1
6091779|NCT00329420|21023778|P2|Re-induction Phase|Withdrawal of Consent|0
6091780|NCT00329420|21023779|P1|Re-induction Phase|Withdrawal of Consent|0
6091781|NCT00329420|21023777|P3|Re-induction Phase|Lack of Efficacy|0
6091782|NCT00329420|21023778|P2|Re-induction Phase|Lack of Efficacy|1
6091783|NCT00329420|21023779|P1|Re-induction Phase|Lack of Efficacy|0
6091784|NCT00329407|21024158|P1|Overall Study|Withdrawal by Subject|1
6091785|NCT00329303|21024165|P2|Overall Study|Patient relocated|1
6091786|NCT00329303|21024166|P1|Overall Study|Patient relocated|0
6091787|NCT00329303|21024165|P2|Overall Study|Patient no longer available|0
6091788|NCT00329303|21024166|P1|Overall Study|Patient no longer available|1
6091789|NCT00329303|21024165|P2|Overall Study|Decision of the sponsor|1
6091790|NCT00329303|21024166|P1|Overall Study|Decision of the sponsor|0
6091791|NCT00329303|21024165|P2|Overall Study|Lack of Efficacy|0
6091792|NCT00329303|21024166|P1|Overall Study|Lack of Efficacy|1
6091793|NCT00329238|21024328|P2|Overall Study|Other reason (not specified)|54
6091794|NCT00329238|21024329|P1|Overall Study|Other reason (not specified)|40
6091795|NCT00329238|21024328|P2|Overall Study|Withdrawal by Subject|58
6091796|NCT00329238|21024329|P1|Overall Study|Withdrawal by Subject|64
6091797|NCT00329238|21024328|P2|Overall Study|Lost to Follow-up|6
6091798|NCT00329238|21024329|P1|Overall Study|Lost to Follow-up|2
6091799|NCT00329238|21024328|P2|Overall Study|Protocol Violation|34
6091800|NCT00329238|21024329|P1|Overall Study|Protocol Violation|23
6091801|NCT00329238|21024328|P2|Overall Study|Adverse Event|129
6091802|NCT00329238|21024329|P1|Overall Study|Adverse Event|147
6091803|NCT00329160|21024365|P1|Overall Study|Incomplete IVUS|45
6091804|NCT00329160|21024365|P1|Overall Study|Did not Receive Study Drug|1
6091805|NCT00329160|21024365|P1|Overall Study|Protocol Violation|2
6091806|NCT00329160|21024365|P1|Overall Study|Withdrawal by Subject|13
6091807|NCT00329160|21024365|P1|Overall Study|Adverse Event|27
6091808|NCT00329108|21024374|P2|Overall Study|Protocol Violation|2
6091809|NCT00329108|21024375|P1|Overall Study|Protocol Violation|0
6091810|NCT00329108|21024374|P2|Overall Study|withdrew patient after SAE resolved|0
6091811|NCT00329108|21024375|P1|Overall Study|withdrew patient after SAE resolved|1
6091812|NCT00329108|21024374|P2|Overall Study|study terminated by sponsor|0
6091813|NCT00329108|21024375|P1|Overall Study|study terminated by sponsor|1
6091814|NCT00329108|21024374|P2|Overall Study|Subject no longer willing to participate|2
6091815|NCT00329108|21024375|P1|Overall Study|Subject no longer willing to participate|2
6091816|NCT00329108|21024374|P2|Overall Study|symptomatic deterioration|1
6091817|NCT00329108|21024375|P1|Overall Study|symptomatic deterioration|1
6091818|NCT00329108|21024374|P2|Overall Study|Withdrawal by Subject|2
6091819|NCT00329108|21024375|P1|Overall Study|Withdrawal by Subject|0
6091820|NCT00329108|21024374|P2|Overall Study|Lack of Efficacy|3
6091821|NCT00329108|21024375|P1|Overall Study|Lack of Efficacy|3
6091822|NCT00329108|21024374|P2|Overall Study|Adverse Event|2
6091823|NCT00329108|21024375|P1|Overall Study|Adverse Event|2
6091824|NCT00329030|21024383|P2|Overall Study|Ineligible Pathology|1
6091825|NCT00329030|21024384|P1|Overall Study|Ineligible Pathology|1
6091826|NCT00329030|21024383|P2|Overall Study|Progressive Disease|2
6091827|NCT00329030|21024384|P1|Overall Study|Progressive Disease|6
6091828|NCT00329030|21024383|P2|Overall Study|Withdrawal by Subject|3
6091829|NCT00329030|21024384|P1|Overall Study|Withdrawal by Subject|1
6091830|NCT00328926|21024415|P3|Overall Study|Lack of ovarian response|0
6091831|NCT00328926|21024416|P2|Overall Study|Lack of ovarian response|1
6091832|NCT00328926|21024417|P1|Overall Study|Lack of ovarian response|0
6091833|NCT00328926|21024415|P3|Overall Study|In vitro fertilization treatment|1
6091834|NCT00328926|21024416|P2|Overall Study|In vitro fertilization treatment|0
6091835|NCT00328926|21024417|P1|Overall Study|In vitro fertilization treatment|0
6091836|NCT00328926|21024415|P3|Overall Study|Death|1
6091837|NCT00328926|21024416|P2|Overall Study|Death|0
6091838|NCT00328926|21024417|P1|Overall Study|Death|0
6091839|NCT00328926|21024415|P3|Overall Study|Lost to Follow-up|0
6091840|NCT00328926|21024416|P2|Overall Study|Lost to Follow-up|1
6091841|NCT00328926|21024417|P1|Overall Study|Lost to Follow-up|0
6091842|NCT00328926|21024415|P3|Overall Study|Pregnancy|0
6091843|NCT00328926|21024416|P2|Overall Study|Pregnancy|1
6091844|NCT00328926|21024417|P1|Overall Study|Pregnancy|2
6091845|NCT00328783|21024442|P1|Overall Study|Withdrawal by Subject|1
6091846|NCT00328783|21024442|P1|Overall Study|No heart in RT field|4
6091847|NCT00328783|21024442|P1|Overall Study|Could not tolerate ABC|21
6091848|NCT00328627|21024468|P12|Overall Study|Other|0
6091849|NCT00328627|21024469|P11|Overall Study|Other|1
6091850|NCT00328627|21024470|P10|Overall Study|Other|1
6091851|NCT00328627|21024471|P9|Overall Study|Other|0
6091852|NCT00328627|21024472|P8|Overall Study|Other|0
6091853|NCT00328627|21024473|P7|Overall Study|Other|1
6091854|NCT00328627|21024474|P6|Overall Study|Other|0
6091855|NCT00328627|21024475|P5|Overall Study|Other|0
6091856|NCT00328627|21024476|P4|Overall Study|Other|1
6091857|NCT00328627|21024477|P3|Overall Study|Other|0
6091858|NCT00328627|21024478|P2|Overall Study|Other|0
6091859|NCT00328627|21024479|P1|Overall Study|Other|0
6091860|NCT00328627|21024468|P12|Overall Study|Physician Decision|0
6091861|NCT00328627|21024469|P11|Overall Study|Physician Decision|1
6091862|NCT00328627|21024470|P10|Overall Study|Physician Decision|2
6091863|NCT00328627|21024471|P9|Overall Study|Physician Decision|3
6091864|NCT00328627|21024472|P8|Overall Study|Physician Decision|0
6091865|NCT00328627|21024473|P7|Overall Study|Physician Decision|1
6091866|NCT00328627|21024474|P6|Overall Study|Physician Decision|1
6091867|NCT00328627|21024475|P5|Overall Study|Physician Decision|1
6091868|NCT00328627|21024476|P4|Overall Study|Physician Decision|2
6091869|NCT00328627|21024477|P3|Overall Study|Physician Decision|1
6091870|NCT00328627|21024478|P2|Overall Study|Physician Decision|3
6091871|NCT00328627|21024479|P1|Overall Study|Physician Decision|4
6091872|NCT00328627|21024468|P12|Overall Study|Pregnancy|0
6091873|NCT00328627|21024469|P11|Overall Study|Pregnancy|0
6091874|NCT00328627|21024470|P10|Overall Study|Pregnancy|0
6091875|NCT00328627|21024471|P9|Overall Study|Pregnancy|0
6091876|NCT00328627|21024472|P8|Overall Study|Pregnancy|0
6091877|NCT00328627|21024473|P7|Overall Study|Pregnancy|0
6091878|NCT00328627|21024474|P6|Overall Study|Pregnancy|0
6091879|NCT00328627|21024475|P5|Overall Study|Pregnancy|0
6091880|NCT00328627|21024476|P4|Overall Study|Pregnancy|0
6091881|NCT00328627|21024477|P3|Overall Study|Pregnancy|0
6091882|NCT00328627|21024478|P2|Overall Study|Pregnancy|1
6091883|NCT00328627|21024479|P1|Overall Study|Pregnancy|0
6091884|NCT00328627|21024468|P12|Overall Study|Withdrawal by Subject|7
6091885|NCT00328627|21024469|P11|Overall Study|Withdrawal by Subject|2
6091886|NCT00328627|21024470|P10|Overall Study|Withdrawal by Subject|5
6091887|NCT00328627|21024471|P9|Overall Study|Withdrawal by Subject|4
6091888|NCT00328627|21024472|P8|Overall Study|Withdrawal by Subject|4
6091889|NCT00328627|21024473|P7|Overall Study|Withdrawal by Subject|4
6091890|NCT00328627|21024474|P6|Overall Study|Withdrawal by Subject|5
6091891|NCT00328627|21024475|P5|Overall Study|Withdrawal by Subject|2
6091892|NCT00328627|21024476|P4|Overall Study|Withdrawal by Subject|6
6091893|NCT00328627|21024477|P3|Overall Study|Withdrawal by Subject|5
6091894|NCT00328627|21024478|P2|Overall Study|Withdrawal by Subject|4
6091895|NCT00328627|21024479|P1|Overall Study|Withdrawal by Subject|5
6091896|NCT00328627|21024468|P12|Overall Study|Lost to Follow-up|1
6091897|NCT00328627|21024469|P11|Overall Study|Lost to Follow-up|0
6091898|NCT00328627|21024470|P10|Overall Study|Lost to Follow-up|2
6091899|NCT00328627|21024471|P9|Overall Study|Lost to Follow-up|3
6091900|NCT00328627|21024472|P8|Overall Study|Lost to Follow-up|0
6091901|NCT00328627|21024473|P7|Overall Study|Lost to Follow-up|3
6091902|NCT00328627|21024474|P6|Overall Study|Lost to Follow-up|2
6091903|NCT00328627|21024475|P5|Overall Study|Lost to Follow-up|0
6091904|NCT00328627|21024476|P4|Overall Study|Lost to Follow-up|4
6091905|NCT00328627|21024477|P3|Overall Study|Lost to Follow-up|2
6091906|NCT00328627|21024478|P2|Overall Study|Lost to Follow-up|2
6091907|NCT00328627|21024479|P1|Overall Study|Lost to Follow-up|4
6091908|NCT00328627|21024468|P12|Overall Study|Protocol Violation|2
6091909|NCT00328627|21024469|P11|Overall Study|Protocol Violation|6
6091910|NCT00328627|21024470|P10|Overall Study|Protocol Violation|4
6091911|NCT00328627|21024471|P9|Overall Study|Protocol Violation|1
6091912|NCT00328627|21024472|P8|Overall Study|Protocol Violation|2
6091913|NCT00328627|21024473|P7|Overall Study|Protocol Violation|6
6091914|NCT00328627|21024474|P6|Overall Study|Protocol Violation|5
6091915|NCT00328627|21024475|P5|Overall Study|Protocol Violation|5
6091916|NCT00328627|21024476|P4|Overall Study|Protocol Violation|8
6091917|NCT00328627|21024477|P3|Overall Study|Protocol Violation|2
6091918|NCT00328627|21024478|P2|Overall Study|Protocol Violation|2
6091919|NCT00328627|21024479|P1|Overall Study|Protocol Violation|2
6091920|NCT00328627|21024468|P12|Overall Study|Adverse Event|4
6091921|NCT00328627|21024469|P11|Overall Study|Adverse Event|5
6091922|NCT00328627|21024470|P10|Overall Study|Adverse Event|7
6091923|NCT00328627|21024471|P9|Overall Study|Adverse Event|0
6091924|NCT00328627|21024472|P8|Overall Study|Adverse Event|2
6091925|NCT00328627|21024473|P7|Overall Study|Adverse Event|1
6091926|NCT00328627|21024474|P6|Overall Study|Adverse Event|2
6091927|NCT00328627|21024475|P5|Overall Study|Adverse Event|1
6091928|NCT00328627|21024476|P4|Overall Study|Adverse Event|3
6091929|NCT00328627|21024477|P3|Overall Study|Adverse Event|2
6091930|NCT00328627|21024478|P2|Overall Study|Adverse Event|1
6091931|NCT00328627|21024479|P1|Overall Study|Adverse Event|3
6091932|NCT00328627|21024468|P12|Overall Study|Hyperglycemic Rescue|2
6091933|NCT00328627|21024469|P11|Overall Study|Hyperglycemic Rescue|3
6091934|NCT00328627|21024470|P10|Overall Study|Hyperglycemic Rescue|11
6091935|NCT00328627|21024471|P9|Overall Study|Hyperglycemic Rescue|6
6091936|NCT00328627|21024472|P8|Overall Study|Hyperglycemic Rescue|6
6091937|NCT00328627|21024473|P7|Overall Study|Hyperglycemic Rescue|19
6091938|NCT00328627|21024474|P6|Overall Study|Hyperglycemic Rescue|5
6091939|NCT00328627|21024475|P5|Overall Study|Hyperglycemic Rescue|6
6091940|NCT00328627|21024476|P4|Overall Study|Hyperglycemic Rescue|13
6091941|NCT00328627|21024477|P3|Overall Study|Hyperglycemic Rescue|16
6091942|NCT00328627|21024478|P2|Overall Study|Hyperglycemic Rescue|18
6091943|NCT00328627|21024479|P1|Overall Study|Hyperglycemic Rescue|41
6091944|NCT00328562|21026016|P1|Overall Study|Disease progression|1
6091945|NCT00328510|21026025|P2|Overall Study|Treatment changed to a single fraction|1
6091946|NCT00328510|21026026|P1|Overall Study|Treatment changed to a single fraction|1
6091947|NCT00328510|21026025|P2|Overall Study|Severe kyphosis, could not use mask|1
6091948|NCT00328510|21026026|P1|Overall Study|Severe kyphosis, could not use mask|0
6091949|NCT00328510|21026025|P2|Overall Study|Withdrawal by Subject|2
6091950|NCT00328510|21026026|P1|Overall Study|Withdrawal by Subject|4
6091951|NCT00328510|21026025|P2|Overall Study|Dentition problems, could not use frame|0
6091952|NCT00328510|21026026|P1|Overall Study|Dentition problems, could not use frame|1
6091953|NCT00328510|21026025|P2|Overall Study|Gag disorder, could not use frame|0
6091954|NCT00328510|21026026|P1|Overall Study|Gag disorder, could not use frame|4
6091955|NCT00328198|21026041|P1|Follow-up|Death|31
6091956|NCT00328198|21026041|P1|Follow-up|Lost to Follow-up|4
6091957|NCT00328198|21026041|P1|Treatment|Confirmed complete response, MRD -|3
6091958|NCT00328198|21026041|P1|Treatment|Non-compliance|1
6091959|NCT00328198|21026041|P1|Treatment|Evidence of disease progression|2
6091960|NCT00328198|21026041|P1|Treatment|Withdrawal by Subject|5
6091961|NCT00328198|21026041|P1|Treatment|Physician Decision|5
6091962|NCT00328198|21026041|P1|Treatment|Death|1
6091963|NCT00328198|21026041|P1|Treatment|Adverse Event|21
6091964|NCT00328172|21026056|P5|Overall Study|Other reason (not specified)|0
6091965|NCT00328172|21026057|P4|Overall Study|Other reason (not specified)|0
6091966|NCT00328172|21026058|P3|Overall Study|Other reason (not specified)|1
6091967|NCT00328172|21026059|P2|Overall Study|Other reason (not specified)|0
6091968|NCT00328172|21026060|P1|Overall Study|Other reason (not specified)|3
6091969|NCT00328172|21026056|P5|Overall Study|Lack of Efficacy|3
6091970|NCT00328172|21026057|P4|Overall Study|Lack of Efficacy|4
6091971|NCT00328172|21026058|P3|Overall Study|Lack of Efficacy|4
6091972|NCT00328172|21026059|P2|Overall Study|Lack of Efficacy|9
6091973|NCT00328172|21026060|P1|Overall Study|Lack of Efficacy|14
6091974|NCT00328172|21026056|P5|Overall Study|Withdrawal by Subject|0
6091975|NCT00328172|21026057|P4|Overall Study|Withdrawal by Subject|6
6091976|NCT00328172|21026058|P3|Overall Study|Withdrawal by Subject|1
6091977|NCT00328172|21026059|P2|Overall Study|Withdrawal by Subject|1
6091978|NCT00328172|21026060|P1|Overall Study|Withdrawal by Subject|1
6091979|NCT00328172|21026056|P5|Overall Study|Lost to Follow-up|1
6091980|NCT00328172|21026057|P4|Overall Study|Lost to Follow-up|1
6091981|NCT00328172|21026058|P3|Overall Study|Lost to Follow-up|2
6091982|NCT00328172|21026059|P2|Overall Study|Lost to Follow-up|1
6091983|NCT00328172|21026060|P1|Overall Study|Lost to Follow-up|1
6091984|NCT00328172|21026056|P5|Overall Study|Protocol Violation|0
6091985|NCT00328172|21026057|P4|Overall Study|Protocol Violation|0
6091986|NCT00328172|21026058|P3|Overall Study|Protocol Violation|1
6091987|NCT00328172|21026059|P2|Overall Study|Protocol Violation|1
6091988|NCT00328172|21026060|P1|Overall Study|Protocol Violation|0
6091989|NCT00328172|21026056|P5|Overall Study|Adverse Event|1
6091990|NCT00328172|21026057|P4|Overall Study|Adverse Event|2
6091991|NCT00328172|21026058|P3|Overall Study|Adverse Event|1
6091992|NCT00328172|21026059|P2|Overall Study|Adverse Event|2
6091993|NCT00328172|21026060|P1|Overall Study|Adverse Event|3
6091994|NCT00328094|21026084|P2|Overall Study|Physician Decision|3
6091995|NCT00328094|21026085|P1|Overall Study|Physician Decision|3
6091996|NCT00327717|21026119|P2|Overall Study|Withdrawal by Subject|7
6091997|NCT00327717|21026120|P1|Overall Study|Withdrawal by Subject|3
6091998|NCT00327717|21026119|P2|Overall Study|Lack of Efficacy|1
6091999|NCT00327717|21026120|P1|Overall Study|Lack of Efficacy|0
6092000|NCT00327717|21026119|P2|Overall Study|Adverse Event|6
6092001|NCT00327717|21026120|P1|Overall Study|Adverse Event|6
6092002|NCT00327470|21026146|P2|Overall Study|Death|4
6092003|NCT00327470|21026147|P1|Overall Study|Death|1
6092004|NCT00327470|21026146|P2|Overall Study|Withdrawal by Subject|12
6092005|NCT00327470|21026147|P1|Overall Study|Withdrawal by Subject|6
6092006|NCT00327470|21026146|P2|Overall Study|Lost to Follow-up|3
6092007|NCT00327470|21026147|P1|Overall Study|Lost to Follow-up|1
6092008|NCT00327470|21026146|P2|Overall Study|Other|9
6092009|NCT00327470|21026147|P1|Overall Study|Other|5
6092010|NCT00327470|21026146|P2|Overall Study|Lack of Efficacy|19
6092011|NCT00327470|21026147|P1|Overall Study|Lack of Efficacy|7
6092012|NCT00327470|21026146|P2|Overall Study|Adverse Event|14
6092013|NCT00327470|21026147|P1|Overall Study|Adverse Event|9
6092014|NCT00327470|21026146|P2|Overall Study|Randomized, but not treated|2
6092015|NCT00327470|21026147|P1|Overall Study|Randomized, but not treated|0
6092016|NCT00327444|21026167|P2|Open Label Treatment (OL) Period|Ongoing Treatment|0
6092017|NCT00327444|21026168|P1|Open Label Treatment (OL) Period|Ongoing Treatment|1
6092018|NCT00327444|21026167|P2|Open Label Treatment (OL) Period|Worsening dyspnea|1
6092019|NCT00327444|21026168|P1|Open Label Treatment (OL) Period|Worsening dyspnea|0
6092020|NCT00327444|21026167|P2|Open Label Treatment (OL) Period|Adverse Event|2
6092021|NCT00327444|21026168|P1|Open Label Treatment (OL) Period|Adverse Event|2
6092022|NCT00327444|21026167|P2|Open Label Treatment (OL) Period|Disease progression|7
6092023|NCT00327444|21026168|P1|Open Label Treatment (OL) Period|Disease progression|8
6092024|NCT00327444|21026167|P2|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|10
6092025|NCT00327444|21026168|P1|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|11
6092026|NCT00327444|21026167|P2|Double Blind Treatment (DB) Period|Subject request|1
6092027|NCT00327444|21026168|P1|Double Blind Treatment (DB) Period|Subject request|0
6092028|NCT00327444|21026167|P2|Double Blind Treatment (DB) Period|Adverse Event|5
6092029|NCT00327444|21026168|P1|Double Blind Treatment (DB) Period|Adverse Event|5
6092030|NCT00327444|21026167|P2|Double Blind Treatment (DB) Period|Disease progression|13
6092031|NCT00327444|21026168|P1|Double Blind Treatment (DB) Period|Disease progression|10
6092032|NCT00327340|21026186|P2|Overall Study|Adverse Event|3
6092033|NCT00327340|21026187|P1|Overall Study|Adverse Event|3
6092034|NCT00327340|21026186|P2|Overall Study|Symptomatic Disease|2
6092035|NCT00327340|21026187|P1|Overall Study|Symptomatic Disease|0
6092036|NCT00327340|21026186|P2|Overall Study|Disease Progression|19
6092037|NCT00327340|21026187|P1|Overall Study|Disease Progression|10
6092038|NCT00327340|21026186|P2|Overall Study|Physician Decision|1
6092039|NCT00327340|21026187|P1|Overall Study|Physician Decision|1
6092040|NCT00327340|21026186|P2|Overall Study|Withdrawal by Subject|5
6092041|NCT00327340|21026187|P1|Overall Study|Withdrawal by Subject|1
6092042|NCT00327171|21026201|P2|Overall Study|Other|0
6092043|NCT00327171|21026202|P1|Overall Study|Other|1
6092044|NCT00327171|21026201|P2|Overall Study|Undisclosed history of ischemia|1
6092045|NCT00327171|21026202|P1|Overall Study|Undisclosed history of ischemia|0
6092046|NCT00327171|21026201|P2|Overall Study|Clinical progression|8
6092047|NCT00327171|21026202|P1|Overall Study|Clinical progression|12
6092048|NCT00327171|21026201|P2|Overall Study|Investigator/participant request|8
6092049|NCT00327171|21026202|P1|Overall Study|Investigator/participant request|1
6092050|NCT00327171|21026201|P2|Overall Study|Disease progression/lack of efficacy|69
6092051|NCT00327171|21026202|P1|Overall Study|Disease progression/lack of efficacy|68
6092052|NCT00327171|21026201|P2|Overall Study|Adverse Event|23
6092053|NCT00327171|21026202|P1|Overall Study|Adverse Event|23
6092054|NCT00327171|21026201|P2|Overall Study|Did not receive study medication|0
6092055|NCT00327171|21026202|P1|Overall Study|Did not receive study medication|3
6092056|NCT00327015|21026234|P4|Overall Study|Administrative Reason by Sponsor|1
6092057|NCT00327015|21026235|P3|Overall Study|Administrative Reason by Sponsor|2
6092058|NCT00327015|21026236|P2|Overall Study|Administrative Reason by Sponsor|2
6092059|NCT00327015|21026237|P1|Overall Study|Administrative Reason by Sponsor|1
6092060|NCT00327015|21026234|P4|Overall Study|Pregnancy|1
6092061|NCT00327015|21026235|P3|Overall Study|Pregnancy|1
6092062|NCT00327015|21026236|P2|Overall Study|Pregnancy|2
6092063|NCT00327015|21026237|P1|Overall Study|Pregnancy|0
6092064|NCT00327015|21026234|P4|Overall Study|Death|3
6092065|NCT00327015|21026235|P3|Overall Study|Death|2
6092066|NCT00327015|21026236|P2|Overall Study|Death|2
6092067|NCT00327015|21026237|P1|Overall Study|Death|1
6092068|NCT00327015|21026234|P4|Overall Study|Physician Decision|2
6092069|NCT00327015|21026235|P3|Overall Study|Physician Decision|3
6092070|NCT00327015|21026236|P2|Overall Study|Physician Decision|1
6092071|NCT00327015|21026237|P1|Overall Study|Physician Decision|0
6092072|NCT00327015|21026234|P4|Overall Study|Poor/Noncompliance|5
6092073|NCT00327015|21026235|P3|Overall Study|Poor/Noncompliance|4
6092074|NCT00327015|21026236|P2|Overall Study|Poor/Noncompliance|8
6092075|NCT00327015|21026237|P1|Overall Study|Poor/Noncompliance|11
6092076|NCT00327015|21026234|P4|Overall Study|Subject no longer meets study criteria|7
6092077|NCT00327015|21026235|P3|Overall Study|Subject no longer meets study criteria|8
6092078|NCT00327015|21026236|P2|Overall Study|Subject no longer meets study criteria|2
6092079|NCT00327015|21026237|P1|Overall Study|Subject no longer meets study criteria|4
6092080|NCT00327015|21026234|P4|Overall Study|Adverse Event|14
6092081|NCT00327015|21026235|P3|Overall Study|Adverse Event|14
6092082|NCT00327015|21026236|P2|Overall Study|Adverse Event|10
6092083|NCT00327015|21026237|P1|Overall Study|Adverse Event|14
6092084|NCT00327015|21026234|P4|Overall Study|Lost to Follow-up|22
6092085|NCT00327015|21026235|P3|Overall Study|Lost to Follow-up|29
6092086|NCT00327015|21026236|P2|Overall Study|Lost to Follow-up|23
6092087|NCT00327015|21026237|P1|Overall Study|Lost to Follow-up|22
6092088|NCT00327015|21026234|P4|Overall Study|Withdrawal of Consent by Subject|25
6092089|NCT00327015|21026235|P3|Overall Study|Withdrawal of Consent by Subject|28
6092090|NCT00327015|21026236|P2|Overall Study|Withdrawal of Consent by Subject|24
6092091|NCT00327015|21026237|P1|Overall Study|Withdrawal of Consent by Subject|20
6092092|NCT00327015|21026234|P4|Overall Study|Lack of Efficacy|29
6092093|NCT00327015|21026235|P3|Overall Study|Lack of Efficacy|35
6092094|NCT00327015|21026236|P2|Overall Study|Lack of Efficacy|18
6092095|NCT00327015|21026237|P1|Overall Study|Lack of Efficacy|18
6092096|NCT00326963|21026279|P1|Overall Study|Administrative / other|1
6092097|NCT00326963|21026279|P1|Overall Study|Other protocol violation|1
6092098|NCT00326963|21026279|P1|Overall Study|Violation of selection criteria at entry|2
6092099|NCT00326963|21026279|P1|Overall Study|Refused treatment / did not cooperate|5
6092100|NCT00326963|21026279|P1|Overall Study|Withdrawal by Subject|10
6092101|NCT00326963|21026279|P1|Overall Study|Failure to return|10
6092102|NCT00326963|21026279|P1|Overall Study|Death|1
6092103|NCT00326963|21026279|P1|Overall Study|Injection site reaction|1
6092104|NCT00326963|21026279|P1|Overall Study|Adverse Event|2
6092105|NCT00326950|21026299|P1|Overall Study|Progressive Disease|1
6092106|NCT00326911|21026321|P2|Overall Study|Withdrawal by subject prior to treatment|1
6092107|NCT00326911|21026322|P1|Overall Study|Withdrawal by subject prior to treatment|0
6092108|NCT00326911|21026321|P2|Overall Study|Physician decision prior to treatment|0
6092109|NCT00326911|21026322|P1|Overall Study|Physician decision prior to treatment|1
6092110|NCT00326911|21026321|P2|Overall Study|Hospitalization prior to treatment|1
6092111|NCT00326911|21026322|P1|Overall Study|Hospitalization prior to treatment|0
6092112|NCT00326898|21026375|P3|Overall Study|Other/Missing/Unknown|32
6092113|NCT00326898|21026376|P2|Overall Study|Other/Missing/Unknown|28
6092114|NCT00326898|21026377|P1|Overall Study|Other/Missing/Unknown|33
6092115|NCT00326898|21026375|P3|Overall Study|Other complicating disease|4
6092116|NCT00326898|21026376|P2|Overall Study|Other complicating disease|5
6092117|NCT00326898|21026377|P1|Overall Study|Other complicating disease|5
6092118|NCT00326898|21026375|P3|Overall Study|Alternative therapy|0
6092119|NCT00326898|21026376|P2|Overall Study|Alternative therapy|0
6092120|NCT00326898|21026377|P1|Overall Study|Alternative therapy|1
6092121|NCT00326898|21026375|P3|Overall Study|Withdrawal by Subject|32
6092122|NCT00326898|21026376|P2|Overall Study|Withdrawal by Subject|128
6092123|NCT00326898|21026377|P1|Overall Study|Withdrawal by Subject|134
6092124|NCT00326898|21026375|P3|Overall Study|Death|0
6092125|NCT00326898|21026376|P2|Overall Study|Death|0
6092126|NCT00326898|21026377|P1|Overall Study|Death|2
6092127|NCT00326898|21026375|P3|Overall Study|Adverse Event|33
6092128|NCT00326898|21026376|P2|Overall Study|Adverse Event|128
6092129|NCT00326898|21026377|P1|Overall Study|Adverse Event|124
6092130|NCT00326898|21026375|P3|Overall Study|Disease progression|102
6092131|NCT00326898|21026376|P2|Overall Study|Disease progression|54
6092132|NCT00326898|21026377|P1|Overall Study|Disease progression|52
6092133|NCT00326885|21026394|P1|Overall Study|Hospice withdrew consent|2
6092134|NCT00326885|21026394|P1|Overall Study|Physician Decision|1
6092135|NCT00326885|21026394|P1|Overall Study|Withdrawal by Subject|3
6092136|NCT00326885|21026394|P1|Overall Study|Adverse Event|1
6092137|NCT00326716|21026425|P4|Pre-Natal Mothers|Discontinued ATV Before Delivery|0
6092138|NCT00326716|21026426|P3|Pre-Natal Mothers|Discontinued ATV Before Delivery|0
6092139|NCT00326716|21026427|P2|Pre-Natal Mothers|Discontinued ATV Before Delivery|2
6092140|NCT00326716|21026428|P1|Pre-Natal Mothers|Discontinued ATV Before Delivery|1
6092141|NCT00326612|21026500|P2|Overall Study|They did not have a seizure requiring tx|137
6092142|NCT00326612|21026501|P1|Overall Study|They did not have a seizure requiring tx|129
6092143|NCT00326599|21026523|P4|Overall Study|Other Unspecified Reason|1
6092144|NCT00326599|21026524|P3|Overall Study|Other Unspecified Reason|2
6092145|NCT00326599|21026525|P2|Overall Study|Other Unspecified Reason|0
6092146|NCT00326599|21026526|P1|Overall Study|Other Unspecified Reason|0
6092147|NCT00326599|21026523|P4|Overall Study|Death|2
6092148|NCT00326599|21026524|P3|Overall Study|Death|1
6092149|NCT00326599|21026525|P2|Overall Study|Death|0
6092150|NCT00326599|21026526|P1|Overall Study|Death|0
6092151|NCT00326599|21026523|P4|Overall Study|Alternate Treatment|0
6092152|NCT00326599|21026524|P3|Overall Study|Alternate Treatment|0
6092153|NCT00326599|21026525|P2|Overall Study|Alternate Treatment|0
6092154|NCT00326599|21026526|P1|Overall Study|Alternate Treatment|1
6092155|NCT00326599|21026523|P4|Overall Study|Disease Progression|11
6092156|NCT00326599|21026524|P3|Overall Study|Disease Progression|13
6092157|NCT00326599|21026525|P2|Overall Study|Disease Progression|1
6092158|NCT00326599|21026526|P1|Overall Study|Disease Progression|3
6092159|NCT00326599|21026523|P4|Overall Study|Adverse Event|3
6092160|NCT00326599|21026524|P3|Overall Study|Adverse Event|32
6092161|NCT00326599|21026525|P2|Overall Study|Adverse Event|0
6092162|NCT00326599|21026526|P1|Overall Study|Adverse Event|1
6092163|NCT00326599|21026523|P4|Overall Study|Withdrawal by Subject|2
6092164|NCT00326599|21026524|P3|Overall Study|Withdrawal by Subject|5
6092165|NCT00326599|21026525|P2|Overall Study|Withdrawal by Subject|0
6092166|NCT00326599|21026526|P1|Overall Study|Withdrawal by Subject|1
6092167|NCT00326495|21026545|P1|Overall Study|Subject off study before assessment|1
6092168|NCT00326495|21026545|P1|Overall Study|Refused further treatment|2
6092169|NCT00326495|21026545|P1|Overall Study|Disease progression before treatment|1
6092170|NCT00326495|21026545|P1|Overall Study|Switched to alternative treatment|1
6092171|NCT00326417|21026552|P4|Overall Study|Death|0
6092172|NCT00326417|21026553|P3|Overall Study|Death|0
6092173|NCT00326417|21026554|P2|Overall Study|Death|0
6092174|NCT00326417|21026555|P1|Overall Study|Death|7
6092175|NCT00326417|21026552|P4|Overall Study|Arm Closed|3
6092176|NCT00326417|21026553|P3|Overall Study|Arm Closed|0
6092177|NCT00326417|21026554|P2|Overall Study|Arm Closed|0
6092178|NCT00326417|21026555|P1|Overall Study|Arm Closed|7
6092179|NCT00326417|21026552|P4|Overall Study|Withdrawal by Subject|0
6092180|NCT00326417|21026553|P3|Overall Study|Withdrawal by Subject|1
6092181|NCT00326417|21026554|P2|Overall Study|Withdrawal by Subject|0
6092182|NCT00326417|21026555|P1|Overall Study|Withdrawal by Subject|0
6092183|NCT00326209|21026571|P1|Overall Study|Pregnancy|1
6092184|NCT00326209|21026571|P1|Overall Study|Withdrawn in error|1
6092185|NCT00326209|21026571|P1|Overall Study|Violation of entry criteria|1
6092186|NCT00326209|21026571|P1|Overall Study|Prohibited medication use|1
6092187|NCT00326209|21026571|P1|Overall Study|Sponsor closed study|173
6092188|NCT00326209|21026571|P1|Overall Study|Participant non-compliant|6
6092189|NCT00326209|21026571|P1|Overall Study|Lost to Follow-up|18
6092190|NCT00326209|21026571|P1|Overall Study|Lack of Efficacy|31
6092191|NCT00326209|21026571|P1|Overall Study|Withdrawal by Subject|22
6092192|NCT00326209|21026571|P1|Overall Study|Adverse Event|28
6092193|NCT00326183|21026589|P2|Overall Study|Adverse Event|0
6092194|NCT00326183|21026590|P1|Overall Study|Adverse Event|1
6092195|NCT00326183|21026589|P2|Overall Study|Other|13
6092196|NCT00326183|21026590|P1|Overall Study|Other|47
6092197|NCT00326183|21026589|P2|Overall Study|Subject Moved|4
6092198|NCT00326183|21026590|P1|Overall Study|Subject Moved|7
6092199|NCT00326183|21026589|P2|Overall Study|Withdrawal by Subject|7
6092200|NCT00326183|21026590|P1|Overall Study|Withdrawal by Subject|35
6092201|NCT00326183|21026589|P2|Overall Study|Protocol Violation|3
6092202|NCT00326183|21026590|P1|Overall Study|Protocol Violation|6
6092203|NCT00326183|21026589|P2|Overall Study|Lost to Follow-up|56
6092204|NCT00326183|21026590|P1|Overall Study|Lost to Follow-up|104
6092205|NCT00326118|21026622|P2|Active Phase|Withdrawal by Subject|1
6092206|NCT00326118|21026623|P1|Active Phase|Withdrawal by Subject|4
6092207|NCT00326001|21026659|P2|Overall Study|Physician Decision|3
6092208|NCT00326001|21026660|P1|Overall Study|Physician Decision|3
6092209|NCT00326001|21026659|P2|Overall Study|Adverse Event|5
6092210|NCT00326001|21026660|P1|Overall Study|Adverse Event|4
6092211|NCT00325897|21026674|P2|Overall Study|Lost to Follow-up|13
6092212|NCT00325897|21026675|P1|Overall Study|Lost to Follow-up|12
6092213|NCT00325819|21026695|P2|Overall Study|Lost to Follow-up|3
6092214|NCT00325819|21026696|P1|Overall Study|Lost to Follow-up|3
6092215|NCT00325819|21026695|P2|Overall Study|Did not take a dose of study product|9
6092216|NCT00325819|21026696|P1|Overall Study|Did not take a dose of study product|4
6092217|NCT00325819|21026695|P2|Overall Study|Study product lost in mail|1
6092218|NCT00325819|21026696|P1|Overall Study|Study product lost in mail|2
6092219|NCT00325754|21026723|P2|Overall Study|Adverse Event|1
6092220|NCT00325754|21026724|P1|Overall Study|Adverse Event|4
6092221|NCT00325468|21026779|P5|Overall Study|site closure etc|1
6092222|NCT00325468|21026780|P4|Overall Study|site closure etc|8
6092223|NCT00325468|21026781|P3|Overall Study|site closure etc|1
6092224|NCT00325468|21026782|P2|Overall Study|site closure etc|2
6092225|NCT00325468|21026783|P1|Overall Study|site closure etc|4
6092226|NCT00325468|21026779|P5|Overall Study|Withdrawal by Subject|4
6092227|NCT00325468|21026780|P4|Overall Study|Withdrawal by Subject|14
6092228|NCT00325468|21026781|P3|Overall Study|Withdrawal by Subject|0
6092229|NCT00325468|21026782|P2|Overall Study|Withdrawal by Subject|1
6092230|NCT00325468|21026783|P1|Overall Study|Withdrawal by Subject|3
6092231|NCT00325468|21026779|P5|Overall Study|Physician Decision|0
6092232|NCT00325468|21026780|P4|Overall Study|Physician Decision|1
6092233|NCT00325468|21026781|P3|Overall Study|Physician Decision|0
6092234|NCT00325468|21026782|P2|Overall Study|Physician Decision|1
6092235|NCT00325468|21026783|P1|Overall Study|Physician Decision|1
6092236|NCT00325468|21026779|P5|Overall Study|Lost to Follow-up|2
6092237|NCT00325468|21026780|P4|Overall Study|Lost to Follow-up|2
6092238|NCT00325468|21026781|P3|Overall Study|Lost to Follow-up|1
6092239|NCT00325468|21026782|P2|Overall Study|Lost to Follow-up|0
6092240|NCT00325468|21026783|P1|Overall Study|Lost to Follow-up|0
6092241|NCT00325468|21026779|P5|Overall Study|Death|0
6092242|NCT00325468|21026780|P4|Overall Study|Death|4
6092243|NCT00325468|21026781|P3|Overall Study|Death|2
6092244|NCT00325468|21026782|P2|Overall Study|Death|0
6092245|NCT00325468|21026783|P1|Overall Study|Death|2
6092246|NCT00325468|21026779|P5|Overall Study|Adverse Event|1
6092247|NCT00325468|21026780|P4|Overall Study|Adverse Event|5
6092248|NCT00325468|21026781|P3|Overall Study|Adverse Event|0
6092249|NCT00325468|21026782|P2|Overall Study|Adverse Event|1
6092250|NCT00325468|21026783|P1|Overall Study|Adverse Event|1
6092251|NCT00325416|21026866|P2|Phase II: Treatment at MTD|Withdrawal by Subject|1
6092252|NCT00325416|21026867|P1|Phase II: Treatment at MTD|Withdrawal by Subject|0
6092253|NCT00325416|21026866|P2|Phase II: Treatment at MTD|denial of insurance coverage|1
6092254|NCT00325416|21026867|P1|Phase II: Treatment at MTD|denial of insurance coverage|0
6092255|NCT00325416|21026866|P2|Phase I: Dose Escalation|Inability to collect adequate stem cells|1
6092256|NCT00325416|21026867|P1|Phase I: Dose Escalation|Inability to collect adequate stem cells|0
6092257|NCT00325416|21026866|P2|Phase I: Dose Escalation|Withdrawal by Subject|2
6092258|NCT00325416|21026867|P1|Phase I: Dose Escalation|Withdrawal by Subject|7
6092259|NCT00325416|21026866|P2|Phase I: Dose Escalation|Denial of insurance coverage|4
6092260|NCT00325416|21026867|P1|Phase I: Dose Escalation|Denial of insurance coverage|7
6092261|NCT00325416|21026866|P2|Phase I: Dose Escalation|Pre-transplant screen failure|9
6092262|NCT00325416|21026867|P1|Phase I: Dose Escalation|Pre-transplant screen failure|8
6092263|NCT00325234|21026920|P2|Overall Study|Progressive Disease|37
6092264|NCT00325234|21026921|P1|Overall Study|Progressive Disease|34
6092265|NCT00325234|21026920|P2|Overall Study|Physician Decision|12
6092266|NCT00325234|21026921|P1|Overall Study|Physician Decision|17
6092267|NCT00325234|21026920|P2|Overall Study|Subject Decision|8
6092268|NCT00325234|21026921|P1|Overall Study|Subject Decision|6
6092269|NCT00325234|21026920|P2|Overall Study|Entry Criteria Not Met|2
6092270|NCT00325234|21026921|P1|Overall Study|Entry Criteria Not Met|1
6092271|NCT00325234|21026920|P2|Overall Study|Death due to Study Disease|0
6092272|NCT00325234|21026921|P1|Overall Study|Death due to Study Disease|1
6092273|NCT00325234|21026920|P2|Overall Study|Adverse Event|7
6092274|NCT00325234|21026921|P1|Overall Study|Adverse Event|10
6092275|NCT00325195|21026940|P3|Received Intervention: ITT Population|Protocol violation/non-compliance|0
6092276|NCT00325195|21026941|P2|Received Intervention: ITT Population|Protocol violation/non-compliance|1
6092277|NCT00325195|21026942|P1|Received Intervention: ITT Population|Protocol violation/non-compliance|1
6092278|NCT00325195|21026940|P3|Received Intervention: ITT Population|Lost to Follow-up|2
6092279|NCT00325195|21026941|P2|Received Intervention: ITT Population|Lost to Follow-up|0
6092280|NCT00325195|21026942|P1|Received Intervention: ITT Population|Lost to Follow-up|0
6092281|NCT00325195|21026940|P3|Received Intervention: ITT Population|Withdrawal by Subject|1
6092282|NCT00325195|21026941|P2|Received Intervention: ITT Population|Withdrawal by Subject|6
6092283|NCT00325195|21026942|P1|Received Intervention: ITT Population|Withdrawal by Subject|7
6092284|NCT00325195|21026940|P3|Received Intervention: ITT Population|Death|0
6092285|NCT00325195|21026941|P2|Received Intervention: ITT Population|Death|1
6092286|NCT00325195|21026942|P1|Received Intervention: ITT Population|Death|3
6092287|NCT00325195|21026940|P3|Received Intervention: ITT Population|Adverse Event|1
6092288|NCT00325195|21026941|P2|Received Intervention: ITT Population|Adverse Event|17
6092289|NCT00325195|21026942|P1|Received Intervention: ITT Population|Adverse Event|15
6092290|NCT00325195|21026940|P3|Randomized|Not dosed|3
6092291|NCT00325195|21026941|P2|Randomized|Not dosed|5
6092292|NCT00325195|21026942|P1|Randomized|Not dosed|5
6092293|NCT00325156|21026965|P1|Overall Study|Withdrawal by Subject|31
6092294|NCT00325156|21026965|P1|Overall Study|Other|1
6092295|NCT00325156|21026965|P1|Overall Study|Lost to follow-up (incompl. vaccination)|16
6092296|NCT00325156|21026965|P1|Overall Study|Adverse event, non-fatal|3
6092297|NCT00325156|21026965|P1|Overall Study|Migrated/moved from study area|12
6092298|NCT00325156|21026965|P1|Overall Study|Lost to follow-up (complete vaccination)|41
6092299|NCT00325156|21026965|P1|Overall Study|Protocol Violation|8
6092300|NCT00325143|21026972|P1|Overall Study|Withdrawal by Subject|8
6092301|NCT00325143|21026972|P1|Overall Study|Lost to follow-up(incompl. vacc. course)|4
6092302|NCT00325143|21026972|P1|Overall Study|Migrated/moved from study area|1
6092303|NCT00325143|21026972|P1|Overall Study|Lost to follow-up(complete vacc. course)|13
6092304|NCT00325130|21026982|P2|Overall Study|Patient Discontinued for Other|0
6092305|NCT00325130|21026983|P1|Overall Study|Patient Discontinued for Other|1
6092306|NCT00325130|21026982|P2|Overall Study|Moved|1
6092307|NCT00325130|21026983|P1|Overall Study|Moved|0
6092308|NCT00325130|21026982|P2|Overall Study|Protocol Deviation|1
6092309|NCT00325130|21026983|P1|Overall Study|Protocol Deviation|0
6092310|NCT00325130|21026982|P2|Overall Study|Withdrawal by Subject|14
6092311|NCT00325130|21026983|P1|Overall Study|Withdrawal by Subject|12
6092312|NCT00325130|21026982|P2|Overall Study|Lost to Follow-up|14
6092313|NCT00325130|21026983|P1|Overall Study|Lost to Follow-up|6
6092314|NCT00325039|21027040|P2|Overall Study|Lost to Follow-up|14
6092315|NCT00325039|21027041|P1|Overall Study|Lost to Follow-up|18
6092316|NCT00324987|21027057|P2|Overall Study|symptomatic deterioration, toxicity, etc|3
6092317|NCT00324987|21027058|P1|Overall Study|symptomatic deterioration, toxicity, etc|2
6092318|NCT00324987|21027057|P2|Overall Study|Progression|1
6092319|NCT00324987|21027058|P1|Overall Study|Progression|1
6092320|NCT00324987|21027057|P2|Overall Study|Withdrawal by Subject|1
6092321|NCT00324987|21027058|P1|Overall Study|Withdrawal by Subject|1
6092322|NCT00324987|21027057|P2|Overall Study|Adverse Event|1
6092323|NCT00324987|21027058|P1|Overall Study|Adverse Event|2
6092324|NCT00324961|21027072|P1|Overall Study|Other|2
6092325|NCT00324961|21027072|P1|Overall Study|Protocol Violation|3
6092326|NCT00324961|21027072|P1|Overall Study|Lost to Follow-up|22
6092327|NCT00324961|21027072|P1|Overall Study|Consent Withdrawn|11
6092328|NCT00324961|21027072|P1|Overall Study|Adverse Event|5
6092329|NCT00324805|21027123|P2|Overall Study|Did not start therapy|17
6092330|NCT00324805|21027124|P1|Overall Study|Did not start therapy|12
6092331|NCT00324805|21027123|P2|Overall Study|Other|2
6092332|NCT00324805|21027124|P1|Overall Study|Other|0
6092333|NCT00324805|21027123|P2|Overall Study|Other reasons|26
6092334|NCT00324805|21027124|P1|Overall Study|Other reasons|7
6092335|NCT00324805|21027123|P2|Overall Study|Other complicating disease|9
6092336|NCT00324805|21027124|P1|Overall Study|Other complicating disease|1
6092337|NCT00324805|21027123|P2|Overall Study|Alternative therapy|8
6092338|NCT00324805|21027124|P1|Overall Study|Alternative therapy|4
6092339|NCT00324805|21027123|P2|Overall Study|Death|9
6092340|NCT00324805|21027124|P1|Overall Study|Death|6
6092341|NCT00324805|21027123|P2|Overall Study|Withdrawal by Subject|174
6092342|NCT00324805|21027124|P1|Overall Study|Withdrawal by Subject|51
6092343|NCT00324805|21027123|P2|Overall Study|Progression|35
6092344|NCT00324805|21027124|P1|Overall Study|Progression|7
6092345|NCT00324805|21027123|P2|Overall Study|Adverse Event|203
6092346|NCT00324805|21027124|P1|Overall Study|Adverse Event|62
6092350|NCT00324675|21027171|P2|Overall Study|Adverse Event|0
6092351|NCT00324675|21027172|P1|Overall Study|Adverse Event|1
6092352|NCT00324649|21027180|P2|Overall Study|Noncompliance|0
6092353|NCT00324649|21027181|P1|Overall Study|Noncompliance|1
6092354|NCT00324649|21027180|P2|Overall Study|Withdrawal by Subject|1
6092355|NCT00324649|21027181|P1|Overall Study|Withdrawal by Subject|0
6092356|NCT00324649|21027180|P2|Overall Study|Adverse Event|4
6092357|NCT00324649|21027181|P1|Overall Study|Adverse Event|1
6092358|NCT00324233|21027312|P2|Second Period|Protocol Violation|6
6092359|NCT00324233|21027313|P1|Second Period|Protocol Violation|4
6092360|NCT00324233|21027312|P2|Second Period|unable to insert catheter|1
6092361|NCT00324233|21027313|P1|Second Period|unable to insert catheter|1
6092362|NCT00324233|21027312|P2|First Period|unable to insert catheter|0
6092363|NCT00324233|21027313|P1|First Period|unable to insert catheter|1
6092364|NCT00324168|21027321|P2|Overall Study|Patient did not visit in f/u window|9
6092365|NCT00324168|21027322|P1|Overall Study|Patient did not visit in f/u window|6
6092366|NCT00324168|21027321|P2|Overall Study|Death|3
6092367|NCT00324168|21027322|P1|Overall Study|Death|3
6092368|NCT00324168|21027321|P2|Overall Study|Lost to Follow-up|18
6092369|NCT00324168|21027322|P1|Overall Study|Lost to Follow-up|19
6092370|NCT00324155|21027350|P2|Follow-up Phase|On-going participants still on drug|6
6092371|NCT00324155|21027351|P1|Follow-up Phase|On-going participants still on drug|11
6092372|NCT00324155|21027350|P2|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|0
6092373|NCT00324155|21027351|P1|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|1
6092374|NCT00324155|21027350|P2|Received Treatment in Maintenance Phase|Adverse Event|3
6092375|NCT00324155|21027351|P1|Received Treatment in Maintenance Phase|Adverse Event|0
6092376|NCT00324155|21027350|P2|Received Treatment in Maintenance Phase|Withdrawal by Subject|3
6092377|NCT00324155|21027351|P1|Received Treatment in Maintenance Phase|Withdrawal by Subject|1
6092378|NCT00324155|21027350|P2|Received Treatment in Maintenance Phase|Study Drug Toxicity|0
6092379|NCT00324155|21027351|P1|Received Treatment in Maintenance Phase|Study Drug Toxicity|4
6092380|NCT00324155|21027350|P2|Received Treatment in Maintenance Phase|Disease Progression|41
6092381|NCT00324155|21027351|P1|Received Treatment in Maintenance Phase|Disease Progression|26
6092382|NCT00324155|21027350|P2|Received Treatment in Induction Phase|Physician Decision|0
6092383|NCT00324155|21027351|P1|Received Treatment in Induction Phase|Physician Decision|2
6092384|NCT00324155|21027350|P2|Received Treatment in Induction Phase|Withdrawal by Subject|5
6092385|NCT00324155|21027351|P1|Received Treatment in Induction Phase|Withdrawal by Subject|6
6092386|NCT00324155|21027350|P2|Received Treatment in Induction Phase|Adverse Event|7
6092387|NCT00324155|21027351|P1|Received Treatment in Induction Phase|Adverse Event|6
6092388|NCT00324155|21027350|P2|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|8
6092389|NCT00324155|21027351|P1|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|9
6092390|NCT00324155|21027350|P2|Received Treatment in Induction Phase|Death|15
6092391|NCT00324155|21027351|P1|Received Treatment in Induction Phase|Death|8
6092392|NCT00324155|21027350|P2|Received Treatment in Induction Phase|Study Drug Toxicity|10
6092393|NCT00324155|21027351|P1|Received Treatment in Induction Phase|Study Drug Toxicity|83
6092394|NCT00324155|21027350|P2|Received Treatment in Induction Phase|Disease Progression|152
6092395|NCT00324155|21027351|P1|Received Treatment in Induction Phase|Disease Progression|88
6092396|NCT00324155|21027350|P2|Enrolled and Randomized|Lost to Follow-up|1
6092397|NCT00324155|21027351|P1|Enrolled and Randomized|Lost to Follow-up|0
6092398|NCT00324155|21027350|P2|Enrolled and Randomized|No longer met study criteria|0
6092399|NCT00324155|21027351|P1|Enrolled and Randomized|No longer met study criteria|3
6092400|NCT00324116|21027381|P1|Overall Study|Other|5
6092401|NCT00324116|21027381|P1|Overall Study|Withdrawal by Subject|5
6092402|NCT00324116|21027381|P1|Overall Study|Lack of Efficacy|17
6092403|NCT00324116|21027381|P1|Overall Study|Adverse Event|5
6092404|NCT00324038|21027393|P2|Overall Study|Other|13
6092405|NCT00324038|21027394|P1|Overall Study|Other|6
6092406|NCT00324038|21027393|P2|Overall Study|Lost to Follow-up|2
6092407|NCT00324038|21027394|P1|Overall Study|Lost to Follow-up|0
6092408|NCT00324038|21027393|P2|Overall Study|Lack of Efficacy|13
6092409|NCT00324038|21027394|P1|Overall Study|Lack of Efficacy|5
6092410|NCT00324038|21027393|P2|Overall Study|Adverse Event|23
6092411|NCT00324038|21027394|P1|Overall Study|Adverse Event|38
6092412|NCT00323882|21027405|P5|Overall Study|Other|1
6092413|NCT00323882|21027406|P4|Overall Study|Other|1
6092414|NCT00323882|21027407|P3|Overall Study|Other|0
6092415|NCT00323882|21027408|P2|Overall Study|Other|0
6092416|NCT00323882|21027409|P1|Overall Study|Other|0
6092417|NCT00323882|21027405|P5|Overall Study|Lost to Follow-up|1
6092418|NCT00323882|21027406|P4|Overall Study|Lost to Follow-up|0
6092419|NCT00323882|21027407|P3|Overall Study|Lost to Follow-up|1
6092420|NCT00323882|21027408|P2|Overall Study|Lost to Follow-up|0
6092421|NCT00323882|21027409|P1|Overall Study|Lost to Follow-up|0
6092422|NCT00323882|21027405|P5|Overall Study|Death|5
6092423|NCT00323882|21027406|P4|Overall Study|Death|0
6092424|NCT00323882|21027407|P3|Overall Study|Death|1
6092425|NCT00323882|21027408|P2|Overall Study|Death|1
6092426|NCT00323882|21027409|P1|Overall Study|Death|0
6092427|NCT00323882|21027405|P5|Overall Study|Disease Progression|22
6092428|NCT00323882|21027406|P4|Overall Study|Disease Progression|5
6092429|NCT00323882|21027407|P3|Overall Study|Disease Progression|10
6092430|NCT00323882|21027408|P2|Overall Study|Disease Progression|4
6092431|NCT00323882|21027409|P1|Overall Study|Disease Progression|6
6092432|NCT00323882|21027405|P5|Overall Study|Adverse Event|3
6092433|NCT00323882|21027406|P4|Overall Study|Adverse Event|1
6092434|NCT00323882|21027407|P3|Overall Study|Adverse Event|1
6092435|NCT00323882|21027408|P2|Overall Study|Adverse Event|1
6092436|NCT00323882|21027409|P1|Overall Study|Adverse Event|2
6092437|NCT00323869|21027480|P1|Overall Study|Death|1
6092438|NCT00323622|21027536|P8|Overall Study|Death|2
6092439|NCT00323622|21027537|P7|Overall Study|Death|0
6092440|NCT00323622|21027538|P6|Overall Study|Death|0
6092441|NCT00323622|21027539|P5|Overall Study|Death|7
6092442|NCT00323622|21027540|P4|Overall Study|Death|0
6092443|NCT00323622|21027541|P3|Overall Study|Death|0
6092444|NCT00323622|21027542|P2|Overall Study|Death|1
6092445|NCT00323622|21027543|P1|Overall Study|Death|1
6092446|NCT00323622|21027536|P8|Overall Study|Other|13
6092447|NCT00323622|21027537|P7|Overall Study|Other|5
6092448|NCT00323622|21027538|P6|Overall Study|Other|74
6092449|NCT00323622|21027539|P5|Overall Study|Other|32
6092450|NCT00323622|21027540|P4|Overall Study|Other|12
6092451|NCT00323622|21027541|P3|Overall Study|Other|4
6092452|NCT00323622|21027542|P2|Overall Study|Other|91
6092453|NCT00323622|21027543|P1|Overall Study|Other|30
6092454|NCT00323609|21027585|P4|Overall Study|Other reason|9
6092455|NCT00323609|21027586|P3|Overall Study|Other reason|4
6092456|NCT00323609|21027587|P2|Overall Study|Other reason|8
6092457|NCT00323609|21027588|P1|Overall Study|Other reason|11
6092458|NCT00323609|21027585|P4|Overall Study|Logistical withdrawal|1
6092459|NCT00323609|21027586|P3|Overall Study|Logistical withdrawal|0
6092460|NCT00323609|21027587|P2|Overall Study|Logistical withdrawal|5
6092461|NCT00323609|21027588|P1|Overall Study|Logistical withdrawal|9
6092462|NCT00323609|21027585|P4|Overall Study|Unrelenting or severe back pain|0
6092463|NCT00323609|21027586|P3|Overall Study|Unrelenting or severe back pain|0
6092464|NCT00323609|21027587|P2|Overall Study|Unrelenting or severe back pain|1
6092465|NCT00323609|21027588|P1|Overall Study|Unrelenting or severe back pain|1
6092466|NCT00323609|21027585|P4|Overall Study|Sponsor discontinued trial|0
6092467|NCT00323609|21027586|P3|Overall Study|Sponsor discontinued trial|0
6092468|NCT00323609|21027587|P2|Overall Study|Sponsor discontinued trial|29
6092469|NCT00323609|21027588|P1|Overall Study|Sponsor discontinued trial|29
6092470|NCT00323609|21027585|P4|Overall Study|Other non-VCF-related medical condition|0
6092471|NCT00323609|21027586|P3|Overall Study|Other non-VCF-related medical condition|0
6092472|NCT00323609|21027587|P2|Overall Study|Other non-VCF-related medical condition|2
6092473|NCT00323609|21027588|P1|Overall Study|Other non-VCF-related medical condition|3
6092474|NCT00323609|21027585|P4|Overall Study|Withdrawal by Subject|4
6092475|NCT00323609|21027586|P3|Overall Study|Withdrawal by Subject|4
6092476|NCT00323609|21027587|P2|Overall Study|Withdrawal by Subject|23
6092477|NCT00323609|21027588|P1|Overall Study|Withdrawal by Subject|11
6092478|NCT00323609|21027585|P4|Overall Study|Physician Decision|1
6092479|NCT00323609|21027586|P3|Overall Study|Physician Decision|0
6092480|NCT00323609|21027587|P2|Overall Study|Physician Decision|0
6092481|NCT00323609|21027588|P1|Overall Study|Physician Decision|2
6092482|NCT00323609|21027585|P4|Overall Study|Lost to Follow-up|0
6092483|NCT00323609|21027586|P3|Overall Study|Lost to Follow-up|0
6092484|NCT00323609|21027587|P2|Overall Study|Lost to Follow-up|10
6092485|NCT00323609|21027588|P1|Overall Study|Lost to Follow-up|9
6092486|NCT00323609|21027585|P4|Overall Study|Death|0
6092487|NCT00323609|21027586|P3|Overall Study|Death|0
6092488|NCT00323609|21027587|P2|Overall Study|Death|21
6092489|NCT00323609|21027588|P1|Overall Study|Death|16
6092490|NCT00323557|21027624|P2|Overall Study|Physician Decision|0
6092491|NCT00323557|21027625|P1|Overall Study|Physician Decision|1
6092492|NCT00323492|21027634|P3|Study Phase 2|Protocol Violation|0
6092493|NCT00323492|21027635|P2|Study Phase 2|Protocol Violation|0
6092494|NCT00323492|21027636|P1|Study Phase 2|Protocol Violation|1
6092495|NCT00323492|21027634|P3|Study Phase 2|Noncompliance with study schedule|1
6092496|NCT00323492|21027635|P2|Study Phase 2|Noncompliance with study schedule|0
6092497|NCT00323492|21027636|P1|Study Phase 2|Noncompliance with study schedule|0
6092498|NCT00323492|21027634|P3|Study Phase 2|Withdrawal by Subject|0
6092499|NCT00323492|21027635|P2|Study Phase 2|Withdrawal by Subject|1
6092500|NCT00323492|21027636|P1|Study Phase 2|Withdrawal by Subject|0
6092501|NCT00323492|21027634|P3|Study Phase 2|Lost to Follow-up|0
6092502|NCT00323492|21027635|P2|Study Phase 2|Lost to Follow-up|0
6092503|NCT00323492|21027636|P1|Study Phase 2|Lost to Follow-up|1
6092504|NCT00323492|21027634|P3|Study Phase 2|Physician Decision|0
6092505|NCT00323492|21027635|P2|Study Phase 2|Physician Decision|0
6092506|NCT00323492|21027636|P1|Study Phase 2|Physician Decision|1
6092507|NCT00323492|21027634|P3|Study Phase 2|Adverse Event|0
6092508|NCT00323492|21027635|P2|Study Phase 2|Adverse Event|0
6092509|NCT00323492|21027636|P1|Study Phase 2|Adverse Event|1
6092510|NCT00323492|21027634|P3|Study Phase 1|Adverse Event|0
6092511|NCT00323492|21027635|P2|Study Phase 1|Adverse Event|0
6092512|NCT00323492|21027636|P1|Study Phase 1|Adverse Event|2
6092513|NCT00323479|21027667|P1|Overall Study|house moving|1
6092514|NCT00323479|21027667|P1|Overall Study|Protocol Violation|3
6092515|NCT00323479|21027667|P1|Overall Study|Withdrawal by Subject|2
6092516|NCT00323479|21027667|P1|Overall Study|Adverse Event|2
6092517|NCT00323414|21027700|P2|Overall Study|Withdrawal by Subject|1
6092518|NCT00323414|21027701|P1|Overall Study|Withdrawal by Subject|0
6092519|NCT00323310|21027723|P1|Overall Study|did not complete the 24-hr f-up visit|1
6092520|NCT00323310|21027723|P1|Overall Study|a parent refused blood draw|1
6092521|NCT00323310|21027723|P1|Overall Study|Withdrawal by Subject|1
6092546|NCT00323258|21027779|P2|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|2
6092547|NCT00323258|21027780|P1|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|1
6092548|NCT00323258|21027779|P2|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|10
6092549|NCT00323258|21027780|P1|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|12
6092550|NCT00323258|21027779|P2|Secondary Outcome (6 Mon Refill Records)|Death|2
6092551|NCT00323258|21027780|P1|Secondary Outcome (6 Mon Refill Records)|Death|1
6092552|NCT00323258|21027779|P2|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|1
6092553|NCT00323258|21027780|P1|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|2
6092554|NCT00323258|21027779|P2|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|5
6092555|NCT00323258|21027780|P1|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|1
6092556|NCT00323258|21027779|P2|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|11
6092557|NCT00323258|21027780|P1|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|12
6092558|NCT00323258|21027779|P2|Primary Outcome (Phone Call at 6 Months)|Death|2
6092559|NCT00323258|21027780|P1|Primary Outcome (Phone Call at 6 Months)|Death|1
6092560|NCT00323115|21027805|P1|Adjuvant Therapy & Survival Follow-Up|Death|8
6092561|NCT00323115|21027805|P1|Vaccine Administration|Adverse Event|1
6092562|NCT00323063|21027832|P2|Overall Study|brain mets discovered prior to treatment|0
6092563|NCT00323063|21027833|P1|Overall Study|brain mets discovered prior to treatment|1
6092564|NCT00323063|21027832|P2|Overall Study|Adverse Event|0
6092565|NCT00323063|21027833|P1|Overall Study|Adverse Event|1
6092566|NCT00322881|21027850|P1|Overall Study|Disease Progression|2
6092567|NCT00322881|21027850|P1|Overall Study|Adverse Event|1
6092568|NCT00322881|21027850|P1|Overall Study|Death|2
6092569|NCT00322868|21027854|P1|Overall Study|disease progression|1
6092570|NCT00322842|21027879|P2|Overall Study|Death|0
6092571|NCT00322842|21027880|P1|Overall Study|Death|1
6092572|NCT00322842|21027879|P2|Overall Study|Refused transplant|0
6092573|NCT00322842|21027880|P1|Overall Study|Refused transplant|1
6092574|NCT00322842|21027879|P2|Overall Study|Lost to Follow-up|1
6092575|NCT00322842|21027880|P1|Overall Study|Lost to Follow-up|0
6092576|NCT00322842|21027879|P2|Overall Study|Withdrawal by Subject|1
6092577|NCT00322842|21027880|P1|Overall Study|Withdrawal by Subject|0
6092578|NCT00322712|21027918|P1|Overall Study|treated with bevacizumab not cetuximab|1
6092579|NCT00322621|21027922|P3|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1
6092580|NCT00322621|21027923|P2|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1
6092581|NCT00322621|21027924|P1|Period III - Maintenance / Rescue Phase|Lost to Follow-up|0
6092582|NCT00322621|21027922|P3|Period III - Maintenance / Rescue Phase|Death|0
6092583|NCT00322621|21027923|P2|Period III - Maintenance / Rescue Phase|Death|1
6092584|NCT00322621|21027924|P1|Period III - Maintenance / Rescue Phase|Death|0
6092585|NCT00322621|21027922|P3|Period III - Maintenance / Rescue Phase|Protocol Violation|5
6092586|NCT00322621|21027923|P2|Period III - Maintenance / Rescue Phase|Protocol Violation|2
6092587|NCT00322621|21027924|P1|Period III - Maintenance / Rescue Phase|Protocol Violation|0
6092588|NCT00322621|21027922|P3|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|1
6092589|NCT00322621|21027923|P2|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|7
6092590|NCT00322621|21027924|P1|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|0
6092591|NCT00322621|21027922|P3|Period III - Maintenance / Rescue Phase|Lack of Efficacy|24
6092592|NCT00322621|21027923|P2|Period III - Maintenance / Rescue Phase|Lack of Efficacy|4
6092593|NCT00322621|21027924|P1|Period III - Maintenance / Rescue Phase|Lack of Efficacy|0
6092594|NCT00322621|21027922|P3|Period III - Maintenance / Rescue Phase|Adverse Event|5
6092595|NCT00322621|21027923|P2|Period III - Maintenance / Rescue Phase|Adverse Event|14
6092596|NCT00322621|21027924|P1|Period III - Maintenance / Rescue Phase|Adverse Event|0
6092597|NCT00322621|21027922|P3|Period II - Acute Therapy Phase|Physician Decision|0
6092598|NCT00322621|21027923|P2|Period II - Acute Therapy Phase|Physician Decision|0
6092599|NCT00322621|21027924|P1|Period II - Acute Therapy Phase|Physician Decision|1
6092600|NCT00322621|21027922|P3|Period II - Acute Therapy Phase|Protocol Violation|0
6092601|NCT00322621|21027923|P2|Period II - Acute Therapy Phase|Protocol Violation|0
6092602|NCT00322621|21027924|P1|Period II - Acute Therapy Phase|Protocol Violation|2
6092603|NCT00322621|21027922|P3|Period II - Acute Therapy Phase|Withdrawal by Subject|0
6092604|NCT00322621|21027923|P2|Period II - Acute Therapy Phase|Withdrawal by Subject|0
6092605|NCT00322621|21027924|P1|Period II - Acute Therapy Phase|Withdrawal by Subject|8
6092606|NCT00322621|21027922|P3|Period II - Acute Therapy Phase|Lack of Efficacy|0
6092607|NCT00322621|21027923|P2|Period II - Acute Therapy Phase|Lack of Efficacy|0
6092608|NCT00322621|21027924|P1|Period II - Acute Therapy Phase|Lack of Efficacy|1
6092609|NCT00322621|21027922|P3|Period II - Acute Therapy Phase|Adverse Event|0
6092610|NCT00322621|21027923|P2|Period II - Acute Therapy Phase|Adverse Event|0
6092611|NCT00322621|21027924|P1|Period II - Acute Therapy Phase|Adverse Event|20
6092612|NCT00322556|21027976|P1|Overall Study|Other Reason|7
6092613|NCT00322556|21027976|P1|Overall Study|Lost to Follow-up|3
6092614|NCT00322556|21027976|P1|Overall Study|Withdrawal by Subject|1
6092615|NCT00322556|21027976|P1|Overall Study|Adverse Event|1
6092616|NCT00322491|21027992|P2|Overall Study|Death|2
6092617|NCT00322491|21027993|P1|Overall Study|Death|1
6092618|NCT00322491|21027992|P2|Overall Study|Adverse Event|0
6092619|NCT00322491|21027993|P1|Overall Study|Adverse Event|1
6092620|NCT00322452|21028083|P2|Overall Study|Death|227
6092621|NCT00322452|21028084|P1|Overall Study|Death|223
6092622|NCT00322452|21028083|P2|Overall Study|Withdrawal by Subject|46
6092623|NCT00322452|21028084|P1|Overall Study|Withdrawal by Subject|19
6092624|NCT00322452|21028083|P2|Overall Study|Lost to Follow-up|2
6092625|NCT00322452|21028084|P1|Overall Study|Lost to Follow-up|5
6092626|NCT00322452|21028083|P2|Overall Study|Eligibility criteria not fulfilled|1
6092627|NCT00322452|21028084|P1|Overall Study|Eligibility criteria not fulfilled|0
6092628|NCT00322387|21028135|P2|Follow-up Period|Death|0
6092629|NCT00322387|21028136|P1|Follow-up Period|Death|1
6092630|NCT00322387|21028135|P2|Follow-up Period|Final assessment not done|3
6092631|NCT00322387|21028136|P1|Follow-up Period|Final assessment not done|1
6092632|NCT00322387|21028135|P2|Treatment Period|Adverse Event|1
6092633|NCT00322387|21028136|P1|Treatment Period|Adverse Event|0
6092634|NCT00322374|21028170|P4|Second Escalation|Study Drug Toxicity|0
6092635|NCT00322374|21028171|P3|Second Escalation|Study Drug Toxicity|1
6092636|NCT00322374|21028172|P2|Second Escalation|Study Drug Toxicity|0
6092637|NCT00322374|21028173|P1|Second Escalation|Study Drug Toxicity|0
6092638|NCT00322374|21028170|P4|Second Escalation|Physician Decision|0
6092639|NCT00322374|21028171|P3|Second Escalation|Physician Decision|5
6092640|NCT00322374|21028172|P2|Second Escalation|Physician Decision|0
6092641|NCT00322374|21028173|P1|Second Escalation|Physician Decision|0
6092642|NCT00322374|21028170|P4|First Escalation|Participant Request|0
6092643|NCT00322374|21028171|P3|First Escalation|Participant Request|0
6092644|NCT00322374|21028172|P2|First Escalation|Participant Request|1
6092645|NCT00322374|21028173|P1|First Escalation|Participant Request|0
6092646|NCT00322374|21028170|P4|First Escalation|Study Drug Toxicity|0
6092647|NCT00322374|21028171|P3|First Escalation|Study Drug Toxicity|0
6092648|NCT00322374|21028172|P2|First Escalation|Study Drug Toxicity|11
6092649|NCT00322374|21028173|P1|First Escalation|Study Drug Toxicity|0
6092650|NCT00322374|21028170|P4|First Escalation|Physician Decision|0
6092651|NCT00322374|21028171|P3|First Escalation|Physician Decision|0
6092652|NCT00322374|21028172|P2|First Escalation|Physician Decision|12
6092653|NCT00322374|21028173|P1|First Escalation|Physician Decision|0
6092654|NCT00322374|21028170|P4|First Escalation|Documented Disease Progression|0
6092655|NCT00322374|21028171|P3|First Escalation|Documented Disease Progression|0
6092656|NCT00322374|21028172|P2|First Escalation|Documented Disease Progression|6
6092657|NCT00322374|21028173|P1|First Escalation|Documented Disease Progression|0
6092658|NCT00322374|21028170|P4|Starting Dose|Study Drug Toxicity|0
6092659|NCT00322374|21028171|P3|Starting Dose|Study Drug Toxicity|0
6092660|NCT00322374|21028172|P2|Starting Dose|Study Drug Toxicity|0
6092661|NCT00322374|21028173|P1|Starting Dose|Study Drug Toxicity|4
6092662|NCT00322374|21028170|P4|Starting Dose|Physician Decision|0
6092663|NCT00322374|21028171|P3|Starting Dose|Physician Decision|0
6092664|NCT00322374|21028172|P2|Starting Dose|Physician Decision|0
6092665|NCT00322374|21028173|P1|Starting Dose|Physician Decision|2
6092666|NCT00322348|21028223|P2|Overall Study|Reasons not specified|1
6092667|NCT00322348|21028224|P1|Overall Study|Reasons not specified|5
6092668|NCT00322348|21028223|P2|Overall Study|Disease Progression|25
6092669|NCT00322348|21028224|P1|Overall Study|Disease Progression|30
6092670|NCT00322348|21028223|P2|Overall Study|Death|2
6092671|NCT00322348|21028224|P1|Overall Study|Death|0
6092672|NCT00322348|21028223|P2|Overall Study|Lost to Follow-up|0
6092673|NCT00322348|21028224|P1|Overall Study|Lost to Follow-up|1
6092674|NCT00322348|21028223|P2|Overall Study|Withdrawal by Subject|4
6092675|NCT00322348|21028224|P1|Overall Study|Withdrawal by Subject|1
6092676|NCT00322348|21028223|P2|Overall Study|Adverse Event|1
6092677|NCT00322348|21028224|P1|Overall Study|Adverse Event|0
6092678|NCT00322153|21028315|P2|Overall Study|Withdrawn for other reasons|4
6092679|NCT00322153|21028316|P1|Overall Study|Withdrawn for other reasons|5
6092680|NCT00322153|21028315|P2|Overall Study|Lost to Follow-up|4
6092681|NCT00322153|21028316|P1|Overall Study|Lost to Follow-up|5
6092682|NCT00322153|21028315|P2|Overall Study|Lack of Efficacy|3
6092683|NCT00322153|21028316|P1|Overall Study|Lack of Efficacy|8
6092684|NCT00322153|21028315|P2|Overall Study|Withdrawal by Subject|10
6092685|NCT00322153|21028316|P1|Overall Study|Withdrawal by Subject|18
6092686|NCT00322153|21028315|P2|Overall Study|Protocol Violation|14
6092687|NCT00322153|21028316|P1|Overall Study|Protocol Violation|6
6092688|NCT00322153|21028315|P2|Overall Study|Adverse Event|34
6092689|NCT00322153|21028316|P1|Overall Study|Adverse Event|21
6092690|NCT00322049|21028349|P4|Overall Study|Infected with Dengue during study|0
6092691|NCT00322049|21028350|P3|Overall Study|Infected with Dengue during study|0
6092692|NCT00322049|21028351|P2|Overall Study|Infected with Dengue during study|1
6092693|NCT00322049|21028352|P1|Overall Study|Infected with Dengue during study|0
6092694|NCT00322049|21028349|P4|Overall Study|Moved out of area|1
6092695|NCT00322049|21028350|P3|Overall Study|Moved out of area|0
6092696|NCT00322049|21028351|P2|Overall Study|Moved out of area|0
6092697|NCT00322049|21028352|P1|Overall Study|Moved out of area|0
6092698|NCT00322023|21028385|P3|Overall Study|various|6
6092699|NCT00322023|21028386|P2|Overall Study|various|2
6092700|NCT00322023|21028387|P1|Overall Study|various|0
6092701|NCT00321984|21028404|P3|Overall Study|Per Sponsor Due to High Baseline Gastrin|0
6092702|NCT00321984|21028405|P2|Overall Study|Per Sponsor Due to High Baseline Gastrin|1
6092703|NCT00321984|21028406|P1|Overall Study|Per Sponsor Due to High Baseline Gastrin|0
6092704|NCT00321984|21028404|P3|Overall Study|Per Investigator Request|0
6092705|NCT00321984|21028405|P2|Overall Study|Per Investigator Request|0
6092706|NCT00321984|21028406|P1|Overall Study|Per Investigator Request|1
6092707|NCT00321984|21028404|P3|Overall Study|Per Subject Request|0
6092708|NCT00321984|21028405|P2|Overall Study|Per Subject Request|0
6092709|NCT00321984|21028406|P1|Overall Study|Per Subject Request|1
6092710|NCT00321984|21028404|P3|Overall Study|Pregnancy|0
6092711|NCT00321984|21028405|P2|Overall Study|Pregnancy|1
6092712|NCT00321984|21028406|P1|Overall Study|Pregnancy|0
6092713|NCT00321984|21028404|P3|Overall Study|Noncompliant|2
6092714|NCT00321984|21028405|P2|Overall Study|Noncompliant|0
6092715|NCT00321984|21028406|P1|Overall Study|Noncompliant|0
6092716|NCT00321984|21028404|P3|Overall Study|Lack of Efficacy|3
6092717|NCT00321984|21028405|P2|Overall Study|Lack of Efficacy|1
6092718|NCT00321984|21028406|P1|Overall Study|Lack of Efficacy|3
6092719|NCT00321984|21028404|P3|Overall Study|Unmet Inclusion/Exclusion Criteria|5
6092720|NCT00321984|21028405|P2|Overall Study|Unmet Inclusion/Exclusion Criteria|1
6092721|NCT00321984|21028406|P1|Overall Study|Unmet Inclusion/Exclusion Criteria|3
6092722|NCT00321984|21028404|P3|Overall Study|Withdrawal by Subject|5
6092723|NCT00321984|21028405|P2|Overall Study|Withdrawal by Subject|6
6092724|NCT00321984|21028406|P1|Overall Study|Withdrawal by Subject|8
6092725|NCT00321984|21028404|P3|Overall Study|Lost to Follow-up|2
6092726|NCT00321984|21028405|P2|Overall Study|Lost to Follow-up|4
6092727|NCT00321984|21028406|P1|Overall Study|Lost to Follow-up|2
6092728|NCT00321984|21028404|P3|Overall Study|Protocol Violation|1
6092729|NCT00321984|21028405|P2|Overall Study|Protocol Violation|1
6092730|NCT00321984|21028406|P1|Overall Study|Protocol Violation|0
6092731|NCT00321984|21028404|P3|Overall Study|Adverse Event|8
6092732|NCT00321984|21028405|P2|Overall Study|Adverse Event|6
6092733|NCT00321984|21028406|P1|Overall Study|Adverse Event|9
6092734|NCT00321932|21028434|P2|Overall Study|Missing data|1
6092735|NCT00321932|21028435|P1|Overall Study|Missing data|2
6092736|NCT00321932|21028434|P2|Overall Study|Early relapse|8
6092737|NCT00321932|21028435|P1|Overall Study|Early relapse|2
6092738|NCT00321932|21028434|P2|Overall Study|Withdrawal by Subject|6
6092739|NCT00321932|21028435|P1|Overall Study|Withdrawal by Subject|3
6092740|NCT00321932|21028434|P2|Overall Study|Death|6
6092741|NCT00321932|21028435|P1|Overall Study|Death|3
6092742|NCT00321919|21028459|P2|Overall Study|Other withdrawal reason|6
6092743|NCT00321919|21028460|P1|Overall Study|Other withdrawal reason|7
6092744|NCT00321919|21028459|P2|Overall Study|Failure to Return|1
6092745|NCT00321919|21028460|P1|Overall Study|Failure to Return|3
6092746|NCT00321919|21028459|P2|Overall Study|Other Protocol Violation|3
6092747|NCT00321919|21028460|P1|Overall Study|Other Protocol Violation|2
6092748|NCT00321919|21028459|P2|Overall Study|Refused Treatment|14
6092749|NCT00321919|21028460|P1|Overall Study|Refused Treatment|23
6092750|NCT00321919|21028459|P2|Overall Study|Violation of Selection Criteria at Entry|1
6092751|NCT00321919|21028460|P1|Overall Study|Violation of Selection Criteria at Entry|1
6092752|NCT00321919|21028459|P2|Overall Study|Insufficient Therapeutic Response|0
6092753|NCT00321919|21028460|P1|Overall Study|Insufficient Therapeutic Response|1
6092754|NCT00321919|21028459|P2|Overall Study|Death|17
6092755|NCT00321919|21028460|P1|Overall Study|Death|21
6092756|NCT00321919|21028459|P2|Overall Study|Adverse Event|10
6092757|NCT00321919|21028460|P1|Overall Study|Adverse Event|17
6092758|NCT00321906|21028502|P2|Overall Study|Withdrawal by Subject|4
6092759|NCT00321906|21028503|P1|Overall Study|Withdrawal by Subject|0
6092760|NCT00321906|21028502|P2|Overall Study|Lost to Follow-up|2
6092761|NCT00321906|21028503|P1|Overall Study|Lost to Follow-up|1
6092762|NCT00321906|21028502|P2|Overall Study|Death|6
6092763|NCT00321906|21028503|P1|Overall Study|Death|9
6092764|NCT00321906|21028502|P2|Overall Study|Adverse Event|44
6092765|NCT00321906|21028503|P1|Overall Study|Adverse Event|36
6092766|NCT00321893|21028525|P2|Overall Study|Adverse Event|3
6092767|NCT00321893|21028526|P1|Overall Study|Adverse Event|6
6092768|NCT00321893|21028525|P2|Overall Study|Lost to Follow-up|1
6092769|NCT00321893|21028526|P1|Overall Study|Lost to Follow-up|2
6092770|NCT00321893|21028525|P2|Overall Study|Non-Compliance/Refusal|10
6092771|NCT00321893|21028526|P1|Overall Study|Non-Compliance/Refusal|16
6092772|NCT00321854|21028540|P2|Overall Study|Other|1
6092773|NCT00321854|21028541|P1|Overall Study|Other|1
6092774|NCT00321854|21028540|P2|Overall Study|Withdrawal by Subject|17
6092775|NCT00321854|21028541|P1|Overall Study|Withdrawal by Subject|6
6092776|NCT00321854|21028540|P2|Overall Study|Lost to Follow-up|2
6092777|NCT00321854|21028541|P1|Overall Study|Lost to Follow-up|0
6092778|NCT00321854|21028540|P2|Overall Study|Protocol Violation|5
6092779|NCT00321854|21028541|P1|Overall Study|Protocol Violation|6
6092780|NCT00321854|21028540|P2|Overall Study|Lack of Efficacy|14
6092781|NCT00321854|21028541|P1|Overall Study|Lack of Efficacy|9
6092782|NCT00321854|21028540|P2|Overall Study|Adverse Event|43
6092783|NCT00321854|21028541|P1|Overall Study|Adverse Event|41
6092784|NCT00321828|21028659|P1|Overall Study|No follow up data|1
6092785|NCT00321828|21028659|P1|Overall Study|Ineligible|3
6092786|NCT00321789|21028665|P2|Overall Study|Protocol Violation|3
6092787|NCT00321789|21028666|P1|Overall Study|Protocol Violation|5
6092788|NCT00321789|21028665|P2|Overall Study|Withdrawal by Subject|6
6092789|NCT00321789|21028666|P1|Overall Study|Withdrawal by Subject|6
6092790|NCT00321789|21028665|P2|Overall Study|Lost to Follow-up|7
6092791|NCT00321789|21028666|P1|Overall Study|Lost to Follow-up|4
6092792|NCT00321763|21028698|P4|Overall Study|Lost to Follow-up|4
6092793|NCT00321763|21028699|P3|Overall Study|Lost to Follow-up|5
6092794|NCT00321763|21028700|P2|Overall Study|Lost to Follow-up|1
6092795|NCT00321763|21028701|P1|Overall Study|Lost to Follow-up|3
6092796|NCT00321763|21028698|P4|Overall Study|Withdrawal by Subject|0
6092797|NCT00321763|21028699|P3|Overall Study|Withdrawal by Subject|1
6092798|NCT00321763|21028700|P2|Overall Study|Withdrawal by Subject|0
6092799|NCT00321763|21028701|P1|Overall Study|Withdrawal by Subject|2
6092800|NCT00321763|21028698|P4|Overall Study|Adverse Event|1
6092801|NCT00321763|21028699|P3|Overall Study|Adverse Event|0
6092802|NCT00321763|21028700|P2|Overall Study|Adverse Event|1
6092803|NCT00321763|21028701|P1|Overall Study|Adverse Event|1
6092804|NCT00321737|21028761|P3|Overall Study|Subject Request/ Subject Unavailable|2
6092805|NCT00321737|21028762|P2|Overall Study|Subject Request/ Subject Unavailable|0
6092806|NCT00321737|21028763|P1|Overall Study|Subject Request/ Subject Unavailable|0
6092807|NCT00321737|21028761|P3|Overall Study|Noncompliance|0
6092808|NCT00321737|21028762|P2|Overall Study|Noncompliance|0
6092809|NCT00321737|21028763|P1|Overall Study|Noncompliance|2
6092810|NCT00321737|21028761|P3|Overall Study|Pregnancy|0
6092811|NCT00321737|21028762|P2|Overall Study|Pregnancy|2
6092812|NCT00321737|21028763|P1|Overall Study|Pregnancy|0
6092813|NCT00321737|21028761|P3|Overall Study|Therapeutic Failure|2
6092814|NCT00321737|21028762|P2|Overall Study|Therapeutic Failure|0
6092815|NCT00321737|21028763|P1|Overall Study|Therapeutic Failure|6
6092816|NCT00321737|21028761|P3|Overall Study|Possible Barrett's Esophagus|1
6092817|NCT00321737|21028762|P2|Overall Study|Possible Barrett's Esophagus|1
6092818|NCT00321737|21028763|P1|Overall Study|Possible Barrett's Esophagus|2
6092819|NCT00321737|21028761|P3|Overall Study|Unmet Inclusion/Exclusion Criteria|0
6092820|NCT00321737|21028762|P2|Overall Study|Unmet Inclusion/Exclusion Criteria|0
6092821|NCT00321737|21028763|P1|Overall Study|Unmet Inclusion/Exclusion Criteria|1
6092822|NCT00321737|21028761|P3|Overall Study|Protocol Violation|1
6092823|NCT00321737|21028762|P2|Overall Study|Protocol Violation|0
6092824|NCT00321737|21028763|P1|Overall Study|Protocol Violation|0
6092825|NCT00321737|21028761|P3|Overall Study|Withdrawal by Subject|17
6092826|NCT00321737|21028762|P2|Overall Study|Withdrawal by Subject|12
6092827|NCT00321737|21028763|P1|Overall Study|Withdrawal by Subject|19
6092828|NCT00321737|21028761|P3|Overall Study|Lost to Follow-up|6
6092829|NCT00321737|21028762|P2|Overall Study|Lost to Follow-up|5
6092830|NCT00321737|21028763|P1|Overall Study|Lost to Follow-up|5
6092831|NCT00321737|21028761|P3|Overall Study|Adverse Event|6
6092832|NCT00321737|21028762|P2|Overall Study|Adverse Event|3
6092833|NCT00321737|21028763|P1|Overall Study|Adverse Event|11
6092834|NCT00321737|21028761|P3|Overall Study|Relapse of Erosive Esophagitis|19
6092835|NCT00321737|21028762|P2|Overall Study|Relapse of Erosive Esophagitis|25
6092836|NCT00321737|21028763|P1|Overall Study|Relapse of Erosive Esophagitis|76
6092837|NCT00321711|21028791|P5|Part B|Death|1
6092838|NCT00321711|21028792|P4|Part B|Death|2
6092839|NCT00321711|21028793|P3|Part B|Death|0
6092840|NCT00321711|21028794|P2|Part B|Death|0
6092841|NCT00321711|21028795|P1|Part B|Death|0
6092842|NCT00321711|21028791|P5|Part B|Physician Decision|2
6092843|NCT00321711|21028792|P4|Part B|Physician Decision|1
6092844|NCT00321711|21028793|P3|Part B|Physician Decision|0
6092845|NCT00321711|21028794|P2|Part B|Physician Decision|0
6092846|NCT00321711|21028795|P1|Part B|Physician Decision|0
6092847|NCT00321711|21028791|P5|Part B|Disease progression|0
6092848|NCT00321711|21028792|P4|Part B|Disease progression|1
6092849|NCT00321711|21028793|P3|Part B|Disease progression|0
6092850|NCT00321711|21028794|P2|Part B|Disease progression|0
6092851|NCT00321711|21028795|P1|Part B|Disease progression|0
6092852|NCT00321711|21028791|P5|Part B|Adverse Event|1
6092853|NCT00321711|21028792|P4|Part B|Adverse Event|2
6092854|NCT00321711|21028793|P3|Part B|Adverse Event|0
6092855|NCT00321711|21028794|P2|Part B|Adverse Event|0
6092856|NCT00321711|21028795|P1|Part B|Adverse Event|0
6092857|NCT00321711|21028791|P5|Part B|Noncompliance|1
6092858|NCT00321711|21028792|P4|Part B|Noncompliance|0
6092859|NCT00321711|21028793|P3|Part B|Noncompliance|0
6092860|NCT00321711|21028794|P2|Part B|Noncompliance|0
6092861|NCT00321711|21028795|P1|Part B|Noncompliance|0
6092862|NCT00321711|21028791|P5|Part A|Protocol deviation|0
6092863|NCT00321711|21028792|P4|Part A|Protocol deviation|0
6092864|NCT00321711|21028793|P3|Part A|Protocol deviation|1
6092865|NCT00321711|21028794|P2|Part A|Protocol deviation|0
6092866|NCT00321711|21028795|P1|Part A|Protocol deviation|0
6092867|NCT00321711|21028791|P5|Part A|Other|0
6092868|NCT00321711|21028792|P4|Part A|Other|0
6092869|NCT00321711|21028793|P3|Part A|Other|3
6092870|NCT00321711|21028794|P2|Part A|Other|2
6092871|NCT00321711|21028795|P1|Part A|Other|1
6092872|NCT00321711|21028791|P5|Part A|Physician Decision|0
6092873|NCT00321711|21028792|P4|Part A|Physician Decision|0
6092874|NCT00321711|21028793|P3|Part A|Physician Decision|3
6092875|NCT00321711|21028794|P2|Part A|Physician Decision|1
6092876|NCT00321711|21028795|P1|Part A|Physician Decision|0
6092877|NCT00321711|21028791|P5|Part A|Requirement for alternative therapy|0
6092878|NCT00321711|21028792|P4|Part A|Requirement for alternative therapy|0
6092879|NCT00321711|21028793|P3|Part A|Requirement for alternative therapy|1
6092880|NCT00321711|21028794|P2|Part A|Requirement for alternative therapy|2
6092881|NCT00321711|21028795|P1|Part A|Requirement for alternative therapy|0
6092882|NCT00321711|21028791|P5|Part A|Disease progression|0
6092883|NCT00321711|21028792|P4|Part A|Disease progression|0
6092884|NCT00321711|21028793|P3|Part A|Disease progression|0
6092885|NCT00321711|21028794|P2|Part A|Disease progression|1
6092886|NCT00321711|21028795|P1|Part A|Disease progression|0
6092887|NCT00321711|21028791|P5|Part A|Withdrawal by Subject|0
6092888|NCT00321711|21028792|P4|Part A|Withdrawal by Subject|0
6092889|NCT00321711|21028793|P3|Part A|Withdrawal by Subject|1
6092890|NCT00321711|21028794|P2|Part A|Withdrawal by Subject|1
6092891|NCT00321711|21028795|P1|Part A|Withdrawal by Subject|1
6092892|NCT00321711|21028791|P5|Part A|Adverse Event|0
6092893|NCT00321711|21028792|P4|Part A|Adverse Event|0
6092894|NCT00321711|21028793|P3|Part A|Adverse Event|2
6092895|NCT00321711|21028794|P2|Part A|Adverse Event|3
6092896|NCT00321711|21028795|P1|Part A|Adverse Event|3
6092897|NCT00321685|21028845|P1|Overall Study|Ineligible|2
6092898|NCT00321685|21028845|P1|Overall Study|Not start protocol therapy|2
6092899|NCT00321685|21028845|P1|Overall Study|Other|5
6092900|NCT00321685|21028845|P1|Overall Study|Complicating disese|1
6092901|NCT00321685|21028845|P1|Overall Study|Alternative therapy|1
6092902|NCT00321685|21028845|P1|Overall Study|Withdrawal by Subject|8
6092903|NCT00321685|21028845|P1|Overall Study|Death|2
6092904|NCT00321685|21028845|P1|Overall Study|Adverse Event|18
6092905|NCT00321672|21028857|P4|Overall Study|Extensive travel required for new job|0
6092906|NCT00321672|21028858|P3|Overall Study|Extensive travel required for new job|0
6092907|NCT00321672|21028859|P2|Overall Study|Extensive travel required for new job|1
6092908|NCT00321672|21028860|P1|Overall Study|Extensive travel required for new job|0
6092909|NCT00321672|21028857|P4|Overall Study|Diagnosis of testicular cancer|0
6092910|NCT00321672|21028858|P3|Overall Study|Diagnosis of testicular cancer|0
6092911|NCT00321672|21028859|P2|Overall Study|Diagnosis of testicular cancer|1
6092912|NCT00321672|21028860|P1|Overall Study|Diagnosis of testicular cancer|0
6092913|NCT00321672|21028857|P4|Overall Study|Protocol Violation|0
6092914|NCT00321672|21028858|P3|Overall Study|Protocol Violation|1
6092915|NCT00321672|21028859|P2|Overall Study|Protocol Violation|0
6092916|NCT00321672|21028860|P1|Overall Study|Protocol Violation|0
6092917|NCT00321672|21028857|P4|Overall Study|Moved out of state|0
6092918|NCT00321672|21028858|P3|Overall Study|Moved out of state|1
6092919|NCT00321672|21028859|P2|Overall Study|Moved out of state|1
6092920|NCT00321672|21028860|P1|Overall Study|Moved out of state|0
6092921|NCT00321672|21028857|P4|Overall Study|Incarcerated|0
6092922|NCT00321672|21028858|P3|Overall Study|Incarcerated|2
6092923|NCT00321672|21028859|P2|Overall Study|Incarcerated|0
6092924|NCT00321672|21028860|P1|Overall Study|Incarcerated|0
6092925|NCT00321672|21028857|P4|Overall Study|Too far to travel for visits|0
6092926|NCT00321672|21028858|P3|Overall Study|Too far to travel for visits|0
6092927|NCT00321672|21028859|P2|Overall Study|Too far to travel for visits|0
6092928|NCT00321672|21028860|P1|Overall Study|Too far to travel for visits|1
6092929|NCT00321672|21028857|P4|Overall Study|Death|0
6092930|NCT00321672|21028858|P3|Overall Study|Death|0
6092931|NCT00321672|21028859|P2|Overall Study|Death|0
6092932|NCT00321672|21028860|P1|Overall Study|Death|1
6092933|NCT00321672|21028857|P4|Overall Study|Lost to Follow-up|2
6092934|NCT00321672|21028858|P3|Overall Study|Lost to Follow-up|4
6092935|NCT00321672|21028859|P2|Overall Study|Lost to Follow-up|0
6092936|NCT00321672|21028860|P1|Overall Study|Lost to Follow-up|2
6092937|NCT00321672|21028857|P4|Overall Study|Lack of Efficacy|0
6092938|NCT00321672|21028858|P3|Overall Study|Lack of Efficacy|0
6092939|NCT00321672|21028859|P2|Overall Study|Lack of Efficacy|1
6092940|NCT00321672|21028860|P1|Overall Study|Lack of Efficacy|1
6092941|NCT00321672|21028857|P4|Overall Study|Adverse Event|0
6092942|NCT00321672|21028858|P3|Overall Study|Adverse Event|0
6092943|NCT00321672|21028859|P2|Overall Study|Adverse Event|1
6092944|NCT00321672|21028860|P1|Overall Study|Adverse Event|1
6092945|NCT00321672|21028857|P4|Overall Study|Noncompliance|0
6092946|NCT00321672|21028858|P3|Overall Study|Noncompliance|1
6092947|NCT00321672|21028859|P2|Overall Study|Noncompliance|2
6092948|NCT00321672|21028860|P1|Overall Study|Noncompliance|1
6092949|NCT00321672|21028857|P4|Overall Study|Withdrawal by Subject|0
6092950|NCT00321672|21028858|P3|Overall Study|Withdrawal by Subject|2
6092951|NCT00321672|21028859|P2|Overall Study|Withdrawal by Subject|1
6092952|NCT00321672|21028860|P1|Overall Study|Withdrawal by Subject|5
6092953|NCT00321646|21028886|P1|Neoadjuvant Chemotherapy|Disease progression|1
6092954|NCT00321646|21028886|P1|Neoadjuvant Chemotherapy|Adverse Event|2
6092955|NCT00321646|21028886|P1|Neoadjuvant Chemotherapy|Withdrawal by Subject|1
6092956|NCT00321620|21028893|P2|Overall Study|Other|33
6092957|NCT00321620|21028894|P1|Overall Study|Other|42
6092958|NCT00321620|21028893|P2|Overall Study|Participant request|52
6092959|NCT00321620|21028894|P1|Overall Study|Participant request|75
6092960|NCT00321620|21028893|P2|Overall Study|Ineligibility determined|3
6092961|NCT00321620|21028894|P1|Overall Study|Ineligibility determined|2
6092962|NCT00321620|21028893|P2|Overall Study|Protocol deviation|3
6092963|NCT00321620|21028894|P1|Overall Study|Protocol deviation|4
6092964|NCT00321620|21028893|P2|Overall Study|Noncompliance|7
6092965|NCT00321620|21028894|P1|Overall Study|Noncompliance|14
6092966|NCT00321620|21028893|P2|Overall Study|Physician Decision|1
6092967|NCT00321620|21028894|P1|Overall Study|Physician Decision|4
6092968|NCT00321620|21028893|P2|Overall Study|Lost to Follow-up|9
6092969|NCT00321620|21028894|P1|Overall Study|Lost to Follow-up|13
6092970|NCT00321620|21028893|P2|Overall Study|Adverse Event|56
6092971|NCT00321620|21028894|P1|Overall Study|Adverse Event|43
6092972|NCT00321620|21028893|P2|Overall Study|Disease progression|117
6092973|NCT00321620|21028894|P1|Overall Study|Disease progression|113
6092974|NCT00321620|21028893|P2|Overall Study|Withdrawal by Subject|147
6092975|NCT00321620|21028894|P1|Overall Study|Withdrawal by Subject|164
6092976|NCT00321620|21028893|P2|Overall Study|Death|294
6092977|NCT00321620|21028894|P1|Overall Study|Death|269
6092978|NCT00321555|21028922|P1|Overall Study|Disease progression on study|1
6092979|NCT00321555|21028922|P1|Overall Study|Physician Decision|1
6092980|NCT00321555|21028922|P1|Overall Study|Switched to alternative treatment|3
6092981|NCT00321555|21028922|P1|Overall Study|Developed antibodies|1
6092982|NCT00321464|21028930|P2|Overall Study|Other|18
6092983|NCT00321464|21028931|P1|Overall Study|Other|21
6092984|NCT00321464|21028930|P2|Overall Study|Ineligibility determined|1
6092985|NCT00321464|21028931|P1|Overall Study|Ineligibility determined|2
6092986|NCT00321464|21028930|P2|Overall Study|Protocol deviation|2
6092987|NCT00321464|21028931|P1|Overall Study|Protocol deviation|0
6092988|NCT00321464|21028930|P2|Overall Study|Lost to Follow-up|8
6092989|NCT00321464|21028931|P1|Overall Study|Lost to Follow-up|7
6092990|NCT00321464|21028930|P2|Overall Study|Noncompliance|10
6092991|NCT00321464|21028931|P1|Overall Study|Noncompliance|4
6092992|NCT00321464|21028930|P2|Overall Study|Physician Decision|14
6092993|NCT00321464|21028931|P1|Overall Study|Physician Decision|15
6092994|NCT00321464|21028930|P2|Overall Study|Adverse Event|28
6092995|NCT00321464|21028931|P1|Overall Study|Adverse Event|43
6092996|NCT00321464|21028930|P2|Overall Study|Participant request|61
6092997|NCT00321464|21028931|P1|Overall Study|Participant request|57
6092998|NCT00321464|21028930|P2|Overall Study|Withdrawal by Subject|118
6092999|NCT00321464|21028931|P1|Overall Study|Withdrawal by Subject|117
6093000|NCT00321464|21028930|P2|Overall Study|Disease progression|124
6093001|NCT00321464|21028931|P1|Overall Study|Disease progression|124
6093002|NCT00321464|21028930|P2|Overall Study|Death|174
6093003|NCT00321464|21028931|P1|Overall Study|Death|169
6093004|NCT00321373|21028944|P3|Overall Study|Other|1
6093005|NCT00321373|21028945|P2|Overall Study|Other|0
6093006|NCT00321373|21028946|P1|Overall Study|Other|0
6093007|NCT00321373|21028944|P3|Overall Study|Withdrawal by Subject|0
6093008|NCT00321373|21028945|P2|Overall Study|Withdrawal by Subject|0
6093009|NCT00321373|21028946|P1|Overall Study|Withdrawal by Subject|1
6093010|NCT00321373|21028944|P3|Overall Study|Lost to Follow-up|1
6093011|NCT00321373|21028945|P2|Overall Study|Lost to Follow-up|0
6093012|NCT00321373|21028946|P1|Overall Study|Lost to Follow-up|1
6093013|NCT00321373|21028944|P3|Overall Study|Adverse Event|1
6093014|NCT00321373|21028945|P2|Overall Study|Adverse Event|0
6093015|NCT00321373|21028946|P1|Overall Study|Adverse Event|0
6093016|NCT00321048|21028986|P2|Overall Study|Withdrawal by Subject|8
6093017|NCT00321048|21028987|P1|Overall Study|Withdrawal by Subject|6
6093018|NCT00320801|21028995|P4|Extension Phase|Lost to Follow-up|3
6093019|NCT00320801|21028996|P3|Extension Phase|Lost to Follow-up|0
6093020|NCT00320801|21028997|P2|Extension Phase|Lost to Follow-up|0
6093021|NCT00320801|21028998|P1|Extension Phase|Lost to Follow-up|0
6093022|NCT00320801|21028995|P4|Extension Phase|Lack of Efficacy|2
6093023|NCT00320801|21028996|P3|Extension Phase|Lack of Efficacy|0
6093024|NCT00320801|21028997|P2|Extension Phase|Lack of Efficacy|0
6093025|NCT00320801|21028998|P1|Extension Phase|Lack of Efficacy|0
6093026|NCT00320801|21028995|P4|Extension Phase|Administrative|29
6093027|NCT00320801|21028996|P3|Extension Phase|Administrative|0
6093028|NCT00320801|21028997|P2|Extension Phase|Administrative|0
6093029|NCT00320801|21028998|P1|Extension Phase|Administrative|0
6093030|NCT00320801|21028995|P4|Extension Phase|Adverse Event|8
6093031|NCT00320801|21028996|P3|Extension Phase|Adverse Event|0
6093032|NCT00320801|21028997|P2|Extension Phase|Adverse Event|0
6093033|NCT00320801|21028998|P1|Extension Phase|Adverse Event|0
6093034|NCT00320801|21028995|P4|Extension Phase|Withdrawal by Subject|6
6093035|NCT00320801|21028996|P3|Extension Phase|Withdrawal by Subject|0
6093036|NCT00320801|21028997|P2|Extension Phase|Withdrawal by Subject|0
6093037|NCT00320801|21028998|P1|Extension Phase|Withdrawal by Subject|0
6093038|NCT00320801|21028995|P4|Double-blind Phase|Lack of Efficacy|0
6093039|NCT00320801|21028996|P3|Double-blind Phase|Lack of Efficacy|1
6093040|NCT00320801|21028997|P2|Double-blind Phase|Lack of Efficacy|9
6093041|NCT00320801|21028998|P1|Double-blind Phase|Lack of Efficacy|0
6093042|NCT00320801|21028995|P4|Double-blind Phase|Administrative|0
6093043|NCT00320801|21028996|P3|Double-blind Phase|Administrative|4
6093044|NCT00320801|21028997|P2|Double-blind Phase|Administrative|0
6093045|NCT00320801|21028998|P1|Double-blind Phase|Administrative|0
6093046|NCT00320801|21028995|P4|Double-blind Phase|Adverse Event|0
6093047|NCT00320801|21028996|P3|Double-blind Phase|Adverse Event|8
6093048|NCT00320801|21028997|P2|Double-blind Phase|Adverse Event|2
6093049|NCT00320801|21028998|P1|Double-blind Phase|Adverse Event|0
6093050|NCT00320801|21028995|P4|Double-blind Phase|Withdrawal by Subject|0
6093051|NCT00320801|21028996|P3|Double-blind Phase|Withdrawal by Subject|1
6093052|NCT00320801|21028997|P2|Double-blind Phase|Withdrawal by Subject|0
6093053|NCT00320801|21028998|P1|Double-blind Phase|Withdrawal by Subject|0
6093054|NCT00320801|21028995|P4|Open-label Run-in Period|Did not qualify|0
6093055|NCT00320801|21028996|P3|Open-label Run-in Period|Did not qualify|0
6093056|NCT00320801|21028997|P2|Open-label Run-in Period|Did not qualify|0
6093057|NCT00320801|21028998|P1|Open-label Run-in Period|Did not qualify|1
6093058|NCT00320801|21028995|P4|Open-label Run-in Period|Lost to Follow-up|0
6093059|NCT00320801|21028996|P3|Open-label Run-in Period|Lost to Follow-up|0
6093060|NCT00320801|21028997|P2|Open-label Run-in Period|Lost to Follow-up|0
6093061|NCT00320801|21028998|P1|Open-label Run-in Period|Lost to Follow-up|2
6093062|NCT00320801|21028995|P4|Open-label Run-in Period|Lack of Efficacy|0
6093063|NCT00320801|21028996|P3|Open-label Run-in Period|Lack of Efficacy|0
6093064|NCT00320801|21028997|P2|Open-label Run-in Period|Lack of Efficacy|0
6093065|NCT00320801|21028998|P1|Open-label Run-in Period|Lack of Efficacy|44
6093066|NCT00320801|21028995|P4|Open-label Run-in Period|Administrative|0
6093067|NCT00320801|21028996|P3|Open-label Run-in Period|Administrative|0
6093068|NCT00320801|21028997|P2|Open-label Run-in Period|Administrative|0
6093069|NCT00320801|21028998|P1|Open-label Run-in Period|Administrative|10
6093070|NCT00320801|21028995|P4|Open-label Run-in Period|Adverse Event|0
6093071|NCT00320801|21028996|P3|Open-label Run-in Period|Adverse Event|0
6093072|NCT00320801|21028997|P2|Open-label Run-in Period|Adverse Event|0
6093073|NCT00320801|21028998|P1|Open-label Run-in Period|Adverse Event|33
6093074|NCT00320801|21028995|P4|Open-label Run-in Period|Withdrawal by Subject|0
6093075|NCT00320801|21028996|P3|Open-label Run-in Period|Withdrawal by Subject|0
6093076|NCT00320801|21028997|P2|Open-label Run-in Period|Withdrawal by Subject|0
6093077|NCT00320801|21028998|P1|Open-label Run-in Period|Withdrawal by Subject|2
6093078|NCT00320788|21029013|P5|Overall Study|Withdrawal by Subject|1
6093079|NCT00320788|21029014|P4|Overall Study|Withdrawal by Subject|3
6093080|NCT00320788|21029015|P3|Overall Study|Withdrawal by Subject|0
6093081|NCT00320788|21029016|P2|Overall Study|Withdrawal by Subject|0
6093082|NCT00320788|21029017|P1|Overall Study|Withdrawal by Subject|3
6093083|NCT00320788|21029013|P5|Overall Study|Protocol Violation|1
6093084|NCT00320788|21029014|P4|Overall Study|Protocol Violation|0
6093085|NCT00320788|21029015|P3|Overall Study|Protocol Violation|0
6093086|NCT00320788|21029016|P2|Overall Study|Protocol Violation|0
6093087|NCT00320788|21029017|P1|Overall Study|Protocol Violation|0
6093088|NCT00320788|21029013|P5|Overall Study|Physician Decision|0
6093089|NCT00320788|21029014|P4|Overall Study|Physician Decision|0
6093090|NCT00320788|21029015|P3|Overall Study|Physician Decision|0
6093091|NCT00320788|21029016|P2|Overall Study|Physician Decision|1
6093092|NCT00320788|21029017|P1|Overall Study|Physician Decision|1
6093093|NCT00320788|21029013|P5|Overall Study|Other|1
6093094|NCT00320788|21029014|P4|Overall Study|Other|1
6093095|NCT00320788|21029015|P3|Overall Study|Other|1
6093096|NCT00320788|21029016|P2|Overall Study|Other|2
6093097|NCT00320788|21029017|P1|Overall Study|Other|1
6093098|NCT00320788|21029013|P5|Overall Study|Decision by the Sponsor|1
6093099|NCT00320788|21029014|P4|Overall Study|Decision by the Sponsor|0
6093100|NCT00320788|21029015|P3|Overall Study|Decision by the Sponsor|0
6093101|NCT00320788|21029016|P2|Overall Study|Decision by the Sponsor|1
6093102|NCT00320788|21029017|P1|Overall Study|Decision by the Sponsor|1
6093103|NCT00320788|21029013|P5|Overall Study|Lost to Follow-up|0
6093104|NCT00320788|21029014|P4|Overall Study|Lost to Follow-up|0
6093105|NCT00320788|21029015|P3|Overall Study|Lost to Follow-up|1
6093106|NCT00320788|21029016|P2|Overall Study|Lost to Follow-up|2
6093107|NCT00320788|21029017|P1|Overall Study|Lost to Follow-up|0
6093108|NCT00320788|21029013|P5|Overall Study|Death|1
6093109|NCT00320788|21029014|P4|Overall Study|Death|0
6093110|NCT00320788|21029015|P3|Overall Study|Death|1
6093111|NCT00320788|21029016|P2|Overall Study|Death|0
6093112|NCT00320788|21029017|P1|Overall Study|Death|0
6093113|NCT00320788|21029013|P5|Overall Study|Adverse Event|0
6093114|NCT00320788|21029014|P4|Overall Study|Adverse Event|1
6093115|NCT00320788|21029015|P3|Overall Study|Adverse Event|0
6093116|NCT00320788|21029016|P2|Overall Study|Adverse Event|0
6093117|NCT00320788|21029017|P1|Overall Study|Adverse Event|0
6093118|NCT00320710|21029071|P3|Overall Study|Lost to Follow-up|0
6093119|NCT00320710|21029072|P2|Overall Study|Lost to Follow-up|0
6093120|NCT00320710|21029073|P1|Overall Study|Lost to Follow-up|1
6093121|NCT00320710|21029071|P3|Overall Study|Adverse Event|1
6093122|NCT00320710|21029072|P2|Overall Study|Adverse Event|14
6093123|NCT00320710|21029073|P1|Overall Study|Adverse Event|18
6093124|NCT00320710|21029071|P3|Overall Study|Abnormal laboratory value(s)|0
6093125|NCT00320710|21029072|P2|Overall Study|Abnormal laboratory value(s)|3
6093126|NCT00320710|21029073|P1|Overall Study|Abnormal laboratory value(s)|12
6093127|NCT00320710|21029071|P3|Overall Study|Abnormal test procedure result(s)|0
6093128|NCT00320710|21029072|P2|Overall Study|Abnormal test procedure result(s)|0
6093129|NCT00320710|21029073|P1|Overall Study|Abnormal test procedure result(s)|2
6093130|NCT00320710|21029071|P3|Overall Study|Protocol Violation|0
6093131|NCT00320710|21029072|P2|Overall Study|Protocol Violation|5
6093132|NCT00320710|21029073|P1|Overall Study|Protocol Violation|6
6093133|NCT00320710|21029071|P3|Overall Study|Withdrawal by Subject|1
6093134|NCT00320710|21029072|P2|Overall Study|Withdrawal by Subject|26
6093135|NCT00320710|21029073|P1|Overall Study|Withdrawal by Subject|20
6093136|NCT00320710|21029071|P3|Overall Study|Administrative problems|0
6093137|NCT00320710|21029072|P2|Overall Study|Administrative problems|2
6093138|NCT00320710|21029073|P1|Overall Study|Administrative problems|1
6093139|NCT00320710|21029071|P3|Overall Study|Death|1
6093140|NCT00320710|21029072|P2|Overall Study|Death|7
6093141|NCT00320710|21029073|P1|Overall Study|Death|10
6093142|NCT00320710|21029071|P3|Overall Study|Disease progression|2
6093143|NCT00320710|21029072|P2|Overall Study|Disease progression|19
6093144|NCT00320710|21029073|P1|Overall Study|Disease progression|24
6093145|NCT00320606|21029103|P1|Overall Study|Withdrawal by Subject|1
6093146|NCT00320606|21029103|P1|Overall Study|Protocol Violation|1
6093147|NCT00320606|21029103|P1|Overall Study|Adverse Event|1
6093148|NCT00320593|21029119|P2|Overall Study|Withdrawal by clinical center|0
6093149|NCT00320593|21029120|P1|Overall Study|Withdrawal by clinical center|1
6093150|NCT00320593|21029119|P2|Overall Study|Withdrawal by Subject|1
6093151|NCT00320593|21029120|P1|Overall Study|Withdrawal by Subject|2
6093152|NCT00320593|21029119|P2|Overall Study|Moved to another state|0
6093153|NCT00320593|21029120|P1|Overall Study|Moved to another state|1
6093154|NCT00320593|21029119|P2|Overall Study|Lost to Follow-up|0
6093155|NCT00320593|21029120|P1|Overall Study|Lost to Follow-up|3
6093156|NCT00320541|21029144|P2|Overall Study|Protocol Entry Criterion Not Met|0
6093157|NCT00320541|21029145|P1|Overall Study|Protocol Entry Criterion Not Met|1
6093158|NCT00320541|21029144|P2|Overall Study|Death due to Adverse Event(s)|0
6093159|NCT00320541|21029145|P1|Overall Study|Death due to Adverse Event(s)|1
6093160|NCT00320541|21029144|P2|Overall Study|Death due to Study Disease|3
6093161|NCT00320541|21029145|P1|Overall Study|Death due to Study Disease|1
6093162|NCT00320541|21029144|P2|Overall Study|Sponsor Decision|1
6093163|NCT00320541|21029145|P1|Overall Study|Sponsor Decision|2
6093164|NCT00320541|21029144|P2|Overall Study|Other|4
6093165|NCT00320541|21029145|P1|Overall Study|Other|3
6093166|NCT00320541|21029144|P2|Overall Study|Physician Decision|13
6093167|NCT00320541|21029145|P1|Overall Study|Physician Decision|9
6093168|NCT00320541|21029144|P2|Overall Study|Withdrawal by Subject|16
6093169|NCT00320541|21029145|P1|Overall Study|Withdrawal by Subject|12
6093170|NCT00320541|21029144|P2|Overall Study|Protocol Violation|1
6093171|NCT00320541|21029145|P1|Overall Study|Protocol Violation|0
6093172|NCT00320541|21029144|P2|Overall Study|Adverse Event|19
6093173|NCT00320541|21029145|P1|Overall Study|Adverse Event|21
6093174|NCT00320528|21029172|P3|Study Period III|Atomoxetine Commercially Available|90
6093175|NCT00320528|21029173|P2|Study Period III|Atomoxetine Commercially Available|25
6093176|NCT00320528|21029174|P1|Study Period III|Atomoxetine Commercially Available|68
6093177|NCT00320528|21029172|P3|Study Period III|Sponsor Decision|1
6093178|NCT00320528|21029173|P2|Study Period III|Sponsor Decision|0
6093179|NCT00320528|21029174|P1|Study Period III|Sponsor Decision|0
6093180|NCT00320528|21029172|P3|Study Period III|Physician Decision|2
6093181|NCT00320528|21029173|P2|Study Period III|Physician Decision|1
6093182|NCT00320528|21029174|P1|Study Period III|Physician Decision|0
6093183|NCT00320528|21029172|P3|Study Period III|Protocol Violation|0
6093184|NCT00320528|21029173|P2|Study Period III|Protocol Violation|1
6093185|NCT00320528|21029174|P1|Study Period III|Protocol Violation|0
6093186|NCT00320528|21029172|P3|Study Period III|Parent/Caregiver Decision|11
6093187|NCT00320528|21029173|P2|Study Period III|Parent/Caregiver Decision|3
6093188|NCT00320528|21029174|P1|Study Period III|Parent/Caregiver Decision|14
6093189|NCT00320528|21029172|P3|Study Period III|Lack of Efficacy|0
6093190|NCT00320528|21029173|P2|Study Period III|Lack of Efficacy|0
6093191|NCT00320528|21029174|P1|Study Period III|Lack of Efficacy|2
6093192|NCT00320528|21029172|P3|Study Period III|Withdrawal by Subject|2
6093193|NCT00320528|21029173|P2|Study Period III|Withdrawal by Subject|1
6093194|NCT00320528|21029174|P1|Study Period III|Withdrawal by Subject|1
6093195|NCT00320528|21029172|P3|Study Period III|Lost to Follow-up|0
6093196|NCT00320528|21029173|P2|Study Period III|Lost to Follow-up|0
6093197|NCT00320528|21029174|P1|Study Period III|Lost to Follow-up|1
6093198|NCT00320528|21029172|P3|Study Period III|Adverse Event|0
6093199|NCT00320528|21029173|P2|Study Period III|Adverse Event|0
6093200|NCT00320528|21029174|P1|Study Period III|Adverse Event|1
6093201|NCT00320528|21029172|P3|Study Period II|Entry Criteria Exclusion|2
6093202|NCT00320528|21029173|P2|Study Period II|Entry Criteria Exclusion|2
6093203|NCT00320528|21029174|P1|Study Period II|Entry Criteria Exclusion|0
6093204|NCT00320528|21029172|P3|Study Period II|Withdrawal by Subject|1
6093205|NCT00320528|21029173|P2|Study Period II|Withdrawal by Subject|1
6093206|NCT00320528|21029174|P1|Study Period II|Withdrawal by Subject|0
6093207|NCT00320528|21029172|P3|Study Period II|Parent/Caregiver Decision|11
6093208|NCT00320528|21029173|P2|Study Period II|Parent/Caregiver Decision|3
6093209|NCT00320528|21029174|P1|Study Period II|Parent/Caregiver Decision|8
6093210|NCT00320528|21029172|P3|Study Period II|Adverse Event|8
6093211|NCT00320528|21029173|P2|Study Period II|Adverse Event|4
6093212|NCT00320528|21029174|P1|Study Period II|Adverse Event|3
6093213|NCT00320515|21029209|P1|Overall Study|Withdrawal by Subject|8
6093214|NCT00320515|21029209|P1|Overall Study|Physician Decision|2
6093215|NCT00320515|21029209|P1|Overall Study|Lost to Follow-up|6
6093216|NCT00320515|21029209|P1|Overall Study|Death|33
6093217|NCT00320489|21029218|P2|Overall Study|Withdrawal by Subject|41
6093218|NCT00320489|21029219|P1|Overall Study|Withdrawal by Subject|39
6093219|NCT00320489|21029218|P2|Overall Study|Sponsor Decision|3
6093220|NCT00320489|21029219|P1|Overall Study|Sponsor Decision|3
6093221|NCT00320489|21029218|P2|Overall Study|Protocol Violation|4
6093222|NCT00320489|21029219|P1|Overall Study|Protocol Violation|4
6093223|NCT00320489|21029218|P2|Overall Study|Physician Decision|8
6093224|NCT00320489|21029219|P1|Overall Study|Physician Decision|8
6093225|NCT00320489|21029218|P2|Overall Study|Lost to Follow-up|22
6093226|NCT00320489|21029219|P1|Overall Study|Lost to Follow-up|21
6093227|NCT00320489|21029218|P2|Overall Study|Lack of Efficacy|7
6093228|NCT00320489|21029219|P1|Overall Study|Lack of Efficacy|16
6093229|NCT00320489|21029218|P2|Overall Study|Entry Criteria Exclusion|4
6093230|NCT00320489|21029219|P1|Overall Study|Entry Criteria Exclusion|2
6093231|NCT00320489|21029218|P2|Overall Study|Death|2
6093232|NCT00320489|21029219|P1|Overall Study|Death|0
6093233|NCT00320489|21029218|P2|Overall Study|Clinical Relapse|20
6093234|NCT00320489|21029219|P1|Overall Study|Clinical Relapse|26
6093235|NCT00320489|21029218|P2|Overall Study|Adverse Event|25
6093236|NCT00320489|21029219|P1|Overall Study|Adverse Event|26
6093237|NCT00320424|21029275|P1|Overall Study|Other|3
6093238|NCT00320424|21029275|P1|Overall Study|Adverse Event|3
6093239|NCT00320411|21029289|P1|Overall Study|No investigational product admin.|4
6093240|NCT00320398|21029312|P2|Overall Study|Other|0
6093241|NCT00320398|21029313|P1|Overall Study|Other|1
6093242|NCT00320398|21029312|P2|Overall Study|Adverse Event|4
6093243|NCT00320398|21029313|P1|Overall Study|Adverse Event|1
6093244|NCT00320385|21029341|P2|Overall Study|Adverse Event|1
6093245|NCT00320385|21029342|P1|Overall Study|Adverse Event|0
6093246|NCT00320385|21029341|P2|Overall Study|Withdrew Consent|0
6093247|NCT00320385|21029342|P1|Overall Study|Withdrew Consent|1
6093248|NCT00320385|21029341|P2|Overall Study|Serious Adverse Event|0
6093249|NCT00320385|21029342|P1|Overall Study|Serious Adverse Event|1
6093250|NCT00320385|21029341|P2|Overall Study|Death|2
6093251|NCT00320385|21029342|P1|Overall Study|Death|1
6093252|NCT00320385|21029341|P2|Overall Study|Investigator Decision|1
6093253|NCT00320385|21029342|P1|Overall Study|Investigator Decision|0
6093254|NCT00320385|21029341|P2|Overall Study|Sponsor Terminated Study|1
6093255|NCT00320385|21029342|P1|Overall Study|Sponsor Terminated Study|2
6093256|NCT00320385|21029341|P2|Overall Study|Withdrawal by Subject|7
6093257|NCT00320385|21029342|P1|Overall Study|Withdrawal by Subject|6
6093258|NCT00320385|21029341|P2|Overall Study|Lost to Follow-up|10
6093259|NCT00320385|21029342|P1|Overall Study|Lost to Follow-up|7
6093260|NCT00320372|21029365|P2|Overall Study|Other (i.e. lost to f/u, site closure)|71
6093261|NCT00320372|21029366|P1|Overall Study|Other (i.e. lost to f/u, site closure)|86
6093262|NCT00320372|21029365|P2|Overall Study|Did not Meet (I/E)|1
6093263|NCT00320372|21029366|P1|Overall Study|Did not Meet (I/E)|3
6093264|NCT00320372|21029365|P2|Overall Study|Non-Compliance|39
6093265|NCT00320372|21029366|P1|Overall Study|Non-Compliance|40
6093266|NCT00320372|21029365|P2|Overall Study|Withdrawal by Subject|37
6093267|NCT00320372|21029366|P1|Overall Study|Withdrawal by Subject|55
6093268|NCT00320372|21029365|P2|Overall Study|Death|8
6093269|NCT00320372|21029366|P1|Overall Study|Death|7
6093270|NCT00320372|21029365|P2|Overall Study|Physician Decision|7
6093271|NCT00320372|21029366|P1|Overall Study|Physician Decision|4
6093272|NCT00320255|21029408|P6|Overall Study|Other|0
6093273|NCT00320255|21029409|P5|Overall Study|Other|0
6093274|NCT00320255|21029410|P4|Overall Study|Other|0
6093275|NCT00320255|21029411|P3|Overall Study|Other|1
6093276|NCT00320255|21029412|P2|Overall Study|Other|2
6093277|NCT00320255|21029413|P1|Overall Study|Other|3
6093278|NCT00320255|21029408|P6|Overall Study|No longer meets study criteria|0
6093279|NCT00320255|21029409|P5|Overall Study|No longer meets study criteria|0
6093280|NCT00320255|21029410|P4|Overall Study|No longer meets study criteria|1
6093281|NCT00320255|21029411|P3|Overall Study|No longer meets study criteria|0
6093282|NCT00320255|21029412|P2|Overall Study|No longer meets study criteria|0
6093283|NCT00320255|21029413|P1|Overall Study|No longer meets study criteria|0
6093284|NCT00320255|21029408|P6|Overall Study|Poor compliance/noncompliance|0
6093285|NCT00320255|21029409|P5|Overall Study|Poor compliance/noncompliance|0
6093286|NCT00320255|21029410|P4|Overall Study|Poor compliance/noncompliance|1
6093287|NCT00320255|21029411|P3|Overall Study|Poor compliance/noncompliance|0
6093288|NCT00320255|21029412|P2|Overall Study|Poor compliance/noncompliance|1
6093289|NCT00320255|21029413|P1|Overall Study|Poor compliance/noncompliance|1
6093290|NCT00320255|21029408|P6|Overall Study|Withdrawal by Subject|0
6093291|NCT00320255|21029409|P5|Overall Study|Withdrawal by Subject|0
6093292|NCT00320255|21029410|P4|Overall Study|Withdrawal by Subject|4
6093293|NCT00320255|21029411|P3|Overall Study|Withdrawal by Subject|2
6093294|NCT00320255|21029412|P2|Overall Study|Withdrawal by Subject|2
6093295|NCT00320255|21029413|P1|Overall Study|Withdrawal by Subject|1
6093296|NCT00320255|21029408|P6|Overall Study|Adverse Event|0
6093297|NCT00320255|21029409|P5|Overall Study|Adverse Event|0
6093298|NCT00320255|21029410|P4|Overall Study|Adverse Event|2
6093299|NCT00320255|21029411|P3|Overall Study|Adverse Event|3
6093300|NCT00320255|21029412|P2|Overall Study|Adverse Event|2
6093301|NCT00320255|21029413|P1|Overall Study|Adverse Event|5
6093302|NCT00320255|21029408|P6|Overall Study|Lack of Efficacy|0
6093303|NCT00320255|21029409|P5|Overall Study|Lack of Efficacy|0
6093304|NCT00320255|21029410|P4|Overall Study|Lack of Efficacy|0
6093305|NCT00320255|21029411|P3|Overall Study|Lack of Efficacy|0
6093306|NCT00320255|21029412|P2|Overall Study|Lack of Efficacy|0
6093307|NCT00320255|21029413|P1|Overall Study|Lack of Efficacy|1
6093308|NCT00320216|21029506|P5|Overall Study|Other|3
6093309|NCT00320216|21029507|P4|Overall Study|Other|1
6093310|NCT00320216|21029508|P3|Overall Study|Other|5
6093311|NCT00320216|21029509|P2|Overall Study|Other|2
6093312|NCT00320216|21029510|P1|Overall Study|Other|7
6093313|NCT00320216|21029506|P5|Overall Study|Lost to Follow-up|0
6093314|NCT00320216|21029507|P4|Overall Study|Lost to Follow-up|0
6093315|NCT00320216|21029508|P3|Overall Study|Lost to Follow-up|0
6093316|NCT00320216|21029509|P2|Overall Study|Lost to Follow-up|0
6093317|NCT00320216|21029510|P1|Overall Study|Lost to Follow-up|3
6093318|NCT00320216|21029506|P5|Overall Study|Lack of Efficacy|1
6093319|NCT00320216|21029507|P4|Overall Study|Lack of Efficacy|0
6093320|NCT00320216|21029508|P3|Overall Study|Lack of Efficacy|1
6093321|NCT00320216|21029509|P2|Overall Study|Lack of Efficacy|2
6093322|NCT00320216|21029510|P1|Overall Study|Lack of Efficacy|6
6093323|NCT00320216|21029506|P5|Overall Study|Adverse Event|2
6093324|NCT00320216|21029507|P4|Overall Study|Adverse Event|2
6093325|NCT00320216|21029508|P3|Overall Study|Adverse Event|0
6093326|NCT00320216|21029509|P2|Overall Study|Adverse Event|6
6093327|NCT00320216|21029510|P1|Overall Study|Adverse Event|0
6093328|NCT00320190|21029544|P2|Long-term (12-month) Extension|Withdrawal by Subject|0
6093329|NCT00320190|21029545|P1|Long-term (12-month) Extension|Withdrawal by Subject|1
6093330|NCT00320190|21029544|P2|Long-term (12-month) Extension|Lack of major molecular response|2
6093331|NCT00320190|21029545|P1|Long-term (12-month) Extension|Lack of major molecular response|1
6093332|NCT00320190|21029544|P2|Long-term (12-month) Extension|Sponsor terminated study|0
6093333|NCT00320190|21029545|P1|Long-term (12-month) Extension|Sponsor terminated study|7
6093334|NCT00320190|21029544|P2|First 12 Months|Withdrawal by Subject|1
6093335|NCT00320190|21029545|P1|First 12 Months|Withdrawal by Subject|0
6093336|NCT00320190|21029544|P2|First 12 Months|Study drug toxicity|1
6093337|NCT00320190|21029545|P1|First 12 Months|Study drug toxicity|0
6093338|NCT00320190|21029544|P2|First 12 Months|Investigator request|1
6093339|NCT00320190|21029545|P1|First 12 Months|Investigator request|0
6093340|NCT00320190|21029544|P2|First 12 Months|Adverse event unrelated to study drug|0
6093341|NCT00320190|21029545|P1|First 12 Months|Adverse event unrelated to study drug|1
6093342|NCT00320190|21029544|P2|First 12 Months|Enrollment failure|1
6093343|NCT00320190|21029545|P1|First 12 Months|Enrollment failure|0
6093344|NCT00320190|21029544|P2|First 12 Months|Lost to Follow-up|1
6093345|NCT00320190|21029545|P1|First 12 Months|Lost to Follow-up|0
6093346|NCT00320190|21029544|P2|First 12 Months|Sponsor terminated study|2
6093347|NCT00320190|21029545|P1|First 12 Months|Sponsor terminated study|2
6093348|NCT00320190|21029544|P2|First 12 Months|Completed but did not enter extension|3
6093349|NCT00320190|21029545|P1|First 12 Months|Completed but did not enter extension|5
6093350|NCT00320112|21029565|P2|Overall Study|Death|1
6093351|NCT00320112|21029566|P1|Overall Study|Death|2
6093352|NCT00320112|21029565|P2|Overall Study|Withdrawal by Subject|0
6093353|NCT00320112|21029566|P1|Overall Study|Withdrawal by Subject|3
6093354|NCT00320112|21029565|P2|Overall Study|Lost to Follow-up|4
6093355|NCT00320112|21029566|P1|Overall Study|Lost to Follow-up|3
6093356|NCT00319982|21029580|P2|Overall Study|Withdrawal by Subject|0
6093357|NCT00319982|21029581|P1|Overall Study|Withdrawal by Subject|1
6093358|NCT00319956|21029601|P2|Overall Study|Death|24
6093359|NCT00319956|21029602|P1|Overall Study|Death|20
6093360|NCT00319839|21029614|P1|Overall Study|Withdrawal by Subject|1
6093361|NCT00319839|21029614|P1|Overall Study|Adverse Event|5
6093362|NCT00319735|21029630|P1|Overall Study|Death|2
6093363|NCT00319696|21029643|P1|Overall Study|Lost to Follow-up|3
6093364|NCT00319696|21029643|P1|Overall Study|administrative|7
6093365|NCT00319696|21029643|P1|Overall Study|withdrawal of consent|14
6093366|NCT00319696|21029643|P1|Overall Study|Adverse Event|36
6093367|NCT00319592|21029680|P2|Overall Study|Physician Decision|1
6093368|NCT00319592|21029681|P1|Overall Study|Physician Decision|0
6093369|NCT00319592|21029680|P2|Overall Study|Protocol Violation|0
6093370|NCT00319592|21029681|P1|Overall Study|Protocol Violation|1
6093371|NCT00319553|21029697|P2|Overall Study|Withdrawal by Subject|1
6093372|NCT00319553|21029698|P1|Overall Study|Withdrawal by Subject|1
6093373|NCT00319553|21029697|P2|Overall Study|Lost to Follow-up|1
6093374|NCT00319553|21029698|P1|Overall Study|Lost to Follow-up|2
6093375|NCT00319553|21029697|P2|Overall Study|Protocol Violation|2
6093376|NCT00319553|21029698|P1|Overall Study|Protocol Violation|1
6093377|NCT00319501|21029712|P2|Open-label Extension Period|Withdrawal by Subject|0
6093378|NCT00319501|21029713|P1|Open-label Extension Period|Withdrawal by Subject|2
6093379|NCT00319501|21029712|P2|Open-label Extension Period|Sponsor request|0
6093380|NCT00319501|21029713|P1|Open-label Extension Period|Sponsor request|26
6093381|NCT00319501|21029712|P2|Open-label Extension Period|Principal investigator decision|0
6093382|NCT00319501|21029713|P1|Open-label Extension Period|Principal investigator decision|2
6093383|NCT00319501|21029712|P2|Open-label Extension Period|Other|0
6093384|NCT00319501|21029713|P1|Open-label Extension Period|Other|1
6093385|NCT00319501|21029712|P2|Open-label Extension Period|Did not receive treatment|0
6093386|NCT00319501|21029713|P1|Open-label Extension Period|Did not receive treatment|18
6093387|NCT00319501|21029712|P2|Open-label Extension Period|Adverse Event|0
6093388|NCT00319501|21029713|P1|Open-label Extension Period|Adverse Event|2
6093389|NCT00319501|21029712|P2|Open-label Period|Other|0
6093390|NCT00319501|21029713|P1|Open-label Period|Other|11
6093391|NCT00319501|21029712|P2|Open-label Period|Did not receive treatment|0
6093392|NCT00319501|21029713|P1|Open-label Period|Did not receive treatment|33
6093393|NCT00319501|21029712|P2|Open-label Period|Lost to Follow-up|0
6093394|NCT00319501|21029713|P1|Open-label Period|Lost to Follow-up|5
6093395|NCT00319501|21029712|P2|Open-label Period|Sponsor request|0
6093396|NCT00319501|21029713|P1|Open-label Period|Sponsor request|12
6093397|NCT00319501|21029712|P2|Open-label Period|Principal Investigator decision|0
6093398|NCT00319501|21029713|P1|Open-label Period|Principal Investigator decision|6
6093399|NCT00319501|21029712|P2|Open-label Period|Withdrawal by Subject|0
6093400|NCT00319501|21029713|P1|Open-label Period|Withdrawal by Subject|38
6093401|NCT00319501|21029712|P2|Open-label Period|Protocol Violation|0
6093402|NCT00319501|21029713|P1|Open-label Period|Protocol Violation|6
6093403|NCT00319501|21029712|P2|Open-label Period|Adverse Event|0
6093404|NCT00319501|21029713|P1|Open-label Period|Adverse Event|5
6093405|NCT00319501|21029712|P2|Double-blind Period|Did not receive treatment|29
6093406|NCT00319501|21029713|P1|Double-blind Period|Did not receive treatment|42
6093407|NCT00319501|21029712|P2|Double-blind Period|Sponsor Request|0
6093408|NCT00319501|21029713|P1|Double-blind Period|Sponsor Request|1
6093409|NCT00319501|21029712|P2|Double-blind Period|Withdrawal by Subject|3
6093410|NCT00319501|21029713|P1|Double-blind Period|Withdrawal by Subject|0
6093411|NCT00319449|21029739|P2|Overall Study|Noncompliance with the protocol|0
6093412|NCT00319449|21029740|P1|Overall Study|Noncompliance with the protocol|1
6093413|NCT00319449|21029739|P2|Overall Study|Subject did not wish to continue|0
6093414|NCT00319449|21029740|P1|Overall Study|Subject did not wish to continue|1
6093415|NCT00319436|21029752|P2|Overall Study|Withdrawal by Subject|7
6093416|NCT00319436|21029753|P1|Overall Study|Withdrawal by Subject|6
6093417|NCT00319254|21029771|P1|Overall Study|Enrolled, Not Treated|2
6093418|NCT00319254|21029771|P1|Overall Study|Lost to Follow-up|2
6093419|NCT00319254|21029771|P1|Overall Study|Death|46
6093420|NCT00319254|21029771|P1|Overall Study|Withdrawal by Subject|4
6093421|NCT00319111|21029784|P1|Overall Study|Treatment failure|1
6093422|NCT00319111|21029784|P1|Overall Study|Administrative|2
6093423|NCT00319111|21029784|P1|Overall Study|Lack of clinical improvement|4
6093424|NCT00319111|21029784|P1|Overall Study|Death|9
6093425|NCT00319111|21029784|P1|Overall Study|Withdrawal of consent|11
6093426|NCT00319111|21029784|P1|Overall Study|Adverse Event|20
6093427|NCT00319098|21029798|P2|Overall Study|Protocol Violation|1
6093428|NCT00319098|21029799|P1|Overall Study|Protocol Violation|3
6093429|NCT00319098|21029798|P2|Overall Study|Others|8
6093430|NCT00319098|21029799|P1|Overall Study|Others|33
6093431|NCT00319098|21029798|P2|Overall Study|Lost to Follow-up|13
6093432|NCT00319098|21029799|P1|Overall Study|Lost to Follow-up|37
6093433|NCT00319098|21029798|P2|Overall Study|Migrated/moved from study area|1
6093434|NCT00319098|21029799|P1|Overall Study|Migrated/moved from study area|2
6093435|NCT00319098|21029798|P2|Overall Study|Withdrawal by Subject|8
6093436|NCT00319098|21029799|P1|Overall Study|Withdrawal by Subject|37
6093437|NCT00319098|21029798|P2|Overall Study|Adverse Event|1
6093438|NCT00319098|21029799|P1|Overall Study|Adverse Event|20
6093439|NCT00319098|21029798|P2|Overall Study|Serious adverse event|0
6093440|NCT00319098|21029799|P1|Overall Study|Serious adverse event|3
6093441|NCT00319046|21029857|P1|Overall Study|administrative reason|1
6093442|NCT00319046|21029857|P1|Overall Study|withdrawal of subject's consent|7
6093443|NCT00319020|21029866|P2|Overall Study|Adverse Event|1
6093444|NCT00319020|21029867|P1|Overall Study|Adverse Event|0
6093445|NCT00319020|21029866|P2|Overall Study|Treatment failure|1
6093446|NCT00319020|21029867|P1|Overall Study|Treatment failure|0
6093447|NCT00319020|21029866|P2|Overall Study|Transplant|1
6093448|NCT00319020|21029867|P1|Overall Study|Transplant|0
6093449|NCT00319020|21029866|P2|Overall Study|Disease progression|2
6093450|NCT00319020|21029867|P1|Overall Study|Disease progression|0
6093451|NCT00319020|21029866|P2|Overall Study|Administrative reason|5
6093452|NCT00319020|21029867|P1|Overall Study|Administrative reason|0
6093453|NCT00319020|21029866|P2|Overall Study|F-1 completed but not enrolled in F-2|0
6093454|NCT00319020|21029867|P1|Overall Study|F-1 completed but not enrolled in F-2|1
6093455|NCT00319020|21029866|P2|Overall Study|Withdrawal by Subject|1
6093456|NCT00319020|21029867|P1|Overall Study|Withdrawal by Subject|4
6093457|NCT00319020|21029866|P2|Overall Study|Death|2
6093458|NCT00319020|21029867|P1|Overall Study|Death|2
6093459|NCT00318656|21029939|P2|Overall Study|Did not receive any treatment|1
6093460|NCT00318656|21029940|P1|Overall Study|Did not receive any treatment|0
6093461|NCT00318656|21029939|P2|Overall Study|Took Avandamet instead of Glim/Met|1
6093462|NCT00318656|21029940|P1|Overall Study|Took Avandamet instead of Glim/Met|0
6093463|NCT00318565|21029997|P1|Overall Study|Excluded per protocol|24
6093464|NCT00318474|21030004|P2|Overall Study|Trial terminated|7
6093465|NCT00318474|21030005|P1|Overall Study|Trial terminated|10
6093466|NCT00318474|21030004|P2|Overall Study|Post-therapy hyperflycemia|1
6093467|NCT00318474|21030005|P1|Overall Study|Post-therapy hyperflycemia|0
6093468|NCT00318474|21030004|P2|Overall Study|Fall in GFR|3
6093469|NCT00318474|21030005|P1|Overall Study|Fall in GFR|3
6093470|NCT00318474|21030004|P2|Overall Study|Withdrawal by Subject|2
6093471|NCT00318474|21030005|P1|Overall Study|Withdrawal by Subject|3
6093472|NCT00318474|21030004|P2|Overall Study|Protocol Violation|0
6093473|NCT00318474|21030005|P1|Overall Study|Protocol Violation|1
6093474|NCT00318474|21030004|P2|Overall Study|Pregnancy|2
6093475|NCT00318474|21030005|P1|Overall Study|Pregnancy|0
6093476|NCT00318474|21030004|P2|Overall Study|Lost to Follow-up|1
6093477|NCT00318474|21030005|P1|Overall Study|Lost to Follow-up|0
6093478|NCT00318474|21030004|P2|Overall Study|Adverse Event|1
6093479|NCT00318474|21030005|P1|Overall Study|Adverse Event|1
6093480|NCT00318461|21030016|P5|Open-Label Extension, 18 Months|Protocol Violation|6
6093481|NCT00318461|21030017|P4|Open-Label Extension, 18 Months|Protocol Violation|4
6093482|NCT00318461|21030018|P3|Open-Label Extension, 18 Months|Protocol Violation|3
6093483|NCT00318461|21030019|P2|Open-Label Extension, 18 Months|Protocol Violation|5
6093484|NCT00318461|21030020|P1|Open-Label Extension, 18 Months|Protocol Violation|7
6093485|NCT00318461|21030016|P5|Open-Label Extension, 18 Months|Lack of Efficacy|63
6093486|NCT00318461|21030017|P4|Open-Label Extension, 18 Months|Lack of Efficacy|27
6093487|NCT00318461|21030018|P3|Open-Label Extension, 18 Months|Lack of Efficacy|37
6093488|NCT00318461|21030019|P2|Open-Label Extension, 18 Months|Lack of Efficacy|33
6093489|NCT00318461|21030020|P1|Open-Label Extension, 18 Months|Lack of Efficacy|41
6093490|NCT00318461|21030016|P5|Open-Label Extension, 18 Months|Adverse Event|6
6093491|NCT00318461|21030017|P4|Open-Label Extension, 18 Months|Adverse Event|1
6093492|NCT00318461|21030018|P3|Open-Label Extension, 18 Months|Adverse Event|6
6093493|NCT00318461|21030019|P2|Open-Label Extension, 18 Months|Adverse Event|8
6093494|NCT00318461|21030020|P1|Open-Label Extension, 18 Months|Adverse Event|11
6093495|NCT00318461|21030016|P5|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|22
6093496|NCT00318461|21030017|P4|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|11
6093497|NCT00318461|21030018|P3|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|27
6093498|NCT00318461|21030019|P2|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|14
6093499|NCT00318461|21030020|P1|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|19
6093500|NCT00318461|21030016|P5|Double-Blind, 6 Months|Fear of experiencing AE again|0
6093501|NCT00318461|21030017|P4|Double-Blind, 6 Months|Fear of experiencing AE again|0
6093502|NCT00318461|21030018|P3|Double-Blind, 6 Months|Fear of experiencing AE again|0
6093503|NCT00318461|21030019|P2|Double-Blind, 6 Months|Fear of experiencing AE again|1
6093504|NCT00318461|21030020|P1|Double-Blind, 6 Months|Fear of experiencing AE again|0
6093505|NCT00318461|21030016|P5|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|1
6093506|NCT00318461|21030017|P4|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0
6093507|NCT00318461|21030018|P3|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0
6093508|NCT00318461|21030019|P2|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0
6093509|NCT00318461|21030020|P1|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0
6093510|NCT00318461|21030016|P5|Double-Blind, 6 Months|Hyperglicaemia|0
6093511|NCT00318461|21030017|P4|Double-Blind, 6 Months|Hyperglicaemia|1
6093512|NCT00318461|21030018|P3|Double-Blind, 6 Months|Hyperglicaemia|0
6093513|NCT00318461|21030019|P2|Double-Blind, 6 Months|Hyperglicaemia|0
6093514|NCT00318461|21030020|P1|Double-Blind, 6 Months|Hyperglicaemia|0
6093515|NCT00318461|21030016|P5|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|2
6093516|NCT00318461|21030017|P4|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0
6093517|NCT00318461|21030018|P3|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0
6093518|NCT00318461|21030019|P2|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0
6093519|NCT00318461|21030020|P1|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0
6093520|NCT00318461|21030016|P5|Double-Blind, 6 Months|Lack of time|0
6093521|NCT00318461|21030017|P4|Double-Blind, 6 Months|Lack of time|0
6093522|NCT00318461|21030018|P3|Double-Blind, 6 Months|Lack of time|0
6093523|NCT00318461|21030019|P2|Double-Blind, 6 Months|Lack of time|0
6093524|NCT00318461|21030020|P1|Double-Blind, 6 Months|Lack of time|1
6093525|NCT00318461|21030016|P5|Double-Blind, 6 Months|Investigator decision|1
6093526|NCT00318461|21030017|P4|Double-Blind, 6 Months|Investigator decision|0
6093527|NCT00318461|21030018|P3|Double-Blind, 6 Months|Investigator decision|0
6093528|NCT00318461|21030019|P2|Double-Blind, 6 Months|Investigator decision|0
6093529|NCT00318461|21030020|P1|Double-Blind, 6 Months|Investigator decision|0
6093530|NCT00318461|21030016|P5|Double-Blind, 6 Months|Work commitment|1
6093531|NCT00318461|21030017|P4|Double-Blind, 6 Months|Work commitment|0
6093532|NCT00318461|21030018|P3|Double-Blind, 6 Months|Work commitment|0
6093533|NCT00318461|21030019|P2|Double-Blind, 6 Months|Work commitment|0
6093534|NCT00318461|21030020|P1|Double-Blind, 6 Months|Work commitment|0
6093535|NCT00318461|21030016|P5|Double-Blind, 6 Months|FPG exceeds limits/too high|0
6093536|NCT00318461|21030017|P4|Double-Blind, 6 Months|FPG exceeds limits/too high|2
6093537|NCT00318461|21030018|P3|Double-Blind, 6 Months|FPG exceeds limits/too high|0
6093538|NCT00318461|21030019|P2|Double-Blind, 6 Months|FPG exceeds limits/too high|0
6093539|NCT00318461|21030020|P1|Double-Blind, 6 Months|FPG exceeds limits/too high|1
6093540|NCT00318461|21030016|P5|Double-Blind, 6 Months|Tendency to low blood glucose levels|1
6093541|NCT00318461|21030017|P4|Double-Blind, 6 Months|Tendency to low blood glucose levels|0
6093542|NCT00318461|21030018|P3|Double-Blind, 6 Months|Tendency to low blood glucose levels|0
6093543|NCT00318461|21030019|P2|Double-Blind, 6 Months|Tendency to low blood glucose levels|0
6093544|NCT00318461|21030020|P1|Double-Blind, 6 Months|Tendency to low blood glucose levels|0
6093545|NCT00318461|21030016|P5|Double-Blind, 6 Months|Move|0
6093546|NCT00318461|21030017|P4|Double-Blind, 6 Months|Move|0
6093547|NCT00318461|21030018|P3|Double-Blind, 6 Months|Move|0
6093548|NCT00318461|21030019|P2|Double-Blind, 6 Months|Move|1
6093549|NCT00318461|21030020|P1|Double-Blind, 6 Months|Move|0
6093550|NCT00318461|21030016|P5|Double-Blind, 6 Months|Subject decision/No wish to continue|2
6093551|NCT00318461|21030017|P4|Double-Blind, 6 Months|Subject decision/No wish to continue|0
6093552|NCT00318461|21030018|P3|Double-Blind, 6 Months|Subject decision/No wish to continue|1
6093553|NCT00318461|21030019|P2|Double-Blind, 6 Months|Subject decision/No wish to continue|2
6093554|NCT00318461|21030020|P1|Double-Blind, 6 Months|Subject decision/No wish to continue|0
6093555|NCT00318461|21030016|P5|Double-Blind, 6 Months|Consent withdrawn|4
6093556|NCT00318461|21030017|P4|Double-Blind, 6 Months|Consent withdrawn|10
6093557|NCT00318461|21030018|P3|Double-Blind, 6 Months|Consent withdrawn|4
6093558|NCT00318461|21030019|P2|Double-Blind, 6 Months|Consent withdrawn|3
6093559|NCT00318461|21030020|P1|Double-Blind, 6 Months|Consent withdrawn|0
6093560|NCT00318461|21030016|P5|Double-Blind, 6 Months|Poor compliance/Non-compliance|0
6093561|NCT00318461|21030017|P4|Double-Blind, 6 Months|Poor compliance/Non-compliance|0
6093562|NCT00318461|21030018|P3|Double-Blind, 6 Months|Poor compliance/Non-compliance|0
6093563|NCT00318461|21030019|P2|Double-Blind, 6 Months|Poor compliance/Non-compliance|1
6093564|NCT00318461|21030020|P1|Double-Blind, 6 Months|Poor compliance/Non-compliance|0
6093565|NCT00318461|21030016|P5|Double-Blind, 6 Months|Lost to follow up|0
6093566|NCT00318461|21030017|P4|Double-Blind, 6 Months|Lost to follow up|0
6093567|NCT00318461|21030018|P3|Double-Blind, 6 Months|Lost to follow up|0
6093568|NCT00318461|21030019|P2|Double-Blind, 6 Months|Lost to follow up|1
6093569|NCT00318461|21030020|P1|Double-Blind, 6 Months|Lost to follow up|0
6093570|NCT00318461|21030016|P5|Double-Blind, 6 Months|Protocol Violation|5
6093571|NCT00318461|21030017|P4|Double-Blind, 6 Months|Protocol Violation|4
6093572|NCT00318461|21030018|P3|Double-Blind, 6 Months|Protocol Violation|4
6093573|NCT00318461|21030019|P2|Double-Blind, 6 Months|Protocol Violation|4
6093574|NCT00318461|21030020|P1|Double-Blind, 6 Months|Protocol Violation|2
6093575|NCT00318461|21030016|P5|Double-Blind, 6 Months|Lack of Efficacy|9
6093576|NCT00318461|21030017|P4|Double-Blind, 6 Months|Lack of Efficacy|29
6093577|NCT00318461|21030018|P3|Double-Blind, 6 Months|Lack of Efficacy|13
6093578|NCT00318461|21030019|P2|Double-Blind, 6 Months|Lack of Efficacy|8
6093579|NCT00318461|21030020|P1|Double-Blind, 6 Months|Lack of Efficacy|19
6093580|NCT00318461|21030016|P5|Double-Blind, 6 Months|Adverse Event|8
6093581|NCT00318461|21030017|P4|Double-Blind, 6 Months|Adverse Event|2
6093582|NCT00318461|21030018|P3|Double-Blind, 6 Months|Adverse Event|29
6093583|NCT00318461|21030019|P2|Double-Blind, 6 Months|Adverse Event|23
6093584|NCT00318461|21030020|P1|Double-Blind, 6 Months|Adverse Event|11
6093585|NCT00318370|21030119|P3|Period 3|Other|3
6093586|NCT00318370|21030120|P2|Period 3|Other|0
6093587|NCT00318370|21030121|P1|Period 3|Other|0
6093588|NCT00318370|21030119|P3|Period 3|Withdrawal by Subject|3
6093589|NCT00318370|21030120|P2|Period 3|Withdrawal by Subject|0
6093590|NCT00318370|21030121|P1|Period 3|Withdrawal by Subject|0
6093591|NCT00318370|21030119|P3|Period 3|Physician Decision|1
6093592|NCT00318370|21030120|P2|Period 3|Physician Decision|0
6093593|NCT00318370|21030121|P1|Period 3|Physician Decision|0
6093594|NCT00318370|21030119|P3|Period 3|Death|1
6093595|NCT00318370|21030120|P2|Period 3|Death|0
6093596|NCT00318370|21030121|P1|Period 3|Death|0
6093597|NCT00318370|21030119|P3|Period 3|Lack of Efficacy|24
6093598|NCT00318370|21030120|P2|Period 3|Lack of Efficacy|0
6093599|NCT00318370|21030121|P1|Period 3|Lack of Efficacy|0
6093600|NCT00318370|21030119|P3|Period 3|Adverse Event|1
6093601|NCT00318370|21030120|P2|Period 3|Adverse Event|0
6093602|NCT00318370|21030121|P1|Period 3|Adverse Event|0
6093603|NCT00318370|21030119|P3|Period 2|Other|0
6093604|NCT00318370|21030120|P2|Period 2|Other|1
6093605|NCT00318370|21030121|P1|Period 2|Other|0
6093606|NCT00318370|21030119|P3|Period 2|Withdrawal by Subject|0
6093607|NCT00318370|21030120|P2|Period 2|Withdrawal by Subject|1
6093608|NCT00318370|21030121|P1|Period 2|Withdrawal by Subject|0
6093609|NCT00318370|21030119|P3|Period 2|Physician Decision|0
6093610|NCT00318370|21030120|P2|Period 2|Physician Decision|1
6093611|NCT00318370|21030121|P1|Period 2|Physician Decision|0
6093612|NCT00318370|21030119|P3|Period 2|Lack of Efficacy|0
6093613|NCT00318370|21030120|P2|Period 2|Lack of Efficacy|5
6093614|NCT00318370|21030121|P1|Period 2|Lack of Efficacy|0
6093615|NCT00318370|21030119|P3|Period 2|Adverse Event|0
6093616|NCT00318370|21030120|P2|Period 2|Adverse Event|3
6093617|NCT00318370|21030121|P1|Period 2|Adverse Event|0
6093618|NCT00318370|21030119|P3|Period 1|Withdrawal by Subject|0
6093619|NCT00318370|21030120|P2|Period 1|Withdrawal by Subject|0
6093620|NCT00318370|21030121|P1|Period 1|Withdrawal by Subject|1
6093621|NCT00318370|21030119|P3|Period 1|Physician Decision|0
6093622|NCT00318370|21030120|P2|Period 1|Physician Decision|0
6093623|NCT00318370|21030121|P1|Period 1|Physician Decision|1
6093624|NCT00318370|21030119|P3|Period 1|Lack of Efficacy|0
6093625|NCT00318370|21030120|P2|Period 1|Lack of Efficacy|0
6093626|NCT00318370|21030121|P1|Period 1|Lack of Efficacy|5
6093627|NCT00318149|21030155|P6|Overall Study|Adverse Event|2
6093628|NCT00318149|21030156|P5|Overall Study|Adverse Event|0
6093629|NCT00318149|21030157|P4|Overall Study|Adverse Event|0
6093630|NCT00318149|21030158|P3|Overall Study|Adverse Event|0
6093631|NCT00318149|21030159|P2|Overall Study|Adverse Event|0
6093632|NCT00318149|21030160|P1|Overall Study|Adverse Event|0
6093633|NCT00317642|21030306|P2|Overall Study|AML Not Centrally Confirmed|5
6093634|NCT00317642|21030307|P1|Overall Study|AML Not Centrally Confirmed|1
6093635|NCT00317642|21030306|P2|Overall Study|Referred For Transplantation|0
6093636|NCT00317642|21030307|P1|Overall Study|Referred For Transplantation|1
6093637|NCT00317642|21030306|P2|Overall Study|Withdrawal by Subject|1
6093638|NCT00317642|21030307|P1|Overall Study|Withdrawal by Subject|0
6093639|NCT00317642|21030306|P2|Overall Study|Not Continue to Consolidation|0
6093640|NCT00317642|21030307|P1|Overall Study|Not Continue to Consolidation|2
6093641|NCT00317642|21030306|P2|Overall Study|Death|7
6093642|NCT00317642|21030307|P1|Overall Study|Death|14
6093643|NCT00317642|21030306|P2|Overall Study|Disease Recurrence|2
6093644|NCT00317642|21030307|P1|Overall Study|Disease Recurrence|1
6093645|NCT00317642|21030306|P2|Overall Study|Treatment Failure|102
6093646|NCT00317642|21030307|P1|Overall Study|Treatment Failure|56
6093647|NCT00317642|21030306|P2|Overall Study|Adverse Event|5
6093648|NCT00317642|21030307|P1|Overall Study|Adverse Event|17
6093649|NCT00317642|21030306|P2|Overall Study|Participant declined treatment|3
6093650|NCT00317642|21030307|P1|Overall Study|Participant declined treatment|14
6093651|NCT00317642|21030306|P2|Overall Study|Physician Decision|7
6093652|NCT00317642|21030307|P1|Overall Study|Physician Decision|15
6093653|NCT00317642|21030306|P2|Overall Study|Not Received Either Study Drug|3
6093654|NCT00317642|21030307|P1|Overall Study|Not Received Either Study Drug|1
6093655|NCT00317473|21030386|P6|Overall Study|Other|0
6093656|NCT00317473|21030387|P5|Overall Study|Other|0
6093657|NCT00317473|21030388|P4|Overall Study|Other|0
6093658|NCT00317473|21030389|P3|Overall Study|Other|0
6093659|NCT00317473|21030390|P2|Overall Study|Other|2
6093660|NCT00317473|21030391|P1|Overall Study|Other|0
6093661|NCT00317473|21030386|P6|Overall Study|Death|0
6093662|NCT00317473|21030387|P5|Overall Study|Death|0
6093663|NCT00317473|21030388|P4|Overall Study|Death|0
6093664|NCT00317473|21030389|P3|Overall Study|Death|0
6093665|NCT00317473|21030390|P2|Overall Study|Death|0
6093666|NCT00317473|21030391|P1|Overall Study|Death|1
6093667|NCT00317473|21030386|P6|Overall Study|Relocation|2
6093668|NCT00317473|21030387|P5|Overall Study|Relocation|5
6093669|NCT00317473|21030388|P4|Overall Study|Relocation|1
6093670|NCT00317473|21030389|P3|Overall Study|Relocation|1
6093671|NCT00317473|21030390|P2|Overall Study|Relocation|0
6093672|NCT00317473|21030391|P1|Overall Study|Relocation|1
6093673|NCT00317473|21030386|P6|Overall Study|Withdrawal by Subject|1
6093674|NCT00317473|21030387|P5|Overall Study|Withdrawal by Subject|3
6093675|NCT00317473|21030388|P4|Overall Study|Withdrawal by Subject|1
6093676|NCT00317473|21030389|P3|Overall Study|Withdrawal by Subject|2
6093677|NCT00317473|21030390|P2|Overall Study|Withdrawal by Subject|1
6093678|NCT00317473|21030391|P1|Overall Study|Withdrawal by Subject|2
6093679|NCT00317109|21030430|P2|Overall Study|Migated/moved from study area|0
6093680|NCT00317109|21030431|P1|Overall Study|Migated/moved from study area|1
6093681|NCT00317109|21030430|P2|Overall Study|Withdrawal by Subject|0
6093682|NCT00317109|21030431|P1|Overall Study|Withdrawal by Subject|2
6093683|NCT00317044|21030468|P3|Overall Study|Multiple Reasons|6
6093684|NCT00317044|21030469|P2|Overall Study|Multiple Reasons|2
6093685|NCT00317044|21030470|P1|Overall Study|Multiple Reasons|6
6093686|NCT00317044|21030468|P3|Overall Study|Lost to Follow-up|3
6093687|NCT00317044|21030469|P2|Overall Study|Lost to Follow-up|2
6093688|NCT00317044|21030470|P1|Overall Study|Lost to Follow-up|0
6093689|NCT00317044|21030468|P3|Overall Study|Withdrawal by Subject|12
6093690|NCT00317044|21030469|P2|Overall Study|Withdrawal by Subject|7
6093691|NCT00317044|21030470|P1|Overall Study|Withdrawal by Subject|10
6093692|NCT00317044|21030468|P3|Overall Study|Adverse Event|4
6093693|NCT00317044|21030469|P2|Overall Study|Adverse Event|7
6093694|NCT00317044|21030470|P1|Overall Study|Adverse Event|4
6093695|NCT00317044|21030468|P3|Overall Study|Protocol Violation|20
6093696|NCT00317044|21030469|P2|Overall Study|Protocol Violation|22
6093697|NCT00317044|21030470|P1|Overall Study|Protocol Violation|28
6093698|NCT00316914|21030516|P2|Overall Study|Missing end of treatment documentation|15
6093699|NCT00316914|21030517|P1|Overall Study|Missing end of treatment documentation|14
6093700|NCT00316914|21030516|P2|Overall Study|Other Problems|11
6093701|NCT00316914|21030517|P1|Overall Study|Other Problems|6
6093702|NCT00316914|21030516|P2|Overall Study|Adverse Event|7
6093703|NCT00316914|21030517|P1|Overall Study|Adverse Event|8
6093704|NCT00316914|21030516|P2|Overall Study|Withdrawal by Subject|3
6093705|NCT00316914|21030517|P1|Overall Study|Withdrawal by Subject|5
6093706|NCT00316888|21030547|P2|Overall Study|Not start protocol therapy|1
6093707|NCT00316888|21030548|P1|Overall Study|Not start protocol therapy|0
6093708|NCT00316888|21030547|P2|Overall Study|Withdrawal by Subject|2
6093709|NCT00316888|21030548|P1|Overall Study|Withdrawal by Subject|2
6093710|NCT00316888|21030547|P2|Overall Study|Adverse Event|5
6093711|NCT00316888|21030548|P1|Overall Study|Adverse Event|4
6093712|NCT00316719|21030570|P2|Overall Study|Consent withdrawn|0
6093713|NCT00316719|21030571|P1|Overall Study|Consent withdrawn|2
6093714|NCT00316719|21030570|P2|Overall Study|Adverse Event|6
6093715|NCT00316719|21030571|P1|Overall Study|Adverse Event|0
6093716|NCT00316706|21030597|P2|Overall Study|Lost to Follow-up|48
6093717|NCT00316706|21030598|P1|Overall Study|Lost to Follow-up|38
6093718|NCT00316693|21030614|P2|Overall Study|Other|44
6093719|NCT00316693|21030615|P1|Overall Study|Other|38
6093720|NCT00316693|21030614|P2|Overall Study|Lost to Follow-up|34
6093721|NCT00316693|21030615|P1|Overall Study|Lost to Follow-up|26
6093722|NCT00316693|21030614|P2|Overall Study|Withdrawal by Subject|6
6093723|NCT00316693|21030615|P1|Overall Study|Withdrawal by Subject|6
6093724|NCT00316693|21030614|P2|Overall Study|Protocol Violation|0
6093725|NCT00316693|21030615|P1|Overall Study|Protocol Violation|1
6093726|NCT00316693|21030614|P2|Overall Study|Adverse Event|1
6093727|NCT00316693|21030615|P1|Overall Study|Adverse Event|6
6093728|NCT00316602|21030657|P2|Overall Study|Other|6
6093729|NCT00316602|21030658|P1|Overall Study|Other|3
6093730|NCT00316602|21030657|P2|Overall Study|Adverse Event|0
6093731|NCT00316602|21030658|P1|Overall Study|Adverse Event|1
6093732|NCT00316602|21030657|P2|Overall Study|Subject unwilling/unable to comply with|17
6093733|NCT00316602|21030658|P1|Overall Study|Subject unwilling/unable to comply with|3
6093734|NCT00316602|21030657|P2|Overall Study|Withdrawal by Subject|2
6093735|NCT00316602|21030658|P1|Overall Study|Withdrawal by Subject|3
6093736|NCT00316589|21030690|P4|Overall Study|Other reason|1
6093737|NCT00316589|21030691|P3|Overall Study|Other reason|1
6093738|NCT00316589|21030692|P2|Overall Study|Other reason|12
6093739|NCT00316589|21030693|P1|Overall Study|Other reason|0
6093740|NCT00316589|21030690|P4|Overall Study|Physician Decision|0
6093741|NCT00316589|21030691|P3|Overall Study|Physician Decision|0
6093742|NCT00316589|21030692|P2|Overall Study|Physician Decision|1
6093743|NCT00316589|21030693|P1|Overall Study|Physician Decision|0
6093744|NCT00316589|21030690|P4|Overall Study|Adverse Event|1
6093745|NCT00316589|21030691|P3|Overall Study|Adverse Event|0
6093746|NCT00316589|21030692|P2|Overall Study|Adverse Event|0
6093747|NCT00316589|21030693|P1|Overall Study|Adverse Event|1
6093748|NCT00316589|21030690|P4|Overall Study|Subject unwilling/unable to comply|2
6093749|NCT00316589|21030691|P3|Overall Study|Subject unwilling/unable to comply|0
6093750|NCT00316589|21030692|P2|Overall Study|Subject unwilling/unable to comply|6
6093751|NCT00316589|21030693|P1|Overall Study|Subject unwilling/unable to comply|0
6093752|NCT00316589|21030690|P4|Overall Study|Withdrawal by Subject|1
6093753|NCT00316589|21030691|P3|Overall Study|Withdrawal by Subject|0
6093754|NCT00316589|21030692|P2|Overall Study|Withdrawal by Subject|5
6093755|NCT00316589|21030693|P1|Overall Study|Withdrawal by Subject|0
6093756|NCT00316303|21030827|P2|Overall Study|Lost to Follow-up|16
6093757|NCT00316303|21030828|P1|Overall Study|Lost to Follow-up|11
6093758|NCT00316277|21030844|P2|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|1
6093759|NCT00316277|21030845|P1|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|0
6093760|NCT00316277|21030844|P2|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|18
6093761|NCT00316277|21030845|P1|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|19
6093762|NCT00316277|21030844|P2|Phase 1 (12 Weeks)|Eligible for Phase 2|225
6093763|NCT00316277|21030845|P1|Phase 1 (12 Weeks)|Eligible for Phase 2|220
6093764|NCT00316277|21030844|P2|Phase 1 (12 Weeks)|Investigator-initiated termination|0
6093765|NCT00316277|21030845|P1|Phase 1 (12 Weeks)|Investigator-initiated termination|2
6093766|NCT00316277|21030844|P2|Phase 1 (12 Weeks)|Lost to Follow-up|75
6093767|NCT00316277|21030845|P1|Phase 1 (12 Weeks)|Lost to Follow-up|88
6093768|NCT00316264|21030866|P3|Overall Study|Other|0
6093769|NCT00316264|21030867|P2|Overall Study|Other|1
6093770|NCT00316264|21030868|P1|Overall Study|Other|1
6093771|NCT00316264|21030866|P3|Overall Study|Death|0
6093772|NCT00316264|21030867|P2|Overall Study|Death|0
6093773|NCT00316264|21030868|P1|Overall Study|Death|2
6093774|NCT00316264|21030866|P3|Overall Study|Withdrawal of Consent|6
6093775|NCT00316264|21030867|P2|Overall Study|Withdrawal of Consent|5
6093776|NCT00316264|21030868|P1|Overall Study|Withdrawal of Consent|3
6093777|NCT00316264|21030866|P3|Overall Study|Lost to Follow-up|0
6093778|NCT00316264|21030867|P2|Overall Study|Lost to Follow-up|1
6093779|NCT00316264|21030868|P1|Overall Study|Lost to Follow-up|0
6093780|NCT00316225|21030936|P1|Overall Study|Death|2
6093781|NCT00316225|21030936|P1|Overall Study|Withdrawal by Subject|3
6093782|NCT00316225|21030936|P1|Overall Study|Progressive Disease|15
6093783|NCT00316225|21030936|P1|Overall Study|Physician Decision|3
6093784|NCT00316225|21030936|P1|Overall Study|Adverse Event|2
6093785|NCT00316199|21030945|P1|Overall Study|Lost to Follow-up|2
6093786|NCT00316199|21030945|P1|Overall Study|Death|8
6093787|NCT00316199|21030945|P1|Overall Study|Adverse Event|2
6093788|NCT00316186|21030953|P1|Overall Study|Other|1
6093789|NCT00316186|21030953|P1|Overall Study|Lost to Follow-up|1
6093790|NCT00316186|21030953|P1|Overall Study|Disease Progression|4
6093791|NCT00316186|21030953|P1|Overall Study|Adverse Event|6
6093792|NCT00316173|21030967|P2|Treatment Phase|Study Follow-up Stopped|34
6093793|NCT00316173|21030968|P1|Treatment Phase|Study Follow-up Stopped|0
6093794|NCT00316173|21030967|P2|Treatment Phase|Withdrawal by Subject|1
6093795|NCT00316173|21030968|P1|Treatment Phase|Withdrawal by Subject|0
6093796|NCT00316173|21030967|P2|Treatment Phase|Lost to Follow-up|3
6093797|NCT00316173|21030968|P1|Treatment Phase|Lost to Follow-up|0
6093798|NCT00316173|21030967|P2|Treatment Phase|Lack of Efficacy|3
6093799|NCT00316173|21030968|P1|Treatment Phase|Lack of Efficacy|0
6093800|NCT00316173|21030967|P2|Treatment Phase|Adverse Event|1
6093801|NCT00316173|21030968|P1|Treatment Phase|Adverse Event|0
6093802|NCT00316173|21030967|P2|Run-in Phase|Study Follow-up Stopped|0
6093803|NCT00316173|21030968|P1|Run-in Phase|Study Follow-up Stopped|5
6093804|NCT00316173|21030967|P2|Run-in Phase|Protocol Violation|0
6093805|NCT00316173|21030968|P1|Run-in Phase|Protocol Violation|1
6093806|NCT00316173|21030967|P2|Run-in Phase|Adverse Event|0
6093807|NCT00316173|21030968|P1|Run-in Phase|Adverse Event|1
6093808|NCT00316121|21030981|P2|Overall Study|Subject did not have 24 month visit|0
6093809|NCT00316121|21030982|P1|Overall Study|Subject did not have 24 month visit|1
6093810|NCT00316121|21030981|P2|Overall Study|Subject no show for visit x 3|0
6093811|NCT00316121|21030982|P1|Overall Study|Subject no show for visit x 3|1
6093812|NCT00316121|21030981|P2|Overall Study|Subject refused to return|0
6093813|NCT00316121|21030982|P1|Overall Study|Subject refused to return|1
6093814|NCT00316121|21030981|P2|Overall Study|Subject relocated|1
6093815|NCT00316121|21030982|P1|Overall Study|Subject relocated|1
6093816|NCT00316121|21030981|P2|Overall Study|Reason is missing|0
6093817|NCT00316121|21030982|P1|Overall Study|Reason is missing|1
6093818|NCT00316121|21030981|P2|Overall Study|Withdrawal by Subject|0
6093819|NCT00316121|21030982|P1|Overall Study|Withdrawal by Subject|2
6093820|NCT00316121|21030981|P2|Overall Study|Lost to Follow-up|8
6093821|NCT00316121|21030982|P1|Overall Study|Lost to Follow-up|14
6093822|NCT00316121|21030981|P2|Overall Study|Death|0
6093823|NCT00316121|21030982|P1|Overall Study|Death|1
6093824|NCT00316082|21030993|P5|Overall Study|Administrative reason by sponsor|0
6093825|NCT00316082|21030994|P4|Overall Study|Administrative reason by sponsor|0
6093826|NCT00316082|21030995|P3|Overall Study|Administrative reason by sponsor|1
6093827|NCT00316082|21030996|P2|Overall Study|Administrative reason by sponsor|0
6093828|NCT00316082|21030997|P1|Overall Study|Administrative reason by sponsor|0
6093829|NCT00316082|21030993|P5|Overall Study|Death|0
6093830|NCT00316082|21030994|P4|Overall Study|Death|0
6093831|NCT00316082|21030995|P3|Overall Study|Death|1
6093832|NCT00316082|21030996|P2|Overall Study|Death|0
6093833|NCT00316082|21030997|P1|Overall Study|Death|0
6093834|NCT00316082|21030993|P5|Overall Study|Physician Decision|1
6093835|NCT00316082|21030994|P4|Overall Study|Physician Decision|1
6093836|NCT00316082|21030995|P3|Overall Study|Physician Decision|2
6093837|NCT00316082|21030996|P2|Overall Study|Physician Decision|1
6093838|NCT00316082|21030997|P1|Overall Study|Physician Decision|1
6093839|NCT00316082|21030993|P5|Overall Study|Subject no longer meets study criteria|1
6093840|NCT00316082|21030994|P4|Overall Study|Subject no longer meets study criteria|2
6093841|NCT00316082|21030995|P3|Overall Study|Subject no longer meets study criteria|2
6093842|NCT00316082|21030996|P2|Overall Study|Subject no longer meets study criteria|1
6093843|NCT00316082|21030997|P1|Overall Study|Subject no longer meets study criteria|3
6093844|NCT00316082|21030993|P5|Overall Study|Adverse Event|3
6093845|NCT00316082|21030994|P4|Overall Study|Adverse Event|1
6093846|NCT00316082|21030995|P3|Overall Study|Adverse Event|5
6093847|NCT00316082|21030996|P2|Overall Study|Adverse Event|2
6093848|NCT00316082|21030997|P1|Overall Study|Adverse Event|4
6093849|NCT00316082|21030993|P5|Overall Study|Poor/noncompliance|4
6093850|NCT00316082|21030994|P4|Overall Study|Poor/noncompliance|1
6093851|NCT00316082|21030995|P3|Overall Study|Poor/noncompliance|4
6093852|NCT00316082|21030996|P2|Overall Study|Poor/noncompliance|1
6093853|NCT00316082|21030997|P1|Overall Study|Poor/noncompliance|6
6093854|NCT00316082|21030993|P5|Overall Study|Lost to Follow-up|6
6093855|NCT00316082|21030994|P4|Overall Study|Lost to Follow-up|8
6093856|NCT00316082|21030995|P3|Overall Study|Lost to Follow-up|7
6093857|NCT00316082|21030996|P2|Overall Study|Lost to Follow-up|6
6093858|NCT00316082|21030997|P1|Overall Study|Lost to Follow-up|7
6093859|NCT00316082|21030993|P5|Overall Study|Withdrawal of Consent by Subject|5
6093860|NCT00316082|21030994|P4|Overall Study|Withdrawal of Consent by Subject|9
6093861|NCT00316082|21030995|P3|Overall Study|Withdrawal of Consent by Subject|2
6093862|NCT00316082|21030996|P2|Overall Study|Withdrawal of Consent by Subject|8
6093863|NCT00316082|21030997|P1|Overall Study|Withdrawal of Consent by Subject|10
6093864|NCT00316082|21030993|P5|Overall Study|Lack of Efficacy|6
6093865|NCT00316082|21030994|P4|Overall Study|Lack of Efficacy|4
6093866|NCT00316082|21030995|P3|Overall Study|Lack of Efficacy|3
6093867|NCT00316082|21030996|P2|Overall Study|Lack of Efficacy|3
6093868|NCT00316082|21030997|P1|Overall Study|Lack of Efficacy|2
6093869|NCT00316017|21031028|P3|Overall Study|Protocol Violation|19
6093870|NCT00316017|21031029|P2|Overall Study|Protocol Violation|13
6093871|NCT00316017|21031030|P1|Overall Study|Protocol Violation|11
6093872|NCT00316004|21031104|P3|Overall Study|Subject was not given study fluid.|21
6093873|NCT00316004|21031105|P2|Overall Study|Subject was not given study fluid.|14
6093874|NCT00316004|21031106|P1|Overall Study|Subject was not given study fluid.|14
6093875|NCT00315731|21031177|P1|Overall Study|Death|5
6093876|NCT00315731|21031177|P1|Overall Study|Lost to Follow-up|1
6093877|NCT00315705|21031205|P1|Phase 2|Death|7
6093878|NCT00315705|21031205|P1|Phase 2|Other|1
6093879|NCT00315705|21031205|P1|Phase 2|Scheduled for transplant|8
6093880|NCT00315705|21031205|P1|Phase 2|Disease relapse|1
6093881|NCT00315705|21031205|P1|Phase 2|Failure to achieve response|3
6093882|NCT00315705|21031205|P1|Phase 2|Adverse Event|1
6093883|NCT00315705|21031205|P1|Phase 2|Physician Decision|4
6093884|NCT00315705|21031205|P1|Phase 1|Death|3
6093885|NCT00315705|21031205|P1|Phase 1|Scheduled for transplant|9
6093886|NCT00315705|21031205|P1|Phase 1|Disease relapse|4
6093887|NCT00315705|21031205|P1|Phase 1|Failure to achieve response|8
6093888|NCT00315705|21031205|P1|Phase 1|Refused further treatment|1
6093889|NCT00315458|21031266|P4|Overall Study|Did not qualify|0
6093890|NCT00315458|21031267|P3|Overall Study|Did not qualify|1
6093891|NCT00315458|21031268|P2|Overall Study|Did not qualify|0
6093892|NCT00315458|21031269|P1|Overall Study|Did not qualify|0
6093893|NCT00315458|21031266|P4|Overall Study|Lack of Efficacy|1
6093894|NCT00315458|21031267|P3|Overall Study|Lack of Efficacy|20
6093895|NCT00315458|21031268|P2|Overall Study|Lack of Efficacy|0
6093896|NCT00315458|21031269|P1|Overall Study|Lack of Efficacy|0
6093897|NCT00315458|21031266|P4|Overall Study|Withdrawal by Subject|2
6093898|NCT00315458|21031267|P3|Overall Study|Withdrawal by Subject|0
6093899|NCT00315458|21031268|P2|Overall Study|Withdrawal by Subject|3
6093900|NCT00315458|21031269|P1|Overall Study|Withdrawal by Subject|0
6093901|NCT00315458|21031266|P4|Overall Study|Lost to Follow-up|2
6093902|NCT00315458|21031267|P3|Overall Study|Lost to Follow-up|0
6093903|NCT00315458|21031268|P2|Overall Study|Lost to Follow-up|2
6093904|NCT00315458|21031269|P1|Overall Study|Lost to Follow-up|1
6093905|NCT00315458|21031266|P4|Overall Study|Adverse Event|3
6093906|NCT00315458|21031267|P3|Overall Study|Adverse Event|23
6093907|NCT00315458|21031268|P2|Overall Study|Adverse Event|4
6093908|NCT00315458|21031269|P1|Overall Study|Adverse Event|2
6093909|NCT00315458|21031266|P4|Overall Study|Administrative|21
6093910|NCT00315458|21031267|P3|Overall Study|Administrative|8
6093911|NCT00315458|21031268|P2|Overall Study|Administrative|3
6093912|NCT00315458|21031269|P1|Overall Study|Administrative|0
6093913|NCT00315445|21031282|P3|Overall Study|Other|0
6093914|NCT00315445|21031283|P2|Overall Study|Other|3
6093915|NCT00315445|21031284|P1|Overall Study|Other|1
6093916|NCT00315445|21031282|P3|Overall Study|Protocol Violation|1
6093917|NCT00315445|21031283|P2|Overall Study|Protocol Violation|0
6093918|NCT00315445|21031284|P1|Overall Study|Protocol Violation|2
6093919|NCT00315445|21031282|P3|Overall Study|Lost to Follow-up|1
6093920|NCT00315445|21031283|P2|Overall Study|Lost to Follow-up|0
6093921|NCT00315445|21031284|P1|Overall Study|Lost to Follow-up|1
6093922|NCT00315445|21031282|P3|Overall Study|Lack of Efficacy|7
6093923|NCT00315445|21031283|P2|Overall Study|Lack of Efficacy|1
6093924|NCT00315445|21031284|P1|Overall Study|Lack of Efficacy|16
6093925|NCT00315445|21031282|P3|Overall Study|Adverse Event|15
6093926|NCT00315445|21031283|P2|Overall Study|Adverse Event|12
6093927|NCT00315445|21031284|P1|Overall Study|Adverse Event|7
6093928|NCT00315055|21031574|P2|Overall Study|Lost to Follow-up|1
6093929|NCT00315055|21031575|P1|Overall Study|Lost to Follow-up|1
6093930|NCT00315055|21031574|P2|Overall Study|Protocol Violation|4
6093931|NCT00315055|21031575|P1|Overall Study|Protocol Violation|2
6093932|NCT00314951|21031593|P2|Follow-up|mITT failure|34
6093933|NCT00314951|21031594|P1|Follow-up|mITT failure|44
6093934|NCT00314951|21031593|P2|Treatment|Didn't meet criteria for mITT population|11
6093935|NCT00314951|21031594|P1|Treatment|Didn't meet criteria for mITT population|16
6093936|NCT00314808|21031604|P1|Overall Study|Withdrawal by Subject/PI without AE|4
6093937|NCT00314808|21031604|P1|Overall Study|Disease Progression without AE|4
6093938|NCT00314795|21031612|P1|Overall Study|Participants Withdrew Consent|2
6093939|NCT00314795|21031612|P1|Overall Study|Renal Transplant|3
6093940|NCT00314795|21031612|P1|Overall Study|Reason not Specified|3
6093941|NCT00314795|21031612|P1|Overall Study|Death|4
6093942|NCT00314795|21031612|P1|Overall Study|Adverse Event|8
6093943|NCT00314574|21031622|P2|Overall Study|Data unknown at database lock|1
6093944|NCT00314574|21031623|P1|Overall Study|Data unknown at database lock|0
6093945|NCT00314574|21031622|P2|Overall Study|Pregnancy|4
6093946|NCT00314574|21031623|P1|Overall Study|Pregnancy|6
6093947|NCT00314574|21031622|P2|Overall Study|Physician Decision|15
6093948|NCT00314574|21031623|P1|Overall Study|Physician Decision|22
6093949|NCT00314574|21031622|P2|Overall Study|Withdrawal by Subject|22
6093950|NCT00314574|21031623|P1|Overall Study|Withdrawal by Subject|33
6093951|NCT00314574|21031622|P2|Overall Study|Lost to Follow-up|25
6093952|NCT00314574|21031623|P1|Overall Study|Lost to Follow-up|19
6093953|NCT00314574|21031622|P2|Overall Study|Adverse Event|16
6093954|NCT00314574|21031623|P1|Overall Study|Adverse Event|11
6093955|NCT00314574|21031622|P2|Overall Study|Death|0
6093956|NCT00314574|21031623|P1|Overall Study|Death|3
6093957|NCT00314366|21031639|P2|Overall Study|not treated due to patient medical condi|0
6093958|NCT00314366|21031640|P1|Overall Study|not treated due to patient medical condi|1
6093959|NCT00314340|21031685|P1|Overall Study|lost interest|1
6093960|NCT00314327|21031691|P1|Overall Study|Withdrawal by Subject|1
6093961|NCT00314262|21031696|P1|Overall Study|Physician Decision|1
6093962|NCT00314262|21031696|P1|Overall Study|Withdrawal by Subject|2
6093963|NCT00314262|21031696|P1|Overall Study|Adverse Event|2
6093964|NCT00314249|21031704|P2|Overall Study|Non-Compliant|6
6093965|NCT00314249|21031705|P1|Overall Study|Non-Compliant|5
6093966|NCT00314249|21031704|P2|Overall Study|Withdrawn for other reasons|1
6093967|NCT00314249|21031705|P1|Overall Study|Withdrawn for other reasons|4
6093968|NCT00314249|21031704|P2|Overall Study|Physician Decision|1
6093969|NCT00314249|21031705|P1|Overall Study|Physician Decision|1
6093970|NCT00314249|21031704|P2|Overall Study|Lost to Follow-up|9
6093971|NCT00314249|21031705|P1|Overall Study|Lost to Follow-up|15
6093972|NCT00314249|21031704|P2|Overall Study|Withdrawal by Subject|28
6093973|NCT00314249|21031705|P1|Overall Study|Withdrawal by Subject|21
6093974|NCT00314249|21031704|P2|Overall Study|Lack of Efficacy|24
6093975|NCT00314249|21031705|P1|Overall Study|Lack of Efficacy|33
6093976|NCT00314249|21031704|P2|Overall Study|Adverse Event|94
6093977|NCT00314249|21031705|P1|Overall Study|Adverse Event|73
6093978|NCT00314145|21031738|P2|Overall Study|Sponsor Decision|0
6093979|NCT00314145|21031739|P1|Overall Study|Sponsor Decision|2
6093980|NCT00314145|21031738|P2|Overall Study|Protocol Violation|0
6093981|NCT00314145|21031739|P1|Overall Study|Protocol Violation|3
6093982|NCT00314145|21031738|P2|Overall Study|Adverse Event|3
6093983|NCT00314145|21031739|P1|Overall Study|Adverse Event|0
6093984|NCT00314145|21031738|P2|Overall Study|Physician Decision|4
6093985|NCT00314145|21031739|P1|Overall Study|Physician Decision|3
6093986|NCT00314145|21031738|P2|Overall Study|Lost to Follow-up|12
6093987|NCT00314145|21031739|P1|Overall Study|Lost to Follow-up|5
6093988|NCT00314145|21031738|P2|Overall Study|Withdrawal by Subject|10
6093989|NCT00314145|21031739|P1|Overall Study|Withdrawal by Subject|8
6093990|NCT00314132|21031753|P2|Overall Study|Physician Decision|0
6093991|NCT00314132|21031754|P1|Overall Study|Physician Decision|1
6093992|NCT00314132|21031753|P2|Overall Study|Adverse Event|0
6093993|NCT00314132|21031754|P1|Overall Study|Adverse Event|1
6093994|NCT00314132|21031753|P2|Overall Study|Withdrawal by Subject|5
6093995|NCT00314132|21031754|P1|Overall Study|Withdrawal by Subject|3
6093996|NCT00314132|21031753|P2|Overall Study|Lost to Follow-up|13
6093997|NCT00314132|21031754|P1|Overall Study|Lost to Follow-up|3
6093998|NCT00313911|21031781|P2|Overall Study|Did not meet age criteria|1
6093999|NCT00313911|21031782|P1|Overall Study|Did not meet age criteria|1
6094000|NCT00313911|21031781|P2|Overall Study|Withdrawal by Subject|12
6094001|NCT00313911|21031782|P1|Overall Study|Withdrawal by Subject|39
6094002|NCT00313911|21031781|P2|Overall Study|Lost to Follow-up|14
6094003|NCT00313911|21031782|P1|Overall Study|Lost to Follow-up|27
6094004|NCT00313911|21031781|P2|Overall Study|Protocol Violation|10
6094005|NCT00313911|21031782|P1|Overall Study|Protocol Violation|19
6094006|NCT00313911|21031781|P2|Overall Study|Adverse Event|3
6094007|NCT00313911|21031782|P1|Overall Study|Adverse Event|2
6094008|NCT00313911|21031781|P2|Overall Study|Serious adverse event|1
6094009|NCT00313911|21031782|P1|Overall Study|Serious adverse event|6
6094010|NCT00313846|21031796|P2|Overall Study|Administrative|3
6094011|NCT00313846|21031797|P1|Overall Study|Administrative|2
6094012|NCT00313846|21031796|P2|Overall Study|Adverse Event|8
6094013|NCT00313846|21031797|P1|Overall Study|Adverse Event|1
6094014|NCT00313846|21031796|P2|Overall Study|Withdrawal by Subject|0
6094015|NCT00313846|21031797|P1|Overall Study|Withdrawal by Subject|2
6094028|NCT00313781|21031847|P3|After Crossover|Other|18
6094029|NCT00313781|21031848|P2|After Crossover|Other|0
6094030|NCT00313781|21031849|P1|After Crossover|Other|0
6094031|NCT00313781|21031847|P3|After Crossover|Withdrawal by Subject|3
6094032|NCT00313781|21031848|P2|After Crossover|Withdrawal by Subject|0
6094033|NCT00313781|21031849|P1|After Crossover|Withdrawal by Subject|0
6094034|NCT00313781|21031847|P3|After Crossover|Death|6
6094035|NCT00313781|21031848|P2|After Crossover|Death|0
6094036|NCT00313781|21031849|P1|After Crossover|Death|0
6094037|NCT00313781|21031847|P3|Before Crossover|Randomized, not treated|0
6094038|NCT00313781|21031848|P2|Before Crossover|Randomized, not treated|0
6094039|NCT00313781|21031849|P1|Before Crossover|Randomized, not treated|5
6094040|NCT00313781|21031847|P3|Before Crossover|Crossover|0
6094041|NCT00313781|21031848|P2|Before Crossover|Crossover|37
6094042|NCT00313781|21031849|P1|Before Crossover|Crossover|0
6094043|NCT00313781|21031847|P3|Before Crossover|Other|0
6094044|NCT00313781|21031848|P2|Before Crossover|Other|30
6094045|NCT00313781|21031849|P1|Before Crossover|Other|45
6094046|NCT00313781|21031847|P3|Before Crossover|Withdrawal by Subject|0
6094047|NCT00313781|21031848|P2|Before Crossover|Withdrawal by Subject|1
6094048|NCT00313781|21031849|P1|Before Crossover|Withdrawal by Subject|3
6094049|NCT00313781|21031847|P3|Before Crossover|Lost to Follow-up|0
6094050|NCT00313781|21031848|P2|Before Crossover|Lost to Follow-up|3
6094051|NCT00313781|21031849|P1|Before Crossover|Lost to Follow-up|0
6094052|NCT00313781|21031847|P3|Before Crossover|Death|0
6094053|NCT00313781|21031848|P2|Before Crossover|Death|8
6094054|NCT00313781|21031849|P1|Before Crossover|Death|22
6094055|NCT00313716|21031895|P6|Overall Study|Withdrawal by Subject|0
6094056|NCT00313716|21031896|P5|Overall Study|Withdrawal by Subject|1
6094057|NCT00313716|21031897|P4|Overall Study|Withdrawal by Subject|0
6094058|NCT00313716|21031898|P3|Overall Study|Withdrawal by Subject|1
6094059|NCT00313716|21031899|P2|Overall Study|Withdrawal by Subject|1
6094060|NCT00313716|21031900|P1|Overall Study|Withdrawal by Subject|0
6094061|NCT00313716|21031895|P6|Overall Study|Lost to Follow-up|4
6094062|NCT00313716|21031896|P5|Overall Study|Lost to Follow-up|0
6094063|NCT00313716|21031897|P4|Overall Study|Lost to Follow-up|1
6094064|NCT00313716|21031898|P3|Overall Study|Lost to Follow-up|2
6094065|NCT00313716|21031899|P2|Overall Study|Lost to Follow-up|5
6094066|NCT00313716|21031900|P1|Overall Study|Lost to Follow-up|2
6094067|NCT00313716|21031895|P6|Overall Study|Death|9
6094068|NCT00313716|21031896|P5|Overall Study|Death|5
6094069|NCT00313716|21031897|P4|Overall Study|Death|3
6094070|NCT00313716|21031898|P3|Overall Study|Death|9
6094071|NCT00313716|21031899|P2|Overall Study|Death|2
6094072|NCT00313716|21031900|P1|Overall Study|Death|3
6094073|NCT00313703|21031927|P4|Overall Study|Lost to Follow-up|12
6094074|NCT00313703|21031928|P3|Overall Study|Lost to Follow-up|5
6094075|NCT00313703|21031929|P2|Overall Study|Lost to Follow-up|2
6094076|NCT00313703|21031930|P1|Overall Study|Lost to Follow-up|11
6094077|NCT00313612|21031946|P2|Overall Study|Patient never received treatment|1
6094078|NCT00313612|21031947|P1|Overall Study|Patient never received treatment|0
6094079|NCT00313586|21031959|P4|Overall Study|Death before starting treatment|0
6094080|NCT00313586|21031960|P3|Overall Study|Death before starting treatment|0
6094081|NCT00313586|21031961|P2|Overall Study|Death before starting treatment|0
6094082|NCT00313586|21031962|P1|Overall Study|Death before starting treatment|1
6094083|NCT00313586|21031959|P4|Overall Study|Moved|0
6094084|NCT00313586|21031960|P3|Overall Study|Moved|0
6094085|NCT00313586|21031961|P2|Overall Study|Moved|1
6094086|NCT00313586|21031962|P1|Overall Study|Moved|0
6094087|NCT00313586|21031959|P4|Overall Study|Lost insurance|0
6094088|NCT00313586|21031960|P3|Overall Study|Lost insurance|0
6094089|NCT00313586|21031961|P2|Overall Study|Lost insurance|1
6094090|NCT00313586|21031962|P1|Overall Study|Lost insurance|0
6094091|NCT00313586|21031959|P4|Overall Study|Absolute neutrophil count not recovered|0
6094092|NCT00313586|21031960|P3|Overall Study|Absolute neutrophil count not recovered|0
6094093|NCT00313586|21031961|P2|Overall Study|Absolute neutrophil count not recovered|1
6094094|NCT00313586|21031962|P1|Overall Study|Absolute neutrophil count not recovered|2
6094095|NCT00313586|21031959|P4|Overall Study|Physician Decision|0
6094096|NCT00313586|21031960|P3|Overall Study|Physician Decision|0
6094097|NCT00313586|21031961|P2|Overall Study|Physician Decision|1
6094098|NCT00313586|21031962|P1|Overall Study|Physician Decision|2
6094099|NCT00313586|21031959|P4|Overall Study|Did not achieve HI-major/better response|1
6094100|NCT00313586|21031960|P3|Overall Study|Did not achieve HI-major/better response|2
6094101|NCT00313586|21031961|P2|Overall Study|Did not achieve HI-major/better response|7
6094102|NCT00313586|21031962|P1|Overall Study|Did not achieve HI-major/better response|10
6094103|NCT00313586|21031959|P4|Overall Study|Other complicating disease|0
6094104|NCT00313586|21031960|P3|Overall Study|Other complicating disease|0
6094105|NCT00313586|21031961|P2|Overall Study|Other complicating disease|2
6094106|NCT00313586|21031962|P1|Overall Study|Other complicating disease|2
6094107|NCT00313586|21031959|P4|Overall Study|Alternative therapy|0
6094108|NCT00313586|21031960|P3|Overall Study|Alternative therapy|2
6094109|NCT00313586|21031961|P2|Overall Study|Alternative therapy|6
6094110|NCT00313586|21031962|P1|Overall Study|Alternative therapy|3
6094111|NCT00313586|21031959|P4|Overall Study|Withdrawal by Subject|2
6094112|NCT00313586|21031960|P3|Overall Study|Withdrawal by Subject|6
6094113|NCT00313586|21031961|P2|Overall Study|Withdrawal by Subject|6
6094114|NCT00313586|21031962|P1|Overall Study|Withdrawal by Subject|13
6094115|NCT00313586|21031959|P4|Overall Study|Death|7
6094116|NCT00313586|21031960|P3|Overall Study|Death|1
6094117|NCT00313586|21031961|P2|Overall Study|Death|8
6094118|NCT00313586|21031962|P1|Overall Study|Death|11
6094119|NCT00313586|21031959|P4|Overall Study|Adverse Event|10
6094120|NCT00313586|21031960|P3|Overall Study|Adverse Event|3
6094121|NCT00313586|21031961|P2|Overall Study|Adverse Event|18
6094122|NCT00313586|21031962|P1|Overall Study|Adverse Event|12
6094123|NCT00313586|21031959|P4|Overall Study|Disease progression|3
6094124|NCT00313586|21031960|P3|Overall Study|Disease progression|10
6094125|NCT00313586|21031961|P2|Overall Study|Disease progression|19
6094126|NCT00313586|21031962|P1|Overall Study|Disease progression|14
6094127|NCT00313313|21031990|P3|Overall Study|Subject No Longer Meets Study Criteria|2
6094128|NCT00313313|21031991|P2|Overall Study|Subject No Longer Meets Study Criteria|3
6094129|NCT00313313|21031992|P1|Overall Study|Subject No Longer Meets Study Criteria|0
6094130|NCT00313313|21031990|P3|Overall Study|Death|2
6094131|NCT00313313|21031991|P2|Overall Study|Death|0
6094132|NCT00313313|21031992|P1|Overall Study|Death|0
6094133|NCT00313313|21031990|P3|Overall Study|Pregnancy|0
6094134|NCT00313313|21031991|P2|Overall Study|Pregnancy|2
6094135|NCT00313313|21031992|P1|Overall Study|Pregnancy|1
6094136|NCT00313313|21031990|P3|Overall Study|Poor/Noncompliance|2
6094137|NCT00313313|21031991|P2|Overall Study|Poor/Noncompliance|6
6094138|NCT00313313|21031992|P1|Overall Study|Poor/Noncompliance|3
6094139|NCT00313313|21031990|P3|Overall Study|Physician Decision|4
6094140|NCT00313313|21031991|P2|Overall Study|Physician Decision|6
6094141|NCT00313313|21031992|P1|Overall Study|Physician Decision|2
6094142|NCT00313313|21031990|P3|Overall Study|Adverse Event|12
6094143|NCT00313313|21031991|P2|Overall Study|Adverse Event|16
6094144|NCT00313313|21031992|P1|Overall Study|Adverse Event|15
6094145|NCT00313313|21031990|P3|Overall Study|Lost to Follow-up|9
6094146|NCT00313313|21031991|P2|Overall Study|Lost to Follow-up|7
6094147|NCT00313313|21031992|P1|Overall Study|Lost to Follow-up|10
6094148|NCT00313313|21031990|P3|Overall Study|Withdrawal of consent by subject|31
6094149|NCT00313313|21031991|P2|Overall Study|Withdrawal of consent by subject|17
6094150|NCT00313313|21031992|P1|Overall Study|Withdrawal of consent by subject|18
6094151|NCT00313313|21031990|P3|Overall Study|Lack of Efficacy|20
6094152|NCT00313313|21031991|P2|Overall Study|Lack of Efficacy|9
6094153|NCT00313313|21031992|P1|Overall Study|Lack of Efficacy|14
6094154|NCT00313300|21032014|P5|Follow-Up(30days)-Randomized Phase B|missing end of study status|0
6094155|NCT00313300|21032015|P4|Follow-Up(30days)-Randomized Phase B|missing end of study status|2
6094156|NCT00313300|21032016|P3|Follow-Up(30days)-Randomized Phase B|missing end of study status|0
6094157|NCT00313300|21032017|P2|Follow-Up(30days)-Randomized Phase B|missing end of study status|0
6094158|NCT00313300|21032018|P1|Follow-Up(30days)-Randomized Phase B|missing end of study status|1
6094159|NCT00313300|21032014|P5|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|1
6094160|NCT00313300|21032015|P4|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|2
6094161|NCT00313300|21032016|P3|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0
6094162|NCT00313300|21032017|P2|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0
6094163|NCT00313300|21032018|P1|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0
6094164|NCT00313300|21032014|P5|Follow-Up(30days)-Randomized Phase B|Death|0
6094165|NCT00313300|21032015|P4|Follow-Up(30days)-Randomized Phase B|Death|0
6094166|NCT00313300|21032016|P3|Follow-Up(30days)-Randomized Phase B|Death|0
6094167|NCT00313300|21032017|P2|Follow-Up(30days)-Randomized Phase B|Death|0
6094168|NCT00313300|21032018|P1|Follow-Up(30days)-Randomized Phase B|Death|1
6094169|NCT00313300|21032014|P5|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1
6094170|NCT00313300|21032015|P4|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1
6094171|NCT00313300|21032016|P3|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|2
6094172|NCT00313300|21032017|P2|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|0
6094173|NCT00313300|21032018|P1|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1
6094174|NCT00313300|21032014|P5|Follow-Up(30days)-Randomized Phase A|Death|0
6094175|NCT00313300|21032015|P4|Follow-Up(30days)-Randomized Phase A|Death|0
6094176|NCT00313300|21032016|P3|Follow-Up(30days)-Randomized Phase A|Death|0
6094177|NCT00313300|21032017|P2|Follow-Up(30days)-Randomized Phase A|Death|1
6094178|NCT00313300|21032018|P1|Follow-Up(30days)-Randomized Phase A|Death|0
6094179|NCT00313300|21032014|P5|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0
6094180|NCT00313300|21032015|P4|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0
6094181|NCT00313300|21032016|P3|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|2
6094182|NCT00313300|21032017|P2|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5
6094183|NCT00313300|21032018|P1|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5
6094184|NCT00313300|21032014|P5|Randomized in Phase B (26 Weeks)|non-specified|0
6094185|NCT00313300|21032015|P4|Randomized in Phase B (26 Weeks)|non-specified|0
6094186|NCT00313300|21032016|P3|Randomized in Phase B (26 Weeks)|non-specified|0
6094187|NCT00313300|21032017|P2|Randomized in Phase B (26 Weeks)|non-specified|0
6094188|NCT00313300|21032018|P1|Randomized in Phase B (26 Weeks)|non-specified|1
6094189|NCT00313300|21032014|P5|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|164
6094190|NCT00313300|21032015|P4|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|193
6094191|NCT00313300|21032016|P3|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|0
6094192|NCT00313300|21032017|P2|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|1
6094193|NCT00313300|21032018|P1|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|2
6094194|NCT00313300|21032014|P5|Randomized in Phase B (26 Weeks)|no longer meets criteria|2
6094195|NCT00313300|21032015|P4|Randomized in Phase B (26 Weeks)|no longer meets criteria|0
6094196|NCT00313300|21032016|P3|Randomized in Phase B (26 Weeks)|no longer meets criteria|2
6094197|NCT00313300|21032017|P2|Randomized in Phase B (26 Weeks)|no longer meets criteria|3
6094198|NCT00313300|21032018|P1|Randomized in Phase B (26 Weeks)|no longer meets criteria|9
6094199|NCT00313300|21032014|P5|Randomized in Phase B (26 Weeks)|poor/non-compliance|0
6094200|NCT00313300|21032015|P4|Randomized in Phase B (26 Weeks)|poor/non-compliance|0
6094201|NCT00313300|21032016|P3|Randomized in Phase B (26 Weeks)|poor/non-compliance|3
6094202|NCT00313300|21032017|P2|Randomized in Phase B (26 Weeks)|poor/non-compliance|1
6094203|NCT00313300|21032018|P1|Randomized in Phase B (26 Weeks)|poor/non-compliance|3
6094204|NCT00313300|21032014|P5|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3
6094205|NCT00313300|21032015|P4|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2
6094206|NCT00313300|21032016|P3|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3
6094207|NCT00313300|21032017|P2|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2
6094208|NCT00313300|21032018|P1|Randomized in Phase B (26 Weeks)|Lost to Follow-up|5
6094209|NCT00313300|21032014|P5|Randomized in Phase B (26 Weeks)|Death|1
6094210|NCT00313300|21032015|P4|Randomized in Phase B (26 Weeks)|Death|0
6094211|NCT00313300|21032016|P3|Randomized in Phase B (26 Weeks)|Death|1
6094212|NCT00313300|21032017|P2|Randomized in Phase B (26 Weeks)|Death|3
6094213|NCT00313300|21032018|P1|Randomized in Phase B (26 Weeks)|Death|5
6094214|NCT00313300|21032014|P5|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19
6094215|NCT00313300|21032015|P4|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|15
6094216|NCT00313300|21032016|P3|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19
6094217|NCT00313300|21032017|P2|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|14
6094218|NCT00313300|21032018|P1|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|35
6094219|NCT00313300|21032014|P5|Randomized in Phase B (26 Weeks)|Adverse Event|19
6094220|NCT00313300|21032015|P4|Randomized in Phase B (26 Weeks)|Adverse Event|23
6094221|NCT00313300|21032016|P3|Randomized in Phase B (26 Weeks)|Adverse Event|12
6094222|NCT00313300|21032017|P2|Randomized in Phase B (26 Weeks)|Adverse Event|9
6094223|NCT00313300|21032018|P1|Randomized in Phase B (26 Weeks)|Adverse Event|34
6094224|NCT00313300|21032014|P5|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0
6094225|NCT00313300|21032015|P4|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0
6094226|NCT00313300|21032016|P3|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0
6094227|NCT00313300|21032017|P2|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0
6094228|NCT00313300|21032018|P1|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|1
6094229|NCT00313300|21032014|P5|Randomized in Phase A (26 Weeks)|no longer meets criteria|0
6094230|NCT00313300|21032015|P4|Randomized in Phase A (26 Weeks)|no longer meets criteria|0
6094231|NCT00313300|21032016|P3|Randomized in Phase A (26 Weeks)|no longer meets criteria|2
6094232|NCT00313300|21032017|P2|Randomized in Phase A (26 Weeks)|no longer meets criteria|3
6094233|NCT00313300|21032018|P1|Randomized in Phase A (26 Weeks)|no longer meets criteria|4
6094234|NCT00313300|21032014|P5|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0
6094235|NCT00313300|21032015|P4|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0
6094236|NCT00313300|21032016|P3|Randomized in Phase A (26 Weeks)|Poor/non-compliance|1
6094237|NCT00313300|21032017|P2|Randomized in Phase A (26 Weeks)|Poor/non-compliance|2
6094238|NCT00313300|21032018|P1|Randomized in Phase A (26 Weeks)|Poor/non-compliance|3
6094239|NCT00313300|21032014|P5|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0
6094240|NCT00313300|21032015|P4|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0
6094241|NCT00313300|21032016|P3|Randomized in Phase A (26 Weeks)|Lost to Follow-up|2
6094242|NCT00313300|21032017|P2|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4
6094243|NCT00313300|21032018|P1|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4
6094244|NCT00313300|21032014|P5|Randomized in Phase A (26 Weeks)|Death|0
6094245|NCT00313300|21032015|P4|Randomized in Phase A (26 Weeks)|Death|0
6094246|NCT00313300|21032016|P3|Randomized in Phase A (26 Weeks)|Death|0
6094247|NCT00313300|21032017|P2|Randomized in Phase A (26 Weeks)|Death|4
6094248|NCT00313300|21032018|P1|Randomized in Phase A (26 Weeks)|Death|3
6094249|NCT00313300|21032014|P5|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0
6094250|NCT00313300|21032015|P4|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0
6094251|NCT00313300|21032016|P3|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|13
6094252|NCT00313300|21032017|P2|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|12
6094253|NCT00313300|21032018|P1|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|20
6094254|NCT00313300|21032014|P5|Randomized in Phase A (26 Weeks)|Adverse Event|0
6094344|NCT00312728|21032319|P1|Overall Study|Protocol Violation|2
6094255|NCT00313300|21032015|P4|Randomized in Phase A (26 Weeks)|Adverse Event|0
6094256|NCT00313300|21032016|P3|Randomized in Phase A (26 Weeks)|Adverse Event|17
6094257|NCT00313300|21032017|P2|Randomized in Phase A (26 Weeks)|Adverse Event|14
6094258|NCT00313300|21032018|P1|Randomized in Phase A (26 Weeks)|Adverse Event|19
6094259|NCT00313170|21032088|P3|Overall Study|Progression (investigators opinion)|0
6094260|NCT00313170|21032089|P2|Overall Study|Progression (investigators opinion)|0
6094261|NCT00313170|21032090|P1|Overall Study|Progression (investigators opinion)|1
6094262|NCT00313170|21032088|P3|Overall Study|Lost to Follow-up|1
6094263|NCT00313170|21032089|P2|Overall Study|Lost to Follow-up|0
6094264|NCT00313170|21032090|P1|Overall Study|Lost to Follow-up|0
6094265|NCT00313170|21032088|P3|Overall Study|Incorrect enrollment|1
6094266|NCT00313170|21032089|P2|Overall Study|Incorrect enrollment|2
6094267|NCT00313170|21032090|P1|Overall Study|Incorrect enrollment|0
6094268|NCT00313170|21032088|P3|Overall Study|Withdrawal by Subject|1
6094269|NCT00313170|21032089|P2|Overall Study|Withdrawal by Subject|0
6094270|NCT00313170|21032090|P1|Overall Study|Withdrawal by Subject|1
6094271|NCT00313170|21032088|P3|Overall Study|Disease progression|27
6094272|NCT00313170|21032089|P2|Overall Study|Disease progression|26
6094273|NCT00313170|21032090|P1|Overall Study|Disease progression|31
6094274|NCT00313170|21032088|P3|Overall Study|Adverse Event|0
6094275|NCT00313170|21032089|P2|Overall Study|Adverse Event|2
6094276|NCT00313170|21032090|P1|Overall Study|Adverse Event|1
6094277|NCT00313170|21032088|P3|Overall Study|Death|2
6094278|NCT00313170|21032089|P2|Overall Study|Death|4
6094279|NCT00313170|21032090|P1|Overall Study|Death|2
6094280|NCT00313144|21032109|P1|Overall Study|Due to termination of the study|66
6094281|NCT00313144|21032109|P1|Overall Study|Change to different product|1
6094282|NCT00313144|21032109|P1|Overall Study|Insurance (homecare provider) change|1
6094283|NCT00313144|21032109|P1|Overall Study|Liver transplant|1
6094284|NCT00313144|21032109|P1|Overall Study|Adverse event - transient|5
6094285|NCT00313144|21032109|P1|Overall Study|Physician Decision|4
6094286|NCT00313144|21032109|P1|Overall Study|Terminated by sponsor/ homecare provider|4
6094287|NCT00313144|21032109|P1|Overall Study|Withdrawal by Subject|4
6094288|NCT00313144|21032109|P1|Overall Study|Lost to Follow-up|5
6094289|NCT00313144|21032109|P1|Overall Study|Death|7
6094290|NCT00313144|21032109|P1|Overall Study|Discontinue Aralast ≥4 consecutive doses|12
6094291|NCT00313014|21032196|P3|Overall Study|Lack of Efficacy|16
6094292|NCT00313014|21032197|P2|Overall Study|Lack of Efficacy|25
6094293|NCT00313014|21032198|P1|Overall Study|Lack of Efficacy|52
6094294|NCT00313014|21032196|P3|Overall Study|Administrative|14
6094295|NCT00313014|21032197|P2|Overall Study|Administrative|6
6094296|NCT00313014|21032198|P1|Overall Study|Administrative|9
6094297|NCT00313014|21032196|P3|Overall Study|Lost to Follow-up|10
6094298|NCT00313014|21032197|P2|Overall Study|Lost to Follow-up|6
6094299|NCT00313014|21032198|P1|Overall Study|Lost to Follow-up|7
6094300|NCT00313014|21032196|P3|Overall Study|Adverse Event|16
6094301|NCT00313014|21032197|P2|Overall Study|Adverse Event|29
6094302|NCT00313014|21032198|P1|Overall Study|Adverse Event|14
6094303|NCT00313014|21032196|P3|Overall Study|Withdrawal by Subject|5
6094304|NCT00313014|21032197|P2|Overall Study|Withdrawal by Subject|7
6094305|NCT00313014|21032198|P1|Overall Study|Withdrawal by Subject|11
6094306|NCT00312897|21032229|P2|Overall Study|discontinued prior to getting treatment|3
6094307|NCT00312897|21032230|P1|Overall Study|discontinued prior to getting treatment|0
6094308|NCT00312897|21032229|P2|Overall Study|Pregnancy|0
6094309|NCT00312897|21032230|P1|Overall Study|Pregnancy|1
6094310|NCT00312897|21032229|P2|Overall Study|Withdrawal by Subject|3
6094311|NCT00312897|21032230|P1|Overall Study|Withdrawal by Subject|1
6094312|NCT00312897|21032229|P2|Overall Study|Physician Decision|0
6094313|NCT00312897|21032230|P1|Overall Study|Physician Decision|1
6094314|NCT00312897|21032229|P2|Overall Study|Lost to Follow-up|0
6094315|NCT00312897|21032230|P1|Overall Study|Lost to Follow-up|2
6094316|NCT00312897|21032229|P2|Overall Study|Adverse Event|0
6094317|NCT00312897|21032230|P1|Overall Study|Adverse Event|1
6094318|NCT00312858|21032255|P2|Overall Study|Other|12
6094319|NCT00312858|21032256|P1|Overall Study|Other|9
6094320|NCT00312858|21032255|P2|Overall Study|Participant Moved|10
6094321|NCT00312858|21032256|P1|Overall Study|Participant Moved|11
6094322|NCT00312858|21032255|P2|Overall Study|Withdraw by Participant|20
6094323|NCT00312858|21032256|P1|Overall Study|Withdraw by Participant|20
6094324|NCT00312858|21032255|P2|Overall Study|Protocol Violation|8
6094325|NCT00312858|21032256|P1|Overall Study|Protocol Violation|3
6094326|NCT00312858|21032255|P2|Overall Study|Lost to Follow-up|42
6094327|NCT00312858|21032256|P1|Overall Study|Lost to Follow-up|25
6094328|NCT00312858|21032255|P2|Overall Study|Adverse Event|1
6094329|NCT00312858|21032256|P1|Overall Study|Adverse Event|0
6094330|NCT00312845|21032310|P2|Overall Study|Other|5
6094331|NCT00312845|21032311|P1|Overall Study|Other|6
6094332|NCT00312845|21032310|P2|Overall Study|Lost to Follow-up|0
6094333|NCT00312845|21032311|P1|Overall Study|Lost to Follow-up|2
6094334|NCT00312845|21032310|P2|Overall Study|Disease Progression|77
6094335|NCT00312845|21032311|P1|Overall Study|Disease Progression|56
6094336|NCT00312845|21032310|P2|Overall Study|Withdrawal by Subject|6
6094337|NCT00312845|21032311|P1|Overall Study|Withdrawal by Subject|14
6094338|NCT00312845|21032310|P2|Overall Study|Death|2
6094339|NCT00312845|21032311|P1|Overall Study|Death|2
6094340|NCT00312845|21032310|P2|Overall Study|Adverse Event|5
6094341|NCT00312845|21032311|P1|Overall Study|Adverse Event|19
6094342|NCT00312728|21032319|P1|Overall Study|Other|1
6094343|NCT00312728|21032319|P1|Overall Study|Other|10
6094345|NCT00312728|21032319|P1|Overall Study|Required non-protocol cancer treatment|2
6094346|NCT00312728|21032319|P1|Overall Study|Withdrawal by Subject|10
6094347|NCT00312728|21032319|P1|Overall Study|Adverse Event|32
6094348|NCT00312728|21032319|P1|Overall Study|Progressive disease|53
6094349|NCT00312702|21032331|P3|Immunization Phase|Lost to Follow-up|0
6094350|NCT00312702|21032332|P2|Immunization Phase|Lost to Follow-up|1
6094351|NCT00312702|21032333|P1|Immunization Phase|Lost to Follow-up|0
6094352|NCT00312663|21032346|P3|Immunization Phase|Adverse Event|0
6094353|NCT00312663|21032347|P2|Immunization Phase|Adverse Event|1
6094354|NCT00312663|21032348|P1|Immunization Phase|Adverse Event|0
6094355|NCT00312572|21032361|P2|Overall Study|Lack of Efficacy|2
6094356|NCT00312572|21032362|P1|Overall Study|Lack of Efficacy|1
6094357|NCT00312572|21032361|P2|Overall Study|Administrative|2
6094358|NCT00312572|21032362|P1|Overall Study|Administrative|4
6094359|NCT00312572|21032361|P2|Overall Study|Lost to Follow-up|1
6094360|NCT00312572|21032362|P1|Overall Study|Lost to Follow-up|1
6094361|NCT00312572|21032361|P2|Overall Study|Adverse Event|16
6094362|NCT00312572|21032362|P1|Overall Study|Adverse Event|10
6094363|NCT00312494|21032373|P3|Overall Study|Other|1
6094364|NCT00312494|21032374|P2|Overall Study|Other|10
6094365|NCT00312494|21032375|P1|Overall Study|Other|10
6094366|NCT00312494|21032373|P3|Overall Study|Withdrawal by Subject|10
6094367|NCT00312494|21032374|P2|Overall Study|Withdrawal by Subject|9
6094368|NCT00312494|21032375|P1|Overall Study|Withdrawal by Subject|6
6094369|NCT00312494|21032373|P3|Overall Study|Lost to Follow-up|8
6094370|NCT00312494|21032374|P2|Overall Study|Lost to Follow-up|8
6094371|NCT00312494|21032375|P1|Overall Study|Lost to Follow-up|8
6094372|NCT00312494|21032373|P3|Overall Study|Laboratory abnormality|0
6094373|NCT00312494|21032374|P2|Overall Study|Laboratory abnormality|0
6094374|NCT00312494|21032375|P1|Overall Study|Laboratory abnormality|1
6094375|NCT00312494|21032373|P3|Overall Study|Lack of Efficacy|8
6094376|NCT00312494|21032374|P2|Overall Study|Lack of Efficacy|6
6094377|NCT00312494|21032375|P1|Overall Study|Lack of Efficacy|4
6094378|NCT00312494|21032373|P3|Overall Study|Adverse Event|11
6094379|NCT00312494|21032374|P2|Overall Study|Adverse Event|15
6094380|NCT00312494|21032375|P1|Overall Study|Adverse Event|33
6094381|NCT00312494|21032373|P3|Overall Study|Randomized; not treated with study drug|5
6094382|NCT00312494|21032374|P2|Overall Study|Randomized; not treated with study drug|10
6094383|NCT00312494|21032375|P1|Overall Study|Randomized; not treated with study drug|9
6094384|NCT00312377|21032409|P2|Overall Study|Site ended participation in study|0
6094385|NCT00312377|21032410|P1|Overall Study|Site ended participation in study|1
6094386|NCT00312377|21032409|P2|Overall Study|Discontinue treatment survival follow up|200
6094387|NCT00312377|21032410|P1|Overall Study|Discontinue treatment survival follow up|202
6094388|NCT00312377|21032409|P2|Overall Study|Randomised but never received treatment|6
6094389|NCT00312377|21032410|P1|Overall Study|Randomised but never received treatment|6
6094390|NCT00312377|21032409|P2|Overall Study|Non-compliance|2
6094391|NCT00312377|21032410|P1|Overall Study|Non-compliance|0
6094392|NCT00312377|21032409|P2|Overall Study|Lost to Follow-up|12
6094393|NCT00312377|21032410|P1|Overall Study|Lost to Follow-up|9
6094394|NCT00312377|21032409|P2|Overall Study|Withdrawal by Subject|30
6094395|NCT00312377|21032410|P1|Overall Study|Withdrawal by Subject|23
6094396|NCT00312377|21032409|P2|Overall Study|Death|418
6094397|NCT00312377|21032410|P1|Overall Study|Death|403
6094398|NCT00312338|21032434|P2|Overall Study|Subsequent infection|0
6094399|NCT00312338|21032435|P1|Overall Study|Subsequent infection|2
6094400|NCT00312338|21032434|P2|Overall Study|Withdrawal by Subject|0
6094401|NCT00312338|21032435|P1|Overall Study|Withdrawal by Subject|4
6094402|NCT00312338|21032434|P2|Overall Study|Lost to Follow-up|1
6094403|NCT00312338|21032435|P1|Overall Study|Lost to Follow-up|9
6094404|NCT00312338|21032434|P2|Overall Study|Adverse Event|2
6094405|NCT00312338|21032435|P1|Overall Study|Adverse Event|7
6094406|NCT00312221|21032448|P4|Double-blind Phase|Lack of Efficacy|10
6094407|NCT00312221|21032449|P3|Double-blind Phase|Lack of Efficacy|6
6094408|NCT00312221|21032450|P2|Double-blind Phase|Lack of Efficacy|17
6094409|NCT00312221|21032451|P1|Double-blind Phase|Lack of Efficacy|0
6094410|NCT00312221|21032448|P4|Double-blind Phase|Administrative|33
6094411|NCT00312221|21032449|P3|Double-blind Phase|Administrative|37
6094412|NCT00312221|21032450|P2|Double-blind Phase|Administrative|26
6094413|NCT00312221|21032451|P1|Double-blind Phase|Administrative|0
6094414|NCT00312221|21032448|P4|Double-blind Phase|Lost to Follow-up|2
6094415|NCT00312221|21032449|P3|Double-blind Phase|Lost to Follow-up|2
6094416|NCT00312221|21032450|P2|Double-blind Phase|Lost to Follow-up|0
6094417|NCT00312221|21032451|P1|Double-blind Phase|Lost to Follow-up|0
6094418|NCT00312221|21032448|P4|Double-blind Phase|Adverse Event|18
6094419|NCT00312221|21032449|P3|Double-blind Phase|Adverse Event|19
6094420|NCT00312221|21032450|P2|Double-blind Phase|Adverse Event|10
6094421|NCT00312221|21032451|P1|Double-blind Phase|Adverse Event|0
6094422|NCT00312221|21032448|P4|Double-blind Phase|Withdrawal by Subject|7
6094423|NCT00312221|21032449|P3|Double-blind Phase|Withdrawal by Subject|8
6094424|NCT00312221|21032450|P2|Double-blind Phase|Withdrawal by Subject|6
6094425|NCT00312221|21032451|P1|Double-blind Phase|Withdrawal by Subject|0
6094426|NCT00312221|21032448|P4|Open-label Run-in Period|Did not qualify|0
6094427|NCT00312221|21032449|P3|Open-label Run-in Period|Did not qualify|0
6094428|NCT00312221|21032450|P2|Open-label Run-in Period|Did not qualify|0
6094429|NCT00312221|21032451|P1|Open-label Run-in Period|Did not qualify|5
6094430|NCT00312221|21032448|P4|Open-label Run-in Period|Lack of Efficacy|0
6094431|NCT00312221|21032449|P3|Open-label Run-in Period|Lack of Efficacy|0
6094432|NCT00312221|21032450|P2|Open-label Run-in Period|Lack of Efficacy|0
6094433|NCT00312221|21032451|P1|Open-label Run-in Period|Lack of Efficacy|102
6094434|NCT00312221|21032448|P4|Open-label Run-in Period|Administrative|0
6094435|NCT00312221|21032449|P3|Open-label Run-in Period|Administrative|0
6094436|NCT00312221|21032450|P2|Open-label Run-in Period|Administrative|0
6094437|NCT00312221|21032451|P1|Open-label Run-in Period|Administrative|42
6094438|NCT00312221|21032448|P4|Open-label Run-in Period|Lost to Follow-up|0
6094439|NCT00312221|21032449|P3|Open-label Run-in Period|Lost to Follow-up|0
6094440|NCT00312221|21032450|P2|Open-label Run-in Period|Lost to Follow-up|0
6094441|NCT00312221|21032451|P1|Open-label Run-in Period|Lost to Follow-up|5
6094442|NCT00312221|21032448|P4|Open-label Run-in Period|Adverse Event|0
6094443|NCT00312221|21032449|P3|Open-label Run-in Period|Adverse Event|0
6094444|NCT00312221|21032450|P2|Open-label Run-in Period|Adverse Event|0
6094445|NCT00312221|21032451|P1|Open-label Run-in Period|Adverse Event|74
6094446|NCT00312221|21032448|P4|Open-label Run-in Period|Withdrawal by Subject|0
6094447|NCT00312221|21032449|P3|Open-label Run-in Period|Withdrawal by Subject|0
6094448|NCT00312221|21032450|P2|Open-label Run-in Period|Withdrawal by Subject|0
6094449|NCT00312221|21032451|P1|Open-label Run-in Period|Withdrawal by Subject|6
6094450|NCT00312208|21032471|P2|Overall Study|Other|7
6094451|NCT00312208|21032472|P1|Overall Study|Other|5
6094452|NCT00312208|21032471|P2|Overall Study|Withdrawal by Subject|42
6094453|NCT00312208|21032472|P1|Overall Study|Withdrawal by Subject|53
6094454|NCT00312208|21032471|P2|Overall Study|Lost to Follow-up|5
6094455|NCT00312208|21032472|P1|Overall Study|Lost to Follow-up|3
6094456|NCT00312208|21032471|P2|Overall Study|Lack of Efficacy|4
6094457|NCT00312208|21032472|P1|Overall Study|Lack of Efficacy|7
6094458|NCT00312208|21032471|P2|Overall Study|Death|1
6094459|NCT00312208|21032472|P1|Overall Study|Death|2
6094460|NCT00312208|21032471|P2|Overall Study|Protocol Violation|3
6094461|NCT00312208|21032472|P1|Overall Study|Protocol Violation|5
6094462|NCT00312208|21032471|P2|Overall Study|Adverse Event|61
6094463|NCT00312208|21032472|P1|Overall Study|Adverse Event|97
6094464|NCT00312195|21032482|P2|Overall Study|Protocol Violation|0
6094465|NCT00312195|21032483|P1|Overall Study|Protocol Violation|1
6094466|NCT00312195|21032482|P2|Overall Study|Lost to Follow-up|0
6094467|NCT00312195|21032483|P1|Overall Study|Lost to Follow-up|1
6094468|NCT00312195|21032482|P2|Overall Study|Adverse Event|6
6094469|NCT00312195|21032483|P1|Overall Study|Adverse Event|4
6094470|NCT00311623|21032511|P3|Overall Study|Physician Decision|2
6094471|NCT00311623|21032512|P2|Overall Study|Physician Decision|0
6094472|NCT00311623|21032513|P1|Overall Study|Physician Decision|0
6094473|NCT00311584|21032555|P2|Overall Study|ineligible|2
6094474|NCT00311584|21032556|P1|Overall Study|ineligible|2
6094475|NCT00311584|21032555|P2|Overall Study|Withdrawal by Subject|1
6094476|NCT00311584|21032556|P1|Overall Study|Withdrawal by Subject|1
6094477|NCT00311584|21032555|P2|Overall Study|Physician Decision|5
6094478|NCT00311584|21032556|P1|Overall Study|Physician Decision|4
6094479|NCT00311584|21032555|P2|Overall Study|Lack of Efficacy|15
6094480|NCT00311584|21032556|P1|Overall Study|Lack of Efficacy|12
6094481|NCT00311584|21032555|P2|Overall Study|Death|0
6094482|NCT00311584|21032556|P1|Overall Study|Death|1
6094483|NCT00311402|21032564|P2|Overall Study|IRB's rejection etc.|3
6094484|NCT00311402|21032565|P1|Overall Study|IRB's rejection etc.|10
6094485|NCT00311402|21032564|P2|Overall Study|Protocol Violation|6
6094486|NCT00311402|21032565|P1|Overall Study|Protocol Violation|7
6094487|NCT00311402|21032564|P2|Overall Study|Lack of Efficacy|42
6094488|NCT00311402|21032565|P1|Overall Study|Lack of Efficacy|58
6094489|NCT00311402|21032564|P2|Overall Study|Withdrawal by Subject|18
6094490|NCT00311402|21032565|P1|Overall Study|Withdrawal by Subject|17
6094491|NCT00311402|21032564|P2|Overall Study|Lost to Follow-up|3
6094492|NCT00311402|21032565|P1|Overall Study|Lost to Follow-up|0
6094493|NCT00311402|21032564|P2|Overall Study|Adverse Event|105
6094494|NCT00311402|21032565|P1|Overall Study|Adverse Event|118
6094495|NCT00311363|21032614|P3|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0
6094496|NCT00311363|21032615|P2|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|1
6094497|NCT00311363|21032616|P1|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0
6094498|NCT00311363|21032614|P3|12-Week Double-Blind Treatment Period|Protocol Violation|2
6094499|NCT00311363|21032615|P2|12-Week Double-Blind Treatment Period|Protocol Violation|1
6094500|NCT00311363|21032616|P1|12-Week Double-Blind Treatment Period|Protocol Violation|0
6094501|NCT00311363|21032614|P3|12-Week Double-Blind Treatment Period|Withdrawal by Subject|4
6094502|NCT00311363|21032615|P2|12-Week Double-Blind Treatment Period|Withdrawal by Subject|2
6094503|NCT00311363|21032616|P1|12-Week Double-Blind Treatment Period|Withdrawal by Subject|0
6094504|NCT00311363|21032614|P3|12-Week Double-Blind Treatment Period|Lack of Efficacy|4
6094505|NCT00311363|21032615|P2|12-Week Double-Blind Treatment Period|Lack of Efficacy|6
6094506|NCT00311363|21032616|P1|12-Week Double-Blind Treatment Period|Lack of Efficacy|0
6094507|NCT00311363|21032614|P3|12-Week Double-Blind Treatment Period|Lost to Follow-up|2
6094508|NCT00311363|21032615|P2|12-Week Double-Blind Treatment Period|Lost to Follow-up|1
6094509|NCT00311363|21032616|P1|12-Week Double-Blind Treatment Period|Lost to Follow-up|0
6094510|NCT00311363|21032614|P3|12-Week Double-Blind Treatment Period|Adverse Event|0
6094511|NCT00311363|21032615|P2|12-Week Double-Blind Treatment Period|Adverse Event|3
6094512|NCT00311363|21032616|P1|12-Week Double-Blind Treatment Period|Adverse Event|0
6094513|NCT00311363|21032614|P3|24-Week Single-Blind Treatment Period|Death|0
6094514|NCT00311363|21032615|P2|24-Week Single-Blind Treatment Period|Death|0
6094515|NCT00311363|21032616|P1|24-Week Single-Blind Treatment Period|Death|1
6094516|NCT00311363|21032614|P3|24-Week Single-Blind Treatment Period|Pregnancy|0
6094517|NCT00311363|21032615|P2|24-Week Single-Blind Treatment Period|Pregnancy|0
6094518|NCT00311363|21032616|P1|24-Week Single-Blind Treatment Period|Pregnancy|1
6094519|NCT00311363|21032614|P3|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0
6094520|NCT00311363|21032615|P2|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0
6094521|NCT00311363|21032616|P1|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|1
6094522|NCT00311363|21032614|P3|24-Week Single-Blind Treatment Period|Elective Surgery|0
6094523|NCT00311363|21032615|P2|24-Week Single-Blind Treatment Period|Elective Surgery|0
6094524|NCT00311363|21032616|P1|24-Week Single-Blind Treatment Period|Elective Surgery|1
6094525|NCT00311363|21032614|P3|24-Week Single-Blind Treatment Period|Protocol Violation|0
6094526|NCT00311363|21032615|P2|24-Week Single-Blind Treatment Period|Protocol Violation|0
6094527|NCT00311363|21032616|P1|24-Week Single-Blind Treatment Period|Protocol Violation|8
6094528|NCT00311363|21032614|P3|24-Week Single-Blind Treatment Period|Lost to Follow-up|0
6094529|NCT00311363|21032615|P2|24-Week Single-Blind Treatment Period|Lost to Follow-up|0
6094530|NCT00311363|21032616|P1|24-Week Single-Blind Treatment Period|Lost to Follow-up|12
6094531|NCT00311363|21032614|P3|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0
6094532|NCT00311363|21032615|P2|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0
6094533|NCT00311363|21032616|P1|24-Week Single-Blind Treatment Period|Withdrawal by Subject|27
6094534|NCT00311363|21032614|P3|24-Week Single-Blind Treatment Period|Lack of Efficacy|0
6094535|NCT00311363|21032615|P2|24-Week Single-Blind Treatment Period|Lack of Efficacy|0
6094536|NCT00311363|21032616|P1|24-Week Single-Blind Treatment Period|Lack of Efficacy|13
6094537|NCT00311363|21032614|P3|24-Week Single-Blind Treatment Period|Adverse Event|0
6094538|NCT00311363|21032615|P2|24-Week Single-Blind Treatment Period|Adverse Event|0
6094539|NCT00311363|21032616|P1|24-Week Single-Blind Treatment Period|Adverse Event|42
6094540|NCT00311311|21032676|P2|Overall Study|Lack of ancillary assistance|1
6094541|NCT00311311|21032677|P1|Overall Study|Lack of ancillary assistance|0
6094542|NCT00311311|21032676|P2|Overall Study|Death|0
6094543|NCT00311311|21032677|P1|Overall Study|Death|1
6094544|NCT00311311|21032676|P2|Overall Study|Study Termination by Sponsor|4
6094545|NCT00311311|21032677|P1|Overall Study|Study Termination by Sponsor|3
6094546|NCT00311311|21032676|P2|Overall Study|Noncompliance|1
6094547|NCT00311311|21032677|P1|Overall Study|Noncompliance|0
6094548|NCT00311311|21032676|P2|Overall Study|Withdrawal by Subject|1
6094549|NCT00311311|21032677|P1|Overall Study|Withdrawal by Subject|1
6094550|NCT00311311|21032676|P2|Overall Study|Adverse Event|2
6094551|NCT00311311|21032677|P1|Overall Study|Adverse Event|3
6094552|NCT00311181|21032735|P1|Overall Study|Final DFTs were not obtained|96
6094553|NCT00311155|21032741|P1|Overall Study|Did not meet entry criteria|55
6094554|NCT00311155|21032741|P1|Overall Study|Withdrawal by Subject|17
6094555|NCT00311155|21032741|P1|Overall Study|Adverse Event|21
6094556|NCT00310856|21032753|P3|Overall Study|Unable to classify|0
6094557|NCT00310856|21032754|P2|Overall Study|Unable to classify|0
6094558|NCT00310856|21032755|P1|Overall Study|Unable to classify|1
6094559|NCT00310856|21032753|P3|Overall Study|Inappropriate enrollment|0
6094560|NCT00310856|21032754|P2|Overall Study|Inappropriate enrollment|1
6094561|NCT00310856|21032755|P1|Overall Study|Inappropriate enrollment|1
6094562|NCT00310856|21032753|P3|Overall Study|Lost to Follow-up|6
6094563|NCT00310856|21032754|P2|Overall Study|Lost to Follow-up|2
6094564|NCT00310856|21032755|P1|Overall Study|Lost to Follow-up|1
6094565|NCT00310856|21032753|P3|Overall Study|Withdrawal by Subject|2
6094566|NCT00310856|21032754|P2|Overall Study|Withdrawal by Subject|2
6094567|NCT00310856|21032755|P1|Overall Study|Withdrawal by Subject|2
6094568|NCT00310817|21032779|P4|Overall Study|Unable to classify|0
6094569|NCT00310817|21032780|P3|Overall Study|Unable to classify|0
6094570|NCT00310817|21032781|P2|Overall Study|Unable to classify|1
6094571|NCT00310817|21032782|P1|Overall Study|Unable to classify|3
6094572|NCT00310817|21032779|P4|Overall Study|Protocol Violation|1
6094573|NCT00310817|21032780|P3|Overall Study|Protocol Violation|1
6094574|NCT00310817|21032781|P2|Overall Study|Protocol Violation|1
6094575|NCT00310817|21032782|P1|Overall Study|Protocol Violation|1
6094576|NCT00310817|21032779|P4|Overall Study|Inappropriate Enrollment|0
6094577|NCT00310817|21032780|P3|Overall Study|Inappropriate Enrollment|1
6094578|NCT00310817|21032781|P2|Overall Study|Inappropriate Enrollment|0
6094579|NCT00310817|21032782|P1|Overall Study|Inappropriate Enrollment|1
6094580|NCT00310817|21032779|P4|Overall Study|Lost to Follow-up|0
6094581|NCT00310817|21032780|P3|Overall Study|Lost to Follow-up|0
6094582|NCT00310817|21032781|P2|Overall Study|Lost to Follow-up|1
6094583|NCT00310817|21032782|P1|Overall Study|Lost to Follow-up|2
6094584|NCT00310817|21032779|P4|Overall Study|Withdrawal by Subject|7
6094585|NCT00310817|21032780|P3|Overall Study|Withdrawal by Subject|6
6094586|NCT00310817|21032781|P2|Overall Study|Withdrawal by Subject|4
6094587|NCT00310817|21032782|P1|Overall Study|Withdrawal by Subject|1
6094588|NCT00310817|21032779|P4|Overall Study|AE or Death|0
6094589|NCT00310817|21032780|P3|Overall Study|AE or Death|0
6094590|NCT00310817|21032781|P2|Overall Study|AE or Death|1
6094591|NCT00310817|21032782|P1|Overall Study|AE or Death|3
6094592|NCT00310804|21032870|P2|Overall Study|Withdrawal by Subject|0
6094593|NCT00310804|21032871|P1|Overall Study|Withdrawal by Subject|3
6094594|NCT00310804|21032870|P2|Overall Study|Lost to Follow-up|0
6094595|NCT00310804|21032871|P1|Overall Study|Lost to Follow-up|2
6094596|NCT00310440|21032930|P2|Overall Study|Missed 12 Month Visit|4
6094597|NCT00310440|21032931|P1|Overall Study|Missed 12 Month Visit|7
6094598|NCT00310440|21032930|P2|Overall Study|Withdrawal by Subject|1
6094599|NCT00310440|21032931|P1|Overall Study|Withdrawal by Subject|2
6094600|NCT00310440|21032930|P2|Overall Study|Lost to Follow-up|8
6094601|NCT00310440|21032931|P1|Overall Study|Lost to Follow-up|17
6094602|NCT00310388|21032995|P2|Safety Follow-up Continuation Phase|Study Closed/Terminated|2
6094603|NCT00310388|21032996|P1|Safety Follow-up Continuation Phase|Study Closed/Terminated|0
6094604|NCT00310388|21032995|P2|Safety Follow-up Continuation Phase|Withdrawal by Subject|5
6094605|NCT00310388|21032996|P1|Safety Follow-up Continuation Phase|Withdrawal by Subject|0
6094606|NCT00310388|21032995|P2|Safety Follow-up Continuation Phase|Adverse Event|1
6094607|NCT00310388|21032996|P1|Safety Follow-up Continuation Phase|Adverse Event|0
6094608|NCT00310388|21032995|P2|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|5
6094609|NCT00310388|21032996|P1|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|0
6094610|NCT00310388|21032995|P2|Primary Reporting Phase|Other|0
6094611|NCT00310388|21032996|P1|Primary Reporting Phase|Other|1
6094612|NCT00310388|21032995|P2|Primary Reporting Phase|Missing|0
6094613|NCT00310388|21032996|P1|Primary Reporting Phase|Missing|1
6094614|NCT00310388|21032995|P2|Primary Reporting Phase|Participant retired the informed consent|0
6094615|NCT00310388|21032996|P1|Primary Reporting Phase|Participant retired the informed consent|1
6094616|NCT00310388|21032995|P2|Primary Reporting Phase|Participant passed away|0
6094617|NCT00310388|21032996|P1|Primary Reporting Phase|Participant passed away|1
6094618|NCT00310388|21032995|P2|Primary Reporting Phase|Due to pigmentation risk concerns|0
6094619|NCT00310388|21032996|P1|Primary Reporting Phase|Due to pigmentation risk concerns|2
6094620|NCT00310388|21032995|P2|Primary Reporting Phase|Ongoing SAE from parent study|0
6094621|NCT00310388|21032996|P1|Primary Reporting Phase|Ongoing SAE from parent study|1
6094622|NCT00310388|21032995|P2|Primary Reporting Phase|Termination of study at sponsor request|0
6094623|NCT00310388|21032996|P1|Primary Reporting Phase|Termination of study at sponsor request|3
6094624|NCT00310388|21032995|P2|Primary Reporting Phase|Participant Immigrated to New Zealand|0
6094625|NCT00310388|21032996|P1|Primary Reporting Phase|Participant Immigrated to New Zealand|1
6094626|NCT00310388|21032995|P2|Primary Reporting Phase|Discontinuation of study|0
6094627|NCT00310388|21032996|P1|Primary Reporting Phase|Discontinuation of study|1
6094628|NCT00310388|21032995|P2|Primary Reporting Phase|Ministry of Health decision|0
6094629|NCT00310388|21032996|P1|Primary Reporting Phase|Ministry of Health decision|25
6094630|NCT00310388|21032995|P2|Primary Reporting Phase|Participant request|0
6094631|NCT00310388|21032996|P1|Primary Reporting Phase|Participant request|2
6094632|NCT00310388|21032995|P2|Primary Reporting Phase|Participant request unrelated to study|0
6094633|NCT00310388|21032996|P1|Primary Reporting Phase|Participant request unrelated to study|2
6094634|NCT00310388|21032995|P2|Primary Reporting Phase|Failed to return|0
6094635|NCT00310388|21032996|P1|Primary Reporting Phase|Failed to return|8
6094636|NCT00310388|21032995|P2|Primary Reporting Phase|Request of the sponsor|0
6094637|NCT00310388|21032996|P1|Primary Reporting Phase|Request of the sponsor|19
6094638|NCT00310388|21032995|P2|Primary Reporting Phase|Physician Decision|0
6094639|NCT00310388|21032996|P1|Primary Reporting Phase|Physician Decision|2
6094640|NCT00310388|21032995|P2|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|0
6094641|NCT00310388|21032996|P1|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|3
6094642|NCT00310388|21032995|P2|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|0
6094643|NCT00310388|21032996|P1|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|3
6094644|NCT00310388|21032995|P2|Primary Reporting Phase|Change in participant medical condition|0
6094645|NCT00310388|21032996|P1|Primary Reporting Phase|Change in participant medical condition|3
6094646|NCT00310388|21032995|P2|Primary Reporting Phase|Pregnancy|0
6094647|NCT00310388|21032996|P1|Primary Reporting Phase|Pregnancy|3
6094648|NCT00310388|21032995|P2|Primary Reporting Phase|Protocol Violation|0
6094649|NCT00310388|21032996|P1|Primary Reporting Phase|Protocol Violation|10
6094650|NCT00310388|21032995|P2|Primary Reporting Phase|Withdrawal by Subject|0
6094651|NCT00310388|21032996|P1|Primary Reporting Phase|Withdrawal by Subject|97
6094652|NCT00310388|21032995|P2|Primary Reporting Phase|Lack of Efficacy|0
6094653|NCT00310388|21032996|P1|Primary Reporting Phase|Lack of Efficacy|56
6094654|NCT00310388|21032995|P2|Primary Reporting Phase|Adverse Event|0
6094655|NCT00310388|21032996|P1|Primary Reporting Phase|Adverse Event|101
6094656|NCT00310375|21033038|P3|Safety Follow-up Continuation Phase|Lost to Follow-up|1
6094657|NCT00310375|21033039|P2|Safety Follow-up Continuation Phase|Lost to Follow-up|0
6094658|NCT00310375|21033040|P1|Safety Follow-up Continuation Phase|Lost to Follow-up|0
6094659|NCT00310375|21033038|P3|Primary Reporting Phase|Request of Ethics Committee|0
6094660|NCT00310375|21033039|P2|Primary Reporting Phase|Request of Ethics Committee|1
6094661|NCT00310375|21033040|P1|Primary Reporting Phase|Request of Ethics Committee|0
6094662|NCT00310375|21033038|P3|Primary Reporting Phase|Par. switched to commercial product|0
6094663|NCT00310375|21033039|P2|Primary Reporting Phase|Par. switched to commercial product|1
6094664|NCT00310375|21033040|P1|Primary Reporting Phase|Par. switched to commercial product|0
6094665|NCT00310375|21033038|P3|Primary Reporting Phase|Missed study drug for 2 months|0
6094666|NCT00310375|21033039|P2|Primary Reporting Phase|Missed study drug for 2 months|0
6094667|NCT00310375|21033040|P1|Primary Reporting Phase|Missed study drug for 2 months|1
6094668|NCT00310375|21033038|P3|Primary Reporting Phase|Site closure|0
6094669|NCT00310375|21033039|P2|Primary Reporting Phase|Site closure|0
6094670|NCT00310375|21033040|P1|Primary Reporting Phase|Site closure|3
6094755|NCT00309777|21033259|P4|Overall Study|Protocol Violation|1
6094671|NCT00310375|21033038|P3|Primary Reporting Phase|Missed study drug >5 days|0
6094672|NCT00310375|21033039|P2|Primary Reporting Phase|Missed study drug >5 days|0
6094673|NCT00310375|21033040|P1|Primary Reporting Phase|Missed study drug >5 days|1
6094674|NCT00310375|21033038|P3|Primary Reporting Phase|Going for temporal lobectomy|0
6094675|NCT00310375|21033039|P2|Primary Reporting Phase|Going for temporal lobectomy|0
6094676|NCT00310375|21033040|P1|Primary Reporting Phase|Going for temporal lobectomy|1
6094677|NCT00310375|21033038|P3|Primary Reporting Phase|Participant request unrelated to study|0
6094678|NCT00310375|21033039|P2|Primary Reporting Phase|Participant request unrelated to study|2
6094679|NCT00310375|21033040|P1|Primary Reporting Phase|Participant request unrelated to study|1
6094680|NCT00310375|21033038|P3|Primary Reporting Phase|Failed to return|0
6094681|NCT00310375|21033039|P2|Primary Reporting Phase|Failed to return|3
6094682|NCT00310375|21033040|P1|Primary Reporting Phase|Failed to return|1
6094683|NCT00310375|21033038|P3|Primary Reporting Phase|Request of the sponsor|0
6094684|NCT00310375|21033039|P2|Primary Reporting Phase|Request of the sponsor|2
6094685|NCT00310375|21033040|P1|Primary Reporting Phase|Request of the sponsor|2
6094686|NCT00310375|21033038|P3|Primary Reporting Phase|Physician Decision|0
6094687|NCT00310375|21033039|P2|Primary Reporting Phase|Physician Decision|3
6094688|NCT00310375|21033040|P1|Primary Reporting Phase|Physician Decision|5
6094689|NCT00310375|21033038|P3|Primary Reporting Phase|Transaminase >5 upper limit of normal|0
6094690|NCT00310375|21033039|P2|Primary Reporting Phase|Transaminase >5 upper limit of normal|1
6094691|NCT00310375|21033040|P1|Primary Reporting Phase|Transaminase >5 upper limit of normal|2
6094692|NCT00310375|21033038|P3|Primary Reporting Phase|Change in Par medical condition|0
6094693|NCT00310375|21033039|P2|Primary Reporting Phase|Change in Par medical condition|0
6094694|NCT00310375|21033040|P1|Primary Reporting Phase|Change in Par medical condition|2
6094695|NCT00310375|21033038|P3|Primary Reporting Phase|Protocol Violation|0
6094696|NCT00310375|21033039|P2|Primary Reporting Phase|Protocol Violation|5
6094697|NCT00310375|21033040|P1|Primary Reporting Phase|Protocol Violation|8
6094698|NCT00310375|21033038|P3|Primary Reporting Phase|Withdrawal by Subject|0
6094699|NCT00310375|21033039|P2|Primary Reporting Phase|Withdrawal by Subject|7
6094700|NCT00310375|21033040|P1|Primary Reporting Phase|Withdrawal by Subject|10
6094701|NCT00310375|21033038|P3|Primary Reporting Phase|Pregnancy|0
6094702|NCT00310375|21033039|P2|Primary Reporting Phase|Pregnancy|2
6094703|NCT00310375|21033040|P1|Primary Reporting Phase|Pregnancy|2
6094704|NCT00310375|21033038|P3|Primary Reporting Phase|Lack of Efficacy|0
6094705|NCT00310375|21033039|P2|Primary Reporting Phase|Lack of Efficacy|19
6094706|NCT00310375|21033040|P1|Primary Reporting Phase|Lack of Efficacy|24
6094707|NCT00310375|21033038|P3|Primary Reporting Phase|Adverse Event|0
6094708|NCT00310375|21033039|P2|Primary Reporting Phase|Adverse Event|22
6094709|NCT00310375|21033040|P1|Primary Reporting Phase|Adverse Event|28
6094710|NCT00310037|21033185|P2|Overall Study|Non-protocol treatment|0
6094711|NCT00310037|21033186|P1|Overall Study|Non-protocol treatment|1
6094712|NCT00310037|21033185|P2|Overall Study|Progression|0
6094713|NCT00310037|21033186|P1|Overall Study|Progression|6
6094714|NCT00310037|21033185|P2|Overall Study|Withdrawal by Subject|3
6094715|NCT00310037|21033186|P1|Overall Study|Withdrawal by Subject|4
6094716|NCT00310037|21033185|P2|Overall Study|Adverse Event|14
6094717|NCT00310037|21033186|P1|Overall Study|Adverse Event|7
6094718|NCT00309985|21033200|P2|Overall Study|Chemotherapy discontinued only|0
6094719|NCT00309985|21033201|P1|Overall Study|Chemotherapy discontinued only|1
6094720|NCT00309985|21033200|P2|Overall Study|Non-compliance|0
6094721|NCT00309985|21033201|P1|Overall Study|Non-compliance|1
6094722|NCT00309985|21033200|P2|Overall Study|Complicating disease|0
6094723|NCT00309985|21033201|P1|Overall Study|Complicating disease|1
6094724|NCT00309985|21033200|P2|Overall Study|Never started treatment|0
6094725|NCT00309985|21033201|P1|Overall Study|Never started treatment|7
6094726|NCT00309985|21033200|P2|Overall Study|Physician Decision|0
6094727|NCT00309985|21033201|P1|Overall Study|Physician Decision|3
6094728|NCT00309985|21033200|P2|Overall Study|Withdrawal by Subject|1
6094729|NCT00309985|21033201|P1|Overall Study|Withdrawal by Subject|5
6094730|NCT00309985|21033200|P2|Overall Study|Death|0
6094731|NCT00309985|21033201|P1|Overall Study|Death|2
6094732|NCT00309985|21033200|P2|Overall Study|Adverse Event|0
6094733|NCT00309985|21033201|P1|Overall Study|Adverse Event|30
6094734|NCT00309985|21033200|P2|Overall Study|Disease progression|0
6094735|NCT00309985|21033201|P1|Overall Study|Disease progression|12
6094736|NCT00309959|21033217|P1|Overall Study|Ineligible - no prior chemotherapy|2
6094737|NCT00309946|21033226|P1|Overall Study|Withdrawal by Subject|1
6094738|NCT00309907|21033232|P1|Overall Study|Major infectious event|4
6094739|NCT00309907|21033232|P1|Overall Study|Ineligible|11
6094740|NCT00309907|21033232|P1|Overall Study|Physician Decision|1
6094741|NCT00309907|21033232|P1|Overall Study|Death|4
6094742|NCT00309842|21033241|P1|Overall Study|Lost to Follow-up|1
6094743|NCT00309777|21033259|P4|Overall Study|Death|0
6094744|NCT00309777|21033260|P3|Overall Study|Death|0
6094745|NCT00309777|21033261|P2|Overall Study|Death|1
6094746|NCT00309777|21033262|P1|Overall Study|Death|0
6094747|NCT00309777|21033259|P4|Overall Study|Lost to Follow-up|0
6094748|NCT00309777|21033260|P3|Overall Study|Lost to Follow-up|1
6094749|NCT00309777|21033261|P2|Overall Study|Lost to Follow-up|0
6094750|NCT00309777|21033262|P1|Overall Study|Lost to Follow-up|0
6094751|NCT00309777|21033259|P4|Overall Study|Withdrawal by Subject|2
6094752|NCT00309777|21033260|P3|Overall Study|Withdrawal by Subject|7
6094753|NCT00309777|21033261|P2|Overall Study|Withdrawal by Subject|5
6094754|NCT00309777|21033262|P1|Overall Study|Withdrawal by Subject|6
6094756|NCT00309777|21033260|P3|Overall Study|Protocol Violation|3
6094757|NCT00309777|21033261|P2|Overall Study|Protocol Violation|1
6094758|NCT00309777|21033262|P1|Overall Study|Protocol Violation|4
6094759|NCT00309777|21033259|P4|Overall Study|Adverse Event|1
6094760|NCT00309777|21033260|P3|Overall Study|Adverse Event|8
6094761|NCT00309777|21033261|P2|Overall Study|Adverse Event|2
6094762|NCT00309777|21033262|P1|Overall Study|Adverse Event|13
6094763|NCT00309608|21033303|P5|Overall Study|Other incl. Lack of efficacy|0
6094764|NCT00309608|21033304|P4|Overall Study|Other incl. Lack of efficacy|4
6094765|NCT00309608|21033305|P3|Overall Study|Other incl. Lack of efficacy|3
6094766|NCT00309608|21033306|P2|Overall Study|Other incl. Lack of efficacy|4
6094767|NCT00309608|21033307|P1|Overall Study|Other incl. Lack of efficacy|10
6094768|NCT00309608|21033303|P5|Overall Study|Withdrawal by Subject|0
6094769|NCT00309608|21033304|P4|Overall Study|Withdrawal by Subject|0
6094770|NCT00309608|21033305|P3|Overall Study|Withdrawal by Subject|2
6094771|NCT00309608|21033306|P2|Overall Study|Withdrawal by Subject|4
6094772|NCT00309608|21033307|P1|Overall Study|Withdrawal by Subject|1
6094773|NCT00309608|21033303|P5|Overall Study|Lost to Follow-up|1
6094774|NCT00309608|21033304|P4|Overall Study|Lost to Follow-up|0
6094775|NCT00309608|21033305|P3|Overall Study|Lost to Follow-up|2
6094776|NCT00309608|21033306|P2|Overall Study|Lost to Follow-up|0
6094777|NCT00309608|21033307|P1|Overall Study|Lost to Follow-up|0
6094778|NCT00309608|21033303|P5|Overall Study|Protocol Violation|0
6094779|NCT00309608|21033304|P4|Overall Study|Protocol Violation|0
6094780|NCT00309608|21033305|P3|Overall Study|Protocol Violation|0
6094781|NCT00309608|21033306|P2|Overall Study|Protocol Violation|0
6094782|NCT00309608|21033307|P1|Overall Study|Protocol Violation|2
6094783|NCT00309608|21033303|P5|Overall Study|Adverse Event|3
6094784|NCT00309608|21033304|P4|Overall Study|Adverse Event|2
6094785|NCT00309608|21033305|P3|Overall Study|Adverse Event|3
6094786|NCT00309608|21033306|P2|Overall Study|Adverse Event|5
6094787|NCT00309608|21033307|P1|Overall Study|Adverse Event|1
6094788|NCT00309452|21033355|P2|Overall Study|Withdrawal by Subject|0
6094789|NCT00309452|21033356|P1|Overall Study|Withdrawal by Subject|3
6094790|NCT00309387|21033384|P2|Overall Study|Lost to Follow-up|86
6094791|NCT00309387|21033385|P1|Overall Study|Lost to Follow-up|70
6094792|NCT00309387|21033384|P2|Overall Study|Death|73
6094793|NCT00309387|21033385|P1|Overall Study|Death|72
6094794|NCT00309244|21033403|P2|Overall Study|Death|1
6094795|NCT00309244|21033404|P1|Overall Study|Death|4
6094796|NCT00309244|21033403|P2|Overall Study|Randomized but not dosed|12
6094797|NCT00309244|21033404|P1|Overall Study|Randomized but not dosed|11
6094798|NCT00309244|21033403|P2|Overall Study|Various|7
6094799|NCT00309244|21033404|P1|Overall Study|Various|7
6094800|NCT00309244|21033403|P2|Overall Study|Withdrawal by Subject|32
6094801|NCT00309244|21033404|P1|Overall Study|Withdrawal by Subject|50
6094802|NCT00309244|21033403|P2|Overall Study|Protocol Violation|3
6094803|NCT00309244|21033404|P1|Overall Study|Protocol Violation|6
6094804|NCT00309244|21033403|P2|Overall Study|Physician Decision|8
6094805|NCT00309244|21033404|P1|Overall Study|Physician Decision|5
6094806|NCT00309244|21033403|P2|Overall Study|Lost to Follow-up|22
6094807|NCT00309244|21033404|P1|Overall Study|Lost to Follow-up|6
6094808|NCT00309244|21033403|P2|Overall Study|Adverse Event|12
6094809|NCT00309244|21033404|P1|Overall Study|Adverse Event|29
6094810|NCT00309166|21033426|P2|Overall Study|Withdrawal by Subject|3
6094811|NCT00309166|21033427|P1|Overall Study|Withdrawal by Subject|4
6094812|NCT00309166|21033426|P2|Overall Study|Adverse event, non-fatal|0
6094813|NCT00309166|21033427|P1|Overall Study|Adverse event, non-fatal|1
6094814|NCT00308997|21033461|P2|Overall Study|Unable to tolerate intervention|0
6094815|NCT00308997|21033462|P1|Overall Study|Unable to tolerate intervention|1
6094816|NCT00308997|21033461|P2|Overall Study|Subject feigned clinical data|1
6094817|NCT00308997|21033462|P1|Overall Study|Subject feigned clinical data|0
6094818|NCT00308737|21033481|P3|Overall Study|Various|8
6094819|NCT00308737|21033482|P2|Overall Study|Various|20
6094820|NCT00308737|21033483|P1|Overall Study|Various|32
6094821|NCT00308737|21033481|P3|Overall Study|Withdrawal by Subject|18
6094822|NCT00308737|21033482|P2|Overall Study|Withdrawal by Subject|166
6094823|NCT00308737|21033483|P1|Overall Study|Withdrawal by Subject|218
6094824|NCT00308737|21033481|P3|Overall Study|Protocol Violation|5
6094825|NCT00308737|21033482|P2|Overall Study|Protocol Violation|9
6094826|NCT00308737|21033483|P1|Overall Study|Protocol Violation|34
6094827|NCT00308737|21033481|P3|Overall Study|Physician Decision|1
6094828|NCT00308737|21033482|P2|Overall Study|Physician Decision|2
6094829|NCT00308737|21033483|P1|Overall Study|Physician Decision|15
6094830|NCT00308737|21033481|P3|Overall Study|Lost to Follow-up|5
6094831|NCT00308737|21033482|P2|Overall Study|Lost to Follow-up|80
6094832|NCT00308737|21033483|P1|Overall Study|Lost to Follow-up|56
6094833|NCT00308737|21033481|P3|Overall Study|Death|0
6094834|NCT00308737|21033482|P2|Overall Study|Death|3
6094835|NCT00308737|21033483|P1|Overall Study|Death|4
6094836|NCT00308737|21033481|P3|Overall Study|Adverse Event|0
6094837|NCT00308737|21033482|P2|Overall Study|Adverse Event|9
6094838|NCT00308737|21033483|P1|Overall Study|Adverse Event|104
6094839|NCT00308711|21033523|P3|Overall Study|Subject incarcerated, data not allowed|1
6094840|NCT00308711|21033524|P2|Overall Study|Subject incarcerated, data not allowed|0
6094841|NCT00308711|21033525|P1|Overall Study|Subject incarcerated, data not allowed|0
6094842|NCT00308711|21033523|P3|Overall Study|Baby not born within 7 days of treatment|2
6094843|NCT00308711|21033524|P2|Overall Study|Baby not born within 7 days of treatment|2
6094844|NCT00308711|21033525|P1|Overall Study|Baby not born within 7 days of treatment|1
6094845|NCT00308711|21033523|P3|Overall Study|Lost to Follow-up|0
6094846|NCT00308711|21033524|P2|Overall Study|Lost to Follow-up|1
6094847|NCT00308711|21033525|P1|Overall Study|Lost to Follow-up|0
6094848|NCT00308711|21033523|P3|Overall Study|Protocol Violation|1
6094849|NCT00308711|21033524|P2|Overall Study|Protocol Violation|1
6094850|NCT00308711|21033525|P1|Overall Study|Protocol Violation|0
6094851|NCT00308711|21033523|P3|Overall Study|Withdrawal by Subject|1
6094852|NCT00308711|21033524|P2|Overall Study|Withdrawal by Subject|0
6094853|NCT00308711|21033525|P1|Overall Study|Withdrawal by Subject|1
6094854|NCT00308620|21033560|P3|Overall Study|Lost to Follow-up|1
6094855|NCT00308620|21033561|P2|Overall Study|Lost to Follow-up|0
6094856|NCT00308620|21033562|P1|Overall Study|Lost to Follow-up|0
6094857|NCT00308620|21033560|P3|Overall Study|Death|0
6094858|NCT00308620|21033561|P2|Overall Study|Death|1
6094859|NCT00308620|21033562|P1|Overall Study|Death|1
6094860|NCT00308581|21033571|P3|Randomized Maintenance Phase|Unknown reason|0
6094861|NCT00308581|21033572|P2|Randomized Maintenance Phase|Unknown reason|0
6094862|NCT00308581|21033573|P1|Randomized Maintenance Phase|Unknown reason|3
6094863|NCT00308581|21033571|P3|Randomized Maintenance Phase|Switched to Q2W open-label treatment|0
6094864|NCT00308581|21033572|P2|Randomized Maintenance Phase|Switched to Q2W open-label treatment|59
6094865|NCT00308581|21033573|P1|Randomized Maintenance Phase|Switched to Q2W open-label treatment|82
6094866|NCT00308581|21033571|P3|Randomized Maintenance Phase|Withdrawal by Subject|0
6094867|NCT00308581|21033572|P2|Randomized Maintenance Phase|Withdrawal by Subject|4
6094868|NCT00308581|21033573|P1|Randomized Maintenance Phase|Withdrawal by Subject|1
6094869|NCT00308581|21033571|P3|Randomized Maintenance Phase|Lost to Follow-up|0
6094870|NCT00308581|21033572|P2|Randomized Maintenance Phase|Lost to Follow-up|2
6094871|NCT00308581|21033573|P1|Randomized Maintenance Phase|Lost to Follow-up|0
6094872|NCT00308581|21033571|P3|Randomized Maintenance Phase|Lack of Efficacy|0
6094873|NCT00308581|21033572|P2|Randomized Maintenance Phase|Lack of Efficacy|21
6094874|NCT00308581|21033573|P1|Randomized Maintenance Phase|Lack of Efficacy|9
6094875|NCT00308581|21033571|P3|Randomized Maintenance Phase|Adverse Event|0
6094876|NCT00308581|21033572|P2|Randomized Maintenance Phase|Adverse Event|17
6094877|NCT00308581|21033573|P1|Randomized Maintenance Phase|Adverse Event|10
6094878|NCT00308581|21033571|P3|Induction Phase|Unknown reason|3
6094879|NCT00308581|21033572|P2|Induction Phase|Unknown reason|0
6094880|NCT00308581|21033573|P1|Induction Phase|Unknown reason|0
6094881|NCT00308581|21033571|P3|Induction Phase|Withdrawal by Subject|5
6094882|NCT00308581|21033572|P2|Induction Phase|Withdrawal by Subject|0
6094883|NCT00308581|21033573|P1|Induction Phase|Withdrawal by Subject|0
6094884|NCT00308581|21033571|P3|Induction Phase|Lack of Efficacy|121
6094885|NCT00308581|21033572|P2|Induction Phase|Lack of Efficacy|0
6094886|NCT00308581|21033573|P1|Induction Phase|Lack of Efficacy|0
6094887|NCT00308581|21033571|P3|Induction Phase|Adverse Event|37
6094888|NCT00308581|21033572|P2|Induction Phase|Adverse Event|0
6094889|NCT00308581|21033573|P1|Induction Phase|Adverse Event|0
6094890|NCT00308555|21033699|P2|Overall Study|Physician Decision|0
6094891|NCT00308555|21033700|P1|Overall Study|Physician Decision|2
6094892|NCT00308555|21033699|P2|Overall Study|Withdrawal by Subject|0
6094893|NCT00308555|21033700|P1|Overall Study|Withdrawal by Subject|1
6094894|NCT00308308|21033717|P2|Overall Study|Other|0
6094895|NCT00308308|21033718|P1|Overall Study|Other|1
6094896|NCT00308308|21033717|P2|Overall Study|Randomized but not dosed|16
6094897|NCT00308308|21033718|P1|Overall Study|Randomized but not dosed|8
6094898|NCT00308308|21033717|P2|Overall Study|Various|5
6094899|NCT00308308|21033718|P1|Overall Study|Various|7
6094900|NCT00308308|21033717|P2|Overall Study|Withdrawal by Subject|19
6094901|NCT00308308|21033718|P1|Overall Study|Withdrawal by Subject|47
6094902|NCT00308308|21033717|P2|Overall Study|Protocol Violation|14
6094903|NCT00308308|21033718|P1|Overall Study|Protocol Violation|3
6094904|NCT00308308|21033717|P2|Overall Study|Physician Decision|7
6094905|NCT00308308|21033718|P1|Overall Study|Physician Decision|15
6094906|NCT00308308|21033717|P2|Overall Study|Lost to Follow-up|5
6094907|NCT00308308|21033718|P1|Overall Study|Lost to Follow-up|5
6094908|NCT00308308|21033717|P2|Overall Study|Adverse Event|2
6094909|NCT00308308|21033718|P1|Overall Study|Adverse Event|17
6094910|NCT00308139|21033797|P2|Overall Study|Other|0
6094911|NCT00308139|21033798|P1|Overall Study|Other|1
6094912|NCT00308139|21033797|P2|Overall Study|Administrative|4
6094913|NCT00308139|21033798|P1|Overall Study|Administrative|1
6094914|NCT00308139|21033797|P2|Overall Study|Loss of Glucose Control|7
6094915|NCT00308139|21033798|P1|Overall Study|Loss of Glucose Control|5
6094916|NCT00308139|21033797|P2|Overall Study|Investigator Decision|10
6094917|NCT00308139|21033798|P1|Overall Study|Investigator Decision|11
6094918|NCT00308139|21033797|P2|Overall Study|Withdrawal of Consent|42
6094919|NCT00308139|21033798|P1|Overall Study|Withdrawal of Consent|40
6094920|NCT00308139|21033797|P2|Overall Study|Protocol Violation|2
6094921|NCT00308139|21033798|P1|Overall Study|Protocol Violation|3
6094922|NCT00308139|21033797|P2|Overall Study|Lost to Follow-up|8
6094923|NCT00308139|21033798|P1|Overall Study|Lost to Follow-up|13
6094924|NCT00308139|21033797|P2|Overall Study|Adverse Event|14
6094925|NCT00308139|21033798|P1|Overall Study|Adverse Event|20
6094926|NCT00308113|21033872|P4|Overall Study|Protocol closure|1
6094927|NCT00308113|21033873|P3|Overall Study|Protocol closure|0
6094928|NCT00308113|21033874|P2|Overall Study|Protocol closure|0
6094929|NCT00308113|21033875|P1|Overall Study|Protocol closure|0
6094930|NCT00308087|21033895|P2|Overall Study|Other|3
6094931|NCT00308087|21033896|P1|Overall Study|Other|4
6094932|NCT00308087|21033895|P2|Overall Study|Withdrawal by Subject|1
6094933|NCT00308087|21033896|P1|Overall Study|Withdrawal by Subject|2
6094934|NCT00308087|21033895|P2|Overall Study|Study Closure|12
6094935|NCT00308087|21033896|P1|Overall Study|Study Closure|11
6094936|NCT00308087|21033895|P2|Overall Study|Progressive Disease|21
6094937|NCT00308087|21033896|P1|Overall Study|Progressive Disease|19
6094938|NCT00308074|21033912|P1|Overall Study|Withdrawal by Subject|1
6094939|NCT00307931|21033929|P1|Overall Study|Adverse Event|1
6094940|NCT00307801|21033946|P2|Overall Study|Pregnancy|1
6094941|NCT00307801|21033947|P1|Overall Study|Pregnancy|0
6094942|NCT00307801|21033946|P2|Overall Study|No reason specified|0
6094943|NCT00307801|21033947|P1|Overall Study|No reason specified|2
6094944|NCT00307801|21033946|P2|Overall Study|Protocol Violation|2
6094945|NCT00307801|21033947|P1|Overall Study|Protocol Violation|3
6094946|NCT00307801|21033946|P2|Overall Study|Frustration with e-diary|0
6094947|NCT00307801|21033947|P1|Overall Study|Frustration with e-diary|1
6094948|NCT00307801|21033946|P2|Overall Study|Lost to Follow-up, moved abroad|1
6094949|NCT00307801|21033947|P1|Overall Study|Lost to Follow-up, moved abroad|1
6094950|NCT00307801|21033946|P2|Overall Study|Lack of Efficacy|2
6094951|NCT00307801|21033947|P1|Overall Study|Lack of Efficacy|0
6094952|NCT00307801|21033946|P2|Overall Study|Wrong Randomization|0
6094953|NCT00307801|21033947|P1|Overall Study|Wrong Randomization|1
6094954|NCT00307801|21033946|P2|Overall Study|Decreased Libido (AE at discontinuation)|1
6094955|NCT00307801|21033947|P1|Overall Study|Decreased Libido (AE at discontinuation)|0
6094956|NCT00307801|21033946|P2|Overall Study|Adverse event (AE)/Withdrawal of consent|0
6094957|NCT00307801|21033947|P1|Overall Study|Adverse event (AE)/Withdrawal of consent|2
6094958|NCT00307801|21033946|P2|Overall Study|Non-compliance, not taken all tablets|2
6094959|NCT00307801|21033947|P1|Overall Study|Non-compliance, not taken all tablets|1
6094960|NCT00307801|21033946|P2|Overall Study|Withdrawal by Subject|4
6094961|NCT00307801|21033947|P1|Overall Study|Withdrawal by Subject|9
6094962|NCT00307801|21033946|P2|Overall Study|Adverse Event|4
6094963|NCT00307801|21033947|P1|Overall Study|Adverse Event|12
6094964|NCT00307736|21034059|P4|Overall Study|Withdrawal by Subject|0
6094965|NCT00307736|21034060|P3|Overall Study|Withdrawal by Subject|2
6094966|NCT00307736|21034061|P2|Overall Study|Withdrawal by Subject|0
6094967|NCT00307736|21034062|P1|Overall Study|Withdrawal by Subject|0
6094968|NCT00307736|21034059|P4|Overall Study|Adverse Event|3
6094969|NCT00307736|21034060|P3|Overall Study|Adverse Event|1
6094970|NCT00307736|21034061|P2|Overall Study|Adverse Event|0
6094971|NCT00307736|21034062|P1|Overall Study|Adverse Event|0
6094972|NCT00307684|21034073|P3|Double Blind Phase|Lack of Efficacy|0
6094973|NCT00307684|21034074|P2|Double Blind Phase|Lack of Efficacy|5
6094974|NCT00307684|21034075|P1|Double Blind Phase|Lack of Efficacy|2
6094975|NCT00307684|21034073|P3|Open Label Phase|other|6
6094976|NCT00307684|21034074|P2|Open Label Phase|other|0
6094977|NCT00307684|21034075|P1|Open Label Phase|other|0
6094978|NCT00307684|21034073|P3|Open Label Phase|non compliance|5
6094979|NCT00307684|21034074|P2|Open Label Phase|non compliance|0
6094980|NCT00307684|21034075|P1|Open Label Phase|non compliance|0
6094981|NCT00307684|21034073|P3|Open Label Phase|Lost to Follow-up|11
6094982|NCT00307684|21034074|P2|Open Label Phase|Lost to Follow-up|0
6094983|NCT00307684|21034075|P1|Open Label Phase|Lost to Follow-up|0
6094984|NCT00307684|21034073|P3|Open Label Phase|Withdrawal by Subject|15
6094985|NCT00307684|21034074|P2|Open Label Phase|Withdrawal by Subject|0
6094986|NCT00307684|21034075|P1|Open Label Phase|Withdrawal by Subject|0
6094987|NCT00307684|21034073|P3|Open Label Phase|Adverse Event|16
6094988|NCT00307684|21034074|P2|Open Label Phase|Adverse Event|0
6094989|NCT00307684|21034075|P1|Open Label Phase|Adverse Event|0
6094990|NCT00307684|21034073|P3|Open Label Phase|Lack of Efficacy|3
6094991|NCT00307684|21034074|P2|Open Label Phase|Lack of Efficacy|0
6094992|NCT00307684|21034075|P1|Open Label Phase|Lack of Efficacy|0
6094993|NCT00307489|21034103|P2|Week 48 Through Week 168|Seroconversion|0
6094994|NCT00307489|21034104|P1|Week 48 Through Week 168|Seroconversion|1
6094995|NCT00307489|21034103|P2|Week 48 Through Week 168|Lost to Follow-up|1
6094996|NCT00307489|21034104|P1|Week 48 Through Week 168|Lost to Follow-up|0
6094997|NCT00307489|21034103|P2|Week 48 Through Week 168|Death|1
6094998|NCT00307489|21034104|P1|Week 48 Through Week 168|Death|0
6094999|NCT00307489|21034103|P2|Week 48 Through Week 168|Lack of Efficacy|2
6095000|NCT00307489|21034104|P1|Week 48 Through Week 168|Lack of Efficacy|2
6095001|NCT00307489|21034103|P2|Week 48 Through Week 168|Withdrawal by Subject|2
6095002|NCT00307489|21034104|P1|Week 48 Through Week 168|Withdrawal by Subject|1
6095003|NCT00307489|21034103|P2|Week 48 Through Week 168|Physician Decision|0
6095004|NCT00307489|21034104|P1|Week 48 Through Week 168|Physician Decision|1
6095005|NCT00307489|21034103|P2|Week 48 Through Week 168|Adverse Event|0
6095006|NCT00307489|21034104|P1|Week 48 Through Week 168|Adverse Event|1
6095007|NCT00307489|21034103|P2|Baseline Through Week 48|Withdrawal by Subject|1
6095008|NCT00307489|21034104|P1|Baseline Through Week 48|Withdrawal by Subject|0
6095009|NCT00307489|21034103|P2|Baseline Through Week 48|Physician Decision|0
6095010|NCT00307489|21034104|P1|Baseline Through Week 48|Physician Decision|1
6095011|NCT00307489|21034103|P2|Baseline Through Week 48|Lost to Follow-up|1
6095012|NCT00307489|21034104|P1|Baseline Through Week 48|Lost to Follow-up|0
6095013|NCT00307437|21034149|P7|After Controlled Period|Other|28
6095014|NCT00307437|21034150|P6|After Controlled Period|Other|40
6095015|NCT00307437|21034151|P5|After Controlled Period|Other|9
6095016|NCT00307437|21034152|P4|After Controlled Period|Other|15
6095017|NCT00307437|21034153|P3|After Controlled Period|Other|0
6095018|NCT00307437|21034154|P2|After Controlled Period|Other|0
6095019|NCT00307437|21034155|P1|After Controlled Period|Other|0
6095020|NCT00307437|21034149|P7|After Controlled Period|Lost to Follow-up|18
6095021|NCT00307437|21034150|P6|After Controlled Period|Lost to Follow-up|13
6095022|NCT00307437|21034151|P5|After Controlled Period|Lost to Follow-up|12
6095023|NCT00307437|21034152|P4|After Controlled Period|Lost to Follow-up|7
6095024|NCT00307437|21034153|P3|After Controlled Period|Lost to Follow-up|0
6095025|NCT00307437|21034154|P2|After Controlled Period|Lost to Follow-up|0
6095026|NCT00307437|21034155|P1|After Controlled Period|Lost to Follow-up|0
6095027|NCT00307437|21034149|P7|After Controlled Period|Lack of Efficacy|24
6095028|NCT00307437|21034150|P6|After Controlled Period|Lack of Efficacy|37
6095029|NCT00307437|21034151|P5|After Controlled Period|Lack of Efficacy|17
6095030|NCT00307437|21034152|P4|After Controlled Period|Lack of Efficacy|15
6095031|NCT00307437|21034153|P3|After Controlled Period|Lack of Efficacy|0
6095032|NCT00307437|21034154|P2|After Controlled Period|Lack of Efficacy|0
6095033|NCT00307437|21034155|P1|After Controlled Period|Lack of Efficacy|0
6095034|NCT00307437|21034149|P7|After Controlled Period|Death|3
6095035|NCT00307437|21034150|P6|After Controlled Period|Death|1
6095036|NCT00307437|21034151|P5|After Controlled Period|Death|1
6095037|NCT00307437|21034152|P4|After Controlled Period|Death|3
6095038|NCT00307437|21034153|P3|After Controlled Period|Death|0
6095039|NCT00307437|21034154|P2|After Controlled Period|Death|0
6095040|NCT00307437|21034155|P1|After Controlled Period|Death|0
6095041|NCT00307437|21034149|P7|After Controlled Period|Adverse Event|40
6095042|NCT00307437|21034150|P6|After Controlled Period|Adverse Event|31
6095043|NCT00307437|21034151|P5|After Controlled Period|Adverse Event|16
6095044|NCT00307437|21034152|P4|After Controlled Period|Adverse Event|18
6095045|NCT00307437|21034153|P3|After Controlled Period|Adverse Event|0
6095046|NCT00307437|21034154|P2|After Controlled Period|Adverse Event|0
6095047|NCT00307437|21034155|P1|After Controlled Period|Adverse Event|0
6095048|NCT00307437|21034149|P7|Controlled Period|Other|0
6095049|NCT00307437|21034150|P6|Controlled Period|Other|0
6095050|NCT00307437|21034151|P5|Controlled Period|Other|0
6095051|NCT00307437|21034152|P4|Controlled Period|Other|0
6095052|NCT00307437|21034153|P3|Controlled Period|Other|3
6095053|NCT00307437|21034154|P2|Controlled Period|Other|1
6095054|NCT00307437|21034155|P1|Controlled Period|Other|5
6095055|NCT00307437|21034149|P7|Controlled Period|Lost to Follow-up|0
6095056|NCT00307437|21034150|P6|Controlled Period|Lost to Follow-up|0
6095057|NCT00307437|21034151|P5|Controlled Period|Lost to Follow-up|0
6095058|NCT00307437|21034152|P4|Controlled Period|Lost to Follow-up|0
6095059|NCT00307437|21034153|P3|Controlled Period|Lost to Follow-up|0
6095060|NCT00307437|21034154|P2|Controlled Period|Lost to Follow-up|3
6095061|NCT00307437|21034155|P1|Controlled Period|Lost to Follow-up|2
6095062|NCT00307437|21034149|P7|Controlled Period|Lack of Efficacy|0
6095063|NCT00307437|21034150|P6|Controlled Period|Lack of Efficacy|0
6095064|NCT00307437|21034151|P5|Controlled Period|Lack of Efficacy|0
6095065|NCT00307437|21034152|P4|Controlled Period|Lack of Efficacy|0
6095066|NCT00307437|21034153|P3|Controlled Period|Lack of Efficacy|0
6095067|NCT00307437|21034154|P2|Controlled Period|Lack of Efficacy|0
6095068|NCT00307437|21034155|P1|Controlled Period|Lack of Efficacy|2
6095069|NCT00307437|21034149|P7|Controlled Period|Death|0
6095070|NCT00307437|21034150|P6|Controlled Period|Death|0
6095071|NCT00307437|21034151|P5|Controlled Period|Death|0
6095072|NCT00307437|21034152|P4|Controlled Period|Death|0
6095073|NCT00307437|21034153|P3|Controlled Period|Death|1
6095074|NCT00307437|21034154|P2|Controlled Period|Death|0
6095075|NCT00307437|21034155|P1|Controlled Period|Death|0
6095076|NCT00307437|21034149|P7|Controlled Period|Adverse Event|0
6095077|NCT00307437|21034150|P6|Controlled Period|Adverse Event|0
6095078|NCT00307437|21034151|P5|Controlled Period|Adverse Event|0
6095079|NCT00307437|21034152|P4|Controlled Period|Adverse Event|0
6095080|NCT00307437|21034153|P3|Controlled Period|Adverse Event|5
6095081|NCT00307437|21034154|P2|Controlled Period|Adverse Event|2
6095082|NCT00307437|21034155|P1|Controlled Period|Adverse Event|7
6095083|NCT00307333|21034181|P2|Overall Study|Lost to Follow-up|3
6095084|NCT00307333|21034182|P1|Overall Study|Lost to Follow-up|11
6095085|NCT00307294|21034194|P1|Overall Study|Withdrawal by Subject|1
6095086|NCT00307164|21034203|P2|Overall Study|Lost to Follow-up|1
6095087|NCT00307164|21034204|P1|Overall Study|Lost to Follow-up|6
6095088|NCT00307164|21034203|P2|Overall Study|Not compliant with requirements|4
6095089|NCT00307164|21034204|P1|Overall Study|Not compliant with requirements|4
6095090|NCT00307164|21034203|P2|Overall Study|Withdrawal by Subject|8
6095091|NCT00307164|21034204|P1|Overall Study|Withdrawal by Subject|1
6095092|NCT00307164|21034203|P2|Overall Study|Subject/parent not able to get to clinic|1
6095093|NCT00307164|21034204|P1|Overall Study|Subject/parent not able to get to clinic|2
6095094|NCT00307164|21034203|P2|Overall Study|Severe debilitation, unable to continue|0
6095095|NCT00307164|21034204|P1|Overall Study|Severe debilitation, unable to continue|1
6095096|NCT00307164|21034203|P2|Overall Study|Death|0
6095097|NCT00307164|21034204|P1|Overall Study|Death|1
6095098|NCT00307151|21034244|P4|Overall Study|Clinic unable to contact subject|1
6095099|NCT00307151|21034245|P3|Overall Study|Clinic unable to contact subject|1
6095100|NCT00307151|21034246|P2|Overall Study|Clinic unable to contact subject|3
6095101|NCT00307151|21034247|P1|Overall Study|Clinic unable to contact subject|3
6095102|NCT00307151|21034244|P4|Overall Study|Not willing to adhere to study reqs|2
6095103|NCT00307151|21034245|P3|Overall Study|Not willing to adhere to study reqs|2
6095104|NCT00307151|21034246|P2|Overall Study|Not willing to adhere to study reqs|0
6095105|NCT00307151|21034247|P1|Overall Study|Not willing to adhere to study reqs|2
6095106|NCT00307151|21034244|P4|Overall Study|Withdrew consent|3
6095107|NCT00307151|21034245|P3|Overall Study|Withdrew consent|1
6095108|NCT00307151|21034246|P2|Overall Study|Withdrew consent|1
6095109|NCT00307151|21034247|P1|Overall Study|Withdrew consent|0
6095110|NCT00307151|21034244|P4|Overall Study|Subject unable to get to clinic|2
6095111|NCT00307151|21034245|P3|Overall Study|Subject unable to get to clinic|6
6095112|NCT00307151|21034246|P2|Overall Study|Subject unable to get to clinic|0
6095113|NCT00307151|21034247|P1|Overall Study|Subject unable to get to clinic|1
6095114|NCT00307151|21034244|P4|Overall Study|Severe debilitation, unable to continue|0
6095115|NCT00307151|21034245|P3|Overall Study|Severe debilitation, unable to continue|0
6095116|NCT00307151|21034246|P2|Overall Study|Severe debilitation, unable to continue|0
6095117|NCT00307151|21034247|P1|Overall Study|Severe debilitation, unable to continue|1
6095118|NCT00307151|21034244|P4|Overall Study|Death|3
6095119|NCT00307151|21034245|P3|Overall Study|Death|10
6095120|NCT00307151|21034246|P2|Overall Study|Death|3
6095121|NCT00307151|21034247|P1|Overall Study|Death|4
6095122|NCT00307125|21034291|P3|Pilot Phase|Withdrawal by Subject|1
6095123|NCT00307125|21034292|P2|Pilot Phase|Withdrawal by Subject|1
6095124|NCT00307125|21034293|P1|Pilot Phase|Withdrawal by Subject|0
6095125|NCT00307125|21034291|P3|Pilot Phase|Lost to Follow-up|0
6095126|NCT00307125|21034292|P2|Pilot Phase|Lost to Follow-up|1
6095127|NCT00307125|21034293|P1|Pilot Phase|Lost to Follow-up|0
6095128|NCT00307125|21034291|P3|Screening Phase|Coronary artery bypass|0
6095129|NCT00307125|21034292|P2|Screening Phase|Coronary artery bypass|0
6095130|NCT00307125|21034293|P1|Screening Phase|Coronary artery bypass|1
6095131|NCT00307125|21034291|P3|Screening Phase|AMR and treated with rituximab|0
6095132|NCT00307125|21034292|P2|Screening Phase|AMR and treated with rituximab|0
6095133|NCT00307125|21034293|P1|Screening Phase|AMR and treated with rituximab|1
6095134|NCT00307125|21034291|P3|Screening Phase|Sample of Anti-HLA Ab was not obtained|0
6095135|NCT00307125|21034292|P2|Screening Phase|Sample of Anti-HLA Ab was not obtained|0
6095136|NCT00307125|21034293|P1|Screening Phase|Sample of Anti-HLA Ab was not obtained|1
6095137|NCT00307125|21034291|P3|Screening Phase|Screen Error|0
6095138|NCT00307125|21034292|P2|Screening Phase|Screen Error|0
6095139|NCT00307125|21034293|P1|Screening Phase|Screen Error|1
6095140|NCT00307125|21034291|P3|Screening Phase|Ineligible|0
6095141|NCT00307125|21034292|P2|Screening Phase|Ineligible|0
6095142|NCT00307125|21034293|P1|Screening Phase|Ineligible|1
6095143|NCT00307125|21034291|P3|Screening Phase|PAK|0
6095144|NCT00307125|21034292|P2|Screening Phase|PAK|0
6095145|NCT00307125|21034293|P1|Screening Phase|PAK|1
6095146|NCT00307125|21034291|P3|Screening Phase|Malignancy|0
6095147|NCT00307125|21034292|P2|Screening Phase|Malignancy|0
6095148|NCT00307125|21034293|P1|Screening Phase|Malignancy|1
6095149|NCT00307125|21034291|P3|Screening Phase|Metastatic colon cancer|0
6095150|NCT00307125|21034292|P2|Screening Phase|Metastatic colon cancer|0
6095151|NCT00307125|21034293|P1|Screening Phase|Metastatic colon cancer|1
6095152|NCT00307125|21034291|P3|Screening Phase|Developed acute leukemia|0
6095153|NCT00307125|21034292|P2|Screening Phase|Developed acute leukemia|0
6095154|NCT00307125|21034293|P1|Screening Phase|Developed acute leukemia|1
6095155|NCT00307125|21034291|P3|Screening Phase|Try to get pregnant|0
6095156|NCT00307125|21034292|P2|Screening Phase|Try to get pregnant|0
6095157|NCT00307125|21034293|P1|Screening Phase|Try to get pregnant|1
6095158|NCT00307125|21034291|P3|Screening Phase|Ineligible for pilot|0
6095159|NCT00307125|21034292|P2|Screening Phase|Ineligible for pilot|0
6095160|NCT00307125|21034293|P1|Screening Phase|Ineligible for pilot|4
6095161|NCT00307125|21034291|P3|Screening Phase|Received Pancreas Transplant|0
6095162|NCT00307125|21034292|P2|Screening Phase|Received Pancreas Transplant|0
6095163|NCT00307125|21034293|P1|Screening Phase|Received Pancreas Transplant|8
6095164|NCT00307125|21034291|P3|Screening Phase|Moved or transferred facilities|0
6095165|NCT00307125|21034292|P2|Screening Phase|Moved or transferred facilities|0
6095166|NCT00307125|21034293|P1|Screening Phase|Moved or transferred facilities|34
6095167|NCT00307125|21034291|P3|Screening Phase|Scheduling issues/Non-compliance|0
6095168|NCT00307125|21034292|P2|Screening Phase|Scheduling issues/Non-compliance|0
6095169|NCT00307125|21034293|P1|Screening Phase|Scheduling issues/Non-compliance|55
6095170|NCT00307125|21034291|P3|Screening Phase|Follow-up period ended on Dec 31, 2011|0
6095171|NCT00307125|21034292|P2|Screening Phase|Follow-up period ended on Dec 31, 2011|0
6095172|NCT00307125|21034293|P1|Screening Phase|Follow-up period ended on Dec 31, 2011|83
6095173|NCT00307125|21034291|P3|Screening Phase|Graft Failure|0
6095174|NCT00307125|21034292|P2|Screening Phase|Graft Failure|0
6095175|NCT00307125|21034293|P1|Screening Phase|Graft Failure|8
6095176|NCT00307125|21034291|P3|Screening Phase|Graft Loss|0
6095177|NCT00307125|21034292|P2|Screening Phase|Graft Loss|0
6095178|NCT00307125|21034293|P1|Screening Phase|Graft Loss|3
6095179|NCT00307125|21034291|P3|Screening Phase|Study Terminated|0
6095180|NCT00307125|21034292|P2|Screening Phase|Study Terminated|0
6095181|NCT00307125|21034293|P1|Screening Phase|Study Terminated|17
6095182|NCT00307125|21034291|P3|Screening Phase|Sponsor Decision|0
6095183|NCT00307125|21034292|P2|Screening Phase|Sponsor Decision|0
6095184|NCT00307125|21034293|P1|Screening Phase|Sponsor Decision|4
6095185|NCT00307125|21034291|P3|Screening Phase|Physician Decision|0
6095186|NCT00307125|21034292|P2|Screening Phase|Physician Decision|0
6095187|NCT00307125|21034293|P1|Screening Phase|Physician Decision|26
6095188|NCT00307125|21034291|P3|Screening Phase|Withdrawal by Subject|0
6095189|NCT00307125|21034292|P2|Screening Phase|Withdrawal by Subject|0
6095190|NCT00307125|21034293|P1|Screening Phase|Withdrawal by Subject|77
6095191|NCT00307125|21034291|P3|Screening Phase|Death|0
6095192|NCT00307125|21034292|P2|Screening Phase|Death|0
6095193|NCT00307125|21034293|P1|Screening Phase|Death|10
6095194|NCT00307125|21034291|P3|Screening Phase|Lost to Follow-up|0
6095195|NCT00307125|21034292|P2|Screening Phase|Lost to Follow-up|0
6095196|NCT00307125|21034293|P1|Screening Phase|Lost to Follow-up|87
6095197|NCT00307125|21034291|P3|Screening Phase|Protocol Violation|0
6095198|NCT00307125|21034292|P2|Screening Phase|Protocol Violation|0
6095199|NCT00307125|21034293|P1|Screening Phase|Protocol Violation|27
6095200|NCT00307125|21034291|P3|Screening Phase|Adverse Event|0
6095201|NCT00307125|21034292|P2|Screening Phase|Adverse Event|0
6095202|NCT00307125|21034293|P1|Screening Phase|Adverse Event|1
6095203|NCT00307086|21034315|P1|Overall Study|ineligible|5
6095204|NCT00307047|21034321|P2|Overall Study|All death, all MI, all Revascularization|16
6095205|NCT00307047|21034322|P1|Overall Study|All death, all MI, all Revascularization|27
6095206|NCT00307047|21034321|P2|Overall Study|Lost to follow-up for other reasons|1
6095207|NCT00307047|21034322|P1|Overall Study|Lost to follow-up for other reasons|0
6095208|NCT00307047|21034321|P2|Overall Study|Physician Decision|2
6095209|NCT00307047|21034322|P1|Overall Study|Physician Decision|1
6095210|NCT00307047|21034321|P2|Overall Study|Withdrawal by Subject|6
6095211|NCT00307047|21034322|P1|Overall Study|Withdrawal by Subject|6
6095212|NCT00307047|21034321|P2|Overall Study|Lost to Follow-up|24
6095213|NCT00307047|21034322|P1|Overall Study|Lost to Follow-up|35
6095214|NCT00307034|21034460|P2|Overall Study|Lost to Follow-up|3
6095215|NCT00307034|21034461|P1|Overall Study|Lost to Follow-up|0
6095216|NCT00307034|21034460|P2|Overall Study|Withdrawal by Subject|2
6095217|NCT00307034|21034461|P1|Overall Study|Withdrawal by Subject|1
6095218|NCT00307034|21034460|P2|Overall Study|Adverse Event|2
6095219|NCT00307034|21034461|P1|Overall Study|Adverse Event|1
6095220|NCT00306995|21034506|P7|Study Part II for Subset 2|Serious Adverse Event|0
6095221|NCT00306995|21034507|P6|Study Part II for Subset 2|Serious Adverse Event|0
6095222|NCT00306995|21034508|P5|Study Part II for Subset 2|Serious Adverse Event|0
6095223|NCT00306995|21034509|P4|Study Part II for Subset 2|Serious Adverse Event|0
6095224|NCT00306995|21034510|P3|Study Part II for Subset 2|Serious Adverse Event|0
6095225|NCT00306995|21034511|P2|Study Part II for Subset 2|Serious Adverse Event|1
6095226|NCT00306995|21034512|P1|Study Part II for Subset 2|Serious Adverse Event|0
6095227|NCT00306995|21034506|P7|Study Part I|Withdrawal by Subject|1
6095228|NCT00306995|21034507|P6|Study Part I|Withdrawal by Subject|0
6095229|NCT00306995|21034508|P5|Study Part I|Withdrawal by Subject|0
6095230|NCT00306995|21034509|P4|Study Part I|Withdrawal by Subject|0
6095231|NCT00306995|21034510|P3|Study Part I|Withdrawal by Subject|0
6095232|NCT00306995|21034511|P2|Study Part I|Withdrawal by Subject|0
6095233|NCT00306995|21034512|P1|Study Part I|Withdrawal by Subject|0
6095234|NCT00306891|21034905|P4|Part B|Development of study specific disc crit.|1
6095235|NCT00306891|21034906|P3|Part B|Development of study specific disc crit.|0
6095236|NCT00306891|21034907|P2|Part B|Development of study specific disc crit.|0
6095237|NCT00306891|21034908|P1|Part B|Development of study specific disc crit.|0
6095238|NCT00306891|21034905|P4|Part B|Condition under investigation worsened|8
6095239|NCT00306891|21034906|P3|Part B|Condition under investigation worsened|2
6095240|NCT00306891|21034907|P2|Part B|Condition under investigation worsened|0
6095241|NCT00306891|21034908|P1|Part B|Condition under investigation worsened|0
6095242|NCT00306891|21034905|P4|Part B|Withdrawal by Subject|1
6095243|NCT00306891|21034906|P3|Part B|Withdrawal by Subject|3
6095244|NCT00306891|21034907|P2|Part B|Withdrawal by Subject|0
6095245|NCT00306891|21034908|P1|Part B|Withdrawal by Subject|0
6095246|NCT00306891|21034905|P4|Part B|Adverse Event|5
6095247|NCT00306891|21034906|P3|Part B|Adverse Event|5
6095248|NCT00306891|21034907|P2|Part B|Adverse Event|0
6095249|NCT00306891|21034908|P1|Part B|Adverse Event|0
6095250|NCT00306891|21034905|P4|Part B|Death|2
6095251|NCT00306891|21034906|P3|Part B|Death|1
6095252|NCT00306891|21034907|P2|Part B|Death|0
6095253|NCT00306891|21034908|P1|Part B|Death|0
6095254|NCT00306891|21034905|P4|Part A|QTC interval outwith elig. criteria|0
6095255|NCT00306891|21034906|P3|Part A|QTC interval outwith elig. criteria|0
6095256|NCT00306891|21034907|P2|Part A|QTC interval outwith elig. criteria|0
6095257|NCT00306891|21034908|P1|Part A|QTC interval outwith elig. criteria|1
6095258|NCT00306891|21034905|P4|Part A|Suspicion of second malignancy|0
6095259|NCT00306891|21034906|P3|Part A|Suspicion of second malignancy|0
6095260|NCT00306891|21034907|P2|Part A|Suspicion of second malignancy|1
6095261|NCT00306891|21034908|P1|Part A|Suspicion of second malignancy|0
6095262|NCT00306891|21034905|P4|Part A|Reaccumul. of ascites following drainage|0
6095263|NCT00306891|21034906|P3|Part A|Reaccumul. of ascites following drainage|0
6095264|NCT00306891|21034907|P2|Part A|Reaccumul. of ascites following drainage|1
6095265|NCT00306891|21034908|P1|Part A|Reaccumul. of ascites following drainage|0
6095266|NCT00306891|21034905|P4|Part A|Partial bowel obstruction|0
6095267|NCT00306891|21034906|P3|Part A|Partial bowel obstruction|0
6095268|NCT00306891|21034907|P2|Part A|Partial bowel obstruction|0
6095269|NCT00306891|21034908|P1|Part A|Partial bowel obstruction|1
6095270|NCT00306891|21034905|P4|Part A|Incorrect enrol/entry crit not fulfilled|0
6095271|NCT00306891|21034906|P3|Part A|Incorrect enrol/entry crit not fulfilled|0
6095272|NCT00306891|21034907|P2|Part A|Incorrect enrol/entry crit not fulfilled|1
6095273|NCT00306891|21034908|P1|Part A|Incorrect enrol/entry crit not fulfilled|0
6095274|NCT00306891|21034905|P4|Part A|Condition under investigation worsened|0
6095275|NCT00306891|21034906|P3|Part A|Condition under investigation worsened|0
6095276|NCT00306891|21034907|P2|Part A|Condition under investigation worsened|2
6095277|NCT00306891|21034908|P1|Part A|Condition under investigation worsened|2
6095278|NCT00306891|21034905|P4|Part A|Withdrawal by Subject|0
6095279|NCT00306891|21034906|P3|Part A|Withdrawal by Subject|0
6095280|NCT00306891|21034907|P2|Part A|Withdrawal by Subject|1
6095281|NCT00306891|21034908|P1|Part A|Withdrawal by Subject|1
6095282|NCT00306852|21034931|P2|Overall Study|Lost to Follow-up|24
6095283|NCT00306852|21034932|P1|Overall Study|Lost to Follow-up|15
6095284|NCT00306852|21034931|P2|Overall Study|Death|14
6095285|NCT00306852|21034932|P1|Overall Study|Death|14
6095286|NCT00306787|21034950|P2|Overall Study|Abnormal laboratory value(s)|0
6095287|NCT00306787|21034951|P1|Overall Study|Abnormal laboratory value(s)|1
6095288|NCT00306787|21034950|P2|Overall Study|Administrative problems|0
6095289|NCT00306787|21034951|P1|Overall Study|Administrative problems|4
6095290|NCT00306787|21034950|P2|Overall Study|Lost to Follow-up|6
6095291|NCT00306787|21034951|P1|Overall Study|Lost to Follow-up|9
6095292|NCT00306787|21034950|P2|Overall Study|Withdrawal by Subject|9
6095293|NCT00306787|21034951|P1|Overall Study|Withdrawal by Subject|2
6095294|NCT00306787|21034950|P2|Overall Study|Protocol Violation|10
6095295|NCT00306787|21034951|P1|Overall Study|Protocol Violation|8
6095296|NCT00306787|21034950|P2|Overall Study|Lack of Efficacy|0
6095297|NCT00306787|21034951|P1|Overall Study|Lack of Efficacy|1
6095298|NCT00306787|21034950|P2|Overall Study|Adverse Event|1
6095299|NCT00306787|21034951|P1|Overall Study|Adverse Event|1
6095300|NCT00306787|21034950|P2|Overall Study|Discontinued without taking study drug|215
6095301|NCT00306787|21034951|P1|Overall Study|Discontinued without taking study drug|208
6095302|NCT00306670|21034969|P2|Overall Study|patients recruited; Genentech, the st|2
6095303|NCT00306670|21034970|P1|Overall Study|patients recruited; Genentech, the st|0
6095304|NCT00306592|21034976|P2|Overall Study|48-week Treatment Period Ongoing|20
6095305|NCT00306592|21034977|P1|Overall Study|48-week Treatment Period Ongoing|0
6095306|NCT00306592|21034976|P2|Overall Study|Other|2
6095307|NCT00306592|21034977|P1|Overall Study|Other|1
6095308|NCT00306592|21034976|P2|Overall Study|Other|10
6095309|NCT00306592|21034977|P1|Overall Study|Other|5
6095310|NCT00306592|21034976|P2|Overall Study|Voluntary|6
6095311|NCT00306592|21034977|P1|Overall Study|Voluntary|10
6095312|NCT00306592|21034976|P2|Overall Study|Persistent Antibodies|3
6095313|NCT00306592|21034977|P1|Overall Study|Persistent Antibodies|6
6095314|NCT00306592|21034976|P2|Overall Study|Noncompliance|2
6095315|NCT00306592|21034977|P1|Overall Study|Noncompliance|0
6095316|NCT00306592|21034976|P2|Overall Study|Lost to Follow-up|0
6095317|NCT00306592|21034977|P1|Overall Study|Lost to Follow-up|1
6095318|NCT00306592|21034976|P2|Overall Study|Adverse Event|15
6095319|NCT00306592|21034977|P1|Overall Study|Adverse Event|8
6095320|NCT00306527|21034987|P4|Overall Study|Death|2
6095321|NCT00306527|21034988|P3|Overall Study|Death|1
6095322|NCT00306527|21034989|P2|Overall Study|Death|0
6095323|NCT00306527|21034990|P1|Overall Study|Death|1
6095324|NCT00306527|21034987|P4|Overall Study|Adverse Event|1
6095325|NCT00306527|21034988|P3|Overall Study|Adverse Event|1
6095326|NCT00306527|21034989|P2|Overall Study|Adverse Event|0
6095327|NCT00306527|21034990|P1|Overall Study|Adverse Event|0
6095328|NCT00306527|21034987|P4|Overall Study|Withdrawal by Subject|3
6095329|NCT00306527|21034988|P3|Overall Study|Withdrawal by Subject|0
6095330|NCT00306527|21034989|P2|Overall Study|Withdrawal by Subject|3
6095331|NCT00306527|21034990|P1|Overall Study|Withdrawal by Subject|2
6095332|NCT00306527|21034987|P4|Overall Study|Lost to Follow-up|0
6095333|NCT00306527|21034988|P3|Overall Study|Lost to Follow-up|3
6095334|NCT00306527|21034989|P2|Overall Study|Lost to Follow-up|4
6095335|NCT00306527|21034990|P1|Overall Study|Lost to Follow-up|3
6095336|NCT00306384|21035062|P3|Overall Study|Site closure|0
6095337|NCT00306384|21035063|P2|Overall Study|Site closure|0
6095338|NCT00306384|21035064|P1|Overall Study|Site closure|2
6095339|NCT00306384|21035062|P3|Overall Study|Other|32
6095340|NCT00306384|21035063|P2|Overall Study|Other|70
6095341|NCT00306384|21035064|P1|Overall Study|Other|80
6095342|NCT00306384|21035062|P3|Overall Study|Investigator discretion|21
6095343|NCT00306384|21035063|P2|Overall Study|Investigator discretion|31
6095344|NCT00306384|21035064|P1|Overall Study|Investigator discretion|28
6095345|NCT00306384|21035062|P3|Overall Study|Lack of Efficacy|38
6095346|NCT00306384|21035063|P2|Overall Study|Lack of Efficacy|40
6095347|NCT00306384|21035064|P1|Overall Study|Lack of Efficacy|26
6095348|NCT00306384|21035062|P3|Overall Study|Pregnancy|1
6095349|NCT00306384|21035063|P2|Overall Study|Pregnancy|1
6095350|NCT00306384|21035064|P1|Overall Study|Pregnancy|3
6095351|NCT00306384|21035062|P3|Overall Study|Study termination|1
6095352|NCT00306384|21035063|P2|Overall Study|Study termination|0
6095353|NCT00306384|21035064|P1|Overall Study|Study termination|1
6095354|NCT00306384|21035062|P3|Overall Study|Voluntary withdrawal|91
6095355|NCT00306384|21035063|P2|Overall Study|Voluntary withdrawal|187
6095356|NCT00306384|21035064|P1|Overall Study|Voluntary withdrawal|199
6095357|NCT00306384|21035062|P3|Overall Study|Lost to Follow-up|35
6095358|NCT00306384|21035063|P2|Overall Study|Lost to Follow-up|41
6095359|NCT00306384|21035064|P1|Overall Study|Lost to Follow-up|57
6095360|NCT00306384|21035062|P3|Overall Study|Major protocol deviation|18
6095361|NCT00306384|21035063|P2|Overall Study|Major protocol deviation|51
6095362|NCT00306384|21035064|P1|Overall Study|Major protocol deviation|43
6095363|NCT00306384|21035062|P3|Overall Study|Adverse Event|40
6095364|NCT00306384|21035063|P2|Overall Study|Adverse Event|87
6095365|NCT00306384|21035064|P1|Overall Study|Adverse Event|103
6095366|NCT00306293|21035096|P2|Period 2 (Day 67 to Day 126 )|Pregnancy|0
6095367|NCT00306293|21035097|P1|Period 2 (Day 67 to Day 126 )|Pregnancy|1
6095368|NCT00306293|21035096|P2|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|1
6095369|NCT00306293|21035097|P1|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|0
6095370|NCT00306293|21035096|P2|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|0
6095371|NCT00306293|21035097|P1|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|1
6095372|NCT00306293|21035096|P2|Period 2 (Day 67 to Day 126 )|Adverse Event|0
6095373|NCT00306293|21035097|P1|Period 2 (Day 67 to Day 126 )|Adverse Event|1
6095374|NCT00306293|21035096|P2|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2
6095375|NCT00306293|21035097|P1|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2
6095376|NCT00306293|21035096|P2|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2
6095377|NCT00306293|21035097|P1|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2
6095378|NCT00306293|21035096|P2|Period 1 (Day 1 to Day 60)|Lost to Follow-up|4
6095379|NCT00306293|21035097|P1|Period 1 (Day 1 to Day 60)|Lost to Follow-up|3
6095380|NCT00306293|21035096|P2|Period 1 (Day 1 to Day 60)|Adverse Event|0
6095381|NCT00306293|21035097|P1|Period 1 (Day 1 to Day 60)|Adverse Event|1
6095382|NCT00306189|21035280|P4|Overall Study|Other|0
6095383|NCT00306189|21035281|P3|Overall Study|Other|0
6095384|NCT00306189|21035282|P2|Overall Study|Other|0
6095385|NCT00306189|21035283|P1|Overall Study|Other|1
6095386|NCT00306189|21035280|P4|Overall Study|Ineligibility determined|1
6095387|NCT00306189|21035281|P3|Overall Study|Ineligibility determined|1
6095388|NCT00306189|21035282|P2|Overall Study|Ineligibility determined|1
6095389|NCT00306189|21035283|P1|Overall Study|Ineligibility determined|1
6095390|NCT00306189|21035280|P4|Overall Study|Withdrawal by Subject|1
6095391|NCT00306189|21035281|P3|Overall Study|Withdrawal by Subject|8
6095392|NCT00306189|21035282|P2|Overall Study|Withdrawal by Subject|2
6095393|NCT00306189|21035283|P1|Overall Study|Withdrawal by Subject|4
6095394|NCT00306189|21035280|P4|Overall Study|Adverse Event|2
6095395|NCT00306189|21035281|P3|Overall Study|Adverse Event|2
6095396|NCT00306189|21035282|P2|Overall Study|Adverse Event|3
6095397|NCT00306189|21035283|P1|Overall Study|Adverse Event|3
6095398|NCT00306189|21035280|P4|Overall Study|Physician Decision|1
6095399|NCT00306189|21035281|P3|Overall Study|Physician Decision|0
6095400|NCT00306189|21035282|P2|Overall Study|Physician Decision|0
6095401|NCT00306189|21035283|P1|Overall Study|Physician Decision|0
6095402|NCT00305877|21035310|P2|Overall Study|Transportation issue with daily RT|1
6095403|NCT00305877|21035311|P1|Overall Study|Transportation issue with daily RT|0
6095404|NCT00305877|21035310|P2|Overall Study|Ineligible|1
6095405|NCT00305877|21035311|P1|Overall Study|Ineligible|2
6095406|NCT00305877|21035310|P2|Overall Study|Never start treatment|5
6095407|NCT00305877|21035311|P1|Overall Study|Never start treatment|2
6095408|NCT00305877|21035310|P2|Overall Study|Physician Decision|1
6095409|NCT00305877|21035311|P1|Overall Study|Physician Decision|1
6095410|NCT00305877|21035310|P2|Overall Study|Withdrawal by Subject|2
6095411|NCT00305877|21035311|P1|Overall Study|Withdrawal by Subject|4
6095412|NCT00305877|21035310|P2|Overall Study|Death|1
6095413|NCT00305877|21035311|P1|Overall Study|Death|0
6095414|NCT00305877|21035310|P2|Overall Study|Adverse Event|14
6095415|NCT00305877|21035311|P1|Overall Study|Adverse Event|9
6095416|NCT00305877|21035310|P2|Overall Study|Lack of Efficacy|9
6095417|NCT00305877|21035311|P1|Overall Study|Lack of Efficacy|6
6095418|NCT00305864|21035325|P4|Overall Study|Ineligible / No protocol treatment|13
6095419|NCT00305864|21035326|P3|Overall Study|Ineligible / No protocol treatment|1
6095420|NCT00305864|21035327|P2|Overall Study|Ineligible / No protocol treatment|1
6095421|NCT00305864|21035328|P1|Overall Study|Ineligible / No protocol treatment|0
6095422|NCT00305773|21035341|P2|Overall Study|All other reasons|2
6095423|NCT00305773|21035342|P1|Overall Study|All other reasons|3
6095424|NCT00305773|21035341|P2|Overall Study|Disease Progression|3
6095425|NCT00305773|21035342|P1|Overall Study|Disease Progression|1
6095426|NCT00305773|21035341|P2|Overall Study|Withdrawal by Subject|4
6095427|NCT00305773|21035342|P1|Overall Study|Withdrawal by Subject|1
6095428|NCT00305773|21035341|P2|Overall Study|Physician Decision|1
6095429|NCT00305773|21035342|P1|Overall Study|Physician Decision|1
6095430|NCT00305773|21035341|P2|Overall Study|Alternative Treatment|4
6095431|NCT00305773|21035342|P1|Overall Study|Alternative Treatment|4
6095432|NCT00305773|21035341|P2|Overall Study|Adverse Event|2
6095433|NCT00305773|21035342|P1|Overall Study|Adverse Event|1
6095434|NCT00305773|21035341|P2|Overall Study|Death|2
6095435|NCT00305773|21035342|P1|Overall Study|Death|3
6095436|NCT00305695|21035362|P2|Overall Study|Did not have baseline scan|1
6095437|NCT00305695|21035363|P1|Overall Study|Did not have baseline scan|1
6095438|NCT00305695|21035362|P2|Overall Study|Withdrawal by subject prior to 18 month|26
6095439|NCT00305695|21035363|P1|Overall Study|Withdrawal by subject prior to 18 month|40
6095440|NCT00305604|21035497|P2|Overall Study|Patient moved|0
6095441|NCT00305604|21035498|P1|Overall Study|Patient moved|1
6095442|NCT00305604|21035497|P2|Overall Study|Withdrawal by Subject|21
6095443|NCT00305604|21035498|P1|Overall Study|Withdrawal by Subject|12
6095444|NCT00305604|21035497|P2|Overall Study|Protocol Violation|1
6095445|NCT00305604|21035498|P1|Overall Study|Protocol Violation|2
6095446|NCT00305604|21035497|P2|Overall Study|Lost to Follow-up|4
6095447|NCT00305604|21035498|P1|Overall Study|Lost to Follow-up|0
6095448|NCT00305604|21035497|P2|Overall Study|Lack of Efficacy|18
6095449|NCT00305604|21035498|P1|Overall Study|Lack of Efficacy|11
6095450|NCT00305604|21035497|P2|Overall Study|Adverse Event|3
6095451|NCT00305604|21035498|P1|Overall Study|Adverse Event|6
6095452|NCT00305448|21035642|P3|Overall Study|Tumor Marker Elevation|1
6095453|NCT00305448|21035643|P2|Overall Study|Tumor Marker Elevation|0
6095454|NCT00305448|21035644|P1|Overall Study|Tumor Marker Elevation|0
6095455|NCT00305448|21035642|P3|Overall Study|Subjective Disease Progression|2
6095456|NCT00305448|21035643|P2|Overall Study|Subjective Disease Progression|2
6095457|NCT00305448|21035644|P1|Overall Study|Subjective Disease Progression|1
6095458|NCT00305448|21035642|P3|Overall Study|Disease Progression|28
6095459|NCT00305448|21035643|P2|Overall Study|Disease Progression|31
6095460|NCT00305448|21035644|P1|Overall Study|Disease Progression|27
6095461|NCT00305448|21035642|P3|Overall Study|Adverse Event|1
6095462|NCT00305448|21035643|P2|Overall Study|Adverse Event|0
6095463|NCT00305448|21035644|P1|Overall Study|Adverse Event|1
6095464|NCT00305448|21035642|P3|Overall Study|Withdrawal by Subject|1
6095465|NCT00305448|21035643|P2|Overall Study|Withdrawal by Subject|0
6095466|NCT00305448|21035644|P1|Overall Study|Withdrawal by Subject|2
6095467|NCT00305448|21035642|P3|Overall Study|Protocol Violation|0
6095468|NCT00305448|21035643|P2|Overall Study|Protocol Violation|1
6095469|NCT00305448|21035644|P1|Overall Study|Protocol Violation|0
6095470|NCT00305253|21035666|P2|Overall Study|Withdrawal by Subject|1
6095471|NCT00305253|21035667|P1|Overall Study|Withdrawal by Subject|0
6095472|NCT00305227|21035679|P2|Overall Study|Lost to Follow-up|6
6095473|NCT00305227|21035680|P1|Overall Study|Lost to Follow-up|7
6095474|NCT00305110|21035727|P1|Overall Study|Missing data|29
6095475|NCT00305058|21035800|P2|Overall Study|Missing outcome data|2
6095476|NCT00305058|21035801|P1|Overall Study|Missing outcome data|3
6095477|NCT00305058|21035800|P2|Overall Study|Missing data collection instrument|2
6095478|NCT00305058|21035801|P1|Overall Study|Missing data collection instrument|3
6095479|NCT00305058|21035800|P2|Overall Study|Participant too young|0
6095480|NCT00305058|21035801|P1|Overall Study|Participant too young|1
6095481|NCT00304954|21035817|P4|Overall Study|Adverse Event|0
6095482|NCT00304954|21035818|P3|Overall Study|Adverse Event|0
6095483|NCT00304954|21035819|P2|Overall Study|Adverse Event|0
6095484|NCT00304954|21035820|P1|Overall Study|Adverse Event|1
6095485|NCT00304954|21035817|P4|Overall Study|Withdrawal by Subject|0
6095486|NCT00304954|21035818|P3|Overall Study|Withdrawal by Subject|1
6095487|NCT00304954|21035819|P2|Overall Study|Withdrawal by Subject|0
6095488|NCT00304954|21035820|P1|Overall Study|Withdrawal by Subject|0
6095489|NCT00304915|21035840|P2|Overall Study|Withdrawal by Subject|0
6095490|NCT00304915|21035841|P1|Overall Study|Withdrawal by Subject|3
6095491|NCT00304915|21035840|P2|Overall Study|Death|5
6095492|NCT00304915|21035841|P1|Overall Study|Death|4
6095493|NCT00304915|21035840|P2|Overall Study|Lost to Follow-up|11
6095494|NCT00304915|21035841|P1|Overall Study|Lost to Follow-up|11
6095495|NCT00304356|21035886|P1|Nitazoxanide|Physician Decision|1
6095496|NCT00304356|21035886|P1|Nitazoxanide|Physician Decision|1
6095497|NCT00304356|21035886|P1|Nitazoxanide|Physician Decision|1
6095498|NCT00304356|21035886|P1|Nitazoxanide|number is 0|1
6095499|NCT00304356|21035886|P1|Nitazoxanide|Physician Decision|1
6095500|NCT00304356|21035886|P1|Nitazoxanide|Physician Decision|5
6095501|NCT00304278|21035890|P1|Overall Study|PT had medical condition preventing TX|1
6095502|NCT00304278|21035890|P1|Overall Study|lack of insurance coverage for chemoRT|1
6095503|NCT00304083|21035939|P2|Overall Study|Other|2
6095504|NCT00304083|21035940|P1|Overall Study|Other|5
6095505|NCT00304083|21035939|P2|Overall Study|Disease Progression|1
6095506|NCT00304083|21035940|P1|Overall Study|Disease Progression|5
6095507|NCT00304083|21035939|P2|Overall Study|Physician Decision|3
6095508|NCT00304083|21035940|P1|Overall Study|Physician Decision|8
6095509|NCT00304083|21035939|P2|Overall Study|Withdrawal by Subject|2
6095510|NCT00304083|21035940|P1|Overall Study|Withdrawal by Subject|4
6095511|NCT00304070|21035959|P3|Overall Study|Progressive Disease|4
6095512|NCT00304070|21035960|P2|Overall Study|Progressive Disease|7
6095513|NCT00304070|21035961|P1|Overall Study|Progressive Disease|3
6095514|NCT00304070|21035959|P3|Overall Study|Withdrawal by Subject|1
6095515|NCT00304070|21035960|P2|Overall Study|Withdrawal by Subject|0
6095516|NCT00304070|21035961|P1|Overall Study|Withdrawal by Subject|0
6095517|NCT00304070|21035959|P3|Overall Study|Physician Decision|3
6095518|NCT00304070|21035960|P2|Overall Study|Physician Decision|0
6095519|NCT00304070|21035961|P1|Overall Study|Physician Decision|0
6095520|NCT00304070|21035959|P3|Overall Study|Lost to Follow-up|1
6095521|NCT00304070|21035960|P2|Overall Study|Lost to Follow-up|0
6095522|NCT00304070|21035961|P1|Overall Study|Lost to Follow-up|0
6095523|NCT00304070|21035959|P3|Overall Study|Death|3
6095524|NCT00304070|21035960|P2|Overall Study|Death|0
6095525|NCT00304070|21035961|P1|Overall Study|Death|0
6095526|NCT00304031|21035976|P3|Randomization to Adjuvant TMZ Arm|No follow-up collected|2
6095527|NCT00304031|21035977|P2|Randomization to Adjuvant TMZ Arm|No follow-up collected|0
6095528|NCT00304031|21035978|P1|Randomization to Adjuvant TMZ Arm|No follow-up collected|0
6095529|NCT00304031|21035976|P3|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|0
6095530|NCT00304031|21035977|P2|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|0
6095531|NCT00304031|21035978|P1|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|37
6095532|NCT00304031|21035976|P3|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|0
6095533|NCT00304031|21035977|P2|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|0
6095700|NCT00303446|21036329|P2|Overall Study|Withdrawal by Subject|2
6095534|NCT00304031|21035978|P1|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|1
6095535|NCT00304031|21035976|P3|Concomitant RT+TMZ (Pre-randomization)|Toxicity|0
6095536|NCT00304031|21035977|P2|Concomitant RT+TMZ (Pre-randomization)|Toxicity|0
6095537|NCT00304031|21035978|P1|Concomitant RT+TMZ (Pre-randomization)|Toxicity|10
6095538|NCT00304031|21035976|P3|Concomitant RT+TMZ (Pre-randomization)|Physician preference|0
6095539|NCT00304031|21035977|P2|Concomitant RT+TMZ (Pre-randomization)|Physician preference|0
6095540|NCT00304031|21035978|P1|Concomitant RT+TMZ (Pre-randomization)|Physician preference|15
6095541|NCT00304031|21035976|P3|Concomitant RT+TMZ (Pre-randomization)|Death|0
6095542|NCT00304031|21035977|P2|Concomitant RT+TMZ (Pre-randomization)|Death|0
6095543|NCT00304031|21035978|P1|Concomitant RT+TMZ (Pre-randomization)|Death|18
6095544|NCT00304031|21035976|P3|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|0
6095545|NCT00304031|21035977|P2|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|0
6095546|NCT00304031|21035978|P1|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|19
6095547|NCT00304031|21035976|P3|Concomitant RT+TMZ (Pre-randomization)|Disease progression|0
6095548|NCT00304031|21035977|P2|Concomitant RT+TMZ (Pre-randomization)|Disease progression|0
6095549|NCT00304031|21035978|P1|Concomitant RT+TMZ (Pre-randomization)|Disease progression|48
6095550|NCT00304031|21035976|P3|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|0
6095551|NCT00304031|21035977|P2|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|0
6095552|NCT00304031|21035978|P1|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|144
6095553|NCT00303953|21036060|P1|Overall Study|Physician Decision|1
6095554|NCT00303953|21036060|P1|Overall Study|Lack of Efficacy|12
6095555|NCT00303953|21036060|P1|Overall Study|Adverse Event|4
6095556|NCT00303953|21036060|P1|Overall Study|Death|1
6095557|NCT00303953|21036060|P1|Overall Study|Ineligible|1
6095558|NCT00303719|21036096|P2|Overall Study|Lost to Follow-up|7
6095559|NCT00303719|21036097|P1|Overall Study|Lost to Follow-up|0
6095560|NCT00303719|21036096|P2|Overall Study|Not evaluable, prior therapies|30
6095561|NCT00303719|21036097|P1|Overall Study|Not evaluable, prior therapies|0
6095562|NCT00303667|21036113|P2|Overall Study|Death|4
6095563|NCT00303667|21036114|P1|Overall Study|Death|0
6095564|NCT00303628|21036138|P2|Overall Study|Other|9
6095565|NCT00303628|21036139|P1|Overall Study|Other|8
6095566|NCT00303628|21036138|P2|Overall Study|Not start protocol therapy|5
6095567|NCT00303628|21036139|P1|Overall Study|Not start protocol therapy|3
6095568|NCT00303628|21036138|P2|Overall Study|Other complicating disease|1
6095569|NCT00303628|21036139|P1|Overall Study|Other complicating disease|0
6095570|NCT00303628|21036138|P2|Overall Study|Alternative therapy|0
6095571|NCT00303628|21036139|P1|Overall Study|Alternative therapy|2
6095572|NCT00303628|21036138|P2|Overall Study|Withdrawal by Subject|20
6095573|NCT00303628|21036139|P1|Overall Study|Withdrawal by Subject|11
6095574|NCT00303628|21036138|P2|Overall Study|Death|1
6095575|NCT00303628|21036139|P1|Overall Study|Death|0
6095576|NCT00303628|21036138|P2|Overall Study|Adverse Event|36
6095577|NCT00303628|21036139|P1|Overall Study|Adverse Event|26
6095578|NCT00303628|21036138|P2|Overall Study|Disease progression|1
6095579|NCT00303628|21036139|P1|Overall Study|Disease progression|0
6095580|NCT00303602|21036157|P2|Overall Study|Protocol Violation|0
6095581|NCT00303602|21036158|P1|Overall Study|Protocol Violation|1
6095582|NCT00303602|21036157|P2|Overall Study|Noncompliance|2
6095583|NCT00303602|21036158|P1|Overall Study|Noncompliance|2
6095584|NCT00303602|21036157|P2|Overall Study|Physician Decision|1
6095585|NCT00303602|21036158|P1|Overall Study|Physician Decision|2
6095586|NCT00303602|21036157|P2|Overall Study|Protocol entry criteria not met|2
6095587|NCT00303602|21036158|P1|Overall Study|Protocol entry criteria not met|2
6095588|NCT00303602|21036157|P2|Overall Study|Lost to Follow-up|2
6095589|NCT00303602|21036158|P1|Overall Study|Lost to Follow-up|5
6095590|NCT00303602|21036157|P2|Overall Study|Withdrawal by Subject|6
6095591|NCT00303602|21036158|P1|Overall Study|Withdrawal by Subject|5
6095592|NCT00303602|21036157|P2|Overall Study|Adverse Event|2
6095593|NCT00303602|21036158|P1|Overall Study|Adverse Event|2
6095594|NCT00303485|21036204|P2|Overall Study|Withdrawal by Subject|0
6095595|NCT00303485|21036205|P1|Overall Study|Withdrawal by Subject|1
6095596|NCT00303485|21036204|P2|Overall Study|Failure to return|1
6095597|NCT00303485|21036205|P1|Overall Study|Failure to return|0
6095598|NCT00303485|21036204|P2|Overall Study|Adverse Event/Intercurrent Illness|1
6095599|NCT00303485|21036205|P1|Overall Study|Adverse Event/Intercurrent Illness|0
6095600|NCT00303472|21036236|P7|Treatment Extension (Optional)|Disease Progression (to AML)|0
6095601|NCT00303472|21036237|P6|Treatment Extension (Optional)|Disease Progression (to AML)|1
6095602|NCT00303472|21036238|P5|Treatment Extension (Optional)|Disease Progression (to AML)|0
6095603|NCT00303472|21036239|P4|Treatment Extension (Optional)|Disease Progression (to AML)|0
6095604|NCT00303472|21036240|P3|Treatment Extension (Optional)|Disease Progression (to AML)|0
6095605|NCT00303472|21036241|P2|Treatment Extension (Optional)|Disease Progression (to AML)|0
6095606|NCT00303472|21036242|P1|Treatment Extension (Optional)|Disease Progression (to AML)|1
6095607|NCT00303472|21036236|P7|Treatment Extension (Optional)|Other|0
6095608|NCT00303472|21036237|P6|Treatment Extension (Optional)|Other|0
6095609|NCT00303472|21036238|P5|Treatment Extension (Optional)|Other|1
6095610|NCT00303472|21036239|P4|Treatment Extension (Optional)|Other|2
6095611|NCT00303472|21036240|P3|Treatment Extension (Optional)|Other|4
6095612|NCT00303472|21036241|P2|Treatment Extension (Optional)|Other|2
6095613|NCT00303472|21036242|P1|Treatment Extension (Optional)|Other|0
6095614|NCT00303472|21036236|P7|Treatment Extension (Optional)|Withdrawal by Subject|0
6095615|NCT00303472|21036237|P6|Treatment Extension (Optional)|Withdrawal by Subject|0
6095616|NCT00303472|21036238|P5|Treatment Extension (Optional)|Withdrawal by Subject|1
6095617|NCT00303472|21036239|P4|Treatment Extension (Optional)|Withdrawal by Subject|2
6095618|NCT00303472|21036240|P3|Treatment Extension (Optional)|Withdrawal by Subject|1
6095619|NCT00303472|21036241|P2|Treatment Extension (Optional)|Withdrawal by Subject|0
6095620|NCT00303472|21036242|P1|Treatment Extension (Optional)|Withdrawal by Subject|1
6095621|NCT00303472|21036236|P7|Treatment Extension (Optional)|Physician Decision|0
6095622|NCT00303472|21036237|P6|Treatment Extension (Optional)|Physician Decision|0
6095623|NCT00303472|21036238|P5|Treatment Extension (Optional)|Physician Decision|2
6095624|NCT00303472|21036239|P4|Treatment Extension (Optional)|Physician Decision|3
6095625|NCT00303472|21036240|P3|Treatment Extension (Optional)|Physician Decision|2
6095626|NCT00303472|21036241|P2|Treatment Extension (Optional)|Physician Decision|4
6095627|NCT00303472|21036242|P1|Treatment Extension (Optional)|Physician Decision|0
6095628|NCT00303472|21036236|P7|Treatment Extension (Optional)|Lost to Follow-up|0
6095629|NCT00303472|21036237|P6|Treatment Extension (Optional)|Lost to Follow-up|0
6095630|NCT00303472|21036238|P5|Treatment Extension (Optional)|Lost to Follow-up|0
6095631|NCT00303472|21036239|P4|Treatment Extension (Optional)|Lost to Follow-up|1
6095632|NCT00303472|21036240|P3|Treatment Extension (Optional)|Lost to Follow-up|0
6095633|NCT00303472|21036241|P2|Treatment Extension (Optional)|Lost to Follow-up|0
6095634|NCT00303472|21036242|P1|Treatment Extension (Optional)|Lost to Follow-up|0
6095635|NCT00303472|21036236|P7|Treatment Extension (Optional)|Death|0
6095636|NCT00303472|21036237|P6|Treatment Extension (Optional)|Death|0
6095637|NCT00303472|21036238|P5|Treatment Extension (Optional)|Death|0
6095638|NCT00303472|21036239|P4|Treatment Extension (Optional)|Death|0
6095639|NCT00303472|21036240|P3|Treatment Extension (Optional)|Death|1
6095640|NCT00303472|21036241|P2|Treatment Extension (Optional)|Death|0
6095641|NCT00303472|21036242|P1|Treatment Extension (Optional)|Death|2
6095642|NCT00303472|21036236|P7|Treatment Extension (Optional)|Adverse Event|0
6095643|NCT00303472|21036237|P6|Treatment Extension (Optional)|Adverse Event|0
6095644|NCT00303472|21036238|P5|Treatment Extension (Optional)|Adverse Event|0
6095645|NCT00303472|21036239|P4|Treatment Extension (Optional)|Adverse Event|0
6095646|NCT00303472|21036240|P3|Treatment Extension (Optional)|Adverse Event|1
6095647|NCT00303472|21036241|P2|Treatment Extension (Optional)|Adverse Event|0
6095648|NCT00303472|21036242|P1|Treatment Extension (Optional)|Adverse Event|1
6095649|NCT00303472|21036236|P7|Treatment Period|Disease Progression (to AML)|0
6095650|NCT00303472|21036237|P6|Treatment Period|Disease Progression (to AML)|0
6095651|NCT00303472|21036238|P5|Treatment Period|Disease Progression (to AML)|1
6095652|NCT00303472|21036239|P4|Treatment Period|Disease Progression (to AML)|0
6095653|NCT00303472|21036240|P3|Treatment Period|Disease Progression (to AML)|0
6095654|NCT00303472|21036241|P2|Treatment Period|Disease Progression (to AML)|0
6095655|NCT00303472|21036242|P1|Treatment Period|Disease Progression (to AML)|0
6095656|NCT00303472|21036236|P7|Treatment Period|Other|1
6095657|NCT00303472|21036237|P6|Treatment Period|Other|0
6095658|NCT00303472|21036238|P5|Treatment Period|Other|1
6095659|NCT00303472|21036239|P4|Treatment Period|Other|0
6095660|NCT00303472|21036240|P3|Treatment Period|Other|0
6095661|NCT00303472|21036241|P2|Treatment Period|Other|0
6095662|NCT00303472|21036242|P1|Treatment Period|Other|0
6095663|NCT00303472|21036236|P7|Treatment Period|Withdrawal by Subject|0
6095664|NCT00303472|21036237|P6|Treatment Period|Withdrawal by Subject|1
6095665|NCT00303472|21036238|P5|Treatment Period|Withdrawal by Subject|0
6095666|NCT00303472|21036239|P4|Treatment Period|Withdrawal by Subject|1
6095667|NCT00303472|21036240|P3|Treatment Period|Withdrawal by Subject|0
6095668|NCT00303472|21036241|P2|Treatment Period|Withdrawal by Subject|0
6095669|NCT00303472|21036242|P1|Treatment Period|Withdrawal by Subject|0
6095670|NCT00303472|21036236|P7|Treatment Period|Death|1
6095671|NCT00303472|21036237|P6|Treatment Period|Death|0
6095672|NCT00303472|21036238|P5|Treatment Period|Death|0
6095673|NCT00303472|21036239|P4|Treatment Period|Death|1
6095674|NCT00303472|21036240|P3|Treatment Period|Death|0
6095675|NCT00303472|21036241|P2|Treatment Period|Death|0
6095676|NCT00303472|21036242|P1|Treatment Period|Death|0
6095677|NCT00303472|21036236|P7|Treatment Period|Adverse Event|0
6095678|NCT00303472|21036237|P6|Treatment Period|Adverse Event|0
6095679|NCT00303472|21036238|P5|Treatment Period|Adverse Event|1
6095680|NCT00303472|21036239|P4|Treatment Period|Adverse Event|0
6095681|NCT00303472|21036240|P3|Treatment Period|Adverse Event|0
6095682|NCT00303472|21036241|P2|Treatment Period|Adverse Event|0
6095683|NCT00303472|21036242|P1|Treatment Period|Adverse Event|0
6095684|NCT00303459|21036302|P2|Overall Study|Lung transplantation|1
6095685|NCT00303459|21036303|P1|Overall Study|Lung transplantation|1
6095686|NCT00303459|21036302|P2|Overall Study|Decision by the investigator|7
6095687|NCT00303459|21036303|P1|Overall Study|Decision by the investigator|5
6095688|NCT00303459|21036302|P2|Overall Study|Administrative reason|7
6095689|NCT00303459|21036303|P1|Overall Study|Administrative reason|7
6095690|NCT00303459|21036302|P2|Overall Study|Lost to Follow-up|4
6095691|NCT00303459|21036303|P1|Overall Study|Lost to Follow-up|5
6095692|NCT00303459|21036302|P2|Overall Study|Withdrawal of consent|26
6095693|NCT00303459|21036303|P1|Overall Study|Withdrawal of consent|32
6095694|NCT00303459|21036302|P2|Overall Study|Death|44
6095695|NCT00303459|21036303|P1|Overall Study|Death|33
6095696|NCT00303446|21036329|P2|Overall Study|Physician Decision|1
6095697|NCT00303446|21036330|P1|Overall Study|Physician Decision|0
6095698|NCT00303446|21036329|P2|Overall Study|Death|1
6095699|NCT00303446|21036330|P1|Overall Study|Death|0
6095701|NCT00303446|21036330|P1|Overall Study|Withdrawal by Subject|2
6095702|NCT00303329|21036366|P2|Overall Study|Stopped at end of extension 1|0
6095703|NCT00303329|21036367|P1|Overall Study|Stopped at end of extension 1|1
6095704|NCT00303329|21036366|P2|Overall Study|Stopped at end of core|9
6095705|NCT00303329|21036367|P1|Overall Study|Stopped at end of core|3
6095706|NCT00303329|21036366|P2|Overall Study|Death|12
6095707|NCT00303329|21036367|P1|Overall Study|Death|2
6095708|NCT00303329|21036366|P2|Overall Study|Administrative problems|0
6095709|NCT00303329|21036367|P1|Overall Study|Administrative problems|1
6095710|NCT00303329|21036366|P2|Overall Study|Lost to Follow-up|1
6095711|NCT00303329|21036367|P1|Overall Study|Lost to Follow-up|0
6095712|NCT00303329|21036366|P2|Overall Study|Withdrawal by Subject|15
6095713|NCT00303329|21036367|P1|Overall Study|Withdrawal by Subject|9
6095714|NCT00303329|21036366|P2|Overall Study|Protocol Violation|0
6095715|NCT00303329|21036367|P1|Overall Study|Protocol Violation|3
6095716|NCT00303329|21036366|P2|Overall Study|Condition no longer requires study drug|8
6095717|NCT00303329|21036367|P1|Overall Study|Condition no longer requires study drug|0
6095718|NCT00303329|21036366|P2|Overall Study|Unsatisfactory therapeutic effect|2
6095719|NCT00303329|21036367|P1|Overall Study|Unsatisfactory therapeutic effect|9
6095720|NCT00303329|21036366|P2|Overall Study|Abnormal Laboratory Values|1
6095721|NCT00303329|21036367|P1|Overall Study|Abnormal Laboratory Values|0
6095722|NCT00303329|21036366|P2|Overall Study|Adverse Event|14
6095723|NCT00303329|21036367|P1|Overall Study|Adverse Event|7
6095724|NCT00303316|21036381|P2|Overall Study|Withdrawal by Subject|2
6095725|NCT00303316|21036382|P1|Overall Study|Withdrawal by Subject|1
6095726|NCT00303316|21036381|P2|Overall Study|Lost to Follow-up|1
6095727|NCT00303316|21036382|P1|Overall Study|Lost to Follow-up|0
6095728|NCT00303316|21036381|P2|Overall Study|Protocol Violation|0
6095729|NCT00303316|21036382|P1|Overall Study|Protocol Violation|1
6095730|NCT00303186|21036394|P1|Overall Study|Other|52
6095731|NCT00303108|21036428|P3|Overall Study|ineligible|0
6095732|NCT00303108|21036429|P2|Overall Study|ineligible|1
6095733|NCT00303108|21036430|P1|Overall Study|ineligible|2
6095734|NCT00303108|21036428|P3|Overall Study|Failed Entry|1
6095735|NCT00303108|21036429|P2|Overall Study|Failed Entry|0
6095736|NCT00303108|21036430|P1|Overall Study|Failed Entry|1
6095737|NCT00303108|21036428|P3|Overall Study|Patient Request|8
6095738|NCT00303108|21036429|P2|Overall Study|Patient Request|2
6095739|NCT00303108|21036430|P1|Overall Study|Patient Request|4
6095740|NCT00303108|21036428|P3|Overall Study|Adverse Event|7
6095741|NCT00303108|21036429|P2|Overall Study|Adverse Event|6
6095742|NCT00303108|21036430|P1|Overall Study|Adverse Event|5
6095743|NCT00303069|21036450|P4|Overall Study|Recruitment into Army Reserves|0
6095744|NCT00303069|21036451|P3|Overall Study|Recruitment into Army Reserves|1
6095745|NCT00303069|21036452|P2|Overall Study|Recruitment into Army Reserves|0
6095746|NCT00303069|21036453|P1|Overall Study|Recruitment into Army Reserves|0
6095747|NCT00303069|21036450|P4|Overall Study|subject moved|0
6095748|NCT00303069|21036451|P3|Overall Study|subject moved|0
6095749|NCT00303069|21036452|P2|Overall Study|subject moved|0
6095750|NCT00303069|21036453|P1|Overall Study|subject moved|1
6095751|NCT00303069|21036450|P4|Overall Study|Lost to Follow-up|2
6095752|NCT00303069|21036451|P3|Overall Study|Lost to Follow-up|0
6095753|NCT00303069|21036452|P2|Overall Study|Lost to Follow-up|0
6095754|NCT00303069|21036453|P1|Overall Study|Lost to Follow-up|1
6095755|NCT00302952|21036473|P2|Overall Study|Elevated SGOT (AST) lab value|1
6095756|NCT00302952|21036474|P1|Overall Study|Elevated SGOT (AST) lab value|0
6095757|NCT00302952|21036473|P2|Overall Study|Withdrawal by Subject|3
6095758|NCT00302952|21036474|P1|Overall Study|Withdrawal by Subject|2
6095759|NCT00302952|21036473|P2|Overall Study|Physician Decision|1
6095760|NCT00302952|21036474|P1|Overall Study|Physician Decision|1
6095761|NCT00302731|21036524|P4|Overall Study|cancer unrelated to study discovered|0
6095762|NCT00302731|21036525|P3|Overall Study|cancer unrelated to study discovered|1
6095763|NCT00302731|21036526|P2|Overall Study|cancer unrelated to study discovered|0
6095764|NCT00302731|21036527|P1|Overall Study|cancer unrelated to study discovered|1
6095765|NCT00302731|21036524|P4|Overall Study|Protocol Violation|0
6095766|NCT00302731|21036525|P3|Overall Study|Protocol Violation|0
6095767|NCT00302731|21036526|P2|Overall Study|Protocol Violation|0
6095768|NCT00302731|21036527|P1|Overall Study|Protocol Violation|1
6095769|NCT00302731|21036524|P4|Overall Study|Withdrawal by Subject|0
6095770|NCT00302731|21036525|P3|Overall Study|Withdrawal by Subject|0
6095771|NCT00302731|21036526|P2|Overall Study|Withdrawal by Subject|1
6095772|NCT00302731|21036527|P1|Overall Study|Withdrawal by Subject|1
6095773|NCT00302731|21036524|P4|Overall Study|Adverse Event|0
6095774|NCT00302731|21036525|P3|Overall Study|Adverse Event|2
6095775|NCT00302731|21036526|P2|Overall Study|Adverse Event|2
6095776|NCT00302731|21036527|P1|Overall Study|Adverse Event|0
6095777|NCT00302731|21036524|P4|Overall Study|Lost to Follow-up|0
6095778|NCT00302731|21036525|P3|Overall Study|Lost to Follow-up|0
6095779|NCT00302731|21036526|P2|Overall Study|Lost to Follow-up|2
6095780|NCT00302731|21036527|P1|Overall Study|Lost to Follow-up|1
6095781|NCT00302718|21036553|P4|Overall Study|Participant left primary care setting|1
6095782|NCT00302718|21036554|P3|Overall Study|Participant left primary care setting|2
6095783|NCT00302718|21036555|P2|Overall Study|Participant left primary care setting|0
6095784|NCT00302718|21036556|P1|Overall Study|Participant left primary care setting|0
6095785|NCT00302718|21036553|P4|Overall Study|Withdrawal by Subject|0
6095786|NCT00302718|21036554|P3|Overall Study|Withdrawal by Subject|0
6095787|NCT00302718|21036555|P2|Overall Study|Withdrawal by Subject|1
6095788|NCT00302718|21036556|P1|Overall Study|Withdrawal by Subject|0
6095789|NCT00302718|21036553|P4|Overall Study|Participant left the hospital|1
6095790|NCT00302718|21036554|P3|Overall Study|Participant left the hospital|0
6095791|NCT00302718|21036555|P2|Overall Study|Participant left the hospital|0
6095792|NCT00302718|21036556|P1|Overall Study|Participant left the hospital|1
6095793|NCT00302458|21036622|P1|Overall Study|Withdrawal by Subject|1
6095794|NCT00302458|21036622|P1|Overall Study|Ineligible after screening|1
6095795|NCT00302458|21036622|P1|Overall Study|Lost to Follow-up|1
6095796|NCT00302328|21036633|P3|Overall Study|Physician Decision|0
6095797|NCT00302328|21036634|P2|Overall Study|Physician Decision|1
6095798|NCT00302328|21036635|P1|Overall Study|Physician Decision|0
6095799|NCT00302211|21036652|P5|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0
6095800|NCT00302211|21036653|P4|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|1
6095801|NCT00302211|21036654|P3|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0
6095802|NCT00302211|21036655|P2|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0
6095803|NCT00302211|21036656|P1|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0
6095804|NCT00302211|21036652|P5|Open Label-Patients From Double-Blind|PH requiring lung transplant|1
6095805|NCT00302211|21036653|P4|Open Label-Patients From Double-Blind|PH requiring lung transplant|0
6095806|NCT00302211|21036654|P3|Open Label-Patients From Double-Blind|PH requiring lung transplant|0
6095807|NCT00302211|21036655|P2|Open Label-Patients From Double-Blind|PH requiring lung transplant|0
6095808|NCT00302211|21036656|P1|Open Label-Patients From Double-Blind|PH requiring lung transplant|0
6095809|NCT00302211|21036652|P5|Open Label-Patients From Double-Blind|Lost to Follow-up|1
6095810|NCT00302211|21036653|P4|Open Label-Patients From Double-Blind|Lost to Follow-up|0
6095811|NCT00302211|21036654|P3|Open Label-Patients From Double-Blind|Lost to Follow-up|0
6095812|NCT00302211|21036655|P2|Open Label-Patients From Double-Blind|Lost to Follow-up|0
6095813|NCT00302211|21036656|P1|Open Label-Patients From Double-Blind|Lost to Follow-up|0
6095814|NCT00302211|21036652|P5|Open Label-Patients From Double-Blind|Death|1
6095815|NCT00302211|21036653|P4|Open Label-Patients From Double-Blind|Death|1
6095816|NCT00302211|21036654|P3|Open Label-Patients From Double-Blind|Death|0
6095817|NCT00302211|21036655|P2|Open Label-Patients From Double-Blind|Death|0
6095818|NCT00302211|21036656|P1|Open Label-Patients From Double-Blind|Death|0
6095819|NCT00302211|21036652|P5|Open Label-Patients From Double-Blind|Disease progression|2
6095820|NCT00302211|21036653|P4|Open Label-Patients From Double-Blind|Disease progression|1
6095821|NCT00302211|21036654|P3|Open Label-Patients From Double-Blind|Disease progression|0
6095822|NCT00302211|21036655|P2|Open Label-Patients From Double-Blind|Disease progression|0
6095823|NCT00302211|21036656|P1|Open Label-Patients From Double-Blind|Disease progression|0
6095824|NCT00302211|21036652|P5|Open Label-Patients From Double-Blind|Investigator's judgement|0
6095825|NCT00302211|21036653|P4|Open Label-Patients From Double-Blind|Investigator's judgement|1
6095826|NCT00302211|21036654|P3|Open Label-Patients From Double-Blind|Investigator's judgement|0
6095827|NCT00302211|21036655|P2|Open Label-Patients From Double-Blind|Investigator's judgement|0
6095828|NCT00302211|21036656|P1|Open Label-Patients From Double-Blind|Investigator's judgement|0
6095829|NCT00302211|21036652|P5|Open Label-Patients From Double-Blind|Adverse Event|0
6095830|NCT00302211|21036653|P4|Open Label-Patients From Double-Blind|Adverse Event|1
6095831|NCT00302211|21036654|P3|Open Label-Patients From Double-Blind|Adverse Event|0
6095832|NCT00302211|21036655|P2|Open Label-Patients From Double-Blind|Adverse Event|0
6095833|NCT00302211|21036656|P1|Open Label-Patients From Double-Blind|Adverse Event|0
6095834|NCT00302211|21036652|P5|Open Label-Patients From Double-Blind|Withdrawal by Subject|3
6095835|NCT00302211|21036653|P4|Open Label-Patients From Double-Blind|Withdrawal by Subject|3
6095836|NCT00302211|21036654|P3|Open Label-Patients From Double-Blind|Withdrawal by Subject|0
6095837|NCT00302211|21036655|P2|Open Label-Patients From Double-Blind|Withdrawal by Subject|0
6095838|NCT00302211|21036656|P1|Open Label-Patients From Double-Blind|Withdrawal by Subject|0
6095839|NCT00302211|21036652|P5|Double Blind Period (New Patients)|Disease progression|0
6095840|NCT00302211|21036653|P4|Double Blind Period (New Patients)|Disease progression|0
6095841|NCT00302211|21036654|P3|Double Blind Period (New Patients)|Disease progression|1
6095842|NCT00302211|21036655|P2|Double Blind Period (New Patients)|Disease progression|1
6095843|NCT00302211|21036656|P1|Double Blind Period (New Patients)|Disease progression|0
6095844|NCT00302211|21036652|P5|Double Blind Period (New Patients)|Investigator's judgement|0
6095845|NCT00302211|21036653|P4|Double Blind Period (New Patients)|Investigator's judgement|0
6095846|NCT00302211|21036654|P3|Double Blind Period (New Patients)|Investigator's judgement|0
6095847|NCT00302211|21036655|P2|Double Blind Period (New Patients)|Investigator's judgement|0
6095848|NCT00302211|21036656|P1|Double Blind Period (New Patients)|Investigator's judgement|1
6095849|NCT00302211|21036652|P5|Double Blind Period (New Patients)|Adverse Event|0
6095850|NCT00302211|21036653|P4|Double Blind Period (New Patients)|Adverse Event|0
6095851|NCT00302211|21036654|P3|Double Blind Period (New Patients)|Adverse Event|3
6095852|NCT00302211|21036655|P2|Double Blind Period (New Patients)|Adverse Event|0
6095853|NCT00302211|21036656|P1|Double Blind Period (New Patients)|Adverse Event|0
6095854|NCT00302211|21036652|P5|Double Blind Period (New Patients)|Withdrawal by Subject|0
6095855|NCT00302211|21036653|P4|Double Blind Period (New Patients)|Withdrawal by Subject|0
6095856|NCT00302211|21036654|P3|Double Blind Period (New Patients)|Withdrawal by Subject|0
6095857|NCT00302211|21036655|P2|Double Blind Period (New Patients)|Withdrawal by Subject|1
6095858|NCT00302211|21036656|P1|Double Blind Period (New Patients)|Withdrawal by Subject|2
6095859|NCT00302159|21036682|P1|Overall Study|pt started Avastin|1
6095860|NCT00302159|21036682|P1|Overall Study|pt declined before treatment started|1
6095861|NCT00302107|21036704|P2|Overall Study|Adverse Event|0
6095862|NCT00302107|21036705|P1|Overall Study|Adverse Event|1
6095863|NCT00302107|21036704|P2|Overall Study|Withdrawal by Subject|3
6095864|NCT00302107|21036705|P1|Overall Study|Withdrawal by Subject|0
6095865|NCT00302107|21036704|P2|Overall Study|Relocation|1
6095866|NCT00302107|21036705|P1|Overall Study|Relocation|0
6095867|NCT00302107|21036704|P2|Overall Study|Protocol Violation|0
6095868|NCT00302107|21036705|P1|Overall Study|Protocol Violation|1
6095869|NCT00302107|21036704|P2|Overall Study|Lost to Follow-up|5
6095870|NCT00302107|21036705|P1|Overall Study|Lost to Follow-up|6
6095871|NCT00302081|21036714|P3|Overall Study|Other|5
6095872|NCT00302081|21036715|P2|Overall Study|Other|6
6095873|NCT00302081|21036716|P1|Overall Study|Other|13
6095874|NCT00302081|21036714|P3|Overall Study|Death|0
6095875|NCT00302081|21036715|P2|Overall Study|Death|1
6095876|NCT00302081|21036716|P1|Overall Study|Death|2
6095877|NCT00302081|21036714|P3|Overall Study|Lack of Efficacy|5
6095878|NCT00302081|21036715|P2|Overall Study|Lack of Efficacy|0
6095879|NCT00302081|21036716|P1|Overall Study|Lack of Efficacy|1
6095880|NCT00302081|21036714|P3|Overall Study|Protocol Violation|2
6095881|NCT00302081|21036715|P2|Overall Study|Protocol Violation|1
6095882|NCT00302081|21036716|P1|Overall Study|Protocol Violation|5
6095883|NCT00302081|21036714|P3|Overall Study|Withdrawal by Subject|8
6095884|NCT00302081|21036715|P2|Overall Study|Withdrawal by Subject|12
6095885|NCT00302081|21036716|P1|Overall Study|Withdrawal by Subject|8
6095886|NCT00302081|21036714|P3|Overall Study|Lost to Follow-up|28
6095887|NCT00302081|21036715|P2|Overall Study|Lost to Follow-up|18
6095888|NCT00302081|21036716|P1|Overall Study|Lost to Follow-up|21
6095889|NCT00302081|21036714|P3|Overall Study|Adverse Event|4
6095890|NCT00302081|21036715|P2|Overall Study|Adverse Event|5
6095891|NCT00302081|21036716|P1|Overall Study|Adverse Event|6
6095892|NCT00302003|21036773|P1|Overall Study|Protocol Violation|1
6095893|NCT00302003|21036773|P1|Overall Study|Ineligible|9
6095894|NCT00302003|21036773|P1|Overall Study|Withdrawal by Subject|5
6095895|NCT00302003|21036773|P1|Overall Study|Physician Decision|2
6095896|NCT00302003|21036773|P1|Overall Study|Lost to Follow-up|1
6095897|NCT00302003|21036773|P1|Overall Study|Lack of Efficacy|62
6095898|NCT00301964|21036780|P1|Overall Study|Inadequate pathology|1
6095899|NCT00301964|21036780|P1|Overall Study|Wrong primary|1
6095900|NCT00301964|21036780|P1|Overall Study|Second primary|2
6095901|NCT00301834|21036801|P1|Overall Study|Death|1
6095902|NCT00301821|21036810|P1|Overall Study|Cancel|1
6095903|NCT00301821|21036810|P1|Overall Study|Ineligible|25
6095904|NCT00301808|21036817|P1|Overall Study|Lack of Efficacy|4
6095905|NCT00301808|21036817|P1|Overall Study|Death|3
6095906|NCT00301808|21036817|P1|Overall Study|Adverse Event|5
6095907|NCT00301366|21036842|P1|Overall Study|Adverse Event|1
6095924|NCT00301080|21037007|P5|Original Version (2 Arms & 4 Weeks)|Never received drug|0
6095925|NCT00301080|21037008|P4|Original Version (2 Arms & 4 Weeks)|Never received drug|0
6095926|NCT00301080|21037009|P3|Original Version (2 Arms & 4 Weeks)|Never received drug|0
6095927|NCT00301080|21037010|P2|Original Version (2 Arms & 4 Weeks)|Never received drug|0
6095928|NCT00301080|21037011|P1|Original Version (2 Arms & 4 Weeks)|Never received drug|1
6095929|NCT00301067|21037040|P4|Follow up Until Death|Alive at last data cut point|1
6095930|NCT00301067|21037041|P3|Follow up Until Death|Alive at last data cut point|0
6095931|NCT00301067|21037042|P2|Follow up Until Death|Alive at last data cut point|0
6095932|NCT00301067|21037043|P1|Follow up Until Death|Alive at last data cut point|1
6095933|NCT00301067|21037040|P4|Completed 12 Cycles of Treatment|Adverse Event|1
6095934|NCT00301067|21037041|P3|Completed 12 Cycles of Treatment|Adverse Event|0
6095935|NCT00301067|21037042|P2|Completed 12 Cycles of Treatment|Adverse Event|0
6095936|NCT00301067|21037043|P1|Completed 12 Cycles of Treatment|Adverse Event|0
6095937|NCT00301067|21037040|P4|Completed 12 Cycles of Treatment|Progressive Disease|1
6095938|NCT00301067|21037041|P3|Completed 12 Cycles of Treatment|Progressive Disease|0
6095939|NCT00301067|21037042|P2|Completed 12 Cycles of Treatment|Progressive Disease|1
6095940|NCT00301067|21037043|P1|Completed 12 Cycles of Treatment|Progressive Disease|0
6095941|NCT00301067|21037040|P4|Completed 4 Cycles of Treatment|Progressive disease|5
6095942|NCT00301067|21037041|P3|Completed 4 Cycles of Treatment|Progressive disease|2
6095943|NCT00301067|21037042|P2|Completed 4 Cycles of Treatment|Progressive disease|1
6095944|NCT00301067|21037043|P1|Completed 4 Cycles of Treatment|Progressive disease|1
6095945|NCT00301067|21037040|P4|Reached 1st Response/2 Cycles|Progressive Disease|2
6095946|NCT00301067|21037041|P3|Reached 1st Response/2 Cycles|Progressive Disease|1
6095947|NCT00301067|21037042|P2|Reached 1st Response/2 Cycles|Progressive Disease|1
6095948|NCT00301067|21037043|P1|Reached 1st Response/2 Cycles|Progressive Disease|2
6095949|NCT00301067|21037040|P4|Completed DLT Period/1st Cycle|Progressive Disease|1
6095950|NCT00301067|21037041|P3|Completed DLT Period/1st Cycle|Progressive Disease|0
6095951|NCT00301067|21037042|P2|Completed DLT Period/1st Cycle|Progressive Disease|0
6095952|NCT00301067|21037043|P1|Completed DLT Period/1st Cycle|Progressive Disease|1
6095953|NCT00300885|21037068|P2|Follow-up|Withdrawal by Subject|25
6095954|NCT00300885|21037069|P1|Follow-up|Withdrawal by Subject|26
6095955|NCT00300885|21037068|P2|Follow-up|Lost to Follow-up|7
6095956|NCT00300885|21037069|P1|Follow-up|Lost to Follow-up|11
6095957|NCT00300885|21037068|P2|Follow-up|Death|163
6095958|NCT00300885|21037069|P1|Follow-up|Death|141
6095959|NCT00300885|21037068|P2|Treatment|Non-compliant with study medication|4
6095960|NCT00300885|21037069|P1|Treatment|Non-compliant with study medication|3
6095961|NCT00300885|21037068|P2|Treatment|Random code broken (subject died)|1
6095962|NCT00300885|21037069|P1|Treatment|Random code broken (subject died)|0
6095963|NCT00300885|21037068|P2|Treatment|Disease progression|238
6095964|NCT00300885|21037069|P1|Treatment|Disease progression|171
6095965|NCT00300885|21037068|P2|Treatment|Withdrawal by Subject|23
6095966|NCT00300885|21037069|P1|Treatment|Withdrawal by Subject|26
6095967|NCT00300885|21037068|P2|Treatment|Protocol Violation|11
6095968|NCT00300885|21037069|P1|Treatment|Protocol Violation|11
6095969|NCT00300885|21037068|P2|Treatment|Physician Decision|5
6095970|NCT00300885|21037069|P1|Treatment|Physician Decision|4
6095971|NCT00300885|21037068|P2|Treatment|Lost to Follow-up|2
6095972|NCT00300885|21037069|P1|Treatment|Lost to Follow-up|3
6095973|NCT00300885|21037068|P2|Treatment|Lack of Efficacy|1
6095974|NCT00300885|21037069|P1|Treatment|Lack of Efficacy|1
6095975|NCT00300885|21037068|P2|Treatment|Death|7
6095976|NCT00300885|21037069|P1|Treatment|Death|20
6095977|NCT00300885|21037068|P2|Treatment|Adverse Event|82
6095978|NCT00300885|21037069|P1|Treatment|Adverse Event|134
6095979|NCT00300781|21037087|P2|Overall Study|Lost to Follow-up|1
6095980|NCT00300781|21037088|P1|Overall Study|Lost to Follow-up|0
6095981|NCT00300781|21037087|P2|Overall Study|Symptomatic Deterioration|0
6095982|NCT00300781|21037088|P1|Overall Study|Symptomatic Deterioration|1
6095983|NCT00300781|21037087|P2|Overall Study|Not Recorded|1
6095984|NCT00300781|21037088|P1|Overall Study|Not Recorded|0
6095985|NCT00300781|21037087|P2|Overall Study|Physician Decision|0
6095986|NCT00300781|21037088|P1|Overall Study|Physician Decision|1
6095987|NCT00300781|21037087|P2|Overall Study|Withdrawal by Subject|2
6095988|NCT00300781|21037088|P1|Overall Study|Withdrawal by Subject|1
6095989|NCT00300781|21037087|P2|Overall Study|Adverse Event|6
6095990|NCT00300781|21037088|P1|Overall Study|Adverse Event|5
6095991|NCT00300781|21037087|P2|Overall Study|Disease Progression|52
6095992|NCT00300781|21037088|P1|Overall Study|Disease Progression|55
6095993|NCT00300755|21037103|P3|Overall Study|Protocol Violation|1
6095994|NCT00300755|21037104|P2|Overall Study|Protocol Violation|0
6095995|NCT00300755|21037105|P1|Overall Study|Protocol Violation|0
6095996|NCT00300755|21037103|P3|Overall Study|Withdrawal by Subject|0
6095997|NCT00300755|21037104|P2|Overall Study|Withdrawal by Subject|2
6095998|NCT00300755|21037105|P1|Overall Study|Withdrawal by Subject|0
6095999|NCT00300755|21037103|P3|Overall Study|Adverse Event|1
6096000|NCT00300755|21037104|P2|Overall Study|Adverse Event|2
6096001|NCT00300755|21037105|P1|Overall Study|Adverse Event|1
6096002|NCT00300495|21037139|P2|Overall Study|Protocol Violation|1
6096003|NCT00300495|21037140|P1|Overall Study|Protocol Violation|4
6096004|NCT00300365|21037407|P2|Overall Study|Adverse Event|2
6096005|NCT00300365|21037408|P1|Overall Study|Adverse Event|0
6096006|NCT00300365|21037407|P2|Overall Study|Withdrawal by Subject|0
6096007|NCT00300365|21037408|P1|Overall Study|Withdrawal by Subject|1
6096008|NCT00300365|21037407|P2|Overall Study|Physician Decision|0
6096009|NCT00300365|21037408|P1|Overall Study|Physician Decision|2
6096010|NCT00300365|21037407|P2|Overall Study|Lost to Follow-up|0
6096011|NCT00300365|21037408|P1|Overall Study|Lost to Follow-up|1
6096012|NCT00300274|21037417|P3|Overall Study|Re-transplant|1
6096013|NCT00300274|21037418|P2|Overall Study|Re-transplant|0
6096014|NCT00300274|21037419|P1|Overall Study|Re-transplant|0
6096015|NCT00300274|21037417|P3|Overall Study|Death|25
6096016|NCT00300274|21037418|P2|Overall Study|Death|20
6096017|NCT00300274|21037419|P1|Overall Study|Death|31
6096018|NCT00300274|21037417|P3|Overall Study|Lost to Follow-up|5
6096019|NCT00300274|21037418|P2|Overall Study|Lost to Follow-up|4
6096020|NCT00300274|21037419|P1|Overall Study|Lost to Follow-up|3
6096021|NCT00300274|21037417|P3|Overall Study|Withdrawal by Subject|14
6096022|NCT00300274|21037418|P2|Overall Study|Withdrawal by Subject|3
6096023|NCT00300274|21037419|P1|Overall Study|Withdrawal by Subject|12
6096024|NCT00300053|21037478|P3|Overall Study|Lost to Follow-up|0
6096025|NCT00300053|21037479|P2|Overall Study|Lost to Follow-up|1
6096026|NCT00300053|21037480|P1|Overall Study|Lost to Follow-up|0
6096027|NCT00300053|21037478|P3|Overall Study|Death|3
6096028|NCT00300053|21037479|P2|Overall Study|Death|0
6096029|NCT00300053|21037480|P1|Overall Study|Death|0
6096030|NCT00300053|21037478|P3|Overall Study|Patient/Caregiver Preference|3
6096031|NCT00300053|21037479|P2|Overall Study|Patient/Caregiver Preference|2
6096032|NCT00300053|21037480|P1|Overall Study|Patient/Caregiver Preference|2
6096033|NCT00299975|21037518|P3|Overall Study|Physician Decision|1
6096034|NCT00299975|21037519|P2|Overall Study|Physician Decision|0
6096035|NCT00299975|21037520|P1|Overall Study|Physician Decision|0
6096036|NCT00299975|21037518|P3|Overall Study|Withdrawal by Subject|3
6096037|NCT00299975|21037519|P2|Overall Study|Withdrawal by Subject|1
6096038|NCT00299975|21037520|P1|Overall Study|Withdrawal by Subject|0
6096039|NCT00299975|21037518|P3|Overall Study|Lost to Follow-up|0
6096040|NCT00299975|21037519|P2|Overall Study|Lost to Follow-up|0
6096041|NCT00299975|21037520|P1|Overall Study|Lost to Follow-up|1
6096042|NCT00299975|21037518|P3|Overall Study|Lack of Efficacy|1
6096043|NCT00299975|21037519|P2|Overall Study|Lack of Efficacy|0
6096044|NCT00299975|21037520|P1|Overall Study|Lack of Efficacy|1
6096045|NCT00299975|21037518|P3|Overall Study|Pregnancy|1
6096046|NCT00299975|21037519|P2|Overall Study|Pregnancy|0
6096047|NCT00299975|21037520|P1|Overall Study|Pregnancy|0
6096048|NCT00299975|21037518|P3|Overall Study|Adverse Event|2
6096049|NCT00299975|21037519|P2|Overall Study|Adverse Event|0
6096050|NCT00299975|21037520|P1|Overall Study|Adverse Event|1
6096051|NCT00299702|21037577|P2|Overall Study|Admin issues, sponsor decision, etc.|9
6096052|NCT00299702|21037578|P1|Overall Study|Admin issues, sponsor decision, etc.|5
6096053|NCT00299702|21037577|P2|Overall Study|Insufficient Response|3
6096054|NCT00299702|21037578|P1|Overall Study|Insufficient Response|4
6096055|NCT00299702|21037577|P2|Overall Study|Pregnancy|1
6096056|NCT00299702|21037578|P1|Overall Study|Pregnancy|0
6096057|NCT00299702|21037577|P2|Overall Study|Withdrawal by Subject|23
6096058|NCT00299702|21037578|P1|Overall Study|Withdrawal by Subject|25
6096059|NCT00299702|21037577|P2|Overall Study|Lost to Follow-up|10
6096060|NCT00299702|21037578|P1|Overall Study|Lost to Follow-up|18
6096061|NCT00299702|21037577|P2|Overall Study|Adverse Event|4
6096062|NCT00299702|21037578|P1|Overall Study|Adverse Event|0
6096063|NCT00299702|21037577|P2|Overall Study|Death|0
6096064|NCT00299702|21037578|P1|Overall Study|Death|1
6096065|NCT00299546|21037593|P3|Overall Study|Not treated|1
6096066|NCT00299546|21037594|P2|Overall Study|Not treated|1
6096067|NCT00299546|21037595|P1|Overall Study|Not treated|0
6096068|NCT00299546|21037593|P3|Overall Study|Other|19
6096069|NCT00299546|21037594|P2|Overall Study|Other|26
6096070|NCT00299546|21037595|P1|Overall Study|Other|24
6096071|NCT00299546|21037593|P3|Overall Study|Unsatisfactory therapeutic effect|34
6096072|NCT00299546|21037594|P2|Overall Study|Unsatisfactory therapeutic effect|39
6096073|NCT00299546|21037595|P1|Overall Study|Unsatisfactory therapeutic effect|34
6096074|NCT00299546|21037593|P3|Overall Study|Adverse Event|27
6096075|NCT00299546|21037594|P2|Overall Study|Adverse Event|22
6096076|NCT00299546|21037595|P1|Overall Study|Adverse Event|37
6096077|NCT00299546|21037593|P3|Overall Study|Lost to Follow-up|5
6096078|NCT00299546|21037594|P2|Overall Study|Lost to Follow-up|2
6096079|NCT00299546|21037595|P1|Overall Study|Lost to Follow-up|2
6096080|NCT00299546|21037593|P3|Overall Study|Death|0
6096081|NCT00299546|21037594|P2|Overall Study|Death|2
6096082|NCT00299546|21037595|P1|Overall Study|Death|3
6096083|NCT00299494|21037626|P6|Overall Study|Other - site closure|1
6096084|NCT00299494|21037627|P5|Overall Study|Other - site closure|1
6096085|NCT00299494|21037628|P4|Overall Study|Other - site closure|1
6096086|NCT00299494|21037629|P3|Overall Study|Other - site closure|0
6096087|NCT00299494|21037630|P2|Overall Study|Other - site closure|0
6096088|NCT00299494|21037631|P1|Overall Study|Other - site closure|0
6096089|NCT00299494|21037626|P6|Overall Study|Other - Unspecified|1
6096090|NCT00299494|21037627|P5|Overall Study|Other - Unspecified|3
6096091|NCT00299494|21037628|P4|Overall Study|Other - Unspecified|0
6096092|NCT00299494|21037629|P3|Overall Study|Other - Unspecified|0
6096093|NCT00299494|21037630|P2|Overall Study|Other - Unspecified|0
6096094|NCT00299494|21037631|P1|Overall Study|Other - Unspecified|0
6096095|NCT00299494|21037626|P6|Overall Study|Lost to Follow-up|1
6096096|NCT00299494|21037627|P5|Overall Study|Lost to Follow-up|3
6096097|NCT00299494|21037628|P4|Overall Study|Lost to Follow-up|0
6096098|NCT00299494|21037629|P3|Overall Study|Lost to Follow-up|0
6096099|NCT00299494|21037630|P2|Overall Study|Lost to Follow-up|0
6096100|NCT00299494|21037631|P1|Overall Study|Lost to Follow-up|0
6096101|NCT00299494|21037626|P6|Overall Study|Death|19
6096102|NCT00299494|21037627|P5|Overall Study|Death|18
6096103|NCT00299494|21037628|P4|Overall Study|Death|6
6096104|NCT00299494|21037629|P3|Overall Study|Death|4
6096105|NCT00299494|21037630|P2|Overall Study|Death|1
6096106|NCT00299494|21037631|P1|Overall Study|Death|3
6096107|NCT00299494|21037626|P6|Overall Study|Physician Decision|0
6096108|NCT00299494|21037627|P5|Overall Study|Physician Decision|1
6096109|NCT00299494|21037628|P4|Overall Study|Physician Decision|0
6096110|NCT00299494|21037629|P3|Overall Study|Physician Decision|0
6096111|NCT00299494|21037630|P2|Overall Study|Physician Decision|0
6096112|NCT00299494|21037631|P1|Overall Study|Physician Decision|0
6096113|NCT00299494|21037626|P6|Overall Study|Withdrawal by Subject|4
6096114|NCT00299494|21037627|P5|Overall Study|Withdrawal by Subject|1
6096115|NCT00299494|21037628|P4|Overall Study|Withdrawal by Subject|3
6096116|NCT00299494|21037629|P3|Overall Study|Withdrawal by Subject|0
6096117|NCT00299494|21037630|P2|Overall Study|Withdrawal by Subject|0
6096118|NCT00299494|21037631|P1|Overall Study|Withdrawal by Subject|0
6096119|NCT00299156|21037777|P3|Period 2 (Randomized)|Screen Failure|0
6096120|NCT00299156|21037778|P2|Period 2 (Randomized)|Screen Failure|1
6096121|NCT00299156|21037779|P1|Period 2 (Randomized)|Screen Failure|0
6096122|NCT00299130|21037790|P3|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|4
6096123|NCT00299130|21037791|P2|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|3
6096124|NCT00299130|21037792|P1|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|0
6096125|NCT00299130|21037790|P3|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2
6096126|NCT00299130|21037791|P2|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2
6096127|NCT00299130|21037792|P1|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|0
6096128|NCT00299130|21037790|P3|Extended SFU (ESFU) (up to 5.1 Years)|Death|0
6096129|NCT00299130|21037791|P2|Extended SFU (ESFU) (up to 5.1 Years)|Death|3
6096130|NCT00299130|21037792|P1|Extended SFU (ESFU) (up to 5.1 Years)|Death|0
6096131|NCT00299130|21037790|P3|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|21
6096132|NCT00299130|21037791|P2|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22
6096133|NCT00299130|21037792|P1|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22
6096134|NCT00299130|21037790|P3|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0
6096135|NCT00299130|21037791|P2|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|1
6096136|NCT00299130|21037792|P1|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0
6096137|NCT00299130|21037790|P3|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|15
6096138|NCT00299130|21037791|P2|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|7
6096139|NCT00299130|21037792|P1|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|14
6096140|NCT00299130|21037790|P3|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|2
6096141|NCT00299130|21037791|P2|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1
6096142|NCT00299130|21037792|P1|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1
6096143|NCT00299130|21037790|P3|Safety Follow-up (SFU) (48 Weeks)|Death|3
6096144|NCT00299130|21037791|P2|Safety Follow-up (SFU) (48 Weeks)|Death|5
6096145|NCT00299130|21037792|P1|Safety Follow-up (SFU) (48 Weeks)|Death|4
6096146|NCT00299130|21037790|P3|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4
6096147|NCT00299130|21037791|P2|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|9
6096148|NCT00299130|21037792|P1|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4
6096149|NCT00299130|21037790|P3|Treatment Period (up to 5 Years)|Withdrawal by Subject|1
6096150|NCT00299130|21037791|P2|Treatment Period (up to 5 Years)|Withdrawal by Subject|1
6096151|NCT00299130|21037792|P1|Treatment Period (up to 5 Years)|Withdrawal by Subject|0
6096152|NCT00299130|21037790|P3|Treatment Period (up to 5 Years)|Reason not Specified|4
6096153|NCT00299130|21037791|P2|Treatment Period (up to 5 Years)|Reason not Specified|6
6096154|NCT00299130|21037792|P1|Treatment Period (up to 5 Years)|Reason not Specified|4
6096155|NCT00299130|21037790|P3|Treatment Period (up to 5 Years)|Failure to Return|6
6096156|NCT00299130|21037791|P2|Treatment Period (up to 5 Years)|Failure to Return|6
6096157|NCT00299130|21037792|P1|Treatment Period (up to 5 Years)|Failure to Return|4
6096158|NCT00299130|21037790|P3|Treatment Period (up to 5 Years)|Refused Treatment|19
6096159|NCT00299130|21037791|P2|Treatment Period (up to 5 Years)|Refused Treatment|12
6096160|NCT00299130|21037792|P1|Treatment Period (up to 5 Years)|Refused Treatment|12
6096161|NCT00299130|21037790|P3|Treatment Period (up to 5 Years)|Protocol Violation|0
6096162|NCT00299130|21037791|P2|Treatment Period (up to 5 Years)|Protocol Violation|1
6096163|NCT00299130|21037792|P1|Treatment Period (up to 5 Years)|Protocol Violation|0
6096164|NCT00299130|21037790|P3|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6
6096165|NCT00299130|21037791|P2|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6
6096166|NCT00299130|21037792|P1|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|19
6096167|NCT00299130|21037790|P3|Treatment Period (up to 5 Years)|Death|1
6096168|NCT00299130|21037791|P2|Treatment Period (up to 5 Years)|Death|3
6096169|NCT00299130|21037792|P1|Treatment Period (up to 5 Years)|Death|1
6096170|NCT00299130|21037790|P3|Treatment Period (up to 5 Years)|Adverse Event|13
6096171|NCT00299130|21037791|P2|Treatment Period (up to 5 Years)|Adverse Event|8
6096172|NCT00299130|21037792|P1|Treatment Period (up to 5 Years)|Adverse Event|13
6096173|NCT00299104|21037897|P3|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2
6096174|NCT00299104|21037898|P2|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2
6096175|NCT00299104|21037899|P1|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|1
6096176|NCT00299104|21037897|P3|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|8
6096177|NCT00299104|21037898|P2|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|4
6096178|NCT00299104|21037899|P1|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|2
6096179|NCT00299104|21037897|P3|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2
6096180|NCT00299104|21037898|P2|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2
6096181|NCT00299104|21037899|P1|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2
6096182|NCT00299104|21037897|P3|Extended Safety Follow-Up (ESFU) Period|Death|0
6096183|NCT00299104|21037898|P2|Extended Safety Follow-Up (ESFU) Period|Death|1
6096184|NCT00299104|21037899|P1|Extended Safety Follow-Up (ESFU) Period|Death|0
6096185|NCT00299104|21037897|P3|Safety Follow-Up (SFU) Period|Administrative reasons|5
6096186|NCT00299104|21037898|P2|Safety Follow-Up (SFU) Period|Administrative reasons|7
6096187|NCT00299104|21037899|P1|Safety Follow-Up (SFU) Period|Administrative reasons|27
6096188|NCT00299104|21037897|P3|Safety Follow-Up (SFU) Period|Withdrawal by Subject|11
6096189|NCT00299104|21037898|P2|Safety Follow-Up (SFU) Period|Withdrawal by Subject|21
6096190|NCT00299104|21037899|P1|Safety Follow-Up (SFU) Period|Withdrawal by Subject|16
6096191|NCT00299104|21037897|P3|Safety Follow-Up (SFU) Period|Lost to Follow-up|20
6096192|NCT00299104|21037898|P2|Safety Follow-Up (SFU) Period|Lost to Follow-up|11
6096193|NCT00299104|21037899|P1|Safety Follow-Up (SFU) Period|Lost to Follow-up|9
6096194|NCT00299104|21037897|P3|Safety Follow-Up (SFU) Period|Death|1
6096195|NCT00299104|21037898|P2|Safety Follow-Up (SFU) Period|Death|2
6096196|NCT00299104|21037899|P1|Safety Follow-Up (SFU) Period|Death|3
6096197|NCT00299104|21037897|P3|Treatment Period|Administrative reasons|137
6096198|NCT00299104|21037898|P2|Treatment Period|Administrative reasons|120
6096199|NCT00299104|21037899|P1|Treatment Period|Administrative reasons|106
6096200|NCT00299104|21037897|P3|Treatment Period|Withdrew consent|9
6096201|NCT00299104|21037898|P2|Treatment Period|Withdrew consent|19
6096202|NCT00299104|21037899|P1|Treatment Period|Withdrew consent|14
6096203|NCT00299104|21037897|P3|Treatment Period|Refused treatment|2
6096204|NCT00299104|21037898|P2|Treatment Period|Refused treatment|2
6096205|NCT00299104|21037899|P1|Treatment Period|Refused treatment|9
6096206|NCT00299104|21037897|P3|Treatment Period|Protocol Violation|0
6096207|NCT00299104|21037898|P2|Treatment Period|Protocol Violation|1
6096208|NCT00299104|21037899|P1|Treatment Period|Protocol Violation|1
6096209|NCT00299104|21037897|P3|Treatment Period|Violation of selection criteria|0
6096210|NCT00299104|21037898|P2|Treatment Period|Violation of selection criteria|2
6096211|NCT00299104|21037899|P1|Treatment Period|Violation of selection criteria|1
6096212|NCT00299104|21037897|P3|Treatment Period|Failure to return|8
6096213|NCT00299104|21037898|P2|Treatment Period|Failure to return|8
6096214|NCT00299104|21037899|P1|Treatment Period|Failure to return|9
6096215|NCT00299104|21037897|P3|Treatment Period|Insufficient therapeutic response|8
6096216|NCT00299104|21037898|P2|Treatment Period|Insufficient therapeutic response|13
6096217|NCT00299104|21037899|P1|Treatment Period|Insufficient therapeutic response|34
6096218|NCT00299104|21037897|P3|Treatment Period|Death|1
6096219|NCT00299104|21037898|P2|Treatment Period|Death|1
6096220|NCT00299104|21037899|P1|Treatment Period|Death|1
6096221|NCT00299104|21037897|P3|Treatment Period|Adverse Event|7
6096222|NCT00299104|21037898|P2|Treatment Period|Adverse Event|9
6096223|NCT00299104|21037899|P1|Treatment Period|Adverse Event|14
6096224|NCT00298896|21038009|P1|Overall Study|Assigned to treatment in error|1
6096225|NCT00298896|21038009|P1|Overall Study|Withdrawal by Subject|2
6096226|NCT00298896|21038009|P1|Overall Study|Disease Progression|41
6096227|NCT00298896|21038009|P1|Overall Study|Intercurrent Illness|1
6096228|NCT00298896|21038009|P1|Overall Study|Physician Decision|2
6096229|NCT00298896|21038009|P1|Overall Study|Death|3
6096230|NCT00298831|21038014|P1|Overall Study|Participants did not receive treatment|27
6096231|NCT00298831|21038014|P1|Overall Study|Withdrawal by Subject|1
6096232|NCT00298831|21038014|P1|Overall Study|Lost to Follow-up|3
6096233|NCT00298831|21038014|P1|Overall Study|Adverse Event|1
6096234|NCT00298766|21038023|P1|Overall Study|Other|4
6096235|NCT00298766|21038023|P1|Overall Study|Subjects overall condition deterioration|4
6096236|NCT00298766|21038023|P1|Overall Study|Deterioration in KPS and organ function|1
6096237|NCT00298766|21038023|P1|Overall Study|Progression of amyloid markers|4
6096238|NCT00298766|21038023|P1|Overall Study|Treatment ongoing|4
6096239|NCT00298766|21038023|P1|Overall Study|Withdrawal by Subject|9
6096240|NCT00298766|21038023|P1|Overall Study|Death|2
6096241|NCT00298766|21038023|P1|Overall Study|Adverse Event|18
6096242|NCT00298740|21038032|P1|Overall Study|Withdrawal by Subject|3
6096243|NCT00298740|21038032|P1|Overall Study|Lack of Efficacy|6
6096244|NCT00298363|21038102|P3|Overall Study|Lack of Efficacy|0
6096245|NCT00298363|21038103|P2|Overall Study|Lack of Efficacy|3
6096246|NCT00298363|21038104|P1|Overall Study|Lack of Efficacy|2
6096247|NCT00298363|21038102|P3|Overall Study|Adverse Event|2
6096248|NCT00298363|21038103|P2|Overall Study|Adverse Event|2
6096249|NCT00298363|21038104|P1|Overall Study|Adverse Event|5
6096250|NCT00298363|21038102|P3|Overall Study|Withdrawal by Subject|3
6096251|NCT00298363|21038103|P2|Overall Study|Withdrawal by Subject|1
6096252|NCT00298363|21038104|P1|Overall Study|Withdrawal by Subject|5
6096253|NCT00298363|21038102|P3|Overall Study|Protocol Violation|0
6096254|NCT00298363|21038103|P2|Overall Study|Protocol Violation|1
6096255|NCT00298363|21038104|P1|Overall Study|Protocol Violation|1
6096256|NCT00298363|21038102|P3|Overall Study|Physician Decision|0
6096257|NCT00298363|21038103|P2|Overall Study|Physician Decision|1
6096258|NCT00298363|21038104|P1|Overall Study|Physician Decision|4
6096259|NCT00298363|21038102|P3|Overall Study|Lost to Follow-up|1
6096260|NCT00298363|21038103|P2|Overall Study|Lost to Follow-up|0
6096261|NCT00298363|21038104|P1|Overall Study|Lost to Follow-up|0
6096262|NCT00298272|21038262|P2|Safety Follow-up Phase|Administrative/Other Reason|1
6096263|NCT00298272|21038263|P1|Safety Follow-up Phase|Administrative/Other Reason|1
6096264|NCT00298272|21038262|P2|Safety Follow-up Phase|Withdrawal by Subject|2
6096265|NCT00298272|21038263|P1|Safety Follow-up Phase|Withdrawal by Subject|2
6096266|NCT00298272|21038262|P2|Safety Follow-up Phase|Failure to Return|1
6096267|NCT00298272|21038263|P1|Safety Follow-up Phase|Failure to Return|1
6096268|NCT00298272|21038262|P2|Open Label Retreatment Phase|Administrative/Other Reason|0
6096269|NCT00298272|21038263|P1|Open Label Retreatment Phase|Administrative/Other Reason|2
6096270|NCT00298272|21038262|P2|Open Label Retreatment Phase|Withdrawal by Subject|0
6096271|NCT00298272|21038263|P1|Open Label Retreatment Phase|Withdrawal by Subject|1
6096272|NCT00298272|21038262|P2|Open Label Retreatment Phase|Protocol Violation|1
6096273|NCT00298272|21038263|P1|Open Label Retreatment Phase|Protocol Violation|2
6096274|NCT00298272|21038262|P2|Open Label Retreatment Phase|Failure to Return|0
6096275|NCT00298272|21038263|P1|Open Label Retreatment Phase|Failure to Return|1
6096276|NCT00298272|21038262|P2|Open Label Retreatment Phase|Insufficient Therapeutic Response|1
6096277|NCT00298272|21038263|P1|Open Label Retreatment Phase|Insufficient Therapeutic Response|2
6096278|NCT00298272|21038262|P2|Open Label Retreatment Phase|Adverse Event|2
6096279|NCT00298272|21038263|P1|Open Label Retreatment Phase|Adverse Event|1
6096280|NCT00298272|21038262|P2|Double-blind Phase|Withdrawal by Subject|0
6096281|NCT00298272|21038263|P1|Double-blind Phase|Withdrawal by Subject|2
6096282|NCT00298272|21038262|P2|Double-blind Phase|Protocol Violation|0
6096283|NCT00298272|21038263|P1|Double-blind Phase|Protocol Violation|2
6096284|NCT00298272|21038262|P2|Double-blind Phase|Failure to Return|0
6096285|NCT00298272|21038263|P1|Double-blind Phase|Failure to Return|2
6096286|NCT00298272|21038262|P2|Double-blind Phase|Adverse Event|0
6096287|NCT00298272|21038263|P1|Double-blind Phase|Adverse Event|2
6096288|NCT00298038|21038327|P2|Overall Study|Severe Gastrointestinal Bleed|0
6096289|NCT00298038|21038328|P1|Overall Study|Severe Gastrointestinal Bleed|1
6096290|NCT00298038|21038327|P2|Overall Study|Cocaine Abuse|0
6096291|NCT00298038|21038328|P1|Overall Study|Cocaine Abuse|1
6096292|NCT00298038|21038327|P2|Overall Study|Noncompliance|0
6096293|NCT00298038|21038328|P1|Overall Study|Noncompliance|1
6096294|NCT00298038|21038327|P2|Overall Study|Breakthrough overt HE episode|69
6096295|NCT00298038|21038328|P1|Overall Study|Breakthrough overt HE episode|28
6096296|NCT00298038|21038327|P2|Overall Study|Adverse Event|7
6096297|NCT00298038|21038328|P1|Overall Study|Adverse Event|8
6096298|NCT00298038|21038327|P2|Overall Study|Withdrawal by Subject|9
6096299|NCT00298038|21038328|P1|Overall Study|Withdrawal by Subject|6
6096300|NCT00298038|21038327|P2|Overall Study|Death|3
6096301|NCT00298038|21038328|P1|Overall Study|Death|6
6096302|NCT00298038|21038327|P2|Overall Study|Protocol Violation|3
6096303|NCT00298038|21038328|P1|Overall Study|Protocol Violation|1
6096304|NCT00298038|21038327|P2|Overall Study|Liver Transplant|1
6096305|NCT00298038|21038328|P1|Overall Study|Liver Transplant|0
6096306|NCT00298038|21038327|P2|Overall Study|Lost to Follow-up|1
6096307|NCT00298038|21038328|P1|Overall Study|Lost to Follow-up|0
6096308|NCT00297830|21038347|P3|12 Month Visit|Withdrawal by Subject|0
6096309|NCT00297830|21038348|P2|12 Month Visit|Withdrawal by Subject|3
6096310|NCT00297830|21038349|P1|12 Month Visit|Withdrawal by Subject|0
6096311|NCT00297830|21038347|P3|12 Month Visit|Adverse Event|0
6096312|NCT00297830|21038348|P2|12 Month Visit|Adverse Event|3
6096313|NCT00297830|21038349|P1|12 Month Visit|Adverse Event|0
6096314|NCT00297830|21038347|P3|12 Month Visit|Lost to Follow-up|0
6096315|NCT00297830|21038348|P2|12 Month Visit|Lost to Follow-up|0
6096316|NCT00297830|21038349|P1|12 Month Visit|Lost to Follow-up|1
6096317|NCT00297830|21038347|P3|6 Month Visit|Adverse Event|0
6096318|NCT00297830|21038348|P2|6 Month Visit|Adverse Event|1
6096319|NCT00297830|21038349|P1|6 Month Visit|Adverse Event|0
6096320|NCT00297830|21038347|P3|6 Month Visit|Withdrawal by Subject|1
6096321|NCT00297830|21038348|P2|6 Month Visit|Withdrawal by Subject|1
6096322|NCT00297830|21038349|P1|6 Month Visit|Withdrawal by Subject|2
6096323|NCT00297830|21038347|P3|6 Month Visit|Death|2
6096324|NCT00297830|21038348|P2|6 Month Visit|Death|0
6096325|NCT00297830|21038349|P1|6 Month Visit|Death|1
6096326|NCT00297778|21038368|P2|Overall Study|Other|1
6096327|NCT00297778|21038369|P1|Overall Study|Other|0
6096328|NCT00297778|21038368|P2|Overall Study|Non-compliant with trial protocol|3
6096329|NCT00297778|21038369|P1|Overall Study|Non-compliant with trial protocol|0
6096330|NCT00297778|21038368|P2|Overall Study|Lack of Efficacy|1
6096331|NCT00297778|21038369|P1|Overall Study|Lack of Efficacy|2
6096332|NCT00297778|21038368|P2|Overall Study|Withdrawal by Subject|5
6096333|NCT00297778|21038369|P1|Overall Study|Withdrawal by Subject|1
6096334|NCT00297778|21038368|P2|Overall Study|Adverse Event|10
6096335|NCT00297778|21038369|P1|Overall Study|Adverse Event|16
6096336|NCT00297648|21038403|P1|Overall Study|Other: Incompliance|1
6096337|NCT00297648|21038403|P1|Overall Study|Withdrawal by Subject|3
6096338|NCT00297648|21038403|P1|Overall Study|Lost to Follow-up|1
6096339|NCT00297648|21038403|P1|Overall Study|Lack of Efficacy|18
6096340|NCT00297648|21038403|P1|Overall Study|Adverse Event|13
6096341|NCT00297492|21038449|P3|6 Month Follow-up|Lost to Follow-up|27
6096342|NCT00297492|21038450|P2|6 Month Follow-up|Lost to Follow-up|49
6096343|NCT00297492|21038451|P1|6 Month Follow-up|Lost to Follow-up|63
6096344|NCT00297492|21038449|P3|Set Quit Date|Lost to Follow-up|5
6096345|NCT00297492|21038450|P2|Set Quit Date|Lost to Follow-up|13
6096346|NCT00297492|21038451|P1|Set Quit Date|Lost to Follow-up|7
6096347|NCT00297479|21038462|P3|Overall Study|Lost to Follow-up|51
6096348|NCT00297479|21038463|P2|Overall Study|Lost to Follow-up|54
6096349|NCT00297479|21038464|P1|Overall Study|Lost to Follow-up|37
6096350|NCT00297427|21038483|P2|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|0
6096351|NCT00297427|21038484|P1|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|2
6096352|NCT00297427|21038483|P2|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|0
6096353|NCT00297427|21038484|P1|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|3
6096354|NCT00297427|21038483|P2|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|0
6096355|NCT00297427|21038484|P1|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|29
6096356|NCT00297427|21038483|P2|Phase 2: Optional Crossover for Sham|Lost to Follow-up|0
6096357|NCT00297427|21038484|P1|Phase 2: Optional Crossover for Sham|Lost to Follow-up|1
6096358|NCT00297427|21038483|P2|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|0
6096359|NCT00297427|21038484|P1|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|15
6096360|NCT00297427|21038483|P2|Phase 1: Initial Intervention|Death|1
6096361|NCT00297427|21038484|P1|Phase 1: Initial Intervention|Death|0
6096362|NCT00297427|21038483|P2|Phase 1: Initial Intervention|Lost to Follow-up|3
6096363|NCT00297427|21038484|P1|Phase 1: Initial Intervention|Lost to Follow-up|0
6096364|NCT00297427|21038483|P2|Phase 1: Initial Intervention|Withdrawal by Subject|5
6096365|NCT00297427|21038484|P1|Phase 1: Initial Intervention|Withdrawal by Subject|8
6096366|NCT00297258|21038525|P1|Overall Study|Interruption: Cold/Flu-like Symptoms|1
6096367|NCT00297258|21038525|P1|Overall Study|Switch to Commercial Treatment|1
6096368|NCT00297258|21038525|P1|Overall Study|Surgery Performed on Target Lesion|1
6096369|NCT00297258|21038525|P1|Overall Study|Radiotherapy to Destroy Last Lesion|1
6096370|NCT00297258|21038525|P1|Overall Study|Deteriorization of General Condition|1
6096371|NCT00297258|21038525|P1|Overall Study|Intercurrent Death|2
6096372|NCT00297258|21038525|P1|Overall Study|Intercurrent Illness|3
6096373|NCT00297258|21038525|P1|Overall Study|Patient Refusal: Not Related to Toxicity|2
6096374|NCT00297258|21038525|P1|Overall Study|Toxicity (or Toxic Death)|10
6096375|NCT00297258|21038525|P1|Overall Study|Disease Progression, Relapse, Death|120
6096376|NCT00297232|21038544|P1|Overall Study|Other|1
6096377|NCT00297232|21038544|P1|Overall Study|No data available after Week 264|161
6096378|NCT00297232|21038544|P1|Overall Study|Did Not Enroll to Week 480|17
6096379|NCT00297232|21038544|P1|Overall Study|Did Not Enroll to Week 264|34
6096380|NCT00297232|21038544|P1|Overall Study|Investigator Withdrew From Program|19
6096381|NCT00297232|21038544|P1|Overall Study|Persistently Positive Antibodies|11
6096382|NCT00297232|21038544|P1|Overall Study|Subject Withdrew Consent|37
6096383|NCT00297232|21038544|P1|Overall Study|Subject Relocated|7
6096384|NCT00297232|21038544|P1|Overall Study|Sponsor Decision|34
6096385|NCT00297232|21038544|P1|Overall Study|Miscellaneous|5
6096386|NCT00297232|21038544|P1|Overall Study|Anti-JCV Antibody Positive|13
6096387|NCT00297232|21038544|P1|Overall Study|Fear of PML|10
6096388|NCT00297232|21038544|P1|Overall Study|Disease Progression|8
6096389|NCT00297232|21038544|P1|Overall Study|Switched to Commercial Tysabri|22
6096390|NCT00297232|21038544|P1|Overall Study|Anti-natalizumab Positive|8
6096391|NCT00297232|21038544|P1|Overall Study|Death|9
6096392|NCT00297232|21038544|P1|Overall Study|Subject was Noncompliant|9
6096393|NCT00297232|21038544|P1|Overall Study|Voluntary Withdrawal|120
6096394|NCT00297232|21038544|P1|Overall Study|Adverse Event|63
6096395|NCT00297232|21038544|P1|Overall Study|Lost to Follow-up|10
6096396|NCT00297232|21038544|P1|Overall Study|Lack of Efficacy|7
6096397|NCT00297167|21038550|P3|Second Double-blind Intervention Period|Protocol Violation|0
6096398|NCT00297167|21038551|P2|Second Double-blind Intervention Period|Protocol Violation|0
6096399|NCT00297167|21038552|P1|Second Double-blind Intervention Period|Protocol Violation|1
6096400|NCT00297167|21038550|P3|Open-label Dose Normalization Period 1|Withdrawal by Subject|1
6096401|NCT00297167|21038551|P2|Open-label Dose Normalization Period 1|Withdrawal by Subject|0
6096402|NCT00297167|21038552|P1|Open-label Dose Normalization Period 1|Withdrawal by Subject|0
6096403|NCT00297037|21038616|P2|Overall Study|Withdrawal by Subject|0
6096404|NCT00297037|21038617|P1|Overall Study|Withdrawal by Subject|2
6096405|NCT00296816|21038629|P1|Overall Study|ineligibility due to radiation treatment|1
6096406|NCT00296816|21038629|P1|Overall Study|Proteinuria|1
6096407|NCT00296816|21038629|P1|Overall Study|Neuropathy/patient preference|1
6096408|NCT00296816|21038629|P1|Overall Study|Urine protein/creatinine ratio delay|1
6096409|NCT00296816|21038629|P1|Overall Study|Noncompliance/decision to discontinue|1
6096410|NCT00296816|21038629|P1|Overall Study|Relocation to Florida|1
6096411|NCT00296816|21038629|P1|Overall Study|Poor performance status|1
6096412|NCT00296816|21038629|P1|Overall Study|Progression based on CA-125 (biomarker)|2
6096413|NCT00296816|21038629|P1|Overall Study|Missing for end of treatment|4
6096414|NCT00296816|21038629|P1|Overall Study|Non-compliance|1
6096415|NCT00296816|21038629|P1|Overall Study|Investigator/Participant request|5
6096416|NCT00296816|21038629|P1|Overall Study|Adverse Event|18
6096417|NCT00296816|21038629|P1|Overall Study|Disease Progression|37
6096418|NCT00296725|21038641|P1|Phase 2: Imipramine (1-6 Weeks)|Lost to Follow-up|1
6096419|NCT00296725|21038641|P1|Phase 1: Fluoxetine (1-12 Weeks)|Adverse Event|4
6096420|NCT00296725|21038641|P1|Phase 1: Fluoxetine (1-12 Weeks)|Lost to Follow-up|1
6096421|NCT00296647|21038654|P5|Overall Study|Withdrawal by Subject|19
6096422|NCT00296647|21038655|P4|Overall Study|Withdrawal by Subject|16
6096423|NCT00296647|21038656|P3|Overall Study|Withdrawal by Subject|32
6096424|NCT00296647|21038657|P2|Overall Study|Withdrawal by Subject|27
6096425|NCT00296647|21038658|P1|Overall Study|Withdrawal by Subject|28
6096426|NCT00296647|21038654|P5|Overall Study|Death|1
6096427|NCT00296647|21038655|P4|Overall Study|Death|1
6096428|NCT00296647|21038656|P3|Overall Study|Death|2
6096429|NCT00296647|21038657|P2|Overall Study|Death|1
6096430|NCT00296647|21038658|P1|Overall Study|Death|4
6096431|NCT00296517|21038672|P2|Dose Level 3 - Weeks 3-12|Other|2
6096432|NCT00296517|21038673|P1|Dose Level 3 - Weeks 3-12|Other|0
6096433|NCT00296517|21038672|P2|Dose Level 3 - Weeks 3-12|Non - Compliance|0
6096434|NCT00296517|21038673|P1|Dose Level 3 - Weeks 3-12|Non - Compliance|1
6096435|NCT00296517|21038672|P2|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|18
6096436|NCT00296517|21038673|P1|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|7
6096437|NCT00296517|21038672|P2|Dose Level 3 - Weeks 3-12|Protocol Violation|0
6096438|NCT00296517|21038673|P1|Dose Level 3 - Weeks 3-12|Protocol Violation|1
6096439|NCT00296517|21038672|P2|Dose Level 3 - Weeks 3-12|Lost to Follow-up|2
6096440|NCT00296517|21038673|P1|Dose Level 3 - Weeks 3-12|Lost to Follow-up|3
6096441|NCT00296517|21038672|P2|Dose Level 3 - Weeks 3-12|Lack of Efficacy|6
6096442|NCT00296517|21038673|P1|Dose Level 3 - Weeks 3-12|Lack of Efficacy|3
6096443|NCT00296517|21038672|P2|Dose Level 3 - Weeks 3-12|Adverse Event|34
6096444|NCT00296517|21038673|P1|Dose Level 3 - Weeks 3-12|Adverse Event|30
6096445|NCT00296517|21038672|P2|Dose Level 2 - Week 2|Withdrawal by Subject|0
6096446|NCT00296517|21038673|P1|Dose Level 2 - Week 2|Withdrawal by Subject|1
6096447|NCT00296517|21038672|P2|Dose Level 2 - Week 2|Adverse Event|5
6096448|NCT00296517|21038673|P1|Dose Level 2 - Week 2|Adverse Event|1
6096449|NCT00296504|21038709|P9|Final Analysis|Poor Adherence|1
6096450|NCT00296504|21038710|P8|Final Analysis|Poor Adherence|0
6096451|NCT00296504|21038711|P7|Final Analysis|Poor Adherence|0
6096452|NCT00296504|21038712|P6|Final Analysis|Poor Adherence|0
6096453|NCT00296504|21038713|P5|Final Analysis|Poor Adherence|0
6096454|NCT00296504|21038714|P4|Final Analysis|Poor Adherence|0
6096455|NCT00296504|21038715|P3|Final Analysis|Poor Adherence|0
6096456|NCT00296504|21038716|P2|Final Analysis|Poor Adherence|0
6096457|NCT00296504|21038717|P1|Final Analysis|Poor Adherence|0
6096458|NCT00296504|21038709|P9|Final Analysis|Participant Moved to Another Country|1
6096459|NCT00296504|21038710|P8|Final Analysis|Participant Moved to Another Country|0
6096460|NCT00296504|21038711|P7|Final Analysis|Participant Moved to Another Country|0
6096461|NCT00296504|21038712|P6|Final Analysis|Participant Moved to Another Country|0
6096462|NCT00296504|21038713|P5|Final Analysis|Participant Moved to Another Country|0
6096463|NCT00296504|21038714|P4|Final Analysis|Participant Moved to Another Country|0
6096464|NCT00296504|21038715|P3|Final Analysis|Participant Moved to Another Country|0
6096465|NCT00296504|21038716|P2|Final Analysis|Participant Moved to Another Country|0
6096466|NCT00296504|21038717|P1|Final Analysis|Participant Moved to Another Country|0
6096467|NCT00296504|21038709|P9|Final Analysis|Tuberculosis|1
6096468|NCT00296504|21038710|P8|Final Analysis|Tuberculosis|0
6096469|NCT00296504|21038711|P7|Final Analysis|Tuberculosis|0
6096470|NCT00296504|21038712|P6|Final Analysis|Tuberculosis|0
6096471|NCT00296504|21038713|P5|Final Analysis|Tuberculosis|0
6096472|NCT00296504|21038714|P4|Final Analysis|Tuberculosis|0
6096473|NCT00296504|21038715|P3|Final Analysis|Tuberculosis|0
6096474|NCT00296504|21038716|P2|Final Analysis|Tuberculosis|0
6096475|NCT00296504|21038717|P1|Final Analysis|Tuberculosis|0
6096476|NCT00296504|21038709|P9|Final Analysis|Pregnancy|4
6096477|NCT00296504|21038710|P8|Final Analysis|Pregnancy|0
6096478|NCT00296504|21038711|P7|Final Analysis|Pregnancy|0
6096479|NCT00296504|21038712|P6|Final Analysis|Pregnancy|0
6096480|NCT00296504|21038713|P5|Final Analysis|Pregnancy|0
6096481|NCT00296504|21038714|P4|Final Analysis|Pregnancy|0
6096482|NCT00296504|21038715|P3|Final Analysis|Pregnancy|0
6096483|NCT00296504|21038716|P2|Final Analysis|Pregnancy|0
6096484|NCT00296504|21038717|P1|Final Analysis|Pregnancy|0
6096485|NCT00296504|21038709|P9|Final Analysis|Adverse Event|2
6096486|NCT00296504|21038710|P8|Final Analysis|Adverse Event|0
6096487|NCT00296504|21038711|P7|Final Analysis|Adverse Event|0
6096488|NCT00296504|21038712|P6|Final Analysis|Adverse Event|0
6096489|NCT00296504|21038713|P5|Final Analysis|Adverse Event|0
6096490|NCT00296504|21038714|P4|Final Analysis|Adverse Event|0
6096491|NCT00296504|21038715|P3|Final Analysis|Adverse Event|0
6096492|NCT00296504|21038716|P2|Final Analysis|Adverse Event|0
6096493|NCT00296504|21038717|P1|Final Analysis|Adverse Event|0
6096494|NCT00296504|21038709|P9|Final Analysis|Insufficient Viral Load Response|6
6096495|NCT00296504|21038710|P8|Final Analysis|Insufficient Viral Load Response|0
6096496|NCT00296504|21038711|P7|Final Analysis|Insufficient Viral Load Response|0
6096497|NCT00296504|21038712|P6|Final Analysis|Insufficient Viral Load Response|0
6096498|NCT00296504|21038713|P5|Final Analysis|Insufficient Viral Load Response|0
6096499|NCT00296504|21038714|P4|Final Analysis|Insufficient Viral Load Response|0
6096500|NCT00296504|21038715|P3|Final Analysis|Insufficient Viral Load Response|0
6096501|NCT00296504|21038716|P2|Final Analysis|Insufficient Viral Load Response|0
6096502|NCT00296504|21038717|P1|Final Analysis|Insufficient Viral Load Response|0
6096503|NCT00296504|21038709|P9|Final Analysis|Lost to Follow-up|5
6096504|NCT00296504|21038710|P8|Final Analysis|Lost to Follow-up|0
6096505|NCT00296504|21038711|P7|Final Analysis|Lost to Follow-up|0
6096506|NCT00296504|21038712|P6|Final Analysis|Lost to Follow-up|0
6096507|NCT00296504|21038713|P5|Final Analysis|Lost to Follow-up|0
6096508|NCT00296504|21038714|P4|Final Analysis|Lost to Follow-up|0
6096509|NCT00296504|21038715|P3|Final Analysis|Lost to Follow-up|0
6096510|NCT00296504|21038716|P2|Final Analysis|Lost to Follow-up|0
6096511|NCT00296504|21038717|P1|Final Analysis|Lost to Follow-up|0
6096512|NCT00296504|21038709|P9|Final Analysis|Withdrawal by Subject|1
6096513|NCT00296504|21038710|P8|Final Analysis|Withdrawal by Subject|0
6096514|NCT00296504|21038711|P7|Final Analysis|Withdrawal by Subject|0
6096515|NCT00296504|21038712|P6|Final Analysis|Withdrawal by Subject|0
6096516|NCT00296504|21038713|P5|Final Analysis|Withdrawal by Subject|0
6096517|NCT00296504|21038714|P4|Final Analysis|Withdrawal by Subject|0
6096518|NCT00296504|21038715|P3|Final Analysis|Withdrawal by Subject|0
6096519|NCT00296504|21038716|P2|Final Analysis|Withdrawal by Subject|0
6096520|NCT00296504|21038717|P1|Final Analysis|Withdrawal by Subject|0
6096521|NCT00296504|21038709|P9|Interim Analysis|Ongoing|0
6096522|NCT00296504|21038710|P8|Interim Analysis|Ongoing|1
6096523|NCT00296504|21038711|P7|Interim Analysis|Ongoing|30
6096524|NCT00296504|21038712|P6|Interim Analysis|Ongoing|0
6096525|NCT00296504|21038713|P5|Interim Analysis|Ongoing|0
6096526|NCT00296504|21038714|P4|Interim Analysis|Ongoing|22
6096527|NCT00296504|21038715|P3|Interim Analysis|Ongoing|16
6096528|NCT00296504|21038716|P2|Interim Analysis|Ongoing|12
6096529|NCT00296504|21038717|P1|Interim Analysis|Ongoing|32
6096530|NCT00296504|21038709|P9|Interim Analysis|Participant Needed Interferon|0
6096531|NCT00296504|21038710|P8|Interim Analysis|Participant Needed Interferon|1
6096532|NCT00296504|21038711|P7|Interim Analysis|Participant Needed Interferon|0
6096533|NCT00296504|21038712|P6|Interim Analysis|Participant Needed Interferon|0
6096534|NCT00296504|21038713|P5|Interim Analysis|Participant Needed Interferon|0
6096535|NCT00296504|21038714|P4|Interim Analysis|Participant Needed Interferon|0
6096536|NCT00296504|21038715|P3|Interim Analysis|Participant Needed Interferon|0
6096537|NCT00296504|21038716|P2|Interim Analysis|Participant Needed Interferon|0
6096538|NCT00296504|21038717|P1|Interim Analysis|Participant Needed Interferon|0
6096539|NCT00296504|21038709|P9|Interim Analysis|Study Ended|0
6096540|NCT00296504|21038710|P8|Interim Analysis|Study Ended|0
6096541|NCT00296504|21038711|P7|Interim Analysis|Study Ended|1
6096542|NCT00296504|21038712|P6|Interim Analysis|Study Ended|0
6096543|NCT00296504|21038713|P5|Interim Analysis|Study Ended|0
6096544|NCT00296504|21038714|P4|Interim Analysis|Study Ended|0
6096545|NCT00296504|21038715|P3|Interim Analysis|Study Ended|0
6096546|NCT00296504|21038716|P2|Interim Analysis|Study Ended|0
6096547|NCT00296504|21038717|P1|Interim Analysis|Study Ended|0
6096548|NCT00296504|21038709|P9|Interim Analysis|Participant Stopped HIV Medications|0
6096549|NCT00296504|21038710|P8|Interim Analysis|Participant Stopped HIV Medications|0
6096550|NCT00296504|21038711|P7|Interim Analysis|Participant Stopped HIV Medications|1
6096551|NCT00296504|21038712|P6|Interim Analysis|Participant Stopped HIV Medications|0
6096552|NCT00296504|21038713|P5|Interim Analysis|Participant Stopped HIV Medications|0
6096553|NCT00296504|21038714|P4|Interim Analysis|Participant Stopped HIV Medications|0
6096554|NCT00296504|21038715|P3|Interim Analysis|Participant Stopped HIV Medications|0
6096555|NCT00296504|21038716|P2|Interim Analysis|Participant Stopped HIV Medications|0
6096556|NCT00296504|21038717|P1|Interim Analysis|Participant Stopped HIV Medications|0
6096557|NCT00296504|21038709|P9|Interim Analysis|Physician and Participant Decision|0
6096558|NCT00296504|21038710|P8|Interim Analysis|Physician and Participant Decision|0
6096559|NCT00296504|21038711|P7|Interim Analysis|Physician and Participant Decision|0
6096560|NCT00296504|21038712|P6|Interim Analysis|Physician and Participant Decision|1
6096561|NCT00296504|21038713|P5|Interim Analysis|Physician and Participant Decision|0
6096562|NCT00296504|21038714|P4|Interim Analysis|Physician and Participant Decision|0
6096563|NCT00296504|21038715|P3|Interim Analysis|Physician and Participant Decision|0
6096564|NCT00296504|21038716|P2|Interim Analysis|Physician and Participant Decision|0
6096565|NCT00296504|21038717|P1|Interim Analysis|Physician and Participant Decision|0
6096566|NCT00296504|21038709|P9|Interim Analysis|Participant Stopped|0
6096567|NCT00296504|21038710|P8|Interim Analysis|Participant Stopped|0
6096568|NCT00296504|21038711|P7|Interim Analysis|Participant Stopped|0
6096569|NCT00296504|21038712|P6|Interim Analysis|Participant Stopped|0
6096570|NCT00296504|21038713|P5|Interim Analysis|Participant Stopped|1
6096571|NCT00296504|21038714|P4|Interim Analysis|Participant Stopped|0
6096572|NCT00296504|21038715|P3|Interim Analysis|Participant Stopped|0
6096573|NCT00296504|21038716|P2|Interim Analysis|Participant Stopped|0
6096574|NCT00296504|21038717|P1|Interim Analysis|Participant Stopped|0
6096575|NCT00296504|21038709|P9|Interim Analysis|Inclusion in Other Protocol|0
6096576|NCT00296504|21038710|P8|Interim Analysis|Inclusion in Other Protocol|0
6096577|NCT00296504|21038711|P7|Interim Analysis|Inclusion in Other Protocol|0
6096578|NCT00296504|21038712|P6|Interim Analysis|Inclusion in Other Protocol|0
6096579|NCT00296504|21038713|P5|Interim Analysis|Inclusion in Other Protocol|0
6096580|NCT00296504|21038714|P4|Interim Analysis|Inclusion in Other Protocol|1
6096581|NCT00296504|21038715|P3|Interim Analysis|Inclusion in Other Protocol|0
6096582|NCT00296504|21038716|P2|Interim Analysis|Inclusion in Other Protocol|0
6096583|NCT00296504|21038717|P1|Interim Analysis|Inclusion in Other Protocol|0
6096584|NCT00296504|21038709|P9|Interim Analysis|Missed Schedule Date|0
6096585|NCT00296504|21038710|P8|Interim Analysis|Missed Schedule Date|0
6096586|NCT00296504|21038711|P7|Interim Analysis|Missed Schedule Date|0
6096587|NCT00296504|21038712|P6|Interim Analysis|Missed Schedule Date|0
6096588|NCT00296504|21038713|P5|Interim Analysis|Missed Schedule Date|0
6096589|NCT00296504|21038714|P4|Interim Analysis|Missed Schedule Date|0
6096590|NCT00296504|21038715|P3|Interim Analysis|Missed Schedule Date|0
6096591|NCT00296504|21038716|P2|Interim Analysis|Missed Schedule Date|0
6096592|NCT00296504|21038717|P1|Interim Analysis|Missed Schedule Date|1
6096593|NCT00296504|21038709|P9|Interim Analysis|Lack of Personnel at Site|0
6096594|NCT00296504|21038710|P8|Interim Analysis|Lack of Personnel at Site|0
6096595|NCT00296504|21038711|P7|Interim Analysis|Lack of Personnel at Site|0
6096596|NCT00296504|21038712|P6|Interim Analysis|Lack of Personnel at Site|0
6096597|NCT00296504|21038713|P5|Interim Analysis|Lack of Personnel at Site|0
6096598|NCT00296504|21038714|P4|Interim Analysis|Lack of Personnel at Site|0
6096599|NCT00296504|21038715|P3|Interim Analysis|Lack of Personnel at Site|0
6096600|NCT00296504|21038716|P2|Interim Analysis|Lack of Personnel at Site|0
6096601|NCT00296504|21038717|P1|Interim Analysis|Lack of Personnel at Site|1
6096602|NCT00296504|21038709|P9|Interim Analysis|Site Closing|0
6096603|NCT00296504|21038710|P8|Interim Analysis|Site Closing|0
6096604|NCT00296504|21038711|P7|Interim Analysis|Site Closing|2
6096605|NCT00296504|21038712|P6|Interim Analysis|Site Closing|1
6096606|NCT00296504|21038713|P5|Interim Analysis|Site Closing|0
6096607|NCT00296504|21038714|P4|Interim Analysis|Site Closing|0
6096608|NCT00296504|21038715|P3|Interim Analysis|Site Closing|0
6096609|NCT00296504|21038716|P2|Interim Analysis|Site Closing|0
6096610|NCT00296504|21038717|P1|Interim Analysis|Site Closing|1
6096611|NCT00296504|21038709|P9|Interim Analysis|Non-adherence|0
6096612|NCT00296504|21038710|P8|Interim Analysis|Non-adherence|1
6096613|NCT00296504|21038711|P7|Interim Analysis|Non-adherence|0
6096614|NCT00296504|21038712|P6|Interim Analysis|Non-adherence|0
6096615|NCT00296504|21038713|P5|Interim Analysis|Non-adherence|1
6096616|NCT00296504|21038714|P4|Interim Analysis|Non-adherence|0
6096617|NCT00296504|21038715|P3|Interim Analysis|Non-adherence|0
6096618|NCT00296504|21038716|P2|Interim Analysis|Non-adherence|0
6096619|NCT00296504|21038717|P1|Interim Analysis|Non-adherence|2
6096620|NCT00296504|21038709|P9|Interim Analysis|Principle Investigator Terminated Study|0
6096621|NCT00296504|21038710|P8|Interim Analysis|Principle Investigator Terminated Study|0
6096622|NCT00296504|21038711|P7|Interim Analysis|Principle Investigator Terminated Study|0
6096623|NCT00296504|21038712|P6|Interim Analysis|Principle Investigator Terminated Study|0
6096624|NCT00296504|21038713|P5|Interim Analysis|Principle Investigator Terminated Study|0
6096625|NCT00296504|21038714|P4|Interim Analysis|Principle Investigator Terminated Study|0
6096626|NCT00296504|21038715|P3|Interim Analysis|Principle Investigator Terminated Study|1
6096627|NCT00296504|21038716|P2|Interim Analysis|Principle Investigator Terminated Study|0
6096628|NCT00296504|21038717|P1|Interim Analysis|Principle Investigator Terminated Study|0
6096629|NCT00296504|21038709|P9|Interim Analysis|Principle Investigator Discretion|0
6096630|NCT00296504|21038710|P8|Interim Analysis|Principle Investigator Discretion|0
6096631|NCT00296504|21038711|P7|Interim Analysis|Principle Investigator Discretion|0
6096632|NCT00296504|21038712|P6|Interim Analysis|Principle Investigator Discretion|0
6096633|NCT00296504|21038713|P5|Interim Analysis|Principle Investigator Discretion|0
6096634|NCT00296504|21038714|P4|Interim Analysis|Principle Investigator Discretion|1
6096635|NCT00296504|21038715|P3|Interim Analysis|Principle Investigator Discretion|1
6096636|NCT00296504|21038716|P2|Interim Analysis|Principle Investigator Discretion|0
6096637|NCT00296504|21038717|P1|Interim Analysis|Principle Investigator Discretion|2
6096638|NCT00296504|21038709|P9|Interim Analysis|Physician Decision|0
6096639|NCT00296504|21038710|P8|Interim Analysis|Physician Decision|0
6096640|NCT00296504|21038711|P7|Interim Analysis|Physician Decision|0
6096641|NCT00296504|21038712|P6|Interim Analysis|Physician Decision|0
6096642|NCT00296504|21038713|P5|Interim Analysis|Physician Decision|0
6096643|NCT00296504|21038714|P4|Interim Analysis|Physician Decision|0
6096644|NCT00296504|21038715|P3|Interim Analysis|Physician Decision|1
6096645|NCT00296504|21038716|P2|Interim Analysis|Physician Decision|0
6096646|NCT00296504|21038717|P1|Interim Analysis|Physician Decision|0
6096647|NCT00296504|21038709|P9|Interim Analysis|Resistance to FPV|0
6096648|NCT00296504|21038710|P8|Interim Analysis|Resistance to FPV|0
6096649|NCT00296504|21038711|P7|Interim Analysis|Resistance to FPV|0
6096650|NCT00296504|21038712|P6|Interim Analysis|Resistance to FPV|0
6096651|NCT00296504|21038713|P5|Interim Analysis|Resistance to FPV|0
6096652|NCT00296504|21038714|P4|Interim Analysis|Resistance to FPV|0
6096653|NCT00296504|21038715|P3|Interim Analysis|Resistance to FPV|1
6096654|NCT00296504|21038716|P2|Interim Analysis|Resistance to FPV|0
6096655|NCT00296504|21038717|P1|Interim Analysis|Resistance to FPV|0
6096656|NCT00296504|21038709|P9|Interim Analysis|Participant Was Incarcerated|0
6096657|NCT00296504|21038710|P8|Interim Analysis|Participant Was Incarcerated|0
6096658|NCT00296504|21038711|P7|Interim Analysis|Participant Was Incarcerated|0
6096659|NCT00296504|21038712|P6|Interim Analysis|Participant Was Incarcerated|0
6096660|NCT00296504|21038713|P5|Interim Analysis|Participant Was Incarcerated|0
6096661|NCT00296504|21038714|P4|Interim Analysis|Participant Was Incarcerated|0
6096662|NCT00296504|21038715|P3|Interim Analysis|Participant Was Incarcerated|1
6096663|NCT00296504|21038716|P2|Interim Analysis|Participant Was Incarcerated|0
6096664|NCT00296504|21038717|P1|Interim Analysis|Participant Was Incarcerated|2
6096665|NCT00296504|21038709|P9|Interim Analysis|Participant Moved|0
6096666|NCT00296504|21038710|P8|Interim Analysis|Participant Moved|0
6096667|NCT00296504|21038711|P7|Interim Analysis|Participant Moved|1
6096668|NCT00296504|21038712|P6|Interim Analysis|Participant Moved|1
6096669|NCT00296504|21038713|P5|Interim Analysis|Participant Moved|0
6096670|NCT00296504|21038714|P4|Interim Analysis|Participant Moved|0
6096671|NCT00296504|21038715|P3|Interim Analysis|Participant Moved|1
6096672|NCT00296504|21038716|P2|Interim Analysis|Participant Moved|0
6096673|NCT00296504|21038717|P1|Interim Analysis|Participant Moved|1
6096674|NCT00296504|21038709|P9|Interim Analysis|Participant Had Problems with Alcohol|0
6096675|NCT00296504|21038710|P8|Interim Analysis|Participant Had Problems with Alcohol|0
6096676|NCT00296504|21038711|P7|Interim Analysis|Participant Had Problems with Alcohol|0
6096677|NCT00296504|21038712|P6|Interim Analysis|Participant Had Problems with Alcohol|0
6096678|NCT00296504|21038713|P5|Interim Analysis|Participant Had Problems with Alcohol|0
6096679|NCT00296504|21038714|P4|Interim Analysis|Participant Had Problems with Alcohol|0
6096680|NCT00296504|21038715|P3|Interim Analysis|Participant Had Problems with Alcohol|1
6096681|NCT00296504|21038716|P2|Interim Analysis|Participant Had Problems with Alcohol|0
6096682|NCT00296504|21038717|P1|Interim Analysis|Participant Had Problems with Alcohol|0
6096683|NCT00296504|21038709|P9|Interim Analysis|To Simplify Treatment|0
6096684|NCT00296504|21038710|P8|Interim Analysis|To Simplify Treatment|0
6096685|NCT00296504|21038711|P7|Interim Analysis|To Simplify Treatment|2
6096686|NCT00296504|21038712|P6|Interim Analysis|To Simplify Treatment|0
6096687|NCT00296504|21038713|P5|Interim Analysis|To Simplify Treatment|0
6096688|NCT00296504|21038714|P4|Interim Analysis|To Simplify Treatment|0
6096689|NCT00296504|21038715|P3|Interim Analysis|To Simplify Treatment|1
6096690|NCT00296504|21038716|P2|Interim Analysis|To Simplify Treatment|0
6096691|NCT00296504|21038717|P1|Interim Analysis|To Simplify Treatment|0
6096692|NCT00296504|21038709|P9|Interim Analysis|Participant Wanted to Become Pregnant|0
6096693|NCT00296504|21038710|P8|Interim Analysis|Participant Wanted to Become Pregnant|0
6096694|NCT00296504|21038711|P7|Interim Analysis|Participant Wanted to Become Pregnant|0
6096695|NCT00296504|21038712|P6|Interim Analysis|Participant Wanted to Become Pregnant|1
6096696|NCT00296504|21038713|P5|Interim Analysis|Participant Wanted to Become Pregnant|0
6096697|NCT00296504|21038714|P4|Interim Analysis|Participant Wanted to Become Pregnant|0
6096698|NCT00296504|21038715|P3|Interim Analysis|Participant Wanted to Become Pregnant|2
6096699|NCT00296504|21038716|P2|Interim Analysis|Participant Wanted to Become Pregnant|0
6096700|NCT00296504|21038717|P1|Interim Analysis|Participant Wanted to Become Pregnant|0
6096701|NCT00296504|21038709|P9|Interim Analysis|Participant Non-compliant|0
6096702|NCT00296504|21038710|P8|Interim Analysis|Participant Non-compliant|2
6096703|NCT00296504|21038711|P7|Interim Analysis|Participant Non-compliant|6
6096704|NCT00296504|21038712|P6|Interim Analysis|Participant Non-compliant|3
6096705|NCT00296504|21038713|P5|Interim Analysis|Participant Non-compliant|1
6096706|NCT00296504|21038714|P4|Interim Analysis|Participant Non-compliant|1
6096707|NCT00296504|21038715|P3|Interim Analysis|Participant Non-compliant|2
6096708|NCT00296504|21038716|P2|Interim Analysis|Participant Non-compliant|1
6096709|NCT00296504|21038717|P1|Interim Analysis|Participant Non-compliant|0
6096710|NCT00296504|21038709|P9|Interim Analysis|Death|0
6096711|NCT00296504|21038710|P8|Interim Analysis|Death|0
6096712|NCT00296504|21038711|P7|Interim Analysis|Death|0
6096713|NCT00296504|21038712|P6|Interim Analysis|Death|0
6096714|NCT00296504|21038713|P5|Interim Analysis|Death|0
6096715|NCT00296504|21038714|P4|Interim Analysis|Death|0
6096716|NCT00296504|21038715|P3|Interim Analysis|Death|3
6096717|NCT00296504|21038716|P2|Interim Analysis|Death|0
6096718|NCT00296504|21038717|P1|Interim Analysis|Death|1
6096719|NCT00296504|21038709|P9|Interim Analysis|Pregnancy|0
6096720|NCT00296504|21038710|P8|Interim Analysis|Pregnancy|1
6096721|NCT00296504|21038711|P7|Interim Analysis|Pregnancy|1
6096722|NCT00296504|21038712|P6|Interim Analysis|Pregnancy|1
6096723|NCT00296504|21038713|P5|Interim Analysis|Pregnancy|0
6096724|NCT00296504|21038714|P4|Interim Analysis|Pregnancy|2
6096725|NCT00296504|21038715|P3|Interim Analysis|Pregnancy|4
6096726|NCT00296504|21038716|P2|Interim Analysis|Pregnancy|1
6096727|NCT00296504|21038717|P1|Interim Analysis|Pregnancy|4
6096728|NCT00296504|21038709|P9|Interim Analysis|Switched to Commercially Available Drug|0
6096729|NCT00296504|21038710|P8|Interim Analysis|Switched to Commercially Available Drug|4
6096730|NCT00296504|21038711|P7|Interim Analysis|Switched to Commercially Available Drug|3
6096731|NCT00296504|21038712|P6|Interim Analysis|Switched to Commercially Available Drug|5
6096732|NCT00296504|21038713|P5|Interim Analysis|Switched to Commercially Available Drug|0
6096733|NCT00296504|21038714|P4|Interim Analysis|Switched to Commercially Available Drug|1
6096734|NCT00296504|21038715|P3|Interim Analysis|Switched to Commercially Available Drug|4
6096735|NCT00296504|21038716|P2|Interim Analysis|Switched to Commercially Available Drug|0
6096736|NCT00296504|21038717|P1|Interim Analysis|Switched to Commercially Available Drug|2
6096737|NCT00296504|21038709|P9|Interim Analysis|Insufficient CD4 Response|0
6096738|NCT00296504|21038710|P8|Interim Analysis|Insufficient CD4 Response|0
6096739|NCT00296504|21038711|P7|Interim Analysis|Insufficient CD4 Response|0
6096740|NCT00296504|21038712|P6|Interim Analysis|Insufficient CD4 Response|1
6096741|NCT00296504|21038713|P5|Interim Analysis|Insufficient CD4 Response|1
6096742|NCT00296504|21038714|P4|Interim Analysis|Insufficient CD4 Response|0
6096743|NCT00296504|21038715|P3|Interim Analysis|Insufficient CD4 Response|0
6096744|NCT00296504|21038716|P2|Interim Analysis|Insufficient CD4 Response|0
6096745|NCT00296504|21038717|P1|Interim Analysis|Insufficient CD4 Response|0
6096746|NCT00296504|21038709|P9|Interim Analysis|Protocol Violation|0
6096747|NCT00296504|21038710|P8|Interim Analysis|Protocol Violation|1
6096748|NCT00296504|21038711|P7|Interim Analysis|Protocol Violation|0
6096749|NCT00296504|21038712|P6|Interim Analysis|Protocol Violation|0
6096750|NCT00296504|21038713|P5|Interim Analysis|Protocol Violation|1
6096751|NCT00296504|21038714|P4|Interim Analysis|Protocol Violation|0
6096752|NCT00296504|21038715|P3|Interim Analysis|Protocol Violation|2
6096753|NCT00296504|21038716|P2|Interim Analysis|Protocol Violation|0
6096754|NCT00296504|21038717|P1|Interim Analysis|Protocol Violation|0
6096755|NCT00296504|21038709|P9|Interim Analysis|Adverse Event|0
6096756|NCT00296504|21038710|P8|Interim Analysis|Adverse Event|5
6096757|NCT00296504|21038711|P7|Interim Analysis|Adverse Event|4
6096758|NCT00296504|21038712|P6|Interim Analysis|Adverse Event|3
6096759|NCT00296504|21038713|P5|Interim Analysis|Adverse Event|6
6096760|NCT00296504|21038714|P4|Interim Analysis|Adverse Event|4
6096761|NCT00296504|21038715|P3|Interim Analysis|Adverse Event|13
6096762|NCT00296504|21038716|P2|Interim Analysis|Adverse Event|0
6096763|NCT00296504|21038717|P1|Interim Analysis|Adverse Event|0
6096764|NCT00296504|21038709|P9|Interim Analysis|Insufficient Viral Load Response|0
6096765|NCT00296504|21038710|P8|Interim Analysis|Insufficient Viral Load Response|24
6096766|NCT00296504|21038711|P7|Interim Analysis|Insufficient Viral Load Response|2
6096767|NCT00296504|21038712|P6|Interim Analysis|Insufficient Viral Load Response|9
6096768|NCT00296504|21038713|P5|Interim Analysis|Insufficient Viral Load Response|7
6096769|NCT00296504|21038714|P4|Interim Analysis|Insufficient Viral Load Response|2
6096770|NCT00296504|21038715|P3|Interim Analysis|Insufficient Viral Load Response|12
6096771|NCT00296504|21038716|P2|Interim Analysis|Insufficient Viral Load Response|1
6096772|NCT00296504|21038717|P1|Interim Analysis|Insufficient Viral Load Response|5
6096773|NCT00296504|21038709|P9|Interim Analysis|Clinical Progression|0
6096774|NCT00296504|21038710|P8|Interim Analysis|Clinical Progression|2
6096775|NCT00296504|21038711|P7|Interim Analysis|Clinical Progression|1
6096776|NCT00296504|21038712|P6|Interim Analysis|Clinical Progression|2
6096777|NCT00296504|21038713|P5|Interim Analysis|Clinical Progression|0
6096778|NCT00296504|21038714|P4|Interim Analysis|Clinical Progression|1
6096779|NCT00296504|21038715|P3|Interim Analysis|Clinical Progression|1
6096780|NCT00296504|21038716|P2|Interim Analysis|Clinical Progression|0
6096781|NCT00296504|21038717|P1|Interim Analysis|Clinical Progression|1
6096782|NCT00296504|21038709|P9|Interim Analysis|Lost to Follow-up|0
6096783|NCT00296504|21038710|P8|Interim Analysis|Lost to Follow-up|4
6096784|NCT00296504|21038711|P7|Interim Analysis|Lost to Follow-up|11
6096785|NCT00296504|21038712|P6|Interim Analysis|Lost to Follow-up|4
6096786|NCT00296504|21038713|P5|Interim Analysis|Lost to Follow-up|14
6096787|NCT00296504|21038714|P4|Interim Analysis|Lost to Follow-up|8
6096788|NCT00296504|21038715|P3|Interim Analysis|Lost to Follow-up|26
6096789|NCT00296504|21038716|P2|Interim Analysis|Lost to Follow-up|3
6096790|NCT00296504|21038717|P1|Interim Analysis|Lost to Follow-up|13
6096791|NCT00296504|21038709|P9|Interim Analysis|Withdrawal by Subject|0
6096792|NCT00296504|21038710|P8|Interim Analysis|Withdrawal by Subject|3
6096793|NCT00296504|21038711|P7|Interim Analysis|Withdrawal by Subject|9
6096794|NCT00296504|21038712|P6|Interim Analysis|Withdrawal by Subject|5
6096795|NCT00296504|21038713|P5|Interim Analysis|Withdrawal by Subject|5
6096796|NCT00296504|21038714|P4|Interim Analysis|Withdrawal by Subject|0
6096797|NCT00296504|21038715|P3|Interim Analysis|Withdrawal by Subject|12
6096798|NCT00296504|21038716|P2|Interim Analysis|Withdrawal by Subject|0
6096799|NCT00296504|21038717|P1|Interim Analysis|Withdrawal by Subject|8
6096800|NCT00296491|21038810|P4|Overall Study|Lost to Follow-up|0
6096801|NCT00296491|21038811|P3|Overall Study|Lost to Follow-up|2
6096802|NCT00296491|21038812|P2|Overall Study|Lost to Follow-up|2
6096803|NCT00296491|21038813|P1|Overall Study|Lost to Follow-up|0
6096804|NCT00296491|21038810|P4|Overall Study|Non-Compliance|14
6096805|NCT00296491|21038811|P3|Overall Study|Non-Compliance|10
6096806|NCT00296491|21038812|P2|Overall Study|Non-Compliance|13
6096807|NCT00296491|21038813|P1|Overall Study|Non-Compliance|12
6096808|NCT00296491|21038810|P4|Overall Study|Withdrawal by Subject|2
6096809|NCT00296491|21038811|P3|Overall Study|Withdrawal by Subject|3
6096810|NCT00296491|21038812|P2|Overall Study|Withdrawal by Subject|3
6096811|NCT00296491|21038813|P1|Overall Study|Withdrawal by Subject|7
6096812|NCT00296491|21038810|P4|Overall Study|Withdrawn due to Asthma|4
6096813|NCT00296491|21038811|P3|Overall Study|Withdrawn due to Asthma|0
6096814|NCT00296491|21038812|P2|Overall Study|Withdrawn due to Asthma|0
6096815|NCT00296491|21038813|P1|Overall Study|Withdrawn due to Asthma|0
6096816|NCT00296491|21038810|P4|Overall Study|Adverse Event|4
6096817|NCT00296491|21038811|P3|Overall Study|Adverse Event|1
6096818|NCT00296491|21038812|P2|Overall Study|Adverse Event|3
6096819|NCT00296491|21038813|P1|Overall Study|Adverse Event|1
6096820|NCT00296491|21038810|P4|Overall Study|Protocol Violation|3
6096821|NCT00296491|21038811|P3|Overall Study|Protocol Violation|2
6096822|NCT00296491|21038812|P2|Overall Study|Protocol Violation|6
6096823|NCT00296491|21038813|P1|Overall Study|Protocol Violation|4
6096824|NCT00296491|21038810|P4|Overall Study|Low Pollen Counts|16
6096825|NCT00296491|21038811|P3|Overall Study|Low Pollen Counts|25
6096826|NCT00296491|21038812|P2|Overall Study|Low Pollen Counts|26
6096827|NCT00296491|21038813|P1|Overall Study|Low Pollen Counts|18
6096828|NCT00296400|21038842|P3|Overall Study|Pregnancy|0
6096829|NCT00296400|21038843|P2|Overall Study|Pregnancy|2
6096830|NCT00296400|21038844|P1|Overall Study|Pregnancy|1
6096831|NCT00296400|21038842|P3|Overall Study|Visit 10 was performed earlier|0
6096832|NCT00296400|21038843|P2|Overall Study|Visit 10 was performed earlier|1
6096833|NCT00296400|21038844|P1|Overall Study|Visit 10 was performed earlier|0
6096834|NCT00296400|21038842|P3|Overall Study|Study specific discontinuation criteria|1
6096835|NCT00296400|21038843|P2|Overall Study|Study specific discontinuation criteria|0
6096836|NCT00296400|21038844|P1|Overall Study|Study specific discontinuation criteria|0
6096837|NCT00296400|21038842|P3|Overall Study|Lost to Follow-up|2
6096838|NCT00296400|21038843|P2|Overall Study|Lost to Follow-up|1
6096839|NCT00296400|21038844|P1|Overall Study|Lost to Follow-up|1
6096840|NCT00296400|21038842|P3|Overall Study|Protocol Violation|1
6096841|NCT00296400|21038843|P2|Overall Study|Protocol Violation|1
6096842|NCT00296400|21038844|P1|Overall Study|Protocol Violation|1
6096843|NCT00296400|21038842|P3|Overall Study|Incorrect enrollment|0
6096844|NCT00296400|21038843|P2|Overall Study|Incorrect enrollment|0
6096845|NCT00296400|21038844|P1|Overall Study|Incorrect enrollment|2
6096846|NCT00296400|21038842|P3|Overall Study|Withdrawal by Subject|2
6096847|NCT00296400|21038843|P2|Overall Study|Withdrawal by Subject|6
6096848|NCT00296400|21038844|P1|Overall Study|Withdrawal by Subject|5
6096849|NCT00296400|21038842|P3|Overall Study|Adverse Event|7
6096850|NCT00296400|21038843|P2|Overall Study|Adverse Event|7
6096851|NCT00296400|21038844|P1|Overall Study|Adverse Event|7
6096852|NCT00296374|21039068|P3|Overall Study|Other|1
6096853|NCT00296374|21039069|P2|Overall Study|Other|0
6096854|NCT00296374|21039070|P1|Overall Study|Other|0
6096855|NCT00296374|21039068|P3|Overall Study|Pregnancy|2
6096856|NCT00296374|21039069|P2|Overall Study|Pregnancy|0
6096857|NCT00296374|21039070|P1|Overall Study|Pregnancy|0
6096858|NCT00296374|21039068|P3|Overall Study|Nephrologist introduced ACE|0
6096859|NCT00296374|21039069|P2|Overall Study|Nephrologist introduced ACE|1
6096860|NCT00296374|21039070|P1|Overall Study|Nephrologist introduced ACE|0
6096861|NCT00296374|21039068|P3|Overall Study|Stopped drug before end of study visit|0
6096862|NCT00296374|21039069|P2|Overall Study|Stopped drug before end of study visit|1
6096863|NCT00296374|21039070|P1|Overall Study|Stopped drug before end of study visit|0
6096864|NCT00296374|21039068|P3|Overall Study|Relocated to another state|0
6096865|NCT00296374|21039069|P2|Overall Study|Relocated to another state|0
6096866|NCT00296374|21039070|P1|Overall Study|Relocated to another state|1
6096867|NCT00296374|21039068|P3|Overall Study|Lost to Follow-up|1
6096868|NCT00296374|21039069|P2|Overall Study|Lost to Follow-up|1
6096869|NCT00296374|21039070|P1|Overall Study|Lost to Follow-up|3
6096870|NCT00296374|21039068|P3|Overall Study|Protocol Violation|3
6096871|NCT00296374|21039069|P2|Overall Study|Protocol Violation|2
6096872|NCT00296374|21039070|P1|Overall Study|Protocol Violation|1
6096873|NCT00296374|21039068|P3|Overall Study|Incorrect enrollment|4
6096874|NCT00296374|21039069|P2|Overall Study|Incorrect enrollment|3
6096875|NCT00296374|21039070|P1|Overall Study|Incorrect enrollment|3
6096876|NCT00296374|21039068|P3|Overall Study|Withdrawal by Subject|11
6096877|NCT00296374|21039069|P2|Overall Study|Withdrawal by Subject|5
6096878|NCT00296374|21039070|P1|Overall Study|Withdrawal by Subject|3
6096879|NCT00296374|21039068|P3|Overall Study|Adverse Event|7
6096880|NCT00296374|21039069|P2|Overall Study|Adverse Event|10
6096881|NCT00296374|21039070|P1|Overall Study|Adverse Event|14
6096882|NCT00296335|21039293|P2|Overall Study|Physician Decision|11
6096883|NCT00296335|21039294|P1|Overall Study|Physician Decision|3
6096884|NCT00296335|21039293|P2|Overall Study|Lost to Follow-up|33
6096885|NCT00296335|21039294|P1|Overall Study|Lost to Follow-up|7
6096886|NCT00296335|21039293|P2|Overall Study|Adverse Event|27
6096887|NCT00296335|21039294|P1|Overall Study|Adverse Event|17
6096888|NCT00296335|21039293|P2|Overall Study|Recurrence|51
6096889|NCT00296335|21039294|P1|Overall Study|Recurrence|3
6096890|NCT00296244|21039334|P2|Overall Study|Underwent retransplant|1
6096891|NCT00296244|21039335|P1|Overall Study|Underwent retransplant|0
6096892|NCT00296140|21039399|P2|Overall Study|Discharge to Nursing Home|0
6096893|NCT00296140|21039400|P1|Overall Study|Discharge to Nursing Home|1
6096894|NCT00296140|21039399|P2|Overall Study|Withdrawal by Subject|0
6096895|NCT00296140|21039400|P1|Overall Study|Withdrawal by Subject|1
6096896|NCT00296140|21039399|P2|Overall Study|Lost to Follow-up|0
6096897|NCT00296140|21039400|P1|Overall Study|Lost to Follow-up|1
6096898|NCT00296036|21039412|P6|Overall Study|Protocol Violation|3
6096899|NCT00296036|21039413|P5|Overall Study|Protocol Violation|0
6096900|NCT00296036|21039414|P4|Overall Study|Protocol Violation|0
6096901|NCT00296036|21039415|P3|Overall Study|Protocol Violation|0
6096902|NCT00296036|21039416|P2|Overall Study|Protocol Violation|0
6096903|NCT00296036|21039417|P1|Overall Study|Protocol Violation|0
6096904|NCT00296036|21039412|P6|Overall Study|Withdrawal by Subject|1
6096905|NCT00296036|21039413|P5|Overall Study|Withdrawal by Subject|2
6096906|NCT00296036|21039414|P4|Overall Study|Withdrawal by Subject|1
6096907|NCT00296036|21039415|P3|Overall Study|Withdrawal by Subject|2
6096908|NCT00296036|21039416|P2|Overall Study|Withdrawal by Subject|0
6096909|NCT00296036|21039417|P1|Overall Study|Withdrawal by Subject|1
6096910|NCT00295932|21039454|P11|Overall Study|Not Treated|1
6096911|NCT00295932|21039455|P10|Overall Study|Not Treated|0
6096912|NCT00295932|21039456|P9|Overall Study|Not Treated|0
6096913|NCT00295932|21039457|P8|Overall Study|Not Treated|0
6096914|NCT00295932|21039458|P7|Overall Study|Not Treated|0
6096915|NCT00295932|21039459|P6|Overall Study|Not Treated|0
6096916|NCT00295932|21039460|P5|Overall Study|Not Treated|0
6096917|NCT00295932|21039461|P4|Overall Study|Not Treated|0
6096918|NCT00295932|21039462|P3|Overall Study|Not Treated|0
6096919|NCT00295932|21039463|P2|Overall Study|Not Treated|0
6096920|NCT00295932|21039464|P1|Overall Study|Not Treated|0
6096921|NCT00295880|21039498|P1|Overall Study|Unit randomization did not occur|1
6096922|NCT00295880|21039498|P1|Overall Study|IBMI unit could not be volume reduced|1
6096923|NCT00295854|21039518|P3|Overall Study|Other|1
6096924|NCT00295854|21039519|P2|Overall Study|Other|5
6096925|NCT00295854|21039520|P1|Overall Study|Other|3
6096926|NCT00295854|21039518|P3|Overall Study|required a prohibited medication|0
6096927|NCT00295854|21039519|P2|Overall Study|required a prohibited medication|0
6096928|NCT00295854|21039520|P1|Overall Study|required a prohibited medication|1
6096929|NCT00295854|21039518|P3|Overall Study|did not continue to meet criteria|2
6096930|NCT00295854|21039519|P2|Overall Study|did not continue to meet criteria|1
6096931|NCT00295854|21039520|P1|Overall Study|did not continue to meet criteria|1
6096932|NCT00295854|21039518|P3|Overall Study|Withdrawal by Subject|4
6096933|NCT00295854|21039519|P2|Overall Study|Withdrawal by Subject|7
6096934|NCT00295854|21039520|P1|Overall Study|Withdrawal by Subject|3
6096935|NCT00295854|21039518|P3|Overall Study|Lost to Follow-up|1
6096936|NCT00295854|21039519|P2|Overall Study|Lost to Follow-up|0
6096937|NCT00295854|21039520|P1|Overall Study|Lost to Follow-up|2
6096938|NCT00295854|21039518|P3|Overall Study|Protocol Violation|1
6096939|NCT00295854|21039519|P2|Overall Study|Protocol Violation|1
6096940|NCT00295854|21039520|P1|Overall Study|Protocol Violation|1
6096941|NCT00295854|21039518|P3|Overall Study|Adverse Event|6
6096942|NCT00295854|21039519|P2|Overall Study|Adverse Event|7
6096943|NCT00295854|21039520|P1|Overall Study|Adverse Event|7
6096944|NCT00295750|21039534|P3|Overall Study|Protocol Violation|2
6096945|NCT00295750|21039535|P2|Overall Study|Protocol Violation|4
6096946|NCT00295750|21039536|P1|Overall Study|Protocol Violation|2
6096947|NCT00295750|21039534|P3|Overall Study|Withdrawal by Subject|7
6096948|NCT00295750|21039535|P2|Overall Study|Withdrawal by Subject|4
6096949|NCT00295750|21039536|P1|Overall Study|Withdrawal by Subject|9
6096950|NCT00295750|21039534|P3|Overall Study|Randomized but never received trial drug|3
6096951|NCT00295750|21039535|P2|Overall Study|Randomized but never received trial drug|3
6096952|NCT00295750|21039536|P1|Overall Study|Randomized but never received trial drug|4
6096953|NCT00295750|21039534|P3|Overall Study|Personal reasons|0
6096954|NCT00295750|21039535|P2|Overall Study|Personal reasons|1
6096955|NCT00295750|21039536|P1|Overall Study|Personal reasons|0
6096956|NCT00295750|21039534|P3|Overall Study|Disease progression|0
6096957|NCT00295750|21039535|P2|Overall Study|Disease progression|1
6096958|NCT00295750|21039536|P1|Overall Study|Disease progression|2
6096959|NCT00295750|21039534|P3|Overall Study|Trial drug errors|0
6096960|NCT00295750|21039535|P2|Overall Study|Trial drug errors|1
6096961|NCT00295750|21039536|P1|Overall Study|Trial drug errors|1
6096962|NCT00295750|21039534|P3|Overall Study|Administrative errors|5
6096963|NCT00295750|21039535|P2|Overall Study|Administrative errors|4
6096964|NCT00295750|21039536|P1|Overall Study|Administrative errors|2
6096965|NCT00295750|21039534|P3|Overall Study|Taking prohibited therapy|2
6096966|NCT00295750|21039535|P2|Overall Study|Taking prohibited therapy|3
6096967|NCT00295750|21039536|P1|Overall Study|Taking prohibited therapy|2
6096968|NCT00295750|21039534|P3|Overall Study|Lost to Follow-up|1
6096969|NCT00295750|21039535|P2|Overall Study|Lost to Follow-up|4
6096970|NCT00295750|21039536|P1|Overall Study|Lost to Follow-up|1
6096971|NCT00295750|21039534|P3|Overall Study|Lack of Efficacy|0
6096972|NCT00295750|21039535|P2|Overall Study|Lack of Efficacy|1
6096973|NCT00295750|21039536|P1|Overall Study|Lack of Efficacy|1
6096974|NCT00295750|21039534|P3|Overall Study|Adverse Event|12
6096975|NCT00295750|21039535|P2|Overall Study|Adverse Event|15
6096976|NCT00295750|21039536|P1|Overall Study|Adverse Event|19
6096977|NCT00295633|21039571|P3|Overall Study|Administrative reason by sponsor|1
6096978|NCT00295633|21039572|P2|Overall Study|Administrative reason by sponsor|0
6096979|NCT00295633|21039573|P1|Overall Study|Administrative reason by sponsor|0
6096980|NCT00295633|21039571|P3|Overall Study|Death|0
6096981|NCT00295633|21039572|P2|Overall Study|Death|1
6096982|NCT00295633|21039573|P1|Overall Study|Death|1
6096983|NCT00295633|21039571|P3|Overall Study|Subject No Longer Meets Study Criteria|3
6096984|NCT00295633|21039572|P2|Overall Study|Subject No Longer Meets Study Criteria|3
6096985|NCT00295633|21039573|P1|Overall Study|Subject No Longer Meets Study Criteria|0
6096986|NCT00295633|21039571|P3|Overall Study|Poor/Noncompliance|6
6096987|NCT00295633|21039572|P2|Overall Study|Poor/Noncompliance|2
6096988|NCT00295633|21039573|P1|Overall Study|Poor/Noncompliance|2
6096989|NCT00295633|21039571|P3|Overall Study|Physician Decision|8
6096990|NCT00295633|21039572|P2|Overall Study|Physician Decision|10
6096991|NCT00295633|21039573|P1|Overall Study|Physician Decision|9
6096992|NCT00295633|21039571|P3|Overall Study|Lost to Follow-up|7
6096993|NCT00295633|21039572|P2|Overall Study|Lost to Follow-up|11
6096994|NCT00295633|21039573|P1|Overall Study|Lost to Follow-up|6
6096995|NCT00295633|21039571|P3|Overall Study|Adverse Event|9
6096996|NCT00295633|21039572|P2|Overall Study|Adverse Event|17
6096997|NCT00295633|21039573|P1|Overall Study|Adverse Event|9
6096998|NCT00295633|21039571|P3|Overall Study|Withdrawal of consent by subject|26
6096999|NCT00295633|21039572|P2|Overall Study|Withdrawal of consent by subject|16
6097000|NCT00295633|21039573|P1|Overall Study|Withdrawal of consent by subject|16
6097001|NCT00295633|21039571|P3|Overall Study|Lack of Efficacy|16
6097002|NCT00295633|21039572|P2|Overall Study|Lack of Efficacy|7
6097003|NCT00295633|21039573|P1|Overall Study|Lack of Efficacy|19
6097004|NCT00295620|21039592|P2|Overall Study|Protocol Violation|32
6097005|NCT00295620|21039593|P1|Overall Study|Protocol Violation|30
6097006|NCT00295620|21039592|P2|Overall Study|Discontinuation by sponsor|593
6097007|NCT00295620|21039593|P1|Overall Study|Discontinuation by sponsor|580
6097008|NCT00295620|21039592|P2|Overall Study|Other reasons|9
6097009|NCT00295620|21039593|P1|Overall Study|Other reasons|10
6097010|NCT00295620|21039592|P2|Overall Study|Death|207
6097011|NCT00295620|21039593|P1|Overall Study|Death|206
6097012|NCT00295620|21039592|P2|Overall Study|Withdrawal by Subject|50
6097013|NCT00295620|21039593|P1|Overall Study|Withdrawal by Subject|37
6097014|NCT00295620|21039592|P2|Overall Study|Lost to Follow-up|5
6097015|NCT00295620|21039593|P1|Overall Study|Lost to Follow-up|9
6097016|NCT00295490|21039617|P4|Overall Study|Other|1
6097017|NCT00295490|21039618|P3|Overall Study|Other|0
6097018|NCT00295490|21039619|P2|Overall Study|Other|2
6097019|NCT00295490|21039620|P1|Overall Study|Other|0
6097020|NCT00295490|21039617|P4|Overall Study|Adverse Event|0
6097021|NCT00295490|21039618|P3|Overall Study|Adverse Event|0
6097022|NCT00295490|21039619|P2|Overall Study|Adverse Event|0
6097023|NCT00295490|21039620|P1|Overall Study|Adverse Event|1
6097024|NCT00295490|21039617|P4|Overall Study|Lost to Follow-up|0
6097025|NCT00295490|21039618|P3|Overall Study|Lost to Follow-up|1
6097026|NCT00295490|21039619|P2|Overall Study|Lost to Follow-up|0
6097027|NCT00295490|21039620|P1|Overall Study|Lost to Follow-up|0
6097028|NCT00295490|21039617|P4|Overall Study|Withdrawal by Subject|1
6097029|NCT00295490|21039618|P3|Overall Study|Withdrawal by Subject|0
6097030|NCT00295490|21039619|P2|Overall Study|Withdrawal by Subject|2
6097031|NCT00295490|21039620|P1|Overall Study|Withdrawal by Subject|0
6097032|NCT00295490|21039617|P4|Overall Study|Protocol Violation|3
6097033|NCT00295490|21039618|P3|Overall Study|Protocol Violation|3
6097034|NCT00295490|21039619|P2|Overall Study|Protocol Violation|0
6097035|NCT00295490|21039620|P1|Overall Study|Protocol Violation|0
6097036|NCT00295022|21039670|P3|Overall Study|Withdrawal by Subject|2
6097037|NCT00295022|21039671|P2|Overall Study|Withdrawal by Subject|0
6097038|NCT00295022|21039672|P1|Overall Study|Withdrawal by Subject|0
6097039|NCT00295022|21039670|P3|Overall Study|Lost to Follow-up|1
6097040|NCT00295022|21039671|P2|Overall Study|Lost to Follow-up|0
6097041|NCT00295022|21039672|P1|Overall Study|Lost to Follow-up|0
6097042|NCT00295022|21039670|P3|Overall Study|Adverse Event|2
6097043|NCT00295022|21039671|P2|Overall Study|Adverse Event|1
6097044|NCT00295022|21039672|P1|Overall Study|Adverse Event|1
6097045|NCT00294762|21039788|P2|Overall Study|Did not receive study treatment|3
6097046|NCT00294762|21039789|P1|Overall Study|Did not receive study treatment|3
6097047|NCT00294723|21039808|P3|Additional Open-Label Extension 91 Weeks|Not specified in study report|3
6097048|NCT00294723|21039809|P2|Additional Open-Label Extension 91 Weeks|Not specified in study report|5
6097049|NCT00294723|21039810|P1|Additional Open-Label Extension 91 Weeks|Not specified in study report|2
6097050|NCT00294723|21039808|P3|Additional Open-Label Extension 91 Weeks|Protocol Violation|1
6097051|NCT00294723|21039809|P2|Additional Open-Label Extension 91 Weeks|Protocol Violation|1
6097052|NCT00294723|21039810|P1|Additional Open-Label Extension 91 Weeks|Protocol Violation|1
6097053|NCT00294723|21039808|P3|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|16
6097054|NCT00294723|21039809|P2|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|14
6097055|NCT00294723|21039810|P1|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|24
6097056|NCT00294723|21039808|P3|Additional Open-Label Extension 91 Weeks|Adverse Event|0
6097057|NCT00294723|21039809|P2|Additional Open-Label Extension 91 Weeks|Adverse Event|1
6097058|NCT00294723|21039810|P1|Additional Open-Label Extension 91 Weeks|Adverse Event|1
6097059|NCT00294723|21039808|P3|Open-Label Extension 52 Weeks|Not specified in study report|14
6097060|NCT00294723|21039809|P2|Open-Label Extension 52 Weeks|Not specified in study report|16
6097061|NCT00294723|21039810|P1|Open-Label Extension 52 Weeks|Not specified in study report|19
6097062|NCT00294723|21039808|P3|Open-Label Extension 52 Weeks|Protocol Violation|3
6097063|NCT00294723|21039809|P2|Open-Label Extension 52 Weeks|Protocol Violation|3
6097064|NCT00294723|21039810|P1|Open-Label Extension 52 Weeks|Protocol Violation|4
6097065|NCT00294723|21039808|P3|Open-Label Extension 52 Weeks|Lack of Efficacy|21
6097066|NCT00294723|21039809|P2|Open-Label Extension 52 Weeks|Lack of Efficacy|15
6097067|NCT00294723|21039810|P1|Open-Label Extension 52 Weeks|Lack of Efficacy|12
6097068|NCT00294723|21039808|P3|Open-Label Extension 52 Weeks|Adverse Event|2
6097069|NCT00294723|21039809|P2|Open-Label Extension 52 Weeks|Adverse Event|5
6097070|NCT00294723|21039810|P1|Open-Label Extension 52 Weeks|Adverse Event|5
6097071|NCT00294723|21039808|P3|Double-Blind Period 52 Weeks|Not specified in study report|51
6097072|NCT00294723|21039809|P2|Double-Blind Period 52 Weeks|Not specified in study report|38
6097073|NCT00294723|21039810|P1|Double-Blind Period 52 Weeks|Not specified in study report|36
6097074|NCT00294723|21039808|P3|Double-Blind Period 52 Weeks|Protocol Violation|5
6097075|NCT00294723|21039809|P2|Double-Blind Period 52 Weeks|Protocol Violation|11
6097076|NCT00294723|21039810|P1|Double-Blind Period 52 Weeks|Protocol Violation|11
6097077|NCT00294723|21039808|P3|Double-Blind Period 52 Weeks|Lack of Efficacy|25
6097078|NCT00294723|21039809|P2|Double-Blind Period 52 Weeks|Lack of Efficacy|15
6097079|NCT00294723|21039810|P1|Double-Blind Period 52 Weeks|Lack of Efficacy|9
6097080|NCT00294723|21039808|P3|Double-Blind Period 52 Weeks|Adverse Event|15
6097081|NCT00294723|21039809|P2|Double-Blind Period 52 Weeks|Adverse Event|25
6097082|NCT00294723|21039810|P1|Double-Blind Period 52 Weeks|Adverse Event|18
6097083|NCT00294684|21039871|P2|Overall Study|Lost to Follow-up|8
6097084|NCT00294684|21039872|P1|Overall Study|Lost to Follow-up|5
6097085|NCT00294671|21039912|P2|Overall Study|Death|1
6097086|NCT00294671|21039913|P1|Overall Study|Death|0
6097087|NCT00294671|21039912|P2|Overall Study|Non-compliance|0
6097088|NCT00294671|21039913|P1|Overall Study|Non-compliance|1
6097089|NCT00294671|21039912|P2|Overall Study|Lost to Follow-up|3
6097090|NCT00294671|21039913|P1|Overall Study|Lost to Follow-up|1
6097091|NCT00294671|21039912|P2|Overall Study|Non-drug related AE|2
6097092|NCT00294671|21039913|P1|Overall Study|Non-drug related AE|3
6097093|NCT00294671|21039912|P2|Overall Study|Drug related adverse event (AE)|2
6097094|NCT00294671|21039913|P1|Overall Study|Drug related adverse event (AE)|4
6097095|NCT00294671|21039912|P2|Overall Study|Liver transplant|9
6097096|NCT00294671|21039913|P1|Overall Study|Liver transplant|7
6097097|NCT00294671|21039912|P2|Overall Study|Lack of Efficacy|23
6097098|NCT00294671|21039913|P1|Overall Study|Lack of Efficacy|11
6097099|NCT00294658|21039929|P2|Overall Study|Patient and family were not satisfied|1
6097100|NCT00294658|21039930|P1|Overall Study|Patient and family were not satisfied|0
6097101|NCT00294658|21039929|P2|Overall Study|Found to have invasive thymoma|0
6097102|NCT00294658|21039930|P1|Overall Study|Found to have invasive thymoma|1
6097103|NCT00294658|21039929|P2|Overall Study|Withdrawal by Subject|4
6097104|NCT00294658|21039930|P1|Overall Study|Withdrawal by Subject|0
6097105|NCT00294658|21039929|P2|Overall Study|Pregnancy|1
6097106|NCT00294658|21039930|P1|Overall Study|Pregnancy|0
6097107|NCT00294658|21039929|P2|Overall Study|Physician Decision|2
6097108|NCT00294658|21039930|P1|Overall Study|Physician Decision|1
6097109|NCT00294658|21039929|P2|Overall Study|Lost to Follow-up|0
6097110|NCT00294658|21039930|P1|Overall Study|Lost to Follow-up|4
6097111|NCT00294658|21039929|P2|Overall Study|Death|1
6097112|NCT00294658|21039930|P1|Overall Study|Death|0
6097113|NCT00294645|21039994|P2|Overall Study|Other|10
6097114|NCT00294645|21039995|P1|Overall Study|Other|4
6097115|NCT00294645|21039994|P2|Overall Study|Physician Decision|20
6097116|NCT00294645|21039995|P1|Overall Study|Physician Decision|15
6097117|NCT00294645|21039994|P2|Overall Study|Withdrawal by Subject|34
6097118|NCT00294645|21039995|P1|Overall Study|Withdrawal by Subject|18
6097119|NCT00294645|21039994|P2|Overall Study|Lost to Follow-up|10
6097120|NCT00294645|21039995|P1|Overall Study|Lost to Follow-up|1
6097121|NCT00294645|21039994|P2|Overall Study|Death|18
6097122|NCT00294645|21039995|P1|Overall Study|Death|10
6097123|NCT00294554|21040039|P2|Overall Study|Physician Decision|1
6097124|NCT00294554|21040040|P1|Overall Study|Physician Decision|0
6097125|NCT00294554|21040039|P2|Overall Study|Lack of Efficacy|1
6097126|NCT00294554|21040040|P1|Overall Study|Lack of Efficacy|0
6097127|NCT00294398|21040067|P2|Overall Study|Lost to Follow-up|26
6097128|NCT00294398|21040068|P1|Overall Study|Lost to Follow-up|21
6097129|NCT00294060|21040076|P1|Overall Study|Device explanted/not replaced|23
6097130|NCT00294060|21040076|P1|Overall Study|Medical condition|3
6097131|NCT00294060|21040076|P1|Overall Study|Physician Decision|797
6097132|NCT00294060|21040076|P1|Overall Study|Withdrawal by Subject|11
6097133|NCT00294060|21040076|P1|Overall Study|Lost to Follow-up|55
6097134|NCT00294060|21040076|P1|Overall Study|Other|59
6097135|NCT00294060|21040076|P1|Overall Study|Death|225
6097136|NCT00294047|21040084|P2|Month 84|No consent for Month 84 Follow-up|754
6097137|NCT00294047|21040085|P1|Month 84|No consent for Month 84 Follow-up|731
6097138|NCT00294047|21040084|P2|Month 84|Visit missed|1
6097139|NCT00294047|21040085|P1|Month 84|Visit missed|0
6097140|NCT00294047|21040084|P2|Month 84|Under investigation locally|0
6097141|NCT00294047|21040085|P1|Month 84|Under investigation locally|1
6097142|NCT00294047|21040084|P2|Month 84|Unable to reach study site|0
6097143|NCT00294047|21040085|P1|Month 84|Unable to reach study site|1
6097144|NCT00294047|21040084|P2|Month 84|Transport reimbursement delayed|1
6097145|NCT00294047|21040085|P1|Month 84|Transport reimbursement delayed|0
6097146|NCT00294047|21040084|P2|Month 84|Subject does not want male physician|0
6097147|NCT00294047|21040085|P1|Month 84|Subject does not want male physician|1
6097148|NCT00294047|21040084|P2|Month 84|Personal reason|4
6097149|NCT00294047|21040085|P1|Month 84|Personal reason|2
6097150|NCT00294047|21040084|P2|Month 84|Lack of time|1
6097151|NCT00294047|21040085|P1|Month 84|Lack of time|3
6097152|NCT00294047|21040084|P2|Month 84|Family problems|2
6097153|NCT00294047|21040085|P1|Month 84|Family problems|2
6097154|NCT00294047|21040084|P2|Month 84|Center closed, subject did not transfer|0
6097155|NCT00294047|21040085|P1|Month 84|Center closed, subject did not transfer|1
6097156|NCT00294047|21040084|P2|Month 84|Work related reasons|2
6097157|NCT00294047|21040085|P1|Month 84|Work related reasons|4
6097158|NCT00294047|21040084|P2|Month 84|Absent Cervix|0
6097159|NCT00294047|21040085|P1|Month 84|Absent Cervix|2
6097160|NCT00294047|21040084|P2|Month 84|Lost to Follow-up|190
6097161|NCT00294047|21040085|P1|Month 84|Lost to Follow-up|187
6097162|NCT00294047|21040084|P2|Month 84|Withdrawal by Subject|31
6097163|NCT00294047|21040085|P1|Month 84|Withdrawal by Subject|33
6097164|NCT00294047|21040084|P2|Month 84|Protocol Violation|1
6097165|NCT00294047|21040085|P1|Month 84|Protocol Violation|1
6097166|NCT00294047|21040084|P2|Month 84|Adverse Event|2
6097167|NCT00294047|21040085|P1|Month 84|Adverse Event|4
6097168|NCT00294047|21040084|P2|Month 48|Other|14
6097169|NCT00294047|21040085|P1|Month 48|Other|10
6097170|NCT00294047|21040084|P2|Month 48|Lost to Follow-up|287
6097171|NCT00294047|21040085|P1|Month 48|Lost to Follow-up|272
6097172|NCT00294047|21040084|P2|Month 48|Withdrawal by Subject|115
6097173|NCT00294047|21040085|P1|Month 48|Withdrawal by Subject|111
6097174|NCT00294047|21040084|P2|Month 48|Protocol Violation|4
6097175|NCT00294047|21040085|P1|Month 48|Protocol Violation|4
6097176|NCT00294047|21040084|P2|Month 48|Adverse Event|13
6097177|NCT00294047|21040085|P1|Month 48|Adverse Event|28
6097178|NCT00293813|21040190|P3|Overall Study|Noncompliance|0
6097179|NCT00293813|21040191|P2|Overall Study|Noncompliance|1
6097180|NCT00293813|21040192|P1|Overall Study|Noncompliance|0
6097181|NCT00293813|21040190|P3|Overall Study|Lost to Follow-up|3
6097182|NCT00293813|21040191|P2|Overall Study|Lost to Follow-up|2
6097183|NCT00293813|21040192|P1|Overall Study|Lost to Follow-up|3
6097184|NCT00293813|21040190|P3|Overall Study|Withdrawal by Subject|4
6097185|NCT00293813|21040191|P2|Overall Study|Withdrawal by Subject|4
6097186|NCT00293813|21040192|P1|Overall Study|Withdrawal by Subject|7
6097187|NCT00293813|21040190|P3|Overall Study|Adverse Event|1
6097188|NCT00293813|21040191|P2|Overall Study|Adverse Event|1
6097189|NCT00293813|21040192|P1|Overall Study|Adverse Event|3
6097190|NCT00293813|21040190|P3|Overall Study|Physician Decision|0
6097191|NCT00293813|21040191|P2|Overall Study|Physician Decision|1
6097192|NCT00293813|21040192|P1|Overall Study|Physician Decision|0
6097193|NCT00293722|21040203|P1|Overall Study|Other|427
6097194|NCT00293709|21040217|P1|Overall Study|Other|47
6097195|NCT00293579|21040231|P1|Overall Study|Withdrawal by Subject|1
6097196|NCT00293462|21040250|P3|Overall Study|Physician Decision|0
6097197|NCT00293462|21040251|P2|Overall Study|Physician Decision|1
6097198|NCT00293462|21040252|P1|Overall Study|Physician Decision|0
6097199|NCT00293462|21040250|P3|Overall Study|Low radiation dose in oral cavity|0
6097200|NCT00293462|21040251|P2|Overall Study|Low radiation dose in oral cavity|1
6097201|NCT00293462|21040252|P1|Overall Study|Low radiation dose in oral cavity|0
6097202|NCT00293462|21040250|P3|Overall Study|Possible Tracheostomy leakage|0
6097203|NCT00293462|21040251|P2|Overall Study|Possible Tracheostomy leakage|1
6097204|NCT00293462|21040252|P1|Overall Study|Possible Tracheostomy leakage|0
6097205|NCT00293462|21040250|P3|Overall Study|Ischemic stroke after chemotherapy|1
6097206|NCT00293462|21040251|P2|Overall Study|Ischemic stroke after chemotherapy|0
6097207|NCT00293462|21040252|P1|Overall Study|Ischemic stroke after chemotherapy|0
6097208|NCT00293462|21040250|P3|Overall Study|Blood clot after chemotherapy|1
6097209|NCT00293462|21040251|P2|Overall Study|Blood clot after chemotherapy|0
6097210|NCT00293462|21040252|P1|Overall Study|Blood clot after chemotherapy|0
6097211|NCT00293462|21040250|P3|Overall Study|Went back to his home country|1
6097212|NCT00293462|21040251|P2|Overall Study|Went back to his home country|0
6097213|NCT00293462|21040252|P1|Overall Study|Went back to his home country|0
6097214|NCT00293462|21040250|P3|Overall Study|No Show|1
6097215|NCT00293462|21040251|P2|Overall Study|No Show|0
6097216|NCT00293462|21040252|P1|Overall Study|No Show|0
6097217|NCT00293462|21040250|P3|Overall Study|Refuse Radiation Treatment|0
6097218|NCT00293462|21040251|P2|Overall Study|Refuse Radiation Treatment|0
6097219|NCT00293462|21040252|P1|Overall Study|Refuse Radiation Treatment|1
6097220|NCT00293462|21040250|P3|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0
6097221|NCT00293462|21040251|P2|Overall Study|Hypersensitive Reaction (to Salt & Soda)|1
6097222|NCT00293462|21040252|P1|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0
6097223|NCT00293462|21040250|P3|Overall Study|Change Treatment Regimen (ineligible)|0
6097224|NCT00293462|21040251|P2|Overall Study|Change Treatment Regimen (ineligible)|0
6097225|NCT00293462|21040252|P1|Overall Study|Change Treatment Regimen (ineligible)|1
6097226|NCT00293462|21040250|P3|Overall Study|Lost to Follow-up|0
6097227|NCT00293462|21040251|P2|Overall Study|Lost to Follow-up|1
6097228|NCT00293462|21040252|P1|Overall Study|Lost to Follow-up|0
6097229|NCT00293462|21040250|P3|Overall Study|Death|0
6097230|NCT00293462|21040251|P2|Overall Study|Death|0
6097231|NCT00293462|21040252|P1|Overall Study|Death|1
6097232|NCT00293462|21040250|P3|Overall Study|Withdrawal by Subject|6
6097233|NCT00293462|21040251|P2|Overall Study|Withdrawal by Subject|3
6097234|NCT00293462|21040252|P1|Overall Study|Withdrawal by Subject|4
6097235|NCT00293397|21040271|P1|Overall Study|Death|2
6097236|NCT00293384|21040281|P1|Overall Study|Ineligible|2
6097237|NCT00293384|21040281|P1|Overall Study|Missed dosage/study drug|1
6097238|NCT00293384|21040281|P1|Overall Study|Non-compliance|2
6097239|NCT00293293|21040290|P2|Overall Study|Patient discontinued chemotherapy|1
6097240|NCT00293293|21040291|P1|Overall Study|Patient discontinued chemotherapy|0
6097241|NCT00293293|21040290|P2|Overall Study|"Patient too anxious to complete trial"|0
6097242|NCT00293293|21040291|P1|Overall Study|"Patient too anxious to complete trial"|1
6097243|NCT00293293|21040290|P2|Overall Study|Withdrawal by Subject|1
6097244|NCT00293293|21040291|P1|Overall Study|Withdrawal by Subject|1
6097245|NCT00293267|21040319|P2|Open-Label Post Virologic Failure Phase|Other Reason|5
6097246|NCT00293267|21040320|P1|Open-Label Post Virologic Failure Phase|Other Reason|4
6097247|NCT00293267|21040319|P2|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|2
6097248|NCT00293267|21040320|P1|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|0
6097249|NCT00293267|21040319|P2|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|2
6097250|NCT00293267|21040320|P1|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|0
6097251|NCT00293267|21040319|P2|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2
6097252|NCT00293267|21040320|P1|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2
6097253|NCT00293267|21040319|P2|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|4
6097254|NCT00293267|21040320|P1|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|2
6097255|NCT00293267|21040319|P2|Open-Label Post Virologic Failure Phase|Lack of Efficacy|19
6097256|NCT00293267|21040320|P1|Open-Label Post Virologic Failure Phase|Lack of Efficacy|23
6097257|NCT00293267|21040319|P2|Open-Label Post Virologic Failure Phase|Adverse Event|3
6097258|NCT00293267|21040320|P1|Open-Label Post Virologic Failure Phase|Adverse Event|2
6097259|NCT00293267|21040319|P2|Extension - Open-Label Week 157-240|Other Reason|1
6097260|NCT00293267|21040320|P1|Extension - Open-Label Week 157-240|Other Reason|3
6097261|NCT00293267|21040319|P2|Extension - Open-Label Week 157-240|Participant relocated or site terminated|0
6097262|NCT00293267|21040320|P1|Extension - Open-Label Week 157-240|Participant relocated or site terminated|2
6097263|NCT00293267|21040319|P2|Extension - Open-Label Week 157-240|Withdrawal by Subject|1
6097264|NCT00293267|21040320|P1|Extension - Open-Label Week 157-240|Withdrawal by Subject|2
6097265|NCT00293267|21040319|P2|Extension - Open-Label Week 157-240|Lost to Follow-up|0
6097266|NCT00293267|21040320|P1|Extension - Open-Label Week 157-240|Lost to Follow-up|1
6097267|NCT00293267|21040319|P2|Extension - Open-Label Week 157-240|Lack of Efficacy|0
6097268|NCT00293267|21040320|P1|Extension - Open-Label Week 157-240|Lack of Efficacy|7
6097269|NCT00293267|21040319|P2|Extension - Open-Label Week 157-240|Adverse Event|0
6097270|NCT00293267|21040320|P1|Extension - Open-Label Week 157-240|Adverse Event|5
6097271|NCT00293267|21040319|P2|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|6
6097272|NCT00293267|21040320|P1|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15
6097273|NCT00293267|21040319|P2|Extension - Double-Blind Week 49-156|Other Reason|0
6097274|NCT00293267|21040320|P1|Extension - Double-Blind Week 49-156|Other Reason|7
6097275|NCT00293267|21040319|P2|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|0
6097276|NCT00293267|21040320|P1|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|2
6097277|NCT00293267|21040319|P2|Extension - Double-Blind Week 49-156|Death|0
6097278|NCT00293267|21040320|P1|Extension - Double-Blind Week 49-156|Death|3
6097279|NCT00293267|21040319|P2|Extension - Double-Blind Week 49-156|Withdrawal by Subject|4
6097280|NCT00293267|21040320|P1|Extension - Double-Blind Week 49-156|Withdrawal by Subject|13
6097281|NCT00293267|21040319|P2|Extension - Double-Blind Week 49-156|Lost to Follow-up|0
6097282|NCT00293267|21040320|P1|Extension - Double-Blind Week 49-156|Lost to Follow-up|4
6097283|NCT00293267|21040319|P2|Extension - Double-Blind Week 49-156|Lack of Efficacy|1
6097284|NCT00293267|21040320|P1|Extension - Double-Blind Week 49-156|Lack of Efficacy|7
6097285|NCT00293267|21040319|P2|Extension - Double-Blind Week 49-156|Adverse Event|4
6097286|NCT00293267|21040320|P1|Extension - Double-Blind Week 49-156|Adverse Event|1
6097287|NCT00293267|21040319|P2|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|60
6097288|NCT00293267|21040320|P1|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|33
6097289|NCT00293267|21040319|P2|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1
6097290|NCT00293267|21040320|P1|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1
6097291|NCT00293267|21040319|P2|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1
6097292|NCT00293267|21040320|P1|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1
6097293|NCT00293267|21040319|P2|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2
6097294|NCT00293267|21040320|P1|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|0
6097295|NCT00293267|21040319|P2|Primary Study - Double-Blind Week 0-48|Death|3
6097296|NCT00293267|21040320|P1|Primary Study - Double-Blind Week 0-48|Death|3
6097297|NCT00293267|21040319|P2|Primary Study - Double-Blind Week 0-48|Adverse Event|1
6097298|NCT00293267|21040320|P1|Primary Study - Double-Blind Week 0-48|Adverse Event|1
6097299|NCT00293267|21040319|P2|Primary Study - Double-Blind Week 0-48|Never Treated|0
6097300|NCT00293267|21040320|P1|Primary Study - Double-Blind Week 0-48|Never Treated|2
6097301|NCT00293254|21040360|P2|Open-Label Post Virologic Failure Phase|Other Reason|2
6097302|NCT00293254|21040361|P1|Open-Label Post Virologic Failure Phase|Other Reason|1
6097303|NCT00293254|21040360|P2|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1
6097304|NCT00293254|21040361|P1|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1
6097305|NCT00293254|21040360|P2|Open-Label Post Virologic Failure Phase|Lost to Follow-up|0
6097306|NCT00293254|21040361|P1|Open-Label Post Virologic Failure Phase|Lost to Follow-up|3
6097307|NCT00293254|21040360|P2|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|3
6097308|NCT00293254|21040361|P1|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|6
6097309|NCT00293254|21040360|P2|Open-Label Post Virologic Failure Phase|Lack of Efficacy|14
6097310|NCT00293254|21040361|P1|Open-Label Post Virologic Failure Phase|Lack of Efficacy|16
6097311|NCT00293254|21040360|P2|Open-Label Post Virologic Failure Phase|Adverse Event|7
6097312|NCT00293254|21040361|P1|Open-Label Post Virologic Failure Phase|Adverse Event|4
6097313|NCT00293254|21040360|P2|Extension - Open-Label Week 157-240|Other Reason|0
6097314|NCT00293254|21040361|P1|Extension - Open-Label Week 157-240|Other Reason|4
6097315|NCT00293254|21040360|P2|Extension - Open-Label Week 157-240|Lost to Follow-up|0
6097316|NCT00293254|21040361|P1|Extension - Open-Label Week 157-240|Lost to Follow-up|2
6097317|NCT00293254|21040360|P2|Extension - Open-Label Week 157-240|Withdrawal by Subject|0
6097318|NCT00293254|21040361|P1|Extension - Open-Label Week 157-240|Withdrawal by Subject|1
6097319|NCT00293254|21040360|P2|Extension - Open-Label Week 157-240|Lack of Efficacy|0
6097320|NCT00293254|21040361|P1|Extension - Open-Label Week 157-240|Lack of Efficacy|1
6097321|NCT00293254|21040360|P2|Extension - Open-Label Week 157-240|Adverse Event|1
6097322|NCT00293254|21040361|P1|Extension - Open-Label Week 157-240|Adverse Event|2
6097323|NCT00293254|21040360|P2|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|7
6097324|NCT00293254|21040361|P1|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15
6097325|NCT00293254|21040360|P2|Extension - Double-Blind Week 49-156|Other Reason|2
6097326|NCT00293254|21040361|P1|Extension - Double-Blind Week 49-156|Other Reason|10
6097327|NCT00293254|21040360|P2|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|3
6097328|NCT00293254|21040361|P1|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|6
6097329|NCT00293254|21040360|P2|Extension - Double-Blind Week 49-156|Withdrawal by Subject|8
6097330|NCT00293254|21040361|P1|Extension - Double-Blind Week 49-156|Withdrawal by Subject|12
6097331|NCT00293254|21040360|P2|Extension - Double-Blind Week 49-156|Lost to Follow-up|3
6097332|NCT00293254|21040361|P1|Extension - Double-Blind Week 49-156|Lost to Follow-up|3
6097333|NCT00293254|21040360|P2|Extension - Double-Blind Week 49-156|Lack of Efficacy|4
6097334|NCT00293254|21040361|P1|Extension - Double-Blind Week 49-156|Lack of Efficacy|3
6097335|NCT00293254|21040360|P2|Extension - Double-Blind Week 49-156|Death|1
6097336|NCT00293254|21040361|P1|Extension - Double-Blind Week 49-156|Death|4
6097337|NCT00293254|21040360|P2|Extension - Double-Blind Week 49-156|Adverse Event|1
6097338|NCT00293254|21040361|P1|Extension - Double-Blind Week 49-156|Adverse Event|4
6097339|NCT00293254|21040360|P2|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|57
6097340|NCT00293254|21040361|P1|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|35
6097341|NCT00293254|21040360|P2|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|0
6097342|NCT00293254|21040361|P1|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|1
6097343|NCT00293254|21040360|P2|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1
6097344|NCT00293254|21040361|P1|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|5
6097345|NCT00293254|21040360|P2|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1
6097346|NCT00293254|21040361|P1|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|3
6097347|NCT00293254|21040360|P2|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2
6097348|NCT00293254|21040361|P1|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2
6097349|NCT00293254|21040360|P2|Primary Study - Double-Blind Week 0-48|Death|2
6097350|NCT00293254|21040361|P1|Primary Study - Double-Blind Week 0-48|Death|5
6097351|NCT00293254|21040360|P2|Primary Study - Double-Blind Week 0-48|Adverse Event|1
6097352|NCT00293254|21040361|P1|Primary Study - Double-Blind Week 0-48|Adverse Event|2
6097353|NCT00293254|21040360|P2|Primary Study - Double-Blind Week 0-48|Never Treated|0
6097354|NCT00293254|21040361|P1|Primary Study - Double-Blind Week 0-48|Never Treated|2
6097355|NCT00293241|21040401|P2|Overall Study|Withdrawal by Subject|8
6097356|NCT00293241|21040402|P1|Overall Study|Withdrawal by Subject|4
6097357|NCT00293241|21040401|P2|Overall Study|Physician Decision|17
6097358|NCT00293241|21040402|P1|Overall Study|Physician Decision|23
6097359|NCT00293241|21040401|P2|Overall Study|Lost to Follow-up|16
6097360|NCT00293241|21040402|P1|Overall Study|Lost to Follow-up|9
6097361|NCT00293215|21040446|P2|Overall Study|Adverse Event|2
6097362|NCT00293215|21040447|P1|Overall Study|Adverse Event|2
6097363|NCT00293215|21040446|P2|Overall Study|Progressive disease|1
6097364|NCT00293215|21040447|P1|Overall Study|Progressive disease|3
6097365|NCT00293059|21040469|P2|Overall Study|missing|5
6097366|NCT00293059|21040470|P1|Overall Study|missing|3
6097367|NCT00293059|21040469|P2|Overall Study|Noncompliant - sanitary pads collection|1
6097368|NCT00293059|21040470|P1|Overall Study|Noncompliant - sanitary pads collection|0
6097369|NCT00293059|21040469|P2|Overall Study|Participant stopped study drug|0
6097370|NCT00293059|21040470|P1|Overall Study|Participant stopped study drug|1
6097371|NCT00293059|21040469|P2|Overall Study|Participant moved out of state|0
6097372|NCT00293059|21040470|P1|Overall Study|Participant moved out of state|1
6097373|NCT00293059|21040469|P2|Overall Study|Withdrawal by Subject|5
6097374|NCT00293059|21040470|P1|Overall Study|Withdrawal by Subject|11
6097375|NCT00293059|21040469|P2|Overall Study|Protocol Violation|0
6097376|NCT00293059|21040470|P1|Overall Study|Protocol Violation|2
6097377|NCT00293059|21040469|P2|Overall Study|Pregnancy|1
6097378|NCT00293059|21040470|P1|Overall Study|Pregnancy|1
6097379|NCT00293059|21040469|P2|Overall Study|Lost to Follow-up|3
6097380|NCT00293059|21040470|P1|Overall Study|Lost to Follow-up|2
6097381|NCT00293059|21040469|P2|Overall Study|Lack of Efficacy|0
6097382|NCT00293059|21040470|P1|Overall Study|Lack of Efficacy|2
6097383|NCT00293059|21040469|P2|Overall Study|Adverse Event|4
6097384|NCT00293059|21040470|P1|Overall Study|Adverse Event|12
6097385|NCT00293033|21040582|P1|Double-blind Treatment Period|Noncompliance|4
6097386|NCT00293033|21040582|P1|Double-blind Treatment Period|Withdrawal by Subject|4
6097387|NCT00293033|21040582|P1|Double-blind Treatment Period|Lack of Efficacy|1
6097388|NCT00293033|21040582|P1|Double-blind Treatment Period|Adverse Event|3
6097389|NCT00293033|21040582|P1|Open-label Titration Period|Noncompliance and other|27
6097390|NCT00293033|21040582|P1|Open-label Titration Period|Withdrawal by Subject|22
6097391|NCT00293033|21040582|P1|Open-label Titration Period|Protocol Violation|2
6097392|NCT00293033|21040582|P1|Open-label Titration Period|Lack of Efficacy|5
6097393|NCT00293033|21040582|P1|Open-label Titration Period|Death|3
6097394|NCT00293033|21040582|P1|Open-label Titration Period|Adverse Event|10
6097395|NCT00293020|21040685|P1|Overall Study|No dose taken|1
6097396|NCT00293020|21040685|P1|Overall Study|Other Reason|22
6097397|NCT00293020|21040685|P1|Overall Study|Physician Decision|21
6097398|NCT00293020|21040685|P1|Overall Study|Protocol Violation|6
6097399|NCT00293020|21040685|P1|Overall Study|Lost to Follow-up|4
6097400|NCT00293020|21040685|P1|Overall Study|Lack of Efficacy|12
6097401|NCT00293020|21040685|P1|Overall Study|Death|32
6097402|NCT00293020|21040685|P1|Overall Study|Adverse Event|30
6097403|NCT00293020|21040685|P1|Overall Study|Withdrawal by Subject|34
6097404|NCT00292981|21040689|P1|Overall Study|Other|3
6097405|NCT00292981|21040689|P1|Overall Study|Withdrawal by Subject|22
6097406|NCT00292981|21040689|P1|Overall Study|Lost to Follow-up|13
6097407|NCT00292981|21040689|P1|Overall Study|Adverse Event|1
6097408|NCT00292942|21040700|P4|Overall Study|Adverse Event|1
6097409|NCT00292942|21040701|P3|Overall Study|Adverse Event|0
6097410|NCT00292942|21040702|P2|Overall Study|Adverse Event|0
6097411|NCT00292942|21040703|P1|Overall Study|Adverse Event|0
6097412|NCT00292942|21040700|P4|Overall Study|Withdrawal by Subject|0
6097413|NCT00292942|21040701|P3|Overall Study|Withdrawal by Subject|1
6097414|NCT00292942|21040702|P2|Overall Study|Withdrawal by Subject|0
6097415|NCT00292942|21040703|P1|Overall Study|Withdrawal by Subject|0
6097416|NCT00292461|21040749|P2|Overall Study|Lost to Follow-up|0
6097417|NCT00292461|21040750|P1|Overall Study|Lost to Follow-up|1
6097418|NCT00292461|21040749|P2|Overall Study|Protocol Violation|3
6097419|NCT00292461|21040750|P1|Overall Study|Protocol Violation|4
6097420|NCT00292461|21040749|P2|Overall Study|Withdrawal by Subject|1
6097421|NCT00292461|21040750|P1|Overall Study|Withdrawal by Subject|0
6097422|NCT00292461|21040749|P2|Overall Study|Lack of Efficacy|0
6097423|NCT00292461|21040750|P1|Overall Study|Lack of Efficacy|1
6097424|NCT00292461|21040749|P2|Overall Study|Adverse Event|2
6097425|NCT00292461|21040750|P1|Overall Study|Adverse Event|4
6097426|NCT00292370|21040765|P3|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|5
6097427|NCT00292370|21040766|P2|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|1
6097428|NCT00292370|21040767|P1|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|0
6097429|NCT00292370|21040765|P3|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|2
6097430|NCT00292370|21040766|P2|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|3
6097431|NCT00292370|21040767|P1|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|0
6097432|NCT00292370|21040765|P3|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0
6097433|NCT00292370|21040766|P2|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0
6097434|NCT00292370|21040767|P1|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|4
6097435|NCT00292370|21040765|P3|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0
6097436|NCT00292370|21040766|P2|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0
6097437|NCT00292370|21040767|P1|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|8
6097438|NCT00292370|21040765|P3|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0
6097439|NCT00292370|21040766|P2|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0
6097440|NCT00292370|21040767|P1|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|22
6097441|NCT00292370|21040765|P3|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0
6097442|NCT00292370|21040766|P2|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0
6097443|NCT00292370|21040767|P1|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|12
6097444|NCT00292318|21040792|P2|Overall Study|Study terminated by officials|1
6097445|NCT00292318|21040793|P1|Overall Study|Study terminated by officials|2
6097446|NCT00292227|21040803|P3|Patch Period|Withdrawal by Subject|1
6097447|NCT00292227|21040804|P2|Patch Period|Withdrawal by Subject|0
6097448|NCT00292227|21040805|P1|Patch Period|Withdrawal by Subject|0
6097449|NCT00292227|21040803|P3|Patch Period|Adverse Event|2
6097450|NCT00292227|21040804|P2|Patch Period|Adverse Event|0
6097451|NCT00292227|21040805|P1|Patch Period|Adverse Event|1
6097491|NCT00292045|21040967|P1|Core Study (Through Week 13)|Withdrawal by Subject|1
6097492|NCT00292045|21040967|P1|Core Study (Through Week 13)|Adverse Event|1
6097493|NCT00291668|21041006|P3|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0
6097494|NCT00291668|21041007|P2|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0
6097495|NCT00291668|21041008|P1|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
6097496|NCT00291668|21041006|P3|Overall Study|AE, non-serious non-fatal|0
6097497|NCT00291668|21041007|P2|Overall Study|AE, non-serious non-fatal|0
6097498|NCT00291668|21041008|P1|Overall Study|AE, non-serious non-fatal|1
6097499|NCT00291668|21041006|P3|Overall Study|SAE, non-fatal|1
6097500|NCT00291668|21041007|P2|Overall Study|SAE, non-fatal|1
6097501|NCT00291668|21041008|P1|Overall Study|SAE, non-fatal|1
6097502|NCT00291668|21041006|P3|Overall Study|Lack of Efficacy|0
6097503|NCT00291668|21041007|P2|Overall Study|Lack of Efficacy|0
6097504|NCT00291668|21041008|P1|Overall Study|Lack of Efficacy|1
6097505|NCT00291642|21041104|P5|Overall Study|Intake of prohibited medication|0
6097506|NCT00291642|21041105|P4|Overall Study|Intake of prohibited medication|0
6097507|NCT00291642|21041106|P3|Overall Study|Intake of prohibited medication|0
6097508|NCT00291642|21041107|P2|Overall Study|Intake of prohibited medication|0
6097509|NCT00291642|21041108|P1|Overall Study|Intake of prohibited medication|1
6097510|NCT00291642|21041104|P5|Overall Study|Patient missed visit|0
6097511|NCT00291642|21041105|P4|Overall Study|Patient missed visit|0
6097512|NCT00291642|21041106|P3|Overall Study|Patient missed visit|1
6097513|NCT00291642|21041107|P2|Overall Study|Patient missed visit|0
6097514|NCT00291642|21041108|P1|Overall Study|Patient missed visit|0
6097515|NCT00291642|21041104|P5|Overall Study|Adverse Event|1
6097516|NCT00291642|21041105|P4|Overall Study|Adverse Event|0
6097517|NCT00291642|21041106|P3|Overall Study|Adverse Event|1
6097518|NCT00291642|21041107|P2|Overall Study|Adverse Event|0
6097519|NCT00291642|21041108|P1|Overall Study|Adverse Event|1
6097520|NCT00291577|21041160|P1|Overall Study|Lack of Efficacy|14
6097521|NCT00291577|21041160|P1|Overall Study|Withdrawal by Subject|2
6097522|NCT00291577|21041160|P1|Overall Study|Other|4
6097523|NCT00291577|21041160|P1|Overall Study|Adverse Event|1
6097524|NCT00291551|21041179|P1|Overall Study|Withdrawal by Subject|6
6097525|NCT00291551|21041179|P1|Overall Study|Death|7
6097526|NCT00291330|21041227|P2|Overall Study|Other|1
6097527|NCT00291330|21041228|P1|Overall Study|Other|3
6097528|NCT00291330|21041227|P2|Overall Study|Withdrawal by Subject|25
6097529|NCT00291330|21041228|P1|Overall Study|Withdrawal by Subject|22
6097530|NCT00291330|21041227|P2|Overall Study|Lost to Follow-up|11
6097531|NCT00291330|21041228|P1|Overall Study|Lost to Follow-up|16
6097532|NCT00291330|21041227|P2|Overall Study|Protocol Violation|20
6097533|NCT00291330|21041228|P1|Overall Study|Protocol Violation|13
6097534|NCT00291330|21041227|P2|Overall Study|Adverse Event|40
6097535|NCT00291330|21041228|P1|Overall Study|Adverse Event|47
6097536|NCT00291187|21041270|P4|Overall Study|Protocol Violation- No Drug Administered|0
6097537|NCT00291187|21041271|P3|Overall Study|Protocol Violation- No Drug Administered|1
6097538|NCT00291187|21041272|P2|Overall Study|Protocol Violation- No Drug Administered|0
6097539|NCT00291187|21041273|P1|Overall Study|Protocol Violation- No Drug Administered|0
6097540|NCT00291018|21041317|P3|Overall Study|Lost to Follow-up|18
6097541|NCT00291018|21041318|P2|Overall Study|Lost to Follow-up|4
6097542|NCT00291018|21041319|P1|Overall Study|Lost to Follow-up|3
6097543|NCT00291018|21041317|P3|Overall Study|Failures|5
6097544|NCT00291018|21041318|P2|Overall Study|Failures|12
6097545|NCT00291018|21041319|P1|Overall Study|Failures|5
6097546|NCT00291018|21041317|P3|Overall Study|Withdrawal by Subject|1
6097547|NCT00291018|21041318|P2|Overall Study|Withdrawal by Subject|8
6097548|NCT00291018|21041319|P1|Overall Study|Withdrawal by Subject|2
6097549|NCT00291018|21041317|P3|Overall Study|Death|4
6097550|NCT00291018|21041318|P2|Overall Study|Death|3
6097551|NCT00291018|21041319|P1|Overall Study|Death|3
6097552|NCT00291018|21041317|P3|Overall Study|Not Consented or Declined PAS|15
6097553|NCT00291018|21041318|P2|Overall Study|Not Consented or Declined PAS|15
6097554|NCT00291018|21041319|P1|Overall Study|Not Consented or Declined PAS|12
6097555|NCT00290888|21041359|P2|Overall Study|Physician Decision|1
6097556|NCT00290888|21041360|P1|Overall Study|Physician Decision|3
6097557|NCT00290771|21041377|P2|Overall Study|Lost to Follow-up|1
6097558|NCT00290771|21041378|P1|Overall Study|Lost to Follow-up|0
6097559|NCT00290771|21041377|P2|Overall Study|Protocol Violation|0
6097560|NCT00290771|21041378|P1|Overall Study|Protocol Violation|2
6097561|NCT00290771|21041377|P2|Overall Study|Administrative problems|1
6097562|NCT00290771|21041378|P1|Overall Study|Administrative problems|2
6097563|NCT00290771|21041377|P2|Overall Study|Withdrawal by Subject|6
6097564|NCT00290771|21041378|P1|Overall Study|Withdrawal by Subject|5
6097565|NCT00290771|21041377|P2|Overall Study|Adverse Event|6
6097566|NCT00290771|21041378|P1|Overall Study|Adverse Event|12
6097567|NCT00290771|21041377|P2|Overall Study|Death|10
6097568|NCT00290771|21041378|P1|Overall Study|Death|11
6097569|NCT00290771|21041377|P2|Overall Study|Disease progression|73
6097570|NCT00290771|21041378|P1|Overall Study|Disease progression|95
6097571|NCT00290758|21041402|P2|Post Intervention rFNA|<4000 Epithelial Cells|5
6097572|NCT00290758|21041403|P1|Post Intervention rFNA|<4000 Epithelial Cells|6
6097573|NCT00290758|21041402|P2|Pre-Intervention rFNA Through Follow-Up|Non Compliant|1
6097574|NCT00290758|21041403|P1|Pre-Intervention rFNA Through Follow-Up|Non Compliant|0
6097575|NCT00290758|21041402|P2|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|0
6097576|NCT00290758|21041403|P1|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|1
6097577|NCT00290758|21041402|P2|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|5
6097578|NCT00290758|21041403|P1|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|0
6097579|NCT00290758|21041402|P2|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1
6097580|NCT00290758|21041403|P1|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1
6097581|NCT00290758|21041402|P2|Pre-Intervention rFNA Through Follow-Up|Physician Decision|1
6097582|NCT00290758|21041403|P1|Pre-Intervention rFNA Through Follow-Up|Physician Decision|3
6097583|NCT00290758|21041402|P2|Pre-Intervention rFNA Through Follow-Up|ConMeds|0
6097584|NCT00290758|21041403|P1|Pre-Intervention rFNA Through Follow-Up|ConMeds|1
6097585|NCT00290758|21041402|P2|Pre-Intervention rFNA Through Follow-Up|Adverse Event|2
6097586|NCT00290758|21041403|P1|Pre-Intervention rFNA Through Follow-Up|Adverse Event|1
6097587|NCT00290745|21041423|P1|Overall Study|Baseline MRI not available|3
6097588|NCT00290745|21041423|P1|Overall Study|Surgery after 3 months for progression|3
6097589|NCT00290745|21041423|P1|Overall Study|Physician Decision|2
6097590|NCT00290745|21041423|P1|Overall Study|Withdrawal by Subject|4
6097591|NCT00290732|21041437|P5|Overall Study|Inability to instill drug intraductally.|0
6097592|NCT00290732|21041438|P4|Overall Study|Inability to instill drug intraductally.|0
6097593|NCT00290732|21041439|P3|Overall Study|Inability to instill drug intraductally.|1
6097594|NCT00290732|21041440|P2|Overall Study|Inability to instill drug intraductally.|1
6097595|NCT00290732|21041441|P1|Overall Study|Inability to instill drug intraductally.|0
6097596|NCT00290706|21041463|P4|Overall Study|Physician Decision|1
6097597|NCT00290706|21041464|P3|Overall Study|Physician Decision|0
6097598|NCT00290706|21041465|P2|Overall Study|Physician Decision|0
6097599|NCT00290706|21041466|P1|Overall Study|Physician Decision|0
6097600|NCT00290706|21041463|P4|Overall Study|Receive auto transplant or radiation|1
6097601|NCT00290706|21041464|P3|Overall Study|Receive auto transplant or radiation|0
6097602|NCT00290706|21041465|P2|Overall Study|Receive auto transplant or radiation|0
6097603|NCT00290706|21041466|P1|Overall Study|Receive auto transplant or radiation|0
6097604|NCT00290706|21041463|P4|Overall Study|Adverse Event|0
6097605|NCT00290706|21041464|P3|Overall Study|Adverse Event|2
6097606|NCT00290706|21041465|P2|Overall Study|Adverse Event|1
6097607|NCT00290706|21041466|P1|Overall Study|Adverse Event|0
6097608|NCT00290706|21041463|P4|Overall Study|Progressive Disease|10
6097609|NCT00290706|21041464|P3|Overall Study|Progressive Disease|4
6097610|NCT00290706|21041465|P2|Overall Study|Progressive Disease|5
6097611|NCT00290706|21041466|P1|Overall Study|Progressive Disease|3
6097612|NCT00290706|21041463|P4|Overall Study|Withdrawal by Subject|0
6097613|NCT00290706|21041464|P3|Overall Study|Withdrawal by Subject|0
6097614|NCT00290706|21041465|P2|Overall Study|Withdrawal by Subject|0
6097615|NCT00290706|21041466|P1|Overall Study|Withdrawal by Subject|2
6097616|NCT00290693|21041485|P1|Overall Study|Withdrawal by Subject|2
6097617|NCT00290589|21041513|P2|Overall Study|Lost to Follow-up|2
6097618|NCT00290589|21041514|P1|Overall Study|Lost to Follow-up|2
6097619|NCT00290498|21041532|P2|Overall Study|Non-Compliance|0
6097620|NCT00290498|21041533|P1|Overall Study|Non-Compliance|1
6097621|NCT00290498|21041532|P2|Overall Study|Ineligible|0
6097622|NCT00290498|21041533|P1|Overall Study|Ineligible|3
6097623|NCT00290498|21041532|P2|Overall Study|Withdrawal by Subject|0
6097624|NCT00290498|21041533|P1|Overall Study|Withdrawal by Subject|1
6097625|NCT00290498|21041532|P2|Overall Study|Physician Decision|0
6097626|NCT00290498|21041533|P1|Overall Study|Physician Decision|1
6097627|NCT00290498|21041532|P2|Overall Study|Death|0
6097628|NCT00290498|21041533|P1|Overall Study|Death|2
6097629|NCT00290433|21041558|P1|Overall Study|Unrelated Infection/Death|1
6097630|NCT00290433|21041558|P1|Overall Study|Transplant in CR|5
6097631|NCT00290433|21041558|P1|Overall Study|Congestive Heart Failure|1
6097632|NCT00290433|21041558|P1|Overall Study|Non-Compliance|1
6097633|NCT00290433|21041558|P1|Overall Study|Withdrawal by Subject|1
6097634|NCT00290433|21041558|P1|Overall Study|Adverse Event|14
6097635|NCT00290433|21041558|P1|Overall Study|Disease Progression|13
6097636|NCT00290407|21041562|P1|Overall Study|Physician Decision|2
6097637|NCT00290355|21041569|P2|Overall Study|Other|0
6097638|NCT00290355|21041570|P1|Overall Study|Other|2
6097639|NCT00290355|21041569|P2|Overall Study|Lost to Follow-up|1
6097640|NCT00290355|21041570|P1|Overall Study|Lost to Follow-up|3
6097641|NCT00290355|21041569|P2|Overall Study|Migrated / moved from the study area|0
6097642|NCT00290355|21041570|P1|Overall Study|Migrated / moved from the study area|1
6097643|NCT00290355|21041569|P2|Overall Study|Withdrawal by Subject|0
6097644|NCT00290355|21041570|P1|Overall Study|Withdrawal by Subject|2
6097645|NCT00290355|21041569|P2|Overall Study|Protocol Violation|0
6097646|NCT00290355|21041570|P1|Overall Study|Protocol Violation|1
6097647|NCT00290355|21041569|P2|Overall Study|Study product reactogenicity|0
6097648|NCT00290355|21041570|P1|Overall Study|Study product reactogenicity|1
6097649|NCT00290355|21041569|P2|Overall Study|Serious adverse event|4
6097650|NCT00290355|21041570|P1|Overall Study|Serious adverse event|7
6097651|NCT00290342|21041614|P2|Overall Study|Lost to Follow-up|0
6097652|NCT00290342|21041615|P1|Overall Study|Lost to Follow-up|1
6097653|NCT00290342|21041614|P2|Overall Study|Withdrawal by Subject|4
6097654|NCT00290342|21041615|P1|Overall Study|Withdrawal by Subject|6
6097655|NCT00290342|21041614|P2|Overall Study|Other|1
6097656|NCT00290342|21041615|P1|Overall Study|Other|0
6097657|NCT00290290|21041670|P2|Overall Study|Underwent clean surgical procedure|12
6097658|NCT00290290|21041671|P1|Overall Study|Underwent clean surgical procedure|13
6097659|NCT00290290|21041670|P2|Overall Study|Withdrawal by Subject|2
6097660|NCT00290290|21041671|P1|Overall Study|Withdrawal by Subject|2
6097661|NCT00290290|21041670|P2|Overall Study|Death|4
6097662|NCT00290290|21041671|P1|Overall Study|Death|3
6097663|NCT00290251|21041677|P3|Treatment 2 (Months 4 - 6)|Lost to Follow-up|0
6097664|NCT00290251|21041678|P2|Treatment 2 (Months 4 - 6)|Lost to Follow-up|0
6097665|NCT00290251|21041679|P1|Treatment 2 (Months 4 - 6)|Lost to Follow-up|2
6097666|NCT00290251|21041677|P3|Treatment 1 (Months 1 - 3)|Out of body experience|0
6097667|NCT00290251|21041678|P2|Treatment 1 (Months 1 - 3)|Out of body experience|0
6097668|NCT00290251|21041679|P1|Treatment 1 (Months 1 - 3)|Out of body experience|1
6097669|NCT00290251|21041677|P3|Treatment 1 (Months 1 - 3)|headache|0
6097670|NCT00290251|21041678|P2|Treatment 1 (Months 1 - 3)|headache|1
6097671|NCT00290251|21041679|P1|Treatment 1 (Months 1 - 3)|headache|0
6097672|NCT00290251|21041677|P3|Treatment 1 (Months 1 - 3)|Withdrawal by Subject|2
6097673|NCT00290251|21041678|P2|Treatment 1 (Months 1 - 3)|Withdrawal by Subject|0
6097674|NCT00290251|21041679|P1|Treatment 1 (Months 1 - 3)|Withdrawal by Subject|0
6097675|NCT00290238|21041691|P2|Overall Study|Withdrawal by Subject|13
6097676|NCT00290238|21041692|P1|Overall Study|Withdrawal by Subject|15
6097677|NCT00290238|21041691|P2|Overall Study|Lost to Follow-up|1
6097678|NCT00290238|21041692|P1|Overall Study|Lost to Follow-up|0
6097679|NCT00290238|21041691|P2|Overall Study|Study terminated|27
6097680|NCT00290238|21041692|P1|Overall Study|Study terminated|27
6097681|NCT00290186|21041717|P2|Overall Study|Withdrawal by Subject|1
6097682|NCT00290186|21041718|P1|Overall Study|Withdrawal by Subject|0
6097683|NCT00290186|21041717|P2|Overall Study|Study was terminated prior to 3-month te|1
6097684|NCT00290186|21041718|P1|Overall Study|Study was terminated prior to 3-month te|1
6097685|NCT00290186|21041717|P2|Overall Study|Lost to Follow-up|2
6097686|NCT00290186|21041718|P1|Overall Study|Lost to Follow-up|3
6097687|NCT00290186|21041717|P2|Overall Study|Adverse Event|1
6097688|NCT00290186|21041718|P1|Overall Study|Adverse Event|1
6097689|NCT00289991|21041769|P2|Overall Study|Other|14
6097690|NCT00289991|21041770|P1|Overall Study|Other|5
6097691|NCT00289991|21041769|P2|Overall Study|Withdrawal by Subject|12
6097692|NCT00289991|21041770|P1|Overall Study|Withdrawal by Subject|2
6097693|NCT00289991|21041769|P2|Overall Study|Lost to Follow-up|1
6097694|NCT00289991|21041770|P1|Overall Study|Lost to Follow-up|0
6097695|NCT00289991|21041769|P2|Overall Study|Fungal breakthrough infection|1
6097696|NCT00289991|21041770|P1|Overall Study|Fungal breakthrough infection|0
6097697|NCT00289991|21041769|P2|Overall Study|Failure of prophylaxis|1
6097698|NCT00289991|21041770|P1|Overall Study|Failure of prophylaxis|1
6097699|NCT00289991|21041769|P2|Overall Study|Adverse Event|13
6097700|NCT00289991|21041770|P1|Overall Study|Adverse Event|15
6097701|NCT00289991|21041769|P2|Overall Study|Death|38
6097702|NCT00289991|21041770|P1|Overall Study|Death|35
6097703|NCT00289978|21041795|P3|Overall Study|Death|2
6097704|NCT00289978|21041796|P2|Overall Study|Death|0
6097705|NCT00289978|21041797|P1|Overall Study|Death|1
6097706|NCT00289978|21041795|P3|Overall Study|Abnormal test procedure result(s)|1
6097707|NCT00289978|21041796|P2|Overall Study|Abnormal test procedure result(s)|1
6097708|NCT00289978|21041797|P1|Overall Study|Abnormal test procedure result(s)|2
6097709|NCT00289978|21041795|P3|Overall Study|Protocol Violation|4
6097710|NCT00289978|21041796|P2|Overall Study|Protocol Violation|5
6097711|NCT00289978|21041797|P1|Overall Study|Protocol Violation|5
6097712|NCT00289978|21041795|P3|Overall Study|Lost to Follow-up|7
6097713|NCT00289978|21041796|P2|Overall Study|Lost to Follow-up|5
6097714|NCT00289978|21041797|P1|Overall Study|Lost to Follow-up|3
6097715|NCT00289978|21041795|P3|Overall Study|Abnormal laboratory value(s)|1
6097716|NCT00289978|21041796|P2|Overall Study|Abnormal laboratory value(s)|9
6097717|NCT00289978|21041797|P1|Overall Study|Abnormal laboratory value(s)|20
6097718|NCT00289978|21041795|P3|Overall Study|Lack of Efficacy|25
6097719|NCT00289978|21041796|P2|Overall Study|Lack of Efficacy|6
6097720|NCT00289978|21041797|P1|Overall Study|Lack of Efficacy|13
6097721|NCT00289978|21041795|P3|Overall Study|Adverse Event|18
6097722|NCT00289978|21041796|P2|Overall Study|Adverse Event|13
6097723|NCT00289978|21041797|P1|Overall Study|Adverse Event|22
6097724|NCT00289978|21041795|P3|Overall Study|Withdrawal by Subject|28
6097725|NCT00289978|21041796|P2|Overall Study|Withdrawal by Subject|17
6097726|NCT00289978|21041797|P1|Overall Study|Withdrawal by Subject|31
6097727|NCT00289913|21041816|P5|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0
6097728|NCT00289913|21041817|P4|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0
6097729|NCT00289913|21041818|P3|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0
6097730|NCT00289913|21041819|P2|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|1
6097731|NCT00289913|21041820|P1|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0
6097732|NCT00289913|21041816|P5|Visit 3 (Stage I and Stage II)|Moved after safety F/U|1
6097733|NCT00289913|21041817|P4|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0
6097734|NCT00289913|21041818|P3|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0
6097735|NCT00289913|21041819|P2|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0
6097736|NCT00289913|21041820|P1|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0
6097737|NCT00289913|21041816|P5|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0
6097738|NCT00289913|21041817|P4|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0
6097739|NCT00289913|21041818|P3|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1
6097740|NCT00289913|21041819|P2|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1
6097741|NCT00289913|21041820|P1|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0
6097742|NCT00289913|21041816|P5|Visit 3 (Stage I and Stage II)|Lost after safety F/U|4
6097743|NCT00289913|21041817|P4|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1
6097744|NCT00289913|21041818|P3|Visit 3 (Stage I and Stage II)|Lost after safety F/U|0
6097745|NCT00289913|21041819|P2|Visit 3 (Stage I and Stage II)|Lost after safety F/U|2
6097746|NCT00289913|21041820|P1|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1
6097747|NCT00289913|21041816|P5|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|1
6097748|NCT00289913|21041817|P4|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0
6097749|NCT00289913|21041818|P3|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0
6097750|NCT00289913|21041819|P2|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0
6097751|NCT00289913|21041820|P1|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0
6097752|NCT00289913|21041816|P5|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0
6097753|NCT00289913|21041817|P4|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|1
6097754|NCT00289913|21041818|P3|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0
6097755|NCT00289913|21041819|P2|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0
6097756|NCT00289913|21041820|P1|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0
6097757|NCT00289913|21041816|P5|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2
6097758|NCT00289913|21041817|P4|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2
6097759|NCT00289913|21041818|P3|Visit 3 (Stage I and Stage II)|Lost during safety F/U|1
6097760|NCT00289913|21041819|P2|Visit 3 (Stage I and Stage II)|Lost during safety F/U|3
6097761|NCT00289913|21041820|P1|Visit 3 (Stage I and Stage II)|Lost during safety F/U|8
6097762|NCT00289913|21041816|P5|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0
6097763|NCT00289913|21041817|P4|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0
6097764|NCT00289913|21041818|P3|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0
6097765|NCT00289913|21041819|P2|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|1
6097766|NCT00289913|21041820|P1|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0
6097767|NCT00289913|21041816|P5|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|9
6097768|NCT00289913|21041817|P4|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0
6097769|NCT00289913|21041818|P3|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0
6097770|NCT00289913|21041819|P2|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0
6097771|NCT00289913|21041820|P1|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0
6097772|NCT00289913|21041816|P5|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|7
6097773|NCT00289913|21041817|P4|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0
6097774|NCT00289913|21041818|P3|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0
6097775|NCT00289913|21041819|P2|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0
6097776|NCT00289913|21041820|P1|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0
6097777|NCT00289913|21041816|P5|Visit 2 (Stage I and Stage II)|Moved (Stage II)|6
6097778|NCT00289913|21041817|P4|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0
6097779|NCT00289913|21041818|P3|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0
6097780|NCT00289913|21041819|P2|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0
6097781|NCT00289913|21041820|P1|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0
6097782|NCT00289913|21041816|P5|Visit 2 (Stage I and Stage II)|Lost (Stage II)|11
6097783|NCT00289913|21041817|P4|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0
6097784|NCT00289913|21041818|P3|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0
6097785|NCT00289913|21041819|P2|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0
6097786|NCT00289913|21041820|P1|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0
6097787|NCT00289913|21041816|P5|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|7
6097788|NCT00289913|21041817|P4|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0
6097789|NCT00289913|21041818|P3|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0
6097790|NCT00289913|21041819|P2|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0
6097791|NCT00289913|21041820|P1|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0
6097792|NCT00289913|21041816|P5|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0
6097793|NCT00289913|21041817|P4|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0
6097794|NCT00289913|21041818|P3|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0
6097795|NCT00289913|21041819|P2|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0
6097796|NCT00289913|21041820|P1|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|1
6097797|NCT00289913|21041816|P5|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0
6097798|NCT00289913|21041817|P4|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0
6097799|NCT00289913|21041818|P3|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|2
6097800|NCT00289913|21041819|P2|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|1
6097801|NCT00289913|21041820|P1|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0
6097802|NCT00289913|21041816|P5|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0
6097803|NCT00289913|21041817|P4|Visit 2 (Stage I and Stage II)|Lost after safety F/U|3
6097804|NCT00289913|21041818|P3|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0
6097805|NCT00289913|21041819|P2|Visit 2 (Stage I and Stage II)|Lost after safety F/U|5
6097806|NCT00289913|21041820|P1|Visit 2 (Stage I and Stage II)|Lost after safety F/U|2
6097807|NCT00289913|21041816|P5|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0
6097808|NCT00289913|21041817|P4|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1
6097809|NCT00289913|21041818|P3|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|3
6097810|NCT00289913|21041819|P2|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1
6097811|NCT00289913|21041820|P1|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0
6097812|NCT00289913|21041816|P5|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0
6097813|NCT00289913|21041817|P4|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0
6097814|NCT00289913|21041818|P3|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1
6097815|NCT00289913|21041819|P2|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0
6097816|NCT00289913|21041820|P1|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1
6097817|NCT00289913|21041816|P5|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0
6097818|NCT00289913|21041817|P4|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0
6097819|NCT00289913|21041818|P3|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|1
6097820|NCT00289913|21041819|P2|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|2
6097821|NCT00289913|21041820|P1|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|3
6097822|NCT00289913|21041816|P5|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0
6097823|NCT00289913|21041817|P4|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0
6097824|NCT00289913|21041818|P3|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0
6097825|NCT00289913|21041819|P2|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|1
6097826|NCT00289913|21041820|P1|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0
6097827|NCT00289913|21041816|P5|Visit 2 (Stage I and Stage II)|Lost during safety F/U|0
6097828|NCT00289913|21041817|P4|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2
6097829|NCT00289913|21041818|P3|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2
6097830|NCT00289913|21041819|P2|Visit 2 (Stage I and Stage II)|Lost during safety F/U|11
6097831|NCT00289913|21041820|P1|Visit 2 (Stage I and Stage II)|Lost during safety F/U|8
6097832|NCT00289913|21041816|P5|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0
6097833|NCT00289913|21041817|P4|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0
6097834|NCT00289913|21041818|P3|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|1
6097835|NCT00289913|21041819|P2|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0
6097836|NCT00289913|21041820|P1|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0
6097837|NCT00289913|21041816|P5|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0
6097838|NCT00289913|21041817|P4|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0
6097839|NCT00289913|21041818|P3|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|2
6097840|NCT00289913|21041819|P2|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0
6097841|NCT00289913|21041820|P1|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|1
6097842|NCT00289913|21041816|P5|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0
6097843|NCT00289913|21041817|P4|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|6
6097844|NCT00289913|21041818|P3|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|5
6097845|NCT00289913|21041819|P2|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|8
6097846|NCT00289913|21041820|P1|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0
6097847|NCT00289913|21041816|P5|Visit 1 (Stage I and Stage II)|Lost after safety F/U|5
6097848|NCT00289913|21041817|P4|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0
6097849|NCT00289913|21041818|P3|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0
6097850|NCT00289913|21041819|P2|Visit 1 (Stage I and Stage II)|Lost after safety F/U|1
6097851|NCT00289913|21041820|P1|Visit 1 (Stage I and Stage II)|Lost after safety F/U|2
6097852|NCT00289913|21041816|P5|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0
6097853|NCT00289913|21041817|P4|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0
6097854|NCT00289913|21041818|P3|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0
6097855|NCT00289913|21041819|P2|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|2
6097856|NCT00289913|21041820|P1|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|1
6097857|NCT00289913|21041816|P5|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0
6097858|NCT00289913|21041817|P4|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|1
6097859|NCT00289913|21041818|P3|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0
6097860|NCT00289913|21041819|P2|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0
6097861|NCT00289913|21041820|P1|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0
6097862|NCT00289913|21041816|P5|Visit 1 (Stage I and Stage II)|Moved during safety F/U|1
6097863|NCT00289913|21041817|P4|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0
6097864|NCT00289913|21041818|P3|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0
6097865|NCT00289913|21041819|P2|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0
6097866|NCT00289913|21041820|P1|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0
6097867|NCT00289913|21041816|P5|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2
6097868|NCT00289913|21041817|P4|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2
6097869|NCT00289913|21041818|P3|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|0
6097870|NCT00289913|21041819|P2|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2
6097871|NCT00289913|21041820|P1|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2
6097872|NCT00289913|21041816|P5|Visit 1 (Stage I and Stage II)|Lost during safety F/U|1
6097873|NCT00289913|21041817|P4|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2
6097874|NCT00289913|21041818|P3|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2
6097875|NCT00289913|21041819|P2|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2
6097876|NCT00289913|21041820|P1|Visit 1 (Stage I and Stage II)|Lost during safety F/U|3
6097877|NCT00289913|21041816|P5|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0
6097878|NCT00289913|21041817|P4|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0
6097879|NCT00289913|21041818|P3|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0
6097880|NCT00289913|21041819|P2|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|1
6097881|NCT00289913|21041820|P1|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0
6097882|NCT00289900|21041851|P6|Overall Study|Not treated|0
6097883|NCT00289900|21041852|P5|Overall Study|Not treated|0
6097884|NCT00289900|21041853|P4|Overall Study|Not treated|0
6097885|NCT00289900|21041854|P3|Overall Study|Not treated|0
6097886|NCT00289900|21041855|P2|Overall Study|Not treated|1
6097887|NCT00289900|21041856|P1|Overall Study|Not treated|0
6097888|NCT00289900|21041851|P6|Overall Study|site terminated|0
6097889|NCT00289900|21041852|P5|Overall Study|site terminated|0
6097890|NCT00289900|21041853|P4|Overall Study|site terminated|0
6097891|NCT00289900|21041854|P3|Overall Study|site terminated|1
6097892|NCT00289900|21041855|P2|Overall Study|site terminated|0
6097893|NCT00289900|21041856|P1|Overall Study|site terminated|1
6097894|NCT00289900|21041851|P6|Overall Study|Protocol Violation|4
6097895|NCT00289900|21041852|P5|Overall Study|Protocol Violation|7
6097896|NCT00289900|21041853|P4|Overall Study|Protocol Violation|6
6097897|NCT00289900|21041854|P3|Overall Study|Protocol Violation|2
6097898|NCT00289900|21041855|P2|Overall Study|Protocol Violation|9
6097899|NCT00289900|21041856|P1|Overall Study|Protocol Violation|3
6097900|NCT00289900|21041851|P6|Overall Study|Withdrawal by Subject|11
6097901|NCT00289900|21041852|P5|Overall Study|Withdrawal by Subject|12
6097902|NCT00289900|21041853|P4|Overall Study|Withdrawal by Subject|18
6097903|NCT00289900|21041854|P3|Overall Study|Withdrawal by Subject|8
6097904|NCT00289900|21041855|P2|Overall Study|Withdrawal by Subject|21
6097905|NCT00289900|21041856|P1|Overall Study|Withdrawal by Subject|10
6097906|NCT00289900|21041851|P6|Overall Study|Participant moved|1
6097907|NCT00289900|21041852|P5|Overall Study|Participant moved|1
6097908|NCT00289900|21041853|P4|Overall Study|Participant moved|1
6097909|NCT00289900|21041854|P3|Overall Study|Participant moved|0
6097910|NCT00289900|21041855|P2|Overall Study|Participant moved|0
6097911|NCT00289900|21041856|P1|Overall Study|Participant moved|1
6097912|NCT00289900|21041851|P6|Overall Study|Other|0
6097913|NCT00289900|21041852|P5|Overall Study|Other|1
6097914|NCT00289900|21041853|P4|Overall Study|Other|5
6097915|NCT00289900|21041854|P3|Overall Study|Other|0
6097916|NCT00289900|21041855|P2|Overall Study|Other|0
6097917|NCT00289900|21041856|P1|Overall Study|Other|0
6097918|NCT00289900|21041851|P6|Overall Study|Participant had flushing|4
6097919|NCT00289900|21041852|P5|Overall Study|Participant had flushing|0
6097920|NCT00289900|21041853|P4|Overall Study|Participant had flushing|2
6097921|NCT00289900|21041854|P3|Overall Study|Participant had flushing|1
6097922|NCT00289900|21041855|P2|Overall Study|Participant had flushing|42
6097923|NCT00289900|21041856|P1|Overall Study|Participant had flushing|18
6097924|NCT00289900|21041851|P6|Overall Study|Lost to Follow-up|8
6097925|NCT00289900|21041852|P5|Overall Study|Lost to Follow-up|4
6097926|NCT00289900|21041853|P4|Overall Study|Lost to Follow-up|8
6097927|NCT00289900|21041854|P3|Overall Study|Lost to Follow-up|8
6097928|NCT00289900|21041855|P2|Overall Study|Lost to Follow-up|7
6097929|NCT00289900|21041856|P1|Overall Study|Lost to Follow-up|7
6097930|NCT00289900|21041851|P6|Overall Study|Adverse Event|33
6097931|NCT00289900|21041852|P5|Overall Study|Adverse Event|20
6097932|NCT00289900|21041853|P4|Overall Study|Adverse Event|19
6097933|NCT00289900|21041854|P3|Overall Study|Adverse Event|13
6097934|NCT00289900|21041855|P2|Overall Study|Adverse Event|40
6097935|NCT00289900|21041856|P1|Overall Study|Adverse Event|28
6097936|NCT00289887|21041960|P2|Overall Study|Other|3
6097937|NCT00289887|21041961|P1|Overall Study|Other|7
6097938|NCT00289887|21041960|P2|Overall Study|Withdrawal by Subject|8
6097939|NCT00289887|21041961|P1|Overall Study|Withdrawal by Subject|3
6097940|NCT00289887|21041960|P2|Overall Study|Protocol Violation|1
6097941|NCT00289887|21041961|P1|Overall Study|Protocol Violation|3
6097942|NCT00289887|21041960|P2|Overall Study|Lost to Follow-up|3
6097943|NCT00289887|21041961|P1|Overall Study|Lost to Follow-up|3
6097944|NCT00289887|21041960|P2|Overall Study|Lack of Efficacy|11
6097945|NCT00289887|21041961|P1|Overall Study|Lack of Efficacy|3
6097946|NCT00289887|21041960|P2|Overall Study|Adverse Event|3
6097947|NCT00289887|21041961|P1|Overall Study|Adverse Event|3
6097948|NCT00289874|21041979|P2|Overall Study|Did not meet eligibility|0
6097949|NCT00289874|21041980|P1|Overall Study|Did not meet eligibility|1
6097950|NCT00289874|21041979|P2|Overall Study|Protocol Violation|2
6097951|NCT00289874|21041980|P1|Overall Study|Protocol Violation|3
6097952|NCT00289874|21041979|P2|Overall Study|Lost to Follow-up|1
6097953|NCT00289874|21041980|P1|Overall Study|Lost to Follow-up|1
6097954|NCT00289874|21041979|P2|Overall Study|Adverse Event|5
6097955|NCT00289874|21041980|P1|Overall Study|Adverse Event|1
6097956|NCT00289848|21041990|P2|Overall Study|Open-Label AHA Treatment Requested|1
6097957|NCT00289848|21041991|P1|Overall Study|Open-Label AHA Treatment Requested|0
6097958|NCT00289848|21041990|P2|Overall Study|Patient Moved|2
6097959|NCT00289848|21041991|P1|Overall Study|Patient Moved|6
6097960|NCT00289848|21041990|P2|Overall Study|Withdrawal by Subject|11
6097961|NCT00289848|21041991|P1|Overall Study|Withdrawal by Subject|5
6097962|NCT00289848|21041990|P2|Overall Study|Protocol Violation|2
6097963|NCT00289848|21041991|P1|Overall Study|Protocol Violation|5
6097964|NCT00289848|21041990|P2|Overall Study|Lost to Follow-up|1
6097965|NCT00289848|21041991|P1|Overall Study|Lost to Follow-up|3
6097966|NCT00289848|21041990|P2|Overall Study|Lack of Efficacy|24
6097967|NCT00289848|21041991|P1|Overall Study|Lack of Efficacy|20
6097968|NCT00289848|21041990|P2|Overall Study|Death|0
6097969|NCT00289848|21041991|P1|Overall Study|Death|1
6097970|NCT00289848|21041990|P2|Overall Study|Adverse Event|4
6097971|NCT00289848|21041991|P1|Overall Study|Adverse Event|6
6097972|NCT00289783|21042003|P2|Fourth Dose Phase|Other|10
6097973|NCT00289783|21042004|P1|Fourth Dose Phase|Other|22
6097974|NCT00289783|21042003|P2|Fourth Dose Phase|Migration from the study area|1
6097975|NCT00289783|21042004|P1|Fourth Dose Phase|Migration from the study area|1
6097976|NCT00289783|21042003|P2|Fourth Dose Phase|Lost to Follow-up|12
6097977|NCT00289783|21042004|P1|Fourth Dose Phase|Lost to Follow-up|53
6097978|NCT00289783|21042003|P2|Fourth Dose Phase|Withdrawal by Subject|1
6097979|NCT00289783|21042004|P1|Fourth Dose Phase|Withdrawal by Subject|10
6097980|NCT00289783|21042003|P2|Fourth Dose Phase|Adverse Event|0
6097981|NCT00289783|21042004|P1|Fourth Dose Phase|Adverse Event|1
6097982|NCT00289783|21042003|P2|Primary Phase|Other|12
6097983|NCT00289783|21042004|P1|Primary Phase|Other|32
6097984|NCT00289783|21042003|P2|Primary Phase|Migration from the study area|10
6097985|NCT00289783|21042004|P1|Primary Phase|Migration from the study area|26
6097986|NCT00289783|21042003|P2|Primary Phase|Lost to Follow-up|14
6097987|NCT00289783|21042004|P1|Primary Phase|Lost to Follow-up|60
6097988|NCT00289783|21042003|P2|Primary Phase|Withdrawal by Subject|40
6097989|NCT00289783|21042004|P1|Primary Phase|Withdrawal by Subject|93
6097990|NCT00289783|21042003|P2|Primary Phase|Protocol Violation|6
6097991|NCT00289783|21042004|P1|Primary Phase|Protocol Violation|27
6097992|NCT00289783|21042003|P2|Primary Phase|Adverse Event|1
6097993|NCT00289783|21042004|P1|Primary Phase|Adverse Event|10
6097994|NCT00289770|21042182|P1|Year 15|Withdrawal by Subject|1
6097995|NCT00289731|21042228|P3|Overall Study|Other|0
6097996|NCT00289731|21042229|P2|Overall Study|Other|0
6097997|NCT00289731|21042230|P1|Overall Study|Other|1
6097998|NCT00289731|21042228|P3|Overall Study|Adverse Event|2
6097999|NCT00289731|21042229|P2|Overall Study|Adverse Event|2
6098000|NCT00289731|21042230|P1|Overall Study|Adverse Event|1
6098001|NCT00289536|21042342|P3|Period 3|Lost to Follow-up|1
6098002|NCT00289536|21042343|P2|Period 3|Lost to Follow-up|0
6098003|NCT00289536|21042344|P1|Period 3|Lost to Follow-up|0
6098004|NCT00289458|21042390|P3|Overall Study|Withdrawal by Subject|4
6098005|NCT00289458|21042391|P2|Overall Study|Withdrawal by Subject|2
6098006|NCT00289458|21042392|P1|Overall Study|Withdrawal by Subject|2
6098007|NCT00289458|21042390|P3|Overall Study|Physician Decision|2
6098008|NCT00289458|21042391|P2|Overall Study|Physician Decision|4
6098009|NCT00289458|21042392|P1|Overall Study|Physician Decision|3
6098010|NCT00289458|21042390|P3|Overall Study|Death|0
6098011|NCT00289458|21042391|P2|Overall Study|Death|0
6098012|NCT00289458|21042392|P1|Overall Study|Death|1
6098013|NCT00289289|21042453|P3|Overall Study|Other Exit Reason|12
6098014|NCT00289289|21042454|P2|Overall Study|Other Exit Reason|4
6098015|NCT00289289|21042455|P1|Overall Study|Other Exit Reason|6
6098016|NCT00289289|21042453|P3|Overall Study|Did not meet inclusion/exclusion|6
6098017|NCT00289289|21042454|P2|Overall Study|Did not meet inclusion/exclusion|0
6098018|NCT00289289|21042455|P1|Overall Study|Did not meet inclusion/exclusion|0
6098019|NCT00289289|21042453|P3|Overall Study|Non-study device implanted|3
6098020|NCT00289289|21042454|P2|Overall Study|Non-study device implanted|1
6098021|NCT00289289|21042455|P1|Overall Study|Non-study device implanted|2
6098022|NCT00289289|21042453|P3|Overall Study|Physician Decision|6
6098023|NCT00289289|21042454|P2|Overall Study|Physician Decision|0
6098024|NCT00289289|21042455|P1|Overall Study|Physician Decision|1
6098025|NCT00289289|21042453|P3|Overall Study|No implant attempted|1
6098026|NCT00289289|21042454|P2|Overall Study|No implant attempted|0
6098027|NCT00289289|21042455|P1|Overall Study|No implant attempted|0
6098028|NCT00289289|21042453|P3|Overall Study|Death|5
6098029|NCT00289289|21042454|P2|Overall Study|Death|2
6098030|NCT00289289|21042455|P1|Overall Study|Death|4
6098031|NCT00289289|21042453|P3|Overall Study|Lost to Follow-up|1
6098032|NCT00289289|21042454|P2|Overall Study|Lost to Follow-up|0
6098033|NCT00289289|21042455|P1|Overall Study|Lost to Follow-up|1
6098034|NCT00289289|21042453|P3|Overall Study|Withdrawal by Subject|15
6098035|NCT00289289|21042454|P2|Overall Study|Withdrawal by Subject|3
6098036|NCT00289289|21042455|P1|Overall Study|Withdrawal by Subject|5
6098037|NCT00289276|21042470|P2|Second Part of FAST Study (Expansion)|Lost to Follow-up|1
6098038|NCT00289276|21042471|P1|Second Part of FAST Study (Expansion)|Lost to Follow-up|0
6098039|NCT00289276|21042470|P2|Second Part of FAST Study (Expansion)|Death|2
6098040|NCT00289276|21042471|P1|Second Part of FAST Study (Expansion)|Death|0
6098041|NCT00289198|21042506|P2|Overall Study|Other: Impossible to come on visit|1
6098042|NCT00289198|21042507|P1|Overall Study|Other: Impossible to come on visit|0
6098043|NCT00289198|21042506|P2|Overall Study|Other: Miscalculation of the visit date|22
6098044|NCT00289198|21042507|P1|Overall Study|Other: Miscalculation of the visit date|21
6098045|NCT00289198|21042506|P2|Overall Study|Other: Unable to attend on schedule|1
6098046|NCT00289198|21042507|P1|Overall Study|Other: Unable to attend on schedule|2
6098047|NCT00289198|21042506|P2|Overall Study|Other: Physician's decision|1
6098048|NCT00289198|21042507|P1|Overall Study|Other: Physician's decision|0
6098049|NCT00289198|21042506|P2|Overall Study|Other: Low compliance|1
6098050|NCT00289198|21042507|P1|Overall Study|Other: Low compliance|0
6098051|NCT00289198|21042506|P2|Overall Study|Lack of Efficacy|0
6098052|NCT00289198|21042507|P1|Overall Study|Lack of Efficacy|2
6098053|NCT00289198|21042506|P2|Overall Study|Withdrawal by Subject|1
6098054|NCT00289198|21042507|P1|Overall Study|Withdrawal by Subject|4
6098055|NCT00289198|21042506|P2|Overall Study|Protocol Violation|1
6098056|NCT00289198|21042507|P1|Overall Study|Protocol Violation|2
6098057|NCT00289198|21042506|P2|Overall Study|Adverse Event|2
6098058|NCT00289198|21042507|P1|Overall Study|Adverse Event|0
6098059|NCT00289185|21042557|P2|Overall Study|Death|1
6098060|NCT00289185|21042558|P1|Overall Study|Death|1
6098061|NCT00289185|21042557|P2|Overall Study|Lost to Follow-up|17
6098062|NCT00289185|21042558|P1|Overall Study|Lost to Follow-up|23
6098063|NCT00289185|21042557|P2|Overall Study|Withdrawal by Subject|8
6098064|NCT00289185|21042558|P1|Overall Study|Withdrawal by Subject|4
6098065|NCT00289133|21042605|P2|Overall Study|Lost to Follow-up|115
6098066|NCT00289133|21042606|P1|Overall Study|Lost to Follow-up|92
6098067|NCT00289133|21042605|P2|Overall Study|Revision|6
6098068|NCT00289133|21042606|P1|Overall Study|Revision|8
6098069|NCT00289133|21042605|P2|Overall Study|Physician Decision|45
6098070|NCT00289133|21042606|P1|Overall Study|Physician Decision|41
6098071|NCT00289133|21042605|P2|Overall Study|Lost to Follow-up - Hurricane Katri|74
6098072|NCT00289133|21042606|P1|Overall Study|Lost to Follow-up - Hurricane Katri|73
6098073|NCT00289133|21042605|P2|Overall Study|Death|10
6098074|NCT00289133|21042606|P1|Overall Study|Death|5
6098075|NCT00289133|21042605|P2|Overall Study|Withdrawal by Subject|10
6098076|NCT00289133|21042606|P1|Overall Study|Withdrawal by Subject|9
6098077|NCT00289133|21042605|P2|Overall Study|Protocol Violation|38
6098078|NCT00289133|21042606|P1|Overall Study|Protocol Violation|32
6098079|NCT00289133|21042605|P2|Overall Study|Non-study device implanted|0
6098080|NCT00289133|21042606|P1|Overall Study|Non-study device implanted|12
6098081|NCT00289016|21042662|P1|Overall Study|Other|1
6098082|NCT00289016|21042662|P1|Overall Study|Adverse Event|1
6098083|NCT00289016|21042662|P1|Overall Study|Withdrawal by Subject|2
6098084|NCT00289016|21042662|P1|Overall Study|Unrelated Medical Condition or Accident|2
6098085|NCT00289016|21042662|P1|Overall Study|Death|2
6098086|NCT00289016|21042662|P1|Overall Study|Disease Progression|29
6098087|NCT00288912|21042674|P3|Overall Study|Withdrawal by Subject|12
6098088|NCT00288912|21042675|P2|Overall Study|Withdrawal by Subject|5
6098089|NCT00288912|21042676|P1|Overall Study|Withdrawal by Subject|4
6098090|NCT00288912|21042674|P3|Overall Study|Lost to Follow-up|9
6098091|NCT00288912|21042675|P2|Overall Study|Lost to Follow-up|6
6098092|NCT00288912|21042676|P1|Overall Study|Lost to Follow-up|9
6098093|NCT00288912|21042674|P3|Overall Study|Developed exclusion criterion|7
6098094|NCT00288912|21042675|P2|Overall Study|Developed exclusion criterion|6
6098095|NCT00288912|21042676|P1|Overall Study|Developed exclusion criterion|4
6098096|NCT00288860|21042716|P2|Overall Study|Lost to Follow-up|71
6098097|NCT00288860|21042717|P1|Overall Study|Lost to Follow-up|74
6098098|NCT00288860|21042716|P2|Overall Study|Withdrawal by Subject|15
6098099|NCT00288860|21042717|P1|Overall Study|Withdrawal by Subject|20
6098100|NCT00288860|21042716|P2|Overall Study|Death|3
6098101|NCT00288860|21042717|P1|Overall Study|Death|4
6098102|NCT00288860|21042716|P2|Overall Study|Did not complete intake|8
6098103|NCT00288860|21042717|P1|Overall Study|Did not complete intake|4
6098104|NCT00288704|21042730|P3|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|1
6098105|NCT00288704|21042731|P2|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0
6098106|NCT00288704|21042732|P1|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0
6098107|NCT00288704|21042730|P3|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|15
6098108|NCT00288704|21042731|P2|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0
6098109|NCT00288704|21042732|P1|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0
6098110|NCT00288704|21042730|P3|Open-Label Extension (OLE) Weeks 24-117|Death|2
6098111|NCT00288704|21042731|P2|Open-Label Extension (OLE) Weeks 24-117|Death|0
6098112|NCT00288704|21042732|P1|Open-Label Extension (OLE) Weeks 24-117|Death|0
6098113|NCT00288704|21042730|P3|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|1
6098114|NCT00288704|21042731|P2|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0
6098115|NCT00288704|21042732|P1|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0
6098116|NCT00288704|21042730|P3|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|1
6098117|NCT00288704|21042731|P2|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0
6098118|NCT00288704|21042732|P1|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0
6098119|NCT00288704|21042730|P3|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0
6098120|NCT00288704|21042731|P2|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|1
6098121|NCT00288704|21042732|P1|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0
6098122|NCT00288704|21042730|P3|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0
6098123|NCT00288704|21042731|P2|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|1
6098124|NCT00288704|21042732|P1|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0
6098125|NCT00288639|21042759|P1|Overall Study|Other|1
6098126|NCT00288639|21042759|P1|Overall Study|Withdrawal by Subject|2
6098127|NCT00288639|21042759|P1|Overall Study|Lack of Efficacy|4
6098128|NCT00288639|21042759|P1|Overall Study|Adverse Event|5
6098129|NCT00288626|21042776|P1|Overall Study|Withdrawal by Subject|4
6098130|NCT00288626|21042776|P1|Overall Study|Death|3
6098131|NCT00288587|21042810|P2|Overall Study|Severe Aortic Stenosis|0
6098132|NCT00288587|21042811|P1|Overall Study|Severe Aortic Stenosis|1
6098133|NCT00288587|21042810|P2|Overall Study|Physician Decision|2
6098134|NCT00288587|21042811|P1|Overall Study|Physician Decision|0
6098135|NCT00288587|21042810|P2|Overall Study|Adverse Event|1
6098136|NCT00288587|21042811|P1|Overall Study|Adverse Event|0
6098137|NCT00288587|21042810|P2|Overall Study|Transplant|3
6098138|NCT00288587|21042811|P1|Overall Study|Transplant|0
6098139|NCT00288587|21042810|P2|Overall Study|Death|4
6098140|NCT00288587|21042811|P1|Overall Study|Death|4
6098141|NCT00288509|21042854|P1|Treatment Cycle 4|Treatment stopped according to protocol|1
6098142|NCT00288509|21042854|P1|Treatment Cycle 4|Physician Decision|4
6098143|NCT00288509|21042854|P1|Treatment Cycle 4|Withdrawal by Subject|3
6098144|NCT00288509|21042854|P1|Treatment Cycle 3|Treatment stopped according to protocol|1
6098145|NCT00288509|21042854|P1|Treatment Cycle 3|Lost to Follow-up|2
6098146|NCT00288509|21042854|P1|Treatment Cycle 3|Withdrawal by Subject|1
6098147|NCT00288509|21042854|P1|Treatment Cycle 3|Lack of Efficacy|1
6098148|NCT00288509|21042854|P1|Treatment Cycle 2|Withdrawal by Subject|2
6098149|NCT00288509|21042854|P1|Treatment Cycle 2|Lack of Efficacy|1
6098150|NCT00288509|21042854|P1|Treatment Cycle 1|Treatment stopped according to protocol|1
6098151|NCT00288509|21042854|P1|Treatment Cycle 1|Lost to Follow-up|2
6098152|NCT00288509|21042854|P1|Treatment Cycle 1|Withdrawal by Subject|1
6098153|NCT00288509|21042854|P1|Treatment Cycle 1|Lack of Efficacy|1
6098154|NCT00288509|21042854|P1|Treatment Cycle 1|Adverse Event|1
6098155|NCT00288080|21042872|P2|Overall Study|Protocol Violation|20
6098156|NCT00288080|21042873|P1|Overall Study|Protocol Violation|25
6098157|NCT00288080|21042872|P2|Overall Study|Withdrawal by Subject|3
6098158|NCT00288080|21042873|P1|Overall Study|Withdrawal by Subject|1
6098159|NCT00288054|21042895|P1|Overall Study|Not protocol specified|2
6098160|NCT00288054|21042895|P1|Overall Study|Withdrawal by Subject|1
6098161|NCT00288054|21042895|P1|Overall Study|Adverse Event|3
6098162|NCT00288054|21042895|P1|Overall Study|Lack of Efficacy|16
6098163|NCT00288054|21042895|P1|Overall Study|Protocol Violation|2
6098164|NCT00288015|21042903|P1|Follow up for Survival x 2 Years|Other|9
6098165|NCT00288015|21042903|P1|Follow up for Survival x 2 Years|Lost to Follow-up|4
6098166|NCT00288015|21042903|P1|Follow up for Survival x 2 Years|Death|13
6098167|NCT00288015|21042903|P1|Continued Bevacizumab Cycle 3+|Disease progressed|7
6098168|NCT00288015|21042903|P1|First Response Assessment|Physician Decision|2
6098169|NCT00288015|21042903|P1|First Response Assessment|Death|1
6098170|NCT00288015|21042903|P1|First Response Assessment|Withdrawal by Subject|1
6098171|NCT00288015|21042903|P1|Bevacizumab Treatment Cycles 1-2|Physician Decision|1
6098172|NCT00288015|21042903|P1|Bevacizumab Treatment Cycles 1-2|Withdrawal by Subject|1
6098173|NCT00287690|21042995|P2|Overall Study|Protocol Violation|26
6098174|NCT00287690|21042996|P1|Overall Study|Protocol Violation|20
6098175|NCT00287586|21043008|P2|Overall Study|Recurrent Melanoma|1
6098176|NCT00287586|21043009|P1|Overall Study|Recurrent Melanoma|0
6098177|NCT00287586|21043008|P2|Overall Study|Itchy Swollen Eyes|1
6098178|NCT00287586|21043009|P1|Overall Study|Itchy Swollen Eyes|0
6098179|NCT00287586|21043008|P2|Overall Study|Bradycardia|1
6098180|NCT00287586|21043009|P1|Overall Study|Bradycardia|0
6098181|NCT00287586|21043008|P2|Overall Study|Mood Swings and Irritability|1
6098182|NCT00287586|21043009|P1|Overall Study|Mood Swings and Irritability|0
6098183|NCT00287586|21043008|P2|Overall Study|Mastodynia and Gynecomastia|1
6098184|NCT00287586|21043009|P1|Overall Study|Mastodynia and Gynecomastia|0
6098185|NCT00287586|21043008|P2|Overall Study|Retroperitoneal Cancer|1
6098186|NCT00287586|21043009|P1|Overall Study|Retroperitoneal Cancer|0
6098187|NCT00287586|21043008|P2|Overall Study|Elevated IPSS Score|1
6098188|NCT00287586|21043009|P1|Overall Study|Elevated IPSS Score|0
6098189|NCT00287586|21043008|P2|Overall Study|Lung Cancer|2
6098190|NCT00287586|21043009|P1|Overall Study|Lung Cancer|0
6098191|NCT00287586|21043008|P2|Overall Study|Major Depression|2
6098192|NCT00287586|21043009|P1|Overall Study|Major Depression|0
6098193|NCT00287586|21043008|P2|Overall Study|Enrolled in Another Study|0
6098194|NCT00287586|21043009|P1|Overall Study|Enrolled in Another Study|1
6098195|NCT00287586|21043008|P2|Overall Study|Nonadherence|1
6098196|NCT00287586|21043009|P1|Overall Study|Nonadherence|1
6098197|NCT00287586|21043008|P2|Overall Study|Inappropriate Behaviour with Staff|0
6098198|NCT00287586|21043009|P1|Overall Study|Inappropriate Behaviour with Staff|1
6098199|NCT00287586|21043008|P2|Overall Study|Shoulder Pain|0
6098200|NCT00287586|21043009|P1|Overall Study|Shoulder Pain|1
6098201|NCT00287586|21043008|P2|Overall Study|Sleep Apnea|0
6098202|NCT00287586|21043009|P1|Overall Study|Sleep Apnea|1
6098203|NCT00287586|21043008|P2|Overall Study|Pancreatic Cancer|3
6098204|NCT00287586|21043009|P1|Overall Study|Pancreatic Cancer|1
6098205|NCT00287586|21043008|P2|Overall Study|Cognitive Impairment|0
6098206|NCT00287586|21043009|P1|Overall Study|Cognitive Impairment|1
6098207|NCT00287586|21043008|P2|Overall Study|Lower Urinary Tract Symptoms|0
6098208|NCT00287586|21043009|P1|Overall Study|Lower Urinary Tract Symptoms|1
6098209|NCT00287586|21043008|P2|Overall Study|Myocardial Infarction|0
6098210|NCT00287586|21043009|P1|Overall Study|Myocardial Infarction|1
6098211|NCT00287586|21043008|P2|Overall Study|Stroke|0
6098212|NCT00287586|21043009|P1|Overall Study|Stroke|2
6098213|NCT00287586|21043008|P2|Overall Study|Elevated Prostate Specific Antigen|0
6098214|NCT00287586|21043009|P1|Overall Study|Elevated Prostate Specific Antigen|2
6098215|NCT00287586|21043008|P2|Overall Study|Rash|0
6098216|NCT00287586|21043009|P1|Overall Study|Rash|3
6098217|NCT00287586|21043008|P2|Overall Study|Elevated Hematocrit|0
6098218|NCT00287586|21043009|P1|Overall Study|Elevated Hematocrit|3
6098219|NCT00287586|21043008|P2|Overall Study|Death|3
6098220|NCT00287586|21043009|P1|Overall Study|Death|2
6098221|NCT00287586|21043008|P2|Overall Study|Lost to Follow-up|4
6098222|NCT00287586|21043009|P1|Overall Study|Lost to Follow-up|5
6098223|NCT00287586|21043008|P2|Overall Study|Withdrew Consent|30
6098224|NCT00287586|21043009|P1|Overall Study|Withdrew Consent|19
6098225|NCT00287469|21043047|P2|Overall Study|Lost to Follow-up|69
6098226|NCT00287469|21043048|P1|Overall Study|Lost to Follow-up|74
6098227|NCT00287469|21043047|P2|Overall Study|moved from area|138
6098228|NCT00287469|21043048|P1|Overall Study|moved from area|144
6098229|NCT00287469|21043047|P2|Overall Study|Adverse Event|1
6098230|NCT00287469|21043048|P1|Overall Study|Adverse Event|1
6098231|NCT00287469|21043047|P2|Overall Study|serious adverse event|6
6098232|NCT00287469|21043048|P1|Overall Study|serious adverse event|1
6098233|NCT00287365|21043058|P1|Overall Study|sample not acquired|13
6098234|NCT00287118|21043084|P1|Overall Study|Other|7
6098235|NCT00287118|21043084|P1|Overall Study|Protocol Violation|2
6098236|NCT00287118|21043084|P1|Overall Study|Lost to Follow-up|1
6098237|NCT00287118|21043084|P1|Overall Study|Lack of Efficacy|11
6098238|NCT00287118|21043084|P1|Overall Study|Death|1
6098239|NCT00287118|21043084|P1|Overall Study|Adverse Event|30
6098240|NCT00287079|21043090|P2|Overall Study|Other|0
6098241|NCT00287079|21043091|P1|Overall Study|Other|3
6098242|NCT00287079|21043090|P2|Overall Study|Protocol Violation|0
6098243|NCT00287079|21043091|P1|Overall Study|Protocol Violation|1
6098244|NCT00287079|21043090|P2|Overall Study|Adverse Event|0
6098245|NCT00287079|21043091|P1|Overall Study|Adverse Event|5
6098246|NCT00287079|21043090|P2|Overall Study|Non-qualifying relapse|0
6098247|NCT00287079|21043091|P1|Overall Study|Non-qualifying relapse|1
6098248|NCT00287079|21043090|P2|Overall Study|Qualifying relapse|1
6098249|NCT00287079|21043091|P1|Overall Study|Qualifying relapse|12
6098250|NCT00286754|21043119|P3|Overall Study|Moved out of state|1
6098251|NCT00286754|21043120|P2|Overall Study|Moved out of state|0
6098252|NCT00286754|21043121|P1|Overall Study|Moved out of state|0
6098253|NCT00286754|21043119|P3|Overall Study|Lost to Follow-up|6
6098254|NCT00286754|21043120|P2|Overall Study|Lost to Follow-up|14
6098255|NCT00286754|21043121|P1|Overall Study|Lost to Follow-up|12
6098256|NCT00286754|21043119|P3|Overall Study|Withdrawal by Subject|0
6098257|NCT00286754|21043120|P2|Overall Study|Withdrawal by Subject|2
6098258|NCT00286754|21043121|P1|Overall Study|Withdrawal by Subject|6
6098259|NCT00286754|21043119|P3|Overall Study|Adverse Event|3
6098260|NCT00286754|21043120|P2|Overall Study|Adverse Event|2
6098261|NCT00286754|21043121|P1|Overall Study|Adverse Event|2
6098262|NCT00286494|21043180|P3|Overall Study|Protocol Violation|2
6098263|NCT00286494|21043181|P2|Overall Study|Protocol Violation|1
6098264|NCT00286494|21043182|P1|Overall Study|Protocol Violation|1
6098265|NCT00286494|21043180|P3|Overall Study|Lost to Follow-up|3
6098266|NCT00286494|21043181|P2|Overall Study|Lost to Follow-up|1
6098267|NCT00286494|21043182|P1|Overall Study|Lost to Follow-up|3
6098268|NCT00286494|21043180|P3|Overall Study|Physician Decision|1
6098269|NCT00286494|21043181|P2|Overall Study|Physician Decision|5
6098270|NCT00286494|21043182|P1|Overall Study|Physician Decision|5
6098271|NCT00286494|21043180|P3|Overall Study|Adverse Event|6
6098272|NCT00286494|21043181|P2|Overall Study|Adverse Event|8
6098273|NCT00286494|21043182|P1|Overall Study|Adverse Event|3
6098274|NCT00286494|21043180|P3|Overall Study|Withdrawal by Subject|9
6098275|NCT00286494|21043181|P2|Overall Study|Withdrawal by Subject|10
6098276|NCT00286494|21043182|P1|Overall Study|Withdrawal by Subject|2
6098277|NCT00286494|21043180|P3|Overall Study|Hyperglycemic rescue|18
6098278|NCT00286494|21043181|P2|Overall Study|Hyperglycemic rescue|19
6098279|NCT00286494|21043182|P1|Overall Study|Hyperglycemic rescue|12
6098280|NCT00286468|21043343|P3|Overall Study|Physician Decision|1
6098281|NCT00286468|21043344|P2|Overall Study|Physician Decision|2
6098282|NCT00286468|21043345|P1|Overall Study|Physician Decision|3
6098283|NCT00286468|21043343|P3|Overall Study|Withdrawal by Subject|11
6098284|NCT00286468|21043344|P2|Overall Study|Withdrawal by Subject|8
6098285|NCT00286468|21043345|P1|Overall Study|Withdrawal by Subject|3
6098286|NCT00286468|21043343|P3|Overall Study|Lost to Follow-up|2
6098287|NCT00286468|21043344|P2|Overall Study|Lost to Follow-up|1
6098288|NCT00286468|21043345|P1|Overall Study|Lost to Follow-up|1
6098289|NCT00286468|21043343|P3|Overall Study|Protocol Violation|1
6098290|NCT00286468|21043344|P2|Overall Study|Protocol Violation|3
6098291|NCT00286468|21043345|P1|Overall Study|Protocol Violation|0
6098292|NCT00286468|21043343|P3|Overall Study|Adverse Event|4
6098293|NCT00286468|21043344|P2|Overall Study|Adverse Event|6
6098294|NCT00286468|21043345|P1|Overall Study|Adverse Event|2
6098295|NCT00286468|21043343|P3|Overall Study|Hyperglycemic Rescue|31
6098296|NCT00286468|21043344|P2|Overall Study|Hyperglycemic Rescue|30
6098297|NCT00286468|21043345|P1|Overall Study|Hyperglycemic Rescue|28
6098298|NCT00286455|21043506|P3|Overall Study|Withdrawal by Subject|7
6098299|NCT00286455|21043507|P2|Overall Study|Withdrawal by Subject|8
6098300|NCT00286455|21043508|P1|Overall Study|Withdrawal by Subject|0
6098301|NCT00286455|21043506|P3|Overall Study|Participant Non-compliance|0
6098302|NCT00286455|21043507|P2|Overall Study|Participant Non-compliance|0
6098303|NCT00286455|21043508|P1|Overall Study|Participant Non-compliance|1
6098304|NCT00286455|21043506|P3|Overall Study|Protocol Violation|0
6098305|NCT00286455|21043507|P2|Overall Study|Protocol Violation|1
6098306|NCT00286455|21043508|P1|Overall Study|Protocol Violation|1
6098307|NCT00286455|21043506|P3|Overall Study|Physician Decision|2
6098308|NCT00286455|21043507|P2|Overall Study|Physician Decision|0
6098309|NCT00286455|21043508|P1|Overall Study|Physician Decision|3
6098310|NCT00286455|21043506|P3|Overall Study|Lost to Follow-up|3
6098311|NCT00286455|21043507|P2|Overall Study|Lost to Follow-up|3
6098312|NCT00286455|21043508|P1|Overall Study|Lost to Follow-up|0
6098313|NCT00286455|21043506|P3|Overall Study|Adverse Event|2
6098314|NCT00286455|21043507|P2|Overall Study|Adverse Event|3
6098315|NCT00286455|21043508|P1|Overall Study|Adverse Event|1
6098316|NCT00286455|21043506|P3|Overall Study|Hyperglycemia rescue|10
6098317|NCT00286455|21043507|P2|Overall Study|Hyperglycemia rescue|13
6098318|NCT00286455|21043508|P1|Overall Study|Hyperglycemia rescue|19
6098319|NCT00286442|21043687|P3|Overall Study|Withdrawal by Subject|2
6098320|NCT00286442|21043688|P2|Overall Study|Withdrawal by Subject|14
6098321|NCT00286442|21043689|P1|Overall Study|Withdrawal by Subject|2
6098322|NCT00286442|21043687|P3|Overall Study|Administrative Error|0
6098323|NCT00286442|21043688|P2|Overall Study|Administrative Error|1
6098324|NCT00286442|21043689|P1|Overall Study|Administrative Error|1
6098325|NCT00286442|21043687|P3|Overall Study|Physician Decision|1
6098326|NCT00286442|21043688|P2|Overall Study|Physician Decision|1
6098327|NCT00286442|21043689|P1|Overall Study|Physician Decision|1
6098328|NCT00286442|21043687|P3|Overall Study|Lost to Follow-up|1
6098329|NCT00286442|21043688|P2|Overall Study|Lost to Follow-up|2
6098330|NCT00286442|21043689|P1|Overall Study|Lost to Follow-up|5
6098331|NCT00286442|21043687|P3|Overall Study|Protocol Violation|2
6098332|NCT00286442|21043688|P2|Overall Study|Protocol Violation|4
6098333|NCT00286442|21043689|P1|Overall Study|Protocol Violation|2
6098334|NCT00286442|21043687|P3|Overall Study|Adverse Event|1
6098335|NCT00286442|21043688|P2|Overall Study|Adverse Event|6
6098336|NCT00286442|21043689|P1|Overall Study|Adverse Event|7
6098337|NCT00286442|21043687|P3|Overall Study|Hyperglycemic Rescue|25
6098338|NCT00286442|21043688|P2|Overall Study|Hyperglycemic Rescue|17
6098339|NCT00286442|21043689|P1|Overall Study|Hyperglycemic Rescue|19
6098340|NCT00286429|21043850|P3|Overall Study|Administrative Decision|0
6098341|NCT00286429|21043851|P2|Overall Study|Administrative Decision|1
6098342|NCT00286429|21043852|P1|Overall Study|Administrative Decision|0
6098343|NCT00286429|21043850|P3|Overall Study|Administrative Error|1
6098344|NCT00286429|21043851|P2|Overall Study|Administrative Error|1
6098345|NCT00286429|21043852|P1|Overall Study|Administrative Error|1
6098346|NCT00286429|21043850|P3|Overall Study|Withdrawal by Subject|6
6098347|NCT00286429|21043851|P2|Overall Study|Withdrawal by Subject|2
6098348|NCT00286429|21043852|P1|Overall Study|Withdrawal by Subject|3
6098349|NCT00286429|21043850|P3|Overall Study|Protocol Violation|4
6098350|NCT00286429|21043851|P2|Overall Study|Protocol Violation|5
6098351|NCT00286429|21043852|P1|Overall Study|Protocol Violation|3
6098352|NCT00286429|21043850|P3|Overall Study|Physician Decision|7
6098353|NCT00286429|21043851|P2|Overall Study|Physician Decision|7
6098354|NCT00286429|21043852|P1|Overall Study|Physician Decision|10
6098355|NCT00286429|21043850|P3|Overall Study|Lost to Follow-up|3
6098356|NCT00286429|21043851|P2|Overall Study|Lost to Follow-up|4
6098357|NCT00286429|21043852|P1|Overall Study|Lost to Follow-up|2
6098358|NCT00286429|21043850|P3|Overall Study|Lack of Efficacy|25
6098359|NCT00286429|21043851|P2|Overall Study|Lack of Efficacy|27
6098360|NCT00286429|21043852|P1|Overall Study|Lack of Efficacy|52
6098361|NCT00286429|21043850|P3|Overall Study|Adverse Event|6
6098362|NCT00286429|21043851|P2|Overall Study|Adverse Event|1
6098363|NCT00286429|21043852|P1|Overall Study|Adverse Event|4
6098364|NCT00286221|21043968|P4|Overall Study|Unrecognized exclusion criteria met|0
6098365|NCT00286221|21043969|P3|Overall Study|Unrecognized exclusion criteria met|0
6098366|NCT00286221|21043970|P2|Overall Study|Unrecognized exclusion criteria met|1
6098367|NCT00286221|21043971|P1|Overall Study|Unrecognized exclusion criteria met|0
6098368|NCT00286221|21043968|P4|Overall Study|Inability to trigger PCA|0
6098369|NCT00286221|21043969|P3|Overall Study|Inability to trigger PCA|0
6098370|NCT00286221|21043970|P2|Overall Study|Inability to trigger PCA|0
6098371|NCT00286221|21043971|P1|Overall Study|Inability to trigger PCA|2
6098372|NCT00286221|21043968|P4|Overall Study|Unanticipated Neurosurgical Complication|2
6098373|NCT00286221|21043969|P3|Overall Study|Unanticipated Neurosurgical Complication|3
6098374|NCT00286221|21043970|P2|Overall Study|Unanticipated Neurosurgical Complication|3
6098375|NCT00286221|21043971|P1|Overall Study|Unanticipated Neurosurgical Complication|6
6098376|NCT00286221|21043968|P4|Overall Study|Protocol Violation|4
6098377|NCT00286221|21043969|P3|Overall Study|Protocol Violation|6
6098378|NCT00286221|21043970|P2|Overall Study|Protocol Violation|1
6098379|NCT00286221|21043971|P1|Overall Study|Protocol Violation|2
6098380|NCT00286156|21043997|P3|Overall Study|AE: pneumonia|0
6098381|NCT00286156|21043998|P2|Overall Study|AE: pneumonia|0
6098382|NCT00286156|21043999|P1|Overall Study|AE: pneumonia|1
6098383|NCT00286156|21043997|P3|Overall Study|AE: nephrotic-range proteinuruia|0
6098384|NCT00286156|21043998|P2|Overall Study|AE: nephrotic-range proteinuruia|0
6098385|NCT00286156|21043999|P1|Overall Study|AE: nephrotic-range proteinuruia|1
6098386|NCT00286156|21043997|P3|Overall Study|AE: pulmonary embolus|0
6098387|NCT00286156|21043998|P2|Overall Study|AE: pulmonary embolus|1
6098388|NCT00286156|21043999|P1|Overall Study|AE: pulmonary embolus|0
6098389|NCT00286156|21043997|P3|Overall Study|Missed 12 month visit|1
6098390|NCT00286156|21043998|P2|Overall Study|Missed 12 month visit|0
6098391|NCT00286156|21043999|P1|Overall Study|Missed 12 month visit|0
6098392|NCT00286091|21044012|P2|Open-label Treatment Phase|Missing End of Study Information|1
6098393|NCT00286091|21044013|P1|Open-label Treatment Phase|Missing End of Study Information|0
6098394|NCT00286091|21044012|P2|Open-label Treatment Phase|Protocol-specified Criteria|0
6098395|NCT00286091|21044013|P1|Open-label Treatment Phase|Protocol-specified Criteria|1
6098396|NCT00286091|21044012|P2|Open-label Treatment Phase|Lost to Follow-up|1
6098397|NCT00286091|21044013|P1|Open-label Treatment Phase|Lost to Follow-up|0
6098398|NCT00286091|21044012|P2|Open-label Treatment Phase|Noncompliance|1
6098399|NCT00286091|21044013|P1|Open-label Treatment Phase|Noncompliance|3
6098400|NCT00286091|21044012|P2|Open-label Treatment Phase|Disease Progression|3
6098401|NCT00286091|21044013|P1|Open-label Treatment Phase|Disease Progression|9
6098402|NCT00286091|21044012|P2|Open-label Treatment Phase|Death|7
6098403|NCT00286091|21044013|P1|Open-label Treatment Phase|Death|10
6098404|NCT00286091|21044012|P2|Open-label Treatment Phase|Withdrawal by Subject|10
6098405|NCT00286091|21044013|P1|Open-label Treatment Phase|Withdrawal by Subject|14
6098406|NCT00286091|21044012|P2|Open-label Treatment Phase|Other|11
6098407|NCT00286091|21044013|P1|Open-label Treatment Phase|Other|11
6098408|NCT00286091|21044012|P2|Open-label Treatment Phase|Adverse Event|16
6098409|NCT00286091|21044013|P1|Open-label Treatment Phase|Adverse Event|5
6098410|NCT00286091|21044012|P2|Open-label Treatment Phase|Physician Decision|21
6098411|NCT00286091|21044013|P1|Open-label Treatment Phase|Physician Decision|24
6098412|NCT00286091|21044012|P2|Double-blind Treatment Phase|Ineligibility Determined|2
6098413|NCT00286091|21044013|P1|Double-blind Treatment Phase|Ineligibility Determined|1
6098414|NCT00286091|21044012|P2|Double-blind Treatment Phase|Protocol Deviation|3
6098415|NCT00286091|21044013|P1|Double-blind Treatment Phase|Protocol Deviation|1
6098416|NCT00286091|21044012|P2|Double-blind Treatment Phase|Lost to Follow-up|4
6098417|NCT00286091|21044013|P1|Double-blind Treatment Phase|Lost to Follow-up|11
6098418|NCT00286091|21044012|P2|Double-blind Treatment Phase|Noncompliance|8
6098419|NCT00286091|21044013|P1|Double-blind Treatment Phase|Noncompliance|8
6098420|NCT00286091|21044012|P2|Double-blind Treatment Phase|Administrative Decision|21
6098421|NCT00286091|21044013|P1|Double-blind Treatment Phase|Administrative Decision|20
6098422|NCT00286091|21044012|P2|Double-blind Treatment Phase|Other|33
6098423|NCT00286091|21044013|P1|Double-blind Treatment Phase|Other|25
6098424|NCT00286091|21044012|P2|Double-blind Treatment Phase|Disease Progression|35
6098425|NCT00286091|21044013|P1|Double-blind Treatment Phase|Disease Progression|22
6098426|NCT00286091|21044012|P2|Double-blind Treatment Phase|Adverse Event|40
6098427|NCT00286091|21044013|P1|Double-blind Treatment Phase|Adverse Event|28
6098428|NCT00286091|21044012|P2|Double-blind Treatment Phase|Death|65
6098429|NCT00286091|21044013|P1|Double-blind Treatment Phase|Death|58
6098430|NCT00286091|21044012|P2|Double-blind Treatment Phase|Protocol-Specified Criteria|269
6098431|NCT00286091|21044013|P1|Double-blind Treatment Phase|Protocol-Specified Criteria|307
6098432|NCT00286091|21044012|P2|Double-blind Treatment Phase|Withdrawal by Subject|113
6098433|NCT00286091|21044013|P1|Double-blind Treatment Phase|Withdrawal by Subject|103
6098434|NCT00285857|21044036|P1|Overall Study|Adverse Event|1
6098435|NCT00285857|21044036|P1|Overall Study|Inadequate initial breast cytology|1
6098436|NCT00285857|21044036|P1|Overall Study|Withdrawal by Subject|2
6098437|NCT00285818|21044049|P2|Overall Study|Lost to Follow-up|0
6098438|NCT00285818|21044050|P1|Overall Study|Lost to Follow-up|1
6098439|NCT00285818|21044049|P2|Overall Study|Withdrawal by Subject|2
6098440|NCT00285818|21044050|P1|Overall Study|Withdrawal by Subject|3
6098441|NCT00285649|21044095|P3|Overall Study|Withdrawal by Subject|2
6098442|NCT00285649|21044096|P2|Overall Study|Withdrawal by Subject|2
6098443|NCT00285649|21044097|P1|Overall Study|Withdrawal by Subject|3
6098444|NCT00285649|21044095|P3|Overall Study|Lost to Follow-up|4
6098445|NCT00285649|21044096|P2|Overall Study|Lost to Follow-up|4
6098446|NCT00285649|21044097|P1|Overall Study|Lost to Follow-up|6
6098447|NCT00285584|21044107|P2|Month 6|Lost to Follow-up|1
6098448|NCT00285584|21044108|P1|Month 6|Lost to Follow-up|0
6098449|NCT00285584|21044107|P2|Month 3|Withdrawal by Subject|0
6098450|NCT00285584|21044108|P1|Month 3|Withdrawal by Subject|1
6098451|NCT00285584|21044107|P2|Month 3|Lost to Follow-up|3
6098452|NCT00285584|21044108|P1|Month 3|Lost to Follow-up|3
6098453|NCT00285207|21044140|P2|Overall Study|non-compliance|1
6098454|NCT00285207|21044141|P1|Overall Study|non-compliance|0
6098455|NCT00285207|21044140|P2|Overall Study|Pregnancy|1
6098456|NCT00285207|21044141|P1|Overall Study|Pregnancy|1
6098457|NCT00285207|21044140|P2|Overall Study|Withdrawal by Subject|2
6098458|NCT00285207|21044141|P1|Overall Study|Withdrawal by Subject|5
6098459|NCT00285207|21044140|P2|Overall Study|Lost to Follow-up|2
6098460|NCT00285207|21044141|P1|Overall Study|Lost to Follow-up|3
6098461|NCT00285012|21044149|P2|Received Study Tx|Other|5
6098462|NCT00285012|21044150|P1|Received Study Tx|Other|5
6098463|NCT00285012|21044149|P2|Received Study Tx|Withdrawal by Subject|43
6098464|NCT00285012|21044150|P1|Received Study Tx|Withdrawal by Subject|31
6098465|NCT00285012|21044149|P2|Received Study Tx|Lost to Follow-up|31
6098466|NCT00285012|21044150|P1|Received Study Tx|Lost to Follow-up|29
6098467|NCT00285012|21044149|P2|Received Study Tx|Lack of Efficacy|3
6098468|NCT00285012|21044150|P1|Received Study Tx|Lack of Efficacy|0
6098469|NCT00285012|21044149|P2|Received Study Tx|Adverse Event|11
6098470|NCT00285012|21044150|P1|Received Study Tx|Adverse Event|5
6098471|NCT00285012|21044149|P2|Received Study Tx|Death|1
6098472|NCT00285012|21044150|P1|Received Study Tx|Death|2
6098473|NCT00285012|21044149|P2|Assigned to Study Treatment (Tx)|Other|3
6098474|NCT00285012|21044150|P1|Assigned to Study Treatment (Tx)|Other|2
6098475|NCT00284934|21044176|P2|Overall Study|Other reasons|1
6098476|NCT00284934|21044177|P1|Overall Study|Other reasons|3
6098477|NCT00284934|21044176|P2|Overall Study|Adverse Event|2
6098478|NCT00284934|21044177|P1|Overall Study|Adverse Event|1
6098479|NCT00284856|21044192|P3|Overall Study|Other|4
6098480|NCT00284856|21044193|P2|Overall Study|Other|5
6098481|NCT00284856|21044194|P1|Overall Study|Other|4
6098482|NCT00284856|21044192|P3|Overall Study|Withdrawal by Subject|18
6098483|NCT00284856|21044193|P2|Overall Study|Withdrawal by Subject|16
6098484|NCT00284856|21044194|P1|Overall Study|Withdrawal by Subject|12
6098485|NCT00284856|21044192|P3|Overall Study|Protocol Violation|5
6098486|NCT00284856|21044193|P2|Overall Study|Protocol Violation|4
6098487|NCT00284856|21044194|P1|Overall Study|Protocol Violation|5
6098488|NCT00284856|21044192|P3|Overall Study|Lost to Follow-up|22
6098489|NCT00284856|21044193|P2|Overall Study|Lost to Follow-up|21
6098490|NCT00284856|21044194|P1|Overall Study|Lost to Follow-up|25
6098491|NCT00284856|21044192|P3|Overall Study|Lack of Efficacy|8
6098492|NCT00284856|21044193|P2|Overall Study|Lack of Efficacy|1
6098493|NCT00284856|21044194|P1|Overall Study|Lack of Efficacy|2
6098494|NCT00284856|21044192|P3|Overall Study|Adverse Event|3
6098495|NCT00284856|21044193|P2|Overall Study|Adverse Event|3
6098496|NCT00284856|21044194|P1|Overall Study|Adverse Event|3
6098497|NCT00284141|21044293|P1|Overall Study|Ongoing treatment|2
6098498|NCT00284141|21044293|P1|Overall Study|Did not take study medication|2
6098499|NCT00284141|21044293|P1|Overall Study|Pneumonia|1
6098500|NCT00284141|21044293|P1|Overall Study|General decline|1
6098501|NCT00284141|21044293|P1|Overall Study|Clinical deterioration / death|2
6098502|NCT00284141|21044293|P1|Overall Study|Symptomatic / Clinical Progression|11
6098503|NCT00284141|21044293|P1|Overall Study|Participant's request|9
6098504|NCT00284141|21044293|P1|Overall Study|Adverse Event|19
6098505|NCT00284141|21044293|P1|Overall Study|Disease Progression / Lack of efficacy|51
6098506|NCT00284089|21044316|P4|Extension Phase|Withdrawal by Subject|3
6098507|NCT00284089|21044317|P3|Extension Phase|Withdrawal by Subject|1
6098508|NCT00284089|21044318|P2|Extension Phase|Withdrawal by Subject|0
6098509|NCT00284089|21044319|P1|Extension Phase|Withdrawal by Subject|0
6098510|NCT00284089|21044316|P4|Extension Phase|Protocol Violation|0
6098511|NCT00284089|21044317|P3|Extension Phase|Protocol Violation|1
6098512|NCT00284089|21044318|P2|Extension Phase|Protocol Violation|0
6098513|NCT00284089|21044319|P1|Extension Phase|Protocol Violation|0
6098514|NCT00284089|21044316|P4|Extension Phase|condition no longer requires study drug|7
6098515|NCT00284089|21044317|P3|Extension Phase|condition no longer requires study drug|2
6098516|NCT00284089|21044318|P2|Extension Phase|condition no longer requires study drug|0
6098517|NCT00284089|21044319|P1|Extension Phase|condition no longer requires study drug|2
6098518|NCT00284089|21044316|P4|Extension Phase|Adverse Event|2
6098519|NCT00284089|21044317|P3|Extension Phase|Adverse Event|2
6098520|NCT00284089|21044318|P2|Extension Phase|Adverse Event|0
6098521|NCT00284089|21044319|P1|Extension Phase|Adverse Event|0
6098522|NCT00284089|21044316|P4|Multiple Dose Phase|Death|1
6098523|NCT00284089|21044317|P3|Multiple Dose Phase|Death|1
6098524|NCT00284089|21044318|P2|Multiple Dose Phase|Death|0
6098525|NCT00284089|21044319|P1|Multiple Dose Phase|Death|0
6098526|NCT00284089|21044316|P4|Multiple Dose Phase|Withdrawal by Subject|2
6098527|NCT00284089|21044317|P3|Multiple Dose Phase|Withdrawal by Subject|1
6098528|NCT00284089|21044318|P2|Multiple Dose Phase|Withdrawal by Subject|0
6098529|NCT00284089|21044319|P1|Multiple Dose Phase|Withdrawal by Subject|0
6098530|NCT00284089|21044316|P4|Multiple Dose Phase|Protocol Violation|0
6098531|NCT00284089|21044317|P3|Multiple Dose Phase|Protocol Violation|1
6098532|NCT00284089|21044318|P2|Multiple Dose Phase|Protocol Violation|0
6098533|NCT00284089|21044319|P1|Multiple Dose Phase|Protocol Violation|0
6098534|NCT00284089|21044316|P4|Multiple Dose Phase|Adverse Event|1
6098535|NCT00284089|21044317|P3|Multiple Dose Phase|Adverse Event|1
6098536|NCT00284089|21044318|P2|Multiple Dose Phase|Adverse Event|0
6098537|NCT00284089|21044319|P1|Multiple Dose Phase|Adverse Event|1
6098538|NCT00284050|21044348|P3|Overall Study|Death|0
6098539|NCT00284050|21044349|P2|Overall Study|Death|0
6098540|NCT00284050|21044350|P1|Overall Study|Death|1
6098541|NCT00284050|21044348|P3|Overall Study|Lost to Follow-up|1
6098542|NCT00284050|21044349|P2|Overall Study|Lost to Follow-up|0
6098543|NCT00284050|21044350|P1|Overall Study|Lost to Follow-up|1
6098544|NCT00284050|21044348|P3|Overall Study|Withdrawal by Subject|2
6098545|NCT00284050|21044349|P2|Overall Study|Withdrawal by Subject|2
6098546|NCT00284050|21044350|P1|Overall Study|Withdrawal by Subject|2
6098547|NCT00284050|21044348|P3|Overall Study|Protocol Violation|2
6098548|NCT00284050|21044349|P2|Overall Study|Protocol Violation|1
6098549|NCT00284050|21044350|P1|Overall Study|Protocol Violation|0
6098550|NCT00284050|21044348|P3|Overall Study|Lack of Efficacy|3
6098551|NCT00284050|21044349|P2|Overall Study|Lack of Efficacy|1
6098552|NCT00284050|21044350|P1|Overall Study|Lack of Efficacy|0
6098553|NCT00284050|21044348|P3|Overall Study|Adverse Event|1
6098554|NCT00284050|21044349|P2|Overall Study|Adverse Event|1
6098555|NCT00284050|21044350|P1|Overall Study|Adverse Event|1
6098556|NCT00283959|21044364|P1|Extension Period|Low Compliance|1
6098557|NCT00283868|21044376|P2|Overall Study|Lost to Follow-up|8
6098558|NCT00283868|21044377|P1|Overall Study|Lost to Follow-up|7
6098559|NCT00283842|21044394|P5|Overall Study|Lost to Follow-up|1
6098560|NCT00283842|21044395|P4|Overall Study|Lost to Follow-up|1
6098561|NCT00283842|21044396|P3|Overall Study|Lost to Follow-up|4
6098562|NCT00283842|21044397|P2|Overall Study|Lost to Follow-up|2
6098563|NCT00283842|21044398|P1|Overall Study|Lost to Follow-up|0
6098564|NCT00283842|21044394|P5|Overall Study|Lack of Efficacy|3
6098565|NCT00283842|21044395|P4|Overall Study|Lack of Efficacy|0
6098566|NCT00283842|21044396|P3|Overall Study|Lack of Efficacy|1
6098567|NCT00283842|21044397|P2|Overall Study|Lack of Efficacy|3
6098568|NCT00283842|21044398|P1|Overall Study|Lack of Efficacy|1
6098569|NCT00283842|21044394|P5|Overall Study|Withdrawal by Subject|4
6098570|NCT00283842|21044395|P4|Overall Study|Withdrawal by Subject|5
6098571|NCT00283842|21044396|P3|Overall Study|Withdrawal by Subject|1
6098572|NCT00283842|21044397|P2|Overall Study|Withdrawal by Subject|1
6098573|NCT00283842|21044398|P1|Overall Study|Withdrawal by Subject|2
6098574|NCT00283842|21044394|P5|Overall Study|Protocol deviation|2
6098575|NCT00283842|21044395|P4|Overall Study|Protocol deviation|0
6098576|NCT00283842|21044396|P3|Overall Study|Protocol deviation|0
6098577|NCT00283842|21044397|P2|Overall Study|Protocol deviation|0
6098578|NCT00283842|21044398|P1|Overall Study|Protocol deviation|0
6098579|NCT00283842|21044394|P5|Overall Study|Protocol Violation|0
6098580|NCT00283842|21044395|P4|Overall Study|Protocol Violation|0
6098581|NCT00283842|21044396|P3|Overall Study|Protocol Violation|4
6098582|NCT00283842|21044397|P2|Overall Study|Protocol Violation|5
6098583|NCT00283842|21044398|P1|Overall Study|Protocol Violation|1
6098584|NCT00283842|21044394|P5|Overall Study|Adverse Event|5
6098585|NCT00283842|21044395|P4|Overall Study|Adverse Event|21
6098586|NCT00283842|21044396|P3|Overall Study|Adverse Event|21
6098587|NCT00283842|21044397|P2|Overall Study|Adverse Event|7
6098588|NCT00283842|21044398|P1|Overall Study|Adverse Event|8
6098589|NCT00283803|21044430|P1|Overall Study|Withdrawal by Subject|4
6098590|NCT00283803|21044430|P1|Overall Study|Physician Decision|9
6098591|NCT00283712|21044438|P2|Overall Study|Death|1
6098592|NCT00283712|21044439|P1|Overall Study|Death|0
6098593|NCT00283686|21044477|P4|Overall Study|Less than full participation|12
6098594|NCT00283686|21044478|P3|Overall Study|Less than full participation|6
6098595|NCT00283686|21044479|P2|Overall Study|Less than full participation|9
6098596|NCT00283686|21044480|P1|Overall Study|Less than full participation|7
6098597|NCT00283686|21044477|P4|Overall Study|Lost to Follow-up|20
6098598|NCT00283686|21044478|P3|Overall Study|Lost to Follow-up|26
6098599|NCT00283686|21044479|P2|Overall Study|Lost to Follow-up|31
6098600|NCT00283686|21044480|P1|Overall Study|Lost to Follow-up|21
6098601|NCT00283686|21044477|P4|Overall Study|Death|0
6098602|NCT00283686|21044478|P3|Overall Study|Death|1
6098603|NCT00283686|21044479|P2|Overall Study|Death|1
6098604|NCT00283686|21044480|P1|Overall Study|Death|1
6098605|NCT00283595|21044524|P2|Overall Study|Withdrawal by Subject|2
6098606|NCT00283595|21044525|P1|Overall Study|Withdrawal by Subject|1
6098607|NCT00283439|21044550|P4|Overall Study|Other|0
6098608|NCT00283439|21044551|P3|Overall Study|Other|0
6098609|NCT00283439|21044552|P2|Overall Study|Other|0
6098610|NCT00283439|21044553|P1|Overall Study|Other|1
6098611|NCT00283439|21044550|P4|Overall Study|Treatment discontinued|3
6098612|NCT00283439|21044551|P3|Overall Study|Treatment discontinued|1
6098613|NCT00283439|21044552|P2|Overall Study|Treatment discontinued|2
6098614|NCT00283439|21044553|P1|Overall Study|Treatment discontinued|0
6098615|NCT00283439|21044550|P4|Overall Study|Stem cell transplant|3
6098616|NCT00283439|21044551|P3|Overall Study|Stem cell transplant|4
6098617|NCT00283439|21044552|P2|Overall Study|Stem cell transplant|6
6098618|NCT00283439|21044553|P1|Overall Study|Stem cell transplant|6
6098619|NCT00283439|21044550|P4|Overall Study|Requirement for alternative therapy|2
6098620|NCT00283439|21044551|P3|Overall Study|Requirement for alternative therapy|5
6098621|NCT00283439|21044552|P2|Overall Study|Requirement for alternative therapy|2
6098622|NCT00283439|21044553|P1|Overall Study|Requirement for alternative therapy|1
6098623|NCT00283439|21044550|P4|Overall Study|Disease progression|0
6098624|NCT00283439|21044551|P3|Overall Study|Disease progression|0
6098625|NCT00283439|21044552|P2|Overall Study|Disease progression|1
6098626|NCT00283439|21044553|P1|Overall Study|Disease progression|0
6098627|NCT00283439|21044550|P4|Overall Study|Death|0
6098628|NCT00283439|21044551|P3|Overall Study|Death|1
6098629|NCT00283439|21044552|P2|Overall Study|Death|0
6098630|NCT00283439|21044553|P1|Overall Study|Death|0
6098631|NCT00283439|21044550|P4|Overall Study|Adverse Event|1
6098632|NCT00283439|21044551|P3|Overall Study|Adverse Event|0
6098633|NCT00283439|21044552|P2|Overall Study|Adverse Event|0
6098634|NCT00283439|21044553|P1|Overall Study|Adverse Event|0
6098635|NCT00283400|21044579|P4|Overall Study|Death|0
6098636|NCT00283400|21044580|P3|Overall Study|Death|1
6098637|NCT00283400|21044581|P2|Overall Study|Death|0
6098638|NCT00283400|21044582|P1|Overall Study|Death|1
6098639|NCT00283400|21044579|P4|Overall Study|Withdrawal by Subject|0
6098640|NCT00283400|21044580|P3|Overall Study|Withdrawal by Subject|0
6098641|NCT00283400|21044581|P2|Overall Study|Withdrawal by Subject|1
6098642|NCT00283400|21044582|P1|Overall Study|Withdrawal by Subject|1
6098643|NCT00283387|21044600|P2|First Intervention|Withdrawal by Subject|1
6098644|NCT00283387|21044601|P1|First Intervention|Withdrawal by Subject|0
6098645|NCT00283387|21044600|P2|First Intervention|Subject non-compliant|1
6098646|NCT00283387|21044601|P1|First Intervention|Subject non-compliant|1
6098647|NCT00283296|21044607|P1|Overall Study|in-home trial not completed|5
6098648|NCT00283244|21044638|P3|Overall Study|Clinical deterioration|3
6098649|NCT00283244|21044639|P2|Overall Study|Clinical deterioration|3
6098650|NCT00283244|21044640|P1|Overall Study|Clinical deterioration|1
6098651|NCT00283244|21044638|P3|Overall Study|Medical illness (other complicating dz)|6
6098652|NCT00283244|21044639|P2|Overall Study|Medical illness (other complicating dz)|3
6098653|NCT00283244|21044640|P1|Overall Study|Medical illness (other complicating dz)|4
6098654|NCT00283244|21044638|P3|Overall Study|Physician Decision|1
6098655|NCT00283244|21044639|P2|Overall Study|Physician Decision|0
6098656|NCT00283244|21044640|P1|Overall Study|Physician Decision|0
6098657|NCT00283244|21044638|P3|Overall Study|Withdrawal by Subject|2
6098658|NCT00283244|21044639|P2|Overall Study|Withdrawal by Subject|2
6098659|NCT00283244|21044640|P1|Overall Study|Withdrawal by Subject|1
6098660|NCT00283244|21044638|P3|Overall Study|Lack of Efficacy|26
6098661|NCT00283244|21044639|P2|Overall Study|Lack of Efficacy|32
6098662|NCT00283244|21044640|P1|Overall Study|Lack of Efficacy|8
6098663|NCT00283244|21044638|P3|Overall Study|Death|2
6098664|NCT00283244|21044639|P2|Overall Study|Death|3
6098665|NCT00283244|21044640|P1|Overall Study|Death|4
6098666|NCT00283244|21044638|P3|Overall Study|Adverse Event|11
6098667|NCT00283244|21044639|P2|Overall Study|Adverse Event|8
6098668|NCT00283244|21044640|P1|Overall Study|Adverse Event|0
6098669|NCT00283062|21044676|P4|Overall Study|chemotherapy not completed (cycle 6)|0
6098670|NCT00283062|21044677|P3|Overall Study|chemotherapy not completed (cycle 6)|0
6098671|NCT00283062|21044678|P2|Overall Study|chemotherapy not completed (cycle 6)|0
6098672|NCT00283062|21044679|P1|Overall Study|chemotherapy not completed (cycle 6)|1
6098673|NCT00283062|21044676|P4|Overall Study|Undefined|4
6098674|NCT00283062|21044677|P3|Overall Study|Undefined|1
6098675|NCT00283062|21044678|P2|Overall Study|Undefined|1
6098676|NCT00283062|21044679|P1|Overall Study|Undefined|0
6098677|NCT00283062|21044676|P4|Overall Study|Participant did not wish to continue|0
6098678|NCT00283062|21044677|P3|Overall Study|Participant did not wish to continue|1
6098679|NCT00283062|21044678|P2|Overall Study|Participant did not wish to continue|2
6098680|NCT00283062|21044679|P1|Overall Study|Participant did not wish to continue|3
6098681|NCT00283062|21044676|P4|Overall Study|Progressive disease|0
6098682|NCT00283062|21044677|P3|Overall Study|Progressive disease|1
6098683|NCT00283062|21044678|P2|Overall Study|Progressive disease|0
6098684|NCT00283062|21044679|P1|Overall Study|Progressive disease|0
6098685|NCT00283062|21044676|P4|Overall Study|Lost to Follow-up|0
6098686|NCT00283062|21044677|P3|Overall Study|Lost to Follow-up|1
6098687|NCT00283062|21044678|P2|Overall Study|Lost to Follow-up|0
6098688|NCT00283062|21044679|P1|Overall Study|Lost to Follow-up|1
6098689|NCT00283062|21044676|P4|Overall Study|Adverse Event|0
6098690|NCT00283062|21044677|P3|Overall Study|Adverse Event|1
6098691|NCT00283062|21044678|P2|Overall Study|Adverse Event|0
6098692|NCT00283062|21044679|P1|Overall Study|Adverse Event|2
6098693|NCT00283062|21044676|P4|Overall Study|Did not receive any study medication|45
6098694|NCT00283062|21044677|P3|Overall Study|Did not receive any study medication|36
6098695|NCT00283062|21044678|P2|Overall Study|Did not receive any study medication|4
6098696|NCT00283062|21044679|P1|Overall Study|Did not receive any study medication|5
6098697|NCT00283049|21044712|P3|Overall Study|No longer requires study treatment|1
6098698|NCT00283049|21044713|P2|Overall Study|No longer requires study treatment|0
6098699|NCT00283049|21044714|P1|Overall Study|No longer requires study treatment|0
6098700|NCT00283049|21044712|P3|Overall Study|Discontinuation of Study|20
6098701|NCT00283049|21044713|P2|Overall Study|Discontinuation of Study|16
6098702|NCT00283049|21044714|P1|Overall Study|Discontinuation of Study|18
6098703|NCT00283049|21044712|P3|Overall Study|Withdrawal by Subject|19
6098704|NCT00283049|21044713|P2|Overall Study|Withdrawal by Subject|24
6098705|NCT00283049|21044714|P1|Overall Study|Withdrawal by Subject|26
6098706|NCT00283049|21044712|P3|Overall Study|Lost to Follow-up|5
6098707|NCT00283049|21044713|P2|Overall Study|Lost to Follow-up|2
6098708|NCT00283049|21044714|P1|Overall Study|Lost to Follow-up|4
6098709|NCT00283049|21044712|P3|Overall Study|Lack of Efficacy|1
6098710|NCT00283049|21044713|P2|Overall Study|Lack of Efficacy|1
6098711|NCT00283049|21044714|P1|Overall Study|Lack of Efficacy|0
6098712|NCT00283049|21044712|P3|Overall Study|Death|1
6098713|NCT00283049|21044713|P2|Overall Study|Death|1
6098714|NCT00283049|21044714|P1|Overall Study|Death|1
6098715|NCT00283049|21044712|P3|Overall Study|Protocol Violation|3
6098716|NCT00283049|21044713|P2|Overall Study|Protocol Violation|0
6098717|NCT00283049|21044714|P1|Overall Study|Protocol Violation|3
6098718|NCT00283049|21044712|P3|Overall Study|Adverse Event|4
6098719|NCT00283049|21044713|P2|Overall Study|Adverse Event|1
6098720|NCT00283049|21044714|P1|Overall Study|Adverse Event|6
6098721|NCT00282984|21044742|P2|Overall Study|Protocol Violation|0
6098722|NCT00282984|21044743|P1|Overall Study|Protocol Violation|2
6098723|NCT00282984|21044742|P2|Overall Study|in prison|1
6098724|NCT00282984|21044743|P1|Overall Study|in prison|0
6098725|NCT00282984|21044742|P2|Overall Study|lack of motivation|0
6098726|NCT00282984|21044743|P1|Overall Study|lack of motivation|1
6098727|NCT00282984|21044742|P2|Overall Study|Participant used antipsychosis meds|1
6098728|NCT00282984|21044743|P1|Overall Study|Participant used antipsychosis meds|0
6098729|NCT00282984|21044742|P2|Overall Study|Participant only allowed phone follow-up|1
6098730|NCT00282984|21044743|P1|Overall Study|Participant only allowed phone follow-up|0
6098731|NCT00282984|21044742|P2|Overall Study|Participant stopped study medication|2
6098732|NCT00282984|21044743|P1|Overall Study|Participant stopped study medication|2
6098733|NCT00282984|21044742|P2|Overall Study|Withdrawal by Participant|34
6098734|NCT00282984|21044743|P1|Overall Study|Withdrawal by Participant|22
6098735|NCT00282984|21044742|P2|Overall Study|Lost to Follow-up|10
6098736|NCT00282984|21044743|P1|Overall Study|Lost to Follow-up|14
6098737|NCT00282984|21044742|P2|Overall Study|Lack of Efficacy|2
6098738|NCT00282984|21044743|P1|Overall Study|Lack of Efficacy|0
6098739|NCT00282984|21044742|P2|Overall Study|Adverse Event|5
6098740|NCT00282984|21044743|P1|Overall Study|Adverse Event|8
6098741|NCT00282984|21044742|P2|Overall Study|Death|5
6098742|NCT00282984|21044743|P1|Overall Study|Death|2
6098743|NCT00282919|21044780|P1|Overall Study|Asymptomatic Parasitemia|2
6098744|NCT00282919|21044780|P1|Overall Study|Withdrawal by Subject|1
6098745|NCT00282919|21044780|P1|Overall Study|Lack of Efficacy|4
6098746|NCT00282867|21044795|P3|Overall Study|d/c prior to prim outcome, 3 m f/u done|0
6098747|NCT00282867|21044796|P2|Overall Study|d/c prior to prim outcome, 3 m f/u done|1
6098748|NCT00282867|21044797|P1|Overall Study|d/c prior to prim outcome, 3 m f/u done|1
6098749|NCT00282568|21044899|P1|Extended Treatment Period|Lost to Follow-up|2
6098750|NCT00282568|21044899|P1|Extended Treatment Period|Physician Decision|1
6098751|NCT00282568|21044899|P1|Extended Treatment Period|Non-compliance|4
6098752|NCT00282568|21044899|P1|Extended Treatment Period|Adverse Event|17
6098753|NCT00282568|21044899|P1|Pharmacokinetic Treatment Period|Enrolled erroneously|1
6098754|NCT00282568|21044899|P1|Pharmacokinetic Treatment Period|Discontinued prior to Day 1|2
6098755|NCT00282464|21044925|P2|Overall Study|dropped due to missed visits|1
6098756|NCT00282464|21044926|P1|Overall Study|dropped due to missed visits|0
6098757|NCT00282464|21044925|P2|Overall Study|dispensed wrong kit|1
6098758|NCT00282464|21044926|P1|Overall Study|dispensed wrong kit|0
6098759|NCT00282464|21044925|P2|Overall Study|family crisis|1
6098760|NCT00282464|21044926|P1|Overall Study|family crisis|0
6098761|NCT00282464|21044925|P2|Overall Study|patient incarcerated|1
6098762|NCT00282464|21044926|P1|Overall Study|patient incarcerated|0
6098763|NCT00282464|21044925|P2|Overall Study|patient no show|1
6098764|NCT00282464|21044926|P1|Overall Study|patient no show|0
6098765|NCT00282464|21044925|P2|Overall Study|patient non-compliant|0
6098766|NCT00282464|21044926|P1|Overall Study|patient non-compliant|3
6098767|NCT00282464|21044925|P2|Overall Study|Patient moved|0
6098768|NCT00282464|21044926|P1|Overall Study|Patient moved|1
6098769|NCT00282464|21044925|P2|Overall Study|Protocol Violation|7
6098770|NCT00282464|21044926|P1|Overall Study|Protocol Violation|0
6098771|NCT00282464|21044925|P2|Overall Study|laboratory abnormality|2
6098772|NCT00282464|21044926|P1|Overall Study|laboratory abnormality|1
6098773|NCT00282464|21044925|P2|Overall Study|Withdrawal by Subject|10
6098774|NCT00282464|21044926|P1|Overall Study|Withdrawal by Subject|24
6098775|NCT00282464|21044925|P2|Overall Study|Lost to Follow-up|10
6098776|NCT00282464|21044926|P1|Overall Study|Lost to Follow-up|10
6098777|NCT00282464|21044925|P2|Overall Study|Lack of Efficacy|8
6098778|NCT00282464|21044926|P1|Overall Study|Lack of Efficacy|8
6098779|NCT00282464|21044925|P2|Overall Study|Adverse Event|20
6098780|NCT00282464|21044926|P1|Overall Study|Adverse Event|26
6098781|NCT00282438|21044976|P2|Overall Study|Death|1
6098782|NCT00282438|21044977|P1|Overall Study|Death|0
6098783|NCT00282438|21044976|P2|Overall Study|Lack of Efficacy|0
6098784|NCT00282438|21044977|P1|Overall Study|Lack of Efficacy|1
6098785|NCT00282412|21044987|P1|Overall Study|Death|2
6098786|NCT00282347|21044993|P2|B Cell Follow-up Period|Reason Not Specified|0
6098787|NCT00282347|21044994|P1|B Cell Follow-up Period|Reason Not Specified|2
6098788|NCT00282347|21044993|P2|B Cell Follow-up Period|Physician Decision|0
6098789|NCT00282347|21044994|P1|B Cell Follow-up Period|Physician Decision|1
6098790|NCT00282347|21044993|P2|B Cell Follow-up Period|Withdrawal by Subject|0
6098791|NCT00282347|21044994|P1|B Cell Follow-up Period|Withdrawal by Subject|2
6098792|NCT00282347|21044993|P2|Safety Follow-up Period|Protocol Deviation|2
6098793|NCT00282347|21044994|P1|Safety Follow-up Period|Protocol Deviation|0
6098794|NCT00282347|21044993|P2|Safety Follow-up Period|Physician Decision|1
6098795|NCT00282347|21044994|P1|Safety Follow-up Period|Physician Decision|1
6098796|NCT00282347|21044993|P2|Safety Follow-up Period|Withdrawal by Subject|1
6098797|NCT00282347|21044994|P1|Safety Follow-up Period|Withdrawal by Subject|2
6098798|NCT00282347|21044993|P2|Safety Follow-up Period|Lost to Follow-up|2
6098799|NCT00282347|21044994|P1|Safety Follow-up Period|Lost to Follow-up|0
6098800|NCT00282347|21044993|P2|Treatment Period|Physician Decision|1
6098801|NCT00282347|21044994|P1|Treatment Period|Physician Decision|0
6098802|NCT00282347|21044993|P2|Treatment Period|Withdrawal by Subject|3
6098803|NCT00282347|21044994|P1|Treatment Period|Withdrawal by Subject|1
6098804|NCT00282347|21044993|P2|Treatment Period|Lost to Follow-up|5
6098805|NCT00282347|21044994|P1|Treatment Period|Lost to Follow-up|2
6098806|NCT00282347|21044993|P2|Treatment Period|Death|0
6098807|NCT00282347|21044994|P1|Treatment Period|Death|2
6098808|NCT00282334|21045020|P2|Overall Study|Withdrawal by Subject|5
6098809|NCT00282334|21045021|P1|Overall Study|Withdrawal by Subject|8
6098810|NCT00282308|21045029|P3|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|12
6098811|NCT00282308|21045030|P2|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0
6098812|NCT00282308|21045031|P1|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0
6098813|NCT00282308|21045029|P3|Safety Follow-up Period|Physician Decision to Withdraw|1
6098814|NCT00282308|21045030|P2|Safety Follow-up Period|Physician Decision to Withdraw|0
6098815|NCT00282308|21045031|P1|Safety Follow-up Period|Physician Decision to Withdraw|0
6098816|NCT00282308|21045029|P3|Safety Follow-up Period|Lost to Follow-up|5
6098817|NCT00282308|21045030|P2|Safety Follow-up Period|Lost to Follow-up|0
6098818|NCT00282308|21045031|P1|Safety Follow-up Period|Lost to Follow-up|0
6098819|NCT00282308|21045029|P3|Safety Follow-up Period|Adverse Event|1
6098820|NCT00282308|21045030|P2|Safety Follow-up Period|Adverse Event|0
6098821|NCT00282308|21045031|P1|Safety Follow-up Period|Adverse Event|0
6098822|NCT00282308|21045029|P3|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|1
6098823|NCT00282308|21045030|P2|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0
6098824|NCT00282308|21045031|P1|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0
6098825|NCT00282308|21045029|P3|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|1
6098826|NCT00282308|21045030|P2|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0
6098827|NCT00282308|21045031|P1|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0
6098828|NCT00282308|21045029|P3|Optional Extension Re-treatment Period|Adverse Event|4
6098829|NCT00282308|21045030|P2|Optional Extension Re-treatment Period|Adverse Event|0
6098830|NCT00282308|21045031|P1|Optional Extension Re-treatment Period|Adverse Event|0
6098831|NCT00282308|21045029|P3|Treatment Period|Not Treated with Study Drug|0
6098832|NCT00282308|21045030|P2|Treatment Period|Not Treated with Study Drug|0
6098833|NCT00282308|21045031|P1|Treatment Period|Not Treated with Study Drug|1
6098834|NCT00282308|21045029|P3|Treatment Period|Adverse Event|0
6098835|NCT00282308|21045030|P2|Treatment Period|Adverse Event|2
6098836|NCT00282308|21045031|P1|Treatment Period|Adverse Event|0
6098837|NCT00282308|21045029|P3|Treatment Period|Subject/Guardian Decision to Withdraw|0
6098838|NCT00282308|21045030|P2|Treatment Period|Subject/Guardian Decision to Withdraw|4
6098839|NCT00282308|21045031|P1|Treatment Period|Subject/Guardian Decision to Withdraw|2
6098840|NCT00282308|21045029|P3|Treatment Period|Lost to Follow-up|0
6098841|NCT00282308|21045030|P2|Treatment Period|Lost to Follow-up|0
6098842|NCT00282308|21045031|P1|Treatment Period|Lost to Follow-up|1
6098843|NCT00282295|21045061|P3|Overall Study|Other|0
6098844|NCT00282295|21045062|P2|Overall Study|Other|1
6098845|NCT00282295|21045063|P1|Overall Study|Other|0
6098846|NCT00282295|21045061|P3|Overall Study|Lost to Follow-up|2
6098847|NCT00282295|21045062|P2|Overall Study|Lost to Follow-up|7
6098848|NCT00282295|21045063|P1|Overall Study|Lost to Follow-up|1
6098849|NCT00282295|21045061|P3|Overall Study|Withdrawal by Subject|4
6098850|NCT00282295|21045062|P2|Overall Study|Withdrawal by Subject|6
6098851|NCT00282295|21045063|P1|Overall Study|Withdrawal by Subject|2
6098852|NCT00282295|21045061|P3|Overall Study|Protocol Violation|1
6098853|NCT00282295|21045062|P2|Overall Study|Protocol Violation|2
6098854|NCT00282295|21045063|P1|Overall Study|Protocol Violation|0
6098855|NCT00282295|21045061|P3|Overall Study|Serious Adverse Events|1
6098856|NCT00282295|21045062|P2|Overall Study|Serious Adverse Events|0
6098857|NCT00282295|21045063|P1|Overall Study|Serious Adverse Events|0
6098858|NCT00282295|21045061|P3|Overall Study|Adverse Event|0
6098859|NCT00282295|21045062|P2|Overall Study|Adverse Event|1
6098860|NCT00282295|21045063|P1|Overall Study|Adverse Event|0
6098861|NCT00282256|21045118|P1|Extension Treatment Period|Adverse Event|2
6098862|NCT00282256|21045118|P1|Pharmacokinetic Treatment Period|Poor venous access|1
6098863|NCT00282243|21045139|P1|Extension Treatment Period|Physician Decision|1
6098864|NCT00282243|21045139|P1|Extension Treatment Period|Non-compliance|2
6098865|NCT00282243|21045139|P1|Extension Treatment Period|Withdrawal by Subject|4
6098866|NCT00282243|21045139|P1|Extension Treatment Period|Adverse Event|15
6098867|NCT00282243|21045139|P1|Pharmacokinetic Treatment Period|Withdrawal by Subject|2
6098868|NCT00282243|21045139|P1|Pharmacokinetic Treatment Period|Adverse Event|3
6098869|NCT00282152|21045165|P2|Overall Study|Withdrawal by Subject|0
6098870|NCT00282152|21045166|P1|Overall Study|Withdrawal by Subject|1
6098871|NCT00282113|21045187|P3|Overall Study|Removed at parents request|0
6098872|NCT00282113|21045188|P2|Overall Study|Removed at parents request|0
6098873|NCT00282113|21045189|P1|Overall Study|Removed at parents request|1
6098874|NCT00282087|21045203|P1|Overall Study|Death|1
6098875|NCT00282048|21045216|P1|Overall Study|Ongoing|1
6098876|NCT00282048|21045216|P1|Overall Study|Other|8
6098877|NCT00282048|21045216|P1|Overall Study|Withdrawal by Subject|1
6098878|NCT00282048|21045216|P1|Overall Study|Adverse Event|22
6098879|NCT00282048|21045216|P1|Overall Study|Lack of Efficacy|30
6098880|NCT00281957|21045230|P2|Overall Study|Refusal unrelated to adverse events|1
6098881|NCT00281957|21045231|P1|Overall Study|Refusal unrelated to adverse events|0
6098882|NCT00281957|21045230|P2|Overall Study|Did not start treatment|1
6098883|NCT00281957|21045231|P1|Overall Study|Did not start treatment|3
6098884|NCT00281957|21045230|P2|Overall Study|Not eligible|2
6098885|NCT00281957|21045231|P1|Overall Study|Not eligible|1
6098886|NCT00281957|21045230|P2|Overall Study|Not protocol specified|1
6098887|NCT00281957|21045231|P1|Overall Study|Not protocol specified|8
6098888|NCT00281957|21045230|P2|Overall Study|Progression/relapse|35
6098889|NCT00281957|21045231|P1|Overall Study|Progression/relapse|47
6098890|NCT00281957|21045230|P2|Overall Study|Death|0
6098891|NCT00281957|21045231|P1|Overall Study|Death|1
6098892|NCT00281957|21045230|P2|Overall Study|Adverse Event|2
6098893|NCT00281957|21045231|P1|Overall Study|Adverse Event|7
6098894|NCT00281840|21045305|P1|Overall Study|Complicating Disease|1
6098895|NCT00281840|21045305|P1|Overall Study|exceed maximum delay in treatment|1
6098896|NCT00281840|21045305|P1|Overall Study|Disease Progression|2
6098897|NCT00281840|21045305|P1|Overall Study|Withdrawal by Subject|3
6098898|NCT00281840|21045305|P1|Overall Study|Physician Decision|6
6098899|NCT00281840|21045305|P1|Overall Study|Adverse Event|12
6098900|NCT00281697|21045321|P2|Overall Study|Did not receive study drug|2
6098901|NCT00281697|21045322|P1|Overall Study|Did not receive study drug|3
6098902|NCT00281697|21045321|P2|Overall Study|Subject/guardian's decision to withdraw|6
6098903|NCT00281697|21045322|P1|Overall Study|Subject/guardian's decision to withdraw|33
6098904|NCT00281697|21045321|P2|Overall Study|Physician's decision to withdraw|12
6098905|NCT00281697|21045322|P1|Overall Study|Physician's decision to withdraw|15
6098906|NCT00281697|21045321|P2|Overall Study|Other|6
6098907|NCT00281697|21045322|P1|Overall Study|Other|5
6098908|NCT00281697|21045321|P2|Overall Study|Disease progression|149
6098909|NCT00281697|21045322|P1|Overall Study|Disease progression|279
6098910|NCT00281697|21045321|P2|Overall Study|Death|3
6098911|NCT00281697|21045322|P1|Overall Study|Death|8
6098912|NCT00281697|21045321|P2|Overall Study|Adverse Event|15
6098913|NCT00281697|21045322|P1|Overall Study|Adverse Event|54
6098914|NCT00281697|21045321|P2|Overall Study|> 60 days since last dose of study drug|4
6098915|NCT00281697|21045322|P1|Overall Study|> 60 days since last dose of study drug|4
6098916|NCT00281684|21045342|P4|Overall Study|Withdrawal by Subject|0
6098917|NCT00281684|21045343|P3|Overall Study|Withdrawal by Subject|0
6098918|NCT00281684|21045344|P2|Overall Study|Withdrawal by Subject|0
6098919|NCT00281684|21045345|P1|Overall Study|Withdrawal by Subject|1
6098920|NCT00281684|21045342|P4|Overall Study|Lost to Follow-up|0
6098921|NCT00281684|21045343|P3|Overall Study|Lost to Follow-up|1
6098922|NCT00281684|21045344|P2|Overall Study|Lost to Follow-up|0
6098923|NCT00281684|21045345|P1|Overall Study|Lost to Follow-up|0
6098924|NCT00281658|21045432|P3|Open-label Monotherapy Extension Phase|Withdrawal by Subject|1
6098925|NCT00281658|21045433|P2|Open-label Monotherapy Extension Phase|Withdrawal by Subject|0
6098926|NCT00281658|21045434|P1|Open-label Monotherapy Extension Phase|Withdrawal by Subject|0
6098927|NCT00281658|21045432|P3|Open-label Monotherapy Extension Phase|Lost to Follow-up|3
6098928|NCT00281658|21045433|P2|Open-label Monotherapy Extension Phase|Lost to Follow-up|0
6098929|NCT00281658|21045434|P1|Open-label Monotherapy Extension Phase|Lost to Follow-up|0
6098930|NCT00281658|21045432|P3|Open-label Monotherapy Extension Phase|Death|97
6098931|NCT00281658|21045433|P2|Open-label Monotherapy Extension Phase|Death|0
6098932|NCT00281658|21045434|P1|Open-label Monotherapy Extension Phase|Death|0
6098933|NCT00281658|21045432|P3|Double-blind, Randomized Phase|Screen Failure; Randomized in Error|0
6098934|NCT00281658|21045433|P2|Double-blind, Randomized Phase|Screen Failure; Randomized in Error|1
6098935|NCT00281658|21045434|P1|Double-blind, Randomized Phase|Screen Failure; Randomized in Error|0
6098936|NCT00281658|21045432|P3|Double-blind, Randomized Phase|Participant Entered New Protocol|0
6098937|NCT00281658|21045433|P2|Double-blind, Randomized Phase|Participant Entered New Protocol|1
6098938|NCT00281658|21045434|P1|Double-blind, Randomized Phase|Participant Entered New Protocol|1
6098939|NCT00281658|21045432|P3|Double-blind, Randomized Phase|Withdrawal by Subject|0
6098940|NCT00281658|21045433|P2|Double-blind, Randomized Phase|Withdrawal by Subject|1
6098941|NCT00281658|21045434|P1|Double-blind, Randomized Phase|Withdrawal by Subject|4
6098942|NCT00281658|21045432|P3|Double-blind, Randomized Phase|Lost to Follow-up|0
6098943|NCT00281658|21045433|P2|Double-blind, Randomized Phase|Lost to Follow-up|5
6098944|NCT00281658|21045434|P1|Double-blind, Randomized Phase|Lost to Follow-up|12
6098945|NCT00281658|21045432|P3|Double-blind, Randomized Phase|Death|0
6098946|NCT00281658|21045433|P2|Double-blind, Randomized Phase|Death|46
6098947|NCT00281658|21045434|P1|Double-blind, Randomized Phase|Death|120
6098948|NCT00281632|21045451|P1|Overall Study|Ongoing|3
6098949|NCT00281632|21045451|P1|Overall Study|Physician Decision|1
6098950|NCT00281632|21045451|P1|Overall Study|Death|1
6098951|NCT00281632|21045451|P1|Overall Study|Disease Progression|22
6098952|NCT00281632|21045451|P1|Overall Study|Withdrawal by Subject|2
6098953|NCT00281632|21045451|P1|Overall Study|Adverse Event|7
6098954|NCT00281580|21045493|P16|Overall Study|Randomised in error; pregnancy; moving|2
6098955|NCT00281580|21045494|P15|Overall Study|Randomised in error; pregnancy; moving|1
6098956|NCT00281580|21045495|P14|Overall Study|Randomised in error; pregnancy; moving|0
6098957|NCT00281580|21045496|P13|Overall Study|Randomised in error; pregnancy; moving|2
6098958|NCT00281580|21045497|P12|Overall Study|Randomised in error; pregnancy; moving|1
6098959|NCT00281580|21045498|P11|Overall Study|Randomised in error; pregnancy; moving|1
6098960|NCT00281580|21045499|P10|Overall Study|Randomised in error; pregnancy; moving|1
6098961|NCT00281580|21045500|P9|Overall Study|Randomised in error; pregnancy; moving|2
6098962|NCT00281580|21045501|P8|Overall Study|Randomised in error; pregnancy; moving|0
6098963|NCT00281580|21045502|P7|Overall Study|Randomised in error; pregnancy; moving|1
6098964|NCT00281580|21045503|P6|Overall Study|Randomised in error; pregnancy; moving|0
6098965|NCT00281580|21045504|P5|Overall Study|Randomised in error; pregnancy; moving|0
6098966|NCT00281580|21045505|P4|Overall Study|Randomised in error; pregnancy; moving|2
6098967|NCT00281580|21045506|P3|Overall Study|Randomised in error; pregnancy; moving|0
6098968|NCT00281580|21045507|P2|Overall Study|Randomised in error; pregnancy; moving|0
6098969|NCT00281580|21045508|P1|Overall Study|Randomised in error; pregnancy; moving|0
6098970|NCT00281580|21045493|P16|Overall Study|Lost to Follow-up|0
6098971|NCT00281580|21045494|P15|Overall Study|Lost to Follow-up|0
6098972|NCT00281580|21045495|P14|Overall Study|Lost to Follow-up|0
6098973|NCT00281580|21045496|P13|Overall Study|Lost to Follow-up|1
6098974|NCT00281580|21045497|P12|Overall Study|Lost to Follow-up|0
6098975|NCT00281580|21045498|P11|Overall Study|Lost to Follow-up|1
6098976|NCT00281580|21045499|P10|Overall Study|Lost to Follow-up|1
6098977|NCT00281580|21045500|P9|Overall Study|Lost to Follow-up|2
6098978|NCT00281580|21045501|P8|Overall Study|Lost to Follow-up|1
6098979|NCT00281580|21045502|P7|Overall Study|Lost to Follow-up|0
6098980|NCT00281580|21045503|P6|Overall Study|Lost to Follow-up|1
6098981|NCT00281580|21045504|P5|Overall Study|Lost to Follow-up|0
6098982|NCT00281580|21045505|P4|Overall Study|Lost to Follow-up|3
6098983|NCT00281580|21045506|P3|Overall Study|Lost to Follow-up|0
6098984|NCT00281580|21045507|P2|Overall Study|Lost to Follow-up|0
6098985|NCT00281580|21045508|P1|Overall Study|Lost to Follow-up|0
6098986|NCT00281580|21045493|P16|Overall Study|Lack of Efficacy|0
6098987|NCT00281580|21045494|P15|Overall Study|Lack of Efficacy|1
6098988|NCT00281580|21045495|P14|Overall Study|Lack of Efficacy|2
6098989|NCT00281580|21045496|P13|Overall Study|Lack of Efficacy|0
6098990|NCT00281580|21045497|P12|Overall Study|Lack of Efficacy|1
6098991|NCT00281580|21045498|P11|Overall Study|Lack of Efficacy|0
6098992|NCT00281580|21045499|P10|Overall Study|Lack of Efficacy|0
6098993|NCT00281580|21045500|P9|Overall Study|Lack of Efficacy|0
6098994|NCT00281580|21045501|P8|Overall Study|Lack of Efficacy|0
6098995|NCT00281580|21045502|P7|Overall Study|Lack of Efficacy|0
6098996|NCT00281580|21045503|P6|Overall Study|Lack of Efficacy|0
6098997|NCT00281580|21045504|P5|Overall Study|Lack of Efficacy|2
6098998|NCT00281580|21045505|P4|Overall Study|Lack of Efficacy|6
6098999|NCT00281580|21045506|P3|Overall Study|Lack of Efficacy|1
6099000|NCT00281580|21045507|P2|Overall Study|Lack of Efficacy|1
6099001|NCT00281580|21045508|P1|Overall Study|Lack of Efficacy|2
6099002|NCT00281580|21045493|P16|Overall Study|Withdrawal by Subject|5
6099003|NCT00281580|21045494|P15|Overall Study|Withdrawal by Subject|1
6099004|NCT00281580|21045495|P14|Overall Study|Withdrawal by Subject|2
6099005|NCT00281580|21045496|P13|Overall Study|Withdrawal by Subject|2
6099006|NCT00281580|21045497|P12|Overall Study|Withdrawal by Subject|1
6099007|NCT00281580|21045498|P11|Overall Study|Withdrawal by Subject|1
6099008|NCT00281580|21045499|P10|Overall Study|Withdrawal by Subject|4
6099009|NCT00281580|21045500|P9|Overall Study|Withdrawal by Subject|1
6099010|NCT00281580|21045501|P8|Overall Study|Withdrawal by Subject|0
6099011|NCT00281580|21045502|P7|Overall Study|Withdrawal by Subject|2
6099012|NCT00281580|21045503|P6|Overall Study|Withdrawal by Subject|2
6099013|NCT00281580|21045504|P5|Overall Study|Withdrawal by Subject|1
6099014|NCT00281580|21045505|P4|Overall Study|Withdrawal by Subject|1
6099015|NCT00281580|21045506|P3|Overall Study|Withdrawal by Subject|1
6099016|NCT00281580|21045507|P2|Overall Study|Withdrawal by Subject|0
6099017|NCT00281580|21045508|P1|Overall Study|Withdrawal by Subject|3
6099018|NCT00281580|21045493|P16|Overall Study|Protocol Violation|3
6099019|NCT00281580|21045494|P15|Overall Study|Protocol Violation|1
6099020|NCT00281580|21045495|P14|Overall Study|Protocol Violation|1
6099021|NCT00281580|21045496|P13|Overall Study|Protocol Violation|0
6099022|NCT00281580|21045497|P12|Overall Study|Protocol Violation|2
6099023|NCT00281580|21045498|P11|Overall Study|Protocol Violation|1
6099024|NCT00281580|21045499|P10|Overall Study|Protocol Violation|0
6099025|NCT00281580|21045500|P9|Overall Study|Protocol Violation|2
6099026|NCT00281580|21045501|P8|Overall Study|Protocol Violation|0
6099027|NCT00281580|21045502|P7|Overall Study|Protocol Violation|1
6099028|NCT00281580|21045503|P6|Overall Study|Protocol Violation|0
6099029|NCT00281580|21045504|P5|Overall Study|Protocol Violation|0
6099030|NCT00281580|21045505|P4|Overall Study|Protocol Violation|1
6099031|NCT00281580|21045506|P3|Overall Study|Protocol Violation|1
6099032|NCT00281580|21045507|P2|Overall Study|Protocol Violation|0
6099033|NCT00281580|21045508|P1|Overall Study|Protocol Violation|0
6099034|NCT00281580|21045493|P16|Overall Study|Adverse Event|3
6099035|NCT00281580|21045494|P15|Overall Study|Adverse Event|3
6099036|NCT00281580|21045495|P14|Overall Study|Adverse Event|2
6099037|NCT00281580|21045496|P13|Overall Study|Adverse Event|8
6099038|NCT00281580|21045497|P12|Overall Study|Adverse Event|5
6099039|NCT00281580|21045498|P11|Overall Study|Adverse Event|0
6099040|NCT00281580|21045499|P10|Overall Study|Adverse Event|6
6099041|NCT00281580|21045500|P9|Overall Study|Adverse Event|1
6099042|NCT00281580|21045501|P8|Overall Study|Adverse Event|0
6099043|NCT00281580|21045502|P7|Overall Study|Adverse Event|1
6099044|NCT00281580|21045503|P6|Overall Study|Adverse Event|0
6099045|NCT00281580|21045504|P5|Overall Study|Adverse Event|1
6099046|NCT00281580|21045505|P4|Overall Study|Adverse Event|4
6099047|NCT00281580|21045506|P3|Overall Study|Adverse Event|2
6099048|NCT00281580|21045507|P2|Overall Study|Adverse Event|0
6099049|NCT00281580|21045508|P1|Overall Study|Adverse Event|2
6099050|NCT00281528|21045855|P3|Overall Study|Other|5
6099051|NCT00281528|21045856|P2|Overall Study|Other|3
6099052|NCT00281528|21045857|P1|Overall Study|Other|6
6099053|NCT00281528|21045855|P3|Overall Study|Withdrawal by Subject|7
6099054|NCT00281528|21045856|P2|Overall Study|Withdrawal by Subject|5
6099055|NCT00281528|21045857|P1|Overall Study|Withdrawal by Subject|5
6099056|NCT00281528|21045855|P3|Overall Study|Protocol Violation|1
6099057|NCT00281528|21045856|P2|Overall Study|Protocol Violation|0
6099058|NCT00281528|21045857|P1|Overall Study|Protocol Violation|1
6099059|NCT00281528|21045855|P3|Overall Study|Physician Decision|5
6099060|NCT00281528|21045856|P2|Overall Study|Physician Decision|4
6099061|NCT00281528|21045857|P1|Overall Study|Physician Decision|11
6099062|NCT00281528|21045855|P3|Overall Study|Adverse Event-unrelated to treatment|2
6099063|NCT00281528|21045856|P2|Overall Study|Adverse Event-unrelated to treatment|0
6099064|NCT00281528|21045857|P1|Overall Study|Adverse Event-unrelated to treatment|3
6099065|NCT00281528|21045855|P3|Overall Study|Unacceptable Toxicity-related to trt|32
6099066|NCT00281528|21045856|P2|Overall Study|Unacceptable Toxicity-related to trt|24
6099067|NCT00281528|21045857|P1|Overall Study|Unacceptable Toxicity-related to trt|21
6099068|NCT00281528|21045855|P3|Overall Study|Progressive Disease|27
6099069|NCT00281528|21045856|P2|Overall Study|Progressive Disease|18
6099070|NCT00281528|21045857|P1|Overall Study|Progressive Disease|28
6099071|NCT00281320|21045908|P2|Overall Study|Other|1
6099072|NCT00281320|21045909|P1|Overall Study|Other|3
6099073|NCT00281320|21045908|P2|Overall Study|Lost to Follow-up|2
6099074|NCT00281320|21045909|P1|Overall Study|Lost to Follow-up|1
6099075|NCT00281320|21045908|P2|Overall Study|Withdrawal by Subject|6
6099076|NCT00281320|21045909|P1|Overall Study|Withdrawal by Subject|5
6099077|NCT00281320|21045908|P2|Overall Study|Lack of Efficacy|3
6099078|NCT00281320|21045909|P1|Overall Study|Lack of Efficacy|4
6099079|NCT00281320|21045908|P2|Overall Study|Adverse Event|9
6099080|NCT00281320|21045909|P1|Overall Study|Adverse Event|12
6099081|NCT00281099|21045931|P2|Overall Study|Heart Transplant/Device Exit/Changeout|4
6099082|NCT00281099|21045932|P1|Overall Study|Heart Transplant/Device Exit/Changeout|5
6099083|NCT00281099|21045931|P2|Overall Study|Physician Decision|72
6099084|NCT00281099|21045932|P1|Overall Study|Physician Decision|79
6099085|NCT00281099|21045931|P2|Overall Study|Withdrawal by Subject|70
6099086|NCT00281099|21045932|P1|Overall Study|Withdrawal by Subject|65
6099087|NCT00281099|21045931|P2|Overall Study|Lost to Follow-up|19
6099088|NCT00281099|21045932|P1|Overall Study|Lost to Follow-up|10
6099089|NCT00281099|21045931|P2|Overall Study|Death|57
6099090|NCT00281099|21045932|P1|Overall Study|Death|46
6099091|NCT00280917|21045981|P4|Overall Study|Noncompliance|0
6099092|NCT00280917|21045982|P3|Overall Study|Noncompliance|2
6099093|NCT00280917|21045983|P2|Overall Study|Noncompliance|1
6099094|NCT00280917|21045984|P1|Overall Study|Noncompliance|0
6099095|NCT00280917|21045981|P4|Overall Study|Withdrawal by Subject|1
6099096|NCT00280917|21045982|P3|Overall Study|Withdrawal by Subject|0
6099097|NCT00280917|21045983|P2|Overall Study|Withdrawal by Subject|2
6099098|NCT00280917|21045984|P1|Overall Study|Withdrawal by Subject|0
6099099|NCT00280917|21045981|P4|Overall Study|Change Therapy|0
6099100|NCT00280917|21045982|P3|Overall Study|Change Therapy|0
6099101|NCT00280917|21045983|P2|Overall Study|Change Therapy|2
6099102|NCT00280917|21045984|P1|Overall Study|Change Therapy|1
6099103|NCT00280917|21045981|P4|Overall Study|Adverse Event|1
6099104|NCT00280917|21045982|P3|Overall Study|Adverse Event|4
6099105|NCT00280917|21045983|P2|Overall Study|Adverse Event|1
6099106|NCT00280917|21045984|P1|Overall Study|Adverse Event|1
6099107|NCT00280748|21046007|P1|Overall Study|Extra-cranial disease progression|1
6099108|NCT00280748|21046007|P1|Overall Study|Decline in performance|3
6099109|NCT00280735|21046017|P1|Overall Study|Intercurrent Illness|2
6099110|NCT00280735|21046017|P1|Overall Study|Withdrawal by Subject|8
6099111|NCT00280735|21046017|P1|Overall Study|Lack of Efficacy|3
6099112|NCT00280735|21046017|P1|Overall Study|Adverse Event|5
6099113|NCT00280683|21046029|P2|Overall Study|Adverse Event|1
6099114|NCT00280683|21046030|P1|Overall Study|Adverse Event|1
6099115|NCT00280683|21046029|P2|Overall Study|Withdrawal by Subject|2
6099116|NCT00280683|21046030|P1|Overall Study|Withdrawal by Subject|1
6099117|NCT00280566|21046040|P3|Period 2 Double Blind|miscellaneous|5
6099118|NCT00280566|21046041|P2|Period 2 Double Blind|miscellaneous|10
6099119|NCT00280566|21046042|P1|Period 2 Double Blind|miscellaneous|0
6099120|NCT00280566|21046040|P3|Period 2 Double Blind|Withdrawal by Subject|9
6099121|NCT00280566|21046041|P2|Period 2 Double Blind|Withdrawal by Subject|9
6099122|NCT00280566|21046042|P1|Period 2 Double Blind|Withdrawal by Subject|0
6099123|NCT00280566|21046040|P3|Period 2 Double Blind|Lost to Follow-up|6
6099124|NCT00280566|21046041|P2|Period 2 Double Blind|Lost to Follow-up|3
6099125|NCT00280566|21046042|P1|Period 2 Double Blind|Lost to Follow-up|0
6099126|NCT00280566|21046040|P3|Period 2 Double Blind|Adverse Event|15
6099127|NCT00280566|21046041|P2|Period 2 Double Blind|Adverse Event|11
6099128|NCT00280566|21046042|P1|Period 2 Double Blind|Adverse Event|0
6099129|NCT00280566|21046040|P3|Period 2 Double Blind|Laboratory Abnormality|0
6099130|NCT00280566|21046041|P2|Period 2 Double Blind|Laboratory Abnormality|1
6099131|NCT00280566|21046042|P1|Period 2 Double Blind|Laboratory Abnormality|0
6099132|NCT00280566|21046040|P3|Period 2 Double Blind|Lack of Efficacy|22
6099133|NCT00280566|21046041|P2|Period 2 Double Blind|Lack of Efficacy|9
6099134|NCT00280566|21046042|P1|Period 2 Double Blind|Lack of Efficacy|0
6099135|NCT00280566|21046040|P3|Period 1 Open Label Ziprasidone|Miscellaneous|0
6099136|NCT00280566|21046041|P2|Period 1 Open Label Ziprasidone|Miscellaneous|0
6099137|NCT00280566|21046042|P1|Period 1 Open Label Ziprasidone|Miscellaneous|50
6099138|NCT00280566|21046040|P3|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0
6099139|NCT00280566|21046041|P2|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0
6099140|NCT00280566|21046042|P1|Period 1 Open Label Ziprasidone|Withdrawal by Subject|76
6099141|NCT00280566|21046040|P3|Period 1 Open Label Ziprasidone|Lost to Follow-up|0
6099142|NCT00280566|21046041|P2|Period 1 Open Label Ziprasidone|Lost to Follow-up|0
6099143|NCT00280566|21046042|P1|Period 1 Open Label Ziprasidone|Lost to Follow-up|35
6099144|NCT00280566|21046040|P3|Period 1 Open Label Ziprasidone|Adverse Event|0
6099145|NCT00280566|21046041|P2|Period 1 Open Label Ziprasidone|Adverse Event|0
6099146|NCT00280566|21046042|P1|Period 1 Open Label Ziprasidone|Adverse Event|148
6099147|NCT00280566|21046040|P3|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0
6099148|NCT00280566|21046041|P2|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0
6099149|NCT00280566|21046042|P1|Period 1 Open Label Ziprasidone|Laboratory Abnormality|3
6099150|NCT00280566|21046040|P3|Period 1 Open Label Ziprasidone|Lack of Efficacy|0
6099151|NCT00280566|21046041|P2|Period 1 Open Label Ziprasidone|Lack of Efficacy|0
6099152|NCT00280566|21046042|P1|Period 1 Open Label Ziprasidone|Lack of Efficacy|31
6099153|NCT00280397|21046067|P1|Overall Study|Adverse Event|1
6099154|NCT00280293|21046133|P2|Overall Study|Adverse Event|1
6099155|NCT00280293|21046134|P1|Overall Study|Adverse Event|0
6099156|NCT00280293|21046133|P2|Overall Study|Incarceration/Legal Reasons|1
6099157|NCT00280293|21046134|P1|Overall Study|Incarceration/Legal Reasons|1
6099158|NCT00280293|21046133|P2|Overall Study|Withdrawal by Subject|5
6099159|NCT00280293|21046134|P1|Overall Study|Withdrawal by Subject|3
6099160|NCT00280293|21046133|P2|Overall Study|Lost to Follow-up|12
6099161|NCT00280293|21046134|P1|Overall Study|Lost to Follow-up|14
6099162|NCT00280293|21046133|P2|Overall Study|Physician Decision|4
6099163|NCT00280293|21046134|P1|Overall Study|Physician Decision|5
6099164|NCT00280293|21046133|P2|Overall Study|Protocol Violation|0
6099165|NCT00280293|21046134|P1|Overall Study|Protocol Violation|3
6099166|NCT00280150|21046157|P4|Overall Study|Declining Performance Status|1
6099167|NCT00280150|21046158|P3|Overall Study|Declining Performance Status|0
6099168|NCT00280150|21046159|P2|Overall Study|Declining Performance Status|0
6099169|NCT00280150|21046160|P1|Overall Study|Declining Performance Status|0
6099170|NCT00280150|21046157|P4|Overall Study|Did not get consolidation therapy|0
6099171|NCT00280150|21046158|P3|Overall Study|Did not get consolidation therapy|3
6099172|NCT00280150|21046159|P2|Overall Study|Did not get consolidation therapy|0
6099173|NCT00280150|21046160|P1|Overall Study|Did not get consolidation therapy|3
6099174|NCT00280150|21046157|P4|Overall Study|Withdrawal by Subject|1
6099175|NCT00280150|21046158|P3|Overall Study|Withdrawal by Subject|0
6099176|NCT00280150|21046159|P2|Overall Study|Withdrawal by Subject|0
6099177|NCT00280150|21046160|P1|Overall Study|Withdrawal by Subject|0
6099178|NCT00280150|21046157|P4|Overall Study|Protocol Violation|1
6099179|NCT00280150|21046158|P3|Overall Study|Protocol Violation|0
6099180|NCT00280150|21046159|P2|Overall Study|Protocol Violation|0
6099181|NCT00280150|21046160|P1|Overall Study|Protocol Violation|0
6099182|NCT00280150|21046157|P4|Overall Study|Physician Decision|1
6099183|NCT00280150|21046158|P3|Overall Study|Physician Decision|0
6099184|NCT00280150|21046159|P2|Overall Study|Physician Decision|0
6099185|NCT00280150|21046160|P1|Overall Study|Physician Decision|0
6099186|NCT00280150|21046157|P4|Overall Study|Lack of Efficacy|3
6099187|NCT00280150|21046158|P3|Overall Study|Lack of Efficacy|0
6099188|NCT00280150|21046159|P2|Overall Study|Lack of Efficacy|0
6099189|NCT00280150|21046160|P1|Overall Study|Lack of Efficacy|0
6099190|NCT00280150|21046157|P4|Overall Study|Adverse Event|3
6099191|NCT00280150|21046158|P3|Overall Study|Adverse Event|2
6099192|NCT00280150|21046159|P2|Overall Study|Adverse Event|1
6099193|NCT00280150|21046160|P1|Overall Study|Adverse Event|0
6099194|NCT00279916|21046191|P2|Overall Study|Lost to Follow-up|2
6099195|NCT00279916|21046192|P1|Overall Study|Lost to Follow-up|3
6099196|NCT00279916|21046191|P2|Overall Study|Withdrawal by Subject|3
6099197|NCT00279916|21046192|P1|Overall Study|Withdrawal by Subject|4
6099198|NCT00279812|21046218|P6|Overall Study|Adverse Event|1
6099199|NCT00279812|21046219|P5|Overall Study|Adverse Event|2
6099200|NCT00279812|21046220|P4|Overall Study|Adverse Event|0
6099201|NCT00279812|21046221|P3|Overall Study|Adverse Event|1
6099202|NCT00279812|21046222|P2|Overall Study|Adverse Event|1
6099203|NCT00279812|21046223|P1|Overall Study|Adverse Event|0
6099204|NCT00279812|21046218|P6|Overall Study|Withdrawal by Subject|0
6099205|NCT00279812|21046219|P5|Overall Study|Withdrawal by Subject|0
6099206|NCT00279812|21046220|P4|Overall Study|Withdrawal by Subject|0
6099207|NCT00279812|21046221|P3|Overall Study|Withdrawal by Subject|2
6099208|NCT00279812|21046222|P2|Overall Study|Withdrawal by Subject|4
6099209|NCT00279812|21046223|P1|Overall Study|Withdrawal by Subject|0
6099210|NCT00279812|21046218|P6|Overall Study|Protocol Violation|0
6099211|NCT00279812|21046219|P5|Overall Study|Protocol Violation|1
6099212|NCT00279812|21046220|P4|Overall Study|Protocol Violation|0
6099213|NCT00279812|21046221|P3|Overall Study|Protocol Violation|0
6099214|NCT00279812|21046222|P2|Overall Study|Protocol Violation|1
6099215|NCT00279812|21046223|P1|Overall Study|Protocol Violation|1
6099216|NCT00279708|21046251|P2|Overall Study|Adverse Event|1
6099217|NCT00279708|21046252|P1|Overall Study|Adverse Event|1
6099218|NCT00279708|21046251|P2|Overall Study|Withdrawal by Subject|3
6099219|NCT00279708|21046252|P1|Overall Study|Withdrawal by Subject|2
6099220|NCT00279305|21046290|P2|Overall Study|FDA Safety Alert|1
6099221|NCT00279305|21046291|P1|Overall Study|FDA Safety Alert|4
6099222|NCT00279305|21046290|P2|Overall Study|Dificulting establishing IV|0
6099223|NCT00279305|21046291|P1|Overall Study|Dificulting establishing IV|1
6099224|NCT00279305|21046290|P2|Overall Study|Withdrawal by Subject|0
6099225|NCT00279305|21046291|P1|Overall Study|Withdrawal by Subject|2
6099226|NCT00279305|21046290|P2|Overall Study|Pregnancy|0
6099227|NCT00279305|21046291|P1|Overall Study|Pregnancy|1
6099228|NCT00279214|21046299|P2|Overall Study|Physician Decision|2
6099229|NCT00279214|21046300|P1|Overall Study|Physician Decision|3
6099230|NCT00279201|21046330|P6|Intensification Addendum|Death|0
6099231|NCT00279201|21046331|P5|Intensification Addendum|Death|1
6099232|NCT00279201|21046332|P4|Intensification Addendum|Death|0
6099233|NCT00279201|21046333|P3|Intensification Addendum|Death|0
6099234|NCT00279201|21046334|P2|Intensification Addendum|Death|0
6099235|NCT00279201|21046335|P1|Intensification Addendum|Death|0
6099236|NCT00279201|21046330|P6|Intensification Addendum|Lack of Efficacy|0
6099237|NCT00279201|21046331|P5|Intensification Addendum|Lack of Efficacy|1
6099238|NCT00279201|21046332|P4|Intensification Addendum|Lack of Efficacy|1
6099239|NCT00279201|21046333|P3|Intensification Addendum|Lack of Efficacy|0
6099240|NCT00279201|21046334|P2|Intensification Addendum|Lack of Efficacy|0
6099241|NCT00279201|21046335|P1|Intensification Addendum|Lack of Efficacy|0
6099242|NCT00279201|21046330|P6|Intensification Addendum|Entry Criteria Exclusion|0
6099243|NCT00279201|21046331|P5|Intensification Addendum|Entry Criteria Exclusion|0
6099244|NCT00279201|21046332|P4|Intensification Addendum|Entry Criteria Exclusion|0
6099245|NCT00279201|21046333|P3|Intensification Addendum|Entry Criteria Exclusion|1
6099246|NCT00279201|21046334|P2|Intensification Addendum|Entry Criteria Exclusion|0
6099247|NCT00279201|21046335|P1|Intensification Addendum|Entry Criteria Exclusion|0
6099248|NCT00279201|21046330|P6|Intensification Addendum|Sponsor Decision|1
6099249|NCT00279201|21046331|P5|Intensification Addendum|Sponsor Decision|1
6099250|NCT00279201|21046332|P4|Intensification Addendum|Sponsor Decision|0
6099251|NCT00279201|21046333|P3|Intensification Addendum|Sponsor Decision|0
6099252|NCT00279201|21046334|P2|Intensification Addendum|Sponsor Decision|0
6099253|NCT00279201|21046335|P1|Intensification Addendum|Sponsor Decision|0
6099254|NCT00279201|21046330|P6|Intensification Addendum|Physician Decision|2
6099255|NCT00279201|21046331|P5|Intensification Addendum|Physician Decision|3
6099256|NCT00279201|21046332|P4|Intensification Addendum|Physician Decision|1
6099257|NCT00279201|21046333|P3|Intensification Addendum|Physician Decision|4
6099258|NCT00279201|21046334|P2|Intensification Addendum|Physician Decision|0
6099259|NCT00279201|21046335|P1|Intensification Addendum|Physician Decision|0
6099260|NCT00279201|21046330|P6|Intensification Addendum|Adverse Event|3
6099261|NCT00279201|21046331|P5|Intensification Addendum|Adverse Event|1
6099262|NCT00279201|21046332|P4|Intensification Addendum|Adverse Event|4
6099263|NCT00279201|21046333|P3|Intensification Addendum|Adverse Event|0
6099264|NCT00279201|21046334|P2|Intensification Addendum|Adverse Event|0
6099265|NCT00279201|21046335|P1|Intensification Addendum|Adverse Event|0
6099266|NCT00279201|21046330|P6|Intensification Addendum|Protocol Violation|6
6099267|NCT00279201|21046331|P5|Intensification Addendum|Protocol Violation|6
6099268|NCT00279201|21046332|P4|Intensification Addendum|Protocol Violation|2
6099269|NCT00279201|21046333|P3|Intensification Addendum|Protocol Violation|2
6099270|NCT00279201|21046334|P2|Intensification Addendum|Protocol Violation|0
6099271|NCT00279201|21046335|P1|Intensification Addendum|Protocol Violation|0
6099272|NCT00279201|21046330|P6|Intensification Addendum|Lost to Follow-up|7
6099273|NCT00279201|21046331|P5|Intensification Addendum|Lost to Follow-up|7
6099274|NCT00279201|21046332|P4|Intensification Addendum|Lost to Follow-up|6
6099275|NCT00279201|21046333|P3|Intensification Addendum|Lost to Follow-up|4
6099276|NCT00279201|21046334|P2|Intensification Addendum|Lost to Follow-up|0
6099277|NCT00279201|21046335|P1|Intensification Addendum|Lost to Follow-up|0
6099278|NCT00279201|21046330|P6|Intensification Addendum|Withdrawal by Subject|18
6099279|NCT00279201|21046331|P5|Intensification Addendum|Withdrawal by Subject|9
6099280|NCT00279201|21046332|P4|Intensification Addendum|Withdrawal by Subject|14
6099281|NCT00279201|21046333|P3|Intensification Addendum|Withdrawal by Subject|12
6099282|NCT00279201|21046334|P2|Intensification Addendum|Withdrawal by Subject|0
6099283|NCT00279201|21046335|P1|Intensification Addendum|Withdrawal by Subject|0
6099284|NCT00279201|21046330|P6|Maintenance|HbA1c>7.5%|0
6099285|NCT00279201|21046331|P5|Maintenance|HbA1c>7.5%|0
6099286|NCT00279201|21046332|P4|Maintenance|HbA1c>7.5%|0
6099287|NCT00279201|21046333|P3|Maintenance|HbA1c>7.5%|0
6099288|NCT00279201|21046334|P2|Maintenance|HbA1c>7.5%|126
6099289|NCT00279201|21046335|P1|Maintenance|HbA1c>7.5%|123
6099290|NCT00279201|21046330|P6|Maintenance|Sponsor Decision|0
6099291|NCT00279201|21046331|P5|Maintenance|Sponsor Decision|0
6099292|NCT00279201|21046332|P4|Maintenance|Sponsor Decision|0
6099293|NCT00279201|21046333|P3|Maintenance|Sponsor Decision|0
6099294|NCT00279201|21046334|P2|Maintenance|Sponsor Decision|0
6099295|NCT00279201|21046335|P1|Maintenance|Sponsor Decision|4
6099296|NCT00279201|21046330|P6|Maintenance|Physician Decision|0
6099297|NCT00279201|21046331|P5|Maintenance|Physician Decision|0
6099298|NCT00279201|21046332|P4|Maintenance|Physician Decision|0
6099299|NCT00279201|21046333|P3|Maintenance|Physician Decision|0
6099300|NCT00279201|21046334|P2|Maintenance|Physician Decision|9
6099301|NCT00279201|21046335|P1|Maintenance|Physician Decision|9
6099302|NCT00279201|21046330|P6|Maintenance|Withdrawal by Subject|0
6099303|NCT00279201|21046331|P5|Maintenance|Withdrawal by Subject|0
6099304|NCT00279201|21046332|P4|Maintenance|Withdrawal by Subject|0
6099305|NCT00279201|21046333|P3|Maintenance|Withdrawal by Subject|0
6099306|NCT00279201|21046334|P2|Maintenance|Withdrawal by Subject|18
6099307|NCT00279201|21046335|P1|Maintenance|Withdrawal by Subject|18
6099308|NCT00279201|21046330|P6|Maintenance|Protocol Violation|0
6099309|NCT00279201|21046331|P5|Maintenance|Protocol Violation|0
6099310|NCT00279201|21046332|P4|Maintenance|Protocol Violation|0
6099311|NCT00279201|21046333|P3|Maintenance|Protocol Violation|0
6099312|NCT00279201|21046334|P2|Maintenance|Protocol Violation|24
6099313|NCT00279201|21046335|P1|Maintenance|Protocol Violation|16
6099314|NCT00279201|21046330|P6|Maintenance|Entry Criteria Exclusion|0
6099315|NCT00279201|21046331|P5|Maintenance|Entry Criteria Exclusion|0
6099316|NCT00279201|21046332|P4|Maintenance|Entry Criteria Exclusion|0
6099317|NCT00279201|21046333|P3|Maintenance|Entry Criteria Exclusion|0
6099318|NCT00279201|21046334|P2|Maintenance|Entry Criteria Exclusion|4
6099319|NCT00279201|21046335|P1|Maintenance|Entry Criteria Exclusion|1
6099320|NCT00279201|21046330|P6|Maintenance|Lost to Follow-up|0
6099321|NCT00279201|21046331|P5|Maintenance|Lost to Follow-up|0
6099322|NCT00279201|21046332|P4|Maintenance|Lost to Follow-up|0
6099323|NCT00279201|21046333|P3|Maintenance|Lost to Follow-up|0
6099324|NCT00279201|21046334|P2|Maintenance|Lost to Follow-up|13
6099325|NCT00279201|21046335|P1|Maintenance|Lost to Follow-up|17
6099326|NCT00279201|21046330|P6|Maintenance|Death|0
6099327|NCT00279201|21046331|P5|Maintenance|Death|0
6099328|NCT00279201|21046332|P4|Maintenance|Death|0
6099329|NCT00279201|21046333|P3|Maintenance|Death|0
6099330|NCT00279201|21046334|P2|Maintenance|Death|4
6099331|NCT00279201|21046335|P1|Maintenance|Death|4
6099332|NCT00279201|21046330|P6|Maintenance|Adverse Event|0
6099333|NCT00279201|21046331|P5|Maintenance|Adverse Event|0
6099334|NCT00279201|21046332|P4|Maintenance|Adverse Event|0
6099335|NCT00279201|21046333|P3|Maintenance|Adverse Event|0
6099336|NCT00279201|21046334|P2|Maintenance|Adverse Event|4
6099337|NCT00279201|21046335|P1|Maintenance|Adverse Event|4
6099338|NCT00279201|21046330|P6|Maintenance|Discontinuation Antihyperglycemic Drugs|0
6099339|NCT00279201|21046331|P5|Maintenance|Discontinuation Antihyperglycemic Drugs|0
6099340|NCT00279201|21046332|P4|Maintenance|Discontinuation Antihyperglycemic Drugs|0
6099341|NCT00279201|21046333|P3|Maintenance|Discontinuation Antihyperglycemic Drugs|0
6099342|NCT00279201|21046334|P2|Maintenance|Discontinuation Antihyperglycemic Drugs|2
6099343|NCT00279201|21046335|P1|Maintenance|Discontinuation Antihyperglycemic Drugs|3
6099344|NCT00279201|21046330|P6|Maintenance|Lack of Efficacy|0
6099345|NCT00279201|21046331|P5|Maintenance|Lack of Efficacy|0
6099346|NCT00279201|21046332|P4|Maintenance|Lack of Efficacy|0
6099347|NCT00279201|21046333|P3|Maintenance|Lack of Efficacy|0
6099348|NCT00279201|21046334|P2|Maintenance|Lack of Efficacy|30
6099349|NCT00279201|21046335|P1|Maintenance|Lack of Efficacy|32
6099350|NCT00279201|21046330|P6|Initiation|Discontinuation Oral Antihyperglycemics|0
6099351|NCT00279201|21046331|P5|Initiation|Discontinuation Oral Antihyperglycemics|0
6099352|NCT00279201|21046332|P4|Initiation|Discontinuation Oral Antihyperglycemics|0
6099353|NCT00279201|21046333|P3|Initiation|Discontinuation Oral Antihyperglycemics|0
6099354|NCT00279201|21046334|P2|Initiation|Discontinuation Oral Antihyperglycemics|1
6099355|NCT00279201|21046335|P1|Initiation|Discontinuation Oral Antihyperglycemics|0
6099356|NCT00279201|21046330|P6|Initiation|Sponsor Decision|0
6099357|NCT00279201|21046331|P5|Initiation|Sponsor Decision|0
6099358|NCT00279201|21046332|P4|Initiation|Sponsor Decision|0
6099359|NCT00279201|21046333|P3|Initiation|Sponsor Decision|0
6099360|NCT00279201|21046334|P2|Initiation|Sponsor Decision|5
6099361|NCT00279201|21046335|P1|Initiation|Sponsor Decision|13
6099362|NCT00279201|21046330|P6|Initiation|Physician Decision|0
6099363|NCT00279201|21046331|P5|Initiation|Physician Decision|0
6099364|NCT00279201|21046332|P4|Initiation|Physician Decision|0
6099365|NCT00279201|21046333|P3|Initiation|Physician Decision|0
6099366|NCT00279201|21046334|P2|Initiation|Physician Decision|18
6099367|NCT00279201|21046335|P1|Initiation|Physician Decision|15
6099368|NCT00279201|21046330|P6|Initiation|Withdrawal by Subject|0
6099369|NCT00279201|21046331|P5|Initiation|Withdrawal by Subject|0
6099370|NCT00279201|21046332|P4|Initiation|Withdrawal by Subject|0
6099371|NCT00279201|21046333|P3|Initiation|Withdrawal by Subject|0
6099372|NCT00279201|21046334|P2|Initiation|Withdrawal by Subject|41
6099373|NCT00279201|21046335|P1|Initiation|Withdrawal by Subject|35
6099374|NCT00279201|21046330|P6|Initiation|Protocol Violation|0
6099375|NCT00279201|21046331|P5|Initiation|Protocol Violation|0
6099376|NCT00279201|21046332|P4|Initiation|Protocol Violation|0
6099377|NCT00279201|21046333|P3|Initiation|Protocol Violation|0
6099378|NCT00279201|21046334|P2|Initiation|Protocol Violation|10
6099379|NCT00279201|21046335|P1|Initiation|Protocol Violation|9
6099380|NCT00279201|21046330|P6|Initiation|Entry Criteria Exclusion|0
6099381|NCT00279201|21046331|P5|Initiation|Entry Criteria Exclusion|0
6099382|NCT00279201|21046332|P4|Initiation|Entry Criteria Exclusion|0
6099383|NCT00279201|21046333|P3|Initiation|Entry Criteria Exclusion|0
6099384|NCT00279201|21046334|P2|Initiation|Entry Criteria Exclusion|9
6099385|NCT00279201|21046335|P1|Initiation|Entry Criteria Exclusion|7
6099386|NCT00279201|21046330|P6|Initiation|Lost to Follow-up|0
6099387|NCT00279201|21046331|P5|Initiation|Lost to Follow-up|0
6099388|NCT00279201|21046332|P4|Initiation|Lost to Follow-up|0
6099389|NCT00279201|21046333|P3|Initiation|Lost to Follow-up|0
6099390|NCT00279201|21046334|P2|Initiation|Lost to Follow-up|41
6099391|NCT00279201|21046335|P1|Initiation|Lost to Follow-up|42
6099392|NCT00279201|21046330|P6|Initiation|Adverse Event|0
6099393|NCT00279201|21046331|P5|Initiation|Adverse Event|0
6099394|NCT00279201|21046332|P4|Initiation|Adverse Event|0
6099395|NCT00279201|21046333|P3|Initiation|Adverse Event|0
6099396|NCT00279201|21046334|P2|Initiation|Adverse Event|15
6099397|NCT00279201|21046335|P1|Initiation|Adverse Event|6
6099398|NCT00279201|21046330|P6|Initiation|Death|0
6099399|NCT00279201|21046331|P5|Initiation|Death|0
6099400|NCT00279201|21046332|P4|Initiation|Death|0
6099401|NCT00279201|21046333|P3|Initiation|Death|0
6099402|NCT00279201|21046334|P2|Initiation|Death|5
6099403|NCT00279201|21046335|P1|Initiation|Death|1
6099404|NCT00278993|21046479|P1|Overall Study|Not Otherwise Specified|4
6099405|NCT00278993|21046479|P1|Overall Study|Physician Decision|9
6099406|NCT00278993|21046479|P1|Overall Study|Progressive Disease|65
6099407|NCT00278993|21046479|P1|Overall Study|Withdrawal by Subject|5
6099408|NCT00278993|21046479|P1|Overall Study|Adverse Event|24
6099409|NCT00278954|21046487|P1|Overall Study|Withdrawal by Subject|1
6099410|NCT00278954|21046487|P1|Overall Study|Lost to Follow-up|1
6099411|NCT00278954|21046487|P1|Overall Study|Adverse Event|3
6099412|NCT00278915|21046495|P1|Overall Study|Lack of Efficacy|1
6099413|NCT00278889|21046531|P3|Overall Study|Death|17
6099414|NCT00278889|21046532|P2|Overall Study|Death|21
6099415|NCT00278889|21046533|P1|Overall Study|Death|24
6099416|NCT00278889|21046531|P3|Overall Study|Lost to Follow-up|0
6099417|NCT00278889|21046532|P2|Overall Study|Lost to Follow-up|1
6099418|NCT00278889|21046533|P1|Overall Study|Lost to Follow-up|1
6099419|NCT00278889|21046531|P3|Overall Study|Withdrawal by Subject|3
6099420|NCT00278889|21046532|P2|Overall Study|Withdrawal by Subject|5
6099421|NCT00278889|21046533|P1|Overall Study|Withdrawal by Subject|0
6099422|NCT00278629|21046581|P1|Overall Study|Non-CIDP Immune-Mediated Peripheral Neur|14
6099423|NCT00278564|21046588|P1|Overall Study|Lack of Efficacy|4
6099424|NCT00278512|21046609|P2|Overall Study|Death|0
6099425|NCT00278512|21046610|P1|Overall Study|Death|1
6099426|NCT00278473|21046618|P2|Overall Study|drop out|3
6099427|NCT00278473|21046619|P1|Overall Study|drop out|4
6099428|NCT00278395|21046635|P1|Overall Study|Nonevaluable|1
6099429|NCT00278395|21046635|P1|Overall Study|Adverse Event|2
6099430|NCT00278200|21046653|P2|Overall Study|Physician Decision|1
6099431|NCT00278200|21046654|P1|Overall Study|Physician Decision|0
6099432|NCT00278200|21046653|P2|Overall Study|Death|3
6099433|NCT00278200|21046654|P1|Overall Study|Death|1
6099434|NCT00278161|21046663|P1|Overall Study|Death|11
6099435|NCT00278148|21046669|P3|Phase II - Expansion Phase|Adverse Event|2
6099436|NCT00278148|21046670|P2|Phase II - Expansion Phase|Adverse Event|0
6099437|NCT00278148|21046671|P1|Phase II - Expansion Phase|Adverse Event|0
6099438|NCT00278148|21046669|P3|Phase II - Expansion Phase|Disease progression|4
6099439|NCT00278148|21046670|P2|Phase II - Expansion Phase|Disease progression|0
6099440|NCT00278148|21046671|P1|Phase II - Expansion Phase|Disease progression|0
6099441|NCT00278109|21046683|P1|Overall Study|social circumstances|1
6099442|NCT00278109|21046683|P1|Overall Study|Adverse Event|3
6099443|NCT00277355|21046729|P2|Overall Study|Physician Decision|0
6099444|NCT00277355|21046730|P1|Overall Study|Physician Decision|1
6099445|NCT00277355|21046729|P2|Overall Study|Death|0
6099446|NCT00277355|21046730|P1|Overall Study|Death|3
6099447|NCT00277355|21046729|P2|Overall Study|Adverse Event|0
6099448|NCT00277355|21046730|P1|Overall Study|Adverse Event|5
6099449|NCT00277355|21046729|P2|Overall Study|Lost to Follow-up|2
6099450|NCT00277355|21046730|P1|Overall Study|Lost to Follow-up|2
6099451|NCT00277355|21046729|P2|Overall Study|Withdrawal by Subject|3
6099452|NCT00277355|21046730|P1|Overall Study|Withdrawal by Subject|3
6099453|NCT00277212|21046738|P3|Phase 2 - Double-Blind Treatment|Other reasons|5
6099454|NCT00277212|21046739|P2|Phase 2 - Double-Blind Treatment|Other reasons|7
6099455|NCT00277212|21046740|P1|Phase 2 - Double-Blind Treatment|Other reasons|0
6099456|NCT00277212|21046738|P3|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|3
6099457|NCT00277212|21046739|P2|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|1
6099458|NCT00277212|21046740|P1|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|0
6099459|NCT00277212|21046738|P3|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|6
6099460|NCT00277212|21046739|P2|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|4
6099461|NCT00277212|21046740|P1|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|0
6099462|NCT00277212|21046738|P3|Phase 2 - Double-Blind Treatment|Pregnancy|2
6099463|NCT00277212|21046739|P2|Phase 2 - Double-Blind Treatment|Pregnancy|2
6099464|NCT00277212|21046740|P1|Phase 2 - Double-Blind Treatment|Pregnancy|0
6099465|NCT00277212|21046738|P3|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|8
6099466|NCT00277212|21046739|P2|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|7
6099467|NCT00277212|21046740|P1|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|0
6099468|NCT00277212|21046738|P3|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18
6099469|NCT00277212|21046739|P2|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18
6099470|NCT00277212|21046740|P1|Phase 2 - Double-Blind Treatment|Lost to Follow-up|0
6099471|NCT00277212|21046738|P3|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|16
6099472|NCT00277212|21046739|P2|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|17
6099473|NCT00277212|21046740|P1|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|0
6099474|NCT00277212|21046738|P3|Phase 2 - Double-Blind Treatment|Adverse Event|16
6099475|NCT00277212|21046739|P2|Phase 2 - Double-Blind Treatment|Adverse Event|10
6099476|NCT00277212|21046740|P1|Phase 2 - Double-Blind Treatment|Adverse Event|0
6099477|NCT00277212|21046738|P3|Phase 2 - Double-Blind Treatment|Lack of Efficacy|39
6099478|NCT00277212|21046739|P2|Phase 2 - Double-Blind Treatment|Lack of Efficacy|54
6099479|NCT00277212|21046740|P1|Phase 2 - Double-Blind Treatment|Lack of Efficacy|0
6099480|NCT00277212|21046738|P3|Phase 1 - Single-Blind Treatment|Other Reasons|0
6099481|NCT00277212|21046739|P2|Phase 1 - Single-Blind Treatment|Other Reasons|0
6099482|NCT00277212|21046740|P1|Phase 1 - Single-Blind Treatment|Other Reasons|12
6099483|NCT00277212|21046738|P3|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0
6099484|NCT00277212|21046739|P2|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0
6099485|NCT00277212|21046740|P1|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|1
6099486|NCT00277212|21046738|P3|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0
6099487|NCT00277212|21046739|P2|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0
6099488|NCT00277212|21046740|P1|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|44
6099489|NCT00277212|21046738|P3|Phase 1 - Single-Blind Treatment|Pregnancy|0
6099490|NCT00277212|21046739|P2|Phase 1 - Single-Blind Treatment|Pregnancy|0
6099491|NCT00277212|21046740|P1|Phase 1 - Single-Blind Treatment|Pregnancy|6
6099492|NCT00277212|21046738|P3|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0
6099493|NCT00277212|21046739|P2|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0
6099494|NCT00277212|21046740|P1|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|35
6099495|NCT00277212|21046738|P3|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0
6099496|NCT00277212|21046739|P2|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0
6099497|NCT00277212|21046740|P1|Phase 1 - Single-Blind Treatment|Lost to Follow-up|87
6099498|NCT00277212|21046738|P3|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0
6099499|NCT00277212|21046739|P2|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0
6099500|NCT00277212|21046740|P1|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|96
6099501|NCT00277212|21046738|P3|Phase 1 - Single-Blind Treatment|Adverse Event|0
6099502|NCT00277212|21046739|P2|Phase 1 - Single-Blind Treatment|Adverse Event|0
6099503|NCT00277212|21046740|P1|Phase 1 - Single-Blind Treatment|Adverse Event|93
6099504|NCT00277212|21046738|P3|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0
6099505|NCT00277212|21046739|P2|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0
6099506|NCT00277212|21046740|P1|Phase 1 - Single-Blind Treatment|Lack of Efficacy|61
6099507|NCT00277095|21046778|P1|Overall Study|Physician Decision|1
6099508|NCT00277095|21046778|P1|Overall Study|Missed Follow-up|9
6099509|NCT00277095|21046778|P1|Overall Study|Lost to Follow-up|2
6099510|NCT00277095|21046778|P1|Overall Study|Explanted|7
6099511|NCT00277095|21046778|P1|Overall Study|Death|2
6099512|NCT00276744|21046787|P1|PART A|Reason unknown|98
6099513|NCT00276614|21046791|P1|Overall Study|Progression of disease under study|3
6099514|NCT00276484|21046802|P2|Overall Study|Could not take time off work|1
6099515|NCT00276484|21046803|P1|Overall Study|Could not take time off work|0
6099516|NCT00276484|21046802|P2|Overall Study|Withdrawal by Subject|3
6099517|NCT00276484|21046803|P1|Overall Study|Withdrawal by Subject|4
6099518|NCT00276484|21046802|P2|Overall Study|Protocol Violation|1
6099519|NCT00276484|21046803|P1|Overall Study|Protocol Violation|0
6099520|NCT00276484|21046802|P2|Overall Study|Lost to Follow-up|1
6099521|NCT00276484|21046803|P1|Overall Study|Lost to Follow-up|1
6099522|NCT00276484|21046802|P2|Overall Study|Adverse Event|7
6099523|NCT00276484|21046803|P1|Overall Study|Adverse Event|4
6099524|NCT00276458|21046835|P2|Overall Study|Protocol Violation|3
6099525|NCT00276458|21046836|P1|Overall Study|Protocol Violation|4
6099526|NCT00276458|21046835|P2|Overall Study|Lost to Follow-up|2
6099527|NCT00276458|21046836|P1|Overall Study|Lost to Follow-up|2
6099528|NCT00276458|21046835|P2|Overall Study|Adverse Event|2
6099529|NCT00276458|21046836|P1|Overall Study|Adverse Event|0
6099530|NCT00276419|21046870|P2|First Intervention|Withdrawal by Subject|2
6099531|NCT00276419|21046871|P1|First Intervention|Withdrawal by Subject|0
6099532|NCT00276419|21046870|P2|First Intervention|Adverse Event|0
6099533|NCT00276419|21046871|P1|First Intervention|Adverse Event|1
6099534|NCT00276380|21046914|P2|Overall Study|Abnormal aPPT Levels|1
6099535|NCT00276380|21046915|P1|Overall Study|Abnormal aPPT Levels|0
6099536|NCT00276380|21046914|P2|Overall Study|Death|3
6099537|NCT00276380|21046915|P1|Overall Study|Death|5
6099538|NCT00276380|21046914|P2|Overall Study|Withdrawal by Subject|6
6099539|NCT00276380|21046915|P1|Overall Study|Withdrawal by Subject|3
6099540|NCT00276380|21046914|P2|Overall Study|Lost to Follow-up|1
6099541|NCT00276380|21046915|P1|Overall Study|Lost to Follow-up|1
6099542|NCT00276380|21046914|P2|Overall Study|Adverse Event|3
6099543|NCT00276380|21046915|P1|Overall Study|Adverse Event|5
6099544|NCT00276159|21046970|P1|Overall Study|Did not receive all 24 doses of 852A|6
6099545|NCT00276094|21046980|P3|Overall Study|Other-Study medication lost|1
6099546|NCT00276094|21046981|P2|Overall Study|Other-Study medication lost|0
6099547|NCT00276094|21046982|P1|Overall Study|Other-Study medication lost|0
6099548|NCT00276094|21046980|P3|Overall Study|Other-Relocation|0
6099549|NCT00276094|21046981|P2|Overall Study|Other-Relocation|1
6099550|NCT00276094|21046982|P1|Overall Study|Other-Relocation|0
6099551|NCT00276094|21046980|P3|Overall Study|Other-Repeat safety labs-exclusionary|0
6099552|NCT00276094|21046981|P2|Overall Study|Other-Repeat safety labs-exclusionary|1
6099553|NCT00276094|21046982|P1|Overall Study|Other-Repeat safety labs-exclusionary|0
6099554|NCT00276094|21046980|P3|Overall Study|Other-Refused follow-up visit|0
6099555|NCT00276094|21046981|P2|Overall Study|Other-Refused follow-up visit|0
6099556|NCT00276094|21046982|P1|Overall Study|Other-Refused follow-up visit|1
6099557|NCT00276094|21046980|P3|Overall Study|Other-Lack of efficacy|0
6099558|NCT00276094|21046981|P2|Overall Study|Other-Lack of efficacy|0
6099559|NCT00276094|21046982|P1|Overall Study|Other-Lack of efficacy|1
6099560|NCT00276094|21046980|P3|Overall Study|Other-Scheduled gastroplasty|0
6099561|NCT00276094|21046981|P2|Overall Study|Other-Scheduled gastroplasty|0
6099562|NCT00276094|21046982|P1|Overall Study|Other-Scheduled gastroplasty|1
6099563|NCT00276094|21046980|P3|Overall Study|Other-Subject moved out of country|0
6099564|NCT00276094|21046981|P2|Overall Study|Other-Subject moved out of country|0
6099565|NCT00276094|21046982|P1|Overall Study|Other-Subject moved out of country|1
6099566|NCT00276094|21046980|P3|Overall Study|Lost to Follow-up|4
6099567|NCT00276094|21046981|P2|Overall Study|Lost to Follow-up|6
6099568|NCT00276094|21046982|P1|Overall Study|Lost to Follow-up|8
6099569|NCT00276094|21046980|P3|Overall Study|Protocol Violation|10
6099570|NCT00276094|21046981|P2|Overall Study|Protocol Violation|7
6099571|NCT00276094|21046982|P1|Overall Study|Protocol Violation|16
6099572|NCT00276094|21046980|P3|Overall Study|Withdrawal by Subject|12
6099573|NCT00276094|21046981|P2|Overall Study|Withdrawal by Subject|14
6099574|NCT00276094|21046982|P1|Overall Study|Withdrawal by Subject|14
6099575|NCT00276094|21046980|P3|Overall Study|Adverse Event|11
6099576|NCT00276094|21046981|P2|Overall Study|Adverse Event|13
6099577|NCT00276094|21046982|P1|Overall Study|Adverse Event|15
6099578|NCT00276016|21047035|P6|Intervention 1|Withdrawal by Subject|0
6099579|NCT00276016|21047036|P5|Intervention 1|Withdrawal by Subject|0
6099580|NCT00276016|21047037|P4|Intervention 1|Withdrawal by Subject|0
6099581|NCT00276016|21047038|P3|Intervention 1|Withdrawal by Subject|0
6099582|NCT00276016|21047039|P2|Intervention 1|Withdrawal by Subject|1
6099583|NCT00276016|21047040|P1|Intervention 1|Withdrawal by Subject|0
6099584|NCT00275821|21047086|P3|Overall Study|Protocol Violation|0
6099585|NCT00275821|21047087|P2|Overall Study|Protocol Violation|1
6099586|NCT00275821|21047088|P1|Overall Study|Protocol Violation|5
6099587|NCT00275821|21047086|P3|Overall Study|Lack of Efficacy|0
6099588|NCT00275821|21047087|P2|Overall Study|Lack of Efficacy|1
6099589|NCT00275821|21047088|P1|Overall Study|Lack of Efficacy|2
6099590|NCT00275821|21047086|P3|Overall Study|Death|1
6099591|NCT00275821|21047087|P2|Overall Study|Death|2
6099592|NCT00275821|21047088|P1|Overall Study|Death|0
6099593|NCT00275821|21047086|P3|Overall Study|Lost to Follow-up|1
6099594|NCT00275821|21047087|P2|Overall Study|Lost to Follow-up|1
6099595|NCT00275821|21047088|P1|Overall Study|Lost to Follow-up|0
6099596|NCT00275821|21047086|P3|Overall Study|Withdrawal by Subject|1
6099597|NCT00275821|21047087|P2|Overall Study|Withdrawal by Subject|2
6099598|NCT00275821|21047088|P1|Overall Study|Withdrawal by Subject|0
6099599|NCT00275821|21047086|P3|Overall Study|Administrative problems|4
6099600|NCT00275821|21047087|P2|Overall Study|Administrative problems|4
6099601|NCT00275821|21047088|P1|Overall Study|Administrative problems|3
6099602|NCT00275821|21047086|P3|Overall Study|Adverse Event|5
6099603|NCT00275821|21047087|P2|Overall Study|Adverse Event|12
6099604|NCT00275821|21047088|P1|Overall Study|Adverse Event|4
6099605|NCT00275561|21047107|P2|Overall Study|Family Issues|2
6099606|NCT00275561|21047108|P1|Overall Study|Family Issues|0
6099607|NCT00275561|21047107|P2|Overall Study|Scheduling|2
6099608|NCT00275561|21047108|P1|Overall Study|Scheduling|1
6099609|NCT00275561|21047107|P2|Overall Study|Travel|1
6099610|NCT00275561|21047108|P1|Overall Study|Travel|1
6099611|NCT00275561|21047107|P2|Overall Study|Withdrawal by Subject|1
6099612|NCT00275561|21047108|P1|Overall Study|Withdrawal by Subject|0
6099613|NCT00275509|21047120|P2|Overall Study|graft thrombosis, post-operative day #8|1
6099614|NCT00275509|21047121|P1|Overall Study|graft thrombosis, post-operative day #8|0
6099615|NCT00275340|21047144|P2|Overall Study|Lost to Follow-up|4
6099616|NCT00275340|21047145|P1|Overall Study|Lost to Follow-up|2
6099617|NCT00275301|21047149|P1|Overall Study|Adverse Event|5
6099618|NCT00275262|21047168|P2|Overall Study|Started Chemotherapy|0
6099619|NCT00275262|21047169|P1|Overall Study|Started Chemotherapy|1
6099620|NCT00275262|21047168|P2|Overall Study|Death|0
6099621|NCT00275262|21047169|P1|Overall Study|Death|1
6099622|NCT00275262|21047168|P2|Overall Study|Protocol Violation|2
6099623|NCT00275262|21047169|P1|Overall Study|Protocol Violation|0
6099624|NCT00275262|21047168|P2|Overall Study|Lost to Follow-up|2
6099625|NCT00275262|21047169|P1|Overall Study|Lost to Follow-up|0
6099626|NCT00275262|21047168|P2|Overall Study|Disease progression|5
6099627|NCT00275262|21047169|P1|Overall Study|Disease progression|2
6099628|NCT00275262|21047168|P2|Overall Study|Adverse Event|0
6099629|NCT00275262|21047169|P1|Overall Study|Adverse Event|2
6099630|NCT00275028|21047183|P1|Overall Study|Physician Decision|2
6099631|NCT00275028|21047183|P1|Overall Study|Progressive Disease|30
6099632|NCT00275028|21047183|P1|Overall Study|Adverse Event|9
6099633|NCT00275028|21047183|P1|Overall Study|Withdrawal by Subject|5
6099634|NCT00275028|21047183|P1|Overall Study|Withdrew consent before treatment began|1
6099635|NCT00275002|21047190|P2|Overall Study|Adverse Event|1
6099636|NCT00275002|21047191|P1|Overall Study|Adverse Event|0
6099637|NCT00275002|21047190|P2|Overall Study|Disease progression|15
6099638|NCT00275002|21047191|P1|Overall Study|Disease progression|21
6099639|NCT00275002|21047190|P2|Overall Study|Death|0
6099640|NCT00275002|21047191|P1|Overall Study|Death|1
6099641|NCT00274937|21047199|P1|Overall Study|Progressive Disease|4
6099642|NCT00274937|21047199|P1|Overall Study|Withdrawal by Subject|6
6099643|NCT00274937|21047199|P1|Overall Study|Physician Decision|10
6099644|NCT00274924|21047211|P3|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0
6099645|NCT00274924|21047212|P2|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|1
6099646|NCT00274924|21047213|P1|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0
6099647|NCT00274924|21047211|P3|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0
6099648|NCT00274924|21047212|P2|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|1
6099649|NCT00274924|21047213|P1|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0
6099650|NCT00274924|21047211|P3|Step 2 (Tx Based on Mid-treatment PET)|Death|0
6099651|NCT00274924|21047212|P2|Step 2 (Tx Based on Mid-treatment PET)|Death|1
6099652|NCT00274924|21047213|P1|Step 2 (Tx Based on Mid-treatment PET)|Death|0
6099653|NCT00274924|21047211|P3|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0
6099654|NCT00274924|21047212|P2|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0
6099655|NCT00274924|21047213|P1|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|1
6099656|NCT00274924|21047211|P3|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0
6099657|NCT00274924|21047212|P2|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0
6099658|NCT00274924|21047213|P1|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|1
6099659|NCT00274924|21047211|P3|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0
6099660|NCT00274924|21047212|P2|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0
6099661|NCT00274924|21047213|P1|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|1
6099662|NCT00274924|21047211|P3|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|0
6099663|NCT00274924|21047212|P2|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|15
6099664|NCT00274924|21047213|P1|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|4
6099665|NCT00274924|21047211|P3|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|1
6099666|NCT00274924|21047212|P2|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0
6099667|NCT00274924|21047213|P1|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0
6099668|NCT00274924|21047211|P3|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|1
6099669|NCT00274924|21047212|P2|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0
6099670|NCT00274924|21047213|P1|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0
6099671|NCT00274924|21047211|P3|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|1
6099672|NCT00274924|21047212|P2|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0
6099673|NCT00274924|21047213|P1|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0
6099674|NCT00274924|21047211|P3|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|1
6099675|NCT00274924|21047212|P2|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0
6099676|NCT00274924|21047213|P1|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0
6099677|NCT00274924|21047211|P3|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|1
6099678|NCT00274924|21047212|P2|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0
6099679|NCT00274924|21047213|P1|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0
6099680|NCT00274924|21047211|P3|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|1
6099681|NCT00274924|21047212|P2|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|14
6099682|NCT00274924|21047213|P1|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|4
6099683|NCT00274846|21047222|P1|Overall Study|Did not receive adequate NK cells|1
6099684|NCT00274742|21047251|P6|Overall Study|Other|0
6099685|NCT00274742|21047252|P5|Overall Study|Other|2
6099686|NCT00274742|21047253|P4|Overall Study|Other|0
6099687|NCT00274742|21047254|P3|Overall Study|Other|0
6099688|NCT00274742|21047255|P2|Overall Study|Other|3
6099689|NCT00274742|21047256|P1|Overall Study|Other|0
6099690|NCT00274742|21047251|P6|Overall Study|Disease Progression|0
6099691|NCT00274742|21047252|P5|Overall Study|Disease Progression|1
6099692|NCT00274742|21047253|P4|Overall Study|Disease Progression|0
6099693|NCT00274742|21047254|P3|Overall Study|Disease Progression|1
6099694|NCT00274742|21047255|P2|Overall Study|Disease Progression|1
6099695|NCT00274742|21047256|P1|Overall Study|Disease Progression|0
6099696|NCT00274742|21047251|P6|Overall Study|End of Study|0
6099697|NCT00274742|21047252|P5|Overall Study|End of Study|0
6099698|NCT00274742|21047253|P4|Overall Study|End of Study|1
6099699|NCT00274742|21047254|P3|Overall Study|End of Study|0
6099700|NCT00274742|21047255|P2|Overall Study|End of Study|0
6099701|NCT00274742|21047256|P1|Overall Study|End of Study|0
6099702|NCT00274742|21047251|P6|Overall Study|Lost to Follow-up|0
6099703|NCT00274742|21047252|P5|Overall Study|Lost to Follow-up|1
6099704|NCT00274742|21047253|P4|Overall Study|Lost to Follow-up|0
6099705|NCT00274742|21047254|P3|Overall Study|Lost to Follow-up|0
6099706|NCT00274742|21047255|P2|Overall Study|Lost to Follow-up|0
6099707|NCT00274742|21047256|P1|Overall Study|Lost to Follow-up|0
6099708|NCT00274742|21047251|P6|Overall Study|Adverse Event|3
6099709|NCT00274742|21047252|P5|Overall Study|Adverse Event|12
6099710|NCT00274742|21047253|P4|Overall Study|Adverse Event|4
6099711|NCT00274742|21047254|P3|Overall Study|Adverse Event|1
6099712|NCT00274742|21047255|P2|Overall Study|Adverse Event|4
6099713|NCT00274742|21047256|P1|Overall Study|Adverse Event|0
6099714|NCT00274716|21047294|P6|Phase B|Lost to Follow-up|0
6099715|NCT00274716|21047295|P5|Phase B|Lost to Follow-up|0
6099716|NCT00274716|21047296|P4|Phase B|Lost to Follow-up|0
6099717|NCT00274716|21047297|P3|Phase B|Lost to Follow-up|0
6099718|NCT00274716|21047298|P2|Phase B|Lost to Follow-up|1
6099719|NCT00274716|21047299|P1|Phase B|Lost to Follow-up|0
6099720|NCT00274716|21047294|P6|Phase B|Other non-reported reason|0
6099721|NCT00274716|21047295|P5|Phase B|Other non-reported reason|0
6099722|NCT00274716|21047296|P4|Phase B|Other non-reported reason|1
6099723|NCT00274716|21047297|P3|Phase B|Other non-reported reason|1
6099724|NCT00274716|21047298|P2|Phase B|Other non-reported reason|0
6099725|NCT00274716|21047299|P1|Phase B|Other non-reported reason|0
6099726|NCT00274716|21047294|P6|Phase B|Participant moved|0
6099727|NCT00274716|21047295|P5|Phase B|Participant moved|0
6099728|NCT00274716|21047296|P4|Phase B|Participant moved|0
6099729|NCT00274716|21047297|P3|Phase B|Participant moved|0
6099730|NCT00274716|21047298|P2|Phase B|Participant moved|0
6099731|NCT00274716|21047299|P1|Phase B|Participant moved|1
6099732|NCT00274716|21047294|P6|Phase B|Withdrawal by Subject|0
6099733|NCT00274716|21047295|P5|Phase B|Withdrawal by Subject|0
6099734|NCT00274716|21047296|P4|Phase B|Withdrawal by Subject|0
6099735|NCT00274716|21047297|P3|Phase B|Withdrawal by Subject|0
6099736|NCT00274716|21047298|P2|Phase B|Withdrawal by Subject|1
6099737|NCT00274716|21047299|P1|Phase B|Withdrawal by Subject|0
6099738|NCT00274716|21047294|P6|Phase B|Protocol Violation|0
6099739|NCT00274716|21047295|P5|Phase B|Protocol Violation|0
6099740|NCT00274716|21047296|P4|Phase B|Protocol Violation|0
6099741|NCT00274716|21047297|P3|Phase B|Protocol Violation|0
6099742|NCT00274716|21047298|P2|Phase B|Protocol Violation|2
6099743|NCT00274716|21047299|P1|Phase B|Protocol Violation|0
6099744|NCT00274716|21047294|P6|Phase B|Adverse Event|1
6099745|NCT00274716|21047295|P5|Phase B|Adverse Event|0
6099746|NCT00274716|21047296|P4|Phase B|Adverse Event|0
6099747|NCT00274716|21047297|P3|Phase B|Adverse Event|2
6099748|NCT00274716|21047298|P2|Phase B|Adverse Event|0
6099749|NCT00274716|21047299|P1|Phase B|Adverse Event|0
6099750|NCT00274716|21047294|P6|Phase A|Completed but did not enter Phase B|1
6099751|NCT00274716|21047295|P5|Phase A|Completed but did not enter Phase B|1
6099752|NCT00274716|21047296|P4|Phase A|Completed but did not enter Phase B|2
6099753|NCT00274716|21047297|P3|Phase A|Completed but did not enter Phase B|2
6099754|NCT00274716|21047298|P2|Phase A|Completed but did not enter Phase B|2
6099755|NCT00274716|21047299|P1|Phase A|Completed but did not enter Phase B|1
6099756|NCT00274716|21047294|P6|Phase A|Adverse Event|0
6099757|NCT00274716|21047295|P5|Phase A|Adverse Event|2
6099758|NCT00274716|21047296|P4|Phase A|Adverse Event|0
6099759|NCT00274716|21047297|P3|Phase A|Adverse Event|3
6099760|NCT00274716|21047298|P2|Phase A|Adverse Event|3
6099761|NCT00274716|21047299|P1|Phase A|Adverse Event|2
6099762|NCT00274716|21047294|P6|Phase A|Withdrawal by Subject|1
6099763|NCT00274716|21047295|P5|Phase A|Withdrawal by Subject|0
6099764|NCT00274716|21047296|P4|Phase A|Withdrawal by Subject|3
6099765|NCT00274716|21047297|P3|Phase A|Withdrawal by Subject|1
6099766|NCT00274716|21047298|P2|Phase A|Withdrawal by Subject|2
6099767|NCT00274716|21047299|P1|Phase A|Withdrawal by Subject|2
6099768|NCT00274716|21047294|P6|Phase A|Met criteria for discontinuation|0
6099769|NCT00274716|21047295|P5|Phase A|Met criteria for discontinuation|0
6099770|NCT00274716|21047296|P4|Phase A|Met criteria for discontinuation|0
6099771|NCT00274716|21047297|P3|Phase A|Met criteria for discontinuation|0
6099772|NCT00274716|21047298|P2|Phase A|Met criteria for discontinuation|1
6099773|NCT00274716|21047299|P1|Phase A|Met criteria for discontinuation|1
6099774|NCT00274716|21047294|P6|Phase A|Protocol Violation|0
6099775|NCT00274716|21047295|P5|Phase A|Protocol Violation|0
6099776|NCT00274716|21047296|P4|Phase A|Protocol Violation|1
6099777|NCT00274716|21047297|P3|Phase A|Protocol Violation|0
6099778|NCT00274716|21047298|P2|Phase A|Protocol Violation|0
6099779|NCT00274716|21047299|P1|Phase A|Protocol Violation|1
6099780|NCT00274716|21047294|P6|Phase A|Site Terminated|0
6099781|NCT00274716|21047295|P5|Phase A|Site Terminated|0
6099782|NCT00274716|21047296|P4|Phase A|Site Terminated|1
6099783|NCT00274716|21047297|P3|Phase A|Site Terminated|0
6099784|NCT00274716|21047298|P2|Phase A|Site Terminated|0
6099785|NCT00274716|21047299|P1|Phase A|Site Terminated|0
6099786|NCT00274716|21047294|P6|Phase A|Participant moved|1
6099787|NCT00274716|21047295|P5|Phase A|Participant moved|0
6099788|NCT00274716|21047296|P4|Phase A|Participant moved|0
6099789|NCT00274716|21047297|P3|Phase A|Participant moved|1
6099790|NCT00274716|21047298|P2|Phase A|Participant moved|0
6099791|NCT00274716|21047299|P1|Phase A|Participant moved|0
6099792|NCT00274716|21047294|P6|Phase A|Other non-reported reason|1
6099793|NCT00274716|21047295|P5|Phase A|Other non-reported reason|0
6099794|NCT00274716|21047296|P4|Phase A|Other non-reported reason|2
6099795|NCT00274716|21047297|P3|Phase A|Other non-reported reason|1
6099796|NCT00274716|21047298|P2|Phase A|Other non-reported reason|2
6099797|NCT00274716|21047299|P1|Phase A|Other non-reported reason|4
6099798|NCT00274651|21047361|P2|Overall Study|Physician Decision|7
6099799|NCT00274651|21047362|P1|Overall Study|Physician Decision|8
6099800|NCT00274651|21047361|P2|Overall Study|Withdrawal by Subject|1
6099801|NCT00274651|21047362|P1|Overall Study|Withdrawal by Subject|0
6099802|NCT00274651|21047361|P2|Overall Study|Death|3
6099803|NCT00274651|21047362|P1|Overall Study|Death|1
6099804|NCT00274651|21047361|P2|Overall Study|Lack of Efficacy|6
6099805|NCT00274651|21047362|P1|Overall Study|Lack of Efficacy|13
6099806|NCT00274651|21047361|P2|Overall Study|Adverse Event|3
6099807|NCT00274651|21047362|P1|Overall Study|Adverse Event|6
6099808|NCT00274625|21047377|P2|Overall Study|Excluded from analysis|8
6099809|NCT00274625|21047378|P1|Overall Study|Excluded from analysis|14
6099810|NCT00274625|21047377|P2|Overall Study|Lost to Follow-up|54
6099811|NCT00274625|21047378|P1|Overall Study|Lost to Follow-up|46
6099812|NCT00274469|21047386|P2|Overall Study|Did not consent to OS follow-up|19
6099813|NCT00274469|21047387|P1|Overall Study|Did not consent to OS follow-up|16
6099814|NCT00274469|21047386|P2|Overall Study|Death|74
6099815|NCT00274469|21047387|P1|Overall Study|Death|63
6099816|NCT00274456|21047407|P4|Overall Study|Withdrawal by Subject|13
6099817|NCT00274456|21047408|P3|Overall Study|Withdrawal by Subject|9
6099818|NCT00274456|21047409|P2|Overall Study|Withdrawal by Subject|13
6099819|NCT00274456|21047410|P1|Overall Study|Withdrawal by Subject|18
6099820|NCT00274456|21047407|P4|Overall Study|Lost to Follow-up|0
6099821|NCT00274456|21047408|P3|Overall Study|Lost to Follow-up|1
6099822|NCT00274456|21047409|P2|Overall Study|Lost to Follow-up|0
6099823|NCT00274456|21047410|P1|Overall Study|Lost to Follow-up|0
6099824|NCT00274456|21047407|P4|Overall Study|Physician Decision|13
6099825|NCT00274456|21047408|P3|Overall Study|Physician Decision|6
6099826|NCT00274456|21047409|P2|Overall Study|Physician Decision|5
6099827|NCT00274456|21047410|P1|Overall Study|Physician Decision|7
6099828|NCT00274456|21047407|P4|Overall Study|Adverse Event|2
6099829|NCT00274456|21047408|P3|Overall Study|Adverse Event|2
6099830|NCT00274456|21047409|P2|Overall Study|Adverse Event|1
6099831|NCT00274456|21047410|P1|Overall Study|Adverse Event|0
6099832|NCT00274456|21047407|P4|Overall Study|Unacceptable toxicity|16
6099833|NCT00274456|21047408|P3|Overall Study|Unacceptable toxicity|12
6099834|NCT00274456|21047409|P2|Overall Study|Unacceptable toxicity|5
6099835|NCT00274456|21047410|P1|Overall Study|Unacceptable toxicity|10
6099836|NCT00274456|21047407|P4|Overall Study|Still on treatment|1
6099837|NCT00274456|21047408|P3|Overall Study|Still on treatment|5
6099838|NCT00274456|21047409|P2|Overall Study|Still on treatment|3
6099839|NCT00274456|21047410|P1|Overall Study|Still on treatment|2
6099840|NCT00274287|21047452|P1|Overall Study|subject non-compliance|1
6099841|NCT00274287|21047452|P1|Overall Study|Withdrawal by Subject|1
6099842|NCT00274261|21047462|P2|Overall Study|Lost to Follow-up|75
6099843|NCT00274261|21047463|P1|Overall Study|Lost to Follow-up|106
6099844|NCT00274261|21047462|P2|Overall Study|Protocol Violation|42
6099845|NCT00274261|21047463|P1|Overall Study|Protocol Violation|71
6099846|NCT00274261|21047462|P2|Overall Study|Withdrawal by Subject|126
6099847|NCT00274261|21047463|P1|Overall Study|Withdrawal by Subject|179
6099848|NCT00274261|21047462|P2|Overall Study|Pregnancy|83
6099849|NCT00274261|21047463|P1|Overall Study|Pregnancy|114
6099850|NCT00274261|21047462|P2|Overall Study|Adverse Event|11
6099851|NCT00274261|21047463|P1|Overall Study|Adverse Event|19
6099852|NCT00273858|21047502|P1|Overall Study|Adverse Event|81
6099853|NCT00273858|21047502|P1|Overall Study|Withdrawal by Subject|21
6099854|NCT00273858|21047502|P1|Overall Study|Lost to Follow-up|101
6099855|NCT00273858|21047502|P1|Overall Study|Not completed 24 month observation time|334
6099856|NCT00273182|21047570|P1|Overall Study|Site exit, system change, 36 m FU missed|36
6099857|NCT00273182|21047570|P1|Overall Study|Device/System Explant|154
6099858|NCT00273182|21047570|P1|Overall Study|Withdrawal by Subject|257
6099859|NCT00273182|21047570|P1|Overall Study|Lost to Follow-up|88
6099860|NCT00273182|21047570|P1|Overall Study|Death|450
6099861|NCT00273052|21047580|P2|Overall Study|Worsening serum lipid levels|2
6099862|NCT00273052|21047581|P1|Overall Study|Worsening serum lipid levels|0
6099863|NCT00273052|21047580|P2|Overall Study|Other|0
6099864|NCT00273052|21047581|P1|Overall Study|Other|2
6099865|NCT00273052|21047580|P2|Overall Study|Non-Compliance|1
6099866|NCT00273052|21047581|P1|Overall Study|Non-Compliance|3
6099867|NCT00273052|21047580|P2|Overall Study|Lack of Efficacy|4
6099868|NCT00273052|21047581|P1|Overall Study|Lack of Efficacy|6
6099869|NCT00273052|21047580|P2|Overall Study|Lost to Follow-up|25
6099870|NCT00273052|21047581|P1|Overall Study|Lost to Follow-up|7
6099871|NCT00273052|21047580|P2|Overall Study|Protocol Violation|18
6099872|NCT00273052|21047581|P1|Overall Study|Protocol Violation|14
6099873|NCT00273052|21047580|P2|Overall Study|Adverse Event|19
6099874|NCT00273052|21047581|P1|Overall Study|Adverse Event|21
6099875|NCT00273052|21047580|P2|Overall Study|Withdrawal by Subject|19
6099876|NCT00273052|21047581|P1|Overall Study|Withdrawal by Subject|16
6099877|NCT00272987|21047616|P3|Overall Study|Death|0
6099878|NCT00272987|21047617|P2|Overall Study|Death|0
6099879|NCT00272987|21047618|P1|Overall Study|Death|1
6099880|NCT00272987|21047616|P3|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|4
6099881|NCT00272987|21047617|P2|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|1
6099882|NCT00272987|21047618|P1|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|2
6099883|NCT00272987|21047616|P3|Overall Study|Disease progression|2
6099884|NCT00272987|21047617|P2|Overall Study|Disease progression|1
6099885|NCT00272987|21047618|P1|Overall Study|Disease progression|1
6099886|NCT00272987|21047616|P3|Overall Study|Sponsor Terminated study|1
6099887|NCT00272987|21047617|P2|Overall Study|Sponsor Terminated study|1
6099888|NCT00272987|21047618|P1|Overall Study|Sponsor Terminated study|0
6099889|NCT00272987|21047616|P3|Overall Study|Withdrawal by Subject|3
6099890|NCT00272987|21047617|P2|Overall Study|Withdrawal by Subject|0
6099891|NCT00272987|21047618|P1|Overall Study|Withdrawal by Subject|1
6099892|NCT00272987|21047616|P3|Overall Study|Lost to Follow-up|1
6099893|NCT00272987|21047617|P2|Overall Study|Lost to Follow-up|1
6099894|NCT00272987|21047618|P1|Overall Study|Lost to Follow-up|3
6099895|NCT00272987|21047616|P3|Overall Study|Adverse Event|0
6099896|NCT00272987|21047617|P2|Overall Study|Adverse Event|0
6099897|NCT00272987|21047618|P1|Overall Study|Adverse Event|1
6099898|NCT00272961|21047688|P5|Treatment Phase: Week 3 Up to Week 12|Other|2
6099899|NCT00272961|21047689|P4|Treatment Phase: Week 3 Up to Week 12|Other|2
6099900|NCT00272961|21047690|P3|Treatment Phase: Week 3 Up to Week 12|Other|3
6099901|NCT00272961|21047691|P2|Treatment Phase: Week 3 Up to Week 12|Other|3
6099902|NCT00272961|21047692|P1|Treatment Phase: Week 3 Up to Week 12|Other|1
6099903|NCT00272961|21047688|P5|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0
6099904|NCT00272961|21047689|P4|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0
6099905|NCT00272961|21047690|P3|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1
6099906|NCT00272961|21047691|P2|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0
6099907|NCT00272961|21047692|P1|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1
6099908|NCT00272961|21047688|P5|Treatment Phase: Week 3 Up to Week 12|Adverse Event|2
6099909|NCT00272961|21047689|P4|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1
6099910|NCT00272961|21047690|P3|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0
6099911|NCT00272961|21047691|P2|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1
6099912|NCT00272961|21047692|P1|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0
6099913|NCT00272961|21047688|P5|Placebo Run-in Phase: Up to Week 2|Other|0
6099914|NCT00272961|21047689|P4|Placebo Run-in Phase: Up to Week 2|Other|0
6099915|NCT00272961|21047690|P3|Placebo Run-in Phase: Up to Week 2|Other|0
6099916|NCT00272961|21047691|P2|Placebo Run-in Phase: Up to Week 2|Other|0
6099917|NCT00272961|21047692|P1|Placebo Run-in Phase: Up to Week 2|Other|2
6099918|NCT00272961|21047688|P5|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0
6099919|NCT00272961|21047689|P4|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0
6099920|NCT00272961|21047690|P3|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0
6099921|NCT00272961|21047691|P2|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0
6099922|NCT00272961|21047692|P1|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|2
6099923|NCT00272961|21047688|P5|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0
6099924|NCT00272961|21047689|P4|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0
6099925|NCT00272961|21047690|P3|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0
6099926|NCT00272961|21047691|P2|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0
6099927|NCT00272961|21047692|P1|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|5
6099928|NCT00272961|21047688|P5|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0
6099929|NCT00272961|21047689|P4|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0
6099930|NCT00272961|21047690|P3|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0
6099931|NCT00272961|21047691|P2|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0
6099932|NCT00272961|21047692|P1|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|1
6099933|NCT00272961|21047688|P5|Placebo Run-in Phase: Up to Week 2|Physician Decision|0
6099934|NCT00272961|21047689|P4|Placebo Run-in Phase: Up to Week 2|Physician Decision|0
6099935|NCT00272961|21047690|P3|Placebo Run-in Phase: Up to Week 2|Physician Decision|0
6099936|NCT00272961|21047691|P2|Placebo Run-in Phase: Up to Week 2|Physician Decision|0
6099937|NCT00272961|21047692|P1|Placebo Run-in Phase: Up to Week 2|Physician Decision|1
6099938|NCT00272844|21047749|P1|Overall Study|Withdrawal by Subject|5
6099939|NCT00272792|21047757|P2|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|1
6099940|NCT00272792|21047758|P1|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|0
6099941|NCT00272792|21047757|P2|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|0
6099942|NCT00272792|21047758|P1|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|1
6099943|NCT00272792|21047757|P2|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|2
6099944|NCT00272792|21047758|P1|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|0
6099945|NCT00272792|21047757|P2|Part 1: Responsiveness|Lost to Follow-up|0
6099946|NCT00272792|21047758|P1|Part 1: Responsiveness|Lost to Follow-up|1
6099947|NCT00272779|21047768|P2|Baseline Through Week 96|Continuing on treatment|38
6099948|NCT00272779|21047769|P1|Baseline Through Week 96|Continuing on treatment|61
6099949|NCT00272779|21047768|P2|Baseline Through Week 96|Never treated|3
6099950|NCT00272779|21047769|P1|Baseline Through Week 96|Never treated|2
6099951|NCT00272779|21047768|P2|Baseline Through Week 96|Pregnancy at Week 96|0
6099952|NCT00272779|21047769|P1|Baseline Through Week 96|Pregnancy at Week 96|1
6099953|NCT00272779|21047768|P2|Baseline Through Week 96|Poor/non compliance at Week 96]|0
6099954|NCT00272779|21047769|P1|Baseline Through Week 96|Poor/non compliance at Week 96]|2
6099955|NCT00272779|21047768|P2|Baseline Through Week 96|Lost to follow-up at Week 96|0
6099956|NCT00272779|21047769|P1|Baseline Through Week 96|Lost to follow-up at Week 96|1
6099957|NCT00272779|21047768|P2|Baseline Through Week 96|Changed address before Week 96|1
6099958|NCT00272779|21047769|P1|Baseline Through Week 96|Changed address before Week 96|0
6099959|NCT00272779|21047768|P2|Baseline Through Week 96|Withdrew consent before Week 96|18
6099960|NCT00272779|21047769|P1|Baseline Through Week 96|Withdrew consent before Week 96|5
6099961|NCT00272779|21047768|P2|Baseline Through Week 96|No longer meets criteria before Week 96|3
6099962|NCT00272779|21047769|P1|Baseline Through Week 96|No longer meets criteria before Week 96|4
6099963|NCT00272779|21047768|P2|Baseline Through Week 96|Pregnancy before Week 96|7
6099964|NCT00272779|21047769|P1|Baseline Through Week 96|Pregnancy before Week 96|5
6099965|NCT00272779|21047768|P2|Baseline Through Week 96|Poor/non compliance before Week 96|16
6099966|NCT00272779|21047769|P1|Baseline Through Week 96|Poor/non compliance before Week 96|12
6099967|NCT00272779|21047768|P2|Baseline Through Week 96|Participant Imprisoned before Week 96|0
6099968|NCT00272779|21047769|P1|Baseline Through Week 96|Participant Imprisoned before Week 96|1
6099969|NCT00272779|21047768|P2|Baseline Through Week 96|Lost to follow up before Week 96|13
6099970|NCT00272779|21047769|P1|Baseline Through Week 96|Lost to follow up before Week 96|10
6099971|NCT00272779|21047768|P2|Baseline Through Week 96|Lack of efficacy before Week 96|10
6099972|NCT00272779|21047769|P1|Baseline Through Week 96|Lack of efficacy before Week 96|16
6099973|NCT00272779|21047768|P2|Baseline Through Week 96|Death before Week 96|5
6099974|NCT00272779|21047769|P1|Baseline Through Week 96|Death before Week 96|6
6099975|NCT00272779|21047768|P2|Baseline Through Week 96|Adverse event before Week 96|22
6099976|NCT00272779|21047769|P1|Baseline Through Week 96|Adverse event before Week 96|13
6099977|NCT00272779|21047768|P2|Baseline Through Week 48|Never treated|3
6099978|NCT00272779|21047769|P1|Baseline Through Week 48|Never treated|2
6099979|NCT00272779|21047768|P2|Baseline Through Week 48|Lost to follow-up on/after Week 48|3
6099980|NCT00272779|21047769|P1|Baseline Through Week 48|Lost to follow-up on/after Week 48|0
6099981|NCT00272779|21047768|P2|Baseline Through Week 48|Continuing treatment|368
6099982|NCT00272779|21047769|P1|Baseline Through Week 48|Continuing treatment|385
6099983|NCT00272779|21047768|P2|Baseline Through Week 48|Withdrew consent on/after Week 48|2
6099984|NCT00272779|21047769|P1|Baseline Through Week 48|Withdrew consent on/after Week 48|0
6099985|NCT00272779|21047768|P2|Baseline Through Week 48|Pregnancy on/after Week 48|2
6099986|NCT00272779|21047769|P1|Baseline Through Week 48|Pregnancy on/after Week 48|1
6099987|NCT00272779|21047768|P2|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2
6099988|NCT00272779|21047769|P1|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2
6099989|NCT00272779|21047768|P2|Baseline Through Week 48|Poor/non compliance on/after Week|2
6099990|NCT00272779|21047769|P1|Baseline Through Week 48|Poor/non compliance on/after Week|2
6099991|NCT00272779|21047768|P2|Baseline Through Week 48|Lack of efficacy on/after Week 48|1
6099992|NCT00272779|21047769|P1|Baseline Through Week 48|Lack of efficacy on/after Week 48|7
6099993|NCT00272779|21047768|P2|Baseline Through Week 48|Death on/after Week 48|1
6099994|NCT00272779|21047769|P1|Baseline Through Week 48|Death on/after Week 48|1
6099995|NCT00272779|21047768|P2|Baseline Through Week 48|Adverse event on/after Week 48|1
6099996|NCT00272779|21047769|P1|Baseline Through Week 48|Adverse event on/after Week 48|1
6099997|NCT00272779|21047768|P2|Baseline Through Week 48|Chose different site before wk 48|1
6099998|NCT00272779|21047769|P1|Baseline Through Week 48|Chose different site before wk 48|0
6099999|NCT00272779|21047768|P2|Baseline Through Week 48|Participant's decision before wk 48|1
6100000|NCT00272779|21047769|P1|Baseline Through Week 48|Participant's decision before wk 48|0
6100001|NCT00272779|21047768|P2|Baseline Through Week 48|Withdrew consent before Week 48|13
6100002|NCT00272779|21047769|P1|Baseline Through Week 48|Withdrew consent before Week 48|4
6100003|NCT00272779|21047768|P2|Baseline Through Week 48|No longer meets criteria before Week 48|0
6100004|NCT00272779|21047769|P1|Baseline Through Week 48|No longer meets criteria before Week 48|1
6100005|NCT00272779|21047768|P2|Baseline Through Week 48|Pregnancy before Week 48|2
6100006|NCT00272779|21047769|P1|Baseline Through Week 48|Pregnancy before Week 48|2
6100007|NCT00272779|21047768|P2|Baseline Through Week 48|Poor/non compliance before Week 48|9
6100008|NCT00272779|21047769|P1|Baseline Through Week 48|Poor/non compliance before Week 48|6
6100009|NCT00272779|21047768|P2|Baseline Through Week 48|Viral load rebound before Week 48|0
6100010|NCT00272779|21047769|P1|Baseline Through Week 48|Viral load rebound before Week 48|1
6100011|NCT00272779|21047768|P2|Baseline Through Week 48|Lost to follow-up before Week 48|6
6100012|NCT00272779|21047769|P1|Baseline Through Week 48|Lost to follow-up before Week 48|6
6100013|NCT00272779|21047768|P2|Baseline Through Week 48|Lack of efficacy before Week 48|8
6100014|NCT00272779|21047769|P1|Baseline Through Week 48|Lack of efficacy before Week 48|5
6100015|NCT00272779|21047768|P2|Baseline Through Week 48|Death before Week 48|4
6100016|NCT00272779|21047769|P1|Baseline Through Week 48|Death before Week 48|4
6100017|NCT00272779|21047768|P2|Baseline Through Week 48|Adverse event before Week 48|14
6100018|NCT00272779|21047769|P1|Baseline Through Week 48|Adverse event before Week 48|10
6100019|NCT00272038|21048029|P1|Overall Study|withdrew before they received 2 cycles|7
6100020|NCT00271947|21048035|P1|Overall Study|Lost to Follow-up|1
6100021|NCT00271856|21048041|P2|Overall Study|Lost to Follow-up|11
6100022|NCT00271856|21048042|P1|Overall Study|Lost to Follow-up|10
6100023|NCT00271856|21048041|P2|Overall Study|Withdrawal by Subject|7
6100024|NCT00271856|21048042|P1|Overall Study|Withdrawal by Subject|1
6100025|NCT00271817|21048061|P3|Part 2|LDL < 50 mg/dL|4
6100026|NCT00271817|21048062|P2|Part 2|LDL < 50 mg/dL|3
6100027|NCT00271817|21048063|P1|Part 2|LDL < 50 mg/dL|0
6100028|NCT00271817|21048061|P3|Part 2|Withdrawal by Subject|13
6100029|NCT00271817|21048062|P2|Part 2|Withdrawal by Subject|2
6100030|NCT00271817|21048063|P1|Part 2|Withdrawal by Subject|0
6100031|NCT00271817|21048061|P3|Part 2|Patient Moved|5
6100032|NCT00271817|21048062|P2|Part 2|Patient Moved|0
6100033|NCT00271817|21048063|P1|Part 2|Patient Moved|0
6100034|NCT00271817|21048061|P3|Part 2|Protocol Violation|5
6100035|NCT00271817|21048062|P2|Part 2|Protocol Violation|3
6100036|NCT00271817|21048063|P1|Part 2|Protocol Violation|0
6100037|NCT00271817|21048061|P3|Part 2|Lost to Follow-up|18
6100038|NCT00271817|21048062|P2|Part 2|Lost to Follow-up|6
6100039|NCT00271817|21048063|P1|Part 2|Lost to Follow-up|0
6100040|NCT00271817|21048061|P3|Part 2|Lack of Efficacy|6
6100041|NCT00271817|21048062|P2|Part 2|Lack of Efficacy|1
6100042|NCT00271817|21048063|P1|Part 2|Lack of Efficacy|0
6100043|NCT00271817|21048061|P3|Part 2|Adverse Event|33
6100044|NCT00271817|21048062|P2|Part 2|Adverse Event|17
6100045|NCT00271817|21048063|P1|Part 2|Adverse Event|0
6100046|NCT00271817|21048061|P3|Part 1|LDL < 50 mg/dL|48
6100047|NCT00271817|21048062|P2|Part 1|LDL < 50 mg/dL|4
6100048|NCT00271817|21048063|P1|Part 1|LDL < 50 mg/dL|1
6100049|NCT00271817|21048061|P3|Part 1|Withdrawal by Subject|45
6100050|NCT00271817|21048062|P2|Part 1|Withdrawal by Subject|17
6100051|NCT00271817|21048063|P1|Part 1|Withdrawal by Subject|23
6100052|NCT00271817|21048061|P3|Part 1|Patient Moved|5
6100053|NCT00271817|21048062|P2|Part 1|Patient Moved|1
6100054|NCT00271817|21048063|P1|Part 1|Patient Moved|3
6100055|NCT00271817|21048061|P3|Part 1|Protocol Violation|7
6100056|NCT00271817|21048062|P2|Part 1|Protocol Violation|4
6100057|NCT00271817|21048063|P1|Part 1|Protocol Violation|5
6100058|NCT00271817|21048061|P3|Part 1|Lost to Follow-up|24
6100059|NCT00271817|21048062|P2|Part 1|Lost to Follow-up|8
6100060|NCT00271817|21048063|P1|Part 1|Lost to Follow-up|6
6100061|NCT00271817|21048061|P3|Part 1|Adverse Event|156
6100062|NCT00271817|21048062|P2|Part 1|Adverse Event|25
6100063|NCT00271817|21048063|P1|Part 1|Adverse Event|68
6100064|NCT00271609|21048105|P2|Overall Study|Withdrawal by Subject|0
6100065|NCT00271609|21048106|P1|Overall Study|Withdrawal by Subject|2
6100066|NCT00271609|21048105|P2|Overall Study|Adverse Event|3
6100067|NCT00271609|21048106|P1|Overall Study|Adverse Event|11
6100068|NCT00271596|21048116|P2|Overall Study|Withdrawal by Subject|1
6100069|NCT00271596|21048117|P1|Overall Study|Withdrawal by Subject|0
6100070|NCT00271596|21048116|P2|Overall Study|Protocol Violation|0
6100071|NCT00271596|21048117|P1|Overall Study|Protocol Violation|1
6100072|NCT00271544|21048152|P1|Overall Study|Implant not attempted|4
6100073|NCT00271544|21048152|P1|Overall Study|Model 4196 lead not attempted|9
6100074|NCT00271544|21048152|P1|Overall Study|Subjects did not receive a 4196 lead|7
6100075|NCT00271505|21048173|P1|Overall Study|Death|1
6100076|NCT00271505|21048173|P1|Overall Study|Adverse Event|1
6100077|NCT00271505|21048173|P1|Overall Study|Screen Failure|3
6100078|NCT00271024|21048272|P4|Overall Study|Time Commitment, Scheduling, or Travel|4
6100079|NCT00271024|21048273|P3|Overall Study|Time Commitment, Scheduling, or Travel|4
6100080|NCT00271024|21048274|P2|Overall Study|Time Commitment, Scheduling, or Travel|2
6100081|NCT00271024|21048275|P1|Overall Study|Time Commitment, Scheduling, or Travel|6
6100082|NCT00271024|21048272|P4|Overall Study|Unpleasant Reaction To Tablet|2
6100083|NCT00271024|21048273|P3|Overall Study|Unpleasant Reaction To Tablet|4
6100084|NCT00271024|21048274|P2|Overall Study|Unpleasant Reaction To Tablet|3
6100085|NCT00271024|21048275|P1|Overall Study|Unpleasant Reaction To Tablet|1
6100086|NCT00271024|21048272|P4|Overall Study|Protocol Violation|11
6100087|NCT00271024|21048273|P3|Overall Study|Protocol Violation|5
6100088|NCT00271024|21048274|P2|Overall Study|Protocol Violation|6
6100089|NCT00271024|21048275|P1|Overall Study|Protocol Violation|1
6100090|NCT00271024|21048272|P4|Overall Study|Unknown/Unspecified|4
6100091|NCT00271024|21048273|P3|Overall Study|Unknown/Unspecified|8
6100092|NCT00271024|21048274|P2|Overall Study|Unknown/Unspecified|11
6100093|NCT00271024|21048275|P1|Overall Study|Unknown/Unspecified|11
6100094|NCT00271024|21048272|P4|Overall Study|Lost Interest|3
6100095|NCT00271024|21048273|P3|Overall Study|Lost Interest|2
6100096|NCT00271024|21048274|P2|Overall Study|Lost Interest|4
6100097|NCT00271024|21048275|P1|Overall Study|Lost Interest|3
6100098|NCT00270998|21048325|P3|12 Month Follow-up|Received/desired alternate treatment|1
6100099|NCT00270998|21048326|P2|12 Month Follow-up|Received/desired alternate treatment|4
6100100|NCT00270998|21048327|P1|12 Month Follow-up|Received/desired alternate treatment|1
6100101|NCT00270998|21048325|P3|12 Month Follow-up|Personal/family health|1
6100102|NCT00270998|21048326|P2|12 Month Follow-up|Personal/family health|5
6100103|NCT00270998|21048327|P1|12 Month Follow-up|Personal/family health|0
6100104|NCT00270998|21048325|P3|12 Month Follow-up|Pessary did not fit|0
6100105|NCT00270998|21048326|P2|12 Month Follow-up|Pessary did not fit|0
6100106|NCT00270998|21048327|P1|12 Month Follow-up|Pessary did not fit|1
6100107|NCT00270998|21048325|P3|12 Month Follow-up|Withdrawal by Subject|16
6100108|NCT00270998|21048326|P2|12 Month Follow-up|Withdrawal by Subject|12
6100109|NCT00270998|21048327|P1|12 Month Follow-up|Withdrawal by Subject|7
6100110|NCT00270998|21048325|P3|12 Month Follow-up|Lack of Efficacy|3
6100111|NCT00270998|21048326|P2|12 Month Follow-up|Lack of Efficacy|4
6100112|NCT00270998|21048327|P1|12 Month Follow-up|Lack of Efficacy|5
6100113|NCT00270998|21048325|P3|3 Month Follow-up|Received/desired alternate treatment|2
6100114|NCT00270998|21048326|P2|3 Month Follow-up|Received/desired alternate treatment|5
6100115|NCT00270998|21048327|P1|3 Month Follow-up|Received/desired alternate treatment|13
6100116|NCT00270998|21048325|P3|3 Month Follow-up|Personal/family health|0
6100117|NCT00270998|21048326|P2|3 Month Follow-up|Personal/family health|1
6100118|NCT00270998|21048327|P1|3 Month Follow-up|Personal/family health|1
6100119|NCT00270998|21048325|P3|3 Month Follow-up|Pessary did not fit|0
6100120|NCT00270998|21048326|P2|3 Month Follow-up|Pessary did not fit|0
6100121|NCT00270998|21048327|P1|3 Month Follow-up|Pessary did not fit|12
6100122|NCT00270998|21048325|P3|3 Month Follow-up|Withdrawal by Subject|15
6100123|NCT00270998|21048326|P2|3 Month Follow-up|Withdrawal by Subject|14
6100124|NCT00270998|21048327|P1|3 Month Follow-up|Withdrawal by Subject|11
6100125|NCT00270998|21048325|P3|3 Month Follow-up|Lack of Efficacy|1
6100126|NCT00270998|21048326|P2|3 Month Follow-up|Lack of Efficacy|2
6100127|NCT00270998|21048327|P1|3 Month Follow-up|Lack of Efficacy|1
6100128|NCT00270998|21048325|P3|3 Month Follow-up|Adverse Event|0
6100129|NCT00270998|21048326|P2|3 Month Follow-up|Adverse Event|0
6100130|NCT00270998|21048327|P1|3 Month Follow-up|Adverse Event|1
6100131|NCT00270894|21048356|P1|Overall Study|Withdrawal by Subject|1
6100132|NCT00270894|21048356|P1|Overall Study|Adverse Event|1
6100133|NCT00270855|21048368|P2|Overall Study|Withdrawal by Subject|8
6100134|NCT00270855|21048369|P1|Overall Study|Withdrawal by Subject|8
6100135|NCT00270257|21048505|P2|Overall Study|Data Safety Monitoring Board (DSMB) halt|424
6100136|NCT00270257|21048506|P1|Overall Study|Data Safety Monitoring Board (DSMB) halt|412
6100137|NCT00270231|21048524|P2|Second Intervention|Lost to Follow-up|1
6100138|NCT00270231|21048525|P1|Second Intervention|Lost to Follow-up|0
6100139|NCT00270231|21048524|P2|Washout Period|Lost to Follow-up|0
6100140|NCT00270231|21048525|P1|Washout Period|Lost to Follow-up|1
6100141|NCT00270231|21048524|P2|First Intervention|Lost to Follow-up|1
6100142|NCT00270231|21048525|P1|First Intervention|Lost to Follow-up|1
6100143|NCT00270205|21048535|P4|Overall Study|Lost to Follow-up|1
6100144|NCT00270205|21048536|P3|Overall Study|Lost to Follow-up|0
6100145|NCT00270205|21048537|P2|Overall Study|Lost to Follow-up|0
6100146|NCT00270205|21048538|P1|Overall Study|Lost to Follow-up|1
6100147|NCT00269919|21048656|P1|Overall Study|Started but not treated|1
6100148|NCT00269919|21048656|P1|Overall Study|Other|26
6100149|NCT00269633|21048675|P2|Overall Study|Withdrawal by Subject|0
6100150|NCT00269633|21048676|P1|Overall Study|Withdrawal by Subject|1
6100151|NCT00269477|21048686|P4|Overall Study|Missed post-vaccination blood draw|0
6100152|NCT00269477|21048687|P3|Overall Study|Missed post-vaccination blood draw|0
6100153|NCT00269477|21048688|P2|Overall Study|Missed post-vaccination blood draw|1
6100154|NCT00269477|21048689|P1|Overall Study|Missed post-vaccination blood draw|0
6100155|NCT00269477|21048686|P4|Overall Study|Protocol Violation|0
6100156|NCT00269477|21048687|P3|Overall Study|Protocol Violation|1
6100157|NCT00269477|21048688|P2|Overall Study|Protocol Violation|5
6100158|NCT00269477|21048689|P1|Overall Study|Protocol Violation|5
6100159|NCT00269399|21048705|P2|Overall Study|Development of exclusion criteria|1
6100160|NCT00269399|21048706|P1|Overall Study|Development of exclusion criteria|0
6100161|NCT00269399|21048705|P2|Overall Study|Other|4
6100162|NCT00269399|21048706|P1|Overall Study|Other|0
6100163|NCT00269399|21048705|P2|Overall Study|Negative Lab Result for C. difficile|3
6100164|NCT00269399|21048706|P1|Overall Study|Negative Lab Result for C. difficile|2
6100165|NCT00269399|21048705|P2|Overall Study|Withdrawal by Subject|5
6100166|NCT00269399|21048706|P1|Overall Study|Withdrawal by Subject|2
6100167|NCT00269399|21048705|P2|Overall Study|Adverse Event|4
6100168|NCT00269399|21048706|P1|Overall Study|Adverse Event|10
6100169|NCT00269399|21048705|P2|Overall Study|Lack of Efficacy|10
6100170|NCT00269399|21048706|P1|Overall Study|Lack of Efficacy|27
6100171|NCT00269152|21048716|P2|Overall Study|Protocol Violation|1
6100172|NCT00269152|21048717|P1|Overall Study|Protocol Violation|0
6100173|NCT00269152|21048716|P2|Overall Study|Physician Decision|3
6100174|NCT00269152|21048717|P1|Overall Study|Physician Decision|2
6100175|NCT00269152|21048716|P2|Overall Study|Withdrawal by Subject|3
6100176|NCT00269152|21048717|P1|Overall Study|Withdrawal by Subject|7
6100177|NCT00269152|21048716|P2|Overall Study|Adverse Event|3
6100178|NCT00269152|21048717|P1|Overall Study|Adverse Event|9
6100179|NCT00269113|21048733|P2|Overall Study|Other|2
6100180|NCT00269113|21048734|P1|Overall Study|Other|0
6100181|NCT00269113|21048733|P2|Overall Study|Protocol Violation|5
6100182|NCT00269113|21048734|P1|Overall Study|Protocol Violation|15
6100183|NCT00269113|21048733|P2|Overall Study|Lost to Follow-up|1
6100184|NCT00269113|21048734|P1|Overall Study|Lost to Follow-up|2
6100185|NCT00269113|21048733|P2|Overall Study|Death|2
6100186|NCT00269113|21048734|P1|Overall Study|Death|6
6100187|NCT00269113|21048733|P2|Overall Study|Withdrawal by Subject|2
6100188|NCT00269113|21048734|P1|Overall Study|Withdrawal by Subject|0
6100189|NCT00269113|21048733|P2|Overall Study|Early Improvement|0
6100190|NCT00269113|21048734|P1|Overall Study|Early Improvement|2
6100191|NCT00269113|21048733|P2|Overall Study|Lack of Efficacy|18
6100192|NCT00269113|21048734|P1|Overall Study|Lack of Efficacy|35
6100193|NCT00269113|21048733|P2|Overall Study|Adverse Event|7
6100194|NCT00269113|21048734|P1|Overall Study|Adverse Event|14
6100195|NCT00269087|21048752|P1|Overall Study|Exacerbation of COPD|13
6100196|NCT00269087|21048752|P1|Overall Study|Withdrawal by Subject|1
6100197|NCT00269087|21048752|P1|Overall Study|Adverse Event|20
6100198|NCT00268996|21048782|P2|Overall Study|Other|1
6100199|NCT00268996|21048783|P1|Overall Study|Other|1
6100200|NCT00268996|21048782|P2|Overall Study|Non-compliance|0
6100201|NCT00268996|21048783|P1|Overall Study|Non-compliance|1
6100202|NCT00268996|21048782|P2|Overall Study|Withdrawal by Subject|11
6100203|NCT00268996|21048783|P1|Overall Study|Withdrawal by Subject|5
6100204|NCT00268996|21048782|P2|Overall Study|Lost to Follow-up|1
6100205|NCT00268996|21048783|P1|Overall Study|Lost to Follow-up|3
6100206|NCT00268996|21048782|P2|Overall Study|Adverse Event|7
6100207|NCT00268996|21048783|P1|Overall Study|Adverse Event|11
6100208|NCT00268983|21048827|P2|Overall Study|Death|0
6100209|NCT00268983|21048828|P1|Overall Study|Death|3
6100210|NCT00268905|21048871|P3|Overall Study|Clinical Progression|1
6100211|NCT00268905|21048872|P2|Overall Study|Clinical Progression|4
6100212|NCT00268905|21048873|P1|Overall Study|Clinical Progression|9
6100213|NCT00268905|21048871|P3|Overall Study|Physician Decision|1
6100214|NCT00268905|21048872|P2|Overall Study|Physician Decision|0
6100215|NCT00268905|21048873|P1|Overall Study|Physician Decision|3
6100216|NCT00268905|21048871|P3|Overall Study|Progressive Disease|3
6100217|NCT00268905|21048872|P2|Overall Study|Progressive Disease|4
6100218|NCT00268905|21048873|P1|Overall Study|Progressive Disease|28
6100219|NCT00268905|21048871|P3|Overall Study|Withdrawal by Subject|3
6100220|NCT00268905|21048872|P2|Overall Study|Withdrawal by Subject|0
6100221|NCT00268905|21048873|P1|Overall Study|Withdrawal by Subject|0
6100222|NCT00268905|21048871|P3|Overall Study|Lost to Follow-up|0
6100223|NCT00268905|21048872|P2|Overall Study|Lost to Follow-up|1
6100224|NCT00268905|21048873|P1|Overall Study|Lost to Follow-up|0
6100225|NCT00268905|21048871|P3|Overall Study|Adverse Event|4
6100226|NCT00268905|21048872|P2|Overall Study|Adverse Event|0
6100227|NCT00268905|21048873|P1|Overall Study|Adverse Event|3
6100228|NCT00268892|21048890|P3|Overall Study|Trial Site Closed|2
6100229|NCT00268892|21048891|P2|Overall Study|Trial Site Closed|2
6100230|NCT00268892|21048892|P1|Overall Study|Trial Site Closed|4
6100231|NCT00268892|21048890|P3|Overall Study|Disease Progression|0
6100232|NCT00268892|21048891|P2|Overall Study|Disease Progression|1
6100233|NCT00268892|21048892|P1|Overall Study|Disease Progression|1
6100234|NCT00268892|21048890|P3|Overall Study|Protocol Violation|0
6100235|NCT00268892|21048891|P2|Overall Study|Protocol Violation|1
6100236|NCT00268892|21048892|P1|Overall Study|Protocol Violation|0
6100237|NCT00268892|21048890|P3|Overall Study|Lost to Follow-up|4
6100238|NCT00268892|21048891|P2|Overall Study|Lost to Follow-up|2
6100239|NCT00268892|21048892|P1|Overall Study|Lost to Follow-up|5
6100240|NCT00268892|21048890|P3|Overall Study|Physician Decision|0
6100241|NCT00268892|21048891|P2|Overall Study|Physician Decision|1
6100242|NCT00268892|21048892|P1|Overall Study|Physician Decision|0
6100243|NCT00268892|21048890|P3|Overall Study|Withdrawal by Subject|13
6100244|NCT00268892|21048891|P2|Overall Study|Withdrawal by Subject|15
6100245|NCT00268892|21048892|P1|Overall Study|Withdrawal by Subject|14
6100246|NCT00268892|21048890|P3|Overall Study|Lack of Efficacy|0
6100247|NCT00268892|21048891|P2|Overall Study|Lack of Efficacy|3
6100248|NCT00268892|21048892|P1|Overall Study|Lack of Efficacy|1
6100249|NCT00268892|21048890|P3|Overall Study|Adverse Event|20
6100250|NCT00268892|21048891|P2|Overall Study|Adverse Event|17
6100251|NCT00268892|21048892|P1|Overall Study|Adverse Event|14
6100252|NCT00268463|21048911|P2|Overall Study|study terminated due to low accrual|12
6100253|NCT00268463|21048912|P1|Overall Study|study terminated due to low accrual|10
6100254|NCT00268437|21048928|P1|Overall Study|Ineligible|1
6100255|NCT00268346|21048935|P2|Overall Study|Withdrawal by Subject|1
6100256|NCT00268346|21048936|P1|Overall Study|Withdrawal by Subject|0
6100257|NCT00268346|21048935|P2|Overall Study|Death|1
6100258|NCT00268346|21048936|P1|Overall Study|Death|0
6100259|NCT00268346|21048935|P2|Overall Study|Adverse Event|1
6100260|NCT00268346|21048936|P1|Overall Study|Adverse Event|0
6100261|NCT00268242|21048942|P1|Overall Study|Death|1
6100262|NCT00268203|21048951|P1|Overall Study|Completed 2 Years of Follow-up|62
6100263|NCT00268203|21048951|P1|Overall Study|Reason Not Specified|34
6100264|NCT00268203|21048951|P1|Overall Study|Death|84
6100265|NCT00268203|21048951|P1|Overall Study|Progressive Disease|359
6100266|NCT00268203|21048951|P1|Overall Study|Received Other NHL Therapy|7
6100267|NCT00268203|21048951|P1|Overall Study|Withdrawal by Subject|9
6100268|NCT00268203|21048951|P1|Overall Study|Lost to Follow-up|92
6100269|NCT00267969|21048965|P7|After Controlled Period|Other|25
6100270|NCT00267969|21048966|P6|After Controlled Period|Other|22
6100271|NCT00267969|21048967|P5|After Controlled Period|Other|11
6100272|NCT00267969|21048968|P4|After Controlled Period|Other|13
6100273|NCT00267969|21048969|P3|After Controlled Period|Other|0
6100274|NCT00267969|21048970|P2|After Controlled Period|Other|0
6100275|NCT00267969|21048971|P1|After Controlled Period|Other|0
6100276|NCT00267969|21048965|P7|After Controlled Period|Lost to Follow-up|10
6100277|NCT00267969|21048966|P6|After Controlled Period|Lost to Follow-up|9
6100278|NCT00267969|21048967|P5|After Controlled Period|Lost to Follow-up|8
6100279|NCT00267969|21048968|P4|After Controlled Period|Lost to Follow-up|5
6100280|NCT00267969|21048969|P3|After Controlled Period|Lost to Follow-up|0
6100281|NCT00267969|21048970|P2|After Controlled Period|Lost to Follow-up|0
6100282|NCT00267969|21048971|P1|After Controlled Period|Lost to Follow-up|0
6100283|NCT00267969|21048965|P7|After Controlled Period|Lack of Efficacy|15
6100284|NCT00267969|21048966|P6|After Controlled Period|Lack of Efficacy|28
6100285|NCT00267969|21048967|P5|After Controlled Period|Lack of Efficacy|6
6100286|NCT00267969|21048968|P4|After Controlled Period|Lack of Efficacy|10
6100287|NCT00267969|21048969|P3|After Controlled Period|Lack of Efficacy|0
6100288|NCT00267969|21048970|P2|After Controlled Period|Lack of Efficacy|0
6100289|NCT00267969|21048971|P1|After Controlled Period|Lack of Efficacy|0
6100290|NCT00267969|21048965|P7|After Controlled Period|Death|1
6100291|NCT00267969|21048966|P6|After Controlled Period|Death|0
6100292|NCT00267969|21048967|P5|After Controlled Period|Death|2
6100293|NCT00267969|21048968|P4|After Controlled Period|Death|1
6100294|NCT00267969|21048969|P3|After Controlled Period|Death|0
6100295|NCT00267969|21048970|P2|After Controlled Period|Death|0
6100296|NCT00267969|21048971|P1|After Controlled Period|Death|0
6100297|NCT00267969|21048965|P7|After Controlled Period|Adverse Event|21
6100298|NCT00267969|21048966|P6|After Controlled Period|Adverse Event|23
6100299|NCT00267969|21048967|P5|After Controlled Period|Adverse Event|8
6100300|NCT00267969|21048968|P4|After Controlled Period|Adverse Event|7
6100301|NCT00267969|21048969|P3|After Controlled Period|Adverse Event|0
6100302|NCT00267969|21048970|P2|After Controlled Period|Adverse Event|0
6100303|NCT00267969|21048971|P1|After Controlled Period|Adverse Event|0
6100304|NCT00267969|21048965|P7|Controlled Period|Other|0
6100305|NCT00267969|21048966|P6|Controlled Period|Other|0
6100306|NCT00267969|21048967|P5|Controlled Period|Other|0
6100307|NCT00267969|21048968|P4|Controlled Period|Other|0
6100308|NCT00267969|21048969|P3|Controlled Period|Other|6
6100309|NCT00267969|21048970|P2|Controlled Period|Other|1
6100310|NCT00267969|21048971|P1|Controlled Period|Other|2
6100311|NCT00267969|21048965|P7|Controlled Period|Randomized but not treated|0
6100312|NCT00267969|21048966|P6|Controlled Period|Randomized but not treated|0
6100313|NCT00267969|21048967|P5|Controlled Period|Randomized but not treated|0
6100314|NCT00267969|21048968|P4|Controlled Period|Randomized but not treated|0
6100315|NCT00267969|21048969|P3|Controlled Period|Randomized but not treated|1
6100316|NCT00267969|21048970|P2|Controlled Period|Randomized but not treated|0
6100317|NCT00267969|21048971|P1|Controlled Period|Randomized but not treated|0
6100318|NCT00267969|21048965|P7|Controlled Period|Lost to Follow-up|0
6100319|NCT00267969|21048966|P6|Controlled Period|Lost to Follow-up|0
6100320|NCT00267969|21048967|P5|Controlled Period|Lost to Follow-up|0
6100321|NCT00267969|21048968|P4|Controlled Period|Lost to Follow-up|0
6100322|NCT00267969|21048969|P3|Controlled Period|Lost to Follow-up|1
6100323|NCT00267969|21048970|P2|Controlled Period|Lost to Follow-up|0
6100324|NCT00267969|21048971|P1|Controlled Period|Lost to Follow-up|1
6100325|NCT00267969|21048965|P7|Controlled Period|Lack of Efficacy|0
6100326|NCT00267969|21048966|P6|Controlled Period|Lack of Efficacy|0
6100327|NCT00267969|21048967|P5|Controlled Period|Lack of Efficacy|0
6100328|NCT00267969|21048968|P4|Controlled Period|Lack of Efficacy|0
6100329|NCT00267969|21048969|P3|Controlled Period|Lack of Efficacy|1
6100330|NCT00267969|21048970|P2|Controlled Period|Lack of Efficacy|0
6100331|NCT00267969|21048971|P1|Controlled Period|Lack of Efficacy|3
6100332|NCT00267969|21048965|P7|Controlled Period|Adverse Event|0
6100333|NCT00267969|21048966|P6|Controlled Period|Adverse Event|0
6100334|NCT00267969|21048967|P5|Controlled Period|Adverse Event|0
6100335|NCT00267969|21048968|P4|Controlled Period|Adverse Event|0
6100336|NCT00267969|21048969|P3|Controlled Period|Adverse Event|2
6100337|NCT00267969|21048970|P2|Controlled Period|Adverse Event|0
6100338|NCT00267969|21048971|P1|Controlled Period|Adverse Event|6
6100339|NCT00267956|21048997|P4|After Controlled Period|Withdrew consent|0
6100340|NCT00267956|21048998|P3|After Controlled Period|Withdrew consent|1
6100341|NCT00267956|21048999|P2|After Controlled Period|Withdrew consent|0
6100342|NCT00267956|21049000|P1|After Controlled Period|Withdrew consent|0
6100343|NCT00267956|21048997|P4|After Controlled Period|Lost to Follow-up|0
6100344|NCT00267956|21048998|P3|After Controlled Period|Lost to Follow-up|1
6100345|NCT00267956|21048999|P2|After Controlled Period|Lost to Follow-up|0
6100346|NCT00267956|21049000|P1|After Controlled Period|Lost to Follow-up|0
6100347|NCT00267956|21048997|P4|After Controlled Period|Lack of Efficacy|1
6100348|NCT00267956|21048998|P3|After Controlled Period|Lack of Efficacy|1
6100349|NCT00267956|21048999|P2|After Controlled Period|Lack of Efficacy|0
6100350|NCT00267956|21049000|P1|After Controlled Period|Lack of Efficacy|0
6100351|NCT00267956|21048997|P4|After Controlled Period|Adverse Event|1
6100352|NCT00267956|21048998|P3|After Controlled Period|Adverse Event|2
6100353|NCT00267956|21048999|P2|After Controlled Period|Adverse Event|0
6100354|NCT00267956|21049000|P1|After Controlled Period|Adverse Event|0
6100355|NCT00267956|21048997|P4|Controlled Period|Withdrew consent|0
6100356|NCT00267956|21048998|P3|Controlled Period|Withdrew consent|0
6100357|NCT00267956|21048999|P2|Controlled Period|Withdrew consent|1
6100358|NCT00267956|21049000|P1|Controlled Period|Withdrew consent|3
6100359|NCT00267956|21048997|P4|Controlled Period|Lost to Follow-up|0
6100360|NCT00267956|21048998|P3|Controlled Period|Lost to Follow-up|0
6100361|NCT00267956|21048999|P2|Controlled Period|Lost to Follow-up|0
6100362|NCT00267956|21049000|P1|Controlled Period|Lost to Follow-up|2
6100363|NCT00267956|21048997|P4|Controlled Period|Lack of Efficacy|0
6100364|NCT00267956|21048998|P3|Controlled Period|Lack of Efficacy|0
6100365|NCT00267956|21048999|P2|Controlled Period|Lack of Efficacy|2
6100366|NCT00267956|21049000|P1|Controlled Period|Lack of Efficacy|4
6100367|NCT00267956|21048997|P4|Controlled Period|Adverse Event|0
6100368|NCT00267956|21048998|P3|Controlled Period|Adverse Event|0
6100369|NCT00267956|21048999|P2|Controlled Period|Adverse Event|1
6100370|NCT00267956|21049000|P1|Controlled Period|Adverse Event|4
6100371|NCT00267865|21049018|P1|Induction Treatment|Started induction w/MTX, RIX, & Temozol|1
6100372|NCT00267865|21049018|P1|Induction Treatment|Died before completing.|2
6100373|NCT00267748|21049041|P3|Randomized Period|randomized but not treated|3
6100374|NCT00267748|21049042|P2|Randomized Period|randomized but not treated|0
6100375|NCT00267748|21049043|P1|Randomized Period|randomized but not treated|0
6100376|NCT00267748|21049041|P3|Randomized Period|Other|6
6100377|NCT00267748|21049042|P2|Randomized Period|Other|9
6100378|NCT00267748|21049043|P1|Randomized Period|Other|0
6100379|NCT00267748|21049041|P3|Randomized Period|Withdrawal by Subject|2
6100380|NCT00267748|21049042|P2|Randomized Period|Withdrawal by Subject|9
6100381|NCT00267748|21049043|P1|Randomized Period|Withdrawal by Subject|0
6100382|NCT00267748|21049041|P3|Randomized Period|Objective progression or relapse|86
6100383|NCT00267748|21049042|P2|Randomized Period|Objective progression or relapse|77
6100384|NCT00267748|21049043|P1|Randomized Period|Objective progression or relapse|0
6100385|NCT00267748|21049041|P3|Randomized Period|Lost to Follow-up|0
6100386|NCT00267748|21049042|P2|Randomized Period|Lost to Follow-up|1
6100387|NCT00267748|21049043|P1|Randomized Period|Lost to Follow-up|0
6100388|NCT00267748|21049041|P3|Randomized Period|Global deterioration of health status|7
6100389|NCT00267748|21049042|P2|Randomized Period|Global deterioration of health status|6
6100390|NCT00267748|21049043|P1|Randomized Period|Global deterioration of health status|0
6100391|NCT00267748|21049041|P3|Randomized Period|Adverse Event|25
6100392|NCT00267748|21049042|P2|Randomized Period|Adverse Event|23
6100393|NCT00267748|21049043|P1|Randomized Period|Adverse Event|0
6100394|NCT00267748|21049041|P3|Randomized Period|Death|3
6100395|NCT00267748|21049042|P2|Randomized Period|Death|2
6100396|NCT00267748|21049043|P1|Randomized Period|Death|0
6100397|NCT00267748|21049041|P3|Non-randomized Period|Other|0
6100398|NCT00267748|21049042|P2|Non-randomized Period|Other|0
6100399|NCT00267748|21049043|P1|Non-randomized Period|Other|3
6100400|NCT00267748|21049041|P3|Non-randomized Period|Participant not willing to participate|0
6100401|NCT00267748|21049042|P2|Non-randomized Period|Participant not willing to participate|0
6100402|NCT00267748|21049043|P1|Non-randomized Period|Participant not willing to participate|1
6100403|NCT00267748|21049041|P3|Non-randomized Period|Death|0
6100404|NCT00267748|21049042|P2|Non-randomized Period|Death|0
6100405|NCT00267748|21049043|P1|Non-randomized Period|Death|1
6100406|NCT00267748|21049041|P3|Non-randomized Period|Adverse Event|0
6100407|NCT00267748|21049042|P2|Non-randomized Period|Adverse Event|0
6100408|NCT00267748|21049043|P1|Non-randomized Period|Adverse Event|8
6100409|NCT00267748|21049041|P3|Non-randomized Period|Progressive disease|0
6100410|NCT00267748|21049042|P2|Non-randomized Period|Progressive disease|0
6100411|NCT00267748|21049043|P1|Non-randomized Period|Progressive disease|10
6100412|NCT00267488|21049100|P1|Overall Study|Other (Disease Progression)|1
6100413|NCT00267488|21049100|P1|Overall Study|Protocol Violation|1
6100414|NCT00267488|21049100|P1|Overall Study|Sponsor Terminated Study|9
6100415|NCT00267202|21049124|P2|Overall Study|Lost to Follow-up|0
6100416|NCT00267202|21049125|P1|Overall Study|Lost to Follow-up|3
6100417|NCT00267202|21049124|P2|Overall Study|Administrative problems|1
6100418|NCT00267202|21049125|P1|Overall Study|Administrative problems|2
6100419|NCT00267202|21049124|P2|Overall Study|Protocol Violation|3
6100420|NCT00267202|21049125|P1|Overall Study|Protocol Violation|2
6100421|NCT00267202|21049124|P2|Overall Study|Adverse Event|7
6100422|NCT00267202|21049125|P1|Overall Study|Adverse Event|13
6100423|NCT00267202|21049124|P2|Overall Study|Withdrawal by Subject|15
6100424|NCT00267202|21049125|P1|Overall Study|Withdrawal by Subject|12
6100425|NCT00267202|21049124|P2|Overall Study|Unsatisfactory therapeutic effect|8
6100426|NCT00267202|21049125|P1|Overall Study|Unsatisfactory therapeutic effect|21
6100427|NCT00267189|21049146|P2|Overall Study|Missing|0
6100428|NCT00267189|21049147|P1|Overall Study|Missing|3
6100429|NCT00267189|21049146|P2|Overall Study|Death|0
6100430|NCT00267189|21049147|P1|Overall Study|Death|1
6100431|NCT00267189|21049146|P2|Overall Study|Patient withdrew consent|1
6100432|NCT00267189|21049147|P1|Overall Study|Patient withdrew consent|1
6100433|NCT00267150|21049157|P1|Overall Study|Adverse Event|1
6100434|NCT00267098|21049181|P8|Overall Study|Sponsor withdrew subject|0
6100435|NCT00267098|21049182|P7|Overall Study|Sponsor withdrew subject|0
6100436|NCT00267098|21049183|P6|Overall Study|Sponsor withdrew subject|0
6100437|NCT00267098|21049184|P5|Overall Study|Sponsor withdrew subject|0
6100438|NCT00267098|21049185|P4|Overall Study|Sponsor withdrew subject|1
6100439|NCT00267098|21049186|P3|Overall Study|Sponsor withdrew subject|0
6100440|NCT00267098|21049187|P2|Overall Study|Sponsor withdrew subject|0
6100441|NCT00267098|21049188|P1|Overall Study|Sponsor withdrew subject|0
6100442|NCT00267098|21049181|P8|Overall Study|Subject listed for heart transplant|0
6100443|NCT00267098|21049182|P7|Overall Study|Subject listed for heart transplant|1
6100444|NCT00267098|21049183|P6|Overall Study|Subject listed for heart transplant|0
6100445|NCT00267098|21049184|P5|Overall Study|Subject listed for heart transplant|0
6100446|NCT00267098|21049185|P4|Overall Study|Subject listed for heart transplant|0
6100447|NCT00267098|21049186|P3|Overall Study|Subject listed for heart transplant|0
6100448|NCT00267098|21049187|P2|Overall Study|Subject listed for heart transplant|0
6100449|NCT00267098|21049188|P1|Overall Study|Subject listed for heart transplant|0
6100450|NCT00267098|21049181|P8|Overall Study|Non-Medtronic LV Lead Implanted|0
6100451|NCT00267098|21049182|P7|Overall Study|Non-Medtronic LV Lead Implanted|0
6100452|NCT00267098|21049183|P6|Overall Study|Non-Medtronic LV Lead Implanted|0
6100453|NCT00267098|21049184|P5|Overall Study|Non-Medtronic LV Lead Implanted|2
6100454|NCT00267098|21049185|P4|Overall Study|Non-Medtronic LV Lead Implanted|0
6100455|NCT00267098|21049186|P3|Overall Study|Non-Medtronic LV Lead Implanted|0
6100456|NCT00267098|21049187|P2|Overall Study|Non-Medtronic LV Lead Implanted|0
6100457|NCT00267098|21049188|P1|Overall Study|Non-Medtronic LV Lead Implanted|0
6100458|NCT00267098|21049181|P8|Overall Study|Explanted Medtronic device|0
6100459|NCT00267098|21049182|P7|Overall Study|Explanted Medtronic device|0
6100460|NCT00267098|21049183|P6|Overall Study|Explanted Medtronic device|0
6100461|NCT00267098|21049184|P5|Overall Study|Explanted Medtronic device|0
6100462|NCT00267098|21049185|P4|Overall Study|Explanted Medtronic device|1
6100463|NCT00267098|21049186|P3|Overall Study|Explanted Medtronic device|0
6100464|NCT00267098|21049187|P2|Overall Study|Explanted Medtronic device|0
6100465|NCT00267098|21049188|P1|Overall Study|Explanted Medtronic device|0
6100466|NCT00267098|21049181|P8|Overall Study|Site closure|0
6100467|NCT00267098|21049182|P7|Overall Study|Site closure|1
6100468|NCT00267098|21049183|P6|Overall Study|Site closure|1
6100469|NCT00267098|21049184|P5|Overall Study|Site closure|0
6100470|NCT00267098|21049185|P4|Overall Study|Site closure|1
6100471|NCT00267098|21049186|P3|Overall Study|Site closure|0
6100472|NCT00267098|21049187|P2|Overall Study|Site closure|0
6100473|NCT00267098|21049188|P1|Overall Study|Site closure|0
6100474|NCT00267098|21049181|P8|Overall Study|Unsuccessful Implant Exit Per Protocol|0
6100475|NCT00267098|21049182|P7|Overall Study|Unsuccessful Implant Exit Per Protocol|0
6100476|NCT00267098|21049183|P6|Overall Study|Unsuccessful Implant Exit Per Protocol|0
6100477|NCT00267098|21049184|P5|Overall Study|Unsuccessful Implant Exit Per Protocol|0
6100478|NCT00267098|21049185|P4|Overall Study|Unsuccessful Implant Exit Per Protocol|0
6100479|NCT00267098|21049186|P3|Overall Study|Unsuccessful Implant Exit Per Protocol|0
6100480|NCT00267098|21049187|P2|Overall Study|Unsuccessful Implant Exit Per Protocol|51
6100481|NCT00267098|21049188|P1|Overall Study|Unsuccessful Implant Exit Per Protocol|0
6100482|NCT00267098|21049181|P8|Overall Study|Inclusion/Exclusion Criteria Not Met|0
6100483|NCT00267098|21049182|P7|Overall Study|Inclusion/Exclusion Criteria Not Met|0
6100484|NCT00267098|21049183|P6|Overall Study|Inclusion/Exclusion Criteria Not Met|0
6100485|NCT00267098|21049184|P5|Overall Study|Inclusion/Exclusion Criteria Not Met|2
6100486|NCT00267098|21049185|P4|Overall Study|Inclusion/Exclusion Criteria Not Met|0
6100487|NCT00267098|21049186|P3|Overall Study|Inclusion/Exclusion Criteria Not Met|0
6100488|NCT00267098|21049187|P2|Overall Study|Inclusion/Exclusion Criteria Not Met|0
6100489|NCT00267098|21049188|P1|Overall Study|Inclusion/Exclusion Criteria Not Met|96
6100490|NCT00267098|21049181|P8|Overall Study|Physician Decision|0
6100491|NCT00267098|21049182|P7|Overall Study|Physician Decision|3
6100492|NCT00267098|21049183|P6|Overall Study|Physician Decision|4
6100493|NCT00267098|21049184|P5|Overall Study|Physician Decision|5
6100494|NCT00267098|21049185|P4|Overall Study|Physician Decision|11
6100495|NCT00267098|21049186|P3|Overall Study|Physician Decision|7
6100496|NCT00267098|21049187|P2|Overall Study|Physician Decision|0
6100497|NCT00267098|21049188|P1|Overall Study|Physician Decision|5
6100498|NCT00267098|21049181|P8|Overall Study|Withdrawal by Subject|5
6100499|NCT00267098|21049182|P7|Overall Study|Withdrawal by Subject|12
6100500|NCT00267098|21049183|P6|Overall Study|Withdrawal by Subject|9
6100501|NCT00267098|21049184|P5|Overall Study|Withdrawal by Subject|12
6100502|NCT00267098|21049185|P4|Overall Study|Withdrawal by Subject|21
6100503|NCT00267098|21049186|P3|Overall Study|Withdrawal by Subject|24
6100504|NCT00267098|21049187|P2|Overall Study|Withdrawal by Subject|0
6100505|NCT00267098|21049188|P1|Overall Study|Withdrawal by Subject|8
6100506|NCT00267098|21049181|P8|Overall Study|Lost to Follow-up|1
6100507|NCT00267098|21049182|P7|Overall Study|Lost to Follow-up|1
6100508|NCT00267098|21049183|P6|Overall Study|Lost to Follow-up|3
6100509|NCT00267098|21049184|P5|Overall Study|Lost to Follow-up|2
6100510|NCT00267098|21049185|P4|Overall Study|Lost to Follow-up|5
6100511|NCT00267098|21049186|P3|Overall Study|Lost to Follow-up|6
6100512|NCT00267098|21049187|P2|Overall Study|Lost to Follow-up|0
6100513|NCT00267098|21049188|P1|Overall Study|Lost to Follow-up|0
6100514|NCT00267098|21049181|P8|Overall Study|Death|9
6100515|NCT00267098|21049182|P7|Overall Study|Death|28
6100516|NCT00267098|21049183|P6|Overall Study|Death|23
6100517|NCT00267098|21049184|P5|Overall Study|Death|14
6100518|NCT00267098|21049185|P4|Overall Study|Death|66
6100519|NCT00267098|21049186|P3|Overall Study|Death|57
6100520|NCT00267098|21049187|P2|Overall Study|Death|0
6100521|NCT00267098|21049188|P1|Overall Study|Death|0
6100522|NCT00267046|21049331|P2|Overall Study|Radiation|1
6100523|NCT00267046|21049332|P1|Overall Study|Radiation|0
6100524|NCT00267046|21049331|P2|Overall Study|Withdrawal by Subject|0
6100525|NCT00267046|21049332|P1|Overall Study|Withdrawal by Subject|1
6100526|NCT00267046|21049331|P2|Overall Study|Surgery|1
6100527|NCT00267046|21049332|P1|Overall Study|Surgery|3
6100528|NCT00267046|21049331|P2|Overall Study|Open-label palifermin|7
6100529|NCT00267046|21049332|P1|Overall Study|Open-label palifermin|2
6100530|NCT00267046|21049331|P2|Overall Study|Chemotoxicity|0
6100531|NCT00267046|21049332|P1|Overall Study|Chemotoxicity|2
6100532|NCT00267046|21049331|P2|Overall Study|Disease progression|2
6100533|NCT00267046|21049332|P1|Overall Study|Disease progression|4
6100534|NCT00267020|21049342|P2|Overall Study|Other|2
6100535|NCT00267020|21049343|P1|Overall Study|Other|1
6100536|NCT00267020|21049342|P2|Overall Study|Sponsor Request|0
6100537|NCT00267020|21049343|P1|Overall Study|Sponsor Request|1
6100538|NCT00267020|21049342|P2|Overall Study|Unrelated Complication|1
6100539|NCT00267020|21049343|P1|Overall Study|Unrelated Complication|1
6100540|NCT00267020|21049342|P2|Overall Study|Disease Progression|25
6100541|NCT00267020|21049343|P1|Overall Study|Disease Progression|39
6100542|NCT00267020|21049342|P2|Overall Study|Physician Decision|2
6100543|NCT00267020|21049343|P1|Overall Study|Physician Decision|3
6100544|NCT00267020|21049342|P2|Overall Study|Withdrawal by Subject|7
6100545|NCT00267020|21049343|P1|Overall Study|Withdrawal by Subject|17
6100546|NCT00267020|21049342|P2|Overall Study|Death|1
6100547|NCT00267020|21049343|P1|Overall Study|Death|2
6100548|NCT00267020|21049342|P2|Overall Study|Adverse Event|5
6100549|NCT00267020|21049343|P1|Overall Study|Adverse Event|22
6100550|NCT00267007|21049365|P2|Overall Study|Adverse Event|0
6100551|NCT00267007|21049366|P1|Overall Study|Adverse Event|1
6100552|NCT00267007|21049365|P2|Overall Study|Non-compliance|1
6100553|NCT00267007|21049366|P1|Overall Study|Non-compliance|0
6100554|NCT00267007|21049365|P2|Overall Study|Lost to Follow-up|0
6100555|NCT00267007|21049366|P1|Overall Study|Lost to Follow-up|1
6100556|NCT00267007|21049365|P2|Overall Study|Withdrawal by Subject|0
6100557|NCT00267007|21049366|P1|Overall Study|Withdrawal by Subject|6
6100558|NCT00266877|21049377|P3|Overall Study|Concomitant Radiotherapy|0
6100559|NCT00266877|21049378|P2|Overall Study|Concomitant Radiotherapy|1
6100560|NCT00266877|21049379|P1|Overall Study|Concomitant Radiotherapy|0
6100561|NCT00266877|21049377|P3|Overall Study|Hospitalization|0
6100562|NCT00266877|21049378|P2|Overall Study|Hospitalization|0
6100563|NCT00266877|21049379|P1|Overall Study|Hospitalization|1
6100564|NCT00266877|21049377|P3|Overall Study|Symptomatic Deterioration|1
6100565|NCT00266877|21049378|P2|Overall Study|Symptomatic Deterioration|3
6100566|NCT00266877|21049379|P1|Overall Study|Symptomatic Deterioration|6
6100567|NCT00266877|21049377|P3|Overall Study|Disease Progression|23
6100568|NCT00266877|21049378|P2|Overall Study|Disease Progression|37
6100569|NCT00266877|21049379|P1|Overall Study|Disease Progression|72
6100570|NCT00266877|21049377|P3|Overall Study|Withdrawal by Subject|1
6100571|NCT00266877|21049378|P2|Overall Study|Withdrawal by Subject|1
6100572|NCT00266877|21049379|P1|Overall Study|Withdrawal by Subject|3
6100573|NCT00266877|21049377|P3|Overall Study|Physician Decision|1
6100574|NCT00266877|21049378|P2|Overall Study|Physician Decision|1
6100575|NCT00266877|21049379|P1|Overall Study|Physician Decision|2
6100576|NCT00266877|21049377|P3|Overall Study|Adverse Event|1
6100577|NCT00266877|21049378|P2|Overall Study|Adverse Event|4
6100578|NCT00266877|21049379|P1|Overall Study|Adverse Event|6
6100579|NCT00266877|21049377|P3|Overall Study|Death|1
6100580|NCT00266877|21049378|P2|Overall Study|Death|1
6100581|NCT00266877|21049379|P1|Overall Study|Death|1
6100582|NCT00266864|21049398|P2|Overall Study|Withdrawal by Subject|1
6100583|NCT00266864|21049399|P1|Overall Study|Withdrawal by Subject|1
6100584|NCT00266864|21049398|P2|Overall Study|Lost to Follow-up|1
6100585|NCT00266864|21049399|P1|Overall Study|Lost to Follow-up|4
6100586|NCT00266825|21049430|P2|Completed Follow-Up|Withdrawal by Subject|5
6100587|NCT00266825|21049431|P1|Completed Follow-Up|Withdrawal by Subject|11
6100588|NCT00266825|21049430|P2|Completed Follow-Up|Lost to Follow-up|19
6100589|NCT00266825|21049431|P1|Completed Follow-Up|Lost to Follow-up|14
6100590|NCT00266812|21049457|P2|Overall Study|Discontinued before starting study drug|0
6100591|NCT00266812|21049458|P1|Overall Study|Discontinued before starting study drug|4
6100592|NCT00266812|21049457|P2|Overall Study|Withdrawal by Subject|2
6100593|NCT00266812|21049458|P1|Overall Study|Withdrawal by Subject|0
6100594|NCT00266812|21049457|P2|Overall Study|Protocol Violation|1
6100595|NCT00266812|21049458|P1|Overall Study|Protocol Violation|0
6100596|NCT00266812|21049457|P2|Overall Study|Adverse Event|1
6100597|NCT00266812|21049458|P1|Overall Study|Adverse Event|3
6100598|NCT00266812|21049457|P2|Overall Study|Death|4
6100599|NCT00266812|21049458|P1|Overall Study|Death|5
6100600|NCT00266812|21049457|P2|Overall Study|Disease Progression|3
6100601|NCT00266812|21049458|P1|Overall Study|Disease Progression|9
6100602|NCT00266708|21049483|P2|Overall Study|Asthma|2
6100603|NCT00266708|21049484|P1|Overall Study|Asthma|0
6100604|NCT00266708|21049483|P2|Overall Study|Refused biopsy|6
6100605|NCT00266708|21049484|P1|Overall Study|Refused biopsy|3
6100606|NCT00266708|21049483|P2|Overall Study|No renal function|1
6100607|NCT00266708|21049484|P1|Overall Study|No renal function|1
6100608|NCT00266695|21049524|P1|Overall Study|Withdrawal by Subject|15
6100609|NCT00266695|21049524|P1|Overall Study|Lost to Follow-up|3
6100610|NCT00266695|21049524|P1|Overall Study|Physician Decision|1
6100611|NCT00266695|21049524|P1|Overall Study|Death|9
6100612|NCT00266695|21049524|P1|Overall Study|Adverse Event|1
6100613|NCT00266656|21049536|P2|Overall Study|Parent/Caregiver Decision|2
6100614|NCT00266656|21049537|P1|Overall Study|Parent/Caregiver Decision|1
6100615|NCT00266656|21049536|P2|Overall Study|Did Not Reach Final Height|8
6100616|NCT00266656|21049537|P1|Overall Study|Did Not Reach Final Height|4
6100617|NCT00266656|21049536|P2|Overall Study|Withdrawal by Subject|2
6100618|NCT00266656|21049537|P1|Overall Study|Withdrawal by Subject|4
6100619|NCT00266656|21049536|P2|Overall Study|Lost to Follow-up|1
6100620|NCT00266656|21049537|P1|Overall Study|Lost to Follow-up|4
6100621|NCT00266656|21049536|P2|Overall Study|Death|0
6100622|NCT00266656|21049537|P1|Overall Study|Death|1
6100623|NCT00266630|21049561|P2|Overall Study|Other|11
6100624|NCT00266630|21049562|P1|Overall Study|Other|19
6100625|NCT00266630|21049561|P2|Overall Study|Lost to Follow-up|0
6100626|NCT00266630|21049562|P1|Overall Study|Lost to Follow-up|1
6100627|NCT00266630|21049561|P2|Overall Study|Withdrawal by Subject|2
6100628|NCT00266630|21049562|P1|Overall Study|Withdrawal by Subject|10
6100629|NCT00266630|21049561|P2|Overall Study|Physician Decision|2
6100630|NCT00266630|21049562|P1|Overall Study|Physician Decision|1
6100631|NCT00266630|21049561|P2|Overall Study|Protocol Violation|3
6100632|NCT00266630|21049562|P1|Overall Study|Protocol Violation|1
6100633|NCT00266630|21049561|P2|Overall Study|Entry Criteria not met|0
6100634|NCT00266630|21049562|P1|Overall Study|Entry Criteria not met|1
6100635|NCT00266630|21049561|P2|Overall Study|Lack of Efficacy|4
6100636|NCT00266630|21049562|P1|Overall Study|Lack of Efficacy|1
6100637|NCT00266630|21049561|P2|Overall Study|Adverse Event|6
6100638|NCT00266630|21049562|P1|Overall Study|Adverse Event|8
6100639|NCT00266409|21049604|P4|Overall Study|Other|0
6100640|NCT00266409|21049605|P3|Overall Study|Other|2
6100641|NCT00266409|21049606|P2|Overall Study|Other|4
6100642|NCT00266409|21049607|P1|Overall Study|Other|7
6100643|NCT00266409|21049604|P4|Overall Study|Protocol Violation|2
6100644|NCT00266409|21049605|P3|Overall Study|Protocol Violation|4
6100645|NCT00266409|21049606|P2|Overall Study|Protocol Violation|3
6100646|NCT00266409|21049607|P1|Overall Study|Protocol Violation|5
6100647|NCT00266409|21049604|P4|Overall Study|Withdrawal by Subject|9
6100648|NCT00266409|21049605|P3|Overall Study|Withdrawal by Subject|3
6100649|NCT00266409|21049606|P2|Overall Study|Withdrawal by Subject|10
6100650|NCT00266409|21049607|P1|Overall Study|Withdrawal by Subject|6
6100651|NCT00266409|21049604|P4|Overall Study|Lost to Follow-up|8
6100652|NCT00266409|21049605|P3|Overall Study|Lost to Follow-up|6
6100653|NCT00266409|21049606|P2|Overall Study|Lost to Follow-up|21
6100654|NCT00266409|21049607|P1|Overall Study|Lost to Follow-up|18
6100655|NCT00266409|21049604|P4|Overall Study|Adverse Event|1
6100656|NCT00266409|21049605|P3|Overall Study|Adverse Event|1
6100657|NCT00266409|21049606|P2|Overall Study|Adverse Event|2
6100658|NCT00266409|21049607|P1|Overall Study|Adverse Event|7
6100659|NCT00266409|21049604|P4|Overall Study|Lack of Efficacy|2
6100660|NCT00266409|21049605|P3|Overall Study|Lack of Efficacy|1
6100661|NCT00266409|21049606|P2|Overall Study|Lack of Efficacy|6
6100662|NCT00266409|21049607|P1|Overall Study|Lack of Efficacy|2
6100663|NCT00266227|21049896|P3|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|0
6100664|NCT00266227|21049897|P2|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|10
6100665|NCT00266227|21049898|P1|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|15
6100666|NCT00266227|21049896|P3|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|0
6100667|NCT00266227|21049897|P2|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|29
6100668|NCT00266227|21049898|P1|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|41
6100669|NCT00266227|21049896|P3|Retreatment: Week 48 to Week 72|Lost to Follow-up|0
6100670|NCT00266227|21049897|P2|Retreatment: Week 48 to Week 72|Lost to Follow-up|0
6100671|NCT00266227|21049898|P1|Retreatment: Week 48 to Week 72|Lost to Follow-up|1
6100672|NCT00266227|21049896|P3|Retreatment: Week 48 to Week 72|Adverse Event|0
6100673|NCT00266227|21049897|P2|Retreatment: Week 48 to Week 72|Adverse Event|2
6100674|NCT00266227|21049898|P1|Retreatment: Week 48 to Week 72|Adverse Event|6
6100675|NCT00266227|21049896|P3|Retreatment: Week 48 to Week 72|Death|0
6100676|NCT00266227|21049897|P2|Retreatment: Week 48 to Week 72|Death|1
6100677|NCT00266227|21049898|P1|Retreatment: Week 48 to Week 72|Death|1
6100678|NCT00266227|21049896|P3|Retreatment: Up to Week 48|Pregnancy|0
6100679|NCT00266227|21049897|P2|Retreatment: Up to Week 48|Pregnancy|0
6100680|NCT00266227|21049898|P1|Retreatment: Up to Week 48|Pregnancy|1
6100681|NCT00266227|21049896|P3|Retreatment: Up to Week 48|Physician's Decision to Withdraw|0
6100682|NCT00266227|21049897|P2|Retreatment: Up to Week 48|Physician's Decision to Withdraw|2
6100683|NCT00266227|21049898|P1|Retreatment: Up to Week 48|Physician's Decision to Withdraw|4
6100684|NCT00266227|21049896|P3|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|0
6100685|NCT00266227|21049897|P2|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|14
6100686|NCT00266227|21049898|P1|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|11
6100687|NCT00266227|21049896|P3|Retreatment: Up to Week 48|Lost to Follow-up|0
6100688|NCT00266227|21049897|P2|Retreatment: Up to Week 48|Lost to Follow-up|0
6100689|NCT00266227|21049898|P1|Retreatment: Up to Week 48|Lost to Follow-up|3
6100690|NCT00266227|21049896|P3|Retreatment: Up to Week 48|Adverse Event|0
6100691|NCT00266227|21049897|P2|Retreatment: Up to Week 48|Adverse Event|7
6100692|NCT00266227|21049898|P1|Retreatment: Up to Week 48|Adverse Event|7
6100693|NCT00266227|21049896|P3|Retreatment: Up to Week 48|Death|0
6100694|NCT00266227|21049897|P2|Retreatment: Up to Week 48|Death|0
6100695|NCT00266227|21049898|P1|Retreatment: Up to Week 48|Death|1
6100696|NCT00266227|21049896|P3|Initial Treatment|Pregnancy|1
6100697|NCT00266227|21049897|P2|Initial Treatment|Pregnancy|0
6100698|NCT00266227|21049898|P1|Initial Treatment|Pregnancy|0
6100699|NCT00266227|21049896|P3|Initial Treatment|Physician decision to withdraw|12
6100700|NCT00266227|21049897|P2|Initial Treatment|Physician decision to withdraw|0
6100701|NCT00266227|21049898|P1|Initial Treatment|Physician decision to withdraw|0
6100702|NCT00266227|21049896|P3|Initial Treatment|Subject/Guardian decision to withdraw|45
6100703|NCT00266227|21049897|P2|Initial Treatment|Subject/Guardian decision to withdraw|0
6100704|NCT00266227|21049898|P1|Initial Treatment|Subject/Guardian decision to withdraw|0
6100705|NCT00266227|21049896|P3|Initial Treatment|Lost to Follow-up|6
6100706|NCT00266227|21049897|P2|Initial Treatment|Lost to Follow-up|0
6100707|NCT00266227|21049898|P1|Initial Treatment|Lost to Follow-up|0
6100708|NCT00266227|21049896|P3|Initial Treatment|Adverse Event|13
6100709|NCT00266227|21049897|P2|Initial Treatment|Adverse Event|0
6100710|NCT00266227|21049898|P1|Initial Treatment|Adverse Event|0
6100711|NCT00266032|21049952|P3|Open-label Safety Extension|patient moved/wish for pregnancy/no need|1
6100712|NCT00266032|21049953|P2|Open-label Safety Extension|patient moved/wish for pregnancy/no need|2
6100713|NCT00266032|21049954|P1|Open-label Safety Extension|patient moved/wish for pregnancy/no need|10
6100714|NCT00266032|21049952|P3|Open-label Safety Extension|Withdrawal by Subject|12
6100715|NCT00266032|21049953|P2|Open-label Safety Extension|Withdrawal by Subject|3
6100716|NCT00266032|21049954|P1|Open-label Safety Extension|Withdrawal by Subject|19
6100717|NCT00266032|21049952|P3|Open-label Safety Extension|Protocol Violation|2
6100718|NCT00266032|21049953|P2|Open-label Safety Extension|Protocol Violation|3
6100719|NCT00266032|21049954|P1|Open-label Safety Extension|Protocol Violation|1
6100720|NCT00266032|21049952|P3|Open-label Safety Extension|Pregnancy|2
6100721|NCT00266032|21049953|P2|Open-label Safety Extension|Pregnancy|1
6100722|NCT00266032|21049954|P1|Open-label Safety Extension|Pregnancy|4
6100723|NCT00266032|21049952|P3|Open-label Safety Extension|Lost to Follow-up|4
6100724|NCT00266032|21049953|P2|Open-label Safety Extension|Lost to Follow-up|5
6100725|NCT00266032|21049954|P1|Open-label Safety Extension|Lost to Follow-up|2
6100726|NCT00266032|21049952|P3|Open-label Safety Extension|Adverse Event|4
6100727|NCT00266032|21049953|P2|Open-label Safety Extension|Adverse Event|0
6100728|NCT00266032|21049954|P1|Open-label Safety Extension|Adverse Event|5
6100729|NCT00266032|21049952|P3|Treatment|patient moved/wish for pregnancy/no need|8
6100730|NCT00266032|21049953|P2|Treatment|patient moved/wish for pregnancy/no need|5
6100731|NCT00266032|21049954|P1|Treatment|patient moved/wish for pregnancy/no need|13
6100732|NCT00266032|21049952|P3|Treatment|Withdrawal by Subject|12
6100733|NCT00266032|21049953|P2|Treatment|Withdrawal by Subject|13
6100734|NCT00266032|21049954|P1|Treatment|Withdrawal by Subject|28
6100735|NCT00266032|21049952|P3|Treatment|Protocol Violation|13
6100736|NCT00266032|21049953|P2|Treatment|Protocol Violation|14
6100737|NCT00266032|21049954|P1|Treatment|Protocol Violation|6
6100738|NCT00266032|21049952|P3|Treatment|Pregnancy|2
6100739|NCT00266032|21049953|P2|Treatment|Pregnancy|2
6100740|NCT00266032|21049954|P1|Treatment|Pregnancy|3
6100741|NCT00266032|21049952|P3|Treatment|Lost to Follow-up|2
6100742|NCT00266032|21049953|P2|Treatment|Lost to Follow-up|4
6100743|NCT00266032|21049954|P1|Treatment|Lost to Follow-up|19
6100744|NCT00266032|21049952|P3|Treatment|Adverse Event|10
6100745|NCT00266032|21049953|P2|Treatment|Adverse Event|26
6100746|NCT00266032|21049954|P1|Treatment|Adverse Event|42
6100747|NCT00265941|21049989|P2|Overall Study|Lost to Follow-up|1
6100748|NCT00265941|21049990|P1|Overall Study|Lost to Follow-up|1
6100749|NCT00265941|21049989|P2|Overall Study|Protocol Violation|25
6100750|NCT00265941|21049990|P1|Overall Study|Protocol Violation|22
6100751|NCT00265889|21050022|P1|Overall Study|Insurance denied the request|3
6100752|NCT00265889|21050022|P1|Overall Study|Protocol Violation|1
6100753|NCT00265889|21050022|P1|Overall Study|Physician Decision|1
6100754|NCT00265785|21050049|P1|Overall Study|Did not receive protocol treatment|2
6100755|NCT00265785|21050049|P1|Overall Study|Ineligible|1
6100756|NCT00265785|21050049|P1|Overall Study|Not protocol specified|2
6100757|NCT00265785|21050049|P1|Overall Study|Progression/Relapse|15
6100758|NCT00265785|21050049|P1|Overall Study|Withdrawal by Subject|3
6100759|NCT00265785|21050049|P1|Overall Study|Adverse Event|4
6100760|NCT00265759|21050062|P4|Overall Study|Discontinued due to intolerability|1
6100761|NCT00265759|21050063|P3|Overall Study|Discontinued due to intolerability|0
6100762|NCT00265759|21050064|P2|Overall Study|Discontinued due to intolerability|0
6100763|NCT00265759|21050065|P1|Overall Study|Discontinued due to intolerability|0
6100764|NCT00265759|21050062|P4|Overall Study|Bilateral disease|2
6100765|NCT00265759|21050063|P3|Overall Study|Bilateral disease|0
6100766|NCT00265759|21050064|P2|Overall Study|Bilateral disease|0
6100767|NCT00265759|21050065|P1|Overall Study|Bilateral disease|0
6100768|NCT00265759|21050062|P4|Overall Study|Ineligible|1
6100769|NCT00265759|21050063|P3|Overall Study|Ineligible|0
6100770|NCT00265759|21050064|P2|Overall Study|Ineligible|0
6100771|NCT00265759|21050065|P1|Overall Study|Ineligible|0
6100772|NCT00265759|21050062|P4|Overall Study|Cancel|3
6100773|NCT00265759|21050063|P3|Overall Study|Cancel|0
6100774|NCT00265759|21050064|P2|Overall Study|Cancel|0
6100775|NCT00265759|21050065|P1|Overall Study|Cancel|0
6100776|NCT00265759|21050062|P4|Overall Study|Withdrawal by Subject|2
6100777|NCT00265759|21050063|P3|Overall Study|Withdrawal by Subject|2
6100778|NCT00265759|21050064|P2|Overall Study|Withdrawal by Subject|1
6100779|NCT00265759|21050065|P1|Overall Study|Withdrawal by Subject|0
6100780|NCT00265564|21050115|P2|Overall Study|met exclusion criteria|2
6100781|NCT00265564|21050116|P1|Overall Study|met exclusion criteria|5
6100782|NCT00265564|21050115|P2|Overall Study|Lost to Follow-up|7
6100783|NCT00265564|21050116|P1|Overall Study|Lost to Follow-up|5
6100784|NCT00265395|21050166|P2|Overall Study|Administrative|1
6100785|NCT00265395|21050167|P1|Overall Study|Administrative|0
6100786|NCT00265395|21050166|P2|Overall Study|Lack of Efficacy|1
6100787|NCT00265395|21050167|P1|Overall Study|Lack of Efficacy|0
6100788|NCT00265395|21050166|P2|Overall Study|Protocol Violation|2
6100789|NCT00265395|21050167|P1|Overall Study|Protocol Violation|2
6100790|NCT00265395|21050166|P2|Overall Study|Withdrawal by Subject|6
6100791|NCT00265395|21050167|P1|Overall Study|Withdrawal by Subject|1
6100792|NCT00265395|21050166|P2|Overall Study|Lost to Follow-up|1
6100793|NCT00265395|21050167|P1|Overall Study|Lost to Follow-up|2
6100794|NCT00265395|21050166|P2|Overall Study|Adverse Event|6
6100795|NCT00265395|21050167|P1|Overall Study|Adverse Event|3
6100796|NCT00265382|21050172|P1|Overall Study|Death|1
6100797|NCT00265382|21050172|P1|Overall Study|Study terminated by sponsor|94
6100798|NCT00265382|21050172|P1|Overall Study|Withdrawal by Subject|13
6100799|NCT00265382|21050172|P1|Overall Study|Miscellaneous|6
6100800|NCT00265382|21050172|P1|Overall Study|Lack of Efficacy|6
6100801|NCT00265382|21050172|P1|Overall Study|Lost to Follow-up|3
6100802|NCT00265382|21050172|P1|Overall Study|Laboratory Abnormality|1
6100803|NCT00265382|21050172|P1|Overall Study|Adverse Event|21
6100804|NCT00265343|21050192|P2|Overall Study|Other|3
6100805|NCT00265343|21050193|P1|Overall Study|Other|8
6100806|NCT00265343|21050192|P2|Overall Study|Withdrawal by Subject|9
6100807|NCT00265343|21050193|P1|Overall Study|Withdrawal by Subject|3
6100808|NCT00265343|21050192|P2|Overall Study|Adverse Event|7
6100809|NCT00265343|21050193|P1|Overall Study|Adverse Event|10
6100810|NCT00265330|21050201|P1|Overall Study|Protocol Violation|1
6100811|NCT00265330|21050201|P1|Overall Study|Withdrew Consent|1
6100812|NCT00265330|21050201|P1|Overall Study|Principal Investigators Request|1
6100813|NCT00265330|21050201|P1|Overall Study|Site Closed by Sponsor|1
6100814|NCT00265330|21050201|P1|Overall Study|Discharged from Unit for Long Term Care|1
6100815|NCT00265330|21050201|P1|Overall Study|Began Taking Formulary Geodon|1
6100816|NCT00265330|21050201|P1|Overall Study|Family Scheduling Conflicts|1
6100817|NCT00265330|21050201|P1|Overall Study|Lack of Efficacy|4
6100818|NCT00265330|21050201|P1|Overall Study|Patient Wanted to Start Psychotherapy|1
6100819|NCT00265330|21050201|P1|Overall Study|Withdrawal by Subject|34
6100820|NCT00265330|21050201|P1|Overall Study|Lost to Follow-up|8
6100821|NCT00265330|21050201|P1|Overall Study|Adverse Event|41
6100822|NCT00265317|21050227|P4|Phase 2|Other|1
6100823|NCT00265317|21050228|P3|Phase 2|Other|1
6100824|NCT00265317|21050229|P2|Phase 2|Other|0
6100825|NCT00265317|21050230|P1|Phase 2|Other|0
6100826|NCT00265317|21050227|P4|Phase 2|Study terminated by sponsor|0
6100827|NCT00265317|21050228|P3|Phase 2|Study terminated by sponsor|1
6100828|NCT00265317|21050229|P2|Phase 2|Study terminated by sponsor|0
6100829|NCT00265317|21050230|P1|Phase 2|Study terminated by sponsor|0
6100830|NCT00265317|21050227|P4|Phase 2|Withdrawal/other than adverse event|1
6100831|NCT00265317|21050228|P3|Phase 2|Withdrawal/other than adverse event|2
6100832|NCT00265317|21050229|P2|Phase 2|Withdrawal/other than adverse event|0
6100833|NCT00265317|21050230|P1|Phase 2|Withdrawal/other than adverse event|0
6100834|NCT00265317|21050227|P4|Phase 2|Lost to Follow-up|1
6100835|NCT00265317|21050228|P3|Phase 2|Lost to Follow-up|0
6100836|NCT00265317|21050229|P2|Phase 2|Lost to Follow-up|0
6100837|NCT00265317|21050230|P1|Phase 2|Lost to Follow-up|0
6100838|NCT00265317|21050227|P4|Phase 2|Protocol Violation|4
6100839|NCT00265317|21050228|P3|Phase 2|Protocol Violation|1
6100840|NCT00265317|21050229|P2|Phase 2|Protocol Violation|0
6100841|NCT00265317|21050230|P1|Phase 2|Protocol Violation|0
6100842|NCT00265317|21050227|P4|Phase 2|Death|15
6100843|NCT00265317|21050228|P3|Phase 2|Death|12
6100844|NCT00265317|21050229|P2|Phase 2|Death|0
6100845|NCT00265317|21050230|P1|Phase 2|Death|0
6100846|NCT00265317|21050227|P4|Phase 2|Adverse Event|5
6100847|NCT00265317|21050228|P3|Phase 2|Adverse Event|7
6100848|NCT00265317|21050229|P2|Phase 2|Adverse Event|0
6100849|NCT00265317|21050230|P1|Phase 2|Adverse Event|0
6100850|NCT00265317|21050227|P4|Phase 2|Global deterioration of health status|0
6100851|NCT00265317|21050228|P3|Phase 2|Global deterioration of health status|3
6100852|NCT00265317|21050229|P2|Phase 2|Global deterioration of health status|0
6100853|NCT00265317|21050230|P1|Phase 2|Global deterioration of health status|0
6100854|NCT00265317|21050227|P4|Phase 2|Objective progression or relapse|38
6100855|NCT00265317|21050228|P3|Phase 2|Objective progression or relapse|37
6100856|NCT00265317|21050229|P2|Phase 2|Objective progression or relapse|0
6100857|NCT00265317|21050230|P1|Phase 2|Objective progression or relapse|0
6100858|NCT00265317|21050227|P4|Lead-In|Withdrawal/other than adverse event|0
6100859|NCT00265317|21050228|P3|Lead-In|Withdrawal/other than adverse event|0
6100860|NCT00265317|21050229|P2|Lead-In|Withdrawal/other than adverse event|0
6100861|NCT00265317|21050230|P1|Lead-In|Withdrawal/other than adverse event|1
6100862|NCT00265317|21050227|P4|Lead-In|Death|0
6100863|NCT00265317|21050228|P3|Lead-In|Death|0
6100864|NCT00265317|21050229|P2|Lead-In|Death|5
6100865|NCT00265317|21050230|P1|Lead-In|Death|3
6100866|NCT00265317|21050227|P4|Lead-In|Adverse Event|0
6100867|NCT00265317|21050228|P3|Lead-In|Adverse Event|0
6100868|NCT00265317|21050229|P2|Lead-In|Adverse Event|1
6100869|NCT00265317|21050230|P1|Lead-In|Adverse Event|2
6100870|NCT00265317|21050227|P4|Lead-In|Objective progression or relapse|0
6100871|NCT00265317|21050228|P3|Lead-In|Objective progression or relapse|0
6100872|NCT00265317|21050229|P2|Lead-In|Objective progression or relapse|11
6100873|NCT00265317|21050230|P1|Lead-In|Objective progression or relapse|6
6100874|NCT00265239|21050345|P2|Overall Study|Adverse Event|1
6100875|NCT00265239|21050346|P1|Overall Study|Adverse Event|2
6100876|NCT00265148|21050364|P2|Overall Study|Subject chose to change of the dose|0
6100877|NCT00265148|21050365|P1|Overall Study|Subject chose to change of the dose|1
6100878|NCT00265148|21050364|P2|Overall Study|Increasing frailty|1
6100879|NCT00265148|21050365|P1|Overall Study|Increasing frailty|0
6100880|NCT00265148|21050364|P2|Overall Study|Physician Decision|0
6100881|NCT00265148|21050365|P1|Overall Study|Physician Decision|1
6100882|NCT00265148|21050364|P2|Overall Study|Withdrawal by Subject|1
6100883|NCT00265148|21050365|P1|Overall Study|Withdrawal by Subject|2
6100884|NCT00265148|21050364|P2|Overall Study|Lost to Follow-up|1
6100885|NCT00265148|21050365|P1|Overall Study|Lost to Follow-up|0
6100886|NCT00265148|21050364|P2|Overall Study|Protocol Violation|2
6100887|NCT00265148|21050365|P1|Overall Study|Protocol Violation|3
6100888|NCT00265148|21050364|P2|Overall Study|Lack of Efficacy|2
6100889|NCT00265148|21050365|P1|Overall Study|Lack of Efficacy|0
6100890|NCT00265148|21050364|P2|Overall Study|Adverse Event|2
6100891|NCT00265148|21050365|P1|Overall Study|Adverse Event|2
6100892|NCT00265122|21050429|P6|Intervention Period 2 (Weeks 8 to 28):|Other|0
6100893|NCT00265122|21050430|P5|Intervention Period 2 (Weeks 8 to 28):|Other|0
6100894|NCT00265122|21050431|P4|Intervention Period 2 (Weeks 8 to 28):|Other|1
6100895|NCT00265122|21050432|P3|Intervention Period 2 (Weeks 8 to 28):|Other|1
6100896|NCT00265122|21050433|P2|Intervention Period 2 (Weeks 8 to 28):|Other|0
6100897|NCT00265122|21050434|P1|Intervention Period 2 (Weeks 8 to 28):|Other|4
6100898|NCT00265122|21050429|P6|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1
6100899|NCT00265122|21050430|P5|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2
6100900|NCT00265122|21050431|P4|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2
6100901|NCT00265122|21050432|P3|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0
6100902|NCT00265122|21050433|P2|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0
6100903|NCT00265122|21050434|P1|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1
6100904|NCT00265122|21050429|P6|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|0
6100905|NCT00265122|21050430|P5|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3
6100906|NCT00265122|21050431|P4|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1
6100907|NCT00265122|21050432|P3|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3
6100908|NCT00265122|21050433|P2|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1
6100909|NCT00265122|21050434|P1|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|2
6100910|NCT00265122|21050429|P6|Intervention Period 1 (Weeks 0 to 8):|Other|0
6100911|NCT00265122|21050430|P5|Intervention Period 1 (Weeks 0 to 8):|Other|0
6100912|NCT00265122|21050431|P4|Intervention Period 1 (Weeks 0 to 8):|Other|1
6100913|NCT00265122|21050432|P3|Intervention Period 1 (Weeks 0 to 8):|Other|2
6100914|NCT00265122|21050433|P2|Intervention Period 1 (Weeks 0 to 8):|Other|1
6100915|NCT00265122|21050434|P1|Intervention Period 1 (Weeks 0 to 8):|Other|0
6100916|NCT00265122|21050429|P6|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0
6100917|NCT00265122|21050430|P5|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0
6100918|NCT00265122|21050431|P4|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1
6100919|NCT00265122|21050432|P3|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0
6100920|NCT00265122|21050433|P2|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0
6100921|NCT00265122|21050434|P1|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1
6100922|NCT00265122|21050429|P6|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0
6100923|NCT00265122|21050430|P5|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1
6100924|NCT00265122|21050431|P4|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0
6100925|NCT00265122|21050432|P3|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|3
6100926|NCT00265122|21050433|P2|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1
6100927|NCT00265122|21050434|P1|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1
6100928|NCT00265109|21050456|P1|Overall Study|Adverse Event|1
6100929|NCT00265109|21050456|P1|Overall Study|Withdrawal by Subject|5
6100930|NCT00265096|21050475|P3|Overall Study|Other|10
6100931|NCT00265096|21050476|P2|Overall Study|Other|19
6100932|NCT00265096|21050477|P1|Overall Study|Other|11
6100933|NCT00265096|21050475|P3|Overall Study|Unsatisfactory therapeutic effect|6
6100934|NCT00265096|21050476|P2|Overall Study|Unsatisfactory therapeutic effect|8
6100935|NCT00265096|21050477|P1|Overall Study|Unsatisfactory therapeutic effect|9
6100936|NCT00265096|21050475|P3|Overall Study|Death|2
6100937|NCT00265096|21050476|P2|Overall Study|Death|1
6100938|NCT00265096|21050477|P1|Overall Study|Death|0
6100939|NCT00265096|21050475|P3|Overall Study|Lost to Follow-up|3
6100940|NCT00265096|21050476|P2|Overall Study|Lost to Follow-up|5
6100941|NCT00265096|21050477|P1|Overall Study|Lost to Follow-up|2
6100942|NCT00265096|21050475|P3|Overall Study|Adverse Event|18
6100943|NCT00265096|21050476|P2|Overall Study|Adverse Event|18
6100944|NCT00265096|21050477|P1|Overall Study|Adverse Event|14
6100945|NCT00265083|21050509|P3|Overall Study|Other|9
6100946|NCT00265083|21050510|P2|Overall Study|Other|12
6100947|NCT00265083|21050511|P1|Overall Study|Other|1
6100948|NCT00265083|21050509|P3|Overall Study|Unsatisfactory therapeutic effect|14
6100949|NCT00265083|21050510|P2|Overall Study|Unsatisfactory therapeutic effect|13
6100950|NCT00265083|21050511|P1|Overall Study|Unsatisfactory therapeutic effect|8
6100951|NCT00265083|21050509|P3|Overall Study|Lost to Follow-up|4
6100952|NCT00265083|21050510|P2|Overall Study|Lost to Follow-up|4
6100953|NCT00265083|21050511|P1|Overall Study|Lost to Follow-up|3
6100954|NCT00265083|21050509|P3|Overall Study|Adverse Event|15
6100955|NCT00265083|21050510|P2|Overall Study|Adverse Event|13
6100956|NCT00265083|21050511|P1|Overall Study|Adverse Event|5
6100957|NCT00264875|21050532|P1|Overall Study|Withdrawal by Subject|7
6100958|NCT00264875|21050532|P1|Overall Study|Protocol Violation|11
6100959|NCT00264875|21050532|P1|Overall Study|Lost to Follow-up|6
6100960|NCT00264875|21050532|P1|Overall Study|Adverse Event|6
6100961|NCT00264849|21050538|P2|Overall Study|Administrative Problems|0
6100962|NCT00264849|21050539|P1|Overall Study|Administrative Problems|2
6100963|NCT00264849|21050538|P2|Overall Study|Death|1
6100964|NCT00264849|21050539|P1|Overall Study|Death|0
6100965|NCT00264849|21050538|P2|Overall Study|Lost to Follow-up|2
6100966|NCT00264849|21050539|P1|Overall Study|Lost to Follow-up|0
6100967|NCT00264849|21050538|P2|Overall Study|Lack of Efficacy|6
6100968|NCT00264849|21050539|P1|Overall Study|Lack of Efficacy|1
6100969|NCT00264849|21050538|P2|Overall Study|Protocol Violation|3
6100970|NCT00264849|21050539|P1|Overall Study|Protocol Violation|5
6100971|NCT00264849|21050538|P2|Overall Study|Withdrawal by Subject|11
6100972|NCT00264849|21050539|P1|Overall Study|Withdrawal by Subject|7
6100973|NCT00264849|21050538|P2|Overall Study|Adverse Event|2
6100974|NCT00264849|21050539|P1|Overall Study|Adverse Event|7
6100975|NCT00264810|21050573|P2|Open Label Evaluation Period|Pursue Other Treatment Options|3
6100976|NCT00264810|21050574|P1|Open Label Evaluation Period|Pursue Other Treatment Options|2
6100977|NCT00264810|21050573|P2|Open Label Evaluation Period|Death|2
6100978|NCT00264810|21050574|P1|Open Label Evaluation Period|Death|3
6100979|NCT00264810|21050573|P2|Open Label Evaluation Period|Explant due to infection|1
6100980|NCT00264810|21050574|P1|Open Label Evaluation Period|Explant due to infection|1
6100981|NCT00264810|21050573|P2|Blinded Evaluation Period|Explant due to infection|1
6100982|NCT00264810|21050574|P1|Blinded Evaluation Period|Explant due to infection|1
6100983|NCT00264810|21050573|P2|Stimulation Optimization Period|Death|1
6100984|NCT00264810|21050574|P1|Stimulation Optimization Period|Death|0
6100985|NCT00264810|21050573|P2|Stimulation Optimization Period|Withdrawal by Subject|0
6100986|NCT00264810|21050574|P1|Stimulation Optimization Period|Withdrawal by Subject|1
6100987|NCT00264810|21050573|P2|Baseline|Other|1
6100988|NCT00264810|21050574|P1|Baseline|Other|0
6100989|NCT00264810|21050573|P2|Baseline|Did not Meet/Maintain Study I/E Criteria|2
6100990|NCT00264810|21050574|P1|Baseline|Did not Meet/Maintain Study I/E Criteria|1
6100991|NCT00264810|21050573|P2|Baseline|Insufficient Seizure Frequency|2
6100992|NCT00264810|21050574|P1|Baseline|Insufficient Seizure Frequency|2
6100993|NCT00264810|21050573|P2|Baseline|Subject Compliance Failure|3
6100994|NCT00264810|21050574|P1|Baseline|Subject Compliance Failure|3
6100995|NCT00264810|21050573|P2|Baseline|Physician Decision|8
6100996|NCT00264810|21050574|P1|Baseline|Physician Decision|7
6100997|NCT00264810|21050573|P2|Baseline|Withdrawal by Subject|10
6100998|NCT00264810|21050574|P1|Baseline|Withdrawal by Subject|10
6100999|NCT00264797|21050584|P2|Overall Study|Other|4
6101000|NCT00264797|21050585|P1|Overall Study|Other|3
6101001|NCT00264797|21050584|P2|Overall Study|Feels treatment not necessary, not worki|1
6101002|NCT00264797|21050585|P1|Overall Study|Feels treatment not necessary, not worki|0
6101003|NCT00264797|21050584|P2|Overall Study|Pressure/advice from Outsiders|1
6101004|NCT00264797|21050585|P1|Overall Study|Pressure/advice from Outsiders|1
6101005|NCT00264797|21050584|P2|Overall Study|Incarceration|5
6101006|NCT00264797|21050585|P1|Overall Study|Incarceration|4
6101007|NCT00264797|21050584|P2|Overall Study|Practical Problems|3
6101008|NCT00264797|21050585|P1|Overall Study|Practical Problems|2
6101009|NCT00264797|21050584|P2|Overall Study|Moved from area|1
6101010|NCT00264797|21050585|P1|Overall Study|Moved from area|3
6101011|NCT00264797|21050584|P2|Overall Study|Lost to Follow-up|17
6101012|NCT00264797|21050585|P1|Overall Study|Lost to Follow-up|9
6101013|NCT00264797|21050584|P2|Overall Study|Withdrawal by Subject|11
6101014|NCT00264797|21050585|P1|Overall Study|Withdrawal by Subject|11
6101015|NCT00264576|21050607|P2|Overall Study|Lost to Follow-up|1
6101016|NCT00264576|21050608|P1|Overall Study|Lost to Follow-up|1
6101017|NCT00264550|21050632|P4|Overall Study|Other|9
6101018|NCT00264550|21050633|P3|Overall Study|Other|3
6101019|NCT00264550|21050634|P2|Overall Study|Other|7
6101020|NCT00264550|21050635|P1|Overall Study|Other|13
6101021|NCT00264550|21050632|P4|Overall Study|Discontinued oral study agent|0
6101022|NCT00264550|21050633|P3|Overall Study|Discontinued oral study agent|0
6101023|NCT00264550|21050634|P2|Overall Study|Discontinued oral study agent|1
6101024|NCT00264550|21050635|P1|Overall Study|Discontinued oral study agent|0
6101025|NCT00264550|21050632|P4|Overall Study|Unsatisfactory therapeutic effect|6
6101026|NCT00264550|21050633|P3|Overall Study|Unsatisfactory therapeutic effect|4
6101027|NCT00264550|21050634|P2|Overall Study|Unsatisfactory therapeutic effect|11
6101028|NCT00264550|21050635|P1|Overall Study|Unsatisfactory therapeutic effect|4
6101029|NCT00264550|21050632|P4|Overall Study|Adverse Event|14
6101030|NCT00264550|21050633|P3|Overall Study|Adverse Event|9
6101031|NCT00264550|21050634|P2|Overall Study|Adverse Event|18
6101032|NCT00264550|21050635|P1|Overall Study|Adverse Event|23
6101033|NCT00264550|21050632|P4|Overall Study|Lost to Follow-up|1
6101034|NCT00264550|21050633|P3|Overall Study|Lost to Follow-up|1
6101035|NCT00264550|21050634|P2|Overall Study|Lost to Follow-up|1
6101036|NCT00264550|21050635|P1|Overall Study|Lost to Follow-up|3
6101037|NCT00264550|21050632|P4|Overall Study|Death|0
6101038|NCT00264550|21050633|P3|Overall Study|Death|0
6101039|NCT00264550|21050634|P2|Overall Study|Death|3
6101040|NCT00264550|21050635|P1|Overall Study|Death|0
6101041|NCT00264537|21050674|P4|Overall Study|Not treated|0
6101042|NCT00264537|21050675|P3|Overall Study|Not treated|1
6101043|NCT00264537|21050676|P2|Overall Study|Not treated|2
6101044|NCT00264537|21050677|P1|Overall Study|Not treated|0
6101045|NCT00264537|21050674|P4|Overall Study|Other|11
6101046|NCT00264537|21050675|P3|Overall Study|Other|10
6101047|NCT00264537|21050676|P2|Overall Study|Other|11
6101048|NCT00264537|21050677|P1|Overall Study|Other|21
6101049|NCT00264537|21050674|P4|Overall Study|Unsatisfactory therapeutic effect|7
6101050|NCT00264537|21050675|P3|Overall Study|Unsatisfactory therapeutic effect|5
6101051|NCT00264537|21050676|P2|Overall Study|Unsatisfactory therapeutic effect|6
6101052|NCT00264537|21050677|P1|Overall Study|Unsatisfactory therapeutic effect|5
6101053|NCT00264537|21050674|P4|Overall Study|Adverse Event|34
6101054|NCT00264537|21050675|P3|Overall Study|Adverse Event|24
6101055|NCT00264537|21050676|P2|Overall Study|Adverse Event|32
6101056|NCT00264537|21050677|P1|Overall Study|Adverse Event|21
6101057|NCT00264537|21050674|P4|Overall Study|Lost to Follow-up|6
6101058|NCT00264537|21050675|P3|Overall Study|Lost to Follow-up|7
6101059|NCT00264537|21050676|P2|Overall Study|Lost to Follow-up|4
6101060|NCT00264537|21050677|P1|Overall Study|Lost to Follow-up|3
6101061|NCT00264537|21050674|P4|Overall Study|Death|2
6101062|NCT00264537|21050675|P3|Overall Study|Death|3
6101063|NCT00264537|21050676|P2|Overall Study|Death|3
6101064|NCT00264537|21050677|P1|Overall Study|Death|0
6101065|NCT00264498|21050709|P2|Crossover Treatment|Withdrawal by Subject|0
6101066|NCT00264498|21050710|P1|Crossover Treatment|Withdrawal by Subject|1
6101067|NCT00264498|21050709|P2|Crossover Treatment|Study closure|1
6101068|NCT00264498|21050710|P1|Crossover Treatment|Study closure|0
6101069|NCT00264498|21050709|P2|Crossover Treatment|Objective disease progression|5
6101070|NCT00264498|21050710|P1|Crossover Treatment|Objective disease progression|4
6101071|NCT00264498|21050709|P2|Crossover Treatment|Death|3
6101072|NCT00264498|21050710|P1|Crossover Treatment|Death|1
6101073|NCT00264498|21050709|P2|Randomized Treatment|Protocol Violation|0
6101074|NCT00264498|21050710|P1|Randomized Treatment|Protocol Violation|1
6101075|NCT00264498|21050709|P2|Randomized Treatment|Study Closure|0
6101076|NCT00264498|21050710|P1|Randomized Treatment|Study Closure|1
6101077|NCT00264498|21050709|P2|Randomized Treatment|Incorrectly randomized|0
6101078|NCT00264498|21050710|P1|Randomized Treatment|Incorrectly randomized|1
6101079|NCT00264498|21050709|P2|Randomized Treatment|Physician Decision|0
6101080|NCT00264498|21050710|P1|Randomized Treatment|Physician Decision|1
6101081|NCT00264498|21050709|P2|Randomized Treatment|Objective disease Progression|14
6101082|NCT00264498|21050710|P1|Randomized Treatment|Objective disease Progression|13
6101083|NCT00264498|21050709|P2|Randomized Treatment|Withdrawal by Subject|1
6101084|NCT00264498|21050710|P1|Randomized Treatment|Withdrawal by Subject|0
6101085|NCT00264498|21050709|P2|Randomized Treatment|Death|3
6101086|NCT00264498|21050710|P1|Randomized Treatment|Death|0
6101087|NCT00264303|21050733|P2|Overall Study|Various reasons listed in study report|7
6101088|NCT00264303|21050734|P1|Overall Study|Various reasons listed in study report|6
6101089|NCT00264303|21050733|P2|Overall Study|Withdrawal by Subject|3
6101090|NCT00264303|21050734|P1|Overall Study|Withdrawal by Subject|2
6101091|NCT00264303|21050733|P2|Overall Study|Lost to Follow-up|3
6101092|NCT00264303|21050734|P1|Overall Study|Lost to Follow-up|3
6101093|NCT00264303|21050733|P2|Overall Study|Lack of Efficacy|13
6101094|NCT00264303|21050734|P1|Overall Study|Lack of Efficacy|10
6101095|NCT00264303|21050733|P2|Overall Study|Adverse Event|3
6101096|NCT00264303|21050734|P1|Overall Study|Adverse Event|4
6101097|NCT00264290|21050752|P2|Intervention (8 Weeks)|Adverse Event|0
6101098|NCT00264290|21050753|P1|Intervention (8 Weeks)|Adverse Event|1
6101099|NCT00264238|21050769|P1|Overall Study|Protocol Violation|1
6101100|NCT00264147|21050781|P6|Treatment II Period|Pre-scheduled total hip replacement|1
6101101|NCT00264147|21050782|P5|Treatment II Period|Pre-scheduled total hip replacement|0
6101102|NCT00264147|21050783|P4|Treatment II Period|Pre-scheduled total hip replacement|0
6101103|NCT00264147|21050784|P3|Treatment II Period|Pre-scheduled total hip replacement|0
6101104|NCT00264147|21050785|P2|Treatment II Period|Pre-scheduled total hip replacement|0
6101105|NCT00264147|21050786|P1|Treatment II Period|Pre-scheduled total hip replacement|0
6101106|NCT00264147|21050781|P6|Treatment II Period|Withdrawal by Subject|2
6101107|NCT00264147|21050782|P5|Treatment II Period|Withdrawal by Subject|3
6101108|NCT00264147|21050783|P4|Treatment II Period|Withdrawal by Subject|0
6101109|NCT00264147|21050784|P3|Treatment II Period|Withdrawal by Subject|0
6101110|NCT00264147|21050785|P2|Treatment II Period|Withdrawal by Subject|0
6101111|NCT00264147|21050786|P1|Treatment II Period|Withdrawal by Subject|0
6101112|NCT00264147|21050781|P6|Treatment II Period|Lost to Follow-up|1
6101113|NCT00264147|21050782|P5|Treatment II Period|Lost to Follow-up|1
6101114|NCT00264147|21050783|P4|Treatment II Period|Lost to Follow-up|0
6101115|NCT00264147|21050784|P3|Treatment II Period|Lost to Follow-up|0
6101116|NCT00264147|21050785|P2|Treatment II Period|Lost to Follow-up|0
6101117|NCT00264147|21050786|P1|Treatment II Period|Lost to Follow-up|0
6101118|NCT00264147|21050781|P6|Treatment II Period|Lack of Efficacy|19
6101119|NCT00264147|21050782|P5|Treatment II Period|Lack of Efficacy|20
6101120|NCT00264147|21050783|P4|Treatment II Period|Lack of Efficacy|0
6101121|NCT00264147|21050784|P3|Treatment II Period|Lack of Efficacy|0
6101122|NCT00264147|21050785|P2|Treatment II Period|Lack of Efficacy|0
6101123|NCT00264147|21050786|P1|Treatment II Period|Lack of Efficacy|0
6101124|NCT00264147|21050781|P6|Treatment II Period|Laboratory Adverse Event|1
6101125|NCT00264147|21050782|P5|Treatment II Period|Laboratory Adverse Event|0
6101126|NCT00264147|21050783|P4|Treatment II Period|Laboratory Adverse Event|0
6101127|NCT00264147|21050784|P3|Treatment II Period|Laboratory Adverse Event|0
6101128|NCT00264147|21050785|P2|Treatment II Period|Laboratory Adverse Event|0
6101129|NCT00264147|21050786|P1|Treatment II Period|Laboratory Adverse Event|0
6101130|NCT00264147|21050781|P6|Treatment II Period|Adverse Event|9
6101131|NCT00264147|21050782|P5|Treatment II Period|Adverse Event|9
6101132|NCT00264147|21050783|P4|Treatment II Period|Adverse Event|0
6101133|NCT00264147|21050784|P3|Treatment II Period|Adverse Event|0
6101134|NCT00264147|21050785|P2|Treatment II Period|Adverse Event|0
6101135|NCT00264147|21050786|P1|Treatment II Period|Adverse Event|0
6101136|NCT00264147|21050781|P6|Treatment I Period|Reassigned to Treatment II Period|0
6101137|NCT00264147|21050782|P5|Treatment I Period|Reassigned to Treatment II Period|45
6101138|NCT00264147|21050783|P4|Treatment I Period|Reassigned to Treatment II Period|63
6101139|NCT00264147|21050784|P3|Treatment I Period|Reassigned to Treatment II Period|65
6101140|NCT00264147|21050785|P2|Treatment I Period|Reassigned to Treatment II Period|72
6101141|NCT00264147|21050786|P1|Treatment I Period|Reassigned to Treatment II Period|84
6101142|NCT00264147|21050781|P6|Treatment I Period|Unblinded due to Serious Adverse Event|0
6101143|NCT00264147|21050782|P5|Treatment I Period|Unblinded due to Serious Adverse Event|0
6101144|NCT00264147|21050783|P4|Treatment I Period|Unblinded due to Serious Adverse Event|0
6101145|NCT00264147|21050784|P3|Treatment I Period|Unblinded due to Serious Adverse Event|1
6101146|NCT00264147|21050785|P2|Treatment I Period|Unblinded due to Serious Adverse Event|0
6101147|NCT00264147|21050786|P1|Treatment I Period|Unblinded due to Serious Adverse Event|0
6101148|NCT00264147|21050781|P6|Treatment I Period|Patient out of town for an extended time|0
6101149|NCT00264147|21050782|P5|Treatment I Period|Patient out of town for an extended time|0
6101150|NCT00264147|21050783|P4|Treatment I Period|Patient out of town for an extended time|0
6101151|NCT00264147|21050784|P3|Treatment I Period|Patient out of town for an extended time|0
6101152|NCT00264147|21050785|P2|Treatment I Period|Patient out of town for an extended time|1
6101153|NCT00264147|21050786|P1|Treatment I Period|Patient out of town for an extended time|0
6101154|NCT00264147|21050781|P6|Treatment I Period|Withdrawal by Subject|0
6101155|NCT00264147|21050782|P5|Treatment I Period|Withdrawal by Subject|2
6101156|NCT00264147|21050783|P4|Treatment I Period|Withdrawal by Subject|2
6101157|NCT00264147|21050784|P3|Treatment I Period|Withdrawal by Subject|0
6101158|NCT00264147|21050785|P2|Treatment I Period|Withdrawal by Subject|0
6101159|NCT00264147|21050786|P1|Treatment I Period|Withdrawal by Subject|2
6101160|NCT00264147|21050781|P6|Treatment I Period|Protocol Violation|0
6101161|NCT00264147|21050782|P5|Treatment I Period|Protocol Violation|0
6101162|NCT00264147|21050783|P4|Treatment I Period|Protocol Violation|0
6101163|NCT00264147|21050784|P3|Treatment I Period|Protocol Violation|0
6101164|NCT00264147|21050785|P2|Treatment I Period|Protocol Violation|2
6101165|NCT00264147|21050786|P1|Treatment I Period|Protocol Violation|2
6101166|NCT00264147|21050781|P6|Treatment I Period|Lost to Follow-up|0
6101167|NCT00264147|21050782|P5|Treatment I Period|Lost to Follow-up|1
6101168|NCT00264147|21050783|P4|Treatment I Period|Lost to Follow-up|1
6101169|NCT00264147|21050784|P3|Treatment I Period|Lost to Follow-up|0
6101170|NCT00264147|21050785|P2|Treatment I Period|Lost to Follow-up|0
6101171|NCT00264147|21050786|P1|Treatment I Period|Lost to Follow-up|1
6101172|NCT00264147|21050781|P6|Treatment I Period|Lack of Efficacy|0
6101173|NCT00264147|21050782|P5|Treatment I Period|Lack of Efficacy|1
6101174|NCT00264147|21050783|P4|Treatment I Period|Lack of Efficacy|0
6101175|NCT00264147|21050784|P3|Treatment I Period|Lack of Efficacy|8
6101176|NCT00264147|21050785|P2|Treatment I Period|Lack of Efficacy|2
6101177|NCT00264147|21050786|P1|Treatment I Period|Lack of Efficacy|6
6101178|NCT00264147|21050781|P6|Treatment I Period|Laboratory Adverse Event|0
6101179|NCT00264147|21050782|P5|Treatment I Period|Laboratory Adverse Event|0
6101180|NCT00264147|21050783|P4|Treatment I Period|Laboratory Adverse Event|1
6101181|NCT00264147|21050784|P3|Treatment I Period|Laboratory Adverse Event|0
6101182|NCT00264147|21050785|P2|Treatment I Period|Laboratory Adverse Event|0
6101183|NCT00264147|21050786|P1|Treatment I Period|Laboratory Adverse Event|0
6101184|NCT00264147|21050781|P6|Treatment I Period|Adverse Event|0
6101185|NCT00264147|21050782|P5|Treatment I Period|Adverse Event|7
6101186|NCT00264147|21050783|P4|Treatment I Period|Adverse Event|5
6101187|NCT00264147|21050784|P3|Treatment I Period|Adverse Event|3
6101188|NCT00264147|21050785|P2|Treatment I Period|Adverse Event|6
6101189|NCT00264147|21050786|P1|Treatment I Period|Adverse Event|3
6101190|NCT00264004|21050829|P4|Overall Study|Not treated|2
6101191|NCT00264004|21050830|P3|Overall Study|Not treated|2
6101192|NCT00264004|21050831|P2|Overall Study|Not treated|0
6101193|NCT00264004|21050832|P1|Overall Study|Not treated|3
6101194|NCT00264004|21050829|P4|Overall Study|Cond. under inv. worsened|4
6101195|NCT00264004|21050830|P3|Overall Study|Cond. under inv. worsened|3
6101196|NCT00264004|21050831|P2|Overall Study|Cond. under inv. worsened|5
6101197|NCT00264004|21050832|P1|Overall Study|Cond. under inv. worsened|9
6101198|NCT00264004|21050829|P4|Overall Study|Development study specific disc. crit.|0
6101199|NCT00264004|21050830|P3|Overall Study|Development study specific disc. crit.|1
6101200|NCT00264004|21050831|P2|Overall Study|Development study specific disc. crit.|0
6101201|NCT00264004|21050832|P1|Overall Study|Development study specific disc. crit.|1
6101202|NCT00264004|21050829|P4|Overall Study|Other|3
6101203|NCT00264004|21050830|P3|Overall Study|Other|0
6101204|NCT00264004|21050831|P2|Overall Study|Other|2
6101205|NCT00264004|21050832|P1|Overall Study|Other|2
6101206|NCT00264004|21050829|P4|Overall Study|Withdrawal by Subject|2
6101207|NCT00264004|21050830|P3|Overall Study|Withdrawal by Subject|2
6101208|NCT00264004|21050831|P2|Overall Study|Withdrawal by Subject|1
6101209|NCT00264004|21050832|P1|Overall Study|Withdrawal by Subject|0
6101210|NCT00264004|21050829|P4|Overall Study|Adverse Event|4
6101211|NCT00264004|21050830|P3|Overall Study|Adverse Event|6
6101212|NCT00264004|21050831|P2|Overall Study|Adverse Event|3
6101213|NCT00264004|21050832|P1|Overall Study|Adverse Event|2
6101214|NCT00263887|21050860|P2|Overall Study|Lack of Efficacy|1
6101215|NCT00263887|21050861|P1|Overall Study|Lack of Efficacy|0
6101216|NCT00263887|21050860|P2|Overall Study|Disease progression|1
6101217|NCT00263887|21050861|P1|Overall Study|Disease progression|0
6101218|NCT00263887|21050860|P2|Overall Study|Adverse Event|2
6101219|NCT00263887|21050861|P1|Overall Study|Adverse Event|0
6101220|NCT00263887|21050860|P2|Overall Study|Too ill to attend visit|0
6101221|NCT00263887|21050861|P1|Overall Study|Too ill to attend visit|1
6101222|NCT00263887|21050860|P2|Overall Study|Lung transplantation|2
6101223|NCT00263887|21050861|P1|Overall Study|Lung transplantation|1
6101224|NCT00263887|21050860|P2|Overall Study|Withdrawal by Subject|1
6101225|NCT00263887|21050861|P1|Overall Study|Withdrawal by Subject|1
6101226|NCT00263757|21050869|P2|Overall Study|Adverse Event|3
6101227|NCT00263757|21050870|P1|Overall Study|Adverse Event|3
6101228|NCT00263757|21050869|P2|Overall Study|Screen failure|1
6101229|NCT00263757|21050870|P1|Overall Study|Screen failure|0
6101230|NCT00263757|21050869|P2|Overall Study|Withdrawal by Subject|4
6101231|NCT00263757|21050870|P1|Overall Study|Withdrawal by Subject|5
6101232|NCT00263666|21050882|P2|Overall Study|Withdrawal by Subject|1
6101233|NCT00263666|21050883|P1|Overall Study|Withdrawal by Subject|0
6101234|NCT00263666|21050882|P2|Overall Study|Lost to Follow-up|2
6101235|NCT00263666|21050883|P1|Overall Study|Lost to Follow-up|1
6101236|NCT00263666|21050882|P2|Overall Study|Adverse Event|8
6101237|NCT00263666|21050883|P1|Overall Study|Adverse Event|6
6101238|NCT00263588|21050936|P2|Overall Study|Sponsor terminated study|1
6101239|NCT00263588|21050937|P1|Overall Study|Sponsor terminated study|0
6101240|NCT00263588|21050936|P2|Overall Study|Investigator decision|15
6101241|NCT00263588|21050937|P1|Overall Study|Investigator decision|7
6101242|NCT00263588|21050936|P2|Overall Study|Protocol Violation|1
6101243|NCT00263588|21050937|P1|Overall Study|Protocol Violation|0
6101244|NCT00263588|21050936|P2|Overall Study|Withdrawal by Subject|4
6101245|NCT00263588|21050937|P1|Overall Study|Withdrawal by Subject|3
6101246|NCT00263588|21050936|P2|Overall Study|Lost to Follow-up|10
6101247|NCT00263588|21050937|P1|Overall Study|Lost to Follow-up|7
6101248|NCT00263588|21050936|P2|Overall Study|disease progression, coma, 1 unknown|11
6101249|NCT00263588|21050937|P1|Overall Study|disease progression, coma, 1 unknown|10
6101250|NCT00263588|21050936|P2|Overall Study|Death|90
6101251|NCT00263588|21050937|P1|Overall Study|Death|54
6101252|NCT00263575|21050960|P1|Maintence Period|Other|7
6101253|NCT00263575|21050960|P1|Maintence Period|Sponsor Decision|24
6101254|NCT00263575|21050960|P1|Maintence Period|Lost to Follow-up|1
6101255|NCT00263575|21050960|P1|Maintence Period|Physician Decision|6
6101256|NCT00263575|21050960|P1|Maintence Period|Lack of Efficacy|4
6101257|NCT00263575|21050960|P1|Maintence Period|Protocol Violation|4
6101258|NCT00263575|21050960|P1|Maintence Period|Withdrawal by Subject|8
6101259|NCT00263575|21050960|P1|Maintence Period|Adverse Event|23
6101260|NCT00263575|21050960|P1|Titration Period|Lack of Efficacy|6
6101261|NCT00263575|21050960|P1|Titration Period|Other|2
6101262|NCT00263575|21050960|P1|Titration Period|Sponsor Decision|2
6101263|NCT00263575|21050960|P1|Titration Period|Protocol Violation|9
6101264|NCT00263575|21050960|P1|Titration Period|Withdrawal by Subject|10
6101265|NCT00263575|21050960|P1|Titration Period|Adverse Event|14
6101266|NCT00263562|21050968|P2|Overall Study|Protocol Violation|0
6101267|NCT00263562|21050969|P1|Overall Study|Protocol Violation|3
6101268|NCT00263328|21050986|P3|Overall Study|Adverse Event|4
6101269|NCT00263328|21050987|P2|Overall Study|Adverse Event|1
6101270|NCT00263328|21050988|P1|Overall Study|Adverse Event|1
6101271|NCT00263328|21050986|P3|Overall Study|Other|1
6101272|NCT00263328|21050987|P2|Overall Study|Other|0
6101273|NCT00263328|21050988|P1|Overall Study|Other|3
6101274|NCT00263328|21050986|P3|Overall Study|Withdrawal by Subject|1
6101275|NCT00263328|21050987|P2|Overall Study|Withdrawal by Subject|0
6101276|NCT00263328|21050988|P1|Overall Study|Withdrawal by Subject|3
6101277|NCT00263328|21050986|P3|Overall Study|Lost to Follow-up|0
6101278|NCT00263328|21050987|P2|Overall Study|Lost to Follow-up|1
6101279|NCT00263328|21050988|P1|Overall Study|Lost to Follow-up|1
6101280|NCT00263328|21050986|P3|Overall Study|Death|1
6101281|NCT00263328|21050987|P2|Overall Study|Death|0
6101282|NCT00263328|21050988|P1|Overall Study|Death|0
6101283|NCT00263211|21051146|P2|Overall Study|Disease Progression|1
6101284|NCT00263211|21051147|P1|Overall Study|Disease Progression|0
6101285|NCT00263211|21051146|P2|Overall Study|Protocol Violation|0
6101286|NCT00263211|21051147|P1|Overall Study|Protocol Violation|1
6101287|NCT00263211|21051146|P2|Overall Study|Withdrawal by Subject|0
6101288|NCT00263211|21051147|P1|Overall Study|Withdrawal by Subject|3
6101289|NCT00263211|21051146|P2|Overall Study|Death|0
6101290|NCT00263211|21051147|P1|Overall Study|Death|1
6101291|NCT00262951|21051198|P1|Overall Study|Off treatment for other disease|1
6101292|NCT00262951|21051198|P1|Overall Study|Alternative treatment|3
6101293|NCT00262951|21051198|P1|Overall Study|Withdrawal by Subject|1
6101294|NCT00262951|21051198|P1|Overall Study|Death|1
6101295|NCT00262951|21051198|P1|Overall Study|Adverse Event|7
6101296|NCT00262951|21051198|P1|Overall Study|Progressive disease/relapse|3
6101297|NCT00262925|21051203|P1|Overall Study|Other|1
6101298|NCT00262925|21051203|P1|Overall Study|alternative therapy|1
6101299|NCT00262925|21051203|P1|Overall Study|Death|2
6101300|NCT00262925|21051203|P1|Overall Study|Adverse Event|4
6101301|NCT00262925|21051203|P1|Overall Study|Lack of Efficacy|3
6101302|NCT00262873|21051209|P1|Overall Study|Withdrawal by Subject|5
6101303|NCT00262873|21051209|P1|Overall Study|Adverse Event|3
6101304|NCT00262860|21051220|P1|Overall Study|Adverse Event|2
6101305|NCT00262847|21051229|P3|Overall Study|Did not receive study treatment|4
6101306|NCT00262847|21051230|P2|Overall Study|Did not receive study treatment|1
6101307|NCT00262847|21051231|P1|Overall Study|Did not receive study treatment|4
6101308|NCT00262847|21051229|P3|Overall Study|Other Reasons|27
6101309|NCT00262847|21051230|P2|Overall Study|Other Reasons|88
6101310|NCT00262847|21051231|P1|Overall Study|Other Reasons|79
6101311|NCT00262847|21051229|P3|Overall Study|Concomitant disease|4
6101312|NCT00262847|21051230|P2|Overall Study|Concomitant disease|2
6101313|NCT00262847|21051231|P1|Overall Study|Concomitant disease|3
6101314|NCT00262847|21051229|P3|Overall Study|Death|11
6101315|NCT00262847|21051230|P2|Overall Study|Death|8
6101316|NCT00262847|21051231|P1|Overall Study|Death|8
6101317|NCT00262847|21051229|P3|Overall Study|Adverse Event|108
6101318|NCT00262847|21051230|P2|Overall Study|Adverse Event|88
6101319|NCT00262847|21051231|P1|Overall Study|Adverse Event|74
6101320|NCT00262847|21051229|P3|Overall Study|Patient Refusal|47
6101321|NCT00262847|21051230|P2|Overall Study|Patient Refusal|52
6101322|NCT00262847|21051231|P1|Overall Study|Patient Refusal|41
6101323|NCT00262847|21051229|P3|Overall Study|Disease Progression|195
6101324|NCT00262847|21051230|P2|Overall Study|Disease Progression|274
6101325|NCT00262847|21051231|P1|Overall Study|Disease Progression|309
6101326|NCT00262834|21051250|P2|Overall Study|Surgery delayed/tissue not collected|4
6101327|NCT00262834|21051251|P1|Overall Study|Surgery delayed/tissue not collected|1
6101328|NCT00262821|21051264|P2|Overall Study|Inevaluable - inadequate data|4
6101329|NCT00262821|21051265|P1|Overall Study|Inevaluable - inadequate data|0
6101330|NCT00262821|21051264|P2|Overall Study|Ineligible - required test not done|4
6101331|NCT00262821|21051265|P1|Overall Study|Ineligible - required test not done|1
6101332|NCT00262821|21051264|P2|Overall Study|Ineligible - elevated creatinine|2
6101333|NCT00262821|21051265|P1|Overall Study|Ineligible - elevated creatinine|0
6101334|NCT00262821|21051264|P2|Overall Study|Ineligible - inadequate pathology|3
6101335|NCT00262821|21051265|P1|Overall Study|Ineligible - inadequate pathology|1
6101336|NCT00262821|21051264|P2|Overall Study|Ineligible - wrong primary|1
6101337|NCT00262821|21051265|P1|Overall Study|Ineligible - wrong primary|0
6101338|NCT00262821|21051264|P2|Overall Study|Ineligible - wrong cell type|2
6101339|NCT00262821|21051265|P1|Overall Study|Ineligible - wrong cell type|2
6101340|NCT00262821|21051264|P2|Overall Study|Ineligible - wrong stage|3
6101341|NCT00262821|21051265|P1|Overall Study|Ineligible - wrong stage|0
6101342|NCT00262743|21051277|P2|Overall Study|Disease progression|3
6101343|NCT00262743|21051278|P1|Overall Study|Disease progression|0
6101344|NCT00262743|21051277|P2|Overall Study|Adverse Event|9
6101345|NCT00262743|21051278|P1|Overall Study|Adverse Event|0
6101346|NCT00262600|21051313|P3|Overall Study|Other|62
6101347|NCT00262600|21051314|P2|Overall Study|Other|59
6101348|NCT00262600|21051315|P1|Overall Study|Other|58
6101349|NCT00262600|21051313|P3|Overall Study|Not Treated|24
6101350|NCT00262600|21051314|P2|Overall Study|Not Treated|17
6101351|NCT00262600|21051315|P1|Overall Study|Not Treated|32
6101352|NCT00262600|21051313|P3|Overall Study|Withdrawal by Subject|139
6101353|NCT00262600|21051314|P2|Overall Study|Withdrawal by Subject|145
6101354|NCT00262600|21051315|P1|Overall Study|Withdrawal by Subject|128
6101355|NCT00262600|21051313|P3|Overall Study|Lost to Follow-up|41
6101356|NCT00262600|21051314|P2|Overall Study|Lost to Follow-up|31
6101357|NCT00262600|21051315|P1|Overall Study|Lost to Follow-up|17
6101358|NCT00262522|21051342|P4|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0
6101359|NCT00262522|21051343|P3|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|9
6101360|NCT00262522|21051344|P2|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0
6101361|NCT00262522|21051345|P1|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|10
6101362|NCT00262522|21051342|P4|Study Start Through 96 Weeks|Virologic failure|0
6101525|NCT00262028|21051533|P7|Overall Study|Administrative Reason|4
6101363|NCT00262522|21051343|P3|Study Start Through 96 Weeks|Virologic failure|8
6101364|NCT00262522|21051344|P2|Study Start Through 96 Weeks|Virologic failure|0
6101365|NCT00262522|21051345|P1|Study Start Through 96 Weeks|Virologic failure|5
6101366|NCT00262522|21051342|P4|Study Start Through 96 Weeks|Death|0
6101367|NCT00262522|21051343|P3|Study Start Through 96 Weeks|Death|2
6101368|NCT00262522|21051344|P2|Study Start Through 96 Weeks|Death|0
6101369|NCT00262522|21051345|P1|Study Start Through 96 Weeks|Death|2
6101370|NCT00262522|21051342|P4|Study Start Through 96 Weeks|Noncompliance|0
6101371|NCT00262522|21051343|P3|Study Start Through 96 Weeks|Noncompliance|11
6101372|NCT00262522|21051344|P2|Study Start Through 96 Weeks|Noncompliance|0
6101373|NCT00262522|21051345|P1|Study Start Through 96 Weeks|Noncompliance|6
6101374|NCT00262522|21051342|P4|Study Start Through 96 Weeks|Lost to Follow-up|0
6101375|NCT00262522|21051343|P3|Study Start Through 96 Weeks|Lost to Follow-up|18
6101376|NCT00262522|21051344|P2|Study Start Through 96 Weeks|Lost to Follow-up|0
6101377|NCT00262522|21051345|P1|Study Start Through 96 Weeks|Lost to Follow-up|19
6101378|NCT00262522|21051342|P4|Study Start Through 96 Weeks|Withdrawal by Subject|0
6101379|NCT00262522|21051343|P3|Study Start Through 96 Weeks|Withdrawal by Subject|13
6101380|NCT00262522|21051344|P2|Study Start Through 96 Weeks|Withdrawal by Subject|0
6101381|NCT00262522|21051345|P1|Study Start Through 96 Weeks|Withdrawal by Subject|15
6101382|NCT00262522|21051342|P4|Study Start Through 96 Weeks|Adverse Event|0
6101383|NCT00262522|21051343|P3|Study Start Through 96 Weeks|Adverse Event|16
6101384|NCT00262522|21051344|P2|Study Start Through 96 Weeks|Adverse Event|0
6101385|NCT00262522|21051345|P1|Study Start Through 96 Weeks|Adverse Event|20
6101386|NCT00262522|21051342|P4|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0
6101387|NCT00262522|21051343|P3|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|7
6101388|NCT00262522|21051344|P2|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0
6101389|NCT00262522|21051345|P1|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|8
6101390|NCT00262522|21051342|P4|Study Start Through 48 Weeks|Virologic failure|0
6101391|NCT00262522|21051343|P3|Study Start Through 48 Weeks|Virologic failure|4
6101392|NCT00262522|21051344|P2|Study Start Through 48 Weeks|Virologic failure|0
6101393|NCT00262522|21051345|P1|Study Start Through 48 Weeks|Virologic failure|2
6101394|NCT00262522|21051342|P4|Study Start Through 48 Weeks|Death|0
6101395|NCT00262522|21051343|P3|Study Start Through 48 Weeks|Death|1
6101396|NCT00262522|21051344|P2|Study Start Through 48 Weeks|Death|0
6101397|NCT00262522|21051345|P1|Study Start Through 48 Weeks|Death|2
6101398|NCT00262522|21051342|P4|Study Start Through 48 Weeks|Noncompliance|0
6101399|NCT00262522|21051343|P3|Study Start Through 48 Weeks|Noncompliance|8
6101400|NCT00262522|21051344|P2|Study Start Through 48 Weeks|Noncompliance|0
6101401|NCT00262522|21051345|P1|Study Start Through 48 Weeks|Noncompliance|3
6101402|NCT00262522|21051342|P4|Study Start Through 48 Weeks|Lost to Follow-up|0
6101403|NCT00262522|21051343|P3|Study Start Through 48 Weeks|Lost to Follow-up|14
6101404|NCT00262522|21051344|P2|Study Start Through 48 Weeks|Lost to Follow-up|0
6101405|NCT00262522|21051345|P1|Study Start Through 48 Weeks|Lost to Follow-up|8
6101406|NCT00262522|21051342|P4|Study Start Through 48 Weeks|Withdrawal by Subject|0
6101407|NCT00262522|21051343|P3|Study Start Through 48 Weeks|Withdrawal by Subject|11
6101408|NCT00262522|21051344|P2|Study Start Through 48 Weeks|Withdrawal by Subject|0
6101409|NCT00262522|21051345|P1|Study Start Through 48 Weeks|Withdrawal by Subject|10
6101410|NCT00262522|21051342|P4|Study Start Through 48 Weeks|Adverse Event|0
6101411|NCT00262522|21051343|P3|Study Start Through 48 Weeks|Adverse Event|10
6101412|NCT00262522|21051344|P2|Study Start Through 48 Weeks|Adverse Event|0
6101413|NCT00262522|21051345|P1|Study Start Through 48 Weeks|Adverse Event|16
6101414|NCT00262522|21051342|P4|Study Start Through 8 Weeks|Death|0
6101415|NCT00262522|21051343|P3|Study Start Through 8 Weeks|Death|0
6101416|NCT00262522|21051344|P2|Study Start Through 8 Weeks|Death|0
6101417|NCT00262522|21051345|P1|Study Start Through 8 Weeks|Death|1
6101418|NCT00262522|21051342|P4|Study Start Through 8 Weeks|Noncompliance|2
6101419|NCT00262522|21051343|P3|Study Start Through 8 Weeks|Noncompliance|2
6101420|NCT00262522|21051344|P2|Study Start Through 8 Weeks|Noncompliance|0
6101421|NCT00262522|21051345|P1|Study Start Through 8 Weeks|Noncompliance|0
6101422|NCT00262522|21051342|P4|Study Start Through 8 Weeks|Lost to Follow-up|2
6101423|NCT00262522|21051343|P3|Study Start Through 8 Weeks|Lost to Follow-up|3
6101424|NCT00262522|21051344|P2|Study Start Through 8 Weeks|Lost to Follow-up|2
6101425|NCT00262522|21051345|P1|Study Start Through 8 Weeks|Lost to Follow-up|1
6101426|NCT00262522|21051342|P4|Study Start Through 8 Weeks|Withdrawal by Subject|0
6101427|NCT00262522|21051343|P3|Study Start Through 8 Weeks|Withdrawal by Subject|3
6101428|NCT00262522|21051344|P2|Study Start Through 8 Weeks|Withdrawal by Subject|1
6101429|NCT00262522|21051345|P1|Study Start Through 8 Weeks|Withdrawal by Subject|1
6101430|NCT00262522|21051342|P4|Study Start Through 8 Weeks|Adverse Event|1
6101431|NCT00262522|21051343|P3|Study Start Through 8 Weeks|Adverse Event|3
6101432|NCT00262522|21051344|P2|Study Start Through 8 Weeks|Adverse Event|2
6101433|NCT00262522|21051345|P1|Study Start Through 8 Weeks|Adverse Event|1
6101434|NCT00262314|21051374|P1|Overall Study|Administrative withdrawal|30
6101435|NCT00262314|21051374|P1|Overall Study|Lost to Follow-up|70
6101436|NCT00262314|21051374|P1|Overall Study|Other|95
6101437|NCT00262314|21051374|P1|Overall Study|Patient's decision|92
6101438|NCT00262314|21051374|P1|Overall Study|Death|12
6101439|NCT00262314|21051374|P1|Overall Study|Changing physicians|38
6101440|NCT00262301|21051392|P3|Double-blind Phase|"worsening of HAE symptoms"|0
6101441|NCT00262301|21051393|P2|Double-blind Phase|"worsening of HAE symptoms"|1
6101442|NCT00262301|21051394|P1|Double-blind Phase|"worsening of HAE symptoms"|0
6101443|NCT00262301|21051392|P3|Double-blind Phase|Lost to Follow-up|0
6101444|NCT00262301|21051393|P2|Double-blind Phase|Lost to Follow-up|0
6101445|NCT00262301|21051394|P1|Double-blind Phase|Lost to Follow-up|1
6101446|NCT00262223|21051407|P2|12-month Post-treatment Follow-up|Lost to Follow-up|7
6101447|NCT00262223|21051408|P1|12-month Post-treatment Follow-up|Lost to Follow-up|7
6101448|NCT00262223|21051407|P2|6-month Post-treatment Follow-up|Lost to Follow-up|1
6101449|NCT00262223|21051408|P1|6-month Post-treatment Follow-up|Lost to Follow-up|6
6101450|NCT00262223|21051407|P2|1-week Post-treatment Follow-up|Lost to Follow-up|4
6101451|NCT00262223|21051408|P1|1-week Post-treatment Follow-up|Lost to Follow-up|4
6101452|NCT00262223|21051407|P2|Treatment Phase|Adverse Event|2
6101453|NCT00262223|21051408|P1|Treatment Phase|Adverse Event|1
6101454|NCT00262223|21051407|P2|Treatment Phase|Withdrawal by Subject|6
6101455|NCT00262223|21051408|P1|Treatment Phase|Withdrawal by Subject|3
6101456|NCT00262119|21051419|P3|Overall Study|Death|16
6101457|NCT00262119|21051420|P2|Overall Study|Death|19
6101458|NCT00262119|21051421|P1|Overall Study|Death|20
6101459|NCT00262119|21051419|P3|Overall Study|Lost to Follow-up|42
6101460|NCT00262119|21051420|P2|Overall Study|Lost to Follow-up|51
6101461|NCT00262119|21051421|P1|Overall Study|Lost to Follow-up|38
6101462|NCT00262080|21051441|P3|Repeat Dose Treatment Period|enrolled in EDEMA4|0
6101463|NCT00262080|21051442|P2|Repeat Dose Treatment Period|enrolled in EDEMA4|0
6101464|NCT00262080|21051443|P1|Repeat Dose Treatment Period|enrolled in EDEMA4|1
6101465|NCT00262080|21051441|P3|Repeat Dose Treatment Period|Decision to discontinue the study|2
6101466|NCT00262080|21051442|P2|Repeat Dose Treatment Period|Decision to discontinue the study|0
6101467|NCT00262080|21051443|P1|Repeat Dose Treatment Period|Decision to discontinue the study|0
6101468|NCT00262080|21051441|P3|Repeat Dose Treatment Period|Lost to Follow-up|2
6101469|NCT00262080|21051442|P2|Repeat Dose Treatment Period|Lost to Follow-up|0
6101470|NCT00262080|21051443|P1|Repeat Dose Treatment Period|Lost to Follow-up|2
6101471|NCT00262080|21051441|P3|Repeat Dose Treatment Period|Withdrawal by Subject|1
6101472|NCT00262080|21051442|P2|Repeat Dose Treatment Period|Withdrawal by Subject|1
6101473|NCT00262080|21051443|P1|Repeat Dose Treatment Period|Withdrawal by Subject|0
6101474|NCT00262080|21051441|P3|Repeat Dose Treatment Period|Adverse Event|0
6101475|NCT00262080|21051442|P2|Repeat Dose Treatment Period|Adverse Event|0
6101476|NCT00262080|21051443|P1|Repeat Dose Treatment Period|Adverse Event|1
6101477|NCT00262080|21051441|P3|Double Blind Treatment Period|Lost to Follow-up|0
6101478|NCT00262080|21051442|P2|Double Blind Treatment Period|Lost to Follow-up|0
6101479|NCT00262080|21051443|P1|Double Blind Treatment Period|Lost to Follow-up|1
6101480|NCT00262067|21051463|P4|Overall Study|Patient Withdrew for Survival Follow-up|9
6101481|NCT00262067|21051464|P3|Overall Study|Patient Withdrew for Survival Follow-up|23
6101482|NCT00262067|21051465|P2|Overall Study|Patient Withdrew for Survival Follow-up|7
6101483|NCT00262067|21051466|P1|Overall Study|Patient Withdrew for Survival Follow-up|23
6101484|NCT00262067|21051463|P4|Overall Study|Sponsor's Decision to Terminate Study|0
6101485|NCT00262067|21051464|P3|Overall Study|Sponsor's Decision to Terminate Study|0
6101486|NCT00262067|21051465|P2|Overall Study|Sponsor's Decision to Terminate Study|0
6101487|NCT00262067|21051466|P1|Overall Study|Sponsor's Decision to Terminate Study|1
6101488|NCT00262067|21051463|P4|Overall Study|Lost to Follow-up|5
6101489|NCT00262067|21051464|P3|Overall Study|Lost to Follow-up|7
6101490|NCT00262067|21051465|P2|Overall Study|Lost to Follow-up|4
6101491|NCT00262067|21051466|P1|Overall Study|Lost to Follow-up|5
6101492|NCT00262067|21051463|P4|Overall Study|Death|99
6101493|NCT00262067|21051464|P3|Overall Study|Death|186
6101494|NCT00262067|21051465|P2|Overall Study|Death|89
6101495|NCT00262067|21051466|P1|Overall Study|Death|190
6101496|NCT00262041|21051500|P3|Overall Study|Unable to classify|0
6101497|NCT00262041|21051501|P2|Overall Study|Unable to classify|0
6101498|NCT00262041|21051502|P1|Overall Study|Unable to classify|1
6101499|NCT00262041|21051500|P3|Overall Study|Lost to Follow-up|5
6101500|NCT00262041|21051501|P2|Overall Study|Lost to Follow-up|1
6101501|NCT00262041|21051502|P1|Overall Study|Lost to Follow-up|1
6101502|NCT00262041|21051500|P3|Overall Study|Withdrawal by Subject|1
6101503|NCT00262041|21051501|P2|Overall Study|Withdrawal by Subject|3
6101504|NCT00262041|21051502|P1|Overall Study|Withdrawal by Subject|0
6101505|NCT00262028|21051531|P9|Overall Study|Unable to classify|1
6101506|NCT00262028|21051532|P8|Overall Study|Unable to classify|0
6101507|NCT00262028|21051533|P7|Overall Study|Unable to classify|0
6101508|NCT00262028|21051534|P6|Overall Study|Unable to classify|0
6101509|NCT00262028|21051535|P5|Overall Study|Unable to classify|0
6101510|NCT00262028|21051536|P4|Overall Study|Unable to classify|0
6101511|NCT00262028|21051537|P3|Overall Study|Unable to classify|0
6101512|NCT00262028|21051538|P2|Overall Study|Unable to classify|3
6101513|NCT00262028|21051539|P1|Overall Study|Unable to classify|0
6101514|NCT00262028|21051531|P9|Overall Study|Protocol Violation|0
6101515|NCT00262028|21051532|P8|Overall Study|Protocol Violation|0
6101516|NCT00262028|21051533|P7|Overall Study|Protocol Violation|0
6101517|NCT00262028|21051534|P6|Overall Study|Protocol Violation|0
6101518|NCT00262028|21051535|P5|Overall Study|Protocol Violation|0
6101519|NCT00262028|21051536|P4|Overall Study|Protocol Violation|1
6101520|NCT00262028|21051537|P3|Overall Study|Protocol Violation|0
6101521|NCT00262028|21051538|P2|Overall Study|Protocol Violation|0
6101522|NCT00262028|21051539|P1|Overall Study|Protocol Violation|0
6101523|NCT00262028|21051531|P9|Overall Study|Administrative Reason|10
6101524|NCT00262028|21051532|P8|Overall Study|Administrative Reason|6
6101526|NCT00262028|21051534|P6|Overall Study|Administrative Reason|7
6101527|NCT00262028|21051535|P5|Overall Study|Administrative Reason|6
6101528|NCT00262028|21051536|P4|Overall Study|Administrative Reason|12
6101529|NCT00262028|21051537|P3|Overall Study|Administrative Reason|9
6101530|NCT00262028|21051538|P2|Overall Study|Administrative Reason|14
6101531|NCT00262028|21051539|P1|Overall Study|Administrative Reason|11
6101532|NCT00262028|21051531|P9|Overall Study|Lost to Follow-up|6
6101533|NCT00262028|21051532|P8|Overall Study|Lost to Follow-up|5
6101534|NCT00262028|21051533|P7|Overall Study|Lost to Follow-up|3
6101535|NCT00262028|21051534|P6|Overall Study|Lost to Follow-up|3
6101536|NCT00262028|21051535|P5|Overall Study|Lost to Follow-up|4
6101537|NCT00262028|21051536|P4|Overall Study|Lost to Follow-up|5
6101538|NCT00262028|21051537|P3|Overall Study|Lost to Follow-up|5
6101539|NCT00262028|21051538|P2|Overall Study|Lost to Follow-up|7
6101540|NCT00262028|21051539|P1|Overall Study|Lost to Follow-up|7
6101541|NCT00262028|21051531|P9|Overall Study|Withdrawal by Subject|2
6101542|NCT00262028|21051532|P8|Overall Study|Withdrawal by Subject|7
6101543|NCT00262028|21051533|P7|Overall Study|Withdrawal by Subject|5
6101544|NCT00262028|21051534|P6|Overall Study|Withdrawal by Subject|3
6101545|NCT00262028|21051535|P5|Overall Study|Withdrawal by Subject|2
6101546|NCT00262028|21051536|P4|Overall Study|Withdrawal by Subject|5
6101547|NCT00262028|21051537|P3|Overall Study|Withdrawal by Subject|6
6101548|NCT00262028|21051538|P2|Overall Study|Withdrawal by Subject|3
6101549|NCT00262028|21051539|P1|Overall Study|Withdrawal by Subject|6
6101550|NCT00262002|21051601|P7|Overall Study|Unable to classify|2
6101551|NCT00262002|21051602|P6|Overall Study|Unable to classify|0
6101552|NCT00262002|21051603|P5|Overall Study|Unable to classify|0
6101553|NCT00262002|21051604|P4|Overall Study|Unable to classify|0
6101554|NCT00262002|21051605|P3|Overall Study|Unable to classify|0
6101555|NCT00262002|21051606|P2|Overall Study|Unable to classify|0
6101556|NCT00262002|21051607|P1|Overall Study|Unable to classify|0
6101557|NCT00262002|21051601|P7|Overall Study|Protocol Violation|2
6101558|NCT00262002|21051602|P6|Overall Study|Protocol Violation|3
6101559|NCT00262002|21051603|P5|Overall Study|Protocol Violation|5
6101560|NCT00262002|21051604|P4|Overall Study|Protocol Violation|2
6101561|NCT00262002|21051605|P3|Overall Study|Protocol Violation|0
6101562|NCT00262002|21051606|P2|Overall Study|Protocol Violation|2
6101563|NCT00262002|21051607|P1|Overall Study|Protocol Violation|3
6101564|NCT00262002|21051601|P7|Overall Study|Inapropriate enrollment|0
6101565|NCT00262002|21051602|P6|Overall Study|Inapropriate enrollment|0
6101566|NCT00262002|21051603|P5|Overall Study|Inapropriate enrollment|0
6101567|NCT00262002|21051604|P4|Overall Study|Inapropriate enrollment|0
6101568|NCT00262002|21051605|P3|Overall Study|Inapropriate enrollment|0
6101569|NCT00262002|21051606|P2|Overall Study|Inapropriate enrollment|1
6101570|NCT00262002|21051607|P1|Overall Study|Inapropriate enrollment|0
6101571|NCT00262002|21051601|P7|Overall Study|Lost to Follow-up|0
6101572|NCT00262002|21051602|P6|Overall Study|Lost to Follow-up|1
6101573|NCT00262002|21051603|P5|Overall Study|Lost to Follow-up|0
6101574|NCT00262002|21051604|P4|Overall Study|Lost to Follow-up|2
6101575|NCT00262002|21051605|P3|Overall Study|Lost to Follow-up|0
6101576|NCT00262002|21051606|P2|Overall Study|Lost to Follow-up|0
6101577|NCT00262002|21051607|P1|Overall Study|Lost to Follow-up|2
6101578|NCT00262002|21051601|P7|Overall Study|Withdrawal by Subject|2
6101579|NCT00262002|21051602|P6|Overall Study|Withdrawal by Subject|2
6101580|NCT00262002|21051603|P5|Overall Study|Withdrawal by Subject|2
6101581|NCT00262002|21051604|P4|Overall Study|Withdrawal by Subject|1
6101582|NCT00262002|21051605|P3|Overall Study|Withdrawal by Subject|0
6101583|NCT00262002|21051606|P2|Overall Study|Withdrawal by Subject|2
6101584|NCT00262002|21051607|P1|Overall Study|Withdrawal by Subject|4
6101585|NCT00262002|21051601|P7|Overall Study|Adverse Event|0
6101586|NCT00262002|21051602|P6|Overall Study|Adverse Event|1
6101587|NCT00262002|21051603|P5|Overall Study|Adverse Event|0
6101588|NCT00262002|21051604|P4|Overall Study|Adverse Event|0
6101589|NCT00262002|21051605|P3|Overall Study|Adverse Event|0
6101590|NCT00262002|21051606|P2|Overall Study|Adverse Event|1
6101591|NCT00262002|21051607|P1|Overall Study|Adverse Event|2
6101592|NCT00261950|21051700|P1|Overall Study|Protocol specified Criteria|11
6101593|NCT00261950|21051700|P1|Overall Study|Physician Decision|1
6101594|NCT00261950|21051700|P1|Overall Study|Other|1
6101595|NCT00261950|21051700|P1|Overall Study|Withdrawal by Subject|5
6101596|NCT00261950|21051700|P1|Overall Study|Death|6
6101597|NCT00261950|21051700|P1|Overall Study|Lost to Follow-up|2
6101598|NCT00261846|21051725|P12|Period 2: Part 2 (Efficacy)|Extension study|1
6101599|NCT00261846|21051726|P11|Period 2: Part 2 (Efficacy)|Extension study|1
6101600|NCT00261846|21051727|P10|Period 2: Part 2 (Efficacy)|Extension study|9
6101601|NCT00261846|21051728|P9|Period 2: Part 2 (Efficacy)|Extension study|5
6101602|NCT00261846|21051729|P8|Period 2: Part 2 (Efficacy)|Extension study|9
6101603|NCT00261846|21051730|P7|Period 2: Part 2 (Efficacy)|Extension study|4
6101604|NCT00261846|21051731|P6|Period 2: Part 2 (Efficacy)|Extension study|0
6101605|NCT00261846|21051732|P5|Period 2: Part 2 (Efficacy)|Extension study|27
6101606|NCT00261846|21051733|P4|Period 2: Part 2 (Efficacy)|Extension study|61
6101607|NCT00261846|21051734|P3|Period 2: Part 2 (Efficacy)|Extension study|0
6101608|NCT00261846|21051735|P2|Period 2: Part 2 (Efficacy)|Extension study|0
6101609|NCT00261846|21051736|P1|Period 2: Part 2 (Efficacy)|Extension study|0
6101610|NCT00261846|21051725|P12|Period 2: Part 2 (Efficacy)|Death|22
6101611|NCT00261846|21051726|P11|Period 2: Part 2 (Efficacy)|Death|44
6101612|NCT00261846|21051727|P10|Period 2: Part 2 (Efficacy)|Death|30
6101613|NCT00261846|21051728|P9|Period 2: Part 2 (Efficacy)|Death|3
6101614|NCT00261846|21051729|P8|Period 2: Part 2 (Efficacy)|Death|12
6101615|NCT00261846|21051730|P7|Period 2: Part 2 (Efficacy)|Death|10
6101616|NCT00261846|21051731|P6|Period 2: Part 2 (Efficacy)|Death|1
6101617|NCT00261846|21051732|P5|Period 2: Part 2 (Efficacy)|Death|7
6101618|NCT00261846|21051733|P4|Period 2: Part 2 (Efficacy)|Death|37
6101619|NCT00261846|21051734|P3|Period 2: Part 2 (Efficacy)|Death|0
6101620|NCT00261846|21051735|P2|Period 2: Part 2 (Efficacy)|Death|0
6101621|NCT00261846|21051736|P1|Period 2: Part 2 (Efficacy)|Death|0
6101622|NCT00261846|21051725|P12|Period 2: Part 2 (Efficacy)|Other|0
6101623|NCT00261846|21051726|P11|Period 2: Part 2 (Efficacy)|Other|0
6101624|NCT00261846|21051727|P10|Period 2: Part 2 (Efficacy)|Other|4
6101625|NCT00261846|21051728|P9|Period 2: Part 2 (Efficacy)|Other|4
6101626|NCT00261846|21051729|P8|Period 2: Part 2 (Efficacy)|Other|5
6101627|NCT00261846|21051730|P7|Period 2: Part 2 (Efficacy)|Other|1
6101628|NCT00261846|21051731|P6|Period 2: Part 2 (Efficacy)|Other|0
6101629|NCT00261846|21051732|P5|Period 2: Part 2 (Efficacy)|Other|4
6101630|NCT00261846|21051733|P4|Period 2: Part 2 (Efficacy)|Other|15
6101631|NCT00261846|21051734|P3|Period 2: Part 2 (Efficacy)|Other|0
6101632|NCT00261846|21051735|P2|Period 2: Part 2 (Efficacy)|Other|0
6101633|NCT00261846|21051736|P1|Period 2: Part 2 (Efficacy)|Other|0
6101634|NCT00261846|21051725|P12|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0
6101635|NCT00261846|21051726|P11|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4
6101636|NCT00261846|21051727|P10|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4
6101637|NCT00261846|21051728|P9|Period 2: Part 2 (Efficacy)|Lost to Follow-up|1
6101638|NCT00261846|21051729|P8|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0
6101639|NCT00261846|21051730|P7|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4
6101640|NCT00261846|21051731|P6|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0
6101641|NCT00261846|21051732|P5|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4
6101642|NCT00261846|21051733|P4|Period 2: Part 2 (Efficacy)|Lost to Follow-up|12
6101643|NCT00261846|21051734|P3|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0
6101644|NCT00261846|21051735|P2|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0
6101645|NCT00261846|21051736|P1|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0
6101646|NCT00261846|21051725|P12|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0
6101647|NCT00261846|21051726|P11|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0
6101648|NCT00261846|21051727|P10|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|2
6101649|NCT00261846|21051728|P9|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0
6101650|NCT00261846|21051729|P8|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3
6101651|NCT00261846|21051730|P7|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3
6101652|NCT00261846|21051731|P6|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|1
6101653|NCT00261846|21051732|P5|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|8
6101654|NCT00261846|21051733|P4|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|9
6101655|NCT00261846|21051734|P3|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0
6101656|NCT00261846|21051735|P2|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0
6101657|NCT00261846|21051736|P1|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0
6101658|NCT00261846|21051725|P12|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
6101659|NCT00261846|21051726|P11|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
6101660|NCT00261846|21051727|P10|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
6101661|NCT00261846|21051728|P9|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1
6101662|NCT00261846|21051729|P8|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
6101663|NCT00261846|21051730|P7|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
6101664|NCT00261846|21051731|P6|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
6101665|NCT00261846|21051732|P5|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
6101666|NCT00261846|21051733|P4|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1
6101667|NCT00261846|21051734|P3|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
6101668|NCT00261846|21051735|P2|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
6101669|NCT00261846|21051736|P1|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
6101670|NCT00261846|21051725|P12|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
6101671|NCT00261846|21051726|P11|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
6101672|NCT00261846|21051727|P10|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
6101673|NCT00261846|21051728|P9|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
6101674|NCT00261846|21051729|P8|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
6101675|NCT00261846|21051730|P7|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
6101676|NCT00261846|21051731|P6|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
6101677|NCT00261846|21051732|P5|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
6101678|NCT00261846|21051733|P4|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
6101679|NCT00261846|21051734|P3|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|12
6101680|NCT00261846|21051735|P2|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3
6101681|NCT00261846|21051736|P1|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3
6101682|NCT00261833|21051995|P2|Overall Study|Not interested in being participant|1
6101683|NCT00261833|21051996|P1|Overall Study|Not interested in being participant|0
6101684|NCT00261833|21051995|P2|Overall Study|Missing reason|0
6101685|NCT00261833|21051996|P1|Overall Study|Missing reason|1
6101686|NCT00261833|21051995|P2|Overall Study|Lung transplantation|1
6101687|NCT00261833|21051996|P1|Overall Study|Lung transplantation|1
6101688|NCT00261833|21051995|P2|Overall Study|Suspicion of pulmonary cancer|1
6101689|NCT00261833|21051996|P1|Overall Study|Suspicion of pulmonary cancer|0
6101690|NCT00261833|21051995|P2|Overall Study|Protocol Violation|1
6101691|NCT00261833|21051996|P1|Overall Study|Protocol Violation|0
6101692|NCT00261833|21051995|P2|Overall Study|Withdrawal by Subject|7
6101693|NCT00261833|21051996|P1|Overall Study|Withdrawal by Subject|5
6101694|NCT00261833|21051995|P2|Overall Study|Adverse Event|4
6101695|NCT00261833|21051996|P1|Overall Study|Adverse Event|1
6101696|NCT00261833|21051995|P2|Overall Study|Death|3
6101697|NCT00261833|21051996|P1|Overall Study|Death|1
6101698|NCT00261716|21052030|P2|Overall Study|Lost to Follow-up|2
6101699|NCT00261716|21052031|P1|Overall Study|Lost to Follow-up|0
6101700|NCT00261716|21052030|P2|Overall Study|Withdrawal by Subject|8
6101701|NCT00261716|21052031|P1|Overall Study|Withdrawal by Subject|6
6101702|NCT00261495|21052051|P2|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
6101703|NCT00261495|21052052|P1|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1
6101704|NCT00261495|21052051|P2|Extension Phase (Weeks 24 to 52)|Non-compliance|0
6101705|NCT00261495|21052052|P1|Extension Phase (Weeks 24 to 52)|Non-compliance|1
6101706|NCT00261495|21052051|P2|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1
6101707|NCT00261495|21052052|P1|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0
6101708|NCT00261495|21052051|P2|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1
6101709|NCT00261495|21052052|P1|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0
6101710|NCT00261495|21052051|P2|Extension Phase (Weeks 24 to 52)|Adverse Event|1
6101711|NCT00261495|21052052|P1|Extension Phase (Weeks 24 to 52)|Adverse Event|4
6101712|NCT00261495|21052051|P2|Extension Phase (Weeks 24 to 52)|Other|2
6101713|NCT00261495|21052052|P1|Extension Phase (Weeks 24 to 52)|Other|4
6101714|NCT00261495|21052051|P2|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|0
6101715|NCT00261495|21052052|P1|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|2
6101716|NCT00261495|21052051|P2|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|0
6101717|NCT00261495|21052052|P1|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|2
6101718|NCT00261495|21052051|P2|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1
6101719|NCT00261495|21052052|P1|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1
6101720|NCT00261495|21052051|P2|Maintenance Phase (Weeks 4 to 24)|Other|5
6101721|NCT00261495|21052052|P1|Maintenance Phase (Weeks 4 to 24)|Other|6
6101722|NCT00261495|21052051|P2|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|2
6101723|NCT00261495|21052052|P1|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|5
6101724|NCT00261495|21052051|P2|Maintenance Phase (Weeks 4 to 24)|Non-compliance|5
6101725|NCT00261495|21052052|P1|Maintenance Phase (Weeks 4 to 24)|Non-compliance|1
6101726|NCT00261495|21052051|P2|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|5
6101727|NCT00261495|21052052|P1|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|6
6101728|NCT00261495|21052051|P2|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|10
6101729|NCT00261495|21052052|P1|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|14
6101730|NCT00261495|21052051|P2|Maintenance Phase (Weeks 4 to 24)|Adverse Event|20
6101731|NCT00261495|21052052|P1|Maintenance Phase (Weeks 4 to 24)|Adverse Event|29
6101732|NCT00261495|21052051|P2|Titration Phase (Weeks 0 to 4)|Protocol Violation|4
6101733|NCT00261495|21052052|P1|Titration Phase (Weeks 0 to 4)|Protocol Violation|1
6101734|NCT00261495|21052051|P2|Titration Phase (Weeks 0 to 4)|Non-compliance|5
6101735|NCT00261495|21052052|P1|Titration Phase (Weeks 0 to 4)|Non-compliance|2
6101736|NCT00261495|21052051|P2|Titration Phase (Weeks 0 to 4)|Physician Decision|1
6101737|NCT00261495|21052052|P1|Titration Phase (Weeks 0 to 4)|Physician Decision|3
6101738|NCT00261495|21052051|P2|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8
6101739|NCT00261495|21052052|P1|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8
6101740|NCT00261495|21052051|P2|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|11
6101741|NCT00261495|21052052|P1|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|6
6101742|NCT00261495|21052051|P2|Titration Phase (Weeks 0 to 4)|Adverse Event|36
6101743|NCT00261495|21052052|P1|Titration Phase (Weeks 0 to 4)|Adverse Event|28
6101744|NCT00261443|21052216|P3|4: Extension Phase|Lost to Follow-up|0
6101745|NCT00261443|21052217|P2|4: Extension Phase|Lost to Follow-up|1
6101746|NCT00261443|21052218|P1|4: Extension Phase|Lost to Follow-up|0
6101747|NCT00261443|21052216|P3|4: Extension Phase|Withdrawal by Subject|2
6101748|NCT00261443|21052217|P2|4: Extension Phase|Withdrawal by Subject|1
6101749|NCT00261443|21052218|P1|4: Extension Phase|Withdrawal by Subject|0
6101750|NCT00261443|21052216|P3|4: Extension Phase|Adverse Event|0
6101751|NCT00261443|21052217|P2|4: Extension Phase|Adverse Event|1
6101752|NCT00261443|21052218|P1|4: Extension Phase|Adverse Event|0
6101753|NCT00261443|21052216|P3|3: Assessment of Relapse|Other Reasons|3
6101754|NCT00261443|21052217|P2|3: Assessment of Relapse|Other Reasons|4
6101755|NCT00261443|21052218|P1|3: Assessment of Relapse|Other Reasons|0
6101756|NCT00261443|21052216|P3|3: Assessment of Relapse|Administrative Reason By Sponsor|2
6101757|NCT00261443|21052217|P2|3: Assessment of Relapse|Administrative Reason By Sponsor|0
6101758|NCT00261443|21052218|P1|3: Assessment of Relapse|Administrative Reason By Sponsor|0
6101759|NCT00261443|21052216|P3|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|1
6101760|NCT00261443|21052217|P2|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|2
6101761|NCT00261443|21052218|P1|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|0
6101762|NCT00261443|21052216|P3|3: Assessment of Relapse|Pregnancy|1
6101763|NCT00261443|21052217|P2|3: Assessment of Relapse|Pregnancy|2
6101764|NCT00261443|21052218|P1|3: Assessment of Relapse|Pregnancy|0
6101765|NCT00261443|21052216|P3|3: Assessment of Relapse|Poor/Noncompliance|3
6101766|NCT00261443|21052217|P2|3: Assessment of Relapse|Poor/Noncompliance|5
6101767|NCT00261443|21052218|P1|3: Assessment of Relapse|Poor/Noncompliance|0
6101768|NCT00261443|21052216|P3|3: Assessment of Relapse|Lost to Follow-up|6
6101769|NCT00261443|21052217|P2|3: Assessment of Relapse|Lost to Follow-up|7
6101770|NCT00261443|21052218|P1|3: Assessment of Relapse|Lost to Follow-up|0
6101771|NCT00261443|21052216|P3|3: Assessment of Relapse|Death|1
6101772|NCT00261443|21052217|P2|3: Assessment of Relapse|Death|0
6101773|NCT00261443|21052218|P1|3: Assessment of Relapse|Death|0
6101774|NCT00261443|21052216|P3|3: Assessment of Relapse|Withdrawal by Subject|15
6101775|NCT00261443|21052217|P2|3: Assessment of Relapse|Withdrawal by Subject|14
6101776|NCT00261443|21052218|P1|3: Assessment of Relapse|Withdrawal by Subject|0
6101777|NCT00261443|21052216|P3|3: Assessment of Relapse|Adverse Event|19
6101778|NCT00261443|21052217|P2|3: Assessment of Relapse|Adverse Event|15
6101779|NCT00261443|21052218|P1|3: Assessment of Relapse|Adverse Event|0
6101780|NCT00261443|21052216|P3|3: Assessment of Relapse|Lack of Efficacy|14
6101781|NCT00261443|21052217|P2|3: Assessment of Relapse|Lack of Efficacy|31
6101782|NCT00261443|21052218|P1|3: Assessment of Relapse|Lack of Efficacy|0
6101783|NCT00261443|21052216|P3|2: Stability & Maintenance of Stability|Other Reasons|0
6101784|NCT00261443|21052217|P2|2: Stability & Maintenance of Stability|Other Reasons|0
6101785|NCT00261443|21052218|P1|2: Stability & Maintenance of Stability|Other Reasons|13
6101786|NCT00261443|21052216|P3|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0
6101787|NCT00261443|21052217|P2|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0
6101788|NCT00261443|21052218|P1|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|1
6101789|NCT00261443|21052216|P3|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0
6101790|NCT00261443|21052217|P2|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0
6101791|NCT00261443|21052218|P1|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|32
6101792|NCT00261443|21052216|P3|2: Stability & Maintenance of Stability|Pregnancy|0
6101793|NCT00261443|21052217|P2|2: Stability & Maintenance of Stability|Pregnancy|0
6101794|NCT00261443|21052218|P1|2: Stability & Maintenance of Stability|Pregnancy|1
6101795|NCT00261443|21052216|P3|2: Stability & Maintenance of Stability|Poor/Noncompliance|0
6101796|NCT00261443|21052217|P2|2: Stability & Maintenance of Stability|Poor/Noncompliance|0
6101797|NCT00261443|21052218|P1|2: Stability & Maintenance of Stability|Poor/Noncompliance|33
6101798|NCT00261443|21052216|P3|2: Stability & Maintenance of Stability|Lost to Follow-up|0
6101799|NCT00261443|21052217|P2|2: Stability & Maintenance of Stability|Lost to Follow-up|0
6101800|NCT00261443|21052218|P1|2: Stability & Maintenance of Stability|Lost to Follow-up|59
6101801|NCT00261443|21052216|P3|2: Stability & Maintenance of Stability|Withdrawal by Subject|0
6101802|NCT00261443|21052217|P2|2: Stability & Maintenance of Stability|Withdrawal by Subject|0
6101803|NCT00261443|21052218|P1|2: Stability & Maintenance of Stability|Withdrawal by Subject|65
6101804|NCT00261443|21052216|P3|2: Stability & Maintenance of Stability|Adverse Event|0
6101805|NCT00261443|21052217|P2|2: Stability & Maintenance of Stability|Adverse Event|0
6101806|NCT00261443|21052218|P1|2: Stability & Maintenance of Stability|Adverse Event|93
6101807|NCT00261443|21052216|P3|2: Stability & Maintenance of Stability|Lack of Efficacy|0
6101808|NCT00261443|21052217|P2|2: Stability & Maintenance of Stability|Lack of Efficacy|0
6101809|NCT00261443|21052218|P1|2: Stability & Maintenance of Stability|Lack of Efficacy|43
6101810|NCT00261443|21052216|P3|1: Confirmation of Partial Nonresponse|Other Reasons|0
6101811|NCT00261443|21052217|P2|1: Confirmation of Partial Nonresponse|Other Reasons|0
6101812|NCT00261443|21052218|P1|1: Confirmation of Partial Nonresponse|Other Reasons|16
6101813|NCT00261443|21052216|P3|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0
6101814|NCT00261443|21052217|P2|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0
6101815|NCT00261443|21052218|P1|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|307
6101816|NCT00261443|21052216|P3|1: Confirmation of Partial Nonresponse|Pregnancy|0
6101817|NCT00261443|21052217|P2|1: Confirmation of Partial Nonresponse|Pregnancy|0
6101818|NCT00261443|21052218|P1|1: Confirmation of Partial Nonresponse|Pregnancy|1
6101819|NCT00261443|21052216|P3|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0
6101820|NCT00261443|21052217|P2|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0
6101821|NCT00261443|21052218|P1|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|23
6101822|NCT00261443|21052216|P3|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0
6101823|NCT00261443|21052217|P2|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0
6101824|NCT00261443|21052218|P1|1: Confirmation of Partial Nonresponse|Lost to Follow-up|111
6101825|NCT00261443|21052216|P3|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0
6101826|NCT00261443|21052217|P2|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0
6101827|NCT00261443|21052218|P1|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|93
6101828|NCT00261443|21052216|P3|1: Confirmation of Partial Nonresponse|Adverse Event|0
6101829|NCT00261443|21052217|P2|1: Confirmation of Partial Nonresponse|Adverse Event|0
6101830|NCT00261443|21052218|P1|1: Confirmation of Partial Nonresponse|Adverse Event|33
6101831|NCT00260832|21052503|P2|Overall Study|Protocol Violation|1
6101832|NCT00260832|21052504|P1|Overall Study|Protocol Violation|3
6101833|NCT00260832|21052503|P2|Overall Study|Other|7
6101834|NCT00260832|21052504|P1|Overall Study|Other|10
6101835|NCT00260832|21052503|P2|Overall Study|Death|62
6101836|NCT00260832|21052504|P1|Overall Study|Death|43
6101837|NCT00260832|21052503|P2|Overall Study|Physician Decision|9
6101838|NCT00260832|21052504|P1|Overall Study|Physician Decision|15
6101839|NCT00260832|21052503|P2|Overall Study|Withdrawal by Subject|17
6101840|NCT00260832|21052504|P1|Overall Study|Withdrawal by Subject|15
6101841|NCT00260832|21052503|P2|Overall Study|Progression|96
6101842|NCT00260832|21052504|P1|Overall Study|Progression|116
6101843|NCT00260832|21052503|P2|Overall Study|Adverse Event|19
6101844|NCT00260832|21052504|P1|Overall Study|Adverse Event|26
6101845|NCT00260533|21052533|P2|Overall Study|Other|3
6101846|NCT00260533|21052534|P1|Overall Study|Other|3
6101847|NCT00260429|21052542|P2|Overall Study|scheduled hand surgery|0
6101848|NCT00260429|21052543|P1|Overall Study|scheduled hand surgery|1
6101849|NCT00260429|21052542|P2|Overall Study|failure to follow appointments|0
6101850|NCT00260429|21052543|P1|Overall Study|failure to follow appointments|1
6101851|NCT00260208|21052551|P2|Overall Study|Missing|16
6101852|NCT00260208|21052552|P1|Overall Study|Missing|18
6101853|NCT00260208|21052551|P2|Overall Study|Death|10
6101854|NCT00260208|21052552|P1|Overall Study|Death|12
6101855|NCT00260208|21052551|P2|Overall Study|Lost to Follow-up|1
6101856|NCT00260208|21052552|P1|Overall Study|Lost to Follow-up|6
6101857|NCT00260208|21052551|P2|Overall Study|Subject withdrew consent|7
6101858|NCT00260208|21052552|P1|Overall Study|Subject withdrew consent|11
6101859|NCT00260065|21052595|P1|Overall Study|Medication Noncompliance|1
6101860|NCT00260065|21052595|P1|Overall Study|Not otherwise specified|8
6101861|NCT00260065|21052595|P1|Overall Study|Physician Decision|19
6101862|NCT00260065|21052595|P1|Overall Study|Withdrawal by Subject|13
6101863|NCT00260065|21052595|P1|Overall Study|Death|13
6101864|NCT00260065|21052595|P1|Overall Study|Adverse Event|17
6101865|NCT00260065|21052595|P1|Overall Study|Progressive Disease|22
6101866|NCT00259857|21052602|P2|24 Months Treatment|Lost to Follow-up|3
6101867|NCT00259857|21052603|P1|24 Months Treatment|Lost to Follow-up|0
6101868|NCT00259857|21052602|P2|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|2
6101869|NCT00259857|21052603|P1|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|1
6101870|NCT00259740|21052621|P2|Overall Study|Requirement for alternative therapy|4
6101871|NCT00259740|21052622|P1|Overall Study|Requirement for alternative therapy|0
6101872|NCT00259740|21052621|P2|Overall Study|Other|0
6101873|NCT00259740|21052622|P1|Overall Study|Other|3
6101874|NCT00259740|21052621|P2|Overall Study|Ongoing|3
6101875|NCT00259740|21052622|P1|Overall Study|Ongoing|17
6101876|NCT00259740|21052621|P2|Overall Study|Disease progression|36
6101877|NCT00259740|21052622|P1|Overall Study|Disease progression|19
6101878|NCT00259740|21052621|P2|Overall Study|Death|1
6101879|NCT00259740|21052622|P1|Overall Study|Death|1
6101880|NCT00259740|21052621|P2|Overall Study|Withdrawal by Subject|6
6101881|NCT00259740|21052622|P1|Overall Study|Withdrawal by Subject|2
6101882|NCT00259740|21052621|P2|Overall Study|Adverse Event|2
6101883|NCT00259740|21052622|P1|Overall Study|Adverse Event|0
6101884|NCT00259740|21052621|P2|Overall Study|Physician Decision|1
6101885|NCT00259740|21052622|P1|Overall Study|Physician Decision|1
6101886|NCT00259649|21052632|P1|Overall Study|irregular menses|3
6101887|NCT00259649|21052632|P1|Overall Study|Lost to Follow-up|7
6101888|NCT00259610|21052640|P4|Overall Study|Serious Adverse Event|2
6101889|NCT00259610|21052641|P3|Overall Study|Serious Adverse Event|2
6101890|NCT00259610|21052642|P2|Overall Study|Serious Adverse Event|2
6101891|NCT00259610|21052643|P1|Overall Study|Serious Adverse Event|8
6101892|NCT00259610|21052640|P4|Overall Study|Adverse Event|2
6101893|NCT00259610|21052641|P3|Overall Study|Adverse Event|5
6101894|NCT00259610|21052642|P2|Overall Study|Adverse Event|4
6101895|NCT00259610|21052643|P1|Overall Study|Adverse Event|3
6101896|NCT00259610|21052640|P4|Overall Study|non medical reason|3
6101897|NCT00259610|21052641|P3|Overall Study|non medical reason|10
6101898|NCT00259610|21052642|P2|Overall Study|non medical reason|2
6101899|NCT00259610|21052643|P1|Overall Study|non medical reason|6
6101900|NCT00259610|21052640|P4|Overall Study|Death|0
6101901|NCT00259610|21052641|P3|Overall Study|Death|2
6101902|NCT00259610|21052642|P2|Overall Study|Death|1
6101903|NCT00259610|21052643|P1|Overall Study|Death|1
6101904|NCT00259610|21052640|P4|Overall Study|Physician Decision|2
6101905|NCT00259610|21052641|P3|Overall Study|Physician Decision|7
6101906|NCT00259610|21052642|P2|Overall Study|Physician Decision|4
6101907|NCT00259610|21052643|P1|Overall Study|Physician Decision|6
6101908|NCT00259610|21052640|P4|Overall Study|Lost to Follow-up|15
6101909|NCT00259610|21052641|P3|Overall Study|Lost to Follow-up|18
6101910|NCT00259610|21052642|P2|Overall Study|Lost to Follow-up|8
6101911|NCT00259610|21052643|P1|Overall Study|Lost to Follow-up|19
6101912|NCT00259610|21052640|P4|Overall Study|Withdrawal by Subject|19
6101913|NCT00259610|21052641|P3|Overall Study|Withdrawal by Subject|29
6101914|NCT00259610|21052642|P2|Overall Study|Withdrawal by Subject|25
6101915|NCT00259610|21052643|P1|Overall Study|Withdrawal by Subject|33
6101916|NCT00259298|21052657|P1|Overall Study|Physician Decision|2
6101917|NCT00259298|21052657|P1|Overall Study|Withdrawal by Subject|1
6101918|NCT00259272|21052675|P4|Overall Study|Lost to Follow-up|1
6101919|NCT00259272|21052676|P3|Overall Study|Lost to Follow-up|0
6101920|NCT00259272|21052677|P2|Overall Study|Lost to Follow-up|0
6101921|NCT00259272|21052678|P1|Overall Study|Lost to Follow-up|1
6101922|NCT00259272|21052675|P4|Overall Study|Withdrawal by Subject|7
6101923|NCT00259272|21052676|P3|Overall Study|Withdrawal by Subject|2
6101924|NCT00259272|21052677|P2|Overall Study|Withdrawal by Subject|2
6101925|NCT00259272|21052678|P1|Overall Study|Withdrawal by Subject|4
6101926|NCT00259272|21052675|P4|Overall Study|Sponsor Decision|0
6101927|NCT00259272|21052676|P3|Overall Study|Sponsor Decision|0
6101928|NCT00259272|21052677|P2|Overall Study|Sponsor Decision|1
6101929|NCT00259272|21052678|P1|Overall Study|Sponsor Decision|0
6101930|NCT00259272|21052675|P4|Overall Study|Protocol Violation|1
6101931|NCT00259272|21052676|P3|Overall Study|Protocol Violation|0
6101932|NCT00259272|21052677|P2|Overall Study|Protocol Violation|0
6101933|NCT00259272|21052678|P1|Overall Study|Protocol Violation|2
6101934|NCT00259272|21052675|P4|Overall Study|Physician Decision|3
6101935|NCT00259272|21052676|P3|Overall Study|Physician Decision|1
6101936|NCT00259272|21052677|P2|Overall Study|Physician Decision|2
6101937|NCT00259272|21052678|P1|Overall Study|Physician Decision|1
6101938|NCT00259272|21052675|P4|Overall Study|Lack of Efficacy|6
6101939|NCT00259272|21052676|P3|Overall Study|Lack of Efficacy|2
6101940|NCT00259272|21052677|P2|Overall Study|Lack of Efficacy|1
6101941|NCT00259272|21052678|P1|Overall Study|Lack of Efficacy|5
6101942|NCT00259272|21052675|P4|Overall Study|Adverse Event|3
6101943|NCT00259272|21052676|P3|Overall Study|Adverse Event|0
6101944|NCT00259272|21052677|P2|Overall Study|Adverse Event|1
6101945|NCT00259272|21052678|P1|Overall Study|Adverse Event|2
6101946|NCT00259012|21052774|P2|Overall Study|Protocol Violation|1
6101947|NCT00259012|21052775|P1|Overall Study|Protocol Violation|1
6101948|NCT00259012|21052774|P2|Overall Study|Lost to Follow-up|1
6101949|NCT00259012|21052775|P1|Overall Study|Lost to Follow-up|0
6101950|NCT00259012|21052774|P2|Overall Study|Physician Decision|1
6101951|NCT00259012|21052775|P1|Overall Study|Physician Decision|0
6101952|NCT00259012|21052774|P2|Overall Study|Withdrawal by Subject|0
6101953|NCT00259012|21052775|P1|Overall Study|Withdrawal by Subject|1
6101954|NCT00259012|21052774|P2|Overall Study|Adverse Event|1
6101955|NCT00259012|21052775|P1|Overall Study|Adverse Event|0
6101956|NCT00258960|21052807|P1|Overall Study|Mistake|2
6101957|NCT00258960|21052807|P1|Overall Study|Withdrawal by Subject|1
6101958|NCT00258960|21052807|P1|Overall Study|Physician Decision|1
6101959|NCT00258960|21052807|P1|Overall Study|Adverse Event|4
6101960|NCT00258960|21052807|P1|Overall Study|Disease Progression|7
6101961|NCT00258960|21052807|P1|Overall Study|Death|2
6101962|NCT00258895|21052823|P2|Overall Study|Withdrawal by Subject|0
6101963|NCT00258895|21052824|P1|Overall Study|Withdrawal by Subject|1
6101964|NCT00258895|21052823|P2|Overall Study|Protocol Violation|2
6101965|NCT00258895|21052824|P1|Overall Study|Protocol Violation|6
6101966|NCT00258895|21052823|P2|Overall Study|Lost to Follow-up|1
6101967|NCT00258895|21052824|P1|Overall Study|Lost to Follow-up|3
6101968|NCT00258856|21052860|P4|Overall Study|Non-compliance|1
6101969|NCT00258856|21052861|P3|Overall Study|Non-compliance|0
6101970|NCT00258856|21052862|P2|Overall Study|Non-compliance|0
6101971|NCT00258856|21052863|P1|Overall Study|Non-compliance|2
6101972|NCT00258856|21052860|P4|Overall Study|Lost to Follow-up|0
6101973|NCT00258856|21052861|P3|Overall Study|Lost to Follow-up|2
6101974|NCT00258856|21052862|P2|Overall Study|Lost to Follow-up|0
6101975|NCT00258856|21052863|P1|Overall Study|Lost to Follow-up|1
6101976|NCT00258674|21052904|P3|Overall Study|Death|34
6101977|NCT00258674|21052905|P2|Overall Study|Death|53
6101978|NCT00258674|21052906|P1|Overall Study|Death|32
6101979|NCT00258440|21052965|P3|Overall Study|Withdrawal by Subject|1
6101980|NCT00258440|21052966|P2|Overall Study|Withdrawal by Subject|0
6101981|NCT00258440|21052967|P1|Overall Study|Withdrawal by Subject|0
6101982|NCT00258154|21053005|P2|Overall Study|Patient Moved|1
6101983|NCT00258154|21053006|P1|Overall Study|Patient Moved|3
6101984|NCT00258154|21053005|P2|Overall Study|Withdrawal by Subject|4
6101985|NCT00258154|21053006|P1|Overall Study|Withdrawal by Subject|3
6101986|NCT00258154|21053005|P2|Overall Study|Protocol Violation|1
6101987|NCT00258154|21053006|P1|Overall Study|Protocol Violation|2
6101988|NCT00258154|21053005|P2|Overall Study|Lost to Follow-up|1
6101989|NCT00258154|21053006|P1|Overall Study|Lost to Follow-up|0
6101990|NCT00258154|21053005|P2|Overall Study|Adverse Event|0
6101991|NCT00258154|21053006|P1|Overall Study|Adverse Event|1
6101992|NCT00257920|21053101|P2|Period: Second Intervention|Other|1
6101993|NCT00257920|21053102|P1|Period: Second Intervention|Other|2
6101994|NCT00257920|21053101|P2|Period: Washout Period of Two Weeks|Lost to Follow-up|1
6101995|NCT00257920|21053102|P1|Period: Washout Period of Two Weeks|Lost to Follow-up|0
6101996|NCT00257725|21053125|P1|Overall Study|Adverse Event|3
6101997|NCT00257660|21053164|P2|Overall Study|No longer wanted to do blood draws|0
6101998|NCT00257660|21053165|P1|Overall Study|No longer wanted to do blood draws|1
6101999|NCT00257660|21053164|P2|Overall Study|PI & Subject Schedule Conflicts|0
6102000|NCT00257660|21053165|P1|Overall Study|PI & Subject Schedule Conflicts|1
6102001|NCT00257660|21053164|P2|Overall Study|Lost to Follow-up|0
6102002|NCT00257660|21053165|P1|Overall Study|Lost to Follow-up|1
6102003|NCT00257660|21053164|P2|Overall Study|Withdrawal by Subject|0
6102004|NCT00257660|21053165|P1|Overall Study|Withdrawal by Subject|2
6102005|NCT00257660|21053164|P2|Overall Study|Lack of Efficacy|23
6102006|NCT00257660|21053165|P1|Overall Study|Lack of Efficacy|5
6102007|NCT00257608|21053195|P3|Post Chemotherapy Phase|Not treated|7
6102008|NCT00257608|21053196|P2|Post Chemotherapy Phase|Not treated|4
6102009|NCT00257608|21053197|P1|Post Chemotherapy Phase|Not treated|0
6102010|NCT00257608|21053195|P3|Post Chemotherapy Phase|Sponsor's decision to terminate study|0
6102011|NCT00257608|21053196|P2|Post Chemotherapy Phase|Sponsor's decision to terminate study|1
6102012|NCT00257608|21053197|P1|Post Chemotherapy Phase|Sponsor's decision to terminate study|0
6102013|NCT00257608|21053195|P3|Post Chemotherapy Phase|Physician Decision|11
6102014|NCT00257608|21053196|P2|Post Chemotherapy Phase|Physician Decision|8
6102015|NCT00257608|21053197|P1|Post Chemotherapy Phase|Physician Decision|0
6102016|NCT00257608|21053195|P3|Post Chemotherapy Phase|Lost to Follow-up|1
6102017|NCT00257608|21053196|P2|Post Chemotherapy Phase|Lost to Follow-up|0
6102018|NCT00257608|21053197|P1|Post Chemotherapy Phase|Lost to Follow-up|0
6102019|NCT00257608|21053195|P3|Post Chemotherapy Phase|Unrelated intercurrent illness|1
6102020|NCT00257608|21053196|P2|Post Chemotherapy Phase|Unrelated intercurrent illness|0
6102021|NCT00257608|21053197|P1|Post Chemotherapy Phase|Unrelated intercurrent illness|0
6102022|NCT00257608|21053195|P3|Post Chemotherapy Phase|Patient's decision to discontinue|8
6102023|NCT00257608|21053196|P2|Post Chemotherapy Phase|Patient's decision to discontinue|4
6102024|NCT00257608|21053197|P1|Post Chemotherapy Phase|Patient's decision to discontinue|0
6102025|NCT00257608|21053195|P3|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5
6102026|NCT00257608|21053196|P2|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5
6102027|NCT00257608|21053197|P1|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|0
6102028|NCT00257608|21053195|P3|Post Chemotherapy Phase|Unwillingness or inability to comply|5
6102029|NCT00257608|21053196|P2|Post Chemotherapy Phase|Unwillingness or inability to comply|4
6102030|NCT00257608|21053197|P1|Post Chemotherapy Phase|Unwillingness or inability to comply|0
6102031|NCT00257608|21053195|P3|Post Chemotherapy Phase|Disease progression|168
6102032|NCT00257608|21053196|P2|Post Chemotherapy Phase|Disease progression|204
6102033|NCT00257608|21053197|P1|Post Chemotherapy Phase|Disease progression|0
6102034|NCT00257608|21053195|P3|Post Chemotherapy Phase|Adverse Event|38
6102035|NCT00257608|21053196|P2|Post Chemotherapy Phase|Adverse Event|34
6102036|NCT00257608|21053197|P1|Post Chemotherapy Phase|Adverse Event|0
6102037|NCT00257608|21053195|P3|Chemotherapy Phase|Physician Decision|0
6102038|NCT00257608|21053196|P2|Chemotherapy Phase|Physician Decision|0
6102039|NCT00257608|21053197|P1|Chemotherapy Phase|Physician Decision|28
6102040|NCT00257608|21053195|P3|Chemotherapy Phase|Unrelated intercurrent illness|0
6102041|NCT00257608|21053196|P2|Chemotherapy Phase|Unrelated intercurrent illness|0
6102042|NCT00257608|21053197|P1|Chemotherapy Phase|Unrelated intercurrent illness|3
6102043|NCT00257608|21053195|P3|Chemotherapy Phase|Patient's decision to discontinue|0
6102044|NCT00257608|21053196|P2|Chemotherapy Phase|Patient's decision to discontinue|0
6102045|NCT00257608|21053197|P1|Chemotherapy Phase|Patient's decision to discontinue|35
6102046|NCT00257608|21053195|P3|Chemotherapy Phase|Need for concomitant/ancillary therapy|0
6102047|NCT00257608|21053196|P2|Chemotherapy Phase|Need for concomitant/ancillary therapy|0
6102048|NCT00257608|21053197|P1|Chemotherapy Phase|Need for concomitant/ancillary therapy|27
6102049|NCT00257608|21053195|P3|Chemotherapy Phase|Unwillingness or inability to comply|0
6102050|NCT00257608|21053196|P2|Chemotherapy Phase|Unwillingness or inability to comply|0
6102051|NCT00257608|21053197|P1|Chemotherapy Phase|Unwillingness or inability to comply|6
6102052|NCT00257608|21053195|P3|Chemotherapy Phase|Disease progression|0
6102053|NCT00257608|21053196|P2|Chemotherapy Phase|Disease progression|0
6102054|NCT00257608|21053197|P1|Chemotherapy Phase|Disease progression|139
6102055|NCT00257608|21053195|P3|Chemotherapy Phase|Adverse Event|0
6102056|NCT00257608|21053196|P2|Chemotherapy Phase|Adverse Event|0
6102057|NCT00257608|21053197|P1|Chemotherapy Phase|Adverse Event|138
6102058|NCT00257556|21053223|P2|Overall Study|other reason|6
6102059|NCT00257556|21053224|P1|Overall Study|other reason|4
6102060|NCT00257556|21053223|P2|Overall Study|Did not meet hCG criterion|0
6102061|NCT00257556|21053224|P1|Overall Study|Did not meet hCG criterion|3
6102062|NCT00257556|21053223|P2|Overall Study|Physician Decision|0
6102063|NCT00257556|21053224|P1|Overall Study|Physician Decision|6
6102064|NCT00257556|21053223|P2|Overall Study|Adverse Event|4
6102065|NCT00257556|21053224|P1|Overall Study|Adverse Event|1
6102066|NCT00257192|21053268|P2|Overall Study|Miscellaneous|4
6102067|NCT00257192|21053269|P1|Overall Study|Miscellaneous|0
6102068|NCT00257192|21053268|P2|Overall Study|Study terminated by sponsor|0
6102069|NCT00257192|21053269|P1|Overall Study|Study terminated by sponsor|1
6102070|NCT00257192|21053268|P2|Overall Study|Randomized but not treated|1
6102071|NCT00257192|21053269|P1|Overall Study|Randomized but not treated|0
6102072|NCT00257192|21053268|P2|Overall Study|Withdrawal by Subject|2
6102073|NCT00257192|21053269|P1|Overall Study|Withdrawal by Subject|14
6102074|NCT00257192|21053268|P2|Overall Study|Insufficient clinical response|18
6102075|NCT00257192|21053269|P1|Overall Study|Insufficient clinical response|18
6102076|NCT00257192|21053268|P2|Overall Study|Lost to Follow-up|3
6102077|NCT00257192|21053269|P1|Overall Study|Lost to Follow-up|3
6102078|NCT00257192|21053268|P2|Overall Study|Laboratory abnormality|1
6102079|NCT00257192|21053269|P1|Overall Study|Laboratory abnormality|1
6102080|NCT00257192|21053268|P2|Overall Study|Adverse Event|10
6102081|NCT00257192|21053269|P1|Overall Study|Adverse Event|21
6102082|NCT00257166|21053313|P2|Overall Study|Randomized, but not treated|0
6102083|NCT00257166|21053314|P1|Overall Study|Randomized, but not treated|1
6102084|NCT00257166|21053313|P2|Overall Study|Other|21
6102085|NCT00257166|21053314|P1|Overall Study|Other|16
6102086|NCT00257166|21053313|P2|Overall Study|Withdrawal by Subject|2
6102087|NCT00257166|21053314|P1|Overall Study|Withdrawal by Subject|9
6102088|NCT00257166|21053313|P2|Overall Study|Lost to Follow-up|1
6102089|NCT00257166|21053314|P1|Overall Study|Lost to Follow-up|8
6102090|NCT00257166|21053313|P2|Overall Study|Laboratory abnormality|0
6102091|NCT00257166|21053314|P1|Overall Study|Laboratory abnormality|1
6102092|NCT00257166|21053313|P2|Overall Study|Adverse Event|13
6102093|NCT00257166|21053314|P1|Overall Study|Adverse Event|18
6102094|NCT00257010|21053326|P1|Overall Study|no headache reported|9
6102095|NCT00257010|21053326|P1|Overall Study|various|11
6102096|NCT00257010|21053326|P1|Overall Study|Adverse Event|10
6102097|NCT00257010|21053326|P1|Overall Study|Withdrawal by Subject|34
6102098|NCT00257010|21053326|P1|Overall Study|Lost to Follow-up|53
6102099|NCT00257010|21053326|P1|Overall Study|Lack of Efficacy|11
6102100|NCT00256997|21053337|P2|Overall Study|Investigator Withdrew Participant|1
6102101|NCT00256997|21053338|P1|Overall Study|Investigator Withdrew Participant|2
6102102|NCT00256997|21053337|P2|Overall Study|Participant Non-compliant|6
6102103|NCT00256997|21053338|P1|Overall Study|Participant Non-compliant|3
6102104|NCT00256997|21053337|P2|Overall Study|End of Study (As Per Sponsor)|24
6102105|NCT00256997|21053338|P1|Overall Study|End of Study (As Per Sponsor)|12
6102106|NCT00256997|21053337|P2|Overall Study|Other|8
6102107|NCT00256997|21053338|P1|Overall Study|Other|5
6102108|NCT00256997|21053337|P2|Overall Study|Started but not treated|0
6102109|NCT00256997|21053338|P1|Overall Study|Started but not treated|2
6102110|NCT00256997|21053337|P2|Overall Study|Withdrawal by Subject|3
6102111|NCT00256997|21053338|P1|Overall Study|Withdrawal by Subject|13
6102112|NCT00256997|21053337|P2|Overall Study|Lost to Follow-up|5
6102113|NCT00256997|21053338|P1|Overall Study|Lost to Follow-up|3
6102114|NCT00256997|21053337|P2|Overall Study|Adverse Event|0
6102115|NCT00256997|21053338|P1|Overall Study|Adverse Event|4
6102116|NCT00256997|21053337|P2|Overall Study|Death|0
6102117|NCT00256997|21053338|P1|Overall Study|Death|2
6102118|NCT00256997|21053337|P2|Overall Study|Lack of Efficacy|4
6102119|NCT00256997|21053338|P1|Overall Study|Lack of Efficacy|1
6102120|NCT00256997|21053337|P2|Overall Study|Protocol Violation|4
6102121|NCT00256997|21053338|P1|Overall Study|Protocol Violation|1
6102122|NCT00256867|21053380|P8|Overall Study|Withdrawal by participant|0
6102123|NCT00256867|21053381|P7|Overall Study|Withdrawal by participant|0
6102124|NCT00256867|21053382|P6|Overall Study|Withdrawal by participant|1
6102125|NCT00256867|21053383|P5|Overall Study|Withdrawal by participant|0
6102126|NCT00256867|21053384|P4|Overall Study|Withdrawal by participant|0
6102127|NCT00256867|21053385|P3|Overall Study|Withdrawal by participant|0
6102128|NCT00256867|21053386|P2|Overall Study|Withdrawal by participant|0
6102129|NCT00256867|21053387|P1|Overall Study|Withdrawal by participant|0
6102130|NCT00256867|21053380|P8|Overall Study|Participant out of assessment window|0
6102131|NCT00256867|21053381|P7|Overall Study|Participant out of assessment window|0
6102132|NCT00256867|21053382|P6|Overall Study|Participant out of assessment window|0
6102133|NCT00256867|21053383|P5|Overall Study|Participant out of assessment window|0
6102134|NCT00256867|21053384|P4|Overall Study|Participant out of assessment window|0
6102135|NCT00256867|21053385|P3|Overall Study|Participant out of assessment window|1
6102136|NCT00256867|21053386|P2|Overall Study|Participant out of assessment window|0
6102137|NCT00256867|21053387|P1|Overall Study|Participant out of assessment window|0
6102138|NCT00256867|21053380|P8|Overall Study|Participant travelled Overseas|0
6102139|NCT00256867|21053381|P7|Overall Study|Participant travelled Overseas|0
6102140|NCT00256867|21053382|P6|Overall Study|Participant travelled Overseas|0
6102141|NCT00256867|21053383|P5|Overall Study|Participant travelled Overseas|0
6102142|NCT00256867|21053384|P4|Overall Study|Participant travelled Overseas|0
6102143|NCT00256867|21053385|P3|Overall Study|Participant travelled Overseas|0
6102144|NCT00256867|21053386|P2|Overall Study|Participant travelled Overseas|1
6102145|NCT00256867|21053387|P1|Overall Study|Participant travelled Overseas|0
6102146|NCT00256867|21053380|P8|Overall Study|Non-compliance with study medication|1
6102147|NCT00256867|21053381|P7|Overall Study|Non-compliance with study medication|0
6102148|NCT00256867|21053382|P6|Overall Study|Non-compliance with study medication|0
6102149|NCT00256867|21053383|P5|Overall Study|Non-compliance with study medication|0
6102150|NCT00256867|21053384|P4|Overall Study|Non-compliance with study medication|0
6102151|NCT00256867|21053385|P3|Overall Study|Non-compliance with study medication|0
6102152|NCT00256867|21053386|P2|Overall Study|Non-compliance with study medication|0
6102153|NCT00256867|21053387|P1|Overall Study|Non-compliance with study medication|0
6102154|NCT00256867|21053380|P8|Overall Study|Investigator's Decision|0
6102155|NCT00256867|21053381|P7|Overall Study|Investigator's Decision|0
6102156|NCT00256867|21053382|P6|Overall Study|Investigator's Decision|0
6102157|NCT00256867|21053383|P5|Overall Study|Investigator's Decision|1
6102158|NCT00256867|21053384|P4|Overall Study|Investigator's Decision|0
6102159|NCT00256867|21053385|P3|Overall Study|Investigator's Decision|0
6102160|NCT00256867|21053386|P2|Overall Study|Investigator's Decision|0
6102161|NCT00256867|21053387|P1|Overall Study|Investigator's Decision|0
6102162|NCT00256867|21053380|P8|Overall Study|Glycemia over 13.3 millimole per litre|1
6102163|NCT00256867|21053381|P7|Overall Study|Glycemia over 13.3 millimole per litre|0
6102164|NCT00256867|21053382|P6|Overall Study|Glycemia over 13.3 millimole per litre|0
6102165|NCT00256867|21053383|P5|Overall Study|Glycemia over 13.3 millimole per litre|0
6102166|NCT00256867|21053384|P4|Overall Study|Glycemia over 13.3 millimole per litre|0
6102167|NCT00256867|21053385|P3|Overall Study|Glycemia over 13.3 millimole per litre|0
6102168|NCT00256867|21053386|P2|Overall Study|Glycemia over 13.3 millimole per litre|0
6102169|NCT00256867|21053387|P1|Overall Study|Glycemia over 13.3 millimole per litre|0
6102170|NCT00256867|21053380|P8|Overall Study|Fasting plasma glucose >240 mg/dL|0
6102171|NCT00256867|21053381|P7|Overall Study|Fasting plasma glucose >240 mg/dL|0
6102172|NCT00256867|21053382|P6|Overall Study|Fasting plasma glucose >240 mg/dL|0
6102173|NCT00256867|21053383|P5|Overall Study|Fasting plasma glucose >240 mg/dL|0
6102174|NCT00256867|21053384|P4|Overall Study|Fasting plasma glucose >240 mg/dL|0
6102175|NCT00256867|21053385|P3|Overall Study|Fasting plasma glucose >240 mg/dL|0
6102176|NCT00256867|21053386|P2|Overall Study|Fasting plasma glucose >240 mg/dL|1
6102177|NCT00256867|21053387|P1|Overall Study|Fasting plasma glucose >240 mg/dL|0
6102178|NCT00256867|21053380|P8|Overall Study|Withdrawal by Subject|2
6102179|NCT00256867|21053381|P7|Overall Study|Withdrawal by Subject|3
6102180|NCT00256867|21053382|P6|Overall Study|Withdrawal by Subject|2
6102181|NCT00256867|21053383|P5|Overall Study|Withdrawal by Subject|2
6102182|NCT00256867|21053384|P4|Overall Study|Withdrawal by Subject|1
6102183|NCT00256867|21053385|P3|Overall Study|Withdrawal by Subject|1
6102184|NCT00256867|21053386|P2|Overall Study|Withdrawal by Subject|0
6102185|NCT00256867|21053387|P1|Overall Study|Withdrawal by Subject|0
6102186|NCT00256867|21053380|P8|Overall Study|Protocol Violation|1
6102187|NCT00256867|21053381|P7|Overall Study|Protocol Violation|0
6102188|NCT00256867|21053382|P6|Overall Study|Protocol Violation|1
6102189|NCT00256867|21053383|P5|Overall Study|Protocol Violation|0
6102190|NCT00256867|21053384|P4|Overall Study|Protocol Violation|1
6102191|NCT00256867|21053385|P3|Overall Study|Protocol Violation|0
6102192|NCT00256867|21053386|P2|Overall Study|Protocol Violation|0
6102193|NCT00256867|21053387|P1|Overall Study|Protocol Violation|0
6102194|NCT00256867|21053380|P8|Overall Study|Lost to Follow-up|2
6102195|NCT00256867|21053381|P7|Overall Study|Lost to Follow-up|1
6102196|NCT00256867|21053382|P6|Overall Study|Lost to Follow-up|0
6102197|NCT00256867|21053383|P5|Overall Study|Lost to Follow-up|2
6102198|NCT00256867|21053384|P4|Overall Study|Lost to Follow-up|3
6102199|NCT00256867|21053385|P3|Overall Study|Lost to Follow-up|2
6102200|NCT00256867|21053386|P2|Overall Study|Lost to Follow-up|2
6102201|NCT00256867|21053387|P1|Overall Study|Lost to Follow-up|2
6102202|NCT00256867|21053380|P8|Overall Study|Adverse Event|4
6102203|NCT00256867|21053381|P7|Overall Study|Adverse Event|1
6102204|NCT00256867|21053382|P6|Overall Study|Adverse Event|2
6102205|NCT00256867|21053383|P5|Overall Study|Adverse Event|2
6102206|NCT00256867|21053384|P4|Overall Study|Adverse Event|1
6102207|NCT00256867|21053385|P3|Overall Study|Adverse Event|1
6102208|NCT00256867|21053386|P2|Overall Study|Adverse Event|1
6102209|NCT00256867|21053387|P1|Overall Study|Adverse Event|0
6102210|NCT00256854|21053477|P6|Overall Study|Not compliant with the study drug|0
6102211|NCT00256854|21053478|P5|Overall Study|Not compliant with the study drug|1
6102212|NCT00256854|21053479|P4|Overall Study|Not compliant with the study drug|0
6102213|NCT00256854|21053480|P3|Overall Study|Not compliant with the study drug|0
6102214|NCT00256854|21053481|P2|Overall Study|Not compliant with the study drug|0
6102215|NCT00256854|21053482|P1|Overall Study|Not compliant with the study drug|0
6102216|NCT00256854|21053477|P6|Overall Study|Adverse Event|1
6102217|NCT00256854|21053478|P5|Overall Study|Adverse Event|0
6102218|NCT00256854|21053479|P4|Overall Study|Adverse Event|2
6102219|NCT00256854|21053480|P3|Overall Study|Adverse Event|2
6102220|NCT00256854|21053481|P2|Overall Study|Adverse Event|0
6102221|NCT00256854|21053482|P1|Overall Study|Adverse Event|0
6102222|NCT00256854|21053477|P6|Overall Study|Protocol Violation|0
6102223|NCT00256854|21053478|P5|Overall Study|Protocol Violation|0
6102224|NCT00256854|21053479|P4|Overall Study|Protocol Violation|1
6102225|NCT00256854|21053480|P3|Overall Study|Protocol Violation|1
6102226|NCT00256854|21053481|P2|Overall Study|Protocol Violation|1
6102227|NCT00256854|21053482|P1|Overall Study|Protocol Violation|0
6102228|NCT00256854|21053477|P6|Overall Study|Lack of Efficacy|0
6102229|NCT00256854|21053478|P5|Overall Study|Lack of Efficacy|0
6102230|NCT00256854|21053479|P4|Overall Study|Lack of Efficacy|0
6102231|NCT00256854|21053480|P3|Overall Study|Lack of Efficacy|0
6102232|NCT00256854|21053481|P2|Overall Study|Lack of Efficacy|0
6102233|NCT00256854|21053482|P1|Overall Study|Lack of Efficacy|1
6102234|NCT00256854|21053477|P6|Overall Study|Withdrawal by Subject|0
6102235|NCT00256854|21053478|P5|Overall Study|Withdrawal by Subject|0
6102236|NCT00256854|21053479|P4|Overall Study|Withdrawal by Subject|0
6102237|NCT00256854|21053480|P3|Overall Study|Withdrawal by Subject|0
6102238|NCT00256854|21053481|P2|Overall Study|Withdrawal by Subject|3
6102239|NCT00256854|21053482|P1|Overall Study|Withdrawal by Subject|2
6102240|NCT00256750|21053541|P3|Long Term Extension (LTE; 84 Months)|Other|5
6102241|NCT00256750|21053542|P2|Long Term Extension (LTE; 84 Months)|Other|4
6102242|NCT00256750|21053543|P1|Long Term Extension (LTE; 84 Months)|Other|5
6102243|NCT00256750|21053541|P3|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|0
6102244|NCT00256750|21053542|P2|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1
6102245|NCT00256750|21053543|P1|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1
6102246|NCT00256750|21053541|P3|Long Term Extension (LTE; 84 Months)|Pregnancy|2
6102247|NCT00256750|21053542|P2|Long Term Extension (LTE; 84 Months)|Pregnancy|1
6102248|NCT00256750|21053543|P1|Long Term Extension (LTE; 84 Months)|Pregnancy|0
6102249|NCT00256750|21053541|P3|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1
6102250|NCT00256750|21053542|P2|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1
6102251|NCT00256750|21053543|P1|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|4
6102252|NCT00256750|21053541|P3|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|0
6102253|NCT00256750|21053542|P2|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|3
6102254|NCT00256750|21053543|P1|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|6
6102255|NCT00256750|21053541|P3|Long Term Extension (LTE; 84 Months)|Death|4
6102256|NCT00256750|21053542|P2|Long Term Extension (LTE; 84 Months)|Death|4
6102257|NCT00256750|21053543|P1|Long Term Extension (LTE; 84 Months)|Death|9
6102258|NCT00256750|21053541|P3|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1
6102259|NCT00256750|21053542|P2|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1
6102260|NCT00256750|21053543|P1|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|4
6102261|NCT00256750|21053541|P3|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|1
6102262|NCT00256750|21053542|P2|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|4
6102263|NCT00256750|21053543|P1|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|5
6102264|NCT00256750|21053541|P3|Long Term Extension (LTE; 84 Months)|Adverse Event|14
6102265|NCT00256750|21053542|P2|Long Term Extension (LTE; 84 Months)|Adverse Event|11
6102342|NCT00256698|21053691|P1|Overall Study|still ongoing at data cut-off|41
6102266|NCT00256750|21053543|P1|Long Term Extension (LTE; 84 Months)|Adverse Event|13
6102267|NCT00256750|21053541|P3|Post-Transplant Treated (36 Months)|Other|1
6102268|NCT00256750|21053542|P2|Post-Transplant Treated (36 Months)|Other|1
6102269|NCT00256750|21053543|P1|Post-Transplant Treated (36 Months)|Other|0
6102270|NCT00256750|21053541|P3|Post-Transplant Treated (36 Months)|Protocol Violation|0
6102271|NCT00256750|21053542|P2|Post-Transplant Treated (36 Months)|Protocol Violation|1
6102272|NCT00256750|21053543|P1|Post-Transplant Treated (36 Months)|Protocol Violation|0
6102273|NCT00256750|21053541|P3|Post-Transplant Treated (36 Months)|Lack of Efficacy|0
6102274|NCT00256750|21053542|P2|Post-Transplant Treated (36 Months)|Lack of Efficacy|1
6102275|NCT00256750|21053543|P1|Post-Transplant Treated (36 Months)|Lack of Efficacy|4
6102276|NCT00256750|21053541|P3|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|1
6102277|NCT00256750|21053542|P2|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0
6102278|NCT00256750|21053543|P1|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0
6102279|NCT00256750|21053541|P3|Post-Transplant Treated (36 Months)|Death|1
6102280|NCT00256750|21053542|P2|Post-Transplant Treated (36 Months)|Death|2
6102281|NCT00256750|21053543|P1|Post-Transplant Treated (36 Months)|Death|0
6102282|NCT00256750|21053541|P3|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1
6102283|NCT00256750|21053542|P2|Post-Transplant Treated (36 Months)|Withdrawal by Subject|0
6102284|NCT00256750|21053543|P1|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1
6102285|NCT00256750|21053541|P3|Post-Transplant Treated (36 Months)|Adverse Event|2
6102286|NCT00256750|21053542|P2|Post-Transplant Treated (36 Months)|Adverse Event|1
6102287|NCT00256750|21053543|P1|Post-Transplant Treated (36 Months)|Adverse Event|5
6102288|NCT00256750|21053541|P3|Post-Transplant Treated (24 Months)|Other|1
6102289|NCT00256750|21053542|P2|Post-Transplant Treated (24 Months)|Other|0
6102290|NCT00256750|21053543|P1|Post-Transplant Treated (24 Months)|Other|2
6102291|NCT00256750|21053541|P3|Post-Transplant Treated (24 Months)|Lack of Efficacy|2
6102292|NCT00256750|21053542|P2|Post-Transplant Treated (24 Months)|Lack of Efficacy|3
6102293|NCT00256750|21053543|P1|Post-Transplant Treated (24 Months)|Lack of Efficacy|4
6102294|NCT00256750|21053541|P3|Post-Transplant Treated (24 Months)|Death|0
6102295|NCT00256750|21053542|P2|Post-Transplant Treated (24 Months)|Death|0
6102296|NCT00256750|21053543|P1|Post-Transplant Treated (24 Months)|Death|3
6102297|NCT00256750|21053541|P3|Post-Transplant Treated (24 Months)|Withdrawal by Subject|0
6102298|NCT00256750|21053542|P2|Post-Transplant Treated (24 Months)|Withdrawal by Subject|1
6102299|NCT00256750|21053543|P1|Post-Transplant Treated (24 Months)|Withdrawal by Subject|5
6102300|NCT00256750|21053541|P3|Post-Transplant Treated (24 Months)|Adverse Event|6
6102301|NCT00256750|21053542|P2|Post-Transplant Treated (24 Months)|Adverse Event|3
6102302|NCT00256750|21053543|P1|Post-Transplant Treated (24 Months)|Adverse Event|7
6102303|NCT00256750|21053541|P3|Post-Transplant Treated (12 Months)|Protocol Violation|0
6102304|NCT00256750|21053542|P2|Post-Transplant Treated (12 Months)|Protocol Violation|0
6102305|NCT00256750|21053543|P1|Post-Transplant Treated (12 Months)|Protocol Violation|2
6102306|NCT00256750|21053541|P3|Post-Transplant Treated (12 Months)|Withdrawal by Subject|5
6102307|NCT00256750|21053542|P2|Post-Transplant Treated (12 Months)|Withdrawal by Subject|3
6102308|NCT00256750|21053543|P1|Post-Transplant Treated (12 Months)|Withdrawal by Subject|0
6102309|NCT00256750|21053541|P3|Post-Transplant Treated (12 Months)|Other|2
6102310|NCT00256750|21053542|P2|Post-Transplant Treated (12 Months)|Other|4
6102311|NCT00256750|21053543|P1|Post-Transplant Treated (12 Months)|Other|5
6102312|NCT00256750|21053541|P3|Post-Transplant Treated (12 Months)|Lost to Follow-up|0
6102313|NCT00256750|21053542|P2|Post-Transplant Treated (12 Months)|Lost to Follow-up|0
6102314|NCT00256750|21053543|P1|Post-Transplant Treated (12 Months)|Lost to Follow-up|1
6102315|NCT00256750|21053541|P3|Post-Transplant Treated (12 Months)|Lack of Efficacy|27
6102316|NCT00256750|21053542|P2|Post-Transplant Treated (12 Months)|Lack of Efficacy|22
6102317|NCT00256750|21053543|P1|Post-Transplant Treated (12 Months)|Lack of Efficacy|10
6102318|NCT00256750|21053541|P3|Post-Transplant Treated (12 Months)|Death|4
6102319|NCT00256750|21053542|P2|Post-Transplant Treated (12 Months)|Death|2
6102320|NCT00256750|21053543|P1|Post-Transplant Treated (12 Months)|Death|3
6102321|NCT00256750|21053541|P3|Post-Transplant Treated (12 Months)|Adverse Event|8
6102322|NCT00256750|21053542|P2|Post-Transplant Treated (12 Months)|Adverse Event|12
6102323|NCT00256750|21053543|P1|Post-Transplant Treated (12 Months)|Adverse Event|20
6102324|NCT00256750|21053541|P3|Transplanted Pre-Treatment|Death|0
6102325|NCT00256750|21053542|P2|Transplanted Pre-Treatment|Death|0
6102326|NCT00256750|21053543|P1|Transplanted Pre-Treatment|Death|1
6102327|NCT00256750|21053541|P3|Transplanted Pre-Treatment|Other|0
6102328|NCT00256750|21053542|P2|Transplanted Pre-Treatment|Other|0
6102329|NCT00256750|21053543|P1|Transplanted Pre-Treatment|Other|2
6102330|NCT00256750|21053541|P3|Transplanted Pre-Treatment|Withdrawal by Subject|0
6102331|NCT00256750|21053542|P2|Transplanted Pre-Treatment|Withdrawal by Subject|0
6102332|NCT00256750|21053543|P1|Transplanted Pre-Treatment|Withdrawal by Subject|3
6102333|NCT00256724|21053679|P2|Overall Study|Protocol Violation|3
6102334|NCT00256724|21053680|P1|Overall Study|Protocol Violation|3
6102335|NCT00256724|21053679|P2|Overall Study|Physician Decision|5
6102336|NCT00256724|21053680|P1|Overall Study|Physician Decision|2
6102337|NCT00256698|21053690|P2|Overall Study|Prematurely Discontinued|0
6102338|NCT00256698|21053691|P1|Overall Study|Prematurely Discontinued|1
6102339|NCT00256698|21053690|P2|Overall Study|withdrawn due to osteoporosis|0
6102340|NCT00256698|21053691|P1|Overall Study|withdrawn due to osteoporosis|1
6102341|NCT00256698|21053690|P2|Overall Study|still ongoing at data cut-off|46
6102343|NCT00256698|21053690|P2|Overall Study|disease progression|105
6102344|NCT00256698|21053691|P1|Overall Study|disease progression|97
6102345|NCT00256698|21053690|P2|Overall Study|Lost to Follow-up|3
6102346|NCT00256698|21053691|P1|Overall Study|Lost to Follow-up|1
6102347|NCT00256698|21053690|P2|Overall Study|Protocol Violation|5
6102348|NCT00256698|21053691|P1|Overall Study|Protocol Violation|6
6102349|NCT00256698|21053690|P2|Overall Study|Adverse Event|6
6102350|NCT00256698|21053691|P1|Overall Study|Adverse Event|13
6102351|NCT00256698|21053690|P2|Overall Study|Withdrawal by Subject|7
6102352|NCT00256698|21053691|P1|Overall Study|Withdrawal by Subject|7
6102353|NCT00256308|21053738|P1|Overall Study|Death|2
6102354|NCT00256295|21053746|P1|Overall Study|Death|1
6102355|NCT00256295|21053746|P1|Overall Study|Withdrawal by Subject|3
6102356|NCT00256282|21053752|P1|Overall Study|Physician Decision|1
6102357|NCT00256282|21053752|P1|Overall Study|Adverse Event|3
6102358|NCT00256282|21053752|P1|Overall Study|Disease progression, relapse during acti|12
6102359|NCT00256243|21053757|P1|Overall Study|Not treated|1
6102360|NCT00256243|21053757|P1|Overall Study|Death|7
6102361|NCT00256243|21053757|P1|Overall Study|Lost to Follow-up|2
6102362|NCT00256204|21053766|P4|Overall Study|Need for additional prohibited treatment|25
6102363|NCT00256204|21053767|P3|Overall Study|Need for additional prohibited treatment|27
6102364|NCT00256204|21053768|P2|Overall Study|Need for additional prohibited treatment|28
6102365|NCT00256204|21053769|P1|Overall Study|Need for additional prohibited treatment|38
6102366|NCT00256204|21053766|P4|Overall Study|Withdrawal by Subject|5
6102367|NCT00256204|21053767|P3|Overall Study|Withdrawal by Subject|7
6102368|NCT00256204|21053768|P2|Overall Study|Withdrawal by Subject|6
6102369|NCT00256204|21053769|P1|Overall Study|Withdrawal by Subject|17
6102370|NCT00256204|21053766|P4|Overall Study|Physician Decision|2
6102371|NCT00256204|21053767|P3|Overall Study|Physician Decision|1
6102372|NCT00256204|21053768|P2|Overall Study|Physician Decision|0
6102373|NCT00256204|21053769|P1|Overall Study|Physician Decision|0
6102374|NCT00256204|21053766|P4|Overall Study|Protocol Violation|1
6102375|NCT00256204|21053767|P3|Overall Study|Protocol Violation|2
6102376|NCT00256204|21053768|P2|Overall Study|Protocol Violation|0
6102377|NCT00256204|21053769|P1|Overall Study|Protocol Violation|1
6102378|NCT00256204|21053766|P4|Overall Study|Lost to Follow-up|2
6102379|NCT00256204|21053767|P3|Overall Study|Lost to Follow-up|1
6102380|NCT00256204|21053768|P2|Overall Study|Lost to Follow-up|1
6102381|NCT00256204|21053769|P1|Overall Study|Lost to Follow-up|1
6102382|NCT00256204|21053766|P4|Overall Study|Death|0
6102383|NCT00256204|21053767|P3|Overall Study|Death|0
6102384|NCT00256204|21053768|P2|Overall Study|Death|1
6102385|NCT00256204|21053769|P1|Overall Study|Death|0
6102386|NCT00256204|21053766|P4|Overall Study|Adverse Event|14
6102387|NCT00256204|21053767|P3|Overall Study|Adverse Event|16
6102388|NCT00256204|21053768|P2|Overall Study|Adverse Event|14
6102389|NCT00256204|21053769|P1|Overall Study|Adverse Event|10
6102390|NCT00256126|21053784|P2|Overall Study|Other|2
6102391|NCT00256126|21053785|P1|Overall Study|Other|1
6102392|NCT00256126|21053784|P2|Overall Study|Adverse Event|0
6102393|NCT00256126|21053785|P1|Overall Study|Adverse Event|1
6102394|NCT00255944|21053824|P2|Overall Study|Lost to Follow-up|834
6102395|NCT00255944|21053825|P1|Overall Study|Lost to Follow-up|797
6102396|NCT00255840|21053833|P2|Overall Study|Discontinued intervention|56
6102397|NCT00255840|21053834|P1|Overall Study|Discontinued intervention|53
6102398|NCT00255840|21053833|P2|Overall Study|Lost to Follow-up|14
6102399|NCT00255840|21053834|P1|Overall Study|Lost to Follow-up|10
6102400|NCT00255723|21053847|P2|Overall Study|Response Data Not Available|0
6102401|NCT00255723|21053848|P1|Overall Study|Response Data Not Available|1
6102402|NCT00255723|21053847|P2|Overall Study|Death|1
6102403|NCT00255723|21053848|P1|Overall Study|Death|0
6102404|NCT00255723|21053847|P2|Overall Study|Adverse Event|1
6102405|NCT00255723|21053848|P1|Overall Study|Adverse Event|1
6102406|NCT00255346|21053864|P5|Overall Study|Adverse Event|0
6102407|NCT00255346|21053865|P4|Overall Study|Adverse Event|0
6102408|NCT00255346|21053866|P3|Overall Study|Adverse Event|0
6102409|NCT00255346|21053867|P2|Overall Study|Adverse Event|0
6102410|NCT00255346|21053868|P1|Overall Study|Adverse Event|1
6102411|NCT00255190|21053883|P2|Overall Study|Various|23
6102412|NCT00255190|21053884|P1|Overall Study|Various|4
6102413|NCT00255190|21053883|P2|Overall Study|Erosive esophagitis not healed|20
6102414|NCT00255190|21053884|P1|Overall Study|Erosive esophagitis not healed|0
6102415|NCT00255190|21053883|P2|Overall Study|Inclusion/Exclusion criteria not met|1
6102416|NCT00255190|21053884|P1|Overall Study|Inclusion/Exclusion criteria not met|0
6102417|NCT00255190|21053883|P2|Overall Study|Withdrew Consent|48
6102418|NCT00255190|21053884|P1|Overall Study|Withdrew Consent|17
6102419|NCT00255190|21053883|P2|Overall Study|Lost to Follow-up|27
6102420|NCT00255190|21053884|P1|Overall Study|Lost to Follow-up|10
6102421|NCT00255190|21053883|P2|Overall Study|Protocol Violation|2
6102422|NCT00255190|21053884|P1|Overall Study|Protocol Violation|2
6102423|NCT00255190|21053883|P2|Overall Study|Adverse Event|36
6102424|NCT00255190|21053884|P1|Overall Study|Adverse Event|17
6102425|NCT00255164|21053968|P3|Overall Study|Therapeutic Failure|3
6102426|NCT00255164|21053969|P2|Overall Study|Therapeutic Failure|2
6102427|NCT00255164|21053970|P1|Overall Study|Therapeutic Failure|11
6102428|NCT00255164|21053968|P3|Overall Study|Esophageal Stricture|1
6102429|NCT00255164|21053969|P2|Overall Study|Esophageal Stricture|0
6102430|NCT00255164|21053970|P1|Overall Study|Esophageal Stricture|0
6102431|NCT00255164|21053968|P3|Overall Study|Possible Barrett's Esophagus|8
6102432|NCT00255164|21053969|P2|Overall Study|Possible Barrett's Esophagus|3
6102433|NCT00255164|21053970|P1|Overall Study|Possible Barrett's Esophagus|1
6102434|NCT00255164|21053968|P3|Overall Study|Relapse of Erosive Esophagitis|12
6102435|NCT00255164|21053969|P2|Overall Study|Relapse of Erosive Esophagitis|16
6102436|NCT00255164|21053970|P1|Overall Study|Relapse of Erosive Esophagitis|78
6102437|NCT00255164|21053968|P3|Overall Study|Subject Request/Subject Unavailable|2
6102438|NCT00255164|21053969|P2|Overall Study|Subject Request/Subject Unavailable|1
6102439|NCT00255164|21053970|P1|Overall Study|Subject Request/Subject Unavailable|1
6102440|NCT00255164|21053968|P3|Overall Study|Noncompliance|2
6102441|NCT00255164|21053969|P2|Overall Study|Noncompliance|1
6102442|NCT00255164|21053970|P1|Overall Study|Noncompliance|0
6102443|NCT00255164|21053968|P3|Overall Study|Withdrawal by Subject|8
6102444|NCT00255164|21053969|P2|Overall Study|Withdrawal by Subject|17
6102445|NCT00255164|21053970|P1|Overall Study|Withdrawal by Subject|18
6102446|NCT00255164|21053968|P3|Overall Study|Lost to Follow-up|4
6102447|NCT00255164|21053969|P2|Overall Study|Lost to Follow-up|3
6102448|NCT00255164|21053970|P1|Overall Study|Lost to Follow-up|4
6102449|NCT00255164|21053968|P3|Overall Study|Adverse Event|9
6102450|NCT00255164|21053969|P2|Overall Study|Adverse Event|6
6102451|NCT00255164|21053970|P1|Overall Study|Adverse Event|10
6102452|NCT00255151|21053996|P3|Overall Study|Therapeutic Failure|3
6102453|NCT00255151|21053997|P2|Overall Study|Therapeutic Failure|2
6102454|NCT00255151|21053998|P1|Overall Study|Therapeutic Failure|11
6102455|NCT00255151|21053996|P3|Overall Study|Esophageal Stricture|1
6102456|NCT00255151|21053997|P2|Overall Study|Esophageal Stricture|0
6102457|NCT00255151|21053998|P1|Overall Study|Esophageal Stricture|0
6102458|NCT00255151|21053996|P3|Overall Study|Possible Barrett's Esophagus|8
6102459|NCT00255151|21053997|P2|Overall Study|Possible Barrett's Esophagus|3
6102460|NCT00255151|21053998|P1|Overall Study|Possible Barrett's Esophagus|1
6102461|NCT00255151|21053996|P3|Overall Study|Relapse of Erosive Esophagitis|12
6102462|NCT00255151|21053997|P2|Overall Study|Relapse of Erosive Esophagitis|16
6102463|NCT00255151|21053998|P1|Overall Study|Relapse of Erosive Esophagitis|78
6102464|NCT00255151|21053996|P3|Overall Study|Subject Request/Subject Unavailable|2
6102465|NCT00255151|21053997|P2|Overall Study|Subject Request/Subject Unavailable|1
6102466|NCT00255151|21053998|P1|Overall Study|Subject Request/Subject Unavailable|1
6102467|NCT00255151|21053996|P3|Overall Study|Noncompliance|2
6102468|NCT00255151|21053997|P2|Overall Study|Noncompliance|1
6102469|NCT00255151|21053998|P1|Overall Study|Noncompliance|0
6102470|NCT00255151|21053996|P3|Overall Study|Withdrawal by Subject|8
6102471|NCT00255151|21053997|P2|Overall Study|Withdrawal by Subject|17
6102472|NCT00255151|21053998|P1|Overall Study|Withdrawal by Subject|18
6102473|NCT00255151|21053996|P3|Overall Study|Lost to Follow-up|4
6102474|NCT00255151|21053997|P2|Overall Study|Lost to Follow-up|3
6102475|NCT00255151|21053998|P1|Overall Study|Lost to Follow-up|4
6102476|NCT00255151|21053996|P3|Overall Study|Adverse Event|9
6102477|NCT00255151|21053997|P2|Overall Study|Adverse Event|6
6102478|NCT00255151|21053998|P1|Overall Study|Adverse Event|10
6102479|NCT00255086|21054036|P2|Overall Study|Protocol Violation|1
6102480|NCT00255086|21054037|P1|Overall Study|Protocol Violation|1
6102481|NCT00255086|21054036|P2|Overall Study|Adverse Event|1
6102482|NCT00255086|21054037|P1|Overall Study|Adverse Event|1
6102483|NCT00255047|21054049|P4|Overall Study|Withdrawal by Subject|18
6102484|NCT00255047|21054050|P3|Overall Study|Withdrawal by Subject|25
6102485|NCT00255047|21054051|P2|Overall Study|Withdrawal by Subject|23
6102486|NCT00255047|21054052|P1|Overall Study|Withdrawal by Subject|24
6102487|NCT00255047|21054049|P4|Overall Study|Lost to Follow-up|6
6102488|NCT00255047|21054050|P3|Overall Study|Lost to Follow-up|5
6102489|NCT00255047|21054051|P2|Overall Study|Lost to Follow-up|8
6102490|NCT00255047|21054052|P1|Overall Study|Lost to Follow-up|9
6102491|NCT00255047|21054049|P4|Overall Study|Protocol Violation|20
6102492|NCT00255047|21054050|P3|Overall Study|Protocol Violation|16
6102493|NCT00255047|21054051|P2|Overall Study|Protocol Violation|13
6102494|NCT00255047|21054052|P1|Overall Study|Protocol Violation|13
6102495|NCT00255047|21054049|P4|Overall Study|Adverse Event|1
6102496|NCT00255047|21054050|P3|Overall Study|Adverse Event|2
6102497|NCT00255047|21054051|P2|Overall Study|Adverse Event|3
6102498|NCT00255047|21054052|P1|Overall Study|Adverse Event|0
6102499|NCT00255047|21054049|P4|Overall Study|Serious Adverse Events|1
6102500|NCT00255047|21054050|P3|Overall Study|Serious Adverse Events|2
6102501|NCT00255047|21054051|P2|Overall Study|Serious Adverse Events|1
6102502|NCT00255047|21054052|P1|Overall Study|Serious Adverse Events|2
6102503|NCT00255034|21054076|P2|Overall Study|Withdrawal by Subject|38
6102504|NCT00255034|21054077|P1|Overall Study|Withdrawal by Subject|15
6102505|NCT00255008|21054087|P4|Overall Study|Other|2
6102506|NCT00255008|21054088|P3|Overall Study|Other|3
6102507|NCT00255008|21054089|P2|Overall Study|Other|0
6102508|NCT00255008|21054090|P1|Overall Study|Other|7
6102509|NCT00255008|21054087|P4|Overall Study|Adverse lab experience|0
6102510|NCT00255008|21054088|P3|Overall Study|Adverse lab experience|0
6102511|NCT00255008|21054089|P2|Overall Study|Adverse lab experience|0
6102512|NCT00255008|21054090|P1|Overall Study|Adverse lab experience|1
6102513|NCT00255008|21054087|P4|Overall Study|Sponsor request|17
6102514|NCT00255008|21054088|P3|Overall Study|Sponsor request|8
6102515|NCT00255008|21054089|P2|Overall Study|Sponsor request|3
6102516|NCT00255008|21054090|P1|Overall Study|Sponsor request|18
6102517|NCT00255008|21054087|P4|Overall Study|Withdrew consent|0
6102518|NCT00255008|21054088|P3|Overall Study|Withdrew consent|2
6102519|NCT00255008|21054089|P2|Overall Study|Withdrew consent|0
6102520|NCT00255008|21054090|P1|Overall Study|Withdrew consent|0
6102685|NCT00254293|21054272|P2|LTE Open Label Variable SC Dosing|Death|0
6102521|NCT00255008|21054087|P4|Overall Study|Did not meet viral reduction criteria|1
6102522|NCT00255008|21054088|P3|Overall Study|Did not meet viral reduction criteria|0
6102523|NCT00255008|21054089|P2|Overall Study|Did not meet viral reduction criteria|5
6102524|NCT00255008|21054090|P1|Overall Study|Did not meet viral reduction criteria|4
6102525|NCT00255008|21054087|P4|Overall Study|Lost to Follow-up|2
6102526|NCT00255008|21054088|P3|Overall Study|Lost to Follow-up|1
6102527|NCT00255008|21054089|P2|Overall Study|Lost to Follow-up|0
6102528|NCT00255008|21054090|P1|Overall Study|Lost to Follow-up|1
6102529|NCT00255008|21054087|P4|Overall Study|Adverse Event|0
6102530|NCT00255008|21054088|P3|Overall Study|Adverse Event|2
6102531|NCT00255008|21054089|P2|Overall Study|Adverse Event|1
6102532|NCT00255008|21054090|P1|Overall Study|Adverse Event|1
6102533|NCT00254982|21054126|P2|Overall Study|Abnormal liver function tests|1
6102534|NCT00254982|21054127|P1|Overall Study|Abnormal liver function tests|2
6102535|NCT00254982|21054126|P2|Overall Study|Opportunistic infection|0
6102536|NCT00254982|21054127|P1|Overall Study|Opportunistic infection|1
6102537|NCT00254982|21054126|P2|Overall Study|Malignancy|2
6102538|NCT00254982|21054127|P1|Overall Study|Malignancy|0
6102539|NCT00254982|21054126|P2|Overall Study|Diagnosis of Tuberculosis|1
6102540|NCT00254982|21054127|P1|Overall Study|Diagnosis of Tuberculosis|1
6102541|NCT00254982|21054126|P2|Overall Study|Protocol deviation|1
6102542|NCT00254982|21054127|P1|Overall Study|Protocol deviation|1
6102543|NCT00254982|21054126|P2|Overall Study|Inclusion/exclusion criteria violation|2
6102544|NCT00254982|21054127|P1|Overall Study|Inclusion/exclusion criteria violation|0
6102545|NCT00254982|21054126|P2|Overall Study|Withdrawal by Subject|1
6102546|NCT00254982|21054127|P1|Overall Study|Withdrawal by Subject|1
6102547|NCT00254982|21054126|P2|Overall Study|Adverse Event|16
6102548|NCT00254982|21054127|P1|Overall Study|Adverse Event|18
6102549|NCT00254982|21054126|P2|Overall Study|Lost to Follow-up|3
6102550|NCT00254982|21054127|P1|Overall Study|Lost to Follow-up|5
6102551|NCT00254982|21054126|P2|Overall Study|Lack of Efficacy|3
6102552|NCT00254982|21054127|P1|Overall Study|Lack of Efficacy|5
6102553|NCT00254982|21054126|P2|Overall Study|Other|1
6102554|NCT00254982|21054127|P1|Overall Study|Other|2
6102555|NCT00254566|21054139|P2|Overall Study|Lost to Follow-up|2
6102556|NCT00254566|21054140|P1|Overall Study|Lost to Follow-up|7
6102557|NCT00254566|21054139|P2|Overall Study|Withdrawal by Subject|6
6102558|NCT00254566|21054140|P1|Overall Study|Withdrawal by Subject|5
6102559|NCT00254566|21054139|P2|Overall Study|Other|5
6102560|NCT00254566|21054140|P1|Overall Study|Other|1
6102561|NCT00254566|21054139|P2|Overall Study|Lack of Efficacy|9
6102562|NCT00254566|21054140|P1|Overall Study|Lack of Efficacy|12
6102563|NCT00254566|21054139|P2|Overall Study|Adverse Event|4
6102564|NCT00254566|21054140|P1|Overall Study|Adverse Event|5
6102565|NCT00254566|21054139|P2|Overall Study|Death|0
6102566|NCT00254566|21054140|P1|Overall Study|Death|1
6102567|NCT00254540|21054164|P2|Overall Study|Laboratory Test Abnormality|1
6102568|NCT00254540|21054165|P1|Overall Study|Laboratory Test Abnormality|0
6102569|NCT00254540|21054164|P2|Overall Study|Death|1
6102570|NCT00254540|21054165|P1|Overall Study|Death|0
6102571|NCT00254540|21054164|P2|Overall Study|Lack of Efficacy|13
6102572|NCT00254540|21054165|P1|Overall Study|Lack of Efficacy|13
6102573|NCT00254540|21054164|P2|Overall Study|Adverse Event|7
6102574|NCT00254540|21054165|P1|Overall Study|Adverse Event|6
6102575|NCT00254501|21054194|P2|Overall Study|Lost to Follow-up|1
6102576|NCT00254501|21054195|P1|Overall Study|Lost to Follow-up|1
6102577|NCT00254397|21054240|P4|Overall Study|Adverse Event|1
6102578|NCT00254397|21054241|P3|Overall Study|Adverse Event|3
6102579|NCT00254397|21054242|P2|Overall Study|Adverse Event|0
6102580|NCT00254397|21054243|P1|Overall Study|Adverse Event|2
6102581|NCT00254397|21054240|P4|Overall Study|Non-Compliant|1
6102582|NCT00254397|21054241|P3|Overall Study|Non-Compliant|0
6102583|NCT00254397|21054242|P2|Overall Study|Non-Compliant|0
6102584|NCT00254397|21054243|P1|Overall Study|Non-Compliant|0
6102585|NCT00254397|21054240|P4|Overall Study|Disease Progression|23
6102586|NCT00254397|21054241|P3|Overall Study|Disease Progression|16
6102587|NCT00254397|21054242|P2|Overall Study|Disease Progression|1
6102588|NCT00254397|21054243|P1|Overall Study|Disease Progression|4
6102589|NCT00254293|21054267|P7|LTE Open Label Fixed Dosing|Other|1
6102590|NCT00254293|21054268|P6|LTE Open Label Fixed Dosing|Other|0
6102591|NCT00254293|21054269|P5|LTE Open Label Fixed Dosing|Other|0
6102592|NCT00254293|21054270|P4|LTE Open Label Fixed Dosing|Other|0
6102593|NCT00254293|21054271|P3|LTE Open Label Fixed Dosing|Other|0
6102594|NCT00254293|21054272|P2|LTE Open Label Fixed Dosing|Other|0
6102595|NCT00254293|21054273|P1|LTE Open Label Fixed Dosing|Other|0
6102596|NCT00254293|21054267|P7|LTE Open Label Fixed Dosing|Poor or non-compliance|1
6102597|NCT00254293|21054268|P6|LTE Open Label Fixed Dosing|Poor or non-compliance|0
6102598|NCT00254293|21054269|P5|LTE Open Label Fixed Dosing|Poor or non-compliance|0
6102599|NCT00254293|21054270|P4|LTE Open Label Fixed Dosing|Poor or non-compliance|0
6102600|NCT00254293|21054271|P3|LTE Open Label Fixed Dosing|Poor or non-compliance|0
6102601|NCT00254293|21054272|P2|LTE Open Label Fixed Dosing|Poor or non-compliance|0
6102602|NCT00254293|21054273|P1|LTE Open Label Fixed Dosing|Poor or non-compliance|0
6102603|NCT00254293|21054267|P7|LTE Open Label Fixed Dosing|Withdrawal by Subject|3
6102604|NCT00254293|21054268|P6|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
6102605|NCT00254293|21054269|P5|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
6102606|NCT00254293|21054270|P4|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
6102607|NCT00254293|21054271|P3|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
6102686|NCT00254293|21054273|P1|LTE Open Label Variable SC Dosing|Death|0
6102608|NCT00254293|21054272|P2|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
6102609|NCT00254293|21054273|P1|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
6102610|NCT00254293|21054267|P7|LTE Open Label Fixed Dosing|Lost to Follow-up|1
6102611|NCT00254293|21054268|P6|LTE Open Label Fixed Dosing|Lost to Follow-up|0
6102612|NCT00254293|21054269|P5|LTE Open Label Fixed Dosing|Lost to Follow-up|0
6102613|NCT00254293|21054270|P4|LTE Open Label Fixed Dosing|Lost to Follow-up|0
6102614|NCT00254293|21054271|P3|LTE Open Label Fixed Dosing|Lost to Follow-up|0
6102615|NCT00254293|21054272|P2|LTE Open Label Fixed Dosing|Lost to Follow-up|0
6102616|NCT00254293|21054273|P1|LTE Open Label Fixed Dosing|Lost to Follow-up|0
6102617|NCT00254293|21054267|P7|LTE Open Label Fixed Dosing|Lack of Efficacy|3
6102618|NCT00254293|21054268|P6|LTE Open Label Fixed Dosing|Lack of Efficacy|0
6102619|NCT00254293|21054269|P5|LTE Open Label Fixed Dosing|Lack of Efficacy|0
6102620|NCT00254293|21054270|P4|LTE Open Label Fixed Dosing|Lack of Efficacy|0
6102621|NCT00254293|21054271|P3|LTE Open Label Fixed Dosing|Lack of Efficacy|0
6102622|NCT00254293|21054272|P2|LTE Open Label Fixed Dosing|Lack of Efficacy|0
6102623|NCT00254293|21054273|P1|LTE Open Label Fixed Dosing|Lack of Efficacy|0
6102624|NCT00254293|21054267|P7|LTE Open Label Fixed Dosing|Adverse Event|1
6102625|NCT00254293|21054268|P6|LTE Open Label Fixed Dosing|Adverse Event|0
6102626|NCT00254293|21054269|P5|LTE Open Label Fixed Dosing|Adverse Event|0
6102627|NCT00254293|21054270|P4|LTE Open Label Fixed Dosing|Adverse Event|0
6102628|NCT00254293|21054271|P3|LTE Open Label Fixed Dosing|Adverse Event|0
6102629|NCT00254293|21054272|P2|LTE Open Label Fixed Dosing|Adverse Event|0
6102630|NCT00254293|21054273|P1|LTE Open Label Fixed Dosing|Adverse Event|0
6102631|NCT00254293|21054267|P7|LTE Open Label Fixed Dosing|Death|3
6102632|NCT00254293|21054268|P6|LTE Open Label Fixed Dosing|Death|0
6102633|NCT00254293|21054269|P5|LTE Open Label Fixed Dosing|Death|0
6102634|NCT00254293|21054270|P4|LTE Open Label Fixed Dosing|Death|0
6102635|NCT00254293|21054271|P3|LTE Open Label Fixed Dosing|Death|0
6102636|NCT00254293|21054272|P2|LTE Open Label Fixed Dosing|Death|0
6102637|NCT00254293|21054273|P1|LTE Open Label Fixed Dosing|Death|0
6102638|NCT00254293|21054267|P7|LTE Open Label Variable SC Dosing|Other|0
6102639|NCT00254293|21054268|P6|LTE Open Label Variable SC Dosing|Other|0
6102640|NCT00254293|21054269|P5|LTE Open Label Variable SC Dosing|Other|0
6102641|NCT00254293|21054270|P4|LTE Open Label Variable SC Dosing|Other|0
6102642|NCT00254293|21054271|P3|LTE Open Label Variable SC Dosing|Other|2
6102643|NCT00254293|21054272|P2|LTE Open Label Variable SC Dosing|Other|0
6102644|NCT00254293|21054273|P1|LTE Open Label Variable SC Dosing|Other|0
6102645|NCT00254293|21054267|P7|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
6102646|NCT00254293|21054268|P6|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
6102647|NCT00254293|21054269|P5|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
6102648|NCT00254293|21054270|P4|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
6102649|NCT00254293|21054271|P3|LTE Open Label Variable SC Dosing|Poor or non-compliance|1
6102650|NCT00254293|21054272|P2|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
6102651|NCT00254293|21054273|P1|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
6102652|NCT00254293|21054267|P7|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
6102653|NCT00254293|21054268|P6|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
6102654|NCT00254293|21054269|P5|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
6102655|NCT00254293|21054270|P4|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
6102656|NCT00254293|21054271|P3|LTE Open Label Variable SC Dosing|Withdrawal by Subject|1
6102657|NCT00254293|21054272|P2|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
6102658|NCT00254293|21054273|P1|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
6102659|NCT00254293|21054267|P7|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
6102660|NCT00254293|21054268|P6|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
6102661|NCT00254293|21054269|P5|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
6102662|NCT00254293|21054270|P4|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
6102663|NCT00254293|21054271|P3|LTE Open Label Variable SC Dosing|Lost to Follow-up|1
6102664|NCT00254293|21054272|P2|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
6102665|NCT00254293|21054273|P1|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
6102666|NCT00254293|21054267|P7|LTE Open Label Variable SC Dosing|Lack of Efficacy|0
6102667|NCT00254293|21054268|P6|LTE Open Label Variable SC Dosing|Lack of Efficacy|0
6102668|NCT00254293|21054269|P5|LTE Open Label Variable SC Dosing|Lack of Efficacy|1
6102669|NCT00254293|21054270|P4|LTE Open Label Variable SC Dosing|Lack of Efficacy|0
6102670|NCT00254293|21054271|P3|LTE Open Label Variable SC Dosing|Lack of Efficacy|2
6102671|NCT00254293|21054272|P2|LTE Open Label Variable SC Dosing|Lack of Efficacy|0
6102672|NCT00254293|21054273|P1|LTE Open Label Variable SC Dosing|Lack of Efficacy|2
6102673|NCT00254293|21054267|P7|LTE Open Label Variable SC Dosing|Adverse Event|0
6102674|NCT00254293|21054268|P6|LTE Open Label Variable SC Dosing|Adverse Event|0
6102675|NCT00254293|21054269|P5|LTE Open Label Variable SC Dosing|Adverse Event|1
6102676|NCT00254293|21054270|P4|LTE Open Label Variable SC Dosing|Adverse Event|0
6102677|NCT00254293|21054271|P3|LTE Open Label Variable SC Dosing|Adverse Event|2
6102678|NCT00254293|21054272|P2|LTE Open Label Variable SC Dosing|Adverse Event|0
6102679|NCT00254293|21054273|P1|LTE Open Label Variable SC Dosing|Adverse Event|1
6102680|NCT00254293|21054267|P7|LTE Open Label Variable SC Dosing|Death|0
6102681|NCT00254293|21054268|P6|LTE Open Label Variable SC Dosing|Death|0
6102682|NCT00254293|21054269|P5|LTE Open Label Variable SC Dosing|Death|0
6102683|NCT00254293|21054270|P4|LTE Open Label Variable SC Dosing|Death|0
6102684|NCT00254293|21054271|P3|LTE Open Label Variable SC Dosing|Death|1
6102687|NCT00254293|21054267|P7|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
6102688|NCT00254293|21054268|P6|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
6102689|NCT00254293|21054269|P5|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
6102690|NCT00254293|21054270|P4|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
6102691|NCT00254293|21054271|P3|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|2
6102692|NCT00254293|21054272|P2|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
6102693|NCT00254293|21054273|P1|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
6102694|NCT00254293|21054267|P7|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
6102695|NCT00254293|21054268|P6|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
6102696|NCT00254293|21054269|P5|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
6102697|NCT00254293|21054270|P4|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
6102698|NCT00254293|21054271|P3|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|1
6102699|NCT00254293|21054272|P2|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
6102700|NCT00254293|21054273|P1|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
6102701|NCT00254293|21054267|P7|Short Term (12 Week) Randomized Dosing|Adverse Event|0
6102702|NCT00254293|21054268|P6|Short Term (12 Week) Randomized Dosing|Adverse Event|0
6102703|NCT00254293|21054269|P5|Short Term (12 Week) Randomized Dosing|Adverse Event|0
6102704|NCT00254293|21054270|P4|Short Term (12 Week) Randomized Dosing|Adverse Event|1
6102705|NCT00254293|21054271|P3|Short Term (12 Week) Randomized Dosing|Adverse Event|0
6102706|NCT00254293|21054272|P2|Short Term (12 Week) Randomized Dosing|Adverse Event|1
6102707|NCT00254293|21054273|P1|Short Term (12 Week) Randomized Dosing|Adverse Event|0
6102708|NCT00254163|21054356|P2|Overall Study|Other|8
6102709|NCT00254163|21054357|P1|Overall Study|Other|8
6102710|NCT00254163|21054356|P2|Overall Study|Death|1
6102711|NCT00254163|21054357|P1|Overall Study|Death|0
6102712|NCT00254163|21054356|P2|Overall Study|Progressive disease|1
6102713|NCT00254163|21054357|P1|Overall Study|Progressive disease|0
6102714|NCT00254163|21054356|P2|Overall Study|Failed entry|3
6102715|NCT00254163|21054357|P1|Overall Study|Failed entry|1
6102716|NCT00254163|21054356|P2|Overall Study|Investigator request|3
6102717|NCT00254163|21054357|P1|Overall Study|Investigator request|1
6102718|NCT00254163|21054356|P2|Overall Study|Patient request/withdrew consent|4
6102719|NCT00254163|21054357|P1|Overall Study|Patient request/withdrew consent|6
6102720|NCT00254163|21054356|P2|Overall Study|Adverse Event|26
6102721|NCT00254163|21054357|P1|Overall Study|Adverse Event|29
6102722|NCT00253747|21054408|P2|Overall Study|Administrative Discharge (1), Other (2)|2
6102723|NCT00253747|21054409|P1|Overall Study|Administrative Discharge (1), Other (2)|1
6102724|NCT00253747|21054408|P2|Overall Study|Withdrawal by Subject|11
6102725|NCT00253747|21054409|P1|Overall Study|Withdrawal by Subject|10
6102726|NCT00253747|21054408|P2|Overall Study|Lost to Follow-up|14
6102727|NCT00253747|21054409|P1|Overall Study|Lost to Follow-up|13
6102728|NCT00253643|21054462|P4|Overall Study|Non-Compliance|2
6102729|NCT00253643|21054463|P3|Overall Study|Non-Compliance|0
6102730|NCT00253643|21054464|P2|Overall Study|Non-Compliance|0
6102731|NCT00253643|21054465|P1|Overall Study|Non-Compliance|0
6102732|NCT00253643|21054462|P4|Overall Study|Withdrawal by Subject|1
6102733|NCT00253643|21054463|P3|Overall Study|Withdrawal by Subject|1
6102734|NCT00253643|21054464|P2|Overall Study|Withdrawal by Subject|0
6102735|NCT00253643|21054465|P1|Overall Study|Withdrawal by Subject|0
6102736|NCT00253630|21054479|P1|Overall Study|ineligible|2
6102737|NCT00253448|21054495|P1|Overall Study|Withdrawal by Subject|1
6102738|NCT00253370|21054514|P1|Overall Study|Abdominal pain due to disease|1
6102739|NCT00253370|21054514|P1|Overall Study|Protocol Violation|1
6102740|NCT00253370|21054514|P1|Overall Study|Physician Decision|1
6102741|NCT00253370|21054514|P1|Overall Study|Non-protocol therapy|1
6102742|NCT00253370|21054514|P1|Overall Study|Withdrawal by Subject|6
6102743|NCT00253370|21054514|P1|Overall Study|Death|2
6102744|NCT00253370|21054514|P1|Overall Study|Disease progression|13
6102745|NCT00253370|21054514|P1|Overall Study|Adverse Event|18
6102746|NCT00252733|21054560|P2|Overall Study|Multiple Reasons|14
6102747|NCT00252733|21054561|P1|Overall Study|Multiple Reasons|14
6102748|NCT00252733|21054560|P2|Overall Study|Lost to Follow-up|6
6102749|NCT00252733|21054561|P1|Overall Study|Lost to Follow-up|12
6102750|NCT00252733|21054560|P2|Overall Study|Death|5
6102751|NCT00252733|21054561|P1|Overall Study|Death|7
6102752|NCT00252733|21054560|P2|Overall Study|Withdrawal by Subject|67
6102753|NCT00252733|21054561|P1|Overall Study|Withdrawal by Subject|73
6102754|NCT00252720|21054571|P2|Overall Study|Mainly patients lost to follow-up|18
6102755|NCT00252720|21054572|P1|Overall Study|Mainly patients lost to follow-up|7
6102756|NCT00252720|21054571|P2|Overall Study|Moving|42
6102757|NCT00252720|21054572|P1|Overall Study|Moving|23
6102758|NCT00252720|21054571|P2|Overall Study|Death|8
6102759|NCT00252720|21054572|P1|Overall Study|Death|7
6102760|NCT00252720|21054571|P2|Overall Study|Withdrawal by Subject|97
6102761|NCT00252720|21054572|P1|Overall Study|Withdrawal by Subject|95
6102762|NCT00252694|21054586|P2|Overall Study|Patient Moving|16
6102763|NCT00252694|21054587|P1|Overall Study|Patient Moving|17
6102764|NCT00252694|21054586|P2|Overall Study|Mostly Lost to Follow Up|13
6102765|NCT00252694|21054587|P1|Overall Study|Mostly Lost to Follow Up|8
6102766|NCT00252694|21054586|P2|Overall Study|Death|34
6102767|NCT00252694|21054587|P1|Overall Study|Death|36
6102768|NCT00252694|21054586|P2|Overall Study|Withdrawal by Subject|91
6102769|NCT00252694|21054587|P1|Overall Study|Withdrawal by Subject|83
6102770|NCT00252577|21054633|P1|Overall Study|Lost to Follow-up|20
6102771|NCT00252564|21054639|P2|Overall Study|Withdrawal by Subject|2
6102772|NCT00252564|21054640|P1|Overall Study|Withdrawal by Subject|0
6102773|NCT00252564|21054639|P2|Overall Study|Patient Request|5
6102774|NCT00252564|21054640|P1|Overall Study|Patient Request|4
6102775|NCT00252564|21054639|P2|Overall Study|Lost to Follow-up|0
6102776|NCT00252564|21054640|P1|Overall Study|Lost to Follow-up|1
6102777|NCT00252564|21054639|P2|Overall Study|Physician Decision|0
6102778|NCT00252564|21054640|P1|Overall Study|Physician Decision|1
6102779|NCT00252564|21054639|P2|Overall Study|Death|3
6102780|NCT00252564|21054640|P1|Overall Study|Death|0
6102781|NCT00252564|21054639|P2|Overall Study|Disease Progression|20
6102782|NCT00252564|21054640|P1|Overall Study|Disease Progression|14
6102783|NCT00252564|21054639|P2|Overall Study|Unrelated Complication|1
6102784|NCT00252564|21054640|P1|Overall Study|Unrelated Complication|2
6102785|NCT00252564|21054639|P2|Overall Study|Adverse Event|13
6102786|NCT00252564|21054640|P1|Overall Study|Adverse Event|17
6102787|NCT00252499|21054680|P3|Overall Study|Lost to Follow-up|0
6102788|NCT00252499|21054681|P2|Overall Study|Lost to Follow-up|0
6102789|NCT00252499|21054682|P1|Overall Study|Lost to Follow-up|1
6102790|NCT00252239|21054714|P4|Overall Study|Lost to Follow-up|0
6102791|NCT00252239|21054715|P3|Overall Study|Lost to Follow-up|2
6102792|NCT00252239|21054716|P2|Overall Study|Lost to Follow-up|0
6102793|NCT00252239|21054717|P1|Overall Study|Lost to Follow-up|0
6102794|NCT00252239|21054714|P4|Overall Study|Withdrawal by Subject|1
6102795|NCT00252239|21054715|P3|Overall Study|Withdrawal by Subject|0
6102796|NCT00252239|21054716|P2|Overall Study|Withdrawal by Subject|0
6102797|NCT00252239|21054717|P1|Overall Study|Withdrawal by Subject|1
6102798|NCT00252187|21054729|P2|Overall Study|Withdrawal by Subject|0
6102799|NCT00252187|21054730|P1|Overall Study|Withdrawal by Subject|1
6102800|NCT00252187|21054729|P2|Overall Study|Adverse Event|1
6102801|NCT00252187|21054730|P1|Overall Study|Adverse Event|3
6102802|NCT00252174|21054753|P3|Overall Study|Withdrawal by Subject|0
6102803|NCT00252174|21054754|P2|Overall Study|Withdrawal by Subject|1
6102804|NCT00252174|21054755|P1|Overall Study|Withdrawal by Subject|0
6102805|NCT00252057|21054795|P2|Overall Study|Participant previously enrolled|1
6102806|NCT00252057|21054796|P1|Overall Study|Participant previously enrolled|0
6102807|NCT00252057|21054795|P2|Overall Study|Death|2
6102808|NCT00252057|21054796|P1|Overall Study|Death|1
6102809|NCT00252057|21054795|P2|Overall Study|Withdrawal by Subject|5
6102810|NCT00252057|21054796|P1|Overall Study|Withdrawal by Subject|2
6102811|NCT00251979|21054804|P2|Overall Study|Death|5
6102812|NCT00251979|21054805|P1|Overall Study|Death|3
6102813|NCT00251979|21054804|P2|Overall Study|Lost to Follow-up|6
6102814|NCT00251979|21054805|P1|Overall Study|Lost to Follow-up|8
6102815|NCT00251979|21054804|P2|Overall Study|Withdrawal by Subject|7
6102816|NCT00251979|21054805|P1|Overall Study|Withdrawal by Subject|13
6102817|NCT00251979|21054804|P2|Overall Study|Adverse Event|17
6102818|NCT00251979|21054805|P1|Overall Study|Adverse Event|11
6102819|NCT00251979|21054804|P2|Overall Study|Protocol Violation|5
6102820|NCT00251979|21054805|P1|Overall Study|Protocol Violation|3
6102821|NCT00251927|21054837|P2|Overall Study|Study procedure non-compliance|6
6102822|NCT00251927|21054838|P1|Overall Study|Study procedure non-compliance|5
6102823|NCT00251927|21054837|P2|Overall Study|Study-specific discont. achieved|2
6102824|NCT00251927|21054838|P1|Overall Study|Study-specific discont. achieved|13
6102825|NCT00251927|21054837|P2|Overall Study|Withdrawal by Subject|25
6102826|NCT00251927|21054838|P1|Overall Study|Withdrawal by Subject|40
6102827|NCT00251927|21054837|P2|Overall Study|Pregnancy|0
6102828|NCT00251927|21054838|P1|Overall Study|Pregnancy|2
6102829|NCT00251927|21054837|P2|Overall Study|Protocol Violation|2
6102830|NCT00251927|21054838|P1|Overall Study|Protocol Violation|1
6102831|NCT00251927|21054837|P2|Overall Study|Lost to Follow-up|8
6102832|NCT00251927|21054838|P1|Overall Study|Lost to Follow-up|22
6102833|NCT00251927|21054837|P2|Overall Study|Lack of Efficacy|16
6102834|NCT00251927|21054838|P1|Overall Study|Lack of Efficacy|22
6102835|NCT00251927|21054837|P2|Overall Study|Adverse Event|15
6102836|NCT00251927|21054838|P1|Overall Study|Adverse Event|3
6102837|NCT00251758|21054890|P3|Overall Study|Per Investigator Request|0
6102838|NCT00251758|21054891|P2|Overall Study|Per Investigator Request|0
6102839|NCT00251758|21054892|P1|Overall Study|Per Investigator Request|1
6102840|NCT00251758|21054890|P3|Overall Study|Per Subject Request|1
6102841|NCT00251758|21054891|P2|Overall Study|Per Subject Request|0
6102842|NCT00251758|21054892|P1|Overall Study|Per Subject Request|0
6102843|NCT00251758|21054890|P3|Overall Study|Pregnancy|0
6102844|NCT00251758|21054891|P2|Overall Study|Pregnancy|1
6102845|NCT00251758|21054892|P1|Overall Study|Pregnancy|0
6102846|NCT00251758|21054890|P3|Overall Study|Noncompliant|2
6102847|NCT00251758|21054891|P2|Overall Study|Noncompliant|2
6102848|NCT00251758|21054892|P1|Overall Study|Noncompliant|0
6102849|NCT00251758|21054890|P3|Overall Study|Lack of Efficacy|0
6102850|NCT00251758|21054891|P2|Overall Study|Lack of Efficacy|0
6102851|NCT00251758|21054892|P1|Overall Study|Lack of Efficacy|3
6102852|NCT00251758|21054890|P3|Overall Study|Unmet Inclusion/Exclusion Criteria|5
6102853|NCT00251758|21054891|P2|Overall Study|Unmet Inclusion/Exclusion Criteria|6
6102854|NCT00251758|21054892|P1|Overall Study|Unmet Inclusion/Exclusion Criteria|0
6102855|NCT00251758|21054890|P3|Overall Study|Withdrawal by Subject|3
6102856|NCT00251758|21054891|P2|Overall Study|Withdrawal by Subject|7
6102857|NCT00251758|21054892|P1|Overall Study|Withdrawal by Subject|13
6102858|NCT00251758|21054890|P3|Overall Study|Lost to Follow-up|5
6102859|NCT00251758|21054891|P2|Overall Study|Lost to Follow-up|2
6102860|NCT00251758|21054892|P1|Overall Study|Lost to Follow-up|4
6102861|NCT00251758|21054890|P3|Overall Study|Adverse Event|11
6102862|NCT00251758|21054891|P2|Overall Study|Adverse Event|9
6102863|NCT00251758|21054892|P1|Overall Study|Adverse Event|7
6102864|NCT00251745|21054912|P3|Overall Study|Per Investigator Request|0
6102865|NCT00251745|21054913|P2|Overall Study|Per Investigator Request|0
6102866|NCT00251745|21054914|P1|Overall Study|Per Investigator Request|1
6102867|NCT00251745|21054912|P3|Overall Study|Per Subject Request|1
6102868|NCT00251745|21054913|P2|Overall Study|Per Subject Request|0
6102869|NCT00251745|21054914|P1|Overall Study|Per Subject Request|0
6102870|NCT00251745|21054912|P3|Overall Study|Pregnancy|0
6102871|NCT00251745|21054913|P2|Overall Study|Pregnancy|1
6102872|NCT00251745|21054914|P1|Overall Study|Pregnancy|0
6102873|NCT00251745|21054912|P3|Overall Study|Noncompliant|2
6102874|NCT00251745|21054913|P2|Overall Study|Noncompliant|2
6102875|NCT00251745|21054914|P1|Overall Study|Noncompliant|0
6102876|NCT00251745|21054912|P3|Overall Study|Lack of Efficacy|0
6102877|NCT00251745|21054913|P2|Overall Study|Lack of Efficacy|0
6102878|NCT00251745|21054914|P1|Overall Study|Lack of Efficacy|3
6102879|NCT00251745|21054912|P3|Overall Study|Unmet Inclusion/Exclusion Criteria|5
6102880|NCT00251745|21054913|P2|Overall Study|Unmet Inclusion/Exclusion Criteria|6
6102881|NCT00251745|21054914|P1|Overall Study|Unmet Inclusion/Exclusion Criteria|0
6102882|NCT00251745|21054912|P3|Overall Study|Withdrawal by Subject|3
6102883|NCT00251745|21054913|P2|Overall Study|Withdrawal by Subject|7
6102884|NCT00251745|21054914|P1|Overall Study|Withdrawal by Subject|13
6102885|NCT00251745|21054912|P3|Overall Study|Lost to Follow-up|5
6102886|NCT00251745|21054913|P2|Overall Study|Lost to Follow-up|2
6102887|NCT00251745|21054914|P1|Overall Study|Lost to Follow-up|4
6102888|NCT00251745|21054912|P3|Overall Study|Adverse Event|11
6102889|NCT00251745|21054913|P2|Overall Study|Adverse Event|9
6102890|NCT00251745|21054914|P1|Overall Study|Adverse Event|7
6102891|NCT00251719|21054934|P3|Overall Study|Barrett's esophagus|0
6102892|NCT00251719|21054935|P2|Overall Study|Barrett's esophagus|2
6102893|NCT00251719|21054936|P1|Overall Study|Barrett's esophagus|2
6102894|NCT00251719|21054934|P3|Overall Study|Noncompliance|1
6102895|NCT00251719|21054935|P2|Overall Study|Noncompliance|3
6102896|NCT00251719|21054936|P1|Overall Study|Noncompliance|2
6102897|NCT00251719|21054934|P3|Overall Study|Investigator decision|0
6102898|NCT00251719|21054935|P2|Overall Study|Investigator decision|1
6102899|NCT00251719|21054936|P1|Overall Study|Investigator decision|1
6102900|NCT00251719|21054934|P3|Overall Study|Inclusion/exclusion criteria not met|2
6102901|NCT00251719|21054935|P2|Overall Study|Inclusion/exclusion criteria not met|6
6102902|NCT00251719|21054936|P1|Overall Study|Inclusion/exclusion criteria not met|12
6102903|NCT00251719|21054934|P3|Overall Study|Lack of Efficacy|0
6102904|NCT00251719|21054935|P2|Overall Study|Lack of Efficacy|1
6102905|NCT00251719|21054936|P1|Overall Study|Lack of Efficacy|2
6102906|NCT00251719|21054934|P3|Overall Study|Withdrawal by Subject|11
6102907|NCT00251719|21054935|P2|Overall Study|Withdrawal by Subject|12
6102908|NCT00251719|21054936|P1|Overall Study|Withdrawal by Subject|14
6102909|NCT00251719|21054934|P3|Overall Study|Lost to Follow-up|8
6102910|NCT00251719|21054935|P2|Overall Study|Lost to Follow-up|11
6102911|NCT00251719|21054936|P1|Overall Study|Lost to Follow-up|5
6102912|NCT00251719|21054934|P3|Overall Study|Protocol Violation|1
6102913|NCT00251719|21054935|P2|Overall Study|Protocol Violation|1
6102914|NCT00251719|21054936|P1|Overall Study|Protocol Violation|1
6102915|NCT00251719|21054934|P3|Overall Study|Adverse Event|7
6102916|NCT00251719|21054935|P2|Overall Study|Adverse Event|8
6102917|NCT00251719|21054936|P1|Overall Study|Adverse Event|14
6102918|NCT00251693|21054962|P3|Overall Study|Abnormal laboratory findings|1
6102919|NCT00251693|21054963|P2|Overall Study|Abnormal laboratory findings|0
6102920|NCT00251693|21054964|P1|Overall Study|Abnormal laboratory findings|0
6102921|NCT00251693|21054962|P3|Overall Study|Subject request/subject unavailable|0
6102922|NCT00251693|21054963|P2|Overall Study|Subject request/subject unavailable|2
6102923|NCT00251693|21054964|P1|Overall Study|Subject request/subject unavailable|1
6102924|NCT00251693|21054962|P3|Overall Study|Possible Barrett's esophagus|2
6102925|NCT00251693|21054963|P2|Overall Study|Possible Barrett's esophagus|5
6102926|NCT00251693|21054964|P1|Overall Study|Possible Barrett's esophagus|3
6102927|NCT00251693|21054962|P3|Overall Study|Noncompliant|2
6102928|NCT00251693|21054963|P2|Overall Study|Noncompliant|0
6102929|NCT00251693|21054964|P1|Overall Study|Noncompliant|0
6102930|NCT00251693|21054962|P3|Overall Study|Inclusion/exclusion criteria not met|8
6102931|NCT00251693|21054963|P2|Overall Study|Inclusion/exclusion criteria not met|3
6102932|NCT00251693|21054964|P1|Overall Study|Inclusion/exclusion criteria not met|5
6102933|NCT00251693|21054962|P3|Overall Study|Lack of Efficacy|0
6102934|NCT00251693|21054963|P2|Overall Study|Lack of Efficacy|1
6102935|NCT00251693|21054964|P1|Overall Study|Lack of Efficacy|0
6102936|NCT00251693|21054962|P3|Overall Study|Withdrawal by Subject|14
6102937|NCT00251693|21054963|P2|Overall Study|Withdrawal by Subject|17
6102938|NCT00251693|21054964|P1|Overall Study|Withdrawal by Subject|11
6102939|NCT00251693|21054962|P3|Overall Study|Lost to Follow-up|8
6102940|NCT00251693|21054963|P2|Overall Study|Lost to Follow-up|7
6102941|NCT00251693|21054964|P1|Overall Study|Lost to Follow-up|12
6102942|NCT00251693|21054962|P3|Overall Study|Protocol Violation|2
6102943|NCT00251693|21054963|P2|Overall Study|Protocol Violation|0
6102944|NCT00251693|21054964|P1|Overall Study|Protocol Violation|2
6102945|NCT00251693|21054962|P3|Overall Study|Adverse Event|9
6102946|NCT00251693|21054963|P2|Overall Study|Adverse Event|9
6102947|NCT00251693|21054964|P1|Overall Study|Adverse Event|17
6102948|NCT00251641|21054989|P2|Overall Study|Switched Treatment|63
6102949|NCT00251641|21054990|P1|Overall Study|Switched Treatment|9
6102950|NCT00251641|21054989|P2|Overall Study|Did not Meet protocol Eligibility|1
6102951|NCT00251641|21054990|P1|Overall Study|Did not Meet protocol Eligibility|2
6102952|NCT00251641|21054989|P2|Overall Study|Protocol Violation|2
6102953|NCT00251641|21054990|P1|Overall Study|Protocol Violation|10
6102954|NCT00251641|21054989|P2|Overall Study|Withdrawal by Subject|8
6102955|NCT00251641|21054990|P1|Overall Study|Withdrawal by Subject|6
6102956|NCT00251641|21054989|P2|Overall Study|Lost to Follow-up|3
6102957|NCT00251641|21054990|P1|Overall Study|Lost to Follow-up|3
6102958|NCT00251641|21054989|P2|Overall Study|Progression of Disease|2
6102959|NCT00251641|21054990|P1|Overall Study|Progression of Disease|0
6102960|NCT00251641|21054989|P2|Overall Study|Lack of Efficacy|1
6102961|NCT00251641|21054990|P1|Overall Study|Lack of Efficacy|2
6102962|NCT00251641|21054989|P2|Overall Study|Adverse Event|8
6102963|NCT00251641|21054990|P1|Overall Study|Adverse Event|80
6102964|NCT00251589|21055008|P4|Overall Study|Discontinued due to progressive disease|1
6102965|NCT00251589|21055009|P3|Overall Study|Discontinued due to progressive disease|0
6102966|NCT00251589|21055010|P2|Overall Study|Discontinued due to progressive disease|1
6102967|NCT00251589|21055011|P1|Overall Study|Discontinued due to progressive disease|9
6102968|NCT00251589|21055008|P4|Overall Study|Withdrawal by Subject|0
6102969|NCT00251589|21055009|P3|Overall Study|Withdrawal by Subject|0
6102970|NCT00251589|21055010|P2|Overall Study|Withdrawal by Subject|1
6102971|NCT00251589|21055011|P1|Overall Study|Withdrawal by Subject|1
6102972|NCT00251589|21055008|P4|Overall Study|Adverse Event|1
6102973|NCT00251589|21055009|P3|Overall Study|Adverse Event|2
6102974|NCT00251589|21055010|P2|Overall Study|Adverse Event|1
6102975|NCT00251589|21055011|P1|Overall Study|Adverse Event|5
6102976|NCT00251316|21055048|P2|Overall Study|Physician Decision|3
6102977|NCT00251316|21055049|P1|Overall Study|Physician Decision|2
6102978|NCT00251004|21055088|P3|Overall Study|Graft Loss|8
6102979|NCT00251004|21055089|P2|Overall Study|Graft Loss|13
6102980|NCT00251004|21055090|P1|Overall Study|Graft Loss|12
6102981|NCT00251004|21055088|P3|Overall Study|Lost to Follow-up|1
6102982|NCT00251004|21055089|P2|Overall Study|Lost to Follow-up|2
6102983|NCT00251004|21055090|P1|Overall Study|Lost to Follow-up|1
6102984|NCT00251004|21055088|P3|Overall Study|Death|8
6102985|NCT00251004|21055089|P2|Overall Study|Death|10
6102986|NCT00251004|21055090|P1|Overall Study|Death|9
6102987|NCT00251004|21055088|P3|Overall Study|Withdrawal by Subject|14
6102988|NCT00251004|21055089|P2|Overall Study|Withdrawal by Subject|16
6102989|NCT00251004|21055090|P1|Overall Study|Withdrawal by Subject|23
6102990|NCT00250835|21055114|P1|Overall Study|Withdrawal by Subject|1
6102991|NCT00250718|21055123|P1|Overall Study|Withdrawal by Subject|1
6102992|NCT00250718|21055123|P1|Overall Study|Adverse Event|1
6102993|NCT00250718|21055123|P1|Overall Study|Death|1
6102994|NCT00250705|21055128|P1|Overall Study|Lack of Efficacy|2
6102995|NCT00250679|21055139|P3|Overall Study|various single events: hip surgery,diary|1
6102996|NCT00250679|21055140|P2|Overall Study|various single events: hip surgery,diary|1
6102997|NCT00250679|21055141|P1|Overall Study|various single events: hip surgery,diary|3
6102998|NCT00250679|21055139|P3|Overall Study|Non-compliance|0
6102999|NCT00250679|21055140|P2|Overall Study|Non-compliance|1
6103000|NCT00250679|21055141|P1|Overall Study|Non-compliance|1
6103001|NCT00250679|21055139|P3|Overall Study|Moved|0
6103002|NCT00250679|21055140|P2|Overall Study|Moved|1
6103003|NCT00250679|21055141|P1|Overall Study|Moved|1
6103004|NCT00250679|21055139|P3|Overall Study|Technical Holter issues|2
6103005|NCT00250679|21055140|P2|Overall Study|Technical Holter issues|0
6103006|NCT00250679|21055141|P1|Overall Study|Technical Holter issues|1
6103007|NCT00250679|21055139|P3|Overall Study|Lack of Efficacy|3
6103008|NCT00250679|21055140|P2|Overall Study|Lack of Efficacy|1
6103009|NCT00250679|21055141|P1|Overall Study|Lack of Efficacy|0
6103010|NCT00250679|21055139|P3|Overall Study|Does Not Meet Entry Criteria|2
6103011|NCT00250679|21055140|P2|Overall Study|Does Not Meet Entry Criteria|4
6103012|NCT00250679|21055141|P1|Overall Study|Does Not Meet Entry Criteria|1
6103013|NCT00250679|21055139|P3|Overall Study|Lost to Follow-up|2
6103014|NCT00250679|21055140|P2|Overall Study|Lost to Follow-up|4
6103015|NCT00250679|21055141|P1|Overall Study|Lost to Follow-up|3
6103016|NCT00250679|21055139|P3|Overall Study|Withdrawal by Subject|15
6103017|NCT00250679|21055140|P2|Overall Study|Withdrawal by Subject|18
6103018|NCT00250679|21055141|P1|Overall Study|Withdrawal by Subject|15
6103019|NCT00250679|21055139|P3|Overall Study|Protocol Violation|3
6103020|NCT00250679|21055140|P2|Overall Study|Protocol Violation|4
6103021|NCT00250679|21055141|P1|Overall Study|Protocol Violation|2
6103022|NCT00250679|21055139|P3|Overall Study|Adverse Event|16
6103023|NCT00250679|21055140|P2|Overall Study|Adverse Event|15
6103024|NCT00250679|21055141|P1|Overall Study|Adverse Event|12
6103025|NCT00250588|21055242|P3|Overall Study|Lost to Follow-up|13
6103026|NCT00250588|21055243|P2|Overall Study|Lost to Follow-up|13
6103027|NCT00250588|21055244|P1|Overall Study|Lost to Follow-up|6
6103028|NCT00250588|21055242|P3|Overall Study|Withdrawal by Subject|0
6103029|NCT00250588|21055243|P2|Overall Study|Withdrawal by Subject|6
6103030|NCT00250588|21055244|P1|Overall Study|Withdrawal by Subject|3
6103031|NCT00250458|21055292|P2|Overall Study|Other|0
6103032|NCT00250458|21055293|P1|Overall Study|Other|1
6103033|NCT00250458|21055292|P2|Overall Study|Qualifying migraine but did not treat|3
6103034|NCT00250458|21055293|P1|Overall Study|Qualifying migraine but did not treat|3
6103035|NCT00250458|21055292|P2|Overall Study|Lack of Migraine Attack|9
6103036|NCT00250458|21055293|P1|Overall Study|Lack of Migraine Attack|20
6103037|NCT00250458|21055292|P2|Overall Study|Withdrawal by Subject|2
6103038|NCT00250458|21055293|P1|Overall Study|Withdrawal by Subject|4
6103039|NCT00250458|21055292|P2|Overall Study|Protocol Violation|1
6103040|NCT00250458|21055293|P1|Overall Study|Protocol Violation|0
6103041|NCT00250458|21055292|P2|Overall Study|Lost to Follow-up|2
6103042|NCT00250458|21055293|P1|Overall Study|Lost to Follow-up|4
6103043|NCT00250432|21055303|P2|Overall Study|Pt was considered untreatable|1
6103044|NCT00250432|21055304|P1|Overall Study|Pt was considered untreatable|0
6103045|NCT00250432|21055303|P2|Overall Study|Pt died out of posttherapy report period|5
6103046|NCT00250432|21055304|P1|Overall Study|Pt died out of posttherapy report period|6
6103047|NCT00250432|21055303|P2|Overall Study|Withdrawal by Subject|2
6103048|NCT00250432|21055304|P1|Overall Study|Withdrawal by Subject|6
6103049|NCT00250432|21055303|P2|Overall Study|Protocol Violation|3
6103050|NCT00250432|21055304|P1|Overall Study|Protocol Violation|0
6103051|NCT00250432|21055303|P2|Overall Study|Patient Moved|1
6103052|NCT00250432|21055304|P1|Overall Study|Patient Moved|0
6103053|NCT00250432|21055303|P2|Overall Study|Lost to Follow-up|5
6103054|NCT00250432|21055304|P1|Overall Study|Lost to Follow-up|6
6103055|NCT00250432|21055303|P2|Overall Study|Lack of Efficacy|1
6103056|NCT00250432|21055304|P1|Overall Study|Lack of Efficacy|2
6103057|NCT00250432|21055303|P2|Overall Study|Adverse Event|29
6103058|NCT00250432|21055304|P1|Overall Study|Adverse Event|25
6103059|NCT00250276|21055316|P4|Overall Study|Lost to Follow-up|8
6103060|NCT00250276|21055317|P3|Overall Study|Lost to Follow-up|13
6103061|NCT00250276|21055318|P2|Overall Study|Lost to Follow-up|18
6103062|NCT00250276|21055319|P1|Overall Study|Lost to Follow-up|11
6103063|NCT00250276|21055316|P4|Overall Study|Migrated/moved from study area|7
6103064|NCT00250276|21055317|P3|Overall Study|Migrated/moved from study area|2
6103065|NCT00250276|21055318|P2|Overall Study|Migrated/moved from study area|0
6103066|NCT00250276|21055319|P1|Overall Study|Migrated/moved from study area|3
6103067|NCT00250276|21055316|P4|Overall Study|Withdrawal by Subject|2
6103068|NCT00250276|21055317|P3|Overall Study|Withdrawal by Subject|3
6103069|NCT00250276|21055318|P2|Overall Study|Withdrawal by Subject|2
6103070|NCT00250276|21055319|P1|Overall Study|Withdrawal by Subject|1
6103071|NCT00250276|21055316|P4|Overall Study|Protocol Violation|0
6103072|NCT00250276|21055317|P3|Overall Study|Protocol Violation|0
6103073|NCT00250276|21055318|P2|Overall Study|Protocol Violation|1
6103074|NCT00250276|21055319|P1|Overall Study|Protocol Violation|0
6103075|NCT00250276|21055316|P4|Overall Study|Non-serious Adverse Event|2
6103076|NCT00250276|21055317|P3|Overall Study|Non-serious Adverse Event|0
6103077|NCT00250276|21055318|P2|Overall Study|Non-serious Adverse Event|0
6103078|NCT00250276|21055319|P1|Overall Study|Non-serious Adverse Event|2
6103079|NCT00250276|21055316|P4|Overall Study|Serious Adverse Event|0
6103080|NCT00250276|21055317|P3|Overall Study|Serious Adverse Event|1
6103081|NCT00250276|21055318|P2|Overall Study|Serious Adverse Event|0
6103082|NCT00250276|21055319|P1|Overall Study|Serious Adverse Event|0
6103083|NCT00249873|21055399|P2|Overall Study|Thromboembolic/outcome event|122
6103084|NCT00249873|21055400|P1|Overall Study|Thromboembolic/outcome event|82
6103085|NCT00249873|21055399|P2|Overall Study|Event related to cardiac condition|21
6103086|NCT00249873|21055400|P1|Overall Study|Event related to cardiac condition|12
6103087|NCT00249873|21055399|P2|Overall Study|Surgery/ procedure|9
6103088|NCT00249873|21055400|P1|Overall Study|Surgery/ procedure|9
6103089|NCT00249873|21055399|P2|Overall Study|Study drug intolerance|0
6103090|NCT00249873|21055400|P1|Overall Study|Study drug intolerance|5
6103091|NCT00249873|21055399|P2|Overall Study|Oral anticoagulant required|157
6103092|NCT00249873|21055400|P1|Overall Study|Oral anticoagulant required|159
6103093|NCT00249873|21055399|P2|Overall Study|Angiotensin II receptor blocker required|0
6103094|NCT00249873|21055400|P1|Overall Study|Angiotensin II receptor blocker required|1
6103095|NCT00249873|21055399|P2|Overall Study|Open label clopidogrel required|42
6103096|NCT00249873|21055400|P1|Overall Study|Open label clopidogrel required|31
6103097|NCT00249873|21055399|P2|Overall Study|Physician withdrew consent|60
6103098|NCT00249873|21055400|P1|Overall Study|Physician withdrew consent|59
6103099|NCT00249873|21055399|P2|Overall Study|Patient not wish to continue after May08|4
6103100|NCT00249873|21055400|P1|Overall Study|Patient not wish to continue after May08|3
6103101|NCT00249873|21055399|P2|Overall Study|Other contraindicated medication|0
6103102|NCT00249873|21055400|P1|Overall Study|Other contraindicated medication|1
6103103|NCT00249873|21055399|P2|Overall Study|Other non serious Adverse Event|108
6103104|NCT00249873|21055400|P1|Overall Study|Other non serious Adverse Event|112
6103105|NCT00249873|21055399|P2|Overall Study|Non-compliance|46
6103106|NCT00249873|21055400|P1|Overall Study|Non-compliance|41
6103107|NCT00249873|21055399|P2|Overall Study|Minor bleeding|37
6103108|NCT00249873|21055400|P1|Overall Study|Minor bleeding|99
6103109|NCT00249873|21055399|P2|Overall Study|Lost to Follow-up|7
6103110|NCT00249873|21055400|P1|Overall Study|Lost to Follow-up|4
6103111|NCT00249873|21055399|P2|Overall Study|Withdrawal by Subject|466
6103112|NCT00249873|21055400|P1|Overall Study|Withdrawal by Subject|504
6103113|NCT00249873|21055399|P2|Overall Study|Contraindication to oral anticoagulant|8
6103114|NCT00249873|21055400|P1|Overall Study|Contraindication to oral anticoagulant|4
6103115|NCT00249873|21055399|P2|Overall Study|Qualifying condition not present|23
6103116|NCT00249873|21055400|P1|Overall Study|Qualifying condition not present|20
6103117|NCT00249873|21055399|P2|Overall Study|Other Serious Adverse Event|97
6103118|NCT00249873|21055400|P1|Overall Study|Other Serious Adverse Event|86
6103119|NCT00249873|21055399|P2|Overall Study|Serious haemorrhagic Adverse Event|30
6103120|NCT00249873|21055400|P1|Overall Study|Serious haemorrhagic Adverse Event|74
6103121|NCT00249873|21055399|P2|Overall Study|Severe allergic reaction|1
6103122|NCT00249873|21055400|P1|Overall Study|Severe allergic reaction|8
6103123|NCT00249873|21055399|P2|Overall Study|Significant thrombocytopenia|8
6103124|NCT00249873|21055400|P1|Overall Study|Significant thrombocytopenia|9
6103125|NCT00249873|21055399|P2|Overall Study|Not treated|8
6103126|NCT00249873|21055400|P1|Overall Study|Not treated|7
6103127|NCT00249834|21055420|P8|Overall Study|Protocol Violation|0
6103128|NCT00249834|21055421|P7|Overall Study|Protocol Violation|0
6103129|NCT00249834|21055422|P6|Overall Study|Protocol Violation|2
6103130|NCT00249834|21055423|P5|Overall Study|Protocol Violation|5
6103131|NCT00249834|21055424|P4|Overall Study|Protocol Violation|8
6103132|NCT00249834|21055425|P3|Overall Study|Protocol Violation|14
6103133|NCT00249834|21055426|P2|Overall Study|Protocol Violation|19
6103134|NCT00249834|21055427|P1|Overall Study|Protocol Violation|0
6103135|NCT00249834|21055420|P8|Overall Study|Failure of down-regulation|0
6103136|NCT00249834|21055421|P7|Overall Study|Failure of down-regulation|1
6103137|NCT00249834|21055422|P6|Overall Study|Failure of down-regulation|0
6103138|NCT00249834|21055423|P5|Overall Study|Failure of down-regulation|0
6103139|NCT00249834|21055424|P4|Overall Study|Failure of down-regulation|0
6103140|NCT00249834|21055425|P3|Overall Study|Failure of down-regulation|0
6103141|NCT00249834|21055426|P2|Overall Study|Failure of down-regulation|0
6103142|NCT00249834|21055427|P1|Overall Study|Failure of down-regulation|0
6103143|NCT00249834|21055420|P8|Overall Study|Ovarian stimulation failed|0
6103144|NCT00249834|21055421|P7|Overall Study|Ovarian stimulation failed|0
6103145|NCT00249834|21055422|P6|Overall Study|Ovarian stimulation failed|0
6103146|NCT00249834|21055423|P5|Overall Study|Ovarian stimulation failed|0
6103147|NCT00249834|21055424|P4|Overall Study|Ovarian stimulation failed|0
6103148|NCT00249834|21055425|P3|Overall Study|Ovarian stimulation failed|0
6103149|NCT00249834|21055426|P2|Overall Study|Ovarian stimulation failed|0
6103150|NCT00249834|21055427|P1|Overall Study|Ovarian stimulation failed|1
6103151|NCT00249821|21055476|P2|Overall Study|Technical problem|1
6103152|NCT00249821|21055477|P1|Overall Study|Technical problem|0
6103153|NCT00249808|21055497|P1|Overall Study|Did Not Provide Post-Baseline Data|11
6103154|NCT00249808|21055497|P1|Overall Study|Lack of Efficacy|52
6103155|NCT00249808|21055497|P1|Overall Study|Adverse Event|81
6103156|NCT00249808|21055497|P1|Overall Study|Lost to Follow-up|8
6103157|NCT00249808|21055497|P1|Overall Study|Protocol Violation|3
6103158|NCT00249808|21055497|P1|Overall Study|Other|27
6103159|NCT00249795|21055505|P2|Overall Study|Missing|1
6103160|NCT00249795|21055506|P1|Overall Study|Missing|0
6103161|NCT00249795|21055505|P2|Overall Study|Lost to Follow-up|2
6103162|NCT00249795|21055506|P1|Overall Study|Lost to Follow-up|0
6103163|NCT00249795|21055505|P2|Overall Study|Site not agree to continue after May08|1
6103164|NCT00249795|21055506|P1|Overall Study|Site not agree to continue after May08|1
6103165|NCT00249795|21055505|P2|Overall Study|Patient not wish to continue after May08|6
6103166|NCT00249795|21055506|P1|Overall Study|Patient not wish to continue after May08|4
6103167|NCT00249795|21055505|P2|Overall Study|Event related to cardiac condition|16
6103168|NCT00249795|21055506|P1|Overall Study|Event related to cardiac condition|17
6103169|NCT00249795|21055505|P2|Overall Study|Other contraindicated medication|1
6103170|NCT00249795|21055506|P1|Overall Study|Other contraindicated medication|1
6103171|NCT00249795|21055505|P2|Overall Study|Hypotension (non-symptomatic)|5
6103172|NCT00249795|21055506|P1|Overall Study|Hypotension (non-symptomatic)|5
6103173|NCT00249795|21055505|P2|Overall Study|Lightheadedness / dizziness|11
6103174|NCT00249795|21055506|P1|Overall Study|Lightheadedness / dizziness|15
6103175|NCT00249795|21055505|P2|Overall Study|Angiotensin II receptor blocker required|58
6103176|NCT00249795|21055506|P1|Overall Study|Angiotensin II receptor blocker required|35
6103177|NCT00249795|21055505|P2|Overall Study|Surgery / procedure|5
6103178|NCT00249795|21055506|P1|Overall Study|Surgery / procedure|4
6103179|NCT00249795|21055505|P2|Overall Study|Physician withdrew consent|63
6103180|NCT00249795|21055506|P1|Overall Study|Physician withdrew consent|71
6103181|NCT00249795|21055505|P2|Overall Study|Other adverse events (non-serious)|159
6103182|NCT00249795|21055506|P1|Overall Study|Other adverse events (non-serious)|188
6103183|NCT00249795|21055505|P2|Overall Study|Study drug intolerance|3
6103184|NCT00249795|21055506|P1|Overall Study|Study drug intolerance|3
6103185|NCT00249795|21055505|P2|Overall Study|Non-compliance|69
6103186|NCT00249795|21055506|P1|Overall Study|Non-compliance|71
6103187|NCT00249795|21055505|P2|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|3
6103188|NCT00249795|21055506|P1|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|7
6103189|NCT00249795|21055505|P2|Overall Study|Oral anticoagulant required|0
6103190|NCT00249795|21055506|P1|Overall Study|Oral anticoagulant required|2
6103191|NCT00249795|21055505|P2|Overall Study|Thromboembolic / outcome event|45
6103192|NCT00249795|21055506|P1|Overall Study|Thromboembolic / outcome event|39
6103193|NCT00249795|21055505|P2|Overall Study|Withdrawal by Subject|742
6103194|NCT00249795|21055506|P1|Overall Study|Withdrawal by Subject|678
6103195|NCT00249795|21055505|P2|Overall Study|Qualifying condition not present|29
6103196|NCT00249795|21055506|P1|Overall Study|Qualifying condition not present|26
6103197|NCT00249795|21055505|P2|Overall Study|Other Serious Adverse Event|93
6103198|NCT00249795|21055506|P1|Overall Study|Other Serious Adverse Event|84
6103199|NCT00249795|21055505|P2|Overall Study|Symptomatic hypotension|64
6103200|NCT00249795|21055506|P1|Overall Study|Symptomatic hypotension|127
6103201|NCT00249795|21055505|P2|Overall Study|Not treated|14
6103202|NCT00249795|21055506|P1|Overall Study|Not treated|16
6103203|NCT00249769|21055527|P3|Overall Study|Lost to Follow-up|3
6103204|NCT00249769|21055528|P2|Overall Study|Lost to Follow-up|0
6103205|NCT00249769|21055529|P1|Overall Study|Lost to Follow-up|0
6103206|NCT00249769|21055527|P3|Overall Study|Physician Decision|2
6103207|NCT00249769|21055528|P2|Overall Study|Physician Decision|0
6103208|NCT00249769|21055529|P1|Overall Study|Physician Decision|0
6103209|NCT00249769|21055527|P3|Overall Study|Adverse Event|1
6103210|NCT00249769|21055528|P2|Overall Study|Adverse Event|0
6103211|NCT00249769|21055529|P1|Overall Study|Adverse Event|0
6103212|NCT00249769|21055527|P3|Overall Study|Miscellaneous|2
6103213|NCT00249769|21055528|P2|Overall Study|Miscellaneous|2
6103214|NCT00249769|21055529|P1|Overall Study|Miscellaneous|0
6103215|NCT00249769|21055527|P3|Overall Study|Migration from Study Area|14
6103216|NCT00249769|21055528|P2|Overall Study|Migration from Study Area|3
6103217|NCT00249769|21055529|P1|Overall Study|Migration from Study Area|1
6103218|NCT00249769|21055527|P3|Overall Study|Withdrawal by Subject|6
6103219|NCT00249769|21055528|P2|Overall Study|Withdrawal by Subject|10
6103220|NCT00249769|21055529|P1|Overall Study|Withdrawal by Subject|1
6103221|NCT00249613|21055557|P2|12 Month Follow-up|Lost to Follow-up|8
6103222|NCT00249613|21055558|P1|12 Month Follow-up|Lost to Follow-up|10
6103223|NCT00249613|21055557|P2|12 Month Follow-up|Withdrawal by Subject|6
6103224|NCT00249613|21055558|P1|12 Month Follow-up|Withdrawal by Subject|6
6103225|NCT00249613|21055557|P2|12 Month Follow-up|Death|1
6103226|NCT00249613|21055558|P1|12 Month Follow-up|Death|1
6103227|NCT00249444|21055599|P2|Overall Study|life event|1
6103228|NCT00249444|21055600|P1|Overall Study|life event|0
6103229|NCT00249444|21055599|P2|Overall Study|Adverse Event|1
6103230|NCT00249444|21055600|P1|Overall Study|Adverse Event|1
6103231|NCT00249444|21055599|P2|Overall Study|non-compliant|11
6103232|NCT00249444|21055600|P1|Overall Study|non-compliant|9
6103233|NCT00249444|21055599|P2|Overall Study|Lost to Follow-up|2
6103234|NCT00249444|21055600|P1|Overall Study|Lost to Follow-up|2
6103235|NCT00249288|21055625|P2|Overall Study|Withdrawal by Subject|2
6103236|NCT00249288|21055626|P1|Overall Study|Withdrawal by Subject|2
6103237|NCT00249288|21055625|P2|Overall Study|Lost to Follow-up|3
6103238|NCT00249288|21055626|P1|Overall Study|Lost to Follow-up|3
6103239|NCT00249002|21055718|P1|Overall Study|Other|2
6103240|NCT00249002|21055718|P1|Overall Study|Study cancellation|3
6103241|NCT00249002|21055718|P1|Overall Study|Adverse Event|2
6103242|NCT00248833|21055737|P3|Overall Study|Other|0
6103243|NCT00248833|21055738|P2|Overall Study|Other|1
6103244|NCT00248833|21055739|P1|Overall Study|Other|0
6103245|NCT00248833|21055737|P3|Overall Study|Lost to Follow-up|1
6103246|NCT00248833|21055738|P2|Overall Study|Lost to Follow-up|1
6103247|NCT00248833|21055739|P1|Overall Study|Lost to Follow-up|1
6103248|NCT00248833|21055737|P3|Overall Study|Withdrawal by Subject|1
6103249|NCT00248833|21055738|P2|Overall Study|Withdrawal by Subject|1
6103250|NCT00248833|21055739|P1|Overall Study|Withdrawal by Subject|0
6103251|NCT00248833|21055737|P3|Overall Study|Adverse Event|0
6103252|NCT00248833|21055738|P2|Overall Study|Adverse Event|0
6103253|NCT00248833|21055739|P1|Overall Study|Adverse Event|2
6103254|NCT00248794|21055775|P3|Overall Study|Lost to Follow-up|3
6103255|NCT00248794|21055776|P2|Overall Study|Lost to Follow-up|8
6103256|NCT00248794|21055777|P1|Overall Study|Lost to Follow-up|6
6103257|NCT00248651|21055827|P3|Overall Study|Withdrawal by Subject|32
6103258|NCT00248651|21055828|P2|Overall Study|Withdrawal by Subject|40
6103259|NCT00248651|21055829|P1|Overall Study|Withdrawal by Subject|28
6103260|NCT00248625|21055865|P2|Overall Study|Withdrawal by Subject|2
6103261|NCT00248625|21055866|P1|Overall Study|Withdrawal by Subject|0
6103262|NCT00248495|21055958|P1|Overall Study|Withdrawal by Subject|1
6103263|NCT00248287|21055969|P2|Overall Study|Other|2
6103264|NCT00248287|21055970|P1|Overall Study|Other|3
6103265|NCT00248287|21055969|P2|Overall Study|Patient Request|3
6103266|NCT00248287|21055970|P1|Overall Study|Patient Request|5
6103267|NCT00248287|21055969|P2|Overall Study|Investigator Request|3
6103268|NCT00248287|21055970|P1|Overall Study|Investigator Request|4
6103269|NCT00248287|21055969|P2|Overall Study|Lost to Follow-up|1
6103270|NCT00248287|21055970|P1|Overall Study|Lost to Follow-up|0
6103271|NCT00248287|21055969|P2|Overall Study|Death|0
6103272|NCT00248287|21055970|P1|Overall Study|Death|1
6103273|NCT00248287|21055969|P2|Overall Study|Adverse Event|10
6103274|NCT00248287|21055970|P1|Overall Study|Adverse Event|11
6103275|NCT00248170|21055984|P2|Overall Study|Protocol deviation|19
6103276|NCT00248170|21055985|P1|Overall Study|Protocol deviation|17
6103277|NCT00248170|21055984|P2|Overall Study|Abnormal laboratory values|0
6103278|NCT00248170|21055985|P1|Overall Study|Abnormal laboratory values|4
6103279|NCT00248170|21055984|P2|Overall Study|Abnormal test procedure(s) result|61
6103280|NCT00248170|21055985|P1|Overall Study|Abnormal test procedure(s) result|49
6103281|NCT00248170|21055984|P2|Overall Study|Administrative problems|25
6103282|NCT00248170|21055985|P1|Overall Study|Administrative problems|22
6103283|NCT00248170|21055984|P2|Overall Study|Adverse Event|296
6103284|NCT00248170|21055985|P1|Overall Study|Adverse Event|311
6103285|NCT00248170|21055984|P2|Overall Study|Death|47
6103286|NCT00248170|21055985|P1|Overall Study|Death|28
6103287|NCT00248170|21055984|P2|Overall Study|Disease progression|216
6103288|NCT00248170|21055985|P1|Overall Study|Disease progression|196
6103289|NCT00248170|21055984|P2|Overall Study|Lost to Follow-up|35
6103290|NCT00248170|21055985|P1|Overall Study|Lost to Follow-up|28
6103291|NCT00248170|21055984|P2|Overall Study|Protocol Violation|30
6103292|NCT00248170|21055985|P1|Overall Study|Protocol Violation|35
6103293|NCT00248170|21055984|P2|Overall Study|Withdrawal by Subject|79
6103294|NCT00248170|21055985|P1|Overall Study|Withdrawal by Subject|71
6103295|NCT00248040|21056008|P3|Overall Study|Death|1
6103296|NCT00248040|21056009|P2|Overall Study|Death|0
6103297|NCT00248040|21056010|P1|Overall Study|Death|0
6103298|NCT00248040|21056008|P3|Overall Study|transplant cancelled post treat start|0
6103299|NCT00248040|21056009|P2|Overall Study|transplant cancelled post treat start|0
6103300|NCT00248040|21056010|P1|Overall Study|transplant cancelled post treat start|1
6103301|NCT00248040|21056008|P3|Overall Study|transplantectomy|3
6103302|NCT00248040|21056009|P2|Overall Study|transplantectomy|1
6103303|NCT00248040|21056010|P1|Overall Study|transplantectomy|2
6103304|NCT00247962|21056059|P2|Overall Study|Lack of Efficacy|2
6103305|NCT00247962|21056060|P1|Overall Study|Lack of Efficacy|4
6103306|NCT00247962|21056059|P2|Overall Study|Withdrawal by Subject|2
6103307|NCT00247962|21056060|P1|Overall Study|Withdrawal by Subject|3
6103308|NCT00247962|21056059|P2|Overall Study|Protocol Violation|1
6103309|NCT00247962|21056060|P1|Overall Study|Protocol Violation|1
6103310|NCT00247962|21056059|P2|Overall Study|Physician Decision|1
6103311|NCT00247962|21056060|P1|Overall Study|Physician Decision|0
6103312|NCT00247962|21056059|P2|Overall Study|Lost to Follow-up|1
6103313|NCT00247962|21056060|P1|Overall Study|Lost to Follow-up|3
6103314|NCT00247962|21056059|P2|Overall Study|Adverse Event|12
6103315|NCT00247962|21056060|P1|Overall Study|Adverse Event|15
6103316|NCT00247676|21056087|P1|Overall Study|Withdrawal by Subject|2
6103317|NCT00247676|21056087|P1|Overall Study|Other|3
6103318|NCT00247676|21056087|P1|Overall Study|Lack of Efficacy|15
6103319|NCT00247676|21056087|P1|Overall Study|Adverse Event|11
6103320|NCT00247676|21056087|P1|Overall Study|Death|5
6103321|NCT00247611|21056132|P2|Baselined|Completed baseline only|8
6103322|NCT00247611|21056133|P1|Baselined|Completed baseline only|9
6103323|NCT00247611|21056132|P2|Baselined|Completed baseline, never placed on ARVs|5
6103324|NCT00247611|21056133|P1|Baselined|Completed baseline, never placed on ARVs|8
6103325|NCT00247416|21056151|P2|Overall Study|3 patients were found to be ineligible|2
6103326|NCT00247416|21056152|P1|Overall Study|3 patients were found to be ineligible|1
6103327|NCT00247273|21056193|P2|Overall Study|Did not take any study drug|0
6103328|NCT00247273|21056194|P1|Overall Study|Did not take any study drug|2
6103329|NCT00247273|21056193|P2|Overall Study|Withdrawal by Subject|47
6103330|NCT00247273|21056194|P1|Overall Study|Withdrawal by Subject|46
6103331|NCT00247273|21056193|P2|Overall Study|Lost to Follow-up|7
6103332|NCT00247273|21056194|P1|Overall Study|Lost to Follow-up|7
6103333|NCT00247273|21056193|P2|Overall Study|Physician Decision|3
6103334|NCT00247273|21056194|P1|Overall Study|Physician Decision|6
6103335|NCT00247273|21056193|P2|Overall Study|Adverse Event|80
6103336|NCT00247273|21056194|P1|Overall Study|Adverse Event|85
6103337|NCT00246805|21056240|P2|Phase 1|Lost to Follow-up|0
6103338|NCT00246805|21056241|P1|Phase 1|Lost to Follow-up|1
6103339|NCT00246753|21056247|P1|Overall Study|Unacceptable toxicity|2
6103340|NCT00246753|21056247|P1|Overall Study|Adverse Event|2
6103341|NCT00246753|21056247|P1|Overall Study|Physician Decision|2
6103342|NCT00246753|21056247|P1|Overall Study|Withdrawal by Subject|2
6103343|NCT00246740|21056255|P2|Initial Enrollment|Other|2
6103344|NCT00246740|21056256|P1|Initial Enrollment|Other|1
6103345|NCT00246740|21056255|P2|Initial Enrollment|Surgery schedule change|4
6103346|NCT00246740|21056256|P1|Initial Enrollment|Surgery schedule change|4
6103347|NCT00246740|21056255|P2|Initial Enrollment|Additional surgery scheduled|2
6103348|NCT00246740|21056256|P1|Initial Enrollment|Additional surgery scheduled|0
6103349|NCT00246740|21056255|P2|Initial Enrollment|Death|0
6103350|NCT00246740|21056256|P1|Initial Enrollment|Death|1
6103351|NCT00246571|21056280|P2|Overall Study|Crossover participants|74
6103352|NCT00246571|21056281|P1|Overall Study|Crossover participants|0
6103353|NCT00246571|21056280|P2|Overall Study|Laboratory abnormalities|0
6103354|NCT00246571|21056281|P1|Overall Study|Laboratory abnormalities|1
6103355|NCT00246571|21056280|P2|Overall Study|Did not meet entrance criteria|1
6103356|NCT00246571|21056281|P1|Overall Study|Did not meet entrance criteria|2
6103357|NCT00246571|21056280|P2|Overall Study|Sponsor|1
6103358|NCT00246571|21056281|P1|Overall Study|Sponsor|0
6103359|NCT00246571|21056280|P2|Overall Study|Death|3
6103360|NCT00246571|21056281|P1|Overall Study|Death|17
6103361|NCT00246571|21056280|P2|Overall Study|Lack of Efficacy|21
6103362|NCT00246571|21056281|P1|Overall Study|Lack of Efficacy|84
6103363|NCT00246571|21056280|P2|Overall Study|Withdrawal by Subject|3
6103364|NCT00246571|21056281|P1|Overall Study|Withdrawal by Subject|2
6103365|NCT00246571|21056280|P2|Overall Study|Protocol Violation|1
6103366|NCT00246571|21056281|P1|Overall Study|Protocol Violation|0
6103367|NCT00246571|21056280|P2|Overall Study|Adverse Event|0
6103368|NCT00246571|21056281|P1|Overall Study|Adverse Event|7
6103369|NCT00246376|21056346|P5|Overall Study|Lost to Follow-up|13
6103370|NCT00246376|21056347|P4|Overall Study|Lost to Follow-up|16
6103371|NCT00246376|21056348|P3|Overall Study|Lost to Follow-up|11
6103372|NCT00246376|21056349|P2|Overall Study|Lost to Follow-up|11
6103373|NCT00246376|21056350|P1|Overall Study|Lost to Follow-up|2
6103374|NCT00246376|21056346|P5|Overall Study|Adverse Event|1
6103375|NCT00246376|21056347|P4|Overall Study|Adverse Event|3
6103376|NCT00246376|21056348|P3|Overall Study|Adverse Event|1
6103377|NCT00246376|21056349|P2|Overall Study|Adverse Event|3
6103378|NCT00246376|21056350|P1|Overall Study|Adverse Event|2
6103379|NCT00246376|21056346|P5|Overall Study|Dropped/withdrew during dietary run-in|3
6103380|NCT00246376|21056347|P4|Overall Study|Dropped/withdrew during dietary run-in|7
6103381|NCT00246376|21056348|P3|Overall Study|Dropped/withdrew during dietary run-in|4
6103382|NCT00246376|21056349|P2|Overall Study|Dropped/withdrew during dietary run-in|5
6103383|NCT00246376|21056350|P1|Overall Study|Dropped/withdrew during dietary run-in|11
6103384|NCT00246337|21056401|P9|Overall Study|Reported as completing trial in error|0
6103385|NCT00246337|21056402|P8|Overall Study|Reported as completing trial in error|1
6103386|NCT00246337|21056403|P7|Overall Study|Reported as completing trial in error|0
6103387|NCT00246337|21056404|P6|Overall Study|Reported as completing trial in error|0
6103388|NCT00246337|21056405|P5|Overall Study|Reported as completing trial in error|0
6103389|NCT00246337|21056406|P4|Overall Study|Reported as completing trial in error|0
6103390|NCT00246337|21056407|P3|Overall Study|Reported as completing trial in error|0
6103391|NCT00246337|21056408|P2|Overall Study|Reported as completing trial in error|0
6103392|NCT00246337|21056409|P1|Overall Study|Reported as completing trial in error|0
6103393|NCT00246337|21056401|P9|Overall Study|Protocol Violator|0
6103394|NCT00246337|21056402|P8|Overall Study|Protocol Violator|0
6103395|NCT00246337|21056403|P7|Overall Study|Protocol Violator|0
6103396|NCT00246337|21056404|P6|Overall Study|Protocol Violator|0
6103397|NCT00246337|21056405|P5|Overall Study|Protocol Violator|0
6103398|NCT00246337|21056406|P4|Overall Study|Protocol Violator|0
6103399|NCT00246337|21056407|P3|Overall Study|Protocol Violator|0
6103400|NCT00246337|21056408|P2|Overall Study|Protocol Violator|0
6103401|NCT00246337|21056409|P1|Overall Study|Protocol Violator|1
6103402|NCT00246337|21056401|P9|Overall Study|Overwhelmed|0
6103403|NCT00246337|21056402|P8|Overall Study|Overwhelmed|0
6103404|NCT00246337|21056403|P7|Overall Study|Overwhelmed|0
6103405|NCT00246337|21056404|P6|Overall Study|Overwhelmed|1
6103406|NCT00246337|21056405|P5|Overall Study|Overwhelmed|0
6103407|NCT00246337|21056406|P4|Overall Study|Overwhelmed|0
6103408|NCT00246337|21056407|P3|Overall Study|Overwhelmed|0
6103409|NCT00246337|21056408|P2|Overall Study|Overwhelmed|0
6103410|NCT00246337|21056409|P1|Overall Study|Overwhelmed|0
6103411|NCT00246337|21056401|P9|Overall Study|Abnormal baseline lab values|4
6103412|NCT00246337|21056402|P8|Overall Study|Abnormal baseline lab values|0
6103413|NCT00246337|21056403|P7|Overall Study|Abnormal baseline lab values|2
6103414|NCT00246337|21056404|P6|Overall Study|Abnormal baseline lab values|2
6103415|NCT00246337|21056405|P5|Overall Study|Abnormal baseline lab values|0
6103416|NCT00246337|21056406|P4|Overall Study|Abnormal baseline lab values|0
6103417|NCT00246337|21056407|P3|Overall Study|Abnormal baseline lab values|2
6103418|NCT00246337|21056408|P2|Overall Study|Abnormal baseline lab values|0
6103419|NCT00246337|21056409|P1|Overall Study|Abnormal baseline lab values|7
6103420|NCT00246337|21056401|P9|Overall Study|Site Terminated|2
6103421|NCT00246337|21056402|P8|Overall Study|Site Terminated|6
6103422|NCT00246337|21056403|P7|Overall Study|Site Terminated|1
6103423|NCT00246337|21056404|P6|Overall Study|Site Terminated|7
6103424|NCT00246337|21056405|P5|Overall Study|Site Terminated|0
6103425|NCT00246337|21056406|P4|Overall Study|Site Terminated|0
6103426|NCT00246337|21056407|P3|Overall Study|Site Terminated|0
6103427|NCT00246337|21056408|P2|Overall Study|Site Terminated|0
6103428|NCT00246337|21056409|P1|Overall Study|Site Terminated|10
6103429|NCT00246337|21056401|P9|Overall Study|Lack of Qualifying Event|5
6103430|NCT00246337|21056402|P8|Overall Study|Lack of Qualifying Event|2
6103431|NCT00246337|21056403|P7|Overall Study|Lack of Qualifying Event|3
6103432|NCT00246337|21056404|P6|Overall Study|Lack of Qualifying Event|3
6103433|NCT00246337|21056405|P5|Overall Study|Lack of Qualifying Event|1
6103434|NCT00246337|21056406|P4|Overall Study|Lack of Qualifying Event|1
6103435|NCT00246337|21056407|P3|Overall Study|Lack of Qualifying Event|1
6103436|NCT00246337|21056408|P2|Overall Study|Lack of Qualifying Event|2
6103437|NCT00246337|21056409|P1|Overall Study|Lack of Qualifying Event|8
6103438|NCT00246337|21056401|P9|Overall Study|Withdrawal by Subject|0
6103439|NCT00246337|21056402|P8|Overall Study|Withdrawal by Subject|1
6103440|NCT00246337|21056403|P7|Overall Study|Withdrawal by Subject|1
6103441|NCT00246337|21056404|P6|Overall Study|Withdrawal by Subject|0
6103442|NCT00246337|21056405|P5|Overall Study|Withdrawal by Subject|0
6103443|NCT00246337|21056406|P4|Overall Study|Withdrawal by Subject|0
6103444|NCT00246337|21056407|P3|Overall Study|Withdrawal by Subject|0
6103445|NCT00246337|21056408|P2|Overall Study|Withdrawal by Subject|0
6103446|NCT00246337|21056409|P1|Overall Study|Withdrawal by Subject|2
6103447|NCT00246337|21056401|P9|Overall Study|Protocol Violation|0
6103448|NCT00246337|21056402|P8|Overall Study|Protocol Violation|1
6103449|NCT00246337|21056403|P7|Overall Study|Protocol Violation|1
6103450|NCT00246337|21056404|P6|Overall Study|Protocol Violation|0
6103451|NCT00246337|21056405|P5|Overall Study|Protocol Violation|1
6103452|NCT00246337|21056406|P4|Overall Study|Protocol Violation|0
6103453|NCT00246337|21056407|P3|Overall Study|Protocol Violation|0
6103454|NCT00246337|21056408|P2|Overall Study|Protocol Violation|0
6103455|NCT00246337|21056409|P1|Overall Study|Protocol Violation|1
6103456|NCT00246337|21056401|P9|Overall Study|Lost to Follow-up|0
6103457|NCT00246337|21056402|P8|Overall Study|Lost to Follow-up|2
6103458|NCT00246337|21056403|P7|Overall Study|Lost to Follow-up|1
6103459|NCT00246337|21056404|P6|Overall Study|Lost to Follow-up|2
6103460|NCT00246337|21056405|P5|Overall Study|Lost to Follow-up|2
6103461|NCT00246337|21056406|P4|Overall Study|Lost to Follow-up|0
6103462|NCT00246337|21056407|P3|Overall Study|Lost to Follow-up|0
6103463|NCT00246337|21056408|P2|Overall Study|Lost to Follow-up|0
6103464|NCT00246337|21056409|P1|Overall Study|Lost to Follow-up|3
6103465|NCT00246324|21056456|P1|Overall Study|Withdrawal by Subject|1
6103466|NCT00246259|21056463|P2|Overall Study|randomly assigned, not eligible for ITT|6
6103467|NCT00246259|21056464|P1|Overall Study|randomly assigned, not eligible for ITT|2
6103468|NCT00246259|21056463|P2|Overall Study|Withdrawal by Subject|1
6103469|NCT00246259|21056464|P1|Overall Study|Withdrawal by Subject|5
6103470|NCT00246259|21056463|P2|Overall Study|Lost to Follow-up|4
6103471|NCT00246259|21056464|P1|Overall Study|Lost to Follow-up|3
6103472|NCT00246259|21056463|P2|Overall Study|Adverse Event|0
6103473|NCT00246259|21056464|P1|Overall Study|Adverse Event|5
6103474|NCT00246259|21056463|P2|Overall Study|Investigator withdrew participant|0
6103475|NCT00246259|21056464|P1|Overall Study|Investigator withdrew participant|2
6103476|NCT00246259|21056463|P2|Overall Study|Lack of Efficacy|2
6103477|NCT00246259|21056464|P1|Overall Study|Lack of Efficacy|2
6103478|NCT00246259|21056463|P2|Overall Study|Participant non-compliant|9
6103479|NCT00246259|21056464|P1|Overall Study|Participant non-compliant|4
6103480|NCT00246259|21056463|P2|Overall Study|Not stable by Week 18|1
6103481|NCT00246259|21056464|P1|Overall Study|Not stable by Week 18|2
6103482|NCT00246259|21056463|P2|Overall Study|Other|3
6103483|NCT00246259|21056464|P1|Overall Study|Other|3
6103484|NCT00246090|21056498|P1|Overall Study|Not Otherwise Specified|10
6103485|NCT00246090|21056498|P1|Overall Study|Physician Decision|11
6103486|NCT00246090|21056498|P1|Overall Study|Clinical Progression|30
6103487|NCT00246090|21056498|P1|Overall Study|Progressive Disease|212
6103488|NCT00246090|21056498|P1|Overall Study|Withdrawal by Subject|7
6103489|NCT00246090|21056498|P1|Overall Study|Adverse Event|25
6103490|NCT00246025|21056507|P4|Overall Study|unsuitable medical history was found|1
6103491|NCT00246025|21056508|P3|Overall Study|unsuitable medical history was found|0
6103492|NCT00246025|21056509|P2|Overall Study|unsuitable medical history was found|0
6103493|NCT00246025|21056510|P1|Overall Study|unsuitable medical history was found|0
6103494|NCT00246025|21056507|P4|Overall Study|Withdrawal by Subject|2
6103495|NCT00246025|21056508|P3|Overall Study|Withdrawal by Subject|1
6103496|NCT00246025|21056509|P2|Overall Study|Withdrawal by Subject|0
6103497|NCT00246025|21056510|P1|Overall Study|Withdrawal by Subject|3
6103498|NCT00246025|21056507|P4|Overall Study|Adverse Event|10
6103499|NCT00246025|21056508|P3|Overall Study|Adverse Event|9
6103500|NCT00246025|21056509|P2|Overall Study|Adverse Event|9
6103501|NCT00246025|21056510|P1|Overall Study|Adverse Event|7
6103502|NCT00246012|21056569|P9|Overall Study|Randomly assigned but not treated|0
6103503|NCT00246012|21056570|P8|Overall Study|Randomly assigned but not treated|0
6103504|NCT00246012|21056571|P7|Overall Study|Randomly assigned but not treated|1
6103505|NCT00246012|21056572|P6|Overall Study|Randomly assigned but not treated|1
6103506|NCT00246012|21056573|P5|Overall Study|Randomly assigned but not treated|0
6103507|NCT00246012|21056574|P4|Overall Study|Randomly assigned but not treated|0
6103508|NCT00246012|21056575|P3|Overall Study|Randomly assigned but not treated|0
6103509|NCT00246012|21056576|P2|Overall Study|Randomly assigned but not treated|0
6103510|NCT00246012|21056577|P1|Overall Study|Randomly assigned but not treated|0
6103511|NCT00246012|21056569|P9|Overall Study|Other|0
6103512|NCT00246012|21056570|P8|Overall Study|Other|1
6103513|NCT00246012|21056571|P7|Overall Study|Other|0
6103514|NCT00246012|21056572|P6|Overall Study|Other|0
6103515|NCT00246012|21056573|P5|Overall Study|Other|0
6103516|NCT00246012|21056574|P4|Overall Study|Other|0
6103517|NCT00246012|21056575|P3|Overall Study|Other|0
6103518|NCT00246012|21056576|P2|Overall Study|Other|0
6103519|NCT00246012|21056577|P1|Overall Study|Other|0
6103520|NCT00246012|21056569|P9|Overall Study|Disease progression|26
6103521|NCT00246012|21056570|P8|Overall Study|Disease progression|27
6103522|NCT00246012|21056571|P7|Overall Study|Disease progression|30
6103523|NCT00246012|21056572|P6|Overall Study|Disease progression|25
6103524|NCT00246012|21056573|P5|Overall Study|Disease progression|3
6103525|NCT00246012|21056574|P4|Overall Study|Disease progression|3
6103526|NCT00246012|21056575|P3|Overall Study|Disease progression|2
6103527|NCT00246012|21056576|P2|Overall Study|Disease progression|1
6103528|NCT00246012|21056577|P1|Overall Study|Disease progression|3
6103529|NCT00246012|21056569|P9|Overall Study|Withdrawal by Subject|0
6103530|NCT00246012|21056570|P8|Overall Study|Withdrawal by Subject|0
6103531|NCT00246012|21056571|P7|Overall Study|Withdrawal by Subject|0
6103532|NCT00246012|21056572|P6|Overall Study|Withdrawal by Subject|1
6103533|NCT00246012|21056573|P5|Overall Study|Withdrawal by Subject|0
6103534|NCT00246012|21056574|P4|Overall Study|Withdrawal by Subject|0
6103535|NCT00246012|21056575|P3|Overall Study|Withdrawal by Subject|0
6103536|NCT00246012|21056576|P2|Overall Study|Withdrawal by Subject|0
6103537|NCT00246012|21056577|P1|Overall Study|Withdrawal by Subject|0
6103538|NCT00246012|21056569|P9|Overall Study|Adverse Event|2
6103539|NCT00246012|21056570|P8|Overall Study|Adverse Event|0
6103540|NCT00246012|21056571|P7|Overall Study|Adverse Event|0
6103541|NCT00246012|21056572|P6|Overall Study|Adverse Event|1
6103542|NCT00246012|21056573|P5|Overall Study|Adverse Event|0
6103543|NCT00246012|21056574|P4|Overall Study|Adverse Event|0
6103544|NCT00246012|21056575|P3|Overall Study|Adverse Event|0
6103545|NCT00246012|21056576|P2|Overall Study|Adverse Event|0
6103546|NCT00246012|21056577|P1|Overall Study|Adverse Event|0
6103547|NCT00245960|21056672|P2|Overall Study|Lack of Efficacy|6
6103548|NCT00245960|21056673|P1|Overall Study|Lack of Efficacy|4
6103549|NCT00245960|21056672|P2|Overall Study|Withdrawal by Subject|7
6103550|NCT00245960|21056673|P1|Overall Study|Withdrawal by Subject|5
6103551|NCT00245960|21056672|P2|Overall Study|Protocol Violation|3
6103552|NCT00245960|21056673|P1|Overall Study|Protocol Violation|4
6103553|NCT00245960|21056672|P2|Overall Study|Lost to Follow-up|2
6103554|NCT00245960|21056673|P1|Overall Study|Lost to Follow-up|2
6103555|NCT00245960|21056672|P2|Overall Study|Adverse Event|10
6103556|NCT00245960|21056673|P1|Overall Study|Adverse Event|14
6103557|NCT00245856|21056681|P2|Period Two|Withdrawal by Subject|1
6103558|NCT00245856|21056682|P1|Period Two|Withdrawal by Subject|0
6103559|NCT00245765|21056692|P3|Overall Study|Other|4
6103560|NCT00245765|21056693|P2|Overall Study|Other|4
6103561|NCT00245765|21056694|P1|Overall Study|Other|13
6103562|NCT00245765|21056692|P3|Overall Study|Other reason|1
6103563|NCT00245765|21056693|P2|Overall Study|Other reason|0
6103564|NCT00245765|21056694|P1|Overall Study|Other reason|2
6103565|NCT00245765|21056692|P3|Overall Study|Withdrawal by Subject|3
6103566|NCT00245765|21056693|P2|Overall Study|Withdrawal by Subject|0
6103567|NCT00245765|21056694|P1|Overall Study|Withdrawal by Subject|1
6103568|NCT00245765|21056692|P3|Overall Study|Lost to Follow-up|0
6103569|NCT00245765|21056693|P2|Overall Study|Lost to Follow-up|2
6103570|NCT00245765|21056694|P1|Overall Study|Lost to Follow-up|1
6103571|NCT00245765|21056692|P3|Overall Study|Lack of Efficacy|0
6103572|NCT00245765|21056693|P2|Overall Study|Lack of Efficacy|7
6103573|NCT00245765|21056694|P1|Overall Study|Lack of Efficacy|14
6103574|NCT00245765|21056692|P3|Overall Study|Adverse Event|0
6103575|NCT00245765|21056693|P2|Overall Study|Adverse Event|1
6103576|NCT00245765|21056694|P1|Overall Study|Adverse Event|1
6103577|NCT00245583|21056743|P2|Overall Study|Withdrawal by Subject|3
6103578|NCT00245583|21056744|P1|Overall Study|Withdrawal by Subject|2
6103579|NCT00245583|21056743|P2|Overall Study|Lack of Efficacy|0
6103580|NCT00245583|21056744|P1|Overall Study|Lack of Efficacy|1
6103581|NCT00245583|21056743|P2|Overall Study|Adverse Event|1
6103582|NCT00245583|21056744|P1|Overall Study|Adverse Event|2
6103583|NCT00245583|21056743|P2|Overall Study|Lost to Follow-up|5
6103584|NCT00245583|21056744|P1|Overall Study|Lost to Follow-up|1
6103585|NCT00245570|21056764|P6|Washout Between Periods III and IV|Adverse Event|0
6103586|NCT00245570|21056765|P5|Washout Between Periods III and IV|Adverse Event|0
6103587|NCT00245570|21056766|P4|Washout Between Periods III and IV|Adverse Event|0
6103588|NCT00245570|21056767|P3|Washout Between Periods III and IV|Adverse Event|0
6103589|NCT00245570|21056768|P2|Washout Between Periods III and IV|Adverse Event|1
6103590|NCT00245570|21056769|P1|Washout Between Periods III and IV|Adverse Event|0
6103591|NCT00245466|21056903|P3|Overall Study|Administrative reasons|0
6103592|NCT00245466|21056904|P2|Overall Study|Administrative reasons|1
6103593|NCT00245466|21056905|P1|Overall Study|Administrative reasons|0
6103594|NCT00245466|21056903|P3|Overall Study|Death|0
6103595|NCT00245466|21056904|P2|Overall Study|Death|2
6103596|NCT00245466|21056905|P1|Overall Study|Death|0
6103597|NCT00245466|21056903|P3|Overall Study|Protocol Violation|2
6103598|NCT00245466|21056904|P2|Overall Study|Protocol Violation|2
6103599|NCT00245466|21056905|P1|Overall Study|Protocol Violation|1
6103600|NCT00245466|21056903|P3|Overall Study|Disease progression|1
6103601|NCT00245466|21056904|P2|Overall Study|Disease progression|3
6103602|NCT00245466|21056905|P1|Overall Study|Disease progression|0
6103603|NCT00245466|21056903|P3|Overall Study|Lost to Follow-up|0
6103604|NCT00245466|21056904|P2|Overall Study|Lost to Follow-up|0
6103605|NCT00245466|21056905|P1|Overall Study|Lost to Follow-up|3
6103606|NCT00245466|21056903|P3|Overall Study|Withdrawal by Subject|1
6103607|NCT00245466|21056904|P2|Overall Study|Withdrawal by Subject|2
6103608|NCT00245466|21056905|P1|Overall Study|Withdrawal by Subject|2
6103609|NCT00245466|21056903|P3|Overall Study|Insufficient PSA and testosterone suppr|3
6103610|NCT00245466|21056904|P2|Overall Study|Insufficient PSA and testosterone suppr|0
6103611|NCT00245466|21056905|P1|Overall Study|Insufficient PSA and testosterone suppr|0
6103612|NCT00245466|21056903|P3|Overall Study|Insufficient testosterone suppr|21
6103613|NCT00245466|21056904|P2|Overall Study|Insufficient testosterone suppr|12
6103614|NCT00245466|21056905|P1|Overall Study|Insufficient testosterone suppr|12
6103615|NCT00245466|21056903|P3|Overall Study|Low prostate specific antigen suppr|5
6103616|NCT00245466|21056904|P2|Overall Study|Low prostate specific antigen suppr|14
6103617|NCT00245466|21056905|P1|Overall Study|Low prostate specific antigen suppr|16
6103618|NCT00245466|21056903|P3|Overall Study|Adverse Event|4
6103619|NCT00245466|21056904|P2|Overall Study|Adverse Event|8
6103620|NCT00245466|21056905|P1|Overall Study|Adverse Event|2
6103621|NCT00245102|21056948|P6|Overall Study|Clinical progression|0
6103622|NCT00245102|21056949|P5|Overall Study|Clinical progression|0
6103623|NCT00245102|21056950|P4|Overall Study|Clinical progression|0
6103624|NCT00245102|21056951|P3|Overall Study|Clinical progression|0
6103625|NCT00245102|21056952|P2|Overall Study|Clinical progression|0
6103626|NCT00245102|21056953|P1|Overall Study|Clinical progression|1
6103627|NCT00245102|21056948|P6|Overall Study|Participant needed surgery|0
6103628|NCT00245102|21056949|P5|Overall Study|Participant needed surgery|0
6103629|NCT00245102|21056950|P4|Overall Study|Participant needed surgery|0
6103630|NCT00245102|21056951|P3|Overall Study|Participant needed surgery|1
6103631|NCT00245102|21056952|P2|Overall Study|Participant needed surgery|0
6103632|NCT00245102|21056953|P1|Overall Study|Participant needed surgery|0
6103633|NCT00245102|21056948|P6|Overall Study|Decline in performance|2
6103634|NCT00245102|21056949|P5|Overall Study|Decline in performance|0
6103635|NCT00245102|21056950|P4|Overall Study|Decline in performance|1
6103636|NCT00245102|21056951|P3|Overall Study|Decline in performance|0
6103637|NCT00245102|21056952|P2|Overall Study|Decline in performance|2
6103638|NCT00245102|21056953|P1|Overall Study|Decline in performance|0
6103639|NCT00245102|21056948|P6|Overall Study|Adverse Event|2
6103640|NCT00245102|21056949|P5|Overall Study|Adverse Event|0
6103641|NCT00245102|21056950|P4|Overall Study|Adverse Event|1
6103642|NCT00245102|21056951|P3|Overall Study|Adverse Event|5
6103643|NCT00245102|21056952|P2|Overall Study|Adverse Event|2
6103644|NCT00245102|21056953|P1|Overall Study|Adverse Event|4
6103645|NCT00245102|21056948|P6|Overall Study|Death|0
6103646|NCT00245102|21056949|P5|Overall Study|Death|0
6103647|NCT00245102|21056950|P4|Overall Study|Death|1
6103648|NCT00245102|21056951|P3|Overall Study|Death|0
6103649|NCT00245102|21056952|P2|Overall Study|Death|0
6103650|NCT00245102|21056953|P1|Overall Study|Death|0
6103651|NCT00245102|21056948|P6|Overall Study|Protocol Violation|0
6103652|NCT00245102|21056949|P5|Overall Study|Protocol Violation|0
6103653|NCT00245102|21056950|P4|Overall Study|Protocol Violation|0
6103654|NCT00245102|21056951|P3|Overall Study|Protocol Violation|0
6103655|NCT00245102|21056952|P2|Overall Study|Protocol Violation|0
6103656|NCT00245102|21056953|P1|Overall Study|Protocol Violation|1
6103657|NCT00245102|21056948|P6|Overall Study|Not Treated|0
6103658|NCT00245102|21056949|P5|Overall Study|Not Treated|0
6103659|NCT00245102|21056950|P4|Overall Study|Not Treated|0
6103660|NCT00245102|21056951|P3|Overall Study|Not Treated|1
6103661|NCT00245102|21056952|P2|Overall Study|Not Treated|0
6103662|NCT00245102|21056953|P1|Overall Study|Not Treated|1
6103663|NCT00245063|21056969|P2|Overall Study|Death|0
6103664|NCT00245063|21056970|P1|Overall Study|Death|1
6103665|NCT00245063|21056969|P2|Overall Study|Adverse Event|5
6103666|NCT00245063|21056970|P1|Overall Study|Adverse Event|6
6103667|NCT00245050|21056978|P2|Overall Study|Adverse Event|2
6103668|NCT00245050|21056979|P1|Overall Study|Adverse Event|3
6103669|NCT00245037|21056987|P1|Overall Study|Death|17
6103670|NCT00245011|21056997|P1|Overall Study|Lack of Efficacy|1
6103672|NCT00244881|21057018|P1|Overall Study|Withdrawal by Subject|3
6103673|NCT00244855|21057026|P2|Overall Study|Withdrawal by Subject|1
6103674|NCT00244855|21057027|P1|Overall Study|Withdrawal by Subject|0
6103675|NCT00244764|21057035|P1|Overall Study|Developed Secondary Malignancy|1
6103676|NCT00244764|21057035|P1|Overall Study|Sponsor Terminated Study|2
6103677|NCT00244764|21057035|P1|Overall Study|Primary Investigator Discretion|2
6103678|NCT00244764|21057035|P1|Overall Study|Participant was Hospitalized until Death|1
6103679|NCT00244764|21057035|P1|Overall Study|Declining Performance Status|1
6103680|NCT00244764|21057035|P1|Overall Study|Off Study Medication for >21 Days|1
6103681|NCT00244764|21057035|P1|Overall Study|Death|1
6103682|NCT00244764|21057035|P1|Overall Study|Protocol Violation|2
6103683|NCT00244764|21057035|P1|Overall Study|Disease Progression|13
6103684|NCT00244764|21057035|P1|Overall Study|Withdrawal by Subject|12
6103685|NCT00244764|21057035|P1|Overall Study|Lost to Follow-up|23
6103686|NCT00244764|21057035|P1|Overall Study|Adverse Event|37
6103687|NCT00244751|21057045|P3|Overall Study|Participant randomized by mistake|1
6103688|NCT00244751|21057046|P2|Overall Study|Participant randomized by mistake|0
6103689|NCT00244751|21057047|P1|Overall Study|Participant randomized by mistake|0
6103690|NCT00244751|21057045|P3|Overall Study|Safety reasons|0
6103691|NCT00244751|21057046|P2|Overall Study|Safety reasons|1
6103692|NCT00244751|21057047|P1|Overall Study|Safety reasons|0
6103693|NCT00244751|21057045|P3|Overall Study|Lack of compliance with protocol|0
6103694|NCT00244751|21057046|P2|Overall Study|Lack of compliance with protocol|1
6103695|NCT00244751|21057047|P1|Overall Study|Lack of compliance with protocol|0
6103696|NCT00244751|21057045|P3|Overall Study|Elevated liver enzymes|0
6103697|NCT00244751|21057046|P2|Overall Study|Elevated liver enzymes|0
6103698|NCT00244751|21057047|P1|Overall Study|Elevated liver enzymes|1
6103699|NCT00244751|21057045|P3|Overall Study|Withdrawal by Subject|3
6103700|NCT00244751|21057046|P2|Overall Study|Withdrawal by Subject|5
6103701|NCT00244751|21057047|P1|Overall Study|Withdrawal by Subject|7
6103702|NCT00244751|21057045|P3|Overall Study|Protocol Violation|1
6103703|NCT00244751|21057046|P2|Overall Study|Protocol Violation|0
6103704|NCT00244751|21057047|P1|Overall Study|Protocol Violation|1
6103705|NCT00244751|21057045|P3|Overall Study|Lost to Follow-up|0
6103706|NCT00244751|21057046|P2|Overall Study|Lost to Follow-up|1
6103707|NCT00244751|21057047|P1|Overall Study|Lost to Follow-up|0
6103708|NCT00244751|21057045|P3|Overall Study|Adverse Event|5
6103709|NCT00244751|21057046|P2|Overall Study|Adverse Event|7
6103710|NCT00244751|21057047|P1|Overall Study|Adverse Event|7
6103711|NCT00244725|21057148|P4|Overall Study|Failed to follow-up|1
6103712|NCT00244725|21057149|P3|Overall Study|Failed to follow-up|1
6103713|NCT00244725|21057150|P2|Overall Study|Failed to follow-up|0
6103714|NCT00244725|21057151|P1|Overall Study|Failed to follow-up|0
6103715|NCT00244725|21057148|P4|Overall Study|Vomit|0
6103716|NCT00244725|21057149|P3|Overall Study|Vomit|1
6103717|NCT00244725|21057150|P2|Overall Study|Vomit|0
6103718|NCT00244725|21057151|P1|Overall Study|Vomit|0
6103719|NCT00244725|21057148|P4|Overall Study|Administrative reason|0
6103720|NCT00244725|21057149|P3|Overall Study|Administrative reason|1
6103721|NCT00244725|21057150|P2|Overall Study|Administrative reason|0
6103722|NCT00244725|21057151|P1|Overall Study|Administrative reason|0
6103723|NCT00244725|21057148|P4|Overall Study|Confirmed venous thromboembolism (VTE)|0
6103724|NCT00244725|21057149|P3|Overall Study|Confirmed venous thromboembolism (VTE)|0
6103725|NCT00244725|21057150|P2|Overall Study|Confirmed venous thromboembolism (VTE)|1
6103726|NCT00244725|21057151|P1|Overall Study|Confirmed venous thromboembolism (VTE)|0
6103727|NCT00244725|21057148|P4|Overall Study|Received prohibited medication|1
6103728|NCT00244725|21057149|P3|Overall Study|Received prohibited medication|0
6103729|NCT00244725|21057150|P2|Overall Study|Received prohibited medication|1
6103730|NCT00244725|21057151|P1|Overall Study|Received prohibited medication|0
6103731|NCT00244725|21057148|P4|Overall Study|Headache|0
6103732|NCT00244725|21057149|P3|Overall Study|Headache|0
6103733|NCT00244725|21057150|P2|Overall Study|Headache|1
6103734|NCT00244725|21057151|P1|Overall Study|Headache|0
6103735|NCT00244725|21057148|P4|Overall Study|Rehab Refused to allow participantion|0
6103736|NCT00244725|21057149|P3|Overall Study|Rehab Refused to allow participantion|0
6103737|NCT00244725|21057150|P2|Overall Study|Rehab Refused to allow participantion|1
6103738|NCT00244725|21057151|P1|Overall Study|Rehab Refused to allow participantion|0
6103739|NCT00244725|21057148|P4|Overall Study|Mediciation Error|0
6103740|NCT00244725|21057149|P3|Overall Study|Mediciation Error|0
6103741|NCT00244725|21057150|P2|Overall Study|Mediciation Error|1
6103742|NCT00244725|21057151|P1|Overall Study|Mediciation Error|0
6103743|NCT00244725|21057148|P4|Overall Study|Sponsor withdrew the participant|1
6103744|NCT00244725|21057149|P3|Overall Study|Sponsor withdrew the participant|0
6103745|NCT00244725|21057150|P2|Overall Study|Sponsor withdrew the participant|0
6103746|NCT00244725|21057151|P1|Overall Study|Sponsor withdrew the participant|1
6103747|NCT00244725|21057148|P4|Overall Study|Liver function test abnormality|1
6103748|NCT00244725|21057149|P3|Overall Study|Liver function test abnormality|0
6103749|NCT00244725|21057150|P2|Overall Study|Liver function test abnormality|0
6103750|NCT00244725|21057151|P1|Overall Study|Liver function test abnormality|2
6103751|NCT00244725|21057148|P4|Overall Study|Withdrwal by participant|1
6103752|NCT00244725|21057149|P3|Overall Study|Withdrwal by participant|0
6103753|NCT00244725|21057150|P2|Overall Study|Withdrwal by participant|0
6103754|NCT00244725|21057151|P1|Overall Study|Withdrwal by participant|1
6103755|NCT00244725|21057148|P4|Overall Study|Adverse Events|4
6103756|NCT00244725|21057149|P3|Overall Study|Adverse Events|4
6103757|NCT00244725|21057150|P2|Overall Study|Adverse Events|1
6103758|NCT00244725|21057151|P1|Overall Study|Adverse Events|3
6103759|NCT00244725|21057148|P4|Overall Study|Physician Decision|2
6103760|NCT00244725|21057149|P3|Overall Study|Physician Decision|1
6103761|NCT00244725|21057150|P2|Overall Study|Physician Decision|0
6103762|NCT00244725|21057151|P1|Overall Study|Physician Decision|3
6103763|NCT00244725|21057148|P4|Overall Study|Not meet treatment eligibility criteria|0
6103764|NCT00244725|21057149|P3|Overall Study|Not meet treatment eligibility criteria|0
6103765|NCT00244725|21057150|P2|Overall Study|Not meet treatment eligibility criteria|2
6103766|NCT00244725|21057151|P1|Overall Study|Not meet treatment eligibility criteria|1
6103767|NCT00244725|21057148|P4|Overall Study|Withdrawal by Subject|8
6103768|NCT00244725|21057149|P3|Overall Study|Withdrawal by Subject|7
6103769|NCT00244725|21057150|P2|Overall Study|Withdrawal by Subject|7
6103770|NCT00244725|21057151|P1|Overall Study|Withdrawal by Subject|9
6103771|NCT00244725|21057148|P4|Overall Study|Lost to Follow-up|2
6103772|NCT00244725|21057149|P3|Overall Study|Lost to Follow-up|9
6103773|NCT00244725|21057150|P2|Overall Study|Lost to Follow-up|4
6103774|NCT00244725|21057151|P1|Overall Study|Lost to Follow-up|3
6103775|NCT00244712|21057207|P2|Overall Study|Protocol Violation, disease progression|11
6103776|NCT00244712|21057208|P1|Overall Study|Protocol Violation, disease progression|13
6103777|NCT00244712|21057207|P2|Overall Study|Withdrawal by Subject|23
6103778|NCT00244712|21057208|P1|Overall Study|Withdrawal by Subject|13
6103779|NCT00244712|21057207|P2|Overall Study|Lost to Follow-up|52
6103780|NCT00244712|21057208|P1|Overall Study|Lost to Follow-up|45
6103781|NCT00244712|21057207|P2|Overall Study|Lack of Compliance|11
6103782|NCT00244712|21057208|P1|Overall Study|Lack of Compliance|10
6103783|NCT00244712|21057207|P2|Overall Study|Protocol-Defined Virologic Failure|6
6103784|NCT00244712|21057208|P1|Overall Study|Protocol-Defined Virologic Failure|8
6103785|NCT00244712|21057207|P2|Overall Study|Adverse Event|21
6103786|NCT00244712|21057208|P1|Overall Study|Adverse Event|20
6103787|NCT00244621|21057243|P3|Open-label Treatment Period|Moved abroad|1
6103788|NCT00244621|21057244|P2|Open-label Treatment Period|Moved abroad|0
6103789|NCT00244621|21057245|P1|Open-label Treatment Period|Moved abroad|0
6103790|NCT00244621|21057243|P3|Open-label Treatment Period|Adverse Event|1
6103791|NCT00244621|21057244|P2|Open-label Treatment Period|Adverse Event|0
6103792|NCT00244621|21057245|P1|Open-label Treatment Period|Adverse Event|0
6103793|NCT00244621|21057243|P3|Open-label Treatment Period|Withdrawal by Subject|0
6103794|NCT00244621|21057244|P2|Open-label Treatment Period|Withdrawal by Subject|0
6103795|NCT00244621|21057245|P1|Open-label Treatment Period|Withdrawal by Subject|1
6103796|NCT00244621|21057243|P3|Open-label Treatment Period|Lost to Follow-up|0
6103797|NCT00244621|21057244|P2|Open-label Treatment Period|Lost to Follow-up|1
6103798|NCT00244621|21057245|P1|Open-label Treatment Period|Lost to Follow-up|0
6103799|NCT00244621|21057243|P3|Double-blind Treatment Period|Multiple Reasons|1
6103800|NCT00244621|21057244|P2|Double-blind Treatment Period|Multiple Reasons|1
6103801|NCT00244621|21057245|P1|Double-blind Treatment Period|Multiple Reasons|2
6103802|NCT00244621|21057243|P3|Double-blind Treatment Period|Lack of Efficacy|0
6103803|NCT00244621|21057244|P2|Double-blind Treatment Period|Lack of Efficacy|1
6103804|NCT00244621|21057245|P1|Double-blind Treatment Period|Lack of Efficacy|0
6103805|NCT00244621|21057243|P3|Double-blind Treatment Period|Withdrawal by Subject|0
6103806|NCT00244621|21057244|P2|Double-blind Treatment Period|Withdrawal by Subject|1
6103807|NCT00244621|21057245|P1|Double-blind Treatment Period|Withdrawal by Subject|0
6103808|NCT00244621|21057243|P3|Double-blind Treatment Period|Lost to Follow-up|1
6103809|NCT00244621|21057244|P2|Double-blind Treatment Period|Lost to Follow-up|0
6103810|NCT00244621|21057245|P1|Double-blind Treatment Period|Lost to Follow-up|0
6103811|NCT00244374|21057262|P5|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0
6103812|NCT00244374|21057263|P4|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0
6103813|NCT00244374|21057264|P3|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0
6103814|NCT00244374|21057265|P2|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0
6103815|NCT00244374|21057266|P1|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|12
6103816|NCT00244374|21057262|P5|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0
6103817|NCT00244374|21057263|P4|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0
6103818|NCT00244374|21057264|P3|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0
6103819|NCT00244374|21057265|P2|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0
6103820|NCT00244374|21057266|P1|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|4
6103821|NCT00244374|21057262|P5|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0
6103822|NCT00244374|21057263|P4|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0
6103823|NCT00244374|21057264|P3|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0
6103824|NCT00244374|21057265|P2|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0
6103825|NCT00244374|21057266|P1|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|34
6103826|NCT00244374|21057262|P5|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0
6103827|NCT00244374|21057263|P4|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0
6103828|NCT00244374|21057264|P3|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0
6103829|NCT00244374|21057265|P2|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0
6103830|NCT00244374|21057266|P1|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|51
6103831|NCT00244374|21057262|P5|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0
6103832|NCT00244374|21057263|P4|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0
6103833|NCT00244374|21057264|P3|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0
6103834|NCT00244374|21057265|P2|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0
6103835|NCT00244374|21057266|P1|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|172
6103836|NCT00244374|21057262|P5|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0
6103837|NCT00244374|21057263|P4|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0
6103838|NCT00244374|21057264|P3|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0
6103839|NCT00244374|21057265|P2|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0
6103840|NCT00244374|21057266|P1|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|1
6103841|NCT00244374|21057262|P5|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0
6103842|NCT00244374|21057263|P4|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0
6103843|NCT00244374|21057264|P3|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0
6103844|NCT00244374|21057265|P2|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0
6103845|NCT00244374|21057266|P1|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|14
6103846|NCT00244374|21057262|P5|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0
6103847|NCT00244374|21057263|P4|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0
6103848|NCT00244374|21057264|P3|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0
6103849|NCT00244374|21057265|P2|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0
6103850|NCT00244374|21057266|P1|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|17
6103851|NCT00244374|21057262|P5|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0
6103852|NCT00244374|21057263|P4|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0
6103853|NCT00244374|21057264|P3|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0
6103854|NCT00244374|21057265|P2|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0
6103855|NCT00244374|21057266|P1|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|105
6103856|NCT00243932|21057322|P3|Stage 1: Dose Selection|Lost to Follow-up|0
6103857|NCT00243932|21057323|P2|Stage 1: Dose Selection|Lost to Follow-up|0
6103858|NCT00243932|21057324|P1|Stage 1: Dose Selection|Lost to Follow-up|2
6103859|NCT00243919|21057335|P3|Overall Study|Physician Decision|0
6103860|NCT00243919|21057336|P2|Overall Study|Physician Decision|1
6103861|NCT00243919|21057337|P1|Overall Study|Physician Decision|1
6103862|NCT00243919|21057335|P3|Overall Study|Administrative Error|0
6103863|NCT00243919|21057336|P2|Overall Study|Administrative Error|0
6103864|NCT00243919|21057337|P1|Overall Study|Administrative Error|1
6103865|NCT00243919|21057335|P3|Overall Study|Lost to Follow-up|3
6103866|NCT00243919|21057336|P2|Overall Study|Lost to Follow-up|7
6103867|NCT00243919|21057337|P1|Overall Study|Lost to Follow-up|6
6103868|NCT00243919|21057335|P3|Overall Study|Withdrawal by Subject|2
6103869|NCT00243919|21057336|P2|Overall Study|Withdrawal by Subject|6
6103870|NCT00243919|21057337|P1|Overall Study|Withdrawal by Subject|6
6103871|NCT00243919|21057335|P3|Overall Study|Death|6
6103872|NCT00243919|21057336|P2|Overall Study|Death|4
6103873|NCT00243919|21057337|P1|Overall Study|Death|3
6103874|NCT00243841|21057381|P6|Overall Study|Physician Decision|2
6103875|NCT00243841|21057382|P5|Overall Study|Physician Decision|0
6103876|NCT00243841|21057383|P4|Overall Study|Physician Decision|0
6103877|NCT00243841|21057384|P3|Overall Study|Physician Decision|1
6103878|NCT00243841|21057385|P2|Overall Study|Physician Decision|0
6103879|NCT00243841|21057386|P1|Overall Study|Physician Decision|0
6103880|NCT00243659|21057408|P2|Overall Study|Protocol Violation|2
6103881|NCT00243659|21057409|P1|Overall Study|Protocol Violation|1
6103882|NCT00243659|21057408|P2|Overall Study|Withdrawal by Subject|1
6103883|NCT00243659|21057409|P1|Overall Study|Withdrawal by Subject|1
6103884|NCT00243503|21057417|P1|Overall Study|Other|1
6103885|NCT00243503|21057417|P1|Overall Study|Death|1
6103886|NCT00243503|21057417|P1|Overall Study|Lack of Efficacy|44
6103887|NCT00243503|21057417|P1|Overall Study|Withdrawal by Subject|1
6103888|NCT00243503|21057417|P1|Overall Study|Adverse Event|11
6103889|NCT00243412|21057434|P2|Overall Study|Other|1
6103890|NCT00243412|21057435|P1|Overall Study|Other|1
6103891|NCT00243412|21057434|P2|Overall Study|Withdrawal by Subject|5
6103892|NCT00243412|21057435|P1|Overall Study|Withdrawal by Subject|4
6103893|NCT00243412|21057434|P2|Overall Study|Physician Decision|1
6103894|NCT00243412|21057435|P1|Overall Study|Physician Decision|1
6103895|NCT00243412|21057434|P2|Overall Study|Lost to Follow-up|1
6103896|NCT00243412|21057435|P1|Overall Study|Lost to Follow-up|0
6103897|NCT00243412|21057434|P2|Overall Study|Adverse Event|2
6103898|NCT00243412|21057435|P1|Overall Study|Adverse Event|4
6103899|NCT00243412|21057434|P2|Overall Study|Death|1
6103900|NCT00243412|21057435|P1|Overall Study|Death|0
6103901|NCT00243386|21057461|P3|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0
6103902|NCT00243386|21057462|P2|PK-Driven or Standard Prophylaxis|Lack of Efficacy|1
6103903|NCT00243386|21057463|P1|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0
6103904|NCT00243386|21057461|P3|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0
6103905|NCT00243386|21057462|P2|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|2
6103906|NCT00243386|21057463|P1|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0
6103907|NCT00243386|21057461|P3|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0
6103908|NCT00243386|21057462|P2|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0
6103909|NCT00243386|21057463|P1|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|1
6103910|NCT00243386|21057461|P3|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0
6103911|NCT00243386|21057462|P2|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0
6103912|NCT00243386|21057463|P1|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|1
6103913|NCT00243386|21057461|P3|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0
6103914|NCT00243386|21057462|P2|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0
6103915|NCT00243386|21057463|P1|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|1
6103916|NCT00243386|21057461|P3|On-Demand Regimen (Study Part 1)|Screen Failures|0
6103917|NCT00243386|21057462|P2|On-Demand Regimen (Study Part 1)|Screen Failures|0
6103918|NCT00243386|21057463|P1|On-Demand Regimen (Study Part 1)|Screen Failures|2
6103919|NCT00243386|21057461|P3|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0
6103920|NCT00243386|21057462|P2|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0
6103921|NCT00243386|21057463|P1|On-Demand Regimen (Study Part 1)|Lost to Follow-up|1
6103922|NCT00243386|21057461|P3|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0
6103923|NCT00243386|21057462|P2|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0
6103924|NCT00243386|21057463|P1|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|1
6103925|NCT00243347|21057528|P1|Overall Study|Condition worsened|7
6103926|NCT00243347|21057528|P1|Overall Study|Withdrawal by Subject|5
6103927|NCT00243347|21057528|P1|Overall Study|Death|1
6103928|NCT00243347|21057528|P1|Overall Study|Adverse Event|2
6103929|NCT00243347|21057528|P1|Overall Study|Lack of Efficacy|4
6103930|NCT00243269|21057537|P4|Overall Study|Lost to Follow-up|3
6103931|NCT00243269|21057538|P3|Overall Study|Lost to Follow-up|1
6103932|NCT00243269|21057539|P2|Overall Study|Lost to Follow-up|0
6103933|NCT00243269|21057540|P1|Overall Study|Lost to Follow-up|1
6103934|NCT00243269|21057537|P4|Overall Study|Protocol Violation|1
6103935|NCT00243269|21057538|P3|Overall Study|Protocol Violation|0
6103936|NCT00243269|21057539|P2|Overall Study|Protocol Violation|1
6103937|NCT00243269|21057540|P1|Overall Study|Protocol Violation|2
6103938|NCT00243074|21057575|P1|Overall Study|Did not receive any treatment|1
6103939|NCT00243074|21057575|P1|Overall Study|not protocol specified|1
6103940|NCT00243074|21057575|P1|Overall Study|Death|2
6103941|NCT00243074|21057575|P1|Overall Study|Lack of Efficacy|36
6103942|NCT00243074|21057575|P1|Overall Study|Withdrawal by Subject|2
6103943|NCT00243074|21057575|P1|Overall Study|Adverse Event|6
6103944|NCT00243074|21057575|P1|Overall Study|Ineligible|6
6103945|NCT00243022|21057601|P2|Overall Study|Difficult Travel Distance|1
6103946|NCT00243022|21057602|P1|Overall Study|Difficult Travel Distance|0
6103947|NCT00243022|21057601|P2|Overall Study|Death|0
6103948|NCT00243022|21057602|P1|Overall Study|Death|1
6103949|NCT00243022|21057601|P2|Overall Study|Withdrawal by Subject|0
6103950|NCT00243022|21057602|P1|Overall Study|Withdrawal by Subject|1
6103951|NCT00242710|21057626|P4|Study Extension (up to Year 2)|Withdrawal by Subject|1
6103952|NCT00242710|21057627|P3|Study Extension (up to Year 2)|Withdrawal by Subject|4
6103953|NCT00242710|21057628|P2|Study Extension (up to Year 2)|Withdrawal by Subject|6
6103954|NCT00242710|21057629|P1|Study Extension (up to Year 2)|Withdrawal by Subject|10
6103955|NCT00242710|21057626|P4|Study Extension (up to Year 2)|Protocol Violation|1
6103956|NCT00242710|21057627|P3|Study Extension (up to Year 2)|Protocol Violation|0
6103957|NCT00242710|21057628|P2|Study Extension (up to Year 2)|Protocol Violation|2
6103958|NCT00242710|21057629|P1|Study Extension (up to Year 2)|Protocol Violation|0
6103959|NCT00242710|21057626|P4|Study Extension (up to Year 2)|Other|3
6103960|NCT00242710|21057627|P3|Study Extension (up to Year 2)|Other|4
6103961|NCT00242710|21057628|P2|Study Extension (up to Year 2)|Other|5
6103962|NCT00242710|21057629|P1|Study Extension (up to Year 2)|Other|3
6104041|NCT00242580|21057719|P2|Overall Study|Lost to Follow-up|3
6103963|NCT00242710|21057626|P4|Study Extension (up to Year 2)|Lost to Follow-up|0
6103964|NCT00242710|21057627|P3|Study Extension (up to Year 2)|Lost to Follow-up|5
6103965|NCT00242710|21057628|P2|Study Extension (up to Year 2)|Lost to Follow-up|7
6103966|NCT00242710|21057629|P1|Study Extension (up to Year 2)|Lost to Follow-up|7
6103967|NCT00242710|21057626|P4|Study Extension (up to Year 2)|Death|1
6103968|NCT00242710|21057627|P3|Study Extension (up to Year 2)|Death|0
6103969|NCT00242710|21057628|P2|Study Extension (up to Year 2)|Death|0
6103970|NCT00242710|21057629|P1|Study Extension (up to Year 2)|Death|0
6103971|NCT00242710|21057626|P4|Study Extension (up to Year 2)|Adverse Event|4
6103972|NCT00242710|21057627|P3|Study Extension (up to Year 2)|Adverse Event|2
6103973|NCT00242710|21057628|P2|Study Extension (up to Year 2)|Adverse Event|9
6103974|NCT00242710|21057629|P1|Study Extension (up to Year 2)|Adverse Event|7
6103975|NCT00242710|21057626|P4|Period Between Core Study and Extension|Withdrawal by Subject|28
6103976|NCT00242710|21057627|P3|Period Between Core Study and Extension|Withdrawal by Subject|24
6103977|NCT00242710|21057628|P2|Period Between Core Study and Extension|Withdrawal by Subject|63
6103978|NCT00242710|21057629|P1|Period Between Core Study and Extension|Withdrawal by Subject|75
6103979|NCT00242710|21057626|P4|Period Between Core Study and Extension|Protocol Violation|1
6103980|NCT00242710|21057627|P3|Period Between Core Study and Extension|Protocol Violation|2
6103981|NCT00242710|21057628|P2|Period Between Core Study and Extension|Protocol Violation|0
6103982|NCT00242710|21057629|P1|Period Between Core Study and Extension|Protocol Violation|0
6103983|NCT00242710|21057626|P4|Period Between Core Study and Extension|Extension not Available|7
6103984|NCT00242710|21057627|P3|Period Between Core Study and Extension|Extension not Available|8
6103985|NCT00242710|21057628|P2|Period Between Core Study and Extension|Extension not Available|21
6103986|NCT00242710|21057629|P1|Period Between Core Study and Extension|Extension not Available|17
6103987|NCT00242710|21057626|P4|Period Between Core Study and Extension|Other|11
6103988|NCT00242710|21057627|P3|Period Between Core Study and Extension|Other|9
6103989|NCT00242710|21057628|P2|Period Between Core Study and Extension|Other|24
6103990|NCT00242710|21057629|P1|Period Between Core Study and Extension|Other|24
6103991|NCT00242710|21057626|P4|Period Between Core Study and Extension|Physician Decision|0
6103992|NCT00242710|21057627|P3|Period Between Core Study and Extension|Physician Decision|0
6103993|NCT00242710|21057628|P2|Period Between Core Study and Extension|Physician Decision|1
6103994|NCT00242710|21057629|P1|Period Between Core Study and Extension|Physician Decision|1
6103995|NCT00242710|21057626|P4|Period Between Core Study and Extension|Adverse Event|2
6103996|NCT00242710|21057627|P3|Period Between Core Study and Extension|Adverse Event|5
6103997|NCT00242710|21057628|P2|Period Between Core Study and Extension|Adverse Event|3
6103998|NCT00242710|21057629|P1|Period Between Core Study and Extension|Adverse Event|2
6103999|NCT00242710|21057626|P4|Core Study (up to Year 1)|Randomized but not Treated|2
6104000|NCT00242710|21057627|P3|Core Study (up to Year 1)|Randomized but not Treated|4
6104001|NCT00242710|21057628|P2|Core Study (up to Year 1)|Randomized but not Treated|4
6104002|NCT00242710|21057629|P1|Core Study (up to Year 1)|Randomized but not Treated|12
6104003|NCT00242710|21057626|P4|Core Study (up to Year 1)|Lack of Efficacy|0
6104004|NCT00242710|21057627|P3|Core Study (up to Year 1)|Lack of Efficacy|0
6104005|NCT00242710|21057628|P2|Core Study (up to Year 1)|Lack of Efficacy|0
6104006|NCT00242710|21057629|P1|Core Study (up to Year 1)|Lack of Efficacy|1
6104007|NCT00242710|21057626|P4|Core Study (up to Year 1)|Withdrawal by Subject|6
6104008|NCT00242710|21057627|P3|Core Study (up to Year 1)|Withdrawal by Subject|15
6104009|NCT00242710|21057628|P2|Core Study (up to Year 1)|Withdrawal by Subject|16
6104010|NCT00242710|21057629|P1|Core Study (up to Year 1)|Withdrawal by Subject|27
6104011|NCT00242710|21057626|P4|Core Study (up to Year 1)|Protocol Violation|3
6104012|NCT00242710|21057627|P3|Core Study (up to Year 1)|Protocol Violation|1
6104013|NCT00242710|21057628|P2|Core Study (up to Year 1)|Protocol Violation|9
6104014|NCT00242710|21057629|P1|Core Study (up to Year 1)|Protocol Violation|2
6104015|NCT00242710|21057626|P4|Core Study (up to Year 1)|Other|2
6104016|NCT00242710|21057627|P3|Core Study (up to Year 1)|Other|0
6104017|NCT00242710|21057628|P2|Core Study (up to Year 1)|Other|1
6104018|NCT00242710|21057629|P1|Core Study (up to Year 1)|Other|6
6104019|NCT00242710|21057626|P4|Core Study (up to Year 1)|Lost to Follow-up|3
6104020|NCT00242710|21057627|P3|Core Study (up to Year 1)|Lost to Follow-up|7
6104021|NCT00242710|21057628|P2|Core Study (up to Year 1)|Lost to Follow-up|8
6104022|NCT00242710|21057629|P1|Core Study (up to Year 1)|Lost to Follow-up|8
6104023|NCT00242710|21057626|P4|Core Study (up to Year 1)|Physician Decision|1
6104024|NCT00242710|21057627|P3|Core Study (up to Year 1)|Physician Decision|0
6104025|NCT00242710|21057628|P2|Core Study (up to Year 1)|Physician Decision|1
6104026|NCT00242710|21057629|P1|Core Study (up to Year 1)|Physician Decision|0
6104027|NCT00242710|21057626|P4|Core Study (up to Year 1)|Death|0
6104028|NCT00242710|21057627|P3|Core Study (up to Year 1)|Death|1
6104029|NCT00242710|21057628|P2|Core Study (up to Year 1)|Death|0
6104030|NCT00242710|21057629|P1|Core Study (up to Year 1)|Death|0
6104031|NCT00242710|21057626|P4|Core Study (up to Year 1)|Adverse Event|14
6104032|NCT00242710|21057627|P3|Core Study (up to Year 1)|Adverse Event|23
6104033|NCT00242710|21057628|P2|Core Study (up to Year 1)|Adverse Event|25
6104034|NCT00242710|21057629|P1|Core Study (up to Year 1)|Adverse Event|30
6104035|NCT00242658|21057686|P2|Overall Study|Lost to Follow-up|19
6104036|NCT00242658|21057687|P1|Overall Study|Lost to Follow-up|22
6104037|NCT00242580|21057718|P3|Overall Study|Death|1
6104038|NCT00242580|21057719|P2|Overall Study|Death|2
6104039|NCT00242580|21057720|P1|Overall Study|Death|1
6104040|NCT00242580|21057718|P3|Overall Study|Lost to Follow-up|0
6104042|NCT00242580|21057720|P1|Overall Study|Lost to Follow-up|0
6104043|NCT00242580|21057718|P3|Overall Study|Subject withdrew consent|5
6104044|NCT00242580|21057719|P2|Overall Study|Subject withdrew consent|2
6104045|NCT00242580|21057720|P1|Overall Study|Subject withdrew consent|2
6104046|NCT00242580|21057718|P3|Overall Study|Protocol Violation|1
6104047|NCT00242580|21057719|P2|Overall Study|Protocol Violation|0
6104048|NCT00242580|21057720|P1|Overall Study|Protocol Violation|0
6104049|NCT00242580|21057718|P3|Overall Study|Unsatisfactory therapeutic effect|5
6104050|NCT00242580|21057719|P2|Overall Study|Unsatisfactory therapeutic effect|5
6104051|NCT00242580|21057720|P1|Overall Study|Unsatisfactory therapeutic effect|4
6104052|NCT00242580|21057718|P3|Overall Study|Adverse Event|2
6104053|NCT00242580|21057719|P2|Overall Study|Adverse Event|0
6104054|NCT00242580|21057720|P1|Overall Study|Adverse Event|3
6104055|NCT00242567|21057745|P2|Overall Study|Other|9
6104056|NCT00242567|21057746|P1|Overall Study|Other|14
6104057|NCT00242567|21057745|P2|Overall Study|Use of an inhibitor of bone resorption|2
6104058|NCT00242567|21057746|P1|Overall Study|Use of an inhibitor of bone resorption|0
6104059|NCT00242567|21057745|P2|Overall Study|Protocol Violation|12
6104060|NCT00242567|21057746|P1|Overall Study|Protocol Violation|12
6104061|NCT00242567|21057745|P2|Overall Study|Withdrawal by Subject|28
6104062|NCT00242567|21057746|P1|Overall Study|Withdrawal by Subject|33
6104063|NCT00242567|21057745|P2|Overall Study|Lost to Follow-up|19
6104064|NCT00242567|21057746|P1|Overall Study|Lost to Follow-up|9
6104065|NCT00242567|21057745|P2|Overall Study|Lack of Efficacy|2
6104066|NCT00242567|21057746|P1|Overall Study|Lack of Efficacy|2
6104067|NCT00242567|21057745|P2|Overall Study|Symptomatic deterioration|3
6104068|NCT00242567|21057746|P1|Overall Study|Symptomatic deterioration|9
6104069|NCT00242567|21057745|P2|Overall Study|Disease Progression|22
6104070|NCT00242567|21057746|P1|Overall Study|Disease Progression|17
6104071|NCT00242567|21057745|P2|Overall Study|Adverse Event|43
6104072|NCT00242567|21057746|P1|Overall Study|Adverse Event|70
6104073|NCT00242216|21057793|P2|Overall Study|no medicaiton dispensed|1
6104074|NCT00242216|21057794|P1|Overall Study|no medicaiton dispensed|1
6104075|NCT00242216|21057793|P2|Overall Study|Lack of Efficacy|2
6104076|NCT00242216|21057794|P1|Overall Study|Lack of Efficacy|1
6104077|NCT00242216|21057793|P2|Overall Study|Death|2
6104078|NCT00242216|21057794|P1|Overall Study|Death|4
6104079|NCT00242216|21057793|P2|Overall Study|Lost to Follow-up|17
6104080|NCT00242216|21057794|P1|Overall Study|Lost to Follow-up|12
6104081|NCT00241839|21057832|P2|Overall Study|Adverse Event|1
6104082|NCT00241839|21057833|P1|Overall Study|Adverse Event|1
6104083|NCT00241839|21057832|P2|Overall Study|Withdrawal by Subject|17
6104084|NCT00241839|21057833|P1|Overall Study|Withdrawal by Subject|18
6104085|NCT00241644|21057849|P4|Second Efficacy Period (Year 2)|Consenting parent passed away|2
6104086|NCT00241644|21057850|P3|Second Efficacy Period (Year 2)|Consenting parent passed away|2
6104087|NCT00241644|21057851|P2|Second Efficacy Period (Year 2)|Consenting parent passed away|1
6104088|NCT00241644|21057852|P1|Second Efficacy Period (Year 2)|Consenting parent passed away|1
6104089|NCT00241644|21057849|P4|Second Efficacy Period (Year 2)|Lost to Follow-up|86
6104090|NCT00241644|21057850|P3|Second Efficacy Period (Year 2)|Lost to Follow-up|46
6104091|NCT00241644|21057851|P2|Second Efficacy Period (Year 2)|Lost to Follow-up|43
6104092|NCT00241644|21057852|P1|Second Efficacy Period (Year 2)|Lost to Follow-up|43
6104093|NCT00241644|21057849|P4|Second Efficacy Period (Year 2)|Withdrawal by Subject|7
6104094|NCT00241644|21057850|P3|Second Efficacy Period (Year 2)|Withdrawal by Subject|2
6104095|NCT00241644|21057851|P2|Second Efficacy Period (Year 2)|Withdrawal by Subject|3
6104096|NCT00241644|21057852|P1|Second Efficacy Period (Year 2)|Withdrawal by Subject|4
6104097|NCT00241644|21057849|P4|Second Efficacy Period (Year 2)|Protocol Violation|3
6104098|NCT00241644|21057850|P3|Second Efficacy Period (Year 2)|Protocol Violation|2
6104099|NCT00241644|21057851|P2|Second Efficacy Period (Year 2)|Protocol Violation|1
6104100|NCT00241644|21057852|P1|Second Efficacy Period (Year 2)|Protocol Violation|2
6104101|NCT00241644|21057849|P4|Second Efficacy Period (Year 2)|Adverse Event|20
6104102|NCT00241644|21057850|P3|Second Efficacy Period (Year 2)|Adverse Event|12
6104103|NCT00241644|21057851|P2|Second Efficacy Period (Year 2)|Adverse Event|9
6104104|NCT00241644|21057852|P1|Second Efficacy Period (Year 2)|Adverse Event|11
6104105|NCT00241644|21057849|P4|First Efficacy Period (Year 1)|Subject's parent passed away|1
6104106|NCT00241644|21057850|P3|First Efficacy Period (Year 1)|Subject's parent passed away|0
6104107|NCT00241644|21057851|P2|First Efficacy Period (Year 1)|Subject's parent passed away|1
6104108|NCT00241644|21057852|P1|First Efficacy Period (Year 1)|Subject's parent passed away|0
6104109|NCT00241644|21057849|P4|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0
6104110|NCT00241644|21057850|P3|First Efficacy Period (Year 1)|Vaccinated at regular clinic|1
6104111|NCT00241644|21057851|P2|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0
6104112|NCT00241644|21057852|P1|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0
6104113|NCT00241644|21057849|P4|First Efficacy Period (Year 1)|Return dates not reliable|1
6104114|NCT00241644|21057850|P3|First Efficacy Period (Year 1)|Return dates not reliable|0
6104115|NCT00241644|21057851|P2|First Efficacy Period (Year 1)|Return dates not reliable|0
6104116|NCT00241644|21057852|P1|First Efficacy Period (Year 1)|Return dates not reliable|1
6104117|NCT00241644|21057849|P4|First Efficacy Period (Year 1)|Non-compliance|3
6104118|NCT00241644|21057850|P3|First Efficacy Period (Year 1)|Non-compliance|2
6104119|NCT00241644|21057851|P2|First Efficacy Period (Year 1)|Non-compliance|1
6104120|NCT00241644|21057852|P1|First Efficacy Period (Year 1)|Non-compliance|2
6104121|NCT00241644|21057849|P4|First Efficacy Period (Year 1)|Lost to Follow-up|258
6104122|NCT00241644|21057850|P3|First Efficacy Period (Year 1)|Lost to Follow-up|116
6104123|NCT00241644|21057851|P2|First Efficacy Period (Year 1)|Lost to Follow-up|142
6104124|NCT00241644|21057852|P1|First Efficacy Period (Year 1)|Lost to Follow-up|116
6104125|NCT00241644|21057849|P4|First Efficacy Period (Year 1)|Withdrawal by Subject|133
6104126|NCT00241644|21057850|P3|First Efficacy Period (Year 1)|Withdrawal by Subject|81
6104127|NCT00241644|21057851|P2|First Efficacy Period (Year 1)|Withdrawal by Subject|74
6104128|NCT00241644|21057852|P1|First Efficacy Period (Year 1)|Withdrawal by Subject|59
6104129|NCT00241644|21057849|P4|First Efficacy Period (Year 1)|Protocol Violation|8
6104130|NCT00241644|21057850|P3|First Efficacy Period (Year 1)|Protocol Violation|4
6104131|NCT00241644|21057851|P2|First Efficacy Period (Year 1)|Protocol Violation|5
6104132|NCT00241644|21057852|P1|First Efficacy Period (Year 1)|Protocol Violation|3
6104133|NCT00241644|21057849|P4|First Efficacy Period (Year 1)|Adverse Event|91
6104134|NCT00241644|21057850|P3|First Efficacy Period (Year 1)|Adverse Event|45
6104135|NCT00241644|21057851|P2|First Efficacy Period (Year 1)|Adverse Event|45
6104136|NCT00241644|21057852|P1|First Efficacy Period (Year 1)|Adverse Event|46
6104137|NCT00241631|21057936|P2|Phase 1 (4 Weeks)|Lack of Efficacy|1
6104138|NCT00241631|21057937|P1|Phase 1 (4 Weeks)|Lack of Efficacy|0
6104139|NCT00241631|21057936|P2|Phase 1 (4 Weeks)|Lost to Follow-up|0
6104140|NCT00241631|21057937|P1|Phase 1 (4 Weeks)|Lost to Follow-up|3
6104141|NCT00241631|21057936|P2|Phase 1 (4 Weeks)|Withdrawal by Subject|4
6104142|NCT00241631|21057937|P1|Phase 1 (4 Weeks)|Withdrawal by Subject|4
6104143|NCT00241631|21057936|P2|Phase 1 (4 Weeks)|sore throat|0
6104144|NCT00241631|21057937|P1|Phase 1 (4 Weeks)|sore throat|1
6104145|NCT00241631|21057936|P2|Run in (2 Weeks)|Physician Decision|3
6104146|NCT00241631|21057937|P1|Run in (2 Weeks)|Physician Decision|3
6104147|NCT00241358|21057950|P3|Overall Study|Determined to be not ineligible|1
6104148|NCT00241358|21057951|P2|Overall Study|Determined to be not ineligible|1
6104149|NCT00241358|21057952|P1|Overall Study|Determined to be not ineligible|0
6104150|NCT00241280|21057985|P2|Overall Study|Excessive Dryness|1
6104151|NCT00241280|21057986|P1|Overall Study|Excessive Dryness|0
6104152|NCT00241280|21057985|P2|Overall Study|Coating on Lens|0
6104153|NCT00241280|21057986|P1|Overall Study|Coating on Lens|1
6104154|NCT00241280|21057985|P2|Overall Study|History of Ocular Surgery|1
6104155|NCT00241280|21057986|P1|Overall Study|History of Ocular Surgery|0
6104156|NCT00241280|21057985|P2|Overall Study|Scheduling Conflict|2
6104157|NCT00241280|21057986|P1|Overall Study|Scheduling Conflict|0
6104158|NCT00241280|21057985|P2|Overall Study|Unacceptable Fit|1
6104159|NCT00241280|21057986|P1|Overall Study|Unacceptable Fit|0
6104160|NCT00241280|21057985|P2|Overall Study|Dispensed incorrect test article|2
6104161|NCT00241280|21057986|P1|Overall Study|Dispensed incorrect test article|1
6104162|NCT00241280|21057985|P2|Overall Study|Subject Ineligible/Dispensed|6
6104163|NCT00241280|21057986|P1|Overall Study|Subject Ineligible/Dispensed|9
6104164|NCT00241280|21057985|P2|Overall Study|Diabetic|0
6104165|NCT00241280|21057986|P1|Overall Study|Diabetic|1
6104166|NCT00241280|21057985|P2|Overall Study|Unsatisfactory Visual Response|1
6104167|NCT00241280|21057986|P1|Overall Study|Unsatisfactory Visual Response|1
6104168|NCT00241280|21057985|P2|Overall Study|Unsatisfactory Physiological Response|1
6104169|NCT00241280|21057986|P1|Overall Study|Unsatisfactory Physiological Response|1
6104170|NCT00241280|21057985|P2|Overall Study|Relocation|4
6104171|NCT00241280|21057986|P1|Overall Study|Relocation|4
6104172|NCT00241280|21057985|P2|Overall Study|Protocol Violation|10
6104173|NCT00241280|21057986|P1|Overall Study|Protocol Violation|4
6104174|NCT00241280|21057985|P2|Overall Study|Withdrawal by Subject|4
6104175|NCT00241280|21057986|P1|Overall Study|Withdrawal by Subject|7
6104176|NCT00241280|21057985|P2|Overall Study|Lost to Follow-up|8
6104177|NCT00241280|21057986|P1|Overall Study|Lost to Follow-up|5
6104178|NCT00241280|21057985|P2|Overall Study|Pregnancy|5
6104179|NCT00241280|21057986|P1|Overall Study|Pregnancy|1
6104180|NCT00241280|21057985|P2|Overall Study|Discomfort|16
6104181|NCT00241280|21057986|P1|Overall Study|Discomfort|11
6104182|NCT00241280|21057985|P2|Overall Study|Adverse Event|6
6104183|NCT00241280|21057986|P1|Overall Study|Adverse Event|2
6104184|NCT00240994|21058001|P1|Overall Study|Graft failure|1
6104185|NCT00240994|21058001|P1|Overall Study|Protocol Violation|1
6104186|NCT00240994|21058001|P1|Overall Study|Lost to Follow-up|1
6104187|NCT00240331|21058136|P2|Overall Study|Option selected by investigator|2
6104188|NCT00240331|21058137|P1|Overall Study|Option selected by investigator|1
6104189|NCT00240331|21058136|P2|Overall Study|Withdrawal by Subject|132
6104190|NCT00240331|21058137|P1|Overall Study|Withdrawal by Subject|125
6104191|NCT00240110|21058180|P2|Overall Study|Lost to Follow-up|7
6104192|NCT00240110|21058181|P1|Overall Study|Lost to Follow-up|6
6104193|NCT00240097|21058189|P1|Part II|did not continue from Part I|23
6104194|NCT00240097|21058189|P1|Part I|unevaluable|1
6104195|NCT00240097|21058189|P1|Part I|histology|1
6104196|NCT00240097|21058189|P1|Part I|Death|1
6104197|NCT00240097|21058189|P1|Part I|Adverse Event|1
6104198|NCT00240071|21058199|P1|Overall Study|Withdrawal by Subject|3
6104199|NCT00239928|21058204|P1|Overall Study|Withdrawal by Subject|2
6104200|NCT00239928|21058204|P1|Overall Study|Not need to continue study|3
6104201|NCT00239928|21058204|P1|Overall Study|Adverse Event|4
6104202|NCT00239928|21058204|P1|Overall Study|Lack of Efficacy|1
6104203|NCT00239837|21058216|P2|Overall Study|Lost to Follow-up|7
6104204|NCT00239837|21058217|P1|Overall Study|Lost to Follow-up|3
6104205|NCT00239720|21058244|P2|Overall Study|Lost to Follow-up|1
6104206|NCT00239720|21058245|P1|Overall Study|Lost to Follow-up|0
6104207|NCT00239720|21058244|P2|Overall Study|Adverse Event|0
6104208|NCT00239720|21058245|P1|Overall Study|Adverse Event|1
6104209|NCT00239681|21058253|P2|Overall Study|No information chacked on CaseReportForm|84
6104210|NCT00239681|21058254|P1|Overall Study|No information chacked on CaseReportForm|90
6104211|NCT00239681|21058253|P2|Overall Study|Physician Decision|17
6104212|NCT00239681|21058254|P1|Overall Study|Physician Decision|13
6104213|NCT00239681|21058253|P2|Overall Study|Protocol Violation|4
6104214|NCT00239681|21058254|P1|Overall Study|Protocol Violation|4
6104215|NCT00239681|21058253|P2|Overall Study|Lost to Follow-up|22
6104216|NCT00239681|21058254|P1|Overall Study|Lost to Follow-up|28
6104217|NCT00239681|21058253|P2|Overall Study|Withdrawal by Subject|489
6104218|NCT00239681|21058254|P1|Overall Study|Withdrawal by Subject|458
6104219|NCT00239681|21058253|P2|Overall Study|Adverse Event|99
6104220|NCT00239681|21058254|P1|Overall Study|Adverse Event|100
6104221|NCT00239590|21058307|P2|Completed Study Protocol|Withdrawal by Subject|1
6104222|NCT00239590|21058308|P1|Completed Study Protocol|Withdrawal by Subject|0
6104223|NCT00239590|21058307|P2|Completed Study Protocol|Adverse Event|1
6104224|NCT00239590|21058308|P1|Completed Study Protocol|Adverse Event|1
6104225|NCT00239590|21058307|P2|Randomized|Withdrawal by Subject|1
6104226|NCT00239590|21058308|P1|Randomized|Withdrawal by Subject|0
6104227|NCT00239590|21058307|P2|Randomized|Lost to Follow-up|1
6104228|NCT00239590|21058308|P1|Randomized|Lost to Follow-up|0
6104229|NCT00239577|21058320|P4|Primary Phase|Other|0
6104230|NCT00239577|21058321|P3|Primary Phase|Other|2
6104231|NCT00239577|21058322|P2|Primary Phase|Other|3
6104232|NCT00239577|21058323|P1|Primary Phase|Other|5
6104233|NCT00239577|21058320|P4|Primary Phase|Adverse Event|0
6104234|NCT00239577|21058321|P3|Primary Phase|Adverse Event|1
6104235|NCT00239577|21058322|P2|Primary Phase|Adverse Event|0
6104236|NCT00239577|21058323|P1|Primary Phase|Adverse Event|0
6104237|NCT00239356|21058427|P2|Overall Study|Drug available on market|2
6104238|NCT00239356|21058428|P1|Overall Study|Drug available on market|11
6104239|NCT00239356|21058427|P2|Overall Study|Administrative reason|1
6104240|NCT00239356|21058428|P1|Overall Study|Administrative reason|0
6104241|NCT00239356|21058427|P2|Overall Study|Pregnancy|0
6104242|NCT00239356|21058428|P1|Overall Study|Pregnancy|1
6104243|NCT00239356|21058427|P2|Overall Study|poor/non-compliance|0
6104244|NCT00239356|21058428|P1|Overall Study|poor/non-compliance|2
6104245|NCT00239356|21058427|P2|Overall Study|Lost to Follow-up|0
6104246|NCT00239356|21058428|P1|Overall Study|Lost to Follow-up|3
6104247|NCT00239356|21058427|P2|Overall Study|Withdrawal by Subject|6
6104248|NCT00239356|21058428|P1|Overall Study|Withdrawal by Subject|15
6104249|NCT00239356|21058427|P2|Overall Study|Adverse Event|0
6104250|NCT00239356|21058428|P1|Overall Study|Adverse Event|6
6104251|NCT00239356|21058427|P2|Overall Study|Lack of Efficacy|0
6104252|NCT00239356|21058428|P1|Overall Study|Lack of Efficacy|1
6104253|NCT00239226|21058450|P4|Overall Study|Lost to Follow-up|0
6104254|NCT00239226|21058451|P3|Overall Study|Lost to Follow-up|1
6104255|NCT00239226|21058452|P2|Overall Study|Lost to Follow-up|0
6104256|NCT00239226|21058453|P1|Overall Study|Lost to Follow-up|1
6104257|NCT00239226|21058450|P4|Overall Study|permAF during stabilization period|3
6104258|NCT00239226|21058451|P3|Overall Study|permAF during stabilization period|0
6104259|NCT00239226|21058452|P2|Overall Study|permAF during stabilization period|0
6104260|NCT00239226|21058453|P1|Overall Study|permAF during stabilization period|0
6104261|NCT00239005|21058465|P2|Overall Study|Lost to Follow-up|1
6104262|NCT00239005|21058466|P1|Overall Study|Lost to Follow-up|0
6104263|NCT00239005|21058465|P2|Overall Study|Subj. cond. no longer needs study drug|1
6104264|NCT00239005|21058466|P1|Overall Study|Subj. cond. no longer needs study drug|0
6104265|NCT00239005|21058465|P2|Overall Study|Protocol Violation|0
6104266|NCT00239005|21058466|P1|Overall Study|Protocol Violation|1
6104267|NCT00239005|21058465|P2|Overall Study|Unsatisfactory Therapeutic effect|0
6104268|NCT00239005|21058466|P1|Overall Study|Unsatisfactory Therapeutic effect|2
6104269|NCT00239005|21058465|P2|Overall Study|Withdrawal by Subject|4
6104270|NCT00239005|21058466|P1|Overall Study|Withdrawal by Subject|3
6104271|NCT00239005|21058465|P2|Overall Study|Adverse Event|6
6104272|NCT00239005|21058466|P1|Overall Study|Adverse Event|6
6104273|NCT00238433|21058482|P1|Overall Study|Death|1
6104274|NCT00238433|21058482|P1|Overall Study|Lost to Follow-up|1
6104275|NCT00238433|21058482|P1|Overall Study|Screen failure|1
6104276|NCT00238420|21058489|P2|Overall Study|Protocol Violation|1
6104277|NCT00238420|21058490|P1|Overall Study|Protocol Violation|1
6104278|NCT00238303|21058507|P3|Overall Study|Adverse Event|3
6104279|NCT00238303|21058508|P2|Overall Study|Adverse Event|1
6104280|NCT00238303|21058509|P1|Overall Study|Adverse Event|0
6104281|NCT00238303|21058507|P3|Overall Study|Poor tolerance of study treatment|1
6104282|NCT00238303|21058508|P2|Overall Study|Poor tolerance of study treatment|0
6104283|NCT00238303|21058509|P1|Overall Study|Poor tolerance of study treatment|1
6104284|NCT00238303|21058507|P3|Overall Study|Other Medical Problems|2
6104285|NCT00238303|21058508|P2|Overall Study|Other Medical Problems|0
6104286|NCT00238303|21058509|P1|Overall Study|Other Medical Problems|2
6104287|NCT00238303|21058507|P3|Overall Study|Death|1
6104288|NCT00238303|21058508|P2|Overall Study|Death|0
6104289|NCT00238303|21058509|P1|Overall Study|Death|1
6104290|NCT00238303|21058507|P3|Overall Study|Withdrawal by Subject|2
6104291|NCT00238303|21058508|P2|Overall Study|Withdrawal by Subject|1
6104292|NCT00238303|21058509|P1|Overall Study|Withdrawal by Subject|11
6104293|NCT00238264|21058526|P1|Overall Study|Ineligible|7
6104294|NCT00238264|21058526|P1|Overall Study|Withdrawal by Subject|4
6104295|NCT00238264|21058526|P1|Overall Study|Lost to Follow-up|18
6104296|NCT00238264|21058526|P1|Overall Study|Death|7
6104297|NCT00238238|21058539|P3|Overall Study|Withdrawal by Subject|0
6104298|NCT00238238|21058540|P2|Overall Study|Withdrawal by Subject|3
6104299|NCT00238238|21058541|P1|Overall Study|Withdrawal by Subject|0
6104300|NCT00238121|21058554|P2|Overall Study|Adverse Event|1
6104301|NCT00238121|21058555|P1|Overall Study|Adverse Event|2
6104302|NCT00238121|21058554|P2|Overall Study|Withdrawal by Subject|1
6104303|NCT00238121|21058555|P1|Overall Study|Withdrawal by Subject|1
6104304|NCT00237809|21058581|P4|Overall Study|Lost to Follow-up|9
6104305|NCT00237809|21058582|P3|Overall Study|Lost to Follow-up|9
6104306|NCT00237809|21058583|P2|Overall Study|Lost to Follow-up|10
6104307|NCT00237809|21058584|P1|Overall Study|Lost to Follow-up|11
6104308|NCT00237796|21058620|P2|Overall Study|Baseline and one other ILSS required|5
6104309|NCT00237796|21058621|P1|Overall Study|Baseline and one other ILSS required|10
6104310|NCT00237744|21058655|P3|Overall Study|Withdrawal by Subject|0
6104311|NCT00237744|21058656|P2|Overall Study|Withdrawal by Subject|1
6104312|NCT00237744|21058657|P1|Overall Study|Withdrawal by Subject|3
6104313|NCT00237692|21058683|P4|Overall Study|Withdrawal by Subject|4
6104314|NCT00237692|21058684|P3|Overall Study|Withdrawal by Subject|10
6104315|NCT00237692|21058685|P2|Overall Study|Withdrawal by Subject|6
6104316|NCT00237692|21058686|P1|Overall Study|Withdrawal by Subject|4
6104317|NCT00237692|21058683|P4|Overall Study|Excluded - did not meet criteria|9
6104318|NCT00237692|21058684|P3|Overall Study|Excluded - did not meet criteria|5
6104319|NCT00237692|21058685|P2|Overall Study|Excluded - did not meet criteria|3
6104320|NCT00237692|21058686|P1|Overall Study|Excluded - did not meet criteria|4
6104321|NCT00237692|21058683|P4|Overall Study|Death|3
6104322|NCT00237692|21058684|P3|Overall Study|Death|2
6104323|NCT00237692|21058685|P2|Overall Study|Death|2
6104324|NCT00237692|21058686|P1|Overall Study|Death|1
6104325|NCT00237692|21058683|P4|Overall Study|Lost to Follow-up|3
6104326|NCT00237692|21058684|P3|Overall Study|Lost to Follow-up|5
6104327|NCT00237692|21058685|P2|Overall Study|Lost to Follow-up|3
6104328|NCT00237692|21058686|P1|Overall Study|Lost to Follow-up|9
6104329|NCT00237458|21058726|P1|Overall Study|Withdrawal by Subject|1
6104330|NCT00237458|21058726|P1|Overall Study|Adverse Event|1
6104331|NCT00237458|21058726|P1|Overall Study|Lack of Efficacy|1
6104332|NCT00237185|21058744|P2|Extension|Death|1
6104333|NCT00237185|21058745|P1|Extension|Death|1
6104334|NCT00237185|21058744|P2|Extension|Administrative problems|0
6104335|NCT00237185|21058745|P1|Extension|Administrative problems|1
6104336|NCT00237185|21058744|P2|Extension|Lost to Follow-up|0
6104337|NCT00237185|21058745|P1|Extension|Lost to Follow-up|1
6104338|NCT00237185|21058744|P2|Extension|Withdrawal by Subject|2
6104339|NCT00237185|21058745|P1|Extension|Withdrawal by Subject|3
6104340|NCT00237185|21058744|P2|Extension|Condition no longer required study drug|1
6104341|NCT00237185|21058745|P1|Extension|Condition no longer required study drug|0
6104342|NCT00237185|21058744|P2|Extension|Lack of Efficacy|14
6104343|NCT00237185|21058745|P1|Extension|Lack of Efficacy|9
6104344|NCT00237185|21058744|P2|Extension|Abnormal laboratory value|1
6104345|NCT00237185|21058745|P1|Extension|Abnormal laboratory value|0
6104346|NCT00237185|21058744|P2|Extension|Adverse Event|0
6104347|NCT00237185|21058745|P1|Extension|Adverse Event|1
6104348|NCT00237185|21058744|P2|Core|Determined ineligible post randomization|0
6104349|NCT00237185|21058745|P1|Core|Determined ineligible post randomization|1
6104350|NCT00237185|21058744|P2|Core|Death|0
6104351|NCT00237185|21058745|P1|Core|Death|4
6104352|NCT00237185|21058744|P2|Core|Administrative problems|1
6104353|NCT00237185|21058745|P1|Core|Administrative problems|0
6104354|NCT00237185|21058744|P2|Core|Withdrawal by Subject|4
6104355|NCT00237185|21058745|P1|Core|Withdrawal by Subject|4
6104356|NCT00237185|21058744|P2|Core|Protocol Violation|1
6104357|NCT00237185|21058745|P1|Core|Protocol Violation|1
6104358|NCT00237185|21058744|P2|Core|Lack of Efficacy|23
6104359|NCT00237185|21058745|P1|Core|Lack of Efficacy|30
6104360|NCT00237185|21058744|P2|Core|Abnormal test procedure results|0
6104361|NCT00237185|21058745|P1|Core|Abnormal test procedure results|1
6104362|NCT00237185|21058744|P2|Core|Abnormal laboratory value|4
6104363|NCT00237185|21058745|P1|Core|Abnormal laboratory value|0
6104364|NCT00237185|21058744|P2|Core|Adverse Event|4
6104365|NCT00237185|21058745|P1|Core|Adverse Event|3
6104366|NCT00237042|21058776|P3|Long Term (12 Month) Follow up|Lost to Follow-up|9
6104367|NCT00237042|21058777|P2|Long Term (12 Month) Follow up|Lost to Follow-up|9
6104368|NCT00237042|21058778|P1|Long Term (12 Month) Follow up|Lost to Follow-up|11
6104369|NCT00237042|21058776|P3|Short Term (6 Month) Follow up|Lost to Follow-up|11
6104370|NCT00237042|21058777|P2|Short Term (6 Month) Follow up|Lost to Follow-up|8
6104371|NCT00237042|21058778|P1|Short Term (6 Month) Follow up|Lost to Follow-up|9
6104372|NCT00237042|21058776|P3|Treatment|Completed no treatment|21
6104373|NCT00237042|21058777|P2|Treatment|Completed no treatment|5
6104374|NCT00237042|21058778|P1|Treatment|Completed no treatment|5
6104375|NCT00237042|21058776|P3|Treatment|Moved out of state|1
6104376|NCT00237042|21058777|P2|Treatment|Moved out of state|1
6104377|NCT00237042|21058778|P1|Treatment|Moved out of state|1
6104378|NCT00237042|21058776|P3|Treatment|Became ineligible post-randomization|16
6104379|NCT00237042|21058777|P2|Treatment|Became ineligible post-randomization|1
6104380|NCT00237042|21058778|P1|Treatment|Became ineligible post-randomization|0
6104381|NCT00236899|21058852|P4|Overall Study|Lack of Efficacy|23
6104382|NCT00236899|21058853|P3|Overall Study|Lack of Efficacy|25
6104383|NCT00236899|21058854|P2|Overall Study|Lack of Efficacy|18
6104384|NCT00236899|21058855|P1|Overall Study|Lack of Efficacy|18
6104385|NCT00236899|21058852|P4|Overall Study|Satisfactory Response|1
6104386|NCT00236899|21058853|P3|Overall Study|Satisfactory Response|0
6104387|NCT00236899|21058854|P2|Overall Study|Satisfactory Response|0
6104388|NCT00236899|21058855|P1|Overall Study|Satisfactory Response|2
6104389|NCT00236899|21058852|P4|Overall Study|Physician Decision|6
6104390|NCT00236899|21058853|P3|Overall Study|Physician Decision|7
6104391|NCT00236899|21058854|P2|Overall Study|Physician Decision|8
6104392|NCT00236899|21058855|P1|Overall Study|Physician Decision|7
6104393|NCT00236899|21058852|P4|Overall Study|Withdrawal by Subject|2
6104394|NCT00236899|21058853|P3|Overall Study|Withdrawal by Subject|5
6104395|NCT00236899|21058854|P2|Overall Study|Withdrawal by Subject|4
6104396|NCT00236899|21058855|P1|Overall Study|Withdrawal by Subject|6
6104397|NCT00236899|21058852|P4|Overall Study|Protocol Violation|0
6104398|NCT00236899|21058853|P3|Overall Study|Protocol Violation|0
6104399|NCT00236899|21058854|P2|Overall Study|Protocol Violation|0
6104400|NCT00236899|21058855|P1|Overall Study|Protocol Violation|1
6104401|NCT00236899|21058852|P4|Overall Study|Entry Criteria Exclusion|0
6104402|NCT00236899|21058853|P3|Overall Study|Entry Criteria Exclusion|1
6104403|NCT00236899|21058854|P2|Overall Study|Entry Criteria Exclusion|1
6104404|NCT00236899|21058855|P1|Overall Study|Entry Criteria Exclusion|0
6104405|NCT00236899|21058852|P4|Overall Study|Lost to Follow-up|0
6104406|NCT00236899|21058853|P3|Overall Study|Lost to Follow-up|0
6104407|NCT00236899|21058854|P2|Overall Study|Lost to Follow-up|1
6104408|NCT00236899|21058855|P1|Overall Study|Lost to Follow-up|0
6104409|NCT00236899|21058852|P4|Overall Study|Death (Study Drug Toxicity)|0
6104410|NCT00236899|21058853|P3|Overall Study|Death (Study Drug Toxicity)|0
6104411|NCT00236899|21058854|P2|Overall Study|Death (Study Drug Toxicity)|0
6104412|NCT00236899|21058855|P1|Overall Study|Death (Study Drug Toxicity)|1
6104413|NCT00236899|21058852|P4|Overall Study|Death (Not Study Related)|0
6104414|NCT00236899|21058853|P3|Overall Study|Death (Not Study Related)|0
6104415|NCT00236899|21058854|P2|Overall Study|Death (Not Study Related)|0
6104416|NCT00236899|21058855|P1|Overall Study|Death (Not Study Related)|2
6104417|NCT00236899|21058852|P4|Overall Study|Death (Study Disease)|0
6104418|NCT00236899|21058853|P3|Overall Study|Death (Study Disease)|0
6104419|NCT00236899|21058854|P2|Overall Study|Death (Study Disease)|4
6104420|NCT00236899|21058855|P1|Overall Study|Death (Study Disease)|1
6104421|NCT00236899|21058852|P4|Overall Study|Adverse Event (Not Study Related)|7
6104422|NCT00236899|21058853|P3|Overall Study|Adverse Event (Not Study Related)|4
6104423|NCT00236899|21058854|P2|Overall Study|Adverse Event (Not Study Related)|3
6104424|NCT00236899|21058855|P1|Overall Study|Adverse Event (Not Study Related)|3
6104425|NCT00236899|21058852|P4|Overall Study|Adverse Event (Study Related)|1
6104426|NCT00236899|21058853|P3|Overall Study|Adverse Event (Study Related)|2
6104427|NCT00236899|21058854|P2|Overall Study|Adverse Event (Study Related)|1
6104428|NCT00236899|21058855|P1|Overall Study|Adverse Event (Study Related)|1
6104429|NCT00236197|21058887|P2|Overall Study|Other|2
6104430|NCT00236197|21058888|P1|Overall Study|Other|0
6104431|NCT00236197|21058887|P2|Overall Study|Medication non-compliance|2
6104432|NCT00236197|21058888|P1|Overall Study|Medication non-compliance|1
6104433|NCT00236197|21058887|P2|Overall Study|Protocol Violation|3
6104434|NCT00236197|21058888|P1|Overall Study|Protocol Violation|0
6104435|NCT00236197|21058887|P2|Overall Study|Lost to Follow-up|5
6104436|NCT00236197|21058888|P1|Overall Study|Lost to Follow-up|1
6104437|NCT00236197|21058887|P2|Overall Study|Withdrawal by Subject|2
6104438|NCT00236197|21058888|P1|Overall Study|Withdrawal by Subject|3
6104439|NCT00236184|21058896|P2|Overall Study|other|2
6104440|NCT00236184|21058897|P1|Overall Study|other|1
6104441|NCT00236184|21058896|P2|Overall Study|non-compliance with study drug|1
6104442|NCT00236184|21058897|P1|Overall Study|non-compliance with study drug|2
6104443|NCT00236184|21058896|P2|Overall Study|Protocol Violation|0
6104444|NCT00236184|21058897|P1|Overall Study|Protocol Violation|3
6104445|NCT00236184|21058896|P2|Overall Study|Withdrawal by Subject|0
6104446|NCT00236184|21058897|P1|Overall Study|Withdrawal by Subject|3
6104447|NCT00236184|21058896|P2|Overall Study|Physician Decision|1
6104448|NCT00236184|21058897|P1|Overall Study|Physician Decision|1
6104449|NCT00236184|21058896|P2|Overall Study|Lost to Follow-up|4
6104450|NCT00236184|21058897|P1|Overall Study|Lost to Follow-up|3
6104451|NCT00236184|21058896|P2|Overall Study|Lack of Efficacy|1
6104452|NCT00236184|21058897|P1|Overall Study|Lack of Efficacy|0
6104453|NCT00236184|21058896|P2|Overall Study|Adverse Event|2
6104454|NCT00236184|21058897|P1|Overall Study|Adverse Event|5
6104455|NCT00236080|21058908|P5|Overall Study|Miscellaneous|0
6104456|NCT00236080|21058909|P4|Overall Study|Miscellaneous|0
6104457|NCT00236080|21058910|P3|Overall Study|Miscellaneous|1
6104458|NCT00236080|21058911|P2|Overall Study|Miscellaneous|0
6104459|NCT00236080|21058912|P1|Overall Study|Miscellaneous|0
6104460|NCT00236080|21058908|P5|Overall Study|Withdrawal by Subject|0
6104461|NCT00236080|21058909|P4|Overall Study|Withdrawal by Subject|0
6104462|NCT00236080|21058910|P3|Overall Study|Withdrawal by Subject|0
6104463|NCT00236080|21058911|P2|Overall Study|Withdrawal by Subject|0
6104464|NCT00236080|21058912|P1|Overall Study|Withdrawal by Subject|1
6104465|NCT00236080|21058908|P5|Overall Study|Physician Decision|1
6104466|NCT00236080|21058909|P4|Overall Study|Physician Decision|1
6104467|NCT00236080|21058910|P3|Overall Study|Physician Decision|1
6104468|NCT00236080|21058911|P2|Overall Study|Physician Decision|0
6104469|NCT00236080|21058912|P1|Overall Study|Physician Decision|1
6104470|NCT00236080|21058908|P5|Overall Study|Lost to Follow-up|0
6104471|NCT00236080|21058909|P4|Overall Study|Lost to Follow-up|0
6104472|NCT00236080|21058910|P3|Overall Study|Lost to Follow-up|0
6104473|NCT00236080|21058911|P2|Overall Study|Lost to Follow-up|1
6104474|NCT00236080|21058912|P1|Overall Study|Lost to Follow-up|0
6104475|NCT00236080|21058908|P5|Overall Study|Adverse Event|0
6104476|NCT00236080|21058909|P4|Overall Study|Adverse Event|1
6104477|NCT00236080|21058910|P3|Overall Study|Adverse Event|3
6104478|NCT00236080|21058911|P2|Overall Study|Adverse Event|0
6104479|NCT00236080|21058912|P1|Overall Study|Adverse Event|0
6104480|NCT00235989|21058933|P6|Extension Treatment Period (ET)|´Other´ not further itemized|0
6104481|NCT00235989|21058934|P5|Extension Treatment Period (ET)|´Other´ not further itemized|0
6104482|NCT00235989|21058935|P4|Extension Treatment Period (ET)|´Other´ not further itemized|2
6104483|NCT00235989|21058936|P3|Extension Treatment Period (ET)|´Other´ not further itemized|1
6104484|NCT00235989|21058937|P2|Extension Treatment Period (ET)|´Other´ not further itemized|3
6104485|NCT00235989|21058938|P1|Extension Treatment Period (ET)|´Other´ not further itemized|2
6104486|NCT00235989|21058933|P6|Extension Treatment Period (ET)|Withdrawal by Subject|0
6104487|NCT00235989|21058934|P5|Extension Treatment Period (ET)|Withdrawal by Subject|0
6104488|NCT00235989|21058935|P4|Extension Treatment Period (ET)|Withdrawal by Subject|4
6104489|NCT00235989|21058936|P3|Extension Treatment Period (ET)|Withdrawal by Subject|1
6104490|NCT00235989|21058937|P2|Extension Treatment Period (ET)|Withdrawal by Subject|1
6104491|NCT00235989|21058938|P1|Extension Treatment Period (ET)|Withdrawal by Subject|1
6104492|NCT00235989|21058933|P6|Extension Treatment Period (ET)|Lost to Follow-up|0
6104493|NCT00235989|21058934|P5|Extension Treatment Period (ET)|Lost to Follow-up|0
6104494|NCT00235989|21058935|P4|Extension Treatment Period (ET)|Lost to Follow-up|0
6104495|NCT00235989|21058936|P3|Extension Treatment Period (ET)|Lost to Follow-up|1
6104496|NCT00235989|21058937|P2|Extension Treatment Period (ET)|Lost to Follow-up|0
6104497|NCT00235989|21058938|P1|Extension Treatment Period (ET)|Lost to Follow-up|2
6104498|NCT00235989|21058933|P6|Extension Treatment Period (ET)|Adverse Event|0
6104499|NCT00235989|21058934|P5|Extension Treatment Period (ET)|Adverse Event|0
6104500|NCT00235989|21058935|P4|Extension Treatment Period (ET)|Adverse Event|0
6104501|NCT00235989|21058936|P3|Extension Treatment Period (ET)|Adverse Event|2
6104502|NCT00235989|21058937|P2|Extension Treatment Period (ET)|Adverse Event|0
6104503|NCT00235989|21058938|P1|Extension Treatment Period (ET)|Adverse Event|3
6104504|NCT00235989|21058933|P6|Core Treatment Period (CT)|Lost to Follow-up|2
6104505|NCT00235989|21058934|P5|Core Treatment Period (CT)|Lost to Follow-up|0
6104506|NCT00235989|21058935|P4|Core Treatment Period (CT)|Lost to Follow-up|0
6104507|NCT00235989|21058936|P3|Core Treatment Period (CT)|Lost to Follow-up|0
6104508|NCT00235989|21058937|P2|Core Treatment Period (CT)|Lost to Follow-up|0
6104509|NCT00235989|21058938|P1|Core Treatment Period (CT)|Lost to Follow-up|0
6104510|NCT00235872|21058952|P1|Overall Study|Administrative reason|61
6104511|NCT00235872|21058952|P1|Overall Study|Withdrawal by Subject|50
6104512|NCT00235872|21058952|P1|Overall Study|Lost to Follow-up|1
6104513|NCT00235872|21058952|P1|Overall Study|Death|1
6104514|NCT00235872|21058952|P1|Overall Study|Adverse Event|34
6104515|NCT00235755|21058983|P3|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0
6104516|NCT00235755|21058984|P2|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0
6104517|NCT00235755|21058985|P1|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|1
6104518|NCT00235755|21058983|P3|12-Week Maintenance Phase|Withdrawal by Subject|3
6104519|NCT00235755|21058984|P2|12-Week Maintenance Phase|Withdrawal by Subject|8
6104520|NCT00235755|21058985|P1|12-Week Maintenance Phase|Withdrawal by Subject|0
6104521|NCT00235755|21058983|P3|12-Week Maintenance Phase|Protocol Violation|2
6104522|NCT00235755|21058984|P2|12-Week Maintenance Phase|Protocol Violation|4
6104523|NCT00235755|21058985|P1|12-Week Maintenance Phase|Protocol Violation|0
6104524|NCT00235755|21058983|P3|12-Week Maintenance Phase|Lack of Efficacy|0
6104525|NCT00235755|21058984|P2|12-Week Maintenance Phase|Lack of Efficacy|0
6104526|NCT00235755|21058985|P1|12-Week Maintenance Phase|Lack of Efficacy|5
6104527|NCT00235755|21058983|P3|12-Week Maintenance Phase|Lost to Follow-up|0
6104528|NCT00235755|21058984|P2|12-Week Maintenance Phase|Lost to Follow-up|3
6104529|NCT00235755|21058985|P1|12-Week Maintenance Phase|Lost to Follow-up|2
6104530|NCT00235755|21058983|P3|12-Week Maintenance Phase|Adverse Event|26
6104531|NCT00235755|21058984|P2|12-Week Maintenance Phase|Adverse Event|12
6104532|NCT00235755|21058985|P1|12-Week Maintenance Phase|Adverse Event|8
6104533|NCT00235755|21058983|P3|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0
6104534|NCT00235755|21058984|P2|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0
6104535|NCT00235755|21058985|P1|4-Week Titration Phase|Prolonged QT Interval at Visit 3|1
6104536|NCT00235755|21058983|P3|4-Week Titration Phase|Randomization Occurred in Error|0
6104537|NCT00235755|21058984|P2|4-Week Titration Phase|Randomization Occurred in Error|0
6104538|NCT00235755|21058985|P1|4-Week Titration Phase|Randomization Occurred in Error|1
6104539|NCT00235755|21058983|P3|4-Week Titration Phase|Participant Did Not Receive Study Drug|1
6104540|NCT00235755|21058984|P2|4-Week Titration Phase|Participant Did Not Receive Study Drug|0
6104541|NCT00235755|21058985|P1|4-Week Titration Phase|Participant Did Not Receive Study Drug|0
6104542|NCT00235755|21058983|P3|4-Week Titration Phase|Withdrawal by Subject|3
6104543|NCT00235755|21058984|P2|4-Week Titration Phase|Withdrawal by Subject|2
6104544|NCT00235755|21058985|P1|4-Week Titration Phase|Withdrawal by Subject|1
6104545|NCT00235755|21058983|P3|4-Week Titration Phase|Protocol Violation|1
6104546|NCT00235755|21058984|P2|4-Week Titration Phase|Protocol Violation|2
6104547|NCT00235755|21058985|P1|4-Week Titration Phase|Protocol Violation|2
6104548|NCT00235755|21058983|P3|4-Week Titration Phase|Lost to Follow-up|1
6104549|NCT00235755|21058984|P2|4-Week Titration Phase|Lost to Follow-up|1
6104550|NCT00235755|21058985|P1|4-Week Titration Phase|Lost to Follow-up|0
6104551|NCT00235755|21058983|P3|4-Week Titration Phase|Adverse Event|20
6104552|NCT00235755|21058984|P2|4-Week Titration Phase|Adverse Event|14
6104553|NCT00235755|21058985|P1|4-Week Titration Phase|Adverse Event|6
6104554|NCT00235716|21059063|P4|Overall Study|Physician Decision|3
6104555|NCT00235716|21059064|P3|Overall Study|Physician Decision|1
6104556|NCT00235716|21059065|P2|Overall Study|Physician Decision|1
6104557|NCT00235716|21059066|P1|Overall Study|Physician Decision|0
6104558|NCT00235716|21059063|P4|Overall Study|Adverse Event|0
6104559|NCT00235716|21059064|P3|Overall Study|Adverse Event|1
6104560|NCT00235716|21059065|P2|Overall Study|Adverse Event|1
6104561|NCT00235716|21059066|P1|Overall Study|Adverse Event|1
6104562|NCT00235716|21059063|P4|Overall Study|Lost to Follow-up|10
6104563|NCT00235716|21059064|P3|Overall Study|Lost to Follow-up|14
6104564|NCT00235716|21059065|P2|Overall Study|Lost to Follow-up|7
6104565|NCT00235716|21059066|P1|Overall Study|Lost to Follow-up|12
6104566|NCT00235716|21059063|P4|Overall Study|Withdrawal by Subject|18
6104567|NCT00235716|21059064|P3|Overall Study|Withdrawal by Subject|17
6104568|NCT00235716|21059065|P2|Overall Study|Withdrawal by Subject|19
6104569|NCT00235716|21059066|P1|Overall Study|Withdrawal by Subject|23
6104570|NCT00235716|21059063|P4|Overall Study|Death|31
6104571|NCT00235716|21059064|P3|Overall Study|Death|32
6104572|NCT00235716|21059065|P2|Overall Study|Death|39
6104573|NCT00235716|21059066|P1|Overall Study|Death|26
6104574|NCT00235495|21059117|P2|Overall Study|Visit/assessmen outside window/missing|10
6104575|NCT00235495|21059118|P1|Overall Study|Visit/assessmen outside window/missing|0
6104576|NCT00235495|21059117|P2|Overall Study|Lost to Follow-up|13
6104577|NCT00235495|21059118|P1|Overall Study|Lost to Follow-up|11
6104578|NCT00235495|21059117|P2|Overall Study|Withdrawal by Subject|3
6104579|NCT00235495|21059118|P1|Overall Study|Withdrawal by Subject|5
6104580|NCT00235495|21059117|P2|Overall Study|Death|42
6104581|NCT00235495|21059118|P1|Overall Study|Death|52
6104582|NCT00235443|21059191|P6|Overall Study|Other reasons for premature termination|6
6104583|NCT00235443|21059192|P5|Overall Study|Other reasons for premature termination|3
6104584|NCT00235443|21059193|P4|Overall Study|Other reasons for premature termination|7
6104585|NCT00235443|21059194|P3|Overall Study|Other reasons for premature termination|6
6104586|NCT00235443|21059195|P2|Overall Study|Other reasons for premature termination|6
6104587|NCT00235443|21059196|P1|Overall Study|Other reasons for premature termination|1
6104588|NCT00235443|21059191|P6|Overall Study|Unsatisfactory compliance|0
6104589|NCT00235443|21059192|P5|Overall Study|Unsatisfactory compliance|1
6104590|NCT00235443|21059193|P4|Overall Study|Unsatisfactory compliance|4
6104591|NCT00235443|21059194|P3|Overall Study|Unsatisfactory compliance|3
6104592|NCT00235443|21059195|P2|Overall Study|Unsatisfactory compliance|2
6104593|NCT00235443|21059196|P1|Overall Study|Unsatisfactory compliance|0
6104594|NCT00235443|21059191|P6|Overall Study|Lost to Follow-up|3
6104595|NCT00235443|21059192|P5|Overall Study|Lost to Follow-up|4
6104596|NCT00235443|21059193|P4|Overall Study|Lost to Follow-up|6
6104597|NCT00235443|21059194|P3|Overall Study|Lost to Follow-up|6
6104598|NCT00235443|21059195|P2|Overall Study|Lost to Follow-up|8
6104599|NCT00235443|21059196|P1|Overall Study|Lost to Follow-up|0
6104600|NCT00235443|21059191|P6|Overall Study|Withdrawal by Subject|12
6104601|NCT00235443|21059192|P5|Overall Study|Withdrawal by Subject|10
6104602|NCT00235443|21059193|P4|Overall Study|Withdrawal by Subject|24
6104603|NCT00235443|21059194|P3|Overall Study|Withdrawal by Subject|25
6104604|NCT00235443|21059195|P2|Overall Study|Withdrawal by Subject|9
6104605|NCT00235443|21059196|P1|Overall Study|Withdrawal by Subject|3
6104606|NCT00235443|21059191|P6|Overall Study|Lack of Efficacy|9
6104607|NCT00235443|21059192|P5|Overall Study|Lack of Efficacy|2
6104608|NCT00235443|21059193|P4|Overall Study|Lack of Efficacy|12
6104609|NCT00235443|21059194|P3|Overall Study|Lack of Efficacy|5
6104610|NCT00235443|21059195|P2|Overall Study|Lack of Efficacy|1
6104611|NCT00235443|21059196|P1|Overall Study|Lack of Efficacy|0
6104612|NCT00235443|21059191|P6|Overall Study|Adverse Event|15
6104613|NCT00235443|21059192|P5|Overall Study|Adverse Event|10
6104614|NCT00235443|21059193|P4|Overall Study|Adverse Event|44
6104615|NCT00235443|21059194|P3|Overall Study|Adverse Event|17
6104616|NCT00235443|21059195|P2|Overall Study|Adverse Event|12
6104617|NCT00235443|21059196|P1|Overall Study|Adverse Event|4
6104618|NCT00235391|21059337|P6|Overall Study|Death|0
6104619|NCT00235391|21059338|P5|Overall Study|Death|0
6104620|NCT00235391|21059339|P4|Overall Study|Death|4
6104621|NCT00235391|21059340|P3|Overall Study|Death|1
6104622|NCT00235391|21059341|P2|Overall Study|Death|0
6104623|NCT00235391|21059342|P1|Overall Study|Death|0
6104624|NCT00235391|21059337|P6|Overall Study|Administrative problems|0
6104625|NCT00235391|21059338|P5|Overall Study|Administrative problems|0
6104626|NCT00235391|21059339|P4|Overall Study|Administrative problems|1
6104627|NCT00235391|21059340|P3|Overall Study|Administrative problems|0
6104628|NCT00235391|21059341|P2|Overall Study|Administrative problems|0
6104629|NCT00235391|21059342|P1|Overall Study|Administrative problems|0
6104630|NCT00235391|21059337|P6|Overall Study|Lost to Follow-up|0
6104631|NCT00235391|21059338|P5|Overall Study|Lost to Follow-up|0
6104632|NCT00235391|21059339|P4|Overall Study|Lost to Follow-up|16
6104633|NCT00235391|21059340|P3|Overall Study|Lost to Follow-up|3
6104634|NCT00235391|21059341|P2|Overall Study|Lost to Follow-up|3
6104635|NCT00235391|21059342|P1|Overall Study|Lost to Follow-up|0
6104636|NCT00235391|21059337|P6|Overall Study|Withdrawal by Subject|0
6104637|NCT00235391|21059338|P5|Overall Study|Withdrawal by Subject|5
6104638|NCT00235391|21059339|P4|Overall Study|Withdrawal by Subject|61
6104639|NCT00235391|21059340|P3|Overall Study|Withdrawal by Subject|3
6104640|NCT00235391|21059341|P2|Overall Study|Withdrawal by Subject|3
6104641|NCT00235391|21059342|P1|Overall Study|Withdrawal by Subject|2
6104642|NCT00235391|21059337|P6|Overall Study|Protocol deviation|0
6104643|NCT00235391|21059338|P5|Overall Study|Protocol deviation|0
6104644|NCT00235391|21059339|P4|Overall Study|Protocol deviation|11
6104645|NCT00235391|21059340|P3|Overall Study|Protocol deviation|1
6104646|NCT00235391|21059341|P2|Overall Study|Protocol deviation|0
6104647|NCT00235391|21059342|P1|Overall Study|Protocol deviation|0
6104648|NCT00235391|21059337|P6|Overall Study|Condition no longer requires treatment|0
6104649|NCT00235391|21059338|P5|Overall Study|Condition no longer requires treatment|1
6104650|NCT00235391|21059339|P4|Overall Study|Condition no longer requires treatment|11
6104651|NCT00235391|21059340|P3|Overall Study|Condition no longer requires treatment|0
6104652|NCT00235391|21059341|P2|Overall Study|Condition no longer requires treatment|0
6104653|NCT00235391|21059342|P1|Overall Study|Condition no longer requires treatment|3
6104654|NCT00235391|21059337|P6|Overall Study|Unsatisfactory therapeutic effect|0
6104655|NCT00235391|21059338|P5|Overall Study|Unsatisfactory therapeutic effect|0
6104656|NCT00235391|21059339|P4|Overall Study|Unsatisfactory therapeutic effect|17
6104657|NCT00235391|21059340|P3|Overall Study|Unsatisfactory therapeutic effect|2
6104658|NCT00235391|21059341|P2|Overall Study|Unsatisfactory therapeutic effect|2
6104659|NCT00235391|21059342|P1|Overall Study|Unsatisfactory therapeutic effect|0
6104660|NCT00235391|21059337|P6|Overall Study|Abnormal laboratory value(s)|2
6104661|NCT00235391|21059338|P5|Overall Study|Abnormal laboratory value(s)|1
6104662|NCT00235391|21059339|P4|Overall Study|Abnormal laboratory value(s)|27
6104663|NCT00235391|21059340|P3|Overall Study|Abnormal laboratory value(s)|4
6104664|NCT00235391|21059341|P2|Overall Study|Abnormal laboratory value(s)|5
6104665|NCT00235391|21059342|P1|Overall Study|Abnormal laboratory value(s)|3
6104666|NCT00235391|21059337|P6|Overall Study|Adverse Event|2
6104667|NCT00235391|21059338|P5|Overall Study|Adverse Event|5
6104668|NCT00235391|21059339|P4|Overall Study|Adverse Event|72
6104669|NCT00235391|21059340|P3|Overall Study|Adverse Event|10
6104670|NCT00235391|21059341|P2|Overall Study|Adverse Event|5
6104671|NCT00235391|21059342|P1|Overall Study|Adverse Event|4
6104672|NCT00235326|21059359|P2|Overall Study|Lost to Follow-up|1400
6104673|NCT00235326|21059360|P1|Overall Study|Lost to Follow-up|746
6104674|NCT00234533|21059400|P1|Overall Study|Enrolled but not treated|3
6104675|NCT00234533|21059400|P1|Overall Study|Adverse Event|2
6104676|NCT00234533|21059400|P1|Overall Study|Withdrawal by Subject|6
6104677|NCT00234494|21059419|P1|Overall Study|Protocol Violation|2
6104678|NCT00234104|21059465|P4|Overall Study|Physician Decision|2
6104679|NCT00234104|21059466|P3|Overall Study|Physician Decision|2
6104680|NCT00234104|21059467|P2|Overall Study|Physician Decision|1
6104681|NCT00234104|21059468|P1|Overall Study|Physician Decision|0
6104682|NCT00234104|21059465|P4|Overall Study|Protocol Violation|1
6104683|NCT00234104|21059466|P3|Overall Study|Protocol Violation|0
6104684|NCT00234104|21059467|P2|Overall Study|Protocol Violation|0
6104685|NCT00234104|21059468|P1|Overall Study|Protocol Violation|0
6104686|NCT00234104|21059465|P4|Overall Study|Adverse Event|5
6104687|NCT00234104|21059466|P3|Overall Study|Adverse Event|3
6104688|NCT00234104|21059467|P2|Overall Study|Adverse Event|0
6104689|NCT00234104|21059468|P1|Overall Study|Adverse Event|4
6104690|NCT00234065|21059509|P2|Overall Study|Not Classified|112
6104691|NCT00234065|21059510|P1|Overall Study|Not Classified|111
6104692|NCT00234065|21059509|P2|Overall Study|Physician Decision|22
6104693|NCT00234065|21059510|P1|Overall Study|Physician Decision|23
6104694|NCT00234065|21059509|P2|Overall Study|Withdrawal by Subject|56
6104695|NCT00234065|21059510|P1|Overall Study|Withdrawal by Subject|73
6104696|NCT00234065|21059509|P2|Overall Study|Adverse Event|166
6104697|NCT00234065|21059510|P1|Overall Study|Adverse Event|268
6104698|NCT00234052|21059526|P1|Follow-up for 5 Years|Other|7
6104699|NCT00234052|21059526|P1|Follow-up for 5 Years|Lost to Follow-up|1
6104700|NCT00234052|21059526|P1|Follow-up for 5 Years|Death|41
6104701|NCT00234052|21059526|P1|Treatment|Progressive Disease|11
6104702|NCT00234052|21059526|P1|Treatment|Death|2
6104703|NCT00234052|21059526|P1|Treatment|Adverse Event|5
6104704|NCT00234052|21059526|P1|Treatment|Withdrawal by Subject|3
6104705|NCT00234039|21059536|P1|Overall Study|No Protocol Treatment Received|2
6104706|NCT00234039|21059536|P1|Overall Study|Ineligible|9
6104707|NCT00234039|21059536|P1|Overall Study|Other - Not Protocol Specified|3
6104708|NCT00234039|21059536|P1|Overall Study|Progression/relapse|34
6104709|NCT00234039|21059536|P1|Overall Study|Adverse Event|2
6104710|NCT00233987|21059543|P1|Overall Study|Ineligible|4
6104711|NCT00233987|21059543|P1|Overall Study|Eligible but No Treatment Received|2
6104712|NCT00233987|21059543|P1|Overall Study|Other - Not Protocol Specified|5
6104713|NCT00233987|21059543|P1|Overall Study|Reason Under Review|1
6104714|NCT00233987|21059543|P1|Overall Study|Lack of Efficacy|2
6104715|NCT00233987|21059543|P1|Overall Study|Withdrawal by Subject|1
6104716|NCT00233948|21059552|P6|Overall Study|Adverse Event|0
6104717|NCT00233948|21059553|P5|Overall Study|Adverse Event|0
6104718|NCT00233948|21059554|P4|Overall Study|Adverse Event|0
6104719|NCT00233948|21059555|P3|Overall Study|Adverse Event|0
6104720|NCT00233948|21059556|P2|Overall Study|Adverse Event|0
6104721|NCT00233948|21059557|P1|Overall Study|Adverse Event|1
6104722|NCT00233480|21059583|P2|Overall Study|Underwent status II heart transplant|1
6104723|NCT00233480|21059584|P1|Overall Study|Underwent status II heart transplant|0
6104724|NCT00233454|21059600|P1|Overall Study|Death|6
6104725|NCT00233402|21059608|P2|Overall Study|Lost to follow up etc|21
6104726|NCT00233402|21059609|P1|Overall Study|Lost to follow up etc|3
6104727|NCT00233402|21059608|P2|Overall Study|No Ta/T1|94
6104728|NCT00233402|21059609|P1|Overall Study|No Ta/T1|89
6104729|NCT00233402|21059608|P2|Overall Study|No pathology data|9
6104730|NCT00233402|21059609|P1|Overall Study|No pathology data|12
6104731|NCT00233324|21059624|P4|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7
6104732|NCT00233324|21059625|P3|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|13
6104733|NCT00233324|21059626|P2|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7
6104734|NCT00233324|21059627|P1|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|8
6104735|NCT00233324|21059624|P4|Follow up at 18-22 Months Corrected Age|Death|4
6104736|NCT00233324|21059625|P3|Follow up at 18-22 Months Corrected Age|Death|5
6104737|NCT00233324|21059626|P2|Follow up at 18-22 Months Corrected Age|Death|7
6104738|NCT00233324|21059627|P1|Follow up at 18-22 Months Corrected Age|Death|5
6104739|NCT00233324|21059624|P4|Main Study|Death|47
6104740|NCT00233324|21059625|P3|Main Study|Death|62
6104741|NCT00233324|21059626|P2|Main Study|Death|60
6104742|NCT00233324|21059627|P1|Main Study|Death|68
6104743|NCT00233064|21059749|P2|Overall Study|Moved to Dom. Republic|0
6104744|NCT00233064|21059750|P1|Overall Study|Moved to Dom. Republic|1
6104745|NCT00233064|21059749|P2|Overall Study|Protocol Violation|0
6104746|NCT00233064|21059750|P1|Overall Study|Protocol Violation|1
6104747|NCT00233064|21059749|P2|Overall Study|Relocation|1
6104748|NCT00233064|21059750|P1|Overall Study|Relocation|0
6104749|NCT00233064|21059749|P2|Overall Study|Death|1
6104750|NCT00233064|21059750|P1|Overall Study|Death|0
6104751|NCT00233064|21059749|P2|Overall Study|Withdrawal by Subject|3
6104752|NCT00233064|21059750|P1|Overall Study|Withdrawal by Subject|5
6104753|NCT00233064|21059749|P2|Overall Study|Lost to Follow-up|7
6104754|NCT00233064|21059750|P1|Overall Study|Lost to Follow-up|7
6104755|NCT00232596|21059776|P2|12-Week Maintenance Phase|Other|3
6104756|NCT00232596|21059777|P1|12-Week Maintenance Phase|Other|1
6104757|NCT00232596|21059776|P2|12-Week Maintenance Phase|Protocol Violation|1
6104758|NCT00232596|21059777|P1|12-Week Maintenance Phase|Protocol Violation|3
6104759|NCT00232596|21059776|P2|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|2
6104760|NCT00232596|21059777|P1|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|1
6104761|NCT00232596|21059776|P2|12-Week Maintenance Phase|Adverse Event|22
6104762|NCT00232596|21059777|P1|12-Week Maintenance Phase|Adverse Event|7
6104763|NCT00232596|21059776|P2|6-Week Titration Phase|Participant Did Not Receive Study Drug|1
6104764|NCT00232596|21059777|P1|6-Week Titration Phase|Participant Did Not Receive Study Drug|0
6104765|NCT00232596|21059776|P2|6-Week Titration Phase|Other|3
6104766|NCT00232596|21059777|P1|6-Week Titration Phase|Other|3
6104767|NCT00232596|21059776|P2|6-Week Titration Phase|Participant Request Unrelated to Study|0
6104768|NCT00232596|21059777|P1|6-Week Titration Phase|Participant Request Unrelated to Study|1
6104769|NCT00232596|21059776|P2|6-Week Titration Phase|Protocol Violation|3
6104770|NCT00232596|21059777|P1|6-Week Titration Phase|Protocol Violation|1
6104771|NCT00232596|21059776|P2|6-Week Titration Phase|Unsatisfactory Response - Efficacy|2
6104772|NCT00232596|21059777|P1|6-Week Titration Phase|Unsatisfactory Response - Efficacy|1
6104773|NCT00232596|21059776|P2|6-Week Titration Phase|Failed to Return|1
6104774|NCT00232596|21059777|P1|6-Week Titration Phase|Failed to Return|2
6104775|NCT00232596|21059776|P2|6-Week Titration Phase|Adverse Event|19
6104776|NCT00232596|21059777|P1|6-Week Titration Phase|Adverse Event|6
6104777|NCT00232557|21059868|P2|Overall Study|Lost to Follow-up|5
6104778|NCT00232557|21059869|P1|Overall Study|Lost to Follow-up|3
6104779|NCT00232544|21059879|P2|Overall Study|Lost to Follow-up|15
6104780|NCT00232544|21059880|P1|Overall Study|Lost to Follow-up|20
6104781|NCT00232180|21059911|P3|Open Label Phase|Randomized but not treated|1
6104782|NCT00232180|21059912|P2|Open Label Phase|Randomized but not treated|0
6104783|NCT00232180|21059913|P1|Open Label Phase|Randomized but not treated|0
6104784|NCT00232180|21059911|P3|Open Label Phase|Laboratory abnormality|10
6104785|NCT00232180|21059912|P2|Open Label Phase|Laboratory abnormality|0
6104786|NCT00232180|21059913|P1|Open Label Phase|Laboratory abnormality|0
6104787|NCT00232180|21059911|P3|Open Label Phase|Adverse Event|25
6104788|NCT00232180|21059912|P2|Open Label Phase|Adverse Event|0
6104789|NCT00232180|21059913|P1|Open Label Phase|Adverse Event|0
6104790|NCT00232180|21059911|P3|Open Label Phase|Other|16
6104791|NCT00232180|21059912|P2|Open Label Phase|Other|0
6104792|NCT00232180|21059913|P1|Open Label Phase|Other|0
6104793|NCT00232180|21059911|P3|Open Label Phase|Withdrawal by Subject|37
6104794|NCT00232180|21059912|P2|Open Label Phase|Withdrawal by Subject|0
6104795|NCT00232180|21059913|P1|Open Label Phase|Withdrawal by Subject|0
6104796|NCT00232180|21059911|P3|Open Label Phase|Study terminated by sponsor|3
6104797|NCT00232180|21059912|P2|Open Label Phase|Study terminated by sponsor|0
6104798|NCT00232180|21059913|P1|Open Label Phase|Study terminated by sponsor|0
6104799|NCT00232180|21059911|P3|Open Label Phase|Protocol Violation|3
6104800|NCT00232180|21059912|P2|Open Label Phase|Protocol Violation|0
6104801|NCT00232180|21059913|P1|Open Label Phase|Protocol Violation|0
6104802|NCT00232180|21059911|P3|Open Label Phase|Lost to Follow-up|5
6104803|NCT00232180|21059912|P2|Open Label Phase|Lost to Follow-up|0
6104804|NCT00232180|21059913|P1|Open Label Phase|Lost to Follow-up|0
6104805|NCT00232180|21059911|P3|Open Label Phase|Death|48
6104806|NCT00232180|21059912|P2|Open Label Phase|Death|0
6104807|NCT00232180|21059913|P1|Open Label Phase|Death|0
6104808|NCT00232180|21059911|P3|Double-blind (DB) Phase|Laboratory abnormality|0
6104809|NCT00232180|21059912|P2|Double-blind (DB) Phase|Laboratory abnormality|7
6104810|NCT00232180|21059913|P1|Double-blind (DB) Phase|Laboratory abnormality|6
6104811|NCT00232180|21059911|P3|Double-blind (DB) Phase|Randomized but not treated|0
6104812|NCT00232180|21059912|P2|Double-blind (DB) Phase|Randomized but not treated|4
6104813|NCT00232180|21059913|P1|Double-blind (DB) Phase|Randomized but not treated|3
6104814|NCT00232180|21059911|P3|Double-blind (DB) Phase|Other|0
6104815|NCT00232180|21059912|P2|Double-blind (DB) Phase|Other|75
6104816|NCT00232180|21059913|P1|Double-blind (DB) Phase|Other|70
6104817|NCT00232180|21059911|P3|Double-blind (DB) Phase|Adverse Event|0
6104818|NCT00232180|21059912|P2|Double-blind (DB) Phase|Adverse Event|100
6104819|NCT00232180|21059913|P1|Double-blind (DB) Phase|Adverse Event|83
6104820|NCT00232180|21059911|P3|Double-blind (DB) Phase|Protocol Violation|0
6104821|NCT00232180|21059912|P2|Double-blind (DB) Phase|Protocol Violation|21
6104822|NCT00232180|21059913|P1|Double-blind (DB) Phase|Protocol Violation|28
6104823|NCT00232180|21059911|P3|Double-blind (DB) Phase|Withdrawal by Subject|0
6104824|NCT00232180|21059912|P2|Double-blind (DB) Phase|Withdrawal by Subject|148
6104825|NCT00232180|21059913|P1|Double-blind (DB) Phase|Withdrawal by Subject|131
6104826|NCT00232180|21059911|P3|Double-blind (DB) Phase|Lost to Follow-up|0
6104827|NCT00232180|21059912|P2|Double-blind (DB) Phase|Lost to Follow-up|28
6104828|NCT00232180|21059913|P1|Double-blind (DB) Phase|Lost to Follow-up|34
6104829|NCT00232180|21059911|P3|Double-blind (DB) Phase|Death|0
6104830|NCT00232180|21059912|P2|Double-blind (DB) Phase|Death|222
6104831|NCT00232180|21059913|P1|Double-blind (DB) Phase|Death|186
6104842|NCT00231894|21060029|P2|Overall Study|Withdrawal by Subject|1
6104843|NCT00231894|21060030|P1|Overall Study|Withdrawal by Subject|1
6104844|NCT00231842|21060056|P1|Overall Study|Did not complete the last 3 cycle|8
6104845|NCT00231842|21060056|P1|Overall Study|Withdrawal by Subject|3
6104846|NCT00231816|21060063|P2|Overall Study|Other|1
6104847|NCT00231816|21060064|P1|Overall Study|Other|2
6104848|NCT00231816|21060063|P2|Overall Study|Withdrawal by Subject|3
6104849|NCT00231816|21060064|P1|Overall Study|Withdrawal by Subject|3
6104850|NCT00231816|21060063|P2|Overall Study|Protocol Violation|3
6104851|NCT00231816|21060064|P1|Overall Study|Protocol Violation|2
6104852|NCT00231816|21060063|P2|Overall Study|Lost to Follow-up|5
6104853|NCT00231816|21060064|P1|Overall Study|Lost to Follow-up|8
6104854|NCT00231816|21060063|P2|Overall Study|Adverse Event|0
6104855|NCT00231816|21060064|P1|Overall Study|Adverse Event|1
6104856|NCT00231777|21060079|P2|Overall Study|Other|2
6104857|NCT00231777|21060080|P1|Overall Study|Other|3
6104858|NCT00231777|21060079|P2|Overall Study|Lost to Follow-up|0
6104859|NCT00231777|21060080|P1|Overall Study|Lost to Follow-up|3
6104860|NCT00231478|21060094|P2|Overall Study|Administrative|2
6104861|NCT00231478|21060095|P1|Overall Study|Administrative|3
6104862|NCT00231478|21060094|P2|Overall Study|Adverse Event|1
6104863|NCT00231478|21060095|P1|Overall Study|Adverse Event|0
6104864|NCT00231478|21060094|P2|Overall Study|Withdrawal by Subject|0
6104865|NCT00231478|21060095|P1|Overall Study|Withdrawal by Subject|1
6104866|NCT00231478|21060094|P2|Overall Study|Refused Treatment|1
6104867|NCT00231478|21060095|P1|Overall Study|Refused Treatment|1
6104868|NCT00231478|21060094|P2|Overall Study|Protocol Violation|2
6104869|NCT00231478|21060095|P1|Overall Study|Protocol Violation|3
6104870|NCT00231465|21060107|P1|Overall Study|Did not have follow up CT scans|1
6104871|NCT00231465|21060107|P1|Overall Study|Completed only one cycle|1
6104872|NCT00231413|21060120|P7|Overall Study|Pregnancy|0
6104873|NCT00231413|21060121|P6|Overall Study|Pregnancy|0
6104874|NCT00231413|21060122|P5|Overall Study|Pregnancy|0
6104875|NCT00231413|21060123|P4|Overall Study|Pregnancy|0
6104876|NCT00231413|21060124|P3|Overall Study|Pregnancy|0
6104877|NCT00231413|21060125|P2|Overall Study|Pregnancy|0
6104878|NCT00231413|21060126|P1|Overall Study|Pregnancy|1
6104879|NCT00231413|21060120|P7|Overall Study|Lost to Follow-up|0
6104880|NCT00231413|21060121|P6|Overall Study|Lost to Follow-up|4
6104881|NCT00231413|21060122|P5|Overall Study|Lost to Follow-up|1
6104882|NCT00231413|21060123|P4|Overall Study|Lost to Follow-up|1
6104883|NCT00231413|21060124|P3|Overall Study|Lost to Follow-up|1
6104884|NCT00231413|21060125|P2|Overall Study|Lost to Follow-up|4
6104885|NCT00231413|21060126|P1|Overall Study|Lost to Follow-up|4
6104886|NCT00231413|21060120|P7|Overall Study|Migrated/moved from study area|0
6104887|NCT00231413|21060121|P6|Overall Study|Migrated/moved from study area|1
6104888|NCT00231413|21060122|P5|Overall Study|Migrated/moved from study area|0
6104889|NCT00231413|21060123|P4|Overall Study|Migrated/moved from study area|0
6104890|NCT00231413|21060124|P3|Overall Study|Migrated/moved from study area|1
6104891|NCT00231413|21060125|P2|Overall Study|Migrated/moved from study area|0
6104892|NCT00231413|21060126|P1|Overall Study|Migrated/moved from study area|0
6104893|NCT00231413|21060120|P7|Overall Study|Withdrawal by Subject|3
6104894|NCT00231413|21060121|P6|Overall Study|Withdrawal by Subject|0
6104895|NCT00231413|21060122|P5|Overall Study|Withdrawal by Subject|2
6104896|NCT00231413|21060123|P4|Overall Study|Withdrawal by Subject|2
6104897|NCT00231413|21060124|P3|Overall Study|Withdrawal by Subject|4
6104898|NCT00231413|21060125|P2|Overall Study|Withdrawal by Subject|1
6104899|NCT00231413|21060126|P1|Overall Study|Withdrawal by Subject|3
6104900|NCT00231413|21060120|P7|Overall Study|Non-serious AE|1
6104901|NCT00231413|21060121|P6|Overall Study|Non-serious AE|0
6104902|NCT00231413|21060122|P5|Overall Study|Non-serious AE|0
6104903|NCT00231413|21060123|P4|Overall Study|Non-serious AE|0
6104904|NCT00231413|21060124|P3|Overall Study|Non-serious AE|1
6104905|NCT00231413|21060125|P2|Overall Study|Non-serious AE|0
6104906|NCT00231413|21060126|P1|Overall Study|Non-serious AE|0
6104907|NCT00231179|21060296|P2|Overall Study|Withdrawal by Subject|3
6104908|NCT00231179|21060297|P1|Overall Study|Withdrawal by Subject|3
6104909|NCT00231179|21060296|P2|Overall Study|Lost to Follow-up|21
6104910|NCT00231179|21060297|P1|Overall Study|Lost to Follow-up|21
6104911|NCT00231114|21060324|P2|Post-Treatment Period|Withdrawal by Subject|0
6104912|NCT00231114|21060325|P1|Post-Treatment Period|Withdrawal by Subject|1
6104913|NCT00231114|21060324|P2|Post-Treatment Period|Physician Decision|0
6104914|NCT00231114|21060325|P1|Post-Treatment Period|Physician Decision|1
6104915|NCT00231114|21060324|P2|Post-Treatment Period|Lost to Follow-up|1
6104916|NCT00231114|21060325|P1|Post-Treatment Period|Lost to Follow-up|6
6104917|NCT00231114|21060324|P2|Treatment Period|Death: Motor Vehicle Accident|0
6104918|NCT00231114|21060325|P1|Treatment Period|Death: Motor Vehicle Accident|1
6104919|NCT00231114|21060324|P2|Randomized|Withdrawal by Subject|3
6104920|NCT00231114|21060325|P1|Randomized|Withdrawal by Subject|6
6104921|NCT00231062|21060361|P1|Overall Study|Physician Decision|6
6104922|NCT00230971|21060369|P2|Baseline Participants|Reintervention|0
6104923|NCT00230971|21060370|P1|Baseline Participants|Reintervention|1
6104924|NCT00230971|21060369|P2|Baseline Participants|Failure to return|1
6104925|NCT00230971|21060370|P1|Baseline Participants|Failure to return|1
6104926|NCT00230971|21060369|P2|Baseline Participants|No bacteria observed|0
6104927|NCT00230971|21060370|P1|Baseline Participants|No bacteria observed|1
6104928|NCT00230971|21060369|P2|Baseline Participants|Adverse Event|0
6104929|NCT00230971|21060370|P1|Baseline Participants|Adverse Event|1
6104930|NCT00230971|21060369|P2|Baseline Participants|Withdrawal by Subject|1
6104931|NCT00230971|21060370|P1|Baseline Participants|Withdrawal by Subject|7
6104932|NCT00230971|21060369|P2|Baseline Participants|Death|5
6104933|NCT00230971|21060370|P1|Baseline Participants|Death|6
6104934|NCT00230971|21060369|P2|Baseline Participants|Lost to Follow-up|12
6104935|NCT00230971|21060370|P1|Baseline Participants|Lost to Follow-up|5
6104936|NCT00230971|21060369|P2|Randomization|No study drug administered|3
6104937|NCT00230971|21060370|P1|Randomization|No study drug administered|3
6104938|NCT00230282|21060408|P1|Fludarabine + Cyclophosphamide|Richters transformation (progression)|2
6104939|NCT00230282|21060408|P1|Fludarabine + Cyclophosphamide|Change in diagnosis|1
6104940|NCT00230282|21060408|P1|Fludarabine + Cyclophosphamide|Withdrawal by Subject|1
6104941|NCT00230282|21060408|P1|Fludarabine + Cyclophosphamide|Lost to Follow-up|4
6104942|NCT00230178|21060416|P3|Overall Study|Various other reasons|4
6104943|NCT00230178|21060417|P2|Overall Study|Various other reasons|2
6104944|NCT00230178|21060418|P1|Overall Study|Various other reasons|3
6104945|NCT00230178|21060416|P3|Overall Study|Withdrawal by Subject|1
6104946|NCT00230178|21060417|P2|Overall Study|Withdrawal by Subject|0
6104947|NCT00230178|21060418|P1|Overall Study|Withdrawal by Subject|0
6104948|NCT00230178|21060416|P3|Overall Study|Adverse Event|2
6104949|NCT00230178|21060417|P2|Overall Study|Adverse Event|5
6104950|NCT00230178|21060418|P1|Overall Study|Adverse Event|1
6104951|NCT00230048|21060470|P2|Overall Study|Lost to Follow-up|18
6104952|NCT00230048|21060471|P1|Overall Study|Lost to Follow-up|13
6104953|NCT00229931|21060529|P2|Overall Study|Lost to Follow-up|2
6104954|NCT00229931|21060530|P1|Overall Study|Lost to Follow-up|3
6104955|NCT00229931|21060529|P2|Overall Study|Death|0
6104956|NCT00229931|21060530|P1|Overall Study|Death|1
6104957|NCT00229723|21060545|P7|Maintenance Phase|Other|1
6104958|NCT00229723|21060546|P6|Maintenance Phase|Other|3
6104959|NCT00229723|21060547|P5|Maintenance Phase|Other|3
6104960|NCT00229723|21060548|P4|Maintenance Phase|Other|2
6104961|NCT00229723|21060549|P3|Maintenance Phase|Other|1
6104962|NCT00229723|21060550|P2|Maintenance Phase|Other|4
6104963|NCT00229723|21060551|P1|Maintenance Phase|Other|5
6104964|NCT00229723|21060545|P7|Maintenance Phase|Severe non-compliance|0
6104965|NCT00229723|21060546|P6|Maintenance Phase|Severe non-compliance|0
6104966|NCT00229723|21060547|P5|Maintenance Phase|Severe non-compliance|1
6104967|NCT00229723|21060548|P4|Maintenance Phase|Severe non-compliance|0
6104968|NCT00229723|21060549|P3|Maintenance Phase|Severe non-compliance|0
6104969|NCT00229723|21060550|P2|Maintenance Phase|Severe non-compliance|1
6104970|NCT00229723|21060551|P1|Maintenance Phase|Severe non-compliance|3
6104971|NCT00229723|21060545|P7|Maintenance Phase|Informed consent withdrawn|0
6104972|NCT00229723|21060546|P6|Maintenance Phase|Informed consent withdrawn|1
6104973|NCT00229723|21060547|P5|Maintenance Phase|Informed consent withdrawn|1
6104974|NCT00229723|21060548|P4|Maintenance Phase|Informed consent withdrawn|1
6104975|NCT00229723|21060549|P3|Maintenance Phase|Informed consent withdrawn|0
6104976|NCT00229723|21060550|P2|Maintenance Phase|Informed consent withdrawn|0
6104977|NCT00229723|21060551|P1|Maintenance Phase|Informed consent withdrawn|1
6104978|NCT00229723|21060545|P7|Maintenance Phase|Lost to Follow-up|1
6104979|NCT00229723|21060546|P6|Maintenance Phase|Lost to Follow-up|0
6104980|NCT00229723|21060547|P5|Maintenance Phase|Lost to Follow-up|0
6104981|NCT00229723|21060548|P4|Maintenance Phase|Lost to Follow-up|2
6104982|NCT00229723|21060549|P3|Maintenance Phase|Lost to Follow-up|2
6104983|NCT00229723|21060550|P2|Maintenance Phase|Lost to Follow-up|1
6104984|NCT00229723|21060551|P1|Maintenance Phase|Lost to Follow-up|0
6104985|NCT00229723|21060545|P7|Maintenance Phase|Clinical progression|1
6104986|NCT00229723|21060546|P6|Maintenance Phase|Clinical progression|1
6104987|NCT00229723|21060547|P5|Maintenance Phase|Clinical progression|1
6104988|NCT00229723|21060548|P4|Maintenance Phase|Clinical progression|2
6104989|NCT00229723|21060549|P3|Maintenance Phase|Clinical progression|2
6104990|NCT00229723|21060550|P2|Maintenance Phase|Clinical progression|1
6104991|NCT00229723|21060551|P1|Maintenance Phase|Clinical progression|4
6104992|NCT00229723|21060545|P7|Maintenance Phase|Objective disease progression|5
6104993|NCT00229723|21060546|P6|Maintenance Phase|Objective disease progression|9
6104994|NCT00229723|21060547|P5|Maintenance Phase|Objective disease progression|2
6104995|NCT00229723|21060548|P4|Maintenance Phase|Objective disease progression|6
6104996|NCT00229723|21060549|P3|Maintenance Phase|Objective disease progression|3
6104997|NCT00229723|21060550|P2|Maintenance Phase|Objective disease progression|5
6104998|NCT00229723|21060551|P1|Maintenance Phase|Objective disease progression|5
6104999|NCT00229723|21060545|P7|Maintenance Phase|Adverse Event|2
6105000|NCT00229723|21060546|P6|Maintenance Phase|Adverse Event|5
6105001|NCT00229723|21060547|P5|Maintenance Phase|Adverse Event|7
6105002|NCT00229723|21060548|P4|Maintenance Phase|Adverse Event|4
6105003|NCT00229723|21060549|P3|Maintenance Phase|Adverse Event|1
6105004|NCT00229723|21060550|P2|Maintenance Phase|Adverse Event|2
6105005|NCT00229723|21060551|P1|Maintenance Phase|Adverse Event|7
6105006|NCT00229723|21060545|P7|Concomitant Phase|Other|0
6105007|NCT00229723|21060546|P6|Concomitant Phase|Other|2
6105008|NCT00229723|21060547|P5|Concomitant Phase|Other|0
6105009|NCT00229723|21060548|P4|Concomitant Phase|Other|1
6105010|NCT00229723|21060549|P3|Concomitant Phase|Other|1
6105011|NCT00229723|21060550|P2|Concomitant Phase|Other|0
6105012|NCT00229723|21060551|P1|Concomitant Phase|Other|3
6105013|NCT00229723|21060545|P7|Concomitant Phase|Severe non-compliance|0
6105014|NCT00229723|21060546|P6|Concomitant Phase|Severe non-compliance|0
6105015|NCT00229723|21060547|P5|Concomitant Phase|Severe non-compliance|1
6105016|NCT00229723|21060548|P4|Concomitant Phase|Severe non-compliance|0
6105017|NCT00229723|21060549|P3|Concomitant Phase|Severe non-compliance|0
6105018|NCT00229723|21060550|P2|Concomitant Phase|Severe non-compliance|1
6105019|NCT00229723|21060551|P1|Concomitant Phase|Severe non-compliance|0
6105020|NCT00229723|21060545|P7|Concomitant Phase|Informed consent withdrawn|0
6105021|NCT00229723|21060546|P6|Concomitant Phase|Informed consent withdrawn|0
6105022|NCT00229723|21060547|P5|Concomitant Phase|Informed consent withdrawn|0
6105023|NCT00229723|21060548|P4|Concomitant Phase|Informed consent withdrawn|2
6105024|NCT00229723|21060549|P3|Concomitant Phase|Informed consent withdrawn|0
6105025|NCT00229723|21060550|P2|Concomitant Phase|Informed consent withdrawn|2
6105026|NCT00229723|21060551|P1|Concomitant Phase|Informed consent withdrawn|3
6105027|NCT00229723|21060545|P7|Concomitant Phase|Lost to Follow-up|0
6105028|NCT00229723|21060546|P6|Concomitant Phase|Lost to Follow-up|0
6105029|NCT00229723|21060547|P5|Concomitant Phase|Lost to Follow-up|1
6105030|NCT00229723|21060548|P4|Concomitant Phase|Lost to Follow-up|0
6105031|NCT00229723|21060549|P3|Concomitant Phase|Lost to Follow-up|0
6105032|NCT00229723|21060550|P2|Concomitant Phase|Lost to Follow-up|0
6105033|NCT00229723|21060551|P1|Concomitant Phase|Lost to Follow-up|0
6105034|NCT00229723|21060545|P7|Concomitant Phase|Clinical progression|1
6105035|NCT00229723|21060546|P6|Concomitant Phase|Clinical progression|0
6105036|NCT00229723|21060547|P5|Concomitant Phase|Clinical progression|0
6105037|NCT00229723|21060548|P4|Concomitant Phase|Clinical progression|0
6105038|NCT00229723|21060549|P3|Concomitant Phase|Clinical progression|0
6105039|NCT00229723|21060550|P2|Concomitant Phase|Clinical progression|0
6105040|NCT00229723|21060551|P1|Concomitant Phase|Clinical progression|0
6105041|NCT00229723|21060545|P7|Concomitant Phase|Objective disease progression|0
6105042|NCT00229723|21060546|P6|Concomitant Phase|Objective disease progression|0
6105043|NCT00229723|21060547|P5|Concomitant Phase|Objective disease progression|0
6105044|NCT00229723|21060548|P4|Concomitant Phase|Objective disease progression|0
6105045|NCT00229723|21060549|P3|Concomitant Phase|Objective disease progression|0
6105046|NCT00229723|21060550|P2|Concomitant Phase|Objective disease progression|0
6105047|NCT00229723|21060551|P1|Concomitant Phase|Objective disease progression|0
6105048|NCT00229723|21060545|P7|Concomitant Phase|Adverse Event|2
6105049|NCT00229723|21060546|P6|Concomitant Phase|Adverse Event|1
6105050|NCT00229723|21060547|P5|Concomitant Phase|Adverse Event|0
6105051|NCT00229723|21060548|P4|Concomitant Phase|Adverse Event|2
6105052|NCT00229723|21060549|P3|Concomitant Phase|Adverse Event|5
6105053|NCT00229723|21060550|P2|Concomitant Phase|Adverse Event|2
6105054|NCT00229723|21060551|P1|Concomitant Phase|Adverse Event|4
6105055|NCT00229658|21060604|P2|Overall Study|Withdrawal of consent|39
6105056|NCT00229658|21060605|P1|Overall Study|Withdrawal of consent|46
6105057|NCT00229658|21060604|P2|Overall Study|Serious Adverse Event|2
6105058|NCT00229658|21060605|P1|Overall Study|Serious Adverse Event|2
6105059|NCT00229658|21060604|P2|Overall Study|Lost to Follow-up|55
6105060|NCT00229658|21060605|P1|Overall Study|Lost to Follow-up|82
6105061|NCT00229658|21060604|P2|Overall Study|Other|60
6105062|NCT00229658|21060605|P1|Overall Study|Other|80
6105063|NCT00229658|21060604|P2|Overall Study|Investigator decision|10
6105064|NCT00229658|21060605|P1|Overall Study|Investigator decision|13
6105065|NCT00229658|21060604|P2|Overall Study|Administrative|1
6105066|NCT00229658|21060605|P1|Overall Study|Administrative|2
6105067|NCT00229203|21060641|P2|Overall Study|Withdrawal by Subject|4
6105068|NCT00229203|21060642|P1|Overall Study|Withdrawal by Subject|1
6105069|NCT00229203|21060641|P2|Overall Study|Other|3
6105070|NCT00229203|21060642|P1|Overall Study|Other|3
6105071|NCT00229203|21060641|P2|Overall Study|Death|2
6105072|NCT00229203|21060642|P1|Overall Study|Death|4
6105073|NCT00229203|21060641|P2|Overall Study|Toxicity|1
6105074|NCT00229203|21060642|P1|Overall Study|Toxicity|6
6105075|NCT00229203|21060641|P2|Overall Study|Progressive disease|9
6105076|NCT00229203|21060642|P1|Overall Study|Progressive disease|18
6105077|NCT00228917|21060670|P8|Overall Study|Migrated/moved from study area|0
6105078|NCT00228917|21060671|P7|Overall Study|Migrated/moved from study area|0
6105079|NCT00228917|21060672|P6|Overall Study|Migrated/moved from study area|2
6105080|NCT00228917|21060673|P5|Overall Study|Migrated/moved from study area|0
6105081|NCT00228917|21060674|P4|Overall Study|Migrated/moved from study area|0
6105082|NCT00228917|21060675|P3|Overall Study|Migrated/moved from study area|0
6105083|NCT00228917|21060676|P2|Overall Study|Migrated/moved from study area|0
6105084|NCT00228917|21060677|P1|Overall Study|Migrated/moved from study area|0
6105085|NCT00228813|21060723|P1|Overall Study|Death|4
6105086|NCT00228566|21060729|P1|Overall Study|Miscellaneous|1
6105087|NCT00228566|21060729|P1|Overall Study|Withdrawal by Subject|4
6105088|NCT00228566|21060729|P1|Overall Study|Physician Decision|5
6105089|NCT00228566|21060729|P1|Overall Study|Lost to Follow-up|16
6105090|NCT00228566|21060729|P1|Overall Study|Lack of Efficacy|14
6105091|NCT00228566|21060729|P1|Overall Study|Adverse Event|31
6105092|NCT00228553|21060733|P1|Overall Study|Miscellaneous|46
6105093|NCT00228553|21060733|P1|Overall Study|Pregnancy|2
6105094|NCT00228553|21060733|P1|Overall Study|Withdrawal by Subject|115
6105095|NCT00228553|21060733|P1|Overall Study|Protocol Violation|6
6105096|NCT00228553|21060733|P1|Overall Study|Physician Decision|48
6105097|NCT00228553|21060733|P1|Overall Study|Lost to Follow-up|67
6105098|NCT00228553|21060733|P1|Overall Study|Lack of Efficacy|34
6105099|NCT00228553|21060733|P1|Overall Study|Adverse Event|112
6105100|NCT00228384|21060739|P2|Overall Study|Physician Decision|1
6105101|NCT00228384|21060740|P1|Overall Study|Physician Decision|0
6105102|NCT00228384|21060739|P2|Overall Study|Withdrawal by Subject|10
6105103|NCT00228384|21060740|P1|Overall Study|Withdrawal by Subject|9
6105104|NCT00228384|21060739|P2|Overall Study|Surgical Intervention (bypass)|5
6105105|NCT00228384|21060740|P1|Overall Study|Surgical Intervention (bypass)|5
6105106|NCT00228384|21060739|P2|Overall Study|Lost to Follow-up|10
6105107|NCT00228384|21060740|P1|Overall Study|Lost to Follow-up|6
6105108|NCT00228384|21060739|P2|Overall Study|Death|3
6105109|NCT00228384|21060740|P1|Overall Study|Death|9
6105110|NCT00227903|21060791|P2|Overall Study|Miscarriage|0
6105111|NCT00227903|21060792|P1|Overall Study|Miscarriage|1
6105112|NCT00227903|21060791|P2|Overall Study|Lost to Follow-up|3
6105113|NCT00227903|21060792|P1|Overall Study|Lost to Follow-up|1
6105114|NCT00227903|21060791|P2|Overall Study|Subject moved out of area|2
6105115|NCT00227903|21060792|P1|Overall Study|Subject moved out of area|1
6105116|NCT00227903|21060791|P2|Overall Study|Withdrawal by Subject|5
6105117|NCT00227903|21060792|P1|Overall Study|Withdrawal by Subject|2
6105118|NCT00227877|21060856|P4|12-months Follow-up|Lost to Follow-up|26
6105119|NCT00227877|21060857|P3|12-months Follow-up|Lost to Follow-up|30
6105120|NCT00227877|21060858|P2|12-months Follow-up|Lost to Follow-up|189
6105121|NCT00227877|21060859|P1|12-months Follow-up|Lost to Follow-up|232
6105122|NCT00227877|21060856|P4|12-months Follow-up|Completed late|0
6105123|NCT00227877|21060857|P3|12-months Follow-up|Completed late|1
6105124|NCT00227877|21060858|P2|12-months Follow-up|Completed late|74
6105125|NCT00227877|21060859|P1|12-months Follow-up|Completed late|78
6105126|NCT00227877|21060856|P4|3-months Follow-up|Lost to Follow-up|13
6105127|NCT00227877|21060857|P3|3-months Follow-up|Lost to Follow-up|18
6105128|NCT00227877|21060858|P2|3-months Follow-up|Lost to Follow-up|139
6105129|NCT00227877|21060859|P1|3-months Follow-up|Lost to Follow-up|178
6105130|NCT00227877|21060856|P4|3-months Follow-up|Completed late|8
6105131|NCT00227877|21060857|P3|3-months Follow-up|Completed late|34
6105132|NCT00227877|21060858|P2|3-months Follow-up|Completed late|128
6105133|NCT00227877|21060859|P1|3-months Follow-up|Completed late|135
6105134|NCT00227877|21060856|P4|Post-visit Checklist|Lost to Follow-up|0
6105135|NCT00227877|21060857|P3|Post-visit Checklist|Lost to Follow-up|1
6105136|NCT00227877|21060858|P2|Post-visit Checklist|Lost to Follow-up|13
6105137|NCT00227877|21060859|P1|Post-visit Checklist|Lost to Follow-up|24
6105138|NCT00227877|21060856|P4|Pre-visit Assessment|Technical difficulties|0
6105139|NCT00227877|21060857|P3|Pre-visit Assessment|Technical difficulties|0
6105140|NCT00227877|21060858|P2|Pre-visit Assessment|Technical difficulties|3
6105141|NCT00227877|21060859|P1|Pre-visit Assessment|Technical difficulties|7
6105142|NCT00227721|21060895|P1|Overall Study|On study, but never treated.|1
6105143|NCT00227591|21060918|P1|Overall Study|Withdrawal by Subject|1
6105144|NCT00227539|21060922|P1|Overall Study|Protocol Violation|1
6105145|NCT00227370|21060930|P2|Overall Study|Other reasons|1
6105146|NCT00227370|21060931|P1|Overall Study|Other reasons|2
6105147|NCT00227370|21060930|P2|Overall Study|Physician Decision|6
6105148|NCT00227370|21060931|P1|Overall Study|Physician Decision|9
6105149|NCT00227370|21060930|P2|Overall Study|Adverse Event|11
6105150|NCT00227370|21060931|P1|Overall Study|Adverse Event|6
6105151|NCT00227370|21060930|P2|Overall Study|Death|4
6105152|NCT00227370|21060931|P1|Overall Study|Death|3
6105153|NCT00227370|21060930|P2|Overall Study|Withdrawal by Subject|2
6105154|NCT00227370|21060931|P1|Overall Study|Withdrawal by Subject|1
6105155|NCT00227344|21060951|P2|Overall Study|study terminated early|5
6105156|NCT00227344|21060952|P1|Overall Study|study terminated early|12
6105157|NCT00227305|21060972|P1|Overall Study|NECESSITY OF USING ANTI DEPRESSANT|1
6105158|NCT00227305|21060972|P1|Overall Study|LEAVING TOWN FOR 6 WEEKS|1
6105159|NCT00227305|21060972|P1|Overall Study|PERIOD SHORTENED FROM 6 wks to 4 wks|1
6105160|NCT00227305|21060972|P1|Overall Study|Physician Decision|3
6105161|NCT00227305|21060972|P1|Overall Study|Lack of Efficacy|7
6105162|NCT00227305|21060972|P1|Overall Study|MOVED OUT OF AREA|3
6105163|NCT00227305|21060972|P1|Overall Study|Study specific discontinuation|13
6105164|NCT00227305|21060972|P1|Overall Study|Lost to Follow-up|33
6105165|NCT00227305|21060972|P1|Overall Study|Withdrawal by Subject|42
6105166|NCT00227305|21060972|P1|Overall Study|Adverse Event|40
6105167|NCT00227266|21060989|P3|Overall Study|Excessive weight gain|2
6105168|NCT00227266|21060990|P2|Overall Study|Excessive weight gain|0
6105169|NCT00227266|21060991|P1|Overall Study|Excessive weight gain|0
6105170|NCT00227266|21060989|P3|Overall Study|Protocol Violation|1
6105171|NCT00227266|21060990|P2|Overall Study|Protocol Violation|0
6105172|NCT00227266|21060991|P1|Overall Study|Protocol Violation|1
6105173|NCT00227266|21060989|P3|Overall Study|Withdrawal by Subject|1
6105174|NCT00227266|21060990|P2|Overall Study|Withdrawal by Subject|0
6105175|NCT00227266|21060991|P1|Overall Study|Withdrawal by Subject|0
6105176|NCT00226941|21061021|P4|Overall Study|Withdrawn by investigator - unrelated AE|1
6105177|NCT00226941|21061022|P3|Overall Study|Withdrawn by investigator - unrelated AE|0
6105178|NCT00226941|21061023|P2|Overall Study|Withdrawn by investigator - unrelated AE|0
6105179|NCT00226941|21061024|P1|Overall Study|Withdrawn by investigator - unrelated AE|0
6105180|NCT00226941|21061021|P4|Overall Study|Withdrawal by subject - toxicity|1
6105181|NCT00226941|21061022|P3|Overall Study|Withdrawal by subject - toxicity|0
6105182|NCT00226941|21061023|P2|Overall Study|Withdrawal by subject - toxicity|0
6105183|NCT00226941|21061024|P1|Overall Study|Withdrawal by subject - toxicity|0
6105184|NCT00226811|21061058|P1|Overall Study|Withdrawal by Subject|2
6105185|NCT00226811|21061058|P1|Overall Study|Lack of Efficacy|55
6105186|NCT00226811|21061058|P1|Overall Study|Adverse Event|11
6105187|NCT00226811|21061058|P1|Overall Study|Death|8
6105188|NCT00226655|21061068|P1|Overall Study|Clinical deterioration|10
6105189|NCT00226655|21061068|P1|Overall Study|Physician Decision|6
6105190|NCT00226655|21061068|P1|Overall Study|Adverse Event|35
6105191|NCT00226655|21061068|P1|Overall Study|Withdrawal by Subject|15
6105192|NCT00226655|21061068|P1|Overall Study|Death|13
6105193|NCT00226499|21061090|P3|Overall Study|Others|356
6105194|NCT00226499|21061091|P2|Overall Study|Others|1066
6105195|NCT00226499|21061092|P1|Overall Study|Others|1064
6105196|NCT00226499|21061090|P3|Overall Study|Adverse Event|3
6105197|NCT00226499|21061091|P2|Overall Study|Adverse Event|6
6105198|NCT00226499|21061092|P1|Overall Study|Adverse Event|10
6105199|NCT00225758|21061227|P1|Overall Study|Adverse Event|4
6105200|NCT00225277|21061259|P2|Overall Study|Other|9
6105201|NCT00225277|21061260|P1|Overall Study|Other|7
6105202|NCT00225277|21061259|P2|Overall Study|Withdrawal by Subject|34
6105203|NCT00225277|21061260|P1|Overall Study|Withdrawal by Subject|40
6105204|NCT00225277|21061259|P2|Overall Study|Protocol Violation|3
6105205|NCT00225277|21061260|P1|Overall Study|Protocol Violation|6
6105206|NCT00225277|21061259|P2|Overall Study|Physician Decision|8
6105207|NCT00225277|21061260|P1|Overall Study|Physician Decision|6
6105208|NCT00225277|21061259|P2|Overall Study|Lost to Follow-up|6
6105209|NCT00225277|21061260|P1|Overall Study|Lost to Follow-up|4
6105210|NCT00225277|21061259|P2|Overall Study|Lack of Efficacy|1
6105211|NCT00225277|21061260|P1|Overall Study|Lack of Efficacy|4
6105212|NCT00225277|21061259|P2|Overall Study|Adverse Event|34
6105213|NCT00225277|21061260|P1|Overall Study|Adverse Event|30
6105214|NCT00225251|21061278|P2|Overall Study|Withdrawal by Subject|1
6105215|NCT00225251|21061279|P1|Overall Study|Withdrawal by Subject|1
6105216|NCT00225212|21061293|P1|Overall Study|Intercurrent illness|1
6105217|NCT00225212|21061293|P1|Overall Study|Adverse Event|2
6105218|NCT00225212|21061293|P1|Overall Study|Death|1
6105219|NCT00225212|21061293|P1|Overall Study|Disease progression|2
6105220|NCT00225147|21061302|P4|Open-label Phase|Withdrawal by Subject|6
6105221|NCT00225147|21061303|P3|Open-label Phase|Withdrawal by Subject|0
6105222|NCT00225147|21061304|P2|Open-label Phase|Withdrawal by Subject|0
6105223|NCT00225147|21061305|P1|Open-label Phase|Withdrawal by Subject|0
6105224|NCT00225147|21061302|P4|Open-label Phase|Lost to Follow-up|4
6105225|NCT00225147|21061303|P3|Open-label Phase|Lost to Follow-up|0
6105226|NCT00225147|21061304|P2|Open-label Phase|Lost to Follow-up|0
6105227|NCT00225147|21061305|P1|Open-label Phase|Lost to Follow-up|0
6105228|NCT00224874|21061352|P4|Overall Study|Withdrawal by Subject|0
6105229|NCT00224874|21061353|P3|Overall Study|Withdrawal by Subject|1
6105230|NCT00224874|21061354|P2|Overall Study|Withdrawal by Subject|0
6105231|NCT00224874|21061355|P1|Overall Study|Withdrawal by Subject|0
6105232|NCT00224770|21061400|P3|Overall Study|Lost to Follow-up|0
6105233|NCT00224770|21061401|P2|Overall Study|Lost to Follow-up|2
6105234|NCT00224770|21061402|P1|Overall Study|Lost to Follow-up|4
6105235|NCT00224484|21061437|P3|Overall Study|Reason not specified|2
6105236|NCT00224484|21061438|P2|Overall Study|Reason not specified|4
6105237|NCT00224484|21061439|P1|Overall Study|Reason not specified|5
6105238|NCT00224484|21061437|P3|Overall Study|Lost to Follow-up|36
6105239|NCT00224484|21061438|P2|Overall Study|Lost to Follow-up|28
6105240|NCT00224484|21061439|P1|Overall Study|Lost to Follow-up|66
6105241|NCT00224484|21061437|P3|Overall Study|Migrated/moved from study area|5
6105242|NCT00224484|21061438|P2|Overall Study|Migrated/moved from study area|5
6105243|NCT00224484|21061439|P1|Overall Study|Migrated/moved from study area|18
6105244|NCT00224484|21061437|P3|Overall Study|Withdrawal by Subject|16
6105245|NCT00224484|21061438|P2|Overall Study|Withdrawal by Subject|18
6105246|NCT00224484|21061439|P1|Overall Study|Withdrawal by Subject|49
6105247|NCT00224484|21061437|P3|Overall Study|Protocol Violation|0
6105248|NCT00224484|21061438|P2|Overall Study|Protocol Violation|2
6105249|NCT00224484|21061439|P1|Overall Study|Protocol Violation|2
6105250|NCT00224484|21061437|P3|Overall Study|Non-Serious Adverse Event|3
6105251|NCT00224484|21061438|P2|Overall Study|Non-Serious Adverse Event|7
6105252|NCT00224484|21061439|P1|Overall Study|Non-Serious Adverse Event|5
6105253|NCT00224484|21061437|P3|Overall Study|Serious Adverse Event|0
6105254|NCT00224484|21061438|P2|Overall Study|Serious Adverse Event|1
6105255|NCT00224484|21061439|P1|Overall Study|Serious Adverse Event|1
6105256|NCT00224133|21061503|P1|Overall Study|Other|14
6105257|NCT00224133|21061503|P1|Overall Study|Physician Decision|1
6105258|NCT00224133|21061503|P1|Overall Study|Lost to Follow-up|21
6105259|NCT00224133|21061503|P1|Overall Study|Lack of Efficacy|58
6105260|NCT00224133|21061503|P1|Overall Study|Withdrawal by Subject|33
6105261|NCT00224133|21061503|P1|Overall Study|Protocol Violation|6
6105262|NCT00224133|21061503|P1|Overall Study|Adverse Event|93
6105263|NCT00224120|21061509|P2|Overall Study|Other|5
6105264|NCT00224120|21061510|P1|Overall Study|Other|4
6105265|NCT00224120|21061509|P2|Overall Study|Lost to Follow-up|3
6105266|NCT00224120|21061510|P1|Overall Study|Lost to Follow-up|2
6105267|NCT00224120|21061509|P2|Overall Study|Lack of Efficacy|2
6105268|NCT00224120|21061510|P1|Overall Study|Lack of Efficacy|0
6105269|NCT00224120|21061509|P2|Overall Study|Withdrawal by Subject|10
6105270|NCT00224120|21061510|P1|Overall Study|Withdrawal by Subject|5
6105271|NCT00224120|21061509|P2|Overall Study|Protocol Violation|0
6105272|NCT00224120|21061510|P1|Overall Study|Protocol Violation|1
6105273|NCT00224120|21061509|P2|Overall Study|Adverse Event|4
6105274|NCT00224120|21061510|P1|Overall Study|Adverse Event|10
6105275|NCT00224107|21061520|P2|Overall Study|Other|1
6105276|NCT00224107|21061521|P1|Overall Study|Other|1
6105277|NCT00224107|21061520|P2|Overall Study|Physician Decision|0
6105278|NCT00224107|21061521|P1|Overall Study|Physician Decision|1
6105279|NCT00224107|21061520|P2|Overall Study|Lost to Follow-up|0
6105280|NCT00224107|21061521|P1|Overall Study|Lost to Follow-up|4
6105281|NCT00224107|21061520|P2|Overall Study|Lack of Efficacy|0
6105282|NCT00224107|21061521|P1|Overall Study|Lack of Efficacy|2
6105283|NCT00224107|21061520|P2|Overall Study|Withdrawal by Subject|4
6105284|NCT00224107|21061521|P1|Overall Study|Withdrawal by Subject|1
6105285|NCT00224107|21061520|P2|Overall Study|Protocol Violation|3
6105286|NCT00224107|21061521|P1|Overall Study|Protocol Violation|2
6105287|NCT00224107|21061520|P2|Overall Study|Adverse Event|6
6105288|NCT00224107|21061521|P1|Overall Study|Adverse Event|20
6105289|NCT00224055|21061531|P2|Overall Study|Other|0
6105290|NCT00224055|21061532|P1|Overall Study|Other|1
6105291|NCT00224055|21061531|P2|Overall Study|Withdrawal by Subject|2
6105292|NCT00224055|21061532|P1|Overall Study|Withdrawal by Subject|0
6105293|NCT00224055|21061531|P2|Overall Study|Inclusion Violation|6
6105294|NCT00224055|21061532|P1|Overall Study|Inclusion Violation|3
6105295|NCT00224055|21061531|P2|Overall Study|Protocol Violation|1
6105296|NCT00224055|21061532|P1|Overall Study|Protocol Violation|1
6105297|NCT00224055|21061531|P2|Overall Study|Lost to Follow-up|2
6105298|NCT00224055|21061532|P1|Overall Study|Lost to Follow-up|1
6105299|NCT00224055|21061531|P2|Overall Study|Adverse Event|3
6105300|NCT00224055|21061532|P1|Overall Study|Adverse Event|9
6105301|NCT00224042|21061542|P2|Overall Study|Other|0
6105302|NCT00224042|21061543|P1|Overall Study|Other|2
6105303|NCT00224042|21061542|P2|Overall Study|Did not meet lab incusion criteria|3
6105304|NCT00224042|21061543|P1|Overall Study|Did not meet lab incusion criteria|2
6105305|NCT00224042|21061542|P2|Overall Study|Physician Decision|1
6105306|NCT00224042|21061543|P1|Overall Study|Physician Decision|0
6105307|NCT00224042|21061542|P2|Overall Study|Protocol Violation|1
6105308|NCT00224042|21061543|P1|Overall Study|Protocol Violation|0
6105309|NCT00224042|21061542|P2|Overall Study|Adverse Event|1
6105310|NCT00224042|21061543|P1|Overall Study|Adverse Event|2
6105311|NCT00224029|21061555|P1|Overall Study|Other|1
6105312|NCT00224029|21061555|P1|Overall Study|Withdrawal by Subject|4
6105313|NCT00224029|21061555|P1|Overall Study|Lost to Follow-up|1
6105314|NCT00224016|21061561|P2|Maintenance Period|Lost to Follow-up|1
6105315|NCT00224016|21061562|P1|Maintenance Period|Lost to Follow-up|0
6105316|NCT00224016|21061561|P2|Maintenance Period|Withdrawal by Subject|0
6105317|NCT00224016|21061562|P1|Maintenance Period|Withdrawal by Subject|2
6105318|NCT00224016|21061561|P2|Titration Period|Lost to Follow-up|0
6105319|NCT00224016|21061562|P1|Titration Period|Lost to Follow-up|1
6105320|NCT00224016|21061561|P2|Titration Period|Withdrawal by Subject|1
6105321|NCT00224016|21061562|P1|Titration Period|Withdrawal by Subject|0
6105322|NCT00224003|21061570|P1|Overall Study|unk|3
6105323|NCT00224003|21061570|P1|Overall Study|Withdrawal by Subject|1
6105324|NCT00224003|21061570|P1|Overall Study|Protocol Violation|2
6105325|NCT00224003|21061570|P1|Overall Study|Adverse Event|1
6105332|NCT00223977|21061602|P3|Overall Study|Other|0
6105333|NCT00223977|21061603|P2|Overall Study|Other|0
6105334|NCT00223977|21061604|P1|Overall Study|Other|1
6105335|NCT00223977|21061602|P3|Overall Study|Withdrawal by Subject|2
6105336|NCT00223977|21061603|P2|Overall Study|Withdrawal by Subject|1
6105337|NCT00223977|21061604|P1|Overall Study|Withdrawal by Subject|1
6105338|NCT00223977|21061602|P3|Overall Study|Protocol Violation|1
6105339|NCT00223977|21061603|P2|Overall Study|Protocol Violation|0
6105340|NCT00223977|21061604|P1|Overall Study|Protocol Violation|0
6105341|NCT00223977|21061602|P3|Overall Study|Adverse Event|0
6105342|NCT00223977|21061603|P2|Overall Study|Adverse Event|10
6105343|NCT00223977|21061604|P1|Overall Study|Adverse Event|7
6105344|NCT00223808|21061638|P3|Overall Study|<5 hrs therapy before discharge|5
6105345|NCT00223808|21061639|P2|Overall Study|<5 hrs therapy before discharge|5
6105346|NCT00223808|21061640|P1|Overall Study|<5 hrs therapy before discharge|3
6105347|NCT00223795|21061657|P2|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1
6105348|NCT00223795|21061658|P1|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1
6105349|NCT00223795|21061657|P2|First Intervention - Eight Weeks|Lost to Follow-up|9
6105350|NCT00223795|21061658|P1|First Intervention - Eight Weeks|Lost to Follow-up|7
6105351|NCT00223496|21061736|P1|Overall Study|Physician Decision|2
6105352|NCT00223496|21061736|P1|Overall Study|Withdrawal by Subject|1
6105353|NCT00223496|21061736|P1|Overall Study|Lack of Efficacy|6
6105354|NCT00223496|21061736|P1|Overall Study|Lost to Follow-up|4
6105355|NCT00223496|21061736|P1|Overall Study|screen failure|9
6105356|NCT00223080|21061766|P2|Overall Study|Adverse Event|1
6105357|NCT00223080|21061767|P1|Overall Study|Adverse Event|0
6105358|NCT00223080|21061766|P2|Overall Study|Reason not provided|140
6105359|NCT00223080|21061767|P1|Overall Study|Reason not provided|141
6105360|NCT00223080|21061766|P2|Overall Study|Other|11
6105361|NCT00223080|21061767|P1|Overall Study|Other|14
6105362|NCT00223080|21061766|P2|Overall Study|Death|74
6105363|NCT00223080|21061767|P1|Overall Study|Death|85
6105364|NCT00223080|21061766|P2|Overall Study|Lost to Follow-up|284
6105365|NCT00223080|21061767|P1|Overall Study|Lost to Follow-up|259
6105366|NCT00223080|21061766|P2|Overall Study|Moved from study area|47
6105367|NCT00223080|21061767|P1|Overall Study|Moved from study area|37
6105368|NCT00223080|21061766|P2|Overall Study|Non-compliant|7
6105369|NCT00223080|21061767|P1|Overall Study|Non-compliant|7
6105370|NCT00223080|21061766|P2|Overall Study|Required contraindicated med|1
6105371|NCT00223080|21061767|P1|Overall Study|Required contraindicated med|0
6105372|NCT00223080|21061766|P2|Overall Study|Withdrawal by Subject|232
6105373|NCT00223080|21061767|P1|Overall Study|Withdrawal by Subject|253
6105374|NCT00222729|21061785|P1|Overall Study|Adverse Event|3
6105375|NCT00222105|21061803|P1|Overall Study|Death|2
6105376|NCT00222105|21061803|P1|Overall Study|Treatment delays|2
6105377|NCT00222105|21061803|P1|Overall Study|Adverse Event|8
6105378|NCT00222105|21061803|P1|Overall Study|Withdrawal by Subject|1
6105379|NCT00222105|21061803|P1|Overall Study|Removed due to wrong diagnosis|1
6105380|NCT00221403|21061811|P3|Overall Study|Adverse Event|0
6105381|NCT00221403|21061812|P2|Overall Study|Adverse Event|1
6105382|NCT00221403|21061813|P1|Overall Study|Adverse Event|0
6105383|NCT00221403|21061811|P3|Overall Study|Lack of Efficacy|0
6105384|NCT00221403|21061812|P2|Overall Study|Lack of Efficacy|1
6105385|NCT00221403|21061813|P1|Overall Study|Lack of Efficacy|0
6105386|NCT00221403|21061811|P3|Overall Study|Withdrawal by Subject|0
6105387|NCT00221403|21061812|P2|Overall Study|Withdrawal by Subject|3
6105388|NCT00221403|21061813|P1|Overall Study|Withdrawal by Subject|0
6105389|NCT00221403|21061811|P3|Overall Study|Physician Decision|0
6105390|NCT00221403|21061812|P2|Overall Study|Physician Decision|0
6105391|NCT00221403|21061813|P1|Overall Study|Physician Decision|1
6105392|NCT00221403|21061811|P3|Overall Study|Protocol Violation|0
6105393|NCT00221403|21061812|P2|Overall Study|Protocol Violation|0
6105394|NCT00221403|21061813|P1|Overall Study|Protocol Violation|1
6105395|NCT00221195|21061856|P2|Therapy 2 (Months 10-15)|Adverse Event|0
6105396|NCT00221195|21061857|P1|Therapy 2 (Months 10-15)|Adverse Event|1
6105397|NCT00221195|21061856|P2|Therapy 2 (Months 10-15)|Death|0
6105398|NCT00221195|21061857|P1|Therapy 2 (Months 10-15)|Death|1
6105399|NCT00221195|21061856|P2|Washout Period (Months 7-9)|Death|1
6105400|NCT00221195|21061857|P1|Washout Period (Months 7-9)|Death|0
6105401|NCT00221195|21061856|P2|Therapy 1 (Months 1-6)|Lost to Follow-up|1
6105402|NCT00221195|21061857|P1|Therapy 1 (Months 1-6)|Lost to Follow-up|0
6105403|NCT00221195|21061856|P2|Therapy 1 (Months 1-6)|Withdrawal by Subject|1
6105404|NCT00221195|21061857|P1|Therapy 1 (Months 1-6)|Withdrawal by Subject|3
6105405|NCT00221104|21061879|P2|Overall Study|Others|47
6105406|NCT00221104|21061880|P1|Overall Study|Others|37
6105407|NCT00221104|21061879|P2|Overall Study|Withdrawal by Subject|29
6105408|NCT00221104|21061880|P1|Overall Study|Withdrawal by Subject|42
6105409|NCT00221104|21061879|P2|Overall Study|Protocol Violation|0
6105410|NCT00221104|21061880|P1|Overall Study|Protocol Violation|2
6105411|NCT00221104|21061879|P2|Overall Study|Physician Decision|0
6105412|NCT00221104|21061880|P1|Overall Study|Physician Decision|1
6105413|NCT00221104|21061879|P2|Overall Study|Adverse Event|0
6105414|NCT00221104|21061880|P1|Overall Study|Adverse Event|1
6105415|NCT00220805|21061913|P2|Overall Study|Develop. of choroidal neovascularization|8
6105416|NCT00220805|21061914|P1|Overall Study|Develop. of choroidal neovascularization|3
6105417|NCT00220805|21061913|P2|Overall Study|Lack of Efficacy|0
6105418|NCT00220805|21061914|P1|Overall Study|Lack of Efficacy|1
6105419|NCT00220805|21061913|P2|Overall Study|Withdrawal by Subject|0
6105420|NCT00220805|21061914|P1|Overall Study|Withdrawal by Subject|3
6105421|NCT00220805|21061913|P2|Overall Study|Adverse Event|3
6105422|NCT00220805|21061914|P1|Overall Study|Adverse Event|1
6105423|NCT00220779|21061935|P3|Overall Study|Lack of Efficacy|1
6105424|NCT00220779|21061936|P2|Overall Study|Lack of Efficacy|0
6105425|NCT00220779|21061937|P1|Overall Study|Lack of Efficacy|3
6105426|NCT00220779|21061935|P3|Overall Study|Pregnancy|2
6105427|NCT00220779|21061936|P2|Overall Study|Pregnancy|0
6105428|NCT00220779|21061937|P1|Overall Study|Pregnancy|0
6105429|NCT00220779|21061935|P3|Overall Study|Too time consuming|0
6105430|NCT00220779|21061936|P2|Overall Study|Too time consuming|0
6105431|NCT00220779|21061937|P1|Overall Study|Too time consuming|1
6105432|NCT00220779|21061935|P3|Overall Study|Non-compliance|0
6105433|NCT00220779|21061936|P2|Overall Study|Non-compliance|0
6105434|NCT00220779|21061937|P1|Overall Study|Non-compliance|1
6105435|NCT00220779|21061935|P3|Overall Study|Withdrawal by Subject|1
6105436|NCT00220779|21061936|P2|Overall Study|Withdrawal by Subject|4
6105437|NCT00220779|21061937|P1|Overall Study|Withdrawal by Subject|1
6105438|NCT00220779|21061935|P3|Overall Study|Adverse Event|0
6105439|NCT00220779|21061936|P2|Overall Study|Adverse Event|0
6105440|NCT00220779|21061937|P1|Overall Study|Adverse Event|1
6105441|NCT00220740|21061947|P2|Efficacy Period|Entered Rescue Treatment with IGIV-C|45
6105442|NCT00220740|21061948|P1|Efficacy Period|Entered Rescue Treatment with IGIV-C|0
6105443|NCT00220740|21061947|P2|Efficacy Period|Protocol Violation|0
6105444|NCT00220740|21061948|P1|Efficacy Period|Protocol Violation|1
6105445|NCT00220740|21061947|P2|Efficacy Period|Withdrawal by Subject|0
6105446|NCT00220740|21061948|P1|Efficacy Period|Withdrawal by Subject|1
6105447|NCT00220740|21061947|P2|Efficacy Period|Adverse Event|1
6105448|NCT00220740|21061948|P1|Efficacy Period|Adverse Event|1
6105449|NCT00220740|21061947|P2|Efficacy Period|Entered rescue treatment with placebo|0
6105450|NCT00220740|21061948|P1|Efficacy Period|Entered rescue treatment with placebo|23
6105451|NCT00220727|21061962|P2|Second Infusion (Week <6)|Pt did not meet study requirement|0
6105452|NCT00220727|21061963|P1|Second Infusion (Week <6)|Pt did not meet study requirement|1
6105453|NCT00220701|21061979|P2|Overall Study|Lost to Follow-up|4
6105454|NCT00220701|21061980|P1|Overall Study|Lost to Follow-up|5
6105455|NCT00220636|21061996|P1|Overall Study|Withdrawal by Subject|4
6105456|NCT00219557|21062006|P3|Phase 2|Treatment not received|3
6105457|NCT00219557|21062007|P2|Phase 2|Treatment not received|1
6105458|NCT00219557|21062008|P1|Phase 2|Treatment not received|0
6105459|NCT00219557|21062006|P3|Phase 2|Withdrawal by Subject|5
6105460|NCT00219557|21062007|P2|Phase 2|Withdrawal by Subject|9
6105461|NCT00219557|21062008|P1|Phase 2|Withdrawal by Subject|0
6105462|NCT00219557|21062006|P3|Phase 2|Other|6
6105463|NCT00219557|21062007|P2|Phase 2|Other|8
6105464|NCT00219557|21062008|P1|Phase 2|Other|0
6105465|NCT00219557|21062006|P3|Phase 2|Death|2
6105466|NCT00219557|21062007|P2|Phase 2|Death|8
6105467|NCT00219557|21062008|P1|Phase 2|Death|0
6105468|NCT00219557|21062006|P3|Phase 2|Adverse Event|2
6105469|NCT00219557|21062007|P2|Phase 2|Adverse Event|22
6105470|NCT00219557|21062008|P1|Phase 2|Adverse Event|0
6105471|NCT00219557|21062006|P3|Phase 2|Lack of Efficacy|15
6105472|NCT00219557|21062007|P2|Phase 2|Lack of Efficacy|21
6105473|NCT00219557|21062008|P1|Phase 2|Lack of Efficacy|0
6105474|NCT00219557|21062006|P3|Phase 1|Started chemotherapy at other institute|0
6105475|NCT00219557|21062007|P2|Phase 1|Started chemotherapy at other institute|0
6105476|NCT00219557|21062008|P1|Phase 1|Started chemotherapy at other institute|1
6105477|NCT00219557|21062006|P3|Phase 1|Withdrawal by Subject|0
6105478|NCT00219557|21062007|P2|Phase 1|Withdrawal by Subject|0
6105479|NCT00219557|21062008|P1|Phase 1|Withdrawal by Subject|1
6105480|NCT00219557|21062006|P3|Phase 1|Adverse Event|0
6105481|NCT00219557|21062007|P2|Phase 1|Adverse Event|0
6105482|NCT00219557|21062008|P1|Phase 1|Adverse Event|2
6105483|NCT00219557|21062006|P3|Phase 1|Lack of Efficacy|0
6105484|NCT00219557|21062007|P2|Phase 1|Lack of Efficacy|0
6105485|NCT00219557|21062008|P1|Phase 1|Lack of Efficacy|3
6105486|NCT00219544|21062036|P2|Single Blind Treatment Period|Withdrawal by Subject|0
6105487|NCT00219544|21062037|P1|Single Blind Treatment Period|Withdrawal by Subject|1
6105488|NCT00219544|21062036|P2|Single Blind Treatment Period|Investigator decision to withdraw|0
6105489|NCT00219544|21062037|P1|Single Blind Treatment Period|Investigator decision to withdraw|1
6105490|NCT00219544|21062036|P2|Single Blind Treatment Period|Lost to Follow-up|0
6105491|NCT00219544|21062037|P1|Single Blind Treatment Period|Lost to Follow-up|2
6105492|NCT00219544|21062036|P2|Single Blind Treatment Period|Protocol Violation|0
6105493|NCT00219544|21062037|P1|Single Blind Treatment Period|Protocol Violation|4
6105494|NCT00219544|21062036|P2|Single Blind Treatment Period|Adverse Event|0
6105495|NCT00219544|21062037|P1|Single Blind Treatment Period|Adverse Event|9
6105496|NCT00219544|21062036|P2|Single Blind Treatment Period|Lack of Efficacy|0
6105497|NCT00219544|21062037|P1|Single Blind Treatment Period|Lack of Efficacy|5
6105498|NCT00219349|21062075|P1|Escitalopram Phase|Withdrawal by Subject|3
6105499|NCT00219349|21062075|P1|Cognitive Behavioral Therapy Phase|Protocol Violation|2
6105500|NCT00219349|21062075|P1|Cognitive Behavioral Therapy Phase|Withdrawal by Subject|2
6105501|NCT00219349|21062075|P1|Cognitive Behavioral Therapy Phase|Lost to Follow-up|6
6105502|NCT00219284|21062088|P2|Extension Phase - 8 Weeks|Lost to Follow-up|2
6105503|NCT00219284|21062089|P1|Extension Phase - 8 Weeks|Lost to Follow-up|0
6105504|NCT00219284|21062088|P2|Extension Phase - 8 Weeks|Withdrawal by Subject|2
6105505|NCT00219284|21062089|P1|Extension Phase - 8 Weeks|Withdrawal by Subject|0
6105506|NCT00219284|21062088|P2|Extension Phase - 8 Weeks|Adverse Event|3
6105507|NCT00219284|21062089|P1|Extension Phase - 8 Weeks|Adverse Event|2
6105508|NCT00219284|21062088|P2|Treatment Phase - 16 Weeks|Lost to Follow-up|2
6105509|NCT00219284|21062089|P1|Treatment Phase - 16 Weeks|Lost to Follow-up|1
6105510|NCT00219284|21062088|P2|Treatment Phase - 16 Weeks|Withdrawal by Subject|9
6105511|NCT00219284|21062089|P1|Treatment Phase - 16 Weeks|Withdrawal by Subject|5
6105512|NCT00219284|21062088|P2|Treatment Phase - 16 Weeks|Protocol Violation|5
6105513|NCT00219284|21062089|P1|Treatment Phase - 16 Weeks|Protocol Violation|9
6105514|NCT00219284|21062088|P2|Treatment Phase - 16 Weeks|Lack of Efficacy|10
6105515|NCT00219284|21062089|P1|Treatment Phase - 16 Weeks|Lack of Efficacy|3
6105516|NCT00219284|21062088|P2|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|1
6105517|NCT00219284|21062089|P1|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|0
6105518|NCT00219284|21062088|P2|Treatment Phase - 16 Weeks|Adverse Event|24
6105519|NCT00219284|21062089|P1|Treatment Phase - 16 Weeks|Adverse Event|26
6105520|NCT00219141|21062114|P3|Overall Study|Condition no longer requires study drug|0
6105521|NCT00219141|21062115|P2|Overall Study|Condition no longer requires study drug|0
6105522|NCT00219141|21062116|P1|Overall Study|Condition no longer requires study drug|1
6105523|NCT00219141|21062114|P3|Overall Study|Withdrawal by Subject|5
6105524|NCT00219141|21062115|P2|Overall Study|Withdrawal by Subject|3
6105525|NCT00219141|21062116|P1|Overall Study|Withdrawal by Subject|1
6105526|NCT00219141|21062114|P3|Overall Study|Protocol Violation|1
6105527|NCT00219141|21062115|P2|Overall Study|Protocol Violation|1
6105528|NCT00219141|21062116|P1|Overall Study|Protocol Violation|3
6105529|NCT00219141|21062114|P3|Overall Study|Lost to Follow-up|1
6105530|NCT00219141|21062115|P2|Overall Study|Lost to Follow-up|4
6105531|NCT00219141|21062116|P1|Overall Study|Lost to Follow-up|2
6105532|NCT00219141|21062114|P3|Overall Study|Administrative problems|0
6105533|NCT00219141|21062115|P2|Overall Study|Administrative problems|1
6105534|NCT00219141|21062116|P1|Overall Study|Administrative problems|0
6105535|NCT00219141|21062114|P3|Overall Study|Lack of Efficacy|0
6105536|NCT00219141|21062115|P2|Overall Study|Lack of Efficacy|2
6105537|NCT00219141|21062116|P1|Overall Study|Lack of Efficacy|3
6105538|NCT00219141|21062114|P3|Overall Study|Adverse Event|5
6105539|NCT00219141|21062115|P2|Overall Study|Adverse Event|10
6105540|NCT00219141|21062116|P1|Overall Study|Adverse Event|4
6105541|NCT00218634|21062162|P2|Overall Study|Lost to Follow-up|15
6105542|NCT00218634|21062163|P1|Overall Study|Lost to Follow-up|8
6105543|NCT00218543|21062183|P1|Overall Study|Adverse Event|2
6105544|NCT00218543|21062183|P1|Overall Study|Physician Decision|3
6105545|NCT00218543|21062183|P1|Overall Study|Withdrawal by Subject|1
6105546|NCT00218543|21062183|P1|Overall Study|relocated|1
6105547|NCT00218543|21062183|P1|Overall Study|Lost to Follow-up|8
6105548|NCT00218296|21062361|P2|Overall Study|Randomized but did not enter treatment|67
6105549|NCT00218296|21062362|P1|Overall Study|Randomized but did not enter treatment|66
6105550|NCT00218296|21062361|P2|Overall Study|Withdrawal by Subject|47
6105551|NCT00218296|21062362|P1|Overall Study|Withdrawal by Subject|36
6105552|NCT00218296|21062361|P2|Overall Study|Lost to Follow-up|7
6105553|NCT00218296|21062362|P1|Overall Study|Lost to Follow-up|9
6105554|NCT00218257|21062378|P2|Period Between Visit 1 and 2|Lost to Follow-up|3
6105555|NCT00218257|21062379|P1|Period Between Visit 1 and 2|Lost to Follow-up|4
6105556|NCT00217971|21062480|P2|Overall Study|non compliant|0
6105557|NCT00217971|21062481|P1|Overall Study|non compliant|1
6105558|NCT00217971|21062480|P2|Overall Study|Withdrawal by Subject|12
6105559|NCT00217971|21062481|P1|Overall Study|Withdrawal by Subject|7
6105560|NCT00217971|21062480|P2|Overall Study|Physician Decision|1
6105561|NCT00217971|21062481|P1|Overall Study|Physician Decision|0
6105562|NCT00217971|21062480|P2|Overall Study|Lost to Follow-up|19
6105563|NCT00217971|21062481|P1|Overall Study|Lost to Follow-up|15
6105564|NCT00217971|21062480|P2|Overall Study|Adverse Event|1
6105565|NCT00217971|21062481|P1|Overall Study|Adverse Event|1
6105566|NCT00217672|21062496|P2|Follow-up|Lost to Follow-up|0
6105567|NCT00217672|21062497|P1|Follow-up|Lost to Follow-up|1
6105568|NCT00217672|21062496|P2|Follow-up|Withdrawal by Subject|0
6105569|NCT00217672|21062497|P1|Follow-up|Withdrawal by Subject|4
6105570|NCT00217672|21062496|P2|Treatment|secondary malignancy|0
6105571|NCT00217672|21062497|P1|Treatment|secondary malignancy|1
6105572|NCT00217672|21062496|P2|Treatment|Death|0
6105573|NCT00217672|21062497|P1|Treatment|Death|2
6105574|NCT00217672|21062496|P2|Treatment|insurance issues|1
6105575|NCT00217672|21062497|P1|Treatment|insurance issues|1
6105576|NCT00217672|21062496|P2|Treatment|Physician Decision|0
6105577|NCT00217672|21062497|P1|Treatment|Physician Decision|6
6105578|NCT00217672|21062496|P2|Treatment|reqd treatment not permitted by protocol|0
6105579|NCT00217672|21062497|P1|Treatment|reqd treatment not permitted by protocol|6
6105580|NCT00217672|21062496|P2|Treatment|Adverse Event|2
6105581|NCT00217672|21062497|P1|Treatment|Adverse Event|18
6105582|NCT00217672|21062496|P2|Treatment|disease progression|4
6105583|NCT00217672|21062497|P1|Treatment|disease progression|33
6105584|NCT00217672|21062496|P2|Allocation|Ineligible|0
6105585|NCT00217672|21062497|P1|Allocation|Ineligible|2
6105586|NCT00217620|21062503|P1|Overall Study|Never received treatment|1
6105587|NCT00217620|21062503|P1|Overall Study|Ineligible|13
6105588|NCT00217620|21062503|P1|Overall Study|Not Protocol Specified|4
6105589|NCT00217620|21062503|P1|Overall Study|Progression|31
6105590|NCT00217620|21062503|P1|Overall Study|Adverse Event|2
6105591|NCT00217581|21062518|P1|Overall Study|Withdrawal by Subject|1
6105592|NCT00217464|21062547|P1|Overall Study|Other|2
6105593|NCT00217464|21062547|P1|Overall Study|Progression|15
6105594|NCT00217425|21062563|P1|Overall Study|Other|4
6105595|NCT00217425|21062563|P1|Overall Study|Other complicating disease|1
6105596|NCT00217425|21062563|P1|Overall Study|Withdrawal by Subject|4
6105597|NCT00217425|21062563|P1|Overall Study|Adverse Event|8
6105598|NCT00217425|21062563|P1|Overall Study|Lack of Efficacy|13
6105599|NCT00217425|21062563|P1|Overall Study|Patient ineligible|5
6105600|NCT00217425|21062563|P1|Overall Study|Never started treatment|2
6105601|NCT00217087|21062577|P2|Overall Study|completed less than 12 months return|18
6105602|NCT00217087|21062578|P1|Overall Study|completed less than 12 months return|10
6105603|NCT00217087|21062577|P2|Overall Study|decided to have esophagectomy|2
6105604|NCT00217087|21062578|P1|Overall Study|decided to have esophagectomy|1
6105605|NCT00217022|21062592|P2|Overall Study|Withdrawal by Subject|1
6105606|NCT00217022|21062593|P1|Overall Study|Withdrawal by Subject|1
6105607|NCT00216736|21062603|P2|Overall Study|Lost to Follow-up|1
6105608|NCT00216736|21062604|P1|Overall Study|Lost to Follow-up|1
6105609|NCT00216671|21062618|P2|Overall Study|Insufficient Response Adverse Event|1
6105610|NCT00216671|21062619|P1|Overall Study|Insufficient Response Adverse Event|2
6105611|NCT00216671|21062618|P2|Overall Study|Ineligible, no efficacy data|2
6105612|NCT00216671|21062619|P1|Overall Study|Ineligible, no efficacy data|2
6105613|NCT00216671|21062618|P2|Overall Study|Patient Moved|1
6105614|NCT00216671|21062619|P1|Overall Study|Patient Moved|0
6105615|NCT00216671|21062618|P2|Overall Study|Investigator Illness|1
6105616|NCT00216671|21062619|P1|Overall Study|Investigator Illness|0
6105617|NCT00216671|21062618|P2|Overall Study|Relapse|0
6105618|NCT00216671|21062619|P1|Overall Study|Relapse|1
6105619|NCT00216671|21062618|P2|Overall Study|Protocol Violation|5
6105620|NCT00216671|21062619|P1|Overall Study|Protocol Violation|3
6105621|NCT00216671|21062618|P2|Overall Study|Physician Decision|1
6105622|NCT00216671|21062619|P1|Overall Study|Physician Decision|1
6105623|NCT00216671|21062618|P2|Overall Study|Ineligible|2
6105624|NCT00216671|21062619|P1|Overall Study|Ineligible|0
6105625|NCT00216671|21062618|P2|Overall Study|Non compliant|2
6105626|NCT00216671|21062619|P1|Overall Study|Non compliant|2
6105627|NCT00216671|21062618|P2|Overall Study|Lost to Follow-up|5
6105628|NCT00216671|21062619|P1|Overall Study|Lost to Follow-up|3
6105629|NCT00216671|21062618|P2|Overall Study|Insufficient Response|4
6105630|NCT00216671|21062619|P1|Overall Study|Insufficient Response|9
6105631|NCT00216671|21062618|P2|Overall Study|No Need to Continue Medication|1
6105632|NCT00216671|21062619|P1|Overall Study|No Need to Continue Medication|1
6105633|NCT00216671|21062618|P2|Overall Study|Refused Injections|13
6105634|NCT00216671|21062619|P1|Overall Study|Refused Injections|3
6105635|NCT00216671|21062618|P2|Overall Study|Withdrawal by Subject|2
6105636|NCT00216671|21062619|P1|Overall Study|Withdrawal by Subject|4
6105637|NCT00216671|21062618|P2|Overall Study|Pregnancy|1
6105638|NCT00216671|21062619|P1|Overall Study|Pregnancy|0
6105639|NCT00216671|21062618|P2|Overall Study|Adverse Event|9
6105640|NCT00216671|21062619|P1|Overall Study|Adverse Event|4
6105641|NCT00216476|21062637|P3|Overall Study|Patient Moved|0
6105642|NCT00216476|21062638|P2|Overall Study|Patient Moved|2
6105643|NCT00216476|21062639|P1|Overall Study|Patient Moved|2
6105644|NCT00216476|21062637|P3|Overall Study|Protocol Deviation|0
6105645|NCT00216476|21062638|P2|Overall Study|Protocol Deviation|1
6105646|NCT00216476|21062639|P1|Overall Study|Protocol Deviation|5
6105647|NCT00216476|21062637|P3|Overall Study|Administrative Reasons|0
6105648|NCT00216476|21062638|P2|Overall Study|Administrative Reasons|1
6105649|NCT00216476|21062639|P1|Overall Study|Administrative Reasons|1
6105650|NCT00216476|21062637|P3|Overall Study|Higher dose/Extra Medication Required|2
6105651|NCT00216476|21062638|P2|Overall Study|Higher dose/Extra Medication Required|0
6105652|NCT00216476|21062639|P1|Overall Study|Higher dose/Extra Medication Required|2
6105653|NCT00216476|21062637|P3|Overall Study|Non-compliance|1
6105654|NCT00216476|21062638|P2|Overall Study|Non-compliance|4
6105655|NCT00216476|21062639|P1|Overall Study|Non-compliance|0
6105656|NCT00216476|21062637|P3|Overall Study|No Further Need for Treatment|1
6105657|NCT00216476|21062638|P2|Overall Study|No Further Need for Treatment|4
6105658|NCT00216476|21062639|P1|Overall Study|No Further Need for Treatment|3
6105659|NCT00216476|21062637|P3|Overall Study|Refuses Injection|0
6105660|NCT00216476|21062638|P2|Overall Study|Refuses Injection|0
6105661|NCT00216476|21062639|P1|Overall Study|Refuses Injection|11
6105662|NCT00216476|21062637|P3|Overall Study|Other|1
6105663|NCT00216476|21062638|P2|Overall Study|Other|0
6105664|NCT00216476|21062639|P1|Overall Study|Other|0
6105665|NCT00216476|21062637|P3|Overall Study|Pregnancy|1
6105666|NCT00216476|21062638|P2|Overall Study|Pregnancy|1
6105667|NCT00216476|21062639|P1|Overall Study|Pregnancy|0
6105668|NCT00216476|21062637|P3|Overall Study|Death|0
6105669|NCT00216476|21062638|P2|Overall Study|Death|0
6105670|NCT00216476|21062639|P1|Overall Study|Death|2
6105671|NCT00216476|21062637|P3|Overall Study|Lack of Efficacy|0
6105672|NCT00216476|21062638|P2|Overall Study|Lack of Efficacy|3
6105673|NCT00216476|21062639|P1|Overall Study|Lack of Efficacy|4
6105674|NCT00216476|21062637|P3|Overall Study|Adverse Event|1
6105675|NCT00216476|21062638|P2|Overall Study|Adverse Event|10
6105676|NCT00216476|21062639|P1|Overall Study|Adverse Event|6
6105677|NCT00216476|21062637|P3|Overall Study|Lost to Follow-up|1
6105678|NCT00216476|21062638|P2|Overall Study|Lost to Follow-up|9
6105679|NCT00216476|21062639|P1|Overall Study|Lost to Follow-up|10
6105680|NCT00216476|21062637|P3|Overall Study|Withdrawal by Subject|9
6105681|NCT00216476|21062638|P2|Overall Study|Withdrawal by Subject|72
6105682|NCT00216476|21062639|P1|Overall Study|Withdrawal by Subject|59
6105683|NCT00216203|21062676|P1|Overall Study|Withdrawal by Subject|2
6105684|NCT00216086|21062706|P1|Overall Study|Social Reasons|2
6105685|NCT00216086|21062706|P1|Overall Study|Diagnosis of Metastatic Disease|1
6105686|NCT00216086|21062706|P1|Overall Study|Protocol Violation|1
6105687|NCT00215943|21062738|P2|Overall Study|Other complications|1
6105688|NCT00215943|21062739|P1|Overall Study|Other complications|3
6105689|NCT00215943|21062738|P2|Overall Study|Other disease|1
6105690|NCT00215943|21062739|P1|Overall Study|Other disease|0
6105691|NCT00215943|21062738|P2|Overall Study|Adverse Event|6
6105692|NCT00215943|21062739|P1|Overall Study|Adverse Event|3
6105693|NCT00215943|21062738|P2|Overall Study|Alternate therapy|1
6105694|NCT00215943|21062739|P1|Overall Study|Alternate therapy|0
6105695|NCT00215943|21062738|P2|Overall Study|Disease Progression|5
6105696|NCT00215943|21062739|P1|Overall Study|Disease Progression|3
6105697|NCT00215683|21062764|P3|Overall Study|Intermittent therapy required|0
6105698|NCT00215683|21062765|P2|Overall Study|Intermittent therapy required|1
6105699|NCT00215683|21062766|P1|Overall Study|Intermittent therapy required|0
6105700|NCT00215683|21062764|P3|Overall Study|No study drug available|0
6105701|NCT00215683|21062765|P2|Overall Study|No study drug available|1
6105702|NCT00215683|21062766|P1|Overall Study|No study drug available|0
6105703|NCT00215683|21062764|P3|Overall Study|Difficult to attend visits|0
6105704|NCT00215683|21062765|P2|Overall Study|Difficult to attend visits|1
6105705|NCT00215683|21062766|P1|Overall Study|Difficult to attend visits|0
6105706|NCT00215683|21062764|P3|Overall Study|Physician Decision|1
6105707|NCT00215683|21062765|P2|Overall Study|Physician Decision|0
6105708|NCT00215683|21062766|P1|Overall Study|Physician Decision|0
6105709|NCT00215683|21062764|P3|Overall Study|Withdrawal by Subject|13
6105710|NCT00215683|21062765|P2|Overall Study|Withdrawal by Subject|4
6105711|NCT00215683|21062766|P1|Overall Study|Withdrawal by Subject|9
6105712|NCT00215683|21062764|P3|Overall Study|Lost to Follow-up|1
6105713|NCT00215683|21062765|P2|Overall Study|Lost to Follow-up|2
6105714|NCT00215683|21062766|P1|Overall Study|Lost to Follow-up|0
6105715|NCT00215683|21062764|P3|Overall Study|Lack of Efficacy|2
6105716|NCT00215683|21062765|P2|Overall Study|Lack of Efficacy|1
6105717|NCT00215683|21062766|P1|Overall Study|Lack of Efficacy|5
6105718|NCT00215683|21062764|P3|Overall Study|Adverse Event|15
6105719|NCT00215683|21062765|P2|Overall Study|Adverse Event|16
6105720|NCT00215683|21062766|P1|Overall Study|Adverse Event|15
6105721|NCT00215657|21062785|P8|Overall Study|Other|1
6105722|NCT00215657|21062786|P7|Overall Study|Other|6
6105723|NCT00215657|21062787|P6|Overall Study|Other|4
6105724|NCT00215657|21062788|P5|Overall Study|Other|5
6105725|NCT00215657|21062789|P4|Overall Study|Other|3
6105726|NCT00215657|21062790|P3|Overall Study|Other|2
6105727|NCT00215657|21062791|P2|Overall Study|Other|1
6105728|NCT00215657|21062792|P1|Overall Study|Other|3
6105729|NCT00215657|21062785|P8|Overall Study|Insufficient testosterone response|7
6105730|NCT00215657|21062786|P7|Overall Study|Insufficient testosterone response|4
6105731|NCT00215657|21062787|P6|Overall Study|Insufficient testosterone response|12
6105732|NCT00215657|21062788|P5|Overall Study|Insufficient testosterone response|8
6105733|NCT00215657|21062789|P4|Overall Study|Insufficient testosterone response|12
6105734|NCT00215657|21062790|P3|Overall Study|Insufficient testosterone response|1
6105735|NCT00215657|21062791|P2|Overall Study|Insufficient testosterone response|4
6105736|NCT00215657|21062792|P1|Overall Study|Insufficient testosterone response|5
6105737|NCT00215657|21062785|P8|Overall Study|Insuff prostate specific antigen resp|2
6105738|NCT00215657|21062786|P7|Overall Study|Insuff prostate specific antigen resp|3
6105739|NCT00215657|21062787|P6|Overall Study|Insuff prostate specific antigen resp|2
6105740|NCT00215657|21062788|P5|Overall Study|Insuff prostate specific antigen resp|1
6105741|NCT00215657|21062789|P4|Overall Study|Insuff prostate specific antigen resp|2
6105742|NCT00215657|21062790|P3|Overall Study|Insuff prostate specific antigen resp|2
6105743|NCT00215657|21062791|P2|Overall Study|Insuff prostate specific antigen resp|2
6105744|NCT00215657|21062792|P1|Overall Study|Insuff prostate specific antigen resp|3
6105745|NCT00215657|21062785|P8|Overall Study|Withdrawal by Subject|3
6105746|NCT00215657|21062786|P7|Overall Study|Withdrawal by Subject|10
6105747|NCT00215657|21062787|P6|Overall Study|Withdrawal by Subject|1
6105748|NCT00215657|21062788|P5|Overall Study|Withdrawal by Subject|6
6105749|NCT00215657|21062789|P4|Overall Study|Withdrawal by Subject|1
6105750|NCT00215657|21062790|P3|Overall Study|Withdrawal by Subject|3
6105751|NCT00215657|21062791|P2|Overall Study|Withdrawal by Subject|3
6105752|NCT00215657|21062792|P1|Overall Study|Withdrawal by Subject|6
6105753|NCT00215657|21062785|P8|Overall Study|Adverse Event|3
6105754|NCT00215657|21062786|P7|Overall Study|Adverse Event|0
6105755|NCT00215657|21062787|P6|Overall Study|Adverse Event|1
6105756|NCT00215657|21062788|P5|Overall Study|Adverse Event|3
6105757|NCT00215657|21062789|P4|Overall Study|Adverse Event|0
6105758|NCT00215657|21062790|P3|Overall Study|Adverse Event|3
6105759|NCT00215657|21062791|P2|Overall Study|Adverse Event|1
6105760|NCT00215657|21062792|P1|Overall Study|Adverse Event|5
6105761|NCT00215644|21062820|P2|Overall Study|Randomized but Not Treated|0
6105762|NCT00215644|21062821|P1|Overall Study|Randomized but Not Treated|1
6105763|NCT00215644|21062820|P2|Overall Study|Other|15
6105764|NCT00215644|21062821|P1|Overall Study|Other|3
6105765|NCT00215644|21062820|P2|Overall Study|Withdrawal by Subject|0
6105766|NCT00215644|21062821|P1|Overall Study|Withdrawal by Subject|1
6105767|NCT00215644|21062820|P2|Overall Study|Death|2
6105768|NCT00215644|21062821|P1|Overall Study|Death|1
6105769|NCT00215644|21062820|P2|Overall Study|Adverse Event|9
6105770|NCT00215644|21062821|P1|Overall Study|Adverse Event|2
6105771|NCT00215644|21062820|P2|Overall Study|Disease Progression|10
6105772|NCT00215644|21062821|P1|Overall Study|Disease Progression|28
6105773|NCT00215553|21062848|P7|Overall Study|Adverse Event|0
6105774|NCT00215553|21062849|P6|Overall Study|Adverse Event|6
6105775|NCT00215553|21062850|P5|Overall Study|Adverse Event|2
6105776|NCT00215553|21062851|P4|Overall Study|Adverse Event|1
6105777|NCT00215553|21062852|P3|Overall Study|Adverse Event|2
6105778|NCT00215553|21062853|P2|Overall Study|Adverse Event|1
6105779|NCT00215553|21062854|P1|Overall Study|Adverse Event|0
6105780|NCT00215540|21062887|P3|Overall Study|Withdrew from study medication|0
6105781|NCT00215540|21062888|P2|Overall Study|Withdrew from study medication|0
6105782|NCT00215540|21062889|P1|Overall Study|Withdrew from study medication|1
6105783|NCT00215150|21062924|P1|Randomization Phase Placebo|Withdrawal by Subject|1
6105784|NCT00215150|21062924|P1|Randomization Phase Ziprasidone|Withdrawal by Subject|1
6105785|NCT00215150|21062924|P1|Randomization Phase Ziprasidone|Lost to Follow-up|2
6105786|NCT00215150|21062924|P1|Open Label Phase|Did not meet randomization criteria|9
6105787|NCT00215150|21062924|P1|Open Label Phase|Did not complete a post base visit|13
6105788|NCT00215150|21062924|P1|Open Label Phase|Withdrawal by Subject|1
6105789|NCT00215150|21062924|P1|Open Label Phase|Lost to Follow-up|7
6105790|NCT00215137|21062932|P3|Randomization Period|Withdrawal by Subject|0
6105791|NCT00215137|21062933|P2|Randomization Period|Withdrawal by Subject|1
6105792|NCT00215137|21062934|P1|Randomization Period|Withdrawal by Subject|0
6105793|NCT00215137|21062932|P3|Randomization Period|Lost to Follow-up|0
6105794|NCT00215137|21062933|P2|Randomization Period|Lost to Follow-up|1
6105795|NCT00215137|21062934|P1|Randomization Period|Lost to Follow-up|0
6105796|NCT00215137|21062932|P3|Open Label Escitalopram|Lack of Efficacy|0
6105797|NCT00215137|21062933|P2|Open Label Escitalopram|Lack of Efficacy|0
6105798|NCT00215137|21062934|P1|Open Label Escitalopram|Lack of Efficacy|1
6105799|NCT00214500|21063032|P1|Extension Period|Withdrawal by Subject|2
6105800|NCT00214500|21063032|P1|Treatment Period|Adverse Event|1
6105801|NCT00214461|21063053|P4|Overall Study|Withdrawal by Subject|0
6105802|NCT00214461|21063054|P3|Overall Study|Withdrawal by Subject|1
6105803|NCT00214461|21063055|P2|Overall Study|Withdrawal by Subject|0
6105804|NCT00214461|21063056|P1|Overall Study|Withdrawal by Subject|0
6105805|NCT00214461|21063053|P4|Overall Study|Adverse Event|1
6105806|NCT00214461|21063054|P3|Overall Study|Adverse Event|1
6105807|NCT00214461|21063055|P2|Overall Study|Adverse Event|0
6105808|NCT00214461|21063056|P1|Overall Study|Adverse Event|0
6105809|NCT00214422|21063073|P3|Overall Study|Unable to make a radiation treatment|1
6105810|NCT00214422|21063074|P2|Overall Study|Unable to make a radiation treatment|0
6105811|NCT00214422|21063075|P1|Overall Study|Unable to make a radiation treatment|0
6105812|NCT00214422|21063073|P3|Overall Study|Disease progression on study|0
6105813|NCT00214422|21063074|P2|Overall Study|Disease progression on study|0
6105814|NCT00214422|21063075|P1|Overall Study|Disease progression on study|1
6105815|NCT00214422|21063073|P3|Overall Study|Pt taken off study|0
6105816|NCT00214422|21063074|P2|Overall Study|Pt taken off study|1
6105817|NCT00214422|21063075|P1|Overall Study|Pt taken off study|1
6105818|NCT00214422|21063073|P3|Overall Study|Developed esophageal ca|0
6105819|NCT00214422|21063074|P2|Overall Study|Developed esophageal ca|0
6105820|NCT00214422|21063075|P1|Overall Study|Developed esophageal ca|1
6105821|NCT00214422|21063073|P3|Overall Study|Physician Decision|0
6105822|NCT00214422|21063074|P2|Overall Study|Physician Decision|0
6105823|NCT00214422|21063075|P1|Overall Study|Physician Decision|2
6105824|NCT00214383|21063098|P2|Overall Study|Lost to Follow-up|26
6105825|NCT00214383|21063099|P1|Overall Study|Lost to Follow-up|16
6105826|NCT00214201|21063111|P2|Overall Study|Death|2
6105827|NCT00214201|21063112|P1|Overall Study|Death|0
6105828|NCT00214201|21063111|P2|Overall Study|Withdrawal by Subject|0
6105829|NCT00214201|21063112|P1|Overall Study|Withdrawal by Subject|2
6105830|NCT00214136|21063127|P1|Overall Study|Death|5
6105831|NCT00214019|21063172|P1|Overall Study|Screen Failed prior to randomization|17
6105832|NCT00214019|21063172|P1|Overall Study|Withdrawal by Subject|2
6105833|NCT00214019|21063172|P1|Overall Study|Lost to Follow-up|11
6105834|NCT00213980|21063181|P2|Overall Study|Failed to obtain all 3 DXAs|3
6105835|NCT00213980|21063182|P1|Overall Study|Failed to obtain all 3 DXAs|1
6105836|NCT00213980|21063181|P2|Overall Study|Developed ovarian cancer|0
6105837|NCT00213980|21063182|P1|Overall Study|Developed ovarian cancer|1
6105838|NCT00213980|21063181|P2|Overall Study|Disease progression|2
6105839|NCT00213980|21063182|P1|Overall Study|Disease progression|0
6105840|NCT00213980|21063181|P2|Overall Study|Adverse Event|1
6105841|NCT00213980|21063182|P1|Overall Study|Adverse Event|1
6105842|NCT00213980|21063181|P2|Overall Study|Withdrawal by Subject|1
6105843|NCT00213980|21063182|P1|Overall Study|Withdrawal by Subject|3
6105844|NCT00213148|21063209|P5|Cycle 3 (1 Month)|Other|0
6105845|NCT00213148|21063210|P4|Cycle 3 (1 Month)|Other|1
6105846|NCT00213148|21063211|P3|Cycle 3 (1 Month)|Other|1
6105847|NCT00213148|21063212|P2|Cycle 3 (1 Month)|Other|0
6105848|NCT00213148|21063213|P1|Cycle 3 (1 Month)|Other|0
6105849|NCT00213148|21063209|P5|Cycle 3 (1 Month)|Lost to Follow-up|1
6105850|NCT00213148|21063210|P4|Cycle 3 (1 Month)|Lost to Follow-up|0
6105851|NCT00213148|21063211|P3|Cycle 3 (1 Month)|Lost to Follow-up|0
6105852|NCT00213148|21063212|P2|Cycle 3 (1 Month)|Lost to Follow-up|2
6105853|NCT00213148|21063213|P1|Cycle 3 (1 Month)|Lost to Follow-up|0
6105854|NCT00213148|21063209|P5|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|6
6105855|NCT00213148|21063210|P4|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3
6105856|NCT00213148|21063211|P3|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3
6105857|NCT00213148|21063212|P2|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|1
6105858|NCT00213148|21063213|P1|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|10
6105859|NCT00213148|21063209|P5|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0
6105860|NCT00213148|21063210|P4|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0
6105861|NCT00213148|21063211|P3|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0
6105862|NCT00213148|21063212|P2|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0
6105863|NCT00213148|21063213|P1|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|1
6105864|NCT00213148|21063209|P5|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0
6105865|NCT00213148|21063210|P4|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0
6105866|NCT00213148|21063211|P3|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0
6105867|NCT00213148|21063212|P2|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|1
6105868|NCT00213148|21063213|P1|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0
6105869|NCT00213148|21063209|P5|Cycle 2 (1 Month)|Other|7
6105870|NCT00213148|21063210|P4|Cycle 2 (1 Month)|Other|8
6105871|NCT00213148|21063211|P3|Cycle 2 (1 Month)|Other|2
6105872|NCT00213148|21063212|P2|Cycle 2 (1 Month)|Other|1
6105873|NCT00213148|21063213|P1|Cycle 2 (1 Month)|Other|2
6105874|NCT00213148|21063209|P5|Cycle 2 (1 Month)|Lack of Efficacy|16
6105875|NCT00213148|21063210|P4|Cycle 2 (1 Month)|Lack of Efficacy|6
6105876|NCT00213148|21063211|P3|Cycle 2 (1 Month)|Lack of Efficacy|7
6105877|NCT00213148|21063212|P2|Cycle 2 (1 Month)|Lack of Efficacy|3
6105878|NCT00213148|21063213|P1|Cycle 2 (1 Month)|Lack of Efficacy|1
6105879|NCT00213148|21063209|P5|Cycle 2 (1 Month)|Lost to Follow-up|1
6105880|NCT00213148|21063210|P4|Cycle 2 (1 Month)|Lost to Follow-up|2
6105881|NCT00213148|21063211|P3|Cycle 2 (1 Month)|Lost to Follow-up|2
6105882|NCT00213148|21063212|P2|Cycle 2 (1 Month)|Lost to Follow-up|0
6105883|NCT00213148|21063213|P1|Cycle 2 (1 Month)|Lost to Follow-up|0
6105884|NCT00213148|21063209|P5|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5
6105885|NCT00213148|21063210|P4|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|8
6105886|NCT00213148|21063211|P3|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5
6105887|NCT00213148|21063212|P2|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|0
6105888|NCT00213148|21063213|P1|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|15
6105889|NCT00213148|21063209|P5|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|1
6105890|NCT00213148|21063210|P4|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0
6105891|NCT00213148|21063211|P3|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0
6105892|NCT00213148|21063212|P2|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0
6105893|NCT00213148|21063213|P1|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0
6105894|NCT00213148|21063209|P5|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0
6105895|NCT00213148|21063210|P4|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|1
6105896|NCT00213148|21063211|P3|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0
6105897|NCT00213148|21063212|P2|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0
6105898|NCT00213148|21063213|P1|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0
6105899|NCT00213148|21063209|P5|Cycle 1 (1 Month)|Other|7
6105900|NCT00213148|21063210|P4|Cycle 1 (1 Month)|Other|2
6105901|NCT00213148|21063211|P3|Cycle 1 (1 Month)|Other|2
6105902|NCT00213148|21063212|P2|Cycle 1 (1 Month)|Other|0
6105903|NCT00213148|21063213|P1|Cycle 1 (1 Month)|Other|3
6105904|NCT00213148|21063209|P5|Cycle 1 (1 Month)|Protocol Violation|0
6105905|NCT00213148|21063210|P4|Cycle 1 (1 Month)|Protocol Violation|0
6105906|NCT00213148|21063211|P3|Cycle 1 (1 Month)|Protocol Violation|1
6105907|NCT00213148|21063212|P2|Cycle 1 (1 Month)|Protocol Violation|0
6105908|NCT00213148|21063213|P1|Cycle 1 (1 Month)|Protocol Violation|1
6105909|NCT00213148|21063209|P5|Cycle 1 (1 Month)|Lack of Efficacy|8
6105910|NCT00213148|21063210|P4|Cycle 1 (1 Month)|Lack of Efficacy|5
6105911|NCT00213148|21063211|P3|Cycle 1 (1 Month)|Lack of Efficacy|8
6105912|NCT00213148|21063212|P2|Cycle 1 (1 Month)|Lack of Efficacy|0
6105913|NCT00213148|21063213|P1|Cycle 1 (1 Month)|Lack of Efficacy|4
6105914|NCT00213148|21063209|P5|Cycle 1 (1 Month)|Adverse Event|0
6105915|NCT00213148|21063210|P4|Cycle 1 (1 Month)|Adverse Event|0
6105916|NCT00213148|21063211|P3|Cycle 1 (1 Month)|Adverse Event|1
6105917|NCT00213148|21063212|P2|Cycle 1 (1 Month)|Adverse Event|0
6105918|NCT00213148|21063213|P1|Cycle 1 (1 Month)|Adverse Event|0
6105919|NCT00213148|21063209|P5|Cycle 1 (1 Month)|Lost to Follow-up|1
6105920|NCT00213148|21063210|P4|Cycle 1 (1 Month)|Lost to Follow-up|2
6105921|NCT00213148|21063211|P3|Cycle 1 (1 Month)|Lost to Follow-up|2
6105922|NCT00213148|21063212|P2|Cycle 1 (1 Month)|Lost to Follow-up|0
6105923|NCT00213148|21063213|P1|Cycle 1 (1 Month)|Lost to Follow-up|1
6105924|NCT00213135|21063240|P3|Overall Study|Other|15
6105925|NCT00213135|21063241|P2|Overall Study|Other|12
6105926|NCT00213135|21063242|P1|Overall Study|Other|21
6105927|NCT00213135|21063240|P3|Overall Study|Disease progression|21
6105928|NCT00213135|21063241|P2|Overall Study|Disease progression|5
6105929|NCT00213135|21063242|P1|Overall Study|Disease progression|4
6105930|NCT00213135|21063240|P3|Overall Study|Death|2
6105931|NCT00213135|21063241|P2|Overall Study|Death|1
6105932|NCT00213135|21063242|P1|Overall Study|Death|1
6105933|NCT00213135|21063240|P3|Overall Study|Protocol Violation|10
6105934|NCT00213135|21063241|P2|Overall Study|Protocol Violation|4
6105935|NCT00213135|21063242|P1|Overall Study|Protocol Violation|4
6105936|NCT00213135|21063240|P3|Overall Study|Lost to Follow-up|4
6105937|NCT00213135|21063241|P2|Overall Study|Lost to Follow-up|8
6105938|NCT00213135|21063242|P1|Overall Study|Lost to Follow-up|11
6105939|NCT00213135|21063240|P3|Overall Study|Adverse Event|5
6105940|NCT00213135|21063241|P2|Overall Study|Adverse Event|5
6105941|NCT00213135|21063242|P1|Overall Study|Adverse Event|9
6105942|NCT00212758|21063285|P2|Standard Therapy of GH (12 Months)|Lost to Follow-up|1
6105943|NCT00212758|21063286|P1|Standard Therapy of GH (12 Months)|Lost to Follow-up|1
6105944|NCT00212758|21063285|P2|Standard Therapy of GH (12 Months)|Adverse Event|0
6105945|NCT00212758|21063286|P1|Standard Therapy of GH (12 Months)|Adverse Event|1
6105946|NCT00212355|21063302|P1|Overall Study|A change of address|1
6105947|NCT00212355|21063302|P1|Overall Study|Withdrawal by Subject|1
6105948|NCT00212355|21063302|P1|Overall Study|Adverse Event|1
6105949|NCT00212134|21063323|P2|Phase 3 (Age 10 Years)|On Going|21
6105950|NCT00212134|21063324|P1|Phase 3 (Age 10 Years)|On Going|21
6105951|NCT00211887|21063345|P3|Overall Study|Side effects|5
6105952|NCT00211887|21063346|P2|Overall Study|Side effects|13
6105953|NCT00211887|21063347|P1|Overall Study|Side effects|19
6105954|NCT00211887|21063345|P3|Overall Study|Other medical reason|7
6105955|NCT00211887|21063346|P2|Overall Study|Other medical reason|11
6105956|NCT00211887|21063347|P1|Overall Study|Other medical reason|15
6105957|NCT00211887|21063345|P3|Overall Study|Non-medical reason|8
6105958|NCT00211887|21063346|P2|Overall Study|Non-medical reason|14
6105959|NCT00211887|21063347|P1|Overall Study|Non-medical reason|31
6105960|NCT00211887|21063345|P3|Overall Study|Lost to Follow-up|9
6105961|NCT00211887|21063346|P2|Overall Study|Lost to Follow-up|13
6105962|NCT00211887|21063347|P1|Overall Study|Lost to Follow-up|28
6105963|NCT00211887|21063345|P3|Overall Study|Death|1
6105964|NCT00211887|21063346|P2|Overall Study|Death|1
6105965|NCT00211887|21063347|P1|Overall Study|Death|1
6105966|NCT00211887|21063345|P3|Overall Study|Adverse Event|6
6105967|NCT00211887|21063346|P2|Overall Study|Adverse Event|4
6105968|NCT00211887|21063347|P1|Overall Study|Adverse Event|8
6105969|NCT00211809|21063364|P1|Overall Study|side effects|2
6105970|NCT00211809|21063364|P1|Overall Study|Pregnancy|1
6105971|NCT00211809|21063364|P1|Overall Study|Lost to Follow-up|2
6105972|NCT00211809|21063364|P1|Overall Study|Lack of Efficacy|1
6105973|NCT00211757|21063380|P2|Overall Study|Lack of Efficacy|1
6105974|NCT00211757|21063381|P1|Overall Study|Lack of Efficacy|0
6105975|NCT00211757|21063380|P2|Overall Study|Withdrawal by Subject|1
6105976|NCT00211757|21063381|P1|Overall Study|Withdrawal by Subject|1
6105977|NCT00211536|21063402|P2|Overall Study|Adverse Event|0
6105978|NCT00211536|21063403|P1|Overall Study|Adverse Event|2
6105979|NCT00211536|21063402|P2|Overall Study|Physician Decision|5
6105980|NCT00211536|21063403|P1|Overall Study|Physician Decision|0
6105981|NCT00211536|21063402|P2|Overall Study|Withdrawal by Subject|2
6105982|NCT00211536|21063403|P1|Overall Study|Withdrawal by Subject|2
6105983|NCT00211510|21063419|P2|Overall Study|Withdrawal by Subject|1
6105984|NCT00211510|21063420|P1|Overall Study|Withdrawal by Subject|3
6105985|NCT00211510|21063419|P2|Overall Study|Physician Decision|1
6105986|NCT00211510|21063420|P1|Overall Study|Physician Decision|3
6105987|NCT00211237|21063438|P3|12 Months|unrelated medical problem|1
6105988|NCT00211237|21063439|P2|12 Months|unrelated medical problem|0
6105989|NCT00211237|21063440|P1|12 Months|unrelated medical problem|0
6105990|NCT00211237|21063438|P3|12 Months|Withdrew|1
6105991|NCT00211237|21063439|P2|12 Months|Withdrew|0
6105992|NCT00211237|21063440|P1|12 Months|Withdrew|0
6105993|NCT00211237|21063438|P3|12 Months|Lost to Follow-up|1
6105994|NCT00211237|21063439|P2|12 Months|Lost to Follow-up|0
6105995|NCT00211237|21063440|P1|12 Months|Lost to Follow-up|1
6105996|NCT00211237|21063438|P3|12 Months|Death|3
6105997|NCT00211237|21063439|P2|12 Months|Death|2
6105998|NCT00211237|21063440|P1|12 Months|Death|8
6105999|NCT00211237|21063438|P3|6 Months|Could not comply with protocol|0
6106000|NCT00211237|21063439|P2|6 Months|Could not comply with protocol|2
6106001|NCT00211237|21063440|P1|6 Months|Could not comply with protocol|0
6106002|NCT00211237|21063438|P3|6 Months|Lost to Follow-up|0
6106003|NCT00211237|21063439|P2|6 Months|Lost to Follow-up|0
6106004|NCT00211237|21063440|P1|6 Months|Lost to Follow-up|2
6106005|NCT00211237|21063438|P3|6 Months|Death|3
6106006|NCT00211237|21063439|P2|6 Months|Death|0
6106007|NCT00211237|21063440|P1|6 Months|Death|6
6106008|NCT00211237|21063438|P3|3 Months|Non-medical problem|1
6106009|NCT00211237|21063439|P2|3 Months|Non-medical problem|0
6106010|NCT00211237|21063440|P1|3 Months|Non-medical problem|0
6106011|NCT00211237|21063438|P3|3 Months|Withdrew|0
6106012|NCT00211237|21063439|P2|3 Months|Withdrew|1
6106013|NCT00211237|21063440|P1|3 Months|Withdrew|0
6106014|NCT00211237|21063438|P3|3 Months|Could not comply with protocol|0
6106015|NCT00211237|21063439|P2|3 Months|Could not comply with protocol|0
6106016|NCT00211237|21063440|P1|3 Months|Could not comply with protocol|1
6106017|NCT00211237|21063438|P3|3 Months|Death|0
6106018|NCT00211237|21063439|P2|3 Months|Death|3
6106019|NCT00211237|21063440|P1|3 Months|Death|7
6106020|NCT00211237|21063438|P3|1 Month|Non-medical problem|0
6106021|NCT00211237|21063439|P2|1 Month|Non-medical problem|2
6106022|NCT00211237|21063440|P1|1 Month|Non-medical problem|0
6106023|NCT00211237|21063438|P3|1 Month|Additional surgery needed|0
6106024|NCT00211237|21063439|P2|1 Month|Additional surgery needed|0
6106025|NCT00211237|21063440|P1|1 Month|Additional surgery needed|1
6106026|NCT00211237|21063438|P3|1 Month|Withdrew|0
6106027|NCT00211237|21063439|P2|1 Month|Withdrew|4
6106028|NCT00211237|21063440|P1|1 Month|Withdrew|0
6106029|NCT00211237|21063438|P3|1 Month|Lost to Follow-up|0
6106030|NCT00211237|21063439|P2|1 Month|Lost to Follow-up|2
6106031|NCT00211237|21063440|P1|1 Month|Lost to Follow-up|0
6106032|NCT00211237|21063438|P3|1 Month|Death|0
6106033|NCT00211237|21063439|P2|1 Month|Death|1
6106034|NCT00211237|21063440|P1|1 Month|Death|2
6106035|NCT00211237|21063438|P3|Baseline|Refused random assignment|0
6106036|NCT00211237|21063439|P2|Baseline|Refused random assignment|0
6106037|NCT00211237|21063440|P1|Baseline|Refused random assignment|1
6106038|NCT00211237|21063438|P3|Baseline|Withdrew|0
6106039|NCT00211237|21063439|P2|Baseline|Withdrew|3
6106040|NCT00211237|21063440|P1|Baseline|Withdrew|1
6106041|NCT00211185|21063530|P1|Overall Study|Physician Decision|5
6106042|NCT00211185|21063530|P1|Overall Study|Withdrawal by Subject|6
6106043|NCT00211185|21063530|P1|Overall Study|Disease progression|7
6106044|NCT00211185|21063530|P1|Overall Study|Death|2
6106045|NCT00211172|21063544|P2|Overall Study|Died or lost health plan eligibility|32
6106046|NCT00211172|21063545|P1|Overall Study|Died or lost health plan eligibility|39
6106047|NCT00211081|21063551|P1|Overall Study|Withdrawal by Subject|2
6106048|NCT00210639|21063563|P2|Overall Study|Other|12
6106049|NCT00210639|21063564|P1|Overall Study|Other|18
6106050|NCT00210639|21063563|P2|Overall Study|Withdrawal by Subject|1
6106051|NCT00210639|21063564|P1|Overall Study|Withdrawal by Subject|8
6106052|NCT00210639|21063563|P2|Overall Study|Lost to Follow-up|29
6106053|NCT00210639|21063564|P1|Overall Study|Lost to Follow-up|37
6106054|NCT00210626|21063572|P2|Overall Study|Other|5
6106055|NCT00210626|21063573|P1|Overall Study|Other|4
6106056|NCT00210626|21063572|P2|Overall Study|Sponser Request|0
6106057|NCT00210626|21063573|P1|Overall Study|Sponser Request|1
6106058|NCT00210626|21063572|P2|Overall Study|Physician Decision|2
6106059|NCT00210626|21063573|P1|Overall Study|Physician Decision|0
6106060|NCT00210626|21063572|P2|Overall Study|Withdrawal by Subject|20
6106061|NCT00210626|21063573|P1|Overall Study|Withdrawal by Subject|29
6106062|NCT00210626|21063572|P2|Overall Study|Death|0
6106063|NCT00210626|21063573|P1|Overall Study|Death|1
6106064|NCT00210626|21063572|P2|Overall Study|Lost to Follow-up|11
6106065|NCT00210626|21063573|P1|Overall Study|Lost to Follow-up|11
6106066|NCT00210626|21063572|P2|Overall Study|Protocol Violation|5
6106067|NCT00210626|21063573|P1|Overall Study|Protocol Violation|1
6106068|NCT00210626|21063572|P2|Overall Study|Adverse Event|2
6106069|NCT00210626|21063573|P1|Overall Study|Adverse Event|1
6106070|NCT00209560|21063620|P2|Overall Study|Lack of Efficacy|0
6106071|NCT00209560|21063621|P1|Overall Study|Lack of Efficacy|1
6106072|NCT00209339|21063640|P1|At 5 Years Follow-up|Death|1
6106073|NCT00209339|21063640|P1|At 5 Years Follow-up|Withdrawal because of other reasons|5
6106074|NCT00209339|21063640|P1|At 5 Years Follow-up|Withdrawal by Subject|2
6106075|NCT00209339|21063640|P1|At 4 Years Follow-up|Death|1
6106076|NCT00209339|21063640|P1|At 4 Years Follow-up|Withdrawal by Subject|4
6106077|NCT00209339|21063640|P1|At 3 Years Follow-up|Withdrawal by Subject|1
6106078|NCT00209339|21063640|P1|At 24 Months Follow-up|Death|1
6106079|NCT00209339|21063640|P1|At 24 Months Follow-up|Withdrawal because of other reasons|6
6106080|NCT00209339|21063640|P1|At 24 Months Follow-up|Withdrawal by Subject|4
6106081|NCT00209339|21063640|P1|At 12 Months Follow-up|No MitraClip Device Implanted|6
6106082|NCT00209339|21063640|P1|At 12 Months Follow-up|Death|1
6106083|NCT00209339|21063640|P1|At 12 Months Follow-up|Withdrawal by Subject|8
6106084|NCT00209274|21063724|P2|Overall Study|Randomized not treated (RNT)|15
6106085|NCT00209274|21063725|P1|Overall Study|Randomized not treated (RNT)|6
6106086|NCT00209274|21063724|P2|Overall Study|Withdrawal by Subject|15
6106087|NCT00209274|21063725|P1|Overall Study|Withdrawal by Subject|30
6106088|NCT00209274|21063724|P2|Overall Study|Death|15
6106089|NCT00209274|21063725|P1|Overall Study|Death|32
6106090|NCT00209274|21063724|P2|Overall Study|Missed visit|2
6106091|NCT00209274|21063725|P1|Overall Study|Missed visit|3
6106092|NCT00209170|21064045|P2|Overall Study|Lack of Efficacy|1
6106093|NCT00209170|21064046|P1|Overall Study|Lack of Efficacy|0
6106094|NCT00209170|21064045|P2|Overall Study|Withdrawal by Subject|1
6106095|NCT00209170|21064046|P1|Overall Study|Withdrawal by Subject|2
6106096|NCT00209170|21064045|P2|Overall Study|Adverse Event|1
6106097|NCT00209170|21064046|P1|Overall Study|Adverse Event|0
6106098|NCT00209131|21064054|P2|Overall Study|Lack of personnel due to turnovers.|11
6106099|NCT00209131|21064055|P1|Overall Study|Lack of personnel due to turnovers.|15
6106100|NCT00209092|21064065|P2|Overall Study|Withdrawal by Subject|0
6106101|NCT00209092|21064066|P1|Overall Study|Withdrawal by Subject|1
6106102|NCT00209092|21064065|P2|Overall Study|Adverse Event|1
6106103|NCT00209092|21064066|P1|Overall Study|Adverse Event|0
6106104|NCT00209092|21064065|P2|Overall Study|Progression of disease|1
6106105|NCT00209092|21064066|P1|Overall Study|Progression of disease|7
6106106|NCT00209027|21064076|P2|Overall Study|study terminated|0
6106107|NCT00209027|21064077|P1|Overall Study|study terminated|10
6106108|NCT00208767|21064101|P2|Overall Study|Lost to Follow-up|3
6106109|NCT00208767|21064102|P1|Overall Study|Lost to Follow-up|3
6106110|NCT00208767|21064101|P2|Overall Study|Death|0
6106111|NCT00208767|21064102|P1|Overall Study|Death|1
6106112|NCT00208767|21064101|P2|Overall Study|Withdrawal by Subject|3
6106113|NCT00208767|21064102|P1|Overall Study|Withdrawal by Subject|14
6106114|NCT00208767|21064101|P2|Overall Study|Adverse Event|1
6106115|NCT00208767|21064102|P1|Overall Study|Adverse Event|9
6106116|NCT00208325|21064130|P4|Overall Study|Mis-Randomized|0
6106117|NCT00208325|21064131|P3|Overall Study|Mis-Randomized|0
6106118|NCT00208325|21064132|P2|Overall Study|Mis-Randomized|20
6106119|NCT00208325|21064133|P1|Overall Study|Mis-Randomized|17
6106120|NCT00208325|21064130|P4|Overall Study|Other|0
6106121|NCT00208325|21064131|P3|Overall Study|Other|1
6106122|NCT00208325|21064132|P2|Overall Study|Other|1
6106123|NCT00208325|21064133|P1|Overall Study|Other|2
6106124|NCT00208325|21064130|P4|Overall Study|Does not wish to Continue in Study|2
6106125|NCT00208325|21064131|P3|Overall Study|Does not wish to Continue in Study|3
6106126|NCT00208325|21064132|P2|Overall Study|Does not wish to Continue in Study|8
6106127|NCT00208325|21064133|P1|Overall Study|Does not wish to Continue in Study|5
6106128|NCT00208325|21064130|P4|Overall Study|Unsurfaced to Resurfaced Patella|3
6106129|NCT00208325|21064131|P3|Overall Study|Unsurfaced to Resurfaced Patella|1
6106130|NCT00208325|21064132|P2|Overall Study|Unsurfaced to Resurfaced Patella|4
6106131|NCT00208325|21064133|P1|Overall Study|Unsurfaced to Resurfaced Patella|4
6106132|NCT00208325|21064130|P4|Overall Study|Lost to Follow-up|0
6106133|NCT00208325|21064131|P3|Overall Study|Lost to Follow-up|2
6106134|NCT00208325|21064132|P2|Overall Study|Lost to Follow-up|0
6106135|NCT00208325|21064133|P1|Overall Study|Lost to Follow-up|1
6106136|NCT00208325|21064130|P4|Overall Study|Revision|4
6106137|NCT00208325|21064131|P3|Overall Study|Revision|0
6106138|NCT00208325|21064132|P2|Overall Study|Revision|1
6106139|NCT00208325|21064133|P1|Overall Study|Revision|4
6106140|NCT00208325|21064130|P4|Overall Study|Withdrawal by Subject|0
6106141|NCT00208325|21064131|P3|Overall Study|Withdrawal by Subject|0
6106142|NCT00208325|21064132|P2|Overall Study|Withdrawal by Subject|1
6106143|NCT00208325|21064133|P1|Overall Study|Withdrawal by Subject|0
6106144|NCT00208325|21064130|P4|Overall Study|Death|5
6106145|NCT00208325|21064131|P3|Overall Study|Death|7
6106146|NCT00208325|21064132|P2|Overall Study|Death|19
6106147|NCT00208325|21064133|P1|Overall Study|Death|18
6106148|NCT00207740|21064270|P4|Overall Study|Other|5
6106149|NCT00207740|21064271|P3|Overall Study|Other|7
6106150|NCT00207740|21064272|P2|Overall Study|Other|10
6106151|NCT00207740|21064273|P1|Overall Study|Other|2
6106152|NCT00207740|21064270|P4|Overall Study|Sponsor Directive|21
6106153|NCT00207740|21064271|P3|Overall Study|Sponsor Directive|16
6106154|NCT00207740|21064272|P2|Overall Study|Sponsor Directive|15
6106155|NCT00207740|21064273|P1|Overall Study|Sponsor Directive|22
6106156|NCT00207740|21064270|P4|Overall Study|Death|1
6106157|NCT00207740|21064271|P3|Overall Study|Death|0
6106158|NCT00207740|21064272|P2|Overall Study|Death|0
6106159|NCT00207740|21064273|P1|Overall Study|Death|0
6106160|NCT00207740|21064270|P4|Overall Study|Lost to Follow-up|1
6106161|NCT00207740|21064271|P3|Overall Study|Lost to Follow-up|1
6106162|NCT00207740|21064272|P2|Overall Study|Lost to Follow-up|2
6106163|NCT00207740|21064273|P1|Overall Study|Lost to Follow-up|0
6106164|NCT00207740|21064270|P4|Overall Study|Unsatisfactory therapeutic effect|4
6106165|NCT00207740|21064271|P3|Overall Study|Unsatisfactory therapeutic effect|2
6106166|NCT00207740|21064272|P2|Overall Study|Unsatisfactory therapeutic effect|0
6106167|NCT00207740|21064273|P1|Overall Study|Unsatisfactory therapeutic effect|1
6106168|NCT00207740|21064270|P4|Overall Study|Adverse Event|11
6106169|NCT00207740|21064271|P3|Overall Study|Adverse Event|14
6106170|NCT00207740|21064272|P2|Overall Study|Adverse Event|14
6106171|NCT00207740|21064273|P1|Overall Study|Adverse Event|4
6106172|NCT00207727|21064319|P5|Overall Study|Other|33
6106173|NCT00207727|21064320|P4|Overall Study|Other|37
6106174|NCT00207727|21064321|P3|Overall Study|Other|41
6106175|NCT00207727|21064322|P2|Overall Study|Other|41
6106176|NCT00207727|21064323|P1|Overall Study|Other|38
6106177|NCT00207727|21064319|P5|Overall Study|Lost to Follow-up|0
6106178|NCT00207727|21064320|P4|Overall Study|Lost to Follow-up|0
6106179|NCT00207727|21064321|P3|Overall Study|Lost to Follow-up|0
6106180|NCT00207727|21064322|P2|Overall Study|Lost to Follow-up|1
6106181|NCT00207727|21064323|P1|Overall Study|Lost to Follow-up|0
6106182|NCT00207727|21064319|P5|Overall Study|Withdrawal by Subject|1
6106183|NCT00207727|21064320|P4|Overall Study|Withdrawal by Subject|0
6106184|NCT00207727|21064321|P3|Overall Study|Withdrawal by Subject|0
6106185|NCT00207727|21064322|P2|Overall Study|Withdrawal by Subject|0
6106186|NCT00207727|21064323|P1|Overall Study|Withdrawal by Subject|0
6106187|NCT00207714|21064350|P5|Overall Study|Other|0
6106188|NCT00207714|21064351|P4|Overall Study|Other|1
6106189|NCT00207714|21064352|P3|Overall Study|Other|5
6106190|NCT00207714|21064353|P2|Overall Study|Other|2
6106191|NCT00207714|21064354|P1|Overall Study|Other|3
6106192|NCT00207714|21064350|P5|Overall Study|Unsatisfactory therapeutic effect|4
6106193|NCT00207714|21064351|P4|Overall Study|Unsatisfactory therapeutic effect|4
6106194|NCT00207714|21064352|P3|Overall Study|Unsatisfactory therapeutic effect|1
6106195|NCT00207714|21064353|P2|Overall Study|Unsatisfactory therapeutic effect|3
6106196|NCT00207714|21064354|P1|Overall Study|Unsatisfactory therapeutic effect|5
6106197|NCT00207714|21064350|P5|Overall Study|Adverse Event|1
6106198|NCT00207714|21064351|P4|Overall Study|Adverse Event|3
6106199|NCT00207714|21064352|P3|Overall Study|Adverse Event|4
6106200|NCT00207714|21064353|P2|Overall Study|Adverse Event|2
6106201|NCT00207714|21064354|P1|Overall Study|Adverse Event|6
6106202|NCT00207142|21064376|P4|Maintenance Phase/Rescue Phase|Lack of Efficacy|1
6106203|NCT00207142|21064377|P3|Maintenance Phase/Rescue Phase|Lack of Efficacy|0
6106204|NCT00207142|21064378|P2|Maintenance Phase/Rescue Phase|Lack of Efficacy|0
6106205|NCT00207142|21064379|P1|Maintenance Phase/Rescue Phase|Lack of Efficacy|0
6106206|NCT00207142|21064376|P4|Maintenance Phase/Rescue Phase|Death|1
6106207|NCT00207142|21064377|P3|Maintenance Phase/Rescue Phase|Death|0
6106208|NCT00207142|21064378|P2|Maintenance Phase/Rescue Phase|Death|0
6106209|NCT00207142|21064379|P1|Maintenance Phase/Rescue Phase|Death|0
6106210|NCT00207142|21064376|P4|Maintenance Phase/Rescue Phase|Withdrawal by Subject|1
6106211|NCT00207142|21064377|P3|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2
6106212|NCT00207142|21064378|P2|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2
6106213|NCT00207142|21064379|P1|Maintenance Phase/Rescue Phase|Withdrawal by Subject|0
6106214|NCT00207142|21064376|P4|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0
6106215|NCT00207142|21064377|P3|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|1
6106300|NCT00206518|21064456|P2|Overall Study|Lack of Efficacy|4
6106216|NCT00207142|21064378|P2|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0
6106217|NCT00207142|21064379|P1|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0
6106218|NCT00207142|21064376|P4|Maintenance Phase/Rescue Phase|Pregnancy|0
6106219|NCT00207142|21064377|P3|Maintenance Phase/Rescue Phase|Pregnancy|2
6106220|NCT00207142|21064378|P2|Maintenance Phase/Rescue Phase|Pregnancy|2
6106221|NCT00207142|21064379|P1|Maintenance Phase/Rescue Phase|Pregnancy|0
6106222|NCT00207142|21064376|P4|Maintenance Phase/Rescue Phase|Poor/noncompliance|3
6106223|NCT00207142|21064377|P3|Maintenance Phase/Rescue Phase|Poor/noncompliance|2
6106224|NCT00207142|21064378|P2|Maintenance Phase/Rescue Phase|Poor/noncompliance|3
6106225|NCT00207142|21064379|P1|Maintenance Phase/Rescue Phase|Poor/noncompliance|0
6106226|NCT00207142|21064376|P4|Maintenance Phase/Rescue Phase|RTV intake impossible|0
6106227|NCT00207142|21064377|P3|Maintenance Phase/Rescue Phase|RTV intake impossible|1
6106228|NCT00207142|21064378|P2|Maintenance Phase/Rescue Phase|RTV intake impossible|0
6106229|NCT00207142|21064379|P1|Maintenance Phase/Rescue Phase|RTV intake impossible|0
6106230|NCT00207142|21064376|P4|Maintenance Phase/Rescue Phase|Lost to Follow-up|2
6106231|NCT00207142|21064377|P3|Maintenance Phase/Rescue Phase|Lost to Follow-up|1
6106232|NCT00207142|21064378|P2|Maintenance Phase/Rescue Phase|Lost to Follow-up|1
6106233|NCT00207142|21064379|P1|Maintenance Phase/Rescue Phase|Lost to Follow-up|0
6106234|NCT00207142|21064376|P4|Maintenance Phase/Rescue Phase|Adverse Event|1
6106235|NCT00207142|21064377|P3|Maintenance Phase/Rescue Phase|Adverse Event|4
6106236|NCT00207142|21064378|P2|Maintenance Phase/Rescue Phase|Adverse Event|1
6106237|NCT00207142|21064379|P1|Maintenance Phase/Rescue Phase|Adverse Event|0
6106238|NCT00207142|21064376|P4|Induction Phase|Missing lab data|0
6106239|NCT00207142|21064377|P3|Induction Phase|Missing lab data|0
6106240|NCT00207142|21064378|P2|Induction Phase|Missing lab data|0
6106241|NCT00207142|21064379|P1|Induction Phase|Missing lab data|1
6106242|NCT00207142|21064376|P4|Induction Phase|Incarceration|0
6106243|NCT00207142|21064377|P3|Induction Phase|Incarceration|0
6106244|NCT00207142|21064378|P2|Induction Phase|Incarceration|0
6106245|NCT00207142|21064379|P1|Induction Phase|Incarceration|1
6106246|NCT00207142|21064376|P4|Induction Phase|Withdrawal by Subject|0
6106247|NCT00207142|21064377|P3|Induction Phase|Withdrawal by Subject|0
6106248|NCT00207142|21064378|P2|Induction Phase|Withdrawal by Subject|0
6106249|NCT00207142|21064379|P1|Induction Phase|Withdrawal by Subject|4
6106250|NCT00207142|21064376|P4|Induction Phase|Subject no longer meets study criteria|0
6106251|NCT00207142|21064377|P3|Induction Phase|Subject no longer meets study criteria|0
6106252|NCT00207142|21064378|P2|Induction Phase|Subject no longer meets study criteria|0
6106253|NCT00207142|21064379|P1|Induction Phase|Subject no longer meets study criteria|3
6106254|NCT00207142|21064376|P4|Induction Phase|Pregnancy|0
6106255|NCT00207142|21064377|P3|Induction Phase|Pregnancy|0
6106256|NCT00207142|21064378|P2|Induction Phase|Pregnancy|0
6106257|NCT00207142|21064379|P1|Induction Phase|Pregnancy|1
6106258|NCT00207142|21064376|P4|Induction Phase|Poor/noncompliance|0
6106259|NCT00207142|21064377|P3|Induction Phase|Poor/noncompliance|0
6106260|NCT00207142|21064378|P2|Induction Phase|Poor/noncompliance|0
6106261|NCT00207142|21064379|P1|Induction Phase|Poor/noncompliance|2
6106262|NCT00207142|21064376|P4|Induction Phase|Physician Decision|0
6106263|NCT00207142|21064377|P3|Induction Phase|Physician Decision|0
6106264|NCT00207142|21064378|P2|Induction Phase|Physician Decision|0
6106265|NCT00207142|21064379|P1|Induction Phase|Physician Decision|2
6106266|NCT00207142|21064376|P4|Induction Phase|Lost to Follow-up|0
6106267|NCT00207142|21064377|P3|Induction Phase|Lost to Follow-up|0
6106268|NCT00207142|21064378|P2|Induction Phase|Lost to Follow-up|0
6106269|NCT00207142|21064379|P1|Induction Phase|Lost to Follow-up|5
6106270|NCT00207142|21064376|P4|Induction Phase|Lack of Efficacy|0
6106271|NCT00207142|21064377|P3|Induction Phase|Lack of Efficacy|0
6106272|NCT00207142|21064378|P2|Induction Phase|Lack of Efficacy|0
6106273|NCT00207142|21064379|P1|Induction Phase|Lack of Efficacy|1
6106274|NCT00207142|21064376|P4|Induction Phase|Death|0
6106275|NCT00207142|21064377|P3|Induction Phase|Death|0
6106276|NCT00207142|21064378|P2|Induction Phase|Death|0
6106277|NCT00207142|21064379|P1|Induction Phase|Death|1
6106278|NCT00207142|21064376|P4|Induction Phase|Adverse Event|0
6106279|NCT00207142|21064377|P3|Induction Phase|Adverse Event|0
6106280|NCT00207142|21064378|P2|Induction Phase|Adverse Event|0
6106281|NCT00207142|21064379|P1|Induction Phase|Adverse Event|9
6106282|NCT00207090|21064416|P1|Overall Study|Physician Decision|1
6106283|NCT00207090|21064416|P1|Overall Study|Disease progression/relapse|2
6106284|NCT00207090|21064416|P1|Overall Study|Chest wall mass larger|1
6106285|NCT00207090|21064416|P1|Overall Study|Study drug toxicity|3
6106286|NCT00206726|21064445|P1|Overall Study|Withdrawal by Subject|8
6106287|NCT00206726|21064445|P1|Overall Study|Protocol Violation|1
6106288|NCT00206726|21064445|P1|Overall Study|Death|4
6106289|NCT00206726|21064445|P1|Overall Study|Adverse Event|17
6106290|NCT00206726|21064445|P1|Overall Study|Bone marrow transplant|1
6106291|NCT00206726|21064445|P1|Overall Study|Placed on new protocol|1
6106292|NCT00206726|21064445|P1|Overall Study|Progressive disease or relapsed disease|18
6106293|NCT00206726|21064445|P1|Overall Study|Delayed recovery of blood counts|1
6106294|NCT00206518|21064456|P2|Overall Study|Protocol Violation|1
6106295|NCT00206518|21064457|P1|Overall Study|Protocol Violation|1
6106296|NCT00206518|21064456|P2|Overall Study|Physician Decision|0
6106297|NCT00206518|21064457|P1|Overall Study|Physician Decision|1
6106298|NCT00206518|21064456|P2|Overall Study|Adverse Event|1
6106299|NCT00206518|21064457|P1|Overall Study|Adverse Event|2
6106301|NCT00206518|21064457|P1|Overall Study|Lack of Efficacy|6
6106302|NCT00206440|21064469|P2|Overall Study|Adverse Event|2
6106303|NCT00206440|21064470|P1|Overall Study|Adverse Event|4
6106304|NCT00206440|21064469|P2|Overall Study|Protocol Violation|2
6106305|NCT00206440|21064470|P1|Overall Study|Protocol Violation|1
6106306|NCT00206427|21064476|P1|Overall Study|Adverse Event|2
6106307|NCT00206375|21064483|P3|Overall Study|Study terminated due to lack of funds|1
6106308|NCT00206375|21064484|P2|Overall Study|Study terminated due to lack of funds|1
6106309|NCT00206375|21064485|P1|Overall Study|Study terminated due to lack of funds|0
6106310|NCT00206375|21064483|P3|Overall Study|Withdrawal by Subject|3
6106311|NCT00206375|21064484|P2|Overall Study|Withdrawal by Subject|1
6106312|NCT00206375|21064485|P1|Overall Study|Withdrawal by Subject|2
6106313|NCT00206375|21064483|P3|Overall Study|Lost to Follow-up|0
6106314|NCT00206375|21064484|P2|Overall Study|Lost to Follow-up|0
6106315|NCT00206375|21064485|P1|Overall Study|Lost to Follow-up|1
6106316|NCT00206323|21064505|P2|Overall Study|Lost to Follow-up|1
6106317|NCT00206323|21064506|P1|Overall Study|Lost to Follow-up|1
6106318|NCT00206323|21064505|P2|Overall Study|Adverse Event|1
6106319|NCT00206323|21064506|P1|Overall Study|Adverse Event|1
6106320|NCT00206323|21064505|P2|Overall Study|Lack of Efficacy|1
6106321|NCT00206323|21064506|P1|Overall Study|Lack of Efficacy|4
6106322|NCT00206102|21064514|P2|Overall Study|None of those categories|36
6106323|NCT00206102|21064515|P1|Overall Study|None of those categories|42
6106324|NCT00206102|21064514|P2|Overall Study|Study-specific discontinuation criteria|17
6106325|NCT00206102|21064515|P1|Overall Study|Study-specific discontinuation criteria|18
6106326|NCT00206102|21064514|P2|Overall Study|Withdrawal by Subject|101
6106327|NCT00206102|21064515|P1|Overall Study|Withdrawal by Subject|118
6106328|NCT00206102|21064514|P2|Overall Study|Lost to Follow-up|66
6106329|NCT00206102|21064515|P1|Overall Study|Lost to Follow-up|95
6106330|NCT00206102|21064514|P2|Overall Study|Lack of therapeutic response|11
6106331|NCT00206102|21064515|P1|Overall Study|Lack of therapeutic response|16
6106332|NCT00206102|21064514|P2|Overall Study|Protocol Violation|2
6106333|NCT00206102|21064515|P1|Overall Study|Protocol Violation|0
6106334|NCT00206102|21064514|P2|Overall Study|Adverse Event|82
6106335|NCT00206102|21064515|P1|Overall Study|Adverse Event|119
6106336|NCT00206076|21064551|P2|Overall Study|Withdrawal by Subject|1
6106337|NCT00206076|21064552|P1|Overall Study|Withdrawal by Subject|1
6106338|NCT00206076|21064551|P2|Overall Study|Physician Decision|0
6106339|NCT00206076|21064552|P1|Overall Study|Physician Decision|2
6106340|NCT00205881|21064562|P1|Overall Study|Withdrawal by Subject|16
6106341|NCT00205855|21064567|P1|Overall Study|Withdrawal by Subject|5
6106342|NCT00205855|21064567|P1|Overall Study|Only received temporary implants|16
6106343|NCT00205803|21064573|P2|Toddler Dose|Lost to Follow-up|3
6106344|NCT00205803|21064574|P1|Toddler Dose|Lost to Follow-up|2
6106345|NCT00205803|21064573|P2|After Infant Series|Other|4
6106346|NCT00205803|21064574|P1|After Infant Series|Other|10
6106347|NCT00205803|21064573|P2|After Infant Series|Withdrawal by Subject|4
6106348|NCT00205803|21064574|P1|After Infant Series|Withdrawal by Subject|1
6106349|NCT00205803|21064573|P2|After Infant Series|Physician Decision|2
6106350|NCT00205803|21064574|P1|After Infant Series|Physician Decision|3
6106351|NCT00205803|21064573|P2|After Infant Series|Lost to Follow-up|1
6106352|NCT00205803|21064574|P1|After Infant Series|Lost to Follow-up|2
6106353|NCT00205803|21064573|P2|After Infant Series|Protocol Violation|1
6106354|NCT00205803|21064574|P1|After Infant Series|Protocol Violation|1
6106355|NCT00205803|21064573|P2|After Infant Series|Adverse Event|1
6106356|NCT00205803|21064574|P1|After Infant Series|Adverse Event|1
6106357|NCT00205803|21064573|P2|Infant Series|Sponsor request|0
6106358|NCT00205803|21064574|P1|Infant Series|Sponsor request|1
6106359|NCT00205803|21064573|P2|Infant Series|Non-compliant|0
6106360|NCT00205803|21064574|P1|Infant Series|Non-compliant|1
6106361|NCT00205803|21064573|P2|Infant Series|Lost Kaiser coverage|1
6106362|NCT00205803|21064574|P1|Infant Series|Lost Kaiser coverage|0
6106363|NCT00205803|21064573|P2|Infant Series|Protocol Violation|0
6106364|NCT00205803|21064574|P1|Infant Series|Protocol Violation|1
6106365|NCT00205803|21064573|P2|Infant Series|Physician Decision|1
6106366|NCT00205803|21064574|P1|Infant Series|Physician Decision|3
6106367|NCT00205803|21064573|P2|Infant Series|Withdrawal by Subject|5
6106368|NCT00205803|21064574|P1|Infant Series|Withdrawal by Subject|2
6106369|NCT00205803|21064573|P2|Infant Series|Lost to Follow-up|4
6106370|NCT00205803|21064574|P1|Infant Series|Lost to Follow-up|10
6106371|NCT00205777|21064630|P6|Study Extension II|Enrolled but not treated|131
6106372|NCT00205777|21064631|P5|Study Extension II|Enrolled but not treated|0
6106373|NCT00205777|21064632|P4|Study Extension II|Enrolled but not treated|71
6106374|NCT00205777|21064633|P3|Study Extension II|Enrolled but not treated|0
6106375|NCT00205777|21064634|P2|Study Extension II|Enrolled but not treated|0
6106376|NCT00205777|21064635|P1|Study Extension II|Enrolled but not treated|0
6106377|NCT00205777|21064630|P6|Study Extension II|Other Event|20
6106378|NCT00205777|21064631|P5|Study Extension II|Other Event|0
6106379|NCT00205777|21064632|P4|Study Extension II|Other Event|12
6106380|NCT00205777|21064633|P3|Study Extension II|Other Event|0
6106381|NCT00205777|21064634|P2|Study Extension II|Other Event|0
6106382|NCT00205777|21064635|P1|Study Extension II|Other Event|0
6106383|NCT00205777|21064630|P6|Study Extension II|Failed to return|26
6106384|NCT00205777|21064631|P5|Study Extension II|Failed to return|0
6106385|NCT00205777|21064632|P4|Study Extension II|Failed to return|14
6106386|NCT00205777|21064633|P3|Study Extension II|Failed to return|0
6106387|NCT00205777|21064634|P2|Study Extension II|Failed to return|0
6106388|NCT00205777|21064635|P1|Study Extension II|Failed to return|0
6106389|NCT00205777|21064630|P6|Study Extension II|Lack of Efficacy|1
6106390|NCT00205777|21064631|P5|Study Extension II|Lack of Efficacy|0
6106391|NCT00205777|21064632|P4|Study Extension II|Lack of Efficacy|0
6106392|NCT00205777|21064633|P3|Study Extension II|Lack of Efficacy|0
6106393|NCT00205777|21064634|P2|Study Extension II|Lack of Efficacy|0
6106394|NCT00205777|21064635|P1|Study Extension II|Lack of Efficacy|0
6106395|NCT00205777|21064630|P6|Study Extension II|Protocol Violation|10
6106396|NCT00205777|21064631|P5|Study Extension II|Protocol Violation|0
6106397|NCT00205777|21064632|P4|Study Extension II|Protocol Violation|1
6106398|NCT00205777|21064633|P3|Study Extension II|Protocol Violation|0
6106399|NCT00205777|21064634|P2|Study Extension II|Protocol Violation|0
6106400|NCT00205777|21064635|P1|Study Extension II|Protocol Violation|0
6106401|NCT00205777|21064630|P6|Study Extension II|Withdrawal by Subject|59
6106402|NCT00205777|21064631|P5|Study Extension II|Withdrawal by Subject|0
6106403|NCT00205777|21064632|P4|Study Extension II|Withdrawal by Subject|35
6106404|NCT00205777|21064633|P3|Study Extension II|Withdrawal by Subject|0
6106405|NCT00205777|21064634|P2|Study Extension II|Withdrawal by Subject|0
6106406|NCT00205777|21064635|P1|Study Extension II|Withdrawal by Subject|0
6106407|NCT00205777|21064630|P6|Study Extension II|Death|5
6106408|NCT00205777|21064631|P5|Study Extension II|Death|0
6106409|NCT00205777|21064632|P4|Study Extension II|Death|2
6106410|NCT00205777|21064633|P3|Study Extension II|Death|0
6106411|NCT00205777|21064634|P2|Study Extension II|Death|0
6106412|NCT00205777|21064635|P1|Study Extension II|Death|0
6106413|NCT00205777|21064630|P6|Study Extension II|Adverse Event|30
6106414|NCT00205777|21064631|P5|Study Extension II|Adverse Event|0
6106415|NCT00205777|21064632|P4|Study Extension II|Adverse Event|14
6106416|NCT00205777|21064633|P3|Study Extension II|Adverse Event|0
6106417|NCT00205777|21064634|P2|Study Extension II|Adverse Event|0
6106418|NCT00205777|21064635|P1|Study Extension II|Adverse Event|0
6106419|NCT00205777|21064630|P6|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0
6106420|NCT00205777|21064631|P5|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|258
6106421|NCT00205777|21064632|P4|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|240
6106422|NCT00205777|21064633|P3|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0
6106423|NCT00205777|21064634|P2|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0
6106424|NCT00205777|21064635|P1|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|273
6106425|NCT00205777|21064630|P6|Study Extension I|Withdrawn as per protocol|0
6106426|NCT00205777|21064631|P5|Study Extension I|Withdrawn as per protocol|0
6106427|NCT00205777|21064632|P4|Study Extension I|Withdrawn as per protocol|0
6106428|NCT00205777|21064633|P3|Study Extension I|Withdrawn as per protocol|1070
6106429|NCT00205777|21064634|P2|Study Extension I|Withdrawn as per protocol|0
6106430|NCT00205777|21064635|P1|Study Extension I|Withdrawn as per protocol|0
6106431|NCT00205777|21064630|P6|Study Extension I|Other Event|0
6106432|NCT00205777|21064631|P5|Study Extension I|Other Event|29
6106433|NCT00205777|21064632|P4|Study Extension I|Other Event|34
6106434|NCT00205777|21064633|P3|Study Extension I|Other Event|0
6106435|NCT00205777|21064634|P2|Study Extension I|Other Event|0
6106436|NCT00205777|21064635|P1|Study Extension I|Other Event|34
6106437|NCT00205777|21064630|P6|Study Extension I|Failed to return|0
6106438|NCT00205777|21064631|P5|Study Extension I|Failed to return|13
6106439|NCT00205777|21064632|P4|Study Extension I|Failed to return|17
6106440|NCT00205777|21064633|P3|Study Extension I|Failed to return|0
6106441|NCT00205777|21064634|P2|Study Extension I|Failed to return|0
6106442|NCT00205777|21064635|P1|Study Extension I|Failed to return|15
6106443|NCT00205777|21064630|P6|Study Extension I|Lack of Efficacy|0
6106444|NCT00205777|21064631|P5|Study Extension I|Lack of Efficacy|2
6106445|NCT00205777|21064632|P4|Study Extension I|Lack of Efficacy|1
6106446|NCT00205777|21064633|P3|Study Extension I|Lack of Efficacy|0
6106447|NCT00205777|21064634|P2|Study Extension I|Lack of Efficacy|0
6106448|NCT00205777|21064635|P1|Study Extension I|Lack of Efficacy|0
6106449|NCT00205777|21064630|P6|Study Extension I|Protocol Violation|0
6106450|NCT00205777|21064631|P5|Study Extension I|Protocol Violation|8
6106451|NCT00205777|21064632|P4|Study Extension I|Protocol Violation|8
6106452|NCT00205777|21064633|P3|Study Extension I|Protocol Violation|0
6106453|NCT00205777|21064634|P2|Study Extension I|Protocol Violation|0
6106454|NCT00205777|21064635|P1|Study Extension I|Protocol Violation|4
6106455|NCT00205777|21064630|P6|Study Extension I|Withdrawal by Subject|0
6106456|NCT00205777|21064631|P5|Study Extension I|Withdrawal by Subject|89
6106457|NCT00205777|21064632|P4|Study Extension I|Withdrawal by Subject|106
6106458|NCT00205777|21064633|P3|Study Extension I|Withdrawal by Subject|0
6106459|NCT00205777|21064634|P2|Study Extension I|Withdrawal by Subject|0
6106460|NCT00205777|21064635|P1|Study Extension I|Withdrawal by Subject|99
6106461|NCT00205777|21064630|P6|Study Extension I|Death|0
6106462|NCT00205777|21064631|P5|Study Extension I|Death|2
6106463|NCT00205777|21064632|P4|Study Extension I|Death|1
6106464|NCT00205777|21064633|P3|Study Extension I|Death|0
6106465|NCT00205777|21064634|P2|Study Extension I|Death|0
6106466|NCT00205777|21064635|P1|Study Extension I|Death|5
6106467|NCT00205777|21064630|P6|Study Extension I|Adverse Event|0
6106468|NCT00205777|21064631|P5|Study Extension I|Adverse Event|58
6106469|NCT00205777|21064632|P4|Study Extension I|Adverse Event|61
6106470|NCT00205777|21064633|P3|Study Extension I|Adverse Event|0
6106471|NCT00205777|21064634|P2|Study Extension I|Adverse Event|0
6106472|NCT00205777|21064635|P1|Study Extension I|Adverse Event|57
6106473|NCT00205777|21064630|P6|Completed Core Study, Entered SE I|Other Event|0
6106474|NCT00205777|21064631|P5|Completed Core Study, Entered SE I|Other Event|0
6106475|NCT00205777|21064632|P4|Completed Core Study, Entered SE I|Other Event|50
6106476|NCT00205777|21064633|P3|Completed Core Study, Entered SE I|Other Event|47
6106477|NCT00205777|21064634|P2|Completed Core Study, Entered SE I|Other Event|46
6106478|NCT00205777|21064635|P1|Completed Core Study, Entered SE I|Other Event|52
6106479|NCT00205777|21064630|P6|Completed Core Study, Entered SE I|Withdrawal by Subject|0
6106480|NCT00205777|21064631|P5|Completed Core Study, Entered SE I|Withdrawal by Subject|0
6106481|NCT00205777|21064632|P4|Completed Core Study, Entered SE I|Withdrawal by Subject|174
6106482|NCT00205777|21064633|P3|Completed Core Study, Entered SE I|Withdrawal by Subject|160
6106483|NCT00205777|21064634|P2|Completed Core Study, Entered SE I|Withdrawal by Subject|158
6106484|NCT00205777|21064635|P1|Completed Core Study, Entered SE I|Withdrawal by Subject|180
6106485|NCT00205777|21064630|P6|Core Study (Up to 3 Years)|Randomized but not treated|0
6106486|NCT00205777|21064631|P5|Core Study (Up to 3 Years)|Randomized but not treated|0
6106487|NCT00205777|21064632|P4|Core Study (Up to 3 Years)|Randomized but not treated|29
6106488|NCT00205777|21064633|P3|Core Study (Up to 3 Years)|Randomized but not treated|35
6106489|NCT00205777|21064634|P2|Core Study (Up to 3 Years)|Randomized but not treated|32
6106490|NCT00205777|21064635|P1|Core Study (Up to 3 Years)|Randomized but not treated|21
6106491|NCT00205777|21064630|P6|Core Study (Up to 3 Years)|Lack of Efficacy|0
6106492|NCT00205777|21064631|P5|Core Study (Up to 3 Years)|Lack of Efficacy|0
6106493|NCT00205777|21064632|P4|Core Study (Up to 3 Years)|Lack of Efficacy|75
6106494|NCT00205777|21064633|P3|Core Study (Up to 3 Years)|Lack of Efficacy|39
6106495|NCT00205777|21064634|P2|Core Study (Up to 3 Years)|Lack of Efficacy|52
6106496|NCT00205777|21064635|P1|Core Study (Up to 3 Years)|Lack of Efficacy|52
6106497|NCT00205777|21064630|P6|Core Study (Up to 3 Years)|Protocol Violation|0
6106498|NCT00205777|21064631|P5|Core Study (Up to 3 Years)|Protocol Violation|0
6106499|NCT00205777|21064632|P4|Core Study (Up to 3 Years)|Protocol Violation|42
6106500|NCT00205777|21064633|P3|Core Study (Up to 3 Years)|Protocol Violation|50
6106501|NCT00205777|21064634|P2|Core Study (Up to 3 Years)|Protocol Violation|55
6106502|NCT00205777|21064635|P1|Core Study (Up to 3 Years)|Protocol Violation|53
6106503|NCT00205777|21064630|P6|Core Study (Up to 3 Years)|Withdrawal by Subject|0
6106504|NCT00205777|21064631|P5|Core Study (Up to 3 Years)|Withdrawal by Subject|0
6106505|NCT00205777|21064632|P4|Core Study (Up to 3 Years)|Withdrawal by Subject|162
6106506|NCT00205777|21064633|P3|Core Study (Up to 3 Years)|Withdrawal by Subject|149
6106507|NCT00205777|21064634|P2|Core Study (Up to 3 Years)|Withdrawal by Subject|169
6106508|NCT00205777|21064635|P1|Core Study (Up to 3 Years)|Withdrawal by Subject|144
6106509|NCT00205777|21064630|P6|Core Study (Up to 3 Years)|Other Event|0
6106510|NCT00205777|21064631|P5|Core Study (Up to 3 Years)|Other Event|0
6106511|NCT00205777|21064632|P4|Core Study (Up to 3 Years)|Other Event|58
6106512|NCT00205777|21064633|P3|Core Study (Up to 3 Years)|Other Event|41
6106513|NCT00205777|21064634|P2|Core Study (Up to 3 Years)|Other Event|52
6106514|NCT00205777|21064635|P1|Core Study (Up to 3 Years)|Other Event|49
6106515|NCT00205777|21064630|P6|Core Study (Up to 3 Years)|Failed to return|0
6106516|NCT00205777|21064631|P5|Core Study (Up to 3 Years)|Failed to return|0
6106517|NCT00205777|21064632|P4|Core Study (Up to 3 Years)|Failed to return|27
6106518|NCT00205777|21064633|P3|Core Study (Up to 3 Years)|Failed to return|27
6106519|NCT00205777|21064634|P2|Core Study (Up to 3 Years)|Failed to return|25
6106520|NCT00205777|21064635|P1|Core Study (Up to 3 Years)|Failed to return|40
6106521|NCT00205777|21064630|P6|Core Study (Up to 3 Years)|Death|0
6106522|NCT00205777|21064631|P5|Core Study (Up to 3 Years)|Death|0
6106523|NCT00205777|21064632|P4|Core Study (Up to 3 Years)|Death|7
6106524|NCT00205777|21064633|P3|Core Study (Up to 3 Years)|Death|14
6106525|NCT00205777|21064634|P2|Core Study (Up to 3 Years)|Death|7
6106526|NCT00205777|21064635|P1|Core Study (Up to 3 Years)|Death|9
6106527|NCT00205777|21064630|P6|Core Study (Up to 3 Years)|Adverse Event|0
6106528|NCT00205777|21064631|P5|Core Study (Up to 3 Years)|Adverse Event|0
6106529|NCT00205777|21064632|P4|Core Study (Up to 3 Years)|Adverse Event|232
6106530|NCT00205777|21064633|P3|Core Study (Up to 3 Years)|Adverse Event|252
6106531|NCT00205777|21064634|P2|Core Study (Up to 3 Years)|Adverse Event|267
6106532|NCT00205777|21064635|P1|Core Study (Up to 3 Years)|Adverse Event|260
6106533|NCT00205712|21064844|P2|Overall Study|Lost to Follow-up|1
6106534|NCT00205712|21064845|P1|Overall Study|Lost to Follow-up|0
6106535|NCT00205699|21064858|P3|Overall Study|Lack of Efficacy|0
6106536|NCT00205699|21064859|P2|Overall Study|Lack of Efficacy|1
6106537|NCT00205699|21064860|P1|Overall Study|Lack of Efficacy|0
6106538|NCT00205699|21064858|P3|Overall Study|Withdrawal by Subject|1
6106539|NCT00205699|21064859|P2|Overall Study|Withdrawal by Subject|2
6106540|NCT00205699|21064860|P1|Overall Study|Withdrawal by Subject|1
6106541|NCT00205699|21064858|P3|Overall Study|Adverse Event|0
6106542|NCT00205699|21064859|P2|Overall Study|Adverse Event|0
6106543|NCT00205699|21064860|P1|Overall Study|Adverse Event|1
6106544|NCT00205699|21064858|P3|Overall Study|Lost to Follow-up|5
6106545|NCT00205699|21064859|P2|Overall Study|Lost to Follow-up|3
6106546|NCT00205699|21064860|P1|Overall Study|Lost to Follow-up|1
6106547|NCT00205179|21064940|P2|Overall Study|Adverse Event|1
6106548|NCT00205179|21064941|P1|Overall Study|Adverse Event|1
6106549|NCT00205179|21064940|P2|Overall Study|Physician Decision|1
6106550|NCT00205179|21064941|P1|Overall Study|Physician Decision|1
6106551|NCT00205179|21064940|P2|Overall Study|Death|2
6106552|NCT00205179|21064941|P1|Overall Study|Death|0
6106553|NCT00203996|21065059|P10|Overall Study|Scheduling issue|0
6106554|NCT00203996|21065060|P9|Overall Study|Scheduling issue|0
6106555|NCT00203996|21065061|P8|Overall Study|Scheduling issue|2
6106556|NCT00203996|21065062|P7|Overall Study|Scheduling issue|0
6106557|NCT00203996|21065063|P6|Overall Study|Scheduling issue|0
6106558|NCT00203996|21065064|P5|Overall Study|Scheduling issue|0
6106559|NCT00203996|21065065|P4|Overall Study|Scheduling issue|0
6106560|NCT00203996|21065066|P3|Overall Study|Scheduling issue|0
6106561|NCT00203996|21065067|P2|Overall Study|Scheduling issue|0
6106562|NCT00203996|21065068|P1|Overall Study|Scheduling issue|0
6106563|NCT00203996|21065059|P10|Overall Study|CPAP machine malfunction|0
6106564|NCT00203996|21065060|P9|Overall Study|CPAP machine malfunction|0
6106565|NCT00203996|21065061|P8|Overall Study|CPAP machine malfunction|0
6106566|NCT00203996|21065062|P7|Overall Study|CPAP machine malfunction|0
6106567|NCT00203996|21065063|P6|Overall Study|CPAP machine malfunction|0
6106568|NCT00203996|21065064|P5|Overall Study|CPAP machine malfunction|0
6106569|NCT00203996|21065065|P4|Overall Study|CPAP machine malfunction|1
6106570|NCT00203996|21065066|P3|Overall Study|CPAP machine malfunction|0
6106571|NCT00203996|21065067|P2|Overall Study|CPAP machine malfunction|0
6106572|NCT00203996|21065068|P1|Overall Study|CPAP machine malfunction|0
6106573|NCT00203996|21065059|P10|Overall Study|Physician Decision|1
6106574|NCT00203996|21065060|P9|Overall Study|Physician Decision|0
6106575|NCT00203996|21065061|P8|Overall Study|Physician Decision|0
6106576|NCT00203996|21065062|P7|Overall Study|Physician Decision|0
6106577|NCT00203996|21065063|P6|Overall Study|Physician Decision|0
6106578|NCT00203996|21065064|P5|Overall Study|Physician Decision|0
6106579|NCT00203996|21065065|P4|Overall Study|Physician Decision|2
6106580|NCT00203996|21065066|P3|Overall Study|Physician Decision|0
6106581|NCT00203996|21065067|P2|Overall Study|Physician Decision|0
6106582|NCT00203996|21065068|P1|Overall Study|Physician Decision|0
6106583|NCT00203996|21065059|P10|Overall Study|Protocol Violation|0
6106584|NCT00203996|21065060|P9|Overall Study|Protocol Violation|0
6106585|NCT00203996|21065061|P8|Overall Study|Protocol Violation|0
6106586|NCT00203996|21065062|P7|Overall Study|Protocol Violation|0
6106587|NCT00203996|21065063|P6|Overall Study|Protocol Violation|0
6106588|NCT00203996|21065064|P5|Overall Study|Protocol Violation|1
6106589|NCT00203996|21065065|P4|Overall Study|Protocol Violation|6
6106590|NCT00203996|21065066|P3|Overall Study|Protocol Violation|0
6106591|NCT00203996|21065067|P2|Overall Study|Protocol Violation|0
6106592|NCT00203996|21065068|P1|Overall Study|Protocol Violation|0
6106593|NCT00203996|21065059|P10|Overall Study|Lost to Follow-up|0
6106594|NCT00203996|21065060|P9|Overall Study|Lost to Follow-up|0
6106595|NCT00203996|21065061|P8|Overall Study|Lost to Follow-up|0
6106596|NCT00203996|21065062|P7|Overall Study|Lost to Follow-up|0
6106597|NCT00203996|21065063|P6|Overall Study|Lost to Follow-up|0
6106598|NCT00203996|21065064|P5|Overall Study|Lost to Follow-up|0
6106599|NCT00203996|21065065|P4|Overall Study|Lost to Follow-up|1
6106600|NCT00203996|21065066|P3|Overall Study|Lost to Follow-up|0
6106601|NCT00203996|21065067|P2|Overall Study|Lost to Follow-up|0
6106602|NCT00203996|21065068|P1|Overall Study|Lost to Follow-up|0
6106603|NCT00203892|21065135|P3|Overall Study|Death|0
6106604|NCT00203892|21065136|P2|Overall Study|Death|0
6106605|NCT00203892|21065137|P1|Overall Study|Death|1
6106606|NCT00203892|21065135|P3|Overall Study|Physician Decision|0
6106607|NCT00203892|21065136|P2|Overall Study|Physician Decision|2
6106608|NCT00203892|21065137|P1|Overall Study|Physician Decision|1
6106609|NCT00203502|21065148|P1|Overall Study|Death|1
6106610|NCT00203476|21065159|P3|Overall Study|Withdrawal by Subject|0
6106611|NCT00203476|21065160|P2|Overall Study|Withdrawal by Subject|1
6106612|NCT00203476|21065161|P1|Overall Study|Withdrawal by Subject|0
6106613|NCT00203476|21065159|P3|Overall Study|Lost to Follow-up|0
6106614|NCT00203476|21065160|P2|Overall Study|Lost to Follow-up|0
6106615|NCT00203476|21065161|P1|Overall Study|Lost to Follow-up|1
6106616|NCT00203424|21065178|P1|Follow-up Period|Lost to Follow-up|1
6106617|NCT00203424|21065178|P1|Follow-up Period|progressive disease|4
6106618|NCT00203424|21065178|P1|Follow-up Period|Withdrawal by Subject|1
6106619|NCT00203424|21065178|P1|Treatment Period|progressive disease|2
6106620|NCT00203424|21065178|P1|Treatment Period|Adverse Event|5
6106621|NCT00203424|21065178|P1|Treatment Period|Withdrawal by Subject|4
6106622|NCT00203411|21065185|P1|Follow-up|Progressive Disease|4
6106623|NCT00203307|21065194|P2|First Intervention|Adverse Event|0
6106624|NCT00203307|21065195|P1|First Intervention|Adverse Event|2
6106625|NCT00203294|21065203|P2|Overall Study|Withdrawal by Subject|13
6106626|NCT00203294|21065204|P1|Overall Study|Withdrawal by Subject|8
6106627|NCT00203268|21065210|P1|Early Treatment|Withdrawal by Subject|1
6106628|NCT00203268|21065210|P1|Early Treatment|Lost to Follow-up|1
6106629|NCT00203268|21065210|P1|Early Treatment|only treated one headache|2
6106630|NCT00203242|21065216|P1|Overall Study|Lost to Follow-up|1
6106631|NCT00203047|21065268|P2|Overall Study|Other|5
6106632|NCT00203047|21065269|P1|Overall Study|Other|5
6106633|NCT00203047|21065268|P2|Overall Study|Pregnancy|0
6106634|NCT00203047|21065269|P1|Overall Study|Pregnancy|3
6106635|NCT00203047|21065268|P2|Overall Study|Death|2
6106636|NCT00203047|21065269|P1|Overall Study|Death|1
6106637|NCT00203047|21065268|P2|Overall Study|Adverse Event|18
6106638|NCT00203047|21065269|P1|Overall Study|Adverse Event|8
6106639|NCT00203047|21065268|P2|Overall Study|Lost to Follow-up|5
6106640|NCT00203047|21065269|P1|Overall Study|Lost to Follow-up|11
6106641|NCT00203047|21065268|P2|Overall Study|Protocol Violation|0
6106642|NCT00203047|21065269|P1|Overall Study|Protocol Violation|1
6106643|NCT00203047|21065268|P2|Overall Study|Non-compliance|8
6106644|NCT00203047|21065269|P1|Overall Study|Non-compliance|4
6106645|NCT00203047|21065268|P2|Overall Study|Physician Decision|7
6106646|NCT00203047|21065269|P1|Overall Study|Physician Decision|8
6106647|NCT00203047|21065268|P2|Overall Study|Teva requested participant withdrawal|1
6106648|NCT00203047|21065269|P1|Overall Study|Teva requested participant withdrawal|1
6106649|NCT00203047|21065268|P2|Overall Study|Withdrawal by Subject|47
6106650|NCT00203047|21065269|P1|Overall Study|Withdrawal by Subject|13
6106651|NCT00203047|21065268|P2|Overall Study|Ongoing: not in database - Jan 29, 2009|1
6106652|NCT00203047|21065269|P1|Overall Study|Ongoing: not in database - Jan 29, 2009|5
6106653|NCT00203047|21065268|P2|Overall Study|Ongoing: in database - January 29, 2009|109
6106654|NCT00203047|21065269|P1|Overall Study|Ongoing: in database - January 29, 2009|131
6106655|NCT00203021|21065283|P2|Overall Study|Other than specified|16
6106656|NCT00203021|21065284|P1|Overall Study|Other than specified|11
6106657|NCT00203021|21065283|P2|Overall Study|Lost to Follow-up|7
6106658|NCT00203021|21065284|P1|Overall Study|Lost to Follow-up|9
6106659|NCT00203021|21065283|P2|Overall Study|Withdrawal by Subject|48
6106660|NCT00203021|21065284|P1|Overall Study|Withdrawal by Subject|45
6106661|NCT00203021|21065283|P2|Overall Study|Adverse Event|5
6106662|NCT00203021|21065284|P1|Overall Study|Adverse Event|10
6106663|NCT00203021|21065283|P2|Overall Study|Death|1
6106664|NCT00203021|21065284|P1|Overall Study|Death|4
6106665|NCT00202878|21065302|P2|Overall Study|Withdrawal by Subject|808
6106666|NCT00202878|21065303|P1|Overall Study|Withdrawal by Subject|795
6106667|NCT00202878|21065302|P2|Overall Study|Site Closure|36
6106668|NCT00202878|21065303|P1|Overall Study|Site Closure|39
6106669|NCT00202878|21065302|P2|Overall Study|Lost to Follow-up|49
6106670|NCT00202878|21065303|P1|Overall Study|Lost to Follow-up|44
6106671|NCT00202878|21065302|P2|Overall Study|Only Vital Status Known|356
6106672|NCT00202878|21065303|P1|Overall Study|Only Vital Status Known|357
6106673|NCT00202878|21065302|P2|Overall Study|Death|968
6106674|NCT00202878|21065303|P1|Overall Study|Death|964
6106675|NCT00202839|21065317|P2|Overall Study|Lost to Follow-up|2
6106676|NCT00202839|21065318|P1|Overall Study|Lost to Follow-up|3
6106677|NCT00202839|21065317|P2|Overall Study|Protocol Violation|1
6106678|NCT00202839|21065318|P1|Overall Study|Protocol Violation|2
6106679|NCT00202839|21065317|P2|Overall Study|Withdrawal by Subject|2
6106680|NCT00202839|21065318|P1|Overall Study|Withdrawal by Subject|6
6106681|NCT00202839|21065317|P2|Overall Study|Physician Decision|0
6106682|NCT00202839|21065318|P1|Overall Study|Physician Decision|12
6106683|NCT00202839|21065317|P2|Overall Study|Adverse Event|5
6106684|NCT00202839|21065318|P1|Overall Study|Adverse Event|1
6106685|NCT00202644|21065333|P2|Overall Study|Other|1
6106686|NCT00202644|21065334|P1|Overall Study|Other|9
6106687|NCT00202644|21065333|P2|Overall Study|Lost to Follow-up|1
6106688|NCT00202644|21065334|P1|Overall Study|Lost to Follow-up|0
6106689|NCT00202644|21065333|P2|Overall Study|Lack of Efficacy|6
6106690|NCT00202644|21065334|P1|Overall Study|Lack of Efficacy|6
6106691|NCT00202644|21065333|P2|Overall Study|Withdrawal by Subject|6
6106692|NCT00202644|21065334|P1|Overall Study|Withdrawal by Subject|8
6106693|NCT00202644|21065333|P2|Overall Study|Adverse Event|13
6106694|NCT00202644|21065334|P1|Overall Study|Adverse Event|12
6106695|NCT00201851|21065395|P3|Overall Study|Ineligible post enrollment|1
6106696|NCT00201851|21065396|P2|Overall Study|Ineligible post enrollment|1
6106697|NCT00201851|21065397|P1|Overall Study|Ineligible post enrollment|6
6106698|NCT00201851|21065395|P3|Overall Study|Lost to Follow-up|0
6106699|NCT00201851|21065396|P2|Overall Study|Lost to Follow-up|1
6106700|NCT00201851|21065397|P1|Overall Study|Lost to Follow-up|2
6106701|NCT00201643|21065469|P2|Overall Study|Withdrawal by Subject|4
6106702|NCT00201643|21065470|P1|Overall Study|Withdrawal by Subject|5
6106703|NCT00201201|21065534|P2|Overall Study|Withdrawal by Subject|5
6106704|NCT00201201|21065535|P1|Overall Study|Withdrawal by Subject|5
6106705|NCT00201201|21065534|P2|Overall Study|Death|2
6106706|NCT00201201|21065535|P1|Overall Study|Death|0
6106707|NCT00201006|21065573|P3|Overall Study|Adverse Event|1
6106708|NCT00201006|21065574|P2|Overall Study|Adverse Event|0
6106709|NCT00201006|21065575|P1|Overall Study|Adverse Event|1
6106710|NCT00201006|21065573|P3|Overall Study|Withdrawal by Subject|3
6106711|NCT00201006|21065574|P2|Overall Study|Withdrawal by Subject|2
6106712|NCT00201006|21065575|P1|Overall Study|Withdrawal by Subject|7
6106713|NCT00200967|21065585|P2|Run-out Period|Lost to Follow-up|0
6106714|NCT00200967|21065586|P1|Run-out Period|Lost to Follow-up|1
6106715|NCT00200967|21065585|P2|Second Treatment Period|Withdrawal by Subject|2
6106716|NCT00200967|21065586|P1|Second Treatment Period|Withdrawal by Subject|1
6106717|NCT00200967|21065585|P2|Wash-out Period|Lost to Follow-up|1
6106718|NCT00200967|21065586|P1|Wash-out Period|Lost to Follow-up|0
6106719|NCT00200967|21065585|P2|First Treatment Period|Pregnancy|0
6106720|NCT00200967|21065586|P1|First Treatment Period|Pregnancy|1
6106721|NCT00200967|21065585|P2|First Treatment Period|Withdrawal by Subject|1
6106722|NCT00200967|21065586|P1|First Treatment Period|Withdrawal by Subject|5
6106723|NCT00200850|21065636|P3|Overall Study|Adverse Event|2
6106724|NCT00200850|21065637|P2|Overall Study|Adverse Event|1
6106725|NCT00200850|21065638|P1|Overall Study|Adverse Event|1
6106726|NCT00200850|21065636|P3|Overall Study|optic neuritis|1
6106727|NCT00200850|21065637|P2|Overall Study|optic neuritis|0
6106728|NCT00200850|21065638|P1|Overall Study|optic neuritis|0
6106729|NCT00200850|21065636|P3|Overall Study|Poor adherence|1
6106730|NCT00200850|21065637|P2|Overall Study|Poor adherence|0
6106731|NCT00200850|21065638|P1|Overall Study|Poor adherence|0
6106732|NCT00200850|21065636|P3|Overall Study|Pregnancy|1
6106733|NCT00200850|21065637|P2|Overall Study|Pregnancy|0
6106734|NCT00200850|21065638|P1|Overall Study|Pregnancy|0
6106735|NCT00200850|21065636|P3|Overall Study|too busy|0
6106736|NCT00200850|21065637|P2|Overall Study|too busy|0
6106737|NCT00200850|21065638|P1|Overall Study|too busy|1
6106738|NCT00200850|21065636|P3|Overall Study|relocation|1
6106739|NCT00200850|21065637|P2|Overall Study|relocation|0
6106740|NCT00200850|21065638|P1|Overall Study|relocation|1
6106741|NCT00200356|21065659|P2|Overall Study|Nontreatment|0
6106742|NCT00200356|21065660|P1|Overall Study|Nontreatment|1
6106743|NCT00200356|21065659|P2|Overall Study|Protocol Violation|4
6106744|NCT00200356|21065660|P1|Overall Study|Protocol Violation|4
6106745|NCT00200356|21065659|P2|Overall Study|Lack of Efficacy|3
6106746|NCT00200356|21065660|P1|Overall Study|Lack of Efficacy|3
6106747|NCT00200057|21065727|P1|Overall Study|Death|1
6106748|NCT00200057|21065727|P1|Overall Study|Infection|1
6106749|NCT00200057|21065727|P1|Overall Study|Change in medical condition|1
6106750|NCT00200057|21065727|P1|Overall Study|Withdrawal by Subject|1
6106751|NCT00200057|21065727|P1|Overall Study|Exited due to terminal illness of PI|2
6106752|NCT00200057|21065727|P1|Overall Study|Lack of Efficacy|3
6106753|NCT00199875|21065751|P5|Overall Study|Withdrawal by Subject|1
6106754|NCT00199875|21065752|P4|Overall Study|Withdrawal by Subject|0
6106755|NCT00199875|21065753|P3|Overall Study|Withdrawal by Subject|0
6106756|NCT00199875|21065754|P2|Overall Study|Withdrawal by Subject|0
6106757|NCT00199875|21065755|P1|Overall Study|Withdrawal by Subject|0
6106758|NCT00199381|21065777|P1|Overall Study|Study termination by Sponsor|323
6106759|NCT00199381|21065777|P1|Overall Study|Not including due to early termination|37
6106760|NCT00199381|21065777|P1|Overall Study|Lack of Efficacy|27
6106761|NCT00199381|21065777|P1|Overall Study|Protocol Violation|6
6106762|NCT00199381|21065777|P1|Overall Study|Adverse Event|73
6106763|NCT00199381|21065777|P1|Overall Study|Withdrawal by Subject|38
6106764|NCT00198822|21065784|P3|Overall Study|Lost to Follow-up|21
6106765|NCT00198822|21065785|P2|Overall Study|Lost to Follow-up|20
6106766|NCT00198822|21065786|P1|Overall Study|Lost to Follow-up|14
6106767|NCT00198133|21065805|P2|Overall Study|Physician Decision|0
6106768|NCT00198133|21065806|P1|Overall Study|Physician Decision|1
6106769|NCT00198133|21065805|P2|Overall Study|Withdrawal by Subject|0
6106770|NCT00198133|21065806|P1|Overall Study|Withdrawal by Subject|1
6106771|NCT00198133|21065805|P2|Overall Study|Adverse Event|3
6106772|NCT00198133|21065806|P1|Overall Study|Adverse Event|1
6106773|NCT00198133|21065805|P2|Overall Study|Disease progression|5
6106774|NCT00198133|21065806|P1|Overall Study|Disease progression|2
6106775|NCT00198107|21065818|P3|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|2
6106776|NCT00198107|21065819|P2|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0
6106777|NCT00198107|21065820|P1|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0
6106778|NCT00198107|21065818|P3|Double-Blind Period|Withdrawal by Subject|0
6106779|NCT00198107|21065819|P2|Double-Blind Period|Withdrawal by Subject|1
6106780|NCT00198107|21065820|P1|Double-Blind Period|Withdrawal by Subject|0
6106781|NCT00198107|21065818|P3|Double-Blind Period|Physician Decision|0
6106782|NCT00198107|21065819|P2|Double-Blind Period|Physician Decision|0
6106783|NCT00198107|21065820|P1|Double-Blind Period|Physician Decision|1
6106784|NCT00198107|21065818|P3|Double-Blind Period|Lost to Follow-up|0
6106785|NCT00198107|21065819|P2|Double-Blind Period|Lost to Follow-up|1
6106786|NCT00198107|21065820|P1|Double-Blind Period|Lost to Follow-up|2
6106787|NCT00198107|21065818|P3|Double-Blind Period|Lack of Efficacy|0
6106788|NCT00198107|21065819|P2|Double-Blind Period|Lack of Efficacy|0
6106789|NCT00198107|21065820|P1|Double-Blind Period|Lack of Efficacy|2
6106790|NCT00198107|21065818|P3|Double-Blind Period|Adverse Event|0
6106791|NCT00198107|21065819|P2|Double-Blind Period|Adverse Event|1
6106792|NCT00198107|21065820|P1|Double-Blind Period|Adverse Event|1
6106793|NCT00198029|21065888|P1|Overall Study|Withdrawal by Subject|4
6106794|NCT00197496|21065895|P2|Follow-up|Lost to Follow-up|1
6106795|NCT00197496|21065896|P1|Follow-up|Lost to Follow-up|2
6106796|NCT00197496|21065895|P2|Baseline to Discharge|Protocol Violation|1
6106797|NCT00197496|21065896|P1|Baseline to Discharge|Protocol Violation|0
6106798|NCT00197496|21065895|P2|Baseline to Discharge|Physician Decision|1
6106799|NCT00197496|21065896|P1|Baseline to Discharge|Physician Decision|0
6106800|NCT00197496|21065895|P2|Baseline to Discharge|MRSA|0
6106801|NCT00197496|21065896|P1|Baseline to Discharge|MRSA|1
6106802|NCT00197496|21065895|P2|Baseline to Discharge|not interested|0
6106803|NCT00197496|21065896|P1|Baseline to Discharge|not interested|1
6106804|NCT00197236|21065944|P3|Overall Study|Returned out of specified time window|1
6106805|NCT00197236|21065945|P2|Overall Study|Returned out of specified time window|0
6106806|NCT00197236|21065946|P1|Overall Study|Returned out of specified time window|0
6106807|NCT00197236|21065944|P3|Overall Study|Study drug/medication expiration|3
6106808|NCT00197236|21065945|P2|Overall Study|Study drug/medication expiration|0
6106809|NCT00197236|21065946|P1|Overall Study|Study drug/medication expiration|1
6106810|NCT00197236|21065944|P3|Overall Study|Withdrawal by Subject|11
6106811|NCT00197236|21065945|P2|Overall Study|Withdrawal by Subject|3
6106812|NCT00197236|21065946|P1|Overall Study|Withdrawal by Subject|7
6106813|NCT00197236|21065944|P3|Overall Study|Protocol Violation|1
6106814|NCT00197236|21065945|P2|Overall Study|Protocol Violation|0
6106815|NCT00197236|21065946|P1|Overall Study|Protocol Violation|0
6106816|NCT00197236|21065944|P3|Overall Study|Lost to Follow-up|6
6106817|NCT00197236|21065945|P2|Overall Study|Lost to Follow-up|14
6106818|NCT00197236|21065946|P1|Overall Study|Lost to Follow-up|5
6106819|NCT00197236|21065944|P3|Overall Study|Adverse Event|1
6106820|NCT00197236|21065945|P2|Overall Study|Adverse Event|0
6106821|NCT00197236|21065946|P1|Overall Study|Adverse Event|1
6106822|NCT00197145|21066020|P2|Period 2 : Open Label Phase|Other|0
6106823|NCT00197145|21066021|P1|Period 2 : Open Label Phase|Other|1
6106824|NCT00197145|21066020|P2|Period 2 : Open Label Phase|Were ongoing till data freeze|0
6106825|NCT00197145|21066021|P1|Period 2 : Open Label Phase|Were ongoing till data freeze|3
6106826|NCT00197145|21066020|P2|Period 2 : Open Label Phase|Availability of alternative ART|0
6106827|NCT00197145|21066021|P1|Period 2 : Open Label Phase|Availability of alternative ART|2
6106828|NCT00197145|21066020|P2|Period 2 : Open Label Phase|Protocol defined virological failure|0
6106829|NCT00197145|21066021|P1|Period 2 : Open Label Phase|Protocol defined virological failure|3
6106830|NCT00197145|21066020|P2|Period 2 : Open Label Phase|Insufficient viral load response|0
6106831|NCT00197145|21066021|P1|Period 2 : Open Label Phase|Insufficient viral load response|1
6106832|NCT00197145|21066020|P2|Period 1: Randomized Treatment Phase|Other|2
6106833|NCT00197145|21066021|P1|Period 1: Randomized Treatment Phase|Other|2
6106834|NCT00197145|21066020|P2|Period 1: Randomized Treatment Phase|Sponsor terminated study|8
6106835|NCT00197145|21066021|P1|Period 1: Randomized Treatment Phase|Sponsor terminated study|10
6106836|NCT00197145|21066020|P2|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1
6106837|NCT00197145|21066021|P1|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1
6106838|NCT00197106|21066092|P3|Overall Treatment Period|Withdrawal by Subject|2
6106839|NCT00197106|21066093|P2|Overall Treatment Period|Withdrawal by Subject|0
6106840|NCT00197106|21066094|P1|Overall Treatment Period|Withdrawal by Subject|0
6106841|NCT00197106|21066092|P3|Overall Treatment Period|Protocol Violation|2
6106842|NCT00197106|21066093|P2|Overall Treatment Period|Protocol Violation|0
6106843|NCT00197106|21066094|P1|Overall Treatment Period|Protocol Violation|0
6106844|NCT00197106|21066092|P3|Overall Treatment Period|Lost to Follow-up|2
6106845|NCT00197106|21066093|P2|Overall Treatment Period|Lost to Follow-up|0
6106846|NCT00197106|21066094|P1|Overall Treatment Period|Lost to Follow-up|0
6106847|NCT00197106|21066092|P3|Overall Treatment Period|Lack of Efficacy|0
6106848|NCT00197106|21066093|P2|Overall Treatment Period|Lack of Efficacy|1
6106849|NCT00197106|21066094|P1|Overall Treatment Period|Lack of Efficacy|0
6106850|NCT00197106|21066092|P3|4-Week Run-In Period|Did not meet entry criteria|0
6106851|NCT00197106|21066093|P2|4-Week Run-In Period|Did not meet entry criteria|0
6106852|NCT00197106|21066094|P1|4-Week Run-In Period|Did not meet entry criteria|99
6106862|NCT00197028|21066243|P2|Overall Study|Other|6
6106863|NCT00197028|21066244|P1|Overall Study|Other|3
6106864|NCT00197028|21066243|P2|Overall Study|Lost to Follow-up|0
6106865|NCT00197028|21066244|P1|Overall Study|Lost to Follow-up|1
6106866|NCT00197028|21066243|P2|Overall Study|Withdrawal by Subject|12
6106867|NCT00197028|21066244|P1|Overall Study|Withdrawal by Subject|8
6106868|NCT00197028|21066243|P2|Overall Study|Protocol Violation|1
6106869|NCT00197028|21066244|P1|Overall Study|Protocol Violation|2
6106870|NCT00197028|21066243|P2|Overall Study|Adverse Event|2
6106871|NCT00197028|21066244|P1|Overall Study|Adverse Event|2
6106872|NCT00197015|21066287|P3|Overall Study|Other|2
6106873|NCT00197015|21066288|P2|Overall Study|Other|3
6106874|NCT00197015|21066289|P1|Overall Study|Other|2
6106875|NCT00197015|21066287|P3|Overall Study|Lost to Follow-up|37
6106876|NCT00197015|21066288|P2|Overall Study|Lost to Follow-up|46
6106877|NCT00197015|21066289|P1|Overall Study|Lost to Follow-up|28
6106878|NCT00197015|21066287|P3|Overall Study|Withdrawal by Subject|34
6106879|NCT00197015|21066288|P2|Overall Study|Withdrawal by Subject|37
6106880|NCT00197015|21066289|P1|Overall Study|Withdrawal by Subject|17
6106881|NCT00197015|21066287|P3|Overall Study|Protocol Violation|3
6106882|NCT00197015|21066288|P2|Overall Study|Protocol Violation|3
6106883|NCT00197015|21066289|P1|Overall Study|Protocol Violation|0
6106884|NCT00197015|21066287|P3|Overall Study|Adverse Event|1
6106885|NCT00197015|21066288|P2|Overall Study|Adverse Event|0
6106886|NCT00197015|21066289|P1|Overall Study|Adverse Event|3
6106887|NCT00197002|21066348|P3|Overall Study|Others|1
6106888|NCT00197002|21066349|P2|Overall Study|Others|1
6106889|NCT00197002|21066350|P1|Overall Study|Others|3
6106890|NCT00197002|21066348|P3|Overall Study|Lost to follow-up (compl. vaccination)|1
6106891|NCT00197002|21066349|P2|Overall Study|Lost to follow-up (compl. vaccination)|2
6106892|NCT00197002|21066350|P1|Overall Study|Lost to follow-up (compl. vaccination)|2
6106893|NCT00197002|21066348|P3|Overall Study|Lost to follow-up (incompl. vaccination)|5
6106894|NCT00197002|21066349|P2|Overall Study|Lost to follow-up (incompl. vaccination)|4
6106895|NCT00197002|21066350|P1|Overall Study|Lost to follow-up (incompl. vaccination)|4
6106896|NCT00197002|21066348|P3|Overall Study|Migrated/moved from study area|1
6106897|NCT00197002|21066349|P2|Overall Study|Migrated/moved from study area|5
6106898|NCT00197002|21066350|P1|Overall Study|Migrated/moved from study area|3
6106899|NCT00197002|21066348|P3|Overall Study|Withdrawal by Subject|7
6106900|NCT00197002|21066349|P2|Overall Study|Withdrawal by Subject|5
6106901|NCT00197002|21066350|P1|Overall Study|Withdrawal by Subject|9
6106902|NCT00197002|21066348|P3|Overall Study|Protocol Violation|2
6106903|NCT00197002|21066349|P2|Overall Study|Protocol Violation|0
6106904|NCT00197002|21066350|P1|Overall Study|Protocol Violation|1
6106905|NCT00197002|21066348|P3|Overall Study|Adverse Event|0
6106906|NCT00197002|21066349|P2|Overall Study|Adverse Event|1
6106907|NCT00197002|21066350|P1|Overall Study|Adverse Event|0
6106908|NCT00196976|21066401|P14|Booster Study|Lost to Follow-up|0
6106909|NCT00196976|21066402|P13|Booster Study|Lost to Follow-up|0
6106910|NCT00196976|21066403|P12|Booster Study|Lost to Follow-up|2
6106911|NCT00196976|21066404|P11|Booster Study|Lost to Follow-up|1
6106912|NCT00196976|21066405|P10|Booster Study|Lost to Follow-up|0
6106913|NCT00196976|21066406|P9|Booster Study|Lost to Follow-up|0
6106914|NCT00196976|21066407|P8|Booster Study|Lost to Follow-up|0
6106915|NCT00196976|21066408|P7|Booster Study|Lost to Follow-up|0
6106916|NCT00196976|21066409|P6|Booster Study|Lost to Follow-up|0
6106917|NCT00196976|21066410|P5|Booster Study|Lost to Follow-up|0
6106918|NCT00196976|21066411|P4|Booster Study|Lost to Follow-up|0
6106919|NCT00196976|21066412|P3|Booster Study|Lost to Follow-up|0
6106920|NCT00196976|21066413|P2|Booster Study|Lost to Follow-up|0
6106921|NCT00196976|21066414|P1|Booster Study|Lost to Follow-up|0
6106922|NCT00196976|21066401|P14|Booster Study|Withdrawal by Subject|0
6106923|NCT00196976|21066402|P13|Booster Study|Withdrawal by Subject|0
6106924|NCT00196976|21066403|P12|Booster Study|Withdrawal by Subject|0
6106925|NCT00196976|21066404|P11|Booster Study|Withdrawal by Subject|1
6106926|NCT00196976|21066405|P10|Booster Study|Withdrawal by Subject|0
6106927|NCT00196976|21066406|P9|Booster Study|Withdrawal by Subject|0
6106928|NCT00196976|21066407|P8|Booster Study|Withdrawal by Subject|0
6106929|NCT00196976|21066408|P7|Booster Study|Withdrawal by Subject|0
6106930|NCT00196976|21066409|P6|Booster Study|Withdrawal by Subject|0
6106931|NCT00196976|21066410|P5|Booster Study|Withdrawal by Subject|0
6106932|NCT00196976|21066411|P4|Booster Study|Withdrawal by Subject|0
6106933|NCT00196976|21066412|P3|Booster Study|Withdrawal by Subject|0
6106934|NCT00196976|21066413|P2|Booster Study|Withdrawal by Subject|0
6106935|NCT00196976|21066414|P1|Booster Study|Withdrawal by Subject|0
6106936|NCT00196976|21066401|P14|Primary Study|Other|0
6106937|NCT00196976|21066402|P13|Primary Study|Other|0
6106938|NCT00196976|21066403|P12|Primary Study|Other|0
6106939|NCT00196976|21066404|P11|Primary Study|Other|0
6106940|NCT00196976|21066405|P10|Primary Study|Other|0
6106941|NCT00196976|21066406|P9|Primary Study|Other|0
6106942|NCT00196976|21066407|P8|Primary Study|Other|0
6106943|NCT00196976|21066408|P7|Primary Study|Other|0
6106944|NCT00196976|21066409|P6|Primary Study|Other|0
6106945|NCT00196976|21066410|P5|Primary Study|Other|0
6106946|NCT00196976|21066411|P4|Primary Study|Other|0
6106947|NCT00196976|21066412|P3|Primary Study|Other|2
6106948|NCT00196976|21066413|P2|Primary Study|Other|0
6106949|NCT00196976|21066414|P1|Primary Study|Other|0
6106950|NCT00196976|21066401|P14|Primary Study|Lost to Follow-up|0
6106951|NCT00196976|21066402|P13|Primary Study|Lost to Follow-up|0
6106952|NCT00196976|21066403|P12|Primary Study|Lost to Follow-up|0
6106953|NCT00196976|21066404|P11|Primary Study|Lost to Follow-up|0
6106954|NCT00196976|21066405|P10|Primary Study|Lost to Follow-up|0
6106955|NCT00196976|21066406|P9|Primary Study|Lost to Follow-up|0
6106956|NCT00196976|21066407|P8|Primary Study|Lost to Follow-up|2
6106957|NCT00196976|21066408|P7|Primary Study|Lost to Follow-up|0
6106958|NCT00196976|21066409|P6|Primary Study|Lost to Follow-up|1
6106959|NCT00196976|21066410|P5|Primary Study|Lost to Follow-up|1
6106960|NCT00196976|21066411|P4|Primary Study|Lost to Follow-up|0
6106961|NCT00196976|21066412|P3|Primary Study|Lost to Follow-up|0
6106962|NCT00196976|21066413|P2|Primary Study|Lost to Follow-up|0
6106963|NCT00196976|21066414|P1|Primary Study|Lost to Follow-up|0
6106964|NCT00196976|21066401|P14|Primary Study|Withdrawal by Subject|0
6106965|NCT00196976|21066402|P13|Primary Study|Withdrawal by Subject|0
6106966|NCT00196976|21066403|P12|Primary Study|Withdrawal by Subject|0
6106967|NCT00196976|21066404|P11|Primary Study|Withdrawal by Subject|0
6106968|NCT00196976|21066405|P10|Primary Study|Withdrawal by Subject|1
6106969|NCT00196976|21066406|P9|Primary Study|Withdrawal by Subject|0
6106970|NCT00196976|21066407|P8|Primary Study|Withdrawal by Subject|0
6106971|NCT00196976|21066408|P7|Primary Study|Withdrawal by Subject|0
6106972|NCT00196976|21066409|P6|Primary Study|Withdrawal by Subject|1
6106973|NCT00196976|21066410|P5|Primary Study|Withdrawal by Subject|2
6106974|NCT00196976|21066411|P4|Primary Study|Withdrawal by Subject|1
6106975|NCT00196976|21066412|P3|Primary Study|Withdrawal by Subject|1
6106976|NCT00196976|21066413|P2|Primary Study|Withdrawal by Subject|0
6106977|NCT00196976|21066414|P1|Primary Study|Withdrawal by Subject|1
6106978|NCT00196976|21066401|P14|Primary Study|Protocol Violation|0
6106979|NCT00196976|21066402|P13|Primary Study|Protocol Violation|0
6106980|NCT00196976|21066403|P12|Primary Study|Protocol Violation|0
6106981|NCT00196976|21066404|P11|Primary Study|Protocol Violation|0
6106982|NCT00196976|21066405|P10|Primary Study|Protocol Violation|0
6106983|NCT00196976|21066406|P9|Primary Study|Protocol Violation|0
6106984|NCT00196976|21066407|P8|Primary Study|Protocol Violation|0
6106985|NCT00196976|21066408|P7|Primary Study|Protocol Violation|0
6106986|NCT00196976|21066409|P6|Primary Study|Protocol Violation|0
6106987|NCT00196976|21066410|P5|Primary Study|Protocol Violation|0
6106988|NCT00196976|21066411|P4|Primary Study|Protocol Violation|0
6106989|NCT00196976|21066412|P3|Primary Study|Protocol Violation|1
6106990|NCT00196976|21066413|P2|Primary Study|Protocol Violation|1
6106991|NCT00196976|21066414|P1|Primary Study|Protocol Violation|0
6106992|NCT00196976|21066401|P14|Primary Study|Migrated from study area|0
6106993|NCT00196976|21066402|P13|Primary Study|Migrated from study area|0
6106994|NCT00196976|21066403|P12|Primary Study|Migrated from study area|0
6106995|NCT00196976|21066404|P11|Primary Study|Migrated from study area|0
6106996|NCT00196976|21066405|P10|Primary Study|Migrated from study area|0
6106997|NCT00196976|21066406|P9|Primary Study|Migrated from study area|0
6106998|NCT00196976|21066407|P8|Primary Study|Migrated from study area|1
6106999|NCT00196976|21066408|P7|Primary Study|Migrated from study area|0
6107000|NCT00196976|21066409|P6|Primary Study|Migrated from study area|0
6107001|NCT00196976|21066410|P5|Primary Study|Migrated from study area|0
6107002|NCT00196976|21066411|P4|Primary Study|Migrated from study area|0
6107003|NCT00196976|21066412|P3|Primary Study|Migrated from study area|0
6107004|NCT00196976|21066413|P2|Primary Study|Migrated from study area|0
6107005|NCT00196976|21066414|P1|Primary Study|Migrated from study area|0
6107006|NCT00196937|21066610|P3|Overall Study|Other|1
6107007|NCT00196937|21066611|P2|Overall Study|Other|1
6107008|NCT00196937|21066612|P1|Overall Study|Other|3
6107009|NCT00196937|21066610|P3|Overall Study|Lost to Follow-up|3
6107010|NCT00196937|21066611|P2|Overall Study|Lost to Follow-up|3
6107011|NCT00196937|21066612|P1|Overall Study|Lost to Follow-up|4
6107012|NCT00196937|21066610|P3|Overall Study|Withdrawal by Subject|2
6107013|NCT00196937|21066611|P2|Overall Study|Withdrawal by Subject|0
6107014|NCT00196937|21066612|P1|Overall Study|Withdrawal by Subject|0
6107015|NCT00196937|21066610|P3|Overall Study|Non-serious adverse event|1
6107016|NCT00196937|21066611|P2|Overall Study|Non-serious adverse event|1
6107017|NCT00196937|21066612|P1|Overall Study|Non-serious adverse event|1
6107018|NCT00196937|21066610|P3|Overall Study|Serious Adverse Event|0
6107019|NCT00196937|21066611|P2|Overall Study|Serious Adverse Event|0
6107020|NCT00196937|21066612|P1|Overall Study|Serious Adverse Event|1
6107021|NCT00196326|21066666|P1|Overall Study|Other|22
6107022|NCT00196326|21066666|P1|Overall Study|Lost to Follow-up|304
6107023|NCT00196326|21066666|P1|Overall Study|Pregnancy|34
6107024|NCT00196326|21066666|P1|Overall Study|Adverse Event|253
6107025|NCT00196326|21066666|P1|Overall Study|Withdrawal by Subject|225
6107026|NCT00196326|21066666|P1|Overall Study|Physician Decision|3
6107027|NCT00196326|21066666|P1|Overall Study|Non-compliance with the protocol|81
6107028|NCT00196326|21066666|P1|Overall Study|Did not meet protocol requirements|64
6107029|NCT00196313|21066674|P2|Overall Study|Lost to Follow-up|2
6107030|NCT00196313|21066675|P1|Overall Study|Lost to Follow-up|2
6107031|NCT00196313|21066674|P2|Overall Study|Subject Pregnant|1
6107032|NCT00196313|21066675|P1|Overall Study|Subject Pregnant|1
6107033|NCT00196313|21066674|P2|Overall Study|Adverse Event|1
6107034|NCT00196313|21066675|P1|Overall Study|Adverse Event|3
6107035|NCT00196313|21066674|P2|Overall Study|Withdrawal by Subject|1
6107036|NCT00196313|21066675|P1|Overall Study|Withdrawal by Subject|3
6107037|NCT00196313|21066674|P2|Overall Study|Protocol Violation|3
6107038|NCT00196313|21066675|P1|Overall Study|Protocol Violation|2
6107039|NCT00196196|21066689|P1|Overall Study|Did not have required condition (hydroce|5
6107040|NCT00196196|21066689|P1|Overall Study|Withdrawal by Subject|2
6107041|NCT00196105|21066697|P3|Overall Study|Lost to Follow-up|7
6107042|NCT00196105|21066698|P2|Overall Study|Lost to Follow-up|5
6107043|NCT00196105|21066699|P1|Overall Study|Lost to Follow-up|4
6107044|NCT00195819|21066719|P2|Open-label|Withdrawal by Subject|5
6107045|NCT00195819|21066720|P1|Open-label|Withdrawal by Subject|0
6107046|NCT00195819|21066719|P2|Open-label|Moved|1
6107047|NCT00195819|21066720|P1|Open-label|Moved|0
6107048|NCT00195819|21066719|P2|Open-label|Protocol Violation|2
6107049|NCT00195819|21066720|P1|Open-label|Protocol Violation|0
6107050|NCT00195819|21066719|P2|Open-label|Pregnancy|1
6107051|NCT00195819|21066720|P1|Open-label|Pregnancy|0
6107052|NCT00195819|21066719|P2|Open-label|Lack of Efficacy|2
6107053|NCT00195819|21066720|P1|Open-label|Lack of Efficacy|0
6107054|NCT00195819|21066719|P2|Open-label|Adverse Event|9
6107055|NCT00195819|21066720|P1|Open-label|Adverse Event|0
6107056|NCT00195819|21066719|P2|Double-Blind|Moved|0
6107057|NCT00195819|21066720|P1|Double-Blind|Moved|1
6107058|NCT00195819|21066719|P2|Double-Blind|Withdrawal by Subject|0
6107059|NCT00195819|21066720|P1|Double-Blind|Withdrawal by Subject|1
6107060|NCT00195715|21066770|P1|Overall Study|Sponsor discretion - trial ended early|1
6107061|NCT00195715|21066770|P1|Overall Study|Sponsor discontinued trial|1
6107062|NCT00195715|21066770|P1|Overall Study|Colonic stricture|1
6107063|NCT00195715|21066770|P1|Overall Study|Ineligible|1
6107064|NCT00195715|21066770|P1|Overall Study|Increased infection rate|1
6107065|NCT00195715|21066770|P1|Overall Study|Planned surgery|2
6107066|NCT00195715|21066770|P1|Overall Study|Use of prohibited medication|2
6107067|NCT00195715|21066770|P1|Overall Study|Subject wants to get pregnant|4
6107068|NCT00195715|21066770|P1|Overall Study|Investigator's decision|2
6107069|NCT00195715|21066770|P1|Overall Study|Administrative reasons|2
6107070|NCT00195715|21066770|P1|Overall Study|Sponsor stopped study|1
6107071|NCT00195715|21066770|P1|Overall Study|Loss of response/no improvement|3
6107072|NCT00195715|21066770|P1|Overall Study|Subject choice|3
6107073|NCT00195715|21066770|P1|Overall Study|Subject started commercial Humira|5
6107074|NCT00195715|21066770|P1|Overall Study|Subject non-compliance|6
6107075|NCT00195715|21066770|P1|Overall Study|Subject moved/relocated|7
6107076|NCT00195715|21066770|P1|Overall Study|Investigative site closure|8
6107077|NCT00195715|21066770|P1|Overall Study|Pregnancy|14
6107078|NCT00195715|21066770|P1|Overall Study|Lack of Efficacy|93
6107079|NCT00195715|21066770|P1|Overall Study|Protocol Violation|13
6107080|NCT00195715|21066770|P1|Overall Study|Lost to Follow-up|27
6107081|NCT00195715|21066770|P1|Overall Study|Withdrawal by Subject|58
6107082|NCT00195715|21066770|P1|Overall Study|Adverse Event|122
6107083|NCT00195676|21066870|P1|Period R - Retreatment 16 Weeks|Other reasons|6
6107084|NCT00195676|21066870|P1|Period R - Retreatment 16 Weeks|Withdrawal by Subject|9
6107085|NCT00195676|21066870|P1|Period R - Retreatment 16 Weeks|Lost to Follow-up|11
6107086|NCT00195676|21066870|P1|Period R - Retreatment 16 Weeks|Lack of Efficacy|5
6107087|NCT00195676|21066870|P1|Period R - Retreatment 16 Weeks|Adverse Event|4
6107088|NCT00195676|21066870|P1|Period W (Withdrawal) - No Treatment|Other reasons|18
6107089|NCT00195676|21066870|P1|Period W (Withdrawal) - No Treatment|Administrative reasons|1
6107090|NCT00195676|21066870|P1|Period W (Withdrawal) - No Treatment|Period W Close-out|129
6107091|NCT00195676|21066870|P1|Period W (Withdrawal) - No Treatment|Relapse (PGA >= 3)|397
6107092|NCT00195676|21066870|P1|Period W (Withdrawal) - No Treatment|Withdrawal by Subject|46
6107093|NCT00195676|21066870|P1|Period W (Withdrawal) - No Treatment|Lost to Follow-up|11
6107094|NCT00195676|21066870|P1|Period W (Withdrawal) - No Treatment|Death|2
6107095|NCT00195676|21066870|P1|Period W (Withdrawal) - No Treatment|Adverse Event|4
6107096|NCT00195676|21066870|P1|Period O - Open-label Treatment|Other reasons|68
6107097|NCT00195676|21066870|P1|Period O - Open-label Treatment|Administrative reasons|2
6107098|NCT00195676|21066870|P1|Period O - Open-label Treatment|Withdrawal by Subject|147
6107099|NCT00195676|21066870|P1|Period O - Open-label Treatment|Protocol Violation|12
6107100|NCT00195676|21066870|P1|Period O - Open-label Treatment|Lost to Follow-up|91
6107101|NCT00195676|21066870|P1|Period O - Open-label Treatment|Lack of Efficacy|198
6107102|NCT00195676|21066870|P1|Period O - Open-label Treatment|Death|6
6107103|NCT00195676|21066870|P1|Period O - Open-label Treatment|Adverse Event|82
6107104|NCT00195663|21066884|P3|Open-Label Extension Period|Administrative reasons|13
6107105|NCT00195663|21066885|P2|Open-Label Extension Period|Administrative reasons|11
6107106|NCT00195663|21066886|P1|Open-Label Extension Period|Administrative reasons|11
6107107|NCT00195663|21066884|P3|Open-Label Extension Period|Lack of Efficacy|12
6107108|NCT00195663|21066885|P2|Open-Label Extension Period|Lack of Efficacy|6
6107109|NCT00195663|21066886|P1|Open-Label Extension Period|Lack of Efficacy|14
6107110|NCT00195663|21066884|P3|Open-Label Extension Period|Withdrawal by Subject|22
6107111|NCT00195663|21066885|P2|Open-Label Extension Period|Withdrawal by Subject|15
6107112|NCT00195663|21066886|P1|Open-Label Extension Period|Withdrawal by Subject|16
6107113|NCT00195663|21066884|P3|Open-Label Extension Period|Death|2
6107114|NCT00195663|21066885|P2|Open-Label Extension Period|Death|2
6107115|NCT00195663|21066886|P1|Open-Label Extension Period|Death|2
6107116|NCT00195663|21066884|P3|Open-Label Extension Period|Protocol Violation|4
6107117|NCT00195663|21066885|P2|Open-Label Extension Period|Protocol Violation|4
6107118|NCT00195663|21066886|P1|Open-Label Extension Period|Protocol Violation|3
6107119|NCT00195663|21066884|P3|Open-Label Extension Period|Recovery|2
6107120|NCT00195663|21066885|P2|Open-Label Extension Period|Recovery|2
6107121|NCT00195663|21066886|P1|Open-Label Extension Period|Recovery|0
6107122|NCT00195663|21066884|P3|Open-Label Extension Period|Lost to Follow-up|6
6107123|NCT00195663|21066885|P2|Open-Label Extension Period|Lost to Follow-up|2
6107124|NCT00195663|21066886|P1|Open-Label Extension Period|Lost to Follow-up|9
6107125|NCT00195663|21066884|P3|Open-Label Extension Period|Adverse Event|36
6107126|NCT00195663|21066885|P2|Open-Label Extension Period|Adverse Event|32
6107127|NCT00195663|21066886|P1|Open-Label Extension Period|Adverse Event|21
6107128|NCT00195663|21066884|P3|2-year Double-blind Treatment Period|Administrative reasons|9
6107129|NCT00195663|21066885|P2|2-year Double-blind Treatment Period|Administrative reasons|2
6107130|NCT00195663|21066886|P1|2-year Double-blind Treatment Period|Administrative reasons|3
6107131|NCT00195663|21066884|P3|2-year Double-blind Treatment Period|Recovery|1
6107132|NCT00195663|21066885|P2|2-year Double-blind Treatment Period|Recovery|0
6107133|NCT00195663|21066886|P1|2-year Double-blind Treatment Period|Recovery|1
6107134|NCT00195663|21066884|P3|2-year Double-blind Treatment Period|Planned selection criteria|0
6107135|NCT00195663|21066885|P2|2-year Double-blind Treatment Period|Planned selection criteria|1
6107136|NCT00195663|21066886|P1|2-year Double-blind Treatment Period|Planned selection criteria|0
6107137|NCT00195663|21066884|P3|2-year Double-blind Treatment Period|Protocol Violation|4
6107138|NCT00195663|21066885|P2|2-year Double-blind Treatment Period|Protocol Violation|6
6107139|NCT00195663|21066886|P1|2-year Double-blind Treatment Period|Protocol Violation|6
6107140|NCT00195663|21066884|P3|2-year Double-blind Treatment Period|Lack of Efficacy|13
6107141|NCT00195663|21066885|P2|2-year Double-blind Treatment Period|Lack of Efficacy|52
6107142|NCT00195663|21066886|P1|2-year Double-blind Treatment Period|Lack of Efficacy|47
6107143|NCT00195663|21066884|P3|2-year Double-blind Treatment Period|Withdrawal by Subject|12
6107144|NCT00195663|21066885|P2|2-year Double-blind Treatment Period|Withdrawal by Subject|18
6107145|NCT00195663|21066886|P1|2-year Double-blind Treatment Period|Withdrawal by Subject|15
6107146|NCT00195663|21066884|P3|2-year Double-blind Treatment Period|Lost to Follow-up|1
6107147|NCT00195663|21066885|P2|2-year Double-blind Treatment Period|Lost to Follow-up|0
6107148|NCT00195663|21066886|P1|2-year Double-blind Treatment Period|Lost to Follow-up|0
6107149|NCT00195663|21066884|P3|2-year Double-blind Treatment Period|Death|0
6107150|NCT00195663|21066885|P2|2-year Double-blind Treatment Period|Death|2
6107151|NCT00195663|21066886|P1|2-year Double-blind Treatment Period|Death|0
6107152|NCT00195663|21066884|P3|2-year Double-blind Treatment Period|Adverse Event|32
6107153|NCT00195663|21066885|P2|2-year Double-blind Treatment Period|Adverse Event|27
6107154|NCT00195663|21066886|P1|2-year Double-blind Treatment Period|Adverse Event|21
6107155|NCT00195650|21066980|P1|Overall Study|Administrative reasons|83
6107156|NCT00195650|21066980|P1|Overall Study|Protocol Violation|15
6107157|NCT00195650|21066980|P1|Overall Study|Death|23
6107158|NCT00195650|21066980|P1|Overall Study|Lost to Follow-up|44
6107159|NCT00195650|21066980|P1|Overall Study|Withdrawal by Subject|67
6107160|NCT00195650|21066980|P1|Overall Study|Lack of Efficacy|99
6107161|NCT00195650|21066980|P1|Overall Study|Adverse Event|194
6107162|NCT00195507|21067005|P2|Overall Study|Protocol Deviation|3
6107163|NCT00195507|21067006|P1|Overall Study|Protocol Deviation|6
6107164|NCT00195507|21067005|P2|Overall Study|Withdrawal by Subject|23
6107165|NCT00195507|21067006|P1|Overall Study|Withdrawal by Subject|16
6107166|NCT00195507|21067005|P2|Overall Study|Lack of Efficacy|67
6107167|NCT00195507|21067006|P1|Overall Study|Lack of Efficacy|40
6107168|NCT00195507|21067005|P2|Overall Study|Protocol Violation|4
6107169|NCT00195507|21067006|P1|Overall Study|Protocol Violation|5
6107170|NCT00195507|21067005|P2|Overall Study|Lost to Follow-up|2
6107171|NCT00195507|21067006|P1|Overall Study|Lost to Follow-up|3
6107172|NCT00195507|21067005|P2|Overall Study|Physician Decision|2
6107173|NCT00195507|21067006|P1|Overall Study|Physician Decision|1
6107174|NCT00195507|21067005|P2|Overall Study|Failed to Return|3
6107175|NCT00195507|21067006|P1|Overall Study|Failed to Return|4
6107176|NCT00195507|21067005|P2|Overall Study|Death|1
6107177|NCT00195507|21067006|P1|Overall Study|Death|0
6107178|NCT00195507|21067005|P2|Overall Study|Adverse Event|13
6107179|NCT00195507|21067006|P1|Overall Study|Adverse Event|24
6107180|NCT00195494|21067020|P6|Year 2|System toxicity|0
6107181|NCT00195494|21067021|P5|Year 2|System toxicity|0
6107182|NCT00195494|21067022|P4|Year 2|System toxicity|1
6107183|NCT00195494|21067023|P3|Year 2|System toxicity|0
6107184|NCT00195494|21067024|P2|Year 2|System toxicity|0
6107185|NCT00195494|21067025|P1|Year 2|System toxicity|0
6107186|NCT00195494|21067020|P6|Year 2|Withdrawal by Subject|0
6107187|NCT00195494|21067021|P5|Year 2|Withdrawal by Subject|0
6107188|NCT00195494|21067022|P4|Year 2|Withdrawal by Subject|3
6107189|NCT00195494|21067023|P3|Year 2|Withdrawal by Subject|4
6107190|NCT00195494|21067024|P2|Year 2|Withdrawal by Subject|5
6107191|NCT00195494|21067025|P1|Year 2|Withdrawal by Subject|1
6107192|NCT00195494|21067020|P6|Year 2|Physician Decision|0
6107193|NCT00195494|21067021|P5|Year 2|Physician Decision|0
6107194|NCT00195494|21067022|P4|Year 2|Physician Decision|0
6107195|NCT00195494|21067023|P3|Year 2|Physician Decision|0
6107196|NCT00195494|21067024|P2|Year 2|Physician Decision|1
6107197|NCT00195494|21067025|P1|Year 2|Physician Decision|1
6107198|NCT00195494|21067020|P6|Year 2|Protocol deviation|0
6107199|NCT00195494|21067021|P5|Year 2|Protocol deviation|0
6107200|NCT00195494|21067022|P4|Year 2|Protocol deviation|0
6107201|NCT00195494|21067023|P3|Year 2|Protocol deviation|0
6107202|NCT00195494|21067024|P2|Year 2|Protocol deviation|1
6107203|NCT00195494|21067025|P1|Year 2|Protocol deviation|0
6107204|NCT00195494|21067020|P6|Year 2|Missed >4 consecutive doses|0
6107205|NCT00195494|21067021|P5|Year 2|Missed >4 consecutive doses|0
6107206|NCT00195494|21067022|P4|Year 2|Missed >4 consecutive doses|0
6107207|NCT00195494|21067023|P3|Year 2|Missed >4 consecutive doses|1
6107208|NCT00195494|21067024|P2|Year 2|Missed >4 consecutive doses|1
6107209|NCT00195494|21067025|P1|Year 2|Missed >4 consecutive doses|1
6107210|NCT00195494|21067020|P6|Year 2|Lost to Follow-up|0
6107211|NCT00195494|21067021|P5|Year 2|Lost to Follow-up|0
6107212|NCT00195494|21067022|P4|Year 2|Lost to Follow-up|1
6107213|NCT00195494|21067023|P3|Year 2|Lost to Follow-up|1
6107214|NCT00195494|21067024|P2|Year 2|Lost to Follow-up|0
6107215|NCT00195494|21067025|P1|Year 2|Lost to Follow-up|0
6107216|NCT00195494|21067020|P6|Year 2|Compliance|0
6107217|NCT00195494|21067021|P5|Year 2|Compliance|0
6107218|NCT00195494|21067022|P4|Year 2|Compliance|2
6107219|NCT00195494|21067023|P3|Year 2|Compliance|0
6107220|NCT00195494|21067024|P2|Year 2|Compliance|0
6107221|NCT00195494|21067025|P1|Year 2|Compliance|1
6107222|NCT00195494|21067020|P6|Year 2|Lack of Efficacy|0
6107223|NCT00195494|21067021|P5|Year 2|Lack of Efficacy|0
6107224|NCT00195494|21067022|P4|Year 2|Lack of Efficacy|7
6107225|NCT00195494|21067023|P3|Year 2|Lack of Efficacy|7
6107226|NCT00195494|21067024|P2|Year 2|Lack of Efficacy|1
6107227|NCT00195494|21067025|P1|Year 2|Lack of Efficacy|0
6107228|NCT00195494|21067020|P6|Year 2|Adverse Event|0
6107229|NCT00195494|21067021|P5|Year 2|Adverse Event|0
6107230|NCT00195494|21067022|P4|Year 2|Adverse Event|9
6107231|NCT00195494|21067023|P3|Year 2|Adverse Event|5
6107232|NCT00195494|21067024|P2|Year 2|Adverse Event|7
6107233|NCT00195494|21067025|P1|Year 2|Adverse Event|3
6107234|NCT00195494|21067020|P6|Year 1|Protocol Violation|1
6107235|NCT00195494|21067021|P5|Year 1|Protocol Violation|1
6107236|NCT00195494|21067022|P4|Year 1|Protocol Violation|0
6107237|NCT00195494|21067023|P3|Year 1|Protocol Violation|0
6107238|NCT00195494|21067024|P2|Year 1|Protocol Violation|0
6107239|NCT00195494|21067025|P1|Year 1|Protocol Violation|0
6107240|NCT00195494|21067020|P6|Year 1|Withdrawal by Subject|9
6107241|NCT00195494|21067021|P5|Year 1|Withdrawal by Subject|8
6107242|NCT00195494|21067022|P4|Year 1|Withdrawal by Subject|0
6107243|NCT00195494|21067023|P3|Year 1|Withdrawal by Subject|0
6107244|NCT00195494|21067024|P2|Year 1|Withdrawal by Subject|0
6107245|NCT00195494|21067025|P1|Year 1|Withdrawal by Subject|0
6107246|NCT00195494|21067020|P6|Year 1|Physician Decision|0
6107247|NCT00195494|21067021|P5|Year 1|Physician Decision|1
6107248|NCT00195494|21067022|P4|Year 1|Physician Decision|0
6107249|NCT00195494|21067023|P3|Year 1|Physician Decision|0
6107250|NCT00195494|21067024|P2|Year 1|Physician Decision|0
6107251|NCT00195494|21067025|P1|Year 1|Physician Decision|0
6107252|NCT00195494|21067020|P6|Year 1|Protocol deviation|3
6107253|NCT00195494|21067021|P5|Year 1|Protocol deviation|2
6107254|NCT00195494|21067022|P4|Year 1|Protocol deviation|0
6107255|NCT00195494|21067023|P3|Year 1|Protocol deviation|0
6107256|NCT00195494|21067024|P2|Year 1|Protocol deviation|0
6107257|NCT00195494|21067025|P1|Year 1|Protocol deviation|0
6107258|NCT00195494|21067020|P6|Year 1|Missed >4 consecutive doses|2
6107259|NCT00195494|21067021|P5|Year 1|Missed >4 consecutive doses|3
6107260|NCT00195494|21067022|P4|Year 1|Missed >4 consecutive doses|0
6107261|NCT00195494|21067023|P3|Year 1|Missed >4 consecutive doses|0
6107262|NCT00195494|21067024|P2|Year 1|Missed >4 consecutive doses|0
6107263|NCT00195494|21067025|P1|Year 1|Missed >4 consecutive doses|0
6107264|NCT00195494|21067020|P6|Year 1|Lost to Follow-up|0
6107265|NCT00195494|21067021|P5|Year 1|Lost to Follow-up|1
6107266|NCT00195494|21067022|P4|Year 1|Lost to Follow-up|0
6107267|NCT00195494|21067023|P3|Year 1|Lost to Follow-up|0
6107268|NCT00195494|21067024|P2|Year 1|Lost to Follow-up|0
6107269|NCT00195494|21067025|P1|Year 1|Lost to Follow-up|0
6107270|NCT00195494|21067020|P6|Year 1|Compliance|1
6107271|NCT00195494|21067021|P5|Year 1|Compliance|5
6107272|NCT00195494|21067022|P4|Year 1|Compliance|0
6107273|NCT00195494|21067023|P3|Year 1|Compliance|0
6107274|NCT00195494|21067024|P2|Year 1|Compliance|0
6107275|NCT00195494|21067025|P1|Year 1|Compliance|0
6107276|NCT00195494|21067020|P6|Year 1|Lack of Efficacy|9
6107277|NCT00195494|21067021|P5|Year 1|Lack of Efficacy|24
6107278|NCT00195494|21067022|P4|Year 1|Lack of Efficacy|0
6107279|NCT00195494|21067023|P3|Year 1|Lack of Efficacy|0
6107280|NCT00195494|21067024|P2|Year 1|Lack of Efficacy|0
6107281|NCT00195494|21067025|P1|Year 1|Lack of Efficacy|0
6107282|NCT00195494|21067020|P6|Year 1|System Toxicity|1
6107283|NCT00195494|21067021|P5|Year 1|System Toxicity|0
6107284|NCT00195494|21067022|P4|Year 1|System Toxicity|0
6107285|NCT00195494|21067023|P3|Year 1|System Toxicity|0
6107286|NCT00195494|21067024|P2|Year 1|System Toxicity|0
6107287|NCT00195494|21067025|P1|Year 1|System Toxicity|0
6107288|NCT00195494|21067020|P6|Year 1|Adverse Event|27
6107289|NCT00195494|21067021|P5|Year 1|Adverse Event|34
6107290|NCT00195494|21067022|P4|Year 1|Adverse Event|0
6107291|NCT00195494|21067023|P3|Year 1|Adverse Event|0
6107292|NCT00195494|21067024|P2|Year 1|Adverse Event|0
6107293|NCT00195494|21067025|P1|Year 1|Adverse Event|0
6107294|NCT00195442|21067043|P1|Overall Study|Other|14
6107295|NCT00195442|21067043|P1|Overall Study|Poor cooperation|2
6107296|NCT00195442|21067043|P1|Overall Study|No reason specified|4
6107297|NCT00195442|21067043|P1|Overall Study|Death|7
6107298|NCT00195442|21067043|P1|Overall Study|Intermittent product shortage|21
6107299|NCT00195442|21067043|P1|Overall Study|Switch to other Factor VIII preparation|23
6107300|NCT00195442|21067043|P1|Overall Study|Lost to Follow-up|27
6107301|NCT00195442|21067043|P1|Overall Study|Less than expected therapeutic effect|38
6107302|NCT00195429|21067062|P2|Overall Study|Lost to Follow-up|0
6107303|NCT00195429|21067063|P1|Overall Study|Lost to Follow-up|1
6107304|NCT00195429|21067062|P2|Overall Study|Lack of Efficacy|1
6107305|NCT00195429|21067063|P1|Overall Study|Lack of Efficacy|2
6107306|NCT00195429|21067062|P2|Overall Study|Adverse Event|4
6107307|NCT00195429|21067063|P1|Overall Study|Adverse Event|2
6107308|NCT00195351|21067079|P2|Overall Study|Lack of Efficacy|1
6107309|NCT00195351|21067080|P1|Overall Study|Lack of Efficacy|0
6107310|NCT00195351|21067079|P2|Overall Study|Death|1
6107311|NCT00195351|21067080|P1|Overall Study|Death|3
6107312|NCT00195351|21067079|P2|Overall Study|Protocol Deviation|2
6107313|NCT00195351|21067080|P1|Overall Study|Protocol Deviation|3
6107314|NCT00195351|21067079|P2|Overall Study|Withdrawal by Subject|3
6107315|NCT00195351|21067080|P1|Overall Study|Withdrawal by Subject|6
6107316|NCT00195351|21067079|P2|Overall Study|Lost to Follow-up|9
6107317|NCT00195351|21067080|P1|Overall Study|Lost to Follow-up|9
6107318|NCT00195338|21067090|P1|Overall Study|Early closure of the site|4
6107319|NCT00195338|21067090|P1|Overall Study|Lack of Efficacy|1
6107320|NCT00195338|21067090|P1|Overall Study|Adverse Event|5
6107321|NCT00195338|21067090|P1|Overall Study|Lost to Follow-up|2
6107322|NCT00195273|21067100|P2|Overall Study|Procedural complications|3
6107323|NCT00195273|21067101|P1|Overall Study|Procedural complications|9
6107324|NCT00195273|21067100|P2|Overall Study|Lack of Efficacy|1
6107325|NCT00195273|21067101|P1|Overall Study|Lack of Efficacy|3
6107326|NCT00195273|21067100|P2|Overall Study|Protocol deviation|1
6107327|NCT00195273|21067101|P1|Overall Study|Protocol deviation|0
6107328|NCT00195273|21067100|P2|Overall Study|Adverse Event|9
6107329|NCT00195273|21067101|P1|Overall Study|Adverse Event|9
6107330|NCT00195260|21067115|P11|Part 2: Recommended Phase 2 Dose (RP2D)|Other|3
6107331|NCT00195260|21067116|P10|Part 2: Recommended Phase 2 Dose (RP2D)|Other|4
6107332|NCT00195260|21067117|P9|Part 2: Recommended Phase 2 Dose (RP2D)|Other|6
6107333|NCT00195260|21067118|P8|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
6107334|NCT00195260|21067119|P7|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
6107335|NCT00195260|21067120|P6|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
6107336|NCT00195260|21067121|P5|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
6107337|NCT00195260|21067122|P4|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
6107338|NCT00195260|21067123|P3|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
6107339|NCT00195260|21067124|P2|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
6107340|NCT00195260|21067125|P1|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
6107341|NCT00195260|21067115|P11|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|3
6107342|NCT00195260|21067116|P10|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|2
6107343|NCT00195260|21067117|P9|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|1
6107344|NCT00195260|21067118|P8|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
6107345|NCT00195260|21067119|P7|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
6107346|NCT00195260|21067120|P6|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
6107347|NCT00195260|21067121|P5|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
6107348|NCT00195260|21067122|P4|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
6107349|NCT00195260|21067123|P3|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
6107350|NCT00195260|21067124|P2|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
6107351|NCT00195260|21067125|P1|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
6107352|NCT00195260|21067115|P11|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|2
6107353|NCT00195260|21067116|P10|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|3
6107354|NCT00195260|21067117|P9|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|5
6107355|NCT00195260|21067118|P8|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
6107356|NCT00195260|21067119|P7|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
6107357|NCT00195260|21067120|P6|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
6107358|NCT00195260|21067121|P5|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
6107359|NCT00195260|21067122|P4|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
6107360|NCT00195260|21067123|P3|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
6107361|NCT00195260|21067124|P2|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
6107362|NCT00195260|21067125|P1|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
6107363|NCT00195260|21067115|P11|Part 2: Recommended Phase 2 Dose (RP2D)|Death|15
6107364|NCT00195260|21067116|P10|Part 2: Recommended Phase 2 Dose (RP2D)|Death|29
6107365|NCT00195260|21067117|P9|Part 2: Recommended Phase 2 Dose (RP2D)|Death|21
6107366|NCT00195260|21067118|P8|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
6107367|NCT00195260|21067119|P7|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
6107368|NCT00195260|21067120|P6|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
6107369|NCT00195260|21067121|P5|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
6107370|NCT00195260|21067122|P4|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
6107371|NCT00195260|21067123|P3|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
6107372|NCT00195260|21067124|P2|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
6107373|NCT00195260|21067125|P1|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
6107374|NCT00195260|21067115|P11|Part 1: Dose Escalation|Symptomatic Deterioration|0
6107375|NCT00195260|21067116|P10|Part 1: Dose Escalation|Symptomatic Deterioration|0
6107376|NCT00195260|21067117|P9|Part 1: Dose Escalation|Symptomatic Deterioration|0
6107377|NCT00195260|21067118|P8|Part 1: Dose Escalation|Symptomatic Deterioration|0
6107378|NCT00195260|21067119|P7|Part 1: Dose Escalation|Symptomatic Deterioration|0
6107379|NCT00195260|21067120|P6|Part 1: Dose Escalation|Symptomatic Deterioration|1
6107380|NCT00195260|21067121|P5|Part 1: Dose Escalation|Symptomatic Deterioration|0
6107381|NCT00195260|21067122|P4|Part 1: Dose Escalation|Symptomatic Deterioration|0
6107382|NCT00195260|21067123|P3|Part 1: Dose Escalation|Symptomatic Deterioration|1
6107383|NCT00195260|21067124|P2|Part 1: Dose Escalation|Symptomatic Deterioration|1
6107384|NCT00195260|21067125|P1|Part 1: Dose Escalation|Symptomatic Deterioration|1
6107385|NCT00195260|21067115|P11|Part 1: Dose Escalation|Disease Progression|0
6107386|NCT00195260|21067116|P10|Part 1: Dose Escalation|Disease Progression|0
6107387|NCT00195260|21067117|P9|Part 1: Dose Escalation|Disease Progression|0
6107388|NCT00195260|21067118|P8|Part 1: Dose Escalation|Disease Progression|4
6107389|NCT00195260|21067119|P7|Part 1: Dose Escalation|Disease Progression|7
6107390|NCT00195260|21067120|P6|Part 1: Dose Escalation|Disease Progression|6
6107391|NCT00195260|21067121|P5|Part 1: Dose Escalation|Disease Progression|4
6107392|NCT00195260|21067122|P4|Part 1: Dose Escalation|Disease Progression|6
6107393|NCT00195260|21067123|P3|Part 1: Dose Escalation|Disease Progression|5
6107394|NCT00195260|21067124|P2|Part 1: Dose Escalation|Disease Progression|2
6107395|NCT00195260|21067125|P1|Part 1: Dose Escalation|Disease Progression|3
6107396|NCT00195260|21067115|P11|Part 1: Dose Escalation|Death|0
6107397|NCT00195260|21067116|P10|Part 1: Dose Escalation|Death|0
6107398|NCT00195260|21067117|P9|Part 1: Dose Escalation|Death|0
6107399|NCT00195260|21067118|P8|Part 1: Dose Escalation|Death|1
6107400|NCT00195260|21067119|P7|Part 1: Dose Escalation|Death|0
6107401|NCT00195260|21067120|P6|Part 1: Dose Escalation|Death|0
6107402|NCT00195260|21067121|P5|Part 1: Dose Escalation|Death|0
6107403|NCT00195260|21067122|P4|Part 1: Dose Escalation|Death|0
6107404|NCT00195260|21067123|P3|Part 1: Dose Escalation|Death|0
6107405|NCT00195260|21067124|P2|Part 1: Dose Escalation|Death|0
6107406|NCT00195260|21067125|P1|Part 1: Dose Escalation|Death|0
6107407|NCT00195260|21067115|P11|Part 1: Dose Escalation|Withdrawal by Subject|0
6107408|NCT00195260|21067116|P10|Part 1: Dose Escalation|Withdrawal by Subject|0
6107409|NCT00195260|21067117|P9|Part 1: Dose Escalation|Withdrawal by Subject|0
6107410|NCT00195260|21067118|P8|Part 1: Dose Escalation|Withdrawal by Subject|1
6107411|NCT00195260|21067119|P7|Part 1: Dose Escalation|Withdrawal by Subject|0
6107412|NCT00195260|21067120|P6|Part 1: Dose Escalation|Withdrawal by Subject|0
6107413|NCT00195260|21067121|P5|Part 1: Dose Escalation|Withdrawal by Subject|2
6107414|NCT00195260|21067122|P4|Part 1: Dose Escalation|Withdrawal by Subject|0
6107415|NCT00195260|21067123|P3|Part 1: Dose Escalation|Withdrawal by Subject|0
6107416|NCT00195260|21067124|P2|Part 1: Dose Escalation|Withdrawal by Subject|0
6107417|NCT00195260|21067125|P1|Part 1: Dose Escalation|Withdrawal by Subject|0
6107418|NCT00195260|21067115|P11|Part 1: Dose Escalation|Adverse Event|0
6107419|NCT00195260|21067116|P10|Part 1: Dose Escalation|Adverse Event|0
6107420|NCT00195260|21067117|P9|Part 1: Dose Escalation|Adverse Event|0
6107421|NCT00195260|21067118|P8|Part 1: Dose Escalation|Adverse Event|0
6107422|NCT00195260|21067119|P7|Part 1: Dose Escalation|Adverse Event|3
6107423|NCT00195260|21067120|P6|Part 1: Dose Escalation|Adverse Event|0
6107424|NCT00195260|21067121|P5|Part 1: Dose Escalation|Adverse Event|1
6107425|NCT00195260|21067122|P4|Part 1: Dose Escalation|Adverse Event|1
6107426|NCT00195260|21067123|P3|Part 1: Dose Escalation|Adverse Event|0
6107427|NCT00195260|21067124|P2|Part 1: Dose Escalation|Adverse Event|1
6107428|NCT00195260|21067125|P1|Part 1: Dose Escalation|Adverse Event|0
6107429|NCT00194987|21067293|P2|Overall Study|Withdrawal by Subject|3
6107430|NCT00194987|21067294|P1|Overall Study|Withdrawal by Subject|0
6107431|NCT00194792|21067327|P1|Overall Study|Withdrawal by Subject|1
6107432|NCT00194675|21067351|P2|Overall Study|Death|0
6107433|NCT00194675|21067352|P1|Overall Study|Death|1
6107434|NCT00194675|21067351|P2|Overall Study|Protocol Violation|0
6107435|NCT00194675|21067352|P1|Overall Study|Protocol Violation|1
6107436|NCT00194675|21067351|P2|Overall Study|"withdrew due to edgy feeling"|0
6107437|NCT00194675|21067352|P1|Overall Study|"withdrew due to edgy feeling"|1
6107438|NCT00194675|21067351|P2|Overall Study|lack of interest|1
6107439|NCT00194675|21067352|P1|Overall Study|lack of interest|1
6107440|NCT00194675|21067351|P2|Overall Study|Lost to Follow-up|1
6107441|NCT00194675|21067352|P1|Overall Study|Lost to Follow-up|1
6107442|NCT00194077|21067427|P2|Overall Study|Withdrawal by Subject|1
6107443|NCT00194077|21067428|P1|Overall Study|Withdrawal by Subject|1
6107444|NCT00194077|21067427|P2|Overall Study|Study nonadherence|0
6107445|NCT00194077|21067428|P1|Overall Study|Study nonadherence|1
6107446|NCT00194077|21067427|P2|Overall Study|Lack of Efficacy|29
6107447|NCT00194077|21067428|P1|Overall Study|Lack of Efficacy|22
6107448|NCT00194025|21067434|P1|Overall Study|non-adherence with study medication|4
6107449|NCT00194025|21067434|P1|Overall Study|Adverse Event|1
6107450|NCT00194012|21067449|P2|Open Label Extension (OLE)|Lack of Efficacy|0
6107451|NCT00194012|21067450|P1|Open Label Extension (OLE)|Lack of Efficacy|1
6107452|NCT00194012|21067449|P2|Open Label Extension (OLE)|Lost to Follow-up|5
6107453|NCT00194012|21067450|P1|Open Label Extension (OLE)|Lost to Follow-up|3
6107454|NCT00194012|21067449|P2|Open Label Extension (OLE)|Drowsiness; Jittery|1
6107455|NCT00194012|21067450|P1|Open Label Extension (OLE)|Drowsiness; Jittery|0
6107456|NCT00194012|21067449|P2|Open Label Extension (OLE)|Weight Gain|0
6107457|NCT00194012|21067450|P1|Open Label Extension (OLE)|Weight Gain|1
6107458|NCT00194012|21067449|P2|Randomized Phase|Oral/nasal twitching|1
6107459|NCT00194012|21067450|P1|Randomized Phase|Oral/nasal twitching|0
6107460|NCT00194012|21067449|P2|Randomized Phase|Emesis and enuresis|1
6107461|NCT00194012|21067450|P1|Randomized Phase|Emesis and enuresis|0
6107462|NCT00194012|21067449|P2|Randomized Phase|Participant reported having a rash|0
6107463|NCT00194012|21067450|P1|Randomized Phase|Participant reported having a rash|1
6107464|NCT00194012|21067449|P2|Randomized Phase|Adverse Event|1
6107465|NCT00194012|21067450|P1|Randomized Phase|Adverse Event|2
6107466|NCT00194012|21067449|P2|Randomized Phase|Withdrawal by Subject|3
6107467|NCT00194012|21067450|P1|Randomized Phase|Withdrawal by Subject|3
6107468|NCT00194012|21067449|P2|Randomized Phase|Study nonadherence|1
6107469|NCT00194012|21067450|P1|Randomized Phase|Study nonadherence|2
6107470|NCT00194012|21067449|P2|Randomized Phase|Lack of Efficacy|18
6107471|NCT00194012|21067450|P1|Randomized Phase|Lack of Efficacy|8
6107472|NCT00193609|21067486|P1|Overall Study|Adverse Event|2
6107473|NCT00193609|21067486|P1|Overall Study|Lack of Efficacy|2
6107474|NCT00193479|21067513|P1|Induction Chemotherapy|Disease Progression|1
6107475|NCT00193479|21067513|P1|Induction Chemotherapy|Adverse Event|2
6107476|NCT00193206|21067554|P1|Postoperative Therapy|Protocol Violation|1
6107477|NCT00193206|21067554|P1|Postoperative Therapy|Lack of Efficacy|1
6107478|NCT00193206|21067554|P1|Postoperative Therapy|Intercurrent Illness|2
6107479|NCT00193206|21067554|P1|Postoperative Therapy|Physician Decision|3
6107480|NCT00193206|21067554|P1|Postoperative Therapy|Withdrawal by Subject|7
6107481|NCT00193206|21067554|P1|Preoperative Therapy|False Positive Pregnancy Test|1
6107482|NCT00193206|21067554|P1|Preoperative Therapy|Withdrawal by Subject|2
6107483|NCT00193206|21067554|P1|Preoperative Therapy|Adverse Event|2
6107484|NCT00193206|21067554|P1|Preoperative Therapy|Lack of Efficacy|2
6107485|NCT00193180|21067558|P1|Overall Study|Protocol Violation|1
6107486|NCT00193180|21067558|P1|Overall Study|Adverse Event|8
6107487|NCT00193180|21067558|P1|Overall Study|Lack of Efficacy|1
6107488|NCT00193063|21067573|P1|Overall Study|Adverse Event|1
6107489|NCT00193063|21067573|P1|Overall Study|Lack of Efficacy|3
6107490|NCT00193050|21067579|P1|Adjuvant|Lack of Efficacy|2
6107491|NCT00193050|21067579|P1|Adjuvant|Intercurrent Hospitalization|3
6107492|NCT00193050|21067579|P1|Adjuvant|Physician Decision|5
6107493|NCT00193050|21067579|P1|Neoadjuvant Treatment|Adverse Event|2
6107494|NCT00193050|21067579|P1|Neoadjuvant Treatment|Physician Decision|2
6107495|NCT00193050|21067579|P1|Neoadjuvant Treatment|Intercurrent Illness|3
6107496|NCT00193050|21067579|P1|Neoadjuvant Treatment|Lack of Efficacy|2
6107497|NCT00192647|21067596|P2|Overall Study|Other/Administrative|3
6107498|NCT00192647|21067597|P1|Overall Study|Other/Administrative|5
6107499|NCT00192647|21067596|P2|Overall Study|Failure to Return|13
6107500|NCT00192647|21067597|P1|Overall Study|Failure to Return|11
6107501|NCT00192647|21067596|P2|Overall Study|Refused Treatment/Did not Cooperate|8
6107502|NCT00192647|21067597|P1|Overall Study|Refused Treatment/Did not Cooperate|10
6107503|NCT00192647|21067596|P2|Overall Study|Protocol Violation|1
6107504|NCT00192647|21067597|P1|Overall Study|Protocol Violation|3
6107505|NCT00192647|21067596|P2|Overall Study|Entry Criteria Violation|6
6107506|NCT00192647|21067597|P1|Overall Study|Entry Criteria Violation|6
6107507|NCT00192647|21067596|P2|Overall Study|Insufficient Therapeutic Response|83
6107508|NCT00192647|21067597|P1|Overall Study|Insufficient Therapeutic Response|53
6107509|NCT00192647|21067596|P2|Overall Study|Laboratory Test Abnormality|2
6107510|NCT00192647|21067597|P1|Overall Study|Laboratory Test Abnormality|4
6107511|NCT00192647|21067596|P2|Overall Study|Adverse Event|29
6107512|NCT00192647|21067597|P1|Overall Study|Adverse Event|35
6107513|NCT00192647|21067596|P2|Overall Study|Death|1
6107514|NCT00192647|21067597|P1|Overall Study|Death|1
6107515|NCT00192296|21067617|P4|Overall Study|Withdrawal by Subject|0
6107516|NCT00192296|21067618|P3|Overall Study|Withdrawal by Subject|0
6107517|NCT00192296|21067619|P2|Overall Study|Withdrawal by Subject|1
6107518|NCT00192296|21067620|P1|Overall Study|Withdrawal by Subject|0
6107519|NCT00192114|21067674|P1|Overall Study|Death|1
6107520|NCT00192114|21067674|P1|Overall Study|Clinical Progression|2
6107521|NCT00192114|21067674|P1|Overall Study|Adverse Event|2
6107522|NCT00192114|21067674|P1|Overall Study|Objective Tumor Progression|19
6107523|NCT00192075|21067691|P2|Overall Study|Other|2
6107524|NCT00192075|21067692|P1|Overall Study|Other|5
6107525|NCT00192075|21067691|P2|Overall Study|Unacceptable Toxicity Exhibited by Drug|1
6107526|NCT00192075|21067692|P1|Overall Study|Unacceptable Toxicity Exhibited by Drug|2
6107527|NCT00192075|21067691|P2|Overall Study|Patient Non-Compliance|1
6107528|NCT00192075|21067692|P1|Overall Study|Patient Non-Compliance|0
6107529|NCT00192075|21067691|P2|Overall Study|Withdrawal by Subject|5
6107530|NCT00192075|21067692|P1|Overall Study|Withdrawal by Subject|5
6107531|NCT00192075|21067691|P2|Overall Study|Physician Decision|0
6107532|NCT00192075|21067692|P1|Overall Study|Physician Decision|3
6107533|NCT00192075|21067691|P2|Overall Study|Lack of Efficacy|0
6107534|NCT00192075|21067692|P1|Overall Study|Lack of Efficacy|0
6107535|NCT00192075|21067691|P2|Overall Study|Death|1
6107536|NCT00192075|21067692|P1|Overall Study|Death|0
6107537|NCT00192075|21067691|P2|Overall Study|Adverse Event|3
6107538|NCT00192075|21067692|P1|Overall Study|Adverse Event|1
6107539|NCT00192075|21067691|P2|Overall Study|Disease Progression|6
6107540|NCT00192075|21067692|P1|Overall Study|Disease Progression|23
6107541|NCT00192036|21067717|P1|Overall Study|Unknown or Not Specified|5
6107542|NCT00192036|21067717|P1|Overall Study|Death|1
6107543|NCT00192036|21067717|P1|Overall Study|Clinical Disease Progression|1
6107544|NCT00192036|21067717|P1|Overall Study|Objective Tumor Progression|4
6107545|NCT00192036|21067717|P1|Overall Study|Patient/Physician Perception|1
6107546|NCT00192036|21067717|P1|Overall Study|Adverse Event|6
6107547|NCT00192036|21067717|P1|Overall Study|Protocol Violation|3
6107548|NCT00192023|21067727|P2|Period IV - Optional Open-Label|Physician Decision|0
6107549|NCT00192023|21067728|P1|Period IV - Optional Open-Label|Physician Decision|9
6107550|NCT00192023|21067727|P2|Period IV - Optional Open-Label|Withdrawal by Subject|0
6107551|NCT00192023|21067728|P1|Period IV - Optional Open-Label|Withdrawal by Subject|4
6107552|NCT00192023|21067727|P2|Period IV - Optional Open-Label|Protocol Violation|0
6107553|NCT00192023|21067728|P1|Period IV - Optional Open-Label|Protocol Violation|1
6107554|NCT00192023|21067727|P2|Period IV - Optional Open-Label|Lost to Follow-up|0
6107555|NCT00192023|21067728|P1|Period IV - Optional Open-Label|Lost to Follow-up|2
6107556|NCT00192023|21067727|P2|Period IV - Optional Open-Label|Patient/Caregiver Decision|0
6107557|NCT00192023|21067728|P1|Period IV - Optional Open-Label|Patient/Caregiver Decision|46
6107558|NCT00192023|21067727|P2|Period IV - Optional Open-Label|Lack of Efficacy|0
6107559|NCT00192023|21067728|P1|Period IV - Optional Open-Label|Lack of Efficacy|7
6107560|NCT00192023|21067727|P2|Period IV - Optional Open-Label|Adverse Event|0
6107561|NCT00192023|21067728|P1|Period IV - Optional Open-Label|Adverse Event|6
6107562|NCT00192023|21067727|P2|Period III - Double-Blind|Parent/Caregiver Decision|0
6107563|NCT00192023|21067728|P1|Period III - Double-Blind|Parent/Caregiver Decision|2
6107564|NCT00192023|21067727|P2|Period III - Double-Blind|Physician Decision|0
6107565|NCT00192023|21067728|P1|Period III - Double-Blind|Physician Decision|2
6107566|NCT00192023|21067727|P2|Period III - Double-Blind|Adverse Event|0
6107567|NCT00192023|21067728|P1|Period III - Double-Blind|Adverse Event|3
6107568|NCT00191984|21067750|P1|Overall Study|Physician Decision|4
6107569|NCT00191984|21067750|P1|Overall Study|Withdrawal by Subject|7
6107570|NCT00191984|21067750|P1|Overall Study|Entry Criteria Exclusion|1
6107571|NCT00191984|21067750|P1|Overall Study|Death|2
6107572|NCT00191984|21067750|P1|Overall Study|Adverse Event|4
6107573|NCT00191984|21067750|P1|Overall Study|Disease Progression|21
6107574|NCT00191945|21067760|P2|Double-Blind Acute Treatment|Physician Decision|2
6107575|NCT00191945|21067761|P1|Double-Blind Acute Treatment|Physician Decision|0
6107576|NCT00191945|21067760|P2|Double-Blind Acute Treatment|Non Protocol Compliance|0
6107577|NCT00191945|21067761|P1|Double-Blind Acute Treatment|Non Protocol Compliance|3
6107578|NCT00191945|21067760|P2|Double-Blind Acute Treatment|Lost to Follow-up|1
6107579|NCT00191945|21067761|P1|Double-Blind Acute Treatment|Lost to Follow-up|0
6107580|NCT00191945|21067760|P2|Double-Blind Acute Treatment|Parent's Decision|0
6107581|NCT00191945|21067761|P1|Double-Blind Acute Treatment|Parent's Decision|3
6107582|NCT00191906|21067797|P4|Study Period III|Lack of Efficacy|0
6107583|NCT00191906|21067798|P3|Study Period III|Lack of Efficacy|0
6107584|NCT00191906|21067799|P2|Study Period III|Lack of Efficacy|3
6107585|NCT00191906|21067800|P1|Study Period III|Lack of Efficacy|3
6107586|NCT00191906|21067797|P4|Study Period III|Parent/Caregiver Decision|0
6107587|NCT00191906|21067798|P3|Study Period III|Parent/Caregiver Decision|0
6107588|NCT00191906|21067799|P2|Study Period III|Parent/Caregiver Decision|0
6107589|NCT00191906|21067800|P1|Study Period III|Parent/Caregiver Decision|1
6107590|NCT00191906|21067797|P4|Study Period III|Lost to Follow-up|0
6107591|NCT00191906|21067798|P3|Study Period III|Lost to Follow-up|0
6107592|NCT00191906|21067799|P2|Study Period III|Lost to Follow-up|1
6107593|NCT00191906|21067800|P1|Study Period III|Lost to Follow-up|0
6107594|NCT00191906|21067797|P4|Study Period III|Adverse Event|0
6107595|NCT00191906|21067798|P3|Study Period III|Adverse Event|0
6107596|NCT00191906|21067799|P2|Study Period III|Adverse Event|0
6107597|NCT00191906|21067800|P1|Study Period III|Adverse Event|1
6107598|NCT00191906|21067797|P4|Study Period II|Entry Criteria Exclusion|0
6107599|NCT00191906|21067798|P3|Study Period II|Entry Criteria Exclusion|1
6107600|NCT00191906|21067799|P2|Study Period II|Entry Criteria Exclusion|0
6107601|NCT00191906|21067800|P1|Study Period II|Entry Criteria Exclusion|0
6107602|NCT00191906|21067797|P4|Study Period II|Parent/Caregiver Decision|0
6107603|NCT00191906|21067798|P3|Study Period II|Parent/Caregiver Decision|0
6107604|NCT00191906|21067799|P2|Study Period II|Parent/Caregiver Decision|1
6107605|NCT00191906|21067800|P1|Study Period II|Parent/Caregiver Decision|0
6107606|NCT00191906|21067797|P4|Study Period II|Withdrawal by Subject|0
6107607|NCT00191906|21067798|P3|Study Period II|Withdrawal by Subject|0
6107608|NCT00191906|21067799|P2|Study Period II|Withdrawal by Subject|3
6107609|NCT00191906|21067800|P1|Study Period II|Withdrawal by Subject|0
6107610|NCT00191906|21067797|P4|Study Period II|Adverse Event|0
6107611|NCT00191906|21067798|P3|Study Period II|Adverse Event|0
6107612|NCT00191906|21067799|P2|Study Period II|Adverse Event|1
6107613|NCT00191906|21067800|P1|Study Period II|Adverse Event|0
6107614|NCT00191854|21067843|P3|Overall Study|Screen Failure|1
6107615|NCT00191854|21067844|P2|Overall Study|Screen Failure|0
6107616|NCT00191854|21067845|P1|Overall Study|Screen Failure|0
6107617|NCT00191854|21067843|P3|Overall Study|Sponsor Decision|1
6107618|NCT00191854|21067844|P2|Overall Study|Sponsor Decision|0
6107619|NCT00191854|21067845|P1|Overall Study|Sponsor Decision|0
6107620|NCT00191854|21067843|P3|Overall Study|Withdrawal by Subject|3
6107621|NCT00191854|21067844|P2|Overall Study|Withdrawal by Subject|2
6107622|NCT00191854|21067845|P1|Overall Study|Withdrawal by Subject|4
6107623|NCT00191854|21067843|P3|Overall Study|Lost to Follow-up|5
6107624|NCT00191854|21067844|P2|Overall Study|Lost to Follow-up|5
6107625|NCT00191854|21067845|P1|Overall Study|Lost to Follow-up|7
6107626|NCT00191854|21067843|P3|Overall Study|Death|29
6107627|NCT00191854|21067844|P2|Overall Study|Death|23
6107628|NCT00191854|21067845|P1|Overall Study|Death|26
6107629|NCT00191815|21067865|P1|Overall Study|Withdrawal by Subject|7
6107630|NCT00191815|21067865|P1|Overall Study|Physician Decision|2
6107631|NCT00191815|21067865|P1|Overall Study|Protocol Violation|3
6107632|NCT00191815|21067865|P1|Overall Study|Death|2
6107633|NCT00191815|21067865|P1|Overall Study|Disease progression or relapse|24
6107634|NCT00191815|21067865|P1|Overall Study|Adverse Event|2
6107635|NCT00191789|21067877|P1|Overall Study|Death - Not Study-Drug Related|1
6107636|NCT00191789|21067877|P1|Overall Study|Progressive Disease/Lack of Efficacy|2
6107637|NCT00191789|21067877|P1|Overall Study|Death - Possibly Study Drug Related|4
6107638|NCT00191789|21067877|P1|Overall Study|Withdrawal by Subject|4
6107639|NCT00191789|21067877|P1|Overall Study|Patient/Physician: Satisfactory Response|4
6107640|NCT00191789|21067877|P1|Overall Study|Patient: Satisfactory Response|5
6107641|NCT00191789|21067877|P1|Overall Study|Adverse Event|5
6107642|NCT00191724|21067894|P5|Overall Study|Withdrawal by Subject|0
6107643|NCT00191724|21067895|P4|Overall Study|Withdrawal by Subject|1
6107644|NCT00191724|21067896|P3|Overall Study|Withdrawal by Subject|0
6107645|NCT00191724|21067897|P2|Overall Study|Withdrawal by Subject|0
6107646|NCT00191724|21067898|P1|Overall Study|Withdrawal by Subject|0
6107647|NCT00191724|21067894|P5|Overall Study|Lost to Follow-up|3
6107648|NCT00191724|21067895|P4|Overall Study|Lost to Follow-up|2
6107649|NCT00191724|21067896|P3|Overall Study|Lost to Follow-up|0
6107650|NCT00191724|21067897|P2|Overall Study|Lost to Follow-up|1
6107651|NCT00191724|21067898|P1|Overall Study|Lost to Follow-up|1
6107652|NCT00191724|21067894|P5|Overall Study|Adverse Event|0
6107653|NCT00191724|21067895|P4|Overall Study|Adverse Event|0
6107654|NCT00191724|21067896|P3|Overall Study|Adverse Event|1
6107655|NCT00191724|21067897|P2|Overall Study|Adverse Event|0
6107656|NCT00191724|21067898|P1|Overall Study|Adverse Event|0
6107657|NCT00191646|21067927|P2|Overall Study|Missing Data|11
6107658|NCT00191646|21067928|P1|Overall Study|Missing Data|18
6107659|NCT00191646|21067927|P2|Overall Study|Other|34
6107660|NCT00191646|21067928|P1|Overall Study|Other|33
6107661|NCT00191646|21067927|P2|Overall Study|Death|8
6107662|NCT00191646|21067928|P1|Overall Study|Death|6
6107663|NCT00191646|21067927|P2|Overall Study|Protocol Violation|7
6107664|NCT00191646|21067928|P1|Overall Study|Protocol Violation|5
6107665|NCT00191646|21067927|P2|Overall Study|Withdrawal by Subject|39
6107666|NCT00191646|21067928|P1|Overall Study|Withdrawal by Subject|58
6107667|NCT00191646|21067927|P2|Overall Study|Physician Decision|11
6107668|NCT00191646|21067928|P1|Overall Study|Physician Decision|20
6107669|NCT00191646|21067927|P2|Overall Study|Disease Progression|6
6107670|NCT00191646|21067928|P1|Overall Study|Disease Progression|5
6107671|NCT00191646|21067927|P2|Overall Study|Toxicity|37
6107672|NCT00191646|21067928|P1|Overall Study|Toxicity|26
6107762|NCT00191191|21068093|P2|Overall Study|Physician Decision|2
6107673|NCT00191477|21067948|P2|Overall Study|Discontinued Prior to Instillation|14
6107674|NCT00191477|21067949|P1|Overall Study|Discontinued Prior to Instillation|13
6107675|NCT00191477|21067948|P2|Overall Study|Pathological Specimen Lost|0
6107676|NCT00191477|21067949|P1|Overall Study|Pathological Specimen Lost|1
6107677|NCT00191477|21067948|P2|Overall Study|Not Eligible|38
6107678|NCT00191477|21067949|P1|Overall Study|Not Eligible|41
6107679|NCT00191477|21067948|P2|Overall Study|Other|0
6107680|NCT00191477|21067949|P1|Overall Study|Other|2
6107681|NCT00191477|21067948|P2|Overall Study|Withdrawal by Subject|0
6107682|NCT00191477|21067949|P1|Overall Study|Withdrawal by Subject|2
6107683|NCT00191477|21067948|P2|Overall Study|Treatment Change|0
6107684|NCT00191477|21067949|P1|Overall Study|Treatment Change|2
6107685|NCT00191477|21067948|P2|Overall Study|Protocol Violation|1
6107686|NCT00191477|21067949|P1|Overall Study|Protocol Violation|1
6107687|NCT00191477|21067948|P2|Overall Study|Lost to Follow-up|21
6107688|NCT00191477|21067949|P1|Overall Study|Lost to Follow-up|23
6107689|NCT00191477|21067948|P2|Overall Study|Death, Other Cause|6
6107690|NCT00191477|21067949|P1|Overall Study|Death, Other Cause|3
6107691|NCT00191477|21067948|P2|Overall Study|Death, Study Disease|1
6107692|NCT00191477|21067949|P1|Overall Study|Death, Study Disease|1
6107693|NCT00191477|21067948|P2|Overall Study|Tumor Recurrence|48
6107694|NCT00191477|21067949|P1|Overall Study|Tumor Recurrence|49
6107695|NCT00191451|21067968|P3|Overall Study|Reason Not Specified|3
6107696|NCT00191451|21067969|P2|Overall Study|Reason Not Specified|1
6107697|NCT00191451|21067970|P1|Overall Study|Reason Not Specified|2
6107698|NCT00191451|21067968|P3|Overall Study|Ineligible|0
6107699|NCT00191451|21067969|P2|Overall Study|Ineligible|1
6107700|NCT00191451|21067970|P1|Overall Study|Ineligible|0
6107701|NCT00191451|21067968|P3|Overall Study|Sponsor Decision|0
6107702|NCT00191451|21067969|P2|Overall Study|Sponsor Decision|0
6107703|NCT00191451|21067970|P1|Overall Study|Sponsor Decision|1
6107704|NCT00191451|21067968|P3|Overall Study|Physician Decision|6
6107705|NCT00191451|21067969|P2|Overall Study|Physician Decision|9
6107706|NCT00191451|21067970|P1|Overall Study|Physician Decision|2
6107707|NCT00191451|21067968|P3|Overall Study|Withdrawal by Subject|5
6107708|NCT00191451|21067969|P2|Overall Study|Withdrawal by Subject|3
6107709|NCT00191451|21067970|P1|Overall Study|Withdrawal by Subject|2
6107710|NCT00191386|21067990|P1|Overall Study|Lack of Efficacy|15
6107711|NCT00191386|21067990|P1|Overall Study|Physician Decision|11
6107712|NCT00191386|21067990|P1|Overall Study|Withdrawal by Subject|96
6107713|NCT00191386|21067990|P1|Overall Study|Protocol Violation|18
6107714|NCT00191386|21067990|P1|Overall Study|Entry Criteria Exclusion|3
6107715|NCT00191386|21067990|P1|Overall Study|Lost to Follow-up|1
6107716|NCT00191386|21067990|P1|Overall Study|Adverse Event|16
6107717|NCT00191334|21067997|P1|Overall Study|Withdrawal by Subject|4
6107718|NCT00191334|21067997|P1|Overall Study|Physician Decision|1
6107719|NCT00191334|21067997|P1|Overall Study|Disease Progression or Relapse|8
6107720|NCT00191334|21067997|P1|Overall Study|Adverse Event|4
6107721|NCT00191308|21068005|P1|Overall Study|Adverse Event|1
6107722|NCT00191282|21068015|P2|Overall Study|Lost to Follow-up|31
6107723|NCT00191282|21068016|P1|Overall Study|Lost to Follow-up|24
6107724|NCT00191282|21068015|P2|Overall Study|Sponsor's decision|2
6107725|NCT00191282|21068016|P1|Overall Study|Sponsor's decision|2
6107726|NCT00191282|21068015|P2|Overall Study|Severity of outcome|5
6107727|NCT00191282|21068016|P1|Overall Study|Severity of outcome|2
6107728|NCT00191282|21068015|P2|Overall Study|Protocol Violation|12
6107729|NCT00191282|21068016|P1|Overall Study|Protocol Violation|9
6107730|NCT00191282|21068015|P2|Overall Study|Protocol entry criteria not met|9
6107731|NCT00191282|21068016|P1|Overall Study|Protocol entry criteria not met|14
6107732|NCT00191282|21068015|P2|Overall Study|Physician Decision|15
6107733|NCT00191282|21068016|P1|Overall Study|Physician Decision|18
6107734|NCT00191282|21068015|P2|Overall Study|Withdrawal by Subject|44
6107735|NCT00191282|21068016|P1|Overall Study|Withdrawal by Subject|59
6107736|NCT00191282|21068015|P2|Overall Study|Patient moved|14
6107737|NCT00191282|21068016|P1|Overall Study|Patient moved|11
6107738|NCT00191282|21068015|P2|Overall Study|Noncompliance|17
6107739|NCT00191282|21068016|P1|Overall Study|Noncompliance|14
6107740|NCT00191282|21068015|P2|Overall Study|Lack of Efficacy|6
6107741|NCT00191282|21068016|P1|Overall Study|Lack of Efficacy|11
6107742|NCT00191282|21068015|P2|Overall Study|Death|51
6107743|NCT00191282|21068016|P1|Overall Study|Death|51
6107744|NCT00191282|21068015|P2|Overall Study|Adverse Event|6
6107745|NCT00191282|21068016|P1|Overall Study|Adverse Event|5
6107746|NCT00191269|21068076|P2|Overall Study|Physician Decision|3
6107747|NCT00191269|21068077|P1|Overall Study|Physician Decision|0
6107748|NCT00191269|21068076|P2|Overall Study|Pathologic Aggrevation|1
6107749|NCT00191269|21068077|P1|Overall Study|Pathologic Aggrevation|0
6107750|NCT00191269|21068076|P2|Overall Study|Withdrawal by Subject|1
6107751|NCT00191269|21068077|P1|Overall Study|Withdrawal by Subject|0
6107752|NCT00191269|21068076|P2|Overall Study|Lack of Efficacy|5
6107753|NCT00191269|21068077|P1|Overall Study|Lack of Efficacy|1
6107754|NCT00191269|21068076|P2|Overall Study|Progression of Disease|42
6107755|NCT00191269|21068077|P1|Overall Study|Progression of Disease|4
6107756|NCT00191269|21068076|P2|Overall Study|Adverse Event|4
6107757|NCT00191269|21068077|P1|Overall Study|Adverse Event|1
6107758|NCT00191269|21068076|P2|Overall Study|Protocol Violation|2
6107759|NCT00191269|21068077|P1|Overall Study|Protocol Violation|0
6107760|NCT00191191|21068093|P2|Overall Study|Good Clinical Practice Violation|1
6107761|NCT00191191|21068094|P1|Overall Study|Good Clinical Practice Violation|0
6107763|NCT00191191|21068094|P1|Overall Study|Physician Decision|3
6107764|NCT00191191|21068093|P2|Overall Study|Lost to Follow-up|0
6107765|NCT00191191|21068094|P1|Overall Study|Lost to Follow-up|1
6107766|NCT00191191|21068093|P2|Overall Study|Family/Caregiver Decision|7
6107767|NCT00191191|21068094|P1|Overall Study|Family/Caregiver Decision|5
6107768|NCT00191191|21068093|P2|Overall Study|Toxicity After Dose Reduction|8
6107769|NCT00191191|21068094|P1|Overall Study|Toxicity After Dose Reduction|7
6107770|NCT00191191|21068093|P2|Overall Study|Progressive Disease|72
6107771|NCT00191191|21068094|P1|Overall Study|Progressive Disease|84
6107772|NCT00191191|21068093|P2|Overall Study|Adverse Event|21
6107773|NCT00191191|21068094|P1|Overall Study|Adverse Event|11
6107774|NCT00191191|21068093|P2|Overall Study|Treated with Another Systemic Agent|1
6107775|NCT00191191|21068094|P1|Overall Study|Treated with Another Systemic Agent|1
6107776|NCT00191191|21068093|P2|Overall Study|Entry Criteria Exclusion|0
6107777|NCT00191191|21068094|P1|Overall Study|Entry Criteria Exclusion|2
6107778|NCT00191165|21068110|P2|Overall Study|Participant Moved Away|1
6107779|NCT00191165|21068111|P1|Overall Study|Participant Moved Away|0
6107780|NCT00191165|21068110|P2|Overall Study|Protocol Violation|1
6107781|NCT00191165|21068111|P1|Overall Study|Protocol Violation|0
6107782|NCT00191165|21068110|P2|Overall Study|Adverse Event|0
6107783|NCT00191165|21068111|P1|Overall Study|Adverse Event|2
6107784|NCT00191152|21068123|P2|Crossover Treatment|Other|3
6107785|NCT00191152|21068124|P1|Crossover Treatment|Other|4
6107786|NCT00191152|21068123|P2|Crossover Treatment|Lost to Follow-up|1
6107787|NCT00191152|21068124|P1|Crossover Treatment|Lost to Follow-up|2
6107788|NCT00191152|21068123|P2|Crossover Treatment|Withdrawal by Subject|9
6107789|NCT00191152|21068124|P1|Crossover Treatment|Withdrawal by Subject|6
6107790|NCT00191152|21068123|P2|Crossover Treatment|Physician Decision|7
6107791|NCT00191152|21068124|P1|Crossover Treatment|Physician Decision|7
6107792|NCT00191152|21068123|P2|Crossover Treatment|Adverse Event|8
6107793|NCT00191152|21068124|P1|Crossover Treatment|Adverse Event|8
6107794|NCT00191152|21068123|P2|Initial Treatment|Other|21
6107795|NCT00191152|21068124|P1|Initial Treatment|Other|18
6107796|NCT00191152|21068123|P2|Initial Treatment|Lost to Follow-up|6
6107797|NCT00191152|21068124|P1|Initial Treatment|Lost to Follow-up|0
6107798|NCT00191152|21068123|P2|Initial Treatment|Withdrawal by Subject|28
6107799|NCT00191152|21068124|P1|Initial Treatment|Withdrawal by Subject|40
6107800|NCT00191152|21068123|P2|Initial Treatment|Physician Decision|31
6107801|NCT00191152|21068124|P1|Initial Treatment|Physician Decision|40
6107802|NCT00191152|21068123|P2|Initial Treatment|Adverse Event|67
6107803|NCT00191152|21068124|P1|Initial Treatment|Adverse Event|43
6107804|NCT00191139|21068156|P2|Overall Study|Other|2
6107805|NCT00191139|21068157|P1|Overall Study|Other|1
6107806|NCT00191139|21068156|P2|Overall Study|Disease Progression|1
6107807|NCT00191139|21068157|P1|Overall Study|Disease Progression|0
6107808|NCT00191139|21068156|P2|Overall Study|Withdrawal by Subject|3
6107809|NCT00191139|21068157|P1|Overall Study|Withdrawal by Subject|0
6107810|NCT00191139|21068156|P2|Overall Study|Death|0
6107811|NCT00191139|21068157|P1|Overall Study|Death|2
6107812|NCT00191139|21068156|P2|Overall Study|Adverse Event|6
6107813|NCT00191139|21068157|P1|Overall Study|Adverse Event|2
6107814|NCT00191113|21068173|P2|Core Study|Death|0
6107815|NCT00191113|21068174|P1|Core Study|Death|1
6107816|NCT00191113|21068173|P2|Core Study|Lack of Efficacy|2
6107817|NCT00191113|21068174|P1|Core Study|Lack of Efficacy|0
6107818|NCT00191113|21068173|P2|Core Study|Adverse Event|2
6107819|NCT00191113|21068174|P1|Core Study|Adverse Event|0
6107820|NCT00191113|21068173|P2|Core Study|Lost to Follow-up|0
6107821|NCT00191113|21068174|P1|Core Study|Lost to Follow-up|3
6107822|NCT00191113|21068173|P2|Core Study|Protocol Violation|2
6107823|NCT00191113|21068174|P1|Core Study|Protocol Violation|6
6107824|NCT00191113|21068173|P2|Core Study|Withdrawal by Subject|9
6107825|NCT00191113|21068174|P1|Core Study|Withdrawal by Subject|25
6107826|NCT00191100|21068216|P2|Overall Study|Reason Not Specified|1
6107827|NCT00191100|21068217|P1|Overall Study|Reason Not Specified|0
6107828|NCT00191100|21068216|P2|Overall Study|Death from Other Cause|0
6107829|NCT00191100|21068217|P1|Overall Study|Death from Other Cause|1
6107830|NCT00191100|21068216|P2|Overall Study|Protocol Violation|1
6107831|NCT00191100|21068217|P1|Overall Study|Protocol Violation|1
6107832|NCT00191100|21068216|P2|Overall Study|Death from Study Drug Toxicity|0
6107833|NCT00191100|21068217|P1|Overall Study|Death from Study Drug Toxicity|2
6107834|NCT00191100|21068216|P2|Overall Study|Physician Decision|1
6107835|NCT00191100|21068217|P1|Overall Study|Physician Decision|3
6107836|NCT00191100|21068216|P2|Overall Study|Lack of Efficacy, Stable Disease|0
6107837|NCT00191100|21068217|P1|Overall Study|Lack of Efficacy, Stable Disease|1
6107838|NCT00191100|21068216|P2|Overall Study|Lack of Efficacy, Progressive Disease|2
6107839|NCT00191100|21068217|P1|Overall Study|Lack of Efficacy, Progressive Disease|1
6107840|NCT00191100|21068216|P2|Overall Study|Clinical Relapse|1
6107841|NCT00191100|21068217|P1|Overall Study|Clinical Relapse|2
6107842|NCT00191100|21068216|P2|Overall Study|Protocol Entry Criteria Not Met|1
6107843|NCT00191100|21068217|P1|Overall Study|Protocol Entry Criteria Not Met|2
6107844|NCT00191100|21068216|P2|Overall Study|Withdrawal by Subject|3
6107845|NCT00191100|21068217|P1|Overall Study|Withdrawal by Subject|9
6107846|NCT00191100|21068216|P2|Overall Study|Patient Moved|1
6107847|NCT00191100|21068217|P1|Overall Study|Patient Moved|0
6107848|NCT00191100|21068216|P2|Overall Study|Lost to Follow-up|0
6107849|NCT00191100|21068217|P1|Overall Study|Lost to Follow-up|2
6107850|NCT00191100|21068216|P2|Overall Study|Adverse Event|1
6107851|NCT00191100|21068217|P1|Overall Study|Adverse Event|18
6107852|NCT00190983|21068233|P1|Overall Study|Inevaluable (never treated)|2
6107853|NCT00190775|21068242|P2|Overall Study|Exclusion Criteria Met|3
6107854|NCT00190775|21068243|P1|Overall Study|Exclusion Criteria Met|1
6107855|NCT00190775|21068242|P2|Overall Study|Protocol Violation|1
6107856|NCT00190775|21068243|P1|Overall Study|Protocol Violation|0
6107857|NCT00190775|21068242|P2|Overall Study|Noncompliance|5
6107858|NCT00190775|21068243|P1|Overall Study|Noncompliance|3
6107859|NCT00190775|21068242|P2|Overall Study|Physician Decision|0
6107860|NCT00190775|21068243|P1|Overall Study|Physician Decision|3
6107861|NCT00190775|21068242|P2|Overall Study|Sponsor Decision|0
6107862|NCT00190775|21068243|P1|Overall Study|Sponsor Decision|1
6107863|NCT00190775|21068242|P2|Overall Study|Withdrawal by Subject|13
6107864|NCT00190775|21068243|P1|Overall Study|Withdrawal by Subject|24
6107865|NCT00190775|21068242|P2|Overall Study|Participant Moved|1
6107866|NCT00190775|21068243|P1|Overall Study|Participant Moved|0
6107867|NCT00190775|21068242|P2|Overall Study|Lost to Follow-up|23
6107868|NCT00190775|21068243|P1|Overall Study|Lost to Follow-up|31
6107869|NCT00190775|21068242|P2|Overall Study|Lack of Efficacy|32
6107870|NCT00190775|21068243|P1|Overall Study|Lack of Efficacy|28
6107871|NCT00190775|21068242|P2|Overall Study|Satisfactory Response|0
6107872|NCT00190775|21068243|P1|Overall Study|Satisfactory Response|1
6107873|NCT00190775|21068242|P2|Overall Study|Adverse Event|22
6107874|NCT00190775|21068243|P1|Overall Study|Adverse Event|57
6107875|NCT00190749|21068314|P2|Overall Study|Sponsor Decision|0
6107876|NCT00190749|21068315|P1|Overall Study|Sponsor Decision|1
6107877|NCT00190749|21068314|P2|Overall Study|Reason Not Specified|2
6107878|NCT00190749|21068315|P1|Overall Study|Reason Not Specified|0
6107879|NCT00190749|21068314|P2|Overall Study|Lack of Efficacy|3
6107880|NCT00190749|21068315|P1|Overall Study|Lack of Efficacy|2
6107881|NCT00190749|21068314|P2|Overall Study|Adverse Event|5
6107882|NCT00190749|21068315|P1|Overall Study|Adverse Event|0
6107883|NCT00190749|21068314|P2|Overall Study|Protocol Violation|4
6107884|NCT00190749|21068315|P1|Overall Study|Protocol Violation|5
6107885|NCT00190749|21068314|P2|Overall Study|Withdrawal by Subject|6
6107886|NCT00190749|21068315|P1|Overall Study|Withdrawal by Subject|10
6107887|NCT00190749|21068314|P2|Overall Study|Lost to Follow-up|11
6107888|NCT00190749|21068315|P1|Overall Study|Lost to Follow-up|8
6107889|NCT00190684|21068379|P1|Overall Study|Study Period V Completed|1
6107890|NCT00190684|21068379|P1|Overall Study|Study Period III Completed|103
6107891|NCT00190684|21068379|P1|Overall Study|Protocol Violation|123
6107892|NCT00190684|21068379|P1|Overall Study|Physician Decision|84
6107893|NCT00190684|21068379|P1|Overall Study|Sponsor's decision|17
6107894|NCT00190684|21068379|P1|Overall Study|Clinical relapse|67
6107895|NCT00190684|21068379|P1|Overall Study|Patient Decision|432
6107896|NCT00190684|21068379|P1|Overall Study|Patient moved|60
6107897|NCT00190684|21068379|P1|Overall Study|Lost to Follow-up|232
6107898|NCT00190684|21068379|P1|Overall Study|Lack of efficacy|204
6107899|NCT00190684|21068379|P1|Overall Study|Satisfactory response|80
6107900|NCT00190684|21068379|P1|Overall Study|Adverse Event|86
6107901|NCT00190671|21068400|P2|Overall Study|Withdrawal by Subject|2
6107902|NCT00190671|21068401|P1|Overall Study|Withdrawal by Subject|0
6107903|NCT00190671|21068400|P2|Overall Study|Protocol Violation|1
6107904|NCT00190671|21068401|P1|Overall Study|Protocol Violation|0
6107905|NCT00190671|21068400|P2|Overall Study|Death from Other Causes|2
6107906|NCT00190671|21068401|P1|Overall Study|Death from Other Causes|0
6107907|NCT00190671|21068400|P2|Overall Study|Death from Study-Drug Toxicity|2
6107908|NCT00190671|21068401|P1|Overall Study|Death from Study-Drug Toxicity|0
6107909|NCT00190671|21068400|P2|Overall Study|Clinical Relapse|1
6107910|NCT00190671|21068401|P1|Overall Study|Clinical Relapse|0
6107911|NCT00190671|21068400|P2|Overall Study|Adverse Event|2
6107912|NCT00190671|21068401|P1|Overall Study|Adverse Event|3
6107913|NCT00190671|21068400|P2|Overall Study|Death from Study Disease|1
6107914|NCT00190671|21068401|P1|Overall Study|Death from Study Disease|1
6107915|NCT00190671|21068400|P2|Overall Study|Lack of Efficacy|24
6107916|NCT00190671|21068401|P1|Overall Study|Lack of Efficacy|19
6107917|NCT00190671|21068400|P2|Overall Study|Satisfactory Response|7
6107918|NCT00190671|21068401|P1|Overall Study|Satisfactory Response|4
6107919|NCT00189540|21068421|P2|Overall Study|Death|1
6107920|NCT00189540|21068422|P1|Overall Study|Death|4
6107921|NCT00189540|21068421|P2|Overall Study|Withdrawal by Subject|0
6107922|NCT00189540|21068422|P1|Overall Study|Withdrawal by Subject|3
6107923|NCT00189488|21068440|P2|Overall Study|Other|0
6107924|NCT00189488|21068441|P1|Overall Study|Other|1
6107925|NCT00189488|21068440|P2|Overall Study|Death|8
6107926|NCT00189488|21068441|P1|Overall Study|Death|5
6107927|NCT00189488|21068440|P2|Overall Study|Administrative Decision|2
6107928|NCT00189488|21068441|P1|Overall Study|Administrative Decision|0
6107929|NCT00189488|21068440|P2|Overall Study|Disease progression|4
6107930|NCT00189488|21068441|P1|Overall Study|Disease progression|2
6107931|NCT00189488|21068440|P2|Overall Study|Withdrawal by Subject|6
6107932|NCT00189488|21068441|P1|Overall Study|Withdrawal by Subject|2
6107933|NCT00189488|21068440|P2|Overall Study|Adverse Event|1
6107934|NCT00189488|21068441|P1|Overall Study|Adverse Event|2
6107935|NCT00189488|21068440|P2|Overall Study|Protocol deviation|1
6107936|NCT00189488|21068441|P1|Overall Study|Protocol deviation|2
6107937|NCT00189488|21068440|P2|Overall Study|Ineligibility determined|0
6107938|NCT00189488|21068441|P1|Overall Study|Ineligibility determined|1
6107939|NCT00189462|21068472|P2|Overall Study|Lost to Follow-up|20
6107940|NCT00189462|21068473|P1|Overall Study|Lost to Follow-up|18
6107941|NCT00189462|21068472|P2|Overall Study|Lack of Efficacy|1
6107942|NCT00189462|21068473|P1|Overall Study|Lack of Efficacy|5
6107943|NCT00189423|21068490|P2|Overall Study|Lost to Follow-up|10
6107944|NCT00189423|21068491|P1|Overall Study|Lost to Follow-up|10
6107945|NCT00189423|21068490|P2|Overall Study|Withdrawal by Subject|9
6107946|NCT00189423|21068491|P1|Overall Study|Withdrawal by Subject|9
6107947|NCT00189423|21068490|P2|Overall Study|Death|747
6107948|NCT00189423|21068491|P1|Overall Study|Death|746
6107949|NCT00189306|21068513|P1|Long-Term Follow-up|Evidence of Superficial Basal Cell Ca|20
6107950|NCT00189306|21068513|P1|Long-Term Follow-up|Lost to Follow-up|9
6107951|NCT00189306|21068513|P1|Long-Term Follow-up|Intercurrent disease|2
6107952|NCT00189306|21068513|P1|Long-Term Follow-up|Withdrawal by Subject|1
6107953|NCT00189306|21068513|P1|Long-Term Follow-up|Death|4
6107954|NCT00189306|21068513|P1|Long-Term Follow-up|Adverse Event|2
6107955|NCT00189306|21068513|P1|Posttreatment Period|Local skin reaction/sign|1
6107956|NCT00189306|21068513|P1|Posttreatment Period|Evidence of Superficial Basal Cell Ca|5
6107957|NCT00189306|21068513|P1|Posttreatment Period|Protocol Violation|1
6107958|NCT00189306|21068513|P1|Posttreatment Period|Target lesion excised|1
6107959|NCT00189306|21068513|P1|Posttreatment Period|Noncompliance|1
6107960|NCT00189306|21068513|P1|Posttreatment Period|Withdrawal by Subject|2
6107961|NCT00189306|21068513|P1|Posttreatment Period|Death|1
6107962|NCT00189306|21068513|P1|Treatment Period|Protocol Violation|1
6107963|NCT00189306|21068513|P1|Treatment Period|Adverse Event|2
6107964|NCT00189306|21068513|P1|Treatment Period|Withdrawal by Subject|2
6107965|NCT00189202|21068522|P1|Overall Study|Physician Decision|5
6107966|NCT00187889|21068563|P2|Overall Study|Withdrawal by Subject|4
6107967|NCT00187889|21068564|P1|Overall Study|Withdrawal by Subject|6
6107968|NCT00187486|21068606|P1|Overall Study|Protocol Violation|1
6107969|NCT00187278|21068642|P2|Overall Study|Protocol Violation|13
6107970|NCT00187278|21068643|P1|Overall Study|Protocol Violation|10
6107971|NCT00187135|21068727|P6|Visit Three|Study Discontinued|6
6107972|NCT00187135|21068728|P5|Visit Three|Study Discontinued|7
6107973|NCT00187135|21068729|P4|Visit Three|Study Discontinued|7
6107974|NCT00187135|21068730|P3|Visit Three|Study Discontinued|7
6107975|NCT00187135|21068731|P2|Visit Three|Study Discontinued|6
6107976|NCT00187135|21068732|P1|Visit Three|Study Discontinued|7
6107977|NCT00187135|21068727|P6|Visit Three|Withdrawal by Subject|0
6107978|NCT00187135|21068728|P5|Visit Three|Withdrawal by Subject|0
6107979|NCT00187135|21068729|P4|Visit Three|Withdrawal by Subject|2
6107980|NCT00187135|21068730|P3|Visit Three|Withdrawal by Subject|1
6107981|NCT00187135|21068731|P2|Visit Three|Withdrawal by Subject|1
6107982|NCT00187135|21068732|P1|Visit Three|Withdrawal by Subject|0
6107983|NCT00187135|21068727|P6|Visit Three|Death|0
6107984|NCT00187135|21068728|P5|Visit Three|Death|1
6107985|NCT00187135|21068729|P4|Visit Three|Death|0
6107986|NCT00187135|21068730|P3|Visit Three|Death|1
6107987|NCT00187135|21068731|P2|Visit Three|Death|0
6107988|NCT00187135|21068732|P1|Visit Three|Death|0
6107989|NCT00187135|21068727|P6|Visit Two|Study Discontinued|6
6107990|NCT00187135|21068728|P5|Visit Two|Study Discontinued|5
6107991|NCT00187135|21068729|P4|Visit Two|Study Discontinued|7
6107992|NCT00187135|21068730|P3|Visit Two|Study Discontinued|1
6107993|NCT00187135|21068731|P2|Visit Two|Study Discontinued|2
6107994|NCT00187135|21068732|P1|Visit Two|Study Discontinued|3
6107995|NCT00187135|21068727|P6|Visit Two|Withdrawal by Subject|1
6107996|NCT00187135|21068728|P5|Visit Two|Withdrawal by Subject|1
6107997|NCT00187135|21068729|P4|Visit Two|Withdrawal by Subject|0
6107998|NCT00187135|21068730|P3|Visit Two|Withdrawal by Subject|1
6107999|NCT00187135|21068731|P2|Visit Two|Withdrawal by Subject|1
6108000|NCT00187135|21068732|P1|Visit Two|Withdrawal by Subject|1
6108001|NCT00187135|21068727|P6|Visit Two|Physician Decision|0
6108002|NCT00187135|21068728|P5|Visit Two|Physician Decision|0
6108003|NCT00187135|21068729|P4|Visit Two|Physician Decision|0
6108004|NCT00187135|21068730|P3|Visit Two|Physician Decision|0
6108005|NCT00187135|21068731|P2|Visit Two|Physician Decision|0
6108006|NCT00187135|21068732|P1|Visit Two|Physician Decision|1
6108007|NCT00187135|21068727|P6|Visit Two|Death|1
6108008|NCT00187135|21068728|P5|Visit Two|Death|0
6108009|NCT00187135|21068729|P4|Visit Two|Death|1
6108010|NCT00187135|21068730|P3|Visit Two|Death|0
6108011|NCT00187135|21068731|P2|Visit Two|Death|0
6108012|NCT00187135|21068732|P1|Visit Two|Death|0
6108013|NCT00187135|21068727|P6|Visit One|Physician Decision|1
6108014|NCT00187135|21068728|P5|Visit One|Physician Decision|0
6108015|NCT00187135|21068729|P4|Visit One|Physician Decision|0
6108016|NCT00187135|21068730|P3|Visit One|Physician Decision|0
6108017|NCT00187135|21068731|P2|Visit One|Physician Decision|1
6108018|NCT00187135|21068732|P1|Visit One|Physician Decision|3
6108019|NCT00187135|21068727|P6|Visit One|Withdrawal by Subject|1
6108020|NCT00187135|21068728|P5|Visit One|Withdrawal by Subject|0
6108021|NCT00187135|21068729|P4|Visit One|Withdrawal by Subject|0
6108022|NCT00187135|21068730|P3|Visit One|Withdrawal by Subject|0
6108023|NCT00187135|21068731|P2|Visit One|Withdrawal by Subject|0
6108024|NCT00187135|21068732|P1|Visit One|Withdrawal by Subject|1
6108025|NCT00187096|21068755|P3|Overall Study|unacceptable toxicity|1
6108026|NCT00187096|21068756|P2|Overall Study|unacceptable toxicity|0
6108027|NCT00187096|21068757|P1|Overall Study|unacceptable toxicity|0
6108028|NCT00186901|21068795|P3|Overall Study|Bone Mineral Density > 0|149
6108029|NCT00186901|21068796|P2|Overall Study|Bone Mineral Density > 0|0
6108030|NCT00186901|21068797|P1|Overall Study|Bone Mineral Density > 0|0
6108031|NCT00186901|21068795|P3|Overall Study|Limited adherence to study requirements|0
6108032|NCT00186901|21068796|P2|Overall Study|Limited adherence to study requirements|23
6108033|NCT00186901|21068797|P1|Overall Study|Limited adherence to study requirements|20
6108034|NCT00186901|21068795|P3|Overall Study|Open label|0
6108035|NCT00186901|21068796|P2|Overall Study|Open label|2
6108036|NCT00186901|21068797|P1|Overall Study|Open label|3
6108037|NCT00186901|21068795|P3|Overall Study|Withdrawal by Subject|0
6108038|NCT00186901|21068796|P2|Overall Study|Withdrawal by Subject|5
6108039|NCT00186901|21068797|P1|Overall Study|Withdrawal by Subject|4
6108040|NCT00186901|21068795|P3|Overall Study|ALL relapse or second malignancy|0
6108041|NCT00186901|21068796|P2|Overall Study|ALL relapse or second malignancy|2
6108042|NCT00186901|21068797|P1|Overall Study|ALL relapse or second malignancy|1
6108043|NCT00186901|21068795|P3|Overall Study|Bone Mineral Density dropped > 5%|0
6108044|NCT00186901|21068796|P2|Overall Study|Bone Mineral Density dropped > 5%|7
6108045|NCT00186901|21068797|P1|Overall Study|Bone Mineral Density dropped > 5%|9
6108046|NCT00186901|21068795|P3|Overall Study|Lost to Follow-up|0
6108047|NCT00186901|21068796|P2|Overall Study|Lost to Follow-up|3
6108048|NCT00186901|21068797|P1|Overall Study|Lost to Follow-up|6
6108049|NCT00186901|21068795|P3|Overall Study|Pregnancy|0
6108050|NCT00186901|21068796|P2|Overall Study|Pregnancy|3
6108051|NCT00186901|21068797|P1|Overall Study|Pregnancy|6
6108058|NCT00186628|21068931|P1|Overall Study|Withdrawal by subject (before treatment)|1
6108059|NCT00186628|21068931|P1|Overall Study|Death|2
6108060|NCT00186537|21068942|P3|Overall Study|ALT > 1.5 x ULN|0
6108061|NCT00186537|21068943|P2|Overall Study|ALT > 1.5 x ULN|0
6108062|NCT00186537|21068944|P1|Overall Study|ALT > 1.5 x ULN|3
6108063|NCT00186537|21068942|P3|Overall Study|Withdrawal by Subject|3
6108064|NCT00186537|21068943|P2|Overall Study|Withdrawal by Subject|0
6108065|NCT00186537|21068944|P1|Overall Study|Withdrawal by Subject|4
6108066|NCT00186485|21068967|P1|Overall Study|Lost to Follow-up|3
6108067|NCT00186186|21068979|P1|Overall Study|Not reported as to reason|2
6108068|NCT00186186|21068979|P1|Overall Study|Withdrawal by Subject|3
6108069|NCT00186186|21068979|P1|Overall Study|Lack of Efficacy|3
6108070|NCT00186121|21068984|P1|Overall Study|Not eligible (no treatment)|1
6108071|NCT00186121|21068984|P1|Overall Study|Underwent oophorectomy (no treatment)|1
6108072|NCT00186121|21068984|P1|Overall Study|Subject withdrawal (no treatment)|1
6108073|NCT00186043|21069018|P2|Overall Study|Protocol Violation|1
6108074|NCT00186043|21069019|P1|Overall Study|Protocol Violation|2
6108075|NCT00186043|21069018|P2|Overall Study|Adverse Event|3
6108076|NCT00186043|21069019|P1|Overall Study|Adverse Event|7
6108077|NCT00186043|21069018|P2|Overall Study|Withdrawal by Subject|0
6108078|NCT00186043|21069019|P1|Overall Study|Withdrawal by Subject|1
6108079|NCT00186043|21069018|P2|Overall Study|Lost to Follow-up|6
6108080|NCT00186043|21069019|P1|Overall Study|Lost to Follow-up|4
6108081|NCT00186043|21069018|P2|Overall Study|Lack of Efficacy|3
6108082|NCT00186043|21069019|P1|Overall Study|Lack of Efficacy|1
6108083|NCT00185965|21069046|P2|Overall Study|Adverse Event|1
6108084|NCT00185965|21069047|P1|Overall Study|Adverse Event|0
6108085|NCT00185731|21069072|P1|Overall Study|Not Eligible|1
6108086|NCT00185731|21069072|P1|Overall Study|Withdrawal by Subject|1
6108087|NCT00185640|21069089|P1|Overall Study|Death|138
6108088|NCT00185640|21069089|P1|Overall Study|Withdrawal by Subject|3
6108089|NCT00185640|21069089|P1|Overall Study|Not Eligible|4
6108090|NCT00185614|21069098|P1|Inter-treatment Period|Lack of allogenic donor|1
6108091|NCT00185614|21069098|P1|Inter-treatment Period|Relapse|2
6108092|NCT00185614|21069098|P1|Inter-treatment Period|Physician Decision|1
6108093|NCT00185588|21069110|P4|Overall Study|Physician Decision|0
6108094|NCT00185588|21069111|P3|Overall Study|Physician Decision|1
6108095|NCT00185588|21069112|P2|Overall Study|Physician Decision|0
6108096|NCT00185588|21069113|P1|Overall Study|Physician Decision|0
6108097|NCT00185588|21069110|P4|Overall Study|Withdrawal by Subject|0
6108098|NCT00185588|21069111|P3|Overall Study|Withdrawal by Subject|0
6108099|NCT00185588|21069112|P2|Overall Study|Withdrawal by Subject|1
6108100|NCT00185588|21069113|P1|Overall Study|Withdrawal by Subject|0
6108101|NCT00185588|21069110|P4|Overall Study|Lost to Follow-up|2
6108102|NCT00185588|21069111|P3|Overall Study|Lost to Follow-up|1
6108103|NCT00185588|21069112|P2|Overall Study|Lost to Follow-up|0
6108104|NCT00185588|21069113|P1|Overall Study|Lost to Follow-up|0
6108105|NCT00185588|21069110|P4|Overall Study|Adverse Event|2
6108106|NCT00185588|21069111|P3|Overall Study|Adverse Event|4
6108107|NCT00185588|21069112|P2|Overall Study|Adverse Event|1
6108108|NCT00185588|21069113|P1|Overall Study|Adverse Event|3
6108109|NCT00185458|21069127|P1|HRT Phase|Withdrawal by Subject|3
6108110|NCT00185458|21069127|P1|HRT Phase|Protocol Violation|2
6108111|NCT00185458|21069127|P1|HRT Phase|Lost to Follow-up|4
6108112|NCT00185458|21069127|P1|HRT Phase|Adverse Event|18
6108113|NCT00185458|21069127|P1|Contraception Phase|Withdrawal by Subject|7
6108114|NCT00185458|21069127|P1|Contraception Phase|Physician Decision|2
6108115|NCT00185458|21069127|P1|Contraception Phase|Protocol Violation|2
6108116|NCT00185458|21069127|P1|Contraception Phase|Lost to Follow-up|10
6108117|NCT00185458|21069127|P1|Contraception Phase|Adverse Event|37
6108118|NCT00185380|21069190|P3|Overall Study|personal reason|1
6108119|NCT00185380|21069191|P2|Overall Study|personal reason|1
6108120|NCT00185380|21069192|P1|Overall Study|personal reason|6
6108121|NCT00185380|21069190|P3|Overall Study|Could not attend visits|4
6108122|NCT00185380|21069191|P2|Overall Study|Could not attend visits|0
6108123|NCT00185380|21069192|P1|Overall Study|Could not attend visits|2
6108124|NCT00185380|21069190|P3|Overall Study|No need for contraception|3
6108125|NCT00185380|21069191|P2|Overall Study|No need for contraception|3
6108126|NCT00185380|21069192|P1|Overall Study|No need for contraception|3
6108127|NCT00185380|21069190|P3|Overall Study|Planned pregnancy|12
6108128|NCT00185380|21069191|P2|Overall Study|Planned pregnancy|12
6108129|NCT00185380|21069192|P1|Overall Study|Planned pregnancy|9
6108130|NCT00185380|21069190|P3|Overall Study|Failed insertion|2
6108131|NCT00185380|21069191|P2|Overall Study|Failed insertion|1
6108132|NCT00185380|21069192|P1|Overall Study|Failed insertion|1
6108133|NCT00185380|21069190|P3|Overall Study|Withdrawal by Subject|0
6108134|NCT00185380|21069191|P2|Overall Study|Withdrawal by Subject|2
6108135|NCT00185380|21069192|P1|Overall Study|Withdrawal by Subject|1
6108136|NCT00185380|21069190|P3|Overall Study|Protocol Violation|1
6108137|NCT00185380|21069191|P2|Overall Study|Protocol Violation|2
6108138|NCT00185380|21069192|P1|Overall Study|Protocol Violation|2
6108139|NCT00185380|21069190|P3|Overall Study|Pregnancy|0
6108140|NCT00185380|21069191|P2|Overall Study|Pregnancy|4
6108141|NCT00185380|21069192|P1|Overall Study|Pregnancy|1
6108142|NCT00185380|21069190|P3|Overall Study|Lost to Follow-up|3
6108143|NCT00185380|21069191|P2|Overall Study|Lost to Follow-up|4
6108144|NCT00185380|21069192|P1|Overall Study|Lost to Follow-up|0
6108145|NCT00185380|21069190|P3|Overall Study|Adverse Event|48
6108146|NCT00185380|21069191|P2|Overall Study|Adverse Event|43
6108147|NCT00185380|21069192|P1|Overall Study|Adverse Event|41
6108148|NCT00185211|21069220|P2|Follow-up Study (91031 - This Study)|other disease modif. treatment|2
6108149|NCT00185211|21069221|P1|Follow-up Study (91031 - This Study)|other disease modif. treatment|0
6108150|NCT00185211|21069220|P2|Follow-up Study (91031 - This Study)|Withdrawal by Subject|21
6108151|NCT00185211|21069221|P1|Follow-up Study (91031 - This Study)|Withdrawal by Subject|13
6108152|NCT00185211|21069220|P2|Follow-up Study (91031 - This Study)|Pregnancy|1
6108153|NCT00185211|21069221|P1|Follow-up Study (91031 - This Study)|Pregnancy|0
6108154|NCT00185211|21069220|P2|Follow-up Study (91031 - This Study)|Physician Decision|0
6108155|NCT00185211|21069221|P1|Follow-up Study (91031 - This Study)|Physician Decision|1
6108156|NCT00185211|21069220|P2|Follow-up Study (91031 - This Study)|Lost to Follow-up|4
6108157|NCT00185211|21069221|P1|Follow-up Study (91031 - This Study)|Lost to Follow-up|6
6108158|NCT00185211|21069220|P2|Follow-up Study (91031 - This Study)|Lack of Efficacy|0
6108159|NCT00185211|21069221|P1|Follow-up Study (91031 - This Study)|Lack of Efficacy|1
6108160|NCT00185211|21069220|P2|Follow-up Study (91031 - This Study)|Adverse Event|6
6108161|NCT00185211|21069221|P1|Follow-up Study (91031 - This Study)|Adverse Event|5
6108162|NCT00185211|21069220|P2|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|0
6108163|NCT00185211|21069221|P1|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|1
6108164|NCT00185211|21069220|P2|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|1
6108165|NCT00185211|21069221|P1|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|0
6108166|NCT00185211|21069220|P2|Placebo-controlled Study (92012)|Withdrawal by Subject|7
6108167|NCT00185211|21069221|P1|Placebo-controlled Study (92012)|Withdrawal by Subject|9
6108168|NCT00185211|21069220|P2|Placebo-controlled Study (92012)|Lost to Follow-up|2
6108169|NCT00185211|21069221|P1|Placebo-controlled Study (92012)|Lost to Follow-up|3
6108170|NCT00185211|21069220|P2|Placebo-controlled Study (92012)|Adverse Event|0
6108171|NCT00185211|21069221|P1|Placebo-controlled Study (92012)|Adverse Event|8
6108172|NCT00184600|21069294|P3|Overall Study|Unclassified|3
6108173|NCT00184600|21069295|P2|Overall Study|Unclassified|5
6108174|NCT00184600|21069296|P1|Overall Study|Unclassified|4
6108175|NCT00184600|21069294|P3|Overall Study|Withdrawal by Subject|12
6108176|NCT00184600|21069295|P2|Overall Study|Withdrawal by Subject|28
6108177|NCT00184600|21069296|P1|Overall Study|Withdrawal by Subject|20
6108178|NCT00184600|21069294|P3|Overall Study|Protocol Violation|3
6108179|NCT00184600|21069295|P2|Overall Study|Protocol Violation|2
6108180|NCT00184600|21069296|P1|Overall Study|Protocol Violation|2
6108181|NCT00184600|21069294|P3|Overall Study|Lost to Follow-up|1
6108182|NCT00184600|21069295|P2|Overall Study|Lost to Follow-up|6
6108183|NCT00184600|21069296|P1|Overall Study|Lost to Follow-up|4
6108184|NCT00184600|21069294|P3|Overall Study|Lack of Efficacy|3
6108185|NCT00184600|21069295|P2|Overall Study|Lack of Efficacy|1
6108186|NCT00184600|21069296|P1|Overall Study|Lack of Efficacy|3
6108187|NCT00184600|21069294|P3|Overall Study|Death|7
6108188|NCT00184600|21069295|P2|Overall Study|Death|9
6108189|NCT00184600|21069296|P1|Overall Study|Death|3
6108190|NCT00184600|21069294|P3|Overall Study|Adverse Event|5
6108191|NCT00184600|21069295|P2|Overall Study|Adverse Event|0
6108192|NCT00184600|21069296|P1|Overall Study|Adverse Event|9
6108193|NCT00184093|21069387|P1|Overall Study|Withdrawal by Subject|2
6108194|NCT00184093|21069387|P1|Overall Study|Physician Decision|1
6108195|NCT00184093|21069387|P1|Overall Study|Lost to Follow-up|3
6108196|NCT00184093|21069387|P1|Overall Study|Adverse Event|3
6108197|NCT00184054|21069392|P1|Overall Study|Adverse Event|1
6108198|NCT00184028|21069397|P1|Overall Study|Non-compliance|2
6108199|NCT00184028|21069397|P1|Overall Study|Withdrawal by Subject|1
6108200|NCT00184028|21069397|P1|Overall Study|Adverse Event|2
6108201|NCT00184028|21069397|P1|Overall Study|Lack of Efficacy|4
6108202|NCT00184028|21069397|P1|Overall Study|Death|1
6108203|NCT00184002|21069402|P1|Overall Study|Withdrawal by Subject|4
6108204|NCT00184002|21069402|P1|Overall Study|Physician Decision|1
6108205|NCT00184002|21069402|P1|Overall Study|Death|3
6108206|NCT00184002|21069402|P1|Overall Study|Adverse Event|9
6108207|NCT00183872|21069428|P1|Overall Study|Drug delayed more than 28 days|2
6108208|NCT00183872|21069428|P1|Overall Study|Withdrawal by Subject|2
6108209|NCT00183872|21069428|P1|Overall Study|Adverse Event|9
6108210|NCT00183872|21069428|P1|Overall Study|Death|3
6108211|NCT00183625|21069457|P4|Overall Study|Withdrawal by Subject|14
6108212|NCT00183625|21069458|P3|Overall Study|Withdrawal by Subject|19
6108213|NCT00183625|21069459|P2|Overall Study|Withdrawal by Subject|18
6108214|NCT00183625|21069460|P1|Overall Study|Withdrawal by Subject|18
6108215|NCT00183430|21069557|P2|Overall Study|Withdrawal by Subject|0
6108216|NCT00183430|21069558|P1|Overall Study|Withdrawal by Subject|1
6108217|NCT00183430|21069557|P2|Overall Study|did not meet inclusion criteria|0
6108218|NCT00183430|21069558|P1|Overall Study|did not meet inclusion criteria|1
6108219|NCT00183430|21069557|P2|Overall Study|Lost to Follow-up|0
6108220|NCT00183430|21069558|P1|Overall Study|Lost to Follow-up|3
6108221|NCT00183430|21069557|P2|Overall Study|Adverse Event|0
6108222|NCT00183430|21069558|P1|Overall Study|Adverse Event|1
6108223|NCT00183391|21069570|P2|Block 2 - 5 Weeks|Withdrawal by Subject|2
6108224|NCT00183391|21069571|P1|Block 2 - 5 Weeks|Withdrawal by Subject|4
6108225|NCT00183391|21069570|P2|Block 1 - 5 Weeks|Withdrawal by Subject|14
6108226|NCT00183391|21069571|P1|Block 1 - 5 Weeks|Withdrawal by Subject|13
6108227|NCT00183274|21069644|P6|Phase 3: Double-Blind|Relapsed|2
6108228|NCT00183274|21069645|P5|Phase 3: Double-Blind|Relapsed|11
6108229|NCT00183274|21069646|P4|Phase 3: Double-Blind|Relapsed|1
6108230|NCT00183274|21069647|P3|Phase 3: Double-Blind|Relapsed|0
6108231|NCT00183274|21069648|P2|Phase 3: Double-Blind|Relapsed|0
6108232|NCT00183274|21069649|P1|Phase 3: Double-Blind|Relapsed|0
6108233|NCT00183274|21069644|P6|Phase 3: Double-Blind|Withdrawal by Subject|2
6108234|NCT00183274|21069645|P5|Phase 3: Double-Blind|Withdrawal by Subject|9
6108235|NCT00183274|21069646|P4|Phase 3: Double-Blind|Withdrawal by Subject|1
6108236|NCT00183274|21069647|P3|Phase 3: Double-Blind|Withdrawal by Subject|0
6108237|NCT00183274|21069648|P2|Phase 3: Double-Blind|Withdrawal by Subject|0
6108238|NCT00183274|21069649|P1|Phase 3: Double-Blind|Withdrawal by Subject|0
6108239|NCT00183274|21069644|P6|Phase 2: Double-Blind|Withdrawal by Subject|0
6108240|NCT00183274|21069645|P5|Phase 2: Double-Blind|Withdrawal by Subject|0
6108241|NCT00183274|21069646|P4|Phase 2: Double-Blind|Withdrawal by Subject|0
6108242|NCT00183274|21069647|P3|Phase 2: Double-Blind|Withdrawal by Subject|14
6108243|NCT00183274|21069648|P2|Phase 2: Double-Blind|Withdrawal by Subject|18
6108244|NCT00183274|21069649|P1|Phase 2: Double-Blind|Withdrawal by Subject|0
6108245|NCT00183274|21069644|P6|Phase 2: Double-Blind|Relapsed|0
6108246|NCT00183274|21069645|P5|Phase 2: Double-Blind|Relapsed|0
6108247|NCT00183274|21069646|P4|Phase 2: Double-Blind|Relapsed|0
6108248|NCT00183274|21069647|P3|Phase 2: Double-Blind|Relapsed|29
6108249|NCT00183274|21069648|P2|Phase 2: Double-Blind|Relapsed|8
6108250|NCT00183274|21069649|P1|Phase 2: Double-Blind|Relapsed|0
6108251|NCT00183274|21069644|P6|Phase 1: Open-Label|Other|0
6108252|NCT00183274|21069645|P5|Phase 1: Open-Label|Other|0
6108253|NCT00183274|21069646|P4|Phase 1: Open-Label|Other|0
6108254|NCT00183274|21069647|P3|Phase 1: Open-Label|Other|0
6108255|NCT00183274|21069648|P2|Phase 1: Open-Label|Other|0
6108256|NCT00183274|21069649|P1|Phase 1: Open-Label|Other|9
6108257|NCT00183274|21069644|P6|Phase 1: Open-Label|Lost to Follow-up|0
6108258|NCT00183274|21069645|P5|Phase 1: Open-Label|Lost to Follow-up|0
6108259|NCT00183274|21069646|P4|Phase 1: Open-Label|Lost to Follow-up|0
6108260|NCT00183274|21069647|P3|Phase 1: Open-Label|Lost to Follow-up|0
6108261|NCT00183274|21069648|P2|Phase 1: Open-Label|Lost to Follow-up|0
6108262|NCT00183274|21069649|P1|Phase 1: Open-Label|Lost to Follow-up|33
6108263|NCT00183274|21069644|P6|Phase 1: Open-Label|Withdrawal by Subject|0
6108264|NCT00183274|21069645|P5|Phase 1: Open-Label|Withdrawal by Subject|0
6108265|NCT00183274|21069646|P4|Phase 1: Open-Label|Withdrawal by Subject|0
6108266|NCT00183274|21069647|P3|Phase 1: Open-Label|Withdrawal by Subject|0
6108267|NCT00183274|21069648|P2|Phase 1: Open-Label|Withdrawal by Subject|0
6108268|NCT00183274|21069649|P1|Phase 1: Open-Label|Withdrawal by Subject|13
6108269|NCT00183274|21069644|P6|Phase 1: Open-Label|Protocol Violation|0
6108270|NCT00183274|21069645|P5|Phase 1: Open-Label|Protocol Violation|0
6108271|NCT00183274|21069646|P4|Phase 1: Open-Label|Protocol Violation|0
6108272|NCT00183274|21069647|P3|Phase 1: Open-Label|Protocol Violation|0
6108273|NCT00183274|21069648|P2|Phase 1: Open-Label|Protocol Violation|0
6108274|NCT00183274|21069649|P1|Phase 1: Open-Label|Protocol Violation|11
6108275|NCT00183274|21069644|P6|Phase 1: Open-Label|Lack of Efficacy|0
6108276|NCT00183274|21069645|P5|Phase 1: Open-Label|Lack of Efficacy|0
6108277|NCT00183274|21069646|P4|Phase 1: Open-Label|Lack of Efficacy|0
6108278|NCT00183274|21069647|P3|Phase 1: Open-Label|Lack of Efficacy|0
6108279|NCT00183274|21069648|P2|Phase 1: Open-Label|Lack of Efficacy|0
6108280|NCT00183274|21069649|P1|Phase 1: Open-Label|Lack of Efficacy|13
6108281|NCT00183274|21069644|P6|Phase 1: Open-Label|Adverse Event|0
6108282|NCT00183274|21069645|P5|Phase 1: Open-Label|Adverse Event|0
6108283|NCT00183274|21069646|P4|Phase 1: Open-Label|Adverse Event|0
6108284|NCT00183274|21069647|P3|Phase 1: Open-Label|Adverse Event|0
6108285|NCT00183274|21069648|P2|Phase 1: Open-Label|Adverse Event|0
6108286|NCT00183274|21069649|P1|Phase 1: Open-Label|Adverse Event|31
6108287|NCT00183248|21069666|P2|Overall Study|Focal glomerulosclerosis proteinuria|0
6108288|NCT00183248|21069667|P1|Overall Study|Focal glomerulosclerosis proteinuria|1
6108289|NCT00183248|21069666|P2|Overall Study|Lost to Follow-up|1
6108290|NCT00183248|21069667|P1|Overall Study|Lost to Follow-up|0
6108291|NCT00183196|21069688|P3|Overall Study|Required more intensive care|2
6108292|NCT00183196|21069689|P2|Overall Study|Required more intensive care|1
6108293|NCT00183196|21069690|P1|Overall Study|Required more intensive care|0
6108294|NCT00183196|21069688|P3|Overall Study|Legal event|1
6108295|NCT00183196|21069689|P2|Overall Study|Legal event|1
6108296|NCT00183196|21069690|P1|Overall Study|Legal event|1
6108297|NCT00183196|21069688|P3|Overall Study|Adverse Event|2
6108298|NCT00183196|21069689|P2|Overall Study|Adverse Event|2
6108299|NCT00183196|21069690|P1|Overall Study|Adverse Event|1
6108300|NCT00183196|21069688|P3|Overall Study|Withdrawal by Subject|13
6108301|NCT00183196|21069689|P2|Overall Study|Withdrawal by Subject|11
6108302|NCT00183196|21069690|P1|Overall Study|Withdrawal by Subject|18
6108303|NCT00183170|21069700|P2|Second Intervention|Did not meet targeted BrAC|2
6108304|NCT00183170|21069701|P1|Second Intervention|Did not meet targeted BrAC|0
6108305|NCT00183170|21069700|P2|Second Intervention|Did not complete study|0
6108306|NCT00183170|21069701|P1|Second Intervention|Did not complete study|1
6108307|NCT00183170|21069700|P2|Washout 1 Week|Did not complete study|8
6108308|NCT00183170|21069701|P1|Washout 1 Week|Did not complete study|6
6108309|NCT00183170|21069700|P2|First Intervention|Did not meet targeted BrAC|0
6108310|NCT00183170|21069701|P1|First Intervention|Did not meet targeted BrAC|1
6108311|NCT00183170|21069700|P2|First Intervention|Did not complete study|0
6108312|NCT00183170|21069701|P1|First Intervention|Did not complete study|1
6108313|NCT00182689|21069790|P2|Overall Study|Never received treatment|0
6108314|NCT00182689|21069791|P1|Overall Study|Never received treatment|1
6108315|NCT00182689|21069790|P2|Overall Study|Ineligible|4
6108316|NCT00182689|21069791|P1|Overall Study|Ineligible|1
6108317|NCT00182689|21069790|P2|Overall Study|not protocol specified|3
6108318|NCT00182689|21069791|P1|Overall Study|not protocol specified|0
6108319|NCT00182689|21069790|P2|Overall Study|Death|0
6108320|NCT00182689|21069791|P1|Overall Study|Death|1
6108321|NCT00182689|21069790|P2|Overall Study|Progression|29
6108322|NCT00182689|21069791|P1|Overall Study|Progression|27
6108323|NCT00182689|21069790|P2|Overall Study|Withdrawal by Subject|2
6108324|NCT00182689|21069791|P1|Overall Study|Withdrawal by Subject|2
6108325|NCT00182689|21069790|P2|Overall Study|Adverse Event|11
6108326|NCT00182689|21069791|P1|Overall Study|Adverse Event|8
6108327|NCT00182637|21069801|P1|Overall Study|Disease Progression|1
6108328|NCT00182637|21069801|P1|Overall Study|Adverse Event|2
6108329|NCT00182325|21069809|P2|Overall Study|Did not complete survey|43
6108330|NCT00182325|21069810|P1|Overall Study|Did not complete survey|22
6108331|NCT00182325|21069809|P2|Overall Study|Miscarriage|3
6108332|NCT00182325|21069810|P1|Overall Study|Miscarriage|5
6108333|NCT00182325|21069809|P2|Overall Study|Lost to Follow-up|7
6108334|NCT00182325|21069810|P1|Overall Study|Lost to Follow-up|7
6108335|NCT00182091|21069838|P4|Overall Study|Withdrawal by Subject|0
6108336|NCT00182091|21069839|P3|Overall Study|Withdrawal by Subject|0
6108337|NCT00182091|21069840|P2|Overall Study|Withdrawal by Subject|0
6108338|NCT00182091|21069841|P1|Overall Study|Withdrawal by Subject|1
6108339|NCT00182078|21069857|P2|Overall Study|Withdrawal by Subject|0
6108340|NCT00182078|21069858|P1|Overall Study|Withdrawal by Subject|1
6108341|NCT00181883|21069886|P1|Overall Study|Lost to Follow-up|1
6108342|NCT00181883|21069886|P1|Overall Study|Withdrawal by Subject|4
6108343|NCT00181883|21069886|P1|Overall Study|Treatment Limiting AEs|3
6108344|NCT00181883|21069886|P1|Overall Study|Lack of Efficacy|2
6108345|NCT00181844|21069890|P1|Exposed to Study Medication|Difficulty meeting study schedule|2
6108346|NCT00181844|21069890|P1|Exposed to Study Medication|Withdrawal by Subject|1
6108347|NCT00181844|21069890|P1|Exposed to Study Medication|Non-compliance|2
6108348|NCT00181844|21069890|P1|Exposed to Study Medication|Lack of Efficacy|2
6108349|NCT00181844|21069890|P1|Exposed to Study Medication|Adverse Event|10
6108350|NCT00181844|21069890|P1|Signed Consent|Did not meet entrance criteria|7
6108351|NCT00181844|21069890|P1|Signed Consent|Withdrawal by Subject|5
6108352|NCT00181766|21069894|P1|Overall Study|non-compliance|2
6108353|NCT00181766|21069894|P1|Overall Study|Adverse Event|4
6108354|NCT00181766|21069894|P1|Overall Study|Lost to Follow-up|6
6108355|NCT00181155|21069968|P2|Overall Study|Withdrawal by Subject|0
6108356|NCT00181155|21069969|P1|Overall Study|Withdrawal by Subject|1
6108357|NCT00181155|21069968|P2|Overall Study|Physician Decision|0
6108358|NCT00181155|21069969|P1|Overall Study|Physician Decision|1
6108359|NCT00180713|21069979|P2|Overall Study|Adverse Event|3
6108360|NCT00180713|21069980|P1|Overall Study|Adverse Event|3
6108361|NCT00180713|21069979|P2|Overall Study|Withdrawal by Subject|0
6108362|NCT00180713|21069980|P1|Overall Study|Withdrawal by Subject|2
6108363|NCT00180674|21070023|P1|Phase 2, Warfarin Treatment Period|Adverse Event|1
6108364|NCT00180674|21070023|P1|Phase 1, Observation Period|Withdrawal by Subject|4
6108365|NCT00180479|21070052|P2|Overall Study|Informed consent not signed|1
6108366|NCT00180479|21070053|P1|Overall Study|Informed consent not signed|0
6108367|NCT00180479|21070052|P2|Overall Study|Withdrawal by Subject|3
6108368|NCT00180479|21070053|P1|Overall Study|Withdrawal by Subject|3
6108369|NCT00180479|21070052|P2|Overall Study|Lost to Follow-up|7
6108370|NCT00180479|21070053|P1|Overall Study|Lost to Follow-up|9
6108371|NCT00180479|21070052|P2|Overall Study|Death|2
6108372|NCT00180479|21070053|P1|Overall Study|Death|4
6108373|NCT00179959|21070178|P2|Overall Study|Withdrawal by Subject|2
6108374|NCT00179959|21070179|P1|Overall Study|Withdrawal by Subject|3
6108375|NCT00179959|21070178|P2|Overall Study|Lost to Follow-up|1
6108376|NCT00179959|21070179|P1|Overall Study|Lost to Follow-up|3
6108377|NCT00179673|21070185|P1|Overall Study|Other Observations and options|14
6108378|NCT00179673|21070185|P1|Overall Study|Death|4
6108379|NCT00179673|21070185|P1|Overall Study|Withdrawal by Subject|3
6108380|NCT00179673|21070185|P1|Overall Study|Lack of Efficacy|15
6108381|NCT00179673|21070185|P1|Overall Study|Adverse Event|7
6108382|NCT00179660|21070193|P1|Overall Study|Other - Unspecified|9
6108383|NCT00179660|21070193|P1|Overall Study|Death|3
6108384|NCT00179660|21070193|P1|Overall Study|Lost to Follow-up|1
6108385|NCT00179660|21070193|P1|Overall Study|Withdrawal by Subject|2
6108386|NCT00179660|21070193|P1|Overall Study|Lack of therapeutic effect|28
6108387|NCT00179660|21070193|P1|Overall Study|Adverse Event|7
6108388|NCT00179647|21070202|P1|Overall Study|Other|960
6108389|NCT00179647|21070202|P1|Overall Study|Death|94
6108390|NCT00179647|21070202|P1|Overall Study|Lost to Follow-up|4
6108391|NCT00179647|21070202|P1|Overall Study|Withdrawal by Subject|83
6108392|NCT00179647|21070202|P1|Overall Study|Lack of Efficacy|478
6108393|NCT00179647|21070202|P1|Overall Study|Adverse Event|294
6108394|NCT00179621|21070209|P4|Open-Label Period|Other|2
6108395|NCT00179621|21070210|P3|Open-Label Period|Other|1
6108396|NCT00179621|21070211|P2|Open-Label Period|Other|1
6108397|NCT00179621|21070212|P1|Open-Label Period|Other|0
6108398|NCT00179621|21070209|P4|Open-Label Period|Death|2
6108399|NCT00179621|21070210|P3|Open-Label Period|Death|1
6108400|NCT00179621|21070211|P2|Open-Label Period|Death|0
6108401|NCT00179621|21070212|P1|Open-Label Period|Death|0
6108402|NCT00179621|21070209|P4|Open-Label Period|Withdrawal by Subject|2
6108403|NCT00179621|21070210|P3|Open-Label Period|Withdrawal by Subject|2
6108404|NCT00179621|21070211|P2|Open-Label Period|Withdrawal by Subject|2
6108405|NCT00179621|21070212|P1|Open-Label Period|Withdrawal by Subject|0
6108406|NCT00179621|21070209|P4|Open-Label Period|Adverse Event|6
6108407|NCT00179621|21070210|P3|Open-Label Period|Adverse Event|5
6108408|NCT00179621|21070211|P2|Open-Label Period|Adverse Event|6
6108409|NCT00179621|21070212|P1|Open-Label Period|Adverse Event|0
6108410|NCT00179621|21070209|P4|Open-Label Period|Lack of Therapeutic Effect|31
6108411|NCT00179621|21070210|P3|Open-Label Period|Lack of Therapeutic Effect|19
6108412|NCT00179621|21070211|P2|Open-Label Period|Lack of Therapeutic Effect|19
6108413|NCT00179621|21070212|P1|Open-Label Period|Lack of Therapeutic Effect|0
6108414|NCT00179621|21070209|P4|Double-Blind Period|Other|0
6108415|NCT00179621|21070210|P3|Double-Blind Period|Other|2
6108416|NCT00179621|21070211|P2|Double-Blind Period|Other|2
6108417|NCT00179621|21070212|P1|Double-Blind Period|Other|0
6108418|NCT00179621|21070209|P4|Double-Blind Period|Protocol Violation|0
6108419|NCT00179621|21070210|P3|Double-Blind Period|Protocol Violation|0
6108420|NCT00179621|21070211|P2|Double-Blind Period|Protocol Violation|0
6108421|NCT00179621|21070212|P1|Double-Blind Period|Protocol Violation|1
6108422|NCT00179621|21070209|P4|Double-Blind Period|Death|0
6108423|NCT00179621|21070210|P3|Double-Blind Period|Death|2
6108424|NCT00179621|21070211|P2|Double-Blind Period|Death|1
6108425|NCT00179621|21070212|P1|Double-Blind Period|Death|0
6108426|NCT00179621|21070209|P4|Double-Blind Period|Withdrawal by Subject|0
6108427|NCT00179621|21070210|P3|Double-Blind Period|Withdrawal by Subject|3
6108428|NCT00179621|21070211|P2|Double-Blind Period|Withdrawal by Subject|1
6108429|NCT00179621|21070212|P1|Double-Blind Period|Withdrawal by Subject|2
6108430|NCT00179621|21070209|P4|Double-Blind Period|Adverse Event|0
6108431|NCT00179621|21070210|P3|Double-Blind Period|Adverse Event|4
6108432|NCT00179621|21070211|P2|Double-Blind Period|Adverse Event|7
6108433|NCT00179621|21070212|P1|Double-Blind Period|Adverse Event|2
6108434|NCT00179621|21070209|P4|Double-Blind Period|Lack of Therapeutic Effect|0
6108435|NCT00179621|21070210|P3|Double-Blind Period|Lack of Therapeutic Effect|19
6108436|NCT00179621|21070211|P2|Double-Blind Period|Lack of Therapeutic Effect|35
6108437|NCT00179621|21070212|P1|Double-Blind Period|Lack of Therapeutic Effect|59
6108438|NCT00179517|21070265|P2|Overall Study|Withdrawal by Subject|1
6108439|NCT00179517|21070266|P1|Overall Study|Withdrawal by Subject|2
6108440|NCT00179413|21070304|P2|Overall Study|Withdrawal by Subject|95
6108441|NCT00179413|21070305|P1|Overall Study|Withdrawal by Subject|87
6108442|NCT00179413|21070304|P2|Overall Study|Adverse Event|20
6108443|NCT00179413|21070305|P1|Overall Study|Adverse Event|38
6108444|NCT00179309|21070317|P2|Treatment|Allergy|0
6108445|NCT00179309|21070318|P1|Treatment|Allergy|1
6108446|NCT00179309|21070317|P2|Treatment|Withdrawal by Subject|2
6108447|NCT00179309|21070318|P1|Treatment|Withdrawal by Subject|1
6108448|NCT00179309|21070317|P2|Treatment|Toxicity|3
6108449|NCT00179309|21070318|P1|Treatment|Toxicity|2
6108450|NCT00179010|21070341|P2|Overall Study|Failure to place arterial line|1
6108451|NCT00179010|21070342|P1|Overall Study|Failure to place arterial line|0
6108452|NCT00179010|21070341|P2|Overall Study|Muscle probe defective|1
6108453|NCT00179010|21070342|P1|Overall Study|Muscle probe defective|1
6108454|NCT00178685|21070381|P3|Overall Study|Withdrawal by Subject|7
6108455|NCT00178685|21070382|P2|Overall Study|Withdrawal by Subject|14
6108456|NCT00178685|21070383|P1|Overall Study|Withdrawal by Subject|8
6108457|NCT00178685|21070381|P3|Overall Study|Lost to Follow-up|183
6108458|NCT00178685|21070382|P2|Overall Study|Lost to Follow-up|187
6108459|NCT00178685|21070383|P1|Overall Study|Lost to Follow-up|100
6108460|NCT00178685|21070381|P3|Overall Study|Death|6
6108461|NCT00178685|21070382|P2|Overall Study|Death|3
6108462|NCT00178685|21070383|P1|Overall Study|Death|3
6108463|NCT00178633|21070425|P1|Overall Study|Lost to Follow-up|6
6108464|NCT00178464|21070455|P1|Overall Study|Physician Decision|1
6108465|NCT00178464|21070455|P1|Overall Study|Withdrawal by Subject|1
6108466|NCT00178399|21070460|P1|Overall Study|Lost to Follow-up|1
6108467|NCT00178399|21070460|P1|Overall Study|Withdrawal by Subject|8
6108468|NCT00178399|21070460|P1|Overall Study|Physician Decision|4
6108469|NCT00178256|21070467|P4|Overall Study|Cancer progression|1
6108470|NCT00178256|21070468|P3|Overall Study|Cancer progression|0
6108471|NCT00178256|21070469|P2|Overall Study|Cancer progression|0
6108472|NCT00178256|21070470|P1|Overall Study|Cancer progression|2
6108473|NCT00178256|21070467|P4|Overall Study|Death|1
6108474|NCT00178256|21070468|P3|Overall Study|Death|0
6108475|NCT00178256|21070469|P2|Overall Study|Death|1
6108476|NCT00178256|21070470|P1|Overall Study|Death|0
6108477|NCT00178256|21070467|P4|Overall Study|Adverse Event|0
6108478|NCT00178256|21070468|P3|Overall Study|Adverse Event|0
6108479|NCT00178256|21070469|P2|Overall Study|Adverse Event|0
6108480|NCT00178256|21070470|P1|Overall Study|Adverse Event|2
6108481|NCT00178126|21070509|P2|Overall Study|did not receive intervention|6
6108482|NCT00178126|21070510|P1|Overall Study|did not receive intervention|4
6108483|NCT00178126|21070509|P2|Overall Study|Lost to Follow-up|21
6108484|NCT00178126|21070510|P1|Overall Study|Lost to Follow-up|21
6108485|NCT00177671|21070552|P2|Overall Study|Physician Decision|8
6108486|NCT00177671|21070553|P1|Overall Study|Physician Decision|12
6108487|NCT00177671|21070552|P2|Overall Study|Adverse Event|0
6108488|NCT00177671|21070553|P1|Overall Study|Adverse Event|6
6108489|NCT00177671|21070552|P2|Overall Study|medical complications|0
6108490|NCT00177671|21070553|P1|Overall Study|medical complications|2
6108491|NCT00177671|21070552|P2|Overall Study|Withdrawal by Subject|6
6108492|NCT00177671|21070553|P1|Overall Study|Withdrawal by Subject|5
6108493|NCT00177307|21070565|P1|Overall Study|Withdrawal by Subject|1
6108494|NCT00177294|21070574|P2|Overall Study|Withdrawal by Subject|5
6108495|NCT00177294|21070575|P1|Overall Study|Withdrawal by Subject|7
6108496|NCT00177216|21070589|P3|Overall Study|Withdrawal by Subject|1
6108497|NCT00177216|21070590|P2|Overall Study|Withdrawal by Subject|3
6108498|NCT00177216|21070591|P1|Overall Study|Withdrawal by Subject|6
6108499|NCT00177164|21070607|P2|Overall Study|Pregnancy|1
6108500|NCT00177164|21070608|P1|Overall Study|Pregnancy|0
6108501|NCT00177164|21070607|P2|Overall Study|Lack of Efficacy|1
6108502|NCT00177164|21070608|P1|Overall Study|Lack of Efficacy|2
6108503|NCT00177164|21070607|P2|Overall Study|discharge from hospital|0
6108504|NCT00177164|21070608|P1|Overall Study|discharge from hospital|1
6108505|NCT00177164|21070607|P2|Overall Study|Adverse Event|0
6108506|NCT00177164|21070608|P1|Overall Study|Adverse Event|1
6108507|NCT00177164|21070607|P2|Overall Study|increase in alcohol and drug use|2
6108508|NCT00177164|21070608|P1|Overall Study|increase in alcohol and drug use|1
6108509|NCT00177164|21070607|P2|Overall Study|Lost to Follow-up|5
6108510|NCT00177164|21070608|P1|Overall Study|Lost to Follow-up|4
6108511|NCT00177164|21070607|P2|Overall Study|Protocol Violation|7
6108512|NCT00177164|21070608|P1|Overall Study|Protocol Violation|0
6108513|NCT00176644|21070886|P1|Overall Study|Withdrawal by Subject|1
6108514|NCT00176605|21070899|P1|Overall Study|Withdrawal by Subject|2
6108515|NCT00176488|21070910|P1|Overall Study|Initiated Cycle 1 Day 1 only|1
6108516|NCT00176462|21070918|P2|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|3
6108517|NCT00176462|21070919|P1|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|0
6108518|NCT00176462|21070918|P2|Intensive Continuation (8X8-week Cycles)|Death|0
6108519|NCT00176462|21070919|P1|Intensive Continuation (8X8-week Cycles)|Death|1
6108520|NCT00176462|21070918|P2|Consolidation (12 Weeks)|Not documented|1
6108521|NCT00176462|21070919|P1|Consolidation (12 Weeks)|Not documented|0
6108522|NCT00176462|21070918|P2|Consolidation (12 Weeks)|Lack of Efficacy|2
6108523|NCT00176462|21070919|P1|Consolidation (12 Weeks)|Lack of Efficacy|0
6108524|NCT00176462|21070918|P2|Consolidation (12 Weeks)|Adverse Event|1
6108525|NCT00176462|21070919|P1|Consolidation (12 Weeks)|Adverse Event|0
6108526|NCT00176462|21070918|P2|Consolidation (12 Weeks)|Patient moved to another state|1
6108527|NCT00176462|21070919|P1|Consolidation (12 Weeks)|Patient moved to another state|0
6108528|NCT00176462|21070918|P2|Induction (4 Weeks)|Lack of Efficacy|1
6108529|NCT00176462|21070919|P1|Induction (4 Weeks)|Lack of Efficacy|0
6108530|NCT00176462|21070918|P2|Induction (4 Weeks)|Death|2
6108531|NCT00176462|21070919|P1|Induction (4 Weeks)|Death|1
6108532|NCT00176462|21070918|P2|Induction (4 Weeks)|Withdrawal by Subject|2
6108533|NCT00176462|21070919|P1|Induction (4 Weeks)|Withdrawal by Subject|0
6108534|NCT00176254|21070954|P1|Overall Study|Lost to Follow-up|1
6108535|NCT00175916|21070982|P1|Overall Study|Patient went to prison|1
6108536|NCT00175916|21070982|P1|Overall Study|Site was closed|9
6108537|NCT00175916|21070982|P1|Overall Study|Loss of job and economic burden|1
6108538|NCT00175916|21070982|P1|Overall Study|Moved overseas|1
6108539|NCT00175916|21070982|P1|Overall Study|Treating physiciant's choice|1
6108540|NCT00175916|21070982|P1|Overall Study|Patient's request|2
6108541|NCT00175916|21070982|P1|Overall Study|Pregnancy|1
6108542|NCT00175916|21070982|P1|Overall Study|Administrative reason|1
6108543|NCT00175916|21070982|P1|Overall Study|Seizure - free|4
6108544|NCT00175916|21070982|P1|Overall Study|Withdrawal by Subject|1
6108545|NCT00175916|21070982|P1|Overall Study|Suicidal behaviour|1
6108546|NCT00175916|21070982|P1|Overall Study|Vigabatrin intake|1
6108547|NCT00175916|21070982|P1|Overall Study|Sponsor decision|17
6108548|NCT00175916|21070982|P1|Overall Study|Patient cannot record seizures|1
6108549|NCT00175916|21070982|P1|Overall Study|Lack of compliance|8
6108550|NCT00175916|21070982|P1|Overall Study|Subject Choice|98
6108551|NCT00175916|21070982|P1|Overall Study|Lost to Follow-up|17
6108552|NCT00175916|21070982|P1|Overall Study|Lack of Efficacy|354
6108553|NCT00175916|21070982|P1|Overall Study|Adverse Event|81
6108554|NCT00175916|21070982|P1|Overall Study|Death|19
6108555|NCT00175877|21070991|P1|Overall Study|Withdrawal by subject & Other|1
6108556|NCT00175877|21070991|P1|Overall Study|AE & Other|1
6108557|NCT00175877|21070991|P1|Overall Study|Other Reason|20
6108558|NCT00175877|21070991|P1|Overall Study|Protocol Violation|15
6108559|NCT00175877|21070991|P1|Overall Study|Lack of Efficacy|26
6108560|NCT00175877|21070991|P1|Overall Study|Lost to Follow-up|9
6108561|NCT00175877|21070991|P1|Overall Study|Withdrawal by Subject|141
6108562|NCT00175877|21070991|P1|Overall Study|Adverse Event|136
6108563|NCT00175825|21071026|P4|Overall Study|Withdrawal by Subject|0
6108564|NCT00175825|21071027|P3|Overall Study|Withdrawal by Subject|0
6108565|NCT00175825|21071028|P2|Overall Study|Withdrawal by Subject|0
6108566|NCT00175825|21071029|P1|Overall Study|Withdrawal by Subject|1
6108567|NCT00175825|21071026|P4|Overall Study|Lost to Follow-up|0
6108568|NCT00175825|21071027|P3|Overall Study|Lost to Follow-up|0
6108569|NCT00175825|21071028|P2|Overall Study|Lost to Follow-up|2
6108570|NCT00175825|21071029|P1|Overall Study|Lost to Follow-up|1
6108571|NCT00175825|21071026|P4|Overall Study|Adverse Event|1
6108572|NCT00175825|21071027|P3|Overall Study|Adverse Event|1
6108573|NCT00175825|21071028|P2|Overall Study|Adverse Event|2
6108574|NCT00175825|21071029|P1|Overall Study|Adverse Event|3
6108575|NCT00175019|21071082|P3|Overall Study|Reason Not Specified|11
6108576|NCT00175019|21071083|P2|Overall Study|Reason Not Specified|34
6108577|NCT00175019|21071084|P1|Overall Study|Reason Not Specified|40
6108578|NCT00175019|21071082|P3|Overall Study|Gout Flare|0
6108579|NCT00175019|21071083|P2|Overall Study|Gout Flare|3
6108580|NCT00175019|21071084|P1|Overall Study|Gout Flare|2
6108581|NCT00175019|21071082|P3|Overall Study|Therapeutic Failure|22
6108582|NCT00175019|21071083|P2|Overall Study|Therapeutic Failure|38
6108583|NCT00175019|21071084|P1|Overall Study|Therapeutic Failure|10
6108584|NCT00175019|21071082|P3|Overall Study|Personal Reason(s)|8
6108585|NCT00175019|21071083|P2|Overall Study|Personal Reason(s)|31
6108586|NCT00175019|21071084|P1|Overall Study|Personal Reason(s)|39
6108587|NCT00175019|21071082|P3|Overall Study|Did not continue under Amendment 4|2
6108588|NCT00175019|21071083|P2|Overall Study|Did not continue under Amendment 4|1
6108589|NCT00175019|21071084|P1|Overall Study|Did not continue under Amendment 4|1
6108590|NCT00175019|21071082|P3|Overall Study|Lost to Follow-up|9
6108591|NCT00175019|21071083|P2|Overall Study|Lost to Follow-up|39
6108592|NCT00175019|21071084|P1|Overall Study|Lost to Follow-up|42
6108593|NCT00175019|21071082|P3|Overall Study|Protocol Violation|3
6108594|NCT00175019|21071083|P2|Overall Study|Protocol Violation|3
6108595|NCT00175019|21071084|P1|Overall Study|Protocol Violation|6
6108596|NCT00175019|21071082|P3|Overall Study|Adverse Event|2
6108597|NCT00175019|21071083|P2|Overall Study|Adverse Event|22
6108598|NCT00175019|21071084|P1|Overall Study|Adverse Event|54
6108599|NCT00174967|21071137|P4|Overall Study|Other|0
6108600|NCT00174967|21071138|P3|Overall Study|Other|0
6108601|NCT00174967|21071139|P2|Overall Study|Other|1
6108602|NCT00174967|21071140|P1|Overall Study|Other|0
6108603|NCT00174967|21071137|P4|Overall Study|Gout Flare|1
6108604|NCT00174967|21071138|P3|Overall Study|Gout Flare|0
6108605|NCT00174967|21071139|P2|Overall Study|Gout Flare|0
6108606|NCT00174967|21071140|P1|Overall Study|Gout Flare|0
6108607|NCT00174967|21071137|P4|Overall Study|Adverse Event|1
6108608|NCT00174967|21071138|P3|Overall Study|Adverse Event|2
6108609|NCT00174967|21071139|P2|Overall Study|Adverse Event|2
6108610|NCT00174967|21071140|P1|Overall Study|Adverse Event|1
6108611|NCT00174954|21071186|P1|Overall Study|Physician Decision|1
6108612|NCT00174954|21071186|P1|Overall Study|No tophi found in MRI|1
6108613|NCT00174954|21071186|P1|Overall Study|Adverse Event|2
6108614|NCT00174941|21071194|P4|Overall Study|Reason Not Specified|9
6108615|NCT00174941|21071195|P3|Overall Study|Reason Not Specified|2
6108616|NCT00174941|21071196|P2|Overall Study|Reason Not Specified|6
6108617|NCT00174941|21071197|P1|Overall Study|Reason Not Specified|1
6108618|NCT00174941|21071194|P4|Overall Study|Gout Flare|8
6108619|NCT00174941|21071195|P3|Overall Study|Gout Flare|4
6108620|NCT00174941|21071196|P2|Overall Study|Gout Flare|4
6108621|NCT00174941|21071197|P1|Overall Study|Gout Flare|0
6108622|NCT00174941|21071194|P4|Overall Study|Personal Reason(s)|22
6108623|NCT00174941|21071195|P3|Overall Study|Personal Reason(s)|8
6108624|NCT00174941|21071196|P2|Overall Study|Personal Reason(s)|14
6108625|NCT00174941|21071197|P1|Overall Study|Personal Reason(s)|0
6108626|NCT00174941|21071194|P4|Overall Study|Lost to Follow-up|5
6108627|NCT00174941|21071195|P3|Overall Study|Lost to Follow-up|2
6108628|NCT00174941|21071196|P2|Overall Study|Lost to Follow-up|3
6108629|NCT00174941|21071197|P1|Overall Study|Lost to Follow-up|0
6108630|NCT00174941|21071194|P4|Overall Study|Protocol Violation|1
6108631|NCT00174941|21071195|P3|Overall Study|Protocol Violation|0
6108632|NCT00174941|21071196|P2|Overall Study|Protocol Violation|1
6108633|NCT00174941|21071197|P1|Overall Study|Protocol Violation|0
6108634|NCT00174941|21071194|P4|Overall Study|Adverse Event|13
6108635|NCT00174941|21071195|P3|Overall Study|Adverse Event|2
6108636|NCT00174941|21071196|P2|Overall Study|Adverse Event|10
6108637|NCT00174941|21071197|P1|Overall Study|Adverse Event|1
6108638|NCT00174915|21071272|P5|Overall Study|Therapeutic Failure|3
6108639|NCT00174915|21071273|P4|Overall Study|Therapeutic Failure|1
6108640|NCT00174915|21071274|P3|Overall Study|Therapeutic Failure|2
6108641|NCT00174915|21071275|P2|Overall Study|Therapeutic Failure|3
6108642|NCT00174915|21071276|P1|Overall Study|Therapeutic Failure|6
6108643|NCT00174915|21071272|P5|Overall Study|Protocol Violation|3
6108644|NCT00174915|21071273|P4|Overall Study|Protocol Violation|6
6108645|NCT00174915|21071274|P3|Overall Study|Protocol Violation|3
6108646|NCT00174915|21071275|P2|Overall Study|Protocol Violation|3
6108647|NCT00174915|21071276|P1|Overall Study|Protocol Violation|6
6108648|NCT00174915|21071272|P5|Overall Study|Gout Flare|0
6108649|NCT00174915|21071273|P4|Overall Study|Gout Flare|1
6108650|NCT00174915|21071274|P3|Overall Study|Gout Flare|8
6108651|NCT00174915|21071275|P2|Overall Study|Gout Flare|6
6108652|NCT00174915|21071276|P1|Overall Study|Gout Flare|13
6108653|NCT00174915|21071272|P5|Overall Study|Other|3
6108654|NCT00174915|21071273|P4|Overall Study|Other|5
6108655|NCT00174915|21071274|P3|Overall Study|Other|6
6108656|NCT00174915|21071275|P2|Overall Study|Other|8
6108657|NCT00174915|21071276|P1|Overall Study|Other|15
6108658|NCT00174915|21071272|P5|Overall Study|Personal Reason(s)|9
6108659|NCT00174915|21071273|P4|Overall Study|Personal Reason(s)|9
6108660|NCT00174915|21071274|P3|Overall Study|Personal Reason(s)|9
6108661|NCT00174915|21071275|P2|Overall Study|Personal Reason(s)|16
6108662|NCT00174915|21071276|P1|Overall Study|Personal Reason(s)|16
6108663|NCT00174915|21071272|P5|Overall Study|Adverse Event|5
6108664|NCT00174915|21071273|P4|Overall Study|Adverse Event|18
6108665|NCT00174915|21071274|P3|Overall Study|Adverse Event|11
6108666|NCT00174915|21071275|P2|Overall Study|Adverse Event|16
6108667|NCT00174915|21071276|P1|Overall Study|Adverse Event|18
6108668|NCT00174915|21071272|P5|Overall Study|Lost to Follow-up|10
6108669|NCT00174915|21071273|P4|Overall Study|Lost to Follow-up|17
6108670|NCT00174915|21071274|P3|Overall Study|Lost to Follow-up|9
6108671|NCT00174915|21071275|P2|Overall Study|Lost to Follow-up|17
6108672|NCT00174915|21071276|P1|Overall Study|Lost to Follow-up|19
6108673|NCT00174785|21071335|P2|Overall Study|Not pre-specified/Not coded|70
6108674|NCT00174785|21071336|P1|Overall Study|Not pre-specified/Not coded|56
6108675|NCT00174785|21071335|P2|Overall Study|Family request|8
6108676|NCT00174785|21071336|P1|Overall Study|Family request|6
6108677|NCT00174785|21071335|P2|Overall Study|Other prohibited medication|3
6108678|NCT00174785|21071336|P1|Overall Study|Other prohibited medication|5
6108679|NCT00174785|21071335|P2|Overall Study|Prohibited antiarrhythmic medication|88
6108680|NCT00174785|21071336|P1|Overall Study|Prohibited antiarrhythmic medication|39
6108681|NCT00174785|21071335|P2|Overall Study|Atrial Fibrillation/Flutter recurrence|167
6108682|NCT00174785|21071336|P1|Overall Study|Atrial Fibrillation/Flutter recurrence|110
6108683|NCT00174785|21071335|P2|Overall Study|Withdrawal by Subject|175
6108684|NCT00174785|21071336|P1|Overall Study|Withdrawal by Subject|173
6108685|NCT00174785|21071335|P2|Overall Study|Protocol Violation|14
6108686|NCT00174785|21071336|P1|Overall Study|Protocol Violation|14
6108687|NCT00174785|21071335|P2|Overall Study|Adverse Event|191
6108688|NCT00174785|21071336|P1|Overall Study|Adverse Event|293
6108689|NCT00174460|21071352|P2|Overall Study|Withdrawal by Subject|1
6108690|NCT00174460|21071353|P1|Overall Study|Withdrawal by Subject|0
6108691|NCT00174447|21071399|P1|Overall Study|Administrative reason/Other|2
6108692|NCT00174447|21071399|P1|Overall Study|Lack of Efficacy|1
6108693|NCT00174447|21071399|P1|Overall Study|Protocol Violation|1
6108694|NCT00174447|21071399|P1|Overall Study|Withdrawal by Subject|15
6108695|NCT00174447|21071399|P1|Overall Study|Adverse Event|19
6108696|NCT00174382|21071408|P1|Overall Study|Lost to Follow-up|1
6108697|NCT00174382|21071408|P1|Overall Study|Subject felt pill not effective enough|1
6108698|NCT00174382|21071408|P1|Overall Study|Arrived early for last visit in error|1
6108699|NCT00174382|21071408|P1|Overall Study|Protocol Violation|3
6108700|NCT00174382|21071408|P1|Overall Study|Withdrawal by Subject|6
6108701|NCT00174382|21071408|P1|Overall Study|Adverse Event|19
6108702|NCT00174382|21071408|P1|Overall Study|Death|2
6108703|NCT00174291|21071427|P2|Overall Study|Withdrawal by Subject|3
6108704|NCT00174291|21071428|P1|Overall Study|Withdrawal by Subject|3
6108705|NCT00174291|21071427|P2|Overall Study|Study terminated by sponsor|0
6108706|NCT00174291|21071428|P1|Overall Study|Study terminated by sponsor|1
6108707|NCT00174291|21071427|P2|Overall Study|Protocol Violation|2
6108708|NCT00174291|21071428|P1|Overall Study|Protocol Violation|0
6108709|NCT00174291|21071427|P2|Overall Study|Lost to Follow-up|1
6108710|NCT00174291|21071428|P1|Overall Study|Lost to Follow-up|1
6108711|NCT00174265|21071458|P2|Overall Study|Other (Not specified)|10
6108712|NCT00174265|21071459|P1|Overall Study|Other (Not specified)|16
6108713|NCT00174265|21071458|P2|Overall Study|Lost to Follow-up|0
6108714|NCT00174265|21071459|P1|Overall Study|Lost to Follow-up|1
6108715|NCT00174265|21071458|P2|Overall Study|Withdrawal by Subject|5
6108716|NCT00174265|21071459|P1|Overall Study|Withdrawal by Subject|3
6108717|NCT00174265|21071458|P2|Overall Study|Lack of Efficacy|2
6108718|NCT00174265|21071459|P1|Overall Study|Lack of Efficacy|2
6108719|NCT00174265|21071458|P2|Overall Study|Adverse Event|4
6108720|NCT00174265|21071459|P1|Overall Study|Adverse Event|7
6108721|NCT00174252|21071467|P1|Overall Study|Protocol Violation|2
6108722|NCT00174187|21071502|P3|Period 2 (After 3 Years)|Other|5
6108723|NCT00174187|21071503|P2|Period 2 (After 3 Years)|Other|0
6108724|NCT00174187|21071504|P1|Period 2 (After 3 Years)|Other|0
6108725|NCT00174187|21071502|P3|Period 2 (After 3 Years)|Withdrawal by Subject|1
6108726|NCT00174187|21071503|P2|Period 2 (After 3 Years)|Withdrawal by Subject|0
6108727|NCT00174187|21071504|P1|Period 2 (After 3 Years)|Withdrawal by Subject|0
6108728|NCT00174187|21071502|P3|Period 2 (After 3 Years)|Lost to Follow-up|2
6108729|NCT00174187|21071503|P2|Period 2 (After 3 Years)|Lost to Follow-up|0
6108730|NCT00174187|21071504|P1|Period 2 (After 3 Years)|Lost to Follow-up|0
6108731|NCT00174187|21071502|P3|Between Period 1 and Period 2|Consented, not assigned to treatment|3
6108732|NCT00174187|21071503|P2|Between Period 1 and Period 2|Consented, not assigned to treatment|0
6108733|NCT00174187|21071504|P1|Between Period 1 and Period 2|Consented, not assigned to treatment|0
6108734|NCT00174187|21071502|P3|Between Period 1 and Period 2|Did not consent to continue treatment|2
6108735|NCT00174187|21071503|P2|Between Period 1 and Period 2|Did not consent to continue treatment|0
6108736|NCT00174187|21071504|P1|Between Period 1 and Period 2|Did not consent to continue treatment|0
6108737|NCT00174187|21071502|P3|Period 1 (up to 3 Years)|Other|0
6108738|NCT00174187|21071503|P2|Period 1 (up to 3 Years)|Other|1
6108739|NCT00174187|21071504|P1|Period 1 (up to 3 Years)|Other|0
6108740|NCT00174187|21071502|P3|Period 1 (up to 3 Years)|Withdrawal by Subject|0
6108741|NCT00174187|21071503|P2|Period 1 (up to 3 Years)|Withdrawal by Subject|1
6108742|NCT00174187|21071504|P1|Period 1 (up to 3 Years)|Withdrawal by Subject|0
6108743|NCT00174187|21071502|P3|Period 1 (up to 3 Years)|Non compliance|0
6108744|NCT00174187|21071503|P2|Period 1 (up to 3 Years)|Non compliance|1
6108745|NCT00174187|21071504|P1|Period 1 (up to 3 Years)|Non compliance|0
6108746|NCT00174187|21071502|P3|Period 1 (up to 3 Years)|Serious adverse event|0
6108747|NCT00174187|21071503|P2|Period 1 (up to 3 Years)|Serious adverse event|1
6108748|NCT00174187|21071504|P1|Period 1 (up to 3 Years)|Serious adverse event|0
6108749|NCT00172185|21071569|P4|Overall Study|Withdrawal by Subject|0
6108750|NCT00172185|21071570|P3|Overall Study|Withdrawal by Subject|1
6108751|NCT00172185|21071571|P2|Overall Study|Withdrawal by Subject|0
6108752|NCT00172185|21071572|P1|Overall Study|Withdrawal by Subject|0
6108753|NCT00172185|21071569|P4|Overall Study|SPONSOR Decision|0
6108754|NCT00172185|21071570|P3|Overall Study|SPONSOR Decision|0
6108755|NCT00172185|21071571|P2|Overall Study|SPONSOR Decision|1
6108756|NCT00172185|21071572|P1|Overall Study|SPONSOR Decision|0
6108757|NCT00172185|21071569|P4|Overall Study|Physician Decision|0
6108758|NCT00172185|21071570|P3|Overall Study|Physician Decision|1
6108759|NCT00172185|21071571|P2|Overall Study|Physician Decision|0
6108760|NCT00172185|21071572|P1|Overall Study|Physician Decision|0
6108761|NCT00172185|21071569|P4|Overall Study|Adverse Event|4
6108762|NCT00172185|21071570|P3|Overall Study|Adverse Event|3
6108763|NCT00172185|21071571|P2|Overall Study|Adverse Event|1
6108764|NCT00172185|21071572|P1|Overall Study|Adverse Event|0
6108765|NCT00172042|21071588|P2|Overall Study|Death|42
6108766|NCT00172042|21071589|P1|Overall Study|Death|42
6108767|NCT00172042|21071588|P2|Overall Study|Administrative problems|10
6108768|NCT00172042|21071589|P1|Overall Study|Administrative problems|13
6108769|NCT00172042|21071588|P2|Overall Study|Lost to Follow-up|5
6108770|NCT00172042|21071589|P1|Overall Study|Lost to Follow-up|3
6108771|NCT00172042|21071588|P2|Overall Study|Withdrawal by Subject|25
6108772|NCT00172042|21071589|P1|Overall Study|Withdrawal by Subject|37
6108773|NCT00172042|21071588|P2|Overall Study|Protocol Violation|7
6108774|NCT00172042|21071589|P1|Overall Study|Protocol Violation|8
6108775|NCT00172042|21071588|P2|Overall Study|Patient no longer requires study drug|8
6108776|NCT00172042|21071589|P1|Overall Study|Patient no longer requires study drug|10
6108777|NCT00172042|21071588|P2|Overall Study|Unsatisfactory therapeutic effect|11
6108778|NCT00172042|21071589|P1|Overall Study|Unsatisfactory therapeutic effect|13
6108779|NCT00172042|21071588|P2|Overall Study|Abnormal test procedure(s)|3
6108780|NCT00172042|21071589|P1|Overall Study|Abnormal test procedure(s)|0
6108781|NCT00172042|21071588|P2|Overall Study|Abnormal laboratory value(s)|1
6108782|NCT00172042|21071589|P1|Overall Study|Abnormal laboratory value(s)|5
6108783|NCT00172042|21071588|P2|Overall Study|Adverse Event|13
6108784|NCT00172042|21071589|P1|Overall Study|Adverse Event|27
6108785|NCT00171925|21071611|P2|Overall Study|Death|2
6108786|NCT00171925|21071612|P1|Overall Study|Death|1
6108787|NCT00171925|21071611|P2|Overall Study|Administrative problems|11
6108788|NCT00171925|21071612|P1|Overall Study|Administrative problems|10
6108789|NCT00171925|21071611|P2|Overall Study|Lost to Follow-up|2
6108790|NCT00171925|21071612|P1|Overall Study|Lost to Follow-up|2
6108791|NCT00171925|21071611|P2|Overall Study|Withdrawal by Subject|9
6108792|NCT00171925|21071612|P1|Overall Study|Withdrawal by Subject|6
6108793|NCT00171925|21071611|P2|Overall Study|Protocol Violation|1
6108794|NCT00171925|21071612|P1|Overall Study|Protocol Violation|1
6108795|NCT00171925|21071611|P2|Overall Study|Adverse Event|6
6108796|NCT00171925|21071612|P1|Overall Study|Adverse Event|10
6108797|NCT00171873|21071624|P2|Overall Study|Switched to Octreotide|1
6108798|NCT00171873|21071625|P1|Overall Study|Switched to Octreotide|0
6108799|NCT00171873|21071624|P2|Overall Study|Adverse Event|0
6108800|NCT00171873|21071625|P1|Overall Study|Adverse Event|5
6108801|NCT00171873|21071624|P2|Overall Study|Withdrawal by Subject|2
6108802|NCT00171873|21071625|P1|Overall Study|Withdrawal by Subject|4
6108803|NCT00171834|21071638|P7|Overall Study|Treatment Duration Completed|0
6108804|NCT00171834|21071639|P6|Overall Study|Treatment Duration Completed|1
6108805|NCT00171834|21071640|P5|Overall Study|Treatment Duration Completed|2
6108806|NCT00171834|21071641|P4|Overall Study|Treatment Duration Completed|0
6108807|NCT00171834|21071642|P3|Overall Study|Treatment Duration Completed|1
6108808|NCT00171834|21071643|P2|Overall Study|Treatment Duration Completed|0
6108809|NCT00171834|21071644|P1|Overall Study|Treatment Duration Completed|0
6108810|NCT00171834|21071638|P7|Overall Study|Disease Progression|3
6108811|NCT00171834|21071639|P6|Overall Study|Disease Progression|18
6108812|NCT00171834|21071640|P5|Overall Study|Disease Progression|2
6108813|NCT00171834|21071641|P4|Overall Study|Disease Progression|9
6108814|NCT00171834|21071642|P3|Overall Study|Disease Progression|8
6108815|NCT00171834|21071643|P2|Overall Study|Disease Progression|8
6108816|NCT00171834|21071644|P1|Overall Study|Disease Progression|4
6108817|NCT00171834|21071638|P7|Overall Study|Death from study indication|0
6108818|NCT00171834|21071639|P6|Overall Study|Death from study indication|0
6108819|NCT00171834|21071640|P5|Overall Study|Death from study indication|1
6108820|NCT00171834|21071641|P4|Overall Study|Death from study indication|0
6108821|NCT00171834|21071642|P3|Overall Study|Death from study indication|0
6108822|NCT00171834|21071643|P2|Overall Study|Death from study indication|1
6108823|NCT00171834|21071644|P1|Overall Study|Death from study indication|0
6108824|NCT00171834|21071638|P7|Overall Study|Withdrawal by Subject|0
6108825|NCT00171834|21071639|P6|Overall Study|Withdrawal by Subject|1
6108826|NCT00171834|21071640|P5|Overall Study|Withdrawal by Subject|1
6108827|NCT00171834|21071641|P4|Overall Study|Withdrawal by Subject|1
6108828|NCT00171834|21071642|P3|Overall Study|Withdrawal by Subject|0
6108829|NCT00171834|21071643|P2|Overall Study|Withdrawal by Subject|2
6108830|NCT00171834|21071644|P1|Overall Study|Withdrawal by Subject|0
6108831|NCT00171834|21071638|P7|Overall Study|Adverse Event|1
6108832|NCT00171834|21071639|P6|Overall Study|Adverse Event|15
6108833|NCT00171834|21071640|P5|Overall Study|Adverse Event|2
6108834|NCT00171834|21071641|P4|Overall Study|Adverse Event|2
6108835|NCT00171834|21071642|P3|Overall Study|Adverse Event|3
6108836|NCT00171834|21071643|P2|Overall Study|Adverse Event|1
6108837|NCT00171834|21071644|P1|Overall Study|Adverse Event|2
6108838|NCT00171704|21071684|P2|Overall Study|Protocol Violation|1
6108839|NCT00171704|21071685|P1|Overall Study|Protocol Violation|0
6108840|NCT00171704|21071684|P2|Overall Study|Withdrawal by Subject|3
6108841|NCT00171704|21071685|P1|Overall Study|Withdrawal by Subject|1
6108842|NCT00171704|21071684|P2|Overall Study|Death|2
6108843|NCT00171704|21071685|P1|Overall Study|Death|2
6108844|NCT00171704|21071684|P2|Overall Study|Administrative Problems|1
6108845|NCT00171704|21071685|P1|Overall Study|Administrative Problems|2
6108846|NCT00171704|21071684|P2|Overall Study|New therapy for 2nd non-breast prim canc|0
6108847|NCT00171704|21071685|P1|Overall Study|New therapy for 2nd non-breast prim canc|1
6108848|NCT00171704|21071684|P2|Overall Study|Disease Progression|9
6108849|NCT00171704|21071685|P1|Overall Study|Disease Progression|14
6108850|NCT00171704|21071684|P2|Overall Study|Adverse Event|33
6108851|NCT00171704|21071685|P1|Overall Study|Adverse Event|24
6108852|NCT00171340|21071707|P2|Overall Study|Death|6
6108853|NCT00171340|21071708|P1|Overall Study|Death|6
6108854|NCT00171340|21071707|P2|Overall Study|Administrative Problems|2
6108855|NCT00171340|21071708|P1|Overall Study|Administrative Problems|5
6108856|NCT00171340|21071707|P2|Overall Study|No Longer Required Study Drug|1
6108857|NCT00171340|21071708|P1|Overall Study|No Longer Required Study Drug|1
6108858|NCT00171340|21071707|P2|Overall Study|Abnormal Test Procedure Results|11
6108859|NCT00171340|21071708|P1|Overall Study|Abnormal Test Procedure Results|6
6108860|NCT00171340|21071707|P2|Overall Study|Abnormal Laboratory Results|0
6108861|NCT00171340|21071708|P1|Overall Study|Abnormal Laboratory Results|2
6108862|NCT00171340|21071707|P2|Overall Study|Lost to Follow-up|5
6108863|NCT00171340|21071708|P1|Overall Study|Lost to Follow-up|0
6108864|NCT00171340|21071707|P2|Overall Study|Withdrawal by Subject|19
6108865|NCT00171340|21071708|P1|Overall Study|Withdrawal by Subject|22
6108866|NCT00171340|21071707|P2|Overall Study|Protocol Violation|8
6108867|NCT00171340|21071708|P1|Overall Study|Protocol Violation|7
6108868|NCT00171340|21071707|P2|Overall Study|Lack of Efficacy|41
6108869|NCT00171340|21071708|P1|Overall Study|Lack of Efficacy|29
6108870|NCT00171340|21071707|P2|Overall Study|Adverse Event|42
6108871|NCT00171340|21071708|P1|Overall Study|Adverse Event|46
6108872|NCT00171314|21071724|P2|Overall Study|Death|1
6108873|NCT00171314|21071725|P1|Overall Study|Death|2
6108874|NCT00171314|21071724|P2|Overall Study|Lost to Follow-up|3
6108875|NCT00171314|21071725|P1|Overall Study|Lost to Follow-up|1
6108876|NCT00171314|21071724|P2|Overall Study|Administrative Problems|3
6108877|NCT00171314|21071725|P1|Overall Study|Administrative Problems|4
6108878|NCT00171314|21071724|P2|Overall Study|Protocol Violation|7
6108879|NCT00171314|21071725|P1|Overall Study|Protocol Violation|3
6108880|NCT00171314|21071724|P2|Overall Study|Abnormal Test Procedure Results|3
6108881|NCT00171314|21071725|P1|Overall Study|Abnormal Test Procedure Results|9
6108882|NCT00171314|21071724|P2|Overall Study|Withdrawal by Subject|6
6108883|NCT00171314|21071725|P1|Overall Study|Withdrawal by Subject|9
6108884|NCT00171314|21071724|P2|Overall Study|Lack of Efficacy|14
6108885|NCT00171314|21071725|P1|Overall Study|Lack of Efficacy|19
6108886|NCT00171314|21071724|P2|Overall Study|Adverse Event|41
6108887|NCT00171314|21071725|P1|Overall Study|Adverse Event|44
6108888|NCT00171301|21071741|P2|Overall Study|Withdrawal by Subject|1
6108889|NCT00171301|21071742|P1|Overall Study|Withdrawal by Subject|0
6108890|NCT00171301|21071741|P2|Overall Study|Protocol Violation|2
6108891|NCT00171301|21071742|P1|Overall Study|Protocol Violation|0
6108892|NCT00171301|21071741|P2|Overall Study|Lost to Follow-up|2
6108893|NCT00171301|21071742|P1|Overall Study|Lost to Follow-up|6
6108894|NCT00171301|21071741|P2|Overall Study|Adverse Event|2
6108895|NCT00171301|21071742|P1|Overall Study|Adverse Event|1
6108896|NCT00171301|21071741|P2|Overall Study|Death|2
6108897|NCT00171301|21071742|P1|Overall Study|Death|1
6108898|NCT00171210|21071755|P2|Overall Study|Stopped at end of extension 1|1
6108899|NCT00171210|21071756|P1|Overall Study|Stopped at end of extension 1|0
6108900|NCT00171210|21071755|P2|Overall Study|Stopped at end of core|32
6108901|NCT00171210|21071756|P1|Overall Study|Stopped at end of core|0
6108902|NCT00171210|21071755|P2|Overall Study|Death|3
6108903|NCT00171210|21071756|P1|Overall Study|Death|2
6108904|NCT00171210|21071755|P2|Overall Study|Administrative problems|1
6108905|NCT00171210|21071756|P1|Overall Study|Administrative problems|1
6108906|NCT00171210|21071755|P2|Overall Study|Lost to Follow-up|0
6108907|NCT00171210|21071756|P1|Overall Study|Lost to Follow-up|1
6108908|NCT00171210|21071755|P2|Overall Study|Withdrawal by Subject|30
6108909|NCT00171210|21071756|P1|Overall Study|Withdrawal by Subject|32
6108910|NCT00171210|21071755|P2|Overall Study|Protocol Violation|2
6108911|NCT00171210|21071756|P1|Overall Study|Protocol Violation|0
6108912|NCT00171210|21071755|P2|Overall Study|Unsatisfactory therapeutic effect|15
6108913|NCT00171210|21071756|P1|Overall Study|Unsatisfactory therapeutic effect|11
6108914|NCT00171210|21071755|P2|Overall Study|Abnormal test procedure result(s)|1
6108915|NCT00171210|21071756|P1|Overall Study|Abnormal test procedure result(s)|0
6108916|NCT00171210|21071755|P2|Overall Study|Abnormal laboratory value(s)|3
6108917|NCT00171210|21071756|P1|Overall Study|Abnormal laboratory value(s)|6
6108918|NCT00171210|21071755|P2|Overall Study|Adverse Event|27
6108919|NCT00171210|21071756|P1|Overall Study|Adverse Event|16
6108920|NCT00171054|21071786|P2|Overall Study|Condition no longer required study drug|1
6108921|NCT00171054|21071787|P1|Overall Study|Condition no longer required study drug|0
6108922|NCT00171054|21071786|P2|Overall Study|Adverse Event|8
6108923|NCT00171054|21071787|P1|Overall Study|Adverse Event|8
6108924|NCT00171054|21071786|P2|Overall Study|Lost to Follow-up|1
6108925|NCT00171054|21071787|P1|Overall Study|Lost to Follow-up|0
6108926|NCT00171054|21071786|P2|Overall Study|Patient withdrew consent|0
6108927|NCT00171054|21071787|P1|Overall Study|Patient withdrew consent|1
6108928|NCT00171054|21071786|P2|Overall Study|Protocol Violation|2
6108929|NCT00171054|21071787|P1|Overall Study|Protocol Violation|1
6108930|NCT00170950|21071819|P2|Overall Study|Termination Data Not Recorded|22
6108931|NCT00170950|21071820|P1|Overall Study|Termination Data Not Recorded|17
6108932|NCT00170950|21071819|P2|Overall Study|Missing|1
6108933|NCT00170950|21071820|P1|Overall Study|Missing|2
6108934|NCT00170950|21071819|P2|Overall Study|Lost to Follow-up|115
6108935|NCT00170950|21071820|P1|Overall Study|Lost to Follow-up|134
6108936|NCT00170950|21071819|P2|Overall Study|Withdrawal by Subject|498
6108937|NCT00170950|21071820|P1|Overall Study|Withdrawal by Subject|496
6108938|NCT00170950|21071819|P2|Overall Study|Death|274
6108939|NCT00170950|21071820|P1|Overall Study|Death|236
6108940|NCT00170846|21071833|P3|Overall Study|Reason Missing|0
6108941|NCT00170846|21071834|P2|Overall Study|Reason Missing|1
6108942|NCT00170846|21071835|P1|Overall Study|Reason Missing|0
6108943|NCT00170846|21071833|P3|Overall Study|Death|3
6108944|NCT00170846|21071834|P2|Overall Study|Death|3
6108945|NCT00170846|21071835|P1|Overall Study|Death|0
6108946|NCT00170846|21071833|P3|Overall Study|Lost to Follow-up|2
6108947|NCT00170846|21071834|P2|Overall Study|Lost to Follow-up|3
6108948|NCT00170846|21071835|P1|Overall Study|Lost to Follow-up|6
6108949|NCT00170846|21071833|P3|Overall Study|Subject withdrew Informed Consent|8
6108950|NCT00170846|21071834|P2|Overall Study|Subject withdrew Informed Consent|12
6108951|NCT00170846|21071835|P1|Overall Study|Subject withdrew Informed Consent|5
6108952|NCT00169442|21071867|P6|Overall Study|Lost to follow-up (compl. vaccination)|0
6108953|NCT00169442|21071868|P5|Overall Study|Lost to follow-up (compl. vaccination)|0
6108954|NCT00169442|21071869|P4|Overall Study|Lost to follow-up (compl. vaccination)|0
6108955|NCT00169442|21071870|P3|Overall Study|Lost to follow-up (compl. vaccination)|0
6108956|NCT00169442|21071871|P2|Overall Study|Lost to follow-up (compl. vaccination)|1
6108957|NCT00169442|21071872|P1|Overall Study|Lost to follow-up (compl. vaccination)|0
6108958|NCT00169442|21071867|P6|Overall Study|Lost to follow-up (incompl. vaccination)|0
6108959|NCT00169442|21071868|P5|Overall Study|Lost to follow-up (incompl. vaccination)|1
6108960|NCT00169442|21071869|P4|Overall Study|Lost to follow-up (incompl. vaccination)|0
6108961|NCT00169442|21071870|P3|Overall Study|Lost to follow-up (incompl. vaccination)|0
6108962|NCT00169442|21071871|P2|Overall Study|Lost to follow-up (incompl. vaccination)|0
6108963|NCT00169442|21071872|P1|Overall Study|Lost to follow-up (incompl. vaccination)|0
6108964|NCT00169442|21071867|P6|Overall Study|Migrated/moved from study area|2
6108965|NCT00169442|21071868|P5|Overall Study|Migrated/moved from study area|0
6108966|NCT00169442|21071869|P4|Overall Study|Migrated/moved from study area|0
6108967|NCT00169442|21071870|P3|Overall Study|Migrated/moved from study area|0
6108968|NCT00169442|21071871|P2|Overall Study|Migrated/moved from study area|0
6108969|NCT00169442|21071872|P1|Overall Study|Migrated/moved from study area|0
6108970|NCT00169442|21071867|P6|Overall Study|Withdrawal by Subject|0
6108971|NCT00169442|21071868|P5|Overall Study|Withdrawal by Subject|0
6108972|NCT00169442|21071869|P4|Overall Study|Withdrawal by Subject|0
6108973|NCT00169442|21071870|P3|Overall Study|Withdrawal by Subject|1
6108974|NCT00169442|21071871|P2|Overall Study|Withdrawal by Subject|0
6108975|NCT00169442|21071872|P1|Overall Study|Withdrawal by Subject|0
6108976|NCT00169104|21071981|P2|Overall Study|Physician Decision|1
6108977|NCT00169104|21071982|P1|Overall Study|Physician Decision|0
6108978|NCT00169104|21071981|P2|Overall Study|Protocol Violation|1
6108979|NCT00169104|21071982|P1|Overall Study|Protocol Violation|0
6108980|NCT00169104|21071981|P2|Overall Study|Withdrawal by Subject|0
6108981|NCT00169104|21071982|P1|Overall Study|Withdrawal by Subject|2
6108982|NCT00168844|21071996|P3|Overall Study|Other|9
6108983|NCT00168844|21071997|P2|Overall Study|Other|7
6108984|NCT00168844|21071998|P1|Overall Study|Other|6
6108985|NCT00168844|21071996|P3|Overall Study|Protocol Violation|4
6108986|NCT00168844|21071997|P2|Overall Study|Protocol Violation|2
6108987|NCT00168844|21071998|P1|Overall Study|Protocol Violation|2
6108988|NCT00168844|21071996|P3|Overall Study|Withdrawal by Subject|19
6108989|NCT00168844|21071997|P2|Overall Study|Withdrawal by Subject|9
6108990|NCT00168844|21071998|P1|Overall Study|Withdrawal by Subject|12
6108991|NCT00168844|21071996|P3|Overall Study|Lost to Follow-up|11
6108992|NCT00168844|21071997|P2|Overall Study|Lost to Follow-up|5
6108993|NCT00168844|21071998|P1|Overall Study|Lost to Follow-up|4
6108994|NCT00168844|21071996|P3|Overall Study|Adverse Event|48
6108995|NCT00168844|21071997|P2|Overall Study|Adverse Event|32
6108996|NCT00168844|21071998|P1|Overall Study|Adverse Event|31
6108997|NCT00168831|21072180|P3|Overall Study|Other|6
6108998|NCT00168831|21072181|P2|Overall Study|Other|3
6108999|NCT00168831|21072182|P1|Overall Study|Other|6
6109000|NCT00168831|21072180|P3|Overall Study|Protocol Violation|11
6109001|NCT00168831|21072181|P2|Overall Study|Protocol Violation|11
6109002|NCT00168831|21072182|P1|Overall Study|Protocol Violation|6
6109003|NCT00168831|21072180|P3|Overall Study|Withdrawal by Subject|19
6109004|NCT00168831|21072181|P2|Overall Study|Withdrawal by Subject|14
6109005|NCT00168831|21072182|P1|Overall Study|Withdrawal by Subject|7
6109006|NCT00168831|21072180|P3|Overall Study|Lost to Follow-up|4
6109007|NCT00168831|21072181|P2|Overall Study|Lost to Follow-up|6
6109008|NCT00168831|21072182|P1|Overall Study|Lost to Follow-up|5
6109009|NCT00168831|21072180|P3|Overall Study|Adverse Event|74
6109010|NCT00168831|21072181|P2|Overall Study|Adverse Event|47
6109011|NCT00168831|21072182|P1|Overall Study|Adverse Event|36
6109012|NCT00168818|21072364|P3|Treatment|Other|31
6109013|NCT00168818|21072365|P2|Treatment|Other|29
6109014|NCT00168818|21072366|P1|Treatment|Other|23
6109015|NCT00168818|21072364|P3|Treatment|Withdrawal by Subject|22
6109016|NCT00168818|21072365|P2|Treatment|Withdrawal by Subject|20
6109017|NCT00168818|21072366|P1|Treatment|Withdrawal by Subject|25
6109018|NCT00168818|21072364|P3|Treatment|Lost to Follow-up|1
6109019|NCT00168818|21072365|P2|Treatment|Lost to Follow-up|2
6109020|NCT00168818|21072366|P1|Treatment|Lost to Follow-up|0
6109021|NCT00168818|21072364|P3|Treatment|Protocol Violation|11
6109022|NCT00168818|21072365|P2|Treatment|Protocol Violation|11
6109023|NCT00168818|21072366|P1|Treatment|Protocol Violation|8
6109024|NCT00168818|21072364|P3|Treatment|Adverse Event|68
6109025|NCT00168818|21072365|P2|Treatment|Adverse Event|89
6109026|NCT00168818|21072366|P1|Treatment|Adverse Event|77
6109027|NCT00168818|21072364|P3|Overall Study|Other|30
6109028|NCT00168818|21072365|P2|Overall Study|Other|24
6109029|NCT00168818|21072366|P1|Overall Study|Other|22
6109030|NCT00168818|21072364|P3|Overall Study|Withdrawal by Subject|37
6109031|NCT00168818|21072365|P2|Overall Study|Withdrawal by Subject|41
6109032|NCT00168818|21072366|P1|Overall Study|Withdrawal by Subject|43
6109033|NCT00168818|21072364|P3|Overall Study|Lost to Follow-up|15
6109034|NCT00168818|21072365|P2|Overall Study|Lost to Follow-up|4
6109035|NCT00168818|21072366|P1|Overall Study|Lost to Follow-up|13
6109036|NCT00168818|21072364|P3|Overall Study|Protocol Violation|11
6109037|NCT00168818|21072365|P2|Overall Study|Protocol Violation|11
6109038|NCT00168818|21072366|P1|Overall Study|Protocol Violation|16
6109039|NCT00168818|21072364|P3|Overall Study|Adverse Event|31
6109040|NCT00168818|21072365|P2|Overall Study|Adverse Event|29
6109041|NCT00168818|21072366|P1|Overall Study|Adverse Event|23
6109042|NCT00168805|21072410|P3|Treatment|Other|17
6109043|NCT00168805|21072411|P2|Treatment|Other|18
6109044|NCT00168805|21072412|P1|Treatment|Other|18
6109045|NCT00168805|21072410|P3|Treatment|Withdrawal by Subject|8
6109046|NCT00168805|21072411|P2|Treatment|Withdrawal by Subject|7
6109047|NCT00168805|21072412|P1|Treatment|Withdrawal by Subject|3
6109048|NCT00168805|21072410|P3|Treatment|Protocol Violation|5
6109049|NCT00168805|21072411|P2|Treatment|Protocol Violation|5
6109050|NCT00168805|21072412|P1|Treatment|Protocol Violation|3
6109051|NCT00168805|21072410|P3|Treatment|Adverse Event|32
6109052|NCT00168805|21072411|P2|Treatment|Adverse Event|26
6109053|NCT00168805|21072412|P1|Treatment|Adverse Event|25
6109054|NCT00168805|21072410|P3|Overall Study|Other|22
6109055|NCT00168805|21072411|P2|Overall Study|Other|21
6109056|NCT00168805|21072412|P1|Overall Study|Other|24
6109057|NCT00168805|21072410|P3|Overall Study|Withdrawal by Subject|21
6109058|NCT00168805|21072411|P2|Overall Study|Withdrawal by Subject|18
6109059|NCT00168805|21072412|P1|Overall Study|Withdrawal by Subject|16
6109060|NCT00168805|21072410|P3|Overall Study|Lost to Follow-up|11
6109061|NCT00168805|21072411|P2|Overall Study|Lost to Follow-up|17
6109062|NCT00168805|21072412|P1|Overall Study|Lost to Follow-up|12
6109063|NCT00168805|21072410|P3|Overall Study|Protocol Violation|8
6109064|NCT00168805|21072411|P2|Overall Study|Protocol Violation|11
6109065|NCT00168805|21072412|P1|Overall Study|Protocol Violation|12
6109066|NCT00168805|21072410|P3|Overall Study|Adverse Event|16
6109067|NCT00168805|21072411|P2|Overall Study|Adverse Event|11
6109068|NCT00168805|21072412|P1|Overall Study|Adverse Event|7
6109069|NCT00168103|21072648|P4|Overall Study|Lost to Follow-up|0
6109070|NCT00168103|21072649|P3|Overall Study|Lost to Follow-up|0
6109071|NCT00168103|21072650|P2|Overall Study|Lost to Follow-up|3
6109072|NCT00168103|21072651|P1|Overall Study|Lost to Follow-up|1
6109073|NCT00168103|21072648|P4|Overall Study|Withdrawal by Subject|0
6109074|NCT00168103|21072649|P3|Overall Study|Withdrawal by Subject|1
6109075|NCT00168103|21072650|P2|Overall Study|Withdrawal by Subject|2
6109076|NCT00168103|21072651|P1|Overall Study|Withdrawal by Subject|1
6109077|NCT00168064|21072673|P2|Overall Study|Various|3
6109078|NCT00168064|21072674|P1|Overall Study|Various|4
6109079|NCT00168064|21072673|P2|Overall Study|Subject's Best interest|2
6109080|NCT00168064|21072674|P1|Overall Study|Subject's Best interest|2
6109081|NCT00168064|21072673|P2|Overall Study|Concurrent Illness|3
6109082|NCT00168064|21072674|P1|Overall Study|Concurrent Illness|4
6109083|NCT00168064|21072673|P2|Overall Study|Non-compliance|3
6109084|NCT00168064|21072674|P1|Overall Study|Non-compliance|2
6109085|NCT00168064|21072673|P2|Overall Study|Lost to Follow-up|3
6109086|NCT00168064|21072674|P1|Overall Study|Lost to Follow-up|4
6109087|NCT00168064|21072673|P2|Overall Study|Lack of Efficacy|4
6109088|NCT00168064|21072674|P1|Overall Study|Lack of Efficacy|4
6109089|NCT00168064|21072673|P2|Overall Study|Withdrawal by Subject|4
6109090|NCT00168064|21072674|P1|Overall Study|Withdrawal by Subject|3
6109091|NCT00168064|21072673|P2|Overall Study|Adverse Event|22
6109092|NCT00168064|21072674|P1|Overall Study|Adverse Event|26
6109093|NCT00168038|21072682|P1|Overall Study|Therapy failure|1
6109094|NCT00168038|21072682|P1|Overall Study|Adverse Event|1
6109095|NCT00167778|21072705|P1|Overall Study|Withdrawal by Subject|1
6109096|NCT00167414|21072784|P1|Overall Study|Death|10
6109097|NCT00167310|21072809|P2|Overall Study|Withdrawal by Subject|7
6109098|NCT00167310|21072810|P1|Overall Study|Withdrawal by Subject|3
6109099|NCT00167310|21072809|P2|Overall Study|Protocol Violation|3
6109100|NCT00167310|21072810|P1|Overall Study|Protocol Violation|5
6109101|NCT00167245|21072820|P2|Overall Study|Drowsy|0
6109102|NCT00167245|21072821|P1|Overall Study|Drowsy|1
6109103|NCT00167245|21072820|P2|Overall Study|Incarcerated|2
6109104|NCT00167245|21072821|P1|Overall Study|Incarcerated|3
6109105|NCT00167245|21072820|P2|Overall Study|Withdrawal by Subject|8
6109106|NCT00167245|21072821|P1|Overall Study|Withdrawal by Subject|5
6109107|NCT00167245|21072820|P2|Overall Study|Lost to Follow-up|31
6109108|NCT00167245|21072821|P1|Overall Study|Lost to Follow-up|20
6109109|NCT00166712|21072875|P2|Overall Study|Physician Decision|2
6109110|NCT00166712|21072876|P1|Overall Study|Physician Decision|0
6109111|NCT00166712|21072875|P2|Overall Study|Withdrawal by Subject|2
6109112|NCT00166712|21072876|P1|Overall Study|Withdrawal by Subject|1
6109113|NCT00166712|21072875|P2|Overall Study|Adverse Event|0
6109114|NCT00166712|21072876|P1|Overall Study|Adverse Event|1
6109115|NCT00166712|21072875|P2|Overall Study|Death|1
6109116|NCT00166712|21072876|P1|Overall Study|Death|0
6109117|NCT00166517|21072893|P2|Overall Study|Withdrawal by Subject|1
6109118|NCT00166517|21072894|P1|Overall Study|Withdrawal by Subject|0
6109119|NCT00166517|21072893|P2|Overall Study|Protocol Violation|1
6109120|NCT00166517|21072894|P1|Overall Study|Protocol Violation|4
6109121|NCT00166517|21072893|P2|Overall Study|Lost to Follow-up|0
6109122|NCT00166517|21072894|P1|Overall Study|Lost to Follow-up|1
6109123|NCT00166504|21072904|P2|Overall Study|Withdrawal by Subject|0
6109124|NCT00166504|21072905|P1|Overall Study|Withdrawal by Subject|1
6109125|NCT00166504|21072904|P2|Overall Study|Lost to Follow-up|1
6109126|NCT00166504|21072905|P1|Overall Study|Lost to Follow-up|1
6109127|NCT00166504|21072904|P2|Overall Study|Adverse Event|3
6109128|NCT00166504|21072905|P1|Overall Study|Adverse Event|3
6109129|NCT00166439|21072911|P1|Overall Study|Ineligible|5
6109130|NCT00166296|21072928|P2|Overall Study|Lost to Follow-up|2
6109131|NCT00166296|21072929|P1|Overall Study|Lost to Follow-up|4
6109132|NCT00166296|21072928|P2|Overall Study|Adverse Event|4
6109133|NCT00166296|21072929|P1|Overall Study|Adverse Event|2
6109134|NCT00166296|21072928|P2|Overall Study|Withdrawal by Subject|3
6109135|NCT00166296|21072929|P1|Overall Study|Withdrawal by Subject|1
6109136|NCT00166114|21072981|P2|Overall Study|Adverse Event|1
6109137|NCT00166114|21072982|P1|Overall Study|Adverse Event|2
6109138|NCT00166114|21072981|P2|Overall Study|Withdrawal by Subject|4
6109139|NCT00166114|21072982|P1|Overall Study|Withdrawal by Subject|10
6109140|NCT00166114|21072981|P2|Overall Study|Protocol Violation|1
6109141|NCT00166114|21072982|P1|Overall Study|Protocol Violation|2
6109142|NCT00165984|21072999|P1|Overall Study|Death|15
6109143|NCT00165841|21073017|P2|Overall Study|Medication Noncompliance|1
6109144|NCT00165841|21073018|P1|Overall Study|Medication Noncompliance|1
6109145|NCT00165841|21073017|P2|Overall Study|Other|5
6109146|NCT00165841|21073018|P1|Overall Study|Other|3
6109147|NCT00165841|21073017|P2|Overall Study|Protocol Violation|8
6109148|NCT00165841|21073018|P1|Overall Study|Protocol Violation|6
6109149|NCT00165841|21073017|P2|Overall Study|Physician Decision|0
6109150|NCT00165841|21073018|P1|Overall Study|Physician Decision|1
6109151|NCT00165841|21073017|P2|Overall Study|Withdrawal by Subject|8
6109152|NCT00165841|21073018|P1|Overall Study|Withdrawal by Subject|7
6109153|NCT00165841|21073017|P2|Overall Study|Lost to Follow-up|4
6109154|NCT00165841|21073018|P1|Overall Study|Lost to Follow-up|4
6109155|NCT00165841|21073017|P2|Overall Study|Lack of Efficacy|33
6109156|NCT00165841|21073018|P1|Overall Study|Lack of Efficacy|6
6109157|NCT00165841|21073017|P2|Overall Study|Adverse Event|3
6109158|NCT00165841|21073018|P1|Overall Study|Adverse Event|2
6109159|NCT00165789|21073028|P4|Overall Study|Withdrawal by Subject|2
6109160|NCT00165789|21073029|P3|Overall Study|Withdrawal by Subject|1
6109161|NCT00165789|21073030|P2|Overall Study|Withdrawal by Subject|1
6109162|NCT00165789|21073031|P1|Overall Study|Withdrawal by Subject|0
6109163|NCT00165789|21073028|P4|Overall Study|Adverse Event|12
6109164|NCT00165789|21073029|P3|Overall Study|Adverse Event|0
6109165|NCT00165789|21073030|P2|Overall Study|Adverse Event|3
6109166|NCT00165789|21073031|P1|Overall Study|Adverse Event|0
6109167|NCT00165776|21073085|P4|Overall Study|Worsening of Cervical Dystonia|1
6109168|NCT00165776|21073086|P3|Overall Study|Worsening of Cervical Dystonia|0
6109169|NCT00165776|21073087|P2|Overall Study|Worsening of Cervical Dystonia|0
6109170|NCT00165776|21073088|P1|Overall Study|Worsening of Cervical Dystonia|0
6109171|NCT00165776|21073085|P4|Overall Study|Withdrawal by Subject|0
6109172|NCT00165776|21073086|P3|Overall Study|Withdrawal by Subject|2
6109173|NCT00165776|21073087|P2|Overall Study|Withdrawal by Subject|1
6109174|NCT00165776|21073088|P1|Overall Study|Withdrawal by Subject|4
6109175|NCT00165776|21073085|P4|Overall Study|Lack of Efficacy|1
6109176|NCT00165776|21073086|P3|Overall Study|Lack of Efficacy|0
6109177|NCT00165776|21073087|P2|Overall Study|Lack of Efficacy|0
6109178|NCT00165776|21073088|P1|Overall Study|Lack of Efficacy|0
6109179|NCT00165698|21073124|P2|Overall Study|Not Taken/Lost the medicine|2
6109180|NCT00165698|21073125|P1|Overall Study|Not Taken/Lost the medicine|1
6109181|NCT00165698|21073124|P2|Overall Study|Protocol Violation|0
6109182|NCT00165698|21073125|P1|Overall Study|Protocol Violation|1
6109183|NCT00165698|21073124|P2|Overall Study|Withdrawal by Subject|1
6109184|NCT00165698|21073125|P1|Overall Study|Withdrawal by Subject|2
6109185|NCT00165698|21073124|P2|Overall Study|Lost to Follow-up|2
6109186|NCT00165698|21073125|P1|Overall Study|Lost to Follow-up|2
6109187|NCT00165698|21073124|P2|Overall Study|Adverse Event|10
6109188|NCT00165698|21073125|P1|Overall Study|Adverse Event|2
6109189|NCT00165672|21073151|P2|Overall Study|Adverse Event|1
6109190|NCT00165672|21073152|P1|Overall Study|Adverse Event|0
6109191|NCT00165646|21073161|P3|Overall Study|Protocol Violation|0
6109192|NCT00165646|21073162|P2|Overall Study|Protocol Violation|0
6109193|NCT00165646|21073163|P1|Overall Study|Protocol Violation|1
6109194|NCT00165646|21073161|P3|Overall Study|Physician Decision|2
6109195|NCT00165646|21073162|P2|Overall Study|Physician Decision|0
6109196|NCT00165646|21073163|P1|Overall Study|Physician Decision|2
6109197|NCT00165646|21073161|P3|Overall Study|Withdrawal by Subject|1
6109198|NCT00165646|21073162|P2|Overall Study|Withdrawal by Subject|2
6109199|NCT00165646|21073163|P1|Overall Study|Withdrawal by Subject|0
6109200|NCT00165646|21073161|P3|Overall Study|Lack of Efficacy|0
6109201|NCT00165646|21073162|P2|Overall Study|Lack of Efficacy|2
6109202|NCT00165646|21073163|P1|Overall Study|Lack of Efficacy|1
6109203|NCT00165646|21073161|P3|Overall Study|Adverse Event|1
6109204|NCT00165646|21073162|P2|Overall Study|Adverse Event|1
6109205|NCT00165646|21073163|P1|Overall Study|Adverse Event|1
6109206|NCT00165503|21073171|P1|Overall Study|Unresectable|3
6109207|NCT00165503|21073171|P1|Overall Study|Lost to Follow-up|12
6109208|NCT00165503|21073171|P1|Overall Study|Death|1
6109209|NCT00163657|21073178|P3|Overall Study|Other reason|3
6109210|NCT00163657|21073179|P2|Overall Study|Other reason|1
6109211|NCT00163657|21073180|P1|Overall Study|Other reason|0
6109212|NCT00163657|21073178|P3|Overall Study|Lost to Follow-up|10
6109213|NCT00163657|21073179|P2|Overall Study|Lost to Follow-up|3
6109214|NCT00163657|21073180|P1|Overall Study|Lost to Follow-up|1
6109215|NCT00163657|21073178|P3|Overall Study|Non Compliance|0
6109216|NCT00163657|21073179|P2|Overall Study|Non Compliance|0
6109217|NCT00163657|21073180|P1|Overall Study|Non Compliance|1
6109218|NCT00163657|21073178|P3|Overall Study|Physician Decision|1
6109219|NCT00163657|21073179|P2|Overall Study|Physician Decision|1
6109220|NCT00163657|21073180|P1|Overall Study|Physician Decision|0
6109221|NCT00163657|21073178|P3|Overall Study|Withdrawal by Subject|2
6109222|NCT00163657|21073179|P2|Overall Study|Withdrawal by Subject|3
6109223|NCT00163657|21073180|P1|Overall Study|Withdrawal by Subject|2
6109224|NCT00163657|21073178|P3|Overall Study|graft loss|2
6109225|NCT00163657|21073179|P2|Overall Study|graft loss|1
6109226|NCT00163657|21073180|P1|Overall Study|graft loss|4
6109227|NCT00163657|21073178|P3|Overall Study|Death|19
6109228|NCT00163657|21073179|P2|Overall Study|Death|14
6109229|NCT00163657|21073180|P1|Overall Study|Death|12
6109230|NCT00163215|21073270|P1|Overall Study|Other|7
6109231|NCT00163215|21073270|P1|Overall Study|Withdrawal by Subject|5
6109232|NCT00163215|21073270|P1|Overall Study|Lack of Efficacy|3
6109233|NCT00163189|21073290|P1|Overall Study|Did not meet continuation criterion|16
6109234|NCT00163189|21073290|P1|Overall Study|Withdrawal by Subject|11
6109235|NCT00163189|21073290|P1|Overall Study|Study terminated by sponsor|11
6109236|NCT00163189|21073290|P1|Overall Study|Lack of Efficacy|7
6109237|NCT00163189|21073290|P1|Overall Study|Adverse Event|6
6109238|NCT00163189|21073290|P1|Overall Study|Death|3
6109239|NCT00163189|21073290|P1|Overall Study|Protocol Violation|2
6109240|NCT00163189|21073290|P1|Overall Study|Lost to Follow-up|1
6109241|NCT00163189|21073290|P1|Overall Study|Other|6
6109242|NCT00163020|21073314|P2|Overall Study|Lost to Follow-up|2
6109243|NCT00163020|21073315|P1|Overall Study|Lost to Follow-up|0
6109244|NCT00162981|21073355|P2|Overall Study|Physician Decision|0
6109245|NCT00162981|21073356|P1|Overall Study|Physician Decision|1
6109246|NCT00162981|21073355|P2|Overall Study|Withdrawal by Subject|1
6109247|NCT00162981|21073356|P1|Overall Study|Withdrawal by Subject|1
6109248|NCT00162981|21073355|P2|Overall Study|Adverse Event|5
6109249|NCT00162981|21073356|P1|Overall Study|Adverse Event|2
6109250|NCT00162942|21073372|P2|Overall Study|2 or more consecutive treatments missed|0
6109251|NCT00162942|21073373|P1|Overall Study|2 or more consecutive treatments missed|1
6109252|NCT00162942|21073372|P2|Overall Study|Flare During Active Treatment|3
6109253|NCT00162942|21073373|P1|Overall Study|Flare During Active Treatment|7
6109254|NCT00162942|21073372|P2|Overall Study|Lack of Efficacy|0
6109255|NCT00162942|21073373|P1|Overall Study|Lack of Efficacy|1
6109256|NCT00162942|21073372|P2|Overall Study|Alternate Therapy|2
6109257|NCT00162942|21073373|P1|Overall Study|Alternate Therapy|6
6109258|NCT00162942|21073372|P2|Overall Study|Enter Open-Label Study|35
6109259|NCT00162942|21073373|P1|Overall Study|Enter Open-Label Study|76
6109260|NCT00162942|21073372|P2|Overall Study|Physician Decision|0
6109261|NCT00162942|21073373|P1|Overall Study|Physician Decision|1
6109262|NCT00162942|21073372|P2|Overall Study|Withdrawal by Subject|6
6109263|NCT00162942|21073373|P1|Overall Study|Withdrawal by Subject|3
6109264|NCT00162942|21073372|P2|Overall Study|Death|0
6109265|NCT00162942|21073373|P1|Overall Study|Death|1
6109266|NCT00162942|21073372|P2|Overall Study|Adverse Event|6
6109267|NCT00162942|21073373|P1|Overall Study|Adverse Event|10
6109268|NCT00162773|21073421|P1|Overall Study|P.I, Left institution. Study terminated|22
6109269|NCT00162370|21073425|P1|Efficacy Population|Lost to Follow-up|51
6109270|NCT00162266|21073433|P4|Open-Label Period|Other Reasons|15
6109271|NCT00162266|21073434|P3|Open-Label Period|Other Reasons|0
6109272|NCT00162266|21073435|P2|Open-Label Period|Other Reasons|0
6109273|NCT00162266|21073436|P1|Open-Label Period|Other Reasons|0
6109274|NCT00162266|21073433|P4|Open-Label Period|Administrative Reason By Sponsor|9
6109275|NCT00162266|21073434|P3|Open-Label Period|Administrative Reason By Sponsor|0
6109276|NCT00162266|21073435|P2|Open-Label Period|Administrative Reason By Sponsor|0
6109277|NCT00162266|21073436|P1|Open-Label Period|Administrative Reason By Sponsor|0
6109278|NCT00162266|21073433|P4|Open-Label Period|Withdrawal by Subject|31
6109279|NCT00162266|21073434|P3|Open-Label Period|Withdrawal by Subject|0
6109280|NCT00162266|21073435|P2|Open-Label Period|Withdrawal by Subject|0
6109281|NCT00162266|21073436|P1|Open-Label Period|Withdrawal by Subject|0
6109282|NCT00162266|21073433|P4|Open-Label Period|Lost to Follow-up|3
6109283|NCT00162266|21073434|P3|Open-Label Period|Lost to Follow-up|0
6109284|NCT00162266|21073435|P2|Open-Label Period|Lost to Follow-up|0
6109285|NCT00162266|21073436|P1|Open-Label Period|Lost to Follow-up|0
6109286|NCT00162266|21073433|P4|Open-Label Period|Lack of Efficacy|26
6109287|NCT00162266|21073434|P3|Open-Label Period|Lack of Efficacy|0
6109288|NCT00162266|21073435|P2|Open-Label Period|Lack of Efficacy|0
6109289|NCT00162266|21073436|P1|Open-Label Period|Lack of Efficacy|0
6109290|NCT00162266|21073433|P4|Open-Label Period|Adverse Event|46
6109291|NCT00162266|21073434|P3|Open-Label Period|Adverse Event|0
6109292|NCT00162266|21073435|P2|Open-Label Period|Adverse Event|0
6109293|NCT00162266|21073436|P1|Open-Label Period|Adverse Event|0
6109294|NCT00162266|21073433|P4|Open-Label Period|Death|7
6109295|NCT00162266|21073434|P3|Open-Label Period|Death|0
6109296|NCT00162266|21073435|P2|Open-Label Period|Death|0
6109297|NCT00162266|21073436|P1|Open-Label Period|Death|0
6109298|NCT00162266|21073433|P4|Double-Blind Period|Withdrawal by Subject|0
6109299|NCT00162266|21073434|P3|Double-Blind Period|Withdrawal by Subject|6
6109300|NCT00162266|21073435|P2|Double-Blind Period|Withdrawal by Subject|2
6109301|NCT00162266|21073436|P1|Double-Blind Period|Withdrawal by Subject|5
6109302|NCT00162266|21073433|P4|Double-Blind Period|Lack of Efficacy|0
6109303|NCT00162266|21073434|P3|Double-Blind Period|Lack of Efficacy|30
6109304|NCT00162266|21073435|P2|Double-Blind Period|Lack of Efficacy|17
6109305|NCT00162266|21073436|P1|Double-Blind Period|Lack of Efficacy|13
6109306|NCT00162266|21073433|P4|Double-Blind Period|Other Reason|0
6109307|NCT00162266|21073434|P3|Double-Blind Period|Other Reason|1
6109308|NCT00162266|21073435|P2|Double-Blind Period|Other Reason|0
6109309|NCT00162266|21073436|P1|Double-Blind Period|Other Reason|1
6109310|NCT00162266|21073433|P4|Double-Blind Period|Lost to Follow-up|0
6109311|NCT00162266|21073434|P3|Double-Blind Period|Lost to Follow-up|0
6109312|NCT00162266|21073435|P2|Double-Blind Period|Lost to Follow-up|2
6109313|NCT00162266|21073436|P1|Double-Blind Period|Lost to Follow-up|1
6109314|NCT00162266|21073433|P4|Double-Blind Period|Death|0
6109315|NCT00162266|21073434|P3|Double-Blind Period|Death|0
6109316|NCT00162266|21073435|P2|Double-Blind Period|Death|1
6109317|NCT00162266|21073436|P1|Double-Blind Period|Death|0
6109318|NCT00162266|21073433|P4|Double-Blind Period|Adverse Event|0
6109319|NCT00162266|21073434|P3|Double-Blind Period|Adverse Event|11
6109320|NCT00162266|21073435|P2|Double-Blind Period|Adverse Event|9
6109321|NCT00162266|21073436|P1|Double-Blind Period|Adverse Event|5
6109322|NCT00162136|21073637|P1|Overall Study|Withdrawal by Subject|1
6109323|NCT00162136|21073637|P1|Overall Study|Study Drug Toxicity|4
6109324|NCT00162136|21073637|P1|Overall Study|Investigator Request|5
6109325|NCT00162136|21073637|P1|Overall Study|Disease Progression/Relapse|23
6109326|NCT00162136|21073637|P1|Overall Study|Death|1
6109327|NCT00162136|21073637|P1|Overall Study|Adverse Event|1
6109328|NCT00162123|21073669|P8|Overall Study|Follow-up only (not treated or assessed)|57
6109329|NCT00162123|21073670|P7|Overall Study|Follow-up only (not treated or assessed)|0
6109330|NCT00162123|21073671|P6|Overall Study|Follow-up only (not treated or assessed)|0
6109331|NCT00162123|21073672|P5|Overall Study|Follow-up only (not treated or assessed)|0
6109332|NCT00162123|21073673|P4|Overall Study|Follow-up only (not treated or assessed)|0
6109333|NCT00162123|21073674|P3|Overall Study|Follow-up only (not treated or assessed)|0
6109334|NCT00162123|21073675|P2|Overall Study|Follow-up only (not treated or assessed)|0
6109335|NCT00162123|21073676|P1|Overall Study|Follow-up only (not treated or assessed)|0
6109336|NCT00162123|21073669|P8|Overall Study|Tumor assessment only (not treated)|1
6109337|NCT00162123|21073670|P7|Overall Study|Tumor assessment only (not treated)|0
6109338|NCT00162123|21073671|P6|Overall Study|Tumor assessment only (not treated)|0
6109339|NCT00162123|21073672|P5|Overall Study|Tumor assessment only (not treated)|0
6109340|NCT00162123|21073673|P4|Overall Study|Tumor assessment only (not treated)|0
6109341|NCT00162123|21073674|P3|Overall Study|Tumor assessment only (not treated)|0
6109342|NCT00162123|21073675|P2|Overall Study|Tumor assessment only (not treated)|0
6109343|NCT00162123|21073676|P1|Overall Study|Tumor assessment only (not treated)|0
6109344|NCT00162123|21073669|P8|Overall Study|Physician Decision|0
6109345|NCT00162123|21073670|P7|Overall Study|Physician Decision|1
6109346|NCT00162123|21073671|P6|Overall Study|Physician Decision|1
6109347|NCT00162123|21073672|P5|Overall Study|Physician Decision|0
6109348|NCT00162123|21073673|P4|Overall Study|Physician Decision|0
6109349|NCT00162123|21073674|P3|Overall Study|Physician Decision|0
6109350|NCT00162123|21073675|P2|Overall Study|Physician Decision|2
6109351|NCT00162123|21073676|P1|Overall Study|Physician Decision|1
6109352|NCT00162123|21073669|P8|Overall Study|Not specified (after start of treatment)|0
6109353|NCT00162123|21073670|P7|Overall Study|Not specified (after start of treatment)|0
6109354|NCT00162123|21073671|P6|Overall Study|Not specified (after start of treatment)|0
6109355|NCT00162123|21073672|P5|Overall Study|Not specified (after start of treatment)|3
6109356|NCT00162123|21073673|P4|Overall Study|Not specified (after start of treatment)|0
6109357|NCT00162123|21073674|P3|Overall Study|Not specified (after start of treatment)|0
6109358|NCT00162123|21073675|P2|Overall Study|Not specified (after start of treatment)|0
6109359|NCT00162123|21073676|P1|Overall Study|Not specified (after start of treatment)|0
6109360|NCT00162123|21073669|P8|Overall Study|Not specified (before treatment)|0
6109361|NCT00162123|21073670|P7|Overall Study|Not specified (before treatment)|0
6109362|NCT00162123|21073671|P6|Overall Study|Not specified (before treatment)|1
6109363|NCT00162123|21073672|P5|Overall Study|Not specified (before treatment)|12
6109364|NCT00162123|21073673|P4|Overall Study|Not specified (before treatment)|0
6109365|NCT00162123|21073674|P3|Overall Study|Not specified (before treatment)|0
6109366|NCT00162123|21073675|P2|Overall Study|Not specified (before treatment)|0
6109367|NCT00162123|21073676|P1|Overall Study|Not specified (before treatment)|2
6109368|NCT00162123|21073669|P8|Overall Study|Adverse Event|0
6109369|NCT00162123|21073670|P7|Overall Study|Adverse Event|0
6109370|NCT00162123|21073671|P6|Overall Study|Adverse Event|0
6109371|NCT00162123|21073672|P5|Overall Study|Adverse Event|1
6109372|NCT00162123|21073673|P4|Overall Study|Adverse Event|2
6109373|NCT00162123|21073674|P3|Overall Study|Adverse Event|0
6109374|NCT00162123|21073675|P2|Overall Study|Adverse Event|2
6109375|NCT00162123|21073676|P1|Overall Study|Adverse Event|1
6109376|NCT00162123|21073669|P8|Overall Study|Deterioration without progression|0
6109377|NCT00162123|21073670|P7|Overall Study|Deterioration without progression|0
6109378|NCT00162123|21073671|P6|Overall Study|Deterioration without progression|0
6109379|NCT00162123|21073672|P5|Overall Study|Deterioration without progression|1
6109380|NCT00162123|21073673|P4|Overall Study|Deterioration without progression|0
6109381|NCT00162123|21073674|P3|Overall Study|Deterioration without progression|3
6109382|NCT00162123|21073675|P2|Overall Study|Deterioration without progression|2
6109383|NCT00162123|21073676|P1|Overall Study|Deterioration without progression|2
6109384|NCT00162123|21073669|P8|Overall Study|Withdrawal by Subject|0
6109385|NCT00162123|21073670|P7|Overall Study|Withdrawal by Subject|1
6109386|NCT00162123|21073671|P6|Overall Study|Withdrawal by Subject|2
6109387|NCT00162123|21073672|P5|Overall Study|Withdrawal by Subject|1
6109388|NCT00162123|21073673|P4|Overall Study|Withdrawal by Subject|1
6109389|NCT00162123|21073674|P3|Overall Study|Withdrawal by Subject|2
6109390|NCT00162123|21073675|P2|Overall Study|Withdrawal by Subject|0
6109391|NCT00162123|21073676|P1|Overall Study|Withdrawal by Subject|2
6109392|NCT00162123|21073669|P8|Overall Study|Death|0
6109393|NCT00162123|21073670|P7|Overall Study|Death|0
6109394|NCT00162123|21073671|P6|Overall Study|Death|1
6109395|NCT00162123|21073672|P5|Overall Study|Death|1
6109396|NCT00162123|21073673|P4|Overall Study|Death|1
6109397|NCT00162123|21073674|P3|Overall Study|Death|1
6109398|NCT00162123|21073675|P2|Overall Study|Death|3
6109399|NCT00162123|21073676|P1|Overall Study|Death|3
6109400|NCT00162123|21073669|P8|Overall Study|Study drug toxicity|0
6109401|NCT00162123|21073670|P7|Overall Study|Study drug toxicity|1
6109402|NCT00162123|21073671|P6|Overall Study|Study drug toxicity|1
6109403|NCT00162123|21073672|P5|Overall Study|Study drug toxicity|4
6109404|NCT00162123|21073673|P4|Overall Study|Study drug toxicity|0
6109405|NCT00162123|21073674|P3|Overall Study|Study drug toxicity|5
6109406|NCT00162123|21073675|P2|Overall Study|Study drug toxicity|1
6109407|NCT00162123|21073676|P1|Overall Study|Study drug toxicity|6
6109408|NCT00162123|21073669|P8|Overall Study|Disease progression|0
6109409|NCT00162123|21073670|P7|Overall Study|Disease progression|1
6109410|NCT00162123|21073671|P6|Overall Study|Disease progression|3
6109411|NCT00162123|21073672|P5|Overall Study|Disease progression|8
6109412|NCT00162123|21073673|P4|Overall Study|Disease progression|4
6109413|NCT00162123|21073674|P3|Overall Study|Disease progression|10
6109414|NCT00162123|21073675|P2|Overall Study|Disease progression|19
6109415|NCT00162123|21073676|P1|Overall Study|Disease progression|27
6109416|NCT00162097|21073709|P4|Overall Study|Participant no longer met study criteria|1
6109417|NCT00162097|21073710|P3|Overall Study|Participant no longer met study criteria|0
6109418|NCT00162097|21073711|P2|Overall Study|Participant no longer met study criteria|0
6109419|NCT00162097|21073712|P1|Overall Study|Participant no longer met study criteria|0
6109420|NCT00162032|21073774|P2|Overall Study|Reason not specified|0
6109421|NCT00162032|21073775|P1|Overall Study|Reason not specified|1
6109422|NCT00162032|21073774|P2|Overall Study|Lost to Follow-up|2
6109423|NCT00162032|21073775|P1|Overall Study|Lost to Follow-up|4
6109424|NCT00161616|21073796|P2|Overall Study|Protocol deviation|0
6109425|NCT00161616|21073797|P1|Overall Study|Protocol deviation|1
6109426|NCT00161616|21073796|P2|Overall Study|Lost to Follow-up|13
6109427|NCT00161616|21073797|P1|Overall Study|Lost to Follow-up|17
6109428|NCT00161616|21073796|P2|Overall Study|Death|1
6109429|NCT00161616|21073797|P1|Overall Study|Death|1
6109430|NCT00161616|21073796|P2|Overall Study|Physician Decision|0
6109431|NCT00161616|21073797|P1|Overall Study|Physician Decision|1
6109432|NCT00161616|21073796|P2|Overall Study|Withdrawal by Subject|5
6109433|NCT00161616|21073797|P1|Overall Study|Withdrawal by Subject|6
6109434|NCT00161213|21073829|P1|Overall Study|Evaluable for toxicity but not response|1
6109435|NCT00161213|21073829|P1|Overall Study|Withdrawal by Subject|1
6109436|NCT00160706|21073836|P1|Overall Study|Other Reason|11
6109437|NCT00160706|21073836|P1|Overall Study|Lack of Efficacy and Other|1
6109438|NCT00160706|21073836|P1|Overall Study|Lack of Efficacy|42
6109439|NCT00160706|21073836|P1|Overall Study|Lost to Follow-up and Other|1
6109440|NCT00160706|21073836|P1|Overall Study|Lost to Follow-up|4
6109441|NCT00160706|21073836|P1|Overall Study|Physician Decision and Other|3
6109442|NCT00160706|21073836|P1|Overall Study|Physician Decision|10
6109443|NCT00160706|21073836|P1|Overall Study|Withdrawal by Subject and Other|12
6109444|NCT00160706|21073836|P1|Overall Study|Withdrawal by Subject|41
6109445|NCT00160706|21073836|P1|Overall Study|Protocol Violation|3
6109446|NCT00160706|21073836|P1|Overall Study|Adverse Event and Other Reason|105
6109447|NCT00160706|21073836|P1|Overall Study|Adverse Event|53
6109448|NCT00160693|21073848|P1|Overall Study|Study terminated by sponsor|15
6109449|NCT00160693|21073848|P1|Overall Study|Withdrawal by Subject|54
6109450|NCT00160693|21073848|P1|Overall Study|Lost to Follow-up|15
6109451|NCT00160693|21073848|P1|Overall Study|Protocol Violation|24
6109452|NCT00160693|21073848|P1|Overall Study|Lack of Efficacy|30
6109453|NCT00160693|21073848|P1|Overall Study|Adverse Event|97
6109454|NCT00160680|21073867|P2|Overall Study|Withdrawal by Subject|9
6109455|NCT00160680|21073868|P1|Overall Study|Withdrawal by Subject|4
6109456|NCT00160680|21073867|P2|Overall Study|Lost to Follow-up|2
6109457|NCT00160680|21073868|P1|Overall Study|Lost to Follow-up|3
6109458|NCT00160680|21073867|P2|Overall Study|Lack of Efficacy|1
6109459|NCT00160680|21073868|P1|Overall Study|Lack of Efficacy|2
6109460|NCT00160680|21073867|P2|Overall Study|Adverse Event|1
6109461|NCT00160680|21073868|P1|Overall Study|Adverse Event|0
6109462|NCT00160667|21073903|P3|Overall Study|Patient decision|1
6109463|NCT00160667|21073904|P2|Overall Study|Patient decision|0
6109464|NCT00160667|21073905|P1|Overall Study|Patient decision|0
6109465|NCT00160667|21073903|P3|Overall Study|Protocol Violation|0
6109466|NCT00160667|21073904|P2|Overall Study|Protocol Violation|1
6109467|NCT00160667|21073905|P1|Overall Study|Protocol Violation|0
6109468|NCT00160667|21073903|P3|Overall Study|Lack of Efficacy|0
6109469|NCT00160667|21073904|P2|Overall Study|Lack of Efficacy|1
6109470|NCT00160667|21073905|P1|Overall Study|Lack of Efficacy|0
6109471|NCT00160667|21073903|P3|Overall Study|Withdrawal by Subject|1
6109472|NCT00160667|21073904|P2|Overall Study|Withdrawal by Subject|0
6109473|NCT00160667|21073905|P1|Overall Study|Withdrawal by Subject|2
6109474|NCT00160667|21073903|P3|Overall Study|Adverse Event|4
6109475|NCT00160667|21073904|P2|Overall Study|Adverse Event|1
6109476|NCT00160667|21073905|P1|Overall Study|Adverse Event|3
6109477|NCT00160654|21073952|P1|Overall Study|Met exclusion criteria|1
6109478|NCT00160654|21073952|P1|Overall Study|Poor compliance, dilantin toxicity|1
6109479|NCT00160654|21073952|P1|Overall Study|Patient decision|1
6109480|NCT00160654|21073952|P1|Overall Study|Patient met exclusion criteria|1
6109481|NCT00160654|21073952|P1|Overall Study|Sponsor decision|1
6109482|NCT00160654|21073952|P1|Overall Study|Psychological trauma|1
6109483|NCT00160654|21073952|P1|Overall Study|Intake of expired drug|7
6109484|NCT00160654|21073952|P1|Overall Study|Lost to Follow-up|2
6109485|NCT00160654|21073952|P1|Overall Study|Lack of Efficacy|4
6109486|NCT00160654|21073952|P1|Overall Study|Adverse Event|14
6109487|NCT00160641|21073962|P1|Overall Study|Other|9
6109488|NCT00160641|21073962|P1|Overall Study|Protocol Violation|3
6109489|NCT00160641|21073962|P1|Overall Study|Lack of Efficacy|12
6109490|NCT00160641|21073962|P1|Overall Study|Lost to Follow-up|8
6109491|NCT00160641|21073962|P1|Overall Study|Withdrawal by Subject|87
6109492|NCT00160641|21073962|P1|Overall Study|Adverse Event|102
6109493|NCT00160615|21073995|P2|Overall Study|Poor compliance|1
6109494|NCT00160615|21073996|P1|Overall Study|Poor compliance|0
6109495|NCT00160615|21073995|P2|Overall Study|Non-compliance was suspected|1
6109496|NCT00160615|21073996|P1|Overall Study|Non-compliance was suspected|0
6109497|NCT00160615|21073995|P2|Overall Study|Switch to surgical treatment|2
6109498|NCT00160615|21073996|P1|Overall Study|Switch to surgical treatment|0
6109499|NCT00160615|21073995|P2|Overall Study|AE agents had to be discontinued (exam.)|1
6109500|NCT00160615|21073996|P1|Overall Study|AE agents had to be discontinued (exam.)|0
6109501|NCT00160615|21073995|P2|Overall Study|Investigator decision|1
6109502|NCT00160615|21073996|P1|Overall Study|Investigator decision|1
6109503|NCT00160615|21073995|P2|Overall Study|Patient decision|2
6109504|NCT00160615|21073996|P1|Overall Study|Patient decision|1
6109505|NCT00160615|21073995|P2|Overall Study|Lack of Efficacy|23
6109506|NCT00160615|21073996|P1|Overall Study|Lack of Efficacy|11
6109507|NCT00160615|21073995|P2|Overall Study|Withdrawal by Subject|2
6109508|NCT00160615|21073996|P1|Overall Study|Withdrawal by Subject|0
6109509|NCT00160615|21073995|P2|Overall Study|Adverse Event|12
6109510|NCT00160615|21073996|P1|Overall Study|Adverse Event|5
6109511|NCT00160563|21074019|P3|Overall Study|Missing reason|0
6109512|NCT00160563|21074020|P2|Overall Study|Missing reason|1
6109513|NCT00160563|21074021|P1|Overall Study|Missing reason|0
6109514|NCT00160563|21074019|P3|Overall Study|Other (listed in the study report)|81
6109515|NCT00160563|21074020|P2|Overall Study|Other (listed in the study report)|40
6109516|NCT00160563|21074021|P1|Overall Study|Other (listed in the study report)|48
6109517|NCT00160563|21074019|P3|Overall Study|Withdrawal by Subject|3
6109518|NCT00160563|21074020|P2|Overall Study|Withdrawal by Subject|2
6109519|NCT00160563|21074021|P1|Overall Study|Withdrawal by Subject|1
6109520|NCT00160563|21074019|P3|Overall Study|Protocol Violation|3
6109521|NCT00160563|21074020|P2|Overall Study|Protocol Violation|0
6109522|NCT00160563|21074021|P1|Overall Study|Protocol Violation|0
6109523|NCT00160563|21074019|P3|Overall Study|Lost to Follow-up|2
6109524|NCT00160563|21074020|P2|Overall Study|Lost to Follow-up|1
6109525|NCT00160563|21074021|P1|Overall Study|Lost to Follow-up|1
6109526|NCT00160563|21074019|P3|Overall Study|Adverse Event|1
6109527|NCT00160563|21074020|P2|Overall Study|Adverse Event|1
6109528|NCT00160563|21074021|P1|Overall Study|Adverse Event|1
6109529|NCT00160524|21074033|P1|Overall Study|Other|20
6109530|NCT00160524|21074033|P1|Overall Study|Lack of Efficacy and Other|1
6109531|NCT00160524|21074033|P1|Overall Study|Lack of Efficacy|21
6109532|NCT00160524|21074033|P1|Overall Study|Lost to Follow-up and Other|1
6109533|NCT00160524|21074033|P1|Overall Study|Lost to Follow-up|13
6109534|NCT00160524|21074033|P1|Overall Study|Physician Decision and Other|6
6109535|NCT00160524|21074033|P1|Overall Study|Physician Decision|27
6109536|NCT00160524|21074033|P1|Overall Study|Withdrawal by Subject and Other|17
6109537|NCT00160524|21074033|P1|Overall Study|Withdrawal by Subject|141
6109538|NCT00160524|21074033|P1|Overall Study|Protocol Violation and Other|2
6109539|NCT00160524|21074033|P1|Overall Study|Protocol Violation|16
6109540|NCT00160524|21074033|P1|Overall Study|Adverse Event and Other|94
6109541|NCT00160524|21074033|P1|Overall Study|Adverse Event|119
6109542|NCT00160251|21074050|P8|Post-amendment 2|Lost to follow-up/withdrawal by subject|11
6109543|NCT00160251|21074051|P7|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
6109544|NCT00160251|21074052|P6|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
6109545|NCT00160251|21074053|P5|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
6109546|NCT00160251|21074054|P4|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
6109547|NCT00160251|21074055|P3|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
6109548|NCT00160251|21074056|P2|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
6109549|NCT00160251|21074057|P1|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
6109550|NCT00160251|21074050|P8|Post-amendment 2|Lack of Efficacy|24
6109551|NCT00160251|21074051|P7|Post-amendment 2|Lack of Efficacy|0
6109552|NCT00160251|21074052|P6|Post-amendment 2|Lack of Efficacy|0
6109553|NCT00160251|21074053|P5|Post-amendment 2|Lack of Efficacy|0
6109554|NCT00160251|21074054|P4|Post-amendment 2|Lack of Efficacy|0
6109555|NCT00160251|21074055|P3|Post-amendment 2|Lack of Efficacy|0
6109556|NCT00160251|21074056|P2|Post-amendment 2|Lack of Efficacy|0
6109557|NCT00160251|21074057|P1|Post-amendment 2|Lack of Efficacy|0
6109558|NCT00160251|21074050|P8|Post-amendment 2|Adverse Event|20
6109559|NCT00160251|21074051|P7|Post-amendment 2|Adverse Event|0
6109560|NCT00160251|21074052|P6|Post-amendment 2|Adverse Event|0
6109561|NCT00160251|21074053|P5|Post-amendment 2|Adverse Event|0
6109562|NCT00160251|21074054|P4|Post-amendment 2|Adverse Event|0
6109563|NCT00160251|21074055|P3|Post-amendment 2|Adverse Event|0
6109564|NCT00160251|21074056|P2|Post-amendment 2|Adverse Event|0
6109565|NCT00160251|21074057|P1|Post-amendment 2|Adverse Event|0
6109566|NCT00160251|21074050|P8|Prior to Amendment 2|Completed Treatment Phase|0
6109567|NCT00160251|21074051|P7|Prior to Amendment 2|Completed Treatment Phase|0
6109568|NCT00160251|21074052|P6|Prior to Amendment 2|Completed Treatment Phase|23
6109569|NCT00160251|21074053|P5|Prior to Amendment 2|Completed Treatment Phase|0
6109570|NCT00160251|21074054|P4|Prior to Amendment 2|Completed Treatment Phase|0
6109571|NCT00160251|21074055|P3|Prior to Amendment 2|Completed Treatment Phase|0
6109572|NCT00160251|21074056|P2|Prior to Amendment 2|Completed Treatment Phase|0
6109573|NCT00160251|21074057|P1|Prior to Amendment 2|Completed Treatment Phase|3
6109574|NCT00160251|21074050|P8|Prior to Amendment 2|Noncompliance with protocol|0
6109575|NCT00160251|21074051|P7|Prior to Amendment 2|Noncompliance with protocol|0
6109576|NCT00160251|21074052|P6|Prior to Amendment 2|Noncompliance with protocol|0
6109577|NCT00160251|21074053|P5|Prior to Amendment 2|Noncompliance with protocol|0
6109578|NCT00160251|21074054|P4|Prior to Amendment 2|Noncompliance with protocol|0
6109579|NCT00160251|21074055|P3|Prior to Amendment 2|Noncompliance with protocol|0
6109580|NCT00160251|21074056|P2|Prior to Amendment 2|Noncompliance with protocol|0
6109581|NCT00160251|21074057|P1|Prior to Amendment 2|Noncompliance with protocol|1
6109582|NCT00160251|21074050|P8|Prior to Amendment 2|Withdrawal by Subject|0
6109583|NCT00160251|21074051|P7|Prior to Amendment 2|Withdrawal by Subject|3
6109584|NCT00160251|21074052|P6|Prior to Amendment 2|Withdrawal by Subject|3
6109585|NCT00160251|21074053|P5|Prior to Amendment 2|Withdrawal by Subject|2
6109586|NCT00160251|21074054|P4|Prior to Amendment 2|Withdrawal by Subject|4
6109587|NCT00160251|21074055|P3|Prior to Amendment 2|Withdrawal by Subject|3
6109588|NCT00160251|21074056|P2|Prior to Amendment 2|Withdrawal by Subject|1
6109589|NCT00160251|21074057|P1|Prior to Amendment 2|Withdrawal by Subject|3
6109590|NCT00160251|21074050|P8|Prior to Amendment 2|Lost to Follow-up|0
6109591|NCT00160251|21074051|P7|Prior to Amendment 2|Lost to Follow-up|0
6109592|NCT00160251|21074052|P6|Prior to Amendment 2|Lost to Follow-up|1
6109593|NCT00160251|21074053|P5|Prior to Amendment 2|Lost to Follow-up|1
6109594|NCT00160251|21074054|P4|Prior to Amendment 2|Lost to Follow-up|0
6109595|NCT00160251|21074055|P3|Prior to Amendment 2|Lost to Follow-up|1
6109596|NCT00160251|21074056|P2|Prior to Amendment 2|Lost to Follow-up|0
6109597|NCT00160251|21074057|P1|Prior to Amendment 2|Lost to Follow-up|0
6109598|NCT00160251|21074050|P8|Prior to Amendment 2|Lack of Efficacy|0
6109599|NCT00160251|21074051|P7|Prior to Amendment 2|Lack of Efficacy|0
6109600|NCT00160251|21074052|P6|Prior to Amendment 2|Lack of Efficacy|55
6109601|NCT00160251|21074053|P5|Prior to Amendment 2|Lack of Efficacy|24
6109602|NCT00160251|21074054|P4|Prior to Amendment 2|Lack of Efficacy|35
6109603|NCT00160251|21074055|P3|Prior to Amendment 2|Lack of Efficacy|37
6109604|NCT00160251|21074056|P2|Prior to Amendment 2|Lack of Efficacy|4
6109605|NCT00160251|21074057|P1|Prior to Amendment 2|Lack of Efficacy|0
6109606|NCT00160251|21074050|P8|Prior to Amendment 2|Adverse Event|0
6109607|NCT00160251|21074051|P7|Prior to Amendment 2|Adverse Event|1
6109608|NCT00160251|21074052|P6|Prior to Amendment 2|Adverse Event|1
6109609|NCT00160251|21074053|P5|Prior to Amendment 2|Adverse Event|1
6109610|NCT00160251|21074054|P4|Prior to Amendment 2|Adverse Event|1
6109611|NCT00160251|21074055|P3|Prior to Amendment 2|Adverse Event|3
6109612|NCT00160251|21074056|P2|Prior to Amendment 2|Adverse Event|1
6109613|NCT00160251|21074057|P1|Prior to Amendment 2|Adverse Event|2
6109614|NCT00160199|21074133|P2|Overall Study|Protocol Violation|8
6109615|NCT00160199|21074134|P1|Overall Study|Protocol Violation|8
6109616|NCT00160199|21074133|P2|Overall Study|Administrative|1
6109617|NCT00160199|21074134|P1|Overall Study|Administrative|0
6109618|NCT00160199|21074133|P2|Overall Study|Withdrawal by Subject|6
6109619|NCT00160199|21074134|P1|Overall Study|Withdrawal by Subject|4
6109620|NCT00160199|21074133|P2|Overall Study|Lost to Follow-up|7
6109621|NCT00160199|21074134|P1|Overall Study|Lost to Follow-up|7
6109622|NCT00160199|21074133|P2|Overall Study|Lack of Efficacy|1
6109623|NCT00160199|21074134|P1|Overall Study|Lack of Efficacy|0
6109624|NCT00160199|21074133|P2|Overall Study|Adverse Event|14
6109625|NCT00160199|21074134|P1|Overall Study|Adverse Event|5
6109727|NCT00159822|21074466|P1|Post-treatment Follow-up Period|Reason unspecified|1
6109728|NCT00159822|21074466|P1|Post-treatment Follow-up Period|Withdrawal by Subject|1
6109729|NCT00159822|21074466|P1|Post-treatment Follow-up Period|Death|1
6109730|NCT00159822|21074466|P1|Voriconazole Treatment Period|Withdrawal by Subject|2
6109731|NCT00159822|21074466|P1|Voriconazole Treatment Period|Lost to Follow-up|2
6109732|NCT00159822|21074466|P1|Voriconazole Treatment Period|Protocol Violation|2
6109733|NCT00159822|21074466|P1|Voriconazole Treatment Period|Death|4
6109734|NCT00159822|21074466|P1|Voriconazole Treatment Period|Adverse Event|9
6109735|NCT00159822|21074466|P1|Voriconazole Treatment Period|Lack of Efficacy|3
6109736|NCT00159783|21074484|P3|Overall Study|Other|4
6109737|NCT00159783|21074485|P2|Overall Study|Other|2
6109738|NCT00159783|21074486|P1|Overall Study|Other|0
6109739|NCT00159783|21074484|P3|Overall Study|Lost to Follow-up|11
6109740|NCT00159783|21074485|P2|Overall Study|Lost to Follow-up|5
6109741|NCT00159783|21074486|P1|Overall Study|Lost to Follow-up|6
6109742|NCT00159783|21074484|P3|Overall Study|Withdrawal by Subject|12
6109743|NCT00159783|21074485|P2|Overall Study|Withdrawal by Subject|11
6109744|NCT00159783|21074486|P1|Overall Study|Withdrawal by Subject|7
6109745|NCT00159783|21074484|P3|Overall Study|Lack of Efficacy|3
6109746|NCT00159783|21074485|P2|Overall Study|Lack of Efficacy|2
6109747|NCT00159783|21074486|P1|Overall Study|Lack of Efficacy|1
6109748|NCT00159783|21074484|P3|Overall Study|Adverse Event|9
6109749|NCT00159783|21074485|P2|Overall Study|Adverse Event|7
6109750|NCT00159783|21074486|P1|Overall Study|Adverse Event|5
6109751|NCT00159432|21074516|P1|Overall Study|Lack of Efficacy|8
6109752|NCT00159432|21074516|P1|Overall Study|Death|1
6109753|NCT00159432|21074516|P1|Overall Study|Adverse Event|1
6109754|NCT00158860|21074590|P2|Overall Study|Closed per sponsor|1
6109755|NCT00158860|21074591|P1|Overall Study|Closed per sponsor|0
6109756|NCT00158860|21074590|P2|Overall Study|Lost to Follow up but returned per GSK|1
6109757|NCT00158860|21074591|P1|Overall Study|Lost to Follow up but returned per GSK|0
6109758|NCT00158860|21074590|P2|Overall Study|SPONSOR REQUEST|1
6109759|NCT00158860|21074591|P1|Overall Study|SPONSOR REQUEST|0
6109760|NCT00158860|21074590|P2|Overall Study|SPONSOR STOPPED STUDY|2
6109761|NCT00158860|21074591|P1|Overall Study|SPONSOR STOPPED STUDY|2
6109762|NCT00158860|21074590|P2|Overall Study|Pregnancy|3
6109763|NCT00158860|21074591|P1|Overall Study|Pregnancy|3
6109764|NCT00158860|21074590|P2|Overall Study|MOVING OUT OF STATE|0
6109765|NCT00158860|21074591|P1|Overall Study|MOVING OUT OF STATE|1
6109766|NCT00158860|21074590|P2|Overall Study|Withdrawal by Subject|17
6109767|NCT00158860|21074591|P1|Overall Study|Withdrawal by Subject|7
6109768|NCT00158860|21074590|P2|Overall Study|Protocol Violation|23
6109769|NCT00158860|21074591|P1|Overall Study|Protocol Violation|8
6109770|NCT00158860|21074590|P2|Overall Study|Lost to Follow-up|17
6109771|NCT00158860|21074591|P1|Overall Study|Lost to Follow-up|11
6109772|NCT00158860|21074590|P2|Overall Study|Adverse Event|6
6109773|NCT00158860|21074591|P1|Overall Study|Adverse Event|3
6109774|NCT00158756|21074610|P5|Overall Study|Serious adverse event|0
6109775|NCT00158756|21074611|P4|Overall Study|Serious adverse event|0
6109776|NCT00158756|21074612|P3|Overall Study|Serious adverse event|1
6109777|NCT00158756|21074613|P2|Overall Study|Serious adverse event|0
6109778|NCT00158756|21074614|P1|Overall Study|Serious adverse event|0
6109779|NCT00158756|21074610|P5|Overall Study|Adverse Event|0
6109780|NCT00158756|21074611|P4|Overall Study|Adverse Event|0
6109781|NCT00158756|21074612|P3|Overall Study|Adverse Event|1
6109782|NCT00158756|21074613|P2|Overall Study|Adverse Event|0
6109783|NCT00158756|21074614|P1|Overall Study|Adverse Event|0
6109784|NCT00158756|21074610|P5|Overall Study|Withdrawal by Subject|3
6109785|NCT00158756|21074611|P4|Overall Study|Withdrawal by Subject|1
6109786|NCT00158756|21074612|P3|Overall Study|Withdrawal by Subject|6
6109787|NCT00158756|21074613|P2|Overall Study|Withdrawal by Subject|0
6109788|NCT00158756|21074614|P1|Overall Study|Withdrawal by Subject|5
6109789|NCT00158600|21074720|P2|Overall Study|Withdrawal by Subject|2
6109790|NCT00158600|21074721|P1|Overall Study|Withdrawal by Subject|2
6109791|NCT00158600|21074720|P2|Overall Study|Death|0
6109792|NCT00158600|21074721|P1|Overall Study|Death|1
6109793|NCT00158600|21074720|P2|Overall Study|Adverse Event|1
6109794|NCT00158600|21074721|P1|Overall Study|Adverse Event|2
6109795|NCT00158600|21074720|P2|Overall Study|unable to commit time to study|1
6109796|NCT00158600|21074721|P1|Overall Study|unable to commit time to study|0
6109797|NCT00158262|21074746|P2|Overall Study|Lost to Follow-up|1
6109798|NCT00158262|21074747|P1|Overall Study|Lost to Follow-up|1
6109799|NCT00158184|21074808|P2|Overall Study|Adverse Event|1
6109800|NCT00158184|21074809|P1|Overall Study|Adverse Event|1
6109801|NCT00158184|21074808|P2|Overall Study|failed for follow unit/study rules|0
6109802|NCT00158184|21074809|P1|Overall Study|failed for follow unit/study rules|2
6109803|NCT00158184|21074808|P2|Overall Study|personal issues|1
6109804|NCT00158184|21074809|P1|Overall Study|personal issues|3
6109805|NCT00158054|21074819|P2|Overall Study|Unavailable for follow up|3
6109806|NCT00158054|21074820|P1|Overall Study|Unavailable for follow up|7
6109807|NCT00158054|21074819|P2|Overall Study|Refused to continue|0
6109808|NCT00158054|21074820|P1|Overall Study|Refused to continue|3
6109809|NCT00157950|21074834|P2|Overall Study|Death|0
6109810|NCT00157950|21074835|P1|Overall Study|Death|1
6109811|NCT00157820|21074852|P3|2nd 8 Months|Premature cross-over|9
6109812|NCT00157820|21074853|P2|2nd 8 Months|Premature cross-over|7
6109813|NCT00157820|21074854|P1|2nd 8 Months|Premature cross-over|1
6109814|NCT00157820|21074852|P3|2nd 8 Months|Lost to Follow-up|2
6109815|NCT00157820|21074853|P2|2nd 8 Months|Lost to Follow-up|5
6109816|NCT00157820|21074854|P1|2nd 8 Months|Lost to Follow-up|1
6109817|NCT00157820|21074852|P3|2nd 8 Months|Death|3
6109818|NCT00157820|21074853|P2|2nd 8 Months|Death|1
6109819|NCT00157820|21074854|P1|2nd 8 Months|Death|3
6109820|NCT00157820|21074852|P3|1st 8 Month|Premature cross-over|2
6109821|NCT00157820|21074853|P2|1st 8 Month|Premature cross-over|2
6109822|NCT00157820|21074854|P1|1st 8 Month|Premature cross-over|0
6109823|NCT00157820|21074852|P3|1st 8 Month|Lost to Follow-up|1
6109824|NCT00157820|21074853|P2|1st 8 Month|Lost to Follow-up|2
6109825|NCT00157820|21074854|P1|1st 8 Month|Lost to Follow-up|1
6109826|NCT00157820|21074852|P3|1st 8 Month|Death|3
6109827|NCT00157820|21074853|P2|1st 8 Month|Death|8
6109828|NCT00157820|21074854|P1|1st 8 Month|Death|7
6109829|NCT00157820|21074852|P3|Randomized|Protocol Violation|2
6109830|NCT00157820|21074853|P2|Randomized|Protocol Violation|1
6109831|NCT00157820|21074854|P1|Randomized|Protocol Violation|2
6109832|NCT00157820|21074852|P3|Randomized|Withdrawal by Subject|3
6109833|NCT00157820|21074853|P2|Randomized|Withdrawal by Subject|2
6109834|NCT00157820|21074854|P1|Randomized|Withdrawal by Subject|1
6109835|NCT00157820|21074852|P3|Randomized|Physician Decision|3
6109836|NCT00157820|21074853|P2|Randomized|Physician Decision|2
6109837|NCT00157820|21074854|P1|Randomized|Physician Decision|4
6109838|NCT00157755|21074867|P6|Overall Study|Study completion|2
6109839|NCT00157755|21074868|P5|Overall Study|Study completion|1
6109840|NCT00157755|21074869|P4|Overall Study|Study completion|0
6109841|NCT00157755|21074870|P3|Overall Study|Study completion|0
6109842|NCT00157755|21074871|P2|Overall Study|Study completion|0
6109843|NCT00157755|21074872|P1|Overall Study|Study completion|0
6109844|NCT00157755|21074867|P6|Overall Study|Subject non-compliance|1
6109845|NCT00157755|21074868|P5|Overall Study|Subject non-compliance|0
6109846|NCT00157755|21074869|P4|Overall Study|Subject non-compliance|0
6109847|NCT00157755|21074870|P3|Overall Study|Subject non-compliance|0
6109848|NCT00157755|21074871|P2|Overall Study|Subject non-compliance|0
6109849|NCT00157755|21074872|P1|Overall Study|Subject non-compliance|0
6109850|NCT00157755|21074867|P6|Overall Study|Study site closure|0
6109851|NCT00157755|21074868|P5|Overall Study|Study site closure|0
6109852|NCT00157755|21074869|P4|Overall Study|Study site closure|0
6109853|NCT00157755|21074870|P3|Overall Study|Study site closure|0
6109854|NCT00157755|21074871|P2|Overall Study|Study site closure|1
6109855|NCT00157755|21074872|P1|Overall Study|Study site closure|0
6109856|NCT00157755|21074867|P6|Overall Study|Medical reason|0
6109857|NCT00157755|21074868|P5|Overall Study|Medical reason|0
6109858|NCT00157755|21074869|P4|Overall Study|Medical reason|1
6109859|NCT00157755|21074870|P3|Overall Study|Medical reason|1
6109860|NCT00157755|21074871|P2|Overall Study|Medical reason|0
6109861|NCT00157755|21074872|P1|Overall Study|Medical reason|0
6109862|NCT00157755|21074867|P6|Overall Study|Explant due to infection|0
6109863|NCT00157755|21074868|P5|Overall Study|Explant due to infection|0
6109864|NCT00157755|21074869|P4|Overall Study|Explant due to infection|0
6109865|NCT00157755|21074870|P3|Overall Study|Explant due to infection|1
6109866|NCT00157755|21074871|P2|Overall Study|Explant due to infection|0
6109867|NCT00157755|21074872|P1|Overall Study|Explant due to infection|0
6109868|NCT00157755|21074867|P6|Overall Study|Withdrawal by Subject|2
6109869|NCT00157755|21074868|P5|Overall Study|Withdrawal by Subject|1
6109870|NCT00157755|21074869|P4|Overall Study|Withdrawal by Subject|1
6109871|NCT00157755|21074870|P3|Overall Study|Withdrawal by Subject|1
6109872|NCT00157755|21074871|P2|Overall Study|Withdrawal by Subject|0
6109873|NCT00157755|21074872|P1|Overall Study|Withdrawal by Subject|0
6109874|NCT00157755|21074867|P6|Overall Study|Lost to Follow-up|0
6109875|NCT00157755|21074868|P5|Overall Study|Lost to Follow-up|0
6109876|NCT00157755|21074869|P4|Overall Study|Lost to Follow-up|0
6109877|NCT00157755|21074870|P3|Overall Study|Lost to Follow-up|1
6109878|NCT00157755|21074871|P2|Overall Study|Lost to Follow-up|0
6109879|NCT00157755|21074872|P1|Overall Study|Lost to Follow-up|0
6109880|NCT00157755|21074867|P6|Overall Study|Death|0
6109881|NCT00157755|21074868|P5|Overall Study|Death|0
6109882|NCT00157755|21074869|P4|Overall Study|Death|2
6109883|NCT00157755|21074870|P3|Overall Study|Death|3
6109884|NCT00157755|21074871|P2|Overall Study|Death|3
6109885|NCT00157755|21074872|P1|Overall Study|Death|2
6109886|NCT00157248|21074908|P4|Overall Study|site closures, subject moving|9
6109887|NCT00157248|21074909|P3|Overall Study|site closures, subject moving|3
6109888|NCT00157248|21074910|P2|Overall Study|site closures, subject moving|7
6109889|NCT00157248|21074911|P1|Overall Study|site closures, subject moving|7
6109890|NCT00157248|21074908|P4|Overall Study|Withdrawal by Subject|3
6109891|NCT00157248|21074909|P3|Overall Study|Withdrawal by Subject|3
6109892|NCT00157248|21074910|P2|Overall Study|Withdrawal by Subject|4
6109893|NCT00157248|21074911|P1|Overall Study|Withdrawal by Subject|1
6109894|NCT00157248|21074908|P4|Overall Study|Lost to Follow-up|0
6109895|NCT00157248|21074909|P3|Overall Study|Lost to Follow-up|0
6109896|NCT00157248|21074910|P2|Overall Study|Lost to Follow-up|1
6109897|NCT00157248|21074911|P1|Overall Study|Lost to Follow-up|0
6109898|NCT00157248|21074908|P4|Overall Study|Protocol Violation|2
6109899|NCT00157248|21074909|P3|Overall Study|Protocol Violation|2
6109900|NCT00157248|21074910|P2|Overall Study|Protocol Violation|0
6109901|NCT00157248|21074911|P1|Overall Study|Protocol Violation|4
6109902|NCT00157248|21074908|P4|Overall Study|Adverse Event|33
6109903|NCT00157248|21074909|P3|Overall Study|Adverse Event|13
6109904|NCT00157248|21074910|P2|Overall Study|Adverse Event|25
6109905|NCT00157248|21074911|P1|Overall Study|Adverse Event|36
6109906|NCT00157209|21075017|P2|Overall Study|Ongoing at data cut-off|0
6109907|NCT00157209|21075018|P1|Overall Study|Ongoing at data cut-off|10
6109908|NCT00157196|21075032|P1|Overall Study|Ongoing at data cut-off|9
6109909|NCT00157157|21075038|P1|Overall Study|Inclusion not met- baseline FVIII value|1
6109910|NCT00157157|21075038|P1|Overall Study|Met exclusion criteria|1
6109911|NCT00157157|21075038|P1|Overall Study|Enrolled in another study|1
6109912|NCT00157157|21075038|P1|Overall Study|Lost to Follow-up|1
6109913|NCT00157157|21075038|P1|Overall Study|Physician Decision|1
6109914|NCT00157157|21075038|P1|Overall Study|Withdrawal by Subject|6
6109915|NCT00157014|21075065|P4|Overall Study|Withdrawal by Subject|0
6109916|NCT00157014|21075066|P3|Overall Study|Withdrawal by Subject|0
6109917|NCT00157014|21075067|P2|Overall Study|Withdrawal by Subject|0
6109918|NCT00157014|21075068|P1|Overall Study|Withdrawal by Subject|1
6109919|NCT00157014|21075065|P4|Overall Study|Patient would not receive transplant|0
6109920|NCT00157014|21075066|P3|Overall Study|Patient would not receive transplant|0
6109921|NCT00157014|21075067|P2|Overall Study|Patient would not receive transplant|1
6109922|NCT00157014|21075068|P1|Overall Study|Patient would not receive transplant|0
6109923|NCT00157014|21075065|P4|Overall Study|Patient unable to return in nursing home|0
6109924|NCT00157014|21075066|P3|Overall Study|Patient unable to return in nursing home|0
6109925|NCT00157014|21075067|P2|Overall Study|Patient unable to return in nursing home|0
6109926|NCT00157014|21075068|P1|Overall Study|Patient unable to return in nursing home|1
6109927|NCT00157014|21075065|P4|Overall Study|Patient withdrawn by investigator|0
6109928|NCT00157014|21075066|P3|Overall Study|Patient withdrawn by investigator|0
6109929|NCT00157014|21075067|P2|Overall Study|Patient withdrawn by investigator|0
6109930|NCT00157014|21075068|P1|Overall Study|Patient withdrawn by investigator|1
6109931|NCT00157014|21075065|P4|Overall Study|Medications withdrawn on family request|0
6109932|NCT00157014|21075066|P3|Overall Study|Medications withdrawn on family request|0
6109933|NCT00157014|21075067|P2|Overall Study|Medications withdrawn on family request|1
6109934|NCT00157014|21075068|P1|Overall Study|Medications withdrawn on family request|0
6109935|NCT00157014|21075065|P4|Overall Study|Physician Decision|0
6109936|NCT00157014|21075066|P3|Overall Study|Physician Decision|0
6109937|NCT00157014|21075067|P2|Overall Study|Physician Decision|1
6109938|NCT00157014|21075068|P1|Overall Study|Physician Decision|0
6109939|NCT00157014|21075065|P4|Overall Study|Death|1
6109940|NCT00157014|21075066|P3|Overall Study|Death|1
6109941|NCT00157014|21075067|P2|Overall Study|Death|2
6109942|NCT00157014|21075068|P1|Overall Study|Death|4
6109943|NCT00156819|21075184|P3|Overall Study|Lost to Follow-up|3
6109944|NCT00156819|21075185|P2|Overall Study|Lost to Follow-up|1
6109945|NCT00156819|21075186|P1|Overall Study|Lost to Follow-up|1
6109946|NCT00156533|21075203|P4|Overall Study|Failed Screening|1
6109947|NCT00156533|21075204|P3|Overall Study|Failed Screening|1
6109948|NCT00156533|21075205|P2|Overall Study|Failed Screening|0
6109949|NCT00156533|21075206|P1|Overall Study|Failed Screening|1
6109950|NCT00156533|21075203|P4|Overall Study|Withdrawal by Subject|1
6109951|NCT00156533|21075204|P3|Overall Study|Withdrawal by Subject|0
6109952|NCT00156533|21075205|P2|Overall Study|Withdrawal by Subject|0
6109953|NCT00156533|21075206|P1|Overall Study|Withdrawal by Subject|1
6109954|NCT00156533|21075203|P4|Overall Study|Withdrawn - Medication Expiration|0
6109955|NCT00156533|21075204|P3|Overall Study|Withdrawn - Medication Expiration|1
6109956|NCT00156533|21075205|P2|Overall Study|Withdrawn - Medication Expiration|2
6109957|NCT00156533|21075206|P1|Overall Study|Withdrawn - Medication Expiration|0
6109958|NCT00156065|21075240|P3|Overall Study|Other|3
6109959|NCT00156065|21075241|P2|Overall Study|Other|9
6109960|NCT00156065|21075242|P1|Overall Study|Other|2
6109961|NCT00156065|21075240|P3|Overall Study|Lost to Follow-up|1
6109962|NCT00156065|21075241|P2|Overall Study|Lost to Follow-up|7
6109963|NCT00156065|21075242|P1|Overall Study|Lost to Follow-up|5
6109964|NCT00156065|21075240|P3|Overall Study|Withdrawal by Subject|16
6109965|NCT00156065|21075241|P2|Overall Study|Withdrawal by Subject|26
6109966|NCT00156065|21075242|P1|Overall Study|Withdrawal by Subject|13
6109967|NCT00156065|21075240|P3|Overall Study|Lack of Efficacy|3
6109968|NCT00156065|21075241|P2|Overall Study|Lack of Efficacy|9
6109969|NCT00156065|21075242|P1|Overall Study|Lack of Efficacy|2
6109970|NCT00156065|21075240|P3|Overall Study|Adverse Event|4
6109971|NCT00156065|21075241|P2|Overall Study|Adverse Event|11
6109972|NCT00156065|21075242|P1|Overall Study|Adverse Event|8
6109973|NCT00156065|21075240|P3|Overall Study|Enrolled But Never Received Treatment|0
6109974|NCT00156065|21075241|P2|Overall Study|Enrolled But Never Received Treatment|1
6109975|NCT00156065|21075242|P1|Overall Study|Enrolled But Never Received Treatment|1
6109976|NCT00154375|21075276|P2|Overall Study|Suspected progression of disease|30
6109977|NCT00154375|21075277|P1|Overall Study|Suspected progression of disease|44
6109978|NCT00154375|21075276|P2|Overall Study|Protocol Violation|1
6109979|NCT00154375|21075277|P1|Overall Study|Protocol Violation|0
6109980|NCT00154375|21075276|P2|Overall Study|Abnormal laboratory value(s)|2
6109981|NCT00154375|21075277|P1|Overall Study|Abnormal laboratory value(s)|0
6109982|NCT00154375|21075276|P2|Overall Study|Lost to Follow-up|1
6109983|NCT00154375|21075277|P1|Overall Study|Lost to Follow-up|2
6109984|NCT00154375|21075276|P2|Overall Study|Study drug no longer required|3
6109985|NCT00154375|21075277|P1|Overall Study|Study drug no longer required|5
6109986|NCT00154375|21075276|P2|Overall Study|Death|13
6109987|NCT00154375|21075277|P1|Overall Study|Death|5
6109988|NCT00154375|21075276|P2|Overall Study|Withdrawal by Subject|10
6109989|NCT00154375|21075277|P1|Overall Study|Withdrawal by Subject|14
6109990|NCT00154375|21075276|P2|Overall Study|Adverse Event|20
6109991|NCT00154375|21075277|P1|Overall Study|Adverse Event|18
6109992|NCT00154375|21075276|P2|Overall Study|Unsatisfactory therapeutic effect|26
6109993|NCT00154375|21075277|P1|Overall Study|Unsatisfactory therapeutic effect|25
6109994|NCT00154310|21075288|P2|Overall Study|Death|1
6109995|NCT00154310|21075289|P1|Overall Study|Death|0
6109996|NCT00154310|21075288|P2|Overall Study|Administrative problems|1
6109997|NCT00154310|21075289|P1|Overall Study|Administrative problems|0
6109998|NCT00154310|21075288|P2|Overall Study|Lost to Follow-up|8
6109999|NCT00154310|21075289|P1|Overall Study|Lost to Follow-up|0
6110000|NCT00154310|21075288|P2|Overall Study|Withdrawal by Subject|3
6110001|NCT00154310|21075289|P1|Overall Study|Withdrawal by Subject|9
6110002|NCT00154310|21075288|P2|Overall Study|Protocol Violation|2
6110003|NCT00154310|21075289|P1|Overall Study|Protocol Violation|4
6110004|NCT00154310|21075288|P2|Overall Study|Lack of Efficacy|4
6110005|NCT00154310|21075289|P1|Overall Study|Lack of Efficacy|5
6110006|NCT00154310|21075288|P2|Overall Study|Adverse Event|9
6110007|NCT00154310|21075289|P1|Overall Study|Adverse Event|19
6110008|NCT00154297|21075305|P2|Overall Study|Lost to Follow-up|0
6110009|NCT00154297|21075306|P1|Overall Study|Lost to Follow-up|3
6110010|NCT00154297|21075305|P2|Overall Study|Withdrawal by Subject|5
6110011|NCT00154297|21075306|P1|Overall Study|Withdrawal by Subject|0
6110012|NCT00154297|21075305|P2|Overall Study|Death|2
6110013|NCT00154297|21075306|P1|Overall Study|Death|5
6110014|NCT00154284|21075324|P2|Overall Study|Protocol Violation|1
6110015|NCT00154284|21075325|P1|Overall Study|Protocol Violation|0
6110016|NCT00154284|21075324|P2|Overall Study|Lack of Efficacy|2
6110017|NCT00154284|21075325|P1|Overall Study|Lack of Efficacy|1
6110018|NCT00154284|21075324|P2|Overall Study|Abnormal laboratory value(s)|1
6110019|NCT00154284|21075325|P1|Overall Study|Abnormal laboratory value(s)|0
6110020|NCT00154284|21075324|P2|Overall Study|Adverse Event|9
6110021|NCT00154284|21075325|P1|Overall Study|Adverse Event|6
6110022|NCT00154102|21075339|P2|Overall Study|investigational study phase ongoing|2
6110023|NCT00154102|21075340|P1|Overall Study|investigational study phase ongoing|7
6110024|NCT00154063|21075376|P2|Overall Study|Other|3
6110025|NCT00154063|21075377|P1|Overall Study|Other|3
6110026|NCT00154063|21075376|P2|Overall Study|Withdrawal by Subject|9
6110027|NCT00154063|21075377|P1|Overall Study|Withdrawal by Subject|4
6110028|NCT00154063|21075376|P2|Overall Study|Investigator or Sponsor Request|1
6110029|NCT00154063|21075377|P1|Overall Study|Investigator or Sponsor Request|0
6110030|NCT00154063|21075376|P2|Overall Study|Protocol Violation|1
6110031|NCT00154063|21075377|P1|Overall Study|Protocol Violation|1
6110032|NCT00154063|21075376|P2|Overall Study|Adverse Event|8
6110033|NCT00154063|21075377|P1|Overall Study|Adverse Event|4
6110034|NCT00153920|21075439|P1|Overall Study|Progressive Disease before Trt|1
6110035|NCT00153920|21075439|P1|Overall Study|Withdrawal of Consent before Trt|1
6110036|NCT00153920|21075439|P1|Overall Study|Non-Protocol Therapy|1
6110037|NCT00153920|21075439|P1|Overall Study|Withdrawal by Subject|1
6110038|NCT00153920|21075439|P1|Overall Study|Death|2
6110039|NCT00153920|21075439|P1|Overall Study|Lack of Response|3
6110040|NCT00153920|21075439|P1|Overall Study|Physician Decision|3
6110041|NCT00153920|21075439|P1|Overall Study|Progressive Disease|9
6110042|NCT00153920|21075439|P1|Overall Study|Adverse Event|9
6110043|NCT00153816|21075465|P6|Overall Study|Follow-up exam done, histology missing|2
6110044|NCT00153816|21075466|P5|Overall Study|Follow-up exam done, histology missing|1
6110045|NCT00153816|21075467|P4|Overall Study|Follow-up exam done, histology missing|3
6110046|NCT00153816|21075468|P3|Overall Study|Follow-up exam done, histology missing|3
6110047|NCT00153816|21075469|P2|Overall Study|Follow-up exam done, histology missing|3
6110048|NCT00153816|21075470|P1|Overall Study|Follow-up exam done, histology missing|2
6110049|NCT00153816|21075465|P6|Overall Study|Follow-up exam not done|9
6110050|NCT00153816|21075466|P5|Overall Study|Follow-up exam not done|8
6110051|NCT00153816|21075467|P4|Overall Study|Follow-up exam not done|10
6110052|NCT00153816|21075468|P3|Overall Study|Follow-up exam not done|11
6110053|NCT00153816|21075469|P2|Overall Study|Follow-up exam not done|7
6110054|NCT00153816|21075470|P1|Overall Study|Follow-up exam not done|8
6110055|NCT00153816|21075465|P6|Overall Study|Withdrawal by Subject|5
6110056|NCT00153816|21075466|P5|Overall Study|Withdrawal by Subject|1
6110057|NCT00153816|21075467|P4|Overall Study|Withdrawal by Subject|4
6110058|NCT00153816|21075468|P3|Overall Study|Withdrawal by Subject|9
6110059|NCT00153816|21075469|P2|Overall Study|Withdrawal by Subject|9
6110060|NCT00153816|21075470|P1|Overall Study|Withdrawal by Subject|9
6110061|NCT00153816|21075465|P6|Overall Study|Lost to Follow-up|9
6110062|NCT00153816|21075466|P5|Overall Study|Lost to Follow-up|7
6110063|NCT00153816|21075467|P4|Overall Study|Lost to Follow-up|8
6110064|NCT00153816|21075468|P3|Overall Study|Lost to Follow-up|5
6110065|NCT00153816|21075469|P2|Overall Study|Lost to Follow-up|8
6110066|NCT00153816|21075470|P1|Overall Study|Lost to Follow-up|7
6110067|NCT00153816|21075465|P6|Overall Study|Death|2
6110068|NCT00153816|21075466|P5|Overall Study|Death|0
6110069|NCT00153816|21075467|P4|Overall Study|Death|6
6110070|NCT00153816|21075468|P3|Overall Study|Death|4
6110071|NCT00153816|21075469|P2|Overall Study|Death|5
6110072|NCT00153816|21075470|P1|Overall Study|Death|6
6110073|NCT00153179|21075511|P4|Study Visit Day 2|Withdrawal by Subject|2
6110074|NCT00153179|21075512|P3|Study Visit Day 2|Withdrawal by Subject|2
6110075|NCT00153179|21075513|P2|Study Visit Day 2|Withdrawal by Subject|0
6110076|NCT00153179|21075514|P1|Study Visit Day 2|Withdrawal by Subject|1
6110077|NCT00153101|21075546|P5|Overall Study|Withdrawal by Subject|5
6110078|NCT00153101|21075547|P4|Overall Study|Withdrawal by Subject|3
6110079|NCT00153101|21075548|P3|Overall Study|Withdrawal by Subject|3
6110080|NCT00153101|21075549|P2|Overall Study|Withdrawal by Subject|4
6110081|NCT00153101|21075550|P1|Overall Study|Withdrawal by Subject|3
6110082|NCT00153101|21075546|P5|Overall Study|Lost to Follow-up|5
6110083|NCT00153101|21075547|P4|Overall Study|Lost to Follow-up|5
6110084|NCT00153101|21075548|P3|Overall Study|Lost to Follow-up|12
6110085|NCT00153101|21075549|P2|Overall Study|Lost to Follow-up|14
6110086|NCT00153101|21075550|P1|Overall Study|Lost to Follow-up|14
6110087|NCT00153062|21075658|P4|Overall Study|Other|0
6110088|NCT00153062|21075659|P3|Overall Study|Other|1
6110089|NCT00153062|21075660|P2|Overall Study|Other|0
6110090|NCT00153062|21075661|P1|Overall Study|Other|0
6110091|NCT00153062|21075658|P4|Overall Study|No disposition data available|1
6110092|NCT00153062|21075659|P3|Overall Study|No disposition data available|1
6110093|NCT00153062|21075660|P2|Overall Study|No disposition data available|1
6110094|NCT00153062|21075661|P1|Overall Study|No disposition data available|1
6110095|NCT00153062|21075658|P4|Overall Study|Protocol Violation|1
6110096|NCT00153062|21075659|P3|Overall Study|Protocol Violation|1
6110097|NCT00153062|21075660|P2|Overall Study|Protocol Violation|2
6110098|NCT00153062|21075661|P1|Overall Study|Protocol Violation|0
6110099|NCT00153062|21075658|P4|Overall Study|Adverse Event|0
6110100|NCT00153062|21075659|P3|Overall Study|Adverse Event|1
6110101|NCT00153062|21075660|P2|Overall Study|Adverse Event|1
6110102|NCT00153062|21075661|P1|Overall Study|Adverse Event|0
6110103|NCT00153062|21075658|P4|Overall Study|Lost to Follow-up|16
6110104|NCT00153062|21075659|P3|Overall Study|Lost to Follow-up|15
6110105|NCT00153062|21075660|P2|Overall Study|Lost to Follow-up|20
6110106|NCT00153062|21075661|P1|Overall Study|Lost to Follow-up|12
6110107|NCT00153062|21075658|P4|Overall Study|Withdrawal by Subject|28
6110108|NCT00153062|21075659|P3|Overall Study|Withdrawal by Subject|27
6110109|NCT00153062|21075660|P2|Overall Study|Withdrawal by Subject|30
6110110|NCT00153062|21075661|P1|Overall Study|Withdrawal by Subject|14
6110111|NCT00153062|21075658|P4|Overall Study|Death|365
6110112|NCT00153062|21075659|P3|Overall Study|Death|369
6110113|NCT00153062|21075660|P2|Overall Study|Death|352
6110114|NCT00153062|21075661|P1|Overall Study|Death|360
6110115|NCT00152971|21075680|P3|Treatment|Other|10
6110116|NCT00152971|21075681|P2|Treatment|Other|11
6110117|NCT00152971|21075682|P1|Treatment|Other|9
6110118|NCT00152971|21075680|P3|Treatment|Withdrawal by Subject|5
6110119|NCT00152971|21075681|P2|Treatment|Withdrawal by Subject|4
6110120|NCT00152971|21075682|P1|Treatment|Withdrawal by Subject|4
6110121|NCT00152971|21075680|P3|Treatment|Lost to Follow-up|1
6110122|NCT00152971|21075681|P2|Treatment|Lost to Follow-up|2
6110123|NCT00152971|21075682|P1|Treatment|Lost to Follow-up|1
6110124|NCT00152971|21075680|P3|Treatment|Protocol Violation|10
6110125|NCT00152971|21075681|P2|Treatment|Protocol Violation|6
6110126|NCT00152971|21075682|P1|Treatment|Protocol Violation|8
6110127|NCT00152971|21075680|P3|Treatment|Adverse Event|54
6110128|NCT00152971|21075681|P2|Treatment|Adverse Event|40
6110129|NCT00152971|21075682|P1|Treatment|Adverse Event|49
6110130|NCT00152971|21075680|P3|Overall Study|Other|5
6110131|NCT00152971|21075681|P2|Overall Study|Other|5
6110132|NCT00152971|21075682|P1|Overall Study|Other|3
6110133|NCT00152971|21075680|P3|Overall Study|Withdrawal by Subject|14
6110134|NCT00152971|21075681|P2|Overall Study|Withdrawal by Subject|8
6110135|NCT00152971|21075682|P1|Overall Study|Withdrawal by Subject|9
6110136|NCT00152971|21075680|P3|Overall Study|Lost to Follow-up|13
6110137|NCT00152971|21075681|P2|Overall Study|Lost to Follow-up|14
6110138|NCT00152971|21075682|P1|Overall Study|Lost to Follow-up|17
6110139|NCT00152971|21075680|P3|Overall Study|Protocol Violation|8
6110140|NCT00152971|21075681|P2|Overall Study|Protocol Violation|11
6110141|NCT00152971|21075682|P1|Overall Study|Protocol Violation|10
6110142|NCT00152971|21075680|P3|Overall Study|Adverse Event|9
6110143|NCT00152971|21075681|P2|Overall Study|Adverse Event|10
6110144|NCT00152971|21075682|P1|Overall Study|Adverse Event|12
6110145|NCT00152763|21075718|P4|Overall Study|Lost to Follow-up|13
6110146|NCT00152763|21075719|P3|Overall Study|Lost to Follow-up|2
6110147|NCT00152763|21075720|P2|Overall Study|Lost to Follow-up|4
6110148|NCT00152763|21075721|P1|Overall Study|Lost to Follow-up|6
6110149|NCT00152763|21075718|P4|Overall Study|Death|1
6110150|NCT00152763|21075719|P3|Overall Study|Death|2
6110151|NCT00152763|21075720|P2|Overall Study|Death|1
6110152|NCT00152763|21075721|P1|Overall Study|Death|4
6110153|NCT00152516|21075837|P1|Overall Study|Other: Sz Worsening, Seeking 2nd Opinion|1
6110154|NCT00152516|21075837|P1|Overall Study|Other: Underwent Surgery for Epilepsy|1
6110155|NCT00152516|21075837|P1|Overall Study|Other: Moved Out Of State|1
6110156|NCT00152516|21075837|P1|Overall Study|Other: Primary Care Physician's Decision|1
6110157|NCT00152516|21075837|P1|Overall Study|Other: Non-Compliance|2
6110158|NCT00152516|21075837|P1|Overall Study|Other: Parents Withdrew Consent|2
6110159|NCT00152516|21075837|P1|Overall Study|Other: Given Commercial Drug in Error|2
6110160|NCT00152516|21075837|P1|Overall Study|Other: Mother Refused To Cooperate|1
6110161|NCT00152516|21075837|P1|Overall Study|Protocol Violation|3
6110162|NCT00152516|21075837|P1|Overall Study|Withdrawal by Subject|8
6110163|NCT00152516|21075837|P1|Overall Study|Lost to Follow-up|5
6110164|NCT00152516|21075837|P1|Overall Study|Lack and Loss of Efficacy|30
6110165|NCT00152516|21075837|P1|Overall Study|Adverse Event|18
6110166|NCT00152464|21075863|P2|Overall Study|Patient relocated|0
6110167|NCT00152464|21075864|P1|Overall Study|Patient relocated|1
6110168|NCT00152464|21075863|P2|Overall Study|Eczema poorly controlled|0
6110169|NCT00152464|21075864|P1|Overall Study|Eczema poorly controlled|1
6110170|NCT00152464|21075863|P2|Overall Study|Lack of Efficacy|0
6110171|NCT00152464|21075864|P1|Overall Study|Lack of Efficacy|1
6110172|NCT00152464|21075863|P2|Overall Study|Investigator decision|0
6110173|NCT00152464|21075864|P1|Overall Study|Investigator decision|1
6110174|NCT00152464|21075863|P2|Overall Study|Parent decision|1
6110175|NCT00152464|21075864|P1|Overall Study|Parent decision|1
6110176|NCT00152464|21075863|P2|Overall Study|Eczema deterioration|1
6110177|NCT00152464|21075864|P1|Overall Study|Eczema deterioration|0
6110178|NCT00152464|21075863|P2|Overall Study|Atopic dermatitis poorly controlled|1
6110179|NCT00152464|21075864|P1|Overall Study|Atopic dermatitis poorly controlled|0
6110180|NCT00152464|21075863|P2|Overall Study|Withdrawal by Subject|22
6110181|NCT00152464|21075864|P1|Overall Study|Withdrawal by Subject|21
6110182|NCT00152464|21075863|P2|Overall Study|Protocol Violation|1
6110183|NCT00152464|21075864|P1|Overall Study|Protocol Violation|3
6110184|NCT00152464|21075863|P2|Overall Study|Lost to Follow-up|4
6110185|NCT00152464|21075864|P1|Overall Study|Lost to Follow-up|8
6110186|NCT00152464|21075863|P2|Overall Study|Adverse Event|6
6110187|NCT00152464|21075864|P1|Overall Study|Adverse Event|3
6110188|NCT00152009|21075892|P4|Overall Study|Sponsor's decision|3
6110189|NCT00152009|21075893|P3|Overall Study|Sponsor's decision|1
6110190|NCT00152009|21075894|P2|Overall Study|Sponsor's decision|3
6110191|NCT00152009|21075895|P1|Overall Study|Sponsor's decision|3
6110192|NCT00152009|21075892|P4|Overall Study|ECG abnormalities|1
6110193|NCT00152009|21075893|P3|Overall Study|ECG abnormalities|2
6110194|NCT00152009|21075894|P2|Overall Study|ECG abnormalities|2
6110195|NCT00152009|21075895|P1|Overall Study|ECG abnormalities|2
6110196|NCT00152009|21075892|P4|Overall Study|Lack of Efficacy|15
6110197|NCT00152009|21075893|P3|Overall Study|Lack of Efficacy|7
6110198|NCT00152009|21075894|P2|Overall Study|Lack of Efficacy|6
6110199|NCT00152009|21075895|P1|Overall Study|Lack of Efficacy|8
6110200|NCT00152009|21075892|P4|Overall Study|Lost to Follow-up|3
6110201|NCT00152009|21075893|P3|Overall Study|Lost to Follow-up|3
6110202|NCT00152009|21075894|P2|Overall Study|Lost to Follow-up|4
6110203|NCT00152009|21075895|P1|Overall Study|Lost to Follow-up|2
6110204|NCT00152009|21075892|P4|Overall Study|Withdrawal by Subject|9
6110205|NCT00152009|21075893|P3|Overall Study|Withdrawal by Subject|4
6110206|NCT00152009|21075894|P2|Overall Study|Withdrawal by Subject|3
6110207|NCT00152009|21075895|P1|Overall Study|Withdrawal by Subject|2
6110208|NCT00152009|21075892|P4|Overall Study|Protocol Violation|1
6110209|NCT00152009|21075893|P3|Overall Study|Protocol Violation|0
6110210|NCT00152009|21075894|P2|Overall Study|Protocol Violation|0
6110211|NCT00152009|21075895|P1|Overall Study|Protocol Violation|3
6110212|NCT00152009|21075892|P4|Overall Study|Adverse Event|1
6110213|NCT00152009|21075893|P3|Overall Study|Adverse Event|20
6110214|NCT00152009|21075894|P2|Overall Study|Adverse Event|13
6110215|NCT00152009|21075895|P1|Overall Study|Adverse Event|9
6110216|NCT00151996|21075927|P2|Overall Study|Sponsor's decision|2
6110217|NCT00151996|21075928|P1|Overall Study|Sponsor's decision|0
6110218|NCT00151996|21075927|P2|Overall Study|Protocol Violation|2
6110219|NCT00151996|21075928|P1|Overall Study|Protocol Violation|1
6110220|NCT00151996|21075927|P2|Overall Study|Withdrawal by Subject|1
6110221|NCT00151996|21075928|P1|Overall Study|Withdrawal by Subject|1
6110222|NCT00151996|21075927|P2|Overall Study|Adverse Event|2
6110223|NCT00151996|21075928|P1|Overall Study|Adverse Event|3
6110224|NCT00151892|21075944|P2|Overall Study|Lack of study medication at center|1
6110225|NCT00151892|21075945|P1|Overall Study|Lack of study medication at center|0
6110226|NCT00151892|21075944|P2|Overall Study|Used prohibited corticosteroids|0
6110227|NCT00151892|21075945|P1|Overall Study|Used prohibited corticosteroids|1
6110228|NCT00151892|21075944|P2|Overall Study|Did not return for a visit|0
6110229|NCT00151892|21075945|P1|Overall Study|Did not return for a visit|1
6110230|NCT00151892|21075944|P2|Overall Study|Pregnancy|1
6110231|NCT00151892|21075945|P1|Overall Study|Pregnancy|0
6110232|NCT00151892|21075944|P2|Overall Study|Non-compliance|1
6110233|NCT00151892|21075945|P1|Overall Study|Non-compliance|0
6110234|NCT00151892|21075944|P2|Overall Study|Protocol Violation|3
6110235|NCT00151892|21075945|P1|Overall Study|Protocol Violation|3
6110236|NCT00151892|21075944|P2|Overall Study|Adverse Event|3
6110237|NCT00151892|21075945|P1|Overall Study|Adverse Event|6
6110238|NCT00151892|21075944|P2|Overall Study|Lost to Follow-up|10
6110239|NCT00151892|21075945|P1|Overall Study|Lost to Follow-up|5
6110240|NCT00151892|21075944|P2|Overall Study|Patient request|7
6110241|NCT00151892|21075945|P1|Overall Study|Patient request|10
6110242|NCT00151892|21075944|P2|Overall Study|Lack of Efficacy|57
6110243|NCT00151892|21075945|P1|Overall Study|Lack of Efficacy|50
6110244|NCT00151775|21075990|P12|Period 4: Open Label|Protocol Violation|0
6110245|NCT00151775|21075991|P11|Period 4: Open Label|Protocol Violation|0
6110246|NCT00151775|21075992|P10|Period 4: Open Label|Protocol Violation|0
6110247|NCT00151775|21075993|P9|Period 4: Open Label|Protocol Violation|0
6110248|NCT00151775|21075994|P8|Period 4: Open Label|Protocol Violation|0
6110249|NCT00151775|21075995|P7|Period 4: Open Label|Protocol Violation|0
6110250|NCT00151775|21075996|P6|Period 4: Open Label|Protocol Violation|0
6110251|NCT00151775|21075997|P5|Period 4: Open Label|Protocol Violation|1
6110252|NCT00151775|21075998|P4|Period 4: Open Label|Protocol Violation|0
6110253|NCT00151775|21075999|P3|Period 4: Open Label|Protocol Violation|0
6110254|NCT00151775|21076000|P2|Period 4: Open Label|Protocol Violation|0
6110255|NCT00151775|21076001|P1|Period 4: Open Label|Protocol Violation|0
6110256|NCT00151775|21075990|P12|Period 4: Open Label|Physician Decision|0
6110257|NCT00151775|21075991|P11|Period 4: Open Label|Physician Decision|0
6110258|NCT00151775|21075992|P10|Period 4: Open Label|Physician Decision|2
6110259|NCT00151775|21075993|P9|Period 4: Open Label|Physician Decision|0
6110260|NCT00151775|21075994|P8|Period 4: Open Label|Physician Decision|0
6110261|NCT00151775|21075995|P7|Period 4: Open Label|Physician Decision|0
6110262|NCT00151775|21075996|P6|Period 4: Open Label|Physician Decision|0
6110263|NCT00151775|21075997|P5|Period 4: Open Label|Physician Decision|0
6110264|NCT00151775|21075998|P4|Period 4: Open Label|Physician Decision|0
6110265|NCT00151775|21075999|P3|Period 4: Open Label|Physician Decision|0
6110266|NCT00151775|21076000|P2|Period 4: Open Label|Physician Decision|0
6110267|NCT00151775|21076001|P1|Period 4: Open Label|Physician Decision|0
6110268|NCT00151775|21075990|P12|Period 4: Open Label|Other|0
6110269|NCT00151775|21075991|P11|Period 4: Open Label|Other|0
6110270|NCT00151775|21075992|P10|Period 4: Open Label|Other|3
6110271|NCT00151775|21075993|P9|Period 4: Open Label|Other|0
6110272|NCT00151775|21075994|P8|Period 4: Open Label|Other|0
6110273|NCT00151775|21075995|P7|Period 4: Open Label|Other|0
6110274|NCT00151775|21075996|P6|Period 4: Open Label|Other|0
6110275|NCT00151775|21075997|P5|Period 4: Open Label|Other|1
6110276|NCT00151775|21075998|P4|Period 4: Open Label|Other|0
6110277|NCT00151775|21075999|P3|Period 4: Open Label|Other|0
6110278|NCT00151775|21076000|P2|Period 4: Open Label|Other|0
6110279|NCT00151775|21076001|P1|Period 4: Open Label|Other|0
6110280|NCT00151775|21075990|P12|Period 4: Open Label|Non-compliance with protocol|0
6110281|NCT00151775|21075991|P11|Period 4: Open Label|Non-compliance with protocol|0
6110282|NCT00151775|21075992|P10|Period 4: Open Label|Non-compliance with protocol|4
6110283|NCT00151775|21075993|P9|Period 4: Open Label|Non-compliance with protocol|0
6110284|NCT00151775|21075994|P8|Period 4: Open Label|Non-compliance with protocol|0
6110285|NCT00151775|21075995|P7|Period 4: Open Label|Non-compliance with protocol|0
6110286|NCT00151775|21075996|P6|Period 4: Open Label|Non-compliance with protocol|0
6110287|NCT00151775|21075997|P5|Period 4: Open Label|Non-compliance with protocol|4
6110288|NCT00151775|21075998|P4|Period 4: Open Label|Non-compliance with protocol|0
6110289|NCT00151775|21075999|P3|Period 4: Open Label|Non-compliance with protocol|0
6110290|NCT00151775|21076000|P2|Period 4: Open Label|Non-compliance with protocol|0
6110291|NCT00151775|21076001|P1|Period 4: Open Label|Non-compliance with protocol|0
6110292|NCT00151775|21075990|P12|Period 4: Open Label|Lost to Follow-up|0
6110293|NCT00151775|21075991|P11|Period 4: Open Label|Lost to Follow-up|0
6110294|NCT00151775|21075992|P10|Period 4: Open Label|Lost to Follow-up|7
6110295|NCT00151775|21075993|P9|Period 4: Open Label|Lost to Follow-up|0
6110296|NCT00151775|21075994|P8|Period 4: Open Label|Lost to Follow-up|0
6110297|NCT00151775|21075995|P7|Period 4: Open Label|Lost to Follow-up|0
6110298|NCT00151775|21075996|P6|Period 4: Open Label|Lost to Follow-up|0
6110299|NCT00151775|21075997|P5|Period 4: Open Label|Lost to Follow-up|17
6110300|NCT00151775|21075998|P4|Period 4: Open Label|Lost to Follow-up|0
6110301|NCT00151775|21075999|P3|Period 4: Open Label|Lost to Follow-up|0
6110302|NCT00151775|21076000|P2|Period 4: Open Label|Lost to Follow-up|0
6110303|NCT00151775|21076001|P1|Period 4: Open Label|Lost to Follow-up|0
6110304|NCT00151775|21075990|P12|Period 4: Open Label|Adverse Event|0
6110305|NCT00151775|21075991|P11|Period 4: Open Label|Adverse Event|0
6110306|NCT00151775|21075992|P10|Period 4: Open Label|Adverse Event|2
6110307|NCT00151775|21075993|P9|Period 4: Open Label|Adverse Event|0
6110308|NCT00151775|21075994|P8|Period 4: Open Label|Adverse Event|0
6110309|NCT00151775|21075995|P7|Period 4: Open Label|Adverse Event|0
6110310|NCT00151775|21075996|P6|Period 4: Open Label|Adverse Event|0
6110311|NCT00151775|21075997|P5|Period 4: Open Label|Adverse Event|1
6110312|NCT00151775|21075998|P4|Period 4: Open Label|Adverse Event|0
6110313|NCT00151775|21075999|P3|Period 4: Open Label|Adverse Event|0
6110314|NCT00151775|21076000|P2|Period 4: Open Label|Adverse Event|0
6110315|NCT00151775|21076001|P1|Period 4: Open Label|Adverse Event|0
6110316|NCT00151775|21075990|P12|Period 4: Open Label|Withdrawal by Subject|0
6110317|NCT00151775|21075991|P11|Period 4: Open Label|Withdrawal by Subject|0
6110318|NCT00151775|21075992|P10|Period 4: Open Label|Withdrawal by Subject|2
6110319|NCT00151775|21075993|P9|Period 4: Open Label|Withdrawal by Subject|0
6110320|NCT00151775|21075994|P8|Period 4: Open Label|Withdrawal by Subject|0
6110321|NCT00151775|21075995|P7|Period 4: Open Label|Withdrawal by Subject|0
6110322|NCT00151775|21075996|P6|Period 4: Open Label|Withdrawal by Subject|0
6110323|NCT00151775|21075997|P5|Period 4: Open Label|Withdrawal by Subject|5
6110324|NCT00151775|21075998|P4|Period 4: Open Label|Withdrawal by Subject|0
6110325|NCT00151775|21075999|P3|Period 4: Open Label|Withdrawal by Subject|0
6110326|NCT00151775|21076000|P2|Period 4: Open Label|Withdrawal by Subject|0
6110327|NCT00151775|21076001|P1|Period 4: Open Label|Withdrawal by Subject|0
6110328|NCT00151775|21075990|P12|Period 4: Open Label|Increased blood pressure|0
6110329|NCT00151775|21075991|P11|Period 4: Open Label|Increased blood pressure|0
6110330|NCT00151775|21075992|P10|Period 4: Open Label|Increased blood pressure|1
6110331|NCT00151775|21075993|P9|Period 4: Open Label|Increased blood pressure|0
6110332|NCT00151775|21075994|P8|Period 4: Open Label|Increased blood pressure|0
6110333|NCT00151775|21075995|P7|Period 4: Open Label|Increased blood pressure|0
6110334|NCT00151775|21075996|P6|Period 4: Open Label|Increased blood pressure|0
6110335|NCT00151775|21075997|P5|Period 4: Open Label|Increased blood pressure|1
6110336|NCT00151775|21075998|P4|Period 4: Open Label|Increased blood pressure|0
6110337|NCT00151775|21075999|P3|Period 4: Open Label|Increased blood pressure|0
6110338|NCT00151775|21076000|P2|Period 4: Open Label|Increased blood pressure|0
6110339|NCT00151775|21076001|P1|Period 4: Open Label|Increased blood pressure|0
6110340|NCT00151775|21075990|P12|Period 3: Double-blind, Withdrawal|Lost to Follow-up|1
6110341|NCT00151775|21075991|P11|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
6110342|NCT00151775|21075992|P10|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
6110343|NCT00151775|21075993|P9|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
6110344|NCT00151775|21075994|P8|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
6110345|NCT00151775|21075995|P7|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
6110346|NCT00151775|21075996|P6|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
6110347|NCT00151775|21075997|P5|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
6110348|NCT00151775|21075998|P4|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
6110349|NCT00151775|21075999|P3|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
6110350|NCT00151775|21076000|P2|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
6110351|NCT00151775|21076001|P1|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
6110352|NCT00151775|21075990|P12|Period 3: Double-blind, Withdrawal|Protocol Violation|0
6110353|NCT00151775|21075991|P11|Period 3: Double-blind, Withdrawal|Protocol Violation|0
6110354|NCT00151775|21075992|P10|Period 3: Double-blind, Withdrawal|Protocol Violation|0
6110355|NCT00151775|21075993|P9|Period 3: Double-blind, Withdrawal|Protocol Violation|0
6110356|NCT00151775|21075994|P8|Period 3: Double-blind, Withdrawal|Protocol Violation|0
6110357|NCT00151775|21075995|P7|Period 3: Double-blind, Withdrawal|Protocol Violation|0
6110358|NCT00151775|21075996|P6|Period 3: Double-blind, Withdrawal|Protocol Violation|0
6110359|NCT00151775|21075997|P5|Period 3: Double-blind, Withdrawal|Protocol Violation|0
6110360|NCT00151775|21075998|P4|Period 3: Double-blind, Withdrawal|Protocol Violation|0
6110361|NCT00151775|21075999|P3|Period 3: Double-blind, Withdrawal|Protocol Violation|1
6110362|NCT00151775|21076000|P2|Period 3: Double-blind, Withdrawal|Protocol Violation|0
6110363|NCT00151775|21076001|P1|Period 3: Double-blind, Withdrawal|Protocol Violation|0
6110364|NCT00151775|21075990|P12|Period 3: Double-blind, Withdrawal|Adverse Event|0
6110365|NCT00151775|21075991|P11|Period 3: Double-blind, Withdrawal|Adverse Event|0
6110366|NCT00151775|21075992|P10|Period 3: Double-blind, Withdrawal|Adverse Event|0
6110367|NCT00151775|21075993|P9|Period 3: Double-blind, Withdrawal|Adverse Event|0
6110368|NCT00151775|21075994|P8|Period 3: Double-blind, Withdrawal|Adverse Event|0
6110369|NCT00151775|21075995|P7|Period 3: Double-blind, Withdrawal|Adverse Event|0
6110370|NCT00151775|21075996|P6|Period 3: Double-blind, Withdrawal|Adverse Event|0
6110371|NCT00151775|21075997|P5|Period 3: Double-blind, Withdrawal|Adverse Event|0
6110372|NCT00151775|21075998|P4|Period 3: Double-blind, Withdrawal|Adverse Event|0
6110373|NCT00151775|21075999|P3|Period 3: Double-blind, Withdrawal|Adverse Event|1
6110374|NCT00151775|21076000|P2|Period 3: Double-blind, Withdrawal|Adverse Event|0
6110375|NCT00151775|21076001|P1|Period 3: Double-blind, Withdrawal|Adverse Event|0
6110376|NCT00151775|21075990|P12|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
6110377|NCT00151775|21075991|P11|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
6110378|NCT00151775|21075992|P10|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
6110379|NCT00151775|21075993|P9|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
6110380|NCT00151775|21075994|P8|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
6110381|NCT00151775|21075995|P7|Period 3: Double-blind, Withdrawal|Met blood pressure goal|1
6110382|NCT00151775|21075996|P6|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
6110383|NCT00151775|21075997|P5|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
6110384|NCT00151775|21075998|P4|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
6110385|NCT00151775|21075999|P3|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
6110386|NCT00151775|21076000|P2|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
6110387|NCT00151775|21076001|P1|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
6110388|NCT00151775|21075990|P12|Period 3: Double-blind, Withdrawal|Other|0
6110389|NCT00151775|21075991|P11|Period 3: Double-blind, Withdrawal|Other|0
6110390|NCT00151775|21075992|P10|Period 3: Double-blind, Withdrawal|Other|0
6110391|NCT00151775|21075993|P9|Period 3: Double-blind, Withdrawal|Other|0
6110392|NCT00151775|21075994|P8|Period 3: Double-blind, Withdrawal|Other|1
6110393|NCT00151775|21075995|P7|Period 3: Double-blind, Withdrawal|Other|0
6110394|NCT00151775|21075996|P6|Period 3: Double-blind, Withdrawal|Other|0
6110395|NCT00151775|21075997|P5|Period 3: Double-blind, Withdrawal|Other|0
6110396|NCT00151775|21075998|P4|Period 3: Double-blind, Withdrawal|Other|0
6110397|NCT00151775|21075999|P3|Period 3: Double-blind, Withdrawal|Other|1
6110398|NCT00151775|21076000|P2|Period 3: Double-blind, Withdrawal|Other|0
6110399|NCT00151775|21076001|P1|Period 3: Double-blind, Withdrawal|Other|0
6110400|NCT00151775|21075990|P12|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
6110401|NCT00151775|21075991|P11|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
6110402|NCT00151775|21075992|P10|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
6110403|NCT00151775|21075993|P9|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
6110404|NCT00151775|21075994|P8|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
6110405|NCT00151775|21075995|P7|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
6110406|NCT00151775|21075996|P6|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|1
6110407|NCT00151775|21075997|P5|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
6110408|NCT00151775|21075998|P4|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
6110409|NCT00151775|21075999|P3|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
6110410|NCT00151775|21076000|P2|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
6110411|NCT00151775|21076001|P1|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
6110412|NCT00151775|21075990|P12|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
6110413|NCT00151775|21075991|P11|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
6110414|NCT00151775|21075992|P10|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
6110415|NCT00151775|21075993|P9|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
6110416|NCT00151775|21075994|P8|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
6110417|NCT00151775|21075995|P7|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|1
6110418|NCT00151775|21075996|P6|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
6110419|NCT00151775|21075997|P5|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
6110420|NCT00151775|21075998|P4|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
6110421|NCT00151775|21075999|P3|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
6110422|NCT00151775|21076000|P2|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
6110423|NCT00151775|21076001|P1|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
6110424|NCT00151775|21075990|P12|Period 2 - Double-Blind Dose Response|Physician Decision|0
6110425|NCT00151775|21075991|P11|Period 2 - Double-Blind Dose Response|Physician Decision|0
6110426|NCT00151775|21075992|P10|Period 2 - Double-Blind Dose Response|Physician Decision|0
6110427|NCT00151775|21075993|P9|Period 2 - Double-Blind Dose Response|Physician Decision|0
6110428|NCT00151775|21075994|P8|Period 2 - Double-Blind Dose Response|Physician Decision|0
6110429|NCT00151775|21075995|P7|Period 2 - Double-Blind Dose Response|Physician Decision|0
6110430|NCT00151775|21075996|P6|Period 2 - Double-Blind Dose Response|Physician Decision|1
6110431|NCT00151775|21075997|P5|Period 2 - Double-Blind Dose Response|Physician Decision|0
6110432|NCT00151775|21075998|P4|Period 2 - Double-Blind Dose Response|Physician Decision|0
6110433|NCT00151775|21075999|P3|Period 2 - Double-Blind Dose Response|Physician Decision|0
6110434|NCT00151775|21076000|P2|Period 2 - Double-Blind Dose Response|Physician Decision|0
6110435|NCT00151775|21076001|P1|Period 2 - Double-Blind Dose Response|Physician Decision|0
6110436|NCT00151775|21075990|P12|Period 2 - Double-Blind Dose Response|non-compliance|0
6110437|NCT00151775|21075991|P11|Period 2 - Double-Blind Dose Response|non-compliance|0
6110438|NCT00151775|21075992|P10|Period 2 - Double-Blind Dose Response|non-compliance|0
6110439|NCT00151775|21075993|P9|Period 2 - Double-Blind Dose Response|non-compliance|0
6110440|NCT00151775|21075994|P8|Period 2 - Double-Blind Dose Response|non-compliance|0
6110441|NCT00151775|21075995|P7|Period 2 - Double-Blind Dose Response|non-compliance|0
6110442|NCT00151775|21075996|P6|Period 2 - Double-Blind Dose Response|non-compliance|1
6110443|NCT00151775|21075997|P5|Period 2 - Double-Blind Dose Response|non-compliance|0
6110444|NCT00151775|21075998|P4|Period 2 - Double-Blind Dose Response|non-compliance|0
6110445|NCT00151775|21075999|P3|Period 2 - Double-Blind Dose Response|non-compliance|0
6110446|NCT00151775|21076000|P2|Period 2 - Double-Blind Dose Response|non-compliance|0
6110447|NCT00151775|21076001|P1|Period 2 - Double-Blind Dose Response|non-compliance|0
6110448|NCT00151775|21075990|P12|Period 2 - Double-Blind Dose Response|Other|0
6110449|NCT00151775|21075991|P11|Period 2 - Double-Blind Dose Response|Other|0
6110450|NCT00151775|21075992|P10|Period 2 - Double-Blind Dose Response|Other|0
6110451|NCT00151775|21075993|P9|Period 2 - Double-Blind Dose Response|Other|0
6110452|NCT00151775|21075994|P8|Period 2 - Double-Blind Dose Response|Other|0
6110453|NCT00151775|21075995|P7|Period 2 - Double-Blind Dose Response|Other|1
6110454|NCT00151775|21075996|P6|Period 2 - Double-Blind Dose Response|Other|0
6110455|NCT00151775|21075997|P5|Period 2 - Double-Blind Dose Response|Other|0
6110456|NCT00151775|21075998|P4|Period 2 - Double-Blind Dose Response|Other|0
6110457|NCT00151775|21075999|P3|Period 2 - Double-Blind Dose Response|Other|0
6110458|NCT00151775|21076000|P2|Period 2 - Double-Blind Dose Response|Other|0
6110459|NCT00151775|21076001|P1|Period 2 - Double-Blind Dose Response|Other|0
6110460|NCT00151775|21075990|P12|Period 2 - Double-Blind Dose Response|Protocol Violation|0
6110461|NCT00151775|21075991|P11|Period 2 - Double-Blind Dose Response|Protocol Violation|0
6110462|NCT00151775|21075992|P10|Period 2 - Double-Blind Dose Response|Protocol Violation|0
6110463|NCT00151775|21075993|P9|Period 2 - Double-Blind Dose Response|Protocol Violation|0
6110464|NCT00151775|21075994|P8|Period 2 - Double-Blind Dose Response|Protocol Violation|0
6110465|NCT00151775|21075995|P7|Period 2 - Double-Blind Dose Response|Protocol Violation|0
6110466|NCT00151775|21075996|P6|Period 2 - Double-Blind Dose Response|Protocol Violation|0
6110467|NCT00151775|21075997|P5|Period 2 - Double-Blind Dose Response|Protocol Violation|0
6110468|NCT00151775|21075998|P4|Period 2 - Double-Blind Dose Response|Protocol Violation|0
6110469|NCT00151775|21075999|P3|Period 2 - Double-Blind Dose Response|Protocol Violation|0
6110470|NCT00151775|21076000|P2|Period 2 - Double-Blind Dose Response|Protocol Violation|4
6110471|NCT00151775|21076001|P1|Period 2 - Double-Blind Dose Response|Protocol Violation|0
6110472|NCT00151775|21075990|P12|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
6110473|NCT00151775|21075991|P11|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1
6110474|NCT00151775|21075992|P10|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
6110475|NCT00151775|21075993|P9|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
6110476|NCT00151775|21075994|P8|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
6110477|NCT00151775|21075995|P7|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1
6110478|NCT00151775|21075996|P6|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
6110479|NCT00151775|21075997|P5|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
6110480|NCT00151775|21075998|P4|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
6110481|NCT00151775|21075999|P3|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
6110482|NCT00151775|21076000|P2|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
6110483|NCT00151775|21076001|P1|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1
6110484|NCT00151775|21075990|P12|Period 2 - Double-Blind Dose Response|Adverse Event|0
6110485|NCT00151775|21075991|P11|Period 2 - Double-Blind Dose Response|Adverse Event|0
6110486|NCT00151775|21075992|P10|Period 2 - Double-Blind Dose Response|Adverse Event|0
6110487|NCT00151775|21075993|P9|Period 2 - Double-Blind Dose Response|Adverse Event|0
6110488|NCT00151775|21075994|P8|Period 2 - Double-Blind Dose Response|Adverse Event|0
6110489|NCT00151775|21075995|P7|Period 2 - Double-Blind Dose Response|Adverse Event|0
6110490|NCT00151775|21075996|P6|Period 2 - Double-Blind Dose Response|Adverse Event|0
6110491|NCT00151775|21075997|P5|Period 2 - Double-Blind Dose Response|Adverse Event|0
6110492|NCT00151775|21075998|P4|Period 2 - Double-Blind Dose Response|Adverse Event|0
6110493|NCT00151775|21075999|P3|Period 2 - Double-Blind Dose Response|Adverse Event|0
6110494|NCT00151775|21076000|P2|Period 2 - Double-Blind Dose Response|Adverse Event|2
6110495|NCT00151775|21076001|P1|Period 2 - Double-Blind Dose Response|Adverse Event|1
6110496|NCT00151476|21076045|P2|FAP Analyzed Subjects|Other study participation|1
6110497|NCT00151476|21076046|P1|FAP Analyzed Subjects|Other study participation|0
6110498|NCT00151476|21076045|P2|FAP Analyzed Subjects|Lost to Follow-up|2
6110499|NCT00151476|21076046|P1|FAP Analyzed Subjects|Lost to Follow-up|0
6110500|NCT00151476|21076045|P2|FAP Identified Subjects|Protocol Violation|1
6110501|NCT00151476|21076046|P1|FAP Identified Subjects|Protocol Violation|0
6110502|NCT00151411|21076103|P2|Overall Study|Pregnancy|4
6110503|NCT00151411|21076104|P1|Overall Study|Pregnancy|0
6110504|NCT00151411|21076103|P2|Overall Study|Adverse Event|0
6110505|NCT00151411|21076104|P1|Overall Study|Adverse Event|6
6110506|NCT00151411|21076103|P2|Overall Study|Withdrawal by Subject|20
6110507|NCT00151411|21076104|P1|Overall Study|Withdrawal by Subject|12
6110508|NCT00151411|21076103|P2|Overall Study|Lost to Follow-up|19
6110509|NCT00151411|21076104|P1|Overall Study|Lost to Follow-up|15
6110510|NCT00151372|21076116|P2|Overall Study|Withdrawal by Subject|7
6110511|NCT00151372|21076117|P1|Overall Study|Withdrawal by Subject|7
6110512|NCT00151372|21076116|P2|Overall Study|Too sick medically to continue|6
6110513|NCT00151372|21076117|P1|Overall Study|Too sick medically to continue|5
6110514|NCT00151372|21076116|P2|Overall Study|Lost to Follow-up|5
6110515|NCT00151372|21076117|P1|Overall Study|Lost to Follow-up|5
6110516|NCT00151372|21076116|P2|Overall Study|Death|11
6110517|NCT00151372|21076117|P1|Overall Study|Death|12
6110518|NCT00151281|21076132|P1|Overall Study|Not evaluable|3
6110519|NCT00150969|21076141|P2|24-48 Month Extension|Other Reason|91
6110520|NCT00150969|21076142|P1|24-48 Month Extension|Other Reason|81
6110521|NCT00150969|21076141|P2|24-48 Month Extension|Adverse Event|3
6110522|NCT00150969|21076142|P1|24-48 Month Extension|Adverse Event|1
6110523|NCT00150969|21076141|P2|24-48 Month Extension|Lack of Efficacy|1
6110524|NCT00150969|21076142|P1|24-48 Month Extension|Lack of Efficacy|0
6110525|NCT00150969|21076141|P2|24-48 Month Extension|Withdrawal by Subject|5
6110526|NCT00150969|21076142|P1|24-48 Month Extension|Withdrawal by Subject|6
6110527|NCT00150969|21076141|P2|24 Month Main Study|Withdrawal by Subject|4
6110528|NCT00150969|21076142|P1|24 Month Main Study|Withdrawal by Subject|7
6110529|NCT00150969|21076141|P2|24 Month Main Study|Protocol Violation|2
6110530|NCT00150969|21076142|P1|24 Month Main Study|Protocol Violation|4
6110531|NCT00150969|21076141|P2|24 Month Main Study|Lost to Follow-up|2
6110532|NCT00150969|21076142|P1|24 Month Main Study|Lost to Follow-up|3
6110533|NCT00150969|21076141|P2|24 Month Main Study|Lack of Efficacy|8
6110534|NCT00150969|21076142|P1|24 Month Main Study|Lack of Efficacy|1
6110535|NCT00150969|21076141|P2|24 Month Main Study|Death|1
6110536|NCT00150969|21076142|P1|24 Month Main Study|Death|1
6110537|NCT00150969|21076141|P2|24 Month Main Study|Adverse Event|4
6110538|NCT00150969|21076142|P1|24 Month Main Study|Adverse Event|3
6110539|NCT00150813|21076174|P1|Overall Study|Switch to commercially available LEV|2
6110540|NCT00150813|21076174|P1|Overall Study|Planned pregancy|1
6110541|NCT00150813|21076174|P1|Overall Study|Remission|3
6110542|NCT00150813|21076174|P1|Overall Study|Withdrawal by Subject|5
6110543|NCT00150813|21076174|P1|Overall Study|Lost to Follow-up|5
6110544|NCT00150813|21076174|P1|Overall Study|Lack of Efficacy|1
6110545|NCT00150813|21076174|P1|Overall Study|Adverse Event|1
6110546|NCT00150800|21076178|P1|Overall Study|PI discontinuation request|1
6110547|NCT00150800|21076178|P1|Overall Study|Pregnancy planned|1
6110548|NCT00150800|21076178|P1|Overall Study|Surgical intervention|4
6110549|NCT00150800|21076178|P1|Overall Study|Patient insurance|1
6110550|NCT00150800|21076178|P1|Overall Study|PI leaving site|2
6110551|NCT00150800|21076178|P1|Overall Study|PI retiring|2
6110552|NCT00150800|21076178|P1|Overall Study|Moved from area/country|8
6110553|NCT00150800|21076178|P1|Overall Study|Generalized Epilepsy|1
6110554|NCT00150800|21076178|P1|Overall Study|Sponsor's request|2
6110555|NCT00150800|21076178|P1|Overall Study|Visit refusal|3
6110556|NCT00150800|21076178|P1|Overall Study|BRV monotherapy|1
6110557|NCT00150800|21076178|P1|Overall Study|Neurosurgery|2
6110558|NCT00150800|21076178|P1|Overall Study|Distance too long for patient|1
6110559|NCT00150800|21076178|P1|Overall Study|Nobody to accompany patient|1
6110560|NCT00150800|21076178|P1|Overall Study|Protocol non-adherence|2
6110561|NCT00150800|21076178|P1|Overall Study|Site closure|24
6110562|NCT00150800|21076178|P1|Overall Study|IP misshandling|1
6110563|NCT00150800|21076178|P1|Overall Study|No compliance|18
6110564|NCT00150800|21076178|P1|Overall Study|Subject's choice|90
6110565|NCT00150800|21076178|P1|Overall Study|Lost to Follow-up|58
6110566|NCT00150800|21076178|P1|Overall Study|Lack of Efficacy|166
6110567|NCT00150800|21076178|P1|Overall Study|Death|18
6110568|NCT00150800|21076178|P1|Overall Study|Adverse Event|89
6110569|NCT00150618|21076192|P5|Overall Study|Sponsor's decision|0
6110570|NCT00150618|21076193|P4|Overall Study|Sponsor's decision|1
6110571|NCT00150618|21076194|P3|Overall Study|Sponsor's decision|0
6110572|NCT00150618|21076195|P2|Overall Study|Sponsor's decision|0
6110573|NCT00150618|21076196|P1|Overall Study|Sponsor's decision|0
6110574|NCT00150618|21076192|P5|Overall Study|Abnormal ECG|0
6110575|NCT00150618|21076193|P4|Overall Study|Abnormal ECG|0
6110576|NCT00150618|21076194|P3|Overall Study|Abnormal ECG|0
6110577|NCT00150618|21076195|P2|Overall Study|Abnormal ECG|0
6110578|NCT00150618|21076196|P1|Overall Study|Abnormal ECG|1
6110579|NCT00150618|21076192|P5|Overall Study|Lack of compliance|1
6110580|NCT00150618|21076193|P4|Overall Study|Lack of compliance|0
6110581|NCT00150618|21076194|P3|Overall Study|Lack of compliance|1
6110582|NCT00150618|21076195|P2|Overall Study|Lack of compliance|1
6110583|NCT00150618|21076196|P1|Overall Study|Lack of compliance|2
6110584|NCT00150618|21076192|P5|Overall Study|Physician Decision|1
6110585|NCT00150618|21076193|P4|Overall Study|Physician Decision|0
6110586|NCT00150618|21076194|P3|Overall Study|Physician Decision|0
6110587|NCT00150618|21076195|P2|Overall Study|Physician Decision|2
6110588|NCT00150618|21076196|P1|Overall Study|Physician Decision|0
6110589|NCT00150618|21076192|P5|Overall Study|No study meds|2
6110590|NCT00150618|21076193|P4|Overall Study|No study meds|0
6110591|NCT00150618|21076194|P3|Overall Study|No study meds|0
6110592|NCT00150618|21076195|P2|Overall Study|No study meds|0
6110593|NCT00150618|21076196|P1|Overall Study|No study meds|0
6110594|NCT00150618|21076192|P5|Overall Study|Lack of Efficacy|6
6110595|NCT00150618|21076193|P4|Overall Study|Lack of Efficacy|4
6110596|NCT00150618|21076194|P3|Overall Study|Lack of Efficacy|7
6110597|NCT00150618|21076195|P2|Overall Study|Lack of Efficacy|4
6110598|NCT00150618|21076196|P1|Overall Study|Lack of Efficacy|1
6110599|NCT00150618|21076192|P5|Overall Study|Protocol Violation|1
6110600|NCT00150618|21076193|P4|Overall Study|Protocol Violation|0
6110601|NCT00150618|21076194|P3|Overall Study|Protocol Violation|0
6110602|NCT00150618|21076195|P2|Overall Study|Protocol Violation|0
6110603|NCT00150618|21076196|P1|Overall Study|Protocol Violation|1
6110604|NCT00150618|21076192|P5|Overall Study|Lost to Follow-up|4
6110605|NCT00150618|21076193|P4|Overall Study|Lost to Follow-up|8
6110606|NCT00150618|21076194|P3|Overall Study|Lost to Follow-up|5
6110607|NCT00150618|21076195|P2|Overall Study|Lost to Follow-up|1
6110608|NCT00150618|21076196|P1|Overall Study|Lost to Follow-up|4
6110609|NCT00150618|21076192|P5|Overall Study|Withdrawal by Subject|5
6110610|NCT00150618|21076193|P4|Overall Study|Withdrawal by Subject|4
6110611|NCT00150618|21076194|P3|Overall Study|Withdrawal by Subject|8
6110612|NCT00150618|21076195|P2|Overall Study|Withdrawal by Subject|8
6110613|NCT00150618|21076196|P1|Overall Study|Withdrawal by Subject|6
6110614|NCT00150618|21076192|P5|Overall Study|Adverse Event|5
6110615|NCT00150618|21076193|P4|Overall Study|Adverse Event|9
6110616|NCT00150618|21076194|P3|Overall Study|Adverse Event|6
6110617|NCT00150618|21076195|P2|Overall Study|Adverse Event|2
6110618|NCT00150618|21076196|P1|Overall Study|Adverse Event|2
6110619|NCT00150592|21076230|P2|Overall Study|Non-compliance|0
6110620|NCT00150592|21076231|P1|Overall Study|Non-compliance|1
6110621|NCT00150592|21076230|P2|Overall Study|Withdrawal by Subject|2
6110622|NCT00150592|21076231|P1|Overall Study|Withdrawal by Subject|1
6110623|NCT00150592|21076230|P2|Overall Study|Protocol Violation|0
6110624|NCT00150592|21076231|P1|Overall Study|Protocol Violation|1
6110625|NCT00150592|21076230|P2|Overall Study|Adverse Event|1
6110626|NCT00150592|21076231|P1|Overall Study|Adverse Event|4
6110627|NCT00150462|21076262|P11|Overall Study|Other|1
6110628|NCT00150462|21076263|P10|Overall Study|Other|1
6110629|NCT00150462|21076264|P9|Overall Study|Other|0
6110630|NCT00150462|21076265|P8|Overall Study|Other|0
6110631|NCT00150462|21076266|P7|Overall Study|Other|0
6110632|NCT00150462|21076267|P6|Overall Study|Other|0
6110633|NCT00150462|21076268|P5|Overall Study|Other|0
6110634|NCT00150462|21076269|P4|Overall Study|Other|0
6110635|NCT00150462|21076270|P3|Overall Study|Other|0
6110636|NCT00150462|21076271|P2|Overall Study|Other|0
6110637|NCT00150462|21076272|P1|Overall Study|Other|0
6110638|NCT00150462|21076262|P11|Overall Study|Physician Decision|0
6110639|NCT00150462|21076263|P10|Overall Study|Physician Decision|0
6110640|NCT00150462|21076264|P9|Overall Study|Physician Decision|0
6110641|NCT00150462|21076265|P8|Overall Study|Physician Decision|0
6110642|NCT00150462|21076266|P7|Overall Study|Physician Decision|0
6110643|NCT00150462|21076267|P6|Overall Study|Physician Decision|0
6110644|NCT00150462|21076268|P5|Overall Study|Physician Decision|0
6110645|NCT00150462|21076269|P4|Overall Study|Physician Decision|1
6110646|NCT00150462|21076270|P3|Overall Study|Physician Decision|1
6110647|NCT00150462|21076271|P2|Overall Study|Physician Decision|0
6110648|NCT00150462|21076272|P1|Overall Study|Physician Decision|0
6110649|NCT00150462|21076262|P11|Overall Study|Adverse Event|0
6110650|NCT00150462|21076263|P10|Overall Study|Adverse Event|1
6110651|NCT00150462|21076264|P9|Overall Study|Adverse Event|0
6110652|NCT00150462|21076265|P8|Overall Study|Adverse Event|2
6110653|NCT00150462|21076266|P7|Overall Study|Adverse Event|0
6110654|NCT00150462|21076267|P6|Overall Study|Adverse Event|0
6110655|NCT00150462|21076268|P5|Overall Study|Adverse Event|0
6110656|NCT00150462|21076269|P4|Overall Study|Adverse Event|1
6110657|NCT00150462|21076270|P3|Overall Study|Adverse Event|0
6110658|NCT00150462|21076271|P2|Overall Study|Adverse Event|0
6110659|NCT00150462|21076272|P1|Overall Study|Adverse Event|0
6110660|NCT00150462|21076262|P11|Overall Study|Death|0
6110661|NCT00150462|21076263|P10|Overall Study|Death|0
6110662|NCT00150462|21076264|P9|Overall Study|Death|1
6110663|NCT00150462|21076265|P8|Overall Study|Death|0
6110664|NCT00150462|21076266|P7|Overall Study|Death|0
6110665|NCT00150462|21076267|P6|Overall Study|Death|0
6110666|NCT00150462|21076268|P5|Overall Study|Death|0
6110667|NCT00150462|21076269|P4|Overall Study|Death|0
6110668|NCT00150462|21076270|P3|Overall Study|Death|0
6110669|NCT00150462|21076271|P2|Overall Study|Death|1
6110670|NCT00150462|21076272|P1|Overall Study|Death|0
6110671|NCT00150462|21076262|P11|Overall Study|Withdrawal by Subject|0
6110672|NCT00150462|21076263|P10|Overall Study|Withdrawal by Subject|1
6110673|NCT00150462|21076264|P9|Overall Study|Withdrawal by Subject|0
6110674|NCT00150462|21076265|P8|Overall Study|Withdrawal by Subject|1
6110675|NCT00150462|21076266|P7|Overall Study|Withdrawal by Subject|0
6110676|NCT00150462|21076267|P6|Overall Study|Withdrawal by Subject|2
6110677|NCT00150462|21076268|P5|Overall Study|Withdrawal by Subject|1
6110678|NCT00150462|21076269|P4|Overall Study|Withdrawal by Subject|0
6110679|NCT00150462|21076270|P3|Overall Study|Withdrawal by Subject|1
6110680|NCT00150462|21076271|P2|Overall Study|Withdrawal by Subject|1
6110681|NCT00150462|21076272|P1|Overall Study|Withdrawal by Subject|0
6110682|NCT00150462|21076262|P11|Overall Study|Disease Progression or Relapse|2
6110683|NCT00150462|21076263|P10|Overall Study|Disease Progression or Relapse|3
6110684|NCT00150462|21076264|P9|Overall Study|Disease Progression or Relapse|5
6110685|NCT00150462|21076265|P8|Overall Study|Disease Progression or Relapse|5
6110686|NCT00150462|21076266|P7|Overall Study|Disease Progression or Relapse|3
6110687|NCT00150462|21076267|P6|Overall Study|Disease Progression or Relapse|2
6110688|NCT00150462|21076268|P5|Overall Study|Disease Progression or Relapse|2
6110689|NCT00150462|21076269|P4|Overall Study|Disease Progression or Relapse|1
6110690|NCT00150462|21076270|P3|Overall Study|Disease Progression or Relapse|2
6110691|NCT00150462|21076271|P2|Overall Study|Disease Progression or Relapse|1
6110692|NCT00150462|21076272|P1|Overall Study|Disease Progression or Relapse|3
6110693|NCT00150345|21076382|P2|Overall Study|Other|14
6110694|NCT00150345|21076383|P1|Overall Study|Other|12
6110695|NCT00150345|21076382|P2|Overall Study|Laboratory abnormality|2
6110696|NCT00150345|21076383|P1|Overall Study|Laboratory abnormality|1
6110697|NCT00150345|21076382|P2|Overall Study|Withdrawal by Subject|4
6110698|NCT00150345|21076383|P1|Overall Study|Withdrawal by Subject|3
6110699|NCT00150345|21076382|P2|Overall Study|Lack of Efficacy|4
6110700|NCT00150345|21076383|P1|Overall Study|Lack of Efficacy|5
6110701|NCT00150345|21076382|P2|Overall Study|Adverse Event|6
6110702|NCT00150345|21076383|P1|Overall Study|Adverse Event|8
6110703|NCT00150345|21076382|P2|Overall Study|Death|2
6110704|NCT00150345|21076383|P1|Overall Study|Death|5
6110705|NCT00150176|21076447|P2|Overall Study|OTHER|13
6110706|NCT00150176|21076448|P1|Overall Study|OTHER|11
6110707|NCT00150176|21076447|P2|Overall Study|Lost to Follow-up|3
6110708|NCT00150176|21076448|P1|Overall Study|Lost to Follow-up|3
6110709|NCT00150176|21076447|P2|Overall Study|Withdrawal by Subject|12
6110710|NCT00150176|21076448|P1|Overall Study|Withdrawal by Subject|19
6110800|NCT00147745|21076916|P2|Overall Study|Withdrawal by Subject|0
6110711|NCT00150176|21076447|P2|Overall Study|Relapse/Impending relapse, non-AE|39
6110712|NCT00150176|21076448|P1|Overall Study|Relapse/Impending relapse, non-AE|10
6110713|NCT00150176|21076447|P2|Overall Study|Adverse Event|53
6110714|NCT00150176|21076448|P1|Overall Study|Adverse Event|16
6110715|NCT00149994|21076459|P2|Overall Study|Protocol Violation|1
6110716|NCT00149994|21076460|P1|Overall Study|Protocol Violation|0
6110717|NCT00149994|21076459|P2|Overall Study|Administrative problems:|0
6110718|NCT00149994|21076460|P1|Overall Study|Administrative problems:|1
6110719|NCT00149890|21076468|P2|Overall Study|Graft Loss|1
6110720|NCT00149890|21076469|P1|Overall Study|Graft Loss|2
6110721|NCT00149890|21076468|P2|Overall Study|Lost to Follow-up|0
6110722|NCT00149890|21076469|P1|Overall Study|Lost to Follow-up|1
6110723|NCT00149890|21076468|P2|Overall Study|Protocol Violation|0
6110724|NCT00149890|21076469|P1|Overall Study|Protocol Violation|1
6110725|NCT00149890|21076468|P2|Overall Study|Lack of Efficacy|9
6110726|NCT00149890|21076469|P1|Overall Study|Lack of Efficacy|8
6110727|NCT00149890|21076468|P2|Overall Study|Adverse Event|8
6110728|NCT00149890|21076469|P1|Overall Study|Adverse Event|1
6110729|NCT00149825|21076504|P2|Overall Study|Other|0
6110730|NCT00149825|21076505|P1|Overall Study|Other|1
6110731|NCT00149825|21076504|P2|Overall Study|Not liking insomnia therapy|0
6110732|NCT00149825|21076505|P1|Overall Study|Not liking insomnia therapy|1
6110733|NCT00149825|21076504|P2|Overall Study|Time commitments|1
6110734|NCT00149825|21076505|P1|Overall Study|Time commitments|2
6110735|NCT00149825|21076504|P2|Overall Study|Intolerance to medication side effects|2
6110736|NCT00149825|21076505|P1|Overall Study|Intolerance to medication side effects|1
6110737|NCT00149747|21076533|P2|Overall Study|Withdrawal by Subject|3
6110738|NCT00149747|21076534|P1|Overall Study|Withdrawal by Subject|3
6110739|NCT00149747|21076533|P2|Overall Study|Death|0
6110740|NCT00149747|21076534|P1|Overall Study|Death|1
6110741|NCT00149630|21076580|P2|Overall Study|Adverse Event|0
6110742|NCT00149630|21076581|P1|Overall Study|Adverse Event|2
6110743|NCT00149630|21076580|P2|Overall Study|Treatment Programs|5
6110744|NCT00149630|21076581|P1|Overall Study|Treatment Programs|4
6110745|NCT00149630|21076580|P2|Overall Study|Incarceration|0
6110746|NCT00149630|21076581|P1|Overall Study|Incarceration|2
6110747|NCT00149396|21076591|P1|Overall Study|other treatment|5
6110748|NCT00149396|21076591|P1|Overall Study|Subject noncompliance|2
6110749|NCT00149396|21076591|P1|Overall Study|Withdrawal by Subject|1
6110750|NCT00149396|21076591|P1|Overall Study|Death|15
6110751|NCT00149214|21076661|P2|Overall Study|Progressive Disease|3
6110752|NCT00149214|21076662|P1|Overall Study|Progressive Disease|7
6110753|NCT00149214|21076661|P2|Overall Study|Sponsor Decision|1
6110754|NCT00149214|21076662|P1|Overall Study|Sponsor Decision|0
6110755|NCT00149214|21076661|P2|Overall Study|Physician Decision|3
6110756|NCT00149214|21076662|P1|Overall Study|Physician Decision|3
6110757|NCT00149214|21076661|P2|Overall Study|Withdrawal by Subject|1
6110758|NCT00149214|21076662|P1|Overall Study|Withdrawal by Subject|4
6110759|NCT00149214|21076661|P2|Overall Study|Adverse Event|9
6110760|NCT00149214|21076662|P1|Overall Study|Adverse Event|12
6110761|NCT00148941|21076689|P4|Overall Study|Other|2
6110762|NCT00148941|21076690|P3|Overall Study|Other|1
6110763|NCT00148941|21076691|P2|Overall Study|Other|0
6110764|NCT00148941|21076692|P1|Overall Study|Other|0
6110765|NCT00148941|21076689|P4|Overall Study|Withdrawal by Subject|0
6110766|NCT00148941|21076690|P3|Overall Study|Withdrawal by Subject|1
6110767|NCT00148941|21076691|P2|Overall Study|Withdrawal by Subject|0
6110768|NCT00148941|21076692|P1|Overall Study|Withdrawal by Subject|1
6110769|NCT00148941|21076689|P4|Overall Study|Lost to Follow-up|22
6110770|NCT00148941|21076690|P3|Overall Study|Lost to Follow-up|18
6110771|NCT00148941|21076691|P2|Overall Study|Lost to Follow-up|24
6110772|NCT00148941|21076692|P1|Overall Study|Lost to Follow-up|17
6110773|NCT00148759|21076807|P2|Overall Study|Lost to Follow-up|0
6110774|NCT00148759|21076808|P1|Overall Study|Lost to Follow-up|1
6110775|NCT00148759|21076807|P2|Overall Study|Withdrawal by Subject|1
6110776|NCT00148759|21076808|P1|Overall Study|Withdrawal by Subject|1
6110777|NCT00148343|21076836|P2|Overall Study|Physician Decision|4
6110778|NCT00148343|21076837|P1|Overall Study|Physician Decision|3
6110779|NCT00148343|21076836|P2|Overall Study|Withdrawal by Subject|7
6110780|NCT00148343|21076837|P1|Overall Study|Withdrawal by Subject|12
6110781|NCT00148317|21076851|P1|Mobilization (VEL+CYTOXAN+FILGRASTIM)|unable to tolerate|1
6110782|NCT00148317|21076851|P1|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Lack of Efficacy|2
6110783|NCT00148317|21076851|P1|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Adverse Event|8
6110784|NCT00148122|21076858|P1|Overall Study|Withdrawal by Subject|2
6110785|NCT00148109|21076866|P2|Overall Study|Withdrawal by Subject|0
6110786|NCT00148109|21076867|P1|Overall Study|Withdrawal by Subject|2
6110787|NCT00148109|21076866|P2|Overall Study|Adverse Event|2
6110788|NCT00148109|21076867|P1|Overall Study|Adverse Event|0
6110789|NCT00148109|21076866|P2|Overall Study|Lack of Efficacy|18
6110790|NCT00148109|21076867|P1|Overall Study|Lack of Efficacy|10
6110791|NCT00147823|21076883|P2|Overall Study|Did not receive vitoss due to infection|2
6110792|NCT00147823|21076884|P1|Overall Study|Did not receive vitoss due to infection|6
6110793|NCT00147823|21076883|P2|Overall Study|Withdrawal by Subject|1
6110794|NCT00147823|21076884|P1|Overall Study|Withdrawal by Subject|0
6110795|NCT00147823|21076883|P2|Overall Study|Physician Decision|0
6110796|NCT00147823|21076884|P1|Overall Study|Physician Decision|1
6110797|NCT00147823|21076883|P2|Overall Study|Lost to Follow-up|12
6110798|NCT00147823|21076884|P1|Overall Study|Lost to Follow-up|6
6110799|NCT00147745|21076915|P3|Overall Study|Withdrawal by Subject|0
6110801|NCT00147745|21076917|P1|Overall Study|Withdrawal by Subject|1
6110802|NCT00147537|21076939|P11|Phase 2|Randomized but not treated|1
6110803|NCT00147537|21076940|P10|Phase 2|Randomized but not treated|1
6110804|NCT00147537|21076941|P9|Phase 2|Randomized but not treated|0
6110805|NCT00147537|21076942|P8|Phase 2|Randomized but not treated|0
6110806|NCT00147537|21076943|P7|Phase 2|Randomized but not treated|0
6110807|NCT00147537|21076944|P6|Phase 2|Randomized but not treated|0
6110808|NCT00147537|21076945|P5|Phase 2|Randomized but not treated|0
6110809|NCT00147537|21076946|P4|Phase 2|Randomized but not treated|0
6110810|NCT00147537|21076947|P3|Phase 2|Randomized but not treated|0
6110811|NCT00147537|21076948|P2|Phase 2|Randomized but not treated|0
6110812|NCT00147537|21076949|P1|Phase 2|Randomized but not treated|0
6110813|NCT00147537|21076939|P11|Phase 2|Withdrawal by Subject|4
6110814|NCT00147537|21076940|P10|Phase 2|Withdrawal by Subject|16
6110815|NCT00147537|21076941|P9|Phase 2|Withdrawal by Subject|0
6110816|NCT00147537|21076942|P8|Phase 2|Withdrawal by Subject|0
6110817|NCT00147537|21076943|P7|Phase 2|Withdrawal by Subject|0
6110818|NCT00147537|21076944|P6|Phase 2|Withdrawal by Subject|0
6110819|NCT00147537|21076945|P5|Phase 2|Withdrawal by Subject|0
6110820|NCT00147537|21076946|P4|Phase 2|Withdrawal by Subject|0
6110821|NCT00147537|21076947|P3|Phase 2|Withdrawal by Subject|0
6110822|NCT00147537|21076948|P2|Phase 2|Withdrawal by Subject|0
6110823|NCT00147537|21076949|P1|Phase 2|Withdrawal by Subject|0
6110824|NCT00147537|21076939|P11|Phase 2|Other|12
6110825|NCT00147537|21076940|P10|Phase 2|Other|47
6110826|NCT00147537|21076941|P9|Phase 2|Other|0
6110827|NCT00147537|21076942|P8|Phase 2|Other|0
6110828|NCT00147537|21076943|P7|Phase 2|Other|0
6110829|NCT00147537|21076944|P6|Phase 2|Other|0
6110830|NCT00147537|21076945|P5|Phase 2|Other|0
6110831|NCT00147537|21076946|P4|Phase 2|Other|0
6110832|NCT00147537|21076947|P3|Phase 2|Other|0
6110833|NCT00147537|21076948|P2|Phase 2|Other|0
6110834|NCT00147537|21076949|P1|Phase 2|Other|0
6110835|NCT00147537|21076939|P11|Phase 2|Lost to Follow-up|4
6110836|NCT00147537|21076940|P10|Phase 2|Lost to Follow-up|12
6110837|NCT00147537|21076941|P9|Phase 2|Lost to Follow-up|0
6110838|NCT00147537|21076942|P8|Phase 2|Lost to Follow-up|0
6110839|NCT00147537|21076943|P7|Phase 2|Lost to Follow-up|0
6110840|NCT00147537|21076944|P6|Phase 2|Lost to Follow-up|0
6110841|NCT00147537|21076945|P5|Phase 2|Lost to Follow-up|0
6110842|NCT00147537|21076946|P4|Phase 2|Lost to Follow-up|0
6110843|NCT00147537|21076947|P3|Phase 2|Lost to Follow-up|0
6110844|NCT00147537|21076948|P2|Phase 2|Lost to Follow-up|0
6110845|NCT00147537|21076949|P1|Phase 2|Lost to Follow-up|0
6110846|NCT00147537|21076939|P11|Phase 2|Death|31
6110847|NCT00147537|21076940|P10|Phase 2|Death|85
6110848|NCT00147537|21076941|P9|Phase 2|Death|0
6110849|NCT00147537|21076942|P8|Phase 2|Death|0
6110850|NCT00147537|21076943|P7|Phase 2|Death|0
6110851|NCT00147537|21076944|P6|Phase 2|Death|0
6110852|NCT00147537|21076945|P5|Phase 2|Death|0
6110853|NCT00147537|21076946|P4|Phase 2|Death|0
6110854|NCT00147537|21076947|P3|Phase 2|Death|0
6110855|NCT00147537|21076948|P2|Phase 2|Death|0
6110856|NCT00147537|21076949|P1|Phase 2|Death|0
6110857|NCT00147537|21076939|P11|Phase 1b|Randomized but not treated|0
6110858|NCT00147537|21076940|P10|Phase 1b|Randomized but not treated|0
6110859|NCT00147537|21076941|P9|Phase 1b|Randomized but not treated|1
6110860|NCT00147537|21076942|P8|Phase 1b|Randomized but not treated|0
6110861|NCT00147537|21076943|P7|Phase 1b|Randomized but not treated|1
6110862|NCT00147537|21076944|P6|Phase 1b|Randomized but not treated|0
6110863|NCT00147537|21076945|P5|Phase 1b|Randomized but not treated|0
6110864|NCT00147537|21076946|P4|Phase 1b|Randomized but not treated|0
6110865|NCT00147537|21076947|P3|Phase 1b|Randomized but not treated|0
6110866|NCT00147537|21076948|P2|Phase 1b|Randomized but not treated|0
6110867|NCT00147537|21076949|P1|Phase 1b|Randomized but not treated|0
6110868|NCT00147537|21076939|P11|Phase 1b|Withdrawal by Subject|0
6110869|NCT00147537|21076940|P10|Phase 1b|Withdrawal by Subject|0
6110870|NCT00147537|21076941|P9|Phase 1b|Withdrawal by Subject|2
6110871|NCT00147537|21076942|P8|Phase 1b|Withdrawal by Subject|0
6110872|NCT00147537|21076943|P7|Phase 1b|Withdrawal by Subject|0
6110873|NCT00147537|21076944|P6|Phase 1b|Withdrawal by Subject|0
6110874|NCT00147537|21076945|P5|Phase 1b|Withdrawal by Subject|0
6110875|NCT00147537|21076946|P4|Phase 1b|Withdrawal by Subject|0
6110876|NCT00147537|21076947|P3|Phase 1b|Withdrawal by Subject|0
6110877|NCT00147537|21076948|P2|Phase 1b|Withdrawal by Subject|0
6110878|NCT00147537|21076949|P1|Phase 1b|Withdrawal by Subject|0
6110879|NCT00147537|21076939|P11|Phase 1b|Other|0
6110880|NCT00147537|21076940|P10|Phase 1b|Other|0
6110881|NCT00147537|21076941|P9|Phase 1b|Other|4
6110882|NCT00147537|21076942|P8|Phase 1b|Other|4
6110883|NCT00147537|21076943|P7|Phase 1b|Other|14
6110884|NCT00147537|21076944|P6|Phase 1b|Other|1
6110885|NCT00147537|21076945|P5|Phase 1b|Other|1
6110886|NCT00147537|21076946|P4|Phase 1b|Other|1
6110887|NCT00147537|21076947|P3|Phase 1b|Other|2
6110888|NCT00147537|21076948|P2|Phase 1b|Other|0
6110889|NCT00147537|21076949|P1|Phase 1b|Other|0
6110890|NCT00147537|21076939|P11|Phase 1b|Lost to Follow-up|0
6110891|NCT00147537|21076940|P10|Phase 1b|Lost to Follow-up|0
6110892|NCT00147537|21076941|P9|Phase 1b|Lost to Follow-up|1
6110893|NCT00147537|21076942|P8|Phase 1b|Lost to Follow-up|0
6110894|NCT00147537|21076943|P7|Phase 1b|Lost to Follow-up|2
6110895|NCT00147537|21076944|P6|Phase 1b|Lost to Follow-up|0
6110896|NCT00147537|21076945|P5|Phase 1b|Lost to Follow-up|0
6110897|NCT00147537|21076946|P4|Phase 1b|Lost to Follow-up|0
6110898|NCT00147537|21076947|P3|Phase 1b|Lost to Follow-up|0
6110899|NCT00147537|21076948|P2|Phase 1b|Lost to Follow-up|1
6110900|NCT00147537|21076949|P1|Phase 1b|Lost to Follow-up|2
6110901|NCT00147537|21076939|P11|Phase 1b|Death|0
6110902|NCT00147537|21076940|P10|Phase 1b|Death|0
6110903|NCT00147537|21076941|P9|Phase 1b|Death|9
6110904|NCT00147537|21076942|P8|Phase 1b|Death|3
6110905|NCT00147537|21076943|P7|Phase 1b|Death|1
6110906|NCT00147537|21076944|P6|Phase 1b|Death|2
6110907|NCT00147537|21076945|P5|Phase 1b|Death|2
6110908|NCT00147537|21076946|P4|Phase 1b|Death|1
6110909|NCT00147537|21076947|P3|Phase 1b|Death|2
6110910|NCT00147537|21076948|P2|Phase 1b|Death|1
6110911|NCT00147537|21076949|P1|Phase 1b|Death|0
6110912|NCT00147498|21077132|P4|Overall Study|Other|3
6110913|NCT00147498|21077133|P3|Overall Study|Other|3
6110914|NCT00147498|21077134|P2|Overall Study|Other|1
6110915|NCT00147498|21077135|P1|Overall Study|Other|1
6110916|NCT00147498|21077132|P4|Overall Study|Participant defaulted|3
6110917|NCT00147498|21077133|P3|Overall Study|Participant defaulted|4
6110918|NCT00147498|21077134|P2|Overall Study|Participant defaulted|1
6110919|NCT00147498|21077135|P1|Overall Study|Participant defaulted|0
6110920|NCT00147498|21077132|P4|Overall Study|Laboratory abnormality|0
6110921|NCT00147498|21077133|P3|Overall Study|Laboratory abnormality|2
6110922|NCT00147498|21077134|P2|Overall Study|Laboratory abnormality|0
6110923|NCT00147498|21077135|P1|Overall Study|Laboratory abnormality|0
6110924|NCT00147498|21077132|P4|Overall Study|Lack of Efficacy|8
6110925|NCT00147498|21077133|P3|Overall Study|Lack of Efficacy|1
6110926|NCT00147498|21077134|P2|Overall Study|Lack of Efficacy|1
6110927|NCT00147498|21077135|P1|Overall Study|Lack of Efficacy|1
6110928|NCT00147498|21077132|P4|Overall Study|Adverse Event|3
6110929|NCT00147498|21077133|P3|Overall Study|Adverse Event|7
6110930|NCT00147498|21077134|P2|Overall Study|Adverse Event|6
6110931|NCT00147498|21077135|P1|Overall Study|Adverse Event|1
6110932|NCT00147238|21077259|P1|Overall Study|Inevaluable|8
6110933|NCT00147225|21077269|P6|Overall Study|Chemotherapy Changed|1
6110934|NCT00147225|21077270|P5|Overall Study|Chemotherapy Changed|0
6110935|NCT00147225|21077271|P4|Overall Study|Chemotherapy Changed|0
6110936|NCT00147225|21077272|P3|Overall Study|Chemotherapy Changed|0
6110937|NCT00147225|21077273|P2|Overall Study|Chemotherapy Changed|0
6110938|NCT00147225|21077274|P1|Overall Study|Chemotherapy Changed|0
6110939|NCT00147225|21077269|P6|Overall Study|Screen Failure|0
6110940|NCT00147225|21077270|P5|Overall Study|Screen Failure|1
6110941|NCT00147225|21077271|P4|Overall Study|Screen Failure|0
6110942|NCT00147225|21077272|P3|Overall Study|Screen Failure|0
6110943|NCT00147225|21077273|P2|Overall Study|Screen Failure|0
6110944|NCT00147225|21077274|P1|Overall Study|Screen Failure|0
6110945|NCT00147225|21077269|P6|Overall Study|Adverse Event|0
6110946|NCT00147225|21077270|P5|Overall Study|Adverse Event|0
6110947|NCT00147225|21077271|P4|Overall Study|Adverse Event|1
6110948|NCT00147225|21077272|P3|Overall Study|Adverse Event|1
6110949|NCT00147225|21077273|P2|Overall Study|Adverse Event|0
6110950|NCT00147225|21077274|P1|Overall Study|Adverse Event|0
6110951|NCT00147225|21077269|P6|Overall Study|Withdrawal by Subject|1
6110952|NCT00147225|21077270|P5|Overall Study|Withdrawal by Subject|0
6110953|NCT00147225|21077271|P4|Overall Study|Withdrawal by Subject|0
6110954|NCT00147225|21077272|P3|Overall Study|Withdrawal by Subject|1
6110955|NCT00147225|21077273|P2|Overall Study|Withdrawal by Subject|0
6110956|NCT00147225|21077274|P1|Overall Study|Withdrawal by Subject|1
6110957|NCT00146848|21077449|P3|Post-randomization|Withdrawn|27
6110958|NCT00146848|21077450|P2|Post-randomization|Withdrawn|32
6110959|NCT00146848|21077451|P1|Post-randomization|Withdrawn|26
6110960|NCT00146848|21077449|P3|Post-randomization|Lost to Follow-up|12
6110961|NCT00146848|21077450|P2|Post-randomization|Lost to Follow-up|15
6110962|NCT00146848|21077451|P1|Post-randomization|Lost to Follow-up|12
6110963|NCT00146848|21077449|P3|Pre-randomization|Withdrawal by Subject|0
6110964|NCT00146848|21077450|P2|Pre-randomization|Withdrawal by Subject|0
6110965|NCT00146848|21077451|P1|Pre-randomization|Withdrawal by Subject|40
6110966|NCT00146848|21077449|P3|Pre-randomization|Protocol Violation|0
6110967|NCT00146848|21077450|P2|Pre-randomization|Protocol Violation|0
6110968|NCT00146848|21077451|P1|Pre-randomization|Protocol Violation|172
6110969|NCT00146848|21077449|P3|Pre-randomization|Physician Decision|0
6110970|NCT00146848|21077450|P2|Pre-randomization|Physician Decision|0
6110971|NCT00146848|21077451|P1|Pre-randomization|Physician Decision|8
6110972|NCT00146848|21077449|P3|Pre-randomization|Lost to Follow-up|0
6110973|NCT00146848|21077450|P2|Pre-randomization|Lost to Follow-up|0
6110974|NCT00146848|21077451|P1|Pre-randomization|Lost to Follow-up|70
6110975|NCT00146848|21077449|P3|Pre-randomization|Death|0
6110976|NCT00146848|21077450|P2|Pre-randomization|Death|0
6110977|NCT00146848|21077451|P1|Pre-randomization|Death|19
6110978|NCT00146770|21077467|P2|Overall Study|Withdrawal by Subject|0
6110979|NCT00146770|21077468|P1|Overall Study|Withdrawal by Subject|2
6110980|NCT00146770|21077467|P2|Overall Study|Pregnancy|0
6110981|NCT00146770|21077468|P1|Overall Study|Pregnancy|1
6110982|NCT00146770|21077467|P2|Overall Study|Adverse Event|0
6110983|NCT00146770|21077468|P1|Overall Study|Adverse Event|2
6110984|NCT00146757|21077486|P2|Overall Study|Adverse Event|0
6110985|NCT00146757|21077487|P1|Overall Study|Adverse Event|1
6110986|NCT00146757|21077486|P2|Overall Study|Death|0
6110987|NCT00146757|21077487|P1|Overall Study|Death|1
6110988|NCT00146640|21077506|P2|Overall Study|Non-Medical Reasons|4
6110989|NCT00146640|21077507|P1|Overall Study|Non-Medical Reasons|8
6110990|NCT00146640|21077506|P2|Overall Study|Medical Reasons|0
6110991|NCT00146640|21077507|P1|Overall Study|Medical Reasons|3
6110992|NCT00146640|21077506|P2|Overall Study|Adverse Event|10
6110993|NCT00146640|21077507|P1|Overall Study|Adverse Event|12
6110994|NCT00146328|21077530|P3|Overall Study|Interaction with other medication|1
6110995|NCT00146328|21077531|P2|Overall Study|Interaction with other medication|0
6110996|NCT00146328|21077532|P1|Overall Study|Interaction with other medication|2
6110997|NCT00146328|21077530|P3|Overall Study|Moved|0
6110998|NCT00146328|21077531|P2|Overall Study|Moved|0
6110999|NCT00146328|21077532|P1|Overall Study|Moved|2
6111000|NCT00146328|21077530|P3|Overall Study|Death|1
6111001|NCT00146328|21077531|P2|Overall Study|Death|1
6111002|NCT00146328|21077532|P1|Overall Study|Death|0
6111003|NCT00146328|21077530|P3|Overall Study|Enroll into other trial|2
6111004|NCT00146328|21077531|P2|Overall Study|Enroll into other trial|4
6111005|NCT00146328|21077532|P1|Overall Study|Enroll into other trial|2
6111006|NCT00146328|21077530|P3|Overall Study|Patient decision to end|6
6111007|NCT00146328|21077531|P2|Overall Study|Patient decision to end|1
6111008|NCT00146328|21077532|P1|Overall Study|Patient decision to end|0
6111009|NCT00146328|21077530|P3|Overall Study|Trial ended/site closed|19
6111010|NCT00146328|21077531|P2|Overall Study|Trial ended/site closed|2
6111011|NCT00146328|21077532|P1|Overall Study|Trial ended/site closed|8
6111012|NCT00146328|21077530|P3|Overall Study|Virologic Failure/lack of efficacy|142
6111013|NCT00146328|21077531|P2|Overall Study|Virologic Failure/lack of efficacy|72
6111014|NCT00146328|21077532|P1|Overall Study|Virologic Failure/lack of efficacy|54
6111015|NCT00146328|21077530|P3|Overall Study|Withdrawal by Subject|22
6111016|NCT00146328|21077531|P2|Overall Study|Withdrawal by Subject|16
6111017|NCT00146328|21077532|P1|Overall Study|Withdrawal by Subject|16
6111018|NCT00146328|21077530|P3|Overall Study|Lost to Follow-up|7
6111019|NCT00146328|21077531|P2|Overall Study|Lost to Follow-up|4
6111020|NCT00146328|21077532|P1|Overall Study|Lost to Follow-up|7
6111021|NCT00146328|21077530|P3|Overall Study|Protocol Violation|12
6111022|NCT00146328|21077531|P2|Overall Study|Protocol Violation|6
6111023|NCT00146328|21077532|P1|Overall Study|Protocol Violation|11
6111024|NCT00146328|21077530|P3|Overall Study|Adverse Event|79
6111025|NCT00146328|21077531|P2|Overall Study|Adverse Event|48
6111026|NCT00146328|21077532|P1|Overall Study|Adverse Event|39
6111027|NCT00146172|21077623|P8|Overall Study|Symptomatic Deterioration|2
6111028|NCT00146172|21077624|P7|Overall Study|Symptomatic Deterioration|0
6111029|NCT00146172|21077625|P6|Overall Study|Symptomatic Deterioration|2
6111030|NCT00146172|21077626|P5|Overall Study|Symptomatic Deterioration|1
6111031|NCT00146172|21077627|P4|Overall Study|Symptomatic Deterioration|0
6111032|NCT00146172|21077628|P3|Overall Study|Symptomatic Deterioration|1
6111033|NCT00146172|21077629|P2|Overall Study|Symptomatic Deterioration|0
6111034|NCT00146172|21077630|P1|Overall Study|Symptomatic Deterioration|1
6111035|NCT00146172|21077623|P8|Overall Study|Withdrawal by Subject|4
6111036|NCT00146172|21077624|P7|Overall Study|Withdrawal by Subject|1
6111037|NCT00146172|21077625|P6|Overall Study|Withdrawal by Subject|1
6111038|NCT00146172|21077626|P5|Overall Study|Withdrawal by Subject|0
6111039|NCT00146172|21077627|P4|Overall Study|Withdrawal by Subject|0
6111040|NCT00146172|21077628|P3|Overall Study|Withdrawal by Subject|0
6111041|NCT00146172|21077629|P2|Overall Study|Withdrawal by Subject|0
6111042|NCT00146172|21077630|P1|Overall Study|Withdrawal by Subject|0
6111043|NCT00146172|21077623|P8|Overall Study|Physician Decision|1
6111044|NCT00146172|21077624|P7|Overall Study|Physician Decision|0
6111045|NCT00146172|21077625|P6|Overall Study|Physician Decision|0
6111046|NCT00146172|21077626|P5|Overall Study|Physician Decision|0
6111047|NCT00146172|21077627|P4|Overall Study|Physician Decision|0
6111048|NCT00146172|21077628|P3|Overall Study|Physician Decision|0
6111049|NCT00146172|21077629|P2|Overall Study|Physician Decision|0
6111050|NCT00146172|21077630|P1|Overall Study|Physician Decision|0
6111051|NCT00146172|21077623|P8|Overall Study|Death|0
6111052|NCT00146172|21077624|P7|Overall Study|Death|1
6111053|NCT00146172|21077625|P6|Overall Study|Death|0
6111054|NCT00146172|21077626|P5|Overall Study|Death|0
6111055|NCT00146172|21077627|P4|Overall Study|Death|0
6111056|NCT00146172|21077628|P3|Overall Study|Death|0
6111057|NCT00146172|21077629|P2|Overall Study|Death|0
6111058|NCT00146172|21077630|P1|Overall Study|Death|0
6111059|NCT00146172|21077623|P8|Overall Study|Disease Progression|22
6111060|NCT00146172|21077624|P7|Overall Study|Disease Progression|1
6111061|NCT00146172|21077625|P6|Overall Study|Disease Progression|2
6111062|NCT00146172|21077626|P5|Overall Study|Disease Progression|2
6111063|NCT00146172|21077627|P4|Overall Study|Disease Progression|5
6111064|NCT00146172|21077628|P3|Overall Study|Disease Progression|2
6111065|NCT00146172|21077629|P2|Overall Study|Disease Progression|4
6111066|NCT00146172|21077630|P1|Overall Study|Disease Progression|2
6111067|NCT00146172|21077623|P8|Overall Study|Lost to Follow-up|1
6111068|NCT00146172|21077624|P7|Overall Study|Lost to Follow-up|0
6111069|NCT00146172|21077625|P6|Overall Study|Lost to Follow-up|0
6111070|NCT00146172|21077626|P5|Overall Study|Lost to Follow-up|0
6111071|NCT00146172|21077627|P4|Overall Study|Lost to Follow-up|0
6111072|NCT00146172|21077628|P3|Overall Study|Lost to Follow-up|0
6111073|NCT00146172|21077629|P2|Overall Study|Lost to Follow-up|0
6111074|NCT00146172|21077630|P1|Overall Study|Lost to Follow-up|0
6111075|NCT00146172|21077623|P8|Overall Study|Adverse Event|10
6111076|NCT00146172|21077624|P7|Overall Study|Adverse Event|3
6111077|NCT00146172|21077625|P6|Overall Study|Adverse Event|2
6111078|NCT00146172|21077626|P5|Overall Study|Adverse Event|0
6111079|NCT00146172|21077627|P4|Overall Study|Adverse Event|1
6111080|NCT00146172|21077628|P3|Overall Study|Adverse Event|1
6111081|NCT00146172|21077629|P2|Overall Study|Adverse Event|0
6111082|NCT00146172|21077630|P1|Overall Study|Adverse Event|0
6111083|NCT00145977|21077665|P2|Overall Study|Withdrawal by Subject|0
6111084|NCT00145977|21077666|P1|Overall Study|Withdrawal by Subject|1
6111085|NCT00145977|21077665|P2|Overall Study|Lost to Follow-up|0
6111086|NCT00145977|21077666|P1|Overall Study|Lost to Follow-up|1
6111087|NCT00145977|21077665|P2|Overall Study|Lack of Efficacy|4
6111088|NCT00145977|21077666|P1|Overall Study|Lack of Efficacy|0
6111089|NCT00145795|21077692|P2|Overall Study|Adverse Event|0
6111090|NCT00145795|21077693|P1|Overall Study|Adverse Event|1
6111091|NCT00145626|21077728|P1|Overall Study|Withdrawal by Subject|1
6111092|NCT00145626|21077728|P1|Overall Study|Death|1
6111093|NCT00145626|21077728|P1|Overall Study|Turned 2 years old before treatment|1
6111094|NCT00145626|21077728|P1|Overall Study|Did not have NK infusions|2
6111095|NCT00145600|21077774|P4|Overall Study|Withdrawal by Subject|1
6111096|NCT00145600|21077775|P3|Overall Study|Withdrawal by Subject|0
6111097|NCT00145600|21077776|P2|Overall Study|Withdrawal by Subject|2
6111098|NCT00145600|21077777|P1|Overall Study|Withdrawal by Subject|1
6111099|NCT00145600|21077774|P4|Overall Study|Noncompliance|0
6111100|NCT00145600|21077775|P3|Overall Study|Noncompliance|0
6111101|NCT00145600|21077776|P2|Overall Study|Noncompliance|0
6111102|NCT00145600|21077777|P1|Overall Study|Noncompliance|1
6111103|NCT00145600|21077774|P4|Overall Study|Lost to Follow-up|4
6111104|NCT00145600|21077775|P3|Overall Study|Lost to Follow-up|2
6111105|NCT00145600|21077776|P2|Overall Study|Lost to Follow-up|6
6111106|NCT00145600|21077777|P1|Overall Study|Lost to Follow-up|2
6111107|NCT00145600|21077774|P4|Overall Study|Ineligible|5
6111108|NCT00145600|21077775|P3|Overall Study|Ineligible|1
6111109|NCT00145600|21077776|P2|Overall Study|Ineligible|0
6111110|NCT00145600|21077777|P1|Overall Study|Ineligible|3
6111111|NCT00145600|21077774|P4|Overall Study|Death|6
6111112|NCT00145600|21077775|P3|Overall Study|Death|2
6111113|NCT00145600|21077776|P2|Overall Study|Death|2
6111114|NCT00145600|21077777|P1|Overall Study|Death|1
6111115|NCT00145574|21077901|P3|Open Label Long-term Extension|required restricted medicine|1
6111116|NCT00145574|21077902|P2|Open Label Long-term Extension|required restricted medicine|0
6111117|NCT00145574|21077903|P1|Open Label Long-term Extension|required restricted medicine|0
6111118|NCT00145574|21077901|P3|Open Label Long-term Extension|Withdrawal by Subject|4
6111119|NCT00145574|21077902|P2|Open Label Long-term Extension|Withdrawal by Subject|0
6111120|NCT00145574|21077903|P1|Open Label Long-term Extension|Withdrawal by Subject|0
6111121|NCT00145574|21077901|P3|Open Label Long-term Extension|Lost to Follow-up|1
6111122|NCT00145574|21077902|P2|Open Label Long-term Extension|Lost to Follow-up|0
6111123|NCT00145574|21077903|P1|Open Label Long-term Extension|Lost to Follow-up|0
6111124|NCT00145574|21077901|P3|Open Label Long-term Extension|Adverse Event|5
6111125|NCT00145574|21077902|P2|Open Label Long-term Extension|Adverse Event|0
6111126|NCT00145574|21077903|P1|Open Label Long-term Extension|Adverse Event|0
6111127|NCT00145574|21077901|P3|Double Blind|required restricted medicine|0
6111128|NCT00145574|21077902|P2|Double Blind|required restricted medicine|1
6111129|NCT00145574|21077903|P1|Double Blind|required restricted medicine|0
6111130|NCT00145574|21077901|P3|Double Blind|Withdrawal by Subject|1
6111131|NCT00145574|21077902|P2|Double Blind|Withdrawal by Subject|1
6111132|NCT00145574|21077903|P1|Double Blind|Withdrawal by Subject|1
6111133|NCT00145574|21077901|P3|Double Blind|Adverse Event|1
6111134|NCT00145574|21077902|P2|Double Blind|Adverse Event|3
6111135|NCT00145574|21077903|P1|Double Blind|Adverse Event|0
6111136|NCT00145509|21077960|P2|Overall Study|Reason not provided|1
6111137|NCT00145509|21077961|P1|Overall Study|Reason not provided|2
6111138|NCT00145509|21077960|P2|Overall Study|Withdrew Consent|7
6111139|NCT00145509|21077961|P1|Overall Study|Withdrew Consent|2
6111140|NCT00145509|21077960|P2|Overall Study|Lost to Follow-up|9
6111141|NCT00145509|21077961|P1|Overall Study|Lost to Follow-up|5
6111142|NCT00145509|21077960|P2|Overall Study|Lack of Efficacy|1
6111143|NCT00145509|21077961|P1|Overall Study|Lack of Efficacy|3
6111144|NCT00145509|21077960|P2|Overall Study|Adverse Event|3
6111145|NCT00145509|21077961|P1|Overall Study|Adverse Event|10
6111146|NCT00145496|21077975|P2|Overall Study|Other|13
6111147|NCT00145496|21077976|P1|Overall Study|Other|25
6111148|NCT00145496|21077975|P2|Overall Study|Lost to Follow-up|5
6111149|NCT00145496|21077976|P1|Overall Study|Lost to Follow-up|12
6111150|NCT00145496|21077975|P2|Overall Study|Withdrawal by Subject|26
6111151|NCT00145496|21077976|P1|Overall Study|Withdrawal by Subject|32
6111152|NCT00145496|21077975|P2|Overall Study|Lack of Efficacy|7
6111153|NCT00145496|21077976|P1|Overall Study|Lack of Efficacy|12
6111154|NCT00145496|21077975|P2|Overall Study|Adverse Event|30
6111155|NCT00145496|21077976|P1|Overall Study|Adverse Event|42
6111156|NCT00145470|21077988|P2|Overall Study|Reason Not Reported|9
6111157|NCT00145470|21077989|P1|Overall Study|Reason Not Reported|9
6111158|NCT00145470|21077988|P2|Overall Study|Lost to Follow-up|17
6111159|NCT00145470|21077989|P1|Overall Study|Lost to Follow-up|21
6111160|NCT00145470|21077988|P2|Overall Study|Withdrawal by Subject|34
6111161|NCT00145470|21077989|P1|Overall Study|Withdrawal by Subject|36
6111162|NCT00145470|21077988|P2|Overall Study|Lack of Efficacy|13
6111163|NCT00145470|21077989|P1|Overall Study|Lack of Efficacy|27
6111164|NCT00145470|21077988|P2|Overall Study|Adverse Event|25
6111165|NCT00145470|21077989|P1|Overall Study|Adverse Event|19
6111166|NCT00145327|21078059|P3|Overall Study|Missing - not stated|1
6111167|NCT00145327|21078060|P2|Overall Study|Missing - not stated|0
6111168|NCT00145327|21078061|P1|Overall Study|Missing - not stated|1
6111169|NCT00145327|21078059|P3|Overall Study|Abnormal laboratory value(s)|2
6111170|NCT00145327|21078060|P2|Overall Study|Abnormal laboratory value(s)|0
6111171|NCT00145327|21078061|P1|Overall Study|Abnormal laboratory value(s)|1
6111172|NCT00145327|21078059|P3|Overall Study|Protocol Violation|2
6111173|NCT00145327|21078060|P2|Overall Study|Protocol Violation|0
6111174|NCT00145327|21078061|P1|Overall Study|Protocol Violation|2
6111175|NCT00145327|21078059|P3|Overall Study|Administrative problems|13
6111176|NCT00145327|21078060|P2|Overall Study|Administrative problems|9
6111177|NCT00145327|21078061|P1|Overall Study|Administrative problems|12
6111178|NCT00145327|21078059|P3|Overall Study|Lost to Follow-up|14
6111179|NCT00145327|21078060|P2|Overall Study|Lost to Follow-up|14
6111180|NCT00145327|21078061|P1|Overall Study|Lost to Follow-up|9
6111181|NCT00145327|21078059|P3|Overall Study|Adverse Event|22
6111182|NCT00145327|21078060|P2|Overall Study|Adverse Event|11
6111183|NCT00145327|21078061|P1|Overall Study|Adverse Event|14
6111184|NCT00145327|21078059|P3|Overall Study|Death|30
6111185|NCT00145327|21078060|P2|Overall Study|Death|18
6111186|NCT00145327|21078061|P1|Overall Study|Death|26
6111187|NCT00145327|21078059|P3|Overall Study|Withdrawal by Subject|164
6111188|NCT00145327|21078060|P2|Overall Study|Withdrawal by Subject|72
6111189|NCT00145327|21078061|P1|Overall Study|Withdrawal by Subject|77
6111190|NCT00145119|21078160|P1|Overall Study|Death|45
6111191|NCT00144781|21078178|P4|Overall Study|Non-compliant|0
6111192|NCT00144781|21078179|P3|Overall Study|Non-compliant|0
6111193|NCT00144781|21078180|P2|Overall Study|Non-compliant|1
6111194|NCT00144781|21078181|P1|Overall Study|Non-compliant|0
6111195|NCT00144781|21078178|P4|Overall Study|Adverse Event|0
6111196|NCT00144781|21078179|P3|Overall Study|Adverse Event|0
6111197|NCT00144781|21078180|P2|Overall Study|Adverse Event|1
6111198|NCT00144781|21078181|P1|Overall Study|Adverse Event|0
6111199|NCT00144339|21078210|P2|Overall Study|Other|60
6111200|NCT00144339|21078211|P1|Overall Study|Other|58
6111201|NCT00144339|21078210|P2|Overall Study|Lost to Follow-up|64
6111202|NCT00144339|21078211|P1|Overall Study|Lost to Follow-up|76
6111203|NCT00144339|21078210|P2|Overall Study|Withdrawal by Subject|300
6111204|NCT00144339|21078211|P1|Overall Study|Withdrawal by Subject|403
6111205|NCT00144339|21078210|P2|Overall Study|Protocol Violation|48
6111206|NCT00144339|21078211|P1|Overall Study|Protocol Violation|75
6111207|NCT00144339|21078210|P2|Overall Study|Adverse Event|627
6111208|NCT00144339|21078211|P1|Overall Study|Adverse Event|746
6111209|NCT00144300|21078419|P2|Overall Study|Other reason (not specified)|3
6111210|NCT00144300|21078420|P1|Overall Study|Other reason (not specified)|1
6111211|NCT00144300|21078419|P2|Overall Study|Withdrawal by Subject|6
6111212|NCT00144300|21078420|P1|Overall Study|Withdrawal by Subject|6
6111213|NCT00144300|21078419|P2|Overall Study|Lost to Follow-up|0
6111214|NCT00144300|21078420|P1|Overall Study|Lost to Follow-up|3
6111215|NCT00144300|21078419|P2|Overall Study|Protocol Violation|3
6111216|NCT00144300|21078420|P1|Overall Study|Protocol Violation|1
6111217|NCT00144300|21078419|P2|Overall Study|Adverse Event|16
6111218|NCT00144300|21078420|P1|Overall Study|Adverse Event|18
6111219|NCT00144170|21078468|P2|Overall Study|Other reason not defined above|316
6111220|NCT00144170|21078469|P1|Overall Study|Other reason not defined above|211
6111221|NCT00144170|21078468|P2|Overall Study|Withdrawal by Subject|13
6111222|NCT00144170|21078469|P1|Overall Study|Withdrawal by Subject|29
6111223|NCT00144170|21078468|P2|Overall Study|Lost to Follow-up|10
6111224|NCT00144170|21078469|P1|Overall Study|Lost to Follow-up|5
6111225|NCT00144170|21078468|P2|Overall Study|Protocol Violation|16
6111226|NCT00144170|21078469|P1|Overall Study|Protocol Violation|23
6111227|NCT00144170|21078468|P2|Overall Study|Adverse Event|41
6111228|NCT00144170|21078469|P1|Overall Study|Adverse Event|84
6111229|NCT00144027|21078659|P2|Overall Study|did not complete baseline assessment|6
6111230|NCT00144027|21078660|P1|Overall Study|did not complete baseline assessment|0
6111231|NCT00144027|21078659|P2|Overall Study|Withdrawal by Subject|2
6111232|NCT00144027|21078660|P1|Overall Study|Withdrawal by Subject|2
6111233|NCT00144027|21078659|P2|Overall Study|Lost to Follow-up|3
6111234|NCT00144027|21078660|P1|Overall Study|Lost to Follow-up|1
6111235|NCT00143598|21078690|P2|Overall Study|Death|36
6111236|NCT00143598|21078691|P1|Overall Study|Death|36
6111237|NCT00143598|21078690|P2|Overall Study|Withdrawal by Subject|37
6111238|NCT00143598|21078691|P1|Overall Study|Withdrawal by Subject|33
6111239|NCT00143598|21078690|P2|Overall Study|Lost to Follow-up|21
6111240|NCT00143598|21078691|P1|Overall Study|Lost to Follow-up|23
6111241|NCT00143507|21078705|P2|Overall Study|Withdrawn by sponsor's decision|3
6111242|NCT00143507|21078706|P1|Overall Study|Withdrawn by sponsor's decision|0
6111243|NCT00143507|21078705|P2|Overall Study|Lost to Follow-up|0
6111244|NCT00143507|21078706|P1|Overall Study|Lost to Follow-up|1
6111245|NCT00143507|21078705|P2|Overall Study|Withdrawal by Subject|102
6111246|NCT00143507|21078706|P1|Overall Study|Withdrawal by Subject|114
6111247|NCT00143507|21078705|P2|Overall Study|Death|547
6111248|NCT00143507|21078706|P1|Overall Study|Death|572
6111249|NCT00143455|21078740|P4|Cohort 2|Randomized But Not Treated|1
6111250|NCT00143455|21078741|P3|Cohort 2|Randomized But Not Treated|1
6111251|NCT00143455|21078742|P2|Cohort 2|Randomized But Not Treated|0
6111252|NCT00143455|21078743|P1|Cohort 2|Randomized But Not Treated|0
6111253|NCT00143455|21078740|P4|Cohort 2|Other|6
6111254|NCT00143455|21078741|P3|Cohort 2|Other|7
6111255|NCT00143455|21078742|P2|Cohort 2|Other|0
6111256|NCT00143455|21078743|P1|Cohort 2|Other|0
6111257|NCT00143455|21078740|P4|Cohort 2|Withdrawal by Subject|12
6111258|NCT00143455|21078741|P3|Cohort 2|Withdrawal by Subject|13
6111259|NCT00143455|21078742|P2|Cohort 2|Withdrawal by Subject|0
6111260|NCT00143455|21078743|P1|Cohort 2|Withdrawal by Subject|0
6111261|NCT00143455|21078740|P4|Cohort 2|Progressive Disease|27
6111262|NCT00143455|21078741|P3|Cohort 2|Progressive Disease|20
6111263|NCT00143455|21078742|P2|Cohort 2|Progressive Disease|0
6111264|NCT00143455|21078743|P1|Cohort 2|Progressive Disease|0
6111265|NCT00143455|21078740|P4|Cohort 2|Death|12
6111266|NCT00143455|21078741|P3|Cohort 2|Death|20
6111267|NCT00143455|21078742|P2|Cohort 2|Death|0
6111268|NCT00143455|21078743|P1|Cohort 2|Death|0
6111269|NCT00143455|21078740|P4|Cohort 2|Lost to Follow-up|4
6111270|NCT00143455|21078741|P3|Cohort 2|Lost to Follow-up|1
6111271|NCT00143455|21078742|P2|Cohort 2|Lost to Follow-up|0
6111272|NCT00143455|21078743|P1|Cohort 2|Lost to Follow-up|0
6111273|NCT00143455|21078740|P4|Cohort 2|Protocol Violation|1
6111274|NCT00143455|21078741|P3|Cohort 2|Protocol Violation|1
6111275|NCT00143455|21078742|P2|Cohort 2|Protocol Violation|0
6111276|NCT00143455|21078743|P1|Cohort 2|Protocol Violation|0
6111277|NCT00143455|21078740|P4|Cohort 2|No Longer Required Study Treatment|0
6111278|NCT00143455|21078741|P3|Cohort 2|No Longer Required Study Treatment|1
6111279|NCT00143455|21078742|P2|Cohort 2|No Longer Required Study Treatment|0
6111280|NCT00143455|21078743|P1|Cohort 2|No Longer Required Study Treatment|0
6111281|NCT00143455|21078740|P4|Cohort 2|Adverse Event|30
6111282|NCT00143455|21078741|P3|Cohort 2|Adverse Event|42
6111283|NCT00143455|21078742|P2|Cohort 2|Adverse Event|0
6111284|NCT00143455|21078743|P1|Cohort 2|Adverse Event|0
6111285|NCT00143455|21078740|P4|Cohort 1|Randomized But Not Treated|0
6111286|NCT00143455|21078741|P3|Cohort 1|Randomized But Not Treated|0
6111287|NCT00143455|21078742|P2|Cohort 1|Randomized But Not Treated|1
6111288|NCT00143455|21078743|P1|Cohort 1|Randomized But Not Treated|0
6111289|NCT00143455|21078740|P4|Cohort 1|Withdrawal by Subject|0
6111290|NCT00143455|21078741|P3|Cohort 1|Withdrawal by Subject|0
6111291|NCT00143455|21078742|P2|Cohort 1|Withdrawal by Subject|4
6111292|NCT00143455|21078743|P1|Cohort 1|Withdrawal by Subject|1
6111293|NCT00143455|21078740|P4|Cohort 1|Progressive Disease|0
6111294|NCT00143455|21078741|P3|Cohort 1|Progressive Disease|0
6111295|NCT00143455|21078742|P2|Cohort 1|Progressive Disease|6
6111296|NCT00143455|21078743|P1|Cohort 1|Progressive Disease|0
6111297|NCT00143455|21078740|P4|Cohort 1|Death|0
6111298|NCT00143455|21078741|P3|Cohort 1|Death|0
6111299|NCT00143455|21078742|P2|Cohort 1|Death|2
6111300|NCT00143455|21078743|P1|Cohort 1|Death|5
6111301|NCT00143455|21078740|P4|Cohort 1|Adverse Event|0
6111302|NCT00143455|21078741|P3|Cohort 1|Adverse Event|0
6111303|NCT00143455|21078742|P2|Cohort 1|Adverse Event|4
6111304|NCT00143455|21078743|P1|Cohort 1|Adverse Event|8
6111305|NCT00143403|21078777|P2|Overall Study|Randomized Not Treated|8
6111306|NCT00143403|21078778|P1|Overall Study|Randomized Not Treated|7
6111307|NCT00143403|21078777|P2|Overall Study|specified by site|9
6111308|NCT00143403|21078778|P1|Overall Study|specified by site|4
6111309|NCT00143403|21078777|P2|Overall Study|Protocol Violation|2
6111310|NCT00143403|21078778|P1|Overall Study|Protocol Violation|2
6111311|NCT00143403|21078777|P2|Overall Study|Relapse|7
6111312|NCT00143403|21078778|P1|Overall Study|Relapse|15
6111313|NCT00143403|21078777|P2|Overall Study|Withdrawal by Subject|12
6111314|NCT00143403|21078778|P1|Overall Study|Withdrawal by Subject|3
6111315|NCT00143403|21078777|P2|Overall Study|Death|0
6111316|NCT00143403|21078778|P1|Overall Study|Death|1
6111317|NCT00143403|21078777|P2|Overall Study|Adverse Event|8
6111318|NCT00143403|21078778|P1|Overall Study|Adverse Event|3
6111319|NCT00143390|21078788|P2|Overall Study|Other|2
6111320|NCT00143390|21078789|P1|Overall Study|Other|1
6111321|NCT00143390|21078788|P2|Overall Study|Adverse Event|8
6111322|NCT00143390|21078789|P1|Overall Study|Adverse Event|9
6111323|NCT00143390|21078788|P2|Overall Study|Study termination|15
6111324|NCT00143390|21078789|P1|Overall Study|Study termination|10
6111325|NCT00143390|21078788|P2|Overall Study|Protocol Violation|0
6111326|NCT00143390|21078789|P1|Overall Study|Protocol Violation|2
6111327|NCT00143390|21078788|P2|Overall Study|Progressive disease|115
6111328|NCT00143390|21078789|P1|Overall Study|Progressive disease|119
6111329|NCT00143390|21078788|P2|Overall Study|Withdrawal by Subject|4
6111330|NCT00143390|21078789|P1|Overall Study|Withdrawal by Subject|4
6111331|NCT00143390|21078788|P2|Overall Study|Not meeting entry criteria|5
6111332|NCT00143390|21078789|P1|Overall Study|Not meeting entry criteria|2
6111333|NCT00143390|21078788|P2|Overall Study|Death|0
6111334|NCT00143390|21078789|P1|Overall Study|Death|2
6111335|NCT00143312|21078805|P1|Overall Study|Withdrawal by Subject|1
6111336|NCT00143312|21078805|P1|Overall Study|Other|1
6111337|NCT00143312|21078805|P1|Overall Study|Lost to Follow-up|1
6111338|NCT00143312|21078805|P1|Overall Study|Adverse Event|2
6111339|NCT00143312|21078805|P1|Overall Study|Death|11
6111340|NCT00143247|21078815|P1|Overall Study|Other|12
6111341|NCT00143247|21078815|P1|Overall Study|following inaccurate lab adverse event|1
6111342|NCT00143247|21078815|P1|Overall Study|Lost to Follow-up|12
6111343|NCT00143247|21078815|P1|Overall Study|Protocol Violation|15
6111344|NCT00143247|21078815|P1|Overall Study|Study terminated by sponsor|31
6111345|NCT00143247|21078815|P1|Overall Study|Withdrawal by Subject|55
6111346|NCT00143247|21078815|P1|Overall Study|Lack of Efficacy|3
6111347|NCT00143247|21078815|P1|Overall Study|Adverse Event|19
6111348|NCT00143247|21078815|P1|Overall Study|Death|8
6111349|NCT00142935|21078832|P3|Overall Study|Death|1
6111350|NCT00142935|21078833|P2|Overall Study|Death|2
6111351|NCT00142935|21078834|P1|Overall Study|Death|0
6111352|NCT00142935|21078832|P3|Overall Study|Lost to Follow-up|5
6111353|NCT00142935|21078833|P2|Overall Study|Lost to Follow-up|5
6111354|NCT00142935|21078834|P1|Overall Study|Lost to Follow-up|2
6111355|NCT00142935|21078832|P3|Overall Study|Other reason|1
6111356|NCT00142935|21078833|P2|Overall Study|Other reason|1
6111357|NCT00142935|21078834|P1|Overall Study|Other reason|1
6111358|NCT00142909|21078859|P2|Medications Begin|Withdrawal by Subject|0
6111359|NCT00142909|21078860|P1|Medications Begin|Withdrawal by Subject|2
6111360|NCT00142909|21078859|P2|Medications Begin|Withdrawal by Subject|3
6111361|NCT00142909|21078860|P1|Medications Begin|Withdrawal by Subject|5
6111362|NCT00142909|21078859|P2|Medications Begin|Protocol Violation|0
6111363|NCT00142909|21078860|P1|Medications Begin|Protocol Violation|2
6111364|NCT00142909|21078859|P2|Randomization|Various Reasons|10
6111365|NCT00142909|21078860|P1|Randomization|Various Reasons|7
6111366|NCT00142792|21078900|P3|Overall Study|No category|1
6111367|NCT00142792|21078901|P2|Overall Study|No category|2
6111368|NCT00142792|21078902|P1|Overall Study|No category|1
6111369|NCT00142792|21078900|P3|Overall Study|Lost to Follow-up|7
6111370|NCT00142792|21078901|P2|Overall Study|Lost to Follow-up|11
6111371|NCT00142792|21078902|P1|Overall Study|Lost to Follow-up|8
6111372|NCT00142792|21078900|P3|Overall Study|Withdrawal by Subject|3
6111373|NCT00142792|21078901|P2|Overall Study|Withdrawal by Subject|2
6111374|NCT00142792|21078902|P1|Overall Study|Withdrawal by Subject|3
6111375|NCT00142792|21078900|P3|Overall Study|Death|1
6111376|NCT00142792|21078901|P2|Overall Study|Death|0
6111377|NCT00142792|21078902|P1|Overall Study|Death|0
6111378|NCT00142519|21078924|P2|Overall Study|Withdrawal by Subject|7
6111379|NCT00142519|21078925|P1|Overall Study|Withdrawal by Subject|10
6111380|NCT00142519|21078924|P2|Overall Study|Protocol Violation|0
6111381|NCT00142519|21078925|P1|Overall Study|Protocol Violation|1
6111382|NCT00142519|21078924|P2|Overall Study|Not Treated|9
6111383|NCT00142519|21078925|P1|Overall Study|Not Treated|7
6111384|NCT00142415|21078954|P6|Overall Study|Physician Decision|2
6111385|NCT00142415|21078955|P5|Overall Study|Physician Decision|1
6111386|NCT00142415|21078956|P4|Overall Study|Physician Decision|0
6111387|NCT00142415|21078957|P3|Overall Study|Physician Decision|0
6111388|NCT00142415|21078958|P2|Overall Study|Physician Decision|0
6111389|NCT00142415|21078959|P1|Overall Study|Physician Decision|0
6111390|NCT00142298|21078997|P10|Overall Study|Treatment Failure|0
6111391|NCT00142298|21078998|P9|Overall Study|Treatment Failure|0
6111392|NCT00142298|21078999|P8|Overall Study|Treatment Failure|0
6111393|NCT00142298|21079000|P7|Overall Study|Treatment Failure|2
6111394|NCT00142298|21079001|P6|Overall Study|Treatment Failure|2
6111395|NCT00142298|21079002|P5|Overall Study|Treatment Failure|0
6111396|NCT00142298|21079003|P4|Overall Study|Treatment Failure|0
6111397|NCT00142298|21079004|P3|Overall Study|Treatment Failure|0
6111398|NCT00142298|21079005|P2|Overall Study|Treatment Failure|0
6111399|NCT00142298|21079006|P1|Overall Study|Treatment Failure|0
6111400|NCT00142298|21078997|P10|Overall Study|Lost to Follow-up|0
6111401|NCT00142298|21078998|P9|Overall Study|Lost to Follow-up|0
6111402|NCT00142298|21078999|P8|Overall Study|Lost to Follow-up|0
6111403|NCT00142298|21079000|P7|Overall Study|Lost to Follow-up|2
6111404|NCT00142298|21079001|P6|Overall Study|Lost to Follow-up|0
6111405|NCT00142298|21079002|P5|Overall Study|Lost to Follow-up|0
6111406|NCT00142298|21079003|P4|Overall Study|Lost to Follow-up|0
6111407|NCT00142298|21079004|P3|Overall Study|Lost to Follow-up|0
6111408|NCT00142298|21079005|P2|Overall Study|Lost to Follow-up|0
6111409|NCT00142298|21079006|P1|Overall Study|Lost to Follow-up|0
6111410|NCT00142298|21078997|P10|Overall Study|Other- not specified|0
6111411|NCT00142298|21078998|P9|Overall Study|Other- not specified|0
6111412|NCT00142298|21078999|P8|Overall Study|Other- not specified|0
6111413|NCT00142298|21079000|P7|Overall Study|Other- not specified|0
6111414|NCT00142298|21079001|P6|Overall Study|Other- not specified|0
6111415|NCT00142298|21079002|P5|Overall Study|Other- not specified|0
6111416|NCT00142298|21079003|P4|Overall Study|Other- not specified|1
6111417|NCT00142298|21079004|P3|Overall Study|Other- not specified|0
6111418|NCT00142298|21079005|P2|Overall Study|Other- not specified|3
6111419|NCT00142298|21079006|P1|Overall Study|Other- not specified|0
6111420|NCT00142298|21078997|P10|Overall Study|Virologic breakthrough|0
6111421|NCT00142298|21078998|P9|Overall Study|Virologic breakthrough|0
6111422|NCT00142298|21078999|P8|Overall Study|Virologic breakthrough|0
6111423|NCT00142298|21079000|P7|Overall Study|Virologic breakthrough|3
6111424|NCT00142298|21079001|P6|Overall Study|Virologic breakthrough|3
6111425|NCT00142298|21079002|P5|Overall Study|Virologic breakthrough|2
6111426|NCT00142298|21079003|P4|Overall Study|Virologic breakthrough|7
6111427|NCT00142298|21079004|P3|Overall Study|Virologic breakthrough|9
6111428|NCT00142298|21079005|P2|Overall Study|Virologic breakthrough|23
6111429|NCT00142298|21079006|P1|Overall Study|Virologic breakthrough|19
6111430|NCT00142298|21078997|P10|Overall Study|Pregnancy|0
6111431|NCT00142298|21078998|P9|Overall Study|Pregnancy|1
6111432|NCT00142298|21078999|P8|Overall Study|Pregnancy|0
6111433|NCT00142298|21079000|P7|Overall Study|Pregnancy|0
6111434|NCT00142298|21079001|P6|Overall Study|Pregnancy|0
6111435|NCT00142298|21079002|P5|Overall Study|Pregnancy|0
6111436|NCT00142298|21079003|P4|Overall Study|Pregnancy|3
6111437|NCT00142298|21079004|P3|Overall Study|Pregnancy|2
6111438|NCT00142298|21079005|P2|Overall Study|Pregnancy|4
6111439|NCT00142298|21079006|P1|Overall Study|Pregnancy|4
6111440|NCT00142298|21078997|P10|Overall Study|Patient, Investigator,or Sponsor request|0
6111441|NCT00142298|21078998|P9|Overall Study|Patient, Investigator,or Sponsor request|1
6111442|NCT00142298|21078999|P8|Overall Study|Patient, Investigator,or Sponsor request|4
6111443|NCT00142298|21079000|P7|Overall Study|Patient, Investigator,or Sponsor request|1
6111444|NCT00142298|21079001|P6|Overall Study|Patient, Investigator,or Sponsor request|3
6111445|NCT00142298|21079002|P5|Overall Study|Patient, Investigator,or Sponsor request|4
6111446|NCT00142298|21079003|P4|Overall Study|Patient, Investigator,or Sponsor request|51
6111447|NCT00142298|21079004|P3|Overall Study|Patient, Investigator,or Sponsor request|11
6111448|NCT00142298|21079005|P2|Overall Study|Patient, Investigator,or Sponsor request|60
6111449|NCT00142298|21079006|P1|Overall Study|Patient, Investigator,or Sponsor request|66
6111450|NCT00142298|21078997|P10|Overall Study|Non-compliance|0
6111451|NCT00142298|21078998|P9|Overall Study|Non-compliance|3
6111452|NCT00142298|21078999|P8|Overall Study|Non-compliance|3
6111453|NCT00142298|21079000|P7|Overall Study|Non-compliance|0
6111454|NCT00142298|21079001|P6|Overall Study|Non-compliance|0
6111455|NCT00142298|21079002|P5|Overall Study|Non-compliance|1
6111456|NCT00142298|21079003|P4|Overall Study|Non-compliance|6
6111457|NCT00142298|21079004|P3|Overall Study|Non-compliance|0
6111458|NCT00142298|21079005|P2|Overall Study|Non-compliance|13
6111459|NCT00142298|21079006|P1|Overall Study|Non-compliance|15
6111460|NCT00142298|21078997|P10|Overall Study|Lack of Efficacy|0
6111461|NCT00142298|21078998|P9|Overall Study|Lack of Efficacy|0
6111462|NCT00142298|21078999|P8|Overall Study|Lack of Efficacy|1
6111463|NCT00142298|21079000|P7|Overall Study|Lack of Efficacy|0
6111464|NCT00142298|21079001|P6|Overall Study|Lack of Efficacy|0
6111465|NCT00142298|21079002|P5|Overall Study|Lack of Efficacy|1
6111466|NCT00142298|21079003|P4|Overall Study|Lack of Efficacy|12
6111467|NCT00142298|21079004|P3|Overall Study|Lack of Efficacy|9
6111468|NCT00142298|21079005|P2|Overall Study|Lack of Efficacy|62
6111469|NCT00142298|21079006|P1|Overall Study|Lack of Efficacy|44
6111470|NCT00142298|21078997|P10|Overall Study|Death|0
6111471|NCT00142298|21078998|P9|Overall Study|Death|0
6111472|NCT00142298|21078999|P8|Overall Study|Death|0
6111473|NCT00142298|21079000|P7|Overall Study|Death|0
6111474|NCT00142298|21079001|P6|Overall Study|Death|6
6111475|NCT00142298|21079002|P5|Overall Study|Death|0
6111476|NCT00142298|21079003|P4|Overall Study|Death|0
6111477|NCT00142298|21079004|P3|Overall Study|Death|1
6111478|NCT00142298|21079005|P2|Overall Study|Death|1
6111479|NCT00142298|21079006|P1|Overall Study|Death|1
6111480|NCT00142298|21078997|P10|Overall Study|Clinical disease progression|0
6111481|NCT00142298|21078998|P9|Overall Study|Clinical disease progression|0
6111482|NCT00142298|21078999|P8|Overall Study|Clinical disease progression|0
6111483|NCT00142298|21079000|P7|Overall Study|Clinical disease progression|0
6111484|NCT00142298|21079001|P6|Overall Study|Clinical disease progression|0
6111485|NCT00142298|21079002|P5|Overall Study|Clinical disease progression|0
6111486|NCT00142298|21079003|P4|Overall Study|Clinical disease progression|0
6111487|NCT00142298|21079004|P3|Overall Study|Clinical disease progression|0
6111488|NCT00142298|21079005|P2|Overall Study|Clinical disease progression|0
6111489|NCT00142298|21079006|P1|Overall Study|Clinical disease progression|1
6111490|NCT00142298|21078997|P10|Overall Study|Adverse Event|0
6111491|NCT00142298|21078998|P9|Overall Study|Adverse Event|0
6111492|NCT00142298|21078999|P8|Overall Study|Adverse Event|0
6111493|NCT00142298|21079000|P7|Overall Study|Adverse Event|0
6111494|NCT00142298|21079001|P6|Overall Study|Adverse Event|2
6111495|NCT00142298|21079002|P5|Overall Study|Adverse Event|2
6111496|NCT00142298|21079003|P4|Overall Study|Adverse Event|5
6111497|NCT00142298|21079004|P3|Overall Study|Adverse Event|1
6111498|NCT00142298|21079005|P2|Overall Study|Adverse Event|10
6111499|NCT00142298|21079006|P1|Overall Study|Adverse Event|10
6111500|NCT00141921|21079040|P1|Overall Study|Other|8
6111501|NCT00141921|21079040|P1|Overall Study|Ineligibility Determined|2
6111502|NCT00141921|21079040|P1|Overall Study|Pregnancy|4
6111503|NCT00141921|21079040|P1|Overall Study|Administrative Decision|2
6111504|NCT00141921|21079040|P1|Overall Study|Adverse Event|5
6111505|NCT00141921|21079040|P1|Overall Study|Protocol Deviation|7
6111506|NCT00141921|21079040|P1|Overall Study|Disease Progression|7
6111507|NCT00141921|21079040|P1|Overall Study|Noncompliance|17
6111508|NCT00141921|21079040|P1|Overall Study|Lost to Follow-up|19
6111509|NCT00141921|21079040|P1|Overall Study|Withdrawal by Subject|42
6111510|NCT00141921|21079040|P1|Overall Study|Remain on Study|28
6111511|NCT00141817|21079066|P4|Overall Study|Parent request|0
6111512|NCT00141817|21079067|P3|Overall Study|Parent request|0
6111513|NCT00141817|21079068|P2|Overall Study|Parent request|0
6111514|NCT00141817|21079069|P1|Overall Study|Parent request|1
6111515|NCT00141817|21079066|P4|Overall Study|Protocol Violation|0
6111516|NCT00141817|21079067|P3|Overall Study|Protocol Violation|1
6111517|NCT00141817|21079068|P2|Overall Study|Protocol Violation|0
6111518|NCT00141817|21079069|P1|Overall Study|Protocol Violation|0
6111519|NCT00141778|21079110|P3|Started Study Medication|Chest Discomfort|1
6111520|NCT00141778|21079111|P2|Started Study Medication|Chest Discomfort|0
6111521|NCT00141778|21079112|P1|Started Study Medication|Chest Discomfort|0
6111522|NCT00141778|21079110|P3|Started Study Medication|Difficulty Swallowing|0
6111523|NCT00141778|21079111|P2|Started Study Medication|Difficulty Swallowing|1
6111524|NCT00141778|21079112|P1|Started Study Medication|Difficulty Swallowing|0
6111525|NCT00141778|21079110|P3|Started Study Medication|Withdrawal by Subject|0
6111526|NCT00141778|21079111|P2|Started Study Medication|Withdrawal by Subject|2
6111527|NCT00141778|21079112|P1|Started Study Medication|Withdrawal by Subject|0
6111528|NCT00141778|21079110|P3|Started Study Medication|Met safety criteria for discontinuation|3
6111529|NCT00141778|21079111|P2|Started Study Medication|Met safety criteria for discontinuation|4
6111622|NCT00141271|21079667|P2|Overall Study|Lack of Efficacy|7
6111530|NCT00141778|21079112|P1|Started Study Medication|Met safety criteria for discontinuation|2
6111531|NCT00141778|21079110|P3|Randomization Prior to Study Med|Withdrawal by Subject|6
6111532|NCT00141778|21079111|P2|Randomization Prior to Study Med|Withdrawal by Subject|2
6111533|NCT00141778|21079112|P1|Randomization Prior to Study Med|Withdrawal by Subject|5
6111534|NCT00141726|21079165|P1|Overall Study|Completed <50% Scheduled Dosing|3
6111535|NCT00141518|21079173|P3|Overall Study|Lack of Efficacy|0
6111536|NCT00141518|21079174|P2|Overall Study|Lack of Efficacy|0
6111537|NCT00141518|21079175|P1|Overall Study|Lack of Efficacy|5
6111538|NCT00141518|21079173|P3|Overall Study|Protocol Violation|2
6111539|NCT00141518|21079174|P2|Overall Study|Protocol Violation|1
6111540|NCT00141518|21079175|P1|Overall Study|Protocol Violation|1
6111541|NCT00141518|21079173|P3|Overall Study|Withdrawal by Subject|2
6111542|NCT00141518|21079174|P2|Overall Study|Withdrawal by Subject|0
6111543|NCT00141518|21079175|P1|Overall Study|Withdrawal by Subject|2
6111544|NCT00141518|21079173|P3|Overall Study|Adverse Event|2
6111545|NCT00141518|21079174|P2|Overall Study|Adverse Event|5
6111546|NCT00141518|21079175|P1|Overall Study|Adverse Event|7
6111547|NCT00141518|21079173|P3|Overall Study|Withdrew Consent Prior to Treatment|0
6111548|NCT00141518|21079174|P2|Overall Study|Withdrew Consent Prior to Treatment|0
6111549|NCT00141518|21079175|P1|Overall Study|Withdrew Consent Prior to Treatment|1
6111550|NCT00141453|21079364|P2|Overall Study|Protocol Violation|5
6111551|NCT00141453|21079365|P1|Overall Study|Protocol Violation|6
6111552|NCT00141297|21079379|P10|Overall Study|Transitioned|0
6111553|NCT00141297|21079380|P9|Overall Study|Transitioned|0
6111554|NCT00141297|21079381|P8|Overall Study|Transitioned|0
6111555|NCT00141297|21079382|P7|Overall Study|Transitioned|0
6111556|NCT00141297|21079383|P6|Overall Study|Transitioned|0
6111557|NCT00141297|21079384|P5|Overall Study|Transitioned|1
6111558|NCT00141297|21079385|P4|Overall Study|Transitioned|0
6111559|NCT00141297|21079386|P3|Overall Study|Transitioned|0
6111560|NCT00141297|21079387|P2|Overall Study|Transitioned|0
6111561|NCT00141297|21079388|P1|Overall Study|Transitioned|0
6111562|NCT00141297|21079379|P10|Overall Study|Progressive Disease|6
6111563|NCT00141297|21079380|P9|Overall Study|Progressive Disease|15
6111564|NCT00141297|21079381|P8|Overall Study|Progressive Disease|3
6111565|NCT00141297|21079382|P7|Overall Study|Progressive Disease|3
6111566|NCT00141297|21079383|P6|Overall Study|Progressive Disease|2
6111567|NCT00141297|21079384|P5|Overall Study|Progressive Disease|15
6111568|NCT00141297|21079385|P4|Overall Study|Progressive Disease|2
6111569|NCT00141297|21079386|P3|Overall Study|Progressive Disease|6
6111570|NCT00141297|21079387|P2|Overall Study|Progressive Disease|3
6111571|NCT00141297|21079388|P1|Overall Study|Progressive Disease|2
6111572|NCT00141297|21079379|P10|Overall Study|Other|0
6111573|NCT00141297|21079380|P9|Overall Study|Other|2
6111574|NCT00141297|21079381|P8|Overall Study|Other|0
6111575|NCT00141297|21079382|P7|Overall Study|Other|0
6111576|NCT00141297|21079383|P6|Overall Study|Other|0
6111577|NCT00141297|21079384|P5|Overall Study|Other|5
6111578|NCT00141297|21079385|P4|Overall Study|Other|1
6111579|NCT00141297|21079386|P3|Overall Study|Other|0
6111580|NCT00141297|21079387|P2|Overall Study|Other|0
6111581|NCT00141297|21079388|P1|Overall Study|Other|0
6111582|NCT00141297|21079379|P10|Overall Study|Withdrawal by Subject|0
6111583|NCT00141297|21079380|P9|Overall Study|Withdrawal by Subject|1
6111584|NCT00141297|21079381|P8|Overall Study|Withdrawal by Subject|0
6111585|NCT00141297|21079382|P7|Overall Study|Withdrawal by Subject|0
6111586|NCT00141297|21079383|P6|Overall Study|Withdrawal by Subject|0
6111587|NCT00141297|21079384|P5|Overall Study|Withdrawal by Subject|0
6111588|NCT00141297|21079385|P4|Overall Study|Withdrawal by Subject|0
6111589|NCT00141297|21079386|P3|Overall Study|Withdrawal by Subject|0
6111590|NCT00141297|21079387|P2|Overall Study|Withdrawal by Subject|0
6111591|NCT00141297|21079388|P1|Overall Study|Withdrawal by Subject|0
6111592|NCT00141297|21079379|P10|Overall Study|Death|0
6111593|NCT00141297|21079380|P9|Overall Study|Death|1
6111594|NCT00141297|21079381|P8|Overall Study|Death|0
6111595|NCT00141297|21079382|P7|Overall Study|Death|0
6111596|NCT00141297|21079383|P6|Overall Study|Death|0
6111597|NCT00141297|21079384|P5|Overall Study|Death|0
6111598|NCT00141297|21079385|P4|Overall Study|Death|0
6111599|NCT00141297|21079386|P3|Overall Study|Death|0
6111600|NCT00141297|21079387|P2|Overall Study|Death|0
6111601|NCT00141297|21079388|P1|Overall Study|Death|1
6111602|NCT00141297|21079379|P10|Overall Study|Adverse Event|0
6111603|NCT00141297|21079380|P9|Overall Study|Adverse Event|1
6111604|NCT00141297|21079381|P8|Overall Study|Adverse Event|1
6111605|NCT00141297|21079382|P7|Overall Study|Adverse Event|0
6111606|NCT00141297|21079383|P6|Overall Study|Adverse Event|1
6111607|NCT00141297|21079384|P5|Overall Study|Adverse Event|1
6111608|NCT00141297|21079385|P4|Overall Study|Adverse Event|0
6111609|NCT00141297|21079386|P3|Overall Study|Adverse Event|1
6111610|NCT00141297|21079387|P2|Overall Study|Adverse Event|0
6111611|NCT00141297|21079388|P1|Overall Study|Adverse Event|0
6111612|NCT00141271|21079666|P3|Overall Study|Other|5
6111613|NCT00141271|21079667|P2|Overall Study|Other|12
6111614|NCT00141271|21079668|P1|Overall Study|Other|11
6111615|NCT00141271|21079666|P3|Overall Study|Withdrawal by Subject|10
6111616|NCT00141271|21079667|P2|Overall Study|Withdrawal by Subject|9
6111617|NCT00141271|21079668|P1|Overall Study|Withdrawal by Subject|14
6111618|NCT00141271|21079666|P3|Overall Study|Lost to Follow-up|21
6111619|NCT00141271|21079667|P2|Overall Study|Lost to Follow-up|15
6111620|NCT00141271|21079668|P1|Overall Study|Lost to Follow-up|15
6111621|NCT00141271|21079666|P3|Overall Study|Lack of Efficacy|3
6111623|NCT00141271|21079668|P1|Overall Study|Lack of Efficacy|7
6111624|NCT00141271|21079666|P3|Overall Study|Laboratory Abnormality|1
6111625|NCT00141271|21079667|P2|Overall Study|Laboratory Abnormality|1
6111626|NCT00141271|21079668|P1|Overall Study|Laboratory Abnormality|2
6111627|NCT00141271|21079666|P3|Overall Study|Adverse Event|17
6111628|NCT00141271|21079667|P2|Overall Study|Adverse Event|19
6111629|NCT00141271|21079668|P1|Overall Study|Adverse Event|31
6111638|NCT00141102|21079847|P2|Overall Study|Death|2
6111639|NCT00141102|21079848|P1|Overall Study|Death|2
6111640|NCT00141102|21079847|P2|Overall Study|Randomized But Did Not Receive Treatment|9
6111641|NCT00141102|21079848|P1|Overall Study|Randomized But Did Not Receive Treatment|15
6111642|NCT00141102|21079847|P2|Overall Study|Withdrawal by Subject|142
6111643|NCT00141102|21079848|P1|Overall Study|Withdrawal by Subject|112
6111644|NCT00141102|21079847|P2|Overall Study|Other|76
6111645|NCT00141102|21079848|P1|Overall Study|Other|87
6111646|NCT00141102|21079847|P2|Overall Study|Lost to Follow-up|32
6111647|NCT00141102|21079848|P1|Overall Study|Lost to Follow-up|29
6111648|NCT00141102|21079847|P2|Overall Study|Lack of Efficacy|26
6111649|NCT00141102|21079848|P1|Overall Study|Lack of Efficacy|21
6111650|NCT00141102|21079847|P2|Overall Study|Laboratory Abnormality|33
6111651|NCT00141102|21079848|P1|Overall Study|Laboratory Abnormality|9
6111652|NCT00141102|21079847|P2|Overall Study|Adverse Event|305
6111653|NCT00141102|21079848|P1|Overall Study|Adverse Event|233
6111654|NCT00141037|21079888|P2|Overall Study|Graft Failure|4
6111655|NCT00141037|21079889|P1|Overall Study|Graft Failure|3
6111656|NCT00141037|21079888|P2|Overall Study|Moved from area|7
6111657|NCT00141037|21079889|P1|Overall Study|Moved from area|1
6111658|NCT00141037|21079888|P2|Overall Study|Other|1
6111659|NCT00141037|21079889|P1|Overall Study|Other|0
6111660|NCT00141037|21079888|P2|Overall Study|Withdrawal by Subject|1
6111661|NCT00141037|21079889|P1|Overall Study|Withdrawal by Subject|2
6111662|NCT00141037|21079888|P2|Overall Study|Protocol Violation|2
6111663|NCT00141037|21079889|P1|Overall Study|Protocol Violation|0
6111664|NCT00141037|21079888|P2|Overall Study|Lost to Follow-up|1
6111665|NCT00141037|21079889|P1|Overall Study|Lost to Follow-up|3
6111666|NCT00141037|21079888|P2|Overall Study|Physician Decision|2
6111667|NCT00141037|21079889|P1|Overall Study|Physician Decision|1
6111668|NCT00140426|21079924|P2|Overall Study|Withdrawal by Subject|3
6111669|NCT00140426|21079925|P1|Overall Study|Withdrawal by Subject|0
6111670|NCT00140413|21079958|P2|Overall Study|Withdrawal by Subject|0
6111671|NCT00140413|21079959|P1|Overall Study|Withdrawal by Subject|2
6111672|NCT00140413|21079958|P2|Overall Study|Lost to Follow-up|0
6111673|NCT00140413|21079959|P1|Overall Study|Lost to Follow-up|1
6111674|NCT00140140|21080090|P3|Overall Study|Physician Decision|0
6111675|NCT00140140|21080091|P2|Overall Study|Physician Decision|1
6111676|NCT00140140|21080092|P1|Overall Study|Physician Decision|1
6111677|NCT00140140|21080090|P3|Overall Study|Unacceptable toxicity|2
6111678|NCT00140140|21080091|P2|Overall Study|Unacceptable toxicity|1
6111679|NCT00140140|21080092|P1|Overall Study|Unacceptable toxicity|1
6111680|NCT00139776|21080142|P4|Period III|Withdrawal by Subject|21
6111681|NCT00139776|21080143|P3|Period III|Withdrawal by Subject|16
6111682|NCT00139776|21080144|P2|Period III|Withdrawal by Subject|0
6111683|NCT00139776|21080145|P1|Period III|Withdrawal by Subject|0
6111684|NCT00139776|21080142|P4|Period III|Lost to Follow-up|4
6111685|NCT00139776|21080143|P3|Period III|Lost to Follow-up|5
6111686|NCT00139776|21080144|P2|Period III|Lost to Follow-up|0
6111687|NCT00139776|21080145|P1|Period III|Lost to Follow-up|0
6111688|NCT00139776|21080142|P4|Period III|Lack of Efficacy|24
6111689|NCT00139776|21080143|P3|Period III|Lack of Efficacy|10
6111690|NCT00139776|21080144|P2|Period III|Lack of Efficacy|0
6111691|NCT00139776|21080145|P1|Period III|Lack of Efficacy|0
6111692|NCT00139776|21080142|P4|Period III|Other|34
6111693|NCT00139776|21080143|P3|Period III|Other|23
6111694|NCT00139776|21080144|P2|Period III|Other|0
6111695|NCT00139776|21080145|P1|Period III|Other|0
6111696|NCT00139776|21080142|P4|Period III|Adverse Event|23
6111697|NCT00139776|21080143|P3|Period III|Adverse Event|22
6111698|NCT00139776|21080144|P2|Period III|Adverse Event|0
6111699|NCT00139776|21080145|P1|Period III|Adverse Event|0
6111700|NCT00139776|21080142|P4|Period II|Not Randomized into Period III|0
6111701|NCT00139776|21080143|P3|Period II|Not Randomized into Period III|0
6111702|NCT00139776|21080144|P2|Period II|Not Randomized into Period III|322
6111703|NCT00139776|21080145|P1|Period II|Not Randomized into Period III|0
6111704|NCT00139776|21080142|P4|Period I|Did not enter Period II|0
6111705|NCT00139776|21080143|P3|Period I|Did not enter Period II|0
6111706|NCT00139776|21080144|P2|Period I|Did not enter Period II|0
6111707|NCT00139776|21080145|P1|Period I|Did not enter Period II|575
6111708|NCT00139737|21080180|P1|Overall Study|Screened, Not Treated|13
6111709|NCT00139737|21080180|P1|Overall Study|Did Not Meet Entrance Criteria|1
6111710|NCT00139737|21080180|P1|Overall Study|Withdrew During Screening Phase|8
6111711|NCT00139737|21080180|P1|Overall Study|Protocol Violation|18
6111712|NCT00139737|21080180|P1|Overall Study|Laboratory Abnormality|2
6111713|NCT00139737|21080180|P1|Overall Study|Death|3
6111714|NCT00139737|21080180|P1|Overall Study|Lost to Follow-up|8
6111715|NCT00139737|21080180|P1|Overall Study|Lack of Efficacy|40
6111716|NCT00139737|21080180|P1|Overall Study|Adverse Event|58
6111717|NCT00139737|21080180|P1|Overall Study|Withdrawal by Subject|190
6111718|NCT00139659|21080186|P2|Overall Study|Withdrawal by Subject|10
6111719|NCT00139659|21080187|P1|Overall Study|Withdrawal by Subject|14
6111720|NCT00139659|21080186|P2|Overall Study|Reason not Specified|3
6111721|NCT00139659|21080187|P1|Overall Study|Reason not Specified|6
6111722|NCT00139659|21080186|P2|Overall Study|Lost to Follow-up|3
6111723|NCT00139659|21080187|P1|Overall Study|Lost to Follow-up|7
6111724|NCT00139659|21080186|P2|Overall Study|Lack of Efficacy|1
6111725|NCT00139659|21080187|P1|Overall Study|Lack of Efficacy|1
6111726|NCT00139659|21080186|P2|Overall Study|Adverse Event|1
6111727|NCT00139659|21080187|P1|Overall Study|Adverse Event|12
6111728|NCT00139477|21080265|P2|Second Intervention -6Months to 12Months|Lost to Follow-up|3
6111729|NCT00139477|21080266|P1|Second Intervention -6Months to 12Months|Lost to Follow-up|4
6111730|NCT00139477|21080265|P2|Second Intervention -6Months to 12Months|Relocation|0
6111731|NCT00139477|21080266|P1|Second Intervention -6Months to 12Months|Relocation|1
6111732|NCT00139477|21080265|P2|Second Intervention -6Months to 12Months|No Longer Interested|2
6111733|NCT00139477|21080266|P1|Second Intervention -6Months to 12Months|No Longer Interested|0
6111734|NCT00139477|21080265|P2|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|0
6111735|NCT00139477|21080266|P1|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|2
6111736|NCT00139477|21080265|P2|First Intervention -Baseline to 6Months|Lost to Follow-up|3
6111737|NCT00139477|21080266|P1|First Intervention -Baseline to 6Months|Lost to Follow-up|3
6111738|NCT00139477|21080265|P2|First Intervention -Baseline to 6Months|Relocation|2
6111739|NCT00139477|21080266|P1|First Intervention -Baseline to 6Months|Relocation|1
6111740|NCT00139477|21080265|P2|First Intervention -Baseline to 6Months|No Longer Interested|7
6111741|NCT00139477|21080266|P1|First Intervention -Baseline to 6Months|No Longer Interested|6
6111742|NCT00138671|21080301|P2|Overall Study|Other|3
6111743|NCT00138671|21080302|P1|Overall Study|Other|3
6111744|NCT00138671|21080301|P2|Overall Study|Withdrawal by Subject|5
6111745|NCT00138671|21080302|P1|Overall Study|Withdrawal by Subject|3
6111746|NCT00138671|21080301|P2|Overall Study|Lost to Follow-up|2
6111747|NCT00138671|21080302|P1|Overall Study|Lost to Follow-up|1
6111748|NCT00138671|21080301|P2|Overall Study|Adverse Event|3
6111749|NCT00138671|21080302|P1|Overall Study|Adverse Event|6
6111750|NCT00138671|21080301|P2|Overall Study|Death|3
6111751|NCT00138671|21080302|P1|Overall Study|Death|0
6111752|NCT00138658|21080352|P1|Overall Study|Withdrawal by Subject|5
6111753|NCT00138658|21080352|P1|Overall Study|Physician Decision|11
6111754|NCT00138658|21080352|P1|Overall Study|Disease Progression|21
6111755|NCT00138658|21080352|P1|Overall Study|Death|1
6111756|NCT00138658|21080352|P1|Overall Study|Adverse Event|23
6111757|NCT00138424|21080375|P4|Overall Study|Physician Decision|0
6111758|NCT00138424|21080376|P3|Overall Study|Physician Decision|0
6111759|NCT00138424|21080377|P2|Overall Study|Physician Decision|1
6111760|NCT00138424|21080378|P1|Overall Study|Physician Decision|0
6111761|NCT00138151|21080461|P1|Overall Study|Physician Decision|1
6111762|NCT00138151|21080461|P1|Overall Study|Withdrawal by Subject|3
6111763|NCT00138073|21080476|P1|Overall Study|lack of resources|55
6111764|NCT00137839|21080515|P1|Overall Study|Prolonged Treatment Delay|1
6111765|NCT00137839|21080515|P1|Overall Study|Not Start Treatment|1
6111766|NCT00137839|21080515|P1|Overall Study|Disease Progression|60
6111767|NCT00137839|21080515|P1|Overall Study|Death|8
6111768|NCT00137839|21080515|P1|Overall Study|Physician Decision|7
6111769|NCT00137839|21080515|P1|Overall Study|Adverse Event|7
6111770|NCT00137631|21080528|P2|Overall Study|Lost to Follow-up|41
6111771|NCT00137631|21080529|P1|Overall Study|Lost to Follow-up|37
6111772|NCT00137449|21080545|P2|Overall Study|Withdrawal by Subject|1
6111773|NCT00137449|21080546|P1|Overall Study|Withdrawal by Subject|1
6111774|NCT00137449|21080545|P2|Overall Study|Adverse Event|1
6111775|NCT00137449|21080546|P1|Overall Study|Adverse Event|3
6111776|NCT00137449|21080545|P2|Overall Study|Death|3
6111777|NCT00137449|21080546|P1|Overall Study|Death|4
6111778|NCT00137449|21080545|P2|Overall Study|Disease Progression|13
6111779|NCT00137449|21080546|P1|Overall Study|Disease Progression|8
6111780|NCT00137436|21080583|P1|Overall Study|Other|5
6111781|NCT00137436|21080583|P1|Overall Study|Withdrawal by Subject|6
6111782|NCT00137436|21080583|P1|Overall Study|Lack of Efficacy|17
6111783|NCT00137436|21080583|P1|Overall Study|Death|2
6111784|NCT00137436|21080583|P1|Overall Study|Adverse Event|13
6111785|NCT00137423|21080602|P2|Overall Study|Death|1
6111786|NCT00137423|21080603|P1|Overall Study|Death|0
6111787|NCT00137423|21080602|P2|Overall Study|Lack of Efficacy|33
6111788|NCT00137423|21080603|P1|Overall Study|Lack of Efficacy|31
6111789|NCT00137423|21080602|P2|Overall Study|consent withdrawn|1
6111790|NCT00137423|21080603|P1|Overall Study|consent withdrawn|1
6111791|NCT00137423|21080602|P2|Overall Study|Adverse Event|9
6111792|NCT00137423|21080603|P1|Overall Study|Adverse Event|7
6111793|NCT00137267|21080640|P2|Overall Study|Lost to Follow-up|21
6111794|NCT00137267|21080641|P1|Overall Study|Lost to Follow-up|15
6111795|NCT00137111|21080653|P4|Total Therapy|Non Compliance|0
6111796|NCT00137111|21080654|P3|Total Therapy|Non Compliance|0
6111797|NCT00137111|21080655|P2|Total Therapy|Non Compliance|0
6111798|NCT00137111|21080656|P1|Total Therapy|Non Compliance|5
6111799|NCT00137111|21080653|P4|Total Therapy|Death|0
6111800|NCT00137111|21080654|P3|Total Therapy|Death|0
6111801|NCT00137111|21080655|P2|Total Therapy|Death|0
6111802|NCT00137111|21080656|P1|Total Therapy|Death|35
6111803|NCT00137046|21080670|P2|Overall Study|Withdrew prior to study treatment|1
6111804|NCT00137046|21080671|P1|Overall Study|Withdrew prior to study treatment|1
6111805|NCT00137046|21080670|P2|Overall Study|Adverse Event 4 Days after Last Dose|0
6111806|NCT00137046|21080671|P1|Overall Study|Adverse Event 4 Days after Last Dose|1
6111807|NCT00137046|21080670|P2|Overall Study|Withdrawal by Subject|42
6111808|NCT00137046|21080671|P1|Overall Study|Withdrawal by Subject|33
6111809|NCT00137046|21080670|P2|Overall Study|Other|19
6111810|NCT00137046|21080671|P1|Overall Study|Other|23
6111811|NCT00137046|21080670|P2|Overall Study|Lost to Follow-up|24
6111812|NCT00137046|21080671|P1|Overall Study|Lost to Follow-up|8
6111813|NCT00137046|21080670|P2|Overall Study|Lack of Efficacy|1
6111814|NCT00137046|21080671|P1|Overall Study|Lack of Efficacy|13
6111815|NCT00137046|21080670|P2|Overall Study|Laboratory Abnormality|0
6111816|NCT00137046|21080671|P1|Overall Study|Laboratory Abnormality|2
6111817|NCT00137046|21080670|P2|Overall Study|Adverse Event|5
6111818|NCT00137046|21080671|P1|Overall Study|Adverse Event|16
6111819|NCT00137046|21080670|P2|Overall Study|Death|1
6111820|NCT00137046|21080671|P1|Overall Study|Death|2
6111821|NCT00136955|21080719|P1|Overall Study|Incl. prog. disease, protocol violation|12
6111822|NCT00136955|21080719|P1|Overall Study|Withdrawal by Subject|2
6111823|NCT00136955|21080719|P1|Overall Study|Lost to Follow-up|1
6111824|NCT00136955|21080719|P1|Overall Study|Adverse Event|8
6111825|NCT00136916|21080728|P2|Overall Study|Discontinued in follow up period|0
6111826|NCT00136916|21080729|P1|Overall Study|Discontinued in follow up period|3
6111827|NCT00136916|21080728|P2|Overall Study|Other|24
6111828|NCT00136916|21080729|P1|Overall Study|Other|22
6111829|NCT00136916|21080728|P2|Overall Study|Withdrawal by Subject|46
6111830|NCT00136916|21080729|P1|Overall Study|Withdrawal by Subject|44
6111831|NCT00136916|21080728|P2|Overall Study|Lost to Follow-up|14
6111832|NCT00136916|21080729|P1|Overall Study|Lost to Follow-up|12
6111833|NCT00136916|21080728|P2|Overall Study|Lack of Efficacy|3
6111834|NCT00136916|21080729|P1|Overall Study|Lack of Efficacy|13
6111835|NCT00136916|21080728|P2|Overall Study|Laboratory abnormality|1
6111836|NCT00136916|21080729|P1|Overall Study|Laboratory abnormality|0
6111837|NCT00136916|21080728|P2|Overall Study|Adverse Event|8
6111838|NCT00136916|21080729|P1|Overall Study|Adverse Event|27
6111839|NCT00136916|21080728|P2|Overall Study|Death|3
6111840|NCT00136916|21080729|P1|Overall Study|Death|1
6111841|NCT00136916|21080728|P2|Overall Study|Never received study treatment|5
6111842|NCT00136916|21080729|P1|Overall Study|Never received study treatment|3
6111843|NCT00136604|21080836|P5|Overall Study|Migrated/moved from study area|0
6111844|NCT00136604|21080837|P4|Overall Study|Migrated/moved from study area|0
6111845|NCT00136604|21080838|P3|Overall Study|Migrated/moved from study area|0
6111846|NCT00136604|21080839|P2|Overall Study|Migrated/moved from study area|1
6111847|NCT00136604|21080840|P1|Overall Study|Migrated/moved from study area|0
6111848|NCT00136604|21080836|P5|Overall Study|Lost to Follow-up|1
6111849|NCT00136604|21080837|P4|Overall Study|Lost to Follow-up|0
6111850|NCT00136604|21080838|P3|Overall Study|Lost to Follow-up|0
6111851|NCT00136604|21080839|P2|Overall Study|Lost to Follow-up|0
6111852|NCT00136604|21080840|P1|Overall Study|Lost to Follow-up|1
6111853|NCT00136357|21080948|P2|Overall Study|Withdrawal by Subject|2
6111854|NCT00136357|21080949|P1|Overall Study|Withdrawal by Subject|3
6111855|NCT00136318|21080957|P2|Overall Study|Withdrawal by Subject|2
6111856|NCT00136318|21080958|P1|Overall Study|Withdrawal by Subject|2
6111857|NCT00136318|21080957|P2|Overall Study|Adverse Event|5
6111858|NCT00136318|21080958|P1|Overall Study|Adverse Event|5
6111859|NCT00136084|21080985|P2|Overall Study|Withdrawal by Subject|1
6111860|NCT00136084|21080986|P1|Overall Study|Withdrawal by Subject|5
6111861|NCT00136084|21080985|P2|Overall Study|No Response|2
6111862|NCT00136084|21080986|P1|Overall Study|No Response|1
6111863|NCT00136084|21080985|P2|Overall Study|Lost to Follow-up|0
6111864|NCT00136084|21080986|P1|Overall Study|Lost to Follow-up|2
6111865|NCT00136084|21080985|P2|Overall Study|Relapse|23
6111866|NCT00136084|21080986|P1|Overall Study|Relapse|20
6111867|NCT00136084|21080985|P2|Overall Study|Unacceptable toxicity|11
6111868|NCT00136084|21080986|P1|Overall Study|Unacceptable toxicity|8
6111869|NCT00136084|21080985|P2|Overall Study|Death|5
6111870|NCT00136084|21080986|P1|Overall Study|Death|12
6111871|NCT00135707|21081022|P2|Overall Study|Institutional review board request|0
6111872|NCT00135707|21081023|P1|Overall Study|Institutional review board request|1
6111873|NCT00135707|21081022|P2|Overall Study|Withdrawal by Subject|1
6111874|NCT00135707|21081023|P1|Overall Study|Withdrawal by Subject|0
6111875|NCT00135707|21081022|P2|Overall Study|Lost to Follow-up|89
6111876|NCT00135707|21081023|P1|Overall Study|Lost to Follow-up|94
6111877|NCT00135694|21081106|P3|Overall Study|Ineligible for Random assignment|0
6111878|NCT00135694|21081107|P2|Overall Study|Ineligible for Random assignment|0
6111879|NCT00135694|21081108|P1|Overall Study|Ineligible for Random assignment|42
6111880|NCT00135694|21081106|P3|Overall Study|Hepatitis C related reasons|0
6111881|NCT00135694|21081107|P2|Overall Study|Hepatitis C related reasons|1
6111882|NCT00135694|21081108|P1|Overall Study|Hepatitis C related reasons|39
6111883|NCT00135694|21081106|P3|Overall Study|Protocol Violation|0
6111884|NCT00135694|21081107|P2|Overall Study|Protocol Violation|1
6111885|NCT00135694|21081108|P1|Overall Study|Protocol Violation|19
6111886|NCT00135694|21081106|P3|Overall Study|Withdrawal by Subject|4
6111887|NCT00135694|21081107|P2|Overall Study|Withdrawal by Subject|7
6111888|NCT00135694|21081108|P1|Overall Study|Withdrawal by Subject|41
6111889|NCT00135694|21081106|P3|Overall Study|Lost to Follow-up|1
6111890|NCT00135694|21081107|P2|Overall Study|Lost to Follow-up|7
6111891|NCT00135694|21081108|P1|Overall Study|Lost to Follow-up|8
6111892|NCT00135694|21081106|P3|Overall Study|Death|2
6111893|NCT00135694|21081107|P2|Overall Study|Death|1
6111894|NCT00135694|21081108|P1|Overall Study|Death|14
6111895|NCT00135694|21081106|P3|Overall Study|Adverse Event|0
6111896|NCT00135694|21081107|P2|Overall Study|Adverse Event|4
6111897|NCT00135694|21081108|P1|Overall Study|Adverse Event|17
6111898|NCT00135512|21081126|P1|Overall Study|Other|42
6111899|NCT00135512|21081126|P1|Overall Study|Lack of Efficacy|25
6111900|NCT00135512|21081126|P1|Overall Study|Adverse Event|56
6111901|NCT00135356|21081138|P2|Overall Study|Withdrawal by Subject|4
6111902|NCT00135356|21081139|P1|Overall Study|Withdrawal by Subject|2
6111903|NCT00135356|21081138|P2|Overall Study|No longer meets study criteria|0
6111904|NCT00135356|21081139|P1|Overall Study|No longer meets study criteria|2
6111905|NCT00135356|21081138|P2|Overall Study|Poor/noncompliance|1
6111906|NCT00135356|21081139|P1|Overall Study|Poor/noncompliance|1
6111907|NCT00135356|21081138|P2|Overall Study|Change in antiviral regimen|1
6111908|NCT00135356|21081139|P1|Overall Study|Change in antiviral regimen|0
6111909|NCT00135356|21081138|P2|Overall Study|Surgery for abdominal fat|0
6111910|NCT00135356|21081139|P1|Overall Study|Surgery for abdominal fat|1
6111911|NCT00135356|21081138|P2|Overall Study|Lost to Follow-up|1
6111912|NCT00135356|21081139|P1|Overall Study|Lost to Follow-up|3
6111913|NCT00135356|21081138|P2|Overall Study|Lack of Efficacy|0
6111914|NCT00135356|21081139|P1|Overall Study|Lack of Efficacy|2
6111915|NCT00135356|21081138|P2|Overall Study|Adverse Event|2
6111916|NCT00135356|21081139|P1|Overall Study|Adverse Event|6
6111917|NCT00135330|21081182|P3|Overall Study|Sponsor Decision|0
6111918|NCT00135330|21081183|P2|Overall Study|Sponsor Decision|1
6111919|NCT00135330|21081184|P1|Overall Study|Sponsor Decision|0
6111920|NCT00135330|21081182|P3|Overall Study|Patient Decision|4
6111921|NCT00135330|21081183|P2|Overall Study|Patient Decision|1
6111922|NCT00135330|21081184|P1|Overall Study|Patient Decision|5
6111923|NCT00135330|21081182|P3|Overall Study|Protocol Violation|3
6111924|NCT00135330|21081183|P2|Overall Study|Protocol Violation|3
6111925|NCT00135330|21081184|P1|Overall Study|Protocol Violation|4
6111926|NCT00135330|21081182|P3|Overall Study|Physician Decision|0
6111927|NCT00135330|21081183|P2|Overall Study|Physician Decision|1
6111928|NCT00135330|21081184|P1|Overall Study|Physician Decision|1
6111929|NCT00135330|21081182|P3|Overall Study|Lost to Follow-up|3
6111930|NCT00135330|21081183|P2|Overall Study|Lost to Follow-up|2
6111931|NCT00135330|21081184|P1|Overall Study|Lost to Follow-up|0
6111932|NCT00135330|21081182|P3|Overall Study|Adverse Event|1
6111933|NCT00135330|21081183|P2|Overall Study|Adverse Event|5
6111934|NCT00135330|21081184|P1|Overall Study|Adverse Event|2
6111935|NCT00134901|21081382|P2|Overall Study|discontinued intervention|10
6111936|NCT00134901|21081383|P1|Overall Study|discontinued intervention|12
6111937|NCT00134901|21081382|P2|Overall Study|Lost to Follow-up|5
6111938|NCT00134901|21081383|P1|Overall Study|Lost to Follow-up|5
6111939|NCT00134784|21081395|P4|Overall Study|Withdrawal by Subject|1
6111940|NCT00134784|21081396|P3|Overall Study|Withdrawal by Subject|2
6111941|NCT00134784|21081397|P2|Overall Study|Withdrawal by Subject|2
6111942|NCT00134784|21081398|P1|Overall Study|Withdrawal by Subject|2
6111943|NCT00134719|21081408|P3|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0
6111944|NCT00134719|21081409|P2|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0
6111945|NCT00134719|21081410|P1|Fourth Dose Vaccination Phase|Mother just delivered a new baby|1
6111946|NCT00134719|21081408|P3|Fourth Dose Vaccination Phase|Lost to Follow-up|1
6111947|NCT00134719|21081409|P2|Fourth Dose Vaccination Phase|Lost to Follow-up|3
6111948|NCT00134719|21081410|P1|Fourth Dose Vaccination Phase|Lost to Follow-up|1
6111949|NCT00134719|21081408|P3|Primary Vaccination Phase|Lost to Follow-up|3
6111950|NCT00134719|21081409|P2|Primary Vaccination Phase|Lost to Follow-up|3
6111951|NCT00134719|21081410|P1|Primary Vaccination Phase|Lost to Follow-up|7
6111952|NCT00134719|21081408|P3|Primary Vaccination Phase|Withdrawal by Subject|2
6111953|NCT00134719|21081409|P2|Primary Vaccination Phase|Withdrawal by Subject|3
6111954|NCT00134719|21081410|P1|Primary Vaccination Phase|Withdrawal by Subject|2
6111955|NCT00134719|21081408|P3|Primary Vaccination Phase|Protocol Violation|0
6111956|NCT00134719|21081409|P2|Primary Vaccination Phase|Protocol Violation|0
6111957|NCT00134719|21081410|P1|Primary Vaccination Phase|Protocol Violation|1
6111958|NCT00134719|21081408|P3|Primary Vaccination Phase|Adverse Event|0
6111959|NCT00134719|21081409|P2|Primary Vaccination Phase|Adverse Event|0
6111960|NCT00134719|21081410|P1|Primary Vaccination Phase|Adverse Event|4
6111961|NCT00134563|21081541|P3|Overall Study|Reason other than above|5
6111962|NCT00134563|21081542|P2|Overall Study|Reason other than above|2
6111963|NCT00134563|21081543|P1|Overall Study|Reason other than above|0
6111964|NCT00134563|21081541|P3|Overall Study|did not wish to continue|26
6111965|NCT00134563|21081542|P2|Overall Study|did not wish to continue|32
6111966|NCT00134563|21081543|P1|Overall Study|did not wish to continue|33
6111967|NCT00134563|21081541|P3|Overall Study|progressive disease|2
6111968|NCT00134563|21081542|P2|Overall Study|progressive disease|4
6111969|NCT00134563|21081543|P1|Overall Study|progressive disease|11
6111970|NCT00134563|21081541|P3|Overall Study|Lost to Follow-up|2
6111971|NCT00134563|21081542|P2|Overall Study|Lost to Follow-up|0
6111972|NCT00134563|21081543|P1|Overall Study|Lost to Follow-up|4
6111973|NCT00134563|21081541|P3|Overall Study|Protocol Violation|5
6111974|NCT00134563|21081542|P2|Overall Study|Protocol Violation|2
6111975|NCT00134563|21081543|P1|Overall Study|Protocol Violation|3
6111976|NCT00134563|21081541|P3|Overall Study|Lack of Efficacy|17
6111977|NCT00134563|21081542|P2|Overall Study|Lack of Efficacy|14
6111978|NCT00134563|21081543|P1|Overall Study|Lack of Efficacy|24
6111979|NCT00134563|21081541|P3|Overall Study|Adverse Event|38
6111980|NCT00134563|21081542|P2|Overall Study|Adverse Event|37
6111981|NCT00134563|21081543|P1|Overall Study|Adverse Event|29
6111982|NCT00134563|21081541|P3|Overall Study|Not treated due to protocol violation|1
6111983|NCT00134563|21081542|P2|Overall Study|Not treated due to protocol violation|1
6111984|NCT00134563|21081543|P1|Overall Study|Not treated due to protocol violation|0
6111985|NCT00134082|21081604|P1|Overall Study|Death|1
6111986|NCT00134082|21081604|P1|Overall Study|Adverse Event|2
6111987|NCT00134056|21081613|P2|Eligible for Protocol Assigned Treatment|Other|56
6111988|NCT00134056|21081614|P1|Eligible for Protocol Assigned Treatment|Other|55
6111989|NCT00134056|21081613|P2|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|21
6111990|NCT00134056|21081614|P1|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|20
6111991|NCT00134056|21081613|P2|Eligible for Protocol Assigned Treatment|Adverse Event|67
6111992|NCT00134056|21081614|P1|Eligible for Protocol Assigned Treatment|Adverse Event|81
6111993|NCT00134056|21081613|P2|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171
6111994|NCT00134056|21081614|P1|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171
6111995|NCT00134056|21081613|P2|Randomization|Not eligible for assigned treatment|20
6111996|NCT00134056|21081614|P1|Randomization|Not eligible for assigned treatment|22
6111997|NCT00133991|21081658|P1|Overall Study|Death|4
6111998|NCT00133952|21081697|P2|Overall Study|Sponsor Decision|1
6111999|NCT00133952|21081698|P1|Overall Study|Sponsor Decision|0
6112000|NCT00133952|21081697|P2|Overall Study|Physician Decision|3
6112001|NCT00133952|21081698|P1|Overall Study|Physician Decision|4
6112002|NCT00133952|21081697|P2|Overall Study|Withdrawal by Subject|4
6112003|NCT00133952|21081698|P1|Overall Study|Withdrawal by Subject|20
6112004|NCT00133952|21081697|P2|Overall Study|Protocol Violation|1
6112005|NCT00133952|21081698|P1|Overall Study|Protocol Violation|1
6112006|NCT00133952|21081697|P2|Overall Study|Protocol Entry Criteria Exclusion|1
6112007|NCT00133952|21081698|P1|Overall Study|Protocol Entry Criteria Exclusion|4
6112008|NCT00133952|21081697|P2|Overall Study|Lost to Follow-up|14
6112009|NCT00133952|21081698|P1|Overall Study|Lost to Follow-up|9
6112010|NCT00133952|21081697|P2|Overall Study|Death|2
6112011|NCT00133952|21081698|P1|Overall Study|Death|3
6112012|NCT00133952|21081697|P2|Overall Study|Adverse Event|2
6112013|NCT00133952|21081698|P1|Overall Study|Adverse Event|1
6112014|NCT00133705|21081729|P2|Overall Study|Withdrawal by Subject|3
6112015|NCT00133705|21081730|P1|Overall Study|Withdrawal by Subject|2
6112016|NCT00132873|21081884|P1|Overall Study|Planned Pregnancy|1
6112017|NCT00132873|21081884|P1|Overall Study|Withdrawal by Subject|3
6112018|NCT00132873|21081884|P1|Overall Study|Lack of Efficacy|1
6112019|NCT00132873|21081884|P1|Overall Study|Lost to Follow-up|1
6112020|NCT00132873|21081884|P1|Overall Study|Adverse Event|3
6112021|NCT00132808|21081892|P3|Stratum II|Withdrawal by Subject|6
6112022|NCT00132808|21081893|P2|Stratum II|Withdrawal by Subject|9
6112023|NCT00132808|21081894|P1|Stratum II|Withdrawal by Subject|4
6112024|NCT00132808|21081892|P3|Stratum II|Protocol Violation|1
6112025|NCT00132808|21081893|P2|Stratum II|Protocol Violation|2
6112026|NCT00132808|21081894|P1|Stratum II|Protocol Violation|0
6112027|NCT00132808|21081892|P3|Stratum II|Lost to Follow-up|1
6112028|NCT00132808|21081893|P2|Stratum II|Lost to Follow-up|2
6112029|NCT00132808|21081894|P1|Stratum II|Lost to Follow-up|2
6112030|NCT00132808|21081892|P3|Stratum II|Death|0
6112031|NCT00132808|21081893|P2|Stratum II|Death|0
6112032|NCT00132808|21081894|P1|Stratum II|Death|1
6112033|NCT00132808|21081892|P3|Stratum II|Adverse Event|1
6112034|NCT00132808|21081893|P2|Stratum II|Adverse Event|2
6112035|NCT00132808|21081894|P1|Stratum II|Adverse Event|1
6112036|NCT00132808|21081892|P3|Stratum I|Abnormal test procedure result (s)|1
6112037|NCT00132808|21081893|P2|Stratum I|Abnormal test procedure result (s)|0
6112038|NCT00132808|21081894|P1|Stratum I|Abnormal test procedure result (s)|0
6112039|NCT00132808|21081892|P3|Stratum I|Withdrawal by Subject|3
6112040|NCT00132808|21081893|P2|Stratum I|Withdrawal by Subject|7
6112041|NCT00132808|21081894|P1|Stratum I|Withdrawal by Subject|4
6112042|NCT00132808|21081892|P3|Stratum I|Lost to Follow-up|1
6112043|NCT00132808|21081893|P2|Stratum I|Lost to Follow-up|4
6112044|NCT00132808|21081894|P1|Stratum I|Lost to Follow-up|3
6112045|NCT00132808|21081892|P3|Stratum I|Adverse Event|0
6112046|NCT00132808|21081893|P2|Stratum I|Adverse Event|1
6112047|NCT00132808|21081894|P1|Stratum I|Adverse Event|2
6112048|NCT00132769|21081919|P2|Overall Study|Protocol Violation|1
6112049|NCT00132769|21081920|P1|Overall Study|Protocol Violation|1
6112050|NCT00132769|21081919|P2|Overall Study|Adverse Event|1
6112051|NCT00132769|21081920|P1|Overall Study|Adverse Event|2
6112052|NCT00132769|21081919|P2|Overall Study|Lack of Efficacy|6
6112053|NCT00132769|21081920|P1|Overall Study|Lack of Efficacy|7
6112054|NCT00132769|21081919|P2|Overall Study|Withdrawal by Subject|3
6112055|NCT00132769|21081920|P1|Overall Study|Withdrawal by Subject|1
6112056|NCT00132730|21081946|P6|Period V - Open-label Extension (EXT2)|Site terminated|2
6112057|NCT00132730|21081947|P5|Period V - Open-label Extension (EXT2)|Site terminated|7
6112058|NCT00132730|21081948|P4|Period V - Open-label Extension (EXT2)|Site terminated|0
6112059|NCT00132730|21081949|P3|Period V - Open-label Extension (EXT2)|Site terminated|0
6112060|NCT00132730|21081950|P2|Period V - Open-label Extension (EXT2)|Site terminated|0
6112061|NCT00132730|21081951|P1|Period V - Open-label Extension (EXT2)|Site terminated|0
6112062|NCT00132730|21081946|P6|Period IV - Open-label Extension (EXT2)|Other reasons|0
6112063|NCT00132730|21081947|P5|Period IV - Open-label Extension (EXT2)|Other reasons|6
6112064|NCT00132730|21081948|P4|Period IV - Open-label Extension (EXT2)|Other reasons|0
6112065|NCT00132730|21081949|P3|Period IV - Open-label Extension (EXT2)|Other reasons|0
6112066|NCT00132730|21081950|P2|Period IV - Open-label Extension (EXT2)|Other reasons|0
6112067|NCT00132730|21081951|P1|Period IV - Open-label Extension (EXT2)|Other reasons|0
6112068|NCT00132730|21081946|P6|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0
6112069|NCT00132730|21081947|P5|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|1
6112070|NCT00132730|21081948|P4|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0
6112071|NCT00132730|21081949|P3|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0
6112072|NCT00132730|21081950|P2|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0
6112073|NCT00132730|21081951|P1|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0
6112074|NCT00132730|21081946|P6|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0
6112075|NCT00132730|21081947|P5|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|3
6112076|NCT00132730|21081948|P4|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0
6112077|NCT00132730|21081949|P3|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0
6112078|NCT00132730|21081950|P2|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0
6112079|NCT00132730|21081951|P1|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0
6112080|NCT00132730|21081946|P6|Period IV - Open-label Extension (EXT2)|Site terminated|68
6112081|NCT00132730|21081947|P5|Period IV - Open-label Extension (EXT2)|Site terminated|169
6112082|NCT00132730|21081948|P4|Period IV - Open-label Extension (EXT2)|Site terminated|0
6112083|NCT00132730|21081949|P3|Period IV - Open-label Extension (EXT2)|Site terminated|0
6112084|NCT00132730|21081950|P2|Period IV - Open-label Extension (EXT2)|Site terminated|0
6112085|NCT00132730|21081951|P1|Period IV - Open-label Extension (EXT2)|Site terminated|0
6112086|NCT00132730|21081946|P6|Period III - Blinded Extension (EXT1)|Other reasons|0
6112087|NCT00132730|21081947|P5|Period III - Blinded Extension (EXT1)|Other reasons|0
6112088|NCT00132730|21081948|P4|Period III - Blinded Extension (EXT1)|Other reasons|3
6112089|NCT00132730|21081949|P3|Period III - Blinded Extension (EXT1)|Other reasons|14
6112090|NCT00132730|21081950|P2|Period III - Blinded Extension (EXT1)|Other reasons|0
6112091|NCT00132730|21081951|P1|Period III - Blinded Extension (EXT1)|Other reasons|0
6112092|NCT00132730|21081946|P6|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0
6112093|NCT00132730|21081947|P5|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0
6112094|NCT00132730|21081948|P4|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|1
6112095|NCT00132730|21081949|P3|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0
6112096|NCT00132730|21081950|P2|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0
6112097|NCT00132730|21081951|P1|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0
6112098|NCT00132730|21081946|P6|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0
6112099|NCT00132730|21081947|P5|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0
6112100|NCT00132730|21081948|P4|Period III - Blinded Extension (EXT1)|Clinical adverse experience|1
6112101|NCT00132730|21081949|P3|Period III - Blinded Extension (EXT1)|Clinical adverse experience|11
6112102|NCT00132730|21081950|P2|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0
6112103|NCT00132730|21081951|P1|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0
6112104|NCT00132730|21081946|P6|Period III - Blinded Extension (EXT1)|Site terminated|0
6112105|NCT00132730|21081947|P5|Period III - Blinded Extension (EXT1)|Site terminated|0
6112106|NCT00132730|21081948|P4|Period III - Blinded Extension (EXT1)|Site terminated|20
6112107|NCT00132730|21081949|P3|Period III - Blinded Extension (EXT1)|Site terminated|57
6112108|NCT00132730|21081950|P2|Period III - Blinded Extension (EXT1)|Site terminated|0
6112109|NCT00132730|21081951|P1|Period III - Blinded Extension (EXT1)|Site terminated|0
6112110|NCT00132730|21081946|P6|Period II - 12-week Treatment (Base)|Other reasons|0
6112111|NCT00132730|21081947|P5|Period II - 12-week Treatment (Base)|Other reasons|0
6112112|NCT00132730|21081948|P4|Period II - 12-week Treatment (Base)|Other reasons|13
6112113|NCT00132730|21081949|P3|Period II - 12-week Treatment (Base)|Other reasons|9
6112114|NCT00132730|21081950|P2|Period II - 12-week Treatment (Base)|Other reasons|10
6112115|NCT00132730|21081951|P1|Period II - 12-week Treatment (Base)|Other reasons|11
6112116|NCT00132730|21081946|P6|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0
6112117|NCT00132730|21081947|P5|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0
6112118|NCT00132730|21081948|P4|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0
6112119|NCT00132730|21081949|P3|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0
6112120|NCT00132730|21081950|P2|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1
6112121|NCT00132730|21081951|P1|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1
6112122|NCT00132730|21081946|P6|Period II - 12-week Treatment (Base)|Clinical adverse experience|0
6112123|NCT00132730|21081947|P5|Period II - 12-week Treatment (Base)|Clinical adverse experience|0
6112124|NCT00132730|21081948|P4|Period II - 12-week Treatment (Base)|Clinical adverse experience|9
6112125|NCT00132730|21081949|P3|Period II - 12-week Treatment (Base)|Clinical adverse experience|9
6112126|NCT00132730|21081950|P2|Period II - 12-week Treatment (Base)|Clinical adverse experience|4
6112127|NCT00132730|21081951|P1|Period II - 12-week Treatment (Base)|Clinical adverse experience|11
6112128|NCT00132691|21081995|P2|Overall Study|Death|0
6112129|NCT00132691|21081996|P1|Overall Study|Death|2
6112130|NCT00132691|21081995|P2|Overall Study|Missed 2-year visit|4
6112131|NCT00132691|21081996|P1|Overall Study|Missed 2-year visit|4
6112132|NCT00132691|21081995|P2|Overall Study|Lost to Follow-up|8
6112133|NCT00132691|21081996|P1|Overall Study|Lost to Follow-up|5
6112134|NCT00132678|21082036|P3|Period IV (Double-Blind Treatment)|Pregnancy|0
6112135|NCT00132678|21082037|P2|Period IV (Double-Blind Treatment)|Pregnancy|2
6112136|NCT00132678|21082038|P1|Period IV (Double-Blind Treatment)|Pregnancy|0
6112137|NCT00132678|21082036|P3|Period IV (Double-Blind Treatment)|Subject Non-compliant|0
6112138|NCT00132678|21082037|P2|Period IV (Double-Blind Treatment)|Subject Non-compliant|1
6112139|NCT00132678|21082038|P1|Period IV (Double-Blind Treatment)|Subject Non-compliant|2
6112140|NCT00132678|21082036|P3|Period IV (Double-Blind Treatment)|Physician Decision|0
6112141|NCT00132678|21082037|P2|Period IV (Double-Blind Treatment)|Physician Decision|14
6112142|NCT00132678|21082038|P1|Period IV (Double-Blind Treatment)|Physician Decision|10
6112143|NCT00132678|21082036|P3|Period IV (Double-Blind Treatment)|Withdrawal by Subject|0
6112144|NCT00132678|21082037|P2|Period IV (Double-Blind Treatment)|Withdrawal by Subject|15
6112145|NCT00132678|21082038|P1|Period IV (Double-Blind Treatment)|Withdrawal by Subject|14
6112146|NCT00132678|21082036|P3|Period IV (Double-Blind Treatment)|Lost to Follow-up|0
6112147|NCT00132678|21082037|P2|Period IV (Double-Blind Treatment)|Lost to Follow-up|3
6112148|NCT00132678|21082038|P1|Period IV (Double-Blind Treatment)|Lost to Follow-up|6
6112149|NCT00132678|21082036|P3|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|0
6112150|NCT00132678|21082037|P2|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4
6112151|NCT00132678|21082038|P1|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4
6112152|NCT00132678|21082036|P3|Period IV (Double-Blind Treatment)|Adverse Event|0
6112153|NCT00132678|21082037|P2|Period IV (Double-Blind Treatment)|Adverse Event|1
6112154|NCT00132678|21082038|P1|Period IV (Double-Blind Treatment)|Adverse Event|1
6112155|NCT00132678|21082036|P3|Period III (Open-Label Stabilization)|Pregnancy|0
6112156|NCT00132678|21082037|P2|Period III (Open-Label Stabilization)|Pregnancy|0
6112157|NCT00132678|21082038|P1|Period III (Open-Label Stabilization)|Pregnancy|2
6112158|NCT00132678|21082036|P3|Period III (Open-Label Stabilization)|Physician Decision|0
6112159|NCT00132678|21082037|P2|Period III (Open-Label Stabilization)|Physician Decision|0
6112160|NCT00132678|21082038|P1|Period III (Open-Label Stabilization)|Physician Decision|1
6112161|NCT00132678|21082036|P3|Period III (Open-Label Stabilization)|Subject non-compliant|0
6112162|NCT00132678|21082037|P2|Period III (Open-Label Stabilization)|Subject non-compliant|0
6112163|NCT00132678|21082038|P1|Period III (Open-Label Stabilization)|Subject non-compliant|1
6112164|NCT00132678|21082036|P3|Period III (Open-Label Stabilization)|Withdrawal by Subject|0
6112165|NCT00132678|21082037|P2|Period III (Open-Label Stabilization)|Withdrawal by Subject|0
6112166|NCT00132678|21082038|P1|Period III (Open-Label Stabilization)|Withdrawal by Subject|49
6112167|NCT00132678|21082036|P3|Period III (Open-Label Stabilization)|Lost to Follow-up|0
6112168|NCT00132678|21082037|P2|Period III (Open-Label Stabilization)|Lost to Follow-up|0
6112169|NCT00132678|21082038|P1|Period III (Open-Label Stabilization)|Lost to Follow-up|19
6112170|NCT00132678|21082036|P3|Period III (Open-Label Stabilization)|Ineligible to continue trial|0
6112171|NCT00132678|21082037|P2|Period III (Open-Label Stabilization)|Ineligible to continue trial|0
6112172|NCT00132678|21082038|P1|Period III (Open-Label Stabilization)|Ineligible to continue trial|5
6112173|NCT00132678|21082036|P3|Period III (Open-Label Stabilization)|Non responder|0
6112174|NCT00132678|21082037|P2|Period III (Open-Label Stabilization)|Non responder|0
6112175|NCT00132678|21082038|P1|Period III (Open-Label Stabilization)|Non responder|107
6112176|NCT00132678|21082036|P3|Period III (Open-Label Stabilization)|Adverse Event|0
6112177|NCT00132678|21082037|P2|Period III (Open-Label Stabilization)|Adverse Event|0
6112178|NCT00132678|21082038|P1|Period III (Open-Label Stabilization)|Adverse Event|12
6112179|NCT00132678|21082036|P3|Period III (Open-Label Stabilization)|Death|0
6112180|NCT00132678|21082037|P2|Period III (Open-Label Stabilization)|Death|0
6112181|NCT00132678|21082038|P1|Period III (Open-Label Stabilization)|Death|2
6112182|NCT00132678|21082036|P3|Period II (Open-Label Oral Risperidone)|Physician Decision|1
6112183|NCT00132678|21082037|P2|Period II (Open-Label Oral Risperidone)|Physician Decision|0
6112184|NCT00132678|21082038|P1|Period II (Open-Label Oral Risperidone)|Physician Decision|0
6112185|NCT00132678|21082036|P3|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|16
6112186|NCT00132678|21082037|P2|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0
6112187|NCT00132678|21082038|P1|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0
6112188|NCT00132678|21082036|P3|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|14
6112189|NCT00132678|21082037|P2|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0
6112190|NCT00132678|21082038|P1|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0
6112191|NCT00132678|21082036|P3|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|7
6112192|NCT00132678|21082037|P2|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0
6112193|NCT00132678|21082038|P1|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0
6112194|NCT00132678|21082036|P3|Period II (Open-Label Oral Risperidone)|Non responder|6
6112195|NCT00132678|21082037|P2|Period II (Open-Label Oral Risperidone)|Non responder|0
6112196|NCT00132678|21082038|P1|Period II (Open-Label Oral Risperidone)|Non responder|0
6112197|NCT00132678|21082036|P3|Period II (Open-Label Oral Risperidone)|Adverse Event|13
6112198|NCT00132678|21082037|P2|Period II (Open-Label Oral Risperidone)|Adverse Event|0
6112199|NCT00132678|21082038|P1|Period II (Open-Label Oral Risperidone)|Adverse Event|0
6112200|NCT00132678|21082036|P3|Period II (Open-Label Oral Risperidone)|Death|1
6112201|NCT00132678|21082037|P2|Period II (Open-Label Oral Risperidone)|Death|0
6112202|NCT00132678|21082038|P1|Period II (Open-Label Oral Risperidone)|Death|0
6112203|NCT00132496|21082052|P2|Overall Study|Physician Decision|0
6112204|NCT00132496|21082053|P1|Overall Study|Physician Decision|1
6112205|NCT00132496|21082052|P2|Overall Study|Withdrawal by Subject|2
6112206|NCT00132496|21082053|P1|Overall Study|Withdrawal by Subject|1
6112207|NCT00132314|21082061|P2|Overall Study|Refused intervention at baseline|7
6112208|NCT00132314|21082062|P1|Overall Study|Refused intervention at baseline|2
6112209|NCT00132314|21082061|P2|Overall Study|Lacked SSN|3
6112210|NCT00132314|21082062|P1|Overall Study|Lacked SSN|1
6112211|NCT00132314|21082061|P2|Overall Study|Lost to Follow-up|62
6112212|NCT00132314|21082062|P1|Overall Study|Lost to Follow-up|70
6112213|NCT00132301|21082072|P2|Overall Study|Excluded by Data Monitoring Committee|0
6112214|NCT00132301|21082073|P1|Overall Study|Excluded by Data Monitoring Committee|1
6112215|NCT00132301|21082072|P2|Overall Study|Other|1
6112216|NCT00132301|21082073|P1|Overall Study|Other|1
6112217|NCT00132301|21082072|P2|Overall Study|Lost to Follow-up|3
6112218|NCT00132301|21082073|P1|Overall Study|Lost to Follow-up|5
6112219|NCT00132301|21082072|P2|Overall Study|Physician Decision|1
6112220|NCT00132301|21082073|P1|Overall Study|Physician Decision|1
6112221|NCT00132301|21082072|P2|Overall Study|Withdrawal by Subject|2
6112222|NCT00132301|21082073|P1|Overall Study|Withdrawal by Subject|5
6112223|NCT00132301|21082072|P2|Overall Study|Death|6
6112224|NCT00132301|21082073|P1|Overall Study|Death|7
6112225|NCT00132132|21082081|P2|Overall Study|Lost to Follow-up|2
6112226|NCT00132132|21082082|P1|Overall Study|Lost to Follow-up|7
6112227|NCT00132041|21082090|P1|18 Months Post Ablation|ExtraHepatic tumor|1
6112228|NCT00132041|21082090|P1|18 Months Post Ablation|Non-Protocol Treatment|3
6112229|NCT00132041|21082090|P1|18 Months Post Ablation|Transplant|1
6112230|NCT00132041|21082090|P1|18 Months Post Ablation|Withdrawal by Subject|1
6112231|NCT00132041|21082090|P1|15 Months Post Ablation|Non-Protocol Treatment|1
6112232|NCT00132041|21082090|P1|15 Months Post Ablation|Transplant|5
6112233|NCT00132041|21082090|P1|15 Months Post Ablation|Death|1
6112234|NCT00132041|21082090|P1|15 Months Post Ablation|Withdrawal by Subject|1
6112235|NCT00132041|21082090|P1|12 Months Post Ablation|non-protocol Treatment|1
6112236|NCT00132041|21082090|P1|12 Months Post Ablation|Transplant|1
6112237|NCT00132041|21082090|P1|12 Months Post Ablation|Death|1
6112238|NCT00132041|21082090|P1|12 Months Post Ablation|Withdrawal by Subject|1
6112239|NCT00132041|21082090|P1|9 Months Post Ablation|Transplant|1
6112240|NCT00132041|21082090|P1|9 Months Post Ablation|Death|1
6112241|NCT00132041|21082090|P1|6 Months Post Ablation|Transplant|6
6112242|NCT00132041|21082090|P1|6 Months Post Ablation|Death|2
6112243|NCT00132041|21082090|P1|6 Months Post Ablation|Withdrawal by Subject|2
6112244|NCT00132041|21082090|P1|3 Months Post Ablation|Non-Protocol Treatment|2
6112245|NCT00132041|21082090|P1|3 Months Post Ablation|Transplant|1
6112246|NCT00132041|21082090|P1|Baseline|Ineligible|6
6112247|NCT00132028|21082105|P1|Overall Study|Physician Decision|3
6112248|NCT00132028|21082105|P1|Overall Study|not eligible|2
6112249|NCT00132028|21082105|P1|Overall Study|Withdrawal by Subject|2
6112250|NCT00132028|21082105|P1|Overall Study|Lack of Efficacy|11
6112251|NCT00132028|21082105|P1|Overall Study|Death|2
6112252|NCT00132028|21082105|P1|Overall Study|Adverse Event|7
6112253|NCT00131937|21082117|P1|Overall Study|Alternative therapy|1
6112254|NCT00131937|21082117|P1|Overall Study|Disease Progression|7
6112255|NCT00131937|21082117|P1|Overall Study|Physician Decision|1
6112256|NCT00131937|21082117|P1|Overall Study|Withdrawal by Subject|2
6112257|NCT00131937|21082117|P1|Overall Study|Adverse Event|3
6112258|NCT00131911|21082125|P2|Overall Study|Withdrawal by Subject|0
6112259|NCT00131911|21082126|P1|Overall Study|Withdrawal by Subject|1
6112260|NCT00131664|21082196|P6|Second Period (Additional Drug Added)|Administrative reasons|0
6112261|NCT00131664|21082197|P5|Second Period (Additional Drug Added)|Administrative reasons|1
6112262|NCT00131664|21082198|P4|Second Period (Additional Drug Added)|Administrative reasons|0
6112263|NCT00131664|21082199|P3|Second Period (Additional Drug Added)|Administrative reasons|0
6112264|NCT00131664|21082200|P2|Second Period (Additional Drug Added)|Administrative reasons|2
6112265|NCT00131664|21082201|P1|Second Period (Additional Drug Added)|Administrative reasons|4
6112266|NCT00131664|21082196|P6|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0
6112267|NCT00131664|21082197|P5|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0
6112268|NCT00131664|21082198|P4|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|1
6112269|NCT00131664|21082199|P3|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0
6112270|NCT00131664|21082200|P2|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0
6112271|NCT00131664|21082201|P1|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0
6112272|NCT00131664|21082196|P6|Second Period (Additional Drug Added)|Adverse Event|1
6112273|NCT00131664|21082197|P5|Second Period (Additional Drug Added)|Adverse Event|0
6112274|NCT00131664|21082198|P4|Second Period (Additional Drug Added)|Adverse Event|0
6112275|NCT00131664|21082199|P3|Second Period (Additional Drug Added)|Adverse Event|0
6112276|NCT00131664|21082200|P2|Second Period (Additional Drug Added)|Adverse Event|1
6112277|NCT00131664|21082201|P1|Second Period (Additional Drug Added)|Adverse Event|0
6112278|NCT00131664|21082196|P6|Second Period (Additional Drug Added)|Withdrawal by Subject|0
6112279|NCT00131664|21082197|P5|Second Period (Additional Drug Added)|Withdrawal by Subject|0
6112280|NCT00131664|21082198|P4|Second Period (Additional Drug Added)|Withdrawal by Subject|0
6112281|NCT00131664|21082199|P3|Second Period (Additional Drug Added)|Withdrawal by Subject|0
6112282|NCT00131664|21082200|P2|Second Period (Additional Drug Added)|Withdrawal by Subject|0
6112283|NCT00131664|21082201|P1|Second Period (Additional Drug Added)|Withdrawal by Subject|2
6112284|NCT00131664|21082196|P6|Second Period (Additional Drug Added)|Protocol Violation|0
6112285|NCT00131664|21082197|P5|Second Period (Additional Drug Added)|Protocol Violation|0
6112286|NCT00131664|21082198|P4|Second Period (Additional Drug Added)|Protocol Violation|0
6112287|NCT00131664|21082199|P3|Second Period (Additional Drug Added)|Protocol Violation|1
6112288|NCT00131664|21082200|P2|Second Period (Additional Drug Added)|Protocol Violation|1
6112289|NCT00131664|21082201|P1|Second Period (Additional Drug Added)|Protocol Violation|0
6112290|NCT00131664|21082196|P6|Second Period (Additional Drug Added)|Lost to Follow-up|2
6112291|NCT00131664|21082197|P5|Second Period (Additional Drug Added)|Lost to Follow-up|0
6112292|NCT00131664|21082198|P4|Second Period (Additional Drug Added)|Lost to Follow-up|1
6112293|NCT00131664|21082199|P3|Second Period (Additional Drug Added)|Lost to Follow-up|2
6112294|NCT00131664|21082200|P2|Second Period (Additional Drug Added)|Lost to Follow-up|0
6112295|NCT00131664|21082201|P1|Second Period (Additional Drug Added)|Lost to Follow-up|3
6112296|NCT00131664|21082196|P6|First Period (First 6 Months)|Administrative reasons|0
6112297|NCT00131664|21082197|P5|First Period (First 6 Months)|Administrative reasons|0
6112298|NCT00131664|21082198|P4|First Period (First 6 Months)|Administrative reasons|0
6112299|NCT00131664|21082199|P3|First Period (First 6 Months)|Administrative reasons|5
6112300|NCT00131664|21082200|P2|First Period (First 6 Months)|Administrative reasons|0
6112301|NCT00131664|21082201|P1|First Period (First 6 Months)|Administrative reasons|2
6112302|NCT00131664|21082196|P6|First Period (First 6 Months)|Clinically significant lab abnormalities|0
6112303|NCT00131664|21082197|P5|First Period (First 6 Months)|Clinically significant lab abnormalities|0
6112304|NCT00131664|21082198|P4|First Period (First 6 Months)|Clinically significant lab abnormalities|0
6112305|NCT00131664|21082199|P3|First Period (First 6 Months)|Clinically significant lab abnormalities|0
6112306|NCT00131664|21082200|P2|First Period (First 6 Months)|Clinically significant lab abnormalities|2
6112307|NCT00131664|21082201|P1|First Period (First 6 Months)|Clinically significant lab abnormalities|1
6112308|NCT00131664|21082196|P6|First Period (First 6 Months)|Adverse Event|0
6112309|NCT00131664|21082197|P5|First Period (First 6 Months)|Adverse Event|0
6112310|NCT00131664|21082198|P4|First Period (First 6 Months)|Adverse Event|0
6112311|NCT00131664|21082199|P3|First Period (First 6 Months)|Adverse Event|5
6112312|NCT00131664|21082200|P2|First Period (First 6 Months)|Adverse Event|4
6112313|NCT00131664|21082201|P1|First Period (First 6 Months)|Adverse Event|9
6112314|NCT00131664|21082196|P6|First Period (First 6 Months)|Withdrawal by Subject|0
6112315|NCT00131664|21082197|P5|First Period (First 6 Months)|Withdrawal by Subject|0
6112316|NCT00131664|21082198|P4|First Period (First 6 Months)|Withdrawal by Subject|0
6112317|NCT00131664|21082199|P3|First Period (First 6 Months)|Withdrawal by Subject|2
6112318|NCT00131664|21082200|P2|First Period (First 6 Months)|Withdrawal by Subject|6
6112319|NCT00131664|21082201|P1|First Period (First 6 Months)|Withdrawal by Subject|4
6112320|NCT00131664|21082196|P6|First Period (First 6 Months)|Protocol Violation|0
6112321|NCT00131664|21082197|P5|First Period (First 6 Months)|Protocol Violation|0
6112322|NCT00131664|21082198|P4|First Period (First 6 Months)|Protocol Violation|0
6112323|NCT00131664|21082199|P3|First Period (First 6 Months)|Protocol Violation|1
6112324|NCT00131664|21082200|P2|First Period (First 6 Months)|Protocol Violation|2
6112325|NCT00131664|21082201|P1|First Period (First 6 Months)|Protocol Violation|2
6112326|NCT00131664|21082196|P6|First Period (First 6 Months)|Death|0
6112327|NCT00131664|21082197|P5|First Period (First 6 Months)|Death|0
6112328|NCT00131664|21082198|P4|First Period (First 6 Months)|Death|0
6112329|NCT00131664|21082199|P3|First Period (First 6 Months)|Death|0
6112330|NCT00131664|21082200|P2|First Period (First 6 Months)|Death|1
6112331|NCT00131664|21082201|P1|First Period (First 6 Months)|Death|0
6112332|NCT00131664|21082196|P6|First Period (First 6 Months)|Lost to Follow-up|0
6112333|NCT00131664|21082197|P5|First Period (First 6 Months)|Lost to Follow-up|0
6112334|NCT00131664|21082198|P4|First Period (First 6 Months)|Lost to Follow-up|0
6112335|NCT00131664|21082199|P3|First Period (First 6 Months)|Lost to Follow-up|3
6112336|NCT00131664|21082200|P2|First Period (First 6 Months)|Lost to Follow-up|3
6112337|NCT00131664|21082201|P1|First Period (First 6 Months)|Lost to Follow-up|7
6112338|NCT00131508|21082273|P2|Overall Study|Withdrawal by Subject|2
6112339|NCT00131508|21082274|P1|Overall Study|Withdrawal by Subject|1
6112340|NCT00131508|21082273|P2|Overall Study|Non-Compliance|4
6112341|NCT00131508|21082274|P1|Overall Study|Non-Compliance|2
6112342|NCT00131508|21082273|P2|Overall Study|Disease progression|2
6112343|NCT00131508|21082274|P1|Overall Study|Disease progression|0
6112344|NCT00131469|21082298|P2|Overall Study|scan not analyzable|6
6112345|NCT00131469|21082299|P1|Overall Study|scan not analyzable|3
6112346|NCT00131469|21082298|P2|Overall Study|Lost to Follow-up|1
6112347|NCT00131469|21082299|P1|Overall Study|Lost to Follow-up|0
6112348|NCT00131469|21082298|P2|Overall Study|Death|1
6112349|NCT00131469|21082299|P1|Overall Study|Death|0
6112350|NCT00131469|21082298|P2|Overall Study|Protocol Violation|1
6112351|NCT00131469|21082299|P1|Overall Study|Protocol Violation|3
6112352|NCT00131469|21082298|P2|Overall Study|Withdrawal by Subject|4
6112353|NCT00131469|21082299|P1|Overall Study|Withdrawal by Subject|3
6112354|NCT00131365|21082345|P1|Overall Study|Alternative treatment|3
6112355|NCT00131365|21082345|P1|Overall Study|Withdrawal by Subject|1
6112356|NCT00131352|21082352|P2|Repeat Treatment Period|Other|0
6112357|NCT00131352|21082353|P1|Repeat Treatment Period|Other|1
6112358|NCT00131352|21082352|P2|Repeat Treatment Period|Adverse Event|0
6112359|NCT00131352|21082353|P1|Repeat Treatment Period|Adverse Event|1
6112360|NCT00131352|21082352|P2|Initial Treatment Period|Other|2
6112361|NCT00131352|21082353|P1|Initial Treatment Period|Other|0
6112362|NCT00131352|21082352|P2|Initial Treatment Period|Lack of Efficacy|4
6112363|NCT00131352|21082353|P1|Initial Treatment Period|Lack of Efficacy|6
6112364|NCT00131352|21082352|P2|Initial Treatment Period|Withdrawal by Subject|1
6112365|NCT00131352|21082353|P1|Initial Treatment Period|Withdrawal by Subject|1
6112366|NCT00131352|21082352|P2|Initial Treatment Period|Non-compliant|2
6112367|NCT00131352|21082353|P1|Initial Treatment Period|Non-compliant|1
6112368|NCT00131352|21082352|P2|Initial Treatment Period|Adverse Event|3
6112369|NCT00131352|21082353|P1|Initial Treatment Period|Adverse Event|1
6112370|NCT00131248|21082375|P2|Intervention 1 (3-day Course)|Withdrawal by Subject|0
6112371|NCT00131248|21082376|P1|Intervention 1 (3-day Course)|Withdrawal by Subject|1
6112372|NCT00130832|21082403|P2|Overall Study|Other|3
6112373|NCT00130832|21082404|P1|Overall Study|Other|0
6112374|NCT00130832|21082403|P2|Overall Study|Moved|2
6112375|NCT00130832|21082404|P1|Overall Study|Moved|2
6112376|NCT00130832|21082403|P2|Overall Study|Withdrawal by Subject|1
6112377|NCT00130832|21082404|P1|Overall Study|Withdrawal by Subject|6
6112378|NCT00130832|21082403|P2|Overall Study|Protocol Violation|8
6112379|NCT00130832|21082404|P1|Overall Study|Protocol Violation|6
6112380|NCT00130832|21082403|P2|Overall Study|Lost to Follow-up|2
6112381|NCT00130832|21082404|P1|Overall Study|Lost to Follow-up|1
6112382|NCT00130832|21082403|P2|Overall Study|Adverse Event|1
6112383|NCT00130832|21082404|P1|Overall Study|Adverse Event|1
6112384|NCT00130793|21082416|P2|Overall Study|Withdrew consent|0
6112385|NCT00130793|21082417|P1|Overall Study|Withdrew consent|2
6112386|NCT00130793|21082416|P2|Overall Study|Lost to Follow-up|4
6112387|NCT00130793|21082417|P1|Overall Study|Lost to Follow-up|1
6112388|NCT00130728|21082438|P2|Overall Study|Withdrawal by Subject|2
6112389|NCT00130728|21082439|P1|Overall Study|Withdrawal by Subject|0
6112390|NCT00130728|21082438|P2|Overall Study|Lost to Follow-up|0
6112391|NCT00130728|21082439|P1|Overall Study|Lost to Follow-up|4
6112392|NCT00130728|21082438|P2|Overall Study|Death|258
6112393|NCT00130728|21082439|P1|Overall Study|Death|258
6112394|NCT00130689|21082451|P1|Overall Study|Ineligible|6
6112395|NCT00130689|21082451|P1|Overall Study|Withdrawal by Subject|3
6112396|NCT00130689|21082451|P1|Overall Study|Clinical Deterioration|4
6112397|NCT00130689|21082451|P1|Overall Study|Death|1
6112398|NCT00130689|21082451|P1|Overall Study|Progressive Disease|29
6112399|NCT00130637|21082455|P1|Overall Study|Withdrawal by Subject|1
6112400|NCT00130637|21082455|P1|Overall Study|Adverse Event|2
6112401|NCT00130533|21082462|P2|Overall Study|Other|5
6112402|NCT00130533|21082463|P1|Overall Study|Other|12
6112403|NCT00130533|21082462|P2|Overall Study|Second Primary Malignancy|1
6112404|NCT00130533|21082463|P1|Overall Study|Second Primary Malignancy|0
6112405|NCT00130533|21082462|P2|Overall Study|Sponsor´s decision|0
6112406|NCT00130533|21082463|P1|Overall Study|Sponsor´s decision|2
6112407|NCT00130533|21082462|P2|Overall Study|Lost to Follow-up|1
6112408|NCT00130533|21082463|P1|Overall Study|Lost to Follow-up|1
6112409|NCT00130533|21082462|P2|Overall Study|Protocol Violation|1
6112410|NCT00130533|21082463|P1|Overall Study|Protocol Violation|5
6112411|NCT00130533|21082462|P2|Overall Study|Death|2
6112412|NCT00130533|21082463|P1|Overall Study|Death|4
6112413|NCT00130533|21082462|P2|Overall Study|Interruption of treatment > 3 weeks|0
6112414|NCT00130533|21082463|P1|Overall Study|Interruption of treatment > 3 weeks|11
6112415|NCT00130533|21082462|P2|Overall Study|Disease relapse|13
6112416|NCT00130533|21082463|P1|Overall Study|Disease relapse|9
6112417|NCT00130533|21082462|P2|Overall Study|Adverse Event|1
6112418|NCT00130533|21082463|P1|Overall Study|Adverse Event|34
6112419|NCT00130533|21082462|P2|Overall Study|Withdrawal by Subject|6
6112420|NCT00130533|21082463|P1|Overall Study|Withdrawal by Subject|33
6112421|NCT00130520|21082475|P1|Overall Study|Did not meet re-treatment criteria|1
6112422|NCT00130520|21082475|P1|Overall Study|Protocol non-compliance|1
6112423|NCT00130520|21082475|P1|Overall Study|Disease Progression|23
6112424|NCT00130520|21082475|P1|Overall Study|Withdrawal by Subject|1
6112425|NCT00130520|21082475|P1|Overall Study|Physician Decision|1
6112426|NCT00130520|21082475|P1|Overall Study|Death|1
6112427|NCT00130520|21082475|P1|Overall Study|Adverse Event|11
6112428|NCT00130442|21082483|P2|Overall Study|did not meet criteria|1
6112429|NCT00130442|21082484|P1|Overall Study|did not meet criteria|1
6112430|NCT00130442|21082483|P2|Overall Study|Withdrawal by Subject|1
6112431|NCT00130442|21082484|P1|Overall Study|Withdrawal by Subject|0
6112432|NCT00130286|21082502|P4|Overall Study|Missing lab specimens|0
6112433|NCT00130286|21082503|P3|Overall Study|Missing lab specimens|0
6112434|NCT00130286|21082504|P2|Overall Study|Missing lab specimens|2
6112435|NCT00130286|21082505|P1|Overall Study|Missing lab specimens|0
6112436|NCT00130286|21082502|P4|Overall Study|Adverse Event|0
6112437|NCT00130286|21082503|P3|Overall Study|Adverse Event|2
6112438|NCT00130286|21082504|P2|Overall Study|Adverse Event|0
6112439|NCT00130286|21082505|P1|Overall Study|Adverse Event|0
6112440|NCT00130286|21082502|P4|Overall Study|Withdrawal by Subject|2
6112441|NCT00130286|21082503|P3|Overall Study|Withdrawal by Subject|2
6112442|NCT00130286|21082504|P2|Overall Study|Withdrawal by Subject|1
6112443|NCT00130286|21082505|P1|Overall Study|Withdrawal by Subject|0
6112444|NCT00130247|21082525|P2|Overall Study|Not compliant with DOT|2
6112445|NCT00130247|21082526|P1|Overall Study|Not compliant with DOT|0
6112446|NCT00130247|21082525|P2|Overall Study|Post-randomization exclusion|2
6112447|NCT00130247|21082526|P1|Overall Study|Post-randomization exclusion|1
6112448|NCT00130247|21082525|P2|Overall Study|Pregnancy|0
6112449|NCT00130247|21082526|P1|Overall Study|Pregnancy|1
6112450|NCT00130208|21082544|P2|Washout Period (8 Weeks)|Other|1
6112451|NCT00130208|21082545|P1|Washout Period (8 Weeks)|Other|1
6112452|NCT00130208|21082544|P2|Washout Period (8 Weeks)|Lost to Follow-up|1
6112453|NCT00130208|21082545|P1|Washout Period (8 Weeks)|Lost to Follow-up|0
6112454|NCT00130208|21082544|P2|Washout Period (8 Weeks)|Withdrawal by Subject|4
6112455|NCT00130208|21082545|P1|Washout Period (8 Weeks)|Withdrawal by Subject|2
6112456|NCT00130208|21082544|P2|Washout Period (8 Weeks)|Adverse Event|6
6112457|NCT00130208|21082545|P1|Washout Period (8 Weeks)|Adverse Event|3
6112458|NCT00130208|21082544|P2|Maintenance Period (26 Weeks)|Other|1
6112459|NCT00130208|21082545|P1|Maintenance Period (26 Weeks)|Other|1
6112460|NCT00130208|21082544|P2|Maintenance Period (26 Weeks)|Lost to Follow-up|4
6112461|NCT00130208|21082545|P1|Maintenance Period (26 Weeks)|Lost to Follow-up|5
6112462|NCT00130208|21082544|P2|Maintenance Period (26 Weeks)|Withdrawal by Subject|11
6112463|NCT00130208|21082545|P1|Maintenance Period (26 Weeks)|Withdrawal by Subject|8
6112464|NCT00130208|21082544|P2|Maintenance Period (26 Weeks)|Physician Decision|2
6112465|NCT00130208|21082545|P1|Maintenance Period (26 Weeks)|Physician Decision|0
6112466|NCT00130208|21082544|P2|Maintenance Period (26 Weeks)|Adverse Event|12
6112467|NCT00130208|21082545|P1|Maintenance Period (26 Weeks)|Adverse Event|10
6112468|NCT00130039|21082581|P2|Overall Study|clinical events without follow up MRI|4
6112469|NCT00130039|21082582|P1|Overall Study|clinical events without follow up MRI|5
6112470|NCT00130039|21082581|P2|Overall Study|Physician Decision|0
6112471|NCT00130039|21082582|P1|Overall Study|Physician Decision|3
6112472|NCT00130039|21082581|P2|Overall Study|Adverse Event|2
6112473|NCT00130039|21082582|P1|Overall Study|Adverse Event|4
6112474|NCT00130039|21082581|P2|Overall Study|Lost to Follow-up|1
6112475|NCT00130039|21082582|P1|Overall Study|Lost to Follow-up|3
6112476|NCT00130039|21082581|P2|Overall Study|Withdrawal by Subject|11
6112477|NCT00130039|21082582|P1|Overall Study|Withdrawal by Subject|15
6112478|NCT00129987|21082600|P2|1 Year|Withdrawal by Subject|21
6112479|NCT00129987|21082601|P1|1 Year|Withdrawal by Subject|32
6112480|NCT00129987|21082600|P2|1st Educational Session|Withdrawal by Subject|109
6112481|NCT00129987|21082601|P1|1st Educational Session|Withdrawal by Subject|141
6112482|NCT00129974|21082613|P1|Overall Study|Other|1
6112483|NCT00129961|21082620|P2|Overall Study|Missing Record|1
6112484|NCT00129961|21082621|P1|Overall Study|Missing Record|0
6112485|NCT00129961|21082620|P2|Overall Study|Withdrawal by Subject|1
6112486|NCT00129961|21082621|P1|Overall Study|Withdrawal by Subject|2
6112487|NCT00129961|21082620|P2|Overall Study|Physician Decision|0
6112488|NCT00129961|21082621|P1|Overall Study|Physician Decision|1
6112489|NCT00129961|21082620|P2|Overall Study|Withdrawal by Sponsor|20
6112490|NCT00129961|21082621|P1|Overall Study|Withdrawal by Sponsor|14
6112491|NCT00129961|21082620|P2|Overall Study|Death|1
6112492|NCT00129961|21082621|P1|Overall Study|Death|1
6112493|NCT00129961|21082620|P2|Overall Study|Adverse Event|0
6112494|NCT00129961|21082621|P1|Overall Study|Adverse Event|1
6112495|NCT00129935|21082657|P2|Overall Study|Incorrect study treatment|0
6112496|NCT00129935|21082658|P1|Overall Study|Incorrect study treatment|1
6112497|NCT00129935|21082657|P2|Overall Study|Crossed to the other arm|1
6112498|NCT00129935|21082658|P1|Overall Study|Crossed to the other arm|2
6112499|NCT00129935|21082657|P2|Overall Study|Other|2
6112500|NCT00129935|21082658|P1|Overall Study|Other|3
6112501|NCT00129935|21082657|P2|Overall Study|Second primary|1
6112502|NCT00129935|21082658|P1|Overall Study|Second primary|0
6112503|NCT00129935|21082657|P2|Overall Study|Recurrence|3
6112504|NCT00129935|21082658|P1|Overall Study|Recurrence|1
6112505|NCT00129935|21082657|P2|Overall Study|Physician Decision|4
6112506|NCT00129935|21082658|P1|Overall Study|Physician Decision|3
6112507|NCT00129935|21082657|P2|Overall Study|Protocol Violation|4
6112508|NCT00129935|21082658|P1|Overall Study|Protocol Violation|0
6112509|NCT00129935|21082657|P2|Overall Study|Withdrawal by Subject|20
6112510|NCT00129935|21082658|P1|Overall Study|Withdrawal by Subject|7
6112511|NCT00129935|21082657|P2|Overall Study|Death|1
6112512|NCT00129935|21082658|P1|Overall Study|Death|1
6112513|NCT00129935|21082657|P2|Overall Study|Adverse Event|56
6112514|NCT00129935|21082658|P1|Overall Study|Adverse Event|18
6112515|NCT00129766|21082676|P2|Overall Study|Lost to Follow-up|21
6112516|NCT00129766|21082677|P1|Overall Study|Lost to Follow-up|26
6112517|NCT00129766|21082676|P2|Overall Study|Withdrawal of consent|30
6112518|NCT00129766|21082677|P1|Overall Study|Withdrawal of consent|31
6112519|NCT00129766|21082676|P2|Overall Study|Death|8
6112520|NCT00129766|21082677|P1|Overall Study|Death|3
6112521|NCT00129701|21082726|P1|Overall Study|Withdrawal by Subject|33
6112522|NCT00129649|21082735|P2|Overall Study|Withdrawal by Subject|65
6112523|NCT00129649|21082736|P1|Overall Study|Withdrawal by Subject|76
6112524|NCT00129623|21082744|P2|Overall Study|Uncertainty to return|1
6112525|NCT00129623|21082745|P1|Overall Study|Uncertainty to return|0
6112526|NCT00129623|21082744|P2|Overall Study|Relocated job out of state|0
6112527|NCT00129623|21082745|P1|Overall Study|Relocated job out of state|1
6112528|NCT00129623|21082744|P2|Overall Study|Failure to Return|1
6112529|NCT00129623|21082745|P1|Overall Study|Failure to Return|1
6112530|NCT00129623|21082744|P2|Overall Study|Refused Treatment|3
6112531|NCT00129623|21082745|P1|Overall Study|Refused Treatment|5
6112532|NCT00129623|21082744|P2|Overall Study|Adverse Event|7
6112533|NCT00129623|21082745|P1|Overall Study|Adverse Event|3
6112534|NCT00129545|21082770|P3|Overall Study|Device not implanted|0
6112535|NCT00129545|21082771|P2|Overall Study|Device not implanted|61
6112536|NCT00129545|21082772|P1|Overall Study|Device not implanted|16
6112537|NCT00129545|21082770|P3|Overall Study|Physician Decision|10
6112538|NCT00129545|21082771|P2|Overall Study|Physician Decision|3
6112539|NCT00129545|21082772|P1|Overall Study|Physician Decision|0
6112540|NCT00129545|21082770|P3|Overall Study|Lost to Follow-up|13
6112541|NCT00129545|21082771|P2|Overall Study|Lost to Follow-up|22
6112542|NCT00129545|21082772|P1|Overall Study|Lost to Follow-up|2
6112543|NCT00129545|21082770|P3|Overall Study|Withdrawal by Subject|44
6112544|NCT00129545|21082771|P2|Overall Study|Withdrawal by Subject|18
6112545|NCT00129545|21082772|P1|Overall Study|Withdrawal by Subject|3
6112546|NCT00129545|21082770|P3|Overall Study|Death|44
6112547|NCT00129545|21082771|P2|Overall Study|Death|60
6112548|NCT00129545|21082772|P1|Overall Study|Death|5
6112549|NCT00129467|21082801|P2|Open Label for SSRI+Methylphenidate Arm|Delirium|0
6112550|NCT00129467|21082802|P1|Open Label for SSRI+Methylphenidate Arm|Delirium|1
6112551|NCT00129467|21082801|P2|Open Label for SSRI+Methylphenidate Arm|Death|0
6112552|NCT00129467|21082802|P1|Open Label for SSRI+Methylphenidate Arm|Death|1
6112553|NCT00129467|21082801|P2|Received Intervention|Dizzyness, fatigue|1
6112554|NCT00129467|21082802|P1|Received Intervention|Dizzyness, fatigue|0
6112555|NCT00129467|21082801|P2|Received Intervention|Intolerance to citalopram|1
6112556|NCT00129467|21082802|P1|Received Intervention|Intolerance to citalopram|0
6112557|NCT00129467|21082801|P2|Received Intervention|Nausea|0
6112558|NCT00129467|21082802|P1|Received Intervention|Nausea|1
6112559|NCT00129467|21082801|P2|Received Intervention|Withdrawal by Subject|0
6112560|NCT00129467|21082802|P1|Received Intervention|Withdrawal by Subject|1
6112561|NCT00129467|21082801|P2|Received Intervention|Delirium|0
6112562|NCT00129467|21082802|P1|Received Intervention|Delirium|2
6112563|NCT00129467|21082801|P2|Received Intervention|Cardiac SAE (hypertension)|1
6112564|NCT00129467|21082802|P1|Received Intervention|Cardiac SAE (hypertension)|1
6112565|NCT00129467|21082801|P2|Received Intervention|Death|1
6112566|NCT00129467|21082802|P1|Received Intervention|Death|1
6112567|NCT00129402|21082833|P7|Start Period3 to End Period3(Week 34-53)|Protocol Violation|1
6112568|NCT00129402|21082834|P6|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
6112569|NCT00129402|21082835|P5|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
6112570|NCT00129402|21082836|P4|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
6112571|NCT00129402|21082837|P3|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
6112572|NCT00129402|21082838|P2|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
6112573|NCT00129402|21082839|P1|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
6112574|NCT00129402|21082833|P7|Start Period3 to End Period3(Week 34-53)|Subject moved|1
6112575|NCT00129402|21082834|P6|Start Period3 to End Period3(Week 34-53)|Subject moved|0
6112576|NCT00129402|21082835|P5|Start Period3 to End Period3(Week 34-53)|Subject moved|0
6112577|NCT00129402|21082836|P4|Start Period3 to End Period3(Week 34-53)|Subject moved|0
6112578|NCT00129402|21082837|P3|Start Period3 to End Period3(Week 34-53)|Subject moved|0
6112579|NCT00129402|21082838|P2|Start Period3 to End Period3(Week 34-53)|Subject moved|0
6112580|NCT00129402|21082839|P1|Start Period3 to End Period3(Week 34-53)|Subject moved|0
6112581|NCT00129402|21082833|P7|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|3
6112582|NCT00129402|21082834|P6|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
6112583|NCT00129402|21082835|P5|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
6112584|NCT00129402|21082836|P4|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
6112585|NCT00129402|21082837|P3|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
6112586|NCT00129402|21082838|P2|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
6112587|NCT00129402|21082839|P1|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
6112588|NCT00129402|21082833|P7|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|1
6112589|NCT00129402|21082834|P6|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
6112590|NCT00129402|21082835|P5|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
6112591|NCT00129402|21082836|P4|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
6112592|NCT00129402|21082837|P3|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
6112593|NCT00129402|21082838|P2|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
6112594|NCT00129402|21082839|P1|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
6112595|NCT00129402|21082833|P7|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0
6112596|NCT00129402|21082834|P6|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1
6112597|NCT00129402|21082835|P5|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0
6112598|NCT00129402|21082836|P4|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0
6112599|NCT00129402|21082837|P3|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1
6112600|NCT00129402|21082838|P2|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0
6112601|NCT00129402|21082839|P1|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0
6112602|NCT00129402|21082833|P7|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0
6112603|NCT00129402|21082834|P6|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|3
6112604|NCT00129402|21082835|P5|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0
6112605|NCT00129402|21082836|P4|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0
6112606|NCT00129402|21082837|P3|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|1
6112607|NCT00129402|21082838|P2|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0
6112608|NCT00129402|21082839|P1|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0
6112609|NCT00129402|21082833|P7|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
6112610|NCT00129402|21082834|P6|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
6112611|NCT00129402|21082835|P5|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
6112612|NCT00129402|21082836|P4|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
6112613|NCT00129402|21082837|P3|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|1
6112614|NCT00129402|21082838|P2|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
6112615|NCT00129402|21082839|P1|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
6112616|NCT00129402|21082833|P7|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0
6112617|NCT00129402|21082834|P6|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|1
6112618|NCT00129402|21082835|P5|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0
6112619|NCT00129402|21082836|P4|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0
6112620|NCT00129402|21082837|P3|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|3
6112621|NCT00129402|21082838|P2|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0
6112622|NCT00129402|21082839|P1|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0
6112623|NCT00129402|21082833|P7|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
6112624|NCT00129402|21082834|P6|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
6112625|NCT00129402|21082835|P5|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
6112626|NCT00129402|21082836|P4|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
6112627|NCT00129402|21082837|P3|Start Period2 to End Period2 (Week 7-33)|Adverse Event|2
6112628|NCT00129402|21082838|P2|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
6112629|NCT00129402|21082839|P1|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
6112630|NCT00129402|21082833|P7|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0
6112631|NCT00129402|21082834|P6|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0
6112632|NCT00129402|21082835|P5|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1
6112633|NCT00129402|21082836|P4|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0
6112634|NCT00129402|21082837|P3|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1
6112635|NCT00129402|21082838|P2|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0
6112636|NCT00129402|21082839|P1|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0
6112637|NCT00129402|21082833|P7|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
6112638|NCT00129402|21082834|P6|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
6112639|NCT00129402|21082835|P5|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
6112640|NCT00129402|21082836|P4|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|1
6112641|NCT00129402|21082837|P3|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
6112642|NCT00129402|21082838|P2|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
6112643|NCT00129402|21082839|P1|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
6112644|NCT00129402|21082833|P7|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
6112645|NCT00129402|21082834|P6|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|1
6112646|NCT00129402|21082835|P5|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
6112647|NCT00129402|21082836|P4|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
6112648|NCT00129402|21082837|P3|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
6112649|NCT00129402|21082838|P2|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
6112650|NCT00129402|21082839|P1|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
6112651|NCT00129402|21082833|P7|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0
6112652|NCT00129402|21082834|P6|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1
6112653|NCT00129402|21082835|P5|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0
6112654|NCT00129402|21082836|P4|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0
6112655|NCT00129402|21082837|P3|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1
6112656|NCT00129402|21082838|P2|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1
6112657|NCT00129402|21082839|P1|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0
6112658|NCT00129389|21082858|P2|Overall Study|Crossed to the other arm|16
6112659|NCT00129389|21082859|P1|Overall Study|Crossed to the other arm|1
6112660|NCT00129389|21082858|P2|Overall Study|Not eligible|2
6112661|NCT00129389|21082859|P1|Overall Study|Not eligible|1
6112662|NCT00129389|21082858|P2|Overall Study|Relapse|0
6112663|NCT00129389|21082859|P1|Overall Study|Relapse|1
6112664|NCT00129389|21082858|P2|Overall Study|Withdrawal by Subject|23
6112665|NCT00129389|21082859|P1|Overall Study|Withdrawal by Subject|9
6112666|NCT00129389|21082858|P2|Overall Study|Protocol Violation|6
6112667|NCT00129389|21082859|P1|Overall Study|Protocol Violation|0
6112668|NCT00129389|21082858|P2|Overall Study|Physician Decision|4
6112669|NCT00129389|21082859|P1|Overall Study|Physician Decision|0
6112670|NCT00129389|21082858|P2|Overall Study|Lost to Follow-up|1
6112671|NCT00129389|21082859|P1|Overall Study|Lost to Follow-up|2
6112672|NCT00129389|21082858|P2|Overall Study|Death|1
6112673|NCT00129389|21082859|P1|Overall Study|Death|0
6112674|NCT00129389|21082858|P2|Overall Study|Adverse Event|87
6112675|NCT00129389|21082859|P1|Overall Study|Adverse Event|19
6112676|NCT00129376|21082867|P1|Overall Study|Lack of Efficacy|1
6112677|NCT00129376|21082867|P1|Overall Study|Adverse Event|1
6112678|NCT00129311|21082877|P2|Overall Study|Withdrawal by Subject|19
6112679|NCT00129311|21082878|P1|Overall Study|Withdrawal by Subject|12
6112680|NCT00129272|21082907|P2|Overall Study|Withdrawal by Subject|11
6112681|NCT00129272|21082908|P1|Overall Study|Withdrawal by Subject|5
6112682|NCT00129272|21082907|P2|Overall Study|Lost to Follow-up|11
6112683|NCT00129272|21082908|P1|Overall Study|Lost to Follow-up|12
6112684|NCT00129259|21082918|P2|Overall Study|Only available minimal phone assessments|1
6112685|NCT00129259|21082919|P1|Overall Study|Only available minimal phone assessments|0
6112686|NCT00129259|21082918|P2|Overall Study|Withdrawal by Subject|1
6112687|NCT00129259|21082919|P1|Overall Study|Withdrawal by Subject|2
6112688|NCT00129259|21082918|P2|Overall Study|Lost to Follow-up|1
6112689|NCT00129259|21082919|P1|Overall Study|Lost to Follow-up|1
6112690|NCT00129220|21082947|P3|Study Period III|Reason Not Specified|2
6112691|NCT00129220|21082948|P2|Study Period III|Reason Not Specified|0
6112692|NCT00129220|21082949|P1|Study Period III|Reason Not Specified|9
6112693|NCT00129220|21082947|P3|Study Period III|Sponsor Decision|0
6112694|NCT00129220|21082948|P2|Study Period III|Sponsor Decision|0
6112695|NCT00129220|21082949|P1|Study Period III|Sponsor Decision|1
6112696|NCT00129220|21082947|P3|Study Period III|Withdrawal by Subject|3
6112697|NCT00129220|21082948|P2|Study Period III|Withdrawal by Subject|0
6112698|NCT00129220|21082949|P1|Study Period III|Withdrawal by Subject|1
6112699|NCT00129220|21082947|P3|Study Period III|Protocol Violation|2
6112700|NCT00129220|21082948|P2|Study Period III|Protocol Violation|1
6112701|NCT00129220|21082949|P1|Study Period III|Protocol Violation|1
6112702|NCT00129220|21082947|P3|Study Period III|Adverse Event|3
6112703|NCT00129220|21082948|P2|Study Period III|Adverse Event|0
6112704|NCT00129220|21082949|P1|Study Period III|Adverse Event|1
6112705|NCT00129220|21082947|P3|Study Period II|Reason Not Specified|5
6112706|NCT00129220|21082948|P2|Study Period II|Reason Not Specified|0
6112707|NCT00129220|21082949|P1|Study Period II|Reason Not Specified|2
6112708|NCT00129220|21082947|P3|Study Period II|Withdrawal by Subject|4
6112709|NCT00129220|21082948|P2|Study Period II|Withdrawal by Subject|3
6112710|NCT00129220|21082949|P1|Study Period II|Withdrawal by Subject|1
6112711|NCT00129220|21082947|P3|Study Period II|Physician Decision|0
6112712|NCT00129220|21082948|P2|Study Period II|Physician Decision|1
6112713|NCT00129220|21082949|P1|Study Period II|Physician Decision|0
6112714|NCT00129220|21082947|P3|Study Period II|Protocol Violation|1
6112715|NCT00129220|21082948|P2|Study Period II|Protocol Violation|2
6112716|NCT00129220|21082949|P1|Study Period II|Protocol Violation|4
6112717|NCT00129220|21082947|P3|Study Period II|Entry Criteria Not Met|2
6112718|NCT00129220|21082948|P2|Study Period II|Entry Criteria Not Met|0
6112719|NCT00129220|21082949|P1|Study Period II|Entry Criteria Not Met|2
6112720|NCT00129220|21082947|P3|Study Period II|Lack of Efficacy|28
6112721|NCT00129220|21082948|P2|Study Period II|Lack of Efficacy|1
6112722|NCT00129220|21082949|P1|Study Period II|Lack of Efficacy|15
6112723|NCT00129220|21082947|P3|Study Period II|Adverse Event|7
6112724|NCT00129220|21082948|P2|Study Period II|Adverse Event|5
6112725|NCT00129220|21082949|P1|Study Period II|Adverse Event|9
6112726|NCT00129129|21082989|P5|Fourth Dose Phase|Protocol Violation|0
6112727|NCT00129129|21082990|P4|Fourth Dose Phase|Protocol Violation|1
6112728|NCT00129129|21082991|P3|Fourth Dose Phase|Protocol Violation|0
6112729|NCT00129129|21082992|P2|Fourth Dose Phase|Protocol Violation|0
6112730|NCT00129129|21082993|P1|Fourth Dose Phase|Protocol Violation|0
6112731|NCT00129129|21082989|P5|Fourth Dose Phase|Other|1
6112732|NCT00129129|21082990|P4|Fourth Dose Phase|Other|1
6112733|NCT00129129|21082991|P3|Fourth Dose Phase|Other|0
6112734|NCT00129129|21082992|P2|Fourth Dose Phase|Other|0
6112735|NCT00129129|21082993|P1|Fourth Dose Phase|Other|0
6112736|NCT00129129|21082989|P5|Fourth Dose Phase|Migration from study area|2
6112737|NCT00129129|21082990|P4|Fourth Dose Phase|Migration from study area|0
6112738|NCT00129129|21082991|P3|Fourth Dose Phase|Migration from study area|0
6112739|NCT00129129|21082992|P2|Fourth Dose Phase|Migration from study area|0
6112740|NCT00129129|21082993|P1|Fourth Dose Phase|Migration from study area|0
6112741|NCT00129129|21082989|P5|Fourth Dose Phase|Withdrawal by Subject|1
6112742|NCT00129129|21082990|P4|Fourth Dose Phase|Withdrawal by Subject|0
6112743|NCT00129129|21082991|P3|Fourth Dose Phase|Withdrawal by Subject|0
6112744|NCT00129129|21082992|P2|Fourth Dose Phase|Withdrawal by Subject|0
6112745|NCT00129129|21082993|P1|Fourth Dose Phase|Withdrawal by Subject|0
6112746|NCT00129129|21082989|P5|Fourth Dose Phase|Lost to Follow-up|2
6112747|NCT00129129|21082990|P4|Fourth Dose Phase|Lost to Follow-up|2
6112748|NCT00129129|21082991|P3|Fourth Dose Phase|Lost to Follow-up|0
6112749|NCT00129129|21082992|P2|Fourth Dose Phase|Lost to Follow-up|0
6112750|NCT00129129|21082993|P1|Fourth Dose Phase|Lost to Follow-up|4
6112751|NCT00129129|21082989|P5|Primary Phase|Other|0
6112752|NCT00129129|21082990|P4|Primary Phase|Other|0
6112753|NCT00129129|21082991|P3|Primary Phase|Other|0
6112754|NCT00129129|21082992|P2|Primary Phase|Other|5
6112755|NCT00129129|21082993|P1|Primary Phase|Other|2
6112756|NCT00129129|21082989|P5|Primary Phase|Lost to Follow-up|0
6112757|NCT00129129|21082990|P4|Primary Phase|Lost to Follow-up|0
6112758|NCT00129129|21082991|P3|Primary Phase|Lost to Follow-up|0
6112759|NCT00129129|21082992|P2|Primary Phase|Lost to Follow-up|6
6112760|NCT00129129|21082993|P1|Primary Phase|Lost to Follow-up|8
6112761|NCT00129129|21082989|P5|Primary Phase|Migration from study area|0
6112762|NCT00129129|21082990|P4|Primary Phase|Migration from study area|0
6112763|NCT00129129|21082991|P3|Primary Phase|Migration from study area|0
6112764|NCT00129129|21082992|P2|Primary Phase|Migration from study area|3
6112765|NCT00129129|21082993|P1|Primary Phase|Migration from study area|1
6112766|NCT00129129|21082989|P5|Primary Phase|Withdrawal by Subject|0
6112767|NCT00129129|21082990|P4|Primary Phase|Withdrawal by Subject|0
6112768|NCT00129129|21082991|P3|Primary Phase|Withdrawal by Subject|0
6112769|NCT00129129|21082992|P2|Primary Phase|Withdrawal by Subject|10
6112770|NCT00129129|21082993|P1|Primary Phase|Withdrawal by Subject|12
6112771|NCT00129129|21082989|P5|Primary Phase|Adverse Event|0
6112772|NCT00129129|21082990|P4|Primary Phase|Adverse Event|0
6112773|NCT00129129|21082991|P3|Primary Phase|Adverse Event|0
6112774|NCT00129129|21082992|P2|Primary Phase|Adverse Event|1
6112775|NCT00129129|21082993|P1|Primary Phase|Adverse Event|2
6112776|NCT00129116|21083200|P5|Booster Phase|Lost to Follow-up|1
6112777|NCT00129116|21083201|P4|Booster Phase|Lost to Follow-up|0
6112778|NCT00129116|21083202|P3|Booster Phase|Lost to Follow-up|0
6112779|NCT00129116|21083203|P2|Booster Phase|Lost to Follow-up|0
6112780|NCT00129116|21083204|P1|Booster Phase|Lost to Follow-up|2
6112781|NCT00129116|21083200|P5|Primary Phase|Other|0
6112782|NCT00129116|21083201|P4|Primary Phase|Other|0
6112783|NCT00129116|21083202|P3|Primary Phase|Other|1
6112784|NCT00129116|21083203|P2|Primary Phase|Other|0
6112785|NCT00129116|21083204|P1|Primary Phase|Other|0
6112786|NCT00129116|21083200|P5|Primary Phase|Withdrawal by Subject|0
6112787|NCT00129116|21083201|P4|Primary Phase|Withdrawal by Subject|0
6112788|NCT00129116|21083202|P3|Primary Phase|Withdrawal by Subject|0
6112789|NCT00129116|21083203|P2|Primary Phase|Withdrawal by Subject|1
6112790|NCT00129116|21083204|P1|Primary Phase|Withdrawal by Subject|0
6112791|NCT00129116|21083200|P5|Primary Phase|Adverse Event|0
6112792|NCT00129116|21083201|P4|Primary Phase|Adverse Event|0
6112793|NCT00129116|21083202|P3|Primary Phase|Adverse Event|0
6112794|NCT00129116|21083203|P2|Primary Phase|Adverse Event|1
6112795|NCT00129116|21083204|P1|Primary Phase|Adverse Event|1
6112796|NCT00129116|21083200|P5|Primary Phase|Protocol Violation|0
6112797|NCT00129116|21083201|P4|Primary Phase|Protocol Violation|0
6112798|NCT00129116|21083202|P3|Primary Phase|Protocol Violation|0
6112799|NCT00129116|21083203|P2|Primary Phase|Protocol Violation|1
6112800|NCT00129116|21083204|P1|Primary Phase|Protocol Violation|0
6112801|NCT00129116|21083200|P5|Primary Phase|Lost to Follow-up|1
6112802|NCT00129116|21083201|P4|Primary Phase|Lost to Follow-up|1
6112803|NCT00129116|21083202|P3|Primary Phase|Lost to Follow-up|0
6112804|NCT00129116|21083203|P2|Primary Phase|Lost to Follow-up|1
6112805|NCT00129116|21083204|P1|Primary Phase|Lost to Follow-up|1
6112806|NCT00128830|21083488|P1|Overall Study|Other|9
6112807|NCT00128830|21083488|P1|Overall Study|Discontinued or ineligible for study|2
6112808|NCT00128830|21083488|P1|Overall Study|Non-compliant|4
6112809|NCT00128830|21083488|P1|Overall Study|Reached a virologic endpoint|29
6112810|NCT00128830|21083488|P1|Overall Study|Lost to Follow-up|4
6112811|NCT00128830|21083488|P1|Overall Study|Withdrawal by Subject|14
6112812|NCT00128830|21083488|P1|Overall Study|Adverse Event|10
6112813|NCT00128661|21083530|P2|Overall Study|Other|8
6112814|NCT00128661|21083531|P1|Overall Study|Other|7
6112815|NCT00128661|21083530|P2|Overall Study|Withdrawal by Subject|232
6112816|NCT00128661|21083531|P1|Overall Study|Withdrawal by Subject|243
6112817|NCT00128661|21083530|P2|Overall Study|Lost to Follow-up|7
6112818|NCT00128661|21083531|P1|Overall Study|Lost to Follow-up|10
6112819|NCT00128661|21083530|P2|Overall Study|Adverse Event|11
6112820|NCT00128661|21083531|P1|Overall Study|Adverse Event|14
6112821|NCT00128492|21083577|P2|Overall Study|Pregnancy|1
6112822|NCT00128492|21083578|P1|Overall Study|Pregnancy|0
6112823|NCT00128492|21083577|P2|Overall Study|Withdrawal by Subject|5
6112824|NCT00128492|21083578|P1|Overall Study|Withdrawal by Subject|3
6112825|NCT00128492|21083577|P2|Overall Study|Personal or administrative|22
6112826|NCT00128492|21083578|P1|Overall Study|Personal or administrative|10
6112827|NCT00128492|21083577|P2|Overall Study|Noncompliance|5
6112828|NCT00128492|21083578|P1|Overall Study|Noncompliance|0
6112829|NCT00128492|21083577|P2|Overall Study|Lost to Follow-up|5
6112830|NCT00128492|21083578|P1|Overall Study|Lost to Follow-up|1
6112831|NCT00128492|21083577|P2|Overall Study|Death|0
6112832|NCT00128492|21083578|P1|Overall Study|Death|1
6112833|NCT00128492|21083577|P2|Overall Study|AE related to study|4
6112834|NCT00128492|21083578|P1|Overall Study|AE related to study|1
6112835|NCT00128492|21083577|P2|Overall Study|Study drug intolerance (AE)|8
6112836|NCT00128492|21083578|P1|Overall Study|Study drug intolerance (AE)|2
6112837|NCT00128492|21083577|P2|Overall Study|AE unrelated to study|9
6112838|NCT00128492|21083578|P1|Overall Study|AE unrelated to study|2
6112839|NCT00128206|21083735|P2|Overall Study|Adverse Event|2
6112840|NCT00128206|21083736|P1|Overall Study|Adverse Event|0
6112841|NCT00128206|21083735|P2|Overall Study|Lost to Follow-up|118
6112842|NCT00128206|21083736|P1|Overall Study|Lost to Follow-up|137
6112843|NCT00128102|21084032|P2|Overall Study|Protocol Violation|2
6112844|NCT00128102|21084033|P1|Overall Study|Protocol Violation|2
6112845|NCT00128102|21084032|P2|Overall Study|Withdrawal by Subject|11
6112846|NCT00128102|21084033|P1|Overall Study|Withdrawal by Subject|19
6112847|NCT00128102|21084032|P2|Overall Study|Physician Decision|3
6112848|NCT00128102|21084033|P1|Overall Study|Physician Decision|3
6112849|NCT00128102|21084032|P2|Overall Study|Death|13
6112850|NCT00128102|21084033|P1|Overall Study|Death|12
6112851|NCT00128102|21084032|P2|Overall Study|Adverse Event|11
6112852|NCT00128102|21084033|P1|Overall Study|Adverse Event|34
6112853|NCT00128102|21084032|P2|Overall Study|Progressive Disease|285
6112854|NCT00128102|21084033|P1|Overall Study|Progressive Disease|255
6112855|NCT00128102|21084032|P2|Overall Study|Other|1
6112856|NCT00128102|21084033|P1|Overall Study|Other|0
6112857|NCT00128102|21084032|P2|Overall Study|Site Discontinued|6
6112858|NCT00128102|21084033|P1|Overall Study|Site Discontinued|3
6112859|NCT00127933|21084059|P2|Overall Study|Randomized but not dosed|0
6112860|NCT00127933|21084060|P1|Overall Study|Randomized but not dosed|1
6112861|NCT00127855|21084081|P5|Primary Vaccination Course|Other|1
6112862|NCT00127855|21084082|P4|Primary Vaccination Course|Other|0
6112863|NCT00127855|21084083|P3|Primary Vaccination Course|Other|0
6112864|NCT00127855|21084084|P2|Primary Vaccination Course|Other|0
6112865|NCT00127855|21084085|P1|Primary Vaccination Course|Other|0
6112866|NCT00127855|21084081|P5|Primary Vaccination Course|Lost to Follow-up|2
6112867|NCT00127855|21084082|P4|Primary Vaccination Course|Lost to Follow-up|0
6112868|NCT00127855|21084083|P3|Primary Vaccination Course|Lost to Follow-up|1
6112869|NCT00127855|21084084|P2|Primary Vaccination Course|Lost to Follow-up|1
6112870|NCT00127855|21084085|P1|Primary Vaccination Course|Lost to Follow-up|1
6112871|NCT00127855|21084081|P5|Primary Vaccination Course|Withdrawal by Subject|1
6112872|NCT00127855|21084082|P4|Primary Vaccination Course|Withdrawal by Subject|0
6112873|NCT00127855|21084083|P3|Primary Vaccination Course|Withdrawal by Subject|0
6112874|NCT00127855|21084084|P2|Primary Vaccination Course|Withdrawal by Subject|0
6112875|NCT00127855|21084085|P1|Primary Vaccination Course|Withdrawal by Subject|1
6112876|NCT00127855|21084081|P5|Primary Vaccination Course|Adverse Event|0
6112877|NCT00127855|21084082|P4|Primary Vaccination Course|Adverse Event|0
6112878|NCT00127855|21084083|P3|Primary Vaccination Course|Adverse Event|1
6112879|NCT00127855|21084084|P2|Primary Vaccination Course|Adverse Event|0
6112880|NCT00127855|21084085|P1|Primary Vaccination Course|Adverse Event|0
6112881|NCT00127842|21084267|P1|Overall Study|Other|5
6112882|NCT00127842|21084267|P1|Overall Study|Protocol Violation|1
6112883|NCT00127842|21084267|P1|Overall Study|Noncompliance|2
6112884|NCT00127842|21084267|P1|Overall Study|Lack of Efficacy|12
6112885|NCT00127842|21084267|P1|Overall Study|Lost to Follow-up|1
6112886|NCT00127842|21084267|P1|Overall Study|Withdrawal by Subject|3
6112887|NCT00127842|21084267|P1|Overall Study|Adverse Event|15
6112888|NCT00127803|21084285|P4|Overall Study|Lost to Follow-up|1
6112889|NCT00127803|21084286|P3|Overall Study|Lost to Follow-up|0
6112890|NCT00127803|21084287|P2|Overall Study|Lost to Follow-up|0
6112891|NCT00127803|21084288|P1|Overall Study|Lost to Follow-up|0
6112892|NCT00127803|21084285|P4|Overall Study|Withdrawal by Subject|0
6112893|NCT00127803|21084286|P3|Overall Study|Withdrawal by Subject|0
6112894|NCT00127803|21084287|P2|Overall Study|Withdrawal by Subject|0
6112895|NCT00127803|21084288|P1|Overall Study|Withdrawal by Subject|1
6112896|NCT00127803|21084285|P4|Overall Study|Adverse Event|0
6112897|NCT00127803|21084286|P3|Overall Study|Adverse Event|0
6112898|NCT00127803|21084287|P2|Overall Study|Adverse Event|0
6112899|NCT00127803|21084288|P1|Overall Study|Adverse Event|2
6112900|NCT00127712|21084337|P2|Overall Study|Lack of GI access to continue|0
6112901|NCT00127712|21084338|P1|Overall Study|Lack of GI access to continue|2
6112902|NCT00127712|21084337|P2|Overall Study|Adverse Event|0
6112903|NCT00127712|21084338|P1|Overall Study|Adverse Event|3
6112904|NCT00127660|21084354|P4|Overall Study|Protocol Violation|0
6112905|NCT00127660|21084355|P3|Overall Study|Protocol Violation|5
6112906|NCT00127660|21084356|P2|Overall Study|Protocol Violation|3
6112907|NCT00127660|21084357|P1|Overall Study|Protocol Violation|3
6112908|NCT00127608|21084367|P1|Overall Study|VZV DNA negative|1
6112909|NCT00127413|21084411|P4|Overall Study|Lost to Follow-up|2
6112910|NCT00127413|21084412|P3|Overall Study|Lost to Follow-up|8
6112911|NCT00127413|21084413|P2|Overall Study|Lost to Follow-up|4
6112912|NCT00127413|21084414|P1|Overall Study|Lost to Follow-up|6
6112913|NCT00127205|21084455|P3|Overall Study|Progression|84
6112914|NCT00127205|21084456|P2|Overall Study|Progression|130
6112915|NCT00127205|21084457|P1|Overall Study|Progression|127
6112916|NCT00127205|21084455|P3|Overall Study|Under Review|6
6112917|NCT00127205|21084456|P2|Overall Study|Under Review|21
6112918|NCT00127205|21084457|P1|Overall Study|Under Review|13
6112919|NCT00127205|21084455|P3|Overall Study|Other-non protocol specified|77
6112920|NCT00127205|21084456|P2|Overall Study|Other-non protocol specified|129
6112921|NCT00127205|21084457|P1|Overall Study|Other-non protocol specified|141
6112922|NCT00127205|21084455|P3|Overall Study|Withdrawal by Subject|172
6112923|NCT00127205|21084456|P2|Overall Study|Withdrawal by Subject|308
6112924|NCT00127205|21084457|P1|Overall Study|Withdrawal by Subject|318
6112925|NCT00127205|21084455|P3|Overall Study|Death|6
6112926|NCT00127205|21084456|P2|Overall Study|Death|6
6112927|NCT00127205|21084457|P1|Overall Study|Death|8
6112928|NCT00127205|21084455|P3|Overall Study|Adverse Event|272
6112929|NCT00127205|21084456|P2|Overall Study|Adverse Event|386
6112930|NCT00127205|21084457|P1|Overall Study|Adverse Event|228
6112931|NCT00127192|21084479|P5|Overall Study|Adverse event in pre-treatment period|0
6112932|NCT00127192|21084480|P4|Overall Study|Adverse event in pre-treatment period|0
6112933|NCT00127192|21084481|P3|Overall Study|Adverse event in pre-treatment period|0
6112934|NCT00127192|21084482|P2|Overall Study|Adverse event in pre-treatment period|0
6112935|NCT00127192|21084483|P1|Overall Study|Adverse event in pre-treatment period|1
6112936|NCT00127192|21084479|P5|Overall Study|Withdrawal by Subject|3
6112937|NCT00127192|21084480|P4|Overall Study|Withdrawal by Subject|0
6112938|NCT00127192|21084481|P3|Overall Study|Withdrawal by Subject|1
6112939|NCT00127192|21084482|P2|Overall Study|Withdrawal by Subject|0
6112940|NCT00127192|21084483|P1|Overall Study|Withdrawal by Subject|0
6112941|NCT00127192|21084479|P5|Overall Study|Lack of Efficacy|2
6112942|NCT00127192|21084480|P4|Overall Study|Lack of Efficacy|0
6112943|NCT00127192|21084481|P3|Overall Study|Lack of Efficacy|0
6112944|NCT00127192|21084482|P2|Overall Study|Lack of Efficacy|0
6112945|NCT00127192|21084483|P1|Overall Study|Lack of Efficacy|2
6112946|NCT00127192|21084479|P5|Overall Study|Adverse Event|0
6112947|NCT00127192|21084480|P4|Overall Study|Adverse Event|1
6112948|NCT00127192|21084481|P3|Overall Study|Adverse Event|1
6112949|NCT00127192|21084482|P2|Overall Study|Adverse Event|1
6112950|NCT00127192|21084483|P1|Overall Study|Adverse Event|0
6112951|NCT00127166|21084507|P2|Period II|Patient did not perform Visit 6 exercise|0
6112952|NCT00127166|21084508|P1|Period II|Patient did not perform Visit 6 exercise|1
6112953|NCT00127166|21084507|P2|Period II|Withdrawal by Subject|0
6112954|NCT00127166|21084508|P1|Period II|Withdrawal by Subject|2
6113044|NCT00126503|21084709|P2|Overall Study|alternative therapy|1
6112955|NCT00127166|21084507|P2|Washout Period|Patient did not meet inclusion criteria|1
6112956|NCT00127166|21084508|P1|Washout Period|Patient did not meet inclusion criteria|0
6112957|NCT00127166|21084507|P2|Period I|Patient did not meet inclusion criteria|0
6112958|NCT00127166|21084508|P1|Period I|Patient did not meet inclusion criteria|1
6112959|NCT00127166|21084507|P2|Period I|Withdrawal by Subject|0
6112960|NCT00127166|21084508|P1|Period I|Withdrawal by Subject|2
6112961|NCT00127166|21084507|P2|Period I|Protocol Violation|2
6112962|NCT00127166|21084508|P1|Period I|Protocol Violation|0
6112963|NCT00127101|21084528|P6|Continuation Phase|Withdrawal by Subject|1
6112964|NCT00127101|21084529|P5|Continuation Phase|Withdrawal by Subject|2
6112965|NCT00127101|21084530|P4|Continuation Phase|Withdrawal by Subject|0
6112966|NCT00127101|21084531|P3|Continuation Phase|Withdrawal by Subject|1
6112967|NCT00127101|21084532|P2|Continuation Phase|Withdrawal by Subject|0
6112968|NCT00127101|21084533|P1|Continuation Phase|Withdrawal by Subject|0
6112969|NCT00127101|21084528|P6|Continuation Phase|Lack of Efficacy|1
6112970|NCT00127101|21084529|P5|Continuation Phase|Lack of Efficacy|0
6112971|NCT00127101|21084530|P4|Continuation Phase|Lack of Efficacy|0
6112972|NCT00127101|21084531|P3|Continuation Phase|Lack of Efficacy|0
6112973|NCT00127101|21084532|P2|Continuation Phase|Lack of Efficacy|0
6112974|NCT00127101|21084533|P1|Continuation Phase|Lack of Efficacy|0
6112975|NCT00127101|21084528|P6|Continuation Phase|Adverse Event|1
6112976|NCT00127101|21084529|P5|Continuation Phase|Adverse Event|1
6112977|NCT00127101|21084530|P4|Continuation Phase|Adverse Event|0
6112978|NCT00127101|21084531|P3|Continuation Phase|Adverse Event|0
6112979|NCT00127101|21084532|P2|Continuation Phase|Adverse Event|0
6112980|NCT00127101|21084533|P1|Continuation Phase|Adverse Event|0
6112981|NCT00127101|21084528|P6|Base Protocol|Withdrawal by Subject|1
6112982|NCT00127101|21084529|P5|Base Protocol|Withdrawal by Subject|0
6112983|NCT00127101|21084530|P4|Base Protocol|Withdrawal by Subject|0
6112984|NCT00127101|21084531|P3|Base Protocol|Withdrawal by Subject|1
6112985|NCT00127101|21084532|P2|Base Protocol|Withdrawal by Subject|2
6112986|NCT00127101|21084533|P1|Base Protocol|Withdrawal by Subject|1
6112987|NCT00127101|21084528|P6|Base Protocol|Lack of Efficacy|0
6112988|NCT00127101|21084529|P5|Base Protocol|Lack of Efficacy|2
6112989|NCT00127101|21084530|P4|Base Protocol|Lack of Efficacy|0
6112990|NCT00127101|21084531|P3|Base Protocol|Lack of Efficacy|0
6112991|NCT00127101|21084532|P2|Base Protocol|Lack of Efficacy|0
6112992|NCT00127101|21084533|P1|Base Protocol|Lack of Efficacy|1
6112993|NCT00127101|21084528|P6|Base Protocol|Adverse Event|0
6112994|NCT00127101|21084529|P5|Base Protocol|Adverse Event|0
6112995|NCT00127101|21084530|P4|Base Protocol|Adverse Event|0
6112996|NCT00127101|21084531|P3|Base Protocol|Adverse Event|1
6112997|NCT00127101|21084532|P2|Base Protocol|Adverse Event|2
6112998|NCT00127101|21084533|P1|Base Protocol|Adverse Event|0
6112999|NCT00127036|21084568|P2|Overall Study|Screen Failure|0
6113000|NCT00127036|21084569|P1|Overall Study|Screen Failure|2
6113001|NCT00127036|21084568|P2|Overall Study|Insufficient Data for Analysis|11
6113002|NCT00127036|21084569|P1|Overall Study|Insufficient Data for Analysis|6
6113003|NCT00126776|21084581|P2|Overall Study|follow up complete on all patients|0
6113004|NCT00126776|21084582|P1|Overall Study|follow up complete on all patients|0
6113005|NCT00126659|21084631|P3|Overall Study|Adverse Event|2
6113006|NCT00126659|21084632|P2|Overall Study|Adverse Event|0
6113007|NCT00126659|21084633|P1|Overall Study|Adverse Event|0
6113008|NCT00126594|21084641|P2|Overall Study|Disease Progression|24
6113009|NCT00126594|21084642|P1|Overall Study|Disease Progression|29
6113010|NCT00126594|21084641|P2|Overall Study|Non-compliance|1
6113011|NCT00126594|21084642|P1|Overall Study|Non-compliance|0
6113012|NCT00126594|21084641|P2|Overall Study|Adverse Event|5
6113013|NCT00126594|21084642|P1|Overall Study|Adverse Event|7
6113014|NCT00126594|21084641|P2|Overall Study|Physician Decision|3
6113015|NCT00126594|21084642|P1|Overall Study|Physician Decision|1
6113016|NCT00126594|21084641|P2|Overall Study|Withdrawal by Subject|4
6113017|NCT00126594|21084642|P1|Overall Study|Withdrawal by Subject|0
6113018|NCT00126594|21084641|P2|Overall Study|Ineligible|0
6113019|NCT00126594|21084642|P1|Overall Study|Ineligible|2
6113020|NCT00126581|21084659|P2|Overall Study|Other illness/MD discretion|4
6113021|NCT00126581|21084660|P1|Overall Study|Other illness/MD discretion|3
6113022|NCT00126581|21084659|P2|Overall Study|Alternative therapy|3
6113023|NCT00126581|21084660|P1|Overall Study|Alternative therapy|3
6113024|NCT00126581|21084659|P2|Overall Study|Withdrawal by Subject|4
6113025|NCT00126581|21084660|P1|Overall Study|Withdrawal by Subject|1
6113026|NCT00126581|21084659|P2|Overall Study|Death|2
6113027|NCT00126581|21084660|P1|Overall Study|Death|3
6113028|NCT00126581|21084659|P2|Overall Study|Adverse Event|7
6113029|NCT00126581|21084660|P1|Overall Study|Adverse Event|3
6113030|NCT00126568|21084680|P1|Overall Study|Death|2
6113031|NCT00126555|21084687|P1|Overall Study|Progressive Disease|3
6113032|NCT00126555|21084687|P1|Overall Study|Adverse Event|2
6113033|NCT00126555|21084687|P1|Overall Study|Withdrawal by Subject|1
6113034|NCT00126503|21084709|P2|Overall Study|Physician Decision|1
6113035|NCT00126503|21084710|P1|Overall Study|Physician Decision|2
6113036|NCT00126503|21084709|P2|Overall Study|non-compliant|0
6113037|NCT00126503|21084710|P1|Overall Study|non-compliant|1
6113038|NCT00126503|21084709|P2|Overall Study|Adverse Event|3
6113039|NCT00126503|21084710|P1|Overall Study|Adverse Event|13
6113040|NCT00126503|21084709|P2|Overall Study|Death|0
6113041|NCT00126503|21084710|P1|Overall Study|Death|3
6113042|NCT00126503|21084709|P2|Overall Study|other complicating disease|1
6113043|NCT00126503|21084710|P1|Overall Study|other complicating disease|4
6113045|NCT00126503|21084710|P1|Overall Study|alternative therapy|1
6113046|NCT00126503|21084709|P2|Overall Study|Withdrawal by Subject|1
6113047|NCT00126503|21084710|P1|Overall Study|Withdrawal by Subject|0
6113048|NCT00126503|21084709|P2|Overall Study|disease progression|14
6113049|NCT00126503|21084710|P1|Overall Study|disease progression|23
6113050|NCT00126490|21084722|P1|Overall Study|Stopped after 1 infusion (fall/injury)|1
6113051|NCT00126438|21084732|P2|Overall Study|Withdrawal by Subject|2
6113052|NCT00126438|21084733|P1|Overall Study|Withdrawal by Subject|3
6113053|NCT00126438|21084732|P2|Overall Study|Protocol Violation|8
6113054|NCT00126438|21084733|P1|Overall Study|Protocol Violation|8
6113055|NCT00126438|21084732|P2|Overall Study|Lost to Follow-up|0
6113056|NCT00126438|21084733|P1|Overall Study|Lost to Follow-up|22
6113057|NCT00126438|21084732|P2|Overall Study|Withdrawal due to adverse event|0
6113058|NCT00126438|21084733|P1|Overall Study|Withdrawal due to adverse event|1
6113059|NCT00126425|21084741|P2|Overall Study|Other|0
6113060|NCT00126425|21084742|P1|Overall Study|Other|5
6113061|NCT00126425|21084741|P2|Overall Study|Failed Inclusion Exclusion Criteria|0
6113062|NCT00126425|21084742|P1|Overall Study|Failed Inclusion Exclusion Criteria|1
6113063|NCT00126425|21084741|P2|Overall Study|Adverse Event|0
6113064|NCT00126425|21084742|P1|Overall Study|Adverse Event|1
6113065|NCT00126425|21084741|P2|Overall Study|Protocol Violation|6
6113066|NCT00126425|21084742|P1|Overall Study|Protocol Violation|9
6113067|NCT00126425|21084741|P2|Overall Study|Lost to Follow-up|4
6113068|NCT00126425|21084742|P1|Overall Study|Lost to Follow-up|8
6113069|NCT00126425|21084741|P2|Overall Study|Withdrawal by Subject|1
6113070|NCT00126425|21084742|P1|Overall Study|Withdrawal by Subject|17
6113071|NCT00126191|21084750|P2|Overall Study|Death|1
6113072|NCT00126191|21084751|P1|Overall Study|Death|0
6113073|NCT00126191|21084750|P2|Overall Study|Physician Decision|1
6113074|NCT00126191|21084751|P1|Overall Study|Physician Decision|0
6113075|NCT00126126|21084761|P2|Overall Study|Lost to Follow-up|2
6113076|NCT00126126|21084762|P1|Overall Study|Lost to Follow-up|0
6113077|NCT00125853|21084801|P2|Wash-out (4 Weeks)|Lost to Follow-up|7
6113078|NCT00125853|21084802|P1|Wash-out (4 Weeks)|Lost to Follow-up|3
6113079|NCT00125359|21084916|P1|Overall Study|Physician Decision|14
6113080|NCT00125359|21084916|P1|Overall Study|Adverse Event|5
6113081|NCT00125359|21084916|P1|Overall Study|Death|4
6113082|NCT00125268|21084925|P2|Overall Study|Withdrawal by Subject|1
6113083|NCT00125268|21084926|P1|Overall Study|Withdrawal by Subject|1
6113084|NCT00125242|21084938|P2|Overall Study|did not qualify|2
6113085|NCT00125242|21084939|P1|Overall Study|did not qualify|7
6113086|NCT00125190|21084944|P1|Overall Study|Lost to Follow-up|4
6113087|NCT00125190|21084944|P1|Overall Study|Other|1
6113088|NCT00125190|21084944|P1|Overall Study|Adverse Event|1
6113089|NCT00125190|21084944|P1|Overall Study|Non-compliance|2
6113090|NCT00125190|21084944|P1|Overall Study|Subject/Parent Decision|7
6113091|NCT00125164|21084960|P4|Overall Study|Withdrawal by Subject|1
6113092|NCT00125164|21084961|P3|Overall Study|Withdrawal by Subject|1
6113093|NCT00125164|21084962|P2|Overall Study|Withdrawal by Subject|0
6113094|NCT00125164|21084963|P1|Overall Study|Withdrawal by Subject|2
6113095|NCT00125164|21084960|P4|Overall Study|Lost to Follow-up|1
6113096|NCT00125164|21084961|P3|Overall Study|Lost to Follow-up|1
6113097|NCT00125164|21084962|P2|Overall Study|Lost to Follow-up|0
6113098|NCT00125164|21084963|P1|Overall Study|Lost to Follow-up|0
6113099|NCT00125164|21084960|P4|Overall Study|Adverse Event|4
6113100|NCT00125164|21084961|P3|Overall Study|Adverse Event|2
6113101|NCT00125164|21084962|P2|Overall Study|Adverse Event|0
6113102|NCT00125164|21084963|P1|Overall Study|Adverse Event|0
6113103|NCT00125138|21085017|P4|Overall Study|Sponsor decision-pt moved to assist care|1
6113104|NCT00125138|21085018|P3|Overall Study|Sponsor decision-pt moved to assist care|0
6113105|NCT00125138|21085019|P2|Overall Study|Sponsor decision-pt moved to assist care|0
6113106|NCT00125138|21085020|P1|Overall Study|Sponsor decision-pt moved to assist care|0
6113107|NCT00125138|21085017|P4|Overall Study|Lack of Efficacy|1
6113108|NCT00125138|21085018|P3|Overall Study|Lack of Efficacy|0
6113109|NCT00125138|21085019|P2|Overall Study|Lack of Efficacy|0
6113110|NCT00125138|21085020|P1|Overall Study|Lack of Efficacy|0
6113111|NCT00125138|21085017|P4|Overall Study|Withdrawal by Subject|1
6113112|NCT00125138|21085018|P3|Overall Study|Withdrawal by Subject|1
6113113|NCT00125138|21085019|P2|Overall Study|Withdrawal by Subject|3
6113114|NCT00125138|21085020|P1|Overall Study|Withdrawal by Subject|2
6113115|NCT00125138|21085017|P4|Overall Study|Adverse Event|2
6113116|NCT00125138|21085018|P3|Overall Study|Adverse Event|3
6113117|NCT00125138|21085019|P2|Overall Study|Adverse Event|0
6113118|NCT00125138|21085020|P1|Overall Study|Adverse Event|1
6113119|NCT00124982|21085069|P3|Long-term Period|Neurologist Recommendation|1
6113120|NCT00124982|21085070|P2|Long-term Period|Neurologist Recommendation|0
6113121|NCT00124982|21085071|P1|Long-term Period|Neurologist Recommendation|0
6113122|NCT00124982|21085069|P3|Long-term Period|Administrative Reason by Sponsor|1
6113123|NCT00124982|21085070|P2|Long-term Period|Administrative Reason by Sponsor|0
6113124|NCT00124982|21085071|P1|Long-term Period|Administrative Reason by Sponsor|0
6113125|NCT00124982|21085069|P3|Long-term Period|Poor/Non-compliance|2
6113126|NCT00124982|21085070|P2|Long-term Period|Poor/Non-compliance|0
6113127|NCT00124982|21085071|P1|Long-term Period|Poor/Non-compliance|0
6113128|NCT00124982|21085069|P3|Long-term Period|Pregnancy|1
6113129|NCT00124982|21085070|P2|Long-term Period|Pregnancy|0
6113130|NCT00124982|21085071|P1|Long-term Period|Pregnancy|0
6113131|NCT00124982|21085069|P3|Long-term Period|Withdrawal by Subject|16
6113132|NCT00124982|21085070|P2|Long-term Period|Withdrawal by Subject|0
6113133|NCT00124982|21085071|P1|Long-term Period|Withdrawal by Subject|0
6113134|NCT00124982|21085069|P3|Long-term Period|Lost to Follow-up|4
6113135|NCT00124982|21085070|P2|Long-term Period|Lost to Follow-up|0
6113136|NCT00124982|21085071|P1|Long-term Period|Lost to Follow-up|0
6113137|NCT00124982|21085069|P3|Long-term Period|Lack of Efficacy|46
6113138|NCT00124982|21085070|P2|Long-term Period|Lack of Efficacy|0
6113139|NCT00124982|21085071|P1|Long-term Period|Lack of Efficacy|0
6113140|NCT00124982|21085069|P3|Long-term Period|Adverse Event|17
6113141|NCT00124982|21085070|P2|Long-term Period|Adverse Event|0
6113142|NCT00124982|21085071|P1|Long-term Period|Adverse Event|0
6113143|NCT00124982|21085069|P3|Long-term Period|Death|1
6113144|NCT00124982|21085070|P2|Long-term Period|Death|0
6113145|NCT00124982|21085071|P1|Long-term Period|Death|0
6113146|NCT00124982|21085069|P3|Short-term Period|Participant Had Lymphopenia|0
6113147|NCT00124982|21085070|P2|Short-term Period|Participant Had Lymphopenia|0
6113148|NCT00124982|21085071|P1|Short-term Period|Participant Had Lymphopenia|1
6113149|NCT00124982|21085069|P3|Short-term Period|Investigator Decision-No Specific AE|0
6113150|NCT00124982|21085070|P2|Short-term Period|Investigator Decision-No Specific AE|0
6113151|NCT00124982|21085071|P1|Short-term Period|Investigator Decision-No Specific AE|1
6113152|NCT00124982|21085069|P3|Short-term Period|Participant Chose Own Doctor|0
6113153|NCT00124982|21085070|P2|Short-term Period|Participant Chose Own Doctor|1
6113154|NCT00124982|21085071|P1|Short-term Period|Participant Chose Own Doctor|0
6113155|NCT00124982|21085069|P3|Short-term Period|Participant Decision|0
6113156|NCT00124982|21085070|P2|Short-term Period|Participant Decision|0
6113157|NCT00124982|21085071|P1|Short-term Period|Participant Decision|1
6113158|NCT00124982|21085069|P3|Short-term Period|No Longer Meets Study Criteria|0
6113159|NCT00124982|21085070|P2|Short-term Period|No Longer Meets Study Criteria|2
6113160|NCT00124982|21085071|P1|Short-term Period|No Longer Meets Study Criteria|1
6113161|NCT00124982|21085069|P3|Short-term Period|Poor/Non-compliance|0
6113162|NCT00124982|21085070|P2|Short-term Period|Poor/Non-compliance|1
6113163|NCT00124982|21085071|P1|Short-term Period|Poor/Non-compliance|3
6113164|NCT00124982|21085069|P3|Short-term Period|Withdrawal of Consent|0
6113165|NCT00124982|21085070|P2|Short-term Period|Withdrawal of Consent|9
6113166|NCT00124982|21085071|P1|Short-term Period|Withdrawal of Consent|7
6113167|NCT00124982|21085069|P3|Short-term Period|Lost to Follow-up|0
6113168|NCT00124982|21085070|P2|Short-term Period|Lost to Follow-up|5
6113169|NCT00124982|21085071|P1|Short-term Period|Lost to Follow-up|8
6113170|NCT00124982|21085069|P3|Short-term Period|Lack of Efficacy|0
6113171|NCT00124982|21085070|P2|Short-term Period|Lack of Efficacy|73
6113172|NCT00124982|21085071|P1|Short-term Period|Lack of Efficacy|32
6113173|NCT00124982|21085069|P3|Short-term Period|Adverse Event|0
6113174|NCT00124982|21085070|P2|Short-term Period|Adverse Event|22
6113175|NCT00124982|21085071|P1|Short-term Period|Adverse Event|17
6113176|NCT00124982|21085069|P3|Short-term Period|Death|0
6113177|NCT00124982|21085070|P2|Short-term Period|Death|1
6113178|NCT00124982|21085071|P1|Short-term Period|Death|1
6113179|NCT00124943|21085153|P4|Phase II|Withdrawal by Subject|2
6113180|NCT00124943|21085154|P3|Phase II|Withdrawal by Subject|0
6113181|NCT00124943|21085155|P2|Phase II|Withdrawal by Subject|0
6113182|NCT00124943|21085156|P1|Phase II|Withdrawal by Subject|0
6113183|NCT00124943|21085153|P4|Phase II|Lost to Follow-up|1
6113184|NCT00124943|21085154|P3|Phase II|Lost to Follow-up|0
6113185|NCT00124943|21085155|P2|Phase II|Lost to Follow-up|0
6113186|NCT00124943|21085156|P1|Phase II|Lost to Follow-up|0
6113187|NCT00124943|21085153|P4|Phase II|Protocol Violation|1
6113188|NCT00124943|21085154|P3|Phase II|Protocol Violation|0
6113189|NCT00124943|21085155|P2|Phase II|Protocol Violation|0
6113190|NCT00124943|21085156|P1|Phase II|Protocol Violation|0
6113191|NCT00124943|21085153|P4|Phase II|Adverse Event|1
6113192|NCT00124943|21085154|P3|Phase II|Adverse Event|0
6113193|NCT00124943|21085155|P2|Phase II|Adverse Event|2
6113194|NCT00124943|21085156|P1|Phase II|Adverse Event|0
6113195|NCT00124917|21085194|P1|Overall Study|Physician Decision|3
6113196|NCT00124748|21085204|P2|Overall Study|Death|3
6113197|NCT00124748|21085205|P1|Overall Study|Death|1
6113198|NCT00124748|21085204|P2|Overall Study|Administrative Problem(Study Terminated)|174
6113199|NCT00124748|21085205|P1|Overall Study|Administrative Problem(Study Terminated)|101
6113200|NCT00124748|21085204|P2|Overall Study|Lost to Follow-up|7
6113201|NCT00124748|21085205|P1|Overall Study|Lost to Follow-up|2
6113202|NCT00124748|21085204|P2|Overall Study|Withdrawal by Subject|15
6113203|NCT00124748|21085205|P1|Overall Study|Withdrawal by Subject|5
6113204|NCT00124748|21085204|P2|Overall Study|Protocol Violation|1
6113205|NCT00124748|21085205|P1|Overall Study|Protocol Violation|3
6113206|NCT00124748|21085204|P2|Overall Study|No longer requires study drug|1
6113207|NCT00124748|21085205|P1|Overall Study|No longer requires study drug|1
6113208|NCT00124748|21085204|P2|Overall Study|Lack of Efficacy|41
6113209|NCT00124748|21085205|P1|Overall Study|Lack of Efficacy|20
6113210|NCT00124748|21085204|P2|Overall Study|Abnormal Procedure|1
6113211|NCT00124748|21085205|P1|Overall Study|Abnormal Procedure|0
6113212|NCT00124748|21085204|P2|Overall Study|Abnormal laboratory Value|2
6113213|NCT00124748|21085205|P1|Overall Study|Abnormal laboratory Value|2
6113214|NCT00124748|21085204|P2|Overall Study|Adverse Event|39
6113215|NCT00124748|21085205|P1|Overall Study|Adverse Event|8
6113216|NCT00124709|21085312|P2|Overall Study|Lost to Follow-up|120
6113217|NCT00124709|21085313|P1|Overall Study|Lost to Follow-up|114
6113218|NCT00124709|21085312|P2|Overall Study|Withdrawal by Subject|136
6113219|NCT00124709|21085313|P1|Overall Study|Withdrawal by Subject|127
6113220|NCT00124709|21085312|P2|Overall Study|Protocol Violation|5
6113221|NCT00124709|21085313|P1|Overall Study|Protocol Violation|3
6113222|NCT00124709|21085312|P2|Overall Study|Lack of Efficacy|10
6113223|NCT00124709|21085313|P1|Overall Study|Lack of Efficacy|5
6113224|NCT00124709|21085312|P2|Overall Study|Adverse Event|0
6113225|NCT00124709|21085313|P1|Overall Study|Adverse Event|3
6113226|NCT00124709|21085312|P2|Overall Study|Randomized but did not take medication|1
6113227|NCT00124709|21085313|P1|Overall Study|Randomized but did not take medication|3
6113228|NCT00124657|21085330|P3|Overall Study|Intercurrent illness|0
6113229|NCT00124657|21085331|P2|Overall Study|Intercurrent illness|0
6113230|NCT00124657|21085332|P1|Overall Study|Intercurrent illness|1
6113231|NCT00124657|21085330|P3|Overall Study|Progressive disease|27
6113232|NCT00124657|21085331|P2|Overall Study|Progressive disease|5
6113233|NCT00124657|21085332|P1|Overall Study|Progressive disease|14
6113234|NCT00124657|21085330|P3|Overall Study|Non-compliance|4
6113235|NCT00124657|21085331|P2|Overall Study|Non-compliance|0
6113236|NCT00124657|21085332|P1|Overall Study|Non-compliance|1
6113237|NCT00124657|21085330|P3|Overall Study|Toxicity|1
6113238|NCT00124657|21085331|P2|Overall Study|Toxicity|0
6113239|NCT00124657|21085332|P1|Overall Study|Toxicity|0
6113240|NCT00124618|21085367|P1|Overall Study|Ineligible|1
6113241|NCT00124462|21085399|P2|Overall Study|Device fitting, n=2, other hlth issues|1
6113242|NCT00124462|21085400|P1|Overall Study|Device fitting, n=2, other hlth issues|1
6113243|NCT00124462|21085399|P2|Overall Study|Withdrawal by Subject|5
6113244|NCT00124462|21085400|P1|Overall Study|Withdrawal by Subject|4
6113245|NCT00124462|21085399|P2|Overall Study|Physician Decision|4
6113246|NCT00124462|21085400|P1|Overall Study|Physician Decision|3
6113247|NCT00124462|21085399|P2|Overall Study|Lost to Follow-up|3
6113248|NCT00124462|21085400|P1|Overall Study|Lost to Follow-up|3
6113249|NCT00124449|21085410|P2|18-Month Untreated Observation Period|Relocated|0
6113250|NCT00124449|21085411|P1|18-Month Untreated Observation Period|Relocated|1
6113251|NCT00124449|21085410|P2|18-Month Untreated Observation Period|Poor/Noncompliance|0
6113252|NCT00124449|21085411|P1|18-Month Untreated Observation Period|Poor/Noncompliance|1
6113253|NCT00124449|21085410|P2|18-Month Untreated Observation Period|Pregnancy|0
6113254|NCT00124449|21085411|P1|18-Month Untreated Observation Period|Pregnancy|1
6113255|NCT00124449|21085410|P2|18-Month Untreated Observation Period|Lost to Follow-up|0
6113256|NCT00124449|21085411|P1|18-Month Untreated Observation Period|Lost to Follow-up|1
6113257|NCT00124449|21085410|P2|18-Month Untreated Observation Period|Lack of Efficacy|12
6113258|NCT00124449|21085411|P1|18-Month Untreated Observation Period|Lack of Efficacy|11
6113259|NCT00124449|21085410|P2|18-Month Untreated Observation Period|Adverse Event|1
6113260|NCT00124449|21085411|P1|18-Month Untreated Observation Period|Adverse Event|0
6113261|NCT00124449|21085410|P2|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|1
6113262|NCT00124449|21085411|P1|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|0
6113263|NCT00124449|21085410|P2|6-month Double-Blind Treatment Period|Sponsor request|1
6113264|NCT00124449|21085411|P1|6-month Double-Blind Treatment Period|Sponsor request|0
6113265|NCT00124449|21085410|P2|6-month Double-Blind Treatment Period|Poor/Noncompliance|0
6113266|NCT00124449|21085411|P1|6-month Double-Blind Treatment Period|Poor/Noncompliance|1
6113267|NCT00124449|21085410|P2|6-month Double-Blind Treatment Period|Withdrawal by Subject|1
6113268|NCT00124449|21085411|P1|6-month Double-Blind Treatment Period|Withdrawal by Subject|1
6113269|NCT00124449|21085410|P2|6-month Double-Blind Treatment Period|Lack of Efficacy|8
6113270|NCT00124449|21085411|P1|6-month Double-Blind Treatment Period|Lack of Efficacy|3
6113271|NCT00124449|21085410|P2|6-month Double-Blind Treatment Period|Adverse Event|0
6113272|NCT00124449|21085411|P1|6-month Double-Blind Treatment Period|Adverse Event|1
6113273|NCT00124072|21085465|P4|Overall Study|Death|480
6113274|NCT00124072|21085466|P3|Overall Study|Death|471
6113275|NCT00124072|21085467|P2|Overall Study|Death|484
6113276|NCT00124072|21085468|P1|Overall Study|Death|499
6113277|NCT00124072|21085465|P4|Overall Study|Lost to Follow-up for Morbidity|18
6113278|NCT00124072|21085466|P3|Overall Study|Lost to Follow-up for Morbidity|19
6113279|NCT00124072|21085467|P2|Overall Study|Lost to Follow-up for Morbidity|25
6113280|NCT00124072|21085468|P1|Overall Study|Lost to Follow-up for Morbidity|15
6113281|NCT00124072|21085465|P4|Overall Study|Lost to Follow-up for Mortality|2
6113282|NCT00124072|21085466|P3|Overall Study|Lost to Follow-up for Mortality|2
6113283|NCT00124072|21085467|P2|Overall Study|Lost to Follow-up for Mortality|3
6113284|NCT00124072|21085468|P1|Overall Study|Lost to Follow-up for Mortality|0
6113285|NCT00124020|21085480|P2|Overall Study|Transfer to another hospital|0
6113286|NCT00124020|21085481|P1|Overall Study|Transfer to another hospital|2
6113287|NCT00124020|21085480|P2|Overall Study|Other|1
6113288|NCT00124020|21085481|P1|Overall Study|Other|1
6113289|NCT00124020|21085480|P2|Overall Study|Lost to Follow-up|8
6113290|NCT00124020|21085481|P1|Overall Study|Lost to Follow-up|5
6113291|NCT00124020|21085480|P2|Overall Study|Withdrawal by Subject|11
6113292|NCT00124020|21085481|P1|Overall Study|Withdrawal by Subject|13
6113293|NCT00124020|21085480|P2|Overall Study|Death|71
6113294|NCT00124020|21085481|P1|Overall Study|Death|67
6113295|NCT00123955|21085489|P2|Overall Study|Death|1
6113296|NCT00123955|21085490|P1|Overall Study|Death|0
6113297|NCT00123955|21085489|P2|Overall Study|Withdrawal by Subject|3
6113298|NCT00123955|21085490|P1|Overall Study|Withdrawal by Subject|4
6113299|NCT00123955|21085489|P2|Overall Study|Adverse Event|0
6113300|NCT00123955|21085490|P1|Overall Study|Adverse Event|1
6113301|NCT00123734|21085502|P1|Overall Study|Withdrawal by Subject|1
6113302|NCT00123734|21085502|P1|Overall Study|Dropout|1
6113303|NCT00123734|21085502|P1|Overall Study|Lost to Follow-up|3
6113304|NCT00123734|21085502|P1|Overall Study|Death|3
6113305|NCT00123487|21085587|P2|Treated With Study Drug|Unknown (case report form lost)|1
6113306|NCT00123487|21085588|P1|Treated With Study Drug|Unknown (case report form lost)|0
6113307|NCT00123487|21085587|P2|Treated With Study Drug|Withdrawal by Subject|13
6113308|NCT00123487|21085588|P1|Treated With Study Drug|Withdrawal by Subject|11
6113309|NCT00123487|21085587|P2|Treated With Study Drug|Study Drug Toxicity|80
6113310|NCT00123487|21085588|P1|Treated With Study Drug|Study Drug Toxicity|62
6113311|NCT00123487|21085587|P2|Treated With Study Drug|Other|58
6113312|NCT00123487|21085588|P1|Treated With Study Drug|Other|59
6113313|NCT00123487|21085587|P2|Treated With Study Drug|Physician Decision|9
6113314|NCT00123487|21085588|P1|Treated With Study Drug|Physician Decision|8
6113315|NCT00123487|21085587|P2|Treated With Study Drug|Disease Progression|122
6113316|NCT00123487|21085588|P1|Treated With Study Drug|Disease Progression|141
6113317|NCT00123487|21085587|P2|Treated With Study Drug|Adverse Event|22
6113318|NCT00123487|21085588|P1|Treated With Study Drug|Adverse Event|23
6113319|NCT00123487|21085587|P2|Randomized|SAE prior to starting treatment|0
6113320|NCT00123487|21085588|P1|Randomized|SAE prior to starting treatment|1
6113321|NCT00123487|21085587|P2|Randomized|Death prior to starting treatment|1
6113322|NCT00123487|21085588|P1|Randomized|Death prior to starting treatment|0
6113323|NCT00123474|21085632|P4|As Treated at Study Closure|Withdrawal by Subject|16
6113324|NCT00123474|21085633|P3|As Treated at Study Closure|Withdrawal by Subject|18
6113325|NCT00123474|21085634|P2|As Treated at Study Closure|Withdrawal by Subject|19
6113326|NCT00123474|21085635|P1|As Treated at Study Closure|Withdrawal by Subject|14
6113327|NCT00123474|21085632|P4|As Treated at Study Closure|Study Drug Toxicity|51
6113328|NCT00123474|21085633|P3|As Treated at Study Closure|Study Drug Toxicity|45
6113329|NCT00123474|21085634|P2|As Treated at Study Closure|Study Drug Toxicity|45
6113330|NCT00123474|21085635|P1|As Treated at Study Closure|Study Drug Toxicity|39
6113331|NCT00123474|21085632|P4|As Treated at Study Closure|non-specified|60
6113332|NCT00123474|21085633|P3|As Treated at Study Closure|non-specified|57
6113333|NCT00123474|21085634|P2|As Treated at Study Closure|non-specified|47
6113334|NCT00123474|21085635|P1|As Treated at Study Closure|non-specified|54
6113335|NCT00123474|21085632|P4|As Treated at Study Closure|Investigator Request|5
6113336|NCT00123474|21085633|P3|As Treated at Study Closure|Investigator Request|7
6113337|NCT00123474|21085634|P2|As Treated at Study Closure|Investigator Request|6
6113338|NCT00123474|21085635|P1|As Treated at Study Closure|Investigator Request|12
6113339|NCT00123474|21085632|P4|As Treated at Study Closure|Disease Progression|27
6113340|NCT00123474|21085633|P3|As Treated at Study Closure|Disease Progression|29
6113341|NCT00123474|21085634|P2|As Treated at Study Closure|Disease Progression|42
6113342|NCT00123474|21085635|P1|As Treated at Study Closure|Disease Progression|35
6113343|NCT00123474|21085632|P4|As Treated at Study Closure|Adverse Event|8
6113344|NCT00123474|21085633|P3|As Treated at Study Closure|Adverse Event|10
6113345|NCT00123474|21085634|P2|As Treated at Study Closure|Adverse Event|4
6113346|NCT00123474|21085635|P1|As Treated at Study Closure|Adverse Event|10
6113347|NCT00123474|21085632|P4|As Treated at Study Closure|not reported when site closed|0
6113348|NCT00123474|21085633|P3|As Treated at Study Closure|not reported when site closed|1
6113349|NCT00123474|21085634|P2|As Treated at Study Closure|not reported when site closed|0
6113350|NCT00123474|21085635|P1|As Treated at Study Closure|not reported when site closed|1
6113351|NCT00123474|21085632|P4|Randomized to Treatment|Randomized, never treated|1
6113352|NCT00123474|21085633|P3|Randomized to Treatment|Randomized, never treated|2
6113353|NCT00123474|21085634|P2|Randomized to Treatment|Randomized, never treated|4
6113354|NCT00123474|21085635|P1|Randomized to Treatment|Randomized, never treated|1
6113355|NCT00123422|21085729|P3|Overall Study|Lost to Follow-up|2
6113356|NCT00123422|21085730|P2|Overall Study|Lost to Follow-up|2
6113357|NCT00123422|21085731|P1|Overall Study|Lost to Follow-up|1
6113358|NCT00123422|21085729|P3|Overall Study|Withdrawal by Subject|2
6113359|NCT00123422|21085730|P2|Overall Study|Withdrawal by Subject|2
6113360|NCT00123422|21085731|P1|Overall Study|Withdrawal by Subject|1
6113361|NCT00123422|21085729|P3|Overall Study|Physician Decision|6
6113362|NCT00123422|21085730|P2|Overall Study|Physician Decision|2
6113363|NCT00123422|21085731|P1|Overall Study|Physician Decision|2
6113364|NCT00122980|21085819|P2|Overall Study|Study termination|35
6113365|NCT00122980|21085820|P1|Overall Study|Study termination|27
6113366|NCT00122980|21085819|P2|Overall Study|Adjudicated stroke (study endpoint)|0
6113367|NCT00122980|21085820|P1|Overall Study|Adjudicated stroke (study endpoint)|7
6113368|NCT00122980|21085819|P2|Overall Study|Withdrawal by Subject|3
6113369|NCT00122980|21085820|P1|Overall Study|Withdrawal by Subject|2
6113370|NCT00122980|21085819|P2|Overall Study|Protocol Violation|1
6113371|NCT00122980|21085820|P1|Overall Study|Protocol Violation|5
6113372|NCT00122980|21085819|P2|Overall Study|Physician Decision|0
6113373|NCT00122980|21085820|P1|Overall Study|Physician Decision|2
6113374|NCT00122980|21085819|P2|Overall Study|Death|1
6113375|NCT00122980|21085820|P1|Overall Study|Death|0
6113376|NCT00122954|21085844|P2|Overall Study|Protocol Violation|1
6113377|NCT00122954|21085845|P1|Overall Study|Protocol Violation|0
6113378|NCT00122954|21085844|P2|Overall Study|Withdrawal by Subject|2
6113379|NCT00122954|21085845|P1|Overall Study|Withdrawal by Subject|2
6113380|NCT00122681|21085855|P2|Overall Study|Personal reasons|147
6113381|NCT00122681|21085856|P1|Overall Study|Personal reasons|150
6113382|NCT00122681|21085855|P2|Overall Study|Withdrawal by Subject|251
6113383|NCT00122681|21085856|P1|Overall Study|Withdrawal by Subject|257
6113384|NCT00122681|21085855|P2|Overall Study|Protocol Violation|10
6113385|NCT00122681|21085856|P1|Overall Study|Protocol Violation|7
6113386|NCT00122681|21085855|P2|Overall Study|Lost to Follow-up|1097
6113387|NCT00122681|21085856|P1|Overall Study|Lost to Follow-up|1080
6113388|NCT00122681|21085855|P2|Overall Study|Adverse Event|16
6113389|NCT00122681|21085856|P1|Overall Study|Adverse Event|20
6113390|NCT00122460|21085930|P2|Overall Study|investigational study phase ongoing|1
6113391|NCT00122460|21085931|P1|Overall Study|investigational study phase ongoing|7
6113392|NCT00122382|21085980|P3|Open-Label Study|Withdrawal of Consent|4
6113393|NCT00122382|21085981|P2|Open-Label Study|Withdrawal of Consent|0
6113394|NCT00122382|21085982|P1|Open-Label Study|Withdrawal of Consent|0
6113395|NCT00122382|21085980|P3|Open-Label Study|Poor/Non-Compliance|1
6113396|NCT00122382|21085981|P2|Open-Label Study|Poor/Non-Compliance|0
6113397|NCT00122382|21085982|P1|Open-Label Study|Poor/Non-Compliance|0
6113398|NCT00122382|21085980|P3|Open-Label Study|Pregnancy|2
6113399|NCT00122382|21085981|P2|Open-Label Study|Pregnancy|0
6113400|NCT00122382|21085982|P1|Open-Label Study|Pregnancy|0
6113401|NCT00122382|21085980|P3|Open-Label Study|Lost to Follow-up|3
6113402|NCT00122382|21085981|P2|Open-Label Study|Lost to Follow-up|0
6113403|NCT00122382|21085982|P1|Open-Label Study|Lost to Follow-up|0
6113404|NCT00122382|21085980|P3|Open-Label Study|Lack of Efficacy|3
6113405|NCT00122382|21085981|P2|Open-Label Study|Lack of Efficacy|0
6113406|NCT00122382|21085982|P1|Open-Label Study|Lack of Efficacy|0
6113407|NCT00122382|21085980|P3|Open-Label Study|Death|2
6113408|NCT00122382|21085981|P2|Open-Label Study|Death|0
6113409|NCT00122382|21085982|P1|Open-Label Study|Death|0
6113410|NCT00122382|21085980|P3|Open-Label Study|Adverse Event|11
6113411|NCT00122382|21085981|P2|Open-Label Study|Adverse Event|0
6113412|NCT00122382|21085982|P1|Open-Label Study|Adverse Event|0
6113413|NCT00122382|21085980|P3|Double-Blind Study|Randomized but not treated|0
6113414|NCT00122382|21085981|P2|Double-Blind Study|Randomized but not treated|2
6113415|NCT00122382|21085982|P1|Double-Blind Study|Randomized but not treated|0
6113416|NCT00122382|21085980|P3|Double-Blind Study|Methotrexate Discontinued|0
6113417|NCT00122382|21085981|P2|Double-Blind Study|Methotrexate Discontinued|1
6113418|NCT00122382|21085982|P1|Double-Blind Study|Methotrexate Discontinued|0
6113419|NCT00122382|21085980|P3|Double-Blind Study|Protocol Violation|0
6113420|NCT00122382|21085981|P2|Double-Blind Study|Protocol Violation|0
6113421|NCT00122382|21085982|P1|Double-Blind Study|Protocol Violation|1
6113422|NCT00122382|21085980|P3|Double-Blind Study|Withdrawal of Consent|0
6113423|NCT00122382|21085981|P2|Double-Blind Study|Withdrawal of Consent|3
6113424|NCT00122382|21085982|P1|Double-Blind Study|Withdrawal of Consent|7
6113425|NCT00122382|21085980|P3|Double-Blind Study|Subject No Longer Meets Study Criteria|0
6113426|NCT00122382|21085981|P2|Double-Blind Study|Subject No Longer Meets Study Criteria|0
6113427|NCT00122382|21085982|P1|Double-Blind Study|Subject No Longer Meets Study Criteria|1
6113428|NCT00122382|21085980|P3|Double-Blind Study|Pregnancy|0
6113429|NCT00122382|21085981|P2|Double-Blind Study|Pregnancy|0
6113430|NCT00122382|21085982|P1|Double-Blind Study|Pregnancy|2
6113431|NCT00122382|21085980|P3|Double-Blind Study|Lost to Follow-up|0
6113432|NCT00122382|21085981|P2|Double-Blind Study|Lost to Follow-up|1
6113433|NCT00122382|21085982|P1|Double-Blind Study|Lost to Follow-up|2
6113434|NCT00122382|21085980|P3|Double-Blind Study|Lack of Efficacy|0
6113435|NCT00122382|21085981|P2|Double-Blind Study|Lack of Efficacy|8
6113436|NCT00122382|21085982|P1|Double-Blind Study|Lack of Efficacy|0
6113437|NCT00122382|21085980|P3|Double-Blind Study|Death|0
6113438|NCT00122382|21085981|P2|Double-Blind Study|Death|2
6113439|NCT00122382|21085982|P1|Double-Blind Study|Death|2
6113440|NCT00122382|21085980|P3|Double-Blind Study|Adverse Event|0
6113441|NCT00122382|21085981|P2|Double-Blind Study|Adverse Event|11
6113442|NCT00122382|21085982|P1|Double-Blind Study|Adverse Event|9
6113443|NCT00122317|21086126|P1|Overall Study|Withdrawal by Subject|1
6113444|NCT00122317|21086126|P1|Overall Study|patient non-compliance|1
6113445|NCT00122317|21086126|P1|Overall Study|Physician Decision|2
6113446|NCT00122317|21086126|P1|Overall Study|Adverse Event|4
6113447|NCT00122317|21086126|P1|Overall Study|Death|3
6113448|NCT00122278|21086135|P2|Overall Study|Lost to Follow-up|0
6113449|NCT00122278|21086136|P1|Overall Study|Lost to Follow-up|2
6113450|NCT00122187|21086146|P2|Overall Study|Withdrew because of resource limitations|2
6113451|NCT00122187|21086147|P1|Overall Study|Withdrew because of resource limitations|2
6113452|NCT00122135|21086161|P2|Overall Study|Withdrawal by Subject|0
6113453|NCT00122135|21086162|P1|Overall Study|Withdrawal by Subject|3
6113454|NCT00122109|21086170|P2|Overall Study|Did not meet criteria|7
6113455|NCT00122109|21086171|P1|Overall Study|Did not meet criteria|6
6113456|NCT00121992|21086197|P2|Overall Study|Treatment not received|11
6113457|NCT00121992|21086198|P1|Overall Study|Treatment not received|2
6113458|NCT00121667|21086460|P4|Short Term (ST) + Long Term (LT) Period|Death|2
6113459|NCT00121667|21086461|P3|Short Term (ST) + Long Term (LT) Period|Death|0
6113460|NCT00121667|21086462|P2|Short Term (ST) + Long Term (LT) Period|Death|0
6113461|NCT00121667|21086463|P1|Short Term (ST) + Long Term (LT) Period|Death|1
6113462|NCT00121667|21086460|P4|Short Term (ST) + Long Term (LT) Period|Pregnancy|1
6113463|NCT00121667|21086461|P3|Short Term (ST) + Long Term (LT) Period|Pregnancy|0
6113464|NCT00121667|21086462|P2|Short Term (ST) + Long Term (LT) Period|Pregnancy|1
6113465|NCT00121667|21086463|P1|Short Term (ST) + Long Term (LT) Period|Pregnancy|1
6113466|NCT00121667|21086460|P4|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|4
6113542|NCT00121641|21086563|P3|48-month Short Term + Long Term Period|Death|0
6113467|NCT00121667|21086461|P3|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|8
6113468|NCT00121667|21086462|P2|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|5
6113469|NCT00121667|21086463|P1|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|3
6113470|NCT00121667|21086460|P4|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|9
6113471|NCT00121667|21086461|P3|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|5
6113472|NCT00121667|21086462|P2|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|6
6113473|NCT00121667|21086463|P1|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|3
6113474|NCT00121667|21086460|P4|Short Term (ST) + Long Term (LT) Period|Other Reason|3
6113475|NCT00121667|21086461|P3|Short Term (ST) + Long Term (LT) Period|Other Reason|6
6113476|NCT00121667|21086462|P2|Short Term (ST) + Long Term (LT) Period|Other Reason|7
6113477|NCT00121667|21086463|P1|Short Term (ST) + Long Term (LT) Period|Other Reason|5
6113478|NCT00121667|21086460|P4|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|16
6113479|NCT00121667|21086461|P3|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|13
6113480|NCT00121667|21086462|P2|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11
6113481|NCT00121667|21086463|P1|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11
6113482|NCT00121667|21086460|P4|Short Term (ST) + Long Term (LT) Period|Adverse Event|10
6113483|NCT00121667|21086461|P3|Short Term (ST) + Long Term (LT) Period|Adverse Event|13
6113484|NCT00121667|21086462|P2|Short Term (ST) + Long Term (LT) Period|Adverse Event|18
6113485|NCT00121667|21086463|P1|Short Term (ST) + Long Term (LT) Period|Adverse Event|12
6113486|NCT00121667|21086460|P4|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|30
6113487|NCT00121667|21086461|P3|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|26
6113488|NCT00121667|21086462|P2|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|34
6113489|NCT00121667|21086463|P1|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|38
6113490|NCT00121667|21086460|P4|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|65
6113491|NCT00121667|21086461|P3|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|42
6113492|NCT00121667|21086462|P2|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|51
6113493|NCT00121667|21086463|P1|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|54
6113494|NCT00121667|21086460|P4|Short Term (ST) Period|Pregnancy|1
6113495|NCT00121667|21086461|P3|Short Term (ST) Period|Pregnancy|0
6113496|NCT00121667|21086462|P2|Short Term (ST) Period|Pregnancy|0
6113497|NCT00121667|21086463|P1|Short Term (ST) Period|Pregnancy|0
6113498|NCT00121667|21086460|P4|Short Term (ST) Period|Death|1
6113499|NCT00121667|21086461|P3|Short Term (ST) Period|Death|0
6113500|NCT00121667|21086462|P2|Short Term (ST) Period|Death|0
6113501|NCT00121667|21086463|P1|Short Term (ST) Period|Death|0
6113502|NCT00121667|21086460|P4|Short Term (ST) Period|Other Reason|0
6113503|NCT00121667|21086461|P3|Short Term (ST) Period|Other Reason|0
6113504|NCT00121667|21086462|P2|Short Term (ST) Period|Other Reason|0
6113505|NCT00121667|21086463|P1|Short Term (ST) Period|Other Reason|3
6113506|NCT00121667|21086460|P4|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2
6113507|NCT00121667|21086461|P3|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0
6113508|NCT00121667|21086462|P2|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2
6113509|NCT00121667|21086463|P1|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0
6113510|NCT00121667|21086460|P4|Short Term (ST) Period|Poor / Non-compliance|2
6113511|NCT00121667|21086461|P3|Short Term (ST) Period|Poor / Non-compliance|1
6113512|NCT00121667|21086462|P2|Short Term (ST) Period|Poor / Non-compliance|1
6113513|NCT00121667|21086463|P1|Short Term (ST) Period|Poor / Non-compliance|0
6113514|NCT00121667|21086460|P4|Short Term (ST) Period|Lost to Follow-up|3
6113515|NCT00121667|21086461|P3|Short Term (ST) Period|Lost to Follow-up|4
6113516|NCT00121667|21086462|P2|Short Term (ST) Period|Lost to Follow-up|4
6113517|NCT00121667|21086463|P1|Short Term (ST) Period|Lost to Follow-up|3
6113518|NCT00121667|21086460|P4|Short Term (ST) Period|Adverse Event|3
6113519|NCT00121667|21086461|P3|Short Term (ST) Period|Adverse Event|5
6113520|NCT00121667|21086462|P2|Short Term (ST) Period|Adverse Event|6
6113521|NCT00121667|21086463|P1|Short Term (ST) Period|Adverse Event|5
6113522|NCT00121667|21086460|P4|Short Term (ST) Period|Subject Withdrew Consent|11
6113523|NCT00121667|21086461|P3|Short Term (ST) Period|Subject Withdrew Consent|4
6113524|NCT00121667|21086462|P2|Short Term (ST) Period|Subject Withdrew Consent|13
6113525|NCT00121667|21086463|P1|Short Term (ST) Period|Subject Withdrew Consent|8
6113526|NCT00121667|21086460|P4|Short Term (ST) Period|Lack of Efficacy|44
6113527|NCT00121667|21086461|P3|Short Term (ST) Period|Lack of Efficacy|27
6113528|NCT00121667|21086462|P2|Short Term (ST) Period|Lack of Efficacy|22
6113529|NCT00121667|21086463|P1|Short Term (ST) Period|Lack of Efficacy|25
6113530|NCT00121641|21086561|P5|48-month Short Term + Long Term Period|Other Reason|1
6113531|NCT00121641|21086562|P4|48-month Short Term + Long Term Period|Other Reason|0
6113532|NCT00121641|21086563|P3|48-month Short Term + Long Term Period|Other Reason|2
6113533|NCT00121641|21086564|P2|48-month Short Term + Long Term Period|Other Reason|3
6113534|NCT00121641|21086565|P1|48-month Short Term + Long Term Period|Other Reason|5
6113535|NCT00121641|21086561|P5|48-month Short Term + Long Term Period|Missing|0
6113536|NCT00121641|21086562|P4|48-month Short Term + Long Term Period|Missing|0
6113537|NCT00121641|21086563|P3|48-month Short Term + Long Term Period|Missing|1
6113538|NCT00121641|21086564|P2|48-month Short Term + Long Term Period|Missing|0
6113539|NCT00121641|21086565|P1|48-month Short Term + Long Term Period|Missing|0
6113540|NCT00121641|21086561|P5|48-month Short Term + Long Term Period|Death|0
6113541|NCT00121641|21086562|P4|48-month Short Term + Long Term Period|Death|1
6113543|NCT00121641|21086564|P2|48-month Short Term + Long Term Period|Death|0
6113544|NCT00121641|21086565|P1|48-month Short Term + Long Term Period|Death|0
6113545|NCT00121641|21086561|P5|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1
6113546|NCT00121641|21086562|P4|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0
6113547|NCT00121641|21086563|P3|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1
6113548|NCT00121641|21086564|P2|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|2
6113549|NCT00121641|21086565|P1|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0
6113550|NCT00121641|21086561|P5|48-month Short Term + Long Term Period|Pregnancy|0
6113551|NCT00121641|21086562|P4|48-month Short Term + Long Term Period|Pregnancy|1
6113552|NCT00121641|21086563|P3|48-month Short Term + Long Term Period|Pregnancy|0
6113553|NCT00121641|21086564|P2|48-month Short Term + Long Term Period|Pregnancy|1
6113554|NCT00121641|21086565|P1|48-month Short Term + Long Term Period|Pregnancy|0
6113555|NCT00121641|21086561|P5|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2
6113556|NCT00121641|21086562|P4|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1
6113557|NCT00121641|21086563|P3|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2
6113558|NCT00121641|21086564|P2|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|3
6113559|NCT00121641|21086565|P1|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1
6113560|NCT00121641|21086561|P5|48-month Short Term + Long Term Period|Poor / Non-compliance|2
6113561|NCT00121641|21086562|P4|48-month Short Term + Long Term Period|Poor / Non-compliance|2
6113562|NCT00121641|21086563|P3|48-month Short Term + Long Term Period|Poor / Non-compliance|4
6113563|NCT00121641|21086564|P2|48-month Short Term + Long Term Period|Poor / Non-compliance|1
6113564|NCT00121641|21086565|P1|48-month Short Term + Long Term Period|Poor / Non-compliance|4
6113565|NCT00121641|21086561|P5|48-month Short Term + Long Term Period|Lost to Follow-up|12
6113566|NCT00121641|21086562|P4|48-month Short Term + Long Term Period|Lost to Follow-up|11
6113567|NCT00121641|21086563|P3|48-month Short Term + Long Term Period|Lost to Follow-up|12
6113568|NCT00121641|21086564|P2|48-month Short Term + Long Term Period|Lost to Follow-up|7
6113569|NCT00121641|21086565|P1|48-month Short Term + Long Term Period|Lost to Follow-up|9
6113570|NCT00121641|21086561|P5|48-month Short Term + Long Term Period|Adverse Event|5
6113571|NCT00121641|21086562|P4|48-month Short Term + Long Term Period|Adverse Event|5
6113572|NCT00121641|21086563|P3|48-month Short Term + Long Term Period|Adverse Event|10
6113573|NCT00121641|21086564|P2|48-month Short Term + Long Term Period|Adverse Event|10
6113574|NCT00121641|21086565|P1|48-month Short Term + Long Term Period|Adverse Event|9
6113575|NCT00121641|21086561|P5|48-month Short Term + Long Term Period|Subject Withdrew Consent|10
6113576|NCT00121641|21086562|P4|48-month Short Term + Long Term Period|Subject Withdrew Consent|24
6113577|NCT00121641|21086563|P3|48-month Short Term + Long Term Period|Subject Withdrew Consent|17
6113578|NCT00121641|21086564|P2|48-month Short Term + Long Term Period|Subject Withdrew Consent|28
6113579|NCT00121641|21086565|P1|48-month Short Term + Long Term Period|Subject Withdrew Consent|25
6113580|NCT00121641|21086561|P5|48-month Short Term + Long Term Period|Lack of Efficacy|25
6113581|NCT00121641|21086562|P4|48-month Short Term + Long Term Period|Lack of Efficacy|26
6113582|NCT00121641|21086563|P3|48-month Short Term + Long Term Period|Lack of Efficacy|21
6113583|NCT00121641|21086564|P2|48-month Short Term + Long Term Period|Lack of Efficacy|27
6113584|NCT00121641|21086565|P1|48-month Short Term + Long Term Period|Lack of Efficacy|26
6113585|NCT00121641|21086561|P5|24-week Short-term Treatment Period|Other Reason|0
6113586|NCT00121641|21086562|P4|24-week Short-term Treatment Period|Other Reason|0
6113587|NCT00121641|21086563|P3|24-week Short-term Treatment Period|Other Reason|0
6113588|NCT00121641|21086564|P2|24-week Short-term Treatment Period|Other Reason|0
6113589|NCT00121641|21086565|P1|24-week Short-term Treatment Period|Other Reason|1
6113590|NCT00121641|21086561|P5|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1
6113591|NCT00121641|21086562|P4|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0
6113592|NCT00121641|21086563|P3|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0
6113593|NCT00121641|21086564|P2|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1
6113594|NCT00121641|21086565|P1|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1
6113595|NCT00121641|21086561|P5|24-week Short-term Treatment Period|Poor / Non-compliance|1
6113596|NCT00121641|21086562|P4|24-week Short-term Treatment Period|Poor / Non-compliance|1
6113597|NCT00121641|21086563|P3|24-week Short-term Treatment Period|Poor / Non-compliance|3
6113598|NCT00121641|21086564|P2|24-week Short-term Treatment Period|Poor / Non-compliance|0
6113599|NCT00121641|21086565|P1|24-week Short-term Treatment Period|Poor / Non-compliance|0
6113600|NCT00121641|21086561|P5|24-week Short-term Treatment Period|Lost to Follow-up|4
6113601|NCT00121641|21086562|P4|24-week Short-term Treatment Period|Lost to Follow-up|4
6113602|NCT00121641|21086563|P3|24-week Short-term Treatment Period|Lost to Follow-up|3
6113603|NCT00121641|21086564|P2|24-week Short-term Treatment Period|Lost to Follow-up|2
6113604|NCT00121641|21086565|P1|24-week Short-term Treatment Period|Lost to Follow-up|0
6113605|NCT00121641|21086561|P5|24-week Short-term Treatment Period|Adverse Event|2
6113606|NCT00121641|21086562|P4|24-week Short-term Treatment Period|Adverse Event|0
6113607|NCT00121641|21086563|P3|24-week Short-term Treatment Period|Adverse Event|4
6113608|NCT00121641|21086564|P2|24-week Short-term Treatment Period|Adverse Event|3
6113609|NCT00121641|21086565|P1|24-week Short-term Treatment Period|Adverse Event|3
6113610|NCT00121641|21086561|P5|24-week Short-term Treatment Period|Subject Withdrew Consent|3
6113611|NCT00121641|21086562|P4|24-week Short-term Treatment Period|Subject Withdrew Consent|10
6113612|NCT00121641|21086563|P3|24-week Short-term Treatment Period|Subject Withdrew Consent|5
6113613|NCT00121641|21086564|P2|24-week Short-term Treatment Period|Subject Withdrew Consent|11
6113614|NCT00121641|21086565|P1|24-week Short-term Treatment Period|Subject Withdrew Consent|9
6113615|NCT00121641|21086561|P5|24-week Short-term Treatment Period|Lack of Efficacy|30
6113616|NCT00121641|21086562|P4|24-week Short-term Treatment Period|Lack of Efficacy|25
6113617|NCT00121641|21086563|P3|24-week Short-term Treatment Period|Lack of Efficacy|14
6113618|NCT00121641|21086564|P2|24-week Short-term Treatment Period|Lack of Efficacy|21
6113619|NCT00121641|21086565|P1|24-week Short-term Treatment Period|Lack of Efficacy|15
6113620|NCT00121485|21086678|P2|Overall Study|Crossover|2
6113621|NCT00121485|21086679|P1|Overall Study|Crossover|0
6113622|NCT00121485|21086678|P2|Overall Study|Not implanted|5
6113623|NCT00121485|21086679|P1|Overall Study|Not implanted|1
6113624|NCT00121238|21086724|P1|Overall Study|Protocol Violation|2
6113625|NCT00121238|21086724|P1|Overall Study|disease progression before intervention|1
6113626|NCT00121199|21086740|P1|Overall Study|Ineligible|9
6113627|NCT00121199|21086740|P1|Overall Study|Other - Not Protocol Specified|3
6113628|NCT00121199|21086740|P1|Overall Study|Death|3
6113629|NCT00121199|21086740|P1|Overall Study|Progression/Relapse|1
6113630|NCT00121199|21086740|P1|Overall Study|Refusal Unrelated to Adverse Event|1
6113631|NCT00121199|21086740|P1|Overall Study|Adverse Event|11
6113632|NCT00121134|21086784|P4|Overall Study|Patient Personal Reasons|0
6113633|NCT00121134|21086785|P3|Overall Study|Patient Personal Reasons|0
6113634|NCT00121134|21086786|P2|Overall Study|Patient Personal Reasons|1
6113635|NCT00121134|21086787|P1|Overall Study|Patient Personal Reasons|0
6113636|NCT00121134|21086784|P4|Overall Study|Intercurrent Illness|1
6113637|NCT00121134|21086785|P3|Overall Study|Intercurrent Illness|0
6113638|NCT00121134|21086786|P2|Overall Study|Intercurrent Illness|0
6113639|NCT00121134|21086787|P1|Overall Study|Intercurrent Illness|0
6113640|NCT00121134|21086784|P4|Overall Study|Treatment Delay|0
6113641|NCT00121134|21086785|P3|Overall Study|Treatment Delay|0
6113642|NCT00121134|21086786|P2|Overall Study|Treatment Delay|0
6113643|NCT00121134|21086787|P1|Overall Study|Treatment Delay|1
6113644|NCT00121134|21086784|P4|Overall Study|Physician Decision|1
6113645|NCT00121134|21086785|P3|Overall Study|Physician Decision|4
6113646|NCT00121134|21086786|P2|Overall Study|Physician Decision|4
6113647|NCT00121134|21086787|P1|Overall Study|Physician Decision|6
6113648|NCT00121134|21086784|P4|Overall Study|Toxicity|5
6113649|NCT00121134|21086785|P3|Overall Study|Toxicity|13
6113650|NCT00121134|21086786|P2|Overall Study|Toxicity|7
6113651|NCT00121134|21086787|P1|Overall Study|Toxicity|4
6113652|NCT00121134|21086784|P4|Overall Study|Progression of Disease|2
6113653|NCT00121134|21086785|P3|Overall Study|Progression of Disease|4
6113654|NCT00121134|21086786|P2|Overall Study|Progression of Disease|3
6113655|NCT00121134|21086787|P1|Overall Study|Progression of Disease|5
6113656|NCT00120874|21086799|P2|Overall Study|Death|1
6113657|NCT00120874|21086800|P1|Overall Study|Death|0
6113658|NCT00120627|21086838|P2|Overall Study|Withdrawal by Subject|5
6113659|NCT00120627|21086839|P1|Overall Study|Withdrawal by Subject|5
6113660|NCT00120406|21086890|P2|Overall Study|patient moved but has not withdrawn|1
6113661|NCT00120406|21086891|P1|Overall Study|patient moved but has not withdrawn|0
6113662|NCT00120406|21086890|P2|Overall Study|received non-study stent|2
6113663|NCT00120406|21086891|P1|Overall Study|received non-study stent|0
6113664|NCT00120406|21086890|P2|Overall Study|Lost to Follow-up|2
6113665|NCT00120406|21086891|P1|Overall Study|Lost to Follow-up|5
6113666|NCT00120406|21086890|P2|Overall Study|Withdrawal by Subject|7
6113667|NCT00120406|21086891|P1|Overall Study|Withdrawal by Subject|5
6113668|NCT00120406|21086890|P2|Overall Study|Death|4
6113669|NCT00120406|21086891|P1|Overall Study|Death|9
6113670|NCT00120289|21086901|P2|Overall Study|Withdrawal by Subject|13
6113671|NCT00120289|21086902|P1|Overall Study|Withdrawal by Subject|14
6113672|NCT00120289|21086901|P2|Overall Study|Lost to Follow-up|14
6113673|NCT00120289|21086902|P1|Overall Study|Lost to Follow-up|11
6113674|NCT00120289|21086901|P2|Overall Study|Death|82
6113675|NCT00120289|21086902|P1|Overall Study|Death|96
6113676|NCT00120250|21086914|P2|Overall Study|Protocol Violation|1
6113677|NCT00120250|21086915|P1|Overall Study|Protocol Violation|0
6113678|NCT00120250|21086914|P2|Overall Study|Lost to Follow-up|1
6113679|NCT00120250|21086915|P1|Overall Study|Lost to Follow-up|1
6113680|NCT00120042|21086931|P3|Overall Study|all completed protocl|0
6113681|NCT00120042|21086932|P2|Overall Study|all completed protocl|0
6113682|NCT00120042|21086933|P1|Overall Study|all completed protocl|0
6113683|NCT00119678|21086956|P2|Open-label Treatment Period|Administrative reasons by sponsor|0
6113684|NCT00119678|21086957|P1|Open-label Treatment Period|Administrative reasons by sponsor|87
6113685|NCT00119678|21086956|P2|Open-label Treatment Period|Pregnancy|0
6113686|NCT00119678|21086957|P1|Open-label Treatment Period|Pregnancy|1
6113687|NCT00119678|21086956|P2|Open-label Treatment Period|Participants not meeting study criteria|0
6113688|NCT00119678|21086957|P1|Open-label Treatment Period|Participants not meeting study criteria|2
6113689|NCT00119678|21086956|P2|Open-label Treatment Period|Participant withdrew consent|0
6113690|NCT00119678|21086957|P1|Open-label Treatment Period|Participant withdrew consent|4
6113691|NCT00119678|21086956|P2|Open-label Treatment Period|Lost to Follow-up|0
6113692|NCT00119678|21086957|P1|Open-label Treatment Period|Lost to Follow-up|3
6113693|NCT00119678|21086956|P2|Open-label Treatment Period|Lack of Efficacy|0
6113694|NCT00119678|21086957|P1|Open-label Treatment Period|Lack of Efficacy|9
6113695|NCT00119678|21086956|P2|Open-label Treatment Period|Adverse Event|0
6113696|NCT00119678|21086957|P1|Open-label Treatment Period|Adverse Event|3
6113697|NCT00119678|21086956|P2|Open-label Treatment Period|Death|0
6113698|NCT00119678|21086957|P1|Open-label Treatment Period|Death|1
6113699|NCT00119678|21086956|P2|Double-blind Treatment Period|Site closed due to non-compliance|2
6113700|NCT00119678|21086957|P1|Double-blind Treatment Period|Site closed due to non-compliance|3
6113701|NCT00119678|21086956|P2|Double-blind Treatment Period|Not treated|2
6113702|NCT00119678|21086957|P1|Double-blind Treatment Period|Not treated|1
6113703|NCT00119678|21086956|P2|Double-blind Treatment Period|Pregnancy|2
6113704|NCT00119678|21086957|P1|Double-blind Treatment Period|Pregnancy|0
6113705|NCT00119678|21086956|P2|Double-blind Treatment Period|Poor/Non-compliance|0
6113706|NCT00119678|21086957|P1|Double-blind Treatment Period|Poor/Non-compliance|3
6113707|NCT00119678|21086956|P2|Double-blind Treatment Period|Participants not meeting study criteria|1
6113708|NCT00119678|21086957|P1|Double-blind Treatment Period|Participants not meeting study criteria|0
6113709|NCT00119678|21086956|P2|Double-blind Treatment Period|Participant withdrew consent|4
6113710|NCT00119678|21086957|P1|Double-blind Treatment Period|Participant withdrew consent|4
6113711|NCT00119678|21086956|P2|Double-blind Treatment Period|Lost to Follow-up|2
6113712|NCT00119678|21086957|P1|Double-blind Treatment Period|Lost to Follow-up|1
6113713|NCT00119678|21086956|P2|Double-blind Treatment Period|Lack of Efficacy|12
6113714|NCT00119678|21086957|P1|Double-blind Treatment Period|Lack of Efficacy|21
6113715|NCT00119678|21086956|P2|Double-blind Treatment Period|Adverse Event|1
6113716|NCT00119678|21086957|P1|Double-blind Treatment Period|Adverse Event|7
6113717|NCT00119678|21086956|P2|Double-blind Treatment Period|Death|0
6113718|NCT00119678|21086957|P1|Double-blind Treatment Period|Death|1
6113719|NCT00119405|21087003|P1|Overall Study|Withdrawal by Subject|1
6113720|NCT00119379|21087017|P2|Overall Study|Adverse Event|1
6113721|NCT00119379|21087018|P1|Overall Study|Adverse Event|4
6113722|NCT00119262|21087036|P2|Overall Study|others|5
6113723|NCT00119262|21087037|P1|Overall Study|others|0
6113724|NCT00119262|21087036|P2|Overall Study|ineligble|2
6113725|NCT00119262|21087037|P1|Overall Study|ineligble|1
6113726|NCT00119262|21087036|P2|Overall Study|other disease|2
6113727|NCT00119262|21087037|P1|Overall Study|other disease|0
6113728|NCT00119262|21087036|P2|Overall Study|Adverse Event|35
6113729|NCT00119262|21087037|P1|Overall Study|Adverse Event|33
6113730|NCT00119262|21087036|P2|Overall Study|Withdrawal by Subject|11
6113731|NCT00119262|21087037|P1|Overall Study|Withdrawal by Subject|12
6113732|NCT00119262|21087036|P2|Overall Study|Lack of Efficacy|3
6113733|NCT00119262|21087037|P1|Overall Study|Lack of Efficacy|0
6113736|NCT00119015|21087097|P3|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0
6113737|NCT00119015|21087098|P2|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0
6113738|NCT00119015|21087099|P1|Open-Label Phase (2 Weeks)|Did not have residual symptoms|48
6113739|NCT00118911|21087115|P2|Overall Study|Withdrawal by Subject|5
6113740|NCT00118911|21087116|P1|Overall Study|Withdrawal by Subject|2
6113741|NCT00118898|21087128|P4|Overall Study|Not able to get to clinic|40
6113742|NCT00118898|21087129|P3|Overall Study|Not able to get to clinic|31
6113743|NCT00118898|21087130|P2|Overall Study|Not able to get to clinic|43
6113744|NCT00118898|21087131|P1|Overall Study|Not able to get to clinic|34
6113745|NCT00118898|21087128|P4|Overall Study|Not compliant with requirements|11
6113746|NCT00118898|21087129|P3|Overall Study|Not compliant with requirements|11
6113747|NCT00118898|21087130|P2|Overall Study|Not compliant with requirements|13
6113748|NCT00118898|21087131|P1|Overall Study|Not compliant with requirements|11
6113749|NCT00118898|21087128|P4|Overall Study|Severe debilitation|4
6113750|NCT00118898|21087129|P3|Overall Study|Severe debilitation|6
6113751|NCT00118898|21087130|P2|Overall Study|Severe debilitation|4
6113752|NCT00118898|21087131|P1|Overall Study|Severe debilitation|1
6113753|NCT00118898|21087128|P4|Overall Study|Site Closure|37
6113754|NCT00118898|21087129|P3|Overall Study|Site Closure|28
6113755|NCT00118898|21087130|P2|Overall Study|Site Closure|31
6113756|NCT00118898|21087131|P1|Overall Study|Site Closure|33
6113757|NCT00118898|21087128|P4|Overall Study|Withdrawal by Subject|8
6113758|NCT00118898|21087129|P3|Overall Study|Withdrawal by Subject|8
6113759|NCT00118898|21087130|P2|Overall Study|Withdrawal by Subject|5
6113760|NCT00118898|21087131|P1|Overall Study|Withdrawal by Subject|10
6113761|NCT00118898|21087128|P4|Overall Study|Lost to Follow-up|33
6113762|NCT00118898|21087129|P3|Overall Study|Lost to Follow-up|33
6113763|NCT00118898|21087130|P2|Overall Study|Lost to Follow-up|34
6113764|NCT00118898|21087131|P1|Overall Study|Lost to Follow-up|26
6113765|NCT00118898|21087128|P4|Overall Study|Death|8
6113766|NCT00118898|21087129|P3|Overall Study|Death|6
6113767|NCT00118898|21087130|P2|Overall Study|Death|11
6113768|NCT00118898|21087131|P1|Overall Study|Death|6
6113769|NCT00118716|21087257|P2|Overall Study|Investigator discretion|1
6113770|NCT00118716|21087258|P1|Overall Study|Investigator discretion|0
6113771|NCT00118716|21087257|P2|Overall Study|Expired drug use|2
6113772|NCT00118716|21087258|P1|Overall Study|Expired drug use|1
6113773|NCT00118716|21087257|P2|Overall Study|misrandomized|1
6113774|NCT00118716|21087258|P1|Overall Study|misrandomized|1
6113775|NCT00118716|21087257|P2|Overall Study|Non-compliance|3
6113776|NCT00118716|21087258|P1|Overall Study|Non-compliance|1
6113777|NCT00118716|21087257|P2|Overall Study|Discontinued by sponsor|1
6113778|NCT00118716|21087258|P1|Overall Study|Discontinued by sponsor|1
6113779|NCT00118716|21087257|P2|Overall Study|Exacerbation|2
6113780|NCT00118716|21087258|P1|Overall Study|Exacerbation|2
6113781|NCT00118716|21087257|P2|Overall Study|Withdrawal by Subject|1
6113782|NCT00118716|21087258|P1|Overall Study|Withdrawal by Subject|0
6113783|NCT00118716|21087257|P2|Overall Study|Protocol Violation|4
6113784|NCT00118716|21087258|P1|Overall Study|Protocol Violation|5
6113785|NCT00118716|21087257|P2|Overall Study|Adverse Event|7
6113786|NCT00118716|21087258|P1|Overall Study|Adverse Event|2
6113787|NCT00118703|21087278|P2|Overall Study|Lost to Follow-up|2
6113788|NCT00118703|21087279|P1|Overall Study|Lost to Follow-up|1
6113789|NCT00118703|21087278|P2|Overall Study|Withdrawal by Subject|5
6113790|NCT00118703|21087279|P1|Overall Study|Withdrawal by Subject|2
6113791|NCT00118703|21087278|P2|Overall Study|Participant took two different treatment|1
6113792|NCT00118703|21087279|P1|Overall Study|Participant took two different treatment|0
6113793|NCT00118703|21087278|P2|Overall Study|Adverse Event|1
6113794|NCT00118703|21087279|P1|Overall Study|Adverse Event|1
6113795|NCT00118703|21087278|P2|Overall Study|Protocol Violation|0
6113796|NCT00118703|21087279|P1|Overall Study|Protocol Violation|1
6113797|NCT00118482|21087376|P2|Overall Study|Withdrawal by Subject|22
6113798|NCT00118482|21087377|P1|Overall Study|Withdrawal by Subject|23
6113799|NCT00118482|21087376|P2|Overall Study|Lost to Follow-up|7
6113800|NCT00118482|21087377|P1|Overall Study|Lost to Follow-up|7
6113801|NCT00118430|21087392|P3|Overall Study|Lost to Follow-up|28
6113802|NCT00118430|21087393|P2|Overall Study|Lost to Follow-up|22
6113803|NCT00118430|21087394|P1|Overall Study|Lost to Follow-up|15
6113804|NCT00118430|21087392|P3|Overall Study|Withdrawal by Subject|0
6113805|NCT00118430|21087393|P2|Overall Study|Withdrawal by Subject|2
6113806|NCT00118430|21087394|P1|Overall Study|Withdrawal by Subject|6
6113807|NCT00118417|21087409|P2|Phase II (Weeks 6 to 12)|Remission|2
6113808|NCT00118417|21087410|P1|Phase II (Weeks 6 to 12)|Remission|1
6113809|NCT00118417|21087409|P2|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1
6113810|NCT00118417|21087410|P1|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1
6113811|NCT00118417|21087409|P2|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|0
6113812|NCT00118417|21087410|P1|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|4
6113813|NCT00118417|21087409|P2|Phase I (Weeks 0 to 6)|Lost to Follow-up|0
6113814|NCT00118417|21087410|P1|Phase I (Weeks 0 to 6)|Lost to Follow-up|6
6113815|NCT00118417|21087409|P2|Phase I (Weeks 0 to 6)|Remission|0
6113816|NCT00118417|21087410|P1|Phase I (Weeks 0 to 6)|Remission|8
6113817|NCT00118287|21087554|P1|Overall Study|Muscle pain|1
6113818|NCT00118287|21087554|P1|Overall Study|Intracranial haemorrhage|1
6113819|NCT00118157|21087587|P1|Overall Study|Withdrawal by Subject|2
6113820|NCT00118157|21087587|P1|Overall Study|Death|8
6113821|NCT00118157|21087587|P1|Overall Study|Adverse Event|2
6113822|NCT00118092|21087605|P1|Overall Study|Protocol Violation|1
6113823|NCT00118092|21087605|P1|Overall Study|Withdrawal by Subject|1
6113824|NCT00118040|21087623|P3|Overall Study|Other|1
6113825|NCT00118040|21087624|P2|Overall Study|Other|0
6113826|NCT00118040|21087625|P1|Overall Study|Other|0
6113827|NCT00118040|21087623|P3|Overall Study|Non-Compliant Participant|2
6113828|NCT00118040|21087624|P2|Overall Study|Non-Compliant Participant|1
6113829|NCT00118040|21087625|P1|Overall Study|Non-Compliant Participant|1
6113830|NCT00118040|21087623|P3|Overall Study|Medical Contraindication|1
6113831|NCT00118040|21087624|P2|Overall Study|Medical Contraindication|0
6113832|NCT00118040|21087625|P1|Overall Study|Medical Contraindication|0
6113833|NCT00118040|21087623|P3|Overall Study|Withdrawal by Subject|2
6113834|NCT00118040|21087624|P2|Overall Study|Withdrawal by Subject|0
6113835|NCT00118040|21087625|P1|Overall Study|Withdrawal by Subject|0
6113836|NCT00118040|21087623|P3|Overall Study|Adverse Event|0
6113837|NCT00118040|21087624|P2|Overall Study|Adverse Event|1
6113838|NCT00118040|21087625|P1|Overall Study|Adverse Event|0
6113839|NCT00117988|21087686|P1|Overall Study|Adverse Event|1
6113840|NCT00117988|21087686|P1|Overall Study|Death|3
6113841|NCT00117949|21087709|P4|Overall Study|Hepatic abnormalities|1
6113842|NCT00117949|21087710|P3|Overall Study|Hepatic abnormalities|0
6113843|NCT00117949|21087711|P2|Overall Study|Hepatic abnormalities|1
6113844|NCT00117949|21087712|P1|Overall Study|Hepatic abnormalities|0
6113845|NCT00117949|21087709|P4|Overall Study|PSA reduction <=50%|4
6113846|NCT00117949|21087710|P3|Overall Study|PSA reduction <=50%|2
6113847|NCT00117949|21087711|P2|Overall Study|PSA reduction <=50%|2
6113848|NCT00117949|21087712|P1|Overall Study|PSA reduction <=50%|0
6113849|NCT00117949|21087709|P4|Overall Study|PSA increase >=10ng/mL|0
6113850|NCT00117949|21087710|P3|Overall Study|PSA increase >=10ng/mL|1
6113851|NCT00117949|21087711|P2|Overall Study|PSA increase >=10ng/mL|1
6113852|NCT00117949|21087712|P1|Overall Study|PSA increase >=10ng/mL|0
6113853|NCT00117949|21087709|P4|Overall Study|Prostate-specific antigen increase >=25%|2
6113854|NCT00117949|21087710|P3|Overall Study|Prostate-specific antigen increase >=25%|1
6113855|NCT00117949|21087711|P2|Overall Study|Prostate-specific antigen increase >=25%|1
6113856|NCT00117949|21087712|P1|Overall Study|Prostate-specific antigen increase >=25%|0
6113857|NCT00117949|21087709|P4|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2
6113858|NCT00117949|21087710|P3|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3
6113859|NCT00117949|21087711|P2|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1
6113860|NCT00117949|21087712|P1|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0
6113861|NCT00117949|21087709|P4|Overall Study|Testosterone >1.0 ng/mL|15
6113862|NCT00117949|21087710|P3|Overall Study|Testosterone >1.0 ng/mL|17
6113863|NCT00117949|21087711|P2|Overall Study|Testosterone >1.0 ng/mL|18
6113864|NCT00117949|21087712|P1|Overall Study|Testosterone >1.0 ng/mL|10
6113865|NCT00117845|21087746|P1|Overall Study|stopped treatment/drug supplyinterrupted|1
6113866|NCT00117793|21087764|P1|Overall Study|Withdrawal by Subject|12
6113867|NCT00117676|21087787|P2|Open-label Period: Weeks 433 - 480|Withdrew Consent|1
6113868|NCT00117676|21087788|P1|Open-label Period: Weeks 433 - 480|Withdrew Consent|0
6113869|NCT00117676|21087787|P2|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1
6113870|NCT00117676|21087788|P1|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1
6113871|NCT00117676|21087787|P2|Open-label Period: Weeks 433 - 480|Lost to Follow-up|0
6113872|NCT00117676|21087788|P1|Open-label Period: Weeks 433 - 480|Lost to Follow-up|1
6113873|NCT00117676|21087787|P2|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|1
6113874|NCT00117676|21087788|P1|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|0
6113875|NCT00117676|21087787|P2|Open-label Period: Weeks 385 - 432|Investigator's Discretion|1
6113876|NCT00117676|21087788|P1|Open-label Period: Weeks 385 - 432|Investigator's Discretion|0
6113877|NCT00117676|21087787|P2|Open-label Period: Weeks 337 - 384|Withdrew Consent|1
6113878|NCT00117676|21087788|P1|Open-label Period: Weeks 337 - 384|Withdrew Consent|2
6113879|NCT00117676|21087787|P2|Open-label Period: Weeks 337 - 384|Study Site Discontinued|0
6113880|NCT00117676|21087788|P1|Open-label Period: Weeks 337 - 384|Study Site Discontinued|1
6113881|NCT00117676|21087787|P2|Open-label Period: Weeks 337 - 384|Lost to Follow-up|1
6113882|NCT00117676|21087788|P1|Open-label Period: Weeks 337 - 384|Lost to Follow-up|3
6113883|NCT00117676|21087787|P2|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1
6113884|NCT00117676|21087788|P1|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1
6113885|NCT00117676|21087787|P2|Open-label Period: Weeks 289 - 336|Withdrew Consent|1
6113886|NCT00117676|21087788|P1|Open-label Period: Weeks 289 - 336|Withdrew Consent|0
6113887|NCT00117676|21087787|P2|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2
6113888|NCT00117676|21087788|P1|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2
6113889|NCT00117676|21087787|P2|Open-label Period: Weeks 289 - 336|Investigator's Discretion|4
6113890|NCT00117676|21087788|P1|Open-label Period: Weeks 289 - 336|Investigator's Discretion|7
6113891|NCT00117676|21087787|P2|Open-label Period: Weeks 241 - 288|Withdrew Consent|1
6113892|NCT00117676|21087788|P1|Open-label Period: Weeks 241 - 288|Withdrew Consent|5
6113893|NCT00117676|21087787|P2|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0
6113894|NCT00117676|21087788|P1|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|1
6113895|NCT00117676|21087787|P2|Open-label Period: Weeks 241 - 288|Protocol Violation|0
6113896|NCT00117676|21087788|P1|Open-label Period: Weeks 241 - 288|Protocol Violation|2
6113897|NCT00117676|21087787|P2|Open-label Period: Weeks 241 - 288|Lost to Follow-up|1
6113898|NCT00117676|21087788|P1|Open-label Period: Weeks 241 - 288|Lost to Follow-up|2
6113899|NCT00117676|21087787|P2|Open-label Period: Weeks 241 - 288|Investigator's Discretion|1
6113900|NCT00117676|21087788|P1|Open-label Period: Weeks 241 - 288|Investigator's Discretion|0
6113901|NCT00117676|21087787|P2|Open-label Period: Weeks 193 - 240|Withdrew Consent|1
6113902|NCT00117676|21087788|P1|Open-label Period: Weeks 193 - 240|Withdrew Consent|4
6113903|NCT00117676|21087787|P2|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|0
6113904|NCT00117676|21087788|P1|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2
6113905|NCT00117676|21087787|P2|Open-label Period: Weeks 193 - 240|Lost to Follow-up|1
6113906|NCT00117676|21087788|P1|Open-label Period: Weeks 193 - 240|Lost to Follow-up|0
6113907|NCT00117676|21087787|P2|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1
6113908|NCT00117676|21087788|P1|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1
6113909|NCT00117676|21087787|P2|Open-label Period: Weeks 145 - 192|Withdrew Consent|2
6113910|NCT00117676|21087788|P1|Open-label Period: Weeks 145 - 192|Withdrew Consent|5
6113911|NCT00117676|21087787|P2|Open-label Period: Weeks 145 - 192|Lost to Follow-up|1
6113912|NCT00117676|21087788|P1|Open-label Period: Weeks 145 - 192|Lost to Follow-up|3
6113913|NCT00117676|21087787|P2|Open-label Period: Weeks 145 - 192|Investigator's Discretion|0
6113914|NCT00117676|21087788|P1|Open-label Period: Weeks 145 - 192|Investigator's Discretion|2
6113915|NCT00117676|21087787|P2|Open-label Period: Weeks 97 - 144|Withdrew Consent|0
6113916|NCT00117676|21087788|P1|Open-label Period: Weeks 97 - 144|Withdrew Consent|1
6113917|NCT00117676|21087787|P2|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|0
6113918|NCT00117676|21087788|P1|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|1
6113919|NCT00117676|21087787|P2|Open-label Period: Weeks 97 - 144|Lost to Follow-up|1
6113920|NCT00117676|21087788|P1|Open-label Period: Weeks 97 - 144|Lost to Follow-up|4
6113921|NCT00117676|21087787|P2|Open-label Period: Weeks 49 - 96|Withdrew Consent|1
6113922|NCT00117676|21087788|P1|Open-label Period: Weeks 49 - 96|Withdrew Consent|5
6113923|NCT00117676|21087787|P2|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1
6113924|NCT00117676|21087788|P1|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|3
6113925|NCT00117676|21087787|P2|Open-label Period: Weeks 49 - 96|Lost to Follow-up|0
6113926|NCT00117676|21087788|P1|Open-label Period: Weeks 49 - 96|Lost to Follow-up|2
6113927|NCT00117676|21087787|P2|Double-blind Period Through Week 48|Withdrew Consent|1
6113928|NCT00117676|21087788|P1|Double-blind Period Through Week 48|Withdrew Consent|0
6113929|NCT00117676|21087787|P2|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|2
6113930|NCT00117676|21087788|P1|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|5
6113931|NCT00117676|21087787|P2|Double-blind Period Through Week 48|Protocol Violation|1
6113932|NCT00117676|21087788|P1|Double-blind Period Through Week 48|Protocol Violation|0
6113933|NCT00117676|21087787|P2|Double-blind Period Through Week 48|Lost to Follow-up|0
6113934|NCT00117676|21087788|P1|Double-blind Period Through Week 48|Lost to Follow-up|1
6113935|NCT00117676|21087787|P2|Double-blind Period Through Week 48|Randomized but Not Treated|3
6113936|NCT00117676|21087788|P1|Double-blind Period Through Week 48|Randomized but Not Treated|4
6113937|NCT00117637|21087877|P2|Second Intervention (Period 2)|reason not reported|0
6113938|NCT00117637|21087878|P1|Second Intervention (Period 2)|reason not reported|1
6113939|NCT00117637|21087877|P2|Second Intervention (Period 2)|non compliant with study medication|1
6113940|NCT00117637|21087878|P1|Second Intervention (Period 2)|non compliant with study medication|1
6113941|NCT00117637|21087877|P2|Second Intervention (Period 2)|study terminated by the sponsor|9
6113942|NCT00117637|21087878|P1|Second Intervention (Period 2)|study terminated by the sponsor|2
6113943|NCT00117637|21087877|P2|Second Intervention (Period 2)|Withdrawal by Subject|3
6113944|NCT00117637|21087878|P1|Second Intervention (Period 2)|Withdrawal by Subject|4
6113945|NCT00117637|21087877|P2|Second Intervention (Period 2)|Protocol Violation|0
6113946|NCT00117637|21087878|P1|Second Intervention (Period 2)|Protocol Violation|1
6113947|NCT00117637|21087877|P2|Second Intervention (Period 2)|Lost to Follow-up|0
6113948|NCT00117637|21087878|P1|Second Intervention (Period 2)|Lost to Follow-up|1
6113949|NCT00117637|21087877|P2|Second Intervention (Period 2)|Adverse Event|9
6113950|NCT00117637|21087878|P1|Second Intervention (Period 2)|Adverse Event|0
6113951|NCT00117637|21087877|P2|First Intervention (Period 1)|reason not reported|1
6113952|NCT00117637|21087878|P1|First Intervention (Period 1)|reason not reported|0
6113953|NCT00117637|21087877|P2|First Intervention (Period 1)|investig. decision, not protocol driven|1
6113954|NCT00117637|21087878|P1|First Intervention (Period 1)|investig. decision, not protocol driven|0
6113955|NCT00117637|21087877|P2|First Intervention (Period 1)|protocol driven decision point|0
6113956|NCT00117637|21087878|P1|First Intervention (Period 1)|protocol driven decision point|1
6113957|NCT00117637|21087877|P2|First Intervention (Period 1)|study terminated by the sponsor|1
6113958|NCT00117637|21087878|P1|First Intervention (Period 1)|study terminated by the sponsor|3
6113959|NCT00117637|21087877|P2|First Intervention (Period 1)|Withdrawal by Subject|4
6113960|NCT00117637|21087878|P1|First Intervention (Period 1)|Withdrawal by Subject|2
6113961|NCT00117637|21087877|P2|First Intervention (Period 1)|Protocol Violation|0
6113962|NCT00117637|21087878|P1|First Intervention (Period 1)|Protocol Violation|1
6113963|NCT00117637|21087877|P2|First Intervention (Period 1)|Lost to Follow-up|2
6113964|NCT00117637|21087878|P1|First Intervention (Period 1)|Lost to Follow-up|0
6113965|NCT00117637|21087877|P2|First Intervention (Period 1)|Adverse Event|16
6113966|NCT00117637|21087878|P1|First Intervention (Period 1)|Adverse Event|11
6113967|NCT00117598|21087953|P5|After Treament Cross Over|Other|2
6113968|NCT00117598|21087954|P4|After Treament Cross Over|Other|1
6113969|NCT00117598|21087955|P3|After Treament Cross Over|Other|0
6113970|NCT00117598|21087956|P2|After Treament Cross Over|Other|0
6113971|NCT00117598|21087957|P1|After Treament Cross Over|Other|0
6113972|NCT00117598|21087953|P5|After Treament Cross Over|Withdrawal by Subject|0
6113973|NCT00117598|21087954|P4|After Treament Cross Over|Withdrawal by Subject|1
6113974|NCT00117598|21087955|P3|After Treament Cross Over|Withdrawal by Subject|0
6113975|NCT00117598|21087956|P2|After Treament Cross Over|Withdrawal by Subject|0
6113976|NCT00117598|21087957|P1|After Treament Cross Over|Withdrawal by Subject|0
6113977|NCT00117598|21087953|P5|After Treament Cross Over|Death|2
6113978|NCT00117598|21087954|P4|After Treament Cross Over|Death|1
6113979|NCT00117598|21087955|P3|After Treament Cross Over|Death|0
6113980|NCT00117598|21087956|P2|After Treament Cross Over|Death|0
6113981|NCT00117598|21087957|P1|After Treament Cross Over|Death|0
6113982|NCT00117598|21087953|P5|Prior to Treatment Cross Over|Other|0
6113983|NCT00117598|21087954|P4|Prior to Treatment Cross Over|Other|0
6113984|NCT00117598|21087955|P3|Prior to Treatment Cross Over|Other|9
6113985|NCT00117598|21087956|P2|Prior to Treatment Cross Over|Other|9
6113986|NCT00117598|21087957|P1|Prior to Treatment Cross Over|Other|15
6113987|NCT00117598|21087953|P5|Prior to Treatment Cross Over|Withdrawal by Subject|0
6113988|NCT00117598|21087954|P4|Prior to Treatment Cross Over|Withdrawal by Subject|0
6113989|NCT00117598|21087955|P3|Prior to Treatment Cross Over|Withdrawal by Subject|4
6113990|NCT00117598|21087956|P2|Prior to Treatment Cross Over|Withdrawal by Subject|1
6113991|NCT00117598|21087957|P1|Prior to Treatment Cross Over|Withdrawal by Subject|2
6113992|NCT00117598|21087953|P5|Prior to Treatment Cross Over|Lost to Follow-up|0
6113993|NCT00117598|21087954|P4|Prior to Treatment Cross Over|Lost to Follow-up|0
6113994|NCT00117598|21087955|P3|Prior to Treatment Cross Over|Lost to Follow-up|2
6113995|NCT00117598|21087956|P2|Prior to Treatment Cross Over|Lost to Follow-up|2
6113996|NCT00117598|21087957|P1|Prior to Treatment Cross Over|Lost to Follow-up|0
6113997|NCT00117598|21087953|P5|Prior to Treatment Cross Over|Death|0
6113998|NCT00117598|21087954|P4|Prior to Treatment Cross Over|Death|0
6113999|NCT00117598|21087955|P3|Prior to Treatment Cross Over|Death|37
6114000|NCT00117598|21087956|P2|Prior to Treatment Cross Over|Death|41
6114001|NCT00117598|21087957|P1|Prior to Treatment Cross Over|Death|40
6114002|NCT00117572|21087991|P2|Overall Study|Protocol Violation|0
6114003|NCT00117572|21087992|P1|Overall Study|Protocol Violation|1
6114004|NCT00117572|21087991|P2|Overall Study|Withdrawal by Subject|3
6114005|NCT00117572|21087992|P1|Overall Study|Withdrawal by Subject|3
6114006|NCT00117572|21087991|P2|Overall Study|Site withdrew before starting treatment|3
6114007|NCT00117572|21087992|P1|Overall Study|Site withdrew before starting treatment|2
6114008|NCT00117338|21088033|P2|Overall Study|Lack of Efficacy|1
6114009|NCT00117338|21088034|P1|Overall Study|Lack of Efficacy|0
6114010|NCT00117338|21088033|P2|Overall Study|Did not meet Inclusion Criteria|0
6114011|NCT00117338|21088034|P1|Overall Study|Did not meet Inclusion Criteria|1
6114012|NCT00117338|21088033|P2|Overall Study|Withdrawal by Subject|0
6114013|NCT00117338|21088034|P1|Overall Study|Withdrawal by Subject|1
6114014|NCT00117338|21088033|P2|Overall Study|Protocol Violation|2
6114015|NCT00117338|21088034|P1|Overall Study|Protocol Violation|3
6114016|NCT00117338|21088033|P2|Overall Study|Adverse Event|1
6114017|NCT00117338|21088034|P1|Overall Study|Adverse Event|0
6114018|NCT00117325|21088054|P2|Overall Study|Admisnitrative|0
6114019|NCT00117325|21088055|P1|Overall Study|Admisnitrative|1
6114020|NCT00117325|21088054|P2|Overall Study|Early termination|1
6114021|NCT00117325|21088055|P1|Overall Study|Early termination|1
6114022|NCT00117325|21088054|P2|Overall Study|Use of prohibited medicine|2
6114023|NCT00117325|21088055|P1|Overall Study|Use of prohibited medicine|1
6114024|NCT00117325|21088054|P2|Overall Study|Lack of Efficacy|0
6114025|NCT00117325|21088055|P1|Overall Study|Lack of Efficacy|1
6114026|NCT00117325|21088054|P2|Overall Study|Withdrawal by Subject|2
6114027|NCT00117325|21088055|P1|Overall Study|Withdrawal by Subject|3
6114028|NCT00117325|21088054|P2|Overall Study|Protocol Violation|3
6114029|NCT00117325|21088055|P1|Overall Study|Protocol Violation|2
6114030|NCT00117325|21088054|P2|Overall Study|Lost to Follow-up|1
6114031|NCT00117325|21088055|P1|Overall Study|Lost to Follow-up|1
6114032|NCT00117325|21088054|P2|Overall Study|Adverse Event|3
6114033|NCT00117325|21088055|P1|Overall Study|Adverse Event|3
6114034|NCT00117312|21088087|P4|Overall Study|Withdrawal by Subject|0
6114035|NCT00117312|21088088|P3|Overall Study|Withdrawal by Subject|0
6114036|NCT00117312|21088089|P2|Overall Study|Withdrawal by Subject|2
6114037|NCT00117312|21088090|P1|Overall Study|Withdrawal by Subject|0
6114038|NCT00117312|21088087|P4|Overall Study|Hepatic abnormality|1
6114039|NCT00117312|21088088|P3|Overall Study|Hepatic abnormality|0
6114040|NCT00117312|21088089|P2|Overall Study|Hepatic abnormality|1
6114041|NCT00117312|21088090|P1|Overall Study|Hepatic abnormality|0
6114042|NCT00117312|21088087|P4|Overall Study|PSA increase >= 10ng/mL|0
6114043|NCT00117312|21088088|P3|Overall Study|PSA increase >= 10ng/mL|1
6114044|NCT00117312|21088089|P2|Overall Study|PSA increase >= 10ng/mL|1
6114045|NCT00117312|21088090|P1|Overall Study|PSA increase >= 10ng/mL|0
6114046|NCT00117312|21088087|P4|Overall Study|PSA decrease <=50%|4
6114047|NCT00117312|21088088|P3|Overall Study|PSA decrease <=50%|2
6114048|NCT00117312|21088089|P2|Overall Study|PSA decrease <=50%|2
6114049|NCT00117312|21088090|P1|Overall Study|PSA decrease <=50%|0
6114050|NCT00117312|21088087|P4|Overall Study|Protocol Violation|0
6114051|NCT00117312|21088088|P3|Overall Study|Protocol Violation|3
6114052|NCT00117312|21088089|P2|Overall Study|Protocol Violation|1
6114053|NCT00117312|21088090|P1|Overall Study|Protocol Violation|0
6114054|NCT00117312|21088087|P4|Overall Study|Adverse Event|0
6114055|NCT00117312|21088088|P3|Overall Study|Adverse Event|0
6114056|NCT00117312|21088089|P2|Overall Study|Adverse Event|2
6114057|NCT00117312|21088090|P1|Overall Study|Adverse Event|0
6114058|NCT00117312|21088087|P4|Overall Study|Patient choice|1
6114059|NCT00117312|21088088|P3|Overall Study|Patient choice|2
6114060|NCT00117312|21088089|P2|Overall Study|Patient choice|0
6114061|NCT00117312|21088090|P1|Overall Study|Patient choice|0
6114062|NCT00117312|21088087|P4|Overall Study|Other|1
6114063|NCT00117312|21088088|P3|Overall Study|Other|3
6114064|NCT00117312|21088089|P2|Overall Study|Other|1
6114065|NCT00117312|21088090|P1|Overall Study|Other|0
6114066|NCT00117312|21088087|P4|Overall Study|Prostate-specific antigen increase >=25%|3
6114067|NCT00117312|21088088|P3|Overall Study|Prostate-specific antigen increase >=25%|5
6114068|NCT00117312|21088089|P2|Overall Study|Prostate-specific antigen increase >=25%|1
6114069|NCT00117312|21088090|P1|Overall Study|Prostate-specific antigen increase >=25%|0
6114070|NCT00117312|21088087|P4|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2
6114071|NCT00117312|21088088|P3|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3
6114072|NCT00117312|21088089|P2|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0
6114073|NCT00117312|21088090|P1|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1
6114074|NCT00117312|21088087|P4|Overall Study|Testosterone >1.0 ng/mL|9
6114075|NCT00117312|21088088|P3|Overall Study|Testosterone >1.0 ng/mL|5
6114076|NCT00117312|21088089|P2|Overall Study|Testosterone >1.0 ng/mL|9
6114077|NCT00117312|21088090|P1|Overall Study|Testosterone >1.0 ng/mL|9
6114078|NCT00117286|21088106|P2|Overall Study|Research site closing|2
6114079|NCT00117286|21088107|P1|Overall Study|Research site closing|0
6114080|NCT00117286|21088106|P2|Overall Study|Lack of Efficacy|1
6114081|NCT00117286|21088107|P1|Overall Study|Lack of Efficacy|2
6114082|NCT00117286|21088106|P2|Overall Study|Physician Decision|7
6114083|NCT00117286|21088107|P1|Overall Study|Physician Decision|3
6114084|NCT00117286|21088106|P2|Overall Study|Withdrawal by Subject|2
6114085|NCT00117286|21088107|P1|Overall Study|Withdrawal by Subject|6
6114086|NCT00117286|21088106|P2|Overall Study|Protocol Violation|3
6114087|NCT00117286|21088107|P1|Overall Study|Protocol Violation|3
6114088|NCT00117286|21088106|P2|Overall Study|Lost to Follow-up|0
6114089|NCT00117286|21088107|P1|Overall Study|Lost to Follow-up|2
6114090|NCT00117286|21088106|P2|Overall Study|Adverse Event|6
6114091|NCT00117286|21088107|P1|Overall Study|Adverse Event|12
6114092|NCT00117156|21088115|P1|Overall Study|Trt for Pre-Exist Second Primary|1
6114093|NCT00117156|21088115|P1|Overall Study|Physician Decision|1
6114094|NCT00117156|21088115|P1|Overall Study|Adverse Event|9
6114095|NCT00116844|21088183|P2|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1
6114096|NCT00116844|21088184|P1|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1
6114097|NCT00116844|21088183|P2|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|1
6114098|NCT00116844|21088184|P1|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|0
6114099|NCT00116844|21088183|P2|Period 1: Treatment Period 2 (60 Days)|Other|2
6114100|NCT00116844|21088184|P1|Period 1: Treatment Period 2 (60 Days)|Other|0
6114101|NCT00116844|21088183|P2|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|1
6114102|NCT00116844|21088184|P1|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|2
6114103|NCT00116844|21088183|P2|Period 1: Treatment Period 2 (60 Days)|Adverse Event|0
6114104|NCT00116844|21088184|P1|Period 1: Treatment Period 2 (60 Days)|Adverse Event|1
6114105|NCT00116844|21088183|P2|Period 1: Treatment Period 1 (60 Days)|Other|1
6114106|NCT00116844|21088184|P1|Period 1: Treatment Period 1 (60 Days)|Other|1
6114107|NCT00116844|21088183|P2|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|0
6114108|NCT00116844|21088184|P1|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|5
6114109|NCT00116844|21088183|P2|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|1
6114110|NCT00116844|21088184|P1|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|0
6114111|NCT00116844|21088183|P2|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1
6114112|NCT00116844|21088184|P1|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1
6114113|NCT00116831|21088202|P2|Overall Study|Missing data for participant|0
6114114|NCT00116831|21088203|P1|Overall Study|Missing data for participant|1
6114115|NCT00116831|21088202|P2|Overall Study|Insufficient therapeutic effect|1
6114116|NCT00116831|21088203|P1|Overall Study|Insufficient therapeutic effect|0
6114117|NCT00116831|21088202|P2|Overall Study|Withdrawal by Subject|32
6114118|NCT00116831|21088203|P1|Overall Study|Withdrawal by Subject|32
6114119|NCT00116831|21088202|P2|Overall Study|Withdrawn investigational product|0
6114120|NCT00116831|21088203|P1|Overall Study|Withdrawn investigational product|1
6114121|NCT00116831|21088202|P2|Overall Study|Low haemoglobin on screening|0
6114122|NCT00116831|21088203|P1|Overall Study|Low haemoglobin on screening|1
6114123|NCT00116831|21088202|P2|Overall Study|Hypoglycaemic events|0
6114124|NCT00116831|21088203|P1|Overall Study|Hypoglycaemic events|1
6114125|NCT00116831|21088202|P2|Overall Study|Protocol Violation|6
6114126|NCT00116831|21088203|P1|Overall Study|Protocol Violation|3
6114127|NCT00116831|21088202|P2|Overall Study|Lost to Follow-up|6
6114128|NCT00116831|21088203|P1|Overall Study|Lost to Follow-up|8
6114129|NCT00116831|21088202|P2|Overall Study|Baseline IVUS determined unevaluable|11
6114130|NCT00116831|21088203|P1|Overall Study|Baseline IVUS determined unevaluable|12
6114131|NCT00116831|21088202|P2|Overall Study|Adverse Event|16
6114132|NCT00116831|21088203|P1|Overall Study|Adverse Event|14
6114133|NCT00116805|21088281|P2|Open-label Period Weeks 433 - 480|Withdrew Consent|0
6114134|NCT00116805|21088282|P1|Open-label Period Weeks 433 - 480|Withdrew Consent|3
6114135|NCT00116805|21088281|P2|Open-label Period Weeks 433 - 480|Investigator's Discretion|0
6114136|NCT00116805|21088282|P1|Open-label Period Weeks 433 - 480|Investigator's Discretion|1
6114137|NCT00116805|21088281|P2|Open-label Period Weeks 385 - 432|Withdrew Consent|0
6114138|NCT00116805|21088282|P1|Open-label Period Weeks 385 - 432|Withdrew Consent|1
6114139|NCT00116805|21088281|P2|Open-label Period Weeks 385 - 432|Investigator's Discretion|0
6114140|NCT00116805|21088282|P1|Open-label Period Weeks 385 - 432|Investigator's Discretion|1
6114141|NCT00116805|21088281|P2|Open-label Period Weeks 337 - 384|Withdrew Consent|1
6114142|NCT00116805|21088282|P1|Open-label Period Weeks 337 - 384|Withdrew Consent|3
6114143|NCT00116805|21088281|P2|Open-label Period Weeks 337 - 384|Protocol Violation|0
6114144|NCT00116805|21088282|P1|Open-label Period Weeks 337 - 384|Protocol Violation|1
6114145|NCT00116805|21088281|P2|Open-label Period Weeks 337 - 384|Lost to Follow-up|0
6114146|NCT00116805|21088282|P1|Open-label Period Weeks 337 - 384|Lost to Follow-up|2
6114147|NCT00116805|21088281|P2|Open-label Period Weeks 337 - 384|Investigator's Discretion|0
6114148|NCT00116805|21088282|P1|Open-label Period Weeks 337 - 384|Investigator's Discretion|1
6114149|NCT00116805|21088281|P2|Open-label Period Weeks 337 - 384|Completed Study|0
6114150|NCT00116805|21088282|P1|Open-label Period Weeks 337 - 384|Completed Study|1
6114151|NCT00116805|21088281|P2|Open-label Period Weeks 289 - 336|Withdrew Consent|0
6114152|NCT00116805|21088282|P1|Open-label Period Weeks 289 - 336|Withdrew Consent|2
6114153|NCT00116805|21088281|P2|Open-label Period Weeks 289 - 336|Study Site Discontinued|1
6114154|NCT00116805|21088282|P1|Open-label Period Weeks 289 - 336|Study Site Discontinued|0
6114155|NCT00116805|21088281|P2|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|1
6114156|NCT00116805|21088282|P1|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|0
6114157|NCT00116805|21088281|P2|Open-label Period Weeks 289 - 336|Protocol Violation|1
6114158|NCT00116805|21088282|P1|Open-label Period Weeks 289 - 336|Protocol Violation|0
6114159|NCT00116805|21088281|P2|Open-label Period Weeks 289 - 336|Lost to Follow-up|1
6114160|NCT00116805|21088282|P1|Open-label Period Weeks 289 - 336|Lost to Follow-up|1
6114161|NCT00116805|21088281|P2|Open-label Period Weeks 289 - 336|Investigator's Discretion|2
6114162|NCT00116805|21088282|P1|Open-label Period Weeks 289 - 336|Investigator's Discretion|3
6114163|NCT00116805|21088281|P2|Open-label Period Weeks 289 - 336|Completed Study|1
6114164|NCT00116805|21088282|P1|Open-label Period Weeks 289 - 336|Completed Study|0
6114165|NCT00116805|21088281|P2|Open-label Period Weeks 241 - 288|Withdrew Consent|0
6114166|NCT00116805|21088282|P1|Open-label Period Weeks 241 - 288|Withdrew Consent|4
6114167|NCT00116805|21088281|P2|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0
6114168|NCT00116805|21088282|P1|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|2
6114169|NCT00116805|21088281|P2|Open-label Period Weeks 193 - 240|Withdrew Consent|1
6114170|NCT00116805|21088282|P1|Open-label Period Weeks 193 - 240|Withdrew Consent|7
6114171|NCT00116805|21088281|P2|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2
6114172|NCT00116805|21088282|P1|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2
6114173|NCT00116805|21088281|P2|Open-label Period Weeks 193 - 240|Lost to Follow-up|0
6114174|NCT00116805|21088282|P1|Open-label Period Weeks 193 - 240|Lost to Follow-up|3
6114175|NCT00116805|21088281|P2|Open-label Period Weeks 193 - 240|Investigator's Discretion|0
6114253|NCT00116753|21088409|P3|Overall Study|Lost to Follow-up|1
6114176|NCT00116805|21088282|P1|Open-label Period Weeks 193 - 240|Investigator's Discretion|1
6114177|NCT00116805|21088281|P2|Open-label Period Weeks 193 - 240|Completed Study|1
6114178|NCT00116805|21088282|P1|Open-label Period Weeks 193 - 240|Completed Study|0
6114179|NCT00116805|21088281|P2|Open-label Period Weeks 145 - 192|Withdrew Consent|2
6114180|NCT00116805|21088282|P1|Open-label Period Weeks 145 - 192|Withdrew Consent|3
6114181|NCT00116805|21088281|P2|Open-label Period Weeks 145 - 192|Seroconversion|1
6114182|NCT00116805|21088282|P1|Open-label Period Weeks 145 - 192|Seroconversion|0
6114183|NCT00116805|21088281|P2|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|1
6114184|NCT00116805|21088282|P1|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|0
6114185|NCT00116805|21088281|P2|Open-label Period Weeks 145 - 192|Protocol Violation|0
6114186|NCT00116805|21088282|P1|Open-label Period Weeks 145 - 192|Protocol Violation|1
6114187|NCT00116805|21088281|P2|Open-label Period Weeks 145 - 192|Lost to Follow-up|1
6114188|NCT00116805|21088282|P1|Open-label Period Weeks 145 - 192|Lost to Follow-up|3
6114189|NCT00116805|21088281|P2|Open-label Period Weeks 145 - 192|Investigator's Discretion|0
6114190|NCT00116805|21088282|P1|Open-label Period Weeks 145 - 192|Investigator's Discretion|2
6114191|NCT00116805|21088281|P2|Open-label Period Weeks 145 - 192|Completed Study|1
6114192|NCT00116805|21088282|P1|Open-label Period Weeks 145 - 192|Completed Study|1
6114193|NCT00116805|21088281|P2|Open-label Period Weeks 97 - 144|Withdrew Consent|3
6114194|NCT00116805|21088282|P1|Open-label Period Weeks 97 - 144|Withdrew Consent|1
6114195|NCT00116805|21088281|P2|Open-label Period Weeks 97 - 144|Seroconversion|3
6114196|NCT00116805|21088282|P1|Open-label Period Weeks 97 - 144|Seroconversion|2
6114197|NCT00116805|21088281|P2|Open-label Period Weeks 97 - 144|Protocol Violation|1
6114198|NCT00116805|21088282|P1|Open-label Period Weeks 97 - 144|Protocol Violation|0
6114199|NCT00116805|21088281|P2|Open-label Period Weeks 97 - 144|Lost to Follow-up|2
6114200|NCT00116805|21088282|P1|Open-label Period Weeks 97 - 144|Lost to Follow-up|5
6114201|NCT00116805|21088281|P2|Open-label Period Weeks 97 - 144|Investigator's Discretion|0
6114202|NCT00116805|21088282|P1|Open-label Period Weeks 97 - 144|Investigator's Discretion|2
6114203|NCT00116805|21088281|P2|Open-label Period Weeks 97 - 144|Completed Study|0
6114204|NCT00116805|21088282|P1|Open-label Period Weeks 97 - 144|Completed Study|1
6114205|NCT00116805|21088281|P2|Open-label Period Weeks 49 - 96|Withdrew Consent|1
6114206|NCT00116805|21088282|P1|Open-label Period Weeks 49 - 96|Withdrew Consent|2
6114207|NCT00116805|21088281|P2|Open-label Period Weeks 49 - 96|Seroconversion|0
6114208|NCT00116805|21088282|P1|Open-label Period Weeks 49 - 96|Seroconversion|2
6114209|NCT00116805|21088281|P2|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|0
6114210|NCT00116805|21088282|P1|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1
6114211|NCT00116805|21088281|P2|Open-label Period Weeks 49 - 96|Protocol Violation|0
6114212|NCT00116805|21088282|P1|Open-label Period Weeks 49 - 96|Protocol Violation|2
6114213|NCT00116805|21088281|P2|Open-label Period Weeks 49 - 96|Lost to Follow-up|0
6114214|NCT00116805|21088282|P1|Open-label Period Weeks 49 - 96|Lost to Follow-up|2
6114215|NCT00116805|21088281|P2|Open-label Period Weeks 49 - 96|Investigator's Discretion|0
6114216|NCT00116805|21088282|P1|Open-label Period Weeks 49 - 96|Investigator's Discretion|1
6114217|NCT00116805|21088281|P2|Double-blind Period Through Week 48|Withdrew Consent|2
6114218|NCT00116805|21088282|P1|Double-blind Period Through Week 48|Withdrew Consent|4
6114219|NCT00116805|21088281|P2|Double-blind Period Through Week 48|Protocol Violation|1
6114220|NCT00116805|21088282|P1|Double-blind Period Through Week 48|Protocol Violation|1
6114221|NCT00116805|21088281|P2|Double-blind Period Through Week 48|Lost to Follow-up|2
6114222|NCT00116805|21088282|P1|Double-blind Period Through Week 48|Lost to Follow-up|6
6114223|NCT00116779|21088375|P2|Overall Study|Elevated PSA levels|2
6114224|NCT00116779|21088376|P1|Overall Study|Elevated PSA levels|2
6114225|NCT00116779|21088375|P2|Overall Study|Physician Decision|1
6114226|NCT00116779|21088376|P1|Overall Study|Physician Decision|3
6114227|NCT00116779|21088375|P2|Overall Study|Inadequate testosterone suppression|9
6114228|NCT00116779|21088376|P1|Overall Study|Inadequate testosterone suppression|7
6114229|NCT00116779|21088375|P2|Overall Study|Withdrawal by Subject|1
6114230|NCT00116779|21088376|P1|Overall Study|Withdrawal by Subject|4
6114231|NCT00116779|21088375|P2|Overall Study|Protocol Violation|4
6114232|NCT00116779|21088376|P1|Overall Study|Protocol Violation|1
6114233|NCT00116779|21088375|P2|Overall Study|Adverse Event|2
6114234|NCT00116779|21088376|P1|Overall Study|Adverse Event|4
6114235|NCT00116753|21088409|P3|Overall Study|Dosing Error|0
6114236|NCT00116753|21088410|P2|Overall Study|Dosing Error|1
6114237|NCT00116753|21088411|P1|Overall Study|Dosing Error|0
6114238|NCT00116753|21088409|P3|Overall Study|Progressive Parkinson's Disease|0
6114239|NCT00116753|21088410|P2|Overall Study|Progressive Parkinson's Disease|0
6114240|NCT00116753|21088411|P1|Overall Study|Progressive Parkinson's Disease|1
6114241|NCT00116753|21088409|P3|Overall Study|Abnormal Echocardiogram|1
6114242|NCT00116753|21088410|P2|Overall Study|Abnormal Echocardiogram|0
6114243|NCT00116753|21088411|P1|Overall Study|Abnormal Echocardiogram|0
6114244|NCT00116753|21088409|P3|Overall Study|Disease Progression|3
6114245|NCT00116753|21088410|P2|Overall Study|Disease Progression|4
6114246|NCT00116753|21088411|P1|Overall Study|Disease Progression|3
6114247|NCT00116753|21088409|P3|Overall Study|Did not Fulfil Eligibility Criteria|3
6114248|NCT00116753|21088410|P2|Overall Study|Did not Fulfil Eligibility Criteria|1
6114249|NCT00116753|21088411|P1|Overall Study|Did not Fulfil Eligibility Criteria|1
6114250|NCT00116753|21088409|P3|Overall Study|Protocol Violation|1
6114251|NCT00116753|21088410|P2|Overall Study|Protocol Violation|0
6114252|NCT00116753|21088411|P1|Overall Study|Protocol Violation|0
6114254|NCT00116753|21088410|P2|Overall Study|Lost to Follow-up|2
6114255|NCT00116753|21088411|P1|Overall Study|Lost to Follow-up|0
6114256|NCT00116753|21088409|P3|Overall Study|Withdrawal by Subject|8
6114257|NCT00116753|21088410|P2|Overall Study|Withdrawal by Subject|12
6114258|NCT00116753|21088411|P1|Overall Study|Withdrawal by Subject|11
6114259|NCT00116753|21088409|P3|Overall Study|Adverse Event|7
6114260|NCT00116753|21088410|P2|Overall Study|Adverse Event|10
6114261|NCT00116753|21088411|P1|Overall Study|Adverse Event|16
6114262|NCT00116688|21088433|P2|Overall Study|Other|0
6114263|NCT00116688|21088434|P1|Overall Study|Other|11
6114264|NCT00116688|21088433|P2|Overall Study|Pregnancy|0
6114265|NCT00116688|21088434|P1|Overall Study|Pregnancy|1
6114266|NCT00116688|21088433|P2|Overall Study|Protocol-specified criteria|0
6114267|NCT00116688|21088434|P1|Overall Study|Protocol-specified criteria|3
6114268|NCT00116688|21088433|P2|Overall Study|Death|0
6114269|NCT00116688|21088434|P1|Overall Study|Death|15
6114270|NCT00116688|21088433|P2|Overall Study|Lost to Follow-up|0
6114271|NCT00116688|21088434|P1|Overall Study|Lost to Follow-up|3
6114272|NCT00116688|21088433|P2|Overall Study|Physician Decision|0
6114273|NCT00116688|21088434|P1|Overall Study|Physician Decision|7
6114274|NCT00116688|21088433|P2|Overall Study|Requirement for alternative therapy|1
6114275|NCT00116688|21088434|P1|Overall Study|Requirement for alternative therapy|11
6114276|NCT00116688|21088433|P2|Overall Study|Withdrawal by Subject|2
6114277|NCT00116688|21088434|P1|Overall Study|Withdrawal by Subject|26
6114278|NCT00116688|21088433|P2|Overall Study|Adverse Event|0
6114279|NCT00116688|21088434|P1|Overall Study|Adverse Event|11
6114280|NCT00116688|21088433|P2|Overall Study|Noncompliance|1
6114281|NCT00116688|21088434|P1|Overall Study|Noncompliance|3
6114282|NCT00116688|21088433|P2|Overall Study|Protocol deviation|0
6114283|NCT00116688|21088434|P1|Overall Study|Protocol deviation|1
6114284|NCT00116649|21088449|P1|Overall Study|Protocol Specified|7
6114285|NCT00116649|21088449|P1|Overall Study|Various Reasons|18
6114286|NCT00116649|21088449|P1|Overall Study|Local Skin Reaction|9
6114287|NCT00116649|21088449|P1|Overall Study|Withdrawal by Subject|68
6114288|NCT00116649|21088449|P1|Overall Study|Lost to Follow-up|32
6114289|NCT00116649|21088449|P1|Overall Study|Lack of Efficacy|1
6114290|NCT00116649|21088449|P1|Overall Study|Adverse Event|20
6114291|NCT00116584|21088456|P2|Overall Study|Protocol Violation|1
6114292|NCT00116584|21088457|P1|Overall Study|Protocol Violation|1
6114293|NCT00116584|21088456|P2|Overall Study|Withdrawal by Subject|0
6114294|NCT00116584|21088457|P1|Overall Study|Withdrawal by Subject|1
6114295|NCT00116558|21088470|P3|Overall Study|disease progression|18
6114296|NCT00116558|21088471|P2|Overall Study|disease progression|7
6114297|NCT00116558|21088472|P1|Overall Study|disease progression|3
6114298|NCT00116558|21088470|P3|Overall Study|Withdrawal by Subject|12
6114299|NCT00116558|21088471|P2|Overall Study|Withdrawal by Subject|3
6114300|NCT00116558|21088472|P1|Overall Study|Withdrawal by Subject|17
6114301|NCT00116558|21088470|P3|Overall Study|Death|3
6114302|NCT00116558|21088471|P2|Overall Study|Death|5
6114303|NCT00116558|21088472|P1|Overall Study|Death|11
6114304|NCT00116428|21088483|P2|Overall Study|Did not meet inclusion criteria|0
6114305|NCT00116428|21088484|P1|Overall Study|Did not meet inclusion criteria|1
6114306|NCT00116428|21088483|P2|Overall Study|Withdrawal by Subject|5
6114307|NCT00116428|21088484|P1|Overall Study|Withdrawal by Subject|2
6114308|NCT00116272|21088513|P2|Overall Study|Lost to Follow-up|6
6114309|NCT00116272|21088514|P1|Overall Study|Lost to Follow-up|11
6114310|NCT00116168|21088583|P4|Overall Study|Lost to Follow-up|0
6114311|NCT00116168|21088584|P3|Overall Study|Lost to Follow-up|0
6114312|NCT00116168|21088585|P2|Overall Study|Lost to Follow-up|5
6114313|NCT00116168|21088586|P1|Overall Study|Lost to Follow-up|6
6114314|NCT00115934|21088650|P2|Overall Study|Did not receive intervention|2
6114315|NCT00115934|21088651|P1|Overall Study|Did not receive intervention|3
6114316|NCT00115934|21088650|P2|Overall Study|Lost to Follow-up|0
6114317|NCT00115934|21088651|P1|Overall Study|Lost to Follow-up|1
6114318|NCT00115804|21088700|P1|Overall Study|Adverse Event|2
6114319|NCT00115778|21088711|P2|Overall Study|Withdrawal by Subject|1
6114320|NCT00115778|21088712|P1|Overall Study|Withdrawal by Subject|0
6114321|NCT00115765|21088732|P4|Overall Study|Other|2
6114322|NCT00115765|21088733|P3|Overall Study|Other|9
6114323|NCT00115765|21088734|P2|Overall Study|Other|12
6114324|NCT00115765|21088735|P1|Overall Study|Other|6
6114325|NCT00115765|21088732|P4|Overall Study|Lost to Follow-up|1
6114326|NCT00115765|21088733|P3|Overall Study|Lost to Follow-up|18
6114327|NCT00115765|21088734|P2|Overall Study|Lost to Follow-up|20
6114328|NCT00115765|21088735|P1|Overall Study|Lost to Follow-up|3
6114329|NCT00115765|21088732|P4|Overall Study|Physician Decision|13
6114330|NCT00115765|21088733|P3|Overall Study|Physician Decision|18
6114331|NCT00115765|21088734|P2|Overall Study|Physician Decision|15
6114332|NCT00115765|21088735|P1|Overall Study|Physician Decision|4
6114333|NCT00115765|21088732|P4|Overall Study|Withdrawal by Subject|15
6114334|NCT00115765|21088733|P3|Overall Study|Withdrawal by Subject|76
6114335|NCT00115765|21088734|P2|Overall Study|Withdrawal by Subject|53
6114336|NCT00115765|21088735|P1|Overall Study|Withdrawal by Subject|22
6114337|NCT00115739|21088773|P1|Overall Study|Lost to Follow-up|3
6114338|NCT00115349|21088782|P2|Overall Study|Study closed due to low enrollment.|9
6114339|NCT00115349|21088783|P1|Overall Study|Study closed due to low enrollment.|11
6114340|NCT00115336|21088791|P2|Overall Study|Hospital discharge before study drug|1
6114341|NCT00115336|21088792|P1|Overall Study|Hospital discharge before study drug|0
6114342|NCT00115063|21088829|P2|Overall Study|Death|0
6114343|NCT00115063|21088830|P1|Overall Study|Death|1
6114344|NCT00115063|21088829|P2|Overall Study|Lost to Follow-up|104
6114345|NCT00115063|21088830|P1|Overall Study|Lost to Follow-up|98
6114346|NCT00115037|21088848|P6|Phase2|Lost to Follow-up|10
6114347|NCT00115037|21088849|P5|Phase2|Lost to Follow-up|4
6114348|NCT00115037|21088850|P4|Phase2|Lost to Follow-up|14
6114349|NCT00115037|21088851|P3|Phase2|Lost to Follow-up|12
6114350|NCT00115037|21088852|P2|Phase2|Lost to Follow-up|0
6114351|NCT00115037|21088853|P1|Phase2|Lost to Follow-up|0
6114352|NCT00115037|21088848|P6|Phase2|Withdrawal by Subject|1
6114353|NCT00115037|21088849|P5|Phase2|Withdrawal by Subject|2
6114354|NCT00115037|21088850|P4|Phase2|Withdrawal by Subject|1
6114355|NCT00115037|21088851|P3|Phase2|Withdrawal by Subject|2
6114356|NCT00115037|21088852|P2|Phase2|Withdrawal by Subject|0
6114357|NCT00115037|21088853|P1|Phase2|Withdrawal by Subject|0
6114358|NCT00115037|21088848|P6|Phase2|Death|1
6114359|NCT00115037|21088849|P5|Phase2|Death|0
6114360|NCT00115037|21088850|P4|Phase2|Death|0
6114361|NCT00115037|21088851|P3|Phase2|Death|1
6114362|NCT00115037|21088852|P2|Phase2|Death|0
6114363|NCT00115037|21088853|P1|Phase2|Death|0
6114364|NCT00115037|21088848|P6|Phase1|Withdrawal by Subject|0
6114365|NCT00115037|21088849|P5|Phase1|Withdrawal by Subject|0
6114366|NCT00115037|21088850|P4|Phase1|Withdrawal by Subject|0
6114367|NCT00115037|21088851|P3|Phase1|Withdrawal by Subject|0
6114368|NCT00115037|21088852|P2|Phase1|Withdrawal by Subject|4
6114369|NCT00115037|21088853|P1|Phase1|Withdrawal by Subject|9
6114370|NCT00115037|21088848|P6|Phase1|Lost to Follow-up|0
6114371|NCT00115037|21088849|P5|Phase1|Lost to Follow-up|0
6114372|NCT00115037|21088850|P4|Phase1|Lost to Follow-up|0
6114373|NCT00115037|21088851|P3|Phase1|Lost to Follow-up|0
6114374|NCT00115037|21088852|P2|Phase1|Lost to Follow-up|23
6114375|NCT00115037|21088853|P1|Phase1|Lost to Follow-up|16
6114376|NCT00114972|21088869|P2|Overall Study|Lost to Follow-up|5
6114377|NCT00114972|21088870|P1|Overall Study|Lost to Follow-up|8
6114378|NCT00114972|21088869|P2|Overall Study|Withdrawal by Subject|7
6114379|NCT00114972|21088870|P1|Overall Study|Withdrawal by Subject|40
6114380|NCT00114959|21088890|P1|Overall Study|Death|1
6114381|NCT00114959|21088890|P1|Overall Study|Physician Decision|1
6114382|NCT00114959|21088890|P1|Overall Study|Lack of Efficacy|6
6114383|NCT00114777|21088900|P3|Long-Term Extension to Month 84|Other|2
6114384|NCT00114777|21088901|P2|Long-Term Extension to Month 84|Other|0
6114385|NCT00114777|21088902|P1|Long-Term Extension to Month 84|Other|2
6114386|NCT00114777|21088900|P3|Long-Term Extension to Month 84|Administrative Reason by Sponsor|1
6114387|NCT00114777|21088901|P2|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0
6114388|NCT00114777|21088902|P1|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0
6114389|NCT00114777|21088900|P3|Long-Term Extension to Month 84|Lost to Follow-up|2
6114390|NCT00114777|21088901|P2|Long-Term Extension to Month 84|Lost to Follow-up|0
6114391|NCT00114777|21088902|P1|Long-Term Extension to Month 84|Lost to Follow-up|0
6114392|NCT00114777|21088900|P3|Long-Term Extension to Month 84|Withdrawal by Subject|6
6114393|NCT00114777|21088901|P2|Long-Term Extension to Month 84|Withdrawal by Subject|1
6114394|NCT00114777|21088902|P1|Long-Term Extension to Month 84|Withdrawal by Subject|2
6114395|NCT00114777|21088900|P3|Long-Term Extension to Month 84|Adverse Event|7
6114396|NCT00114777|21088901|P2|Long-Term Extension to Month 84|Adverse Event|14
6114397|NCT00114777|21088902|P1|Long-Term Extension to Month 84|Adverse Event|15
6114398|NCT00114777|21088900|P3|Long-Term Extension to Month 84|Poor or Non-Compliance|3
6114399|NCT00114777|21088901|P2|Long-Term Extension to Month 84|Poor or Non-Compliance|1
6114400|NCT00114777|21088902|P1|Long-Term Extension to Month 84|Poor or Non-Compliance|1
6114401|NCT00114777|21088900|P3|Long-Term Extension to Month 84|Lack of Efficacy|1
6114402|NCT00114777|21088901|P2|Long-Term Extension to Month 84|Lack of Efficacy|0
6114403|NCT00114777|21088902|P1|Long-Term Extension to Month 84|Lack of Efficacy|1
6114404|NCT00114777|21088900|P3|Long-Term Extension to Month 84|No Longer Met Study Criteria|1
6114405|NCT00114777|21088901|P2|Long-Term Extension to Month 84|No Longer Met Study Criteria|0
6114406|NCT00114777|21088902|P1|Long-Term Extension to Month 84|No Longer Met Study Criteria|1
6114407|NCT00114777|21088900|P3|Long-Term Extension to Month 84|Death|7
6114408|NCT00114777|21088901|P2|Long-Term Extension to Month 84|Death|13
6114409|NCT00114777|21088902|P1|Long-Term Extension to Month 84|Death|8
6114410|NCT00114777|21088900|P3|Randomization to Month 36|Other|12
6114411|NCT00114777|21088901|P2|Randomization to Month 36|Other|3
6114412|NCT00114777|21088902|P1|Randomization to Month 36|Other|9
6114413|NCT00114777|21088900|P3|Randomization to Month 36|Withdrawal by Subject|5
6114414|NCT00114777|21088901|P2|Randomization to Month 36|Withdrawal by Subject|4
6114415|NCT00114777|21088902|P1|Randomization to Month 36|Withdrawal by Subject|3
6114416|NCT00114777|21088900|P3|Randomization to Month 36|Adverse Event|44
6114417|NCT00114777|21088901|P2|Randomization to Month 36|Adverse Event|35
6114418|NCT00114777|21088902|P1|Randomization to Month 36|Adverse Event|34
6114419|NCT00114777|21088900|P3|Randomization to Month 36|Poor or Non-Compliance|1
6114420|NCT00114777|21088901|P2|Randomization to Month 36|Poor or Non-Compliance|0
6114421|NCT00114777|21088902|P1|Randomization to Month 36|Poor or Non-Compliance|0
6114422|NCT00114777|21088900|P3|Randomization to Month 36|Lack of Efficacy|17
6114423|NCT00114777|21088901|P2|Randomization to Month 36|Lack of Efficacy|15
6114424|NCT00114777|21088902|P1|Randomization to Month 36|Lack of Efficacy|19
6114425|NCT00114777|21088900|P3|Randomization to Month 36|No Longer Met Study Criteria|2
6114426|NCT00114777|21088901|P2|Randomization to Month 36|No Longer Met Study Criteria|0
6114427|NCT00114777|21088902|P1|Randomization to Month 36|No Longer Met Study Criteria|0
6114428|NCT00114777|21088900|P3|Randomization to Month 36|Death|3
6114429|NCT00114777|21088901|P2|Randomization to Month 36|Death|4
6114430|NCT00114777|21088902|P1|Randomization to Month 36|Death|10
6114431|NCT00114738|21088976|P3|Screening for Randomization|Other|0
6114432|NCT00114738|21088977|P2|Screening for Randomization|Other|0
6114433|NCT00114738|21088978|P1|Screening for Randomization|Other|1
6114434|NCT00114738|21088976|P3|Screening for Randomization|CNS Hemorrhage|0
6114435|NCT00114738|21088977|P2|Screening for Randomization|CNS Hemorrhage|0
6114436|NCT00114738|21088978|P1|Screening for Randomization|CNS Hemorrhage|1
6114437|NCT00114738|21088976|P3|Screening for Randomization|Progressive disease|0
6114438|NCT00114738|21088977|P2|Screening for Randomization|Progressive disease|0
6114439|NCT00114738|21088978|P1|Screening for Randomization|Progressive disease|2
6114440|NCT00114738|21088976|P3|Screening for Randomization|Neuropathy|0
6114441|NCT00114738|21088977|P2|Screening for Randomization|Neuropathy|0
6114442|NCT00114738|21088978|P1|Screening for Randomization|Neuropathy|17
6114443|NCT00114738|21088976|P3|Bortezomib Then Bortezomib + Induction|Progressive Disease|0
6114444|NCT00114738|21088977|P2|Bortezomib Then Bortezomib + Induction|Progressive Disease|0
6114445|NCT00114738|21088978|P1|Bortezomib Then Bortezomib + Induction|Progressive Disease|1
6114446|NCT00114738|21088976|P3|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0
6114447|NCT00114738|21088977|P2|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0
6114448|NCT00114738|21088978|P1|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|1
6114449|NCT00114634|21088991|P1|Overall Study|failure to return forms|3
6114450|NCT00114530|21089007|P2|Overall Study|Ineligible|0
6114451|NCT00114530|21089008|P1|Overall Study|Ineligible|1
6114452|NCT00114530|21089007|P2|Overall Study|Subject decision after endpoint failure|1
6114453|NCT00114530|21089008|P1|Overall Study|Subject decision after endpoint failure|0
6114454|NCT00114530|21089007|P2|Overall Study|Breast Cancer|0
6114455|NCT00114530|21089008|P1|Overall Study|Breast Cancer|1
6114456|NCT00114530|21089007|P2|Overall Study|Withdrawal by Subject|6
6114457|NCT00114530|21089008|P1|Overall Study|Withdrawal by Subject|2
6114458|NCT00114530|21089007|P2|Overall Study|Physician Decision|1
6114459|NCT00114530|21089008|P1|Overall Study|Physician Decision|1
6114460|NCT00114530|21089007|P2|Overall Study|Lost to Follow-up|1
6114461|NCT00114530|21089008|P1|Overall Study|Lost to Follow-up|1
6114462|NCT00114530|21089007|P2|Overall Study|Death|11
6114463|NCT00114530|21089008|P1|Overall Study|Death|3
6114464|NCT00114244|21089145|P2|Overall Study|Withdrawal by Subject|2
6114465|NCT00114244|21089146|P1|Overall Study|Withdrawal by Subject|0
6114466|NCT00114244|21089145|P2|Overall Study|Adverse Event|5
6114467|NCT00114244|21089146|P1|Overall Study|Adverse Event|2
6114468|NCT00114231|21089158|P2|Overall Study|Biopsy done after registration|0
6114469|NCT00114231|21089159|P1|Overall Study|Biopsy done after registration|1
6114470|NCT00114231|21089158|P2|Overall Study|No Absolute Neutrophil Count|0
6114471|NCT00114231|21089159|P1|Overall Study|No Absolute Neutrophil Count|2
6114472|NCT00114231|21089158|P2|Overall Study|Tumor fixed on digital exam|1
6114473|NCT00114231|21089159|P1|Overall Study|Tumor fixed on digital exam|0
6114474|NCT00114231|21089158|P2|Overall Study|Tumor size > 4cm|0
6114475|NCT00114231|21089159|P1|Overall Study|Tumor size > 4cm|1
6114476|NCT00114231|21089158|P2|Overall Study|Low creatinine clearance|1
6114477|NCT00114231|21089159|P1|Overall Study|Low creatinine clearance|0
6114478|NCT00114231|21089158|P2|Overall Study|No adenocarcinoma|0
6114479|NCT00114231|21089159|P1|Overall Study|No adenocarcinoma|1
6114480|NCT00114231|21089158|P2|Overall Study|Suspected metastatic disease|0
6114481|NCT00114231|21089159|P1|Overall Study|Suspected metastatic disease|1
6114482|NCT00114231|21089158|P2|Overall Study|QARC requirement not met|0
6114483|NCT00114231|21089159|P1|Overall Study|QARC requirement not met|1
6114484|NCT00114231|21089158|P2|Overall Study|No consent|0
6114485|NCT00114231|21089159|P1|Overall Study|No consent|2
6114486|NCT00114218|21089168|P1|Overall Study|Never Treated|1
6114487|NCT00114218|21089168|P1|Overall Study|Wrong Primary|1
6114488|NCT00114218|21089168|P1|Overall Study|Wrong Cell Type|2
6114489|NCT00114166|21089175|P2|Overall Study|Wrong primary|1
6114490|NCT00114166|21089176|P1|Overall Study|Wrong primary|0
6114491|NCT00114140|21089186|P1|Overall Study|Protocol Violation|7
6114492|NCT00114127|21089200|P2|Overall Study|Withdrawal by Subject|3
6114493|NCT00114127|21089201|P1|Overall Study|Withdrawal by Subject|1
6114494|NCT00114127|21089200|P2|Overall Study|Lost to Follow-up|0
6114495|NCT00114127|21089201|P1|Overall Study|Lost to Follow-up|1
6114496|NCT00114127|21089200|P2|Overall Study|Adverse Event|1
6114497|NCT00114127|21089201|P1|Overall Study|Adverse Event|2
6114498|NCT00113919|21089273|P1|Overall Study|Death|6
6114499|NCT00113919|21089273|P1|Overall Study|Physician Decision|8
6114500|NCT00113841|21089341|P2|Overall Study|Non-compliant|0
6114501|NCT00113841|21089342|P1|Overall Study|Non-compliant|1
6114502|NCT00113841|21089341|P2|Overall Study|Disease progression|2
6114503|NCT00113841|21089342|P1|Overall Study|Disease progression|0
6114504|NCT00113763|21089350|P2|Overall Study|Ongoing|0
6114505|NCT00113763|21089351|P1|Overall Study|Ongoing|1
6114506|NCT00113763|21089350|P2|Overall Study|Non-compliance|0
6114507|NCT00113763|21089351|P1|Overall Study|Non-compliance|1
6114508|NCT00113763|21089350|P2|Overall Study|Other|6
6114509|NCT00113763|21089351|P1|Overall Study|Other|27
6114510|NCT00113763|21089350|P2|Overall Study|Withdrawal by Subject|4
6114511|NCT00113763|21089351|P1|Overall Study|Withdrawal by Subject|1
6114512|NCT00113763|21089350|P2|Overall Study|Lost to Follow-up|0
6114513|NCT00113763|21089351|P1|Overall Study|Lost to Follow-up|10
6114514|NCT00113763|21089350|P2|Overall Study|Disease Progression|14
6114515|NCT00113763|21089351|P1|Overall Study|Disease Progression|28
6114516|NCT00113763|21089350|P2|Overall Study|Adverse Event|2
6114517|NCT00113763|21089351|P1|Overall Study|Adverse Event|5
6114518|NCT00113607|21089377|P2|Overall Study|Other|32
6114519|NCT00113607|21089378|P1|Overall Study|Other|43
6114520|NCT00113607|21089377|P2|Overall Study|Complete Response (Confirmed)|24
6114521|NCT00113607|21089378|P1|Overall Study|Complete Response (Confirmed)|14
6114522|NCT00113607|21089377|P2|Overall Study|Disease Progression|142
6114523|NCT00113607|21089378|P1|Overall Study|Disease Progression|180
6114524|NCT00113607|21089377|P2|Overall Study|Lost to Follow-up|2
6114525|NCT00113607|21089378|P1|Overall Study|Lost to Follow-up|0
6114526|NCT00113607|21089377|P2|Overall Study|Withdrawal by Subject|58
6114527|NCT00113607|21089378|P1|Overall Study|Withdrawal by Subject|50
6114528|NCT00113607|21089377|P2|Overall Study|Death|8
6114529|NCT00113607|21089378|P1|Overall Study|Death|8
6114530|NCT00113607|21089377|P2|Overall Study|Adverse Event|71
6114531|NCT00113607|21089378|P1|Overall Study|Adverse Event|40
6114532|NCT00113568|21089392|P1|Overall Study|Other|112
6114533|NCT00113568|21089392|P1|Overall Study|Withdrawal by Subject|117
6114534|NCT00113568|21089392|P1|Overall Study|Protocol Violation|32
6114535|NCT00113568|21089392|P1|Overall Study|Lost to Follow-up|156
6114536|NCT00113568|21089392|P1|Overall Study|Lack of Efficacy|30
6114537|NCT00113568|21089392|P1|Overall Study|Death|1
6114538|NCT00113568|21089392|P1|Overall Study|Adverse Event|97
6114539|NCT00113555|21089404|P1|Overall Study|Lost to Follow-up|8
6114540|NCT00113555|21089404|P1|Overall Study|Missed Followup|4
6114541|NCT00113555|21089404|P1|Overall Study|Death|1
6114542|NCT00113555|21089404|P1|Overall Study|Permanently Explanted|7
6114543|NCT00113555|21089404|P1|Overall Study|Baseline Failure|59
6114544|NCT00113529|21089414|P1|Overall Study|Withdrawal by Subject|4
6114545|NCT00113529|21089414|P1|Overall Study|Decision of sponsor|6
6114546|NCT00113529|21089414|P1|Overall Study|Lack of Efficacy|20
6114547|NCT00113529|21089414|P1|Overall Study|Adverse Event|4
6114548|NCT00113516|21089447|P2|Part 2|Ongoing|1
6114549|NCT00113516|21089448|P1|Part 2|Ongoing|0
6114550|NCT00113516|21089447|P2|Part 2|Laboratory Abnormality|1
6114551|NCT00113516|21089448|P1|Part 2|Laboratory Abnormality|0
6114552|NCT00113516|21089447|P2|Part 2|Other|3
6114553|NCT00113516|21089448|P1|Part 2|Other|0
6114554|NCT00113516|21089447|P2|Part 2|Withdrawal by Subject|3
6114555|NCT00113516|21089448|P1|Part 2|Withdrawal by Subject|0
6114556|NCT00113516|21089447|P2|Part 2|Lack of Efficacy|37
6114557|NCT00113516|21089448|P1|Part 2|Lack of Efficacy|0
6114558|NCT00113516|21089447|P2|Part 2|Death|5
6114559|NCT00113516|21089448|P1|Part 2|Death|0
6114560|NCT00113516|21089447|P2|Part 2|Adverse Event|16
6114561|NCT00113516|21089448|P1|Part 2|Adverse Event|0
6114562|NCT00113516|21089447|P2|Part 1|Missing|0
6114563|NCT00113516|21089448|P1|Part 1|Missing|65
6114564|NCT00113516|21089447|P2|Part 1|Ongoing|0
6114565|NCT00113516|21089448|P1|Part 1|Ongoing|1
6114566|NCT00113516|21089447|P2|Part 1|Laboratory Abnormality|0
6114567|NCT00113516|21089448|P1|Part 1|Laboratory Abnormality|1
6114568|NCT00113516|21089447|P2|Part 1|Did Not Meet Entrance Criteria|0
6114569|NCT00113516|21089448|P1|Part 1|Did Not Meet Entrance Criteria|1
6114570|NCT00113516|21089447|P2|Part 1|Lack of Efficacy|0
6114571|NCT00113516|21089448|P1|Part 1|Lack of Efficacy|2
6114572|NCT00113516|21089447|P2|Part 1|Withdrawal by Subject|0
6114573|NCT00113516|21089448|P1|Part 1|Withdrawal by Subject|2
6114574|NCT00113516|21089447|P2|Part 1|Other|0
6114575|NCT00113516|21089448|P1|Part 1|Other|3
6114576|NCT00113516|21089447|P2|Part 1|Death|0
6114577|NCT00113516|21089448|P1|Part 1|Death|3
6114578|NCT00113516|21089447|P2|Part 1|Adverse Event|0
6114579|NCT00113516|21089448|P1|Part 1|Adverse Event|6
6114580|NCT00113490|21089491|P2|Overall Study|Lost to Follow-up|0
6114581|NCT00113490|21089492|P1|Overall Study|Lost to Follow-up|1
6114582|NCT00113490|21089491|P2|Overall Study|Withdrawal by Subject|3
6114583|NCT00113490|21089492|P1|Overall Study|Withdrawal by Subject|1
6114584|NCT00113399|21089525|P2|Overall Study|Other|1
6114585|NCT00113399|21089526|P1|Overall Study|Other|0
6114586|NCT00113399|21089525|P2|Overall Study|Complete Response|1
6114587|NCT00113399|21089526|P1|Overall Study|Complete Response|0
6114588|NCT00113399|21089525|P2|Overall Study|Withdrawal by Subject|2
6114589|NCT00113399|21089526|P1|Overall Study|Withdrawal by Subject|1
6114590|NCT00113399|21089525|P2|Overall Study|Death|1
6114591|NCT00113399|21089526|P1|Overall Study|Death|1
6114592|NCT00113386|21089534|P2|Overall Study|Unknown - Lost to Follow-Up|1
6114593|NCT00113386|21089535|P1|Overall Study|Unknown - Lost to Follow-Up|2
6114594|NCT00113386|21089534|P2|Overall Study|Ineligible|2
6114595|NCT00113386|21089535|P1|Overall Study|Ineligible|1
6114596|NCT00113386|21089534|P2|Overall Study|Toxicity|0
6114597|NCT00113386|21089535|P1|Overall Study|Toxicity|3
6114598|NCT00113386|21089534|P2|Overall Study|Physician Decision|1
6114599|NCT00113386|21089535|P1|Overall Study|Physician Decision|0
6114600|NCT00113386|21089534|P2|Overall Study|Withdrawal by Subject|0
6114601|NCT00113386|21089535|P1|Overall Study|Withdrawal by Subject|1
6114602|NCT00113373|21089541|P1|Overall Study|Never Treated|1
6114603|NCT00113373|21089541|P1|Overall Study|Ineligible: second primary|1
6114604|NCT00113373|21089541|P1|Overall Study|Ineligible: wrong primary|1
6114605|NCT00113360|21089556|P1|Overall Study|Did not meet eligibility criteria|3
6114606|NCT00113360|21089556|P1|Overall Study|Subject required surgery|1
6114607|NCT00113360|21089556|P1|Overall Study|Adverse Event|3
6114608|NCT00113295|21089570|P2|Overall Study|Unrelated Medical Illness|0
6114609|NCT00113295|21089571|P1|Overall Study|Unrelated Medical Illness|1
6114610|NCT00113295|21089570|P2|Overall Study|Adverse Event|1
6114611|NCT00113295|21089571|P1|Overall Study|Adverse Event|4
6114612|NCT00113269|21089590|P4|Overall Study|Unable to return for follow up|0
6114613|NCT00113269|21089591|P3|Overall Study|Unable to return for follow up|0
6114614|NCT00113269|21089592|P2|Overall Study|Unable to return for follow up|1
6114615|NCT00113269|21089593|P1|Overall Study|Unable to return for follow up|2
6114616|NCT00113269|21089590|P4|Overall Study|Did not meet eligibility criteria|1
6114617|NCT00113269|21089591|P3|Overall Study|Did not meet eligibility criteria|0
6114618|NCT00113269|21089592|P2|Overall Study|Did not meet eligibility criteria|0
6114619|NCT00113269|21089593|P1|Overall Study|Did not meet eligibility criteria|1
6114620|NCT00113269|21089590|P4|Overall Study|Withdrew consent, Prednisone initiated|1
6114621|NCT00113269|21089591|P3|Overall Study|Withdrew consent, Prednisone initiated|0
6114622|NCT00113269|21089592|P2|Overall Study|Withdrew consent, Prednisone initiated|0
6114623|NCT00113269|21089593|P1|Overall Study|Withdrew consent, Prednisone initiated|0
6114624|NCT00113269|21089590|P4|Overall Study|Received pancreas transplant|2
6114625|NCT00113269|21089591|P3|Overall Study|Received pancreas transplant|0
6114626|NCT00113269|21089592|P2|Overall Study|Received pancreas transplant|0
6114627|NCT00113269|21089593|P1|Overall Study|Received pancreas transplant|0
6114628|NCT00113269|21089590|P4|Overall Study|Moved|3
6114629|NCT00113269|21089591|P3|Overall Study|Moved|0
6114630|NCT00113269|21089592|P2|Overall Study|Moved|1
6114631|NCT00113269|21089593|P1|Overall Study|Moved|0
6114632|NCT00113269|21089590|P4|Overall Study|Discontinued due to rejection|0
6114633|NCT00113269|21089591|P3|Overall Study|Discontinued due to rejection|1
6114634|NCT00113269|21089592|P2|Overall Study|Discontinued due to rejection|0
6114635|NCT00113269|21089593|P1|Overall Study|Discontinued due to rejection|0
6114636|NCT00113269|21089590|P4|Overall Study|Sponsor elected to discontinue patient|1
6114637|NCT00113269|21089591|P3|Overall Study|Sponsor elected to discontinue patient|0
6114638|NCT00113269|21089592|P2|Overall Study|Sponsor elected to discontinue patient|0
6114639|NCT00113269|21089593|P1|Overall Study|Sponsor elected to discontinue patient|1
6114640|NCT00113269|21089590|P4|Overall Study|Lost to Follow-up|3
6114641|NCT00113269|21089591|P3|Overall Study|Lost to Follow-up|6
6114642|NCT00113269|21089592|P2|Overall Study|Lost to Follow-up|3
6114643|NCT00113269|21089593|P1|Overall Study|Lost to Follow-up|2
6114644|NCT00113269|21089590|P4|Overall Study|Protocol Violation|2
6114645|NCT00113269|21089591|P3|Overall Study|Protocol Violation|4
6114646|NCT00113269|21089592|P2|Overall Study|Protocol Violation|0
6114647|NCT00113269|21089593|P1|Overall Study|Protocol Violation|1
6114648|NCT00113269|21089590|P4|Overall Study|Graft loss|9
6114649|NCT00113269|21089591|P3|Overall Study|Graft loss|4
6114650|NCT00113269|21089592|P2|Overall Study|Graft loss|6
6114651|NCT00113269|21089593|P1|Overall Study|Graft loss|6
6114652|NCT00113269|21089590|P4|Overall Study|Withdrawal by Subject|2
6114653|NCT00113269|21089591|P3|Overall Study|Withdrawal by Subject|4
6114654|NCT00113269|21089592|P2|Overall Study|Withdrawal by Subject|3
6114655|NCT00113269|21089593|P1|Overall Study|Withdrawal by Subject|4
6114656|NCT00113269|21089590|P4|Overall Study|Adverse Event|7
6114657|NCT00113269|21089591|P3|Overall Study|Adverse Event|11
6114658|NCT00113269|21089592|P2|Overall Study|Adverse Event|7
6114659|NCT00113269|21089593|P1|Overall Study|Adverse Event|2
6114660|NCT00113269|21089590|P4|Overall Study|Did not meet eligibility - pre-treatment|2
6114661|NCT00113269|21089591|P3|Overall Study|Did not meet eligibility - pre-treatment|0
6114662|NCT00113269|21089592|P2|Overall Study|Did not meet eligibility - pre-treatment|0
6114663|NCT00113269|21089593|P1|Overall Study|Did not meet eligibility - pre-treatment|0
6114664|NCT00113269|21089590|P4|Overall Study|Death in operating room|1
6114665|NCT00113269|21089591|P3|Overall Study|Death in operating room|0
6114666|NCT00113269|21089592|P2|Overall Study|Death in operating room|0
6114667|NCT00113269|21089593|P1|Overall Study|Death in operating room|0
6114668|NCT00113269|21089590|P4|Overall Study|Early graft loss, technical|0
6114669|NCT00113269|21089591|P3|Overall Study|Early graft loss, technical|2
6114670|NCT00113269|21089592|P2|Overall Study|Early graft loss, technical|0
6114671|NCT00113269|21089593|P1|Overall Study|Early graft loss, technical|0
6114672|NCT00113269|21089590|P4|Overall Study|Not transplanted, recipient issues|4
6114673|NCT00113269|21089591|P3|Overall Study|Not transplanted, recipient issues|7
6114674|NCT00113269|21089592|P2|Overall Study|Not transplanted, recipient issues|1
6114675|NCT00113269|21089593|P1|Overall Study|Not transplanted, recipient issues|2
6114676|NCT00113269|21089590|P4|Overall Study|Not transplanted, donor issues|2
6114677|NCT00113269|21089591|P3|Overall Study|Not transplanted, donor issues|2
6114678|NCT00113269|21089592|P2|Overall Study|Not transplanted, donor issues|0
6114679|NCT00113269|21089593|P1|Overall Study|Not transplanted, donor issues|4
6114680|NCT00113087|21089653|P2|Overall Study|Family or MD withdrew subject|5
6114681|NCT00113087|21089654|P1|Overall Study|Family or MD withdrew subject|10
6114682|NCT00113087|21089653|P2|Overall Study|Death or Transplant|16
6114683|NCT00113087|21089654|P1|Overall Study|Death or Transplant|14
6114684|NCT00112957|21089725|P1|Overall Study|Physician Decision|1
6114685|NCT00112957|21089725|P1|Overall Study|Progressive disease|18
6114686|NCT00112905|21089765|P1|Overall Study|performance status was deteiorating|1
6114687|NCT00112905|21089765|P1|Overall Study|Alternative treatment|1
6114688|NCT00112905|21089765|P1|Overall Study|Ineligibility|5
6114689|NCT00112905|21089765|P1|Overall Study|Death|1
6114690|NCT00112905|21089765|P1|Overall Study|Adverse Event|4
6114691|NCT00112866|21089774|P2|Overall Study|did not start treatment post-op|2
6114692|NCT00112866|21089775|P1|Overall Study|did not start treatment post-op|1
6114693|NCT00112866|21089774|P2|Overall Study|Protocol Violation|0
6114694|NCT00112866|21089775|P1|Overall Study|Protocol Violation|1
6114695|NCT00112840|21089797|P3|Overall Study|Protocol Violation|5
6114696|NCT00112840|21089798|P2|Overall Study|Protocol Violation|0
6114697|NCT00112840|21089799|P1|Overall Study|Protocol Violation|0
6114698|NCT00112840|21089797|P3|Overall Study|Withdrawal by Subject|1
6114699|NCT00112840|21089798|P2|Overall Study|Withdrawal by Subject|0
6114700|NCT00112840|21089799|P1|Overall Study|Withdrawal by Subject|1
6114701|NCT00112840|21089797|P3|Overall Study|Physician Decision|0
6114702|NCT00112840|21089798|P2|Overall Study|Physician Decision|0
6114703|NCT00112840|21089799|P1|Overall Study|Physician Decision|1
6114704|NCT00112736|21089818|P2|Overall Study|1 pt never had had RX due rapid decline|0
6114705|NCT00112736|21089819|P1|Overall Study|1 pt never had had RX due rapid decline|1
6114706|NCT00112489|21089876|P1|Overall Study|Ineligible|7
6114707|NCT00112489|21089876|P1|Overall Study|Patient never treated|2
6114708|NCT00112489|21089876|P1|Overall Study|Other, Not Specified|9
6114709|NCT00112489|21089876|P1|Overall Study|Death|2
6114710|NCT00112489|21089876|P1|Overall Study|Adverse Event|12
6114711|NCT00112489|21089876|P1|Overall Study|Refused further treatment|8
6114712|NCT00112463|21089886|P1|Overall Study|Never started treatment|2
6114713|NCT00112463|21089886|P1|Overall Study|Withdrawal by Subject|2
6114714|NCT00112463|21089886|P1|Overall Study|Toxicity|3
6114715|NCT00112463|21089886|P1|Overall Study|Second Primary|1
6114716|NCT00112463|21089886|P1|Overall Study|Progression|30
6114717|NCT00112463|21089886|P1|Overall Study|Physician Decision|1
6114718|NCT00112437|21089898|P26|Years 6-10 (60-Month Extension)|Withdrawal by Subject|3
6114719|NCT00112437|21089899|P25|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
6114720|NCT00112437|21089900|P24|Years 6-10 (60-Month Extension)|Withdrawal by Subject|6
6114721|NCT00112437|21089901|P23|Years 6-10 (60-Month Extension)|Withdrawal by Subject|4
6114722|NCT00112437|21089902|P22|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
6114723|NCT00112437|21089903|P21|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
6114724|NCT00112437|21089904|P20|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
6114725|NCT00112437|21089905|P19|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
6114726|NCT00112437|21089906|P18|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
6114727|NCT00112437|21089907|P17|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
6114728|NCT00112437|21089908|P16|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
6114729|NCT00112437|21089909|P15|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
6114730|NCT00112437|21089910|P14|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
6114731|NCT00112437|21089911|P13|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
6114732|NCT00112437|21089912|P12|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
6114733|NCT00112437|21089913|P11|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
6114734|NCT00112437|21089914|P10|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
6114735|NCT00112437|21089915|P9|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
6114736|NCT00112437|21089916|P8|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
6114737|NCT00112437|21089917|P7|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
6114738|NCT00112437|21089918|P6|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
6114739|NCT00112437|21089919|P5|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
6114740|NCT00112437|21089920|P4|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
6114741|NCT00112437|21089921|P3|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
6114742|NCT00112437|21089922|P2|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
6114743|NCT00112437|21089923|P1|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
6114744|NCT00112437|21089898|P26|Years 6-10 (60-Month Extension)|Physician Decision|0
6114745|NCT00112437|21089899|P25|Years 6-10 (60-Month Extension)|Physician Decision|0
6114746|NCT00112437|21089900|P24|Years 6-10 (60-Month Extension)|Physician Decision|2
6114747|NCT00112437|21089901|P23|Years 6-10 (60-Month Extension)|Physician Decision|0
6114748|NCT00112437|21089902|P22|Years 6-10 (60-Month Extension)|Physician Decision|0
6114749|NCT00112437|21089903|P21|Years 6-10 (60-Month Extension)|Physician Decision|0
6114750|NCT00112437|21089904|P20|Years 6-10 (60-Month Extension)|Physician Decision|0
6114751|NCT00112437|21089905|P19|Years 6-10 (60-Month Extension)|Physician Decision|0
6114752|NCT00112437|21089906|P18|Years 6-10 (60-Month Extension)|Physician Decision|0
6114753|NCT00112437|21089907|P17|Years 6-10 (60-Month Extension)|Physician Decision|0
6114754|NCT00112437|21089908|P16|Years 6-10 (60-Month Extension)|Physician Decision|0
6114755|NCT00112437|21089909|P15|Years 6-10 (60-Month Extension)|Physician Decision|0
6114756|NCT00112437|21089910|P14|Years 6-10 (60-Month Extension)|Physician Decision|0
6114757|NCT00112437|21089911|P13|Years 6-10 (60-Month Extension)|Physician Decision|0
6114758|NCT00112437|21089912|P12|Years 6-10 (60-Month Extension)|Physician Decision|0
6114759|NCT00112437|21089913|P11|Years 6-10 (60-Month Extension)|Physician Decision|0
6114760|NCT00112437|21089914|P10|Years 6-10 (60-Month Extension)|Physician Decision|0
6114761|NCT00112437|21089915|P9|Years 6-10 (60-Month Extension)|Physician Decision|0
6114762|NCT00112437|21089916|P8|Years 6-10 (60-Month Extension)|Physician Decision|0
6114763|NCT00112437|21089917|P7|Years 6-10 (60-Month Extension)|Physician Decision|0
6114764|NCT00112437|21089918|P6|Years 6-10 (60-Month Extension)|Physician Decision|0
6114765|NCT00112437|21089919|P5|Years 6-10 (60-Month Extension)|Physician Decision|0
6114766|NCT00112437|21089920|P4|Years 6-10 (60-Month Extension)|Physician Decision|0
6114767|NCT00112437|21089921|P3|Years 6-10 (60-Month Extension)|Physician Decision|0
6114768|NCT00112437|21089922|P2|Years 6-10 (60-Month Extension)|Physician Decision|0
6114769|NCT00112437|21089923|P1|Years 6-10 (60-Month Extension)|Physician Decision|0
6114770|NCT00112437|21089898|P26|Years 6-10 (60-Month Extension)|Other|0
6114771|NCT00112437|21089899|P25|Years 6-10 (60-Month Extension)|Other|1
6114772|NCT00112437|21089900|P24|Years 6-10 (60-Month Extension)|Other|0
6114773|NCT00112437|21089901|P23|Years 6-10 (60-Month Extension)|Other|0
6114774|NCT00112437|21089902|P22|Years 6-10 (60-Month Extension)|Other|0
6114775|NCT00112437|21089903|P21|Years 6-10 (60-Month Extension)|Other|0
6114776|NCT00112437|21089904|P20|Years 6-10 (60-Month Extension)|Other|0
6114777|NCT00112437|21089905|P19|Years 6-10 (60-Month Extension)|Other|0
6114778|NCT00112437|21089906|P18|Years 6-10 (60-Month Extension)|Other|0
6114779|NCT00112437|21089907|P17|Years 6-10 (60-Month Extension)|Other|0
6114780|NCT00112437|21089908|P16|Years 6-10 (60-Month Extension)|Other|0
6114781|NCT00112437|21089909|P15|Years 6-10 (60-Month Extension)|Other|0
6114782|NCT00112437|21089910|P14|Years 6-10 (60-Month Extension)|Other|0
6114783|NCT00112437|21089911|P13|Years 6-10 (60-Month Extension)|Other|0
6114784|NCT00112437|21089912|P12|Years 6-10 (60-Month Extension)|Other|0
6114785|NCT00112437|21089913|P11|Years 6-10 (60-Month Extension)|Other|0
6114786|NCT00112437|21089914|P10|Years 6-10 (60-Month Extension)|Other|0
6114787|NCT00112437|21089915|P9|Years 6-10 (60-Month Extension)|Other|0
6114788|NCT00112437|21089916|P8|Years 6-10 (60-Month Extension)|Other|0
6114789|NCT00112437|21089917|P7|Years 6-10 (60-Month Extension)|Other|0
6114790|NCT00112437|21089918|P6|Years 6-10 (60-Month Extension)|Other|0
6114791|NCT00112437|21089919|P5|Years 6-10 (60-Month Extension)|Other|0
6114792|NCT00112437|21089920|P4|Years 6-10 (60-Month Extension)|Other|0
6114793|NCT00112437|21089921|P3|Years 6-10 (60-Month Extension)|Other|0
6114794|NCT00112437|21089922|P2|Years 6-10 (60-Month Extension)|Other|0
6114795|NCT00112437|21089923|P1|Years 6-10 (60-Month Extension)|Other|0
6114796|NCT00112437|21089898|P26|Years 6-10 (60-Month Extension)|Lost to Follow-up|1
6114797|NCT00112437|21089899|P25|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
6114798|NCT00112437|21089900|P24|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
6114799|NCT00112437|21089901|P23|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
6114800|NCT00112437|21089902|P22|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
6114801|NCT00112437|21089903|P21|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
6114802|NCT00112437|21089904|P20|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
6114803|NCT00112437|21089905|P19|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
6114804|NCT00112437|21089906|P18|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
6114805|NCT00112437|21089907|P17|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
6114806|NCT00112437|21089908|P16|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
6114807|NCT00112437|21089909|P15|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
6114808|NCT00112437|21089910|P14|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
6114809|NCT00112437|21089911|P13|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
6114810|NCT00112437|21089912|P12|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
6114811|NCT00112437|21089913|P11|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
6114812|NCT00112437|21089914|P10|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
6114813|NCT00112437|21089915|P9|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
6114814|NCT00112437|21089916|P8|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
6114815|NCT00112437|21089917|P7|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
6114816|NCT00112437|21089918|P6|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
6114817|NCT00112437|21089919|P5|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
6114818|NCT00112437|21089920|P4|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
6114819|NCT00112437|21089921|P3|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
6114820|NCT00112437|21089922|P2|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
6114821|NCT00112437|21089923|P1|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
6114822|NCT00112437|21089898|P26|Years 6-10 (60-Month Extension)|Death|0
6114823|NCT00112437|21089899|P25|Years 6-10 (60-Month Extension)|Death|0
6114824|NCT00112437|21089900|P24|Years 6-10 (60-Month Extension)|Death|2
6114825|NCT00112437|21089901|P23|Years 6-10 (60-Month Extension)|Death|0
6114826|NCT00112437|21089902|P22|Years 6-10 (60-Month Extension)|Death|0
6114827|NCT00112437|21089903|P21|Years 6-10 (60-Month Extension)|Death|0
6114828|NCT00112437|21089904|P20|Years 6-10 (60-Month Extension)|Death|0
6114829|NCT00112437|21089905|P19|Years 6-10 (60-Month Extension)|Death|0
6114830|NCT00112437|21089906|P18|Years 6-10 (60-Month Extension)|Death|0
6114831|NCT00112437|21089907|P17|Years 6-10 (60-Month Extension)|Death|0
6114832|NCT00112437|21089908|P16|Years 6-10 (60-Month Extension)|Death|0
6114833|NCT00112437|21089909|P15|Years 6-10 (60-Month Extension)|Death|0
6114834|NCT00112437|21089910|P14|Years 6-10 (60-Month Extension)|Death|0
6114835|NCT00112437|21089911|P13|Years 6-10 (60-Month Extension)|Death|0
6114836|NCT00112437|21089912|P12|Years 6-10 (60-Month Extension)|Death|0
6114837|NCT00112437|21089913|P11|Years 6-10 (60-Month Extension)|Death|0
6114838|NCT00112437|21089914|P10|Years 6-10 (60-Month Extension)|Death|0
6114839|NCT00112437|21089915|P9|Years 6-10 (60-Month Extension)|Death|0
6114840|NCT00112437|21089916|P8|Years 6-10 (60-Month Extension)|Death|0
6114841|NCT00112437|21089917|P7|Years 6-10 (60-Month Extension)|Death|0
6114842|NCT00112437|21089918|P6|Years 6-10 (60-Month Extension)|Death|0
6114843|NCT00112437|21089919|P5|Years 6-10 (60-Month Extension)|Death|0
6114844|NCT00112437|21089920|P4|Years 6-10 (60-Month Extension)|Death|0
6114845|NCT00112437|21089921|P3|Years 6-10 (60-Month Extension)|Death|0
6114846|NCT00112437|21089922|P2|Years 6-10 (60-Month Extension)|Death|0
6114847|NCT00112437|21089923|P1|Years 6-10 (60-Month Extension)|Death|0
6114848|NCT00112437|21089898|P26|Years 6-10 (60-Month Extension)|Adverse Event|1
6114849|NCT00112437|21089899|P25|Years 6-10 (60-Month Extension)|Adverse Event|0
6114850|NCT00112437|21089900|P24|Years 6-10 (60-Month Extension)|Adverse Event|2
6114851|NCT00112437|21089901|P23|Years 6-10 (60-Month Extension)|Adverse Event|1
6114852|NCT00112437|21089902|P22|Years 6-10 (60-Month Extension)|Adverse Event|0
6114853|NCT00112437|21089903|P21|Years 6-10 (60-Month Extension)|Adverse Event|0
6114854|NCT00112437|21089904|P20|Years 6-10 (60-Month Extension)|Adverse Event|0
6114855|NCT00112437|21089905|P19|Years 6-10 (60-Month Extension)|Adverse Event|0
6114856|NCT00112437|21089906|P18|Years 6-10 (60-Month Extension)|Adverse Event|0
6114857|NCT00112437|21089907|P17|Years 6-10 (60-Month Extension)|Adverse Event|0
6114858|NCT00112437|21089908|P16|Years 6-10 (60-Month Extension)|Adverse Event|0
6114859|NCT00112437|21089909|P15|Years 6-10 (60-Month Extension)|Adverse Event|0
6114860|NCT00112437|21089910|P14|Years 6-10 (60-Month Extension)|Adverse Event|0
6114861|NCT00112437|21089911|P13|Years 6-10 (60-Month Extension)|Adverse Event|0
6114862|NCT00112437|21089912|P12|Years 6-10 (60-Month Extension)|Adverse Event|0
6114863|NCT00112437|21089913|P11|Years 6-10 (60-Month Extension)|Adverse Event|0
6114864|NCT00112437|21089914|P10|Years 6-10 (60-Month Extension)|Adverse Event|0
6114865|NCT00112437|21089915|P9|Years 6-10 (60-Month Extension)|Adverse Event|0
6114866|NCT00112437|21089916|P8|Years 6-10 (60-Month Extension)|Adverse Event|0
6114867|NCT00112437|21089917|P7|Years 6-10 (60-Month Extension)|Adverse Event|0
6114868|NCT00112437|21089918|P6|Years 6-10 (60-Month Extension)|Adverse Event|0
6114869|NCT00112437|21089919|P5|Years 6-10 (60-Month Extension)|Adverse Event|0
6114870|NCT00112437|21089920|P4|Years 6-10 (60-Month Extension)|Adverse Event|0
6114871|NCT00112437|21089921|P3|Years 6-10 (60-Month Extension)|Adverse Event|0
6114872|NCT00112437|21089922|P2|Years 6-10 (60-Month Extension)|Adverse Event|0
6114873|NCT00112437|21089923|P1|Years 6-10 (60-Month Extension)|Adverse Event|0
6114874|NCT00112437|21089898|P26|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
6114875|NCT00112437|21089899|P25|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
6114876|NCT00112437|21089900|P24|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
6114877|NCT00112437|21089901|P23|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
6114878|NCT00112437|21089902|P22|Years 4-5 (24-Month Extension)|Withdrawal by Subject|2
6114879|NCT00112437|21089903|P21|Years 4-5 (24-Month Extension)|Withdrawal by Subject|1
6114880|NCT00112437|21089904|P20|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
6114881|NCT00112437|21089905|P19|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
6114882|NCT00112437|21089906|P18|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
6114883|NCT00112437|21089907|P17|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
6114884|NCT00112437|21089908|P16|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
6114885|NCT00112437|21089909|P15|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
6114886|NCT00112437|21089910|P14|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
6114887|NCT00112437|21089911|P13|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
6114888|NCT00112437|21089912|P12|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
6114889|NCT00112437|21089913|P11|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
6114890|NCT00112437|21089914|P10|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
6114891|NCT00112437|21089915|P9|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
6114892|NCT00112437|21089916|P8|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
6114893|NCT00112437|21089917|P7|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
6114894|NCT00112437|21089918|P6|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
6114895|NCT00112437|21089919|P5|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
6114896|NCT00112437|21089920|P4|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
6114897|NCT00112437|21089921|P3|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
6114898|NCT00112437|21089922|P2|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
6114899|NCT00112437|21089923|P1|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
6114900|NCT00112437|21089898|P26|Years 4-5 (24-Month Extension)|Participant moved|0
6114901|NCT00112437|21089899|P25|Years 4-5 (24-Month Extension)|Participant moved|0
6114902|NCT00112437|21089900|P24|Years 4-5 (24-Month Extension)|Participant moved|0
6114903|NCT00112437|21089901|P23|Years 4-5 (24-Month Extension)|Participant moved|0
6114904|NCT00112437|21089902|P22|Years 4-5 (24-Month Extension)|Participant moved|1
6114905|NCT00112437|21089903|P21|Years 4-5 (24-Month Extension)|Participant moved|0
6114906|NCT00112437|21089904|P20|Years 4-5 (24-Month Extension)|Participant moved|0
6114907|NCT00112437|21089905|P19|Years 4-5 (24-Month Extension)|Participant moved|0
6114908|NCT00112437|21089906|P18|Years 4-5 (24-Month Extension)|Participant moved|0
6114909|NCT00112437|21089907|P17|Years 4-5 (24-Month Extension)|Participant moved|0
6114910|NCT00112437|21089908|P16|Years 4-5 (24-Month Extension)|Participant moved|0
6114911|NCT00112437|21089909|P15|Years 4-5 (24-Month Extension)|Participant moved|0
6114912|NCT00112437|21089910|P14|Years 4-5 (24-Month Extension)|Participant moved|0
6114913|NCT00112437|21089911|P13|Years 4-5 (24-Month Extension)|Participant moved|0
6114914|NCT00112437|21089912|P12|Years 4-5 (24-Month Extension)|Participant moved|0
6114915|NCT00112437|21089913|P11|Years 4-5 (24-Month Extension)|Participant moved|0
6114916|NCT00112437|21089914|P10|Years 4-5 (24-Month Extension)|Participant moved|0
6114917|NCT00112437|21089915|P9|Years 4-5 (24-Month Extension)|Participant moved|0
6114918|NCT00112437|21089916|P8|Years 4-5 (24-Month Extension)|Participant moved|0
6114919|NCT00112437|21089917|P7|Years 4-5 (24-Month Extension)|Participant moved|0
6114920|NCT00112437|21089918|P6|Years 4-5 (24-Month Extension)|Participant moved|0
6114921|NCT00112437|21089919|P5|Years 4-5 (24-Month Extension)|Participant moved|0
6114922|NCT00112437|21089920|P4|Years 4-5 (24-Month Extension)|Participant moved|0
6114923|NCT00112437|21089921|P3|Years 4-5 (24-Month Extension)|Participant moved|0
6114924|NCT00112437|21089922|P2|Years 4-5 (24-Month Extension)|Participant moved|0
6114925|NCT00112437|21089923|P1|Years 4-5 (24-Month Extension)|Participant moved|0
6114926|NCT00112437|21089898|P26|Years 4-5 (24-Month Extension)|Adverse Event|0
6114927|NCT00112437|21089899|P25|Years 4-5 (24-Month Extension)|Adverse Event|0
6114928|NCT00112437|21089900|P24|Years 4-5 (24-Month Extension)|Adverse Event|0
6114929|NCT00112437|21089901|P23|Years 4-5 (24-Month Extension)|Adverse Event|0
6114930|NCT00112437|21089902|P22|Years 4-5 (24-Month Extension)|Adverse Event|4
6114931|NCT00112437|21089903|P21|Years 4-5 (24-Month Extension)|Adverse Event|0
6114932|NCT00112437|21089904|P20|Years 4-5 (24-Month Extension)|Adverse Event|0
6114933|NCT00112437|21089905|P19|Years 4-5 (24-Month Extension)|Adverse Event|0
6114934|NCT00112437|21089906|P18|Years 4-5 (24-Month Extension)|Adverse Event|0
6114935|NCT00112437|21089907|P17|Years 4-5 (24-Month Extension)|Adverse Event|0
6114936|NCT00112437|21089908|P16|Years 4-5 (24-Month Extension)|Adverse Event|0
6114937|NCT00112437|21089909|P15|Years 4-5 (24-Month Extension)|Adverse Event|0
6114938|NCT00112437|21089910|P14|Years 4-5 (24-Month Extension)|Adverse Event|0
6114939|NCT00112437|21089911|P13|Years 4-5 (24-Month Extension)|Adverse Event|0
6114940|NCT00112437|21089912|P12|Years 4-5 (24-Month Extension)|Adverse Event|0
6114941|NCT00112437|21089913|P11|Years 4-5 (24-Month Extension)|Adverse Event|0
6114942|NCT00112437|21089914|P10|Years 4-5 (24-Month Extension)|Adverse Event|0
6114943|NCT00112437|21089915|P9|Years 4-5 (24-Month Extension)|Adverse Event|0
6114944|NCT00112437|21089916|P8|Years 4-5 (24-Month Extension)|Adverse Event|0
6114945|NCT00112437|21089917|P7|Years 4-5 (24-Month Extension)|Adverse Event|0
6114946|NCT00112437|21089918|P6|Years 4-5 (24-Month Extension)|Adverse Event|0
6114947|NCT00112437|21089919|P5|Years 4-5 (24-Month Extension)|Adverse Event|0
6114948|NCT00112437|21089920|P4|Years 4-5 (24-Month Extension)|Adverse Event|0
6114949|NCT00112437|21089921|P3|Years 4-5 (24-Month Extension)|Adverse Event|0
6114950|NCT00112437|21089922|P2|Years 4-5 (24-Month Extension)|Adverse Event|0
6114951|NCT00112437|21089923|P1|Years 4-5 (24-Month Extension)|Adverse Event|0
6114952|NCT00112437|21089898|P26|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
6114953|NCT00112437|21089899|P25|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
6114954|NCT00112437|21089900|P24|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
6114955|NCT00112437|21089901|P23|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
6114956|NCT00112437|21089902|P22|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
6114957|NCT00112437|21089903|P21|Years 4-5 (24-Month Extension)|Discontinued for other reasons|1
6114958|NCT00112437|21089904|P20|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
6114959|NCT00112437|21089905|P19|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
6114960|NCT00112437|21089906|P18|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
6114961|NCT00112437|21089907|P17|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
6114962|NCT00112437|21089908|P16|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
6114963|NCT00112437|21089909|P15|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
6114964|NCT00112437|21089910|P14|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
6114965|NCT00112437|21089911|P13|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
6114966|NCT00112437|21089912|P12|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
6114967|NCT00112437|21089913|P11|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
6114968|NCT00112437|21089914|P10|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
6114969|NCT00112437|21089915|P9|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
6114970|NCT00112437|21089916|P8|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
6114971|NCT00112437|21089917|P7|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
6114972|NCT00112437|21089918|P6|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
6114973|NCT00112437|21089919|P5|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
6114974|NCT00112437|21089920|P4|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
6114975|NCT00112437|21089921|P3|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
6114976|NCT00112437|21089922|P2|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
6114977|NCT00112437|21089923|P1|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
6114978|NCT00112437|21089898|P26|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
6114979|NCT00112437|21089899|P25|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
6114980|NCT00112437|21089900|P24|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
6114981|NCT00112437|21089901|P23|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
6114982|NCT00112437|21089902|P22|Years 4-5 (24-Month Extension)|Lack of Efficacy|1
6114983|NCT00112437|21089903|P21|Years 4-5 (24-Month Extension)|Lack of Efficacy|2
6114984|NCT00112437|21089904|P20|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
6114985|NCT00112437|21089905|P19|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
6114986|NCT00112437|21089906|P18|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
6114987|NCT00112437|21089907|P17|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
6114988|NCT00112437|21089908|P16|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
6114989|NCT00112437|21089909|P15|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
6114990|NCT00112437|21089910|P14|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
6114991|NCT00112437|21089911|P13|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
6114992|NCT00112437|21089912|P12|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
6114993|NCT00112437|21089913|P11|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
6114994|NCT00112437|21089914|P10|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
6114995|NCT00112437|21089915|P9|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
6114996|NCT00112437|21089916|P8|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
6114997|NCT00112437|21089917|P7|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
6114998|NCT00112437|21089918|P6|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
6114999|NCT00112437|21089919|P5|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
6115000|NCT00112437|21089920|P4|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
6115001|NCT00112437|21089921|P3|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
6115002|NCT00112437|21089922|P2|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
6115003|NCT00112437|21089923|P1|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
6115004|NCT00112437|21089898|P26|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
6115005|NCT00112437|21089899|P25|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
6115006|NCT00112437|21089900|P24|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
6115007|NCT00112437|21089901|P23|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
6115008|NCT00112437|21089902|P22|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
6115009|NCT00112437|21089903|P21|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
6115010|NCT00112437|21089904|P20|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
6115011|NCT00112437|21089905|P19|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
6115012|NCT00112437|21089906|P18|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
6115013|NCT00112437|21089907|P17|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
6115014|NCT00112437|21089908|P16|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
6115015|NCT00112437|21089909|P15|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
6115016|NCT00112437|21089910|P14|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
6115017|NCT00112437|21089911|P13|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
6115018|NCT00112437|21089912|P12|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1
6115019|NCT00112437|21089913|P11|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1
6115020|NCT00112437|21089914|P10|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
6115021|NCT00112437|21089915|P9|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
6115022|NCT00112437|21089916|P8|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
6115023|NCT00112437|21089917|P7|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
6115024|NCT00112437|21089918|P6|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
6115025|NCT00112437|21089919|P5|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
6115026|NCT00112437|21089920|P4|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
6115027|NCT00112437|21089921|P3|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
6115028|NCT00112437|21089922|P2|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
6115029|NCT00112437|21089923|P1|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
6115030|NCT00112437|21089898|P26|Year 3 (12-Month Extension)|Withdrawal by Subject|0
6115031|NCT00112437|21089899|P25|Year 3 (12-Month Extension)|Withdrawal by Subject|0
6115032|NCT00112437|21089900|P24|Year 3 (12-Month Extension)|Withdrawal by Subject|0
6115033|NCT00112437|21089901|P23|Year 3 (12-Month Extension)|Withdrawal by Subject|0
6115034|NCT00112437|21089902|P22|Year 3 (12-Month Extension)|Withdrawal by Subject|0
6115035|NCT00112437|21089903|P21|Year 3 (12-Month Extension)|Withdrawal by Subject|0
6115036|NCT00112437|21089904|P20|Year 3 (12-Month Extension)|Withdrawal by Subject|0
6115037|NCT00112437|21089905|P19|Year 3 (12-Month Extension)|Withdrawal by Subject|0
6115038|NCT00112437|21089906|P18|Year 3 (12-Month Extension)|Withdrawal by Subject|0
6115039|NCT00112437|21089907|P17|Year 3 (12-Month Extension)|Withdrawal by Subject|0
6115040|NCT00112437|21089908|P16|Year 3 (12-Month Extension)|Withdrawal by Subject|0
6115041|NCT00112437|21089909|P15|Year 3 (12-Month Extension)|Withdrawal by Subject|1
6115042|NCT00112437|21089910|P14|Year 3 (12-Month Extension)|Withdrawal by Subject|0
6115043|NCT00112437|21089911|P13|Year 3 (12-Month Extension)|Withdrawal by Subject|0
6115044|NCT00112437|21089912|P12|Year 3 (12-Month Extension)|Withdrawal by Subject|3
6115045|NCT00112437|21089913|P11|Year 3 (12-Month Extension)|Withdrawal by Subject|0
6115046|NCT00112437|21089914|P10|Year 3 (12-Month Extension)|Withdrawal by Subject|0
6115047|NCT00112437|21089915|P9|Year 3 (12-Month Extension)|Withdrawal by Subject|0
6115048|NCT00112437|21089916|P8|Year 3 (12-Month Extension)|Withdrawal by Subject|0
6115049|NCT00112437|21089917|P7|Year 3 (12-Month Extension)|Withdrawal by Subject|0
6115050|NCT00112437|21089918|P6|Year 3 (12-Month Extension)|Withdrawal by Subject|0
6115051|NCT00112437|21089919|P5|Year 3 (12-Month Extension)|Withdrawal by Subject|0
6115052|NCT00112437|21089920|P4|Year 3 (12-Month Extension)|Withdrawal by Subject|0
6115053|NCT00112437|21089921|P3|Year 3 (12-Month Extension)|Withdrawal by Subject|0
6115054|NCT00112437|21089922|P2|Year 3 (12-Month Extension)|Withdrawal by Subject|0
6115055|NCT00112437|21089923|P1|Year 3 (12-Month Extension)|Withdrawal by Subject|0
6115056|NCT00112437|21089898|P26|Year 3 (12-Month Extension)|Protocol Violation|0
6115057|NCT00112437|21089899|P25|Year 3 (12-Month Extension)|Protocol Violation|0
6115058|NCT00112437|21089900|P24|Year 3 (12-Month Extension)|Protocol Violation|0
6115059|NCT00112437|21089901|P23|Year 3 (12-Month Extension)|Protocol Violation|0
6115060|NCT00112437|21089902|P22|Year 3 (12-Month Extension)|Protocol Violation|0
6115061|NCT00112437|21089903|P21|Year 3 (12-Month Extension)|Protocol Violation|0
6115062|NCT00112437|21089904|P20|Year 3 (12-Month Extension)|Protocol Violation|0
6115063|NCT00112437|21089905|P19|Year 3 (12-Month Extension)|Protocol Violation|0
6115064|NCT00112437|21089906|P18|Year 3 (12-Month Extension)|Protocol Violation|0
6115065|NCT00112437|21089907|P17|Year 3 (12-Month Extension)|Protocol Violation|0
6115066|NCT00112437|21089908|P16|Year 3 (12-Month Extension)|Protocol Violation|1
6115067|NCT00112437|21089909|P15|Year 3 (12-Month Extension)|Protocol Violation|0
6115068|NCT00112437|21089910|P14|Year 3 (12-Month Extension)|Protocol Violation|0
6115069|NCT00112437|21089911|P13|Year 3 (12-Month Extension)|Protocol Violation|0
6115070|NCT00112437|21089912|P12|Year 3 (12-Month Extension)|Protocol Violation|0
6115071|NCT00112437|21089913|P11|Year 3 (12-Month Extension)|Protocol Violation|0
6115072|NCT00112437|21089914|P10|Year 3 (12-Month Extension)|Protocol Violation|0
6115073|NCT00112437|21089915|P9|Year 3 (12-Month Extension)|Protocol Violation|0
6115074|NCT00112437|21089916|P8|Year 3 (12-Month Extension)|Protocol Violation|0
6115075|NCT00112437|21089917|P7|Year 3 (12-Month Extension)|Protocol Violation|0
6115076|NCT00112437|21089918|P6|Year 3 (12-Month Extension)|Protocol Violation|0
6115077|NCT00112437|21089919|P5|Year 3 (12-Month Extension)|Protocol Violation|0
6115078|NCT00112437|21089920|P4|Year 3 (12-Month Extension)|Protocol Violation|0
6115079|NCT00112437|21089921|P3|Year 3 (12-Month Extension)|Protocol Violation|0
6115080|NCT00112437|21089922|P2|Year 3 (12-Month Extension)|Protocol Violation|0
6115081|NCT00112437|21089923|P1|Year 3 (12-Month Extension)|Protocol Violation|0
6115082|NCT00112437|21089898|P26|Year 3 (12-Month Extension)|Lost to Follow-up|0
6115083|NCT00112437|21089899|P25|Year 3 (12-Month Extension)|Lost to Follow-up|0
6115084|NCT00112437|21089900|P24|Year 3 (12-Month Extension)|Lost to Follow-up|0
6115085|NCT00112437|21089901|P23|Year 3 (12-Month Extension)|Lost to Follow-up|0
6115086|NCT00112437|21089902|P22|Year 3 (12-Month Extension)|Lost to Follow-up|0
6115087|NCT00112437|21089903|P21|Year 3 (12-Month Extension)|Lost to Follow-up|0
6115088|NCT00112437|21089904|P20|Year 3 (12-Month Extension)|Lost to Follow-up|0
6115089|NCT00112437|21089905|P19|Year 3 (12-Month Extension)|Lost to Follow-up|0
6115090|NCT00112437|21089906|P18|Year 3 (12-Month Extension)|Lost to Follow-up|0
6115091|NCT00112437|21089907|P17|Year 3 (12-Month Extension)|Lost to Follow-up|0
6115092|NCT00112437|21089908|P16|Year 3 (12-Month Extension)|Lost to Follow-up|1
6115093|NCT00112437|21089909|P15|Year 3 (12-Month Extension)|Lost to Follow-up|0
6115094|NCT00112437|21089910|P14|Year 3 (12-Month Extension)|Lost to Follow-up|0
6115095|NCT00112437|21089911|P13|Year 3 (12-Month Extension)|Lost to Follow-up|0
6115096|NCT00112437|21089912|P12|Year 3 (12-Month Extension)|Lost to Follow-up|0
6115097|NCT00112437|21089913|P11|Year 3 (12-Month Extension)|Lost to Follow-up|0
6115098|NCT00112437|21089914|P10|Year 3 (12-Month Extension)|Lost to Follow-up|0
6115099|NCT00112437|21089915|P9|Year 3 (12-Month Extension)|Lost to Follow-up|0
6115100|NCT00112437|21089916|P8|Year 3 (12-Month Extension)|Lost to Follow-up|0
6115101|NCT00112437|21089917|P7|Year 3 (12-Month Extension)|Lost to Follow-up|0
6115102|NCT00112437|21089918|P6|Year 3 (12-Month Extension)|Lost to Follow-up|0
6115103|NCT00112437|21089919|P5|Year 3 (12-Month Extension)|Lost to Follow-up|0
6115104|NCT00112437|21089920|P4|Year 3 (12-Month Extension)|Lost to Follow-up|0
6115105|NCT00112437|21089921|P3|Year 3 (12-Month Extension)|Lost to Follow-up|0
6115106|NCT00112437|21089922|P2|Year 3 (12-Month Extension)|Lost to Follow-up|0
6115107|NCT00112437|21089923|P1|Year 3 (12-Month Extension)|Lost to Follow-up|0
6115108|NCT00112437|21089898|P26|Year 3 (12-Month Extension)|Lack of Efficacy|0
6115109|NCT00112437|21089899|P25|Year 3 (12-Month Extension)|Lack of Efficacy|0
6115110|NCT00112437|21089900|P24|Year 3 (12-Month Extension)|Lack of Efficacy|0
6115111|NCT00112437|21089901|P23|Year 3 (12-Month Extension)|Lack of Efficacy|0
6115112|NCT00112437|21089902|P22|Year 3 (12-Month Extension)|Lack of Efficacy|0
6115113|NCT00112437|21089903|P21|Year 3 (12-Month Extension)|Lack of Efficacy|0
6115114|NCT00112437|21089904|P20|Year 3 (12-Month Extension)|Lack of Efficacy|0
6115115|NCT00112437|21089905|P19|Year 3 (12-Month Extension)|Lack of Efficacy|2
6115116|NCT00112437|21089906|P18|Year 3 (12-Month Extension)|Lack of Efficacy|0
6115117|NCT00112437|21089907|P17|Year 3 (12-Month Extension)|Lack of Efficacy|0
6115118|NCT00112437|21089908|P16|Year 3 (12-Month Extension)|Lack of Efficacy|1
6115119|NCT00112437|21089909|P15|Year 3 (12-Month Extension)|Lack of Efficacy|0
6115120|NCT00112437|21089910|P14|Year 3 (12-Month Extension)|Lack of Efficacy|1
6115121|NCT00112437|21089911|P13|Year 3 (12-Month Extension)|Lack of Efficacy|0
6115122|NCT00112437|21089912|P12|Year 3 (12-Month Extension)|Lack of Efficacy|1
6115123|NCT00112437|21089913|P11|Year 3 (12-Month Extension)|Lack of Efficacy|0
6115124|NCT00112437|21089914|P10|Year 3 (12-Month Extension)|Lack of Efficacy|0
6115125|NCT00112437|21089915|P9|Year 3 (12-Month Extension)|Lack of Efficacy|0
6115126|NCT00112437|21089916|P8|Year 3 (12-Month Extension)|Lack of Efficacy|0
6115127|NCT00112437|21089917|P7|Year 3 (12-Month Extension)|Lack of Efficacy|0
6115128|NCT00112437|21089918|P6|Year 3 (12-Month Extension)|Lack of Efficacy|0
6115129|NCT00112437|21089919|P5|Year 3 (12-Month Extension)|Lack of Efficacy|0
6115130|NCT00112437|21089920|P4|Year 3 (12-Month Extension)|Lack of Efficacy|0
6115131|NCT00112437|21089921|P3|Year 3 (12-Month Extension)|Lack of Efficacy|0
6115132|NCT00112437|21089922|P2|Year 3 (12-Month Extension)|Lack of Efficacy|0
6115133|NCT00112437|21089923|P1|Year 3 (12-Month Extension)|Lack of Efficacy|0
6115134|NCT00112437|21089898|P26|Year 3 (12-Month Extension)|Adverse Event|0
6115135|NCT00112437|21089899|P25|Year 3 (12-Month Extension)|Adverse Event|0
6115136|NCT00112437|21089900|P24|Year 3 (12-Month Extension)|Adverse Event|0
6115137|NCT00112437|21089901|P23|Year 3 (12-Month Extension)|Adverse Event|0
6115138|NCT00112437|21089902|P22|Year 3 (12-Month Extension)|Adverse Event|0
6115139|NCT00112437|21089903|P21|Year 3 (12-Month Extension)|Adverse Event|0
6115140|NCT00112437|21089904|P20|Year 3 (12-Month Extension)|Adverse Event|1
6115141|NCT00112437|21089905|P19|Year 3 (12-Month Extension)|Adverse Event|0
6115142|NCT00112437|21089906|P18|Year 3 (12-Month Extension)|Adverse Event|1
6115143|NCT00112437|21089907|P17|Year 3 (12-Month Extension)|Adverse Event|3
6115144|NCT00112437|21089908|P16|Year 3 (12-Month Extension)|Adverse Event|1
6115145|NCT00112437|21089909|P15|Year 3 (12-Month Extension)|Adverse Event|0
6115146|NCT00112437|21089910|P14|Year 3 (12-Month Extension)|Adverse Event|0
6115147|NCT00112437|21089911|P13|Year 3 (12-Month Extension)|Adverse Event|0
6115148|NCT00112437|21089912|P12|Year 3 (12-Month Extension)|Adverse Event|0
6115149|NCT00112437|21089913|P11|Year 3 (12-Month Extension)|Adverse Event|1
6115150|NCT00112437|21089914|P10|Year 3 (12-Month Extension)|Adverse Event|0
6115151|NCT00112437|21089915|P9|Year 3 (12-Month Extension)|Adverse Event|0
6115152|NCT00112437|21089916|P8|Year 3 (12-Month Extension)|Adverse Event|0
6115153|NCT00112437|21089917|P7|Year 3 (12-Month Extension)|Adverse Event|0
6115154|NCT00112437|21089918|P6|Year 3 (12-Month Extension)|Adverse Event|0
6115155|NCT00112437|21089919|P5|Year 3 (12-Month Extension)|Adverse Event|0
6115156|NCT00112437|21089920|P4|Year 3 (12-Month Extension)|Adverse Event|0
6115157|NCT00112437|21089921|P3|Year 3 (12-Month Extension)|Adverse Event|0
6115158|NCT00112437|21089922|P2|Year 3 (12-Month Extension)|Adverse Event|0
6115159|NCT00112437|21089923|P1|Year 3 (12-Month Extension)|Adverse Event|0
6115160|NCT00112437|21089898|P26|Year 2 (12-Month Extension)|Moved|0
6115161|NCT00112437|21089899|P25|Year 2 (12-Month Extension)|Moved|0
6115162|NCT00112437|21089900|P24|Year 2 (12-Month Extension)|Moved|0
6115163|NCT00112437|21089901|P23|Year 2 (12-Month Extension)|Moved|0
6115164|NCT00112437|21089902|P22|Year 2 (12-Month Extension)|Moved|0
6115165|NCT00112437|21089903|P21|Year 2 (12-Month Extension)|Moved|0
6115166|NCT00112437|21089904|P20|Year 2 (12-Month Extension)|Moved|0
6115167|NCT00112437|21089905|P19|Year 2 (12-Month Extension)|Moved|0
6115168|NCT00112437|21089906|P18|Year 2 (12-Month Extension)|Moved|0
6115169|NCT00112437|21089907|P17|Year 2 (12-Month Extension)|Moved|0
6115170|NCT00112437|21089908|P16|Year 2 (12-Month Extension)|Moved|0
6115171|NCT00112437|21089909|P15|Year 2 (12-Month Extension)|Moved|0
6115172|NCT00112437|21089910|P14|Year 2 (12-Month Extension)|Moved|0
6115173|NCT00112437|21089911|P13|Year 2 (12-Month Extension)|Moved|0
6115174|NCT00112437|21089912|P12|Year 2 (12-Month Extension)|Moved|0
6115175|NCT00112437|21089913|P11|Year 2 (12-Month Extension)|Moved|0
6115176|NCT00112437|21089914|P10|Year 2 (12-Month Extension)|Moved|1
6115177|NCT00112437|21089915|P9|Year 2 (12-Month Extension)|Moved|0
6115178|NCT00112437|21089916|P8|Year 2 (12-Month Extension)|Moved|0
6115179|NCT00112437|21089917|P7|Year 2 (12-Month Extension)|Moved|0
6115180|NCT00112437|21089918|P6|Year 2 (12-Month Extension)|Moved|0
6115181|NCT00112437|21089919|P5|Year 2 (12-Month Extension)|Moved|0
6115182|NCT00112437|21089920|P4|Year 2 (12-Month Extension)|Moved|0
6115183|NCT00112437|21089921|P3|Year 2 (12-Month Extension)|Moved|0
6115184|NCT00112437|21089922|P2|Year 2 (12-Month Extension)|Moved|0
6115185|NCT00112437|21089923|P1|Year 2 (12-Month Extension)|Moved|0
6115186|NCT00112437|21089898|P26|Year 2 (12-Month Extension)|patient was out of windows|0
6115187|NCT00112437|21089899|P25|Year 2 (12-Month Extension)|patient was out of windows|0
6115188|NCT00112437|21089900|P24|Year 2 (12-Month Extension)|patient was out of windows|0
6115189|NCT00112437|21089901|P23|Year 2 (12-Month Extension)|patient was out of windows|0
6115190|NCT00112437|21089902|P22|Year 2 (12-Month Extension)|patient was out of windows|0
6115191|NCT00112437|21089903|P21|Year 2 (12-Month Extension)|patient was out of windows|0
6115192|NCT00112437|21089904|P20|Year 2 (12-Month Extension)|patient was out of windows|0
6115193|NCT00112437|21089905|P19|Year 2 (12-Month Extension)|patient was out of windows|0
6115194|NCT00112437|21089906|P18|Year 2 (12-Month Extension)|patient was out of windows|0
6115195|NCT00112437|21089907|P17|Year 2 (12-Month Extension)|patient was out of windows|0
6115196|NCT00112437|21089908|P16|Year 2 (12-Month Extension)|patient was out of windows|0
6115197|NCT00112437|21089909|P15|Year 2 (12-Month Extension)|patient was out of windows|0
6115198|NCT00112437|21089910|P14|Year 2 (12-Month Extension)|patient was out of windows|0
6115199|NCT00112437|21089911|P13|Year 2 (12-Month Extension)|patient was out of windows|0
6115200|NCT00112437|21089912|P12|Year 2 (12-Month Extension)|patient was out of windows|0
6115201|NCT00112437|21089913|P11|Year 2 (12-Month Extension)|patient was out of windows|0
6115202|NCT00112437|21089914|P10|Year 2 (12-Month Extension)|patient was out of windows|1
6115203|NCT00112437|21089915|P9|Year 2 (12-Month Extension)|patient was out of windows|0
6115204|NCT00112437|21089916|P8|Year 2 (12-Month Extension)|patient was out of windows|0
6115205|NCT00112437|21089917|P7|Year 2 (12-Month Extension)|patient was out of windows|0
6115206|NCT00112437|21089918|P6|Year 2 (12-Month Extension)|patient was out of windows|0
6115207|NCT00112437|21089919|P5|Year 2 (12-Month Extension)|patient was out of windows|0
6115208|NCT00112437|21089920|P4|Year 2 (12-Month Extension)|patient was out of windows|0
6115209|NCT00112437|21089921|P3|Year 2 (12-Month Extension)|patient was out of windows|0
6115210|NCT00112437|21089922|P2|Year 2 (12-Month Extension)|patient was out of windows|0
6115211|NCT00112437|21089923|P1|Year 2 (12-Month Extension)|patient was out of windows|0
6115212|NCT00112437|21089898|P26|Year 2 (12-Month Extension)|Patient stopped taking medication|0
6115213|NCT00112437|21089899|P25|Year 2 (12-Month Extension)|Patient stopped taking medication|0
6115214|NCT00112437|21089900|P24|Year 2 (12-Month Extension)|Patient stopped taking medication|0
6115215|NCT00112437|21089901|P23|Year 2 (12-Month Extension)|Patient stopped taking medication|0
6115216|NCT00112437|21089902|P22|Year 2 (12-Month Extension)|Patient stopped taking medication|0
6115217|NCT00112437|21089903|P21|Year 2 (12-Month Extension)|Patient stopped taking medication|0
6115218|NCT00112437|21089904|P20|Year 2 (12-Month Extension)|Patient stopped taking medication|0
6115219|NCT00112437|21089905|P19|Year 2 (12-Month Extension)|Patient stopped taking medication|0
6115220|NCT00112437|21089906|P18|Year 2 (12-Month Extension)|Patient stopped taking medication|0
6115221|NCT00112437|21089907|P17|Year 2 (12-Month Extension)|Patient stopped taking medication|0
6115222|NCT00112437|21089908|P16|Year 2 (12-Month Extension)|Patient stopped taking medication|0
6115223|NCT00112437|21089909|P15|Year 2 (12-Month Extension)|Patient stopped taking medication|0
6115224|NCT00112437|21089910|P14|Year 2 (12-Month Extension)|Patient stopped taking medication|0
6115225|NCT00112437|21089911|P13|Year 2 (12-Month Extension)|Patient stopped taking medication|0
6115226|NCT00112437|21089912|P12|Year 2 (12-Month Extension)|Patient stopped taking medication|0
6115227|NCT00112437|21089913|P11|Year 2 (12-Month Extension)|Patient stopped taking medication|0
6115228|NCT00112437|21089914|P10|Year 2 (12-Month Extension)|Patient stopped taking medication|1
6115229|NCT00112437|21089915|P9|Year 2 (12-Month Extension)|Patient stopped taking medication|0
6115230|NCT00112437|21089916|P8|Year 2 (12-Month Extension)|Patient stopped taking medication|0
6115231|NCT00112437|21089917|P7|Year 2 (12-Month Extension)|Patient stopped taking medication|0
6115232|NCT00112437|21089918|P6|Year 2 (12-Month Extension)|Patient stopped taking medication|0
6115233|NCT00112437|21089919|P5|Year 2 (12-Month Extension)|Patient stopped taking medication|0
6115234|NCT00112437|21089920|P4|Year 2 (12-Month Extension)|Patient stopped taking medication|0
6115235|NCT00112437|21089921|P3|Year 2 (12-Month Extension)|Patient stopped taking medication|0
6115236|NCT00112437|21089922|P2|Year 2 (12-Month Extension)|Patient stopped taking medication|0
6115237|NCT00112437|21089923|P1|Year 2 (12-Month Extension)|Patient stopped taking medication|0
6115238|NCT00112437|21089898|P26|Year 2 (12-Month Extension)|Withdrawal by Subject|0
6115239|NCT00112437|21089899|P25|Year 2 (12-Month Extension)|Withdrawal by Subject|0
6115240|NCT00112437|21089900|P24|Year 2 (12-Month Extension)|Withdrawal by Subject|0
6115241|NCT00112437|21089901|P23|Year 2 (12-Month Extension)|Withdrawal by Subject|0
6115242|NCT00112437|21089902|P22|Year 2 (12-Month Extension)|Withdrawal by Subject|0
6115243|NCT00112437|21089903|P21|Year 2 (12-Month Extension)|Withdrawal by Subject|0
6115244|NCT00112437|21089904|P20|Year 2 (12-Month Extension)|Withdrawal by Subject|0
6115245|NCT00112437|21089905|P19|Year 2 (12-Month Extension)|Withdrawal by Subject|0
6115246|NCT00112437|21089906|P18|Year 2 (12-Month Extension)|Withdrawal by Subject|0
6115247|NCT00112437|21089907|P17|Year 2 (12-Month Extension)|Withdrawal by Subject|0
6115248|NCT00112437|21089908|P16|Year 2 (12-Month Extension)|Withdrawal by Subject|0
6115249|NCT00112437|21089909|P15|Year 2 (12-Month Extension)|Withdrawal by Subject|0
6115250|NCT00112437|21089910|P14|Year 2 (12-Month Extension)|Withdrawal by Subject|0
6115251|NCT00112437|21089911|P13|Year 2 (12-Month Extension)|Withdrawal by Subject|0
6115252|NCT00112437|21089912|P12|Year 2 (12-Month Extension)|Withdrawal by Subject|0
6115253|NCT00112437|21089913|P11|Year 2 (12-Month Extension)|Withdrawal by Subject|0
6115254|NCT00112437|21089914|P10|Year 2 (12-Month Extension)|Withdrawal by Subject|1
6115255|NCT00112437|21089915|P9|Year 2 (12-Month Extension)|Withdrawal by Subject|4
6115256|NCT00112437|21089916|P8|Year 2 (12-Month Extension)|Withdrawal by Subject|2
6115257|NCT00112437|21089917|P7|Year 2 (12-Month Extension)|Withdrawal by Subject|1
6115258|NCT00112437|21089918|P6|Year 2 (12-Month Extension)|Withdrawal by Subject|1
6115259|NCT00112437|21089919|P5|Year 2 (12-Month Extension)|Withdrawal by Subject|0
6115260|NCT00112437|21089920|P4|Year 2 (12-Month Extension)|Withdrawal by Subject|0
6115261|NCT00112437|21089921|P3|Year 2 (12-Month Extension)|Withdrawal by Subject|0
6115262|NCT00112437|21089922|P2|Year 2 (12-Month Extension)|Withdrawal by Subject|0
6115263|NCT00112437|21089923|P1|Year 2 (12-Month Extension)|Withdrawal by Subject|0
6115264|NCT00112437|21089898|P26|Year 2 (12-Month Extension)|Protocol Violation|0
6115265|NCT00112437|21089899|P25|Year 2 (12-Month Extension)|Protocol Violation|0
6115266|NCT00112437|21089900|P24|Year 2 (12-Month Extension)|Protocol Violation|0
6115267|NCT00112437|21089901|P23|Year 2 (12-Month Extension)|Protocol Violation|0
6115268|NCT00112437|21089902|P22|Year 2 (12-Month Extension)|Protocol Violation|0
6115269|NCT00112437|21089903|P21|Year 2 (12-Month Extension)|Protocol Violation|0
6115270|NCT00112437|21089904|P20|Year 2 (12-Month Extension)|Protocol Violation|0
6115271|NCT00112437|21089905|P19|Year 2 (12-Month Extension)|Protocol Violation|0
6115272|NCT00112437|21089906|P18|Year 2 (12-Month Extension)|Protocol Violation|0
6115273|NCT00112437|21089907|P17|Year 2 (12-Month Extension)|Protocol Violation|0
6115274|NCT00112437|21089908|P16|Year 2 (12-Month Extension)|Protocol Violation|0
6115275|NCT00112437|21089909|P15|Year 2 (12-Month Extension)|Protocol Violation|0
6115276|NCT00112437|21089910|P14|Year 2 (12-Month Extension)|Protocol Violation|0
6115277|NCT00112437|21089911|P13|Year 2 (12-Month Extension)|Protocol Violation|0
6115278|NCT00112437|21089912|P12|Year 2 (12-Month Extension)|Protocol Violation|0
6115279|NCT00112437|21089913|P11|Year 2 (12-Month Extension)|Protocol Violation|0
6115280|NCT00112437|21089914|P10|Year 2 (12-Month Extension)|Protocol Violation|0
6115281|NCT00112437|21089915|P9|Year 2 (12-Month Extension)|Protocol Violation|1
6115282|NCT00112437|21089916|P8|Year 2 (12-Month Extension)|Protocol Violation|0
6115283|NCT00112437|21089917|P7|Year 2 (12-Month Extension)|Protocol Violation|0
6115284|NCT00112437|21089918|P6|Year 2 (12-Month Extension)|Protocol Violation|0
6115285|NCT00112437|21089919|P5|Year 2 (12-Month Extension)|Protocol Violation|0
6115286|NCT00112437|21089920|P4|Year 2 (12-Month Extension)|Protocol Violation|0
6115287|NCT00112437|21089921|P3|Year 2 (12-Month Extension)|Protocol Violation|0
6115288|NCT00112437|21089922|P2|Year 2 (12-Month Extension)|Protocol Violation|0
6115289|NCT00112437|21089923|P1|Year 2 (12-Month Extension)|Protocol Violation|0
6115290|NCT00112437|21089898|P26|Year 2 (12-Month Extension)|Lost to Follow-up|0
6115291|NCT00112437|21089899|P25|Year 2 (12-Month Extension)|Lost to Follow-up|0
6115292|NCT00112437|21089900|P24|Year 2 (12-Month Extension)|Lost to Follow-up|0
6115293|NCT00112437|21089901|P23|Year 2 (12-Month Extension)|Lost to Follow-up|0
6115294|NCT00112437|21089902|P22|Year 2 (12-Month Extension)|Lost to Follow-up|0
6115295|NCT00112437|21089903|P21|Year 2 (12-Month Extension)|Lost to Follow-up|0
6115296|NCT00112437|21089904|P20|Year 2 (12-Month Extension)|Lost to Follow-up|0
6115297|NCT00112437|21089905|P19|Year 2 (12-Month Extension)|Lost to Follow-up|0
6115298|NCT00112437|21089906|P18|Year 2 (12-Month Extension)|Lost to Follow-up|0
6115299|NCT00112437|21089907|P17|Year 2 (12-Month Extension)|Lost to Follow-up|0
6115300|NCT00112437|21089908|P16|Year 2 (12-Month Extension)|Lost to Follow-up|0
6115301|NCT00112437|21089909|P15|Year 2 (12-Month Extension)|Lost to Follow-up|0
6115302|NCT00112437|21089910|P14|Year 2 (12-Month Extension)|Lost to Follow-up|0
6115303|NCT00112437|21089911|P13|Year 2 (12-Month Extension)|Lost to Follow-up|0
6115304|NCT00112437|21089912|P12|Year 2 (12-Month Extension)|Lost to Follow-up|0
6115305|NCT00112437|21089913|P11|Year 2 (12-Month Extension)|Lost to Follow-up|0
6115306|NCT00112437|21089914|P10|Year 2 (12-Month Extension)|Lost to Follow-up|0
6115307|NCT00112437|21089915|P9|Year 2 (12-Month Extension)|Lost to Follow-up|1
6115308|NCT00112437|21089916|P8|Year 2 (12-Month Extension)|Lost to Follow-up|0
6115309|NCT00112437|21089917|P7|Year 2 (12-Month Extension)|Lost to Follow-up|0
6115310|NCT00112437|21089918|P6|Year 2 (12-Month Extension)|Lost to Follow-up|0
6115311|NCT00112437|21089919|P5|Year 2 (12-Month Extension)|Lost to Follow-up|0
6115312|NCT00112437|21089920|P4|Year 2 (12-Month Extension)|Lost to Follow-up|0
6115313|NCT00112437|21089921|P3|Year 2 (12-Month Extension)|Lost to Follow-up|0
6115314|NCT00112437|21089922|P2|Year 2 (12-Month Extension)|Lost to Follow-up|0
6115315|NCT00112437|21089923|P1|Year 2 (12-Month Extension)|Lost to Follow-up|0
6115316|NCT00112437|21089898|P26|Year 2 (12-Month Extension)|Lack of Efficacy|0
6115317|NCT00112437|21089899|P25|Year 2 (12-Month Extension)|Lack of Efficacy|0
6115318|NCT00112437|21089900|P24|Year 2 (12-Month Extension)|Lack of Efficacy|0
6115319|NCT00112437|21089901|P23|Year 2 (12-Month Extension)|Lack of Efficacy|0
6115320|NCT00112437|21089902|P22|Year 2 (12-Month Extension)|Lack of Efficacy|0
6115321|NCT00112437|21089903|P21|Year 2 (12-Month Extension)|Lack of Efficacy|0
6115322|NCT00112437|21089904|P20|Year 2 (12-Month Extension)|Lack of Efficacy|0
6115323|NCT00112437|21089905|P19|Year 2 (12-Month Extension)|Lack of Efficacy|0
6115324|NCT00112437|21089906|P18|Year 2 (12-Month Extension)|Lack of Efficacy|0
6115325|NCT00112437|21089907|P17|Year 2 (12-Month Extension)|Lack of Efficacy|0
6115326|NCT00112437|21089908|P16|Year 2 (12-Month Extension)|Lack of Efficacy|0
6115327|NCT00112437|21089909|P15|Year 2 (12-Month Extension)|Lack of Efficacy|0
6115328|NCT00112437|21089910|P14|Year 2 (12-Month Extension)|Lack of Efficacy|0
6115329|NCT00112437|21089911|P13|Year 2 (12-Month Extension)|Lack of Efficacy|0
6115330|NCT00112437|21089912|P12|Year 2 (12-Month Extension)|Lack of Efficacy|0
6115331|NCT00112437|21089913|P11|Year 2 (12-Month Extension)|Lack of Efficacy|0
6115332|NCT00112437|21089914|P10|Year 2 (12-Month Extension)|Lack of Efficacy|2
6115333|NCT00112437|21089915|P9|Year 2 (12-Month Extension)|Lack of Efficacy|0
6115334|NCT00112437|21089916|P8|Year 2 (12-Month Extension)|Lack of Efficacy|0
6115335|NCT00112437|21089917|P7|Year 2 (12-Month Extension)|Lack of Efficacy|6
6115336|NCT00112437|21089918|P6|Year 2 (12-Month Extension)|Lack of Efficacy|1
6115337|NCT00112437|21089919|P5|Year 2 (12-Month Extension)|Lack of Efficacy|0
6115338|NCT00112437|21089920|P4|Year 2 (12-Month Extension)|Lack of Efficacy|0
6115339|NCT00112437|21089921|P3|Year 2 (12-Month Extension)|Lack of Efficacy|0
6115340|NCT00112437|21089922|P2|Year 2 (12-Month Extension)|Lack of Efficacy|0
6115341|NCT00112437|21089923|P1|Year 2 (12-Month Extension)|Lack of Efficacy|0
6115342|NCT00112437|21089898|P26|Year 2 (12-Month Extension)|Adverse Event|0
6115343|NCT00112437|21089899|P25|Year 2 (12-Month Extension)|Adverse Event|0
6115344|NCT00112437|21089900|P24|Year 2 (12-Month Extension)|Adverse Event|0
6115345|NCT00112437|21089901|P23|Year 2 (12-Month Extension)|Adverse Event|0
6115346|NCT00112437|21089902|P22|Year 2 (12-Month Extension)|Adverse Event|0
6115347|NCT00112437|21089903|P21|Year 2 (12-Month Extension)|Adverse Event|0
6115348|NCT00112437|21089904|P20|Year 2 (12-Month Extension)|Adverse Event|0
6115349|NCT00112437|21089905|P19|Year 2 (12-Month Extension)|Adverse Event|0
6115350|NCT00112437|21089906|P18|Year 2 (12-Month Extension)|Adverse Event|0
6115351|NCT00112437|21089907|P17|Year 2 (12-Month Extension)|Adverse Event|0
6115352|NCT00112437|21089908|P16|Year 2 (12-Month Extension)|Adverse Event|0
6115353|NCT00112437|21089909|P15|Year 2 (12-Month Extension)|Adverse Event|0
6115354|NCT00112437|21089910|P14|Year 2 (12-Month Extension)|Adverse Event|0
6115355|NCT00112437|21089911|P13|Year 2 (12-Month Extension)|Adverse Event|0
6115356|NCT00112437|21089912|P12|Year 2 (12-Month Extension)|Adverse Event|0
6115357|NCT00112437|21089913|P11|Year 2 (12-Month Extension)|Adverse Event|0
6115358|NCT00112437|21089914|P10|Year 2 (12-Month Extension)|Adverse Event|7
6115359|NCT00112437|21089915|P9|Year 2 (12-Month Extension)|Adverse Event|1
6115360|NCT00112437|21089916|P8|Year 2 (12-Month Extension)|Adverse Event|6
6115361|NCT00112437|21089917|P7|Year 2 (12-Month Extension)|Adverse Event|2
6115362|NCT00112437|21089918|P6|Year 2 (12-Month Extension)|Adverse Event|1
6115363|NCT00112437|21089919|P5|Year 2 (12-Month Extension)|Adverse Event|0
6115364|NCT00112437|21089920|P4|Year 2 (12-Month Extension)|Adverse Event|0
6115365|NCT00112437|21089921|P3|Year 2 (12-Month Extension)|Adverse Event|0
6115366|NCT00112437|21089922|P2|Year 2 (12-Month Extension)|Adverse Event|0
6115367|NCT00112437|21089923|P1|Year 2 (12-Month Extension)|Adverse Event|0
6115368|NCT00112437|21089898|P26|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
6115369|NCT00112437|21089899|P25|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
6115370|NCT00112437|21089900|P24|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
6115442|NCT00112437|21089920|P4|Year 1 (12-Month Base Study)|moved|0
6115371|NCT00112437|21089901|P23|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
6115372|NCT00112437|21089902|P22|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
6115373|NCT00112437|21089903|P21|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
6115374|NCT00112437|21089904|P20|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
6115375|NCT00112437|21089905|P19|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
6115376|NCT00112437|21089906|P18|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
6115377|NCT00112437|21089907|P17|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
6115378|NCT00112437|21089908|P16|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
6115379|NCT00112437|21089909|P15|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
6115380|NCT00112437|21089910|P14|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
6115381|NCT00112437|21089911|P13|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
6115382|NCT00112437|21089912|P12|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
6115383|NCT00112437|21089913|P11|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
6115384|NCT00112437|21089914|P10|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
6115385|NCT00112437|21089915|P9|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
6115386|NCT00112437|21089916|P8|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
6115387|NCT00112437|21089917|P7|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
6115388|NCT00112437|21089918|P6|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
6115389|NCT00112437|21089919|P5|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|1
6115390|NCT00112437|21089920|P4|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
6115391|NCT00112437|21089921|P3|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
6115392|NCT00112437|21089922|P2|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
6115393|NCT00112437|21089923|P1|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
6115394|NCT00112437|21089898|P26|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
6115395|NCT00112437|21089899|P25|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
6115396|NCT00112437|21089900|P24|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
6115397|NCT00112437|21089901|P23|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
6115398|NCT00112437|21089902|P22|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
6115399|NCT00112437|21089903|P21|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
6115400|NCT00112437|21089904|P20|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
6115401|NCT00112437|21089905|P19|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
6115402|NCT00112437|21089906|P18|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
6115403|NCT00112437|21089907|P17|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
6115404|NCT00112437|21089908|P16|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
6115405|NCT00112437|21089909|P15|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
6115406|NCT00112437|21089910|P14|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
6115407|NCT00112437|21089911|P13|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
6115408|NCT00112437|21089912|P12|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
6115409|NCT00112437|21089913|P11|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
6115410|NCT00112437|21089914|P10|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
6115411|NCT00112437|21089915|P9|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
6115412|NCT00112437|21089916|P8|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
6115413|NCT00112437|21089917|P7|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
6115414|NCT00112437|21089918|P6|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
6115415|NCT00112437|21089919|P5|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
6115416|NCT00112437|21089920|P4|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|2
6115417|NCT00112437|21089921|P3|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
6115418|NCT00112437|21089922|P2|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
6115419|NCT00112437|21089923|P1|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
6115420|NCT00112437|21089898|P26|Year 1 (12-Month Base Study)|moved|0
6115421|NCT00112437|21089899|P25|Year 1 (12-Month Base Study)|moved|0
6115422|NCT00112437|21089900|P24|Year 1 (12-Month Base Study)|moved|0
6115423|NCT00112437|21089901|P23|Year 1 (12-Month Base Study)|moved|0
6115424|NCT00112437|21089902|P22|Year 1 (12-Month Base Study)|moved|0
6115425|NCT00112437|21089903|P21|Year 1 (12-Month Base Study)|moved|0
6115426|NCT00112437|21089904|P20|Year 1 (12-Month Base Study)|moved|0
6115427|NCT00112437|21089905|P19|Year 1 (12-Month Base Study)|moved|0
6115428|NCT00112437|21089906|P18|Year 1 (12-Month Base Study)|moved|0
6115429|NCT00112437|21089907|P17|Year 1 (12-Month Base Study)|moved|0
6115430|NCT00112437|21089908|P16|Year 1 (12-Month Base Study)|moved|0
6115431|NCT00112437|21089909|P15|Year 1 (12-Month Base Study)|moved|0
6115432|NCT00112437|21089910|P14|Year 1 (12-Month Base Study)|moved|0
6115433|NCT00112437|21089911|P13|Year 1 (12-Month Base Study)|moved|0
6115434|NCT00112437|21089912|P12|Year 1 (12-Month Base Study)|moved|0
6115435|NCT00112437|21089913|P11|Year 1 (12-Month Base Study)|moved|0
6115436|NCT00112437|21089914|P10|Year 1 (12-Month Base Study)|moved|0
6115437|NCT00112437|21089915|P9|Year 1 (12-Month Base Study)|moved|0
6115438|NCT00112437|21089916|P8|Year 1 (12-Month Base Study)|moved|0
6115439|NCT00112437|21089917|P7|Year 1 (12-Month Base Study)|moved|0
6115440|NCT00112437|21089918|P6|Year 1 (12-Month Base Study)|moved|0
6115441|NCT00112437|21089919|P5|Year 1 (12-Month Base Study)|moved|0
6115443|NCT00112437|21089921|P3|Year 1 (12-Month Base Study)|moved|1
6115444|NCT00112437|21089922|P2|Year 1 (12-Month Base Study)|moved|1
6115445|NCT00112437|21089923|P1|Year 1 (12-Month Base Study)|moved|0
6115446|NCT00112437|21089898|P26|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
6115447|NCT00112437|21089899|P25|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
6115448|NCT00112437|21089900|P24|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
6115449|NCT00112437|21089901|P23|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
6115450|NCT00112437|21089902|P22|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
6115451|NCT00112437|21089903|P21|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
6115452|NCT00112437|21089904|P20|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
6115453|NCT00112437|21089905|P19|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
6115454|NCT00112437|21089906|P18|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
6115455|NCT00112437|21089907|P17|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
6115456|NCT00112437|21089908|P16|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
6115457|NCT00112437|21089909|P15|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
6115458|NCT00112437|21089910|P14|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
6115459|NCT00112437|21089911|P13|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
6115460|NCT00112437|21089912|P12|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
6115461|NCT00112437|21089913|P11|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
6115462|NCT00112437|21089914|P10|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
6115463|NCT00112437|21089915|P9|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
6115464|NCT00112437|21089916|P8|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
6115465|NCT00112437|21089917|P7|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
6115466|NCT00112437|21089918|P6|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
6115467|NCT00112437|21089919|P5|Year 1 (12-Month Base Study)|Withdrawal by Subject|7
6115468|NCT00112437|21089920|P4|Year 1 (12-Month Base Study)|Withdrawal by Subject|1
6115469|NCT00112437|21089921|P3|Year 1 (12-Month Base Study)|Withdrawal by Subject|2
6115470|NCT00112437|21089922|P2|Year 1 (12-Month Base Study)|Withdrawal by Subject|5
6115471|NCT00112437|21089923|P1|Year 1 (12-Month Base Study)|Withdrawal by Subject|5
6115472|NCT00112437|21089898|P26|Year 1 (12-Month Base Study)|Protocol Violation|0
6115473|NCT00112437|21089899|P25|Year 1 (12-Month Base Study)|Protocol Violation|0
6115474|NCT00112437|21089900|P24|Year 1 (12-Month Base Study)|Protocol Violation|0
6115475|NCT00112437|21089901|P23|Year 1 (12-Month Base Study)|Protocol Violation|0
6115476|NCT00112437|21089902|P22|Year 1 (12-Month Base Study)|Protocol Violation|0
6115477|NCT00112437|21089903|P21|Year 1 (12-Month Base Study)|Protocol Violation|0
6115478|NCT00112437|21089904|P20|Year 1 (12-Month Base Study)|Protocol Violation|0
6115479|NCT00112437|21089905|P19|Year 1 (12-Month Base Study)|Protocol Violation|0
6115480|NCT00112437|21089906|P18|Year 1 (12-Month Base Study)|Protocol Violation|0
6115481|NCT00112437|21089907|P17|Year 1 (12-Month Base Study)|Protocol Violation|0
6115482|NCT00112437|21089908|P16|Year 1 (12-Month Base Study)|Protocol Violation|0
6115483|NCT00112437|21089909|P15|Year 1 (12-Month Base Study)|Protocol Violation|0
6115484|NCT00112437|21089910|P14|Year 1 (12-Month Base Study)|Protocol Violation|0
6115485|NCT00112437|21089911|P13|Year 1 (12-Month Base Study)|Protocol Violation|0
6115486|NCT00112437|21089912|P12|Year 1 (12-Month Base Study)|Protocol Violation|0
6115487|NCT00112437|21089913|P11|Year 1 (12-Month Base Study)|Protocol Violation|0
6115488|NCT00112437|21089914|P10|Year 1 (12-Month Base Study)|Protocol Violation|0
6115489|NCT00112437|21089915|P9|Year 1 (12-Month Base Study)|Protocol Violation|0
6115490|NCT00112437|21089916|P8|Year 1 (12-Month Base Study)|Protocol Violation|0
6115491|NCT00112437|21089917|P7|Year 1 (12-Month Base Study)|Protocol Violation|0
6115492|NCT00112437|21089918|P6|Year 1 (12-Month Base Study)|Protocol Violation|0
6115493|NCT00112437|21089919|P5|Year 1 (12-Month Base Study)|Protocol Violation|1
6115494|NCT00112437|21089920|P4|Year 1 (12-Month Base Study)|Protocol Violation|1
6115495|NCT00112437|21089921|P3|Year 1 (12-Month Base Study)|Protocol Violation|3
6115496|NCT00112437|21089922|P2|Year 1 (12-Month Base Study)|Protocol Violation|0
6115497|NCT00112437|21089923|P1|Year 1 (12-Month Base Study)|Protocol Violation|1
6115498|NCT00112437|21089898|P26|Year 1 (12-Month Base Study)|Lost to Follow-up|0
6115499|NCT00112437|21089899|P25|Year 1 (12-Month Base Study)|Lost to Follow-up|0
6115500|NCT00112437|21089900|P24|Year 1 (12-Month Base Study)|Lost to Follow-up|0
6115501|NCT00112437|21089901|P23|Year 1 (12-Month Base Study)|Lost to Follow-up|0
6115502|NCT00112437|21089902|P22|Year 1 (12-Month Base Study)|Lost to Follow-up|0
6115503|NCT00112437|21089903|P21|Year 1 (12-Month Base Study)|Lost to Follow-up|0
6115504|NCT00112437|21089904|P20|Year 1 (12-Month Base Study)|Lost to Follow-up|0
6115505|NCT00112437|21089905|P19|Year 1 (12-Month Base Study)|Lost to Follow-up|0
6115506|NCT00112437|21089906|P18|Year 1 (12-Month Base Study)|Lost to Follow-up|0
6115507|NCT00112437|21089907|P17|Year 1 (12-Month Base Study)|Lost to Follow-up|0
6115508|NCT00112437|21089908|P16|Year 1 (12-Month Base Study)|Lost to Follow-up|0
6115509|NCT00112437|21089909|P15|Year 1 (12-Month Base Study)|Lost to Follow-up|0
6115510|NCT00112437|21089910|P14|Year 1 (12-Month Base Study)|Lost to Follow-up|0
6115511|NCT00112437|21089911|P13|Year 1 (12-Month Base Study)|Lost to Follow-up|0
6115512|NCT00112437|21089912|P12|Year 1 (12-Month Base Study)|Lost to Follow-up|0
6115513|NCT00112437|21089913|P11|Year 1 (12-Month Base Study)|Lost to Follow-up|0
6115514|NCT00112437|21089914|P10|Year 1 (12-Month Base Study)|Lost to Follow-up|0
6115515|NCT00112437|21089915|P9|Year 1 (12-Month Base Study)|Lost to Follow-up|0
6115516|NCT00112437|21089916|P8|Year 1 (12-Month Base Study)|Lost to Follow-up|0
6115517|NCT00112437|21089917|P7|Year 1 (12-Month Base Study)|Lost to Follow-up|0
6115518|NCT00112437|21089918|P6|Year 1 (12-Month Base Study)|Lost to Follow-up|0
6115519|NCT00112437|21089919|P5|Year 1 (12-Month Base Study)|Lost to Follow-up|0
6115520|NCT00112437|21089920|P4|Year 1 (12-Month Base Study)|Lost to Follow-up|0
6115521|NCT00112437|21089921|P3|Year 1 (12-Month Base Study)|Lost to Follow-up|0
6115522|NCT00112437|21089922|P2|Year 1 (12-Month Base Study)|Lost to Follow-up|1
6115523|NCT00112437|21089923|P1|Year 1 (12-Month Base Study)|Lost to Follow-up|0
6115524|NCT00112437|21089898|P26|Year 1 (12-Month Base Study)|Lack of Efficacy|0
6115525|NCT00112437|21089899|P25|Year 1 (12-Month Base Study)|Lack of Efficacy|0
6115526|NCT00112437|21089900|P24|Year 1 (12-Month Base Study)|Lack of Efficacy|0
6115527|NCT00112437|21089901|P23|Year 1 (12-Month Base Study)|Lack of Efficacy|0
6115528|NCT00112437|21089902|P22|Year 1 (12-Month Base Study)|Lack of Efficacy|0
6115529|NCT00112437|21089903|P21|Year 1 (12-Month Base Study)|Lack of Efficacy|0
6115530|NCT00112437|21089904|P20|Year 1 (12-Month Base Study)|Lack of Efficacy|0
6115531|NCT00112437|21089905|P19|Year 1 (12-Month Base Study)|Lack of Efficacy|0
6115532|NCT00112437|21089906|P18|Year 1 (12-Month Base Study)|Lack of Efficacy|0
6115533|NCT00112437|21089907|P17|Year 1 (12-Month Base Study)|Lack of Efficacy|0
6115534|NCT00112437|21089908|P16|Year 1 (12-Month Base Study)|Lack of Efficacy|0
6115535|NCT00112437|21089909|P15|Year 1 (12-Month Base Study)|Lack of Efficacy|0
6115536|NCT00112437|21089910|P14|Year 1 (12-Month Base Study)|Lack of Efficacy|0
6115537|NCT00112437|21089911|P13|Year 1 (12-Month Base Study)|Lack of Efficacy|0
6115538|NCT00112437|21089912|P12|Year 1 (12-Month Base Study)|Lack of Efficacy|0
6115539|NCT00112437|21089913|P11|Year 1 (12-Month Base Study)|Lack of Efficacy|0
6115540|NCT00112437|21089914|P10|Year 1 (12-Month Base Study)|Lack of Efficacy|0
6115541|NCT00112437|21089915|P9|Year 1 (12-Month Base Study)|Lack of Efficacy|0
6115542|NCT00112437|21089916|P8|Year 1 (12-Month Base Study)|Lack of Efficacy|0
6115543|NCT00112437|21089917|P7|Year 1 (12-Month Base Study)|Lack of Efficacy|0
6115544|NCT00112437|21089918|P6|Year 1 (12-Month Base Study)|Lack of Efficacy|0
6115545|NCT00112437|21089919|P5|Year 1 (12-Month Base Study)|Lack of Efficacy|0
6115546|NCT00112437|21089920|P4|Year 1 (12-Month Base Study)|Lack of Efficacy|0
6115547|NCT00112437|21089921|P3|Year 1 (12-Month Base Study)|Lack of Efficacy|0
6115548|NCT00112437|21089922|P2|Year 1 (12-Month Base Study)|Lack of Efficacy|1
6115549|NCT00112437|21089923|P1|Year 1 (12-Month Base Study)|Lack of Efficacy|0
6115550|NCT00112437|21089898|P26|Year 1 (12-Month Base Study)|Adverse Event|0
6115551|NCT00112437|21089899|P25|Year 1 (12-Month Base Study)|Adverse Event|0
6115552|NCT00112437|21089900|P24|Year 1 (12-Month Base Study)|Adverse Event|0
6115553|NCT00112437|21089901|P23|Year 1 (12-Month Base Study)|Adverse Event|0
6115554|NCT00112437|21089902|P22|Year 1 (12-Month Base Study)|Adverse Event|0
6115555|NCT00112437|21089903|P21|Year 1 (12-Month Base Study)|Adverse Event|0
6115556|NCT00112437|21089904|P20|Year 1 (12-Month Base Study)|Adverse Event|0
6115557|NCT00112437|21089905|P19|Year 1 (12-Month Base Study)|Adverse Event|0
6115558|NCT00112437|21089906|P18|Year 1 (12-Month Base Study)|Adverse Event|0
6115559|NCT00112437|21089907|P17|Year 1 (12-Month Base Study)|Adverse Event|0
6115560|NCT00112437|21089908|P16|Year 1 (12-Month Base Study)|Adverse Event|0
6115561|NCT00112437|21089909|P15|Year 1 (12-Month Base Study)|Adverse Event|0
6115562|NCT00112437|21089910|P14|Year 1 (12-Month Base Study)|Adverse Event|0
6115563|NCT00112437|21089911|P13|Year 1 (12-Month Base Study)|Adverse Event|0
6115564|NCT00112437|21089912|P12|Year 1 (12-Month Base Study)|Adverse Event|0
6115565|NCT00112437|21089913|P11|Year 1 (12-Month Base Study)|Adverse Event|0
6115566|NCT00112437|21089914|P10|Year 1 (12-Month Base Study)|Adverse Event|0
6115567|NCT00112437|21089915|P9|Year 1 (12-Month Base Study)|Adverse Event|0
6115568|NCT00112437|21089916|P8|Year 1 (12-Month Base Study)|Adverse Event|0
6115569|NCT00112437|21089917|P7|Year 1 (12-Month Base Study)|Adverse Event|0
6115570|NCT00112437|21089918|P6|Year 1 (12-Month Base Study)|Adverse Event|0
6115571|NCT00112437|21089919|P5|Year 1 (12-Month Base Study)|Adverse Event|3
6115572|NCT00112437|21089920|P4|Year 1 (12-Month Base Study)|Adverse Event|4
6115573|NCT00112437|21089921|P3|Year 1 (12-Month Base Study)|Adverse Event|6
6115574|NCT00112437|21089922|P2|Year 1 (12-Month Base Study)|Adverse Event|10
6115575|NCT00112437|21089923|P1|Year 1 (12-Month Base Study)|Adverse Event|9
6115576|NCT00112385|21090203|P2|Overall Study|Withdrawal by Subject|1
6115577|NCT00112385|21090204|P1|Overall Study|Withdrawal by Subject|0
6115578|NCT00112385|21090203|P2|Overall Study|Lost to Follow-up|0
6115579|NCT00112385|21090204|P1|Overall Study|Lost to Follow-up|1
6115580|NCT00112359|21090294|P2|Overall Study|Other|0
6115581|NCT00112359|21090295|P1|Overall Study|Other|3
6115582|NCT00112359|21090294|P2|Overall Study|Personal/administrative|1
6115583|NCT00112359|21090295|P1|Overall Study|Personal/administrative|1
6115584|NCT00112359|21090294|P2|Overall Study|Lost to Follow-up|1
6115585|NCT00112359|21090295|P1|Overall Study|Lost to Follow-up|0
6115586|NCT00112359|21090294|P2|Overall Study|Related adverse event|3
6115587|NCT00112359|21090295|P1|Overall Study|Related adverse event|5
6115588|NCT00112359|21090294|P2|Overall Study|Trial drug intolerance (adverse event)|0
6115589|NCT00112359|21090295|P1|Overall Study|Trial drug intolerance (adverse event)|2
6115590|NCT00112359|21090294|P2|Overall Study|Unrelated adverse event|8
6115591|NCT00112359|21090295|P1|Overall Study|Unrelated adverse event|16
6115592|NCT00112294|21090321|P2|Overall Study|Still on study|0
6115593|NCT00112294|21090322|P1|Overall Study|Still on study|5
6115594|NCT00112047|21090630|P2|Atripla Phase|Other|1
6115595|NCT00112047|21090631|P1|Atripla Phase|Other|3
6115596|NCT00112047|21090630|P2|Atripla Phase|Non-compliance|0
6115597|NCT00112047|21090631|P1|Atripla Phase|Non-compliance|1
6115598|NCT00112047|21090630|P2|Atripla Phase|Sub-optimal virological response|1
6115599|NCT00112047|21090631|P1|Atripla Phase|Sub-optimal virological response|0
6115600|NCT00112047|21090630|P2|Atripla Phase|Withdrew consent|7
6115601|NCT00112047|21090631|P1|Atripla Phase|Withdrew consent|7
6115602|NCT00112047|21090630|P2|Atripla Phase|Death|2
6115603|NCT00112047|21090631|P1|Atripla Phase|Death|0
6115604|NCT00112047|21090630|P2|Atripla Phase|Pregnancy|1
6115605|NCT00112047|21090631|P1|Atripla Phase|Pregnancy|0
6115606|NCT00112047|21090630|P2|Atripla Phase|Lost to Follow-up|7
6115607|NCT00112047|21090631|P1|Atripla Phase|Lost to Follow-up|5
6115608|NCT00112047|21090630|P2|Atripla Phase|Adverse Event|1
6115609|NCT00112047|21090631|P1|Atripla Phase|Adverse Event|2
6115610|NCT00112047|21090630|P2|Randomized Phase|High Hepatitis B DNA|1
6115611|NCT00112047|21090631|P1|Randomized Phase|High Hepatitis B DNA|0
6115612|NCT00112047|21090630|P2|Randomized Phase|Baseline NNRTI resistance mutations|0
6115613|NCT00112047|21090631|P1|Randomized Phase|Baseline NNRTI resistance mutations|4
6115614|NCT00112047|21090630|P2|Randomized Phase|Moved out of State|1
6115615|NCT00112047|21090631|P1|Randomized Phase|Moved out of State|0
6115616|NCT00112047|21090630|P2|Randomized Phase|Incarceration|2
6115617|NCT00112047|21090631|P1|Randomized Phase|Incarceration|3
6115618|NCT00112047|21090630|P2|Randomized Phase|Inability to swallow pills|1
6115619|NCT00112047|21090631|P1|Randomized Phase|Inability to swallow pills|0
6115620|NCT00112047|21090630|P2|Randomized Phase|Hepatitis C treatment contraindicated|1
6115621|NCT00112047|21090631|P1|Randomized Phase|Hepatitis C treatment contraindicated|0
6115622|NCT00112047|21090630|P2|Randomized Phase|Death|3
6115623|NCT00112047|21090631|P1|Randomized Phase|Death|1
6115624|NCT00112047|21090630|P2|Randomized Phase|Pregnancy|1
6115625|NCT00112047|21090631|P1|Randomized Phase|Pregnancy|3
6115626|NCT00112047|21090630|P2|Randomized Phase|Protocol Violation|0
6115627|NCT00112047|21090631|P1|Randomized Phase|Protocol Violation|2
6115628|NCT00112047|21090630|P2|Randomized Phase|Noncompliance|4
6115629|NCT00112047|21090631|P1|Randomized Phase|Noncompliance|8
6115630|NCT00112047|21090630|P2|Randomized Phase|Sub-optimal virological response|13
6115631|NCT00112047|21090631|P1|Randomized Phase|Sub-optimal virological response|3
6115632|NCT00112047|21090630|P2|Randomized Phase|Withrawal of consent|18
6115633|NCT00112047|21090631|P1|Randomized Phase|Withrawal of consent|10
6115634|NCT00112047|21090630|P2|Randomized Phase|Adverse Event|10
6115635|NCT00112047|21090631|P1|Randomized Phase|Adverse Event|10
6115636|NCT00112047|21090630|P2|Randomized Phase|Lost to Follow-up|33
6115637|NCT00112047|21090631|P1|Randomized Phase|Lost to Follow-up|26
6115638|NCT00111917|21090731|P2|Overall Study|Withdrawal by Subject|1
6115639|NCT00111917|21090732|P1|Overall Study|Withdrawal by Subject|1
6115640|NCT00111839|21090747|P3|Overall Study|Randomized but Not Treated|2
6115641|NCT00111839|21090748|P2|Overall Study|Randomized but Not Treated|0
6115642|NCT00111839|21090749|P1|Overall Study|Randomized but Not Treated|0
6115643|NCT00111839|21090747|P3|Overall Study|Other|3
6115644|NCT00111839|21090748|P2|Overall Study|Other|3
6115645|NCT00111839|21090749|P1|Overall Study|Other|6
6115646|NCT00111839|21090747|P3|Overall Study|Logistical Constraint|0
6115647|NCT00111839|21090748|P2|Overall Study|Logistical Constraint|0
6115648|NCT00111839|21090749|P1|Overall Study|Logistical Constraint|1
6115649|NCT00111839|21090747|P3|Overall Study|Lost to Follow-up|0
6115650|NCT00111839|21090748|P2|Overall Study|Lost to Follow-up|0
6115651|NCT00111839|21090749|P1|Overall Study|Lost to Follow-up|1
6115652|NCT00111839|21090747|P3|Overall Study|Withdrawal by Subject|2
6115653|NCT00111839|21090748|P2|Overall Study|Withdrawal by Subject|2
6115654|NCT00111839|21090749|P1|Overall Study|Withdrawal by Subject|2
6115655|NCT00111839|21090747|P3|Overall Study|Death|6
6115656|NCT00111839|21090748|P2|Overall Study|Death|1
6115657|NCT00111839|21090749|P1|Overall Study|Death|1
6115658|NCT00111839|21090747|P3|Overall Study|Protocol Violation|2
6115659|NCT00111839|21090748|P2|Overall Study|Protocol Violation|4
6115660|NCT00111839|21090749|P1|Overall Study|Protocol Violation|2
6115661|NCT00111839|21090747|P3|Overall Study|Adverse Event|1
6115662|NCT00111839|21090748|P2|Overall Study|Adverse Event|3
6115663|NCT00111839|21090749|P1|Overall Study|Adverse Event|5
6115664|NCT00111839|21090747|P3|Overall Study|Disease Progression|33
6115665|NCT00111839|21090748|P2|Overall Study|Disease Progression|33
6115666|NCT00111839|21090749|P1|Overall Study|Disease Progression|30
6115667|NCT00111813|21090769|P6|Overall Study|Other|0
6115668|NCT00111813|21090770|P5|Overall Study|Other|0
6115669|NCT00111813|21090771|P4|Overall Study|Other|0
6115670|NCT00111813|21090772|P3|Overall Study|Other|1
6115671|NCT00111813|21090773|P2|Overall Study|Other|0
6115672|NCT00111813|21090774|P1|Overall Study|Other|0
6115673|NCT00111813|21090769|P6|Overall Study|Lack of Efficacy|1
6115674|NCT00111813|21090770|P5|Overall Study|Lack of Efficacy|0
6115675|NCT00111813|21090771|P4|Overall Study|Lack of Efficacy|0
6115676|NCT00111813|21090772|P3|Overall Study|Lack of Efficacy|0
6115677|NCT00111813|21090773|P2|Overall Study|Lack of Efficacy|0
6115678|NCT00111813|21090774|P1|Overall Study|Lack of Efficacy|0
6115679|NCT00111813|21090769|P6|Overall Study|Progressive disease|3
6115680|NCT00111813|21090770|P5|Overall Study|Progressive disease|4
6115681|NCT00111813|21090771|P4|Overall Study|Progressive disease|3
6115682|NCT00111813|21090772|P3|Overall Study|Progressive disease|5
6115683|NCT00111813|21090773|P2|Overall Study|Progressive disease|1
6115684|NCT00111813|21090774|P1|Overall Study|Progressive disease|2
6115685|NCT00111813|21090769|P6|Overall Study|Adverse Event|2
6115686|NCT00111813|21090770|P5|Overall Study|Adverse Event|2
6115687|NCT00111813|21090771|P4|Overall Study|Adverse Event|2
6115688|NCT00111813|21090772|P3|Overall Study|Adverse Event|4
6115689|NCT00111813|21090773|P2|Overall Study|Adverse Event|2
6115690|NCT00111813|21090774|P1|Overall Study|Adverse Event|1
6115691|NCT00111800|21090813|P6|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0
6115692|NCT00111800|21090814|P5|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0
6115693|NCT00111800|21090815|P4|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0
6115694|NCT00111800|21090816|P3|Period 2: Extension Phase (12 Weeks)|Participant received metformin|1
6115695|NCT00111800|21090817|P2|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0
6115696|NCT00111800|21090818|P1|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0
6115697|NCT00111800|21090813|P6|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0
6115698|NCT00111800|21090814|P5|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0
6115699|NCT00111800|21090815|P4|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0
6115700|NCT00111800|21090816|P3|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|1
6115701|NCT00111800|21090817|P2|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0
6115702|NCT00111800|21090818|P1|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0
6115703|NCT00111800|21090813|P6|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0
6115704|NCT00111800|21090814|P5|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0
6115705|NCT00111800|21090815|P4|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0
6115706|NCT00111800|21090816|P3|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0
6115707|NCT00111800|21090817|P2|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|1
6115708|NCT00111800|21090818|P1|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0
6115709|NCT00111800|21090813|P6|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1
6115710|NCT00111800|21090814|P5|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1
6115711|NCT00111800|21090815|P4|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1
6115712|NCT00111800|21090816|P3|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|0
6115713|NCT00111800|21090817|P2|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1
6115714|NCT00111800|21090818|P1|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1
6115715|NCT00111800|21090813|P6|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1
6115716|NCT00111800|21090814|P5|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0
6115717|NCT00111800|21090815|P4|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1
6115718|NCT00111800|21090816|P3|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1
6115719|NCT00111800|21090817|P2|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0
6115720|NCT00111800|21090818|P1|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1
6115721|NCT00111800|21090813|P6|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0
6115722|NCT00111800|21090814|P5|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|3
6115723|NCT00111800|21090815|P4|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0
6115724|NCT00111800|21090816|P3|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2
6115725|NCT00111800|21090817|P2|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2
6115726|NCT00111800|21090818|P1|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0
6115727|NCT00111800|21090813|P6|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0
6115728|NCT00111800|21090814|P5|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0
6115729|NCT00111800|21090815|P4|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0
6115730|NCT00111800|21090816|P3|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1
6115731|NCT00111800|21090817|P2|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1
6115732|NCT00111800|21090818|P1|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0
6115733|NCT00111800|21090813|P6|Period 2: Extension Phase (12 Weeks)|Adverse Event|0
6115734|NCT00111800|21090814|P5|Period 2: Extension Phase (12 Weeks)|Adverse Event|0
6115735|NCT00111800|21090815|P4|Period 2: Extension Phase (12 Weeks)|Adverse Event|3
6115736|NCT00111800|21090816|P3|Period 2: Extension Phase (12 Weeks)|Adverse Event|1
6115737|NCT00111800|21090817|P2|Period 2: Extension Phase (12 Weeks)|Adverse Event|2
6115738|NCT00111800|21090818|P1|Period 2: Extension Phase (12 Weeks)|Adverse Event|0
6115739|NCT00111800|21090813|P6|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|1
6115740|NCT00111800|21090814|P5|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0
6115741|NCT00111800|21090815|P4|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0
6115742|NCT00111800|21090816|P3|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0
6115743|NCT00111800|21090817|P2|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0
6115744|NCT00111800|21090818|P1|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0
6115745|NCT00111800|21090813|P6|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0
6115746|NCT00111800|21090814|P5|Period 1: Main Phase (12 Weeks)|Participant moved out of area|1
6115747|NCT00111800|21090815|P4|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0
6115748|NCT00111800|21090816|P3|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0
6115749|NCT00111800|21090817|P2|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0
6115750|NCT00111800|21090818|P1|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0
6115751|NCT00111800|21090813|P6|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0
6115752|NCT00111800|21090814|P5|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|1
6115753|NCT00111800|21090815|P4|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0
6115754|NCT00111800|21090816|P3|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0
6115755|NCT00111800|21090817|P2|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0
6115756|NCT00111800|21090818|P1|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0
6115757|NCT00111800|21090813|P6|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0
6115758|NCT00111800|21090814|P5|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0
6115759|NCT00111800|21090815|P4|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|1
6115760|NCT00111800|21090816|P3|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0
6115761|NCT00111800|21090817|P2|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0
6115762|NCT00111800|21090818|P1|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0
6115763|NCT00111800|21090813|P6|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0
6115764|NCT00111800|21090814|P5|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0
6115765|NCT00111800|21090815|P4|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|1
6115766|NCT00111800|21090816|P3|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0
6115767|NCT00111800|21090817|P2|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0
6115768|NCT00111800|21090818|P1|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0
6115769|NCT00111800|21090813|P6|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0
6115770|NCT00111800|21090814|P5|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0
6115771|NCT00111800|21090815|P4|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0
6115772|NCT00111800|21090816|P3|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0
6115773|NCT00111800|21090817|P2|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|1
6115774|NCT00111800|21090818|P1|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0
6115775|NCT00111800|21090813|P6|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0
6115776|NCT00111800|21090814|P5|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0
6115777|NCT00111800|21090815|P4|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0
6115778|NCT00111800|21090816|P3|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0
6115779|NCT00111800|21090817|P2|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|1
6115780|NCT00111800|21090818|P1|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0
6115781|NCT00111800|21090813|P6|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0
6115782|NCT00111800|21090814|P5|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0
6115783|NCT00111800|21090815|P4|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0
6115784|NCT00111800|21090816|P3|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0
6115785|NCT00111800|21090817|P2|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|1
6115786|NCT00111800|21090818|P1|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0
6115787|NCT00111800|21090813|P6|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0
6115788|NCT00111800|21090814|P5|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0
6115789|NCT00111800|21090815|P4|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0
6115790|NCT00111800|21090816|P3|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0
6115791|NCT00111800|21090817|P2|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|1
6115792|NCT00111800|21090818|P1|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0
6115793|NCT00111800|21090813|P6|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0
6115794|NCT00111800|21090814|P5|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0
6115795|NCT00111800|21090815|P4|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0
6115796|NCT00111800|21090816|P3|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0
6115797|NCT00111800|21090817|P2|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0
6115798|NCT00111800|21090818|P1|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|1
6115799|NCT00111800|21090813|P6|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0
6115800|NCT00111800|21090814|P5|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0
6115801|NCT00111800|21090815|P4|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0
6115802|NCT00111800|21090816|P3|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0
6115803|NCT00111800|21090817|P2|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1
6115804|NCT00111800|21090818|P1|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1
6115805|NCT00111800|21090813|P6|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0
6115806|NCT00111800|21090814|P5|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0
6115807|NCT00111800|21090815|P4|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1
6115808|NCT00111800|21090816|P3|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0
6115809|NCT00111800|21090817|P2|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1
6115810|NCT00111800|21090818|P1|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1
6115811|NCT00111800|21090813|P6|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0
6115812|NCT00111800|21090814|P5|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1
6115813|NCT00111800|21090815|P4|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0
6115814|NCT00111800|21090816|P3|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0
6115815|NCT00111800|21090817|P2|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0
6115816|NCT00111800|21090818|P1|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1
6115817|NCT00111800|21090813|P6|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0
6115818|NCT00111800|21090814|P5|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0
6115819|NCT00111800|21090815|P4|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|1
6115820|NCT00111800|21090816|P3|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0
6115821|NCT00111800|21090817|P2|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0
6115822|NCT00111800|21090818|P1|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|3
6115992|NCT00110617|21091289|P2|Overall Study|Administrative problems|5
6115823|NCT00111800|21090813|P6|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|1
6115824|NCT00111800|21090814|P5|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0
6115825|NCT00111800|21090815|P4|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0
6115826|NCT00111800|21090816|P3|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|3
6115827|NCT00111800|21090817|P2|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2
6115828|NCT00111800|21090818|P1|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2
6115829|NCT00111800|21090813|P6|Period 1: Main Phase (12 Weeks)|Protocol Violation|1
6115830|NCT00111800|21090814|P5|Period 1: Main Phase (12 Weeks)|Protocol Violation|1
6115831|NCT00111800|21090815|P4|Period 1: Main Phase (12 Weeks)|Protocol Violation|2
6115832|NCT00111800|21090816|P3|Period 1: Main Phase (12 Weeks)|Protocol Violation|4
6115833|NCT00111800|21090817|P2|Period 1: Main Phase (12 Weeks)|Protocol Violation|2
6115834|NCT00111800|21090818|P1|Period 1: Main Phase (12 Weeks)|Protocol Violation|0
6115835|NCT00111800|21090813|P6|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2
6115836|NCT00111800|21090814|P5|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0
6115837|NCT00111800|21090815|P4|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0
6115838|NCT00111800|21090816|P3|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2
6115839|NCT00111800|21090817|P2|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0
6115840|NCT00111800|21090818|P1|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|1
6115841|NCT00111800|21090813|P6|Period 1: Main Phase (12 Weeks)|Adverse Event|0
6115842|NCT00111800|21090814|P5|Period 1: Main Phase (12 Weeks)|Adverse Event|1
6115843|NCT00111800|21090815|P4|Period 1: Main Phase (12 Weeks)|Adverse Event|0
6115844|NCT00111800|21090816|P3|Period 1: Main Phase (12 Weeks)|Adverse Event|0
6115845|NCT00111800|21090817|P2|Period 1: Main Phase (12 Weeks)|Adverse Event|4
6115846|NCT00111800|21090818|P1|Period 1: Main Phase (12 Weeks)|Adverse Event|5
6115847|NCT00111761|21090988|P2|Part 2|Other|0
6115848|NCT00111761|21090989|P1|Part 2|Other|1
6115849|NCT00111761|21090988|P2|Part 2|Protocol-specified criteria|0
6115850|NCT00111761|21090989|P1|Part 2|Protocol-specified criteria|1
6115851|NCT00111761|21090988|P2|Part 2|Disease progression|0
6115852|NCT00111761|21090989|P1|Part 2|Disease progression|3
6115853|NCT00111761|21090988|P2|Part 2|Death|0
6115854|NCT00111761|21090989|P1|Part 2|Death|1
6115855|NCT00111761|21090988|P2|Part 2|Physician Decision|0
6115856|NCT00111761|21090989|P1|Part 2|Physician Decision|1
6115857|NCT00111761|21090988|P2|Part 2|Adverse Event|0
6115858|NCT00111761|21090989|P1|Part 2|Adverse Event|1
6115859|NCT00111761|21090988|P2|Part 1|Withdrawal by Subject|1
6115860|NCT00111761|21090989|P1|Part 1|Withdrawal by Subject|0
6115861|NCT00111761|21090988|P2|Part 1|Other|1
6115862|NCT00111761|21090989|P1|Part 1|Other|0
6115863|NCT00111761|21090988|P2|Part 1|Death|2
6115864|NCT00111761|21090989|P1|Part 1|Death|0
6115865|NCT00111761|21090988|P2|Part 1|Physician Decision|1
6115866|NCT00111761|21090989|P1|Part 1|Physician Decision|0
6115867|NCT00111475|21091026|P10|Overall Study|Lost to Follow-up|0
6115868|NCT00111475|21091027|P9|Overall Study|Lost to Follow-up|0
6115869|NCT00111475|21091028|P8|Overall Study|Lost to Follow-up|0
6115870|NCT00111475|21091029|P7|Overall Study|Lost to Follow-up|0
6115871|NCT00111475|21091030|P6|Overall Study|Lost to Follow-up|1
6115872|NCT00111475|21091031|P5|Overall Study|Lost to Follow-up|0
6115873|NCT00111475|21091032|P4|Overall Study|Lost to Follow-up|0
6115874|NCT00111475|21091033|P3|Overall Study|Lost to Follow-up|0
6115875|NCT00111475|21091034|P2|Overall Study|Lost to Follow-up|0
6115876|NCT00111475|21091035|P1|Overall Study|Lost to Follow-up|0
6115877|NCT00111241|21091153|P2|Overall Study|Adverse Event|0
6115878|NCT00111241|21091154|P1|Overall Study|Adverse Event|1
6115879|NCT00111241|21091153|P2|Overall Study|Protocol Violation|8
6115880|NCT00111241|21091154|P1|Overall Study|Protocol Violation|9
6115881|NCT00111241|21091153|P2|Overall Study|Withdrawal by Subject|0
6115882|NCT00111241|21091154|P1|Overall Study|Withdrawal by Subject|4
6115883|NCT00111241|21091153|P2|Overall Study|Lost to Follow-up|0
6115884|NCT00111241|21091154|P1|Overall Study|Lost to Follow-up|1
6115885|NCT00111228|21091165|P3|Overall Study|Withdrawal by Subject|0
6115886|NCT00111228|21091166|P2|Overall Study|Withdrawal by Subject|1
6115887|NCT00111228|21091167|P1|Overall Study|Withdrawal by Subject|5
6115888|NCT00111007|21091180|P2|Long Term Follow-up|Missing|3
6115889|NCT00111007|21091181|P1|Long Term Follow-up|Missing|10
6115890|NCT00111007|21091180|P2|Long Term Follow-up|Disease progression/recurrence/relapse|1
6115891|NCT00111007|21091181|P1|Long Term Follow-up|Disease progression/recurrence/relapse|2
6115892|NCT00111007|21091180|P2|Long Term Follow-up|Withdrawal by Subject|1
6115893|NCT00111007|21091181|P1|Long Term Follow-up|Withdrawal by Subject|0
6115894|NCT00111007|21091180|P2|Long Term Follow-up|Lost to Follow-up|1
6115895|NCT00111007|21091181|P1|Long Term Follow-up|Lost to Follow-up|1
6115896|NCT00111007|21091180|P2|Long Term Follow-up|Death|39
6115897|NCT00111007|21091181|P1|Long Term Follow-up|Death|34
6115898|NCT00111007|21091180|P2|Active Follow-up|Disease progression/recurrence/relapse|2
6115899|NCT00111007|21091181|P1|Active Follow-up|Disease progression/recurrence/relapse|3
6115900|NCT00111007|21091180|P2|Active Follow-up|Death|0
6115901|NCT00111007|21091181|P1|Active Follow-up|Death|2
6115902|NCT00111007|21091180|P2|Active Follow-up|Adverse Event|0
6115903|NCT00111007|21091181|P1|Active Follow-up|Adverse Event|1
6115904|NCT00111007|21091180|P2|Double-blind (DB) Treatment|Primary reason with other category|1
6115905|NCT00111007|21091181|P1|Double-blind (DB) Treatment|Primary reason with other category|0
6115906|NCT00111007|21091180|P2|Double-blind (DB) Treatment|Radiological and symptomatic progression|93
6115907|NCT00111007|21091181|P1|Double-blind (DB) Treatment|Radiological and symptomatic progression|83
6115908|NCT00111007|21091180|P2|Double-blind (DB) Treatment|Progression by clinical judgement|2
6115909|NCT00111007|21091181|P1|Double-blind (DB) Treatment|Progression by clinical judgement|0
6115910|NCT00111007|21091180|P2|Double-blind (DB) Treatment|Relapse|0
6115911|NCT00111007|21091181|P1|Double-blind (DB) Treatment|Relapse|1
6115912|NCT00111007|21091180|P2|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|0
6115913|NCT00111007|21091181|P1|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|1
6115914|NCT00111007|21091180|P2|Double-blind (DB) Treatment|Withdrawal by Subject|8
6115915|NCT00111007|21091181|P1|Double-blind (DB) Treatment|Withdrawal by Subject|6
6115916|NCT00111007|21091180|P2|Double-blind (DB) Treatment|Protocol Violation|1
6115917|NCT00111007|21091181|P1|Double-blind (DB) Treatment|Protocol Violation|0
6115918|NCT00111007|21091180|P2|Double-blind (DB) Treatment|Death|2
6115919|NCT00111007|21091181|P1|Double-blind (DB) Treatment|Death|5
6115920|NCT00111007|21091180|P2|Double-blind (DB) Treatment|Adverse Event|4
6115921|NCT00111007|21091181|P1|Double-blind (DB) Treatment|Adverse Event|12
6115922|NCT00110994|21091197|P2|Long Term Follow-up|Death|17
6115923|NCT00110994|21091198|P1|Long Term Follow-up|Death|19
6115924|NCT00110994|21091197|P2|Active Follow-up|Other reasons|2
6115925|NCT00110994|21091198|P1|Active Follow-up|Other reasons|0
6115926|NCT00110994|21091197|P2|Active Follow-up|Disease progression/recurrence/replace|0
6115927|NCT00110994|21091198|P1|Active Follow-up|Disease progression/recurrence/replace|1
6115928|NCT00110994|21091197|P2|Double-blind (DB) Treatment|other reasons|3
6115929|NCT00110994|21091198|P1|Double-blind (DB) Treatment|other reasons|2
6115930|NCT00110994|21091197|P2|Double-blind (DB) Treatment|Radiological and symptomatic progression|41
6115931|NCT00110994|21091198|P1|Double-blind (DB) Treatment|Radiological and symptomatic progression|34
6115932|NCT00110994|21091197|P2|Double-blind (DB) Treatment|Progression by clinical judgement|1
6115933|NCT00110994|21091198|P1|Double-blind (DB) Treatment|Progression by clinical judgement|2
6115934|NCT00110994|21091197|P2|Double-blind (DB) Treatment|Withdrawal by Subject|2
6115935|NCT00110994|21091198|P1|Double-blind (DB) Treatment|Withdrawal by Subject|0
6115936|NCT00110994|21091197|P2|Double-blind (DB) Treatment|Death|0
6115937|NCT00110994|21091198|P1|Double-blind (DB) Treatment|Death|1
6115938|NCT00110994|21091197|P2|Double-blind (DB) Treatment|Adverse Event|0
6115939|NCT00110994|21091198|P1|Double-blind (DB) Treatment|Adverse Event|3
6115940|NCT00110890|21091224|P2|Overall Study|Did not enter follow-up phase|4
6115941|NCT00110890|21091225|P1|Overall Study|Did not enter follow-up phase|10
6115942|NCT00110890|21091224|P2|Overall Study|Parathyroidectomy|1
6115943|NCT00110890|21091225|P1|Overall Study|Parathyroidectomy|0
6115944|NCT00110890|21091224|P2|Overall Study|Disease progression|1
6115945|NCT00110890|21091225|P1|Overall Study|Disease progression|0
6115946|NCT00110890|21091224|P2|Overall Study|Requirement for alternative therapy|1
6115947|NCT00110890|21091225|P1|Overall Study|Requirement for alternative therapy|0
6115948|NCT00110890|21091224|P2|Overall Study|Ineligibility determined|0
6115949|NCT00110890|21091225|P1|Overall Study|Ineligibility determined|3
6115950|NCT00110890|21091224|P2|Overall Study|Other|23
6115951|NCT00110890|21091225|P1|Overall Study|Other|34
6115952|NCT00110890|21091224|P2|Overall Study|Invest. Product Commercially Available|110
6115953|NCT00110890|21091225|P1|Overall Study|Invest. Product Commercially Available|217
6115954|NCT00110890|21091224|P2|Overall Study|Kidney Transplant|12
6115955|NCT00110890|21091225|P1|Overall Study|Kidney Transplant|16
6115956|NCT00110890|21091224|P2|Overall Study|Noncompliance|0
6115957|NCT00110890|21091225|P1|Overall Study|Noncompliance|10
6115958|NCT00110890|21091224|P2|Overall Study|Protocol Deviation|0
6115959|NCT00110890|21091225|P1|Overall Study|Protocol Deviation|1
6115960|NCT00110890|21091224|P2|Overall Study|Withdrawal by Subject|5
6115961|NCT00110890|21091225|P1|Overall Study|Withdrawal by Subject|17
6115962|NCT00110890|21091224|P2|Overall Study|Physician Decision|5
6115963|NCT00110890|21091225|P1|Overall Study|Physician Decision|4
6115964|NCT00110890|21091224|P2|Overall Study|Lost to Follow-up|1
6115965|NCT00110890|21091225|P1|Overall Study|Lost to Follow-up|3
6115966|NCT00110890|21091224|P2|Overall Study|Death|9
6115967|NCT00110890|21091225|P1|Overall Study|Death|16
6115968|NCT00110890|21091224|P2|Overall Study|Adverse Event|7
6115969|NCT00110890|21091225|P1|Overall Study|Adverse Event|30
6115970|NCT00110812|21091242|P3|Extended Follow-up|Lost to Follow-up|1
6115971|NCT00110812|21091243|P2|Extended Follow-up|Lost to Follow-up|3
6115972|NCT00110812|21091244|P1|Extended Follow-up|Lost to Follow-up|1
6115973|NCT00110812|21091242|P3|Extended Follow-up|Withdrawal by Subject|0
6115974|NCT00110812|21091243|P2|Extended Follow-up|Withdrawal by Subject|1
6115975|NCT00110812|21091244|P1|Extended Follow-up|Withdrawal by Subject|0
6115976|NCT00110812|21091242|P3|Extended Follow-up|Death|3
6115977|NCT00110812|21091243|P2|Extended Follow-up|Death|0
6115978|NCT00110812|21091244|P1|Extended Follow-up|Death|1
6115979|NCT00110812|21091242|P3|Main Study|Lost to Follow-up|10
6115980|NCT00110812|21091243|P2|Main Study|Lost to Follow-up|11
6115981|NCT00110812|21091244|P1|Main Study|Lost to Follow-up|8
6115982|NCT00110812|21091242|P3|Main Study|Withdrawal by Subject|1
6115983|NCT00110812|21091243|P2|Main Study|Withdrawal by Subject|0
6115984|NCT00110812|21091244|P1|Main Study|Withdrawal by Subject|0
6115985|NCT00110812|21091242|P3|Main Study|Death|2
6115986|NCT00110812|21091243|P2|Main Study|Death|0
6115987|NCT00110812|21091244|P1|Main Study|Death|0
6115988|NCT00110617|21091289|P2|Overall Study|Did not receive study drug|12
6115989|NCT00110617|21091290|P1|Overall Study|Did not receive study drug|0
6115990|NCT00110617|21091289|P2|Overall Study|Death|1
6115991|NCT00110617|21091290|P1|Overall Study|Death|1
6115993|NCT00110617|21091290|P1|Overall Study|Administrative problems|6
6115994|NCT00110617|21091289|P2|Overall Study|Lost to Follow-up|1
6115995|NCT00110617|21091290|P1|Overall Study|Lost to Follow-up|9
6115996|NCT00110617|21091289|P2|Overall Study|Withdrawal by Subject|4
6115997|NCT00110617|21091290|P1|Overall Study|Withdrawal by Subject|10
6115998|NCT00110617|21091289|P2|Overall Study|Protocol Violation|0
6115999|NCT00110617|21091290|P1|Overall Study|Protocol Violation|5
6116000|NCT00110617|21091289|P2|Overall Study|Patient no longer requires study drug|0
6116001|NCT00110617|21091290|P1|Overall Study|Patient no longer requires study drug|1
6116002|NCT00110617|21091289|P2|Overall Study|Lack of Efficacy|0
6116003|NCT00110617|21091290|P1|Overall Study|Lack of Efficacy|1
6116004|NCT00110617|21091289|P2|Overall Study|Abnormal Laboratory Value|2
6116005|NCT00110617|21091290|P1|Overall Study|Abnormal Laboratory Value|4
6116006|NCT00110617|21091289|P2|Overall Study|Adverse Event|4
6116007|NCT00110617|21091290|P1|Overall Study|Adverse Event|2
6116008|NCT00110396|21091407|P1|Overall Study|Patient is to be administered copaxone|1
6116009|NCT00110396|21091407|P1|Overall Study|The patient has refused to visit site|1
6116010|NCT00110396|21091407|P1|Overall Study|The patient has refused|2
6116011|NCT00110396|21091407|P1|Overall Study|Patient refused to come back|1
6116012|NCT00110396|21091407|P1|Overall Study|Protocol Violation|2
6116013|NCT00110396|21091407|P1|Overall Study|Pregnancy (Protocol violation)|2
6116014|NCT00110396|21091407|P1|Overall Study|Pregnancy|1
6116015|NCT00110396|21091407|P1|Overall Study|Participation in MS vaccine study|1
6116016|NCT00110396|21091407|P1|Overall Study|Patient's decision|1
6116017|NCT00110396|21091407|P1|Overall Study|Patient will|1
6116018|NCT00110396|21091407|P1|Overall Study|Patient refused to participate|1
6116019|NCT00110396|21091407|P1|Overall Study|Patient refused to continue|1
6116020|NCT00110396|21091407|P1|Overall Study|Patient non-compliance|1
6116021|NCT00110396|21091407|P1|Overall Study|Decided not to continue treatment|1
6116022|NCT00110396|21091407|P1|Overall Study|Lack of Efficacy|1
6116023|NCT00110396|21091407|P1|Overall Study|Initiated mitoxantrone therapy|1
6116024|NCT00110396|21091407|P1|Overall Study|Administration of plasmapheresis|1
6116025|NCT00110396|21091407|P1|Overall Study|Lost to Follow-up|1
6116026|NCT00110396|21091407|P1|Overall Study|Adverse Event|15
6116027|NCT00110357|21091415|P2|Overall Study|Withdrawal by Subject|1
6116028|NCT00110357|21091416|P1|Overall Study|Withdrawal by Subject|3
6116029|NCT00110357|21091415|P2|Overall Study|Study Drug Toxicity|3
6116030|NCT00110357|21091416|P1|Overall Study|Study Drug Toxicity|1
6116031|NCT00110357|21091415|P2|Overall Study|Study Closure|0
6116032|NCT00110357|21091416|P1|Overall Study|Study Closure|1
6116033|NCT00110357|21091415|P2|Overall Study|Disease progression/relapse|15
6116034|NCT00110357|21091416|P1|Overall Study|Disease progression/relapse|20
6116035|NCT00110357|21091415|P2|Overall Study|Deterioration without progression|0
6116036|NCT00110357|21091416|P1|Overall Study|Deterioration without progression|2
6116037|NCT00110305|21091504|P2|Overall Study|Other|2
6116038|NCT00110305|21091505|P1|Overall Study|Other|8
6116039|NCT00110305|21091504|P2|Overall Study|Lost to Follow-up|3
6116040|NCT00110305|21091505|P1|Overall Study|Lost to Follow-up|20
6116041|NCT00110305|21091504|P2|Overall Study|Withdrawal by Subject|7
6116042|NCT00110305|21091505|P1|Overall Study|Withdrawal by Subject|7
6116043|NCT00110305|21091504|P2|Overall Study|Protocol Violation|1
6116044|NCT00110305|21091505|P1|Overall Study|Protocol Violation|0
6116045|NCT00110305|21091504|P2|Overall Study|Subject Reached A Virologic Endpoint|3
6116046|NCT00110305|21091505|P1|Overall Study|Subject Reached A Virologic Endpoint|21
6116047|NCT00110305|21091504|P2|Overall Study|Subject Ineligible To Continue The Trial|1
6116048|NCT00110305|21091505|P1|Overall Study|Subject Ineligible To Continue The Trial|2
6116049|NCT00110305|21091504|P2|Overall Study|Subject Non-Compliant|2
6116050|NCT00110305|21091505|P1|Overall Study|Subject Non-Compliant|9
6116051|NCT00110305|21091504|P2|Overall Study|Sponsors Decision|0
6116052|NCT00110305|21091505|P1|Overall Study|Sponsors Decision|1
6116053|NCT00110305|21091504|P2|Overall Study|Adverse Event|13
6116054|NCT00110305|21091505|P1|Overall Study|Adverse Event|46
6116055|NCT00110214|21091558|P2|Overall Study|Other (not specified)|75
6116056|NCT00110214|21091559|P1|Overall Study|Other (not specified)|61
6116057|NCT00110214|21091558|P2|Overall Study|Refused further treatment|65
6116058|NCT00110214|21091559|P1|Overall Study|Refused further treatment|52
6116059|NCT00110214|21091558|P2|Overall Study|Adverse Event|192
6116060|NCT00110214|21091559|P1|Overall Study|Adverse Event|115
6116061|NCT00110214|21091558|P2|Overall Study|Disease progression or death|151
6116062|NCT00110214|21091559|P1|Overall Study|Disease progression or death|260
6116063|NCT00110214|21091558|P2|Overall Study|Never started treatment|20
6116064|NCT00110214|21091559|P1|Overall Study|Never started treatment|21
6116065|NCT00110149|21091571|P1|Overall Study|Physician Decision|3
6116066|NCT00110084|21091585|P1|Overall Study|Other|2
6116067|NCT00110084|21091585|P1|Overall Study|Intercurrent Illness|1
6116068|NCT00110084|21091585|P1|Overall Study|Alternate Therapy|5
6116069|NCT00110084|21091585|P1|Overall Study|Patient Refusal|10
6116070|NCT00110084|21091585|P1|Overall Study|Death|1
6116071|NCT00110084|21091585|P1|Overall Study|Adverse Event|9
6116072|NCT00110019|21091594|P2|Overall Study|other reasons|30
6116073|NCT00110019|21091595|P1|Overall Study|other reasons|22
6116074|NCT00110019|21091594|P2|Overall Study|Not start protocol therapy|16
6116075|NCT00110019|21091595|P1|Overall Study|Not start protocol therapy|17
6116076|NCT00110019|21091594|P2|Overall Study|symptom deterioration|16
6116077|NCT00110019|21091595|P1|Overall Study|symptom deterioration|13
6116078|NCT00110019|21091594|P2|Overall Study|complicating disease|1
6116079|NCT00110019|21091595|P1|Overall Study|complicating disease|1
6116080|NCT00110019|21091594|P2|Overall Study|alternative therapy|1
6116081|NCT00110019|21091595|P1|Overall Study|alternative therapy|5
6116082|NCT00110019|21091594|P2|Overall Study|Withdrawal by Subject|9
6116083|NCT00110019|21091595|P1|Overall Study|Withdrawal by Subject|21
6116084|NCT00110019|21091594|P2|Overall Study|Death|15
6116085|NCT00110019|21091595|P1|Overall Study|Death|13
6116086|NCT00110019|21091594|P2|Overall Study|Adverse Event|40
6116087|NCT00110019|21091595|P1|Overall Study|Adverse Event|61
6116088|NCT00110019|21091594|P2|Overall Study|Lack of Efficacy|285
6116089|NCT00110019|21091595|P1|Overall Study|Lack of Efficacy|253
6116090|NCT00109967|21091607|P2|Overall Study|Death|2
6116091|NCT00109967|21091608|P1|Overall Study|Death|0
6116092|NCT00109967|21091607|P2|Overall Study|Physician Decision|3
6116093|NCT00109967|21091608|P1|Overall Study|Physician Decision|1
6116094|NCT00109967|21091607|P2|Overall Study|Withdrawal by Subject|0
6116095|NCT00109967|21091608|P1|Overall Study|Withdrawal by Subject|5
6116096|NCT00109967|21091607|P2|Overall Study|Adverse Event|1
6116097|NCT00109967|21091608|P1|Overall Study|Adverse Event|12
6116098|NCT00109967|21091607|P2|Overall Study|Cancel Prior to Treatment|0
6116099|NCT00109967|21091608|P1|Overall Study|Cancel Prior to Treatment|2
6116100|NCT00109928|21091622|P1|Overall Study|not eligible|1
6116101|NCT00109928|21091622|P1|Overall Study|not protocol specified|2
6116102|NCT00109928|21091622|P1|Overall Study|Death|2
6116103|NCT00109928|21091622|P1|Overall Study|Progression|6
6116104|NCT00109928|21091622|P1|Overall Study|Adverse Event|2
6116105|NCT00109850|21091639|P1|Overall Study|Ineligible|1
6116106|NCT00109850|21091639|P1|Overall Study|Death|2
6116107|NCT00109850|21091639|P1|Overall Study|Adverse Event|1
6116108|NCT00109837|21091646|P1|Overall Study|Ineligible|1
6116109|NCT00109837|21091646|P1|Overall Study|Not treated|1
6116110|NCT00109837|21091646|P1|Overall Study|BCR/ABL+ or Ph+|17
6116111|NCT00109837|21091646|P1|Overall Study|Death|1
6116112|NCT00109837|21091646|P1|Overall Study|Refusal unrelated to adverse effects|1
6116113|NCT00109837|21091646|P1|Overall Study|Adverse Event|2
6116114|NCT00109772|21091656|P2|Open-label Extension|Other|10
6116115|NCT00109772|21091657|P1|Open-label Extension|Other|4
6116116|NCT00109772|21091656|P2|Open-label Extension|Protocol Violation|2
6116117|NCT00109772|21091657|P1|Open-label Extension|Protocol Violation|2
6116118|NCT00109772|21091656|P2|Open-label Extension|Death|1
6116119|NCT00109772|21091657|P1|Open-label Extension|Death|0
6116120|NCT00109772|21091656|P2|Open-label Extension|Lost to Follow-up|0
6116121|NCT00109772|21091657|P1|Open-label Extension|Lost to Follow-up|1
6116122|NCT00109772|21091656|P2|Open-label Extension|Withdrawal by Subject|6
6116123|NCT00109772|21091657|P1|Open-label Extension|Withdrawal by Subject|9
6116124|NCT00109772|21091656|P2|Open-label Extension|Lack of Efficacy|11
6116125|NCT00109772|21091657|P1|Open-label Extension|Lack of Efficacy|19
6116126|NCT00109772|21091656|P2|Open-label Extension|Adverse Event|19
6116127|NCT00109772|21091657|P1|Open-label Extension|Adverse Event|10
6116128|NCT00109772|21091656|P2|Double-blind Treatment|Withdrew prior to treatment|1
6116129|NCT00109772|21091657|P1|Double-blind Treatment|Withdrew prior to treatment|3
6116130|NCT00109772|21091656|P2|Double-blind Treatment|Other|4
6116131|NCT00109772|21091657|P1|Double-blind Treatment|Other|0
6116132|NCT00109772|21091656|P2|Double-blind Treatment|Protocol Violation|1
6116133|NCT00109772|21091657|P1|Double-blind Treatment|Protocol Violation|0
6116134|NCT00109772|21091656|P2|Double-blind Treatment|Lost to Follow-up|3
6116135|NCT00109772|21091657|P1|Double-blind Treatment|Lost to Follow-up|2
6116136|NCT00109772|21091656|P2|Double-blind Treatment|Withdrawal by Subject|1
6116137|NCT00109772|21091657|P1|Double-blind Treatment|Withdrawal by Subject|2
6116138|NCT00109772|21091656|P2|Double-blind Treatment|Lack of Efficacy|0
6116139|NCT00109772|21091657|P1|Double-blind Treatment|Lack of Efficacy|1
6116140|NCT00109772|21091656|P2|Double-blind Treatment|Adverse Event|5
6116141|NCT00109772|21091657|P1|Double-blind Treatment|Adverse Event|14
6116142|NCT00109733|21091697|P2|Overall Study|Could not commit time for study|1
6116143|NCT00109733|21091698|P1|Overall Study|Could not commit time for study|1
6116144|NCT00109733|21091697|P2|Overall Study|Non-compliant|1
6116145|NCT00109733|21091698|P1|Overall Study|Non-compliant|0
6116146|NCT00109733|21091697|P2|Overall Study|Stopped taking study drug|1
6116147|NCT00109733|21091698|P1|Overall Study|Stopped taking study drug|1
6116148|NCT00109733|21091697|P2|Overall Study|Protocol Violation|1
6116149|NCT00109733|21091698|P1|Overall Study|Protocol Violation|0
6116150|NCT00109590|21091715|P3|Overall Study|Never Started Treatment|3
6116151|NCT00109590|21091716|P2|Overall Study|Never Started Treatment|2
6116152|NCT00109590|21091717|P1|Overall Study|Never Started Treatment|1
6116153|NCT00109590|21091715|P3|Overall Study|Lost to Follow-up|1
6116154|NCT00109590|21091716|P2|Overall Study|Lost to Follow-up|0
6116155|NCT00109590|21091717|P1|Overall Study|Lost to Follow-up|1
6116156|NCT00109577|21091759|P2|Overall Study|Withdrawal by Subject|3
6116157|NCT00109577|21091760|P1|Overall Study|Withdrawal by Subject|3
6116158|NCT00109343|21091793|P3|Overall Study|Other|1
6116159|NCT00109343|21091794|P2|Overall Study|Other|2
6116160|NCT00109343|21091795|P1|Overall Study|Other|5
6116161|NCT00109343|21091793|P3|Overall Study|Subject Moved|1
6116162|NCT00109343|21091794|P2|Overall Study|Subject Moved|2
6116163|NCT00109343|21091795|P1|Overall Study|Subject Moved|6
6116164|NCT00109343|21091793|P3|Overall Study|Withdrawal by Subject|10
6116165|NCT00109343|21091794|P2|Overall Study|Withdrawal by Subject|11
6116166|NCT00109343|21091795|P1|Overall Study|Withdrawal by Subject|15
6116167|NCT00109343|21091793|P3|Overall Study|Protocol Violation|2
6116168|NCT00109343|21091794|P2|Overall Study|Protocol Violation|2
6116169|NCT00109343|21091795|P1|Overall Study|Protocol Violation|1
6116170|NCT00109343|21091793|P3|Overall Study|Lost to Follow-up|14
6116171|NCT00109343|21091794|P2|Overall Study|Lost to Follow-up|20
6116172|NCT00109343|21091795|P1|Overall Study|Lost to Follow-up|35
6116173|NCT00109343|21091793|P3|Overall Study|Lack of Efficacy|0
6116174|NCT00109343|21091794|P2|Overall Study|Lack of Efficacy|0
6116175|NCT00109343|21091795|P1|Overall Study|Lack of Efficacy|1
6116176|NCT00109343|21091793|P3|Overall Study|Adverse Event|2
6116177|NCT00109343|21091794|P2|Overall Study|Adverse Event|0
6116178|NCT00109343|21091795|P1|Overall Study|Adverse Event|1
6116179|NCT00109031|21091840|P4|Overall Study|Protocol Violation|0
6116180|NCT00109031|21091841|P3|Overall Study|Protocol Violation|1
6116181|NCT00109031|21091842|P2|Overall Study|Protocol Violation|0
6116182|NCT00109031|21091843|P1|Overall Study|Protocol Violation|0
6116183|NCT00109031|21091840|P4|Overall Study|Physician Decision|0
6116184|NCT00109031|21091841|P3|Overall Study|Physician Decision|0
6116185|NCT00109031|21091842|P2|Overall Study|Physician Decision|1
6116186|NCT00109031|21091843|P1|Overall Study|Physician Decision|0
6116187|NCT00109031|21091840|P4|Overall Study|Withdrawal by Subject|0
6116188|NCT00109031|21091841|P3|Overall Study|Withdrawal by Subject|0
6116189|NCT00109031|21091842|P2|Overall Study|Withdrawal by Subject|1
6116190|NCT00109031|21091843|P1|Overall Study|Withdrawal by Subject|0
6116191|NCT00109031|21091840|P4|Overall Study|Adverse Event|0
6116192|NCT00109031|21091841|P3|Overall Study|Adverse Event|1
6116193|NCT00109031|21091842|P2|Overall Study|Adverse Event|0
6116194|NCT00109031|21091843|P1|Overall Study|Adverse Event|0
6116195|NCT00108953|21091894|P2|Follow-up|Study terminated by sponsor|6
6116196|NCT00108953|21091895|P1|Follow-up|Study terminated by sponsor|10
6116197|NCT00108953|21091894|P2|Follow-up|Lost to Follow-up|1
6116198|NCT00108953|21091895|P1|Follow-up|Lost to Follow-up|1
6116199|NCT00108953|21091894|P2|Follow-up|Death|26
6116200|NCT00108953|21091895|P1|Follow-up|Death|18
6116201|NCT00108862|21091917|P2|Overall Study|Lost to Follow-up|19
6116202|NCT00108862|21091918|P1|Overall Study|Lost to Follow-up|27
6116203|NCT00108862|21091917|P2|Overall Study|Withdrawal by Subject|6
6116204|NCT00108862|21091918|P1|Overall Study|Withdrawal by Subject|10
6116205|NCT00108862|21091917|P2|Overall Study|Death|37
6116206|NCT00108862|21091918|P1|Overall Study|Death|31
6116207|NCT00108732|21091946|P1|Step 2 (Androgen Ablation and Vaccine)|Other|1
6116208|NCT00108732|21091946|P1|Step 2 (Androgen Ablation and Vaccine)|Withdrawal by Subject|1
6116209|NCT00108732|21091946|P1|Step 2 (Androgen Ablation and Vaccine)|Adverse Event|3
6116210|NCT00108732|21091946|P1|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Non-compliance|1
6116211|NCT00108732|21091946|P1|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Ineligible|10
6116212|NCT00108732|21091946|P1|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Withdrawal by Subject|2
6116213|NCT00108732|21091946|P1|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Adverse Event|1
6116214|NCT00108628|21091955|P2|Overall Study|Death|0
6116215|NCT00108628|21091956|P1|Overall Study|Death|1
6116216|NCT00108628|21091955|P2|Overall Study|Lack of Efficacy|1
6116217|NCT00108628|21091956|P1|Overall Study|Lack of Efficacy|2
6116218|NCT00108628|21091955|P2|Overall Study|Withdrawal by Subject|9
6116219|NCT00108628|21091956|P1|Overall Study|Withdrawal by Subject|17
6116220|NCT00108485|21092006|P2|Overall Study|Lost to Follow-up|2
6116221|NCT00108485|21092007|P1|Overall Study|Lost to Follow-up|0
6116222|NCT00108485|21092006|P2|Overall Study|Withdrawal by Subject|0
6116223|NCT00108485|21092007|P1|Overall Study|Withdrawal by Subject|3
6116224|NCT00108433|21092015|P2|Overall Study|Other|14
6116225|NCT00108433|21092016|P1|Overall Study|Other|14
6116226|NCT00108433|21092015|P2|Overall Study|Adverse Event|1
6116227|NCT00108433|21092016|P1|Overall Study|Adverse Event|3
6116228|NCT00108433|21092015|P2|Overall Study|Death|0
6116229|NCT00108433|21092016|P1|Overall Study|Death|3
6116230|NCT00108433|21092015|P2|Overall Study|Lack of Efficacy|2
6116231|NCT00108433|21092016|P1|Overall Study|Lack of Efficacy|1
6116232|NCT00108355|21092032|P2|Overall Study|Loculated ascites, limiting paracentesis|1
6116233|NCT00108355|21092033|P1|Overall Study|Loculated ascites, limiting paracentesis|1
6116234|NCT00108355|21092032|P2|Overall Study|Peritonitis at index paracentesis|1
6116235|NCT00108355|21092033|P1|Overall Study|Peritonitis at index paracentesis|1
6116236|NCT00108160|21092082|P2|Overall Study|Protocol Violation|5
6116237|NCT00108160|21092083|P1|Overall Study|Protocol Violation|9
6116238|NCT00108160|21092082|P2|Overall Study|Withdrawal by Subject|2
6116239|NCT00108160|21092083|P1|Overall Study|Withdrawal by Subject|4
6116240|NCT00108160|21092082|P2|Overall Study|Death|2
6116241|NCT00108160|21092083|P1|Overall Study|Death|1
6116242|NCT00108160|21092082|P2|Overall Study|Lost to Follow-up|12
6116243|NCT00108160|21092083|P1|Overall Study|Lost to Follow-up|25
6116244|NCT00108082|21092096|P3|Overall Study|Blood Pressure Not Controlled|0
6116245|NCT00108082|21092097|P2|Overall Study|Blood Pressure Not Controlled|0
6116246|NCT00108082|21092098|P1|Overall Study|Blood Pressure Not Controlled|1
6116247|NCT00108082|21092096|P3|Overall Study|Investigator Not at Site|0
6116248|NCT00108082|21092097|P2|Overall Study|Investigator Not at Site|0
6116249|NCT00108082|21092098|P1|Overall Study|Investigator Not at Site|1
6116250|NCT00108082|21092096|P3|Overall Study|Subject Left Site Location|0
6116251|NCT00108082|21092097|P2|Overall Study|Subject Left Site Location|0
6116252|NCT00108082|21092098|P1|Overall Study|Subject Left Site Location|1
6116253|NCT00108082|21092096|P3|Overall Study|Study Medication Not Tapered|0
6116254|NCT00108082|21092097|P2|Overall Study|Study Medication Not Tapered|1
6116255|NCT00108082|21092098|P1|Overall Study|Study Medication Not Tapered|0
6116256|NCT00108082|21092096|P3|Overall Study|Protocol Amendment|0
6116257|NCT00108082|21092097|P2|Overall Study|Protocol Amendment|1
6116258|NCT00108082|21092098|P1|Overall Study|Protocol Amendment|0
6116259|NCT00108082|21092096|P3|Overall Study|Site Closed Study|0
6116260|NCT00108082|21092097|P2|Overall Study|Site Closed Study|2
6116261|NCT00108082|21092098|P1|Overall Study|Site Closed Study|0
6116262|NCT00108082|21092096|P3|Overall Study|Stopped Study Medication|1
6116263|NCT00108082|21092097|P2|Overall Study|Stopped Study Medication|0
6116264|NCT00108082|21092098|P1|Overall Study|Stopped Study Medication|0
6116265|NCT00108082|21092096|P3|Overall Study|Non-compliance|2
6116266|NCT00108082|21092097|P2|Overall Study|Non-compliance|0
6116267|NCT00108082|21092098|P1|Overall Study|Non-compliance|1
6116268|NCT00108082|21092096|P3|Overall Study|Incorrectly Randomized|2
6116269|NCT00108082|21092097|P2|Overall Study|Incorrectly Randomized|0
6116270|NCT00108082|21092098|P1|Overall Study|Incorrectly Randomized|0
6116271|NCT00108082|21092096|P3|Overall Study|Woman of Child-bearing Potential|2
6116272|NCT00108082|21092097|P2|Overall Study|Woman of Child-bearing Potential|0
6116273|NCT00108082|21092098|P1|Overall Study|Woman of Child-bearing Potential|2
6116274|NCT00108082|21092096|P3|Overall Study|Amendment 4: > Month 12|5
6116275|NCT00108082|21092097|P2|Overall Study|Amendment 4: > Month 12|7
6116276|NCT00108082|21092098|P1|Overall Study|Amendment 4: > Month 12|5
6116277|NCT00108082|21092096|P3|Overall Study|Lack of Efficacy|2
6116278|NCT00108082|21092097|P2|Overall Study|Lack of Efficacy|1
6116279|NCT00108082|21092098|P1|Overall Study|Lack of Efficacy|3
6116280|NCT00108082|21092096|P3|Overall Study|Protocol Violation|0
6116281|NCT00108082|21092097|P2|Overall Study|Protocol Violation|2
6116282|NCT00108082|21092098|P1|Overall Study|Protocol Violation|1
6116283|NCT00108082|21092096|P3|Overall Study|Consent Withdrawn|5
6116284|NCT00108082|21092097|P2|Overall Study|Consent Withdrawn|3
6116285|NCT00108082|21092098|P1|Overall Study|Consent Withdrawn|3
6116286|NCT00108082|21092096|P3|Overall Study|Lost to Follow-up|7
6116287|NCT00108082|21092097|P2|Overall Study|Lost to Follow-up|3
6116288|NCT00108082|21092098|P1|Overall Study|Lost to Follow-up|6
6116289|NCT00108082|21092096|P3|Overall Study|Adverse Event|17
6116290|NCT00108082|21092097|P2|Overall Study|Adverse Event|12
6116291|NCT00108082|21092098|P1|Overall Study|Adverse Event|14
6116292|NCT00108069|21092147|P2|Overall Study|Progessive disease|11
6116293|NCT00108069|21092148|P1|Overall Study|Progessive disease|27
6116294|NCT00108069|21092147|P2|Overall Study|Death|0
6116295|NCT00108069|21092148|P1|Overall Study|Death|1
6116296|NCT00108069|21092147|P2|Overall Study|Withdrawal by Subject|0
6116297|NCT00108069|21092148|P1|Overall Study|Withdrawal by Subject|1
6116298|NCT00108069|21092147|P2|Overall Study|Adverse Event|1
6116299|NCT00108069|21092148|P1|Overall Study|Adverse Event|1
6116300|NCT00108069|21092147|P2|Overall Study|Never rec'd study drug|1
6116301|NCT00108069|21092148|P1|Overall Study|Never rec'd study drug|0
6116302|NCT00107991|21092162|P1|18-Week Post Treatment Assessment|Adverse Event|2
6116303|NCT00107991|21092162|P1|12 Week Treatment Period|Incarcerated|1
6116304|NCT00107991|21092162|P1|12 Week Treatment Period|Protocol Violation|1
6116305|NCT00107991|21092162|P1|12 Week Treatment Period|Adverse Event|1
6116306|NCT00107991|21092162|P1|12 Week Treatment Period|Lack of Efficacy|2
6116307|NCT00107991|21092162|P1|Eligibility Assessment|hx of alcohol abuse in past 12 months|1
6116308|NCT00107991|21092162|P1|Eligibility Assessment|chronic uncontrolled asthma|1
6116309|NCT00107991|21092162|P1|Eligibility Assessment|Ongoing treatment with antibiotics|1
6116310|NCT00107991|21092162|P1|Eligibility Assessment|Abnormal labs|2
6116311|NCT00107991|21092162|P1|Eligibility Assessment|Positive purified protein derivative|4
6116312|NCT00107991|21092162|P1|Eligibility Assessment|Unwilling to participate|7
6116313|NCT00107991|21092162|P1|Eligibility Assessment|Disease not severe enough|7
6116314|NCT00107978|21092172|P2|Overall Study|Other|4
6116315|NCT00107978|21092173|P1|Overall Study|Other|5
6116316|NCT00107978|21092172|P2|Overall Study|Protocol Violation|1
6116317|NCT00107978|21092173|P1|Overall Study|Protocol Violation|0
6116318|NCT00107978|21092172|P2|Overall Study|Withdrawal by Subject|9
6116319|NCT00107978|21092173|P1|Overall Study|Withdrawal by Subject|4
6116320|NCT00107978|21092172|P2|Overall Study|Lost to Follow-up|28
6116321|NCT00107978|21092173|P1|Overall Study|Lost to Follow-up|20
6116322|NCT00107978|21092172|P2|Overall Study|Death|3
6116323|NCT00107978|21092173|P1|Overall Study|Death|3
6116324|NCT00107978|21092172|P2|Overall Study|Adverse Event|5
6116325|NCT00107978|21092173|P1|Overall Study|Adverse Event|1
6116326|NCT00107952|21092181|P2|Overall Study|Never received study treatment|6
6116327|NCT00107952|21092182|P1|Overall Study|Never received study treatment|9
6116328|NCT00107952|21092181|P2|Overall Study|Other|5
6116329|NCT00107952|21092182|P1|Overall Study|Other|2
6116330|NCT00107952|21092181|P2|Overall Study|Withdrawal by Subject|6
6116331|NCT00107952|21092182|P1|Overall Study|Withdrawal by Subject|9
6116332|NCT00107952|21092181|P2|Overall Study|Lost to Follow-up|3
6116333|NCT00107952|21092182|P1|Overall Study|Lost to Follow-up|0
6116334|NCT00107952|21092181|P2|Overall Study|Death|61
6116335|NCT00107952|21092182|P1|Overall Study|Death|75
6116336|NCT00107900|21092194|P6|Overall Study|Administrative Reasons|0
6116337|NCT00107900|21092195|P5|Overall Study|Administrative Reasons|2
6116338|NCT00107900|21092196|P4|Overall Study|Administrative Reasons|2
6116339|NCT00107900|21092197|P3|Overall Study|Administrative Reasons|2
6116340|NCT00107900|21092198|P2|Overall Study|Administrative Reasons|0
6116341|NCT00107900|21092199|P1|Overall Study|Administrative Reasons|1
6116342|NCT00107900|21092194|P6|Overall Study|Withdrawal by Subject|1
6116343|NCT00107900|21092195|P5|Overall Study|Withdrawal by Subject|1
6116344|NCT00107900|21092196|P4|Overall Study|Withdrawal by Subject|0
6116345|NCT00107900|21092197|P3|Overall Study|Withdrawal by Subject|5
6116346|NCT00107900|21092198|P2|Overall Study|Withdrawal by Subject|0
6116347|NCT00107900|21092199|P1|Overall Study|Withdrawal by Subject|1
6116348|NCT00107900|21092194|P6|Overall Study|Protocol Violation|0
6116349|NCT00107900|21092195|P5|Overall Study|Protocol Violation|7
6116350|NCT00107900|21092196|P4|Overall Study|Protocol Violation|5
6116351|NCT00107900|21092197|P3|Overall Study|Protocol Violation|5
6116352|NCT00107900|21092198|P2|Overall Study|Protocol Violation|0
6116353|NCT00107900|21092199|P1|Overall Study|Protocol Violation|1
6116354|NCT00107900|21092194|P6|Overall Study|Lost to Follow-up|5
6116355|NCT00107900|21092195|P5|Overall Study|Lost to Follow-up|5
6116356|NCT00107900|21092196|P4|Overall Study|Lost to Follow-up|2
6116357|NCT00107900|21092197|P3|Overall Study|Lost to Follow-up|3
6116358|NCT00107900|21092198|P2|Overall Study|Lost to Follow-up|1
6116359|NCT00107900|21092199|P1|Overall Study|Lost to Follow-up|4
6116360|NCT00107900|21092194|P6|Overall Study|Death|0
6116361|NCT00107900|21092195|P5|Overall Study|Death|1
6116362|NCT00107900|21092196|P4|Overall Study|Death|0
6116363|NCT00107900|21092197|P3|Overall Study|Death|0
6116364|NCT00107900|21092198|P2|Overall Study|Death|0
6116365|NCT00107900|21092199|P1|Overall Study|Death|0
6116366|NCT00107900|21092194|P6|Overall Study|Adverse Event|3
6116367|NCT00107900|21092195|P5|Overall Study|Adverse Event|5
6116368|NCT00107900|21092196|P4|Overall Study|Adverse Event|3
6116369|NCT00107900|21092197|P3|Overall Study|Adverse Event|10
6116370|NCT00107900|21092198|P2|Overall Study|Adverse Event|2
6116371|NCT00107900|21092199|P1|Overall Study|Adverse Event|3
6116372|NCT00107783|21092233|P2|Overall Study|Second hip replacement|1
6116373|NCT00107783|21092234|P1|Overall Study|Second hip replacement|1
6116374|NCT00107783|21092233|P2|Overall Study|Withdrawal by Subject|0
6116375|NCT00107783|21092234|P1|Overall Study|Withdrawal by Subject|2
6116376|NCT00107783|21092233|P2|Overall Study|Death|1
6116377|NCT00107783|21092234|P1|Overall Study|Death|0
6116378|NCT00107783|21092233|P2|Overall Study|Adverse Event|2
6116379|NCT00107783|21092234|P1|Overall Study|Adverse Event|0
6116380|NCT00107653|21092269|P2|Overall Study|Administrative Reasons|3
6116381|NCT00107653|21092270|P1|Overall Study|Administrative Reasons|3
6116382|NCT00107653|21092269|P2|Overall Study|Lost to Follow-up|5
6116383|NCT00107653|21092270|P1|Overall Study|Lost to Follow-up|13
6116384|NCT00107653|21092269|P2|Overall Study|Withdrawal by Subject|13
6116385|NCT00107653|21092270|P1|Overall Study|Withdrawal by Subject|12
6116386|NCT00107653|21092269|P2|Overall Study|Protocol Violation|0
6116387|NCT00107653|21092270|P1|Overall Study|Protocol Violation|1
6116388|NCT00107653|21092269|P2|Overall Study|Violation of Selection Criteria at Entry|1
6116389|NCT00107653|21092270|P1|Overall Study|Violation of Selection Criteria at Entry|1
6116390|NCT00107653|21092269|P2|Overall Study|Insufficient Therapeutic Response|11
6116391|NCT00107653|21092270|P1|Overall Study|Insufficient Therapeutic Response|25
6116392|NCT00107653|21092269|P2|Overall Study|Adverse Event|43
6116393|NCT00107653|21092270|P1|Overall Study|Adverse Event|24
6116394|NCT00107614|21092316|P1|Overall Study|Death|2
6116395|NCT00107614|21092316|P1|Overall Study|Physician Decision|10
6116396|NCT00107380|21092347|P1|Overall Study|Ineligible|2
6116397|NCT00107380|21092347|P1|Overall Study|Other - not protocol specified|7
6116398|NCT00107380|21092347|P1|Overall Study|Death|3
6116399|NCT00107380|21092347|P1|Overall Study|Progression/relapse|4
6116400|NCT00107380|21092347|P1|Overall Study|Refusal Unrelated to Adverse Event|7
6116401|NCT00107380|21092347|P1|Overall Study|Adverse Event|7
6116402|NCT00107315|21092353|P1|Overall Study|Withdrawal by Subject|2
6116403|NCT00107315|21092353|P1|Overall Study|Adverse Event|4
6116404|NCT00107315|21092353|P1|Overall Study|Disease Progression|9
6116405|NCT00107276|21092360|P1|Overall Study|Ineligible|16
6116406|NCT00107276|21092360|P1|Overall Study|Death|1
6116407|NCT00107276|21092360|P1|Overall Study|Patient refusal|1
6116408|NCT00107276|21092360|P1|Overall Study|M.D. decision|2
6116409|NCT00107276|21092360|P1|Overall Study|Adverse Event|6
6116410|NCT00107276|21092360|P1|Overall Study|Progression|46
6116411|NCT00107198|21092366|P1|Overall Study|Ineligible|5
6116412|NCT00107198|21092366|P1|Overall Study|Withdrawal by Subject|6
6116413|NCT00107198|21092366|P1|Overall Study|Protocol Violation|1
6116414|NCT00107198|21092366|P1|Overall Study|Lost to Follow-up|12
6116415|NCT00107198|21092366|P1|Overall Study|Lack of Efficacy|28
6116416|NCT00107172|21092376|P2|Overall Study|Other Reason|3
6116417|NCT00107172|21092377|P1|Overall Study|Other Reason|4
6116418|NCT00107172|21092376|P2|Overall Study|Death|2
6116419|NCT00107172|21092377|P1|Overall Study|Death|0
6116420|NCT00107172|21092376|P2|Overall Study|Withdrawal by Subject|0
6116421|NCT00107172|21092377|P1|Overall Study|Withdrawal by Subject|1
6116422|NCT00107120|21092407|P2|Overall Study|death of parent|1
6116423|NCT00107120|21092408|P1|Overall Study|death of parent|0
6116424|NCT00107120|21092407|P2|Overall Study|moving away from site|1
6116425|NCT00107120|21092408|P1|Overall Study|moving away from site|1
6116426|NCT00107120|21092407|P2|Overall Study|Pregnancy|1
6116427|NCT00107120|21092408|P1|Overall Study|Pregnancy|0
6116428|NCT00107120|21092407|P2|Overall Study|Lost to Follow-up|6
6116429|NCT00107120|21092408|P1|Overall Study|Lost to Follow-up|8
6116430|NCT00107120|21092407|P2|Overall Study|Withdrawal by Subject|9
6116431|NCT00107120|21092408|P1|Overall Study|Withdrawal by Subject|8
6116432|NCT00107120|21092407|P2|Overall Study|Protocol Violation|0
6116433|NCT00107120|21092408|P1|Overall Study|Protocol Violation|3
6116434|NCT00107120|21092407|P2|Overall Study|Lack of Efficacy|5
6116435|NCT00107120|21092408|P1|Overall Study|Lack of Efficacy|5
6116436|NCT00107120|21092407|P2|Overall Study|Adverse Event|1
6116437|NCT00107120|21092408|P1|Overall Study|Adverse Event|4
6116438|NCT00107042|21092420|P2|Overall Study|Disallowed medications|2
6116439|NCT00107042|21092421|P1|Overall Study|Disallowed medications|0
6116440|NCT00107042|21092420|P2|Overall Study|vaccinated outside window|1
6116441|NCT00107042|21092421|P1|Overall Study|vaccinated outside window|1
6116442|NCT00107042|21092420|P2|Overall Study|Inadvertent enrollment|1
6116443|NCT00107042|21092421|P1|Overall Study|Inadvertent enrollment|0
6116444|NCT00107042|21092420|P2|Overall Study|Pregnancy|1
6116445|NCT00107042|21092421|P1|Overall Study|Pregnancy|1
6116446|NCT00107042|21092420|P2|Overall Study|Moved out of area|3
6116447|NCT00107042|21092421|P1|Overall Study|Moved out of area|5
6116448|NCT00107042|21092420|P2|Overall Study|Withdrawal by Subject|1
6116449|NCT00107042|21092421|P1|Overall Study|Withdrawal by Subject|6
6116450|NCT00107042|21092420|P2|Overall Study|Lost to Follow-up|7
6116451|NCT00107042|21092421|P1|Overall Study|Lost to Follow-up|9
6116452|NCT00106964|21092487|P3|Overall Study|Required disallowed medication|0
6116453|NCT00106964|21092488|P2|Overall Study|Required disallowed medication|1
6116454|NCT00106964|21092489|P1|Overall Study|Required disallowed medication|0
6116455|NCT00106964|21092487|P3|Overall Study|Did not meet eligibility criteria|2
6116456|NCT00106964|21092488|P2|Overall Study|Did not meet eligibility criteria|2
6116457|NCT00106964|21092489|P1|Overall Study|Did not meet eligibility criteria|0
6116458|NCT00106964|21092487|P3|Overall Study|Failure to adhere|0
6116459|NCT00106964|21092488|P2|Overall Study|Failure to adhere|0
6116460|NCT00106964|21092489|P1|Overall Study|Failure to adhere|2
6116461|NCT00106964|21092487|P3|Overall Study|Site Funding Terminated|1
6116462|NCT00106964|21092488|P2|Overall Study|Site Funding Terminated|1
6116463|NCT00106964|21092489|P1|Overall Study|Site Funding Terminated|0
6116464|NCT00106964|21092487|P3|Overall Study|Incarceration|0
6116465|NCT00106964|21092488|P2|Overall Study|Incarceration|1
6116466|NCT00106964|21092489|P1|Overall Study|Incarceration|0
6116467|NCT00106964|21092487|P3|Overall Study|Death|0
6116468|NCT00106964|21092488|P2|Overall Study|Death|1
6116469|NCT00106964|21092489|P1|Overall Study|Death|1
6116470|NCT00106964|21092487|P3|Overall Study|Pregnancy|2
6116471|NCT00106964|21092488|P2|Overall Study|Pregnancy|3
6116472|NCT00106964|21092489|P1|Overall Study|Pregnancy|2
6116473|NCT00106964|21092487|P3|Overall Study|Lost to Follow-up|2
6116474|NCT00106964|21092488|P2|Overall Study|Lost to Follow-up|6
6116475|NCT00106964|21092489|P1|Overall Study|Lost to Follow-up|8
6116476|NCT00106704|21092584|P2|Overall Study|Laboratory test|1
6116477|NCT00106704|21092585|P1|Overall Study|Laboratory test|1
6116478|NCT00106704|21092584|P2|Overall Study|Unable to re-enter US|0
6116479|NCT00106704|21092585|P1|Overall Study|Unable to re-enter US|1
6116480|NCT00106704|21092584|P2|Overall Study|Patient Received Glycemic Medication|41
6116481|NCT00106704|21092585|P1|Overall Study|Patient Received Glycemic Medication|22
6116482|NCT00106704|21092584|P2|Overall Study|Planned major surgery|0
6116483|NCT00106704|21092585|P1|Overall Study|Planned major surgery|1
6116484|NCT00106704|21092584|P2|Overall Study|Site terminated|1
6116485|NCT00106704|21092585|P1|Overall Study|Site terminated|0
6116486|NCT00106704|21092584|P2|Overall Study|Patient moved|0
6116487|NCT00106704|21092585|P1|Overall Study|Patient moved|1
6116488|NCT00106704|21092584|P2|Overall Study|Withdrawal by Subject|21
6116489|NCT00106704|21092585|P1|Overall Study|Withdrawal by Subject|14
6116490|NCT00106704|21092584|P2|Overall Study|Protocol Violation|7
6116491|NCT00106704|21092585|P1|Overall Study|Protocol Violation|4
6116492|NCT00106704|21092584|P2|Overall Study|Pregnancy|0
6116493|NCT00106704|21092585|P1|Overall Study|Pregnancy|1
6116494|NCT00106704|21092584|P2|Overall Study|Lost to Follow-up|3
6116495|NCT00106704|21092585|P1|Overall Study|Lost to Follow-up|7
6116496|NCT00106704|21092584|P2|Overall Study|Lack of Efficacy|69
6116497|NCT00106704|21092585|P1|Overall Study|Lack of Efficacy|67
6116498|NCT00106704|21092584|P2|Overall Study|Death|1
6116499|NCT00106704|21092585|P1|Overall Study|Death|2
6116500|NCT00106704|21092584|P2|Overall Study|Adverse Event|7
6116501|NCT00106704|21092585|P1|Overall Study|Adverse Event|10
6116502|NCT00106639|21092596|P3|Overall Study|Participant defaulted|1
6116503|NCT00106639|21092597|P2|Overall Study|Participant defaulted|1
6116504|NCT00106639|21092598|P1|Overall Study|Participant defaulted|0
6116505|NCT00106639|21092596|P3|Overall Study|Withdrawal by Subject|0
6116506|NCT00106639|21092597|P2|Overall Study|Withdrawal by Subject|1
6116507|NCT00106639|21092598|P1|Overall Study|Withdrawal by Subject|0
6116508|NCT00106639|21092596|P3|Overall Study|Protocol Violation|0
6116509|NCT00106639|21092597|P2|Overall Study|Protocol Violation|1
6116510|NCT00106639|21092598|P1|Overall Study|Protocol Violation|0
6116511|NCT00106639|21092596|P3|Overall Study|Adverse Event|1
6116512|NCT00106639|21092597|P2|Overall Study|Adverse Event|4
6116513|NCT00106639|21092598|P1|Overall Study|Adverse Event|3
6116514|NCT00106626|21092725|P4|Overall Study|> 14 day delay in therapy start|0
6116515|NCT00106626|21092726|P3|Overall Study|> 14 day delay in therapy start|0
6116516|NCT00106626|21092727|P2|Overall Study|> 14 day delay in therapy start|1
6116517|NCT00106626|21092728|P1|Overall Study|> 14 day delay in therapy start|0
6116518|NCT00106626|21092725|P4|Overall Study|Received radiation on new therapy|0
6116519|NCT00106626|21092726|P3|Overall Study|Received radiation on new therapy|0
6116520|NCT00106626|21092727|P2|Overall Study|Received radiation on new therapy|0
6116521|NCT00106626|21092728|P1|Overall Study|Received radiation on new therapy|1
6116522|NCT00106626|21092725|P4|Overall Study|Progressive Disease|10
6116523|NCT00106626|21092726|P3|Overall Study|Progressive Disease|9
6116524|NCT00106626|21092727|P2|Overall Study|Progressive Disease|1
6116525|NCT00106626|21092728|P1|Overall Study|Progressive Disease|4
6116526|NCT00106626|21092725|P4|Overall Study|Adverse Event|3
6116527|NCT00106626|21092726|P3|Overall Study|Adverse Event|3
6116528|NCT00106626|21092727|P2|Overall Study|Adverse Event|4
6116529|NCT00106626|21092728|P1|Overall Study|Adverse Event|5
6116530|NCT00106353|21093073|P7|Part 2|Physician Decision|0
6116531|NCT00106353|21093074|P6|Part 2|Physician Decision|1
6116532|NCT00106353|21093075|P5|Part 2|Physician Decision|0
6116533|NCT00106353|21093076|P4|Part 2|Physician Decision|0
6116534|NCT00106353|21093077|P3|Part 2|Physician Decision|0
6116535|NCT00106353|21093078|P2|Part 2|Physician Decision|0
6116536|NCT00106353|21093079|P1|Part 2|Physician Decision|0
6116537|NCT00106353|21093073|P7|Part 2|Withdrawal by Subject|0
6116538|NCT00106353|21093074|P6|Part 2|Withdrawal by Subject|0
6116539|NCT00106353|21093075|P5|Part 2|Withdrawal by Subject|1
6116540|NCT00106353|21093076|P4|Part 2|Withdrawal by Subject|0
6116541|NCT00106353|21093077|P3|Part 2|Withdrawal by Subject|0
6116542|NCT00106353|21093078|P2|Part 2|Withdrawal by Subject|0
6116543|NCT00106353|21093079|P1|Part 2|Withdrawal by Subject|0
6116544|NCT00106353|21093073|P7|Part 2|Other|1
6116545|NCT00106353|21093074|P6|Part 2|Other|1
6116546|NCT00106353|21093075|P5|Part 2|Other|1
6116547|NCT00106353|21093076|P4|Part 2|Other|0
6116548|NCT00106353|21093077|P3|Part 2|Other|0
6116549|NCT00106353|21093078|P2|Part 2|Other|0
6116550|NCT00106353|21093079|P1|Part 2|Other|0
6116551|NCT00106353|21093073|P7|Part 2|Adverse Event|1
6116552|NCT00106353|21093074|P6|Part 2|Adverse Event|2
6116553|NCT00106353|21093075|P5|Part 2|Adverse Event|0
6116554|NCT00106353|21093076|P4|Part 2|Adverse Event|0
6116555|NCT00106353|21093077|P3|Part 2|Adverse Event|0
6116556|NCT00106353|21093078|P2|Part 2|Adverse Event|0
6116557|NCT00106353|21093079|P1|Part 2|Adverse Event|0
6116558|NCT00106353|21093073|P7|Part 2|Symptomatic deterioration|0
6116559|NCT00106353|21093074|P6|Part 2|Symptomatic deterioration|0
6116560|NCT00106353|21093075|P5|Part 2|Symptomatic deterioration|3
6116561|NCT00106353|21093076|P4|Part 2|Symptomatic deterioration|0
6116562|NCT00106353|21093077|P3|Part 2|Symptomatic deterioration|0
6116563|NCT00106353|21093078|P2|Part 2|Symptomatic deterioration|0
6116564|NCT00106353|21093079|P1|Part 2|Symptomatic deterioration|0
6116565|NCT00106353|21093073|P7|Part 2|Death|1
6116566|NCT00106353|21093074|P6|Part 2|Death|0
6116567|NCT00106353|21093075|P5|Part 2|Death|3
6116568|NCT00106353|21093076|P4|Part 2|Death|0
6116569|NCT00106353|21093077|P3|Part 2|Death|0
6116570|NCT00106353|21093078|P2|Part 2|Death|0
6116571|NCT00106353|21093079|P1|Part 2|Death|0
6116572|NCT00106353|21093073|P7|Part 2|Disease progression|13
6116573|NCT00106353|21093074|P6|Part 2|Disease progression|14
6116574|NCT00106353|21093075|P5|Part 2|Disease progression|8
6116575|NCT00106353|21093076|P4|Part 2|Disease progression|0
6116576|NCT00106353|21093077|P3|Part 2|Disease progression|0
6116577|NCT00106353|21093078|P2|Part 2|Disease progression|0
6116578|NCT00106353|21093079|P1|Part 2|Disease progression|0
6116579|NCT00106353|21093073|P7|Part 1|Adverse Event|0
6116580|NCT00106353|21093074|P6|Part 1|Adverse Event|0
6116581|NCT00106353|21093075|P5|Part 1|Adverse Event|0
6116582|NCT00106353|21093076|P4|Part 1|Adverse Event|1
6116583|NCT00106353|21093077|P3|Part 1|Adverse Event|0
6116584|NCT00106353|21093078|P2|Part 1|Adverse Event|0
6116585|NCT00106353|21093079|P1|Part 1|Adverse Event|0
6116586|NCT00106353|21093073|P7|Part 1|Entered follow-up phase|0
6116587|NCT00106353|21093074|P6|Part 1|Entered follow-up phase|0
6116588|NCT00106353|21093075|P5|Part 1|Entered follow-up phase|0
6116589|NCT00106353|21093076|P4|Part 1|Entered follow-up phase|1
6116590|NCT00106353|21093077|P3|Part 1|Entered follow-up phase|0
6116591|NCT00106353|21093078|P2|Part 1|Entered follow-up phase|1
6116592|NCT00106353|21093079|P1|Part 1|Entered follow-up phase|1
6116593|NCT00106353|21093073|P7|Part 1|Symptomatic deterioration|0
6116594|NCT00106353|21093074|P6|Part 1|Symptomatic deterioration|0
6116595|NCT00106353|21093075|P5|Part 1|Symptomatic deterioration|0
6116596|NCT00106353|21093076|P4|Part 1|Symptomatic deterioration|0
6116597|NCT00106353|21093077|P3|Part 1|Symptomatic deterioration|1
6116598|NCT00106353|21093078|P2|Part 1|Symptomatic deterioration|0
6116599|NCT00106353|21093079|P1|Part 1|Symptomatic deterioration|0
6116600|NCT00106353|21093073|P7|Part 1|Withdrawal by Subject|0
6116601|NCT00106353|21093074|P6|Part 1|Withdrawal by Subject|0
6116602|NCT00106353|21093075|P5|Part 1|Withdrawal by Subject|0
6116603|NCT00106353|21093076|P4|Part 1|Withdrawal by Subject|2
6116604|NCT00106353|21093077|P3|Part 1|Withdrawal by Subject|1
6116605|NCT00106353|21093078|P2|Part 1|Withdrawal by Subject|0
6116606|NCT00106353|21093079|P1|Part 1|Withdrawal by Subject|0
6116607|NCT00106353|21093073|P7|Part 1|Disease progression|0
6116608|NCT00106353|21093074|P6|Part 1|Disease progression|0
6116609|NCT00106353|21093075|P5|Part 1|Disease progression|0
6116610|NCT00106353|21093076|P4|Part 1|Disease progression|3
6116611|NCT00106353|21093077|P3|Part 1|Disease progression|1
6116612|NCT00106353|21093078|P2|Part 1|Disease progression|4
6116613|NCT00106353|21093079|P1|Part 1|Disease progression|3
6116614|NCT00106249|21093206|P2|Overall Study|Lost to Follow-up|2
6116615|NCT00106249|21093207|P1|Overall Study|Lost to Follow-up|3
6116616|NCT00106184|21093219|P2|Overall Study|Withdrawal by Subject|2
6116617|NCT00106184|21093220|P1|Overall Study|Withdrawal by Subject|3
6116618|NCT00106080|21093262|P2|Overall Study|Withdrew/Loss to follow-up|27
6116619|NCT00106080|21093263|P1|Overall Study|Withdrew/Loss to follow-up|43
6116620|NCT00106028|21093273|P2|Overall Study|Lost to Follow-up|1
6116621|NCT00106028|21093274|P1|Overall Study|Lost to Follow-up|0
6116622|NCT00106028|21093273|P2|Overall Study|Withdrawal by Subject|8
6116623|NCT00106028|21093274|P1|Overall Study|Withdrawal by Subject|2
6116624|NCT00106028|21093273|P2|Overall Study|Protocol Violation|1
6116625|NCT00106028|21093274|P1|Overall Study|Protocol Violation|1
6116626|NCT00106028|21093273|P2|Overall Study|Adverse Event|2
6116627|NCT00106028|21093274|P1|Overall Study|Adverse Event|3
6116628|NCT00106002|21093368|P1|Overall Study|Ineligible after Registration|1
6116629|NCT00106002|21093368|P1|Overall Study|Did not take any study drug|1
6116630|NCT00105989|21093376|P2|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0
6116631|NCT00105989|21093377|P1|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0
6116632|NCT00105989|21093376|P2|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|43
6116633|NCT00105989|21093377|P1|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|14
6116634|NCT00105989|21093376|P2|Maintenance - Double-Blind:Week 34-86|Death|0
6116635|NCT00105989|21093377|P1|Maintenance - Double-Blind:Week 34-86|Death|0
6116636|NCT00105989|21093376|P2|Maintenance - Double-Blind:Week 34-86|Physician Decision|1
6116637|NCT00105989|21093377|P1|Maintenance - Double-Blind:Week 34-86|Physician Decision|4
6116638|NCT00105989|21093376|P2|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|0
6116639|NCT00105989|21093377|P1|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|4
6116640|NCT00105989|21093376|P2|Maintenance - Double-Blind:Week 34-86|Protocol Violation|4
6116641|NCT00105989|21093377|P1|Maintenance - Double-Blind:Week 34-86|Protocol Violation|5
6116642|NCT00105989|21093376|P2|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0
6116643|NCT00105989|21093377|P1|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0
6116644|NCT00105989|21093376|P2|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0
6116645|NCT00105989|21093377|P1|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0
6116646|NCT00105989|21093376|P2|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|18
6116647|NCT00105989|21093377|P1|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|17
6116648|NCT00105989|21093376|P2|Maintenance - Double-Blind:Week 34-86|Adverse Event|3
6116649|NCT00105989|21093377|P1|Maintenance - Double-Blind:Week 34-86|Adverse Event|6
6116650|NCT00105989|21093376|P2|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0
6116651|NCT00105989|21093377|P1|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0
6116652|NCT00105989|21093376|P2|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|0
6116653|NCT00105989|21093377|P1|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|2
6116654|NCT00105989|21093376|P2|Continuation - Open Label:Week 10-34|Death|0
6116655|NCT00105989|21093377|P1|Continuation - Open Label:Week 10-34|Death|0
6116656|NCT00105989|21093376|P2|Continuation - Open Label:Week 10-34|Physician Decision|0
6116657|NCT00105989|21093377|P1|Continuation - Open Label:Week 10-34|Physician Decision|3
6116658|NCT00105989|21093376|P2|Continuation - Open Label:Week 10-34|Lost to Follow-up|0
6116659|NCT00105989|21093377|P1|Continuation - Open Label:Week 10-34|Lost to Follow-up|9
6116660|NCT00105989|21093376|P2|Continuation - Open Label:Week 10-34|Protocol Violation|0
6116661|NCT00105989|21093377|P1|Continuation - Open Label:Week 10-34|Protocol Violation|5
6116662|NCT00105989|21093376|P2|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|0
6116663|NCT00105989|21093377|P1|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|16
6116664|NCT00105989|21093376|P2|Continuation - Open Label:Week 10-34|Lack of Efficacy|0
6116665|NCT00105989|21093377|P1|Continuation - Open Label:Week 10-34|Lack of Efficacy|15
6116666|NCT00105989|21093376|P2|Continuation - Open Label:Week 10-34|Withdrawal by Subject|0
6116667|NCT00105989|21093377|P1|Continuation - Open Label:Week 10-34|Withdrawal by Subject|50
6116668|NCT00105989|21093376|P2|Continuation - Open Label:Week 10-34|Adverse Event|0
6116669|NCT00105989|21093377|P1|Continuation - Open Label:Week 10-34|Adverse Event|25
6116670|NCT00105989|21093376|P2|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0
6116671|NCT00105989|21093377|P1|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0
6116672|NCT00105989|21093376|P2|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0
6116673|NCT00105989|21093377|P1|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0
6116674|NCT00105989|21093376|P2|Acute - Open Label: Week 0-10|Death|0
6116675|NCT00105989|21093377|P1|Acute - Open Label: Week 0-10|Death|1
6116676|NCT00105989|21093376|P2|Acute - Open Label: Week 0-10|Physician Decision|0
6116677|NCT00105989|21093377|P1|Acute - Open Label: Week 0-10|Physician Decision|0
6116678|NCT00105989|21093376|P2|Acute - Open Label: Week 0-10|Lost to Follow-up|0
6116679|NCT00105989|21093377|P1|Acute - Open Label: Week 0-10|Lost to Follow-up|4
6116680|NCT00105989|21093376|P2|Acute - Open Label: Week 0-10|Protocol Violation|0
6116681|NCT00105989|21093377|P1|Acute - Open Label: Week 0-10|Protocol Violation|8
6116682|NCT00105989|21093376|P2|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|0
6116683|NCT00105989|21093377|P1|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|14
6116684|NCT00105989|21093376|P2|Acute - Open Label: Week 0-10|Lack of Efficacy|0
6116685|NCT00105989|21093377|P1|Acute - Open Label: Week 0-10|Lack of Efficacy|17
6116686|NCT00105989|21093376|P2|Acute - Open Label: Week 0-10|Withdrawal by Subject|0
6116687|NCT00105989|21093377|P1|Acute - Open Label: Week 0-10|Withdrawal by Subject|24
6116688|NCT00105989|21093376|P2|Acute - Open Label: Week 0-10|Adverse Event|0
6116689|NCT00105989|21093377|P1|Acute - Open Label: Week 0-10|Adverse Event|33
6116690|NCT00105586|21093493|P2|Overall Study|Physician Decision|13
6116691|NCT00105586|21093494|P1|Overall Study|Physician Decision|13
6116692|NCT00105586|21093493|P2|Overall Study|Adverse Event|3
6116693|NCT00105586|21093494|P1|Overall Study|Adverse Event|4
6116694|NCT00105560|21093502|P1|Overall Study|Lost to Follow-up|1
6116695|NCT00105534|21093524|P2|Overall Study|Other Reason|2
6116696|NCT00105534|21093525|P1|Overall Study|Other Reason|0
6116697|NCT00105534|21093524|P2|Overall Study|Treatment unmasked|0
6116698|NCT00105534|21093525|P1|Overall Study|Treatment unmasked|1
6116699|NCT00105534|21093524|P2|Overall Study|Lack of Efficacy|15
6116700|NCT00105534|21093525|P1|Overall Study|Lack of Efficacy|7
6116701|NCT00105534|21093524|P2|Overall Study|Lost to Follow-up|1
6116702|NCT00105534|21093525|P1|Overall Study|Lost to Follow-up|5
6116703|NCT00105534|21093524|P2|Overall Study|Withdrawal by Subject|6
6116704|NCT00105534|21093525|P1|Overall Study|Withdrawal by Subject|6
6116705|NCT00105534|21093524|P2|Overall Study|Protocol Violation|4
6116706|NCT00105534|21093525|P1|Overall Study|Protocol Violation|1
6116707|NCT00105534|21093524|P2|Overall Study|Adverse Event|5
6116708|NCT00105534|21093525|P1|Overall Study|Adverse Event|2
6116709|NCT00105521|21093537|P4|Overall Study|Lost to Follow-up|0
6116710|NCT00105521|21093538|P3|Overall Study|Lost to Follow-up|0
6116711|NCT00105521|21093539|P2|Overall Study|Lost to Follow-up|1
6116712|NCT00105521|21093540|P1|Overall Study|Lost to Follow-up|0
6116713|NCT00105521|21093537|P4|Overall Study|Protocol Violation|4
6116714|NCT00105521|21093538|P3|Overall Study|Protocol Violation|4
6116715|NCT00105521|21093539|P2|Overall Study|Protocol Violation|5
6116716|NCT00105521|21093540|P1|Overall Study|Protocol Violation|3
6116717|NCT00105521|21093537|P4|Overall Study|Lack of Efficacy|1
6116718|NCT00105521|21093538|P3|Overall Study|Lack of Efficacy|0
6116719|NCT00105521|21093539|P2|Overall Study|Lack of Efficacy|0
6116720|NCT00105521|21093540|P1|Overall Study|Lack of Efficacy|0
6116721|NCT00105521|21093537|P4|Overall Study|Withdrawal by Subject|4
6116722|NCT00105521|21093538|P3|Overall Study|Withdrawal by Subject|1
6116723|NCT00105521|21093539|P2|Overall Study|Withdrawal by Subject|0
6116724|NCT00105521|21093540|P1|Overall Study|Withdrawal by Subject|1
6116725|NCT00105521|21093537|P4|Overall Study|Adverse Event|8
6116726|NCT00105521|21093538|P3|Overall Study|Adverse Event|10
6116727|NCT00105521|21093539|P2|Overall Study|Adverse Event|4
6116728|NCT00105521|21093540|P1|Overall Study|Adverse Event|10
6116729|NCT00105521|21093537|P4|Overall Study|Other|0
6116730|NCT00105521|21093538|P3|Overall Study|Other|2
6116731|NCT00105521|21093539|P2|Overall Study|Other|1
6116732|NCT00105521|21093540|P1|Overall Study|Other|1
6116733|NCT00105508|21093564|P2|Overall Study|Other|9
6116734|NCT00105508|21093565|P1|Overall Study|Other|8
6116735|NCT00105508|21093564|P2|Overall Study|Protocol Violation|2
6116736|NCT00105508|21093565|P1|Overall Study|Protocol Violation|1
6116737|NCT00105508|21093564|P2|Overall Study|Lost to Follow-up|0
6116738|NCT00105508|21093565|P1|Overall Study|Lost to Follow-up|3
6116739|NCT00105508|21093564|P2|Overall Study|Withdrawal by Subject|6
6116740|NCT00105508|21093565|P1|Overall Study|Withdrawal by Subject|10
6116741|NCT00105508|21093564|P2|Overall Study|Insufficient Efficacy|0
6116742|NCT00105508|21093565|P1|Overall Study|Insufficient Efficacy|1
6116743|NCT00105508|21093564|P2|Overall Study|Adverse Event|19
6116744|NCT00105508|21093565|P1|Overall Study|Adverse Event|16
6116745|NCT00105508|21093564|P2|Overall Study|Prephase Dropout|0
6116746|NCT00105508|21093565|P1|Overall Study|Prephase Dropout|1
6116747|NCT00105482|21093579|P2|Overall Study|Withdrawn by PI|1
6116748|NCT00105482|21093580|P1|Overall Study|Withdrawn by PI|1
6116749|NCT00105482|21093579|P2|Overall Study|Scheduling Conflict|3
6116750|NCT00105482|21093580|P1|Overall Study|Scheduling Conflict|2
6116751|NCT00105482|21093579|P2|Overall Study|Lost Interest|32
6116752|NCT00105482|21093580|P1|Overall Study|Lost Interest|29
6116753|NCT00105482|21093579|P2|Overall Study|Withdrawal by Subject|1
6116754|NCT00105482|21093580|P1|Overall Study|Withdrawal by Subject|0
6116755|NCT00105482|21093579|P2|Overall Study|Lost to Follow-up|17
6116756|NCT00105482|21093580|P1|Overall Study|Lost to Follow-up|26
6116757|NCT00105482|21093579|P2|Overall Study|Adverse Event|1
6116758|NCT00105482|21093580|P1|Overall Study|Adverse Event|1
6116759|NCT00105469|21093596|P2|Overall Study|Other Reason|0
6116760|NCT00105469|21093597|P1|Overall Study|Other Reason|4
6116761|NCT00105469|21093596|P2|Overall Study|Lack of Efficacy|0
6116762|NCT00105469|21093597|P1|Overall Study|Lack of Efficacy|2
6116763|NCT00105469|21093596|P2|Overall Study|Lost to Follow-up|0
6116764|NCT00105469|21093597|P1|Overall Study|Lost to Follow-up|1
6116765|NCT00105469|21093596|P2|Overall Study|Withdrawal by Subject|3
6116766|NCT00105469|21093597|P1|Overall Study|Withdrawal by Subject|2
6116767|NCT00105469|21093596|P2|Overall Study|Protocol Violation|0
6116768|NCT00105469|21093597|P1|Overall Study|Protocol Violation|4
6116769|NCT00105469|21093596|P2|Overall Study|Adverse Event|8
6116770|NCT00105469|21093597|P1|Overall Study|Adverse Event|9
6116771|NCT00105443|21093607|P4|Follow-up and/or Open Label Nexavar|Switch to commercial drug|11
6116772|NCT00105443|21093608|P3|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0
6116773|NCT00105443|21093609|P2|Follow-up and/or Open Label Nexavar|Switch to commercial drug|23
6116774|NCT00105443|21093610|P1|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0
6116775|NCT00105443|21093607|P4|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1
6116776|NCT00105443|21093608|P3|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0
6116777|NCT00105443|21093609|P2|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1
6116778|NCT00105443|21093610|P1|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0
6116779|NCT00105443|21093607|P4|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|1
6116780|NCT00105443|21093608|P3|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0
6116781|NCT00105443|21093609|P2|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0
6116782|NCT00105443|21093610|P1|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0
6116783|NCT00105443|21093607|P4|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0
6116784|NCT00105443|21093608|P3|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0
6116785|NCT00105443|21093609|P2|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0
6116786|NCT00105443|21093610|P1|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|1
6116787|NCT00105443|21093607|P4|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2
6116788|NCT00105443|21093608|P3|Follow-up and/or Open Label Nexavar|Endpoint record not completed|1
6116789|NCT00105443|21093609|P2|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2
6116790|NCT00105443|21093610|P1|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2
6116791|NCT00105443|21093607|P4|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0
6116792|NCT00105443|21093608|P3|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|1
6116793|NCT00105443|21093609|P2|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0
6116794|NCT00105443|21093610|P1|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|6
6116795|NCT00105443|21093607|P4|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3
6116796|NCT00105443|21093608|P3|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0
6116797|NCT00105443|21093609|P2|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3
6116798|NCT00105443|21093610|P1|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0
6116799|NCT00105443|21093607|P4|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|5
6116800|NCT00105443|21093608|P3|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0
6116801|NCT00105443|21093609|P2|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|2
6116802|NCT00105443|21093610|P1|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0
6116803|NCT00105443|21093607|P4|Follow-up and/or Open Label Nexavar|Protocol Violation|0
6116804|NCT00105443|21093608|P3|Follow-up and/or Open Label Nexavar|Protocol Violation|0
6116805|NCT00105443|21093609|P2|Follow-up and/or Open Label Nexavar|Protocol Violation|2
6116806|NCT00105443|21093610|P1|Follow-up and/or Open Label Nexavar|Protocol Violation|0
6116807|NCT00105443|21093607|P4|Follow-up and/or Open Label Nexavar|Physician Decision|0
6116808|NCT00105443|21093608|P3|Follow-up and/or Open Label Nexavar|Physician Decision|1
6116809|NCT00105443|21093609|P2|Follow-up and/or Open Label Nexavar|Physician Decision|0
6116810|NCT00105443|21093610|P1|Follow-up and/or Open Label Nexavar|Physician Decision|1
6116811|NCT00105443|21093607|P4|Follow-up and/or Open Label Nexavar|Adverse Event|16
6116812|NCT00105443|21093608|P3|Follow-up and/or Open Label Nexavar|Adverse Event|0
6116813|NCT00105443|21093609|P2|Follow-up and/or Open Label Nexavar|Adverse Event|14
6116814|NCT00105443|21093610|P1|Follow-up and/or Open Label Nexavar|Adverse Event|0
6116815|NCT00105443|21093607|P4|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|4
6116816|NCT00105443|21093608|P3|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|13
6116817|NCT00105443|21093609|P2|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|3
6116818|NCT00105443|21093610|P1|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|24
6116819|NCT00105443|21093607|P4|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0
6116820|NCT00105443|21093608|P3|Follow-up and/or Open Label Nexavar|Lost to Follow-up|10
6116821|NCT00105443|21093609|P2|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0
6116822|NCT00105443|21093610|P1|Follow-up and/or Open Label Nexavar|Lost to Follow-up|14
6116823|NCT00105443|21093607|P4|Follow-up and/or Open Label Nexavar|Death|4
6116824|NCT00105443|21093608|P3|Follow-up and/or Open Label Nexavar|Death|219
6116825|NCT00105443|21093609|P2|Follow-up and/or Open Label Nexavar|Death|7
6116826|NCT00105443|21093610|P1|Follow-up and/or Open Label Nexavar|Death|180
6116827|NCT00105443|21093607|P4|Double-Blind Treatment|Radiological and symptomatic progression|0
6116828|NCT00105443|21093608|P3|Double-Blind Treatment|Radiological and symptomatic progression|1
6116829|NCT00105443|21093609|P2|Double-Blind Treatment|Radiological and symptomatic progression|0
6116830|NCT00105443|21093610|P1|Double-Blind Treatment|Radiological and symptomatic progression|4
6116831|NCT00105443|21093607|P4|Double-Blind Treatment|Physician Decision|0
6116832|NCT00105443|21093608|P3|Double-Blind Treatment|Physician Decision|2
6116833|NCT00105443|21093609|P2|Double-Blind Treatment|Physician Decision|0
6116834|NCT00105443|21093610|P1|Double-Blind Treatment|Physician Decision|1
6116835|NCT00105443|21093607|P4|Double-Blind Treatment|Withdrawal by Subject|0
6116836|NCT00105443|21093608|P3|Double-Blind Treatment|Withdrawal by Subject|7
6116837|NCT00105443|21093609|P2|Double-Blind Treatment|Withdrawal by Subject|0
6116838|NCT00105443|21093610|P1|Double-Blind Treatment|Withdrawal by Subject|8
6116839|NCT00105443|21093607|P4|Double-Blind Treatment|Lost to Follow-up|0
6116840|NCT00105443|21093608|P3|Double-Blind Treatment|Lost to Follow-up|1
6116841|NCT00105443|21093609|P2|Double-Blind Treatment|Lost to Follow-up|0
6116842|NCT00105443|21093610|P1|Double-Blind Treatment|Lost to Follow-up|0
6116843|NCT00105443|21093607|P4|Double-Blind Treatment|Adverse Event|0
6116844|NCT00105443|21093608|P3|Double-Blind Treatment|Adverse Event|0
6116845|NCT00105443|21093609|P2|Double-Blind Treatment|Adverse Event|0
6116846|NCT00105443|21093610|P1|Double-Blind Treatment|Adverse Event|1
6116847|NCT00105235|21093637|P1|Overall Study|Withdrawal by Subject|2
6116848|NCT00105235|21093637|P1|Overall Study|Physician Decision|1
6116849|NCT00105235|21093637|P1|Overall Study|Death|4
6116850|NCT00105196|21093650|P2|Overall Study|Subject became unblinded|1
6116851|NCT00105196|21093651|P1|Overall Study|Subject became unblinded|0
6116852|NCT00105196|21093650|P2|Overall Study|marijuana use|1
6116853|NCT00105196|21093651|P1|Overall Study|marijuana use|0
6116854|NCT00105196|21093650|P2|Overall Study|pending surgery|1
6116855|NCT00105196|21093651|P1|Overall Study|pending surgery|0
6116856|NCT00105196|21093650|P2|Overall Study|Protocol Violation|2
6116857|NCT00105196|21093651|P1|Overall Study|Protocol Violation|5
6116858|NCT00105196|21093650|P2|Overall Study|Poor/noncompliance|4
6116859|NCT00105196|21093651|P1|Overall Study|Poor/noncompliance|3
6116860|NCT00105196|21093650|P2|Overall Study|Lost to Follow-up|2
6116861|NCT00105196|21093651|P1|Overall Study|Lost to Follow-up|3
6116862|NCT00105196|21093650|P2|Overall Study|Withdrawal by Subject|6
6116863|NCT00105196|21093651|P1|Overall Study|Withdrawal by Subject|6
6116864|NCT00105196|21093650|P2|Overall Study|Adverse Event|3
6116865|NCT00105196|21093651|P1|Overall Study|Adverse Event|11
6116866|NCT00105196|21093650|P2|Overall Study|Lack of Efficacy|3
6116867|NCT00105196|21093651|P1|Overall Study|Lack of Efficacy|2
6116868|NCT00105183|21093674|P3|Overall Study|Other reason|0
6116869|NCT00105183|21093675|P2|Overall Study|Other reason|2
6116870|NCT00105183|21093676|P1|Overall Study|Other reason|1
6116871|NCT00105183|21093674|P3|Overall Study|Lost to Follow-up|1
6116872|NCT00105183|21093675|P2|Overall Study|Lost to Follow-up|1
6116873|NCT00105183|21093676|P1|Overall Study|Lost to Follow-up|0
6116874|NCT00105183|21093674|P3|Overall Study|Physician Decision|3
6116875|NCT00105183|21093675|P2|Overall Study|Physician Decision|2
6116876|NCT00105183|21093676|P1|Overall Study|Physician Decision|1
6116877|NCT00105183|21093674|P3|Overall Study|Withdrawal by Subject|4
6116878|NCT00105183|21093675|P2|Overall Study|Withdrawal by Subject|1
6116879|NCT00105183|21093676|P1|Overall Study|Withdrawal by Subject|1
6116880|NCT00105183|21093674|P3|Overall Study|Death|15
6116881|NCT00105183|21093675|P2|Overall Study|Death|13
6116882|NCT00105183|21093676|P1|Overall Study|Death|19
6116883|NCT00105157|21093712|P4|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1
6116884|NCT00105157|21093713|P3|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1
6116885|NCT00105157|21093714|P2|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|0
6116886|NCT00105157|21093715|P1|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1
6116887|NCT00105157|21093712|P4|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|5
6116888|NCT00105157|21093713|P3|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0
6116889|NCT00105157|21093714|P2|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0
6116890|NCT00105157|21093715|P1|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0
6116891|NCT00105157|21093712|P4|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1
6116892|NCT00105157|21093713|P3|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0
6116893|NCT00105157|21093714|P2|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0
6116894|NCT00105157|21093715|P1|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1
6116895|NCT00105157|21093712|P4|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|10
6116896|NCT00105157|21093713|P3|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|5
6116897|NCT00105157|21093714|P2|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|6
6116898|NCT00105157|21093715|P1|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|7
6116899|NCT00105157|21093712|P4|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|1
6116900|NCT00105157|21093713|P3|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0
6116901|NCT00105157|21093714|P2|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0
6116902|NCT00105157|21093715|P1|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0
6116903|NCT00105157|21093712|P4|Open-Label Continuation of DB|Patient moved/site stopped trial|0
6116904|NCT00105157|21093713|P3|Open-Label Continuation of DB|Patient moved/site stopped trial|2
6116905|NCT00105157|21093714|P2|Open-Label Continuation of DB|Patient moved/site stopped trial|3
6116906|NCT00105157|21093715|P1|Open-Label Continuation of DB|Patient moved/site stopped trial|1
6116907|NCT00105157|21093712|P4|Open-Label Continuation of DB|Patient did not continue in extension|0
6116908|NCT00105157|21093713|P3|Open-Label Continuation of DB|Patient did not continue in extension|0
6116909|NCT00105157|21093714|P2|Open-Label Continuation of DB|Patient did not continue in extension|0
6116910|NCT00105157|21093715|P1|Open-Label Continuation of DB|Patient did not continue in extension|1
6116911|NCT00105157|21093712|P4|Open-Label Continuation of DB|Withdrawal by Subject|0
6116912|NCT00105157|21093713|P3|Open-Label Continuation of DB|Withdrawal by Subject|3
6116913|NCT00105157|21093714|P2|Open-Label Continuation of DB|Withdrawal by Subject|1
6116914|NCT00105157|21093715|P1|Open-Label Continuation of DB|Withdrawal by Subject|0
6116915|NCT00105157|21093712|P4|Open-Label Continuation of DB|Lost to Follow-up|0
6116916|NCT00105157|21093713|P3|Open-Label Continuation of DB|Lost to Follow-up|1
6116917|NCT00105157|21093714|P2|Open-Label Continuation of DB|Lost to Follow-up|1
6116918|NCT00105157|21093715|P1|Open-Label Continuation of DB|Lost to Follow-up|1
6116919|NCT00105157|21093712|P4|Open-Label Continuation of DB|Lack of Efficacy|1
6116920|NCT00105157|21093713|P3|Open-Label Continuation of DB|Lack of Efficacy|3
6116921|NCT00105157|21093714|P2|Open-Label Continuation of DB|Lack of Efficacy|4
6116922|NCT00105157|21093715|P1|Open-Label Continuation of DB|Lack of Efficacy|1
6116923|NCT00105157|21093712|P4|Open-Label Continuation of DB|Adverse Event|0
6116924|NCT00105157|21093713|P3|Open-Label Continuation of DB|Adverse Event|0
6116925|NCT00105157|21093714|P2|Open-Label Continuation of DB|Adverse Event|1
6116926|NCT00105157|21093715|P1|Open-Label Continuation of DB|Adverse Event|3
6116927|NCT00105157|21093712|P4|Double-Blind (DB)|Lack of Efficacy|38
6116928|NCT00105157|21093713|P3|Double-Blind (DB)|Lack of Efficacy|11
6116929|NCT00105157|21093714|P2|Double-Blind (DB)|Lack of Efficacy|14
6116930|NCT00105157|21093715|P1|Double-Blind (DB)|Lack of Efficacy|11
6116931|NCT00105157|21093712|P4|Double-Blind (DB)|Adverse Event|1
6116932|NCT00105157|21093713|P3|Double-Blind (DB)|Adverse Event|1
6116933|NCT00105157|21093714|P2|Double-Blind (DB)|Adverse Event|0
6116934|NCT00105157|21093715|P1|Double-Blind (DB)|Adverse Event|2
6116935|NCT00105157|21093712|P4|Double-Blind (DB)|Never Treated|0
6116936|NCT00105157|21093713|P3|Double-Blind (DB)|Never Treated|0
6116937|NCT00105157|21093714|P2|Double-Blind (DB)|Never Treated|0
6116938|NCT00105157|21093715|P1|Double-Blind (DB)|Never Treated|1
6116939|NCT00105079|21093909|P2|Overall Study|Other|1
6116940|NCT00105079|21093910|P1|Overall Study|Other|3
6116941|NCT00105079|21093909|P2|Overall Study|Protocol Violation|0
6116942|NCT00105079|21093910|P1|Overall Study|Protocol Violation|1
6116943|NCT00105079|21093909|P2|Overall Study|Violation of selection criteria at entry|2
6116944|NCT00105079|21093910|P1|Overall Study|Violation of selection criteria at entry|0
6116945|NCT00105079|21093909|P2|Overall Study|Refused treatment|4
6116946|NCT00105079|21093910|P1|Overall Study|Refused treatment|6
6116947|NCT00105079|21093909|P2|Overall Study|Lack of Efficacy|3
6116948|NCT00105079|21093910|P1|Overall Study|Lack of Efficacy|9
6116949|NCT00105079|21093909|P2|Overall Study|Lost to Follow-up|12
6116950|NCT00105079|21093910|P1|Overall Study|Lost to Follow-up|12
6116951|NCT00105079|21093909|P2|Overall Study|Death|1
6116952|NCT00105079|21093910|P1|Overall Study|Death|3
6116953|NCT00105079|21093909|P2|Overall Study|Adverse Event|12
6116954|NCT00105079|21093910|P1|Overall Study|Adverse Event|5
6116955|NCT00105066|21093928|P2|Overall Study|Adverse Event|5
6116956|NCT00105066|21093929|P1|Overall Study|Adverse Event|2
6116957|NCT00104884|21094007|P1|Overall Study|Disease progression|4
6116958|NCT00104871|21094011|P1|Overall Study|Not evaluable|1
6116959|NCT00104728|21094032|P1|Overall Study|screen failures|19
6116960|NCT00104650|21094040|P3|Follow-up Period|Other|0
6116961|NCT00104650|21094041|P2|Follow-up Period|Other|1
6116962|NCT00104650|21094042|P1|Follow-up Period|Other|0
6116963|NCT00104650|21094040|P3|Follow-up Period|Lost to Follow-up|2
6116964|NCT00104650|21094041|P2|Follow-up Period|Lost to Follow-up|1
6116965|NCT00104650|21094042|P1|Follow-up Period|Lost to Follow-up|0
6116966|NCT00104650|21094040|P3|Follow-up Period|Disease progression|0
6116967|NCT00104650|21094041|P2|Follow-up Period|Disease progression|1
6116968|NCT00104650|21094042|P1|Follow-up Period|Disease progression|3
6116969|NCT00104650|21094040|P3|Follow-up Period|Death|4
6116970|NCT00104650|21094041|P2|Follow-up Period|Death|6
6116971|NCT00104650|21094042|P1|Follow-up Period|Death|6
6116972|NCT00104650|21094040|P3|Follow-up Period|Withdrawal by Subject|3
6116973|NCT00104650|21094041|P2|Follow-up Period|Withdrawal by Subject|3
6116974|NCT00104650|21094042|P1|Follow-up Period|Withdrawal by Subject|0
6116975|NCT00104650|21094040|P3|Follow-up Period|Adverse Event|1
6116976|NCT00104650|21094041|P2|Follow-up Period|Adverse Event|0
6116977|NCT00104650|21094042|P1|Follow-up Period|Adverse Event|1
6116978|NCT00104650|21094040|P3|Follow-up Period|Physician Decision|0
6116979|NCT00104650|21094041|P2|Follow-up Period|Physician Decision|1
6116980|NCT00104650|21094042|P1|Follow-up Period|Physician Decision|1
6116981|NCT00104650|21094040|P3|Treatment Period (25 Weeks)|Protocol deviation|0
6116982|NCT00104650|21094041|P2|Treatment Period (25 Weeks)|Protocol deviation|1
6116983|NCT00104650|21094042|P1|Treatment Period (25 Weeks)|Protocol deviation|0
6116984|NCT00104650|21094040|P3|Treatment Period (25 Weeks)|Other|0
6116985|NCT00104650|21094041|P2|Treatment Period (25 Weeks)|Other|0
6116986|NCT00104650|21094042|P1|Treatment Period (25 Weeks)|Other|1
6116987|NCT00104650|21094040|P3|Treatment Period (25 Weeks)|Ineligibility determined|0
6116988|NCT00104650|21094041|P2|Treatment Period (25 Weeks)|Ineligibility determined|1
6116989|NCT00104650|21094042|P1|Treatment Period (25 Weeks)|Ineligibility determined|0
6116990|NCT00104650|21094040|P3|Treatment Period (25 Weeks)|Disease progression|2
6116991|NCT00104650|21094041|P2|Treatment Period (25 Weeks)|Disease progression|3
6116992|NCT00104650|21094042|P1|Treatment Period (25 Weeks)|Disease progression|2
6116993|NCT00104650|21094040|P3|Treatment Period (25 Weeks)|Death|6
6116994|NCT00104650|21094041|P2|Treatment Period (25 Weeks)|Death|5
6116995|NCT00104650|21094042|P1|Treatment Period (25 Weeks)|Death|7
6116996|NCT00104650|21094040|P3|Treatment Period (25 Weeks)|Withdrawal by Subject|1
6116997|NCT00104650|21094041|P2|Treatment Period (25 Weeks)|Withdrawal by Subject|1
6116998|NCT00104650|21094042|P1|Treatment Period (25 Weeks)|Withdrawal by Subject|2
6116999|NCT00104650|21094040|P3|Treatment Period (25 Weeks)|Physician Decision|1
6117000|NCT00104650|21094041|P2|Treatment Period (25 Weeks)|Physician Decision|0
6117001|NCT00104650|21094042|P1|Treatment Period (25 Weeks)|Physician Decision|0
6117002|NCT00104637|21094074|P2|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|0
6117003|NCT00104637|21094075|P1|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|1
6117004|NCT00104572|21094104|P3|Overall Study|Withdrawal by Subject|0
6117005|NCT00104572|21094105|P2|Overall Study|Withdrawal by Subject|3
6117006|NCT00104572|21094106|P1|Overall Study|Withdrawal by Subject|3
6117007|NCT00104520|21094125|P2|Overall Study|Other|5
6117008|NCT00104520|21094126|P1|Overall Study|Other|1
6117009|NCT00104520|21094125|P2|Overall Study|Personal/administrative|1
6117010|NCT00104520|21094126|P1|Overall Study|Personal/administrative|1
6117011|NCT00104520|21094125|P2|Overall Study|Noncompliance|2
6117012|NCT00104520|21094126|P1|Overall Study|Noncompliance|0
6117013|NCT00104520|21094125|P2|Overall Study|Lost to Follow-up|0
6117014|NCT00104520|21094126|P1|Overall Study|Lost to Follow-up|1
6117015|NCT00104520|21094125|P2|Overall Study|Related adverse event|15
6117016|NCT00104520|21094126|P1|Overall Study|Related adverse event|13
6117017|NCT00104520|21094125|P2|Overall Study|Study drug intolerance|1
6117018|NCT00104520|21094126|P1|Overall Study|Study drug intolerance|0
6117019|NCT00104520|21094125|P2|Overall Study|Unrelated adverse event|47
6117020|NCT00104520|21094126|P1|Overall Study|Unrelated adverse event|34
6117021|NCT00104416|21094146|P5|Continuation Phase|Non-compliance|1
6117022|NCT00104416|21094147|P4|Continuation Phase|Non-compliance|0
6117023|NCT00104416|21094148|P3|Continuation Phase|Non-compliance|0
6117024|NCT00104416|21094149|P2|Continuation Phase|Non-compliance|0
6117025|NCT00104416|21094150|P1|Continuation Phase|Non-compliance|0
6117026|NCT00104416|21094146|P5|Continuation Phase|Pregnancy|0
6117027|NCT00104416|21094147|P4|Continuation Phase|Pregnancy|1
6117028|NCT00104416|21094148|P3|Continuation Phase|Pregnancy|1
6117029|NCT00104416|21094149|P2|Continuation Phase|Pregnancy|0
6117030|NCT00104416|21094150|P1|Continuation Phase|Pregnancy|0
6117031|NCT00104416|21094146|P5|Continuation Phase|Withdrawal by Subject|1
6117032|NCT00104416|21094147|P4|Continuation Phase|Withdrawal by Subject|1
6117033|NCT00104416|21094148|P3|Continuation Phase|Withdrawal by Subject|2
6117034|NCT00104416|21094149|P2|Continuation Phase|Withdrawal by Subject|0
6117035|NCT00104416|21094150|P1|Continuation Phase|Withdrawal by Subject|0
6117036|NCT00104416|21094146|P5|Continuation Phase|Lost to Follow-up|1
6117037|NCT00104416|21094147|P4|Continuation Phase|Lost to Follow-up|0
6117038|NCT00104416|21094148|P3|Continuation Phase|Lost to Follow-up|1
6117039|NCT00104416|21094149|P2|Continuation Phase|Lost to Follow-up|0
6117040|NCT00104416|21094150|P1|Continuation Phase|Lost to Follow-up|0
6117041|NCT00104416|21094146|P5|Continuation Phase|Adverse Event|2
6117042|NCT00104416|21094147|P4|Continuation Phase|Adverse Event|0
6117043|NCT00104416|21094148|P3|Continuation Phase|Adverse Event|2
6117044|NCT00104416|21094149|P2|Continuation Phase|Adverse Event|0
6117045|NCT00104416|21094150|P1|Continuation Phase|Adverse Event|0
6117046|NCT00104416|21094146|P5|Double-Blind Phase|Participant Did Not Take Drug|0
6117047|NCT00104416|21094147|P4|Double-Blind Phase|Participant Did Not Take Drug|0
6117048|NCT00104416|21094148|P3|Double-Blind Phase|Participant Did Not Take Drug|0
6117049|NCT00104416|21094149|P2|Double-Blind Phase|Participant Did Not Take Drug|4
6117050|NCT00104416|21094150|P1|Double-Blind Phase|Participant Did Not Take Drug|3
6117051|NCT00104416|21094146|P5|Double-Blind Phase|Pregnancy|0
6117052|NCT00104416|21094147|P4|Double-Blind Phase|Pregnancy|0
6117053|NCT00104416|21094148|P3|Double-Blind Phase|Pregnancy|0
6117054|NCT00104416|21094149|P2|Double-Blind Phase|Pregnancy|0
6117055|NCT00104416|21094150|P1|Double-Blind Phase|Pregnancy|1
6117056|NCT00104416|21094146|P5|Double-Blind Phase|Withdrawal by Subject|0
6117057|NCT00104416|21094147|P4|Double-Blind Phase|Withdrawal by Subject|0
6117058|NCT00104416|21094148|P3|Double-Blind Phase|Withdrawal by Subject|0
6117059|NCT00104416|21094149|P2|Double-Blind Phase|Withdrawal by Subject|3
6117060|NCT00104416|21094150|P1|Double-Blind Phase|Withdrawal by Subject|2
6117061|NCT00104416|21094146|P5|Double-Blind Phase|Protocol Violation|0
6117062|NCT00104416|21094147|P4|Double-Blind Phase|Protocol Violation|0
6117063|NCT00104416|21094148|P3|Double-Blind Phase|Protocol Violation|0
6117064|NCT00104416|21094149|P2|Double-Blind Phase|Protocol Violation|1
6117065|NCT00104416|21094150|P1|Double-Blind Phase|Protocol Violation|0
6117066|NCT00104416|21094146|P5|Double-Blind Phase|Lost to Follow-up|0
6117067|NCT00104416|21094147|P4|Double-Blind Phase|Lost to Follow-up|0
6117068|NCT00104416|21094148|P3|Double-Blind Phase|Lost to Follow-up|0
6117069|NCT00104416|21094149|P2|Double-Blind Phase|Lost to Follow-up|1
6117070|NCT00104416|21094150|P1|Double-Blind Phase|Lost to Follow-up|0
6117071|NCT00104416|21094146|P5|Double-Blind Phase|Adverse Event|0
6117072|NCT00104416|21094147|P4|Double-Blind Phase|Adverse Event|0
6117073|NCT00104416|21094148|P3|Double-Blind Phase|Adverse Event|0
6117074|NCT00104416|21094149|P2|Double-Blind Phase|Adverse Event|1
6117075|NCT00104416|21094150|P1|Double-Blind Phase|Adverse Event|2
6117076|NCT00104299|21094195|P2|Overall Study|To have renal transplant|0
6117077|NCT00104299|21094196|P1|Overall Study|To have renal transplant|1
6117078|NCT00104299|21094195|P2|Overall Study|Physician Decision|1
6117079|NCT00104299|21094196|P1|Overall Study|Physician Decision|1
6117080|NCT00104299|21094195|P2|Overall Study|Withdrawal by Subject|6
6117081|NCT00104299|21094196|P1|Overall Study|Withdrawal by Subject|2
6117082|NCT00104299|21094195|P2|Overall Study|Death|2
6117083|NCT00104299|21094196|P1|Overall Study|Death|2
6117084|NCT00104299|21094195|P2|Overall Study|Adverse Event|1
6117085|NCT00104299|21094196|P1|Overall Study|Adverse Event|3
6117086|NCT00104247|21094218|P2|Overall Study|Noncompliant with dosing|1
6117087|NCT00104247|21094219|P1|Overall Study|Noncompliant with dosing|0
6117088|NCT00104247|21094218|P2|Overall Study|Withdrawal by Subject|0
6117089|NCT00104247|21094219|P1|Overall Study|Withdrawal by Subject|1
6117090|NCT00104104|21094238|P2|Overall Study|Death|6
6117091|NCT00104104|21094239|P1|Overall Study|Death|9
6117092|NCT00104104|21094238|P2|Overall Study|Administrative problems|13
6117093|NCT00104104|21094239|P1|Overall Study|Administrative problems|12
6117094|NCT00104104|21094238|P2|Overall Study|Lost to Follow-up|7
6117095|NCT00104104|21094239|P1|Overall Study|Lost to Follow-up|3
6117096|NCT00104104|21094238|P2|Overall Study|Withdrawal by Subject|15
6117097|NCT00104104|21094239|P1|Overall Study|Withdrawal by Subject|11
6117098|NCT00104104|21094238|P2|Overall Study|Protocol Violation|2
6117099|NCT00104104|21094239|P1|Overall Study|Protocol Violation|5
6117100|NCT00104104|21094238|P2|Overall Study|Condition no longer requires study drug|4
6117101|NCT00104104|21094239|P1|Overall Study|Condition no longer requires study drug|7
6117102|NCT00104104|21094238|P2|Overall Study|Lack of Efficacy|3
6117103|NCT00104104|21094239|P1|Overall Study|Lack of Efficacy|0
6117104|NCT00104104|21094238|P2|Overall Study|Abnormal laboratory value(s)|14
6117105|NCT00104104|21094239|P1|Overall Study|Abnormal laboratory value(s)|20
6117106|NCT00104104|21094238|P2|Overall Study|Adverse Event|8
6117107|NCT00104104|21094239|P1|Overall Study|Adverse Event|8
6117108|NCT00104052|21094253|P1|Overall Study|Discontinuation unrelated to treatment|2
6117109|NCT00104052|21094253|P1|Overall Study|Lack of Efficacy|26
6117110|NCT00104052|21094253|P1|Overall Study|Adverse Event|1
6117111|NCT00103857|21094264|P7|50-Week Extension Study|reason unspecified|0
6117112|NCT00103857|21094265|P6|50-Week Extension Study|reason unspecified|0
6117113|NCT00103857|21094266|P5|50-Week Extension Study|reason unspecified|1
6117114|NCT00103857|21094267|P4|50-Week Extension Study|reason unspecified|0
6117115|NCT00103857|21094268|P3|50-Week Extension Study|reason unspecified|0
6117116|NCT00103857|21094269|P2|50-Week Extension Study|reason unspecified|0
6117117|NCT00103857|21094270|P1|50-Week Extension Study|reason unspecified|0
6117118|NCT00103857|21094264|P7|50-Week Extension Study|patient scheduled for elective surgery|0
6117119|NCT00103857|21094265|P6|50-Week Extension Study|patient scheduled for elective surgery|0
6117120|NCT00103857|21094266|P5|50-Week Extension Study|patient scheduled for elective surgery|0
6117121|NCT00103857|21094267|P4|50-Week Extension Study|patient scheduled for elective surgery|0
6117122|NCT00103857|21094268|P3|50-Week Extension Study|patient scheduled for elective surgery|1
6117123|NCT00103857|21094269|P2|50-Week Extension Study|patient scheduled for elective surgery|0
6117124|NCT00103857|21094270|P1|50-Week Extension Study|patient scheduled for elective surgery|0
6117125|NCT00103857|21094264|P7|50-Week Extension Study|patient moved|0
6117126|NCT00103857|21094265|P6|50-Week Extension Study|patient moved|0
6117127|NCT00103857|21094266|P5|50-Week Extension Study|patient moved|0
6117128|NCT00103857|21094267|P4|50-Week Extension Study|patient moved|2
6117129|NCT00103857|21094268|P3|50-Week Extension Study|patient moved|1
6117130|NCT00103857|21094269|P2|50-Week Extension Study|patient moved|0
6117131|NCT00103857|21094270|P1|50-Week Extension Study|patient moved|0
6117132|NCT00103857|21094264|P7|50-Week Extension Study|non-compliance with study procedures|0
6117133|NCT00103857|21094265|P6|50-Week Extension Study|non-compliance with study procedures|0
6117134|NCT00103857|21094266|P5|50-Week Extension Study|non-compliance with study procedures|1
6117135|NCT00103857|21094267|P4|50-Week Extension Study|non-compliance with study procedures|1
6117136|NCT00103857|21094268|P3|50-Week Extension Study|non-compliance with study procedures|0
6117137|NCT00103857|21094269|P2|50-Week Extension Study|non-compliance with study procedures|0
6117138|NCT00103857|21094270|P1|50-Week Extension Study|non-compliance with study procedures|1
6117139|NCT00103857|21094264|P7|50-Week Extension Study|protocol discontinuation criteria|0
6117140|NCT00103857|21094265|P6|50-Week Extension Study|protocol discontinuation criteria|3
6117141|NCT00103857|21094266|P5|50-Week Extension Study|protocol discontinuation criteria|3
6117142|NCT00103857|21094267|P4|50-Week Extension Study|protocol discontinuation criteria|2
6117143|NCT00103857|21094268|P3|50-Week Extension Study|protocol discontinuation criteria|3
6117144|NCT00103857|21094269|P2|50-Week Extension Study|protocol discontinuation criteria|2
6117145|NCT00103857|21094270|P1|50-Week Extension Study|protocol discontinuation criteria|2
6117146|NCT00103857|21094264|P7|50-Week Extension Study|Withdrawal by Subject|0
6117147|NCT00103857|21094265|P6|50-Week Extension Study|Withdrawal by Subject|3
6117148|NCT00103857|21094266|P5|50-Week Extension Study|Withdrawal by Subject|3
6117149|NCT00103857|21094267|P4|50-Week Extension Study|Withdrawal by Subject|8
6117150|NCT00103857|21094268|P3|50-Week Extension Study|Withdrawal by Subject|2
6117151|NCT00103857|21094269|P2|50-Week Extension Study|Withdrawal by Subject|5
6117152|NCT00103857|21094270|P1|50-Week Extension Study|Withdrawal by Subject|2
6117153|NCT00103857|21094264|P7|50-Week Extension Study|Protocol Violation|0
6117154|NCT00103857|21094265|P6|50-Week Extension Study|Protocol Violation|1
6117155|NCT00103857|21094266|P5|50-Week Extension Study|Protocol Violation|0
6117156|NCT00103857|21094267|P4|50-Week Extension Study|Protocol Violation|2
6117157|NCT00103857|21094268|P3|50-Week Extension Study|Protocol Violation|1
6117158|NCT00103857|21094269|P2|50-Week Extension Study|Protocol Violation|1
6117159|NCT00103857|21094270|P1|50-Week Extension Study|Protocol Violation|1
6117160|NCT00103857|21094264|P7|50-Week Extension Study|Pregnancy|0
6117161|NCT00103857|21094265|P6|50-Week Extension Study|Pregnancy|0
6117162|NCT00103857|21094266|P5|50-Week Extension Study|Pregnancy|1
6117163|NCT00103857|21094267|P4|50-Week Extension Study|Pregnancy|0
6117164|NCT00103857|21094268|P3|50-Week Extension Study|Pregnancy|1
6117165|NCT00103857|21094269|P2|50-Week Extension Study|Pregnancy|0
6117166|NCT00103857|21094270|P1|50-Week Extension Study|Pregnancy|0
6117167|NCT00103857|21094264|P7|50-Week Extension Study|Physician Decision|0
6117168|NCT00103857|21094265|P6|50-Week Extension Study|Physician Decision|0
6117169|NCT00103857|21094266|P5|50-Week Extension Study|Physician Decision|0
6117170|NCT00103857|21094267|P4|50-Week Extension Study|Physician Decision|0
6117171|NCT00103857|21094268|P3|50-Week Extension Study|Physician Decision|1
6117172|NCT00103857|21094269|P2|50-Week Extension Study|Physician Decision|1
6117173|NCT00103857|21094270|P1|50-Week Extension Study|Physician Decision|0
6117174|NCT00103857|21094264|P7|50-Week Extension Study|Lost to Follow-up|0
6117175|NCT00103857|21094265|P6|50-Week Extension Study|Lost to Follow-up|3
6117176|NCT00103857|21094266|P5|50-Week Extension Study|Lost to Follow-up|3
6117177|NCT00103857|21094267|P4|50-Week Extension Study|Lost to Follow-up|4
6117178|NCT00103857|21094268|P3|50-Week Extension Study|Lost to Follow-up|1
6117179|NCT00103857|21094269|P2|50-Week Extension Study|Lost to Follow-up|0
6117180|NCT00103857|21094270|P1|50-Week Extension Study|Lost to Follow-up|4
6117181|NCT00103857|21094264|P7|50-Week Extension Study|Lack of Efficacy|0
6117182|NCT00103857|21094265|P6|50-Week Extension Study|Lack of Efficacy|8
6117183|NCT00103857|21094266|P5|50-Week Extension Study|Lack of Efficacy|8
6117184|NCT00103857|21094267|P4|50-Week Extension Study|Lack of Efficacy|16
6117185|NCT00103857|21094268|P3|50-Week Extension Study|Lack of Efficacy|13
6117186|NCT00103857|21094269|P2|50-Week Extension Study|Lack of Efficacy|15
6117187|NCT00103857|21094270|P1|50-Week Extension Study|Lack of Efficacy|26
6117188|NCT00103857|21094264|P7|50-Week Extension Study|Death|0
6117189|NCT00103857|21094265|P6|50-Week Extension Study|Death|1
6117190|NCT00103857|21094266|P5|50-Week Extension Study|Death|0
6117191|NCT00103857|21094267|P4|50-Week Extension Study|Death|1
6117192|NCT00103857|21094268|P3|50-Week Extension Study|Death|0
6117193|NCT00103857|21094269|P2|50-Week Extension Study|Death|0
6117194|NCT00103857|21094270|P1|50-Week Extension Study|Death|0
6117195|NCT00103857|21094264|P7|50-Week Extension Study|Adverse Event|0
6117196|NCT00103857|21094265|P6|50-Week Extension Study|Adverse Event|1
6117197|NCT00103857|21094266|P5|50-Week Extension Study|Adverse Event|1
6117198|NCT00103857|21094267|P4|50-Week Extension Study|Adverse Event|0
6117199|NCT00103857|21094268|P3|50-Week Extension Study|Adverse Event|2
6117200|NCT00103857|21094269|P2|50-Week Extension Study|Adverse Event|3
6117201|NCT00103857|21094270|P1|50-Week Extension Study|Adverse Event|2
6117202|NCT00103857|21094264|P7|54-Week Base Study|patient intolerance to rescue therapy|0
6117203|NCT00103857|21094265|P6|54-Week Base Study|patient intolerance to rescue therapy|0
6117204|NCT00103857|21094266|P5|54-Week Base Study|patient intolerance to rescue therapy|0
6117205|NCT00103857|21094267|P4|54-Week Base Study|patient intolerance to rescue therapy|0
6117206|NCT00103857|21094268|P3|54-Week Base Study|patient intolerance to rescue therapy|0
6117207|NCT00103857|21094269|P2|54-Week Base Study|patient intolerance to rescue therapy|0
6117208|NCT00103857|21094270|P1|54-Week Base Study|patient intolerance to rescue therapy|1
6117209|NCT00103857|21094264|P7|54-Week Base Study|site error|0
6117210|NCT00103857|21094265|P6|54-Week Base Study|site error|1
6117211|NCT00103857|21094266|P5|54-Week Base Study|site error|0
6117212|NCT00103857|21094267|P4|54-Week Base Study|site error|0
6117213|NCT00103857|21094268|P3|54-Week Base Study|site error|0
6117214|NCT00103857|21094269|P2|54-Week Base Study|site error|0
6117215|NCT00103857|21094270|P1|54-Week Base Study|site error|0
6117216|NCT00103857|21094264|P7|54-Week Base Study|laboratory reporting error|0
6117217|NCT00103857|21094265|P6|54-Week Base Study|laboratory reporting error|0
6117218|NCT00103857|21094266|P5|54-Week Base Study|laboratory reporting error|1
6117219|NCT00103857|21094267|P4|54-Week Base Study|laboratory reporting error|0
6117220|NCT00103857|21094268|P3|54-Week Base Study|laboratory reporting error|0
6117221|NCT00103857|21094269|P2|54-Week Base Study|laboratory reporting error|0
6117222|NCT00103857|21094270|P1|54-Week Base Study|laboratory reporting error|0
6117223|NCT00103857|21094264|P7|54-Week Base Study|patient incarcerated|0
6117224|NCT00103857|21094265|P6|54-Week Base Study|patient incarcerated|1
6117225|NCT00103857|21094266|P5|54-Week Base Study|patient incarcerated|1
6117226|NCT00103857|21094267|P4|54-Week Base Study|patient incarcerated|0
6117227|NCT00103857|21094268|P3|54-Week Base Study|patient incarcerated|0
6117228|NCT00103857|21094269|P2|54-Week Base Study|patient incarcerated|0
6117229|NCT00103857|21094270|P1|54-Week Base Study|patient incarcerated|0
6117230|NCT00103857|21094264|P7|54-Week Base Study|non-compliance with study procedures|0
6117231|NCT00103857|21094265|P6|54-Week Base Study|non-compliance with study procedures|2
6117232|NCT00103857|21094266|P5|54-Week Base Study|non-compliance with study procedures|0
6117233|NCT00103857|21094267|P4|54-Week Base Study|non-compliance with study procedures|0
6117234|NCT00103857|21094268|P3|54-Week Base Study|non-compliance with study procedures|0
6117235|NCT00103857|21094269|P2|54-Week Base Study|non-compliance with study procedures|2
6117236|NCT00103857|21094270|P1|54-Week Base Study|non-compliance with study procedures|1
6117237|NCT00103857|21094264|P7|54-Week Base Study|patient moved|0
6117238|NCT00103857|21094265|P6|54-Week Base Study|patient moved|1
6117239|NCT00103857|21094266|P5|54-Week Base Study|patient moved|3
6117240|NCT00103857|21094267|P4|54-Week Base Study|patient moved|2
6117241|NCT00103857|21094268|P3|54-Week Base Study|patient moved|1
6117242|NCT00103857|21094269|P2|54-Week Base Study|patient moved|1
6117243|NCT00103857|21094270|P1|54-Week Base Study|patient moved|0
6117244|NCT00103857|21094264|P7|54-Week Base Study|protocol discontinuation criteria|5
6117245|NCT00103857|21094265|P6|54-Week Base Study|protocol discontinuation criteria|3
6117246|NCT00103857|21094266|P5|54-Week Base Study|protocol discontinuation criteria|5
6117247|NCT00103857|21094267|P4|54-Week Base Study|protocol discontinuation criteria|6
6117248|NCT00103857|21094268|P3|54-Week Base Study|protocol discontinuation criteria|2
6117249|NCT00103857|21094269|P2|54-Week Base Study|protocol discontinuation criteria|5
6117250|NCT00103857|21094270|P1|54-Week Base Study|protocol discontinuation criteria|2
6117251|NCT00103857|21094264|P7|54-Week Base Study|Withdrawal by Subject|4
6117252|NCT00103857|21094265|P6|54-Week Base Study|Withdrawal by Subject|15
6117253|NCT00103857|21094266|P5|54-Week Base Study|Withdrawal by Subject|10
6117254|NCT00103857|21094267|P4|54-Week Base Study|Withdrawal by Subject|15
6117255|NCT00103857|21094268|P3|54-Week Base Study|Withdrawal by Subject|16
6117256|NCT00103857|21094269|P2|54-Week Base Study|Withdrawal by Subject|16
6117257|NCT00103857|21094270|P1|54-Week Base Study|Withdrawal by Subject|17
6117258|NCT00103857|21094264|P7|54-Week Base Study|Protocol Violation|3
6117259|NCT00103857|21094265|P6|54-Week Base Study|Protocol Violation|3
6117260|NCT00103857|21094266|P5|54-Week Base Study|Protocol Violation|0
6117261|NCT00103857|21094267|P4|54-Week Base Study|Protocol Violation|4
6117262|NCT00103857|21094268|P3|54-Week Base Study|Protocol Violation|2
6117263|NCT00103857|21094269|P2|54-Week Base Study|Protocol Violation|4
6117264|NCT00103857|21094270|P1|54-Week Base Study|Protocol Violation|6
6117265|NCT00103857|21094264|P7|54-Week Base Study|Pregnancy|1
6117266|NCT00103857|21094265|P6|54-Week Base Study|Pregnancy|0
6117267|NCT00103857|21094266|P5|54-Week Base Study|Pregnancy|1
6117268|NCT00103857|21094267|P4|54-Week Base Study|Pregnancy|0
6117269|NCT00103857|21094268|P3|54-Week Base Study|Pregnancy|0
6117270|NCT00103857|21094269|P2|54-Week Base Study|Pregnancy|0
6117271|NCT00103857|21094270|P1|54-Week Base Study|Pregnancy|1
6117272|NCT00103857|21094264|P7|54-Week Base Study|Physician Decision|0
6117273|NCT00103857|21094265|P6|54-Week Base Study|Physician Decision|0
6117274|NCT00103857|21094266|P5|54-Week Base Study|Physician Decision|1
6117275|NCT00103857|21094267|P4|54-Week Base Study|Physician Decision|0
6117276|NCT00103857|21094268|P3|54-Week Base Study|Physician Decision|0
6117277|NCT00103857|21094269|P2|54-Week Base Study|Physician Decision|1
6117278|NCT00103857|21094270|P1|54-Week Base Study|Physician Decision|1
6117279|NCT00103857|21094264|P7|54-Week Base Study|Lost to Follow-up|3
6117280|NCT00103857|21094265|P6|54-Week Base Study|Lost to Follow-up|9
6117281|NCT00103857|21094266|P5|54-Week Base Study|Lost to Follow-up|10
6117282|NCT00103857|21094267|P4|54-Week Base Study|Lost to Follow-up|5
6117283|NCT00103857|21094268|P3|54-Week Base Study|Lost to Follow-up|7
6117284|NCT00103857|21094269|P2|54-Week Base Study|Lost to Follow-up|4
6117285|NCT00103857|21094270|P1|54-Week Base Study|Lost to Follow-up|5
6117286|NCT00103857|21094264|P7|54-Week Base Study|Lack of Efficacy|19
6117287|NCT00103857|21094265|P6|54-Week Base Study|Lack of Efficacy|14
6117288|NCT00103857|21094266|P5|54-Week Base Study|Lack of Efficacy|3
6117289|NCT00103857|21094267|P4|54-Week Base Study|Lack of Efficacy|4
6117290|NCT00103857|21094268|P3|54-Week Base Study|Lack of Efficacy|8
6117291|NCT00103857|21094269|P2|54-Week Base Study|Lack of Efficacy|14
6117292|NCT00103857|21094270|P1|54-Week Base Study|Lack of Efficacy|11
6117293|NCT00103857|21094264|P7|54-Week Base Study|Death|0
6117294|NCT00103857|21094265|P6|54-Week Base Study|Death|1
6117295|NCT00103857|21094266|P5|54-Week Base Study|Death|1
6117296|NCT00103857|21094267|P4|54-Week Base Study|Death|0
6117297|NCT00103857|21094268|P3|54-Week Base Study|Death|0
6117298|NCT00103857|21094269|P2|54-Week Base Study|Death|0
6117299|NCT00103857|21094270|P1|54-Week Base Study|Death|0
6117300|NCT00103857|21094264|P7|54-Week Base Study|Adverse Event|3
6117301|NCT00103857|21094265|P6|54-Week Base Study|Adverse Event|11
6117302|NCT00103857|21094266|P5|54-Week Base Study|Adverse Event|5
6117303|NCT00103857|21094267|P4|54-Week Base Study|Adverse Event|6
6117304|NCT00103857|21094268|P3|54-Week Base Study|Adverse Event|11
6117305|NCT00103857|21094269|P2|54-Week Base Study|Adverse Event|9
6117306|NCT00103857|21094270|P1|54-Week Base Study|Adverse Event|12
6117307|NCT00103740|21094369|P2|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|9
6117308|NCT00103740|21094370|P1|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|30
6117309|NCT00103740|21094369|P2|Period 2 - Extended Observation Period|Death|2
6117310|NCT00103740|21094370|P1|Period 2 - Extended Observation Period|Death|6
6117311|NCT00103740|21094369|P2|Period 2 - Extended Observation Period|Clinical reason other than Paget's|6
6117312|NCT00103740|21094370|P1|Period 2 - Extended Observation Period|Clinical reason other than Paget's|5
6117313|NCT00103740|21094369|P2|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|13
6117314|NCT00103740|21094370|P1|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|21
6117315|NCT00103740|21094369|P2|Period 2 - Extended Observation Period|Lost to Follow-up|6
6117316|NCT00103740|21094370|P1|Period 2 - Extended Observation Period|Lost to Follow-up|7
6117317|NCT00103740|21094369|P2|Period 1 - Core|Patient withdrew consent|2
6117318|NCT00103740|21094370|P1|Period 1 - Core|Patient withdrew consent|3
6117319|NCT00103740|21094369|P2|Period 1 - Core|Protocol Violation|2
6117320|NCT00103740|21094370|P1|Period 1 - Core|Protocol Violation|3
6117321|NCT00103740|21094369|P2|Period 1 - Core|Adverse Event|0
6117322|NCT00103740|21094370|P1|Period 1 - Core|Adverse Event|1
6117323|NCT00103662|21094398|P2|Overall Study|Intercurrent illness|0
6117324|NCT00103662|21094399|P1|Overall Study|Intercurrent illness|1
6117325|NCT00103662|21094398|P2|Overall Study|Failed mobilization|4
6117326|NCT00103662|21094399|P1|Overall Study|Failed mobilization|0
6117327|NCT00103662|21094398|P2|Overall Study|Other|9
6117328|NCT00103662|21094399|P1|Overall Study|Other|6
6117329|NCT00103662|21094398|P2|Overall Study|Lost to Follow-up|1
6117330|NCT00103662|21094399|P1|Overall Study|Lost to Follow-up|0
6117331|NCT00103662|21094398|P2|Overall Study|Elective Withdrawal|5
6117332|NCT00103662|21094399|P1|Overall Study|Elective Withdrawal|5
6117333|NCT00103662|21094398|P2|Overall Study|Death|7
6117334|NCT00103662|21094399|P1|Overall Study|Death|7
6117335|NCT00103662|21094398|P2|Overall Study|Entered Rescue Procedure|7
6117336|NCT00103662|21094399|P1|Overall Study|Entered Rescue Procedure|0
6117337|NCT00103610|21094425|P2|Overall Study|Noncompliance|1
6117338|NCT00103610|21094426|P1|Overall Study|Noncompliance|0
6117339|NCT00103610|21094425|P2|Overall Study|Failed mobilization|5
6117340|NCT00103610|21094426|P1|Overall Study|Failed mobilization|1
6117341|NCT00103610|21094425|P2|Overall Study|Other|7
6117342|NCT00103610|21094426|P1|Overall Study|Other|2
6117343|NCT00103610|21094425|P2|Overall Study|Adverse Event|2
6117344|NCT00103610|21094426|P1|Overall Study|Adverse Event|2
6117345|NCT00103610|21094425|P2|Overall Study|Lost to Follow-up|1
6117346|NCT00103610|21094426|P1|Overall Study|Lost to Follow-up|3
6117347|NCT00103610|21094425|P2|Overall Study|Elective Withdrawal|0
6117348|NCT00103610|21094426|P1|Overall Study|Elective Withdrawal|4
6117349|NCT00103610|21094425|P2|Overall Study|Death|12
6117350|NCT00103610|21094426|P1|Overall Study|Death|16
6117351|NCT00103610|21094425|P2|Overall Study|Entered Rescue Procedure|52
6117352|NCT00103610|21094426|P1|Overall Study|Entered Rescue Procedure|10
6117353|NCT00103506|21094450|P2|Overall Study|Withdrawal by Subject|21
6117354|NCT00103506|21094451|P1|Overall Study|Withdrawal by Subject|18
6117355|NCT00103506|21094450|P2|Overall Study|Lost to Follow-up|13
6117356|NCT00103506|21094451|P1|Overall Study|Lost to Follow-up|13
6117357|NCT00103506|21094450|P2|Overall Study|Death|253
6117358|NCT00103506|21094451|P1|Overall Study|Death|257
6117359|NCT00103506|21094450|P2|Overall Study|Study closed by sponsor|37
6117360|NCT00103506|21094451|P1|Overall Study|Study closed by sponsor|34
6117361|NCT00103402|21094463|P2|Overall Study|Personal constraints/Other|0
6117362|NCT00103402|21094464|P1|Overall Study|Personal constraints/Other|5
6117363|NCT00103402|21094463|P2|Overall Study|Dissatisfied/No longer interested|6
6117364|NCT00103402|21094464|P1|Overall Study|Dissatisfied/No longer interested|6
6117365|NCT00103402|21094463|P2|Overall Study|Lost to Follow-up|7
6117366|NCT00103402|21094464|P1|Overall Study|Lost to Follow-up|8
6117367|NCT00103402|21094463|P2|Overall Study|Adverse Event|4
6117368|NCT00103402|21094464|P1|Overall Study|Adverse Event|3
6117369|NCT00103311|21094505|P2|Overall Study|Adverse Event|0
6117370|NCT00103311|21094506|P1|Overall Study|Adverse Event|1
6117371|NCT00103311|21094505|P2|Overall Study|Withdrawal by Subject|1
6117372|NCT00103311|21094506|P1|Overall Study|Withdrawal by Subject|2
6117373|NCT00103311|21094505|P2|Overall Study|Lost to Follow-up|0
6117374|NCT00103311|21094506|P1|Overall Study|Lost to Follow-up|1
6117375|NCT00103285|21094516|P8|Response Assignment|Other|53
6117376|NCT00103285|21094517|P7|Response Assignment|Other|11
6117377|NCT00103285|21094518|P6|Response Assignment|Other|17
6117378|NCT00103285|21094519|P5|Response Assignment|Other|37
6117379|NCT00103285|21094520|P4|Response Assignment|Other|38
6117380|NCT00103285|21094521|P3|Response Assignment|Other|48
6117381|NCT00103285|21094522|P2|Response Assignment|Other|30
6117382|NCT00103285|21094523|P1|Response Assignment|Other|0
6117383|NCT00103285|21094516|P8|Response Assignment|Refusal|10
6117384|NCT00103285|21094517|P7|Response Assignment|Refusal|30
6117385|NCT00103285|21094518|P6|Response Assignment|Refusal|15
6117386|NCT00103285|21094519|P5|Response Assignment|Refusal|25
6117387|NCT00103285|21094520|P4|Response Assignment|Refusal|3
6117388|NCT00103285|21094521|P3|Response Assignment|Refusal|5
6117389|NCT00103285|21094522|P2|Response Assignment|Refusal|53
6117390|NCT00103285|21094523|P1|Response Assignment|Refusal|0
6117391|NCT00103285|21094516|P8|Response Assignment|Ineligible|5
6117392|NCT00103285|21094517|P7|Response Assignment|Ineligible|1
6117393|NCT00103285|21094518|P6|Response Assignment|Ineligible|3
6117394|NCT00103285|21094519|P5|Response Assignment|Ineligible|0
6117395|NCT00103285|21094520|P4|Response Assignment|Ineligible|2
6117396|NCT00103285|21094521|P3|Response Assignment|Ineligible|6
6117397|NCT00103285|21094522|P2|Response Assignment|Ineligible|8
6117398|NCT00103285|21094523|P1|Response Assignment|Ineligible|0
6117399|NCT00103285|21094516|P8|Response Assignment|Withdrawal by Subject|2
6117400|NCT00103285|21094517|P7|Response Assignment|Withdrawal by Subject|0
6117401|NCT00103285|21094518|P6|Response Assignment|Withdrawal by Subject|2
6117402|NCT00103285|21094519|P5|Response Assignment|Withdrawal by Subject|2
6117403|NCT00103285|21094520|P4|Response Assignment|Withdrawal by Subject|1
6117404|NCT00103285|21094521|P3|Response Assignment|Withdrawal by Subject|1
6117405|NCT00103285|21094522|P2|Response Assignment|Withdrawal by Subject|4
6117406|NCT00103285|21094523|P1|Response Assignment|Withdrawal by Subject|0
6117407|NCT00103285|21094516|P8|Response Assignment|Protocol Violation|0
6117408|NCT00103285|21094517|P7|Response Assignment|Protocol Violation|0
6117409|NCT00103285|21094518|P6|Response Assignment|Protocol Violation|0
6117410|NCT00103285|21094519|P5|Response Assignment|Protocol Violation|0
6117411|NCT00103285|21094520|P4|Response Assignment|Protocol Violation|0
6117412|NCT00103285|21094521|P3|Response Assignment|Protocol Violation|0
6117413|NCT00103285|21094522|P2|Response Assignment|Protocol Violation|2
6117414|NCT00103285|21094523|P1|Response Assignment|Protocol Violation|0
6117415|NCT00103285|21094516|P8|Response Assignment|Physician Decision|35
6117416|NCT00103285|21094517|P7|Response Assignment|Physician Decision|4
6117417|NCT00103285|21094518|P6|Response Assignment|Physician Decision|7
6117418|NCT00103285|21094519|P5|Response Assignment|Physician Decision|13
6117419|NCT00103285|21094520|P4|Response Assignment|Physician Decision|9
6117420|NCT00103285|21094521|P3|Response Assignment|Physician Decision|14
6117421|NCT00103285|21094522|P2|Response Assignment|Physician Decision|13
6117422|NCT00103285|21094523|P1|Response Assignment|Physician Decision|0
6117423|NCT00103285|21094516|P8|Response Assignment|Lost to Follow-up|5
6117424|NCT00103285|21094517|P7|Response Assignment|Lost to Follow-up|2
6117425|NCT00103285|21094518|P6|Response Assignment|Lost to Follow-up|2
6117426|NCT00103285|21094519|P5|Response Assignment|Lost to Follow-up|1
6117427|NCT00103285|21094520|P4|Response Assignment|Lost to Follow-up|5
6117428|NCT00103285|21094521|P3|Response Assignment|Lost to Follow-up|5
6117429|NCT00103285|21094522|P2|Response Assignment|Lost to Follow-up|9
6117430|NCT00103285|21094523|P1|Response Assignment|Lost to Follow-up|0
6117431|NCT00103285|21094516|P8|Response Assignment|Death|8
6117432|NCT00103285|21094517|P7|Response Assignment|Death|0
6117433|NCT00103285|21094518|P6|Response Assignment|Death|1
6117434|NCT00103285|21094519|P5|Response Assignment|Death|3
6117435|NCT00103285|21094520|P4|Response Assignment|Death|2
6117436|NCT00103285|21094521|P3|Response Assignment|Death|2
6117437|NCT00103285|21094522|P2|Response Assignment|Death|5
6117438|NCT00103285|21094523|P1|Response Assignment|Death|0
6117439|NCT00103285|21094516|P8|Response Assignment|Adverse Event|2
6117440|NCT00103285|21094517|P7|Response Assignment|Adverse Event|1
6117441|NCT00103285|21094518|P6|Response Assignment|Adverse Event|1
6117442|NCT00103285|21094519|P5|Response Assignment|Adverse Event|3
6117443|NCT00103285|21094520|P4|Response Assignment|Adverse Event|2
6117444|NCT00103285|21094521|P3|Response Assignment|Adverse Event|3
6117445|NCT00103285|21094522|P2|Response Assignment|Adverse Event|8
6117446|NCT00103285|21094523|P1|Response Assignment|Adverse Event|0
6117447|NCT00103285|21094516|P8|Induction|Other|0
6117448|NCT00103285|21094517|P7|Induction|Other|0
6117449|NCT00103285|21094518|P6|Induction|Other|0
6117450|NCT00103285|21094519|P5|Induction|Other|0
6117451|NCT00103285|21094520|P4|Induction|Other|0
6117452|NCT00103285|21094521|P3|Induction|Other|0
6117453|NCT00103285|21094522|P2|Induction|Other|0
6117454|NCT00103285|21094523|P1|Induction|Other|258
6117455|NCT00103285|21094516|P8|Induction|Refusal|0
6117456|NCT00103285|21094517|P7|Induction|Refusal|0
6117457|NCT00103285|21094518|P6|Induction|Refusal|0
6117458|NCT00103285|21094519|P5|Induction|Refusal|0
6117459|NCT00103285|21094520|P4|Induction|Refusal|0
6117460|NCT00103285|21094521|P3|Induction|Refusal|0
6117461|NCT00103285|21094522|P2|Induction|Refusal|0
6117462|NCT00103285|21094523|P1|Induction|Refusal|906
6117463|NCT00103285|21094516|P8|Induction|Ineligible|0
6117464|NCT00103285|21094517|P7|Induction|Ineligible|0
6117465|NCT00103285|21094518|P6|Induction|Ineligible|0
6117466|NCT00103285|21094519|P5|Induction|Ineligible|0
6117467|NCT00103285|21094520|P4|Induction|Ineligible|0
6117468|NCT00103285|21094521|P3|Induction|Ineligible|0
6117469|NCT00103285|21094522|P2|Induction|Ineligible|0
6117470|NCT00103285|21094523|P1|Induction|Ineligible|43
6117471|NCT00103285|21094516|P8|Induction|Withdrawal by Subject|0
6117472|NCT00103285|21094517|P7|Induction|Withdrawal by Subject|0
6117473|NCT00103285|21094518|P6|Induction|Withdrawal by Subject|0
6117474|NCT00103285|21094519|P5|Induction|Withdrawal by Subject|0
6117475|NCT00103285|21094520|P4|Induction|Withdrawal by Subject|0
6117476|NCT00103285|21094521|P3|Induction|Withdrawal by Subject|0
6117477|NCT00103285|21094522|P2|Induction|Withdrawal by Subject|0
6117478|NCT00103285|21094523|P1|Induction|Withdrawal by Subject|1
6117479|NCT00103285|21094516|P8|Induction|Physician Decision|0
6117480|NCT00103285|21094517|P7|Induction|Physician Decision|0
6117481|NCT00103285|21094518|P6|Induction|Physician Decision|0
6117482|NCT00103285|21094519|P5|Induction|Physician Decision|0
6117483|NCT00103285|21094520|P4|Induction|Physician Decision|0
6117484|NCT00103285|21094521|P3|Induction|Physician Decision|0
6117485|NCT00103285|21094522|P2|Induction|Physician Decision|0
6117486|NCT00103285|21094523|P1|Induction|Physician Decision|103
6117487|NCT00103285|21094516|P8|Induction|Death|0
6117488|NCT00103285|21094517|P7|Induction|Death|0
6117489|NCT00103285|21094518|P6|Induction|Death|0
6117490|NCT00103285|21094519|P5|Induction|Death|0
6117491|NCT00103285|21094520|P4|Induction|Death|0
6117492|NCT00103285|21094521|P3|Induction|Death|0
6117493|NCT00103285|21094522|P2|Induction|Death|0
6117494|NCT00103285|21094523|P1|Induction|Death|24
6117495|NCT00103285|21094516|P8|Induction|Adverse Event|0
6117496|NCT00103285|21094517|P7|Induction|Adverse Event|0
6117497|NCT00103285|21094518|P6|Induction|Adverse Event|0
6117498|NCT00103285|21094519|P5|Induction|Adverse Event|0
6117499|NCT00103285|21094520|P4|Induction|Adverse Event|0
6117500|NCT00103285|21094521|P3|Induction|Adverse Event|0
6117501|NCT00103285|21094522|P2|Induction|Adverse Event|0
6117502|NCT00103285|21094523|P1|Induction|Adverse Event|14
6117503|NCT00103259|21094552|P2|Overall Study|ineligible/no protocol therapy|6
6117504|NCT00103259|21094553|P1|Overall Study|ineligible/no protocol therapy|4
6117505|NCT00103259|21094552|P2|Overall Study|other (reasons were not specified)|1
6117506|NCT00103259|21094553|P1|Overall Study|other (reasons were not specified)|2
6117507|NCT00103259|21094552|P2|Overall Study|alternative therapy|0
6117508|NCT00103259|21094553|P1|Overall Study|alternative therapy|1
6117509|NCT00103259|21094552|P2|Overall Study|Withdrawal by Subject|3
6117510|NCT00103259|21094553|P1|Overall Study|Withdrawal by Subject|2
6117511|NCT00103259|21094552|P2|Overall Study|Death|2
6117512|NCT00103259|21094553|P1|Overall Study|Death|3
6117513|NCT00103207|21094565|P1|Overall Study|Diagnosis of BAC not confirmed|27
6117514|NCT00103207|21094565|P1|Overall Study|Ineligible|4
6117515|NCT00103207|21094565|P1|Overall Study|Other complicating disease|1
6117516|NCT00103207|21094565|P1|Overall Study|Withdrawal by Subject|2
6117517|NCT00103207|21094565|P1|Overall Study|Death|1
6117518|NCT00103207|21094565|P1|Overall Study|Adverse Event|3
6117519|NCT00103142|21094584|P2|Overall Study|Progression of disease|1
6117520|NCT00103142|21094585|P1|Overall Study|Progression of disease|2
6117521|NCT00103142|21094584|P2|Overall Study|Adverse Event|0
6117522|NCT00103142|21094585|P1|Overall Study|Adverse Event|1
6117523|NCT00103012|21094601|P3|Overall Study|Subject non-compliant with medications|1
6117524|NCT00103012|21094602|P2|Overall Study|Subject non-compliant with medications|0
6117525|NCT00103012|21094603|P1|Overall Study|Subject non-compliant with medications|0
6117526|NCT00103012|21094601|P3|Overall Study|Adverse Event|1
6117527|NCT00103012|21094602|P2|Overall Study|Adverse Event|0
6117528|NCT00103012|21094603|P1|Overall Study|Adverse Event|0
6117529|NCT00103012|21094601|P3|Overall Study|Pregnancy|0
6117530|NCT00103012|21094602|P2|Overall Study|Pregnancy|0
6117531|NCT00103012|21094603|P1|Overall Study|Pregnancy|1
6117532|NCT00103012|21094601|P3|Overall Study|Withdrawal by Subject|2
6117533|NCT00103012|21094602|P2|Overall Study|Withdrawal by Subject|1
6117534|NCT00103012|21094603|P1|Overall Study|Withdrawal by Subject|2
6117535|NCT00102960|21094614|P3|Overall Study|Withdrawal by Subject|1
6117536|NCT00102960|21094615|P2|Overall Study|Withdrawal by Subject|0
6117537|NCT00102960|21094616|P1|Overall Study|Withdrawal by Subject|1
6117538|NCT00102960|21094614|P3|Overall Study|Lost to Follow-up|16
6117539|NCT00102960|21094615|P2|Overall Study|Lost to Follow-up|12
6117540|NCT00102960|21094616|P1|Overall Study|Lost to Follow-up|6
6117541|NCT00102960|21094614|P3|Overall Study|Death|11
6117542|NCT00102960|21094615|P2|Overall Study|Death|11
6117543|NCT00102960|21094616|P1|Overall Study|Death|23
6117544|NCT00102804|21094665|P2|Overall Study|Alive, Receiving Treatment|2
6117545|NCT00102804|21094666|P1|Overall Study|Alive, Receiving Treatment|7
6117546|NCT00102804|21094665|P2|Overall Study|Sponsor Decision|0
6117547|NCT00102804|21094666|P1|Overall Study|Sponsor Decision|1
6117548|NCT00102804|21094665|P2|Overall Study|Satisfactory Response|0
6117549|NCT00102804|21094666|P1|Overall Study|Satisfactory Response|2
6117550|NCT00102804|21094665|P2|Overall Study|Protocol Violation|1
6117551|NCT00102804|21094666|P1|Overall Study|Protocol Violation|2
6117552|NCT00102804|21094665|P2|Overall Study|Lost to Follow-up|1
6117553|NCT00102804|21094666|P1|Overall Study|Lost to Follow-up|4
6117554|NCT00102804|21094665|P2|Overall Study|Enrollment Criteria Not Met|0
6117555|NCT00102804|21094666|P1|Overall Study|Enrollment Criteria Not Met|6
6117556|NCT00102804|21094665|P2|Overall Study|Death|6
6117557|NCT00102804|21094666|P1|Overall Study|Death|5
6117558|NCT00102804|21094665|P2|Overall Study|Physician Decision|6
6117559|NCT00102804|21094666|P1|Overall Study|Physician Decision|24
6117560|NCT00102804|21094665|P2|Overall Study|Adverse Event|3
6117561|NCT00102804|21094666|P1|Overall Study|Adverse Event|37
6117562|NCT00102804|21094665|P2|Overall Study|Withdrawal by Subject|7
6117563|NCT00102804|21094666|P1|Overall Study|Withdrawal by Subject|46
6117564|NCT00102804|21094665|P2|Overall Study|Progressive Disease (PD)|196
6117565|NCT00102804|21094666|P1|Overall Study|Progressive Disease (PD)|307
6117566|NCT00102687|21094687|P5|Maintenance Period|Physician Decision|4
6117567|NCT00102687|21094688|P4|Maintenance Period|Physician Decision|0
6117568|NCT00102687|21094689|P3|Maintenance Period|Physician Decision|3
6117569|NCT00102687|21094690|P2|Maintenance Period|Physician Decision|2
6117570|NCT00102687|21094691|P1|Maintenance Period|Physician Decision|1
6117571|NCT00102687|21094687|P5|Maintenance Period|Death|1
6117572|NCT00102687|21094688|P4|Maintenance Period|Death|1
6117573|NCT00102687|21094689|P3|Maintenance Period|Death|0
6117574|NCT00102687|21094690|P2|Maintenance Period|Death|0
6117575|NCT00102687|21094691|P1|Maintenance Period|Death|0
6117576|NCT00102687|21094687|P5|Maintenance Period|Failed Treatment (relapse,disease prog)|4
6117577|NCT00102687|21094688|P4|Maintenance Period|Failed Treatment (relapse,disease prog)|3
6117578|NCT00102687|21094689|P3|Maintenance Period|Failed Treatment (relapse,disease prog)|1
6117579|NCT00102687|21094690|P2|Maintenance Period|Failed Treatment (relapse,disease prog)|1
6117580|NCT00102687|21094691|P1|Maintenance Period|Failed Treatment (relapse,disease prog)|1
6117581|NCT00102687|21094687|P5|Maintenance Period|Transformation to AML (blast > 30%)|0
6117582|NCT00102687|21094688|P4|Maintenance Period|Transformation to AML (blast > 30%)|2
6117583|NCT00102687|21094689|P3|Maintenance Period|Transformation to AML (blast > 30%)|0
6117584|NCT00102687|21094690|P2|Maintenance Period|Transformation to AML (blast > 30%)|1
6117585|NCT00102687|21094691|P1|Maintenance Period|Transformation to AML (blast > 30%)|0
6117586|NCT00102687|21094687|P5|Maintenance Period|Adverse Event|3
6117587|NCT00102687|21094688|P4|Maintenance Period|Adverse Event|1
6117588|NCT00102687|21094689|P3|Maintenance Period|Adverse Event|0
6117589|NCT00102687|21094690|P2|Maintenance Period|Adverse Event|0
6117590|NCT00102687|21094691|P1|Maintenance Period|Adverse Event|1
6117591|NCT00102687|21094687|P5|Maintenance Period|Withdrawal by Subject|1
6117592|NCT00102687|21094688|P4|Maintenance Period|Withdrawal by Subject|3
6117593|NCT00102687|21094689|P3|Maintenance Period|Withdrawal by Subject|2
6117594|NCT00102687|21094690|P2|Maintenance Period|Withdrawal by Subject|0
6117595|NCT00102687|21094691|P1|Maintenance Period|Withdrawal by Subject|4
6117596|NCT00102687|21094687|P5|Initial Period|Death|0
6117597|NCT00102687|21094688|P4|Initial Period|Death|0
6117598|NCT00102687|21094689|P3|Initial Period|Death|1
6117599|NCT00102687|21094690|P2|Initial Period|Death|1
6117600|NCT00102687|21094691|P1|Initial Period|Death|1
6117601|NCT00102687|21094687|P5|Initial Period|Failed Treatments (relapse,disease prog)|0
6117602|NCT00102687|21094688|P4|Initial Period|Failed Treatments (relapse,disease prog)|0
6117603|NCT00102687|21094689|P3|Initial Period|Failed Treatments (relapse,disease prog)|2
6117604|NCT00102687|21094690|P2|Initial Period|Failed Treatments (relapse,disease prog)|4
6117605|NCT00102687|21094691|P1|Initial Period|Failed Treatments (relapse,disease prog)|4
6117606|NCT00102687|21094687|P5|Initial Period|Sponsor's decision|0
6117607|NCT00102687|21094688|P4|Initial Period|Sponsor's decision|0
6117608|NCT00102687|21094689|P3|Initial Period|Sponsor's decision|1
6117609|NCT00102687|21094690|P2|Initial Period|Sponsor's decision|1
6117610|NCT00102687|21094691|P1|Initial Period|Sponsor's decision|0
6117611|NCT00102687|21094687|P5|Initial Period|Physician Decision|0
6117612|NCT00102687|21094688|P4|Initial Period|Physician Decision|0
6117613|NCT00102687|21094689|P3|Initial Period|Physician Decision|6
6117614|NCT00102687|21094690|P2|Initial Period|Physician Decision|9
6117615|NCT00102687|21094691|P1|Initial Period|Physician Decision|2
6117616|NCT00102687|21094687|P5|Initial Period|Protocol Violation|0
6117617|NCT00102687|21094688|P4|Initial Period|Protocol Violation|0
6117618|NCT00102687|21094689|P3|Initial Period|Protocol Violation|2
6117619|NCT00102687|21094690|P2|Initial Period|Protocol Violation|0
6117620|NCT00102687|21094691|P1|Initial Period|Protocol Violation|0
6117621|NCT00102687|21094687|P5|Initial Period|Transformation to AML (blast > 30%)|0
6117622|NCT00102687|21094688|P4|Initial Period|Transformation to AML (blast > 30%)|0
6117623|NCT00102687|21094689|P3|Initial Period|Transformation to AML (blast > 30%)|0
6117624|NCT00102687|21094690|P2|Initial Period|Transformation to AML (blast > 30%)|3
6117625|NCT00102687|21094691|P1|Initial Period|Transformation to AML (blast > 30%)|1
6117626|NCT00102687|21094687|P5|Initial Period|Adverse Event|0
6117627|NCT00102687|21094688|P4|Initial Period|Adverse Event|0
6117628|NCT00102687|21094689|P3|Initial Period|Adverse Event|9
6117629|NCT00102687|21094690|P2|Initial Period|Adverse Event|7
6117630|NCT00102687|21094691|P1|Initial Period|Adverse Event|4
6117631|NCT00102687|21094687|P5|Initial Period|Withdrawal by Subject|0
6117632|NCT00102687|21094688|P4|Initial Period|Withdrawal by Subject|0
6117633|NCT00102687|21094689|P3|Initial Period|Withdrawal by Subject|5
6117634|NCT00102687|21094690|P2|Initial Period|Withdrawal by Subject|3
6117635|NCT00102687|21094691|P1|Initial Period|Withdrawal by Subject|6
6117636|NCT00102596|21094755|P2|Part A|Adverse Event|0
6117637|NCT00102596|21094756|P1|Part A|Adverse Event|1
6117638|NCT00102596|21094755|P2|Part A|Screen failures|0
6117639|NCT00102596|21094756|P1|Part A|Screen failures|6
6117640|NCT00102531|21094767|P2|Overall Study|Physician Decision|1
6117641|NCT00102531|21094768|P1|Overall Study|Physician Decision|0
6117642|NCT00102531|21094767|P2|Overall Study|Disease Progression|9
6117643|NCT00102531|21094768|P1|Overall Study|Disease Progression|5
6117644|NCT00102531|21094767|P2|Overall Study|Adverse Event|1
6117645|NCT00102531|21094768|P1|Overall Study|Adverse Event|0
6117646|NCT00102440|21094783|P3|Overall Study|Protocol Violation|1
6117647|NCT00102440|21094784|P2|Overall Study|Protocol Violation|2
6117648|NCT00102440|21094785|P1|Overall Study|Protocol Violation|7
6117649|NCT00102440|21094783|P3|Overall Study|Other|14
6117650|NCT00102440|21094784|P2|Overall Study|Other|14
6117651|NCT00102440|21094785|P1|Overall Study|Other|11
6117652|NCT00102440|21094783|P3|Overall Study|Personal Reason(s)|13
6117653|NCT00102440|21094784|P2|Overall Study|Personal Reason(s)|13
6117654|NCT00102440|21094785|P1|Overall Study|Personal Reason(s)|19
6117655|NCT00102440|21094783|P3|Overall Study|Gout Flare|9
6117656|NCT00102440|21094784|P2|Overall Study|Gout Flare|28
6117657|NCT00102440|21094785|P1|Overall Study|Gout Flare|10
6117658|NCT00102440|21094783|P3|Overall Study|Adverse Event|8
6117659|NCT00102440|21094784|P2|Overall Study|Adverse Event|23
6117660|NCT00102440|21094785|P1|Overall Study|Adverse Event|16
6117661|NCT00102440|21094783|P3|Overall Study|Lost to Follow-up|21
6117662|NCT00102440|21094784|P2|Overall Study|Lost to Follow-up|18
6117663|NCT00102440|21094785|P1|Overall Study|Lost to Follow-up|25
6117664|NCT00102063|21094835|P3|Overall Study|Protocol Violation|1
6117665|NCT00102063|21094836|P2|Overall Study|Protocol Violation|1
6117666|NCT00102063|21094837|P1|Overall Study|Protocol Violation|0
6117667|NCT00102063|21094835|P3|Overall Study|Lost to Follow-up|1
6117668|NCT00102063|21094836|P2|Overall Study|Lost to Follow-up|0
6117669|NCT00102063|21094837|P1|Overall Study|Lost to Follow-up|0
6117670|NCT00102063|21094835|P3|Overall Study|Withdrawal by Subject|5
6117671|NCT00102063|21094836|P2|Overall Study|Withdrawal by Subject|12
6117672|NCT00102063|21094837|P1|Overall Study|Withdrawal by Subject|4
6117673|NCT00102063|21094835|P3|Overall Study|Adverse Event|2
6117674|NCT00102063|21094836|P2|Overall Study|Adverse Event|4
6117675|NCT00102063|21094837|P1|Overall Study|Adverse Event|7
6117676|NCT00102063|21094835|P3|Overall Study|Lack of Efficacy|1
6117677|NCT00102063|21094836|P2|Overall Study|Lack of Efficacy|1
6117678|NCT00102063|21094837|P1|Overall Study|Lack of Efficacy|5
6117679|NCT00101907|21094895|P6|Overall Study|Withdrawal by Subject|0
6117680|NCT00101907|21094896|P5|Overall Study|Withdrawal by Subject|1
6117681|NCT00101907|21094897|P4|Overall Study|Withdrawal by Subject|0
6117682|NCT00101907|21094898|P3|Overall Study|Withdrawal by Subject|1
6117683|NCT00101907|21094899|P2|Overall Study|Withdrawal by Subject|0
6117684|NCT00101907|21094900|P1|Overall Study|Withdrawal by Subject|1
6117685|NCT00101907|21094895|P6|Overall Study|Physician Decision|0
6117686|NCT00101907|21094896|P5|Overall Study|Physician Decision|1
6117687|NCT00101907|21094897|P4|Overall Study|Physician Decision|1
6117688|NCT00101907|21094898|P3|Overall Study|Physician Decision|0
6117689|NCT00101907|21094899|P2|Overall Study|Physician Decision|0
6117690|NCT00101907|21094900|P1|Overall Study|Physician Decision|0
6117691|NCT00101907|21094895|P6|Overall Study|Death|0
6117692|NCT00101907|21094896|P5|Overall Study|Death|3
6117693|NCT00101907|21094897|P4|Overall Study|Death|0
6117694|NCT00101907|21094898|P3|Overall Study|Death|0
6117695|NCT00101907|21094899|P2|Overall Study|Death|1
6117696|NCT00101907|21094900|P1|Overall Study|Death|0
6117697|NCT00101907|21094895|P6|Overall Study|Adverse Event|0
6117698|NCT00101907|21094896|P5|Overall Study|Adverse Event|0
6117699|NCT00101907|21094897|P4|Overall Study|Adverse Event|0
6117700|NCT00101907|21094898|P3|Overall Study|Adverse Event|0
6117701|NCT00101907|21094899|P2|Overall Study|Adverse Event|0
6117702|NCT00101907|21094900|P1|Overall Study|Adverse Event|1
6117703|NCT00101868|21094942|P2|Overall Study|Lost to Follow-up|13
6117704|NCT00101868|21094943|P1|Overall Study|Lost to Follow-up|8
6117705|NCT00101868|21094942|P2|Overall Study|Protocol Violation|0
6117706|NCT00101868|21094943|P1|Overall Study|Protocol Violation|3
6117707|NCT00101868|21094942|P2|Overall Study|Withdrawal by Subject|9
6117708|NCT00101868|21094943|P1|Overall Study|Withdrawal by Subject|8
6117709|NCT00101868|21094942|P2|Overall Study|Death|10
6117710|NCT00101868|21094943|P1|Overall Study|Death|10
6117711|NCT00101686|21095013|P10|Overall Study|Withdrawal by Subject|9
6117712|NCT00101686|21095014|P9|Overall Study|Withdrawal by Subject|8
6117713|NCT00101686|21095015|P8|Overall Study|Withdrawal by Subject|7
6117714|NCT00101686|21095016|P7|Overall Study|Withdrawal by Subject|7
6117715|NCT00101686|21095017|P6|Overall Study|Withdrawal by Subject|7
6117716|NCT00101686|21095018|P5|Overall Study|Withdrawal by Subject|8
6117717|NCT00101686|21095019|P4|Overall Study|Withdrawal by Subject|8
6117718|NCT00101686|21095020|P3|Overall Study|Withdrawal by Subject|6
6117719|NCT00101686|21095021|P2|Overall Study|Withdrawal by Subject|8
6117720|NCT00101686|21095022|P1|Overall Study|Withdrawal by Subject|9
6117721|NCT00101686|21095013|P10|Overall Study|Other|3
6117722|NCT00101686|21095014|P9|Overall Study|Other|3
6117723|NCT00101686|21095015|P8|Overall Study|Other|5
6117724|NCT00101686|21095016|P7|Overall Study|Other|1
6117725|NCT00101686|21095017|P6|Overall Study|Other|12
6117726|NCT00101686|21095018|P5|Overall Study|Other|2
6117727|NCT00101686|21095019|P4|Overall Study|Other|6
6117728|NCT00101686|21095020|P3|Overall Study|Other|1
6117729|NCT00101686|21095021|P2|Overall Study|Other|4
6117730|NCT00101686|21095022|P1|Overall Study|Other|1
6117731|NCT00101686|21095013|P10|Overall Study|Physician Decision|1
6117732|NCT00101686|21095014|P9|Overall Study|Physician Decision|1
6117733|NCT00101686|21095015|P8|Overall Study|Physician Decision|5
6117734|NCT00101686|21095016|P7|Overall Study|Physician Decision|5
6117735|NCT00101686|21095017|P6|Overall Study|Physician Decision|9
6117736|NCT00101686|21095018|P5|Overall Study|Physician Decision|8
6117737|NCT00101686|21095019|P4|Overall Study|Physician Decision|7
6117738|NCT00101686|21095020|P3|Overall Study|Physician Decision|6
6117739|NCT00101686|21095021|P2|Overall Study|Physician Decision|13
6117740|NCT00101686|21095022|P1|Overall Study|Physician Decision|10
6117741|NCT00101686|21095013|P10|Overall Study|intercurrent non-cancer related illness|1
6117742|NCT00101686|21095014|P9|Overall Study|intercurrent non-cancer related illness|1
6117743|NCT00101686|21095015|P8|Overall Study|intercurrent non-cancer related illness|0
6117744|NCT00101686|21095016|P7|Overall Study|intercurrent non-cancer related illness|1
6117745|NCT00101686|21095017|P6|Overall Study|intercurrent non-cancer related illness|3
6117746|NCT00101686|21095018|P5|Overall Study|intercurrent non-cancer related illness|1
6117747|NCT00101686|21095019|P4|Overall Study|intercurrent non-cancer related illness|0
6117748|NCT00101686|21095020|P3|Overall Study|intercurrent non-cancer related illness|2
6117749|NCT00101686|21095021|P2|Overall Study|intercurrent non-cancer related illness|0
6117750|NCT00101686|21095022|P1|Overall Study|intercurrent non-cancer related illness|0
6117751|NCT00101686|21095013|P10|Overall Study|Randomized but did not receive treament|1
6117752|NCT00101686|21095014|P9|Overall Study|Randomized but did not receive treament|0
6117753|NCT00101686|21095015|P8|Overall Study|Randomized but did not receive treament|1
6117754|NCT00101686|21095016|P7|Overall Study|Randomized but did not receive treament|0
6117755|NCT00101686|21095017|P6|Overall Study|Randomized but did not receive treament|2
6117756|NCT00101686|21095018|P5|Overall Study|Randomized but did not receive treament|2
6117757|NCT00101686|21095019|P4|Overall Study|Randomized but did not receive treament|2
6117758|NCT00101686|21095020|P3|Overall Study|Randomized but did not receive treament|2
6117759|NCT00101686|21095021|P2|Overall Study|Randomized but did not receive treament|6
6117760|NCT00101686|21095022|P1|Overall Study|Randomized but did not receive treament|1
6117761|NCT00101686|21095013|P10|Overall Study|unacceptable toxicity|4
6117762|NCT00101686|21095014|P9|Overall Study|unacceptable toxicity|1
6117763|NCT00101686|21095015|P8|Overall Study|unacceptable toxicity|2
6117764|NCT00101686|21095016|P7|Overall Study|unacceptable toxicity|4
6117765|NCT00101686|21095017|P6|Overall Study|unacceptable toxicity|10
6117766|NCT00101686|21095018|P5|Overall Study|unacceptable toxicity|16
6117767|NCT00101686|21095019|P4|Overall Study|unacceptable toxicity|6
6117768|NCT00101686|21095020|P3|Overall Study|unacceptable toxicity|10
6117769|NCT00101686|21095021|P2|Overall Study|unacceptable toxicity|9
6117770|NCT00101686|21095022|P1|Overall Study|unacceptable toxicity|3
6117771|NCT00101686|21095013|P10|Overall Study|>3 week delay treatment due toxicity|0
6117772|NCT00101686|21095014|P9|Overall Study|>3 week delay treatment due toxicity|3
6117773|NCT00101686|21095015|P8|Overall Study|>3 week delay treatment due toxicity|1
6117774|NCT00101686|21095016|P7|Overall Study|>3 week delay treatment due toxicity|2
6117775|NCT00101686|21095017|P6|Overall Study|>3 week delay treatment due toxicity|3
6117776|NCT00101686|21095018|P5|Overall Study|>3 week delay treatment due toxicity|7
6117777|NCT00101686|21095019|P4|Overall Study|>3 week delay treatment due toxicity|2
6117778|NCT00101686|21095020|P3|Overall Study|>3 week delay treatment due toxicity|1
6117779|NCT00101686|21095021|P2|Overall Study|>3 week delay treatment due toxicity|2
6117780|NCT00101686|21095022|P1|Overall Study|>3 week delay treatment due toxicity|6
6117781|NCT00101686|21095013|P10|Overall Study|initiation other anti-cancer treatment|3
6117782|NCT00101686|21095014|P9|Overall Study|initiation other anti-cancer treatment|3
6117783|NCT00101686|21095015|P8|Overall Study|initiation other anti-cancer treatment|2
6117784|NCT00101686|21095016|P7|Overall Study|initiation other anti-cancer treatment|2
6117785|NCT00101686|21095017|P6|Overall Study|initiation other anti-cancer treatment|1
6117786|NCT00101686|21095018|P5|Overall Study|initiation other anti-cancer treatment|1
6117787|NCT00101686|21095019|P4|Overall Study|initiation other anti-cancer treatment|3
6117788|NCT00101686|21095020|P3|Overall Study|initiation other anti-cancer treatment|4
6117789|NCT00101686|21095021|P2|Overall Study|initiation other anti-cancer treatment|3
6117790|NCT00101686|21095022|P1|Overall Study|initiation other anti-cancer treatment|4
6117791|NCT00101686|21095013|P10|Overall Study|Progressive Disease|8
6117792|NCT00101686|21095014|P9|Overall Study|Progressive Disease|10
6117793|NCT00101686|21095015|P8|Overall Study|Progressive Disease|7
6117794|NCT00101686|21095016|P7|Overall Study|Progressive Disease|5
6117795|NCT00101686|21095017|P6|Overall Study|Progressive Disease|25
6117796|NCT00101686|21095018|P5|Overall Study|Progressive Disease|28
6117797|NCT00101686|21095019|P4|Overall Study|Progressive Disease|38
6117798|NCT00101686|21095020|P3|Overall Study|Progressive Disease|37
6117799|NCT00101686|21095021|P2|Overall Study|Progressive Disease|28
6117800|NCT00101686|21095022|P1|Overall Study|Progressive Disease|37
6117801|NCT00101582|21095139|P2|Overall Study|Other|1
6117802|NCT00101582|21095140|P1|Overall Study|Other|0
6117803|NCT00101582|21095139|P2|Overall Study|Death|5
6117804|NCT00101582|21095140|P1|Overall Study|Death|3
6117805|NCT00101582|21095139|P2|Overall Study|Physician Decision|0
6117806|NCT00101582|21095140|P1|Overall Study|Physician Decision|1
6117807|NCT00101582|21095139|P2|Overall Study|Withdrawal by Subject|4
6117808|NCT00101582|21095140|P1|Overall Study|Withdrawal by Subject|6
6117809|NCT00101582|21095139|P2|Overall Study|Adverse Event|4
6117810|NCT00101582|21095140|P1|Overall Study|Adverse Event|1
6117811|NCT00101582|21095139|P2|Overall Study|Ineligibility determined|1
6117812|NCT00101582|21095140|P1|Overall Study|Ineligibility determined|0
6117813|NCT00101452|21095163|P3|Overall Study|Other|12
6117814|NCT00101452|21095164|P2|Overall Study|Other|16
6117815|NCT00101452|21095165|P1|Overall Study|Other|15
6117816|NCT00101452|21095163|P3|Overall Study|Protocol Violation|3
6117817|NCT00101452|21095164|P2|Overall Study|Protocol Violation|1
6117818|NCT00101452|21095165|P1|Overall Study|Protocol Violation|2
6117819|NCT00101452|21095163|P3|Overall Study|Physician Decision|2
6117820|NCT00101452|21095164|P2|Overall Study|Physician Decision|3
6117821|NCT00101452|21095165|P1|Overall Study|Physician Decision|0
6117822|NCT00101452|21095163|P3|Overall Study|Baseline Fail|2
6117823|NCT00101452|21095164|P2|Overall Study|Baseline Fail|1
6117824|NCT00101452|21095165|P1|Overall Study|Baseline Fail|2
6117825|NCT00101452|21095163|P3|Overall Study|Withdrawal by Subject|9
6117826|NCT00101452|21095164|P2|Overall Study|Withdrawal by Subject|14
6117827|NCT00101452|21095165|P1|Overall Study|Withdrawal by Subject|10
6117828|NCT00101452|21095163|P3|Overall Study|Lost to Follow-up|14
6117829|NCT00101452|21095164|P2|Overall Study|Lost to Follow-up|8
6117830|NCT00101452|21095165|P1|Overall Study|Lost to Follow-up|13
6117831|NCT00101452|21095163|P3|Overall Study|Adverse Event|1
6117832|NCT00101452|21095164|P2|Overall Study|Adverse Event|0
6117833|NCT00101452|21095165|P1|Overall Study|Adverse Event|2
6117834|NCT00101439|21095179|P2|Period 2|Withdrawal by Subject|2
6117835|NCT00101439|21095180|P1|Period 2|Withdrawal by Subject|0
6117836|NCT00101400|21095196|P1|Survival Follow-Up|Alive|7
6117837|NCT00101283|21095216|P2|Overall Study|Prostate Cancer Recurrence|1
6117838|NCT00101283|21095217|P1|Overall Study|Prostate Cancer Recurrence|0
6117839|NCT00101283|21095216|P2|Overall Study|Insurance Refusal|1
6117840|NCT00101283|21095217|P1|Overall Study|Insurance Refusal|0
6117841|NCT00101283|21095216|P2|Overall Study|Withdrawal by Subject|1
6117842|NCT00101283|21095217|P1|Overall Study|Withdrawal by Subject|0
6117843|NCT00101192|21095227|P1|Overall Study|Inevaluable|1
6117844|NCT00101192|21095227|P1|Overall Study|Ineligible|6
6117845|NCT00101166|21095231|P1|Overall Study|progressive disease|10
6117846|NCT00101101|21095239|P1|Overall Study|never received vaccine|20
6117847|NCT00101010|21095260|P1|Overall Study|Physician Decision|1
6117848|NCT00100932|21095267|P2|Overall Study|Other|2
6117849|NCT00100932|21095268|P1|Overall Study|Other|5
6117850|NCT00100932|21095267|P2|Overall Study|Physician Decision|5
6117851|NCT00100932|21095268|P1|Overall Study|Physician Decision|7
6117852|NCT00100932|21095267|P2|Overall Study|Progressive Disease|18
6117853|NCT00100932|21095268|P1|Overall Study|Progressive Disease|44
6117854|NCT00100932|21095267|P2|Overall Study|Withdrawal by Subject|0
6117855|NCT00100932|21095268|P1|Overall Study|Withdrawal by Subject|6
6117856|NCT00100932|21095267|P2|Overall Study|Adverse Event|2
6117857|NCT00100932|21095268|P1|Overall Study|Adverse Event|11
6117858|NCT00100828|21095283|P1|Overall Study|Physician Decision|6
6117859|NCT00100815|21095287|P1|Overall Study|Other|3
6117860|NCT00100815|21095287|P1|Overall Study|Death|4
6117861|NCT00100815|21095287|P1|Overall Study|Adverse Event|18
6117862|NCT00100815|21095287|P1|Overall Study|Progression|24
6117863|NCT00100802|21095295|P1|Overall Study|Ineligible|12
6117864|NCT00100802|21095295|P1|Overall Study|Withdrawal by Subject|5
6117865|NCT00100802|21095295|P1|Overall Study|Protocol Violation|1
6117866|NCT00100802|21095295|P1|Overall Study|Physician Decision|5
6117867|NCT00100802|21095295|P1|Overall Study|Lack of Efficacy|47
6117868|NCT00100802|21095295|P1|Overall Study|Death|1
6117869|NCT00100802|21095295|P1|Overall Study|Adverse Event|9
6117870|NCT00100789|21095300|P1|Overall Study|Never received treatment|1
6117871|NCT00100789|21095300|P1|Overall Study|Ineligible|3
6117872|NCT00100789|21095300|P1|Overall Study|Not protocol specified|5
6117873|NCT00100789|21095300|P1|Overall Study|Death|2
6117874|NCT00100789|21095300|P1|Overall Study|Progression/relapse|42
6117875|NCT00100789|21095300|P1|Overall Study|Withdrawal by Subject|1
6117876|NCT00100789|21095300|P1|Overall Study|Adverse Event|10
6117877|NCT00100178|21095377|P3|Overall Study|Physician Decision|3
6117878|NCT00100178|21095378|P2|Overall Study|Physician Decision|1
6117879|NCT00100178|21095379|P1|Overall Study|Physician Decision|6
6117880|NCT00100178|21095377|P3|Overall Study|Withdrawal by Subject|1
6117881|NCT00100178|21095378|P2|Overall Study|Withdrawal by Subject|1
6117882|NCT00100178|21095379|P1|Overall Study|Withdrawal by Subject|1
6117883|NCT00100178|21095377|P3|Overall Study|Adverse Event|1
6117884|NCT00100178|21095378|P2|Overall Study|Adverse Event|2
6117885|NCT00100178|21095379|P1|Overall Study|Adverse Event|2
6117886|NCT00100178|21095377|P3|Overall Study|Lost to Follow-up|5
6117887|NCT00100178|21095378|P2|Overall Study|Lost to Follow-up|6
6117888|NCT00100178|21095379|P1|Overall Study|Lost to Follow-up|0
6117889|NCT00100048|21095408|P6|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0
6117890|NCT00100048|21095409|P5|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0
6117891|NCT00100048|21095410|P4|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|1
6117892|NCT00100048|21095411|P3|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0
6117893|NCT00100048|21095412|P2|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0
6117894|NCT00100048|21095413|P1|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0
6117895|NCT00100048|21095408|P6|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2
6117896|NCT00100048|21095409|P5|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0
6117897|NCT00100048|21095410|P4|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0
6117898|NCT00100048|21095411|P3|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2
6117899|NCT00100048|21095412|P2|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1
6117900|NCT00100048|21095413|P1|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1
6117901|NCT00100048|21095408|P6|Cohort I & II-Combination Therapy Phase|Other Reason|0
6117902|NCT00100048|21095409|P5|Cohort I & II-Combination Therapy Phase|Other Reason|0
6117903|NCT00100048|21095410|P4|Cohort I & II-Combination Therapy Phase|Other Reason|2
6117904|NCT00100048|21095411|P3|Cohort I & II-Combination Therapy Phase|Other Reason|4
6117905|NCT00100048|21095412|P2|Cohort I & II-Combination Therapy Phase|Other Reason|1
6117906|NCT00100048|21095413|P1|Cohort I & II-Combination Therapy Phase|Other Reason|7
6117907|NCT00100048|21095408|P6|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|4
6117908|NCT00100048|21095409|P5|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|0
6117909|NCT00100048|21095410|P4|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|5
6117910|NCT00100048|21095411|P3|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2
6117911|NCT00100048|21095412|P2|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2
6117912|NCT00100048|21095413|P1|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|1
6117913|NCT00100048|21095408|P6|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3
6117914|NCT00100048|21095409|P5|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|0
6117915|NCT00100048|21095410|P4|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2
6117916|NCT00100048|21095411|P3|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3
6117917|NCT00100048|21095412|P2|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|1
6117918|NCT00100048|21095413|P1|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2
6117919|NCT00100048|21095408|P6|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|2
6117920|NCT00100048|21095409|P5|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0
6117921|NCT00100048|21095410|P4|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0
6117922|NCT00100048|21095411|P3|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0
6117923|NCT00100048|21095412|P2|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|3
6117924|NCT00100048|21095413|P1|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|1
6117925|NCT00100048|21095408|P6|Cohort I & II-Combination Therapy Phase|Adverse Event|1
6117926|NCT00100048|21095409|P5|Cohort I & II-Combination Therapy Phase|Adverse Event|0
6117927|NCT00100048|21095410|P4|Cohort I & II-Combination Therapy Phase|Adverse Event|0
6117928|NCT00100048|21095411|P3|Cohort I & II-Combination Therapy Phase|Adverse Event|2
6117929|NCT00100048|21095412|P2|Cohort I & II-Combination Therapy Phase|Adverse Event|1
6117930|NCT00100048|21095413|P1|Cohort I & II-Combination Therapy Phase|Adverse Event|0
6117931|NCT00100048|21095408|P6|Cohort I & II-Combination Therapy Phase|Never Treated|1
6117932|NCT00100048|21095409|P5|Cohort I & II-Combination Therapy Phase|Never Treated|0
6117933|NCT00100048|21095410|P4|Cohort I & II-Combination Therapy Phase|Never Treated|0
6117934|NCT00100048|21095411|P3|Cohort I & II-Combination Therapy Phase|Never Treated|0
6117935|NCT00100048|21095412|P2|Cohort I & II-Combination Therapy Phase|Never Treated|0
6117936|NCT00100048|21095413|P1|Cohort I & II-Combination Therapy Phase|Never Treated|2
6117937|NCT00099983|21095522|P2|Overall Study|Other issue|0
6117938|NCT00099983|21095523|P1|Overall Study|Other issue|1
6117939|NCT00099983|21095522|P2|Overall Study|Intolerant of burden of visits|1
6117940|NCT00099983|21095523|P1|Overall Study|Intolerant of burden of visits|0
6117941|NCT00099983|21095522|P2|Overall Study|Incarcerated|1
6117942|NCT00099983|21095523|P1|Overall Study|Incarcerated|0
6117943|NCT00099983|21095522|P2|Overall Study|Other psychiatric problem|0
6117944|NCT00099983|21095523|P1|Overall Study|Other psychiatric problem|1
6117945|NCT00099983|21095522|P2|Overall Study|Moved|0
6117946|NCT00099983|21095523|P1|Overall Study|Moved|1
6117947|NCT00099983|21095522|P2|Overall Study|Unable to return for appointments|1
6117948|NCT00099983|21095523|P1|Overall Study|Unable to return for appointments|1
6117949|NCT00099983|21095522|P2|Overall Study|Lack of Efficacy|1
6117950|NCT00099983|21095523|P1|Overall Study|Lack of Efficacy|0
6117951|NCT00099983|21095522|P2|Overall Study|Adverse Event|1
6117952|NCT00099983|21095523|P1|Overall Study|Adverse Event|1
6117953|NCT00099983|21095522|P2|Overall Study|Withdrawal by Subject|2
6117954|NCT00099983|21095523|P1|Overall Study|Withdrawal by Subject|3
6117955|NCT00099983|21095522|P2|Overall Study|Missing Source Documents|15
6117956|NCT00099983|21095523|P1|Overall Study|Missing Source Documents|14
6117957|NCT00099983|21095522|P2|Overall Study|Lost to Follow-up|3
6117958|NCT00099983|21095523|P1|Overall Study|Lost to Follow-up|2
6117959|NCT00099632|21095535|P6|Overall Study|Protocol Violation|1
6117960|NCT00099632|21095536|P5|Overall Study|Protocol Violation|0
6117961|NCT00099632|21095537|P4|Overall Study|Protocol Violation|0
6117962|NCT00099632|21095538|P3|Overall Study|Protocol Violation|0
6117963|NCT00099632|21095539|P2|Overall Study|Protocol Violation|0
6117964|NCT00099632|21095540|P1|Overall Study|Protocol Violation|0
6117965|NCT00099632|21095535|P6|Overall Study|Withdrawal by Subject|1
6117966|NCT00099632|21095536|P5|Overall Study|Withdrawal by Subject|0
6117967|NCT00099632|21095537|P4|Overall Study|Withdrawal by Subject|0
6117968|NCT00099632|21095538|P3|Overall Study|Withdrawal by Subject|0
6117969|NCT00099632|21095539|P2|Overall Study|Withdrawal by Subject|1
6117970|NCT00099632|21095540|P1|Overall Study|Withdrawal by Subject|0
6117971|NCT00099632|21095535|P6|Overall Study|Lost to Follow-up|0
6117972|NCT00099632|21095536|P5|Overall Study|Lost to Follow-up|1
6117973|NCT00099632|21095537|P4|Overall Study|Lost to Follow-up|1
6117974|NCT00099632|21095538|P3|Overall Study|Lost to Follow-up|3
6117975|NCT00099632|21095539|P2|Overall Study|Lost to Follow-up|0
6117976|NCT00099632|21095540|P1|Overall Study|Lost to Follow-up|1
6117977|NCT00099437|21095580|P2|Overall Study|Ongoing in FU but not on treatment|45
6117978|NCT00099437|21095581|P1|Overall Study|Ongoing in FU but not on treatment|37
6117979|NCT00099437|21095580|P2|Overall Study|Withdrawal by Subject|10
6117980|NCT00099437|21095581|P1|Overall Study|Withdrawal by Subject|6
6117981|NCT00099437|21095580|P2|Overall Study|Death|261
6117982|NCT00099437|21095581|P1|Overall Study|Death|293
6117983|NCT00099437|21095580|P2|Overall Study|Lost to Follow-up|33
6117984|NCT00099437|21095581|P1|Overall Study|Lost to Follow-up|30
6117985|NCT00099359|21095604|P3|Overall Study|moved out of area|4
6117986|NCT00099359|21095605|P2|Overall Study|moved out of area|7
6117987|NCT00099359|21095606|P1|Overall Study|moved out of area|9
6117988|NCT00099359|21095604|P3|Overall Study|Lost to Follow-up|24
6117989|NCT00099359|21095605|P2|Overall Study|Lost to Follow-up|24
6117990|NCT00099359|21095606|P1|Overall Study|Lost to Follow-up|15
6117991|NCT00099359|21095604|P3|Overall Study|Withdrawal by Subject|23
6117992|NCT00099359|21095605|P2|Overall Study|Withdrawal by Subject|19
6117993|NCT00099359|21095606|P1|Overall Study|Withdrawal by Subject|19
6117994|NCT00099359|21095604|P3|Overall Study|Death|17
6117995|NCT00099359|21095605|P2|Overall Study|Death|15
6117996|NCT00099359|21095606|P1|Overall Study|Death|11
6117997|NCT00099268|21095629|P2|Overall Study|Death|1
6117998|NCT00099268|21095630|P1|Overall Study|Death|3
6117999|NCT00099268|21095629|P2|Overall Study|Administrative problems|4
6118000|NCT00099268|21095630|P1|Overall Study|Administrative problems|4
6118001|NCT00099268|21095629|P2|Overall Study|Lack of Efficacy|18
6118002|NCT00099268|21095630|P1|Overall Study|Lack of Efficacy|5
6118003|NCT00099268|21095629|P2|Overall Study|Lost to Follow-up|4
6118004|NCT00099268|21095630|P1|Overall Study|Lost to Follow-up|6
6118005|NCT00099268|21095629|P2|Overall Study|Protocol Violation|8
6118006|NCT00099268|21095630|P1|Overall Study|Protocol Violation|9
6118007|NCT00099268|21095629|P2|Overall Study|Adverse Event|19
6118008|NCT00099268|21095630|P1|Overall Study|Adverse Event|19
6118009|NCT00099268|21095629|P2|Overall Study|Withdrawal by Subject|28
6118010|NCT00099268|21095630|P1|Overall Study|Withdrawal by Subject|46
6118011|NCT00098865|21095670|P1|Overall Study|Alternative Therapy|1
6118012|NCT00098865|21095670|P1|Overall Study|Adverse Event|2
6118013|NCT00098865|21095670|P1|Overall Study|Progressive Disease|6
6118014|NCT00098839|21095678|P2|Overall Study|Ineligible|0
6118015|NCT00098839|21095679|P1|Overall Study|Ineligible|2
6118016|NCT00098839|21095678|P2|Overall Study|M2/M3 marrow on Day 15 of Block 2|11
6118017|NCT00098839|21095679|P1|Overall Study|M2/M3 marrow on Day 15 of Block 2|10
6118018|NCT00098839|21095678|P2|Overall Study|Relapse|3
6118019|NCT00098839|21095679|P1|Overall Study|Relapse|6
6118020|NCT00098839|21095678|P2|Overall Study|Refusal of further protocol therapy|1
6118021|NCT00098839|21095679|P1|Overall Study|Refusal of further protocol therapy|3
6118022|NCT00098839|21095678|P2|Overall Study|Withdrawal by Subject|0
6118023|NCT00098839|21095679|P1|Overall Study|Withdrawal by Subject|1
6118024|NCT00098839|21095678|P2|Overall Study|Physician Decision|14
6118025|NCT00098839|21095679|P1|Overall Study|Physician Decision|4
6118026|NCT00098839|21095678|P2|Overall Study|Death|2
6118027|NCT00098839|21095679|P1|Overall Study|Death|1
6118028|NCT00098839|21095678|P2|Overall Study|Adverse Event|2
6118029|NCT00098839|21095679|P1|Overall Study|Adverse Event|5
6118030|NCT00098813|21095690|P1|Overall Study|Reversal of RAI resistance|1
6118031|NCT00098813|21095690|P1|Overall Study|Other complicating disease|1
6118032|NCT00098813|21095690|P1|Overall Study|Progression of Disease|1
6118033|NCT00098813|21095690|P1|Overall Study|Withdrawal by Subject|7
6118034|NCT00098813|21095690|P1|Overall Study|Protocol Violation|1
6118035|NCT00098813|21095690|P1|Overall Study|Death|8
6118036|NCT00098787|21095697|P3|Overall Study|Other|9
6118037|NCT00098787|21095698|P2|Overall Study|Other|6
6118038|NCT00098787|21095699|P1|Overall Study|Other|7
6118039|NCT00098787|21095697|P3|Overall Study|Alternative therapy|13
6118040|NCT00098787|21095698|P2|Overall Study|Alternative therapy|13
6118041|NCT00098787|21095699|P1|Overall Study|Alternative therapy|8
6118042|NCT00098787|21095697|P3|Overall Study|Withdrawal by Subject|6
6118043|NCT00098787|21095698|P2|Overall Study|Withdrawal by Subject|12
6118044|NCT00098787|21095699|P1|Overall Study|Withdrawal by Subject|4
6118045|NCT00098787|21095697|P3|Overall Study|Death|0
6118046|NCT00098787|21095698|P2|Overall Study|Death|1
6118047|NCT00098787|21095699|P1|Overall Study|Death|6
6118048|NCT00098787|21095697|P3|Overall Study|Adverse Event|8
6118049|NCT00098787|21095698|P2|Overall Study|Adverse Event|17
6118050|NCT00098787|21095699|P1|Overall Study|Adverse Event|8
6118051|NCT00098787|21095697|P3|Overall Study|Disease progression|23
6118052|NCT00098787|21095698|P2|Overall Study|Disease progression|17
6118053|NCT00098787|21095699|P1|Overall Study|Disease progression|28
6118054|NCT00098787|21095697|P3|Overall Study|Ineligible|3
6118055|NCT00098787|21095698|P2|Overall Study|Ineligible|7
6118056|NCT00098787|21095699|P1|Overall Study|Ineligible|9
6118057|NCT00098787|21095697|P3|Overall Study|Never started treatment|1
6118058|NCT00098787|21095698|P2|Overall Study|Never started treatment|2
6118059|NCT00098787|21095699|P1|Overall Study|Never started treatment|3
6118060|NCT00098774|21095713|P1|Overall Study|Physician Decision|2
6118061|NCT00098774|21095713|P1|Overall Study|Failed (to respond) during induction|4
6118062|NCT00098774|21095713|P1|Overall Study|Withdrawal by Subject|1
6118063|NCT00098774|21095713|P1|Overall Study|Disease Progression|9
6118064|NCT00098774|21095713|P1|Overall Study|Adverse Event|2
6118065|NCT00098748|21095723|P3|Continued on Open-Label Treatment|Withdrawal by Subject|0
6118066|NCT00098748|21095724|P2|Continued on Open-Label Treatment|Withdrawal by Subject|4
6118067|NCT00098748|21095725|P1|Continued on Open-Label Treatment|Withdrawal by Subject|0
6118068|NCT00098748|21095723|P3|Continued on Open-Label Treatment|Lost to Follow-up|0
6118069|NCT00098748|21095724|P2|Continued on Open-Label Treatment|Lost to Follow-up|1
6118070|NCT00098748|21095725|P1|Continued on Open-Label Treatment|Lost to Follow-up|1
6118071|NCT00098748|21095723|P3|Continued on Open-Label Treatment|Other reason includes protocol violation|0
6118072|NCT00098748|21095724|P2|Continued on Open-Label Treatment|Other reason includes protocol violation|7
6118073|NCT00098748|21095725|P1|Continued on Open-Label Treatment|Other reason includes protocol violation|6
6118074|NCT00098748|21095723|P3|Continued on Open-Label Treatment|Lack of Efficacy|0
6118075|NCT00098748|21095724|P2|Continued on Open-Label Treatment|Lack of Efficacy|2
6118076|NCT00098748|21095725|P1|Continued on Open-Label Treatment|Lack of Efficacy|1
6118077|NCT00098748|21095723|P3|Continued on Open-Label Treatment|Adverse Event|0
6118078|NCT00098748|21095724|P2|Continued on Open-Label Treatment|Adverse Event|1
6118079|NCT00098748|21095725|P1|Continued on Open-Label Treatment|Adverse Event|0
6118080|NCT00098748|21095723|P3|Received Study Treatment|Subject defaulted|4
6118081|NCT00098748|21095724|P2|Received Study Treatment|Subject defaulted|4
6118082|NCT00098748|21095725|P1|Received Study Treatment|Subject defaulted|3
6118083|NCT00098748|21095723|P3|Received Study Treatment|Other|6
6118084|NCT00098748|21095724|P2|Received Study Treatment|Other|2
6118085|NCT00098748|21095725|P1|Received Study Treatment|Other|2
6118086|NCT00098748|21095723|P3|Received Study Treatment|Lack of Efficacy|27
6118087|NCT00098748|21095724|P2|Received Study Treatment|Lack of Efficacy|27
6118088|NCT00098748|21095725|P1|Received Study Treatment|Lack of Efficacy|40
6118089|NCT00098748|21095723|P3|Received Study Treatment|Adverse Event|5
6118090|NCT00098748|21095724|P2|Received Study Treatment|Adverse Event|2
6118091|NCT00098748|21095725|P1|Received Study Treatment|Adverse Event|1
6118092|NCT00098748|21095723|P3|Received Study Treatment|Death|2
6118093|NCT00098748|21095724|P2|Received Study Treatment|Death|1
6118094|NCT00098748|21095725|P1|Received Study Treatment|Death|2
6118095|NCT00098748|21095723|P3|Assigned to Study Treatment|Randomized, but not treated|2
6118096|NCT00098748|21095724|P2|Assigned to Study Treatment|Randomized, but not treated|2
6118097|NCT00098748|21095725|P1|Assigned to Study Treatment|Randomized, but not treated|0
6118098|NCT00098722|21095781|P7|Observation Phase|Other|10
6118099|NCT00098722|21095782|P6|Observation Phase|Other|21
6118100|NCT00098722|21095783|P5|Observation Phase|Other|0
6118101|NCT00098722|21095784|P4|Observation Phase|Other|0
6118102|NCT00098722|21095785|P3|Observation Phase|Other|0
6118103|NCT00098722|21095786|P2|Observation Phase|Other|0
6118104|NCT00098722|21095787|P1|Observation Phase|Other|0
6118105|NCT00098722|21095781|P7|Observation Phase|Participant defaulted|4
6118106|NCT00098722|21095782|P6|Observation Phase|Participant defaulted|17
6118107|NCT00098722|21095783|P5|Observation Phase|Participant defaulted|0
6118108|NCT00098722|21095784|P4|Observation Phase|Participant defaulted|0
6118109|NCT00098722|21095785|P3|Observation Phase|Participant defaulted|0
6118110|NCT00098722|21095786|P2|Observation Phase|Participant defaulted|0
6118111|NCT00098722|21095787|P1|Observation Phase|Participant defaulted|0
6118112|NCT00098722|21095781|P7|Observation Phase|Lack of Efficacy|0
6118113|NCT00098722|21095782|P6|Observation Phase|Lack of Efficacy|2
6118114|NCT00098722|21095783|P5|Observation Phase|Lack of Efficacy|0
6118115|NCT00098722|21095784|P4|Observation Phase|Lack of Efficacy|0
6118116|NCT00098722|21095785|P3|Observation Phase|Lack of Efficacy|0
6118117|NCT00098722|21095786|P2|Observation Phase|Lack of Efficacy|0
6118118|NCT00098722|21095787|P1|Observation Phase|Lack of Efficacy|0
6118119|NCT00098722|21095781|P7|Observation Phase|Death|3
6118120|NCT00098722|21095782|P6|Observation Phase|Death|5
6118121|NCT00098722|21095783|P5|Observation Phase|Death|0
6118122|NCT00098722|21095784|P4|Observation Phase|Death|0
6118123|NCT00098722|21095785|P3|Observation Phase|Death|0
6118124|NCT00098722|21095786|P2|Observation Phase|Death|0
6118125|NCT00098722|21095787|P1|Observation Phase|Death|0
6118126|NCT00098722|21095781|P7|Open Label Phase|Other|0
6118127|NCT00098722|21095782|P6|Open Label Phase|Other|0
6118128|NCT00098722|21095783|P5|Open Label Phase|Other|0
6118129|NCT00098722|21095784|P4|Open Label Phase|Other|18
6118130|NCT00098722|21095785|P3|Open Label Phase|Other|0
6118131|NCT00098722|21095786|P2|Open Label Phase|Other|0
6118132|NCT00098722|21095787|P1|Open Label Phase|Other|0
6118133|NCT00098722|21095781|P7|Open Label Phase|Ongoing at cut-off date|0
6118134|NCT00098722|21095782|P6|Open Label Phase|Ongoing at cut-off date|0
6118135|NCT00098722|21095783|P5|Open Label Phase|Ongoing at cut-off date|50
6118136|NCT00098722|21095784|P4|Open Label Phase|Ongoing at cut-off date|220
6118137|NCT00098722|21095785|P3|Open Label Phase|Ongoing at cut-off date|0
6118138|NCT00098722|21095786|P2|Open Label Phase|Ongoing at cut-off date|0
6118139|NCT00098722|21095787|P1|Open Label Phase|Ongoing at cut-off date|0
6118140|NCT00098722|21095781|P7|Open Label Phase|Participant defaulted|0
6118141|NCT00098722|21095782|P6|Open Label Phase|Participant defaulted|0
6118142|NCT00098722|21095783|P5|Open Label Phase|Participant defaulted|0
6118143|NCT00098722|21095784|P4|Open Label Phase|Participant defaulted|18
6118144|NCT00098722|21095785|P3|Open Label Phase|Participant defaulted|0
6118145|NCT00098722|21095786|P2|Open Label Phase|Participant defaulted|0
6118146|NCT00098722|21095787|P1|Open Label Phase|Participant defaulted|0
6118147|NCT00098722|21095781|P7|Open Label Phase|Pregnancy|0
6118148|NCT00098722|21095782|P6|Open Label Phase|Pregnancy|0
6118149|NCT00098722|21095783|P5|Open Label Phase|Pregnancy|0
6118150|NCT00098722|21095784|P4|Open Label Phase|Pregnancy|1
6118151|NCT00098722|21095785|P3|Open Label Phase|Pregnancy|0
6118152|NCT00098722|21095786|P2|Open Label Phase|Pregnancy|0
6118153|NCT00098722|21095787|P1|Open Label Phase|Pregnancy|0
6118154|NCT00098722|21095781|P7|Open Label Phase|Lack of Efficacy|0
6118155|NCT00098722|21095782|P6|Open Label Phase|Lack of Efficacy|0
6118156|NCT00098722|21095783|P5|Open Label Phase|Lack of Efficacy|0
6118157|NCT00098722|21095784|P4|Open Label Phase|Lack of Efficacy|8
6118158|NCT00098722|21095785|P3|Open Label Phase|Lack of Efficacy|0
6118159|NCT00098722|21095786|P2|Open Label Phase|Lack of Efficacy|0
6118160|NCT00098722|21095787|P1|Open Label Phase|Lack of Efficacy|0
6118161|NCT00098722|21095781|P7|Open Label Phase|Death|0
6118162|NCT00098722|21095782|P6|Open Label Phase|Death|0
6118163|NCT00098722|21095783|P5|Open Label Phase|Death|0
6118164|NCT00098722|21095784|P4|Open Label Phase|Death|2
6118165|NCT00098722|21095785|P3|Open Label Phase|Death|0
6118166|NCT00098722|21095786|P2|Open Label Phase|Death|0
6118167|NCT00098722|21095787|P1|Open Label Phase|Death|0
6118168|NCT00098722|21095781|P7|Open Label Phase|Adverse Event|0
6118169|NCT00098722|21095782|P6|Open Label Phase|Adverse Event|0
6118170|NCT00098722|21095783|P5|Open Label Phase|Adverse Event|0
6118171|NCT00098722|21095784|P4|Open Label Phase|Adverse Event|5
6118172|NCT00098722|21095785|P3|Open Label Phase|Adverse Event|0
6118173|NCT00098722|21095786|P2|Open Label Phase|Adverse Event|0
6118174|NCT00098722|21095787|P1|Open Label Phase|Adverse Event|0
6118175|NCT00098722|21095781|P7|Double Blind Phase|Other|0
6118176|NCT00098722|21095782|P6|Double Blind Phase|Other|0
6118177|NCT00098722|21095783|P5|Double Blind Phase|Other|0
6118178|NCT00098722|21095784|P4|Double Blind Phase|Other|0
6118179|NCT00098722|21095785|P3|Double Blind Phase|Other|7
6118180|NCT00098722|21095786|P2|Double Blind Phase|Other|8
6118181|NCT00098722|21095787|P1|Double Blind Phase|Other|7
6118182|NCT00098722|21095781|P7|Double Blind Phase|Ongoing at cut-off date|0
6118183|NCT00098722|21095782|P6|Double Blind Phase|Ongoing at cut-off date|0
6118184|NCT00098722|21095783|P5|Double Blind Phase|Ongoing at cut-off date|0
6118185|NCT00098722|21095784|P4|Double Blind Phase|Ongoing at cut-off date|0
6118186|NCT00098722|21095785|P3|Double Blind Phase|Ongoing at cut-off date|57
6118187|NCT00098722|21095786|P2|Double Blind Phase|Ongoing at cut-off date|137
6118188|NCT00098722|21095787|P1|Double Blind Phase|Ongoing at cut-off date|128
6118189|NCT00098722|21095781|P7|Double Blind Phase|Randomized, not treated|0
6118190|NCT00098722|21095782|P6|Double Blind Phase|Randomized, not treated|0
6118191|NCT00098722|21095783|P5|Double Blind Phase|Randomized, not treated|0
6118192|NCT00098722|21095784|P4|Double Blind Phase|Randomized, not treated|0
6118193|NCT00098722|21095785|P3|Double Blind Phase|Randomized, not treated|3
6118194|NCT00098722|21095786|P2|Double Blind Phase|Randomized, not treated|3
6118195|NCT00098722|21095787|P1|Double Blind Phase|Randomized, not treated|4
6118196|NCT00098722|21095781|P7|Double Blind Phase|Pregnancy|0
6118197|NCT00098722|21095782|P6|Double Blind Phase|Pregnancy|0
6118198|NCT00098722|21095783|P5|Double Blind Phase|Pregnancy|0
6118199|NCT00098722|21095784|P4|Double Blind Phase|Pregnancy|0
6118200|NCT00098722|21095785|P3|Double Blind Phase|Pregnancy|0
6118201|NCT00098722|21095786|P2|Double Blind Phase|Pregnancy|0
6118202|NCT00098722|21095787|P1|Double Blind Phase|Pregnancy|1
6118203|NCT00098722|21095781|P7|Double Blind Phase|Participant defaulted|0
6118204|NCT00098722|21095782|P6|Double Blind Phase|Participant defaulted|0
6118205|NCT00098722|21095783|P5|Double Blind Phase|Participant defaulted|0
6118206|NCT00098722|21095784|P4|Double Blind Phase|Participant defaulted|0
6118207|NCT00098722|21095785|P3|Double Blind Phase|Participant defaulted|9
6118208|NCT00098722|21095786|P2|Double Blind Phase|Participant defaulted|11
6118209|NCT00098722|21095787|P1|Double Blind Phase|Participant defaulted|16
6118210|NCT00098722|21095781|P7|Double Blind Phase|Lack of Efficacy|0
6118211|NCT00098722|21095782|P6|Double Blind Phase|Lack of Efficacy|0
6118212|NCT00098722|21095783|P5|Double Blind Phase|Lack of Efficacy|0
6118213|NCT00098722|21095784|P4|Double Blind Phase|Lack of Efficacy|0
6118214|NCT00098722|21095785|P3|Double Blind Phase|Lack of Efficacy|15
6118215|NCT00098722|21095786|P2|Double Blind Phase|Lack of Efficacy|23
6118216|NCT00098722|21095787|P1|Double Blind Phase|Lack of Efficacy|21
6118217|NCT00098722|21095781|P7|Double Blind Phase|Death|0
6118218|NCT00098722|21095782|P6|Double Blind Phase|Death|0
6118219|NCT00098722|21095783|P5|Double Blind Phase|Death|0
6118220|NCT00098722|21095784|P4|Double Blind Phase|Death|0
6118221|NCT00098722|21095785|P3|Double Blind Phase|Death|0
6118222|NCT00098722|21095786|P2|Double Blind Phase|Death|5
6118223|NCT00098722|21095787|P1|Double Blind Phase|Death|2
6118224|NCT00098722|21095781|P7|Double Blind Phase|Adverse Event|0
6118225|NCT00098722|21095782|P6|Double Blind Phase|Adverse Event|0
6118226|NCT00098722|21095783|P5|Double Blind Phase|Adverse Event|0
6118227|NCT00098722|21095784|P4|Double Blind Phase|Adverse Event|0
6118228|NCT00098722|21095785|P3|Double Blind Phase|Adverse Event|3
6118229|NCT00098722|21095786|P2|Double Blind Phase|Adverse Event|7
6118230|NCT00098722|21095787|P1|Double Blind Phase|Adverse Event|7
6118231|NCT00098475|21095861|P4|Step 2|Never started treatment|0
6118232|NCT00098475|21095862|P3|Step 2|Never started treatment|0
6118233|NCT00098475|21095863|P2|Step 2|Never started treatment|1
6118234|NCT00098475|21095864|P1|Step 2|Never started treatment|1
6118235|NCT00098475|21095861|P4|Step 2|Alternative therapy|0
6118236|NCT00098475|21095862|P3|Step 2|Alternative therapy|0
6118237|NCT00098475|21095863|P2|Step 2|Alternative therapy|2
6118238|NCT00098475|21095864|P1|Step 2|Alternative therapy|1
6118239|NCT00098475|21095861|P4|Step 2|Physician Decision|0
6118240|NCT00098475|21095862|P3|Step 2|Physician Decision|0
6118241|NCT00098475|21095863|P2|Step 2|Physician Decision|1
6118242|NCT00098475|21095864|P1|Step 2|Physician Decision|0
6118243|NCT00098475|21095861|P4|Step 2|Withdrawal by Subject|0
6118244|NCT00098475|21095862|P3|Step 2|Withdrawal by Subject|0
6118245|NCT00098475|21095863|P2|Step 2|Withdrawal by Subject|2
6118246|NCT00098475|21095864|P1|Step 2|Withdrawal by Subject|0
6118247|NCT00098475|21095861|P4|Step 2|Adverse Event|0
6118248|NCT00098475|21095862|P3|Step 2|Adverse Event|0
6118249|NCT00098475|21095863|P2|Step 2|Adverse Event|0
6118250|NCT00098475|21095864|P1|Step 2|Adverse Event|2
6118251|NCT00098475|21095861|P4|Step 2|Disease progression|0
6118252|NCT00098475|21095862|P3|Step 2|Disease progression|0
6118253|NCT00098475|21095863|P2|Step 2|Disease progression|4
6118254|NCT00098475|21095864|P1|Step 2|Disease progression|1
6118255|NCT00098475|21095861|P4|Step 1|Not documented|0
6118256|NCT00098475|21095862|P3|Step 1|Not documented|0
6118257|NCT00098475|21095863|P2|Step 1|Not documented|1
6118258|NCT00098475|21095864|P1|Step 1|Not documented|0
6118259|NCT00098475|21095861|P4|Step 1|Patient fell with fracture|0
6118260|NCT00098475|21095862|P3|Step 1|Patient fell with fracture|0
6118261|NCT00098475|21095863|P2|Step 1|Patient fell with fracture|0
6118262|NCT00098475|21095864|P1|Step 1|Patient fell with fracture|1
6118263|NCT00098475|21095861|P4|Step 1|Misinterpretation of lab data|0
6118264|NCT00098475|21095862|P3|Step 1|Misinterpretation of lab data|0
6118265|NCT00098475|21095863|P2|Step 1|Misinterpretation of lab data|1
6118266|NCT00098475|21095864|P1|Step 1|Misinterpretation of lab data|0
6118267|NCT00098475|21095861|P4|Step 1|Criteria to continue treatment not met|0
6118268|NCT00098475|21095862|P3|Step 1|Criteria to continue treatment not met|0
6118269|NCT00098475|21095863|P2|Step 1|Criteria to continue treatment not met|1
6118270|NCT00098475|21095864|P1|Step 1|Criteria to continue treatment not met|0
6118271|NCT00098475|21095861|P4|Step 1|Referred to other physicians|0
6118272|NCT00098475|21095862|P3|Step 1|Referred to other physicians|0
6118273|NCT00098475|21095863|P2|Step 1|Referred to other physicians|1
6118274|NCT00098475|21095864|P1|Step 1|Referred to other physicians|0
6118275|NCT00098475|21095861|P4|Step 1|Rising paraprotein|0
6118276|NCT00098475|21095862|P3|Step 1|Rising paraprotein|0
6118277|NCT00098475|21095863|P2|Step 1|Rising paraprotein|1
6118278|NCT00098475|21095864|P1|Step 1|Rising paraprotein|0
6118279|NCT00098475|21095861|P4|Step 1|Insurance issue|0
6118280|NCT00098475|21095862|P3|Step 1|Insurance issue|0
6118281|NCT00098475|21095863|P2|Step 1|Insurance issue|1
6118282|NCT00098475|21095864|P1|Step 1|Insurance issue|0
6118283|NCT00098475|21095861|P4|Step 1|Declining performance status|0
6118284|NCT00098475|21095862|P3|Step 1|Declining performance status|0
6118285|NCT00098475|21095863|P2|Step 1|Declining performance status|1
6118286|NCT00098475|21095864|P1|Step 1|Declining performance status|0
6118287|NCT00098475|21095861|P4|Step 1|Off treatment for > specified timeframe|0
6118288|NCT00098475|21095862|P3|Step 1|Off treatment for > specified timeframe|0
6118289|NCT00098475|21095863|P2|Step 1|Off treatment for > specified timeframe|1
6118290|NCT00098475|21095864|P1|Step 1|Off treatment for > specified timeframe|1
6118291|NCT00098475|21095861|P4|Step 1|Incorrect disease assessment|0
6118292|NCT00098475|21095862|P3|Step 1|Incorrect disease assessment|0
6118293|NCT00098475|21095863|P2|Step 1|Incorrect disease assessment|0
6118294|NCT00098475|21095864|P1|Step 1|Incorrect disease assessment|2
6118295|NCT00098475|21095861|P4|Step 1|Both patient and physician's decision|0
6118296|NCT00098475|21095862|P3|Step 1|Both patient and physician's decision|0
6118297|NCT00098475|21095863|P2|Step 1|Both patient and physician's decision|1
6118298|NCT00098475|21095864|P1|Step 1|Both patient and physician's decision|2
6118299|NCT00098475|21095861|P4|Step 1|Cannot comply due to other tx|0
6118300|NCT00098475|21095862|P3|Step 1|Cannot comply due to other tx|0
6118301|NCT00098475|21095863|P2|Step 1|Cannot comply due to other tx|1
6118302|NCT00098475|21095864|P1|Step 1|Cannot comply due to other tx|0
6118303|NCT00098475|21095861|P4|Step 1|Complications|0
6118304|NCT00098475|21095862|P3|Step 1|Complications|0
6118305|NCT00098475|21095863|P2|Step 1|Complications|0
6118306|NCT00098475|21095864|P1|Step 1|Complications|1
6118307|NCT00098475|21095861|P4|Step 1|Knee surgery|0
6118308|NCT00098475|21095862|P3|Step 1|Knee surgery|0
6118309|NCT00098475|21095863|P2|Step 1|Knee surgery|0
6118310|NCT00098475|21095864|P1|Step 1|Knee surgery|1
6118311|NCT00098475|21095861|P4|Step 1|Still on treatment as of this analysis|0
6118312|NCT00098475|21095862|P3|Step 1|Still on treatment as of this analysis|0
6118313|NCT00098475|21095863|P2|Step 1|Still on treatment as of this analysis|27
6118314|NCT00098475|21095864|P1|Step 1|Still on treatment as of this analysis|14
6118315|NCT00098475|21095861|P4|Step 1|Never started treatment|0
6118316|NCT00098475|21095862|P3|Step 1|Never started treatment|0
6118317|NCT00098475|21095863|P2|Step 1|Never started treatment|2
6118318|NCT00098475|21095864|P1|Step 1|Never started treatment|0
6118319|NCT00098475|21095861|P4|Step 1|Other disease|0
6118320|NCT00098475|21095862|P3|Step 1|Other disease|1
6118321|NCT00098475|21095863|P2|Step 1|Other disease|1
6118322|NCT00098475|21095864|P1|Step 1|Other disease|2
6118323|NCT00098475|21095861|P4|Step 1|Alternative therapy|0
6118324|NCT00098475|21095862|P3|Step 1|Alternative therapy|1
6118325|NCT00098475|21095863|P2|Step 1|Alternative therapy|43
6118326|NCT00098475|21095864|P1|Step 1|Alternative therapy|31
6118327|NCT00098475|21095861|P4|Step 1|Physician Decision|0
6118328|NCT00098475|21095862|P3|Step 1|Physician Decision|0
6118329|NCT00098475|21095863|P2|Step 1|Physician Decision|2
6118330|NCT00098475|21095864|P1|Step 1|Physician Decision|5
6118331|NCT00098475|21095861|P4|Step 1|Withdrawal by Subject|0
6118332|NCT00098475|21095862|P3|Step 1|Withdrawal by Subject|0
6118333|NCT00098475|21095863|P2|Step 1|Withdrawal by Subject|11
6118334|NCT00098475|21095864|P1|Step 1|Withdrawal by Subject|14
6118335|NCT00098475|21095861|P4|Step 1|Death|1
6118336|NCT00098475|21095862|P3|Step 1|Death|0
6118337|NCT00098475|21095863|P2|Step 1|Death|5
6118338|NCT00098475|21095864|P1|Step 1|Death|8
6118339|NCT00098475|21095861|P4|Step 1|Adverse Event|1
6118340|NCT00098475|21095862|P3|Step 1|Adverse Event|0
6118341|NCT00098475|21095863|P2|Step 1|Adverse Event|37
6118342|NCT00098475|21095864|P1|Step 1|Adverse Event|56
6118343|NCT00098475|21095861|P4|Step 1|Progressive disease|1
6118344|NCT00098475|21095862|P3|Step 1|Progressive disease|2
6118345|NCT00098475|21095863|P2|Step 1|Progressive disease|35
6118346|NCT00098475|21095864|P1|Step 1|Progressive disease|33
6118347|NCT00098345|21095901|P1|Overall Study|progression|4
6118348|NCT00098345|21095901|P1|Overall Study|Withdrawal by Subject|2
6118349|NCT00098345|21095901|P1|Overall Study|Adverse Event|7
6118350|NCT00098306|21095914|P7|Observational Phase|Un-specified|4
6118351|NCT00098306|21095915|P6|Observational Phase|Un-specified|7
6118352|NCT00098306|21095916|P5|Observational Phase|Un-specified|0
6118353|NCT00098306|21095917|P4|Observational Phase|Un-specified|0
6118354|NCT00098306|21095918|P3|Observational Phase|Un-specified|0
6118355|NCT00098306|21095919|P2|Observational Phase|Un-specified|0
6118356|NCT00098306|21095920|P1|Observational Phase|Un-specified|0
6118357|NCT00098306|21095914|P7|Observational Phase|Participant defaulted|18
6118358|NCT00098306|21095915|P6|Observational Phase|Participant defaulted|34
6118359|NCT00098306|21095916|P5|Observational Phase|Participant defaulted|0
6118360|NCT00098306|21095917|P4|Observational Phase|Participant defaulted|0
6118361|NCT00098306|21095918|P3|Observational Phase|Participant defaulted|0
6118362|NCT00098306|21095919|P2|Observational Phase|Participant defaulted|0
6118363|NCT00098306|21095920|P1|Observational Phase|Participant defaulted|0
6118364|NCT00098306|21095914|P7|Observational Phase|Death|4
6118365|NCT00098306|21095915|P6|Observational Phase|Death|5
6118366|NCT00098306|21095916|P5|Observational Phase|Death|0
6118367|NCT00098306|21095917|P4|Observational Phase|Death|0
6118368|NCT00098306|21095918|P3|Observational Phase|Death|0
6118369|NCT00098306|21095919|P2|Observational Phase|Death|0
6118370|NCT00098306|21095920|P1|Observational Phase|Death|0
6118371|NCT00098306|21095914|P7|Open Label|Ongoing at cut-off date|0
6118372|NCT00098306|21095915|P6|Open Label|Ongoing at cut-off date|0
6118373|NCT00098306|21095916|P5|Open Label|Ongoing at cut-off date|62
6118374|NCT00098306|21095917|P4|Open Label|Ongoing at cut-off date|269
6118375|NCT00098306|21095918|P3|Open Label|Ongoing at cut-off date|0
6118376|NCT00098306|21095919|P2|Open Label|Ongoing at cut-off date|0
6118377|NCT00098306|21095920|P1|Open Label|Ongoing at cut-off date|0
6118378|NCT00098306|21095914|P7|Open Label|Un-specified|0
6118379|NCT00098306|21095915|P6|Open Label|Un-specified|0
6118380|NCT00098306|21095916|P5|Open Label|Un-specified|0
6118381|NCT00098306|21095917|P4|Open Label|Un-specified|15
6118382|NCT00098306|21095918|P3|Open Label|Un-specified|0
6118383|NCT00098306|21095919|P2|Open Label|Un-specified|0
6118384|NCT00098306|21095920|P1|Open Label|Un-specified|0
6118385|NCT00098306|21095914|P7|Open Label|Participant defaulted|0
6118386|NCT00098306|21095915|P6|Open Label|Participant defaulted|0
6118387|NCT00098306|21095916|P5|Open Label|Participant defaulted|0
6118388|NCT00098306|21095917|P4|Open Label|Participant defaulted|24
6118389|NCT00098306|21095918|P3|Open Label|Participant defaulted|0
6118390|NCT00098306|21095919|P2|Open Label|Participant defaulted|0
6118391|NCT00098306|21095920|P1|Open Label|Participant defaulted|0
6118392|NCT00098306|21095914|P7|Open Label|Death|0
6118393|NCT00098306|21095915|P6|Open Label|Death|0
6118394|NCT00098306|21095916|P5|Open Label|Death|0
6118395|NCT00098306|21095917|P4|Open Label|Death|4
6118396|NCT00098306|21095918|P3|Open Label|Death|0
6118397|NCT00098306|21095919|P2|Open Label|Death|0
6118398|NCT00098306|21095920|P1|Open Label|Death|0
6118399|NCT00098306|21095914|P7|Open Label|Adverse Event|0
6118400|NCT00098306|21095915|P6|Open Label|Adverse Event|0
6118401|NCT00098306|21095916|P5|Open Label|Adverse Event|0
6118402|NCT00098306|21095917|P4|Open Label|Adverse Event|2
6118403|NCT00098306|21095918|P3|Open Label|Adverse Event|0
6118404|NCT00098306|21095919|P2|Open Label|Adverse Event|0
6118405|NCT00098306|21095920|P1|Open Label|Adverse Event|0
6118406|NCT00098306|21095914|P7|Open Label|Lack of Efficacy|0
6118407|NCT00098306|21095915|P6|Open Label|Lack of Efficacy|0
6118408|NCT00098306|21095916|P5|Open Label|Lack of Efficacy|0
6118409|NCT00098306|21095917|P4|Open Label|Lack of Efficacy|13
6118410|NCT00098306|21095918|P3|Open Label|Lack of Efficacy|0
6118411|NCT00098306|21095919|P2|Open Label|Lack of Efficacy|0
6118412|NCT00098306|21095920|P1|Open Label|Lack of Efficacy|0
6118413|NCT00098306|21095914|P7|Double Blind|Un-specified|0
6118414|NCT00098306|21095915|P6|Double Blind|Un-specified|0
6118415|NCT00098306|21095916|P5|Double Blind|Un-specified|0
6118416|NCT00098306|21095917|P4|Double Blind|Un-specified|0
6118417|NCT00098306|21095918|P3|Double Blind|Un-specified|11
6118418|NCT00098306|21095919|P2|Double Blind|Un-specified|3
6118419|NCT00098306|21095920|P1|Double Blind|Un-specified|7
6118420|NCT00098306|21095914|P7|Double Blind|Participant defaulted|0
6118421|NCT00098306|21095915|P6|Double Blind|Participant defaulted|0
6118422|NCT00098306|21095916|P5|Double Blind|Participant defaulted|0
6118423|NCT00098306|21095917|P4|Double Blind|Participant defaulted|0
6118424|NCT00098306|21095918|P3|Double Blind|Participant defaulted|11
6118425|NCT00098306|21095919|P2|Double Blind|Participant defaulted|18
6118426|NCT00098306|21095920|P1|Double Blind|Participant defaulted|19
6118427|NCT00098306|21095914|P7|Double Blind|Death|0
6118428|NCT00098306|21095915|P6|Double Blind|Death|0
6118429|NCT00098306|21095916|P5|Double Blind|Death|0
6118430|NCT00098306|21095917|P4|Double Blind|Death|0
6118431|NCT00098306|21095918|P3|Double Blind|Death|1
6118432|NCT00098306|21095919|P2|Double Blind|Death|4
6118433|NCT00098306|21095920|P1|Double Blind|Death|1
6118434|NCT00098306|21095914|P7|Double Blind|Lack of Efficacy|0
6118435|NCT00098306|21095915|P6|Double Blind|Lack of Efficacy|0
6118436|NCT00098306|21095916|P5|Double Blind|Lack of Efficacy|0
6118437|NCT00098306|21095917|P4|Double Blind|Lack of Efficacy|0
6118438|NCT00098306|21095918|P3|Double Blind|Lack of Efficacy|17
6118439|NCT00098306|21095919|P2|Double Blind|Lack of Efficacy|34
6118440|NCT00098306|21095920|P1|Double Blind|Lack of Efficacy|43
6118441|NCT00098306|21095914|P7|Double Blind|Adverse Event|0
6118442|NCT00098306|21095915|P6|Double Blind|Adverse Event|0
6118443|NCT00098306|21095916|P5|Double Blind|Adverse Event|0
6118444|NCT00098306|21095917|P4|Double Blind|Adverse Event|0
6118445|NCT00098306|21095918|P3|Double Blind|Adverse Event|6
6118446|NCT00098306|21095919|P2|Double Blind|Adverse Event|10
6118447|NCT00098306|21095920|P1|Double Blind|Adverse Event|11
6118448|NCT00098306|21095914|P7|Double Blind|Ongoing at cut-off date|0
6118449|NCT00098306|21095915|P6|Double Blind|Ongoing at cut-off date|0
6118450|NCT00098306|21095916|P5|Double Blind|Ongoing at cut-off date|0
6118451|NCT00098306|21095917|P4|Double Blind|Ongoing at cut-off date|0
6118452|NCT00098306|21095918|P3|Double Blind|Ongoing at cut-off date|72
6118453|NCT00098306|21095919|P2|Double Blind|Ongoing at cut-off date|166
6118454|NCT00098306|21095920|P1|Double Blind|Ongoing at cut-off date|151
6118455|NCT00098306|21095914|P7|Double Blind|Randomized, not treated|0
6118456|NCT00098306|21095915|P6|Double Blind|Randomized, not treated|0
6118457|NCT00098306|21095916|P5|Double Blind|Randomized, not treated|0
6118458|NCT00098306|21095917|P4|Double Blind|Randomized, not treated|0
6118459|NCT00098306|21095918|P3|Double Blind|Randomized, not treated|2
6118460|NCT00098306|21095919|P2|Double Blind|Randomized, not treated|5
6118461|NCT00098306|21095920|P1|Double Blind|Randomized, not treated|9
6118462|NCT00098293|21095986|P5|Supplemental Phase (SP)|Other|22
6118463|NCT00098293|21095987|P4|Supplemental Phase (SP)|Other|0
6118464|NCT00098293|21095988|P3|Supplemental Phase (SP)|Other|0
6118465|NCT00098293|21095989|P2|Supplemental Phase (SP)|Other|0
6118466|NCT00098293|21095990|P1|Supplemental Phase (SP)|Other|0
6118467|NCT00098293|21095986|P5|Supplemental Phase (SP)|Withdrawal by Subject|8
6118468|NCT00098293|21095987|P4|Supplemental Phase (SP)|Withdrawal by Subject|0
6118469|NCT00098293|21095988|P3|Supplemental Phase (SP)|Withdrawal by Subject|0
6118470|NCT00098293|21095989|P2|Supplemental Phase (SP)|Withdrawal by Subject|0
6118471|NCT00098293|21095990|P1|Supplemental Phase (SP)|Withdrawal by Subject|0
6118472|NCT00098293|21095986|P5|Supplemental Phase (SP)|Lost to Follow-up|2
6118473|NCT00098293|21095987|P4|Supplemental Phase (SP)|Lost to Follow-up|0
6118474|NCT00098293|21095988|P3|Supplemental Phase (SP)|Lost to Follow-up|0
6118475|NCT00098293|21095989|P2|Supplemental Phase (SP)|Lost to Follow-up|0
6118476|NCT00098293|21095990|P1|Supplemental Phase (SP)|Lost to Follow-up|0
6118477|NCT00098293|21095986|P5|Supplemental Phase (SP)|Death|1
6118478|NCT00098293|21095987|P4|Supplemental Phase (SP)|Death|0
6118479|NCT00098293|21095988|P3|Supplemental Phase (SP)|Death|0
6118480|NCT00098293|21095989|P2|Supplemental Phase (SP)|Death|0
6118481|NCT00098293|21095990|P1|Supplemental Phase (SP)|Death|0
6118482|NCT00098293|21095986|P5|Open-label (OL) Phase|Death|0
6118483|NCT00098293|21095987|P4|Open-label (OL) Phase|Death|0
6118484|NCT00098293|21095988|P3|Open-label (OL) Phase|Death|3
6118485|NCT00098293|21095989|P2|Open-label (OL) Phase|Death|2
6118486|NCT00098293|21095990|P1|Open-label (OL) Phase|Death|0
6118487|NCT00098293|21095986|P5|Open-label (OL) Phase|Participant Defaulted|0
6118488|NCT00098293|21095987|P4|Open-label (OL) Phase|Participant Defaulted|20
6118489|NCT00098293|21095988|P3|Open-label (OL) Phase|Participant Defaulted|16
6118490|NCT00098293|21095989|P2|Open-label (OL) Phase|Participant Defaulted|6
6118491|NCT00098293|21095990|P1|Open-label (OL) Phase|Participant Defaulted|0
6118492|NCT00098293|21095986|P5|Open-label (OL) Phase|Protocol Violation|0
6118493|NCT00098293|21095987|P4|Open-label (OL) Phase|Protocol Violation|16
6118494|NCT00098293|21095988|P3|Open-label (OL) Phase|Protocol Violation|13
6118495|NCT00098293|21095989|P2|Open-label (OL) Phase|Protocol Violation|6
6118496|NCT00098293|21095990|P1|Open-label (OL) Phase|Protocol Violation|0
6118497|NCT00098293|21095986|P5|Open-label (OL) Phase|Pregnancy|0
6118498|NCT00098293|21095987|P4|Open-label (OL) Phase|Pregnancy|3
6118499|NCT00098293|21095988|P3|Open-label (OL) Phase|Pregnancy|0
6118500|NCT00098293|21095989|P2|Open-label (OL) Phase|Pregnancy|1
6118501|NCT00098293|21095990|P1|Open-label (OL) Phase|Pregnancy|0
6118502|NCT00098293|21095986|P5|Open-label (OL) Phase|Lack of Efficacy|0
6118503|NCT00098293|21095987|P4|Open-label (OL) Phase|Lack of Efficacy|20
6118504|NCT00098293|21095988|P3|Open-label (OL) Phase|Lack of Efficacy|2
6118505|NCT00098293|21095989|P2|Open-label (OL) Phase|Lack of Efficacy|7
6118506|NCT00098293|21095990|P1|Open-label (OL) Phase|Lack of Efficacy|0
6118507|NCT00098293|21095986|P5|Open-label (OL) Phase|Adverse Event|0
6118508|NCT00098293|21095987|P4|Open-label (OL) Phase|Adverse Event|6
6118509|NCT00098293|21095988|P3|Open-label (OL) Phase|Adverse Event|7
6118510|NCT00098293|21095989|P2|Open-label (OL) Phase|Adverse Event|3
6118511|NCT00098293|21095990|P1|Open-label (OL) Phase|Adverse Event|0
6118512|NCT00098293|21095986|P5|Between DB and OL Phase|Did Not Enter Open-label Phase|0
6118513|NCT00098293|21095987|P4|Between DB and OL Phase|Did Not Enter Open-label Phase|0
6118514|NCT00098293|21095988|P3|Between DB and OL Phase|Did Not Enter Open-label Phase|3
6118515|NCT00098293|21095989|P2|Between DB and OL Phase|Did Not Enter Open-label Phase|0
6118516|NCT00098293|21095990|P1|Between DB and OL Phase|Did Not Enter Open-label Phase|0
6118517|NCT00098293|21095986|P5|Double-blind (DB) Phase|Terminated by sponsor|0
6118518|NCT00098293|21095987|P4|Double-blind (DB) Phase|Terminated by sponsor|0
6118519|NCT00098293|21095988|P3|Double-blind (DB) Phase|Terminated by sponsor|0
6118520|NCT00098293|21095989|P2|Double-blind (DB) Phase|Terminated by sponsor|0
6118521|NCT00098293|21095990|P1|Double-blind (DB) Phase|Terminated by sponsor|135
6118522|NCT00098293|21095986|P5|Double-blind (DB) Phase|Protocol Violation|0
6118523|NCT00098293|21095987|P4|Double-blind (DB) Phase|Protocol Violation|0
6118524|NCT00098293|21095988|P3|Double-blind (DB) Phase|Protocol Violation|22
6118525|NCT00098293|21095989|P2|Double-blind (DB) Phase|Protocol Violation|18
6118526|NCT00098293|21095990|P1|Double-blind (DB) Phase|Protocol Violation|2
6118527|NCT00098293|21095986|P5|Double-blind (DB) Phase|Randomized, Not Treated|0
6118528|NCT00098293|21095987|P4|Double-blind (DB) Phase|Randomized, Not Treated|0
6118529|NCT00098293|21095988|P3|Double-blind (DB) Phase|Randomized, Not Treated|11
6118530|NCT00098293|21095989|P2|Double-blind (DB) Phase|Randomized, Not Treated|8
6118531|NCT00098293|21095990|P1|Double-blind (DB) Phase|Randomized, Not Treated|3
6118532|NCT00098293|21095986|P5|Double-blind (DB) Phase|Death|0
6118533|NCT00098293|21095987|P4|Double-blind (DB) Phase|Death|0
6118534|NCT00098293|21095988|P3|Double-blind (DB) Phase|Death|2
6118535|NCT00098293|21095989|P2|Double-blind (DB) Phase|Death|2
6118536|NCT00098293|21095990|P1|Double-blind (DB) Phase|Death|1
6118537|NCT00098293|21095986|P5|Double-blind (DB) Phase|Lack of Efficacy|0
6118538|NCT00098293|21095987|P4|Double-blind (DB) Phase|Lack of Efficacy|0
6118539|NCT00098293|21095988|P3|Double-blind (DB) Phase|Lack of Efficacy|30
6118540|NCT00098293|21095989|P2|Double-blind (DB) Phase|Lack of Efficacy|64
6118541|NCT00098293|21095990|P1|Double-blind (DB) Phase|Lack of Efficacy|11
6118542|NCT00098293|21095986|P5|Double-blind (DB) Phase|Participant Defaulted|0
6118543|NCT00098293|21095987|P4|Double-blind (DB) Phase|Participant Defaulted|0
6118544|NCT00098293|21095988|P3|Double-blind (DB) Phase|Participant Defaulted|36
6118545|NCT00098293|21095989|P2|Double-blind (DB) Phase|Participant Defaulted|40
6118546|NCT00098293|21095990|P1|Double-blind (DB) Phase|Participant Defaulted|11
6118547|NCT00098293|21095986|P5|Double-blind (DB) Phase|Pregnancy|0
6118548|NCT00098293|21095987|P4|Double-blind (DB) Phase|Pregnancy|0
6118549|NCT00098293|21095988|P3|Double-blind (DB) Phase|Pregnancy|9
6118550|NCT00098293|21095989|P2|Double-blind (DB) Phase|Pregnancy|7
6118551|NCT00098293|21095990|P1|Double-blind (DB) Phase|Pregnancy|0
6118552|NCT00098293|21095986|P5|Double-blind (DB) Phase|Adverse Event|0
6118553|NCT00098293|21095987|P4|Double-blind (DB) Phase|Adverse Event|0
6118554|NCT00098293|21095988|P3|Double-blind (DB) Phase|Adverse Event|60
6118555|NCT00098293|21095989|P2|Double-blind (DB) Phase|Adverse Event|27
6118556|NCT00098293|21095990|P1|Double-blind (DB) Phase|Adverse Event|14
6118557|NCT00098254|21096043|P1|Overall Study|Death|1
6118558|NCT00098254|21096043|P1|Overall Study|Adverse Event|2
6118559|NCT00098020|21096109|P1|Overall Study|Low epidermal growth factor receptor|1
6118560|NCT00098020|21096109|P1|Overall Study|Low urine PCR|1
6118561|NCT00098020|21096109|P1|Overall Study|elevated liver enzymes|1
6118562|NCT00098020|21096109|P1|Overall Study|Lost to Follow-up|1
6118563|NCT00098020|21096109|P1|Overall Study|Adverse Event|2
6118564|NCT00097981|21096116|P2|Overall Study|Other|13
6118565|NCT00097981|21096117|P1|Overall Study|Other|19
6118566|NCT00097981|21096116|P2|Overall Study|Transplant planned|27
6118567|NCT00097981|21096117|P1|Overall Study|Transplant planned|28
6118568|NCT00097981|21096116|P2|Overall Study|Disease Progression|2
6118569|NCT00097981|21096117|P1|Overall Study|Disease Progression|8
6118570|NCT00097981|21096116|P2|Overall Study|Physician Decision|1
6118571|NCT00097981|21096117|P1|Overall Study|Physician Decision|7
6118572|NCT00097981|21096116|P2|Overall Study|Death|4
6118573|NCT00097981|21096117|P1|Overall Study|Death|2
6118574|NCT00097981|21096116|P2|Overall Study|Protocol Violation|1
6118575|NCT00097981|21096117|P1|Overall Study|Protocol Violation|1
6118576|NCT00097981|21096116|P2|Overall Study|Withdrawal by Subject|8
6118577|NCT00097981|21096117|P1|Overall Study|Withdrawal by Subject|10
6118578|NCT00097981|21096116|P2|Overall Study|Adverse Event|44
6118579|NCT00097981|21096117|P1|Overall Study|Adverse Event|31
6118580|NCT00097786|21096139|P4|Overall Study|lost to follow-up for all-cause death|310
6118581|NCT00097786|21096140|P3|Overall Study|lost to follow-up for all-cause death|313
6118582|NCT00097786|21096141|P2|Overall Study|lost to follow-up for all-cause death|292
6118583|NCT00097786|21096142|P1|Overall Study|lost to follow-up for all-cause death|296
6118584|NCT00097773|21096164|P4|Overall Study|Other|0
6118585|NCT00097773|21096165|P3|Overall Study|Other|2
6118586|NCT00097773|21096166|P2|Overall Study|Other|0
6118587|NCT00097773|21096167|P1|Overall Study|Other|1
6118588|NCT00097773|21096164|P4|Overall Study|Adverse Event|0
6118589|NCT00097773|21096165|P3|Overall Study|Adverse Event|0
6118590|NCT00097773|21096166|P2|Overall Study|Adverse Event|1
6118591|NCT00097773|21096167|P1|Overall Study|Adverse Event|0
6118592|NCT00097773|21096164|P4|Overall Study|Withdrawal by Subject|1
6118593|NCT00097773|21096165|P3|Overall Study|Withdrawal by Subject|3
6118594|NCT00097773|21096166|P2|Overall Study|Withdrawal by Subject|3
6118595|NCT00097773|21096167|P1|Overall Study|Withdrawal by Subject|3
6118596|NCT00097773|21096164|P4|Overall Study|Physician Decision|1
6118597|NCT00097773|21096165|P3|Overall Study|Physician Decision|3
6118598|NCT00097773|21096166|P2|Overall Study|Physician Decision|2
6118599|NCT00097773|21096167|P1|Overall Study|Physician Decision|2
6118600|NCT00097773|21096164|P4|Overall Study|Lost to Follow-up|1
6118601|NCT00097773|21096165|P3|Overall Study|Lost to Follow-up|0
6118602|NCT00097773|21096166|P2|Overall Study|Lost to Follow-up|2
6118603|NCT00097773|21096167|P1|Overall Study|Lost to Follow-up|2
6118604|NCT00097721|21096187|P2|Overall Study|Reason not given|1
6118605|NCT00097721|21096188|P1|Overall Study|Reason not given|1
6118606|NCT00097721|21096187|P2|Overall Study|Physician Decision|3
6118607|NCT00097721|21096188|P1|Overall Study|Physician Decision|1
6118608|NCT00097721|21096187|P2|Overall Study|Progressive Disease|27
6118609|NCT00097721|21096188|P1|Overall Study|Progressive Disease|55
6118610|NCT00097721|21096187|P2|Overall Study|Withdrawal by Subject|1
6118611|NCT00097721|21096188|P1|Overall Study|Withdrawal by Subject|6
6118612|NCT00097721|21096187|P2|Overall Study|Adverse Event|1
6118613|NCT00097721|21096188|P1|Overall Study|Adverse Event|8
6118614|NCT00097591|21096247|P2|Overall Study|Other|3
6118615|NCT00097591|21096248|P1|Overall Study|Other|0
6118616|NCT00097591|21096247|P2|Overall Study|Lost to follow up|10
6118617|NCT00097591|21096248|P1|Overall Study|Lost to follow up|6
6118618|NCT00097591|21096247|P2|Overall Study|Unable to attend termination visit|51
6118619|NCT00097591|21096248|P1|Overall Study|Unable to attend termination visit|53
6118620|NCT00097591|21096247|P2|Overall Study|Less than 6 months on study drug|7
6118621|NCT00097591|21096248|P1|Overall Study|Less than 6 months on study drug|9
6118622|NCT00097591|21096247|P2|Overall Study|Withdrawal of consent|323
6118623|NCT00097591|21096248|P1|Overall Study|Withdrawal of consent|342
6118624|NCT00097539|21096271|P7|Overall Study|Reason not Specified|2
6118625|NCT00097539|21096272|P6|Overall Study|Reason not Specified|40
6118626|NCT00097539|21096273|P5|Overall Study|Reason not Specified|11
6118627|NCT00097539|21096274|P4|Overall Study|Reason not Specified|21
6118628|NCT00097539|21096275|P3|Overall Study|Reason not Specified|53
6118629|NCT00097539|21096276|P2|Overall Study|Reason not Specified|49
6118630|NCT00097539|21096277|P1|Overall Study|Reason not Specified|111
6118631|NCT00097539|21096271|P7|Overall Study|Reasons Other Than Above|34
6118632|NCT00097539|21096272|P6|Overall Study|Reasons Other Than Above|1244
6118633|NCT00097539|21096273|P5|Overall Study|Reasons Other Than Above|361
6118634|NCT00097539|21096274|P4|Overall Study|Reasons Other Than Above|692
6118635|NCT00097539|21096275|P3|Overall Study|Reasons Other Than Above|1757
6118636|NCT00097539|21096276|P2|Overall Study|Reasons Other Than Above|1382
6118637|NCT00097539|21096277|P1|Overall Study|Reasons Other Than Above|3602
6118638|NCT00097539|21096271|P7|Overall Study|Death|0
6118639|NCT00097539|21096272|P6|Overall Study|Death|3
6118640|NCT00097539|21096273|P5|Overall Study|Death|1
6118641|NCT00097539|21096274|P4|Overall Study|Death|0
6118642|NCT00097539|21096275|P3|Overall Study|Death|0
6118643|NCT00097539|21096276|P2|Overall Study|Death|7
6118644|NCT00097539|21096277|P1|Overall Study|Death|2
6118645|NCT00097539|21096271|P7|Overall Study|Adverse Event|1
6118646|NCT00097539|21096272|P6|Overall Study|Adverse Event|59
6118647|NCT00097539|21096273|P5|Overall Study|Adverse Event|30
6118648|NCT00097539|21096274|P4|Overall Study|Adverse Event|27
6118649|NCT00097539|21096275|P3|Overall Study|Adverse Event|37
6118650|NCT00097539|21096276|P2|Overall Study|Adverse Event|133
6118651|NCT00097539|21096277|P1|Overall Study|Adverse Event|78
6118652|NCT00097539|21096271|P7|Overall Study|Lack of Efficacy|5
6118653|NCT00097539|21096272|P6|Overall Study|Lack of Efficacy|228
6118654|NCT00097539|21096273|P5|Overall Study|Lack of Efficacy|45
6118655|NCT00097539|21096274|P4|Overall Study|Lack of Efficacy|105
6118656|NCT00097539|21096275|P3|Overall Study|Lack of Efficacy|202
6118657|NCT00097539|21096276|P2|Overall Study|Lack of Efficacy|122
6118658|NCT00097539|21096277|P1|Overall Study|Lack of Efficacy|249
6118659|NCT00097539|21096271|P7|Overall Study|Participant Non-compliant|18
6118660|NCT00097539|21096272|P6|Overall Study|Participant Non-compliant|543
6118661|NCT00097539|21096273|P5|Overall Study|Participant Non-compliant|136
6118662|NCT00097539|21096274|P4|Overall Study|Participant Non-compliant|353
6118663|NCT00097539|21096275|P3|Overall Study|Participant Non-compliant|1067
6118664|NCT00097539|21096276|P2|Overall Study|Participant Non-compliant|567
6118665|NCT00097539|21096277|P1|Overall Study|Participant Non-compliant|2140
6118666|NCT00097539|21096271|P7|Overall Study|Withdrawal by Subject|3
6118667|NCT00097539|21096272|P6|Overall Study|Withdrawal by Subject|229
6118668|NCT00097539|21096273|P5|Overall Study|Withdrawal by Subject|68
6118669|NCT00097539|21096274|P4|Overall Study|Withdrawal by Subject|217
6118670|NCT00097539|21096275|P3|Overall Study|Withdrawal by Subject|346
6118671|NCT00097539|21096276|P2|Overall Study|Withdrawal by Subject|323
6118672|NCT00097539|21096277|P1|Overall Study|Withdrawal by Subject|925
6118673|NCT00097539|21096271|P7|Overall Study|Status Unknown (Or no final evaluation)|108
6118674|NCT00097539|21096272|P6|Overall Study|Status Unknown (Or no final evaluation)|3546
6118675|NCT00097539|21096273|P5|Overall Study|Status Unknown (Or no final evaluation)|1106
6118676|NCT00097539|21096274|P4|Overall Study|Status Unknown (Or no final evaluation)|2170
6118677|NCT00097539|21096275|P3|Overall Study|Status Unknown (Or no final evaluation)|5646
6118678|NCT00097539|21096276|P2|Overall Study|Status Unknown (Or no final evaluation)|3948
6118679|NCT00097539|21096277|P1|Overall Study|Status Unknown (Or no final evaluation)|11959
6118680|NCT00097500|21096323|P2|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|2
6118681|NCT00097500|21096324|P1|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|3
6118682|NCT00097500|21096323|P2|Off-drug Period (Week 52 to Week 64)|Physician Decision|1
6118683|NCT00097500|21096324|P1|Off-drug Period (Week 52 to Week 64)|Physician Decision|0
6118684|NCT00097500|21096323|P2|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|1
6118685|NCT00097500|21096324|P1|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|2
6118686|NCT00097500|21096323|P2|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|1
6118687|NCT00097500|21096324|P1|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|0
6118688|NCT00097500|21096323|P2|On-drug Period (Week 0 to Week 52)|Physician Decision|1
6118689|NCT00097500|21096324|P1|On-drug Period (Week 0 to Week 52)|Physician Decision|0
6118690|NCT00097500|21096323|P2|On-drug Period (Week 0 to Week 52)|Adverse Event|0
6118691|NCT00097500|21096324|P1|On-drug Period (Week 0 to Week 52)|Adverse Event|5
6118692|NCT00097500|21096323|P2|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1
6118693|NCT00097500|21096324|P1|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1
6118694|NCT00097370|21096355|P1|Stage 3|Lost to Follow-up|1
6118695|NCT00097370|21096355|P1|Stage 3|Sponsor Terminated Study|52
6118696|NCT00097370|21096355|P1|Stage 3|Lack of Efficacy|1
6118697|NCT00097370|21096355|P1|Stage 3|Withdrawal by Subject|3
6118698|NCT00097370|21096355|P1|Stage 3|Adverse Event|2
6118699|NCT00097370|21096355|P1|Stage 2|Lost to Follow-up|1
6118700|NCT00097370|21096355|P1|Stage 2|Sponsor Terminated Study|2
6118701|NCT00097370|21096355|P1|Stage 2|Pregnancy|1
6118702|NCT00097370|21096355|P1|Stage 2|Lack of Efficacy|3
6118703|NCT00097370|21096355|P1|Stage 2|Withdrawal by Subject|1
6118704|NCT00097370|21096355|P1|Stage 2|Adverse Event|5
6118705|NCT00097370|21096355|P1|Stage 1|Lack of Efficacy|2
6118706|NCT00097370|21096355|P1|Stage 1|Withdrawal by Subject|1
6118707|NCT00097370|21096355|P1|Stage 1|Adverse Event|3
6118708|NCT00096993|21096389|P2|Overall Study|Other unspecified|1
6118709|NCT00096993|21096390|P1|Overall Study|Other unspecified|1
6118710|NCT00096993|21096389|P2|Overall Study|Non-compliance|1
6118711|NCT00096993|21096390|P1|Overall Study|Non-compliance|0
6118712|NCT00096993|21096389|P2|Overall Study|Physician Decision|1
6118713|NCT00096993|21096390|P1|Overall Study|Physician Decision|2
6118714|NCT00096993|21096389|P2|Overall Study|Subject's decision|1
6118715|NCT00096993|21096390|P1|Overall Study|Subject's decision|3
6118716|NCT00096993|21096389|P2|Overall Study|Adverse Event|8
6118717|NCT00096993|21096390|P1|Overall Study|Adverse Event|2
6118718|NCT00096993|21096389|P2|Overall Study|Disease progression|53
6118719|NCT00096993|21096390|P1|Overall Study|Disease progression|56
6118720|NCT00096993|21096389|P2|Overall Study|Death|0
6118721|NCT00096993|21096390|P1|Overall Study|Death|1
6118722|NCT00096954|21096406|P2|Overall Study|Lost to Follow-up|5
6118723|NCT00096954|21096407|P1|Overall Study|Lost to Follow-up|8
6118724|NCT00096954|21096406|P2|Overall Study|Non-compliance|3
6118725|NCT00096954|21096407|P1|Overall Study|Non-compliance|0
6118726|NCT00096954|21096406|P2|Overall Study|Initiation of immunotherapy|0
6118727|NCT00096954|21096407|P1|Overall Study|Initiation of immunotherapy|1
6118728|NCT00096954|21096406|P2|Overall Study|Pregnancy|1
6118729|NCT00096954|21096407|P1|Overall Study|Pregnancy|1
6118730|NCT00096954|21096406|P2|Overall Study|Sponsors Decision|1
6118731|NCT00096954|21096407|P1|Overall Study|Sponsors Decision|1
6118732|NCT00096954|21096406|P2|Overall Study|Physician Decision|1
6118733|NCT00096954|21096407|P1|Overall Study|Physician Decision|1
6118734|NCT00096954|21096406|P2|Overall Study|Withdrawal by Subject|8
6118735|NCT00096954|21096407|P1|Overall Study|Withdrawal by Subject|9
6118736|NCT00096954|21096406|P2|Overall Study|Adverse Event|1
6118737|NCT00096954|21096407|P1|Overall Study|Adverse Event|3
6118738|NCT00096941|21096419|P1|Overall Study|disease progression|3
6118739|NCT00096785|21096426|P2|Overall Study|Relocated|0
6118740|NCT00096785|21096427|P1|Overall Study|Relocated|1
6118741|NCT00096785|21096426|P2|Overall Study|Withdrawal by Subject|1
6118742|NCT00096785|21096427|P1|Overall Study|Withdrawal by Subject|0
6118743|NCT00096785|21096426|P2|Overall Study|Lost to Follow-up|0
6118744|NCT00096785|21096427|P1|Overall Study|Lost to Follow-up|1
6118745|NCT00096538|21096456|P1|Overall Study|Withdrawal by Subject|1
6118746|NCT00096486|21096464|P4|Overall Study|Not Treated|1
6118747|NCT00096486|21096465|P3|Overall Study|Not Treated|1
6118748|NCT00096486|21096466|P2|Overall Study|Not Treated|0
6118749|NCT00096486|21096467|P1|Overall Study|Not Treated|0
6118750|NCT00096486|21096464|P4|Overall Study|Withdrawal by Subject|1
6118751|NCT00096486|21096465|P3|Overall Study|Withdrawal by Subject|1
6118752|NCT00096486|21096466|P2|Overall Study|Withdrawal by Subject|0
6118753|NCT00096486|21096467|P1|Overall Study|Withdrawal by Subject|0
6118754|NCT00096447|21096486|P1|Overall Study|Never treated|1
6118755|NCT00096382|21096502|P2|Overall Study|Death during treatment|0
6118756|NCT00096382|21096503|P1|Overall Study|Death during treatment|1
6118757|NCT00096382|21096502|P2|Overall Study|Not treated|0
6118758|NCT00096382|21096503|P1|Overall Study|Not treated|1
6118759|NCT00096356|21096513|P2|Overall Study|multiple reasons|18
6118760|NCT00096356|21096514|P1|Overall Study|multiple reasons|10
6118761|NCT00096356|21096513|P2|Overall Study|Lack of Efficacy|0
6118762|NCT00096356|21096514|P1|Overall Study|Lack of Efficacy|1
6118763|NCT00096356|21096513|P2|Overall Study|Withdrawal by Subject|23
6118764|NCT00096356|21096514|P1|Overall Study|Withdrawal by Subject|17
6118765|NCT00096356|21096513|P2|Overall Study|Physician Decision|3
6118766|NCT00096356|21096514|P1|Overall Study|Physician Decision|5
6118767|NCT00096356|21096513|P2|Overall Study|Adverse Event|9
6118768|NCT00096356|21096514|P1|Overall Study|Adverse Event|11
6118769|NCT00096278|21096526|P2|Overall Study|Patient not at risk for primary endpoint|2
6118770|NCT00096278|21096527|P1|Overall Study|Patient not at risk for primary endpoint|3
6118771|NCT00096278|21096526|P2|Overall Study|No follow-up data|18
6118772|NCT00096278|21096527|P1|Overall Study|No follow-up data|15
6118773|NCT00096265|21096546|P3|Overall Study|Ineligible|0
6118774|NCT00096265|21096547|P2|Overall Study|Ineligible|0
6118775|NCT00096265|21096548|P1|Overall Study|Ineligible|1
6118776|NCT00096226|21096574|P1|Overall Study|Protocol treatment not started|1
6118777|NCT00096226|21096574|P1|Overall Study|Ineligible|2
6118778|NCT00096200|21096588|P3|Overall Study|Ineligible pathology|0
6118779|NCT00096200|21096589|P2|Overall Study|Ineligible pathology|1
6118780|NCT00096200|21096590|P1|Overall Study|Ineligible pathology|0
6118781|NCT00096200|21096588|P3|Overall Study|Withdrawal by Subject|0
6118782|NCT00096200|21096589|P2|Overall Study|Withdrawal by Subject|2
6118783|NCT00096200|21096590|P1|Overall Study|Withdrawal by Subject|1
6118784|NCT00096200|21096588|P3|Overall Study|Adverse Event|0
6118785|NCT00096200|21096589|P2|Overall Study|Adverse Event|4
6118786|NCT00096200|21096590|P1|Overall Study|Adverse Event|0
6118787|NCT00096174|21096604|P1|Overall Study|other reason|8
6118788|NCT00096174|21096604|P1|Overall Study|Ineligible|6
6118789|NCT00096174|21096604|P1|Overall Study|Not started protocol therapy|3
6118790|NCT00096174|21096604|P1|Overall Study|Withdrawal by Subject|15
6118791|NCT00096174|21096604|P1|Overall Study|Death|6
6118792|NCT00096174|21096604|P1|Overall Study|Adverse Event|15
6118793|NCT00096174|21096604|P1|Overall Study|Lack of Efficacy|9
6118794|NCT00096135|21096649|P2|Overall Study|Ineligible|0
6118795|NCT00096135|21096650|P1|Overall Study|Ineligible|2
6118796|NCT00096135|21096649|P2|Overall Study|Other, specify|3
6118797|NCT00096135|21096650|P1|Overall Study|Other, specify|15
6118798|NCT00096135|21096649|P2|Overall Study|Progressive disease, Marrow,CNS, Relapse|7
6118799|NCT00096135|21096650|P1|Overall Study|Progressive disease, Marrow,CNS, Relapse|22
6118800|NCT00096135|21096649|P2|Overall Study|Refusal of further protocol therapy|1
6118801|NCT00096135|21096650|P1|Overall Study|Refusal of further protocol therapy|4
6118802|NCT00096135|21096649|P2|Overall Study|Physician Decision|4
6118803|NCT00096135|21096650|P1|Overall Study|Physician Decision|20
6118804|NCT00096044|21096666|P1|Overall Study|Disease Progression|4
6118805|NCT00096044|21096666|P1|Overall Study|Adverse Event|21
6118806|NCT00096044|21096666|P1|Overall Study|Withdrawal by Subject|9
6118807|NCT00096031|21096675|P1|Overall Study|Not protocol specified|5
6118808|NCT00096031|21096675|P1|Overall Study|Ineligible|8
6118809|NCT00096031|21096675|P1|Overall Study|Withdrawal by Subject|1
6118810|NCT00096031|21096675|P1|Overall Study|Death|4
6118811|NCT00096031|21096675|P1|Overall Study|Lack of Efficacy|42
6118812|NCT00096031|21096675|P1|Overall Study|Adverse Event|3
6118813|NCT00096018|21096683|P2|Overall Study|Miscellaneous|1
6118814|NCT00096018|21096684|P1|Overall Study|Miscellaneous|2
6118815|NCT00096018|21096683|P2|Overall Study|Withdrawal by Subject|2
6118816|NCT00096018|21096684|P1|Overall Study|Withdrawal by Subject|0
6118817|NCT00096018|21096683|P2|Overall Study|Death|1
6118818|NCT00096018|21096684|P1|Overall Study|Death|0
6118819|NCT00096018|21096683|P2|Overall Study|Adverse Event|5
6118820|NCT00096018|21096684|P1|Overall Study|Adverse Event|0
6118821|NCT00096018|21096683|P2|Overall Study|Miscellaneous (not treated)|2
6118822|NCT00096018|21096684|P1|Overall Study|Miscellaneous (not treated)|0
6118823|NCT00096018|21096683|P2|Overall Study|Became Ineligible (not treated)|3
6118824|NCT00096018|21096684|P1|Overall Study|Became Ineligible (not treated)|0
6118825|NCT00095979|21096692|P1|Overall Study|Ineligible: Second primary cancer site|2
6118826|NCT00095940|21096710|P9|Lapatinib Continuation/Phase II|Adverse Event|0
6118827|NCT00095940|21096711|P8|Lapatinib Continuation/Phase II|Adverse Event|1
6118828|NCT00095940|21096712|P7|Lapatinib Continuation/Phase II|Adverse Event|0
6118829|NCT00095940|21096713|P6|Lapatinib Continuation/Phase II|Adverse Event|0
6118830|NCT00095940|21096714|P5|Lapatinib Continuation/Phase II|Adverse Event|0
6118831|NCT00095940|21096715|P4|Lapatinib Continuation/Phase II|Adverse Event|0
6118832|NCT00095940|21096716|P3|Lapatinib Continuation/Phase II|Adverse Event|0
6118833|NCT00095940|21096717|P2|Lapatinib Continuation/Phase II|Adverse Event|0
6118834|NCT00095940|21096718|P1|Lapatinib Continuation/Phase II|Adverse Event|0
6118835|NCT00095940|21096710|P9|Lapatinib Continuation/Phase II|Withdrawal by Subject|1
6118836|NCT00095940|21096711|P8|Lapatinib Continuation/Phase II|Withdrawal by Subject|0
6118837|NCT00095940|21096712|P7|Lapatinib Continuation/Phase II|Withdrawal by Subject|0
6118838|NCT00095940|21096713|P6|Lapatinib Continuation/Phase II|Withdrawal by Subject|0
6118839|NCT00095940|21096714|P5|Lapatinib Continuation/Phase II|Withdrawal by Subject|0
6118840|NCT00095940|21096715|P4|Lapatinib Continuation/Phase II|Withdrawal by Subject|0
6118841|NCT00095940|21096716|P3|Lapatinib Continuation/Phase II|Withdrawal by Subject|1
6118842|NCT00095940|21096717|P2|Lapatinib Continuation/Phase II|Withdrawal by Subject|1
6118843|NCT00095940|21096718|P1|Lapatinib Continuation/Phase II|Withdrawal by Subject|1
6118844|NCT00095940|21096710|P9|Lapatinib Continuation/Phase II|Disease Progression|12
6118845|NCT00095940|21096711|P8|Lapatinib Continuation/Phase II|Disease Progression|1
6118846|NCT00095940|21096712|P7|Lapatinib Continuation/Phase II|Disease Progression|2
6118847|NCT00095940|21096713|P6|Lapatinib Continuation/Phase II|Disease Progression|13
6118848|NCT00095940|21096714|P5|Lapatinib Continuation/Phase II|Disease Progression|0
6118849|NCT00095940|21096715|P4|Lapatinib Continuation/Phase II|Disease Progression|0
6118850|NCT00095940|21096716|P3|Lapatinib Continuation/Phase II|Disease Progression|15
6118851|NCT00095940|21096717|P2|Lapatinib Continuation/Phase II|Disease Progression|1
6118852|NCT00095940|21096718|P1|Lapatinib Continuation/Phase II|Disease Progression|1
6118853|NCT00095836|21096751|P1|Overall Study|Death|2
6118854|NCT00095836|21096751|P1|Overall Study|Adverse Event|1
6118855|NCT00095836|21096751|P1|Overall Study|Lost to Follow-up|1
6118856|NCT00095628|21096781|P1|Overall Study|Disease progression prior to treatment|1
6118857|NCT00095576|21096792|P2|Overall Study|Subject moved|36
6118858|NCT00095576|21096793|P1|Overall Study|Subject moved|30
6118859|NCT00095576|21096792|P2|Overall Study|Site terminated|67
6118860|NCT00095576|21096793|P1|Overall Study|Site terminated|75
6118861|NCT00095576|21096792|P2|Overall Study|Option to switch to a rollover study|1099
6118862|NCT00095576|21096793|P1|Overall Study|Option to switch to a rollover study|1097
6118863|NCT00095576|21096792|P2|Overall Study|Withdrawal by Subject|47
6118864|NCT00095576|21096793|P1|Overall Study|Withdrawal by Subject|34
6118865|NCT00095576|21096792|P2|Overall Study|Protocol Violation|0
6118866|NCT00095576|21096793|P1|Overall Study|Protocol Violation|1
6118867|NCT00095576|21096792|P2|Overall Study|Lost to Follow-up|229
6118868|NCT00095576|21096793|P1|Overall Study|Lost to Follow-up|233
6118869|NCT00095576|21096792|P2|Overall Study|Adverse Event|3
6118870|NCT00095576|21096793|P1|Overall Study|Adverse Event|5
6118871|NCT00095498|21096817|P3|Overall Study|Requirement for alternative therapy|2
6118872|NCT00095498|21096818|P2|Overall Study|Requirement for alternative therapy|0
6118873|NCT00095498|21096819|P1|Overall Study|Requirement for alternative therapy|1
6118874|NCT00095498|21096817|P3|Overall Study|Protocol Violation|1
6118875|NCT00095498|21096818|P2|Overall Study|Protocol Violation|0
6118876|NCT00095498|21096819|P1|Overall Study|Protocol Violation|0
6118877|NCT00095498|21096817|P3|Overall Study|Other|6
6118878|NCT00095498|21096818|P2|Overall Study|Other|7
6118879|NCT00095498|21096819|P1|Overall Study|Other|6
6118880|NCT00095498|21096817|P3|Overall Study|Noncompliance|1
6118881|NCT00095498|21096818|P2|Overall Study|Noncompliance|0
6118882|NCT00095498|21096819|P1|Overall Study|Noncompliance|1
6118883|NCT00095498|21096817|P3|Overall Study|Lost to Follow-up|2
6118884|NCT00095498|21096818|P2|Overall Study|Lost to Follow-up|1
6118885|NCT00095498|21096819|P1|Overall Study|Lost to Follow-up|1
6118886|NCT00095498|21096817|P3|Overall Study|Ineligibility determined|2
6118887|NCT00095498|21096818|P2|Overall Study|Ineligibility determined|0
6118888|NCT00095498|21096819|P1|Overall Study|Ineligibility determined|3
6118889|NCT00095498|21096817|P3|Overall Study|Disease progression|1
6118890|NCT00095498|21096818|P2|Overall Study|Disease progression|1
6118891|NCT00095498|21096819|P1|Overall Study|Disease progression|0
6118892|NCT00095498|21096817|P3|Overall Study|Withdrawal by Subject|15
6118893|NCT00095498|21096818|P2|Overall Study|Withdrawal by Subject|16
6118894|NCT00095498|21096819|P1|Overall Study|Withdrawal by Subject|15
6118895|NCT00095498|21096817|P3|Overall Study|Adverse Event|1
6118896|NCT00095498|21096818|P2|Overall Study|Adverse Event|0
6118897|NCT00095498|21096819|P1|Overall Study|Adverse Event|1
6118898|NCT00095498|21096817|P3|Overall Study|Physician Decision|8
6118899|NCT00095498|21096818|P2|Overall Study|Physician Decision|10
6118900|NCT00095498|21096819|P1|Overall Study|Physician Decision|9
6118901|NCT00095303|21097246|P2|Follow Up Study|Lost to Follow-up|58
6118902|NCT00095303|21097247|P1|Follow Up Study|Lost to Follow-up|59
6118903|NCT00095303|21097246|P2|Main Study|Lost to Follow-up|87
6118904|NCT00095303|21097247|P1|Main Study|Lost to Follow-up|91
6118905|NCT00095238|21097315|P2|Overall Study|Other Reasons|88
6118906|NCT00095238|21097316|P1|Overall Study|Other Reasons|87
6118907|NCT00095238|21097315|P2|Overall Study|Missing|0
6118908|NCT00095238|21097316|P1|Overall Study|Missing|1
6118909|NCT00095238|21097315|P2|Overall Study|Study terminated by sponsor|1
6118910|NCT00095238|21097316|P1|Overall Study|Study terminated by sponsor|0
6118911|NCT00095238|21097315|P2|Overall Study|No longer met study criteria|5
6118912|NCT00095238|21097316|P1|Overall Study|No longer met study criteria|4
6118913|NCT00095238|21097315|P2|Overall Study|Noncompliance|45
6118914|NCT00095238|21097316|P1|Overall Study|Noncompliance|44
6118915|NCT00095238|21097315|P2|Overall Study|Lost to Follow-up|24
6118916|NCT00095238|21097316|P1|Overall Study|Lost to Follow-up|19
6118917|NCT00095238|21097315|P2|Overall Study|Death|170
6118918|NCT00095238|21097316|P1|Overall Study|Death|154
6118919|NCT00095238|21097315|P2|Overall Study|Subject Withdrew Consent|223
6118920|NCT00095238|21097316|P1|Overall Study|Subject Withdrew Consent|208
6118921|NCT00095238|21097315|P2|Overall Study|Adverse Event|287
6118922|NCT00095238|21097316|P1|Overall Study|Adverse Event|331
6118923|NCT00095238|21097315|P2|Overall Study|Lack of Efficacy|9
6118924|NCT00095238|21097316|P1|Overall Study|Lack of Efficacy|9
6118925|NCT00095212|21097378|P2|Overall Study|Withdrawal by Subject|3
6118926|NCT00095212|21097379|P1|Overall Study|Withdrawal by Subject|1
6118927|NCT00095199|21097409|P4|Overall Study|Data inadvertently lost by site|0
6118928|NCT00095199|21097410|P3|Overall Study|Data inadvertently lost by site|0
6118929|NCT00095199|21097411|P2|Overall Study|Data inadvertently lost by site|0
6118930|NCT00095199|21097412|P1|Overall Study|Data inadvertently lost by site|1
6118931|NCT00095199|21097409|P4|Overall Study|Primary tumor removed in other surgery|0
6118932|NCT00095199|21097410|P3|Overall Study|Primary tumor removed in other surgery|0
6118933|NCT00095199|21097411|P2|Overall Study|Primary tumor removed in other surgery|1
6118934|NCT00095199|21097412|P1|Overall Study|Primary tumor removed in other surgery|0
6118935|NCT00095199|21097409|P4|Overall Study|Started radiotherapy regimen|0
6118936|NCT00095199|21097410|P3|Overall Study|Started radiotherapy regimen|0
6118937|NCT00095199|21097411|P2|Overall Study|Started radiotherapy regimen|1
6118938|NCT00095199|21097412|P1|Overall Study|Started radiotherapy regimen|0
6118939|NCT00095199|21097409|P4|Overall Study|Started Palliative Radiotherapy|0
6118940|NCT00095199|21097410|P3|Overall Study|Started Palliative Radiotherapy|0
6118941|NCT00095199|21097411|P2|Overall Study|Started Palliative Radiotherapy|0
6118942|NCT00095199|21097412|P1|Overall Study|Started Palliative Radiotherapy|1
6118943|NCT00095199|21097409|P4|Overall Study|Not eligible|1
6118944|NCT00095199|21097410|P3|Overall Study|Not eligible|0
6118945|NCT00095199|21097411|P2|Overall Study|Not eligible|7
6118946|NCT00095199|21097412|P1|Overall Study|Not eligible|1
6118947|NCT00095199|21097409|P4|Overall Study|Physician Decision|1
6118948|NCT00095199|21097410|P3|Overall Study|Physician Decision|1
6118949|NCT00095199|21097411|P2|Overall Study|Physician Decision|6
6118950|NCT00095199|21097412|P1|Overall Study|Physician Decision|5
6118951|NCT00095199|21097409|P4|Overall Study|Surgery needed could not start in 7 days|0
6118952|NCT00095199|21097410|P3|Overall Study|Surgery needed could not start in 7 days|1
6118953|NCT00095199|21097411|P2|Overall Study|Surgery needed could not start in 7 days|0
6118954|NCT00095199|21097412|P1|Overall Study|Surgery needed could not start in 7 days|0
6118955|NCT00095199|21097409|P4|Overall Study|Liver function test results elevated|1
6118956|NCT00095199|21097410|P3|Overall Study|Liver function test results elevated|1
6118957|NCT00095199|21097411|P2|Overall Study|Liver function test results elevated|0
6118958|NCT00095199|21097412|P1|Overall Study|Liver function test results elevated|0
6118959|NCT00095199|21097409|P4|Overall Study|Protocol Violation|0
6118960|NCT00095199|21097410|P3|Overall Study|Protocol Violation|2
6118961|NCT00095199|21097411|P2|Overall Study|Protocol Violation|4
6118962|NCT00095199|21097412|P1|Overall Study|Protocol Violation|4
6118963|NCT00095199|21097409|P4|Overall Study|Withdrawal by Subject|22
6118964|NCT00095199|21097410|P3|Overall Study|Withdrawal by Subject|13
6118965|NCT00095199|21097411|P2|Overall Study|Withdrawal by Subject|16
6118966|NCT00095199|21097412|P1|Overall Study|Withdrawal by Subject|21
6118967|NCT00095199|21097409|P4|Overall Study|Death|9
6118968|NCT00095199|21097410|P3|Overall Study|Death|11
6118969|NCT00095199|21097411|P2|Overall Study|Death|6
6118970|NCT00095199|21097412|P1|Overall Study|Death|10
6118971|NCT00095199|21097409|P4|Overall Study|Progressive disease|98
6118972|NCT00095199|21097410|P3|Overall Study|Progressive disease|105
6118973|NCT00095199|21097411|P2|Overall Study|Progressive disease|179
6118974|NCT00095199|21097412|P1|Overall Study|Progressive disease|213
6118975|NCT00095199|21097409|P4|Overall Study|Adverse Event|11
6118976|NCT00095199|21097410|P3|Overall Study|Adverse Event|26
6118977|NCT00095199|21097411|P2|Overall Study|Adverse Event|22
6118978|NCT00095199|21097412|P1|Overall Study|Adverse Event|40
6118979|NCT00095173|21097450|P6|Open-Label Extension Phase (Period C)|Other|8
6118980|NCT00095173|21097451|P5|Open-Label Extension Phase (Period C)|Other|6
6118981|NCT00095173|21097452|P4|Open-Label Extension Phase (Period C)|Other|4
6118982|NCT00095173|21097453|P3|Open-Label Extension Phase (Period C)|Other|0
6118983|NCT00095173|21097454|P2|Open-Label Extension Phase (Period C)|Other|0
6118984|NCT00095173|21097455|P1|Open-Label Extension Phase (Period C)|Other|0
6118985|NCT00095173|21097450|P6|Open-Label Extension Phase (Period C)|Pregnancy|3
6118986|NCT00095173|21097451|P5|Open-Label Extension Phase (Period C)|Pregnancy|2
6118987|NCT00095173|21097452|P4|Open-Label Extension Phase (Period C)|Pregnancy|1
6118988|NCT00095173|21097453|P3|Open-Label Extension Phase (Period C)|Pregnancy|0
6118989|NCT00095173|21097454|P2|Open-Label Extension Phase (Period C)|Pregnancy|0
6118990|NCT00095173|21097455|P1|Open-Label Extension Phase (Period C)|Pregnancy|0
6118991|NCT00095173|21097450|P6|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2
6118992|NCT00095173|21097451|P5|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2
6118993|NCT00095173|21097452|P4|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0
6118994|NCT00095173|21097453|P3|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0
6118995|NCT00095173|21097454|P2|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0
6118996|NCT00095173|21097455|P1|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0
6118997|NCT00095173|21097450|P6|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1
6118998|NCT00095173|21097451|P5|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1
6118999|NCT00095173|21097452|P4|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0
6119000|NCT00095173|21097453|P3|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0
6119001|NCT00095173|21097454|P2|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0
6119002|NCT00095173|21097455|P1|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0
6119003|NCT00095173|21097450|P6|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0
6119004|NCT00095173|21097451|P5|Open-Label Extension Phase (Period C)|Withdrawal by Subject|6
6119005|NCT00095173|21097452|P4|Open-Label Extension Phase (Period C)|Withdrawal by Subject|4
6119006|NCT00095173|21097453|P3|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0
6119007|NCT00095173|21097454|P2|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0
6119008|NCT00095173|21097455|P1|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0
6119009|NCT00095173|21097450|P6|Open-Label Extension Phase (Period C)|Lost to Follow-up|6
6119010|NCT00095173|21097451|P5|Open-Label Extension Phase (Period C)|Lost to Follow-up|5
6119011|NCT00095173|21097452|P4|Open-Label Extension Phase (Period C)|Lost to Follow-up|2
6119012|NCT00095173|21097453|P3|Open-Label Extension Phase (Period C)|Lost to Follow-up|0
6119013|NCT00095173|21097454|P2|Open-Label Extension Phase (Period C)|Lost to Follow-up|0
6119014|NCT00095173|21097455|P1|Open-Label Extension Phase (Period C)|Lost to Follow-up|0
6119015|NCT00095173|21097450|P6|Open-Label Extension Phase (Period C)|Lack of Efficacy|8
6119016|NCT00095173|21097451|P5|Open-Label Extension Phase (Period C)|Lack of Efficacy|5
6119017|NCT00095173|21097452|P4|Open-Label Extension Phase (Period C)|Lack of Efficacy|11
6119018|NCT00095173|21097453|P3|Open-Label Extension Phase (Period C)|Lack of Efficacy|0
6119019|NCT00095173|21097454|P2|Open-Label Extension Phase (Period C)|Lack of Efficacy|0
6119020|NCT00095173|21097455|P1|Open-Label Extension Phase (Period C)|Lack of Efficacy|0
6119021|NCT00095173|21097450|P6|Open-Label Extension Phase (Period C)|Adverse Event|3
6119022|NCT00095173|21097451|P5|Open-Label Extension Phase (Period C)|Adverse Event|2
6119023|NCT00095173|21097452|P4|Open-Label Extension Phase (Period C)|Adverse Event|1
6119024|NCT00095173|21097453|P3|Open-Label Extension Phase (Period C)|Adverse Event|0
6119025|NCT00095173|21097454|P2|Open-Label Extension Phase (Period C)|Adverse Event|0
6119026|NCT00095173|21097455|P1|Open-Label Extension Phase (Period C)|Adverse Event|0
6119027|NCT00095173|21097450|P6|Open-Label Extension Phase (Period C)|Death|1
6119028|NCT00095173|21097451|P5|Open-Label Extension Phase (Period C)|Death|0
6119029|NCT00095173|21097452|P4|Open-Label Extension Phase (Period C)|Death|0
6119030|NCT00095173|21097453|P3|Open-Label Extension Phase (Period C)|Death|0
6119031|NCT00095173|21097454|P2|Open-Label Extension Phase (Period C)|Death|0
6119032|NCT00095173|21097455|P1|Open-Label Extension Phase (Period C)|Death|0
6119033|NCT00095173|21097450|P6|Double-Blind Phase (Period B)|Withdrawal by Subject|0
6119034|NCT00095173|21097451|P5|Double-Blind Phase (Period B)|Withdrawal by Subject|0
6119035|NCT00095173|21097452|P4|Double-Blind Phase (Period B)|Withdrawal by Subject|0
6119036|NCT00095173|21097453|P3|Double-Blind Phase (Period B)|Withdrawal by Subject|0
6119037|NCT00095173|21097454|P2|Double-Blind Phase (Period B)|Withdrawal by Subject|1
6119038|NCT00095173|21097455|P1|Double-Blind Phase (Period B)|Withdrawal by Subject|0
6119039|NCT00095173|21097450|P6|Double-Blind Phase (Period B)|Lack of Efficacy|0
6119040|NCT00095173|21097451|P5|Double-Blind Phase (Period B)|Lack of Efficacy|0
6119041|NCT00095173|21097452|P4|Double-Blind Phase (Period B)|Lack of Efficacy|0
6119042|NCT00095173|21097453|P3|Double-Blind Phase (Period B)|Lack of Efficacy|31
6119043|NCT00095173|21097454|P2|Double-Blind Phase (Period B)|Lack of Efficacy|10
6119044|NCT00095173|21097455|P1|Double-Blind Phase (Period B)|Lack of Efficacy|0
6119045|NCT00095173|21097450|P6|Open-Label Lead-In Phase (Period A)|Other|0
6119046|NCT00095173|21097451|P5|Open-Label Lead-In Phase (Period A)|Other|0
6119047|NCT00095173|21097452|P4|Open-Label Lead-In Phase (Period A)|Other|0
6119048|NCT00095173|21097453|P3|Open-Label Lead-In Phase (Period A)|Other|0
6119049|NCT00095173|21097454|P2|Open-Label Lead-In Phase (Period A)|Other|0
6119050|NCT00095173|21097455|P1|Open-Label Lead-In Phase (Period A)|Other|1
6119051|NCT00095173|21097450|P6|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0
6119052|NCT00095173|21097451|P5|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0
6119053|NCT00095173|21097452|P4|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0
6119054|NCT00095173|21097453|P3|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0
6119055|NCT00095173|21097454|P2|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0
6119056|NCT00095173|21097455|P1|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|1
6119057|NCT00095173|21097450|P6|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0
6119058|NCT00095173|21097451|P5|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0
6119059|NCT00095173|21097452|P4|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0
6119060|NCT00095173|21097453|P3|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0
6119061|NCT00095173|21097454|P2|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0
6119062|NCT00095173|21097455|P1|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|17
6119063|NCT00095173|21097450|P6|Open-Label Lead-In Phase (Period A)|Adverse Event|0
6119064|NCT00095173|21097451|P5|Open-Label Lead-In Phase (Period A)|Adverse Event|0
6119065|NCT00095173|21097452|P4|Open-Label Lead-In Phase (Period A)|Adverse Event|0
6119066|NCT00095173|21097453|P3|Open-Label Lead-In Phase (Period A)|Adverse Event|0
6119067|NCT00095173|21097454|P2|Open-Label Lead-In Phase (Period A)|Adverse Event|0
6119068|NCT00095173|21097455|P1|Open-Label Lead-In Phase (Period A)|Adverse Event|1
6119069|NCT00095147|21097493|P5|Long-term Extension Period|Leaving country|1
6119070|NCT00095147|21097494|P4|Long-term Extension Period|Leaving country|0
6119071|NCT00095147|21097495|P3|Long-term Extension Period|Leaving country|0
6119072|NCT00095147|21097496|P2|Long-term Extension Period|Leaving country|0
6119073|NCT00095147|21097497|P1|Long-term Extension Period|Leaving country|0
6119074|NCT00095147|21097493|P5|Long-term Extension Period|Participant chose to use Revellex|1
6119075|NCT00095147|21097494|P4|Long-term Extension Period|Participant chose to use Revellex|0
6119076|NCT00095147|21097495|P3|Long-term Extension Period|Participant chose to use Revellex|0
6119077|NCT00095147|21097496|P2|Long-term Extension Period|Participant chose to use Revellex|0
6119078|NCT00095147|21097497|P1|Long-term Extension Period|Participant chose to use Revellex|0
6119079|NCT00095147|21097493|P5|Long-term Extension Period|No longer meets study criteria|1
6119080|NCT00095147|21097494|P4|Long-term Extension Period|No longer meets study criteria|0
6119081|NCT00095147|21097495|P3|Long-term Extension Period|No longer meets study criteria|0
6119082|NCT00095147|21097496|P2|Long-term Extension Period|No longer meets study criteria|0
6119083|NCT00095147|21097497|P1|Long-term Extension Period|No longer meets study criteria|0
6119084|NCT00095147|21097493|P5|Long-term Extension Period|Pregnancy|1
6119085|NCT00095147|21097494|P4|Long-term Extension Period|Pregnancy|0
6119086|NCT00095147|21097495|P3|Long-term Extension Period|Pregnancy|0
6119087|NCT00095147|21097496|P2|Long-term Extension Period|Pregnancy|0
6119088|NCT00095147|21097497|P1|Long-term Extension Period|Pregnancy|0
6119089|NCT00095147|21097493|P5|Long-term Extension Period|Withdrawal of consent|12
6119090|NCT00095147|21097494|P4|Long-term Extension Period|Withdrawal of consent|0
6119091|NCT00095147|21097495|P3|Long-term Extension Period|Withdrawal of consent|0
6119092|NCT00095147|21097496|P2|Long-term Extension Period|Withdrawal of consent|0
6119093|NCT00095147|21097497|P1|Long-term Extension Period|Withdrawal of consent|0
6119094|NCT00095147|21097493|P5|Long-term Extension Period|Lost to Follow-up|6
6119095|NCT00095147|21097494|P4|Long-term Extension Period|Lost to Follow-up|0
6119096|NCT00095147|21097495|P3|Long-term Extension Period|Lost to Follow-up|0
6119097|NCT00095147|21097496|P2|Long-term Extension Period|Lost to Follow-up|0
6119098|NCT00095147|21097497|P1|Long-term Extension Period|Lost to Follow-up|0
6119099|NCT00095147|21097493|P5|Long-term Extension Period|Lack of Efficacy|9
6119100|NCT00095147|21097494|P4|Long-term Extension Period|Lack of Efficacy|0
6119101|NCT00095147|21097495|P3|Long-term Extension Period|Lack of Efficacy|0
6119102|NCT00095147|21097496|P2|Long-term Extension Period|Lack of Efficacy|0
6119103|NCT00095147|21097497|P1|Long-term Extension Period|Lack of Efficacy|0
6119104|NCT00095147|21097493|P5|Long-term Extension Period|Adverse Event|11
6119105|NCT00095147|21097494|P4|Long-term Extension Period|Adverse Event|0
6119106|NCT00095147|21097495|P3|Long-term Extension Period|Adverse Event|0
6119107|NCT00095147|21097496|P2|Long-term Extension Period|Adverse Event|0
6119108|NCT00095147|21097497|P1|Long-term Extension Period|Adverse Event|0
6119109|NCT00095147|21097493|P5|Long-term Extension Period|Death|3
6119110|NCT00095147|21097494|P4|Long-term Extension Period|Death|0
6119111|NCT00095147|21097495|P3|Long-term Extension Period|Death|0
6119112|NCT00095147|21097496|P2|Long-term Extension Period|Death|0
6119113|NCT00095147|21097497|P1|Long-term Extension Period|Death|0
6119114|NCT00095147|21097493|P5|Double-blind Period 2 (Days 198-365)|Participant relocation|0
6119115|NCT00095147|21097494|P4|Double-blind Period 2 (Days 198-365)|Participant relocation|1
6119116|NCT00095147|21097495|P3|Double-blind Period 2 (Days 198-365)|Participant relocation|0
6119117|NCT00095147|21097496|P2|Double-blind Period 2 (Days 198-365)|Participant relocation|0
6119118|NCT00095147|21097497|P1|Double-blind Period 2 (Days 198-365)|Participant relocation|1
6119119|NCT00095147|21097493|P5|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0
6119120|NCT00095147|21097494|P4|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0
6119121|NCT00095147|21097495|P3|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0
6119122|NCT00095147|21097496|P2|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|2
6119123|NCT00095147|21097497|P1|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|3
6119124|NCT00095147|21097493|P5|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0
6119125|NCT00095147|21097494|P4|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|1
6119126|NCT00095147|21097495|P3|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0
6119127|NCT00095147|21097496|P2|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|4
6119128|NCT00095147|21097497|P1|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|2
6119129|NCT00095147|21097493|P5|Double-blind Period 2 (Days 198-365)|Adverse Event|0
6119130|NCT00095147|21097494|P4|Double-blind Period 2 (Days 198-365)|Adverse Event|0
6119131|NCT00095147|21097495|P3|Double-blind Period 2 (Days 198-365)|Adverse Event|0
6119132|NCT00095147|21097496|P2|Double-blind Period 2 (Days 198-365)|Adverse Event|4
6119133|NCT00095147|21097497|P1|Double-blind Period 2 (Days 198-365)|Adverse Event|2
6119134|NCT00095147|21097493|P5|Double-blind Period 2 (Days 198-365)|Death|0
6119135|NCT00095147|21097494|P4|Double-blind Period 2 (Days 198-365)|Death|1
6119136|NCT00095147|21097495|P3|Double-blind Period 2 (Days 198-365)|Death|0
6119137|NCT00095147|21097496|P2|Double-blind Period 2 (Days 198-365)|Death|1
6119138|NCT00095147|21097497|P1|Double-blind Period 2 (Days 198-365)|Death|0
6119139|NCT00095147|21097493|P5|Double-blind Period 1 (Days 1-197)|Pregnancy|0
6119140|NCT00095147|21097494|P4|Double-blind Period 1 (Days 1-197)|Pregnancy|0
6119141|NCT00095147|21097495|P3|Double-blind Period 1 (Days 1-197)|Pregnancy|0
6119142|NCT00095147|21097496|P2|Double-blind Period 1 (Days 1-197)|Pregnancy|1
6119143|NCT00095147|21097497|P1|Double-blind Period 1 (Days 1-197)|Pregnancy|1
6119144|NCT00095147|21097493|P5|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0
6119145|NCT00095147|21097494|P4|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0
6119146|NCT00095147|21097495|P3|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1
6119147|NCT00095147|21097496|P2|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0
6119148|NCT00095147|21097497|P1|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1
6119149|NCT00095147|21097493|P5|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0
6119150|NCT00095147|21097494|P4|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0
6119151|NCT00095147|21097495|P3|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0
6119152|NCT00095147|21097496|P2|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2
6119153|NCT00095147|21097497|P1|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2
6119154|NCT00095147|21097493|P5|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0
6119155|NCT00095147|21097494|P4|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0
6119156|NCT00095147|21097495|P3|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|1
6119157|NCT00095147|21097496|P2|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2
6119158|NCT00095147|21097497|P1|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2
6119159|NCT00095147|21097493|P5|Double-blind Period 1 (Days 1-197)|Adverse Event|0
6119160|NCT00095147|21097494|P4|Double-blind Period 1 (Days 1-197)|Adverse Event|0
6119161|NCT00095147|21097495|P3|Double-blind Period 1 (Days 1-197)|Adverse Event|1
6119162|NCT00095147|21097496|P2|Double-blind Period 1 (Days 1-197)|Adverse Event|8
6119163|NCT00095147|21097497|P1|Double-blind Period 1 (Days 1-197)|Adverse Event|2
6119164|NCT00095147|21097493|P5|Double-blind Period 1 (Days 1-197)|Death|0
6119165|NCT00095147|21097494|P4|Double-blind Period 1 (Days 1-197)|Death|0
6119166|NCT00095147|21097495|P3|Double-blind Period 1 (Days 1-197)|Death|0
6119167|NCT00095147|21097496|P2|Double-blind Period 1 (Days 1-197)|Death|0
6119168|NCT00095147|21097497|P1|Double-blind Period 1 (Days 1-197)|Death|1
6119169|NCT00095121|21097692|P2|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|0
6119170|NCT00095121|21097693|P1|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|2
6119171|NCT00095121|21097692|P2|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|0
6119172|NCT00095121|21097693|P1|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|1
6119173|NCT00095056|21097739|P2|Phase B (Weeks 12-54)|Protocol Violation|1
6119174|NCT00095056|21097740|P1|Phase B (Weeks 12-54)|Protocol Violation|0
6119175|NCT00095056|21097739|P2|Phase B (Weeks 12-54)|Protocol specific criteria|0
6119176|NCT00095056|21097740|P1|Phase B (Weeks 12-54)|Protocol specific criteria|1
6119177|NCT00095056|21097739|P2|Phase B (Weeks 12-54)|Death|1
6119178|NCT00095056|21097740|P1|Phase B (Weeks 12-54)|Death|3
6119179|NCT00095056|21097739|P2|Phase B (Weeks 12-54)|Patient Moved|0
6119180|NCT00095056|21097740|P1|Phase B (Weeks 12-54)|Patient Moved|1
6119181|NCT00095056|21097739|P2|Phase B (Weeks 12-54)|Withdrawal by Subject|1
6119182|NCT00095056|21097740|P1|Phase B (Weeks 12-54)|Withdrawal by Subject|2
6119183|NCT00095056|21097739|P2|Phase B (Weeks 12-54)|Lost to Follow-up|0
6119184|NCT00095056|21097740|P1|Phase B (Weeks 12-54)|Lost to Follow-up|1
6119185|NCT00095056|21097739|P2|Phase B (Weeks 12-54)|Adverse Event|2
6119186|NCT00095056|21097740|P1|Phase B (Weeks 12-54)|Adverse Event|2
6119187|NCT00095056|21097739|P2|Phase A (Weeks 0-12)|Protocol specific criteria|0
6119188|NCT00095056|21097740|P1|Phase A (Weeks 0-12)|Protocol specific criteria|2
6119189|NCT00095056|21097739|P2|Phase A (Weeks 0-12)|Death|0
6119190|NCT00095056|21097740|P1|Phase A (Weeks 0-12)|Death|1
6119191|NCT00095056|21097739|P2|Phase A (Weeks 0-12)|Withdrawal by Subject|0
6119192|NCT00095056|21097740|P1|Phase A (Weeks 0-12)|Withdrawal by Subject|3
6119193|NCT00095056|21097739|P2|Phase A (Weeks 0-12)|Adverse Event|1
6119194|NCT00095056|21097740|P1|Phase A (Weeks 0-12)|Adverse Event|1
6119195|NCT00094861|21097869|P2|Overall Study|Other|0
6119196|NCT00094861|21097870|P1|Overall Study|Other|3
6119197|NCT00094861|21097869|P2|Overall Study|Death|2
6119198|NCT00094861|21097870|P1|Overall Study|Death|4
6119199|NCT00094861|21097869|P2|Overall Study|Lost to Follow-up|1
6119200|NCT00094861|21097870|P1|Overall Study|Lost to Follow-up|0
6119201|NCT00094861|21097869|P2|Overall Study|Physician Decision|1
6119202|NCT00094861|21097870|P1|Overall Study|Physician Decision|1
6119203|NCT00094861|21097869|P2|Overall Study|Withdrawal by Subject|3
6119204|NCT00094861|21097870|P1|Overall Study|Withdrawal by Subject|5
6119205|NCT00094861|21097869|P2|Overall Study|Adverse Event|2
6119206|NCT00094861|21097870|P1|Overall Study|Adverse Event|5
6119207|NCT00094835|21097897|P7|Overall Study|Other|0
6119208|NCT00094835|21097898|P6|Overall Study|Other|0
6119209|NCT00094835|21097899|P5|Overall Study|Other|0
6119210|NCT00094835|21097900|P4|Overall Study|Other|1
6119211|NCT00094835|21097901|P3|Overall Study|Other|1
6119212|NCT00094835|21097902|P2|Overall Study|Other|1
6119213|NCT00094835|21097903|P1|Overall Study|Other|1
6119214|NCT00094835|21097897|P7|Overall Study|Non-compliance|1
6119215|NCT00094835|21097898|P6|Overall Study|Non-compliance|2
6119216|NCT00094835|21097899|P5|Overall Study|Non-compliance|2
6119217|NCT00094835|21097900|P4|Overall Study|Non-compliance|0
6119218|NCT00094835|21097901|P3|Overall Study|Non-compliance|2
6119219|NCT00094835|21097902|P2|Overall Study|Non-compliance|2
6119220|NCT00094835|21097903|P1|Overall Study|Non-compliance|1
6119221|NCT00094835|21097897|P7|Overall Study|Death|0
6119222|NCT00094835|21097898|P6|Overall Study|Death|0
6119223|NCT00094835|21097899|P5|Overall Study|Death|1
6119224|NCT00094835|21097900|P4|Overall Study|Death|0
6119225|NCT00094835|21097901|P3|Overall Study|Death|0
6119226|NCT00094835|21097902|P2|Overall Study|Death|0
6119227|NCT00094835|21097903|P1|Overall Study|Death|1
6119228|NCT00094835|21097897|P7|Overall Study|Lost to Follow-up|0
6119229|NCT00094835|21097898|P6|Overall Study|Lost to Follow-up|0
6119230|NCT00094835|21097899|P5|Overall Study|Lost to Follow-up|1
6119231|NCT00094835|21097900|P4|Overall Study|Lost to Follow-up|0
6119232|NCT00094835|21097901|P3|Overall Study|Lost to Follow-up|0
6119233|NCT00094835|21097902|P2|Overall Study|Lost to Follow-up|0
6119234|NCT00094835|21097903|P1|Overall Study|Lost to Follow-up|0
6119235|NCT00094835|21097897|P7|Overall Study|Withdrawal by Subject|1
6119236|NCT00094835|21097898|P6|Overall Study|Withdrawal by Subject|0
6119237|NCT00094835|21097899|P5|Overall Study|Withdrawal by Subject|0
6119238|NCT00094835|21097900|P4|Overall Study|Withdrawal by Subject|0
6119239|NCT00094835|21097901|P3|Overall Study|Withdrawal by Subject|0
6119240|NCT00094835|21097902|P2|Overall Study|Withdrawal by Subject|0
6119241|NCT00094835|21097903|P1|Overall Study|Withdrawal by Subject|0
6119242|NCT00094835|21097897|P7|Overall Study|Physician Decision|0
6119243|NCT00094835|21097898|P6|Overall Study|Physician Decision|1
6119244|NCT00094835|21097899|P5|Overall Study|Physician Decision|0
6119245|NCT00094835|21097900|P4|Overall Study|Physician Decision|0
6119246|NCT00094835|21097901|P3|Overall Study|Physician Decision|0
6119247|NCT00094835|21097902|P2|Overall Study|Physician Decision|0
6119248|NCT00094835|21097903|P1|Overall Study|Physician Decision|1
6119249|NCT00094809|21097981|P2|Overall Study|Other|1
6119250|NCT00094809|21097982|P1|Overall Study|Other|1
6119251|NCT00094809|21097981|P2|Overall Study|Study drug not received|8
6119252|NCT00094809|21097982|P1|Overall Study|Study drug not received|2
6119253|NCT00094809|21097981|P2|Overall Study|Informed consent signed after treatment|0
6119254|NCT00094809|21097982|P1|Overall Study|Informed consent signed after treatment|1
6119255|NCT00094809|21097981|P2|Overall Study|Other|4
6119256|NCT00094809|21097982|P1|Overall Study|Other|2
6119257|NCT00094809|21097981|P2|Overall Study|Protocol-specified criteria|1
6119258|NCT00094809|21097982|P1|Overall Study|Protocol-specified criteria|1
6119259|NCT00094809|21097981|P2|Overall Study|Death|25
6119260|NCT00094809|21097982|P1|Overall Study|Death|19
6119261|NCT00094809|21097981|P2|Overall Study|Lost to Follow-up|6
6119262|NCT00094809|21097982|P1|Overall Study|Lost to Follow-up|6
6119263|NCT00094809|21097981|P2|Overall Study|Physician Decision|5
6119264|NCT00094809|21097982|P1|Overall Study|Physician Decision|3
6119265|NCT00094809|21097981|P2|Overall Study|Disease progression|3
6119266|NCT00094809|21097982|P1|Overall Study|Disease progression|3
6119267|NCT00094809|21097981|P2|Overall Study|Withdrawal by Subject|9
6119268|NCT00094809|21097982|P1|Overall Study|Withdrawal by Subject|8
6119269|NCT00094809|21097981|P2|Overall Study|Adverse Event|1
6119270|NCT00094809|21097982|P1|Overall Study|Adverse Event|3
6119271|NCT00094809|21097981|P2|Overall Study|Noncompliance|0
6119272|NCT00094809|21097982|P1|Overall Study|Noncompliance|1
6119273|NCT00094809|21097981|P2|Overall Study|Protocol deviation|2
6119274|NCT00094809|21097982|P1|Overall Study|Protocol deviation|2
6119275|NCT00094770|21098008|P2|Year 2 (Week 0 to Week 104)|Other|23
6119276|NCT00094770|21098009|P1|Year 2 (Week 0 to Week 104)|Other|15
6119277|NCT00094770|21098008|P2|Year 2 (Week 0 to Week 104)|Site Terminated|2
6119278|NCT00094770|21098009|P1|Year 2 (Week 0 to Week 104)|Site Terminated|2
6119279|NCT00094770|21098008|P2|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|38
6119280|NCT00094770|21098009|P1|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|28
6119281|NCT00094770|21098008|P2|Year 2 (Week 0 to Week 104)|Patient Moved|2
6119282|NCT00094770|21098009|P1|Year 2 (Week 0 to Week 104)|Patient Moved|6
6119283|NCT00094770|21098008|P2|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|30
6119284|NCT00094770|21098009|P1|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|29
6119285|NCT00094770|21098008|P2|Year 2 (Week 0 to Week 104)|Protocol Violation|12
6119286|NCT00094770|21098009|P1|Year 2 (Week 0 to Week 104)|Protocol Violation|13
6119287|NCT00094770|21098008|P2|Year 2 (Week 0 to Week 104)|Lost to Follow-up|15
6119288|NCT00094770|21098009|P1|Year 2 (Week 0 to Week 104)|Lost to Follow-up|25
6119289|NCT00094770|21098008|P2|Year 2 (Week 0 to Week 104)|Lack of Efficacy|162
6119290|NCT00094770|21098009|P1|Year 2 (Week 0 to Week 104)|Lack of Efficacy|180
6119291|NCT00094770|21098008|P2|Year 2 (Week 0 to Week 104)|Adverse Event|36
6119292|NCT00094770|21098009|P1|Year 2 (Week 0 to Week 104)|Adverse Event|35
6119293|NCT00094770|21098008|P2|Year 1 ( Week 0 to Week 52)|Other|11
6119294|NCT00094770|21098009|P1|Year 1 ( Week 0 to Week 52)|Other|10
6119295|NCT00094770|21098008|P2|Year 1 ( Week 0 to Week 52)|Site Terminated|2
6119296|NCT00094770|21098009|P1|Year 1 ( Week 0 to Week 52)|Site Terminated|2
6119297|NCT00094770|21098008|P2|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|28
6119298|NCT00094770|21098009|P1|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|25
6119299|NCT00094770|21098008|P2|Year 1 ( Week 0 to Week 52)|Patient Moved|2
6119300|NCT00094770|21098009|P1|Year 1 ( Week 0 to Week 52)|Patient Moved|6
6119301|NCT00094770|21098008|P2|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|25
6119302|NCT00094770|21098009|P1|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|19
6119303|NCT00094770|21098008|P2|Year 1 ( Week 0 to Week 52)|Protocol Violation|10
6119304|NCT00094770|21098009|P1|Year 1 ( Week 0 to Week 52)|Protocol Violation|10
6119305|NCT00094770|21098008|P2|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|10
6119306|NCT00094770|21098009|P1|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|19
6119307|NCT00094770|21098008|P2|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|58
6119308|NCT00094770|21098009|P1|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|86
6119309|NCT00094770|21098008|P2|Year 1 ( Week 0 to Week 52)|Adverse Event|26
6119310|NCT00094770|21098009|P1|Year 1 ( Week 0 to Week 52)|Adverse Event|25
6119311|NCT00094757|21098040|P3|Overall Study|Protocol specified discontinuation|0
6119312|NCT00094757|21098041|P2|Overall Study|Protocol specified discontinuation|3
6119313|NCT00094757|21098042|P1|Overall Study|Protocol specified discontinuation|1
6119314|NCT00094757|21098040|P3|Overall Study|Other|1
6119315|NCT00094757|21098041|P2|Overall Study|Other|3
6119316|NCT00094757|21098042|P1|Overall Study|Other|3
6119317|NCT00094757|21098040|P3|Overall Study|Withdrawal by Subject|5
6119318|NCT00094757|21098041|P2|Overall Study|Withdrawal by Subject|21
6119319|NCT00094757|21098042|P1|Overall Study|Withdrawal by Subject|14
6119320|NCT00094757|21098040|P3|Overall Study|Protocol Violation|3
6119321|NCT00094757|21098041|P2|Overall Study|Protocol Violation|5
6119322|NCT00094757|21098042|P1|Overall Study|Protocol Violation|8
6119323|NCT00094757|21098040|P3|Overall Study|Patient Moved|1
6119324|NCT00094757|21098041|P2|Overall Study|Patient Moved|1
6119325|NCT00094757|21098042|P1|Overall Study|Patient Moved|2
6119326|NCT00094757|21098040|P3|Overall Study|Lost to Follow-up|6
6119327|NCT00094757|21098041|P2|Overall Study|Lost to Follow-up|5
6119328|NCT00094757|21098042|P1|Overall Study|Lost to Follow-up|3
6119329|NCT00094757|21098040|P3|Overall Study|Lack of Efficacy|8
6119330|NCT00094757|21098041|P2|Overall Study|Lack of Efficacy|15
6119331|NCT00094757|21098042|P1|Overall Study|Lack of Efficacy|11
6119332|NCT00094757|21098040|P3|Overall Study|Adverse Event|6
6119333|NCT00094757|21098041|P2|Overall Study|Adverse Event|9
6119334|NCT00094757|21098042|P1|Overall Study|Adverse Event|11
6119335|NCT00094653|21098062|P3|Overall Study|Protocol Violation|1
6119336|NCT00094653|21098063|P2|Overall Study|Protocol Violation|0
6119337|NCT00094653|21098064|P1|Overall Study|Protocol Violation|0
6119338|NCT00094653|21098062|P3|Overall Study|Lost to Follow-up|1
6119339|NCT00094653|21098063|P2|Overall Study|Lost to Follow-up|2
6119340|NCT00094653|21098064|P1|Overall Study|Lost to Follow-up|3
6119341|NCT00094653|21098062|P3|Overall Study|Other|2
6119342|NCT00094653|21098063|P2|Overall Study|Other|2
6119343|NCT00094653|21098064|P1|Overall Study|Other|2
6119344|NCT00094653|21098062|P3|Overall Study|Subject Withdrew Consent|3
6119345|NCT00094653|21098063|P2|Overall Study|Subject Withdrew Consent|2
6119346|NCT00094653|21098064|P1|Overall Study|Subject Withdrew Consent|10
6119347|NCT00094653|21098062|P3|Overall Study|Death|119
6119348|NCT00094653|21098063|P2|Overall Study|Death|100
6119349|NCT00094653|21098064|P1|Overall Study|Death|306
6119350|NCT00094575|21098127|P2|Overall Study|Death|146
6119351|NCT00094575|21098128|P1|Overall Study|Death|146
6119352|NCT00094536|21098148|P1|Treatment and Follow-up|Unable to attend visits|1
6119353|NCT00094536|21098148|P1|Treatment and Follow-up|Subject non-compliance|9
6119354|NCT00094536|21098148|P1|Treatment and Follow-up|Withdrawal by Subject|1
6119355|NCT00094536|21098148|P1|Treatment and Follow-up|Lost to Follow-up|7
6119356|NCT00094536|21098148|P1|Treatment and Follow-up|Lack of Efficacy|9
6119357|NCT00094536|21098148|P1|Treatment and Follow-up|Adverse Event|4
6119358|NCT00094536|21098148|P1|Inclusion Exclusion Evaluation|Did not qualify for study treatment|24
6119359|NCT00094458|21098172|P6|OLE: Open-Label Extension|Patient decision|0
6119360|NCT00094458|21098173|P5|OLE: Open-Label Extension|Patient decision|1
6119361|NCT00094458|21098174|P4|OLE: Open-Label Extension|Patient decision|0
6119362|NCT00094458|21098175|P3|OLE: Open-Label Extension|Patient decision|0
6119363|NCT00094458|21098176|P2|OLE: Open-Label Extension|Patient decision|0
6119364|NCT00094458|21098177|P1|OLE: Open-Label Extension|Patient decision|0
6119365|NCT00094458|21098172|P6|OLE: Open-Label Extension|Inadequate therapeutic effect|0
6119366|NCT00094458|21098173|P5|OLE: Open-Label Extension|Inadequate therapeutic effect|1
6119367|NCT00094458|21098174|P4|OLE: Open-Label Extension|Inadequate therapeutic effect|1
6119368|NCT00094458|21098175|P3|OLE: Open-Label Extension|Inadequate therapeutic effect|0
6119369|NCT00094458|21098176|P2|OLE: Open-Label Extension|Inadequate therapeutic effect|0
6119370|NCT00094458|21098177|P1|OLE: Open-Label Extension|Inadequate therapeutic effect|0
6119371|NCT00094458|21098172|P6|OLE: Open-Label Extension|Adverse Event|4
6119372|NCT00094458|21098173|P5|OLE: Open-Label Extension|Adverse Event|3
6119373|NCT00094458|21098174|P4|OLE: Open-Label Extension|Adverse Event|0
6119374|NCT00094458|21098175|P3|OLE: Open-Label Extension|Adverse Event|0
6119375|NCT00094458|21098176|P2|OLE: Open-Label Extension|Adverse Event|0
6119376|NCT00094458|21098177|P1|OLE: Open-Label Extension|Adverse Event|0
6119377|NCT00094458|21098172|P6|Study Extension: Week 30 Through Week 50|Other|0
6119378|NCT00094458|21098173|P5|Study Extension: Week 30 Through Week 50|Other|0
6119379|NCT00094458|21098174|P4|Study Extension: Week 30 Through Week 50|Other|0
6119380|NCT00094458|21098175|P3|Study Extension: Week 30 Through Week 50|Other|3
6119381|NCT00094458|21098176|P2|Study Extension: Week 30 Through Week 50|Other|2
6119382|NCT00094458|21098177|P1|Study Extension: Week 30 Through Week 50|Other|1
6119383|NCT00094458|21098172|P6|Study Extension: Week 30 Through Week 50|Adverse Event|0
6119384|NCT00094458|21098173|P5|Study Extension: Week 30 Through Week 50|Adverse Event|0
6119385|NCT00094458|21098174|P4|Study Extension: Week 30 Through Week 50|Adverse Event|0
6119386|NCT00094458|21098175|P3|Study Extension: Week 30 Through Week 50|Adverse Event|7
6119387|NCT00094458|21098176|P2|Study Extension: Week 30 Through Week 50|Adverse Event|9
6119388|NCT00094458|21098177|P1|Study Extension: Week 30 Through Week 50|Adverse Event|3
6119389|NCT00094458|21098172|P6|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0
6119390|NCT00094458|21098173|P5|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0
6119391|NCT00094458|21098174|P4|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0
6119392|NCT00094458|21098175|P3|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|4
6119393|NCT00094458|21098176|P2|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0
6119394|NCT00094458|21098177|P1|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|2
6119395|NCT00094458|21098172|P6|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0
6119396|NCT00094458|21098173|P5|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0
6119397|NCT00094458|21098174|P4|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0
6119398|NCT00094458|21098175|P3|Study Extension: Week 30 Through Week 50|Lost to Follow-up|4
6119399|NCT00094458|21098176|P2|Study Extension: Week 30 Through Week 50|Lost to Follow-up|1
6119400|NCT00094458|21098177|P1|Study Extension: Week 30 Through Week 50|Lost to Follow-up|2
6119401|NCT00094458|21098172|P6|Main Study: Through Week 30|Other|0
6119402|NCT00094458|21098173|P5|Main Study: Through Week 30|Other|0
6119403|NCT00094458|21098174|P4|Main Study: Through Week 30|Other|0
6119404|NCT00094458|21098175|P3|Main Study: Through Week 30|Other|9
6119405|NCT00094458|21098176|P2|Main Study: Through Week 30|Other|16
6119406|NCT00094458|21098177|P1|Main Study: Through Week 30|Other|19
6119407|NCT00094458|21098172|P6|Main Study: Through Week 30|Death|0
6119408|NCT00094458|21098173|P5|Main Study: Through Week 30|Death|0
6119409|NCT00094458|21098174|P4|Main Study: Through Week 30|Death|0
6119410|NCT00094458|21098175|P3|Main Study: Through Week 30|Death|0
6119411|NCT00094458|21098176|P2|Main Study: Through Week 30|Death|0
6119412|NCT00094458|21098177|P1|Main Study: Through Week 30|Death|1
6119413|NCT00094458|21098172|P6|Main Study: Through Week 30|Adverse Event|0
6119414|NCT00094458|21098173|P5|Main Study: Through Week 30|Adverse Event|0
6119415|NCT00094458|21098174|P4|Main Study: Through Week 30|Adverse Event|0
6119416|NCT00094458|21098175|P3|Main Study: Through Week 30|Adverse Event|28
6119417|NCT00094458|21098176|P2|Main Study: Through Week 30|Adverse Event|20
6119418|NCT00094458|21098177|P1|Main Study: Through Week 30|Adverse Event|38
6119419|NCT00094458|21098172|P6|Main Study: Through Week 30|Withdrawal by Subject|0
6119420|NCT00094458|21098173|P5|Main Study: Through Week 30|Withdrawal by Subject|0
6119421|NCT00094458|21098174|P4|Main Study: Through Week 30|Withdrawal by Subject|0
6119422|NCT00094458|21098175|P3|Main Study: Through Week 30|Withdrawal by Subject|7
6119423|NCT00094458|21098176|P2|Main Study: Through Week 30|Withdrawal by Subject|9
6119424|NCT00094458|21098177|P1|Main Study: Through Week 30|Withdrawal by Subject|18
6119425|NCT00094458|21098172|P6|Main Study: Through Week 30|Lost to Follow-up|0
6119426|NCT00094458|21098173|P5|Main Study: Through Week 30|Lost to Follow-up|0
6119427|NCT00094458|21098174|P4|Main Study: Through Week 30|Lost to Follow-up|0
6119428|NCT00094458|21098175|P3|Main Study: Through Week 30|Lost to Follow-up|2
6119429|NCT00094458|21098176|P2|Main Study: Through Week 30|Lost to Follow-up|5
6119430|NCT00094458|21098177|P1|Main Study: Through Week 30|Lost to Follow-up|5
6119431|NCT00094458|21098172|P6|Main Study: Through Week 30|Eligibility criteria not met|0
6119432|NCT00094458|21098173|P5|Main Study: Through Week 30|Eligibility criteria not met|0
6119433|NCT00094458|21098174|P4|Main Study: Through Week 30|Eligibility criteria not met|0
6119434|NCT00094458|21098175|P3|Main Study: Through Week 30|Eligibility criteria not met|2
6119435|NCT00094458|21098176|P2|Main Study: Through Week 30|Eligibility criteria not met|8
6119436|NCT00094458|21098177|P1|Main Study: Through Week 30|Eligibility criteria not met|3
6119437|NCT00094445|21098215|P1|Overall Study|Progressive Disease|2
6119438|NCT00094445|21098215|P1|Overall Study|Lost to Follow-up|1
6119439|NCT00094445|21098215|P1|Overall Study|Withdrawal by Subject|3
6119440|NCT00094328|21098219|P1|Overall Study|Lost to Follow-up|1
6119441|NCT00094302|21098233|P2|Overall Study|Death|246
6119442|NCT00094302|21098234|P1|Overall Study|Death|266
6119443|NCT00094302|21098233|P2|Overall Study|Withdrawal by Subject|111
6119444|NCT00094302|21098234|P1|Overall Study|Withdrawal by Subject|103
6119445|NCT00094302|21098233|P2|Overall Study|Physician Decision|8
6119446|NCT00094302|21098234|P1|Overall Study|Physician Decision|5
6119447|NCT00094302|21098233|P2|Overall Study|Lost to Follow-up|41
6119448|NCT00094302|21098234|P1|Overall Study|Lost to Follow-up|43
6119449|NCT00094172|21098323|P2|Overall Study|Started other MS therapy due to disease|0
6119450|NCT00094172|21098324|P1|Overall Study|Started other MS therapy due to disease|1
6119451|NCT00094172|21098323|P2|Overall Study|Primary endpoint met.|0
6119452|NCT00094172|21098324|P1|Overall Study|Primary endpoint met.|1
6119453|NCT00094172|21098323|P2|Overall Study|Withdrawal by Subject|5
6119454|NCT00094172|21098324|P1|Overall Study|Withdrawal by Subject|10
6119455|NCT00094172|21098323|P2|Overall Study|Protocol Violation|1
6119456|NCT00094172|21098324|P1|Overall Study|Protocol Violation|0
6119457|NCT00094172|21098323|P2|Overall Study|Lost to Follow-up|0
6119458|NCT00094172|21098324|P1|Overall Study|Lost to Follow-up|2
6119459|NCT00094172|21098323|P2|Overall Study|Adverse Event|1
6119460|NCT00094172|21098324|P1|Overall Study|Adverse Event|0
6119461|NCT00094107|21098334|P1|Overall Study|Withdrawal due to Disease Progression|1
6119462|NCT00094107|21098334|P1|Overall Study|Adverse Event|3
6119463|NCT00094107|21098334|P1|Overall Study|Death|5
6119464|NCT00094107|21098334|P1|Overall Study|Lack of Efficacy|23
6119465|NCT00094094|21098343|P1|Overall Study|Adverse Event|7
6119466|NCT00094094|21098343|P1|Overall Study|Lack of Efficacy|23
6119467|NCT00094094|21098343|P1|Overall Study|Death|2
6119468|NCT00094055|21098352|P1|Overall Study|Withdrawal by Subject|9
6119469|NCT00094055|21098352|P1|Overall Study|roll-over to another study|14
6119470|NCT00094055|21098352|P1|Overall Study|clinical progression|1
6119471|NCT00094055|21098352|P1|Overall Study|progressive disease|2
6119472|NCT00094055|21098352|P1|Overall Study|Lost to Follow-up|2
6119473|NCT00094055|21098352|P1|Overall Study|Lack of Efficacy|17
6119474|NCT00094055|21098352|P1|Overall Study|Death|4
6119475|NCT00094055|21098352|P1|Overall Study|Adverse Event|11
6119476|NCT00093808|21098409|P1|Overall Study|Protocol Violation|1
6119477|NCT00093808|21098409|P1|Overall Study|Cancel participation before receiving tx|1
6119478|NCT00093795|21098419|P3|Overall Study|No follow up data|17
6119479|NCT00093795|21098420|P2|Overall Study|No follow up data|16
6119480|NCT00093795|21098421|P1|Overall Study|No follow up data|20
6119481|NCT00093496|21098466|P2|Overall Study|Protocol Violation|3
6119482|NCT00093496|21098467|P1|Overall Study|Protocol Violation|1
6119483|NCT00093470|21098480|P2|Overall Study|ANC < 1000 on day 1 of cycle 1|0
6119484|NCT00093470|21098481|P1|Overall Study|ANC < 1000 on day 1 of cycle 1|1
6119485|NCT00093470|21098480|P2|Overall Study|Never started treatment|0
6119486|NCT00093470|21098481|P1|Overall Study|Never started treatment|1
6119487|NCT00093470|21098480|P2|Overall Study|Physician Decision|0
6119488|NCT00093470|21098481|P1|Overall Study|Physician Decision|2
6119489|NCT00093470|21098480|P2|Overall Study|Other complicating disease|0
6119490|NCT00093470|21098481|P1|Overall Study|Other complicating disease|3
6119491|NCT00093470|21098480|P2|Overall Study|Alternative therapy|0
6119492|NCT00093470|21098481|P1|Overall Study|Alternative therapy|2
6119493|NCT00093470|21098480|P2|Overall Study|Withdrawal by Subject|0
6119494|NCT00093470|21098481|P1|Overall Study|Withdrawal by Subject|8
6119495|NCT00093470|21098480|P2|Overall Study|Death|0
6119496|NCT00093470|21098481|P1|Overall Study|Death|2
6119497|NCT00093470|21098480|P2|Overall Study|Adverse Event|0
6119498|NCT00093470|21098481|P1|Overall Study|Adverse Event|15
6119499|NCT00093470|21098480|P2|Overall Study|Disease progression|0
6119500|NCT00093470|21098481|P1|Overall Study|Disease progression|39
6119501|NCT00093145|21098495|P1|Overall Study|Other|1
6119502|NCT00093145|21098495|P1|Overall Study|Withdrawal by Subject|9
6119503|NCT00093145|21098495|P1|Overall Study|Physician Decision|5
6119504|NCT00093145|21098495|P1|Overall Study|Unacceptable Toxicity Only|2
6119505|NCT00093015|21098537|P2|Overall Study|Death|385
6119506|NCT00093015|21098538|P1|Overall Study|Death|375
6119507|NCT00093015|21098537|P2|Overall Study|Lost to Follow-up|108
6119508|NCT00093015|21098538|P1|Overall Study|Lost to Follow-up|96
6119509|NCT00093015|21098537|P2|Overall Study|Withdrawal by Subject|171
6119510|NCT00093015|21098538|P1|Overall Study|Withdrawal by Subject|194
6119511|NCT00092677|21098566|P2|Overall Study|Adminstrative|9
6119512|NCT00092677|21098567|P1|Overall Study|Adminstrative|5
6119513|NCT00092677|21098566|P2|Overall Study|Lost to Follow-up|2
6119514|NCT00092677|21098567|P1|Overall Study|Lost to Follow-up|0
6119515|NCT00092547|21098611|P3|Long-term Follow-up (Month 42 Visit)|Adverse Event|0
6119516|NCT00092547|21098612|P2|Long-term Follow-up (Month 42 Visit)|Adverse Event|0
6119517|NCT00092547|21098613|P1|Long-term Follow-up (Month 42 Visit)|Adverse Event|1
6119518|NCT00092547|21098611|P3|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|7
6119519|NCT00092547|21098612|P2|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|0
6119520|NCT00092547|21098613|P1|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|14
6119521|NCT00092547|21098611|P3|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|9
6119522|NCT00092547|21098612|P2|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|0
6119523|NCT00092547|21098613|P1|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|6
6119524|NCT00092547|21098611|P3|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0
6119525|NCT00092547|21098612|P2|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0
6119526|NCT00092547|21098613|P1|Extension Vaccine Phase (Month 30 to 37)|Subject moved|3
6119527|NCT00092547|21098611|P3|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0
6119528|NCT00092547|21098612|P2|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0
6119529|NCT00092547|21098613|P1|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|1
6119530|NCT00092547|21098611|P3|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0
6119531|NCT00092547|21098612|P2|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0
6119532|NCT00092547|21098613|P1|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|2
6119533|NCT00092547|21098611|P3|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|0
6119534|NCT00092547|21098612|P2|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|3
6119535|NCT00092547|21098613|P1|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|1
6119536|NCT00092547|21098611|P3|Base Follow-up Phase (Month 18 to 30)|Subject moved|0
6119537|NCT00092547|21098612|P2|Base Follow-up Phase (Month 18 to 30)|Subject moved|2
6119538|NCT00092547|21098613|P1|Base Follow-up Phase (Month 18 to 30)|Subject moved|4
6119539|NCT00092547|21098611|P3|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0
6119540|NCT00092547|21098612|P2|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0
6119541|NCT00092547|21098613|P1|Base Follow-up Phase (Month 7 to 18)|Physician Decision|1
6119542|NCT00092547|21098611|P3|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0
6119543|NCT00092547|21098612|P2|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0
6119544|NCT00092547|21098613|P1|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|1
6119545|NCT00092547|21098611|P3|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|0
6119546|NCT00092547|21098612|P2|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|7
6119547|NCT00092547|21098613|P1|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|13
6119548|NCT00092547|21098611|P3|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|0
6119549|NCT00092547|21098612|P2|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|2
6119550|NCT00092547|21098613|P1|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|4
6119551|NCT00092547|21098611|P3|Base Follow-up Phase (Month 7 to 18)|Subject moved|0
6119552|NCT00092547|21098612|P2|Base Follow-up Phase (Month 7 to 18)|Subject moved|5
6119553|NCT00092547|21098613|P1|Base Follow-up Phase (Month 7 to 18)|Subject moved|1
6119554|NCT00092547|21098611|P3|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|0
6119555|NCT00092547|21098612|P2|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|3
6119556|NCT00092547|21098613|P1|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|5
6119557|NCT00092547|21098611|P3|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0
6119558|NCT00092547|21098612|P2|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|1
6119559|NCT00092547|21098613|P1|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0
6119560|NCT00092547|21098611|P3|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0
6119561|NCT00092547|21098612|P2|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|1
6119562|NCT00092547|21098613|P1|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0
6119563|NCT00092547|21098611|P3|Base Vaccine Phase (Day 1 to Month 7)|Moved|0
6119564|NCT00092547|21098612|P2|Base Vaccine Phase (Day 1 to Month 7)|Moved|1
6119565|NCT00092547|21098613|P1|Base Vaccine Phase (Day 1 to Month 7)|Moved|3
6119566|NCT00092547|21098611|P3|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|0
6119567|NCT00092547|21098612|P2|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|21
6119568|NCT00092547|21098613|P1|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|28
6119569|NCT00092547|21098611|P3|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|0
6119570|NCT00092547|21098612|P2|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|7
6119571|NCT00092547|21098613|P1|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|18
6119572|NCT00092547|21098611|P3|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|0
6119573|NCT00092547|21098612|P2|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|1
6119574|NCT00092547|21098613|P1|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|4
6119575|NCT00092547|21098611|P3|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|0
6119576|NCT00092547|21098612|P2|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|1
6119577|NCT00092547|21098613|P1|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|5
6119578|NCT00092534|21098657|P5|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0
6119579|NCT00092534|21098658|P4|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|1
6119580|NCT00092534|21098659|P3|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0
6119581|NCT00092534|21098660|P2|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0
6119582|NCT00092534|21098661|P1|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0
6119583|NCT00092534|21098657|P5|Base Study EXT|Protocol Violation|0
6119584|NCT00092534|21098658|P4|Base Study EXT|Protocol Violation|0
6119585|NCT00092534|21098659|P3|Base Study EXT|Protocol Violation|15
6119586|NCT00092534|21098660|P2|Base Study EXT|Protocol Violation|0
6119587|NCT00092534|21098661|P1|Base Study EXT|Protocol Violation|0
6119588|NCT00092534|21098657|P5|Base Study EXT|Study ended|0
6119589|NCT00092534|21098658|P4|Base Study EXT|Study ended|0
6119590|NCT00092534|21098659|P3|Base Study EXT|Study ended|29
6119591|NCT00092534|21098660|P2|Base Study EXT|Study ended|0
6119592|NCT00092534|21098661|P1|Base Study EXT|Study ended|0
6119593|NCT00092534|21098657|P5|Base Study EXT|Site closed|0
6119594|NCT00092534|21098658|P4|Base Study EXT|Site closed|0
6119595|NCT00092534|21098659|P3|Base Study EXT|Site closed|21
6119596|NCT00092534|21098660|P2|Base Study EXT|Site closed|0
6119597|NCT00092534|21098661|P1|Base Study EXT|Site closed|0
6119598|NCT00092534|21098657|P5|Base Study EXT|Travel|0
6119599|NCT00092534|21098658|P4|Base Study EXT|Travel|0
6119600|NCT00092534|21098659|P3|Base Study EXT|Travel|2
6119601|NCT00092534|21098660|P2|Base Study EXT|Travel|0
6119602|NCT00092534|21098661|P1|Base Study EXT|Travel|0
6119603|NCT00092534|21098657|P5|Base Study EXT|Participant moved|0
6119604|NCT00092534|21098658|P4|Base Study EXT|Participant moved|0
6119605|NCT00092534|21098659|P3|Base Study EXT|Participant moved|6
6119606|NCT00092534|21098660|P2|Base Study EXT|Participant moved|0
6119607|NCT00092534|21098661|P1|Base Study EXT|Participant moved|0
6119608|NCT00092534|21098657|P5|Base Study EXT|Withdrawal by Subject|0
6119609|NCT00092534|21098658|P4|Base Study EXT|Withdrawal by Subject|0
6119610|NCT00092534|21098659|P3|Base Study EXT|Withdrawal by Subject|18
6119611|NCT00092534|21098660|P2|Base Study EXT|Withdrawal by Subject|0
6119612|NCT00092534|21098661|P1|Base Study EXT|Withdrawal by Subject|0
6119613|NCT00092534|21098657|P5|Base Study EXT|Pregnancy|0
6119614|NCT00092534|21098658|P4|Base Study EXT|Pregnancy|0
6119615|NCT00092534|21098659|P3|Base Study EXT|Pregnancy|12
6119616|NCT00092534|21098660|P2|Base Study EXT|Pregnancy|0
6119617|NCT00092534|21098661|P1|Base Study EXT|Pregnancy|0
6119618|NCT00092534|21098657|P5|Base Study EXT|Physician Decision|0
6119619|NCT00092534|21098658|P4|Base Study EXT|Physician Decision|0
6119620|NCT00092534|21098659|P3|Base Study EXT|Physician Decision|1
6119621|NCT00092534|21098660|P2|Base Study EXT|Physician Decision|0
6119622|NCT00092534|21098661|P1|Base Study EXT|Physician Decision|0
6119623|NCT00092534|21098657|P5|Base Study EXT|Lost to Follow-up|0
6119624|NCT00092534|21098658|P4|Base Study EXT|Lost to Follow-up|0
6119625|NCT00092534|21098659|P3|Base Study EXT|Lost to Follow-up|41
6119626|NCT00092534|21098660|P2|Base Study EXT|Lost to Follow-up|0
6119627|NCT00092534|21098661|P1|Base Study EXT|Lost to Follow-up|0
6119628|NCT00092534|21098657|P5|Base Study Follow-Up Period|Subjects in extension|0
6119629|NCT00092534|21098658|P4|Base Study Follow-Up Period|Subjects in extension|0
6119630|NCT00092534|21098659|P3|Base Study Follow-Up Period|Subjects in extension|0
6119631|NCT00092534|21098660|P2|Base Study Follow-Up Period|Subjects in extension|371
6119632|NCT00092534|21098661|P1|Base Study Follow-Up Period|Subjects in extension|15
6119633|NCT00092534|21098657|P5|Base Study Follow-Up Period|Subjects continuing|0
6119634|NCT00092534|21098658|P4|Base Study Follow-Up Period|Subjects continuing|0
6119635|NCT00092534|21098659|P3|Base Study Follow-Up Period|Subjects continuing|0
6119636|NCT00092534|21098660|P2|Base Study Follow-Up Period|Subjects continuing|31
6119637|NCT00092534|21098661|P1|Base Study Follow-Up Period|Subjects continuing|27
6119638|NCT00092534|21098657|P5|Base Study Follow-Up Period|Site Closed|0
6119639|NCT00092534|21098658|P4|Base Study Follow-Up Period|Site Closed|0
6119640|NCT00092534|21098659|P3|Base Study Follow-Up Period|Site Closed|0
6119641|NCT00092534|21098660|P2|Base Study Follow-Up Period|Site Closed|2
6119642|NCT00092534|21098661|P1|Base Study Follow-Up Period|Site Closed|0
6119643|NCT00092534|21098657|P5|Base Study Follow-Up Period|Travel|0
6119644|NCT00092534|21098658|P4|Base Study Follow-Up Period|Travel|0
6119645|NCT00092534|21098659|P3|Base Study Follow-Up Period|Travel|0
6119646|NCT00092534|21098660|P2|Base Study Follow-Up Period|Travel|7
6119647|NCT00092534|21098661|P1|Base Study Follow-Up Period|Travel|10
6119648|NCT00092534|21098657|P5|Base Study Follow-Up Period|Moved|0
6119649|NCT00092534|21098658|P4|Base Study Follow-Up Period|Moved|0
6119650|NCT00092534|21098659|P3|Base Study Follow-Up Period|Moved|0
6119651|NCT00092534|21098660|P2|Base Study Follow-Up Period|Moved|58
6119652|NCT00092534|21098661|P1|Base Study Follow-Up Period|Moved|62
6119653|NCT00092534|21098657|P5|Base Study Follow-Up Period|Withdrawal by Subject|0
6119654|NCT00092534|21098658|P4|Base Study Follow-Up Period|Withdrawal by Subject|0
6119655|NCT00092534|21098659|P3|Base Study Follow-Up Period|Withdrawal by Subject|0
6119656|NCT00092534|21098660|P2|Base Study Follow-Up Period|Withdrawal by Subject|62
6119657|NCT00092534|21098661|P1|Base Study Follow-Up Period|Withdrawal by Subject|71
6119658|NCT00092534|21098657|P5|Base Study Follow-Up Period|Protocol Violation|0
6119659|NCT00092534|21098658|P4|Base Study Follow-Up Period|Protocol Violation|0
6119660|NCT00092534|21098659|P3|Base Study Follow-Up Period|Protocol Violation|0
6119661|NCT00092534|21098660|P2|Base Study Follow-Up Period|Protocol Violation|2
6119662|NCT00092534|21098661|P1|Base Study Follow-Up Period|Protocol Violation|1
6119663|NCT00092534|21098657|P5|Base Study Follow-Up Period|Pregnancy|0
6119664|NCT00092534|21098658|P4|Base Study Follow-Up Period|Pregnancy|0
6119665|NCT00092534|21098659|P3|Base Study Follow-Up Period|Pregnancy|0
6119666|NCT00092534|21098660|P2|Base Study Follow-Up Period|Pregnancy|10
6119667|NCT00092534|21098661|P1|Base Study Follow-Up Period|Pregnancy|6
6119668|NCT00092534|21098657|P5|Base Study Follow-Up Period|Lost to Follow-up|0
6119669|NCT00092534|21098658|P4|Base Study Follow-Up Period|Lost to Follow-up|0
6119670|NCT00092534|21098659|P3|Base Study Follow-Up Period|Lost to Follow-up|0
6119671|NCT00092534|21098660|P2|Base Study Follow-Up Period|Lost to Follow-up|146
6119672|NCT00092534|21098661|P1|Base Study Follow-Up Period|Lost to Follow-up|120
6119673|NCT00092534|21098657|P5|Base Study Follow-Up Period|Death|0
6119674|NCT00092534|21098658|P4|Base Study Follow-Up Period|Death|0
6119675|NCT00092534|21098659|P3|Base Study Follow-Up Period|Death|0
6119676|NCT00092534|21098660|P2|Base Study Follow-Up Period|Death|1
6119677|NCT00092534|21098661|P1|Base Study Follow-Up Period|Death|2
6119678|NCT00092534|21098657|P5|Base Study Follow-Up Period|Adverse Event|0
6119679|NCT00092534|21098658|P4|Base Study Follow-Up Period|Adverse Event|0
6119680|NCT00092534|21098659|P3|Base Study Follow-Up Period|Adverse Event|0
6119681|NCT00092534|21098660|P2|Base Study Follow-Up Period|Adverse Event|4
6119682|NCT00092534|21098661|P1|Base Study Follow-Up Period|Adverse Event|2
6119683|NCT00092534|21098657|P5|Base Study Vaccination Period|Site Closed|0
6119684|NCT00092534|21098658|P4|Base Study Vaccination Period|Site Closed|0
6119685|NCT00092534|21098659|P3|Base Study Vaccination Period|Site Closed|0
6119686|NCT00092534|21098660|P2|Base Study Vaccination Period|Site Closed|1
6119687|NCT00092534|21098661|P1|Base Study Vaccination Period|Site Closed|0
6119688|NCT00092534|21098657|P5|Base Study Vaccination Period|Travel|0
6119689|NCT00092534|21098658|P4|Base Study Vaccination Period|Travel|0
6119690|NCT00092534|21098659|P3|Base Study Vaccination Period|Travel|0
6119691|NCT00092534|21098660|P2|Base Study Vaccination Period|Travel|0
6119692|NCT00092534|21098661|P1|Base Study Vaccination Period|Travel|1
6119693|NCT00092534|21098657|P5|Base Study Vaccination Period|New Medical History (Not AEs)|0
6119694|NCT00092534|21098658|P4|Base Study Vaccination Period|New Medical History (Not AEs)|0
6119695|NCT00092534|21098659|P3|Base Study Vaccination Period|New Medical History (Not AEs)|0
6119696|NCT00092534|21098660|P2|Base Study Vaccination Period|New Medical History (Not AEs)|0
6119697|NCT00092534|21098661|P1|Base Study Vaccination Period|New Medical History (Not AEs)|5
6119698|NCT00092534|21098657|P5|Base Study Vaccination Period|Moved|0
6119699|NCT00092534|21098658|P4|Base Study Vaccination Period|Moved|0
6119700|NCT00092534|21098659|P3|Base Study Vaccination Period|Moved|0
6119701|NCT00092534|21098660|P2|Base Study Vaccination Period|Moved|12
6119702|NCT00092534|21098661|P1|Base Study Vaccination Period|Moved|14
6119703|NCT00092534|21098657|P5|Base Study Vaccination Period|Withdrawal by Subject|0
6119704|NCT00092534|21098658|P4|Base Study Vaccination Period|Withdrawal by Subject|0
6119705|NCT00092534|21098659|P3|Base Study Vaccination Period|Withdrawal by Subject|0
6119706|NCT00092534|21098660|P2|Base Study Vaccination Period|Withdrawal by Subject|58
6119707|NCT00092534|21098661|P1|Base Study Vaccination Period|Withdrawal by Subject|85
6119708|NCT00092534|21098657|P5|Base Study Vaccination Period|Protocol Violation|0
6119709|NCT00092534|21098658|P4|Base Study Vaccination Period|Protocol Violation|0
6119710|NCT00092534|21098659|P3|Base Study Vaccination Period|Protocol Violation|0
6119711|NCT00092534|21098660|P2|Base Study Vaccination Period|Protocol Violation|1
6119712|NCT00092534|21098661|P1|Base Study Vaccination Period|Protocol Violation|2
6119713|NCT00092534|21098657|P5|Base Study Vaccination Period|Pregnancy|0
6119714|NCT00092534|21098658|P4|Base Study Vaccination Period|Pregnancy|0
6119715|NCT00092534|21098659|P3|Base Study Vaccination Period|Pregnancy|0
6119716|NCT00092534|21098660|P2|Base Study Vaccination Period|Pregnancy|7
6119717|NCT00092534|21098661|P1|Base Study Vaccination Period|Pregnancy|9
6119718|NCT00092534|21098657|P5|Base Study Vaccination Period|Physician Decision|0
6119719|NCT00092534|21098658|P4|Base Study Vaccination Period|Physician Decision|0
6119720|NCT00092534|21098659|P3|Base Study Vaccination Period|Physician Decision|0
6119721|NCT00092534|21098660|P2|Base Study Vaccination Period|Physician Decision|0
6119722|NCT00092534|21098661|P1|Base Study Vaccination Period|Physician Decision|1
6119723|NCT00092534|21098657|P5|Base Study Vaccination Period|Lost to Follow-up|0
6119724|NCT00092534|21098658|P4|Base Study Vaccination Period|Lost to Follow-up|0
6119725|NCT00092534|21098659|P3|Base Study Vaccination Period|Lost to Follow-up|0
6119726|NCT00092534|21098660|P2|Base Study Vaccination Period|Lost to Follow-up|37
6119727|NCT00092534|21098661|P1|Base Study Vaccination Period|Lost to Follow-up|41
6119728|NCT00092534|21098657|P5|Base Study Vaccination Period|Death|0
6119729|NCT00092534|21098658|P4|Base Study Vaccination Period|Death|0
6119730|NCT00092534|21098659|P3|Base Study Vaccination Period|Death|0
6119731|NCT00092534|21098660|P2|Base Study Vaccination Period|Death|4
6119732|NCT00092534|21098661|P1|Base Study Vaccination Period|Death|5
6119733|NCT00092534|21098657|P5|Base Study Vaccination Period|Adverse Event|0
6119734|NCT00092534|21098658|P4|Base Study Vaccination Period|Adverse Event|0
6119735|NCT00092534|21098659|P3|Base Study Vaccination Period|Adverse Event|0
6119736|NCT00092534|21098660|P2|Base Study Vaccination Period|Adverse Event|1
6119737|NCT00092534|21098661|P1|Base Study Vaccination Period|Adverse Event|3
6119738|NCT00092534|21098657|P5|Base Study Vaccination Period|Randomized not Vaccinated|0
6119739|NCT00092534|21098658|P4|Base Study Vaccination Period|Randomized not Vaccinated|0
6119740|NCT00092534|21098659|P3|Base Study Vaccination Period|Randomized not Vaccinated|0
6119741|NCT00092534|21098660|P2|Base Study Vaccination Period|Randomized not Vaccinated|5
6119742|NCT00092534|21098661|P1|Base Study Vaccination Period|Randomized not Vaccinated|5
6119743|NCT00092521|21098692|P4|Extension Study (Group 4)|Unable/unwilling to return|25
6119744|NCT00092521|21098693|P3|Extension Study (Group 4)|Unable/unwilling to return|0
6119745|NCT00092521|21098694|P2|Extension Study (Group 4)|Unable/unwilling to return|0
6119746|NCT00092521|21098695|P1|Extension Study (Group 4)|Unable/unwilling to return|0
6119747|NCT00092521|21098692|P4|Extension Study (Group 4)|Site Terminated|4
6119748|NCT00092521|21098693|P3|Extension Study (Group 4)|Site Terminated|0
6119749|NCT00092521|21098694|P2|Extension Study (Group 4)|Site Terminated|0
6119750|NCT00092521|21098695|P1|Extension Study (Group 4)|Site Terminated|0
6119751|NCT00092521|21098692|P4|Extension Study (Group 4)|Moved|16
6119752|NCT00092521|21098693|P3|Extension Study (Group 4)|Moved|0
6119753|NCT00092521|21098694|P2|Extension Study (Group 4)|Moved|0
6119754|NCT00092521|21098695|P1|Extension Study (Group 4)|Moved|0
6119755|NCT00092521|21098692|P4|Extension Study (Group 4)|Withdrawal by Subject|46
6119756|NCT00092521|21098693|P3|Extension Study (Group 4)|Withdrawal by Subject|0
6119757|NCT00092521|21098694|P2|Extension Study (Group 4)|Withdrawal by Subject|0
6119758|NCT00092521|21098695|P1|Extension Study (Group 4)|Withdrawal by Subject|0
6119759|NCT00092521|21098692|P4|Extension Study (Group 4)|Protocol Violation|2
6119760|NCT00092521|21098693|P3|Extension Study (Group 4)|Protocol Violation|0
6119761|NCT00092521|21098694|P2|Extension Study (Group 4)|Protocol Violation|0
6119762|NCT00092521|21098695|P1|Extension Study (Group 4)|Protocol Violation|0
6119763|NCT00092521|21098692|P4|Extension Study (Group 4)|Pregnancy|4
6119764|NCT00092521|21098693|P3|Extension Study (Group 4)|Pregnancy|0
6119765|NCT00092521|21098694|P2|Extension Study (Group 4)|Pregnancy|0
6119766|NCT00092521|21098695|P1|Extension Study (Group 4)|Pregnancy|0
6119767|NCT00092521|21098692|P4|Extension Study (Group 4)|Lost to Follow-up|87
6119768|NCT00092521|21098693|P3|Extension Study (Group 4)|Lost to Follow-up|0
6119769|NCT00092521|21098694|P2|Extension Study (Group 4)|Lost to Follow-up|0
6119770|NCT00092521|21098695|P1|Extension Study (Group 4)|Lost to Follow-up|0
6119771|NCT00092521|21098692|P4|Extension Study (Group 4)|Adverse Event|2
6119772|NCT00092521|21098693|P3|Extension Study (Group 4)|Adverse Event|0
6119773|NCT00092521|21098694|P2|Extension Study (Group 4)|Adverse Event|0
6119774|NCT00092521|21098695|P1|Extension Study (Group 4)|Adverse Event|0
6119775|NCT00092521|21098692|P4|Extension Study (Group 4)|Excluded ineligible for extension|23
6119776|NCT00092521|21098693|P3|Extension Study (Group 4)|Excluded ineligible for extension|0
6119777|NCT00092521|21098694|P2|Extension Study (Group 4)|Excluded ineligible for extension|0
6119778|NCT00092521|21098695|P1|Extension Study (Group 4)|Excluded ineligible for extension|0
6119779|NCT00092521|21098692|P4|Follow-Up (After Month 7)|Visits Compressed|0
6119780|NCT00092521|21098693|P3|Follow-Up (After Month 7)|Visits Compressed|5
6119781|NCT00092521|21098694|P2|Follow-Up (After Month 7)|Visits Compressed|0
6119782|NCT00092521|21098695|P1|Follow-Up (After Month 7)|Visits Compressed|5
6119783|NCT00092521|21098692|P4|Follow-Up (After Month 7)|Travel|0
6119784|NCT00092521|21098693|P3|Follow-Up (After Month 7)|Travel|0
6119785|NCT00092521|21098694|P2|Follow-Up (After Month 7)|Travel|0
6119786|NCT00092521|21098695|P1|Follow-Up (After Month 7)|Travel|2
6119787|NCT00092521|21098692|P4|Follow-Up (After Month 7)|Site Terminated|0
6119788|NCT00092521|21098693|P3|Follow-Up (After Month 7)|Site Terminated|3
6119789|NCT00092521|21098694|P2|Follow-Up (After Month 7)|Site Terminated|0
6119790|NCT00092521|21098695|P1|Follow-Up (After Month 7)|Site Terminated|3
6119791|NCT00092521|21098692|P4|Follow-Up (After Month 7)|Moved|0
6119792|NCT00092521|21098693|P3|Follow-Up (After Month 7)|Moved|28
6119793|NCT00092521|21098694|P2|Follow-Up (After Month 7)|Moved|2
6119794|NCT00092521|21098695|P1|Follow-Up (After Month 7)|Moved|32
6119795|NCT00092521|21098692|P4|Follow-Up (After Month 7)|Withdrawal by Subject|0
6119796|NCT00092521|21098693|P3|Follow-Up (After Month 7)|Withdrawal by Subject|51
6119797|NCT00092521|21098694|P2|Follow-Up (After Month 7)|Withdrawal by Subject|6
6119798|NCT00092521|21098695|P1|Follow-Up (After Month 7)|Withdrawal by Subject|40
6119799|NCT00092521|21098692|P4|Follow-Up (After Month 7)|Protocol Violation|0
6119800|NCT00092521|21098693|P3|Follow-Up (After Month 7)|Protocol Violation|5
6119801|NCT00092521|21098694|P2|Follow-Up (After Month 7)|Protocol Violation|1
6119802|NCT00092521|21098695|P1|Follow-Up (After Month 7)|Protocol Violation|1
6119803|NCT00092521|21098692|P4|Follow-Up (After Month 7)|Lost to Follow-up|0
6119804|NCT00092521|21098693|P3|Follow-Up (After Month 7)|Lost to Follow-up|108
6119805|NCT00092521|21098694|P2|Follow-Up (After Month 7)|Lost to Follow-up|14
6119806|NCT00092521|21098695|P1|Follow-Up (After Month 7)|Lost to Follow-up|113
6119807|NCT00092521|21098692|P4|Follow-Up (After Month 7)|Death|0
6119808|NCT00092521|21098693|P3|Follow-Up (After Month 7)|Death|1
6119809|NCT00092521|21098694|P2|Follow-Up (After Month 7)|Death|0
6119810|NCT00092521|21098695|P1|Follow-Up (After Month 7)|Death|2
6119811|NCT00092521|21098692|P4|Follow-Up (After Month 7)|Adverse Event|0
6119812|NCT00092521|21098693|P3|Follow-Up (After Month 7)|Adverse Event|0
6119813|NCT00092521|21098694|P2|Follow-Up (After Month 7)|Adverse Event|0
6119814|NCT00092521|21098695|P1|Follow-Up (After Month 7)|Adverse Event|1
6119815|NCT00092521|21098692|P4|Follow-Up (After Month 7)|Subjects in Extension|0
6119816|NCT00092521|21098693|P3|Follow-Up (After Month 7)|Subjects in Extension|412
6119817|NCT00092521|21098694|P2|Follow-Up (After Month 7)|Subjects in Extension|109
6119818|NCT00092521|21098695|P1|Follow-Up (After Month 7)|Subjects in Extension|13
6119819|NCT00092521|21098692|P4|Follow-Up (After Month 7)|Subjects Continuing|0
6119820|NCT00092521|21098693|P3|Follow-Up (After Month 7)|Subjects Continuing|35
6119821|NCT00092521|21098694|P2|Follow-Up (After Month 7)|Subjects Continuing|4
6119822|NCT00092521|21098695|P1|Follow-Up (After Month 7)|Subjects Continuing|34
6119823|NCT00092521|21098692|P4|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0
6119824|NCT00092521|21098693|P3|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0
6119825|NCT00092521|21098694|P2|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0
6119826|NCT00092521|21098695|P1|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|2
6119827|NCT00092521|21098692|P4|Vaccination (Day 1 Through Month 7)|Unblinded|0
6119828|NCT00092521|21098693|P3|Vaccination (Day 1 Through Month 7)|Unblinded|0
6119829|NCT00092521|21098694|P2|Vaccination (Day 1 Through Month 7)|Unblinded|0
6119830|NCT00092521|21098695|P1|Vaccination (Day 1 Through Month 7)|Unblinded|2
6119831|NCT00092521|21098692|P4|Vaccination (Day 1 Through Month 7)|Moved|0
6119832|NCT00092521|21098693|P3|Vaccination (Day 1 Through Month 7)|Moved|18
6119833|NCT00092521|21098694|P2|Vaccination (Day 1 Through Month 7)|Moved|1
6119834|NCT00092521|21098695|P1|Vaccination (Day 1 Through Month 7)|Moved|14
6119835|NCT00092521|21098692|P4|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|0
6119836|NCT00092521|21098693|P3|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|62
6119837|NCT00092521|21098694|P2|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|7
6119838|NCT00092521|21098695|P1|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|59
6119839|NCT00092521|21098692|P4|Vaccination (Day 1 Through Month 7)|Pregnancy|0
6119840|NCT00092521|21098693|P3|Vaccination (Day 1 Through Month 7)|Pregnancy|7
6119841|NCT00092521|21098694|P2|Vaccination (Day 1 Through Month 7)|Pregnancy|0
6119842|NCT00092521|21098695|P1|Vaccination (Day 1 Through Month 7)|Pregnancy|5
6119843|NCT00092521|21098692|P4|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|0
6119844|NCT00092521|21098693|P3|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|44
6119845|NCT00092521|21098694|P2|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|6
6119846|NCT00092521|21098695|P1|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|51
6119847|NCT00092521|21098692|P4|Vaccination (Day 1 Through Month 7)|Death|0
6119848|NCT00092521|21098693|P3|Vaccination (Day 1 Through Month 7)|Death|1
6119849|NCT00092521|21098694|P2|Vaccination (Day 1 Through Month 7)|Death|0
6119850|NCT00092521|21098695|P1|Vaccination (Day 1 Through Month 7)|Death|0
6119851|NCT00092521|21098692|P4|Vaccination (Day 1 Through Month 7)|Adverse Event|0
6119852|NCT00092521|21098693|P3|Vaccination (Day 1 Through Month 7)|Adverse Event|7
6119853|NCT00092521|21098694|P2|Vaccination (Day 1 Through Month 7)|Adverse Event|0
6119854|NCT00092521|21098695|P1|Vaccination (Day 1 Through Month 7)|Adverse Event|1
6119855|NCT00092521|21098692|P4|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0
6119856|NCT00092521|21098693|P3|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|7
6119857|NCT00092521|21098694|P2|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0
6119858|NCT00092521|21098695|P1|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|6
6119859|NCT00092495|21098709|P5|Base Study Follow-up Period|Withdrawal by Subject|0
6119860|NCT00092495|21098710|P4|Base Study Follow-up Period|Withdrawal by Subject|0
6119861|NCT00092495|21098711|P3|Base Study Follow-up Period|Withdrawal by Subject|0
6119862|NCT00092495|21098712|P2|Base Study Follow-up Period|Withdrawal by Subject|0
6119863|NCT00092495|21098713|P1|Base Study Follow-up Period|Withdrawal by Subject|2
6119864|NCT00092495|21098709|P5|Base Study Follow-up Period|Lost to Follow-up|0
6119865|NCT00092495|21098710|P4|Base Study Follow-up Period|Lost to Follow-up|12
6119866|NCT00092495|21098711|P3|Base Study Follow-up Period|Lost to Follow-up|3
6119867|NCT00092495|21098712|P2|Base Study Follow-up Period|Lost to Follow-up|3
6119868|NCT00092495|21098713|P1|Base Study Follow-up Period|Lost to Follow-up|1
6119869|NCT00092495|21098709|P5|Base Study Follow-up Period|Extended|0
6119870|NCT00092495|21098710|P4|Base Study Follow-up Period|Extended|2
6119871|NCT00092495|21098711|P3|Base Study Follow-up Period|Extended|1
6119872|NCT00092495|21098712|P2|Base Study Follow-up Period|Extended|0
6119873|NCT00092495|21098713|P1|Base Study Follow-up Period|Extended|0
6119874|NCT00092495|21098709|P5|Base Study Vaccination Period|Withdrawal by Subject|0
6119875|NCT00092495|21098710|P4|Base Study Vaccination Period|Withdrawal by Subject|25
6119876|NCT00092495|21098711|P3|Base Study Vaccination Period|Withdrawal by Subject|14
6119877|NCT00092495|21098712|P2|Base Study Vaccination Period|Withdrawal by Subject|10
6119878|NCT00092495|21098713|P1|Base Study Vaccination Period|Withdrawal by Subject|9
6119879|NCT00092495|21098709|P5|Base Study Vaccination Period|Protocol Violation|0
6119880|NCT00092495|21098710|P4|Base Study Vaccination Period|Protocol Violation|0
6119881|NCT00092495|21098711|P3|Base Study Vaccination Period|Protocol Violation|0
6119882|NCT00092495|21098712|P2|Base Study Vaccination Period|Protocol Violation|0
6119883|NCT00092495|21098713|P1|Base Study Vaccination Period|Protocol Violation|1
6119884|NCT00092495|21098709|P5|Base Study Vaccination Period|Parent Withdrew Consent|0
6119885|NCT00092495|21098710|P4|Base Study Vaccination Period|Parent Withdrew Consent|5
6119886|NCT00092495|21098711|P3|Base Study Vaccination Period|Parent Withdrew Consent|1
6119887|NCT00092495|21098712|P2|Base Study Vaccination Period|Parent Withdrew Consent|1
6119888|NCT00092495|21098713|P1|Base Study Vaccination Period|Parent Withdrew Consent|1
6119889|NCT00092495|21098709|P5|Base Study Vaccination Period|Pregnancy|0
6119890|NCT00092495|21098710|P4|Base Study Vaccination Period|Pregnancy|0
6119891|NCT00092495|21098711|P3|Base Study Vaccination Period|Pregnancy|0
6119892|NCT00092495|21098712|P2|Base Study Vaccination Period|Pregnancy|0
6119893|NCT00092495|21098713|P1|Base Study Vaccination Period|Pregnancy|2
6119894|NCT00092495|21098709|P5|Base Study Vaccination Period|Other|0
6119895|NCT00092495|21098710|P4|Base Study Vaccination Period|Other|2
6119896|NCT00092495|21098711|P3|Base Study Vaccination Period|Other|0
6119897|NCT00092495|21098712|P2|Base Study Vaccination Period|Other|1
6119898|NCT00092495|21098713|P1|Base Study Vaccination Period|Other|1
6119899|NCT00092495|21098709|P5|Base Study Vaccination Period|Moved|0
6119900|NCT00092495|21098710|P4|Base Study Vaccination Period|Moved|2
6119901|NCT00092495|21098711|P3|Base Study Vaccination Period|Moved|2
6119902|NCT00092495|21098712|P2|Base Study Vaccination Period|Moved|1
6119903|NCT00092495|21098713|P1|Base Study Vaccination Period|Moved|3
6119904|NCT00092495|21098709|P5|Base Study Vaccination Period|Lost to Follow-up|0
6119905|NCT00092495|21098710|P4|Base Study Vaccination Period|Lost to Follow-up|36
6119906|NCT00092495|21098711|P3|Base Study Vaccination Period|Lost to Follow-up|11
6119907|NCT00092495|21098712|P2|Base Study Vaccination Period|Lost to Follow-up|6
6119908|NCT00092495|21098713|P1|Base Study Vaccination Period|Lost to Follow-up|16
6119909|NCT00092495|21098709|P5|Base Study Vaccination Period|Adverse Event|0
6119910|NCT00092495|21098710|P4|Base Study Vaccination Period|Adverse Event|3
6119911|NCT00092495|21098711|P3|Base Study Vaccination Period|Adverse Event|0
6119912|NCT00092495|21098712|P2|Base Study Vaccination Period|Adverse Event|0
6119913|NCT00092495|21098713|P1|Base Study Vaccination Period|Adverse Event|1
6119914|NCT00092495|21098709|P5|Base Study Vaccination Period|*Pregnancy|0
6119915|NCT00092495|21098710|P4|Base Study Vaccination Period|*Pregnancy|7
6119916|NCT00092495|21098711|P3|Base Study Vaccination Period|*Pregnancy|5
6119917|NCT00092495|21098712|P2|Base Study Vaccination Period|*Pregnancy|2
6119918|NCT00092495|21098713|P1|Base Study Vaccination Period|*Pregnancy|0
6119919|NCT00092495|21098709|P5|Base Study Vaccination Period|*Other reasons|0
6119920|NCT00092495|21098710|P4|Base Study Vaccination Period|*Other reasons|1
6119921|NCT00092495|21098711|P3|Base Study Vaccination Period|*Other reasons|0
6119922|NCT00092495|21098712|P2|Base Study Vaccination Period|*Other reasons|0
6119923|NCT00092495|21098713|P1|Base Study Vaccination Period|*Other reasons|1
6119924|NCT00092495|21098709|P5|Base Study Vaccination Period|*Clinical AE|0
6119925|NCT00092495|21098710|P4|Base Study Vaccination Period|*Clinical AE|2
6119926|NCT00092495|21098711|P3|Base Study Vaccination Period|*Clinical AE|1
6119927|NCT00092495|21098712|P2|Base Study Vaccination Period|*Clinical AE|0
6119928|NCT00092495|21098713|P1|Base Study Vaccination Period|*Clinical AE|1
6119929|NCT00092495|21098709|P5|Base Study Vaccination Period|Extended|0
6119930|NCT00092495|21098710|P4|Base Study Vaccination Period|Extended|1
6119931|NCT00092495|21098711|P3|Base Study Vaccination Period|Extended|0
6119932|NCT00092495|21098712|P2|Base Study Vaccination Period|Extended|0
6119933|NCT00092495|21098713|P1|Base Study Vaccination Period|Extended|0
6119934|NCT00092495|21098709|P5|Base Study Vaccination Period|Randomized Not Vaccinated|0
6119935|NCT00092495|21098710|P4|Base Study Vaccination Period|Randomized Not Vaccinated|4
6119936|NCT00092495|21098711|P3|Base Study Vaccination Period|Randomized Not Vaccinated|0
6119937|NCT00092495|21098712|P2|Base Study Vaccination Period|Randomized Not Vaccinated|1
6119938|NCT00092495|21098713|P1|Base Study Vaccination Period|Randomized Not Vaccinated|1
6119939|NCT00092456|21098779|P4|Overall Study|Other|0
6119940|NCT00092456|21098780|P3|Overall Study|Other|3
6119941|NCT00092456|21098781|P2|Overall Study|Other|2
6119942|NCT00092456|21098782|P1|Overall Study|Other|4
6119943|NCT00092456|21098779|P4|Overall Study|Moved|1
6119944|NCT00092456|21098780|P3|Overall Study|Moved|0
6119945|NCT00092456|21098781|P2|Overall Study|Moved|1
6119946|NCT00092456|21098782|P1|Overall Study|Moved|1
6119947|NCT00092456|21098779|P4|Overall Study|Withdrawal by Subject|6
6119948|NCT00092456|21098780|P3|Overall Study|Withdrawal by Subject|16
6119949|NCT00092456|21098781|P2|Overall Study|Withdrawal by Subject|5
6119950|NCT00092456|21098782|P1|Overall Study|Withdrawal by Subject|13
6119951|NCT00092456|21098779|P4|Overall Study|Protocol Violation|6
6119952|NCT00092456|21098780|P3|Overall Study|Protocol Violation|8
6119953|NCT00092456|21098781|P2|Overall Study|Protocol Violation|7
6119954|NCT00092456|21098782|P1|Overall Study|Protocol Violation|5
6119955|NCT00092456|21098779|P4|Overall Study|Lost to Follow-up|2
6119956|NCT00092456|21098780|P3|Overall Study|Lost to Follow-up|1
6119957|NCT00092456|21098781|P2|Overall Study|Lost to Follow-up|2
6119958|NCT00092456|21098782|P1|Overall Study|Lost to Follow-up|2
6119959|NCT00092456|21098779|P4|Overall Study|Adverse Event|1
6119960|NCT00092456|21098780|P3|Overall Study|Adverse Event|1
6119961|NCT00092456|21098781|P2|Overall Study|Adverse Event|0
6119962|NCT00092456|21098782|P1|Overall Study|Adverse Event|0
6119963|NCT00092443|21098830|P2|Overall Study|Other|13
6119964|NCT00092443|21098831|P1|Overall Study|Other|17
6119965|NCT00092443|21098830|P2|Overall Study|Moved|5
6119966|NCT00092443|21098831|P1|Overall Study|Moved|5
6119967|NCT00092443|21098830|P2|Overall Study|Withdrawal by Subject|11
6119968|NCT00092443|21098831|P1|Overall Study|Withdrawal by Subject|9
6119969|NCT00092443|21098830|P2|Overall Study|Protocol Violation|9
6119970|NCT00092443|21098831|P1|Overall Study|Protocol Violation|11
6119971|NCT00092443|21098830|P2|Overall Study|Lost to Follow-up|3
6119972|NCT00092443|21098831|P1|Overall Study|Lost to Follow-up|7
6119973|NCT00092443|21098830|P2|Overall Study|Adverse Event|13
6119974|NCT00092443|21098831|P1|Overall Study|Adverse Event|9
6119975|NCT00092417|21098849|P2|Overall Study|Other|0
6119976|NCT00092417|21098850|P1|Overall Study|Other|1
6119977|NCT00092417|21098849|P2|Overall Study|Withdrawal by Subject|1
6119978|NCT00092417|21098850|P1|Overall Study|Withdrawal by Subject|2
6119979|NCT00092417|21098849|P2|Overall Study|Lost to Follow-up|0
6119980|NCT00092417|21098850|P1|Overall Study|Lost to Follow-up|2
6119981|NCT00092131|21098864|P2|Treatment Period II|Adverse Event|1
6119982|NCT00092131|21098865|P1|Treatment Period II|Adverse Event|0
6119983|NCT00092131|21098864|P2|Treatment Period I|Adverse Event|0
6119984|NCT00092131|21098865|P1|Treatment Period I|Adverse Event|1
6119985|NCT00092118|21098895|P2|Overall Study|Other|5
6119986|NCT00092118|21098896|P1|Overall Study|Other|6
6119987|NCT00092118|21098895|P2|Overall Study|Withdrawal by Subject|10
6119988|NCT00092118|21098896|P1|Overall Study|Withdrawal by Subject|4
6119989|NCT00092118|21098895|P2|Overall Study|Protocol Violation|25
6119990|NCT00092118|21098896|P1|Overall Study|Protocol Violation|23
6119991|NCT00092118|21098895|P2|Overall Study|Lost to Follow-up|3
6119992|NCT00092118|21098896|P1|Overall Study|Lost to Follow-up|4
6119993|NCT00092118|21098895|P2|Overall Study|Lack of Efficacy|14
6119994|NCT00092118|21098896|P1|Overall Study|Lack of Efficacy|12
6119995|NCT00092118|21098895|P2|Overall Study|Adverse Event|32
6119996|NCT00092118|21098896|P1|Overall Study|Adverse Event|35
6119997|NCT00091949|21098930|P2|Overall Study|Lost to Follow-up|41
6119998|NCT00091949|21098931|P1|Overall Study|Lost to Follow-up|58
6119999|NCT00091949|21098930|P2|Overall Study|Withdrawal by Subject|110
6120000|NCT00091949|21098931|P1|Overall Study|Withdrawal by Subject|117
6120001|NCT00091832|21098955|P6|Overall Study|Protocol Violation|1
6120002|NCT00091832|21098956|P5|Overall Study|Protocol Violation|0
6120003|NCT00091832|21098957|P4|Overall Study|Protocol Violation|0
6120004|NCT00091832|21098958|P3|Overall Study|Protocol Violation|1
6120005|NCT00091832|21098959|P2|Overall Study|Protocol Violation|0
6120006|NCT00091832|21098960|P1|Overall Study|Protocol Violation|0
6120007|NCT00091832|21098955|P6|Overall Study|Other|0
6120008|NCT00091832|21098956|P5|Overall Study|Other|0
6120009|NCT00091832|21098957|P4|Overall Study|Other|0
6120010|NCT00091832|21098958|P3|Overall Study|Other|2
6120011|NCT00091832|21098959|P2|Overall Study|Other|1
6120012|NCT00091832|21098960|P1|Overall Study|Other|0
6120013|NCT00091832|21098955|P6|Overall Study|Noncompliance|0
6120014|NCT00091832|21098956|P5|Overall Study|Noncompliance|0
6120015|NCT00091832|21098957|P4|Overall Study|Noncompliance|0
6120016|NCT00091832|21098958|P3|Overall Study|Noncompliance|0
6120017|NCT00091832|21098959|P2|Overall Study|Noncompliance|1
6120018|NCT00091832|21098960|P1|Overall Study|Noncompliance|0
6120019|NCT00091832|21098955|P6|Overall Study|Lost to Follow-up|1
6120020|NCT00091832|21098956|P5|Overall Study|Lost to Follow-up|2
6120021|NCT00091832|21098957|P4|Overall Study|Lost to Follow-up|3
6120022|NCT00091832|21098958|P3|Overall Study|Lost to Follow-up|3
6120023|NCT00091832|21098959|P2|Overall Study|Lost to Follow-up|0
6120024|NCT00091832|21098960|P1|Overall Study|Lost to Follow-up|1
6120025|NCT00091832|21098955|P6|Overall Study|Ineligibility Determined|0
6120026|NCT00091832|21098956|P5|Overall Study|Ineligibility Determined|1
6120027|NCT00091832|21098957|P4|Overall Study|Ineligibility Determined|0
6120028|NCT00091832|21098958|P3|Overall Study|Ineligibility Determined|1
6120029|NCT00091832|21098959|P2|Overall Study|Ineligibility Determined|0
6120030|NCT00091832|21098960|P1|Overall Study|Ineligibility Determined|0
6120031|NCT00091832|21098955|P6|Overall Study|Disease Progression|2
6120032|NCT00091832|21098956|P5|Overall Study|Disease Progression|1
6120033|NCT00091832|21098957|P4|Overall Study|Disease Progression|1
6120034|NCT00091832|21098958|P3|Overall Study|Disease Progression|0
6120035|NCT00091832|21098959|P2|Overall Study|Disease Progression|0
6120036|NCT00091832|21098960|P1|Overall Study|Disease Progression|2
6120037|NCT00091832|21098955|P6|Overall Study|Death|6
6120038|NCT00091832|21098956|P5|Overall Study|Death|5
6120039|NCT00091832|21098957|P4|Overall Study|Death|8
6120040|NCT00091832|21098958|P3|Overall Study|Death|5
6120041|NCT00091832|21098959|P2|Overall Study|Death|4
6120042|NCT00091832|21098960|P1|Overall Study|Death|6
6120043|NCT00091832|21098955|P6|Overall Study|Withdrawal by Subject|1
6120044|NCT00091832|21098956|P5|Overall Study|Withdrawal by Subject|3
6120045|NCT00091832|21098957|P4|Overall Study|Withdrawal by Subject|1
6120046|NCT00091832|21098958|P3|Overall Study|Withdrawal by Subject|0
6120047|NCT00091832|21098959|P2|Overall Study|Withdrawal by Subject|5
6120048|NCT00091832|21098960|P1|Overall Study|Withdrawal by Subject|4
6120049|NCT00091832|21098955|P6|Overall Study|Adverse Event|0
6120050|NCT00091832|21098956|P5|Overall Study|Adverse Event|3
6120051|NCT00091832|21098957|P4|Overall Study|Adverse Event|1
6120052|NCT00091832|21098958|P3|Overall Study|Adverse Event|0
6120053|NCT00091832|21098959|P2|Overall Study|Adverse Event|0
6120054|NCT00091832|21098960|P1|Overall Study|Adverse Event|0
6120055|NCT00091832|21098955|P6|Overall Study|Physician Decision|0
6120056|NCT00091832|21098956|P5|Overall Study|Physician Decision|0
6120057|NCT00091832|21098957|P4|Overall Study|Physician Decision|0
6120058|NCT00091832|21098958|P3|Overall Study|Physician Decision|0
6120059|NCT00091832|21098959|P2|Overall Study|Physician Decision|0
6120060|NCT00091832|21098960|P1|Overall Study|Physician Decision|1
6120061|NCT00091819|21099078|P2|Overall Study|Never received study treatment|4
6120062|NCT00091819|21099079|P1|Overall Study|Never received study treatment|3
6120063|NCT00091819|21099078|P2|Overall Study|Other|3
6120064|NCT00091819|21099079|P1|Overall Study|Other|2
6120065|NCT00091819|21099078|P2|Overall Study|Protocol Violation|2
6120066|NCT00091819|21099079|P1|Overall Study|Protocol Violation|1
6120067|NCT00091819|21099078|P2|Overall Study|Withdrawal by Subject|8
6120068|NCT00091819|21099079|P1|Overall Study|Withdrawal by Subject|5
6120069|NCT00091819|21099078|P2|Overall Study|Lost to Follow-up|23
6120070|NCT00091819|21099079|P1|Overall Study|Lost to Follow-up|26
6120071|NCT00091819|21099078|P2|Overall Study|Death|5
6120072|NCT00091819|21099079|P1|Overall Study|Death|4
6120073|NCT00091819|21099078|P2|Overall Study|Adverse Event|1
6120074|NCT00091819|21099079|P1|Overall Study|Adverse Event|1
6120075|NCT00091793|21099087|P2|Overall Study|Other|0
6120076|NCT00091793|21099088|P1|Overall Study|Other|2
6120077|NCT00091793|21099087|P2|Overall Study|Noncompliance|0
6120078|NCT00091793|21099088|P1|Overall Study|Noncompliance|2
6120079|NCT00091793|21099087|P2|Overall Study|Lost to Follow-up|5
6120080|NCT00091793|21099088|P1|Overall Study|Lost to Follow-up|7
6120081|NCT00091793|21099087|P2|Overall Study|Ineligibility determined|0
6120082|NCT00091793|21099088|P1|Overall Study|Ineligibility determined|2
6120083|NCT00091793|21099087|P2|Overall Study|Withdrawal by Subject|15
6120084|NCT00091793|21099088|P1|Overall Study|Withdrawal by Subject|10
6120085|NCT00091793|21099087|P2|Overall Study|Adverse Event|2
6120086|NCT00091793|21099088|P1|Overall Study|Adverse Event|1
6120087|NCT00091572|21099112|P2|Overall Study|Toxicity (Related AE)|9
6120088|NCT00091572|21099113|P1|Overall Study|Toxicity (Related AE)|53
6120089|NCT00091572|21099112|P2|Overall Study|Major Protocol Violation|0
6120090|NCT00091572|21099113|P1|Overall Study|Major Protocol Violation|2
6120091|NCT00091572|21099112|P2|Overall Study|Ongoing (still on treatment)|12
6120092|NCT00091572|21099113|P1|Overall Study|Ongoing (still on treatment)|8
6120093|NCT00091572|21099112|P2|Overall Study|Other Reason|13
6120094|NCT00091572|21099113|P1|Overall Study|Other Reason|6
6120095|NCT00091572|21099112|P2|Overall Study|Medical Decision unrelated toxicity/PD|22
6120096|NCT00091572|21099113|P1|Overall Study|Medical Decision unrelated toxicity/PD|10
6120097|NCT00091572|21099112|P2|Overall Study|Death not due to malignancy/toxicity|3
6120098|NCT00091572|21099113|P1|Overall Study|Death not due to malignancy/toxicity|1
6120099|NCT00091572|21099112|P2|Overall Study|Subject's Refusal unrelated to toxicity|22
6120100|NCT00091572|21099113|P1|Overall Study|Subject's Refusal unrelated to toxicity|14
6120101|NCT00091572|21099112|P2|Overall Study|Lost to Follow-up|1
6120102|NCT00091572|21099113|P1|Overall Study|Lost to Follow-up|1
6120103|NCT00091442|21099144|P2|Overall Study|Other|6
6120104|NCT00091442|21099145|P1|Overall Study|Other|2
6120105|NCT00091442|21099144|P2|Overall Study|Lost to Follow-up|3
6120106|NCT00091442|21099145|P1|Overall Study|Lost to Follow-up|1
6120107|NCT00091442|21099144|P2|Overall Study|Death|7
6120108|NCT00091442|21099145|P1|Overall Study|Death|9
6120109|NCT00091442|21099144|P2|Overall Study|2cycles therapy beyond Complete response|16
6120110|NCT00091442|21099145|P1|Overall Study|2cycles therapy beyond Complete response|9
6120111|NCT00091442|21099144|P2|Overall Study|Adverse Event|48
6120112|NCT00091442|21099145|P1|Overall Study|Adverse Event|29
6120113|NCT00091442|21099144|P2|Overall Study|Withdrawal by Subject|46
6120114|NCT00091442|21099145|P1|Overall Study|Withdrawal by Subject|38
6120115|NCT00091442|21099144|P2|Overall Study|Physician Decision|58
6120116|NCT00091442|21099145|P1|Overall Study|Physician Decision|61
6120117|NCT00091442|21099144|P2|Overall Study|Progressive Disease|189
6120118|NCT00091442|21099145|P1|Overall Study|Progressive Disease|220
6120119|NCT00091390|21099155|P1|Overall Study|No protocol treatment|3
6120120|NCT00091390|21099155|P1|Overall Study|Protocol Violation|1
6120121|NCT00091169|21099180|P2|Overall Study|Not start protocol therapy|17
6120122|NCT00091169|21099181|P1|Overall Study|Not start protocol therapy|26
6120123|NCT00091169|21099180|P2|Overall Study|Other|4
6120124|NCT00091169|21099181|P1|Overall Study|Other|3
6120125|NCT00091169|21099180|P2|Overall Study|Withdrawal by Subject|13
6120126|NCT00091169|21099181|P1|Overall Study|Withdrawal by Subject|10
6120127|NCT00091169|21099180|P2|Overall Study|Death|1
6120128|NCT00091169|21099181|P1|Overall Study|Death|4
6120129|NCT00091169|21099180|P2|Overall Study|Adverse Event|17
6120130|NCT00091169|21099181|P1|Overall Study|Adverse Event|11
6120131|NCT00091169|21099180|P2|Overall Study|Disease progression|1
6120132|NCT00091169|21099181|P1|Overall Study|Disease progression|3
6120133|NCT00091026|21099199|P2|Overall Study|Unknown-never received treatment|1
6120134|NCT00091026|21099200|P1|Overall Study|Unknown-never received treatment|0
6120135|NCT00091026|21099199|P2|Overall Study|Patient withdrew and never received trea|2
6120136|NCT00091026|21099200|P1|Overall Study|Patient withdrew and never received trea|0
6120137|NCT00091026|21099199|P2|Overall Study|Patient deemed non eligible-never receiv|0
6120138|NCT00091026|21099200|P1|Overall Study|Patient deemed non eligible-never receiv|1
6120139|NCT00090987|21099210|P1|Overall Study|Incarcerated|1
6120140|NCT00090987|21099210|P1|Overall Study|Non-compliance|4
6120141|NCT00090987|21099210|P1|Overall Study|alternative therapy|1
6120142|NCT00090987|21099210|P1|Overall Study|Withdrawal by Subject|3
6120143|NCT00090987|21099210|P1|Overall Study|Lack of Efficacy|7
6120144|NCT00090987|21099210|P1|Overall Study|Adverse Event|5
6120145|NCT00090857|21099223|P2|Overall Study|Adverse Event|2
6120146|NCT00090857|21099224|P1|Overall Study|Adverse Event|2
6120147|NCT00090857|21099223|P2|Overall Study|Withdrawal by Subject|0
6120148|NCT00090857|21099224|P1|Overall Study|Withdrawal by Subject|2
6120149|NCT00090857|21099223|P2|Overall Study|Lost to Follow-up|1
6120150|NCT00090857|21099224|P1|Overall Study|Lost to Follow-up|0
6120151|NCT00090779|21099254|P2|Step 3|Off extended study due to study closure|3
6120152|NCT00090779|21099255|P1|Step 3|Off extended study due to study closure|4
6120153|NCT00090779|21099254|P2|Step 3|Initiation of ART and off extended study|2
6120154|NCT00090779|21099255|P1|Step 3|Initiation of ART and off extended study|3
6120155|NCT00090779|21099254|P2|Step 2|Non-compliance to study requirements|1
6120156|NCT00090779|21099255|P1|Step 2|Non-compliance to study requirements|0
6120157|NCT00090779|21099254|P2|Step 2|Subject relocated|1
6120158|NCT00090779|21099255|P1|Step 2|Subject relocated|0
6120159|NCT00090779|21099254|P2|Step 2|Off study per study closure|16
6120160|NCT00090779|21099255|P1|Step 2|Off study per study closure|6
6120161|NCT00090779|21099254|P2|Step 1|Subject relocated|8
6120162|NCT00090779|21099255|P1|Step 1|Subject relocated|2
6120163|NCT00090779|21099254|P2|Step 1|Non-compliance to study requirements|1
6120164|NCT00090779|21099255|P1|Step 1|Non-compliance to study requirements|0
6120165|NCT00090779|21099254|P2|Step 1|Pregnancy|0
6120166|NCT00090779|21099255|P1|Step 1|Pregnancy|1
6120167|NCT00090779|21099254|P2|Step 1|Physician Decision|0
6120168|NCT00090779|21099255|P1|Step 1|Physician Decision|1
6120169|NCT00090779|21099254|P2|Step 1|Death|2
6120170|NCT00090779|21099255|P1|Step 1|Death|0
6120171|NCT00090779|21099254|P2|Step 1|Lost to Follow-up|2
6120172|NCT00090779|21099255|P1|Step 1|Lost to Follow-up|3
6120173|NCT00090779|21099254|P2|Step 1|Withdrawal by Subject|2
6120174|NCT00090779|21099255|P1|Step 1|Withdrawal by Subject|4
6120175|NCT00090766|21099279|P3|Overall Study|Lost to Follow-up|2
6120176|NCT00090766|21099280|P2|Overall Study|Lost to Follow-up|0
6120177|NCT00090766|21099281|P1|Overall Study|Lost to Follow-up|2
6120178|NCT00090766|21099279|P3|Overall Study|Admin|0
6120179|NCT00090766|21099280|P2|Overall Study|Admin|2
6120180|NCT00090766|21099281|P1|Overall Study|Admin|0
6120181|NCT00090766|21099279|P3|Overall Study|Death|0
6120182|NCT00090766|21099280|P2|Overall Study|Death|0
6120183|NCT00090766|21099281|P1|Overall Study|Death|1
6120184|NCT00090766|21099279|P3|Overall Study|Nephrectomy Planned|1
6120185|NCT00090766|21099280|P2|Overall Study|Nephrectomy Planned|0
6120186|NCT00090766|21099281|P1|Overall Study|Nephrectomy Planned|0
6120187|NCT00090753|21099323|P2|Extended Treatment Period|Other Unrelated to Safety and Efficacy|43
6120188|NCT00090753|21099324|P1|Extended Treatment Period|Other Unrelated to Safety and Efficacy|65
6120189|NCT00090753|21099323|P2|Extended Treatment Period|Mircera Commercialization|93
6120190|NCT00090753|21099324|P1|Extended Treatment Period|Mircera Commercialization|188
6120191|NCT00090753|21099323|P2|Extended Treatment Period|Renal Transplant|12
6120192|NCT00090753|21099324|P1|Extended Treatment Period|Renal Transplant|15
6120193|NCT00090753|21099323|P2|Extended Treatment Period|Lost to Follow-up|1
6120194|NCT00090753|21099324|P1|Extended Treatment Period|Lost to Follow-up|3
6120195|NCT00090753|21099323|P2|Extended Treatment Period|Refused Treatment|12
6120196|NCT00090753|21099324|P1|Extended Treatment Period|Refused Treatment|18
6120197|NCT00090753|21099323|P2|Extended Treatment Period|Lack of Efficacy|0
6120198|NCT00090753|21099324|P1|Extended Treatment Period|Lack of Efficacy|1
6120199|NCT00090753|21099323|P2|Extended Treatment Period|Death|30
6120200|NCT00090753|21099324|P1|Extended Treatment Period|Death|58
6120201|NCT00090753|21099323|P2|Extended Treatment Period|Adverse Event|0
6120202|NCT00090753|21099324|P1|Extended Treatment Period|Adverse Event|11
6120203|NCT00090753|21099323|P2|First Treatment Period|Other Unrelated to Safety and Efficacy|28
6120204|NCT00090753|21099324|P1|First Treatment Period|Other Unrelated to Safety and Efficacy|39
6120205|NCT00090753|21099323|P2|First Treatment Period|Mircera Commercialization|0
6120206|NCT00090753|21099324|P1|First Treatment Period|Mircera Commercialization|1
6120207|NCT00090753|21099323|P2|First Treatment Period|Renal Transplant|50
6120208|NCT00090753|21099324|P1|First Treatment Period|Renal Transplant|70
6120209|NCT00090753|21099323|P2|First Treatment Period|Lost to Follow-up|4
6120210|NCT00090753|21099324|P1|First Treatment Period|Lost to Follow-up|4
6120211|NCT00090753|21099323|P2|First Treatment Period|Refused Treatment|25
6120212|NCT00090753|21099324|P1|First Treatment Period|Refused Treatment|32
6120213|NCT00090753|21099323|P2|First Treatment Period|Lack of Efficacy|1
6120214|NCT00090753|21099324|P1|First Treatment Period|Lack of Efficacy|2
6120215|NCT00090753|21099323|P2|First Treatment Period|Death|62
6120216|NCT00090753|21099324|P1|First Treatment Period|Death|88
6120217|NCT00090753|21099323|P2|First Treatment Period|Adverse Event|8
6120218|NCT00090753|21099324|P1|First Treatment Period|Adverse Event|20
6120219|NCT00090610|21099334|P2|Overall Study|Withdrawal by Subject|1
6120220|NCT00090610|21099335|P1|Overall Study|Withdrawal by Subject|1
6120221|NCT00090584|21099351|P2|Baseline to 8 Months|Lost to Follow-up|41
6120222|NCT00090584|21099352|P1|Baseline to 8 Months|Lost to Follow-up|44
6120223|NCT00090584|21099351|P2|Baseline to 10 Weeks|Lost to Follow-up|12
6120224|NCT00090584|21099352|P1|Baseline to 10 Weeks|Lost to Follow-up|15
6120225|NCT00090519|21099384|P2|Overall Study|Sponsor Decision|1
6120226|NCT00090519|21099385|P1|Overall Study|Sponsor Decision|3
6120227|NCT00090519|21099384|P2|Overall Study|Physician Decision|3
6120228|NCT00090519|21099385|P1|Overall Study|Physician Decision|2
6120229|NCT00090519|21099384|P2|Overall Study|Withdrawal by Subject|29
6120230|NCT00090519|21099385|P1|Overall Study|Withdrawal by Subject|28
6120231|NCT00090519|21099384|P2|Overall Study|Lost to Follow-up|29
6120232|NCT00090519|21099385|P1|Overall Study|Lost to Follow-up|26
6120233|NCT00090519|21099384|P2|Overall Study|Death|9
6120234|NCT00090519|21099385|P1|Overall Study|Death|9
6120235|NCT00090519|21099384|P2|Overall Study|Adverse Event|4
6120236|NCT00090519|21099385|P1|Overall Study|Adverse Event|5
6120237|NCT00090493|21099409|P1|Overall Study|Physician Decision|2
6120238|NCT00090363|21099416|P3|Overall Study|Continuing on study off treatment|16
6120239|NCT00090363|21099417|P2|Overall Study|Continuing on study off treatment|13
6120240|NCT00090363|21099418|P1|Overall Study|Continuing on study off treatment|14
6120241|NCT00090363|21099416|P3|Overall Study|Reasons not specified|1
6120242|NCT00090363|21099417|P2|Overall Study|Reasons not specified|1
6120243|NCT00090363|21099418|P1|Overall Study|Reasons not specified|2
6120244|NCT00090363|21099416|P3|Overall Study|Consent expired|9
6120245|NCT00090363|21099417|P2|Overall Study|Consent expired|10
6120246|NCT00090363|21099418|P1|Overall Study|Consent expired|7
6120247|NCT00090363|21099416|P3|Overall Study|Eligibility criteria not fulfilled|1
6120248|NCT00090363|21099417|P2|Overall Study|Eligibility criteria not fulfilled|0
6120249|NCT00090363|21099418|P1|Overall Study|Eligibility criteria not fulfilled|0
6120250|NCT00090363|21099416|P3|Overall Study|Study-specific discontinuation criteria|62
6120251|NCT00090363|21099417|P2|Overall Study|Study-specific discontinuation criteria|74
6120252|NCT00090363|21099418|P1|Overall Study|Study-specific discontinuation criteria|75
6120253|NCT00090363|21099416|P3|Overall Study|Withdrawal by Subject|6
6120254|NCT00090363|21099417|P2|Overall Study|Withdrawal by Subject|7
6120255|NCT00090363|21099418|P1|Overall Study|Withdrawal by Subject|7
6120256|NCT00090363|21099416|P3|Overall Study|Lost to Follow-up|1
6120257|NCT00090363|21099417|P2|Overall Study|Lost to Follow-up|2
6120258|NCT00090363|21099418|P1|Overall Study|Lost to Follow-up|1
6120259|NCT00090545|21099440|P2|Overall Study|Adverse Event|2
6120260|NCT00090545|21099441|P1|Overall Study|Adverse Event|0
6120261|NCT00090545|21099440|P2|Overall Study|Death|1
6120262|NCT00090545|21099441|P1|Overall Study|Death|0
6120263|NCT00090545|21099440|P2|Overall Study|Refused further treatment|4
6120264|NCT00090545|21099441|P1|Overall Study|Refused further treatment|1
6120265|NCT00090545|21099440|P2|Overall Study|Disease progression on study|17
6120266|NCT00090545|21099441|P1|Overall Study|Disease progression on study|21
6120267|NCT00090285|21099461|P6|Long-term Follow-up (EXT2)|Physician Decision|5
6120268|NCT00090285|21099462|P5|Long-term Follow-up (EXT2)|Physician Decision|6
6120269|NCT00090285|21099463|P4|Long-term Follow-up (EXT2)|Physician Decision|0
6120270|NCT00090285|21099464|P3|Long-term Follow-up (EXT2)|Physician Decision|0
6120271|NCT00090285|21099465|P2|Long-term Follow-up (EXT2)|Physician Decision|0
6120272|NCT00090285|21099466|P1|Long-term Follow-up (EXT2)|Physician Decision|0
6120273|NCT00090285|21099461|P6|Long-term Follow-up (EXT2)|Withdrawal by Subject|53
6120274|NCT00090285|21099462|P5|Long-term Follow-up (EXT2)|Withdrawal by Subject|60
6120275|NCT00090285|21099463|P4|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
6120276|NCT00090285|21099464|P3|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
6120277|NCT00090285|21099465|P2|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
6120278|NCT00090285|21099466|P1|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
6120279|NCT00090285|21099461|P6|Long-term Follow-up (EXT2)|Lost to Follow-up|143
6120280|NCT00090285|21099462|P5|Long-term Follow-up (EXT2)|Lost to Follow-up|156
6120281|NCT00090285|21099463|P4|Long-term Follow-up (EXT2)|Lost to Follow-up|0
6120282|NCT00090285|21099464|P3|Long-term Follow-up (EXT2)|Lost to Follow-up|0
6120283|NCT00090285|21099465|P2|Long-term Follow-up (EXT2)|Lost to Follow-up|0
6120284|NCT00090285|21099466|P1|Long-term Follow-up (EXT2)|Lost to Follow-up|0
6120285|NCT00090285|21099461|P6|Long-term Follow-up (EXT2)|Adverse Event|2
6120286|NCT00090285|21099462|P5|Long-term Follow-up (EXT2)|Adverse Event|5
6120287|NCT00090285|21099463|P4|Long-term Follow-up (EXT2)|Adverse Event|0
6120288|NCT00090285|21099464|P3|Long-term Follow-up (EXT2)|Adverse Event|0
6120289|NCT00090285|21099465|P2|Long-term Follow-up (EXT2)|Adverse Event|0
6120290|NCT00090285|21099466|P1|Long-term Follow-up (EXT2)|Adverse Event|0
6120291|NCT00090285|21099461|P6|Extension 1|Moved|0
6120292|NCT00090285|21099462|P5|Extension 1|Moved|0
6120293|NCT00090285|21099463|P4|Extension 1|Moved|0
6120294|NCT00090285|21099464|P3|Extension 1|Moved|3
6120295|NCT00090285|21099465|P2|Extension 1|Moved|0
6120296|NCT00090285|21099466|P1|Extension 1|Moved|0
6120297|NCT00090285|21099461|P6|Extension 1|Other|0
6120298|NCT00090285|21099462|P5|Extension 1|Other|0
6120299|NCT00090285|21099463|P4|Extension 1|Other|0
6120300|NCT00090285|21099464|P3|Extension 1|Other|4
6120301|NCT00090285|21099465|P2|Extension 1|Other|0
6120302|NCT00090285|21099466|P1|Extension 1|Other|0
6120303|NCT00090285|21099461|P6|Extension 1|Withdrawal by Subject|0
6120304|NCT00090285|21099462|P5|Extension 1|Withdrawal by Subject|0
6120305|NCT00090285|21099463|P4|Extension 1|Withdrawal by Subject|1
6120306|NCT00090285|21099464|P3|Extension 1|Withdrawal by Subject|13
6120307|NCT00090285|21099465|P2|Extension 1|Withdrawal by Subject|0
6120308|NCT00090285|21099466|P1|Extension 1|Withdrawal by Subject|0
6120309|NCT00090285|21099461|P6|Extension 1|Lost to Follow-up|0
6120310|NCT00090285|21099462|P5|Extension 1|Lost to Follow-up|0
6120311|NCT00090285|21099463|P4|Extension 1|Lost to Follow-up|0
6120312|NCT00090285|21099464|P3|Extension 1|Lost to Follow-up|35
6120313|NCT00090285|21099465|P2|Extension 1|Lost to Follow-up|0
6120314|NCT00090285|21099466|P1|Extension 1|Lost to Follow-up|0
6120315|NCT00090285|21099461|P6|Extension 1|Adverse Event|0
6120316|NCT00090285|21099462|P5|Extension 1|Adverse Event|0
6120317|NCT00090285|21099463|P4|Extension 1|Adverse Event|0
6120318|NCT00090285|21099464|P3|Extension 1|Adverse Event|2
6120319|NCT00090285|21099465|P2|Extension 1|Adverse Event|0
6120320|NCT00090285|21099466|P1|Extension 1|Adverse Event|0
6120321|NCT00090285|21099461|P6|Base Study Follow-up Period|Subject Incarcerated|0
6120322|NCT00090285|21099462|P5|Base Study Follow-up Period|Subject Incarcerated|0
6120323|NCT00090285|21099463|P4|Base Study Follow-up Period|Subject Incarcerated|0
6120324|NCT00090285|21099464|P3|Base Study Follow-up Period|Subject Incarcerated|0
6120325|NCT00090285|21099465|P2|Base Study Follow-up Period|Subject Incarcerated|2
6120326|NCT00090285|21099466|P1|Base Study Follow-up Period|Subject Incarcerated|0
6120327|NCT00090285|21099461|P6|Base Study Follow-up Period|Uncooperative|0
6120328|NCT00090285|21099462|P5|Base Study Follow-up Period|Uncooperative|0
6120329|NCT00090285|21099463|P4|Base Study Follow-up Period|Uncooperative|0
6120330|NCT00090285|21099464|P3|Base Study Follow-up Period|Uncooperative|0
6120331|NCT00090285|21099465|P2|Base Study Follow-up Period|Uncooperative|4
6120332|NCT00090285|21099466|P1|Base Study Follow-up Period|Uncooperative|3
6120333|NCT00090285|21099461|P6|Base Study Follow-up Period|Protocol Violation|0
6120334|NCT00090285|21099462|P5|Base Study Follow-up Period|Protocol Violation|0
6120335|NCT00090285|21099463|P4|Base Study Follow-up Period|Protocol Violation|0
6120336|NCT00090285|21099464|P3|Base Study Follow-up Period|Protocol Violation|0
6120337|NCT00090285|21099465|P2|Base Study Follow-up Period|Protocol Violation|0
6120338|NCT00090285|21099466|P1|Base Study Follow-up Period|Protocol Violation|1
6120339|NCT00090285|21099461|P6|Base Study Follow-up Period|Other|0
6120340|NCT00090285|21099462|P5|Base Study Follow-up Period|Other|0
6120341|NCT00090285|21099463|P4|Base Study Follow-up Period|Other|0
6120342|NCT00090285|21099464|P3|Base Study Follow-up Period|Other|0
6120343|NCT00090285|21099465|P2|Base Study Follow-up Period|Other|0
6120344|NCT00090285|21099466|P1|Base Study Follow-up Period|Other|2
6120345|NCT00090285|21099461|P6|Base Study Follow-up Period|Moved|0
6120346|NCT00090285|21099462|P5|Base Study Follow-up Period|Moved|0
6120347|NCT00090285|21099463|P4|Base Study Follow-up Period|Moved|0
6120348|NCT00090285|21099464|P3|Base Study Follow-up Period|Moved|0
6120349|NCT00090285|21099465|P2|Base Study Follow-up Period|Moved|36
6120350|NCT00090285|21099466|P1|Base Study Follow-up Period|Moved|41
6120351|NCT00090285|21099461|P6|Base Study Follow-up Period|Withdrawal by Subject|0
6120352|NCT00090285|21099462|P5|Base Study Follow-up Period|Withdrawal by Subject|0
6120353|NCT00090285|21099463|P4|Base Study Follow-up Period|Withdrawal by Subject|0
6120354|NCT00090285|21099464|P3|Base Study Follow-up Period|Withdrawal by Subject|0
6120355|NCT00090285|21099465|P2|Base Study Follow-up Period|Withdrawal by Subject|64
6120356|NCT00090285|21099466|P1|Base Study Follow-up Period|Withdrawal by Subject|53
6120357|NCT00090285|21099461|P6|Base Study Follow-up Period|Lost to Follow-up|0
6120358|NCT00090285|21099462|P5|Base Study Follow-up Period|Lost to Follow-up|0
6120359|NCT00090285|21099463|P4|Base Study Follow-up Period|Lost to Follow-up|0
6120360|NCT00090285|21099464|P3|Base Study Follow-up Period|Lost to Follow-up|0
6120361|NCT00090285|21099465|P2|Base Study Follow-up Period|Lost to Follow-up|226
6120362|NCT00090285|21099466|P1|Base Study Follow-up Period|Lost to Follow-up|232
6120363|NCT00090285|21099461|P6|Base Study Follow-up Period|Adverse Event|0
6120364|NCT00090285|21099462|P5|Base Study Follow-up Period|Adverse Event|0
6120365|NCT00090285|21099463|P4|Base Study Follow-up Period|Adverse Event|0
6120366|NCT00090285|21099464|P3|Base Study Follow-up Period|Adverse Event|0
6120367|NCT00090285|21099465|P2|Base Study Follow-up Period|Adverse Event|10
6120368|NCT00090285|21099466|P1|Base Study Follow-up Period|Adverse Event|3
6120369|NCT00090285|21099461|P6|Base Study Vaccination Period|HIV positive|0
6120370|NCT00090285|21099462|P5|Base Study Vaccination Period|HIV positive|0
6120371|NCT00090285|21099463|P4|Base Study Vaccination Period|HIV positive|0
6120372|NCT00090285|21099464|P3|Base Study Vaccination Period|HIV positive|0
6120373|NCT00090285|21099465|P2|Base Study Vaccination Period|HIV positive|1
6120374|NCT00090285|21099466|P1|Base Study Vaccination Period|HIV positive|1
6120375|NCT00090285|21099461|P6|Base Study Vaccination Period|Subject Incarcerated|0
6120376|NCT00090285|21099462|P5|Base Study Vaccination Period|Subject Incarcerated|0
6120377|NCT00090285|21099463|P4|Base Study Vaccination Period|Subject Incarcerated|0
6120378|NCT00090285|21099464|P3|Base Study Vaccination Period|Subject Incarcerated|0
6120379|NCT00090285|21099465|P2|Base Study Vaccination Period|Subject Incarcerated|2
6120380|NCT00090285|21099466|P1|Base Study Vaccination Period|Subject Incarcerated|2
6120381|NCT00090285|21099461|P6|Base Study Vaccination Period|Other|0
6120382|NCT00090285|21099462|P5|Base Study Vaccination Period|Other|0
6120383|NCT00090285|21099463|P4|Base Study Vaccination Period|Other|0
6120384|NCT00090285|21099464|P3|Base Study Vaccination Period|Other|0
6120385|NCT00090285|21099465|P2|Base Study Vaccination Period|Other|2
6120386|NCT00090285|21099466|P1|Base Study Vaccination Period|Other|2
6120387|NCT00090285|21099461|P6|Base Study Vaccination Period|Site Terminated|0
6120388|NCT00090285|21099462|P5|Base Study Vaccination Period|Site Terminated|0
6120389|NCT00090285|21099463|P4|Base Study Vaccination Period|Site Terminated|0
6120390|NCT00090285|21099464|P3|Base Study Vaccination Period|Site Terminated|0
6120391|NCT00090285|21099465|P2|Base Study Vaccination Period|Site Terminated|0
6120392|NCT00090285|21099466|P1|Base Study Vaccination Period|Site Terminated|1
6120393|NCT00090285|21099461|P6|Base Study Vaccination Period|Moved|0
6120394|NCT00090285|21099462|P5|Base Study Vaccination Period|Moved|0
6120395|NCT00090285|21099463|P4|Base Study Vaccination Period|Moved|0
6120396|NCT00090285|21099464|P3|Base Study Vaccination Period|Moved|0
6120397|NCT00090285|21099465|P2|Base Study Vaccination Period|Moved|21
6120398|NCT00090285|21099466|P1|Base Study Vaccination Period|Moved|20
6120399|NCT00090285|21099461|P6|Base Study Vaccination Period|Uncooperative|0
6120400|NCT00090285|21099462|P5|Base Study Vaccination Period|Uncooperative|0
6120401|NCT00090285|21099463|P4|Base Study Vaccination Period|Uncooperative|0
6120402|NCT00090285|21099464|P3|Base Study Vaccination Period|Uncooperative|0
6120403|NCT00090285|21099465|P2|Base Study Vaccination Period|Uncooperative|2
6120404|NCT00090285|21099466|P1|Base Study Vaccination Period|Uncooperative|2
6120405|NCT00090285|21099461|P6|Base Study Vaccination Period|Withdrawal by Subject|0
6120406|NCT00090285|21099462|P5|Base Study Vaccination Period|Withdrawal by Subject|0
6120489|NCT00090220|21099547|P4|Extension 1 (EXT1)|Protocol Violation|1
6120407|NCT00090285|21099463|P4|Base Study Vaccination Period|Withdrawal by Subject|0
6120408|NCT00090285|21099464|P3|Base Study Vaccination Period|Withdrawal by Subject|0
6120409|NCT00090285|21099465|P2|Base Study Vaccination Period|Withdrawal by Subject|69
6120410|NCT00090285|21099466|P1|Base Study Vaccination Period|Withdrawal by Subject|64
6120411|NCT00090285|21099461|P6|Base Study Vaccination Period|Protocol Violation|0
6120412|NCT00090285|21099462|P5|Base Study Vaccination Period|Protocol Violation|0
6120413|NCT00090285|21099463|P4|Base Study Vaccination Period|Protocol Violation|0
6120414|NCT00090285|21099464|P3|Base Study Vaccination Period|Protocol Violation|0
6120415|NCT00090285|21099465|P2|Base Study Vaccination Period|Protocol Violation|3
6120416|NCT00090285|21099466|P1|Base Study Vaccination Period|Protocol Violation|2
6120417|NCT00090285|21099461|P6|Base Study Vaccination Period|Lost to Follow-up|0
6120418|NCT00090285|21099462|P5|Base Study Vaccination Period|Lost to Follow-up|0
6120419|NCT00090285|21099463|P4|Base Study Vaccination Period|Lost to Follow-up|0
6120420|NCT00090285|21099464|P3|Base Study Vaccination Period|Lost to Follow-up|0
6120421|NCT00090285|21099465|P2|Base Study Vaccination Period|Lost to Follow-up|112
6120422|NCT00090285|21099466|P1|Base Study Vaccination Period|Lost to Follow-up|111
6120423|NCT00090285|21099461|P6|Base Study Vaccination Period|Adverse Event|0
6120424|NCT00090285|21099462|P5|Base Study Vaccination Period|Adverse Event|0
6120425|NCT00090285|21099463|P4|Base Study Vaccination Period|Adverse Event|0
6120426|NCT00090285|21099464|P3|Base Study Vaccination Period|Adverse Event|0
6120427|NCT00090285|21099465|P2|Base Study Vaccination Period|Adverse Event|4
6120428|NCT00090285|21099466|P1|Base Study Vaccination Period|Adverse Event|2
6120429|NCT00090285|21099461|P6|Base Study Vaccination Period|Randomized Not Vaccinated|0
6120430|NCT00090285|21099462|P5|Base Study Vaccination Period|Randomized Not Vaccinated|0
6120431|NCT00090285|21099463|P4|Base Study Vaccination Period|Randomized Not Vaccinated|0
6120432|NCT00090285|21099464|P3|Base Study Vaccination Period|Randomized Not Vaccinated|0
6120433|NCT00090285|21099465|P2|Base Study Vaccination Period|Randomized Not Vaccinated|3
6120434|NCT00090285|21099466|P1|Base Study Vaccination Period|Randomized Not Vaccinated|7
6120435|NCT00090259|21099503|P2|Overall Study|Investigator site closed|7
6120436|NCT00090259|21099504|P1|Overall Study|Investigator site closed|11
6120437|NCT00090259|21099503|P2|Overall Study|Withdrawal by Subject|15
6120438|NCT00090259|21099504|P1|Overall Study|Withdrawal by Subject|21
6120439|NCT00090259|21099503|P2|Overall Study|Lost to Follow-up|26
6120440|NCT00090259|21099504|P1|Overall Study|Lost to Follow-up|30
6120441|NCT00090233|21099520|P2|Overall Study|Data not available at data cut-off point|1563
6120442|NCT00090233|21099521|P1|Overall Study|Data not available at data cut-off point|1552
6120443|NCT00090233|21099520|P2|Overall Study|Other|1160
6120444|NCT00090233|21099521|P1|Overall Study|Other|1211
6120445|NCT00090233|21099520|P2|Overall Study|Moved|189
6120446|NCT00090233|21099521|P1|Overall Study|Moved|203
6120447|NCT00090233|21099520|P2|Overall Study|Withdrawal by Subject|211
6120448|NCT00090233|21099521|P1|Overall Study|Withdrawal by Subject|182
6120449|NCT00090233|21099520|P2|Overall Study|Protocol Violation|1022
6120450|NCT00090233|21099521|P1|Overall Study|Protocol Violation|960
6120451|NCT00090233|21099520|P2|Overall Study|Lost to Follow-up|95
6120452|NCT00090233|21099521|P1|Overall Study|Lost to Follow-up|68
6120453|NCT00090233|21099520|P2|Overall Study|Adverse Event|198
6120454|NCT00090233|21099521|P1|Overall Study|Adverse Event|214
6120455|NCT00090233|21099520|P2|Overall Study|Randomized Not Vaccinated (Visit 1)|627
6120456|NCT00090233|21099521|P1|Overall Study|Randomized Not Vaccinated (Visit 1)|609
6120457|NCT00090220|21099545|P6|Long-term Follow-up (EXT2)|Other|0
6120458|NCT00090220|21099546|P5|Long-term Follow-up (EXT2)|Other|1
6120459|NCT00090220|21099547|P4|Long-term Follow-up (EXT2)|Other|0
6120460|NCT00090220|21099548|P3|Long-term Follow-up (EXT2)|Other|0
6120461|NCT00090220|21099549|P2|Long-term Follow-up (EXT2)|Other|0
6120462|NCT00090220|21099550|P1|Long-term Follow-up (EXT2)|Other|0
6120463|NCT00090220|21099545|P6|Long-term Follow-up (EXT2)|Withdrawal by Subject|4
6120464|NCT00090220|21099546|P5|Long-term Follow-up (EXT2)|Withdrawal by Subject|4
6120465|NCT00090220|21099547|P4|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
6120466|NCT00090220|21099548|P3|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
6120467|NCT00090220|21099549|P2|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
6120468|NCT00090220|21099550|P1|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
6120469|NCT00090220|21099545|P6|Long-term Follow-up (EXT2)|Death|1
6120470|NCT00090220|21099546|P5|Long-term Follow-up (EXT2)|Death|1
6120471|NCT00090220|21099547|P4|Long-term Follow-up (EXT2)|Death|0
6120472|NCT00090220|21099548|P3|Long-term Follow-up (EXT2)|Death|0
6120473|NCT00090220|21099549|P2|Long-term Follow-up (EXT2)|Death|0
6120474|NCT00090220|21099550|P1|Long-term Follow-up (EXT2)|Death|0
6120475|NCT00090220|21099545|P6|Long-term Follow-up (EXT2)|Lost to Follow-up|23
6120476|NCT00090220|21099546|P5|Long-term Follow-up (EXT2)|Lost to Follow-up|38
6120477|NCT00090220|21099547|P4|Long-term Follow-up (EXT2)|Lost to Follow-up|0
6120478|NCT00090220|21099548|P3|Long-term Follow-up (EXT2)|Lost to Follow-up|0
6120479|NCT00090220|21099549|P2|Long-term Follow-up (EXT2)|Lost to Follow-up|0
6120480|NCT00090220|21099550|P1|Long-term Follow-up (EXT2)|Lost to Follow-up|0
6120481|NCT00090220|21099545|P6|Extension 1 (EXT1)|Other reason|0
6120482|NCT00090220|21099546|P5|Extension 1 (EXT1)|Other reason|0
6120483|NCT00090220|21099547|P4|Extension 1 (EXT1)|Other reason|0
6120484|NCT00090220|21099548|P3|Extension 1 (EXT1)|Other reason|2
6120485|NCT00090220|21099549|P2|Extension 1 (EXT1)|Other reason|0
6120486|NCT00090220|21099550|P1|Extension 1 (EXT1)|Other reason|0
6120487|NCT00090220|21099545|P6|Extension 1 (EXT1)|Protocol Violation|0
6120488|NCT00090220|21099546|P5|Extension 1 (EXT1)|Protocol Violation|0
6120490|NCT00090220|21099548|P3|Extension 1 (EXT1)|Protocol Violation|0
6120491|NCT00090220|21099549|P2|Extension 1 (EXT1)|Protocol Violation|0
6120492|NCT00090220|21099550|P1|Extension 1 (EXT1)|Protocol Violation|0
6120493|NCT00090220|21099545|P6|Extension 1 (EXT1)|Withdrawal by Subject|0
6120494|NCT00090220|21099546|P5|Extension 1 (EXT1)|Withdrawal by Subject|0
6120495|NCT00090220|21099547|P4|Extension 1 (EXT1)|Withdrawal by Subject|0
6120496|NCT00090220|21099548|P3|Extension 1 (EXT1)|Withdrawal by Subject|25
6120497|NCT00090220|21099549|P2|Extension 1 (EXT1)|Withdrawal by Subject|0
6120498|NCT00090220|21099550|P1|Extension 1 (EXT1)|Withdrawal by Subject|0
6120499|NCT00090220|21099545|P6|Extension 1 (EXT1)|Moved|0
6120500|NCT00090220|21099546|P5|Extension 1 (EXT1)|Moved|0
6120501|NCT00090220|21099547|P4|Extension 1 (EXT1)|Moved|1
6120502|NCT00090220|21099548|P3|Extension 1 (EXT1)|Moved|2
6120503|NCT00090220|21099549|P2|Extension 1 (EXT1)|Moved|0
6120504|NCT00090220|21099550|P1|Extension 1 (EXT1)|Moved|0
6120505|NCT00090220|21099545|P6|Extension 1 (EXT1)|Lost to Follow-up|0
6120506|NCT00090220|21099546|P5|Extension 1 (EXT1)|Lost to Follow-up|0
6120507|NCT00090220|21099547|P4|Extension 1 (EXT1)|Lost to Follow-up|0
6120508|NCT00090220|21099548|P3|Extension 1 (EXT1)|Lost to Follow-up|22
6120509|NCT00090220|21099549|P2|Extension 1 (EXT1)|Lost to Follow-up|0
6120510|NCT00090220|21099550|P1|Extension 1 (EXT1)|Lost to Follow-up|0
6120511|NCT00090220|21099545|P6|Extension 1 (EXT1)|Adverse Event|0
6120512|NCT00090220|21099546|P5|Extension 1 (EXT1)|Adverse Event|0
6120513|NCT00090220|21099547|P4|Extension 1 (EXT1)|Adverse Event|0
6120514|NCT00090220|21099548|P3|Extension 1 (EXT1)|Adverse Event|4
6120515|NCT00090220|21099549|P2|Extension 1 (EXT1)|Adverse Event|0
6120516|NCT00090220|21099550|P1|Extension 1 (EXT1)|Adverse Event|0
6120517|NCT00090220|21099545|P6|Base Study Follow-up Period|Other|0
6120518|NCT00090220|21099546|P5|Base Study Follow-up Period|Other|0
6120519|NCT00090220|21099547|P4|Base Study Follow-up Period|Other|0
6120520|NCT00090220|21099548|P3|Base Study Follow-up Period|Other|0
6120521|NCT00090220|21099549|P2|Base Study Follow-up Period|Other|21
6120522|NCT00090220|21099550|P1|Base Study Follow-up Period|Other|19
6120523|NCT00090220|21099545|P6|Base Study Follow-up Period|Patient Moved|0
6120524|NCT00090220|21099546|P5|Base Study Follow-up Period|Patient Moved|0
6120525|NCT00090220|21099547|P4|Base Study Follow-up Period|Patient Moved|0
6120526|NCT00090220|21099548|P3|Base Study Follow-up Period|Patient Moved|0
6120527|NCT00090220|21099549|P2|Base Study Follow-up Period|Patient Moved|28
6120528|NCT00090220|21099550|P1|Base Study Follow-up Period|Patient Moved|20
6120529|NCT00090220|21099545|P6|Base Study Follow-up Period|Withdrawal by Subject|0
6120530|NCT00090220|21099546|P5|Base Study Follow-up Period|Withdrawal by Subject|0
6120531|NCT00090220|21099547|P4|Base Study Follow-up Period|Withdrawal by Subject|0
6120532|NCT00090220|21099548|P3|Base Study Follow-up Period|Withdrawal by Subject|0
6120533|NCT00090220|21099549|P2|Base Study Follow-up Period|Withdrawal by Subject|36
6120534|NCT00090220|21099550|P1|Base Study Follow-up Period|Withdrawal by Subject|27
6120535|NCT00090220|21099545|P6|Base Study Follow-up Period|Lost to Follow-up|0
6120536|NCT00090220|21099546|P5|Base Study Follow-up Period|Lost to Follow-up|0
6120537|NCT00090220|21099547|P4|Base Study Follow-up Period|Lost to Follow-up|0
6120538|NCT00090220|21099548|P3|Base Study Follow-up Period|Lost to Follow-up|0
6120539|NCT00090220|21099549|P2|Base Study Follow-up Period|Lost to Follow-up|78
6120540|NCT00090220|21099550|P1|Base Study Follow-up Period|Lost to Follow-up|88
6120541|NCT00090220|21099545|P6|Base Study Follow-up Period|Adverse Event|0
6120542|NCT00090220|21099546|P5|Base Study Follow-up Period|Adverse Event|0
6120543|NCT00090220|21099547|P4|Base Study Follow-up Period|Adverse Event|0
6120544|NCT00090220|21099548|P3|Base Study Follow-up Period|Adverse Event|0
6120545|NCT00090220|21099549|P2|Base Study Follow-up Period|Adverse Event|1
6120546|NCT00090220|21099550|P1|Base Study Follow-up Period|Adverse Event|6
6120547|NCT00090220|21099545|P6|Base Study Vaccination Period|Other|0
6120548|NCT00090220|21099546|P5|Base Study Vaccination Period|Other|0
6120549|NCT00090220|21099547|P4|Base Study Vaccination Period|Other|0
6120550|NCT00090220|21099548|P3|Base Study Vaccination Period|Other|0
6120551|NCT00090220|21099549|P2|Base Study Vaccination Period|Other|4
6120552|NCT00090220|21099550|P1|Base Study Vaccination Period|Other|4
6120553|NCT00090220|21099545|P6|Base Study Vaccination Period|Patient Moved|0
6120554|NCT00090220|21099546|P5|Base Study Vaccination Period|Patient Moved|0
6120555|NCT00090220|21099547|P4|Base Study Vaccination Period|Patient Moved|0
6120556|NCT00090220|21099548|P3|Base Study Vaccination Period|Patient Moved|0
6120557|NCT00090220|21099549|P2|Base Study Vaccination Period|Patient Moved|2
6120558|NCT00090220|21099550|P1|Base Study Vaccination Period|Patient Moved|6
6120559|NCT00090220|21099545|P6|Base Study Vaccination Period|Withdrawal by Subject|0
6120560|NCT00090220|21099546|P5|Base Study Vaccination Period|Withdrawal by Subject|0
6120561|NCT00090220|21099547|P4|Base Study Vaccination Period|Withdrawal by Subject|0
6120562|NCT00090220|21099548|P3|Base Study Vaccination Period|Withdrawal by Subject|0
6120563|NCT00090220|21099549|P2|Base Study Vaccination Period|Withdrawal by Subject|27
6120564|NCT00090220|21099550|P1|Base Study Vaccination Period|Withdrawal by Subject|23
6120565|NCT00090220|21099545|P6|Base Study Vaccination Period|Lost to Follow-up|0
6120566|NCT00090220|21099546|P5|Base Study Vaccination Period|Lost to Follow-up|0
6120567|NCT00090220|21099547|P4|Base Study Vaccination Period|Lost to Follow-up|0
6120568|NCT00090220|21099548|P3|Base Study Vaccination Period|Lost to Follow-up|0
6120569|NCT00090220|21099549|P2|Base Study Vaccination Period|Lost to Follow-up|28
6120570|NCT00090220|21099550|P1|Base Study Vaccination Period|Lost to Follow-up|24
6120571|NCT00090220|21099545|P6|Base Study Vaccination Period|Adverse Event|0
6120572|NCT00090220|21099546|P5|Base Study Vaccination Period|Adverse Event|0
6120573|NCT00090220|21099547|P4|Base Study Vaccination Period|Adverse Event|0
6120574|NCT00090220|21099548|P3|Base Study Vaccination Period|Adverse Event|0
6120575|NCT00090220|21099549|P2|Base Study Vaccination Period|Adverse Event|1
6120576|NCT00090220|21099550|P1|Base Study Vaccination Period|Adverse Event|6
6120577|NCT00090220|21099545|P6|Base Study Vaccination Period|Randomized not Vaccinated|0
6120578|NCT00090220|21099546|P5|Base Study Vaccination Period|Randomized not Vaccinated|0
6120579|NCT00090220|21099547|P4|Base Study Vaccination Period|Randomized not Vaccinated|0
6120580|NCT00090220|21099548|P3|Base Study Vaccination Period|Randomized not Vaccinated|0
6120581|NCT00090220|21099549|P2|Base Study Vaccination Period|Randomized not Vaccinated|1
6120582|NCT00090220|21099550|P1|Base Study Vaccination Period|Randomized not Vaccinated|1
6120583|NCT00090402|21099645|P3|Overall Study|stopped taking study medication|1
6120584|NCT00090402|21099646|P2|Overall Study|stopped taking study medication|0
6120585|NCT00090402|21099647|P1|Overall Study|stopped taking study medication|1
6120586|NCT00090402|21099645|P3|Overall Study|subject moved|0
6120587|NCT00090402|21099646|P2|Overall Study|subject moved|1
6120588|NCT00090402|21099647|P1|Overall Study|subject moved|0
6120589|NCT00090402|21099645|P3|Overall Study|Death|0
6120590|NCT00090402|21099646|P2|Overall Study|Death|1
6120591|NCT00090402|21099647|P1|Overall Study|Death|1
6120592|NCT00090142|21099661|P2|Treatment Period II|Other|0
6120593|NCT00090142|21099662|P1|Treatment Period II|Other|1
6120594|NCT00090142|21099661|P2|Treatment Period I|Other|1
6120595|NCT00090142|21099662|P1|Treatment Period I|Other|0
6120596|NCT00090142|21099661|P2|Treatment Period I|Withdrawal by Subject|0
6120597|NCT00090142|21099662|P1|Treatment Period I|Withdrawal by Subject|2
6120598|NCT00090142|21099661|P2|Treatment Period I|Protocol Violation|0
6120599|NCT00090142|21099662|P1|Treatment Period I|Protocol Violation|2
6120600|NCT00090142|21099661|P2|Treatment Period I|Lost to Follow-up|2
6120601|NCT00090142|21099662|P1|Treatment Period I|Lost to Follow-up|1
6120602|NCT00090103|21099693|P3|16-Week Safety Follow-up Period|Other|0
6120603|NCT00090103|21099694|P2|16-Week Safety Follow-up Period|Other|1
6120604|NCT00090103|21099695|P1|16-Week Safety Follow-up Period|Other|0
6120605|NCT00090103|21099693|P3|16-Week Safety Follow-up Period|Jailed|0
6120606|NCT00090103|21099694|P2|16-Week Safety Follow-up Period|Jailed|1
6120607|NCT00090103|21099695|P1|16-Week Safety Follow-up Period|Jailed|0
6120608|NCT00090103|21099693|P3|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0
6120609|NCT00090103|21099694|P2|16-Week Safety Follow-up Period|Diabetes Uncontrolled|1
6120610|NCT00090103|21099695|P1|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0
6120611|NCT00090103|21099693|P3|16-Week Safety Follow-up Period|Depression|0
6120612|NCT00090103|21099694|P2|16-Week Safety Follow-up Period|Depression|1
6120613|NCT00090103|21099695|P1|16-Week Safety Follow-up Period|Depression|0
6120614|NCT00090103|21099693|P3|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|3
6120615|NCT00090103|21099694|P2|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|2
6120616|NCT00090103|21099695|P1|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|0
6120617|NCT00090103|21099693|P3|16-Week Safety Follow-up Period|Scheduling Issues|4
6120618|NCT00090103|21099694|P2|16-Week Safety Follow-up Period|Scheduling Issues|2
6120619|NCT00090103|21099695|P1|16-Week Safety Follow-up Period|Scheduling Issues|0
6120620|NCT00090103|21099693|P3|16-Week Safety Follow-up Period|Back Pain|0
6120621|NCT00090103|21099694|P2|16-Week Safety Follow-up Period|Back Pain|1
6120622|NCT00090103|21099695|P1|16-Week Safety Follow-up Period|Back Pain|0
6120623|NCT00090103|21099693|P3|16-Week Safety Follow-up Period|Angina Pectoris|0
6120624|NCT00090103|21099694|P2|16-Week Safety Follow-up Period|Angina Pectoris|1
6120625|NCT00090103|21099695|P1|16-Week Safety Follow-up Period|Angina Pectoris|0
6120626|NCT00090103|21099693|P3|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|3
6120627|NCT00090103|21099694|P2|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|2
6120628|NCT00090103|21099695|P1|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|0
6120629|NCT00090103|21099693|P3|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|4
6120630|NCT00090103|21099694|P2|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|5
6120631|NCT00090103|21099695|P1|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|0
6120632|NCT00090103|21099693|P3|16-Week Safety Follow-up Period|Gyneomastia|0
6120633|NCT00090103|21099694|P2|16-Week Safety Follow-up Period|Gyneomastia|0
6120634|NCT00090103|21099695|P1|16-Week Safety Follow-up Period|Gyneomastia|1
6120635|NCT00090103|21099693|P3|16-Week Safety Follow-up Period|Death|1
6120636|NCT00090103|21099694|P2|16-Week Safety Follow-up Period|Death|0
6120637|NCT00090103|21099695|P1|16-Week Safety Follow-up Period|Death|1
6120638|NCT00090103|21099693|P3|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|6
6120639|NCT00090103|21099694|P2|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|3
6120640|NCT00090103|21099695|P1|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|1
6120641|NCT00090103|21099693|P3|16-Week Safety Follow-up Period|Enrollment Error|2
6120642|NCT00090103|21099694|P2|16-Week Safety Follow-up Period|Enrollment Error|0
6120643|NCT00090103|21099695|P1|16-Week Safety Follow-up Period|Enrollment Error|1
6120644|NCT00090103|21099693|P3|16-Week Safety Follow-up Period|Loss of Libido|0
6120645|NCT00090103|21099694|P2|16-Week Safety Follow-up Period|Loss of Libido|0
6120646|NCT00090103|21099695|P1|16-Week Safety Follow-up Period|Loss of Libido|1
6120647|NCT00090103|21099693|P3|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|13
6120648|NCT00090103|21099694|P2|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|5
6120649|NCT00090103|21099695|P1|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|1
6120650|NCT00090103|21099693|P3|16-Week Safety Follow-up Period|Alcohol Dependent|1
6120651|NCT00090103|21099694|P2|16-Week Safety Follow-up Period|Alcohol Dependent|0
6120652|NCT00090103|21099695|P1|16-Week Safety Follow-up Period|Alcohol Dependent|1
6120653|NCT00090103|21099693|P3|16-Week Safety Follow-up Period|Prohibited Medication|5
6120654|NCT00090103|21099694|P2|16-Week Safety Follow-up Period|Prohibited Medication|3
6120655|NCT00090103|21099695|P1|16-Week Safety Follow-up Period|Prohibited Medication|2
6120656|NCT00090103|21099693|P3|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2
6120657|NCT00090103|21099694|P2|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|1
6120658|NCT00090103|21099695|P1|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2
6120659|NCT00090103|21099693|P3|16-Week Safety Follow-up Period|Participant relocated|1
6120660|NCT00090103|21099694|P2|16-Week Safety Follow-up Period|Participant relocated|3
6120661|NCT00090103|21099695|P1|16-Week Safety Follow-up Period|Participant relocated|2
6120662|NCT00090103|21099693|P3|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1
6120663|NCT00090103|21099694|P2|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1
6120664|NCT00090103|21099695|P1|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|3
6120665|NCT00090103|21099693|P3|16-Week Safety Follow-up Period|Loss of Contact|2
6120666|NCT00090103|21099694|P2|16-Week Safety Follow-up Period|Loss of Contact|0
6120667|NCT00090103|21099695|P1|16-Week Safety Follow-up Period|Loss of Contact|4
6120668|NCT00090103|21099693|P3|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|4
6120669|NCT00090103|21099694|P2|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|6
6120670|NCT00090103|21099695|P1|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|8
6120671|NCT00090103|21099693|P3|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|4
6120672|NCT00090103|21099694|P2|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|5
6120673|NCT00090103|21099695|P1|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|8
6120674|NCT00090103|21099693|P3|16-Week Safety Follow-up Period|Protocol Violation|17
6120675|NCT00090103|21099694|P2|16-Week Safety Follow-up Period|Protocol Violation|18
6120676|NCT00090103|21099695|P1|16-Week Safety Follow-up Period|Protocol Violation|18
6120677|NCT00090103|21099693|P3|16-Week Safety Follow-up Period|Lost to Follow-up|111
6120678|NCT00090103|21099694|P2|16-Week Safety Follow-up Period|Lost to Follow-up|97
6120679|NCT00090103|21099695|P1|16-Week Safety Follow-up Period|Lost to Follow-up|101
6120680|NCT00090103|21099693|P3|16-Week Safety Follow-up Period|Withdrawal by Subject|229
6120681|NCT00090103|21099694|P2|16-Week Safety Follow-up Period|Withdrawal by Subject|212
6120682|NCT00090103|21099695|P1|16-Week Safety Follow-up Period|Withdrawal by Subject|185
6120683|NCT00090103|21099693|P3|16-Week Safety Follow-up Period|Adverse Event|44
6120684|NCT00090103|21099694|P2|16-Week Safety Follow-up Period|Adverse Event|39
6120685|NCT00090103|21099695|P1|16-Week Safety Follow-up Period|Adverse Event|34
6120686|NCT00090103|21099693|P3|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0
6120687|NCT00090103|21099694|P2|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|1
6120688|NCT00090103|21099695|P1|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0
6120689|NCT00090103|21099693|P3|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|1
6120690|NCT00090103|21099694|P2|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0
6120691|NCT00090103|21099695|P1|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0
6120692|NCT00090103|21099693|P3|Four-Year Double-Blind Treatment Period|Enrollment Error|2
6120693|NCT00090103|21099694|P2|Four-Year Double-Blind Treatment Period|Enrollment Error|0
6120694|NCT00090103|21099695|P1|Four-Year Double-Blind Treatment Period|Enrollment Error|0
6120695|NCT00090103|21099693|P3|Four-Year Double-Blind Treatment Period|Investigator Decision|3
6120696|NCT00090103|21099694|P2|Four-Year Double-Blind Treatment Period|Investigator Decision|1
6120697|NCT00090103|21099695|P1|Four-Year Double-Blind Treatment Period|Investigator Decision|0
6120698|NCT00090103|21099693|P3|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0
6120699|NCT00090103|21099694|P2|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|1
6120700|NCT00090103|21099695|P1|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0
6120701|NCT00090103|21099693|P3|Four-Year Double-Blind Treatment Period|Scheduling Issues|0
6120702|NCT00090103|21099694|P2|Four-Year Double-Blind Treatment Period|Scheduling Issues|1
6120703|NCT00090103|21099695|P1|Four-Year Double-Blind Treatment Period|Scheduling Issues|0
6120704|NCT00090103|21099693|P3|Four-Year Double-Blind Treatment Period|Back Pain|0
6120705|NCT00090103|21099694|P2|Four-Year Double-Blind Treatment Period|Back Pain|1
6120706|NCT00090103|21099695|P1|Four-Year Double-Blind Treatment Period|Back Pain|0
6120707|NCT00090103|21099693|P3|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0
6120708|NCT00090103|21099694|P2|Four-Year Double-Blind Treatment Period|Renal Insufficiency|1
6120709|NCT00090103|21099695|P1|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0
6120710|NCT00090103|21099693|P3|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0
6120711|NCT00090103|21099694|P2|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|2
6120712|NCT00090103|21099695|P1|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0
6120713|NCT00090103|21099693|P3|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1
6120714|NCT00090103|21099694|P2|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1
6120715|NCT00090103|21099695|P1|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|0
6120716|NCT00090103|21099693|P3|Four-Year Double-Blind Treatment Period|Loss of Contact|0
6120717|NCT00090103|21099694|P2|Four-Year Double-Blind Treatment Period|Loss of Contact|1
6120718|NCT00090103|21099695|P1|Four-Year Double-Blind Treatment Period|Loss of Contact|0
6120719|NCT00090103|21099693|P3|Four-Year Double-Blind Treatment Period|Angina Pectoris|0
6120720|NCT00090103|21099694|P2|Four-Year Double-Blind Treatment Period|Angina Pectoris|2
6120721|NCT00090103|21099695|P1|Four-Year Double-Blind Treatment Period|Angina Pectoris|0
6120722|NCT00090103|21099693|P3|Four-Year Double-Blind Treatment Period|Loss of Libido|0
6120723|NCT00090103|21099694|P2|Four-Year Double-Blind Treatment Period|Loss of Libido|0
6120724|NCT00090103|21099695|P1|Four-Year Double-Blind Treatment Period|Loss of Libido|1
6120725|NCT00090103|21099693|P3|Four-Year Double-Blind Treatment Period|Financial Problems|0
6120726|NCT00090103|21099694|P2|Four-Year Double-Blind Treatment Period|Financial Problems|0
6120727|NCT00090103|21099695|P1|Four-Year Double-Blind Treatment Period|Financial Problems|1
6120728|NCT00090103|21099693|P3|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|5
6120729|NCT00090103|21099694|P2|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|0
6120730|NCT00090103|21099695|P1|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|1
6120731|NCT00090103|21099693|P3|Four-Year Double-Blind Treatment Period|No Improvement|0
6120732|NCT00090103|21099694|P2|Four-Year Double-Blind Treatment Period|No Improvement|0
6120733|NCT00090103|21099695|P1|Four-Year Double-Blind Treatment Period|No Improvement|1
6120734|NCT00090103|21099693|P3|Four-Year Double-Blind Treatment Period|Screen Failure|0
6120735|NCT00090103|21099694|P2|Four-Year Double-Blind Treatment Period|Screen Failure|0
6120736|NCT00090103|21099695|P1|Four-Year Double-Blind Treatment Period|Screen Failure|1
6120737|NCT00090103|21099693|P3|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0
6120738|NCT00090103|21099694|P2|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0
6120739|NCT00090103|21099695|P1|Four-Year Double-Blind Treatment Period|Alcohol Dependent|1
6120740|NCT00090103|21099693|P3|Four-Year Double-Blind Treatment Period|Investigator Departure|0
6120741|NCT00090103|21099694|P2|Four-Year Double-Blind Treatment Period|Investigator Departure|0
6120742|NCT00090103|21099695|P1|Four-Year Double-Blind Treatment Period|Investigator Departure|2
6120743|NCT00090103|21099693|P3|Four-Year Double-Blind Treatment Period|Prohibited Medication|8
6120744|NCT00090103|21099694|P2|Four-Year Double-Blind Treatment Period|Prohibited Medication|2
6120745|NCT00090103|21099695|P1|Four-Year Double-Blind Treatment Period|Prohibited Medication|2
6120746|NCT00090103|21099693|P3|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|6
6120747|NCT00090103|21099694|P2|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|3
6120748|NCT00090103|21099695|P1|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|2
6120749|NCT00090103|21099693|P3|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|4
6120750|NCT00090103|21099694|P2|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|0
6120751|NCT00090103|21099695|P1|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|2
6120752|NCT00090103|21099693|P3|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|19
6120753|NCT00090103|21099694|P2|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|7
6120754|NCT00090103|21099695|P1|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|3
6120755|NCT00090103|21099693|P3|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|7
6120756|NCT00090103|21099694|P2|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|4
6120757|NCT00090103|21099695|P1|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|6
6120758|NCT00090103|21099693|P3|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|4
6120759|NCT00090103|21099694|P2|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7
6120760|NCT00090103|21099695|P1|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7
6120761|NCT00090103|21099693|P3|Four-Year Double-Blind Treatment Period|Participant Relocated|8
6120762|NCT00090103|21099694|P2|Four-Year Double-Blind Treatment Period|Participant Relocated|2
6120763|NCT00090103|21099695|P1|Four-Year Double-Blind Treatment Period|Participant Relocated|7
6120764|NCT00090103|21099693|P3|Four-Year Double-Blind Treatment Period|Lack of Efficacy|104
6120765|NCT00090103|21099694|P2|Four-Year Double-Blind Treatment Period|Lack of Efficacy|71
6120766|NCT00090103|21099695|P1|Four-Year Double-Blind Treatment Period|Lack of Efficacy|53
6120767|NCT00090103|21099693|P3|Four-Year Double-Blind Treatment Period|Protocol Violation|34
6120768|NCT00090103|21099694|P2|Four-Year Double-Blind Treatment Period|Protocol Violation|29
6120769|NCT00090103|21099695|P1|Four-Year Double-Blind Treatment Period|Protocol Violation|29
6120770|NCT00090103|21099693|P3|Four-Year Double-Blind Treatment Period|Lost to Follow-up|58
6120771|NCT00090103|21099694|P2|Four-Year Double-Blind Treatment Period|Lost to Follow-up|48
6120772|NCT00090103|21099695|P1|Four-Year Double-Blind Treatment Period|Lost to Follow-up|53
6120773|NCT00090103|21099693|P3|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|148
6120774|NCT00090103|21099694|P2|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|160
6120775|NCT00090103|21099695|P1|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|114
6120776|NCT00090103|21099693|P3|Four-Year Double-Blind Treatment Period|Adverse Event|210
6120777|NCT00090103|21099694|P2|Four-Year Double-Blind Treatment Period|Adverse Event|185
6120778|NCT00090103|21099695|P1|Four-Year Double-Blind Treatment Period|Adverse Event|211
6120779|NCT00089999|21099861|P2|Overall Study|Skin Nodule Over Right Mastectomy|1
6120780|NCT00089999|21099862|P1|Overall Study|Skin Nodule Over Right Mastectomy|0
6120781|NCT00089999|21099861|P2|Overall Study|Patient Underwent Surgery|0
6120782|NCT00089999|21099862|P1|Overall Study|Patient Underwent Surgery|2
6120783|NCT00089999|21099861|P2|Overall Study|Physician Decision|2
6120784|NCT00089999|21099862|P1|Overall Study|Physician Decision|2
6120785|NCT00089999|21099861|P2|Overall Study|Clinical Progression|2
6120786|NCT00089999|21099862|P1|Overall Study|Clinical Progression|1
6120787|NCT00089999|21099861|P2|Overall Study|Poor General Condition|0
6120788|NCT00089999|21099862|P1|Overall Study|Poor General Condition|1
6120789|NCT00089999|21099861|P2|Overall Study|Death|3
6120790|NCT00089999|21099862|P1|Overall Study|Death|3
6120791|NCT00089999|21099861|P2|Overall Study|Symptomatic Progression of Cancer|5
6120792|NCT00089999|21099862|P1|Overall Study|Symptomatic Progression of Cancer|2
6120793|NCT00089999|21099861|P2|Overall Study|Radiological Progression of Cancer|44
6120794|NCT00089999|21099862|P1|Overall Study|Radiological Progression of Cancer|52
6120795|NCT00089999|21099861|P2|Overall Study|Lost to Follow-up|1
6120796|NCT00089999|21099862|P1|Overall Study|Lost to Follow-up|2
6120797|NCT00089999|21099861|P2|Overall Study|Withdrawal by Subject|4
6120798|NCT00089999|21099862|P1|Overall Study|Withdrawal by Subject|0
6120799|NCT00089999|21099861|P2|Overall Study|Adverse Event|7
6120800|NCT00089999|21099862|P1|Overall Study|Adverse Event|4
6120801|NCT00089986|21099885|P3|Overall Study|Withdrawal by Subject|2
6120802|NCT00089986|21099886|P2|Overall Study|Withdrawal by Subject|6
6120803|NCT00089986|21099887|P1|Overall Study|Withdrawal by Subject|3
6120804|NCT00089986|21099885|P3|Overall Study|Do not resuscitate (DNR)|1
6120805|NCT00089986|21099886|P2|Overall Study|Do not resuscitate (DNR)|0
6120806|NCT00089986|21099887|P1|Overall Study|Do not resuscitate (DNR)|0
6120807|NCT00089986|21099885|P3|Overall Study|Family decision|0
6120808|NCT00089986|21099886|P2|Overall Study|Family decision|1
6120809|NCT00089986|21099887|P1|Overall Study|Family decision|0
6120810|NCT00089986|21099885|P3|Overall Study|Enrollment in another study|0
6120811|NCT00089986|21099886|P2|Overall Study|Enrollment in another study|1
6120812|NCT00089986|21099887|P1|Overall Study|Enrollment in another study|0
6120813|NCT00089986|21099885|P3|Overall Study|Investigator decision to withdrew|0
6120814|NCT00089986|21099886|P2|Overall Study|Investigator decision to withdrew|1
6120815|NCT00089986|21099887|P1|Overall Study|Investigator decision to withdrew|0
6120816|NCT00089986|21099885|P3|Overall Study|Hemohlobin stopping rule|0
6120817|NCT00089986|21099886|P2|Overall Study|Hemohlobin stopping rule|1
6120818|NCT00089986|21099887|P1|Overall Study|Hemohlobin stopping rule|0
6120819|NCT00089986|21099885|P3|Overall Study|Subject withdrew but agreed follow up|0
6120820|NCT00089986|21099886|P2|Overall Study|Subject withdrew but agreed follow up|2
6120821|NCT00089986|21099887|P1|Overall Study|Subject withdrew but agreed follow up|1
6120822|NCT00089986|21099885|P3|Overall Study|Patient transferred to another hospital|0
6120823|NCT00089986|21099886|P2|Overall Study|Patient transferred to another hospital|1
6120824|NCT00089986|21099887|P1|Overall Study|Patient transferred to another hospital|2
6120825|NCT00089986|21099885|P3|Overall Study|Protocol Violation|0
6120826|NCT00089986|21099886|P2|Overall Study|Protocol Violation|1
6120827|NCT00089986|21099887|P1|Overall Study|Protocol Violation|0
6120828|NCT00089986|21099885|P3|Overall Study|Lost to Follow-up|1
6120829|NCT00089986|21099886|P2|Overall Study|Lost to Follow-up|1
6120830|NCT00089986|21099887|P1|Overall Study|Lost to Follow-up|3
6120831|NCT00089986|21099885|P3|Overall Study|Adverse Event|6
6120832|NCT00089986|21099886|P2|Overall Study|Adverse Event|9
6120833|NCT00089986|21099887|P1|Overall Study|Adverse Event|6
6120834|NCT00089973|21099904|P1|Overall Study|Death|1
6120835|NCT00089973|21099904|P1|Overall Study|Disease progression|45
6120836|NCT00089973|21099904|P1|Overall Study|Withdrawal by Subject|1
6120837|NCT00089973|21099904|P1|Overall Study|Adverse Event|3
6120838|NCT00089895|21099919|P2|Overall Study|Missing|2
6120839|NCT00089895|21099920|P1|Overall Study|Missing|4
6120840|NCT00089895|21099919|P2|Overall Study|Not otherwise specified|8
6120841|NCT00089895|21099920|P1|Overall Study|Not otherwise specified|4
6120842|NCT00089895|21099919|P2|Overall Study|Exclusion criteria met|6
6120843|NCT00089895|21099920|P1|Overall Study|Exclusion criteria met|6
6120844|NCT00089895|21099919|P2|Overall Study|Physician Decision|7
6120845|NCT00089895|21099920|P1|Overall Study|Physician Decision|3
6120846|NCT00089895|21099919|P2|Overall Study|Bleeding|2
6120847|NCT00089895|21099920|P1|Overall Study|Bleeding|0
6120848|NCT00089895|21099919|P2|Overall Study|Surgery|1
6120849|NCT00089895|21099920|P1|Overall Study|Surgery|0
6120850|NCT00089895|21099919|P2|Overall Study|Technical reason|2
6120851|NCT00089895|21099920|P1|Overall Study|Technical reason|7
6120852|NCT00089895|21099919|P2|Overall Study|Consent Withdrawn|14
6120853|NCT00089895|21099920|P1|Overall Study|Consent Withdrawn|11
6120854|NCT00089843|21099932|P4|Overall Study|Physician Decision|1
6120855|NCT00089843|21099933|P3|Overall Study|Physician Decision|0
6120856|NCT00089843|21099934|P2|Overall Study|Physician Decision|0
6120857|NCT00089843|21099935|P1|Overall Study|Physician Decision|1
6120858|NCT00089843|21099932|P4|Overall Study|Withdrawal by Subject|6
6120859|NCT00089843|21099933|P3|Overall Study|Withdrawal by Subject|5
6120860|NCT00089843|21099934|P2|Overall Study|Withdrawal by Subject|4
6120861|NCT00089843|21099935|P1|Overall Study|Withdrawal by Subject|1
6120862|NCT00089791|21099947|P2|Overall Study|Requirement for alternative therapy|4
6120863|NCT00089791|21099948|P1|Overall Study|Requirement for alternative therapy|7
6120864|NCT00089791|21099947|P2|Overall Study|Protocol deviation|10
6120865|NCT00089791|21099948|P1|Overall Study|Protocol deviation|12
6120866|NCT00089791|21099947|P2|Overall Study|Other|32
6120867|NCT00089791|21099948|P1|Overall Study|Other|20
6120868|NCT00089791|21099947|P2|Overall Study|Noncompliance|13
6120869|NCT00089791|21099948|P1|Overall Study|Noncompliance|17
6120870|NCT00089791|21099947|P2|Overall Study|Lost to Follow-up|57
6120871|NCT00089791|21099948|P1|Overall Study|Lost to Follow-up|57
6120872|NCT00089791|21099947|P2|Overall Study|Ineligibility determined|9
6120873|NCT00089791|21099948|P1|Overall Study|Ineligibility determined|12
6120874|NCT00089791|21099947|P2|Overall Study|Disease progression|3
6120875|NCT00089791|21099948|P1|Overall Study|Disease progression|7
6120876|NCT00089791|21099947|P2|Overall Study|Death|62
6120877|NCT00089791|21099948|P1|Overall Study|Death|78
6120878|NCT00089791|21099947|P2|Overall Study|Withdrawal by Subject|344
6120879|NCT00089791|21099948|P1|Overall Study|Withdrawal by Subject|403
6120880|NCT00089791|21099947|P2|Overall Study|Adverse Event|93
6120881|NCT00089791|21099948|P1|Overall Study|Adverse Event|81
6120882|NCT00089791|21099947|P2|Overall Study|Physician Decision|3
6120883|NCT00089791|21099948|P1|Overall Study|Physician Decision|6
6120884|NCT00089778|21099982|P3|Overall Study|Protocol Violation|1
6120885|NCT00089778|21099983|P2|Overall Study|Protocol Violation|0
6120886|NCT00089778|21099984|P1|Overall Study|Protocol Violation|0
6120887|NCT00089674|21099997|P2|Overall Study|Requirement for alternative therapy|4
6120888|NCT00089674|21099998|P1|Overall Study|Requirement for alternative therapy|14
6120889|NCT00089674|21099997|P2|Overall Study|Other|9
6120890|NCT00089674|21099998|P1|Overall Study|Other|5
6120891|NCT00089674|21099997|P2|Overall Study|Noncompliance|3
6120892|NCT00089674|21099998|P1|Overall Study|Noncompliance|7
6120893|NCT00089674|21099997|P2|Overall Study|Lost to Follow-up|17
6120894|NCT00089674|21099998|P1|Overall Study|Lost to Follow-up|21
6120895|NCT00089674|21099997|P2|Overall Study|Ineligibility determined|10
6120896|NCT00089674|21099998|P1|Overall Study|Ineligibility determined|8
6120897|NCT00089674|21099997|P2|Overall Study|Disease progression|23
6120898|NCT00089674|21099998|P1|Overall Study|Disease progression|21
6120899|NCT00089674|21099997|P2|Overall Study|Death|43
6120900|NCT00089674|21099998|P1|Overall Study|Death|43
6120901|NCT00089674|21099997|P2|Overall Study|Withdrawal by Subject|127
6120902|NCT00089674|21099998|P1|Overall Study|Withdrawal by Subject|143
6120903|NCT00089674|21099997|P2|Overall Study|Adverse Event|29
6120904|NCT00089674|21099998|P1|Overall Study|Adverse Event|23
6120905|NCT00089674|21099997|P2|Overall Study|Physician Decision|2
6120906|NCT00089674|21099998|P1|Overall Study|Physician Decision|4
6120907|NCT00089661|21100024|P2|Overall Study|Other|1
6120908|NCT00089661|21100025|P1|Overall Study|Other|2
6120909|NCT00089661|21100024|P2|Overall Study|Noncompliance|4
6120910|NCT00089661|21100025|P1|Overall Study|Noncompliance|2
6120911|NCT00089661|21100024|P2|Overall Study|Ineligibility determined|4
6120912|NCT00089661|21100025|P1|Overall Study|Ineligibility determined|4
6120913|NCT00089661|21100024|P2|Overall Study|Disease progression|3
6120914|NCT00089661|21100025|P1|Overall Study|Disease progression|1
6120915|NCT00089661|21100024|P2|Overall Study|Withdrawal by Subject|9
6120916|NCT00089661|21100025|P1|Overall Study|Withdrawal by Subject|11
6120917|NCT00089661|21100024|P2|Overall Study|Lost to Follow-up|3
6120918|NCT00089661|21100025|P1|Overall Study|Lost to Follow-up|0
6120919|NCT00089661|21100024|P2|Overall Study|Death|0
6120920|NCT00089661|21100025|P1|Overall Study|Death|1
6120921|NCT00089661|21100024|P2|Overall Study|Adverse Event|2
6120922|NCT00089661|21100025|P1|Overall Study|Adverse Event|0
6120923|NCT00089648|21100041|P1|Overall Study|Lack of Efficacy|33
6120924|NCT00089648|21100041|P1|Overall Study|Withdrawal by Subject|1
6120925|NCT00089648|21100041|P1|Overall Study|Adverse Event|7
6120926|NCT00089635|21100057|P1|Overall Study|Other|2
6120927|NCT00089635|21100057|P1|Overall Study|Ineligibility determined|1
6120928|NCT00089635|21100057|P1|Overall Study|Withdrawal by Subject|6
6120929|NCT00089635|21100057|P1|Overall Study|Lost to Follow-up|3
6120930|NCT00089635|21100057|P1|Overall Study|Disease Progression|12
6120931|NCT00089635|21100057|P1|Overall Study|Death|17
6120932|NCT00089635|21100057|P1|Overall Study|Adverse Event|2
6120933|NCT00089583|21100071|P2|Overall Study|Participant Incarcerated|1
6120934|NCT00089583|21100072|P1|Overall Study|Participant Incarcerated|0
6120935|NCT00089583|21100071|P2|Overall Study|Necessity to Use Prohibited Drug|0
6120936|NCT00089583|21100072|P1|Overall Study|Necessity to Use Prohibited Drug|1
6120937|NCT00089583|21100071|P2|Overall Study|Start of Disallowed Medication|1
6120938|NCT00089583|21100072|P1|Overall Study|Start of Disallowed Medication|0
6120939|NCT00089583|21100071|P2|Overall Study|Principal Investigator Decision|10
6120940|NCT00089583|21100072|P1|Overall Study|Principal Investigator Decision|0
6120941|NCT00089583|21100071|P2|Overall Study|Protocol Violation|3
6120942|NCT00089583|21100072|P1|Overall Study|Protocol Violation|0
6120943|NCT00089583|21100071|P2|Overall Study|Reason Not Provided|1
6120944|NCT00089583|21100072|P1|Overall Study|Reason Not Provided|0
6120945|NCT00089583|21100071|P2|Overall Study|Participant Management Criteria Met|1
6120946|NCT00089583|21100072|P1|Overall Study|Participant Management Criteria Met|0
6120947|NCT00089583|21100071|P2|Overall Study|Poor Medical Compliance/Adherence Issues|3
6120948|NCT00089583|21100072|P1|Overall Study|Poor Medical Compliance/Adherence Issues|0
6120949|NCT00089583|21100071|P2|Overall Study|Non-Compliance|4
6120950|NCT00089583|21100072|P1|Overall Study|Non-Compliance|0
6120951|NCT00089583|21100071|P2|Overall Study|Participant Refused Study Medication|2
6120952|NCT00089583|21100072|P1|Overall Study|Participant Refused Study Medication|0
6120953|NCT00089583|21100071|P2|Overall Study|Participant (Par) Didn't Take Medication|0
6120954|NCT00089583|21100072|P1|Overall Study|Participant (Par) Didn't Take Medication|1
6120955|NCT00089583|21100071|P2|Overall Study|Withdrawal by Subject|4
6120956|NCT00089583|21100072|P1|Overall Study|Withdrawal by Subject|0
6120957|NCT00089583|21100071|P2|Overall Study|Insufficient Viral Load Response|5
6120958|NCT00089583|21100072|P1|Overall Study|Insufficient Viral Load Response|5
6120959|NCT00089583|21100071|P2|Overall Study|Adverse Event|3
6120960|NCT00089583|21100072|P1|Overall Study|Adverse Event|0
6120961|NCT00089609|21100166|P2|Overall Study|Withdrawal by Subject|1
6120962|NCT00089609|21100167|P1|Overall Study|Withdrawal by Subject|3
6120963|NCT00089544|21100186|P2|Overall Study|Ineligible|0
6120964|NCT00089544|21100187|P1|Overall Study|Ineligible|1
6120965|NCT00089505|21100201|P4|Overall Study|Protocol Violation|0
6120966|NCT00089505|21100202|P3|Overall Study|Protocol Violation|1
6120967|NCT00089505|21100203|P2|Overall Study|Protocol Violation|0
6120968|NCT00089505|21100204|P1|Overall Study|Protocol Violation|0
6120969|NCT00089505|21100201|P4|Overall Study|Physician Decision|0
6120970|NCT00089505|21100202|P3|Overall Study|Physician Decision|0
6120971|NCT00089505|21100203|P2|Overall Study|Physician Decision|0
6120972|NCT00089505|21100204|P1|Overall Study|Physician Decision|1
6120973|NCT00089505|21100201|P4|Overall Study|Lost to Follow-up|7
6120974|NCT00089505|21100202|P3|Overall Study|Lost to Follow-up|9
6120975|NCT00089505|21100203|P2|Overall Study|Lost to Follow-up|1
6120976|NCT00089505|21100204|P1|Overall Study|Lost to Follow-up|1
6120977|NCT00089505|21100201|P4|Overall Study|Withdrawal by Subject|6
6120978|NCT00089505|21100202|P3|Overall Study|Withdrawal by Subject|6
6120979|NCT00089505|21100203|P2|Overall Study|Withdrawal by Subject|0
6120980|NCT00089505|21100204|P1|Overall Study|Withdrawal by Subject|3
6120981|NCT00089505|21100201|P4|Overall Study|Death|8
6120982|NCT00089505|21100202|P3|Overall Study|Death|5
6120983|NCT00089505|21100203|P2|Overall Study|Death|1
6120984|NCT00089505|21100204|P1|Overall Study|Death|4
6120985|NCT00089479|21100248|P2|Overall Study|Lost to Follow-up|107
6120986|NCT00089479|21100249|P1|Overall Study|Lost to Follow-up|137
6120987|NCT00089479|21100248|P2|Overall Study|Withdrawal by Subject|107
6120988|NCT00089479|21100249|P1|Overall Study|Withdrawal by Subject|86
6120989|NCT00089479|21100248|P2|Overall Study|Death|75
6120990|NCT00089479|21100249|P1|Overall Study|Death|108
6120991|NCT00089297|21100292|P1|Overall Study|Non-compliance|1
6120992|NCT00089297|21100292|P1|Overall Study|IRB approval not ready|1
6120993|NCT00089297|21100292|P1|Overall Study|Secondary malignancy|1
6120994|NCT00089297|21100292|P1|Overall Study|Ineligible|11
6120995|NCT00089297|21100292|P1|Overall Study|Disease progression|2
6120996|NCT00089297|21100292|P1|Overall Study|Withdrawal by Subject|12
6120997|NCT00089297|21100292|P1|Overall Study|Death|1
6120998|NCT00089297|21100292|P1|Overall Study|Adverse Event|9
6120999|NCT00089284|21100304|P7|Overall Study|Adverse event before starting treatment|1
6121000|NCT00089284|21100305|P6|Overall Study|Adverse event before starting treatment|0
6121001|NCT00089284|21100306|P5|Overall Study|Adverse event before starting treatment|0
6121002|NCT00089284|21100307|P4|Overall Study|Adverse event before starting treatment|0
6121003|NCT00089284|21100308|P3|Overall Study|Adverse event before starting treatment|0
6121004|NCT00089284|21100309|P2|Overall Study|Adverse event before starting treatment|0
6121005|NCT00089284|21100310|P1|Overall Study|Adverse event before starting treatment|0
6121006|NCT00089141|21100347|P2|Overall Study|Termination of trial|24
6121007|NCT00089141|21100348|P1|Overall Study|Termination of trial|18
6121008|NCT00089076|21100384|P1|Overall Study|Progression|7
6121009|NCT00089076|21100384|P1|Overall Study|Withdrawal by Subject|2
6121010|NCT00089076|21100384|P1|Overall Study|Alternate Therapy|1
6121011|NCT00088907|21100441|P2|Single Gefitinib Treatment (Step 2)|not start protocol therapy|0
6121012|NCT00088907|21100442|P1|Single Gefitinib Treatment (Step 2)|not start protocol therapy|5
6121013|NCT00088907|21100441|P2|Single Gefitinib Treatment (Step 2)|unknown/not specify|0
6121014|NCT00088907|21100442|P1|Single Gefitinib Treatment (Step 2)|unknown/not specify|2
6121015|NCT00088907|21100441|P2|Single Gefitinib Treatment (Step 2)|Death|0
6121016|NCT00088907|21100442|P1|Single Gefitinib Treatment (Step 2)|Death|1
6121017|NCT00088907|21100441|P2|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|0
6121018|NCT00088907|21100442|P1|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|16
6121019|NCT00088907|21100441|P2|Randomized Study (Step 1)|ineligible or not start protocol therapy|12
6121020|NCT00088907|21100442|P1|Randomized Study (Step 1)|ineligible or not start protocol therapy|19
6121021|NCT00088907|21100441|P2|Randomized Study (Step 1)|unknown/not specify|13
6121022|NCT00088907|21100442|P1|Randomized Study (Step 1)|unknown/not specify|24
6121023|NCT00088907|21100441|P2|Randomized Study (Step 1)|complicating disease|1
6121024|NCT00088907|21100442|P1|Randomized Study (Step 1)|complicating disease|3
6121025|NCT00088907|21100441|P2|Randomized Study (Step 1)|Withdrawal by Subject|15
6121026|NCT00088907|21100442|P1|Randomized Study (Step 1)|Withdrawal by Subject|10
6121027|NCT00088907|21100441|P2|Randomized Study (Step 1)|Death|12
6121028|NCT00088907|21100442|P1|Randomized Study (Step 1)|Death|11
6121029|NCT00088907|21100441|P2|Randomized Study (Step 1)|Adverse Event|19
6121030|NCT00088907|21100442|P1|Randomized Study (Step 1)|Adverse Event|14
6121031|NCT00088907|21100441|P2|Randomized Study (Step 1)|Lack of Efficacy|62
6121032|NCT00088907|21100442|P1|Randomized Study (Step 1)|Lack of Efficacy|55
6121033|NCT00088881|21100453|P1|Step 2 - Zevalin™ Radioimmunotherapy|Other|3
6121034|NCT00088881|21100453|P1|Step 2 - Zevalin™ Radioimmunotherapy|Patient ineligible|8
6121035|NCT00088881|21100453|P1|Step 1 - R-CHOP|Insurance company refused to cover|1
6121036|NCT00088881|21100453|P1|Step 1 - R-CHOP|Physician Decision|1
6121037|NCT00088881|21100453|P1|Step 1 - R-CHOP|Withdrawal by Subject|2
6121038|NCT00088881|21100453|P1|Step 1 - R-CHOP|Adverse Event|1
6121039|NCT00088881|21100453|P1|Step 1 - R-CHOP|Patient ineligible|9
6121040|NCT00088829|21100462|P1|Overall Study|PI left institution and study was close|22
6121041|NCT00088595|21100504|P1|Overall Study|New Cancer Therapy|2
6121042|NCT00088595|21100504|P1|Overall Study|Ongoing (After Core)|7
6121043|NCT00088595|21100504|P1|Overall Study|Withdrawal by Subject|8
6121044|NCT00088595|21100504|P1|Overall Study|Adverse Event|11
6121045|NCT00088530|21100522|P2|Overall Study|Patient never treated|0
6121046|NCT00088530|21100523|P1|Overall Study|Patient never treated|1
6121047|NCT00088530|21100522|P2|Overall Study|Sponsor decision|1
6121048|NCT00088530|21100523|P1|Overall Study|Sponsor decision|0
6121049|NCT00088530|21100522|P2|Overall Study|Physician Decision|0
6121050|NCT00088530|21100523|P1|Overall Study|Physician Decision|2
6121051|NCT00088530|21100522|P2|Overall Study|Lost to Follow-up|0
6121052|NCT00088530|21100523|P1|Overall Study|Lost to Follow-up|2
6121053|NCT00088530|21100522|P2|Overall Study|Withdrawal by Subject|5
6121054|NCT00088530|21100523|P1|Overall Study|Withdrawal by Subject|2
6121055|NCT00088530|21100522|P2|Overall Study|Adverse Event|9
6121056|NCT00088530|21100523|P1|Overall Study|Adverse Event|15
6121057|NCT00088530|21100522|P2|Overall Study|Progressive/Relapsed Disease|39
6121058|NCT00088530|21100523|P1|Overall Study|Progressive/Relapsed Disease|28
6121059|NCT00088465|21100535|P1|Overall Study|Death|11
6121060|NCT00088465|21100535|P1|Overall Study|Protocol Violation|17
6121061|NCT00088465|21100535|P1|Overall Study|Lack of Efficacy|27
6121062|NCT00088465|21100535|P1|Overall Study|Sponsor Decision|37
6121063|NCT00088465|21100535|P1|Overall Study|Physician Decision|45
6121064|NCT00088465|21100535|P1|Overall Study|Lost to Follow-up|57
6121065|NCT00088465|21100535|P1|Overall Study|Adverse Event|77
6121066|NCT00088465|21100535|P1|Overall Study|Withdrawal by Subject|290
6121067|NCT00088452|21100561|P3|Overall Study|Did not receive intervention|1
6121068|NCT00088452|21100562|P2|Overall Study|Did not receive intervention|0
6121069|NCT00088452|21100563|P1|Overall Study|Did not receive intervention|1
6121070|NCT00088413|21100581|P4|Overall Study|Patient unevaluable due to adverse event|0
6121071|NCT00088413|21100582|P3|Overall Study|Patient unevaluable due to adverse event|1
6121072|NCT00088413|21100583|P2|Overall Study|Patient unevaluable due to adverse event|0
6121073|NCT00088413|21100584|P1|Overall Study|Patient unevaluable due to adverse event|0
6121074|NCT00088413|21100581|P4|Overall Study|Other|0
6121075|NCT00088413|21100582|P3|Overall Study|Other|0
6121076|NCT00088413|21100583|P2|Overall Study|Other|1
6121077|NCT00088413|21100584|P1|Overall Study|Other|0
6121078|NCT00088413|21100581|P4|Overall Study|Progressive disease|14
6121079|NCT00088413|21100582|P3|Overall Study|Progressive disease|8
6121080|NCT00088413|21100583|P2|Overall Study|Progressive disease|11
6121081|NCT00088413|21100584|P1|Overall Study|Progressive disease|9
6121082|NCT00088413|21100581|P4|Overall Study|Death|0
6121083|NCT00088413|21100582|P3|Overall Study|Death|0
6121084|NCT00088413|21100583|P2|Overall Study|Death|1
6121085|NCT00088413|21100584|P1|Overall Study|Death|0
6121086|NCT00088413|21100581|P4|Overall Study|Off study due to missing a vaccine dose|0
6121087|NCT00088413|21100582|P3|Overall Study|Off study due to missing a vaccine dose|0
6121088|NCT00088413|21100583|P2|Overall Study|Off study due to missing a vaccine dose|0
6121089|NCT00088413|21100584|P1|Overall Study|Off study due to missing a vaccine dose|1
6121090|NCT00088413|21100581|P4|Overall Study|Refused trmt Off-study per pt wishes|0
6121091|NCT00088413|21100582|P3|Overall Study|Refused trmt Off-study per pt wishes|1
6121092|NCT00088413|21100583|P2|Overall Study|Refused trmt Off-study per pt wishes|1
6121093|NCT00088413|21100584|P1|Overall Study|Refused trmt Off-study per pt wishes|0
6121094|NCT00088413|21100581|P4|Overall Study|Adverse Events/Side Effects|0
6121095|NCT00088413|21100582|P3|Overall Study|Adverse Events/Side Effects|1
6121096|NCT00088413|21100583|P2|Overall Study|Adverse Events/Side Effects|1
6121097|NCT00088413|21100584|P1|Overall Study|Adverse Events/Side Effects|0
6121098|NCT00088413|21100581|P4|Overall Study|Limited supply of trmt drug (PANVAC-f)|0
6121099|NCT00088413|21100582|P3|Overall Study|Limited supply of trmt drug (PANVAC-f)|1
6121100|NCT00088413|21100583|P2|Overall Study|Limited supply of trmt drug (PANVAC-f)|0
6121101|NCT00088413|21100584|P1|Overall Study|Limited supply of trmt drug (PANVAC-f)|0
6121102|NCT00088374|21100598|P1|Overall Study|patient received <1 cycle only of 17AAG|1
6121103|NCT00088374|21100598|P1|Overall Study|patient did not receive any 17AAG|1
6121104|NCT00088205|21100616|P1|Overall Study|Death Due to Study Disease|4
6121105|NCT00088205|21100616|P1|Overall Study|Physician Decision|1
6121106|NCT00088205|21100616|P1|Overall Study|Progressive Disease|51
6121107|NCT00088205|21100616|P1|Overall Study|Adverse Event|4
6121108|NCT00088166|21100633|P2|Overall Study|Withdrawal by Subject|5
6121109|NCT00088166|21100634|P1|Overall Study|Withdrawal by Subject|5
6121110|NCT00088166|21100633|P2|Overall Study|Patient deterioration|39
6121111|NCT00088166|21100634|P1|Overall Study|Patient deterioration|29
6121112|NCT00088166|21100633|P2|Overall Study|Protocol Violation|5
6121113|NCT00088166|21100634|P1|Overall Study|Protocol Violation|1
6121114|NCT00088166|21100633|P2|Overall Study|Physician Decision|1
6121115|NCT00088166|21100634|P1|Overall Study|Physician Decision|4
6121116|NCT00088166|21100633|P2|Overall Study|Lost to Follow-up|1
6121117|NCT00088166|21100634|P1|Overall Study|Lost to Follow-up|0
6121118|NCT00088166|21100633|P2|Overall Study|Death|1
6121119|NCT00088166|21100634|P1|Overall Study|Death|3
6121120|NCT00088166|21100633|P2|Overall Study|Adverse Event|9
6121121|NCT00088166|21100634|P1|Overall Study|Adverse Event|11
6121122|NCT00088153|21100658|P2|Overall Study|Lost to Follow-up|12
6121123|NCT00088153|21100659|P1|Overall Study|Lost to Follow-up|11
6121124|NCT00088153|21100658|P2|Overall Study|Withdrawal by Subject|10
6121125|NCT00088153|21100659|P1|Overall Study|Withdrawal by Subject|10
6121126|NCT00088153|21100658|P2|Overall Study|Physician Decision|3
6121127|NCT00088153|21100659|P1|Overall Study|Physician Decision|3
6121128|NCT00087698|21100669|P1|Overall Study|Protocol Violation|1
6121129|NCT00087698|21100669|P1|Overall Study|Death from Study Drug Toxicity|2
6121130|NCT00087698|21100669|P1|Overall Study|Death from Study Disease|2
6121131|NCT00087698|21100669|P1|Overall Study|Clinical Relapse|1
6121132|NCT00087698|21100669|P1|Overall Study|Protocol Entry Criteria Not Met|2
6121133|NCT00087698|21100669|P1|Overall Study|Lack of Efficacy, Physician Perception|3
6121134|NCT00087698|21100669|P1|Overall Study|Withdrawal by Subject|4
6121135|NCT00087698|21100669|P1|Overall Study|Adverse Event|4
6121136|NCT00087698|21100669|P1|Overall Study|Death from Other Causes|3
6121137|NCT00087698|21100669|P1|Overall Study|Lack of Efficacy, Progressive Disease|14
6121138|NCT00087685|21100678|P1|Overall Study|Withdrawal by Subject|3
6121139|NCT00087685|21100678|P1|Overall Study|Progressive Disease|5
6121140|NCT00087685|21100678|P1|Overall Study|Non-Compliance|1
6121141|NCT00087685|21100678|P1|Overall Study|Adverse Event|5
6121142|NCT00087646|21100691|P4|Overall Study|Violation of Selection Criteria at Entry|1
6121143|NCT00087646|21100692|P3|Overall Study|Violation of Selection Criteria at Entry|0
6121144|NCT00087646|21100693|P2|Overall Study|Violation of Selection Criteria at Entry|0
6121145|NCT00087646|21100694|P1|Overall Study|Violation of Selection Criteria at Entry|1
6121146|NCT00087646|21100691|P4|Overall Study|Other Protocol Violation|0
6121147|NCT00087646|21100692|P3|Overall Study|Other Protocol Violation|0
6121148|NCT00087646|21100693|P2|Overall Study|Other Protocol Violation|1
6121149|NCT00087646|21100694|P1|Overall Study|Other Protocol Violation|3
6121150|NCT00087646|21100691|P4|Overall Study|Administrative/Other|2
6121151|NCT00087646|21100692|P3|Overall Study|Administrative/Other|1
6121152|NCT00087646|21100693|P2|Overall Study|Administrative/Other|1
6121153|NCT00087646|21100694|P1|Overall Study|Administrative/Other|6
6121154|NCT00087646|21100691|P4|Overall Study|Failure to Return|3
6121155|NCT00087646|21100692|P3|Overall Study|Failure to Return|2
6121156|NCT00087646|21100693|P2|Overall Study|Failure to Return|2
6121157|NCT00087646|21100694|P1|Overall Study|Failure to Return|5
6121158|NCT00087646|21100691|P4|Overall Study|Refused Treatment/Did Not Cooperate|5
6121159|NCT00087646|21100692|P3|Overall Study|Refused Treatment/Did Not Cooperate|4
6121160|NCT00087646|21100693|P2|Overall Study|Refused Treatment/Did Not Cooperate|6
6121161|NCT00087646|21100694|P1|Overall Study|Refused Treatment/Did Not Cooperate|13
6121162|NCT00087646|21100691|P4|Overall Study|Insufficient therapeutic response|51
6121163|NCT00087646|21100692|P3|Overall Study|Insufficient therapeutic response|38
6121164|NCT00087646|21100693|P2|Overall Study|Insufficient therapeutic response|24
6121165|NCT00087646|21100694|P1|Overall Study|Insufficient therapeutic response|64
6121166|NCT00087646|21100691|P4|Overall Study|Withdrawal by Subject|2
6121167|NCT00087646|21100692|P3|Overall Study|Withdrawal by Subject|2
6121168|NCT00087646|21100693|P2|Overall Study|Withdrawal by Subject|1
6121169|NCT00087646|21100694|P1|Overall Study|Withdrawal by Subject|6
6121170|NCT00087646|21100691|P4|Overall Study|Death|0
6121171|NCT00087646|21100692|P3|Overall Study|Death|0
6121172|NCT00087646|21100693|P2|Overall Study|Death|1
6121173|NCT00087646|21100694|P1|Overall Study|Death|0
6121174|NCT00087646|21100691|P4|Overall Study|Adverse Event|20
6121175|NCT00087646|21100692|P3|Overall Study|Adverse Event|18
6121176|NCT00087646|21100693|P2|Overall Study|Adverse Event|6
6121177|NCT00087646|21100694|P1|Overall Study|Adverse Event|37
6121178|NCT00087607|21100733|P2|Overall Study|Violation of Selection Criteria at Entry|1
6121179|NCT00087607|21100734|P1|Overall Study|Violation of Selection Criteria at Entry|0
6121180|NCT00087607|21100733|P2|Overall Study|Other Protocol Violation|2
6121181|NCT00087607|21100734|P1|Overall Study|Other Protocol Violation|5
6121182|NCT00087607|21100733|P2|Overall Study|Refused Treatment|7
6121183|NCT00087607|21100734|P1|Overall Study|Refused Treatment|5
6121184|NCT00087607|21100733|P2|Overall Study|Administrative|12
6121185|NCT00087607|21100734|P1|Overall Study|Administrative|12
6121186|NCT00087607|21100733|P2|Overall Study|Withdrew Consent|16
6121187|NCT00087607|21100734|P1|Overall Study|Withdrew Consent|12
6121188|NCT00087607|21100733|P2|Overall Study|Failure to return|17
6121189|NCT00087607|21100734|P1|Overall Study|Failure to return|21
6121190|NCT00087607|21100733|P2|Overall Study|Insufficient Therapeutic Response|42
6121191|NCT00087607|21100734|P1|Overall Study|Insufficient Therapeutic Response|53
6121192|NCT00087607|21100733|P2|Overall Study|Death|1
6121193|NCT00087607|21100734|P1|Overall Study|Death|0
6121194|NCT00087607|21100733|P2|Overall Study|Adverse Event|24
6121195|NCT00087607|21100734|P1|Overall Study|Adverse Event|14
6121196|NCT00087594|21100774|P2|Overall Study|Lack of Efficacy|5
6121197|NCT00087594|21100775|P1|Overall Study|Lack of Efficacy|2
6121198|NCT00087594|21100774|P2|Overall Study|Withdrawal by Subject|2
6121199|NCT00087594|21100775|P1|Overall Study|Withdrawal by Subject|4
6121200|NCT00087594|21100774|P2|Overall Study|Lost to Follow-up|2
6121201|NCT00087594|21100775|P1|Overall Study|Lost to Follow-up|0
6121202|NCT00087594|21100774|P2|Overall Study|Adverse Event|3
6121203|NCT00087594|21100775|P1|Overall Study|Adverse Event|2
6121204|NCT00087568|21100809|P2|Overall Study|Lack of Efficacy|1
6121205|NCT00087568|21100810|P1|Overall Study|Lack of Efficacy|24
6121206|NCT00087568|21100809|P2|Overall Study|Lost to Follow-up|0
6121207|NCT00087568|21100810|P1|Overall Study|Lost to Follow-up|1
6121208|NCT00087568|21100809|P2|Overall Study|Withdrawal by Subject|1
6121209|NCT00087568|21100810|P1|Overall Study|Withdrawal by Subject|1
6121210|NCT00087568|21100809|P2|Overall Study|Adverse Event|0
6121211|NCT00087568|21100810|P1|Overall Study|Adverse Event|4
6121212|NCT00087555|21100837|P3|Overall Study|Patient wanted to go back on Med|0
6121213|NCT00087555|21100838|P2|Overall Study|Patient wanted to go back on Med|0
6121214|NCT00087555|21100839|P1|Overall Study|Patient wanted to go back on Med|1
6121215|NCT00087555|21100837|P3|Overall Study|Chronic Migraine Headaches (Med History)|0
6121216|NCT00087555|21100838|P2|Overall Study|Chronic Migraine Headaches (Med History)|0
6121217|NCT00087555|21100839|P1|Overall Study|Chronic Migraine Headaches (Med History)|1
6121218|NCT00087555|21100837|P3|Overall Study|Non Compliance|1
6121219|NCT00087555|21100838|P2|Overall Study|Non Compliance|0
6121220|NCT00087555|21100839|P1|Overall Study|Non Compliance|0
6121221|NCT00087555|21100837|P3|Overall Study|Lack of Efficacy|1
6121222|NCT00087555|21100838|P2|Overall Study|Lack of Efficacy|0
6121223|NCT00087555|21100839|P1|Overall Study|Lack of Efficacy|2
6121224|NCT00087555|21100837|P3|Overall Study|Withdrawal by Subject|1
6121225|NCT00087555|21100838|P2|Overall Study|Withdrawal by Subject|2
6121226|NCT00087555|21100839|P1|Overall Study|Withdrawal by Subject|3
6121227|NCT00087555|21100837|P3|Overall Study|Pregnancy|1
6121228|NCT00087555|21100838|P2|Overall Study|Pregnancy|1
6121229|NCT00087555|21100839|P1|Overall Study|Pregnancy|0
6121230|NCT00087555|21100837|P3|Overall Study|Screen Failure|0
6121231|NCT00087555|21100838|P2|Overall Study|Screen Failure|1
6121232|NCT00087555|21100839|P1|Overall Study|Screen Failure|1
6121233|NCT00087555|21100837|P3|Overall Study|Protocol Violation|2
6121234|NCT00087555|21100838|P2|Overall Study|Protocol Violation|0
6121235|NCT00087555|21100839|P1|Overall Study|Protocol Violation|0
6121236|NCT00087555|21100837|P3|Overall Study|Non - Compliance|0
6121237|NCT00087555|21100838|P2|Overall Study|Non - Compliance|0
6121238|NCT00087555|21100839|P1|Overall Study|Non - Compliance|1
6121239|NCT00087555|21100837|P3|Overall Study|Lost to Follow-up|1
6121240|NCT00087555|21100838|P2|Overall Study|Lost to Follow-up|1
6121241|NCT00087555|21100839|P1|Overall Study|Lost to Follow-up|0
6121242|NCT00087555|21100837|P3|Overall Study|Adverse Event|14
6121243|NCT00087555|21100838|P2|Overall Study|Adverse Event|6
6121244|NCT00087555|21100839|P1|Overall Study|Adverse Event|3
6121245|NCT00087529|21100849|P2|Overall Study|Did Not Continue to Safety Follow-Up|5
6121246|NCT00087529|21100850|P1|Overall Study|Did Not Continue to Safety Follow-Up|5
6121247|NCT00087529|21100849|P2|Overall Study|Disease Progression|4
6121248|NCT00087529|21100850|P1|Overall Study|Disease Progression|5
6121249|NCT00087529|21100849|P2|Overall Study|Participant Noncompliance|1
6121250|NCT00087529|21100850|P1|Overall Study|Participant Noncompliance|0
6121251|NCT00087529|21100849|P2|Overall Study|Initiation of Excluded Therapy|1
6121252|NCT00087529|21100850|P1|Overall Study|Initiation of Excluded Therapy|0
6121253|NCT00087529|21100849|P2|Overall Study|Physician Decision|8
6121254|NCT00087529|21100850|P1|Overall Study|Physician Decision|4
6121255|NCT00087529|21100849|P2|Overall Study|Participant Decision|37
6121256|NCT00087529|21100850|P1|Overall Study|Participant Decision|14
6121257|NCT00087529|21100849|P2|Overall Study|Lost to Follow-up|3
6121258|NCT00087529|21100850|P1|Overall Study|Lost to Follow-up|2
6121259|NCT00087529|21100849|P2|Overall Study|Pregnancy|1
6121260|NCT00087529|21100850|P1|Overall Study|Pregnancy|0
6121261|NCT00087529|21100849|P2|Overall Study|Adverse Event|8
6121262|NCT00087529|21100850|P1|Overall Study|Adverse Event|0
6121263|NCT00087529|21100849|P2|Overall Study|Death|0
6121264|NCT00087529|21100850|P1|Overall Study|Death|1
6121265|NCT00087516|21100865|P4|Overall Study|Other|0
6121266|NCT00087516|21100866|P3|Overall Study|Other|1
6121267|NCT00087516|21100867|P2|Overall Study|Other|0
6121268|NCT00087516|21100868|P1|Overall Study|Other|0
6121269|NCT00087516|21100865|P4|Overall Study|Recommendation of Primary Care Physician|1
6121270|NCT00087516|21100866|P3|Overall Study|Recommendation of Primary Care Physician|0
6121271|NCT00087516|21100867|P2|Overall Study|Recommendation of Primary Care Physician|0
6121272|NCT00087516|21100868|P1|Overall Study|Recommendation of Primary Care Physician|0
6121273|NCT00087516|21100865|P4|Overall Study|Patient was non-compliant|0
6121274|NCT00087516|21100866|P3|Overall Study|Patient was non-compliant|0
6121275|NCT00087516|21100867|P2|Overall Study|Patient was non-compliant|1
6121276|NCT00087516|21100868|P1|Overall Study|Patient was non-compliant|3
6121277|NCT00087516|21100865|P4|Overall Study|Patient moved|0
6121278|NCT00087516|21100866|P3|Overall Study|Patient moved|1
6121279|NCT00087516|21100867|P2|Overall Study|Patient moved|2
6121280|NCT00087516|21100868|P1|Overall Study|Patient moved|3
6121281|NCT00087516|21100865|P4|Overall Study|Protocol specified discontinuation|26
6121282|NCT00087516|21100866|P3|Overall Study|Protocol specified discontinuation|33
6121283|NCT00087516|21100867|P2|Overall Study|Protocol specified discontinuation|33
6121284|NCT00087516|21100868|P1|Overall Study|Protocol specified discontinuation|35
6121285|NCT00087516|21100865|P4|Overall Study|Site terminated|0
6121286|NCT00087516|21100866|P3|Overall Study|Site terminated|1
6121287|NCT00087516|21100867|P2|Overall Study|Site terminated|2
6121288|NCT00087516|21100868|P1|Overall Study|Site terminated|0
6121289|NCT00087516|21100865|P4|Overall Study|Withdrawal by Subject|12
6121290|NCT00087516|21100866|P3|Overall Study|Withdrawal by Subject|11
6121291|NCT00087516|21100867|P2|Overall Study|Withdrawal by Subject|27
6121292|NCT00087516|21100868|P1|Overall Study|Withdrawal by Subject|16
6121293|NCT00087516|21100865|P4|Overall Study|Protocol Violation|6
6121294|NCT00087516|21100866|P3|Overall Study|Protocol Violation|3
6121295|NCT00087516|21100867|P2|Overall Study|Protocol Violation|8
6121296|NCT00087516|21100868|P1|Overall Study|Protocol Violation|4
6121297|NCT00087516|21100865|P4|Overall Study|Lost to Follow-up|5
6121298|NCT00087516|21100866|P3|Overall Study|Lost to Follow-up|5
6121299|NCT00087516|21100867|P2|Overall Study|Lost to Follow-up|6
6121300|NCT00087516|21100868|P1|Overall Study|Lost to Follow-up|8
6121301|NCT00087516|21100865|P4|Overall Study|Lack of Efficacy|29
6121302|NCT00087516|21100866|P3|Overall Study|Lack of Efficacy|39
6121303|NCT00087516|21100867|P2|Overall Study|Lack of Efficacy|80
6121304|NCT00087516|21100868|P1|Overall Study|Lack of Efficacy|82
6121305|NCT00087516|21100865|P4|Overall Study|Adverse Event|6
6121306|NCT00087516|21100866|P3|Overall Study|Adverse Event|3
6121307|NCT00087516|21100867|P2|Overall Study|Adverse Event|10
6121308|NCT00087516|21100868|P1|Overall Study|Adverse Event|10
6121309|NCT00087490|21100897|P2|Overall Study|Randomized but not treated|18
6121310|NCT00087490|21100898|P1|Overall Study|Randomized but not treated|7
6121311|NCT00087490|21100897|P2|Overall Study|Lost to Follow-Up/participant withdrawal|36
6121312|NCT00087490|21100898|P1|Overall Study|Lost to Follow-Up/participant withdrawal|28
6121313|NCT00087490|21100897|P2|Overall Study|Protocol Violation or (/) Unspecified|201
6121314|NCT00087490|21100898|P1|Overall Study|Protocol Violation or (/) Unspecified|214
6121315|NCT00087490|21100897|P2|Overall Study|Lack of Efficacy|2
6121316|NCT00087490|21100898|P1|Overall Study|Lack of Efficacy|0
6121317|NCT00087490|21100897|P2|Overall Study|Adverse Event|8
6121318|NCT00087490|21100898|P1|Overall Study|Adverse Event|3
6121319|NCT00087490|21100897|P2|Overall Study|Death|4
6121320|NCT00087490|21100898|P1|Overall Study|Death|6
6121321|NCT00087438|21100932|P1|Overall Study|Ineligible / No protocol treatment|4
6121322|NCT00087152|21100942|P1|Overall Study|Ineligible|6
6121323|NCT00087139|21100951|P3|Overall Study|Extradural disease|1
6121324|NCT00087139|21100952|P2|Overall Study|Extradural disease|0
6121325|NCT00087139|21100953|P1|Overall Study|Extradural disease|0
6121326|NCT00087139|21100951|P3|Overall Study|Response achieved|0
6121327|NCT00087139|21100952|P2|Overall Study|Response achieved|1
6121328|NCT00087139|21100953|P1|Overall Study|Response achieved|0
6121329|NCT00087139|21100951|P3|Overall Study|Use of coumadin|0
6121330|NCT00087139|21100952|P2|Overall Study|Use of coumadin|0
6121331|NCT00087139|21100953|P1|Overall Study|Use of coumadin|1
6121332|NCT00087139|21100951|P3|Overall Study|Symptomatic deterioration|3
6121333|NCT00087139|21100952|P2|Overall Study|Symptomatic deterioration|1
6121334|NCT00087139|21100953|P1|Overall Study|Symptomatic deterioration|1
6121335|NCT00087139|21100951|P3|Overall Study|Ineligible|4
6121336|NCT00087139|21100952|P2|Overall Study|Ineligible|7
6121337|NCT00087139|21100953|P1|Overall Study|Ineligible|4
6121338|NCT00087139|21100951|P3|Overall Study|Disease progression|12
6121339|NCT00087139|21100952|P2|Overall Study|Disease progression|19
6121340|NCT00087139|21100953|P1|Overall Study|Disease progression|9
6121341|NCT00087139|21100951|P3|Overall Study|Physician Decision|1
6121342|NCT00087139|21100952|P2|Overall Study|Physician Decision|1
6121343|NCT00087139|21100953|P1|Overall Study|Physician Decision|1
6121344|NCT00087139|21100951|P3|Overall Study|Withdrawal by Subject|2
6121345|NCT00087139|21100952|P2|Overall Study|Withdrawal by Subject|2
6121346|NCT00087139|21100953|P1|Overall Study|Withdrawal by Subject|3
6121347|NCT00087139|21100951|P3|Overall Study|Death|0
6121348|NCT00087139|21100952|P2|Overall Study|Death|1
6121349|NCT00087139|21100953|P1|Overall Study|Death|2
6121350|NCT00087139|21100951|P3|Overall Study|Adverse Event|13
6121351|NCT00087139|21100952|P2|Overall Study|Adverse Event|17
6121352|NCT00087139|21100953|P1|Overall Study|Adverse Event|18
6121353|NCT00087126|21100968|P1|Overall Study|Never treated|1
6121354|NCT00087126|21100968|P1|Overall Study|Ineligible - second primary|1
6121355|NCT00086996|21100993|P1|Overall Study|not eligible|5
6121356|NCT00086996|21100993|P1|Overall Study|Other|6
6121357|NCT00086996|21100993|P1|Overall Study|Withdrawal by Subject|13
6121358|NCT00086996|21100993|P1|Overall Study|progression/relapse|7
6121359|NCT00086996|21100993|P1|Overall Study|Death|4
6121360|NCT00086996|21100993|P1|Overall Study|Adverse Event|29
6121361|NCT00086684|21101015|P3|Overall Study|Other|3
6121362|NCT00086684|21101016|P2|Overall Study|Other|2
6121363|NCT00086684|21101017|P1|Overall Study|Other|4
6121364|NCT00086684|21101015|P3|Overall Study|WITHDRAWAL OF CONSENT|5
6121365|NCT00086684|21101016|P2|Overall Study|WITHDRAWAL OF CONSENT|7
6121366|NCT00086684|21101017|P1|Overall Study|WITHDRAWAL OF CONSENT|5
6121367|NCT00086684|21101015|P3|Overall Study|STUDY TERMINATED BY SPONSOR|0
6121368|NCT00086684|21101016|P2|Overall Study|STUDY TERMINATED BY SPONSOR|1
6121369|NCT00086684|21101017|P1|Overall Study|STUDY TERMINATED BY SPONSOR|0
6121370|NCT00086684|21101015|P3|Overall Study|NONCOMPLIANCE|6
6121371|NCT00086684|21101016|P2|Overall Study|NONCOMPLIANCE|7
6121372|NCT00086684|21101017|P1|Overall Study|NONCOMPLIANCE|5
6121373|NCT00086684|21101015|P3|Overall Study|Withdrawal by Subject|10
6121374|NCT00086684|21101016|P2|Overall Study|Withdrawal by Subject|4
6121375|NCT00086684|21101017|P1|Overall Study|Withdrawal by Subject|0
6121376|NCT00086684|21101015|P3|Overall Study|Protocol Violation|0
6121377|NCT00086684|21101016|P2|Overall Study|Protocol Violation|3
6121378|NCT00086684|21101017|P1|Overall Study|Protocol Violation|8
6121379|NCT00086684|21101015|P3|Overall Study|Lost to Follow-up|10
6121380|NCT00086684|21101016|P2|Overall Study|Lost to Follow-up|8
6121381|NCT00086684|21101017|P1|Overall Study|Lost to Follow-up|15
6121382|NCT00086684|21101015|P3|Overall Study|Lack of Efficacy|5
6121383|NCT00086684|21101016|P2|Overall Study|Lack of Efficacy|6
6121384|NCT00086684|21101017|P1|Overall Study|Lack of Efficacy|6
6121385|NCT00086684|21101015|P3|Overall Study|Adverse Event|14
6121386|NCT00086684|21101016|P2|Overall Study|Adverse Event|17
6121387|NCT00086684|21101017|P1|Overall Study|Adverse Event|12
6121388|NCT00086619|21101030|P2|Overall Study|Protocol Violation|1
6121389|NCT00086619|21101031|P1|Overall Study|Protocol Violation|1
6121390|NCT00086619|21101030|P2|Overall Study|Adverse Event|10
6121391|NCT00086619|21101031|P1|Overall Study|Adverse Event|8
6121392|NCT00086619|21101030|P2|Overall Study|Withdrawal by Subject|6
6121393|NCT00086619|21101031|P1|Overall Study|Withdrawal by Subject|6
6121394|NCT00086580|21101041|P2|Observation Period|Other|7
6121395|NCT00086580|21101042|P1|Observation Period|Other|8
6121396|NCT00086580|21101041|P2|Observation Period|Death|55
6121397|NCT00086580|21101042|P1|Observation Period|Death|33
6121398|NCT00086580|21101041|P2|Observation Period|Withdrawal by Subject|2
6121399|NCT00086580|21101042|P1|Observation Period|Withdrawal by Subject|4
6121400|NCT00086580|21101041|P2|Observation Period|Unable to comply with protocol|1
6121401|NCT00086580|21101042|P1|Observation Period|Unable to comply with protocol|1
6121402|NCT00086580|21101041|P2|Follow-up Period|Other|6
6121403|NCT00086580|21101042|P1|Follow-up Period|Other|7
6121404|NCT00086580|21101041|P2|Follow-up Period|Death|7
6121405|NCT00086580|21101042|P1|Follow-up Period|Death|13
6121406|NCT00086580|21101041|P2|Follow-up Period|AE - not related|0
6121407|NCT00086580|21101042|P1|Follow-up Period|AE - not related|1
6121408|NCT00086580|21101041|P2|Follow-up Period|Physician Decision|1
6121409|NCT00086580|21101042|P1|Follow-up Period|Physician Decision|0
6121410|NCT00086580|21101041|P2|Follow-up Period|Withdrawal by Subject|6
6121411|NCT00086580|21101042|P1|Follow-up Period|Withdrawal by Subject|6
6121412|NCT00086580|21101041|P2|Follow-up Period|Unable to comply with protocol|0
6121413|NCT00086580|21101042|P1|Follow-up Period|Unable to comply with protocol|5
6121414|NCT00086580|21101041|P2|Follow-up Period|Disease progression|99
6121415|NCT00086580|21101042|P1|Follow-up Period|Disease progression|72
6121416|NCT00086580|21101041|P2|Treatment Period|Other|3
6121417|NCT00086580|21101042|P1|Treatment Period|Other|5
6121418|NCT00086580|21101041|P2|Treatment Period|Death|7
6121419|NCT00086580|21101042|P1|Treatment Period|Death|5
6121420|NCT00086580|21101041|P2|Treatment Period|Anemia or thrombocytopenia|4
6121421|NCT00086580|21101042|P1|Treatment Period|Anemia or thrombocytopenia|1
6121422|NCT00086580|21101041|P2|Treatment Period|Toxicity - treatment related|15
6121423|NCT00086580|21101042|P1|Treatment Period|Toxicity - treatment related|15
6121424|NCT00086580|21101041|P2|Treatment Period|AE - not treatment related|7
6121425|NCT00086580|21101042|P1|Treatment Period|AE - not treatment related|7
6121426|NCT00086580|21101041|P2|Treatment Period|Physician Decision|7
6121427|NCT00086580|21101042|P1|Treatment Period|Physician Decision|13
6121428|NCT00086580|21101041|P2|Treatment Period|Withdrawal by Subject|8
6121429|NCT00086580|21101042|P1|Treatment Period|Withdrawal by Subject|7
6121430|NCT00086580|21101041|P2|Treatment Period|Unable to comply with protocol|1
6121431|NCT00086580|21101042|P1|Treatment Period|Unable to comply with protocol|3
6121432|NCT00086580|21101041|P2|Treatment Period|Disease progression|8
6121433|NCT00086580|21101042|P1|Treatment Period|Disease progression|9
6121434|NCT00086411|21101090|P4|Overall Study|Lost to Follow-up|12
6121435|NCT00086411|21101091|P3|Overall Study|Lost to Follow-up|13
6121436|NCT00086411|21101092|P2|Overall Study|Lost to Follow-up|11
6121437|NCT00086411|21101093|P1|Overall Study|Lost to Follow-up|11
6121438|NCT00086385|21101111|P4|Overall Study|Death|1
6121439|NCT00086385|21101112|P3|Overall Study|Death|1
6121440|NCT00086385|21101113|P2|Overall Study|Death|2
6121441|NCT00086385|21101114|P1|Overall Study|Death|2
6121442|NCT00086515|21101126|P2|Phase B (Weeks 24-104)|Discontinued in error|0
6121443|NCT00086515|21101127|P1|Phase B (Weeks 24-104)|Discontinued in error|1
6121444|NCT00086515|21101126|P2|Phase B (Weeks 24-104)|Personal Circumstance|0
6121445|NCT00086515|21101127|P1|Phase B (Weeks 24-104)|Personal Circumstance|1
6121446|NCT00086515|21101126|P2|Phase B (Weeks 24-104)|Patient needed prohibited treatment|1
6121447|NCT00086515|21101127|P1|Phase B (Weeks 24-104)|Patient needed prohibited treatment|0
6121448|NCT00086515|21101126|P2|Phase B (Weeks 24-104)|Patient Died|1
6121449|NCT00086515|21101127|P1|Phase B (Weeks 24-104)|Patient Died|3
6121450|NCT00086515|21101126|P2|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|10
6121451|NCT00086515|21101127|P1|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|36
6121452|NCT00086515|21101126|P2|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|3
6121453|NCT00086515|21101127|P1|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|5
6121454|NCT00086515|21101126|P2|Phase B (Weeks 24-104)|Patient Moved|2
6121455|NCT00086515|21101127|P1|Phase B (Weeks 24-104)|Patient Moved|2
6121456|NCT00086515|21101126|P2|Phase B (Weeks 24-104)|Withdrawal by Subject|5
6121457|NCT00086515|21101127|P1|Phase B (Weeks 24-104)|Withdrawal by Subject|15
6121458|NCT00086515|21101126|P2|Phase B (Weeks 24-104)|Protocol Violation|0
6121459|NCT00086515|21101127|P1|Phase B (Weeks 24-104)|Protocol Violation|1
6121460|NCT00086515|21101126|P2|Phase B (Weeks 24-104)|Physician Decision|0
6121461|NCT00086515|21101127|P1|Phase B (Weeks 24-104)|Physician Decision|3
6121462|NCT00086515|21101126|P2|Phase B (Weeks 24-104)|Lost to Follow-up|4
6121463|NCT00086515|21101127|P1|Phase B (Weeks 24-104)|Lost to Follow-up|13
6121464|NCT00086515|21101126|P2|Phase B (Weeks 24-104)|Lack of Efficacy|19
6121465|NCT00086515|21101127|P1|Phase B (Weeks 24-104)|Lack of Efficacy|94
6121466|NCT00086515|21101126|P2|Phase B (Weeks 24-104)|Adverse Event|10
6121467|NCT00086515|21101127|P1|Phase B (Weeks 24-104)|Adverse Event|16
6121468|NCT00086515|21101126|P2|Phase A to Phase B Transition Period|Patient needed prohibited treatment|0
6121469|NCT00086515|21101127|P1|Phase A to Phase B Transition Period|Patient needed prohibited treatment|1
6121470|NCT00086515|21101126|P2|Phase A to Phase B Transition Period|Poor compliance|0
6121471|NCT00086515|21101127|P1|Phase A to Phase B Transition Period|Poor compliance|1
6121472|NCT00086515|21101126|P2|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1
6121473|NCT00086515|21101127|P1|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1
6121474|NCT00086515|21101126|P2|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|23
6121475|NCT00086515|21101127|P1|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|16
6121476|NCT00086515|21101126|P2|Phase A to Phase B Transition Period|Protocol Violation|1
6121477|NCT00086515|21101127|P1|Phase A to Phase B Transition Period|Protocol Violation|0
6121478|NCT00086515|21101126|P2|Phase A to Phase B Transition Period|Withdrawal by Subject|0
6121479|NCT00086515|21101127|P1|Phase A to Phase B Transition Period|Withdrawal by Subject|1
6121480|NCT00086515|21101126|P2|Phase A to Phase B Transition Period|Lack of Efficacy|2
6121481|NCT00086515|21101127|P1|Phase A to Phase B Transition Period|Lack of Efficacy|2
6121482|NCT00086515|21101126|P2|Phase A to Phase B Transition Period|Adverse Event|1
6121483|NCT00086515|21101127|P1|Phase A to Phase B Transition Period|Adverse Event|2
6121484|NCT00086515|21101126|P2|Phase A (Weeks 0-24)|Personal Circumstance|0
6121485|NCT00086515|21101127|P1|Phase A (Weeks 0-24)|Personal Circumstance|1
6121486|NCT00086515|21101126|P2|Phase A (Weeks 0-24)|Patient needed prohibited treatment|1
6121487|NCT00086515|21101127|P1|Phase A (Weeks 0-24)|Patient needed prohibited treatment|0
6121488|NCT00086515|21101126|P2|Phase A (Weeks 0-24)|Poor compliance|0
6121489|NCT00086515|21101127|P1|Phase A (Weeks 0-24)|Poor compliance|1
6121490|NCT00086515|21101126|P2|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|3
6121491|NCT00086515|21101127|P1|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|4
6121492|NCT00086515|21101126|P2|Phase A (Weeks 0-24)|Patient Moved|3
6121493|NCT00086515|21101127|P1|Phase A (Weeks 0-24)|Patient Moved|2
6121494|NCT00086515|21101126|P2|Phase A (Weeks 0-24)|Withdrawal by Subject|10
6121495|NCT00086515|21101127|P1|Phase A (Weeks 0-24)|Withdrawal by Subject|10
6121496|NCT00086515|21101126|P2|Phase A (Weeks 0-24)|Protocol Violation|1
6121497|NCT00086515|21101127|P1|Phase A (Weeks 0-24)|Protocol Violation|3
6121498|NCT00086515|21101126|P2|Phase A (Weeks 0-24)|Lost to Follow-up|5
6121499|NCT00086515|21101127|P1|Phase A (Weeks 0-24)|Lost to Follow-up|4
6121500|NCT00086515|21101126|P2|Phase A (Weeks 0-24)|Lack of Efficacy|13
6121501|NCT00086515|21101127|P1|Phase A (Weeks 0-24)|Lack of Efficacy|7
6121502|NCT00086515|21101126|P2|Phase A (Weeks 0-24)|Adverse Event|9
6121503|NCT00086515|21101127|P1|Phase A (Weeks 0-24)|Adverse Event|17
6121504|NCT00086502|21101139|P2|Overall Study|Patient Accidentally Unblinded|0
6121505|NCT00086502|21101140|P1|Overall Study|Patient Accidentally Unblinded|1
6121506|NCT00086502|21101139|P2|Overall Study|Protocol Discontinuation Criteria|3
6121507|NCT00086502|21101140|P1|Overall Study|Protocol Discontinuation Criteria|1
6121508|NCT00086502|21101139|P2|Overall Study|Patient Moved|1
6121509|NCT00086502|21101140|P1|Overall Study|Patient Moved|1
6121510|NCT00086502|21101139|P2|Overall Study|Withdrawal by Subject|6
6121511|NCT00086502|21101140|P1|Overall Study|Withdrawal by Subject|5
6121512|NCT00086502|21101139|P2|Overall Study|Protocol Violation|3
6121513|NCT00086502|21101140|P1|Overall Study|Protocol Violation|3
6121514|NCT00086502|21101139|P2|Overall Study|Pregnancy|1
6121515|NCT00086502|21101140|P1|Overall Study|Pregnancy|0
6121516|NCT00086502|21101139|P2|Overall Study|Physician Decision|1
6121517|NCT00086502|21101140|P1|Overall Study|Physician Decision|1
6121518|NCT00086502|21101139|P2|Overall Study|Lost to Follow-up|1
6121519|NCT00086502|21101140|P1|Overall Study|Lost to Follow-up|3
6121520|NCT00086502|21101139|P2|Overall Study|Lack of Efficacy|2
6121521|NCT00086502|21101140|P1|Overall Study|Lack of Efficacy|0
6121522|NCT00086502|21101139|P2|Overall Study|Adverse Event|2
6121523|NCT00086502|21101140|P1|Overall Study|Adverse Event|11
6121524|NCT00086346|21101165|P2|Patients Dosed With Test Article|Lack of Efficacy|0
6121525|NCT00086346|21101166|P1|Patients Dosed With Test Article|Lack of Efficacy|11
6121526|NCT00086346|21101165|P2|Patients Dosed With Test Article|Protocol Violation|3
6121527|NCT00086346|21101166|P1|Patients Dosed With Test Article|Protocol Violation|11
6121528|NCT00086346|21101165|P2|Patients Dosed With Test Article|Withdrawal by Subject|3
6121529|NCT00086346|21101166|P1|Patients Dosed With Test Article|Withdrawal by Subject|16
6121530|NCT00086346|21101165|P2|Patients Dosed With Test Article|Nonmedical event|3
6121531|NCT00086346|21101166|P1|Patients Dosed With Test Article|Nonmedical event|7
6121532|NCT00086346|21101165|P2|Patients Dosed With Test Article|Lost to Follow-up|3
6121533|NCT00086346|21101166|P1|Patients Dosed With Test Article|Lost to Follow-up|1
6121534|NCT00086346|21101165|P2|Patients Dosed With Test Article|Adverse Event|11
6121535|NCT00086346|21101166|P1|Patients Dosed With Test Article|Adverse Event|94
6121536|NCT00086346|21101165|P2|Randomization|Did not receive test article|4
6121537|NCT00086346|21101166|P1|Randomization|Did not receive test article|4
6121538|NCT00086281|21101193|P15|Phase 2|Adverse Event|0
6121539|NCT00086281|21101194|P14|Phase 2|Adverse Event|1
6121540|NCT00086281|21101195|P13|Phase 2|Adverse Event|1
6121541|NCT00086281|21101196|P12|Phase 2|Adverse Event|0
6121542|NCT00086281|21101197|P11|Phase 2|Adverse Event|0
6121543|NCT00086281|21101198|P10|Phase 2|Adverse Event|0
6121544|NCT00086281|21101199|P9|Phase 2|Adverse Event|0
6121545|NCT00086281|21101200|P8|Phase 2|Adverse Event|0
6121546|NCT00086281|21101201|P7|Phase 2|Adverse Event|0
6121547|NCT00086281|21101202|P6|Phase 2|Adverse Event|0
6121548|NCT00086281|21101203|P5|Phase 2|Adverse Event|0
6121549|NCT00086281|21101204|P4|Phase 2|Adverse Event|0
6121550|NCT00086281|21101205|P3|Phase 2|Adverse Event|0
6121551|NCT00086281|21101206|P2|Phase 2|Adverse Event|0
6121552|NCT00086281|21101207|P1|Phase 2|Adverse Event|0
6121553|NCT00086281|21101193|P15|Phase 1|Serious Adverse Event|1
6121554|NCT00086281|21101194|P14|Phase 1|Serious Adverse Event|0
6121555|NCT00086281|21101195|P13|Phase 1|Serious Adverse Event|0
6121556|NCT00086281|21101196|P12|Phase 1|Serious Adverse Event|0
6121557|NCT00086281|21101197|P11|Phase 1|Serious Adverse Event|0
6121558|NCT00086281|21101198|P10|Phase 1|Serious Adverse Event|0
6121559|NCT00086281|21101199|P9|Phase 1|Serious Adverse Event|0
6121560|NCT00086281|21101200|P8|Phase 1|Serious Adverse Event|0
6121561|NCT00086281|21101201|P7|Phase 1|Serious Adverse Event|0
6121562|NCT00086281|21101202|P6|Phase 1|Serious Adverse Event|0
6121563|NCT00086281|21101203|P5|Phase 1|Serious Adverse Event|0
6121564|NCT00086281|21101204|P4|Phase 1|Serious Adverse Event|0
6121565|NCT00086281|21101205|P3|Phase 1|Serious Adverse Event|0
6121566|NCT00086281|21101206|P2|Phase 1|Serious Adverse Event|0
6121567|NCT00086281|21101207|P1|Phase 1|Serious Adverse Event|0
6121568|NCT00086281|21101193|P15|Phase 1|Protocol Violation|0
6121569|NCT00086281|21101194|P14|Phase 1|Protocol Violation|0
6121570|NCT00086281|21101195|P13|Phase 1|Protocol Violation|0
6121571|NCT00086281|21101196|P12|Phase 1|Protocol Violation|0
6121572|NCT00086281|21101197|P11|Phase 1|Protocol Violation|1
6121573|NCT00086281|21101198|P10|Phase 1|Protocol Violation|0
6121574|NCT00086281|21101199|P9|Phase 1|Protocol Violation|0
6121575|NCT00086281|21101200|P8|Phase 1|Protocol Violation|0
6121576|NCT00086281|21101201|P7|Phase 1|Protocol Violation|0
6121577|NCT00086281|21101202|P6|Phase 1|Protocol Violation|0
6121578|NCT00086281|21101203|P5|Phase 1|Protocol Violation|0
6121579|NCT00086281|21101204|P4|Phase 1|Protocol Violation|0
6121580|NCT00086281|21101205|P3|Phase 1|Protocol Violation|0
6121581|NCT00086281|21101206|P2|Phase 1|Protocol Violation|0
6121582|NCT00086281|21101207|P1|Phase 1|Protocol Violation|0
6121583|NCT00086281|21101193|P15|Phase 1|Adverse Event|2
6121584|NCT00086281|21101194|P14|Phase 1|Adverse Event|1
6121585|NCT00086281|21101195|P13|Phase 1|Adverse Event|1
6121586|NCT00086281|21101196|P12|Phase 1|Adverse Event|1
6121587|NCT00086281|21101197|P11|Phase 1|Adverse Event|2
6121588|NCT00086281|21101198|P10|Phase 1|Adverse Event|1
6121589|NCT00086281|21101199|P9|Phase 1|Adverse Event|0
6121590|NCT00086281|21101200|P8|Phase 1|Adverse Event|0
6121591|NCT00086281|21101201|P7|Phase 1|Adverse Event|0
6121592|NCT00086281|21101202|P6|Phase 1|Adverse Event|0
6121593|NCT00086281|21101203|P5|Phase 1|Adverse Event|0
6121594|NCT00086281|21101204|P4|Phase 1|Adverse Event|0
6121595|NCT00086281|21101205|P3|Phase 1|Adverse Event|0
6121596|NCT00086281|21101206|P2|Phase 1|Adverse Event|0
6121597|NCT00086281|21101207|P1|Phase 1|Adverse Event|0
6121598|NCT00086307|21101220|P3|Overall Study|Withdrawal by Subject|2
6121599|NCT00086307|21101221|P2|Overall Study|Withdrawal by Subject|0
6121600|NCT00086307|21101222|P1|Overall Study|Withdrawal by Subject|0
6121601|NCT00086307|21101220|P3|Overall Study|Fatigue and difficulty falling asleep|1
6121602|NCT00086307|21101221|P2|Overall Study|Fatigue and difficulty falling asleep|0
6121603|NCT00086307|21101222|P1|Overall Study|Fatigue and difficulty falling asleep|0
6121604|NCT00086307|21101220|P3|Overall Study|Suicidal ideation|1
6121605|NCT00086307|21101221|P2|Overall Study|Suicidal ideation|0
6121606|NCT00086307|21101222|P1|Overall Study|Suicidal ideation|0
6121607|NCT00086307|21101220|P3|Overall Study|Constipation and sleepiness|1
6121608|NCT00086307|21101221|P2|Overall Study|Constipation and sleepiness|0
6121609|NCT00086307|21101222|P1|Overall Study|Constipation and sleepiness|0
6121610|NCT00086307|21101220|P3|Overall Study|Nausea and headaches|1
6121611|NCT00086307|21101221|P2|Overall Study|Nausea and headaches|0
6121612|NCT00086307|21101222|P1|Overall Study|Nausea and headaches|0
6121613|NCT00086307|21101220|P3|Overall Study|Shortness of breath and muscle spasms|0
6121614|NCT00086307|21101221|P2|Overall Study|Shortness of breath and muscle spasms|0
6121615|NCT00086307|21101222|P1|Overall Study|Shortness of breath and muscle spasms|1
6121616|NCT00086307|21101220|P3|Overall Study|Lack of Efficacy|2
6121617|NCT00086307|21101221|P2|Overall Study|Lack of Efficacy|1
6121618|NCT00086307|21101222|P1|Overall Study|Lack of Efficacy|1
6121619|NCT00086190|21101233|P3|Overall Study|Worsening depression|2
6121620|NCT00086190|21101234|P2|Overall Study|Worsening depression|0
6121621|NCT00086190|21101235|P1|Overall Study|Worsening depression|0
6121622|NCT00086190|21101233|P3|Overall Study|Moved|0
6121623|NCT00086190|21101234|P2|Overall Study|Moved|0
6121624|NCT00086190|21101235|P1|Overall Study|Moved|1
6121625|NCT00086190|21101233|P3|Overall Study|Protocol Violation|0
6121626|NCT00086190|21101234|P2|Overall Study|Protocol Violation|0
6121627|NCT00086190|21101235|P1|Overall Study|Protocol Violation|1
6121628|NCT00086190|21101233|P3|Overall Study|Withdrawal by Subject|2
6121629|NCT00086190|21101234|P2|Overall Study|Withdrawal by Subject|2
6121630|NCT00086190|21101235|P1|Overall Study|Withdrawal by Subject|0
6121631|NCT00086190|21101233|P3|Overall Study|Adverse Event|2
6121632|NCT00086190|21101234|P2|Overall Study|Adverse Event|2
6121633|NCT00086190|21101235|P1|Overall Study|Adverse Event|6
6121634|NCT00086047|21101304|P2|Overall Study|Physician Decision|1
6121635|NCT00086047|21101305|P1|Overall Study|Physician Decision|0
6121636|NCT00086047|21101304|P2|Overall Study|Lost to Follow-up|6
6121637|NCT00086047|21101305|P1|Overall Study|Lost to Follow-up|7
6121638|NCT00085917|21101313|P2|Overall Study|Adverse Event|3
6121639|NCT00085917|21101314|P1|Overall Study|Adverse Event|4
6121700|NCT00085709|21101403|P2|Overall Study|Withdrawal by Subject|1
6121701|NCT00085709|21101404|P1|Overall Study|Withdrawal by Subject|2
6121702|NCT00085709|21101403|P2|Overall Study|Not eligible|19
6121703|NCT00085709|21101404|P1|Overall Study|Not eligible|19
6121704|NCT00085709|21101403|P2|Overall Study|Not protocol specified|22
6121705|NCT00085709|21101404|P1|Overall Study|Not protocol specified|12
6121706|NCT00085709|21101403|P2|Overall Study|Progression|4
6121707|NCT00085709|21101404|P1|Overall Study|Progression|3
6121708|NCT00085709|21101403|P2|Overall Study|Refusal unrelated to adverse events|2
6121709|NCT00085709|21101404|P1|Overall Study|Refusal unrelated to adverse events|1
6121710|NCT00085709|21101403|P2|Overall Study|Death|2
6121711|NCT00085709|21101404|P1|Overall Study|Death|8
6121712|NCT00085709|21101403|P2|Overall Study|Adverse Event|0
6121713|NCT00085709|21101404|P1|Overall Study|Adverse Event|8
6121714|NCT00085644|21101420|P3|Open-Label Period|Personal reason|4
6121715|NCT00085644|21101421|P2|Open-Label Period|Personal reason|0
6121716|NCT00085644|21101422|P1|Open-Label Period|Personal reason|0
6121717|NCT00085644|21101420|P3|Open-Label Period|Protocol Violation|4
6121718|NCT00085644|21101421|P2|Open-Label Period|Protocol Violation|0
6121719|NCT00085644|21101422|P1|Open-Label Period|Protocol Violation|0
6121720|NCT00085644|21101420|P3|Open-Label Period|Contemplating pregnancy|3
6121721|NCT00085644|21101421|P2|Open-Label Period|Contemplating pregnancy|0
6121722|NCT00085644|21101422|P1|Open-Label Period|Contemplating pregnancy|0
6121723|NCT00085644|21101420|P3|Open-Label Period|Pregnancy|3
6121724|NCT00085644|21101421|P2|Open-Label Period|Pregnancy|0
6121725|NCT00085644|21101422|P1|Open-Label Period|Pregnancy|0
6121726|NCT00085644|21101420|P3|Open-Label Period|Lack of Efficacy|15
6121727|NCT00085644|21101421|P2|Open-Label Period|Lack of Efficacy|0
6121728|NCT00085644|21101422|P1|Open-Label Period|Lack of Efficacy|0
6121729|NCT00085644|21101420|P3|Open-Label Period|Lost to Follow-up|13
6121730|NCT00085644|21101421|P2|Open-Label Period|Lost to Follow-up|0
6121731|NCT00085644|21101422|P1|Open-Label Period|Lost to Follow-up|0
6121732|NCT00085644|21101420|P3|Open-Label Period|Withdrawal by Subject|29
6121733|NCT00085644|21101421|P2|Open-Label Period|Withdrawal by Subject|0
6121734|NCT00085644|21101422|P1|Open-Label Period|Withdrawal by Subject|0
6121735|NCT00085644|21101420|P3|Open-Label Period|Adverse Event|38
6121736|NCT00085644|21101421|P2|Open-Label Period|Adverse Event|0
6121737|NCT00085644|21101422|P1|Open-Label Period|Adverse Event|0
6121738|NCT00085644|21101420|P3|Double-Blind Period|Undiagnosed pre-existing condition|0
6121739|NCT00085644|21101421|P2|Double-Blind Period|Undiagnosed pre-existing condition|1
6121740|NCT00085644|21101422|P1|Double-Blind Period|Undiagnosed pre-existing condition|0
6121741|NCT00085644|21101420|P3|Double-Blind Period|Contemplating pregnancy|0
6121742|NCT00085644|21101421|P2|Double-Blind Period|Contemplating pregnancy|0
6121743|NCT00085644|21101422|P1|Double-Blind Period|Contemplating pregnancy|1
6121744|NCT00085644|21101420|P3|Double-Blind Period|Lack/loss of efficacy|0
6121745|NCT00085644|21101421|P2|Double-Blind Period|Lack/loss of efficacy|2
6121746|NCT00085644|21101422|P1|Double-Blind Period|Lack/loss of efficacy|2
6121747|NCT00085644|21101420|P3|Double-Blind Period|Lost to Follow-up|0
6121748|NCT00085644|21101421|P2|Double-Blind Period|Lost to Follow-up|1
6121749|NCT00085644|21101422|P1|Double-Blind Period|Lost to Follow-up|2
6121750|NCT00085644|21101420|P3|Double-Blind Period|Withdrawal by Subject|0
6121751|NCT00085644|21101421|P2|Double-Blind Period|Withdrawal by Subject|0
6121752|NCT00085644|21101422|P1|Double-Blind Period|Withdrawal by Subject|3
6121753|NCT00085644|21101420|P3|Double-Blind Period|Adverse Event|0
6121754|NCT00085644|21101421|P2|Double-Blind Period|Adverse Event|2
6121755|NCT00085644|21101422|P1|Double-Blind Period|Adverse Event|5
6121756|NCT00085631|21101463|P3|Overall Study|Missing Data|7
6121757|NCT00085631|21101464|P2|Overall Study|Missing Data|11
6121758|NCT00085631|21101465|P1|Overall Study|Missing Data|4
6121759|NCT00085566|21101475|P3|Overall Study|Clinical progression|1
6121760|NCT00085566|21101476|P2|Overall Study|Clinical progression|0
6121761|NCT00085566|21101477|P1|Overall Study|Clinical progression|0
6121762|NCT00085566|21101475|P3|Overall Study|Patient Not treated|3
6121763|NCT00085566|21101476|P2|Overall Study|Patient Not treated|0
6121764|NCT00085566|21101477|P1|Overall Study|Patient Not treated|0
6121765|NCT00085566|21101475|P3|Overall Study|Adverse Event|10
6121766|NCT00085566|21101476|P2|Overall Study|Adverse Event|0
6121767|NCT00085566|21101477|P1|Overall Study|Adverse Event|0
6121768|NCT00085540|21101487|P2|Overall Study|Protocol Violation|1
6121769|NCT00085540|21101488|P1|Overall Study|Protocol Violation|0
6121770|NCT00085540|21101487|P2|Overall Study|Withdrawal by Subject|1
6121771|NCT00085540|21101488|P1|Overall Study|Withdrawal by Subject|0
6121772|NCT00085423|21101500|P1|Overall Study|screen failure|1
6121773|NCT00085423|21101500|P1|Overall Study|Withdrawal by Subject|1
6121774|NCT00085202|21101551|P2|Overall Study|Progressive disease|11
6121775|NCT00085202|21101552|P1|Overall Study|Progressive disease|1
6121776|NCT00085202|21101551|P2|Overall Study|Physician Decision|1
6121777|NCT00085202|21101552|P1|Overall Study|Physician Decision|4
6121778|NCT00085202|21101551|P2|Overall Study|Withdrawal by Subject|1
6121779|NCT00085202|21101552|P1|Overall Study|Withdrawal by Subject|2
6121780|NCT00085202|21101551|P2|Overall Study|Non-specified|5
6121781|NCT00085202|21101552|P1|Overall Study|Non-specified|3
6121782|NCT00085202|21101551|P2|Overall Study|Excessive toxicity|5
6121783|NCT00085202|21101552|P1|Overall Study|Excessive toxicity|6
6121784|NCT00085202|21101551|P2|Overall Study|Bone involvement confirmed by bone scan|1
6121785|NCT00085202|21101552|P1|Overall Study|Bone involvement confirmed by bone scan|0
6121786|NCT00085202|21101551|P2|Overall Study|Still on therapy|0
6121787|NCT00085202|21101552|P1|Overall Study|Still on therapy|2
6121788|NCT00085098|21101573|P2|Overall Study|Ineligible|1
6121789|NCT00085098|21101574|P1|Overall Study|Ineligible|1
6121790|NCT00085098|21101573|P2|Overall Study|Withdrawal by Subject|1
6121791|NCT00085098|21101574|P1|Overall Study|Withdrawal by Subject|0
6121792|NCT00084929|21101584|P1|Overall Study|Missing Reference Standard (Colonoscopy)|42
6121793|NCT00084929|21101584|P1|Overall Study|Missing/incomplete CTC exam|9
6121794|NCT00084929|21101584|P1|Overall Study|Withdrawal by Subject|10
6121795|NCT00084929|21101584|P1|Overall Study|Ineligible - Medical history|6
6121796|NCT00084929|21101584|P1|Overall Study|ineligible - Pre-scheduled procedure not|1
6121797|NCT00084929|21101584|P1|Overall Study|ineligible - medical contraindication|1
6121798|NCT00084864|21101606|P4|Overall Study|Adverse Event|0
6121799|NCT00084864|21101607|P3|Overall Study|Adverse Event|0
6121800|NCT00084864|21101608|P2|Overall Study|Adverse Event|0
6121801|NCT00084864|21101609|P1|Overall Study|Adverse Event|1
6121802|NCT00084838|21101635|P1|Overall Study|Ineligible|4
6121803|NCT00084838|21101635|P1|Overall Study|Pt Non-Compliance|1
6121804|NCT00084838|21101635|P1|Overall Study|Progressive Disease|4
6121805|NCT00084838|21101635|P1|Overall Study|Withdrawal by Subject|1
6121806|NCT00084838|21101635|P1|Overall Study|Adverse Event|2
6121807|NCT00084838|21101635|P1|Overall Study|Death|1
6121808|NCT00084747|21101657|P1|Overall Study|Withdrawal by Subject|2
6121809|NCT00084747|21101657|P1|Overall Study|Death|3
6121810|NCT00084747|21101657|P1|Overall Study|Relapsed|8
6121811|NCT00084682|21101662|P1|Overall Study|Withdrawal by Subject|1
6121812|NCT00084617|21101666|P1|Overall Study|Protocol Violation|1
6121813|NCT00084617|21101666|P1|Overall Study|Lack of Efficacy|1
6121814|NCT00084617|21101666|P1|Overall Study|Withdrawal by Subject|7
6121815|NCT00084487|21101672|P1|Overall Study|Death|1
6121816|NCT00084318|21101716|P2|Overall Study|No protocol treatment|0
6121817|NCT00084318|21101717|P1|Overall Study|No protocol treatment|2
6121818|NCT00084318|21101716|P2|Overall Study|Protocol Violation|11
6121819|NCT00084318|21101717|P1|Overall Study|Protocol Violation|15
6121820|NCT00084318|21101716|P2|Overall Study|Withdrawal by Subject|2
6121821|NCT00084318|21101717|P1|Overall Study|Withdrawal by Subject|5
6121822|NCT00084266|21101737|P2|Overall Study|Randomized not treated|20
6121823|NCT00084266|21101738|P1|Overall Study|Randomized not treated|21
6121824|NCT00084266|21101737|P2|Overall Study|Other|344
6121825|NCT00084266|21101738|P1|Overall Study|Other|360
6121826|NCT00084266|21101737|P2|Overall Study|Participant not willing to participate|8
6121827|NCT00084266|21101738|P1|Overall Study|Participant not willing to participate|3
6121828|NCT00084266|21101737|P2|Overall Study|Lost to Follow-up|3
6121829|NCT00084266|21101738|P1|Overall Study|Lost to Follow-up|5
6121830|NCT00084266|21101737|P2|Overall Study|Lack of Efficacy|4
6121831|NCT00084266|21101738|P1|Overall Study|Lack of Efficacy|2
6121832|NCT00084266|21101737|P2|Overall Study|Adverse Event|5
6121833|NCT00084266|21101738|P1|Overall Study|Adverse Event|8
6121834|NCT00084266|21101737|P2|Overall Study|Death|39
6121835|NCT00084266|21101738|P1|Overall Study|Death|42
6121836|NCT00084136|21101796|P3|NRTI Comparison|Not reason above|0
6121837|NCT00084136|21101797|P2|NRTI Comparison|Not reason above|0
6121838|NCT00084136|21101798|P1|NRTI Comparison|Not reason above|1
6121839|NCT00084136|21101796|P3|NRTI Comparison|Clinic site closed|14
6121840|NCT00084136|21101797|P2|NRTI Comparison|Clinic site closed|0
6121841|NCT00084136|21101798|P1|NRTI Comparison|Clinic site closed|12
6121842|NCT00084136|21101796|P3|NRTI Comparison|Withdrawal by Subject|38
6121843|NCT00084136|21101797|P2|NRTI Comparison|Withdrawal by Subject|0
6121844|NCT00084136|21101798|P1|NRTI Comparison|Withdrawal by Subject|54
6121845|NCT00084136|21101796|P3|NRTI Comparison|Lost to Follow-up|12
6121846|NCT00084136|21101797|P2|NRTI Comparison|Lost to Follow-up|0
6121847|NCT00084136|21101798|P1|NRTI Comparison|Lost to Follow-up|14
6121848|NCT00084136|21101796|P3|NRTI Comparison|Death|18
6121849|NCT00084136|21101797|P2|NRTI Comparison|Death|0
6121850|NCT00084136|21101798|P1|NRTI Comparison|Death|20
6121851|NCT00084136|21101796|P3|PI Comparison|Clinic site closed|0
6121852|NCT00084136|21101797|P2|PI Comparison|Clinic site closed|0
6121853|NCT00084136|21101798|P1|PI Comparison|Clinic site closed|1
6121854|NCT00084136|21101796|P3|PI Comparison|Withdrawal by Subject|0
6121855|NCT00084136|21101797|P2|PI Comparison|Withdrawal by Subject|30
6121856|NCT00084136|21101798|P1|PI Comparison|Withdrawal by Subject|33
6121857|NCT00084136|21101796|P3|PI Comparison|Lost to Follow-up|0
6121858|NCT00084136|21101797|P2|PI Comparison|Lost to Follow-up|8
6121859|NCT00084136|21101798|P1|PI Comparison|Lost to Follow-up|11
6121860|NCT00084136|21101796|P3|PI Comparison|Death|0
6121861|NCT00084136|21101797|P2|PI Comparison|Death|9
6121862|NCT00084136|21101798|P1|PI Comparison|Death|10
6121863|NCT00084084|21101857|P1|Phase 2 (Transition to Replagal AF)|Failure to visit clinic as scheduled|1
6121864|NCT00084084|21101857|P1|Phase 1 (Treatment With Replagal RB)|Lost to Follow-up|1
6121865|NCT00083915|21101867|P2|Overall Study|Insurance issues|1
6121866|NCT00083915|21101868|P1|Overall Study|Insurance issues|1
6121867|NCT00083915|21101867|P2|Overall Study|No response|1
6121868|NCT00083915|21101868|P1|Overall Study|No response|3
6121869|NCT00083915|21101867|P2|Overall Study|Failure to collect|0
6121870|NCT00083915|21101868|P1|Overall Study|Failure to collect|3
6121871|NCT00083915|21101867|P2|Overall Study|disease progression|23
6121872|NCT00083915|21101868|P1|Overall Study|disease progression|18
6121873|NCT00083915|21101867|P2|Overall Study|Withdrawal by Subject|3
6121874|NCT00083915|21101868|P1|Overall Study|Withdrawal by Subject|8
6121875|NCT00083915|21101867|P2|Overall Study|Physician Decision|6
6121876|NCT00083915|21101868|P1|Overall Study|Physician Decision|11
6121877|NCT00083915|21101867|P2|Overall Study|Death|3
6121878|NCT00083915|21101868|P1|Overall Study|Death|6
6121879|NCT00083889|21101876|P2|Overall Study|Crossover to SU011248|25
6121880|NCT00083889|21101877|P1|Overall Study|Crossover to SU011248|0
6121881|NCT00083889|21101876|P2|Overall Study|Completed on marketed sunitinub|0
6121882|NCT00083889|21101877|P1|Overall Study|Completed on marketed sunitinub|3
6121883|NCT00083889|21101876|P2|Overall Study|Randomized: did not take study drug|15
6121884|NCT00083889|21101877|P1|Overall Study|Randomized: did not take study drug|0
6121885|NCT00083889|21101876|P2|Overall Study|Decision of sponsor|4
6121886|NCT00083889|21101877|P1|Overall Study|Decision of sponsor|32
6121887|NCT00083889|21101876|P2|Overall Study|Lack of Efficacy|219
6121888|NCT00083889|21101877|P1|Overall Study|Lack of Efficacy|240
6121889|NCT00083889|21101876|P2|Overall Study|Withdrawal by Subject|24
6121890|NCT00083889|21101877|P1|Overall Study|Withdrawal by Subject|22
6121891|NCT00083889|21101876|P2|Overall Study|Protocol Violation|2
6121892|NCT00083889|21101877|P1|Overall Study|Protocol Violation|2
6121893|NCT00083889|21101876|P2|Overall Study|Adverse Event|86
6121894|NCT00083889|21101877|P1|Overall Study|Adverse Event|76
6121895|NCT00083759|21101935|P2|Overall Study|Other|13
6121896|NCT00083759|21101936|P1|Overall Study|Other|14
6121897|NCT00083759|21101935|P2|Overall Study|Sponsor's Discretion|29
6121898|NCT00083759|21101936|P1|Overall Study|Sponsor's Discretion|28
6121899|NCT00083759|21101935|P2|Overall Study|Non-Compliance|0
6121900|NCT00083759|21101936|P1|Overall Study|Non-Compliance|1
6121901|NCT00083759|21101935|P2|Overall Study|Subject Withdrew Consent|2
6121902|NCT00083759|21101936|P1|Overall Study|Subject Withdrew Consent|2
6121903|NCT00083759|21101935|P2|Overall Study|Inadequate Therapeutic Response|35
6121904|NCT00083759|21101936|P1|Overall Study|Inadequate Therapeutic Response|32
6121905|NCT00083759|21101935|P2|Overall Study|Death|1
6121906|NCT00083759|21101936|P1|Overall Study|Death|1
6121907|NCT00083759|21101935|P2|Overall Study|Lost to Follow-up|0
6121908|NCT00083759|21101936|P1|Overall Study|Lost to Follow-up|1
6121909|NCT00083759|21101935|P2|Overall Study|Adverse Event|3
6121910|NCT00083759|21101936|P1|Overall Study|Adverse Event|5
6121911|NCT00083616|21101954|P1|Overall Study|Other|6
6121912|NCT00083616|21101954|P1|Overall Study|Non-compliance|1
6121913|NCT00083616|21101954|P1|Overall Study|Ineligibility determined|2
6121914|NCT00083616|21101954|P1|Overall Study|Withdrawal by Subject|3
6121915|NCT00083616|21101954|P1|Overall Study|Physician Decision|2
6121916|NCT00083616|21101954|P1|Overall Study|Lost to Follow-up|1
6121917|NCT00083616|21101954|P1|Overall Study|Disease Progression|16
6121918|NCT00082888|21101982|P3|Overall Study|Ineligible|0
6121919|NCT00082888|21101983|P2|Overall Study|Ineligible|0
6121920|NCT00082888|21101984|P1|Overall Study|Ineligible|1
6121921|NCT00082810|21102004|P1|Overall Study|Withdrawal by Subject|4
6121922|NCT00082810|21102004|P1|Overall Study|Progressive disease|24
6121923|NCT00082810|21102004|P1|Overall Study|Adverse Event|3
6121924|NCT00082758|21102015|P3|Overall Study|Protocol Violation|0
6121925|NCT00082758|21102016|P2|Overall Study|Protocol Violation|1
6121926|NCT00082758|21102017|P1|Overall Study|Protocol Violation|0
6121927|NCT00082758|21102015|P3|Overall Study|Withdrawal by Subject|0
6121928|NCT00082758|21102016|P2|Overall Study|Withdrawal by Subject|0
6121929|NCT00082758|21102017|P1|Overall Study|Withdrawal by Subject|3
6121930|NCT00082758|21102015|P3|Overall Study|Physician Decision|0
6121931|NCT00082758|21102016|P2|Overall Study|Physician Decision|1
6121932|NCT00082758|21102017|P1|Overall Study|Physician Decision|0
6121933|NCT00082758|21102015|P3|Overall Study|Lack of Efficacy|0
6121934|NCT00082758|21102016|P2|Overall Study|Lack of Efficacy|13
6121935|NCT00082758|21102017|P1|Overall Study|Lack of Efficacy|12
6121936|NCT00082758|21102015|P3|Overall Study|Adverse Event|0
6121937|NCT00082758|21102016|P2|Overall Study|Adverse Event|2
6121938|NCT00082758|21102017|P1|Overall Study|Adverse Event|0
6121939|NCT00083226|21102037|P1|Overall Study|ineligible or not receiving treatment|4
6121940|NCT00083226|21102037|P1|Overall Study|Other|2
6121941|NCT00083226|21102037|P1|Overall Study|Withdrawal by Subject|4
6121942|NCT00083226|21102037|P1|Overall Study|Death|4
6121943|NCT00083226|21102037|P1|Overall Study|Adverse Event|9
6121944|NCT00083226|21102037|P1|Overall Study|Lack of Efficacy|19
6121945|NCT00082628|21102081|P5|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|17
6121946|NCT00082628|21102082|P4|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15
6121947|NCT00082628|21102083|P3|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15
6121948|NCT00082628|21102084|P2|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0
6121949|NCT00082628|21102085|P1|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0
6121950|NCT00082628|21102081|P5|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0
6121951|NCT00082628|21102082|P4|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|1
6121952|NCT00082628|21102083|P3|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0
6121953|NCT00082628|21102084|P2|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0
6121954|NCT00082628|21102085|P1|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0
6121955|NCT00082628|21102081|P5|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|1
6121956|NCT00082628|21102082|P4|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0
6121957|NCT00082628|21102083|P3|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0
6121958|NCT00082628|21102084|P2|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0
6121959|NCT00082628|21102085|P1|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0
6121960|NCT00082628|21102081|P5|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0
6121961|NCT00082628|21102082|P4|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0
6121962|NCT00082628|21102083|P3|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0
6121963|NCT00082628|21102084|P2|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|15
6121964|NCT00082628|21102085|P1|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|1
6121965|NCT00082628|21102081|P5|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0
6121966|NCT00082628|21102082|P4|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0
6121967|NCT00082628|21102083|P3|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0
6121968|NCT00082628|21102084|P2|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|43
6121969|NCT00082628|21102085|P1|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|5
6121970|NCT00082628|21102081|P5|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0
6121971|NCT00082628|21102082|P4|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0
6121972|NCT00082628|21102083|P3|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0
6121973|NCT00082628|21102084|P2|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|1
6121974|NCT00082628|21102085|P1|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|2
6121975|NCT00082628|21102081|P5|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0
6121976|NCT00082628|21102082|P4|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0
6121977|NCT00082628|21102083|P3|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0
6121978|NCT00082628|21102084|P2|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|1
6121979|NCT00082628|21102085|P1|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0
6121980|NCT00082433|21102105|P2|Overall Study|Impending surgery|1
6121981|NCT00082433|21102106|P1|Overall Study|Impending surgery|0
6121982|NCT00082433|21102105|P2|Overall Study|New primary cancer|0
6121983|NCT00082433|21102106|P1|Overall Study|New primary cancer|1
6121984|NCT00082433|21102105|P2|Overall Study|Noncompliance|1
6121985|NCT00082433|21102106|P1|Overall Study|Noncompliance|2
6121986|NCT00082433|21102105|P2|Overall Study|Ineligible|1
6121987|NCT00082433|21102106|P1|Overall Study|Ineligible|2
6121988|NCT00082433|21102105|P2|Overall Study|Not Treated|11
6121989|NCT00082433|21102106|P1|Overall Study|Not Treated|12
6121990|NCT00082433|21102105|P2|Overall Study|Still On Treatment|1
6121991|NCT00082433|21102106|P1|Overall Study|Still On Treatment|2
6121992|NCT00082433|21102105|P2|Overall Study|Withdrawal by Subject|30
6121993|NCT00082433|21102106|P1|Overall Study|Withdrawal by Subject|55
6121994|NCT00082433|21102105|P2|Overall Study|Study Drug Toxicity|66
6121995|NCT00082433|21102106|P1|Overall Study|Study Drug Toxicity|179
6121996|NCT00082433|21102105|P2|Overall Study|Lost to Follow-up|2
6121997|NCT00082433|21102106|P1|Overall Study|Lost to Follow-up|1
6121998|NCT00082433|21102105|P2|Overall Study|Physician Decision|61
6121999|NCT00082433|21102106|P1|Overall Study|Physician Decision|50
6122000|NCT00082433|21102105|P2|Overall Study|Disease Progression/Relapse|388
6122001|NCT00082433|21102106|P1|Overall Study|Disease Progression/Relapse|270
6122002|NCT00082433|21102105|P2|Overall Study|Death|18
6122003|NCT00082433|21102106|P1|Overall Study|Death|8
6122004|NCT00082433|21102105|P2|Overall Study|Adverse Event|17
6122005|NCT00082433|21102106|P1|Overall Study|Adverse Event|12
6122006|NCT00082381|21102126|P2|Overall Study|Loss of Glucose Control|0
6122007|NCT00082381|21102127|P1|Overall Study|Loss of Glucose Control|4
6122008|NCT00082381|21102126|P2|Overall Study|Protocol Violation|11
6122009|NCT00082381|21102127|P1|Overall Study|Protocol Violation|10
6122010|NCT00082381|21102126|P2|Overall Study|Physician Decision|2
6122011|NCT00082381|21102127|P1|Overall Study|Physician Decision|1
6122012|NCT00082381|21102126|P2|Overall Study|Patient Decision|4
6122013|NCT00082381|21102127|P1|Overall Study|Patient Decision|8
6122014|NCT00082381|21102126|P2|Overall Study|Lost to Follow-up|7
6122015|NCT00082381|21102127|P1|Overall Study|Lost to Follow-up|5
6122016|NCT00082381|21102126|P2|Overall Study|Adverse Event|2
6122017|NCT00082381|21102127|P1|Overall Study|Adverse Event|27
6122018|NCT00082407|21102147|P2|Overall Study|Lost to Follow-up|3
6122019|NCT00082407|21102148|P1|Overall Study|Lost to Follow-up|0
6122020|NCT00082407|21102147|P2|Overall Study|Death|1
6122021|NCT00082407|21102148|P1|Overall Study|Death|2
6122022|NCT00082407|21102147|P2|Overall Study|Loss of Glucose Control|2
6122023|NCT00082407|21102148|P1|Overall Study|Loss of Glucose Control|2
6122024|NCT00082407|21102147|P2|Overall Study|Physician Decision|3
6122025|NCT00082407|21102148|P1|Overall Study|Physician Decision|5
6122026|NCT00082407|21102147|P2|Overall Study|Patient Decision|6
6122027|NCT00082407|21102148|P1|Overall Study|Patient Decision|13
6122028|NCT00082407|21102147|P2|Overall Study|Protocol Violation|12
6122029|NCT00082407|21102148|P1|Overall Study|Protocol Violation|14
6122030|NCT00082407|21102147|P2|Overall Study|Adverse Event|0
6122031|NCT00082407|21102148|P1|Overall Study|Adverse Event|20
6122032|NCT00082368|21102166|P1|Overall Study|Not treated-pt had poor IV access|1
6122033|NCT00082355|21102171|P1|5 Year Recurrent Thromboembolism Rate|will be completed 2014|28
6122034|NCT00082355|21102171|P1|Initial Results of Thrombolytic Therapy|Withdrawal by Subject|1
6122035|NCT00082355|21102171|P1|Initial Results of Thrombolytic Therapy|died of causes unrelated to protocol|1
6122036|NCT00082173|21102205|P2|Overall Study|Culture negative or resistant at baselin|6
6122037|NCT00082173|21102206|P1|Overall Study|Culture negative or resistant at baselin|5
6122038|NCT00082173|21102205|P2|Overall Study|Adverse Event|0
6122039|NCT00082173|21102206|P1|Overall Study|Adverse Event|1
6122040|NCT00082173|21102205|P2|Overall Study|Lost to Follow-up|0
6122041|NCT00082173|21102206|P1|Overall Study|Lost to Follow-up|1
6122042|NCT00082173|21102205|P2|Overall Study|Withdrawal by Subject|5
6122043|NCT00082173|21102206|P1|Overall Study|Withdrawal by Subject|3
6122044|NCT00081770|21102251|P3|Overall Study|Other|8
6122045|NCT00081770|21102252|P2|Overall Study|Other|7
6122046|NCT00081770|21102253|P1|Overall Study|Other|2
6122047|NCT00081770|21102251|P3|Overall Study|Administrative|1
6122048|NCT00081770|21102252|P2|Overall Study|Administrative|0
6122049|NCT00081770|21102253|P1|Overall Study|Administrative|1
6122050|NCT00081770|21102251|P3|Overall Study|Did not meet protocol eligibility|3
6122051|NCT00081770|21102252|P2|Overall Study|Did not meet protocol eligibility|0
6122052|NCT00081770|21102253|P1|Overall Study|Did not meet protocol eligibility|2
6122053|NCT00081770|21102251|P3|Overall Study|Withdrawal by Subject|42
6122054|NCT00081770|21102252|P2|Overall Study|Withdrawal by Subject|40
6122055|NCT00081770|21102253|P1|Overall Study|Withdrawal by Subject|45
6122056|NCT00081770|21102251|P3|Overall Study|Protocol Violation|10
6122057|NCT00081770|21102252|P2|Overall Study|Protocol Violation|10
6122058|NCT00081770|21102253|P1|Overall Study|Protocol Violation|15
6122059|NCT00081770|21102251|P3|Overall Study|Lost to Follow-up|45
6122060|NCT00081770|21102252|P2|Overall Study|Lost to Follow-up|34
6122061|NCT00081770|21102253|P1|Overall Study|Lost to Follow-up|45
6122062|NCT00081770|21102251|P3|Overall Study|Lack of Efficacy|211
6122063|NCT00081770|21102252|P2|Overall Study|Lack of Efficacy|357
6122064|NCT00081770|21102253|P1|Overall Study|Lack of Efficacy|262
6122065|NCT00081770|21102251|P3|Overall Study|Adverse Event|136
6122066|NCT00081770|21102252|P2|Overall Study|Adverse Event|98
6122067|NCT00081770|21102253|P1|Overall Study|Adverse Event|130
6122068|NCT00081731|21102272|P2|Overall Study|scientific integrity issue|8
6122069|NCT00081731|21102273|P1|Overall Study|scientific integrity issue|8
6122070|NCT00081653|21102293|P2|Overall Study|Loss of bone mass|2
6122071|NCT00081653|21102294|P1|Overall Study|Loss of bone mass|0
6122072|NCT00081653|21102293|P2|Overall Study|Participant leaving country|0
6122073|NCT00081653|21102294|P1|Overall Study|Participant leaving country|1
6122074|NCT00081653|21102293|P2|Overall Study|Bone loss|0
6122075|NCT00081653|21102294|P1|Overall Study|Bone loss|2
6122076|NCT00081653|21102293|P2|Overall Study|Low bone mineral density|0
6122077|NCT00081653|21102294|P1|Overall Study|Low bone mineral density|1
6122078|NCT00081653|21102293|P2|Overall Study|Refused Treatment|14
6122079|NCT00081653|21102294|P1|Overall Study|Refused Treatment|18
6122080|NCT00081653|21102293|P2|Overall Study|Lost to Follow-up|4
6122081|NCT00081653|21102294|P1|Overall Study|Lost to Follow-up|2
6122082|NCT00081653|21102293|P2|Overall Study|Adverse Event|17
6122083|NCT00081653|21102294|P1|Overall Study|Adverse Event|23
6122084|NCT00081497|21102312|P2|Overall Study|Non-compliance|1
6122085|NCT00081497|21102313|P1|Overall Study|Non-compliance|0
6122086|NCT00081497|21102312|P2|Overall Study|Withdrawal by Subject|0
6122087|NCT00081497|21102313|P1|Overall Study|Withdrawal by Subject|1
6122088|NCT00081497|21102312|P2|Overall Study|Death|1
6122089|NCT00081497|21102313|P1|Overall Study|Death|0
6122090|NCT00081497|21102312|P2|Overall Study|Adverse Event|0
6122091|NCT00081497|21102313|P1|Overall Study|Adverse Event|2
6122092|NCT00081458|21102331|P3|Overall Study|Randomized but not dosed|1
6122093|NCT00081458|21102332|P2|Overall Study|Randomized but not dosed|0
6122094|NCT00081458|21102333|P1|Overall Study|Randomized but not dosed|0
6122095|NCT00081458|21102331|P3|Overall Study|Withdrawal by Subject|1
6122096|NCT00081458|21102332|P2|Overall Study|Withdrawal by Subject|3
6122097|NCT00081458|21102333|P1|Overall Study|Withdrawal by Subject|0
6122098|NCT00081458|21102331|P3|Overall Study|Adverse Event|2
6122099|NCT00081458|21102332|P2|Overall Study|Adverse Event|5
6122100|NCT00081458|21102333|P1|Overall Study|Adverse Event|1
6122101|NCT00081289|21102389|P2|Overall Study|Ineligible / no protocol treatment|4
6122102|NCT00081289|21102390|P1|Overall Study|Ineligible / no protocol treatment|3
6122103|NCT00081289|21102389|P2|Overall Study|Accrued prior to chemotherapy amendment|17
6122104|NCT00081289|21102390|P1|Overall Study|Accrued prior to chemotherapy amendment|18
6122105|NCT00081263|21102434|P2|Overall Study|Inadequate data|10
6122106|NCT00081263|21102435|P1|Overall Study|Inadequate data|5
6122107|NCT00081263|21102434|P2|Overall Study|Never treated|5
6122108|NCT00081263|21102435|P1|Overall Study|Never treated|4
6122109|NCT00081263|21102434|P2|Overall Study|Inadequate pathology|1
6122110|NCT00081263|21102435|P1|Overall Study|Inadequate pathology|0
6122111|NCT00081263|21102434|P2|Overall Study|improper pre-protocol therapy|1
6122112|NCT00081263|21102435|P1|Overall Study|improper pre-protocol therapy|0
6122113|NCT00081263|21102434|P2|Overall Study|wrong cell type|5
6122114|NCT00081263|21102435|P1|Overall Study|wrong cell type|7
6122115|NCT00081263|21102434|P2|Overall Study|clerical error|0
6122116|NCT00081263|21102435|P1|Overall Study|clerical error|1
6122117|NCT00081159|21102445|P2|Overall Study|Lost to Follow-up|1
6122118|NCT00081159|21102446|P1|Overall Study|Lost to Follow-up|2
6122119|NCT00081159|21102445|P2|Overall Study|Myelosuppression prior to treatment|1
6122120|NCT00081159|21102446|P1|Overall Study|Myelosuppression prior to treatment|0
6122121|NCT00081159|21102445|P2|Overall Study|Withdrawal by Subject|3
6122122|NCT00081159|21102446|P1|Overall Study|Withdrawal by Subject|0
6122123|NCT00080938|21102456|P1|Overall Study|Ineligible|4
6122124|NCT00080938|21102456|P1|Overall Study|Not started protocol therapy|1
6122125|NCT00080938|21102456|P1|Overall Study|other disease|1
6122126|NCT00080938|21102456|P1|Overall Study|Lack of Efficacy|7
6122127|NCT00080938|21102456|P1|Overall Study|Death|2
6122128|NCT00080938|21102456|P1|Overall Study|Withdrawal by Subject|6
6122129|NCT00080938|21102456|P1|Overall Study|Adverse Event|3
6122130|NCT00080899|21102472|P1|Overall Study|Adverse Event|1
6122131|NCT00080483|21102484|P2|Overall Study|Physician Decision|1
6122132|NCT00080483|21102485|P1|Overall Study|Physician Decision|1
6122133|NCT00080483|21102484|P2|Overall Study|Lost to Follow-up|1
6122134|NCT00080483|21102485|P1|Overall Study|Lost to Follow-up|1
6122135|NCT00002525|21102493|P2|Overall Study|Never start protocol therapy|0
6122136|NCT00002525|21102494|P1|Overall Study|Never start protocol therapy|8
6122137|NCT00002525|21102493|P2|Overall Study|Other|0
6122138|NCT00002525|21102494|P1|Overall Study|Other|26
6122139|NCT00002525|21102493|P2|Overall Study|Error|0
6122140|NCT00002525|21102494|P1|Overall Study|Error|6
6122141|NCT00002525|21102493|P2|Overall Study|Duke's A, B1, D disease|0
6122142|NCT00002525|21102494|P1|Overall Study|Duke's A, B1, D disease|92
6122143|NCT00002525|21102493|P2|Overall Study|Other complicating disease|0
6122144|NCT00002525|21102494|P1|Overall Study|Other complicating disease|1
6122145|NCT00002525|21102493|P2|Overall Study|Start non-protocol therapy|0
6122146|NCT00002525|21102494|P1|Overall Study|Start non-protocol therapy|1
6122147|NCT00002525|21102493|P2|Overall Study|Withdrawal by Subject|0
6122148|NCT00002525|21102494|P1|Overall Study|Withdrawal by Subject|11
6122149|NCT00002525|21102493|P2|Overall Study|Death|0
6122150|NCT00002525|21102494|P1|Overall Study|Death|5
6122151|NCT00002525|21102493|P2|Overall Study|Adverse Event|0
6122152|NCT00002525|21102494|P1|Overall Study|Adverse Event|36
6122153|NCT00080301|21102521|P2|Overall Study|Still on Treatment as of CSR date|1
6122154|NCT00080301|21102522|P1|Overall Study|Still on Treatment as of CSR date|0
6122155|NCT00080301|21102521|P2|Overall Study|Randomized but Never Treated|10
6122156|NCT00080301|21102522|P1|Overall Study|Randomized but Never Treated|5
6122157|NCT00080288|21102542|P2|Overall Study|Miscellaneous|11
6122158|NCT00080288|21102543|P1|Overall Study|Miscellaneous|11
6122159|NCT00080288|21102542|P2|Overall Study|Withdrawal by Subject|16
6122160|NCT00080288|21102543|P1|Overall Study|Withdrawal by Subject|3
6122161|NCT00080288|21102542|P2|Overall Study|Physician Decision|2
6122162|NCT00080288|21102543|P1|Overall Study|Physician Decision|6
6122163|NCT00080288|21102542|P2|Overall Study|Lost to Follow-up|5
6122164|NCT00080288|21102543|P1|Overall Study|Lost to Follow-up|3
6122165|NCT00080288|21102542|P2|Overall Study|Adverse Event|4
6122166|NCT00080288|21102543|P1|Overall Study|Adverse Event|7
6122167|NCT00080223|21102551|P1|Overall Study|Physician Decision|1
6122168|NCT00080223|21102551|P1|Overall Study|Participant unwilling to continue|2
6122169|NCT00080223|21102551|P1|Overall Study|Non-compliance With Study Treatment|7
6122170|NCT00080223|21102551|P1|Overall Study|Lung Transplantation|9
6122171|NCT00080223|21102551|P1|Overall Study|Withdrawal by Subject|13
6122172|NCT00080223|21102551|P1|Overall Study|Death|21
6122173|NCT00080223|21102551|P1|Overall Study|Adverse Event|23
6122174|NCT00002540|21102561|P2|Overall Study|Refused Screen (Prostate Screening)|2433
6122175|NCT00002540|21102562|P1|Overall Study|Refused Screen (Prostate Screening)|0
6122176|NCT00002540|21102561|P2|Overall Study|Refused ASU (Control)|0
6122177|NCT00002540|21102562|P1|Overall Study|Refused ASU (Control)|597
6122178|NCT00002540|21102561|P2|Overall Study|Died Before ASU (Control)|0
6122179|NCT00002540|21102562|P1|Overall Study|Died Before ASU (Control)|202
6122180|NCT00002540|21102561|P2|Overall Study|Died Before Randomization|6
6122181|NCT00002540|21102562|P1|Overall Study|Died Before Randomization|2
6122182|NCT00002540|21102561|P2|Overall Study|Cancer Before Rand. (Prostate Screening)|25
6122183|NCT00002540|21102562|P1|Overall Study|Cancer Before Rand. (Prostate Screening)|0
6122184|NCT00080119|21102592|P4|Overall Study|Lost to Follow-up|14
6122185|NCT00080119|21102593|P3|Overall Study|Lost to Follow-up|19
6122186|NCT00080119|21102594|P2|Overall Study|Lost to Follow-up|19
6122187|NCT00080119|21102595|P1|Overall Study|Lost to Follow-up|16
6122188|NCT00080119|21102592|P4|Overall Study|Unwilling to adhere to study requirement|1
6122189|NCT00080119|21102593|P3|Overall Study|Unwilling to adhere to study requirement|5
6122190|NCT00080119|21102594|P2|Overall Study|Unwilling to adhere to study requirement|2
6122191|NCT00080119|21102595|P1|Overall Study|Unwilling to adhere to study requirement|3
6122192|NCT00080119|21102592|P4|Overall Study|Consent withdrawn|6
6122193|NCT00080119|21102593|P3|Overall Study|Consent withdrawn|4
6122194|NCT00080119|21102594|P2|Overall Study|Consent withdrawn|17
6122195|NCT00080119|21102595|P1|Overall Study|Consent withdrawn|13
6122196|NCT00080119|21102592|P4|Overall Study|Unable to get to clinic|1
6122197|NCT00080119|21102593|P3|Overall Study|Unable to get to clinic|7
6122198|NCT00080119|21102594|P2|Overall Study|Unable to get to clinic|24
6122199|NCT00080119|21102595|P1|Overall Study|Unable to get to clinic|24
6122200|NCT00080119|21102592|P4|Overall Study|Discontinued because of study closure|141
6122201|NCT00080119|21102593|P3|Overall Study|Discontinued because of study closure|130
6122202|NCT00080119|21102594|P2|Overall Study|Discontinued because of study closure|0
6122203|NCT00080119|21102595|P1|Overall Study|Discontinued because of study closure|0
6122204|NCT00079937|21102629|P2|Overall Study|Administrative problems|11
6122205|NCT00079937|21102630|P1|Overall Study|Administrative problems|22
6122206|NCT00079937|21102629|P2|Overall Study|Lost to Follow-up|5
6122207|NCT00079937|21102630|P1|Overall Study|Lost to Follow-up|12
6122208|NCT00079937|21102629|P2|Overall Study|Withdrawal by Subject|7
6122209|NCT00079937|21102630|P1|Overall Study|Withdrawal by Subject|21
6122210|NCT00079937|21102629|P2|Overall Study|Protocol Violation|6
6122211|NCT00079937|21102630|P1|Overall Study|Protocol Violation|8
6122212|NCT00079937|21102629|P2|Overall Study|Subject no longer requires study drug|0
6122213|NCT00079937|21102630|P1|Overall Study|Subject no longer requires study drug|3
6122214|NCT00079937|21102629|P2|Overall Study|Unsatisfactory therapeutic effect|2
6122215|NCT00079937|21102630|P1|Overall Study|Unsatisfactory therapeutic effect|1
6122216|NCT00079937|21102629|P2|Overall Study|Adverse Event|1
6122217|NCT00079937|21102630|P1|Overall Study|Adverse Event|2
6122218|NCT00009737|21102648|P2|Overall Study|Administrative/Other Reasons|1
6122219|NCT00009737|21102649|P1|Overall Study|Administrative/Other Reasons|7
6122220|NCT00009737|21102648|P2|Overall Study|Lost to Follow-up|1
6122221|NCT00009737|21102649|P1|Overall Study|Lost to Follow-up|1
6122222|NCT00009737|21102648|P2|Overall Study|Refused Treatment|16
6122223|NCT00009737|21102649|P1|Overall Study|Refused Treatment|15
6122224|NCT00009737|21102648|P2|Overall Study|Other Protocol Violation|0
6122225|NCT00009737|21102649|P1|Overall Study|Other Protocol Violation|1
6122226|NCT00009737|21102648|P2|Overall Study|Violation of Selection Criteria at Entry|9
6122227|NCT00009737|21102649|P1|Overall Study|Violation of Selection Criteria at Entry|13
6122228|NCT00009737|21102648|P2|Overall Study|Lack of Efficacy|15
6122229|NCT00009737|21102649|P1|Overall Study|Lack of Efficacy|17
6122230|NCT00009737|21102648|P2|Overall Study|Death|6
6122231|NCT00009737|21102649|P1|Overall Study|Death|4
6122232|NCT00009737|21102648|P2|Overall Study|Adverse Event|75
6122233|NCT00009737|21102649|P1|Overall Study|Adverse Event|112
6122234|NCT00079781|21102668|P3|Follow-up Period|Death|1
6122235|NCT00079781|21102669|P2|Follow-up Period|Death|0
6122236|NCT00079781|21102670|P1|Follow-up Period|Death|0
6122237|NCT00079781|21102668|P3|Follow-up Period|Lost to Follow-up|0
6122238|NCT00079781|21102669|P2|Follow-up Period|Lost to Follow-up|0
6122239|NCT00079781|21102670|P1|Follow-up Period|Lost to Follow-up|1
6122240|NCT00079781|21102668|P3|Follow-up Period|Withdrawal by Subject|1
6122241|NCT00079781|21102669|P2|Follow-up Period|Withdrawal by Subject|0
6122242|NCT00079781|21102670|P1|Follow-up Period|Withdrawal by Subject|3
6122243|NCT00079781|21102668|P3|Pre-implant Period|Did not meet I/E criteria|1
6122244|NCT00079781|21102669|P2|Pre-implant Period|Did not meet I/E criteria|1
6122245|NCT00079781|21102670|P1|Pre-implant Period|Did not meet I/E criteria|1
6122246|NCT00079781|21102668|P3|Pre-implant Period|Withdrawal by Subject|0
6122247|NCT00079781|21102669|P2|Pre-implant Period|Withdrawal by Subject|0
6122248|NCT00079781|21102670|P1|Pre-implant Period|Withdrawal by Subject|2
6122249|NCT00079677|21102679|P2|Overall Study|Miscellaneous|0
6122250|NCT00079677|21102680|P1|Overall Study|Miscellaneous|2
6122251|NCT00079677|21102679|P2|Overall Study|Withdrawal by Subject|3
6122252|NCT00079677|21102680|P1|Overall Study|Withdrawal by Subject|5
6122253|NCT00079677|21102679|P2|Overall Study|Protocol Violation|3
6122254|NCT00079677|21102680|P1|Overall Study|Protocol Violation|2
6122255|NCT00079677|21102679|P2|Overall Study|Physician Decision|0
6122256|NCT00079677|21102680|P1|Overall Study|Physician Decision|3
6122257|NCT00079677|21102679|P2|Overall Study|Lost to Follow-up|2
6122258|NCT00079677|21102680|P1|Overall Study|Lost to Follow-up|2
6122259|NCT00079677|21102679|P2|Overall Study|Lack of Efficacy|0
6122260|NCT00079677|21102680|P1|Overall Study|Lack of Efficacy|1
6122261|NCT00079677|21102679|P2|Overall Study|Adverse Event|6
6122262|NCT00079677|21102680|P1|Overall Study|Adverse Event|5
6122263|NCT00079417|21102696|P1|Overall Study|Ineligible|7
6122264|NCT00079417|21102696|P1|Overall Study|Physician Decision|2
6122265|NCT00079391|21102704|P1|Overall Study|Withdrawal by Subject|1
6122266|NCT00079339|21102716|P3|Overall Study|Disease progression|2
6122267|NCT00079339|21102717|P2|Overall Study|Disease progression|28
6122268|NCT00079339|21102718|P1|Overall Study|Disease progression|3
6122269|NCT00079339|21102716|P3|Overall Study|Withdrawal by Subject|1
6122270|NCT00079339|21102717|P2|Overall Study|Withdrawal by Subject|4
6122271|NCT00079339|21102718|P1|Overall Study|Withdrawal by Subject|0
6122272|NCT00079339|21102716|P3|Overall Study|Non-compliance|1
6122273|NCT00079339|21102717|P2|Overall Study|Non-compliance|0
6122274|NCT00079339|21102718|P1|Overall Study|Non-compliance|0
6122275|NCT00079339|21102716|P3|Overall Study|Death|0
6122276|NCT00079339|21102717|P2|Overall Study|Death|0
6122277|NCT00079339|21102718|P1|Overall Study|Death|1
6122278|NCT00079339|21102716|P3|Overall Study|Adverse Event|2
6122279|NCT00079339|21102717|P2|Overall Study|Adverse Event|7
6122280|NCT00079339|21102718|P1|Overall Study|Adverse Event|1
6122281|NCT00079274|21102749|P7|Overall Study|Other|0
6122282|NCT00079274|21102750|P6|Overall Study|Other|2
6122283|NCT00079274|21102751|P5|Overall Study|Other|1
6122284|NCT00079274|21102752|P4|Overall Study|Other|55
6122285|NCT00079274|21102753|P3|Overall Study|Other|5
6122286|NCT00079274|21102754|P2|Overall Study|Other|7
6122287|NCT00079274|21102755|P1|Overall Study|Other|43
6122288|NCT00079274|21102749|P7|Overall Study|Cytogenetic resistance|0
6122289|NCT00079274|21102750|P6|Overall Study|Cytogenetic resistance|0
6122290|NCT00079274|21102751|P5|Overall Study|Cytogenetic resistance|0
6122291|NCT00079274|21102752|P4|Overall Study|Cytogenetic resistance|2
6122292|NCT00079274|21102753|P3|Overall Study|Cytogenetic resistance|0
6122293|NCT00079274|21102754|P2|Overall Study|Cytogenetic resistance|0
6122294|NCT00079274|21102755|P1|Overall Study|Cytogenetic resistance|0
6122295|NCT00079274|21102749|P7|Overall Study|Death|0
6122296|NCT00079274|21102750|P6|Overall Study|Death|0
6122297|NCT00079274|21102751|P5|Overall Study|Death|0
6122298|NCT00079274|21102752|P4|Overall Study|Death|15
6122299|NCT00079274|21102753|P3|Overall Study|Death|1
6122300|NCT00079274|21102754|P2|Overall Study|Death|0
6122301|NCT00079274|21102755|P1|Overall Study|Death|4
6122302|NCT00079274|21102749|P7|Overall Study|Other Medical Problems|0
6122303|NCT00079274|21102750|P6|Overall Study|Other Medical Problems|0
6122304|NCT00079274|21102751|P5|Overall Study|Other Medical Problems|0
6122305|NCT00079274|21102752|P4|Overall Study|Other Medical Problems|7
6122306|NCT00079274|21102753|P3|Overall Study|Other Medical Problems|0
6122307|NCT00079274|21102754|P2|Overall Study|Other Medical Problems|1
6122308|NCT00079274|21102755|P1|Overall Study|Other Medical Problems|6
6122309|NCT00079274|21102749|P7|Overall Study|Alternate Treatment|0
6122310|NCT00079274|21102750|P6|Overall Study|Alternate Treatment|0
6122311|NCT00079274|21102751|P5|Overall Study|Alternate Treatment|0
6122312|NCT00079274|21102752|P4|Overall Study|Alternate Treatment|3
6122313|NCT00079274|21102753|P3|Overall Study|Alternate Treatment|0
6122314|NCT00079274|21102754|P2|Overall Study|Alternate Treatment|1
6122315|NCT00079274|21102755|P1|Overall Study|Alternate Treatment|6
6122316|NCT00079274|21102749|P7|Overall Study|Recurrence|0
6122317|NCT00079274|21102750|P6|Overall Study|Recurrence|2
6122318|NCT00079274|21102751|P5|Overall Study|Recurrence|0
6122319|NCT00079274|21102752|P4|Overall Study|Recurrence|15
6122320|NCT00079274|21102753|P3|Overall Study|Recurrence|1
6122321|NCT00079274|21102754|P2|Overall Study|Recurrence|0
6122322|NCT00079274|21102755|P1|Overall Study|Recurrence|21
6122323|NCT00079274|21102749|P7|Overall Study|Adverse Event|0
6122324|NCT00079274|21102750|P6|Overall Study|Adverse Event|8
6122325|NCT00079274|21102751|P5|Overall Study|Adverse Event|7
6122326|NCT00079274|21102752|P4|Overall Study|Adverse Event|184
6122327|NCT00079274|21102753|P3|Overall Study|Adverse Event|8
6122328|NCT00079274|21102754|P2|Overall Study|Adverse Event|8
6122329|NCT00079274|21102755|P1|Overall Study|Adverse Event|130
6122330|NCT00079274|21102749|P7|Overall Study|Withdrawal by Subject|0
6122331|NCT00079274|21102750|P6|Overall Study|Withdrawal by Subject|8
6122332|NCT00079274|21102751|P5|Overall Study|Withdrawal by Subject|7
6122333|NCT00079274|21102752|P4|Overall Study|Withdrawal by Subject|163
6122334|NCT00079274|21102753|P3|Overall Study|Withdrawal by Subject|12
6122335|NCT00079274|21102754|P2|Overall Study|Withdrawal by Subject|10
6122336|NCT00079274|21102755|P1|Overall Study|Withdrawal by Subject|111
6122337|NCT00079183|21102776|P1|Overall Study|Specimen collection non-compliance|1
6122338|NCT00079183|21102776|P1|Overall Study|Study medication non-compliance|2
6122339|NCT00079183|21102776|P1|Overall Study|Withdrawal by Subject|4
6122340|NCT00079040|21102791|P1|Overall Study|Ineligible|1
6122341|NCT00079040|21102791|P1|Overall Study|Withdrew before treatment|1
6122342|NCT00078949|21102814|P4|Overall Study|No treated|3
6122343|NCT00078949|21102815|P3|Overall Study|No treated|3
6122344|NCT00078949|21102816|P2|Overall Study|No treated|5
6122345|NCT00078949|21102817|P1|Overall Study|No treated|4
6122346|NCT00078819|21102846|P4|Withdrawal Period: Weeks 37-48|Lost to Follow-up|1
6122347|NCT00078819|21102847|P3|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0
6122348|NCT00078819|21102848|P2|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0
6122349|NCT00078819|21102849|P1|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0
6122350|NCT00078819|21102846|P4|Withdrawal Period: Weeks 37-48|Entered Retreatment|13
6122351|NCT00078819|21102847|P3|Withdrawal Period: Weeks 37-48|Entered Retreatment|29
6122352|NCT00078819|21102848|P2|Withdrawal Period: Weeks 37-48|Entered Retreatment|0
6122353|NCT00078819|21102849|P1|Withdrawal Period: Weeks 37-48|Entered Retreatment|0
6122354|NCT00078819|21102846|P4|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0
6122355|NCT00078819|21102847|P3|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0
6122356|NCT00078819|21102848|P2|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|25
6122357|NCT00078819|21102849|P1|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|34
6122358|NCT00078819|21102846|P4|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0
6122359|NCT00078819|21102847|P3|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0
6122360|NCT00078819|21102848|P2|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2
6122361|NCT00078819|21102849|P1|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2
6122362|NCT00078819|21102846|P4|Open-label Treatment Period: Weeks 13-36|Adverse Event|0
6122363|NCT00078819|21102847|P3|Open-label Treatment Period: Weeks 13-36|Adverse Event|0
6122364|NCT00078819|21102848|P2|Open-label Treatment Period: Weeks 13-36|Adverse Event|2
6122365|NCT00078819|21102849|P1|Open-label Treatment Period: Weeks 13-36|Adverse Event|3
6122366|NCT00078819|21102846|P4|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0
6122367|NCT00078819|21102847|P3|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0
6122368|NCT00078819|21102848|P2|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1
6122369|NCT00078819|21102849|P1|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1
6122370|NCT00078819|21102846|P4|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0
6122371|NCT00078819|21102847|P3|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0
6122372|NCT00078819|21102848|P2|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0
6122373|NCT00078819|21102849|P1|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|1
6122374|NCT00078819|21102846|P4|Double-blind Treatment Period: Week 1-12|Adverse Event|0
6122375|NCT00078819|21102847|P3|Double-blind Treatment Period: Week 1-12|Adverse Event|0
6122376|NCT00078819|21102848|P2|Double-blind Treatment Period: Week 1-12|Adverse Event|1
6122377|NCT00078819|21102849|P1|Double-blind Treatment Period: Week 1-12|Adverse Event|0
6122378|NCT00078806|21102874|P4|Part 2|Adverse Event|0
6122379|NCT00078806|21102875|P3|Part 2|Adverse Event|0
6122380|NCT00078806|21102876|P2|Part 2|Adverse Event|1
6122381|NCT00078806|21102877|P1|Part 2|Adverse Event|0
6122382|NCT00078806|21102874|P4|Part 1B|Lack of Efficacy|0
6122383|NCT00078806|21102875|P3|Part 1B|Lack of Efficacy|0
6122384|NCT00078806|21102876|P2|Part 1B|Lack of Efficacy|0
6122385|NCT00078806|21102877|P1|Part 1B|Lack of Efficacy|7
6122386|NCT00078806|21102874|P4|Part 1B|Adverse Event|0
6122387|NCT00078806|21102875|P3|Part 1B|Adverse Event|0
6122388|NCT00078806|21102876|P2|Part 1B|Adverse Event|0
6122389|NCT00078806|21102877|P1|Part 1B|Adverse Event|1
6122390|NCT00078806|21102874|P4|Part 1A|Other|0
6122391|NCT00078806|21102875|P3|Part 1A|Other|0
6122392|NCT00078806|21102876|P2|Part 1A|Other|0
6122393|NCT00078806|21102877|P1|Part 1A|Other|1
6122394|NCT00078806|21102874|P4|Part 1A|Lack of Efficacy|0
6122395|NCT00078806|21102875|P3|Part 1A|Lack of Efficacy|0
6122396|NCT00078806|21102876|P2|Part 1A|Lack of Efficacy|0
6122397|NCT00078806|21102877|P1|Part 1A|Lack of Efficacy|7
6122398|NCT00078806|21102874|P4|Part 1A|Adverse Event|0
6122399|NCT00078806|21102875|P3|Part 1A|Adverse Event|0
6122400|NCT00078806|21102876|P2|Part 1A|Adverse Event|0
6122401|NCT00078806|21102877|P1|Part 1A|Adverse Event|2
6122402|NCT00078767|21102913|P2|Overall Study|Withdrawal by Subject|1
6122403|NCT00078767|21102914|P1|Overall Study|Withdrawal by Subject|1
6122404|NCT00005947|21102961|P2|Overall Study|Site Closure|0
6122405|NCT00005947|21102962|P1|Overall Study|Site Closure|1
6122406|NCT00005947|21102961|P2|Overall Study|Patient Refused to Continue|1
6122407|NCT00005947|21102962|P1|Overall Study|Patient Refused to Continue|2
6122408|NCT00005947|21102961|P2|Overall Study|Death|40
6122409|NCT00005947|21102962|P1|Overall Study|Death|54
6122410|NCT00002597|21102998|P2|Overall Study|Withdrawal by Subject|6
6122411|NCT00002597|21102999|P1|Overall Study|Withdrawal by Subject|7
6122412|NCT00002597|21102998|P2|Overall Study|Protocol Violation|17
6122413|NCT00002597|21102999|P1|Overall Study|Protocol Violation|19
6122414|NCT00078377|21103024|P3|Overall Study|Miscellaneous|1
6122415|NCT00078377|21103025|P2|Overall Study|Miscellaneous|6
6122416|NCT00078377|21103026|P1|Overall Study|Miscellaneous|2
6122417|NCT00078377|21103024|P3|Overall Study|Withdrawal by Subject|4
6122418|NCT00078377|21103025|P2|Overall Study|Withdrawal by Subject|4
6122419|NCT00078377|21103026|P1|Overall Study|Withdrawal by Subject|3
6122420|NCT00078377|21103024|P3|Overall Study|Physician Decision|0
6122421|NCT00078377|21103025|P2|Overall Study|Physician Decision|0
6122422|NCT00078377|21103026|P1|Overall Study|Physician Decision|2
6122423|NCT00078377|21103024|P3|Overall Study|Lost to Follow-up|1
6122424|NCT00078377|21103025|P2|Overall Study|Lost to Follow-up|1
6122425|NCT00078377|21103026|P1|Overall Study|Lost to Follow-up|0
6122426|NCT00078377|21103024|P3|Overall Study|Lack of Efficacy|2
6122427|NCT00078377|21103025|P2|Overall Study|Lack of Efficacy|0
6122428|NCT00078377|21103026|P1|Overall Study|Lack of Efficacy|2
6122429|NCT00078377|21103024|P3|Overall Study|Adverse Event|1
6122430|NCT00078377|21103025|P2|Overall Study|Adverse Event|5
6122431|NCT00078377|21103026|P1|Overall Study|Adverse Event|2
6122432|NCT00078338|21103041|P2|Overall Study|Subjects randomized, but not treated|3
6122433|NCT00078338|21103042|P1|Overall Study|Subjects randomized, but not treated|3
6122434|NCT00078338|21103041|P2|Overall Study|Other|16
6122435|NCT00078338|21103042|P1|Overall Study|Other|28
6122436|NCT00078338|21103041|P2|Overall Study|Disease Progression|7
6122437|NCT00078338|21103042|P1|Overall Study|Disease Progression|4
6122438|NCT00078338|21103041|P2|Overall Study|Protocol Violation|2
6122439|NCT00078338|21103042|P1|Overall Study|Protocol Violation|2
6122440|NCT00078338|21103041|P2|Overall Study|Lost to Follow-up|2
6122441|NCT00078338|21103042|P1|Overall Study|Lost to Follow-up|17
6122442|NCT00078338|21103041|P2|Overall Study|Adverse Event|24
6122443|NCT00078338|21103042|P1|Overall Study|Adverse Event|31
6122444|NCT00078325|21103135|P3|Overall Study|Miscellaneous|1
6122445|NCT00078325|21103136|P2|Overall Study|Miscellaneous|1
6122446|NCT00078325|21103137|P1|Overall Study|Miscellaneous|1
6122447|NCT00078325|21103135|P3|Overall Study|Physician Decision|1
6122448|NCT00078325|21103136|P2|Overall Study|Physician Decision|0
6122449|NCT00078325|21103137|P1|Overall Study|Physician Decision|2
6122450|NCT00078325|21103135|P3|Overall Study|Lost to Follow-up|1
6122451|NCT00078325|21103136|P2|Overall Study|Lost to Follow-up|1
6122452|NCT00078325|21103137|P1|Overall Study|Lost to Follow-up|0
6122453|NCT00078325|21103135|P3|Overall Study|Withdrawal by Subject|3
6122454|NCT00078325|21103136|P2|Overall Study|Withdrawal by Subject|5
6122455|NCT00078325|21103137|P1|Overall Study|Withdrawal by Subject|1
6122456|NCT00078325|21103135|P3|Overall Study|Protocol Violation|0
6122457|NCT00078325|21103136|P2|Overall Study|Protocol Violation|2
6122458|NCT00078325|21103137|P1|Overall Study|Protocol Violation|2
6122459|NCT00078325|21103135|P3|Overall Study|Adverse Event|5
6122460|NCT00078325|21103136|P2|Overall Study|Adverse Event|10
6122461|NCT00078325|21103137|P1|Overall Study|Adverse Event|15
6122462|NCT00078312|21103148|P1|Overall Study|Miscellaneous|33
6122463|NCT00078312|21103148|P1|Overall Study|Withdrawal by Subject|33
6122464|NCT00078312|21103148|P1|Overall Study|Protocol Violation|3
6122465|NCT00078312|21103148|P1|Overall Study|Physician Decision|9
6122466|NCT00078312|21103148|P1|Overall Study|Lost to Follow-up|41
6122467|NCT00078312|21103148|P1|Overall Study|Lack of Efficacy|15
6122468|NCT00078312|21103148|P1|Overall Study|Adverse Event|43
6122469|NCT00077974|21103163|P1|Overall Study|Decision of Sponsor|2
6122470|NCT00077974|21103163|P1|Overall Study|Lack of Efficacy|76
6122471|NCT00077974|21103163|P1|Overall Study|Withdrawal by Subject|3
6122472|NCT00077974|21103163|P1|Overall Study|Protocol Violation|1
6122473|NCT00077974|21103163|P1|Overall Study|Adverse Event|22
6122474|NCT00077857|21103180|P2|Overall Study|Other|13
6122475|NCT00077857|21103181|P1|Overall Study|Other|15
6122476|NCT00077857|21103180|P2|Overall Study|Failure to return|5
6122477|NCT00077857|21103181|P1|Overall Study|Failure to return|5
6122478|NCT00077857|21103180|P2|Overall Study|Refused treatment|21
6122479|NCT00077857|21103181|P1|Overall Study|Refused treatment|29
6122480|NCT00077857|21103180|P2|Overall Study|Other protocol violation|1
6122481|NCT00077857|21103181|P1|Overall Study|Other protocol violation|0
6122482|NCT00077857|21103180|P2|Overall Study|Violation of selection criteria at entry|1
6122483|NCT00077857|21103181|P1|Overall Study|Violation of selection criteria at entry|3
6122484|NCT00077857|21103180|P2|Overall Study|Insufficient therapeutic response|128
6122485|NCT00077857|21103181|P1|Overall Study|Insufficient therapeutic response|112
6122486|NCT00077857|21103180|P2|Overall Study|Death|3
6122487|NCT00077857|21103181|P1|Overall Study|Death|7
6122488|NCT00077857|21103180|P2|Overall Study|Adverse Event|32
6122489|NCT00077857|21103181|P1|Overall Study|Adverse Event|30
6122490|NCT00077766|21103201|P2|Overall Study|Participants Vacation|1
6122491|NCT00077766|21103202|P1|Overall Study|Participants Vacation|2
6122492|NCT00077766|21103201|P2|Overall Study|Stop Dialysis|1
6122493|NCT00077766|21103202|P1|Overall Study|Stop Dialysis|0
6122494|NCT00077766|21103201|P2|Overall Study|Started Nocturnal Dialysis|1
6122495|NCT00077766|21103202|P1|Overall Study|Started Nocturnal Dialysis|0
6122496|NCT00077766|21103201|P2|Overall Study|Enrolled in Nocturnal Hemodialysis Study|1
6122497|NCT00077766|21103202|P1|Overall Study|Enrolled in Nocturnal Hemodialysis Study|0
6122498|NCT00077766|21103201|P2|Overall Study|Dialysis|1
6122499|NCT00077766|21103202|P1|Overall Study|Dialysis|0
6122500|NCT00077766|21103201|P2|Overall Study|Dialysis Discontinued|0
6122501|NCT00077766|21103202|P1|Overall Study|Dialysis Discontinued|1
6122502|NCT00077766|21103201|P2|Overall Study|Participant's decision|0
6122503|NCT00077766|21103202|P1|Overall Study|Participant's decision|1
6122504|NCT00077766|21103201|P2|Overall Study|Investigators Discretion|0
6122505|NCT00077766|21103202|P1|Overall Study|Investigators Discretion|1
6122506|NCT00077766|21103201|P2|Overall Study|Transplantation|1
6122507|NCT00077766|21103202|P1|Overall Study|Transplantation|5
6122508|NCT00077766|21103201|P2|Overall Study|Kidney Transplantation|5
6122509|NCT00077766|21103202|P1|Overall Study|Kidney Transplantation|9
6122510|NCT00077766|21103201|P2|Overall Study|Protocol Violation|0
6122511|NCT00077766|21103202|P1|Overall Study|Protocol Violation|1
6122512|NCT00077766|21103201|P2|Overall Study|Lost to Follow-up|0
6122513|NCT00077766|21103202|P1|Overall Study|Lost to Follow-up|2
6122514|NCT00077766|21103201|P2|Overall Study|Death|10
6122515|NCT00077766|21103202|P1|Overall Study|Death|12
6122516|NCT00077766|21103201|P2|Overall Study|Withdrawal by Subject|3
6122517|NCT00077766|21103202|P1|Overall Study|Withdrawal by Subject|4
6122518|NCT00077766|21103201|P2|Overall Study|Adverse Event|1
6122519|NCT00077766|21103202|P1|Overall Study|Adverse Event|1
6122520|NCT00077675|21103227|P2|Overall Study|Never received study treatment|3
6122521|NCT00077675|21103228|P1|Overall Study|Never received study treatment|3
6122522|NCT00077675|21103227|P2|Overall Study|Other|1
6122523|NCT00077675|21103228|P1|Overall Study|Other|0
6122524|NCT00077675|21103227|P2|Overall Study|Withdrawal by Subject|0
6122525|NCT00077675|21103228|P1|Overall Study|Withdrawal by Subject|1
6122526|NCT00077675|21103227|P2|Overall Study|Lost to Follow-up|3
6122527|NCT00077675|21103228|P1|Overall Study|Lost to Follow-up|6
6122528|NCT00077675|21103227|P2|Overall Study|Adverse Event|2
6122529|NCT00077675|21103228|P1|Overall Study|Adverse Event|1
6122530|NCT00077649|21103238|P4|Overall Study|Randomized but never dosed|0
6122531|NCT00077649|21103239|P3|Overall Study|Randomized but never dosed|0
6122532|NCT00077649|21103240|P2|Overall Study|Randomized but never dosed|0
6122533|NCT00077649|21103241|P1|Overall Study|Randomized but never dosed|1
6122534|NCT00077649|21103238|P4|Overall Study|Abnormality of Laboratory Test|2
6122535|NCT00077649|21103239|P3|Overall Study|Abnormality of Laboratory Test|1
6122536|NCT00077649|21103240|P2|Overall Study|Abnormality of Laboratory Test|2
6122537|NCT00077649|21103241|P1|Overall Study|Abnormality of Laboratory Test|1
6122538|NCT00077649|21103238|P4|Overall Study|Lost to Follow-up|2
6122539|NCT00077649|21103239|P3|Overall Study|Lost to Follow-up|3
6122540|NCT00077649|21103240|P2|Overall Study|Lost to Follow-up|2
6122541|NCT00077649|21103241|P1|Overall Study|Lost to Follow-up|2
6122542|NCT00077649|21103238|P4|Overall Study|Withdrawal by Subject|2
6122543|NCT00077649|21103239|P3|Overall Study|Withdrawal by Subject|1
6122544|NCT00077649|21103240|P2|Overall Study|Withdrawal by Subject|1
6122545|NCT00077649|21103241|P1|Overall Study|Withdrawal by Subject|0
6122546|NCT00077649|21103238|P4|Overall Study|Lack of Efficacy|2
6122547|NCT00077649|21103239|P3|Overall Study|Lack of Efficacy|3
6122548|NCT00077649|21103240|P2|Overall Study|Lack of Efficacy|3
6122549|NCT00077649|21103241|P1|Overall Study|Lack of Efficacy|5
6122550|NCT00077649|21103238|P4|Overall Study|Adverse Event|9
6122551|NCT00077649|21103239|P3|Overall Study|Adverse Event|7
6122552|NCT00077649|21103240|P2|Overall Study|Adverse Event|1
6122553|NCT00077649|21103241|P1|Overall Study|Adverse Event|5
6122554|NCT00077636|21103289|P2|Overall Study|Abnormality Of Laboratory Test|2
6122555|NCT00077636|21103290|P1|Overall Study|Abnormality Of Laboratory Test|3
6122556|NCT00077636|21103289|P2|Overall Study|Lost to Follow-up|18
6122557|NCT00077636|21103290|P1|Overall Study|Lost to Follow-up|10
6122558|NCT00077636|21103289|P2|Overall Study|Protocol Violation|2
6122559|NCT00077636|21103290|P1|Overall Study|Protocol Violation|0
6122560|NCT00077636|21103289|P2|Overall Study|Adverse Event|34
6122561|NCT00077636|21103290|P1|Overall Study|Adverse Event|17
6122562|NCT00077636|21103289|P2|Overall Study|Withdrawal by Subject|2
6122563|NCT00077636|21103290|P1|Overall Study|Withdrawal by Subject|2
6122564|NCT00077636|21103289|P2|Overall Study|Admin|3
6122565|NCT00077636|21103290|P1|Overall Study|Admin|3
6122566|NCT00077636|21103289|P2|Overall Study|Refused Treatment|31
6122567|NCT00077636|21103290|P1|Overall Study|Refused Treatment|9
6122568|NCT00077623|21103311|P3|Overall Study|Failure to return|0
6122569|NCT00077623|21103312|P2|Overall Study|Failure to return|0
6122570|NCT00077623|21103313|P1|Overall Study|Failure to return|1
6122571|NCT00077623|21103311|P3|Overall Study|Death|11
6122572|NCT00077623|21103312|P2|Overall Study|Death|18
6122573|NCT00077623|21103313|P1|Overall Study|Death|12
6122574|NCT00077623|21103311|P3|Overall Study|Insufficient therapeutic response|0
6122575|NCT00077623|21103312|P2|Overall Study|Insufficient therapeutic response|0
6122576|NCT00077623|21103313|P1|Overall Study|Insufficient therapeutic response|2
6122577|NCT00077623|21103311|P3|Overall Study|Other-Non safety reason|19
6122578|NCT00077623|21103312|P2|Overall Study|Other-Non safety reason|15
6122579|NCT00077623|21103313|P1|Overall Study|Other-Non safety reason|18
6122580|NCT00077623|21103311|P3|Overall Study|Withdrawal by Subject|1
6122581|NCT00077623|21103312|P2|Overall Study|Withdrawal by Subject|10
6122582|NCT00077623|21103313|P1|Overall Study|Withdrawal by Subject|2
6122583|NCT00077623|21103311|P3|Overall Study|Adverse Event|1
6122584|NCT00077623|21103312|P2|Overall Study|Adverse Event|0
6122585|NCT00077623|21103313|P1|Overall Study|Adverse Event|1
6122586|NCT00077610|21103348|P3|Overall Study|Sponsors decision to withdraw|1
6122587|NCT00077610|21103349|P2|Overall Study|Sponsors decision to withdraw|0
6122588|NCT00077610|21103350|P1|Overall Study|Sponsors decision to withdraw|0
6122589|NCT00077610|21103348|P3|Overall Study|Financial issues|0
6122590|NCT00077610|21103349|P2|Overall Study|Financial issues|1
6122591|NCT00077610|21103350|P1|Overall Study|Financial issues|0
6122592|NCT00077610|21103348|P3|Overall Study|Relocation|5
6122593|NCT00077610|21103349|P2|Overall Study|Relocation|8
6122594|NCT00077610|21103350|P1|Overall Study|Relocation|0
6122595|NCT00077610|21103348|P3|Overall Study|Change in dialysis modality|0
6122596|NCT00077610|21103349|P2|Overall Study|Change in dialysis modality|0
6122597|NCT00077610|21103350|P1|Overall Study|Change in dialysis modality|1
6122598|NCT00077610|21103348|P3|Overall Study|Transfer to other center for surgery|0
6122599|NCT00077610|21103349|P2|Overall Study|Transfer to other center for surgery|0
6122600|NCT00077610|21103350|P1|Overall Study|Transfer to other center for surgery|1
6122601|NCT00077610|21103348|P3|Overall Study|Transfer to satellite unit|0
6122602|NCT00077610|21103349|P2|Overall Study|Transfer to satellite unit|0
6122603|NCT00077610|21103350|P1|Overall Study|Transfer to satellite unit|1
6122604|NCT00077610|21103348|P3|Overall Study|Transferred to nursing home|1
6122605|NCT00077610|21103349|P2|Overall Study|Transferred to nursing home|0
6122606|NCT00077610|21103350|P1|Overall Study|Transferred to nursing home|0
6122607|NCT00077610|21103348|P3|Overall Study|Transferred to other unit|1
6122608|NCT00077610|21103349|P2|Overall Study|Transferred to other unit|0
6122609|NCT00077610|21103350|P1|Overall Study|Transferred to other unit|0
6122610|NCT00077610|21103348|P3|Overall Study|Given Epogen in hospital|0
6122611|NCT00077610|21103349|P2|Overall Study|Given Epogen in hospital|0
6122612|NCT00077610|21103350|P1|Overall Study|Given Epogen in hospital|1
6122613|NCT00077610|21103348|P3|Overall Study|Worsening of health condition|0
6122614|NCT00077610|21103349|P2|Overall Study|Worsening of health condition|1
6122615|NCT00077610|21103350|P1|Overall Study|Worsening of health condition|1
6122616|NCT00077610|21103348|P3|Overall Study|Principal Investigator's decision|1
6122617|NCT00077610|21103349|P2|Overall Study|Principal Investigator's decision|0
6122618|NCT00077610|21103350|P1|Overall Study|Principal Investigator's decision|1
6122619|NCT00077610|21103348|P3|Overall Study|Multiple blood transfusions|1
6122620|NCT00077610|21103349|P2|Overall Study|Multiple blood transfusions|0
6122621|NCT00077610|21103350|P1|Overall Study|Multiple blood transfusions|0
6122622|NCT00077610|21103348|P3|Overall Study|Insufficient Therapeutic Response|0
6122623|NCT00077610|21103349|P2|Overall Study|Insufficient Therapeutic Response|0
6122624|NCT00077610|21103350|P1|Overall Study|Insufficient Therapeutic Response|1
6122625|NCT00077610|21103348|P3|Overall Study|Withdrew from dialysis care|3
6122626|NCT00077610|21103349|P2|Overall Study|Withdrew from dialysis care|0
6122627|NCT00077610|21103350|P1|Overall Study|Withdrew from dialysis care|5
6122628|NCT00077610|21103348|P3|Overall Study|Renal transplant|11
6122629|NCT00077610|21103349|P2|Overall Study|Renal transplant|15
6122630|NCT00077610|21103350|P1|Overall Study|Renal transplant|12
6122631|NCT00077610|21103348|P3|Overall Study|Death|13
6122632|NCT00077610|21103349|P2|Overall Study|Death|13
6122633|NCT00077610|21103350|P1|Overall Study|Death|17
6122634|NCT00077610|21103348|P3|Overall Study|Withdrawal by Subject|6
6122635|NCT00077610|21103349|P2|Overall Study|Withdrawal by Subject|10
6122636|NCT00077610|21103350|P1|Overall Study|Withdrawal by Subject|4
6122637|NCT00077610|21103348|P3|Overall Study|Lost to Follow-up|2
6122638|NCT00077610|21103349|P2|Overall Study|Lost to Follow-up|1
6122639|NCT00077610|21103350|P1|Overall Study|Lost to Follow-up|0
6122640|NCT00077610|21103348|P3|Overall Study|Adverse Event|1
6122641|NCT00077610|21103349|P2|Overall Study|Adverse Event|7
6122642|NCT00077610|21103350|P1|Overall Study|Adverse Event|9
6122643|NCT00077376|21103379|P1|Overall Study|Insurance ran out|1
6122644|NCT00077376|21103379|P1|Overall Study|Surgery|1
6122645|NCT00077376|21103379|P1|Overall Study|Symptomatic deterioration|1
6122646|NCT00077376|21103379|P1|Overall Study|Still on treatment|1
6122647|NCT00077376|21103379|P1|Overall Study|Complicating disease|1
6122648|NCT00077376|21103379|P1|Overall Study|Alternative therapy|5
6122649|NCT00077376|21103379|P1|Overall Study|Physician Decision|1
6122650|NCT00077376|21103379|P1|Overall Study|Death|1
6122651|NCT00077376|21103379|P1|Overall Study|Withdrawal by Subject|2
6122652|NCT00077376|21103379|P1|Overall Study|Adverse Event|8
6122653|NCT00077207|21103390|P1|Overall Study|Ineligible|1
6122654|NCT00077207|21103390|P1|Overall Study|Withdrawal by Subject|6
6122655|NCT00077207|21103390|P1|Overall Study|Physician Decision|6
6122656|NCT00077207|21103390|P1|Overall Study|Lack of Efficacy|12
6122657|NCT00077207|21103390|P1|Overall Study|Adverse Event|5
6122658|NCT00077064|21103402|P2|Overall Study|Patient refusal|2
6122659|NCT00077064|21103403|P1|Overall Study|Patient refusal|0
6122660|NCT00077064|21103402|P2|Overall Study|Adverse Event|4
6122661|NCT00077064|21103403|P1|Overall Study|Adverse Event|0
6122662|NCT00076999|21103419|P5|Overall Study|Other reason (not specified)|13
6122663|NCT00076999|21103420|P4|Overall Study|Other reason (not specified)|1
6122664|NCT00076999|21103421|P3|Overall Study|Other reason (not specified)|4
6122665|NCT00076999|21103422|P2|Overall Study|Other reason (not specified)|8
6122666|NCT00076999|21103423|P1|Overall Study|Other reason (not specified)|8
6122667|NCT00076999|21103419|P5|Overall Study|Withdrawal by Subject|1
6122668|NCT00076999|21103420|P4|Overall Study|Withdrawal by Subject|0
6122669|NCT00076999|21103421|P3|Overall Study|Withdrawal by Subject|3
6122670|NCT00076999|21103422|P2|Overall Study|Withdrawal by Subject|4
6122671|NCT00076999|21103423|P1|Overall Study|Withdrawal by Subject|0
6122672|NCT00076999|21103419|P5|Overall Study|Lost to Follow-up|0
6122673|NCT00076999|21103420|P4|Overall Study|Lost to Follow-up|0
6122674|NCT00076999|21103421|P3|Overall Study|Lost to Follow-up|0
6122675|NCT00076999|21103422|P2|Overall Study|Lost to Follow-up|1
6122676|NCT00076999|21103423|P1|Overall Study|Lost to Follow-up|2
6122677|NCT00076999|21103419|P5|Overall Study|Protocol Violation|9
6122678|NCT00076999|21103420|P4|Overall Study|Protocol Violation|0
6122679|NCT00076999|21103421|P3|Overall Study|Protocol Violation|4
6122680|NCT00076999|21103422|P2|Overall Study|Protocol Violation|3
6122681|NCT00076999|21103423|P1|Overall Study|Protocol Violation|0
6122682|NCT00076999|21103419|P5|Overall Study|Adverse Event|2
6122683|NCT00076999|21103420|P4|Overall Study|Adverse Event|0
6122684|NCT00076999|21103421|P3|Overall Study|Adverse Event|6
6122685|NCT00076999|21103422|P2|Overall Study|Adverse Event|8
6122686|NCT00076999|21103423|P1|Overall Study|Adverse Event|2
6122687|NCT00003222|21103542|P2|Overall Study|Physician Decision|1
6122688|NCT00003222|21103543|P1|Overall Study|Physician Decision|0
6122689|NCT00076804|21103555|P2|Overall Study|Early study Closure|32
6122690|NCT00076804|21103556|P1|Overall Study|Early study Closure|32
6122691|NCT00076804|21103555|P2|Overall Study|Withdrawal by Subject|8
6122692|NCT00076804|21103556|P1|Overall Study|Withdrawal by Subject|10
6122693|NCT00076804|21103555|P2|Overall Study|Lost to Follow-up|9
6122694|NCT00076804|21103556|P1|Overall Study|Lost to Follow-up|9
6122695|NCT00076804|21103555|P2|Overall Study|Death|20
6122696|NCT00076804|21103556|P1|Overall Study|Death|9
6122697|NCT00076752|21103568|P1|Overall Study|Withdrawal per PI, PI put study on hold|1
6122698|NCT00076752|21103568|P1|Overall Study|Death|2
6122699|NCT00076570|21103614|P2|Overall Study|Drug intolerance|8
6122700|NCT00076570|21103615|P1|Overall Study|Drug intolerance|8
6122701|NCT00003298|21103623|P1|Step 2 (Adjuvant Therapy)|Withdrawal by Subject|2
6122702|NCT00003298|21103623|P1|Step 2 (Adjuvant Therapy)|Excessive complication|1
6122703|NCT00003298|21103623|P1|Step 2 (Adjuvant Therapy)|Progression before starting treatment|1
6122704|NCT00003298|21103623|P1|Step 2 (Adjuvant Therapy)|Death|1
6122705|NCT00003298|21103623|P1|Step 2 (Adjuvant Therapy)|Ineligible|1
6122706|NCT00003298|21103623|P1|Re-register to Step 2 After Surgery|Ineligible due to tumor staging|3
6122707|NCT00003298|21103623|P1|Re-register to Step 2 After Surgery|Reason unknown|1
6122708|NCT00003298|21103623|P1|Re-register to Step 2 After Surgery|Other complications|2
6122709|NCT00003298|21103623|P1|Re-register to Step 2 After Surgery|Positive margins|5
6122710|NCT00003298|21103623|P1|Re-register to Step 2 After Surgery|Less than 15 nodes examined|7
6122711|NCT00003298|21103623|P1|Surgery|Unevaluable and off study|2
6122712|NCT00003298|21103623|P1|Surgery|Progression before surgery|2
6122713|NCT00003298|21103623|P1|Surgery|Unresectable at surgery|3
6122714|NCT00003298|21103623|P1|Step 1 (Neoadjuvant Therapy)|Adverse Event|3
6122715|NCT00003298|21103623|P1|Step 1 (Neoadjuvant Therapy)|Ineligible for step 1|1
6122716|NCT00076336|21103633|P2|Overall Study|Treatment failure|5
6122717|NCT00076336|21103634|P1|Overall Study|Treatment failure|4
6122718|NCT00076336|21103633|P2|Overall Study|Virologic Breakthrough|16
6122719|NCT00076336|21103634|P1|Overall Study|Virologic Breakthrough|14
6122720|NCT00076336|21103633|P2|Overall Study|Liver Transplantation|3
6122721|NCT00076336|21103634|P1|Overall Study|Liver Transplantation|3
6122722|NCT00076336|21103633|P2|Overall Study|Patient, Investigator, Sponsor request|6
6122723|NCT00076336|21103634|P1|Overall Study|Patient, Investigator, Sponsor request|8
6122724|NCT00076336|21103633|P2|Overall Study|Creatinine Clearance < 30 or Dialysis|1
6122725|NCT00076336|21103634|P1|Overall Study|Creatinine Clearance < 30 or Dialysis|0
6122726|NCT00076336|21103633|P2|Overall Study|Non-Compliance|0
6122727|NCT00076336|21103634|P1|Overall Study|Non-Compliance|2
6122728|NCT00076336|21103633|P2|Overall Study|Lost to Follow-up|4
6122729|NCT00076336|21103634|P1|Overall Study|Lost to Follow-up|4
6122730|NCT00076336|21103633|P2|Overall Study|Adverse Event|4
6122731|NCT00076336|21103634|P1|Overall Study|Adverse Event|4
6122732|NCT00076336|21103633|P2|Overall Study|Death|17
6122733|NCT00076336|21103634|P1|Overall Study|Death|13
6122734|NCT00076102|21103687|P1|Overall Study|refusal of further therapy|2
6122735|NCT00076102|21103687|P1|Overall Study|plexiform neurofibroma surgery|1
6122736|NCT00076102|21103687|P1|Overall Study|Progression in pre-existing brain tumor|1
6122737|NCT00076102|21103687|P1|Overall Study|Clinical progression|1
6122738|NCT00076024|21103715|P4|Phase 2, Open-label|Other|2
6122739|NCT00076024|21103716|P3|Phase 2, Open-label|Other|0
6122740|NCT00076024|21103717|P2|Phase 2, Open-label|Other|0
6122741|NCT00076024|21103718|P1|Phase 2, Open-label|Other|0
6122742|NCT00076024|21103715|P4|Phase 2, Open-label|Withdrawal by Subject|1
6122743|NCT00076024|21103716|P3|Phase 2, Open-label|Withdrawal by Subject|0
6122744|NCT00076024|21103717|P2|Phase 2, Open-label|Withdrawal by Subject|0
6122745|NCT00076024|21103718|P1|Phase 2, Open-label|Withdrawal by Subject|0
6122746|NCT00076024|21103715|P4|Phase 2, Open-label|Lack of Efficacy|11
6122747|NCT00076024|21103716|P3|Phase 2, Open-label|Lack of Efficacy|0
6122748|NCT00076024|21103717|P2|Phase 2, Open-label|Lack of Efficacy|0
6122749|NCT00076024|21103718|P1|Phase 2, Open-label|Lack of Efficacy|0
6122750|NCT00076024|21103715|P4|Phase 2, Open-label|Adverse Event|2
6122751|NCT00076024|21103716|P3|Phase 2, Open-label|Adverse Event|0
6122752|NCT00076024|21103717|P2|Phase 2, Open-label|Adverse Event|0
6122753|NCT00076024|21103718|P1|Phase 2, Open-label|Adverse Event|0
6122754|NCT00076024|21103715|P4|Phase 2, Double-blind|Randomized but not treated|0
6122755|NCT00076024|21103716|P3|Phase 2, Double-blind|Randomized but not treated|0
6122756|NCT00076024|21103717|P2|Phase 2, Double-blind|Randomized but not treated|1
6122757|NCT00076024|21103718|P1|Phase 2, Double-blind|Randomized but not treated|0
6122758|NCT00076024|21103715|P4|Phase 2, Double-blind|Un-specified|0
6122759|NCT00076024|21103716|P3|Phase 2, Double-blind|Un-specified|6
6122760|NCT00076024|21103717|P2|Phase 2, Double-blind|Un-specified|14
6122761|NCT00076024|21103718|P1|Phase 2, Double-blind|Un-specified|0
6122762|NCT00076024|21103715|P4|Phase 2, Double-blind|Adverse Event|0
6122763|NCT00076024|21103716|P3|Phase 2, Double-blind|Adverse Event|6
6122764|NCT00076024|21103717|P2|Phase 2, Double-blind|Adverse Event|25
6122765|NCT00076024|21103718|P1|Phase 2, Double-blind|Adverse Event|0
6122766|NCT00076024|21103715|P4|Phase 2, Double-blind|Withdrawal by Subject|0
6122767|NCT00076024|21103716|P3|Phase 2, Double-blind|Withdrawal by Subject|4
6122768|NCT00076024|21103717|P2|Phase 2, Double-blind|Withdrawal by Subject|13
6122769|NCT00076024|21103718|P1|Phase 2, Double-blind|Withdrawal by Subject|0
6122770|NCT00076024|21103715|P4|Phase 2, Double-blind|Lack of Efficacy|0
6122771|NCT00076024|21103716|P3|Phase 2, Double-blind|Lack of Efficacy|40
6122772|NCT00076024|21103717|P2|Phase 2, Double-blind|Lack of Efficacy|59
6122773|NCT00076024|21103718|P1|Phase 2, Double-blind|Lack of Efficacy|0
6122774|NCT00076024|21103715|P4|Phase 1, Lead-in|Clinical progression|0
6122775|NCT00076024|21103716|P3|Phase 1, Lead-in|Clinical progression|0
6122776|NCT00076024|21103717|P2|Phase 1, Lead-in|Clinical progression|0
6122777|NCT00076024|21103718|P1|Phase 1, Lead-in|Clinical progression|1
6122778|NCT00076024|21103715|P4|Phase 1, Lead-in|Adverse Event|0
6122779|NCT00076024|21103716|P3|Phase 1, Lead-in|Adverse Event|0
6122780|NCT00076024|21103717|P2|Phase 1, Lead-in|Adverse Event|0
6122781|NCT00076024|21103718|P1|Phase 1, Lead-in|Adverse Event|1
6122782|NCT00076024|21103715|P4|Phase 1, Lead-in|Lack of Efficacy|0
6122783|NCT00076024|21103716|P3|Phase 1, Lead-in|Lack of Efficacy|0
6122784|NCT00076024|21103717|P2|Phase 1, Lead-in|Lack of Efficacy|0
6122785|NCT00076024|21103718|P1|Phase 1, Lead-in|Lack of Efficacy|4
6122786|NCT00076011|21103732|P1|Overall Study|Ongoing|1
6122787|NCT00076011|21103732|P1|Overall Study|Other|11
6122788|NCT00076011|21103732|P1|Overall Study|Study terminated by sponsor|3
6122789|NCT00076011|21103732|P1|Overall Study|Withdrawal by Subject|1
6122790|NCT00076011|21103732|P1|Overall Study|Lack of Efficacy|25
6122791|NCT00076011|21103732|P1|Overall Study|Adverse Event|10
6122792|NCT00076011|21103732|P1|Overall Study|Death|1
6122793|NCT00075946|21103744|P5|Overall Study|Other|0
6122794|NCT00075946|21103745|P4|Overall Study|Other|2
6122795|NCT00075946|21103746|P3|Overall Study|Other|0
6122796|NCT00075946|21103747|P2|Overall Study|Other|13
6122797|NCT00075946|21103748|P1|Overall Study|Other|5
6122798|NCT00075946|21103744|P5|Overall Study|Time to progression less than 6 months|0
6122799|NCT00075946|21103745|P4|Overall Study|Time to progression less than 6 months|3
6122800|NCT00075946|21103746|P3|Overall Study|Time to progression less than 6 months|8
6122801|NCT00075946|21103747|P2|Overall Study|Time to progression less than 6 months|30
6122802|NCT00075946|21103748|P1|Overall Study|Time to progression less than 6 months|15
6122803|NCT00075946|21103744|P5|Overall Study|No response to retreatment|0
6122804|NCT00075946|21103745|P4|Overall Study|No response to retreatment|0
6122805|NCT00075946|21103746|P3|Overall Study|No response to retreatment|2
6122806|NCT00075946|21103747|P2|Overall Study|No response to retreatment|0
6122807|NCT00075946|21103748|P1|Overall Study|No response to retreatment|23
6122808|NCT00075946|21103744|P5|Overall Study|Other complicating disease|0
6122809|NCT00075946|21103745|P4|Overall Study|Other complicating disease|4
6122810|NCT00075946|21103746|P3|Overall Study|Other complicating disease|1
6122811|NCT00075946|21103747|P2|Overall Study|Other complicating disease|13
6122812|NCT00075946|21103748|P1|Overall Study|Other complicating disease|7
6122813|NCT00075946|21103744|P5|Overall Study|Alternative therapy|0
6122814|NCT00075946|21103745|P4|Overall Study|Alternative therapy|0
6122815|NCT00075946|21103746|P3|Overall Study|Alternative therapy|5
6122816|NCT00075946|21103747|P2|Overall Study|Alternative therapy|2
6122817|NCT00075946|21103748|P1|Overall Study|Alternative therapy|16
6122818|NCT00075946|21103744|P5|Overall Study|Withdrawal by Subject|0
6122819|NCT00075946|21103745|P4|Overall Study|Withdrawal by Subject|9
6122820|NCT00075946|21103746|P3|Overall Study|Withdrawal by Subject|4
6122821|NCT00075946|21103747|P2|Overall Study|Withdrawal by Subject|58
6122822|NCT00075946|21103748|P1|Overall Study|Withdrawal by Subject|23
6122823|NCT00075946|21103744|P5|Overall Study|Death|0
6122824|NCT00075946|21103745|P4|Overall Study|Death|0
6122825|NCT00075946|21103746|P3|Overall Study|Death|0
6122826|NCT00075946|21103747|P2|Overall Study|Death|1
6122827|NCT00075946|21103748|P1|Overall Study|Death|0
6122828|NCT00075946|21103744|P5|Overall Study|Adverse Event|0
6122829|NCT00075946|21103745|P4|Overall Study|Adverse Event|2
6122830|NCT00075946|21103746|P3|Overall Study|Adverse Event|0
6122831|NCT00075946|21103747|P2|Overall Study|Adverse Event|10
6122832|NCT00075946|21103748|P1|Overall Study|Adverse Event|2
6122833|NCT00075946|21103744|P5|Overall Study|Still on treatment at time of analysis|0
6122834|NCT00075946|21103745|P4|Overall Study|Still on treatment at time of analysis|9
6122835|NCT00075946|21103746|P3|Overall Study|Still on treatment at time of analysis|3
6122836|NCT00075946|21103747|P2|Overall Study|Still on treatment at time of analysis|19
6122837|NCT00075946|21103748|P1|Overall Study|Still on treatment at time of analysis|52
6122838|NCT00075946|21103744|P5|Overall Study|Incorrectly randomized (no response)|0
6122839|NCT00075946|21103745|P4|Overall Study|Incorrectly randomized (no response)|1
6122840|NCT00075946|21103746|P3|Overall Study|Incorrectly randomized (no response)|5
6122841|NCT00075946|21103747|P2|Overall Study|Incorrectly randomized (no response)|5
6122842|NCT00075946|21103748|P1|Overall Study|Incorrectly randomized (no response)|5
6122843|NCT00075946|21103744|P5|Overall Study|Did not achieve response after induction|182
6122844|NCT00075946|21103745|P4|Overall Study|Did not achieve response after induction|0
6122845|NCT00075946|21103746|P3|Overall Study|Did not achieve response after induction|0
6122846|NCT00075946|21103747|P2|Overall Study|Did not achieve response after induction|0
6122847|NCT00075946|21103748|P1|Overall Study|Did not achieve response after induction|0
6122848|NCT00075946|21103744|P5|Overall Study|Path ineligible: undetermined histology|6
6122849|NCT00075946|21103745|P4|Overall Study|Path ineligible: undetermined histology|0
6122850|NCT00075946|21103746|P3|Overall Study|Path ineligible: undetermined histology|0
6122851|NCT00075946|21103747|P2|Overall Study|Path ineligible: undetermined histology|0
6122852|NCT00075946|21103748|P1|Overall Study|Path ineligible: undetermined histology|0
6122853|NCT00075881|21103763|P1|Overall Study|never start protocol therapy|1
6122854|NCT00075881|21103763|P1|Overall Study|Ineligible|1
6122855|NCT00075881|21103763|P1|Overall Study|missing data|2
6122856|NCT00075881|21103763|P1|Overall Study|other|4
6122857|NCT00075881|21103763|P1|Overall Study|other complicating disease|3
6122858|NCT00075881|21103763|P1|Overall Study|Protocol Violation|4
6122859|NCT00075881|21103763|P1|Overall Study|Withdrawal by Subject|2
6122860|NCT00075881|21103763|P1|Overall Study|Death|1
6122861|NCT00075881|21103763|P1|Overall Study|Adverse Event|7
6122862|NCT00075881|21103763|P1|Overall Study|Lack of Efficacy|18
6122863|NCT00075816|21103807|P2|Overall Study|Did not undergo transplantation|11
6122864|NCT00075816|21103808|P1|Overall Study|Did not undergo transplantation|14
6122865|NCT00075764|21103877|P2|Overall Study|Under review|1
6122866|NCT00075764|21103878|P1|Overall Study|Under review|0
6122867|NCT00075764|21103877|P2|Overall Study|Not protocol specified|19
6122868|NCT00075764|21103878|P1|Overall Study|Not protocol specified|27
6122869|NCT00075764|21103877|P2|Overall Study|Delinquent|2
6122870|NCT00075764|21103878|P1|Overall Study|Delinquent|4
6122871|NCT00075764|21103877|P2|Overall Study|Still on treatment|15
6122872|NCT00075764|21103878|P1|Overall Study|Still on treatment|8
6122873|NCT00075764|21103877|P2|Overall Study|Progression|274
6122874|NCT00075764|21103878|P1|Overall Study|Progression|269
6122875|NCT00075764|21103877|P2|Overall Study|Withdrawal by Subject|18
6122876|NCT00075764|21103878|P1|Overall Study|Withdrawal by Subject|28
6122877|NCT00075764|21103877|P2|Overall Study|Death|8
6122878|NCT00075764|21103878|P1|Overall Study|Death|4
6122879|NCT00075764|21103877|P2|Overall Study|Adverse Event|12
6122880|NCT00075764|21103878|P1|Overall Study|Adverse Event|5
6122881|NCT00075725|21103902|P12|Overall Study|Pt incarcerated|0
6122882|NCT00075725|21103903|P11|Overall Study|Pt incarcerated|0
6122883|NCT00075725|21103904|P10|Overall Study|Pt incarcerated|0
6122884|NCT00075725|21103905|P9|Overall Study|Pt incarcerated|0
6122885|NCT00075725|21103906|P8|Overall Study|Pt incarcerated|1
6122886|NCT00075725|21103907|P7|Overall Study|Pt incarcerated|0
6122887|NCT00075725|21103908|P6|Overall Study|Pt incarcerated|0
6122888|NCT00075725|21103909|P5|Overall Study|Pt incarcerated|0
6122889|NCT00075725|21103910|P4|Overall Study|Pt incarcerated|0
6122890|NCT00075725|21103911|P3|Overall Study|Pt incarcerated|0
6122891|NCT00075725|21103912|P2|Overall Study|Pt incarcerated|0
6122892|NCT00075725|21103913|P1|Overall Study|Pt incarcerated|0
6122893|NCT00075725|21103902|P12|Overall Study|Pt care terminated due to pt behavior|0
6122894|NCT00075725|21103903|P11|Overall Study|Pt care terminated due to pt behavior|0
6122895|NCT00075725|21103904|P10|Overall Study|Pt care terminated due to pt behavior|0
6122896|NCT00075725|21103905|P9|Overall Study|Pt care terminated due to pt behavior|0
6122897|NCT00075725|21103906|P8|Overall Study|Pt care terminated due to pt behavior|1
6122898|NCT00075725|21103907|P7|Overall Study|Pt care terminated due to pt behavior|0
6122899|NCT00075725|21103908|P6|Overall Study|Pt care terminated due to pt behavior|0
6122900|NCT00075725|21103909|P5|Overall Study|Pt care terminated due to pt behavior|0
6122901|NCT00075725|21103910|P4|Overall Study|Pt care terminated due to pt behavior|0
6122902|NCT00075725|21103911|P3|Overall Study|Pt care terminated due to pt behavior|0
6122903|NCT00075725|21103912|P2|Overall Study|Pt care terminated due to pt behavior|0
6122904|NCT00075725|21103913|P1|Overall Study|Pt care terminated due to pt behavior|0
6122905|NCT00075725|21103902|P12|Overall Study|Other complications|0
6122906|NCT00075725|21103903|P11|Overall Study|Other complications|0
6122907|NCT00075725|21103904|P10|Overall Study|Other complications|0
6122908|NCT00075725|21103905|P9|Overall Study|Other complications|0
6122909|NCT00075725|21103906|P8|Overall Study|Other complications|0
6122910|NCT00075725|21103907|P7|Overall Study|Other complications|0
6122911|NCT00075725|21103908|P6|Overall Study|Other complications|1
6122912|NCT00075725|21103909|P5|Overall Study|Other complications|0
6122913|NCT00075725|21103910|P4|Overall Study|Other complications|0
6122914|NCT00075725|21103911|P3|Overall Study|Other complications|0
6122915|NCT00075725|21103912|P2|Overall Study|Other complications|0
6122916|NCT00075725|21103913|P1|Overall Study|Other complications|0
6122917|NCT00075725|21103902|P12|Overall Study|Study Closure|0
6122918|NCT00075725|21103903|P11|Overall Study|Study Closure|0
6122919|NCT00075725|21103904|P10|Overall Study|Study Closure|0
6122920|NCT00075725|21103905|P9|Overall Study|Study Closure|0
6122921|NCT00075725|21103906|P8|Overall Study|Study Closure|1
6122922|NCT00075725|21103907|P7|Overall Study|Study Closure|0
6122923|NCT00075725|21103908|P6|Overall Study|Study Closure|3
6122924|NCT00075725|21103909|P5|Overall Study|Study Closure|1
6122925|NCT00075725|21103910|P4|Overall Study|Study Closure|0
6122926|NCT00075725|21103911|P3|Overall Study|Study Closure|0
6122927|NCT00075725|21103912|P2|Overall Study|Study Closure|0
6122928|NCT00075725|21103913|P1|Overall Study|Study Closure|1
6122929|NCT00075725|21103902|P12|Overall Study|Institution Terminated|0
6122930|NCT00075725|21103903|P11|Overall Study|Institution Terminated|0
6122931|NCT00075725|21103904|P10|Overall Study|Institution Terminated|0
6122932|NCT00075725|21103905|P9|Overall Study|Institution Terminated|0
6122933|NCT00075725|21103906|P8|Overall Study|Institution Terminated|3
6122934|NCT00075725|21103907|P7|Overall Study|Institution Terminated|0
6122935|NCT00075725|21103908|P6|Overall Study|Institution Terminated|0
6122936|NCT00075725|21103909|P5|Overall Study|Institution Terminated|1
6122937|NCT00075725|21103910|P4|Overall Study|Institution Terminated|0
6122938|NCT00075725|21103911|P3|Overall Study|Institution Terminated|0
6122939|NCT00075725|21103912|P2|Overall Study|Institution Terminated|0
6122940|NCT00075725|21103913|P1|Overall Study|Institution Terminated|0
6122941|NCT00075725|21103902|P12|Overall Study|Pt relocated|0
6122942|NCT00075725|21103903|P11|Overall Study|Pt relocated|0
6122943|NCT00075725|21103904|P10|Overall Study|Pt relocated|0
6122944|NCT00075725|21103905|P9|Overall Study|Pt relocated|1
6122945|NCT00075725|21103906|P8|Overall Study|Pt relocated|2
6122946|NCT00075725|21103907|P7|Overall Study|Pt relocated|1
6122947|NCT00075725|21103908|P6|Overall Study|Pt relocated|1
6122948|NCT00075725|21103909|P5|Overall Study|Pt relocated|0
6122949|NCT00075725|21103910|P4|Overall Study|Pt relocated|2
6122950|NCT00075725|21103911|P3|Overall Study|Pt relocated|0
6122951|NCT00075725|21103912|P2|Overall Study|Pt relocated|0
6122952|NCT00075725|21103913|P1|Overall Study|Pt relocated|0
6122953|NCT00075725|21103902|P12|Overall Study|Pt received additional steroids|0
6122954|NCT00075725|21103903|P11|Overall Study|Pt received additional steroids|0
6122955|NCT00075725|21103904|P10|Overall Study|Pt received additional steroids|0
6122956|NCT00075725|21103905|P9|Overall Study|Pt received additional steroids|0
6122957|NCT00075725|21103906|P8|Overall Study|Pt received additional steroids|0
6122958|NCT00075725|21103907|P7|Overall Study|Pt received additional steroids|0
6122959|NCT00075725|21103908|P6|Overall Study|Pt received additional steroids|0
6122960|NCT00075725|21103909|P5|Overall Study|Pt received additional steroids|0
6122961|NCT00075725|21103910|P4|Overall Study|Pt received additional steroids|1
6122962|NCT00075725|21103911|P3|Overall Study|Pt received additional steroids|0
6122963|NCT00075725|21103912|P2|Overall Study|Pt received additional steroids|0
6122964|NCT00075725|21103913|P1|Overall Study|Pt received additional steroids|0
6122965|NCT00075725|21103902|P12|Overall Study|Pt went to transplant|0
6122966|NCT00075725|21103903|P11|Overall Study|Pt went to transplant|0
6122967|NCT00075725|21103904|P10|Overall Study|Pt went to transplant|0
6122968|NCT00075725|21103905|P9|Overall Study|Pt went to transplant|0
6122969|NCT00075725|21103906|P8|Overall Study|Pt went to transplant|0
6122970|NCT00075725|21103907|P7|Overall Study|Pt went to transplant|0
6122971|NCT00075725|21103908|P6|Overall Study|Pt went to transplant|1
6122972|NCT00075725|21103909|P5|Overall Study|Pt went to transplant|0
6122973|NCT00075725|21103910|P4|Overall Study|Pt went to transplant|1
6122974|NCT00075725|21103911|P3|Overall Study|Pt went to transplant|0
6122975|NCT00075725|21103912|P2|Overall Study|Pt went to transplant|0
6122976|NCT00075725|21103913|P1|Overall Study|Pt went to transplant|0
6122977|NCT00075725|21103902|P12|Overall Study|specimen(s) not submitted|0
6122978|NCT00075725|21103903|P11|Overall Study|specimen(s) not submitted|0
6122979|NCT00075725|21103904|P10|Overall Study|specimen(s) not submitted|0
6122980|NCT00075725|21103905|P9|Overall Study|specimen(s) not submitted|0
6122981|NCT00075725|21103906|P8|Overall Study|specimen(s) not submitted|0
6122982|NCT00075725|21103907|P7|Overall Study|specimen(s) not submitted|0
6122983|NCT00075725|21103908|P6|Overall Study|specimen(s) not submitted|0
6122984|NCT00075725|21103909|P5|Overall Study|specimen(s) not submitted|0
6122985|NCT00075725|21103910|P4|Overall Study|specimen(s) not submitted|0
6122986|NCT00075725|21103911|P3|Overall Study|specimen(s) not submitted|2
6122987|NCT00075725|21103912|P2|Overall Study|specimen(s) not submitted|0
6122988|NCT00075725|21103913|P1|Overall Study|specimen(s) not submitted|0
6122989|NCT00075725|21103902|P12|Overall Study|Unsuccessful institutional transfer|0
6122990|NCT00075725|21103903|P11|Overall Study|Unsuccessful institutional transfer|0
6122991|NCT00075725|21103904|P10|Overall Study|Unsuccessful institutional transfer|1
6122992|NCT00075725|21103905|P9|Overall Study|Unsuccessful institutional transfer|0
6122993|NCT00075725|21103906|P8|Overall Study|Unsuccessful institutional transfer|0
6122994|NCT00075725|21103907|P7|Overall Study|Unsuccessful institutional transfer|0
6122995|NCT00075725|21103908|P6|Overall Study|Unsuccessful institutional transfer|0
6122996|NCT00075725|21103909|P5|Overall Study|Unsuccessful institutional transfer|0
6122997|NCT00075725|21103910|P4|Overall Study|Unsuccessful institutional transfer|0
6122998|NCT00075725|21103911|P3|Overall Study|Unsuccessful institutional transfer|2
6122999|NCT00075725|21103912|P2|Overall Study|Unsuccessful institutional transfer|0
6123000|NCT00075725|21103913|P1|Overall Study|Unsuccessful institutional transfer|0
6123001|NCT00075725|21103902|P12|Overall Study|Clinic chart lost unable to recreate|0
6123002|NCT00075725|21103903|P11|Overall Study|Clinic chart lost unable to recreate|0
6123003|NCT00075725|21103904|P10|Overall Study|Clinic chart lost unable to recreate|0
6123004|NCT00075725|21103905|P9|Overall Study|Clinic chart lost unable to recreate|0
6123005|NCT00075725|21103906|P8|Overall Study|Clinic chart lost unable to recreate|0
6123006|NCT00075725|21103907|P7|Overall Study|Clinic chart lost unable to recreate|0
6123007|NCT00075725|21103908|P6|Overall Study|Clinic chart lost unable to recreate|0
6123008|NCT00075725|21103909|P5|Overall Study|Clinic chart lost unable to recreate|0
6123009|NCT00075725|21103910|P4|Overall Study|Clinic chart lost unable to recreate|0
6123010|NCT00075725|21103911|P3|Overall Study|Clinic chart lost unable to recreate|1
6123011|NCT00075725|21103912|P2|Overall Study|Clinic chart lost unable to recreate|0
6123012|NCT00075725|21103913|P1|Overall Study|Clinic chart lost unable to recreate|0
6123013|NCT00075725|21103902|P12|Overall Study|Pt trying to find a BM donor|0
6123014|NCT00075725|21103903|P11|Overall Study|Pt trying to find a BM donor|0
6123015|NCT00075725|21103904|P10|Overall Study|Pt trying to find a BM donor|0
6123016|NCT00075725|21103905|P9|Overall Study|Pt trying to find a BM donor|0
6123017|NCT00075725|21103906|P8|Overall Study|Pt trying to find a BM donor|0
6123018|NCT00075725|21103907|P7|Overall Study|Pt trying to find a BM donor|0
6123019|NCT00075725|21103908|P6|Overall Study|Pt trying to find a BM donor|0
6123020|NCT00075725|21103909|P5|Overall Study|Pt trying to find a BM donor|0
6123021|NCT00075725|21103910|P4|Overall Study|Pt trying to find a BM donor|0
6123022|NCT00075725|21103911|P3|Overall Study|Pt trying to find a BM donor|0
6123023|NCT00075725|21103912|P2|Overall Study|Pt trying to find a BM donor|1
6123024|NCT00075725|21103913|P1|Overall Study|Pt trying to find a BM donor|0
6123025|NCT00075725|21103902|P12|Overall Study|Other|3
6123026|NCT00075725|21103903|P11|Overall Study|Other|0
6123027|NCT00075725|21103904|P10|Overall Study|Other|1
6123028|NCT00075725|21103905|P9|Overall Study|Other|2
6123029|NCT00075725|21103906|P8|Overall Study|Other|9
6123030|NCT00075725|21103907|P7|Overall Study|Other|2
6123031|NCT00075725|21103908|P6|Overall Study|Other|4
6123032|NCT00075725|21103909|P5|Overall Study|Other|1
6123033|NCT00075725|21103910|P4|Overall Study|Other|1
6123034|NCT00075725|21103911|P3|Overall Study|Other|1
6123035|NCT00075725|21103912|P2|Overall Study|Other|2
6123036|NCT00075725|21103913|P1|Overall Study|Other|4
6123037|NCT00075725|21103902|P12|Overall Study|Inevaluable|0
6123038|NCT00075725|21103903|P11|Overall Study|Inevaluable|1
6123039|NCT00075725|21103904|P10|Overall Study|Inevaluable|0
6123040|NCT00075725|21103905|P9|Overall Study|Inevaluable|2
6123041|NCT00075725|21103906|P8|Overall Study|Inevaluable|11
6123042|NCT00075725|21103907|P7|Overall Study|Inevaluable|1
6123043|NCT00075725|21103908|P6|Overall Study|Inevaluable|9
6123044|NCT00075725|21103909|P5|Overall Study|Inevaluable|2
6123045|NCT00075725|21103910|P4|Overall Study|Inevaluable|2
6123046|NCT00075725|21103911|P3|Overall Study|Inevaluable|4
6123047|NCT00075725|21103912|P2|Overall Study|Inevaluable|1
6123048|NCT00075725|21103913|P1|Overall Study|Inevaluable|1
6123049|NCT00075725|21103902|P12|Overall Study|Pt has very high risk ALL characteristic|3
6123050|NCT00075725|21103903|P11|Overall Study|Pt has very high risk ALL characteristic|0
6123051|NCT00075725|21103904|P10|Overall Study|Pt has very high risk ALL characteristic|1
6123052|NCT00075725|21103905|P9|Overall Study|Pt has very high risk ALL characteristic|29
6123053|NCT00075725|21103906|P8|Overall Study|Pt has very high risk ALL characteristic|74
6123054|NCT00075725|21103907|P7|Overall Study|Pt has very high risk ALL characteristic|23
6123055|NCT00075725|21103908|P6|Overall Study|Pt has very high risk ALL characteristic|75
6123056|NCT00075725|21103909|P5|Overall Study|Pt has very high risk ALL characteristic|11
6123057|NCT00075725|21103910|P4|Overall Study|Pt has very high risk ALL characteristic|18
6123058|NCT00075725|21103911|P3|Overall Study|Pt has very high risk ALL characteristic|26
6123059|NCT00075725|21103912|P2|Overall Study|Pt has very high risk ALL characteristic|11
6123060|NCT00075725|21103913|P1|Overall Study|Pt has very high risk ALL characteristic|15
6123061|NCT00075725|21103902|P12|Overall Study|MRD positive after extended ind|0
6123062|NCT00075725|21103903|P11|Overall Study|MRD positive after extended ind|0
6123063|NCT00075725|21103904|P10|Overall Study|MRD positive after extended ind|0
6123064|NCT00075725|21103905|P9|Overall Study|MRD positive after extended ind|0
6123065|NCT00075725|21103906|P8|Overall Study|MRD positive after extended ind|1
6123066|NCT00075725|21103907|P7|Overall Study|MRD positive after extended ind|0
6123067|NCT00075725|21103908|P6|Overall Study|MRD positive after extended ind|2
6123068|NCT00075725|21103909|P5|Overall Study|MRD positive after extended ind|1
6123069|NCT00075725|21103910|P4|Overall Study|MRD positive after extended ind|0
6123070|NCT00075725|21103911|P3|Overall Study|MRD positive after extended ind|1
6123071|NCT00075725|21103912|P2|Overall Study|MRD positive after extended ind|1
6123072|NCT00075725|21103913|P1|Overall Study|MRD positive after extended ind|0
6123073|NCT00075725|21103902|P12|Overall Study|Insurance issues|0
6123074|NCT00075725|21103903|P11|Overall Study|Insurance issues|0
6123075|NCT00075725|21103904|P10|Overall Study|Insurance issues|0
6123076|NCT00075725|21103905|P9|Overall Study|Insurance issues|0
6123077|NCT00075725|21103906|P8|Overall Study|Insurance issues|1
6123078|NCT00075725|21103907|P7|Overall Study|Insurance issues|0
6123079|NCT00075725|21103908|P6|Overall Study|Insurance issues|1
6123080|NCT00075725|21103909|P5|Overall Study|Insurance issues|1
6123081|NCT00075725|21103910|P4|Overall Study|Insurance issues|1
6123082|NCT00075725|21103911|P3|Overall Study|Insurance issues|0
6123083|NCT00075725|21103912|P2|Overall Study|Insurance issues|1
6123084|NCT00075725|21103913|P1|Overall Study|Insurance issues|0
6123085|NCT00075725|21103902|P12|Overall Study|Pt age out of range for treatment|0
6123086|NCT00075725|21103903|P11|Overall Study|Pt age out of range for treatment|0
6123087|NCT00075725|21103904|P10|Overall Study|Pt age out of range for treatment|0
6123088|NCT00075725|21103905|P9|Overall Study|Pt age out of range for treatment|0
6123089|NCT00075725|21103906|P8|Overall Study|Pt age out of range for treatment|1
6123090|NCT00075725|21103907|P7|Overall Study|Pt age out of range for treatment|0
6123091|NCT00075725|21103908|P6|Overall Study|Pt age out of range for treatment|1
6123092|NCT00075725|21103909|P5|Overall Study|Pt age out of range for treatment|0
6123093|NCT00075725|21103910|P4|Overall Study|Pt age out of range for treatment|0
6123094|NCT00075725|21103911|P3|Overall Study|Pt age out of range for treatment|0
6123095|NCT00075725|21103912|P2|Overall Study|Pt age out of range for treatment|1
6123096|NCT00075725|21103913|P1|Overall Study|Pt age out of range for treatment|0
6123097|NCT00075725|21103902|P12|Overall Study|Pt non compliant with therapy|0
6123098|NCT00075725|21103903|P11|Overall Study|Pt non compliant with therapy|0
6123099|NCT00075725|21103904|P10|Overall Study|Pt non compliant with therapy|0
6123100|NCT00075725|21103905|P9|Overall Study|Pt non compliant with therapy|3
6123101|NCT00075725|21103906|P8|Overall Study|Pt non compliant with therapy|5
6123102|NCT00075725|21103907|P7|Overall Study|Pt non compliant with therapy|2
6123103|NCT00075725|21103908|P6|Overall Study|Pt non compliant with therapy|14
6123104|NCT00075725|21103909|P5|Overall Study|Pt non compliant with therapy|2
6123105|NCT00075725|21103910|P4|Overall Study|Pt non compliant with therapy|0
6123106|NCT00075725|21103911|P3|Overall Study|Pt non compliant with therapy|1
6123107|NCT00075725|21103912|P2|Overall Study|Pt non compliant with therapy|1
6123108|NCT00075725|21103913|P1|Overall Study|Pt non compliant with therapy|2
6123109|NCT00075725|21103902|P12|Overall Study|Pt/Guardian refused RT therapy|0
6123110|NCT00075725|21103903|P11|Overall Study|Pt/Guardian refused RT therapy|0
6123111|NCT00075725|21103904|P10|Overall Study|Pt/Guardian refused RT therapy|0
6123112|NCT00075725|21103905|P9|Overall Study|Pt/Guardian refused RT therapy|0
6123113|NCT00075725|21103906|P8|Overall Study|Pt/Guardian refused RT therapy|0
6123114|NCT00075725|21103907|P7|Overall Study|Pt/Guardian refused RT therapy|0
6123115|NCT00075725|21103908|P6|Overall Study|Pt/Guardian refused RT therapy|0
6123116|NCT00075725|21103909|P5|Overall Study|Pt/Guardian refused RT therapy|1
6123117|NCT00075725|21103910|P4|Overall Study|Pt/Guardian refused RT therapy|2
6123118|NCT00075725|21103911|P3|Overall Study|Pt/Guardian refused RT therapy|1
6123119|NCT00075725|21103912|P2|Overall Study|Pt/Guardian refused RT therapy|0
6123120|NCT00075725|21103913|P1|Overall Study|Pt/Guardian refused RT therapy|1
6123121|NCT00075725|21103902|P12|Overall Study|Ineligible or wrong diagnosis|4
6123122|NCT00075725|21103903|P11|Overall Study|Ineligible or wrong diagnosis|2
6123123|NCT00075725|21103904|P10|Overall Study|Ineligible or wrong diagnosis|1
6123124|NCT00075725|21103905|P9|Overall Study|Ineligible or wrong diagnosis|10
6123125|NCT00075725|21103906|P8|Overall Study|Ineligible or wrong diagnosis|9
6123126|NCT00075725|21103907|P7|Overall Study|Ineligible or wrong diagnosis|6
6123127|NCT00075725|21103908|P6|Overall Study|Ineligible or wrong diagnosis|17
6123128|NCT00075725|21103909|P5|Overall Study|Ineligible or wrong diagnosis|3
6123129|NCT00075725|21103910|P4|Overall Study|Ineligible or wrong diagnosis|10
6123130|NCT00075725|21103911|P3|Overall Study|Ineligible or wrong diagnosis|3
6123131|NCT00075725|21103912|P2|Overall Study|Ineligible or wrong diagnosis|3
6123132|NCT00075725|21103913|P1|Overall Study|Ineligible or wrong diagnosis|8
6123133|NCT00075725|21103902|P12|Overall Study|Patient off treatment|0
6123134|NCT00075725|21103903|P11|Overall Study|Patient off treatment|0
6123135|NCT00075725|21103904|P10|Overall Study|Patient off treatment|0
6123136|NCT00075725|21103905|P9|Overall Study|Patient off treatment|1
6123137|NCT00075725|21103906|P8|Overall Study|Patient off treatment|2
6123138|NCT00075725|21103907|P7|Overall Study|Patient off treatment|0
6123139|NCT00075725|21103908|P6|Overall Study|Patient off treatment|0
6123140|NCT00075725|21103909|P5|Overall Study|Patient off treatment|1
6123141|NCT00075725|21103910|P4|Overall Study|Patient off treatment|2
6123142|NCT00075725|21103911|P3|Overall Study|Patient off treatment|1
6123143|NCT00075725|21103912|P2|Overall Study|Patient off treatment|0
6123144|NCT00075725|21103913|P1|Overall Study|Patient off treatment|0
6123145|NCT00075725|21103902|P12|Overall Study|Disease Progression, all other reasons|5
6123146|NCT00075725|21103903|P11|Overall Study|Disease Progression, all other reasons|0
6123147|NCT00075725|21103904|P10|Overall Study|Disease Progression, all other reasons|4
6123148|NCT00075725|21103905|P9|Overall Study|Disease Progression, all other reasons|21
6123149|NCT00075725|21103906|P8|Overall Study|Disease Progression, all other reasons|46
6123150|NCT00075725|21103907|P7|Overall Study|Disease Progression, all other reasons|20
6123151|NCT00075725|21103908|P6|Overall Study|Disease Progression, all other reasons|59
6123152|NCT00075725|21103909|P5|Overall Study|Disease Progression, all other reasons|21
6123153|NCT00075725|21103910|P4|Overall Study|Disease Progression, all other reasons|6
6123154|NCT00075725|21103911|P3|Overall Study|Disease Progression, all other reasons|33
6123155|NCT00075725|21103912|P2|Overall Study|Disease Progression, all other reasons|5
6123156|NCT00075725|21103913|P1|Overall Study|Disease Progression, all other reasons|17
6123157|NCT00075725|21103902|P12|Overall Study|Withdrawal by Subject|0
6123158|NCT00075725|21103903|P11|Overall Study|Withdrawal by Subject|0
6123159|NCT00075725|21103904|P10|Overall Study|Withdrawal by Subject|2
6123160|NCT00075725|21103905|P9|Overall Study|Withdrawal by Subject|10
6123161|NCT00075725|21103906|P8|Overall Study|Withdrawal by Subject|31
6123162|NCT00075725|21103907|P7|Overall Study|Withdrawal by Subject|7
6123163|NCT00075725|21103908|P6|Overall Study|Withdrawal by Subject|27
6123164|NCT00075725|21103909|P5|Overall Study|Withdrawal by Subject|6
6123165|NCT00075725|21103910|P4|Overall Study|Withdrawal by Subject|10
6123166|NCT00075725|21103911|P3|Overall Study|Withdrawal by Subject|6
6123167|NCT00075725|21103912|P2|Overall Study|Withdrawal by Subject|3
6123168|NCT00075725|21103913|P1|Overall Study|Withdrawal by Subject|12
6123169|NCT00075725|21103902|P12|Overall Study|Protocol Violation|1
6123170|NCT00075725|21103903|P11|Overall Study|Protocol Violation|0
6123171|NCT00075725|21103904|P10|Overall Study|Protocol Violation|0
6123172|NCT00075725|21103905|P9|Overall Study|Protocol Violation|3
6123173|NCT00075725|21103906|P8|Overall Study|Protocol Violation|2
6123174|NCT00075725|21103907|P7|Overall Study|Protocol Violation|1
6123175|NCT00075725|21103908|P6|Overall Study|Protocol Violation|2
6123176|NCT00075725|21103909|P5|Overall Study|Protocol Violation|3
6123177|NCT00075725|21103910|P4|Overall Study|Protocol Violation|3
6123178|NCT00075725|21103911|P3|Overall Study|Protocol Violation|0
6123179|NCT00075725|21103912|P2|Overall Study|Protocol Violation|1
6123180|NCT00075725|21103913|P1|Overall Study|Protocol Violation|1
6123181|NCT00075725|21103902|P12|Overall Study|Pregnancy|0
6123182|NCT00075725|21103903|P11|Overall Study|Pregnancy|0
6123183|NCT00075725|21103904|P10|Overall Study|Pregnancy|0
6123184|NCT00075725|21103905|P9|Overall Study|Pregnancy|0
6123185|NCT00075725|21103906|P8|Overall Study|Pregnancy|1
6123186|NCT00075725|21103907|P7|Overall Study|Pregnancy|0
6123187|NCT00075725|21103908|P6|Overall Study|Pregnancy|1
6123188|NCT00075725|21103909|P5|Overall Study|Pregnancy|0
6123189|NCT00075725|21103910|P4|Overall Study|Pregnancy|0
6123190|NCT00075725|21103911|P3|Overall Study|Pregnancy|0
6123191|NCT00075725|21103912|P2|Overall Study|Pregnancy|0
6123192|NCT00075725|21103913|P1|Overall Study|Pregnancy|0
6123193|NCT00075725|21103902|P12|Overall Study|Physician Decision|0
6123194|NCT00075725|21103903|P11|Overall Study|Physician Decision|1
6123195|NCT00075725|21103904|P10|Overall Study|Physician Decision|0
6123196|NCT00075725|21103905|P9|Overall Study|Physician Decision|5
6123197|NCT00075725|21103906|P8|Overall Study|Physician Decision|17
6123198|NCT00075725|21103907|P7|Overall Study|Physician Decision|3
6123199|NCT00075725|21103908|P6|Overall Study|Physician Decision|19
6123200|NCT00075725|21103909|P5|Overall Study|Physician Decision|4
6123201|NCT00075725|21103910|P4|Overall Study|Physician Decision|8
6123202|NCT00075725|21103911|P3|Overall Study|Physician Decision|5
6123203|NCT00075725|21103912|P2|Overall Study|Physician Decision|6
6123204|NCT00075725|21103913|P1|Overall Study|Physician Decision|2
6123205|NCT00075725|21103902|P12|Overall Study|Lost to Follow-up|0
6123206|NCT00075725|21103903|P11|Overall Study|Lost to Follow-up|0
6123207|NCT00075725|21103904|P10|Overall Study|Lost to Follow-up|0
6123208|NCT00075725|21103905|P9|Overall Study|Lost to Follow-up|1
6123209|NCT00075725|21103906|P8|Overall Study|Lost to Follow-up|4
6123210|NCT00075725|21103907|P7|Overall Study|Lost to Follow-up|2
6123211|NCT00075725|21103908|P6|Overall Study|Lost to Follow-up|13
6123212|NCT00075725|21103909|P5|Overall Study|Lost to Follow-up|0
6123213|NCT00075725|21103910|P4|Overall Study|Lost to Follow-up|1
6123214|NCT00075725|21103911|P3|Overall Study|Lost to Follow-up|4
6123215|NCT00075725|21103912|P2|Overall Study|Lost to Follow-up|1
6123216|NCT00075725|21103913|P1|Overall Study|Lost to Follow-up|1
6123217|NCT00075725|21103902|P12|Overall Study|Death|0
6123218|NCT00075725|21103903|P11|Overall Study|Death|3
6123219|NCT00075725|21103904|P10|Overall Study|Death|4
6123220|NCT00075725|21103905|P9|Overall Study|Death|14
6123221|NCT00075725|21103906|P8|Overall Study|Death|22
6123222|NCT00075725|21103907|P7|Overall Study|Death|4
6123223|NCT00075725|21103908|P6|Overall Study|Death|25
6123224|NCT00075725|21103909|P5|Overall Study|Death|3
6123225|NCT00075725|21103910|P4|Overall Study|Death|2
6123226|NCT00075725|21103911|P3|Overall Study|Death|10
6123227|NCT00075725|21103912|P2|Overall Study|Death|5
6123228|NCT00075725|21103913|P1|Overall Study|Death|3
6123229|NCT00075725|21103902|P12|Overall Study|Adverse Event|2
6123230|NCT00075725|21103903|P11|Overall Study|Adverse Event|2
6123231|NCT00075725|21103904|P10|Overall Study|Adverse Event|4
6123232|NCT00075725|21103905|P9|Overall Study|Adverse Event|15
6123233|NCT00075725|21103906|P8|Overall Study|Adverse Event|51
6123234|NCT00075725|21103907|P7|Overall Study|Adverse Event|3
6123235|NCT00075725|21103908|P6|Overall Study|Adverse Event|38
6123236|NCT00075725|21103909|P5|Overall Study|Adverse Event|4
6123237|NCT00075725|21103910|P4|Overall Study|Adverse Event|8
6123238|NCT00075725|21103911|P3|Overall Study|Adverse Event|20
6123239|NCT00075725|21103912|P2|Overall Study|Adverse Event|6
6123240|NCT00075725|21103913|P1|Overall Study|Adverse Event|6
6123241|NCT00075582|21104010|P2|Overall Study|Ineligible for study|16
6123242|NCT00075582|21104011|P1|Overall Study|Ineligible for study|36
6123243|NCT00075582|21104010|P2|Overall Study|Withdrawal by Subject|2
6123244|NCT00075582|21104011|P1|Overall Study|Withdrawal by Subject|2
6123245|NCT00075582|21104010|P2|Overall Study|Physician Decision|8
6123246|NCT00075582|21104011|P1|Overall Study|Physician Decision|5
6123247|NCT00075582|21104010|P2|Overall Study|Lack of Efficacy|8
6123248|NCT00075582|21104011|P1|Overall Study|Lack of Efficacy|4
6123249|NCT00075582|21104010|P2|Overall Study|Adverse Event|1
6123250|NCT00075582|21104011|P1|Overall Study|Adverse Event|3
6123251|NCT00075504|21104025|P2|Overall Study|Withdrawal by Subject|7
6123252|NCT00075504|21104026|P1|Overall Study|Withdrawal by Subject|9
6123253|NCT00075478|21104038|P2|Overall Study|Physician Decision|1
6123254|NCT00075478|21104039|P1|Overall Study|Physician Decision|0
6123255|NCT00075478|21104038|P2|Overall Study|not eligible|0
6123256|NCT00075478|21104039|P1|Overall Study|not eligible|1
6123257|NCT00075400|21104059|P1|Overall Study|Never treated|2
6123258|NCT00075400|21104059|P1|Overall Study|Ineligible: wrong primary|1
6123259|NCT00075270|21104080|P2|Overall Study|Missing|13
6123260|NCT00075270|21104081|P1|Overall Study|Missing|26
6123261|NCT00075270|21104080|P2|Overall Study|Other/Unknown|5
6123262|NCT00075270|21104081|P1|Overall Study|Other/Unknown|9
6123263|NCT00075270|21104080|P2|Overall Study|Death|215
6123264|NCT00075270|21104081|P1|Overall Study|Death|198
6123265|NCT00075270|21104080|P2|Overall Study|Protocol Violation|2
6123266|NCT00075270|21104081|P1|Overall Study|Protocol Violation|0
6123267|NCT00075270|21104080|P2|Overall Study|Lost to Follow-up|28
6123268|NCT00075270|21104081|P1|Overall Study|Lost to Follow-up|25
6123269|NCT00075270|21104080|P2|Overall Study|Withdrawal by Subject|21
6123270|NCT00075270|21104081|P1|Overall Study|Withdrawal by Subject|28
6123271|NCT00075218|21104127|P3|Open-Label Treatment|enrolled in a separate continuation|9
6123272|NCT00075218|21104128|P2|Open-Label Treatment|enrolled in a separate continuation|0
6123273|NCT00075218|21104129|P1|Open-Label Treatment|enrolled in a separate continuation|0
6123274|NCT00075218|21104127|P3|Open-Label Treatment|Protocol Violation|1
6123275|NCT00075218|21104128|P2|Open-Label Treatment|Protocol Violation|0
6123276|NCT00075218|21104129|P1|Open-Label Treatment|Protocol Violation|0
6123277|NCT00075218|21104127|P3|Open-Label Treatment|Decision of Sponsor|8
6123278|NCT00075218|21104128|P2|Open-Label Treatment|Decision of Sponsor|0
6123279|NCT00075218|21104129|P1|Open-Label Treatment|Decision of Sponsor|0
6123280|NCT00075218|21104127|P3|Open-Label Treatment|Withdrawal by Subject|12
6123281|NCT00075218|21104128|P2|Open-Label Treatment|Withdrawal by Subject|0
6123282|NCT00075218|21104129|P1|Open-Label Treatment|Withdrawal by Subject|0
6123283|NCT00075218|21104127|P3|Open-Label Treatment|Adverse Event|51
6123284|NCT00075218|21104128|P2|Open-Label Treatment|Adverse Event|0
6123285|NCT00075218|21104129|P1|Open-Label Treatment|Adverse Event|0
6123286|NCT00075218|21104127|P3|Open-Label Treatment|Lack of Efficacy|174
6123287|NCT00075218|21104128|P2|Open-Label Treatment|Lack of Efficacy|0
6123288|NCT00075218|21104129|P1|Open-Label Treatment|Lack of Efficacy|0
6123289|NCT00075218|21104127|P3|Double-Blind Treatment|No study medication taken|0
6123290|NCT00075218|21104128|P2|Double-Blind Treatment|No study medication taken|0
6123291|NCT00075218|21104129|P1|Double-Blind Treatment|No study medication taken|2
6123292|NCT00075218|21104127|P3|Double-Blind Treatment|Decision of Sponsor|0
6123293|NCT00075218|21104128|P2|Double-Blind Treatment|Decision of Sponsor|1
6123294|NCT00075218|21104129|P1|Double-Blind Treatment|Decision of Sponsor|0
6123295|NCT00075218|21104127|P3|Double-Blind Treatment|Lack of Efficacy|0
6123296|NCT00075218|21104128|P2|Double-Blind Treatment|Lack of Efficacy|6
6123297|NCT00075218|21104129|P1|Double-Blind Treatment|Lack of Efficacy|58
6123298|NCT00075218|21104127|P3|Double-Blind Treatment|Lost to Follow-up|0
6123299|NCT00075218|21104128|P2|Double-Blind Treatment|Lost to Follow-up|0
6123300|NCT00075218|21104129|P1|Double-Blind Treatment|Lost to Follow-up|1
6123301|NCT00075218|21104127|P3|Double-Blind Treatment|Withdrawal by Subject|0
6123302|NCT00075218|21104128|P2|Double-Blind Treatment|Withdrawal by Subject|4
6123303|NCT00075218|21104129|P1|Double-Blind Treatment|Withdrawal by Subject|7
6123304|NCT00075218|21104127|P3|Double-Blind Treatment|Adverse Event|0
6123305|NCT00075218|21104128|P2|Double-Blind Treatment|Adverse Event|4
6123306|NCT00075218|21104129|P1|Double-Blind Treatment|Adverse Event|23
6123307|NCT00075023|21104178|P2|Pilot Study|Withdrawal by Subject|0
6123308|NCT00075023|21104179|P1|Pilot Study|Withdrawal by Subject|1
6123309|NCT00075023|21104178|P2|Pilot Study|Physician Decision|2
6123310|NCT00075023|21104179|P1|Pilot Study|Physician Decision|1
6123311|NCT00074984|21104188|P2|Overall Study|Patient Withdrawn Per Protocol|3
6123312|NCT00074984|21104189|P1|Overall Study|Patient Withdrawn Per Protocol|0
6123313|NCT00074984|21104188|P2|Overall Study|Withdrawal by Subject|3
6123314|NCT00074984|21104189|P1|Overall Study|Withdrawal by Subject|2
6123315|NCT00074984|21104188|P2|Overall Study|Death|2
6123316|NCT00074984|21104189|P1|Overall Study|Death|1
6123317|NCT00074958|21104204|P1|Overall Study|Adverse Event|1
6123318|NCT00074711|21104245|P2|Overall Study|Participant stopped study drug|6
6123319|NCT00074711|21104246|P1|Overall Study|Participant stopped study drug|4
6123320|NCT00074711|21104245|P2|Overall Study|Lost to Follow-up|8
6123321|NCT00074711|21104246|P1|Overall Study|Lost to Follow-up|10
6123322|NCT00074711|21104245|P2|Overall Study|Withdrawal by Subject|1
6123323|NCT00074711|21104246|P1|Overall Study|Withdrawal by Subject|1
6123324|NCT00074581|21104264|P2|Overall Study|Other|19
6123325|NCT00074581|21104265|P1|Overall Study|Other|14
6123326|NCT00074581|21104264|P2|Overall Study|Ended relationship w. index participant|106
6123327|NCT00074581|21104265|P1|Overall Study|Ended relationship w. index participant|117
6123328|NCT00074581|21104264|P2|Overall Study|Lost to Follow-up|11
6123329|NCT00074581|21104265|P1|Overall Study|Lost to Follow-up|16
6123330|NCT00074581|21104264|P2|Overall Study|Were withdrawn by investigator|2
6123331|NCT00074581|21104265|P1|Overall Study|Were withdrawn by investigator|5
6123332|NCT00074581|21104264|P2|Overall Study|Relocated|9
6123333|NCT00074581|21104265|P1|Overall Study|Relocated|14
6123334|NCT00074581|21104264|P2|Overall Study|Unable to adhere to visit schedule|14
6123335|NCT00074581|21104265|P1|Overall Study|Unable to adhere to visit schedule|13
6123336|NCT00074581|21104264|P2|Overall Study|Withdrawal by Subject|49
6123337|NCT00074581|21104265|P1|Overall Study|Withdrawal by Subject|50
6123338|NCT00074581|21104264|P2|Overall Study|Death|16
6123339|NCT00074581|21104265|P1|Overall Study|Death|15
6123340|NCT00074490|21104278|P6|Overall Study|Progressive malignancy|0
6123341|NCT00074490|21104279|P5|Overall Study|Progressive malignancy|3
6123342|NCT00074490|21104280|P4|Overall Study|Progressive malignancy|0
6123343|NCT00074490|21104281|P3|Overall Study|Progressive malignancy|0
6123344|NCT00074490|21104282|P2|Overall Study|Progressive malignancy|7
6123345|NCT00074490|21104283|P1|Overall Study|Progressive malignancy|0
6123346|NCT00074412|21104317|P2|Overall Study|Lost to Follow-up|58
6123347|NCT00074412|21104318|P1|Overall Study|Lost to Follow-up|52
6123348|NCT00074412|21104317|P2|Overall Study|Death|26
6123349|NCT00074412|21104318|P1|Overall Study|Death|30
6123350|NCT00074282|21104349|P3|Step 2|Ineligible|1
6123351|NCT00074282|21104350|P2|Step 2|Ineligible|0
6123352|NCT00074282|21104351|P1|Step 2|Ineligible|0
6123353|NCT00074282|21104349|P3|Step 2|Physician Decision|1
6123354|NCT00074282|21104350|P2|Step 2|Physician Decision|0
6123355|NCT00074282|21104351|P1|Step 2|Physician Decision|0
6123356|NCT00074282|21104349|P3|Step 2|Withdrawal by Subject|2
6123357|NCT00074282|21104350|P2|Step 2|Withdrawal by Subject|0
6123358|NCT00074282|21104351|P1|Step 2|Withdrawal by Subject|0
6123359|NCT00074282|21104349|P3|Step 2|Death|3
6123360|NCT00074282|21104350|P2|Step 2|Death|0
6123361|NCT00074282|21104351|P1|Step 2|Death|0
6123362|NCT00074282|21104349|P3|Step 2|Disease progression|5
6123363|NCT00074282|21104350|P2|Step 2|Disease progression|0
6123364|NCT00074282|21104351|P1|Step 2|Disease progression|0
6123365|NCT00074282|21104349|P3|Step 2|Adverse Event|12
6123366|NCT00074282|21104350|P2|Step 2|Adverse Event|2
6123367|NCT00074282|21104351|P1|Step 2|Adverse Event|0
6123368|NCT00074282|21104349|P3|Step 1|Never started treatment|0
6123369|NCT00074282|21104350|P2|Step 1|Never started treatment|0
6123370|NCT00074282|21104351|P1|Step 1|Never started treatment|2
6123371|NCT00074282|21104349|P3|Step 1|Ineligible|0
6123372|NCT00074282|21104350|P2|Step 1|Ineligible|0
6123373|NCT00074282|21104351|P1|Step 1|Ineligible|4
6123374|NCT00074282|21104349|P3|Step 1|Physician Decision|0
6123375|NCT00074282|21104350|P2|Step 1|Physician Decision|0
6123376|NCT00074282|21104351|P1|Step 1|Physician Decision|1
6123377|NCT00074282|21104349|P3|Step 1|Other complicating disease|0
6123378|NCT00074282|21104350|P2|Step 1|Other complicating disease|0
6123379|NCT00074282|21104351|P1|Step 1|Other complicating disease|2
6123380|NCT00074282|21104349|P3|Step 1|Alternative therapy|0
6123381|NCT00074282|21104350|P2|Step 1|Alternative therapy|0
6123382|NCT00074282|21104351|P1|Step 1|Alternative therapy|2
6123383|NCT00074282|21104349|P3|Step 1|Disease progression|0
6123384|NCT00074282|21104350|P2|Step 1|Disease progression|0
6123385|NCT00074282|21104351|P1|Step 1|Disease progression|2
6123386|NCT00074282|21104349|P3|Step 1|Withdrawal by Subject|0
6123387|NCT00074282|21104350|P2|Step 1|Withdrawal by Subject|0
6123388|NCT00074282|21104351|P1|Step 1|Withdrawal by Subject|7
6123389|NCT00074282|21104349|P3|Step 1|Death|0
6123390|NCT00074282|21104350|P2|Step 1|Death|0
6123391|NCT00074282|21104351|P1|Step 1|Death|6
6123392|NCT00074282|21104349|P3|Step 1|Adverse Event|0
6123393|NCT00074282|21104350|P2|Step 1|Adverse Event|0
6123394|NCT00074282|21104351|P1|Step 1|Adverse Event|32
6123395|NCT00074152|21104378|P2|Overall Study|Lack of Efficacy|24
6123396|NCT00074152|21104379|P1|Overall Study|Lack of Efficacy|34
6123397|NCT00074152|21104378|P2|Overall Study|Death|9
6123398|NCT00074152|21104379|P1|Overall Study|Death|21
6123399|NCT00073983|21104396|P1|Overall Study|not evaluable|1
6123400|NCT00073918|21104417|P1|Overall Study|Eligibility requirement not met-low CD20|1
6123401|NCT00073918|21104417|P1|Overall Study|Rapid disease progression|2
6123402|NCT00073918|21104417|P1|Overall Study|Eligibility requirement not met - HAMA+|1
6123403|NCT00073749|21104431|P7|Overall Study|Other|0
6123404|NCT00073749|21104432|P6|Overall Study|Other|2
6123405|NCT00073749|21104433|P5|Overall Study|Other|0
6123406|NCT00073749|21104434|P4|Overall Study|Other|0
6123407|NCT00073749|21104435|P3|Overall Study|Other|0
6123408|NCT00073749|21104436|P2|Overall Study|Other|0
6123409|NCT00073749|21104437|P1|Overall Study|Other|0
6123410|NCT00073749|21104431|P7|Overall Study|Lost to Follow-up|2
6123411|NCT00073749|21104432|P6|Overall Study|Lost to Follow-up|0
6123412|NCT00073749|21104433|P5|Overall Study|Lost to Follow-up|0
6123413|NCT00073749|21104434|P4|Overall Study|Lost to Follow-up|0
6123414|NCT00073749|21104435|P3|Overall Study|Lost to Follow-up|0
6123415|NCT00073749|21104436|P2|Overall Study|Lost to Follow-up|0
6123416|NCT00073749|21104437|P1|Overall Study|Lost to Follow-up|0
6123417|NCT00073749|21104431|P7|Overall Study|Discontinuation of Study by Sponsor|4
6123418|NCT00073749|21104432|P6|Overall Study|Discontinuation of Study by Sponsor|0
6123419|NCT00073749|21104433|P5|Overall Study|Discontinuation of Study by Sponsor|0
6123420|NCT00073749|21104434|P4|Overall Study|Discontinuation of Study by Sponsor|0
6123421|NCT00073749|21104435|P3|Overall Study|Discontinuation of Study by Sponsor|0
6123422|NCT00073749|21104436|P2|Overall Study|Discontinuation of Study by Sponsor|0
6123423|NCT00073749|21104437|P1|Overall Study|Discontinuation of Study by Sponsor|0
6123424|NCT00073749|21104431|P7|Overall Study|Withdrawal by Subject|2
6123425|NCT00073749|21104432|P6|Overall Study|Withdrawal by Subject|0
6123426|NCT00073749|21104433|P5|Overall Study|Withdrawal by Subject|1
6123427|NCT00073749|21104434|P4|Overall Study|Withdrawal by Subject|0
6123428|NCT00073749|21104435|P3|Overall Study|Withdrawal by Subject|0
6123429|NCT00073749|21104436|P2|Overall Study|Withdrawal by Subject|1
6123430|NCT00073749|21104437|P1|Overall Study|Withdrawal by Subject|0
6123431|NCT00073749|21104431|P7|Overall Study|Physician Decision|0
6123432|NCT00073749|21104432|P6|Overall Study|Physician Decision|2
6123433|NCT00073749|21104433|P5|Overall Study|Physician Decision|0
6123434|NCT00073749|21104434|P4|Overall Study|Physician Decision|0
6123435|NCT00073749|21104435|P3|Overall Study|Physician Decision|1
6123436|NCT00073749|21104436|P2|Overall Study|Physician Decision|0
6123437|NCT00073749|21104437|P1|Overall Study|Physician Decision|0
6123438|NCT00073749|21104431|P7|Overall Study|Adverse Event|0
6123439|NCT00073749|21104432|P6|Overall Study|Adverse Event|1
6123440|NCT00073749|21104433|P5|Overall Study|Adverse Event|2
6123441|NCT00073749|21104434|P4|Overall Study|Adverse Event|4
6123442|NCT00073749|21104435|P3|Overall Study|Adverse Event|6
6123443|NCT00073749|21104436|P2|Overall Study|Adverse Event|3
6123444|NCT00073749|21104437|P1|Overall Study|Adverse Event|0
6123445|NCT00073749|21104431|P7|Overall Study|Death|29
6123446|NCT00073749|21104432|P6|Overall Study|Death|0
6123447|NCT00073749|21104433|P5|Overall Study|Death|0
6123448|NCT00073749|21104434|P4|Overall Study|Death|0
6123449|NCT00073749|21104435|P3|Overall Study|Death|1
6123450|NCT00073749|21104436|P2|Overall Study|Death|1
6123451|NCT00073749|21104437|P1|Overall Study|Death|0
6123452|NCT00073749|21104431|P7|Overall Study|Disease Progression|3
6123453|NCT00073749|21104432|P6|Overall Study|Disease Progression|1
6123454|NCT00073749|21104433|P5|Overall Study|Disease Progression|3
6123455|NCT00073749|21104434|P4|Overall Study|Disease Progression|2
6123456|NCT00073749|21104435|P3|Overall Study|Disease Progression|3
6123457|NCT00073749|21104436|P2|Overall Study|Disease Progression|0
6123458|NCT00073749|21104437|P1|Overall Study|Disease Progression|2
6123481|NCT00073307|21104558|P3|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|83
6123482|NCT00073307|21104559|P2|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|0
6123483|NCT00073307|21104560|P1|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|35
6123484|NCT00073307|21104558|P3|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|9
6123485|NCT00073307|21104559|P2|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|0
6123486|NCT00073307|21104560|P1|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|19
6123487|NCT00073307|21104558|P3|Open Label-Sorafenib Only [30Jun2008]|Missing|1
6123488|NCT00073307|21104559|P2|Open Label-Sorafenib Only [30Jun2008]|Missing|0
6123489|NCT00073307|21104560|P1|Open Label-Sorafenib Only [30Jun2008]|Missing|3
6123490|NCT00073307|21104558|P3|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|3
6123491|NCT00073307|21104559|P2|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0
6123492|NCT00073307|21104560|P1|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0
6123493|NCT00073307|21104558|P3|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1
6123494|NCT00073307|21104559|P2|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|0
6123495|NCT00073307|21104560|P1|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1
6123496|NCT00073307|21104558|P3|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1
6123497|NCT00073307|21104559|P2|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|0
6123498|NCT00073307|21104560|P1|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1
6123499|NCT00073307|21104558|P3|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|28
6123500|NCT00073307|21104559|P2|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|0
6123501|NCT00073307|21104560|P1|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|37
6123502|NCT00073307|21104558|P3|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|9
6123503|NCT00073307|21104559|P2|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|0
6123504|NCT00073307|21104560|P1|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|19
6123505|NCT00073307|21104558|P3|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2
6123506|NCT00073307|21104559|P2|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|0
6123507|NCT00073307|21104560|P1|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2
6123508|NCT00073307|21104558|P3|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|19
6123509|NCT00073307|21104559|P2|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|0
6123510|NCT00073307|21104560|P1|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|17
6123511|NCT00073307|21104558|P3|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0
6123512|NCT00073307|21104559|P2|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|1
6123513|NCT00073307|21104560|P1|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0
6123514|NCT00073307|21104558|P3|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|0
6123515|NCT00073307|21104559|P2|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|114
6123516|NCT00073307|21104560|P1|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|165
6123517|NCT00073307|21104558|P3|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0
6123518|NCT00073307|21104559|P2|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|1
6123519|NCT00073307|21104560|P1|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0
6123520|NCT00073307|21104558|P3|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0
6123521|NCT00073307|21104559|P2|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0
6123522|NCT00073307|21104560|P1|Double-Blind (DB, as of ~31May2005)|Unknown reason.|1
6123523|NCT00073307|21104558|P3|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|0
6123524|NCT00073307|21104559|P2|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|2
6123525|NCT00073307|21104560|P1|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|1
6123526|NCT00073307|21104558|P3|Double-Blind (DB, as of ~31May2005)|Protocol Violation|0
6123527|NCT00073307|21104559|P2|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1
6123528|NCT00073307|21104560|P1|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1
6123529|NCT00073307|21104558|P3|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|0
6123530|NCT00073307|21104559|P2|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|11
6123531|NCT00073307|21104560|P1|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|6
6123532|NCT00073307|21104558|P3|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|0
6123533|NCT00073307|21104559|P2|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|6
6123534|NCT00073307|21104560|P1|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|1
6123535|NCT00073307|21104558|P3|Double-Blind (DB, as of ~31May2005)|Adverse Event|0
6123536|NCT00073307|21104559|P2|Double-Blind (DB, as of ~31May2005)|Adverse Event|17
6123537|NCT00073307|21104560|P1|Double-Blind (DB, as of ~31May2005)|Adverse Event|22
6123538|NCT00073021|21104591|P2|Overall Study|Lack of Efficacy|5
6123539|NCT00073021|21104592|P1|Overall Study|Lack of Efficacy|11
6123540|NCT00073021|21104591|P2|Overall Study|Physician Decision|1
6123541|NCT00073021|21104592|P1|Overall Study|Physician Decision|3
6123542|NCT00073021|21104591|P2|Overall Study|Withdrawal by Subject|5
6123543|NCT00073021|21104592|P1|Overall Study|Withdrawal by Subject|6
6123544|NCT00073021|21104591|P2|Overall Study|Adverse Event|4
6123545|NCT00073021|21104592|P1|Overall Study|Adverse Event|4
6123546|NCT00073021|21104591|P2|Overall Study|Protocol Violation|1
6123547|NCT00073021|21104592|P1|Overall Study|Protocol Violation|2
6123548|NCT00073008|21104622|P2|Overall Study|"Other selected on Case Report Form"|5
6123549|NCT00073008|21104623|P1|Overall Study|"Other selected on Case Report Form"|7
6123550|NCT00073008|21104622|P2|Overall Study|Death|47
6123551|NCT00073008|21104623|P1|Overall Study|Death|46
6123552|NCT00073008|21104622|P2|Overall Study|Lost to Follow-up|3
6123553|NCT00073008|21104623|P1|Overall Study|Lost to Follow-up|1
6123554|NCT00073008|21104622|P2|Overall Study|Withdrawal by Subject|2
6123555|NCT00073008|21104623|P1|Overall Study|Withdrawal by Subject|2
6123556|NCT00073008|21104622|P2|Overall Study|Missing|6
6123557|NCT00073008|21104623|P1|Overall Study|Missing|6
6123558|NCT00072475|21104662|P1|Overall Study|Patient/Investigator Decision|4
6123559|NCT00072475|21104662|P1|Overall Study|Withdrawal by Subject|46
6123560|NCT00072475|21104662|P1|Overall Study|Death|3
6123561|NCT00072475|21104662|P1|Overall Study|Adverse Event|44
6123562|NCT00072384|21104677|P1|Overall Study|Ineligible|8
6123563|NCT00072384|21104677|P1|Overall Study|Physician Decision|1
6123564|NCT00072293|21104690|P2|Overall Study|Withdrawal by Subject|1
6123565|NCT00072293|21104691|P1|Overall Study|Withdrawal by Subject|0
6123566|NCT00072293|21104690|P2|Overall Study|Lost to Follow-up|1
6123567|NCT00072293|21104691|P1|Overall Study|Lost to Follow-up|1
6123568|NCT00072280|21104703|P2|Follow-up|Early termination of study|2
6123569|NCT00072280|21104704|P1|Follow-up|Early termination of study|2
6123570|NCT00072280|21104703|P2|Treatment|Found ineligible|2
6123571|NCT00072280|21104704|P1|Treatment|Found ineligible|1
6123572|NCT00072189|21104709|P1|Overall Study|Withdrawal by Subject|1
6123573|NCT00072176|21104717|P2|Overall Study|Protocol Violation|1
6123574|NCT00072176|21104718|P1|Overall Study|Protocol Violation|0
6123575|NCT00072176|21104717|P2|Overall Study|Withdrawal by Subject|0
6123576|NCT00072176|21104718|P1|Overall Study|Withdrawal by Subject|1
6123577|NCT00071981|21104730|P4|Overall Study|others (not specified in the study)|0
6123578|NCT00071981|21104731|P3|Overall Study|others (not specified in the study)|2
6123579|NCT00071981|21104732|P2|Overall Study|others (not specified in the study)|2
6123580|NCT00071981|21104733|P1|Overall Study|others (not specified in the study)|0
6123581|NCT00071981|21104730|P4|Overall Study|No protocol therapy|0
6123582|NCT00071981|21104731|P3|Overall Study|No protocol therapy|1
6123583|NCT00071981|21104732|P2|Overall Study|No protocol therapy|5
6123584|NCT00071981|21104733|P1|Overall Study|No protocol therapy|2
6123585|NCT00071981|21104730|P4|Overall Study|Withdrawal by Subject|0
6123586|NCT00071981|21104731|P3|Overall Study|Withdrawal by Subject|0
6123587|NCT00071981|21104732|P2|Overall Study|Withdrawal by Subject|1
6123588|NCT00071981|21104733|P1|Overall Study|Withdrawal by Subject|3
6123589|NCT00071981|21104730|P4|Overall Study|Death|1
6123590|NCT00071981|21104731|P3|Overall Study|Death|1
6123591|NCT00071981|21104732|P2|Overall Study|Death|0
6123592|NCT00071981|21104733|P1|Overall Study|Death|0
6123593|NCT00071981|21104730|P4|Overall Study|Adverse Event|1
6123594|NCT00071981|21104731|P3|Overall Study|Adverse Event|3
6123595|NCT00071981|21104732|P2|Overall Study|Adverse Event|4
6123596|NCT00071981|21104733|P1|Overall Study|Adverse Event|4
6123597|NCT00071981|21104730|P4|Overall Study|Lack of Efficacy|43
6123598|NCT00071981|21104731|P3|Overall Study|Lack of Efficacy|30
6123599|NCT00071981|21104732|P2|Overall Study|Lack of Efficacy|29
6123600|NCT00071981|21104733|P1|Overall Study|Lack of Efficacy|37
6123601|NCT00071812|21104776|P4|24-Week Open-Label Extension Period|Lack of Compliance|2
6123602|NCT00071812|21104777|P3|24-Week Open-Label Extension Period|Lack of Compliance|1
6123603|NCT00071812|21104778|P2|24-Week Open-Label Extension Period|Lack of Compliance|0
6123604|NCT00071812|21104779|P1|24-Week Open-Label Extension Period|Lack of Compliance|0
6123605|NCT00071812|21104776|P4|24-Week Open-Label Extension Period|Withdrawal by Subject|12
6123606|NCT00071812|21104777|P3|24-Week Open-Label Extension Period|Withdrawal by Subject|0
6123607|NCT00071812|21104778|P2|24-Week Open-Label Extension Period|Withdrawal by Subject|0
6123608|NCT00071812|21104779|P1|24-Week Open-Label Extension Period|Withdrawal by Subject|0
6123609|NCT00071812|21104776|P4|24-Week Open-Label Extension Period|Lost to Follow-up|2
6123610|NCT00071812|21104777|P3|24-Week Open-Label Extension Period|Lost to Follow-up|0
6123611|NCT00071812|21104778|P2|24-Week Open-Label Extension Period|Lost to Follow-up|0
6123612|NCT00071812|21104779|P1|24-Week Open-Label Extension Period|Lost to Follow-up|0
6123613|NCT00071812|21104776|P4|24-Week Open-Label Extension Period|Lack of Efficacy|17
6123614|NCT00071812|21104777|P3|24-Week Open-Label Extension Period|Lack of Efficacy|0
6123615|NCT00071812|21104778|P2|24-Week Open-Label Extension Period|Lack of Efficacy|0
6123616|NCT00071812|21104779|P1|24-Week Open-Label Extension Period|Lack of Efficacy|0
6123617|NCT00071812|21104776|P4|24-Week Open-Label Extension Period|Adverse Event|7
6123618|NCT00071812|21104777|P3|24-Week Open-Label Extension Period|Adverse Event|0
6123619|NCT00071812|21104778|P2|24-Week Open-Label Extension Period|Adverse Event|0
6123620|NCT00071812|21104779|P1|24-Week Open-Label Extension Period|Adverse Event|0
6123621|NCT00071812|21104776|P4|24-Week Double-Blind Period|Protocol Violation|1
6123622|NCT00071812|21104777|P3|24-Week Double-Blind Period|Protocol Violation|0
6123623|NCT00071812|21104778|P2|24-Week Double-Blind Period|Protocol Violation|0
6123624|NCT00071812|21104779|P1|24-Week Double-Blind Period|Protocol Violation|0
6123625|NCT00071812|21104776|P4|24-Week Double-Blind Period|Withdrawal by Subject|5
6123626|NCT00071812|21104777|P3|24-Week Double-Blind Period|Withdrawal by Subject|1
6123627|NCT00071812|21104778|P2|24-Week Double-Blind Period|Withdrawal by Subject|1
6123628|NCT00071812|21104779|P1|24-Week Double-Blind Period|Withdrawal by Subject|5
6123629|NCT00071812|21104776|P4|24-Week Double-Blind Period|Lost to Follow-up|0
6123630|NCT00071812|21104777|P3|24-Week Double-Blind Period|Lost to Follow-up|1
6123631|NCT00071812|21104778|P2|24-Week Double-Blind Period|Lost to Follow-up|1
6123632|NCT00071812|21104779|P1|24-Week Double-Blind Period|Lost to Follow-up|0
6123633|NCT00071812|21104776|P4|24-Week Double-Blind Period|Lack of Efficacy|1
6123634|NCT00071812|21104777|P3|24-Week Double-Blind Period|Lack of Efficacy|2
6123635|NCT00071812|21104778|P2|24-Week Double-Blind Period|Lack of Efficacy|1
6123636|NCT00071812|21104779|P1|24-Week Double-Blind Period|Lack of Efficacy|3
6123637|NCT00071812|21104776|P4|24-Week Double-Blind Period|Adverse Event|4
6123638|NCT00071812|21104777|P3|24-Week Double-Blind Period|Adverse Event|4
6123639|NCT00071812|21104778|P2|24-Week Double-Blind Period|Adverse Event|3
6123640|NCT00071812|21104779|P1|24-Week Double-Blind Period|Adverse Event|2
6123641|NCT00071799|21104821|P2|Overall Study|Not Documented|2
6123642|NCT00071799|21104822|P1|Overall Study|Not Documented|0
6123643|NCT00071799|21104821|P2|Overall Study|Different Central+Local Pathology Review|1
6123644|NCT00071799|21104822|P1|Overall Study|Different Central+Local Pathology Review|0
6123645|NCT00071799|21104821|P2|Overall Study|Disease Progression|20
6123646|NCT00071799|21104822|P1|Overall Study|Disease Progression|23
6123647|NCT00071799|21104821|P2|Overall Study|Lack of Efficacy|18
6123648|NCT00071799|21104822|P1|Overall Study|Lack of Efficacy|11
6123649|NCT00071799|21104821|P2|Overall Study|Physician Decision|2
6123650|NCT00071799|21104822|P1|Overall Study|Physician Decision|0
6123651|NCT00071799|21104821|P2|Overall Study|Withdrawal by Subject|37
6123652|NCT00071799|21104822|P1|Overall Study|Withdrawal by Subject|15
6123653|NCT00071799|21104821|P2|Overall Study|Lost to Follow-up|1
6123654|NCT00071799|21104822|P1|Overall Study|Lost to Follow-up|1
6123655|NCT00071799|21104821|P2|Overall Study|Protocol Violation|7
6123656|NCT00071799|21104822|P1|Overall Study|Protocol Violation|1
6123657|NCT00071799|21104821|P2|Overall Study|Adverse Event|10
6123658|NCT00071799|21104822|P1|Overall Study|Adverse Event|19
6123659|NCT00071760|21104875|P1|Overall Study|Ongoing|25
6123660|NCT00071760|21104875|P1|Overall Study|Study Team Rec./Resistance|1
6123661|NCT00071760|21104875|P1|Overall Study|Investigator's Recommendation (Rec.)|4
6123662|NCT00071760|21104875|P1|Overall Study|Relocation|1
6123663|NCT00071760|21104875|P1|Overall Study|Unavailability of RTV|8
6123664|NCT00071760|21104875|P1|Overall Study|Pulmonary Tuberculosis|1
6123665|NCT00071760|21104875|P1|Overall Study|Insufficient Viral Load Response|3
6123666|NCT00071760|21104875|P1|Overall Study|Withdrawal by Subject|3
6123667|NCT00071760|21104875|P1|Overall Study|Protocol Violation|1
6123668|NCT00071760|21104875|P1|Overall Study|Lost to Follow-up|4
6123669|NCT00071760|21104875|P1|Overall Study|Adverse Event|3
6123670|NCT00071513|21104955|P2|Follow-up Assessment|Withdrawal by Subject|6
6123671|NCT00071513|21104956|P1|Follow-up Assessment|Withdrawal by Subject|6
6123672|NCT00071513|21104955|P2|Intervention Component|Withdrawal by Subject|3
6123673|NCT00071513|21104956|P1|Intervention Component|Withdrawal by Subject|2
6123674|NCT00071487|21104968|P4|24-Week Open-Label Extension Period|Lack of Compliance|2
6123675|NCT00071487|21104969|P3|24-Week Open-Label Extension Period|Lack of Compliance|0
6123676|NCT00071487|21104970|P2|24-Week Open-Label Extension Period|Lack of Compliance|0
6123677|NCT00071487|21104971|P1|24-Week Open-Label Extension Period|Lack of Compliance|0
6123678|NCT00071487|21104968|P4|24-Week Open-Label Extension Period|Lost to Follow-up|2
6123679|NCT00071487|21104969|P3|24-Week Open-Label Extension Period|Lost to Follow-up|0
6123680|NCT00071487|21104970|P2|24-Week Open-Label Extension Period|Lost to Follow-up|0
6123681|NCT00071487|21104971|P1|24-Week Open-Label Extension Period|Lost to Follow-up|0
6123682|NCT00071487|21104968|P4|24-Week Open-Label Extension Period|Pregnancy|1
6123683|NCT00071487|21104969|P3|24-Week Open-Label Extension Period|Pregnancy|0
6123684|NCT00071487|21104970|P2|24-Week Open-Label Extension Period|Pregnancy|0
6123685|NCT00071487|21104971|P1|24-Week Open-Label Extension Period|Pregnancy|0
6123686|NCT00071487|21104968|P4|24-Week Open-Label Extension Period|Withdrawal by Subject|9
6123687|NCT00071487|21104969|P3|24-Week Open-Label Extension Period|Withdrawal by Subject|0
6123688|NCT00071487|21104970|P2|24-Week Open-Label Extension Period|Withdrawal by Subject|0
6123689|NCT00071487|21104971|P1|24-Week Open-Label Extension Period|Withdrawal by Subject|0
6123690|NCT00071487|21104968|P4|24-Week Open-Label Extension Period|Lack of Efficacy|3
6123691|NCT00071487|21104969|P3|24-Week Open-Label Extension Period|Lack of Efficacy|0
6123692|NCT00071487|21104970|P2|24-Week Open-Label Extension Period|Lack of Efficacy|0
6123693|NCT00071487|21104971|P1|24-Week Open-Label Extension Period|Lack of Efficacy|0
6123694|NCT00071487|21104968|P4|24-Week Open-Label Extension Period|Adverse Event|6
6123695|NCT00071487|21104969|P3|24-Week Open-Label Extension Period|Adverse Event|1
6123696|NCT00071487|21104970|P2|24-Week Open-Label Extension Period|Adverse Event|0
6123697|NCT00071487|21104971|P1|24-Week Open-Label Extension Period|Adverse Event|0
6123698|NCT00071487|21104968|P4|52-Week Double-Blind Period|Lack of Compliance|3
6123699|NCT00071487|21104969|P3|52-Week Double-Blind Period|Lack of Compliance|3
6123700|NCT00071487|21104970|P2|52-Week Double-Blind Period|Lack of Compliance|3
6123701|NCT00071487|21104971|P1|52-Week Double-Blind Period|Lack of Compliance|6
6123702|NCT00071487|21104968|P4|52-Week Double-Blind Period|Death|0
6123703|NCT00071487|21104969|P3|52-Week Double-Blind Period|Death|0
6123704|NCT00071487|21104970|P2|52-Week Double-Blind Period|Death|1
6123705|NCT00071487|21104971|P1|52-Week Double-Blind Period|Death|0
6123706|NCT00071487|21104968|P4|52-Week Double-Blind Period|Protocol Violation|0
6123707|NCT00071487|21104969|P3|52-Week Double-Blind Period|Protocol Violation|1
6123708|NCT00071487|21104970|P2|52-Week Double-Blind Period|Protocol Violation|1
6123709|NCT00071487|21104971|P1|52-Week Double-Blind Period|Protocol Violation|0
6123710|NCT00071487|21104968|P4|52-Week Double-Blind Period|Pregnancy|0
6123711|NCT00071487|21104969|P3|52-Week Double-Blind Period|Pregnancy|0
6123712|NCT00071487|21104970|P2|52-Week Double-Blind Period|Pregnancy|1
6123713|NCT00071487|21104971|P1|52-Week Double-Blind Period|Pregnancy|0
6123714|NCT00071487|21104968|P4|52-Week Double-Blind Period|Lost to Follow-up|2
6123715|NCT00071487|21104969|P3|52-Week Double-Blind Period|Lost to Follow-up|2
6123716|NCT00071487|21104970|P2|52-Week Double-Blind Period|Lost to Follow-up|0
6123717|NCT00071487|21104971|P1|52-Week Double-Blind Period|Lost to Follow-up|0
6123718|NCT00071487|21104968|P4|52-Week Double-Blind Period|Physician Decision|0
6123719|NCT00071487|21104969|P3|52-Week Double-Blind Period|Physician Decision|0
6123720|NCT00071487|21104970|P2|52-Week Double-Blind Period|Physician Decision|0
6123721|NCT00071487|21104971|P1|52-Week Double-Blind Period|Physician Decision|1
6123722|NCT00071487|21104968|P4|52-Week Double-Blind Period|Withdrawal by Subject|7
6123723|NCT00071487|21104969|P3|52-Week Double-Blind Period|Withdrawal by Subject|7
6123724|NCT00071487|21104970|P2|52-Week Double-Blind Period|Withdrawal by Subject|11
6123725|NCT00071487|21104971|P1|52-Week Double-Blind Period|Withdrawal by Subject|7
6123726|NCT00071487|21104968|P4|52-Week Double-Blind Period|Lack of Efficacy|1
6123727|NCT00071487|21104969|P3|52-Week Double-Blind Period|Lack of Efficacy|0
6123728|NCT00071487|21104970|P2|52-Week Double-Blind Period|Lack of Efficacy|2
6123729|NCT00071487|21104971|P1|52-Week Double-Blind Period|Lack of Efficacy|1
6123730|NCT00071487|21104968|P4|52-Week Double-Blind Period|Adverse Event|8
6123731|NCT00071487|21104969|P3|52-Week Double-Blind Period|Adverse Event|4
6123732|NCT00071487|21104970|P2|52-Week Double-Blind Period|Adverse Event|8
6123733|NCT00071487|21104971|P1|52-Week Double-Blind Period|Adverse Event|5
6123734|NCT00071396|21105015|P1|Overall Study|Physician Decision|2
6123735|NCT00071396|21105015|P1|Overall Study|Withdrawal by Subject|1
6123736|NCT00071110|21105021|P2|Overall Study|Protocol Violation|4
6123737|NCT00071110|21105022|P1|Overall Study|Protocol Violation|0
6123738|NCT00071032|21105036|P2|Overall Study|Missing Primary Outcome|1
6123739|NCT00071032|21105037|P1|Overall Study|Missing Primary Outcome|0
6123740|NCT00071032|21105036|P2|Overall Study|Withdrawal by Subject|6
6123741|NCT00071032|21105037|P1|Overall Study|Withdrawal by Subject|8
6123742|NCT00071032|21105036|P2|Overall Study|Lost to Follow-up|1
6123743|NCT00071032|21105037|P1|Overall Study|Lost to Follow-up|1
6123744|NCT00071006|21105073|P1|Overall Study|Other|3
6123745|NCT00071006|21105073|P1|Overall Study|Withdrawal by Subject|1
6123746|NCT00071006|21105073|P1|Overall Study|Adverse Event|1
6123747|NCT00071006|21105073|P1|Overall Study|Lack of Efficacy|7
6123748|NCT00070941|21105086|P3|Overall Study|Adverse Event|4
6123749|NCT00070941|21105087|P2|Overall Study|Adverse Event|8
6123750|NCT00070941|21105088|P1|Overall Study|Adverse Event|10
6123751|NCT00071058|21105096|P1|Overall Study|brain tumor-removed from study|1
6123752|NCT00070707|21105103|P2|Overall Study|Unrelated to Study Medication|0
6123753|NCT00070707|21105104|P1|Overall Study|Unrelated to Study Medication|1
6123754|NCT00070707|21105103|P2|Overall Study|Protocol Violation|4
6123755|NCT00070707|21105104|P1|Overall Study|Protocol Violation|8
6123756|NCT00070707|21105103|P2|Overall Study|Lack of Efficacy|1
6123757|NCT00070707|21105104|P1|Overall Study|Lack of Efficacy|4
6123758|NCT00070707|21105103|P2|Overall Study|Adverse Event|2
6123759|NCT00070707|21105104|P1|Overall Study|Adverse Event|1
6123760|NCT00003907|21105152|P2|Overall Study|ineligible or not treated|2
6123761|NCT00003907|21105153|P1|Overall Study|ineligible or not treated|2
6123762|NCT00003907|21105152|P2|Overall Study|Other|3
6123763|NCT00003907|21105153|P1|Overall Study|Other|1
6123764|NCT00003907|21105152|P2|Overall Study|Complicating disease|0
6123765|NCT00003907|21105153|P1|Overall Study|Complicating disease|1
6123766|NCT00003907|21105152|P2|Overall Study|Progressive disease|4
6123767|NCT00003907|21105153|P1|Overall Study|Progressive disease|4
6123768|NCT00003907|21105152|P2|Overall Study|Withdrawal by Subject|3
6123769|NCT00003907|21105153|P1|Overall Study|Withdrawal by Subject|1
6123770|NCT00003907|21105152|P2|Overall Study|Death|0
6123771|NCT00003907|21105153|P1|Overall Study|Death|2
6123772|NCT00003907|21105152|P2|Overall Study|Adverse Event|11
6123773|NCT00003907|21105153|P1|Overall Study|Adverse Event|2
6123774|NCT00070564|21105169|P6|Overall Study|Not reported|0
6123775|NCT00070564|21105170|P5|Overall Study|Not reported|1
6123776|NCT00070564|21105171|P4|Overall Study|Not reported|0
6123777|NCT00070564|21105172|P3|Overall Study|Not reported|0
6123778|NCT00070564|21105173|P2|Overall Study|Not reported|0
6123779|NCT00070564|21105174|P1|Overall Study|Not reported|0
6123780|NCT00070564|21105169|P6|Overall Study|Withdrawal by Subject|8
6123781|NCT00070564|21105170|P5|Overall Study|Withdrawal by Subject|8
6123782|NCT00070564|21105171|P4|Overall Study|Withdrawal by Subject|30
6123783|NCT00070564|21105172|P3|Overall Study|Withdrawal by Subject|23
6123784|NCT00070564|21105173|P2|Overall Study|Withdrawal by Subject|37
6123785|NCT00070564|21105174|P1|Overall Study|Withdrawal by Subject|26
6123786|NCT00070564|21105169|P6|Overall Study|Other, not protocol specified|7
6123787|NCT00070564|21105170|P5|Overall Study|Other, not protocol specified|6
6123788|NCT00070564|21105171|P4|Overall Study|Other, not protocol specified|19
6123789|NCT00070564|21105172|P3|Overall Study|Other, not protocol specified|14
6123790|NCT00070564|21105173|P2|Overall Study|Other, not protocol specified|15
6123791|NCT00070564|21105174|P1|Overall Study|Other, not protocol specified|17
6123792|NCT00070564|21105169|P6|Overall Study|Death|1
6123793|NCT00070564|21105170|P5|Overall Study|Death|0
6123794|NCT00070564|21105171|P4|Overall Study|Death|3
6123795|NCT00070564|21105172|P3|Overall Study|Death|5
6123796|NCT00070564|21105173|P2|Overall Study|Death|1
6123797|NCT00070564|21105174|P1|Overall Study|Death|4
6123798|NCT00070564|21105169|P6|Overall Study|Adverse Event|36
6123799|NCT00070564|21105170|P5|Overall Study|Adverse Event|63
6123800|NCT00070564|21105171|P4|Overall Study|Adverse Event|108
6123801|NCT00070564|21105172|P3|Overall Study|Adverse Event|120
6123802|NCT00070564|21105173|P2|Overall Study|Adverse Event|142
6123803|NCT00070564|21105174|P1|Overall Study|Adverse Event|150
6123804|NCT00070564|21105169|P6|Overall Study|Delinquent|0
6123805|NCT00070564|21105170|P5|Overall Study|Delinquent|0
6123806|NCT00070564|21105171|P4|Overall Study|Delinquent|0
6123807|NCT00070564|21105172|P3|Overall Study|Delinquent|2
6123808|NCT00070564|21105173|P2|Overall Study|Delinquent|4
6123809|NCT00070564|21105174|P1|Overall Study|Delinquent|1
6123810|NCT00070564|21105169|P6|Overall Study|Progression|0
6123811|NCT00070564|21105170|P5|Overall Study|Progression|1
6123812|NCT00070564|21105171|P4|Overall Study|Progression|7
6123813|NCT00070564|21105172|P3|Overall Study|Progression|7
6123814|NCT00070564|21105173|P2|Overall Study|Progression|4
6123815|NCT00070564|21105174|P1|Overall Study|Progression|2
6123816|NCT00070499|21105228|P4|Overall Study|Not eligible|2
6123817|NCT00070499|21105229|P3|Overall Study|Not eligible|3
6123818|NCT00070499|21105230|P2|Overall Study|Not eligible|5
6123819|NCT00070499|21105231|P1|Overall Study|Not eligible|2
6123820|NCT00070499|21105228|P4|Overall Study|Did not start treatment|2
6123821|NCT00070499|21105229|P3|Overall Study|Did not start treatment|0
6123822|NCT00070499|21105230|P2|Overall Study|Did not start treatment|0
6123823|NCT00070499|21105231|P1|Overall Study|Did not start treatment|1
6123824|NCT00070499|21105228|P4|Overall Study|Still on protocol treatment|57
6123825|NCT00070499|21105229|P3|Overall Study|Still on protocol treatment|79
6123826|NCT00070499|21105230|P2|Overall Study|Still on protocol treatment|4
6123827|NCT00070499|21105231|P1|Overall Study|Still on protocol treatment|10
6123828|NCT00070499|21105228|P4|Overall Study|Other - not protocol specified|20
6123829|NCT00070499|21105229|P3|Overall Study|Other - not protocol specified|12
6123830|NCT00070499|21105230|P2|Overall Study|Other - not protocol specified|3
6123831|NCT00070499|21105231|P1|Overall Study|Other - not protocol specified|7
6123832|NCT00070499|21105228|P4|Overall Study|Death|2
6123833|NCT00070499|21105229|P3|Overall Study|Death|1
6123834|NCT00070499|21105230|P2|Overall Study|Death|1
6123835|NCT00070499|21105231|P1|Overall Study|Death|1
6123836|NCT00070499|21105228|P4|Overall Study|Progression/relapse|4
6123837|NCT00070499|21105229|P3|Overall Study|Progression/relapse|1
6123838|NCT00070499|21105230|P2|Overall Study|Progression/relapse|2
6123839|NCT00070499|21105231|P1|Overall Study|Progression/relapse|4
6123840|NCT00070499|21105228|P4|Overall Study|Refusal unrelated to adverse effects|8
6123841|NCT00070499|21105229|P3|Overall Study|Refusal unrelated to adverse effects|5
6123842|NCT00070499|21105230|P2|Overall Study|Refusal unrelated to adverse effects|5
6123843|NCT00070499|21105231|P1|Overall Study|Refusal unrelated to adverse effects|7
6123844|NCT00070499|21105228|P4|Overall Study|Adverse Event|15
6123845|NCT00070499|21105229|P3|Overall Study|Adverse Event|19
6123846|NCT00070499|21105230|P2|Overall Study|Adverse Event|6
6123847|NCT00070499|21105231|P1|Overall Study|Adverse Event|6
6123848|NCT00070317|21105257|P1|Overall Study|Ineligible-Inadequate pathology|6
6123849|NCT00070317|21105257|P1|Overall Study|Ineligible-Improper prior treatment|2
6123850|NCT00070317|21105257|P1|Overall Study|Ineligible required test not done|1
6123851|NCT00070317|21105257|P1|Overall Study|Ineligible Wrong Cell type/primary/stage|3
6123852|NCT00070317|21105257|P1|Overall Study|Inevaluable (Never Treated)|1
6123853|NCT00070291|21105262|P1|Step 2|Adverse Event|1
6123854|NCT00070291|21105262|P1|Step 1|Adverse Event|1
6123855|NCT00070291|21105262|P1|Step 1|Withdrawal by Subject|1
6123856|NCT00070109|21105278|P5|Overall Study|removed from prot thpy prior to chemo|0
6123857|NCT00070109|21105279|P4|Overall Study|removed from prot thpy prior to chemo|1
6123858|NCT00070109|21105280|P3|Overall Study|removed from prot thpy prior to chemo|0
6123859|NCT00070109|21105281|P2|Overall Study|removed from prot thpy prior to chemo|0
6123860|NCT00070109|21105282|P1|Overall Study|removed from prot thpy prior to chemo|0
6123861|NCT00070109|21105278|P5|Overall Study|Adverse Event|2
6123862|NCT00070109|21105279|P4|Overall Study|Adverse Event|4
6123863|NCT00070109|21105280|P3|Overall Study|Adverse Event|2
6123864|NCT00070109|21105281|P2|Overall Study|Adverse Event|0
6123865|NCT00070109|21105282|P1|Overall Study|Adverse Event|0
6123866|NCT00070109|21105278|P5|Overall Study|Withdrawal by Subject|0
6123867|NCT00070109|21105279|P4|Overall Study|Withdrawal by Subject|0
6123868|NCT00070109|21105280|P3|Overall Study|Withdrawal by Subject|1
6123869|NCT00070109|21105281|P2|Overall Study|Withdrawal by Subject|1
6123870|NCT00070109|21105282|P1|Overall Study|Withdrawal by Subject|0
6123871|NCT00070109|21105278|P5|Overall Study|Physician Decision|0
6123872|NCT00070109|21105279|P4|Overall Study|Physician Decision|0
6123873|NCT00070109|21105280|P3|Overall Study|Physician Decision|0
6123874|NCT00070109|21105281|P2|Overall Study|Physician Decision|0
6123875|NCT00070109|21105282|P1|Overall Study|Physician Decision|1
6123876|NCT00070109|21105278|P5|Overall Study|Lack of Efficacy|5
6123877|NCT00070109|21105279|P4|Overall Study|Lack of Efficacy|15
6123878|NCT00070109|21105280|P3|Overall Study|Lack of Efficacy|5
6123879|NCT00070109|21105281|P2|Overall Study|Lack of Efficacy|4
6123880|NCT00070109|21105282|P1|Overall Study|Lack of Efficacy|6
6123881|NCT00070109|21105278|P5|Overall Study|Death|1
6123882|NCT00070109|21105279|P4|Overall Study|Death|0
6123883|NCT00070109|21105280|P3|Overall Study|Death|0
6123884|NCT00070109|21105281|P2|Overall Study|Death|1
6123885|NCT00070109|21105282|P1|Overall Study|Death|1
6123889|NCT00069953|21105314|P1|Overall Study|Protocol Violation|2
6123890|NCT00069784|21105320|P2|Overall Study|Other|0
6123891|NCT00069784|21105321|P1|Overall Study|Other|17
6123892|NCT00069784|21105320|P2|Overall Study|Withdrawal by Subject|0
6123893|NCT00069784|21105321|P1|Overall Study|Withdrawal by Subject|1090
6123894|NCT00069784|21105320|P2|Overall Study|Adverse Event|0
6123895|NCT00069784|21105321|P1|Overall Study|Adverse Event|105
6123896|NCT00069823|21105341|P2|Overall Study|Did not have follow-up diary cards|3
6123897|NCT00069823|21105342|P1|Overall Study|Did not have follow-up diary cards|6
6123898|NCT00069641|21105385|P3|Overall Study|Death|1
6123899|NCT00069641|21105386|P2|Overall Study|Death|0
6123900|NCT00069641|21105387|P1|Overall Study|Death|1
6123901|NCT00069576|21105414|P2|Follow-up Study at 5-10 Years|Not eligible or did not consent|204
6123902|NCT00069576|21105415|P1|Follow-up Study at 5-10 Years|Not eligible or did not consent|196
6123903|NCT00069576|21105414|P2|Original Trial|Lost to Follow-up|33
6123904|NCT00069576|21105415|P1|Original Trial|Lost to Follow-up|25
6123905|NCT00069277|21105465|P1|Overall Study|Physician Decision|2
6123906|NCT00069277|21105465|P1|Overall Study|Progressive Disease|15
6123907|NCT00069277|21105465|P1|Overall Study|Withdrawal by Subject|1
6123908|NCT00069277|21105465|P1|Overall Study|Adverse Event|3
6123909|NCT00069264|21105469|P1|Overall Study|Discon Therapy|3
6123910|NCT00069264|21105469|P1|Overall Study|Withdrawal by Subject|3
6123911|NCT00069264|21105469|P1|Overall Study|Progressive Disease|23
6123912|NCT00069264|21105469|P1|Overall Study|Adverse Event|3
6123913|NCT00069238|21105497|P3|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|2
6123914|NCT00069238|21105498|P2|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0
6123915|NCT00069238|21105499|P1|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0
6123916|NCT00069238|21105497|P3|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0
6123917|NCT00069238|21105498|P2|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|2
6123918|NCT00069238|21105499|P1|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0
6123919|NCT00069238|21105497|P3|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0
6123920|NCT00069238|21105498|P2|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0
6123921|NCT00069238|21105499|P1|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|9
6123922|NCT00069121|21105507|P2|Overall Study|Lost to Follow-up|63
6123923|NCT00069121|21105508|P1|Overall Study|Lost to Follow-up|63
6123924|NCT00069121|21105507|P2|Overall Study|Withdrawal by Subject|20
6123925|NCT00069121|21105508|P1|Overall Study|Withdrawal by Subject|18
6123926|NCT00069121|21105507|P2|Overall Study|Death|242
6123927|NCT00069121|21105508|P1|Overall Study|Death|286
6123928|NCT00069108|21105530|P2|Overall Study|Refused treatment|10
6123929|NCT00069108|21105531|P1|Overall Study|Refused treatment|5
6123930|NCT00069108|21105530|P2|Overall Study|Violation criteria|4
6123931|NCT00069108|21105531|P1|Overall Study|Violation criteria|1
6123932|NCT00069108|21105530|P2|Overall Study|Insufficient therapy|144
6123933|NCT00069108|21105531|P1|Overall Study|Insufficient therapy|117
6123934|NCT00069108|21105530|P2|Overall Study|Administration|4
6123935|NCT00069108|21105531|P1|Overall Study|Administration|15
6123936|NCT00069108|21105530|P2|Overall Study|Death|6
6123937|NCT00069108|21105531|P1|Overall Study|Death|6
6123938|NCT00069108|21105530|P2|Overall Study|Adverse Event|42
6123939|NCT00069108|21105531|P1|Overall Study|Adverse Event|64
6123940|NCT00069108|21105530|P2|Overall Study|Withdrawal by Subject|9
6123941|NCT00069108|21105531|P1|Overall Study|Withdrawal by Subject|5
6123942|NCT00069095|21105563|P6|Follow-up Phase|Death|101
6123943|NCT00069095|21105564|P5|Follow-up Phase|Death|92
6123944|NCT00069095|21105565|P4|Follow-up Phase|Death|112
6123945|NCT00069095|21105566|P3|Follow-up Phase|Death|120
6123946|NCT00069095|21105567|P2|Follow-up Phase|Death|206
6123947|NCT00069095|21105568|P1|Follow-up Phase|Death|174
6123948|NCT00069095|21105563|P6|Post-study Treatment Phase|Investigator decision|1
6123949|NCT00069095|21105564|P5|Post-study Treatment Phase|Investigator decision|0
6123950|NCT00069095|21105565|P4|Post-study Treatment Phase|Investigator decision|0
6123951|NCT00069095|21105566|P3|Post-study Treatment Phase|Investigator decision|0
6123952|NCT00069095|21105567|P2|Post-study Treatment Phase|Investigator decision|0
6123953|NCT00069095|21105568|P1|Post-study Treatment Phase|Investigator decision|0
6123954|NCT00069095|21105563|P6|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0
6123955|NCT00069095|21105564|P5|Post-study Treatment Phase|Preplanned 6 cycles after surgery|1
6123956|NCT00069095|21105565|P4|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0
6123957|NCT00069095|21105566|P3|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0
6123958|NCT00069095|21105567|P2|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0
6123959|NCT00069095|21105568|P1|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0
6123960|NCT00069095|21105563|P6|Post-study Treatment Phase|Participant/Physician decision to stop|0
6123961|NCT00069095|21105564|P5|Post-study Treatment Phase|Participant/Physician decision to stop|1
6123962|NCT00069095|21105565|P4|Post-study Treatment Phase|Participant/Physician decision to stop|0
6123963|NCT00069095|21105566|P3|Post-study Treatment Phase|Participant/Physician decision to stop|0
6123964|NCT00069095|21105567|P2|Post-study Treatment Phase|Participant/Physician decision to stop|0
6123965|NCT00069095|21105568|P1|Post-study Treatment Phase|Participant/Physician decision to stop|0
6123966|NCT00069095|21105563|P6|Post-study Treatment Phase|Participant had progressive disease|0
6123967|NCT00069095|21105564|P5|Post-study Treatment Phase|Participant had progressive disease|1
6123968|NCT00069095|21105565|P4|Post-study Treatment Phase|Participant had progressive disease|0
6123969|NCT00069095|21105566|P3|Post-study Treatment Phase|Participant had progressive disease|0
6123970|NCT00069095|21105567|P2|Post-study Treatment Phase|Participant had progressive disease|0
6123971|NCT00069095|21105568|P1|Post-study Treatment Phase|Participant had progressive disease|0
6123972|NCT00069095|21105563|P6|Post-study Treatment Phase|Death|0
6123973|NCT00069095|21105564|P5|Post-study Treatment Phase|Death|1
6123974|NCT00069095|21105565|P4|Post-study Treatment Phase|Death|0
6123975|NCT00069095|21105566|P3|Post-study Treatment Phase|Death|0
6123976|NCT00069095|21105567|P2|Post-study Treatment Phase|Death|0
6123977|NCT00069095|21105568|P1|Post-study Treatment Phase|Death|0
6123978|NCT00069095|21105563|P6|Post-study Treatment Phase|Surgery|0
6123979|NCT00069095|21105564|P5|Post-study Treatment Phase|Surgery|1
6123980|NCT00069095|21105565|P4|Post-study Treatment Phase|Surgery|1
6123981|NCT00069095|21105566|P3|Post-study Treatment Phase|Surgery|0
6123982|NCT00069095|21105567|P2|Post-study Treatment Phase|Surgery|0
6123983|NCT00069095|21105568|P1|Post-study Treatment Phase|Surgery|0
6123984|NCT00069095|21105563|P6|Post-study Treatment Phase|Participant completed treatment|0
6123985|NCT00069095|21105564|P5|Post-study Treatment Phase|Participant completed treatment|0
6123986|NCT00069095|21105565|P4|Post-study Treatment Phase|Participant completed treatment|1
6123987|NCT00069095|21105566|P3|Post-study Treatment Phase|Participant completed treatment|0
6123988|NCT00069095|21105567|P2|Post-study Treatment Phase|Participant completed treatment|0
6123989|NCT00069095|21105568|P1|Post-study Treatment Phase|Participant completed treatment|0
6123990|NCT00069095|21105563|P6|Post-study Treatment Phase|Participant wanted break from treatment|0
6123991|NCT00069095|21105564|P5|Post-study Treatment Phase|Participant wanted break from treatment|0
6123992|NCT00069095|21105565|P4|Post-study Treatment Phase|Participant wanted break from treatment|1
6123993|NCT00069095|21105566|P3|Post-study Treatment Phase|Participant wanted break from treatment|0
6123994|NCT00069095|21105567|P2|Post-study Treatment Phase|Participant wanted break from treatment|0
6123995|NCT00069095|21105568|P1|Post-study Treatment Phase|Participant wanted break from treatment|0
6123996|NCT00069095|21105563|P6|Post-study Treatment Phase|Participant will start new treatment|0
6123997|NCT00069095|21105564|P5|Post-study Treatment Phase|Participant will start new treatment|0
6123998|NCT00069095|21105565|P4|Post-study Treatment Phase|Participant will start new treatment|0
6123999|NCT00069095|21105566|P3|Post-study Treatment Phase|Participant will start new treatment|1
6124000|NCT00069095|21105567|P2|Post-study Treatment Phase|Participant will start new treatment|0
6124001|NCT00069095|21105568|P1|Post-study Treatment Phase|Participant will start new treatment|0
6124002|NCT00069095|21105563|P6|Post-study Treatment Phase|Participant withdrew consent|0
6124003|NCT00069095|21105564|P5|Post-study Treatment Phase|Participant withdrew consent|0
6124004|NCT00069095|21105565|P4|Post-study Treatment Phase|Participant withdrew consent|0
6124005|NCT00069095|21105566|P3|Post-study Treatment Phase|Participant withdrew consent|1
6124006|NCT00069095|21105567|P2|Post-study Treatment Phase|Participant withdrew consent|0
6124007|NCT00069095|21105568|P1|Post-study Treatment Phase|Participant withdrew consent|0
6124008|NCT00069095|21105563|P6|Post-study Treatment Phase|Investigator decision (enough treatment)|0
6124009|NCT00069095|21105564|P5|Post-study Treatment Phase|Investigator decision (enough treatment)|1
6124010|NCT00069095|21105565|P4|Post-study Treatment Phase|Investigator decision (enough treatment)|0
6124011|NCT00069095|21105566|P3|Post-study Treatment Phase|Investigator decision (enough treatment)|1
6124012|NCT00069095|21105567|P2|Post-study Treatment Phase|Investigator decision (enough treatment)|1
6124013|NCT00069095|21105568|P1|Post-study Treatment Phase|Investigator decision (enough treatment)|0
6124014|NCT00069095|21105563|P6|Post-study Treatment Phase|More than 21 days delay between cycles|0
6124015|NCT00069095|21105564|P5|Post-study Treatment Phase|More than 21 days delay between cycles|0
6124016|NCT00069095|21105565|P4|Post-study Treatment Phase|More than 21 days delay between cycles|0
6124017|NCT00069095|21105566|P3|Post-study Treatment Phase|More than 21 days delay between cycles|0
6124018|NCT00069095|21105567|P2|Post-study Treatment Phase|More than 21 days delay between cycles|1
6124019|NCT00069095|21105568|P1|Post-study Treatment Phase|More than 21 days delay between cycles|0
6124020|NCT00069095|21105563|P6|Post-study Treatment Phase|Participant had complete response|0
6124021|NCT00069095|21105564|P5|Post-study Treatment Phase|Participant had complete response|0
6124022|NCT00069095|21105565|P4|Post-study Treatment Phase|Participant had complete response|0
6124023|NCT00069095|21105566|P3|Post-study Treatment Phase|Participant had complete response|0
6124024|NCT00069095|21105567|P2|Post-study Treatment Phase|Participant had complete response|1
6124025|NCT00069095|21105568|P1|Post-study Treatment Phase|Participant had complete response|1
6124026|NCT00069095|21105563|P6|Post-study Treatment Phase|Participant refusal/Admin reasons|1
6124027|NCT00069095|21105564|P5|Post-study Treatment Phase|Participant refusal/Admin reasons|0
6124028|NCT00069095|21105565|P4|Post-study Treatment Phase|Participant refusal/Admin reasons|0
6124029|NCT00069095|21105566|P3|Post-study Treatment Phase|Participant refusal/Admin reasons|0
6124030|NCT00069095|21105567|P2|Post-study Treatment Phase|Participant refusal/Admin reasons|0
6124031|NCT00069095|21105568|P1|Post-study Treatment Phase|Participant refusal/Admin reasons|1
6124032|NCT00069095|21105563|P6|Post-study Treatment Phase|Insufficient therapeutic response|9
6124033|NCT00069095|21105564|P5|Post-study Treatment Phase|Insufficient therapeutic response|7
6124034|NCT00069095|21105565|P4|Post-study Treatment Phase|Insufficient therapeutic response|6
6124035|NCT00069095|21105566|P3|Post-study Treatment Phase|Insufficient therapeutic response|5
6124036|NCT00069095|21105567|P2|Post-study Treatment Phase|Insufficient therapeutic response|4
6124037|NCT00069095|21105568|P1|Post-study Treatment Phase|Insufficient therapeutic response|1
6124038|NCT00069095|21105563|P6|Post-study Treatment Phase|Eligible for surgery|0
6124039|NCT00069095|21105564|P5|Post-study Treatment Phase|Eligible for surgery|0
6124040|NCT00069095|21105565|P4|Post-study Treatment Phase|Eligible for surgery|0
6124041|NCT00069095|21105566|P3|Post-study Treatment Phase|Eligible for surgery|0
6124042|NCT00069095|21105567|P2|Post-study Treatment Phase|Eligible for surgery|0
6124043|NCT00069095|21105568|P1|Post-study Treatment Phase|Eligible for surgery|2
6124044|NCT00069095|21105563|P6|Post-study Treatment Phase|Adverse Event|1
6124045|NCT00069095|21105564|P5|Post-study Treatment Phase|Adverse Event|5
6124046|NCT00069095|21105565|P4|Post-study Treatment Phase|Adverse Event|0
6124047|NCT00069095|21105566|P3|Post-study Treatment Phase|Adverse Event|1
6124048|NCT00069095|21105567|P2|Post-study Treatment Phase|Adverse Event|3
6124049|NCT00069095|21105568|P1|Post-study Treatment Phase|Adverse Event|2
6124050|NCT00069095|21105563|P6|Post-study Treatment Phase|Missing reason|17
6124051|NCT00069095|21105564|P5|Post-study Treatment Phase|Missing reason|18
6124052|NCT00069095|21105565|P4|Post-study Treatment Phase|Missing reason|8
6124053|NCT00069095|21105566|P3|Post-study Treatment Phase|Missing reason|12
6124054|NCT00069095|21105567|P2|Post-study Treatment Phase|Missing reason|3
6124055|NCT00069095|21105568|P1|Post-study Treatment Phase|Missing reason|1
6124056|NCT00069095|21105563|P6|Primary Treatment Phase|Violation criteria|5
6124057|NCT00069095|21105564|P5|Primary Treatment Phase|Violation criteria|1
6124058|NCT00069095|21105565|P4|Primary Treatment Phase|Violation criteria|3
6124059|NCT00069095|21105566|P3|Primary Treatment Phase|Violation criteria|4
6124060|NCT00069095|21105567|P2|Primary Treatment Phase|Violation criteria|2
6124061|NCT00069095|21105568|P1|Primary Treatment Phase|Violation criteria|0
6124062|NCT00069095|21105563|P6|Primary Treatment Phase|Other Violation|1
6124063|NCT00069095|21105564|P5|Primary Treatment Phase|Other Violation|0
6124064|NCT00069095|21105565|P4|Primary Treatment Phase|Other Violation|1
6124065|NCT00069095|21105566|P3|Primary Treatment Phase|Other Violation|1
6124066|NCT00069095|21105567|P2|Primary Treatment Phase|Other Violation|1
6124067|NCT00069095|21105568|P1|Primary Treatment Phase|Other Violation|0
6124068|NCT00069095|21105563|P6|Primary Treatment Phase|Withdrew|9
6124069|NCT00069095|21105564|P5|Primary Treatment Phase|Withdrew|4
6124070|NCT00069095|21105565|P4|Primary Treatment Phase|Withdrew|2
6124071|NCT00069095|21105566|P3|Primary Treatment Phase|Withdrew|8
6124072|NCT00069095|21105567|P2|Primary Treatment Phase|Withdrew|3
6124073|NCT00069095|21105568|P1|Primary Treatment Phase|Withdrew|2
6124074|NCT00069095|21105563|P6|Primary Treatment Phase|Refused treatment|27
6124075|NCT00069095|21105564|P5|Primary Treatment Phase|Refused treatment|24
6124076|NCT00069095|21105565|P4|Primary Treatment Phase|Refused treatment|31
6124077|NCT00069095|21105566|P3|Primary Treatment Phase|Refused treatment|17
6124078|NCT00069095|21105567|P2|Primary Treatment Phase|Refused treatment|26
6124079|NCT00069095|21105568|P1|Primary Treatment Phase|Refused treatment|15
6124080|NCT00069095|21105563|P6|Primary Treatment Phase|Insufficient Therapeutic Response|102
6124081|NCT00069095|21105564|P5|Primary Treatment Phase|Insufficient Therapeutic Response|101
6124082|NCT00069095|21105565|P4|Primary Treatment Phase|Insufficient Therapeutic Response|154
6124083|NCT00069095|21105566|P3|Primary Treatment Phase|Insufficient Therapeutic Response|175
6124084|NCT00069095|21105567|P2|Primary Treatment Phase|Insufficient Therapeutic Response|127
6124085|NCT00069095|21105568|P1|Primary Treatment Phase|Insufficient Therapeutic Response|131
6124086|NCT00069095|21105563|P6|Primary Treatment Phase|Failure to return|2
6124087|NCT00069095|21105564|P5|Primary Treatment Phase|Failure to return|0
6124088|NCT00069095|21105565|P4|Primary Treatment Phase|Failure to return|0
6124089|NCT00069095|21105566|P3|Primary Treatment Phase|Failure to return|0
6124090|NCT00069095|21105567|P2|Primary Treatment Phase|Failure to return|5
6124091|NCT00069095|21105568|P1|Primary Treatment Phase|Failure to return|5
6124092|NCT00069095|21105563|P6|Primary Treatment Phase|Death|8
6124093|NCT00069095|21105564|P5|Primary Treatment Phase|Death|8
6124094|NCT00069095|21105565|P4|Primary Treatment Phase|Death|5
6124095|NCT00069095|21105566|P3|Primary Treatment Phase|Death|2
6124096|NCT00069095|21105567|P2|Primary Treatment Phase|Death|8
6124097|NCT00069095|21105568|P1|Primary Treatment Phase|Death|14
6124098|NCT00069095|21105563|P6|Primary Treatment Phase|Adverse Event|101
6124099|NCT00069095|21105564|P5|Primary Treatment Phase|Adverse Event|109
6124100|NCT00069095|21105565|P4|Primary Treatment Phase|Adverse Event|72
6124101|NCT00069095|21105566|P3|Primary Treatment Phase|Adverse Event|71
6124102|NCT00069095|21105567|P2|Primary Treatment Phase|Adverse Event|92
6124103|NCT00069095|21105568|P1|Primary Treatment Phase|Adverse Event|99
6124104|NCT00069095|21105563|P6|Primary Treatment Phase|Admin/Other|42
6124105|NCT00069095|21105564|P5|Primary Treatment Phase|Admin/Other|48
6124106|NCT00069095|21105565|P4|Primary Treatment Phase|Admin/Other|45
6124107|NCT00069095|21105566|P3|Primary Treatment Phase|Admin/Other|31
6124108|NCT00069095|21105567|P2|Primary Treatment Phase|Admin/Other|38
6124109|NCT00069095|21105568|P1|Primary Treatment Phase|Admin/Other|29
6124110|NCT00069095|21105563|P6|Primary Treatment Phase|Ongoing|4
6124111|NCT00069095|21105564|P5|Primary Treatment Phase|Ongoing|7
6124112|NCT00069095|21105565|P4|Primary Treatment Phase|Ongoing|7
6124113|NCT00069095|21105566|P3|Primary Treatment Phase|Ongoing|5
6124114|NCT00069095|21105567|P2|Primary Treatment Phase|Ongoing|0
6124115|NCT00069095|21105568|P1|Primary Treatment Phase|Ongoing|0
6124116|NCT00068822|21105638|P2|First Randomized Intervention|Lost to Follow-up|2
6124117|NCT00068822|21105639|P1|First Randomized Intervention|Lost to Follow-up|1
6124118|NCT00068692|21105673|P8|Step 2: Randomization|never start protocol therapy|0
6124119|NCT00068692|21105674|P7|Step 2: Randomization|never start protocol therapy|0
6124120|NCT00068692|21105675|P6|Step 2: Randomization|never start protocol therapy|0
6124121|NCT00068692|21105676|P5|Step 2: Randomization|never start protocol therapy|1
6124122|NCT00068692|21105677|P4|Step 2: Randomization|never start protocol therapy|0
6124123|NCT00068692|21105678|P3|Step 2: Randomization|never start protocol therapy|1
6124124|NCT00068692|21105679|P2|Step 2: Randomization|never start protocol therapy|0
6124125|NCT00068692|21105680|P1|Step 2: Randomization|never start protocol therapy|0
6124126|NCT00068692|21105673|P8|Step 2: Randomization|Other|0
6124127|NCT00068692|21105674|P7|Step 2: Randomization|Other|0
6124128|NCT00068692|21105675|P6|Step 2: Randomization|Other|1
6124129|NCT00068692|21105676|P5|Step 2: Randomization|Other|0
6124130|NCT00068692|21105677|P4|Step 2: Randomization|Other|1
6124131|NCT00068692|21105678|P3|Step 2: Randomization|Other|0
6124132|NCT00068692|21105679|P2|Step 2: Randomization|Other|0
6124133|NCT00068692|21105680|P1|Step 2: Randomization|Other|0
6124134|NCT00068692|21105673|P8|Step 2: Randomization|Physician Decision|0
6124135|NCT00068692|21105674|P7|Step 2: Randomization|Physician Decision|0
6124136|NCT00068692|21105675|P6|Step 2: Randomization|Physician Decision|0
6124137|NCT00068692|21105676|P5|Step 2: Randomization|Physician Decision|1
6124138|NCT00068692|21105677|P4|Step 2: Randomization|Physician Decision|1
6124139|NCT00068692|21105678|P3|Step 2: Randomization|Physician Decision|0
6124140|NCT00068692|21105679|P2|Step 2: Randomization|Physician Decision|0
6124141|NCT00068692|21105680|P1|Step 2: Randomization|Physician Decision|0
6124142|NCT00068692|21105673|P8|Step 2: Randomization|alternative therapy|0
6124143|NCT00068692|21105674|P7|Step 2: Randomization|alternative therapy|0
6124144|NCT00068692|21105675|P6|Step 2: Randomization|alternative therapy|0
6124145|NCT00068692|21105676|P5|Step 2: Randomization|alternative therapy|1
6124146|NCT00068692|21105677|P4|Step 2: Randomization|alternative therapy|1
6124147|NCT00068692|21105678|P3|Step 2: Randomization|alternative therapy|0
6124148|NCT00068692|21105679|P2|Step 2: Randomization|alternative therapy|0
6124149|NCT00068692|21105680|P1|Step 2: Randomization|alternative therapy|0
6124150|NCT00068692|21105673|P8|Step 2: Randomization|Withdrawal by Subject|3
6124151|NCT00068692|21105674|P7|Step 2: Randomization|Withdrawal by Subject|0
6124152|NCT00068692|21105675|P6|Step 2: Randomization|Withdrawal by Subject|2
6124153|NCT00068692|21105676|P5|Step 2: Randomization|Withdrawal by Subject|3
6124154|NCT00068692|21105677|P4|Step 2: Randomization|Withdrawal by Subject|6
6124155|NCT00068692|21105678|P3|Step 2: Randomization|Withdrawal by Subject|4
6124156|NCT00068692|21105679|P2|Step 2: Randomization|Withdrawal by Subject|0
6124157|NCT00068692|21105680|P1|Step 2: Randomization|Withdrawal by Subject|0
6124158|NCT00068692|21105673|P8|Step 2: Randomization|Death|1
6124159|NCT00068692|21105674|P7|Step 2: Randomization|Death|0
6124160|NCT00068692|21105675|P6|Step 2: Randomization|Death|0
6124161|NCT00068692|21105676|P5|Step 2: Randomization|Death|1
6124162|NCT00068692|21105677|P4|Step 2: Randomization|Death|0
6124163|NCT00068692|21105678|P3|Step 2: Randomization|Death|0
6124164|NCT00068692|21105679|P2|Step 2: Randomization|Death|0
6124165|NCT00068692|21105680|P1|Step 2: Randomization|Death|0
6124166|NCT00068692|21105673|P8|Step 2: Randomization|Adverse Event|4
6124167|NCT00068692|21105674|P7|Step 2: Randomization|Adverse Event|4
6124168|NCT00068692|21105675|P6|Step 2: Randomization|Adverse Event|3
6124169|NCT00068692|21105676|P5|Step 2: Randomization|Adverse Event|2
6124170|NCT00068692|21105677|P4|Step 2: Randomization|Adverse Event|2
6124171|NCT00068692|21105678|P3|Step 2: Randomization|Adverse Event|4
6124172|NCT00068692|21105679|P2|Step 2: Randomization|Adverse Event|0
6124173|NCT00068692|21105680|P1|Step 2: Randomization|Adverse Event|0
6124174|NCT00068692|21105673|P8|Step 2: Randomization|Disesae progression/replase|0
6124175|NCT00068692|21105674|P7|Step 2: Randomization|Disesae progression/replase|0
6124176|NCT00068692|21105675|P6|Step 2: Randomization|Disesae progression/replase|0
6124177|NCT00068692|21105676|P5|Step 2: Randomization|Disesae progression/replase|0
6124178|NCT00068692|21105677|P4|Step 2: Randomization|Disesae progression/replase|1
6124179|NCT00068692|21105678|P3|Step 2: Randomization|Disesae progression/replase|1
6124180|NCT00068692|21105679|P2|Step 2: Randomization|Disesae progression/replase|0
6124181|NCT00068692|21105680|P1|Step 2: Randomization|Disesae progression/replase|0
6124182|NCT00068692|21105673|P8|Step 1: Registration|Registered but not randomized|0
6124183|NCT00068692|21105674|P7|Step 1: Registration|Registered but not randomized|0
6124184|NCT00068692|21105675|P6|Step 1: Registration|Registered but not randomized|0
6124185|NCT00068692|21105676|P5|Step 1: Registration|Registered but not randomized|0
6124186|NCT00068692|21105677|P4|Step 1: Registration|Registered but not randomized|0
6124187|NCT00068692|21105678|P3|Step 1: Registration|Registered but not randomized|0
6124188|NCT00068692|21105679|P2|Step 1: Registration|Registered but not randomized|1
6124189|NCT00068692|21105680|P1|Step 1: Registration|Registered but not randomized|0
6124190|NCT00068692|21105673|P8|Step 1: Registration|Not start protocol therapy|0
6124191|NCT00068692|21105674|P7|Step 1: Registration|Not start protocol therapy|0
6124192|NCT00068692|21105675|P6|Step 1: Registration|Not start protocol therapy|0
6124193|NCT00068692|21105676|P5|Step 1: Registration|Not start protocol therapy|0
6124194|NCT00068692|21105677|P4|Step 1: Registration|Not start protocol therapy|0
6124195|NCT00068692|21105678|P3|Step 1: Registration|Not start protocol therapy|0
6124196|NCT00068692|21105679|P2|Step 1: Registration|Not start protocol therapy|0
6124197|NCT00068692|21105680|P1|Step 1: Registration|Not start protocol therapy|3
6124198|NCT00068692|21105673|P8|Step 1: Registration|Other|0
6124199|NCT00068692|21105674|P7|Step 1: Registration|Other|0
6124200|NCT00068692|21105675|P6|Step 1: Registration|Other|0
6124201|NCT00068692|21105676|P5|Step 1: Registration|Other|0
6124202|NCT00068692|21105677|P4|Step 1: Registration|Other|0
6124203|NCT00068692|21105678|P3|Step 1: Registration|Other|0
6124204|NCT00068692|21105679|P2|Step 1: Registration|Other|0
6124205|NCT00068692|21105680|P1|Step 1: Registration|Other|2
6124206|NCT00068692|21105673|P8|Step 1: Registration|Not eligible|0
6124207|NCT00068692|21105674|P7|Step 1: Registration|Not eligible|0
6124208|NCT00068692|21105675|P6|Step 1: Registration|Not eligible|0
6124209|NCT00068692|21105676|P5|Step 1: Registration|Not eligible|0
6124210|NCT00068692|21105677|P4|Step 1: Registration|Not eligible|0
6124211|NCT00068692|21105678|P3|Step 1: Registration|Not eligible|0
6124212|NCT00068692|21105679|P2|Step 1: Registration|Not eligible|0
6124213|NCT00068692|21105680|P1|Step 1: Registration|Not eligible|6
6124214|NCT00068692|21105673|P8|Step 1: Registration|Protocol Violation|0
6124215|NCT00068692|21105674|P7|Step 1: Registration|Protocol Violation|0
6124216|NCT00068692|21105675|P6|Step 1: Registration|Protocol Violation|0
6124217|NCT00068692|21105676|P5|Step 1: Registration|Protocol Violation|0
6124218|NCT00068692|21105677|P4|Step 1: Registration|Protocol Violation|0
6124219|NCT00068692|21105678|P3|Step 1: Registration|Protocol Violation|0
6124220|NCT00068692|21105679|P2|Step 1: Registration|Protocol Violation|0
6124221|NCT00068692|21105680|P1|Step 1: Registration|Protocol Violation|1
6124222|NCT00068692|21105673|P8|Step 1: Registration|Complicating disease|0
6124223|NCT00068692|21105674|P7|Step 1: Registration|Complicating disease|0
6124224|NCT00068692|21105675|P6|Step 1: Registration|Complicating disease|0
6124225|NCT00068692|21105676|P5|Step 1: Registration|Complicating disease|0
6124226|NCT00068692|21105677|P4|Step 1: Registration|Complicating disease|0
6124227|NCT00068692|21105678|P3|Step 1: Registration|Complicating disease|0
6124228|NCT00068692|21105679|P2|Step 1: Registration|Complicating disease|0
6124229|NCT00068692|21105680|P1|Step 1: Registration|Complicating disease|2
6124230|NCT00068692|21105673|P8|Step 1: Registration|Alternative therapy|0
6124231|NCT00068692|21105674|P7|Step 1: Registration|Alternative therapy|0
6124232|NCT00068692|21105675|P6|Step 1: Registration|Alternative therapy|0
6124233|NCT00068692|21105676|P5|Step 1: Registration|Alternative therapy|0
6124234|NCT00068692|21105677|P4|Step 1: Registration|Alternative therapy|0
6124235|NCT00068692|21105678|P3|Step 1: Registration|Alternative therapy|0
6124236|NCT00068692|21105679|P2|Step 1: Registration|Alternative therapy|0
6124237|NCT00068692|21105680|P1|Step 1: Registration|Alternative therapy|2
6124238|NCT00068692|21105673|P8|Step 1: Registration|Withdrawal by Subject|0
6124239|NCT00068692|21105674|P7|Step 1: Registration|Withdrawal by Subject|0
6124240|NCT00068692|21105675|P6|Step 1: Registration|Withdrawal by Subject|0
6124241|NCT00068692|21105676|P5|Step 1: Registration|Withdrawal by Subject|0
6124242|NCT00068692|21105677|P4|Step 1: Registration|Withdrawal by Subject|0
6124243|NCT00068692|21105678|P3|Step 1: Registration|Withdrawal by Subject|0
6124244|NCT00068692|21105679|P2|Step 1: Registration|Withdrawal by Subject|0
6124245|NCT00068692|21105680|P1|Step 1: Registration|Withdrawal by Subject|11
6124246|NCT00068692|21105673|P8|Step 1: Registration|Death|0
6124247|NCT00068692|21105674|P7|Step 1: Registration|Death|0
6124248|NCT00068692|21105675|P6|Step 1: Registration|Death|0
6124249|NCT00068692|21105676|P5|Step 1: Registration|Death|0
6124250|NCT00068692|21105677|P4|Step 1: Registration|Death|0
6124251|NCT00068692|21105678|P3|Step 1: Registration|Death|0
6124252|NCT00068692|21105679|P2|Step 1: Registration|Death|0
6124253|NCT00068692|21105680|P1|Step 1: Registration|Death|1
6124254|NCT00068692|21105673|P8|Step 1: Registration|Adverse Event|0
6124255|NCT00068692|21105674|P7|Step 1: Registration|Adverse Event|0
6124256|NCT00068692|21105675|P6|Step 1: Registration|Adverse Event|0
6124257|NCT00068692|21105676|P5|Step 1: Registration|Adverse Event|0
6124258|NCT00068692|21105677|P4|Step 1: Registration|Adverse Event|0
6124259|NCT00068692|21105678|P3|Step 1: Registration|Adverse Event|0
6124260|NCT00068692|21105679|P2|Step 1: Registration|Adverse Event|0
6124261|NCT00068692|21105680|P1|Step 1: Registration|Adverse Event|7
6124262|NCT00068692|21105673|P8|Step 1: Registration|Disese progression/relapse|0
6124263|NCT00068692|21105674|P7|Step 1: Registration|Disese progression/relapse|0
6124264|NCT00068692|21105675|P6|Step 1: Registration|Disese progression/relapse|0
6124265|NCT00068692|21105676|P5|Step 1: Registration|Disese progression/relapse|0
6124266|NCT00068692|21105677|P4|Step 1: Registration|Disese progression/relapse|0
6124267|NCT00068692|21105678|P3|Step 1: Registration|Disese progression/relapse|0
6124268|NCT00068692|21105679|P2|Step 1: Registration|Disese progression/relapse|0
6124269|NCT00068692|21105680|P1|Step 1: Registration|Disese progression/relapse|5
6124270|NCT00068601|21105703|P2|Overall Study|Missing primary outcome data|34
6124271|NCT00068601|21105704|P1|Overall Study|Missing primary outcome data|30
6124272|NCT00068601|21105703|P2|Overall Study|Lost to Follow-up|2
6124273|NCT00068601|21105704|P1|Overall Study|Lost to Follow-up|3
6124274|NCT00068601|21105703|P2|Overall Study|Death|3
6124275|NCT00068601|21105704|P1|Overall Study|Death|11
6124276|NCT00068601|21105703|P2|Overall Study|Not evaluable: hysterectomy/oophorectomy|4
6124277|NCT00068601|21105704|P1|Overall Study|Not evaluable: hysterectomy/oophorectomy|2
6124278|NCT00068601|21105703|P2|Overall Study|Not evaluable: withdrew consent|4
6124279|NCT00068601|21105704|P1|Overall Study|Not evaluable: withdrew consent|5
6124280|NCT00068601|21105703|P2|Overall Study|Ineligible|13
6124281|NCT00068601|21105704|P1|Overall Study|Ineligible|11
6124282|NCT00068588|21105717|P3|Overall Study|Poor KPS|1
6124283|NCT00068588|21105718|P2|Overall Study|Poor KPS|0
6124284|NCT00068588|21105719|P1|Overall Study|Poor KPS|0
6124285|NCT00068588|21105717|P3|Overall Study|Withdrawal by Subject|1
6124286|NCT00068588|21105718|P2|Overall Study|Withdrawal by Subject|0
6124287|NCT00068588|21105719|P1|Overall Study|Withdrawal by Subject|0
6124288|NCT00068588|21105717|P3|Overall Study|Adverse Event|2
6124289|NCT00068588|21105718|P2|Overall Study|Adverse Event|0
6124290|NCT00068588|21105719|P1|Overall Study|Adverse Event|0
6124291|NCT00068445|21105735|P2|Treatment|Other (Specifics not available)|5
6124292|NCT00068445|21105736|P1|Treatment|Other (Specifics not available)|9
6124293|NCT00068445|21105735|P2|Treatment|Adverse Event|1
6124294|NCT00068445|21105736|P1|Treatment|Adverse Event|7
6124295|NCT00068445|21105735|P2|Treatment|Refused Further Treatment|10
6124296|NCT00068445|21105736|P1|Treatment|Refused Further Treatment|13
6124297|NCT00068445|21105735|P2|Randomization|Ineligible|1
6124298|NCT00068445|21105736|P1|Randomization|Ineligible|1
6124299|NCT00068445|21105735|P2|Randomization|Cancel|3
6124300|NCT00068445|21105736|P1|Randomization|Cancel|1
6124301|NCT00068419|21105760|P1|Overall Study|Ineligible|11
6124302|NCT00068419|21105760|P1|Overall Study|Withdrawal by Subject|14
6124303|NCT00068419|21105760|P1|Overall Study|Physician Decision|7
6124304|NCT00068419|21105760|P1|Overall Study|Lost to Follow-up|1
6124305|NCT00068419|21105760|P1|Overall Study|Lack of Efficacy|24
6124306|NCT00068419|21105760|P1|Overall Study|Adverse Event|3
6124307|NCT00068406|21105769|P1|Overall Study|Ineligible-Inadequate Pathology|2
6124308|NCT00068406|21105769|P1|Overall Study|Ineligible-improper pre-protocol treatm|1
6124309|NCT00068393|21105774|P1|Overall Study|Quality of life worsening|1
6124310|NCT00068393|21105774|P1|Overall Study|Alternative treatment|1
6124311|NCT00068393|21105774|P1|Overall Study|Withdrawal by Subject|3
6124312|NCT00068393|21105774|P1|Overall Study|Death|3
6124313|NCT00068393|21105774|P1|Overall Study|Adverse Event|2
6124314|NCT00068380|21105780|P1|Overall Study|Adverse Event|2
6124315|NCT00068380|21105780|P1|Overall Study|Withdrawal by Subject|3
6124316|NCT00068250|21105824|P4|Phase I: Dose Level 2|Protocol Violation|0
6124317|NCT00068250|21105825|P3|Phase I: Dose Level 2|Protocol Violation|0
6124318|NCT00068250|21105826|P2|Phase I: Dose Level 2|Protocol Violation|1
6124319|NCT00068250|21105827|P1|Phase I: Dose Level 2|Protocol Violation|0
6124320|NCT00068237|21105837|P1|Overall Study|No protocol treatment received|2
6124321|NCT00068237|21105837|P1|Overall Study|Ineligible|3
6124322|NCT00068107|21105849|P1|Overall Study|Withdrawal by Subject|1
6124323|NCT00068107|21105849|P1|Overall Study|Death|2
6124324|NCT00068107|21105849|P1|Overall Study|end-stage renal disease|6
6124325|NCT00067990|21105862|P2|Overall Study|Withdrawal by Subject|12
6124326|NCT00067990|21105863|P1|Overall Study|Withdrawal by Subject|4
6124327|NCT00067990|21105862|P2|Overall Study|ESRD, Non IF/TA|3
6124328|NCT00067990|21105863|P1|Overall Study|ESRD, Non IF/TA|1
6124329|NCT00067990|21105862|P2|Overall Study|Death|7
6124330|NCT00067990|21105863|P1|Overall Study|Death|5
6124331|NCT00067470|21105886|P2|Overall Study|Withdrawal by Subject|1
6124332|NCT00067470|21105887|P1|Overall Study|Withdrawal by Subject|0
6124333|NCT00067002|21105924|P2|Overall Study|Graft Failure|6
6124334|NCT00067002|21105925|P1|Overall Study|Graft Failure|5
6124335|NCT00067002|21105924|P2|Overall Study|Delayed|1
6124336|NCT00067002|21105925|P1|Overall Study|Delayed|1
6124337|NCT00067002|21105924|P2|Overall Study|Early Death|2
6124338|NCT00067002|21105925|P1|Overall Study|Early Death|1
6124339|NCT00066807|21105983|P2|Overall Study|Study was terminated early|15
6124340|NCT00066807|21105984|P1|Overall Study|Study was terminated early|14
6124341|NCT00066742|21106009|P1|Consolidation Chemotherapy|Ineligible|2
6124342|NCT00066742|21106009|P1|Consolidation Chemotherapy|not protocol specified|1
6124343|NCT00066742|21106009|P1|Induction Chemoradiotherapy|Ineligible|3
6124344|NCT00066742|21106009|P1|Induction Chemoradiotherapy|not protocol specified|2
6124345|NCT00066742|21106009|P1|Induction Chemoradiotherapy|Withdrawal by Subject|2
6124346|NCT00066742|21106009|P1|Induction Chemoradiotherapy|Adverse Event|21
6124347|NCT00066742|21106009|P1|Induction Chemoradiotherapy|Did not receive any protocol treatment|1
6124348|NCT00066703|21106018|P2|Overall Study|Treatment ongoing|311
6124349|NCT00066703|21106019|P1|Overall Study|Treatment ongoing|346
6124350|NCT00066703|21106018|P2|Overall Study|Withdrawal by Subject|63
6124351|NCT00066703|21106019|P1|Overall Study|Withdrawal by Subject|38
6124352|NCT00066703|21106018|P2|Overall Study|Lost to Follow-up|28
6124353|NCT00066703|21106019|P1|Overall Study|Lost to Follow-up|31
6124354|NCT00066703|21106018|P2|Overall Study|Lack of Efficacy|69
6124355|NCT00066703|21106019|P1|Overall Study|Lack of Efficacy|114
6124356|NCT00066703|21106018|P2|Overall Study|Death|0
6124357|NCT00066703|21106019|P1|Overall Study|Death|3
6124358|NCT00066703|21106018|P2|Overall Study|Adverse Event|111
6124359|NCT00066703|21106019|P1|Overall Study|Adverse Event|80
6124360|NCT00066690|21106034|P3|Overall Study|Treatment Ongoing|282
6124361|NCT00066690|21106035|P2|Overall Study|Treatment Ongoing|278
6124362|NCT00066690|21106036|P1|Overall Study|Treatment Ongoing|246
6124363|NCT00066690|21106034|P3|Overall Study|Withdrawal by Subject|49
6124364|NCT00066690|21106035|P2|Overall Study|Withdrawal by Subject|55
6124365|NCT00066690|21106036|P1|Overall Study|Withdrawal by Subject|50
6124366|NCT00066690|21106034|P3|Overall Study|Lost to Follow-up|29
6124367|NCT00066690|21106035|P2|Overall Study|Lost to Follow-up|21
6124368|NCT00066690|21106036|P1|Overall Study|Lost to Follow-up|40
6124369|NCT00066690|21106034|P3|Overall Study|Lack of Efficacy|76
6124370|NCT00066690|21106035|P2|Overall Study|Lack of Efficacy|110
6124371|NCT00066690|21106036|P1|Overall Study|Lack of Efficacy|114
6124372|NCT00066690|21106034|P3|Overall Study|Death|2
6124373|NCT00066690|21106035|P2|Overall Study|Death|0
6124374|NCT00066690|21106036|P1|Overall Study|Death|3
6124375|NCT00066690|21106034|P3|Overall Study|Adverse Event|126
6124376|NCT00066690|21106035|P2|Overall Study|Adverse Event|58
6124377|NCT00066690|21106036|P1|Overall Study|Adverse Event|145
6124378|NCT00066573|21106055|P2|Overall Study|Did not received protocol treatment|28
6124379|NCT00066573|21106056|P1|Overall Study|Did not received protocol treatment|28
6124380|NCT00066469|21106068|P1|Overall Study|ineligible|1
6124381|NCT00066469|21106068|P1|Overall Study|Withdrawal by Subject|1
6124382|NCT00066469|21106068|P1|Overall Study|Physician Decision|1
6124383|NCT00066469|21106068|P1|Overall Study|Lost to Follow-up|1
6124384|NCT00066469|21106068|P1|Overall Study|Lack of Efficacy|9
6124385|NCT00066469|21106068|P1|Overall Study|Death|3
6124386|NCT00066365|21106074|P2|Overall Study|Ineligible|2
6124387|NCT00066365|21106075|P1|Overall Study|Ineligible|4
6124388|NCT00066365|21106074|P2|Overall Study|No viable tumor after 1 cycle of therapy|0
6124389|NCT00066365|21106075|P1|Overall Study|No viable tumor after 1 cycle of therapy|2
6124390|NCT00066365|21106074|P2|Overall Study|Physician Decision|0
6124391|NCT00066365|21106075|P1|Overall Study|Physician Decision|1
6124392|NCT00066365|21106074|P2|Overall Study|Lack of Efficacy|12
6124393|NCT00066365|21106075|P1|Overall Study|Lack of Efficacy|15
6124394|NCT00066365|21106074|P2|Overall Study|Adverse Event|0
6124395|NCT00066365|21106075|P1|Overall Study|Adverse Event|1
6124396|NCT00066222|21106103|P1|Overall Study|No protocol treatment received|1
6124397|NCT00066170|21106116|P4|Overall Study|Other|0
6124398|NCT00066170|21106117|P3|Overall Study|Other|2
6124399|NCT00066170|21106118|P2|Overall Study|Other|5
6124400|NCT00066170|21106119|P1|Overall Study|Other|1
6124401|NCT00066170|21106116|P4|Overall Study|Protocol Violation|0
6124402|NCT00066170|21106117|P3|Overall Study|Protocol Violation|0
6124403|NCT00066170|21106118|P2|Overall Study|Protocol Violation|0
6124404|NCT00066170|21106119|P1|Overall Study|Protocol Violation|3
6124405|NCT00066170|21106116|P4|Overall Study|Non-Compliance with Trial Medicine|1
6124406|NCT00066170|21106117|P3|Overall Study|Non-Compliance with Trial Medicine|0
6124407|NCT00066170|21106118|P2|Overall Study|Non-Compliance with Trial Medicine|0
6124408|NCT00066170|21106119|P1|Overall Study|Non-Compliance with Trial Medicine|1
6124409|NCT00066170|21106116|P4|Overall Study|Lost to Follow-up|0
6124410|NCT00066170|21106117|P3|Overall Study|Lost to Follow-up|0
6124411|NCT00066170|21106118|P2|Overall Study|Lost to Follow-up|1
6124412|NCT00066170|21106119|P1|Overall Study|Lost to Follow-up|0
6124413|NCT00066170|21106116|P4|Overall Study|Serious Adverse Event|1
6124414|NCT00066170|21106117|P3|Overall Study|Serious Adverse Event|1
6124415|NCT00066170|21106118|P2|Overall Study|Serious Adverse Event|0
6124416|NCT00066170|21106119|P1|Overall Study|Serious Adverse Event|0
6124417|NCT00066170|21106116|P4|Overall Study|Adverse Event|7
6124418|NCT00066170|21106117|P3|Overall Study|Adverse Event|1
6124419|NCT00066170|21106118|P2|Overall Study|Adverse Event|4
6124420|NCT00066170|21106119|P1|Overall Study|Adverse Event|2
6124421|NCT00066066|21106132|P6|Overall Study|Lost to Follow-up|5
6124422|NCT00066066|21106133|P5|Overall Study|Lost to Follow-up|3
6124423|NCT00066066|21106134|P4|Overall Study|Lost to Follow-up|4
6124424|NCT00066066|21106135|P3|Overall Study|Lost to Follow-up|7
6124425|NCT00066066|21106136|P2|Overall Study|Lost to Follow-up|4
6124426|NCT00066066|21106137|P1|Overall Study|Lost to Follow-up|6
6124427|NCT00065507|21106215|P2|Overall Study|Subject No Longer Meets Study Criteria|0
6124428|NCT00065507|21106216|P1|Overall Study|Subject No Longer Meets Study Criteria|1
6124429|NCT00065507|21106215|P2|Overall Study|Subject Withdrew Consent|1
6124430|NCT00065507|21106216|P1|Overall Study|Subject Withdrew Consent|2
6124431|NCT00065507|21106215|P2|Overall Study|Lost to Follow-up|0
6124432|NCT00065507|21106216|P1|Overall Study|Lost to Follow-up|3
6124433|NCT00065507|21106215|P2|Overall Study|Poor/Non-compliance|2
6124434|NCT00065507|21106216|P1|Overall Study|Poor/Non-compliance|3
6124435|NCT00065507|21106215|P2|Overall Study|Lack of Efficacy|6
6124436|NCT00065507|21106216|P1|Overall Study|Lack of Efficacy|0
6124437|NCT00065507|21106215|P2|Overall Study|Adverse Event|3
6124438|NCT00065507|21106216|P1|Overall Study|Adverse Event|4
6124439|NCT00065507|21106215|P2|Overall Study|Death|17
6124440|NCT00065507|21106216|P1|Overall Study|Death|16
6124441|NCT00065468|21106281|P3|Overall Study|Other|18
6124442|NCT00065468|21106282|P2|Overall Study|Other|24
6124443|NCT00065468|21106283|P1|Overall Study|Other|14
6124444|NCT00065468|21106281|P3|Overall Study|Disease progression|1
6124445|NCT00065468|21106282|P2|Overall Study|Disease progression|0
6124446|NCT00065468|21106283|P1|Overall Study|Disease progression|0
6124447|NCT00065468|21106281|P3|Overall Study|Discontinuation of study by Sponsor|13
6124448|NCT00065468|21106282|P2|Overall Study|Discontinuation of study by Sponsor|9
6124449|NCT00065468|21106283|P1|Overall Study|Discontinuation of study by Sponsor|13
6124450|NCT00065468|21106281|P3|Overall Study|Lost to Follow-up|2
6124451|NCT00065468|21106282|P2|Overall Study|Lost to Follow-up|3
6124452|NCT00065468|21106283|P1|Overall Study|Lost to Follow-up|5
6124453|NCT00065468|21106281|P3|Overall Study|Withdrawal by Subject|5
6124454|NCT00065468|21106282|P2|Overall Study|Withdrawal by Subject|4
6124455|NCT00065468|21106283|P1|Overall Study|Withdrawal by Subject|3
6124456|NCT00065468|21106281|P3|Overall Study|Death|171
6124457|NCT00065468|21106282|P2|Overall Study|Death|169
6124458|NCT00065468|21106283|P1|Overall Study|Death|172
6124459|NCT00065442|21106314|P2|Overall Study|Withdrawal by Subject|9
6124460|NCT00065442|21106315|P1|Overall Study|Withdrawal by Subject|3
6124461|NCT00065442|21106314|P2|Overall Study|Death|210
6124462|NCT00065442|21106315|P1|Overall Study|Death|121
6124463|NCT00065442|21106314|P2|Overall Study|Lost to Follow-up|1
6124464|NCT00065442|21106315|P1|Overall Study|Lost to Follow-up|1
6124465|NCT00065429|21106330|P7|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
6124466|NCT00065429|21106331|P6|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
6124467|NCT00065429|21106332|P5|Phase II - Apr 2003 - Aug 2008|Adverse Event|2
6124468|NCT00065429|21106333|P4|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
6124469|NCT00065429|21106334|P3|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
6124470|NCT00065429|21106335|P2|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
6124471|NCT00065429|21106336|P1|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
6124472|NCT00065429|21106330|P7|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
6124473|NCT00065429|21106331|P6|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
6124474|NCT00065429|21106332|P5|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|4
6124475|NCT00065429|21106333|P4|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
6124476|NCT00065429|21106334|P3|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
6124477|NCT00065429|21106335|P2|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
6124478|NCT00065429|21106336|P1|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
6124479|NCT00065429|21106330|P7|Phase I - May 2001 - Oct 2002|Adverse Event|2
6124480|NCT00065429|21106331|P6|Phase I - May 2001 - Oct 2002|Adverse Event|1
6124481|NCT00065429|21106332|P5|Phase I - May 2001 - Oct 2002|Adverse Event|0
6124482|NCT00065429|21106333|P4|Phase I - May 2001 - Oct 2002|Adverse Event|1
6124483|NCT00065429|21106334|P3|Phase I - May 2001 - Oct 2002|Adverse Event|0
6124484|NCT00065429|21106335|P2|Phase I - May 2001 - Oct 2002|Adverse Event|0
6124485|NCT00065429|21106336|P1|Phase I - May 2001 - Oct 2002|Adverse Event|0
6124486|NCT00065429|21106330|P7|Phase I - May 2001 - Oct 2002|Death|0
6124487|NCT00065429|21106331|P6|Phase I - May 2001 - Oct 2002|Death|0
6124488|NCT00065429|21106332|P5|Phase I - May 2001 - Oct 2002|Death|1
6124489|NCT00065429|21106333|P4|Phase I - May 2001 - Oct 2002|Death|0
6124490|NCT00065429|21106334|P3|Phase I - May 2001 - Oct 2002|Death|0
6124491|NCT00065429|21106335|P2|Phase I - May 2001 - Oct 2002|Death|0
6124492|NCT00065429|21106336|P1|Phase I - May 2001 - Oct 2002|Death|0
6124493|NCT00065429|21106330|P7|Phase I - May 2001 - Oct 2002|Physician Decision|0
6124494|NCT00065429|21106331|P6|Phase I - May 2001 - Oct 2002|Physician Decision|0
6124495|NCT00065429|21106332|P5|Phase I - May 2001 - Oct 2002|Physician Decision|0
6124496|NCT00065429|21106333|P4|Phase I - May 2001 - Oct 2002|Physician Decision|0
6124497|NCT00065429|21106334|P3|Phase I - May 2001 - Oct 2002|Physician Decision|0
6124498|NCT00065429|21106335|P2|Phase I - May 2001 - Oct 2002|Physician Decision|0
6124499|NCT00065429|21106336|P1|Phase I - May 2001 - Oct 2002|Physician Decision|1
6124500|NCT00065429|21106330|P7|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
6124501|NCT00065429|21106331|P6|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
6124502|NCT00065429|21106332|P5|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
6124503|NCT00065429|21106333|P4|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
6124504|NCT00065429|21106334|P3|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|1
6124505|NCT00065429|21106335|P2|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
6124506|NCT00065429|21106336|P1|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
6124507|NCT00065429|21106330|P7|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
6124508|NCT00065429|21106331|P6|Phase I - May 2001 - Oct 2002|Lost to Follow-up|1
6124509|NCT00065429|21106332|P5|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
6124510|NCT00065429|21106333|P4|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
6124511|NCT00065429|21106334|P3|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
6124512|NCT00065429|21106335|P2|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
6124513|NCT00065429|21106336|P1|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
6124514|NCT00065260|21106350|P2|Overall Study|Death|1
6124515|NCT00065260|21106351|P1|Overall Study|Death|0
6124516|NCT00065182|21106359|P2|Overall Study|Decline in Status|1
6124517|NCT00065182|21106360|P1|Overall Study|Decline in Status|0
6124518|NCT00065182|21106359|P2|Overall Study|Death|1
6124519|NCT00065182|21106360|P1|Overall Study|Death|0
6124520|NCT00065182|21106359|P2|Overall Study|No clinical benefit|0
6124521|NCT00065182|21106360|P1|Overall Study|No clinical benefit|1
6124522|NCT00065182|21106359|P2|Overall Study|Withdrawal by Subject|3
6124523|NCT00065182|21106360|P1|Overall Study|Withdrawal by Subject|8
6124524|NCT00065182|21106359|P2|Overall Study|Sponsor Decision|7
6124525|NCT00065182|21106360|P1|Overall Study|Sponsor Decision|11
6124526|NCT00065182|21106359|P2|Overall Study|Serious adverse events (SAE)|0
6124527|NCT00065182|21106360|P1|Overall Study|Serious adverse events (SAE)|1
6124528|NCT00065182|21106359|P2|Overall Study|Protocol Violation|4
6124529|NCT00065182|21106360|P1|Overall Study|Protocol Violation|3
6124530|NCT00065182|21106359|P2|Overall Study|Lost to Follow-up|4
6124531|NCT00065182|21106360|P1|Overall Study|Lost to Follow-up|0
6124532|NCT00065182|21106359|P2|Overall Study|Adverse Event|17
6124533|NCT00065182|21106360|P1|Overall Study|Adverse Event|24
6124534|NCT00065156|21106386|P1|Overall Study|Secondary Malign Disease|1
6124535|NCT00065156|21106386|P1|Overall Study|Loss of Response|1
6124536|NCT00065156|21106386|P1|Overall Study|Non-Compliance|2
6124537|NCT00065156|21106386|P1|Overall Study|Investigator Decision|2
6124538|NCT00065156|21106386|P1|Overall Study|Disease Progression|7
6124539|NCT00065156|21106386|P1|Overall Study|Study Closed by Sponsor|2
6124540|NCT00065156|21106386|P1|Overall Study|Death|11
6124541|NCT00065156|21106386|P1|Overall Study|Lost to Follow-up|1
6124542|NCT00065156|21106386|P1|Overall Study|Withdrawal by Subject|8
6124543|NCT00065156|21106386|P1|Overall Study|Lack of Efficacy|52
6124544|NCT00065156|21106386|P1|Overall Study|Adverse Event|37
6124545|NCT00065065|21106403|P2|Overall Study|Other|2
6124546|NCT00065065|21106404|P1|Overall Study|Other|2
6124547|NCT00065065|21106403|P2|Overall Study|Lack of Efficacy|11
6124548|NCT00065065|21106404|P1|Overall Study|Lack of Efficacy|4
6124549|NCT00065065|21106403|P2|Overall Study|Withdrawal by Subject|5
6124550|NCT00065065|21106404|P1|Overall Study|Withdrawal by Subject|1
6124551|NCT00065065|21106403|P2|Overall Study|Adverse Event|2
6124552|NCT00065065|21106404|P1|Overall Study|Adverse Event|3
6124553|NCT00003895|21106416|P2|Overall Study|Withdrawal by Subject|3
6124554|NCT00003895|21106417|P1|Overall Study|Withdrawal by Subject|0
6124555|NCT00003895|21106416|P2|Overall Study|Patient Vacation|0
6124556|NCT00003895|21106417|P1|Overall Study|Patient Vacation|2
6124557|NCT00003895|21106416|P2|Overall Study|Lack of Efficacy|1
6124558|NCT00003895|21106417|P1|Overall Study|Lack of Efficacy|1
6124559|NCT00003895|21106416|P2|Overall Study|Adverse Event|0
6124560|NCT00003895|21106417|P1|Overall Study|Adverse Event|4
6124561|NCT00064987|21106425|P2|Overall Study|Physician Decision|0
6124562|NCT00064987|21106426|P1|Overall Study|Physician Decision|3
6124563|NCT00064753|21106457|P2|Overall Study|Lost to Follow-up|235
6124564|NCT00064753|21106458|P1|Overall Study|Lost to Follow-up|225
6124565|NCT00064753|21106457|P2|Overall Study|Withdrawal by Subject|171
6124566|NCT00064753|21106458|P1|Overall Study|Withdrawal by Subject|198
6124567|NCT00064753|21106457|P2|Overall Study|Death|242
6124568|NCT00064753|21106458|P1|Overall Study|Death|251
6124569|NCT00003645|21106488|P2|Overall Study|Withdrawal by Subject|3
6124570|NCT00003645|21106489|P1|Overall Study|Withdrawal by Subject|1
6124571|NCT00003645|21106488|P2|Overall Study|Lost to Follow-up|8
6124572|NCT00003645|21106489|P1|Overall Study|Lost to Follow-up|7
6124573|NCT00003645|21106488|P2|Overall Study|Death|1
6124574|NCT00003645|21106489|P1|Overall Study|Death|4
6124575|NCT00064792|21106503|P2|Overall Study|Adverse Event|0
6124576|NCT00064792|21106504|P1|Overall Study|Adverse Event|3
6124577|NCT00064792|21106503|P2|Overall Study|Withdrawal by Subject|0
6124578|NCT00064792|21106504|P1|Overall Study|Withdrawal by Subject|2
6124579|NCT00064701|21106515|P3|Clinical Continuation Phase|Patient opted out|1
6124580|NCT00064701|21106516|P2|Clinical Continuation Phase|Patient opted out|0
6124581|NCT00064701|21106517|P1|Clinical Continuation Phase|Patient opted out|0
6124582|NCT00064701|21106515|P3|Clinical Continuation Phase|Incorrect study drug dispensed|0
6124583|NCT00064701|21106516|P2|Clinical Continuation Phase|Incorrect study drug dispensed|1
6124584|NCT00064701|21106517|P1|Clinical Continuation Phase|Incorrect study drug dispensed|0
6124585|NCT00064701|21106515|P3|Clinical Continuation Phase|Discharged to nursing home|0
6124586|NCT00064701|21106516|P2|Clinical Continuation Phase|Discharged to nursing home|1
6124587|NCT00064701|21106517|P1|Clinical Continuation Phase|Discharged to nursing home|0
6124588|NCT00064701|21106515|P3|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0
6124589|NCT00064701|21106516|P2|Clinical Continuation Phase|Ran out of study drug due to Hurricane|1
6124590|NCT00064701|21106517|P1|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0
6124591|NCT00064701|21106515|P3|Clinical Continuation Phase|Pancreas transplant|0
6124592|NCT00064701|21106516|P2|Clinical Continuation Phase|Pancreas transplant|0
6124593|NCT00064701|21106517|P1|Clinical Continuation Phase|Pancreas transplant|1
6124594|NCT00064701|21106515|P3|Clinical Continuation Phase|Unable to return to site for study visit|1
6124595|NCT00064701|21106516|P2|Clinical Continuation Phase|Unable to return to site for study visit|0
6124596|NCT00064701|21106517|P1|Clinical Continuation Phase|Unable to return to site for study visit|1
6124597|NCT00064701|21106515|P3|Clinical Continuation Phase|Physician Decision|0
6124598|NCT00064701|21106516|P2|Clinical Continuation Phase|Physician Decision|3
6124599|NCT00064701|21106517|P1|Clinical Continuation Phase|Physician Decision|1
6124600|NCT00064701|21106515|P3|Clinical Continuation Phase|Immunosuppressive treatment crossover|6
6124601|NCT00064701|21106516|P2|Clinical Continuation Phase|Immunosuppressive treatment crossover|3
6124602|NCT00064701|21106517|P1|Clinical Continuation Phase|Immunosuppressive treatment crossover|0
6124603|NCT00064701|21106515|P3|Clinical Continuation Phase|Sponsor discontinued study|79
6124604|NCT00064701|21106516|P2|Clinical Continuation Phase|Sponsor discontinued study|129
6124605|NCT00064701|21106517|P1|Clinical Continuation Phase|Sponsor discontinued study|113
6124606|NCT00064701|21106515|P3|Clinical Continuation Phase|Rejection|2
6124607|NCT00064701|21106516|P2|Clinical Continuation Phase|Rejection|2
6124608|NCT00064701|21106517|P1|Clinical Continuation Phase|Rejection|1
6124609|NCT00064701|21106515|P3|Clinical Continuation Phase|Graft Failure|2
6124610|NCT00064701|21106516|P2|Clinical Continuation Phase|Graft Failure|5
6124611|NCT00064701|21106517|P1|Clinical Continuation Phase|Graft Failure|5
6124612|NCT00064701|21106515|P3|Clinical Continuation Phase|Lost to Follow-up|6
6124613|NCT00064701|21106516|P2|Clinical Continuation Phase|Lost to Follow-up|3
6124614|NCT00064701|21106517|P1|Clinical Continuation Phase|Lost to Follow-up|6
6124615|NCT00064701|21106515|P3|Clinical Continuation Phase|Withdrawal by Subject|22
6124616|NCT00064701|21106516|P2|Clinical Continuation Phase|Withdrawal by Subject|3
6124617|NCT00064701|21106517|P1|Clinical Continuation Phase|Withdrawal by Subject|22
6124618|NCT00064701|21106515|P3|Clinical Continuation Phase|Non-compliance|7
6124619|NCT00064701|21106516|P2|Clinical Continuation Phase|Non-compliance|6
6124620|NCT00064701|21106517|P1|Clinical Continuation Phase|Non-compliance|8
6124621|NCT00064701|21106515|P3|Clinical Continuation Phase|Adverse Event|14
6124622|NCT00064701|21106516|P2|Clinical Continuation Phase|Adverse Event|21
6124623|NCT00064701|21106517|P1|Clinical Continuation Phase|Adverse Event|12
6124624|NCT00064701|21106515|P3|One Year Post-transplant|Pancreas transplant|1
6124625|NCT00064701|21106516|P2|One Year Post-transplant|Pancreas transplant|0
6124626|NCT00064701|21106517|P1|One Year Post-transplant|Pancreas transplant|0
6124627|NCT00064701|21106515|P3|One Year Post-transplant|Poor absorption|0
6124628|NCT00064701|21106516|P2|One Year Post-transplant|Poor absorption|1
6124629|NCT00064701|21106517|P1|One Year Post-transplant|Poor absorption|0
6124630|NCT00064701|21106515|P3|One Year Post-transplant|Crossover secondary to possible toxicity|0
6124631|NCT00064701|21106516|P2|One Year Post-transplant|Crossover secondary to possible toxicity|1
6124632|NCT00064701|21106517|P1|One Year Post-transplant|Crossover secondary to possible toxicity|0
6124633|NCT00064701|21106515|P3|One Year Post-transplant|Incorrect study drug dispensed|0
6124634|NCT00064701|21106516|P2|One Year Post-transplant|Incorrect study drug dispensed|1
6124635|NCT00064701|21106517|P1|One Year Post-transplant|Incorrect study drug dispensed|0
6124636|NCT00064701|21106515|P3|One Year Post-transplant|Acute tubular necrosis|0
6124637|NCT00064701|21106516|P2|One Year Post-transplant|Acute tubular necrosis|0
6124638|NCT00064701|21106517|P1|One Year Post-transplant|Acute tubular necrosis|1
6124639|NCT00064701|21106515|P3|One Year Post-transplant|Converted to rapamycin|0
6124640|NCT00064701|21106516|P2|One Year Post-transplant|Converted to rapamycin|0
6124641|NCT00064701|21106517|P1|One Year Post-transplant|Converted to rapamycin|1
6124642|NCT00064701|21106515|P3|One Year Post-transplant|Lost to Follow-up|0
6124643|NCT00064701|21106516|P2|One Year Post-transplant|Lost to Follow-up|0
6124644|NCT00064701|21106517|P1|One Year Post-transplant|Lost to Follow-up|1
6124645|NCT00064701|21106515|P3|One Year Post-transplant|Withdrawal by Subject|1
6124646|NCT00064701|21106516|P2|One Year Post-transplant|Withdrawal by Subject|4
6124647|NCT00064701|21106517|P1|One Year Post-transplant|Withdrawal by Subject|0
6124648|NCT00064701|21106515|P3|One Year Post-transplant|Graft Failure|1
6124649|NCT00064701|21106516|P2|One Year Post-transplant|Graft Failure|2
6124650|NCT00064701|21106517|P1|One Year Post-transplant|Graft Failure|3
6124651|NCT00064701|21106515|P3|One Year Post-transplant|Non-compliance|5
6124652|NCT00064701|21106516|P2|One Year Post-transplant|Non-compliance|2
6124653|NCT00064701|21106517|P1|One Year Post-transplant|Non-compliance|4
6124654|NCT00064701|21106515|P3|One Year Post-transplant|Rejection|16
6124655|NCT00064701|21106516|P2|One Year Post-transplant|Rejection|1
6124656|NCT00064701|21106517|P1|One Year Post-transplant|Rejection|0
6124657|NCT00064701|21106515|P3|One Year Post-transplant|Adverse Event|37
6124658|NCT00064701|21106516|P2|One Year Post-transplant|Adverse Event|19
6124659|NCT00064701|21106517|P1|One Year Post-transplant|Adverse Event|23
6124660|NCT00064701|21106515|P3|One Year Post-transplant|Did not receive study drug|11
6124661|NCT00064701|21106516|P2|One Year Post-transplant|Did not receive study drug|12
6124662|NCT00064701|21106517|P1|One Year Post-transplant|Did not receive study drug|7
6124663|NCT00064662|21106569|P2|Overall Study|Administratively withdrawn|2
6124664|NCT00064662|21106570|P1|Overall Study|Administratively withdrawn|2
6124665|NCT00064662|21106569|P2|Overall Study|Withdrawal by Subject|14
6124666|NCT00064662|21106570|P1|Overall Study|Withdrawal by Subject|14
6124667|NCT00064662|21106569|P2|Overall Study|Lost to Follow-up|44
6124668|NCT00064662|21106570|P1|Overall Study|Lost to Follow-up|57
6124669|NCT00064662|21106569|P2|Overall Study|Death|1
6124670|NCT00064662|21106570|P1|Overall Study|Death|1
6124671|NCT00064350|21106581|P3|Cross-Over|Other|0
6124672|NCT00064350|21106582|P2|Cross-Over|Other|2
6124673|NCT00064350|21106583|P1|Cross-Over|Other|0
6124674|NCT00064350|21106581|P3|Cross-Over|Ineligible or never started treatment|0
6124675|NCT00064350|21106582|P2|Cross-Over|Ineligible or never started treatment|6
6124676|NCT00064350|21106583|P1|Cross-Over|Ineligible or never started treatment|3
6124677|NCT00064350|21106581|P3|Cross-Over|Withdrawal by Subject|0
6124678|NCT00064350|21106582|P2|Cross-Over|Withdrawal by Subject|2
6124679|NCT00064350|21106583|P1|Cross-Over|Withdrawal by Subject|2
6124680|NCT00064350|21106581|P3|Cross-Over|Death|0
6124681|NCT00064350|21106582|P2|Cross-Over|Death|3
6124682|NCT00064350|21106583|P1|Cross-Over|Death|1
6124683|NCT00064350|21106581|P3|Cross-Over|Adverse Event|0
6124684|NCT00064350|21106582|P2|Cross-Over|Adverse Event|1
6124685|NCT00064350|21106583|P1|Cross-Over|Adverse Event|0
6124686|NCT00064350|21106581|P3|Randomization|Other|0
6124687|NCT00064350|21106582|P2|Randomization|Other|0
6124688|NCT00064350|21106583|P1|Randomization|Other|5
6124689|NCT00064350|21106581|P3|Randomization|Ineligible or never started treatment|0
6124690|NCT00064350|21106582|P2|Randomization|Ineligible or never started treatment|15
6124691|NCT00064350|21106583|P1|Randomization|Ineligible or never started treatment|9
6124692|NCT00064350|21106581|P3|Randomization|Withdrawal by Subject|0
6124693|NCT00064350|21106582|P2|Randomization|Withdrawal by Subject|0
6124694|NCT00064350|21106583|P1|Randomization|Withdrawal by Subject|1
6124695|NCT00064350|21106581|P3|Randomization|Death|0
6124696|NCT00064350|21106582|P2|Randomization|Death|0
6124697|NCT00064350|21106583|P1|Randomization|Death|3
6124698|NCT00064350|21106581|P3|Randomization|Adverse Event|0
6124699|NCT00064350|21106582|P2|Randomization|Adverse Event|3
6124700|NCT00064350|21106583|P1|Randomization|Adverse Event|8
6124701|NCT00064350|21106581|P3|Induction Treatment|Other|13
6124702|NCT00064350|21106582|P2|Induction Treatment|Other|0
6124703|NCT00064350|21106583|P1|Induction Treatment|Other|0
6124704|NCT00064350|21106581|P3|Induction Treatment|Ineligible or never started treatment|34
6124705|NCT00064350|21106582|P2|Induction Treatment|Ineligible or never started treatment|6
6124706|NCT00064350|21106583|P1|Induction Treatment|Ineligible or never started treatment|3
6124707|NCT00064350|21106581|P3|Induction Treatment|Withdrawal by Subject|21
6124708|NCT00064350|21106582|P2|Induction Treatment|Withdrawal by Subject|0
6124709|NCT00064350|21106583|P1|Induction Treatment|Withdrawal by Subject|0
6124710|NCT00064350|21106581|P3|Induction Treatment|Death|9
6124711|NCT00064350|21106582|P2|Induction Treatment|Death|0
6124712|NCT00064350|21106583|P1|Induction Treatment|Death|0
6124713|NCT00064350|21106581|P3|Induction Treatment|Adverse Event|49
6124714|NCT00064350|21106582|P2|Induction Treatment|Adverse Event|2
6124715|NCT00064350|21106583|P1|Induction Treatment|Adverse Event|0
6124716|NCT00064350|21106581|P3|Induction Treatment|Disease Progression|110
6124717|NCT00064350|21106582|P2|Induction Treatment|Disease Progression|1
6124718|NCT00064350|21106583|P1|Induction Treatment|Disease Progression|5
6124719|NCT00064337|21106598|P1|Maintenance|Death|1
6124720|NCT00064337|21106598|P1|Maintenance|Not protocol-specified|2
6124721|NCT00064337|21106598|P1|Maintenance|On treatment at time of analysis|2
6124722|NCT00064337|21106598|P1|Maintenance|Progression|2
6124723|NCT00064337|21106598|P1|Maintenance|Adverse Event|3
6124724|NCT00064337|21106598|P1|Transplant|Progression|2
6124725|NCT00064337|21106598|P1|Transplant|Patient Refusal|2
6124726|NCT00064337|21106598|P1|Transplant|Death|3
6124727|NCT00064337|21106598|P1|Transplant|Not protocol-specified|5
6124728|NCT00064337|21106598|P1|Transplant|Adverse Event|9
6124729|NCT00064337|21106598|P1|PBSCC or Induction/PBSCC|Death|2
6124730|NCT00064337|21106598|P1|PBSCC or Induction/PBSCC|Patient Refusal|2
6124731|NCT00064337|21106598|P1|PBSCC or Induction/PBSCC|Progression|3
6124732|NCT00064337|21106598|P1|PBSCC or Induction/PBSCC|Adverse Event|6
6124733|NCT00064337|21106598|P1|PBSCC or Induction/PBSCC|Not protocol-specified|7
6124734|NCT00064298|21106607|P2|Overall Study|Disease Progression|1
6124735|NCT00064298|21106608|P1|Overall Study|Disease Progression|2
6124736|NCT00064298|21106607|P2|Overall Study|Death|1
6124737|NCT00064298|21106608|P1|Overall Study|Death|0
6124738|NCT00064298|21106607|P2|Overall Study|Lost to Follow-up|2
6124739|NCT00064298|21106608|P1|Overall Study|Lost to Follow-up|2
6124740|NCT00064298|21106607|P2|Overall Study|Withdrawal by Subject|1
6124741|NCT00064298|21106608|P1|Overall Study|Withdrawal by Subject|2
6124746|NCT00064077|21106627|P4|Overall Study|Other reasons|2
6124747|NCT00064077|21106628|P3|Overall Study|Other reasons|1
6124748|NCT00064077|21106629|P2|Overall Study|Other reasons|2
6124749|NCT00064077|21106630|P1|Overall Study|Other reasons|2
6124750|NCT00064077|21106627|P4|Overall Study|No tumor|0
6124751|NCT00064077|21106628|P3|Overall Study|No tumor|1
6124752|NCT00064077|21106629|P2|Overall Study|No tumor|0
6124753|NCT00064077|21106630|P1|Overall Study|No tumor|0
6124754|NCT00064077|21106627|P4|Overall Study|No surgery|0
6124755|NCT00064077|21106628|P3|Overall Study|No surgery|1
6124756|NCT00064077|21106629|P2|Overall Study|No surgery|0
6124757|NCT00064077|21106630|P1|Overall Study|No surgery|0
6124758|NCT00064077|21106627|P4|Overall Study|Pathology|4
6124759|NCT00064077|21106628|P3|Overall Study|Pathology|3
6124760|NCT00064077|21106629|P2|Overall Study|Pathology|7
6124761|NCT00064077|21106630|P1|Overall Study|Pathology|10
6124762|NCT00064077|21106627|P4|Overall Study|Poor risk|1
6124763|NCT00064077|21106628|P3|Overall Study|Poor risk|1
6124764|NCT00064077|21106629|P2|Overall Study|Poor risk|0
6124765|NCT00064077|21106630|P1|Overall Study|Poor risk|2
6124766|NCT00064077|21106627|P4|Overall Study|Improper prior treatment|0
6124767|NCT00064077|21106628|P3|Overall Study|Improper prior treatment|0
6124768|NCT00064077|21106629|P2|Overall Study|Improper prior treatment|0
6124769|NCT00064077|21106630|P1|Overall Study|Improper prior treatment|1
6124770|NCT00064025|21106674|P1|Overall Study|Inevaluable|3
6124771|NCT00064025|21106674|P1|Overall Study|Ineligible|4
6124772|NCT00063999|21106683|P2|Overall Study|Ineligible|24
6124773|NCT00063999|21106684|P1|Overall Study|Ineligible|44
6124774|NCT00063999|21106683|P2|Overall Study|Withdrawal by Subject|0
6124775|NCT00063999|21106684|P1|Overall Study|Withdrawal by Subject|1
6124776|NCT00063986|21106700|P1|Overall Study|Intra-operatively ineligible|4
6124777|NCT00063986|21106700|P1|Overall Study|Ineligible|1
6124778|NCT00063986|21106700|P1|Overall Study|Withdrawal by Subject|1
6124779|NCT00063934|21106712|P1|Overall Study|Ineligible|1
6124780|NCT00063882|21106721|P2|Overall Study|Withdrawal by Subject|1
6124781|NCT00063882|21106722|P1|Overall Study|Withdrawal by Subject|2
6124782|NCT00063882|21106721|P2|Overall Study|Protocol Violation|3
6124783|NCT00063882|21106722|P1|Overall Study|Protocol Violation|3
6124784|NCT00063258|21106849|P2|Overall Study|Lack of Efficacy|0
6124785|NCT00063258|21106850|P1|Overall Study|Lack of Efficacy|2
6124786|NCT00063258|21106849|P2|Overall Study|Physician Decision|0
6124787|NCT00063258|21106850|P1|Overall Study|Physician Decision|2
6124788|NCT00063154|21106856|P1|Overall Study|Did not receive treatment|8
6124789|NCT00063154|21106856|P1|Overall Study|Reason unspecified|1
6124790|NCT00063154|21106856|P1|Overall Study|Death|3
6124791|NCT00063154|21106856|P1|Overall Study|Physician Decision|10
6124792|NCT00063154|21106856|P1|Overall Study|Adverse Event|2
6124793|NCT00063154|21106856|P1|Overall Study|Disease progression|27
6124794|NCT00062868|21106890|P21|Dose Level 3|Withdrew|0
6124795|NCT00062868|21106891|P20|Dose Level 3|Withdrew|0
6124796|NCT00062868|21106892|P19|Dose Level 3|Withdrew|0
6124797|NCT00062868|21106893|P18|Dose Level 3|Withdrew|0
6124798|NCT00062868|21106894|P17|Dose Level 3|Withdrew|0
6124799|NCT00062868|21106895|P16|Dose Level 3|Withdrew|0
6124800|NCT00062868|21106896|P15|Dose Level 3|Withdrew|0
6124801|NCT00062868|21106897|P14|Dose Level 3|Withdrew|0
6124802|NCT00062868|21106898|P13|Dose Level 3|Withdrew|0
6124803|NCT00062868|21106899|P12|Dose Level 3|Withdrew|0
6124804|NCT00062868|21106900|P11|Dose Level 3|Withdrew|0
6124805|NCT00062868|21106901|P10|Dose Level 3|Withdrew|0
6124806|NCT00062868|21106902|P9|Dose Level 3|Withdrew|0
6124807|NCT00062868|21106903|P8|Dose Level 3|Withdrew|0
6124808|NCT00062868|21106904|P7|Dose Level 3|Withdrew|0
6124809|NCT00062868|21106905|P6|Dose Level 3|Withdrew|0
6124810|NCT00062868|21106906|P5|Dose Level 3|Withdrew|0
6124811|NCT00062868|21106907|P4|Dose Level 3|Withdrew|0
6124812|NCT00062868|21106908|P3|Dose Level 3|Withdrew|2
6124813|NCT00062868|21106909|P2|Dose Level 3|Withdrew|0
6124814|NCT00062868|21106910|P1|Dose Level 3|Withdrew|0
6124815|NCT00062868|21106890|P21|Dose Level 3|Lost to Follow-up|0
6124816|NCT00062868|21106891|P20|Dose Level 3|Lost to Follow-up|0
6124817|NCT00062868|21106892|P19|Dose Level 3|Lost to Follow-up|0
6124818|NCT00062868|21106893|P18|Dose Level 3|Lost to Follow-up|0
6124819|NCT00062868|21106894|P17|Dose Level 3|Lost to Follow-up|0
6124820|NCT00062868|21106895|P16|Dose Level 3|Lost to Follow-up|0
6124821|NCT00062868|21106896|P15|Dose Level 3|Lost to Follow-up|1
6124822|NCT00062868|21106897|P14|Dose Level 3|Lost to Follow-up|0
6124823|NCT00062868|21106898|P13|Dose Level 3|Lost to Follow-up|0
6124824|NCT00062868|21106899|P12|Dose Level 3|Lost to Follow-up|0
6124825|NCT00062868|21106900|P11|Dose Level 3|Lost to Follow-up|0
6124826|NCT00062868|21106901|P10|Dose Level 3|Lost to Follow-up|0
6124827|NCT00062868|21106902|P9|Dose Level 3|Lost to Follow-up|0
6124828|NCT00062868|21106903|P8|Dose Level 3|Lost to Follow-up|0
6124829|NCT00062868|21106904|P7|Dose Level 3|Lost to Follow-up|0
6124830|NCT00062868|21106905|P6|Dose Level 3|Lost to Follow-up|0
6124831|NCT00062868|21106906|P5|Dose Level 3|Lost to Follow-up|0
6124832|NCT00062868|21106907|P4|Dose Level 3|Lost to Follow-up|0
6124833|NCT00062868|21106908|P3|Dose Level 3|Lost to Follow-up|0
6124834|NCT00062868|21106909|P2|Dose Level 3|Lost to Follow-up|0
6124835|NCT00062868|21106910|P1|Dose Level 3|Lost to Follow-up|0
6124836|NCT00062868|21106890|P21|Dose Level 3|Death|0
6124837|NCT00062868|21106891|P20|Dose Level 3|Death|0
6124838|NCT00062868|21106892|P19|Dose Level 3|Death|0
6124839|NCT00062868|21106893|P18|Dose Level 3|Death|1
6124840|NCT00062868|21106894|P17|Dose Level 3|Death|0
6124841|NCT00062868|21106895|P16|Dose Level 3|Death|0
6124842|NCT00062868|21106896|P15|Dose Level 3|Death|0
6124843|NCT00062868|21106897|P14|Dose Level 3|Death|0
6124844|NCT00062868|21106898|P13|Dose Level 3|Death|0
6124845|NCT00062868|21106899|P12|Dose Level 3|Death|1
6124846|NCT00062868|21106900|P11|Dose Level 3|Death|0
6124847|NCT00062868|21106901|P10|Dose Level 3|Death|0
6124848|NCT00062868|21106902|P9|Dose Level 3|Death|0
6124849|NCT00062868|21106903|P8|Dose Level 3|Death|0
6124850|NCT00062868|21106904|P7|Dose Level 3|Death|0
6124851|NCT00062868|21106905|P6|Dose Level 3|Death|0
6124852|NCT00062868|21106906|P5|Dose Level 3|Death|0
6124853|NCT00062868|21106907|P4|Dose Level 3|Death|0
6124854|NCT00062868|21106908|P3|Dose Level 3|Death|0
6124855|NCT00062868|21106909|P2|Dose Level 3|Death|0
6124856|NCT00062868|21106910|P1|Dose Level 3|Death|0
6124857|NCT00062868|21106890|P21|Dose Level 2|Lost to Follow-up|0
6124858|NCT00062868|21106891|P20|Dose Level 2|Lost to Follow-up|0
6124859|NCT00062868|21106892|P19|Dose Level 2|Lost to Follow-up|0
6124860|NCT00062868|21106893|P18|Dose Level 2|Lost to Follow-up|0
6124861|NCT00062868|21106894|P17|Dose Level 2|Lost to Follow-up|1
6124862|NCT00062868|21106895|P16|Dose Level 2|Lost to Follow-up|0
6124863|NCT00062868|21106896|P15|Dose Level 2|Lost to Follow-up|0
6124864|NCT00062868|21106897|P14|Dose Level 2|Lost to Follow-up|1
6124865|NCT00062868|21106898|P13|Dose Level 2|Lost to Follow-up|0
6124866|NCT00062868|21106899|P12|Dose Level 2|Lost to Follow-up|0
6124867|NCT00062868|21106900|P11|Dose Level 2|Lost to Follow-up|0
6124868|NCT00062868|21106901|P10|Dose Level 2|Lost to Follow-up|0
6124869|NCT00062868|21106902|P9|Dose Level 2|Lost to Follow-up|0
6124870|NCT00062868|21106903|P8|Dose Level 2|Lost to Follow-up|0
6124871|NCT00062868|21106904|P7|Dose Level 2|Lost to Follow-up|0
6124872|NCT00062868|21106905|P6|Dose Level 2|Lost to Follow-up|0
6124873|NCT00062868|21106906|P5|Dose Level 2|Lost to Follow-up|0
6124874|NCT00062868|21106907|P4|Dose Level 2|Lost to Follow-up|0
6124875|NCT00062868|21106908|P3|Dose Level 2|Lost to Follow-up|0
6124876|NCT00062868|21106909|P2|Dose Level 2|Lost to Follow-up|0
6124877|NCT00062868|21106910|P1|Dose Level 2|Lost to Follow-up|0
6124878|NCT00062868|21106890|P21|Dose Level 2|Death|0
6124879|NCT00062868|21106891|P20|Dose Level 2|Death|0
6124880|NCT00062868|21106892|P19|Dose Level 2|Death|0
6124881|NCT00062868|21106893|P18|Dose Level 2|Death|0
6124882|NCT00062868|21106894|P17|Dose Level 2|Death|2
6124883|NCT00062868|21106895|P16|Dose Level 2|Death|0
6124884|NCT00062868|21106896|P15|Dose Level 2|Death|0
6124885|NCT00062868|21106897|P14|Dose Level 2|Death|0
6124886|NCT00062868|21106898|P13|Dose Level 2|Death|0
6124887|NCT00062868|21106899|P12|Dose Level 2|Death|0
6124888|NCT00062868|21106900|P11|Dose Level 2|Death|1
6124889|NCT00062868|21106901|P10|Dose Level 2|Death|0
6124890|NCT00062868|21106902|P9|Dose Level 2|Death|0
6124891|NCT00062868|21106903|P8|Dose Level 2|Death|0
6124892|NCT00062868|21106904|P7|Dose Level 2|Death|0
6124893|NCT00062868|21106905|P6|Dose Level 2|Death|0
6124894|NCT00062868|21106906|P5|Dose Level 2|Death|2
6124895|NCT00062868|21106907|P4|Dose Level 2|Death|0
6124896|NCT00062868|21106908|P3|Dose Level 2|Death|0
6124897|NCT00062868|21106909|P2|Dose Level 2|Death|3
6124898|NCT00062868|21106910|P1|Dose Level 2|Death|0
6124899|NCT00062868|21106890|P21|Dose Level 1|Lost to Follow-up|1
6124900|NCT00062868|21106891|P20|Dose Level 1|Lost to Follow-up|0
6124901|NCT00062868|21106892|P19|Dose Level 1|Lost to Follow-up|2
6124902|NCT00062868|21106893|P18|Dose Level 1|Lost to Follow-up|0
6124903|NCT00062868|21106894|P17|Dose Level 1|Lost to Follow-up|0
6124904|NCT00062868|21106895|P16|Dose Level 1|Lost to Follow-up|0
6124905|NCT00062868|21106896|P15|Dose Level 1|Lost to Follow-up|0
6124906|NCT00062868|21106897|P14|Dose Level 1|Lost to Follow-up|0
6124907|NCT00062868|21106898|P13|Dose Level 1|Lost to Follow-up|1
6124908|NCT00062868|21106899|P12|Dose Level 1|Lost to Follow-up|0
6124909|NCT00062868|21106900|P11|Dose Level 1|Lost to Follow-up|0
6124910|NCT00062868|21106901|P10|Dose Level 1|Lost to Follow-up|0
6124911|NCT00062868|21106902|P9|Dose Level 1|Lost to Follow-up|0
6124912|NCT00062868|21106903|P8|Dose Level 1|Lost to Follow-up|0
6124913|NCT00062868|21106904|P7|Dose Level 1|Lost to Follow-up|0
6124914|NCT00062868|21106905|P6|Dose Level 1|Lost to Follow-up|0
6124915|NCT00062868|21106906|P5|Dose Level 1|Lost to Follow-up|0
6124916|NCT00062868|21106907|P4|Dose Level 1|Lost to Follow-up|0
6124917|NCT00062868|21106908|P3|Dose Level 1|Lost to Follow-up|0
6124918|NCT00062868|21106909|P2|Dose Level 1|Lost to Follow-up|0
6124919|NCT00062868|21106910|P1|Dose Level 1|Lost to Follow-up|0
6124920|NCT00062868|21106890|P21|Dose Level 1|Death|1
6124921|NCT00062868|21106891|P20|Dose Level 1|Death|0
6124922|NCT00062868|21106892|P19|Dose Level 1|Death|7
6124923|NCT00062868|21106893|P18|Dose Level 1|Death|0
6124924|NCT00062868|21106894|P17|Dose Level 1|Death|0
6124925|NCT00062868|21106895|P16|Dose Level 1|Death|0
6124926|NCT00062868|21106896|P15|Dose Level 1|Death|0
6124927|NCT00062868|21106897|P14|Dose Level 1|Death|0
6124928|NCT00062868|21106898|P13|Dose Level 1|Death|0
6124929|NCT00062868|21106899|P12|Dose Level 1|Death|0
6124930|NCT00062868|21106900|P11|Dose Level 1|Death|0
6124931|NCT00062868|21106901|P10|Dose Level 1|Death|0
6124932|NCT00062868|21106902|P9|Dose Level 1|Death|0
6124933|NCT00062868|21106903|P8|Dose Level 1|Death|0
6124934|NCT00062868|21106904|P7|Dose Level 1|Death|3
6124935|NCT00062868|21106905|P6|Dose Level 1|Death|0
6124936|NCT00062868|21106906|P5|Dose Level 1|Death|0
6124937|NCT00062868|21106907|P4|Dose Level 1|Death|2
6124938|NCT00062868|21106908|P3|Dose Level 1|Death|0
6124939|NCT00062868|21106909|P2|Dose Level 1|Death|0
6124940|NCT00062868|21106910|P1|Dose Level 1|Death|2
6124941|NCT00062751|21107009|P5|Overall Study|Death|0
6124942|NCT00062751|21107010|P4|Overall Study|Death|0
6124943|NCT00062751|21107011|P3|Overall Study|Death|1
6124944|NCT00062751|21107012|P2|Overall Study|Death|0
6124945|NCT00062751|21107013|P1|Overall Study|Death|1
6124946|NCT00062751|21107009|P5|Overall Study|Symptomatic deterioration|1
6124947|NCT00062751|21107010|P4|Overall Study|Symptomatic deterioration|0
6124948|NCT00062751|21107011|P3|Overall Study|Symptomatic deterioration|0
6124949|NCT00062751|21107012|P2|Overall Study|Symptomatic deterioration|1
6124950|NCT00062751|21107013|P1|Overall Study|Symptomatic deterioration|1
6124951|NCT00062751|21107009|P5|Overall Study|Withdrawal by Subject|0
6124952|NCT00062751|21107010|P4|Overall Study|Withdrawal by Subject|1
6124953|NCT00062751|21107011|P3|Overall Study|Withdrawal by Subject|2
6124954|NCT00062751|21107012|P2|Overall Study|Withdrawal by Subject|2
6124955|NCT00062751|21107013|P1|Overall Study|Withdrawal by Subject|1
6124956|NCT00062751|21107009|P5|Overall Study|Other|1
6124957|NCT00062751|21107010|P4|Overall Study|Other|0
6124958|NCT00062751|21107011|P3|Overall Study|Other|1
6124959|NCT00062751|21107012|P2|Overall Study|Other|3
6124960|NCT00062751|21107013|P1|Overall Study|Other|2
6124961|NCT00062751|21107009|P5|Overall Study|Adverse Event|2
6124962|NCT00062751|21107010|P4|Overall Study|Adverse Event|2
6124963|NCT00062751|21107011|P3|Overall Study|Adverse Event|2
6124964|NCT00062751|21107012|P2|Overall Study|Adverse Event|7
6124965|NCT00062751|21107013|P1|Overall Study|Adverse Event|4
6124966|NCT00062751|21107009|P5|Overall Study|Disease progression|2
6124967|NCT00062751|21107010|P4|Overall Study|Disease progression|2
6124968|NCT00062751|21107011|P3|Overall Study|Disease progression|24
6124969|NCT00062751|21107012|P2|Overall Study|Disease progression|17
6124970|NCT00062751|21107013|P1|Overall Study|Disease progression|24
6124971|NCT00062647|21107099|P2|Overall Study|Never received study treatment|1
6124972|NCT00062647|21107100|P1|Overall Study|Never received study treatment|1
6124973|NCT00062647|21107099|P2|Overall Study|Other|4
6124974|NCT00062647|21107100|P1|Overall Study|Other|4
6124975|NCT00062647|21107099|P2|Overall Study|Failed continuation criteria|2
6124976|NCT00062647|21107100|P1|Overall Study|Failed continuation criteria|4
6124977|NCT00062647|21107099|P2|Overall Study|Lost to Follow-up|2
6124978|NCT00062647|21107100|P1|Overall Study|Lost to Follow-up|1
6124979|NCT00062647|21107099|P2|Overall Study|Protocol Violation|0
6124980|NCT00062647|21107100|P1|Overall Study|Protocol Violation|1
6124981|NCT00062647|21107099|P2|Overall Study|Withdrawal by Subject|1
6124982|NCT00062647|21107100|P1|Overall Study|Withdrawal by Subject|2
6124983|NCT00062647|21107099|P2|Overall Study|Adverse Event|1
6124984|NCT00062647|21107100|P1|Overall Study|Adverse Event|1
6124985|NCT00062647|21107099|P2|Overall Study|Death|2
6124986|NCT00062647|21107100|P1|Overall Study|Death|2
6124987|NCT00062439|21107106|P1|Consolidation Chemotherapy|Adverse Event|2
6124988|NCT00062439|21107106|P1|Surgery|Adverse Event|2
6124989|NCT00062439|21107106|P1|Surgery|Death|1
6124990|NCT00062439|21107106|P1|Surgery|Physician Decision|4
6125078|NCT00059215|21107372|P1|Overall Study|Physician Decision|1
6124991|NCT00062439|21107106|P1|Post Chemoradiation Assessment|Not eligible to continue to surgery|4
6124992|NCT00062439|21107106|P1|Post Chemoradiation Assessment|Physician Decision|1
6124993|NCT00062439|21107106|P1|Post Chemoradiation Assessment|Withdrawal by Subject|1
6124994|NCT00062439|21107106|P1|Post Chemoradiation Assessment|Disease progression|2
6124995|NCT00062439|21107106|P1|Post Chemoradiation Assessment|Death|1
6124996|NCT00062439|21107106|P1|Induction Chemotherapy + Radiotherapy|Lack of Efficacy|3
6124997|NCT00062439|21107106|P1|Induction Chemotherapy + Radiotherapy|Adverse Event|3
6124998|NCT00062439|21107106|P1|Induction Chemotherapy + Radiotherapy|Refused protocol treatment|1
6124999|NCT00062439|21107106|P1|Induction Chemotherapy + Radiotherapy|Ineligible|1
6125000|NCT00062374|21107118|P1|Overall Study|Not treated|12
6125001|NCT00062166|21107123|P1|Overall Study|Withdrawal by Subject|6
6125002|NCT00062010|21107131|P1|Overall Study|Ineligible|3
6125003|NCT00061945|21107139|P2|Course IV: Alemtuzumab|Early exits|15
6125004|NCT00061945|21107140|P1|Course IV: Alemtuzumab|Early exits|6
6125005|NCT00061945|21107139|P2|Course IV: Alemtuzumab|Declined Alemtuzumab|1
6125006|NCT00061945|21107140|P1|Course IV: Alemtuzumab|Declined Alemtuzumab|1
6125007|NCT00061945|21107139|P2|Registration Through Course 3|Early discontinuation during course I-IV|90
6125008|NCT00061945|21107140|P1|Registration Through Course 3|Early discontinuation during course I-IV|76
6125009|NCT00061945|21107139|P2|Registration Through Course 3|Not Alemtuzumab Eligible|25
6125010|NCT00061945|21107140|P1|Registration Through Course 3|Not Alemtuzumab Eligible|18
6125013|NCT00061633|21107164|P2|Overall Study|Never received study treatment|2
6125014|NCT00061633|21107165|P1|Overall Study|Never received study treatment|0
6125015|NCT00061633|21107164|P2|Overall Study|Other|1
6125016|NCT00061633|21107165|P1|Overall Study|Other|1
6125017|NCT00061633|21107164|P2|Overall Study|Lost to Follow-up|4
6125018|NCT00061633|21107165|P1|Overall Study|Lost to Follow-up|1
6125019|NCT00061633|21107164|P2|Overall Study|Withdrawal by Subject|2
6125020|NCT00061633|21107165|P1|Overall Study|Withdrawal by Subject|2
6125021|NCT00061633|21107164|P2|Overall Study|Adverse Event|2
6125022|NCT00061633|21107165|P1|Overall Study|Adverse Event|1
6125023|NCT00061048|21107190|P1|Overall Study|disease progression|20
6125024|NCT00061048|21107190|P1|Overall Study|Adverse Event|2
6125025|NCT00060944|21107200|P2|Overall Study|randomized but not treated|4
6125026|NCT00060944|21107201|P1|Overall Study|randomized but not treated|6
6125027|NCT00060944|21107200|P2|Overall Study|Other|4
6125028|NCT00060944|21107201|P1|Overall Study|Other|2
6125029|NCT00060944|21107200|P2|Overall Study|Treatment Switch|13
6125030|NCT00060944|21107201|P1|Overall Study|Treatment Switch|0
6125031|NCT00060944|21107200|P2|Overall Study|Subject Ineligible To Continue|1
6125032|NCT00060944|21107201|P1|Overall Study|Subject Ineligible To Continue|2
6125033|NCT00060944|21107200|P2|Overall Study|Lost to Follow-up|0
6125034|NCT00060944|21107201|P1|Overall Study|Lost to Follow-up|1
6125035|NCT00060944|21107200|P2|Overall Study|Disease Progression|94
6125036|NCT00060944|21107201|P1|Overall Study|Disease Progression|93
6125037|NCT00060944|21107200|P2|Overall Study|Withdrawal by Subject|5
6125038|NCT00060944|21107201|P1|Overall Study|Withdrawal by Subject|18
6125039|NCT00060944|21107200|P2|Overall Study|Death|3
6125040|NCT00060944|21107201|P1|Overall Study|Death|2
6125041|NCT00060944|21107200|P2|Overall Study|Adverse Event|10
6125042|NCT00060944|21107201|P1|Overall Study|Adverse Event|12
6125043|NCT00060840|21107217|P2|Overall Study|Other|0
6125044|NCT00060840|21107218|P1|Overall Study|Other|1
6125045|NCT00060840|21107217|P2|Overall Study|Physician Decision|0
6125046|NCT00060840|21107218|P1|Overall Study|Physician Decision|1
6125047|NCT00060840|21107217|P2|Overall Study|Subinvestigator unavailable|1
6125048|NCT00060840|21107218|P1|Overall Study|Subinvestigator unavailable|0
6125049|NCT00060840|21107217|P2|Overall Study|Withdrawal by Subject|1
6125050|NCT00060840|21107218|P1|Overall Study|Withdrawal by Subject|0
6125051|NCT00060840|21107217|P2|Overall Study|Death|1
6125052|NCT00060840|21107218|P1|Overall Study|Death|0
6125053|NCT00060840|21107217|P2|Overall Study|Change in surgical plan|6
6125054|NCT00060840|21107218|P1|Overall Study|Change in surgical plan|2
6125055|NCT00059839|21107284|P2|Overall Study|Ineligible|3
6125056|NCT00059839|21107285|P1|Overall Study|Ineligible|1
6125057|NCT00059839|21107284|P2|Overall Study|Withdrawal by Subject|6
6125058|NCT00059839|21107285|P1|Overall Study|Withdrawal by Subject|1
6125059|NCT00059839|21107284|P2|Overall Study|Physician Decision|2
6125060|NCT00059839|21107285|P1|Overall Study|Physician Decision|1
6125061|NCT00059839|21107284|P2|Overall Study|Lost to Follow-up|0
6125062|NCT00059839|21107285|P1|Overall Study|Lost to Follow-up|2
6125063|NCT00059839|21107284|P2|Overall Study|Lack of Efficacy|5
6125064|NCT00059839|21107285|P1|Overall Study|Lack of Efficacy|6
6125065|NCT00059839|21107284|P2|Overall Study|Death|1
6125066|NCT00059839|21107285|P1|Overall Study|Death|1
6125067|NCT00059787|21107291|P1|Overall Study|Other|4
6125068|NCT00059787|21107291|P1|Overall Study|ineligible|1
6125069|NCT00059787|21107291|P1|Overall Study|disease progression|2
6125070|NCT00059787|21107291|P1|Overall Study|Adverse Event|13
6125071|NCT00059332|21107342|P2|Overall Study|Lost to Follow-up|1
6125072|NCT00059332|21107343|P1|Overall Study|Lost to Follow-up|1
6125073|NCT00059332|21107342|P2|Overall Study|Withdrawal by Subject|1
6125074|NCT00059332|21107343|P1|Overall Study|Withdrawal by Subject|2
6125075|NCT00059215|21107369|P4|Overall Study|Physician Decision|1
6125076|NCT00059215|21107370|P3|Overall Study|Physician Decision|1
6125077|NCT00059215|21107371|P2|Overall Study|Physician Decision|2
6125079|NCT00059215|21107369|P4|Overall Study|Protocol entry criteria not met|2
6125080|NCT00059215|21107370|P3|Overall Study|Protocol entry criteria not met|0
6125081|NCT00059215|21107371|P2|Overall Study|Protocol entry criteria not met|1
6125082|NCT00059215|21107372|P1|Overall Study|Protocol entry criteria not met|1
6125083|NCT00059215|21107369|P4|Overall Study|Protocol Violation|0
6125084|NCT00059215|21107370|P3|Overall Study|Protocol Violation|1
6125085|NCT00059215|21107371|P2|Overall Study|Protocol Violation|0
6125086|NCT00059215|21107372|P1|Overall Study|Protocol Violation|1
6125087|NCT00059215|21107369|P4|Overall Study|Withdrawal by Subject|3
6125088|NCT00059215|21107370|P3|Overall Study|Withdrawal by Subject|1
6125089|NCT00059215|21107371|P2|Overall Study|Withdrawal by Subject|4
6125090|NCT00059215|21107372|P1|Overall Study|Withdrawal by Subject|4
6125091|NCT00059215|21107369|P4|Overall Study|Lost to Follow-up|0
6125092|NCT00059215|21107370|P3|Overall Study|Lost to Follow-up|0
6125093|NCT00059215|21107371|P2|Overall Study|Lost to Follow-up|2
6125094|NCT00059215|21107372|P1|Overall Study|Lost to Follow-up|1
6125095|NCT00059215|21107369|P4|Overall Study|Death|0
6125096|NCT00059215|21107370|P3|Overall Study|Death|3
6125097|NCT00059215|21107371|P2|Overall Study|Death|0
6125098|NCT00059215|21107372|P1|Overall Study|Death|0
6125099|NCT00059215|21107369|P4|Overall Study|Adverse Event|9
6125100|NCT00059215|21107370|P3|Overall Study|Adverse Event|9
6125101|NCT00059215|21107371|P2|Overall Study|Adverse Event|5
6125102|NCT00059215|21107372|P1|Overall Study|Adverse Event|5
6125103|NCT00058825|21107409|P1|Overall Study|Death|3
6125104|NCT00058825|21107409|P1|Overall Study|Graft Failure|5
6125105|NCT00058825|21107409|P1|Overall Study|Progressive Disease|5
6125106|NCT00058825|21107409|P1|Overall Study|Relapse|9
6125107|NCT00058552|21107425|P2|Overall Study|Clinical disease progression|4
6125108|NCT00058552|21107426|P1|Overall Study|Clinical disease progression|0
6125109|NCT00058552|21107425|P2|Overall Study|Physician Decision|5
6125110|NCT00058552|21107426|P1|Overall Study|Physician Decision|2
6125111|NCT00058552|21107425|P2|Overall Study|Withdrawal by Subject|5
6125112|NCT00058552|21107426|P1|Overall Study|Withdrawal by Subject|3
6125113|NCT00058552|21107425|P2|Overall Study|Adverse Event|2
6125114|NCT00058552|21107426|P1|Overall Study|Adverse Event|4
6125115|NCT00058552|21107425|P2|Overall Study|Disease progression|44
6125116|NCT00058552|21107426|P1|Overall Study|Disease progression|52
6125117|NCT00058552|21107425|P2|Overall Study|Died prior to receiving treatment|2
6125118|NCT00058552|21107426|P1|Overall Study|Died prior to receiving treatment|4
6125119|NCT00058539|21107444|P1|Overall Study|Death|1
6125120|NCT00058539|21107444|P1|Overall Study|Physician Decision|9
6125121|NCT00058539|21107444|P1|Overall Study|Withdrawal by Subject|5
6125122|NCT00058539|21107444|P1|Overall Study|Adverse Event|3
6125123|NCT00058539|21107444|P1|Overall Study|Disease progression|24
6125124|NCT00058422|21107454|P1|Overall Study|Not treated|2
6125125|NCT00058214|21107485|P1|Overall Study|Adverse Event|1
6125126|NCT00058123|21107507|P1|Overall Study|Received >3 prior treatments|1
6125127|NCT00058123|21107507|P1|Overall Study|Wrong histology|9
6125128|NCT00058058|21107514|P1|Overall Study|Poor positioning, illness,pain|3
6125129|NCT00058058|21107514|P1|Overall Study|technical issues|6
6125130|NCT00058058|21107514|P1|Overall Study|Claustrophobic|5
6125131|NCT00058058|21107514|P1|Overall Study|Ineligible|20
6125132|NCT00058058|21107514|P1|Overall Study|Withdrawal by Subject|4
6125133|NCT00057954|21107539|P1|Overall Study|Disease progression|1
6125134|NCT00057954|21107539|P1|Overall Study|Death|1
6125135|NCT00057941|21107547|P2|Overall Study|Ineligible|5
6125136|NCT00057941|21107548|P1|Overall Study|Ineligible|2
6125137|NCT00057941|21107547|P2|Overall Study|insurance, symptomatic deterioration|3
6125138|NCT00057941|21107548|P1|Overall Study|insurance, symptomatic deterioration|1
6125139|NCT00057941|21107547|P2|Overall Study|still on treatment|1
6125140|NCT00057941|21107548|P1|Overall Study|still on treatment|3
6125141|NCT00057941|21107547|P2|Overall Study|Withdrawal by Subject|1
6125142|NCT00057941|21107548|P1|Overall Study|Withdrawal by Subject|6
6125143|NCT00057941|21107547|P2|Overall Study|Lack of Efficacy|53
6125144|NCT00057941|21107548|P1|Overall Study|Lack of Efficacy|54
6125145|NCT00057941|21107547|P2|Overall Study|Adverse Event|9
6125146|NCT00057941|21107548|P1|Overall Study|Adverse Event|7
6125147|NCT00057941|21107547|P2|Overall Study|Death|2
6125148|NCT00057941|21107548|P1|Overall Study|Death|1
6125149|NCT00057876|21107556|P2|Overall Study|other complicating disease|0
6125150|NCT00057876|21107557|P1|Overall Study|other complicating disease|1
6125151|NCT00057876|21107556|P2|Overall Study|other reason|2
6125152|NCT00057876|21107557|P1|Overall Study|other reason|2
6125153|NCT00057876|21107556|P2|Overall Study|Ineligible|2
6125154|NCT00057876|21107557|P1|Overall Study|Ineligible|1
6125155|NCT00057876|21107556|P2|Overall Study|Lack of Efficacy|8
6125156|NCT00057876|21107557|P1|Overall Study|Lack of Efficacy|10
6125157|NCT00057876|21107556|P2|Overall Study|Withdrawal by Subject|6
6125158|NCT00057876|21107557|P1|Overall Study|Withdrawal by Subject|5
6125159|NCT00057876|21107556|P2|Overall Study|Death|1
6125160|NCT00057876|21107557|P1|Overall Study|Death|2
6125161|NCT00057876|21107556|P2|Overall Study|Adverse Event|8
6125162|NCT00057876|21107557|P1|Overall Study|Adverse Event|8
6125163|NCT00057863|21107567|P1|Overall Study|Withdrawal by Subject|2
6125164|NCT00057863|21107567|P1|Overall Study|Death|1
6125165|NCT00057837|21107576|P2|Overall Study|Never started treatment|1
6125166|NCT00057837|21107577|P1|Overall Study|Never started treatment|1
6125167|NCT00057837|21107576|P2|Overall Study|Ineligible|3
6125168|NCT00057837|21107577|P1|Overall Study|Ineligible|3
6125169|NCT00057837|21107576|P2|Overall Study|Physician Decision|0
6125170|NCT00057837|21107577|P1|Overall Study|Physician Decision|1
6125171|NCT00057837|21107576|P2|Overall Study|Other complicating disease|1
6125172|NCT00057837|21107577|P1|Overall Study|Other complicating disease|2
6125173|NCT00057837|21107576|P2|Overall Study|Alternative therapy|1
6125174|NCT00057837|21107577|P1|Overall Study|Alternative therapy|0
6125175|NCT00057837|21107576|P2|Overall Study|Withdrawal by Subject|3
6125176|NCT00057837|21107577|P1|Overall Study|Withdrawal by Subject|5
6125177|NCT00057837|21107576|P2|Overall Study|Death|4
6125178|NCT00057837|21107577|P1|Overall Study|Death|5
6125179|NCT00057837|21107576|P2|Overall Study|Adverse Event|12
6125180|NCT00057837|21107577|P1|Overall Study|Adverse Event|2
6125181|NCT00057837|21107576|P2|Overall Study|Progression/relapse|14
6125182|NCT00057837|21107577|P1|Overall Study|Progression/relapse|12
6125183|NCT00057811|21107589|P2|Overall Study|Inevaluable|2
6125184|NCT00057811|21107590|P1|Overall Study|Inevaluable|1
6125185|NCT00057811|21107589|P2|Overall Study|Ineligible|2
6125186|NCT00057811|21107590|P1|Overall Study|Ineligible|4
6125187|NCT00057811|21107589|P2|Overall Study|Withdrawal by Subject|4
6125188|NCT00057811|21107590|P1|Overall Study|Withdrawal by Subject|3
6125189|NCT00057811|21107589|P2|Overall Study|Physician Decision|0
6125190|NCT00057811|21107590|P1|Overall Study|Physician Decision|1
6125191|NCT00057811|21107589|P2|Overall Study|Lack of Efficacy|4
6125192|NCT00057811|21107590|P1|Overall Study|Lack of Efficacy|1
6125193|NCT00057746|21107609|P3|Overall Study|Withdrawal by Subject|1
6125194|NCT00057746|21107610|P2|Overall Study|Withdrawal by Subject|0
6125195|NCT00057746|21107611|P1|Overall Study|Withdrawal by Subject|0
6125196|NCT00023673|21107622|P4|Overall Study|Patient withdrew consent|1
6125197|NCT00023673|21107623|P3|Overall Study|Patient withdrew consent|0
6125198|NCT00023673|21107624|P2|Overall Study|Patient withdrew consent|0
6125199|NCT00023673|21107625|P1|Overall Study|Patient withdrew consent|0
6125200|NCT00023673|21107622|P4|Overall Study|Ineligible / no protocol treatment|1
6125201|NCT00023673|21107623|P3|Overall Study|Ineligible / no protocol treatment|0
6125202|NCT00023673|21107624|P2|Overall Study|Ineligible / no protocol treatment|0
6125203|NCT00023673|21107625|P1|Overall Study|Ineligible / no protocol treatment|0
6125204|NCT00057330|21107689|P2|Overall Study|Other|206
6125205|NCT00057330|21107690|P1|Overall Study|Other|260
6125206|NCT00057330|21107689|P2|Overall Study|Physician Decision|0
6125207|NCT00057330|21107690|P1|Overall Study|Physician Decision|1
6125208|NCT00057330|21107689|P2|Overall Study|Lost to Follow-up|617
6125209|NCT00057330|21107690|P1|Overall Study|Lost to Follow-up|745
6125210|NCT00057330|21107689|P2|Overall Study|Withdrawal by Subject|84
6125211|NCT00057330|21107690|P1|Overall Study|Withdrawal by Subject|115
6125212|NCT00057330|21107689|P2|Overall Study|Protocol Violation|1
6125213|NCT00057330|21107690|P1|Overall Study|Protocol Violation|1
6125214|NCT00057330|21107689|P2|Overall Study|Death|0
6125215|NCT00057330|21107690|P1|Overall Study|Death|1
6125216|NCT00057330|21107689|P2|Overall Study|Adverse Event|12
6125217|NCT00057330|21107690|P1|Overall Study|Adverse Event|9
6125218|NCT00056862|21107720|P2|Overall Study|Protocol Violation|0
6125219|NCT00056862|21107721|P1|Overall Study|Protocol Violation|1
6125220|NCT00056407|21107779|P2|Overall Study|Missing|34
6125221|NCT00056407|21107780|P1|Overall Study|Missing|25
6125222|NCT00056407|21107779|P2|Overall Study|"Listed as Other on Case Report Form"|60
6125223|NCT00056407|21107780|P1|Overall Study|"Listed as Other on Case Report Form"|98
6125224|NCT00056407|21107779|P2|Overall Study|Diagnosed with Prostate Cancer|166
6125225|NCT00056407|21107780|P1|Overall Study|Diagnosed with Prostate Cancer|202
6125226|NCT00056407|21107779|P2|Overall Study|Protocol Violation|95
6125227|NCT00056407|21107780|P1|Overall Study|Protocol Violation|104
6125228|NCT00056407|21107779|P2|Overall Study|Lost to Follow-up|113
6125229|NCT00056407|21107780|P1|Overall Study|Lost to Follow-up|123
6125230|NCT00056407|21107779|P2|Overall Study|Withdrawal by Subject|361
6125231|NCT00056407|21107780|P1|Overall Study|Withdrawal by Subject|377
6125232|NCT00056407|21107779|P2|Overall Study|Adverse Event|364
6125233|NCT00056407|21107780|P1|Overall Study|Adverse Event|282
6125234|NCT00056316|21107838|P2|Overall Study|Death/NH placement of pt|1
6125235|NCT00056316|21107839|P1|Overall Study|Death/NH placement of pt|1
6125236|NCT00056316|21107838|P2|Overall Study|Withdrawal by Subject|2
6125237|NCT00056316|21107839|P1|Overall Study|Withdrawal by Subject|2
6125238|NCT00056160|21107853|P2|Final Follow-up|Adverse Event|0
6125239|NCT00056160|21107854|P1|Final Follow-up|Adverse Event|1
6125240|NCT00056160|21107853|P2|Final Follow-up|Transferred into RevAssist Program|0
6125241|NCT00056160|21107854|P1|Final Follow-up|Transferred into RevAssist Program|2
6125242|NCT00056160|21107853|P2|Final Follow-up|Transferred into expanded access study.|0
6125243|NCT00056160|21107854|P1|Final Follow-up|Transferred into expanded access study.|3
6125244|NCT00056160|21107853|P2|Extended Follow-up Cutoff (23 Jul 2008)|Other|0
6125245|NCT00056160|21107854|P1|Extended Follow-up Cutoff (23 Jul 2008)|Other|21
6125246|NCT00056160|21107853|P2|Extended Follow-up Cutoff (23 Jul 2008)|Death|0
6125247|NCT00056160|21107854|P1|Extended Follow-up Cutoff (23 Jul 2008)|Death|5
6125248|NCT00056160|21107853|P2|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|0
6125249|NCT00056160|21107854|P1|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|11
6125250|NCT00056160|21107853|P2|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|0
6125251|NCT00056160|21107854|P1|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|3
6125252|NCT00056160|21107853|P2|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|0
6125253|NCT00056160|21107854|P1|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|87
6125254|NCT00056160|21107853|P2|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|0
6125255|NCT00056160|21107854|P1|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|44
6125256|NCT00056160|21107853|P2|Up to Unblinding (07 Jun 2005)|Other|7
6125257|NCT00056160|21107854|P1|Up to Unblinding (07 Jun 2005)|Other|8
6125258|NCT00056160|21107853|P2|Up to Unblinding (07 Jun 2005)|Death|1
6125259|NCT00056160|21107854|P1|Up to Unblinding (07 Jun 2005)|Death|2
6125260|NCT00056160|21107853|P2|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8
6125261|NCT00056160|21107854|P1|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8
6125262|NCT00056160|21107853|P2|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|5
6125263|NCT00056160|21107854|P1|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|3
6125264|NCT00056160|21107853|P2|Up to Unblinding (07 Jun 2005)|Progression of disease|124
6125265|NCT00056160|21107854|P1|Up to Unblinding (07 Jun 2005)|Progression of disease|57
6125266|NCT00056160|21107853|P2|Up to Unblinding (07 Jun 2005)|Adverse Event|18
6125267|NCT00056160|21107854|P1|Up to Unblinding (07 Jun 2005)|Adverse Event|35
6125268|NCT00055601|21107877|P2|Overall Study|No protocol treatment received|1
6125269|NCT00055601|21107878|P1|Overall Study|No protocol treatment received|1
6125270|NCT00055601|21107877|P2|Overall Study|Protocol Violation|1
6125271|NCT00055601|21107878|P1|Overall Study|Protocol Violation|1
6125272|NCT00055497|21107892|P4|Overall Study|Other|11
6125273|NCT00055497|21107893|P3|Overall Study|Other|0
6125274|NCT00055497|21107894|P2|Overall Study|Other|0
6125275|NCT00055497|21107895|P1|Overall Study|Other|0
6125276|NCT00055497|21107892|P4|Overall Study|Administrative Reasons|1
6125277|NCT00055497|21107893|P3|Overall Study|Administrative Reasons|0
6125278|NCT00055497|21107894|P2|Overall Study|Administrative Reasons|0
6125279|NCT00055497|21107895|P1|Overall Study|Administrative Reasons|0
6125280|NCT00055497|21107892|P4|Overall Study|Lack of Efficacy|27
6125281|NCT00055497|21107893|P3|Overall Study|Lack of Efficacy|0
6125282|NCT00055497|21107894|P2|Overall Study|Lack of Efficacy|0
6125283|NCT00055497|21107895|P1|Overall Study|Lack of Efficacy|1
6125284|NCT00055497|21107892|P4|Overall Study|Protocol Violation|3
6125285|NCT00055497|21107893|P3|Overall Study|Protocol Violation|0
6125286|NCT00055497|21107894|P2|Overall Study|Protocol Violation|0
6125287|NCT00055497|21107895|P1|Overall Study|Protocol Violation|0
6125288|NCT00055497|21107892|P4|Overall Study|Lost to Follow-up|5
6125289|NCT00055497|21107893|P3|Overall Study|Lost to Follow-up|0
6125290|NCT00055497|21107894|P2|Overall Study|Lost to Follow-up|1
6125291|NCT00055497|21107895|P1|Overall Study|Lost to Follow-up|0
6125292|NCT00055497|21107892|P4|Overall Study|Withdrawal by Subject|15
6125293|NCT00055497|21107893|P3|Overall Study|Withdrawal by Subject|1
6125294|NCT00055497|21107894|P2|Overall Study|Withdrawal by Subject|1
6125295|NCT00055497|21107895|P1|Overall Study|Withdrawal by Subject|3
6125296|NCT00055497|21107892|P4|Overall Study|Adverse Event|28
6125297|NCT00055497|21107893|P3|Overall Study|Adverse Event|1
6125298|NCT00055497|21107894|P2|Overall Study|Adverse Event|1
6125299|NCT00055497|21107895|P1|Overall Study|Adverse Event|1
6125300|NCT00055471|21107940|P3|Period 1: Dose Escalation Period|Disease progression|0
6125301|NCT00055471|21107941|P2|Period 1: Dose Escalation Period|Disease progression|1
6125302|NCT00055471|21107942|P1|Period 1: Dose Escalation Period|Disease progression|0
6125303|NCT00055471|21107940|P3|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|1
6125304|NCT00055471|21107941|P2|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0
6125305|NCT00055471|21107942|P1|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0
6125306|NCT00055471|21107940|P3|Period 1: Dose Escalation Period|Adverse Event|2
6125307|NCT00055471|21107941|P2|Period 1: Dose Escalation Period|Adverse Event|1
6125308|NCT00055471|21107942|P1|Period 1: Dose Escalation Period|Adverse Event|0
6125309|NCT00054717|21107997|P2|Overall Study|Other reason not defined above|217
6125310|NCT00054717|21107998|P1|Overall Study|Other reason not defined above|117
6125311|NCT00054717|21107997|P2|Overall Study|Withdrawal by Subject|20
6125312|NCT00054717|21107998|P1|Overall Study|Withdrawal by Subject|32
6125313|NCT00054717|21107997|P2|Overall Study|Lost to Follow-up|13
6125314|NCT00054717|21107998|P1|Overall Study|Lost to Follow-up|23
6125315|NCT00054717|21107997|P2|Overall Study|Protocol Violation|19
6125316|NCT00054717|21107998|P1|Overall Study|Protocol Violation|18
6125317|NCT00054717|21107997|P2|Overall Study|Adverse Event|22
6125318|NCT00054717|21107998|P1|Overall Study|Adverse Event|70
6125319|NCT00054717|21107997|P2|Overall Study|Randomized but not treated|8
6125320|NCT00054717|21107998|P1|Overall Study|Randomized but not treated|2
6125321|NCT00054704|21108186|P2|Overall Study|Lost to Follow-up|1
6125322|NCT00054704|21108187|P1|Overall Study|Lost to Follow-up|0
6125323|NCT00054704|21108186|P2|Overall Study|Adverse Event|1
6125324|NCT00054704|21108187|P1|Overall Study|Adverse Event|3
6125325|NCT00054704|21108186|P2|Overall Study|Lack of Efficacy|3
6125326|NCT00054704|21108187|P1|Overall Study|Lack of Efficacy|2
6125327|NCT00054691|21108193|P1|Overall Study|Noncompliant|1
6125328|NCT00054691|21108193|P1|Overall Study|Unmeasurable Disease|2
6125329|NCT00054639|21108207|P1|Overall Study|Physician Decision|1
6125330|NCT00054639|21108207|P1|Overall Study|Lack of Efficacy|1
6125331|NCT00054327|21108240|P6|Overall Study|Engraftment failure|0
6125332|NCT00054327|21108241|P5|Overall Study|Engraftment failure|0
6125333|NCT00054327|21108242|P4|Overall Study|Engraftment failure|0
6125334|NCT00054327|21108243|P3|Overall Study|Engraftment failure|0
6125335|NCT00054327|21108244|P2|Overall Study|Engraftment failure|0
6125336|NCT00054327|21108245|P1|Overall Study|Engraftment failure|1
6125337|NCT00054275|21108283|P1|Overall Study|Physician Decision|1
6125338|NCT00054275|21108283|P1|Overall Study|Progressive disease in cycle 1|1
6125339|NCT00054275|21108283|P1|Overall Study|Adverse Event|5
6125340|NCT00054275|21108283|P1|Overall Study|Withdrawal by Subject|4
6125341|NCT00054132|21108289|P1|Overall Study|Not Treated|1
6125342|NCT00053898|21108316|P2|Overall Study|Follow-up from telephone contact only|1
6125343|NCT00053898|21108317|P1|Overall Study|Follow-up from telephone contact only|5
6125344|NCT00053898|21108316|P2|Overall Study|No follow-up data from any source|12
6125345|NCT00053898|21108317|P1|Overall Study|No follow-up data from any source|9
6125346|NCT00053846|21108343|P2|Overall Study|Pills too large|1
6125347|NCT00053846|21108344|P1|Overall Study|Pills too large|0
6125348|NCT00053846|21108343|P2|Overall Study|Quit due to side effects|3
6125349|NCT00053846|21108344|P1|Overall Study|Quit due to side effects|1
6125350|NCT00053846|21108343|P2|Overall Study|Did not return data|2
6125351|NCT00053846|21108344|P1|Overall Study|Did not return data|1
6125352|NCT00053846|21108343|P2|Overall Study|Became ineligible|1
6125353|NCT00053846|21108344|P1|Overall Study|Became ineligible|3
6125354|NCT00053846|21108343|P2|Overall Study|Expired|0
6125355|NCT00053846|21108344|P1|Overall Study|Expired|5
6125356|NCT00053846|21108343|P2|Overall Study|Became too ill|7
6125357|NCT00053846|21108344|P1|Overall Study|Became too ill|8
6125358|NCT00053846|21108343|P2|Overall Study|Changed mind|13
6125359|NCT00053846|21108344|P1|Overall Study|Changed mind|8
6125360|NCT00053417|21108503|P4|Overall Study|Lost to Follow-up|0
6125361|NCT00053417|21108504|P3|Overall Study|Lost to Follow-up|0
6125362|NCT00053417|21108505|P2|Overall Study|Lost to Follow-up|1
6125363|NCT00053417|21108506|P1|Overall Study|Lost to Follow-up|1
6125364|NCT00053417|21108503|P4|Overall Study|Withdrawal by Subject|0
6125365|NCT00053417|21108504|P3|Overall Study|Withdrawal by Subject|0
6125366|NCT00053417|21108505|P2|Overall Study|Withdrawal by Subject|1
6125367|NCT00053417|21108506|P1|Overall Study|Withdrawal by Subject|0
6125368|NCT00053417|21108503|P4|Overall Study|Non-Compliance|1
6125369|NCT00053417|21108504|P3|Overall Study|Non-Compliance|0
6125370|NCT00053417|21108505|P2|Overall Study|Non-Compliance|0
6125371|NCT00053417|21108506|P1|Overall Study|Non-Compliance|0
6125372|NCT00053417|21108503|P4|Overall Study|Adverse Event|5
6125373|NCT00053417|21108504|P3|Overall Study|Adverse Event|1
6125374|NCT00053417|21108505|P2|Overall Study|Adverse Event|0
6125375|NCT00053417|21108506|P1|Overall Study|Adverse Event|1
6125376|NCT00053365|21108516|P1|Overall Study|Never treated|4
6125377|NCT00053365|21108516|P1|Overall Study|Platinum-sensitive interval >12 months|1
6125378|NCT00053365|21108516|P1|Overall Study|Incorrect cell type|1
6125379|NCT00053352|21108525|P2|Overall Study|Disease at new site|0
6125380|NCT00053352|21108526|P1|Overall Study|Disease at new site|1
6125381|NCT00053352|21108525|P2|Overall Study|Ineligible|8
6125382|NCT00053352|21108526|P1|Overall Study|Ineligible|8
6125383|NCT00053352|21108525|P2|Overall Study|Withdrawal by Subject|0
6125384|NCT00053352|21108526|P1|Overall Study|Withdrawal by Subject|1
6125385|NCT00053352|21108525|P2|Overall Study|Physician Decision|1
6125386|NCT00053352|21108526|P1|Overall Study|Physician Decision|11
6125387|NCT00053352|21108525|P2|Overall Study|Lost to Follow-up|1
6125388|NCT00053352|21108526|P1|Overall Study|Lost to Follow-up|0
6125389|NCT00003830|21108542|P2|Overall Study|Sentinel node positive patients|793
6125390|NCT00003830|21108543|P1|Overall Study|Sentinel node positive patients|829
6125391|NCT00003830|21108542|P2|Overall Study|No follow up data|0
6125392|NCT00003830|21108543|P1|Overall Study|No follow up data|3
6125393|NCT00052962|21108569|P2|Overall Study|Not randomized/not evaluable|0
6125394|NCT00052962|21108570|P1|Overall Study|Not randomized/not evaluable|1
6125395|NCT00052962|21108569|P2|Overall Study|Not evaluable|2
6125396|NCT00052962|21108570|P1|Overall Study|Not evaluable|0
6125397|NCT00052715|21108589|P1|Overall Study|wrong histology|1
6125398|NCT00049673|21108605|P2|Overall Study|No receive treatment/lost to follow-up|3
6125399|NCT00049673|21108606|P1|Overall Study|No receive treatment/lost to follow-up|1
6125400|NCT00049543|21108616|P2|Overall Study|still on treatment|9
6125401|NCT00049543|21108617|P1|Overall Study|still on treatment|2
6125402|NCT00049530|21108627|P1|Overall Study|ineligible|3
6125403|NCT00049530|21108627|P1|Overall Study|symptomatic deterioration|1
6125404|NCT00049530|21108627|P1|Overall Study|Death|1
6125405|NCT00049530|21108627|P1|Overall Study|Adverse Event|2
6125406|NCT00049530|21108627|P1|Overall Study|Lack of Efficacy|25
6125407|NCT00049517|21108636|P6|Conditioning/Transplant|Reasons not reported|5
6125408|NCT00049517|21108637|P5|Conditioning/Transplant|Reasons not reported|5
6125409|NCT00049517|21108638|P4|Conditioning/Transplant|Reasons not reported|15
6125410|NCT00049517|21108639|P3|Conditioning/Transplant|Reasons not reported|18
6125411|NCT00049517|21108640|P2|Conditioning/Transplant|Reasons not reported|31
6125412|NCT00049517|21108641|P1|Conditioning/Transplant|Reasons not reported|25
6125413|NCT00049517|21108636|P6|Conditioning/Transplant|Other complicating disease|1
6125414|NCT00049517|21108637|P5|Conditioning/Transplant|Other complicating disease|0
6125415|NCT00049517|21108638|P4|Conditioning/Transplant|Other complicating disease|4
6125416|NCT00049517|21108639|P3|Conditioning/Transplant|Other complicating disease|0
6125417|NCT00049517|21108640|P2|Conditioning/Transplant|Other complicating disease|0
6125418|NCT00049517|21108641|P1|Conditioning/Transplant|Other complicating disease|2
6125419|NCT00049517|21108636|P6|Conditioning/Transplant|Alternative therapy|0
6125420|NCT00049517|21108637|P5|Conditioning/Transplant|Alternative therapy|1
6125421|NCT00049517|21108638|P4|Conditioning/Transplant|Alternative therapy|1
6125422|NCT00049517|21108639|P3|Conditioning/Transplant|Alternative therapy|2
6125423|NCT00049517|21108640|P2|Conditioning/Transplant|Alternative therapy|4
6125424|NCT00049517|21108641|P1|Conditioning/Transplant|Alternative therapy|4
6125425|NCT00049517|21108636|P6|Conditioning/Transplant|Withdrawal by Subject|0
6125426|NCT00049517|21108637|P5|Conditioning/Transplant|Withdrawal by Subject|0
6125427|NCT00049517|21108638|P4|Conditioning/Transplant|Withdrawal by Subject|7
6125428|NCT00049517|21108639|P3|Conditioning/Transplant|Withdrawal by Subject|4
6125429|NCT00049517|21108640|P2|Conditioning/Transplant|Withdrawal by Subject|8
6125430|NCT00049517|21108641|P1|Conditioning/Transplant|Withdrawal by Subject|4
6125431|NCT00049517|21108636|P6|Conditioning/Transplant|Death|0
6125432|NCT00049517|21108637|P5|Conditioning/Transplant|Death|0
6125433|NCT00049517|21108638|P4|Conditioning/Transplant|Death|2
6125434|NCT00049517|21108639|P3|Conditioning/Transplant|Death|0
6125435|NCT00049517|21108640|P2|Conditioning/Transplant|Death|0
6125436|NCT00049517|21108641|P1|Conditioning/Transplant|Death|1
6125437|NCT00049517|21108636|P6|Conditioning/Transplant|Adverse Event|0
6125438|NCT00049517|21108637|P5|Conditioning/Transplant|Adverse Event|0
6125439|NCT00049517|21108638|P4|Conditioning/Transplant|Adverse Event|8
6125440|NCT00049517|21108639|P3|Conditioning/Transplant|Adverse Event|4
6125441|NCT00049517|21108640|P2|Conditioning/Transplant|Adverse Event|1
6125442|NCT00049517|21108641|P1|Conditioning/Transplant|Adverse Event|2
6125443|NCT00049517|21108636|P6|Conditioning/Transplant|Disease progression|0
6125444|NCT00049517|21108637|P5|Conditioning/Transplant|Disease progression|0
6125445|NCT00049517|21108638|P4|Conditioning/Transplant|Disease progression|6
6125446|NCT00049517|21108639|P3|Conditioning/Transplant|Disease progression|10
6125447|NCT00049517|21108640|P2|Conditioning/Transplant|Disease progression|6
6125448|NCT00049517|21108641|P1|Conditioning/Transplant|Disease progression|14
6125449|NCT00049517|21108636|P6|Induction|Reasons not reported|25
6125450|NCT00049517|21108637|P5|Induction|Reasons not reported|22
6125451|NCT00049517|21108638|P4|Induction|Reasons not reported|0
6125452|NCT00049517|21108639|P3|Induction|Reasons not reported|0
6125453|NCT00049517|21108640|P2|Induction|Reasons not reported|0
6125454|NCT00049517|21108641|P1|Induction|Reasons not reported|0
6125455|NCT00049517|21108636|P6|Induction|Other complicating disease|0
6125456|NCT00049517|21108637|P5|Induction|Other complicating disease|3
6125457|NCT00049517|21108638|P4|Induction|Other complicating disease|0
6125458|NCT00049517|21108639|P3|Induction|Other complicating disease|0
6125459|NCT00049517|21108640|P2|Induction|Other complicating disease|0
6125460|NCT00049517|21108641|P1|Induction|Other complicating disease|0
6125461|NCT00049517|21108636|P6|Induction|Alternative therapy|2
6125462|NCT00049517|21108637|P5|Induction|Alternative therapy|2
6125463|NCT00049517|21108638|P4|Induction|Alternative therapy|0
6125464|NCT00049517|21108639|P3|Induction|Alternative therapy|0
6125465|NCT00049517|21108640|P2|Induction|Alternative therapy|0
6125466|NCT00049517|21108641|P1|Induction|Alternative therapy|0
6125467|NCT00049517|21108636|P6|Induction|Withdrawal by Subject|3
6125468|NCT00049517|21108637|P5|Induction|Withdrawal by Subject|1
6125469|NCT00049517|21108638|P4|Induction|Withdrawal by Subject|0
6125470|NCT00049517|21108639|P3|Induction|Withdrawal by Subject|0
6125471|NCT00049517|21108640|P2|Induction|Withdrawal by Subject|0
6125472|NCT00049517|21108641|P1|Induction|Withdrawal by Subject|0
6125473|NCT00049517|21108636|P6|Induction|Death|6
6125474|NCT00049517|21108637|P5|Induction|Death|9
6125475|NCT00049517|21108638|P4|Induction|Death|0
6125476|NCT00049517|21108639|P3|Induction|Death|0
6125477|NCT00049517|21108640|P2|Induction|Death|0
6125478|NCT00049517|21108641|P1|Induction|Death|0
6125479|NCT00049517|21108636|P6|Induction|Adverse Event|7
6125480|NCT00049517|21108637|P5|Induction|Adverse Event|5
6125481|NCT00049517|21108638|P4|Induction|Adverse Event|0
6125482|NCT00049517|21108639|P3|Induction|Adverse Event|0
6125483|NCT00049517|21108640|P2|Induction|Adverse Event|0
6125484|NCT00049517|21108641|P1|Induction|Adverse Event|0
6125485|NCT00049517|21108636|P6|Induction|Disease progression|11
6125486|NCT00049517|21108637|P5|Induction|Disease progression|18
6125487|NCT00049517|21108638|P4|Induction|Disease progression|0
6125488|NCT00049517|21108639|P3|Induction|Disease progression|0
6125489|NCT00049517|21108640|P2|Induction|Disease progression|0
6125490|NCT00049517|21108641|P1|Induction|Disease progression|0
6125491|NCT00049322|21108659|P2|Overall Study|refused angio|3
6125492|NCT00049322|21108660|P1|Overall Study|refused angio|0
6125493|NCT00049322|21108659|P2|Overall Study|Adverse Event|0
6125494|NCT00049322|21108660|P1|Overall Study|Adverse Event|1
6125495|NCT00049322|21108659|P2|Overall Study|disease burden|3
6125496|NCT00049322|21108660|P1|Overall Study|disease burden|0
6125497|NCT00049257|21108672|P1|Follow-up Period for Survival Status|Lost to Follow-up|4
6125498|NCT00049257|21108672|P1|Carboplatin, Paclitaxel|Death|2
6125499|NCT00049257|21108672|P1|Carboplatin, Paclitaxel|Lost to Follow-up|1
6125500|NCT00049257|21108672|P1|Carboplatin, Paclitaxel|Withdrawal by Subject|10
6125501|NCT00049127|21108684|P5|Overall Study|Withdrawal by Subject|0
6125502|NCT00049127|21108685|P4|Overall Study|Withdrawal by Subject|0
6125503|NCT00049127|21108686|P3|Overall Study|Withdrawal by Subject|1
6125504|NCT00049127|21108687|P2|Overall Study|Withdrawal by Subject|0
6125505|NCT00049127|21108688|P1|Overall Study|Withdrawal by Subject|0
6125506|NCT00048997|21108726|P2|Overall Study|Withdrawal by Subject|1
6125507|NCT00048997|21108727|P1|Overall Study|Withdrawal by Subject|6
6125508|NCT00048997|21108726|P2|Overall Study|Protocol Violation|2
6125509|NCT00048997|21108727|P1|Overall Study|Protocol Violation|7
6125510|NCT00047385|21108750|P2|Overall Study|Eligible for screening but had no screen|492
6125511|NCT00047385|21108751|P1|Overall Study|Eligible for screening but had no screen|260
6125512|NCT00047385|21108750|P2|Overall Study|Lung Cancer diagnosed before screening|3
6125513|NCT00047385|21108751|P1|Overall Study|Lung Cancer diagnosed before screening|5
6125514|NCT00047385|21108750|P2|Overall Study|Death before any screening|5
6125515|NCT00047385|21108751|P1|Overall Study|Death before any screening|2
6125516|NCT00047320|21108769|P1|Overall Study|Ineligible|2
6125517|NCT00047320|21108769|P1|Overall Study|Withdrawal by Subject|9
6125518|NCT00047320|21108769|P1|Overall Study|Physician Decision|8
6125519|NCT00047320|21108769|P1|Overall Study|Lost to Follow-up|1
6125520|NCT00047320|21108769|P1|Overall Study|Lack of Efficacy|8
6125521|NCT00047008|21108784|P2|Overall Study|Ineligible|8
6125522|NCT00047008|21108785|P1|Overall Study|Ineligible|9
6125523|NCT00047008|21108784|P2|Overall Study|Withdrawn consent|3
6125524|NCT00047008|21108785|P1|Overall Study|Withdrawn consent|2
6125525|NCT00046930|21108793|P2|Overall Study|Ineligible|4
6125526|NCT00046930|21108794|P1|Overall Study|Ineligible|12
6125527|NCT00046891|21108809|P2|Overall Study|Adverse Event|5
6125528|NCT00046891|21108810|P1|Overall Study|Adverse Event|5
6125529|NCT00046891|21108809|P2|Overall Study|Withdrawal by Subject|15
6125530|NCT00046891|21108810|P1|Overall Study|Withdrawal by Subject|18
6125531|NCT00046891|21108809|P2|Overall Study|Ineligible|1
6125532|NCT00046891|21108810|P1|Overall Study|Ineligible|1
6125533|NCT00046891|21108809|P2|Overall Study|Cancels|9
6125534|NCT00046891|21108810|P1|Overall Study|Cancels|5
6125535|NCT00046839|21108830|P2|Overall Study|Withdrawal of consent|0
6125536|NCT00046839|21108831|P1|Overall Study|Withdrawal of consent|1
6125537|NCT00046839|21108830|P2|Overall Study|Ineligible / No protocol treatment|2
6125538|NCT00046839|21108831|P1|Overall Study|Ineligible / No protocol treatment|0
6125539|NCT00045734|21108838|P1|Overall Study|Protocol Violation|1
6125540|NCT00045708|21108853|P3|Phase 1|early progressive disease|0
6125541|NCT00045708|21108854|P2|Phase 1|early progressive disease|1
6125542|NCT00045708|21108855|P1|Phase 1|early progressive disease|0
6125543|NCT00045630|21108880|P1|Overall Study|Ineligible|2
6125544|NCT00045630|21108880|P1|Overall Study|Death|1
6125545|NCT00045630|21108880|P1|Overall Study|Progression/relapse|1
6125546|NCT00045630|21108880|P1|Overall Study|Refusal unrelated to adverse event|1
6125547|NCT00045630|21108880|P1|Overall Study|Adverse Event|1
6125548|NCT00045305|21108899|P1|Overall Study|site error|2
6125549|NCT00045305|21108899|P1|Overall Study|Death|3
6125550|NCT00045305|21108899|P1|Overall Study|Adverse Event|3
6125551|NCT00045305|21108899|P1|Overall Study|Lack of Efficacy|6
6125552|NCT00045162|21108910|P2|Overall Study|Other|16
6125553|NCT00045162|21108911|P1|Overall Study|Other|21
6125554|NCT00045162|21108910|P2|Overall Study|Withdrawal by Subject|3
6125555|NCT00045162|21108911|P1|Overall Study|Withdrawal by Subject|5
6125556|NCT00045162|21108910|P2|Overall Study|Death|10
6125557|NCT00045162|21108911|P1|Overall Study|Death|10
6125558|NCT00045162|21108910|P2|Overall Study|Lack of Efficacy|29
6125559|NCT00045162|21108911|P1|Overall Study|Lack of Efficacy|32
6125560|NCT00045162|21108910|P2|Overall Study|Adverse Event|50
6125561|NCT00045162|21108911|P1|Overall Study|Adverse Event|55
6125562|NCT00045162|21108910|P2|Overall Study|Not treated|2
6125563|NCT00045162|21108911|P1|Overall Study|Not treated|7
6125564|NCT00045162|21108910|P2|Overall Study|Ineligible|8
6125565|NCT00045162|21108911|P1|Overall Study|Ineligible|12
6125566|NCT00045110|21108926|P3|100mg Phase 1 Dose Escalalation|ineligible histology|1
6125567|NCT00045110|21108927|P2|100mg Phase 1 Dose Escalalation|ineligible histology|0
6125568|NCT00045110|21108928|P1|100mg Phase 1 Dose Escalalation|ineligible histology|0
6125569|NCT00045110|21108926|P3|100mg Phase 1 Dose Escalalation|prior treatment history|0
6125570|NCT00045110|21108927|P2|100mg Phase 1 Dose Escalalation|prior treatment history|4
6125571|NCT00045110|21108928|P1|100mg Phase 1 Dose Escalalation|prior treatment history|0
6125572|NCT00045110|21108926|P3|100mg Phase 1 Dose Escalalation|did not initiate treatment|1
6125573|NCT00045110|21108927|P2|100mg Phase 1 Dose Escalalation|did not initiate treatment|2
6125574|NCT00045110|21108928|P1|100mg Phase 1 Dose Escalalation|did not initiate treatment|0
6125575|NCT00045032|21108977|P3|Overall Study|Other|105
6125576|NCT00045032|21108978|P2|Overall Study|Other|84
6125577|NCT00045032|21108979|P1|Overall Study|Other|93
6125578|NCT00045032|21108977|P3|Overall Study|Failure to Return|61
6125579|NCT00045032|21108978|P2|Overall Study|Failure to Return|62
6125580|NCT00045032|21108979|P1|Overall Study|Failure to Return|57
6125581|NCT00045032|21108977|P3|Overall Study|Refused/Did Not Cooperate/Withdrew|84
6125582|NCT00045032|21108978|P2|Overall Study|Refused/Did Not Cooperate/Withdrew|93
6125583|NCT00045032|21108979|P1|Overall Study|Refused/Did Not Cooperate/Withdrew|142
6125584|NCT00045032|21108977|P3|Overall Study|Other Protocol Violation|1
6125585|NCT00045032|21108978|P2|Overall Study|Other Protocol Violation|0
6125586|NCT00045032|21108979|P1|Overall Study|Other Protocol Violation|2
6125587|NCT00045032|21108977|P3|Overall Study|Violation of Selection Criteria at Entry|6
6125588|NCT00045032|21108978|P2|Overall Study|Violation of Selection Criteria at Entry|6
6125589|NCT00045032|21108979|P1|Overall Study|Violation of Selection Criteria at Entry|3
6125590|NCT00045032|21108977|P3|Overall Study|Insufficient Therapeutic Response|445
6125591|NCT00045032|21108978|P2|Overall Study|Insufficient Therapeutic Response|437
6125592|NCT00045032|21108979|P1|Overall Study|Insufficient Therapeutic Response|542
6125593|NCT00045032|21108977|P3|Overall Study|Death|17
6125594|NCT00045032|21108978|P2|Overall Study|Death|24
6125595|NCT00045032|21108979|P1|Overall Study|Death|22
6125596|NCT00045032|21108977|P3|Overall Study|Adverse Event/Intercurrent Illness|7
6125597|NCT00045032|21108978|P2|Overall Study|Adverse Event/Intercurrent Illness|2
6125689|NCT00040742|21109288|P2|Overall Study|Adverse Event|16
6125598|NCT00045032|21108979|P1|Overall Study|Adverse Event/Intercurrent Illness|2
6125599|NCT00042991|21109113|P7|Overall Study|Alternative Therapy|0
6125600|NCT00042991|21109114|P6|Overall Study|Alternative Therapy|0
6125601|NCT00042991|21109115|P5|Overall Study|Alternative Therapy|1
6125602|NCT00042991|21109116|P4|Overall Study|Alternative Therapy|0
6125603|NCT00042991|21109117|P3|Overall Study|Alternative Therapy|0
6125604|NCT00042991|21109118|P2|Overall Study|Alternative Therapy|0
6125605|NCT00042991|21109119|P1|Overall Study|Alternative Therapy|0
6125606|NCT00042991|21109113|P7|Overall Study|Disease Progression|2
6125607|NCT00042991|21109114|P6|Overall Study|Disease Progression|4
6125608|NCT00042991|21109115|P5|Overall Study|Disease Progression|1
6125609|NCT00042991|21109116|P4|Overall Study|Disease Progression|2
6125610|NCT00042991|21109117|P3|Overall Study|Disease Progression|2
6125611|NCT00042991|21109118|P2|Overall Study|Disease Progression|29
6125612|NCT00042991|21109119|P1|Overall Study|Disease Progression|5
6125613|NCT00042991|21109113|P7|Overall Study|Withdrawal by Subject|0
6125614|NCT00042991|21109114|P6|Overall Study|Withdrawal by Subject|0
6125615|NCT00042991|21109115|P5|Overall Study|Withdrawal by Subject|1
6125616|NCT00042991|21109116|P4|Overall Study|Withdrawal by Subject|0
6125617|NCT00042991|21109117|P3|Overall Study|Withdrawal by Subject|2
6125618|NCT00042991|21109118|P2|Overall Study|Withdrawal by Subject|7
6125619|NCT00042991|21109119|P1|Overall Study|Withdrawal by Subject|0
6125620|NCT00042991|21109113|P7|Overall Study|Adverse Event|0
6125621|NCT00042991|21109114|P6|Overall Study|Adverse Event|1
6125622|NCT00042991|21109115|P5|Overall Study|Adverse Event|0
6125623|NCT00042991|21109116|P4|Overall Study|Adverse Event|0
6125624|NCT00042991|21109117|P3|Overall Study|Adverse Event|2
6125625|NCT00042991|21109118|P2|Overall Study|Adverse Event|4
6125626|NCT00042991|21109119|P1|Overall Study|Adverse Event|1
6125627|NCT00042939|21109162|P2|Overall Study|Did not start treatment|1
6125628|NCT00042939|21109163|P1|Overall Study|Did not start treatment|2
6125629|NCT00042939|21109162|P2|Overall Study|Treatment break > 4 weeks|1
6125630|NCT00042939|21109163|P1|Overall Study|Treatment break > 4 weeks|0
6125631|NCT00042939|21109162|P2|Overall Study|Still on treatment|0
6125632|NCT00042939|21109163|P1|Overall Study|Still on treatment|1
6125633|NCT00042939|21109162|P2|Overall Study|Patient non-compliance|0
6125634|NCT00042939|21109163|P1|Overall Study|Patient non-compliance|1
6125635|NCT00042939|21109162|P2|Overall Study|Rising ca 19-9|0
6125636|NCT00042939|21109163|P1|Overall Study|Rising ca 19-9|1
6125637|NCT00042939|21109162|P2|Overall Study|QOL diminished|0
6125638|NCT00042939|21109163|P1|Overall Study|QOL diminished|1
6125639|NCT00042939|21109162|P2|Overall Study|Deterioration of health|4
6125640|NCT00042939|21109163|P1|Overall Study|Deterioration of health|3
6125641|NCT00042939|21109162|P2|Overall Study|Ineligible|2
6125642|NCT00042939|21109163|P1|Overall Study|Ineligible|2
6125643|NCT00042939|21109162|P2|Overall Study|Other disease|0
6125644|NCT00042939|21109163|P1|Overall Study|Other disease|1
6125645|NCT00042939|21109162|P2|Overall Study|Withdrawal by Subject|4
6125646|NCT00042939|21109163|P1|Overall Study|Withdrawal by Subject|3
6125647|NCT00042939|21109162|P2|Overall Study|Death|2
6125648|NCT00042939|21109163|P1|Overall Study|Death|3
6125649|NCT00042939|21109162|P2|Overall Study|Adverse Event|7
6125650|NCT00042939|21109163|P1|Overall Study|Adverse Event|6
6125651|NCT00041132|21109177|P1|Overall Study|Physician Decision|2
6125652|NCT00041132|21109177|P1|Overall Study|Withdrawal by Subject|1
6125653|NCT00041132|21109177|P1|Overall Study|Not Eligible|7
6125654|NCT00041132|21109177|P1|Overall Study|Death|1
6125655|NCT00041132|21109177|P1|Overall Study|Adverse Event|19
6125656|NCT00041080|21109212|P2|Overall Study|Ineligible|0
6125657|NCT00041080|21109213|P1|Overall Study|Ineligible|1
6125658|NCT00041080|21109212|P2|Overall Study|Did not start therapy|1
6125659|NCT00041080|21109213|P1|Overall Study|Did not start therapy|1
6125660|NCT00041080|21109212|P2|Overall Study|Concommitant Illness/Other|2
6125661|NCT00041080|21109213|P1|Overall Study|Concommitant Illness/Other|1
6125662|NCT00041080|21109212|P2|Overall Study|Withdrawal by Subject|6
6125663|NCT00041080|21109213|P1|Overall Study|Withdrawal by Subject|6
6125664|NCT00041080|21109212|P2|Overall Study|Adverse Event|1
6125665|NCT00041080|21109213|P1|Overall Study|Adverse Event|21
6125666|NCT00041067|21109219|P1|Overall Study|Ineligible|2
6125667|NCT00041067|21109219|P1|Overall Study|Other reasons|23
6125668|NCT00041067|21109219|P1|Overall Study|Patient refusal|12
6125669|NCT00041067|21109219|P1|Overall Study|Progression|19
6125670|NCT00041067|21109219|P1|Overall Study|Adverse Event|20
6125671|NCT00040742|21109286|P4|Overall Study|Other medical|5
6125672|NCT00040742|21109287|P3|Overall Study|Other medical|5
6125673|NCT00040742|21109288|P2|Overall Study|Other medical|5
6125674|NCT00040742|21109289|P1|Overall Study|Other medical|7
6125675|NCT00040742|21109286|P4|Overall Study|Incomplete Forms|5
6125676|NCT00040742|21109287|P3|Overall Study|Incomplete Forms|4
6125677|NCT00040742|21109288|P2|Overall Study|Incomplete Forms|10
6125678|NCT00040742|21109289|P1|Overall Study|Incomplete Forms|6
6125679|NCT00040742|21109286|P4|Overall Study|Chemotoxicity|2
6125680|NCT00040742|21109287|P3|Overall Study|Chemotoxicity|5
6125681|NCT00040742|21109288|P2|Overall Study|Chemotoxicity|3
6125682|NCT00040742|21109289|P1|Overall Study|Chemotoxicity|4
6125683|NCT00040742|21109286|P4|Overall Study|Withdrawal by Subject|13
6125684|NCT00040742|21109287|P3|Overall Study|Withdrawal by Subject|10
6125685|NCT00040742|21109288|P2|Overall Study|Withdrawal by Subject|15
6125686|NCT00040742|21109289|P1|Overall Study|Withdrawal by Subject|7
6125687|NCT00040742|21109286|P4|Overall Study|Adverse Event|9
6125688|NCT00040742|21109287|P3|Overall Study|Adverse Event|21
6125690|NCT00040742|21109289|P1|Overall Study|Adverse Event|15
6125691|NCT00040742|21109286|P4|Overall Study|Death|0
6125692|NCT00040742|21109287|P3|Overall Study|Death|1
6125693|NCT00040742|21109288|P2|Overall Study|Death|0
6125694|NCT00040742|21109289|P1|Overall Study|Death|0
6125695|NCT00039377|21109303|P4|Initial Registration|Withdrawal by Subject|0
6125696|NCT00039377|21109304|P3|Initial Registration|Withdrawal by Subject|0
6125697|NCT00039377|21109305|P2|Initial Registration|Withdrawal by Subject|0
6125698|NCT00039377|21109306|P1|Initial Registration|Withdrawal by Subject|3
6125699|NCT00039377|21109303|P4|Initial Registration|Received non-protocol therapy|0
6125700|NCT00039377|21109304|P3|Initial Registration|Received non-protocol therapy|0
6125701|NCT00039377|21109305|P2|Initial Registration|Received non-protocol therapy|0
6125702|NCT00039377|21109306|P1|Initial Registration|Received non-protocol therapy|11
6125703|NCT00039377|21109303|P4|Initial Registration|Relapsed|0
6125704|NCT00039377|21109304|P3|Initial Registration|Relapsed|0
6125705|NCT00039377|21109305|P2|Initial Registration|Relapsed|0
6125706|NCT00039377|21109306|P1|Initial Registration|Relapsed|6
6125707|NCT00039377|21109303|P4|Initial Registration|Adverse Event|0
6125708|NCT00039377|21109304|P3|Initial Registration|Adverse Event|0
6125709|NCT00039377|21109305|P2|Initial Registration|Adverse Event|0
6125710|NCT00039377|21109306|P1|Initial Registration|Adverse Event|2
6125711|NCT00039130|21109322|P1|Overall Study|Physician Decision|3
6125712|NCT00039130|21109322|P1|Overall Study|Subsequent treatment|2
6125713|NCT00039130|21109322|P1|Overall Study|Progression|2
6125714|NCT00039130|21109322|P1|Overall Study|Withdrawal by Subject|3
6125715|NCT00039130|21109322|P1|Overall Study|Death|9
6125716|NCT00039130|21109322|P1|Overall Study|Adverse Event|11
6125717|NCT00033657|21109338|P2|Adjuvant Chemotherapy|Other|2
6125718|NCT00033657|21109339|P1|Adjuvant Chemotherapy|Other|0
6125719|NCT00033657|21109338|P2|Adjuvant Chemotherapy|alternative therapy|0
6125720|NCT00033657|21109339|P1|Adjuvant Chemotherapy|alternative therapy|1
6125721|NCT00033657|21109338|P2|Adjuvant Chemotherapy|Withdrawal by Subject|3
6125722|NCT00033657|21109339|P1|Adjuvant Chemotherapy|Withdrawal by Subject|5
6125723|NCT00033657|21109338|P2|Adjuvant Chemotherapy|Death|1
6125724|NCT00033657|21109339|P1|Adjuvant Chemotherapy|Death|2
6125725|NCT00033657|21109338|P2|Adjuvant Chemotherapy|Adverse Event|10
6125726|NCT00033657|21109339|P1|Adjuvant Chemotherapy|Adverse Event|7
6125727|NCT00033657|21109338|P2|Adjuvant Chemotherapy|Lack of Efficacy|1
6125728|NCT00033657|21109339|P1|Adjuvant Chemotherapy|Lack of Efficacy|3
6125729|NCT00033657|21109338|P2|Surgical Resection|not complete resection|3
6125730|NCT00033657|21109339|P1|Surgical Resection|not complete resection|0
6125731|NCT00033657|21109338|P2|Neoadjuvant Chemotherapy|Not started protocol therapy|1
6125732|NCT00033657|21109339|P1|Neoadjuvant Chemotherapy|Not started protocol therapy|3
6125733|NCT00033657|21109338|P2|Neoadjuvant Chemotherapy|Ineligible|4
6125734|NCT00033657|21109339|P1|Neoadjuvant Chemotherapy|Ineligible|8
6125735|NCT00033657|21109338|P2|Neoadjuvant Chemotherapy|other complicating disease|1
6125736|NCT00033657|21109339|P1|Neoadjuvant Chemotherapy|other complicating disease|0
6125737|NCT00033657|21109338|P2|Neoadjuvant Chemotherapy|Withdrawal by Subject|0
6125738|NCT00033657|21109339|P1|Neoadjuvant Chemotherapy|Withdrawal by Subject|1
6125739|NCT00033657|21109338|P2|Neoadjuvant Chemotherapy|Death|1
6125740|NCT00033657|21109339|P1|Neoadjuvant Chemotherapy|Death|1
6125741|NCT00033657|21109338|P2|Neoadjuvant Chemotherapy|Adverse Event|2
6125742|NCT00033657|21109339|P1|Neoadjuvant Chemotherapy|Adverse Event|0
6125743|NCT00033657|21109338|P2|Neoadjuvant Chemotherapy|Lack of Efficacy|2
6125744|NCT00033657|21109339|P1|Neoadjuvant Chemotherapy|Lack of Efficacy|1
6125745|NCT00033631|21109353|P2|Overall Study|Withdrawal by Subject|4
6125746|NCT00033631|21109354|P1|Overall Study|Withdrawal by Subject|4
6125747|NCT00033631|21109353|P2|Overall Study|Protocol Violation|11
6125748|NCT00033631|21109354|P1|Overall Study|Protocol Violation|14
6125749|NCT00033540|21109372|P1|Overall Study|Never received treatment|2
6125750|NCT00033540|21109372|P1|Overall Study|Ineligible|3
6125751|NCT00033540|21109372|P1|Overall Study|Other|5
6125752|NCT00033540|21109372|P1|Overall Study|Withdrawal by Subject|6
6125753|NCT00033540|21109372|P1|Overall Study|Progression|26
6125754|NCT00033540|21109372|P1|Overall Study|Death|1
6125755|NCT00033540|21109372|P1|Overall Study|Adverse Event|14
6125756|NCT00033514|21109382|P2|Overall Study|Withdrawal by Subject|3
6125757|NCT00033514|21109383|P1|Overall Study|Withdrawal by Subject|0
6125758|NCT00033514|21109382|P2|Overall Study|Lost to Follow-up|1
6125759|NCT00033514|21109383|P1|Overall Study|Lost to Follow-up|1
6125760|NCT00033371|21109393|P2|Overall Study|Disease Progression|1
6125761|NCT00033371|21109394|P1|Overall Study|Disease Progression|0
6125762|NCT00033371|21109393|P2|Overall Study|Withdrawal by Subject|3
6125763|NCT00033371|21109394|P1|Overall Study|Withdrawal by Subject|3
6125764|NCT00033371|21109393|P2|Overall Study|Lost to Follow-up|1
6125765|NCT00033371|21109394|P1|Overall Study|Lost to Follow-up|2
6125766|NCT00033371|21109393|P2|Overall Study|Adverse Event|5
6125767|NCT00033371|21109394|P1|Overall Study|Adverse Event|1
6125768|NCT00033293|21109412|P2|Overall Study|Treatment refused|6
6125769|NCT00033293|21109413|P1|Overall Study|Treatment refused|0
6125770|NCT00033293|21109412|P2|Overall Study|Could not be weaned from steroid therapy|1
6125771|NCT00033293|21109413|P1|Overall Study|Could not be weaned from steroid therapy|1
6125772|NCT00033293|21109412|P2|Overall Study|Withdrawal by Subject|0
6125773|NCT00033293|21109413|P1|Overall Study|Withdrawal by Subject|1
6125774|NCT00033293|21109412|P2|Overall Study|Physician Decision|1
6125775|NCT00033293|21109413|P1|Overall Study|Physician Decision|3
6125776|NCT00033293|21109412|P2|Overall Study|Lost to Follow-up|1
6125777|NCT00033293|21109413|P1|Overall Study|Lost to Follow-up|0
6125778|NCT00033293|21109412|P2|Overall Study|Lack of Efficacy|8
6125779|NCT00033293|21109413|P1|Overall Study|Lack of Efficacy|5
6125780|NCT00033293|21109412|P2|Overall Study|Death|1
6125781|NCT00033293|21109413|P1|Overall Study|Death|0
6125785|NCT00031590|21109435|P1|Overall Study|Withdrawal by parents|2
6125786|NCT00031590|21109435|P1|Overall Study|Adverse Event|1
6125787|NCT00030901|21109442|P3|Randomization|Ineligible|14
6125788|NCT00030901|21109443|P2|Randomization|Ineligible|15
6125789|NCT00030901|21109444|P1|Randomization|Ineligible|0
6125790|NCT00030901|21109442|P3|Randomization|Other|33
6125791|NCT00030901|21109443|P2|Randomization|Other|36
6125792|NCT00030901|21109444|P1|Randomization|Other|0
6125793|NCT00030901|21109442|P3|Randomization|Death|3
6125794|NCT00030901|21109443|P2|Randomization|Death|1
6125795|NCT00030901|21109444|P1|Randomization|Death|0
6125796|NCT00030901|21109442|P3|Randomization|Progression/Relapse|21
6125797|NCT00030901|21109443|P2|Randomization|Progression/Relapse|22
6125798|NCT00030901|21109444|P1|Randomization|Progression/Relapse|0
6125799|NCT00030901|21109442|P3|Randomization|Refusal Unrelated to Adverse Event|10
6125800|NCT00030901|21109443|P2|Randomization|Refusal Unrelated to Adverse Event|16
6125801|NCT00030901|21109444|P1|Randomization|Refusal Unrelated to Adverse Event|0
6125802|NCT00030901|21109442|P3|Randomization|Adverse Event|7
6125803|NCT00030901|21109443|P2|Randomization|Adverse Event|11
6125804|NCT00030901|21109444|P1|Randomization|Adverse Event|0
6125805|NCT00030901|21109442|P3|Initial Registration|Ineligible|0
6125806|NCT00030901|21109443|P2|Initial Registration|Ineligible|0
6125807|NCT00030901|21109444|P1|Initial Registration|Ineligible|167
6125808|NCT00030823|21109452|P1|Overall Study|Withdrawal by Subject|1
6125809|NCT00028769|21109460|P1|Overall Study|Not Analyzable|1
6125810|NCT00028769|21109460|P1|Overall Study|Ineligible|5
6125811|NCT00028769|21109460|P1|Overall Study|Other - Not Protocol Specified|1
6125812|NCT00028769|21109460|P1|Overall Study|Progression or Death|31
6125813|NCT00028769|21109460|P1|Overall Study|Refusal Unrelated to Adverse Events|1
6125814|NCT00028769|21109460|P1|Overall Study|Adverse Event|2
6125815|NCT00028002|21109466|P1|Overall Study|Ineligible|8
6125816|NCT00028002|21109466|P1|Overall Study|Withdrawal by Subject|3
6125817|NCT00027846|21109476|P3|Overall Study|Neuraxis dissemination during/after ther|5
6125818|NCT00027846|21109477|P2|Overall Study|Neuraxis dissemination during/after ther|2
6125819|NCT00027846|21109478|P1|Overall Study|Neuraxis dissemination during/after ther|0
6125820|NCT00027846|21109476|P3|Overall Study|Entry into another COG therapeutic study|2
6125821|NCT00027846|21109477|P2|Overall Study|Entry into another COG therapeutic study|5
6125822|NCT00027846|21109478|P1|Overall Study|Entry into another COG therapeutic study|0
6125823|NCT00027846|21109476|P3|Overall Study|Ineligible for study|14
6125824|NCT00027846|21109477|P2|Overall Study|Ineligible for study|6
6125825|NCT00027846|21109478|P1|Overall Study|Ineligible for study|2
6125826|NCT00027846|21109476|P3|Overall Study|Withdrawal by Subject|7
6125827|NCT00027846|21109477|P2|Overall Study|Withdrawal by Subject|14
6125828|NCT00027846|21109478|P1|Overall Study|Withdrawal by Subject|0
6125829|NCT00027846|21109476|P3|Overall Study|Lost to Follow-up|9
6125830|NCT00027846|21109477|P2|Overall Study|Lost to Follow-up|41
6125831|NCT00027846|21109478|P1|Overall Study|Lost to Follow-up|0
6125832|NCT00027560|21109496|P1|Overall Study|Withdrawal by Subject|1
6125833|NCT00026494|21109509|P4|Overall Study|Clinical progression|0
6125834|NCT00026494|21109510|P3|Overall Study|Clinical progression|3
6125835|NCT00026494|21109511|P2|Overall Study|Clinical progression|0
6125836|NCT00026494|21109512|P1|Overall Study|Clinical progression|0
6125837|NCT00026494|21109509|P4|Overall Study|Patient not treated|0
6125838|NCT00026494|21109510|P3|Overall Study|Patient not treated|2
6125839|NCT00026494|21109511|P2|Overall Study|Patient not treated|0
6125840|NCT00026494|21109512|P1|Overall Study|Patient not treated|0
6125841|NCT00026494|21109509|P4|Overall Study|Patient non-compliance|0
6125842|NCT00026494|21109510|P3|Overall Study|Patient non-compliance|0
6125843|NCT00026494|21109511|P2|Overall Study|Patient non-compliance|0
6125844|NCT00026494|21109512|P1|Overall Study|Patient non-compliance|1
6125845|NCT00026494|21109509|P4|Overall Study|Withdrawal by Subject|0
6125846|NCT00026494|21109510|P3|Overall Study|Withdrawal by Subject|1
6125847|NCT00026494|21109511|P2|Overall Study|Withdrawal by Subject|0
6125848|NCT00026494|21109512|P1|Overall Study|Withdrawal by Subject|1
6125849|NCT00026312|21109524|P2|Overall Study|Refusal by patient/parent/guardian|59
6125850|NCT00026312|21109525|P1|Overall Study|Refusal by patient/parent/guardian|8
6125851|NCT00026312|21109524|P2|Overall Study|Entry onto another COG study|1
6125852|NCT00026312|21109525|P1|Overall Study|Entry onto another COG study|0
6125853|NCT00026312|21109524|P2|Overall Study|Ineligible|5
6125854|NCT00026312|21109525|P1|Overall Study|Ineligible|4
6125855|NCT00026312|21109524|P2|Overall Study|Withdrawal by Subject|6
6125856|NCT00026312|21109525|P1|Overall Study|Withdrawal by Subject|1
6125857|NCT00026312|21109524|P2|Overall Study|Protocol Violation|3
6125858|NCT00026312|21109525|P1|Overall Study|Protocol Violation|0
6125859|NCT00026312|21109524|P2|Overall Study|Physician Decision|37
6125860|NCT00026312|21109525|P1|Overall Study|Physician Decision|1
6125861|NCT00026312|21109524|P2|Overall Study|Lost to Follow-up|5
6125862|NCT00026312|21109525|P1|Overall Study|Lost to Follow-up|0
6125863|NCT00026312|21109524|P2|Overall Study|Lack of Efficacy|114
6125864|NCT00026312|21109525|P1|Overall Study|Lack of Efficacy|19
6125865|NCT00026312|21109524|P2|Overall Study|Death|7
6125866|NCT00026312|21109525|P1|Overall Study|Death|1
6125867|NCT00026312|21109524|P2|Overall Study|Adverse Event|32
6125868|NCT00026312|21109525|P1|Overall Study|Adverse Event|0
6125869|NCT00026208|21109564|P2|Overall Study|Complications of auto accident|0
6125870|NCT00026208|21109565|P1|Overall Study|Complications of auto accident|1
6125871|NCT00025662|21109583|P1|Overall Study|Technical failure of manipulation|1
6125872|NCT00025662|21109583|P1|Overall Study|Withdrawal by Subject|2
6125873|NCT00025506|21109591|P1|Overall Study|Never Treated|2
6125874|NCT00025506|21109591|P1|Overall Study|Ineligible: inadequate pathology|2
6125875|NCT00025506|21109591|P1|Overall Study|Ineligible: wrong cell type|5
6125876|NCT00025506|21109591|P1|Overall Study|Ineligible: clerical error|1
6125877|NCT00025259|21109612|P7|Overall Study|Adverse Event|0
6125878|NCT00025259|21109613|P6|Overall Study|Adverse Event|0
6125879|NCT00025259|21109614|P5|Overall Study|Adverse Event|0
6125880|NCT00025259|21109615|P4|Overall Study|Adverse Event|0
6125881|NCT00025259|21109616|P3|Overall Study|Adverse Event|0
6125882|NCT00025259|21109617|P2|Overall Study|Adverse Event|0
6125883|NCT00025259|21109618|P1|Overall Study|Adverse Event|1
6125884|NCT00025259|21109612|P7|Overall Study|Randomization error|2
6125885|NCT00025259|21109613|P6|Overall Study|Randomization error|7
6125886|NCT00025259|21109614|P5|Overall Study|Randomization error|1
6125887|NCT00025259|21109615|P4|Overall Study|Randomization error|0
6125888|NCT00025259|21109616|P3|Overall Study|Randomization error|0
6125889|NCT00025259|21109617|P2|Overall Study|Randomization error|0
6125890|NCT00025259|21109618|P1|Overall Study|Randomization error|1
6125891|NCT00025259|21109612|P7|Overall Study|Ineligible|1
6125892|NCT00025259|21109613|P6|Overall Study|Ineligible|0
6125893|NCT00025259|21109614|P5|Overall Study|Ineligible|6
6125894|NCT00025259|21109615|P4|Overall Study|Ineligible|0
6125895|NCT00025259|21109616|P3|Overall Study|Ineligible|0
6125896|NCT00025259|21109617|P2|Overall Study|Ineligible|1
6125897|NCT00025259|21109618|P1|Overall Study|Ineligible|14
6125898|NCT00025259|21109612|P7|Overall Study|Withdrawal by Subject|3
6125899|NCT00025259|21109613|P6|Overall Study|Withdrawal by Subject|8
6125900|NCT00025259|21109614|P5|Overall Study|Withdrawal by Subject|11
6125901|NCT00025259|21109615|P4|Overall Study|Withdrawal by Subject|14
6125902|NCT00025259|21109616|P3|Overall Study|Withdrawal by Subject|6
6125903|NCT00025259|21109617|P2|Overall Study|Withdrawal by Subject|27
6125904|NCT00025259|21109618|P1|Overall Study|Withdrawal by Subject|9
6125905|NCT00025259|21109612|P7|Overall Study|Protocol Violation|3
6125906|NCT00025259|21109613|P6|Overall Study|Protocol Violation|1
6125907|NCT00025259|21109614|P5|Overall Study|Protocol Violation|2
6125908|NCT00025259|21109615|P4|Overall Study|Protocol Violation|1
6125909|NCT00025259|21109616|P3|Overall Study|Protocol Violation|2
6125910|NCT00025259|21109617|P2|Overall Study|Protocol Violation|2
6125911|NCT00025259|21109618|P1|Overall Study|Protocol Violation|3
6125912|NCT00025259|21109612|P7|Overall Study|Physician Decision|1
6125913|NCT00025259|21109613|P6|Overall Study|Physician Decision|2
6125914|NCT00025259|21109614|P5|Overall Study|Physician Decision|4
6125915|NCT00025259|21109615|P4|Overall Study|Physician Decision|5
6125916|NCT00025259|21109616|P3|Overall Study|Physician Decision|0
6125917|NCT00025259|21109617|P2|Overall Study|Physician Decision|1
6125918|NCT00025259|21109618|P1|Overall Study|Physician Decision|12
6125919|NCT00025259|21109612|P7|Overall Study|Lost to Follow-up|1
6125920|NCT00025259|21109613|P6|Overall Study|Lost to Follow-up|3
6125921|NCT00025259|21109614|P5|Overall Study|Lost to Follow-up|1
6125922|NCT00025259|21109615|P4|Overall Study|Lost to Follow-up|13
6125923|NCT00025259|21109616|P3|Overall Study|Lost to Follow-up|13
6125924|NCT00025259|21109617|P2|Overall Study|Lost to Follow-up|9
6125925|NCT00025259|21109618|P1|Overall Study|Lost to Follow-up|2
6125926|NCT00025259|21109612|P7|Overall Study|Lack of Efficacy|38
6125927|NCT00025259|21109613|P6|Overall Study|Lack of Efficacy|30
6125928|NCT00025259|21109614|P5|Overall Study|Lack of Efficacy|11
6125929|NCT00025259|21109615|P4|Overall Study|Lack of Efficacy|78
6125930|NCT00025259|21109616|P3|Overall Study|Lack of Efficacy|60
6125931|NCT00025259|21109617|P2|Overall Study|Lack of Efficacy|46
6125932|NCT00025259|21109618|P1|Overall Study|Lack of Efficacy|2
6125933|NCT00025259|21109612|P7|Overall Study|Death|2
6125934|NCT00025259|21109613|P6|Overall Study|Death|1
6125935|NCT00025259|21109614|P5|Overall Study|Death|0
6125936|NCT00025259|21109615|P4|Overall Study|Death|3
6125937|NCT00025259|21109616|P3|Overall Study|Death|0
6125938|NCT00025259|21109617|P2|Overall Study|Death|3
6125939|NCT00025259|21109618|P1|Overall Study|Death|1
6125940|NCT00025233|21109654|P1|Overall Study|Never treated|1
6125941|NCT00025233|21109654|P1|Overall Study|Ineligible: improper prior treatment|1
6125942|NCT00025233|21109654|P1|Overall Study|Ineligible: wrong primary|1
6125943|NCT00025233|21109654|P1|Overall Study|Ineligible: wrong cell type|1
6125944|NCT00025155|21109669|P1|Overall Study|Ineligible: Second primary cancer site|1
6125945|NCT00025155|21109669|P1|Overall Study|Ineligible: Wrong primary cancer site|1
6125946|NCT00024258|21109680|P1|Overall Study|Disease Progression|8
6125947|NCT00024258|21109680|P1|Overall Study|Withdrawal by Subject|1
6125948|NCT00024167|21109687|P2|Overall Study|Death|47
6125949|NCT00024167|21109688|P1|Overall Study|Death|53
6125950|NCT00023764|21109712|P1|Overall Study|delay in obtaining staging images|1
6125951|NCT00023764|21109712|P1|Overall Study|patient received other treatment|1
6125952|NCT00023764|21109712|P1|Overall Study|Progression of disease|6
6125953|NCT00023764|21109712|P1|Overall Study|Withdrawal by Subject|1
6125954|NCT00023764|21109712|P1|Overall Study|Adverse Event|4
6125955|NCT00023764|21109712|P1|Overall Study|Other|1
6125956|NCT00023712|21109719|P2|Overall Study|Never treated|1
6125957|NCT00023712|21109720|P1|Overall Study|Never treated|1
6125958|NCT00023712|21109719|P2|Overall Study|Not platinum sensitive|0
6125959|NCT00023712|21109720|P1|Overall Study|Not platinum sensitive|1
6125960|NCT00022698|21109744|P2|Overall Study|Administrative /other|7
6125961|NCT00022698|21109745|P1|Overall Study|Administrative /other|1
6125962|NCT00022698|21109744|P2|Overall Study|Insufficient therapeutic response|14
6125963|NCT00022698|21109745|P1|Overall Study|Insufficient therapeutic response|2
6125964|NCT00022698|21109744|P2|Overall Study|Refused treatment|2
6125965|NCT00022698|21109745|P1|Overall Study|Refused treatment|0
6125966|NCT00022698|21109744|P2|Overall Study|Failure to return|1
6125967|NCT00022698|21109745|P1|Overall Study|Failure to return|0
6125968|NCT00022698|21109744|P2|Overall Study|Death|2
6125969|NCT00022698|21109745|P1|Overall Study|Death|0
6125970|NCT00022698|21109744|P2|Overall Study|Adverse Event|9
6125971|NCT00022698|21109745|P1|Overall Study|Adverse Event|5
6125972|NCT00022672|21109770|P2|Extension Phase|Other|1
6125973|NCT00022672|21109771|P1|Extension Phase|Other|1
6125974|NCT00022672|21109770|P2|Extension Phase|Refused Treatment|2
6125975|NCT00022672|21109771|P1|Extension Phase|Refused Treatment|0
6125976|NCT00022672|21109770|P2|Extension Phase|Insufficient Therapeutic Response|44
6125977|NCT00022672|21109771|P1|Extension Phase|Insufficient Therapeutic Response|1
6125978|NCT00022672|21109770|P2|Extension Phase|Death|1
6125979|NCT00022672|21109771|P1|Extension Phase|Death|0
6125980|NCT00022672|21109770|P2|Extension Phase|Adverse Event|3
6125981|NCT00022672|21109771|P1|Extension Phase|Adverse Event|1
6125982|NCT00022672|21109770|P2|Main Phase: 24 Months|Other|0
6125983|NCT00022672|21109771|P1|Main Phase: 24 Months|Other|1
6125984|NCT00022672|21109770|P2|Main Phase: 24 Months|Failure to Return|1
6125985|NCT00022672|21109771|P1|Main Phase: 24 Months|Failure to Return|1
6125986|NCT00022672|21109770|P2|Main Phase: 24 Months|Refused Treatment|4
6125987|NCT00022672|21109771|P1|Main Phase: 24 Months|Refused Treatment|3
6125988|NCT00022672|21109770|P2|Main Phase: 24 Months|Other Protocol Violation|0
6125989|NCT00022672|21109771|P1|Main Phase: 24 Months|Other Protocol Violation|1
6125990|NCT00022672|21109770|P2|Main Phase: 24 Months|Violation of Selection Criteria at Entry|1
6125991|NCT00022672|21109771|P1|Main Phase: 24 Months|Violation of Selection Criteria at Entry|0
6125992|NCT00022672|21109770|P2|Main Phase: 24 Months|Insufficient Therapeutic Response|91
6125993|NCT00022672|21109771|P1|Main Phase: 24 Months|Insufficient Therapeutic Response|75
6125994|NCT00022672|21109770|P2|Main Phase: 24 Months|Death|3
6125995|NCT00022672|21109771|P1|Main Phase: 24 Months|Death|0
6125996|NCT00022672|21109770|P2|Main Phase: 24 Months|Adverse Event|0
6125997|NCT00022672|21109771|P1|Main Phase: 24 Months|Adverse Event|6
6125998|NCT00022659|21109804|P1|Overall Study|Never treated|1
6125999|NCT00022659|21109804|P1|Overall Study|Ineligible: wrong primary|1
6126000|NCT00022633|21109817|P2|Overall Study|Ineligible|0
6126001|NCT00022633|21109818|P1|Overall Study|Ineligible|4
6126002|NCT00022633|21109817|P2|Overall Study|Other - not protocol specified|2
6126003|NCT00022633|21109818|P1|Overall Study|Other - not protocol specified|3
6126004|NCT00022633|21109817|P2|Overall Study|Death|0
6126005|NCT00022633|21109818|P1|Overall Study|Death|4
6126006|NCT00022633|21109817|P2|Overall Study|Progression/relapse|2
6126007|NCT00022633|21109818|P1|Overall Study|Progression/relapse|9
6126008|NCT00022633|21109817|P2|Overall Study|Refusal unrelated to adverse event|0
6126009|NCT00022633|21109818|P1|Overall Study|Refusal unrelated to adverse event|1
6126010|NCT00022633|21109817|P2|Overall Study|Adverse Event|1
6126011|NCT00022633|21109818|P1|Overall Study|Adverse Event|11
6126012|NCT00022516|21109831|P2|Overall Study|Incomplete documentation|27
6126013|NCT00022516|21109832|P1|Overall Study|Incomplete documentation|0
6126014|NCT00022516|21109831|P2|Overall Study|Withdrawal by Subject|113
6126015|NCT00022516|21109832|P1|Overall Study|Withdrawal by Subject|2
6126016|NCT00022516|21109831|P2|Overall Study|Protocol Violation|3
6126017|NCT00022516|21109832|P1|Overall Study|Protocol Violation|1
6126018|NCT00022516|21109831|P2|Overall Study|Physician Decision|1
6126019|NCT00022516|21109832|P1|Overall Study|Physician Decision|0
6126020|NCT00022516|21109831|P2|Overall Study|Lack of Efficacy|27
6126021|NCT00022516|21109832|P1|Overall Study|Lack of Efficacy|0
6126022|NCT00022516|21109831|P2|Overall Study|Adverse Event|59
6126023|NCT00022516|21109832|P1|Overall Study|Adverse Event|0
6126024|NCT00021255|21109851|P3|Overall Study|Randomized but not treated|18
6126025|NCT00021255|21109852|P2|Overall Study|Randomized but not treated|2
6126026|NCT00021255|21109853|P1|Overall Study|Randomized but not treated|28
6126027|NCT00021255|21109851|P3|Overall Study|Missing|13
6126028|NCT00021255|21109852|P2|Overall Study|Missing|27
6126029|NCT00021255|21109853|P1|Overall Study|Missing|0
6126030|NCT00021255|21109851|P3|Overall Study|Other than specified above|19
6126031|NCT00021255|21109852|P2|Overall Study|Other than specified above|38
6126032|NCT00021255|21109853|P1|Overall Study|Other than specified above|0
6126033|NCT00021255|21109851|P3|Overall Study|Protocol Violation|0
6126034|NCT00021255|21109852|P2|Overall Study|Protocol Violation|2
6126035|NCT00021255|21109853|P1|Overall Study|Protocol Violation|0
6126036|NCT00021255|21109851|P3|Overall Study|Adverse Event|18
6126037|NCT00021255|21109852|P2|Overall Study|Adverse Event|30
6126038|NCT00021255|21109853|P1|Overall Study|Adverse Event|46
6126039|NCT00021255|21109851|P3|Overall Study|Herceptin toxicity|6
6126040|NCT00021255|21109852|P2|Overall Study|Herceptin toxicity|22
6126041|NCT00021255|21109853|P1|Overall Study|Herceptin toxicity|0
6126042|NCT00021255|21109851|P3|Overall Study|Cardiac toxicity|32
6126043|NCT00021255|21109852|P2|Overall Study|Cardiac toxicity|61
6126044|NCT00021255|21109853|P1|Overall Study|Cardiac toxicity|0
6126045|NCT00021255|21109851|P3|Overall Study|Lost to Follow-up|3
6126046|NCT00021255|21109852|P2|Overall Study|Lost to Follow-up|2
6126047|NCT00021255|21109853|P1|Overall Study|Lost to Follow-up|0
6126048|NCT00021255|21109851|P3|Overall Study|Withdrawal by Subject|26
6126049|NCT00021255|21109852|P2|Overall Study|Withdrawal by Subject|64
6126050|NCT00021255|21109853|P1|Overall Study|Withdrawal by Subject|41
6126051|NCT00021255|21109851|P3|Overall Study|Second primary malignancy|1
6126052|NCT00021255|21109852|P2|Overall Study|Second primary malignancy|4
6126053|NCT00021255|21109853|P1|Overall Study|Second primary malignancy|0
6126054|NCT00021255|21109851|P3|Overall Study|Breast cancer relapse|11
6126055|NCT00021255|21109852|P2|Overall Study|Breast cancer relapse|18
6126056|NCT00021255|21109853|P1|Overall Study|Breast cancer relapse|5
6126057|NCT00021255|21109851|P3|Overall Study|Death|2
6126058|NCT00021255|21109852|P2|Overall Study|Death|0
6126059|NCT00021255|21109853|P1|Overall Study|Death|1
6126060|NCT00021229|21109870|P3|Overall Study|Punctate hemmorrhage post RT|0
6126061|NCT00021229|21109871|P2|Overall Study|Punctate hemmorrhage post RT|0
6126062|NCT00021229|21109872|P1|Overall Study|Punctate hemmorrhage post RT|2
6126063|NCT00021229|21109870|P3|Overall Study|Physician Decision|1
6126064|NCT00021229|21109871|P2|Overall Study|Physician Decision|0
6126065|NCT00021229|21109872|P1|Overall Study|Physician Decision|0
6126066|NCT00021229|21109870|P3|Overall Study|Protocol Violation|0
6126067|NCT00021229|21109871|P2|Overall Study|Protocol Violation|1
6126068|NCT00021229|21109872|P1|Overall Study|Protocol Violation|1
6126069|NCT00021229|21109870|P3|Overall Study|Progressive Disease|12
6126070|NCT00021229|21109871|P2|Overall Study|Progressive Disease|19
6126071|NCT00021229|21109872|P1|Overall Study|Progressive Disease|15
6126072|NCT00021229|21109870|P3|Overall Study|Withdrawal by Subject|1
6126073|NCT00021229|21109871|P2|Overall Study|Withdrawal by Subject|7
6126074|NCT00021229|21109872|P1|Overall Study|Withdrawal by Subject|7
6126075|NCT00021229|21109870|P3|Overall Study|Death|0
6126076|NCT00021229|21109871|P2|Overall Study|Death|1
6126077|NCT00021229|21109872|P1|Overall Study|Death|0
6126078|NCT00021229|21109870|P3|Overall Study|Adverse Event|2
6126079|NCT00021229|21109871|P2|Overall Study|Adverse Event|5
6126080|NCT00021229|21109872|P1|Overall Study|Adverse Event|10
6126081|NCT00019604|21109927|P1|Overall Study|Details for other not available|4
6126082|NCT00019604|21109927|P1|Overall Study|Unable to evaluate|1
6126083|NCT00019604|21109927|P1|Overall Study|Too much disease|1
6126084|NCT00019604|21109927|P1|Overall Study|Pt going to immunotherapy study|1
6126085|NCT00019604|21109927|P1|Overall Study|Started new chemo regimen|1
6126086|NCT00019604|21109927|P1|Overall Study|Resectable disease|1
6126087|NCT00019604|21109927|P1|Overall Study|Non compliant|1
6126088|NCT00019604|21109927|P1|Overall Study|Non compliant on systemic CH|1
6126089|NCT00019604|21109927|P1|Overall Study|Move to a different study|1
6126090|NCT00019604|21109927|P1|Overall Study|Going to have liver transplant|1
6126091|NCT00019604|21109927|P1|Overall Study|Carcinoid tumor, not treatable|1
6126092|NCT00019604|21109927|P1|Overall Study|Refused treatment|1
6126093|NCT00019604|21109927|P1|Overall Study|Progressive disease|23
6126094|NCT00019604|21109927|P1|Overall Study|Death|1
6126095|NCT00016354|21109950|P8|Overall Study|Lack of Efficacy|1
6126096|NCT00016354|21109951|P7|Overall Study|Lack of Efficacy|0
6126097|NCT00016354|21109952|P6|Overall Study|Lack of Efficacy|0
6126098|NCT00016354|21109953|P5|Overall Study|Lack of Efficacy|0
6126099|NCT00016354|21109954|P4|Overall Study|Lack of Efficacy|0
6126100|NCT00016354|21109955|P3|Overall Study|Lack of Efficacy|0
6126101|NCT00016354|21109956|P2|Overall Study|Lack of Efficacy|0
6126102|NCT00016354|21109957|P1|Overall Study|Lack of Efficacy|0
6126103|NCT00014495|21109971|P4|Overall Study|Clinical deterioration|1
6126104|NCT00014495|21109972|P3|Overall Study|Clinical deterioration|0
6126105|NCT00014495|21109973|P2|Overall Study|Clinical deterioration|0
6126106|NCT00014495|21109974|P1|Overall Study|Clinical deterioration|0
6126107|NCT00014495|21109971|P4|Overall Study|Death|0
6126108|NCT00014495|21109972|P3|Overall Study|Death|1
6126109|NCT00014495|21109973|P2|Overall Study|Death|0
6126110|NCT00014495|21109974|P1|Overall Study|Death|0
6126111|NCT00012012|21110040|P2|Overall Study|Withdrawal by Subject|2
6126112|NCT00012012|21110041|P1|Overall Study|Withdrawal by Subject|0
6126113|NCT00012012|21110040|P2|Overall Study|Protocol Violation|1
6126114|NCT00012012|21110041|P1|Overall Study|Protocol Violation|1
6126115|NCT00010257|21110080|P2|Overall Study|Withdrawal by Subject|0
6126116|NCT00010257|21110081|P1|Overall Study|Withdrawal by Subject|1
6126117|NCT00009945|21110091|P2|Overall Study|no follow up data|5
6126118|NCT00009945|21110092|P1|Overall Study|no follow up data|7
6126119|NCT00008385|21110108|P2|Overall Study|Not start protocol therapy|175
6126120|NCT00008385|21110109|P1|Overall Study|Not start protocol therapy|44
6126121|NCT00008385|21110108|P2|Overall Study|Other|212
6126122|NCT00008385|21110109|P1|Overall Study|Other|105
6126123|NCT00008385|21110108|P2|Overall Study|Maximum dose reached|2
6126124|NCT00008385|21110109|P1|Overall Study|Maximum dose reached|0
6126125|NCT00008385|21110108|P2|Overall Study|Other complicating disease|30
6126126|NCT00008385|21110109|P1|Overall Study|Other complicating disease|17
6126127|NCT00008385|21110108|P2|Overall Study|Start non-protocol therapy|1
6126128|NCT00008385|21110109|P1|Overall Study|Start non-protocol therapy|3
6126129|NCT00008385|21110108|P2|Overall Study|Withdrawal by Subject|157
6126130|NCT00008385|21110109|P1|Overall Study|Withdrawal by Subject|67
6126131|NCT00008385|21110108|P2|Overall Study|Death|18
6126132|NCT00008385|21110109|P1|Overall Study|Death|12
6126133|NCT00008385|21110108|P2|Overall Study|Adverse Event|20
6126134|NCT00008385|21110109|P1|Overall Study|Adverse Event|8
6126135|NCT00008385|21110108|P2|Overall Study|Progressive disease|117
6126136|NCT00008385|21110109|P1|Overall Study|Progressive disease|52
6126137|NCT00008385|21110108|P2|Overall Study|Off treatment reasons not reported|70
6126138|NCT00008385|21110109|P1|Overall Study|Off treatment reasons not reported|79
6126139|NCT00008138|21110119|P1|Post-Cytoreduction Chemotherapy|not protocol specified|1
6126140|NCT00008138|21110119|P1|Post-Cytoreduction Chemotherapy|Progression|1
6126141|NCT00008138|21110119|P1|Post-Cytoreduction Chemotherapy|Adverse Event|6
6126142|NCT00008138|21110119|P1|Interval Debulking|Withdrawal by Subject|2
6126143|NCT00008138|21110119|P1|Neoadjuvant Chemotherapy|not protocol specified|8
6126144|NCT00008138|21110119|P1|Neoadjuvant Chemotherapy|Lack of Efficacy|6
6126145|NCT00008138|21110119|P1|Neoadjuvant Chemotherapy|Withdrawal by Subject|3
6126146|NCT00008138|21110119|P1|Neoadjuvant Chemotherapy|Adverse Event|3
6126147|NCT00006916|21110125|P1|Overall Study|Complication of device insertion|1
6126148|NCT00006916|21110125|P1|Overall Study|Device not inserted|4
6126149|NCT00006903|21110131|P3|Overall Study|Ineligible|2
6126150|NCT00006903|21110132|P2|Overall Study|Ineligible|1
6126151|NCT00006903|21110133|P1|Overall Study|Ineligible|10
6126152|NCT00006903|21110131|P3|Overall Study|Patient never treated|1
6126153|NCT00006903|21110132|P2|Overall Study|Patient never treated|0
6126154|NCT00006903|21110133|P1|Overall Study|Patient never treated|0
6126155|NCT00006903|21110131|P3|Overall Study|Death|0
6126156|NCT00006903|21110132|P2|Overall Study|Death|1
6126157|NCT00006903|21110133|P1|Overall Study|Death|0
6126158|NCT00006903|21110131|P3|Overall Study|Adverse Event|1
6126159|NCT00006903|21110132|P2|Overall Study|Adverse Event|0
6126160|NCT00006903|21110133|P1|Overall Study|Adverse Event|0
6126161|NCT00006903|21110131|P3|Overall Study|Refused further treatment|1
6126162|NCT00006903|21110132|P2|Overall Study|Refused further treatment|2
6126163|NCT00006903|21110133|P1|Overall Study|Refused further treatment|0
6126164|NCT00006903|21110131|P3|Overall Study|Still receiving treatment|1
6126165|NCT00006903|21110132|P2|Overall Study|Still receiving treatment|0
6126166|NCT00006903|21110133|P1|Overall Study|Still receiving treatment|0
6126167|NCT00006721|21110146|P3|Overall Study|Eligible but no Treatment Received|0
6126168|NCT00006721|21110147|P2|Overall Study|Eligible but no Treatment Received|0
6126169|NCT00006721|21110148|P1|Overall Study|Eligible but no Treatment Received|1
6126170|NCT00006721|21110146|P3|Overall Study|Ineligible|10
6126171|NCT00006721|21110147|P2|Overall Study|Ineligible|12
6126172|NCT00006721|21110148|P1|Overall Study|Ineligible|2
6126173|NCT00006721|21110146|P3|Overall Study|Other - Not Protocol Specified|7
6126174|NCT00006721|21110147|P2|Overall Study|Other - Not Protocol Specified|7
6126175|NCT00006721|21110148|P1|Overall Study|Other - Not Protocol Specified|0
6126176|NCT00006721|21110146|P3|Overall Study|Death|2
6126177|NCT00006721|21110147|P2|Overall Study|Death|1
6126178|NCT00006721|21110148|P1|Overall Study|Death|0
6126179|NCT00006721|21110146|P3|Overall Study|Progression/Relapse|2
6126180|NCT00006721|21110147|P2|Overall Study|Progression/Relapse|1
6126181|NCT00006721|21110148|P1|Overall Study|Progression/Relapse|0
6126182|NCT00006721|21110146|P3|Overall Study|Refusal Unrelated to Adverse Event|8
6126183|NCT00006721|21110147|P2|Overall Study|Refusal Unrelated to Adverse Event|0
6126184|NCT00006721|21110148|P1|Overall Study|Refusal Unrelated to Adverse Event|1
6126185|NCT00006721|21110146|P3|Overall Study|Adverse Event|4
6126186|NCT00006721|21110147|P2|Overall Study|Adverse Event|4
6126187|NCT00006721|21110148|P1|Overall Study|Adverse Event|0
6126188|NCT00006478|21110166|P1|Overall Study|Physician Decision|6
6126189|NCT00006478|21110166|P1|Overall Study|Vaccine could not be produced|1
6126190|NCT00006392|21110177|P4|Overall Study|Poor data/ppt mgmt, regulatory problems|155
6126191|NCT00006392|21110178|P3|Overall Study|Poor data/ppt mgmt, regulatory problems|155
6126192|NCT00006392|21110179|P2|Overall Study|Poor data/ppt mgmt, regulatory problems|155
6126193|NCT00006392|21110180|P1|Overall Study|Poor data/ppt mgmt, regulatory problems|156
6126194|NCT00006392|21110177|P4|Overall Study|Ineligible|5
6126195|NCT00006392|21110178|P3|Overall Study|Ineligible|5
6126196|NCT00006392|21110179|P2|Overall Study|Ineligible|3
6126197|NCT00006392|21110180|P1|Overall Study|Ineligible|11
6126198|NCT00006389|21110210|P1|Overall Study|Adverse Event|1
6126199|NCT00006237|21110227|P2|Overall Study|Not protocol specified|5
6126200|NCT00006237|21110228|P1|Overall Study|Not protocol specified|14
6126201|NCT00006237|21110227|P2|Overall Study|Withdrawal by Subject|1
6126202|NCT00006237|21110228|P1|Overall Study|Withdrawal by Subject|0
6126203|NCT00006237|21110227|P2|Overall Study|Not eligible|20
6126204|NCT00006237|21110228|P1|Overall Study|Not eligible|9
6126205|NCT00006237|21110227|P2|Overall Study|Progression/relapse|2
6126206|NCT00006237|21110228|P1|Overall Study|Progression/relapse|54
6126207|NCT00006237|21110227|P2|Overall Study|Refusal unrelated to adverse effects|4
6126208|NCT00006237|21110228|P1|Overall Study|Refusal unrelated to adverse effects|8
6126209|NCT00006237|21110227|P2|Overall Study|Death|0
6126210|NCT00006237|21110228|P1|Overall Study|Death|1
6126211|NCT00006237|21110227|P2|Overall Study|Adverse Event|29
6126212|NCT00006237|21110228|P1|Overall Study|Adverse Event|39
6126213|NCT00006011|21110271|P3|Overall Study|Ineligible|9
6126214|NCT00006011|21110272|P2|Overall Study|Ineligible|16
6126215|NCT00006011|21110273|P1|Overall Study|Ineligible|18
6126216|NCT00006011|21110271|P3|Overall Study|Other|5
6126217|NCT00006011|21110272|P2|Overall Study|Other|2
6126218|NCT00006011|21110273|P1|Overall Study|Other|4
6126219|NCT00006011|21110271|P3|Overall Study|Death|2
6126220|NCT00006011|21110272|P2|Overall Study|Death|1
6126221|NCT00006011|21110273|P1|Overall Study|Death|0
6126222|NCT00006011|21110271|P3|Overall Study|Adverse Event|5
6126223|NCT00006011|21110272|P2|Overall Study|Adverse Event|39
6126224|NCT00006011|21110273|P1|Overall Study|Adverse Event|15
6126225|NCT00006011|21110271|P3|Overall Study|Refused further treatment|26
6126226|NCT00006011|21110272|P2|Overall Study|Refused further treatment|13
6126227|NCT00006011|21110273|P1|Overall Study|Refused further treatment|15
6126228|NCT00006011|21110271|P3|Overall Study|Disease progression|26
6126229|NCT00006011|21110272|P2|Overall Study|Disease progression|6
6126230|NCT00006011|21110273|P1|Overall Study|Disease progression|13
6126231|NCT00005957|21110281|P2|Overall Study|Crossover to the other arm|19
6126232|NCT00005957|21110282|P1|Overall Study|Crossover to the other arm|5
6126233|NCT00005957|21110281|P2|Overall Study|No treated|9
6126234|NCT00005957|21110282|P1|Overall Study|No treated|3
6126235|NCT00005879|21110292|P2|Overall Study|Withdrawal by Subject|10
6126236|NCT00005879|21110293|P1|Overall Study|Withdrawal by Subject|8
6126237|NCT00005047|21110316|P4|Overall Study|Lack of Efficacy|0
6126238|NCT00005047|21110317|P3|Overall Study|Lack of Efficacy|0
6126239|NCT00005047|21110318|P2|Overall Study|Lack of Efficacy|0
6126240|NCT00005047|21110319|P1|Overall Study|Lack of Efficacy|1
6126241|NCT00005047|21110316|P4|Overall Study|Lost to Follow-up|0
6126242|NCT00005047|21110317|P3|Overall Study|Lost to Follow-up|0
6126243|NCT00005047|21110318|P2|Overall Study|Lost to Follow-up|0
6126244|NCT00005047|21110319|P1|Overall Study|Lost to Follow-up|1
6126245|NCT00005047|21110316|P4|Overall Study|Adverse Event|0
6126246|NCT00005047|21110317|P3|Overall Study|Adverse Event|0
6126247|NCT00005047|21110318|P2|Overall Study|Adverse Event|0
6126248|NCT00005047|21110319|P1|Overall Study|Adverse Event|5
6126249|NCT00005047|21110316|P4|Overall Study|Withdrawal by Subject|0
6126250|NCT00005047|21110317|P3|Overall Study|Withdrawal by Subject|0
6126251|NCT00005047|21110318|P2|Overall Study|Withdrawal by Subject|0
6126252|NCT00005047|21110319|P1|Overall Study|Withdrawal by Subject|12
6126253|NCT00005044|21110335|P2|Overall Study|No protocol treatment|1
6126254|NCT00005044|21110336|P1|Overall Study|No protocol treatment|0
6126255|NCT00005044|21110335|P2|Overall Study|Withdrawal by Subject|5
6126256|NCT00005044|21110336|P1|Overall Study|Withdrawal by Subject|1
6126257|NCT00005044|21110335|P2|Overall Study|Protocol Violation|46
6126258|NCT00005044|21110336|P1|Overall Study|Protocol Violation|37
6126259|NCT00004888|21110356|P2|Overall Study|Toxic death|0
6126260|NCT00004888|21110357|P1|Overall Study|Toxic death|1
6126261|NCT00004888|21110356|P2|Overall Study|Death without progressive disease|1
6126262|NCT00004888|21110357|P1|Overall Study|Death without progressive disease|0
6126263|NCT00004888|21110356|P2|Overall Study|Progressive Disease|9
6126264|NCT00004888|21110357|P1|Overall Study|Progressive Disease|4
6126265|NCT00004888|21110356|P2|Overall Study|Physician Decision|1
6126266|NCT00004888|21110357|P1|Overall Study|Physician Decision|1
6126267|NCT00004888|21110356|P2|Overall Study|Withdrawal by Subject|3
6126268|NCT00004888|21110357|P1|Overall Study|Withdrawal by Subject|0
6126269|NCT00004888|21110356|P2|Overall Study|Adverse Event|10
6126270|NCT00004888|21110357|P1|Overall Study|Adverse Event|5
6126271|NCT00004859|21110375|P2|Overall Study|Other|21
6126272|NCT00004859|21110376|P1|Overall Study|Other|13
6126273|NCT00004859|21110375|P2|Overall Study|missing data|11
6126274|NCT00004859|21110376|P1|Overall Study|missing data|14
6126275|NCT00004859|21110375|P2|Overall Study|error|1
6126276|NCT00004859|21110376|P1|Overall Study|error|3
6126277|NCT00004859|21110375|P2|Overall Study|other disease|3
6126278|NCT00004859|21110376|P1|Overall Study|other disease|0
6126279|NCT00004859|21110375|P2|Overall Study|Protocol Violation|2
6126280|NCT00004859|21110376|P1|Overall Study|Protocol Violation|2
6126281|NCT00004859|21110375|P2|Overall Study|Withdrawal by Subject|33
6126282|NCT00004859|21110376|P1|Overall Study|Withdrawal by Subject|7
6126283|NCT00004859|21110375|P2|Overall Study|Death|5
6126284|NCT00004859|21110376|P1|Overall Study|Death|5
6126285|NCT00004859|21110375|P2|Overall Study|Adverse Event|93
6126286|NCT00004859|21110376|P1|Overall Study|Adverse Event|31
6126287|NCT00004859|21110375|P2|Overall Study|Lack of Efficacy|113
6126288|NCT00004859|21110376|P1|Overall Study|Lack of Efficacy|43
6126289|NCT00004259|21110390|P4|Overall Study|Withdrawal by Subject|0
6126290|NCT00004259|21110391|P3|Overall Study|Withdrawal by Subject|0
6126291|NCT00004259|21110392|P2|Overall Study|Withdrawal by Subject|2
6126292|NCT00004259|21110393|P1|Overall Study|Withdrawal by Subject|0
6126293|NCT00004259|21110390|P4|Overall Study|Protocol Violation|0
6126294|NCT00004259|21110391|P3|Overall Study|Protocol Violation|0
6126295|NCT00004259|21110392|P2|Overall Study|Protocol Violation|2
6126296|NCT00004259|21110393|P1|Overall Study|Protocol Violation|1
6126297|NCT00004228|21110418|P7|Overall Study|ineligible|5
6126298|NCT00004228|21110419|P6|Overall Study|ineligible|2
6126299|NCT00004228|21110420|P5|Overall Study|ineligible|1
6126300|NCT00004228|21110421|P4|Overall Study|ineligible|1
6126301|NCT00004228|21110422|P3|Overall Study|ineligible|4
6126302|NCT00004228|21110423|P2|Overall Study|ineligible|2
6126303|NCT00004228|21110424|P1|Overall Study|ineligible|4
6126304|NCT00004228|21110418|P7|Overall Study|Other|0
6126305|NCT00004228|21110419|P6|Overall Study|Other|0
6126306|NCT00004228|21110420|P5|Overall Study|Other|0
6126307|NCT00004228|21110421|P4|Overall Study|Other|0
6126308|NCT00004228|21110422|P3|Overall Study|Other|1
6126309|NCT00004228|21110423|P2|Overall Study|Other|0
6126310|NCT00004228|21110424|P1|Overall Study|Other|0
6126311|NCT00004228|21110418|P7|Overall Study|Withdrawal by Subject|2
6126312|NCT00004228|21110419|P6|Overall Study|Withdrawal by Subject|1
6126313|NCT00004228|21110420|P5|Overall Study|Withdrawal by Subject|2
6126314|NCT00004228|21110421|P4|Overall Study|Withdrawal by Subject|0
6126315|NCT00004228|21110422|P3|Overall Study|Withdrawal by Subject|1
6126316|NCT00004228|21110423|P2|Overall Study|Withdrawal by Subject|0
6126317|NCT00004228|21110424|P1|Overall Study|Withdrawal by Subject|3
6126318|NCT00004228|21110418|P7|Overall Study|Protocol Violation|0
6126319|NCT00004228|21110419|P6|Overall Study|Protocol Violation|2
6126320|NCT00004228|21110420|P5|Overall Study|Protocol Violation|1
6126321|NCT00004228|21110421|P4|Overall Study|Protocol Violation|1
6126322|NCT00004228|21110422|P3|Overall Study|Protocol Violation|2
6126323|NCT00004228|21110423|P2|Overall Study|Protocol Violation|5
6126324|NCT00004228|21110424|P1|Overall Study|Protocol Violation|0
6126325|NCT00004228|21110418|P7|Overall Study|Physician Decision|1
6126326|NCT00004228|21110419|P6|Overall Study|Physician Decision|1
6126327|NCT00004228|21110420|P5|Overall Study|Physician Decision|1
6126328|NCT00004228|21110421|P4|Overall Study|Physician Decision|2
6126329|NCT00004228|21110422|P3|Overall Study|Physician Decision|3
6126330|NCT00004228|21110423|P2|Overall Study|Physician Decision|0
6126331|NCT00004228|21110424|P1|Overall Study|Physician Decision|1
6126332|NCT00004228|21110418|P7|Overall Study|Lost to Follow-up|0
6126333|NCT00004228|21110419|P6|Overall Study|Lost to Follow-up|0
6126334|NCT00004228|21110420|P5|Overall Study|Lost to Follow-up|0
6126335|NCT00004228|21110421|P4|Overall Study|Lost to Follow-up|0
6126336|NCT00004228|21110422|P3|Overall Study|Lost to Follow-up|1
6126337|NCT00004228|21110423|P2|Overall Study|Lost to Follow-up|0
6126338|NCT00004228|21110424|P1|Overall Study|Lost to Follow-up|0
6126339|NCT00004228|21110418|P7|Overall Study|Lack of Efficacy|4
6126340|NCT00004228|21110419|P6|Overall Study|Lack of Efficacy|8
6126341|NCT00004228|21110420|P5|Overall Study|Lack of Efficacy|9
6126342|NCT00004228|21110421|P4|Overall Study|Lack of Efficacy|3
6126343|NCT00004228|21110422|P3|Overall Study|Lack of Efficacy|5
6126344|NCT00004228|21110423|P2|Overall Study|Lack of Efficacy|6
6126345|NCT00004228|21110424|P1|Overall Study|Lack of Efficacy|1
6126346|NCT00004228|21110418|P7|Overall Study|Death|0
6126347|NCT00004228|21110419|P6|Overall Study|Death|0
6126348|NCT00004228|21110420|P5|Overall Study|Death|1
6126349|NCT00004228|21110421|P4|Overall Study|Death|0
6126350|NCT00004228|21110422|P3|Overall Study|Death|2
6126351|NCT00004228|21110423|P2|Overall Study|Death|1
6126352|NCT00004228|21110424|P1|Overall Study|Death|0
6126353|NCT00004228|21110418|P7|Overall Study|Adverse Event|0
6126354|NCT00004228|21110419|P6|Overall Study|Adverse Event|0
6126355|NCT00004228|21110420|P5|Overall Study|Adverse Event|1
6126356|NCT00004228|21110421|P4|Overall Study|Adverse Event|0
6126357|NCT00004228|21110422|P3|Overall Study|Adverse Event|0
6126358|NCT00004228|21110423|P2|Overall Study|Adverse Event|1
6126359|NCT00004228|21110424|P1|Overall Study|Adverse Event|0
6126360|NCT00004124|21110458|P2|Overall Study|Received no protocol therapy|20
6126361|NCT00004124|21110459|P1|Overall Study|Received no protocol therapy|12
6126362|NCT00004088|21110484|P1|Overall Study|Physician Decision|1
6126363|NCT00004088|21110484|P1|Overall Study|Protocol Violation|3
6126364|NCT00004088|21110484|P1|Overall Study|Withdrawal by Subject|1
6126365|NCT00004088|21110484|P1|Overall Study|No C2 given due to study on hold by IRB|4
6126366|NCT00003901|21110517|P1|Overall Study|Medical problems|6
6126367|NCT00003901|21110517|P1|Overall Study|Chest X-Ray not done prior registration|1
6126368|NCT00003901|21110517|P1|Overall Study|CT Scan not within protocol requirement|2
6126369|NCT00003901|21110517|P1|Overall Study|Ineligible|6
6126370|NCT00003901|21110517|P1|Overall Study|Withdrawal by Subject|1
6126371|NCT00003901|21110517|P1|Overall Study|Adverse Event|1
6126372|NCT00003896|21110528|P1|Overall Study|ineligible|5
6126373|NCT00003896|21110528|P1|Overall Study|not protocol specified|3
6126374|NCT00003896|21110528|P1|Overall Study|Death|3
6126375|NCT00003896|21110528|P1|Overall Study|Lack of Efficacy|1
6126376|NCT00003896|21110528|P1|Overall Study|Withdrawal by Subject|1
6126377|NCT00003896|21110528|P1|Overall Study|Adverse Event|16
6126378|NCT00003875|21110534|P1|Overall Study|Screen Failed|1
6126379|NCT00003869|21110543|P2|Overall Study|Alternative treatmnt, medical problems|4
6126380|NCT00003869|21110544|P1|Overall Study|Alternative treatmnt, medical problems|5
6126381|NCT00003869|21110543|P2|Overall Study|Death|2
6126382|NCT00003869|21110544|P1|Overall Study|Death|1
6126383|NCT00003869|21110543|P2|Overall Study|Withdrawal by Subject|3
6126384|NCT00003869|21110544|P1|Overall Study|Withdrawal by Subject|21
6126385|NCT00003869|21110543|P2|Overall Study|Adverse Event|3
6126386|NCT00003869|21110544|P1|Overall Study|Adverse Event|14
6126387|NCT00003782|21110570|P3|Overall Study|No follow up data|26
6126388|NCT00003782|21110571|P2|Overall Study|No follow up data|31
6126389|NCT00003782|21110572|P1|Overall Study|No follow up data|30
6126390|NCT00003702|21110582|P2|Overall Study|Inadequate documentation of disease|3
6126391|NCT00003702|21110583|P1|Overall Study|Inadequate documentation of disease|1
6126392|NCT00003702|21110582|P2|Overall Study|WHO score > 6|1
6126393|NCT00003702|21110583|P1|Overall Study|WHO score > 6|2
6126394|NCT00003702|21110582|P2|Overall Study|Did not meet criteria for persistence|5
6126395|NCT00003702|21110583|P1|Overall Study|Did not meet criteria for persistence|8
6126396|NCT00003702|21110582|P2|Overall Study|Ineligible cell types|2
6126397|NCT00003702|21110583|P1|Overall Study|Ineligible cell types|2
6126398|NCT00003659|21110592|P1|Overall Study|Withdrawal by Subject|3
6126399|NCT00003641|21110613|P2|Overall Study|Never started interferon|12
6126400|NCT00003641|21110614|P1|Overall Study|Never started interferon|567
6126401|NCT00003641|21110613|P2|Overall Study|Should not receive interferon therapy|0
6126402|NCT00003641|21110614|P1|Overall Study|Should not receive interferon therapy|2
6126403|NCT00003641|21110613|P2|Overall Study|Unknown/missing|22
6126404|NCT00003641|21110614|P1|Overall Study|Unknown/missing|0
6126405|NCT00003641|21110613|P2|Overall Study|Disease progression|2
6126406|NCT00003641|21110614|P1|Overall Study|Disease progression|0
6126407|NCT00003641|21110613|P2|Overall Study|Adverse Event|38
6126408|NCT00003641|21110614|P1|Overall Study|Adverse Event|0
6126409|NCT00003641|21110613|P2|Overall Study|Withdrawal by Subject|100
6126410|NCT00003641|21110614|P1|Overall Study|Withdrawal by Subject|0
6126411|NCT00003631|21110625|P3|Overall Study|Evaluable for toxicity only|2
6126412|NCT00003631|21110626|P2|Overall Study|Evaluable for toxicity only|0
6126413|NCT00003631|21110627|P1|Overall Study|Evaluable for toxicity only|0
6126414|NCT00003631|21110625|P3|Overall Study|Death|1
6126415|NCT00003631|21110626|P2|Overall Study|Death|0
6126416|NCT00003631|21110627|P1|Overall Study|Death|0
6126417|NCT00003631|21110625|P3|Overall Study|Adverse Event|5
6126418|NCT00003631|21110626|P2|Overall Study|Adverse Event|1
6126419|NCT00003631|21110627|P1|Overall Study|Adverse Event|1
6126420|NCT00003631|21110625|P3|Overall Study|Protocol Violation|0
6126421|NCT00003631|21110626|P2|Overall Study|Protocol Violation|0
6126422|NCT00003631|21110627|P1|Overall Study|Protocol Violation|1
6126423|NCT00003631|21110625|P3|Overall Study|Patient not treated|1
6126424|NCT00003631|21110626|P2|Overall Study|Patient not treated|0
6126425|NCT00003631|21110627|P1|Overall Study|Patient not treated|1
6126426|NCT00003590|21110635|P1|Overall Study|Physician Decision|1
6126427|NCT00003590|21110635|P1|Overall Study|Death|1
6126428|NCT00003590|21110635|P1|Overall Study|Lack of Efficacy|11
6126429|NCT00003590|21110635|P1|Overall Study|Withdrawal by Subject|1
6126430|NCT00003590|21110635|P1|Overall Study|Adverse Event|7
6126431|NCT00003590|21110635|P1|Overall Study|Ineligible Patient|1
6126432|NCT00003537|21110640|P1|Overall Study|Not evalauable|1
6126433|NCT00003535|21110645|P1|Overall Study|Not evaluable|5
6126434|NCT00003531|21110650|P1|Overall Study|Not evaluable|10
6126435|NCT00003526|21110654|P1|Overall Study|Not evaluable|6
6126436|NCT00003509|21110658|P1|Overall Study|Not evaluable|5
6126437|NCT00003499|21110662|P1|Overall Study|Not evaluable|8
6126438|NCT00003498|21110667|P1|Overall Study|Not evaluable.|4
6126439|NCT00003492|21110671|P1|Overall Study|Not evaluable|6
6126440|NCT00003483|21110675|P1|Overall Study|Not evaluable|1
6126441|NCT00003479|21110680|P1|Overall Study|Not evaluable|3
6126442|NCT00003477|21110685|P1|Overall Study|Not evalauable|4
6126443|NCT00003476|21110690|P1|Overall Study|Not evaluable|1
6126444|NCT00003475|21110695|P1|Overall Study|Not evaluable|13
6126445|NCT00003474|21110700|P1|Overall Study|Not Evaluable|14
6126446|NCT00003473|21110705|P1|Overall Study|Three patients were not evaluable.|3
6126447|NCT00003472|21110710|P1|Overall Study|Not evaluable|3
6126448|NCT00003471|21110715|P1|Overall Study|Not evaluable|4
6126449|NCT00003470|21110720|P1|Overall Study|Not evaluable|6
6126450|NCT00003458|21110745|P1|Overall Study|Not evaluable|4
6126451|NCT00003457|21110750|P1|Overall Study|Not evaluable|9
6126452|NCT00003456|21110755|P1|Overall Study|Not evaluable|8
6126453|NCT00003389|21110772|P2|Overall Study|Ineligible|27
6126454|NCT00003389|21110773|P1|Overall Study|Ineligible|33
6126455|NCT00003389|21110772|P2|Overall Study|Off-treatment reason missing|21
6126456|NCT00003389|21110773|P1|Overall Study|Off-treatment reason missing|31
6126457|NCT00003389|21110772|P2|Overall Study|Complicating disease|0
6126458|NCT00003389|21110773|P1|Overall Study|Complicating disease|1
6126459|NCT00003389|21110772|P2|Overall Study|Alternative therapy|1
6126460|NCT00003389|21110773|P1|Overall Study|Alternative therapy|2
6126461|NCT00003389|21110772|P2|Overall Study|Withdrawal by Subject|5
6126462|NCT00003389|21110773|P1|Overall Study|Withdrawal by Subject|12
6126463|NCT00003389|21110772|P2|Overall Study|Death|3
6126464|NCT00003389|21110773|P1|Overall Study|Death|0
6126465|NCT00003389|21110772|P2|Overall Study|Adverse Event|2
6126466|NCT00003389|21110773|P1|Overall Study|Adverse Event|13
6126467|NCT00003389|21110772|P2|Overall Study|Disease progression|1
6126468|NCT00003389|21110773|P1|Overall Study|Disease progression|6
6126469|NCT00003377|21110788|P5|Period II|Ureteral stent complications|1
6126470|NCT00003377|21110789|P4|Period II|Ureteral stent complications|0
6126471|NCT00003377|21110790|P3|Period II|Ureteral stent complications|0
6126472|NCT00003377|21110791|P2|Period II|Ureteral stent complications|0
6126473|NCT00003377|21110792|P1|Period II|Ureteral stent complications|0
6126474|NCT00003377|21110788|P5|Period I|Dose Limiting Toxicity(DLT)|0
6126475|NCT00003377|21110789|P4|Period I|Dose Limiting Toxicity(DLT)|1
6126476|NCT00003377|21110790|P3|Period I|Dose Limiting Toxicity(DLT)|1
6126477|NCT00003377|21110791|P2|Period I|Dose Limiting Toxicity(DLT)|0
6126478|NCT00003377|21110792|P1|Period I|Dose Limiting Toxicity(DLT)|0
6126479|NCT00003199|21110806|P1|Overall Study|Screen fail|15
6126480|NCT00003199|21110806|P1|Overall Study|Lack of insurance clearance|2
6126481|NCT00003199|21110806|P1|Overall Study|Refused Post-Transplant Immunotherapy|5
6126482|NCT00003138|21110814|P2|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|7
6126483|NCT00003138|21110815|P1|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|6
6126484|NCT00003138|21110814|P2|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|1
6126485|NCT00003138|21110815|P1|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|0
6126486|NCT00003138|21110814|P2|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|19
6126487|NCT00003138|21110815|P1|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|12
6126488|NCT00003138|21110814|P2|Step 2 (Cross Over)|Reasons off treatment not documented|0
6126489|NCT00003138|21110815|P1|Step 2 (Cross Over)|Reasons off treatment not documented|26
6126490|NCT00003138|21110814|P2|Step 1|Never started treatment|0
6126491|NCT00003138|21110815|P1|Step 1|Never started treatment|1
6126492|NCT00003138|21110814|P2|Step 1|Reasons off treatment not documented|57
6126493|NCT00003138|21110815|P1|Step 1|Reasons off treatment not documented|60
6126494|NCT00002931|21110832|P1|Overall Study|rapidly progressing disease during|2
6126495|NCT00002874|21110840|P2|Overall Study|Protocol Violation|34
6126496|NCT00002874|21110841|P1|Overall Study|Protocol Violation|44
6126497|NCT00002874|21110840|P2|Overall Study|Withdrawal by Subject|1
6126498|NCT00002874|21110841|P1|Overall Study|Withdrawal by Subject|1
6126499|NCT00002850|21110866|P3|Overall Study|Withdrawal by Subject|0
6126500|NCT00002850|21110867|P2|Overall Study|Withdrawal by Subject|1
6126501|NCT00002850|21110868|P1|Overall Study|Withdrawal by Subject|0
6126502|NCT00002850|21110866|P3|Overall Study|Protocol Violation|1
6126503|NCT00002850|21110867|P2|Overall Study|Protocol Violation|0
6126504|NCT00002850|21110868|P1|Overall Study|Protocol Violation|1
6126505|NCT00002850|21110866|P3|Overall Study|Death|3
6126506|NCT00002850|21110867|P2|Overall Study|Death|1
6126507|NCT00002850|21110868|P1|Overall Study|Death|4
6126508|NCT00002842|21110876|P1|Overall Study|ineligible for surgical resection|27
6126509|NCT00002766|21110882|P2|Overall Study|Protocol Violation|0
6126510|NCT00002766|21110883|P1|Overall Study|Protocol Violation|1
6126511|NCT00002766|21110882|P2|Overall Study|Adverse Event|1
6126512|NCT00002766|21110883|P1|Overall Study|Adverse Event|1
6126513|NCT00002766|21110882|P2|Overall Study|Patient Not Treated|2
6126514|NCT00002766|21110883|P1|Overall Study|Patient Not Treated|1
6126515|NCT00002766|21110882|P2|Overall Study|Withdrawal by Subject|1
6126516|NCT00002766|21110883|P1|Overall Study|Withdrawal by Subject|0
6126517|NCT00002651|21110891|P3|Consolidation and Randomization|not eligible|112
6126518|NCT00002651|21110892|P2|Consolidation and Randomization|not eligible|102
6126519|NCT00002651|21110893|P1|Consolidation and Randomization|not eligible|0
6126520|NCT00002651|21110891|P3|Consolidation and Randomization|Other|313
6126521|NCT00002651|21110892|P2|Consolidation and Randomization|Other|314
6126522|NCT00002651|21110893|P1|Consolidation and Randomization|Other|0
6126523|NCT00002651|21110891|P3|Consolidation and Randomization|Death|48
6126524|NCT00002651|21110892|P2|Consolidation and Randomization|Death|38
6126525|NCT00002651|21110893|P1|Consolidation and Randomization|Death|0
6126526|NCT00002651|21110891|P3|Consolidation and Randomization|Progression/relapse|298
6126527|NCT00002651|21110892|P2|Consolidation and Randomization|Progression/relapse|295
6126528|NCT00002651|21110893|P1|Consolidation and Randomization|Progression/relapse|0
6126529|NCT00002651|21110891|P3|Consolidation and Randomization|Refusal unrelated to adverse event|75
6126530|NCT00002651|21110892|P2|Consolidation and Randomization|Refusal unrelated to adverse event|53
6126531|NCT00002651|21110893|P1|Consolidation and Randomization|Refusal unrelated to adverse event|0
6126532|NCT00002651|21110891|P3|Consolidation and Randomization|Adverse Event|14
6126533|NCT00002651|21110892|P2|Consolidation and Randomization|Adverse Event|36
6126534|NCT00002651|21110893|P1|Consolidation and Randomization|Adverse Event|0
6126535|NCT00002651|21110891|P3|Induction|not eligible|0
6126536|NCT00002651|21110892|P2|Induction|not eligible|0
6126537|NCT00002651|21110893|P1|Induction|not eligible|90
6126538|NCT00002651|21110891|P3|Induction|Other|0
6126539|NCT00002651|21110892|P2|Induction|Other|0
6126540|NCT00002651|21110893|P1|Induction|Other|823
6126541|NCT00002651|21110891|P3|Induction|Death|0
6126542|NCT00002651|21110892|P2|Induction|Death|0
6126543|NCT00002651|21110893|P1|Induction|Death|62
6126544|NCT00002651|21110891|P3|Induction|Progression/relapse|0
6126545|NCT00002651|21110892|P2|Induction|Progression/relapse|0
6126546|NCT00002651|21110893|P1|Induction|Progression/relapse|274
6126547|NCT00002651|21110891|P3|Induction|Refusal unrelated to adverse event|0
6126548|NCT00002651|21110892|P2|Induction|Refusal unrelated to adverse event|0
6126549|NCT00002651|21110893|P1|Induction|Refusal unrelated to adverse event|50
6126550|NCT00002651|21110891|P3|Induction|Adverse Event|0
6126551|NCT00002651|21110892|P2|Induction|Adverse Event|0
6126552|NCT00002651|21110893|P1|Induction|Adverse Event|44
6126553|NCT00002558|21110911|P2|Overall Study|Withdrawal by Subject|1
6126554|NCT00002558|21110912|P1|Overall Study|Withdrawal by Subject|0
6126555|NCT00051636|21110937|P2|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|12
6126556|NCT00051636|21110938|P1|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|40
6126557|NCT00051636|21110937|P2|Period 2- Extended Observation Period|Death|5
6126558|NCT00051636|21110938|P1|Period 2- Extended Observation Period|Death|4
6126559|NCT00051636|21110937|P2|Period 2- Extended Observation Period|Clinical reasons other than Paget's|2
6126560|NCT00051636|21110938|P1|Period 2- Extended Observation Period|Clinical reasons other than Paget's|9
6126561|NCT00051636|21110937|P2|Period 2- Extended Observation Period|withdrew for nonclinical reason|7
6126562|NCT00051636|21110938|P1|Period 2- Extended Observation Period|withdrew for nonclinical reason|12
6126563|NCT00051636|21110937|P2|Period 2- Extended Observation Period|Lost to Follow-up|4
6126564|NCT00051636|21110938|P1|Period 2- Extended Observation Period|Lost to Follow-up|5
6126565|NCT00051636|21110937|P2|Period 1 - Core|Lost to Follow-up|2
6126566|NCT00051636|21110938|P1|Period 1 - Core|Lost to Follow-up|0
6126567|NCT00051636|21110937|P2|Period 1 - Core|Withdrawal by Subject|2
6126568|NCT00051636|21110938|P1|Period 1 - Core|Withdrawal by Subject|1
6126569|NCT00051636|21110937|P2|Period 1 - Core|Protocol Violation|0
6126570|NCT00051636|21110938|P1|Period 1 - Core|Protocol Violation|1
6126571|NCT00051636|21110937|P2|Period 1 - Core|Adverse Event|2
6126572|NCT00051636|21110938|P1|Period 1 - Core|Adverse Event|2
6126573|NCT00051558|21110966|P2|Overall Study|Physician Decision|0
6126574|NCT00051558|21110967|P1|Overall Study|Physician Decision|5
6126575|NCT00051558|21110966|P2|Overall Study|Significant Lab Value|0
6126576|NCT00051558|21110967|P1|Overall Study|Significant Lab Value|2
6126577|NCT00051558|21110966|P2|Overall Study|Other|1
6126578|NCT00051558|21110967|P1|Overall Study|Other|2
6126579|NCT00051558|21110966|P2|Overall Study|Sponsor Decision|1
6126580|NCT00051558|21110967|P1|Overall Study|Sponsor Decision|6
6126581|NCT00051558|21110966|P2|Overall Study|Protocol Entry Criteria Unmet|2
6126582|NCT00051558|21110967|P1|Overall Study|Protocol Entry Criteria Unmet|1
6126583|NCT00051558|21110966|P2|Overall Study|Protocol Violation|4
6126584|NCT00051558|21110967|P1|Overall Study|Protocol Violation|3
6126585|NCT00051558|21110966|P2|Overall Study|Lost to Follow-up|13
6126586|NCT00051558|21110967|P1|Overall Study|Lost to Follow-up|4
6126587|NCT00051558|21110966|P2|Overall Study|Death|15
6126588|NCT00051558|21110967|P1|Overall Study|Death|9
6126589|NCT00051558|21110966|P2|Overall Study|Withdrawal by Subject|42
6126590|NCT00051558|21110967|P1|Overall Study|Withdrawal by Subject|29
6126591|NCT00051558|21110966|P2|Overall Study|Adverse Event|18
6126592|NCT00051558|21110967|P1|Overall Study|Adverse Event|30
6126593|NCT00051363|21111003|P2|Overall Study|Excluded Pre-Randomization|5
6126594|NCT00051363|21111004|P1|Overall Study|Excluded Pre-Randomization|2
6126595|NCT00051363|21111003|P2|Overall Study|Death|2
6126596|NCT00051363|21111004|P1|Overall Study|Death|2
6126597|NCT00051363|21111003|P2|Overall Study|Disqualified Post-Rand for Any Reason|11
6126598|NCT00051363|21111004|P1|Overall Study|Disqualified Post-Rand for Any Reason|9
6126599|NCT00051363|21111003|P2|Overall Study|Dropped Post-Rand for Any Reason|126
6126600|NCT00051363|21111004|P1|Overall Study|Dropped Post-Rand for Any Reason|102
6126601|NCT00051025|21111044|P2|Overall Study|Death|1
6126602|NCT00051025|21111045|P1|Overall Study|Death|0
6126603|NCT00051025|21111044|P2|Overall Study|Withdrawal by Subject|1
6126604|NCT00051025|21111045|P1|Overall Study|Withdrawal by Subject|0
6126605|NCT00051025|21111044|P2|Overall Study|Adverse Event|1
6126606|NCT00051025|21111045|P1|Overall Study|Adverse Event|1
6126607|NCT00051025|21111044|P2|Overall Study|Progressive Disease|1
6126608|NCT00051025|21111045|P1|Overall Study|Progressive Disease|1
6126609|NCT00050960|21111059|P2|Overall Study|Death|15
6126610|NCT00050960|21111060|P1|Overall Study|Death|13
6126611|NCT00050960|21111059|P2|Overall Study|Non-compliance|1
6126612|NCT00050960|21111060|P1|Overall Study|Non-compliance|3
6126613|NCT00050960|21111059|P2|Overall Study|Administrative|46
6126614|NCT00050960|21111060|P1|Overall Study|Administrative|31
6126615|NCT00050960|21111059|P2|Overall Study|Withdrawal by Subject|18
6126616|NCT00050960|21111060|P1|Overall Study|Withdrawal by Subject|23
6126617|NCT00050960|21111059|P2|Overall Study|Lost to Follow-up|1
6126618|NCT00050960|21111060|P1|Overall Study|Lost to Follow-up|0
6126619|NCT00050960|21111059|P2|Overall Study|Adverse Event|61
6126620|NCT00050960|21111060|P1|Overall Study|Adverse Event|62
6126621|NCT00050960|21111059|P2|Overall Study|Complete Response|2
6126622|NCT00050960|21111060|P1|Overall Study|Complete Response|0
6126623|NCT00050960|21111059|P2|Overall Study|Partial Response|19
6126624|NCT00050960|21111060|P1|Overall Study|Partial Response|14
6126625|NCT00050960|21111059|P2|Overall Study|Stable Disease|48
6126626|NCT00050960|21111060|P1|Overall Study|Stable Disease|19
6126627|NCT00050960|21111059|P2|Overall Study|Progressive Disease|93
6126628|NCT00050960|21111060|P1|Overall Study|Progressive Disease|137
6126629|NCT00050778|21111069|P3|Overall Study|Familial and personal reasons|0
6126630|NCT00050778|21111070|P2|Overall Study|Familial and personal reasons|0
6126631|NCT00050778|21111071|P1|Overall Study|Familial and personal reasons|1
6126632|NCT00050778|21111069|P3|Overall Study|Randomized but not treated|2
6126633|NCT00050778|21111070|P2|Overall Study|Randomized but not treated|5
6126634|NCT00050778|21111071|P1|Overall Study|Randomized but not treated|4
6126635|NCT00050778|21111069|P3|Overall Study|Withdrawal by Subject|4
6126636|NCT00050778|21111070|P2|Overall Study|Withdrawal by Subject|8
6126637|NCT00050778|21111071|P1|Overall Study|Withdrawal by Subject|6
6126638|NCT00050778|21111069|P3|Overall Study|Protocol Violation|1
6126639|NCT00050778|21111070|P2|Overall Study|Protocol Violation|0
6126640|NCT00050778|21111071|P1|Overall Study|Protocol Violation|2
6126641|NCT00050778|21111069|P3|Overall Study|Physician Decision|2
6126642|NCT00050778|21111070|P2|Overall Study|Physician Decision|0
6126643|NCT00050778|21111071|P1|Overall Study|Physician Decision|3
6126644|NCT00050778|21111069|P3|Overall Study|Lost to Follow-up|4
6126645|NCT00050778|21111070|P2|Overall Study|Lost to Follow-up|2
6126646|NCT00050778|21111071|P1|Overall Study|Lost to Follow-up|0
6126647|NCT00050778|21111069|P3|Overall Study|Lack of Efficacy|2
6126648|NCT00050778|21111070|P2|Overall Study|Lack of Efficacy|2
6126649|NCT00050778|21111071|P1|Overall Study|Lack of Efficacy|16
6126650|NCT00050778|21111069|P3|Overall Study|Death|1
6126651|NCT00050778|21111070|P2|Overall Study|Death|1
6126652|NCT00050778|21111071|P1|Overall Study|Death|0
6126653|NCT00050778|21111069|P3|Overall Study|Adverse Event|2
6126654|NCT00050778|21111070|P2|Overall Study|Adverse Event|3
6126655|NCT00050778|21111071|P1|Overall Study|Adverse Event|13
6126656|NCT00050622|21111097|P1|Overall Study|Adverse Event|1
6126657|NCT00050167|21111135|P2|Overall Study|not eligible not invasive|1
6126658|NCT00050167|21111136|P1|Overall Study|not eligible not invasive|1
6126659|NCT00050011|21111169|P2|Overall Study|Unknown - Reason is missing|2
6126660|NCT00050011|21111170|P1|Overall Study|Unknown - Reason is missing|0
6126661|NCT00050011|21111169|P2|Overall Study|Death|4
6126662|NCT00050011|21111170|P1|Overall Study|Death|7
6126663|NCT00050011|21111169|P2|Overall Study|Administrative problems|6
6126664|NCT00050011|21111170|P1|Overall Study|Administrative problems|10
6126665|NCT00050011|21111169|P2|Overall Study|Lost to Follow-up|9
6126666|NCT00050011|21111170|P1|Overall Study|Lost to Follow-up|7
6126667|NCT00050011|21111169|P2|Overall Study|Withdrawal by Subject|26
6126668|NCT00050011|21111170|P1|Overall Study|Withdrawal by Subject|34
6126669|NCT00050011|21111169|P2|Overall Study|Protocol Violation|10
6126670|NCT00050011|21111170|P1|Overall Study|Protocol Violation|4
6126671|NCT00050011|21111169|P2|Overall Study|Participant condition no longer required|0
6126672|NCT00050011|21111170|P1|Overall Study|Participant condition no longer required|1
6126673|NCT00050011|21111169|P2|Overall Study|Lack of Efficacy|21
6126674|NCT00050011|21111170|P1|Overall Study|Lack of Efficacy|16
6126675|NCT00050011|21111169|P2|Overall Study|Abnormal test procedure results|1
6126676|NCT00050011|21111170|P1|Overall Study|Abnormal test procedure results|0
6126677|NCT00050011|21111169|P2|Overall Study|Abnormal laboratory value(s)|1
6126678|NCT00050011|21111170|P1|Overall Study|Abnormal laboratory value(s)|1
6126679|NCT00050011|21111169|P2|Overall Study|Adverse Event|46
6126680|NCT00050011|21111170|P1|Overall Study|Adverse Event|41
6126681|NCT00049842|21111192|P2|Follow-up Phase|Other|4
6126682|NCT00049842|21111193|P1|Follow-up Phase|Other|1
6126683|NCT00049842|21111192|P2|Follow-up Phase|Adverse Event|1
6126684|NCT00049842|21111193|P1|Follow-up Phase|Adverse Event|6
6126685|NCT00049842|21111192|P2|Treatment Phase|Did not meet protocol eligibility|1
6126686|NCT00049842|21111193|P1|Treatment Phase|Did not meet protocol eligibility|0
6126687|NCT00049842|21111192|P2|Treatment Phase|Administrative|3
6126688|NCT00049842|21111193|P1|Treatment Phase|Administrative|0
6126689|NCT00049842|21111192|P2|Treatment Phase|Lost to Follow-up|8
6126690|NCT00049842|21111193|P1|Treatment Phase|Lost to Follow-up|4
6126691|NCT00049842|21111192|P2|Treatment Phase|Non-compliance with protocol|8
6126692|NCT00049842|21111193|P1|Treatment Phase|Non-compliance with protocol|7
6126693|NCT00049842|21111192|P2|Treatment Phase|Withdrawal by Subject|46
6126694|NCT00049842|21111193|P1|Treatment Phase|Withdrawal by Subject|35
6126695|NCT00049842|21111192|P2|Treatment Phase|Adverse Event|12
6126696|NCT00049842|21111193|P1|Treatment Phase|Adverse Event|47
6126697|NCT00048932|21111211|P3|Open Label Period (OL)|Participant Surgery|1
6126698|NCT00048932|21111212|P2|Open Label Period (OL)|Participant Surgery|0
6126699|NCT00048932|21111213|P1|Open Label Period (OL)|Participant Surgery|0
6126700|NCT00048932|21111211|P3|Open Label Period (OL)|Site Not Participating in Open Label|9
6126701|NCT00048932|21111212|P2|Open Label Period (OL)|Site Not Participating in Open Label|0
6126702|NCT00048932|21111213|P1|Open Label Period (OL)|Site Not Participating in Open Label|0
6126703|NCT00048932|21111211|P3|Open Label Period (OL)|Site Staff Issues|2
6126704|NCT00048932|21111212|P2|Open Label Period (OL)|Site Staff Issues|0
6126705|NCT00048932|21111213|P1|Open Label Period (OL)|Site Staff Issues|0
6126706|NCT00048932|21111211|P3|Open Label Period (OL)|Investigator Decision|4
6126707|NCT00048932|21111212|P2|Open Label Period (OL)|Investigator Decision|0
6126708|NCT00048932|21111213|P1|Open Label Period (OL)|Investigator Decision|0
6126709|NCT00048932|21111211|P3|Open Label Period (OL)|Medication Lost Efficacy|1
6126710|NCT00048932|21111212|P2|Open Label Period (OL)|Medication Lost Efficacy|0
6126711|NCT00048932|21111213|P1|Open Label Period (OL)|Medication Lost Efficacy|0
6126712|NCT00048932|21111211|P3|Open Label Period (OL)|Participant Missed Consecutive Doses|5
6126713|NCT00048932|21111212|P2|Open Label Period (OL)|Participant Missed Consecutive Doses|0
6126714|NCT00048932|21111213|P1|Open Label Period (OL)|Participant Missed Consecutive Doses|0
6126715|NCT00048932|21111211|P3|Open Label Period (OL)|Participant Desires Pregnancy|2
6126716|NCT00048932|21111212|P2|Open Label Period (OL)|Participant Desires Pregnancy|0
6126717|NCT00048932|21111213|P1|Open Label Period (OL)|Participant Desires Pregnancy|0
6126718|NCT00048932|21111211|P3|Open Label Period (OL)|Participant Received Wrong Medication|1
6126719|NCT00048932|21111212|P2|Open Label Period (OL)|Participant Received Wrong Medication|0
6126720|NCT00048932|21111213|P1|Open Label Period (OL)|Participant Received Wrong Medication|0
6126721|NCT00048932|21111211|P3|Open Label Period (OL)|Patient Decision|4
6126722|NCT00048932|21111212|P2|Open Label Period (OL)|Patient Decision|0
6126723|NCT00048932|21111213|P1|Open Label Period (OL)|Patient Decision|0
6126724|NCT00048932|21111211|P3|Open Label Period (OL)|Difficult IV Access with Participant|1
6126725|NCT00048932|21111212|P2|Open Label Period (OL)|Difficult IV Access with Participant|0
6126726|NCT00048932|21111213|P1|Open Label Period (OL)|Difficult IV Access with Participant|0
6126727|NCT00048932|21111211|P3|Open Label Period (OL)|Trial Terminated|1
6126728|NCT00048932|21111212|P2|Open Label Period (OL)|Trial Terminated|0
6126729|NCT00048932|21111213|P1|Open Label Period (OL)|Trial Terminated|0
6126730|NCT00048932|21111211|P3|Open Label Period (OL)|Site Closure|3
6126731|NCT00048932|21111212|P2|Open Label Period (OL)|Site Closure|0
6126732|NCT00048932|21111213|P1|Open Label Period (OL)|Site Closure|0
6126733|NCT00048932|21111211|P3|Open Label Period (OL)|Investigator Dosing the Trial|1
6126734|NCT00048932|21111212|P2|Open Label Period (OL)|Investigator Dosing the Trial|0
6126735|NCT00048932|21111213|P1|Open Label Period (OL)|Investigator Dosing the Trial|0
6126736|NCT00048932|21111211|P3|Open Label Period (OL)|Participant Relocated|6
6126737|NCT00048932|21111212|P2|Open Label Period (OL)|Participant Relocated|0
6126738|NCT00048932|21111213|P1|Open Label Period (OL)|Participant Relocated|0
6126739|NCT00048932|21111211|P3|Open Label Period (OL)|Participant Transportation Issues|1
6126740|NCT00048932|21111212|P2|Open Label Period (OL)|Participant Transportation Issues|0
6126741|NCT00048932|21111213|P1|Open Label Period (OL)|Participant Transportation Issues|0
6126742|NCT00048932|21111211|P3|Open Label Period (OL)|Investigator Retiring|2
6126743|NCT00048932|21111212|P2|Open Label Period (OL)|Investigator Retiring|0
6126744|NCT00048932|21111213|P1|Open Label Period (OL)|Investigator Retiring|0
6126745|NCT00048932|21111211|P3|Open Label Period (OL)|Administrative Reason By Sponsor|20
6126746|NCT00048932|21111212|P2|Open Label Period (OL)|Administrative Reason By Sponsor|0
6126747|NCT00048932|21111213|P1|Open Label Period (OL)|Administrative Reason By Sponsor|0
6126748|NCT00048932|21111211|P3|Open Label Period (OL)|Pregnancy|6
6126749|NCT00048932|21111212|P2|Open Label Period (OL)|Pregnancy|0
6126750|NCT00048932|21111213|P1|Open Label Period (OL)|Pregnancy|0
6126751|NCT00048932|21111211|P3|Open Label Period (OL)|Poor/Non-Compliance|13
6126752|NCT00048932|21111212|P2|Open Label Period (OL)|Poor/Non-Compliance|0
6126753|NCT00048932|21111213|P1|Open Label Period (OL)|Poor/Non-Compliance|0
6126754|NCT00048932|21111211|P3|Open Label Period (OL)|No Longer Meets Study Criteria|5
6126755|NCT00048932|21111212|P2|Open Label Period (OL)|No Longer Meets Study Criteria|0
6126756|NCT00048932|21111213|P1|Open Label Period (OL)|No Longer Meets Study Criteria|0
6126757|NCT00048932|21111211|P3|Open Label Period (OL)|Withdrawal by Subject|117
6126758|NCT00048932|21111212|P2|Open Label Period (OL)|Withdrawal by Subject|0
6126759|NCT00048932|21111213|P1|Open Label Period (OL)|Withdrawal by Subject|0
6126760|NCT00048932|21111211|P3|Open Label Period (OL)|Lost to Follow-up|27
6126761|NCT00048932|21111212|P2|Open Label Period (OL)|Lost to Follow-up|0
6126762|NCT00048932|21111213|P1|Open Label Period (OL)|Lost to Follow-up|0
6126763|NCT00048932|21111211|P3|Open Label Period (OL)|Lack of Efficacy|81
6126764|NCT00048932|21111212|P2|Open Label Period (OL)|Lack of Efficacy|0
6126765|NCT00048932|21111213|P1|Open Label Period (OL)|Lack of Efficacy|0
6126766|NCT00048932|21111211|P3|Open Label Period (OL)|Adverse Event|103
6126767|NCT00048932|21111212|P2|Open Label Period (OL)|Adverse Event|0
6126768|NCT00048932|21111213|P1|Open Label Period (OL)|Adverse Event|0
6126769|NCT00048932|21111211|P3|Open Label Period (OL)|Death|25
6126770|NCT00048932|21111212|P2|Open Label Period (OL)|Death|0
6126771|NCT00048932|21111213|P1|Open Label Period (OL)|Death|0
6126772|NCT00048932|21111211|P3|Double Blind Period (DB)|Poor/Non-Compliance|0
6126773|NCT00048932|21111212|P2|Double Blind Period (DB)|Poor/Non-Compliance|4
6126774|NCT00048932|21111213|P1|Double Blind Period (DB)|Poor/Non-Compliance|2
6126775|NCT00048932|21111211|P3|Double Blind Period (DB)|Withdrawal by Subject|0
6126776|NCT00048932|21111212|P2|Double Blind Period (DB)|Withdrawal by Subject|10
6126777|NCT00048932|21111213|P1|Double Blind Period (DB)|Withdrawal by Subject|24
6126778|NCT00048932|21111211|P3|Double Blind Period (DB)|No Longer Meets Study Criteria|0
6126779|NCT00048932|21111212|P2|Double Blind Period (DB)|No Longer Meets Study Criteria|2
6126780|NCT00048932|21111213|P1|Double Blind Period (DB)|No Longer Meets Study Criteria|8
6126781|NCT00048932|21111211|P3|Double Blind Period (DB)|Pregnancy|0
6126782|NCT00048932|21111212|P2|Double Blind Period (DB)|Pregnancy|0
6126783|NCT00048932|21111213|P1|Double Blind Period (DB)|Pregnancy|1
6126784|NCT00048932|21111211|P3|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0
6126785|NCT00048932|21111212|P2|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0
6126786|NCT00048932|21111213|P1|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|1
6126787|NCT00048932|21111211|P3|Double Blind Period (DB)|Uncontrolled hypertension|0
6126788|NCT00048932|21111212|P2|Double Blind Period (DB)|Uncontrolled hypertension|1
6126789|NCT00048932|21111213|P1|Double Blind Period (DB)|Uncontrolled hypertension|0
6126790|NCT00048932|21111211|P3|Double Blind Period (DB)|Relocation|0
6126791|NCT00048932|21111212|P2|Double Blind Period (DB)|Relocation|0
6126792|NCT00048932|21111213|P1|Double Blind Period (DB)|Relocation|1
6126793|NCT00048932|21111211|P3|Double Blind Period (DB)|Lost to Follow-up|0
6126794|NCT00048932|21111212|P2|Double Blind Period (DB)|Lost to Follow-up|4
6126795|NCT00048932|21111213|P1|Double Blind Period (DB)|Lost to Follow-up|3
6126796|NCT00048932|21111211|P3|Double Blind Period (DB)|Lack of Efficacy|0
6126797|NCT00048932|21111212|P2|Double Blind Period (DB)|Lack of Efficacy|44
6126798|NCT00048932|21111213|P1|Double Blind Period (DB)|Lack of Efficacy|26
6126799|NCT00048932|21111211|P3|Double Blind Period (DB)|Death|0
6126800|NCT00048932|21111212|P2|Double Blind Period (DB)|Death|3
6126801|NCT00048932|21111213|P1|Double Blind Period (DB)|Death|5
6126802|NCT00048932|21111211|P3|Double Blind Period (DB)|Adverse Event|0
6126803|NCT00048932|21111212|P2|Double Blind Period (DB)|Adverse Event|19
6126804|NCT00048932|21111213|P1|Double Blind Period (DB)|Adverse Event|51
6126805|NCT00048932|21111211|P3|Double Blind Period (DB)|Administrative Reason By Sponsor|0
6126806|NCT00048932|21111212|P2|Double Blind Period (DB)|Administrative Reason By Sponsor|0
6126807|NCT00048932|21111213|P1|Double Blind Period (DB)|Administrative Reason By Sponsor|1
6126808|NCT00048581|21111255|P3|Open-Label Period|Study Ended By Sponsor|1
6126809|NCT00048581|21111256|P2|Open-Label Period|Study Ended By Sponsor|0
6126810|NCT00048581|21111257|P1|Open-Label Period|Study Ended By Sponsor|0
6126811|NCT00048581|21111255|P3|Open-Label Period|Primary Investigator Retired|2
6126812|NCT00048581|21111256|P2|Open-Label Period|Primary Investigator Retired|0
6126813|NCT00048581|21111257|P1|Open-Label Period|Primary Investigator Retired|0
6126814|NCT00048581|21111255|P3|Open-Label Period|Problem With Transportation To Site|1
6126815|NCT00048581|21111256|P2|Open-Label Period|Problem With Transportation To Site|0
6126816|NCT00048581|21111257|P1|Open-Label Period|Problem With Transportation To Site|0
6126817|NCT00048581|21111255|P3|Open-Label Period|Continue ABA With Primary Rheumatologist|3
6126818|NCT00048581|21111256|P2|Open-Label Period|Continue ABA With Primary Rheumatologist|0
6126819|NCT00048581|21111257|P1|Open-Label Period|Continue ABA With Primary Rheumatologist|0
6126820|NCT00048581|21111255|P3|Open-Label Period|Study Site Closure|2
6126821|NCT00048581|21111256|P2|Open-Label Period|Study Site Closure|0
6126822|NCT00048581|21111257|P1|Open-Label Period|Study Site Closure|0
6126823|NCT00048581|21111255|P3|Open-Label Period|Pregnancy|7
6126824|NCT00048581|21111256|P2|Open-Label Period|Pregnancy|0
6126825|NCT00048581|21111257|P1|Open-Label Period|Pregnancy|0
6126826|NCT00048581|21111255|P3|Open-Label Period|Poor/Non-compliance|5
6126827|NCT00048581|21111256|P2|Open-Label Period|Poor/Non-compliance|0
6126828|NCT00048581|21111257|P1|Open-Label Period|Poor/Non-compliance|0
6126829|NCT00048581|21111255|P3|Open-Label Period|No Longer Meets Study Criteria|2
6126830|NCT00048581|21111256|P2|Open-Label Period|No Longer Meets Study Criteria|0
6126831|NCT00048581|21111257|P1|Open-Label Period|No Longer Meets Study Criteria|0
6126832|NCT00048581|21111255|P3|Open-Label Period|Withdrawal by Subject|20
6126833|NCT00048581|21111256|P2|Open-Label Period|Withdrawal by Subject|0
6126834|NCT00048581|21111257|P1|Open-Label Period|Withdrawal by Subject|0
6126835|NCT00048581|21111255|P3|Open-Label Period|Lost to Follow-up|14
6126836|NCT00048581|21111256|P2|Open-Label Period|Lost to Follow-up|0
6126837|NCT00048581|21111257|P1|Open-Label Period|Lost to Follow-up|0
6126838|NCT00048581|21111255|P3|Open-Label Period|Lack of Efficacy|69
6126839|NCT00048581|21111256|P2|Open-Label Period|Lack of Efficacy|0
6126840|NCT00048581|21111257|P1|Open-Label Period|Lack of Efficacy|0
6126841|NCT00048581|21111255|P3|Open-Label Period|Adverse Event|37
6126842|NCT00048581|21111256|P2|Open-Label Period|Adverse Event|0
6126843|NCT00048581|21111257|P1|Open-Label Period|Adverse Event|0
6126844|NCT00048581|21111255|P3|Open-Label Period|Death|4
6126845|NCT00048581|21111256|P2|Open-Label Period|Death|0
6126846|NCT00048581|21111257|P1|Open-Label Period|Death|0
6126847|NCT00048581|21111255|P3|Double-Blind Period|Investigator Decision|0
6126848|NCT00048581|21111256|P2|Double-Blind Period|Investigator Decision|0
6126849|NCT00048581|21111257|P1|Double-Blind Period|Investigator Decision|1
6126850|NCT00048581|21111255|P3|Double-Blind Period|Participant Has History of Lymphopenia|0
6126851|NCT00048581|21111256|P2|Double-Blind Period|Participant Has History of Lymphopenia|0
6126852|NCT00048581|21111257|P1|Double-Blind Period|Participant Has History of Lymphopenia|1
6126853|NCT00048581|21111255|P3|Double-Blind Period|Withdrawal by Subject|0
6126854|NCT00048581|21111256|P2|Double-Blind Period|Withdrawal by Subject|2
6126855|NCT00048581|21111257|P1|Double-Blind Period|Withdrawal by Subject|5
6126856|NCT00048581|21111255|P3|Double-Blind Period|Lost to Follow-up|0
6126857|NCT00048581|21111256|P2|Double-Blind Period|Lost to Follow-up|0
6126858|NCT00048581|21111257|P1|Double-Blind Period|Lost to Follow-up|5
6126859|NCT00048581|21111255|P3|Double-Blind Period|Lack of Efficacy|0
6126860|NCT00048581|21111256|P2|Double-Blind Period|Lack of Efficacy|27
6126861|NCT00048581|21111257|P1|Double-Blind Period|Lack of Efficacy|14
6126862|NCT00048581|21111255|P3|Double-Blind Period|Adverse Event|0
6126863|NCT00048581|21111256|P2|Double-Blind Period|Adverse Event|5
6126864|NCT00048581|21111257|P1|Double-Blind Period|Adverse Event|9
6126865|NCT00048568|21111424|P3|Open-Label Period|Lost to Follow-up|7
6126866|NCT00048568|21111425|P2|Open-Label Period|Lost to Follow-up|0
6126867|NCT00048568|21111426|P1|Open-Label Period|Lost to Follow-up|0
6126868|NCT00048568|21111424|P3|Open-Label Period|Unknown Reasons|25
6126869|NCT00048568|21111425|P2|Open-Label Period|Unknown Reasons|0
6126870|NCT00048568|21111426|P1|Open-Label Period|Unknown Reasons|0
6126871|NCT00048568|21111424|P3|Open-Label Period|Administrative Decision By Sponsor|1
6126872|NCT00048568|21111425|P2|Open-Label Period|Administrative Decision By Sponsor|0
6126873|NCT00048568|21111426|P1|Open-Label Period|Administrative Decision By Sponsor|0
6126874|NCT00048568|21111424|P3|Open-Label Period|No Longer Met Study Criteria|2
6126875|NCT00048568|21111425|P2|Open-Label Period|No Longer Met Study Criteria|0
6126876|NCT00048568|21111426|P1|Open-Label Period|No Longer Met Study Criteria|0
6126877|NCT00048568|21111424|P3|Open-Label Period|Pregnancy|5
6126878|NCT00048568|21111425|P2|Open-Label Period|Pregnancy|0
6126879|NCT00048568|21111426|P1|Open-Label Period|Pregnancy|0
6126880|NCT00048568|21111424|P3|Open-Label Period|Withdrawal by Subject|26
6126881|NCT00048568|21111425|P2|Open-Label Period|Withdrawal by Subject|0
6126882|NCT00048568|21111426|P1|Open-Label Period|Withdrawal by Subject|0
6126883|NCT00048568|21111424|P3|Open-Label Period|Lack of Efficacy|32
6126884|NCT00048568|21111425|P2|Open-Label Period|Lack of Efficacy|0
6126885|NCT00048568|21111426|P1|Open-Label Period|Lack of Efficacy|0
6126886|NCT00048568|21111424|P3|Open-Label Period|Adverse Event|49
6126887|NCT00048568|21111425|P2|Open-Label Period|Adverse Event|0
6126888|NCT00048568|21111426|P1|Open-Label Period|Adverse Event|0
6126889|NCT00048568|21111424|P3|Open-Label Period|Death|13
6126890|NCT00048568|21111425|P2|Open-Label Period|Death|0
6126891|NCT00048568|21111426|P1|Open-Label Period|Death|0
6126892|NCT00048568|21111424|P3|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|0
6126893|NCT00048568|21111425|P2|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1
6126894|NCT00048568|21111426|P1|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1
6126895|NCT00048568|21111424|P3|Double-Blind Period Days 170 to 365|Pregnancy|0
6126896|NCT00048568|21111425|P2|Double-Blind Period Days 170 to 365|Pregnancy|0
6126897|NCT00048568|21111426|P1|Double-Blind Period Days 170 to 365|Pregnancy|2
6126898|NCT00048568|21111424|P3|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0
6126899|NCT00048568|21111425|P2|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|1
6126900|NCT00048568|21111426|P1|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0
6126901|NCT00048568|21111424|P3|Double-Blind Period Days 170 to 365|Withdrawal by Subject|0
6126902|NCT00048568|21111425|P2|Double-Blind Period Days 170 to 365|Withdrawal by Subject|1
6126903|NCT00048568|21111426|P1|Double-Blind Period Days 170 to 365|Withdrawal by Subject|3
6126904|NCT00048568|21111424|P3|Double-Blind Period Days 170 to 365|Lack of Efficacy|0
6126905|NCT00048568|21111425|P2|Double-Blind Period Days 170 to 365|Lack of Efficacy|7
6126906|NCT00048568|21111426|P1|Double-Blind Period Days 170 to 365|Lack of Efficacy|2
6126907|NCT00048568|21111424|P3|Double-Blind Period Days 170 to 365|Adverse Event|0
6126908|NCT00048568|21111425|P2|Double-Blind Period Days 170 to 365|Adverse Event|1
6126909|NCT00048568|21111426|P1|Double-Blind Period Days 170 to 365|Adverse Event|7
6126910|NCT00048568|21111424|P3|Double-Blind Period Days 170 to 365|Death|0
6126911|NCT00048568|21111425|P2|Double-Blind Period Days 170 to 365|Death|1
6126912|NCT00048568|21111426|P1|Double-Blind Period Days 170 to 365|Death|1
6126913|NCT00048568|21111424|P3|Double-Blind Period Days 1 to 169|Unknown Reasons|0
6126914|NCT00048568|21111425|P2|Double-Blind Period Days 1 to 169|Unknown Reasons|4
6126915|NCT00048568|21111426|P1|Double-Blind Period Days 1 to 169|Unknown Reasons|2
6126916|NCT00048568|21111424|P3|Double-Blind Period Days 1 to 169|Withdrawal by Subject|0
6126917|NCT00048568|21111425|P2|Double-Blind Period Days 1 to 169|Withdrawal by Subject|4
6126918|NCT00048568|21111426|P1|Double-Blind Period Days 1 to 169|Withdrawal by Subject|7
6126919|NCT00048568|21111424|P3|Double-Blind Period Days 1 to 169|Lost to Follow-up|0
6126920|NCT00048568|21111425|P2|Double-Blind Period Days 1 to 169|Lost to Follow-up|1
6126921|NCT00048568|21111426|P1|Double-Blind Period Days 1 to 169|Lost to Follow-up|1
6126922|NCT00048568|21111424|P3|Double-Blind Period Days 1 to 169|Lack of Efficacy|0
6126923|NCT00048568|21111425|P2|Double-Blind Period Days 1 to 169|Lack of Efficacy|33
6126924|NCT00048568|21111426|P1|Double-Blind Period Days 1 to 169|Lack of Efficacy|11
6126925|NCT00048568|21111424|P3|Double-Blind Period Days 1 to 169|Adverse Event|0
6126926|NCT00048568|21111425|P2|Double-Blind Period Days 1 to 169|Adverse Event|3
6126927|NCT00048568|21111426|P1|Double-Blind Period Days 1 to 169|Adverse Event|11
6126928|NCT00048724|21111731|P2|Overall Study|Administrative|1
6126929|NCT00048724|21111732|P1|Overall Study|Administrative|1
6126930|NCT00048724|21111731|P2|Overall Study|Did Not Meet Protocol Eligibility|2
6126931|NCT00048724|21111732|P1|Overall Study|Did Not Meet Protocol Eligibility|2
6126932|NCT00048724|21111731|P2|Overall Study|Noncompliance With Protocol|12
6126933|NCT00048724|21111732|P1|Overall Study|Noncompliance With Protocol|4
6126934|NCT00048724|21111731|P2|Overall Study|Protocol-defined Clinical Event|32
6126935|NCT00048724|21111732|P1|Overall Study|Protocol-defined Clinical Event|17
6126936|NCT00048724|21111731|P2|Overall Study|Lost to Follow-up|5
6126937|NCT00048724|21111732|P1|Overall Study|Lost to Follow-up|5
6126938|NCT00048724|21111731|P2|Overall Study|Withdrawal by Subject|54
6126939|NCT00048724|21111732|P1|Overall Study|Withdrawal by Subject|34
6126940|NCT00048724|21111731|P2|Overall Study|Adverse Event|12
6126941|NCT00048724|21111732|P1|Overall Study|Adverse Event|53
6126942|NCT00048542|21111744|P8|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|8
6126943|NCT00048542|21111745|P7|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|5
6126944|NCT00048542|21111746|P6|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
6126945|NCT00048542|21111747|P5|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
6126946|NCT00048542|21111748|P4|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
6126947|NCT00048542|21111749|P3|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
6126948|NCT00048542|21111750|P2|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
6126949|NCT00048542|21111751|P1|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
6126950|NCT00048542|21111744|P8|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|1
6126951|NCT00048542|21111745|P7|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|2
6126952|NCT00048542|21111746|P6|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
6126953|NCT00048542|21111747|P5|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
6126954|NCT00048542|21111748|P4|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
6126955|NCT00048542|21111749|P3|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
6126956|NCT00048542|21111750|P2|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
6126957|NCT00048542|21111751|P1|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
6126958|NCT00048542|21111744|P8|Open-Label Extension Fixed Dose Phase|Adverse Event|2
6126959|NCT00048542|21111745|P7|Open-Label Extension Fixed Dose Phase|Adverse Event|2
6126960|NCT00048542|21111746|P6|Open-Label Extension Fixed Dose Phase|Adverse Event|0
6126961|NCT00048542|21111747|P5|Open-Label Extension Fixed Dose Phase|Adverse Event|0
6126962|NCT00048542|21111748|P4|Open-Label Extension Fixed Dose Phase|Adverse Event|0
6126963|NCT00048542|21111749|P3|Open-Label Extension Fixed Dose Phase|Adverse Event|0
6126964|NCT00048542|21111750|P2|Open-Label Extension Fixed Dose Phase|Adverse Event|0
6126965|NCT00048542|21111751|P1|Open-Label Extension Fixed Dose Phase|Adverse Event|0
6126966|NCT00048542|21111744|P8|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|7
6126967|NCT00048542|21111745|P7|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|6
6126968|NCT00048542|21111746|P6|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
6126969|NCT00048542|21111747|P5|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
6126970|NCT00048542|21111748|P4|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
6126971|NCT00048542|21111749|P3|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
6126972|NCT00048542|21111750|P2|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
6126973|NCT00048542|21111751|P1|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
6126974|NCT00048542|21111744|P8|Open-Label Extension Fixed Dose Phase|Protocol Violation|1
6126975|NCT00048542|21111745|P7|Open-Label Extension Fixed Dose Phase|Protocol Violation|1
6126976|NCT00048542|21111746|P6|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
6126977|NCT00048542|21111747|P5|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
6126978|NCT00048542|21111748|P4|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
6126979|NCT00048542|21111749|P3|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
6126980|NCT00048542|21111750|P2|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
6126981|NCT00048542|21111751|P1|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
6126982|NCT00048542|21111744|P8|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|3
6126983|NCT00048542|21111745|P7|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|6
6126984|NCT00048542|21111746|P6|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
6126985|NCT00048542|21111747|P5|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
6126986|NCT00048542|21111748|P4|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
6126987|NCT00048542|21111749|P3|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
6126988|NCT00048542|21111750|P2|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
6126989|NCT00048542|21111751|P1|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
6126990|NCT00048542|21111744|P8|Open-Label Extension BSA Phase|Lack of Efficacy|0
6126991|NCT00048542|21111745|P7|Open-Label Extension BSA Phase|Lack of Efficacy|0
6126992|NCT00048542|21111746|P6|Open-Label Extension BSA Phase|Lack of Efficacy|1
6126993|NCT00048542|21111747|P5|Open-Label Extension BSA Phase|Lack of Efficacy|3
6126994|NCT00048542|21111748|P4|Open-Label Extension BSA Phase|Lack of Efficacy|0
6126995|NCT00048542|21111749|P3|Open-Label Extension BSA Phase|Lack of Efficacy|0
6126996|NCT00048542|21111750|P2|Open-Label Extension BSA Phase|Lack of Efficacy|0
6126997|NCT00048542|21111751|P1|Open-Label Extension BSA Phase|Lack of Efficacy|0
6126998|NCT00048542|21111744|P8|Open-Label Extension BSA Phase|Adverse Event|0
6126999|NCT00048542|21111745|P7|Open-Label Extension BSA Phase|Adverse Event|0
6127000|NCT00048542|21111746|P6|Open-Label Extension BSA Phase|Adverse Event|1
6127001|NCT00048542|21111747|P5|Open-Label Extension BSA Phase|Adverse Event|1
6127002|NCT00048542|21111748|P4|Open-Label Extension BSA Phase|Adverse Event|0
6127003|NCT00048542|21111749|P3|Open-Label Extension BSA Phase|Adverse Event|0
6127004|NCT00048542|21111750|P2|Open-Label Extension BSA Phase|Adverse Event|0
6127005|NCT00048542|21111751|P1|Open-Label Extension BSA Phase|Adverse Event|0
6127006|NCT00048542|21111744|P8|Open-Label Extension BSA Phase|Sponsor request or decision|0
6127007|NCT00048542|21111745|P7|Open-Label Extension BSA Phase|Sponsor request or decision|0
6127008|NCT00048542|21111746|P6|Open-Label Extension BSA Phase|Sponsor request or decision|1
6127009|NCT00048542|21111747|P5|Open-Label Extension BSA Phase|Sponsor request or decision|5
6127010|NCT00048542|21111748|P4|Open-Label Extension BSA Phase|Sponsor request or decision|0
6127011|NCT00048542|21111749|P3|Open-Label Extension BSA Phase|Sponsor request or decision|0
6127012|NCT00048542|21111750|P2|Open-Label Extension BSA Phase|Sponsor request or decision|0
6127013|NCT00048542|21111751|P1|Open-Label Extension BSA Phase|Sponsor request or decision|0
6127014|NCT00048542|21111744|P8|Open-Label Extension BSA Phase|Protocol Violation|0
6127015|NCT00048542|21111745|P7|Open-Label Extension BSA Phase|Protocol Violation|0
6127016|NCT00048542|21111746|P6|Open-Label Extension BSA Phase|Protocol Violation|1
6127017|NCT00048542|21111747|P5|Open-Label Extension BSA Phase|Protocol Violation|0
6127018|NCT00048542|21111748|P4|Open-Label Extension BSA Phase|Protocol Violation|0
6127019|NCT00048542|21111749|P3|Open-Label Extension BSA Phase|Protocol Violation|0
6127020|NCT00048542|21111750|P2|Open-Label Extension BSA Phase|Protocol Violation|0
6127021|NCT00048542|21111751|P1|Open-Label Extension BSA Phase|Protocol Violation|0
6127022|NCT00048542|21111744|P8|Open-Label Extension BSA Phase|Withdrawal by Subject|0
6127023|NCT00048542|21111745|P7|Open-Label Extension BSA Phase|Withdrawal by Subject|0
6127024|NCT00048542|21111746|P6|Open-Label Extension BSA Phase|Withdrawal by Subject|6
6127025|NCT00048542|21111747|P5|Open-Label Extension BSA Phase|Withdrawal by Subject|3
6127026|NCT00048542|21111748|P4|Open-Label Extension BSA Phase|Withdrawal by Subject|0
6127027|NCT00048542|21111749|P3|Open-Label Extension BSA Phase|Withdrawal by Subject|0
6127028|NCT00048542|21111750|P2|Open-Label Extension BSA Phase|Withdrawal by Subject|0
6127029|NCT00048542|21111751|P1|Open-Label Extension BSA Phase|Withdrawal by Subject|0
6127030|NCT00048542|21111744|P8|Double-Blind Phase|Randomized in error|0
6127031|NCT00048542|21111745|P7|Double-Blind Phase|Randomized in error|0
6127032|NCT00048542|21111746|P6|Double-Blind Phase|Randomized in error|0
6127033|NCT00048542|21111747|P5|Double-Blind Phase|Randomized in error|0
6127034|NCT00048542|21111748|P4|Double-Blind Phase|Randomized in error|0
6127035|NCT00048542|21111749|P3|Double-Blind Phase|Randomized in error|0
6127036|NCT00048542|21111750|P2|Double-Blind Phase|Randomized in error|0
6127037|NCT00048542|21111751|P1|Double-Blind Phase|Randomized in error|1
6127038|NCT00048542|21111744|P8|Double-Blind Phase|Sponsor request or decision|0
6127039|NCT00048542|21111745|P7|Double-Blind Phase|Sponsor request or decision|0
6127040|NCT00048542|21111746|P6|Double-Blind Phase|Sponsor request or decision|0
6127041|NCT00048542|21111747|P5|Double-Blind Phase|Sponsor request or decision|0
6127042|NCT00048542|21111748|P4|Double-Blind Phase|Sponsor request or decision|0
6127043|NCT00048542|21111749|P3|Double-Blind Phase|Sponsor request or decision|0
6127044|NCT00048542|21111750|P2|Double-Blind Phase|Sponsor request or decision|0
6127045|NCT00048542|21111751|P1|Double-Blind Phase|Sponsor request or decision|2
6127046|NCT00048542|21111744|P8|Double-Blind Phase|Protocol Violation|0
6127047|NCT00048542|21111745|P7|Double-Blind Phase|Protocol Violation|0
6127048|NCT00048542|21111746|P6|Double-Blind Phase|Protocol Violation|0
6127049|NCT00048542|21111747|P5|Double-Blind Phase|Protocol Violation|0
6127050|NCT00048542|21111748|P4|Double-Blind Phase|Protocol Violation|0
6127051|NCT00048542|21111749|P3|Double-Blind Phase|Protocol Violation|1
6127052|NCT00048542|21111750|P2|Double-Blind Phase|Protocol Violation|0
6127053|NCT00048542|21111751|P1|Double-Blind Phase|Protocol Violation|0
6127054|NCT00048542|21111744|P8|Double-Blind Phase|Withdrawal by Subject|0
6127055|NCT00048542|21111745|P7|Double-Blind Phase|Withdrawal by Subject|0
6127056|NCT00048542|21111746|P6|Double-Blind Phase|Withdrawal by Subject|0
6127057|NCT00048542|21111747|P5|Double-Blind Phase|Withdrawal by Subject|0
6127058|NCT00048542|21111748|P4|Double-Blind Phase|Withdrawal by Subject|0
6127059|NCT00048542|21111749|P3|Double-Blind Phase|Withdrawal by Subject|0
6127060|NCT00048542|21111750|P2|Double-Blind Phase|Withdrawal by Subject|1
6127061|NCT00048542|21111751|P1|Double-Blind Phase|Withdrawal by Subject|0
6127062|NCT00048347|21111817|P1|Overall Study|Screen failure|2
6127063|NCT00048165|21111823|P2|Completed 12 Months Study|Did not co-operate/Withdrew|0
6127064|NCT00048165|21111824|P1|Completed 12 Months Study|Did not co-operate/Withdrew|1
6127065|NCT00048165|21111823|P2|Completed 12 Months Study|Death|1
6127066|NCT00048165|21111824|P1|Completed 12 Months Study|Death|2
6127067|NCT00048165|21111823|P2|Completed 12 Months Study|Administration/Other|2
6127068|NCT00048165|21111824|P1|Completed 12 Months Study|Administration/Other|0
6127069|NCT00048165|21111823|P2|Completed 6 Months Study|Did not receive study drug|6
6127070|NCT00048165|21111824|P1|Completed 6 Months Study|Did not receive study drug|6
6127071|NCT00048165|21111823|P2|Completed 6 Months Study|Violation criteria|2
6127072|NCT00048165|21111824|P1|Completed 6 Months Study|Violation criteria|0
6127073|NCT00048165|21111823|P2|Completed 6 Months Study|Refused treatment|5
6127074|NCT00048165|21111824|P1|Completed 6 Months Study|Refused treatment|5
6127075|NCT00048165|21111823|P2|Completed 6 Months Study|Other violation|6
6127076|NCT00048165|21111824|P1|Completed 6 Months Study|Other violation|4
6127077|NCT00048165|21111823|P2|Completed 6 Months Study|Insufficient therapy|4
6127078|NCT00048165|21111824|P1|Completed 6 Months Study|Insufficient therapy|1
6127079|NCT00048165|21111823|P2|Completed 6 Months Study|Death|6
6127080|NCT00048165|21111824|P1|Completed 6 Months Study|Death|12
6127081|NCT00048165|21111823|P2|Completed 6 Months Study|Adverse event/intermittent illness|11
6127082|NCT00048165|21111824|P1|Completed 6 Months Study|Adverse event/intermittent illness|14
6127083|NCT00048165|21111823|P2|Completed 6 Months Study|Abnormality of laboratory test|0
6127084|NCT00048165|21111824|P1|Completed 6 Months Study|Abnormality of laboratory test|1
6127085|NCT00048165|21111823|P2|Completed 6 Months Study|Administration/Other|8
6127086|NCT00048165|21111824|P1|Completed 6 Months Study|Administration/Other|8
6127087|NCT00048074|21111859|P3|Overall Study|Social reasons|0
6127088|NCT00048074|21111860|P2|Overall Study|Social reasons|0
6127089|NCT00048074|21111861|P1|Overall Study|Social reasons|1
6127090|NCT00048074|21111859|P3|Overall Study|Out of station|1
6127091|NCT00048074|21111860|P2|Overall Study|Out of station|1
6127092|NCT00048074|21111861|P1|Overall Study|Out of station|0
6127093|NCT00048074|21111859|P3|Overall Study|Poor compliance|0
6127094|NCT00048074|21111860|P2|Overall Study|Poor compliance|1
6127095|NCT00048074|21111861|P1|Overall Study|Poor compliance|0
6127096|NCT00048074|21111859|P3|Overall Study|Husband ill|0
6127097|NCT00048074|21111860|P2|Overall Study|Husband ill|1
6127098|NCT00048074|21111861|P1|Overall Study|Husband ill|0
6127099|NCT00048074|21111859|P3|Overall Study|Study participation was terminated|0
6127100|NCT00048074|21111860|P2|Overall Study|Study participation was terminated|1
6127101|NCT00048074|21111861|P1|Overall Study|Study participation was terminated|0
6127102|NCT00048074|21111859|P3|Overall Study|Protocol Violation|0
6127103|NCT00048074|21111860|P2|Overall Study|Protocol Violation|3
6127104|NCT00048074|21111861|P1|Overall Study|Protocol Violation|1
6127105|NCT00048074|21111859|P3|Overall Study|Withdrawal by Subject|35
6127106|NCT00048074|21111860|P2|Overall Study|Withdrawal by Subject|30
6127107|NCT00048074|21111861|P1|Overall Study|Withdrawal by Subject|28
6127108|NCT00048074|21111859|P3|Overall Study|Lost to Follow-up|6
6127109|NCT00048074|21111860|P2|Overall Study|Lost to Follow-up|6
6127110|NCT00048074|21111861|P1|Overall Study|Lost to Follow-up|2
6127111|NCT00048074|21111859|P3|Overall Study|Death|2
6127112|NCT00048074|21111860|P2|Overall Study|Death|3
6127113|NCT00048074|21111861|P1|Overall Study|Death|3
6127114|NCT00048074|21111859|P3|Overall Study|Adverse Event|53
6127115|NCT00048074|21111860|P2|Overall Study|Adverse Event|41
6127116|NCT00048074|21111861|P1|Overall Study|Adverse Event|46
6127117|NCT00048061|21111918|P4|Overall Study|Early improvement|0
6127118|NCT00048061|21111919|P3|Overall Study|Early improvement|3
6127119|NCT00048061|21111920|P2|Overall Study|Early improvement|5
6127120|NCT00048061|21111921|P1|Overall Study|Early improvement|6
6127121|NCT00048061|21111918|P4|Overall Study|Did not follow-up|5
6127122|NCT00048061|21111919|P3|Overall Study|Did not follow-up|4
6127123|NCT00048061|21111920|P2|Overall Study|Did not follow-up|5
6127124|NCT00048061|21111921|P1|Overall Study|Did not follow-up|5
6127125|NCT00048061|21111918|P4|Overall Study|Withdrawal by Subject|32
6127126|NCT00048061|21111919|P3|Overall Study|Withdrawal by Subject|29
6127127|NCT00048061|21111920|P2|Overall Study|Withdrawal by Subject|29
6127128|NCT00048061|21111921|P1|Overall Study|Withdrawal by Subject|20
6127129|NCT00048061|21111918|P4|Overall Study|Lost to Follow-up|5
6127130|NCT00048061|21111919|P3|Overall Study|Lost to Follow-up|4
6127131|NCT00048061|21111920|P2|Overall Study|Lost to Follow-up|2
6127132|NCT00048061|21111921|P1|Overall Study|Lost to Follow-up|3
6127133|NCT00048061|21111918|P4|Overall Study|Adverse Event|37
6127134|NCT00048061|21111919|P3|Overall Study|Adverse Event|44
6127135|NCT00048061|21111920|P2|Overall Study|Adverse Event|32
6127136|NCT00048061|21111921|P1|Overall Study|Adverse Event|41
6127137|NCT00048048|21112000|P12|Extension Year 2|Early withdrawals|2
6127138|NCT00048048|21112001|P11|Extension Year 2|Early withdrawals|4
6127139|NCT00048048|21112002|P10|Extension Year 2|Early withdrawals|0
6127140|NCT00048048|21112003|P9|Extension Year 2|Early withdrawals|0
6127141|NCT00048048|21112004|P8|Extension Year 2|Early withdrawals|0
6127142|NCT00048048|21112005|P7|Extension Year 2|Early withdrawals|0
6127143|NCT00048048|21112006|P6|Extension Year 2|Early withdrawals|0
6127144|NCT00048048|21112007|P5|Extension Year 2|Early withdrawals|0
6127145|NCT00048048|21112008|P4|Extension Year 2|Early withdrawals|0
6127146|NCT00048048|21112009|P3|Extension Year 2|Early withdrawals|0
6127147|NCT00048048|21112010|P2|Extension Year 2|Early withdrawals|0
6127148|NCT00048048|21112011|P1|Extension Year 2|Early withdrawals|0
6127149|NCT00048048|21112000|P12|Extension Year 1|Early withdrawals|4
6127150|NCT00048048|21112001|P11|Extension Year 1|Early withdrawals|2
6127151|NCT00048048|21112002|P10|Extension Year 1|Early withdrawals|2
6127152|NCT00048048|21112003|P9|Extension Year 1|Early withdrawals|0
6127153|NCT00048048|21112004|P8|Extension Year 1|Early withdrawals|0
6127154|NCT00048048|21112005|P7|Extension Year 1|Early withdrawals|0
6127155|NCT00048048|21112006|P6|Extension Year 1|Early withdrawals|0
6127156|NCT00048048|21112007|P5|Extension Year 1|Early withdrawals|0
6127157|NCT00048048|21112008|P4|Extension Year 1|Early withdrawals|0
6127158|NCT00048048|21112009|P3|Extension Year 1|Early withdrawals|0
6127159|NCT00048048|21112010|P2|Extension Year 1|Early withdrawals|0
6127160|NCT00048048|21112011|P1|Extension Year 1|Early withdrawals|0
6127161|NCT00048048|21112000|P12|Core Treatment|Adverse Event|0
6127162|NCT00048048|21112001|P11|Core Treatment|Adverse Event|0
6127163|NCT00048048|21112002|P10|Core Treatment|Adverse Event|0
6127164|NCT00048048|21112003|P9|Core Treatment|Adverse Event|0
6127165|NCT00048048|21112004|P8|Core Treatment|Adverse Event|1
6127166|NCT00048048|21112005|P7|Core Treatment|Adverse Event|0
6127167|NCT00048048|21112006|P6|Core Treatment|Adverse Event|0
6127168|NCT00048048|21112007|P5|Core Treatment|Adverse Event|0
6127169|NCT00048048|21112008|P4|Core Treatment|Adverse Event|0
6127170|NCT00048048|21112009|P3|Core Treatment|Adverse Event|0
6127171|NCT00048048|21112010|P2|Core Treatment|Adverse Event|0
6127172|NCT00048048|21112011|P1|Core Treatment|Adverse Event|0
6127173|NCT00048048|21112000|P12|Core Treatment|Withdrawal by Subject|0
6127174|NCT00048048|21112001|P11|Core Treatment|Withdrawal by Subject|0
6127175|NCT00048048|21112002|P10|Core Treatment|Withdrawal by Subject|0
6127176|NCT00048048|21112003|P9|Core Treatment|Withdrawal by Subject|0
6127177|NCT00048048|21112004|P8|Core Treatment|Withdrawal by Subject|0
6127178|NCT00048048|21112005|P7|Core Treatment|Withdrawal by Subject|0
6127179|NCT00048048|21112006|P6|Core Treatment|Withdrawal by Subject|0
6127180|NCT00048048|21112007|P5|Core Treatment|Withdrawal by Subject|0
6127181|NCT00048048|21112008|P4|Core Treatment|Withdrawal by Subject|0
6127182|NCT00048048|21112009|P3|Core Treatment|Withdrawal by Subject|1
6127183|NCT00048048|21112010|P2|Core Treatment|Withdrawal by Subject|0
6127184|NCT00048048|21112011|P1|Core Treatment|Withdrawal by Subject|0
6127185|NCT00048035|21112067|P8|Extension Year 2|Early Withdrawals|3
6127186|NCT00048035|21112068|P7|Extension Year 2|Early Withdrawals|3
6127187|NCT00048035|21112069|P6|Extension Year 2|Early Withdrawals|0
6127188|NCT00048035|21112070|P5|Extension Year 2|Early Withdrawals|0
6127189|NCT00048035|21112071|P4|Extension Year 2|Early Withdrawals|0
6127190|NCT00048035|21112072|P3|Extension Year 2|Early Withdrawals|0
6127191|NCT00048035|21112073|P2|Extension Year 2|Early Withdrawals|0
6127192|NCT00048035|21112074|P1|Extension Year 2|Early Withdrawals|0
6127193|NCT00048035|21112067|P8|Extension Year 1|Early Withdrawals|11
6127194|NCT00048035|21112068|P7|Extension Year 1|Early Withdrawals|11
6127195|NCT00048035|21112069|P6|Extension Year 1|Early Withdrawals|0
6127196|NCT00048035|21112070|P5|Extension Year 1|Early Withdrawals|0
6127197|NCT00048035|21112071|P4|Extension Year 1|Early Withdrawals|0
6127198|NCT00048035|21112072|P3|Extension Year 1|Early Withdrawals|0
6127199|NCT00048035|21112073|P2|Extension Year 1|Early Withdrawals|0
6127200|NCT00048035|21112074|P1|Extension Year 1|Early Withdrawals|0
6127201|NCT00048035|21112067|P8|Core Period|Early Withdrawals|0
6127202|NCT00048035|21112068|P7|Core Period|Early Withdrawals|0
6127203|NCT00048035|21112069|P6|Core Period|Early Withdrawals|1
6127204|NCT00048035|21112070|P5|Core Period|Early Withdrawals|1
6127205|NCT00048035|21112071|P4|Core Period|Early Withdrawals|1
6127206|NCT00048035|21112072|P3|Core Period|Early Withdrawals|1
6127207|NCT00048035|21112073|P2|Core Period|Early Withdrawals|2
6127208|NCT00048035|21112074|P1|Core Period|Early Withdrawals|4
6127209|NCT00047879|21112112|P2|Overall Study|Progressive disease|3
6127210|NCT00047879|21112113|P1|Overall Study|Progressive disease|4
6127211|NCT00047463|21112149|P2|Overall Study|Withdrawal by Subject|3
6127212|NCT00047463|21112150|P1|Overall Study|Withdrawal by Subject|0
6127213|NCT00045942|21112267|P9|PKC412A2104E2|Death|0
6127214|NCT00045942|21112268|P8|PKC412A2104E2|Death|0
6127215|NCT00045942|21112269|P7|PKC412A2104E2|Death|2
6127216|NCT00045942|21112270|P6|PKC412A2104E2|Death|1
6127217|NCT00045942|21112271|P5|PKC412A2104E2|Death|0
6127218|NCT00045942|21112272|P4|PKC412A2104E2|Death|0
6127219|NCT00045942|21112273|P3|PKC412A2104E2|Death|0
6127220|NCT00045942|21112274|P2|PKC412A2104E2|Death|0
6127221|NCT00045942|21112275|P1|PKC412A2104E2|Death|0
6127222|NCT00045942|21112267|P9|PKC412A2104E2|Adverse Event|0
6127223|NCT00045942|21112268|P8|PKC412A2104E2|Adverse Event|1
6127224|NCT00045942|21112269|P7|PKC412A2104E2|Adverse Event|3
6127225|NCT00045942|21112270|P6|PKC412A2104E2|Adverse Event|4
6127226|NCT00045942|21112271|P5|PKC412A2104E2|Adverse Event|0
6127227|NCT00045942|21112272|P4|PKC412A2104E2|Adverse Event|0
6127228|NCT00045942|21112273|P3|PKC412A2104E2|Adverse Event|0
6127229|NCT00045942|21112274|P2|PKC412A2104E2|Adverse Event|0
6127230|NCT00045942|21112275|P1|PKC412A2104E2|Adverse Event|0
6127231|NCT00045942|21112267|P9|PKC412A2104E2|Lack of Efficacy|6
6127232|NCT00045942|21112268|P8|PKC412A2104E2|Lack of Efficacy|2
6127233|NCT00045942|21112269|P7|PKC412A2104E2|Lack of Efficacy|2
6127234|NCT00045942|21112270|P6|PKC412A2104E2|Lack of Efficacy|3
6127235|NCT00045942|21112271|P5|PKC412A2104E2|Lack of Efficacy|0
6127236|NCT00045942|21112272|P4|PKC412A2104E2|Lack of Efficacy|0
6127237|NCT00045942|21112273|P3|PKC412A2104E2|Lack of Efficacy|0
6127238|NCT00045942|21112274|P2|PKC412A2104E2|Lack of Efficacy|0
6127239|NCT00045942|21112275|P1|PKC412A2104E2|Lack of Efficacy|0
6127240|NCT00045942|21112267|P9|PKC412A2104E2|Withdrawal by Subject|0
6127241|NCT00045942|21112268|P8|PKC412A2104E2|Withdrawal by Subject|1
6127242|NCT00045942|21112269|P7|PKC412A2104E2|Withdrawal by Subject|0
6127243|NCT00045942|21112270|P6|PKC412A2104E2|Withdrawal by Subject|1
6127244|NCT00045942|21112271|P5|PKC412A2104E2|Withdrawal by Subject|0
6127245|NCT00045942|21112272|P4|PKC412A2104E2|Withdrawal by Subject|0
6127246|NCT00045942|21112273|P3|PKC412A2104E2|Withdrawal by Subject|0
6127247|NCT00045942|21112274|P2|PKC412A2104E2|Withdrawal by Subject|0
6127248|NCT00045942|21112275|P1|PKC412A2104E2|Withdrawal by Subject|0
6127249|NCT00045942|21112267|P9|PKC412A2104E2|Lost to Follow-up|0
6127250|NCT00045942|21112268|P8|PKC412A2104E2|Lost to Follow-up|3
6127251|NCT00045942|21112269|P7|PKC412A2104E2|Lost to Follow-up|0
6127252|NCT00045942|21112270|P6|PKC412A2104E2|Lost to Follow-up|0
6127253|NCT00045942|21112271|P5|PKC412A2104E2|Lost to Follow-up|0
6127254|NCT00045942|21112272|P4|PKC412A2104E2|Lost to Follow-up|0
6127255|NCT00045942|21112273|P3|PKC412A2104E2|Lost to Follow-up|0
6127256|NCT00045942|21112274|P2|PKC412A2104E2|Lost to Follow-up|0
6127257|NCT00045942|21112275|P1|PKC412A2104E2|Lost to Follow-up|0
6127258|NCT00045942|21112267|P9|PKC412A2104E1|Enrolled into PKC412A2104E2|0
6127259|NCT00045942|21112268|P8|PKC412A2104E1|Enrolled into PKC412A2104E2|0
6127260|NCT00045942|21112269|P7|PKC412A2104E1|Enrolled into PKC412A2104E2|0
6127261|NCT00045942|21112270|P6|PKC412A2104E1|Enrolled into PKC412A2104E2|0
6127262|NCT00045942|21112271|P5|PKC412A2104E1|Enrolled into PKC412A2104E2|0
6127263|NCT00045942|21112272|P4|PKC412A2104E1|Enrolled into PKC412A2104E2|1
6127264|NCT00045942|21112273|P3|PKC412A2104E1|Enrolled into PKC412A2104E2|1
6127265|NCT00045942|21112274|P2|PKC412A2104E1|Enrolled into PKC412A2104E2|0
6127266|NCT00045942|21112275|P1|PKC412A2104E1|Enrolled into PKC412A2104E2|0
6127267|NCT00045942|21112267|P9|PKC412A2104E1|Death|0
6127268|NCT00045942|21112268|P8|PKC412A2104E1|Death|0
6127269|NCT00045942|21112269|P7|PKC412A2104E1|Death|0
6127270|NCT00045942|21112270|P6|PKC412A2104E1|Death|0
6127271|NCT00045942|21112271|P5|PKC412A2104E1|Death|1
6127272|NCT00045942|21112272|P4|PKC412A2104E1|Death|1
6127273|NCT00045942|21112273|P3|PKC412A2104E1|Death|1
6127274|NCT00045942|21112274|P2|PKC412A2104E1|Death|4
6127275|NCT00045942|21112275|P1|PKC412A2104E1|Death|0
6127276|NCT00045942|21112267|P9|PKC412A2104E1|Adverse Event|0
6127277|NCT00045942|21112268|P8|PKC412A2104E1|Adverse Event|0
6127278|NCT00045942|21112269|P7|PKC412A2104E1|Adverse Event|0
6127279|NCT00045942|21112270|P6|PKC412A2104E1|Adverse Event|0
6127280|NCT00045942|21112271|P5|PKC412A2104E1|Adverse Event|6
6127281|NCT00045942|21112272|P4|PKC412A2104E1|Adverse Event|3
6127282|NCT00045942|21112273|P3|PKC412A2104E1|Adverse Event|1
6127283|NCT00045942|21112274|P2|PKC412A2104E1|Adverse Event|1
6127284|NCT00045942|21112275|P1|PKC412A2104E1|Adverse Event|0
6127285|NCT00045942|21112267|P9|PKC412A2104E1|Abnormal laboratory value|0
6127286|NCT00045942|21112268|P8|PKC412A2104E1|Abnormal laboratory value|0
6127287|NCT00045942|21112269|P7|PKC412A2104E1|Abnormal laboratory value|0
6127288|NCT00045942|21112270|P6|PKC412A2104E1|Abnormal laboratory value|0
6127289|NCT00045942|21112271|P5|PKC412A2104E1|Abnormal laboratory value|0
6127290|NCT00045942|21112272|P4|PKC412A2104E1|Abnormal laboratory value|0
6127291|NCT00045942|21112273|P3|PKC412A2104E1|Abnormal laboratory value|0
6127292|NCT00045942|21112274|P2|PKC412A2104E1|Abnormal laboratory value|1
6127293|NCT00045942|21112275|P1|PKC412A2104E1|Abnormal laboratory value|0
6127294|NCT00045942|21112267|P9|PKC412A2104E1|Lack of Efficacy|0
6127295|NCT00045942|21112268|P8|PKC412A2104E1|Lack of Efficacy|0
6127296|NCT00045942|21112269|P7|PKC412A2104E1|Lack of Efficacy|0
6127297|NCT00045942|21112270|P6|PKC412A2104E1|Lack of Efficacy|0
6127298|NCT00045942|21112271|P5|PKC412A2104E1|Lack of Efficacy|17
6127299|NCT00045942|21112272|P4|PKC412A2104E1|Lack of Efficacy|23
6127300|NCT00045942|21112273|P3|PKC412A2104E1|Lack of Efficacy|11
6127301|NCT00045942|21112274|P2|PKC412A2104E1|Lack of Efficacy|11
6127302|NCT00045942|21112275|P1|PKC412A2104E1|Lack of Efficacy|0
6127303|NCT00045942|21112267|P9|PKC412A2104E1|Condition no longer requires study drug|0
6127304|NCT00045942|21112268|P8|PKC412A2104E1|Condition no longer requires study drug|0
6127305|NCT00045942|21112269|P7|PKC412A2104E1|Condition no longer requires study drug|0
6127306|NCT00045942|21112270|P6|PKC412A2104E1|Condition no longer requires study drug|0
6127307|NCT00045942|21112271|P5|PKC412A2104E1|Condition no longer requires study drug|1
6127308|NCT00045942|21112272|P4|PKC412A2104E1|Condition no longer requires study drug|0
6127309|NCT00045942|21112273|P3|PKC412A2104E1|Condition no longer requires study drug|1
6127310|NCT00045942|21112274|P2|PKC412A2104E1|Condition no longer requires study drug|1
6127311|NCT00045942|21112275|P1|PKC412A2104E1|Condition no longer requires study drug|0
6127312|NCT00045942|21112267|P9|PKC412A2104E1|Withdrawal by Subject|0
6127313|NCT00045942|21112268|P8|PKC412A2104E1|Withdrawal by Subject|0
6127314|NCT00045942|21112269|P7|PKC412A2104E1|Withdrawal by Subject|0
6127315|NCT00045942|21112270|P6|PKC412A2104E1|Withdrawal by Subject|0
6127316|NCT00045942|21112271|P5|PKC412A2104E1|Withdrawal by Subject|2
6127317|NCT00045942|21112272|P4|PKC412A2104E1|Withdrawal by Subject|5
6127318|NCT00045942|21112273|P3|PKC412A2104E1|Withdrawal by Subject|2
6127319|NCT00045942|21112274|P2|PKC412A2104E1|Withdrawal by Subject|0
6127320|NCT00045942|21112275|P1|PKC412A2104E1|Withdrawal by Subject|0
6127321|NCT00045942|21112267|P9|PKC412A2104 (Core)|Death|0
6127322|NCT00045942|21112268|P8|PKC412A2104 (Core)|Death|0
6127323|NCT00045942|21112269|P7|PKC412A2104 (Core)|Death|0
6127324|NCT00045942|21112270|P6|PKC412A2104 (Core)|Death|0
6127325|NCT00045942|21112271|P5|PKC412A2104 (Core)|Death|0
6127326|NCT00045942|21112272|P4|PKC412A2104 (Core)|Death|0
6127327|NCT00045942|21112273|P3|PKC412A2104 (Core)|Death|0
6127328|NCT00045942|21112274|P2|PKC412A2104 (Core)|Death|0
6127329|NCT00045942|21112275|P1|PKC412A2104 (Core)|Death|1
6127330|NCT00045942|21112267|P9|PKC412A2104 (Core)|Lack of Efficacy|0
6127331|NCT00045942|21112268|P8|PKC412A2104 (Core)|Lack of Efficacy|0
6127332|NCT00045942|21112269|P7|PKC412A2104 (Core)|Lack of Efficacy|0
6127333|NCT00045942|21112270|P6|PKC412A2104 (Core)|Lack of Efficacy|0
6127334|NCT00045942|21112271|P5|PKC412A2104 (Core)|Lack of Efficacy|0
6127335|NCT00045942|21112272|P4|PKC412A2104 (Core)|Lack of Efficacy|0
6127336|NCT00045942|21112273|P3|PKC412A2104 (Core)|Lack of Efficacy|0
6127337|NCT00045942|21112274|P2|PKC412A2104 (Core)|Lack of Efficacy|0
6127338|NCT00045942|21112275|P1|PKC412A2104 (Core)|Lack of Efficacy|13
6127339|NCT00045942|21112267|P9|PKC412A2104 (Core)|Adverse Event|0
6127340|NCT00045942|21112268|P8|PKC412A2104 (Core)|Adverse Event|0
6127341|NCT00045942|21112269|P7|PKC412A2104 (Core)|Adverse Event|0
6127342|NCT00045942|21112270|P6|PKC412A2104 (Core)|Adverse Event|0
6127343|NCT00045942|21112271|P5|PKC412A2104 (Core)|Adverse Event|0
6127344|NCT00045942|21112272|P4|PKC412A2104 (Core)|Adverse Event|0
6127345|NCT00045942|21112273|P3|PKC412A2104 (Core)|Adverse Event|0
6127346|NCT00045942|21112274|P2|PKC412A2104 (Core)|Adverse Event|0
6127347|NCT00045942|21112275|P1|PKC412A2104 (Core)|Adverse Event|5
6127348|NCT00045942|21112267|P9|PKC412A2104 (Core)|Withdrawal by Subject|0
6127349|NCT00045942|21112268|P8|PKC412A2104 (Core)|Withdrawal by Subject|0
6127350|NCT00045942|21112269|P7|PKC412A2104 (Core)|Withdrawal by Subject|0
6127351|NCT00045942|21112270|P6|PKC412A2104 (Core)|Withdrawal by Subject|0
6127352|NCT00045942|21112271|P5|PKC412A2104 (Core)|Withdrawal by Subject|0
6127353|NCT00045942|21112272|P4|PKC412A2104 (Core)|Withdrawal by Subject|0
6127354|NCT00045942|21112273|P3|PKC412A2104 (Core)|Withdrawal by Subject|0
6127355|NCT00045942|21112274|P2|PKC412A2104 (Core)|Withdrawal by Subject|0
6127356|NCT00045942|21112275|P1|PKC412A2104 (Core)|Withdrawal by Subject|1
6127357|NCT00044512|21112364|P1|Follow Up|Lost to Follow-up|2
6127358|NCT00044213|21112379|P4|Overall Study|Lost to Follow-up|4
6127359|NCT00044213|21112380|P3|Overall Study|Lost to Follow-up|5
6127360|NCT00044213|21112381|P2|Overall Study|Lost to Follow-up|5
6127361|NCT00044213|21112382|P1|Overall Study|Lost to Follow-up|8
6127362|NCT00044213|21112379|P4|Overall Study|Death|49
6127363|NCT00044213|21112380|P3|Overall Study|Death|42
6127364|NCT00044213|21112381|P2|Overall Study|Death|42
6127365|NCT00044213|21112382|P1|Overall Study|Death|42
6127366|NCT00044213|21112379|P4|Overall Study|Withdrawal by Subject|83
6127367|NCT00044213|21112380|P3|Overall Study|Withdrawal by Subject|91
6127368|NCT00044213|21112381|P2|Overall Study|Withdrawal by Subject|65
6127369|NCT00044213|21112382|P1|Overall Study|Withdrawal by Subject|50
6127370|NCT00044083|21112447|P2|Second Intervention (One Week) Patients|Withdrawal by Subject|1
6127371|NCT00044083|21112448|P1|Second Intervention (One Week) Patients|Withdrawal by Subject|0
6127372|NCT00044083|21112447|P2|First Intervention (One Week) Patients|Used illegal drug|0
6127373|NCT00044083|21112448|P1|First Intervention (One Week) Patients|Used illegal drug|1
6127374|NCT00044083|21112447|P2|First Intervention (One Week) Patients|Not follow directions|2
6127375|NCT00044083|21112448|P1|First Intervention (One Week) Patients|Not follow directions|0
6127376|NCT00044083|21112447|P2|First Intervention (One Week)- HV's|Drank while on protocol|1
6127377|NCT00044083|21112448|P1|First Intervention (One Week)- HV's|Drank while on protocol|0
6127378|NCT00044083|21112447|P2|First Intervention (One Week)- HV's|Abnormal MRI|1
6127379|NCT00044083|21112448|P1|First Intervention (One Week)- HV's|Abnormal MRI|0
6127380|NCT00044083|21112447|P2|First Intervention (One Week)- HV's|Used illegal drugs|0
6127381|NCT00044083|21112448|P1|First Intervention (One Week)- HV's|Used illegal drugs|1
6127382|NCT00044083|21112447|P2|First Intervention (One Week)- HV's|Pregnancy|0
6127383|NCT00044083|21112448|P1|First Intervention (One Week)- HV's|Pregnancy|1
6127384|NCT00044083|21112447|P2|First Intervention (One Week)- HV's|Withdrawal by Subject|3
6127385|NCT00044083|21112448|P1|First Intervention (One Week)- HV's|Withdrawal by Subject|5
6127386|NCT00044083|21112447|P2|First Intervention (One Week)- HV's|Not follow directions|2
6127387|NCT00044083|21112448|P1|First Intervention (One Week)- HV's|Not follow directions|2
6127388|NCT00044083|21112447|P2|First Intervention (One Week)- HV's|Adverse Event|0
6127389|NCT00044083|21112448|P1|First Intervention (One Week)- HV's|Adverse Event|1
6127390|NCT00043979|21112486|P3|Period 1|recipient with progressive disease|3
6127391|NCT00043979|21112487|P2|Period 1|recipient with progressive disease|4
6127392|NCT00043979|21112488|P1|Period 1|recipient with progressive disease|7
6127393|NCT00043550|21112509|P3|Overall Study|Withdrawal by Subject|20
6127394|NCT00043550|21112510|P2|Overall Study|Withdrawal by Subject|12
6127395|NCT00043550|21112511|P1|Overall Study|Withdrawal by Subject|22
6127396|NCT00043186|21112528|P9|Overall Study|Other|0
6127397|NCT00043186|21112529|P8|Overall Study|Other|0
6127398|NCT00043186|21112530|P7|Overall Study|Other|0
6127399|NCT00043186|21112531|P6|Overall Study|Other|0
6127400|NCT00043186|21112532|P5|Overall Study|Other|0
6127401|NCT00043186|21112533|P4|Overall Study|Other|1
6127402|NCT00043186|21112534|P3|Overall Study|Other|1
6127403|NCT00043186|21112535|P2|Overall Study|Other|0
6127404|NCT00043186|21112536|P1|Overall Study|Other|0
6127405|NCT00043186|21112528|P9|Overall Study|Noncompliance|0
6127406|NCT00043186|21112529|P8|Overall Study|Noncompliance|0
6127407|NCT00043186|21112530|P7|Overall Study|Noncompliance|0
6127408|NCT00043186|21112531|P6|Overall Study|Noncompliance|0
6127409|NCT00043186|21112532|P5|Overall Study|Noncompliance|0
6127410|NCT00043186|21112533|P4|Overall Study|Noncompliance|1
6127411|NCT00043186|21112534|P3|Overall Study|Noncompliance|1
6127412|NCT00043186|21112535|P2|Overall Study|Noncompliance|0
6127413|NCT00043186|21112536|P1|Overall Study|Noncompliance|0
6127414|NCT00043186|21112528|P9|Overall Study|Lost to Follow-up|2
6127415|NCT00043186|21112529|P8|Overall Study|Lost to Follow-up|1
6127416|NCT00043186|21112530|P7|Overall Study|Lost to Follow-up|1
6127417|NCT00043186|21112531|P6|Overall Study|Lost to Follow-up|1
6127418|NCT00043186|21112532|P5|Overall Study|Lost to Follow-up|1
6127419|NCT00043186|21112533|P4|Overall Study|Lost to Follow-up|1
6127420|NCT00043186|21112534|P3|Overall Study|Lost to Follow-up|1
6127421|NCT00043186|21112535|P2|Overall Study|Lost to Follow-up|5
6127422|NCT00043186|21112536|P1|Overall Study|Lost to Follow-up|3
6127423|NCT00043186|21112528|P9|Overall Study|Ineligibility determined|1
6127424|NCT00043186|21112529|P8|Overall Study|Ineligibility determined|0
6127425|NCT00043186|21112530|P7|Overall Study|Ineligibility determined|0
6127426|NCT00043186|21112531|P6|Overall Study|Ineligibility determined|0
6127427|NCT00043186|21112532|P5|Overall Study|Ineligibility determined|0
6127428|NCT00043186|21112533|P4|Overall Study|Ineligibility determined|0
6127429|NCT00043186|21112534|P3|Overall Study|Ineligibility determined|0
6127430|NCT00043186|21112535|P2|Overall Study|Ineligibility determined|0
6127431|NCT00043186|21112536|P1|Overall Study|Ineligibility determined|0
6127432|NCT00043186|21112528|P9|Overall Study|Disease progression|0
6127433|NCT00043186|21112529|P8|Overall Study|Disease progression|4
6127434|NCT00043186|21112530|P7|Overall Study|Disease progression|0
6127435|NCT00043186|21112531|P6|Overall Study|Disease progression|0
6127436|NCT00043186|21112532|P5|Overall Study|Disease progression|0
6127437|NCT00043186|21112533|P4|Overall Study|Disease progression|3
6127438|NCT00043186|21112534|P3|Overall Study|Disease progression|0
6127439|NCT00043186|21112535|P2|Overall Study|Disease progression|0
6127440|NCT00043186|21112536|P1|Overall Study|Disease progression|1
6127441|NCT00043186|21112528|P9|Overall Study|Death|0
6127442|NCT00043186|21112529|P8|Overall Study|Death|0
6127443|NCT00043186|21112530|P7|Overall Study|Death|2
6127444|NCT00043186|21112531|P6|Overall Study|Death|0
6127445|NCT00043186|21112532|P5|Overall Study|Death|0
6127446|NCT00043186|21112533|P4|Overall Study|Death|0
6127447|NCT00043186|21112534|P3|Overall Study|Death|1
6127448|NCT00043186|21112535|P2|Overall Study|Death|0
6127449|NCT00043186|21112536|P1|Overall Study|Death|0
6127450|NCT00043186|21112528|P9|Overall Study|Withdrawal by Subject|10
6127451|NCT00043186|21112529|P8|Overall Study|Withdrawal by Subject|9
6127452|NCT00043186|21112530|P7|Overall Study|Withdrawal by Subject|12
6127453|NCT00043186|21112531|P6|Overall Study|Withdrawal by Subject|6
6127454|NCT00043186|21112532|P5|Overall Study|Withdrawal by Subject|14
6127455|NCT00043186|21112533|P4|Overall Study|Withdrawal by Subject|13
6127456|NCT00043186|21112534|P3|Overall Study|Withdrawal by Subject|11
6127457|NCT00043186|21112535|P2|Overall Study|Withdrawal by Subject|8
6127458|NCT00043186|21112536|P1|Overall Study|Withdrawal by Subject|11
6127459|NCT00043186|21112528|P9|Overall Study|Adverse Event|3
6127460|NCT00043186|21112529|P8|Overall Study|Adverse Event|1
6127461|NCT00043186|21112530|P7|Overall Study|Adverse Event|2
6127462|NCT00043186|21112531|P6|Overall Study|Adverse Event|1
6127463|NCT00043186|21112532|P5|Overall Study|Adverse Event|2
6127464|NCT00043186|21112533|P4|Overall Study|Adverse Event|3
6127465|NCT00043186|21112534|P3|Overall Study|Adverse Event|2
6127466|NCT00043186|21112535|P2|Overall Study|Adverse Event|2
6127467|NCT00043186|21112536|P1|Overall Study|Adverse Event|2
6127468|NCT00043186|21112528|P9|Overall Study|Physician Decision|1
6127469|NCT00043186|21112529|P8|Overall Study|Physician Decision|1
6127470|NCT00043186|21112530|P7|Overall Study|Physician Decision|0
6127471|NCT00043186|21112531|P6|Overall Study|Physician Decision|0
6127472|NCT00043186|21112532|P5|Overall Study|Physician Decision|1
6127473|NCT00043186|21112533|P4|Overall Study|Physician Decision|0
6127474|NCT00043186|21112534|P3|Overall Study|Physician Decision|3
6127475|NCT00043186|21112535|P2|Overall Study|Physician Decision|0
6127476|NCT00043186|21112536|P1|Overall Study|Physician Decision|0
6127477|NCT00042666|21112862|P1|Overall Study|Other|4
6127478|NCT00042666|21112862|P1|Overall Study|Other|1
6127479|NCT00042666|21112862|P1|Overall Study|Progressive Disease|41
6127480|NCT00042666|21112862|P1|Overall Study|Participant/Physician Perception|1
6127481|NCT00042666|21112862|P1|Overall Study|Protocol Violation|1
6127482|NCT00042666|21112862|P1|Overall Study|Death|4
6127483|NCT00042666|21112862|P1|Overall Study|Adverse Event|2
6127484|NCT00042432|21112874|P2|Overall Study|Other|0
6127485|NCT00042432|21112875|P1|Overall Study|Other|2
6127486|NCT00042432|21112874|P2|Overall Study|Initiation of maintenance dialysis|1
6127487|NCT00042432|21112875|P1|Overall Study|Initiation of maintenance dialysis|1
6127488|NCT00042432|21112874|P2|Overall Study|Ineligibility determined|0
6127489|NCT00042432|21112875|P1|Overall Study|Ineligibility determined|1
6127490|NCT00042432|21112874|P2|Overall Study|Death|2
6127491|NCT00042432|21112875|P1|Overall Study|Death|0
6127492|NCT00042432|21112874|P2|Overall Study|Withdrawal by Subject|3
6127493|NCT00042432|21112875|P1|Overall Study|Withdrawal by Subject|1
6127494|NCT00042432|21112874|P2|Overall Study|Adverse Event|1
6127495|NCT00042432|21112875|P1|Overall Study|Adverse Event|4
6127496|NCT00041756|21112928|P5|Overall Study|Data Monitoring Committee Recommendation|21
6127497|NCT00041756|21112929|P4|Overall Study|Data Monitoring Committee Recommendation|0
6127498|NCT00041756|21112930|P3|Overall Study|Data Monitoring Committee Recommendation|0
6127499|NCT00041756|21112931|P2|Overall Study|Data Monitoring Committee Recommendation|0
6127500|NCT00041756|21112932|P1|Overall Study|Data Monitoring Committee Recommendation|0
6127501|NCT00041756|21112928|P5|Overall Study|Unable to meet protocol criteria|1
6127502|NCT00041756|21112929|P4|Overall Study|Unable to meet protocol criteria|0
6127503|NCT00041756|21112930|P3|Overall Study|Unable to meet protocol criteria|1
6127504|NCT00041756|21112931|P2|Overall Study|Unable to meet protocol criteria|0
6127505|NCT00041756|21112932|P1|Overall Study|Unable to meet protocol criteria|0
6127506|NCT00041756|21112928|P5|Overall Study|Lost to Follow-up|0
6127507|NCT00041756|21112929|P4|Overall Study|Lost to Follow-up|1
6127508|NCT00041756|21112930|P3|Overall Study|Lost to Follow-up|0
6127509|NCT00041756|21112931|P2|Overall Study|Lost to Follow-up|1
6127510|NCT00041756|21112932|P1|Overall Study|Lost to Follow-up|0
6127511|NCT00041756|21112928|P5|Overall Study|Withdrawal by Subject|3
6127512|NCT00041756|21112929|P4|Overall Study|Withdrawal by Subject|2
6127513|NCT00041756|21112930|P3|Overall Study|Withdrawal by Subject|4
6127514|NCT00041756|21112931|P2|Overall Study|Withdrawal by Subject|3
6127515|NCT00041756|21112932|P1|Overall Study|Withdrawal by Subject|3
6127516|NCT00041756|21112928|P5|Overall Study|Protocol Violation|1
6127517|NCT00041756|21112929|P4|Overall Study|Protocol Violation|2
6127518|NCT00041756|21112930|P3|Overall Study|Protocol Violation|2
6127519|NCT00041756|21112931|P2|Overall Study|Protocol Violation|1
6127520|NCT00041756|21112932|P1|Overall Study|Protocol Violation|1
6127521|NCT00041756|21112928|P5|Overall Study|Adverse Event|34
6127522|NCT00041756|21112929|P4|Overall Study|Adverse Event|11
6127523|NCT00041756|21112930|P3|Overall Study|Adverse Event|6
6127524|NCT00041756|21112931|P2|Overall Study|Adverse Event|10
6127525|NCT00041756|21112932|P1|Overall Study|Adverse Event|4
6127526|NCT00041470|21112960|P1|Overall Study|Loss of Funding|38
6127527|NCT00040664|21112965|P4|Overall Study|Non-viability of oral suspension|0
6127528|NCT00040664|21112966|P3|Overall Study|Non-viability of oral suspension|1
6127529|NCT00040664|21112967|P2|Overall Study|Non-viability of oral suspension|0
6127530|NCT00040664|21112968|P1|Overall Study|Non-viability of oral suspension|1
6127531|NCT00040664|21112965|P4|Overall Study|Change of formulation|0
6127532|NCT00040664|21112966|P3|Overall Study|Change of formulation|0
6127533|NCT00040664|21112967|P2|Overall Study|Change of formulation|2
6127534|NCT00040664|21112968|P1|Overall Study|Change of formulation|2
6127535|NCT00040664|21112965|P4|Overall Study|Pharmacokinetic target not achieved|1
6127536|NCT00040664|21112966|P3|Overall Study|Pharmacokinetic target not achieved|0
6127537|NCT00040664|21112967|P2|Overall Study|Pharmacokinetic target not achieved|1
6127538|NCT00040664|21112968|P1|Overall Study|Pharmacokinetic target not achieved|2
6127539|NCT00040664|21112965|P4|Overall Study|Poor taste|0
6127540|NCT00040664|21112966|P3|Overall Study|Poor taste|2
6127541|NCT00040664|21112967|P2|Overall Study|Poor taste|0
6127542|NCT00040664|21112968|P1|Overall Study|Poor taste|2
6127543|NCT00040664|21112965|P4|Overall Study|Medication adherence/compliance problems|5
6127544|NCT00040664|21112966|P3|Overall Study|Medication adherence/compliance problems|1
6127545|NCT00040664|21112967|P2|Overall Study|Medication adherence/compliance problems|2
6127546|NCT00040664|21112968|P1|Overall Study|Medication adherence/compliance problems|8
6127547|NCT00040664|21112965|P4|Overall Study|Pregnancy|3
6127548|NCT00040664|21112966|P3|Overall Study|Pregnancy|0
6127549|NCT00040664|21112967|P2|Overall Study|Pregnancy|0
6127550|NCT00040664|21112968|P1|Overall Study|Pregnancy|3
6127551|NCT00040664|21112965|P4|Overall Study|Withdrawal by Subject|4
6127552|NCT00040664|21112966|P3|Overall Study|Withdrawal by Subject|3
6127553|NCT00040664|21112967|P2|Overall Study|Withdrawal by Subject|0
6127554|NCT00040664|21112968|P1|Overall Study|Withdrawal by Subject|7
6127555|NCT00040664|21112965|P4|Overall Study|Protocol Violation|1
6127556|NCT00040664|21112966|P3|Overall Study|Protocol Violation|0
6127557|NCT00040664|21112967|P2|Overall Study|Protocol Violation|1
6127558|NCT00040664|21112968|P1|Overall Study|Protocol Violation|2
6127559|NCT00040664|21112965|P4|Overall Study|Lost to Follow-up|2
6127560|NCT00040664|21112966|P3|Overall Study|Lost to Follow-up|0
6127561|NCT00040664|21112967|P2|Overall Study|Lost to Follow-up|2
6127562|NCT00040664|21112968|P1|Overall Study|Lost to Follow-up|4
6127563|NCT00040664|21112965|P4|Overall Study|Insufficient CD4 response|0
6127564|NCT00040664|21112966|P3|Overall Study|Insufficient CD4 response|1
6127565|NCT00040664|21112967|P2|Overall Study|Insufficient CD4 response|0
6127566|NCT00040664|21112968|P1|Overall Study|Insufficient CD4 response|1
6127567|NCT00040664|21112965|P4|Overall Study|Lack of Efficacy|4
6127568|NCT00040664|21112966|P3|Overall Study|Lack of Efficacy|3
6127569|NCT00040664|21112967|P2|Overall Study|Lack of Efficacy|2
6127570|NCT00040664|21112968|P1|Overall Study|Lack of Efficacy|9
6127571|NCT00040664|21112965|P4|Overall Study|Adverse Event|7
6127572|NCT00040664|21112966|P3|Overall Study|Adverse Event|2
6127573|NCT00040664|21112967|P2|Overall Study|Adverse Event|3
6127574|NCT00040664|21112968|P1|Overall Study|Adverse Event|12
6127575|NCT00040365|21113034|P1|Overall Study|Lost to Follow-up|3
6127576|NCT00040365|21113034|P1|Overall Study|Progressive disease|7
6127577|NCT00040365|21113034|P1|Overall Study|Death|1
6127578|NCT00039871|21113043|P1|Overall Study|Never entered follow-up|7
6127579|NCT00039871|21113043|P1|Overall Study|Discontinued at Week 12 per protocol|1061
6127580|NCT00039871|21113043|P1|Overall Study|Administrative|1
6127581|NCT00039871|21113043|P1|Overall Study|Did not meet eligibility criteria|11
6127582|NCT00039871|21113043|P1|Overall Study|Withdrawal by Subject|97
6127583|NCT00039871|21113043|P1|Overall Study|Protocol Violation|24
6127584|NCT00039871|21113043|P1|Overall Study|Lost to Follow-up|18
6127585|NCT00039871|21113043|P1|Overall Study|Adverse Event|165
6127586|NCT00039741|21113053|P4|Overall Study|Missed final visit|2
6127587|NCT00039741|21113054|P3|Overall Study|Missed final visit|2
6127588|NCT00039741|21113055|P2|Overall Study|Missed final visit|1
6127589|NCT00039741|21113056|P1|Overall Study|Missed final visit|2
6127590|NCT00039741|21113053|P4|Overall Study|Withdrew consent|1
6127591|NCT00039741|21113054|P3|Overall Study|Withdrew consent|0
6127592|NCT00039741|21113055|P2|Overall Study|Withdrew consent|5
6127593|NCT00039741|21113056|P1|Overall Study|Withdrew consent|0
6127594|NCT00039741|21113053|P4|Overall Study|Non-compliance with protocol|0
6127595|NCT00039741|21113054|P3|Overall Study|Non-compliance with protocol|1
6127596|NCT00039741|21113055|P2|Overall Study|Non-compliance with protocol|0
6127597|NCT00039741|21113056|P1|Overall Study|Non-compliance with protocol|1
6127598|NCT00039741|21113053|P4|Overall Study|Moved|6
6127599|NCT00039741|21113054|P3|Overall Study|Moved|3
6127600|NCT00039741|21113055|P2|Overall Study|Moved|2
6127601|NCT00039741|21113056|P1|Overall Study|Moved|3
6127602|NCT00039741|21113053|P4|Overall Study|Not able to get to clinic|3
6127603|NCT00039741|21113054|P3|Overall Study|Not able to get to clinic|0
6127604|NCT00039741|21113055|P2|Overall Study|Not able to get to clinic|2
6127605|NCT00039741|21113056|P1|Overall Study|Not able to get to clinic|5
6127606|NCT00039741|21113053|P4|Overall Study|Confounding medical condition|0
6127607|NCT00039741|21113054|P3|Overall Study|Confounding medical condition|0
6127608|NCT00039741|21113055|P2|Overall Study|Confounding medical condition|0
6127609|NCT00039741|21113056|P1|Overall Study|Confounding medical condition|1
6127610|NCT00039741|21113053|P4|Overall Study|Lost to Follow-up|2
6127611|NCT00039741|21113054|P3|Overall Study|Lost to Follow-up|5
6127612|NCT00039741|21113055|P2|Overall Study|Lost to Follow-up|1
6127613|NCT00039741|21113056|P1|Overall Study|Lost to Follow-up|3
6127614|NCT00039741|21113053|P4|Overall Study|Death|0
6127615|NCT00039741|21113054|P3|Overall Study|Death|0
6127616|NCT00039741|21113055|P2|Overall Study|Death|1
6127617|NCT00039741|21113056|P1|Overall Study|Death|0
6127618|NCT00038948|21113100|P2|Overall Study|Lack of Efficacy|6
6127619|NCT00038948|21113101|P1|Overall Study|Lack of Efficacy|3
6127620|NCT00038948|21113100|P2|Overall Study|Protocol Violation|7
6127621|NCT00038948|21113101|P1|Overall Study|Protocol Violation|3
6127622|NCT00038948|21113100|P2|Overall Study|Withdrawal by Subject|10
6127623|NCT00038948|21113101|P1|Overall Study|Withdrawal by Subject|23
6127624|NCT00038948|21113100|P2|Overall Study|Nonmedical event|7
6127625|NCT00038948|21113101|P1|Overall Study|Nonmedical event|5
6127626|NCT00038948|21113100|P2|Overall Study|Lost to Follow-up|4
6127627|NCT00038948|21113101|P1|Overall Study|Lost to Follow-up|4
6127628|NCT00038948|21113100|P2|Overall Study|Adverse Event|43
6127629|NCT00038948|21113101|P1|Overall Study|Adverse Event|131
6127630|NCT00038649|21113136|P1|Overall Study|Adverse Event|9
6127631|NCT00038467|21113149|P2|Overall Study|Other|28
6127632|NCT00038467|21113150|P1|Overall Study|Other|26
6127633|NCT00038467|21113149|P2|Overall Study|Randomized, but not treated|35
6127634|NCT00038467|21113150|P1|Overall Study|Randomized, but not treated|31
6127635|NCT00038467|21113149|P2|Overall Study|Recurrence|179
6127636|NCT00038467|21113150|P1|Overall Study|Recurrence|109
6127637|NCT00038467|21113149|P2|Overall Study|Lost to Follow-up|10
6127638|NCT00038467|21113150|P1|Overall Study|Lost to Follow-up|15
6127639|NCT00038467|21113149|P2|Overall Study|Death|16
6127640|NCT00038467|21113150|P1|Overall Study|Death|22
6127641|NCT00038467|21113149|P2|Overall Study|Protocol Violation|22
6127642|NCT00038467|21113150|P1|Overall Study|Protocol Violation|19
6127643|NCT00038467|21113149|P2|Overall Study|Withdrawal by Subject|107
6127644|NCT00038467|21113150|P1|Overall Study|Withdrawal by Subject|150
6127645|NCT00038467|21113149|P2|Overall Study|Adverse Event|145
6127646|NCT00038467|21113150|P1|Overall Study|Adverse Event|170
6127647|NCT00038142|21113212|P2|Overall Study|Unknown Reason|0
6127648|NCT00038142|21113213|P1|Overall Study|Unknown Reason|8
6127649|NCT00038142|21113212|P2|Overall Study|Adverse Event|0
6127650|NCT00038142|21113213|P1|Overall Study|Adverse Event|1
6127651|NCT00038142|21113212|P2|Overall Study|Death|0
6127652|NCT00038142|21113213|P1|Overall Study|Death|1
6127653|NCT00038142|21113212|P2|Overall Study|Progressive Disease|7
6127654|NCT00038142|21113213|P1|Overall Study|Progressive Disease|11
6127655|NCT00038142|21113212|P2|Overall Study|Ineligible|0
6127656|NCT00038142|21113213|P1|Overall Study|Ineligible|1
6127657|NCT00038103|21113221|P2|Overall Study|Randomized/never treated|0
6127658|NCT00038103|21113222|P1|Overall Study|Randomized/never treated|2
6127659|NCT00038103|21113221|P2|Overall Study|Sponsor Decision|1
6127660|NCT00038103|21113222|P1|Overall Study|Sponsor Decision|0
6127661|NCT00038103|21113221|P2|Overall Study|Protocol Violation|2
6127662|NCT00038103|21113222|P1|Overall Study|Protocol Violation|0
6127663|NCT00038103|21113221|P2|Overall Study|Lost to Follow-up|3
6127664|NCT00038103|21113222|P1|Overall Study|Lost to Follow-up|0
6127665|NCT00038103|21113221|P2|Overall Study|Withdrawal by Subject|3
6127666|NCT00038103|21113222|P1|Overall Study|Withdrawal by Subject|0
6127667|NCT00038103|21113221|P2|Overall Study|Lack of Efficacy|41
6127668|NCT00038103|21113222|P1|Overall Study|Lack of Efficacy|48
6127669|NCT00038103|21113221|P2|Overall Study|Adverse Event|6
6127670|NCT00038103|21113222|P1|Overall Study|Adverse Event|5
6127671|NCT00037830|21113245|P3|Overall Study|Unrelated Medical Problem|0
6127672|NCT00037830|21113246|P2|Overall Study|Unrelated Medical Problem|0
6127673|NCT00037830|21113247|P1|Overall Study|Unrelated Medical Problem|2
6127674|NCT00037830|21113245|P3|Overall Study|Protocol Violation|0
6127675|NCT00037830|21113246|P2|Overall Study|Protocol Violation|2
6127676|NCT00037830|21113247|P1|Overall Study|Protocol Violation|2
6127677|NCT00037830|21113245|P3|Overall Study|Withdrawal by Subject|1
6127678|NCT00037830|21113246|P2|Overall Study|Withdrawal by Subject|5
6127679|NCT00037830|21113247|P1|Overall Study|Withdrawal by Subject|4
6127680|NCT00037830|21113245|P3|Overall Study|Adverse Event|0
6127681|NCT00037830|21113246|P2|Overall Study|Adverse Event|0
6127682|NCT00037830|21113247|P1|Overall Study|Adverse Event|2
6127683|NCT00036270|21113279|P2|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|750
6127684|NCT00036270|21113280|P1|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|0
6127685|NCT00036270|21113279|P2|Study Treatment to 5 Year Report|Too early switch|103
6127686|NCT00036270|21113280|P1|Study Treatment to 5 Year Report|Too early switch|0
6127687|NCT00036270|21113279|P2|Study Treatment to 5 Year Report|Intercurrent illness|29
6127688|NCT00036270|21113280|P1|Study Treatment to 5 Year Report|Intercurrent illness|17
6127689|NCT00036270|21113279|P2|Study Treatment to 5 Year Report|Protocol Violation|91
6127690|NCT00036270|21113280|P1|Study Treatment to 5 Year Report|Protocol Violation|23
6127691|NCT00036270|21113279|P2|Study Treatment to 5 Year Report|Randomized but not treated|54
6127692|NCT00036270|21113280|P1|Study Treatment to 5 Year Report|Randomized but not treated|46
6127693|NCT00036270|21113279|P2|Study Treatment to 5 Year Report|Treatment refusal|208
6127694|NCT00036270|21113280|P1|Study Treatment to 5 Year Report|Treatment refusal|113
6127695|NCT00036270|21113279|P2|Study Treatment to 5 Year Report|Other|288
6127696|NCT00036270|21113280|P1|Study Treatment to 5 Year Report|Other|277
6127697|NCT00036270|21113279|P2|Study Treatment to 5 Year Report|Adverse Event|782
6127698|NCT00036270|21113280|P1|Study Treatment to 5 Year Report|Adverse Event|501
6127699|NCT00036270|21113279|P2|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|447
6127700|NCT00036270|21113280|P1|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|507
6127701|NCT00036270|21113279|P2|Study Treatment to 5 Year Report|Ongoing|736
6127702|NCT00036270|21113280|P1|Study Treatment to 5 Year Report|Ongoing|1081
6127703|NCT00036270|21113279|P2|Randomized to Study Treatment|Withdrawal by Subject|7
6127704|NCT00036270|21113280|P1|Randomized to Study Treatment|Withdrawal by Subject|6
6127705|NCT00035932|21113299|P3|Overall Study|Lack of Efficacy|28
6127706|NCT00035932|21113300|P2|Overall Study|Lack of Efficacy|33
6127707|NCT00035932|21113301|P1|Overall Study|Lack of Efficacy|33
6127708|NCT00035932|21113299|P3|Overall Study|Study Termination by Sponsor|0
6127709|NCT00035932|21113300|P2|Overall Study|Study Termination by Sponsor|0
6127710|NCT00035932|21113301|P1|Overall Study|Study Termination by Sponsor|1
6127711|NCT00035932|21113299|P3|Overall Study|Withdrawal by Subject|0
6127712|NCT00035932|21113300|P2|Overall Study|Withdrawal by Subject|5
6127713|NCT00035932|21113301|P1|Overall Study|Withdrawal by Subject|1
6127714|NCT00035932|21113299|P3|Overall Study|Protocol Violation While on Study|2
6127715|NCT00035932|21113300|P2|Overall Study|Protocol Violation While on Study|1
6127716|NCT00035932|21113301|P1|Overall Study|Protocol Violation While on Study|0
6127717|NCT00035932|21113299|P3|Overall Study|Noncompliance|6
6127718|NCT00035932|21113300|P2|Overall Study|Noncompliance|7
6127719|NCT00035932|21113301|P1|Overall Study|Noncompliance|6
6127720|NCT00035932|21113299|P3|Overall Study|Lost to Follow-up|3
6127721|NCT00035932|21113300|P2|Overall Study|Lost to Follow-up|4
6127722|NCT00035932|21113301|P1|Overall Study|Lost to Follow-up|4
6127723|NCT00035932|21113299|P3|Overall Study|Disease Progression / Relapse|0
6127724|NCT00035932|21113300|P2|Overall Study|Disease Progression / Relapse|1
6127725|NCT00035932|21113301|P1|Overall Study|Disease Progression / Relapse|1
6127726|NCT00035932|21113299|P3|Overall Study|Death|1
6127727|NCT00035932|21113300|P2|Overall Study|Death|0
6127728|NCT00035932|21113301|P1|Overall Study|Death|0
6127729|NCT00035932|21113299|P3|Overall Study|Adverse Event|9
6127730|NCT00035932|21113300|P2|Overall Study|Adverse Event|9
6127731|NCT00035932|21113301|P1|Overall Study|Adverse Event|10
6127732|NCT00035815|21113427|P2|Overall Study|Withdrawal by Subject|11
6127733|NCT00035815|21113428|P1|Overall Study|Withdrawal by Subject|17
6127734|NCT00035555|21113441|P3|Overall Study|Received cyclosporin in error|1
6127735|NCT00035555|21113442|P2|Overall Study|Received cyclosporin in error|0
6127736|NCT00035555|21113443|P1|Overall Study|Received cyclosporin in error|0
6127737|NCT00035555|21113441|P3|Overall Study|Investigator deemed not a good candidate|1
6127738|NCT00035555|21113442|P2|Overall Study|Investigator deemed not a good candidate|0
6127739|NCT00035555|21113443|P1|Overall Study|Investigator deemed not a good candidate|0
6127740|NCT00035555|21113441|P3|Overall Study|Withdrawal by Subject|2
6127741|NCT00035555|21113442|P2|Overall Study|Withdrawal by Subject|0
6127742|NCT00035555|21113443|P1|Overall Study|Withdrawal by Subject|2
6127743|NCT00035555|21113441|P3|Overall Study|Treatment failure/lack of efficacy|3
6127744|NCT00035555|21113442|P2|Overall Study|Treatment failure/lack of efficacy|5
6127745|NCT00035555|21113443|P1|Overall Study|Treatment failure/lack of efficacy|7
6127746|NCT00035555|21113441|P3|Overall Study|Prohibited medication|0
6127747|NCT00035555|21113442|P2|Overall Study|Prohibited medication|1
6127748|NCT00035555|21113443|P1|Overall Study|Prohibited medication|1
6127749|NCT00035555|21113441|P3|Overall Study|Noncompliance|1
6127750|NCT00035555|21113442|P2|Overall Study|Noncompliance|1
6127751|NCT00035555|21113443|P1|Overall Study|Noncompliance|0
6127752|NCT00035555|21113441|P3|Overall Study|Lost to Follow-up|1
6127753|NCT00035555|21113442|P2|Overall Study|Lost to Follow-up|0
6127754|NCT00035555|21113443|P1|Overall Study|Lost to Follow-up|0
6127755|NCT00035555|21113441|P3|Overall Study|Death|2
6127756|NCT00035555|21113442|P2|Overall Study|Death|0
6127757|NCT00035555|21113443|P1|Overall Study|Death|0
6127758|NCT00035555|21113441|P3|Overall Study|Allograft loss|2
6127759|NCT00035555|21113442|P2|Overall Study|Allograft loss|1
6127760|NCT00035555|21113443|P1|Overall Study|Allograft loss|1
6127761|NCT00035555|21113441|P3|Overall Study|Adverse Event|9
6127762|NCT00035555|21113442|P2|Overall Study|Adverse Event|8
6127763|NCT00035555|21113443|P1|Overall Study|Adverse Event|5
6127764|NCT00032487|21113527|P2|Overall Study|Had other reason|12
6127765|NCT00032487|21113528|P1|Overall Study|Had other reason|12
6127766|NCT00032487|21113527|P2|Overall Study|Lost to Follow-up|58
6127767|NCT00032487|21113528|P1|Overall Study|Lost to Follow-up|57
6127768|NCT00032487|21113527|P2|Overall Study|Adverse Event|7
6127769|NCT00032487|21113528|P1|Overall Study|Adverse Event|3
6127770|NCT00032487|21113527|P2|Overall Study|Withdrawal by Subject|43
6127771|NCT00032487|21113528|P1|Overall Study|Withdrawal by Subject|67
6127772|NCT00031551|21113538|P2|Overall Study|Withdrew due to chemotherapy effects|0
6127773|NCT00031551|21113539|P1|Overall Study|Withdrew due to chemotherapy effects|2
6127774|NCT00031486|21113551|P2|Overall Study|Other|1
6127775|NCT00031486|21113552|P1|Overall Study|Other|1
6127776|NCT00031486|21113551|P2|Overall Study|Did not meet eligibility requirement|1
6127777|NCT00031486|21113552|P1|Overall Study|Did not meet eligibility requirement|2
6127778|NCT00031486|21113551|P2|Overall Study|Non-compliant|4
6127779|NCT00031486|21113552|P1|Overall Study|Non-compliant|0
6127780|NCT00031486|21113551|P2|Overall Study|Death|3
6127781|NCT00031486|21113552|P1|Overall Study|Death|0
6127782|NCT00031486|21113551|P2|Overall Study|Withdrawal by Subject|2
6127783|NCT00031486|21113552|P1|Overall Study|Withdrawal by Subject|3
6127784|NCT00031486|21113551|P2|Overall Study|Lost to Follow-up|1
6127785|NCT00031486|21113552|P1|Overall Study|Lost to Follow-up|0
6127786|NCT00031486|21113551|P2|Overall Study|Adverse Event|0
6127787|NCT00031486|21113552|P1|Overall Study|Adverse Event|1
6127788|NCT00031460|21113578|P2|Overall Study|Confirmed unevaluable|1
6127789|NCT00031460|21113579|P1|Overall Study|Confirmed unevaluable|0
6127790|NCT00031460|21113578|P2|Overall Study|Disruption of blinded drug supply|0
6127791|NCT00031460|21113579|P1|Overall Study|Disruption of blinded drug supply|2
6127792|NCT00031460|21113578|P2|Overall Study|Reactivation of Disease|9
6127793|NCT00031460|21113579|P1|Overall Study|Reactivation of Disease|5
6127794|NCT00031460|21113578|P2|Overall Study|Death|1
6127795|NCT00031460|21113579|P1|Overall Study|Death|0
6127796|NCT00031460|21113578|P2|Overall Study|Non-Compliant|1
6127797|NCT00031460|21113579|P1|Overall Study|Non-Compliant|1
6127798|NCT00031460|21113578|P2|Overall Study|Withdrawal by Subject|1
6127799|NCT00031460|21113579|P1|Overall Study|Withdrawal by Subject|1
6127800|NCT00031460|21113578|P2|Overall Study|Lost to Follow-up|1
6127801|NCT00031460|21113579|P1|Overall Study|Lost to Follow-up|0
6127802|NCT00031447|21113593|P2|Overall Study|Disruption of blinded study drug supply|4
6127803|NCT00031447|21113594|P1|Overall Study|Disruption of blinded study drug supply|7
6127804|NCT00031447|21113593|P2|Overall Study|Re-activation of Disease|1
6127805|NCT00031447|21113594|P1|Overall Study|Re-activation of Disease|2
6127806|NCT00031447|21113593|P2|Overall Study|Non-compliant|1
6127807|NCT00031447|21113594|P1|Overall Study|Non-compliant|1
6127808|NCT00031447|21113593|P2|Overall Study|Lost to Follow-up|1
6127809|NCT00031447|21113594|P1|Overall Study|Lost to Follow-up|0
6127810|NCT00029146|21113669|P2|Overall Study|Lost to Follow-up|1
6127811|NCT00029146|21113670|P1|Overall Study|Lost to Follow-up|2
6127812|NCT00027378|21113721|P2|Overall Study|Physician Decision|3
6127813|NCT00027378|21113722|P1|Overall Study|Physician Decision|0
6127814|NCT00027027|21113735|P5|Overall Study|Withdrawal by Subject|1
6127815|NCT00027027|21113736|P4|Overall Study|Withdrawal by Subject|0
6127816|NCT00027027|21113737|P3|Overall Study|Withdrawal by Subject|0
6127817|NCT00027027|21113738|P2|Overall Study|Withdrawal by Subject|0
6127818|NCT00027027|21113739|P1|Overall Study|Withdrawal by Subject|0
6127819|NCT00027027|21113735|P5|Overall Study|Physician Decision Due To PD|5
6127820|NCT00027027|21113736|P4|Overall Study|Physician Decision Due To PD|3
6127821|NCT00027027|21113737|P3|Overall Study|Physician Decision Due To PD|2
6127822|NCT00027027|21113738|P2|Overall Study|Physician Decision Due To PD|3
6127823|NCT00027027|21113739|P1|Overall Study|Physician Decision Due To PD|2
6127824|NCT00027027|21113735|P5|Overall Study|PD Requiring Surgery|0
6127825|NCT00027027|21113736|P4|Overall Study|PD Requiring Surgery|0
6127826|NCT00027027|21113737|P3|Overall Study|PD Requiring Surgery|1
6127827|NCT00027027|21113738|P2|Overall Study|PD Requiring Surgery|0
6127828|NCT00027027|21113739|P1|Overall Study|PD Requiring Surgery|0
6127829|NCT00027027|21113735|P5|Overall Study|Clinical Symptoms Progression not PD|0
6127830|NCT00027027|21113736|P4|Overall Study|Clinical Symptoms Progression not PD|0
6127831|NCT00027027|21113737|P3|Overall Study|Clinical Symptoms Progression not PD|0
6127832|NCT00027027|21113738|P2|Overall Study|Clinical Symptoms Progression not PD|0
6127833|NCT00027027|21113739|P1|Overall Study|Clinical Symptoms Progression not PD|1
6127834|NCT00027027|21113735|P5|Overall Study|Admitted for Signs of PD|1
6127835|NCT00027027|21113736|P4|Overall Study|Admitted for Signs of PD|0
6127836|NCT00027027|21113737|P3|Overall Study|Admitted for Signs of PD|0
6127837|NCT00027027|21113738|P2|Overall Study|Admitted for Signs of PD|0
6127838|NCT00027027|21113739|P1|Overall Study|Admitted for Signs of PD|0
6127839|NCT00027027|21113735|P5|Overall Study|Adverse Event|1
6127840|NCT00027027|21113736|P4|Overall Study|Adverse Event|0
6127841|NCT00027027|21113737|P3|Overall Study|Adverse Event|1
6127842|NCT00027027|21113738|P2|Overall Study|Adverse Event|0
6127843|NCT00027027|21113739|P1|Overall Study|Adverse Event|0
6127844|NCT00026793|21113784|P1|Overall Study|Off study|2
6127845|NCT00026793|21113784|P1|Overall Study|Physician Decision|2
6127846|NCT00026793|21113784|P1|Overall Study|Death on study due to underlying disease|4
6127847|NCT00025883|21113794|P1|Overall Study|didn't reach 6 months of Metreleptin|10
6127848|NCT00025883|21113794|P1|Overall Study|Adverse Event|1
6127849|NCT00025883|21113794|P1|Overall Study|Death|1
6127850|NCT00025883|21113794|P1|Overall Study|no baseline data|1
6127851|NCT00025883|21113794|P1|Overall Study|had atypical progeriod lipodystrophy|4
6127852|NCT00023595|21113806|P5|10 Year Follow up|Lost to Follow-up|0
6127853|NCT00023595|21113807|P4|10 Year Follow up|Lost to Follow-up|0
6127854|NCT00023595|21113808|P3|10 Year Follow up|Lost to Follow-up|3
6127855|NCT00023595|21113809|P2|10 Year Follow up|Lost to Follow-up|10
6127856|NCT00023595|21113810|P1|10 Year Follow up|Lost to Follow-up|12
6127857|NCT00023595|21113806|P5|5 Year Follow up|Lost to Follow-up|3
6127858|NCT00023595|21113807|P4|5 Year Follow up|Lost to Follow-up|7
6127859|NCT00023595|21113808|P3|5 Year Follow up|Lost to Follow-up|1
6127860|NCT00023595|21113809|P2|5 Year Follow up|Lost to Follow-up|2
6127861|NCT00023595|21113810|P1|5 Year Follow up|Lost to Follow-up|2
6127862|NCT00023452|21114021|P2|Overall Study|Other|69
6127863|NCT00023452|21114022|P1|Overall Study|Other|204
6127864|NCT00023452|21114021|P2|Overall Study|Pregnant|20
6127865|NCT00023452|21114022|P1|Overall Study|Pregnant|53
6127866|NCT00023452|21114021|P2|Overall Study|Refused Treatment (continued follow-up)|224
6127867|NCT00023452|21114022|P1|Overall Study|Refused Treatment (continued follow-up)|225
6127868|NCT00023452|21114021|P2|Overall Study|Physician Decision|21
6127869|NCT00023452|21114022|P1|Overall Study|Physician Decision|49
6127870|NCT00023452|21114021|P2|Overall Study|Lost to Follow-up|60
6127871|NCT00023452|21114022|P1|Overall Study|Lost to Follow-up|293
6127872|NCT00023452|21114021|P2|Overall Study|Adverse Event|196
6127873|NCT00023452|21114022|P1|Overall Study|Adverse Event|139
6127874|NCT00023452|21114021|P2|Overall Study|Withdrawal by Subject|54
6127875|NCT00023452|21114022|P1|Overall Study|Withdrawal by Subject|66
6127876|NCT00023452|21114021|P2|Overall Study|Death|0
6127877|NCT00023452|21114022|P1|Overall Study|Death|2
6127878|NCT00023452|21114021|P2|Overall Study|Out of Window|69
6127879|NCT00023452|21114022|P1|Overall Study|Out of Window|129
6127880|NCT00023452|21114021|P2|Overall Study|Ineligible for Study|159
6127881|NCT00023452|21114022|P1|Overall Study|Ineligible for Study|163
6127882|NCT00023322|21114046|P1|Overall Study|Lost to Follow-up|1
6127883|NCT00022763|21114070|P2|Overall Study|Admin|2
6127884|NCT00022763|21114071|P1|Overall Study|Admin|3
6127885|NCT00022763|21114070|P2|Overall Study|Insufficient Therapy|0
6127886|NCT00022763|21114071|P1|Overall Study|Insufficient Therapy|1
6127887|NCT00022763|21114070|P2|Overall Study|Withdrawal by Subject|7
6127888|NCT00022763|21114071|P1|Overall Study|Withdrawal by Subject|4
6127889|NCT00022763|21114070|P2|Overall Study|Lost to Follow-up|3
6127890|NCT00022763|21114071|P1|Overall Study|Lost to Follow-up|0
6127891|NCT00022763|21114070|P2|Overall Study|Death|1
6127892|NCT00022763|21114071|P1|Overall Study|Death|0
6127893|NCT00022763|21114070|P2|Overall Study|Injection Site Reactions|2
6127894|NCT00022763|21114071|P1|Overall Study|Injection Site Reactions|0
6127895|NCT00022763|21114070|P2|Overall Study|Adverse Event|2
6127896|NCT00022763|21114071|P1|Overall Study|Adverse Event|1
6127897|NCT00014911|21114113|P1|Overall Study|Immunosuppression-related Side Effects|1
6127898|NCT00014911|21114113|P1|Overall Study|Unknown Reasons|2
6127899|NCT00014911|21114113|P1|Overall Study|Withdrawal by Subject|6
6127900|NCT00014911|21114113|P1|Overall Study|Lost to Follow-up|1
6127901|NCT00014911|21114113|P1|Overall Study|Adverse Event|1
6127902|NCT00006604|21114129|P17|Overall Study|Other Reason|0
6127903|NCT00006604|21114130|P16|Overall Study|Other Reason|0
6127904|NCT00006604|21114131|P15|Overall Study|Other Reason|0
6127905|NCT00006604|21114132|P14|Overall Study|Other Reason|0
6127906|NCT00006604|21114133|P13|Overall Study|Other Reason|0
6127907|NCT00006604|21114134|P12|Overall Study|Other Reason|0
6127908|NCT00006604|21114135|P11|Overall Study|Other Reason|0
6127909|NCT00006604|21114136|P10|Overall Study|Other Reason|1
6127910|NCT00006604|21114137|P9|Overall Study|Other Reason|0
6127911|NCT00006604|21114138|P8|Overall Study|Other Reason|0
6127912|NCT00006604|21114139|P7|Overall Study|Other Reason|0
6127913|NCT00006604|21114140|P6|Overall Study|Other Reason|1
6127914|NCT00006604|21114141|P5|Overall Study|Other Reason|0
6127915|NCT00006604|21114142|P4|Overall Study|Other Reason|0
6127916|NCT00006604|21114143|P3|Overall Study|Other Reason|0
6127917|NCT00006604|21114144|P2|Overall Study|Other Reason|0
6127918|NCT00006604|21114145|P1|Overall Study|Other Reason|0
6127919|NCT00006604|21114129|P17|Overall Study|Lost to Follow-up|3
6127920|NCT00006604|21114130|P16|Overall Study|Lost to Follow-up|1
6127921|NCT00006604|21114131|P15|Overall Study|Lost to Follow-up|0
6127922|NCT00006604|21114132|P14|Overall Study|Lost to Follow-up|0
6127923|NCT00006604|21114133|P13|Overall Study|Lost to Follow-up|0
6127924|NCT00006604|21114134|P12|Overall Study|Lost to Follow-up|0
6127925|NCT00006604|21114135|P11|Overall Study|Lost to Follow-up|0
6127926|NCT00006604|21114136|P10|Overall Study|Lost to Follow-up|2
6127927|NCT00006604|21114137|P9|Overall Study|Lost to Follow-up|0
6127928|NCT00006604|21114138|P8|Overall Study|Lost to Follow-up|1
6127929|NCT00006604|21114139|P7|Overall Study|Lost to Follow-up|0
6127930|NCT00006604|21114140|P6|Overall Study|Lost to Follow-up|0
6127931|NCT00006604|21114141|P5|Overall Study|Lost to Follow-up|0
6127932|NCT00006604|21114142|P4|Overall Study|Lost to Follow-up|0
6127933|NCT00006604|21114143|P3|Overall Study|Lost to Follow-up|0
6127934|NCT00006604|21114144|P2|Overall Study|Lost to Follow-up|0
6127935|NCT00006604|21114145|P1|Overall Study|Lost to Follow-up|0
6127936|NCT00006604|21114129|P17|Overall Study|Subj/parent not willing to adhere to req|4
6127937|NCT00006604|21114130|P16|Overall Study|Subj/parent not willing to adhere to req|3
6127938|NCT00006604|21114131|P15|Overall Study|Subj/parent not willing to adhere to req|3
6127939|NCT00006604|21114132|P14|Overall Study|Subj/parent not willing to adhere to req|2
6127940|NCT00006604|21114133|P13|Overall Study|Subj/parent not willing to adhere to req|0
6127941|NCT00006604|21114134|P12|Overall Study|Subj/parent not willing to adhere to req|0
6127942|NCT00006604|21114135|P11|Overall Study|Subj/parent not willing to adhere to req|3
6127943|NCT00006604|21114136|P10|Overall Study|Subj/parent not willing to adhere to req|6
6127944|NCT00006604|21114137|P9|Overall Study|Subj/parent not willing to adhere to req|0
6127945|NCT00006604|21114138|P8|Overall Study|Subj/parent not willing to adhere to req|1
6127946|NCT00006604|21114139|P7|Overall Study|Subj/parent not willing to adhere to req|3
6127947|NCT00006604|21114140|P6|Overall Study|Subj/parent not willing to adhere to req|0
6127948|NCT00006604|21114141|P5|Overall Study|Subj/parent not willing to adhere to req|0
6127949|NCT00006604|21114142|P4|Overall Study|Subj/parent not willing to adhere to req|3
6127950|NCT00006604|21114143|P3|Overall Study|Subj/parent not willing to adhere to req|1
6127951|NCT00006604|21114144|P2|Overall Study|Subj/parent not willing to adhere to req|0
6127952|NCT00006604|21114145|P1|Overall Study|Subj/parent not willing to adhere to req|0
6127953|NCT00006604|21114129|P17|Overall Study|Withdrawal by Subject|1
6127954|NCT00006604|21114130|P16|Overall Study|Withdrawal by Subject|0
6127955|NCT00006604|21114131|P15|Overall Study|Withdrawal by Subject|1
6127956|NCT00006604|21114132|P14|Overall Study|Withdrawal by Subject|2
6127957|NCT00006604|21114133|P13|Overall Study|Withdrawal by Subject|1
6127958|NCT00006604|21114134|P12|Overall Study|Withdrawal by Subject|0
6127959|NCT00006604|21114135|P11|Overall Study|Withdrawal by Subject|2
6127960|NCT00006604|21114136|P10|Overall Study|Withdrawal by Subject|3
6127961|NCT00006604|21114137|P9|Overall Study|Withdrawal by Subject|1
6127962|NCT00006604|21114138|P8|Overall Study|Withdrawal by Subject|0
6127963|NCT00006604|21114139|P7|Overall Study|Withdrawal by Subject|2
6127964|NCT00006604|21114140|P6|Overall Study|Withdrawal by Subject|2
6127965|NCT00006604|21114141|P5|Overall Study|Withdrawal by Subject|1
6127966|NCT00006604|21114142|P4|Overall Study|Withdrawal by Subject|0
6127967|NCT00006604|21114143|P3|Overall Study|Withdrawal by Subject|2
6127968|NCT00006604|21114144|P2|Overall Study|Withdrawal by Subject|0
6127969|NCT00006604|21114145|P1|Overall Study|Withdrawal by Subject|1
6127970|NCT00006604|21114129|P17|Overall Study|Site closing|1
6127971|NCT00006604|21114130|P16|Overall Study|Site closing|0
6127972|NCT00006604|21114131|P15|Overall Study|Site closing|0
6127973|NCT00006604|21114132|P14|Overall Study|Site closing|1
6127974|NCT00006604|21114133|P13|Overall Study|Site closing|1
6127975|NCT00006604|21114134|P12|Overall Study|Site closing|1
6127976|NCT00006604|21114135|P11|Overall Study|Site closing|0
6127977|NCT00006604|21114136|P10|Overall Study|Site closing|0
6127978|NCT00006604|21114137|P9|Overall Study|Site closing|0
6127979|NCT00006604|21114138|P8|Overall Study|Site closing|1
6127980|NCT00006604|21114139|P7|Overall Study|Site closing|0
6127981|NCT00006604|21114140|P6|Overall Study|Site closing|0
6127982|NCT00006604|21114141|P5|Overall Study|Site closing|0
6127983|NCT00006604|21114142|P4|Overall Study|Site closing|1
6127984|NCT00006604|21114143|P3|Overall Study|Site closing|1
6127985|NCT00006604|21114144|P2|Overall Study|Site closing|0
6127986|NCT00006604|21114145|P1|Overall Study|Site closing|0
6127987|NCT00006604|21114129|P17|Overall Study|Subj/Parent not able to get to clinic|0
6127988|NCT00006604|21114130|P16|Overall Study|Subj/Parent not able to get to clinic|0
6127989|NCT00006604|21114131|P15|Overall Study|Subj/Parent not able to get to clinic|3
6127990|NCT00006604|21114132|P14|Overall Study|Subj/Parent not able to get to clinic|1
6127991|NCT00006604|21114133|P13|Overall Study|Subj/Parent not able to get to clinic|1
6127992|NCT00006604|21114134|P12|Overall Study|Subj/Parent not able to get to clinic|1
6127993|NCT00006604|21114135|P11|Overall Study|Subj/Parent not able to get to clinic|2
6127994|NCT00006604|21114136|P10|Overall Study|Subj/Parent not able to get to clinic|1
6127995|NCT00006604|21114137|P9|Overall Study|Subj/Parent not able to get to clinic|0
6127996|NCT00006604|21114138|P8|Overall Study|Subj/Parent not able to get to clinic|0
6127997|NCT00006604|21114139|P7|Overall Study|Subj/Parent not able to get to clinic|1
6127998|NCT00006604|21114140|P6|Overall Study|Subj/Parent not able to get to clinic|0
6127999|NCT00006604|21114141|P5|Overall Study|Subj/Parent not able to get to clinic|1
6128000|NCT00006604|21114142|P4|Overall Study|Subj/Parent not able to get to clinic|1
6128001|NCT00006604|21114143|P3|Overall Study|Subj/Parent not able to get to clinic|0
6128002|NCT00006604|21114144|P2|Overall Study|Subj/Parent not able to get to clinic|0
6128003|NCT00006604|21114145|P1|Overall Study|Subj/Parent not able to get to clinic|0
6128004|NCT00006604|21114129|P17|Overall Study|Severe debilitation, unable to continue|0
6128005|NCT00006604|21114130|P16|Overall Study|Severe debilitation, unable to continue|0
6128006|NCT00006604|21114131|P15|Overall Study|Severe debilitation, unable to continue|2
6128007|NCT00006604|21114132|P14|Overall Study|Severe debilitation, unable to continue|0
6128008|NCT00006604|21114133|P13|Overall Study|Severe debilitation, unable to continue|1
6128009|NCT00006604|21114134|P12|Overall Study|Severe debilitation, unable to continue|2
6128010|NCT00006604|21114135|P11|Overall Study|Severe debilitation, unable to continue|0
6128011|NCT00006604|21114136|P10|Overall Study|Severe debilitation, unable to continue|5
6128012|NCT00006604|21114137|P9|Overall Study|Severe debilitation, unable to continue|0
6128013|NCT00006604|21114138|P8|Overall Study|Severe debilitation, unable to continue|0
6128014|NCT00006604|21114139|P7|Overall Study|Severe debilitation, unable to continue|3
6128015|NCT00006604|21114140|P6|Overall Study|Severe debilitation, unable to continue|0
6128016|NCT00006604|21114141|P5|Overall Study|Severe debilitation, unable to continue|0
6128017|NCT00006604|21114142|P4|Overall Study|Severe debilitation, unable to continue|0
6128018|NCT00006604|21114143|P3|Overall Study|Severe debilitation, unable to continue|0
6128019|NCT00006604|21114144|P2|Overall Study|Severe debilitation, unable to continue|0
6128020|NCT00006604|21114145|P1|Overall Study|Severe debilitation, unable to continue|0
6128021|NCT00006604|21114129|P17|Overall Study|Death|0
6128022|NCT00006604|21114130|P16|Overall Study|Death|0
6128023|NCT00006604|21114131|P15|Overall Study|Death|0
6128024|NCT00006604|21114132|P14|Overall Study|Death|0
6128025|NCT00006604|21114133|P13|Overall Study|Death|0
6128026|NCT00006604|21114134|P12|Overall Study|Death|1
6128027|NCT00006604|21114135|P11|Overall Study|Death|1
6128028|NCT00006604|21114136|P10|Overall Study|Death|1
6128029|NCT00006604|21114137|P9|Overall Study|Death|0
6128030|NCT00006604|21114138|P8|Overall Study|Death|0
6128031|NCT00006604|21114139|P7|Overall Study|Death|0
6128032|NCT00006604|21114140|P6|Overall Study|Death|0
6128033|NCT00006604|21114141|P5|Overall Study|Death|0
6128034|NCT00006604|21114142|P4|Overall Study|Death|0
6128035|NCT00006604|21114143|P3|Overall Study|Death|0
6128036|NCT00006604|21114144|P2|Overall Study|Death|0
6128037|NCT00006604|21114145|P1|Overall Study|Death|0
6128038|NCT00006604|21114129|P17|Overall Study|Randomization entry error-no RX, no FU|0
6128039|NCT00006604|21114130|P16|Overall Study|Randomization entry error-no RX, no FU|0
6128040|NCT00006604|21114131|P15|Overall Study|Randomization entry error-no RX, no FU|0
6128041|NCT00006604|21114132|P14|Overall Study|Randomization entry error-no RX, no FU|0
6128042|NCT00006604|21114133|P13|Overall Study|Randomization entry error-no RX, no FU|0
6128043|NCT00006604|21114134|P12|Overall Study|Randomization entry error-no RX, no FU|1
6128044|NCT00006604|21114135|P11|Overall Study|Randomization entry error-no RX, no FU|0
6128045|NCT00006604|21114136|P10|Overall Study|Randomization entry error-no RX, no FU|0
6128046|NCT00006604|21114137|P9|Overall Study|Randomization entry error-no RX, no FU|0
6128047|NCT00006604|21114138|P8|Overall Study|Randomization entry error-no RX, no FU|0
6128048|NCT00006604|21114139|P7|Overall Study|Randomization entry error-no RX, no FU|0
6128049|NCT00006604|21114140|P6|Overall Study|Randomization entry error-no RX, no FU|0
6128050|NCT00006604|21114141|P5|Overall Study|Randomization entry error-no RX, no FU|0
6128051|NCT00006604|21114142|P4|Overall Study|Randomization entry error-no RX, no FU|0
6128052|NCT00006604|21114143|P3|Overall Study|Randomization entry error-no RX, no FU|0
6128053|NCT00006604|21114144|P2|Overall Study|Randomization entry error-no RX, no FU|0
6128054|NCT00006604|21114145|P1|Overall Study|Randomization entry error-no RX, no FU|0
6128055|NCT00006604|21114129|P17|Overall Study|Met study objective - no further FU|0
6128056|NCT00006604|21114130|P16|Overall Study|Met study objective - no further FU|1
6128057|NCT00006604|21114131|P15|Overall Study|Met study objective - no further FU|1
6128058|NCT00006604|21114132|P14|Overall Study|Met study objective - no further FU|0
6128059|NCT00006604|21114133|P13|Overall Study|Met study objective - no further FU|0
6128060|NCT00006604|21114134|P12|Overall Study|Met study objective - no further FU|0
6128061|NCT00006604|21114135|P11|Overall Study|Met study objective - no further FU|0
6128062|NCT00006604|21114136|P10|Overall Study|Met study objective - no further FU|0
6128063|NCT00006604|21114137|P9|Overall Study|Met study objective - no further FU|0
6128064|NCT00006604|21114138|P8|Overall Study|Met study objective - no further FU|0
6128065|NCT00006604|21114139|P7|Overall Study|Met study objective - no further FU|0
6128066|NCT00006604|21114140|P6|Overall Study|Met study objective - no further FU|0
6128067|NCT00006604|21114141|P5|Overall Study|Met study objective - no further FU|0
6128068|NCT00006604|21114142|P4|Overall Study|Met study objective - no further FU|0
6128069|NCT00006604|21114143|P3|Overall Study|Met study objective - no further FU|0
6128070|NCT00006604|21114144|P2|Overall Study|Met study objective - no further FU|0
6128071|NCT00006604|21114145|P1|Overall Study|Met study objective - no further FU|1
6128072|NCT00004978|21114261|P2|Overall Study|site closure - not in analysis cohort|20
6128073|NCT00004978|21114262|P1|Overall Study|site closure - not in analysis cohort|19
6128074|NCT00004978|21114261|P2|Overall Study|Withdrawal by Subject|26
6128075|NCT00004978|21114262|P1|Overall Study|Withdrawal by Subject|17
6128076|NCT00004978|21114261|P2|Overall Study|Lost to Follow-up|108
6128077|NCT00004978|21114262|P1|Overall Study|Lost to Follow-up|101
6128078|NCT00004978|21114261|P2|Overall Study|Death|116
6128079|NCT00004978|21114262|P1|Overall Study|Death|107
6128080|NCT00021541|21114288|P2|Period 2-crossover|Pts that did not progress|3
6128081|NCT00021541|21114289|P1|Period 2-crossover|Pts that did not progress|2
6128082|NCT00021541|21114288|P2|Period 2-crossover|non-adherence|0
6128083|NCT00021541|21114289|P1|Period 2-crossover|non-adherence|1
6128084|NCT00021541|21114288|P2|Period 2-crossover|Adverse Event|2
6128085|NCT00021541|21114289|P1|Period 2-crossover|Adverse Event|2
6128086|NCT00021541|21114288|P2|Period 2-crossover|Withdrawal by Subject|4
6128087|NCT00021541|21114289|P1|Period 2-crossover|Withdrawal by Subject|3
6128088|NCT00021541|21114288|P2|Period 2-crossover|refused phase B|2
6128089|NCT00021541|21114289|P1|Period 2-crossover|refused phase B|2
6128090|NCT00021541|21114288|P2|Period 1-First Treatment|Ineligible|2
6128091|NCT00021541|21114289|P1|Period 1-First Treatment|Ineligible|0
6128092|NCT00021541|21114288|P2|Period 1-First Treatment|Pts that did not progress|2
6128093|NCT00021541|21114289|P1|Period 1-First Treatment|Pts that did not progress|2
6128094|NCT00021541|21114288|P2|Period 1-First Treatment|Death|0
6128095|NCT00021541|21114289|P1|Period 1-First Treatment|Death|1
6128096|NCT00021541|21114288|P2|Period 1-First Treatment|non-adherence|0
6128097|NCT00021541|21114289|P1|Period 1-First Treatment|non-adherence|3
6128098|NCT00021541|21114288|P2|Period 1-First Treatment|Adverse Event|1
6128099|NCT00021541|21114289|P1|Period 1-First Treatment|Adverse Event|2
6128100|NCT00021541|21114288|P2|Period 1-First Treatment|Withdrawal by Subject|3
6128101|NCT00021541|21114289|P1|Period 1-First Treatment|Withdrawal by Subject|3
6128102|NCT00015457|21114303|P2|Second Intervention|Withdrawal by Subject|0
6128103|NCT00015457|21114304|P1|Second Intervention|Withdrawal by Subject|1
6128104|NCT00015457|21114303|P2|First Intervention|Lack of Efficacy|1
6128105|NCT00015457|21114304|P1|First Intervention|Lack of Efficacy|0
6128106|NCT00015457|21114303|P2|First Intervention|Adverse Event|2
6128107|NCT00015457|21114304|P1|First Intervention|Adverse Event|0
6128108|NCT00013611|21114314|P2|Overall Study|Lost to Follow-up|100
6128109|NCT00013611|21114315|P1|Overall Study|Lost to Follow-up|91
6128110|NCT00010803|21114333|P2|Overall Study|Withdrawal by Subject|98
6128111|NCT00010803|21114334|P1|Overall Study|Withdrawal by Subject|97
6128112|NCT00010374|21114349|P1|Overall Study|False positive phrenic nerve test|1
6128113|NCT00007475|21114367|P4|Overall Study|Adverse Event|0
6128114|NCT00007475|21114368|P3|Overall Study|Adverse Event|0
6128115|NCT00007475|21114369|P2|Overall Study|Adverse Event|0
6128116|NCT00007475|21114370|P1|Overall Study|Adverse Event|3
6128117|NCT00007475|21114367|P4|Overall Study|Withdrawal by Subject|0
6128118|NCT00007475|21114368|P3|Overall Study|Withdrawal by Subject|0
6128119|NCT00007475|21114369|P2|Overall Study|Withdrawal by Subject|0
6128120|NCT00007475|21114370|P1|Overall Study|Withdrawal by Subject|1
6128121|NCT00007345|21114392|P2|Overall Study|Death on study|1
6128122|NCT00007345|21114393|P1|Overall Study|Death on study|1
6128123|NCT00007345|21114392|P2|Overall Study|Intercurrent illness|0
6128124|NCT00007345|21114393|P1|Overall Study|Intercurrent illness|1
6128125|NCT00007345|21114392|P2|Overall Study|Switched to alternative treatment|3
6128126|NCT00007345|21114393|P1|Overall Study|Switched to alternative treatment|0
6128127|NCT00007345|21114392|P2|Overall Study|Refused further treatment|7
6128128|NCT00007345|21114393|P1|Overall Study|Refused further treatment|0
6128129|NCT00007020|21114411|P1|Overall Study|No evidence of treatment|6
6128130|NCT00007020|21114411|P1|Overall Study|Pt cared for by outside physician|4
6128131|NCT00007020|21114411|P1|Overall Study|Pt withdrawn (liver transplant)|4
6128132|NCT00007020|21114411|P1|Overall Study|Pt withdrawn (worsening cholestasis)|1
6128133|NCT00007020|21114411|P1|Overall Study|Lost to Follow-up|13
6128134|NCT00007020|21114411|P1|Overall Study|Death|16
6128135|NCT00006489|21114424|P4|Overall Study|Death|1
6128136|NCT00006489|21114425|P3|Overall Study|Death|0
6128137|NCT00006489|21114426|P2|Overall Study|Death|0
6128138|NCT00006489|21114427|P1|Overall Study|Death|0
6128139|NCT00006489|21114424|P4|Overall Study|Scheduling Conflict|1
6128140|NCT00006489|21114425|P3|Overall Study|Scheduling Conflict|2
6128141|NCT00006489|21114426|P2|Overall Study|Scheduling Conflict|3
6128142|NCT00006489|21114427|P1|Overall Study|Scheduling Conflict|0
6128143|NCT00006489|21114424|P4|Overall Study|Withdrawal by Subject|6
6128144|NCT00006489|21114425|P3|Overall Study|Withdrawal by Subject|9
6128145|NCT00006489|21114426|P2|Overall Study|Withdrawal by Subject|9
6128146|NCT00006489|21114427|P1|Overall Study|Withdrawal by Subject|10
6128147|NCT00006489|21114424|P4|Overall Study|Adverse Event|3
6128148|NCT00006489|21114425|P3|Overall Study|Adverse Event|4
6128149|NCT00006489|21114426|P2|Overall Study|Adverse Event|2
6128150|NCT00006489|21114427|P1|Overall Study|Adverse Event|3
6128151|NCT00006409|21114462|P6|Post-3 Year Intervention|Protocol Violation|62
6128152|NCT00006409|21114463|P5|Post-3 Year Intervention|Protocol Violation|62
6128153|NCT00006409|21114464|P4|Post-3 Year Intervention|Protocol Violation|0
6128154|NCT00006409|21114465|P3|Post-3 Year Intervention|Protocol Violation|0
6128155|NCT00006409|21114466|P2|Post-3 Year Intervention|Protocol Violation|0
6128156|NCT00006409|21114467|P1|Post-3 Year Intervention|Protocol Violation|0
6128157|NCT00006409|21114462|P6|Post-2 Year Intervention|Protocol Violation|0
6128158|NCT00006409|21114463|P5|Post-2 Year Intervention|Protocol Violation|0
6128159|NCT00006409|21114464|P4|Post-2 Year Intervention|Protocol Violation|168
6128160|NCT00006409|21114465|P3|Post-2 Year Intervention|Protocol Violation|251
6128161|NCT00006409|21114466|P2|Post-2 Year Intervention|Protocol Violation|0
6128162|NCT00006409|21114467|P1|Post-2 Year Intervention|Protocol Violation|0
6128163|NCT00006409|21114462|P6|Baseline|Protocol Violation|0
6128164|NCT00006409|21114463|P5|Baseline|Protocol Violation|0
6128165|NCT00006409|21114464|P4|Baseline|Protocol Violation|0
6128166|NCT00006409|21114465|P3|Baseline|Protocol Violation|0
6128167|NCT00006409|21114466|P2|Baseline|Protocol Violation|70
6128168|NCT00006409|21114467|P1|Baseline|Protocol Violation|48
6128169|NCT00006305|21114506|P4|Overall Study|Withdrawal by Subject|14
6128170|NCT00006305|21114507|P3|Overall Study|Withdrawal by Subject|15
6128171|NCT00006305|21114508|P2|Overall Study|Withdrawal by Subject|10
6128172|NCT00006305|21114509|P1|Overall Study|Withdrawal by Subject|17
6128173|NCT00006289|21114525|P2|Second Intervention (5 Weeks)|Protocol Violation|1
6128174|NCT00006289|21114526|P1|Second Intervention (5 Weeks)|Protocol Violation|1
6128175|NCT00006289|21114525|P2|First Intervention (5 Weeks)|Adverse Event|0
6128176|NCT00006289|21114526|P1|First Intervention (5 Weeks)|Adverse Event|1
6128177|NCT00006184|21114544|P2|Overall Study|Death|0
6128178|NCT00006184|21114545|P1|Overall Study|Death|1
6128179|NCT00006164|21114596|P2|Overall Study|Withdrew or lost to follow-up|81
6128180|NCT00006164|21114597|P1|Overall Study|Withdrew or lost to follow-up|70
6128181|NCT00005937|21114640|P1|Overall Study|Lack of Efficacy|5
6128182|NCT00005908|21114644|P2|Overall Study|Withdrawal by Subject|0
6128183|NCT00005908|21114645|P1|Overall Study|Withdrawal by Subject|1
6128184|NCT00005906|21114654|P1|Overall Study|Lack of Efficacy|3
6128185|NCT00004980|21114698|P2|Overall Study|Physician Decision|1
6128186|NCT00004980|21114699|P1|Overall Study|Physician Decision|0
6128187|NCT00004980|21114698|P2|Overall Study|memory difficulties|1
6128188|NCT00004980|21114699|P1|Overall Study|memory difficulties|1
6128189|NCT00004980|21114698|P2|Overall Study|Withdrawal by Subject|0
6128190|NCT00004980|21114699|P1|Overall Study|Withdrawal by Subject|1
6128191|NCT00004732|21114713|P2|Overall Study|Lost to Follow-up|47
6128192|NCT00004732|21114714|P1|Overall Study|Lost to Follow-up|33
6128193|NCT00004732|21114713|P2|Overall Study|Withdrawal by Subject|64
6128194|NCT00004732|21114714|P1|Overall Study|Withdrawal by Subject|36
6128195|NCT00004635|21114724|P2|Period Two|discrepancy in data entry|1
6128196|NCT00004635|21114725|P1|Period Two|discrepancy in data entry|0
6128197|NCT00004635|21114724|P2|Period Two|Lost to Follow-up|0
6128198|NCT00004635|21114725|P1|Period Two|Lost to Follow-up|1
6128199|NCT00004635|21114724|P2|Period Two|secondary malignancy|1
6128200|NCT00004635|21114725|P1|Period Two|secondary malignancy|1
6128201|NCT00004635|21114724|P2|Period Two|travel issues|1
6128202|NCT00004635|21114725|P1|Period Two|travel issues|0
6128203|NCT00004635|21114724|P2|Period Two|health problem|1
6128204|NCT00004635|21114725|P1|Period Two|health problem|1
6128205|NCT00004635|21114724|P2|Period Two|refused|2
6128206|NCT00004635|21114725|P1|Period Two|refused|0
6128207|NCT00004635|21114724|P2|Period Two|Adverse Event|0
6128208|NCT00004635|21114725|P1|Period Two|Adverse Event|1
6128209|NCT00004635|21114724|P2|Period Two|progression|3
6128210|NCT00004635|21114725|P1|Period Two|progression|2
6128211|NCT00004635|21114724|P2|Period One|discrepancy in data entry|1
6128212|NCT00004635|21114725|P1|Period One|discrepancy in data entry|0
6128213|NCT00004635|21114724|P2|Period One|health problem|1
6128214|NCT00004635|21114725|P1|Period One|health problem|0
6128215|NCT00004635|21114724|P2|Period One|progressed|2
6128216|NCT00004635|21114725|P1|Period One|progressed|0
6128217|NCT00004635|21114724|P2|Period One|second malignancy|0
6128218|NCT00004635|21114725|P1|Period One|second malignancy|1
6128219|NCT00004635|21114724|P2|Period One|PSA did not go <5 ng/mL|0
6128220|NCT00004635|21114725|P1|Period One|PSA did not go <5 ng/mL|1
6128221|NCT00004635|21114724|P2|Period One|Protocol Violation|0
6128222|NCT00004635|21114725|P1|Period One|Protocol Violation|1
6128223|NCT00004635|21114724|P2|Period One|Withdrawal by Subject|1
6128224|NCT00004635|21114725|P1|Period One|Withdrawal by Subject|1
6128225|NCT00004635|21114724|P2|Period One|refused|1
6128226|NCT00004635|21114725|P1|Period One|refused|2
6128227|NCT00004563|21114737|P2|Overall Study|Death|3
6128228|NCT00004563|21114738|P1|Overall Study|Death|2
6128229|NCT00004563|21114737|P2|Overall Study|Lack of Efficacy|5
6128230|NCT00004563|21114738|P1|Overall Study|Lack of Efficacy|3
6128231|NCT00004563|21114737|P2|Overall Study|Withdrawal by Subject|16
6128232|NCT00004563|21114738|P1|Overall Study|Withdrawal by Subject|20
6128233|NCT00004562|21114750|P2|Overall Study|Lost to Follow-up|91
6128234|NCT00004562|21114751|P1|Overall Study|Lost to Follow-up|102
6128235|NCT00001962|21114792|P1|Overall Study|Adverse Event|1
6128236|NCT00001962|21114792|P1|Overall Study|Lost to Follow-up|2
6128237|NCT00001962|21114792|P1|Overall Study|Death|1
6128238|NCT00001962|21114792|P1|Overall Study|Lack of Accrual|6
6128239|NCT00001962|21114792|P1|Overall Study|Lack of Efficacy|18
6128240|NCT00001959|21114796|P1|Overall Study|non-compliance|1
6128241|NCT00001959|21114796|P1|Overall Study|disabling sedation|1
6128242|NCT00001959|21114796|P1|Overall Study|newly diagnosed colon cancer|1
6128243|NCT00001941|21114802|P5|Overall Study|not treated- rapidly progressing disease|1
6128244|NCT00001941|21114803|P4|Overall Study|not treated- rapidly progressing disease|0
6128245|NCT00001941|21114804|P3|Overall Study|not treated- rapidly progressing disease|0
6128246|NCT00001941|21114805|P2|Overall Study|not treated- rapidly progressing disease|0
6128247|NCT00001941|21114806|P1|Overall Study|not treated- rapidly progressing disease|0
6128248|NCT00001849|21114824|P1|Overall Study|tumor remained occult|6
6128249|NCT00001849|21114824|P1|Overall Study|Withdrawal by Subject|2
6128250|NCT00001849|21114824|P1|Overall Study|Lost to Follow-up|2
6128251|NCT00001849|21114824|P1|Overall Study|Death|4
6128252|NCT00001832|21114853|P15|Treatment Period|Not treated|0
6128253|NCT00001832|21114854|P14|Treatment Period|Not treated|0
6128254|NCT00001832|21114855|P13|Treatment Period|Not treated|0
6128255|NCT00001832|21114856|P12|Treatment Period|Not treated|0
6128256|NCT00001832|21114857|P11|Treatment Period|Not treated|0
6128257|NCT00001832|21114858|P10|Treatment Period|Not treated|0
6128258|NCT00001832|21114859|P9|Treatment Period|Not treated|0
6128259|NCT00001832|21114860|P8|Treatment Period|Not treated|1
6128260|NCT00001832|21114861|P7|Treatment Period|Not treated|0
6128261|NCT00001832|21114862|P6|Treatment Period|Not treated|0
6128262|NCT00001832|21114863|P5|Treatment Period|Not treated|0
6128263|NCT00001832|21114864|P4|Treatment Period|Not treated|0
6128264|NCT00001832|21114865|P3|Treatment Period|Not treated|0
6128265|NCT00001832|21114866|P2|Treatment Period|Not treated|0
6128266|NCT00001832|21114867|P1|Treatment Period|Not treated|0
6128267|NCT00001832|21114853|P15|Treatment Period|Death during treatment|0
6128268|NCT00001832|21114854|P14|Treatment Period|Death during treatment|0
6128269|NCT00001832|21114855|P13|Treatment Period|Death during treatment|0
6128270|NCT00001832|21114856|P12|Treatment Period|Death during treatment|0
6128271|NCT00001832|21114857|P11|Treatment Period|Death during treatment|0
6128272|NCT00001832|21114858|P10|Treatment Period|Death during treatment|0
6128273|NCT00001832|21114859|P9|Treatment Period|Death during treatment|0
6128274|NCT00001832|21114860|P8|Treatment Period|Death during treatment|0
6128275|NCT00001832|21114861|P7|Treatment Period|Death during treatment|0
6128276|NCT00001832|21114862|P6|Treatment Period|Death during treatment|1
6128277|NCT00001832|21114863|P5|Treatment Period|Death during treatment|0
6128278|NCT00001832|21114864|P4|Treatment Period|Death during treatment|0
6128279|NCT00001832|21114865|P3|Treatment Period|Death during treatment|0
6128280|NCT00001832|21114866|P2|Treatment Period|Death during treatment|0
6128281|NCT00001832|21114867|P1|Treatment Period|Death during treatment|0
6128282|NCT00001832|21114853|P15|Apheresis Period|not able to manufacture treatment cells|0
6128283|NCT00001832|21114854|P14|Apheresis Period|not able to manufacture treatment cells|0
6128284|NCT00001832|21114855|P13|Apheresis Period|not able to manufacture treatment cells|0
6128285|NCT00001832|21114856|P12|Apheresis Period|not able to manufacture treatment cells|0
6128286|NCT00001832|21114857|P11|Apheresis Period|not able to manufacture treatment cells|0
6128287|NCT00001832|21114858|P10|Apheresis Period|not able to manufacture treatment cells|0
6128288|NCT00001832|21114859|P9|Apheresis Period|not able to manufacture treatment cells|0
6128289|NCT00001832|21114860|P8|Apheresis Period|not able to manufacture treatment cells|0
6128290|NCT00001832|21114861|P7|Apheresis Period|not able to manufacture treatment cells|0
6128291|NCT00001832|21114862|P6|Apheresis Period|not able to manufacture treatment cells|0
6128292|NCT00001832|21114863|P5|Apheresis Period|not able to manufacture treatment cells|0
6128293|NCT00001832|21114864|P4|Apheresis Period|not able to manufacture treatment cells|0
6128294|NCT00001832|21114865|P3|Apheresis Period|not able to manufacture treatment cells|0
6128295|NCT00001832|21114866|P2|Apheresis Period|not able to manufacture treatment cells|0
6128296|NCT00001832|21114867|P1|Apheresis Period|not able to manufacture treatment cells|60
6128297|NCT00001723|21114913|P2|Overall Study|medication intolerance|2
6128298|NCT00001723|21114914|P1|Overall Study|medication intolerance|1
6128299|NCT00001723|21114913|P2|Overall Study|Lost to Follow-up|2
6128300|NCT00001723|21114914|P1|Overall Study|Lost to Follow-up|2
6128301|NCT00001723|21114913|P2|Overall Study|Lack of family interest|5
6128302|NCT00001723|21114914|P1|Overall Study|Lack of family interest|4
6128303|NCT00001723|21114913|P2|Overall Study|Lack of Efficacy|7
6128304|NCT00001723|21114914|P1|Overall Study|Lack of Efficacy|6
6128305|NCT00001703|21114930|P1|Overall Study|recurrent disease|2
6128306|NCT00001703|21114930|P1|Overall Study|No evidence of disease|1
6128307|NCT00001703|21114930|P1|Overall Study|progressed disease|2
6128308|NCT00001596|21114968|P2|Overall Study|Adverse Event|0
6128309|NCT00001596|21114969|P1|Overall Study|Adverse Event|1
6128310|NCT00001596|21114968|P2|Overall Study|Study Termination|9
6128311|NCT00001596|21114969|P1|Overall Study|Study Termination|12
6128312|NCT00001596|21114968|P2|Overall Study|Withdrawal by Subject|1
6128313|NCT00001596|21114969|P1|Overall Study|Withdrawal by Subject|3
6128314|NCT00001596|21114968|P2|Overall Study|Death|0
6128315|NCT00001596|21114969|P1|Overall Study|Death|1
6128316|NCT00001575|21115000|P1|Overall Study|Withdrawn/deaths|23
6128317|NCT00001575|21115000|P1|Overall Study|Screening failures-Ph I portion|22
6128318|NCT00001566|21115006|P1|Overall Study|unable to complete initial apheresis|1
6128319|NCT00001566|21115006|P1|Overall Study|Lost to Follow-up|1
6128320|NCT00001566|21115006|P1|Overall Study|Death|13
6128321|NCT00001566|21115006|P1|Overall Study|stopped after C3 due to symptomatic PD|1
6128322|NCT00001566|21115006|P1|Overall Study|patients' choice to discontinue protocol|3
6128323|NCT00001262|21115046|P3|Overall Study|Withdrawal by Subject|0
6128324|NCT00001262|21115047|P2|Overall Study|Withdrawal by Subject|3
6128325|NCT00001262|21115048|P1|Overall Study|Withdrawal by Subject|0
6128326|NCT00001262|21115046|P3|Overall Study|Death|0
6128327|NCT00001262|21115047|P2|Overall Study|Death|11
6128328|NCT00001262|21115048|P1|Overall Study|Death|10
6128329|NCT00001213|21115074|P1|Overall Study|Death|18
6128330|NCT00000378|21115085|P2|Overall Study|Lack of Efficacy|14
6128331|NCT00000378|21115086|P1|Overall Study|Lack of Efficacy|16
6128332|NCT00000620|21115103|P8|Overall Study|missed closeout visit|16
6128333|NCT00000620|21115104|P7|Overall Study|missed closeout visit|13
6128334|NCT00000620|21115105|P6|Overall Study|missed closeout visit|28
6128335|NCT00000620|21115106|P5|Overall Study|missed closeout visit|26
6128336|NCT00000620|21115107|P4|Overall Study|missed closeout visit|11
6128337|NCT00000620|21115108|P3|Overall Study|missed closeout visit|16
6128338|NCT00000620|21115109|P2|Overall Study|missed closeout visit|28
6128339|NCT00000620|21115110|P1|Overall Study|missed closeout visit|22
6128340|NCT00000620|21115103|P8|Overall Study|Withdrawal by Subject|21
6128341|NCT00000620|21115104|P7|Overall Study|Withdrawal by Subject|32
6128342|NCT00000620|21115105|P6|Overall Study|Withdrawal by Subject|32
6128343|NCT00000620|21115106|P5|Overall Study|Withdrawal by Subject|30
6128344|NCT00000620|21115107|P4|Overall Study|Withdrawal by Subject|27
6128345|NCT00000620|21115108|P3|Overall Study|Withdrawal by Subject|28
6128346|NCT00000620|21115109|P2|Overall Study|Withdrawal by Subject|27
6128347|NCT00000620|21115110|P1|Overall Study|Withdrawal by Subject|40
6128348|NCT00000620|21115103|P8|Overall Study|Lost to Follow-up|14
6128349|NCT00000620|21115104|P7|Overall Study|Lost to Follow-up|13
6128350|NCT00000620|21115105|P6|Overall Study|Lost to Follow-up|15
6128351|NCT00000620|21115106|P5|Overall Study|Lost to Follow-up|15
6128352|NCT00000620|21115107|P4|Overall Study|Lost to Follow-up|14
6128353|NCT00000620|21115108|P3|Overall Study|Lost to Follow-up|14
6128354|NCT00000620|21115109|P2|Overall Study|Lost to Follow-up|14
6128355|NCT00000620|21115110|P1|Overall Study|Lost to Follow-up|14
6128356|NCT00000620|21115103|P8|Overall Study|Death|95
6128357|NCT00000620|21115104|P7|Overall Study|Death|91
6128358|NCT00000620|21115105|P6|Overall Study|Death|77
6128359|NCT00000620|21115106|P5|Overall Study|Death|64
6128360|NCT00000620|21115107|P4|Overall Study|Death|126
6128361|NCT00000620|21115108|P3|Overall Study|Death|112
6128362|NCT00000620|21115109|P2|Overall Study|Death|67
6128363|NCT00000620|21115110|P1|Overall Study|Death|86
6128364|NCT00004445|21115191|P1|Overall Study|Withdrawal by Subject|1
6128365|NCT00004445|21115191|P1|Overall Study|Physician Decision|2
6128366|NCT00004412|21115204|P3|Randomized Period|Moved to Crossover Period|0
6128367|NCT00004412|21115205|P2|Randomized Period|Moved to Crossover Period|0
6128368|NCT00004412|21115206|P1|Randomized Period|Moved to Crossover Period|3
6128369|NCT00000135|21115247|P2|Overall Study|Death|14
6128370|NCT00000135|21115248|P1|Overall Study|Death|27
6128402|NCT04160988|21115324|P1|Overall Study|poor image quality|28
6128453|NCT03250182|21115914|P1|Overall Study|Withdrawal by Subject|1
6128479|NCT03142451|21115986|P2|Overall Study|Other|1
6128480|NCT03142451|21115987|P1|Overall Study|Other|1
6128481|NCT03142451|21115986|P2|Overall Study|Protocol Violation|1
6128482|NCT03142451|21115987|P1|Overall Study|Protocol Violation|3
6128483|NCT03142451|21115986|P2|Overall Study|Participant request|12
6128484|NCT03142451|21115987|P1|Overall Study|Participant request|24
6128485|NCT03142451|21115986|P2|Overall Study|Lost to Follow-up|8
6128486|NCT03142451|21115987|P1|Overall Study|Lost to Follow-up|25
6128487|NCT03142451|21115986|P2|Overall Study|Adverse Event|2
6128488|NCT03142451|21115987|P1|Overall Study|Adverse Event|5
6128545|NCT02833844|21116272|P2|Open-Label Period|Withdrawal by Subject|0
6128546|NCT02833844|21116273|P1|Open-Label Period|Withdrawal by Subject|1
6128547|NCT02833844|21116272|P2|Open-Label Period|Lost to Follow-up|0
6128548|NCT02833844|21116273|P1|Open-Label Period|Lost to Follow-up|1
6128549|NCT02833844|21116272|P2|Open-Label Period|Death|2
6128550|NCT02833844|21116273|P1|Open-Label Period|Death|0
6128551|NCT02833844|21116272|P2|Double-Blind Period|Protocol Violation|4
6128552|NCT02833844|21116273|P1|Double-Blind Period|Protocol Violation|0
6128553|NCT02833844|21116272|P2|Double-Blind Period|Withdrawal by Subject|3
6128554|NCT02833844|21116273|P1|Double-Blind Period|Withdrawal by Subject|2
6128619|NCT02668393|21116664|P2|Overall Study|Lack of benefit and side effects|0
6128620|NCT02668393|21116665|P1|Overall Study|Lack of benefit and side effects|1
6128621|NCT02668393|21116664|P2|Overall Study|Withdrawal from the trial|1
6128622|NCT02668393|21116665|P1|Overall Study|Withdrawal from the trial|0
6128623|NCT02668393|21116664|P2|Overall Study|Adverse Event|2
6128624|NCT02668393|21116665|P1|Overall Study|Adverse Event|0
6128625|NCT02668393|21116664|P2|Overall Study|Progressive disease|3
6128626|NCT02668393|21116665|P1|Overall Study|Progressive disease|6
6128627|NCT02660827|21116674|P1|2-6 Years Old Age Group|Withdrawal by Subject|1
6128629|NCT02635386|21116702|P5|Overall Study|Other medical problems not drug related|0
6128630|NCT02635386|21116703|P4|Overall Study|Other medical problems not drug related|1
6128631|NCT02635386|21116704|P3|Overall Study|Other medical problems not drug related|0
6128632|NCT02635386|21116705|P2|Overall Study|Other medical problems not drug related|0
6128633|NCT02635386|21116706|P1|Overall Study|Other medical problems not drug related|0
6128634|NCT02635386|21116702|P5|Overall Study|needed other major surgery|0
6128635|NCT02635386|21116703|P4|Overall Study|needed other major surgery|0
6128636|NCT02635386|21116704|P3|Overall Study|needed other major surgery|0
6128637|NCT02635386|21116705|P2|Overall Study|needed other major surgery|1
6128638|NCT02635386|21116706|P1|Overall Study|needed other major surgery|0
6128639|NCT02635386|21116702|P5|Overall Study|side effects|6
6128640|NCT02635386|21116703|P4|Overall Study|side effects|4
6128641|NCT02635386|21116704|P3|Overall Study|side effects|1
6128642|NCT02635386|21116705|P2|Overall Study|side effects|0
6128643|NCT02635386|21116706|P1|Overall Study|side effects|0
6128644|NCT02635386|21116702|P5|Overall Study|Noncompliant|1
6128645|NCT02635386|21116703|P4|Overall Study|Noncompliant|1
6128646|NCT02635386|21116704|P3|Overall Study|Noncompliant|1
6128647|NCT02635386|21116705|P2|Overall Study|Noncompliant|2
6128648|NCT02635386|21116706|P1|Overall Study|Noncompliant|0
6128649|NCT02635386|21116702|P5|Overall Study|Moved Out of State|0
6128650|NCT02635386|21116703|P4|Overall Study|Moved Out of State|0
6128651|NCT02635386|21116704|P3|Overall Study|Moved Out of State|0
6128652|NCT02635386|21116705|P2|Overall Study|Moved Out of State|1
6128653|NCT02635386|21116706|P1|Overall Study|Moved Out of State|0
6128654|NCT02635386|21116702|P5|Overall Study|Physician Decision|0
6128655|NCT02635386|21116703|P4|Overall Study|Physician Decision|0
6128656|NCT02635386|21116704|P3|Overall Study|Physician Decision|0
6128657|NCT02635386|21116705|P2|Overall Study|Physician Decision|1
6128658|NCT02635386|21116706|P1|Overall Study|Physician Decision|0
6128659|NCT02635386|21116702|P5|Overall Study|Withdrawal by Subject|0
6128660|NCT02635386|21116703|P4|Overall Study|Withdrawal by Subject|1
6128661|NCT02635386|21116704|P3|Overall Study|Withdrawal by Subject|0
6128662|NCT02635386|21116705|P2|Overall Study|Withdrawal by Subject|1
6128663|NCT02635386|21116706|P1|Overall Study|Withdrawal by Subject|1
6128664|NCT02635386|21116702|P5|Overall Study|Pregnancy|2
6128665|NCT02635386|21116703|P4|Overall Study|Pregnancy|0
6128666|NCT02635386|21116704|P3|Overall Study|Pregnancy|0
6128667|NCT02635386|21116705|P2|Overall Study|Pregnancy|0
6128668|NCT02635386|21116706|P1|Overall Study|Pregnancy|2
6128669|NCT02631577|21116830|P2|Overall Study|Withdrawal by Subject|1
6128670|NCT02631577|21116831|P1|Overall Study|Withdrawal by Subject|0
6128671|NCT02631577|21116830|P2|Overall Study|Death|3
6128672|NCT02631577|21116831|P1|Overall Study|Death|1
6128674|NCT02332590|21116966|P2|Overall Study|Other than specified above|5
6128675|NCT02332590|21116967|P1|Overall Study|Other than specified above|6
6128676|NCT02332590|21116966|P2|Overall Study|Randomized but not treated|0
6128677|NCT02332590|21116967|P1|Overall Study|Randomized but not treated|1
6128678|NCT02332590|21116966|P2|Overall Study|Poor compliance to protocol|1
6128679|NCT02332590|21116967|P1|Overall Study|Poor compliance to protocol|3
6128680|NCT02332590|21116966|P2|Overall Study|Lack of Efficacy|2
6128681|NCT02332590|21116967|P1|Overall Study|Lack of Efficacy|4
6128682|NCT02332590|21116966|P2|Overall Study|Adverse Event|11
6128683|NCT02332590|21116967|P1|Overall Study|Adverse Event|15
6128700|NCT02260258|21117182|P2|Overall Study|2 patients in NMB arm and 1 in control arm had clinical changes that precluded drug administration|1
6128701|NCT02260258|21117183|P1|Overall Study|2 patients in NMB arm and 1 in control arm had clinical changes that precluded drug administration|2
6128702|NCT01973283|21117230|P1|Overall Study|Lost to Follow-up|4
6128703|NCT01912456|21117277|P4|Period 2|Adverse Event|1
6128704|NCT01912456|21117278|P3|Period 2|Adverse Event|0
6128705|NCT01912456|21117279|P2|Period 2|Adverse Event|0
6128706|NCT01912456|21117280|P1|Period 2|Adverse Event|0
6128707|NCT01912456|21117277|P4|Period 2|Lack of Efficacy|0
6128708|NCT01912456|21117278|P3|Period 2|Lack of Efficacy|0
6128709|NCT01912456|21117279|P2|Period 2|Lack of Efficacy|2
6128710|NCT01912456|21117280|P1|Period 2|Lack of Efficacy|0
6128711|NCT01912456|21117277|P4|Period 1|Withdrawal by Subject|1
6128712|NCT01912456|21117278|P3|Period 1|Withdrawal by Subject|1
6128713|NCT01912456|21117279|P2|Period 1|Withdrawal by Subject|1
6128714|NCT01912456|21117280|P1|Period 1|Withdrawal by Subject|0
6128715|NCT01912456|21117277|P4|Period 1|Adverse Event|1
6128716|NCT01912456|21117278|P3|Period 1|Adverse Event|0
6128717|NCT01912456|21117279|P2|Period 1|Adverse Event|0
6128718|NCT01912456|21117280|P1|Period 1|Adverse Event|1
6128719|NCT01912456|21117277|P4|Period 1|non-compliance|1
6128720|NCT01912456|21117278|P3|Period 1|non-compliance|0
6128721|NCT01912456|21117279|P2|Period 1|non-compliance|0
6128722|NCT01912456|21117280|P1|Period 1|non-compliance|1
6128723|NCT01912456|21117277|P4|Period 1|Physician Decision|0
6128724|NCT01912456|21117278|P3|Period 1|Physician Decision|1
6128725|NCT01912456|21117279|P2|Period 1|Physician Decision|0
6128726|NCT01912456|21117280|P1|Period 1|Physician Decision|0
6128794|NCT01812109|21117428|P1|Overall Study|NIRS Unattainable|17
6128795|NCT01812109|21117428|P1|Overall Study|research personnel delay|16
6128826|NCT01380080|21117606|P2|Overall Study|Lost to Follow-up|3
6128827|NCT01380080|21117607|P1|Overall Study|Lost to Follow-up|3
6128828|NCT01380080|21117606|P2|Overall Study|Withdrawal by Subject|2
6128829|NCT01380080|21117607|P1|Overall Study|Withdrawal by Subject|5
6128830|NCT01380080|21117606|P2|Overall Study|Not willing to adhere to requirements|2
6128831|NCT01380080|21117607|P1|Overall Study|Not willing to adhere to requirements|6
6128832|NCT01380080|21117606|P2|Overall Study|Not able to get to clinic|1
6128833|NCT01380080|21117607|P1|Overall Study|Not able to get to clinic|7
6128834|NCT01380080|21117606|P2|Overall Study|Site is closing|31
6128835|NCT01380080|21117607|P1|Overall Study|Site is closing|28
6128836|NCT01380080|21117606|P2|Overall Study|Death|44
6128837|NCT01380080|21117607|P1|Overall Study|Death|36
6128850|NCT01271712|21117714|P2|Survival Follow-up|Not analyzed after cutoff 08Jun2015|6
6128851|NCT01271712|21117715|P1|Survival Follow-up|Not analyzed after cutoff 08Jun2015|15
6128852|NCT01271712|21117714|P2|Safety Follow-up|Progressive disease|0
6128853|NCT01271712|21117715|P1|Safety Follow-up|Progressive disease|1
6128854|NCT01271712|21117714|P2|Safety Follow-up|No follow-up|1
6128855|NCT01271712|21117715|P1|Safety Follow-up|No follow-up|1
6128856|NCT01271712|21117714|P2|Safety Follow-up|Not analyzed after cutoff 08Jun2015|4
6128857|NCT01271712|21117715|P1|Safety Follow-up|Not analyzed after cutoff 08Jun2015|3
6128858|NCT01271712|21117714|P2|Safety Follow-up|Protocol Violation|1
6128859|NCT01271712|21117715|P1|Safety Follow-up|Protocol Violation|1
6128860|NCT01271712|21117714|P2|Safety Follow-up|Withdrawal by Subject|2
6128861|NCT01271712|21117715|P1|Safety Follow-up|Withdrawal by Subject|4
6128862|NCT01271712|21117714|P2|Safety Follow-up|Death|7
6128863|NCT01271712|21117715|P1|Safety Follow-up|Death|11
6128864|NCT01271712|21117714|P2|Open Label Treatment|Switching to other therapy|1
6128865|NCT01271712|21117715|P1|Open Label Treatment|Switching to other therapy|2
6128866|NCT01271712|21117714|P2|Open Label Treatment|Protocol Violation|1
6128867|NCT01271712|21117715|P1|Open Label Treatment|Protocol Violation|0
6128868|NCT01271712|21117714|P2|Open Label Treatment|Non-compliance with study drug|0
6128869|NCT01271712|21117715|P1|Open Label Treatment|Non-compliance with study drug|1
6128870|NCT01271712|21117714|P2|Open Label Treatment|transferred to rollover study|0
6128871|NCT01271712|21117715|P1|Open Label Treatment|transferred to rollover study|1
6128872|NCT01271712|21117714|P2|Open Label Treatment|Progressive disease|32
6128873|NCT01271712|21117715|P1|Open Label Treatment|Progressive disease|59
6128874|NCT01271712|21117714|P2|Open Label Treatment|Adverse Event|8
6128875|NCT01271712|21117715|P1|Open Label Treatment|Adverse Event|14
6128876|NCT01271712|21117714|P2|Open Label Treatment|Physician Decision|0
6128877|NCT01271712|21117715|P1|Open Label Treatment|Physician Decision|2
6128878|NCT01271712|21117714|P2|Open Label Treatment|Withdrawal by Subject|11
6128879|NCT01271712|21117715|P1|Open Label Treatment|Withdrawal by Subject|6
6128880|NCT01271712|21117714|P2|Open Label Treatment|Death|5
6128881|NCT01271712|21117715|P1|Open Label Treatment|Death|6
6128882|NCT01271712|21117714|P2|Double Blind Treatment|receive no study drug|0
6128883|NCT01271712|21117715|P1|Double Blind Treatment|receive no study drug|1
6128884|NCT01271712|21117714|P2|Double Blind Treatment|Non compliance with study drug|0
6128885|NCT01271712|21117715|P1|Double Blind Treatment|Non compliance with study drug|2
6128886|NCT01271712|21117714|P2|Double Blind Treatment|Withdrawal by Subject|1
6128887|NCT01271712|21117715|P1|Double Blind Treatment|Withdrawal by Subject|4
6128888|NCT01271712|21117714|P2|Double Blind Treatment|Progressive disease|3
6128889|NCT01271712|21117715|P1|Double Blind Treatment|Progressive disease|23
6128890|NCT01271712|21117714|P2|Double Blind Treatment|Adverse Event|4
6128891|NCT01271712|21117715|P1|Double Blind Treatment|Adverse Event|9
6128892|NCT01271712|21117714|P2|Double Blind Treatment|Lack of Efficacy|0
6128893|NCT01271712|21117715|P1|Double Blind Treatment|Lack of Efficacy|1
6128894|NCT01271712|21117714|P2|Double Blind Treatment|Death|0
6128895|NCT01271712|21117715|P1|Double Blind Treatment|Death|2
6128905|NCT00923559|21117862|P2|Overall Study|Lost to Follow-up|3
6128906|NCT00923559|21117863|P1|Overall Study|Lost to Follow-up|2
6128925|NCT00664326|21117933|P1|Overall Study|Disease Progression/Recurrence/Relapse|24
6128926|NCT00664326|21117933|P1|Overall Study|Death|2
6128927|NCT00664326|21117933|P1|Overall Study|Other Reasons|3
6128928|NCT00664326|21117933|P1|Overall Study|Physician Decision|1
6128929|NCT00664326|21117933|P1|Overall Study|Withdrawal by Subject|1
6128930|NCT00664326|21117933|P1|Overall Study|Noncompliance with study medication|3
6128931|NCT00664326|21117933|P1|Overall Study|Adverse Event|14
6132571|NCT04674644|21129528|P1|Overall Study|with missing data|37
6132572|NCT04633564|21129535|P2|Period 2|Terminated by Sponsor|3
6132573|NCT04633564|21129536|P1|Period 2|Terminated by Sponsor|9
6132574|NCT04633564|21129535|P2|Period 2|Progressive Disease|82
6132575|NCT04633564|21129536|P1|Period 2|Progressive Disease|74
6132576|NCT04633564|21129535|P2|Period 2|Withdrawal by Subject|1
6132577|NCT04633564|21129536|P1|Period 2|Withdrawal by Subject|5
6132578|NCT04633564|21129535|P2|Period 2|Physician Decision|4
6132579|NCT04633564|21129536|P1|Period 2|Physician Decision|2
6132580|NCT04633564|21129535|P2|Period 2|Lost to Follow-up|1
6132581|NCT04633564|21129536|P1|Period 2|Lost to Follow-up|0
6132582|NCT04633564|21129535|P2|Period 2|Death|2
6132583|NCT04633564|21129536|P1|Period 2|Death|0
6132584|NCT04633564|21129535|P2|Period 2|Adverse Event|4
6132585|NCT04633564|21129536|P1|Period 2|Adverse Event|3
6132586|NCT04633564|21129535|P2|Period 1|Terminated by Sponsor|6
6132587|NCT04633564|21129536|P1|Period 1|Terminated by Sponsor|8
6132588|NCT04633564|21129535|P2|Period 1|Progressive disease|51
6132589|NCT04633564|21129536|P1|Period 1|Progressive disease|47
6132590|NCT04633564|21129535|P2|Period 1|Withdrawal by Subject|8
6132591|NCT04633564|21129536|P1|Period 1|Withdrawal by Subject|10
6132592|NCT04633564|21129535|P2|Period 1|Protocol Violation|1
6132593|NCT04633564|21129536|P1|Period 1|Protocol Violation|0
6132594|NCT04633564|21129535|P2|Period 1|Physician Decision|12
6132595|NCT04633564|21129536|P1|Period 1|Physician Decision|4
6132596|NCT04633564|21129535|P2|Period 1|Lost to Follow-up|5
6132597|NCT04633564|21129536|P1|Period 1|Lost to Follow-up|3
6132598|NCT04633564|21129535|P2|Period 1|Death|7
6132599|NCT04633564|21129536|P1|Period 1|Death|8
6132600|NCT04633564|21129535|P2|Period 1|Adverse Event|19
6132601|NCT04633564|21129536|P1|Period 1|Adverse Event|28
6132602|NCT04194008|21129589|P1|Treatment Phase With Nerivio|Lost to Follow-up|1
6132603|NCT04194008|21129589|P1|Treatment Phase With Nerivio|Missing data|4
6132604|NCT04194008|21129589|P1|Treatment Phase With Nerivio|Withdrawal by Subject|3
6132605|NCT04194008|21129589|P1|Baseline (Run-in) Phase|Lost to Follow-up|2
6132606|NCT04194008|21129589|P1|Baseline (Run-in) Phase|Withdrawal by Subject|6
6132607|NCT04194008|21129589|P1|Baseline (Run-in) Phase|Fail to comply with Run-in phase criteria|19
6132608|NCT04177862|21129603|P2|Overall Study|Protocol Violation|3
6132609|NCT04177862|21129604|P1|Overall Study|Protocol Violation|0
6132612|NCT04144166|21129634|P1|Overall Study|Nail polish could not be removed from finger|1
6132613|NCT04144166|21129634|P1|Overall Study|Pregnancy|1
6132614|NCT04144166|21129634|P1|Overall Study|Discharged before study start|1
6132622|NCT03862625|21129688|P2|Overall Study|Lost to Follow-up|1
6132623|NCT03862625|21129689|P1|Overall Study|Lost to Follow-up|0
6132624|NCT03821064|21129701|P1|Overall Study|did not meet study eligibility criteria of needing adjuvant radiation per NCCN guidelines on path|1
6132625|NCT03798483|21129815|P1|Overall Study|Lost to Follow-up|2
6132626|NCT03751657|21129903|P2|Overall Study|Lost to Follow-up|1
6132627|NCT03751657|21129904|P1|Overall Study|Lost to Follow-up|2
6132628|NCT03751657|21129903|P2|Overall Study|Withdrawal by Subject|1
6132629|NCT03751657|21129904|P1|Overall Study|Withdrawal by Subject|1
6132630|NCT03751657|21129903|P2|Overall Study|Physician Decision|1
6132631|NCT03751657|21129904|P1|Overall Study|Physician Decision|0
6132644|NCT03629249|21130028|P3|Overall Study|Physician Decision|0
6132645|NCT03629249|21130029|P2|Overall Study|Physician Decision|0
6132646|NCT03629249|21130030|P1|Overall Study|Physician Decision|1
6132647|NCT03629249|21130028|P3|Overall Study|Death|0
6132648|NCT03629249|21130029|P2|Overall Study|Death|0
6132649|NCT03629249|21130030|P1|Overall Study|Death|1
6132650|NCT03629249|21130028|P3|Overall Study|Adverse Event|0
6132651|NCT03629249|21130029|P2|Overall Study|Adverse Event|1
6132652|NCT03629249|21130030|P1|Overall Study|Adverse Event|1
6132653|NCT03629249|21130028|P3|Overall Study|Subject decision|3
6132654|NCT03629249|21130029|P2|Overall Study|Subject decision|1
6132655|NCT03629249|21130030|P1|Overall Study|Subject decision|1
6132656|NCT03629249|21130028|P3|Overall Study|Protocol deviation|5
6132657|NCT03629249|21130029|P2|Overall Study|Protocol deviation|2
6132658|NCT03629249|21130030|P1|Overall Study|Protocol deviation|0
6132659|NCT03629249|21130028|P3|Overall Study|Study terminated by sponsor|194
6132660|NCT03629249|21130029|P2|Overall Study|Study terminated by sponsor|197
6132661|NCT03629249|21130030|P1|Overall Study|Study terminated by sponsor|197
6132702|NCT03478956|21130184|P2|Overall Study|Ongoing in the Study|11
6132703|NCT03478956|21130185|P1|Overall Study|Ongoing in the Study|11
6132704|NCT03478956|21130184|P2|Overall Study|Withdrawal by Subject|1
6132705|NCT03478956|21130185|P1|Overall Study|Withdrawal by Subject|0
6132706|NCT03478956|21130184|P2|Overall Study|Adverse Event|0
6132707|NCT03478956|21130185|P1|Overall Study|Adverse Event|1
6132720|NCT03371355|21130354|P4|Overall Study|Reason not Specified|1
6132721|NCT03371355|21130355|P3|Overall Study|Reason not Specified|0
6132722|NCT03371355|21130356|P2|Overall Study|Reason not Specified|1
6132723|NCT03371355|21130357|P1|Overall Study|Reason not Specified|0
6132724|NCT03371355|21130354|P4|Overall Study|Adverse Event|3
6132725|NCT03371355|21130355|P3|Overall Study|Adverse Event|2
6132726|NCT03371355|21130356|P2|Overall Study|Adverse Event|1
6132727|NCT03371355|21130357|P1|Overall Study|Adverse Event|0
6132728|NCT03371355|21130354|P4|Overall Study|Voluntary withdrawal|2
6132729|NCT03371355|21130355|P3|Overall Study|Voluntary withdrawal|1
6132730|NCT03371355|21130356|P2|Overall Study|Voluntary withdrawal|0
6132731|NCT03371355|21130357|P1|Overall Study|Voluntary withdrawal|1
6132732|NCT03371355|21130354|P4|Overall Study|Investigator judgment|1
6132733|NCT03371355|21130355|P3|Overall Study|Investigator judgment|1
6132734|NCT03371355|21130356|P2|Overall Study|Investigator judgment|0
6132735|NCT03371355|21130357|P1|Overall Study|Investigator judgment|0
6132750|NCT03289455|21130531|P3|Overall Study|Progressive disease|5
6132751|NCT03289455|21130532|P2|Overall Study|Progressive disease|4
6132752|NCT03289455|21130533|P1|Overall Study|Progressive disease|3
6132753|NCT03289455|21130531|P3|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|1
6132754|NCT03289455|21130532|P2|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|0
6132755|NCT03289455|21130533|P1|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|0
6132756|NCT03289455|21130531|P3|Overall Study|Sponsor decision due to covid19 restrictions|0
6132757|NCT03289455|21130532|P2|Overall Study|Sponsor decision due to covid19 restrictions|1
6132758|NCT03289455|21130533|P1|Overall Study|Sponsor decision due to covid19 restrictions|0
6132759|NCT03289455|21130531|P3|Overall Study|Death|0
6132760|NCT03289455|21130532|P2|Overall Study|Death|0
6132761|NCT03289455|21130533|P1|Overall Study|Death|1
6132762|NCT03277105|21130586|P2|Overall Study|Ongoing|175
6132763|NCT03277105|21130587|P1|Overall Study|Ongoing|171
6132764|NCT03277105|21130586|P2|Overall Study|Other|3
6132765|NCT03277105|21130587|P1|Overall Study|Other|1
6132766|NCT03277105|21130586|P2|Overall Study|Withdrawal by Subject|9
6132767|NCT03277105|21130587|P1|Overall Study|Withdrawal by Subject|10
6132768|NCT03277105|21130586|P2|Overall Study|Lost to Follow-up|3
6132769|NCT03277105|21130587|P1|Overall Study|Lost to Follow-up|0
6132770|NCT03277105|21130586|P2|Overall Study|Death|73
6132771|NCT03277105|21130587|P1|Overall Study|Death|77
6132788|NCT03227029|21130645|P3|Overall Study|Unable to receive treatment in time (no treatment)|1
6132789|NCT03227029|21130646|P2|Overall Study|Unable to receive treatment in time (no treatment)|0
6132790|NCT03227029|21130647|P1|Overall Study|Unable to receive treatment in time (no treatment)|0
6132791|NCT03227029|21130645|P3|Overall Study|Withdrawal by Subject|0
6132792|NCT03227029|21130646|P2|Overall Study|Withdrawal by Subject|0
6132793|NCT03227029|21130647|P1|Overall Study|Withdrawal by Subject|1
6132794|NCT03227029|21130645|P3|Overall Study|Not able to get to clinic|1
6132795|NCT03227029|21130646|P2|Overall Study|Not able to get to clinic|0
6132796|NCT03227029|21130647|P1|Overall Study|Not able to get to clinic|0
6132797|NCT03227029|21130645|P3|Overall Study|No post RSV season visit due to COVID|2
6132798|NCT03227029|21130646|P2|Overall Study|No post RSV season visit due to COVID|3
6132799|NCT03227029|21130647|P1|Overall Study|No post RSV season visit due to COVID|3
6132800|NCT03227029|21130645|P3|Overall Study|Child Wheezed (no treatment)|0
6132801|NCT03227029|21130646|P2|Overall Study|Child Wheezed (no treatment)|1
6132802|NCT03227029|21130647|P1|Overall Study|Child Wheezed (no treatment)|0
6132809|NCT03178669|21130725|P5|Overall Study|Lost to Follow-up|0
6132810|NCT03178669|21130726|P4|Overall Study|Lost to Follow-up|1
6132811|NCT03178669|21130727|P3|Overall Study|Lost to Follow-up|0
6132812|NCT03178669|21130728|P2|Overall Study|Lost to Follow-up|0
6132813|NCT03178669|21130729|P1|Overall Study|Lost to Follow-up|0
6132814|NCT03178669|21130725|P5|Overall Study|Withdrawal by Subject|0
6132815|NCT03178669|21130726|P4|Overall Study|Withdrawal by Subject|1
6132816|NCT03178669|21130727|P3|Overall Study|Withdrawal by Subject|1
6132817|NCT03178669|21130728|P2|Overall Study|Withdrawal by Subject|0
6132818|NCT03178669|21130729|P1|Overall Study|Withdrawal by Subject|1
6132819|NCT03178669|21130725|P5|Overall Study|Physician Decision|1
6132820|NCT03178669|21130726|P4|Overall Study|Physician Decision|0
6132821|NCT03178669|21130727|P3|Overall Study|Physician Decision|0
6132822|NCT03178669|21130728|P2|Overall Study|Physician Decision|0
6132823|NCT03178669|21130729|P1|Overall Study|Physician Decision|0
6132824|NCT03178669|21130725|P5|Overall Study|Lack of Efficacy|1
6132825|NCT03178669|21130726|P4|Overall Study|Lack of Efficacy|0
6132826|NCT03178669|21130727|P3|Overall Study|Lack of Efficacy|2
6132827|NCT03178669|21130728|P2|Overall Study|Lack of Efficacy|0
6132828|NCT03178669|21130729|P1|Overall Study|Lack of Efficacy|0
6132829|NCT03178669|21130725|P5|Overall Study|Adverse Event|2
6132830|NCT03178669|21130726|P4|Overall Study|Adverse Event|2
6132831|NCT03178669|21130727|P3|Overall Study|Adverse Event|4
6132832|NCT03178669|21130728|P2|Overall Study|Adverse Event|1
6132833|NCT03178669|21130729|P1|Overall Study|Adverse Event|4
6132834|NCT03172325|21130768|P2|Overall Study|Poor Compliance|1
6132835|NCT03172325|21130769|P1|Overall Study|Poor Compliance|1
6132836|NCT03172325|21130768|P2|Overall Study|Positive PPD|0
6132837|NCT03172325|21130769|P1|Overall Study|Positive PPD|1
6132838|NCT03172325|21130768|P2|Overall Study|Adverse Event|3
6132839|NCT03172325|21130769|P1|Overall Study|Adverse Event|2
6132873|NCT03125200|21131099|P7|Overall Study|Consent Withdrawn by Subject|1
6132874|NCT03125200|21131100|P6|Overall Study|Consent Withdrawn by Subject|0
6132875|NCT03125200|21131101|P5|Overall Study|Consent Withdrawn by Subject|1
6132876|NCT03125200|21131102|P4|Overall Study|Consent Withdrawn by Subject|0
6132877|NCT03125200|21131103|P3|Overall Study|Consent Withdrawn by Subject|0
6132878|NCT03125200|21131104|P2|Overall Study|Consent Withdrawn by Subject|1
6132879|NCT03125200|21131105|P1|Overall Study|Consent Withdrawn by Subject|0
6132880|NCT03125200|21131099|P7|Overall Study|Toxicity|0
6132881|NCT03125200|21131100|P6|Overall Study|Toxicity|0
6132882|NCT03125200|21131101|P5|Overall Study|Toxicity|0
6132883|NCT03125200|21131102|P4|Overall Study|Toxicity|1
6132884|NCT03125200|21131103|P3|Overall Study|Toxicity|0
6132885|NCT03125200|21131104|P2|Overall Study|Toxicity|0
6132886|NCT03125200|21131105|P1|Overall Study|Toxicity|0
6132887|NCT03125200|21131099|P7|Overall Study|Lack of Efficacy|0
6132888|NCT03125200|21131100|P6|Overall Study|Lack of Efficacy|0
6132889|NCT03125200|21131101|P5|Overall Study|Lack of Efficacy|0
6132890|NCT03125200|21131102|P4|Overall Study|Lack of Efficacy|1
6132891|NCT03125200|21131103|P3|Overall Study|Lack of Efficacy|0
6132892|NCT03125200|21131104|P2|Overall Study|Lack of Efficacy|0
6132893|NCT03125200|21131105|P1|Overall Study|Lack of Efficacy|0
6132894|NCT03125200|21131099|P7|Overall Study|Progressive Disease|1
6132895|NCT03125200|21131100|P6|Overall Study|Progressive Disease|0
6132896|NCT03125200|21131101|P5|Overall Study|Progressive Disease|2
6132897|NCT03125200|21131102|P4|Overall Study|Progressive Disease|1
6132898|NCT03125200|21131103|P3|Overall Study|Progressive Disease|2
6132899|NCT03125200|21131104|P2|Overall Study|Progressive Disease|1
6132900|NCT03125200|21131105|P1|Overall Study|Progressive Disease|2
6132901|NCT03125200|21131099|P7|Overall Study|Clinical Progression|0
6132902|NCT03125200|21131100|P6|Overall Study|Clinical Progression|1
6132903|NCT03125200|21131101|P5|Overall Study|Clinical Progression|0
6132904|NCT03125200|21131102|P4|Overall Study|Clinical Progression|1
6132905|NCT03125200|21131103|P3|Overall Study|Clinical Progression|0
6132906|NCT03125200|21131104|P2|Overall Study|Clinical Progression|0
6132907|NCT03125200|21131105|P1|Overall Study|Clinical Progression|0
6132908|NCT03125200|21131099|P7|Overall Study|Study Termination|1
6132909|NCT03125200|21131100|P6|Overall Study|Study Termination|2
6132910|NCT03125200|21131101|P5|Overall Study|Study Termination|1
6132911|NCT03125200|21131102|P4|Overall Study|Study Termination|1
6132912|NCT03125200|21131103|P3|Overall Study|Study Termination|0
6132913|NCT03125200|21131104|P2|Overall Study|Study Termination|0
6132914|NCT03125200|21131105|P1|Overall Study|Study Termination|0
6132947|NCT02957136|21131511|P2|Overall Study|Withdrawal by Subject|1
6132948|NCT02957136|21131512|P1|Overall Study|Withdrawal by Subject|2
6132949|NCT02956629|21131540|P6|Overall Study|Withdrawal by Subject|0
6132950|NCT02956629|21131541|P5|Overall Study|Withdrawal by Subject|0
6132951|NCT02956629|21131542|P4|Overall Study|Withdrawal by Subject|0
6132952|NCT02956629|21131543|P3|Overall Study|Withdrawal by Subject|0
6132953|NCT02956629|21131544|P2|Overall Study|Withdrawal by Subject|1
6132954|NCT02956629|21131545|P1|Overall Study|Withdrawal by Subject|3
6132955|NCT02956629|21131540|P6|Overall Study|Lost to Follow-up|1
6132956|NCT02956629|21131541|P5|Overall Study|Lost to Follow-up|0
6132957|NCT02956629|21131542|P4|Overall Study|Lost to Follow-up|1
6132958|NCT02956629|21131543|P3|Overall Study|Lost to Follow-up|3
6132959|NCT02956629|21131544|P2|Overall Study|Lost to Follow-up|5
6132960|NCT02956629|21131545|P1|Overall Study|Lost to Follow-up|2
6132961|NCT02956629|21131540|P6|Overall Study|Adverse Event|0
6132962|NCT02956629|21131541|P5|Overall Study|Adverse Event|0
6132963|NCT02956629|21131542|P4|Overall Study|Adverse Event|0
6132964|NCT02956629|21131543|P3|Overall Study|Adverse Event|1
6132965|NCT02956629|21131544|P2|Overall Study|Adverse Event|0
6132966|NCT02956629|21131545|P1|Overall Study|Adverse Event|0
6133007|NCT02889900|21131701|P1|Overall Study|Not treated|2
6133008|NCT02889900|21131701|P1|Overall Study|Withdrawal by Subject|7
6133009|NCT02889900|21131701|P1|Overall Study|Other|5
6133010|NCT02889900|21131701|P1|Overall Study|Condition under investigation worsened|32
6133011|NCT02889900|21131701|P1|Overall Study|Adverse Event|11
6133014|NCT02865915|21131730|P2|Overall Study|Dosing group discontinued|5
6133015|NCT02865915|21131731|P1|Overall Study|Dosing group discontinued|0
6133016|NCT02865915|21131730|P2|Overall Study|Study terminated by sponsor|18
6133017|NCT02865915|21131731|P1|Overall Study|Study terminated by sponsor|23
6133018|NCT02865915|21131730|P2|Overall Study|Protocol Violation|1
6133019|NCT02865915|21131731|P1|Overall Study|Protocol Violation|0
6133020|NCT02865915|21131730|P2|Overall Study|Lost to Follow-up|1
6133021|NCT02865915|21131731|P1|Overall Study|Lost to Follow-up|0
6133022|NCT02865915|21131730|P2|Overall Study|Adverse Event|4
6133023|NCT02865915|21131731|P1|Overall Study|Adverse Event|0
6133024|NCT02865915|21131730|P2|Overall Study|Withdrawal by Subject|1
6133025|NCT02865915|21131731|P1|Overall Study|Withdrawal by Subject|1
6133026|NCT02865915|21131730|P2|Overall Study|Pregnancy|0
6133027|NCT02865915|21131731|P1|Overall Study|Pregnancy|1
6133037|NCT02810418|21131809|P7|Arm B Dose Escalation|Adverse Event|0
6133038|NCT02810418|21131810|P6|Arm B Dose Escalation|Adverse Event|2
6133039|NCT02810418|21131811|P5|Arm B Dose Escalation|Adverse Event|1
6133040|NCT02810418|21131812|P4|Arm B Dose Escalation|Adverse Event|0
6133041|NCT02810418|21131813|P3|Arm B Dose Escalation|Adverse Event|0
6133042|NCT02810418|21131814|P2|Arm B Dose Escalation|Adverse Event|0
6133043|NCT02810418|21131815|P1|Arm B Dose Escalation|Adverse Event|0
6133044|NCT02810418|21131809|P7|Dose Expansion|Physician Decision|0
6133045|NCT02810418|21131810|P6|Dose Expansion|Physician Decision|0
6133046|NCT02810418|21131811|P5|Dose Expansion|Physician Decision|0
6133047|NCT02810418|21131812|P4|Dose Expansion|Physician Decision|0
6133048|NCT02810418|21131813|P3|Dose Expansion|Physician Decision|2
6133049|NCT02810418|21131814|P2|Dose Expansion|Physician Decision|0
6133050|NCT02810418|21131815|P1|Dose Expansion|Physician Decision|0
6133051|NCT02810418|21131809|P7|Dose Expansion|Adverse Event|0
6133052|NCT02810418|21131810|P6|Dose Expansion|Adverse Event|0
6133053|NCT02810418|21131811|P5|Dose Expansion|Adverse Event|0
6133054|NCT02810418|21131812|P4|Dose Expansion|Adverse Event|0
6133055|NCT02810418|21131813|P3|Dose Expansion|Adverse Event|1
6133056|NCT02810418|21131814|P2|Dose Expansion|Adverse Event|1
6133057|NCT02810418|21131815|P1|Dose Expansion|Adverse Event|0
6133058|NCT02810418|21131809|P7|Arm A Dose Escalation|Adverse Event|0
6133059|NCT02810418|21131810|P6|Arm A Dose Escalation|Adverse Event|0
6133060|NCT02810418|21131811|P5|Arm A Dose Escalation|Adverse Event|0
6133061|NCT02810418|21131812|P4|Arm A Dose Escalation|Adverse Event|0
6133062|NCT02810418|21131813|P3|Arm A Dose Escalation|Adverse Event|0
6133063|NCT02810418|21131814|P2|Arm A Dose Escalation|Adverse Event|1
6133064|NCT02810418|21131815|P1|Arm A Dose Escalation|Adverse Event|2
6133065|NCT02782780|21131909|P2|Overall Study|Protocol Violation|2
6133066|NCT02782780|21131910|P1|Overall Study|Protocol Violation|0
6133067|NCT02782780|21131909|P2|Overall Study|dropped out after randomization.|5
6133068|NCT02782780|21131910|P1|Overall Study|dropped out after randomization.|7
6133085|NCT02746874|21131988|P2|Overall Study|Surgery Date Changed|2
6133086|NCT02746874|21131989|P1|Overall Study|Surgery Date Changed|0
6133087|NCT02746874|21131988|P2|Overall Study|Withdrawal by Subject|1
6133088|NCT02746874|21131989|P1|Overall Study|Withdrawal by Subject|0
6133089|NCT02708966|21132052|P2|Overall Study|Lost to Follow-up|2
6133090|NCT02708966|21132053|P1|Overall Study|Lost to Follow-up|2
6133115|NCT02688621|21132132|P2|Overall Study|Withdrawal by Subject|0
6133116|NCT02688621|21132133|P1|Overall Study|Withdrawal by Subject|1
6133117|NCT02688621|21132132|P2|Overall Study|Lost to Follow-up|15
6133118|NCT02688621|21132133|P1|Overall Study|Lost to Follow-up|38
6133119|NCT02688621|21132132|P2|Overall Study|Pregnancy|3
6133120|NCT02688621|21132133|P1|Overall Study|Pregnancy|1
6133121|NCT02669264|21132156|P7|Overall Study|Miscellaneous|2
6133122|NCT02669264|21132157|P6|Overall Study|Miscellaneous|0
6133123|NCT02669264|21132158|P5|Overall Study|Miscellaneous|0
6133124|NCT02669264|21132159|P4|Overall Study|Miscellaneous|0
6133125|NCT02669264|21132160|P3|Overall Study|Miscellaneous|0
6133126|NCT02669264|21132161|P2|Overall Study|Miscellaneous|0
6133127|NCT02669264|21132162|P1|Overall Study|Miscellaneous|0
6133128|NCT02669264|21132156|P7|Overall Study|Lost to Follow-up|0
6133129|NCT02669264|21132157|P6|Overall Study|Lost to Follow-up|0
6133130|NCT02669264|21132158|P5|Overall Study|Lost to Follow-up|1
6133131|NCT02669264|21132159|P4|Overall Study|Lost to Follow-up|0
6133132|NCT02669264|21132160|P3|Overall Study|Lost to Follow-up|0
6133133|NCT02669264|21132161|P2|Overall Study|Lost to Follow-up|0
6133134|NCT02669264|21132162|P1|Overall Study|Lost to Follow-up|0
6133135|NCT02669264|21132156|P7|Overall Study|Withdrawal by Subject|0
6133136|NCT02669264|21132157|P6|Overall Study|Withdrawal by Subject|0
6133137|NCT02669264|21132158|P5|Overall Study|Withdrawal by Subject|1
6133138|NCT02669264|21132159|P4|Overall Study|Withdrawal by Subject|0
6133139|NCT02669264|21132160|P3|Overall Study|Withdrawal by Subject|0
6133140|NCT02669264|21132161|P2|Overall Study|Withdrawal by Subject|1
6133141|NCT02669264|21132162|P1|Overall Study|Withdrawal by Subject|0
6133142|NCT02669264|21132156|P7|Overall Study|Death|3
6133143|NCT02669264|21132157|P6|Overall Study|Death|6
6133144|NCT02669264|21132158|P5|Overall Study|Death|3
6133145|NCT02669264|21132159|P4|Overall Study|Death|3
6133146|NCT02669264|21132160|P3|Overall Study|Death|3
6133147|NCT02669264|21132161|P2|Overall Study|Death|5
6133148|NCT02669264|21132162|P1|Overall Study|Death|5
6133149|NCT02669017|21132315|P9|Overall Study|Miscellaneous|2
6133150|NCT02669017|21132316|P8|Overall Study|Miscellaneous|13
6133151|NCT02669017|21132317|P7|Overall Study|Miscellaneous|1
6133152|NCT02669017|21132318|P6|Overall Study|Miscellaneous|1
6133153|NCT02669017|21132319|P5|Overall Study|Miscellaneous|2
6133154|NCT02669017|21132320|P4|Overall Study|Miscellaneous|0
6133155|NCT02669017|21132321|P3|Overall Study|Miscellaneous|0
6133156|NCT02669017|21132322|P2|Overall Study|Miscellaneous|0
6133157|NCT02669017|21132323|P1|Overall Study|Miscellaneous|0
6133158|NCT02669017|21132315|P9|Overall Study|Lost to Follow-up|1
6133159|NCT02669017|21132316|P8|Overall Study|Lost to Follow-up|0
6133160|NCT02669017|21132317|P7|Overall Study|Lost to Follow-up|0
6133161|NCT02669017|21132318|P6|Overall Study|Lost to Follow-up|0
6133162|NCT02669017|21132319|P5|Overall Study|Lost to Follow-up|0
6133163|NCT02669017|21132320|P4|Overall Study|Lost to Follow-up|0
6133164|NCT02669017|21132321|P3|Overall Study|Lost to Follow-up|0
6133165|NCT02669017|21132322|P2|Overall Study|Lost to Follow-up|0
6133166|NCT02669017|21132323|P1|Overall Study|Lost to Follow-up|0
6133167|NCT02669017|21132315|P9|Overall Study|Withdrawal by Subject|2
6133168|NCT02669017|21132316|P8|Overall Study|Withdrawal by Subject|2
6133169|NCT02669017|21132317|P7|Overall Study|Withdrawal by Subject|0
6133170|NCT02669017|21132318|P6|Overall Study|Withdrawal by Subject|0
6133171|NCT02669017|21132319|P5|Overall Study|Withdrawal by Subject|2
6133172|NCT02669017|21132320|P4|Overall Study|Withdrawal by Subject|1
6133173|NCT02669017|21132321|P3|Overall Study|Withdrawal by Subject|0
6133174|NCT02669017|21132322|P2|Overall Study|Withdrawal by Subject|0
6133175|NCT02669017|21132323|P1|Overall Study|Withdrawal by Subject|0
6133176|NCT02669017|21132315|P9|Overall Study|Death|20
6133177|NCT02669017|21132316|P8|Overall Study|Death|47
6133178|NCT02669017|21132317|P7|Overall Study|Death|10
6133179|NCT02669017|21132318|P6|Overall Study|Death|18
6133180|NCT02669017|21132319|P5|Overall Study|Death|8
6133181|NCT02669017|21132320|P4|Overall Study|Death|3
6133182|NCT02669017|21132321|P3|Overall Study|Death|2
6133183|NCT02669017|21132322|P2|Overall Study|Death|2
6133184|NCT02669017|21132323|P1|Overall Study|Death|1
6133186|NCT02658448|21132453|P1|Overall Study|Lost to Follow-up|1
6133191|NCT02646423|21132475|P2|Overall Study|Ineligible|1
6133192|NCT02646423|21132476|P1|Overall Study|Ineligible|2
6133193|NCT02646423|21132475|P2|Overall Study|Adverse Event|7
6133194|NCT02646423|21132476|P1|Overall Study|Adverse Event|5
6133228|NCT02559687|21132587|P1|Overall Study|Ongoing Follow-Up|14
6133229|NCT02559687|21132587|P1|Overall Study|Withdrawal by Subject|4
6133230|NCT02559687|21132587|P1|Overall Study|Death|103
6133235|NCT02542397|21132625|P1|Overall Study|Lost to Follow-up|2
6133236|NCT02542397|21132625|P1|Overall Study|Withdrawal by Subject|6
6133237|NCT02542397|21132625|P1|Overall Study|Physician Decision|6
6133238|NCT02542397|21132625|P1|Overall Study|Death|2
6133244|NCT02524288|21132686|P1|Overall Study|Physician Decision|2
6133245|NCT02524288|21132686|P1|Overall Study|Pregnancy|22
6133246|NCT02524288|21132686|P1|Overall Study|Withdrawal by Subject|76
6133247|NCT02524288|21132686|P1|Overall Study|Subject Moved|32
6133248|NCT02524288|21132686|P1|Overall Study|Study Terminated By Sponsor|1417
6133249|NCT02524288|21132686|P1|Overall Study|Site Discontinued Study Participation|1
6133250|NCT02524288|21132686|P1|Overall Study|Screen Failure|2
6133251|NCT02524288|21132686|P1|Overall Study|Protocol Violation|6
6133252|NCT02524288|21132686|P1|Overall Study|Pregnancy Wish|6
6133253|NCT02524288|21132686|P1|Overall Study|Non-Compliance With Study Drug|14
6133254|NCT02524288|21132686|P1|Overall Study|Non-Compliance With Protocol|32
6133255|NCT02524288|21132686|P1|Overall Study|Lost to Follow-up|216
6133256|NCT02524288|21132686|P1|Overall Study|Adverse Event|115
6133257|NCT02465567|21132721|P4|Overall Study|missing PI Signature|0
6133258|NCT02465567|21132722|P3|Overall Study|missing PI Signature|0
6133259|NCT02465567|21132723|P2|Overall Study|missing PI Signature|0
6133260|NCT02465567|21132724|P1|Overall Study|missing PI Signature|1
6133261|NCT02465567|21132721|P4|Overall Study|enrolled in >1 studies|15
6133262|NCT02465567|21132722|P3|Overall Study|enrolled in >1 studies|19
6133263|NCT02465567|21132723|P2|Overall Study|enrolled in >1 studies|11
6133264|NCT02465567|21132724|P1|Overall Study|enrolled in >1 studies|18
6133265|NCT02465567|21132721|P4|Overall Study|Randomized but not treated|5
6133266|NCT02465567|21132722|P3|Overall Study|Randomized but not treated|4
6133267|NCT02465567|21132723|P2|Overall Study|Randomized but not treated|5
6133268|NCT02465567|21132724|P1|Overall Study|Randomized but not treated|1
6133269|NCT02465567|21132721|P4|Overall Study|Administrative Reasons|5
6133270|NCT02465567|21132722|P3|Overall Study|Administrative Reasons|11
6133271|NCT02465567|21132723|P2|Overall Study|Administrative Reasons|9
6133272|NCT02465567|21132724|P1|Overall Study|Administrative Reasons|12
6133273|NCT02465567|21132721|P4|Overall Study|Protocol Specified Criteria|12
6133274|NCT02465567|21132722|P3|Overall Study|Protocol Specified Criteria|9
6133275|NCT02465567|21132723|P2|Overall Study|Protocol Specified Criteria|10
6133276|NCT02465567|21132724|P1|Overall Study|Protocol Specified Criteria|20
6133277|NCT02465567|21132721|P4|Overall Study|Lost to Follow-up|15
6133278|NCT02465567|21132722|P3|Overall Study|Lost to Follow-up|19
6133279|NCT02465567|21132723|P2|Overall Study|Lost to Follow-up|21
6133280|NCT02465567|21132724|P1|Overall Study|Lost to Follow-up|25
6133281|NCT02465567|21132721|P4|Overall Study|Major Protocol Deviation|25
6133282|NCT02465567|21132722|P3|Overall Study|Major Protocol Deviation|22
6133283|NCT02465567|21132723|P2|Overall Study|Major Protocol Deviation|26
6133284|NCT02465567|21132724|P1|Overall Study|Major Protocol Deviation|24
6133285|NCT02465567|21132721|P4|Overall Study|Physician Decision|28
6133286|NCT02465567|21132722|P3|Overall Study|Physician Decision|38
6133287|NCT02465567|21132723|P2|Overall Study|Physician Decision|33
6133288|NCT02465567|21132724|P1|Overall Study|Physician Decision|23
6133289|NCT02465567|21132721|P4|Overall Study|Withdrawal by Subject|130
6133290|NCT02465567|21132722|P3|Overall Study|Withdrawal by Subject|123
6133291|NCT02465567|21132723|P2|Overall Study|Withdrawal by Subject|94
6133292|NCT02465567|21132724|P1|Overall Study|Withdrawal by Subject|104
6133293|NCT02465567|21132721|P4|Overall Study|Lack of Efficacy|135
6133294|NCT02465567|21132722|P3|Overall Study|Lack of Efficacy|171
6133295|NCT02465567|21132723|P2|Overall Study|Lack of Efficacy|102
6133296|NCT02465567|21132724|P1|Overall Study|Lack of Efficacy|103
6133297|NCT02465567|21132721|P4|Overall Study|Adverse Event|138
6133298|NCT02465567|21132722|P3|Overall Study|Adverse Event|147
6133299|NCT02465567|21132723|P2|Overall Study|Adverse Event|113
6133300|NCT02465567|21132724|P1|Overall Study|Adverse Event|118
6133301|NCT02460198|21132756|P2|Overall Study|Ongoing|30
6133302|NCT02460198|21132757|P1|Overall Study|Ongoing|25
6133303|NCT02460198|21132756|P2|Overall Study|Withdrawal by Subject|4
6133304|NCT02460198|21132757|P1|Overall Study|Withdrawal by Subject|2
6133305|NCT02460198|21132756|P2|Overall Study|Lost to Follow-up|1
6133306|NCT02460198|21132757|P1|Overall Study|Lost to Follow-up|1
6133307|NCT02460198|21132756|P2|Overall Study|Death|25
6133308|NCT02460198|21132757|P1|Overall Study|Death|32
6133309|NCT02460198|21132756|P2|Overall Study|Adverse Event|3
6133310|NCT02460198|21132757|P1|Overall Study|Adverse Event|1
6133311|NCT02455557|21132775|P1|Overall Study|Withdrawal by Subject|2
6133328|NCT02286713|21133077|P2|Six Month Follow-Up|Lost to Follow-up|27
6133329|NCT02286713|21133078|P1|Six Month Follow-Up|Lost to Follow-up|30
6133330|NCT02286713|21133077|P2|Six Month Follow-Up|Death|0
6133331|NCT02286713|21133078|P1|Six Month Follow-Up|Death|2
6133332|NCT02286713|21133077|P2|Three Month Follow-Up|Withdrawal by Subject|1
6133333|NCT02286713|21133078|P1|Three Month Follow-Up|Withdrawal by Subject|1
6133334|NCT02286713|21133077|P2|Three Month Follow-Up|Lost to Follow-up|24
6133335|NCT02286713|21133078|P1|Three Month Follow-Up|Lost to Follow-up|26
6133336|NCT02286713|21133077|P2|Three Month Follow-Up|Death|1
6133337|NCT02286713|21133078|P1|Three Month Follow-Up|Death|1
6133338|NCT02286713|21133077|P2|One Week Follow-Up|Withdrawal by Subject|3
6133339|NCT02286713|21133078|P1|One Week Follow-Up|Withdrawal by Subject|6
6133340|NCT02286713|21133077|P2|One Week Follow-Up|Lost to Follow-up|21
6133341|NCT02286713|21133078|P1|One Week Follow-Up|Lost to Follow-up|17
6133342|NCT02286713|21133077|P2|One Week Follow-Up|Death|0
6133343|NCT02286713|21133078|P1|One Week Follow-Up|Death|1
6133366|NCT02272790|21133224|P6|Overall Study|Physician Decision|0
6133367|NCT02272790|21133225|P5|Overall Study|Physician Decision|0
6133368|NCT02272790|21133226|P4|Overall Study|Physician Decision|0
6133369|NCT02272790|21133227|P3|Overall Study|Physician Decision|0
6133370|NCT02272790|21133228|P2|Overall Study|Physician Decision|1
6133371|NCT02272790|21133229|P1|Overall Study|Physician Decision|0
6133372|NCT02260921|21133365|P2|Overall Study|Prohibited Treatment for Knee Pain|0
6133373|NCT02260921|21133366|P1|Overall Study|Prohibited Treatment for Knee Pain|4
6133374|NCT02260921|21133365|P2|Overall Study|Death|0
6133375|NCT02260921|21133366|P1|Overall Study|Death|1
6133376|NCT02260921|21133365|P2|Overall Study|Withdraw Consent|1
6133377|NCT02260921|21133366|P1|Overall Study|Withdraw Consent|4
6133378|NCT02260921|21133365|P2|Overall Study|Lost to Follow-up|3
6133379|NCT02260921|21133366|P1|Overall Study|Lost to Follow-up|4
6133380|NCT02260921|21133365|P2|Overall Study|Adverse Event|0
6133381|NCT02260921|21133366|P1|Overall Study|Adverse Event|1
6133382|NCT02196324|21133398|P2|Overall Study|Other|0
6133383|NCT02196324|21133399|P1|Overall Study|Other|1
6133384|NCT02196324|21133398|P2|Overall Study|Occurrence of an Exclusion Criterion|1
6133385|NCT02196324|21133399|P1|Overall Study|Occurrence of an Exclusion Criterion|0
6133386|NCT02196324|21133398|P2|Overall Study|Adverse Event or Serious Adverse Event|3
6133387|NCT02196324|21133399|P1|Overall Study|Adverse Event or Serious Adverse Event|6
6133388|NCT02196324|21133398|P2|Overall Study|Withdrawal by Subject|4
6133389|NCT02196324|21133399|P1|Overall Study|Withdrawal by Subject|8
6133480|NCT01850524|21133839|P2|Overall Study|Lack of Improvement|1
6133419|NCT02049944|21133577|P1|Overall Study|Protocol Violation|2
6133420|NCT02025985|21133586|P5|Overall Study|Death|17
6133421|NCT02025985|21133587|P4|Overall Study|Death|20
6133422|NCT02025985|21133588|P3|Overall Study|Death|23
6133423|NCT02025985|21133589|P2|Overall Study|Death|20
6133424|NCT02025985|21133590|P1|Overall Study|Death|21
6133425|NCT02025985|21133586|P5|Overall Study|Termination of study by Sponsor|3
6133426|NCT02025985|21133587|P4|Overall Study|Termination of study by Sponsor|1
6133427|NCT02025985|21133588|P3|Overall Study|Termination of study by Sponsor|1
6133428|NCT02025985|21133589|P2|Overall Study|Termination of study by Sponsor|3
6133429|NCT02025985|21133590|P1|Overall Study|Termination of study by Sponsor|4
6133430|NCT02025985|21133586|P5|Overall Study|Consent withdrawn|0
6133431|NCT02025985|21133587|P4|Overall Study|Consent withdrawn|0
6133432|NCT02025985|21133588|P3|Overall Study|Consent withdrawn|1
6133433|NCT02025985|21133589|P2|Overall Study|Consent withdrawn|0
6133434|NCT02025985|21133590|P1|Overall Study|Consent withdrawn|0
6133447|NCT01945775|21133700|P2|Overall Study|Ongoing|19
6133448|NCT01945775|21133701|P1|Overall Study|Ongoing|56
6133449|NCT01945775|21133700|P2|Overall Study|Withdrawal by Subject|21
6133450|NCT01945775|21133701|P1|Overall Study|Withdrawal by Subject|10
6133451|NCT01945775|21133700|P2|Overall Study|Lost to Follow-up|7
6133452|NCT01945775|21133701|P1|Overall Study|Lost to Follow-up|11
6133453|NCT01945775|21133700|P2|Overall Study|Death|97
6133454|NCT01945775|21133701|P1|Overall Study|Death|210
6133467|NCT01927367|21133773|P2|Overall Study|No baseline data|1
6133468|NCT01927367|21133774|P1|Overall Study|No baseline data|0
6133469|NCT01927367|21133773|P2|Overall Study|Withdrawal by Subject|4
6133470|NCT01927367|21133774|P1|Overall Study|Withdrawal by Subject|7
6133471|NCT01904903|21133788|P1|Overall Study|Withdrawal by Subject|1
6133472|NCT01875367|21133803|P2|Overall Study|Not receive study treatment|0
6133473|NCT01875367|21133804|P1|Overall Study|Not receive study treatment|1
6133474|NCT01875367|21133803|P2|Overall Study|Not complete at least 2 questionaries|2
6133475|NCT01875367|21133804|P1|Overall Study|Not complete at least 2 questionaries|4
6133476|NCT01850524|21133839|P2|Overall Study|Comorbidities|0
6133477|NCT01850524|21133840|P1|Overall Study|Comorbidities|1
6133478|NCT01850524|21133839|P2|Overall Study|Minimal Response|0
6133479|NCT01850524|21133840|P1|Overall Study|Minimal Response|1
6133481|NCT01850524|21133840|P1|Overall Study|Lack of Improvement|0
6133482|NCT01850524|21133839|P2|Overall Study|Progressive Disease Per Local Lab|0
6133483|NCT01850524|21133840|P1|Overall Study|Progressive Disease Per Local Lab|1
6133484|NCT01850524|21133839|P2|Overall Study|Participants Decision|2
6133485|NCT01850524|21133840|P1|Overall Study|Participants Decision|2
6133486|NCT01850524|21133839|P2|Overall Study|Medical Monitor Decision|1
6133487|NCT01850524|21133840|P1|Overall Study|Medical Monitor Decision|0
6133488|NCT01850524|21133839|P2|Overall Study|Participants Removed From Study|1
6133489|NCT01850524|21133840|P1|Overall Study|Participants Removed From Study|0
6133490|NCT01850524|21133839|P2|Overall Study|Investigator Decision|4
6133491|NCT01850524|21133840|P1|Overall Study|Investigator Decision|4
6133492|NCT01850524|21133839|P2|Overall Study|Participant Wished to Discontinue Treatment|22
6133493|NCT01850524|21133840|P1|Overall Study|Participant Wished to Discontinue Treatment|15
6133494|NCT01850524|21133839|P2|Overall Study|Withdrawal by Subject|19
6133495|NCT01850524|21133840|P1|Overall Study|Withdrawal by Subject|8
6133496|NCT01850524|21133839|P2|Overall Study|Protocol Violation|2
6133497|NCT01850524|21133840|P1|Overall Study|Protocol Violation|1
6133498|NCT01850524|21133839|P2|Overall Study|Progressive Disease|123
6133499|NCT01850524|21133840|P1|Overall Study|Progressive Disease|166
6133500|NCT01850524|21133839|P2|Overall Study|Lost to Follow-up|0
6133501|NCT01850524|21133840|P1|Overall Study|Lost to Follow-up|2
6133502|NCT01850524|21133839|P2|Overall Study|Adverse Event|122
6133503|NCT01850524|21133840|P1|Overall Study|Adverse Event|96
6133504|NCT01850524|21133839|P2|Overall Study|Ongoing on Treatment|54
6133505|NCT01850524|21133840|P1|Overall Study|Ongoing on Treatment|57
6133506|NCT01833520|21133850|P4|Overall Study|Lack of Efficacy|3
6133507|NCT01833520|21133851|P3|Overall Study|Lack of Efficacy|8
6133508|NCT01833520|21133852|P2|Overall Study|Lack of Efficacy|3
6133509|NCT01833520|21133853|P1|Overall Study|Lack of Efficacy|3
6133510|NCT01831427|21133876|P11|Overall Study|Withdrew Consent|1
6133511|NCT01831427|21133877|P10|Overall Study|Withdrew Consent|1
6133512|NCT01831427|21133878|P9|Overall Study|Withdrew Consent|0
6133513|NCT01831427|21133879|P8|Overall Study|Withdrew Consent|0
6133514|NCT01831427|21133880|P7|Overall Study|Withdrew Consent|2
6133515|NCT01831427|21133881|P6|Overall Study|Withdrew Consent|0
6133516|NCT01831427|21133882|P5|Overall Study|Withdrew Consent|0
6133517|NCT01831427|21133883|P4|Overall Study|Withdrew Consent|0
6133518|NCT01831427|21133884|P3|Overall Study|Withdrew Consent|0
6133519|NCT01831427|21133885|P2|Overall Study|Withdrew Consent|0
6133520|NCT01831427|21133886|P1|Overall Study|Withdrew Consent|0
6133521|NCT01831427|21133876|P11|Overall Study|Investigator's Discretion|0
6133522|NCT01831427|21133877|P10|Overall Study|Investigator's Discretion|0
6133523|NCT01831427|21133878|P9|Overall Study|Investigator's Discretion|0
6133524|NCT01831427|21133879|P8|Overall Study|Investigator's Discretion|0
6133525|NCT01831427|21133880|P7|Overall Study|Investigator's Discretion|0
6133526|NCT01831427|21133881|P6|Overall Study|Investigator's Discretion|0
6133527|NCT01831427|21133882|P5|Overall Study|Investigator's Discretion|0
6133528|NCT01831427|21133883|P4|Overall Study|Investigator's Discretion|1
6133529|NCT01831427|21133884|P3|Overall Study|Investigator's Discretion|0
6133530|NCT01831427|21133885|P2|Overall Study|Investigator's Discretion|0
6133531|NCT01831427|21133886|P1|Overall Study|Investigator's Discretion|0
6133532|NCT01831427|21133876|P11|Overall Study|Adverse Event|2
6133533|NCT01831427|21133877|P10|Overall Study|Adverse Event|0
6133534|NCT01831427|21133878|P9|Overall Study|Adverse Event|0
6133535|NCT01831427|21133879|P8|Overall Study|Adverse Event|1
6133536|NCT01831427|21133880|P7|Overall Study|Adverse Event|0
6133537|NCT01831427|21133881|P6|Overall Study|Adverse Event|1
6133538|NCT01831427|21133882|P5|Overall Study|Adverse Event|0
6133539|NCT01831427|21133883|P4|Overall Study|Adverse Event|0
6133540|NCT01831427|21133884|P3|Overall Study|Adverse Event|0
6133541|NCT01831427|21133885|P2|Overall Study|Adverse Event|1
6133542|NCT01831427|21133886|P1|Overall Study|Adverse Event|0
6133543|NCT01801982|21133943|P1|Overall Study|Lost to Follow-up|1
6133548|NCT01784068|21133962|P2|TFR Phase|Lack of Efficacy|88
6133549|NCT01784068|21133963|P1|TFR Phase|Lack of Efficacy|0
6133550|NCT01784068|21133962|P2|TFR Phase|Death|1
6133551|NCT01784068|21133963|P1|TFR Phase|Death|0
6133552|NCT01784068|21133962|P2|TFR Phase|Patient/guardian decision|3
6133553|NCT01784068|21133963|P1|TFR Phase|Patient/guardian decision|0
6133554|NCT01784068|21133962|P2|TFR Phase|Physician Decision|1
6133555|NCT01784068|21133963|P1|TFR Phase|Physician Decision|0
6133556|NCT01784068|21133962|P2|NTCS Phase|Completed phase = discontinuation of study except for TFR and TFR2 phases|0
6133557|NCT01784068|21133963|P1|NTCS Phase|Completed phase = discontinuation of study except for TFR and TFR2 phases|203
6133558|NCT01784068|21133962|P2|NTCS Phase|Death|0
6133559|NCT01784068|21133963|P1|NTCS Phase|Death|2
6133560|NCT01784068|21133962|P2|NTCS Phase|Patient/guardian decision|0
6133561|NCT01784068|21133963|P1|NTCS Phase|Patient/guardian decision|3
6133562|NCT01784068|21133962|P2|NTCS Phase|Physician Decision|0
6133563|NCT01784068|21133963|P1|NTCS Phase|Physician Decision|2
6133564|NCT01784068|21133962|P2|NTCS Phase|Adverse Event|0
6133565|NCT01784068|21133963|P1|NTCS Phase|Adverse Event|5
6133572|NCT01751906|21134048|P2|Overall Study|Denied on premises for follow-up by law|0
6133573|NCT01751906|21134049|P1|Overall Study|Denied on premises for follow-up by law|1
6133574|NCT01751906|21134048|P2|Overall Study|Death|43
6133575|NCT01751906|21134049|P1|Overall Study|Death|84
6133576|NCT01751906|21134048|P2|Overall Study|Physician Decision|2
6133577|NCT01751906|21134049|P1|Overall Study|Physician Decision|5
6133578|NCT01751906|21134048|P2|Overall Study|Withdrawal by Subject|18
6133579|NCT01751906|21134049|P1|Overall Study|Withdrawal by Subject|22
6133580|NCT01751906|21134048|P2|Overall Study|Lost to Follow-up|68
6133581|NCT01751906|21134049|P1|Overall Study|Lost to Follow-up|151
6133617|NCT01698905|21134212|P1|Overall Study|Death|1
6133618|NCT01698905|21134212|P1|Overall Study|Subject/guardian decision|2
6133619|NCT01698905|21134212|P1|Overall Study|Protocol Violation|1
6133620|NCT01698905|21134212|P1|Overall Study|Pregnancy|1
6133621|NCT01698905|21134212|P1|Overall Study|Physician Decision|2
6133622|NCT01698905|21134212|P1|Overall Study|Adverse Event|4
6133635|NCT01642407|21134238|P1|Part 2(Week17 to Maximum of 119.6 Weeks)|Change of treatment plan|1
6133636|NCT01642407|21134238|P1|Part 2(Week17 to Maximum of 119.6 Weeks)|Coil Embolization|1
6133637|NCT01642407|21134238|P1|Part 1 (Screening Till Week 16)|Insufficient clinical response|3
6133638|NCT01619865|21134283|P1|Overall Study|subject not able to comply|1
6133639|NCT01619865|21134283|P1|Overall Study|Death|2
6133640|NCT01619865|21134283|P1|Overall Study|Adverse Event|1
6133641|NCT01609790|21134291|P3|Overall Study|Protocol Violation|8
6133642|NCT01609790|21134292|P2|Overall Study|Protocol Violation|7
6133643|NCT01609790|21134293|P1|Overall Study|Protocol Violation|1
6133644|NCT01593917|21134331|P1|Overall Study|Physician Decision|3
6133645|NCT01593917|21134331|P1|Overall Study|Protocol Violation|5
6133646|NCT01593917|21134331|P1|Overall Study|Lost to Follow-up|12
6133647|NCT01593917|21134331|P1|Overall Study|Withdrawal by Subject|23
6133648|NCT01593917|21134331|P1|Overall Study|Valve-in-valve Transcatheter Aortic Valve Implantation (TAVI) or Surgical Explant|60
6133649|NCT01593917|21134331|P1|Overall Study|Death|67
6133650|NCT01565941|21134405|P2|Overall Study|Randomized; did not receive intevention|2
6133651|NCT01565941|21134406|P1|Overall Study|Randomized; did not receive intevention|8
6133652|NCT01565941|21134405|P2|Overall Study|Withdrawn by parent/guardian|2
6133653|NCT01565941|21134406|P1|Overall Study|Withdrawn by parent/guardian|3
6133654|NCT01557244|21134457|P7|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0
6133655|NCT01557244|21134458|P6|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0
6133656|NCT01557244|21134459|P5|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0
6133657|NCT01557244|21134460|P4|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0
6133658|NCT01557244|21134461|P3|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0
6133659|NCT01557244|21134462|P2|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|2
6133660|NCT01557244|21134463|P1|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|1
6133661|NCT01557244|21134457|P7|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0
6133662|NCT01557244|21134458|P6|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0
6133663|NCT01557244|21134459|P5|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0
6133664|NCT01557244|21134460|P4|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|1
6133665|NCT01557244|21134461|P3|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0
6133666|NCT01557244|21134462|P2|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0
6133667|NCT01557244|21134463|P1|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0
6133668|NCT01557244|21134457|P7|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0
6133669|NCT01557244|21134458|P6|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0
6133670|NCT01557244|21134459|P5|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0
6133671|NCT01557244|21134460|P4|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0
6133672|NCT01557244|21134461|P3|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0
6133673|NCT01557244|21134462|P2|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|1
6133674|NCT01557244|21134463|P1|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|1
6133675|NCT01557244|21134457|P7|Safety Extension Phase: 12 Weeks|Adverse Event|0
6133676|NCT01557244|21134458|P6|Safety Extension Phase: 12 Weeks|Adverse Event|1
6133677|NCT01557244|21134459|P5|Safety Extension Phase: 12 Weeks|Adverse Event|0
6133678|NCT01557244|21134460|P4|Safety Extension Phase: 12 Weeks|Adverse Event|0
6133679|NCT01557244|21134461|P3|Safety Extension Phase: 12 Weeks|Adverse Event|0
6133680|NCT01557244|21134462|P2|Safety Extension Phase: 12 Weeks|Adverse Event|1
6133681|NCT01557244|21134463|P1|Safety Extension Phase: 12 Weeks|Adverse Event|1
6133682|NCT01557244|21134457|P7|Active Comparator/Efficacy Phase:12Weeks|Other|0
6133683|NCT01557244|21134458|P6|Active Comparator/Efficacy Phase:12Weeks|Other|0
6133684|NCT01557244|21134459|P5|Active Comparator/Efficacy Phase:12Weeks|Other|0
6133685|NCT01557244|21134460|P4|Active Comparator/Efficacy Phase:12Weeks|Other|0
6133686|NCT01557244|21134461|P3|Active Comparator/Efficacy Phase:12Weeks|Other|2
6133687|NCT01557244|21134462|P2|Active Comparator/Efficacy Phase:12Weeks|Other|0
6133688|NCT01557244|21134463|P1|Active Comparator/Efficacy Phase:12Weeks|Other|2
6133689|NCT01557244|21134457|P7|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0
6133690|NCT01557244|21134458|P6|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1
6133691|NCT01557244|21134459|P5|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0
6133692|NCT01557244|21134460|P4|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0
6133693|NCT01557244|21134461|P3|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1
6133694|NCT01557244|21134462|P2|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1
6133695|NCT01557244|21134463|P1|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0
6133696|NCT01557244|21134457|P7|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|1
6133697|NCT01557244|21134458|P6|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|1
6133698|NCT01557244|21134459|P5|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0
6133699|NCT01557244|21134460|P4|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0
6133700|NCT01557244|21134461|P3|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0
6133701|NCT01557244|21134462|P2|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0
6133702|NCT01557244|21134463|P1|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0
6133703|NCT01557244|21134457|P7|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0
6133704|NCT01557244|21134458|P6|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0
6133705|NCT01557244|21134459|P5|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0
6133706|NCT01557244|21134460|P4|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0
6133707|NCT01557244|21134461|P3|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0
6133708|NCT01557244|21134462|P2|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|1
6133709|NCT01557244|21134463|P1|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0
6133710|NCT01557244|21134457|P7|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0
6133711|NCT01557244|21134458|P6|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|3
6133712|NCT01557244|21134459|P5|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0
6133713|NCT01557244|21134460|P4|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0
6133714|NCT01557244|21134461|P3|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0
6133715|NCT01557244|21134462|P2|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0
6133716|NCT01557244|21134463|P1|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|2
6133717|NCT01557244|21134457|P7|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0
6133718|NCT01557244|21134458|P6|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0
6133719|NCT01557244|21134459|P5|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0
6133720|NCT01557244|21134460|P4|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0
6133721|NCT01557244|21134461|P3|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0
6133722|NCT01557244|21134462|P2|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0
6133723|NCT01557244|21134463|P1|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|1
6133724|NCT01557244|21134457|P7|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0
6133725|NCT01557244|21134458|P6|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0
6133726|NCT01557244|21134459|P5|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0
6133727|NCT01557244|21134460|P4|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0
6133728|NCT01557244|21134461|P3|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|1
6133729|NCT01557244|21134462|P2|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0
6133730|NCT01557244|21134463|P1|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|2
6133731|NCT01557244|21134457|P7|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0
6133732|NCT01557244|21134458|P6|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|2
6133733|NCT01557244|21134459|P5|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0
6133734|NCT01557244|21134460|P4|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0
6133735|NCT01557244|21134461|P3|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0
6133736|NCT01557244|21134462|P2|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0
6133737|NCT01557244|21134463|P1|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|2
6133742|NCT01445080|21134797|P9|Overall Study|Ineligible/Inevaluable|6
6133743|NCT01445080|21134798|P8|Overall Study|Ineligible/Inevaluable|0
6133744|NCT01445080|21134799|P7|Overall Study|Ineligible/Inevaluable|0
6133745|NCT01445080|21134800|P6|Overall Study|Ineligible/Inevaluable|3
6133746|NCT01445080|21134801|P5|Overall Study|Ineligible/Inevaluable|2
6133747|NCT01445080|21134802|P4|Overall Study|Ineligible/Inevaluable|1
6133748|NCT01445080|21134803|P3|Overall Study|Ineligible/Inevaluable|0
6133749|NCT01445080|21134804|P2|Overall Study|Ineligible/Inevaluable|2
6133750|NCT01445080|21134805|P1|Overall Study|Ineligible/Inevaluable|1
6133751|NCT01445080|21134797|P9|Overall Study|Withdrawal by Subject|2
6133752|NCT01445080|21134798|P8|Overall Study|Withdrawal by Subject|0
6133753|NCT01445080|21134799|P7|Overall Study|Withdrawal by Subject|0
6133754|NCT01445080|21134800|P6|Overall Study|Withdrawal by Subject|0
6133755|NCT01445080|21134801|P5|Overall Study|Withdrawal by Subject|0
6133756|NCT01445080|21134802|P4|Overall Study|Withdrawal by Subject|1
6133757|NCT01445080|21134803|P3|Overall Study|Withdrawal by Subject|0
6133758|NCT01445080|21134804|P2|Overall Study|Withdrawal by Subject|0
6133759|NCT01445080|21134805|P1|Overall Study|Withdrawal by Subject|1
6133760|NCT01445080|21134797|P9|Overall Study|Physician Decision|0
6133761|NCT01445080|21134798|P8|Overall Study|Physician Decision|2
6133762|NCT01445080|21134799|P7|Overall Study|Physician Decision|2
6133763|NCT01445080|21134800|P6|Overall Study|Physician Decision|3
6133764|NCT01445080|21134801|P5|Overall Study|Physician Decision|0
6133765|NCT01445080|21134802|P4|Overall Study|Physician Decision|0
6133766|NCT01445080|21134803|P3|Overall Study|Physician Decision|1
6133767|NCT01445080|21134804|P2|Overall Study|Physician Decision|0
6133768|NCT01445080|21134805|P1|Overall Study|Physician Decision|0
6133769|NCT01445080|21134797|P9|Overall Study|Adverse Event|10
6133770|NCT01445080|21134798|P8|Overall Study|Adverse Event|3
6133771|NCT01445080|21134799|P7|Overall Study|Adverse Event|0
6133772|NCT01445080|21134800|P6|Overall Study|Adverse Event|3
6133773|NCT01445080|21134801|P5|Overall Study|Adverse Event|2
6133774|NCT01445080|21134802|P4|Overall Study|Adverse Event|6
6133775|NCT01445080|21134803|P3|Overall Study|Adverse Event|11
6133776|NCT01445080|21134804|P2|Overall Study|Adverse Event|3
6133777|NCT01445080|21134805|P1|Overall Study|Adverse Event|5
6133778|NCT01364389|21134941|P3|Overall Study|Adverse Event|0
6133779|NCT01364389|21134942|P2|Overall Study|Adverse Event|0
6133780|NCT01364389|21134943|P1|Overall Study|Adverse Event|1
6133781|NCT01364389|21134941|P3|Overall Study|Administrative problems|0
6133782|NCT01364389|21134942|P2|Overall Study|Administrative problems|0
6133783|NCT01364389|21134943|P1|Overall Study|Administrative problems|1
6133784|NCT01364389|21134941|P3|Overall Study|Protocol deviation|1
6133785|NCT01364389|21134942|P2|Overall Study|Protocol deviation|0
6133786|NCT01364389|21134943|P1|Overall Study|Protocol deviation|0
6133787|NCT01364389|21134941|P3|Overall Study|Withdrawal by Subject|0
6133788|NCT01364389|21134942|P2|Overall Study|Withdrawal by Subject|1
6133789|NCT01364389|21134943|P1|Overall Study|Withdrawal by Subject|0
6133830|NCT01243177|21135173|P2|Overall Study|Other Reason|12
6133831|NCT01243177|21135174|P1|Overall Study|Other Reason|11
6133832|NCT01243177|21135173|P2|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1
6133833|NCT01243177|21135174|P1|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
6133834|NCT01243177|21135173|P2|Overall Study|SAE, fatal + SAE, non-fatal|0
6133835|NCT01243177|21135174|P1|Overall Study|SAE, fatal + SAE, non-fatal|1
6133836|NCT01243177|21135173|P2|Overall Study|AE, non-serious non-fatal|58
6133837|NCT01243177|21135174|P1|Overall Study|AE, non-serious non-fatal|40
6133838|NCT01243177|21135173|P2|Overall Study|SAE, non-fatal|9
6133839|NCT01243177|21135174|P1|Overall Study|SAE, non-fatal|7
6133840|NCT01243177|21135173|P2|Overall Study|AE, serious fatal|1
6133841|NCT01243177|21135174|P1|Overall Study|AE, serious fatal|0
6133842|NCT01243177|21135173|P2|Overall Study|Withdrawal by Subject|38
6133843|NCT01243177|21135174|P1|Overall Study|Withdrawal by Subject|46
6133844|NCT01243177|21135173|P2|Overall Study|Lost to Follow-up|18
6133845|NCT01243177|21135174|P1|Overall Study|Lost to Follow-up|15
6133846|NCT01243177|21135173|P2|Overall Study|Protocol Violation|10
6133847|NCT01243177|21135174|P1|Overall Study|Protocol Violation|11
6133848|NCT01243177|21135173|P2|Overall Study|Lack of Efficacy|31
6133849|NCT01243177|21135174|P1|Overall Study|Lack of Efficacy|47
6133850|NCT01236560|21135196|P6|Overall Study|Progressive disease|0
6133851|NCT01236560|21135197|P5|Overall Study|Progressive disease|0
6133852|NCT01236560|21135198|P4|Overall Study|Progressive disease|16
6133853|NCT01236560|21135199|P3|Overall Study|Progressive disease|9
6133854|NCT01236560|21135200|P2|Overall Study|Progressive disease|19
6133855|NCT01236560|21135201|P1|Overall Study|Progressive disease|5
6133856|NCT01236560|21135196|P6|Overall Study|Withdrawal by Subject|0
6133857|NCT01236560|21135197|P5|Overall Study|Withdrawal by Subject|0
6133858|NCT01236560|21135198|P4|Overall Study|Withdrawal by Subject|2
6133859|NCT01236560|21135199|P3|Overall Study|Withdrawal by Subject|1
6133860|NCT01236560|21135200|P2|Overall Study|Withdrawal by Subject|0
6133861|NCT01236560|21135201|P1|Overall Study|Withdrawal by Subject|0
6133862|NCT01236560|21135196|P6|Overall Study|Physician Decision|0
6133863|NCT01236560|21135197|P5|Overall Study|Physician Decision|0
6133864|NCT01236560|21135198|P4|Overall Study|Physician Decision|0
6133865|NCT01236560|21135199|P3|Overall Study|Physician Decision|8
6133866|NCT01236560|21135200|P2|Overall Study|Physician Decision|1
6133867|NCT01236560|21135201|P1|Overall Study|Physician Decision|0
6133868|NCT01236560|21135196|P6|Overall Study|Lost to Follow-up|0
6133869|NCT01236560|21135197|P5|Overall Study|Lost to Follow-up|0
6133870|NCT01236560|21135198|P4|Overall Study|Lost to Follow-up|0
6133871|NCT01236560|21135199|P3|Overall Study|Lost to Follow-up|1
6133872|NCT01236560|21135200|P2|Overall Study|Lost to Follow-up|1
6133873|NCT01236560|21135201|P1|Overall Study|Lost to Follow-up|0
6133874|NCT01236560|21135196|P6|Overall Study|Death|0
6133875|NCT01236560|21135197|P5|Overall Study|Death|0
6133876|NCT01236560|21135198|P4|Overall Study|Death|1
6133877|NCT01236560|21135199|P3|Overall Study|Death|0
6133878|NCT01236560|21135200|P2|Overall Study|Death|1
6133879|NCT01236560|21135201|P1|Overall Study|Death|0
6133880|NCT01236560|21135196|P6|Overall Study|Adverse Event|0
6133881|NCT01236560|21135197|P5|Overall Study|Adverse Event|0
6133882|NCT01236560|21135198|P4|Overall Study|Adverse Event|3
6133883|NCT01236560|21135199|P3|Overall Study|Adverse Event|1
6133884|NCT01236560|21135200|P2|Overall Study|Adverse Event|2
6133885|NCT01236560|21135201|P1|Overall Study|Adverse Event|0
6133912|NCT01207440|21135265|P7|Overall Study|Reason Not Specified|0
6133913|NCT01207440|21135266|P6|Overall Study|Reason Not Specified|3
6133914|NCT01207440|21135267|P5|Overall Study|Reason Not Specified|4
6133915|NCT01207440|21135268|P4|Overall Study|Reason Not Specified|0
6133916|NCT01207440|21135269|P3|Overall Study|Reason Not Specified|7
6133917|NCT01207440|21135270|P2|Overall Study|Reason Not Specified|10
6133918|NCT01207440|21135271|P1|Overall Study|Reason Not Specified|10
6133919|NCT01207440|21135265|P7|Overall Study|Withdrawal by Subject|0
6133920|NCT01207440|21135266|P6|Overall Study|Withdrawal by Subject|2
6133921|NCT01207440|21135267|P5|Overall Study|Withdrawal by Subject|2
6133922|NCT01207440|21135268|P4|Overall Study|Withdrawal by Subject|3
6133923|NCT01207440|21135269|P3|Overall Study|Withdrawal by Subject|5
6133924|NCT01207440|21135270|P2|Overall Study|Withdrawal by Subject|4
6133925|NCT01207440|21135271|P1|Overall Study|Withdrawal by Subject|29
6133926|NCT01207440|21135265|P7|Overall Study|Site Terminated by Sponsor|2
6133927|NCT01207440|21135266|P6|Overall Study|Site Terminated by Sponsor|0
6133928|NCT01207440|21135267|P5|Overall Study|Site Terminated by Sponsor|3
6133929|NCT01207440|21135268|P4|Overall Study|Site Terminated by Sponsor|2
6133930|NCT01207440|21135269|P3|Overall Study|Site Terminated by Sponsor|12
6133931|NCT01207440|21135270|P2|Overall Study|Site Terminated by Sponsor|19
6133932|NCT01207440|21135271|P1|Overall Study|Site Terminated by Sponsor|69
6133933|NCT01207440|21135265|P7|Overall Study|Protocol Violation|0
6133934|NCT01207440|21135266|P6|Overall Study|Protocol Violation|0
6133935|NCT01207440|21135267|P5|Overall Study|Protocol Violation|0
6133936|NCT01207440|21135268|P4|Overall Study|Protocol Violation|0
6133937|NCT01207440|21135269|P3|Overall Study|Protocol Violation|0
6133938|NCT01207440|21135270|P2|Overall Study|Protocol Violation|0
6133939|NCT01207440|21135271|P1|Overall Study|Protocol Violation|2
6133940|NCT01207440|21135265|P7|Overall Study|Progressive Disease|0
6133941|NCT01207440|21135266|P6|Overall Study|Progressive Disease|27
6133942|NCT01207440|21135267|P5|Overall Study|Progressive Disease|23
6133943|NCT01207440|21135268|P4|Overall Study|Progressive Disease|7
6133944|NCT01207440|21135269|P3|Overall Study|Progressive Disease|19
6133945|NCT01207440|21135270|P2|Overall Study|Progressive Disease|10
6133946|NCT01207440|21135271|P1|Overall Study|Progressive Disease|19
6133947|NCT01207440|21135265|P7|Overall Study|Physician Decision|0
6133948|NCT01207440|21135266|P6|Overall Study|Physician Decision|0
6133949|NCT01207440|21135267|P5|Overall Study|Physician Decision|1
6133950|NCT01207440|21135268|P4|Overall Study|Physician Decision|0
6133951|NCT01207440|21135269|P3|Overall Study|Physician Decision|5
6133952|NCT01207440|21135270|P2|Overall Study|Physician Decision|5
6133953|NCT01207440|21135271|P1|Overall Study|Physician Decision|6
6133954|NCT01207440|21135265|P7|Overall Study|Non-compliance with Study Drug|0
6133955|NCT01207440|21135266|P6|Overall Study|Non-compliance with Study Drug|0
6133956|NCT01207440|21135267|P5|Overall Study|Non-compliance with Study Drug|0
6133957|NCT01207440|21135268|P4|Overall Study|Non-compliance with Study Drug|0
6133958|NCT01207440|21135269|P3|Overall Study|Non-compliance with Study Drug|1
6133959|NCT01207440|21135270|P2|Overall Study|Non-compliance with Study Drug|0
6133960|NCT01207440|21135271|P1|Overall Study|Non-compliance with Study Drug|3
6133961|NCT01207440|21135265|P7|Overall Study|Lost to Follow-up|0
6133962|NCT01207440|21135266|P6|Overall Study|Lost to Follow-up|0
6133963|NCT01207440|21135267|P5|Overall Study|Lost to Follow-up|0
6133964|NCT01207440|21135268|P4|Overall Study|Lost to Follow-up|1
6133965|NCT01207440|21135269|P3|Overall Study|Lost to Follow-up|2
6133966|NCT01207440|21135270|P2|Overall Study|Lost to Follow-up|0
6133967|NCT01207440|21135271|P1|Overall Study|Lost to Follow-up|0
6133968|NCT01207440|21135265|P7|Overall Study|Lack of Efficacy|0
6133969|NCT01207440|21135266|P6|Overall Study|Lack of Efficacy|3
6133970|NCT01207440|21135267|P5|Overall Study|Lack of Efficacy|2
6133971|NCT01207440|21135268|P4|Overall Study|Lack of Efficacy|1
6133972|NCT01207440|21135269|P3|Overall Study|Lack of Efficacy|5
6133973|NCT01207440|21135270|P2|Overall Study|Lack of Efficacy|2
6133974|NCT01207440|21135271|P1|Overall Study|Lack of Efficacy|13
6133975|NCT01207440|21135265|P7|Overall Study|Death|1
6133976|NCT01207440|21135266|P6|Overall Study|Death|5
6133977|NCT01207440|21135267|P5|Overall Study|Death|7
6133978|NCT01207440|21135268|P4|Overall Study|Death|2
6133979|NCT01207440|21135269|P3|Overall Study|Death|2
6133980|NCT01207440|21135270|P2|Overall Study|Death|3
6133981|NCT01207440|21135271|P1|Overall Study|Death|6
6133982|NCT01207440|21135265|P7|Overall Study|Adverse Event|2
6133983|NCT01207440|21135266|P6|Overall Study|Adverse Event|6
6133984|NCT01207440|21135267|P5|Overall Study|Adverse Event|6
6133985|NCT01207440|21135268|P4|Overall Study|Adverse Event|2
6133986|NCT01207440|21135269|P3|Overall Study|Adverse Event|7
6133987|NCT01207440|21135270|P2|Overall Study|Adverse Event|11
6133988|NCT01207440|21135271|P1|Overall Study|Adverse Event|46
6134023|NCT01069861|21135396|P1|Overall Study|Did not meet entrance criteria|1
6134024|NCT01069861|21135396|P1|Overall Study|Adverse Event|1
6134025|NCT01069861|21135396|P1|Overall Study|Death|1
6134026|NCT01062113|21135412|P3|Overall Study|Withdrawal by Subject|0
6134027|NCT01062113|21135413|P2|Overall Study|Withdrawal by Subject|0
6134028|NCT01062113|21135414|P1|Overall Study|Withdrawal by Subject|1
6134029|NCT01062113|21135412|P3|Overall Study|Lack of Efficacy|31
6134030|NCT01062113|21135413|P2|Overall Study|Lack of Efficacy|22
6134031|NCT01062113|21135414|P1|Overall Study|Lack of Efficacy|38
6134032|NCT01062113|21135412|P3|Overall Study|Adverse Event|0
6134033|NCT01062113|21135413|P2|Overall Study|Adverse Event|0
6134034|NCT01062113|21135414|P1|Overall Study|Adverse Event|1
6134053|NCT00994461|21135498|P3|Overall Study|Adverse Event|0
6134054|NCT00994461|21135499|P2|Overall Study|Adverse Event|1
6134055|NCT00994461|21135500|P1|Overall Study|Adverse Event|2
6134056|NCT00976716|21135526|P1|Overall Study|Adverse Event|1
6134057|NCT00946114|21135544|P2|Overall Study|Withdrawal by Subject|0
6134058|NCT00946114|21135545|P1|Overall Study|Withdrawal by Subject|2
6134059|NCT00946114|21135544|P2|Overall Study|Other|0
6134060|NCT00946114|21135545|P1|Overall Study|Other|1
6134061|NCT00946114|21135544|P2|Overall Study|Death|2
6134062|NCT00946114|21135545|P1|Overall Study|Death|5
6134072|NCT00904748|21135611|P6|Overall Study|Adverse Event|0
6134073|NCT00904748|21135612|P5|Overall Study|Adverse Event|1
6134074|NCT00904748|21135613|P4|Overall Study|Adverse Event|0
6134075|NCT00904748|21135614|P3|Overall Study|Adverse Event|0
6134076|NCT00904748|21135615|P2|Overall Study|Adverse Event|0
6134077|NCT00904748|21135616|P1|Overall Study|Adverse Event|0
6134078|NCT00904748|21135611|P6|Overall Study|Withdrawal by Subject|0
6134079|NCT00904748|21135612|P5|Overall Study|Withdrawal by Subject|0
6134080|NCT00904748|21135613|P4|Overall Study|Withdrawal by Subject|2
6134081|NCT00904748|21135614|P3|Overall Study|Withdrawal by Subject|1
6134082|NCT00904748|21135615|P2|Overall Study|Withdrawal by Subject|1
6134083|NCT00904748|21135616|P1|Overall Study|Withdrawal by Subject|1
6134084|NCT00894790|21135642|P2|Overall Study|Did not meet entrance criteria|0
6134085|NCT00894790|21135643|P1|Overall Study|Did not meet entrance criteria|1
6134086|NCT00894790|21135642|P2|Overall Study|Lost to Follow-up|1
6134087|NCT00894790|21135643|P1|Overall Study|Lost to Follow-up|0
6134088|NCT00894790|21135642|P2|Overall Study|Protocol Violation|1
6134089|NCT00894790|21135643|P1|Overall Study|Protocol Violation|0
6134125|NCT00830180|21135813|P1|Overall Study|Other - Unspecified|1
6134126|NCT00830180|21135813|P1|Overall Study|Progressive disease|2
6134127|NCT00830180|21135813|P1|Overall Study|Withdrawal by Subject|5
6134128|NCT00830180|21135813|P1|Overall Study|Insufficient clinical response|1
6134129|NCT00830180|21135813|P1|Overall Study|Death|11
6134130|NCT00830180|21135813|P1|Overall Study|Adverse Event|6
6134131|NCT00807846|21135866|P2|Overall Study|Other|2
6134132|NCT00807846|21135867|P1|Overall Study|Other|1
6134133|NCT00807846|21135866|P2|Overall Study|Withdrawal by Subject|1
6134134|NCT00807846|21135867|P1|Overall Study|Withdrawal by Subject|2
6134135|NCT00807846|21135866|P2|Overall Study|Protocol Violation|1
6134136|NCT00807846|21135867|P1|Overall Study|Protocol Violation|2
6134137|NCT00807846|21135866|P2|Overall Study|Lack of Efficacy|0
6134138|NCT00807846|21135867|P1|Overall Study|Lack of Efficacy|2
6134139|NCT00807846|21135866|P2|Overall Study|Adverse Event|0
6134140|NCT00807846|21135867|P1|Overall Study|Adverse Event|5
6134141|NCT00762463|21135907|P4|Extension Phase (Week 6 to Week 12)|Other|1
6134142|NCT00762463|21135908|P3|Extension Phase (Week 6 to Week 12)|Other|0
6134143|NCT00762463|21135909|P2|Extension Phase (Week 6 to Week 12)|Other|0
6134144|NCT00762463|21135910|P1|Extension Phase (Week 6 to Week 12)|Other|0
6134145|NCT00762463|21135907|P4|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0
6134146|NCT00762463|21135908|P3|Extension Phase (Week 6 to Week 12)|No longer willing to participate|3
6134147|NCT00762463|21135909|P2|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0
6134148|NCT00762463|21135910|P1|Extension Phase (Week 6 to Week 12)|No longer willing to participate|1
6134149|NCT00762463|21135907|P4|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1
6134150|NCT00762463|21135908|P3|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|0
6134151|NCT00762463|21135909|P2|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1
6134152|NCT00762463|21135910|P1|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1
6134153|NCT00762463|21135907|P4|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0
6134154|NCT00762463|21135908|P3|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1
6134155|NCT00762463|21135909|P2|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0
6134156|NCT00762463|21135910|P1|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1
6134157|NCT00762463|21135907|P4|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0
6134158|NCT00762463|21135908|P3|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0
6134159|NCT00762463|21135909|P2|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|1
6134160|NCT00762463|21135910|P1|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|4
6134161|NCT00762463|21135907|P4|Double-blind Phase (Baseline to Week 6)|Adverse Event|0
6134162|NCT00762463|21135908|P3|Double-blind Phase (Baseline to Week 6)|Adverse Event|0
6134163|NCT00762463|21135909|P2|Double-blind Phase (Baseline to Week 6)|Adverse Event|4
6134164|NCT00762463|21135910|P1|Double-blind Phase (Baseline to Week 6)|Adverse Event|2
6134165|NCT00762463|21135907|P4|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0
6134166|NCT00762463|21135908|P3|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0
6134167|NCT00762463|21135909|P2|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|4
6134168|NCT00762463|21135910|P1|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|3
6134169|NCT00762463|21135907|P4|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0
6134170|NCT00762463|21135908|P3|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0
6134171|NCT00762463|21135909|P2|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2
6134172|NCT00762463|21135910|P1|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2
6134173|NCT00759174|21135994|P2|Overall Study|Other|2
6134174|NCT00759174|21135995|P1|Overall Study|Other|0
6134175|NCT00750919|21136004|P1|Overall Study|Other|36
6134176|NCT00750919|21136004|P1|Overall Study|Could not cooperate, unrelated to trial|4
6134177|NCT00750919|21136004|P1|Overall Study|Lack of Efficacy|8
6134178|NCT00750919|21136004|P1|Overall Study|Withdrawal by Subject|1
6134179|NCT00750919|21136004|P1|Overall Study|Adverse Event|9
6134188|NCT00688545|21136041|P2|Overall Study|Unspecified, unrelated to AE/Toxicity|7
6134189|NCT00688545|21136042|P1|Overall Study|Unspecified, unrelated to AE/Toxicity|2
6134190|NCT00688545|21136041|P2|Overall Study|Withdrawal by Subject|3
6134191|NCT00688545|21136042|P1|Overall Study|Withdrawal by Subject|2
6134192|NCT00688545|21136041|P2|Overall Study|Insurance/cost of drug|1
6134193|NCT00688545|21136042|P1|Overall Study|Insurance/cost of drug|0
6134194|NCT00688545|21136041|P2|Overall Study|Lost to Follow-up|4
6134195|NCT00688545|21136042|P1|Overall Study|Lost to Follow-up|1
6134196|NCT00682448|21136052|P2|Overall Study|Withdrawal by Subject|0
6134197|NCT00682448|21136053|P1|Overall Study|Withdrawal by Subject|2
6134198|NCT00682448|21136052|P2|Overall Study|Pregnancy|1
6134199|NCT00682448|21136053|P1|Overall Study|Pregnancy|0
6134200|NCT00682448|21136052|P2|Overall Study|Lost to Follow-up|3
6134201|NCT00682448|21136053|P1|Overall Study|Lost to Follow-up|1
6134202|NCT00682448|21136052|P2|Overall Study|Lack of Efficacy|0
6134203|NCT00682448|21136053|P1|Overall Study|Lack of Efficacy|1
6134204|NCT00682448|21136052|P2|Overall Study|Adverse Event|2
6134205|NCT00682448|21136053|P1|Overall Study|Adverse Event|1
6134206|NCT00666198|21136061|P1|Overall Study|No Drug Administration|4
6134207|NCT00666198|21136061|P1|Overall Study|Safety Not Assessable|6
6134208|NCT00666198|21136061|P1|Overall Study|No Visit After First Day of Treatment|13
6134209|NCT00666198|21136061|P1|Overall Study|Protocol Violation|10
6134210|NCT00653068|21136078|P1|Overall Study|Ineligible|2
6134211|NCT00653068|21136078|P1|Overall Study|Withdrawal by Subject|1
6134212|NCT00653068|21136078|P1|Overall Study|Physician Decision|4
6134213|NCT00653068|21136078|P1|Overall Study|Lack of Efficacy|34
6134214|NCT00653068|21136078|P1|Overall Study|Death|9
6134311|NCT00638157|21136264|P2|Overall Study|Randomized, not treated|0
6134312|NCT00638157|21136265|P1|Overall Study|Randomized, not treated|2
6134313|NCT00638157|21136264|P2|Overall Study|Other|2
6134314|NCT00638157|21136265|P1|Overall Study|Other|1
6134315|NCT00638157|21136264|P2|Overall Study|Physician Decision|0
6134316|NCT00638157|21136265|P1|Overall Study|Physician Decision|1
6134317|NCT00638157|21136264|P2|Overall Study|Lost to Follow-up|0
6134318|NCT00638157|21136265|P1|Overall Study|Lost to Follow-up|1
6134319|NCT00638157|21136264|P2|Overall Study|Microbiological failure|0
6134320|NCT00638157|21136265|P1|Overall Study|Microbiological failure|1
6134321|NCT00638157|21136264|P2|Overall Study|Clinical (symptomatic) failure|1
6134322|NCT00638157|21136265|P1|Overall Study|Clinical (symptomatic) failure|1
6134323|NCT00638157|21136264|P2|Overall Study|Adverse Event|1
6134324|NCT00638157|21136265|P1|Overall Study|Adverse Event|0
6134343|NCT00604500|21136295|P1|Overall Study|Did not meet protocol eligibility|1
6134344|NCT00604500|21136295|P1|Overall Study|Administrative|1
6134345|NCT00604500|21136295|P1|Overall Study|Withdrawal by Subject|4
6134346|NCT00604500|21136295|P1|Overall Study|Treatment Failure|1
6134347|NCT00604500|21136295|P1|Overall Study|Protocol Violation|2
6134348|NCT00604500|21136295|P1|Overall Study|Adverse Event|2
6134352|NCT00591630|21136312|P4|Overall Study|Death|0
6134353|NCT00591630|21136313|P3|Overall Study|Death|1
6134354|NCT00591630|21136314|P2|Overall Study|Death|0
6134355|NCT00591630|21136315|P1|Overall Study|Death|0
6134356|NCT00570765|21136369|P4|LTSE Phase|Physician Decision|4
6134357|NCT00570765|21136370|P3|LTSE Phase|Physician Decision|0
6134358|NCT00570765|21136371|P2|LTSE Phase|Physician Decision|0
6134359|NCT00570765|21136372|P1|LTSE Phase|Physician Decision|0
6134360|NCT00570765|21136369|P4|LTSE Phase|Adverse Event|7
6134361|NCT00570765|21136370|P3|LTSE Phase|Adverse Event|0
6134362|NCT00570765|21136371|P2|LTSE Phase|Adverse Event|0
6134363|NCT00570765|21136372|P1|LTSE Phase|Adverse Event|0
6134364|NCT00570765|21136369|P4|LTSE Phase|Withdrawal by Subject|1
6134365|NCT00570765|21136370|P3|LTSE Phase|Withdrawal by Subject|0
6134366|NCT00570765|21136371|P2|LTSE Phase|Withdrawal by Subject|0
6134367|NCT00570765|21136372|P1|LTSE Phase|Withdrawal by Subject|0
6134368|NCT00570765|21136369|P4|DB Phase|Did Not Receive Study Drug|0
6134369|NCT00570765|21136370|P3|DB Phase|Did Not Receive Study Drug|1
6134370|NCT00570765|21136371|P2|DB Phase|Did Not Receive Study Drug|0
6134371|NCT00570765|21136372|P1|DB Phase|Did Not Receive Study Drug|0
6134372|NCT00570765|21136369|P4|DB Phase|Adverse Event|0
6134373|NCT00570765|21136370|P3|DB Phase|Adverse Event|0
6134374|NCT00570765|21136371|P2|DB Phase|Adverse Event|6
6134375|NCT00570765|21136372|P1|DB Phase|Adverse Event|3
6134376|NCT00570765|21136369|P4|DB Phase|Protocol Violation|0
6134377|NCT00570765|21136370|P3|DB Phase|Protocol Violation|0
6134378|NCT00570765|21136371|P2|DB Phase|Protocol Violation|1
6134379|NCT00570765|21136372|P1|DB Phase|Protocol Violation|0
6134380|NCT00570765|21136369|P4|DB Phase|Withdrawal by Subject|0
6134381|NCT00570765|21136370|P3|DB Phase|Withdrawal by Subject|0
6134382|NCT00570765|21136371|P2|DB Phase|Withdrawal by Subject|0
6134383|NCT00570765|21136372|P1|DB Phase|Withdrawal by Subject|1
6134389|NCT00537017|21136449|P1|Follow-up Phase|Withdrawal by Subject|9
6134390|NCT00537017|21136449|P1|Treatment Phase|Protocol Violation|2
6134391|NCT00537017|21136449|P1|Treatment Phase|Withdrawal by Subject|13
6134392|NCT00537017|21136449|P1|Treatment Phase|Adverse Event|19
6134625|NCT00399490|21136509|P1|Overall Study|Other|25
6134626|NCT00399490|21136509|P1|Overall Study|Withdrawal by Subject|18
6134627|NCT00399490|21136509|P1|Overall Study|Lost to Follow-up|5
6134628|NCT00399490|21136509|P1|Overall Study|Lack of Efficacy|31
6134629|NCT00399490|21136509|P1|Overall Study|Adverse Event|19
6134642|NCT00323297|21136600|P2|Part B (Open-label)|Protocol Violation|1
6134643|NCT00323297|21136601|P1|Part B (Open-label)|Protocol Violation|0
6134644|NCT00323297|21136600|P2|Part B (Open-label)|Adverse Event|5
6134645|NCT00323297|21136601|P1|Part B (Open-label)|Adverse Event|5
6134646|NCT00323297|21136600|P2|Part B (Open-label)|Lack of Efficacy|1
6134647|NCT00323297|21136601|P1|Part B (Open-label)|Lack of Efficacy|3
6134648|NCT00323297|21136600|P2|Part B (Open-label)|Withdrawal by Subject|3
6134649|NCT00323297|21136601|P1|Part B (Open-label)|Withdrawal by Subject|1
6134650|NCT00323297|21136600|P2|Part B (Open-label)|Reason unspecified|1
6134651|NCT00323297|21136601|P1|Part B (Open-label)|Reason unspecified|0
6134652|NCT00323297|21136600|P2|Part B (Open-label)|Death|1
6134653|NCT00323297|21136601|P1|Part B (Open-label)|Death|0
6134654|NCT00323297|21136600|P2|Part A (Double Blind Randomized)|Related adverse event|2
6134655|NCT00323297|21136601|P1|Part A (Double Blind Randomized)|Related adverse event|2
6134656|NCT00323297|21136600|P2|Part A (Double Blind Randomized)|Related and Unrelated adverse event|0
6134657|NCT00323297|21136601|P1|Part A (Double Blind Randomized)|Related and Unrelated adverse event|1
6134658|NCT00323297|21136600|P2|Part A (Double Blind Randomized)|Unrelated adverse event|0
6134659|NCT00323297|21136601|P1|Part A (Double Blind Randomized)|Unrelated adverse event|1
6134660|NCT00323297|21136600|P2|Part A (Double Blind Randomized)|Protocol Violation|3
6134661|NCT00323297|21136601|P1|Part A (Double Blind Randomized)|Protocol Violation|1
6134662|NCT00323297|21136600|P2|Part A (Double Blind Randomized)|Death|1
6134663|NCT00323297|21136601|P1|Part A (Double Blind Randomized)|Death|0
6134664|NCT00323297|21136600|P2|Part A (Double Blind Randomized)|Reason unspecified|1
6134665|NCT00323297|21136601|P1|Part A (Double Blind Randomized)|Reason unspecified|0
6134666|NCT00301262|21136656|P2|Open Label Phase (OL)|Other|0
6134667|NCT00301262|21136657|P1|Open Label Phase (OL)|Other|2
6134668|NCT00301262|21136656|P2|Open Label Phase (OL)|Lost to Follow-up|2
6134669|NCT00301262|21136657|P1|Open Label Phase (OL)|Lost to Follow-up|1
6134670|NCT00301262|21136656|P2|Open Label Phase (OL)|Adverse Event|0
6134671|NCT00301262|21136657|P1|Open Label Phase (OL)|Adverse Event|1
6134672|NCT00301262|21136656|P2|Double Blind Phase (DB)|Other|4
6134673|NCT00301262|21136657|P1|Double Blind Phase (DB)|Other|1
6134674|NCT00301262|21136656|P2|Double Blind Phase (DB)|Withdrawal by Subject|5
6134675|NCT00301262|21136657|P1|Double Blind Phase (DB)|Withdrawal by Subject|5
6134676|NCT00301262|21136656|P2|Double Blind Phase (DB)|Lost to Follow-up|3
6134677|NCT00301262|21136657|P1|Double Blind Phase (DB)|Lost to Follow-up|3
6134678|NCT00301262|21136656|P2|Double Blind Phase (DB)|Lack of Efficacy|1
6134679|NCT00301262|21136657|P1|Double Blind Phase (DB)|Lack of Efficacy|0
6134680|NCT00301262|21136656|P2|Double Blind Phase (DB)|Adverse Event|0
6134681|NCT00301262|21136657|P1|Double Blind Phase (DB)|Adverse Event|1
6134682|NCT00159874|21136835|P7|Overall Study|Pregnancy|0
6134683|NCT00159874|21136836|P6|Overall Study|Pregnancy|0
6134684|NCT00159874|21136837|P5|Overall Study|Pregnancy|0
6134685|NCT00159874|21136838|P4|Overall Study|Pregnancy|0
6134686|NCT00159874|21136839|P3|Overall Study|Pregnancy|0
6134687|NCT00159874|21136840|P2|Overall Study|Pregnancy|1
6134688|NCT00159874|21136841|P1|Overall Study|Pregnancy|1
6134689|NCT00159874|21136835|P7|Overall Study|Withdrawal by Subject|1
6134690|NCT00159874|21136836|P6|Overall Study|Withdrawal by Subject|2
6134691|NCT00159874|21136837|P5|Overall Study|Withdrawal by Subject|3
6134692|NCT00159874|21136838|P4|Overall Study|Withdrawal by Subject|4
6134693|NCT00159874|21136839|P3|Overall Study|Withdrawal by Subject|8
6134694|NCT00159874|21136840|P2|Overall Study|Withdrawal by Subject|6
6134695|NCT00159874|21136841|P1|Overall Study|Withdrawal by Subject|2
6134696|NCT00159874|21136835|P7|Overall Study|Death|0
6134697|NCT00159874|21136836|P6|Overall Study|Death|2
6134698|NCT00159874|21136837|P5|Overall Study|Death|1
6134699|NCT00159874|21136838|P4|Overall Study|Death|0
6134700|NCT00159874|21136839|P3|Overall Study|Death|15
6134701|NCT00159874|21136840|P2|Overall Study|Death|8
6134702|NCT00159874|21136841|P1|Overall Study|Death|3
6134703|NCT00159874|21136835|P7|Overall Study|Protocol Violation|0
6134704|NCT00159874|21136836|P6|Overall Study|Protocol Violation|0
6134705|NCT00159874|21136837|P5|Overall Study|Protocol Violation|0
6134706|NCT00159874|21136838|P4|Overall Study|Protocol Violation|0
6134707|NCT00159874|21136839|P3|Overall Study|Protocol Violation|2
6134708|NCT00159874|21136840|P2|Overall Study|Protocol Violation|5
6134709|NCT00159874|21136841|P1|Overall Study|Protocol Violation|0
6134710|NCT00159874|21136835|P7|Overall Study|Other|3
6134711|NCT00159874|21136836|P6|Overall Study|Other|1
6134712|NCT00159874|21136837|P5|Overall Study|Other|2
6134713|NCT00159874|21136838|P4|Overall Study|Other|0
6134714|NCT00159874|21136839|P3|Overall Study|Other|8
6134715|NCT00159874|21136840|P2|Overall Study|Other|8
6134716|NCT00159874|21136841|P1|Overall Study|Other|8
6134717|NCT00159874|21136835|P7|Overall Study|Lost to Follow-up|1
6134718|NCT00159874|21136836|P6|Overall Study|Lost to Follow-up|2
6134719|NCT00159874|21136837|P5|Overall Study|Lost to Follow-up|1
6134720|NCT00159874|21136838|P4|Overall Study|Lost to Follow-up|0
6134721|NCT00159874|21136839|P3|Overall Study|Lost to Follow-up|3
6134722|NCT00159874|21136840|P2|Overall Study|Lost to Follow-up|0
6134723|NCT00159874|21136841|P1|Overall Study|Lost to Follow-up|1
6134724|NCT00159874|21136835|P7|Overall Study|Lack of Efficacy|0
6134725|NCT00159874|21136836|P6|Overall Study|Lack of Efficacy|3
6134726|NCT00159874|21136837|P5|Overall Study|Lack of Efficacy|0
6134727|NCT00159874|21136838|P4|Overall Study|Lack of Efficacy|1
6134728|NCT00159874|21136839|P3|Overall Study|Lack of Efficacy|1
6134729|NCT00159874|21136840|P2|Overall Study|Lack of Efficacy|0
6134730|NCT00159874|21136841|P1|Overall Study|Lack of Efficacy|2
6134731|NCT00159874|21136835|P7|Overall Study|Does Not Meet Entrance Criteria|0
6134732|NCT00159874|21136836|P6|Overall Study|Does Not Meet Entrance Criteria|0
6134733|NCT00159874|21136837|P5|Overall Study|Does Not Meet Entrance Criteria|0
6134734|NCT00159874|21136838|P4|Overall Study|Does Not Meet Entrance Criteria|0
6134735|NCT00159874|21136839|P3|Overall Study|Does Not Meet Entrance Criteria|1
6134736|NCT00159874|21136840|P2|Overall Study|Does Not Meet Entrance Criteria|0
6134737|NCT00159874|21136841|P1|Overall Study|Does Not Meet Entrance Criteria|1
6134738|NCT00159874|21136835|P7|Overall Study|Adverse Event|0
6134739|NCT00159874|21136836|P6|Overall Study|Adverse Event|2
6134740|NCT00159874|21136837|P5|Overall Study|Adverse Event|1
6134741|NCT00159874|21136838|P4|Overall Study|Adverse Event|1
6134742|NCT00159874|21136839|P3|Overall Study|Adverse Event|5
6134743|NCT00159874|21136840|P2|Overall Study|Adverse Event|2
6134744|NCT00159874|21136841|P1|Overall Study|Adverse Event|2
6134745|NCT00159861|21137011|P2|Extension Study - up to 3 Years|Withdrawal by Subject|9
6134746|NCT00159861|21137012|P1|Extension Study - up to 3 Years|Withdrawal by Subject|7
6134747|NCT00159861|21137011|P2|Extension Study - up to 3 Years|Reason Unspecified|19
6134748|NCT00159861|21137012|P1|Extension Study - up to 3 Years|Reason Unspecified|12
6134749|NCT00159861|21137011|P2|Extension Study - up to 3 Years|Lack of Efficacy|1
6134750|NCT00159861|21137012|P1|Extension Study - up to 3 Years|Lack of Efficacy|5
6134751|NCT00159861|21137011|P2|Extension Study - up to 3 Years|Adverse Event|14
6134752|NCT00159861|21137012|P1|Extension Study - up to 3 Years|Adverse Event|14
6134753|NCT00159861|21137011|P2|Extension Study - up to 3 Years|Death|28
6134754|NCT00159861|21137012|P1|Extension Study - up to 3 Years|Death|24
6134755|NCT00159861|21137011|P2|Core Study - 16 Weeks|Randomized but not Treated|0
6134756|NCT00159861|21137012|P1|Core Study - 16 Weeks|Randomized but not Treated|2
6134757|NCT00159861|21137011|P2|Core Study - 16 Weeks|Subject Defaulted|0
6134758|NCT00159861|21137012|P1|Core Study - 16 Weeks|Subject Defaulted|1
6134759|NCT00159861|21137011|P2|Core Study - 16 Weeks|Reason Unspecified|3
6134760|NCT00159861|21137012|P1|Core Study - 16 Weeks|Reason Unspecified|5
6134761|NCT00159861|21137011|P2|Core Study - 16 Weeks|Lack of Efficacy|3
6134762|NCT00159861|21137012|P1|Core Study - 16 Weeks|Lack of Efficacy|2
6134763|NCT00159861|21137011|P2|Core Study - 16 Weeks|Adverse Event|6
6134764|NCT00159861|21137012|P1|Core Study - 16 Weeks|Adverse Event|12
6134765|NCT00159861|21137011|P2|Core Study - 16 Weeks|Death|0
6134766|NCT00159861|21137012|P1|Core Study - 16 Weeks|Death|3
6134767|NCT00061932|21137035|P2|Overall Study|Withdrawal by Subject|4
6134768|NCT00061932|21137036|P1|Overall Study|Withdrawal by Subject|13
6134769|NCT00004031|21137046|P2|Overall Study|Reason under review|2
6134770|NCT00004031|21137047|P1|Overall Study|Reason under review|3
6134771|NCT00004031|21137046|P2|Overall Study|Other- not protocol specified|3
6134772|NCT00004031|21137047|P1|Overall Study|Other- not protocol specified|3
6134773|NCT00004031|21137046|P2|Overall Study|Death|1
6134774|NCT00004031|21137047|P1|Overall Study|Death|3
6134775|NCT00004031|21137046|P2|Overall Study|Progression/relapse|4
6134776|NCT00004031|21137047|P1|Overall Study|Progression/relapse|9
6134777|NCT00004031|21137046|P2|Overall Study|Refusal unrelated to adverse events|11
6134778|NCT00004031|21137047|P1|Overall Study|Refusal unrelated to adverse events|2
6134779|NCT00004031|21137046|P2|Overall Study|Adverse Event|0
6134780|NCT00004031|21137047|P1|Overall Study|Adverse Event|5
6134781|NCT00003511|21137057|P1|Overall Study|Not evaluable|4
6134793|NCT04096365|21137109|P1|Overall Study|Adverse Event|1
6134846|NCT03583372|21137391|P4|Overall Study|Captured as Other in the Database|1
6134847|NCT03583372|21137392|P3|Overall Study|Captured as Other in the Database|4
6134848|NCT03583372|21137393|P2|Overall Study|Captured as Other in the Database|2
6134849|NCT03583372|21137394|P1|Overall Study|Captured as Other in the Database|1
6134850|NCT03583372|21137391|P4|Overall Study|Did Not Receive Study Drug|0
6134851|NCT03583372|21137392|P3|Overall Study|Did Not Receive Study Drug|0
6134852|NCT03583372|21137393|P2|Overall Study|Did Not Receive Study Drug|1
6134853|NCT03583372|21137394|P1|Overall Study|Did Not Receive Study Drug|0
6134854|NCT03583372|21137391|P4|Overall Study|Subject Withdrawn due to Sponsor|1
6134855|NCT03583372|21137392|P3|Overall Study|Subject Withdrawn due to Sponsor|0
6134856|NCT03583372|21137393|P2|Overall Study|Subject Withdrawn due to Sponsor|0
6134857|NCT03583372|21137394|P1|Overall Study|Subject Withdrawn due to Sponsor|0
6134858|NCT03583372|21137391|P4|Overall Study|Protocol Violation|0
6134859|NCT03583372|21137392|P3|Overall Study|Protocol Violation|0
6134860|NCT03583372|21137393|P2|Overall Study|Protocol Violation|1
6134861|NCT03583372|21137394|P1|Overall Study|Protocol Violation|0
6134862|NCT03583372|21137391|P4|Overall Study|Death|0
6134863|NCT03583372|21137392|P3|Overall Study|Death|0
6134864|NCT03583372|21137393|P2|Overall Study|Death|0
6134865|NCT03583372|21137394|P1|Overall Study|Death|1
6134866|NCT03583372|21137391|P4|Overall Study|Lack of Efficacy|1
6134867|NCT03583372|21137392|P3|Overall Study|Lack of Efficacy|0
6134868|NCT03583372|21137393|P2|Overall Study|Lack of Efficacy|1
6134869|NCT03583372|21137394|P1|Overall Study|Lack of Efficacy|0
6134870|NCT03583372|21137391|P4|Overall Study|Physician Decision|1
6134871|NCT03583372|21137392|P3|Overall Study|Physician Decision|1
6134872|NCT03583372|21137393|P2|Overall Study|Physician Decision|1
6134873|NCT03583372|21137394|P1|Overall Study|Physician Decision|0
6134874|NCT03583372|21137391|P4|Overall Study|Adverse Event|4
6134875|NCT03583372|21137392|P3|Overall Study|Adverse Event|4
6134876|NCT03583372|21137393|P2|Overall Study|Adverse Event|3
6134877|NCT03583372|21137394|P1|Overall Study|Adverse Event|1
6134878|NCT03583372|21137391|P4|Overall Study|Lost to Follow-up|2
6134879|NCT03583372|21137392|P3|Overall Study|Lost to Follow-up|3
6134880|NCT03583372|21137393|P2|Overall Study|Lost to Follow-up|6
6134881|NCT03583372|21137394|P1|Overall Study|Lost to Follow-up|4
6134882|NCT03583372|21137391|P4|Overall Study|Withdrawal by Subject|8
6134883|NCT03583372|21137392|P3|Overall Study|Withdrawal by Subject|7
6134884|NCT03583372|21137393|P2|Overall Study|Withdrawal by Subject|11
6134885|NCT03583372|21137394|P1|Overall Study|Withdrawal by Subject|6
6134895|NCT03391765|21137585|P4|Overall Study|Other, not specified|16
6134896|NCT03391765|21137586|P3|Overall Study|Other, not specified|21
6134897|NCT03391765|21137587|P2|Overall Study|Other, not specified|38
6134898|NCT03391765|21137588|P1|Overall Study|Other, not specified|44
6134899|NCT03391765|21137585|P4|Overall Study|Withdrew consent|5
6134900|NCT03391765|21137586|P3|Overall Study|Withdrew consent|2
6134901|NCT03391765|21137587|P2|Overall Study|Withdrew consent|7
6134902|NCT03391765|21137588|P1|Overall Study|Withdrew consent|5
6134903|NCT03391765|21137585|P4|Overall Study|Adverse Event|2
6134904|NCT03391765|21137586|P3|Overall Study|Adverse Event|0
6134905|NCT03391765|21137587|P2|Overall Study|Adverse Event|0
6134906|NCT03391765|21137588|P1|Overall Study|Adverse Event|2
6134933|NCT03334630|21137729|P2|Overall Study|Subject unable to complete 12-month follow-up visit|1
6134934|NCT03334630|21137730|P1|Overall Study|Subject unable to complete 12-month follow-up visit|1
6134935|NCT03334630|21137729|P2|Overall Study|Subject not treated with study ablation due to technical difficulties|1
6134936|NCT03334630|21137730|P1|Overall Study|Subject not treated with study ablation due to technical difficulties|0
6134937|NCT03334630|21137729|P2|Overall Study|Enrollment closed|1
6134938|NCT03334630|21137730|P1|Overall Study|Enrollment closed|2
6134939|NCT03334630|21137729|P2|Overall Study|Physician Decision|1
6134940|NCT03334630|21137730|P1|Overall Study|Physician Decision|1
6134941|NCT03334630|21137729|P2|Overall Study|Adverse Event|1
6134942|NCT03334630|21137730|P1|Overall Study|Adverse Event|0
6134943|NCT03334630|21137729|P2|Overall Study|Lost to Follow-up|1
6134944|NCT03334630|21137730|P1|Overall Study|Lost to Follow-up|3
6134945|NCT03334630|21137729|P2|Overall Study|Withdrawal by Subject|7
6134946|NCT03334630|21137730|P1|Overall Study|Withdrawal by Subject|7
6134966|NCT03206749|21137839|P3|Overall Study|Lost to Follow-up|1
6134967|NCT03206749|21137840|P2|Overall Study|Lost to Follow-up|0
6134968|NCT03206749|21137841|P1|Overall Study|Lost to Follow-up|0
6134969|NCT03206749|21137839|P3|Overall Study|Withdrawal of consent|6
6134970|NCT03206749|21137840|P2|Overall Study|Withdrawal of consent|3
6134971|NCT03206749|21137841|P1|Overall Study|Withdrawal of consent|5
6134972|NCT03162796|21137871|P3|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|1
6134973|NCT03162796|21137872|P2|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|2
6134974|NCT03162796|21137873|P1|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|1
6134975|NCT03162796|21137871|P3|Active Treatment Period: Week 24 - 52|Adverse Event|0
6134976|NCT03162796|21137872|P2|Active Treatment Period: Week 24 - 52|Adverse Event|2
6134977|NCT03162796|21137873|P1|Active Treatment Period: Week 24 - 52|Adverse Event|3
6134978|NCT03162796|21137871|P3|Active Treatment Period: Week 24 - 52|Lack of Efficacy|1
6134979|NCT03162796|21137872|P2|Active Treatment Period: Week 24 - 52|Lack of Efficacy|3
6134980|NCT03162796|21137873|P1|Active Treatment Period: Week 24 - 52|Lack of Efficacy|4
6134981|NCT03162796|21137871|P3|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|0
6134982|NCT03162796|21137872|P2|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|2
6134983|NCT03162796|21137873|P1|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|0
6134984|NCT03162796|21137871|P3|Placebo Controlled Period: Week 0 - 24|Adverse Event|1
6134985|NCT03162796|21137872|P2|Placebo Controlled Period: Week 0 - 24|Adverse Event|3
6134986|NCT03162796|21137873|P1|Placebo Controlled Period: Week 0 - 24|Adverse Event|2
6134987|NCT03162796|21137871|P3|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|0
6134988|NCT03162796|21137872|P2|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|0
6134989|NCT03162796|21137873|P1|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|4
6134990|NCT03162796|21137871|P3|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|1
6134991|NCT03162796|21137872|P2|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|0
6134992|NCT03162796|21137873|P1|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|3
6134993|NCT03162796|21137871|P3|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|0
6134994|NCT03162796|21137872|P2|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|0
6134995|NCT03162796|21137873|P1|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|1
6134996|NCT03162796|21137871|P3|Placebo Controlled Period: Week 0 - 24|Death|0
6134997|NCT03162796|21137872|P2|Placebo Controlled Period: Week 0 - 24|Death|0
6134998|NCT03162796|21137873|P1|Placebo Controlled Period: Week 0 - 24|Death|1
6134999|NCT03162796|21137871|P3|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|0
6135000|NCT03162796|21137872|P2|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|0
6135001|NCT03162796|21137873|P1|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|1
6135002|NCT03162796|21137871|P3|Placebo Controlled Period: Week 0 - 24|Other|1
6135003|NCT03162796|21137872|P2|Placebo Controlled Period: Week 0 - 24|Other|1
6135004|NCT03162796|21137873|P1|Placebo Controlled Period: Week 0 - 24|Other|0
6135005|NCT03116152|21138188|P2|Overall Study|other|34
6135006|NCT03116152|21138189|P1|Overall Study|other|11
6135007|NCT03116152|21138188|P2|Overall Study|Physician Decision|2
6135008|NCT03116152|21138189|P1|Overall Study|Physician Decision|3
6135009|NCT03116152|21138188|P2|Overall Study|Withdrawal by Subject|1
6135010|NCT03116152|21138189|P1|Overall Study|Withdrawal by Subject|0
6135011|NCT03116152|21138188|P2|Overall Study|Protocol Violation|2
6135012|NCT03116152|21138189|P1|Overall Study|Protocol Violation|2
6135013|NCT03116152|21138188|P2|Overall Study|Adverse Event|7
6135014|NCT03116152|21138189|P1|Overall Study|Adverse Event|21
6135015|NCT03116152|21138188|P2|Overall Study|Death|2
6135016|NCT03116152|21138189|P1|Overall Study|Death|5
6135017|NCT03116152|21138188|P2|Overall Study|Disease Progression|47
6135018|NCT03116152|21138189|P1|Overall Study|Disease Progression|49
6135025|NCT02985879|21138286|P3|Overall Study|Other, not specified|58
6135026|NCT02985879|21138287|P2|Overall Study|Other, not specified|58
6135027|NCT02985879|21138288|P1|Overall Study|Other, not specified|62
6135028|NCT02985879|21138286|P3|Overall Study|Lost to Follow-up|2
6135029|NCT02985879|21138287|P2|Overall Study|Lost to Follow-up|0
6135030|NCT02985879|21138288|P1|Overall Study|Lost to Follow-up|1
6135031|NCT02985879|21138286|P3|Overall Study|Withdrew consent|10
6135032|NCT02985879|21138287|P2|Overall Study|Withdrew consent|8
6135033|NCT02985879|21138288|P1|Overall Study|Withdrew consent|6
6135034|NCT02985879|21138286|P3|Overall Study|Adverse Event|7
6135035|NCT02985879|21138287|P2|Overall Study|Adverse Event|9
6135036|NCT02985879|21138288|P1|Overall Study|Adverse Event|7
6135091|NCT02956486|21138526|P3|Extension Phase|Not Treated|1
6135092|NCT02956486|21138527|P2|Extension Phase|Not Treated|0
6135093|NCT02956486|21138528|P1|Extension Phase|Not Treated|0
6135094|NCT02956486|21138526|P3|Extension Phase|Study terminated by sponsor|16
6135095|NCT02956486|21138527|P2|Extension Phase|Study terminated by sponsor|0
6135096|NCT02956486|21138528|P1|Extension Phase|Study terminated by sponsor|0
6135097|NCT02956486|21138526|P3|Extension Phase|Adverse Event|2
6135098|NCT02956486|21138527|P2|Extension Phase|Adverse Event|0
6135099|NCT02956486|21138528|P1|Extension Phase|Adverse Event|0
6135100|NCT02956486|21138526|P3|Core Phase|Not treated|0
6135101|NCT02956486|21138527|P2|Core Phase|Not treated|3
6135102|NCT02956486|21138528|P1|Core Phase|Not treated|0
6135103|NCT02956486|21138526|P3|Core Phase|Other|0
6135104|NCT02956486|21138527|P2|Core Phase|Other|18
6135105|NCT02956486|21138528|P1|Core Phase|Other|27
6135106|NCT02956486|21138526|P3|Core Phase|Study terminated by sponsor|0
6135107|NCT02956486|21138527|P2|Core Phase|Study terminated by sponsor|848
6135108|NCT02956486|21138528|P1|Core Phase|Study terminated by sponsor|888
6135109|NCT02956486|21138526|P3|Core Phase|Withdrawal by Subject|0
6135110|NCT02956486|21138527|P2|Core Phase|Withdrawal by Subject|104
6135111|NCT02956486|21138528|P1|Core Phase|Withdrawal by Subject|101
6135112|NCT02956486|21138526|P3|Core Phase|Inadequate therapeutic effect|0
6135113|NCT02956486|21138527|P2|Core Phase|Inadequate therapeutic effect|5
6135114|NCT02956486|21138528|P1|Core Phase|Inadequate therapeutic effect|4
6135115|NCT02956486|21138526|P3|Core Phase|Lost to Follow-up|0
6135116|NCT02956486|21138527|P2|Core Phase|Lost to Follow-up|6
6135117|NCT02956486|21138528|P1|Core Phase|Lost to Follow-up|8
6135118|NCT02956486|21138526|P3|Core Phase|Adverse Event|0
6135119|NCT02956486|21138527|P2|Core Phase|Adverse Event|88
6135120|NCT02956486|21138528|P1|Core Phase|Adverse Event|51
6135127|NCT02891915|21138603|P2|Overall Study|Physician Decision|0
6135128|NCT02891915|21138604|P1|Overall Study|Physician Decision|1
6135129|NCT02891915|21138603|P2|Overall Study|Lost to Follow-up|4
6135130|NCT02891915|21138604|P1|Overall Study|Lost to Follow-up|1
6135131|NCT02891915|21138603|P2|Overall Study|Became Ineligible After Enrollment|1
6135132|NCT02891915|21138604|P1|Overall Study|Became Ineligible After Enrollment|2
6135133|NCT02891915|21138603|P2|Overall Study|Withdrawal by Subject|3
6135134|NCT02891915|21138604|P1|Overall Study|Withdrawal by Subject|3
6135135|NCT02891915|21138603|P2|Overall Study|Enrolled but Treatment Not Administered|4
6135136|NCT02891915|21138604|P1|Overall Study|Enrolled but Treatment Not Administered|6
6135137|NCT02873195|21138634|P2|Overall Study|Ineligible|0
6135138|NCT02873195|21138635|P1|Overall Study|Ineligible|5
6135139|NCT02861014|21138647|P1|Overall Study|Commercial ocrelizumab|3
6135140|NCT02861014|21138647|P1|Overall Study|Withdrawal by Subject|14
6135141|NCT02861014|21138647|P1|Overall Study|Study Terminated By Sponsor|3
6135142|NCT02861014|21138647|P1|Overall Study|Protocol Violation|2
6135143|NCT02861014|21138647|P1|Overall Study|Pregnancy|4
6135144|NCT02861014|21138647|P1|Overall Study|Physician Decision|2
6135145|NCT02861014|21138647|P1|Overall Study|Lack of Efficacy|3
6135146|NCT02861014|21138647|P1|Overall Study|Death|1
6135147|NCT02861014|21138647|P1|Overall Study|Adverse Event|7
6135151|NCT02763566|21138760|P4|Overall Study|Withdrawal by Subject|0
6135152|NCT02763566|21138761|P3|Overall Study|Withdrawal by Subject|0
6135153|NCT02763566|21138762|P2|Overall Study|Withdrawal by Subject|1
6135154|NCT02763566|21138763|P1|Overall Study|Withdrawal by Subject|3
6135155|NCT02763566|21138760|P4|Overall Study|On study treatment at study conclusion|13
6135156|NCT02763566|21138761|P3|Overall Study|On study treatment at study conclusion|54
6135157|NCT02763566|21138762|P2|Overall Study|On study treatment at study conclusion|34
6135158|NCT02763566|21138763|P1|Overall Study|On study treatment at study conclusion|114
6135159|NCT02763566|21138760|P4|Overall Study|Lost to Follow-up|1
6135160|NCT02763566|21138761|P3|Overall Study|Lost to Follow-up|0
6135161|NCT02763566|21138762|P2|Overall Study|Lost to Follow-up|4
6135162|NCT02763566|21138763|P1|Overall Study|Lost to Follow-up|1
6135163|NCT02749799|21138791|P1|Overall Study|Withdrawal by Subject|1
6135164|NCT02749799|21138791|P1|Overall Study|Protocol Violation|1
6135165|NCT02749799|21138791|P1|Overall Study|Lost to Follow-up|4
6135166|NCT02749799|21138791|P1|Overall Study|Adverse Event|2
6135201|NCT02658630|21138910|P1|Overall Study|Withdrawal by Subject|4
6135206|NCT02617589|21138934|P2|Treatment Period|Completed Treatment|76
6135207|NCT02617589|21138935|P1|Treatment Period|Completed Treatment|0
6135208|NCT02617589|21138934|P2|Treatment Period|Disease Progression|137
6135209|NCT02617589|21138935|P1|Treatment Period|Disease Progression|214
6135210|NCT02617589|21138934|P2|Treatment Period|Study Drug Toxicity|20
6135211|NCT02617589|21138935|P1|Treatment Period|Study Drug Toxicity|26
6135212|NCT02617589|21138934|P2|Treatment Period|Death|1
6135213|NCT02617589|21138935|P1|Treatment Period|Death|1
6135214|NCT02617589|21138934|P2|Treatment Period|Adverse event unrelated to study drug|9
6135215|NCT02617589|21138935|P1|Treatment Period|Adverse event unrelated to study drug|15
6135216|NCT02617589|21138934|P2|Treatment Period|Participant Request to discontinue|20
6135217|NCT02617589|21138935|P1|Treatment Period|Participant Request to discontinue|12
6135218|NCT02617589|21138934|P2|Treatment Period|Participant Withdrew Consent|6
6135219|NCT02617589|21138935|P1|Treatment Period|Participant Withdrew Consent|2
6135220|NCT02617589|21138934|P2|Treatment Period|Maximum Clinical Benefit|2
6135221|NCT02617589|21138935|P1|Treatment Period|Maximum Clinical Benefit|0
6135222|NCT02617589|21138934|P2|Treatment Period|Poor/Non compliance|1
6135223|NCT02617589|21138935|P1|Treatment Period|Poor/Non compliance|1
6135224|NCT02617589|21138934|P2|Treatment Period|Not reported|0
6135225|NCT02617589|21138935|P1|Treatment Period|Not reported|1
6135226|NCT02617589|21138934|P2|Treatment Period|Other Reasons|2
6135227|NCT02617589|21138935|P1|Treatment Period|Other Reasons|2
6135228|NCT02617589|21138934|P2|All Randomized|Participant Withdrew Consent|2
6135229|NCT02617589|21138935|P1|All Randomized|Participant Withdrew Consent|1
6135230|NCT02617589|21138934|P2|All Randomized|Request to discontinue study treatment|3
6135231|NCT02617589|21138935|P1|All Randomized|Request to discontinue study treatment|1
6135232|NCT02613884|21138949|P1|Overall Study|Lost to Follow-up|1
6135233|NCT02613884|21138949|P1|Overall Study|Death|1
6135254|NCT02550938|21139020|P4|Overall Study|Lost to Follow-up|11
6135255|NCT02550938|21139021|P3|Overall Study|Lost to Follow-up|12
6135256|NCT02550938|21139022|P2|Overall Study|Lost to Follow-up|7
6135257|NCT02550938|21139023|P1|Overall Study|Lost to Follow-up|8
6135258|NCT02536339|21139045|P1|Overall Study|Death|20
6135259|NCT02536339|21139045|P1|Overall Study|Withdrawal by Subject|3
6135260|NCT02536339|21139045|P1|Overall Study|Lost to Follow-up|2
6135261|NCT02536339|21139045|P1|Overall Study|Treatment Ongoing|2
6135262|NCT02536339|21139045|P1|Overall Study|In Survival Follow-Up|4
6135313|NCT02273908|21139405|P2|Overall Study|Withdrawal by Subject|2
6135314|NCT02273908|21139406|P1|Overall Study|Withdrawal by Subject|4
6135315|NCT02273908|21139405|P2|Overall Study|Did not meet entrance criteria|2
6135316|NCT02273908|21139406|P1|Overall Study|Did not meet entrance criteria|3
6135317|NCT02273908|21139405|P2|Overall Study|Lost to Follow-up|1
6135318|NCT02273908|21139406|P1|Overall Study|Lost to Follow-up|10
6135319|NCT02273908|21139405|P2|Overall Study|Adverse Event|0
6135320|NCT02273908|21139406|P1|Overall Study|Adverse Event|16
6135432|NCT02075554|21139744|P1|Overall Study|Physician Decision|3
6135433|NCT02075554|21139744|P1|Overall Study|Withdrawal by Subject|5
6135434|NCT02075554|21139744|P1|Overall Study|Lost to Follow-up|7
6135435|NCT01993329|21139757|P6|Wash-out|Personal reasons|0
6135436|NCT01993329|21139758|P5|Wash-out|Personal reasons|0
6135437|NCT01993329|21139759|P4|Wash-out|Personal reasons|0
6135438|NCT01993329|21139760|P3|Wash-out|Personal reasons|0
6135439|NCT01993329|21139761|P2|Wash-out|Personal reasons|1
6135440|NCT01993329|21139762|P1|Wash-out|Personal reasons|0
6135441|NCT01993329|21139757|P6|Period 2|Adverse Event|1
6135442|NCT01993329|21139758|P5|Period 2|Adverse Event|0
6135443|NCT01993329|21139759|P4|Period 2|Adverse Event|0
6135444|NCT01993329|21139760|P3|Period 2|Adverse Event|0
6135445|NCT01993329|21139761|P2|Period 2|Adverse Event|0
6135446|NCT01993329|21139762|P1|Period 2|Adverse Event|0
6135471|NCT01790113|21139856|P2|Overall Study|Study ended due to FDA clearance|68
6135472|NCT01790113|21139857|P1|Overall Study|Study ended due to FDA clearance|1
6135473|NCT01790113|21139856|P2|Overall Study|Adverse Event|7
6135474|NCT01790113|21139857|P1|Overall Study|Adverse Event|2
6135616|NCT01496885|21140409|P1|Overall Study|Death|1
6135617|NCT01496885|21140409|P1|Overall Study|Clinically significant change in subject status that prevented compliance or impacted stroke outcome|2
6135618|NCT01496885|21140409|P1|Overall Study|Withdrawal by Subject|7
6135619|NCT01496885|21140409|P1|Overall Study|Lost to Follow-up|13
6135620|NCT01349907|21140476|P2|Overall Study|Administrative|1
6135621|NCT01349907|21140477|P1|Overall Study|Administrative|1
6135622|NCT01349907|21140476|P2|Overall Study|Protocol Violation|13
6135623|NCT01349907|21140477|P1|Overall Study|Protocol Violation|33
6135624|NCT01349907|21140476|P2|Overall Study|Withdrawal by Subject|8
6135625|NCT01349907|21140477|P1|Overall Study|Withdrawal by Subject|30
6135626|NCT01349907|21140476|P2|Overall Study|Lost to Follow-up|6
6135627|NCT01349907|21140477|P1|Overall Study|Lost to Follow-up|25
6135628|NCT01349907|21140476|P2|Overall Study|Treatment failure|4
6135629|NCT01349907|21140477|P1|Overall Study|Treatment failure|13
6135630|NCT01349907|21140476|P2|Overall Study|Adverse Event|11
6135631|NCT01349907|21140477|P1|Overall Study|Adverse Event|37
6135632|NCT01279057|21140516|P3|Overall Study|Other|0
6135633|NCT01279057|21140517|P2|Overall Study|Other|3
6135634|NCT01279057|21140518|P1|Overall Study|Other|3
6135635|NCT01279057|21140516|P3|Overall Study|Pregnancy|0
6135636|NCT01279057|21140517|P2|Overall Study|Pregnancy|1
6135637|NCT01279057|21140518|P1|Overall Study|Pregnancy|0
6135638|NCT01279057|21140516|P3|Overall Study|Withdrew consent|1
6135639|NCT01279057|21140517|P2|Overall Study|Withdrew consent|0
6135640|NCT01279057|21140518|P1|Overall Study|Withdrew consent|2
6135641|NCT01279057|21140516|P3|Overall Study|Restricted medication for seasonal allergic rhinitis|0
6135642|NCT01279057|21140517|P2|Overall Study|Restricted medication for seasonal allergic rhinitis|1
6135643|NCT01279057|21140518|P1|Overall Study|Restricted medication for seasonal allergic rhinitis|0
6135644|NCT01279057|21140516|P3|Overall Study|Insufficient therapeutic response|1
6135645|NCT01279057|21140517|P2|Overall Study|Insufficient therapeutic response|0
6135646|NCT01279057|21140518|P1|Overall Study|Insufficient therapeutic response|0
6135647|NCT01279057|21140516|P3|Overall Study|Adverse Event|1
6135648|NCT01279057|21140517|P2|Overall Study|Adverse Event|0
6135649|NCT01279057|21140518|P1|Overall Study|Adverse Event|1
6135650|NCT01265719|21140545|P2|Overall Study|Adverse Event|0
6135651|NCT01265719|21140546|P1|Overall Study|Adverse Event|2
6135652|NCT01265719|21140545|P2|Overall Study|Lost to Follow-up|7
6135653|NCT01265719|21140546|P1|Overall Study|Lost to Follow-up|2
6135654|NCT01265719|21140545|P2|Overall Study|Withdrawal by Subject|3
6135655|NCT01265719|21140546|P1|Overall Study|Withdrawal by Subject|8
6135656|NCT01265719|21140545|P2|Overall Study|Other reasons|0
6135657|NCT01265719|21140546|P1|Overall Study|Other reasons|2
6135658|NCT01265719|21140545|P2|Overall Study|Does not meet entrance criteria|3
6135659|NCT01265719|21140546|P1|Overall Study|Does not meet entrance criteria|0
6135660|NCT01231516|21140593|P2|Open-label Phase|Ongoing at the time of analysis|23
6135661|NCT01231516|21140594|P1|Open-label Phase|Ongoing at the time of analysis|282
6135662|NCT01231516|21140593|P2|Open-label Phase|Withdrawal by Subject|0
6135663|NCT01231516|21140594|P1|Open-label Phase|Withdrawal by Subject|1
6135664|NCT01231516|21140593|P2|Open-label Phase|Lost to Follow-up|0
6135665|NCT01231516|21140594|P1|Open-label Phase|Lost to Follow-up|3
6135666|NCT01231516|21140593|P2|Open-label Phase|Protocol Violation|0
6135667|NCT01231516|21140594|P1|Open-label Phase|Protocol Violation|2
6135668|NCT01231516|21140593|P2|Open-label Phase|Lack of Efficacy|3
6135669|NCT01231516|21140594|P1|Open-label Phase|Lack of Efficacy|7
6135670|NCT01231516|21140593|P2|48 Week Double-blind Phase|Site Closed|1
6135671|NCT01231516|21140594|P1|48 Week Double-blind Phase|Site Closed|3
6135672|NCT01231516|21140593|P2|48 Week Double-blind Phase|Withdrawal by Subject|5
6135673|NCT01231516|21140594|P1|48 Week Double-blind Phase|Withdrawal by Subject|11
6135674|NCT01231516|21140593|P2|48 Week Double-blind Phase|Physician Decision|1
6135675|NCT01231516|21140594|P1|48 Week Double-blind Phase|Physician Decision|1
6135676|NCT01231516|21140593|P2|48 Week Double-blind Phase|Lost to Follow-up|10
6135677|NCT01231516|21140594|P1|48 Week Double-blind Phase|Lost to Follow-up|5
6135678|NCT01231516|21140593|P2|48 Week Double-blind Phase|Met Protocol-Defined Stopping Criteria|3
6135679|NCT01231516|21140594|P1|48 Week Double-blind Phase|Met Protocol-Defined Stopping Criteria|5
6135680|NCT01231516|21140593|P2|48 Week Double-blind Phase|Protocol Violation|6
6135681|NCT01231516|21140594|P1|48 Week Double-blind Phase|Protocol Violation|9
6135682|NCT01231516|21140593|P2|48 Week Double-blind Phase|Lack of Efficacy|42
6135683|NCT01231516|21140594|P1|48 Week Double-blind Phase|Lack of Efficacy|20
6135684|NCT01231516|21140593|P2|48 Week Double-blind Phase|Adverse Event|11
6135685|NCT01231516|21140594|P1|48 Week Double-blind Phase|Adverse Event|4
6135698|NCT01190267|21140644|P2|Overall Study|Protocol Violation|1
6135699|NCT01190267|21140645|P1|Overall Study|Protocol Violation|8
6135700|NCT01190267|21140644|P2|Overall Study|Withdrawal by Subject|1
6135701|NCT01190267|21140645|P1|Overall Study|Withdrawal by Subject|13
6135702|NCT01190267|21140644|P2|Overall Study|Lost to Follow-up|0
6135703|NCT01190267|21140645|P1|Overall Study|Lost to Follow-up|2
6135704|NCT01190267|21140644|P2|Overall Study|Treatment Failure|2
6135705|NCT01190267|21140645|P1|Overall Study|Treatment Failure|8
6135706|NCT01190267|21140644|P2|Overall Study|Adverse Event|0
6135707|NCT01190267|21140645|P1|Overall Study|Adverse Event|10
6135780|NCT01038427|21140735|P3|Overall Study|Other|0
6135781|NCT01038427|21140736|P2|Overall Study|Other|2
6135782|NCT01038427|21140737|P1|Overall Study|Other|0
6135783|NCT01038427|21140735|P3|Overall Study|Enrolled in error|1
6135784|NCT01038427|21140736|P2|Overall Study|Enrolled in error|1
6135785|NCT01038427|21140737|P1|Overall Study|Enrolled in error|0
6135786|NCT01038427|21140735|P3|Overall Study|Adverse Event|1
6135787|NCT01038427|21140736|P2|Overall Study|Adverse Event|2
6135788|NCT01038427|21140737|P1|Overall Study|Adverse Event|2
6135789|NCT01038427|21140735|P3|Overall Study|Withdrew consent|1
6135790|NCT01038427|21140736|P2|Overall Study|Withdrew consent|0
6135791|NCT01038427|21140737|P1|Overall Study|Withdrew consent|0
6135792|NCT01038427|21140735|P3|Overall Study|Restricted medication for seasonal allergic rhinitis|1
6135793|NCT01038427|21140736|P2|Overall Study|Restricted medication for seasonal allergic rhinitis|0
6135794|NCT01038427|21140737|P1|Overall Study|Restricted medication for seasonal allergic rhinitis|0
6135795|NCT01038427|21140735|P3|Overall Study|Lost to follow up|0
6135796|NCT01038427|21140736|P2|Overall Study|Lost to follow up|1
6135797|NCT01038427|21140737|P1|Overall Study|Lost to follow up|1
6135798|NCT00914732|21140761|P3|Overall Study|Adverse Event|0
6135799|NCT00914732|21140762|P2|Overall Study|Adverse Event|0
6135800|NCT00914732|21140763|P1|Overall Study|Adverse Event|1
6135801|NCT00914732|21140761|P3|Overall Study|Withdrawal by Subject|2
6135802|NCT00914732|21140762|P2|Overall Study|Withdrawal by Subject|0
6135803|NCT00914732|21140763|P1|Overall Study|Withdrawal by Subject|3
6135804|NCT00914732|21140761|P3|Overall Study|Lost to Follow-up|9
6135805|NCT00914732|21140762|P2|Overall Study|Lost to Follow-up|7
6135806|NCT00914732|21140763|P1|Overall Study|Lost to Follow-up|6
6135834|NCT00716859|21140959|P2|Overall Study|Not treated|1
6135835|NCT00716859|21140960|P1|Overall Study|Not treated|1
6135836|NCT00716859|21140959|P2|Overall Study|Withdrawal by Subject|3
6135837|NCT00716859|21140960|P1|Overall Study|Withdrawal by Subject|1
6135838|NCT00716859|21140959|P2|Overall Study|Lack of Efficacy|0
6135839|NCT00716859|21140960|P1|Overall Study|Lack of Efficacy|3
6135840|NCT00716859|21140959|P2|Overall Study|Adverse Event|1
6135841|NCT00716859|21140960|P1|Overall Study|Adverse Event|4
6135842|NCT00642941|21141012|P12|Overall Study|Disease progression|7
6135843|NCT00642941|21141013|P11|Overall Study|Disease progression|12
6135844|NCT00642941|21141014|P10|Overall Study|Disease progression|7
6135845|NCT00642941|21141015|P9|Overall Study|Disease progression|10
6135846|NCT00642941|21141016|P8|Overall Study|Disease progression|12
6135847|NCT00642941|21141017|P7|Overall Study|Disease progression|18
6135848|NCT00642941|21141018|P6|Overall Study|Disease progression|39
6135849|NCT00642941|21141019|P5|Overall Study|Disease progression|23
6135850|NCT00642941|21141020|P4|Overall Study|Disease progression|36
6135851|NCT00642941|21141021|P3|Overall Study|Disease progression|5
6135852|NCT00642941|21141022|P2|Overall Study|Disease progression|50
6135853|NCT00642941|21141023|P1|Overall Study|Disease progression|60
6135854|NCT00642941|21141012|P12|Overall Study|Other|1
6135855|NCT00642941|21141013|P11|Overall Study|Other|0
6135856|NCT00642941|21141014|P10|Overall Study|Other|0
6135857|NCT00642941|21141015|P9|Overall Study|Other|0
6135858|NCT00642941|21141016|P8|Overall Study|Other|1
6135859|NCT00642941|21141017|P7|Overall Study|Other|0
6135860|NCT00642941|21141018|P6|Overall Study|Other|1
6135861|NCT00642941|21141019|P5|Overall Study|Other|0
6135862|NCT00642941|21141020|P4|Overall Study|Other|1
6135863|NCT00642941|21141021|P3|Overall Study|Other|1
6135864|NCT00642941|21141022|P2|Overall Study|Other|1
6135865|NCT00642941|21141023|P1|Overall Study|Other|1
6135866|NCT00642941|21141012|P12|Overall Study|Adverse Event|0
6135867|NCT00642941|21141013|P11|Overall Study|Adverse Event|0
6135868|NCT00642941|21141014|P10|Overall Study|Adverse Event|1
6135869|NCT00642941|21141015|P9|Overall Study|Adverse Event|0
6135870|NCT00642941|21141016|P8|Overall Study|Adverse Event|1
6135871|NCT00642941|21141017|P7|Overall Study|Adverse Event|1
6135872|NCT00642941|21141018|P6|Overall Study|Adverse Event|0
6135873|NCT00642941|21141019|P5|Overall Study|Adverse Event|0
6135874|NCT00642941|21141020|P4|Overall Study|Adverse Event|0
6135875|NCT00642941|21141021|P3|Overall Study|Adverse Event|0
6135876|NCT00642941|21141022|P2|Overall Study|Adverse Event|1
6135877|NCT00642941|21141023|P1|Overall Study|Adverse Event|1
6135878|NCT00642941|21141012|P12|Overall Study|Protocol Violation|0
6135879|NCT00642941|21141013|P11|Overall Study|Protocol Violation|0
6135880|NCT00642941|21141014|P10|Overall Study|Protocol Violation|0
6135881|NCT00642941|21141015|P9|Overall Study|Protocol Violation|0
6135882|NCT00642941|21141016|P8|Overall Study|Protocol Violation|0
6135883|NCT00642941|21141017|P7|Overall Study|Protocol Violation|1
6135884|NCT00642941|21141018|P6|Overall Study|Protocol Violation|0
6135885|NCT00642941|21141019|P5|Overall Study|Protocol Violation|0
6135886|NCT00642941|21141020|P4|Overall Study|Protocol Violation|0
6135887|NCT00642941|21141021|P3|Overall Study|Protocol Violation|0
6135888|NCT00642941|21141022|P2|Overall Study|Protocol Violation|0
6135889|NCT00642941|21141023|P1|Overall Study|Protocol Violation|0
6135890|NCT00642941|21141012|P12|Overall Study|Withdrawal by Subject|1
6135891|NCT00642941|21141013|P11|Overall Study|Withdrawal by Subject|0
6135892|NCT00642941|21141014|P10|Overall Study|Withdrawal by Subject|0
6135893|NCT00642941|21141015|P9|Overall Study|Withdrawal by Subject|1
6135894|NCT00642941|21141016|P8|Overall Study|Withdrawal by Subject|0
6135895|NCT00642941|21141017|P7|Overall Study|Withdrawal by Subject|2
6135896|NCT00642941|21141018|P6|Overall Study|Withdrawal by Subject|0
6135897|NCT00642941|21141019|P5|Overall Study|Withdrawal by Subject|0
6135898|NCT00642941|21141020|P4|Overall Study|Withdrawal by Subject|2
6135899|NCT00642941|21141021|P3|Overall Study|Withdrawal by Subject|0
6135900|NCT00642941|21141022|P2|Overall Study|Withdrawal by Subject|0
6135901|NCT00642941|21141023|P1|Overall Study|Withdrawal by Subject|1
6135902|NCT00642941|21141012|P12|Overall Study|Study closed by Sponsor|0
6135903|NCT00642941|21141013|P11|Overall Study|Study closed by Sponsor|0
6135904|NCT00642941|21141014|P10|Overall Study|Study closed by Sponsor|0
6135905|NCT00642941|21141015|P9|Overall Study|Study closed by Sponsor|0
6135906|NCT00642941|21141016|P8|Overall Study|Study closed by Sponsor|0
6135907|NCT00642941|21141017|P7|Overall Study|Study closed by Sponsor|0
6135908|NCT00642941|21141018|P6|Overall Study|Study closed by Sponsor|0
6135909|NCT00642941|21141019|P5|Overall Study|Study closed by Sponsor|0
6135910|NCT00642941|21141020|P4|Overall Study|Study closed by Sponsor|0
6135911|NCT00642941|21141021|P3|Overall Study|Study closed by Sponsor|0
6135912|NCT00642941|21141022|P2|Overall Study|Study closed by Sponsor|1
6135913|NCT00642941|21141023|P1|Overall Study|Study closed by Sponsor|0
6135914|NCT00642941|21141012|P12|Overall Study|Death|1
6135915|NCT00642941|21141013|P11|Overall Study|Death|0
6135916|NCT00642941|21141014|P10|Overall Study|Death|0
6135917|NCT00642941|21141015|P9|Overall Study|Death|0
6135918|NCT00642941|21141016|P8|Overall Study|Death|0
6135919|NCT00642941|21141017|P7|Overall Study|Death|0
6135920|NCT00642941|21141018|P6|Overall Study|Death|1
6135921|NCT00642941|21141019|P5|Overall Study|Death|2
6135922|NCT00642941|21141020|P4|Overall Study|Death|1
6135923|NCT00642941|21141021|P3|Overall Study|Death|1
6135924|NCT00642941|21141022|P2|Overall Study|Death|0
6135925|NCT00642941|21141023|P1|Overall Study|Death|4
6135926|NCT00642941|21141012|P12|Overall Study|Physician Decision|1
6135927|NCT00642941|21141013|P11|Overall Study|Physician Decision|0
6135928|NCT00642941|21141014|P10|Overall Study|Physician Decision|1
6135929|NCT00642941|21141015|P9|Overall Study|Physician Decision|0
6135930|NCT00642941|21141016|P8|Overall Study|Physician Decision|0
6135931|NCT00642941|21141017|P7|Overall Study|Physician Decision|1
6135932|NCT00642941|21141018|P6|Overall Study|Physician Decision|0
6135933|NCT00642941|21141019|P5|Overall Study|Physician Decision|0
6135934|NCT00642941|21141020|P4|Overall Study|Physician Decision|0
6135935|NCT00642941|21141021|P3|Overall Study|Physician Decision|0
6135936|NCT00642941|21141022|P2|Overall Study|Physician Decision|1
6135937|NCT00642941|21141023|P1|Overall Study|Physician Decision|3
6135938|NCT00635570|21141159|P2|Overall Study|Early termination(No sexual activity)|1
6135939|NCT00635570|21141160|P1|Overall Study|Early termination(No sexual activity)|1
6135940|NCT00635570|21141159|P2|Overall Study|Did not complete survey|1
6135941|NCT00635570|21141160|P1|Overall Study|Did not complete survey|2
6135942|NCT00635570|21141159|P2|Overall Study|Physician Decision|0
6135943|NCT00635570|21141160|P1|Overall Study|Physician Decision|1
6135944|NCT00635570|21141159|P2|Overall Study|Adverse Event|0
6135945|NCT00635570|21141160|P1|Overall Study|Adverse Event|2
6135946|NCT00635570|21141159|P2|Overall Study|Withdrawal by Subject|1
6135947|NCT00635570|21141160|P1|Overall Study|Withdrawal by Subject|1
6135948|NCT00635570|21141159|P2|Overall Study|Lost to Follow-up|8
6135949|NCT00635570|21141160|P1|Overall Study|Lost to Follow-up|8
6135950|NCT00620555|21141172|P1|Overall Study|Visit failure against planned|1
6135951|NCT00620555|21141172|P1|Overall Study|Choice of other treatment|1
6135952|NCT00620555|21141172|P1|Overall Study|Withdrawal by Subject|1
6135953|NCT00620555|21141172|P1|Overall Study|Lack of Efficacy|12
6135954|NCT00620555|21141172|P1|Overall Study|Protocol Violation|2
6135955|NCT00620555|21141172|P1|Overall Study|Adverse Event|4
6135956|NCT00603473|21141179|P1|Overall Study|Protocol Violation|1
6135957|NCT00603473|21141179|P1|Overall Study|Lack of Efficacy|4
6135958|NCT00603473|21141179|P1|Overall Study|Adverse Event|4
6135959|NCT00567268|21141196|P1|Overall Study|"Safety Evaluation Not Assessable"|1
6135960|NCT00567268|21141196|P1|Overall Study|No Drug Administration|4
6135961|NCT00567268|21141196|P1|Overall Study|No Visit After First Day of Treatment|2
6135962|NCT00567268|21141196|P1|Overall Study|Lost to Follow-up|36
6135963|NCT00567268|21141196|P1|Overall Study|Protocol Violation|7
6136237|NCT04162795|21141472|P1|Overall Study|Screen failures|10
6136238|NCT04162795|21141472|P1|Overall Study|Other|16
6136265|NCT03913377|21141552|P3|Period 1|No Longer Meets Eligibility Criteria|1
6136266|NCT03913377|21141553|P2|Period 1|No Longer Meets Eligibility Criteria|0
6136267|NCT03913377|21141554|P1|Period 1|No Longer Meets Eligibility Criteria|0
6136268|NCT03913377|21141552|P3|Period 1|Test Article no longer available|0
6136269|NCT03913377|21141553|P2|Period 1|Test Article no longer available|1
6136270|NCT03913377|21141554|P1|Period 1|Test Article no longer available|0
6136277|NCT03680911|21141666|P2|Visit 3 (4 Month Follow up)|Study Termination|1
6136278|NCT03680911|21141667|P1|Visit 3 (4 Month Follow up)|Study Termination|0
6136279|NCT03680911|21141666|P2|At Home Treatment|Withdrawal by Subject|2
6136280|NCT03680911|21141667|P1|At Home Treatment|Withdrawal by Subject|0
6136281|NCT03680911|21141666|P2|At Home Treatment|Lost to Follow-up|1
6136282|NCT03680911|21141667|P1|At Home Treatment|Lost to Follow-up|0
6136283|NCT03680911|21141666|P2|At Home Treatment|Study Termination|0
6136284|NCT03680911|21141667|P1|At Home Treatment|Study Termination|3
6136285|NCT03630120|21141679|P4|Overall Study|Disease progression|1
6136286|NCT03630120|21141680|P3|Overall Study|Disease progression|1
6136287|NCT03630120|21141681|P2|Overall Study|Disease progression|1
6136288|NCT03630120|21141682|P1|Overall Study|Disease progression|0
6136329|NCT03245723|21141964|P2|Overall Study|Image acquisition/reconstruction failure|1
6136330|NCT03245723|21141965|P1|Overall Study|Image acquisition/reconstruction failure|1
6136331|NCT03245723|21141964|P2|Overall Study|Having to abruptly stop the scan to use the restroom|0
6136332|NCT03245723|21141965|P1|Overall Study|Having to abruptly stop the scan to use the restroom|2
6136333|NCT03245723|21141964|P2|Overall Study|Claustrophobia from wearing the mask|0
6136334|NCT03245723|21141965|P1|Overall Study|Claustrophobia from wearing the mask|1
6136335|NCT03245723|21141964|P2|Overall Study|Bigeminy precluding hypoxia exposure|0
6136336|NCT03245723|21141965|P1|Overall Study|Bigeminy precluding hypoxia exposure|1
6136337|NCT03242928|21141975|P2|Overall Study|Withdrawal by Subject|3
6136338|NCT03242928|21141976|P1|Overall Study|Withdrawal by Subject|5
6136339|NCT03242928|21141975|P2|Overall Study|Physician Decision|1
6136340|NCT03242928|21141976|P1|Overall Study|Physician Decision|0
6136341|NCT03242928|21141975|P2|Overall Study|Lost to Follow-up|0
6136342|NCT03242928|21141976|P1|Overall Study|Lost to Follow-up|2
6136343|NCT03242928|21141975|P2|Overall Study|Adverse Event|1
6136344|NCT03242928|21141976|P1|Overall Study|Adverse Event|2
6136345|NCT03044574|21142031|P2|Overall Study|Lost to Follow-up|45
6136346|NCT03044574|21142032|P1|Overall Study|Lost to Follow-up|37
6136347|NCT03020888|21142058|P1|Overall Study|Lost to Follow-up|1
6136348|NCT03020888|21142058|P1|Overall Study|Insurance coverage|2
6136349|NCT03020888|21142058|P1|Overall Study|Withdrawal by Subject|6
6136350|NCT03020888|21142058|P1|Overall Study|Physician Decision|4
6136414|NCT02696902|21142318|P3|Overall Study|Transferred to other hospital|0
6136415|NCT02696902|21142319|P2|Overall Study|Transferred to other hospital|0
6136416|NCT02696902|21142320|P1|Overall Study|Transferred to other hospital|1
6136417|NCT02696902|21142318|P3|Overall Study|Sponsor's decision|0
6136418|NCT02696902|21142319|P2|Overall Study|Sponsor's decision|0
6136419|NCT02696902|21142320|P1|Overall Study|Sponsor's decision|1
6136420|NCT02696902|21142318|P3|Overall Study|Principal investigator's decision|0
6136421|NCT02696902|21142319|P2|Overall Study|Principal investigator's decision|0
6136422|NCT02696902|21142320|P1|Overall Study|Principal investigator's decision|1
6136423|NCT02696902|21142318|P3|Overall Study|Participant not eligible (negative PCR)|1
6136424|NCT02696902|21142319|P2|Overall Study|Participant not eligible (negative PCR)|0
6136425|NCT02696902|21142320|P1|Overall Study|Participant not eligible (negative PCR)|0
6136426|NCT02696902|21142318|P3|Overall Study|Participant not fit post-randomization|1
6136427|NCT02696902|21142319|P2|Overall Study|Participant not fit post-randomization|0
6136428|NCT02696902|21142320|P1|Overall Study|Participant not fit post-randomization|0
6136429|NCT02696902|21142318|P3|Overall Study|Death|24
6136430|NCT02696902|21142319|P2|Overall Study|Death|3
6136431|NCT02696902|21142320|P1|Overall Study|Death|19
6136432|NCT02696902|21142318|P3|Overall Study|Withdrawal by Subject|1
6136433|NCT02696902|21142319|P2|Overall Study|Withdrawal by Subject|0
6136434|NCT02696902|21142320|P1|Overall Study|Withdrawal by Subject|0
6136435|NCT02696902|21142318|P3|Overall Study|Lost to Follow-up|1
6136436|NCT02696902|21142319|P2|Overall Study|Lost to Follow-up|1
6136437|NCT02696902|21142320|P1|Overall Study|Lost to Follow-up|0
6136448|NCT02655887|21142413|P1|Overall Study|Missed 12-month follow-up visit|4
6136449|NCT02655887|21142413|P1|Overall Study|Withdrawal by Subject|3
6136450|NCT02655887|21142413|P1|Overall Study|Death|4
6136451|NCT02655887|21142413|P1|Overall Study|Lost to Follow-up|3
6136492|NCT02447718|21142633|P2|Overall Study|Screen Failure|0
6136493|NCT02447718|21142634|P1|Overall Study|Screen Failure|1
6136494|NCT02447718|21142633|P2|Overall Study|Withdrawal by Subject|0
6136495|NCT02447718|21142634|P1|Overall Study|Withdrawal by Subject|3
6136496|NCT02447718|21142633|P2|Overall Study|Lost to Follow-up|0
6136497|NCT02447718|21142634|P1|Overall Study|Lost to Follow-up|8
6136498|NCT02340221|21142696|P2|Overall Study|Continued on study|290
6136499|NCT02340221|21142697|P1|Overall Study|Continued on study|140
6136500|NCT02340221|21142696|P2|Overall Study|Reason Not Specified|1
6136501|NCT02340221|21142697|P1|Overall Study|Reason Not Specified|0
6136502|NCT02340221|21142696|P2|Overall Study|Lost to Follow-up|3
6136503|NCT02340221|21142697|P1|Overall Study|Lost to Follow-up|2
6136504|NCT02340221|21142696|P2|Overall Study|Withdrawal by Participant|22
6136505|NCT02340221|21142697|P1|Overall Study|Withdrawal by Participant|14
6136506|NCT02340221|21142696|P2|Overall Study|Death|101
6136507|NCT02340221|21142697|P1|Overall Study|Death|58
6136508|NCT02278341|21142727|P2|Overall Study|Miscellaneous|14
6136509|NCT02278341|21142728|P1|Overall Study|Miscellaneous|15
6136510|NCT02278341|21142727|P2|Overall Study|Physician Decision|1
6136511|NCT02278341|21142728|P1|Overall Study|Physician Decision|1
6136512|NCT02278341|21142727|P2|Overall Study|Lost to Follow-up|1
6136513|NCT02278341|21142728|P1|Overall Study|Lost to Follow-up|0
6136514|NCT02278341|21142727|P2|Overall Study|Withdrawal by Subject|19
6136515|NCT02278341|21142728|P1|Overall Study|Withdrawal by Subject|30
6136516|NCT02278341|21142727|P2|Overall Study|Death|56
6136517|NCT02278341|21142728|P1|Overall Study|Death|68
6136518|NCT02278341|21142727|P2|Overall Study|Adverse Event|0
6136519|NCT02278341|21142728|P1|Overall Study|Adverse Event|3
6136520|NCT02278341|21142727|P2|Overall Study|Randomized but never received study drug|1
6136521|NCT02278341|21142728|P1|Overall Study|Randomized but never received study drug|1
6136528|NCT02162719|21142855|P2|Overall Study|Discontinuation of Overall Survival Follow-up|10
6136529|NCT02162719|21142856|P1|Overall Study|Discontinuation of Overall Survival Follow-up|10
6136530|NCT02162719|21142855|P2|Overall Study|Withdrawal by Subject|2
6136531|NCT02162719|21142856|P1|Overall Study|Withdrawal by Subject|8
6136532|NCT02162719|21142855|P2|Overall Study|Disease Progression|1
6136533|NCT02162719|21142856|P1|Overall Study|Disease Progression|2
6136534|NCT02162719|21142855|P2|Overall Study|Lost to Follow-up|3
6136535|NCT02162719|21142856|P1|Overall Study|Lost to Follow-up|1
6136536|NCT02162719|21142855|P2|Overall Study|Death|46
6136537|NCT02162719|21142856|P1|Overall Study|Death|41
6136538|NCT02151981|21142900|P2|Overall Study|Study terminated|1
6136539|NCT02151981|21142901|P1|Overall Study|Study terminated|0
6136540|NCT02151981|21142900|P2|Overall Study|Unwilling to continue to follow up visit|1
6136541|NCT02151981|21142901|P1|Overall Study|Unwilling to continue to follow up visit|0
6136542|NCT02151981|21142900|P2|Overall Study|Patient had no clinical benefit|0
6136543|NCT02151981|21142901|P1|Overall Study|Patient had no clinical benefit|1
6136544|NCT02151981|21142900|P2|Overall Study|Eligibility criteria not fulfilled|1
6136545|NCT02151981|21142901|P1|Overall Study|Eligibility criteria not fulfilled|0
6136546|NCT02151981|21142900|P2|Overall Study|Ongoing Study at Data Cut-off|27
6136547|NCT02151981|21142901|P1|Overall Study|Ongoing Study at Data Cut-off|60
6136548|NCT02151981|21142900|P2|Overall Study|Withdrawal by Subject|21
6136549|NCT02151981|21142901|P1|Overall Study|Withdrawal by Subject|27
6136550|NCT02151981|21142900|P2|Overall Study|Lost to Follow-up|1
6136551|NCT02151981|21142901|P1|Overall Study|Lost to Follow-up|7
6136552|NCT02151981|21142900|P2|Overall Study|Death|88
6136553|NCT02151981|21142901|P1|Overall Study|Death|184
6136633|NCT01932762|21143121|P4|Overall Study|Physician Decision|0
6136634|NCT01932762|21143122|P3|Overall Study|Physician Decision|0
6136635|NCT01932762|21143123|P2|Overall Study|Physician Decision|0
6136636|NCT01932762|21143124|P1|Overall Study|Physician Decision|1
6136637|NCT01932762|21143121|P4|Overall Study|Lost to Follow-up|1
6136638|NCT01932762|21143122|P3|Overall Study|Lost to Follow-up|0
6136639|NCT01932762|21143123|P2|Overall Study|Lost to Follow-up|0
6136640|NCT01932762|21143124|P1|Overall Study|Lost to Follow-up|4
6136641|NCT01932762|21143121|P4|Overall Study|Withdrawal by Subject|0
6136642|NCT01932762|21143122|P3|Overall Study|Withdrawal by Subject|0
6136643|NCT01932762|21143123|P2|Overall Study|Withdrawal by Subject|2
6136644|NCT01932762|21143124|P1|Overall Study|Withdrawal by Subject|1
6136657|NCT01757392|21143240|P1|Overall Study|Screen Fail|3
6136658|NCT01757392|21143240|P1|Overall Study|Withdrawal by Subject|1
6136759|NCT01710501|21143552|P3|Overall Study|Lost to Follow-up|0
6136760|NCT01710501|21143553|P2|Overall Study|Lost to Follow-up|0
6136761|NCT01710501|21143554|P1|Overall Study|Lost to Follow-up|2
6136810|NCT01134614|21143722|P2|Overall Study|Patient in hospice care|1
6136811|NCT01134614|21143723|P1|Overall Study|Patient in hospice care|0
6136812|NCT01134614|21143722|P2|Overall Study|Symptomatic deterioration|1
6136813|NCT01134614|21143723|P1|Overall Study|Symptomatic deterioration|0
6136814|NCT01134614|21143722|P2|Overall Study|Pt received tx not allowed on study|1
6136815|NCT01134614|21143723|P1|Overall Study|Pt received tx not allowed on study|0
6136816|NCT01134614|21143722|P2|Overall Study|Never started treatment|1
6136817|NCT01134614|21143723|P1|Overall Study|Never started treatment|4
6136818|NCT01134614|21143722|P2|Overall Study|Physician's decision|1
6136819|NCT01134614|21143723|P1|Overall Study|Physician's decision|0
6136820|NCT01134614|21143722|P2|Overall Study|Complicating disease|1
6136821|NCT01134614|21143723|P1|Overall Study|Complicating disease|2
6136822|NCT01134614|21143722|P2|Overall Study|Alternative therapy|0
6136823|NCT01134614|21143723|P1|Overall Study|Alternative therapy|2
6136824|NCT01134614|21143722|P2|Overall Study|Withdrawal by Subject|2
6136825|NCT01134614|21143723|P1|Overall Study|Withdrawal by Subject|3
6136826|NCT01134614|21143722|P2|Overall Study|Death|8
6136827|NCT01134614|21143723|P1|Overall Study|Death|5
6136828|NCT01134614|21143722|P2|Overall Study|Adverse Event|39
6136829|NCT01134614|21143723|P1|Overall Study|Adverse Event|26
6136830|NCT01134614|21143722|P2|Overall Study|Progressive disease|54
6136831|NCT01134614|21143723|P1|Overall Study|Progressive disease|60
6136832|NCT01134614|21143722|P2|Overall Study|Still on treatment as of March 2013|13
6136833|NCT01134614|21143723|P1|Overall Study|Still on treatment as of March 2013|21
6136882|NCT00863772|21143802|P3|Overall Study|Randomized but not Treated|0
6136883|NCT00863772|21143803|P2|Overall Study|Randomized but not Treated|0
6136884|NCT00863772|21143804|P1|Overall Study|Randomized but not Treated|1
6136885|NCT00863772|21143802|P3|Overall Study|Other|4
6136886|NCT00863772|21143803|P2|Overall Study|Other|2
6136887|NCT00863772|21143804|P1|Overall Study|Other|1
6136888|NCT00863772|21143802|P3|Overall Study|Entered extension study|9
6136889|NCT00863772|21143803|P2|Overall Study|Entered extension study|4
6136890|NCT00863772|21143804|P1|Overall Study|Entered extension study|6
6136891|NCT00863772|21143802|P3|Overall Study|Study terminated by sponsor|36
6136892|NCT00863772|21143803|P2|Overall Study|Study terminated by sponsor|45
6136893|NCT00863772|21143804|P1|Overall Study|Study terminated by sponsor|44
6136894|NCT00863772|21143802|P3|Overall Study|Withdrawal by Subject|5
6136895|NCT00863772|21143803|P2|Overall Study|Withdrawal by Subject|7
6136896|NCT00863772|21143804|P1|Overall Study|Withdrawal by Subject|4
6136897|NCT00863772|21143802|P3|Overall Study|Protocol Violation|2
6136898|NCT00863772|21143803|P2|Overall Study|Protocol Violation|0
6136899|NCT00863772|21143804|P1|Overall Study|Protocol Violation|2
6136900|NCT00863772|21143802|P3|Overall Study|Lost to Follow-up|1
6136901|NCT00863772|21143803|P2|Overall Study|Lost to Follow-up|1
6136902|NCT00863772|21143804|P1|Overall Study|Lost to Follow-up|5
6136903|NCT00863772|21143802|P3|Overall Study|Lack of Efficacy|4
6136904|NCT00863772|21143803|P2|Overall Study|Lack of Efficacy|2
6136905|NCT00863772|21143804|P1|Overall Study|Lack of Efficacy|4
6136906|NCT00863772|21143802|P3|Overall Study|Adverse Event|0
6136907|NCT00863772|21143803|P2|Overall Study|Adverse Event|4
6136908|NCT00863772|21143804|P1|Overall Study|Adverse Event|1
6136923|NCT00334815|21143961|P2|Overall Study|Physician Decision|4
6136924|NCT00334815|21143962|P1|Overall Study|Physician Decision|2
6136925|NCT00334815|21143961|P2|Overall Study|patient refused treatment|1
6136926|NCT00334815|21143962|P1|Overall Study|patient refused treatment|0
6136927|NCT00334815|21143961|P2|Overall Study|ineligible|1
6136928|NCT00334815|21143962|P1|Overall Study|ineligible|1
6136929|NCT00334815|21143961|P2|Overall Study|Progression|0
6136930|NCT00334815|21143962|P1|Overall Study|Progression|1
6136931|NCT00334815|21143961|P2|Overall Study|Death|2
6136932|NCT00334815|21143962|P1|Overall Study|Death|0
6136933|NCT00334815|21143961|P2|Overall Study|Adverse Event|2
6136934|NCT00334815|21143962|P1|Overall Study|Adverse Event|3
6136941|NCT04439110|21144060|P1|Overall Study|Still on treatment|1
6136942|NCT04439110|21144060|P1|Overall Study|Personal reasons|1
6136943|NCT04439110|21144060|P1|Overall Study|Other complicating disease|1
6136944|NCT04439110|21144060|P1|Overall Study|Alternative therapy|1
6136945|NCT04439110|21144060|P1|Overall Study|Withdrawal by Subject|1
6136946|NCT04439110|21144060|P1|Overall Study|Disease proression|25
6136947|NCT04439110|21144060|P1|Overall Study|Death|2
6136948|NCT04439110|21144060|P1|Overall Study|Adverse Event|4
6136949|NCT04439110|21144060|P1|Overall Study|Ineligible|2
6136950|NCT03996694|21144081|P6|Third Washout (7 Days)|Withdrawal by Subject|0
6136951|NCT03996694|21144082|P5|Third Washout (7 Days)|Withdrawal by Subject|1
6136952|NCT03996694|21144083|P4|Third Washout (7 Days)|Withdrawal by Subject|0
6136953|NCT03996694|21144084|P3|Third Washout (7 Days)|Withdrawal by Subject|0
6136954|NCT03996694|21144085|P2|Third Washout (7 Days)|Withdrawal by Subject|0
6136955|NCT03996694|21144086|P1|Third Washout (7 Days)|Withdrawal by Subject|0
6136956|NCT03996694|21144081|P6|First Washout (7 Days)|Lost to Follow-up|0
6136957|NCT03996694|21144082|P5|First Washout (7 Days)|Lost to Follow-up|0
6136958|NCT03996694|21144083|P4|First Washout (7 Days)|Lost to Follow-up|0
6136959|NCT03996694|21144084|P3|First Washout (7 Days)|Lost to Follow-up|1
6136960|NCT03996694|21144085|P2|First Washout (7 Days)|Lost to Follow-up|0
6136961|NCT03996694|21144086|P1|First Washout (7 Days)|Lost to Follow-up|0
6136962|NCT03996694|21144081|P6|First Washout (7 Days)|Adverse Event|0
6136963|NCT03996694|21144082|P5|First Washout (7 Days)|Adverse Event|0
6136964|NCT03996694|21144083|P4|First Washout (7 Days)|Adverse Event|0
6136965|NCT03996694|21144084|P3|First Washout (7 Days)|Adverse Event|0
6136966|NCT03996694|21144085|P2|First Washout (7 Days)|Adverse Event|1
6136967|NCT03996694|21144086|P1|First Washout (7 Days)|Adverse Event|0
6136968|NCT03996694|21144081|P6|First Washout (7 Days)|positive urine drug screen|0
6136969|NCT03996694|21144082|P5|First Washout (7 Days)|positive urine drug screen|0
6136970|NCT03996694|21144083|P4|First Washout (7 Days)|positive urine drug screen|0
6136971|NCT03996694|21144084|P3|First Washout (7 Days)|positive urine drug screen|1
6136972|NCT03996694|21144085|P2|First Washout (7 Days)|positive urine drug screen|0
6136973|NCT03996694|21144086|P1|First Washout (7 Days)|positive urine drug screen|0
6136974|NCT03979274|21144118|P2|Treatment Period 2|Withdrawal by Subject|1
6136975|NCT03979274|21144119|P1|Treatment Period 2|Withdrawal by Subject|0
6136976|NCT03812679|21144145|P1|Overall Study|Water device replacement|1
6136977|NCT03812679|21144145|P1|Overall Study|Termination of study|2
6136978|NCT03812679|21144145|P1|Overall Study|Withdrawal by Subject|1
6136979|NCT03812679|21144145|P1|Overall Study|Renal transplant|1
6136980|NCT03812679|21144145|P1|Overall Study|Missed >4 consecutive therapy days|1
6136981|NCT03812679|21144145|P1|Overall Study|Adverse Event|2
6136988|NCT03610165|21144206|P2|Overall Study|Device didn't work|1
6136989|NCT03610165|21144207|P1|Overall Study|Device didn't work|0
6136999|NCT03477838|21144262|P1|Overall Study|Lost to Follow-up|14
6137010|NCT03351608|21144385|P5|Overall Study|Other|0
6137011|NCT03351608|21144386|P4|Overall Study|Other|3
6137012|NCT03351608|21144387|P3|Overall Study|Other|1
6137013|NCT03351608|21144388|P2|Overall Study|Other|1
6137014|NCT03351608|21144389|P1|Overall Study|Other|0
6137015|NCT03351608|21144385|P5|Overall Study|Withdrawal by parent/guardian|0
6137016|NCT03351608|21144386|P4|Overall Study|Withdrawal by parent/guardian|1
6137017|NCT03351608|21144387|P3|Overall Study|Withdrawal by parent/guardian|1
6137018|NCT03351608|21144388|P2|Overall Study|Withdrawal by parent/guardian|0
6137019|NCT03351608|21144389|P1|Overall Study|Withdrawal by parent/guardian|0
6137020|NCT03351608|21144385|P5|Overall Study|Randomized by mistake, no treatment given|0
6137021|NCT03351608|21144386|P4|Overall Study|Randomized by mistake, no treatment given|1
6137022|NCT03351608|21144387|P3|Overall Study|Randomized by mistake, no treatment given|0
6137023|NCT03351608|21144388|P2|Overall Study|Randomized by mistake, no treatment given|0
6137024|NCT03351608|21144389|P1|Overall Study|Randomized by mistake, no treatment given|0
6137025|NCT03351608|21144385|P5|Overall Study|Physician Decision|1
6137026|NCT03351608|21144386|P4|Overall Study|Physician Decision|2
6137027|NCT03351608|21144387|P3|Overall Study|Physician Decision|0
6137028|NCT03351608|21144388|P2|Overall Study|Physician Decision|0
6137029|NCT03351608|21144389|P1|Overall Study|Physician Decision|1
6137030|NCT03351608|21144385|P5|Overall Study|Lost to Follow-up|1
6137031|NCT03351608|21144386|P4|Overall Study|Lost to Follow-up|1
6137032|NCT03351608|21144387|P3|Overall Study|Lost to Follow-up|1
6137033|NCT03351608|21144388|P2|Overall Study|Lost to Follow-up|1
6137034|NCT03351608|21144389|P1|Overall Study|Lost to Follow-up|0
6137035|NCT03332498|21144462|P3|Overall Study|Severe illness prior to Day 1 of treatment|2
6137036|NCT03332498|21144463|P2|Overall Study|Severe illness prior to Day 1 of treatment|0
6137037|NCT03332498|21144464|P1|Overall Study|Severe illness prior to Day 1 of treatment|0
6137060|NCT02975349|21144597|P6|Blinded Extension Period (24 Weeks)|Un-specified|0
6137061|NCT02975349|21144598|P5|Blinded Extension Period (24 Weeks)|Un-specified|0
6137062|NCT02975349|21144599|P4|Blinded Extension Period (24 Weeks)|Un-specified|1
6137063|NCT02975349|21144600|P3|Blinded Extension Period (24 Weeks)|Un-specified|0
6137064|NCT02975349|21144601|P2|Blinded Extension Period (24 Weeks)|Un-specified|0
6137065|NCT02975349|21144602|P1|Blinded Extension Period (24 Weeks)|Un-specified|0
6137066|NCT02975349|21144597|P6|Blinded Extension Period (24 Weeks)|Progressive Disease|0
6137067|NCT02975349|21144598|P5|Blinded Extension Period (24 Weeks)|Progressive Disease|0
6137068|NCT02975349|21144599|P4|Blinded Extension Period (24 Weeks)|Progressive Disease|0
6137069|NCT02975349|21144600|P3|Blinded Extension Period (24 Weeks)|Progressive Disease|0
6137070|NCT02975349|21144601|P2|Blinded Extension Period (24 Weeks)|Progressive Disease|1
6137071|NCT02975349|21144602|P1|Blinded Extension Period (24 Weeks)|Progressive Disease|0
6137072|NCT02975349|21144597|P6|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0
6137073|NCT02975349|21144598|P5|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0
6137074|NCT02975349|21144599|P4|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0
6137075|NCT02975349|21144600|P3|Blinded Extension Period (24 Weeks)|Lack of Efficacy|1
6137076|NCT02975349|21144601|P2|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0
6137077|NCT02975349|21144602|P1|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0
6137078|NCT02975349|21144597|P6|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0
6137079|NCT02975349|21144598|P5|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|1
6137080|NCT02975349|21144599|P4|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|1
6137081|NCT02975349|21144600|P3|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|2
6137082|NCT02975349|21144601|P2|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|5
6137083|NCT02975349|21144602|P1|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0
6137084|NCT02975349|21144597|P6|Blinded Extension Period (24 Weeks)|Adverse Event|0
6137085|NCT02975349|21144598|P5|Blinded Extension Period (24 Weeks)|Adverse Event|1
6137086|NCT02975349|21144599|P4|Blinded Extension Period (24 Weeks)|Adverse Event|2
6137087|NCT02975349|21144600|P3|Blinded Extension Period (24 Weeks)|Adverse Event|1
6137088|NCT02975349|21144601|P2|Blinded Extension Period (24 Weeks)|Adverse Event|1
6137089|NCT02975349|21144602|P1|Blinded Extension Period (24 Weeks)|Adverse Event|0
6137090|NCT02975349|21144597|P6|Active Treatment Period (24 Weeks)|Un-specified|0
6137091|NCT02975349|21144598|P5|Active Treatment Period (24 Weeks)|Un-specified|0
6137092|NCT02975349|21144599|P4|Active Treatment Period (24 Weeks)|Un-specified|0
6137093|NCT02975349|21144600|P3|Active Treatment Period (24 Weeks)|Un-specified|1
6137094|NCT02975349|21144601|P2|Active Treatment Period (24 Weeks)|Un-specified|0
6137095|NCT02975349|21144602|P1|Active Treatment Period (24 Weeks)|Un-specified|0
6137096|NCT02975349|21144597|P6|Active Treatment Period (24 Weeks)|Adverse Event|2
6137097|NCT02975349|21144598|P5|Active Treatment Period (24 Weeks)|Adverse Event|6
6137098|NCT02975349|21144599|P4|Active Treatment Period (24 Weeks)|Adverse Event|2
6137099|NCT02975349|21144600|P3|Active Treatment Period (24 Weeks)|Adverse Event|1
6137100|NCT02975349|21144601|P2|Active Treatment Period (24 Weeks)|Adverse Event|0
6137101|NCT02975349|21144602|P1|Active Treatment Period (24 Weeks)|Adverse Event|4
6137102|NCT02975349|21144597|P6|Active Treatment Period (24 Weeks)|Lost to Follow-up|0
6137103|NCT02975349|21144598|P5|Active Treatment Period (24 Weeks)|Lost to Follow-up|0
6137104|NCT02975349|21144599|P4|Active Treatment Period (24 Weeks)|Lost to Follow-up|0
6137105|NCT02975349|21144600|P3|Active Treatment Period (24 Weeks)|Lost to Follow-up|0
6137106|NCT02975349|21144601|P2|Active Treatment Period (24 Weeks)|Lost to Follow-up|0
6137107|NCT02975349|21144602|P1|Active Treatment Period (24 Weeks)|Lost to Follow-up|1
6137108|NCT02975349|21144597|P6|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0
6137109|NCT02975349|21144598|P5|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0
6137110|NCT02975349|21144599|P4|Active Treatment Period (24 Weeks)|Withdrawal by Subject|3
6137111|NCT02975349|21144600|P3|Active Treatment Period (24 Weeks)|Withdrawal by Subject|3
6137112|NCT02975349|21144601|P2|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0
6137113|NCT02975349|21144602|P1|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0
6137124|NCT02933489|21144781|P2|Overall Study|Unable to complete exams (other)|7
6137125|NCT02933489|21144782|P1|Overall Study|Unable to complete exams (other)|14
6137126|NCT02933489|21144781|P2|Overall Study|Withdrawal by Subject|18
6137127|NCT02933489|21144782|P1|Overall Study|Withdrawal by Subject|27
6137128|NCT02933489|21144781|P2|Overall Study|Ineligible|3
6137129|NCT02933489|21144782|P1|Overall Study|Ineligible|3
6137391|NCT02816398|21144863|P1|Overall Study|Lost to Follow-up|1
6137392|NCT02816398|21144863|P1|Overall Study|Lack of Efficacy|8
6137393|NCT02816398|21144863|P1|Overall Study|Death|5
6137396|NCT02681523|21144926|P1|Overall Study|Patient Non-compliance|1
6137397|NCT02681523|21144926|P1|Overall Study|Adverse Event|1
6137398|NCT02662582|21144934|P2|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
6137399|NCT02662582|21144935|P1|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
6137400|NCT02662582|21144934|P2|Treatment Period 1 (14 Days)|Protocol Deviation|0
6137401|NCT02662582|21144935|P1|Treatment Period 1 (14 Days)|Protocol Deviation|1
6137402|NCT02662582|21144934|P2|Treatment Period 1 (14 Days)|Miscellaneous|1
6137403|NCT02662582|21144935|P1|Treatment Period 1 (14 Days)|Miscellaneous|0
6137404|NCT02662582|21144934|P2|Treatment Period 1 (14 Days)|Adverse Event|2
6137405|NCT02662582|21144935|P1|Treatment Period 1 (14 Days)|Adverse Event|3
6137448|NCT02574481|21145206|P4|Overall Study|Death|0
6137449|NCT02574481|21145207|P3|Overall Study|Death|0
6137450|NCT02574481|21145208|P2|Overall Study|Death|6
6137451|NCT02574481|21145209|P1|Overall Study|Death|6
6137452|NCT02574481|21145206|P4|Overall Study|Other|0
6137453|NCT02574481|21145207|P3|Overall Study|Other|0
6137454|NCT02574481|21145208|P2|Overall Study|Other|0
6137455|NCT02574481|21145209|P1|Overall Study|Other|1
6137456|NCT02574481|21145206|P4|Overall Study|Visit Missed|0
6137457|NCT02574481|21145207|P3|Overall Study|Visit Missed|2
6137458|NCT02574481|21145208|P2|Overall Study|Visit Missed|4
6137459|NCT02574481|21145209|P1|Overall Study|Visit Missed|12
6137460|NCT02574481|21145206|P4|Overall Study|Adverse Event|0
6137461|NCT02574481|21145207|P3|Overall Study|Adverse Event|0
6137462|NCT02574481|21145208|P2|Overall Study|Adverse Event|0
6137463|NCT02574481|21145209|P1|Overall Study|Adverse Event|2
6137464|NCT02574481|21145206|P4|Overall Study|Withdrawal by Subject|0
6137465|NCT02574481|21145207|P3|Overall Study|Withdrawal by Subject|1
6137466|NCT02574481|21145208|P2|Overall Study|Withdrawal by Subject|4
6137467|NCT02574481|21145209|P1|Overall Study|Withdrawal by Subject|6
6137468|NCT02526160|21145249|P2|Open-Label Treatment Extension Period II|Other, Not Specified|0
6137469|NCT02526160|21145250|P1|Open-Label Treatment Extension Period II|Other, Not Specified|1
6137470|NCT02526160|21145249|P2|Open-Label Treatment Extension Period I|Lost to Follow-up|1
6137471|NCT02526160|21145250|P1|Open-Label Treatment Extension Period I|Lost to Follow-up|0
6137472|NCT02526160|21145249|P2|Open-Label Treatment Extension Period I|Withdrawal by Subject|1
6137473|NCT02526160|21145250|P1|Open-Label Treatment Extension Period I|Withdrawal by Subject|0
6137474|NCT02526160|21145249|P2|Open-Label Treatment Extension Period I|Other, Not Specified|1
6137475|NCT02526160|21145250|P1|Open-Label Treatment Extension Period I|Other, Not Specified|3
6137476|NCT02526160|21145249|P2|Open-Label Treatment Extension Period I|Death|1
6137477|NCT02526160|21145250|P1|Open-Label Treatment Extension Period I|Death|0
6137478|NCT02526160|21145249|P2|Open-label Treatment Continuation Period|Other, Not Specified|3
6137479|NCT02526160|21145250|P1|Open-label Treatment Continuation Period|Other, Not Specified|3
6137480|NCT02526160|21145249|P2|Open-label Treatment Continuation Period|Withdrawal by Subject|1
6137481|NCT02526160|21145250|P1|Open-label Treatment Continuation Period|Withdrawal by Subject|0
6137482|NCT02526160|21145249|P2|Double-Blind (Placebo-Controlled) Period|Withdrawal by Subject|1
6137483|NCT02526160|21145250|P1|Double-Blind (Placebo-Controlled) Period|Withdrawal by Subject|0
6137484|NCT02481869|21145356|P2|Overall Study|Withdrawal by Subject|0
6137485|NCT02481869|21145357|P1|Overall Study|Withdrawal by Subject|2
6137486|NCT02481869|21145356|P2|Overall Study|Lost to Follow-up|4
6137487|NCT02481869|21145357|P1|Overall Study|Lost to Follow-up|3
6137556|NCT02212379|21145566|P1|From Week 48 to Week 96|Withdrawal by Subject|2
6137557|NCT02212379|21145566|P1|From Week 48 to Week 96|Adverse Event|1
6137558|NCT02212379|21145566|P1|From Week 48 to Week 96|Lack of Efficacy|1
6137559|NCT02212379|21145566|P1|From Baseline to Week 48|Withdrawal by Subject|1
6137560|NCT02212379|21145566|P1|From Baseline to Week 48|Adverse Event|7
6137561|NCT02212379|21145566|P1|From Baseline to Week 48|Lack of Efficacy|1
6137562|NCT02138890|21145599|P2|Overall Study|Adverse Event|0
6137563|NCT02138890|21145600|P1|Overall Study|Adverse Event|1
6137564|NCT02133131|21145647|P7|Overall Study|Protocol Violation|1
6137565|NCT02133131|21145648|P6|Overall Study|Protocol Violation|0
6137566|NCT02133131|21145649|P5|Overall Study|Protocol Violation|0
6137567|NCT02133131|21145650|P4|Overall Study|Protocol Violation|0
6137568|NCT02133131|21145651|P3|Overall Study|Protocol Violation|0
6137569|NCT02133131|21145652|P2|Overall Study|Protocol Violation|0
6137570|NCT02133131|21145653|P1|Overall Study|Protocol Violation|0
6137571|NCT02133131|21145647|P7|Overall Study|Ongoing in study|11
6137572|NCT02133131|21145648|P6|Overall Study|Ongoing in study|14
6137573|NCT02133131|21145649|P5|Overall Study|Ongoing in study|15
6137574|NCT02133131|21145650|P4|Overall Study|Ongoing in study|0
6137575|NCT02133131|21145651|P3|Overall Study|Ongoing in study|0
6137576|NCT02133131|21145652|P2|Overall Study|Ongoing in study|0
6137577|NCT02133131|21145653|P1|Overall Study|Ongoing in study|0
6137578|NCT02133131|21145647|P7|Overall Study|Status not recorded|0
6137579|NCT02133131|21145648|P6|Overall Study|Status not recorded|0
6137580|NCT02133131|21145649|P5|Overall Study|Status not recorded|0
6137581|NCT02133131|21145650|P4|Overall Study|Status not recorded|4
6137582|NCT02133131|21145651|P3|Overall Study|Status not recorded|1
6137583|NCT02133131|21145652|P2|Overall Study|Status not recorded|5
6137584|NCT02133131|21145653|P1|Overall Study|Status not recorded|4
6137585|NCT02133131|21145647|P7|Overall Study|Lost to Follow-up|0
6137586|NCT02133131|21145648|P6|Overall Study|Lost to Follow-up|0
6137587|NCT02133131|21145649|P5|Overall Study|Lost to Follow-up|0
6137588|NCT02133131|21145650|P4|Overall Study|Lost to Follow-up|1
6137589|NCT02133131|21145651|P3|Overall Study|Lost to Follow-up|0
6137590|NCT02133131|21145652|P2|Overall Study|Lost to Follow-up|0
6137591|NCT02133131|21145653|P1|Overall Study|Lost to Follow-up|1
6137592|NCT02133131|21145647|P7|Overall Study|Adverse Event|0
6137593|NCT02133131|21145648|P6|Overall Study|Adverse Event|0
6137594|NCT02133131|21145649|P5|Overall Study|Adverse Event|0
6137595|NCT02133131|21145650|P4|Overall Study|Adverse Event|1
6137596|NCT02133131|21145651|P3|Overall Study|Adverse Event|0
6137597|NCT02133131|21145652|P2|Overall Study|Adverse Event|0
6137598|NCT02133131|21145653|P1|Overall Study|Adverse Event|0
6137599|NCT02124746|21145693|P3|Overall Study|Disease Progression|4
6137600|NCT02124746|21145694|P2|Overall Study|Disease Progression|6
6137601|NCT02124746|21145695|P1|Overall Study|Disease Progression|3
6137602|NCT02124746|21145693|P3|Overall Study|Study Terminated by Sponsor|6
6137603|NCT02124746|21145694|P2|Overall Study|Study Terminated by Sponsor|0
6137604|NCT02124746|21145695|P1|Overall Study|Study Terminated by Sponsor|0
6137605|NCT02124746|21145693|P3|Overall Study|Withdrawal by Subject|0
6137606|NCT02124746|21145694|P2|Overall Study|Withdrawal by Subject|3
6137607|NCT02124746|21145695|P1|Overall Study|Withdrawal by Subject|3
6137608|NCT02124746|21145693|P3|Overall Study|Non-Compliance with Study Drug|0
6137609|NCT02124746|21145694|P2|Overall Study|Non-Compliance with Study Drug|1
6137610|NCT02124746|21145695|P1|Overall Study|Non-Compliance with Study Drug|0
6137611|NCT02124746|21145693|P3|Overall Study|Physician Decision|5
6137612|NCT02124746|21145694|P2|Overall Study|Physician Decision|4
6137613|NCT02124746|21145695|P1|Overall Study|Physician Decision|6
6137614|NCT02124746|21145693|P3|Overall Study|Lack of Efficacy|2
6137615|NCT02124746|21145694|P2|Overall Study|Lack of Efficacy|2
6137616|NCT02124746|21145695|P1|Overall Study|Lack of Efficacy|3
6137617|NCT02124746|21145693|P3|Overall Study|Death|3
6137618|NCT02124746|21145694|P2|Overall Study|Death|1
6137619|NCT02124746|21145695|P1|Overall Study|Death|2
6137620|NCT02124746|21145693|P3|Overall Study|Adverse Event|2
6137621|NCT02124746|21145694|P2|Overall Study|Adverse Event|1
6137622|NCT02124746|21145695|P1|Overall Study|Adverse Event|2
6137623|NCT02105701|21145740|P4|Overall Study|Death|0
6137624|NCT02105701|21145741|P3|Overall Study|Death|0
6137625|NCT02105701|21145742|P2|Overall Study|Death|0
6137626|NCT02105701|21145743|P1|Overall Study|Death|1
6137627|NCT02105701|21145740|P4|Overall Study|Withdrawal by Subject|1
6137628|NCT02105701|21145741|P3|Overall Study|Withdrawal by Subject|0
6137629|NCT02105701|21145742|P2|Overall Study|Withdrawal by Subject|1
6137630|NCT02105701|21145743|P1|Overall Study|Withdrawal by Subject|2
6137631|NCT02105701|21145740|P4|Overall Study|Protocol Violation|0
6137632|NCT02105701|21145741|P3|Overall Study|Protocol Violation|1
6137633|NCT02105701|21145742|P2|Overall Study|Protocol Violation|0
6137634|NCT02105701|21145743|P1|Overall Study|Protocol Violation|0
6137635|NCT02105701|21145740|P4|Overall Study|Lost to Follow-up|1
6137636|NCT02105701|21145741|P3|Overall Study|Lost to Follow-up|2
6137637|NCT02105701|21145742|P2|Overall Study|Lost to Follow-up|0
6137638|NCT02105701|21145743|P1|Overall Study|Lost to Follow-up|1
6137639|NCT02105662|21145765|P1|Overall Study|Withdrawal by Subject|1
6137640|NCT02105662|21145765|P1|Overall Study|Lost to Follow-up|5
6137653|NCT01717326|21145818|P20|Overall Study|Withdrawal by Subject|3
6137654|NCT01717326|21145819|P19|Overall Study|Withdrawal by Subject|2
6137655|NCT01717326|21145820|P18|Overall Study|Withdrawal by Subject|0
6137656|NCT01717326|21145821|P17|Overall Study|Withdrawal by Subject|0
6137657|NCT01717326|21145822|P16|Overall Study|Withdrawal by Subject|1
6137658|NCT01717326|21145823|P15|Overall Study|Withdrawal by Subject|0
6137659|NCT01717326|21145824|P14|Overall Study|Withdrawal by Subject|0
6137660|NCT01717326|21145825|P13|Overall Study|Withdrawal by Subject|1
6137661|NCT01717326|21145826|P12|Overall Study|Withdrawal by Subject|0
6137662|NCT01717326|21145827|P11|Overall Study|Withdrawal by Subject|0
6137663|NCT01717326|21145828|P10|Overall Study|Withdrawal by Subject|1
6137664|NCT01717326|21145829|P9|Overall Study|Withdrawal by Subject|0
6137665|NCT01717326|21145830|P8|Overall Study|Withdrawal by Subject|0
6137666|NCT01717326|21145831|P7|Overall Study|Withdrawal by Subject|0
6137667|NCT01717326|21145832|P6|Overall Study|Withdrawal by Subject|0
6137668|NCT01717326|21145833|P5|Overall Study|Withdrawal by Subject|0
6137669|NCT01717326|21145834|P4|Overall Study|Withdrawal by Subject|0
6137670|NCT01717326|21145835|P3|Overall Study|Withdrawal by Subject|0
6137671|NCT01717326|21145836|P2|Overall Study|Withdrawal by Subject|1
6137672|NCT01717326|21145837|P1|Overall Study|Withdrawal by Subject|0
6137673|NCT01717326|21145818|P20|Overall Study|Protocol Violation|0
6137674|NCT01717326|21145819|P19|Overall Study|Protocol Violation|0
6137675|NCT01717326|21145820|P18|Overall Study|Protocol Violation|0
6137676|NCT01717326|21145821|P17|Overall Study|Protocol Violation|0
6137677|NCT01717326|21145822|P16|Overall Study|Protocol Violation|0
6137678|NCT01717326|21145823|P15|Overall Study|Protocol Violation|0
6137679|NCT01717326|21145824|P14|Overall Study|Protocol Violation|0
6137680|NCT01717326|21145825|P13|Overall Study|Protocol Violation|0
6137681|NCT01717326|21145826|P12|Overall Study|Protocol Violation|0
6137682|NCT01717326|21145827|P11|Overall Study|Protocol Violation|0
6137683|NCT01717326|21145828|P10|Overall Study|Protocol Violation|0
6137684|NCT01717326|21145829|P9|Overall Study|Protocol Violation|0
6137685|NCT01717326|21145830|P8|Overall Study|Protocol Violation|0
6137686|NCT01717326|21145831|P7|Overall Study|Protocol Violation|0
6137687|NCT01717326|21145832|P6|Overall Study|Protocol Violation|0
6137688|NCT01717326|21145833|P5|Overall Study|Protocol Violation|1
6137689|NCT01717326|21145834|P4|Overall Study|Protocol Violation|0
6137690|NCT01717326|21145835|P3|Overall Study|Protocol Violation|0
6137691|NCT01717326|21145836|P2|Overall Study|Protocol Violation|0
6137692|NCT01717326|21145837|P1|Overall Study|Protocol Violation|0
6137693|NCT01717326|21145818|P20|Overall Study|Physician Decision|0
6137694|NCT01717326|21145819|P19|Overall Study|Physician Decision|0
6137695|NCT01717326|21145820|P18|Overall Study|Physician Decision|0
6137696|NCT01717326|21145821|P17|Overall Study|Physician Decision|0
6137697|NCT01717326|21145822|P16|Overall Study|Physician Decision|0
6137698|NCT01717326|21145823|P15|Overall Study|Physician Decision|0
6137699|NCT01717326|21145824|P14|Overall Study|Physician Decision|0
6137700|NCT01717326|21145825|P13|Overall Study|Physician Decision|0
6137701|NCT01717326|21145826|P12|Overall Study|Physician Decision|0
6137702|NCT01717326|21145827|P11|Overall Study|Physician Decision|0
6137703|NCT01717326|21145828|P10|Overall Study|Physician Decision|1
6137704|NCT01717326|21145829|P9|Overall Study|Physician Decision|0
6137705|NCT01717326|21145830|P8|Overall Study|Physician Decision|0
6137706|NCT01717326|21145831|P7|Overall Study|Physician Decision|0
6137707|NCT01717326|21145832|P6|Overall Study|Physician Decision|0
6137708|NCT01717326|21145833|P5|Overall Study|Physician Decision|0
6137709|NCT01717326|21145834|P4|Overall Study|Physician Decision|0
6137710|NCT01717326|21145835|P3|Overall Study|Physician Decision|0
6137711|NCT01717326|21145836|P2|Overall Study|Physician Decision|0
6137712|NCT01717326|21145837|P1|Overall Study|Physician Decision|0
6137713|NCT01717326|21145818|P20|Overall Study|Lost to Follow-up|3
6137714|NCT01717326|21145819|P19|Overall Study|Lost to Follow-up|2
6137715|NCT01717326|21145820|P18|Overall Study|Lost to Follow-up|0
6137716|NCT01717326|21145821|P17|Overall Study|Lost to Follow-up|1
6137717|NCT01717326|21145822|P16|Overall Study|Lost to Follow-up|2
6137718|NCT01717326|21145823|P15|Overall Study|Lost to Follow-up|0
6137719|NCT01717326|21145824|P14|Overall Study|Lost to Follow-up|0
6137720|NCT01717326|21145825|P13|Overall Study|Lost to Follow-up|0
6137721|NCT01717326|21145826|P12|Overall Study|Lost to Follow-up|0
6137722|NCT01717326|21145827|P11|Overall Study|Lost to Follow-up|1
6137723|NCT01717326|21145828|P10|Overall Study|Lost to Follow-up|0
6137724|NCT01717326|21145829|P9|Overall Study|Lost to Follow-up|0
6137725|NCT01717326|21145830|P8|Overall Study|Lost to Follow-up|0
6137726|NCT01717326|21145831|P7|Overall Study|Lost to Follow-up|1
6137727|NCT01717326|21145832|P6|Overall Study|Lost to Follow-up|0
6137728|NCT01717326|21145833|P5|Overall Study|Lost to Follow-up|1
6137729|NCT01717326|21145834|P4|Overall Study|Lost to Follow-up|2
6137730|NCT01717326|21145835|P3|Overall Study|Lost to Follow-up|0
6137731|NCT01717326|21145836|P2|Overall Study|Lost to Follow-up|0
6137732|NCT01717326|21145837|P1|Overall Study|Lost to Follow-up|3
6137733|NCT01717326|21145818|P20|Overall Study|Death|0
6137734|NCT01717326|21145819|P19|Overall Study|Death|0
6137735|NCT01717326|21145820|P18|Overall Study|Death|0
6137736|NCT01717326|21145821|P17|Overall Study|Death|0
6137737|NCT01717326|21145822|P16|Overall Study|Death|0
6137738|NCT01717326|21145823|P15|Overall Study|Death|0
6137739|NCT01717326|21145824|P14|Overall Study|Death|0
6137740|NCT01717326|21145825|P13|Overall Study|Death|0
6137741|NCT01717326|21145826|P12|Overall Study|Death|0
6137742|NCT01717326|21145827|P11|Overall Study|Death|1
6137743|NCT01717326|21145828|P10|Overall Study|Death|0
6137744|NCT01717326|21145829|P9|Overall Study|Death|0
6137745|NCT01717326|21145830|P8|Overall Study|Death|0
6137746|NCT01717326|21145831|P7|Overall Study|Death|0
6137747|NCT01717326|21145832|P6|Overall Study|Death|0
6137748|NCT01717326|21145833|P5|Overall Study|Death|0
6137749|NCT01717326|21145834|P4|Overall Study|Death|0
6137750|NCT01717326|21145835|P3|Overall Study|Death|0
6137751|NCT01717326|21145836|P2|Overall Study|Death|0
6137752|NCT01717326|21145837|P1|Overall Study|Death|0
6137753|NCT01708941|21146110|P4|Overall Study|Ineligible|0
6137754|NCT01708941|21146111|P3|Overall Study|Ineligible|2
6137755|NCT01708941|21146112|P2|Overall Study|Ineligible|0
6137756|NCT01708941|21146113|P1|Overall Study|Ineligible|0
6137757|NCT01708941|21146110|P4|Overall Study|Never started treatment|0
6137758|NCT01708941|21146111|P3|Overall Study|Never started treatment|0
6137759|NCT01708941|21146112|P2|Overall Study|Never started treatment|1
6137760|NCT01708941|21146113|P1|Overall Study|Never started treatment|2
6137761|NCT01708941|21146110|P4|Overall Study|Ineligible and never started treatment|0
6137762|NCT01708941|21146111|P3|Overall Study|Ineligible and never started treatment|1
6137763|NCT01708941|21146112|P2|Overall Study|Ineligible and never started treatment|0
6137764|NCT01708941|21146113|P1|Overall Study|Ineligible and never started treatment|1
6137765|NCT01708941|21146110|P4|Overall Study|Alternative therapy|0
6137766|NCT01708941|21146111|P3|Overall Study|Alternative therapy|2
6137767|NCT01708941|21146112|P2|Overall Study|Alternative therapy|0
6137768|NCT01708941|21146113|P1|Overall Study|Alternative therapy|0
6137769|NCT01708941|21146110|P4|Overall Study|Disease progression|0
6137770|NCT01708941|21146111|P3|Overall Study|Disease progression|8
6137771|NCT01708941|21146112|P2|Overall Study|Disease progression|10
6137772|NCT01708941|21146113|P1|Overall Study|Disease progression|9
6137773|NCT01708941|21146110|P4|Overall Study|Withdrawal by Subject|4
6137774|NCT01708941|21146111|P3|Overall Study|Withdrawal by Subject|3
6137775|NCT01708941|21146112|P2|Overall Study|Withdrawal by Subject|0
6137776|NCT01708941|21146113|P1|Overall Study|Withdrawal by Subject|1
6137777|NCT01708941|21146110|P4|Overall Study|Death|14
6137778|NCT01708941|21146111|P3|Overall Study|Death|2
6137779|NCT01708941|21146112|P2|Overall Study|Death|1
6137780|NCT01708941|21146113|P1|Overall Study|Death|1
6137781|NCT01708941|21146110|P4|Overall Study|Adverse Event|0
6137782|NCT01708941|21146111|P3|Overall Study|Adverse Event|1
6137783|NCT01708941|21146112|P2|Overall Study|Adverse Event|6
6137784|NCT01708941|21146113|P1|Overall Study|Adverse Event|4
6137785|NCT01551745|21146179|P1|Overall Study|Disease Progression|2
6137786|NCT01551745|21146179|P1|Overall Study|Withdrawal by Subject|1
6137787|NCT01532908|21146188|P2|Overall Study|Not Transplanted|0
6137788|NCT01532908|21146189|P1|Overall Study|Not Transplanted|1
6137840|NCT01217437|21146293|P2|Overall Study|Ineligible|1
6137841|NCT01217437|21146294|P1|Overall Study|Ineligible|1
6137842|NCT01217437|21146293|P2|Overall Study|Withdrawal by Subject|2
6137843|NCT01217437|21146294|P1|Overall Study|Withdrawal by Subject|0
6137844|NCT01217437|21146293|P2|Overall Study|Physician Decision|5
6137845|NCT01217437|21146294|P1|Overall Study|Physician Decision|8
6137846|NCT01217437|21146293|P2|Overall Study|Lack of Efficacy|25
6137847|NCT01217437|21146294|P1|Overall Study|Lack of Efficacy|29
6137848|NCT01217437|21146293|P2|Overall Study|Death|0
6137849|NCT01217437|21146294|P1|Overall Study|Death|5
6137850|NCT01217437|21146293|P2|Overall Study|Adverse Event|8
6137851|NCT01217437|21146294|P1|Overall Study|Adverse Event|0
6137976|NCT00551642|21146480|P2|Treatment Period|Withdrawal by Subject|1
6137977|NCT00551642|21146481|P1|Treatment Period|Withdrawal by Subject|2
6137978|NCT00551642|21146480|P2|Treatment Period|Adverse Event|12
6137979|NCT00551642|21146481|P1|Treatment Period|Adverse Event|15
6137980|NCT00551642|21146480|P2|Treatment Period|Inclusion/Exclusion criteria|4
6137981|NCT00551642|21146481|P1|Treatment Period|Inclusion/Exclusion criteria|4
6137982|NCT00551642|21146480|P2|Treatment Period|Death|31
6137983|NCT00551642|21146481|P1|Treatment Period|Death|33
6137984|NCT00551642|21146480|P2|Treatment Period|Physician Decision|1
6137985|NCT00551642|21146481|P1|Treatment Period|Physician Decision|0
6137986|NCT00551642|21146480|P2|Treatment Period|Delivery device failure|3
6137987|NCT00551642|21146481|P1|Treatment Period|Delivery device failure|1
6137988|NCT00551642|21146480|P2|Treatment Period|Protocol Deviation|11
6137989|NCT00551642|21146481|P1|Treatment Period|Protocol Deviation|6
6138226|NCT00186888|21146553|P3|Overall Study|Relapse or progression of disease|0
6138227|NCT00186888|21146554|P2|Overall Study|Relapse or progression of disease|2
6138228|NCT00186888|21146555|P1|Overall Study|Relapse or progression of disease|4
6138229|NCT00186888|21146553|P3|Overall Study|Toxicity|0
6138230|NCT00186888|21146554|P2|Overall Study|Toxicity|1
6138231|NCT00186888|21146555|P1|Overall Study|Toxicity|0
6145267|NCT03896022|21168154|P3|Overall Study|Did not have procedure|0
6145268|NCT03896022|21168155|P2|Overall Study|Did not have procedure|0
6145269|NCT03896022|21168156|P1|Overall Study|Did not have procedure|3
6145270|NCT03896022|21168154|P3|Overall Study|Withdrawal by Subject|0
6145271|NCT03896022|21168155|P2|Overall Study|Withdrawal by Subject|0
6145272|NCT03896022|21168156|P1|Overall Study|Withdrawal by Subject|1
6145277|NCT03681184|21168260|P2|Open-Label Extension Period|Remained in this Period at Time of Data Cut|1
6145278|NCT03681184|21168261|P1|Open-Label Extension Period|Remained in this Period at Time of Data Cut|1
6145279|NCT03681184|21168260|P2|3-Month Blinded Extension Period|Remained in this Period at Time of Data Cut|23
6145280|NCT03681184|21168261|P1|3-Month Blinded Extension Period|Remained in this Period at Time of Data Cut|12
6145281|NCT03681184|21168260|P2|6-Month Double-Blind Period|Parent/Caregiver Withdrew Consent|1
6145282|NCT03681184|21168261|P1|6-Month Double-Blind Period|Parent/Caregiver Withdrew Consent|0
6145283|NCT03652610|21168304|P2|Overall Study|Withdrawal by Subject|5
6145284|NCT03652610|21168305|P1|Overall Study|Withdrawal by Subject|3
6145285|NCT03652610|21168304|P2|Overall Study|Lost to Follow-up|0
6145286|NCT03652610|21168305|P1|Overall Study|Lost to Follow-up|1
6145289|NCT03594071|21168350|P1|Overall Study|Missed visit|2
6145290|NCT03594071|21168350|P1|Overall Study|Re-operation|3
6145308|NCT03511053|21168430|P1|Overall Study|Withdrawal by Subject|1
6145309|NCT03475056|21168445|P2|Overall Study|Moved from Area|2
6145310|NCT03475056|21168446|P1|Overall Study|Moved from Area|0
6145311|NCT03475056|21168445|P2|Overall Study|Lost to Follow-up|1
6145312|NCT03475056|21168446|P1|Overall Study|Lost to Follow-up|0
6145313|NCT03411902|21168505|P2|Overall Study|Lost to Follow-up|0
6145314|NCT03411902|21168506|P1|Overall Study|Lost to Follow-up|3
6145315|NCT03400787|21168531|P2|Overall Study|Unblinded before 3-month follow-upa-|6
6145316|NCT03400787|21168532|P1|Overall Study|Unblinded before 3-month follow-upa-|0
6145317|NCT03400787|21168531|P2|Overall Study|Protocol Violation|2
6145318|NCT03400787|21168532|P1|Overall Study|Protocol Violation|0
6145319|NCT03400787|21168531|P2|Overall Study|Death|0
6145320|NCT03400787|21168532|P1|Overall Study|Death|1
6145321|NCT03400787|21168531|P2|Overall Study|Lost to Follow-up|0
6145322|NCT03400787|21168532|P1|Overall Study|Lost to Follow-up|1
6145323|NCT03380091|21168540|P2|Overall Study|Withdrawal by Subject|1
6145324|NCT03380091|21168541|P1|Overall Study|Withdrawal by Subject|2
6145325|NCT03368859|21168576|P2|Overall Study|Other|1
6145326|NCT03368859|21168577|P1|Overall Study|Other|1
6145327|NCT03368859|21168576|P2|Overall Study|Study terminated by Sponsor|23
6145328|NCT03368859|21168577|P1|Overall Study|Study terminated by Sponsor|18
6145329|NCT03368859|21168576|P2|Overall Study|Death|6
6145330|NCT03368859|21168577|P1|Overall Study|Death|12
6145331|NCT03368859|21168576|P2|Overall Study|Withdrew Consent|4
6145332|NCT03368859|21168577|P1|Overall Study|Withdrew Consent|5
6145333|NCT03355742|21168649|P1|Overall Study|Administrative Closure of the Study, Other Status Change Reason, Missed Visit, Protocol Violation|5
6145334|NCT03355742|21168649|P1|Overall Study|Death|55
6145335|NCT03355742|21168649|P1|Overall Study|Physician Decision|6
6145336|NCT03355742|21168649|P1|Overall Study|Withdrawal by Subject|29
6145337|NCT03355742|21168649|P1|Overall Study|Lost to Follow-up|4
6145342|NCT03319953|21168723|P4|Period 2 (Day 49 to 154)|Reason not Specified|1
6145343|NCT03319953|21168724|P3|Period 2 (Day 49 to 154)|Reason not Specified|1
6145344|NCT03319953|21168725|P2|Period 2 (Day 49 to 154)|Reason not Specified|0
6145345|NCT03319953|21168726|P1|Period 2 (Day 49 to 154)|Reason not Specified|0
6145346|NCT03319953|21168723|P4|Period 2 (Day 49 to 154)|Withdrawal by Subject|0
6145347|NCT03319953|21168724|P3|Period 2 (Day 49 to 154)|Withdrawal by Subject|0
6145348|NCT03319953|21168725|P2|Period 2 (Day 49 to 154)|Withdrawal by Subject|0
6145349|NCT03319953|21168726|P1|Period 2 (Day 49 to 154)|Withdrawal by Subject|1
6145386|NCT03261336|21168814|P1|Overall Study|Adverse Event|1
6145403|NCT03100149|21169005|P3|Overall Study|Withdrawal by Subject|1
6145404|NCT03100149|21169006|P2|Overall Study|Withdrawal by Subject|3
6145405|NCT03100149|21169007|P1|Overall Study|Withdrawal by Subject|0
6145406|NCT03100149|21169005|P3|Overall Study|Participant Moved out of Country|1
6145407|NCT03100149|21169006|P2|Overall Study|Participant Moved out of Country|0
6145408|NCT03100149|21169007|P1|Overall Study|Participant Moved out of Country|0
6145409|NCT03100149|21169005|P3|Overall Study|Adverse Event|0
6145410|NCT03100149|21169006|P2|Overall Study|Adverse Event|1
6145411|NCT03100149|21169007|P1|Overall Study|Adverse Event|0
6145422|NCT03066804|21169106|P2|Overall Study|Technical problems|1
6145423|NCT03066804|21169107|P1|Overall Study|Technical problems|5
6145424|NCT03066804|21169106|P2|Overall Study|Adverse Event|3
6145425|NCT03066804|21169107|P1|Overall Study|Adverse Event|2
6145426|NCT03066804|21169106|P2|Overall Study|Lost to Follow-up|0
6145427|NCT03066804|21169107|P1|Overall Study|Lost to Follow-up|2
6145428|NCT03066804|21169106|P2|Overall Study|Withdrawal by Subject|25
6145429|NCT03066804|21169107|P1|Overall Study|Withdrawal by Subject|19
6145430|NCT03066804|21169106|P2|Overall Study|Death|17
6145431|NCT03066804|21169107|P1|Overall Study|Death|23
6145432|NCT03066804|21169106|P2|Overall Study|Physician Decision|4
6145433|NCT03066804|21169107|P1|Overall Study|Physician Decision|0
6145438|NCT03040986|21169136|P2|Overall Study|Disease progression on study|1
6145439|NCT03040986|21169137|P1|Overall Study|Disease progression on study|3
6145440|NCT03040986|21169136|P2|Overall Study|Adverse Event|1
6145441|NCT03040986|21169137|P1|Overall Study|Adverse Event|2
6145442|NCT03040986|21169136|P2|Overall Study|Hospice|0
6145443|NCT03040986|21169137|P1|Overall Study|Hospice|1
6145444|NCT03020992|21169176|P1|Overall Study|Withdrawal by Subject|1
6145445|NCT03020992|21169176|P1|Overall Study|Adverse Event|5
6145450|NCT02973321|21169319|P5|Overall Study|Adverse Event|3
6145451|NCT02973321|21169320|P4|Overall Study|Adverse Event|13
6145452|NCT02973321|21169321|P3|Overall Study|Adverse Event|11
6145453|NCT02973321|21169322|P2|Overall Study|Adverse Event|10
6145454|NCT02973321|21169323|P1|Overall Study|Adverse Event|1
6145455|NCT02973321|21169319|P5|Overall Study|Lack of Efficacy|1
6145456|NCT02973321|21169320|P4|Overall Study|Lack of Efficacy|0
6145457|NCT02973321|21169321|P3|Overall Study|Lack of Efficacy|0
6145458|NCT02973321|21169322|P2|Overall Study|Lack of Efficacy|0
6145459|NCT02973321|21169323|P1|Overall Study|Lack of Efficacy|0
6145460|NCT02973321|21169319|P5|Overall Study|Other than specified|1
6145461|NCT02973321|21169320|P4|Overall Study|Other than specified|3
6145462|NCT02973321|21169321|P3|Overall Study|Other than specified|3
6145463|NCT02973321|21169322|P2|Overall Study|Other than specified|5
6145464|NCT02973321|21169323|P1|Overall Study|Other than specified|0
6145465|NCT02971228|21169381|P5|Overall Study|Logistical challenges|0
6145466|NCT02971228|21169382|P4|Overall Study|Logistical challenges|0
6145467|NCT02971228|21169383|P3|Overall Study|Logistical challenges|0
6145468|NCT02971228|21169384|P2|Overall Study|Logistical challenges|1
6145469|NCT02971228|21169385|P1|Overall Study|Logistical challenges|0
6145470|NCT02971228|21169381|P5|Overall Study|Withdrawal by Subject|0
6145471|NCT02971228|21169382|P4|Overall Study|Withdrawal by Subject|0
6145472|NCT02971228|21169383|P3|Overall Study|Withdrawal by Subject|0
6145473|NCT02971228|21169384|P2|Overall Study|Withdrawal by Subject|1
6145474|NCT02971228|21169385|P1|Overall Study|Withdrawal by Subject|1
6145475|NCT02953639|21169430|P3|Overall Study|Completed or Discontinued information is missing|0
6145476|NCT02953639|21169431|P2|Overall Study|Completed or Discontinued information is missing|0
6145477|NCT02953639|21169432|P1|Overall Study|Completed or Discontinued information is missing|1
6145478|NCT02953639|21169430|P3|Overall Study|Withdrawal by Subject|10
6145479|NCT02953639|21169431|P2|Overall Study|Withdrawal by Subject|8
6145480|NCT02953639|21169432|P1|Overall Study|Withdrawal by Subject|7
6145481|NCT02953639|21169430|P3|Overall Study|Physician Decision|0
6145482|NCT02953639|21169431|P2|Overall Study|Physician Decision|0
6145483|NCT02953639|21169432|P1|Overall Study|Physician Decision|1
6145484|NCT02953639|21169430|P3|Overall Study|Multiple Reasons|1
6145485|NCT02953639|21169431|P2|Overall Study|Multiple Reasons|0
6145486|NCT02953639|21169432|P1|Overall Study|Multiple Reasons|1
6145487|NCT02953639|21169430|P3|Overall Study|Non-Compliance With Study Drug|1
6145488|NCT02953639|21169431|P2|Overall Study|Non-Compliance With Study Drug|2
6145489|NCT02953639|21169432|P1|Overall Study|Non-Compliance With Study Drug|0
6145490|NCT02953639|21169430|P3|Overall Study|Lost to Follow-up|3
6145491|NCT02953639|21169431|P2|Overall Study|Lost to Follow-up|4
6145492|NCT02953639|21169432|P1|Overall Study|Lost to Follow-up|8
6145493|NCT02953639|21169430|P3|Overall Study|Adverse Event|1
6145494|NCT02953639|21169431|P2|Overall Study|Adverse Event|0
6145495|NCT02953639|21169432|P1|Overall Study|Adverse Event|2
6145507|NCT02911025|21169616|P1|Overall Study|Lost to Follow-up|3
6145508|NCT02901431|21169629|P13|Open Label Part|Withdrawal by Subject|1
6145509|NCT02901431|21169630|P12|Open Label Part|Withdrawal by Subject|3
6145510|NCT02901431|21169631|P11|Open Label Part|Withdrawal by Subject|7
6145511|NCT02901431|21169632|P10|Open Label Part|Withdrawal by Subject|5
6145512|NCT02901431|21169633|P9|Open Label Part|Withdrawal by Subject|6
6145513|NCT02901431|21169634|P8|Open Label Part|Withdrawal by Subject|0
6145514|NCT02901431|21169635|P7|Open Label Part|Withdrawal by Subject|0
6145515|NCT02901431|21169636|P6|Open Label Part|Withdrawal by Subject|0
6145516|NCT02901431|21169637|P5|Open Label Part|Withdrawal by Subject|0
6145517|NCT02901431|21169638|P4|Open Label Part|Withdrawal by Subject|0
6145518|NCT02901431|21169639|P3|Open Label Part|Withdrawal by Subject|0
6145519|NCT02901431|21169640|P2|Open Label Part|Withdrawal by Subject|0
6145520|NCT02901431|21169641|P1|Open Label Part|Withdrawal by Subject|0
6145521|NCT02901431|21169629|P13|Open Label Part|Study Terminated By Sponsor|0
6145522|NCT02901431|21169630|P12|Open Label Part|Study Terminated By Sponsor|31
6145523|NCT02901431|21169631|P11|Open Label Part|Study Terminated By Sponsor|21
6145524|NCT02901431|21169632|P10|Open Label Part|Study Terminated By Sponsor|12
6145525|NCT02901431|21169633|P9|Open Label Part|Study Terminated By Sponsor|35
6145526|NCT02901431|21169634|P8|Open Label Part|Study Terminated By Sponsor|0
6145527|NCT02901431|21169635|P7|Open Label Part|Study Terminated By Sponsor|0
6145528|NCT02901431|21169636|P6|Open Label Part|Study Terminated By Sponsor|0
6145529|NCT02901431|21169637|P5|Open Label Part|Study Terminated By Sponsor|0
6145530|NCT02901431|21169638|P4|Open Label Part|Study Terminated By Sponsor|0
6145531|NCT02901431|21169639|P3|Open Label Part|Study Terminated By Sponsor|0
6145532|NCT02901431|21169640|P2|Open Label Part|Study Terminated By Sponsor|0
6145533|NCT02901431|21169641|P1|Open Label Part|Study Terminated By Sponsor|0
6145534|NCT02901431|21169629|P13|Open Label Part|Physician Decision|0
6145535|NCT02901431|21169630|P12|Open Label Part|Physician Decision|0
6145536|NCT02901431|21169631|P11|Open Label Part|Physician Decision|0
6145537|NCT02901431|21169632|P10|Open Label Part|Physician Decision|1
6145538|NCT02901431|21169633|P9|Open Label Part|Physician Decision|1
6145539|NCT02901431|21169634|P8|Open Label Part|Physician Decision|0
6145540|NCT02901431|21169635|P7|Open Label Part|Physician Decision|0
6145541|NCT02901431|21169636|P6|Open Label Part|Physician Decision|0
6145542|NCT02901431|21169637|P5|Open Label Part|Physician Decision|0
6145543|NCT02901431|21169638|P4|Open Label Part|Physician Decision|0
6145544|NCT02901431|21169639|P3|Open Label Part|Physician Decision|0
6145545|NCT02901431|21169640|P2|Open Label Part|Physician Decision|0
6145546|NCT02901431|21169641|P1|Open Label Part|Physician Decision|0
6145547|NCT02901431|21169629|P13|Open Label Part|Lost to Follow-up|1
6145548|NCT02901431|21169630|P12|Open Label Part|Lost to Follow-up|1
6145549|NCT02901431|21169631|P11|Open Label Part|Lost to Follow-up|1
6145550|NCT02901431|21169632|P10|Open Label Part|Lost to Follow-up|2
6145551|NCT02901431|21169633|P9|Open Label Part|Lost to Follow-up|2
6145552|NCT02901431|21169634|P8|Open Label Part|Lost to Follow-up|0
6145553|NCT02901431|21169635|P7|Open Label Part|Lost to Follow-up|0
6145554|NCT02901431|21169636|P6|Open Label Part|Lost to Follow-up|0
6145555|NCT02901431|21169637|P5|Open Label Part|Lost to Follow-up|0
6145556|NCT02901431|21169638|P4|Open Label Part|Lost to Follow-up|0
6145557|NCT02901431|21169639|P3|Open Label Part|Lost to Follow-up|0
6145558|NCT02901431|21169640|P2|Open Label Part|Lost to Follow-up|0
6145559|NCT02901431|21169641|P1|Open Label Part|Lost to Follow-up|0
6145560|NCT02901431|21169629|P13|Open Label Part|Adverse Event|1
6145561|NCT02901431|21169630|P12|Open Label Part|Adverse Event|4
6145562|NCT02901431|21169631|P11|Open Label Part|Adverse Event|0
6145563|NCT02901431|21169632|P10|Open Label Part|Adverse Event|4
6145564|NCT02901431|21169633|P9|Open Label Part|Adverse Event|4
6145565|NCT02901431|21169634|P8|Open Label Part|Adverse Event|0
6145566|NCT02901431|21169635|P7|Open Label Part|Adverse Event|0
6145567|NCT02901431|21169636|P6|Open Label Part|Adverse Event|0
6145568|NCT02901431|21169637|P5|Open Label Part|Adverse Event|0
6145569|NCT02901431|21169638|P4|Open Label Part|Adverse Event|0
6145570|NCT02901431|21169639|P3|Open Label Part|Adverse Event|0
6145571|NCT02901431|21169640|P2|Open Label Part|Adverse Event|0
6145572|NCT02901431|21169641|P1|Open Label Part|Adverse Event|0
6145573|NCT02901431|21169629|P13|Main Treatment Part|Withdrawal by Subject|0
6145574|NCT02901431|21169630|P12|Main Treatment Part|Withdrawal by Subject|0
6145575|NCT02901431|21169631|P11|Main Treatment Part|Withdrawal by Subject|0
6145576|NCT02901431|21169632|P10|Main Treatment Part|Withdrawal by Subject|0
6145577|NCT02901431|21169633|P9|Main Treatment Part|Withdrawal by Subject|0
6145578|NCT02901431|21169634|P8|Main Treatment Part|Withdrawal by Subject|0
6145579|NCT02901431|21169635|P7|Main Treatment Part|Withdrawal by Subject|6
6145580|NCT02901431|21169636|P6|Main Treatment Part|Withdrawal by Subject|5
6145581|NCT02901431|21169637|P5|Main Treatment Part|Withdrawal by Subject|3
6145582|NCT02901431|21169638|P4|Main Treatment Part|Withdrawal by Subject|18
6145583|NCT02901431|21169639|P3|Main Treatment Part|Withdrawal by Subject|0
6145584|NCT02901431|21169640|P2|Main Treatment Part|Withdrawal by Subject|0
6145585|NCT02901431|21169641|P1|Main Treatment Part|Withdrawal by Subject|0
6145586|NCT02901431|21169629|P13|Main Treatment Part|Physician Decision|0
6145587|NCT02901431|21169630|P12|Main Treatment Part|Physician Decision|0
6145588|NCT02901431|21169631|P11|Main Treatment Part|Physician Decision|0
6145589|NCT02901431|21169632|P10|Main Treatment Part|Physician Decision|0
6145590|NCT02901431|21169633|P9|Main Treatment Part|Physician Decision|0
6145591|NCT02901431|21169634|P8|Main Treatment Part|Physician Decision|0
6145592|NCT02901431|21169635|P7|Main Treatment Part|Physician Decision|1
6145593|NCT02901431|21169636|P6|Main Treatment Part|Physician Decision|0
6145594|NCT02901431|21169637|P5|Main Treatment Part|Physician Decision|0
6145595|NCT02901431|21169638|P4|Main Treatment Part|Physician Decision|1
6145596|NCT02901431|21169639|P3|Main Treatment Part|Physician Decision|0
6145597|NCT02901431|21169640|P2|Main Treatment Part|Physician Decision|0
6145598|NCT02901431|21169641|P1|Main Treatment Part|Physician Decision|0
6145599|NCT02901431|21169629|P13|Main Treatment Part|Withdrawal by Caregiver|0
6145600|NCT02901431|21169630|P12|Main Treatment Part|Withdrawal by Caregiver|0
6145601|NCT02901431|21169631|P11|Main Treatment Part|Withdrawal by Caregiver|0
6145602|NCT02901431|21169632|P10|Main Treatment Part|Withdrawal by Caregiver|0
6145603|NCT02901431|21169633|P9|Main Treatment Part|Withdrawal by Caregiver|0
6145604|NCT02901431|21169634|P8|Main Treatment Part|Withdrawal by Caregiver|0
6145605|NCT02901431|21169635|P7|Main Treatment Part|Withdrawal by Caregiver|0
6145606|NCT02901431|21169636|P6|Main Treatment Part|Withdrawal by Caregiver|1
6145607|NCT02901431|21169637|P5|Main Treatment Part|Withdrawal by Caregiver|0
6145608|NCT02901431|21169638|P4|Main Treatment Part|Withdrawal by Caregiver|0
6145609|NCT02901431|21169639|P3|Main Treatment Part|Withdrawal by Caregiver|0
6145610|NCT02901431|21169640|P2|Main Treatment Part|Withdrawal by Caregiver|0
6145611|NCT02901431|21169641|P1|Main Treatment Part|Withdrawal by Caregiver|0
6145612|NCT02901431|21169629|P13|Main Treatment Part|Lost to Follow-up|0
6145613|NCT02901431|21169630|P12|Main Treatment Part|Lost to Follow-up|0
6145614|NCT02901431|21169631|P11|Main Treatment Part|Lost to Follow-up|0
6145615|NCT02901431|21169632|P10|Main Treatment Part|Lost to Follow-up|0
6145616|NCT02901431|21169633|P9|Main Treatment Part|Lost to Follow-up|0
6145617|NCT02901431|21169634|P8|Main Treatment Part|Lost to Follow-up|0
6145618|NCT02901431|21169635|P7|Main Treatment Part|Lost to Follow-up|3
6145619|NCT02901431|21169636|P6|Main Treatment Part|Lost to Follow-up|2
6145620|NCT02901431|21169637|P5|Main Treatment Part|Lost to Follow-up|1
6145621|NCT02901431|21169638|P4|Main Treatment Part|Lost to Follow-up|3
6145622|NCT02901431|21169639|P3|Main Treatment Part|Lost to Follow-up|0
6145623|NCT02901431|21169640|P2|Main Treatment Part|Lost to Follow-up|0
6145624|NCT02901431|21169641|P1|Main Treatment Part|Lost to Follow-up|0
6145625|NCT02901431|21169629|P13|Main Treatment Part|Lack of Efficacy|0
6145626|NCT02901431|21169630|P12|Main Treatment Part|Lack of Efficacy|0
6145627|NCT02901431|21169631|P11|Main Treatment Part|Lack of Efficacy|0
6145628|NCT02901431|21169632|P10|Main Treatment Part|Lack of Efficacy|0
6145629|NCT02901431|21169633|P9|Main Treatment Part|Lack of Efficacy|0
6145630|NCT02901431|21169634|P8|Main Treatment Part|Lack of Efficacy|0
6145631|NCT02901431|21169635|P7|Main Treatment Part|Lack of Efficacy|0
6145632|NCT02901431|21169636|P6|Main Treatment Part|Lack of Efficacy|0
6145633|NCT02901431|21169637|P5|Main Treatment Part|Lack of Efficacy|0
6145634|NCT02901431|21169638|P4|Main Treatment Part|Lack of Efficacy|1
6145635|NCT02901431|21169639|P3|Main Treatment Part|Lack of Efficacy|0
6145636|NCT02901431|21169640|P2|Main Treatment Part|Lack of Efficacy|0
6145637|NCT02901431|21169641|P1|Main Treatment Part|Lack of Efficacy|0
6145638|NCT02901431|21169629|P13|Main Treatment Part|Adverse Event|0
6145639|NCT02901431|21169630|P12|Main Treatment Part|Adverse Event|0
6145640|NCT02901431|21169631|P11|Main Treatment Part|Adverse Event|0
6145641|NCT02901431|21169632|P10|Main Treatment Part|Adverse Event|0
6145642|NCT02901431|21169633|P9|Main Treatment Part|Adverse Event|0
6145643|NCT02901431|21169634|P8|Main Treatment Part|Adverse Event|0
6145644|NCT02901431|21169635|P7|Main Treatment Part|Adverse Event|1
6145645|NCT02901431|21169636|P6|Main Treatment Part|Adverse Event|4
6145646|NCT02901431|21169637|P5|Main Treatment Part|Adverse Event|3
6145647|NCT02901431|21169638|P4|Main Treatment Part|Adverse Event|3
6145648|NCT02901431|21169639|P3|Main Treatment Part|Adverse Event|0
6145649|NCT02901431|21169640|P2|Main Treatment Part|Adverse Event|0
6145650|NCT02901431|21169641|P1|Main Treatment Part|Adverse Event|0
6145651|NCT02901431|21169629|P13|PK Part|Withdrawal by Subject|0
6145652|NCT02901431|21169630|P12|PK Part|Withdrawal by Subject|0
6145653|NCT02901431|21169631|P11|PK Part|Withdrawal by Subject|0
6145654|NCT02901431|21169632|P10|PK Part|Withdrawal by Subject|0
6145655|NCT02901431|21169633|P9|PK Part|Withdrawal by Subject|0
6145656|NCT02901431|21169634|P8|PK Part|Withdrawal by Subject|0
6145657|NCT02901431|21169635|P7|PK Part|Withdrawal by Subject|0
6145658|NCT02901431|21169636|P6|PK Part|Withdrawal by Subject|0
6145659|NCT02901431|21169637|P5|PK Part|Withdrawal by Subject|0
6145660|NCT02901431|21169638|P4|PK Part|Withdrawal by Subject|0
6145661|NCT02901431|21169639|P3|PK Part|Withdrawal by Subject|3
6145662|NCT02901431|21169640|P2|PK Part|Withdrawal by Subject|1
6145663|NCT02901431|21169641|P1|PK Part|Withdrawal by Subject|1
6145664|NCT02901431|21169629|P13|PK Part|Discontinued per Sponsor|0
6145665|NCT02901431|21169630|P12|PK Part|Discontinued per Sponsor|0
6145666|NCT02901431|21169631|P11|PK Part|Discontinued per Sponsor|0
6145667|NCT02901431|21169632|P10|PK Part|Discontinued per Sponsor|0
6145668|NCT02901431|21169633|P9|PK Part|Discontinued per Sponsor|0
6145669|NCT02901431|21169634|P8|PK Part|Discontinued per Sponsor|0
6145670|NCT02901431|21169635|P7|PK Part|Discontinued per Sponsor|0
6145671|NCT02901431|21169636|P6|PK Part|Discontinued per Sponsor|0
6145672|NCT02901431|21169637|P5|PK Part|Discontinued per Sponsor|0
6145673|NCT02901431|21169638|P4|PK Part|Discontinued per Sponsor|0
6145674|NCT02901431|21169639|P3|PK Part|Discontinued per Sponsor|0
6145675|NCT02901431|21169640|P2|PK Part|Discontinued per Sponsor|3
6145676|NCT02901431|21169641|P1|PK Part|Discontinued per Sponsor|0
6145677|NCT02901431|21169629|P13|PK Part|Stopped on Sponsor instruction pending dose confirmation|0
6145678|NCT02901431|21169630|P12|PK Part|Stopped on Sponsor instruction pending dose confirmation|0
6145679|NCT02901431|21169631|P11|PK Part|Stopped on Sponsor instruction pending dose confirmation|0
6145680|NCT02901431|21169632|P10|PK Part|Stopped on Sponsor instruction pending dose confirmation|0
6145681|NCT02901431|21169633|P9|PK Part|Stopped on Sponsor instruction pending dose confirmation|0
6145682|NCT02901431|21169634|P8|PK Part|Stopped on Sponsor instruction pending dose confirmation|0
6145683|NCT02901431|21169635|P7|PK Part|Stopped on Sponsor instruction pending dose confirmation|0
6145684|NCT02901431|21169636|P6|PK Part|Stopped on Sponsor instruction pending dose confirmation|0
6145685|NCT02901431|21169637|P5|PK Part|Stopped on Sponsor instruction pending dose confirmation|0
6145686|NCT02901431|21169638|P4|PK Part|Stopped on Sponsor instruction pending dose confirmation|0
6145687|NCT02901431|21169639|P3|PK Part|Stopped on Sponsor instruction pending dose confirmation|4
6145688|NCT02901431|21169640|P2|PK Part|Stopped on Sponsor instruction pending dose confirmation|0
6145689|NCT02901431|21169641|P1|PK Part|Stopped on Sponsor instruction pending dose confirmation|1
6145690|NCT02901431|21169629|P13|PK Part|Stopped treatment after 8 weeks|0
6145691|NCT02901431|21169630|P12|PK Part|Stopped treatment after 8 weeks|0
6145692|NCT02901431|21169631|P11|PK Part|Stopped treatment after 8 weeks|0
6145693|NCT02901431|21169632|P10|PK Part|Stopped treatment after 8 weeks|0
6145694|NCT02901431|21169633|P9|PK Part|Stopped treatment after 8 weeks|0
6145695|NCT02901431|21169634|P8|PK Part|Stopped treatment after 8 weeks|0
6145696|NCT02901431|21169635|P7|PK Part|Stopped treatment after 8 weeks|0
6145697|NCT02901431|21169636|P6|PK Part|Stopped treatment after 8 weeks|0
6145698|NCT02901431|21169637|P5|PK Part|Stopped treatment after 8 weeks|0
6145699|NCT02901431|21169638|P4|PK Part|Stopped treatment after 8 weeks|0
6145700|NCT02901431|21169639|P3|PK Part|Stopped treatment after 8 weeks|1
6145701|NCT02901431|21169640|P2|PK Part|Stopped treatment after 8 weeks|0
6145702|NCT02901431|21169641|P1|PK Part|Stopped treatment after 8 weeks|1
6145703|NCT02901431|21169629|P13|PK Part|8 weeks of treatment ran out|0
6145704|NCT02901431|21169630|P12|PK Part|8 weeks of treatment ran out|0
6145705|NCT02901431|21169631|P11|PK Part|8 weeks of treatment ran out|0
6145706|NCT02901431|21169632|P10|PK Part|8 weeks of treatment ran out|0
6145707|NCT02901431|21169633|P9|PK Part|8 weeks of treatment ran out|0
6145708|NCT02901431|21169634|P8|PK Part|8 weeks of treatment ran out|0
6145709|NCT02901431|21169635|P7|PK Part|8 weeks of treatment ran out|0
6145710|NCT02901431|21169636|P6|PK Part|8 weeks of treatment ran out|0
6145711|NCT02901431|21169637|P5|PK Part|8 weeks of treatment ran out|0
6145712|NCT02901431|21169638|P4|PK Part|8 weeks of treatment ran out|0
6145713|NCT02901431|21169639|P3|PK Part|8 weeks of treatment ran out|0
6145714|NCT02901431|21169640|P2|PK Part|8 weeks of treatment ran out|0
6145715|NCT02901431|21169641|P1|PK Part|8 weeks of treatment ran out|2
6145716|NCT02901431|21169629|P13|PK Part|Pending dose confirmation|0
6145717|NCT02901431|21169630|P12|PK Part|Pending dose confirmation|0
6145718|NCT02901431|21169631|P11|PK Part|Pending dose confirmation|0
6145719|NCT02901431|21169632|P10|PK Part|Pending dose confirmation|0
6145720|NCT02901431|21169633|P9|PK Part|Pending dose confirmation|0
6145721|NCT02901431|21169634|P8|PK Part|Pending dose confirmation|0
6145722|NCT02901431|21169635|P7|PK Part|Pending dose confirmation|0
6145723|NCT02901431|21169636|P6|PK Part|Pending dose confirmation|0
6145724|NCT02901431|21169637|P5|PK Part|Pending dose confirmation|0
6145725|NCT02901431|21169638|P4|PK Part|Pending dose confirmation|0
6145726|NCT02901431|21169639|P3|PK Part|Pending dose confirmation|0
6145727|NCT02901431|21169640|P2|PK Part|Pending dose confirmation|1
6145728|NCT02901431|21169641|P1|PK Part|Pending dose confirmation|0
6145729|NCT02901431|21169629|P13|PK Part|Pending IMC/SOC Dose Confirmation|0
6145730|NCT02901431|21169630|P12|PK Part|Pending IMC/SOC Dose Confirmation|0
6145731|NCT02901431|21169631|P11|PK Part|Pending IMC/SOC Dose Confirmation|0
6145732|NCT02901431|21169632|P10|PK Part|Pending IMC/SOC Dose Confirmation|0
6145733|NCT02901431|21169633|P9|PK Part|Pending IMC/SOC Dose Confirmation|0
6145734|NCT02901431|21169634|P8|PK Part|Pending IMC/SOC Dose Confirmation|0
6145735|NCT02901431|21169635|P7|PK Part|Pending IMC/SOC Dose Confirmation|0
6145736|NCT02901431|21169636|P6|PK Part|Pending IMC/SOC Dose Confirmation|0
6145737|NCT02901431|21169637|P5|PK Part|Pending IMC/SOC Dose Confirmation|0
6145738|NCT02901431|21169638|P4|PK Part|Pending IMC/SOC Dose Confirmation|0
6145739|NCT02901431|21169639|P3|PK Part|Pending IMC/SOC Dose Confirmation|0
6145740|NCT02901431|21169640|P2|PK Part|Pending IMC/SOC Dose Confirmation|0
6145741|NCT02901431|21169641|P1|PK Part|Pending IMC/SOC Dose Confirmation|2
6145742|NCT02901431|21169629|P13|PK Part|Lost to Follow-up|0
6145743|NCT02901431|21169630|P12|PK Part|Lost to Follow-up|0
6145744|NCT02901431|21169631|P11|PK Part|Lost to Follow-up|0
6145745|NCT02901431|21169632|P10|PK Part|Lost to Follow-up|0
6145746|NCT02901431|21169633|P9|PK Part|Lost to Follow-up|0
6145747|NCT02901431|21169634|P8|PK Part|Lost to Follow-up|0
6145748|NCT02901431|21169635|P7|PK Part|Lost to Follow-up|0
6145749|NCT02901431|21169636|P6|PK Part|Lost to Follow-up|0
6145750|NCT02901431|21169637|P5|PK Part|Lost to Follow-up|0
6145751|NCT02901431|21169638|P4|PK Part|Lost to Follow-up|0
6145752|NCT02901431|21169639|P3|PK Part|Lost to Follow-up|1
6145753|NCT02901431|21169640|P2|PK Part|Lost to Follow-up|0
6145754|NCT02901431|21169641|P1|PK Part|Lost to Follow-up|0
6145755|NCT02901431|21169629|P13|PK Part|Adverse Event|0
6145756|NCT02901431|21169630|P12|PK Part|Adverse Event|0
6145757|NCT02901431|21169631|P11|PK Part|Adverse Event|0
6145758|NCT02901431|21169632|P10|PK Part|Adverse Event|0
6145759|NCT02901431|21169633|P9|PK Part|Adverse Event|0
6145760|NCT02901431|21169634|P8|PK Part|Adverse Event|0
6145761|NCT02901431|21169635|P7|PK Part|Adverse Event|0
6145762|NCT02901431|21169636|P6|PK Part|Adverse Event|0
6145763|NCT02901431|21169637|P5|PK Part|Adverse Event|0
6145764|NCT02901431|21169638|P4|PK Part|Adverse Event|0
6145765|NCT02901431|21169639|P3|PK Part|Adverse Event|0
6145766|NCT02901431|21169640|P2|PK Part|Adverse Event|1
6145767|NCT02901431|21169641|P1|PK Part|Adverse Event|0
6145907|NCT02685995|21170260|P2|Overall Study|Insertion of immediately puncturable graft.|1
6145908|NCT02685995|21170261|P1|Overall Study|Insertion of immediately puncturable graft.|1
6145909|NCT02658734|21170267|P1|Overall Study|Disease Progression|28
6145910|NCT02658734|21170267|P1|Overall Study|Withdrawal of Consent|16
6145911|NCT02658734|21170267|P1|Overall Study|Lost to Follow-up|7
6145912|NCT02658734|21170267|P1|Overall Study|Death|4
6145913|NCT02658734|21170267|P1|Overall Study|Adverse Event|2
6145914|NCT02649218|21170286|P1|Overall Study|Withdrawal by Subject|2
6145915|NCT02649218|21170286|P1|Overall Study|Physician Decision|1
6145916|NCT02649218|21170286|P1|Overall Study|Protocol Violation|3
6145917|NCT02649218|21170286|P1|Overall Study|Pregnancy|3
6145918|NCT02649218|21170286|P1|Overall Study|Lack of Efficacy|8
6145919|NCT02649218|21170286|P1|Overall Study|Adverse Event|8
6145920|NCT02637895|21170295|P2|Overall Study|Abnormal baseline lab|1
6145921|NCT02637895|21170296|P1|Overall Study|Abnormal baseline lab|0
6145922|NCT02637895|21170295|P2|Overall Study|Withdrawal by Subject|1
6145923|NCT02637895|21170296|P1|Overall Study|Withdrawal by Subject|1
6145924|NCT02637895|21170295|P2|Overall Study|Lack of Efficacy|0
6145925|NCT02637895|21170296|P1|Overall Study|Lack of Efficacy|1
6145926|NCT02637895|21170295|P2|Overall Study|Protocol Violation|1
6145927|NCT02637895|21170296|P1|Overall Study|Protocol Violation|0
6145928|NCT02637895|21170295|P2|Overall Study|Lost to Follow-up|0
6145929|NCT02637895|21170296|P1|Overall Study|Lost to Follow-up|4
6145930|NCT02625974|21170310|P2|Overall Study|Protocol Violation|1
6145931|NCT02625974|21170311|P1|Overall Study|Protocol Violation|0
6145932|NCT02625974|21170310|P2|Overall Study|non-compliance with study drug|2
6145933|NCT02625974|21170311|P1|Overall Study|non-compliance with study drug|0
6145934|NCT02625974|21170310|P2|Overall Study|positive parasitemia|0
6145935|NCT02625974|21170311|P1|Overall Study|positive parasitemia|1
6145936|NCT02625974|21170310|P2|Overall Study|Withdrawal by Subject|1
6145937|NCT02625974|21170311|P1|Overall Study|Withdrawal by Subject|3
6145938|NCT02625974|21170310|P2|Overall Study|Adverse Event|2
6145939|NCT02625974|21170311|P1|Overall Study|Adverse Event|12
6145962|NCT02603432|21170438|P2|Overall Study|Other|1
6145963|NCT02603432|21170439|P1|Overall Study|Other|0
6145964|NCT02603432|21170438|P2|Overall Study|No Longer Meets Eligibility Criteria|0
6145965|NCT02603432|21170439|P1|Overall Study|No Longer Meets Eligibility Criteria|3
6145966|NCT02603432|21170438|P2|Overall Study|Withdrawal by Subject|17
6145967|NCT02603432|21170439|P1|Overall Study|Withdrawal by Subject|9
6145968|NCT02603432|21170438|P2|Overall Study|Progressive Disease|5
6145969|NCT02603432|21170439|P1|Overall Study|Progressive Disease|5
6145970|NCT02603432|21170438|P2|Overall Study|Lost to Follow-up|6
6145971|NCT02603432|21170439|P1|Overall Study|Lost to Follow-up|4
6145972|NCT02603432|21170438|P2|Overall Study|Death|177
6145973|NCT02603432|21170439|P1|Overall Study|Death|144
6145974|NCT02603432|21170438|P2|Overall Study|Adverse Event|0
6145975|NCT02603432|21170439|P1|Overall Study|Adverse Event|1
6145976|NCT02603432|21170438|P2|Overall Study|Ongoing|144
6145977|NCT02603432|21170439|P1|Overall Study|Ongoing|184
6145978|NCT02601313|21170490|P3|Overall Study|Enrolled, did not initiate AC|0
6145979|NCT02601313|21170491|P2|Overall Study|Enrolled, did not initiate AC|0
6145980|NCT02601313|21170492|P1|Overall Study|Enrolled, did not initiate AC|4
6145981|NCT02601313|21170490|P3|Overall Study|Still on study|10
6145982|NCT02601313|21170491|P2|Overall Study|Still on study|52
6145983|NCT02601313|21170492|P1|Overall Study|Still on study|0
6145984|NCT02601313|21170490|P3|Overall Study|Enrolled, did not initiate KTE-X19|1
6145985|NCT02601313|21170491|P2|Overall Study|Enrolled, did not initiate KTE-X19|1
6145986|NCT02601313|21170492|P1|Overall Study|Enrolled, did not initiate KTE-X19|0
6145987|NCT02601313|21170490|P3|Overall Study|Enrolled, did not initiate CTE/KTE-X19|2
6145988|NCT02601313|21170491|P2|Overall Study|Enrolled, did not initiate CTE/KTE-X19|5
6145989|NCT02601313|21170492|P1|Overall Study|Enrolled, did not initiate CTE/KTE-X19|0
6145990|NCT02601313|21170490|P3|Overall Study|Death|4
6145991|NCT02601313|21170491|P2|Overall Study|Death|16
6145992|NCT02601313|21170492|P1|Overall Study|Death|2
6145993|NCT02597478|21170513|P2|Overall Study|Insufficient exertional dyspnea|1
6145994|NCT02597478|21170514|P1|Overall Study|Insufficient exertional dyspnea|0
6145995|NCT02597478|21170513|P2|Overall Study|Change of opioid dose|0
6145996|NCT02597478|21170514|P1|Overall Study|Change of opioid dose|1
6145997|NCT02597478|21170513|P2|Overall Study|Withdrawal by Subject|0
6145998|NCT02597478|21170514|P1|Overall Study|Withdrawal by Subject|2
6146065|NCT02475369|21170774|P2|Run-in Washout Period #1 (7 Days)|Sponsor terminated study prematurely|2
6146066|NCT02475369|21170775|P1|Run-in Washout Period #1 (7 Days)|Sponsor terminated study prematurely|7
6146067|NCT02474199|21170788|P4|Overall Study|Did not meet eligibility criteria|2
6146068|NCT02474199|21170789|P3|Overall Study|Did not meet eligibility criteria|2
6146069|NCT02474199|21170790|P2|Overall Study|Did not meet eligibility criteria|0
6146070|NCT02474199|21170791|P1|Overall Study|Did not meet eligibility criteria|0
6146071|NCT02474199|21170788|P4|Overall Study|Did not receive Tregs due to insufficient manufacture|0
6146072|NCT02474199|21170789|P3|Overall Study|Did not receive Tregs due to insufficient manufacture|0
6146073|NCT02474199|21170790|P2|Overall Study|Did not receive Tregs due to insufficient manufacture|1
6146074|NCT02474199|21170791|P1|Overall Study|Did not receive Tregs due to insufficient manufacture|0
6146075|NCT02474199|21170788|P4|Overall Study|Withdrawal by Subject|1
6146076|NCT02474199|21170789|P3|Overall Study|Withdrawal by Subject|0
6146077|NCT02474199|21170790|P2|Overall Study|Withdrawal by Subject|2
6146078|NCT02474199|21170791|P1|Overall Study|Withdrawal by Subject|1
6146079|NCT02474199|21170788|P4|Overall Study|Lost to Follow-up|0
6146080|NCT02474199|21170789|P3|Overall Study|Lost to Follow-up|0
6146081|NCT02474199|21170790|P2|Overall Study|Lost to Follow-up|0
6146082|NCT02474199|21170791|P1|Overall Study|Lost to Follow-up|1
6146093|NCT02450903|21170844|P1|Overall Study|Subject/guardian decision|1
6146094|NCT02450903|21170844|P1|Overall Study|Switched to commercial drug|1
6146095|NCT02450903|21170844|P1|Overall Study|Progressive disease|15
6146096|NCT02450903|21170844|P1|Overall Study|Adverse Event|3
6146199|NCT02416453|21171162|P8|Overall Study|Lost to Follow-up|3
6146142|NCT02420821|21171079|P2|Overall Study|Death|116
6146143|NCT02420821|21171080|P1|Overall Study|Death|129
6146144|NCT02420821|21171079|P2|Overall Study|Withdrawal by Subject|17
6146145|NCT02420821|21171080|P1|Overall Study|Withdrawal by Subject|31
6146146|NCT02420821|21171079|P2|Overall Study|Physician Decision|2
6146147|NCT02420821|21171080|P1|Overall Study|Physician Decision|5
6146148|NCT02420821|21171079|P2|Overall Study|Non-compliance|2
6146149|NCT02420821|21171080|P1|Overall Study|Non-compliance|1
6146150|NCT02420821|21171079|P2|Overall Study|Lost to Follow-up|0
6146151|NCT02420821|21171080|P1|Overall Study|Lost to Follow-up|2
6146152|NCT02416453|21171159|P11|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0
6146153|NCT02416453|21171160|P10|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0
6146154|NCT02416453|21171161|P9|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0
6146155|NCT02416453|21171162|P8|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0
6146156|NCT02416453|21171163|P7|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0
6146157|NCT02416453|21171164|P6|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|1
6146158|NCT02416453|21171165|P5|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0
6146159|NCT02416453|21171166|P4|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0
6146160|NCT02416453|21171167|P3|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0
6146161|NCT02416453|21171168|P2|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0
6146162|NCT02416453|21171169|P1|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0
6146163|NCT02416453|21171159|P11|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0
6146164|NCT02416453|21171160|P10|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0
6146165|NCT02416453|21171161|P9|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0
6146166|NCT02416453|21171162|P8|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0
6146167|NCT02416453|21171163|P7|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0
6146168|NCT02416453|21171164|P6|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0
6146169|NCT02416453|21171165|P5|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0
6146170|NCT02416453|21171166|P4|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0
6146171|NCT02416453|21171167|P3|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|1
6146172|NCT02416453|21171168|P2|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0
6146173|NCT02416453|21171169|P1|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0
6146174|NCT02416453|21171159|P11|Overall Study|Withdrawal by Subject|0
6146175|NCT02416453|21171160|P10|Overall Study|Withdrawal by Subject|0
6146176|NCT02416453|21171161|P9|Overall Study|Withdrawal by Subject|4
6146177|NCT02416453|21171162|P8|Overall Study|Withdrawal by Subject|8
6146178|NCT02416453|21171163|P7|Overall Study|Withdrawal by Subject|0
6146179|NCT02416453|21171164|P6|Overall Study|Withdrawal by Subject|8
6146180|NCT02416453|21171165|P5|Overall Study|Withdrawal by Subject|1
6146181|NCT02416453|21171166|P4|Overall Study|Withdrawal by Subject|5
6146182|NCT02416453|21171167|P3|Overall Study|Withdrawal by Subject|0
6146183|NCT02416453|21171168|P2|Overall Study|Withdrawal by Subject|0
6146184|NCT02416453|21171169|P1|Overall Study|Withdrawal by Subject|2
6146185|NCT02416453|21171159|P11|Overall Study|Physician Decision|0
6146186|NCT02416453|21171160|P10|Overall Study|Physician Decision|0
6146187|NCT02416453|21171161|P9|Overall Study|Physician Decision|0
6146188|NCT02416453|21171162|P8|Overall Study|Physician Decision|1
6146189|NCT02416453|21171163|P7|Overall Study|Physician Decision|1
6146190|NCT02416453|21171164|P6|Overall Study|Physician Decision|1
6146191|NCT02416453|21171165|P5|Overall Study|Physician Decision|0
6146192|NCT02416453|21171166|P4|Overall Study|Physician Decision|0
6146193|NCT02416453|21171167|P3|Overall Study|Physician Decision|0
6146194|NCT02416453|21171168|P2|Overall Study|Physician Decision|0
6146195|NCT02416453|21171169|P1|Overall Study|Physician Decision|0
6146196|NCT02416453|21171159|P11|Overall Study|Lost to Follow-up|0
6146197|NCT02416453|21171160|P10|Overall Study|Lost to Follow-up|0
6146198|NCT02416453|21171161|P9|Overall Study|Lost to Follow-up|1
6146200|NCT02416453|21171163|P7|Overall Study|Lost to Follow-up|1
6146201|NCT02416453|21171164|P6|Overall Study|Lost to Follow-up|5
6146202|NCT02416453|21171165|P5|Overall Study|Lost to Follow-up|0
6146203|NCT02416453|21171166|P4|Overall Study|Lost to Follow-up|8
6146204|NCT02416453|21171167|P3|Overall Study|Lost to Follow-up|0
6146205|NCT02416453|21171168|P2|Overall Study|Lost to Follow-up|3
6146206|NCT02416453|21171169|P1|Overall Study|Lost to Follow-up|1
6146207|NCT02416453|21171159|P11|Overall Study|Adverse Event|0
6146208|NCT02416453|21171160|P10|Overall Study|Adverse Event|0
6146209|NCT02416453|21171161|P9|Overall Study|Adverse Event|0
6146210|NCT02416453|21171162|P8|Overall Study|Adverse Event|0
6146211|NCT02416453|21171163|P7|Overall Study|Adverse Event|0
6146212|NCT02416453|21171164|P6|Overall Study|Adverse Event|1
6146213|NCT02416453|21171165|P5|Overall Study|Adverse Event|0
6146214|NCT02416453|21171166|P4|Overall Study|Adverse Event|2
6146215|NCT02416453|21171167|P3|Overall Study|Adverse Event|0
6146216|NCT02416453|21171168|P2|Overall Study|Adverse Event|0
6146217|NCT02416453|21171169|P1|Overall Study|Adverse Event|0
6146259|NCT02346708|21171574|P2|Overall Study|Protocol Violation|1
6146260|NCT02346708|21171575|P1|Overall Study|Protocol Violation|0
6146261|NCT02346708|21171574|P2|Overall Study|Adverse Event|0
6146262|NCT02346708|21171575|P1|Overall Study|Adverse Event|2
6146267|NCT02303704|21171692|P2|Overall Study|Protocol Violation|9
6146268|NCT02303704|21171693|P1|Overall Study|Protocol Violation|5
6146304|NCT02225665|21171835|P2|Overall Study|Subject restarted HAART prior to month 18.|1
6146305|NCT02225665|21171836|P1|Overall Study|Subject restarted HAART prior to month 18.|0
6146306|NCT02225665|21171835|P2|Overall Study|Subject moved from area and finds it difficult to return for visits.|0
6146307|NCT02225665|21171836|P1|Overall Study|Subject moved from area and finds it difficult to return for visits.|1
6146370|NCT02095678|21172019|P2|Overall Study|No Visible Lesion or Pathological Finding|0
6146371|NCT02095678|21172020|P1|Overall Study|No Visible Lesion or Pathological Finding|4
6146372|NCT02095678|21172019|P2|Overall Study|Malignant lesions not HCC nor Metastatic|1
6146373|NCT02095678|21172020|P1|Overall Study|Malignant lesions not HCC nor Metastatic|1
6146374|NCT02095678|21172019|P2|Overall Study|No Confirmed Diagnosis|3
6146375|NCT02095678|21172020|P1|Overall Study|No Confirmed Diagnosis|0
6146376|NCT02095678|21172019|P2|Overall Study|lesion impacted by previous treatment|1
6146377|NCT02095678|21172020|P1|Overall Study|lesion impacted by previous treatment|1
6146378|NCT02095678|21172019|P2|Overall Study|Omitted for Severe Image Artifacts or Patient Non-compliance|12
6146379|NCT02095678|21172020|P1|Overall Study|Omitted for Severe Image Artifacts or Patient Non-compliance|11
6146380|NCT02095678|21172019|P2|Overall Study|Withdrawal by Subject|1
6146381|NCT02095678|21172020|P1|Overall Study|Withdrawal by Subject|0
6146581|NCT01701674|21172578|P1|Overall Study|Unable to safely complete treatment|1
6146673|NCT01557751|21172772|P1|Overall Study|Physician Decision|3
6146678|NCT01532687|21172795|P2|Overall Study|Protocol-defined delay > 3 weeks|0
6146679|NCT01532687|21172796|P1|Overall Study|Protocol-defined delay > 3 weeks|3
6146680|NCT01532687|21172795|P2|Overall Study|Physician Decision|1
6146681|NCT01532687|21172796|P1|Overall Study|Physician Decision|2
6146682|NCT01532687|21172795|P2|Overall Study|Withdrawal by Subject|0
6146683|NCT01532687|21172796|P1|Overall Study|Withdrawal by Subject|1
6146684|NCT01532687|21172795|P2|Overall Study|Adverse Event|1
6146685|NCT01532687|21172796|P1|Overall Study|Adverse Event|6
6146686|NCT01532687|21172795|P2|Overall Study|Death|0
6146687|NCT01532687|21172796|P1|Overall Study|Death|2
6146688|NCT01515319|21172818|P10|Overall Study|Protocol Violation|0
6146689|NCT01515319|21172819|P9|Overall Study|Protocol Violation|2
6146690|NCT01515319|21172820|P8|Overall Study|Protocol Violation|0
6146691|NCT01515319|21172821|P7|Overall Study|Protocol Violation|0
6146692|NCT01515319|21172822|P6|Overall Study|Protocol Violation|0
6146693|NCT01515319|21172823|P5|Overall Study|Protocol Violation|0
6146694|NCT01515319|21172824|P4|Overall Study|Protocol Violation|0
6146695|NCT01515319|21172825|P3|Overall Study|Protocol Violation|0
6146696|NCT01515319|21172826|P2|Overall Study|Protocol Violation|0
6146697|NCT01515319|21172827|P1|Overall Study|Protocol Violation|0
6146698|NCT01515319|21172818|P10|Overall Study|Adverse Event|0
6146699|NCT01515319|21172819|P9|Overall Study|Adverse Event|3
6146700|NCT01515319|21172820|P8|Overall Study|Adverse Event|0
6146701|NCT01515319|21172821|P7|Overall Study|Adverse Event|0
6146702|NCT01515319|21172822|P6|Overall Study|Adverse Event|0
6146703|NCT01515319|21172823|P5|Overall Study|Adverse Event|0
6146704|NCT01515319|21172824|P4|Overall Study|Adverse Event|0
6146705|NCT01515319|21172825|P3|Overall Study|Adverse Event|0
6146706|NCT01515319|21172826|P2|Overall Study|Adverse Event|0
6146707|NCT01515319|21172827|P1|Overall Study|Adverse Event|0
6146708|NCT01515319|21172818|P10|Overall Study|Withdrawal by Subject|0
6146709|NCT01515319|21172819|P9|Overall Study|Withdrawal by Subject|0
6146710|NCT01515319|21172820|P8|Overall Study|Withdrawal by Subject|0
6146711|NCT01515319|21172821|P7|Overall Study|Withdrawal by Subject|1
6146712|NCT01515319|21172822|P6|Overall Study|Withdrawal by Subject|0
6146713|NCT01515319|21172823|P5|Overall Study|Withdrawal by Subject|0
6146714|NCT01515319|21172824|P4|Overall Study|Withdrawal by Subject|0
6146715|NCT01515319|21172825|P3|Overall Study|Withdrawal by Subject|0
6146716|NCT01515319|21172826|P2|Overall Study|Withdrawal by Subject|0
6146717|NCT01515319|21172827|P1|Overall Study|Withdrawal by Subject|0
6146722|NCT01425203|21172906|P3|Crossover Phase|Other virologic failure criteria|3
6146723|NCT01425203|21172907|P2|Crossover Phase|Other virologic failure criteria|0
6146724|NCT01425203|21172908|P1|Crossover Phase|Other virologic failure criteria|0
6146725|NCT01425203|21172906|P3|Crossover Phase|Failure at futility timepoint|3
6146726|NCT01425203|21172907|P2|Crossover Phase|Failure at futility timepoint|0
6146727|NCT01425203|21172908|P1|Crossover Phase|Failure at futility timepoint|0
6146728|NCT01425203|21172906|P3|Treatment Phase|Did not receive treatment|0
6146729|NCT01425203|21172907|P2|Treatment Phase|Did not receive treatment|1
6146730|NCT01425203|21172908|P1|Treatment Phase|Did not receive treatment|0
6146731|NCT01425203|21172906|P3|Treatment Phase|Unidentified reasons|0
6146732|NCT01425203|21172907|P2|Treatment Phase|Unidentified reasons|5
6146733|NCT01425203|21172908|P1|Treatment Phase|Unidentified reasons|11
6146734|NCT01425203|21172906|P3|Treatment Phase|Other virologic failure criteria|0
6146735|NCT01425203|21172907|P2|Treatment Phase|Other virologic failure criteria|3
6146736|NCT01425203|21172908|P1|Treatment Phase|Other virologic failure criteria|5
6146737|NCT01425203|21172906|P3|Treatment Phase|Failure at futility timepoint|0
6146738|NCT01425203|21172907|P2|Treatment Phase|Failure at futility timepoint|27
6146739|NCT01425203|21172908|P1|Treatment Phase|Failure at futility timepoint|8
6146740|NCT01425203|21172906|P3|Treatment Phase|DC during PR Lead-in Phase|0
6146741|NCT01425203|21172907|P2|Treatment Phase|DC during PR Lead-in Phase|1
6146742|NCT01425203|21172908|P1|Treatment Phase|DC during PR Lead-in Phase|3
6146822|NCT01146795|21173466|P1|Overall Study|Still in treatment at study closure|10
6146823|NCT01146795|21173466|P1|Overall Study|Adverse Event|6
6146824|NCT01146795|21173466|P1|Overall Study|Withdrawal by Subject|4
6146856|NCT01065454|21173544|P4|Follow up|study ongoing|41
6146857|NCT01065454|21173545|P3|Follow up|study ongoing|15
6146858|NCT01065454|21173546|P2|Follow up|study ongoing|22
6146859|NCT01065454|21173547|P1|Follow up|study ongoing|37
6146860|NCT01065454|21173544|P4|Follow up|Withdrawal by Subject|0
6146861|NCT01065454|21173545|P3|Follow up|Withdrawal by Subject|1
6146862|NCT01065454|21173546|P2|Follow up|Withdrawal by Subject|1
6146863|NCT01065454|21173547|P1|Follow up|Withdrawal by Subject|1
6146864|NCT01065454|21173544|P4|Follow up|Progressive disease|1
6146865|NCT01065454|21173545|P3|Follow up|Progressive disease|0
6146866|NCT01065454|21173546|P2|Follow up|Progressive disease|0
6146867|NCT01065454|21173547|P1|Follow up|Progressive disease|0
6146868|NCT01065454|21173544|P4|Follow up|Lost to Follow-up|1
6146869|NCT01065454|21173545|P3|Follow up|Lost to Follow-up|0
6146870|NCT01065454|21173546|P2|Follow up|Lost to Follow-up|0
6146871|NCT01065454|21173547|P1|Follow up|Lost to Follow-up|0
6146872|NCT01065454|21173544|P4|Follow up|Death|0
6146873|NCT01065454|21173545|P3|Follow up|Death|1
6146874|NCT01065454|21173546|P2|Follow up|Death|1
6146875|NCT01065454|21173547|P1|Follow up|Death|0
6146876|NCT01065454|21173544|P4|Follow up|Adverse Event|1
6146877|NCT01065454|21173545|P3|Follow up|Adverse Event|0
6146878|NCT01065454|21173546|P2|Follow up|Adverse Event|0
6146879|NCT01065454|21173547|P1|Follow up|Adverse Event|1
6146880|NCT01065454|21173544|P4|Treatment|Withdrawal by Subject|3
6146881|NCT01065454|21173545|P3|Treatment|Withdrawal by Subject|2
6146882|NCT01065454|21173546|P2|Treatment|Withdrawal by Subject|1
6146883|NCT01065454|21173547|P1|Treatment|Withdrawal by Subject|3
6146884|NCT01065454|21173544|P4|Treatment|Protocol Violation|0
6146885|NCT01065454|21173545|P3|Treatment|Protocol Violation|1
6146886|NCT01065454|21173546|P2|Treatment|Protocol Violation|0
6146887|NCT01065454|21173547|P1|Treatment|Protocol Violation|1
6146888|NCT01065454|21173544|P4|Treatment|Protocol Decision|2
6146889|NCT01065454|21173545|P3|Treatment|Protocol Decision|3
6146890|NCT01065454|21173546|P2|Treatment|Protocol Decision|0
6146891|NCT01065454|21173547|P1|Treatment|Protocol Decision|0
6146892|NCT01065454|21173544|P4|Treatment|Non-compliance|1
6146893|NCT01065454|21173545|P3|Treatment|Non-compliance|0
6146894|NCT01065454|21173546|P2|Treatment|Non-compliance|0
6146895|NCT01065454|21173547|P1|Treatment|Non-compliance|1
6146896|NCT01065454|21173544|P4|Treatment|Death|0
6146897|NCT01065454|21173545|P3|Treatment|Death|0
6146898|NCT01065454|21173546|P2|Treatment|Death|0
6146899|NCT01065454|21173547|P1|Treatment|Death|1
6146900|NCT01065454|21173544|P4|Treatment|Adverse Event|6
6146901|NCT01065454|21173545|P3|Treatment|Adverse Event|3
6146902|NCT01065454|21173546|P2|Treatment|Adverse Event|4
6146903|NCT01065454|21173547|P1|Treatment|Adverse Event|7
6146907|NCT01023035|21173687|P3|Follow-up Period (up to Week 72)|Non-medical Reason|38
6146908|NCT01023035|21173688|P2|Follow-up Period (up to Week 72)|Non-medical Reason|28
6146909|NCT01023035|21173689|P1|Follow-up Period (up to Week 72)|Non-medical Reason|26
6146910|NCT01023035|21173687|P3|Follow-up Period (up to Week 72)|Adverse Event|1
6146911|NCT01023035|21173688|P2|Follow-up Period (up to Week 72)|Adverse Event|0
6146912|NCT01023035|21173689|P1|Follow-up Period (up to Week 72)|Adverse Event|2
6146913|NCT01023035|21173687|P3|Treatment Period|Treatment Failure|24
6146914|NCT01023035|21173688|P2|Treatment Period|Treatment Failure|31
6146915|NCT01023035|21173689|P1|Treatment Period|Treatment Failure|26
6146916|NCT01023035|21173687|P3|Treatment Period|Non-Medical Reasons|44
6146917|NCT01023035|21173688|P2|Treatment Period|Non-Medical Reasons|22
6146918|NCT01023035|21173689|P1|Treatment Period|Non-Medical Reasons|19
6146919|NCT01023035|21173687|P3|Treatment Period|Adverse Event|50
6146920|NCT01023035|21173688|P2|Treatment Period|Adverse Event|32
6146921|NCT01023035|21173689|P1|Treatment Period|Adverse Event|27
6146926|NCT00977574|21173727|P3|Overall Study|Never Treated|4
6146927|NCT00977574|21173728|P2|Overall Study|Never Treated|2
6146928|NCT00977574|21173729|P1|Overall Study|Never Treated|4
6146929|NCT00960804|21173749|P3|Overall Study|Study terminated by the sponsor|10
6146930|NCT00960804|21173750|P2|Overall Study|Study terminated by the sponsor|4
6146931|NCT00960804|21173751|P1|Overall Study|Study terminated by the sponsor|5
6146932|NCT00960804|21173749|P3|Overall Study|Withdrawal by Subject|0
6146933|NCT00960804|21173750|P2|Overall Study|Withdrawal by Subject|0
6146934|NCT00960804|21173751|P1|Overall Study|Withdrawal by Subject|1
6146935|NCT00960804|21173749|P3|Overall Study|Adverse Event|0
6146936|NCT00960804|21173750|P2|Overall Study|Adverse Event|0
6146937|NCT00960804|21173751|P1|Overall Study|Adverse Event|1
6146945|NCT00943761|21173868|P2|Overall Study|Withdrawal by Subject|1
6146946|NCT00943761|21173869|P1|Overall Study|Withdrawal by Subject|2
6146947|NCT00943761|21173868|P2|Overall Study|Lost to Follow-up|0
6146948|NCT00943761|21173869|P1|Overall Study|Lost to Follow-up|2
6146979|NCT00942331|21173920|P2|Overall Study|Did not start treatment|22
6146980|NCT00942331|21173921|P1|Overall Study|Did not start treatment|15
6146983|NCT00910624|21173946|P4|Follow-Up Phase|Administrative|0
6146984|NCT00910624|21173947|P3|Follow-Up Phase|Administrative|1
6146985|NCT00910624|21173948|P2|Follow-Up Phase|Administrative|1
6146986|NCT00910624|21173949|P1|Follow-Up Phase|Administrative|0
6146987|NCT00910624|21173946|P4|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0
6146988|NCT00910624|21173947|P3|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0
6146989|NCT00910624|21173948|P2|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0
6146990|NCT00910624|21173949|P1|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|1
6146991|NCT00910624|21173946|P4|Follow-Up Phase|Withdrawal by Subject|0
6146992|NCT00910624|21173947|P3|Follow-Up Phase|Withdrawal by Subject|0
6146993|NCT00910624|21173948|P2|Follow-Up Phase|Withdrawal by Subject|0
6146994|NCT00910624|21173949|P1|Follow-Up Phase|Withdrawal by Subject|1
6146995|NCT00910624|21173946|P4|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0
6146996|NCT00910624|21173947|P3|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0
6146997|NCT00910624|21173948|P2|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|2
6146998|NCT00910624|21173949|P1|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|1
6146999|NCT00910624|21173946|P4|Follow-Up Phase|Lost to Follow-up|0
6147000|NCT00910624|21173947|P3|Follow-Up Phase|Lost to Follow-up|2
6147001|NCT00910624|21173948|P2|Follow-Up Phase|Lost to Follow-up|1
6147002|NCT00910624|21173949|P1|Follow-Up Phase|Lost to Follow-up|3
6147003|NCT00910624|21173946|P4|Follow-Up Phase|Adverse Event|0
6147004|NCT00910624|21173947|P3|Follow-Up Phase|Adverse Event|1
6147005|NCT00910624|21173948|P2|Follow-Up Phase|Adverse Event|0
6147006|NCT00910624|21173949|P1|Follow-Up Phase|Adverse Event|0
6147007|NCT00910624|21173946|P4|Treatment Phase|Non-Compliance With Protocol|0
6147008|NCT00910624|21173947|P3|Treatment Phase|Non-Compliance With Protocol|1
6147009|NCT00910624|21173948|P2|Treatment Phase|Non-Compliance With Protocol|1
6147010|NCT00910624|21173949|P1|Treatment Phase|Non-Compliance With Protocol|0
6147011|NCT00910624|21173946|P4|Treatment Phase|Withdrawal by Subject|0
6147012|NCT00910624|21173947|P3|Treatment Phase|Withdrawal by Subject|0
6147013|NCT00910624|21173948|P2|Treatment Phase|Withdrawal by Subject|1
6147014|NCT00910624|21173949|P1|Treatment Phase|Withdrawal by Subject|2
6147015|NCT00910624|21173946|P4|Treatment Phase|Reasons Unrelated To Assigned Treatment|0
6147016|NCT00910624|21173947|P3|Treatment Phase|Reasons Unrelated To Assigned Treatment|1
6147017|NCT00910624|21173948|P2|Treatment Phase|Reasons Unrelated To Assigned Treatment|3
6147018|NCT00910624|21173949|P1|Treatment Phase|Reasons Unrelated To Assigned Treatment|3
6147019|NCT00910624|21173946|P4|Treatment Phase|Lost to Follow-up|0
6147020|NCT00910624|21173947|P3|Treatment Phase|Lost to Follow-up|1
6147021|NCT00910624|21173948|P2|Treatment Phase|Lost to Follow-up|0
6147022|NCT00910624|21173949|P1|Treatment Phase|Lost to Follow-up|0
6147023|NCT00910624|21173946|P4|Treatment Phase|Treatment Failure|0
6147024|NCT00910624|21173947|P3|Treatment Phase|Treatment Failure|0
6147025|NCT00910624|21173948|P2|Treatment Phase|Treatment Failure|10
6147026|NCT00910624|21173949|P1|Treatment Phase|Treatment Failure|23
6147027|NCT00910624|21173946|P4|Treatment Phase|Adverse Event|0
6147028|NCT00910624|21173947|P3|Treatment Phase|Adverse Event|6
6147029|NCT00910624|21173948|P2|Treatment Phase|Adverse Event|6
6147030|NCT00910624|21173949|P1|Treatment Phase|Adverse Event|2
6147031|NCT00861705|21173965|P4|Overall Study|Never Began Treatment|1
6147032|NCT00861705|21173966|P3|Overall Study|Never Began Treatment|0
6147033|NCT00861705|21173967|P2|Overall Study|Never Began Treatment|3
6147034|NCT00861705|21173968|P1|Overall Study|Never Began Treatment|7
6147050|NCT00785291|21174068|P3|Overall Study|Other Medical Reasons|15
6147051|NCT00785291|21174069|P2|Overall Study|Other Medical Reasons|25
6147052|NCT00785291|21174070|P1|Overall Study|Other Medical Reasons|29
6147053|NCT00785291|21174068|P3|Overall Study|Complicating illness|4
6147054|NCT00785291|21174069|P2|Overall Study|Complicating illness|4
6147055|NCT00785291|21174070|P1|Overall Study|Complicating illness|6
6147056|NCT00785291|21174068|P3|Overall Study|Alternative Therapy|7
6147057|NCT00785291|21174069|P2|Overall Study|Alternative Therapy|6
6147058|NCT00785291|21174070|P1|Overall Study|Alternative Therapy|12
6147059|NCT00785291|21174068|P3|Overall Study|Withdrawal by Subject|17
6147060|NCT00785291|21174069|P2|Overall Study|Withdrawal by Subject|36
6147061|NCT00785291|21174070|P1|Overall Study|Withdrawal by Subject|35
6147062|NCT00785291|21174068|P3|Overall Study|Death|3
6147063|NCT00785291|21174069|P2|Overall Study|Death|4
6147064|NCT00785291|21174070|P1|Overall Study|Death|7
6147065|NCT00785291|21174068|P3|Overall Study|Adverse Event|56
6147066|NCT00785291|21174069|P2|Overall Study|Adverse Event|70
6147067|NCT00785291|21174070|P1|Overall Study|Adverse Event|39
6147068|NCT00785291|21174068|P3|Overall Study|Never began treatment|4
6147069|NCT00785291|21174069|P2|Overall Study|Never began treatment|4
6147070|NCT00785291|21174070|P1|Overall Study|Never began treatment|8
6147071|NCT00768664|21174090|P1|Overall Study|Participant refused|1
6147072|NCT00768664|21174090|P1|Overall Study|Other|9
6147073|NCT00768664|21174090|P1|Overall Study|Lost to Follow-up|2
6147074|NCT00768664|21174090|P1|Overall Study|Death|57
6147105|NCT00654940|21174270|P2|Period 1|Intolerable Pain Level|0
6147106|NCT00654940|21174271|P1|Period 1|Intolerable Pain Level|1
6147107|NCT00654940|21174270|P2|Period 1|Adverse Event|1
6147108|NCT00654940|21174271|P1|Period 1|Adverse Event|0
6147129|NCT00553358|21174331|P3|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1
6147130|NCT00553358|21174332|P2|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1
6147131|NCT00553358|21174333|P1|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1
6147132|NCT00553358|21174331|P3|Overall Study|Died after clinical follow-up ended|0
6147133|NCT00553358|21174332|P2|Overall Study|Died after clinical follow-up ended|2
6147134|NCT00553358|21174333|P1|Overall Study|Died after clinical follow-up ended|1
6147135|NCT00553358|21174331|P3|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|2
6147136|NCT00553358|21174332|P2|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|2
6147137|NCT00553358|21174333|P1|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|4
6147138|NCT00553358|21174331|P3|Overall Study|Died during clinical follow-up|32
6147139|NCT00553358|21174332|P2|Overall Study|Died during clinical follow-up|29
6147140|NCT00553358|21174333|P1|Overall Study|Died during clinical follow-up|25
6147141|NCT00553358|21174331|P3|Overall Study|Withdrew completely|34
6147142|NCT00553358|21174332|P2|Overall Study|Withdrew completely|33
6147143|NCT00553358|21174333|P1|Overall Study|Withdrew completely|23
6147144|NCT00553358|21174331|P3|Overall Study|Lost to Follow-up|18
6147145|NCT00553358|21174332|P2|Overall Study|Lost to Follow-up|26
6147146|NCT00553358|21174333|P1|Overall Study|Lost to Follow-up|22
6147147|NCT00553358|21174331|P3|Overall Study|Randomized but did not receive treatment|1
6147148|NCT00553358|21174332|P2|Overall Study|Randomized but did not receive treatment|3
6147149|NCT00553358|21174333|P1|Overall Study|Randomized but did not receive treatment|3
6147171|NCT00467272|21174567|P1|Overall Study|Thrombophlebitis|1
6147172|NCT00467272|21174567|P1|Overall Study|Pneumonia|2
6147213|NCT00437034|21174909|P1|Overall Study|Disease progression during treatment|5
6147214|NCT00437034|21174909|P1|Overall Study|Adverse Event|1
6147237|NCT00408005|21175027|P8|Post Induction Therapy by Tx Assignment|Development of SMN|0
6147238|NCT00408005|21175028|P7|Post Induction Therapy by Tx Assignment|Development of SMN|0
6147239|NCT00408005|21175029|P6|Post Induction Therapy by Tx Assignment|Development of SMN|1
6147240|NCT00408005|21175030|P5|Post Induction Therapy by Tx Assignment|Development of SMN|1
6147241|NCT00408005|21175031|P4|Post Induction Therapy by Tx Assignment|Development of SMN|1
6147242|NCT00408005|21175032|P3|Post Induction Therapy by Tx Assignment|Development of SMN|3
6147243|NCT00408005|21175033|P2|Post Induction Therapy by Tx Assignment|Development of SMN|0
6147244|NCT00408005|21175034|P1|Post Induction Therapy by Tx Assignment|Development of SMN|0
6147245|NCT00408005|21175027|P8|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0
6147246|NCT00408005|21175028|P7|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|1
6147247|NCT00408005|21175029|P6|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|15
6147248|NCT00408005|21175030|P5|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|49
6147249|NCT00408005|21175031|P4|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|7
6147250|NCT00408005|21175032|P3|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|13
6147251|NCT00408005|21175033|P2|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0
6147252|NCT00408005|21175034|P1|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0
6147253|NCT00408005|21175027|P8|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0
6147254|NCT00408005|21175028|P7|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0
6147255|NCT00408005|21175029|P6|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|2
6147256|NCT00408005|21175030|P5|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|1
6147257|NCT00408005|21175031|P4|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0
6147258|NCT00408005|21175032|P3|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0
6147259|NCT00408005|21175033|P2|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0
6147260|NCT00408005|21175034|P1|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0
6147261|NCT00408005|21175027|P8|Post Induction Therapy by Tx Assignment|Protocol Deviation|0
6147262|NCT00408005|21175028|P7|Post Induction Therapy by Tx Assignment|Protocol Deviation|0
6147263|NCT00408005|21175029|P6|Post Induction Therapy by Tx Assignment|Protocol Deviation|2
6147264|NCT00408005|21175030|P5|Post Induction Therapy by Tx Assignment|Protocol Deviation|1
6147265|NCT00408005|21175031|P4|Post Induction Therapy by Tx Assignment|Protocol Deviation|1
6147266|NCT00408005|21175032|P3|Post Induction Therapy by Tx Assignment|Protocol Deviation|2
6147267|NCT00408005|21175033|P2|Post Induction Therapy by Tx Assignment|Protocol Deviation|0
6147268|NCT00408005|21175034|P1|Post Induction Therapy by Tx Assignment|Protocol Deviation|0
6147269|NCT00408005|21175027|P8|Post Induction Therapy by Tx Assignment|Inevaluable|0
6147270|NCT00408005|21175028|P7|Post Induction Therapy by Tx Assignment|Inevaluable|0
6147271|NCT00408005|21175029|P6|Post Induction Therapy by Tx Assignment|Inevaluable|1
6147272|NCT00408005|21175030|P5|Post Induction Therapy by Tx Assignment|Inevaluable|0
6147273|NCT00408005|21175031|P4|Post Induction Therapy by Tx Assignment|Inevaluable|0
6147274|NCT00408005|21175032|P3|Post Induction Therapy by Tx Assignment|Inevaluable|0
6147275|NCT00408005|21175033|P2|Post Induction Therapy by Tx Assignment|Inevaluable|0
6147276|NCT00408005|21175034|P1|Post Induction Therapy by Tx Assignment|Inevaluable|0
6147277|NCT00408005|21175027|P8|Post Induction Therapy by Tx Assignment|Progressive Disease|7
6147278|NCT00408005|21175028|P7|Post Induction Therapy by Tx Assignment|Progressive Disease|7
6147279|NCT00408005|21175029|P6|Post Induction Therapy by Tx Assignment|Progressive Disease|0
6147280|NCT00408005|21175030|P5|Post Induction Therapy by Tx Assignment|Progressive Disease|1
6147281|NCT00408005|21175031|P4|Post Induction Therapy by Tx Assignment|Progressive Disease|0
6147282|NCT00408005|21175032|P3|Post Induction Therapy by Tx Assignment|Progressive Disease|0
6147283|NCT00408005|21175033|P2|Post Induction Therapy by Tx Assignment|Progressive Disease|0
6147284|NCT00408005|21175034|P1|Post Induction Therapy by Tx Assignment|Progressive Disease|0
6147285|NCT00408005|21175027|P8|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0
6147286|NCT00408005|21175028|P7|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1
6147287|NCT00408005|21175029|P6|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0
6147288|NCT00408005|21175030|P5|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1
6147289|NCT00408005|21175031|P4|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1
6147290|NCT00408005|21175032|P3|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|3
6147291|NCT00408005|21175033|P2|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0
6147292|NCT00408005|21175034|P1|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0
6147293|NCT00408005|21175027|P8|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0
6147294|NCT00408005|21175028|P7|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0
6147295|NCT00408005|21175029|P6|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0
6147296|NCT00408005|21175030|P5|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|1
6147297|NCT00408005|21175031|P4|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0
6147298|NCT00408005|21175032|P3|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0
6147299|NCT00408005|21175033|P2|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0
6147300|NCT00408005|21175034|P1|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0
6147301|NCT00408005|21175027|P8|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|2
6147302|NCT00408005|21175028|P7|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|4
6147303|NCT00408005|21175029|P6|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|16
6147304|NCT00408005|21175030|P5|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|36
6147305|NCT00408005|21175031|P4|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|10
6147306|NCT00408005|21175032|P3|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|27
6147307|NCT00408005|21175033|P2|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0
6147308|NCT00408005|21175034|P1|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0
6147309|NCT00408005|21175027|P8|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0
6147310|NCT00408005|21175028|P7|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0
6147311|NCT00408005|21175029|P6|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|2
6147312|NCT00408005|21175030|P5|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0
6147313|NCT00408005|21175031|P4|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1
6147314|NCT00408005|21175032|P3|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1
6147315|NCT00408005|21175033|P2|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0
6147316|NCT00408005|21175034|P1|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0
6147317|NCT00408005|21175027|P8|Post Induction Therapy by Tx Assignment|Physician Decision|4
6147318|NCT00408005|21175028|P7|Post Induction Therapy by Tx Assignment|Physician Decision|10
6147319|NCT00408005|21175029|P6|Post Induction Therapy by Tx Assignment|Physician Decision|45
6147320|NCT00408005|21175030|P5|Post Induction Therapy by Tx Assignment|Physician Decision|27
6147321|NCT00408005|21175031|P4|Post Induction Therapy by Tx Assignment|Physician Decision|19
6147322|NCT00408005|21175032|P3|Post Induction Therapy by Tx Assignment|Physician Decision|24
6147323|NCT00408005|21175033|P2|Post Induction Therapy by Tx Assignment|Physician Decision|0
6147324|NCT00408005|21175034|P1|Post Induction Therapy by Tx Assignment|Physician Decision|0
6147325|NCT00408005|21175027|P8|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0
6147326|NCT00408005|21175028|P7|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0
6147327|NCT00408005|21175029|P6|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0
6147328|NCT00408005|21175030|P5|Post Induction Therapy by Tx Assignment|Lost to Follow-up|1
6147329|NCT00408005|21175031|P4|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0
6147330|NCT00408005|21175032|P3|Post Induction Therapy by Tx Assignment|Lost to Follow-up|2
6147331|NCT00408005|21175033|P2|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0
6147332|NCT00408005|21175034|P1|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0
6147333|NCT00408005|21175027|P8|Post Induction Therapy by Tx Assignment|Death|1
6147334|NCT00408005|21175028|P7|Post Induction Therapy by Tx Assignment|Death|3
6147335|NCT00408005|21175029|P6|Post Induction Therapy by Tx Assignment|Death|5
6147336|NCT00408005|21175030|P5|Post Induction Therapy by Tx Assignment|Death|5
6147337|NCT00408005|21175031|P4|Post Induction Therapy by Tx Assignment|Death|0
6147338|NCT00408005|21175032|P3|Post Induction Therapy by Tx Assignment|Death|3
6147339|NCT00408005|21175033|P2|Post Induction Therapy by Tx Assignment|Death|0
6147340|NCT00408005|21175034|P1|Post Induction Therapy by Tx Assignment|Death|0
6147341|NCT00408005|21175027|P8|Post Induction Therapy by Tx Assignment|Adverse Event|0
6147342|NCT00408005|21175028|P7|Post Induction Therapy by Tx Assignment|Adverse Event|2
6147343|NCT00408005|21175029|P6|Post Induction Therapy by Tx Assignment|Adverse Event|12
6147344|NCT00408005|21175030|P5|Post Induction Therapy by Tx Assignment|Adverse Event|8
6147345|NCT00408005|21175031|P4|Post Induction Therapy by Tx Assignment|Adverse Event|4
6147346|NCT00408005|21175032|P3|Post Induction Therapy by Tx Assignment|Adverse Event|7
6147347|NCT00408005|21175033|P2|Post Induction Therapy by Tx Assignment|Adverse Event|0
6147348|NCT00408005|21175034|P1|Post Induction Therapy by Tx Assignment|Adverse Event|0
6147349|NCT00408005|21175027|P8|Induction|Recurrent leukemia|0
6147350|NCT00408005|21175028|P7|Induction|Recurrent leukemia|0
6147351|NCT00408005|21175029|P6|Induction|Recurrent leukemia|0
6147352|NCT00408005|21175030|P5|Induction|Recurrent leukemia|0
6147353|NCT00408005|21175031|P4|Induction|Recurrent leukemia|0
6147354|NCT00408005|21175032|P3|Induction|Recurrent leukemia|0
6147355|NCT00408005|21175033|P2|Induction|Recurrent leukemia|0
6147356|NCT00408005|21175034|P1|Induction|Recurrent leukemia|1
6147357|NCT00408005|21175027|P8|Induction|Hematopoietic Stem Cell Transplantation|0
6147358|NCT00408005|21175028|P7|Induction|Hematopoietic Stem Cell Transplantation|0
6147359|NCT00408005|21175029|P6|Induction|Hematopoietic Stem Cell Transplantation|0
6147360|NCT00408005|21175030|P5|Induction|Hematopoietic Stem Cell Transplantation|0
6147361|NCT00408005|21175031|P4|Induction|Hematopoietic Stem Cell Transplantation|0
6147362|NCT00408005|21175032|P3|Induction|Hematopoietic Stem Cell Transplantation|0
6147363|NCT00408005|21175033|P2|Induction|Hematopoietic Stem Cell Transplantation|0
6147364|NCT00408005|21175034|P1|Induction|Hematopoietic Stem Cell Transplantation|1
6147365|NCT00408005|21175027|P8|Induction|Protocol Deviation|0
6147366|NCT00408005|21175028|P7|Induction|Protocol Deviation|0
6147367|NCT00408005|21175029|P6|Induction|Protocol Deviation|0
6147368|NCT00408005|21175030|P5|Induction|Protocol Deviation|0
6147369|NCT00408005|21175031|P4|Induction|Protocol Deviation|0
6147370|NCT00408005|21175032|P3|Induction|Protocol Deviation|0
6147371|NCT00408005|21175033|P2|Induction|Protocol Deviation|1
6147372|NCT00408005|21175034|P1|Induction|Protocol Deviation|3
6147373|NCT00408005|21175027|P8|Induction|Failed to Complete Randomization|0
6147374|NCT00408005|21175028|P7|Induction|Failed to Complete Randomization|0
6147375|NCT00408005|21175029|P6|Induction|Failed to Complete Randomization|0
6147376|NCT00408005|21175030|P5|Induction|Failed to Complete Randomization|0
6147377|NCT00408005|21175031|P4|Induction|Failed to Complete Randomization|0
6147378|NCT00408005|21175032|P3|Induction|Failed to Complete Randomization|0
6147379|NCT00408005|21175033|P2|Induction|Failed to Complete Randomization|2
6147380|NCT00408005|21175034|P1|Induction|Failed to Complete Randomization|3
6147381|NCT00408005|21175027|P8|Induction|Inevaluable|0
6147382|NCT00408005|21175028|P7|Induction|Inevaluable|0
6147383|NCT00408005|21175029|P6|Induction|Inevaluable|0
6147384|NCT00408005|21175030|P5|Induction|Inevaluable|0
6147385|NCT00408005|21175031|P4|Induction|Inevaluable|0
6147386|NCT00408005|21175032|P3|Induction|Inevaluable|0
6147387|NCT00408005|21175033|P2|Induction|Inevaluable|14
6147388|NCT00408005|21175034|P1|Induction|Inevaluable|18
6147389|NCT00408005|21175027|P8|Induction|Progressive Disease|0
6147390|NCT00408005|21175028|P7|Induction|Progressive Disease|0
6147391|NCT00408005|21175029|P6|Induction|Progressive Disease|0
6147392|NCT00408005|21175030|P5|Induction|Progressive Disease|0
6147393|NCT00408005|21175031|P4|Induction|Progressive Disease|0
6147394|NCT00408005|21175032|P3|Induction|Progressive Disease|0
6147395|NCT00408005|21175033|P2|Induction|Progressive Disease|1
6147396|NCT00408005|21175034|P1|Induction|Progressive Disease|0
6147397|NCT00408005|21175027|P8|Induction|Identified as Philadelphia Chr. Positive|0
6147398|NCT00408005|21175028|P7|Induction|Identified as Philadelphia Chr. Positive|0
6147399|NCT00408005|21175029|P6|Induction|Identified as Philadelphia Chr. Positive|0
6147400|NCT00408005|21175030|P5|Induction|Identified as Philadelphia Chr. Positive|0
6147401|NCT00408005|21175031|P4|Induction|Identified as Philadelphia Chr. Positive|0
6147402|NCT00408005|21175032|P3|Induction|Identified as Philadelphia Chr. Positive|0
6147403|NCT00408005|21175033|P2|Induction|Identified as Philadelphia Chr. Positive|0
6147404|NCT00408005|21175034|P1|Induction|Identified as Philadelphia Chr. Positive|6
6147405|NCT00408005|21175027|P8|Induction|Patient transferred Tx to Non-COG Site|0
6147406|NCT00408005|21175028|P7|Induction|Patient transferred Tx to Non-COG Site|0
6147407|NCT00408005|21175029|P6|Induction|Patient transferred Tx to Non-COG Site|0
6147408|NCT00408005|21175030|P5|Induction|Patient transferred Tx to Non-COG Site|0
6147409|NCT00408005|21175031|P4|Induction|Patient transferred Tx to Non-COG Site|0
6147410|NCT00408005|21175032|P3|Induction|Patient transferred Tx to Non-COG Site|0
6147411|NCT00408005|21175033|P2|Induction|Patient transferred Tx to Non-COG Site|2
6147412|NCT00408005|21175034|P1|Induction|Patient transferred Tx to Non-COG Site|3
6147413|NCT00408005|21175027|P8|Induction|Entered another COG therapeutic protocol|0
6147414|NCT00408005|21175028|P7|Induction|Entered another COG therapeutic protocol|0
6147415|NCT00408005|21175029|P6|Induction|Entered another COG therapeutic protocol|0
6147416|NCT00408005|21175030|P5|Induction|Entered another COG therapeutic protocol|0
6147417|NCT00408005|21175031|P4|Induction|Entered another COG therapeutic protocol|0
6147418|NCT00408005|21175032|P3|Induction|Entered another COG therapeutic protocol|0
6147419|NCT00408005|21175033|P2|Induction|Entered another COG therapeutic protocol|0
6147420|NCT00408005|21175034|P1|Induction|Entered another COG therapeutic protocol|4
6147421|NCT00408005|21175027|P8|Induction|Refusal of Further Protocol Therapy|0
6147422|NCT00408005|21175028|P7|Induction|Refusal of Further Protocol Therapy|0
6147423|NCT00408005|21175029|P6|Induction|Refusal of Further Protocol Therapy|0
6147424|NCT00408005|21175030|P5|Induction|Refusal of Further Protocol Therapy|0
6147425|NCT00408005|21175031|P4|Induction|Refusal of Further Protocol Therapy|0
6147426|NCT00408005|21175032|P3|Induction|Refusal of Further Protocol Therapy|0
6147427|NCT00408005|21175033|P2|Induction|Refusal of Further Protocol Therapy|44
6147428|NCT00408005|21175034|P1|Induction|Refusal of Further Protocol Therapy|225
6147429|NCT00408005|21175027|P8|Induction|Ineligible|0
6147430|NCT00408005|21175028|P7|Induction|Ineligible|0
6147431|NCT00408005|21175029|P6|Induction|Ineligible|0
6147432|NCT00408005|21175030|P5|Induction|Ineligible|0
6147433|NCT00408005|21175031|P4|Induction|Ineligible|0
6147434|NCT00408005|21175032|P3|Induction|Ineligible|0
6147435|NCT00408005|21175033|P2|Induction|Ineligible|14
6147436|NCT00408005|21175034|P1|Induction|Ineligible|33
6147437|NCT00408005|21175027|P8|Induction|Withdrawal by Subject|0
6147438|NCT00408005|21175028|P7|Induction|Withdrawal by Subject|0
6147439|NCT00408005|21175029|P6|Induction|Withdrawal by Subject|0
6147440|NCT00408005|21175030|P5|Induction|Withdrawal by Subject|0
6147441|NCT00408005|21175031|P4|Induction|Withdrawal by Subject|0
6147442|NCT00408005|21175032|P3|Induction|Withdrawal by Subject|0
6147443|NCT00408005|21175033|P2|Induction|Withdrawal by Subject|4
6147444|NCT00408005|21175034|P1|Induction|Withdrawal by Subject|2
6147445|NCT00408005|21175027|P8|Induction|Physician Decision|0
6147446|NCT00408005|21175028|P7|Induction|Physician Decision|0
6147447|NCT00408005|21175029|P6|Induction|Physician Decision|0
6147448|NCT00408005|21175030|P5|Induction|Physician Decision|0
6147449|NCT00408005|21175031|P4|Induction|Physician Decision|0
6147450|NCT00408005|21175032|P3|Induction|Physician Decision|0
6147451|NCT00408005|21175033|P2|Induction|Physician Decision|9
6147452|NCT00408005|21175034|P1|Induction|Physician Decision|83
6147453|NCT00408005|21175027|P8|Induction|Death|0
6147454|NCT00408005|21175028|P7|Induction|Death|0
6147455|NCT00408005|21175029|P6|Induction|Death|0
6147456|NCT00408005|21175030|P5|Induction|Death|0
6147457|NCT00408005|21175031|P4|Induction|Death|0
6147458|NCT00408005|21175032|P3|Induction|Death|0
6147459|NCT00408005|21175033|P2|Induction|Death|0
6147460|NCT00408005|21175034|P1|Induction|Death|6
6147461|NCT00408005|21175027|P8|Induction|Adverse Event|0
6147462|NCT00408005|21175028|P7|Induction|Adverse Event|0
6147463|NCT00408005|21175029|P6|Induction|Adverse Event|0
6147464|NCT00408005|21175030|P5|Induction|Adverse Event|0
6147465|NCT00408005|21175031|P4|Induction|Adverse Event|0
6147466|NCT00408005|21175032|P3|Induction|Adverse Event|0
6147467|NCT00408005|21175033|P2|Induction|Adverse Event|3
6147468|NCT00408005|21175034|P1|Induction|Adverse Event|19
6147469|NCT00407511|21175064|P1|Overall Study|Withdrawal by Subject|4
6147470|NCT00407511|21175064|P1|Overall Study|Other|5
6147471|NCT00407511|21175064|P1|Overall Study|Lost to Follow-up|4
6147472|NCT00407511|21175064|P1|Overall Study|Adverse Event|9
6147473|NCT00394901|21175082|P4|Double-blind Phase|Found not to meet entrance criteria|1
6147474|NCT00394901|21175083|P3|Double-blind Phase|Found not to meet entrance criteria|0
6147475|NCT00394901|21175084|P2|Double-blind Phase|Found not to meet entrance criteria|0
6147476|NCT00394901|21175085|P1|Double-blind Phase|Found not to meet entrance criteria|0
6147477|NCT00394901|21175082|P4|Double-blind Phase|Entry into another study was found|0
6147478|NCT00394901|21175083|P3|Double-blind Phase|Entry into another study was found|1
6147479|NCT00394901|21175084|P2|Double-blind Phase|Entry into another study was found|0
6147480|NCT00394901|21175085|P1|Double-blind Phase|Entry into another study was found|0
6147481|NCT00394901|21175082|P4|Double-blind Phase|Lack of Compliance|0
6147482|NCT00394901|21175083|P3|Double-blind Phase|Lack of Compliance|0
6147483|NCT00394901|21175084|P2|Double-blind Phase|Lack of Compliance|3
6147484|NCT00394901|21175085|P1|Double-blind Phase|Lack of Compliance|0
6147485|NCT00394901|21175082|P4|Double-blind Phase|Subject's Personal Reason|1
6147486|NCT00394901|21175083|P3|Double-blind Phase|Subject's Personal Reason|0
6147487|NCT00394901|21175084|P2|Double-blind Phase|Subject's Personal Reason|0
6147488|NCT00394901|21175085|P1|Double-blind Phase|Subject's Personal Reason|1
6147489|NCT00394901|21175082|P4|Double-blind Phase|Death|0
6147490|NCT00394901|21175083|P3|Double-blind Phase|Death|0
6147491|NCT00394901|21175084|P2|Double-blind Phase|Death|0
6147492|NCT00394901|21175085|P1|Double-blind Phase|Death|1
6147493|NCT00394901|21175082|P4|Double-blind Phase|Protocol Violation|1
6147494|NCT00394901|21175083|P3|Double-blind Phase|Protocol Violation|0
6147495|NCT00394901|21175084|P2|Double-blind Phase|Protocol Violation|0
6147496|NCT00394901|21175085|P1|Double-blind Phase|Protocol Violation|0
6147497|NCT00394901|21175082|P4|Double-blind Phase|Lost to Follow-up|1
6147498|NCT00394901|21175083|P3|Double-blind Phase|Lost to Follow-up|0
6147499|NCT00394901|21175084|P2|Double-blind Phase|Lost to Follow-up|0
6147500|NCT00394901|21175085|P1|Double-blind Phase|Lost to Follow-up|0
6147501|NCT00394901|21175082|P4|Double-blind Phase|Withdrawal by Subject|0
6147502|NCT00394901|21175083|P3|Double-blind Phase|Withdrawal by Subject|0
6147503|NCT00394901|21175084|P2|Double-blind Phase|Withdrawal by Subject|0
6147504|NCT00394901|21175085|P1|Double-blind Phase|Withdrawal by Subject|2
6147505|NCT00394901|21175082|P4|Double-blind Phase|Lack of Efficacy|3
6147506|NCT00394901|21175083|P3|Double-blind Phase|Lack of Efficacy|1
6147507|NCT00394901|21175084|P2|Double-blind Phase|Lack of Efficacy|4
6147508|NCT00394901|21175085|P1|Double-blind Phase|Lack of Efficacy|6
6147509|NCT00394901|21175082|P4|Double-blind Phase|Adverse Event|20
6147510|NCT00394901|21175083|P3|Double-blind Phase|Adverse Event|16
6147511|NCT00394901|21175084|P2|Double-blind Phase|Adverse Event|7
6147512|NCT00394901|21175085|P1|Double-blind Phase|Adverse Event|5
6147513|NCT00394901|21175082|P4|Baseline Phase|Protocol Violation|0
6147514|NCT00394901|21175083|P3|Baseline Phase|Protocol Violation|1
6147515|NCT00394901|21175084|P2|Baseline Phase|Protocol Violation|0
6147516|NCT00394901|21175085|P1|Baseline Phase|Protocol Violation|0
6147525|NCT00368745|21175331|P2|Double-blind Treatment Period|Other|6
6147526|NCT00368745|21175332|P1|Double-blind Treatment Period|Other|7
6147527|NCT00368745|21175331|P2|Double-blind Treatment Period|Withdrawal by Subject|3
6147528|NCT00368745|21175332|P1|Double-blind Treatment Period|Withdrawal by Subject|5
6147529|NCT00368745|21175331|P2|Double-blind Treatment Period|Lost to Follow-up|0
6147530|NCT00368745|21175332|P1|Double-blind Treatment Period|Lost to Follow-up|1
6147531|NCT00368745|21175331|P2|Double-blind Treatment Period|Lack of Efficacy|16
6147532|NCT00368745|21175332|P1|Double-blind Treatment Period|Lack of Efficacy|7
6147533|NCT00368745|21175331|P2|Double-blind Treatment Period|Adverse Event|6
6147534|NCT00368745|21175332|P1|Double-blind Treatment Period|Adverse Event|6
6147535|NCT00350298|21175419|P2|Overall Study|Withdrawal by Subject|3
6147536|NCT00350298|21175420|P1|Overall Study|Withdrawal by Subject|1
6147537|NCT00350298|21175419|P2|Overall Study|Lost to Follow-up|2
6147538|NCT00350298|21175420|P1|Overall Study|Lost to Follow-up|1
6147539|NCT00350298|21175419|P2|Overall Study|Death|8
6147540|NCT00350298|21175420|P1|Overall Study|Death|7
6147565|NCT00313820|21175524|P2|Pregabalin or Placebo Treatment Period|Other|3
6147566|NCT00313820|21175525|P1|Pregabalin or Placebo Treatment Period|Other|2
6147567|NCT00313820|21175524|P2|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|4
6147568|NCT00313820|21175525|P1|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|6
6147569|NCT00313820|21175524|P2|Pregabalin or Placebo Treatment Period|Lost to Follow-up|7
6147570|NCT00313820|21175525|P1|Pregabalin or Placebo Treatment Period|Lost to Follow-up|0
6147571|NCT00313820|21175524|P2|Pregabalin or Placebo Treatment Period|Lack of Efficacy|1
6147572|NCT00313820|21175525|P1|Pregabalin or Placebo Treatment Period|Lack of Efficacy|0
6147573|NCT00313820|21175524|P2|Pregabalin or Placebo Treatment Period|Adverse Event|4
6147574|NCT00313820|21175525|P1|Pregabalin or Placebo Treatment Period|Adverse Event|9
6147575|NCT00313820|21175524|P2|Assigned to Treatment|Other|0
6147576|NCT00313820|21175525|P1|Assigned to Treatment|Other|1
6147577|NCT00292188|21175724|P3|Double-Blind|Laboratory Abnormality|1
6147578|NCT00292188|21175725|P2|Double-Blind|Laboratory Abnormality|0
6147579|NCT00292188|21175726|P1|Double-Blind|Laboratory Abnormality|0
6147580|NCT00292188|21175724|P3|Double-Blind|Withdrawal by Subject|3
6147581|NCT00292188|21175725|P2|Double-Blind|Withdrawal by Subject|0
6147582|NCT00292188|21175726|P1|Double-Blind|Withdrawal by Subject|0
6147583|NCT00292188|21175724|P3|Double-Blind|Other|4
6147584|NCT00292188|21175725|P2|Double-Blind|Other|3
6147585|NCT00292188|21175726|P1|Double-Blind|Other|0
6147586|NCT00292188|21175724|P3|Double-Blind|Lost to Follow-up|0
6147587|NCT00292188|21175725|P2|Double-Blind|Lost to Follow-up|1
6147588|NCT00292188|21175726|P1|Double-Blind|Lost to Follow-up|0
6147589|NCT00292188|21175724|P3|Double-Blind|Lack of Efficacy|12
6147590|NCT00292188|21175725|P2|Double-Blind|Lack of Efficacy|2
6147591|NCT00292188|21175726|P1|Double-Blind|Lack of Efficacy|0
6147592|NCT00292188|21175724|P3|Double-Blind|Adverse Event|9
6147593|NCT00292188|21175725|P2|Double-Blind|Adverse Event|25
6147594|NCT00292188|21175726|P1|Double-Blind|Adverse Event|0
6147595|NCT00292188|21175724|P3|Single-Blind|Did not receive treatment|0
6147596|NCT00292188|21175725|P2|Single-Blind|Did not receive treatment|0
6147597|NCT00292188|21175726|P1|Single-Blind|Did not receive treatment|1
6147598|NCT00292188|21175724|P3|Single-Blind|Withdrawal by Subject|0
6147599|NCT00292188|21175725|P2|Single-Blind|Withdrawal by Subject|0
6147600|NCT00292188|21175726|P1|Single-Blind|Withdrawal by Subject|12
6147601|NCT00292188|21175724|P3|Single-Blind|Other|0
6147602|NCT00292188|21175725|P2|Single-Blind|Other|0
6147603|NCT00292188|21175726|P1|Single-Blind|Other|77
6147604|NCT00292188|21175724|P3|Single-Blind|Lost to Follow-up|0
6147605|NCT00292188|21175725|P2|Single-Blind|Lost to Follow-up|0
6147606|NCT00292188|21175726|P1|Single-Blind|Lost to Follow-up|3
6147607|NCT00292188|21175724|P3|Single-Blind|Laboratory Abnormality|0
6147608|NCT00292188|21175725|P2|Single-Blind|Laboratory Abnormality|0
6147609|NCT00292188|21175726|P1|Single-Blind|Laboratory Abnormality|5
6147610|NCT00292188|21175724|P3|Single-Blind|Lack of Efficacy|0
6147611|NCT00292188|21175725|P2|Single-Blind|Lack of Efficacy|0
6147612|NCT00292188|21175726|P1|Single-Blind|Lack of Efficacy|2
6147613|NCT00292188|21175724|P3|Single-Blind|Adverse Event|0
6147614|NCT00292188|21175725|P2|Single-Blind|Adverse Event|0
6147615|NCT00292188|21175726|P1|Single-Blind|Adverse Event|14
6147616|NCT00232141|21175809|P2|Overall Study|Withdrawal by Subject|3
6147617|NCT00232141|21175810|P1|Overall Study|Withdrawal by Subject|5
6147618|NCT00232141|21175809|P2|Overall Study|Other|10
6147619|NCT00232141|21175810|P1|Overall Study|Other|8
6147620|NCT00232141|21175809|P2|Overall Study|Lost to Follow-up|6
6147621|NCT00232141|21175810|P1|Overall Study|Lost to Follow-up|9
6147622|NCT00232141|21175809|P2|Overall Study|Lack of Efficacy|3
6147623|NCT00232141|21175810|P1|Overall Study|Lack of Efficacy|0
6147624|NCT00232141|21175809|P2|Overall Study|Adverse Event|4
6147625|NCT00232141|21175810|P1|Overall Study|Adverse Event|9
6147641|NCT00141219|21176061|P2|Overall Study|Withdrawal by Subject|2
6147642|NCT00141219|21176062|P1|Overall Study|Withdrawal by Subject|6
6147643|NCT00141219|21176061|P2|Overall Study|Lack of Efficacy|4
6147644|NCT00141219|21176062|P1|Overall Study|Lack of Efficacy|5
6147645|NCT00141219|21176061|P2|Overall Study|Adverse Event|6
6147646|NCT00141219|21176062|P1|Overall Study|Adverse Event|8
6147647|NCT00141219|21176061|P2|Overall Study|Protocol violations|4
6147648|NCT00141219|21176062|P1|Overall Study|Protocol violations|5
6147663|NCT03616600|21176308|P2|Overall Study|Withdrawal by Subject|0
6147664|NCT03616600|21176309|P1|Overall Study|Withdrawal by Subject|1
6147682|NCT03338816|21176502|P2|Open-Label Extension Period|Ongoing in Study|47
6147683|NCT03338816|21176503|P1|Open-Label Extension Period|Ongoing in Study|46
6147684|NCT03338816|21176502|P2|6-Month Double-blind Period|Adverse Event|1
6147685|NCT03338816|21176503|P1|6-Month Double-blind Period|Adverse Event|0
6147691|NCT03280121|21176549|P1|Overall Study|screen failure - 3 hernia too small and 1 pH too low|4
6147692|NCT03280121|21176549|P1|Overall Study|Lost to Follow-up|1
6147693|NCT03280121|21176549|P1|Overall Study|Physician Decision|1
6147694|NCT03274466|21176557|P2|Overall Study|Protocol Violation|3
6147695|NCT03274466|21176558|P1|Overall Study|Protocol Violation|3
6147696|NCT03274466|21176557|P2|Overall Study|Physician Decision|1
6147697|NCT03274466|21176558|P1|Overall Study|Physician Decision|0
6147698|NCT03274466|21176557|P2|Overall Study|Adverse Event|3
6147699|NCT03274466|21176558|P1|Overall Study|Adverse Event|3
6147700|NCT03274466|21176557|P2|Overall Study|Subject Non-compliance|1
6147701|NCT03274466|21176558|P1|Overall Study|Subject Non-compliance|0
6147702|NCT03274466|21176557|P2|Overall Study|Lost to Follow-up|7
6147703|NCT03274466|21176558|P1|Overall Study|Lost to Follow-up|5
6147704|NCT03274466|21176557|P2|Overall Study|Protocol Specified Withdrawal|11
6147705|NCT03274466|21176558|P1|Overall Study|Protocol Specified Withdrawal|5
6147706|NCT03274466|21176557|P2|Overall Study|Withdrawal by Subject|3
6147707|NCT03274466|21176558|P1|Overall Study|Withdrawal by Subject|7
6147748|NCT03057496|21176784|P1|Overall Study|Device failure|2
6147749|NCT03057496|21176784|P1|Overall Study|Did not use device during home trial|3
6147750|NCT03057496|21176784|P1|Overall Study|Lost to Follow-up|5
6147751|NCT03057496|21176784|P1|Overall Study|Withdrawal by Subject|8
6147752|NCT02981524|21176792|P1|Overall Study|Withdrawal by Subject|1
6147753|NCT02981524|21176792|P1|Overall Study|Treatment Related Toxicity|1
6147754|NCT02981524|21176792|P1|Overall Study|Death (unrelated)|1
6147755|NCT02981524|21176792|P1|Overall Study|Progressive Disease|14
6147756|NCT02949219|21176895|P1|Overall Study|Withdrawal by Subject|1
6147757|NCT02940574|21176904|P2|1-year Follow-up|Lost to Follow-up|4
6147758|NCT02940574|21176905|P1|1-year Follow-up|Lost to Follow-up|3
6147759|NCT02940574|21176904|P2|From Study Start to 1-month Follow-up|Withdrawal by Subject|0
6147760|NCT02940574|21176905|P1|From Study Start to 1-month Follow-up|Withdrawal by Subject|1
6147767|NCT02890355|21177045|P2|Overall Study|Not protocol specified|4
6147768|NCT02890355|21177046|P1|Overall Study|Not protocol specified|3
6147769|NCT02890355|21177045|P2|Overall Study|Progression/relapse|39
6147770|NCT02890355|21177046|P1|Overall Study|Progression/relapse|46
6147771|NCT02890355|21177045|P2|Overall Study|Refusal unrelated to adverse event|10
6147772|NCT02890355|21177046|P1|Overall Study|Refusal unrelated to adverse event|5
6147773|NCT02890355|21177045|P2|Overall Study|Adverse Event|5
6147774|NCT02890355|21177046|P1|Overall Study|Adverse Event|5
6147943|NCT02454933|21177562|P2|Overall Study|Withdrawal by Subject|2
6147944|NCT02454933|21177563|P1|Overall Study|Withdrawal by Subject|0
6147945|NCT02454933|21177562|P2|Overall Study|Adverse Event|1
6147946|NCT02454933|21177563|P1|Overall Study|Adverse Event|1
6147947|NCT02454933|21177562|P2|Overall Study|Progressive disease|5
6147948|NCT02454933|21177563|P1|Overall Study|Progressive disease|7
6147990|NCT02369874|21177853|P3|Overall Study|On Treatment/Off Study|32
6147991|NCT02369874|21177854|P2|Overall Study|On Treatment/Off Study|45
6147992|NCT02369874|21177855|P1|Overall Study|On Treatment/Off Study|34
6147993|NCT02369874|21177853|P3|Overall Study|Miscellaneous|0
6147994|NCT02369874|21177854|P2|Overall Study|Miscellaneous|1
6147995|NCT02369874|21177855|P1|Overall Study|Miscellaneous|1
6147996|NCT02369874|21177853|P3|Overall Study|Withdrawal by Subject|27
6147997|NCT02369874|21177854|P2|Overall Study|Withdrawal by Subject|9
6147998|NCT02369874|21177855|P1|Overall Study|Withdrawal by Subject|7
6147999|NCT02369874|21177853|P3|Overall Study|Lost to Follow-up|2
6148000|NCT02369874|21177854|P2|Overall Study|Lost to Follow-up|2
6148001|NCT02369874|21177855|P1|Overall Study|Lost to Follow-up|2
6148039|NCT02232061|21178078|P1|Overall Study|Withdrawal by Subject|1
6148040|NCT02232061|21178078|P1|Overall Study|Administrative problems|1
6148041|NCT02200614|21178117|P2|Open Label|Protocol deviation|1
6148042|NCT02200614|21178118|P1|Open Label|Protocol deviation|1
6148043|NCT02200614|21178117|P2|Open Label|Personal reason|3
6148044|NCT02200614|21178118|P1|Open Label|Personal reason|29
6148045|NCT02200614|21178117|P2|Open Label|Other reason|1
6148046|NCT02200614|21178118|P1|Open Label|Other reason|6
6148047|NCT02200614|21178117|P2|Open Label|Metastasis by local reading|10
6148048|NCT02200614|21178118|P1|Open Label|Metastasis by local reading|58
6148049|NCT02200614|21178117|P2|Open Label|Judgment of the investigator|0
6148050|NCT02200614|21178118|P1|Open Label|Judgment of the investigator|15
6148051|NCT02200614|21178117|P2|Open Label|Confirmed metastasis|0
6148052|NCT02200614|21178118|P1|Open Label|Confirmed metastasis|1
6148053|NCT02200614|21178117|P2|Open Label|Adverse Event|8
6148054|NCT02200614|21178118|P1|Open Label|Adverse Event|15
6148055|NCT02200614|21178117|P2|Double Blind Treatment|Not treated|0
6148056|NCT02200614|21178118|P1|Double Blind Treatment|Not treated|1
6148057|NCT02200614|21178117|P2|Double Blind Treatment|Protocol deviation|7
6148058|NCT02200614|21178118|P1|Double Blind Treatment|Protocol deviation|14
6148059|NCT02200614|21178117|P2|Double Blind Treatment|Personal reason|85
6148060|NCT02200614|21178118|P1|Double Blind Treatment|Personal reason|77
6148061|NCT02200614|21178117|P2|Double Blind Treatment|Other reason|2
6148062|NCT02200614|21178118|P1|Double Blind Treatment|Other reason|6
6148063|NCT02200614|21178117|P2|Double Blind Treatment|Metastasis by local reading|3
6148064|NCT02200614|21178118|P1|Double Blind Treatment|Metastasis by local reading|1
6148065|NCT02200614|21178117|P2|Double Blind Treatment|Judgment of the investigator|99
6148066|NCT02200614|21178118|P1|Double Blind Treatment|Judgment of the investigator|60
6148067|NCT02200614|21178117|P2|Double Blind Treatment|Confirmed metastasis|140
6148068|NCT02200614|21178118|P1|Double Blind Treatment|Confirmed metastasis|119
6148069|NCT02200614|21178117|P2|Double Blind Treatment|Adverse Event|48
6148070|NCT02200614|21178118|P1|Double Blind Treatment|Adverse Event|86
6148083|NCT02152345|21178215|P2|Overall Study|Withdrawal by Subject|1
6148084|NCT02152345|21178216|P1|Overall Study|Withdrawal by Subject|2
6148085|NCT02152345|21178215|P2|Overall Study|Case Cancellations|4
6148086|NCT02152345|21178216|P1|Overall Study|Case Cancellations|2
6148195|NCT01920152|21178386|P2|Overall Study|Withdrawal by Subject|2
6148196|NCT01920152|21178387|P1|Overall Study|Withdrawal by Subject|1
6148199|NCT01887600|21178450|P2|Overall Study|Progressive Disease|0
6148200|NCT01887600|21178451|P1|Overall Study|Progressive Disease|1
6148201|NCT01887600|21178450|P2|Overall Study|Miscellaneous|2
6148202|NCT01887600|21178451|P1|Overall Study|Miscellaneous|6
6148203|NCT01887600|21178450|P2|Overall Study|Non-compliance with study drug|0
6148204|NCT01887600|21178451|P1|Overall Study|Non-compliance with study drug|3
6148205|NCT01887600|21178450|P2|Overall Study|Adverse Event|9
6148206|NCT01887600|21178451|P1|Overall Study|Adverse Event|21
6148207|NCT01887600|21178450|P2|Overall Study|Withdrawal by Subject|52
6148208|NCT01887600|21178451|P1|Overall Study|Withdrawal by Subject|58
6148209|NCT01887600|21178450|P2|Overall Study|Protocol Deviation|0
6148210|NCT01887600|21178451|P1|Overall Study|Protocol Deviation|3
6148211|NCT01887600|21178450|P2|Overall Study|Physician Decision|8
6148212|NCT01887600|21178451|P1|Overall Study|Physician Decision|7
6148213|NCT01887600|21178450|P2|Overall Study|Lost to Follow-up|1
6148214|NCT01887600|21178451|P1|Overall Study|Lost to Follow-up|5
6148215|NCT01887600|21178450|P2|Overall Study|Lack of Efficacy|26
6148216|NCT01887600|21178451|P1|Overall Study|Lack of Efficacy|3
6148217|NCT01887600|21178450|P2|Overall Study|Death|16
6148218|NCT01887600|21178451|P1|Overall Study|Death|39
6148229|NCT01843374|21178610|P2|Overall Study|Withdrawing due to Other reason|46
6148230|NCT01843374|21178611|P1|Overall Study|Withdrawing due to Other reason|20
6148231|NCT01843374|21178610|P2|Overall Study|Withdrawal by Subject|20
6148232|NCT01843374|21178611|P1|Overall Study|Withdrawal by Subject|14
6148233|NCT01843374|21178610|P2|Overall Study|Death|313
6148234|NCT01843374|21178611|P1|Overall Study|Death|155
6148246|NCT01804816|21178676|P1|Acupuncture (Second 5 Weeks)|Physician Decision|1
6148247|NCT01804816|21178676|P1|No Acupuncture (Initial 5 Weeks)|Withdrawal by Subject|3
6148266|NCT01708954|21178754|P3|Step 2|Withdrawal by Subject|0
6148267|NCT01708954|21178755|P2|Step 2|Withdrawal by Subject|1
6148268|NCT01708954|21178756|P1|Step 2|Withdrawal by Subject|1
6148269|NCT01708954|21178754|P3|Step 2|Adverse Event|0
6148270|NCT01708954|21178755|P2|Step 2|Adverse Event|2
6148271|NCT01708954|21178756|P1|Step 2|Adverse Event|3
6148272|NCT01708954|21178754|P3|Step 2|Disease progression|0
6148273|NCT01708954|21178755|P2|Step 2|Disease progression|4
6148274|NCT01708954|21178756|P1|Step 2|Disease progression|9
6148275|NCT01708954|21178754|P3|Step 1|Ineligible or never received treatment|8
6148276|NCT01708954|21178755|P2|Step 1|Ineligible or never received treatment|2
6148277|NCT01708954|21178756|P1|Step 1|Ineligible or never received treatment|4
6148278|NCT01708954|21178754|P3|Step 1|Off-treatment reason not submitted|1
6148279|NCT01708954|21178755|P2|Step 1|Off-treatment reason not submitted|1
6148280|NCT01708954|21178756|P1|Step 1|Off-treatment reason not submitted|1
6148281|NCT01708954|21178754|P3|Step 1|Symptomatic deterioration|1
6148282|NCT01708954|21178755|P2|Step 1|Symptomatic deterioration|0
6148283|NCT01708954|21178756|P1|Step 1|Symptomatic deterioration|1
6148284|NCT01708954|21178754|P3|Step 1|Crossed over to Step 2|0
6148285|NCT01708954|21178755|P2|Step 1|Crossed over to Step 2|0
6148286|NCT01708954|21178756|P1|Step 1|Crossed over to Step 2|2
6148287|NCT01708954|21178754|P3|Step 1|Other complicating disease|0
6148288|NCT01708954|21178755|P2|Step 1|Other complicating disease|2
6148289|NCT01708954|21178756|P1|Step 1|Other complicating disease|0
6148290|NCT01708954|21178754|P3|Step 1|Withdrawal by Subject|3
6148291|NCT01708954|21178755|P2|Step 1|Withdrawal by Subject|5
6148292|NCT01708954|21178756|P1|Step 1|Withdrawal by Subject|2
6148293|NCT01708954|21178754|P3|Step 1|Death|3
6148294|NCT01708954|21178755|P2|Step 1|Death|2
6148295|NCT01708954|21178756|P1|Step 1|Death|3
6148296|NCT01708954|21178754|P3|Step 1|Adverse Event|13
6148297|NCT01708954|21178755|P2|Step 1|Adverse Event|11
6148298|NCT01708954|21178756|P1|Step 1|Adverse Event|3
6148299|NCT01708954|21178754|P3|Step 1|Disease progression|14
6148300|NCT01708954|21178755|P2|Step 1|Disease progression|17
6148301|NCT01708954|21178756|P1|Step 1|Disease progression|26
6148378|NCT01619085|21178898|P1|Overall Study|Ongoing on trial|27
6148379|NCT01619085|21178898|P1|Overall Study|Not treated|1
6148380|NCT01619085|21178898|P1|Overall Study|Other than specified|94
6148381|NCT01619085|21178898|P1|Overall Study|Withdrawal by Subject|15
6148382|NCT01619085|21178898|P1|Overall Study|Lost to Follow-up|10
6148383|NCT01619085|21178898|P1|Overall Study|Protocol Violation|10
6148384|NCT01619085|21178898|P1|Overall Study|Adverse Event|212
6148425|NCT01297959|21179096|P2|Overall Study|Other|7
6148426|NCT01297959|21179097|P1|Overall Study|Other|13
6148427|NCT01297959|21179096|P2|Overall Study|Unrelated medical illness / complication|2
6148428|NCT01297959|21179097|P1|Overall Study|Unrelated medical illness / complication|0
6148429|NCT01297959|21179096|P2|Overall Study|Physician Decision|1
6148430|NCT01297959|21179097|P1|Overall Study|Physician Decision|0
6148431|NCT01297959|21179096|P2|Overall Study|Withdrawal by Subject|4
6148432|NCT01297959|21179097|P1|Overall Study|Withdrawal by Subject|5
6148433|NCT01297959|21179096|P2|Overall Study|Protocol Violation|1
6148434|NCT01297959|21179097|P1|Overall Study|Protocol Violation|2
6148435|NCT01297959|21179096|P2|Overall Study|Adverse Event|1
6148436|NCT01297959|21179097|P1|Overall Study|Adverse Event|0
6148443|NCT01251861|21179180|P2|Overall Study|Potential interaction of drugs|1
6148444|NCT01251861|21179181|P1|Overall Study|Potential interaction of drugs|0
6148445|NCT01251861|21179180|P2|Overall Study|Never started therapy|1
6148446|NCT01251861|21179181|P1|Overall Study|Never started therapy|4
6148447|NCT01251861|21179180|P2|Overall Study|Other|0
6148448|NCT01251861|21179181|P1|Overall Study|Other|1
6148449|NCT01251861|21179180|P2|Overall Study|Continued treatment beyond 18 cycles|0
6148450|NCT01251861|21179181|P1|Overall Study|Continued treatment beyond 18 cycles|1
6148451|NCT01251861|21179180|P2|Overall Study|Physician Decision|0
6148452|NCT01251861|21179181|P1|Overall Study|Physician Decision|1
6148453|NCT01251861|21179180|P2|Overall Study|Other complicating disease|1
6148454|NCT01251861|21179181|P1|Overall Study|Other complicating disease|0
6148455|NCT01251861|21179180|P2|Overall Study|Alternative therapy|0
6148456|NCT01251861|21179181|P1|Overall Study|Alternative therapy|1
6148457|NCT01251861|21179180|P2|Overall Study|Withdrawal by Subject|2
6148458|NCT01251861|21179181|P1|Overall Study|Withdrawal by Subject|2
6148459|NCT01251861|21179180|P2|Overall Study|Adverse Event|17
6148460|NCT01251861|21179181|P1|Overall Study|Adverse Event|2
6148461|NCT01251861|21179180|P2|Overall Study|Disease progression|6
6148462|NCT01251861|21179181|P1|Overall Study|Disease progression|6
6148464|NCT01165177|21179351|P2|Overall Study|Migrated/ moved from study area|43
6148465|NCT01165177|21179352|P1|Overall Study|Migrated/ moved from study area|48
6148466|NCT01165177|21179351|P2|Overall Study|Lost to Follow-up|194
6148467|NCT01165177|21179352|P1|Overall Study|Lost to Follow-up|183
6148468|NCT01165177|21179351|P2|Overall Study|Suspected HZ episode|2
6148469|NCT01165177|21179352|P1|Overall Study|Suspected HZ episode|0
6148470|NCT01165177|21179351|P2|Overall Study|Other unspecified reasons|35
6148471|NCT01165177|21179352|P1|Overall Study|Other unspecified reasons|47
6148472|NCT01165177|21179351|P2|Overall Study|Non-serious adverse event|18
6148473|NCT01165177|21179352|P1|Overall Study|Non-serious adverse event|30
6148474|NCT01165177|21179351|P2|Overall Study|Protocol Violation|21
6148475|NCT01165177|21179352|P1|Overall Study|Protocol Violation|19
6148476|NCT01165177|21179351|P2|Overall Study|Withdrawal by Subject|354
6148477|NCT01165177|21179352|P1|Overall Study|Withdrawal by Subject|368
6148478|NCT01165177|21179351|P2|Overall Study|Serious Adverse Event|235
6148479|NCT01165177|21179352|P1|Overall Study|Serious Adverse Event|227
6148480|NCT01142388|21179480|P2|Overall Study|Never started therapy|3
6148481|NCT01142388|21179481|P1|Overall Study|Never started therapy|7
6148482|NCT01142388|21179480|P2|Overall Study|Other|1
6148483|NCT01142388|21179481|P1|Overall Study|Other|1
6148484|NCT01142388|21179480|P2|Overall Study|Other complications|2
6148485|NCT01142388|21179481|P1|Overall Study|Other complications|0
6148486|NCT01142388|21179480|P2|Overall Study|Alternative therapy|0
6148487|NCT01142388|21179481|P1|Overall Study|Alternative therapy|1
6148488|NCT01142388|21179480|P2|Overall Study|Withdrawal by Subject|3
6148489|NCT01142388|21179481|P1|Overall Study|Withdrawal by Subject|5
6148490|NCT01142388|21179480|P2|Overall Study|Death|2
6148491|NCT01142388|21179481|P1|Overall Study|Death|3
6148492|NCT01142388|21179480|P2|Overall Study|Adverse Event|5
6148493|NCT01142388|21179481|P1|Overall Study|Adverse Event|9
6148494|NCT01142388|21179480|P2|Overall Study|Lack of Efficacy|31
6148495|NCT01142388|21179481|P1|Overall Study|Lack of Efficacy|21
6148518|NCT00951496|21179600|P3|Overall Study|Did not initiate study treatment|13
6148519|NCT00951496|21179601|P2|Overall Study|Did not initiate study treatment|8
6148520|NCT00951496|21179602|P1|Overall Study|Did not initiate study treatment|10
6148555|NCT00928564|21179684|P2|Overall Study|Lost to Follow-up|0
6148556|NCT00928564|21179685|P1|Overall Study|Lost to Follow-up|6
6148561|NCT00843284|21179704|P1|Overall Study|Death|3
6148562|NCT00843284|21179704|P1|Overall Study|Withdrawal by Subject|4
6148563|NCT00843284|21179704|P1|Overall Study|Other|10
6148564|NCT00843284|21179704|P1|Overall Study|Lost to Follow-up|11
6148565|NCT00843284|21179704|P1|Overall Study|Lack of Efficacy|5
6148566|NCT00843284|21179704|P1|Overall Study|Adverse Event|39
6148572|NCT00684424|21179750|P1|Overall Study|Other|2
6148573|NCT00684424|21179750|P1|Overall Study|Lost to Follow-up|2
6148574|NCT00684424|21179750|P1|Overall Study|Adverse Event|1
6148575|NCT00676403|21179771|P6|Overall Study|Withdrawal by Subject|1
6148576|NCT00676403|21179772|P5|Overall Study|Withdrawal by Subject|0
6148577|NCT00676403|21179773|P4|Overall Study|Withdrawal by Subject|0
6148578|NCT00676403|21179774|P3|Overall Study|Withdrawal by Subject|0
6148579|NCT00676403|21179775|P2|Overall Study|Withdrawal by Subject|0
6148580|NCT00676403|21179776|P1|Overall Study|Withdrawal by Subject|0
6148581|NCT00676403|21179771|P6|Overall Study|Reason Unspecified|1
6148582|NCT00676403|21179772|P5|Overall Study|Reason Unspecified|0
6148583|NCT00676403|21179773|P4|Overall Study|Reason Unspecified|0
6148584|NCT00676403|21179774|P3|Overall Study|Reason Unspecified|1
6148585|NCT00676403|21179775|P2|Overall Study|Reason Unspecified|0
6148586|NCT00676403|21179776|P1|Overall Study|Reason Unspecified|1
6148587|NCT00676403|21179771|P6|Overall Study|Lost to Follow-up|1
6148588|NCT00676403|21179772|P5|Overall Study|Lost to Follow-up|0
6148589|NCT00676403|21179773|P4|Overall Study|Lost to Follow-up|0
6148590|NCT00676403|21179774|P3|Overall Study|Lost to Follow-up|0
6148591|NCT00676403|21179775|P2|Overall Study|Lost to Follow-up|0
6148592|NCT00676403|21179776|P1|Overall Study|Lost to Follow-up|0
6148593|NCT00676403|21179771|P6|Overall Study|Adverse Event|2
6148594|NCT00676403|21179772|P5|Overall Study|Adverse Event|1
6148595|NCT00676403|21179773|P4|Overall Study|Adverse Event|5
6148596|NCT00676403|21179774|P3|Overall Study|Adverse Event|0
6148597|NCT00676403|21179775|P2|Overall Study|Adverse Event|2
6148598|NCT00676403|21179776|P1|Overall Study|Adverse Event|1
6148622|NCT00494234|21179963|P2|Overall Study|Death|1
6148623|NCT00494234|21179964|P1|Overall Study|Death|2
6148624|NCT00494234|21179963|P2|Overall Study|Withdrawal by Subject|0
6148625|NCT00494234|21179964|P1|Overall Study|Withdrawal by Subject|1
6148626|NCT00494234|21179963|P2|Overall Study|Lack of Efficacy|9
6148627|NCT00494234|21179964|P1|Overall Study|Lack of Efficacy|12
6148628|NCT00468845|21179983|P3|Overall Study|Randomized, not treated|2
6148629|NCT00468845|21179984|P2|Overall Study|Randomized, not treated|4
6148630|NCT00468845|21179985|P1|Overall Study|Randomized, not treated|1
6148631|NCT00468845|21179983|P3|Overall Study|No longer willing to participate|10
6148632|NCT00468845|21179984|P2|Overall Study|No longer willing to participate|6
6148633|NCT00468845|21179985|P1|Overall Study|No longer willing to participate|5
6148634|NCT00468845|21179983|P3|Overall Study|Other|5
6148635|NCT00468845|21179984|P2|Overall Study|Other|9
6148636|NCT00468845|21179985|P1|Overall Study|Other|4
6148637|NCT00468845|21179983|P3|Overall Study|Lost to Follow-up|2
6148638|NCT00468845|21179984|P2|Overall Study|Lost to Follow-up|1
6148639|NCT00468845|21179985|P1|Overall Study|Lost to Follow-up|2
6148640|NCT00468845|21179983|P3|Overall Study|Adverse Event|11
6148641|NCT00468845|21179984|P2|Overall Study|Adverse Event|14
6148642|NCT00468845|21179985|P1|Overall Study|Adverse Event|9
6148689|NCT00413010|21180481|P2|Overall Study|Due to termination of the study|52
6148690|NCT00413010|21180482|P1|Overall Study|Due to termination of the study|54
6148691|NCT00413010|21180481|P2|Overall Study|Withdrawal by Subject|2
6148692|NCT00413010|21180482|P1|Overall Study|Withdrawal by Subject|7
6148693|NCT00413010|21180481|P2|Overall Study|Lost to Follow-up|0
6148694|NCT00413010|21180482|P1|Overall Study|Lost to Follow-up|3
6148695|NCT00413010|21180481|P2|Overall Study|Lack of Efficacy|3
6148696|NCT00413010|21180482|P1|Overall Study|Lack of Efficacy|0
6148697|NCT00413010|21180481|P2|Overall Study|Laboratory abnormality|2
6148698|NCT00413010|21180482|P1|Overall Study|Laboratory abnormality|0
6148699|NCT00413010|21180481|P2|Overall Study|Adverse Event|4
6148700|NCT00413010|21180482|P1|Overall Study|Adverse Event|8
6148752|NCT00119106|21181079|P2|Overall Study|HIV infected at baseline|178
6148753|NCT00119106|21181080|P1|Overall Study|HIV infected at baseline|179
6149493|NCT04438785|21184383|P2|Overall Study|change of weight, give up intervention|10
6149494|NCT04438785|21184384|P1|Overall Study|change of weight, give up intervention|2
6149505|NCT04060654|21184495|P1|Overall Study|Lost to Follow-up|5
6149506|NCT04060654|21184495|P1|Overall Study|Withdrawal by Subject|1
6149507|NCT03970395|21184501|P2|Overall Study|Lost to Follow-up|8
6149508|NCT03970395|21184502|P1|Overall Study|Lost to Follow-up|4
6149509|NCT03970395|21184501|P2|Overall Study|Withdrawal by Subject|4
6149510|NCT03970395|21184502|P1|Overall Study|Withdrawal by Subject|3
6149511|NCT03836677|21184545|P2|Period 2|Severe non-compliance to protocol|0
6149512|NCT03836677|21184546|P1|Period 2|Severe non-compliance to protocol|1
6149513|NCT03836677|21184545|P2|Period 1|Adverse Event|1
6149514|NCT03836677|21184546|P1|Period 1|Adverse Event|0
6149515|NCT03522948|21184630|P1|Overall Study|Lost to Follow-up|1
6149516|NCT03515824|21184641|P4|Overall Study|Status not recorded|0
6149517|NCT03515824|21184642|P3|Overall Study|Status not recorded|2
6149518|NCT03515824|21184643|P2|Overall Study|Status not recorded|0
6149519|NCT03515824|21184644|P1|Overall Study|Status not recorded|0
6149520|NCT03515824|21184641|P4|Overall Study|Study terminated by sponsor|0
6149521|NCT03515824|21184642|P3|Overall Study|Study terminated by sponsor|6
6149522|NCT03515824|21184643|P2|Overall Study|Study terminated by sponsor|1
6149523|NCT03515824|21184644|P1|Overall Study|Study terminated by sponsor|0
6149524|NCT03515824|21184641|P4|Overall Study|Lost to Follow-up|0
6149525|NCT03515824|21184642|P3|Overall Study|Lost to Follow-up|1
6149526|NCT03515824|21184643|P2|Overall Study|Lost to Follow-up|1
6149527|NCT03515824|21184644|P1|Overall Study|Lost to Follow-up|0
6149528|NCT03515824|21184641|P4|Overall Study|Death|0
6149529|NCT03515824|21184642|P3|Overall Study|Death|6
6149530|NCT03515824|21184643|P2|Overall Study|Death|2
6149531|NCT03515824|21184644|P1|Overall Study|Death|3
6149533|NCT03312218|21184729|P2|Overall Study|Never signed in to access the app|58
6149534|NCT03312218|21184730|P1|Overall Study|Never signed in to access the app|54
6149535|NCT03293485|21184736|P1|Overall Study|Withdrawal by Subject|2
6149536|NCT03293485|21184736|P1|Overall Study|Screen Failure|2
6149537|NCT03293485|21184736|P1|Overall Study|Death|1
6149538|NCT03273153|21184747|P2|Overall Study|Other|1
6149539|NCT03273153|21184748|P1|Overall Study|Other|0
6149540|NCT03273153|21184747|P2|Overall Study|Symptomatic Deterioration|1
6149541|NCT03273153|21184748|P1|Overall Study|Symptomatic Deterioration|0
6149542|NCT03273153|21184747|P2|Overall Study|Withdrawal by Subject|13
6149543|NCT03273153|21184748|P1|Overall Study|Withdrawal by Subject|16
6149544|NCT03273153|21184747|P2|Overall Study|Protocol Violation|0
6149545|NCT03273153|21184748|P1|Overall Study|Protocol Violation|3
6149546|NCT03273153|21184747|P2|Overall Study|Lost to Follow-up|3
6149547|NCT03273153|21184748|P1|Overall Study|Lost to Follow-up|3
6149548|NCT03273153|21184747|P2|Overall Study|Death|45
6149549|NCT03273153|21184748|P1|Overall Study|Death|41
6149550|NCT03273153|21184747|P2|Overall Study|Remain on Study|159
6149551|NCT03273153|21184748|P1|Overall Study|Remain on Study|161
6149552|NCT03248037|21184770|P2|Overall Study|Adverse Event|0
6149553|NCT03248037|21184771|P1|Overall Study|Adverse Event|15
6149554|NCT03248037|21184770|P2|Overall Study|Withdrawal by Subject|9
6149555|NCT03248037|21184771|P1|Overall Study|Withdrawal by Subject|6
6149556|NCT03125902|21184802|P2|Overall Study|Study is ongoing|282
6149557|NCT03125902|21184803|P1|Overall Study|Study is ongoing|153
6149558|NCT03125902|21184802|P2|Overall Study|Withdrawal by Subject|25
6149559|NCT03125902|21184803|P1|Overall Study|Withdrawal by Subject|13
6149560|NCT03125902|21184802|P2|Overall Study|Physician Decision|0
6149561|NCT03125902|21184803|P1|Overall Study|Physician Decision|1
6149562|NCT03125902|21184802|P2|Overall Study|Mastectomy|1
6149563|NCT03125902|21184803|P1|Overall Study|Mastectomy|0
6149564|NCT03125902|21184802|P2|Overall Study|Lost to Follow-up|0
6149565|NCT03125902|21184803|P1|Overall Study|Lost to Follow-up|1
6149566|NCT03125902|21184802|P2|Overall Study|Death|123
6149567|NCT03125902|21184803|P1|Overall Study|Death|52
6149568|NCT03072160|21184870|P2|Overall Study|No contact|1
6149569|NCT03072160|21184871|P1|Overall Study|No contact|0
6149570|NCT03072160|21184870|P2|Overall Study|Disease progression on study|1
6149571|NCT03072160|21184871|P1|Overall Study|Disease progression on study|1
6149572|NCT03072160|21184870|P2|Overall Study|Physician Decision|0
6149573|NCT03072160|21184871|P1|Overall Study|Physician Decision|1
6149574|NCT03072160|21184870|P2|Overall Study|Refused further treatment|1
6149575|NCT03072160|21184871|P1|Overall Study|Refused further treatment|6
6149576|NCT03072160|21184870|P2|Overall Study|Adverse Event|1
6149577|NCT03072160|21184871|P1|Overall Study|Adverse Event|3
6149578|NCT02930226|21184955|P6|Overall Study|Technical Problems: Leak in plasma bag|0
6149579|NCT02930226|21184956|P5|Overall Study|Technical Problems: Leak in plasma bag|1
6149580|NCT02930226|21184957|P4|Overall Study|Technical Problems: Leak in plasma bag|0
6149581|NCT02930226|21184958|P3|Overall Study|Technical Problems: Leak in plasma bag|0
6149582|NCT02930226|21184959|P2|Overall Study|Technical Problems: Leak in plasma bag|0
6149583|NCT02930226|21184960|P1|Overall Study|Technical Problems: Leak in plasma bag|0
6149584|NCT02706951|21185098|P3|Overall Study|Other|0
6149585|NCT02706951|21185099|P2|Overall Study|Other|1
6149586|NCT02706951|21185100|P1|Overall Study|Other|2
6149587|NCT02706951|21185098|P3|Overall Study|Lost to Follow-up|1
6149588|NCT02706951|21185099|P2|Overall Study|Lost to Follow-up|4
6149589|NCT02706951|21185100|P1|Overall Study|Lost to Follow-up|0
6149590|NCT02706951|21185098|P3|Overall Study|Withdrawal by Subject|6
6149591|NCT02706951|21185099|P2|Overall Study|Withdrawal by Subject|6
6149592|NCT02706951|21185100|P1|Overall Study|Withdrawal by Subject|11
6149593|NCT02706951|21185098|P3|Overall Study|Adverse Event|3
6149594|NCT02706951|21185099|P2|Overall Study|Adverse Event|5
6149595|NCT02706951|21185100|P1|Overall Study|Adverse Event|1
6149596|NCT02706873|21185136|P4|Overall Study|Ongoing|1
6149597|NCT02706873|21185137|P3|Overall Study|Ongoing|0
6149598|NCT02706873|21185138|P2|Overall Study|Ongoing|0
6149599|NCT02706873|21185139|P1|Overall Study|Ongoing|0
6149600|NCT02706873|21185136|P4|Overall Study|Not Dosed|1
6149601|NCT02706873|21185137|P3|Overall Study|Not Dosed|0
6149602|NCT02706873|21185138|P2|Overall Study|Not Dosed|0
6149603|NCT02706873|21185139|P1|Overall Study|Not Dosed|1
6149604|NCT02706873|21185136|P4|Overall Study|Other|3
6149605|NCT02706873|21185137|P3|Overall Study|Other|2
6149606|NCT02706873|21185138|P2|Overall Study|Other|1
6149607|NCT02706873|21185139|P1|Overall Study|Other|5
6149608|NCT02706873|21185136|P4|Overall Study|Lack of Efficacy|3
6149609|NCT02706873|21185137|P3|Overall Study|Lack of Efficacy|0
6149610|NCT02706873|21185138|P2|Overall Study|Lack of Efficacy|0
6149611|NCT02706873|21185139|P1|Overall Study|Lack of Efficacy|10
6149612|NCT02706873|21185136|P4|Overall Study|Lost to Follow-up|2
6149613|NCT02706873|21185137|P3|Overall Study|Lost to Follow-up|4
6149614|NCT02706873|21185138|P2|Overall Study|Lost to Follow-up|0
6149615|NCT02706873|21185139|P1|Overall Study|Lost to Follow-up|3
6149616|NCT02706873|21185136|P4|Overall Study|Withdrawal by Subject|11
6149617|NCT02706873|21185137|P3|Overall Study|Withdrawal by Subject|8
6149618|NCT02706873|21185138|P2|Overall Study|Withdrawal by Subject|0
6149619|NCT02706873|21185139|P1|Overall Study|Withdrawal by Subject|15
6149620|NCT02706873|21185136|P4|Overall Study|Adverse Event|12
6149621|NCT02706873|21185137|P3|Overall Study|Adverse Event|13
6149622|NCT02706873|21185138|P2|Overall Study|Adverse Event|3
6149623|NCT02706873|21185139|P1|Overall Study|Adverse Event|13
6149624|NCT02706847|21185239|P4|Week 12 to Week 24|Other|4
6149625|NCT02706847|21185240|P3|Week 12 to Week 24|Other|1
6149626|NCT02706847|21185241|P2|Week 12 to Week 24|Other|0
6149627|NCT02706847|21185242|P1|Week 12 to Week 24|Other|1
6149628|NCT02706847|21185239|P4|Week 12 to Week 24|Lost to Follow-up|1
6149629|NCT02706847|21185240|P3|Week 12 to Week 24|Lost to Follow-up|0
6149630|NCT02706847|21185241|P2|Week 12 to Week 24|Lost to Follow-up|0
6149631|NCT02706847|21185242|P1|Week 12 to Week 24|Lost to Follow-up|0
6149632|NCT02706847|21185239|P4|Week 12 to Week 24|Withdrawal by Subject|4
6149633|NCT02706847|21185240|P3|Week 12 to Week 24|Withdrawal by Subject|1
6149634|NCT02706847|21185241|P2|Week 12 to Week 24|Withdrawal by Subject|0
6149635|NCT02706847|21185242|P1|Week 12 to Week 24|Withdrawal by Subject|1
6149636|NCT02706847|21185239|P4|Week 12 to Week 24|Adverse Event|5
6149637|NCT02706847|21185240|P3|Week 12 to Week 24|Adverse Event|2
6149638|NCT02706847|21185241|P2|Week 12 to Week 24|Adverse Event|2
6149639|NCT02706847|21185242|P1|Week 12 to Week 24|Adverse Event|1
6149640|NCT02706847|21185239|P4|Day 1 to Week 12|Randomized in Error|0
6149641|NCT02706847|21185240|P3|Day 1 to Week 12|Randomized in Error|1
6149642|NCT02706847|21185241|P2|Day 1 to Week 12|Randomized in Error|0
6149643|NCT02706847|21185242|P1|Day 1 to Week 12|Randomized in Error|0
6149644|NCT02706847|21185239|P4|Day 1 to Week 12|Other|2
6149645|NCT02706847|21185240|P3|Day 1 to Week 12|Other|2
6149646|NCT02706847|21185241|P2|Day 1 to Week 12|Other|4
6149647|NCT02706847|21185242|P1|Day 1 to Week 12|Other|4
6149648|NCT02706847|21185239|P4|Day 1 to Week 12|Lost to Follow-up|0
6149649|NCT02706847|21185240|P3|Day 1 to Week 12|Lost to Follow-up|0
6149650|NCT02706847|21185241|P2|Day 1 to Week 12|Lost to Follow-up|1
6149651|NCT02706847|21185242|P1|Day 1 to Week 12|Lost to Follow-up|2
6149652|NCT02706847|21185239|P4|Day 1 to Week 12|Withdrawal by Subject|2
6149653|NCT02706847|21185240|P3|Day 1 to Week 12|Withdrawal by Subject|4
6149654|NCT02706847|21185241|P2|Day 1 to Week 12|Withdrawal by Subject|1
6149655|NCT02706847|21185242|P1|Day 1 to Week 12|Withdrawal by Subject|2
6149656|NCT02706847|21185239|P4|Day 1 to Week 12|Adverse Event|12
6149657|NCT02706847|21185240|P3|Day 1 to Week 12|Adverse Event|1
6149658|NCT02706847|21185241|P2|Day 1 to Week 12|Adverse Event|2
6149659|NCT02706847|21185242|P1|Day 1 to Week 12|Adverse Event|2
6149660|NCT02616146|21185275|P2|Overall Study|Physician Decision|1
6149661|NCT02616146|21185276|P1|Overall Study|Physician Decision|2
6149662|NCT02616146|21185275|P2|Overall Study|Withdrawal by Subject|24
6149663|NCT02616146|21185276|P1|Overall Study|Withdrawal by Subject|30
6149664|NCT02616146|21185275|P2|Overall Study|Participant moved|3
6149665|NCT02616146|21185276|P1|Overall Study|Participant moved|4
6149666|NCT02616146|21185275|P2|Overall Study|Study terminated by sponsor|432
6149667|NCT02616146|21185276|P1|Overall Study|Study terminated by sponsor|1372
6149668|NCT02616146|21185275|P2|Overall Study|Protocol Violation|3
6149669|NCT02616146|21185276|P1|Overall Study|Protocol Violation|6
6149670|NCT02616146|21185275|P2|Overall Study|Pregnancy wish|0
6149671|NCT02616146|21185276|P1|Overall Study|Pregnancy wish|3
6149672|NCT02616146|21185275|P2|Overall Study|Pregnancy|2
6149673|NCT02616146|21185276|P1|Overall Study|Pregnancy|2
6149674|NCT02616146|21185275|P2|Overall Study|Non-compliance with study drug|2
6149675|NCT02616146|21185276|P1|Overall Study|Non-compliance with study drug|4
6149676|NCT02616146|21185275|P2|Overall Study|Non-compliance with study protocol|0
6149677|NCT02616146|21185276|P1|Overall Study|Non-compliance with study protocol|2
6149678|NCT02616146|21185275|P2|Overall Study|Lost to Follow-up|13
6149679|NCT02616146|21185276|P1|Overall Study|Lost to Follow-up|23
6149680|NCT02616146|21185275|P2|Overall Study|Adverse Event|24
6149681|NCT02616146|21185276|P1|Overall Study|Adverse Event|64
6149682|NCT02547987|21185303|P1|Overall Study|Adverse Event|2
6149683|NCT02547987|21185303|P1|Overall Study|Withdrawal by Subject|1
6149684|NCT02505425|21185311|P4|Overall Study|Death|0
6149685|NCT02505425|21185312|P3|Overall Study|Death|0
6149686|NCT02505425|21185313|P2|Overall Study|Death|12
6149687|NCT02505425|21185314|P1|Overall Study|Death|8
6149688|NCT02505425|21185311|P4|Overall Study|Withdrawal by Subject|7
6149689|NCT02505425|21185312|P3|Overall Study|Withdrawal by Subject|19
6149690|NCT02505425|21185313|P2|Overall Study|Withdrawal by Subject|9
6149691|NCT02505425|21185314|P1|Overall Study|Withdrawal by Subject|39
6149692|NCT02505425|21185311|P4|Overall Study|Lost to Follow-up|19
6149693|NCT02505425|21185312|P3|Overall Study|Lost to Follow-up|31
6149694|NCT02505425|21185313|P2|Overall Study|Lost to Follow-up|61
6149695|NCT02505425|21185314|P1|Overall Study|Lost to Follow-up|41
6149696|NCT02500797|21185448|P8|Overall Study|Withdrawal by Subject|0
6149697|NCT02500797|21185449|P7|Overall Study|Withdrawal by Subject|0
6149698|NCT02500797|21185450|P6|Overall Study|Withdrawal by Subject|0
6149699|NCT02500797|21185451|P5|Overall Study|Withdrawal by Subject|0
6149700|NCT02500797|21185452|P4|Overall Study|Withdrawal by Subject|0
6149701|NCT02500797|21185453|P3|Overall Study|Withdrawal by Subject|0
6149702|NCT02500797|21185454|P2|Overall Study|Withdrawal by Subject|0
6149703|NCT02500797|21185455|P1|Overall Study|Withdrawal by Subject|1
6149704|NCT02500797|21185448|P8|Overall Study|Cancel (rapid disease progression)|0
6149705|NCT02500797|21185449|P7|Overall Study|Cancel (rapid disease progression)|0
6149706|NCT02500797|21185450|P6|Overall Study|Cancel (rapid disease progression)|1
6149707|NCT02500797|21185451|P5|Overall Study|Cancel (rapid disease progression)|1
6149708|NCT02500797|21185452|P4|Overall Study|Cancel (rapid disease progression)|0
6149709|NCT02500797|21185453|P3|Overall Study|Cancel (rapid disease progression)|0
6149710|NCT02500797|21185454|P2|Overall Study|Cancel (rapid disease progression)|0
6149711|NCT02500797|21185455|P1|Overall Study|Cancel (rapid disease progression)|0
6149712|NCT02460991|21185515|P2|Overall Study|Withdrawal by Subject|2
6149713|NCT02460991|21185516|P1|Overall Study|Withdrawal by Subject|0
6149714|NCT02458092|21185532|P2|Overall Study|Withdrawal by Subject|0
6149715|NCT02458092|21185533|P1|Overall Study|Withdrawal by Subject|1
6149716|NCT02445963|21185549|P4|Overall Study|Symptoms post-vaccination|0
6149717|NCT02445963|21185550|P3|Overall Study|Symptoms post-vaccination|1
6149718|NCT02445963|21185551|P2|Overall Study|Symptoms post-vaccination|0
6149719|NCT02445963|21185552|P1|Overall Study|Symptoms post-vaccination|0
6149720|NCT02445963|21185549|P4|Overall Study|Change in employment|0
6149721|NCT02445963|21185550|P3|Overall Study|Change in employment|0
6149722|NCT02445963|21185551|P2|Overall Study|Change in employment|0
6149723|NCT02445963|21185552|P1|Overall Study|Change in employment|1
6149724|NCT02445963|21185549|P4|Overall Study|Lost to Follow-up|0
6149725|NCT02445963|21185550|P3|Overall Study|Lost to Follow-up|0
6149726|NCT02445963|21185551|P2|Overall Study|Lost to Follow-up|0
6149727|NCT02445963|21185552|P1|Overall Study|Lost to Follow-up|1
6149728|NCT02397889|21185576|P2|Overall Study|Physician Decision|0
6149729|NCT02397889|21185577|P1|Overall Study|Physician Decision|1
6149730|NCT02397460|21185601|P8|Treatment Period 4|Physician Decision|0
6149731|NCT02397460|21185602|P7|Treatment Period 4|Physician Decision|0
6149732|NCT02397460|21185603|P6|Treatment Period 4|Physician Decision|0
6149733|NCT02397460|21185604|P5|Treatment Period 4|Physician Decision|1
6149734|NCT02397460|21185605|P4|Treatment Period 4|Physician Decision|0
6149735|NCT02397460|21185606|P3|Treatment Period 4|Physician Decision|0
6149736|NCT02397460|21185607|P2|Treatment Period 4|Physician Decision|0
6149737|NCT02397460|21185608|P1|Treatment Period 4|Physician Decision|0
6149738|NCT02397460|21185601|P8|Treatment Period 4|Adverse Event|0
6149739|NCT02397460|21185602|P7|Treatment Period 4|Adverse Event|0
6149740|NCT02397460|21185603|P6|Treatment Period 4|Adverse Event|0
6149741|NCT02397460|21185604|P5|Treatment Period 4|Adverse Event|0
6149742|NCT02397460|21185605|P4|Treatment Period 4|Adverse Event|0
6149743|NCT02397460|21185606|P3|Treatment Period 4|Adverse Event|0
6149744|NCT02397460|21185607|P2|Treatment Period 4|Adverse Event|1
6149745|NCT02397460|21185608|P1|Treatment Period 4|Adverse Event|0
6149746|NCT02397460|21185601|P8|Treatment Period 2|Adverse Event|1
6149747|NCT02397460|21185602|P7|Treatment Period 2|Adverse Event|0
6149748|NCT02397460|21185603|P6|Treatment Period 2|Adverse Event|0
6149749|NCT02397460|21185604|P5|Treatment Period 2|Adverse Event|0
6149750|NCT02397460|21185605|P4|Treatment Period 2|Adverse Event|0
6149751|NCT02397460|21185606|P3|Treatment Period 2|Adverse Event|0
6149752|NCT02397460|21185607|P2|Treatment Period 2|Adverse Event|0
6149753|NCT02397460|21185608|P1|Treatment Period 2|Adverse Event|0
6149754|NCT02372383|21185805|P3|First Intervention (1 Day)|Unable to collect blood|0
6149755|NCT02372383|21185806|P2|First Intervention (1 Day)|Unable to collect blood|1
6149756|NCT02372383|21185807|P1|First Intervention (1 Day)|Unable to collect blood|0
6149763|NCT02304367|21185893|P1|Overall Study|Ongoing in Study|12
6149764|NCT02304367|21185893|P1|Overall Study|Death|1
6149765|NCT02304367|21185893|P1|Overall Study|Sponsor Decision|3
6149766|NCT02304367|21185893|P1|Overall Study|Lack of Phosphorus Increase|1
6149767|NCT02275780|21185953|P2|Extension Study: up to 192 Weeks|Ongoing|233
6149768|NCT02275780|21185954|P1|Extension Study: up to 192 Weeks|Ongoing|260
6149769|NCT02275780|21185953|P2|Base Study: 96 Weeks|Randomized not treated|1
6149770|NCT02275780|21185954|P1|Base Study: 96 Weeks|Randomized not treated|2
6149771|NCT02275780|21185953|P2|Base Study: 96 Weeks|Pregnancy|1
6149772|NCT02275780|21185954|P1|Base Study: 96 Weeks|Pregnancy|2
6149773|NCT02275780|21185953|P2|Base Study: 96 Weeks|Physician Decision|4
6149774|NCT02275780|21185954|P1|Base Study: 96 Weeks|Physician Decision|2
6149775|NCT02275780|21185953|P2|Base Study: 96 Weeks|Noncompliance with drug|6
6149776|NCT02275780|21185954|P1|Base Study: 96 Weeks|Noncompliance with drug|9
6149777|NCT02275780|21185953|P2|Base Study: 96 Weeks|Withdrawal by Subject|22
6149778|NCT02275780|21185954|P1|Base Study: 96 Weeks|Withdrawal by Subject|19
6149779|NCT02275780|21185953|P2|Base Study: 96 Weeks|Protocol Violation|6
6149780|NCT02275780|21185954|P1|Base Study: 96 Weeks|Protocol Violation|1
6149781|NCT02275780|21185953|P2|Base Study: 96 Weeks|Lost to Follow-up|24
6149782|NCT02275780|21185954|P1|Base Study: 96 Weeks|Lost to Follow-up|28
6149783|NCT02275780|21185953|P2|Base Study: 96 Weeks|Lack of Efficacy|32
6149784|NCT02275780|21185954|P1|Base Study: 96 Weeks|Lack of Efficacy|21
6149785|NCT02275780|21185953|P2|Base Study: 96 Weeks|Death|1
6149786|NCT02275780|21185954|P1|Base Study: 96 Weeks|Death|3
6149787|NCT02275780|21185953|P2|Base Study: 96 Weeks|Adverse Event|14
6149788|NCT02275780|21185954|P1|Base Study: 96 Weeks|Adverse Event|6
6149789|NCT02255097|21185990|P1|Overall Study|Treatment Ongoing|36
6149790|NCT02255097|21185990|P1|Overall Study|Allocated but not treated|1
6149791|NCT02255097|21185990|P1|Overall Study|Withdrawal by Subject|2
6149792|NCT02255097|21185990|P1|Overall Study|Progressive Disease|80
6149793|NCT02255097|21185990|P1|Overall Study|Physician Decision|1
6149794|NCT02255097|21185990|P1|Overall Study|Lost to Follow-up|1
6149795|NCT02255097|21185990|P1|Overall Study|Death|2
6149796|NCT02255097|21185990|P1|Overall Study|Excluded Medication|1
6149797|NCT02255097|21185990|P1|Overall Study|Complete Response|1
6149798|NCT02255097|21185990|P1|Overall Study|Clinical Progression|23
6149799|NCT02255097|21185990|P1|Overall Study|Adverse Event|24
6149800|NCT02186834|21186114|P6|Treatment at RP2D|Died prior to treatment|1
6149801|NCT02186834|21186115|P5|Treatment at RP2D|Died prior to treatment|0
6149802|NCT02186834|21186116|P4|Treatment at RP2D|Died prior to treatment|0
6149803|NCT02186834|21186117|P3|Treatment at RP2D|Died prior to treatment|0
6149804|NCT02186834|21186118|P2|Treatment at RP2D|Died prior to treatment|0
6149805|NCT02186834|21186119|P1|Treatment at RP2D|Died prior to treatment|0
6149806|NCT02186834|21186114|P6|Dose Escalation|Death|0
6149807|NCT02186834|21186115|P5|Dose Escalation|Death|0
6149808|NCT02186834|21186116|P4|Dose Escalation|Death|1
6149809|NCT02186834|21186117|P3|Dose Escalation|Death|0
6149810|NCT02186834|21186118|P2|Dose Escalation|Death|0
6149811|NCT02186834|21186119|P1|Dose Escalation|Death|0
6149818|NCT02116205|21186155|P4|Overall Study|Exclusion criteria|0
6149819|NCT02116205|21186156|P3|Overall Study|Exclusion criteria|1
6149820|NCT02116205|21186157|P2|Overall Study|Exclusion criteria|0
6149821|NCT02116205|21186158|P1|Overall Study|Exclusion criteria|0
6149822|NCT02116205|21186155|P4|Overall Study|Physician Decision|1
6149823|NCT02116205|21186156|P3|Overall Study|Physician Decision|1
6149824|NCT02116205|21186157|P2|Overall Study|Physician Decision|1
6149825|NCT02116205|21186158|P1|Overall Study|Physician Decision|0
6149826|NCT02116205|21186155|P4|Overall Study|Lost to Follow-up|2
6149827|NCT02116205|21186156|P3|Overall Study|Lost to Follow-up|1
6149828|NCT02116205|21186157|P2|Overall Study|Lost to Follow-up|2
6149829|NCT02116205|21186158|P1|Overall Study|Lost to Follow-up|0
6149830|NCT02116205|21186155|P4|Overall Study|Withdrawal by Subject|3
6149831|NCT02116205|21186156|P3|Overall Study|Withdrawal by Subject|1
6149832|NCT02116205|21186157|P2|Overall Study|Withdrawal by Subject|4
6149833|NCT02116205|21186158|P1|Overall Study|Withdrawal by Subject|2
6149854|NCT02063724|21186217|P1|Overall Study|Disease progression|1
6149855|NCT02047734|21186226|P3|Overall Study|Did Not Receive Study Drug|1
6149856|NCT02047734|21186227|P2|Overall Study|Did Not Receive Study Drug|4
6149857|NCT02047734|21186228|P1|Overall Study|Did Not Receive Study Drug|2
6149858|NCT02047734|21186226|P3|Overall Study|Miscellaneous|6
6149859|NCT02047734|21186227|P2|Overall Study|Miscellaneous|4
6149860|NCT02047734|21186228|P1|Overall Study|Miscellaneous|2
6149861|NCT02047734|21186226|P3|Overall Study|Physician Decision|5
6149862|NCT02047734|21186227|P2|Overall Study|Physician Decision|6
6149863|NCT02047734|21186228|P1|Overall Study|Physician Decision|7
6149864|NCT02047734|21186226|P3|Overall Study|Withdrawal by Subject|19
6149865|NCT02047734|21186227|P2|Overall Study|Withdrawal by Subject|31
6149866|NCT02047734|21186228|P1|Overall Study|Withdrawal by Subject|30
6149867|NCT02047734|21186226|P3|Overall Study|Death|0
6149868|NCT02047734|21186227|P2|Overall Study|Death|1
6149869|NCT02047734|21186228|P1|Overall Study|Death|0
6149870|NCT02047734|21186226|P3|Overall Study|Lost to Follow-up|0
6149871|NCT02047734|21186227|P2|Overall Study|Lost to Follow-up|4
6149872|NCT02047734|21186228|P1|Overall Study|Lost to Follow-up|1
6149873|NCT02047734|21186226|P3|Overall Study|Protocol Violation|1
6149874|NCT02047734|21186227|P2|Overall Study|Protocol Violation|1
6149875|NCT02047734|21186228|P1|Overall Study|Protocol Violation|3
6149876|NCT02047734|21186226|P3|Overall Study|Lack of Efficacy|1
6149877|NCT02047734|21186227|P2|Overall Study|Lack of Efficacy|5
6149878|NCT02047734|21186228|P1|Overall Study|Lack of Efficacy|4
6149879|NCT02047734|21186226|P3|Overall Study|Adverse Event|13
6149880|NCT02047734|21186227|P2|Overall Study|Adverse Event|13
6149881|NCT02047734|21186228|P1|Overall Study|Adverse Event|18
6149882|NCT01995175|21186269|P1|Overall Study|Migrated / moved from the study area|49
6149883|NCT01995175|21186269|P1|Overall Study|Other|67
6149884|NCT01995175|21186269|P1|Overall Study|Lost to Follow-up|102
6149885|NCT01995175|21186269|P1|Overall Study|Withdrawal by Subject|35
6149907|NCT01951638|21186698|P5|Follow-up Period|Adverse Event|1
6149908|NCT01951638|21186699|P4|Follow-up Period|Adverse Event|1
6149909|NCT01951638|21186700|P3|Follow-up Period|Adverse Event|2
6149910|NCT01951638|21186701|P2|Follow-up Period|Adverse Event|1
6149911|NCT01951638|21186702|P1|Follow-up Period|Adverse Event|0
6149912|NCT01951638|21186698|P5|Follow-up Period|Death|1
6149913|NCT01951638|21186699|P4|Follow-up Period|Death|4
6149914|NCT01951638|21186700|P3|Follow-up Period|Death|1
6149915|NCT01951638|21186701|P2|Follow-up Period|Death|0
6149916|NCT01951638|21186702|P1|Follow-up Period|Death|1
6149917|NCT01951638|21186698|P5|Follow-up Period|Lost to Follow-up|0
6149918|NCT01951638|21186699|P4|Follow-up Period|Lost to Follow-up|1
6149919|NCT01951638|21186700|P3|Follow-up Period|Lost to Follow-up|0
6149920|NCT01951638|21186701|P2|Follow-up Period|Lost to Follow-up|1
6149921|NCT01951638|21186702|P1|Follow-up Period|Lost to Follow-up|0
6149922|NCT01951638|21186698|P5|Follow-up Period|Withdrawal by Subject|2
6149923|NCT01951638|21186699|P4|Follow-up Period|Withdrawal by Subject|1
6149924|NCT01951638|21186700|P3|Follow-up Period|Withdrawal by Subject|2
6149925|NCT01951638|21186701|P2|Follow-up Period|Withdrawal by Subject|5
6149926|NCT01951638|21186702|P1|Follow-up Period|Withdrawal by Subject|1
6149927|NCT01951638|21186698|P5|Follow-up Period|Logistical difficulties|1
6149928|NCT01951638|21186699|P4|Follow-up Period|Logistical difficulties|0
6149929|NCT01951638|21186700|P3|Follow-up Period|Logistical difficulties|0
6149930|NCT01951638|21186701|P2|Follow-up Period|Logistical difficulties|2
6149931|NCT01951638|21186702|P1|Follow-up Period|Logistical difficulties|0
6149932|NCT01951638|21186698|P5|Follow-up Period|Protocol Violation|0
6149933|NCT01951638|21186699|P4|Follow-up Period|Protocol Violation|1
6149934|NCT01951638|21186700|P3|Follow-up Period|Protocol Violation|0
6149935|NCT01951638|21186701|P2|Follow-up Period|Protocol Violation|0
6149936|NCT01951638|21186702|P1|Follow-up Period|Protocol Violation|0
6149937|NCT01951638|21186698|P5|Treatment Period|Adverse Event|5
6149938|NCT01951638|21186699|P4|Treatment Period|Adverse Event|6
6149939|NCT01951638|21186700|P3|Treatment Period|Adverse Event|8
6149940|NCT01951638|21186701|P2|Treatment Period|Adverse Event|4
6149941|NCT01951638|21186702|P1|Treatment Period|Adverse Event|3
6149942|NCT01951638|21186698|P5|Treatment Period|Death|1
6149943|NCT01951638|21186699|P4|Treatment Period|Death|3
6149944|NCT01951638|21186700|P3|Treatment Period|Death|0
6149945|NCT01951638|21186701|P2|Treatment Period|Death|0
6149946|NCT01951638|21186702|P1|Treatment Period|Death|0
6149947|NCT01951638|21186698|P5|Treatment Period|Withdrawal by Subject|4
6149948|NCT01951638|21186699|P4|Treatment Period|Withdrawal by Subject|5
6149949|NCT01951638|21186700|P3|Treatment Period|Withdrawal by Subject|4
6149950|NCT01951638|21186701|P2|Treatment Period|Withdrawal by Subject|6
6149951|NCT01951638|21186702|P1|Treatment Period|Withdrawal by Subject|9
6149952|NCT01951638|21186698|P5|Treatment Period|Logistical difficulties|0
6149953|NCT01951638|21186699|P4|Treatment Period|Logistical difficulties|0
6149954|NCT01951638|21186700|P3|Treatment Period|Logistical difficulties|1
6149955|NCT01951638|21186701|P2|Treatment Period|Logistical difficulties|1
6149956|NCT01951638|21186702|P1|Treatment Period|Logistical difficulties|0
6149957|NCT01951638|21186698|P5|Treatment Period|Protocol-driven decision point|0
6149958|NCT01951638|21186699|P4|Treatment Period|Protocol-driven decision point|0
6149959|NCT01951638|21186700|P3|Treatment Period|Protocol-driven decision point|0
6149960|NCT01951638|21186701|P2|Treatment Period|Protocol-driven decision point|3
6149961|NCT01951638|21186702|P1|Treatment Period|Protocol-driven decision point|1
6149962|NCT01951638|21186698|P5|Treatment Period|Protocol Violation|0
6149963|NCT01951638|21186699|P4|Treatment Period|Protocol Violation|2
6149964|NCT01951638|21186700|P3|Treatment Period|Protocol Violation|0
6149965|NCT01951638|21186701|P2|Treatment Period|Protocol Violation|0
6149966|NCT01951638|21186702|P1|Treatment Period|Protocol Violation|0
6149967|NCT01908634|21186734|P1|Milk-based Strawberry Beverage w/o Meal|Withdrawal by Subject|5
6149968|NCT01908634|21186734|P1|Water-based Strawberry Beverage Wit Meal|Withdrawal by Subject|1
6149969|NCT01886378|21186759|P1|Overall Study|Withdrawal by Subject|4
6149970|NCT01886378|21186759|P1|Overall Study|Adverse Event|1
6149971|NCT01874353|21186782|P2|Overall Study|Withdrawal by Subject|11
6149972|NCT01874353|21186783|P1|Overall Study|Withdrawal by Subject|13
6149973|NCT01874353|21186782|P2|Overall Study|Death|60
6149974|NCT01874353|21186783|P1|Overall Study|Death|110
6149975|NCT01874353|21186782|P2|Overall Study|Lost to Follow-up|2
6149976|NCT01874353|21186783|P1|Overall Study|Lost to Follow-up|2
6149977|NCT01874353|21186782|P2|Overall Study|Other|0
6149978|NCT01874353|21186783|P1|Overall Study|Other|2
6149979|NCT01835158|21186822|P2|Overall Study|Withdrawal by Subject|6
6149980|NCT01835158|21186823|P1|Overall Study|Withdrawal by Subject|1
6149981|NCT01822353|21186836|P3|Overall Study|Withdrawal by Subject|0
6149982|NCT01822353|21186837|P2|Overall Study|Withdrawal by Subject|1
6149983|NCT01822353|21186838|P1|Overall Study|Withdrawal by Subject|3
6149984|NCT01822353|21186836|P3|Overall Study|Pregnancy|0
6149985|NCT01822353|21186837|P2|Overall Study|Pregnancy|1
6149986|NCT01822353|21186838|P1|Overall Study|Pregnancy|0
6149987|NCT01822353|21186836|P3|Overall Study|Adverse Event|1
6149988|NCT01822353|21186837|P2|Overall Study|Adverse Event|3
6149989|NCT01822353|21186838|P1|Overall Study|Adverse Event|1
6149996|NCT01776424|21186887|P3|Overall Study|Withdrawal by Subject|15
6149997|NCT01776424|21186888|P2|Overall Study|Withdrawal by Subject|11
6149998|NCT01776424|21186889|P1|Overall Study|Withdrawal by Subject|10
6149999|NCT01776424|21186887|P3|Overall Study|Lost to Follow-up|9
6150000|NCT01776424|21186888|P2|Overall Study|Lost to Follow-up|8
6150001|NCT01776424|21186889|P1|Overall Study|Lost to Follow-up|10
6150002|NCT01709084|21186930|P2|Overall Study|Not Treated|2
6150003|NCT01709084|21186931|P1|Overall Study|Not Treated|0
6150004|NCT01709084|21186930|P2|Overall Study|Participant Reached a Virologic Endpoint|1
6150005|NCT01709084|21186931|P1|Overall Study|Participant Reached a Virologic Endpoint|0
6150006|NCT01709084|21186930|P2|Overall Study|Other|3
6150007|NCT01709084|21186931|P1|Overall Study|Other|5
6150008|NCT01709084|21186930|P2|Overall Study|Adverse Event|0
6150009|NCT01709084|21186931|P1|Overall Study|Adverse Event|5
6150010|NCT01709084|21186930|P2|Overall Study|Withdrawal by Subject|2
6150011|NCT01709084|21186931|P1|Overall Study|Withdrawal by Subject|2
6150012|NCT01709084|21186930|P2|Overall Study|Lost to Follow-up|7
6150013|NCT01709084|21186931|P1|Overall Study|Lost to Follow-up|4
6150014|NCT01644565|21186958|P9|Overall Study|Relocation|1
6150015|NCT01644565|21186959|P8|Overall Study|Relocation|0
6150016|NCT01644565|21186960|P7|Overall Study|Relocation|0
6150017|NCT01644565|21186961|P6|Overall Study|Relocation|0
6150018|NCT01644565|21186962|P5|Overall Study|Relocation|0
6150019|NCT01644565|21186963|P4|Overall Study|Relocation|0
6150020|NCT01644565|21186964|P3|Overall Study|Relocation|0
6150021|NCT01644565|21186965|P2|Overall Study|Relocation|0
6150022|NCT01644565|21186966|P1|Overall Study|Relocation|0
6150023|NCT01644565|21186958|P9|Overall Study|Family emergency|0
6150024|NCT01644565|21186959|P8|Overall Study|Family emergency|0
6150025|NCT01644565|21186960|P7|Overall Study|Family emergency|0
6150026|NCT01644565|21186961|P6|Overall Study|Family emergency|0
6150027|NCT01644565|21186962|P5|Overall Study|Family emergency|1
6150028|NCT01644565|21186963|P4|Overall Study|Family emergency|0
6150029|NCT01644565|21186964|P3|Overall Study|Family emergency|0
6150030|NCT01644565|21186965|P2|Overall Study|Family emergency|0
6150031|NCT01644565|21186966|P1|Overall Study|Family emergency|0
6150032|NCT01644565|21186958|P9|Overall Study|Lost to Follow-up|0
6150033|NCT01644565|21186959|P8|Overall Study|Lost to Follow-up|2
6150034|NCT01644565|21186960|P7|Overall Study|Lost to Follow-up|0
6150035|NCT01644565|21186961|P6|Overall Study|Lost to Follow-up|0
6150036|NCT01644565|21186962|P5|Overall Study|Lost to Follow-up|0
6150037|NCT01644565|21186963|P4|Overall Study|Lost to Follow-up|1
6150038|NCT01644565|21186964|P3|Overall Study|Lost to Follow-up|0
6150039|NCT01644565|21186965|P2|Overall Study|Lost to Follow-up|0
6150040|NCT01644565|21186966|P1|Overall Study|Lost to Follow-up|0
6150041|NCT01644565|21186958|P9|Overall Study|Undisclosed Medical History|0
6150042|NCT01644565|21186959|P8|Overall Study|Undisclosed Medical History|0
6150043|NCT01644565|21186960|P7|Overall Study|Undisclosed Medical History|0
6150044|NCT01644565|21186961|P6|Overall Study|Undisclosed Medical History|0
6150045|NCT01644565|21186962|P5|Overall Study|Undisclosed Medical History|0
6150046|NCT01644565|21186963|P4|Overall Study|Undisclosed Medical History|0
6150047|NCT01644565|21186964|P3|Overall Study|Undisclosed Medical History|0
6150048|NCT01644565|21186965|P2|Overall Study|Undisclosed Medical History|0
6150049|NCT01644565|21186966|P1|Overall Study|Undisclosed Medical History|1
6150050|NCT01628393|21187007|P5|Blinded Active Extension Period|Withdrawal by Subject|2
6150051|NCT01628393|21187008|P4|Blinded Active Extension Period|Withdrawal by Subject|0
6150052|NCT01628393|21187009|P3|Blinded Active Extension Period|Withdrawal by Subject|2
6150053|NCT01628393|21187010|P2|Blinded Active Extension Period|Withdrawal by Subject|6
6150054|NCT01628393|21187011|P1|Blinded Active Extension Period|Withdrawal by Subject|0
6150055|NCT01628393|21187007|P5|Blinded Active Extension Period|Protocol Violation|0
6150056|NCT01628393|21187008|P4|Blinded Active Extension Period|Protocol Violation|1
6150057|NCT01628393|21187009|P3|Blinded Active Extension Period|Protocol Violation|2
6150058|NCT01628393|21187010|P2|Blinded Active Extension Period|Protocol Violation|0
6150059|NCT01628393|21187011|P1|Blinded Active Extension Period|Protocol Violation|0
6150060|NCT01628393|21187007|P5|Blinded Active Extension Period|Physician Decision|0
6150061|NCT01628393|21187008|P4|Blinded Active Extension Period|Physician Decision|1
6150062|NCT01628393|21187009|P3|Blinded Active Extension Period|Physician Decision|0
6150063|NCT01628393|21187010|P2|Blinded Active Extension Period|Physician Decision|3
6150064|NCT01628393|21187011|P1|Blinded Active Extension Period|Physician Decision|0
6150065|NCT01628393|21187007|P5|Blinded Active Extension Period|Lack of Efficacy|2
6150066|NCT01628393|21187008|P4|Blinded Active Extension Period|Lack of Efficacy|0
6150067|NCT01628393|21187009|P3|Blinded Active Extension Period|Lack of Efficacy|2
6150068|NCT01628393|21187010|P2|Blinded Active Extension Period|Lack of Efficacy|0
6150069|NCT01628393|21187011|P1|Blinded Active Extension Period|Lack of Efficacy|0
6150070|NCT01628393|21187007|P5|Blinded Active Extension Period|Adverse Event|2
6150071|NCT01628393|21187008|P4|Blinded Active Extension Period|Adverse Event|2
6150072|NCT01628393|21187009|P3|Blinded Active Extension Period|Adverse Event|0
6150073|NCT01628393|21187010|P2|Blinded Active Extension Period|Adverse Event|1
6150074|NCT01628393|21187011|P1|Blinded Active Extension Period|Adverse Event|0
6150075|NCT01628393|21187007|P5|Placebo-controlled Treatment Period|Withdrawal by Subject|0
6150076|NCT01628393|21187008|P4|Placebo-controlled Treatment Period|Withdrawal by Subject|0
6150077|NCT01628393|21187009|P3|Placebo-controlled Treatment Period|Withdrawal by Subject|1
6150078|NCT01628393|21187010|P2|Placebo-controlled Treatment Period|Withdrawal by Subject|1
6150079|NCT01628393|21187011|P1|Placebo-controlled Treatment Period|Withdrawal by Subject|2
6150080|NCT01628393|21187007|P5|Placebo-controlled Treatment Period|Protocol Violation|0
6150081|NCT01628393|21187008|P4|Placebo-controlled Treatment Period|Protocol Violation|0
6150082|NCT01628393|21187009|P3|Placebo-controlled Treatment Period|Protocol Violation|0
6150083|NCT01628393|21187010|P2|Placebo-controlled Treatment Period|Protocol Violation|1
6150084|NCT01628393|21187011|P1|Placebo-controlled Treatment Period|Protocol Violation|0
6150085|NCT01628393|21187007|P5|Placebo-controlled Treatment Period|Lost to Follow-up|0
6150086|NCT01628393|21187008|P4|Placebo-controlled Treatment Period|Lost to Follow-up|0
6150087|NCT01628393|21187009|P3|Placebo-controlled Treatment Period|Lost to Follow-up|0
6150088|NCT01628393|21187010|P2|Placebo-controlled Treatment Period|Lost to Follow-up|0
6150089|NCT01628393|21187011|P1|Placebo-controlled Treatment Period|Lost to Follow-up|1
6150090|NCT01602380|21187047|P2|Overall Study|Eligibility criteria not fulfilled|3
6150091|NCT01602380|21187048|P1|Overall Study|Eligibility criteria not fulfilled|2
6150092|NCT01602380|21187047|P2|Overall Study|Lost to Follow-up|1
6150093|NCT01602380|21187048|P1|Overall Study|Lost to Follow-up|6
6150094|NCT01602380|21187047|P2|Overall Study|Withdrawal by Subject|29
6150095|NCT01602380|21187048|P1|Overall Study|Withdrawal by Subject|22
6150096|NCT01602380|21187047|P2|Overall Study|Death|68
6150097|NCT01602380|21187048|P1|Overall Study|Death|63
6150098|NCT01536795|21187081|P2|Overall Study|Lack of Efficacy|0
6150099|NCT01536795|21187082|P1|Overall Study|Lack of Efficacy|1
6150100|NCT01536795|21187081|P2|Overall Study|Lost to Follow-up|2
6150101|NCT01536795|21187082|P1|Overall Study|Lost to Follow-up|0
6150108|NCT01501955|21187111|P2|Overall Study|Adverse Event|3
6150109|NCT01501955|21187112|P1|Overall Study|Adverse Event|1
6150110|NCT01501955|21187111|P2|Overall Study|Withdrawal by Subject|0
6150111|NCT01501955|21187112|P1|Overall Study|Withdrawal by Subject|1
6150112|NCT01422304|21187156|P2|Overall Study|Not Treated|11
6150113|NCT01422304|21187157|P1|Overall Study|Not Treated|3
6150114|NCT01422304|21187156|P2|Overall Study|Did Not Meet Protocol Eligibility|2
6150115|NCT01422304|21187157|P1|Overall Study|Did Not Meet Protocol Eligibility|0
6150116|NCT01422304|21187156|P2|Overall Study|Withdrawal by Subject|2
6150117|NCT01422304|21187157|P1|Overall Study|Withdrawal by Subject|4
6150118|NCT01422304|21187156|P2|Overall Study|Protocol Violation|0
6150119|NCT01422304|21187157|P1|Overall Study|Protocol Violation|1
6150120|NCT01422304|21187156|P2|Overall Study|Never Entered Follow-up|1
6150121|NCT01422304|21187157|P1|Overall Study|Never Entered Follow-up|2
6150122|NCT01422304|21187156|P2|Overall Study|Lost to Follow-up|20
6150123|NCT01422304|21187157|P1|Overall Study|Lost to Follow-up|14
6150124|NCT01422304|21187156|P2|Overall Study|Adverse Event|1
6150125|NCT01422304|21187157|P1|Overall Study|Adverse Event|0
6150126|NCT01383018|21187187|P1|Overall Study|Subject Incarcerated|1
6150127|NCT01383018|21187187|P1|Overall Study|Patient moved away from site|1
6150128|NCT01383018|21187187|P1|Overall Study|Site closed early-not compliance related|7
6150129|NCT01383018|21187187|P1|Overall Study|Missed Visit|247
6150130|NCT01383018|21187187|P1|Overall Study|Subject not implanted|76
6150131|NCT01383018|21187187|P1|Overall Study|Withdrawal by Subject|9
6150132|NCT01383018|21187187|P1|Overall Study|Physician Decision|5
6150133|NCT01383018|21187187|P1|Overall Study|Lost to Follow-up|5
6150134|NCT01383018|21187187|P1|Overall Study|Death|10
6150135|NCT01383018|21187187|P1|Overall Study|Adverse Event|14
6150136|NCT01275677|21187261|P2|Overall Study|No clinical follow up.|4
6150137|NCT01275677|21187262|P1|Overall Study|No clinical follow up.|1
6150138|NCT01275677|21187261|P2|Overall Study|No follow-up|37
6150139|NCT01275677|21187262|P1|Overall Study|No follow-up|26
6150140|NCT01275677|21187261|P2|Overall Study|Not at risk for recurrence.|1
6150141|NCT01275677|21187262|P1|Overall Study|Not at risk for recurrence.|1
6150142|NCT01250912|21187294|P1|Overall Study|Lost to Follow-up|1
6150143|NCT01116648|21187447|P15|Phase 1 Dose Level 3|Adverse Event|0
6150144|NCT01116648|21187448|P14|Phase 1 Dose Level 3|Adverse Event|0
6150145|NCT01116648|21187449|P13|Phase 1 Dose Level 3|Adverse Event|0
6150146|NCT01116648|21187450|P12|Phase 1 Dose Level 3|Adverse Event|0
6150147|NCT01116648|21187451|P11|Phase 1 Dose Level 3|Adverse Event|0
6150148|NCT01116648|21187452|P10|Phase 1 Dose Level 3|Adverse Event|0
6150149|NCT01116648|21187453|P9|Phase 1 Dose Level 3|Adverse Event|0
6150150|NCT01116648|21187454|P8|Phase 1 Dose Level 3|Adverse Event|0
6150151|NCT01116648|21187455|P7|Phase 1 Dose Level 3|Adverse Event|0
6150152|NCT01116648|21187456|P6|Phase 1 Dose Level 3|Adverse Event|0
6150153|NCT01116648|21187457|P5|Phase 1 Dose Level 3|Adverse Event|0
6150154|NCT01116648|21187458|P4|Phase 1 Dose Level 3|Adverse Event|2
6150155|NCT01116648|21187459|P3|Phase 1 Dose Level 3|Adverse Event|0
6150156|NCT01116648|21187460|P2|Phase 1 Dose Level 3|Adverse Event|0
6150157|NCT01116648|21187461|P1|Phase 1 Dose Level 3|Adverse Event|0
6150158|NCT01052493|21187486|P3|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|0
6150159|NCT01052493|21187487|P2|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|0
6150160|NCT01052493|21187488|P1|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|1
6150161|NCT01015131|21187513|P1|Overall Study|Other Protocol Specified Criteria|4
6150162|NCT01015131|21187513|P1|Overall Study|Withdrawal by Subject|2
6150163|NCT01015131|21187513|P1|Overall Study|Protocol Violation|1
6150164|NCT01015131|21187513|P1|Overall Study|Physician Decision|1
6150243|NCT00948675|21187649|P2|Overall Study|Treatment ongoing|4
6150244|NCT00948675|21187650|P1|Overall Study|Treatment ongoing|5
6150245|NCT00948675|21187649|P2|Overall Study|Lost to Follow-up|0
6150246|NCT00948675|21187650|P1|Overall Study|Lost to Follow-up|2
6150247|NCT00943722|21187669|P5|Overall Study|Withdrawal by Subject|8
6150248|NCT00943722|21187670|P4|Overall Study|Withdrawal by Subject|13
6150249|NCT00943722|21187671|P3|Overall Study|Withdrawal by Subject|2
6150250|NCT00943722|21187672|P2|Overall Study|Withdrawal by Subject|13
6150251|NCT00943722|21187673|P1|Overall Study|Withdrawal by Subject|12
6150252|NCT00943722|21187669|P5|Overall Study|Protocol Violation|2
6150253|NCT00943722|21187670|P4|Overall Study|Protocol Violation|0
6150254|NCT00943722|21187671|P3|Overall Study|Protocol Violation|0
6150255|NCT00943722|21187672|P2|Overall Study|Protocol Violation|1
6150256|NCT00943722|21187673|P1|Overall Study|Protocol Violation|0
6150257|NCT00943722|21187669|P5|Overall Study|Pregnancy|0
6150258|NCT00943722|21187670|P4|Overall Study|Pregnancy|0
6150259|NCT00943722|21187671|P3|Overall Study|Pregnancy|1
6150260|NCT00943722|21187672|P2|Overall Study|Pregnancy|0
6150261|NCT00943722|21187673|P1|Overall Study|Pregnancy|0
6150262|NCT00943722|21187669|P5|Overall Study|Physician Decision|1
6150263|NCT00943722|21187670|P4|Overall Study|Physician Decision|0
6150264|NCT00943722|21187671|P3|Overall Study|Physician Decision|0
6150265|NCT00943722|21187672|P2|Overall Study|Physician Decision|0
6150266|NCT00943722|21187673|P1|Overall Study|Physician Decision|1
6150267|NCT00943722|21187669|P5|Overall Study|Lost to Follow-up|11
6150268|NCT00943722|21187670|P4|Overall Study|Lost to Follow-up|8
6150269|NCT00943722|21187671|P3|Overall Study|Lost to Follow-up|10
6150270|NCT00943722|21187672|P2|Overall Study|Lost to Follow-up|8
6150271|NCT00943722|21187673|P1|Overall Study|Lost to Follow-up|12
6150272|NCT00943722|21187669|P5|Overall Study|Adverse Event|0
6150273|NCT00943722|21187670|P4|Overall Study|Adverse Event|1
6150274|NCT00943722|21187671|P3|Overall Study|Adverse Event|0
6150275|NCT00943722|21187672|P2|Overall Study|Adverse Event|0
6150276|NCT00943722|21187673|P1|Overall Study|Adverse Event|0
6150277|NCT00847912|21187703|P2|Overall Study|Withdrawal by Subject|6
6150278|NCT00847912|21187704|P1|Overall Study|Withdrawal by Subject|3
6150279|NCT00847912|21187703|P2|Overall Study|Protocol Violation|7
6150280|NCT00847912|21187704|P1|Overall Study|Protocol Violation|6
6150281|NCT00813124|21187712|P1|Overall Study|Withdrawal by Subject|1
6150282|NCT00813124|21187712|P1|Overall Study|Ineligible - Participants did not received Azacytidine|9
6150283|NCT00813124|21187712|P1|Overall Study|Death|2
6150284|NCT00794677|21187718|P2|First Intervention|Withdrawal by Subject|0
6150285|NCT00794677|21187719|P1|First Intervention|Withdrawal by Subject|2
6150286|NCT00662012|21187750|P1|Overall Study|Withdrawal by Subject|1
6150287|NCT00662012|21187750|P1|Overall Study|Death|1
6150288|NCT00662012|21187750|P1|Overall Study|Lost to Follow-up|85
6150299|NCT00437281|21187823|P20|Overall Study|Lost to Follow-up|1
6150300|NCT00437281|21187824|P19|Overall Study|Lost to Follow-up|0
6150301|NCT00437281|21187825|P18|Overall Study|Lost to Follow-up|0
6150302|NCT00437281|21187826|P17|Overall Study|Lost to Follow-up|0
6150303|NCT00437281|21187827|P16|Overall Study|Lost to Follow-up|0
6150304|NCT00437281|21187828|P15|Overall Study|Lost to Follow-up|0
6150305|NCT00437281|21187829|P14|Overall Study|Lost to Follow-up|0
6150306|NCT00437281|21187830|P13|Overall Study|Lost to Follow-up|0
6150307|NCT00437281|21187831|P12|Overall Study|Lost to Follow-up|0
6150308|NCT00437281|21187832|P11|Overall Study|Lost to Follow-up|0
6150309|NCT00437281|21187833|P10|Overall Study|Lost to Follow-up|0
6150310|NCT00437281|21187834|P9|Overall Study|Lost to Follow-up|0
6150311|NCT00437281|21187835|P8|Overall Study|Lost to Follow-up|0
6150312|NCT00437281|21187836|P7|Overall Study|Lost to Follow-up|0
6150313|NCT00437281|21187837|P6|Overall Study|Lost to Follow-up|0
6150314|NCT00437281|21187838|P5|Overall Study|Lost to Follow-up|0
6150315|NCT00437281|21187839|P4|Overall Study|Lost to Follow-up|0
6150316|NCT00437281|21187840|P3|Overall Study|Lost to Follow-up|0
6150317|NCT00437281|21187841|P2|Overall Study|Lost to Follow-up|0
6150318|NCT00437281|21187842|P1|Overall Study|Lost to Follow-up|0
6150319|NCT00437281|21187823|P20|Overall Study|Adverse Event|0
6150320|NCT00437281|21187824|P19|Overall Study|Adverse Event|1
6150321|NCT00437281|21187825|P18|Overall Study|Adverse Event|0
6150322|NCT00437281|21187826|P17|Overall Study|Adverse Event|0
6150323|NCT00437281|21187827|P16|Overall Study|Adverse Event|0
6150324|NCT00437281|21187828|P15|Overall Study|Adverse Event|1
6150325|NCT00437281|21187829|P14|Overall Study|Adverse Event|1
6150326|NCT00437281|21187830|P13|Overall Study|Adverse Event|0
6150327|NCT00437281|21187831|P12|Overall Study|Adverse Event|0
6150328|NCT00437281|21187832|P11|Overall Study|Adverse Event|0
6150329|NCT00437281|21187833|P10|Overall Study|Adverse Event|1
6150330|NCT00437281|21187834|P9|Overall Study|Adverse Event|0
6150331|NCT00437281|21187835|P8|Overall Study|Adverse Event|0
6150332|NCT00437281|21187836|P7|Overall Study|Adverse Event|0
6150333|NCT00437281|21187837|P6|Overall Study|Adverse Event|1
6150334|NCT00437281|21187838|P5|Overall Study|Adverse Event|0
6150335|NCT00437281|21187839|P4|Overall Study|Adverse Event|1
6150336|NCT00437281|21187840|P3|Overall Study|Adverse Event|0
6150337|NCT00437281|21187841|P2|Overall Study|Adverse Event|0
6150338|NCT00437281|21187842|P1|Overall Study|Adverse Event|0
6150339|NCT00415623|21188138|P2|Overall Study|Withdrawal by Subject|1
6150340|NCT00415623|21188139|P1|Overall Study|Withdrawal by Subject|1
6150341|NCT00415623|21188138|P2|Overall Study|Death|0
6150342|NCT00415623|21188139|P1|Overall Study|Death|1
6150343|NCT00415623|21188138|P2|Overall Study|Adverse Event|4
6150344|NCT00415623|21188139|P1|Overall Study|Adverse Event|3
6150345|NCT00412113|21188165|P2|Overall Study|did not receive treatment|0
6150346|NCT00412113|21188166|P1|Overall Study|did not receive treatment|1
6150347|NCT00412113|21188165|P2|Overall Study|Adverse Event|15
6150348|NCT00412113|21188166|P1|Overall Study|Adverse Event|11
6150349|NCT00380874|21188220|P2|Overall Study|Not related to study drug|2
6150350|NCT00380874|21188221|P1|Overall Study|Not related to study drug|3
6150351|NCT00380874|21188220|P2|Overall Study|Withdrawal by Subject|1
6150352|NCT00380874|21188221|P1|Overall Study|Withdrawal by Subject|2
6150353|NCT00380874|21188220|P2|Overall Study|Death|0
6150354|NCT00380874|21188221|P1|Overall Study|Death|1
6150355|NCT00380874|21188220|P2|Overall Study|Adverse Event|7
6150356|NCT00380874|21188221|P1|Overall Study|Adverse Event|7
6150357|NCT00333866|21188296|P4|Overall Study|Randomized but not Treated|1
6150358|NCT00333866|21188297|P3|Overall Study|Randomized but not Treated|2
6150359|NCT00333866|21188298|P2|Overall Study|Randomized but not Treated|3
6150360|NCT00333866|21188299|P1|Overall Study|Randomized but not Treated|5
6150361|NCT00333866|21188296|P4|Overall Study|Withdrawal by Subject|9
6150362|NCT00333866|21188297|P3|Overall Study|Withdrawal by Subject|4
6150363|NCT00333866|21188298|P2|Overall Study|Withdrawal by Subject|14
6150364|NCT00333866|21188299|P1|Overall Study|Withdrawal by Subject|8
6150365|NCT00333866|21188296|P4|Overall Study|Lost to Follow-up|2
6150366|NCT00333866|21188297|P3|Overall Study|Lost to Follow-up|2
6150367|NCT00333866|21188298|P2|Overall Study|Lost to Follow-up|2
6150368|NCT00333866|21188299|P1|Overall Study|Lost to Follow-up|1
6150369|NCT00333866|21188296|P4|Overall Study|Lack of Efficacy|5
6150370|NCT00333866|21188297|P3|Overall Study|Lack of Efficacy|3
6150371|NCT00333866|21188298|P2|Overall Study|Lack of Efficacy|6
6150372|NCT00333866|21188299|P1|Overall Study|Lack of Efficacy|8
6150373|NCT00333866|21188296|P4|Overall Study|Other|2
6150374|NCT00333866|21188297|P3|Overall Study|Other|2
6150375|NCT00333866|21188298|P2|Overall Study|Other|2
6150376|NCT00333866|21188299|P1|Overall Study|Other|3
6150377|NCT00333866|21188296|P4|Overall Study|Adverse Event|47
6150378|NCT00333866|21188297|P3|Overall Study|Adverse Event|38
6150379|NCT00333866|21188298|P2|Overall Study|Adverse Event|37
6150380|NCT00333866|21188299|P1|Overall Study|Adverse Event|23
6150390|NCT00223990|21188415|P2|Overall Study|Lost to Follow-up|0
6150391|NCT00223990|21188416|P1|Overall Study|Lost to Follow-up|1
6150392|NCT00223990|21188415|P2|Overall Study|Withdrawal by Subject|8
6150393|NCT00223990|21188416|P1|Overall Study|Withdrawal by Subject|4
6150394|NCT00223990|21188415|P2|Overall Study|Moved from area|1
6150395|NCT00223990|21188416|P1|Overall Study|Moved from area|2
6150396|NCT00197054|21188468|P3|Overall Study|Lost to Follow-up|0
6150397|NCT00197054|21188469|P2|Overall Study|Lost to Follow-up|4
6150398|NCT00197054|21188470|P1|Overall Study|Lost to Follow-up|1
6150399|NCT00197054|21188468|P3|Overall Study|Moved from area|9
6150400|NCT00197054|21188469|P2|Overall Study|Moved from area|14
6150401|NCT00197054|21188470|P1|Overall Study|Moved from area|7
6150402|NCT00197054|21188468|P3|Overall Study|Withdrawal by Subject|3
6150403|NCT00197054|21188469|P2|Overall Study|Withdrawal by Subject|3
6150404|NCT00197054|21188470|P1|Overall Study|Withdrawal by Subject|9
6151929|NCT04071158|21196045|P5|Overall Study|Randomized but not treated|0
6151930|NCT04071158|21196046|P4|Overall Study|Randomized but not treated|0
6151931|NCT04071158|21196047|P3|Overall Study|Randomized but not treated|0
6151932|NCT04071158|21196048|P2|Overall Study|Randomized but not treated|2
6151933|NCT04071158|21196049|P1|Overall Study|Randomized but not treated|2
6151934|NCT04071158|21196045|P5|Overall Study|Lost to Follow-up|5
6151935|NCT04071158|21196046|P4|Overall Study|Lost to Follow-up|3
6151936|NCT04071158|21196047|P3|Overall Study|Lost to Follow-up|3
6151937|NCT04071158|21196048|P2|Overall Study|Lost to Follow-up|2
6151938|NCT04071158|21196049|P1|Overall Study|Lost to Follow-up|1
6152046|NCT03332628|21197262|P1|Overall Study|Physician Decision|2
6152507|NCT02314780|21199408|P3|Overall Study|Adverse Event|0
6152508|NCT02314780|21199409|P2|Overall Study|Adverse Event|1
6152509|NCT02314780|21199410|P1|Overall Study|Adverse Event|0
6152510|NCT02314780|21199408|P3|Overall Study|organizational reasons|0
6152511|NCT02314780|21199409|P2|Overall Study|organizational reasons|2
6152512|NCT02314780|21199410|P1|Overall Study|organizational reasons|0
6152577|NCT02147626|21199752|P2|Overall Study|Withdrawal by Subject|1
6152578|NCT02147626|21199753|P1|Overall Study|Withdrawal by Subject|0
6152579|NCT02147626|21199752|P2|Overall Study|Pregnancy|2
6152580|NCT02147626|21199753|P1|Overall Study|Pregnancy|1
6152581|NCT02147626|21199752|P2|Overall Study|Lost to Follow-up|4
6152582|NCT02147626|21199753|P1|Overall Study|Lost to Follow-up|4
6152590|NCT02094417|21199831|P4|Overall Study|Withdrawal by Subject|3
6152591|NCT02094417|21199832|P3|Overall Study|Withdrawal by Subject|1
6152592|NCT02094417|21199833|P2|Overall Study|Withdrawal by Subject|2
6152593|NCT02094417|21199834|P1|Overall Study|Withdrawal by Subject|1
6152594|NCT02094417|21199831|P4|Overall Study|Unable to conduct observations or assess|0
6152595|NCT02094417|21199832|P3|Overall Study|Unable to conduct observations or assess|0
6152596|NCT02094417|21199833|P2|Overall Study|Unable to conduct observations or assess|1
6152597|NCT02094417|21199834|P1|Overall Study|Unable to conduct observations or assess|0
6152598|NCT02094417|21199831|P4|Overall Study|No responder|3
6152599|NCT02094417|21199832|P3|Overall Study|No responder|4
6152600|NCT02094417|21199833|P2|Overall Study|No responder|4
6152601|NCT02094417|21199834|P1|Overall Study|No responder|4
6152602|NCT02094417|21199831|P4|Overall Study|Eligibility criteria|0
6152603|NCT02094417|21199832|P3|Overall Study|Eligibility criteria|0
6152604|NCT02094417|21199833|P2|Overall Study|Eligibility criteria|1
6152605|NCT02094417|21199834|P1|Overall Study|Eligibility criteria|0
6152606|NCT02094417|21199831|P4|Overall Study|Adverse Event|1
6152607|NCT02094417|21199832|P3|Overall Study|Adverse Event|0
6152608|NCT02094417|21199833|P2|Overall Study|Adverse Event|0
6152609|NCT02094417|21199834|P1|Overall Study|Adverse Event|0
6152665|NCT01986881|21200048|P3|Overall Study|Other|2
6152666|NCT01986881|21200049|P2|Overall Study|Other|2
6152667|NCT01986881|21200050|P1|Overall Study|Other|1
6152668|NCT01986881|21200048|P3|Overall Study|Subject Moved|0
6152669|NCT01986881|21200049|P2|Overall Study|Subject Moved|1
6152670|NCT01986881|21200050|P1|Overall Study|Subject Moved|0
6152671|NCT01986881|21200048|P3|Overall Study|Withdrawal by Subject|45
6152672|NCT01986881|21200049|P2|Overall Study|Withdrawal by Subject|60
6152673|NCT01986881|21200050|P1|Overall Study|Withdrawal by Subject|41
6152674|NCT01986881|21200048|P3|Overall Study|Study Site Terminated by Sponsor|3
6152675|NCT01986881|21200049|P2|Overall Study|Study Site Terminated by Sponsor|2
6152676|NCT01986881|21200050|P1|Overall Study|Study Site Terminated by Sponsor|2
6152677|NCT01986881|21200048|P3|Overall Study|Physician Decision|6
6152678|NCT01986881|21200049|P2|Overall Study|Physician Decision|4
6152679|NCT01986881|21200050|P1|Overall Study|Physician Decision|7
6152680|NCT01986881|21200048|P3|Overall Study|Lost to Follow-up|55
6152681|NCT01986881|21200049|P2|Overall Study|Lost to Follow-up|44
6152682|NCT01986881|21200050|P1|Overall Study|Lost to Follow-up|51
6152683|NCT01986881|21200048|P3|Overall Study|Death|247
6152684|NCT01986881|21200049|P2|Overall Study|Death|233
6152685|NCT01986881|21200050|P1|Overall Study|Death|228
6152798|NCT01779856|21200691|P1|Overall Study|Subject ineligible for Implant|2
6152799|NCT01779856|21200691|P1|Overall Study|Delays in scheduling implant|1
6152800|NCT01779856|21200691|P1|Overall Study|Inclusion/Exclusion Not Met|2
6152801|NCT01779856|21200691|P1|Overall Study|Physician Decision|1
6152802|NCT01779856|21200691|P1|Overall Study|Death|3
6152803|NCT01779856|21200691|P1|Overall Study|Withdrawal by Subject|15
6153111|NCT01502072|21201155|P3|Overall Study|Death|0
6153112|NCT01502072|21201156|P2|Overall Study|Death|1
6153113|NCT01502072|21201157|P1|Overall Study|Death|0
6153114|NCT01502072|21201155|P3|Overall Study|Withdrawal by Subject|0
6153115|NCT01502072|21201156|P2|Overall Study|Withdrawal by Subject|0
6153116|NCT01502072|21201157|P1|Overall Study|Withdrawal by Subject|1
6153236|NCT00991276|21201419|P6|Third Intervention Period|Withdrawal by Subject|0
6153237|NCT00991276|21201420|P5|Third Intervention Period|Withdrawal by Subject|0
6153238|NCT00991276|21201421|P4|Third Intervention Period|Withdrawal by Subject|1
6153239|NCT00991276|21201422|P3|Third Intervention Period|Withdrawal by Subject|0
6153240|NCT00991276|21201423|P2|Third Intervention Period|Withdrawal by Subject|0
6153241|NCT00991276|21201424|P1|Third Intervention Period|Withdrawal by Subject|0
6153242|NCT00991276|21201419|P6|Third Intervention Period|Adverse Event|0
6153243|NCT00991276|21201420|P5|Third Intervention Period|Adverse Event|0
6153244|NCT00991276|21201421|P4|Third Intervention Period|Adverse Event|0
6153245|NCT00991276|21201422|P3|Third Intervention Period|Adverse Event|1
6153246|NCT00991276|21201423|P2|Third Intervention Period|Adverse Event|0
6153247|NCT00991276|21201424|P1|Third Intervention Period|Adverse Event|0
6153248|NCT00991276|21201419|P6|Third Intervention Period|Other|1
6153249|NCT00991276|21201420|P5|Third Intervention Period|Other|0
6153250|NCT00991276|21201421|P4|Third Intervention Period|Other|0
6153251|NCT00991276|21201422|P3|Third Intervention Period|Other|0
6153252|NCT00991276|21201423|P2|Third Intervention Period|Other|0
6153253|NCT00991276|21201424|P1|Third Intervention Period|Other|0
6153254|NCT00991276|21201419|P6|Third Intervention Period|Protocol Violation|0
6153255|NCT00991276|21201420|P5|Third Intervention Period|Protocol Violation|0
6153256|NCT00991276|21201421|P4|Third Intervention Period|Protocol Violation|0
6153257|NCT00991276|21201422|P3|Third Intervention Period|Protocol Violation|0
6153258|NCT00991276|21201423|P2|Third Intervention Period|Protocol Violation|0
6153259|NCT00991276|21201424|P1|Third Intervention Period|Protocol Violation|1
6153260|NCT00991276|21201419|P6|Second Intervention Period|Other|1
6153261|NCT00991276|21201420|P5|Second Intervention Period|Other|0
6153262|NCT00991276|21201421|P4|Second Intervention Period|Other|1
6153263|NCT00991276|21201422|P3|Second Intervention Period|Other|0
6153264|NCT00991276|21201423|P2|Second Intervention Period|Other|0
6153265|NCT00991276|21201424|P1|Second Intervention Period|Other|0
6153266|NCT00991276|21201419|P6|Second Intervention Period|Protocol Violation|0
6153267|NCT00991276|21201420|P5|Second Intervention Period|Protocol Violation|0
6153268|NCT00991276|21201421|P4|Second Intervention Period|Protocol Violation|0
6153269|NCT00991276|21201422|P3|Second Intervention Period|Protocol Violation|0
6153270|NCT00991276|21201423|P2|Second Intervention Period|Protocol Violation|0
6153271|NCT00991276|21201424|P1|Second Intervention Period|Protocol Violation|1
6153272|NCT00991276|21201419|P6|Second Intervention Period|Adverse Event|0
6153273|NCT00991276|21201420|P5|Second Intervention Period|Adverse Event|1
6153274|NCT00991276|21201421|P4|Second Intervention Period|Adverse Event|1
6153275|NCT00991276|21201422|P3|Second Intervention Period|Adverse Event|0
6153276|NCT00991276|21201423|P2|Second Intervention Period|Adverse Event|2
6153277|NCT00991276|21201424|P1|Second Intervention Period|Adverse Event|0
6153278|NCT00991276|21201419|P6|First Intervention Period|Lost to Follow-up|0
6153279|NCT00991276|21201420|P5|First Intervention Period|Lost to Follow-up|0
6153280|NCT00991276|21201421|P4|First Intervention Period|Lost to Follow-up|1
6153281|NCT00991276|21201422|P3|First Intervention Period|Lost to Follow-up|0
6153282|NCT00991276|21201423|P2|First Intervention Period|Lost to Follow-up|1
6153283|NCT00991276|21201424|P1|First Intervention Period|Lost to Follow-up|0
6153284|NCT00991276|21201419|P6|First Intervention Period|Withdrawal by Subject|1
6153285|NCT00991276|21201420|P5|First Intervention Period|Withdrawal by Subject|0
6153286|NCT00991276|21201421|P4|First Intervention Period|Withdrawal by Subject|1
6153287|NCT00991276|21201422|P3|First Intervention Period|Withdrawal by Subject|0
6153288|NCT00991276|21201423|P2|First Intervention Period|Withdrawal by Subject|1
6153289|NCT00991276|21201424|P1|First Intervention Period|Withdrawal by Subject|0
6153290|NCT00991276|21201419|P6|First Intervention Period|Other|0
6153291|NCT00991276|21201420|P5|First Intervention Period|Other|1
6153292|NCT00991276|21201421|P4|First Intervention Period|Other|1
6153293|NCT00991276|21201422|P3|First Intervention Period|Other|0
6153294|NCT00991276|21201423|P2|First Intervention Period|Other|0
6153295|NCT00991276|21201424|P1|First Intervention Period|Other|0
6153296|NCT00991276|21201419|P6|First Intervention Period|Insufficient clinical response|0
6153297|NCT00991276|21201420|P5|First Intervention Period|Insufficient clinical response|1
6153298|NCT00991276|21201421|P4|First Intervention Period|Insufficient clinical response|0
6153299|NCT00991276|21201422|P3|First Intervention Period|Insufficient clinical response|0
6153300|NCT00991276|21201423|P2|First Intervention Period|Insufficient clinical response|0
6153301|NCT00991276|21201424|P1|First Intervention Period|Insufficient clinical response|0
6153302|NCT00991276|21201419|P6|First Intervention Period|Protocol Violation|0
6153303|NCT00991276|21201420|P5|First Intervention Period|Protocol Violation|2
6153304|NCT00991276|21201421|P4|First Intervention Period|Protocol Violation|0
6153305|NCT00991276|21201422|P3|First Intervention Period|Protocol Violation|0
6153306|NCT00991276|21201423|P2|First Intervention Period|Protocol Violation|0
6153307|NCT00991276|21201424|P1|First Intervention Period|Protocol Violation|0
6153308|NCT00991276|21201419|P6|First Intervention Period|Adverse Event|0
6153309|NCT00991276|21201420|P5|First Intervention Period|Adverse Event|0
6153310|NCT00991276|21201421|P4|First Intervention Period|Adverse Event|1
6153311|NCT00991276|21201422|P3|First Intervention Period|Adverse Event|0
6153312|NCT00991276|21201423|P2|First Intervention Period|Adverse Event|1
6153313|NCT00991276|21201424|P1|First Intervention Period|Adverse Event|0
6153411|NCT00539981|21201830|P2|Overall Study|Other reason-unspecified|13
6153412|NCT00539981|21201831|P1|Overall Study|Other reason-unspecified|9
6153413|NCT00539981|21201830|P2|Overall Study|Death|1
6153414|NCT00539981|21201831|P1|Overall Study|Death|1
6153415|NCT00539981|21201830|P2|Overall Study|Withdrew consent|14
6153416|NCT00539981|21201831|P1|Overall Study|Withdrew consent|22
6153417|NCT00539981|21201830|P2|Overall Study|Lost to Follow-up|251
6153418|NCT00539981|21201831|P1|Overall Study|Lost to Follow-up|260
6153419|NCT00539981|21201830|P2|Overall Study|Adverse events (AE)|3
6153420|NCT00539981|21201831|P1|Overall Study|Adverse events (AE)|3
6153520|NCT00317369|21202061|P3|Overall Study|Withdrawal by Subject|1
6153521|NCT00317369|21202062|P2|Overall Study|Withdrawal by Subject|0
6153522|NCT00317369|21202063|P1|Overall Study|Withdrawal by Subject|0
6153523|NCT00317369|21202061|P3|Overall Study|Lack of Efficacy|1
6153524|NCT00317369|21202062|P2|Overall Study|Lack of Efficacy|1
6153525|NCT00317369|21202063|P1|Overall Study|Lack of Efficacy|0
6153526|NCT00317369|21202061|P3|Overall Study|Adverse Event|0
6153527|NCT00317369|21202062|P2|Overall Study|Adverse Event|1
6153528|NCT00317369|21202063|P1|Overall Study|Adverse Event|2
6153553|NCT04245202|21202199|P2|Overall Study|Lack of Efficacy|1
6153554|NCT04245202|21202200|P1|Overall Study|Lack of Efficacy|10
6153555|NCT04170686|21202266|P2|Randomization and Treatment|Lost to Follow-up|15
6153556|NCT04170686|21202267|P1|Randomization and Treatment|Lost to Follow-up|26
6153557|NCT04170686|21202266|P2|Screening|Physician Decision|13
6153558|NCT04170686|21202267|P1|Screening|Physician Decision|12
6153559|NCT04161807|21202289|P1|Overall Study|Performed only 1 treatment|2
6153560|NCT04161807|21202289|P1|Overall Study|Withdrawal by Subject|2
6153561|NCT04093258|21202301|P2|Period 2|Subject no longer meets the eligibility criteria|0
6153562|NCT04093258|21202302|P1|Period 2|Subject no longer meets the eligibility criteria|1
6153565|NCT03769649|21202817|P1|Overall Study|Lost to Follow-up|4
6153576|NCT03521635|21203021|P2|Overall Study|Patient not taken study medicine|1
6153577|NCT03521635|21203022|P1|Overall Study|Patient not taken study medicine|0
6153578|NCT03521635|21203021|P2|Overall Study|Meet exclusion criteria|1
6153579|NCT03521635|21203022|P1|Overall Study|Meet exclusion criteria|0
6153580|NCT03521635|21203021|P2|Overall Study|Lost to Follow-up|1
6153581|NCT03521635|21203022|P1|Overall Study|Lost to Follow-up|0
6153582|NCT03521635|21203021|P2|Overall Study|Refused to continue trial medication|2
6153583|NCT03521635|21203022|P1|Overall Study|Refused to continue trial medication|2
6153584|NCT03521635|21203021|P2|Overall Study|Refused to complete study visit|0
6153585|NCT03521635|21203022|P1|Overall Study|Refused to complete study visit|1
6153586|NCT03521635|21203021|P2|Overall Study|Adverse Event|1
6153587|NCT03521635|21203022|P1|Overall Study|Adverse Event|1
6153591|NCT03499873|21203113|P3|Overall Study|Investigational Product (IP) Missed dose compliance|0
6153592|NCT03499873|21203114|P2|Overall Study|Investigational Product (IP) Missed dose compliance|1
6153593|NCT03499873|21203115|P1|Overall Study|Investigational Product (IP) Missed dose compliance|1
6153594|NCT03499873|21203113|P3|Overall Study|Miscellaneous|2
6153595|NCT03499873|21203114|P2|Overall Study|Miscellaneous|2
6153596|NCT03499873|21203115|P1|Overall Study|Miscellaneous|1
6153597|NCT03499873|21203113|P3|Overall Study|Concomitant therapy|7
6153598|NCT03499873|21203114|P2|Overall Study|Concomitant therapy|4
6153599|NCT03499873|21203115|P1|Overall Study|Concomitant therapy|5
6153600|NCT03499873|21203113|P3|Overall Study|Administrative reasons|0
6153601|NCT03499873|21203114|P2|Overall Study|Administrative reasons|1
6153602|NCT03499873|21203115|P1|Overall Study|Administrative reasons|0
6153603|NCT03499873|21203113|P3|Overall Study|Physician Decision|0
6153604|NCT03499873|21203114|P2|Overall Study|Physician Decision|0
6153605|NCT03499873|21203115|P1|Overall Study|Physician Decision|1
6153606|NCT03499873|21203113|P3|Overall Study|Adverse Event|6
6153607|NCT03499873|21203114|P2|Overall Study|Adverse Event|3
6153608|NCT03499873|21203115|P1|Overall Study|Adverse Event|8
6153609|NCT03499873|21203113|P3|Overall Study|Subjects condition worsened|11
6153610|NCT03499873|21203114|P2|Overall Study|Subjects condition worsened|3
6153611|NCT03499873|21203115|P1|Overall Study|Subjects condition worsened|0
6153612|NCT03499873|21203113|P3|Overall Study|Withdrawal by Subject|1
6153613|NCT03499873|21203114|P2|Overall Study|Withdrawal by Subject|6
6153614|NCT03499873|21203115|P1|Overall Study|Withdrawal by Subject|4
6153644|NCT03389555|21203305|P2|Overall Study|Death|0
6153645|NCT03389555|21203306|P1|Overall Study|Death|1
6153646|NCT03389555|21203305|P2|Overall Study|Protocol Violation|3
6153647|NCT03389555|21203306|P1|Overall Study|Protocol Violation|1
6153656|NCT03361293|21203414|P2|Overall Study|Withdrawal by Subject|3
6153657|NCT03361293|21203415|P1|Overall Study|Withdrawal by Subject|1
6153658|NCT03361293|21203414|P2|Overall Study|Lost to Follow-up|2
6153659|NCT03361293|21203415|P1|Overall Study|Lost to Follow-up|0
6153690|NCT03216226|21203592|P2|Overall Study|Patient withdrawn prior to treatment. Patient veins unsuitable for blood draws|1
6153691|NCT03216226|21203593|P1|Overall Study|Patient withdrawn prior to treatment. Patient veins unsuitable for blood draws|0
6153692|NCT03216226|21203592|P2|Overall Study|Deviation from protocol window during visit as patient had to leave for work|1
6153693|NCT03216226|21203593|P1|Overall Study|Deviation from protocol window during visit as patient had to leave for work|0
6153694|NCT03216226|21203592|P2|Overall Study|Patient unable to take time off work to come in for the third injection|0
6153695|NCT03216226|21203593|P1|Overall Study|Patient unable to take time off work to come in for the third injection|1
6153696|NCT03216226|21203592|P2|Overall Study|Protocol Violation|3
6153697|NCT03216226|21203593|P1|Overall Study|Protocol Violation|1
6153698|NCT03216226|21203592|P2|Overall Study|Adverse Event|0
6153699|NCT03216226|21203593|P1|Overall Study|Adverse Event|3
6153704|NCT03173313|21203636|P2|Overall Study|Bone Fracture|0
6153705|NCT03173313|21203637|P1|Overall Study|Bone Fracture|1
6153706|NCT03173313|21203636|P2|Overall Study|Diagnosis of Takotsubo Cardiomyopathy|1
6153707|NCT03173313|21203637|P1|Overall Study|Diagnosis of Takotsubo Cardiomyopathy|0
6153708|NCT03173313|21203636|P2|Overall Study|Physician Decision|0
6153709|NCT03173313|21203637|P1|Overall Study|Physician Decision|1
6153710|NCT03173313|21203636|P2|Overall Study|Death|0
6153711|NCT03173313|21203637|P1|Overall Study|Death|5
6153712|NCT03173313|21203636|P2|Overall Study|Withdrawal by Subject|1
6153713|NCT03173313|21203637|P1|Overall Study|Withdrawal by Subject|0
6153714|NCT03173313|21203636|P2|Overall Study|Lost to Follow-up|3
6153715|NCT03173313|21203637|P1|Overall Study|Lost to Follow-up|2
6153755|NCT03078751|21203727|P2|Overall Study|Untreated|4
6153756|NCT03078751|21203728|P1|Overall Study|Untreated|0
6153757|NCT03078751|21203727|P2|Overall Study|Subject/guardian decision|1
6153758|NCT03078751|21203728|P1|Overall Study|Subject/guardian decision|8
6153759|NCT03078751|21203727|P2|Overall Study|Terminated by Sponsor = early terminated recruitment|23
6153760|NCT03078751|21203728|P1|Overall Study|Terminated by Sponsor = early terminated recruitment|0
6153761|NCT03078751|21203727|P2|Overall Study|Physician Decision|0
6153762|NCT03078751|21203728|P1|Overall Study|Physician Decision|1
6153763|NCT03078751|21203727|P2|Overall Study|Adverse Event|0
6153764|NCT03078751|21203728|P1|Overall Study|Adverse Event|4
6153803|NCT02964338|21203878|P3|Overall Study|Did not meet criteria|0
6153804|NCT02964338|21203879|P2|Overall Study|Did not meet criteria|0
6153805|NCT02964338|21203880|P1|Overall Study|Did not meet criteria|1
6153806|NCT02964338|21203878|P3|Overall Study|Non-compliant with e-diary|0
6153807|NCT02964338|21203879|P2|Overall Study|Non-compliant with e-diary|1
6153808|NCT02964338|21203880|P1|Overall Study|Non-compliant with e-diary|0
6153809|NCT02964338|21203878|P3|Overall Study|Adverse Event|1
6153810|NCT02964338|21203879|P2|Overall Study|Adverse Event|1
6153811|NCT02964338|21203880|P1|Overall Study|Adverse Event|2
6153812|NCT02964338|21203878|P3|Overall Study|Withdrawal by Subject|1
6153813|NCT02964338|21203879|P2|Overall Study|Withdrawal by Subject|3
6153814|NCT02964338|21203880|P1|Overall Study|Withdrawal by Subject|1
6153815|NCT02964338|21203878|P3|Overall Study|Protocol Violation|0
6153816|NCT02964338|21203879|P2|Overall Study|Protocol Violation|1
6153817|NCT02964338|21203880|P1|Overall Study|Protocol Violation|0
6153818|NCT02964338|21203878|P3|Overall Study|Lost to Follow-up|3
6153819|NCT02964338|21203879|P2|Overall Study|Lost to Follow-up|0
6153820|NCT02964338|21203880|P1|Overall Study|Lost to Follow-up|1
6153821|NCT02964338|21203878|P3|Overall Study|Lack of Efficacy|0
6153822|NCT02964338|21203879|P2|Overall Study|Lack of Efficacy|3
6153823|NCT02964338|21203880|P1|Overall Study|Lack of Efficacy|0
6153824|NCT02964338|21203878|P3|Overall Study|Sponsor terminated study for futility|14
6153825|NCT02964338|21203879|P2|Overall Study|Sponsor terminated study for futility|15
6153826|NCT02964338|21203880|P1|Overall Study|Sponsor terminated study for futility|12
6153890|NCT02891681|21204090|P3|Overall Study|Taken off study after first imaging appointment|0
6153891|NCT02891681|21204091|P2|Overall Study|Taken off study after first imaging appointment|0
6153892|NCT02891681|21204092|P1|Overall Study|Taken off study after first imaging appointment|1
6153893|NCT02891681|21204090|P3|Overall Study|Developed metastases prior to completing neoadjuvant therapy|0
6153894|NCT02891681|21204091|P2|Overall Study|Developed metastases prior to completing neoadjuvant therapy|0
6153895|NCT02891681|21204092|P1|Overall Study|Developed metastases prior to completing neoadjuvant therapy|2
6153896|NCT02891681|21204090|P3|Overall Study|Did not complete all timepoints in Endocrine Cohort|1
6153897|NCT02891681|21204091|P2|Overall Study|Did not complete all timepoints in Endocrine Cohort|0
6153898|NCT02891681|21204092|P1|Overall Study|Did not complete all timepoints in Endocrine Cohort|0
6153899|NCT02874742|21204103|P3|Overall Study|Ongoing|15
6153900|NCT02874742|21204104|P2|Overall Study|Ongoing|98
6153901|NCT02874742|21204105|P1|Overall Study|Ongoing|87
6153902|NCT02874742|21204103|P3|Overall Study|Other|0
6153903|NCT02874742|21204104|P2|Overall Study|Other|1
6153904|NCT02874742|21204105|P1|Overall Study|Other|3
6153905|NCT02874742|21204103|P3|Overall Study|Withdrawal by Subject|0
6153906|NCT02874742|21204104|P2|Overall Study|Withdrawal by Subject|4
6153907|NCT02874742|21204105|P1|Overall Study|Withdrawal by Subject|8
6153908|NCT02874742|21204103|P3|Overall Study|Lost to Follow-up|0
6153909|NCT02874742|21204104|P2|Overall Study|Lost to Follow-up|0
6153910|NCT02874742|21204105|P1|Overall Study|Lost to Follow-up|2
6153911|NCT02874742|21204103|P3|Overall Study|Death|1
6153912|NCT02874742|21204104|P2|Overall Study|Death|1
6153913|NCT02874742|21204105|P1|Overall Study|Death|3
6153914|NCT02865538|21204171|P5|Overall Study|Lost to Follow-up|0
6153915|NCT02865538|21204172|P4|Overall Study|Lost to Follow-up|0
6153916|NCT02865538|21204173|P3|Overall Study|Lost to Follow-up|0
6153917|NCT02865538|21204174|P2|Overall Study|Lost to Follow-up|0
6153918|NCT02865538|21204175|P1|Overall Study|Lost to Follow-up|1
6153919|NCT02865538|21204171|P5|Overall Study|Withdrawal by Subject|0
6153920|NCT02865538|21204172|P4|Overall Study|Withdrawal by Subject|0
6153921|NCT02865538|21204173|P3|Overall Study|Withdrawal by Subject|1
6153922|NCT02865538|21204174|P2|Overall Study|Withdrawal by Subject|0
6153923|NCT02865538|21204175|P1|Overall Study|Withdrawal by Subject|0
6153944|NCT02772978|21204501|P2|Overall Study|Withdrawal by Subject|1
6153945|NCT02772978|21204502|P1|Overall Study|Withdrawal by Subject|1
6154010|NCT02652949|21204864|P1|24-Month Follow-up Secondary Endpoint|Subject declined reconsenting to extended follow-up out to 5 years|28
6154011|NCT02652949|21204864|P1|24-Month Follow-up Secondary Endpoint|Lost to Follow-up|2
6154012|NCT02652949|21204864|P1|24-Month Follow-up Secondary Endpoint|Withdrawal by Subject|3
6154013|NCT02652949|21204864|P1|24-Month Follow-up Secondary Endpoint|Death|2
6154014|NCT02652949|21204864|P1|12-Month Follow-up Secondary Endpoint|Death|4
6154015|NCT02652949|21204864|P1|6-Month Follow-up Secondary Endpoint|Lost to Follow-up|1
6154016|NCT02652949|21204864|P1|6-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2
6154017|NCT02652949|21204864|P1|6-Month Follow-up Secondary Endpoint|Death|5
6154018|NCT02652949|21204864|P1|30-Day Follow-up for Secondary Endpoint|Death|1
6154019|NCT02652949|21204864|P1|30-Day Follow-up for Primary Endpoint|Death|1
6154020|NCT02625324|21204965|P1|24-Month Follow-up Secondary Endpoint|Subject declined reconsenting to extended follow-up out to 5 years|28
6154021|NCT02625324|21204965|P1|24-Month Follow-up Secondary Endpoint|Lost to Follow-up|2
6154022|NCT02625324|21204965|P1|24-Month Follow-up Secondary Endpoint|Withdrawal by Subject|3
6154023|NCT02625324|21204965|P1|24-Month Follow-up Secondary Endpoint|Death|2
6154024|NCT02625324|21204965|P1|12-Month Follow-up Secondary Endpoint|Death|4
6154025|NCT02625324|21204965|P1|6-Month Follow-up Subject Accountability|Lost to Follow-up|1
6154026|NCT02625324|21204965|P1|6-Month Follow-up Subject Accountability|Withdrawal by Subject|2
6154027|NCT02625324|21204965|P1|6-Month Follow-up Subject Accountability|Death|5
6154028|NCT02625324|21204965|P1|30-Day Follow-up for Secondary Endpoint|Death|1
6154029|NCT02625324|21204965|P1|30-Day Follow-up for Primary Endpoint|Death|1
6154054|NCT02583048|21205040|P3|Overall Study|Failed to meet eligibility criterion|1
6154055|NCT02583048|21205041|P2|Overall Study|Failed to meet eligibility criterion|0
6154056|NCT02583048|21205042|P1|Overall Study|Failed to meet eligibility criterion|0
6154057|NCT02583048|21205040|P3|Overall Study|Withdrawal by Subject|0
6154058|NCT02583048|21205041|P2|Overall Study|Withdrawal by Subject|1
6154059|NCT02583048|21205042|P1|Overall Study|Withdrawal by Subject|0
6154060|NCT02499159|21205130|P2|30-Day Follow-Up Phone Call|Other|0
6154061|NCT02499159|21205131|P1|30-Day Follow-Up Phone Call|Other|1
6154062|NCT02499159|21205130|P2|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|0
6154063|NCT02499159|21205131|P1|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|2
6154064|NCT02499159|21205130|P2|30-Day Follow-Up Phone Call|Lost to Follow-up|1
6154065|NCT02499159|21205131|P1|30-Day Follow-Up Phone Call|Lost to Follow-up|3
6154066|NCT02499159|21205130|P2|30-Day Follow-Up Phone Call|Withdrawal by Subject|1
6154067|NCT02499159|21205131|P1|30-Day Follow-Up Phone Call|Withdrawal by Subject|1
6154068|NCT02499159|21205130|P2|Randomization|Protocol Violation|1
6154069|NCT02499159|21205131|P1|Randomization|Protocol Violation|1
6154139|NCT02235298|21205615|P2|Overall Study|Withdrawal by Subject|1
6154140|NCT02235298|21205616|P1|Overall Study|Withdrawal by Subject|0
6154141|NCT02235298|21205615|P2|Overall Study|Adverse Event|2
6154142|NCT02235298|21205616|P1|Overall Study|Adverse Event|2
6154143|NCT02235298|21205615|P2|Overall Study|Lost to Follow-up|5
6154144|NCT02235298|21205616|P1|Overall Study|Lost to Follow-up|6
6154149|NCT02206685|21205671|P2|Overall Study|Protocol Violation|2
6154150|NCT02206685|21205672|P1|Overall Study|Protocol Violation|2
6154151|NCT02206685|21205671|P2|Overall Study|Withdrawal by Subject|2
6154152|NCT02206685|21205672|P1|Overall Study|Withdrawal by Subject|1
6154153|NCT02206685|21205671|P2|Overall Study|Surgery cancelled/changed|3
6154154|NCT02206685|21205672|P1|Overall Study|Surgery cancelled/changed|2
6154159|NCT02178722|21205805|P5|Overall Study|Participants Ongoing in study|74
6154160|NCT02178722|21205806|P4|Overall Study|Participants Ongoing in study|2
6154161|NCT02178722|21205807|P3|Overall Study|Participants Ongoing in study|4
6154162|NCT02178722|21205808|P2|Overall Study|Participants Ongoing in study|1
6154163|NCT02178722|21205809|P1|Overall Study|Participants Ongoing in study|1
6154164|NCT02178722|21205805|P5|Overall Study|Other Unspecified|1
6154165|NCT02178722|21205806|P4|Overall Study|Other Unspecified|0
6154166|NCT02178722|21205807|P3|Overall Study|Other Unspecified|0
6154167|NCT02178722|21205808|P2|Overall Study|Other Unspecified|0
6154168|NCT02178722|21205809|P1|Overall Study|Other Unspecified|0
6154169|NCT02178722|21205805|P5|Overall Study|Physician Decision|2
6154170|NCT02178722|21205806|P4|Overall Study|Physician Decision|0
6154171|NCT02178722|21205807|P3|Overall Study|Physician Decision|0
6154172|NCT02178722|21205808|P2|Overall Study|Physician Decision|0
6154173|NCT02178722|21205809|P1|Overall Study|Physician Decision|0
6154174|NCT02178722|21205805|P5|Overall Study|Participant trial terminated by sponsor|65
6154175|NCT02178722|21205806|P4|Overall Study|Participant trial terminated by sponsor|3
6154176|NCT02178722|21205807|P3|Overall Study|Participant trial terminated by sponsor|2
6154177|NCT02178722|21205808|P2|Overall Study|Participant trial terminated by sponsor|6
6154178|NCT02178722|21205809|P1|Overall Study|Participant trial terminated by sponsor|1
6154179|NCT02178722|21205805|P5|Overall Study|Lost to Follow-up|11
6154180|NCT02178722|21205806|P4|Overall Study|Lost to Follow-up|2
6154181|NCT02178722|21205807|P3|Overall Study|Lost to Follow-up|0
6154182|NCT02178722|21205808|P2|Overall Study|Lost to Follow-up|0
6154183|NCT02178722|21205809|P1|Overall Study|Lost to Follow-up|0
6154184|NCT02178722|21205805|P5|Overall Study|Death|199
6154185|NCT02178722|21205806|P4|Overall Study|Death|11
6154186|NCT02178722|21205807|P3|Overall Study|Death|12
6154187|NCT02178722|21205808|P2|Overall Study|Death|13
6154188|NCT02178722|21205809|P1|Overall Study|Death|2
6154189|NCT02178722|21205805|P5|Overall Study|Participant decision|30
6154190|NCT02178722|21205806|P4|Overall Study|Participant decision|2
6154191|NCT02178722|21205807|P3|Overall Study|Participant decision|0
6154192|NCT02178722|21205808|P2|Overall Study|Participant decision|0
6154193|NCT02178722|21205809|P1|Overall Study|Participant decision|0
6154194|NCT02139280|21205823|P2|Overall Study|No longer eligible|0
6154195|NCT02139280|21205824|P1|Overall Study|No longer eligible|2
6154201|NCT02068885|21205880|P3|Overall Study|Withdrew|8
6154202|NCT02068885|21205881|P2|Overall Study|Withdrew|5
6154203|NCT02068885|21205882|P1|Overall Study|Withdrew|3
6154368|NCT01756898|21206314|P4|Overall Study|Other|0
6154369|NCT01756898|21206315|P3|Overall Study|Other|2
6154370|NCT01756898|21206316|P2|Overall Study|Other|2
6154371|NCT01756898|21206317|P1|Overall Study|Other|0
6154372|NCT01756898|21206314|P4|Overall Study|Withdrew Consent|6
6154373|NCT01756898|21206315|P3|Overall Study|Withdrew Consent|5
6154374|NCT01756898|21206316|P2|Overall Study|Withdrew Consent|3
6154375|NCT01756898|21206317|P1|Overall Study|Withdrew Consent|5
6154376|NCT01756898|21206314|P4|Overall Study|Protocol Violation|1
6154377|NCT01756898|21206315|P3|Overall Study|Protocol Violation|2
6154378|NCT01756898|21206316|P2|Overall Study|Protocol Violation|2
6154379|NCT01756898|21206317|P1|Overall Study|Protocol Violation|1
6154380|NCT01756898|21206314|P4|Overall Study|Lost to Follow-up|3
6154381|NCT01756898|21206315|P3|Overall Study|Lost to Follow-up|2
6154382|NCT01756898|21206316|P2|Overall Study|Lost to Follow-up|4
6154383|NCT01756898|21206317|P1|Overall Study|Lost to Follow-up|2
6154384|NCT01756898|21206314|P4|Overall Study|Lack of Efficacy|6
6154385|NCT01756898|21206315|P3|Overall Study|Lack of Efficacy|6
6154386|NCT01756898|21206316|P2|Overall Study|Lack of Efficacy|7
6154387|NCT01756898|21206317|P1|Overall Study|Lack of Efficacy|4
6154388|NCT01756898|21206314|P4|Overall Study|Adverse Event|0
6154389|NCT01756898|21206315|P3|Overall Study|Adverse Event|0
6154390|NCT01756898|21206316|P2|Overall Study|Adverse Event|1
6154391|NCT01756898|21206317|P1|Overall Study|Adverse Event|7
6154656|NCT01581593|21206609|P1|Overall Study|Withdrawal by Subject|1
6154657|NCT01576783|21206629|P2|Overall Study|Withdrawal by Subject|1
6154658|NCT01576783|21206630|P1|Overall Study|Withdrawal by Subject|5
6154659|NCT01576783|21206629|P2|Overall Study|Lost to Follow-up|16
6154660|NCT01576783|21206630|P1|Overall Study|Lost to Follow-up|14
6154661|NCT01576783|21206629|P2|Overall Study|Change in Medical Care|0
6154662|NCT01576783|21206630|P1|Overall Study|Change in Medical Care|1
6154669|NCT01568320|21206668|P1|Overall Study|Patient fell outside of the consented window, data outside of the consented 5-year was not collected|1
6154670|NCT01568320|21206668|P1|Overall Study|Conversion to open repair|1
6154671|NCT01568320|21206668|P1|Overall Study|Withdrawal by Subject|10
6154672|NCT01568320|21206668|P1|Overall Study|Lost to Follow-up|9
6154673|NCT01568320|21206668|P1|Overall Study|Death|20
6154772|NCT01102231|21206927|P1|Overall Study|Did not received the treatment|4
6154773|NCT01102231|21206927|P1|Overall Study|Withdrawal by Subject|1
6154774|NCT01102231|21206927|P1|Overall Study|Adverse Event|3
6154775|NCT01102231|21206927|P1|Overall Study|Death|2
6154776|NCT01102231|21206927|P1|Overall Study|Lack of Efficacy|2
6154777|NCT01102231|21206927|P1|Overall Study|Protocol Violation|3
6154794|NCT00866697|21207027|P2|Overall Study|Withdrawal by Subject|57
6154795|NCT00866697|21207028|P1|Overall Study|Withdrawal by Subject|33
6154796|NCT00866697|21207027|P2|Overall Study|Physician Decision|5
6154797|NCT00866697|21207028|P1|Overall Study|Physician Decision|3
6154798|NCT00866697|21207027|P2|Overall Study|Lost to Follow-up|28
6154799|NCT00866697|21207028|P1|Overall Study|Lost to Follow-up|22
6154800|NCT00866697|21207027|P2|Overall Study|Study closed/terminated|138
6154801|NCT00866697|21207028|P1|Overall Study|Study closed/terminated|156
6155014|NCT03905096|21207673|P2|Period 2 for Trial Part 1 and 2|Adverse Event|0
6155015|NCT03905096|21207674|P1|Period 2 for Trial Part 1 and 2|Adverse Event|1
6155024|NCT03576066|21207805|P2|Overall Study|Noncompliance with study drug|1
6155025|NCT03576066|21207806|P1|Overall Study|Noncompliance with study drug|0
6155037|NCT03473301|21207952|P3|Overall Study|Missed study visit due to pandemic restrictions|6
6155038|NCT03473301|21207953|P2|Overall Study|Missed study visit due to pandemic restrictions|5
6155039|NCT03473301|21207954|P1|Overall Study|Missed study visit due to pandemic restrictions|7
6155040|NCT03473301|21207952|P3|Overall Study|Withdrawal by Subject|0
6155041|NCT03473301|21207953|P2|Overall Study|Withdrawal by Subject|1
6155042|NCT03473301|21207954|P1|Overall Study|Withdrawal by Subject|0
6155043|NCT03473301|21207952|P3|Overall Study|Protocol Violation|0
6155044|NCT03473301|21207953|P2|Overall Study|Protocol Violation|0
6155045|NCT03473301|21207954|P1|Overall Study|Protocol Violation|4
6155046|NCT03433482|21207987|P4|Overall Study|Unknown reason|0
6155047|NCT03433482|21207988|P3|Overall Study|Unknown reason|2
6155048|NCT03433482|21207989|P2|Overall Study|Unknown reason|0
6155049|NCT03433482|21207990|P1|Overall Study|Unknown reason|0
6155050|NCT03433482|21207987|P4|Overall Study|Withdrawal by Subject|0
6155051|NCT03433482|21207988|P3|Overall Study|Withdrawal by Subject|1
6155052|NCT03433482|21207989|P2|Overall Study|Withdrawal by Subject|0
6155053|NCT03433482|21207990|P1|Overall Study|Withdrawal by Subject|0
6155054|NCT03433482|21207987|P4|Overall Study|Lost to Follow-up|1
6155055|NCT03433482|21207988|P3|Overall Study|Lost to Follow-up|1
6155056|NCT03433482|21207989|P2|Overall Study|Lost to Follow-up|0
6155057|NCT03433482|21207990|P1|Overall Study|Lost to Follow-up|1
6155096|NCT03193736|21208308|P1|Overall Study|implant not received|1
6155097|NCT03193736|21208308|P1|Overall Study|Lost to Follow-up|1
6155098|NCT03193736|21208308|P1|Overall Study|Withdrawal by Subject|1
6155099|NCT03193736|21208308|P1|Overall Study|Death|2
6155139|NCT03008915|21208392|P2|Treatment 1|Withdrawal by Subject|1
6155140|NCT03008915|21208393|P1|Treatment 1|Withdrawal by Subject|0
6155147|NCT02978781|21208423|P5|Part C|Tremor not improved due to Topamax discontinuation|1
6155148|NCT02978781|21208424|P4|Part C|Tremor not improved due to Topamax discontinuation|0
6155149|NCT02978781|21208425|P3|Part C|Tremor not improved due to Topamax discontinuation|0
6155150|NCT02978781|21208426|P2|Part C|Tremor not improved due to Topamax discontinuation|0
6155151|NCT02978781|21208427|P1|Part C|Tremor not improved due to Topamax discontinuation|0
6155152|NCT02978781|21208423|P5|Part C|Withdrawal by Subject|1
6155153|NCT02978781|21208424|P4|Part C|Withdrawal by Subject|0
6155154|NCT02978781|21208425|P3|Part C|Withdrawal by Subject|0
6155155|NCT02978781|21208426|P2|Part C|Withdrawal by Subject|0
6155156|NCT02978781|21208427|P1|Part C|Withdrawal by Subject|0
6155157|NCT02978781|21208423|P5|Part C|Adverse Event|2
6155158|NCT02978781|21208424|P4|Part C|Adverse Event|0
6155159|NCT02978781|21208425|P3|Part C|Adverse Event|0
6155160|NCT02978781|21208426|P2|Part C|Adverse Event|0
6155161|NCT02978781|21208427|P1|Part C|Adverse Event|0
6155162|NCT02978781|21208423|P5|Part B|Withdrawal by Subject|0
6155163|NCT02978781|21208424|P4|Part B|Withdrawal by Subject|1
6155164|NCT02978781|21208425|P3|Part B|Withdrawal by Subject|0
6155165|NCT02978781|21208426|P2|Part B|Withdrawal by Subject|0
6155166|NCT02978781|21208427|P1|Part B|Withdrawal by Subject|0
6155167|NCT02978781|21208423|P5|Part A|Withdrawal by Subject|0
6155168|NCT02978781|21208424|P4|Part A|Withdrawal by Subject|0
6155169|NCT02978781|21208425|P3|Part A|Withdrawal by Subject|0
6155170|NCT02978781|21208426|P2|Part A|Withdrawal by Subject|1
6155171|NCT02978781|21208427|P1|Part A|Withdrawal by Subject|0
6155172|NCT02978781|21208423|P5|Part A|Adverse Event|0
6155173|NCT02978781|21208424|P4|Part A|Adverse Event|0
6155174|NCT02978781|21208425|P3|Part A|Adverse Event|0
6155175|NCT02978781|21208426|P2|Part A|Adverse Event|1
6155176|NCT02978781|21208427|P1|Part A|Adverse Event|1
6155177|NCT02935452|21208505|P2|Overall Study|work and life commintment|1
6155178|NCT02935452|21208506|P1|Overall Study|work and life commintment|3
6155182|NCT02928224|21208526|P4|Overall Study|not listed|0
6155183|NCT02928224|21208527|P3|Overall Study|not listed|1
6155184|NCT02928224|21208528|P2|Overall Study|not listed|3
6155185|NCT02928224|21208529|P1|Overall Study|not listed|0
6155186|NCT02928224|21208526|P4|Overall Study|Physician Decision|2
6155187|NCT02928224|21208527|P3|Overall Study|Physician Decision|4
6155188|NCT02928224|21208528|P2|Overall Study|Physician Decision|2
6155189|NCT02928224|21208529|P1|Overall Study|Physician Decision|0
6155190|NCT02928224|21208526|P4|Overall Study|Patient Decision to Discontinue Drug|4
6155191|NCT02928224|21208527|P3|Overall Study|Patient Decision to Discontinue Drug|2
6155192|NCT02928224|21208528|P2|Overall Study|Patient Decision to Discontinue Drug|2
6155193|NCT02928224|21208529|P1|Overall Study|Patient Decision to Discontinue Drug|0
6155194|NCT02928224|21208526|P4|Overall Study|Dose Interruptions>28|4
6155195|NCT02928224|21208527|P3|Overall Study|Dose Interruptions>28|2
6155196|NCT02928224|21208528|P2|Overall Study|Dose Interruptions>28|2
6155197|NCT02928224|21208529|P1|Overall Study|Dose Interruptions>28|1
6155198|NCT02928224|21208526|P4|Overall Study|Withdrawal by Subject|9
6155199|NCT02928224|21208527|P3|Overall Study|Withdrawal by Subject|3
6155200|NCT02928224|21208528|P2|Overall Study|Withdrawal by Subject|4
6155201|NCT02928224|21208529|P1|Overall Study|Withdrawal by Subject|1
6155202|NCT02928224|21208526|P4|Overall Study|Death|11
6155203|NCT02928224|21208527|P3|Overall Study|Death|5
6155204|NCT02928224|21208528|P2|Overall Study|Death|7
6155205|NCT02928224|21208529|P1|Overall Study|Death|1
6155206|NCT02928224|21208526|P4|Overall Study|Changes in Patient's Condition|13
6155207|NCT02928224|21208527|P3|Overall Study|Changes in Patient's Condition|9
6155208|NCT02928224|21208528|P2|Overall Study|Changes in Patient's Condition|9
6155209|NCT02928224|21208529|P1|Overall Study|Changes in Patient's Condition|3
6155210|NCT02928224|21208526|P4|Overall Study|Adverse Event|10
6155211|NCT02928224|21208527|P3|Overall Study|Adverse Event|11
6155212|NCT02928224|21208528|P2|Overall Study|Adverse Event|11
6155213|NCT02928224|21208529|P1|Overall Study|Adverse Event|2
6155214|NCT02928224|21208526|P4|Overall Study|Progressive Disease|103
6155215|NCT02928224|21208527|P3|Overall Study|Progressive Disease|101
6155216|NCT02928224|21208528|P2|Overall Study|Progressive Disease|104
6155217|NCT02928224|21208529|P1|Overall Study|Progressive Disease|23
6155218|NCT02928224|21208526|P4|Overall Study|Treatment Ongoing|37
6155219|NCT02928224|21208527|P3|Overall Study|Treatment Ongoing|78
6155220|NCT02928224|21208528|P2|Overall Study|Treatment Ongoing|78
6155221|NCT02928224|21208529|P1|Overall Study|Treatment Ongoing|6
6155222|NCT02928224|21208526|P4|Overall Study|Randomized, Not Treated|28
6155223|NCT02928224|21208527|P3|Overall Study|Randomized, Not Treated|4
6155224|NCT02928224|21208528|P2|Overall Study|Randomized, Not Treated|2
6155225|NCT02928224|21208529|P1|Overall Study|Randomized, Not Treated|0
6155226|NCT02924883|21208633|P2|Overall Study|Study Terminated by Sponsor|32
6155227|NCT02924883|21208634|P1|Overall Study|Study Terminated by Sponsor|69
6155228|NCT02924883|21208633|P2|Overall Study|Progressive Disease|0
6155229|NCT02924883|21208634|P1|Overall Study|Progressive Disease|1
6155230|NCT02924883|21208633|P2|Overall Study|Withdrawal by Subject|16
6155231|NCT02924883|21208634|P1|Overall Study|Withdrawal by Subject|22
6155232|NCT02924883|21208633|P2|Overall Study|Protocol Violation|0
6155233|NCT02924883|21208634|P1|Overall Study|Protocol Violation|1
6155234|NCT02924883|21208633|P2|Overall Study|Symptomatic Deterioration/ Clinical Progression|1
6155235|NCT02924883|21208634|P1|Overall Study|Symptomatic Deterioration/ Clinical Progression|0
6155236|NCT02924883|21208633|P2|Overall Study|Lost to Follow-up|0
6155237|NCT02924883|21208634|P1|Overall Study|Lost to Follow-up|1
6155238|NCT02924883|21208633|P2|Overall Study|Death|20
6155239|NCT02924883|21208634|P1|Overall Study|Death|39
6155250|NCT02832622|21208686|P1|Overall Study|Physician Decision|6
6155251|NCT02832622|21208686|P1|Overall Study|System explant|24
6155252|NCT02832622|21208686|P1|Overall Study|Withdrawal by other reasons|25
6155253|NCT02832622|21208686|P1|Overall Study|Patient non-compliance|42
6155254|NCT02832622|21208686|P1|Overall Study|Lost to Follow-up|45
6155255|NCT02832622|21208686|P1|Overall Study|Unsuccessful CRT implant|93
6155256|NCT02832622|21208686|P1|Overall Study|Death|119
6155257|NCT02832622|21208686|P1|Overall Study|Withdrawal by Subject|123
6155258|NCT02832622|21208686|P1|Overall Study|MPP not programmed|1259
6155259|NCT02804178|21208699|P1|Overall Study|Adverse Event|1
6155260|NCT02748616|21208703|P1|Overall Study|Did Not Complete Ursodial Course|2
6155261|NCT02748616|21208703|P1|Overall Study|Physician Decision|2
6155262|NCT02748616|21208703|P1|Overall Study|Withdrawal by Subject|2
6155263|NCT02748616|21208703|P1|Overall Study|Lost to Follow-up|1
6155269|NCT02691702|21208725|P11|Overall Study|Protocol Violation|0
6155270|NCT02691702|21208726|P10|Overall Study|Protocol Violation|2
6155271|NCT02691702|21208727|P9|Overall Study|Protocol Violation|0
6155272|NCT02691702|21208728|P8|Overall Study|Protocol Violation|0
6155273|NCT02691702|21208729|P7|Overall Study|Protocol Violation|0
6155274|NCT02691702|21208730|P6|Overall Study|Protocol Violation|0
6155275|NCT02691702|21208731|P5|Overall Study|Protocol Violation|0
6155276|NCT02691702|21208732|P4|Overall Study|Protocol Violation|0
6155277|NCT02691702|21208733|P3|Overall Study|Protocol Violation|0
6155278|NCT02691702|21208734|P2|Overall Study|Protocol Violation|0
6155279|NCT02691702|21208735|P1|Overall Study|Protocol Violation|0
6155280|NCT02691702|21208725|P11|Overall Study|Other|0
6155281|NCT02691702|21208726|P10|Overall Study|Other|0
6155282|NCT02691702|21208727|P9|Overall Study|Other|1
6155283|NCT02691702|21208728|P8|Overall Study|Other|0
6155284|NCT02691702|21208729|P7|Overall Study|Other|1
6155285|NCT02691702|21208730|P6|Overall Study|Other|0
6155286|NCT02691702|21208731|P5|Overall Study|Other|0
6155287|NCT02691702|21208732|P4|Overall Study|Other|0
6155288|NCT02691702|21208733|P3|Overall Study|Other|0
6155289|NCT02691702|21208734|P2|Overall Study|Other|0
6155290|NCT02691702|21208735|P1|Overall Study|Other|0
6155291|NCT02691702|21208725|P11|Overall Study|Withdrawal by Subject|0
6155292|NCT02691702|21208726|P10|Overall Study|Withdrawal by Subject|0
6155293|NCT02691702|21208727|P9|Overall Study|Withdrawal by Subject|0
6155294|NCT02691702|21208728|P8|Overall Study|Withdrawal by Subject|0
6155295|NCT02691702|21208729|P7|Overall Study|Withdrawal by Subject|2
6155296|NCT02691702|21208730|P6|Overall Study|Withdrawal by Subject|1
6155297|NCT02691702|21208731|P5|Overall Study|Withdrawal by Subject|0
6155298|NCT02691702|21208732|P4|Overall Study|Withdrawal by Subject|0
6155299|NCT02691702|21208733|P3|Overall Study|Withdrawal by Subject|0
6155300|NCT02691702|21208734|P2|Overall Study|Withdrawal by Subject|1
6155301|NCT02691702|21208735|P1|Overall Study|Withdrawal by Subject|1
6155302|NCT02691702|21208725|P11|Overall Study|Lost to Follow-up|1
6155303|NCT02691702|21208726|P10|Overall Study|Lost to Follow-up|0
6155304|NCT02691702|21208727|P9|Overall Study|Lost to Follow-up|0
6155305|NCT02691702|21208728|P8|Overall Study|Lost to Follow-up|0
6155306|NCT02691702|21208729|P7|Overall Study|Lost to Follow-up|0
6155307|NCT02691702|21208730|P6|Overall Study|Lost to Follow-up|2
6155308|NCT02691702|21208731|P5|Overall Study|Lost to Follow-up|0
6155309|NCT02691702|21208732|P4|Overall Study|Lost to Follow-up|0
6155310|NCT02691702|21208733|P3|Overall Study|Lost to Follow-up|1
6155311|NCT02691702|21208734|P2|Overall Study|Lost to Follow-up|0
6155312|NCT02691702|21208735|P1|Overall Study|Lost to Follow-up|0
6155313|NCT02691702|21208725|P11|Overall Study|Adverse Event|1
6155314|NCT02691702|21208726|P10|Overall Study|Adverse Event|0
6155315|NCT02691702|21208727|P9|Overall Study|Adverse Event|1
6155316|NCT02691702|21208728|P8|Overall Study|Adverse Event|0
6155317|NCT02691702|21208729|P7|Overall Study|Adverse Event|0
6155318|NCT02691702|21208730|P6|Overall Study|Adverse Event|0
6155319|NCT02691702|21208731|P5|Overall Study|Adverse Event|0
6155320|NCT02691702|21208732|P4|Overall Study|Adverse Event|0
6155321|NCT02691702|21208733|P3|Overall Study|Adverse Event|0
6155322|NCT02691702|21208734|P2|Overall Study|Adverse Event|0
6155323|NCT02691702|21208735|P1|Overall Study|Adverse Event|1
6155326|NCT02586025|21209088|P2|Treatment-Free Follow-Up|Remain in Treatment-Free Follow-Up|35
6155327|NCT02586025|21209089|P1|Treatment-Free Follow-Up|Remain in Treatment-Free Follow-Up|56
6155328|NCT02586025|21209088|P2|Adjuvant Treatment|Recurrent Disease|4
6155329|NCT02586025|21209089|P1|Adjuvant Treatment|Recurrent Disease|1
6155330|NCT02586025|21209088|P2|Adjuvant Treatment|Physician Decision|1
6155331|NCT02586025|21209089|P1|Adjuvant Treatment|Physician Decision|0
6155332|NCT02586025|21209088|P2|Adjuvant Treatment|Withdrawal by Subject|3
6155333|NCT02586025|21209089|P1|Adjuvant Treatment|Withdrawal by Subject|5
6155334|NCT02586025|21209088|P2|Adjuvant Treatment|Remain in Adjuvant Treatment|61
6155335|NCT02586025|21209089|P1|Adjuvant Treatment|Remain in Adjuvant Treatment|133
6155336|NCT02586025|21209088|P2|Neoadjuvant Treatment|Progressive Disease|3
6155337|NCT02586025|21209089|P1|Neoadjuvant Treatment|Progressive Disease|2
6155338|NCT02586025|21209088|P2|Neoadjuvant Treatment|Physician Decision|1
6155339|NCT02586025|21209089|P1|Neoadjuvant Treatment|Physician Decision|2
6155340|NCT02586025|21209088|P2|Neoadjuvant Treatment|Withdrawal by Subject|3
6155341|NCT02586025|21209089|P1|Neoadjuvant Treatment|Withdrawal by Subject|4
6155342|NCT02586025|21209088|P2|Neoadjuvant Treatment|Adverse Event|0
6155343|NCT02586025|21209089|P1|Neoadjuvant Treatment|Adverse Event|1
6155344|NCT02586025|21209088|P2|Neoadjuvant Treatment|Death|0
6155345|NCT02586025|21209089|P1|Neoadjuvant Treatment|Death|1
6155346|NCT02586025|21209088|P2|Neoadjuvant Treatment|Did Not Receive Study Drug|0
6155347|NCT02586025|21209089|P1|Neoadjuvant Treatment|Did Not Receive Study Drug|1
6155358|NCT02462759|21209158|P3|Part 1: Double Blind|Death|0
6155359|NCT02462759|21209159|P2|Part 1: Double Blind|Death|0
6155360|NCT02462759|21209160|P1|Part 1: Double Blind|Death|1
6155361|NCT02443740|21209212|P11|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
6155362|NCT02443740|21209213|P10|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
6155363|NCT02443740|21209214|P9|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
6155364|NCT02443740|21209215|P8|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
6155365|NCT02443740|21209216|P7|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
6155366|NCT02443740|21209217|P6|Intervention Period 1 (3 Days)|Withdrawal by Subject|1
6155367|NCT02443740|21209218|P5|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
6155368|NCT02443740|21209219|P4|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
6155369|NCT02443740|21209220|P3|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
6155370|NCT02443740|21209221|P2|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
6155371|NCT02443740|21209222|P1|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
6155372|NCT02443740|21209212|P11|Intervention Period 1 (3 Days)|Protocol Violation|0
6155373|NCT02443740|21209213|P10|Intervention Period 1 (3 Days)|Protocol Violation|0
6155374|NCT02443740|21209214|P9|Intervention Period 1 (3 Days)|Protocol Violation|0
6155375|NCT02443740|21209215|P8|Intervention Period 1 (3 Days)|Protocol Violation|0
6155376|NCT02443740|21209216|P7|Intervention Period 1 (3 Days)|Protocol Violation|1
6155377|NCT02443740|21209217|P6|Intervention Period 1 (3 Days)|Protocol Violation|0
6155378|NCT02443740|21209218|P5|Intervention Period 1 (3 Days)|Protocol Violation|0
6155379|NCT02443740|21209219|P4|Intervention Period 1 (3 Days)|Protocol Violation|0
6155380|NCT02443740|21209220|P3|Intervention Period 1 (3 Days)|Protocol Violation|0
6155381|NCT02443740|21209221|P2|Intervention Period 1 (3 Days)|Protocol Violation|0
6155382|NCT02443740|21209222|P1|Intervention Period 1 (3 Days)|Protocol Violation|1
6155383|NCT02443740|21209212|P11|Intervention Period 1 (3 Days)|Adverse Event|0
6155384|NCT02443740|21209213|P10|Intervention Period 1 (3 Days)|Adverse Event|0
6155385|NCT02443740|21209214|P9|Intervention Period 1 (3 Days)|Adverse Event|0
6155386|NCT02443740|21209215|P8|Intervention Period 1 (3 Days)|Adverse Event|0
6155387|NCT02443740|21209216|P7|Intervention Period 1 (3 Days)|Adverse Event|0
6155388|NCT02443740|21209217|P6|Intervention Period 1 (3 Days)|Adverse Event|1
6155389|NCT02443740|21209218|P5|Intervention Period 1 (3 Days)|Adverse Event|0
6155390|NCT02443740|21209219|P4|Intervention Period 1 (3 Days)|Adverse Event|0
6155391|NCT02443740|21209220|P3|Intervention Period 1 (3 Days)|Adverse Event|0
6155392|NCT02443740|21209221|P2|Intervention Period 1 (3 Days)|Adverse Event|0
6155393|NCT02443740|21209222|P1|Intervention Period 1 (3 Days)|Adverse Event|0
6155421|NCT02193074|21209648|P2|Overall Study|Adverse Event|13
6155422|NCT02193074|21209649|P1|Overall Study|Adverse Event|16
6155423|NCT02193074|21209648|P2|Overall Study|Withdrawal by Subject|2
6155424|NCT02193074|21209649|P1|Overall Study|Withdrawal by Subject|1
6155429|NCT02114606|21209717|P1|Overall Study|Unable to swallow Cytosponge|6
6155468|NCT02005471|21209798|P2|Overall Study|Withdrawal by Subject|7
6155469|NCT02005471|21209799|P1|Overall Study|Withdrawal by Subject|18
6155470|NCT02005471|21209798|P2|Overall Study|Progressive Disease|0
6155471|NCT02005471|21209799|P1|Overall Study|Progressive Disease|3
6155472|NCT02005471|21209798|P2|Overall Study|Physician Decision|1
6155473|NCT02005471|21209799|P1|Overall Study|Physician Decision|2
6155474|NCT02005471|21209798|P2|Overall Study|Lost to Follow-up|0
6155475|NCT02005471|21209799|P1|Overall Study|Lost to Follow-up|1
6155476|NCT02005471|21209798|P2|Overall Study|Death|15
6155477|NCT02005471|21209799|P1|Overall Study|Death|26
6155478|NCT02005471|21209798|P2|Overall Study|Adverse Event|0
6155479|NCT02005471|21209799|P1|Overall Study|Adverse Event|1
6155480|NCT02005471|21209798|P2|Overall Study|Ongoing in Study|171
6155481|NCT02005471|21209799|P1|Overall Study|Ongoing in Study|144
6155578|NCT01844986|21209976|P2|Overall Study|Death|26
6155579|NCT01844986|21209977|P1|Overall Study|Death|55
6155580|NCT01844986|21209976|P2|Overall Study|Withdrawal by Subject|14
6155581|NCT01844986|21209977|P1|Overall Study|Withdrawal by Subject|21
6155582|NCT01844986|21209976|P2|Overall Study|Severe non-compliance to protocol|0
6155583|NCT01844986|21209977|P1|Overall Study|Severe non-compliance to protocol|1
6155584|NCT01839656|21210015|P2|Overall Study|Adverse Event|0
6155585|NCT01839656|21210016|P1|Overall Study|Adverse Event|1
6155586|NCT01839656|21210015|P2|Overall Study|Early study closure|11
6155587|NCT01839656|21210016|P1|Overall Study|Early study closure|0
6155588|NCT01839656|21210015|P2|Overall Study|Adverse event, serious fatal|4
6155589|NCT01839656|21210016|P1|Overall Study|Adverse event, serious fatal|1
6155590|NCT01839656|21210015|P2|Overall Study|Withdrawal by Subject|1
6155591|NCT01839656|21210016|P1|Overall Study|Withdrawal by Subject|1
6155594|NCT01670097|21210085|P2|Overall Study|Disease progression|1
6155595|NCT01670097|21210086|P1|Overall Study|Disease progression|0
6155596|NCT01670097|21210085|P2|Overall Study|Clinical deterioration|1
6155597|NCT01670097|21210086|P1|Overall Study|Clinical deterioration|0
6155598|NCT01670097|21210085|P2|Overall Study|Neutropenia|1
6155599|NCT01670097|21210086|P1|Overall Study|Neutropenia|0
6155600|NCT01670097|21210085|P2|Overall Study|COPD exacerbation|1
6155601|NCT01670097|21210086|P1|Overall Study|COPD exacerbation|0
6155602|NCT01670097|21210085|P2|Overall Study|Study burden|0
6155603|NCT01670097|21210086|P1|Overall Study|Study burden|1
6155604|NCT01670097|21210085|P2|Overall Study|Started Phase 1 cancer treatment|0
6155605|NCT01670097|21210086|P1|Overall Study|Started Phase 1 cancer treatment|1
6155606|NCT01609556|21210114|P16|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0
6155607|NCT01609556|21210115|P15|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0
6155608|NCT01609556|21210116|P14|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0
6155609|NCT01609556|21210117|P13|Dose Expansion: Maximum 124 Weeks|Other Than Specified|1
6155610|NCT01609556|21210118|P12|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0
6155611|NCT01609556|21210119|P11|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0
6155612|NCT01609556|21210120|P10|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0
6155613|NCT01609556|21210121|P9|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0
6155614|NCT01609556|21210122|P8|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0
6155615|NCT01609556|21210123|P7|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0
6155616|NCT01609556|21210124|P6|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0
6155617|NCT01609556|21210125|P5|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0
6155618|NCT01609556|21210126|P4|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0
6155619|NCT01609556|21210127|P3|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0
6155620|NCT01609556|21210128|P2|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0
6155621|NCT01609556|21210129|P1|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0
6155622|NCT01609556|21210114|P16|Dose Expansion: Maximum 124 Weeks|Death|3
6155623|NCT01609556|21210115|P15|Dose Expansion: Maximum 124 Weeks|Death|0
6155624|NCT01609556|21210116|P14|Dose Expansion: Maximum 124 Weeks|Death|2
6155625|NCT01609556|21210117|P13|Dose Expansion: Maximum 124 Weeks|Death|4
6155626|NCT01609556|21210118|P12|Dose Expansion: Maximum 124 Weeks|Death|0
6155627|NCT01609556|21210119|P11|Dose Expansion: Maximum 124 Weeks|Death|0
6155628|NCT01609556|21210120|P10|Dose Expansion: Maximum 124 Weeks|Death|0
6155629|NCT01609556|21210121|P9|Dose Expansion: Maximum 124 Weeks|Death|0
6155630|NCT01609556|21210122|P8|Dose Expansion: Maximum 124 Weeks|Death|0
6155631|NCT01609556|21210123|P7|Dose Expansion: Maximum 124 Weeks|Death|0
6155632|NCT01609556|21210124|P6|Dose Expansion: Maximum 124 Weeks|Death|0
6155633|NCT01609556|21210125|P5|Dose Expansion: Maximum 124 Weeks|Death|0
6155634|NCT01609556|21210126|P4|Dose Expansion: Maximum 124 Weeks|Death|0
6155635|NCT01609556|21210127|P3|Dose Expansion: Maximum 124 Weeks|Death|0
6155636|NCT01609556|21210128|P2|Dose Expansion: Maximum 124 Weeks|Death|0
6155637|NCT01609556|21210129|P1|Dose Expansion: Maximum 124 Weeks|Death|0
6155638|NCT01609556|21210114|P16|Dose Expansion: Maximum 124 Weeks|Investigator Decision|1
6155639|NCT01609556|21210115|P15|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0
6155640|NCT01609556|21210116|P14|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0
6155641|NCT01609556|21210117|P13|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0
6155642|NCT01609556|21210118|P12|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0
6155643|NCT01609556|21210119|P11|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0
6155644|NCT01609556|21210120|P10|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0
6155645|NCT01609556|21210121|P9|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0
6155646|NCT01609556|21210122|P8|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0
6155647|NCT01609556|21210123|P7|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0
6155648|NCT01609556|21210124|P6|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0
6155649|NCT01609556|21210125|P5|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0
6155650|NCT01609556|21210126|P4|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0
6155651|NCT01609556|21210127|P3|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0
6155652|NCT01609556|21210128|P2|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0
6155653|NCT01609556|21210129|P1|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0
6155654|NCT01609556|21210114|P16|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|5
6155655|NCT01609556|21210115|P15|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|2
6155656|NCT01609556|21210116|P14|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|4
6155657|NCT01609556|21210117|P13|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|1
6155658|NCT01609556|21210118|P12|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0
6155659|NCT01609556|21210119|P11|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0
6155660|NCT01609556|21210120|P10|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0
6155661|NCT01609556|21210121|P9|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0
6155662|NCT01609556|21210122|P8|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0
6155663|NCT01609556|21210123|P7|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0
6155664|NCT01609556|21210124|P6|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0
6155665|NCT01609556|21210125|P5|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0
6155666|NCT01609556|21210126|P4|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0
6155667|NCT01609556|21210127|P3|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0
6155668|NCT01609556|21210128|P2|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0
6155669|NCT01609556|21210129|P1|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0
6155670|NCT01609556|21210114|P16|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0
6155671|NCT01609556|21210115|P15|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0
6155672|NCT01609556|21210116|P14|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0
6155673|NCT01609556|21210117|P13|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|1
6155674|NCT01609556|21210118|P12|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0
6155675|NCT01609556|21210119|P11|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0
6155676|NCT01609556|21210120|P10|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0
6155677|NCT01609556|21210121|P9|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0
6155678|NCT01609556|21210122|P8|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0
6155679|NCT01609556|21210123|P7|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0
6155680|NCT01609556|21210124|P6|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0
6155681|NCT01609556|21210125|P5|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0
6155682|NCT01609556|21210126|P4|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0
6155683|NCT01609556|21210127|P3|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0
6155684|NCT01609556|21210128|P2|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0
6155685|NCT01609556|21210129|P1|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0
6155686|NCT01609556|21210114|P16|Dose Expansion: Maximum 124 Weeks|Clinical Progression|2
6155687|NCT01609556|21210115|P15|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3
6155688|NCT01609556|21210116|P14|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3
6155689|NCT01609556|21210117|P13|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3
6155690|NCT01609556|21210118|P12|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0
6155691|NCT01609556|21210119|P11|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0
6155692|NCT01609556|21210120|P10|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0
6155693|NCT01609556|21210121|P9|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0
6155694|NCT01609556|21210122|P8|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0
6155695|NCT01609556|21210123|P7|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0
6155696|NCT01609556|21210124|P6|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0
6155697|NCT01609556|21210125|P5|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0
6155698|NCT01609556|21210126|P4|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0
6155699|NCT01609556|21210127|P3|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0
6155700|NCT01609556|21210128|P2|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0
6155701|NCT01609556|21210129|P1|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0
6155702|NCT01609556|21210114|P16|Dose Expansion: Maximum 124 Weeks|Disease Progression|27
6155703|NCT01609556|21210115|P15|Dose Expansion: Maximum 124 Weeks|Disease Progression|20
6155704|NCT01609556|21210116|P14|Dose Expansion: Maximum 124 Weeks|Disease Progression|13
6155705|NCT01609556|21210117|P13|Dose Expansion: Maximum 124 Weeks|Disease Progression|32
6155706|NCT01609556|21210118|P12|Dose Expansion: Maximum 124 Weeks|Disease Progression|0
6155707|NCT01609556|21210119|P11|Dose Expansion: Maximum 124 Weeks|Disease Progression|0
6155708|NCT01609556|21210120|P10|Dose Expansion: Maximum 124 Weeks|Disease Progression|0
6155709|NCT01609556|21210121|P9|Dose Expansion: Maximum 124 Weeks|Disease Progression|0
6155710|NCT01609556|21210122|P8|Dose Expansion: Maximum 124 Weeks|Disease Progression|0
6155711|NCT01609556|21210123|P7|Dose Expansion: Maximum 124 Weeks|Disease Progression|0
6155712|NCT01609556|21210124|P6|Dose Expansion: Maximum 124 Weeks|Disease Progression|0
6155713|NCT01609556|21210125|P5|Dose Expansion: Maximum 124 Weeks|Disease Progression|0
6155714|NCT01609556|21210126|P4|Dose Expansion: Maximum 124 Weeks|Disease Progression|0
6155715|NCT01609556|21210127|P3|Dose Expansion: Maximum 124 Weeks|Disease Progression|0
6155716|NCT01609556|21210128|P2|Dose Expansion: Maximum 124 Weeks|Disease Progression|0
6155717|NCT01609556|21210129|P1|Dose Expansion: Maximum 124 Weeks|Disease Progression|0
6155718|NCT01609556|21210114|P16|Dose Expansion: Maximum 124 Weeks|Adverse Event|2
6155719|NCT01609556|21210115|P15|Dose Expansion: Maximum 124 Weeks|Adverse Event|2
6155720|NCT01609556|21210116|P14|Dose Expansion: Maximum 124 Weeks|Adverse Event|2
6155721|NCT01609556|21210117|P13|Dose Expansion: Maximum 124 Weeks|Adverse Event|4
6155722|NCT01609556|21210118|P12|Dose Expansion: Maximum 124 Weeks|Adverse Event|0
6155723|NCT01609556|21210119|P11|Dose Expansion: Maximum 124 Weeks|Adverse Event|0
6155724|NCT01609556|21210120|P10|Dose Expansion: Maximum 124 Weeks|Adverse Event|0
6155725|NCT01609556|21210121|P9|Dose Expansion: Maximum 124 Weeks|Adverse Event|0
6155726|NCT01609556|21210122|P8|Dose Expansion: Maximum 124 Weeks|Adverse Event|0
6155727|NCT01609556|21210123|P7|Dose Expansion: Maximum 124 Weeks|Adverse Event|0
6155728|NCT01609556|21210124|P6|Dose Expansion: Maximum 124 Weeks|Adverse Event|0
6155729|NCT01609556|21210125|P5|Dose Expansion: Maximum 124 Weeks|Adverse Event|0
6155730|NCT01609556|21210126|P4|Dose Expansion: Maximum 124 Weeks|Adverse Event|0
6155731|NCT01609556|21210127|P3|Dose Expansion: Maximum 124 Weeks|Adverse Event|0
6155732|NCT01609556|21210128|P2|Dose Expansion: Maximum 124 Weeks|Adverse Event|0
6155733|NCT01609556|21210129|P1|Dose Expansion: Maximum 124 Weeks|Adverse Event|0
6155734|NCT01609556|21210114|P16|Dose Escalation: Maximum 101.3 Weeks|Death|0
6155735|NCT01609556|21210115|P15|Dose Escalation: Maximum 101.3 Weeks|Death|0
6155736|NCT01609556|21210116|P14|Dose Escalation: Maximum 101.3 Weeks|Death|0
6155737|NCT01609556|21210117|P13|Dose Escalation: Maximum 101.3 Weeks|Death|0
6155738|NCT01609556|21210118|P12|Dose Escalation: Maximum 101.3 Weeks|Death|0
6155739|NCT01609556|21210119|P11|Dose Escalation: Maximum 101.3 Weeks|Death|1
6155740|NCT01609556|21210120|P10|Dose Escalation: Maximum 101.3 Weeks|Death|0
6155741|NCT01609556|21210121|P9|Dose Escalation: Maximum 101.3 Weeks|Death|0
6155742|NCT01609556|21210122|P8|Dose Escalation: Maximum 101.3 Weeks|Death|0
6155743|NCT01609556|21210123|P7|Dose Escalation: Maximum 101.3 Weeks|Death|0
6155744|NCT01609556|21210124|P6|Dose Escalation: Maximum 101.3 Weeks|Death|1
6155745|NCT01609556|21210125|P5|Dose Escalation: Maximum 101.3 Weeks|Death|0
6155746|NCT01609556|21210126|P4|Dose Escalation: Maximum 101.3 Weeks|Death|0
6155747|NCT01609556|21210127|P3|Dose Escalation: Maximum 101.3 Weeks|Death|0
6155748|NCT01609556|21210128|P2|Dose Escalation: Maximum 101.3 Weeks|Death|0
6155749|NCT01609556|21210129|P1|Dose Escalation: Maximum 101.3 Weeks|Death|2
6155750|NCT01609556|21210114|P16|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0
6155751|NCT01609556|21210115|P15|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0
6155752|NCT01609556|21210116|P14|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0
6155753|NCT01609556|21210117|P13|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0
6155754|NCT01609556|21210118|P12|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0
6155755|NCT01609556|21210119|P11|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0
6155756|NCT01609556|21210120|P10|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0
6155757|NCT01609556|21210121|P9|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|1
6155758|NCT01609556|21210122|P8|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0
6155759|NCT01609556|21210123|P7|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0
6155760|NCT01609556|21210124|P6|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0
6155761|NCT01609556|21210125|P5|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0
6155762|NCT01609556|21210126|P4|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0
6155763|NCT01609556|21210127|P3|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0
6155764|NCT01609556|21210128|P2|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0
6155765|NCT01609556|21210129|P1|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0
6155766|NCT01609556|21210114|P16|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0
6155767|NCT01609556|21210115|P15|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0
6155768|NCT01609556|21210116|P14|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0
6155769|NCT01609556|21210117|P13|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0
6155770|NCT01609556|21210118|P12|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0
6155771|NCT01609556|21210119|P11|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0
6155772|NCT01609556|21210120|P10|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0
6155773|NCT01609556|21210121|P9|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0
6155774|NCT01609556|21210122|P8|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0
6155775|NCT01609556|21210123|P7|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0
6155776|NCT01609556|21210124|P6|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|1
6155777|NCT01609556|21210125|P5|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0
6155778|NCT01609556|21210126|P4|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0
6155779|NCT01609556|21210127|P3|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0
6155780|NCT01609556|21210128|P2|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0
6155781|NCT01609556|21210129|P1|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0
6155782|NCT01609556|21210114|P16|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0
6155783|NCT01609556|21210115|P15|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0
6155784|NCT01609556|21210116|P14|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0
6155785|NCT01609556|21210117|P13|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0
6155786|NCT01609556|21210118|P12|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|1
6155787|NCT01609556|21210119|P11|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0
6155788|NCT01609556|21210120|P10|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0
6155789|NCT01609556|21210121|P9|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0
6155790|NCT01609556|21210122|P8|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0
6155791|NCT01609556|21210123|P7|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0
6155792|NCT01609556|21210124|P6|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|1
6155793|NCT01609556|21210125|P5|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0
6155794|NCT01609556|21210126|P4|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0
6155795|NCT01609556|21210127|P3|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0
6155796|NCT01609556|21210128|P2|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0
6155797|NCT01609556|21210129|P1|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0
6155798|NCT01609556|21210114|P16|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0
6155799|NCT01609556|21210115|P15|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0
6155800|NCT01609556|21210116|P14|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0
6155801|NCT01609556|21210117|P13|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0
6155802|NCT01609556|21210118|P12|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2
6155803|NCT01609556|21210119|P11|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|1
6155804|NCT01609556|21210120|P10|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|1
6155805|NCT01609556|21210121|P9|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0
6155806|NCT01609556|21210122|P8|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0
6155807|NCT01609556|21210123|P7|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2
6155808|NCT01609556|21210124|P6|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2
6155809|NCT01609556|21210125|P5|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0
6155810|NCT01609556|21210126|P4|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0
6155811|NCT01609556|21210127|P3|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0
6155812|NCT01609556|21210128|P2|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0
6155813|NCT01609556|21210129|P1|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0
6155814|NCT01609556|21210114|P16|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0
6155815|NCT01609556|21210115|P15|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0
6155816|NCT01609556|21210116|P14|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0
6155817|NCT01609556|21210117|P13|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0
6155818|NCT01609556|21210118|P12|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3
6155819|NCT01609556|21210119|P11|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|6
6155820|NCT01609556|21210120|P10|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3
6155821|NCT01609556|21210121|P9|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3
6155822|NCT01609556|21210122|P8|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|4
6155823|NCT01609556|21210123|P7|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|5
6155824|NCT01609556|21210124|P6|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|13
6155825|NCT01609556|21210125|P5|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|8
6155826|NCT01609556|21210126|P4|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1
6155827|NCT01609556|21210127|P3|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1
6155828|NCT01609556|21210128|P2|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1
6155829|NCT01609556|21210129|P1|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0
6155830|NCT01609556|21210114|P16|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0
6155831|NCT01609556|21210115|P15|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0
6155832|NCT01609556|21210116|P14|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0
6155833|NCT01609556|21210117|P13|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0
6155834|NCT01609556|21210118|P12|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1
6155835|NCT01609556|21210119|P11|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1
6155836|NCT01609556|21210120|P10|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0
6155837|NCT01609556|21210121|P9|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1
6155838|NCT01609556|21210122|P8|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1
6155839|NCT01609556|21210123|P7|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0
6155840|NCT01609556|21210124|P6|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0
6155841|NCT01609556|21210125|P5|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1
6155842|NCT01609556|21210126|P4|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0
6155843|NCT01609556|21210127|P3|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0
6155844|NCT01609556|21210128|P2|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0
6155845|NCT01609556|21210129|P1|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0
6155846|NCT01584648|21210291|P2|Overall Study|Crossover to Dabrafenib + Trametinib|28
6155847|NCT01584648|21210292|P1|Overall Study|Crossover to Dabrafenib + Trametinib|0
6155848|NCT01584648|21210291|P2|Overall Study|Study closed/terminated|23
6155849|NCT01584648|21210292|P1|Overall Study|Study closed/terminated|50
6155850|NCT01584648|21210291|P2|Overall Study|Withdrew consent|4
6155851|NCT01584648|21210292|P1|Overall Study|Withdrew consent|13
6155852|NCT01584648|21210291|P2|Overall Study|Investigator discretion|2
6155853|NCT01584648|21210292|P1|Overall Study|Investigator discretion|3
6155854|NCT01584648|21210291|P2|Overall Study|Lost to Follow-up|9
6155855|NCT01584648|21210292|P1|Overall Study|Lost to Follow-up|9
6155856|NCT01584648|21210291|P2|Overall Study|Death|146
6155857|NCT01584648|21210292|P1|Overall Study|Death|136
6155858|NCT01571596|21210319|P3|Overall Study|Study Terminated by the Sponsor|1
6155859|NCT01571596|21210320|P2|Overall Study|Study Terminated by the Sponsor|1
6155860|NCT01571596|21210321|P1|Overall Study|Study Terminated by the Sponsor|0
6155861|NCT01571596|21210319|P3|Overall Study|Adverse Event|0
6155862|NCT01571596|21210320|P2|Overall Study|Adverse Event|0
6155863|NCT01571596|21210321|P1|Overall Study|Adverse Event|2
6155864|NCT01530256|21210356|P1|Overall Study|Death|2
6155926|NCT01470248|21210425|P1|Overall Study|Withdrawal by Subject|1
6155945|NCT01270321|21210524|P3|Overall Study|Adverse Event|5
6155946|NCT01270321|21210525|P2|Overall Study|Adverse Event|9
6155947|NCT01270321|21210526|P1|Overall Study|Adverse Event|7
6155948|NCT01270321|21210524|P3|Overall Study|Death|4
6155949|NCT01270321|21210525|P2|Overall Study|Death|1
6155950|NCT01270321|21210526|P1|Overall Study|Death|3
6155953|NCT01178411|21210552|P1|Overall Study|Drug manufacturing ended|1
6155954|NCT01178411|21210552|P1|Overall Study|No reason provided|1
6155955|NCT01178411|21210552|P1|Overall Study|Death|1
6155956|NCT01178411|21210552|P1|Overall Study|Physician Decision|6
6155957|NCT01178411|21210552|P1|Overall Study|Progressive disease per clinician|9
6155958|NCT01178411|21210552|P1|Overall Study|Progressive disease per RECIST|32
6155959|NCT01178411|21210552|P1|Overall Study|Protocol Violation|1
6155960|NCT01178411|21210552|P1|Overall Study|Withdrawal by Subject|4
6155961|NCT01178411|21210552|P1|Overall Study|Adverse Event|5
6156028|NCT00616967|21210789|P3|Overall Study|Withdrawal by Subject|1
6156029|NCT00616967|21210790|P2|Overall Study|Withdrawal by Subject|0
6156030|NCT00616967|21210791|P1|Overall Study|Withdrawal by Subject|0
6156067|NCT00497874|21210860|P2|Overall Study|Unable to schedule|24
6156068|NCT00497874|21210861|P1|Overall Study|Unable to schedule|37
6156069|NCT00497874|21210860|P2|Overall Study|Unable to contact|67
6156070|NCT00497874|21210861|P1|Overall Study|Unable to contact|52
6156071|NCT00497874|21210860|P2|Overall Study|Death|4
6156072|NCT00497874|21210861|P1|Overall Study|Death|2
6156073|NCT00497874|21210860|P2|Overall Study|Illness|4
6156074|NCT00497874|21210861|P1|Overall Study|Illness|8
6156075|NCT00497874|21210860|P2|Overall Study|Withdrawal by Subject|17
6156076|NCT00497874|21210861|P1|Overall Study|Withdrawal by Subject|48
6156080|NCT00448812|21210923|P2|Year 5|Missed visit but remained in study|0
6156081|NCT00448812|21210924|P1|Year 5|Missed visit but remained in study|1
6156082|NCT00448812|21210923|P2|Year 3|Missed visit but remained in study|0
6156083|NCT00448812|21210924|P1|Year 3|Missed visit but remained in study|2
6156084|NCT00448812|21210923|P2|Year 3|Lost to Follow-up|0
6156085|NCT00448812|21210924|P1|Year 3|Lost to Follow-up|1
6156086|NCT00448812|21210923|P2|Year 3|Withdrawal by Subject|3
6156087|NCT00448812|21210924|P1|Year 3|Withdrawal by Subject|1
6156088|NCT00448812|21210923|P2|Year 2|Missed visit but remained in study|1
6156089|NCT00448812|21210924|P1|Year 2|Missed visit but remained in study|4
6156183|NCT00064259|21211128|P4|Overall Study|Adverse Event|1
6156184|NCT00064259|21211129|P3|Overall Study|Adverse Event|0
6156185|NCT00064259|21211130|P2|Overall Study|Adverse Event|0
6156186|NCT00064259|21211131|P1|Overall Study|Adverse Event|1
6156187|NCT00031694|21211136|P1|Overall Study|Withdrawal by Subject|5
6156188|NCT00031694|21211136|P1|Overall Study|Death|2
6156189|NCT00031694|21211136|P1|Overall Study|Adverse Event|12
6156213|NCT03650452|21211450|P2|Overall Study|Early Withdrawal from Study Treatment|0
6156214|NCT03650452|21211451|P1|Overall Study|Early Withdrawal from Study Treatment|3
6156215|NCT03650452|21211450|P2|Overall Study|Adverse Event|4
6156216|NCT03650452|21211451|P1|Overall Study|Adverse Event|3
6156217|NCT03650452|21211450|P2|Overall Study|Withdrawal by Parent/Guardian|1
6156218|NCT03650452|21211451|P1|Overall Study|Withdrawal by Parent/Guardian|3
6156219|NCT03650452|21211450|P2|Overall Study|Physician Decision|0
6156220|NCT03650452|21211451|P1|Overall Study|Physician Decision|1
6156221|NCT03511326|21211631|P1|Overall Study|Withdrawal by Subject|1
6156222|NCT03502798|21211638|P2|Overall Study|equipment failure|7
6156223|NCT03502798|21211639|P1|Overall Study|equipment failure|0
6156224|NCT03489369|21211666|P4|Overall Study|Clinical Progression (Worsening of Clini|0
6156225|NCT03489369|21211667|P3|Overall Study|Clinical Progression (Worsening of Clini|0
6156226|NCT03489369|21211668|P2|Overall Study|Clinical Progression (Worsening of Clini|1
6156227|NCT03489369|21211669|P1|Overall Study|Clinical Progression (Worsening of Clini|0
6156228|NCT03489369|21211666|P4|Overall Study|Documented Progressive Disease|6
6156229|NCT03489369|21211667|P3|Overall Study|Documented Progressive Disease|3
6156230|NCT03489369|21211668|P2|Overall Study|Documented Progressive Disease|2
6156231|NCT03489369|21211669|P1|Overall Study|Documented Progressive Disease|3
6156247|NCT03364751|21211763|P4|Overall Study|Lost to Follow-up|0
6156248|NCT03364751|21211764|P3|Overall Study|Lost to Follow-up|0
6156249|NCT03364751|21211765|P2|Overall Study|Lost to Follow-up|1
6156250|NCT03364751|21211766|P1|Overall Study|Lost to Follow-up|0
6156251|NCT03364751|21211763|P4|Overall Study|Withdrawal by Subject|0
6156252|NCT03364751|21211764|P3|Overall Study|Withdrawal by Subject|0
6156253|NCT03364751|21211765|P2|Overall Study|Withdrawal by Subject|0
6156254|NCT03364751|21211766|P1|Overall Study|Withdrawal by Subject|1
6156259|NCT03334903|21211850|P2|Overall Study|Withdrawal by Subject|1
6156260|NCT03334903|21211851|P1|Overall Study|Withdrawal by Subject|0
6156261|NCT03334903|21211850|P2|Overall Study|Adverse Event|1
6156262|NCT03334903|21211851|P1|Overall Study|Adverse Event|1
6156263|NCT03334903|21211850|P2|Overall Study|Surgery postponed|0
6156264|NCT03334903|21211851|P1|Overall Study|Surgery postponed|1
6156265|NCT03334903|21211850|P2|Overall Study|Protocol Violation|3
6156266|NCT03334903|21211851|P1|Overall Study|Protocol Violation|1
6156267|NCT03334903|21211850|P2|Overall Study|Use of medical marijuana - determined ineligible later in study|0
6156268|NCT03334903|21211851|P1|Overall Study|Use of medical marijuana - determined ineligible later in study|1
6156296|NCT03284710|21212296|P4|Overall Study|HIV Infection|1
6156297|NCT03284710|21212297|P3|Overall Study|HIV Infection|2
6156298|NCT03284710|21212298|P2|Overall Study|HIV Infection|2
6156299|NCT03284710|21212299|P1|Overall Study|HIV Infection|0
6156300|NCT03284710|21212296|P4|Overall Study|Participant Unable to Adhere to Visit Schedule|1
6156301|NCT03284710|21212297|P3|Overall Study|Participant Unable to Adhere to Visit Schedule|0
6156302|NCT03284710|21212298|P2|Overall Study|Participant Unable to Adhere to Visit Schedule|0
6156303|NCT03284710|21212299|P1|Overall Study|Participant Unable to Adhere to Visit Schedule|1
6156304|NCT03284710|21212296|P4|Overall Study|Physician Decision|0
6156305|NCT03284710|21212297|P3|Overall Study|Physician Decision|0
6156306|NCT03284710|21212298|P2|Overall Study|Physician Decision|0
6156307|NCT03284710|21212299|P1|Overall Study|Physician Decision|1
6156308|NCT03284710|21212296|P4|Overall Study|Lost to Follow-up|0
6156309|NCT03284710|21212297|P3|Overall Study|Lost to Follow-up|1
6156310|NCT03284710|21212298|P2|Overall Study|Lost to Follow-up|3
6156311|NCT03284710|21212299|P1|Overall Study|Lost to Follow-up|3
6156312|NCT03284710|21212296|P4|Overall Study|Withdrawal by Subject|6
6156313|NCT03284710|21212297|P3|Overall Study|Withdrawal by Subject|1
6156314|NCT03284710|21212298|P2|Overall Study|Withdrawal by Subject|0
6156315|NCT03284710|21212299|P1|Overall Study|Withdrawal by Subject|1
6156320|NCT03168711|21212461|P2|Overall Study|Death|1
6156321|NCT03168711|21212462|P1|Overall Study|Death|0
6156322|NCT03168711|21212461|P2|Overall Study|Withdrawal by Subject|1
6156323|NCT03168711|21212462|P1|Overall Study|Withdrawal by Subject|0
6156324|NCT03168711|21212461|P2|Overall Study|Adverse Event|0
6156325|NCT03168711|21212462|P1|Overall Study|Adverse Event|2
6156326|NCT03161483|21212526|P4|Overall Study|Other reasons|1
6156327|NCT03161483|21212527|P3|Overall Study|Other reasons|0
6156328|NCT03161483|21212528|P2|Overall Study|Other reasons|0
6156329|NCT03161483|21212529|P1|Overall Study|Other reasons|1
6156330|NCT03161483|21212526|P4|Overall Study|Protocol Violation|0
6156331|NCT03161483|21212527|P3|Overall Study|Protocol Violation|1
6156332|NCT03161483|21212528|P2|Overall Study|Protocol Violation|0
6156333|NCT03161483|21212529|P1|Overall Study|Protocol Violation|0
6156334|NCT03161483|21212526|P4|Overall Study|Lost to Follow-up|0
6156335|NCT03161483|21212527|P3|Overall Study|Lost to Follow-up|1
6156336|NCT03161483|21212528|P2|Overall Study|Lost to Follow-up|0
6156337|NCT03161483|21212529|P1|Overall Study|Lost to Follow-up|0
6156338|NCT03161483|21212526|P4|Overall Study|Withdrawal by Subject|5
6156339|NCT03161483|21212527|P3|Overall Study|Withdrawal by Subject|6
6156340|NCT03161483|21212528|P2|Overall Study|Withdrawal by Subject|2
6156341|NCT03161483|21212529|P1|Overall Study|Withdrawal by Subject|2
6156342|NCT03161483|21212526|P4|Overall Study|Lack of Efficacy|0
6156343|NCT03161483|21212527|P3|Overall Study|Lack of Efficacy|1
6156344|NCT03161483|21212528|P2|Overall Study|Lack of Efficacy|0
6156345|NCT03161483|21212529|P1|Overall Study|Lack of Efficacy|0
6156346|NCT03161483|21212526|P4|Overall Study|Pregnancy|0
6156347|NCT03161483|21212527|P3|Overall Study|Pregnancy|0
6156348|NCT03161483|21212528|P2|Overall Study|Pregnancy|0
6156349|NCT03161483|21212529|P1|Overall Study|Pregnancy|1
6156350|NCT03161483|21212526|P4|Overall Study|Adverse Event|2
6156351|NCT03161483|21212527|P3|Overall Study|Adverse Event|11
6156352|NCT03161483|21212528|P2|Overall Study|Adverse Event|1
6156353|NCT03161483|21212529|P1|Overall Study|Adverse Event|5
6156354|NCT03161483|21212526|P4|Overall Study|Death|0
6156355|NCT03161483|21212527|P3|Overall Study|Death|0
6156356|NCT03161483|21212528|P2|Overall Study|Death|0
6156357|NCT03161483|21212529|P1|Overall Study|Death|1
6156400|NCT03078868|21212808|P1|Overall Study|Physician Decision|3
6156401|NCT02994940|21212814|P2|Overall Study|Did not receive study medications: red dye allergy|1
6156402|NCT02994940|21212815|P1|Overall Study|Did not receive study medications: red dye allergy|0
6156403|NCT02994940|21212814|P2|Overall Study|Did not receive study medications: vomited after ingestion|0
6156404|NCT02994940|21212815|P1|Overall Study|Did not receive study medications: vomited after ingestion|1
6156405|NCT02994940|21212814|P2|Overall Study|Did not receive study medications: Study drug not available prior to anesthesia induction|0
6156406|NCT02994940|21212815|P1|Overall Study|Did not receive study medications: Study drug not available prior to anesthesia induction|6
6156418|NCT02932267|21213058|P1|Overall Study|Pregnancy|1
6156419|NCT02932267|21213058|P1|Overall Study|Lost to Follow-up|4
6156420|NCT02932267|21213058|P1|Overall Study|Withdrawal by Subject|3
6156421|NCT02836249|21213073|P2|Overall Study|Still on Study|55
6156422|NCT02836249|21213074|P1|Overall Study|Still on Study|121
6156423|NCT02836249|21213073|P2|Overall Study|Lost to Follow-up|1
6156424|NCT02836249|21213074|P1|Overall Study|Lost to Follow-up|0
6156425|NCT02836249|21213073|P2|Overall Study|Withdrew Consent|1
6156426|NCT02836249|21213074|P1|Overall Study|Withdrew Consent|0
6156427|NCT02836249|21213073|P2|Overall Study|Pregnancy|0
6156428|NCT02836249|21213074|P1|Overall Study|Pregnancy|2
6156429|NCT02836249|21213073|P2|Overall Study|Randomized but Never Treated|1
6156430|NCT02836249|21213074|P1|Overall Study|Randomized but Never Treated|0
6156431|NCT02735421|21213109|P1|Overall Study|Pregnancy|1
6156432|NCT02735421|21213109|P1|Overall Study|Inadequate compliance to treatment|1
6156433|NCT02735421|21213109|P1|Overall Study|Lost to Follow-up|3
6156434|NCT02735421|21213109|P1|Overall Study|Withdrawal by Subject|6
6156435|NCT02735421|21213109|P1|Overall Study|Adverse Event|2
6156519|NCT02589405|21213544|P1|Overall Study|Withdrawal by Subject|1
6156520|NCT02589405|21213544|P1|Overall Study|Adverse Event|3
6156556|NCT02480114|21213684|P2|Overall Study|Not eligible|1
6156557|NCT02480114|21213685|P1|Overall Study|Not eligible|0
6156558|NCT02480114|21213684|P2|Overall Study|Improper completion of survey|1
6156559|NCT02480114|21213685|P1|Overall Study|Improper completion of survey|1
6156560|NCT02480114|21213684|P2|Overall Study|Disease progression|0
6156561|NCT02480114|21213685|P1|Overall Study|Disease progression|3
6156562|NCT02480114|21213684|P2|Overall Study|Withdrawal by Subject|4
6156563|NCT02480114|21213685|P1|Overall Study|Withdrawal by Subject|2
6156564|NCT02480114|21213684|P2|Overall Study|Not completing surveys|2
6156565|NCT02480114|21213685|P1|Overall Study|Not completing surveys|3
6156578|NCT02396849|21213763|P2|Overall Study|Did not tolerate intervention|1
6156579|NCT02396849|21213764|P1|Overall Study|Did not tolerate intervention|1
6156580|NCT02396849|21213763|P2|Overall Study|Lost to Follow-up|1
6156581|NCT02396849|21213764|P1|Overall Study|Lost to Follow-up|1
6156592|NCT02366312|21213791|P2|Overall Study|Lost to Follow-up|1
6156593|NCT02366312|21213792|P1|Overall Study|Lost to Follow-up|0
6156663|NCT02307266|21213921|P3|Overall Study|Lost to Follow-up|0
6156664|NCT02307266|21213922|P2|Overall Study|Lost to Follow-up|0
6156665|NCT02307266|21213923|P1|Overall Study|Lost to Follow-up|3
6156666|NCT02307266|21213921|P3|Overall Study|Withdrawal by Subject|1
6156667|NCT02307266|21213922|P2|Overall Study|Withdrawal by Subject|0
6156668|NCT02307266|21213923|P1|Overall Study|Withdrawal by Subject|2
6156669|NCT02307266|21213921|P3|Overall Study|Adverse Event|5
6156670|NCT02307266|21213922|P2|Overall Study|Adverse Event|1
6156671|NCT02307266|21213923|P1|Overall Study|Adverse Event|3
6156674|NCT02207946|21214049|P2|Overall Study|Adverse Event|1
6156675|NCT02207946|21214050|P1|Overall Study|Adverse Event|0
6156676|NCT02207946|21214049|P2|Overall Study|Lost to Follow-up|0
6156677|NCT02207946|21214050|P1|Overall Study|Lost to Follow-up|1
6156690|NCT02125279|21214129|P1|Overall Study|Lost to Follow-up|4
6156691|NCT02125279|21214129|P1|Overall Study|Protocol Violation|1
6156692|NCT02125279|21214129|P1|Overall Study|Withdrawal by Subject|6
6156693|NCT02125279|21214129|P1|Overall Study|Lack of Efficacy|2
6156700|NCT02065570|21214173|P4|Maintenance Study|Other, Not Specified|5
6156701|NCT02065570|21214174|P3|Maintenance Study|Other, Not Specified|11
6156702|NCT02065570|21214175|P2|Maintenance Study|Other, Not Specified|0
6156703|NCT02065570|21214176|P1|Maintenance Study|Other, Not Specified|0
6156704|NCT02065570|21214173|P4|Maintenance Study|Lost to Follow-up|2
6156705|NCT02065570|21214174|P3|Maintenance Study|Lost to Follow-up|2
6156706|NCT02065570|21214175|P2|Maintenance Study|Lost to Follow-up|0
6156707|NCT02065570|21214176|P1|Maintenance Study|Lost to Follow-up|0
6156708|NCT02065570|21214173|P4|Maintenance Study|Withdrawal by Subject|4
6156709|NCT02065570|21214174|P3|Maintenance Study|Withdrawal by Subject|1
6156710|NCT02065570|21214175|P2|Maintenance Study|Withdrawal by Subject|0
6156711|NCT02065570|21214176|P1|Maintenance Study|Withdrawal by Subject|0
6156712|NCT02065570|21214173|P4|Maintenance Study|Adverse Event|8
6156713|NCT02065570|21214174|P3|Maintenance Study|Adverse Event|8
6156714|NCT02065570|21214175|P2|Maintenance Study|Adverse Event|0
6156715|NCT02065570|21214176|P1|Maintenance Study|Adverse Event|0
6156716|NCT02065570|21214173|P4|Induction Study|Other, Not Specified|0
6156717|NCT02065570|21214174|P3|Induction Study|Other, Not Specified|0
6156718|NCT02065570|21214175|P2|Induction Study|Other, Not Specified|5
6156719|NCT02065570|21214176|P1|Induction Study|Other, Not Specified|6
6156720|NCT02065570|21214173|P4|Induction Study|Lost to Follow-up|0
6156721|NCT02065570|21214174|P3|Induction Study|Lost to Follow-up|0
6156722|NCT02065570|21214175|P2|Induction Study|Lost to Follow-up|1
6156723|NCT02065570|21214176|P1|Induction Study|Lost to Follow-up|1
6156724|NCT02065570|21214173|P4|Induction Study|Withdrawal by Subject|0
6156725|NCT02065570|21214174|P3|Induction Study|Withdrawal by Subject|0
6156726|NCT02065570|21214175|P2|Induction Study|Withdrawal by Subject|3
6156727|NCT02065570|21214176|P1|Induction Study|Withdrawal by Subject|2
6156728|NCT02065570|21214173|P4|Induction Study|Adverse Event|0
6156729|NCT02065570|21214174|P3|Induction Study|Adverse Event|0
6156730|NCT02065570|21214175|P2|Induction Study|Adverse Event|12
6156731|NCT02065570|21214176|P1|Induction Study|Adverse Event|5
6156732|NCT02063828|21214223|P3|Overall Study|Death|1
6156733|NCT02063828|21214224|P2|Overall Study|Death|0
6156734|NCT02063828|21214225|P1|Overall Study|Death|0
6156735|NCT02063828|21214223|P3|Overall Study|Withdrawal by Subject|3
6156736|NCT02063828|21214224|P2|Overall Study|Withdrawal by Subject|6
6156737|NCT02063828|21214225|P1|Overall Study|Withdrawal by Subject|4
6156844|NCT01948427|21214766|P5|Overall Study|Other, Not Specified|2
6156845|NCT01948427|21214767|P4|Overall Study|Other, Not Specified|0
6156846|NCT01948427|21214768|P3|Overall Study|Other, Not Specified|0
6156847|NCT01948427|21214769|P2|Overall Study|Other, Not Specified|9
6156848|NCT01948427|21214770|P1|Overall Study|Other, Not Specified|1
6156849|NCT01948427|21214766|P5|Overall Study|Withdrawal by Subject|1
6156850|NCT01948427|21214767|P4|Overall Study|Withdrawal by Subject|0
6156851|NCT01948427|21214768|P3|Overall Study|Withdrawal by Subject|0
6156852|NCT01948427|21214769|P2|Overall Study|Withdrawal by Subject|0
6156853|NCT01948427|21214770|P1|Overall Study|Withdrawal by Subject|2
6156854|NCT01948427|21214766|P5|Overall Study|Lost to Follow-up|4
6156855|NCT01948427|21214767|P4|Overall Study|Lost to Follow-up|0
6156856|NCT01948427|21214768|P3|Overall Study|Lost to Follow-up|0
6156857|NCT01948427|21214769|P2|Overall Study|Lost to Follow-up|0
6156858|NCT01948427|21214770|P1|Overall Study|Lost to Follow-up|1
6156859|NCT01948427|21214766|P5|Overall Study|Investigator Request|6
6156860|NCT01948427|21214767|P4|Overall Study|Investigator Request|0
6156861|NCT01948427|21214768|P3|Overall Study|Investigator Request|0
6156862|NCT01948427|21214769|P2|Overall Study|Investigator Request|8
6156863|NCT01948427|21214770|P1|Overall Study|Investigator Request|0
6156864|NCT01948427|21214766|P5|Overall Study|Serious Adverse Event|1
6156865|NCT01948427|21214767|P4|Overall Study|Serious Adverse Event|0
6156866|NCT01948427|21214768|P3|Overall Study|Serious Adverse Event|0
6156867|NCT01948427|21214769|P2|Overall Study|Serious Adverse Event|0
6156868|NCT01948427|21214770|P1|Overall Study|Serious Adverse Event|3
6156873|NCT01940471|21214818|P2|Open-Label Extension|Still in Open-Label Extension Phase|8
6156874|NCT01940471|21214819|P1|Open-Label Extension|Still in Open-Label Extension Phase|14
6156875|NCT01940471|21214818|P2|Double-Blind Phase|Still in Double-Blind Phase|270
6156876|NCT01940471|21214819|P1|Double-Blind Phase|Still in Double-Blind Phase|539
6156877|NCT01940471|21214818|P2|Double-Blind Phase|Protocol Violation|1
6156878|NCT01940471|21214819|P1|Double-Blind Phase|Protocol Violation|0
6156879|NCT01940471|21214818|P2|Double-Blind Phase|Lack of Efficacy|0
6156880|NCT01940471|21214819|P1|Double-Blind Phase|Lack of Efficacy|1
6156881|NCT01940471|21214818|P2|Double-Blind Phase|Death|0
6156882|NCT01940471|21214819|P1|Double-Blind Phase|Death|1
6156883|NCT01940471|21214818|P2|Double-Blind Phase|Protocol-Specified Criteria|0
6156884|NCT01940471|21214819|P1|Double-Blind Phase|Protocol-Specified Criteria|1
6156885|NCT01940471|21214818|P2|Double-Blind Phase|Non-Compliance with Study Drug|1
6156886|NCT01940471|21214819|P1|Double-Blind Phase|Non-Compliance with Study Drug|1
6156887|NCT01940471|21214818|P2|Double-Blind Phase|Investigator's Discretion|0
6156888|NCT01940471|21214819|P1|Double-Blind Phase|Investigator's Discretion|5
6156889|NCT01940471|21214818|P2|Double-Blind Phase|Pregnancy|1
6156890|NCT01940471|21214819|P1|Double-Blind Phase|Pregnancy|2
6156891|NCT01940471|21214818|P2|Double-Blind Phase|Lost to Follow-up|2
6156892|NCT01940471|21214819|P1|Double-Blind Phase|Lost to Follow-up|3
6156893|NCT01940471|21214818|P2|Double-Blind Phase|Adverse Event|2
6156894|NCT01940471|21214819|P1|Double-Blind Phase|Adverse Event|1
6156895|NCT01940471|21214818|P2|Double-Blind Phase|Withdrew Consent|7
6156896|NCT01940471|21214819|P1|Double-Blind Phase|Withdrew Consent|13
6156897|NCT01940471|21214818|P2|Double-Blind Phase|Randomized but Never Treated|1
6156898|NCT01940471|21214819|P1|Double-Blind Phase|Randomized but Never Treated|1
6156899|NCT01927341|21214840|P5|Phase 2|Follow-up completed|2
6156900|NCT01927341|21214841|P4|Phase 2|Follow-up completed|5
6156901|NCT01927341|21214842|P3|Phase 2|Follow-up completed|3
6156902|NCT01927341|21214843|P2|Phase 2|Follow-up completed|6
6156903|NCT01927341|21214844|P1|Phase 2|Follow-up completed|0
6156904|NCT01927341|21214840|P5|Phase 2|Disease progression|0
6156905|NCT01927341|21214841|P4|Phase 2|Disease progression|1
6156906|NCT01927341|21214842|P3|Phase 2|Disease progression|1
6156907|NCT01927341|21214843|P2|Phase 2|Disease progression|1
6156908|NCT01927341|21214844|P1|Phase 2|Disease progression|0
6156909|NCT01927341|21214840|P5|Phase 2|New cancer therapy|1
6156910|NCT01927341|21214841|P4|Phase 2|New cancer therapy|4
6156911|NCT01927341|21214842|P3|Phase 2|New cancer therapy|0
6156912|NCT01927341|21214843|P2|Phase 2|New cancer therapy|1
6156913|NCT01927341|21214844|P1|Phase 2|New cancer therapy|0
6156914|NCT01927341|21214840|P5|Phase 2|Death|2
6156915|NCT01927341|21214841|P4|Phase 2|Death|3
6156916|NCT01927341|21214842|P3|Phase 2|Death|0
6156917|NCT01927341|21214843|P2|Phase 2|Death|4
6156918|NCT01927341|21214844|P1|Phase 2|Death|0
6156919|NCT01927341|21214840|P5|Phase 2|Participant withdrew consent|3
6156920|NCT01927341|21214841|P4|Phase 2|Participant withdrew consent|2
6156921|NCT01927341|21214842|P3|Phase 2|Participant withdrew consent|1
6156922|NCT01927341|21214843|P2|Phase 2|Participant withdrew consent|2
6156923|NCT01927341|21214844|P1|Phase 2|Participant withdrew consent|0
6156924|NCT01927341|21214840|P5|Phase 2|Lost to Follow-up|0
6156925|NCT01927341|21214841|P4|Phase 2|Lost to Follow-up|0
6156926|NCT01927341|21214842|P3|Phase 2|Lost to Follow-up|0
6156927|NCT01927341|21214843|P2|Phase 2|Lost to Follow-up|1
6156928|NCT01927341|21214844|P1|Phase 2|Lost to Follow-up|0
6156929|NCT01927341|21214840|P5|Phase 1b|Follow-up completed|0
6156930|NCT01927341|21214841|P4|Phase 1b|Follow-up completed|0
6156931|NCT01927341|21214842|P3|Phase 1b|Follow-up completed|0
6156932|NCT01927341|21214843|P2|Phase 1b|Follow-up completed|0
6156933|NCT01927341|21214844|P1|Phase 1b|Follow-up completed|7
6156934|NCT01927341|21214840|P5|Phase 1b|Death|0
6156935|NCT01927341|21214841|P4|Phase 1b|Death|0
6156936|NCT01927341|21214842|P3|Phase 1b|Death|0
6156937|NCT01927341|21214843|P2|Phase 1b|Death|0
6156938|NCT01927341|21214844|P1|Phase 1b|Death|2
6156939|NCT01927341|21214840|P5|Phase 1b|Lost to Follow-up|0
6156940|NCT01927341|21214841|P4|Phase 1b|Lost to Follow-up|0
6156941|NCT01927341|21214842|P3|Phase 1b|Lost to Follow-up|0
6156942|NCT01927341|21214843|P2|Phase 1b|Lost to Follow-up|0
6156943|NCT01927341|21214844|P1|Phase 1b|Lost to Follow-up|1
6156962|NCT01821391|21214938|P2|Overall Study|Adverse Event|0
6156963|NCT01821391|21214939|P1|Overall Study|Adverse Event|1
6156967|NCT01494467|21215036|P2|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|2
6156968|NCT01494467|21215037|P1|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|8
6156969|NCT01494467|21215036|P2|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10
6156970|NCT01494467|21215037|P1|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|26
6156971|NCT01494467|21215036|P2|Part B Long Term Active Control 40 Weeks|Protocol Violation|5
6156972|NCT01494467|21215037|P1|Part B Long Term Active Control 40 Weeks|Protocol Violation|3
6156973|NCT01494467|21215036|P2|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|24
6156974|NCT01494467|21215037|P1|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|32
6156975|NCT01494467|21215036|P2|Part B Long Term Active Control 40 Weeks|Adverse Event|5
6156976|NCT01494467|21215037|P1|Part B Long Term Active Control 40 Weeks|Adverse Event|3
6156977|NCT01494467|21215036|P2|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3
6156978|NCT01494467|21215037|P1|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|1
6156979|NCT01494467|21215036|P2|Part B Long Term Active Control 40 Weeks|Pregnancy|0
6156980|NCT01494467|21215037|P1|Part B Long Term Active Control 40 Weeks|Pregnancy|2
6156981|NCT01494467|21215036|P2|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0
6156982|NCT01494467|21215037|P1|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1
6156983|NCT01494467|21215036|P2|Part A Vehicle Control (12 Weeks)|Other|1
6156984|NCT01494467|21215037|P1|Part A Vehicle Control (12 Weeks)|Other|1
6156985|NCT01494467|21215036|P2|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8
6156986|NCT01494467|21215037|P1|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8
6156987|NCT01494467|21215036|P2|Part A Vehicle Control (12 Weeks)|Protocol Violation|0
6156988|NCT01494467|21215037|P1|Part A Vehicle Control (12 Weeks)|Protocol Violation|4
6156989|NCT01494467|21215036|P2|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|8
6156990|NCT01494467|21215037|P1|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|9
6156991|NCT01494467|21215036|P2|Part A Vehicle Control (12 Weeks)|Adverse Event|4
6156992|NCT01494467|21215037|P1|Part A Vehicle Control (12 Weeks)|Adverse Event|6
6156993|NCT01494467|21215036|P2|Part A Vehicle Control (12 Weeks)|Pregnancy|0
6156994|NCT01494467|21215037|P1|Part A Vehicle Control (12 Weeks)|Pregnancy|1
6156995|NCT01493687|21215055|P2|Part C Safety Follow up (4 Weeks)|Adverse Event|1
6156996|NCT01493687|21215056|P1|Part C Safety Follow up (4 Weeks)|Adverse Event|0
6156997|NCT01493687|21215055|P2|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|1
6156998|NCT01493687|21215056|P1|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|5
6156999|NCT01493687|21215055|P2|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10
6157000|NCT01493687|21215056|P1|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|16
6157001|NCT01493687|21215055|P2|Part B Long Term Active Control 40 Weeks|Protocol Violation|0
6157002|NCT01493687|21215056|P1|Part B Long Term Active Control 40 Weeks|Protocol Violation|1
6157003|NCT01493687|21215055|P2|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|16
6157004|NCT01493687|21215056|P1|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|27
6157005|NCT01493687|21215055|P2|Part B Long Term Active Control 40 Weeks|Adverse Event|4
6157006|NCT01493687|21215056|P1|Part B Long Term Active Control 40 Weeks|Adverse Event|5
6157007|NCT01493687|21215055|P2|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3
6157008|NCT01493687|21215056|P1|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|2
6157009|NCT01493687|21215055|P2|Part B Long Term Active Control 40 Weeks|Pregnancy|1
6157010|NCT01493687|21215056|P1|Part B Long Term Active Control 40 Weeks|Pregnancy|5
6157011|NCT01493687|21215055|P2|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1
6157012|NCT01493687|21215056|P1|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1
6157013|NCT01493687|21215055|P2|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8
6157014|NCT01493687|21215056|P1|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|7
6157015|NCT01493687|21215055|P2|Part A Vehicle Control (12 Weeks)|Protocol Violation|1
6157016|NCT01493687|21215056|P1|Part A Vehicle Control (12 Weeks)|Protocol Violation|2
6157017|NCT01493687|21215055|P2|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|7
6157018|NCT01493687|21215056|P1|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|18
6157019|NCT01493687|21215055|P2|Part A Vehicle Control (12 Weeks)|Adverse Event|4
6157020|NCT01493687|21215056|P1|Part A Vehicle Control (12 Weeks)|Adverse Event|7
6157021|NCT01493687|21215055|P2|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1
6157022|NCT01493687|21215056|P1|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0
6157023|NCT01493687|21215055|P2|Part A Vehicle Control (12 Weeks)|Pregnancy|0
6157024|NCT01493687|21215056|P1|Part A Vehicle Control (12 Weeks)|Pregnancy|2
6157025|NCT01475071|21215072|P1|Overall Study|Lost to Follow-up|1
6157026|NCT01475071|21215072|P1|Overall Study|Withdrawal by Subject|6
6157027|NCT01475071|21215072|P1|Overall Study|Physician Decision|1
6157068|NCT01320033|21215219|P3|Overall Study|Other|1
6157069|NCT01320033|21215220|P2|Overall Study|Other|3
6157070|NCT01320033|21215221|P1|Overall Study|Other|2
6157071|NCT01320033|21215219|P3|Overall Study|Lost to Follow-up|17
6157072|NCT01320033|21215220|P2|Overall Study|Lost to Follow-up|26
6157073|NCT01320033|21215221|P1|Overall Study|Lost to Follow-up|22
6157074|NCT01320033|21215219|P3|Overall Study|Protocol Violation|3
6157075|NCT01320033|21215220|P2|Overall Study|Protocol Violation|5
6157076|NCT01320033|21215221|P1|Overall Study|Protocol Violation|3
6157077|NCT01320033|21215219|P3|Overall Study|Withdrawal by Subject|23
6157078|NCT01320033|21215220|P2|Overall Study|Withdrawal by Subject|23
6157079|NCT01320033|21215221|P1|Overall Study|Withdrawal by Subject|22
6157080|NCT01320033|21215219|P3|Overall Study|Adverse Event|8
6157081|NCT01320033|21215220|P2|Overall Study|Adverse Event|7
6157082|NCT01320033|21215221|P1|Overall Study|Adverse Event|9
6157083|NCT01320033|21215219|P3|Overall Study|Lack of Efficacy|1
6157084|NCT01320033|21215220|P2|Overall Study|Lack of Efficacy|0
6157085|NCT01320033|21215221|P1|Overall Study|Lack of Efficacy|0
6157090|NCT01188538|21215316|P2|Overall Study|Lost to Follow-up|1
6157091|NCT01188538|21215317|P1|Overall Study|Lost to Follow-up|0
6157098|NCT01014689|21215371|P2|Overall Study|Pregnancy|0
6157099|NCT01014689|21215372|P1|Overall Study|Pregnancy|1
6157100|NCT01014689|21215371|P2|Overall Study|Lost to Follow-up|7
6157101|NCT01014689|21215372|P1|Overall Study|Lost to Follow-up|3
6157102|NCT01014689|21215371|P2|Overall Study|Protocol Violation|1
6157103|NCT01014689|21215372|P1|Overall Study|Protocol Violation|1
6157104|NCT01014689|21215371|P2|Overall Study|Withdrawal by Subject|4
6157105|NCT01014689|21215372|P1|Overall Study|Withdrawal by Subject|5
6157106|NCT01014689|21215371|P2|Overall Study|Adverse Event|0
6157107|NCT01014689|21215372|P1|Overall Study|Adverse Event|3
6157108|NCT01014689|21215371|P2|Overall Study|Lack of Efficacy|1
6157109|NCT01014689|21215372|P1|Overall Study|Lack of Efficacy|0
6157110|NCT00993915|21215380|P1|Overall Study|Ongoing|3
6157111|NCT00993915|21215380|P1|Overall Study|Other|1
6157112|NCT00993915|21215380|P1|Overall Study|Withdrawal by Subject|2
6157113|NCT00993915|21215380|P1|Overall Study|Insufficient clinical response|3
6157133|NCT00862654|21215514|P4|Overall Study|Included after end of inclusions|0
6157134|NCT00862654|21215515|P3|Overall Study|Included after end of inclusions|1
6157135|NCT00862654|21215516|P2|Overall Study|Included after end of inclusions|0
6157136|NCT00862654|21215517|P1|Overall Study|Included after end of inclusions|0
6157137|NCT00862654|21215514|P4|Overall Study|Never used study drugs|0
6157138|NCT00862654|21215515|P3|Overall Study|Never used study drugs|0
6157139|NCT00862654|21215516|P2|Overall Study|Never used study drugs|0
6157140|NCT00862654|21215517|P1|Overall Study|Never used study drugs|1
6157141|NCT00862654|21215514|P4|Overall Study|Familly constraint|0
6157142|NCT00862654|21215515|P3|Overall Study|Familly constraint|0
6157143|NCT00862654|21215516|P2|Overall Study|Familly constraint|1
6157144|NCT00862654|21215517|P1|Overall Study|Familly constraint|0
6157145|NCT00862654|21215514|P4|Overall Study|Subject mistake|0
6157146|NCT00862654|21215515|P3|Overall Study|Subject mistake|0
6157147|NCT00862654|21215516|P2|Overall Study|Subject mistake|1
6157148|NCT00862654|21215517|P1|Overall Study|Subject mistake|0
6157149|NCT00862654|21215514|P4|Overall Study|Withdrawal by Subject|3
6157150|NCT00862654|21215515|P3|Overall Study|Withdrawal by Subject|2
6157151|NCT00862654|21215516|P2|Overall Study|Withdrawal by Subject|2
6157152|NCT00862654|21215517|P1|Overall Study|Withdrawal by Subject|2
6157153|NCT00862654|21215514|P4|Overall Study|Pregnancy|0
6157154|NCT00862654|21215515|P3|Overall Study|Pregnancy|0
6157155|NCT00862654|21215516|P2|Overall Study|Pregnancy|1
6157156|NCT00862654|21215517|P1|Overall Study|Pregnancy|1
6157157|NCT00862654|21215514|P4|Overall Study|Adverse Event|0
6157158|NCT00862654|21215515|P3|Overall Study|Adverse Event|1
6157159|NCT00862654|21215516|P2|Overall Study|Adverse Event|1
6157160|NCT00862654|21215517|P1|Overall Study|Adverse Event|0
6157161|NCT00862654|21215514|P4|Overall Study|Lost to Follow-up|3
6157162|NCT00862654|21215515|P3|Overall Study|Lost to Follow-up|1
6157163|NCT00862654|21215516|P2|Overall Study|Lost to Follow-up|2
6157164|NCT00862654|21215517|P1|Overall Study|Lost to Follow-up|1
6157165|NCT00862654|21215514|P4|Overall Study|Lack of Efficacy|0
6157166|NCT00862654|21215515|P3|Overall Study|Lack of Efficacy|1
6157167|NCT00862654|21215516|P2|Overall Study|Lack of Efficacy|0
6157168|NCT00862654|21215517|P1|Overall Study|Lack of Efficacy|1
6157265|NCT00688064|21215693|P2|Overall Study|Any other reasons|3
6157266|NCT00688064|21215694|P1|Overall Study|Any other reasons|1
6157267|NCT00688064|21215693|P2|Overall Study|Pregnancy|0
6157268|NCT00688064|21215694|P1|Overall Study|Pregnancy|1
6157269|NCT00688064|21215693|P2|Overall Study|Lack of Efficacy|1
6157270|NCT00688064|21215694|P1|Overall Study|Lack of Efficacy|0
6157271|NCT00688064|21215693|P2|Overall Study|Lost to Follow-up|10
6157272|NCT00688064|21215694|P1|Overall Study|Lost to Follow-up|10
6157273|NCT00688064|21215693|P2|Overall Study|Withdrawal by Subject|7
6157274|NCT00688064|21215694|P1|Overall Study|Withdrawal by Subject|7
6157275|NCT00688064|21215693|P2|Overall Study|Adverse Event|4
6157276|NCT00688064|21215694|P1|Overall Study|Adverse Event|2
6157277|NCT00688064|21215693|P2|Overall Study|Protocol Violation|1
6157278|NCT00688064|21215694|P1|Overall Study|Protocol Violation|0
6157325|NCT00599521|21216211|P2|Overall Study|Pregnancy|2
6157326|NCT00599521|21216212|P1|Overall Study|Pregnancy|0
6157327|NCT00599521|21216211|P2|Overall Study|Lost to Follow-up|23
6157328|NCT00599521|21216212|P1|Overall Study|Lost to Follow-up|23
6157329|NCT00599521|21216211|P2|Overall Study|Protocol Violation|1
6157330|NCT00599521|21216212|P1|Overall Study|Protocol Violation|1
6157331|NCT00599521|21216211|P2|Overall Study|Withdrawal by Subject|34
6157332|NCT00599521|21216212|P1|Overall Study|Withdrawal by Subject|28
6157333|NCT00599521|21216211|P2|Overall Study|Adverse Event|1
6157334|NCT00599521|21216212|P1|Overall Study|Adverse Event|4
6157335|NCT00599521|21216211|P2|Overall Study|Lack of Efficacy|8
6157336|NCT00599521|21216212|P1|Overall Study|Lack of Efficacy|4
6157337|NCT00598832|21216228|P2|Overall Study|Non compliance|0
6157338|NCT00598832|21216229|P1|Overall Study|Non compliance|1
6157339|NCT00598832|21216228|P2|Overall Study|Physician Decision|4
6157340|NCT00598832|21216229|P1|Overall Study|Physician Decision|1
6157341|NCT00598832|21216228|P2|Overall Study|Pregnancy|2
6157342|NCT00598832|21216229|P1|Overall Study|Pregnancy|2
6157343|NCT00598832|21216228|P2|Overall Study|Lost to Follow-up|29
6157344|NCT00598832|21216229|P1|Overall Study|Lost to Follow-up|24
6157345|NCT00598832|21216228|P2|Overall Study|Protocol Violation|2
6157346|NCT00598832|21216229|P1|Overall Study|Protocol Violation|0
6157347|NCT00598832|21216228|P2|Overall Study|Withdrawal by Subject|36
6157348|NCT00598832|21216229|P1|Overall Study|Withdrawal by Subject|25
6157349|NCT00598832|21216228|P2|Overall Study|Adverse Event|2
6157350|NCT00598832|21216229|P1|Overall Study|Adverse Event|6
6157351|NCT00598832|21216228|P2|Overall Study|Lack of Efficacy|7
6157352|NCT00598832|21216229|P1|Overall Study|Lack of Efficacy|3
6157365|NCT00560703|21216260|P2|Overall Study|non-compliance|1
6157366|NCT00560703|21216261|P1|Overall Study|non-compliance|0
6157367|NCT00560703|21216260|P2|Overall Study|Withdrawal by Subject|1
6157368|NCT00560703|21216261|P1|Overall Study|Withdrawal by Subject|0
6157369|NCT00560703|21216260|P2|Overall Study|Protocol Violation|2
6157370|NCT00560703|21216261|P1|Overall Study|Protocol Violation|0
6157371|NCT00560703|21216260|P2|Overall Study|Adverse Event|2
6157372|NCT00560703|21216261|P1|Overall Study|Adverse Event|0
6157397|NCT00468650|21216342|P1|Overall Study|Protocol Violation|1
6157398|NCT00468650|21216342|P1|Overall Study|Withdrawal by Subject|2
6157399|NCT00468650|21216342|P1|Overall Study|Lost to Follow-up|4
6157424|NCT00438399|21216534|P6|Overall Study|Patien stopped study at visit 4 by error|0
6157425|NCT00438399|21216535|P5|Overall Study|Patien stopped study at visit 4 by error|0
6157426|NCT00438399|21216536|P4|Overall Study|Patien stopped study at visit 4 by error|0
6157427|NCT00438399|21216537|P3|Overall Study|Patien stopped study at visit 4 by error|0
6157428|NCT00438399|21216538|P2|Overall Study|Patien stopped study at visit 4 by error|0
6157429|NCT00438399|21216539|P1|Overall Study|Patien stopped study at visit 4 by error|1
6157430|NCT00438399|21216534|P6|Overall Study|Pregnancy|1
6157431|NCT00438399|21216535|P5|Overall Study|Pregnancy|0
6157432|NCT00438399|21216536|P4|Overall Study|Pregnancy|0
6157433|NCT00438399|21216537|P3|Overall Study|Pregnancy|0
6157434|NCT00438399|21216538|P2|Overall Study|Pregnancy|0
6157435|NCT00438399|21216539|P1|Overall Study|Pregnancy|0
6157436|NCT00438399|21216534|P6|Overall Study|Subje stopped study|0
6157437|NCT00438399|21216535|P5|Overall Study|Subje stopped study|0
6157438|NCT00438399|21216536|P4|Overall Study|Subje stopped study|0
6157439|NCT00438399|21216537|P3|Overall Study|Subje stopped study|1
6157440|NCT00438399|21216538|P2|Overall Study|Subje stopped study|0
6157441|NCT00438399|21216539|P1|Overall Study|Subje stopped study|0
6157442|NCT00438399|21216534|P6|Overall Study|Protocol Violation|1
6157443|NCT00438399|21216535|P5|Overall Study|Protocol Violation|0
6157444|NCT00438399|21216536|P4|Overall Study|Protocol Violation|0
6157445|NCT00438399|21216537|P3|Overall Study|Protocol Violation|1
6157446|NCT00438399|21216538|P2|Overall Study|Protocol Violation|0
6157447|NCT00438399|21216539|P1|Overall Study|Protocol Violation|0
6157448|NCT00438399|21216534|P6|Overall Study|Withdrawal by Subject|2
6157449|NCT00438399|21216535|P5|Overall Study|Withdrawal by Subject|2
6157450|NCT00438399|21216536|P4|Overall Study|Withdrawal by Subject|2
6157451|NCT00438399|21216537|P3|Overall Study|Withdrawal by Subject|3
6157452|NCT00438399|21216538|P2|Overall Study|Withdrawal by Subject|6
6157453|NCT00438399|21216539|P1|Overall Study|Withdrawal by Subject|5
6157454|NCT00438399|21216534|P6|Overall Study|Adverse Event|1
6157455|NCT00438399|21216535|P5|Overall Study|Adverse Event|0
6157456|NCT00438399|21216536|P4|Overall Study|Adverse Event|1
6157457|NCT00438399|21216537|P3|Overall Study|Adverse Event|1
6157458|NCT00438399|21216538|P2|Overall Study|Adverse Event|0
6157459|NCT00438399|21216539|P1|Overall Study|Adverse Event|0
6157460|NCT00438399|21216534|P6|Overall Study|Lost to Follow-up|1
6157461|NCT00438399|21216535|P5|Overall Study|Lost to Follow-up|1
6157462|NCT00438399|21216536|P4|Overall Study|Lost to Follow-up|1
6157463|NCT00438399|21216537|P3|Overall Study|Lost to Follow-up|1
6157464|NCT00438399|21216538|P2|Overall Study|Lost to Follow-up|2
6157465|NCT00438399|21216539|P1|Overall Study|Lost to Follow-up|2
6157466|NCT00421993|21216552|P4|Overall Study|Subject transportation issues|1
6157467|NCT00421993|21216553|P3|Overall Study|Subject transportation issues|0
6157468|NCT00421993|21216554|P2|Overall Study|Subject transportation issues|0
6157469|NCT00421993|21216555|P1|Overall Study|Subject transportation issues|0
6157470|NCT00421993|21216552|P4|Overall Study|Pregnancy|2
6157471|NCT00421993|21216553|P3|Overall Study|Pregnancy|1
6157472|NCT00421993|21216554|P2|Overall Study|Pregnancy|1
6157473|NCT00421993|21216555|P1|Overall Study|Pregnancy|0
6157474|NCT00421993|21216552|P4|Overall Study|Lack of Efficacy|5
6157475|NCT00421993|21216553|P3|Overall Study|Lack of Efficacy|0
6157476|NCT00421993|21216554|P2|Overall Study|Lack of Efficacy|3
6157477|NCT00421993|21216555|P1|Overall Study|Lack of Efficacy|0
6157478|NCT00421993|21216552|P4|Overall Study|Protocol Violation|1
6157479|NCT00421993|21216553|P3|Overall Study|Protocol Violation|0
6157480|NCT00421993|21216554|P2|Overall Study|Protocol Violation|2
6157481|NCT00421993|21216555|P1|Overall Study|Protocol Violation|2
6157482|NCT00421993|21216552|P4|Overall Study|Adverse Event|4
6157483|NCT00421993|21216553|P3|Overall Study|Adverse Event|6
6157484|NCT00421993|21216554|P2|Overall Study|Adverse Event|1
6157485|NCT00421993|21216555|P1|Overall Study|Adverse Event|11
6157486|NCT00421993|21216552|P4|Overall Study|Lost to Follow-up|20
6157487|NCT00421993|21216553|P3|Overall Study|Lost to Follow-up|22
6157488|NCT00421993|21216554|P2|Overall Study|Lost to Follow-up|19
6157489|NCT00421993|21216555|P1|Overall Study|Lost to Follow-up|18
6157490|NCT00421993|21216552|P4|Overall Study|Withdrawal by Subject|24
6157491|NCT00421993|21216553|P3|Overall Study|Withdrawal by Subject|23
6157492|NCT00421993|21216554|P2|Overall Study|Withdrawal by Subject|23
6157493|NCT00421993|21216555|P1|Overall Study|Withdrawal by Subject|22
6157524|NCT00335738|21216624|P2|Overall Study|Ineligible|4
6157525|NCT00335738|21216625|P1|Overall Study|Ineligible|3
6157526|NCT00335738|21216624|P2|Overall Study|Withdrawal by Subject|0
6157527|NCT00335738|21216625|P1|Overall Study|Withdrawal by Subject|2
6157528|NCT00335738|21216624|P2|Overall Study|Physician Decision|0
6157529|NCT00335738|21216625|P1|Overall Study|Physician Decision|6
6157530|NCT00244933|21216677|P1|Overall Study|Not response evaluable|2
6157531|NCT00159913|21216685|P4|Overall Study|Protocol Violation|0
6157532|NCT00159913|21216686|P3|Overall Study|Protocol Violation|1
6157533|NCT00159913|21216687|P2|Overall Study|Protocol Violation|0
6157534|NCT00159913|21216688|P1|Overall Study|Protocol Violation|1
6157535|NCT00159913|21216685|P4|Overall Study|Lost to Follow-up|1
6157536|NCT00159913|21216686|P3|Overall Study|Lost to Follow-up|0
6157537|NCT00159913|21216687|P2|Overall Study|Lost to Follow-up|0
6157538|NCT00159913|21216688|P1|Overall Study|Lost to Follow-up|0
6157539|NCT00159913|21216685|P4|Overall Study|Withdrawal by Subject|1
6157540|NCT00159913|21216686|P3|Overall Study|Withdrawal by Subject|0
6157541|NCT00159913|21216687|P2|Overall Study|Withdrawal by Subject|0
6157542|NCT00159913|21216688|P1|Overall Study|Withdrawal by Subject|0
6157543|NCT00159913|21216685|P4|Overall Study|Adverse Event|0
6157544|NCT00159913|21216686|P3|Overall Study|Adverse Event|1
6157545|NCT00159913|21216687|P2|Overall Study|Adverse Event|0
6157546|NCT00159913|21216688|P1|Overall Study|Adverse Event|1
6159772|NCT04419311|21226732|P2|Overall Study|Lost to Follow-up|0
6159773|NCT04419311|21226733|P1|Overall Study|Lost to Follow-up|1
6159785|NCT03835975|21227127|P5|Overall Study|Withdrawal by Subject|0
6159786|NCT03835975|21227128|P4|Overall Study|Withdrawal by Subject|1
6159787|NCT03835975|21227129|P3|Overall Study|Withdrawal by Subject|1
6159788|NCT03835975|21227130|P2|Overall Study|Withdrawal by Subject|0
6159789|NCT03835975|21227131|P1|Overall Study|Withdrawal by Subject|1
6159790|NCT03835975|21227127|P5|Overall Study|Protocol Violation|0
6159791|NCT03835975|21227128|P4|Overall Study|Protocol Violation|0
6159792|NCT03835975|21227129|P3|Overall Study|Protocol Violation|2
6159793|NCT03835975|21227130|P2|Overall Study|Protocol Violation|1
6159794|NCT03835975|21227131|P1|Overall Study|Protocol Violation|1
6159795|NCT03835975|21227127|P5|Overall Study|No longer met eligibility criteria|0
6159796|NCT03835975|21227128|P4|Overall Study|No longer met eligibility criteria|0
6159797|NCT03835975|21227129|P3|Overall Study|No longer met eligibility criteria|0
6159798|NCT03835975|21227130|P2|Overall Study|No longer met eligibility criteria|1
6159799|NCT03835975|21227131|P1|Overall Study|No longer met eligibility criteria|0
6159800|NCT03835975|21227127|P5|Overall Study|Lost to Follow-up|0
6159801|NCT03835975|21227128|P4|Overall Study|Lost to Follow-up|0
6159802|NCT03835975|21227129|P3|Overall Study|Lost to Follow-up|0
6159803|NCT03835975|21227130|P2|Overall Study|Lost to Follow-up|1
6159804|NCT03835975|21227131|P1|Overall Study|Lost to Follow-up|1
6159805|NCT03819218|21227209|P1|Overall Study|Protocol Violation|1
6159839|NCT03400852|21227618|P3|Open Label Period|Study terminated by sponsor|21
6159840|NCT03400852|21227619|P2|Open Label Period|Study terminated by sponsor|0
6159841|NCT03400852|21227620|P1|Open Label Period|Study terminated by sponsor|0
6159842|NCT03400852|21227618|P3|Open Label Period|Physician Decision|1
6159843|NCT03400852|21227619|P2|Open Label Period|Physician Decision|0
6159844|NCT03400852|21227620|P1|Open Label Period|Physician Decision|0
6159845|NCT03400852|21227618|P3|Blinded Treatment Period|Study terminated by sponsor|0
6159846|NCT03400852|21227619|P2|Blinded Treatment Period|Study terminated by sponsor|4
6159847|NCT03400852|21227620|P1|Blinded Treatment Period|Study terminated by sponsor|8
6159848|NCT03400852|21227618|P3|Blinded Treatment Period|Adverse Event|0
6159849|NCT03400852|21227619|P2|Blinded Treatment Period|Adverse Event|1
6159850|NCT03400852|21227620|P1|Blinded Treatment Period|Adverse Event|1
6159851|NCT03400852|21227618|P3|Blinded Treatment Period|Physician Decision|0
6159852|NCT03400852|21227619|P2|Blinded Treatment Period|Physician Decision|1
6159853|NCT03400852|21227620|P1|Blinded Treatment Period|Physician Decision|0
6159855|NCT03359590|21227660|P2|First Intervention|Protocol Violation|1
6159856|NCT03359590|21227661|P1|First Intervention|Protocol Violation|0
6159857|NCT03359590|21227660|P2|First Intervention|Withdrawal by Subject|1
6159858|NCT03359590|21227661|P1|First Intervention|Withdrawal by Subject|1
6159898|NCT03303469|21227806|P1|Overall Study|Lost to Follow-up|2
6159899|NCT03300570|21227814|P2|Overall Study|Inadequate bowel prep|0
6159900|NCT03300570|21227815|P1|Overall Study|Inadequate bowel prep|1
6159901|NCT03300570|21227814|P2|Overall Study|Withdrawal by Subject|0
6159902|NCT03300570|21227815|P1|Overall Study|Withdrawal by Subject|1
6159903|NCT03300570|21227814|P2|Overall Study|Adverse Event|1
6159904|NCT03300570|21227815|P1|Overall Study|Adverse Event|0
6159905|NCT03300050|21227830|P5|Overall Study|Not Eligible at Randomization|0
6159906|NCT03300050|21227831|P4|Overall Study|Not Eligible at Randomization|1
6159907|NCT03300050|21227832|P3|Overall Study|Not Eligible at Randomization|1
6159908|NCT03300050|21227833|P2|Overall Study|Not Eligible at Randomization|0
6159909|NCT03300050|21227834|P1|Overall Study|Not Eligible at Randomization|0
6159910|NCT03300050|21227830|P5|Overall Study|Death|0
6159911|NCT03300050|21227831|P4|Overall Study|Death|0
6159912|NCT03300050|21227832|P3|Overall Study|Death|1
6159913|NCT03300050|21227833|P2|Overall Study|Death|0
6159914|NCT03300050|21227834|P1|Overall Study|Death|0
6159915|NCT03300050|21227830|P5|Overall Study|Withdrawal by Subject|0
6159916|NCT03300050|21227831|P4|Overall Study|Withdrawal by Subject|0
6159917|NCT03300050|21227832|P3|Overall Study|Withdrawal by Subject|1
6159918|NCT03300050|21227833|P2|Overall Study|Withdrawal by Subject|1
6159919|NCT03300050|21227834|P1|Overall Study|Withdrawal by Subject|1
6159920|NCT03300050|21227830|P5|Overall Study|Lost to Follow-up|1
6159921|NCT03300050|21227831|P4|Overall Study|Lost to Follow-up|0
6159922|NCT03300050|21227832|P3|Overall Study|Lost to Follow-up|0
6159923|NCT03300050|21227833|P2|Overall Study|Lost to Follow-up|1
6159924|NCT03300050|21227834|P1|Overall Study|Lost to Follow-up|2
6159933|NCT03263780|21228244|P1|Overall Study|Ineligible (incomplete post-HIFU)|7
6159934|NCT03263780|21228244|P1|Overall Study|Withdrawal by Subject|3
6159952|NCT03205566|21228283|P2|Phase 1|Protocol Violation|1
6159953|NCT03205566|21228284|P1|Phase 1|Protocol Violation|1
6159960|NCT03146663|21228435|P2|Overall Study|Did not receive study treatment|1
6159961|NCT03146663|21228436|P1|Overall Study|Did not receive study treatment|1
6159962|NCT03145766|21228449|P5|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|0
6159963|NCT03145766|21228450|P4|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|0
6159964|NCT03145766|21228451|P3|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1
6159965|NCT03145766|21228452|P2|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1
6159966|NCT03145766|21228453|P1|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1
6159967|NCT03145766|21228449|P5|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|3
6159968|NCT03145766|21228450|P4|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|2
6159969|NCT03145766|21228451|P3|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|4
6159970|NCT03145766|21228452|P2|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|1
6159971|NCT03145766|21228453|P1|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|4
6159972|NCT03145766|21228449|P5|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0
6159973|NCT03145766|21228450|P4|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|1
6159974|NCT03145766|21228451|P3|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0
6159975|NCT03145766|21228452|P2|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0
6159976|NCT03145766|21228453|P1|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|2
6159977|NCT03145766|21228449|P5|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|0
6159978|NCT03145766|21228450|P4|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1
6159979|NCT03145766|21228451|P3|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1
6159980|NCT03145766|21228452|P2|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1
6159981|NCT03145766|21228453|P1|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|4
6159982|NCT03145766|21228449|P5|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|0
6159983|NCT03145766|21228450|P4|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|3
6159984|NCT03145766|21228451|P3|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|0
6159985|NCT03145766|21228452|P2|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|1
6159986|NCT03145766|21228453|P1|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|1
6159987|NCT03145766|21228449|P5|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|1
6159988|NCT03145766|21228450|P4|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|2
6159989|NCT03145766|21228451|P3|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|1
6159990|NCT03145766|21228452|P2|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|0
6159991|NCT03145766|21228453|P1|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|0
6159992|NCT03145766|21228449|P5|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|2
6159993|NCT03145766|21228450|P4|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1
6159994|NCT03145766|21228451|P3|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|0
6159995|NCT03145766|21228452|P2|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1
6159996|NCT03145766|21228453|P1|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1
6159997|NCT03135210|21228613|P2|Overall Study|Death|1
6159998|NCT03135210|21228614|P1|Overall Study|Death|0
6159999|NCT03087851|21228623|P3|Overall Study|Withdraw on medical grounds|2
6160000|NCT03087851|21228624|P2|Overall Study|Withdraw on medical grounds|1
6160001|NCT03087851|21228625|P1|Overall Study|Withdraw on medical grounds|0
6160024|NCT02980705|21228832|P2|Overall Study|Lost to Follow-up|0
6160025|NCT02980705|21228833|P1|Overall Study|Lost to Follow-up|2
6160026|NCT02980705|21228832|P2|Overall Study|withdrew participation|1
6160027|NCT02980705|21228833|P1|Overall Study|withdrew participation|0
6160028|NCT02980705|21228832|P2|Overall Study|Withdrawal by Subject|9
6160029|NCT02980705|21228833|P1|Overall Study|Withdrawal by Subject|6
6160030|NCT02980705|21228832|P2|Overall Study|Adverse Event|1
6160031|NCT02980705|21228833|P1|Overall Study|Adverse Event|0
6160032|NCT02975700|21228842|P1|Overall Study|Failed screening criteria|2
6160033|NCT02975700|21228842|P1|Overall Study|Progressive disease|3
6160034|NCT02975700|21228842|P1|Overall Study|Adverse Event|1
6160209|NCT02734433|21229433|P2|Overall Study|Withdrawal by Subject|2
6160210|NCT02734433|21229434|P1|Overall Study|Withdrawal by Subject|1
6160211|NCT02734433|21229433|P2|Overall Study|Clinical progression|1
6160212|NCT02734433|21229434|P1|Overall Study|Clinical progression|0
6160213|NCT02734433|21229433|P2|Overall Study|Disease progression|5
6160214|NCT02734433|21229434|P1|Overall Study|Disease progression|1
6160215|NCT02731729|21229468|P2|Overall Study|Withdrawal by Subject|0
6160216|NCT02731729|21229469|P1|Overall Study|Withdrawal by Subject|1
6160217|NCT02731729|21229468|P2|Overall Study|Study terminated by Sponsor|6
6160218|NCT02731729|21229469|P1|Overall Study|Study terminated by Sponsor|6
6160219|NCT02731729|21229468|P2|Overall Study|Death|2
6160220|NCT02731729|21229469|P1|Overall Study|Death|2
6160229|NCT02724020|21229495|P3|Overall Study|Withdrawal by Subject|5
6160230|NCT02724020|21229496|P2|Overall Study|Withdrawal by Subject|3
6160231|NCT02724020|21229497|P1|Overall Study|Withdrawal by Subject|1
6160232|NCT02724020|21229495|P3|Overall Study|Site Terminated by Sponsor|8
6160233|NCT02724020|21229496|P2|Overall Study|Site Terminated by Sponsor|8
6160234|NCT02724020|21229497|P1|Overall Study|Site Terminated by Sponsor|13
6160235|NCT02724020|21229495|P3|Overall Study|Lost to Follow-up|0
6160236|NCT02724020|21229496|P2|Overall Study|Lost to Follow-up|3
6160237|NCT02724020|21229497|P1|Overall Study|Lost to Follow-up|0
6160238|NCT02724020|21229495|P3|Overall Study|Death|19
6160239|NCT02724020|21229496|P2|Overall Study|Death|18
6160240|NCT02724020|21229497|P1|Overall Study|Death|16
6160241|NCT02724020|21229495|P3|Overall Study|Ongoing at Data Cut-off: 6 Mar 2020|0
6160242|NCT02724020|21229496|P2|Overall Study|Ongoing at Data Cut-off: 6 Mar 2020|0
6160243|NCT02724020|21229497|P1|Overall Study|Ongoing at Data Cut-off: 6 Mar 2020|2
6160244|NCT02699749|21229537|P14|Overall Study|Lost to Follow-up|0
6160245|NCT02699749|21229538|P13|Overall Study|Lost to Follow-up|0
6160246|NCT02699749|21229539|P12|Overall Study|Lost to Follow-up|0
6160247|NCT02699749|21229540|P11|Overall Study|Lost to Follow-up|0
6160248|NCT02699749|21229541|P10|Overall Study|Lost to Follow-up|0
6160249|NCT02699749|21229542|P9|Overall Study|Lost to Follow-up|0
6160250|NCT02699749|21229543|P8|Overall Study|Lost to Follow-up|1
6160251|NCT02699749|21229544|P7|Overall Study|Lost to Follow-up|0
6160252|NCT02699749|21229545|P6|Overall Study|Lost to Follow-up|1
6160253|NCT02699749|21229546|P5|Overall Study|Lost to Follow-up|0
6160254|NCT02699749|21229547|P4|Overall Study|Lost to Follow-up|0
6160255|NCT02699749|21229548|P3|Overall Study|Lost to Follow-up|0
6160256|NCT02699749|21229549|P2|Overall Study|Lost to Follow-up|0
6160257|NCT02699749|21229550|P1|Overall Study|Lost to Follow-up|0
6160258|NCT02699749|21229537|P14|Overall Study|Death|1
6160259|NCT02699749|21229538|P13|Overall Study|Death|0
6160260|NCT02699749|21229539|P12|Overall Study|Death|0
6160261|NCT02699749|21229540|P11|Overall Study|Death|0
6160262|NCT02699749|21229541|P10|Overall Study|Death|0
6160263|NCT02699749|21229542|P9|Overall Study|Death|0
6160264|NCT02699749|21229543|P8|Overall Study|Death|0
6160265|NCT02699749|21229544|P7|Overall Study|Death|0
6160266|NCT02699749|21229545|P6|Overall Study|Death|0
6160267|NCT02699749|21229546|P5|Overall Study|Death|0
6160268|NCT02699749|21229547|P4|Overall Study|Death|0
6160269|NCT02699749|21229548|P3|Overall Study|Death|0
6160270|NCT02699749|21229549|P2|Overall Study|Death|0
6160271|NCT02699749|21229550|P1|Overall Study|Death|0
6160272|NCT02699749|21229537|P14|Overall Study|Progressive Disease|5
6160273|NCT02699749|21229538|P13|Overall Study|Progressive Disease|3
6160274|NCT02699749|21229539|P12|Overall Study|Progressive Disease|4
6160275|NCT02699749|21229540|P11|Overall Study|Progressive Disease|5
6160276|NCT02699749|21229541|P10|Overall Study|Progressive Disease|6
6160277|NCT02699749|21229542|P9|Overall Study|Progressive Disease|6
6160278|NCT02699749|21229543|P8|Overall Study|Progressive Disease|5
6160279|NCT02699749|21229544|P7|Overall Study|Progressive Disease|5
6160280|NCT02699749|21229545|P6|Overall Study|Progressive Disease|7
6160281|NCT02699749|21229546|P5|Overall Study|Progressive Disease|3
6160282|NCT02699749|21229547|P4|Overall Study|Progressive Disease|3
6160283|NCT02699749|21229548|P3|Overall Study|Progressive Disease|14
6160284|NCT02699749|21229549|P2|Overall Study|Progressive Disease|3
6160285|NCT02699749|21229550|P1|Overall Study|Progressive Disease|3
6160286|NCT02699749|21229537|P14|Overall Study|Other|0
6160287|NCT02699749|21229538|P13|Overall Study|Other|0
6160288|NCT02699749|21229539|P12|Overall Study|Other|0
6160289|NCT02699749|21229540|P11|Overall Study|Other|1
6160290|NCT02699749|21229541|P10|Overall Study|Other|0
6160291|NCT02699749|21229542|P9|Overall Study|Other|0
6160292|NCT02699749|21229543|P8|Overall Study|Other|0
6160293|NCT02699749|21229544|P7|Overall Study|Other|1
6160294|NCT02699749|21229545|P6|Overall Study|Other|1
6160295|NCT02699749|21229546|P5|Overall Study|Other|0
6160296|NCT02699749|21229547|P4|Overall Study|Other|0
6160297|NCT02699749|21229548|P3|Overall Study|Other|2
6160298|NCT02699749|21229549|P2|Overall Study|Other|0
6160299|NCT02699749|21229550|P1|Overall Study|Other|0
6160419|NCT02565615|21230227|P5|Overall Study|Untreated|567
6160420|NCT02565615|21230228|P4|Overall Study|Untreated|0
6160421|NCT02565615|21230229|P3|Overall Study|Untreated|0
6160422|NCT02565615|21230230|P2|Overall Study|Untreated|0
6160423|NCT02565615|21230231|P1|Overall Study|Untreated|0
6160424|NCT02565615|21230227|P5|Overall Study|Adverse Event|9
6160425|NCT02565615|21230228|P4|Overall Study|Adverse Event|0
6160426|NCT02565615|21230229|P3|Overall Study|Adverse Event|0
6160427|NCT02565615|21230230|P2|Overall Study|Adverse Event|1
6160428|NCT02565615|21230231|P1|Overall Study|Adverse Event|1
6160429|NCT02565615|21230227|P5|Overall Study|Reason not defined|62
6160430|NCT02565615|21230228|P4|Overall Study|Reason not defined|1
6160431|NCT02565615|21230229|P3|Overall Study|Reason not defined|0
6160432|NCT02565615|21230230|P2|Overall Study|Reason not defined|2
6160433|NCT02565615|21230231|P1|Overall Study|Reason not defined|0
6160434|NCT02565615|21230227|P5|Overall Study|Not meeting eligibility criteria|25
6160435|NCT02565615|21230228|P4|Overall Study|Not meeting eligibility criteria|0
6160436|NCT02565615|21230229|P3|Overall Study|Not meeting eligibility criteria|0
6160437|NCT02565615|21230230|P2|Overall Study|Not meeting eligibility criteria|7
6160438|NCT02565615|21230231|P1|Overall Study|Not meeting eligibility criteria|0
6160439|NCT02565615|21230227|P5|Overall Study|Lost to Follow-up|765
6160440|NCT02565615|21230228|P4|Overall Study|Lost to Follow-up|1
6160441|NCT02565615|21230229|P3|Overall Study|Lost to Follow-up|0
6160442|NCT02565615|21230230|P2|Overall Study|Lost to Follow-up|4
6160443|NCT02565615|21230231|P1|Overall Study|Lost to Follow-up|0
6160444|NCT02565615|21230227|P5|Overall Study|Not willing to participate in study|169
6160445|NCT02565615|21230228|P4|Overall Study|Not willing to participate in study|1
6160446|NCT02565615|21230229|P3|Overall Study|Not willing to participate in study|0
6160447|NCT02565615|21230230|P2|Overall Study|Not willing to participate in study|21
6160448|NCT02565615|21230231|P1|Overall Study|Not willing to participate in study|2
6160449|NCT02565615|21230227|P5|Overall Study|Death|4
6160450|NCT02565615|21230228|P4|Overall Study|Death|0
6160451|NCT02565615|21230229|P3|Overall Study|Death|0
6160452|NCT02565615|21230230|P2|Overall Study|Death|1
6160453|NCT02565615|21230231|P1|Overall Study|Death|0
6160460|NCT02470091|21230551|P2|Overall Study|Ineligible|2
6160461|NCT02470091|21230552|P1|Overall Study|Ineligible|0
6160462|NCT02470091|21230551|P2|Overall Study|Withdrawal by Subject|0
6160463|NCT02470091|21230552|P1|Overall Study|Withdrawal by Subject|1
6160511|NCT02371889|21230800|P2|Overall Study|Relapse|1
6160512|NCT02371889|21230801|P1|Overall Study|Relapse|0
6160513|NCT02371889|21230800|P2|Overall Study|Lack of Efficacy|2
6160514|NCT02371889|21230801|P1|Overall Study|Lack of Efficacy|0
6160515|NCT02371889|21230800|P2|Overall Study|Personal time constraints|4
6160516|NCT02371889|21230801|P1|Overall Study|Personal time constraints|2
6160517|NCT02371889|21230800|P2|Overall Study|Lost to Follow-up|5
6160518|NCT02371889|21230801|P1|Overall Study|Lost to Follow-up|6
6160519|NCT02371889|21230800|P2|Overall Study|Adverse medication effect|2
6160520|NCT02371889|21230801|P1|Overall Study|Adverse medication effect|11
6160521|NCT02352948|21230821|P6|Overall Study|Other|0
6160522|NCT02352948|21230822|P5|Overall Study|Other|0
6160523|NCT02352948|21230823|P4|Overall Study|Other|0
6160524|NCT02352948|21230824|P3|Overall Study|Other|2
6160525|NCT02352948|21230825|P2|Overall Study|Other|0
6160526|NCT02352948|21230826|P1|Overall Study|Other|0
6160527|NCT02352948|21230821|P6|Overall Study|Eligibility criteria not fulfilled|0
6160528|NCT02352948|21230822|P5|Overall Study|Eligibility criteria not fulfilled|0
6160529|NCT02352948|21230823|P4|Overall Study|Eligibility criteria not fulfilled|1
6160530|NCT02352948|21230824|P3|Overall Study|Eligibility criteria not fulfilled|0
6160531|NCT02352948|21230825|P2|Overall Study|Eligibility criteria not fulfilled|1
6160532|NCT02352948|21230826|P1|Overall Study|Eligibility criteria not fulfilled|0
6160533|NCT02352948|21230821|P6|Overall Study|Withdrawal by Subject|4
6160534|NCT02352948|21230822|P5|Overall Study|Withdrawal by Subject|9
6160535|NCT02352948|21230823|P4|Overall Study|Withdrawal by Subject|23
6160536|NCT02352948|21230824|P3|Overall Study|Withdrawal by Subject|11
6160537|NCT02352948|21230825|P2|Overall Study|Withdrawal by Subject|10
6160538|NCT02352948|21230826|P1|Overall Study|Withdrawal by Subject|1
6160539|NCT02352948|21230821|P6|Overall Study|Lost to Follow-up|1
6160540|NCT02352948|21230822|P5|Overall Study|Lost to Follow-up|2
6160541|NCT02352948|21230823|P4|Overall Study|Lost to Follow-up|1
6160542|NCT02352948|21230824|P3|Overall Study|Lost to Follow-up|2
6160543|NCT02352948|21230825|P2|Overall Study|Lost to Follow-up|0
6160544|NCT02352948|21230826|P1|Overall Study|Lost to Follow-up|1
6160545|NCT02352948|21230821|P6|Overall Study|Death|44
6160546|NCT02352948|21230822|P5|Overall Study|Death|77
6160547|NCT02352948|21230823|P4|Overall Study|Death|74
6160548|NCT02352948|21230824|P3|Overall Study|Death|114
6160549|NCT02352948|21230825|P2|Overall Study|Death|48
6160550|NCT02352948|21230826|P1|Overall Study|Death|47
6160586|NCT02322814|21230950|P5|Overall Study|Withdrawal by Subject|3
6160587|NCT02322814|21230951|P4|Overall Study|Withdrawal by Subject|1
6160588|NCT02322814|21230952|P3|Overall Study|Withdrawal by Subject|2
6160589|NCT02322814|21230953|P2|Overall Study|Withdrawal by Subject|4
6160590|NCT02322814|21230954|P1|Overall Study|Withdrawal by Subject|5
6160591|NCT02322814|21230950|P5|Overall Study|Death|6
6160592|NCT02322814|21230951|P4|Overall Study|Death|10
6160593|NCT02322814|21230952|P3|Overall Study|Death|30
6160594|NCT02322814|21230953|P2|Overall Study|Death|22
6160595|NCT02322814|21230954|P1|Overall Study|Death|7
6160596|NCT02322814|21230950|P5|Overall Study|Protocol Violation|0
6160597|NCT02322814|21230951|P4|Overall Study|Protocol Violation|0
6160598|NCT02322814|21230952|P3|Overall Study|Protocol Violation|0
6160599|NCT02322814|21230953|P2|Overall Study|Protocol Violation|0
6160600|NCT02322814|21230954|P1|Overall Study|Protocol Violation|1
6160601|NCT02322814|21230950|P5|Overall Study|Other|0
6160602|NCT02322814|21230951|P4|Overall Study|Other|0
6160603|NCT02322814|21230952|P3|Overall Study|Other|0
6160604|NCT02322814|21230953|P2|Overall Study|Other|0
6160605|NCT02322814|21230954|P1|Overall Study|Other|2
6160606|NCT02322814|21230950|P5|Overall Study|Lost to Follow-up|0
6160607|NCT02322814|21230951|P4|Overall Study|Lost to Follow-up|0
6160608|NCT02322814|21230952|P3|Overall Study|Lost to Follow-up|1
6160609|NCT02322814|21230953|P2|Overall Study|Lost to Follow-up|2
6160610|NCT02322814|21230954|P1|Overall Study|Lost to Follow-up|1
6160611|NCT02322814|21230950|P5|Overall Study|Progressive Disease|0
6160612|NCT02322814|21230951|P4|Overall Study|Progressive Disease|1
6160613|NCT02322814|21230952|P3|Overall Study|Progressive Disease|0
6160614|NCT02322814|21230953|P2|Overall Study|Progressive Disease|2
6160615|NCT02322814|21230954|P1|Overall Study|Progressive Disease|0
6160616|NCT02322814|21230950|P5|Overall Study|Ongoing Study|22
6160617|NCT02322814|21230951|P4|Overall Study|Ongoing Study|20
6160618|NCT02322814|21230952|P3|Overall Study|Ongoing Study|14
6160619|NCT02322814|21230953|P2|Overall Study|Ongoing Study|13
6160620|NCT02322814|21230954|P1|Overall Study|Ongoing Study|0
6160621|NCT02308735|21230974|P4|Overall Study|Physician Decision|2
6160622|NCT02308735|21230975|P3|Overall Study|Physician Decision|0
6160623|NCT02308735|21230976|P2|Overall Study|Physician Decision|0
6160624|NCT02308735|21230977|P1|Overall Study|Physician Decision|2
6160839|NCT02217501|21231503|P2|Overall Study|Death|4
6160840|NCT02217501|21231504|P1|Overall Study|Death|3
6160841|NCT02206061|21231534|P3|Overall Study|Lost to Follow-up|11
6160842|NCT02206061|21231535|P2|Overall Study|Lost to Follow-up|7
6160843|NCT02206061|21231536|P1|Overall Study|Lost to Follow-up|14
6160844|NCT02206061|21231534|P3|Overall Study|Withdrawal by Subject|1
6160845|NCT02206061|21231535|P2|Overall Study|Withdrawal by Subject|7
6160846|NCT02206061|21231536|P1|Overall Study|Withdrawal by Subject|4
6160881|NCT02172911|21231707|P2|Overall Study|Loss of insurance coverage|0
6160882|NCT02172911|21231708|P1|Overall Study|Loss of insurance coverage|1
6160883|NCT02172911|21231707|P2|Overall Study|Progression of Disease|1
6160884|NCT02172911|21231708|P1|Overall Study|Progression of Disease|0
6160885|NCT02172911|21231707|P2|Overall Study|Serious Adverse Event|1
6160886|NCT02172911|21231708|P1|Overall Study|Serious Adverse Event|0
6160891|NCT02078102|21231766|P2|Overall Study|Physician Decision|1
6160892|NCT02078102|21231767|P1|Overall Study|Physician Decision|0
6160893|NCT02078102|21231766|P2|Overall Study|Withdrawal by Subject|0
6160894|NCT02078102|21231767|P1|Overall Study|Withdrawal by Subject|1
6160895|NCT02078102|21231766|P2|Overall Study|Adverse Event|0
6160896|NCT02078102|21231767|P1|Overall Study|Adverse Event|1
6160909|NCT02059239|21231815|P2|Overall Study|Physician Decision|0
6160910|NCT02059239|21231816|P1|Overall Study|Physician Decision|1
6160911|NCT02059239|21231815|P2|Overall Study|Progressive Disease after Bendamustine|3
6160912|NCT02059239|21231816|P1|Overall Study|Progressive Disease after Bendamustine|1
6160963|NCT01984164|21231963|P2|Overall Study|Lost to Follow-up|3
6160964|NCT01984164|21231964|P1|Overall Study|Lost to Follow-up|1
6160965|NCT01984164|21231963|P2|Overall Study|Adverse Event|19
6160966|NCT01984164|21231964|P1|Overall Study|Adverse Event|5
6160967|NCT01984164|21231963|P2|Overall Study|Withdrawal by Subject|3
6160968|NCT01984164|21231964|P1|Overall Study|Withdrawal by Subject|4
6160969|NCT01970865|21232001|P17|Overall Study|Study ongoing|2
6160970|NCT01970865|21232002|P16|Overall Study|Study ongoing|29
6160971|NCT01970865|21232003|P15|Overall Study|Study ongoing|29
6160972|NCT01970865|21232004|P14|Overall Study|Study ongoing|41
6160973|NCT01970865|21232005|P13|Overall Study|Study ongoing|43
6160974|NCT01970865|21232006|P12|Overall Study|Study ongoing|22
6160975|NCT01970865|21232007|P11|Overall Study|Study ongoing|29
6160976|NCT01970865|21232008|P10|Overall Study|Study ongoing|3
6160977|NCT01970865|21232009|P9|Overall Study|Study ongoing|1
6160978|NCT01970865|21232010|P8|Overall Study|Study ongoing|0
6160979|NCT01970865|21232011|P7|Overall Study|Study ongoing|2
6160980|NCT01970865|21232012|P6|Overall Study|Study ongoing|0
6160981|NCT01970865|21232013|P5|Overall Study|Study ongoing|8
6160982|NCT01970865|21232014|P4|Overall Study|Study ongoing|6
6160983|NCT01970865|21232015|P3|Overall Study|Study ongoing|0
6160984|NCT01970865|21232016|P2|Overall Study|Study ongoing|2
6160985|NCT01970865|21232017|P1|Overall Study|Study ongoing|0
6160986|NCT01970865|21232001|P17|Overall Study|Other|0
6160987|NCT01970865|21232002|P16|Overall Study|Other|1
6160988|NCT01970865|21232003|P15|Overall Study|Other|0
6160989|NCT01970865|21232004|P14|Overall Study|Other|1
6160990|NCT01970865|21232005|P13|Overall Study|Other|0
6160991|NCT01970865|21232006|P12|Overall Study|Other|0
6160992|NCT01970865|21232007|P11|Overall Study|Other|0
6160993|NCT01970865|21232008|P10|Overall Study|Other|0
6160994|NCT01970865|21232009|P9|Overall Study|Other|0
6160995|NCT01970865|21232010|P8|Overall Study|Other|0
6160996|NCT01970865|21232011|P7|Overall Study|Other|0
6160997|NCT01970865|21232012|P6|Overall Study|Other|0
6160998|NCT01970865|21232013|P5|Overall Study|Other|0
6160999|NCT01970865|21232014|P4|Overall Study|Other|1
6161000|NCT01970865|21232015|P3|Overall Study|Other|0
6161001|NCT01970865|21232016|P2|Overall Study|Other|0
6161002|NCT01970865|21232017|P1|Overall Study|Other|0
6161003|NCT01970865|21232001|P17|Overall Study|Withdrawal by Subject|0
6161004|NCT01970865|21232002|P16|Overall Study|Withdrawal by Subject|7
6161005|NCT01970865|21232003|P15|Overall Study|Withdrawal by Subject|2
6161006|NCT01970865|21232004|P14|Overall Study|Withdrawal by Subject|5
6161007|NCT01970865|21232005|P13|Overall Study|Withdrawal by Subject|2
6161008|NCT01970865|21232006|P12|Overall Study|Withdrawal by Subject|1
6161009|NCT01970865|21232007|P11|Overall Study|Withdrawal by Subject|0
6161010|NCT01970865|21232008|P10|Overall Study|Withdrawal by Subject|0
6161011|NCT01970865|21232009|P9|Overall Study|Withdrawal by Subject|0
6161012|NCT01970865|21232010|P8|Overall Study|Withdrawal by Subject|0
6161013|NCT01970865|21232011|P7|Overall Study|Withdrawal by Subject|0
6161014|NCT01970865|21232012|P6|Overall Study|Withdrawal by Subject|0
6161015|NCT01970865|21232013|P5|Overall Study|Withdrawal by Subject|2
6161016|NCT01970865|21232014|P4|Overall Study|Withdrawal by Subject|1
6161017|NCT01970865|21232015|P3|Overall Study|Withdrawal by Subject|0
6161018|NCT01970865|21232016|P2|Overall Study|Withdrawal by Subject|0
6161019|NCT01970865|21232017|P1|Overall Study|Withdrawal by Subject|0
6161020|NCT01970865|21232001|P17|Overall Study|Lost to Follow-up|0
6161021|NCT01970865|21232002|P16|Overall Study|Lost to Follow-up|0
6161022|NCT01970865|21232003|P15|Overall Study|Lost to Follow-up|0
6161023|NCT01970865|21232004|P14|Overall Study|Lost to Follow-up|0
6161024|NCT01970865|21232005|P13|Overall Study|Lost to Follow-up|1
6161025|NCT01970865|21232006|P12|Overall Study|Lost to Follow-up|0
6161026|NCT01970865|21232007|P11|Overall Study|Lost to Follow-up|0
6161027|NCT01970865|21232008|P10|Overall Study|Lost to Follow-up|0
6161028|NCT01970865|21232009|P9|Overall Study|Lost to Follow-up|0
6161029|NCT01970865|21232010|P8|Overall Study|Lost to Follow-up|0
6161030|NCT01970865|21232011|P7|Overall Study|Lost to Follow-up|0
6161031|NCT01970865|21232012|P6|Overall Study|Lost to Follow-up|0
6161032|NCT01970865|21232013|P5|Overall Study|Lost to Follow-up|1
6161033|NCT01970865|21232014|P4|Overall Study|Lost to Follow-up|1
6161034|NCT01970865|21232015|P3|Overall Study|Lost to Follow-up|0
6161035|NCT01970865|21232016|P2|Overall Study|Lost to Follow-up|0
6161036|NCT01970865|21232017|P1|Overall Study|Lost to Follow-up|0
6161037|NCT01970865|21232001|P17|Overall Study|Death|1
6161038|NCT01970865|21232002|P16|Overall Study|Death|10
6161039|NCT01970865|21232003|P15|Overall Study|Death|15
6161040|NCT01970865|21232004|P14|Overall Study|Death|19
6161041|NCT01970865|21232005|P13|Overall Study|Death|14
6161042|NCT01970865|21232006|P12|Overall Study|Death|4
6161043|NCT01970865|21232007|P11|Overall Study|Death|1
6161044|NCT01970865|21232008|P10|Overall Study|Death|1
6161045|NCT01970865|21232009|P9|Overall Study|Death|2
6161046|NCT01970865|21232010|P8|Overall Study|Death|3
6161047|NCT01970865|21232011|P7|Overall Study|Death|1
6161048|NCT01970865|21232012|P6|Overall Study|Death|3
6161049|NCT01970865|21232013|P5|Overall Study|Death|6
6161050|NCT01970865|21232014|P4|Overall Study|Death|4
6161051|NCT01970865|21232015|P3|Overall Study|Death|3
6161052|NCT01970865|21232016|P2|Overall Study|Death|1
6161053|NCT01970865|21232017|P1|Overall Study|Death|3
6161054|NCT01964326|21232445|P1|Overall Study|Did not meet eligibility criteria|1
6161055|NCT01964326|21232445|P1|Overall Study|Other|9
6161056|NCT01964326|21232445|P1|Overall Study|Investigator Discretion|1
6161057|NCT01964326|21232445|P1|Overall Study|Physician Decision|55
6161058|NCT01964326|21232445|P1|Overall Study|No Longer Meets Eligibility Criteria|1
6161059|NCT01964326|21232445|P1|Overall Study|Pregnancy|1
6161060|NCT01964326|21232445|P1|Overall Study|Withdrawal by Subject|87
6161061|NCT01964326|21232445|P1|Overall Study|Lost to Follow-up|88
6161062|NCT01964326|21232445|P1|Overall Study|Protocol Violation|4
6161063|NCT01964326|21232445|P1|Overall Study|Death|2
6161064|NCT01964326|21232445|P1|Overall Study|Adverse Event|48
6161065|NCT01945021|21232452|P1|Overall Study|Death|65
6161066|NCT01945021|21232452|P1|Overall Study|Lost to Follow-up|5
6161067|NCT01945021|21232452|P1|Overall Study|Withdrawal of consent|12
6161068|NCT01945021|21232452|P1|Overall Study|Adverse Event|1
6161081|NCT01888497|21232504|P4|Washout Period 2|Withdrawal by Subject|1
6161082|NCT01888497|21232505|P3|Washout Period 2|Withdrawal by Subject|0
6161083|NCT01888497|21232506|P2|Washout Period 2|Withdrawal by Subject|0
6161084|NCT01888497|21232507|P1|Washout Period 2|Withdrawal by Subject|0
6161085|NCT01888497|21232504|P4|Washout Period 2|Adverse Event|1
6161086|NCT01888497|21232505|P3|Washout Period 2|Adverse Event|0
6161087|NCT01888497|21232506|P2|Washout Period 2|Adverse Event|0
6161088|NCT01888497|21232507|P1|Washout Period 2|Adverse Event|0
6161089|NCT01888497|21232504|P4|Washout Period 1|Withdrawal by Subject|1
6161090|NCT01888497|21232505|P3|Washout Period 1|Withdrawal by Subject|1
6161091|NCT01888497|21232506|P2|Washout Period 1|Withdrawal by Subject|0
6161092|NCT01888497|21232507|P1|Washout Period 1|Withdrawal by Subject|0
6161093|NCT01885195|21232525|P1|Overall Study|Patient/guardian decision|8
6161094|NCT01885195|21232525|P1|Overall Study|Physician Decision|3
6161095|NCT01885195|21232525|P1|Overall Study|Protocol Deviation|2
6161096|NCT01885195|21232525|P1|Overall Study|Disease Progression|67
6161097|NCT01885195|21232525|P1|Overall Study|Death|1
6161098|NCT01885195|21232525|P1|Overall Study|Adverse Event|29
6161129|NCT01789320|21232586|P1|Overall Study|Lost to Follow-up|1
6161130|NCT01789320|21232586|P1|Overall Study|Re-enrolled into study|1
6161191|NCT01616563|21232693|P1|Overall Study|Lost to Follow-up|40
6161226|NCT01420926|21232948|P2|Overall Study|Continues on active treatment|3
6161227|NCT01420926|21232949|P1|Overall Study|Continues on active treatment|1
6161228|NCT01420926|21232948|P2|Overall Study|Physician Decision|5
6161229|NCT01420926|21232949|P1|Overall Study|Physician Decision|7
6161230|NCT01420926|21232948|P2|Overall Study|Non-protocol treatment|20
6161231|NCT01420926|21232949|P1|Overall Study|Non-protocol treatment|17
6161232|NCT01420926|21232948|P2|Overall Study|Withdrawal by Subject|16
6161233|NCT01420926|21232949|P1|Overall Study|Withdrawal by Subject|11
6161234|NCT01420926|21232948|P2|Overall Study|Death|17
6161235|NCT01420926|21232949|P1|Overall Study|Death|18
6161236|NCT01420926|21232948|P2|Overall Study|Adverse Event|4
6161237|NCT01420926|21232949|P1|Overall Study|Adverse Event|6
6161248|NCT01327612|21232994|P7|Overall Study|Death|0
6161249|NCT01327612|21232995|P6|Overall Study|Death|0
6161250|NCT01327612|21232996|P5|Overall Study|Death|1
6161251|NCT01327612|21232997|P4|Overall Study|Death|0
6161252|NCT01327612|21232998|P3|Overall Study|Death|0
6161253|NCT01327612|21232999|P2|Overall Study|Death|0
6161254|NCT01327612|21233000|P1|Overall Study|Death|0
6161255|NCT01327612|21232994|P7|Overall Study|Administrative Decision|0
6161256|NCT01327612|21232995|P6|Overall Study|Administrative Decision|0
6161257|NCT01327612|21232996|P5|Overall Study|Administrative Decision|0
6161258|NCT01327612|21232997|P4|Overall Study|Administrative Decision|1
6161259|NCT01327612|21232998|P3|Overall Study|Administrative Decision|0
6161260|NCT01327612|21232999|P2|Overall Study|Administrative Decision|0
6161261|NCT01327612|21233000|P1|Overall Study|Administrative Decision|0
6161262|NCT01327612|21232994|P7|Overall Study|Disease Progression|2
6161263|NCT01327612|21232995|P6|Overall Study|Disease Progression|2
6161264|NCT01327612|21232996|P5|Overall Study|Disease Progression|1
6161265|NCT01327612|21232997|P4|Overall Study|Disease Progression|0
6161266|NCT01327612|21232998|P3|Overall Study|Disease Progression|1
6161267|NCT01327612|21232999|P2|Overall Study|Disease Progression|1
6161268|NCT01327612|21233000|P1|Overall Study|Disease Progression|1
6161269|NCT01327612|21232994|P7|Overall Study|Withdrawal by Subject|0
6161270|NCT01327612|21232995|P6|Overall Study|Withdrawal by Subject|1
6161271|NCT01327612|21232996|P5|Overall Study|Withdrawal by Subject|0
6161272|NCT01327612|21232997|P4|Overall Study|Withdrawal by Subject|0
6161273|NCT01327612|21232998|P3|Overall Study|Withdrawal by Subject|0
6161274|NCT01327612|21232999|P2|Overall Study|Withdrawal by Subject|0
6161275|NCT01327612|21233000|P1|Overall Study|Withdrawal by Subject|0
6161341|NCT01191541|21233237|P2|All the Patients|economic reasons|0
6161342|NCT01191541|21233238|P1|All the Patients|economic reasons|1
6161343|NCT01191008|21233254|P1|Overall Study|Lost to Follow-up|8
6161344|NCT01191008|21233254|P1|Overall Study|Protocol Violation|7
6161345|NCT01169532|21233271|P1|Overall Study|Withdrawal by Subject|1
6161471|NCT01041638|21233418|P1|Overall Study|Withdrawal by Subject|11
6161472|NCT01041638|21233418|P1|Overall Study|Physician Decision|4
6161473|NCT01041638|21233418|P1|Overall Study|Lack of Efficacy|7
6161474|NCT01041638|21233418|P1|Overall Study|Death|1
6161475|NCT01041638|21233418|P1|Overall Study|Adverse Event|4
6161479|NCT00924170|21233455|P2|Overall Study|Death|0
6161480|NCT00924170|21233456|P1|Overall Study|Death|1
6161481|NCT00924170|21233455|P2|Overall Study|Stopped due to neutralizing antibodies|0
6161482|NCT00924170|21233456|P1|Overall Study|Stopped due to neutralizing antibodies|3
6161483|NCT00924170|21233455|P2|Overall Study|Progressive disease|6
6161484|NCT00924170|21233456|P1|Overall Study|Progressive disease|3
6161485|NCT00924170|21233455|P2|Overall Study|Physician Decision|1
6161486|NCT00924170|21233456|P1|Overall Study|Physician Decision|0
6161487|NCT00924170|21233455|P2|Overall Study|Refused further treatment|1
6161488|NCT00924170|21233456|P1|Overall Study|Refused further treatment|0
6161489|NCT00917644|21233494|P2|Period 2: Second Intervention|family emergency|0
6161490|NCT00917644|21233495|P1|Period 2: Second Intervention|family emergency|1
6161491|NCT00917644|21233494|P2|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|0
6161492|NCT00917644|21233495|P1|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|1
6161493|NCT00917644|21233494|P2|Period: Washout Period of > = 2 Weeks|Protocol Violation|0
6161494|NCT00917644|21233495|P1|Period: Washout Period of > = 2 Weeks|Protocol Violation|1
6161495|NCT00879879|21233520|P1|Overall Study|Physician Decision|1
6161496|NCT00879879|21233520|P1|Overall Study|Withdrawal by Subject|1
6161497|NCT00879879|21233520|P1|Overall Study|Death|1
6161506|NCT00840177|21233548|P3|Overall Study|Did not start treatment|1
6161507|NCT00840177|21233549|P2|Overall Study|Did not start treatment|0
6161508|NCT00840177|21233550|P1|Overall Study|Did not start treatment|0
6161509|NCT00840177|21233548|P3|Overall Study|Ineligible|3
6161510|NCT00840177|21233549|P2|Overall Study|Ineligible|0
6161511|NCT00840177|21233550|P1|Overall Study|Ineligible|0
6161512|NCT00840177|21233548|P3|Overall Study|not protocol specified|0
6161513|NCT00840177|21233549|P2|Overall Study|not protocol specified|3
6161514|NCT00840177|21233550|P1|Overall Study|not protocol specified|6
6161515|NCT00840177|21233548|P3|Overall Study|Death|5
6161516|NCT00840177|21233549|P2|Overall Study|Death|5
6161517|NCT00840177|21233550|P1|Overall Study|Death|4
6161518|NCT00840177|21233548|P3|Overall Study|Progression/relapse|0
6161519|NCT00840177|21233549|P2|Overall Study|Progression/relapse|0
6161520|NCT00840177|21233550|P1|Overall Study|Progression/relapse|2
6161521|NCT00840177|21233548|P3|Overall Study|Refusal unrelated to adverse events|1
6161522|NCT00840177|21233549|P2|Overall Study|Refusal unrelated to adverse events|0
6161523|NCT00840177|21233550|P1|Overall Study|Refusal unrelated to adverse events|1
6161524|NCT00840177|21233548|P3|Overall Study|Adverse Event|1
6161525|NCT00840177|21233549|P2|Overall Study|Adverse Event|1
6161526|NCT00840177|21233550|P1|Overall Study|Adverse Event|5
6161527|NCT00828945|21233567|P1|Overall Study|Other|36
6161528|NCT00828945|21233567|P1|Overall Study|Participant was missing|1
6161529|NCT00828945|21233567|P1|Overall Study|Death|4
6161530|NCT00827606|21233583|P2|Overall Study|Adverse Event|2
6161531|NCT00827606|21233584|P1|Overall Study|Adverse Event|4
6161532|NCT00827606|21233583|P2|Overall Study|LDL below 2.59 mmol/L|12
6161533|NCT00827606|21233584|P1|Overall Study|LDL below 2.59 mmol/L|4
6161534|NCT00827606|21233583|P2|Overall Study|Other|13
6161535|NCT00827606|21233584|P1|Overall Study|Other|5
6161536|NCT00827606|21233583|P2|Overall Study|Pregnancy|1
6161537|NCT00827606|21233584|P1|Overall Study|Pregnancy|0
6161538|NCT00827606|21233583|P2|Overall Study|Withdrawal by Subject|6
6161539|NCT00827606|21233584|P1|Overall Study|Withdrawal by Subject|7
6161540|NCT00827606|21233583|P2|Overall Study|Lost to Follow-up|1
6161541|NCT00827606|21233584|P1|Overall Study|Lost to Follow-up|3
6161542|NCT00827606|21233583|P2|Overall Study|Protocol Violation|3
6161543|NCT00827606|21233584|P1|Overall Study|Protocol Violation|4
6161547|NCT00822120|21233654|P6|PET-directed Therapy|Protocol Violation|0
6161548|NCT00822120|21233655|P5|PET-directed Therapy|Protocol Violation|0
6161549|NCT00822120|21233656|P4|PET-directed Therapy|Protocol Violation|6
6161550|NCT00822120|21233657|P3|PET-directed Therapy|Protocol Violation|0
6161551|NCT00822120|21233658|P2|PET-directed Therapy|Protocol Violation|0
6161552|NCT00822120|21233659|P1|PET-directed Therapy|Protocol Violation|0
6161553|NCT00822120|21233654|P6|PET-directed Therapy|Death|0
6161554|NCT00822120|21233655|P5|PET-directed Therapy|Death|0
6161555|NCT00822120|21233656|P4|PET-directed Therapy|Death|2
6161556|NCT00822120|21233657|P3|PET-directed Therapy|Death|0
6161557|NCT00822120|21233658|P2|PET-directed Therapy|Death|0
6161558|NCT00822120|21233659|P1|PET-directed Therapy|Death|0
6161559|NCT00822120|21233654|P6|PET-directed Therapy|Refusal Unrelated to Adverse Event|0
6161560|NCT00822120|21233655|P5|PET-directed Therapy|Refusal Unrelated to Adverse Event|0
6161561|NCT00822120|21233656|P4|PET-directed Therapy|Refusal Unrelated to Adverse Event|1
6161562|NCT00822120|21233657|P3|PET-directed Therapy|Refusal Unrelated to Adverse Event|0
6161563|NCT00822120|21233658|P2|PET-directed Therapy|Refusal Unrelated to Adverse Event|0
6161564|NCT00822120|21233659|P1|PET-directed Therapy|Refusal Unrelated to Adverse Event|0
6161565|NCT00822120|21233654|P6|PET-directed Therapy|Adverse Event|0
6161566|NCT00822120|21233655|P5|PET-directed Therapy|Adverse Event|0
6161567|NCT00822120|21233656|P4|PET-directed Therapy|Adverse Event|1
6161568|NCT00822120|21233657|P3|PET-directed Therapy|Adverse Event|0
6161569|NCT00822120|21233658|P2|PET-directed Therapy|Adverse Event|0
6161570|NCT00822120|21233659|P1|PET-directed Therapy|Adverse Event|0
6161571|NCT00822120|21233654|P6|Initial Registration|Ineligible|0
6161572|NCT00822120|21233655|P5|Initial Registration|Ineligible|0
6161573|NCT00822120|21233656|P4|Initial Registration|Ineligible|0
6161574|NCT00822120|21233657|P3|Initial Registration|Ineligible|0
6161575|NCT00822120|21233658|P2|Initial Registration|Ineligible|1
6161576|NCT00822120|21233659|P1|Initial Registration|Ineligible|22
6161577|NCT00822120|21233654|P6|Initial Registration|Reasons not Protocol Specified|0
6161578|NCT00822120|21233655|P5|Initial Registration|Reasons not Protocol Specified|0
6161579|NCT00822120|21233656|P4|Initial Registration|Reasons not Protocol Specified|0
6161580|NCT00822120|21233657|P3|Initial Registration|Reasons not Protocol Specified|0
6161581|NCT00822120|21233658|P2|Initial Registration|Reasons not Protocol Specified|0
6161582|NCT00822120|21233659|P1|Initial Registration|Reasons not Protocol Specified|2
6161583|NCT00822120|21233654|P6|Initial Registration|Refusal Unrelated to Adverse Event|0
6161584|NCT00822120|21233655|P5|Initial Registration|Refusal Unrelated to Adverse Event|0
6161585|NCT00822120|21233656|P4|Initial Registration|Refusal Unrelated to Adverse Event|0
6161586|NCT00822120|21233657|P3|Initial Registration|Refusal Unrelated to Adverse Event|0
6161587|NCT00822120|21233658|P2|Initial Registration|Refusal Unrelated to Adverse Event|0
6161588|NCT00822120|21233659|P1|Initial Registration|Refusal Unrelated to Adverse Event|1
6161589|NCT00822120|21233654|P6|Initial Registration|Adverse Event|0
6161590|NCT00822120|21233655|P5|Initial Registration|Adverse Event|0
6161591|NCT00822120|21233656|P4|Initial Registration|Adverse Event|0
6161592|NCT00822120|21233657|P3|Initial Registration|Adverse Event|0
6161593|NCT00822120|21233658|P2|Initial Registration|Adverse Event|0
6161594|NCT00822120|21233659|P1|Initial Registration|Adverse Event|1
6161604|NCT00728988|21233757|P2|Overall Study|Withdrawal by Subject|6
6161605|NCT00728988|21233758|P1|Overall Study|Withdrawal by Subject|2
6161606|NCT00728988|21233757|P2|Overall Study|Other|77
6161607|NCT00728988|21233758|P1|Overall Study|Other|85
6161608|NCT00728988|21233757|P2|Overall Study|Adverse Event|2
6161609|NCT00728988|21233758|P1|Overall Study|Adverse Event|3
6161610|NCT00728988|21233757|P2|Overall Study|Death|1
6161611|NCT00728988|21233758|P1|Overall Study|Death|1
6161612|NCT00728988|21233757|P2|Overall Study|Not Treated|2
6161613|NCT00728988|21233758|P1|Overall Study|Not Treated|2
6161620|NCT00673660|21233815|P1|Overall Study|Lost to Follow-up|107
6161621|NCT00669409|21233832|P11|Part 2|Withdrawal by Subject|0
6161622|NCT00669409|21233833|P10|Part 2|Withdrawal by Subject|1
6161623|NCT00669409|21233834|P9|Part 2|Withdrawal by Subject|0
6161624|NCT00669409|21233835|P8|Part 2|Withdrawal by Subject|0
6161625|NCT00669409|21233836|P7|Part 2|Withdrawal by Subject|0
6161626|NCT00669409|21233837|P6|Part 2|Withdrawal by Subject|0
6161627|NCT00669409|21233838|P5|Part 2|Withdrawal by Subject|0
6161628|NCT00669409|21233839|P4|Part 2|Withdrawal by Subject|0
6161629|NCT00669409|21233840|P3|Part 2|Withdrawal by Subject|0
6161630|NCT00669409|21233841|P2|Part 2|Withdrawal by Subject|0
6161631|NCT00669409|21233842|P1|Part 2|Withdrawal by Subject|0
6161632|NCT00662558|21234226|P2|Overall Study|Randomized But Did Not Receive Treatment|8
6161633|NCT00662558|21234227|P1|Overall Study|Randomized But Did Not Receive Treatment|2
6161634|NCT00662558|21234226|P2|Overall Study|Withdrawal by Subject|12
6161635|NCT00662558|21234227|P1|Overall Study|Withdrawal by Subject|7
6161636|NCT00662558|21234226|P2|Overall Study|Other|14
6161637|NCT00662558|21234227|P1|Overall Study|Other|9
6161638|NCT00662558|21234226|P2|Overall Study|Lost to Follow-up|10
6161639|NCT00662558|21234227|P1|Overall Study|Lost to Follow-up|13
6161640|NCT00662558|21234226|P2|Overall Study|Lack of Efficacy|7
6161641|NCT00662558|21234227|P1|Overall Study|Lack of Efficacy|4
6161642|NCT00662558|21234226|P2|Overall Study|Adverse Event|59
6161643|NCT00662558|21234227|P1|Overall Study|Adverse Event|21
6161644|NCT00602641|21234261|P2|Overall Study|Other|1
6161645|NCT00602641|21234262|P1|Overall Study|Other|3
6161646|NCT00602641|21234261|P2|Overall Study|Administrative Closure|1
6161647|NCT00602641|21234262|P1|Overall Study|Administrative Closure|1
6161648|NCT00602641|21234261|P2|Overall Study|Physician Decision|4
6161649|NCT00602641|21234262|P1|Overall Study|Physician Decision|5
6161650|NCT00602641|21234261|P2|Overall Study|Other Complicating Disease|2
6161651|NCT00602641|21234262|P1|Overall Study|Other Complicating Disease|5
6161652|NCT00602641|21234261|P2|Overall Study|Alternative therapy|2
6161653|NCT00602641|21234262|P1|Overall Study|Alternative therapy|5
6161654|NCT00602641|21234261|P2|Overall Study|Withdrawal by Subject|12
6161655|NCT00602641|21234262|P1|Overall Study|Withdrawal by Subject|15
6161656|NCT00602641|21234261|P2|Overall Study|Death|5
6161657|NCT00602641|21234262|P1|Overall Study|Death|6
6161658|NCT00602641|21234261|P2|Overall Study|Disease progression|55
6161659|NCT00602641|21234262|P1|Overall Study|Disease progression|38
6161660|NCT00602641|21234261|P2|Overall Study|Adverse Event|53
6161661|NCT00602641|21234262|P1|Overall Study|Adverse Event|62
6161662|NCT00602641|21234261|P2|Overall Study|Still on treatment at time of analysis|15
6161663|NCT00602641|21234262|P1|Overall Study|Still on treatment at time of analysis|8
6161664|NCT00602641|21234261|P2|Overall Study|Never started protocol therapy|2
6161665|NCT00602641|21234262|P1|Overall Study|Never started protocol therapy|6
6161666|NCT00585312|21234276|P2|Overall Study|Study terminated by the sponsor|31
6161667|NCT00585312|21234277|P1|Overall Study|Study terminated by the sponsor|34
6161668|NCT00585312|21234276|P2|Overall Study|Withdrawal by Subject|1
6161669|NCT00585312|21234277|P1|Overall Study|Withdrawal by Subject|5
6161670|NCT00585312|21234276|P2|Overall Study|Reason not specified|0
6161671|NCT00585312|21234277|P1|Overall Study|Reason not specified|2
6161672|NCT00585312|21234276|P2|Overall Study|Lost to Follow-up|1
6161673|NCT00585312|21234277|P1|Overall Study|Lost to Follow-up|1
6161674|NCT00585312|21234276|P2|Overall Study|Lack of Efficacy|11
6161675|NCT00585312|21234277|P1|Overall Study|Lack of Efficacy|6
6161676|NCT00585312|21234276|P2|Overall Study|Adverse Event|0
6161677|NCT00585312|21234277|P1|Overall Study|Adverse Event|3
6161678|NCT00549549|21234293|P4|Overall Study|Randomized but not treated|1
6161679|NCT00549549|21234294|P3|Overall Study|Randomized but not treated|1
6161680|NCT00549549|21234295|P2|Overall Study|Randomized but not treated|0
6161681|NCT00549549|21234296|P1|Overall Study|Randomized but not treated|0
6161682|NCT00549549|21234293|P4|Overall Study|Other|11
6161683|NCT00549549|21234294|P3|Overall Study|Other|9
6161684|NCT00549549|21234295|P2|Overall Study|Other|9
6161685|NCT00549549|21234296|P1|Overall Study|Other|9
6161686|NCT00549549|21234293|P4|Overall Study|Withdrawal by Subject|0
6161687|NCT00549549|21234294|P3|Overall Study|Withdrawal by Subject|1
6161688|NCT00549549|21234295|P2|Overall Study|Withdrawal by Subject|4
6161689|NCT00549549|21234296|P1|Overall Study|Withdrawal by Subject|0
6161690|NCT00549549|21234293|P4|Overall Study|Lost to Follow-up|2
6161691|NCT00549549|21234294|P3|Overall Study|Lost to Follow-up|1
6161692|NCT00549549|21234295|P2|Overall Study|Lost to Follow-up|0
6161693|NCT00549549|21234296|P1|Overall Study|Lost to Follow-up|1
6161694|NCT00549549|21234293|P4|Overall Study|Lack of Efficacy|2
6161695|NCT00549549|21234294|P3|Overall Study|Lack of Efficacy|4
6161696|NCT00549549|21234295|P2|Overall Study|Lack of Efficacy|6
6161697|NCT00549549|21234296|P1|Overall Study|Lack of Efficacy|9
6161698|NCT00549549|21234293|P4|Overall Study|Adverse Event|9
6161699|NCT00549549|21234294|P3|Overall Study|Adverse Event|1
6161700|NCT00549549|21234295|P2|Overall Study|Adverse Event|3
6161701|NCT00549549|21234296|P1|Overall Study|Adverse Event|5
6161716|NCT00454207|21234396|P2|Overall Study|Protocol Violation|1
6161717|NCT00454207|21234397|P1|Overall Study|Protocol Violation|0
6161718|NCT00454207|21234396|P2|Overall Study|Lack of Efficacy|0
6161719|NCT00454207|21234397|P1|Overall Study|Lack of Efficacy|1
6161720|NCT00454207|21234396|P2|Overall Study|Adverse Event|1
6161721|NCT00454207|21234397|P1|Overall Study|Adverse Event|3
6161722|NCT00446797|21234442|P2|Overall Study|did not meet entrance criteria|1
6161723|NCT00446797|21234443|P1|Overall Study|did not meet entrance criteria|0
6161724|NCT00446797|21234442|P2|Overall Study|subject entered at another site|1
6161725|NCT00446797|21234443|P1|Overall Study|subject entered at another site|0
6161726|NCT00446797|21234442|P2|Overall Study|Protocol Violation|3
6161727|NCT00446797|21234443|P1|Overall Study|Protocol Violation|1
6161728|NCT00446797|21234442|P2|Overall Study|Withdrawal by Subject|2
6161729|NCT00446797|21234443|P1|Overall Study|Withdrawal by Subject|2
6161730|NCT00446797|21234442|P2|Overall Study|Lost to Follow-up|3
6161731|NCT00446797|21234443|P1|Overall Study|Lost to Follow-up|5
6161732|NCT00446797|21234442|P2|Overall Study|Lack of Efficacy|2
6161733|NCT00446797|21234443|P1|Overall Study|Lack of Efficacy|0
6161734|NCT00443599|21234489|P2|Overall Study|Cardiopulmonary bypass canceled|1
6161735|NCT00443599|21234490|P1|Overall Study|Cardiopulmonary bypass canceled|3
6161736|NCT00443599|21234489|P2|Overall Study|Death|1
6161737|NCT00443599|21234490|P1|Overall Study|Death|1
6161738|NCT00443599|21234489|P2|Overall Study|Physician Decision|1
6161739|NCT00443599|21234490|P1|Overall Study|Physician Decision|2
6161740|NCT00378105|21234524|P2|Overall Study|necessity to increase lenalidomide dose|1
6161741|NCT00378105|21234525|P1|Overall Study|necessity to increase lenalidomide dose|0
6161742|NCT00378105|21234524|P2|Overall Study|Going non-protocol therapy|1
6161743|NCT00378105|21234525|P1|Overall Study|Going non-protocol therapy|0
6161744|NCT00378105|21234524|P2|Overall Study|Physician Decision|2
6161745|NCT00378105|21234525|P1|Overall Study|Physician Decision|0
6161746|NCT00378105|21234524|P2|Overall Study|remain on study|11
6161747|NCT00378105|21234525|P1|Overall Study|remain on study|3
6161748|NCT00378105|21234524|P2|Overall Study|Progressive disease|3
6161749|NCT00378105|21234525|P1|Overall Study|Progressive disease|3
6161750|NCT00378105|21234524|P2|Overall Study|Going to transplant|8
6161751|NCT00378105|21234525|P1|Overall Study|Going to transplant|7
6161752|NCT00378105|21234524|P2|Overall Study|Death|0
6161753|NCT00378105|21234525|P1|Overall Study|Death|1
6161754|NCT00378105|21234524|P2|Overall Study|Withdrawal by Subject|3
6161755|NCT00378105|21234525|P1|Overall Study|Withdrawal by Subject|3
6161756|NCT00378105|21234524|P2|Overall Study|Adverse Event|1
6161757|NCT00378105|21234525|P1|Overall Study|Adverse Event|3
6161758|NCT00351611|21234536|P2|Overall Study|Protocol Violation|2
6161759|NCT00351611|21234537|P1|Overall Study|Protocol Violation|0
6161760|NCT00351611|21234536|P2|Overall Study|Other|0
6161761|NCT00351611|21234537|P1|Overall Study|Other|1
6161762|NCT00351611|21234536|P2|Overall Study|No Longer Willing to Participate in Study|5
6161763|NCT00351611|21234537|P1|Overall Study|No Longer Willing to Participate in Study|0
6161764|NCT00351611|21234536|P2|Overall Study|Lost to Follow-up|0
6161765|NCT00351611|21234537|P1|Overall Study|Lost to Follow-up|1
6161766|NCT00351611|21234536|P2|Overall Study|Death|0
6161767|NCT00351611|21234537|P1|Overall Study|Death|1
6161768|NCT00351611|21234536|P2|Overall Study|Adverse Event|3
6161769|NCT00351611|21234537|P1|Overall Study|Adverse Event|11
6161787|NCT00070018|21234671|P1|Overall Study|Withdrawal by Subject|1
6161788|NCT00070018|21234671|P1|Overall Study|Lack of Efficacy|1
6161789|NCT00070018|21234671|P1|Overall Study|Adverse Event|2
6161790|NCT00003508|21234675|P1|Overall Study|Not evaluable|5
6165504|NCT03981861|21248711|P1|Overall Study|Withdrawal by Subject|3
6165545|NCT03760068|21249090|P2|Overall Study|Subject Moved Out of State|0
6165546|NCT03760068|21249091|P1|Overall Study|Subject Moved Out of State|1
6165547|NCT03760068|21249090|P2|Overall Study|Lost to Follow-up|9
6165548|NCT03760068|21249091|P1|Overall Study|Lost to Follow-up|4
6165549|NCT03760068|21249090|P2|Overall Study|Physician Decision|2
6165550|NCT03760068|21249091|P1|Overall Study|Physician Decision|1
6165551|NCT03760068|21249090|P2|Overall Study|Administrative Decision by Sponsor|2
6165552|NCT03760068|21249091|P1|Overall Study|Administrative Decision by Sponsor|0
6165553|NCT03760068|21249090|P2|Overall Study|Adverse Event|2
6165554|NCT03760068|21249091|P1|Overall Study|Adverse Event|1
6165555|NCT03760068|21249090|P2|Overall Study|Withdrawal by Subject|8
6165556|NCT03760068|21249091|P1|Overall Study|Withdrawal by Subject|7
6165557|NCT03743038|21249109|P1|Overall Study|Physician Decision|1
6165591|NCT03415022|21249477|P2|Overall Study|Lost to Follow-up|0
6165592|NCT03415022|21249478|P1|Overall Study|Lost to Follow-up|2
6165593|NCT03415022|21249477|P2|Overall Study|COVID-19 Suspension|3
6165594|NCT03415022|21249478|P1|Overall Study|COVID-19 Suspension|2
6165595|NCT03415022|21249477|P2|Overall Study|Withdrawal by Subject|2
6165596|NCT03415022|21249478|P1|Overall Study|Withdrawal by Subject|1
6165600|NCT03335150|21249593|P2|Overall Study|Adverse Event|1
6165601|NCT03335150|21249594|P1|Overall Study|Adverse Event|0
6165602|NCT03335150|21249593|P2|Overall Study|Withdrawal by Subject|4
6165603|NCT03335150|21249594|P1|Overall Study|Withdrawal by Subject|10
6165604|NCT03329690|21249621|P5|Overall Study|Did not receive treatment|0
6165605|NCT03329690|21249622|P4|Overall Study|Did not receive treatment|1
6165606|NCT03329690|21249623|P3|Overall Study|Did not receive treatment|0
6165607|NCT03329690|21249624|P2|Overall Study|Did not receive treatment|0
6165608|NCT03329690|21249625|P1|Overall Study|Did not receive treatment|1
6165609|NCT03329690|21249621|P5|Overall Study|Physician Decision|1
6165610|NCT03329690|21249622|P4|Overall Study|Physician Decision|0
6165611|NCT03329690|21249623|P3|Overall Study|Physician Decision|0
6165612|NCT03329690|21249624|P2|Overall Study|Physician Decision|0
6165613|NCT03329690|21249625|P1|Overall Study|Physician Decision|1
6165614|NCT03329690|21249621|P5|Overall Study|Withdrawal by Subject|0
6165615|NCT03329690|21249622|P4|Overall Study|Withdrawal by Subject|1
6165616|NCT03329690|21249623|P3|Overall Study|Withdrawal by Subject|0
6165617|NCT03329690|21249624|P2|Overall Study|Withdrawal by Subject|3
6165618|NCT03329690|21249625|P1|Overall Study|Withdrawal by Subject|2
6165619|NCT03329690|21249621|P5|Overall Study|Death|0
6165620|NCT03329690|21249622|P4|Overall Study|Death|1
6165621|NCT03329690|21249623|P3|Overall Study|Death|0
6165622|NCT03329690|21249624|P2|Overall Study|Death|0
6165623|NCT03329690|21249625|P1|Overall Study|Death|2
6165624|NCT03329690|21249621|P5|Overall Study|Adverse Event|2
6165625|NCT03329690|21249622|P4|Overall Study|Adverse Event|1
6165626|NCT03329690|21249623|P3|Overall Study|Adverse Event|0
6165627|NCT03329690|21249624|P2|Overall Study|Adverse Event|4
6165628|NCT03329690|21249625|P1|Overall Study|Adverse Event|19
6165629|NCT03329690|21249621|P5|Overall Study|Clinical progression|0
6165630|NCT03329690|21249622|P4|Overall Study|Clinical progression|1
6165631|NCT03329690|21249623|P3|Overall Study|Clinical progression|1
6165632|NCT03329690|21249624|P2|Overall Study|Clinical progression|4
6165633|NCT03329690|21249625|P1|Overall Study|Clinical progression|6
6165634|NCT03329690|21249621|P5|Overall Study|Progressive disease per RECIST|19
6165635|NCT03329690|21249622|P4|Overall Study|Progressive disease per RECIST|16
6165636|NCT03329690|21249623|P3|Overall Study|Progressive disease per RECIST|5
6165637|NCT03329690|21249624|P2|Overall Study|Progressive disease per RECIST|42
6165638|NCT03329690|21249625|P1|Overall Study|Progressive disease per RECIST|67
6165639|NCT03282357|21249703|P1|Overall Study|Other|9
6165640|NCT03282357|21249703|P1|Overall Study|Adverse Event|1
6165641|NCT03282357|21249703|P1|Overall Study|Withdrawal by Subject|4
6165642|NCT03282357|21249703|P1|Overall Study|Lost to Follow-up|3
6165643|NCT03277794|21249712|P2|Overall Study|Withdrew due to high acuity|0
6165644|NCT03277794|21249713|P1|Overall Study|Withdrew due to high acuity|1
6165645|NCT03277794|21249712|P2|Overall Study|Lost to Follow-up|4
6165646|NCT03277794|21249713|P1|Overall Study|Lost to Follow-up|2
6165662|NCT03213210|21249786|P1|Overall Study|Study termination|3
6165663|NCT03213210|21249786|P1|Overall Study|Lost to Follow-up|2
6165664|NCT03157089|21249824|P2|Overall Study|Progressive disease|8
6165665|NCT03157089|21249825|P1|Overall Study|Progressive disease|6
6165666|NCT03157089|21249824|P2|Overall Study|Adverse Event|4
6165667|NCT03157089|21249825|P1|Overall Study|Adverse Event|5
6165668|NCT03157089|21249824|P2|Overall Study|Treated only with pembrolizumab|0
6165669|NCT03157089|21249825|P1|Overall Study|Treated only with pembrolizumab|1
6165670|NCT03078907|21249917|P2|Overall Study|Protocol Violation|1
6165671|NCT03078907|21249918|P1|Overall Study|Protocol Violation|0
6165672|NCT03078907|21249917|P2|Overall Study|Other|0
6165673|NCT03078907|21249918|P1|Overall Study|Other|1
6165674|NCT03078907|21249917|P2|Overall Study|Adverse Event|0
6165675|NCT03078907|21249918|P1|Overall Study|Adverse Event|2
6165676|NCT03077646|21249955|P3|Overall Study|Lost to Follow-up|31
6165677|NCT03077646|21249956|P2|Overall Study|Lost to Follow-up|30
6165678|NCT03077646|21249957|P1|Overall Study|Lost to Follow-up|29
6165749|NCT02968563|21250276|P2|Overall Study|Still on Study|17
6165750|NCT02968563|21250277|P1|Overall Study|Still on Study|0
6165751|NCT02968563|21250276|P2|Overall Study|Death|1
6165752|NCT02968563|21250277|P1|Overall Study|Death|1
6165753|NCT02968563|21250276|P2|Overall Study|Adverse Event|5
6165754|NCT02968563|21250277|P1|Overall Study|Adverse Event|0
6165916|NCT02875080|21250558|P3|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|0
6165917|NCT02875080|21250559|P2|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|0
6165918|NCT02875080|21250560|P1|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|2
6165919|NCT02859454|21250571|P1|Overall Study|PI discretion/off study prior to trtmt|1
6165920|NCT02840474|21250584|P2|Overall Study|Lost to Follow-up|0
6165921|NCT02840474|21250585|P1|Overall Study|Lost to Follow-up|1
6165967|NCT02755818|21250777|P4|Overall Study|withdrawal by PI|1
6165968|NCT02755818|21250778|P3|Overall Study|withdrawal by PI|1
6165969|NCT02755818|21250779|P2|Overall Study|withdrawal by PI|0
6165970|NCT02755818|21250780|P1|Overall Study|withdrawal by PI|0
6165971|NCT02755818|21250777|P4|Overall Study|Withdrawal by Subject|2
6165972|NCT02755818|21250778|P3|Overall Study|Withdrawal by Subject|0
6165973|NCT02755818|21250779|P2|Overall Study|Withdrawal by Subject|0
6165974|NCT02755818|21250780|P1|Overall Study|Withdrawal by Subject|0
6165975|NCT02728830|21250829|P1|Overall Study|Language Barrier|1
6165976|NCT02728830|21250829|P1|Overall Study|Contraindicated Illness|1
6165977|NCT02728830|21250829|P1|Overall Study|Exclusionary Lab Values|1
6165978|NCT02728830|21250829|P1|Overall Study|Lost to Follow-up|1
6165979|NCT02728830|21250829|P1|Overall Study|Withdrawal by Subject|2
6165980|NCT02728830|21250829|P1|Overall Study|Physician Decision|3
6165981|NCT02728830|21250829|P1|Overall Study|Exclusionary Pathology|6
6165982|NCT02728830|21250829|P1|Overall Study|Exclusionary Surgery|9
6166054|NCT02674061|21251039|P2|Overall Study|Ongoing in Study|20
6166055|NCT02674061|21251040|P1|Overall Study|Ongoing in Study|71
6166056|NCT02674061|21251039|P2|Overall Study|Withdrawal by Subject|2
6166057|NCT02674061|21251040|P1|Overall Study|Withdrawal by Subject|9
6166058|NCT02674061|21251039|P2|Overall Study|Lost to Follow-up|0
6166059|NCT02674061|21251040|P1|Overall Study|Lost to Follow-up|1
6166060|NCT02674061|21251039|P2|Overall Study|Death|69
6166061|NCT02674061|21251040|P1|Overall Study|Death|204
6166068|NCT02659150|21251251|P1|Study Drug Dosing|Adverse Event|1
6166069|NCT02659150|21251251|P1|Baseline Imaging|Physician Decision|1
6166070|NCT02659150|21251251|P1|Baseline Imaging|Withdrawal by Subject|1
6166071|NCT02659150|21251251|P1|Subject Enrollment|Withdrawal by Subject|2
6166072|NCT02659150|21251251|P1|Subject Enrollment|Physician Decision|3
6166073|NCT02642042|21251333|P1|Overall Study|Not Protocol Specified|2
6166074|NCT02642042|21251333|P1|Overall Study|Death|1
6166075|NCT02642042|21251333|P1|Overall Study|Progression/Relapse|28
6166076|NCT02642042|21251333|P1|Overall Study|Refusal Unrelated to Adverse Event|1
6166077|NCT02642042|21251333|P1|Overall Study|Adverse Event|22
6166078|NCT02628444|21251349|P9|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|2
6166079|NCT02628444|21251350|P8|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1
6166080|NCT02628444|21251351|P7|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|3
6166081|NCT02628444|21251352|P6|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|2
6166082|NCT02628444|21251353|P5|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1
6166083|NCT02628444|21251354|P4|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1
6166084|NCT02628444|21251355|P3|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0
6166085|NCT02628444|21251356|P2|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0
6166086|NCT02628444|21251357|P1|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0
6166087|NCT02628444|21251349|P9|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|3
6166088|NCT02628444|21251350|P8|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|2
6166089|NCT02628444|21251351|P7|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0
6166090|NCT02628444|21251352|P6|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0
6166091|NCT02628444|21251353|P5|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|3
6166092|NCT02628444|21251354|P4|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0
6166093|NCT02628444|21251355|P3|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0
6166094|NCT02628444|21251356|P2|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0
6166095|NCT02628444|21251357|P1|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0
6166096|NCT02628444|21251349|P9|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|9
6166097|NCT02628444|21251350|P8|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|11
6166098|NCT02628444|21251351|P7|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|12
6166099|NCT02628444|21251352|P6|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|10
6166100|NCT02628444|21251353|P5|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|6
6166101|NCT02628444|21251354|P4|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|5
6166102|NCT02628444|21251355|P3|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0
6166103|NCT02628444|21251356|P2|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0
6166104|NCT02628444|21251357|P1|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0
6166105|NCT02628444|21251349|P9|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|85
6166106|NCT02628444|21251350|P8|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|84
6166107|NCT02628444|21251351|P7|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|81
6166108|NCT02628444|21251352|P6|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83
6166109|NCT02628444|21251353|P5|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83
6166110|NCT02628444|21251354|P4|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83
6166111|NCT02628444|21251355|P3|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0
6166112|NCT02628444|21251356|P2|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0
6166113|NCT02628444|21251357|P1|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0
6166114|NCT02628444|21251349|P9|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0
6166115|NCT02628444|21251350|P8|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0
6166116|NCT02628444|21251351|P7|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0
6166117|NCT02628444|21251352|P6|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0
6166118|NCT02628444|21251353|P5|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0
6166119|NCT02628444|21251354|P4|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|1
6166120|NCT02628444|21251355|P3|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0
6166121|NCT02628444|21251356|P2|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0
6166122|NCT02628444|21251357|P1|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0
6166123|NCT02628444|21251349|P9|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0
6166124|NCT02628444|21251350|P8|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0
6166125|NCT02628444|21251351|P7|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0
6166126|NCT02628444|21251352|P6|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0
6166127|NCT02628444|21251353|P5|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0
6166128|NCT02628444|21251354|P4|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0
6166129|NCT02628444|21251355|P3|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|5
6166130|NCT02628444|21251356|P2|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|3
6166131|NCT02628444|21251357|P1|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|5
6166132|NCT02628444|21251349|P9|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0
6166133|NCT02628444|21251350|P8|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0
6166134|NCT02628444|21251351|P7|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0
6166135|NCT02628444|21251352|P6|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0
6166136|NCT02628444|21251353|P5|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0
6166137|NCT02628444|21251354|P4|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0
6166138|NCT02628444|21251355|P3|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|9
6166139|NCT02628444|21251356|P2|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|16
6166140|NCT02628444|21251357|P1|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|9
6166141|NCT02628444|21251349|P9|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0
6166142|NCT02628444|21251350|P8|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0
6166143|NCT02628444|21251351|P7|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0
6166144|NCT02628444|21251352|P6|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0
6166145|NCT02628444|21251353|P5|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0
6166146|NCT02628444|21251354|P4|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0
6166147|NCT02628444|21251355|P3|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|25
6166148|NCT02628444|21251356|P2|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|16
6166149|NCT02628444|21251357|P1|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|21
6166150|NCT02628444|21251349|P9|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0
6166151|NCT02628444|21251350|P8|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0
6166152|NCT02628444|21251351|P7|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0
6166153|NCT02628444|21251352|P6|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0
6166154|NCT02628444|21251353|P5|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0
6166155|NCT02628444|21251354|P4|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0
6166156|NCT02628444|21251355|P3|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|3
6166157|NCT02628444|21251356|P2|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|4
6166158|NCT02628444|21251357|P1|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0
6166159|NCT02628444|21251349|P9|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0
6166160|NCT02628444|21251350|P8|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0
6166161|NCT02628444|21251351|P7|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0
6166162|NCT02628444|21251352|P6|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0
6166163|NCT02628444|21251353|P5|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0
6166164|NCT02628444|21251354|P4|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0
6166165|NCT02628444|21251355|P3|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0
6166166|NCT02628444|21251356|P2|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0
6166167|NCT02628444|21251357|P1|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|1
6166168|NCT02586207|21251463|P1|Overall Study|Withdrawal by Subject|1
6166169|NCT02586207|21251463|P1|Overall Study|Physician Decision|1
6166230|NCT02520310|21251517|P1|AT 4 Year Clinical Follow-up|missed visit|1
6166231|NCT02520310|21251517|P1|AT 4 Year Clinical Follow-up|Death|1
6166232|NCT02520310|21251517|P1|AT 3 Year Clinical Follow-up|Withdrawal by Subject|2
6166233|NCT02520310|21251517|P1|AT 3 Year Clinical Follow-up|Death|2
6166234|NCT02520310|21251517|P1|At 1 Year Clinical Follow-up|Withdrawal by Subject|1
6166235|NCT02520310|21251517|P1|At 6 Months Clinical Follow-up|Death|1
6166236|NCT02457910|21251713|P6|Overall Study|Death|0
6166237|NCT02457910|21251714|P5|Overall Study|Death|0
6166238|NCT02457910|21251715|P4|Overall Study|Death|0
6166239|NCT02457910|21251716|P3|Overall Study|Death|1
6166240|NCT02457910|21251717|P2|Overall Study|Death|0
6166241|NCT02457910|21251718|P1|Overall Study|Death|0
6166242|NCT02457910|21251713|P6|Overall Study|Other complicating illness|1
6166243|NCT02457910|21251714|P5|Overall Study|Other complicating illness|0
6166244|NCT02457910|21251715|P4|Overall Study|Other complicating illness|0
6166245|NCT02457910|21251716|P3|Overall Study|Other complicating illness|0
6166246|NCT02457910|21251717|P2|Overall Study|Other complicating illness|0
6166247|NCT02457910|21251718|P1|Overall Study|Other complicating illness|0
6166248|NCT02457910|21251713|P6|Overall Study|Disease progression|6
6166249|NCT02457910|21251714|P5|Overall Study|Disease progression|4
6166250|NCT02457910|21251715|P4|Overall Study|Disease progression|1
6166251|NCT02457910|21251716|P3|Overall Study|Disease progression|1
6166252|NCT02457910|21251717|P2|Overall Study|Disease progression|3
6166253|NCT02457910|21251718|P1|Overall Study|Disease progression|3
6166254|NCT02457910|21251713|P6|Overall Study|Adverse Event|3
6166255|NCT02457910|21251714|P5|Overall Study|Adverse Event|1
6166256|NCT02457910|21251715|P4|Overall Study|Adverse Event|1
6166257|NCT02457910|21251716|P3|Overall Study|Adverse Event|1
6166258|NCT02457910|21251717|P2|Overall Study|Adverse Event|2
6166259|NCT02457910|21251718|P1|Overall Study|Adverse Event|0
6166260|NCT02457910|21251713|P6|Overall Study|Withdrawal by Subject|1
6166261|NCT02457910|21251714|P5|Overall Study|Withdrawal by Subject|0
6166262|NCT02457910|21251715|P4|Overall Study|Withdrawal by Subject|0
6166263|NCT02457910|21251716|P3|Overall Study|Withdrawal by Subject|0
6166264|NCT02457910|21251717|P2|Overall Study|Withdrawal by Subject|0
6166265|NCT02457910|21251718|P1|Overall Study|Withdrawal by Subject|0
6166373|NCT02376790|21252434|P3|Overall Study|Lost to Follow-up|12
6166374|NCT02376790|21252435|P2|Overall Study|Lost to Follow-up|10
6166375|NCT02376790|21252436|P1|Overall Study|Lost to Follow-up|15
6166376|NCT02376790|21252434|P3|Overall Study|Decision by Sponsor|4
6166377|NCT02376790|21252435|P2|Overall Study|Decision by Sponsor|1
6166378|NCT02376790|21252436|P1|Overall Study|Decision by Sponsor|2
6166379|NCT02376790|21252434|P3|Overall Study|Withdrawal by Subject|37
6166380|NCT02376790|21252435|P2|Overall Study|Withdrawal by Subject|36
6166381|NCT02376790|21252436|P1|Overall Study|Withdrawal by Subject|43
6166585|NCT02273739|21252970|P4|Overall Study|Physician Decision|1
6166586|NCT02273739|21252971|P3|Overall Study|Physician Decision|0
6166587|NCT02273739|21252972|P2|Overall Study|Physician Decision|0
6166588|NCT02273739|21252973|P1|Overall Study|Physician Decision|0
6166589|NCT02273739|21252970|P4|Overall Study|Withdrawal by Subject|1
6166590|NCT02273739|21252971|P3|Overall Study|Withdrawal by Subject|2
6166591|NCT02273739|21252972|P2|Overall Study|Withdrawal by Subject|0
6166592|NCT02273739|21252973|P1|Overall Study|Withdrawal by Subject|0
6166593|NCT02273739|21252970|P4|Overall Study|Adverse Event|1
6166594|NCT02273739|21252971|P3|Overall Study|Adverse Event|0
6166595|NCT02273739|21252972|P2|Overall Study|Adverse Event|0
6166596|NCT02273739|21252973|P1|Overall Study|Adverse Event|0
6166597|NCT02273739|21252970|P4|Overall Study|Death|2
6166598|NCT02273739|21252971|P3|Overall Study|Death|0
6166599|NCT02273739|21252972|P2|Overall Study|Death|0
6166600|NCT02273739|21252973|P1|Overall Study|Death|0
6166601|NCT02273739|21252970|P4|Overall Study|Progression of Disease|2
6166602|NCT02273739|21252971|P3|Overall Study|Progression of Disease|5
6166603|NCT02273739|21252972|P2|Overall Study|Progression of Disease|4
6166604|NCT02273739|21252973|P1|Overall Study|Progression of Disease|3
6166613|NCT02242942|21253085|P3|Overall Study|On-going in Study|11
6166614|NCT02242942|21253086|P2|Overall Study|On-going in Study|186
6166615|NCT02242942|21253087|P1|Overall Study|On-going in Study|190
6166616|NCT02242942|21253085|P3|Overall Study|Withdrawal by Subject|0
6166617|NCT02242942|21253086|P2|Overall Study|Withdrawal by Subject|10
6166618|NCT02242942|21253087|P1|Overall Study|Withdrawal by Subject|8
6166619|NCT02242942|21253085|P3|Overall Study|Physician Decision|0
6166620|NCT02242942|21253086|P2|Overall Study|Physician Decision|0
6166621|NCT02242942|21253087|P1|Overall Study|Physician Decision|1
6166622|NCT02242942|21253085|P3|Overall Study|Death|2
6166623|NCT02242942|21253086|P2|Overall Study|Death|20
6166624|NCT02242942|21253087|P1|Overall Study|Death|17
6166626|NCT02227238|21253122|P2|Overall Study|Lost to Follow-up|5
6166627|NCT02227238|21253123|P1|Overall Study|Lost to Follow-up|7
6166628|NCT02227238|21253122|P2|Overall Study|Physician Decision|9
6166629|NCT02227238|21253123|P1|Overall Study|Physician Decision|0
6166630|NCT02227238|21253122|P2|Overall Study|Withdrawal by Subject|4
6166631|NCT02227238|21253123|P1|Overall Study|Withdrawal by Subject|5
6166632|NCT02227238|21253122|P2|Overall Study|Protocol Violation|8
6166633|NCT02227238|21253123|P1|Overall Study|Protocol Violation|7
6166634|NCT02227238|21253122|P2|Overall Study|Lack of Efficacy|22
6166635|NCT02227238|21253123|P1|Overall Study|Lack of Efficacy|10
6166636|NCT02227238|21253122|P2|Overall Study|Adverse Event|18
6166637|NCT02227238|21253123|P1|Overall Study|Adverse Event|8
6166638|NCT02227238|21253122|P2|Overall Study|Other: Reached stopping criteria|1
6166639|NCT02227238|21253123|P1|Overall Study|Other: Reached stopping criteria|0
6166678|NCT02094261|21253392|P1|Overall Study|Ongoing Study at Data Cut-off|181
6166679|NCT02094261|21253392|P1|Overall Study|Withdrawal by Subject|4
6166680|NCT02094261|21253392|P1|Overall Study|Lost to Follow-up|1
6166681|NCT02094261|21253392|P1|Overall Study|Death|24
6166687|NCT02076009|21253488|P2|Overall Study|Subjects randomized but not treated|3
6166688|NCT02076009|21253489|P1|Overall Study|Subjects randomized but not treated|2
6166689|NCT02076009|21253488|P2|Overall Study|Ongoing|249
6166690|NCT02076009|21253489|P1|Overall Study|Ongoing|226
6166691|NCT02076009|21253488|P2|Overall Study|Progressive disease|0
6166692|NCT02076009|21253489|P1|Overall Study|Progressive disease|1
6166693|NCT02076009|21253488|P2|Overall Study|Lost to Follow-up|1
6166694|NCT02076009|21253489|P1|Overall Study|Lost to Follow-up|1
6166695|NCT02076009|21253488|P2|Overall Study|Withdrawal by Subject|3
6166696|NCT02076009|21253489|P1|Overall Study|Withdrawal by Subject|9
6166697|NCT02076009|21253488|P2|Overall Study|Death|30
6166698|NCT02076009|21253489|P1|Overall Study|Death|44
6166719|NCT02003924|21253557|P3|Long-term Follow-up Phase|Other|1
6166720|NCT02003924|21253558|P2|Long-term Follow-up Phase|Other|2
6166721|NCT02003924|21253559|P1|Long-term Follow-up Phase|Other|5
6166722|NCT02003924|21253557|P3|Long-term Follow-up Phase|Withdrew Consent to Be Followed|1
6166723|NCT02003924|21253558|P2|Long-term Follow-up Phase|Withdrew Consent to Be Followed|55
6166724|NCT02003924|21253559|P1|Long-term Follow-up Phase|Withdrew Consent to Be Followed|66
6166725|NCT02003924|21253557|P3|Long-term Follow-up Phase|Lost to Follow-up|1
6166726|NCT02003924|21253558|P2|Long-term Follow-up Phase|Lost to Follow-up|6
6166727|NCT02003924|21253559|P1|Long-term Follow-up Phase|Lost to Follow-up|8
6166728|NCT02003924|21253557|P3|Long-term Follow-up Phase|Death|4
6166729|NCT02003924|21253558|P2|Long-term Follow-up Phase|Death|174
6166730|NCT02003924|21253559|P1|Long-term Follow-up Phase|Death|288
6166731|NCT02003924|21253557|P3|Open-label Phase|Other|0
6166732|NCT02003924|21253558|P2|Open-label Phase|Other|0
6166733|NCT02003924|21253559|P1|Open-label Phase|Other|7
6166734|NCT02003924|21253557|P3|Open-label Phase|Adverse Event|10
6166735|NCT02003924|21253558|P2|Open-label Phase|Adverse Event|0
6166736|NCT02003924|21253559|P1|Open-label Phase|Adverse Event|25
6166737|NCT02003924|21253557|P3|Open-label Phase|Disease Progression|5
6166738|NCT02003924|21253558|P2|Open-label Phase|Disease Progression|0
6166739|NCT02003924|21253559|P1|Open-label Phase|Disease Progression|59
6166740|NCT02003924|21253557|P3|Open-label Phase|Withdrawal Consent to Continue Treatment|1
6166741|NCT02003924|21253558|P2|Open-label Phase|Withdrawal Consent to Continue Treatment|0
6166742|NCT02003924|21253559|P1|Open-label Phase|Withdrawal Consent to Continue Treatment|9
6166743|NCT02003924|21253557|P3|Open-label Phase|Lost to Follow-up|1
6166744|NCT02003924|21253558|P2|Open-label Phase|Lost to Follow-up|0
6166745|NCT02003924|21253559|P1|Open-label Phase|Lost to Follow-up|0
6166746|NCT02003924|21253557|P3|Double-blind Phase|Other|0
6166747|NCT02003924|21253558|P2|Double-blind Phase|Other|50
6166748|NCT02003924|21253559|P1|Double-blind Phase|Other|29
6166749|NCT02003924|21253557|P3|Double-blind Phase|Randomized But not Treated|0
6166750|NCT02003924|21253558|P2|Double-blind Phase|Randomized But not Treated|3
6166751|NCT02003924|21253559|P1|Double-blind Phase|Randomized But not Treated|3
6166752|NCT02003924|21253557|P3|Double-blind Phase|Adverse Event|0
6166753|NCT02003924|21253558|P2|Double-blind Phase|Adverse Event|31
6166754|NCT02003924|21253559|P1|Double-blind Phase|Adverse Event|120
6166755|NCT02003924|21253557|P3|Double-blind Phase|Disease Progression|0
6166756|NCT02003924|21253558|P2|Double-blind Phase|Disease Progression|247
6166757|NCT02003924|21253559|P1|Double-blind Phase|Disease Progression|229
6166758|NCT02003924|21253557|P3|Double-blind Phase|Withdrawal Consent to Continue Treatment|0
6166759|NCT02003924|21253558|P2|Double-blind Phase|Withdrawal Consent to Continue Treatment|47
6166760|NCT02003924|21253559|P1|Double-blind Phase|Withdrawal Consent to Continue Treatment|71
6166761|NCT02003924|21253557|P3|Double-blind Phase|Protocol Violation|0
6166762|NCT02003924|21253558|P2|Double-blind Phase|Protocol Violation|2
6166763|NCT02003924|21253559|P1|Double-blind Phase|Protocol Violation|1
6166764|NCT02003924|21253557|P3|Double-blind Phase|Lost to Follow-up|0
6166765|NCT02003924|21253558|P2|Double-blind Phase|Lost to Follow-up|1
6166766|NCT02003924|21253559|P1|Double-blind Phase|Lost to Follow-up|2
6166767|NCT01989546|21253667|P1|Overall Study|Disease progression on study|8
6166768|NCT01989546|21253667|P1|Overall Study|Clinical Progression|1
6166769|NCT01938001|21253675|P2|Overall Study|Death|26
6166770|NCT01938001|21253676|P1|Overall Study|Death|16
6166771|NCT01938001|21253675|P2|Overall Study|Lost to Follow-up|3
6166772|NCT01938001|21253676|P1|Overall Study|Lost to Follow-up|1
6166773|NCT01938001|21253675|P2|Overall Study|Participant Moved|1
6166774|NCT01938001|21253676|P1|Overall Study|Participant Moved|0
6166775|NCT01938001|21253675|P2|Overall Study|Non-compliant|0
6166776|NCT01938001|21253676|P1|Overall Study|Non-compliant|1
6166777|NCT01938001|21253675|P2|Overall Study|Withdrawal by Subject|17
6166778|NCT01938001|21253676|P1|Overall Study|Withdrawal by Subject|25
6166868|NCT01754753|21253890|P2|Overall Study|Lost to Follow-up|5
6166869|NCT01754753|21253891|P1|Overall Study|Lost to Follow-up|9
6166870|NCT01754753|21253890|P2|Overall Study|Study close|44
6166871|NCT01754753|21253891|P1|Overall Study|Study close|43
6166872|NCT01736124|21253917|P2|12 Mo. Post-Intervention Assessment|End of study|10
6166873|NCT01736124|21253918|P1|12 Mo. Post-Intervention Assessment|End of study|10
6166874|NCT01736124|21253917|P2|12 Mo. Post-Intervention Assessment|Withdrawal by Subject|2
6166875|NCT01736124|21253918|P1|12 Mo. Post-Intervention Assessment|Withdrawal by Subject|0
6166876|NCT01736124|21253917|P2|12 Mo. Post-Intervention Assessment|Moved away|0
6166877|NCT01736124|21253918|P1|12 Mo. Post-Intervention Assessment|Moved away|1
6166878|NCT01736124|21253917|P2|12 Mo. Post-Intervention Assessment|Death|0
6166879|NCT01736124|21253918|P1|12 Mo. Post-Intervention Assessment|Death|1
6166880|NCT01736124|21253917|P2|6 Mo. Post-Intervention Assessment|Temporarily away|4
6166881|NCT01736124|21253918|P1|6 Mo. Post-Intervention Assessment|Temporarily away|1
6166882|NCT01736124|21253917|P2|6 Mo. Post-Intervention Assessment|Illness|2
6166883|NCT01736124|21253918|P1|6 Mo. Post-Intervention Assessment|Illness|1
6166884|NCT01736124|21253917|P2|6 Mo. Post-Intervention Assessment|Withdrawal by Subject|3
6166885|NCT01736124|21253918|P1|6 Mo. Post-Intervention Assessment|Withdrawal by Subject|3
6166886|NCT01736124|21253917|P2|6 Mo. Post-Intervention Assessment|Moved away|2
6166887|NCT01736124|21253918|P1|6 Mo. Post-Intervention Assessment|Moved away|0
6166888|NCT01736124|21253917|P2|6 Mo. Post-Intervention Assessment|Death|1
6166889|NCT01736124|21253918|P1|6 Mo. Post-Intervention Assessment|Death|0
6166890|NCT01736124|21253917|P2|Post-intervention Assessment|Temporarily away|1
6166891|NCT01736124|21253918|P1|Post-intervention Assessment|Temporarily away|3
6166892|NCT01736124|21253917|P2|Post-intervention Assessment|Lost to Follow-up|5
6166893|NCT01736124|21253918|P1|Post-intervention Assessment|Lost to Follow-up|8
6166894|NCT01736124|21253917|P2|Post-intervention Assessment|Illness|2
6166895|NCT01736124|21253918|P1|Post-intervention Assessment|Illness|3
6166896|NCT01736124|21253917|P2|Post-intervention Assessment|Withdrawal by Subject|9
6166897|NCT01736124|21253918|P1|Post-intervention Assessment|Withdrawal by Subject|11
6166898|NCT01736124|21253917|P2|Post-intervention Assessment|Moved away|1
6166899|NCT01736124|21253918|P1|Post-intervention Assessment|Moved away|3
6166900|NCT01736124|21253917|P2|Post-intervention Assessment|lost computer access|1
6166901|NCT01736124|21253918|P1|Post-intervention Assessment|lost computer access|1
6166902|NCT01736124|21253917|P2|Post-intervention Assessment|Death|2
6166903|NCT01736124|21253918|P1|Post-intervention Assessment|Death|2
6166980|NCT01660451|21254061|P3|Overall Study|Ongoing with treatment|46
6166981|NCT01660451|21254062|P2|Overall Study|Ongoing with treatment|3
6166982|NCT01660451|21254063|P1|Overall Study|Ongoing with treatment|3
6166983|NCT01660451|21254061|P3|Overall Study|Withdrawal by Subject|16
6166984|NCT01660451|21254062|P2|Overall Study|Withdrawal by Subject|0
6166985|NCT01660451|21254063|P1|Overall Study|Withdrawal by Subject|1
6166986|NCT01660451|21254061|P3|Overall Study|Physician Decision|5
6166987|NCT01660451|21254062|P2|Overall Study|Physician Decision|2
6166988|NCT01660451|21254063|P1|Overall Study|Physician Decision|1
6166989|NCT01660451|21254061|P3|Overall Study|Protocol Deviation|1
6166990|NCT01660451|21254062|P2|Overall Study|Protocol Deviation|0
6166991|NCT01660451|21254063|P1|Overall Study|Protocol Deviation|0
6166992|NCT01660451|21254061|P3|Overall Study|Sponsor Decision|1
6166993|NCT01660451|21254062|P2|Overall Study|Sponsor Decision|0
6166994|NCT01660451|21254063|P1|Overall Study|Sponsor Decision|0
6166995|NCT01660451|21254061|P3|Overall Study|AE with Clinical PD|9
6166996|NCT01660451|21254062|P2|Overall Study|AE with Clinical PD|3
6166997|NCT01660451|21254063|P1|Overall Study|AE with Clinical PD|1
6166998|NCT01660451|21254061|P3|Overall Study|Adverse Event (AE) without Clinical PD|26
6166999|NCT01660451|21254062|P2|Overall Study|Adverse Event (AE) without Clinical PD|8
6167000|NCT01660451|21254063|P1|Overall Study|Adverse Event (AE) without Clinical PD|11
6167001|NCT01660451|21254061|P3|Overall Study|Protocol Violation|1
6167002|NCT01660451|21254062|P2|Overall Study|Protocol Violation|1
6167003|NCT01660451|21254063|P1|Overall Study|Protocol Violation|0
6167006|NCT01609842|21254106|P2|Concurrent Intervention Control|pharmacy data not available|0
6167007|NCT01609842|21254107|P1|Concurrent Intervention Control|pharmacy data not available|2
6167042|NCT01338987|21254386|P5|Overall Study|Disease progression on study|0
6167043|NCT01338987|21254387|P4|Overall Study|Disease progression on study|0
6167044|NCT01338987|21254388|P3|Overall Study|Disease progression on study|1
6167045|NCT01338987|21254389|P2|Overall Study|Disease progression on study|1
6167046|NCT01338987|21254390|P1|Overall Study|Disease progression on study|2
6167047|NCT01338987|21254386|P5|Overall Study|enrolled on new protocol|0
6167048|NCT01338987|21254387|P4|Overall Study|enrolled on new protocol|0
6167049|NCT01338987|21254388|P3|Overall Study|enrolled on new protocol|1
6167050|NCT01338987|21254389|P2|Overall Study|enrolled on new protocol|0
6167051|NCT01338987|21254390|P1|Overall Study|enrolled on new protocol|0
6167052|NCT01302834|21254407|P2|Overall Study|HIV positive|3
6167053|NCT01302834|21254408|P1|Overall Study|HIV positive|1
6167054|NCT01302834|21254407|P2|Overall Study|Protocol Violation|23
6167055|NCT01302834|21254408|P1|Overall Study|Protocol Violation|17
6167070|NCT01216683|21254533|P3|Continuation|Never started treatment|5
6167071|NCT01216683|21254534|P2|Continuation|Never started treatment|1
6167072|NCT01216683|21254535|P1|Continuation|Never started treatment|0
6167073|NCT01216683|21254533|P3|Continuation|Not reported|1
6167074|NCT01216683|21254534|P2|Continuation|Not reported|0
6167075|NCT01216683|21254535|P1|Continuation|Not reported|0
6167076|NCT01216683|21254533|P3|Continuation|Mistakenly stayed on treatment for longer than expected|0
6167077|NCT01216683|21254534|P2|Continuation|Mistakenly stayed on treatment for longer than expected|1
6167078|NCT01216683|21254535|P1|Continuation|Mistakenly stayed on treatment for longer than expected|0
6167079|NCT01216683|21254533|P3|Continuation|Insurance change|0
6167080|NCT01216683|21254534|P2|Continuation|Insurance change|1
6167081|NCT01216683|21254535|P1|Continuation|Insurance change|0
6167082|NCT01216683|21254533|P3|Continuation|Non-compliance|1
6167083|NCT01216683|21254534|P2|Continuation|Non-compliance|0
6167084|NCT01216683|21254535|P1|Continuation|Non-compliance|1
6167085|NCT01216683|21254533|P3|Continuation|Physician Decision|1
6167086|NCT01216683|21254534|P2|Continuation|Physician Decision|0
6167087|NCT01216683|21254535|P1|Continuation|Physician Decision|1
6167088|NCT01216683|21254533|P3|Continuation|Other diseases|1
6167089|NCT01216683|21254534|P2|Continuation|Other diseases|2
6167090|NCT01216683|21254535|P1|Continuation|Other diseases|0
6167091|NCT01216683|21254533|P3|Continuation|Withdrawal by Subject|9
6167092|NCT01216683|21254534|P2|Continuation|Withdrawal by Subject|5
6167093|NCT01216683|21254535|P1|Continuation|Withdrawal by Subject|4
6167094|NCT01216683|21254533|P3|Continuation|Death|2
6167095|NCT01216683|21254534|P2|Continuation|Death|0
6167096|NCT01216683|21254535|P1|Continuation|Death|1
6167097|NCT01216683|21254533|P3|Continuation|Adverse Event|16
6167098|NCT01216683|21254534|P2|Continuation|Adverse Event|3
6167099|NCT01216683|21254535|P1|Continuation|Adverse Event|5
6167100|NCT01216683|21254533|P3|Continuation|Lack of Efficacy|7
6167101|NCT01216683|21254534|P2|Continuation|Lack of Efficacy|2
6167102|NCT01216683|21254535|P1|Continuation|Lack of Efficacy|3
6167103|NCT01216683|21254533|P3|Induction|Other disease|2
6167104|NCT01216683|21254534|P2|Induction|Other disease|1
6167105|NCT01216683|21254535|P1|Induction|Other disease|0
6167106|NCT01216683|21254533|P3|Induction|Withdrawal by Subject|2
6167107|NCT01216683|21254534|P2|Induction|Withdrawal by Subject|4
6167108|NCT01216683|21254535|P1|Induction|Withdrawal by Subject|0
6167109|NCT01216683|21254533|P3|Induction|Death|2
6167110|NCT01216683|21254534|P2|Induction|Death|0
6167111|NCT01216683|21254535|P1|Induction|Death|0
6167112|NCT01216683|21254533|P3|Induction|Adverse Event|5
6167113|NCT01216683|21254534|P2|Induction|Adverse Event|5
6167114|NCT01216683|21254535|P1|Induction|Adverse Event|0
6167115|NCT01216683|21254533|P3|Induction|Lack of Efficacy|7
6167116|NCT01216683|21254534|P2|Induction|Lack of Efficacy|3
6167117|NCT01216683|21254535|P1|Induction|Lack of Efficacy|4
6167118|NCT01216683|21254533|P3|Induction|Never started treatment|3
6167119|NCT01216683|21254534|P2|Induction|Never started treatment|6
6167120|NCT01216683|21254535|P1|Induction|Never started treatment|0
6167132|NCT01107626|21254689|P4|Step 2: Maintenance Therapy|Off treatment reason not reported|10
6167133|NCT01107626|21254690|P3|Step 2: Maintenance Therapy|Off treatment reason not reported|4
6167134|NCT01107626|21254691|P2|Step 2: Maintenance Therapy|Off treatment reason not reported|4
6167135|NCT01107626|21254692|P1|Step 2: Maintenance Therapy|Off treatment reason not reported|0
6167136|NCT01107626|21254689|P4|Step 2: Maintenance Therapy|Pain|1
6167137|NCT01107626|21254690|P3|Step 2: Maintenance Therapy|Pain|0
6167138|NCT01107626|21254691|P2|Step 2: Maintenance Therapy|Pain|0
6167139|NCT01107626|21254692|P1|Step 2: Maintenance Therapy|Pain|0
6167140|NCT01107626|21254689|P4|Step 2: Maintenance Therapy|Non-compliance|2
6167141|NCT01107626|21254690|P3|Step 2: Maintenance Therapy|Non-compliance|0
6167142|NCT01107626|21254691|P2|Step 2: Maintenance Therapy|Non-compliance|0
6167143|NCT01107626|21254692|P1|Step 2: Maintenance Therapy|Non-compliance|0
6167144|NCT01107626|21254689|P4|Step 2: Maintenance Therapy|Hospice care|0
6167145|NCT01107626|21254690|P3|Step 2: Maintenance Therapy|Hospice care|2
6167146|NCT01107626|21254691|P2|Step 2: Maintenance Therapy|Hospice care|1
6167147|NCT01107626|21254692|P1|Step 2: Maintenance Therapy|Hospice care|0
6167148|NCT01107626|21254689|P4|Step 2: Maintenance Therapy|Physician Decision|3
6167149|NCT01107626|21254690|P3|Step 2: Maintenance Therapy|Physician Decision|3
6167150|NCT01107626|21254691|P2|Step 2: Maintenance Therapy|Physician Decision|2
6167151|NCT01107626|21254692|P1|Step 2: Maintenance Therapy|Physician Decision|0
6167152|NCT01107626|21254689|P4|Step 2: Maintenance Therapy|Financial reason|0
6167153|NCT01107626|21254690|P3|Step 2: Maintenance Therapy|Financial reason|0
6167154|NCT01107626|21254691|P2|Step 2: Maintenance Therapy|Financial reason|2
6167155|NCT01107626|21254692|P1|Step 2: Maintenance Therapy|Financial reason|0
6167156|NCT01107626|21254689|P4|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|0
6167157|NCT01107626|21254690|P3|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|1
6167158|NCT01107626|21254691|P2|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|1
6167159|NCT01107626|21254692|P1|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|0
6167160|NCT01107626|21254689|P4|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|3
6167161|NCT01107626|21254690|P3|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|2
6167162|NCT01107626|21254691|P2|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|2
6167163|NCT01107626|21254692|P1|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|0
6167164|NCT01107626|21254689|P4|Step 2: Maintenance Therapy|Symptomatic deterioration|3
6167165|NCT01107626|21254690|P3|Step 2: Maintenance Therapy|Symptomatic deterioration|4
6167166|NCT01107626|21254691|P2|Step 2: Maintenance Therapy|Symptomatic deterioration|2
6167167|NCT01107626|21254692|P1|Step 2: Maintenance Therapy|Symptomatic deterioration|0
6167168|NCT01107626|21254689|P4|Step 2: Maintenance Therapy|Other complicating disease|9
6167169|NCT01107626|21254690|P3|Step 2: Maintenance Therapy|Other complicating disease|5
6167170|NCT01107626|21254691|P2|Step 2: Maintenance Therapy|Other complicating disease|2
6167171|NCT01107626|21254692|P1|Step 2: Maintenance Therapy|Other complicating disease|0
6167172|NCT01107626|21254689|P4|Step 2: Maintenance Therapy|Alternative therapy|5
6167173|NCT01107626|21254690|P3|Step 2: Maintenance Therapy|Alternative therapy|4
6167174|NCT01107626|21254691|P2|Step 2: Maintenance Therapy|Alternative therapy|2
6167175|NCT01107626|21254692|P1|Step 2: Maintenance Therapy|Alternative therapy|0
6167176|NCT01107626|21254689|P4|Step 2: Maintenance Therapy|Withdrawal by Subject|27
6167177|NCT01107626|21254690|P3|Step 2: Maintenance Therapy|Withdrawal by Subject|21
6167178|NCT01107626|21254691|P2|Step 2: Maintenance Therapy|Withdrawal by Subject|11
6167179|NCT01107626|21254692|P1|Step 2: Maintenance Therapy|Withdrawal by Subject|0
6167180|NCT01107626|21254689|P4|Step 2: Maintenance Therapy|Death|13
6167181|NCT01107626|21254690|P3|Step 2: Maintenance Therapy|Death|2
6167182|NCT01107626|21254691|P2|Step 2: Maintenance Therapy|Death|8
6167183|NCT01107626|21254692|P1|Step 2: Maintenance Therapy|Death|0
6167184|NCT01107626|21254689|P4|Step 2: Maintenance Therapy|Adverse Event|46
6167185|NCT01107626|21254690|P3|Step 2: Maintenance Therapy|Adverse Event|29
6167186|NCT01107626|21254691|P2|Step 2: Maintenance Therapy|Adverse Event|32
6167187|NCT01107626|21254692|P1|Step 2: Maintenance Therapy|Adverse Event|0
6167188|NCT01107626|21254689|P4|Step 2: Maintenance Therapy|Lack of Efficacy|170
6167189|NCT01107626|21254690|P3|Step 2: Maintenance Therapy|Lack of Efficacy|217
6167190|NCT01107626|21254691|P2|Step 2: Maintenance Therapy|Lack of Efficacy|217
6167191|NCT01107626|21254692|P1|Step 2: Maintenance Therapy|Lack of Efficacy|0
6167192|NCT01107626|21254689|P4|Step 1: Induction Therapy|Off treatment reason not reported|0
6167193|NCT01107626|21254690|P3|Step 1: Induction Therapy|Off treatment reason not reported|0
6167194|NCT01107626|21254691|P2|Step 1: Induction Therapy|Off treatment reason not reported|0
6167195|NCT01107626|21254692|P1|Step 1: Induction Therapy|Off treatment reason not reported|50
6167196|NCT01107626|21254689|P4|Step 1: Induction Therapy|Physician Decision|0
6167197|NCT01107626|21254690|P3|Step 1: Induction Therapy|Physician Decision|0
6167198|NCT01107626|21254691|P2|Step 1: Induction Therapy|Physician Decision|0
6167199|NCT01107626|21254692|P1|Step 1: Induction Therapy|Physician Decision|1
6167200|NCT01107626|21254689|P4|Step 1: Induction Therapy|Hospice care|0
6167201|NCT01107626|21254690|P3|Step 1: Induction Therapy|Hospice care|0
6167202|NCT01107626|21254691|P2|Step 1: Induction Therapy|Hospice care|0
6167203|NCT01107626|21254692|P1|Step 1: Induction Therapy|Hospice care|1
6167204|NCT01107626|21254689|P4|Step 1: Induction Therapy|Protocol Violation|0
6167205|NCT01107626|21254690|P3|Step 1: Induction Therapy|Protocol Violation|0
6167206|NCT01107626|21254691|P2|Step 1: Induction Therapy|Protocol Violation|0
6167207|NCT01107626|21254692|P1|Step 1: Induction Therapy|Protocol Violation|1
6167208|NCT01107626|21254689|P4|Step 1: Induction Therapy|Pain|0
6167209|NCT01107626|21254690|P3|Step 1: Induction Therapy|Pain|0
6167210|NCT01107626|21254691|P2|Step 1: Induction Therapy|Pain|0
6167211|NCT01107626|21254692|P1|Step 1: Induction Therapy|Pain|4
6167212|NCT01107626|21254689|P4|Step 1: Induction Therapy|Non-compliance|0
6167213|NCT01107626|21254690|P3|Step 1: Induction Therapy|Non-compliance|0
6167214|NCT01107626|21254691|P2|Step 1: Induction Therapy|Non-compliance|0
6167215|NCT01107626|21254692|P1|Step 1: Induction Therapy|Non-compliance|4
6167216|NCT01107626|21254689|P4|Step 1: Induction Therapy|Symptomatic deterioration|0
6167217|NCT01107626|21254690|P3|Step 1: Induction Therapy|Symptomatic deterioration|0
6167218|NCT01107626|21254691|P2|Step 1: Induction Therapy|Symptomatic deterioration|0
6167219|NCT01107626|21254692|P1|Step 1: Induction Therapy|Symptomatic deterioration|10
6167220|NCT01107626|21254689|P4|Step 1: Induction Therapy|Alternative therapy|0
6167221|NCT01107626|21254690|P3|Step 1: Induction Therapy|Alternative therapy|0
6167222|NCT01107626|21254691|P2|Step 1: Induction Therapy|Alternative therapy|0
6167223|NCT01107626|21254692|P1|Step 1: Induction Therapy|Alternative therapy|12
6167224|NCT01107626|21254689|P4|Step 1: Induction Therapy|Complicating disease|0
6167225|NCT01107626|21254690|P3|Step 1: Induction Therapy|Complicating disease|0
6167226|NCT01107626|21254691|P2|Step 1: Induction Therapy|Complicating disease|0
6167227|NCT01107626|21254692|P1|Step 1: Induction Therapy|Complicating disease|13
6167228|NCT01107626|21254689|P4|Step 1: Induction Therapy|Withdrawal by Subject|0
6167229|NCT01107626|21254690|P3|Step 1: Induction Therapy|Withdrawal by Subject|0
6167230|NCT01107626|21254691|P2|Step 1: Induction Therapy|Withdrawal by Subject|0
6167231|NCT01107626|21254692|P1|Step 1: Induction Therapy|Withdrawal by Subject|54
6167232|NCT01107626|21254689|P4|Step 1: Induction Therapy|Death|0
6167233|NCT01107626|21254690|P3|Step 1: Induction Therapy|Death|0
6167234|NCT01107626|21254691|P2|Step 1: Induction Therapy|Death|0
6167235|NCT01107626|21254692|P1|Step 1: Induction Therapy|Death|62
6167236|NCT01107626|21254689|P4|Step 1: Induction Therapy|Adverse Event|0
6167237|NCT01107626|21254690|P3|Step 1: Induction Therapy|Adverse Event|0
6167238|NCT01107626|21254691|P2|Step 1: Induction Therapy|Adverse Event|0
6167239|NCT01107626|21254692|P1|Step 1: Induction Therapy|Adverse Event|198
6167240|NCT01107626|21254689|P4|Step 1: Induction Therapy|Lack of Efficacy|0
6167241|NCT01107626|21254690|P3|Step 1: Induction Therapy|Lack of Efficacy|0
6167242|NCT01107626|21254691|P2|Step 1: Induction Therapy|Lack of Efficacy|0
6167243|NCT01107626|21254692|P1|Step 1: Induction Therapy|Lack of Efficacy|167
6167304|NCT01054144|21254846|P1|Overall Study|Death|2
6167430|NCT00794339|21255393|P1|Overall Study|Tx not per protocol|1
6167431|NCT00794339|21255393|P1|Overall Study|ATSM imaging not complete or inadequate|3
6167432|NCT00794339|21255393|P1|Overall Study|Tx prior to ATSM|3
6167433|NCT00794339|21255393|P1|Overall Study|Ineligible|4
6167434|NCT00794339|21255393|P1|Overall Study|Withdrawal by Subject|3
6167435|NCT00777491|21255447|P2|Overall Study|Did not receive any protocol treatment|0
6167436|NCT00777491|21255448|P1|Overall Study|Did not receive any protocol treatment|2
6167437|NCT00777491|21255447|P2|Overall Study|Protocol Violation|2
6167438|NCT00777491|21255448|P1|Overall Study|Protocol Violation|0
6167552|NCT00537095|21255829|P2|Overall Study|Incorrect enrolment|1
6167553|NCT00537095|21255830|P1|Overall Study|Incorrect enrolment|0
6167554|NCT00537095|21255829|P2|Overall Study|subjective disease progression|1
6167555|NCT00537095|21255830|P1|Overall Study|subjective disease progression|0
6167556|NCT00537095|21255829|P2|Overall Study|Withdrawal by Subject|2
6167557|NCT00537095|21255830|P1|Overall Study|Withdrawal by Subject|2
6167558|NCT00537095|21255829|P2|Overall Study|Death|1
6167559|NCT00537095|21255830|P1|Overall Study|Death|3
6167560|NCT00537095|21255829|P2|Overall Study|disease progression|48
6167561|NCT00537095|21255830|P1|Overall Study|disease progression|21
6167562|NCT00537095|21255829|P2|Overall Study|Adverse Event|4
6167563|NCT00537095|21255830|P1|Overall Study|Adverse Event|24
6167564|NCT00537095|21255829|P2|Overall Study|surgery|0
6167565|NCT00537095|21255830|P1|Overall Study|surgery|1
6167576|NCT00324740|21256125|P3|Overall Study|Withdrawal by Subject|1
6167577|NCT00324740|21256126|P2|Overall Study|Withdrawal by Subject|0
6167578|NCT00324740|21256127|P1|Overall Study|Withdrawal by Subject|1
6167653|NCT04238663|21256466|P3|Overall Study|Lost to Follow-up|0
6167654|NCT04238663|21256467|P2|Overall Study|Lost to Follow-up|1
6167655|NCT04238663|21256468|P1|Overall Study|Lost to Follow-up|0
6167656|NCT04238650|21256499|P2|Overall Study|Withdrawal by Subject|1
6167657|NCT04238650|21256500|P1|Overall Study|Withdrawal by Subject|0
6167658|NCT04102345|21256530|P2|Overall Study|Withdrawal by Subject|0
6167659|NCT04102345|21256531|P1|Overall Study|Withdrawal by Subject|1
6167664|NCT04082663|21256566|P1|Overall Study|Lost to Follow-up|1
6167665|NCT04082663|21256566|P1|Overall Study|Adverse Event|6
6167669|NCT03974334|21256642|P1|Overall Study|Lost to Follow-up|1
6167715|NCT03631355|21257031|P2|Overall Study|Lost to Follow-up|2
6167716|NCT03631355|21257032|P1|Overall Study|Lost to Follow-up|1
6167717|NCT03615144|21257044|P2|Overall Study|Participant no longer eligible for this protocol|0
6167718|NCT03615144|21257045|P1|Overall Study|Participant no longer eligible for this protocol|1
6167722|NCT03567382|21257076|P4|Overall Study|Withdrawal by Subject|12
6167723|NCT03567382|21257077|P3|Overall Study|Withdrawal by Subject|1
6167724|NCT03567382|21257078|P2|Overall Study|Withdrawal by Subject|14
6167725|NCT03567382|21257079|P1|Overall Study|Withdrawal by Subject|2
6167726|NCT03567382|21257076|P4|Overall Study|Lost to Follow-up|21
6167727|NCT03567382|21257077|P3|Overall Study|Lost to Follow-up|1
6167728|NCT03567382|21257078|P2|Overall Study|Lost to Follow-up|21
6167729|NCT03567382|21257079|P1|Overall Study|Lost to Follow-up|1
6167732|NCT03547687|21257103|P1|Overall Study|Death|1
6167733|NCT03547687|21257103|P1|Overall Study|Withdrawal by Subject|1
6167742|NCT03372096|21257287|P1|Overall Study|Study Closed|8
6167745|NCT03241342|21257355|P3|Overall Study|not reported|19
6167746|NCT03241342|21257356|P2|Overall Study|not reported|21
6167747|NCT03241342|21257357|P1|Overall Study|not reported|15
6167748|NCT03241342|21257355|P3|Overall Study|sponsor decision|2
6167749|NCT03241342|21257356|P2|Overall Study|sponsor decision|1
6167750|NCT03241342|21257357|P1|Overall Study|sponsor decision|0
6167751|NCT03241342|21257355|P3|Overall Study|noncompliance with study drug|1
6167752|NCT03241342|21257356|P2|Overall Study|noncompliance with study drug|1
6167753|NCT03241342|21257357|P1|Overall Study|noncompliance with study drug|2
6167754|NCT03241342|21257355|P3|Overall Study|Lack of Efficacy|1
6167755|NCT03241342|21257356|P2|Overall Study|Lack of Efficacy|0
6167756|NCT03241342|21257357|P1|Overall Study|Lack of Efficacy|0
6167757|NCT03241342|21257355|P3|Overall Study|Adverse Event|4
6167758|NCT03241342|21257356|P2|Overall Study|Adverse Event|8
6167759|NCT03241342|21257357|P1|Overall Study|Adverse Event|5
6167785|NCT02990338|21257643|P2|Overall Study|Randomized but not treated|2
6167786|NCT02990338|21257644|P1|Overall Study|Randomized but not treated|4
6167787|NCT02990338|21257643|P2|Overall Study|Other|4
6167788|NCT02990338|21257644|P1|Overall Study|Other|1
6167789|NCT02990338|21257643|P2|Overall Study|Withdrawal by Subject|5
6167790|NCT02990338|21257644|P1|Overall Study|Withdrawal by Subject|6
6167791|NCT02990338|21257643|P2|Overall Study|Poor compliance to protocol|1
6167792|NCT02990338|21257644|P1|Overall Study|Poor compliance to protocol|0
6167793|NCT02990338|21257643|P2|Overall Study|Progressive disease|66
6167794|NCT02990338|21257644|P1|Overall Study|Progressive disease|88
6167795|NCT02990338|21257643|P2|Overall Study|Adverse Event|11
6167796|NCT02990338|21257644|P1|Overall Study|Adverse Event|19
6167797|NCT02987959|21257690|P1|Overall Study|Grantor stopped supply of drugs|6
6167830|NCT02952586|21257740|P2|LT Follow-up (up to Approx. 40 Months)|Ongoing at the time of data cut-off 23-Dec-2019|172
6167831|NCT02952586|21257741|P1|LT Follow-up (up to Approx. 40 Months)|Ongoing at the time of data cut-off 23-Dec-2019|166
6167832|NCT02952586|21257740|P2|LT Follow-up (up to Approx. 40 Months)|Lost to Follow-up|1
6167833|NCT02952586|21257741|P1|LT Follow-up (up to Approx. 40 Months)|Lost to Follow-up|1
6167834|NCT02952586|21257740|P2|LT Follow-up (up to Approx. 40 Months)|Withdrawal by Subject|1
6167835|NCT02952586|21257741|P1|LT Follow-up (up to Approx. 40 Months)|Withdrawal by Subject|4
6167836|NCT02952586|21257740|P2|LT Follow-up (up to Approx. 40 Months)|Death|27
6167837|NCT02952586|21257741|P1|LT Follow-up (up to Approx. 40 Months)|Death|38
6167838|NCT02952586|21257740|P2|Follow-Up Phase (90 Days)|Ongoing at the time of data cut-off 23-Dec-2019|39
6167839|NCT02952586|21257741|P1|Follow-Up Phase (90 Days)|Ongoing at the time of data cut-off 23-Dec-2019|35
6167840|NCT02952586|21257740|P2|Follow-Up Phase (90 Days)|Other|5
6167841|NCT02952586|21257741|P1|Follow-Up Phase (90 Days)|Other|5
6167842|NCT02952586|21257740|P2|Follow-Up Phase (90 Days)|Lost to Follow-up|1
6167843|NCT02952586|21257741|P1|Follow-Up Phase (90 Days)|Lost to Follow-up|1
6167844|NCT02952586|21257740|P2|Follow-Up Phase (90 Days)|Withdrawal by Subject|2
6167845|NCT02952586|21257741|P1|Follow-Up Phase (90 Days)|Withdrawal by Subject|6
6167846|NCT02952586|21257740|P2|Follow-Up Phase (90 Days)|Death|10
6167847|NCT02952586|21257741|P1|Follow-Up Phase (90 Days)|Death|12
6167848|NCT02952586|21257740|P2|Maintenance Phase (12 Months)|Ongoing at the time of data cut-off 23-Dec-2019|48
6167849|NCT02952586|21257741|P1|Maintenance Phase (12 Months)|Ongoing at the time of data cut-off 23-Dec-2019|35
6167850|NCT02952586|21257740|P2|Maintenance Phase (12 Months)|Other|1
6167851|NCT02952586|21257741|P1|Maintenance Phase (12 Months)|Other|2
6167852|NCT02952586|21257740|P2|Maintenance Phase (12 Months)|Lost to Follow-up|2
6167853|NCT02952586|21257741|P1|Maintenance Phase (12 Months)|Lost to Follow-up|1
6167854|NCT02952586|21257740|P2|Maintenance Phase (12 Months)|Withdrawal by Subject|25
6167855|NCT02952586|21257741|P1|Maintenance Phase (12 Months)|Withdrawal by Subject|31
6167856|NCT02952586|21257740|P2|Maintenance Phase (12 Months)|Global deterioration of health status|5
6167857|NCT02952586|21257741|P1|Maintenance Phase (12 Months)|Global deterioration of health status|12
6167858|NCT02952586|21257740|P2|Maintenance Phase (12 Months)|Physician Decision|1
6167859|NCT02952586|21257741|P1|Maintenance Phase (12 Months)|Physician Decision|2
6167860|NCT02952586|21257740|P2|Maintenance Phase (12 Months)|Non-compliance with study drug|1
6167861|NCT02952586|21257741|P1|Maintenance Phase (12 Months)|Non-compliance with study drug|1
6167862|NCT02952586|21257740|P2|Maintenance Phase (12 Months)|Adverse Event|20
6167863|NCT02952586|21257741|P1|Maintenance Phase (12 Months)|Adverse Event|24
6167864|NCT02952586|21257740|P2|Maintenance Phase (12 Months)|Progressive disease|53
6167865|NCT02952586|21257741|P1|Maintenance Phase (12 Months)|Progressive disease|59
6167866|NCT02952586|21257740|P2|Maintenance Phase (12 Months)|Death|11
6167867|NCT02952586|21257741|P1|Maintenance Phase (12 Months)|Death|17
6167868|NCT02952586|21257740|P2|CRT for IMRT (63 Days)|Other|0
6167869|NCT02952586|21257741|P1|CRT for IMRT (63 Days)|Other|1
6167870|NCT02952586|21257740|P2|CRT for IMRT (63 Days)|Lost to Follow-up|1
6167871|NCT02952586|21257741|P1|CRT for IMRT (63 Days)|Lost to Follow-up|1
6167872|NCT02952586|21257740|P2|CRT for IMRT (63 Days)|Withdrawal by Subject|6
6167873|NCT02952586|21257741|P1|CRT for IMRT (63 Days)|Withdrawal by Subject|10
6167874|NCT02952586|21257740|P2|CRT for IMRT (63 Days)|Global deterioration of health status|0
6167875|NCT02952586|21257741|P1|CRT for IMRT (63 Days)|Global deterioration of health status|1
6167876|NCT02952586|21257740|P2|CRT for IMRT (63 Days)|Adverse Event|5
6167877|NCT02952586|21257741|P1|CRT for IMRT (63 Days)|Adverse Event|5
6167878|NCT02952586|21257740|P2|CRT for IMRT (63 Days)|Death|8
6167879|NCT02952586|21257741|P1|CRT for IMRT (63 Days)|Death|5
6167880|NCT02952586|21257740|P2|CRT for Cisplatin (63 Days)|Other|1
6167881|NCT02952586|21257741|P1|CRT for Cisplatin (63 Days)|Other|1
6167882|NCT02952586|21257740|P2|CRT for Cisplatin (63 Days)|Lost to Follow-up|1
6167883|NCT02952586|21257741|P1|CRT for Cisplatin (63 Days)|Lost to Follow-up|1
6167884|NCT02952586|21257740|P2|CRT for Cisplatin (63 Days)|Withdrawal by Subject|3
6167885|NCT02952586|21257741|P1|CRT for Cisplatin (63 Days)|Withdrawal by Subject|11
6167886|NCT02952586|21257740|P2|CRT for Cisplatin (63 Days)|Global deterioration of health status|0
6167887|NCT02952586|21257741|P1|CRT for Cisplatin (63 Days)|Global deterioration of health status|1
6167888|NCT02952586|21257740|P2|CRT for Cisplatin (63 Days)|Physician Decision|10
6167889|NCT02952586|21257741|P1|CRT for Cisplatin (63 Days)|Physician Decision|12
6167890|NCT02952586|21257740|P2|CRT for Cisplatin (63 Days)|Adverse Event|81
6167891|NCT02952586|21257741|P1|CRT for Cisplatin (63 Days)|Adverse Event|82
6167892|NCT02952586|21257740|P2|CRT for Cisplatin (63 Days)|Death|8
6167893|NCT02952586|21257741|P1|CRT for Cisplatin (63 Days)|Death|3
6167894|NCT02952586|21257740|P2|CRT for Avelumab or Placebo (63 Days)|Other|1
6167895|NCT02952586|21257741|P1|CRT for Avelumab or Placebo (63 Days)|Other|2
6167896|NCT02952586|21257740|P2|CRT for Avelumab or Placebo (63 Days)|Lost to Follow-up|1
6167897|NCT02952586|21257741|P1|CRT for Avelumab or Placebo (63 Days)|Lost to Follow-up|1
6167898|NCT02952586|21257740|P2|CRT for Avelumab or Placebo (63 Days)|Withdrawal by Subject|4
6167899|NCT02952586|21257741|P1|CRT for Avelumab or Placebo (63 Days)|Withdrawal by Subject|10
6167900|NCT02952586|21257740|P2|CRT for Avelumab or Placebo (63 Days)|Global deterioration of health status|0
6167901|NCT02952586|21257741|P1|CRT for Avelumab or Placebo (63 Days)|Global deterioration of health status|1
6167902|NCT02952586|21257740|P2|CRT for Avelumab or Placebo (63 Days)|Physician Decision|1
6167903|NCT02952586|21257741|P1|CRT for Avelumab or Placebo (63 Days)|Physician Decision|3
6167904|NCT02952586|21257740|P2|CRT for Avelumab or Placebo (63 Days)|Adverse Event|12
6167905|NCT02952586|21257741|P1|CRT for Avelumab or Placebo (63 Days)|Adverse Event|11
6167906|NCT02952586|21257740|P2|CRT for Avelumab or Placebo (63 Days)|Death|8
6167907|NCT02952586|21257741|P1|CRT for Avelumab or Placebo (63 Days)|Death|5
6167908|NCT02952586|21257740|P2|Lead-In Phase (7 Days)|Withdrawal by Subject|2
6167909|NCT02952586|21257741|P1|Lead-In Phase (7 Days)|Withdrawal by Subject|2
6167910|NCT02952586|21257740|P2|Lead-In Phase (7 Days)|No longer met eligibility criteria|1
6167911|NCT02952586|21257741|P1|Lead-In Phase (7 Days)|No longer met eligibility criteria|0
6167912|NCT02952586|21257740|P2|Lead-In Phase (7 Days)|Adverse Event|0
6167913|NCT02952586|21257741|P1|Lead-In Phase (7 Days)|Adverse Event|3
6167914|NCT02952586|21257740|P2|Lead-In Phase (7 Days)|Death|1
6167915|NCT02952586|21257741|P1|Lead-In Phase (7 Days)|Death|0
6167916|NCT02943070|21257779|P1|Overall Study|Subjects exited after their 48 month visit per the Sponsor's decision to close the study.|18
6167917|NCT02943070|21257779|P1|Overall Study|Retreatment or TURP|13
6167918|NCT02943070|21257779|P1|Overall Study|Lost to Follow-up|4
6167919|NCT02943070|21257779|P1|Overall Study|Withdrawal by Subject|3
6167920|NCT02943070|21257779|P1|Overall Study|Death|2
6167921|NCT02943070|21257779|P1|Overall Study|Adverse Event|2
6167922|NCT02943070|21257779|P1|Overall Study|Physician Decision|1
6167923|NCT02939014|21257813|P2|Overall Study|Death|3
6167924|NCT02939014|21257814|P1|Overall Study|Death|4
6167925|NCT02939014|21257813|P2|Overall Study|Lost to Follow-up|0
6167926|NCT02939014|21257814|P1|Overall Study|Lost to Follow-up|1
6167927|NCT02894502|21257866|P3|Third Follow up|Death|0
6167928|NCT02894502|21257867|P2|Third Follow up|Death|1
6167929|NCT02894502|21257868|P1|Third Follow up|Death|1
6167930|NCT02894502|21257866|P3|Third Follow up|Withdrawal by Subject|3
6167931|NCT02894502|21257867|P2|Third Follow up|Withdrawal by Subject|6
6167932|NCT02894502|21257868|P1|Third Follow up|Withdrawal by Subject|5
6167933|NCT02894502|21257866|P3|Second Follow up|Death|1
6167934|NCT02894502|21257867|P2|Second Follow up|Death|3
6167935|NCT02894502|21257868|P1|Second Follow up|Death|2
6167936|NCT02894502|21257866|P3|Second Follow up|Withdrawal by Subject|13
6167937|NCT02894502|21257867|P2|Second Follow up|Withdrawal by Subject|15
6167938|NCT02894502|21257868|P1|Second Follow up|Withdrawal by Subject|13
6167939|NCT02894502|21257866|P3|First Follow up|Death|3
6167940|NCT02894502|21257867|P2|First Follow up|Death|2
6167941|NCT02894502|21257868|P1|First Follow up|Death|2
6167942|NCT02894502|21257866|P3|First Follow up|Withdrawal by Subject|37
6167943|NCT02894502|21257867|P2|First Follow up|Withdrawal by Subject|29
6167944|NCT02894502|21257868|P1|First Follow up|Withdrawal by Subject|32
6167945|NCT02894502|21257866|P3|Baseline|Death|9
6167946|NCT02894502|21257867|P2|Baseline|Death|1
6167947|NCT02894502|21257868|P1|Baseline|Death|3
6167948|NCT02894502|21257866|P3|Baseline|Withdrawal by Subject|36
6167949|NCT02894502|21257867|P2|Baseline|Withdrawal by Subject|31
6167950|NCT02894502|21257868|P1|Baseline|Withdrawal by Subject|24
6167991|NCT02832037|21257992|P5|Overall Study|Adverse Event|4
6167992|NCT02832037|21257993|P4|Overall Study|Adverse Event|2
6167993|NCT02832037|21257994|P3|Overall Study|Adverse Event|0
6167994|NCT02832037|21257995|P2|Overall Study|Adverse Event|4
6167995|NCT02832037|21257996|P1|Overall Study|Adverse Event|5
6167996|NCT02832037|21257992|P5|Overall Study|Withdrawal by Subject|8
6167997|NCT02832037|21257993|P4|Overall Study|Withdrawal by Subject|4
6167998|NCT02832037|21257994|P3|Overall Study|Withdrawal by Subject|0
6167999|NCT02832037|21257995|P2|Overall Study|Withdrawal by Subject|8
6168000|NCT02832037|21257996|P1|Overall Study|Withdrawal by Subject|9
6168001|NCT02832037|21257992|P5|Overall Study|Lost to Follow-up|5
6168002|NCT02832037|21257993|P4|Overall Study|Lost to Follow-up|0
6168003|NCT02832037|21257994|P3|Overall Study|Lost to Follow-up|3
6168004|NCT02832037|21257995|P2|Overall Study|Lost to Follow-up|0
6168005|NCT02832037|21257996|P1|Overall Study|Lost to Follow-up|2
6168006|NCT02832037|21257992|P5|Overall Study|Protocol Violation|2
6168007|NCT02832037|21257993|P4|Overall Study|Protocol Violation|1
6168008|NCT02832037|21257994|P3|Overall Study|Protocol Violation|4
6168009|NCT02832037|21257995|P2|Overall Study|Protocol Violation|0
6168010|NCT02832037|21257996|P1|Overall Study|Protocol Violation|3
6168011|NCT02832037|21257992|P5|Overall Study|Administrative reasons|0
6168012|NCT02832037|21257993|P4|Overall Study|Administrative reasons|0
6168013|NCT02832037|21257994|P3|Overall Study|Administrative reasons|1
6168014|NCT02832037|21257995|P2|Overall Study|Administrative reasons|0
6168015|NCT02832037|21257996|P1|Overall Study|Administrative reasons|0
6168028|NCT02807857|21258067|P1|Follow-Up Set|Relocation|2
6168029|NCT02807857|21258067|P1|Follow-Up Set|Death|27
6168030|NCT02807857|21258067|P1|Follow-Up Set|Adverse Event|3
6168031|NCT02807857|21258067|P1|Follow-Up Set|Physician Decision|6
6168032|NCT02807857|21258067|P1|Follow-Up Set|Lost to Follow-up|7
6168033|NCT02807857|21258067|P1|Follow-Up Set|Withdrawal by Subject|8
6168034|NCT02807857|21258067|P1|Follow-Up Set|Study Terminated By Sponsor|131
6168035|NCT02807857|21258067|P1|Enrolled Set|Patients not suitable for follow-up.|551
6168098|NCT02675231|21258289|P3|Overall Study|On study treatment/follow up|23
6168099|NCT02675231|21258290|P2|Overall Study|On study treatment/follow up|31
6168100|NCT02675231|21258291|P1|Overall Study|On study treatment/follow up|23
6168101|NCT02675231|21258289|P3|Overall Study|Lost to Follow-up|2
6168102|NCT02675231|21258290|P2|Overall Study|Lost to Follow-up|2
6168103|NCT02675231|21258291|P1|Overall Study|Lost to Follow-up|2
6168104|NCT02675231|21258289|P3|Overall Study|Withdrawal by Subject|1
6168105|NCT02675231|21258290|P2|Overall Study|Withdrawal by Subject|3
6168106|NCT02675231|21258291|P1|Overall Study|Withdrawal by Subject|1
6168272|NCT02409342|21259107|P2|Overall Study|Lost to Follow-up|3
6168273|NCT02409342|21259108|P1|Overall Study|Lost to Follow-up|3
6168274|NCT02409342|21259107|P2|Overall Study|On-going in study|92
6168275|NCT02409342|21259108|P1|Overall Study|On-going in study|79
6168276|NCT02409342|21259107|P2|Overall Study|Withdrawal by Subject|16
6168277|NCT02409342|21259108|P1|Overall Study|Withdrawal by Subject|24
6168278|NCT02409342|21259107|P2|Overall Study|Death|174
6168279|NCT02409342|21259108|P1|Overall Study|Death|181
6168280|NCT02336165|21259186|P5|Overall Study|Other|0
6168281|NCT02336165|21259187|P4|Overall Study|Other|1
6168282|NCT02336165|21259188|P3|Overall Study|Other|0
6168283|NCT02336165|21259189|P2|Overall Study|Other|0
6168284|NCT02336165|21259190|P1|Overall Study|Other|1
6168285|NCT02336165|21259186|P5|Overall Study|Non-compliance|0
6168286|NCT02336165|21259187|P4|Overall Study|Non-compliance|1
6168287|NCT02336165|21259188|P3|Overall Study|Non-compliance|0
6168288|NCT02336165|21259189|P2|Overall Study|Non-compliance|0
6168289|NCT02336165|21259190|P1|Overall Study|Non-compliance|1
6168290|NCT02336165|21259186|P5|Overall Study|Progressive disease|19
6168291|NCT02336165|21259187|P4|Overall Study|Progressive disease|24
6168292|NCT02336165|21259188|P3|Overall Study|Progressive disease|27
6168293|NCT02336165|21259189|P2|Overall Study|Progressive disease|22
6168294|NCT02336165|21259190|P1|Overall Study|Progressive disease|23
6168295|NCT02336165|21259186|P5|Overall Study|Adverse Event|1
6168296|NCT02336165|21259187|P4|Overall Study|Adverse Event|4
6168297|NCT02336165|21259188|P3|Overall Study|Adverse Event|2
6168298|NCT02336165|21259189|P2|Overall Study|Adverse Event|1
6168299|NCT02336165|21259190|P1|Overall Study|Adverse Event|4
6168300|NCT02336165|21259186|P5|Overall Study|Withdrawal by Subject|1
6168301|NCT02336165|21259187|P4|Overall Study|Withdrawal by Subject|0
6168302|NCT02336165|21259188|P3|Overall Study|Withdrawal by Subject|1
6168303|NCT02336165|21259189|P2|Overall Study|Withdrawal by Subject|0
6168304|NCT02336165|21259190|P1|Overall Study|Withdrawal by Subject|0
6168305|NCT02336165|21259186|P5|Overall Study|Physician Decision|0
6168306|NCT02336165|21259187|P4|Overall Study|Physician Decision|1
6168307|NCT02336165|21259188|P3|Overall Study|Physician Decision|1
6168308|NCT02336165|21259189|P2|Overall Study|Physician Decision|2
6168309|NCT02336165|21259190|P1|Overall Study|Physician Decision|2
6168310|NCT02336165|21259186|P5|Overall Study|Death|1
6168311|NCT02336165|21259187|P4|Overall Study|Death|0
6168312|NCT02336165|21259188|P3|Overall Study|Death|0
6168313|NCT02336165|21259189|P2|Overall Study|Death|0
6168314|NCT02336165|21259190|P1|Overall Study|Death|3
6168315|NCT02291614|21259251|P11|Overall Study|Death|0
6168316|NCT02291614|21259252|P10|Overall Study|Death|0
6168317|NCT02291614|21259253|P9|Overall Study|Death|0
6168318|NCT02291614|21259254|P8|Overall Study|Death|0
6168319|NCT02291614|21259255|P7|Overall Study|Death|1
6168320|NCT02291614|21259256|P6|Overall Study|Death|1
6168321|NCT02291614|21259257|P5|Overall Study|Death|1
6168322|NCT02291614|21259258|P4|Overall Study|Death|0
6168323|NCT02291614|21259259|P3|Overall Study|Death|1
6168324|NCT02291614|21259260|P2|Overall Study|Death|0
6168325|NCT02291614|21259261|P1|Overall Study|Death|0
6168326|NCT02291614|21259251|P11|Overall Study|Decision by sponsor|0
6168327|NCT02291614|21259252|P10|Overall Study|Decision by sponsor|0
6168328|NCT02291614|21259253|P9|Overall Study|Decision by sponsor|0
6168329|NCT02291614|21259254|P8|Overall Study|Decision by sponsor|0
6168330|NCT02291614|21259255|P7|Overall Study|Decision by sponsor|0
6168331|NCT02291614|21259256|P6|Overall Study|Decision by sponsor|0
6168332|NCT02291614|21259257|P5|Overall Study|Decision by sponsor|0
6168333|NCT02291614|21259258|P4|Overall Study|Decision by sponsor|1
6168334|NCT02291614|21259259|P3|Overall Study|Decision by sponsor|0
6168335|NCT02291614|21259260|P2|Overall Study|Decision by sponsor|0
6168336|NCT02291614|21259261|P1|Overall Study|Decision by sponsor|0
6168337|NCT02291614|21259251|P11|Overall Study|Withdrawal by Subject|2
6168338|NCT02291614|21259252|P10|Overall Study|Withdrawal by Subject|2
6168339|NCT02291614|21259253|P9|Overall Study|Withdrawal by Subject|0
6168340|NCT02291614|21259254|P8|Overall Study|Withdrawal by Subject|0
6168341|NCT02291614|21259255|P7|Overall Study|Withdrawal by Subject|0
6168342|NCT02291614|21259256|P6|Overall Study|Withdrawal by Subject|0
6168343|NCT02291614|21259257|P5|Overall Study|Withdrawal by Subject|0
6168344|NCT02291614|21259258|P4|Overall Study|Withdrawal by Subject|0
6168345|NCT02291614|21259259|P3|Overall Study|Withdrawal by Subject|0
6168346|NCT02291614|21259260|P2|Overall Study|Withdrawal by Subject|1
6168347|NCT02291614|21259261|P1|Overall Study|Withdrawal by Subject|0
6168348|NCT02291614|21259251|P11|Overall Study|Lost to Follow-up|0
6168349|NCT02291614|21259252|P10|Overall Study|Lost to Follow-up|0
6168350|NCT02291614|21259253|P9|Overall Study|Lost to Follow-up|0
6168351|NCT02291614|21259254|P8|Overall Study|Lost to Follow-up|1
6168352|NCT02291614|21259255|P7|Overall Study|Lost to Follow-up|0
6168353|NCT02291614|21259256|P6|Overall Study|Lost to Follow-up|0
6168354|NCT02291614|21259257|P5|Overall Study|Lost to Follow-up|0
6168355|NCT02291614|21259258|P4|Overall Study|Lost to Follow-up|0
6168356|NCT02291614|21259259|P3|Overall Study|Lost to Follow-up|0
6168357|NCT02291614|21259260|P2|Overall Study|Lost to Follow-up|0
6168358|NCT02291614|21259261|P1|Overall Study|Lost to Follow-up|0
6168359|NCT02291289|21259443|P12|Maintenance Treatment Phase|No Treatment Received|0
6168360|NCT02291289|21259444|P11|Maintenance Treatment Phase|No Treatment Received|1
6168361|NCT02291289|21259445|P10|Maintenance Treatment Phase|No Treatment Received|0
6168362|NCT02291289|21259446|P9|Maintenance Treatment Phase|No Treatment Received|0
6168363|NCT02291289|21259447|P8|Maintenance Treatment Phase|No Treatment Received|0
6168364|NCT02291289|21259448|P7|Maintenance Treatment Phase|No Treatment Received|0
6168365|NCT02291289|21259449|P6|Maintenance Treatment Phase|No Treatment Received|5
6168366|NCT02291289|21259450|P5|Maintenance Treatment Phase|No Treatment Received|4
6168367|NCT02291289|21259451|P4|Maintenance Treatment Phase|No Treatment Received|0
6168368|NCT02291289|21259452|P3|Maintenance Treatment Phase|No Treatment Received|2
6168369|NCT02291289|21259453|P2|Maintenance Treatment Phase|No Treatment Received|0
6168370|NCT02291289|21259454|P1|Maintenance Treatment Phase|No Treatment Received|0
6168371|NCT02291289|21259443|P12|Maintenance Treatment Phase|Multiple Reasons|0
6168372|NCT02291289|21259444|P11|Maintenance Treatment Phase|Multiple Reasons|0
6168373|NCT02291289|21259445|P10|Maintenance Treatment Phase|Multiple Reasons|0
6168374|NCT02291289|21259446|P9|Maintenance Treatment Phase|Multiple Reasons|0
6168375|NCT02291289|21259447|P8|Maintenance Treatment Phase|Multiple Reasons|0
6168376|NCT02291289|21259448|P7|Maintenance Treatment Phase|Multiple Reasons|0
6168377|NCT02291289|21259449|P6|Maintenance Treatment Phase|Multiple Reasons|1
6168378|NCT02291289|21259450|P5|Maintenance Treatment Phase|Multiple Reasons|4
6168379|NCT02291289|21259451|P4|Maintenance Treatment Phase|Multiple Reasons|0
6168380|NCT02291289|21259452|P3|Maintenance Treatment Phase|Multiple Reasons|0
6168381|NCT02291289|21259453|P2|Maintenance Treatment Phase|Multiple Reasons|0
6168382|NCT02291289|21259454|P1|Maintenance Treatment Phase|Multiple Reasons|0
6168383|NCT02291289|21259443|P12|Maintenance Treatment Phase|Physician Decision|1
6168384|NCT02291289|21259444|P11|Maintenance Treatment Phase|Physician Decision|0
6168385|NCT02291289|21259445|P10|Maintenance Treatment Phase|Physician Decision|0
6168386|NCT02291289|21259446|P9|Maintenance Treatment Phase|Physician Decision|0
6168387|NCT02291289|21259447|P8|Maintenance Treatment Phase|Physician Decision|0
6168388|NCT02291289|21259448|P7|Maintenance Treatment Phase|Physician Decision|0
6168389|NCT02291289|21259449|P6|Maintenance Treatment Phase|Physician Decision|0
6168390|NCT02291289|21259450|P5|Maintenance Treatment Phase|Physician Decision|2
6168391|NCT02291289|21259451|P4|Maintenance Treatment Phase|Physician Decision|0
6168392|NCT02291289|21259452|P3|Maintenance Treatment Phase|Physician Decision|0
6168393|NCT02291289|21259453|P2|Maintenance Treatment Phase|Physician Decision|0
6168394|NCT02291289|21259454|P1|Maintenance Treatment Phase|Physician Decision|0
6168395|NCT02291289|21259443|P12|Maintenance Treatment Phase|Other|0
6168396|NCT02291289|21259444|P11|Maintenance Treatment Phase|Other|0
6168397|NCT02291289|21259445|P10|Maintenance Treatment Phase|Other|0
6168398|NCT02291289|21259446|P9|Maintenance Treatment Phase|Other|1
6168399|NCT02291289|21259447|P8|Maintenance Treatment Phase|Other|0
6168400|NCT02291289|21259448|P7|Maintenance Treatment Phase|Other|0
6168401|NCT02291289|21259449|P6|Maintenance Treatment Phase|Other|8
6168402|NCT02291289|21259450|P5|Maintenance Treatment Phase|Other|29
6168403|NCT02291289|21259451|P4|Maintenance Treatment Phase|Other|0
6168404|NCT02291289|21259452|P3|Maintenance Treatment Phase|Other|1
6168405|NCT02291289|21259453|P2|Maintenance Treatment Phase|Other|0
6168406|NCT02291289|21259454|P1|Maintenance Treatment Phase|Other|0
6168407|NCT02291289|21259443|P12|Maintenance Treatment Phase|Lost to Follow-up|1
6168408|NCT02291289|21259444|P11|Maintenance Treatment Phase|Lost to Follow-up|2
6168409|NCT02291289|21259445|P10|Maintenance Treatment Phase|Lost to Follow-up|0
6168410|NCT02291289|21259446|P9|Maintenance Treatment Phase|Lost to Follow-up|0
6168411|NCT02291289|21259447|P8|Maintenance Treatment Phase|Lost to Follow-up|1
6168412|NCT02291289|21259448|P7|Maintenance Treatment Phase|Lost to Follow-up|0
6168413|NCT02291289|21259449|P6|Maintenance Treatment Phase|Lost to Follow-up|3
6168414|NCT02291289|21259450|P5|Maintenance Treatment Phase|Lost to Follow-up|12
6168415|NCT02291289|21259451|P4|Maintenance Treatment Phase|Lost to Follow-up|0
6168416|NCT02291289|21259452|P3|Maintenance Treatment Phase|Lost to Follow-up|0
6168417|NCT02291289|21259453|P2|Maintenance Treatment Phase|Lost to Follow-up|0
6168418|NCT02291289|21259454|P1|Maintenance Treatment Phase|Lost to Follow-up|0
6168419|NCT02291289|21259443|P12|Maintenance Treatment Phase|Adverse Event|0
6168420|NCT02291289|21259444|P11|Maintenance Treatment Phase|Adverse Event|0
6168421|NCT02291289|21259445|P10|Maintenance Treatment Phase|Adverse Event|0
6168422|NCT02291289|21259446|P9|Maintenance Treatment Phase|Adverse Event|0
6168423|NCT02291289|21259447|P8|Maintenance Treatment Phase|Adverse Event|0
6168424|NCT02291289|21259448|P7|Maintenance Treatment Phase|Adverse Event|0
6168425|NCT02291289|21259449|P6|Maintenance Treatment Phase|Adverse Event|0
6168426|NCT02291289|21259450|P5|Maintenance Treatment Phase|Adverse Event|1
6168427|NCT02291289|21259451|P4|Maintenance Treatment Phase|Adverse Event|0
6168428|NCT02291289|21259452|P3|Maintenance Treatment Phase|Adverse Event|0
6168429|NCT02291289|21259453|P2|Maintenance Treatment Phase|Adverse Event|0
6168430|NCT02291289|21259454|P1|Maintenance Treatment Phase|Adverse Event|0
6168431|NCT02291289|21259443|P12|Maintenance Treatment Phase|Death|11
6168432|NCT02291289|21259444|P11|Maintenance Treatment Phase|Death|26
6168433|NCT02291289|21259445|P10|Maintenance Treatment Phase|Death|0
6168434|NCT02291289|21259446|P9|Maintenance Treatment Phase|Death|1
6168435|NCT02291289|21259447|P8|Maintenance Treatment Phase|Death|1
6168436|NCT02291289|21259448|P7|Maintenance Treatment Phase|Death|0
6168437|NCT02291289|21259449|P6|Maintenance Treatment Phase|Death|100
6168438|NCT02291289|21259450|P5|Maintenance Treatment Phase|Death|185
6168439|NCT02291289|21259451|P4|Maintenance Treatment Phase|Death|0
6168440|NCT02291289|21259452|P3|Maintenance Treatment Phase|Death|13
6168441|NCT02291289|21259453|P2|Maintenance Treatment Phase|Death|23
6168442|NCT02291289|21259454|P1|Maintenance Treatment Phase|Death|0
6168443|NCT02291289|21259443|P12|Maintenance Treatment Phase|Protocol Violation|0
6168444|NCT02291289|21259444|P11|Maintenance Treatment Phase|Protocol Violation|0
6168445|NCT02291289|21259445|P10|Maintenance Treatment Phase|Protocol Violation|0
6168446|NCT02291289|21259446|P9|Maintenance Treatment Phase|Protocol Violation|0
6168447|NCT02291289|21259447|P8|Maintenance Treatment Phase|Protocol Violation|0
6168448|NCT02291289|21259448|P7|Maintenance Treatment Phase|Protocol Violation|0
6168449|NCT02291289|21259449|P6|Maintenance Treatment Phase|Protocol Violation|1
6168450|NCT02291289|21259450|P5|Maintenance Treatment Phase|Protocol Violation|2
6168451|NCT02291289|21259451|P4|Maintenance Treatment Phase|Protocol Violation|0
6168452|NCT02291289|21259452|P3|Maintenance Treatment Phase|Protocol Violation|0
6168453|NCT02291289|21259453|P2|Maintenance Treatment Phase|Protocol Violation|1
6168454|NCT02291289|21259454|P1|Maintenance Treatment Phase|Protocol Violation|0
6168455|NCT02291289|21259443|P12|Maintenance Treatment Phase|Withdrawal by Subject|3
6168456|NCT02291289|21259444|P11|Maintenance Treatment Phase|Withdrawal by Subject|2
6168457|NCT02291289|21259445|P10|Maintenance Treatment Phase|Withdrawal by Subject|0
6168458|NCT02291289|21259446|P9|Maintenance Treatment Phase|Withdrawal by Subject|0
6168459|NCT02291289|21259447|P8|Maintenance Treatment Phase|Withdrawal by Subject|0
6168460|NCT02291289|21259448|P7|Maintenance Treatment Phase|Withdrawal by Subject|0
6168461|NCT02291289|21259449|P6|Maintenance Treatment Phase|Withdrawal by Subject|11
6168462|NCT02291289|21259450|P5|Maintenance Treatment Phase|Withdrawal by Subject|13
6168463|NCT02291289|21259451|P4|Maintenance Treatment Phase|Withdrawal by Subject|0
6168464|NCT02291289|21259452|P3|Maintenance Treatment Phase|Withdrawal by Subject|0
6168465|NCT02291289|21259453|P2|Maintenance Treatment Phase|Withdrawal by Subject|0
6168466|NCT02291289|21259454|P1|Maintenance Treatment Phase|Withdrawal by Subject|0
6168467|NCT02291289|21259443|P12|Induction Treatment|Not Dosed|0
6168468|NCT02291289|21259444|P11|Induction Treatment|Not Dosed|0
6168469|NCT02291289|21259445|P10|Induction Treatment|Not Dosed|1
6168470|NCT02291289|21259446|P9|Induction Treatment|Not Dosed|0
6168471|NCT02291289|21259447|P8|Induction Treatment|Not Dosed|0
6168472|NCT02291289|21259448|P7|Induction Treatment|Not Dosed|0
6168473|NCT02291289|21259449|P6|Induction Treatment|Not Dosed|0
6168474|NCT02291289|21259450|P5|Induction Treatment|Not Dosed|0
6168475|NCT02291289|21259451|P4|Induction Treatment|Not Dosed|9
6168476|NCT02291289|21259452|P3|Induction Treatment|Not Dosed|0
6168477|NCT02291289|21259453|P2|Induction Treatment|Not Dosed|0
6168478|NCT02291289|21259454|P1|Induction Treatment|Not Dosed|2
6168479|NCT02285361|21259516|P1|Overall Study|Consented prior to the contract date|1
6168480|NCT02285361|21259516|P1|Overall Study|Not taken GIOTRIF|2
6168481|NCT02285361|21259516|P1|Overall Study|Lost to Follow-up|5
6168482|NCT02285361|21259516|P1|Overall Study|Protocol Violation|43
6168520|NCT02178358|21259707|P3|Overall Study|On study treatment at study conclusion|2
6168521|NCT02178358|21259708|P2|Overall Study|On study treatment at study conclusion|1
6168522|NCT02178358|21259709|P1|Overall Study|On study treatment at study conclusion|0
6168523|NCT02178358|21259707|P3|Overall Study|Withdrawal by Subject|2
6168524|NCT02178358|21259708|P2|Overall Study|Withdrawal by Subject|2
6168525|NCT02178358|21259709|P1|Overall Study|Withdrawal by Subject|0
6168555|NCT01894620|21259907|P2|Overall Study|Withdrawal by Subject|1
6168556|NCT01894620|21259908|P1|Overall Study|Withdrawal by Subject|0
6168567|NCT01802632|21260014|P6|Overall Study|Other (not specified)|1
6168568|NCT01802632|21260015|P5|Overall Study|Other (not specified)|0
6168569|NCT01802632|21260016|P4|Overall Study|Other (not specified)|1
6168570|NCT01802632|21260017|P3|Overall Study|Other (not specified)|7
6168571|NCT01802632|21260018|P2|Overall Study|Other (not specified)|0
6168572|NCT01802632|21260019|P1|Overall Study|Other (not specified)|0
6168573|NCT01802632|21260014|P6|Overall Study|Ongoing Study at Data Cut-off|22
6168574|NCT01802632|21260015|P5|Overall Study|Ongoing Study at Data Cut-off|6
6168575|NCT01802632|21260016|P4|Overall Study|Ongoing Study at Data Cut-off|50
6168576|NCT01802632|21260017|P3|Overall Study|Ongoing Study at Data Cut-off|115
6168577|NCT01802632|21260018|P2|Overall Study|Ongoing Study at Data Cut-off|16
6168578|NCT01802632|21260019|P1|Overall Study|Ongoing Study at Data Cut-off|168
6168579|NCT01802632|21260014|P6|Overall Study|Objective Disease Progression|4
6168580|NCT01802632|21260015|P5|Overall Study|Objective Disease Progression|4
6168581|NCT01802632|21260016|P4|Overall Study|Objective Disease Progression|6
6168582|NCT01802632|21260017|P3|Overall Study|Objective Disease Progression|104
6168583|NCT01802632|21260018|P2|Overall Study|Objective Disease Progression|12
6168584|NCT01802632|21260019|P1|Overall Study|Objective Disease Progression|1
6168585|NCT01802632|21260014|P6|Overall Study|Withdrawal by Subject|1
6168586|NCT01802632|21260015|P5|Overall Study|Withdrawal by Subject|0
6168587|NCT01802632|21260016|P4|Overall Study|Withdrawal by Subject|3
6168588|NCT01802632|21260017|P3|Overall Study|Withdrawal by Subject|7
6168589|NCT01802632|21260018|P2|Overall Study|Withdrawal by Subject|2
6168590|NCT01802632|21260019|P1|Overall Study|Withdrawal by Subject|4
6168591|NCT01802632|21260014|P6|Overall Study|Death|0
6168592|NCT01802632|21260015|P5|Overall Study|Death|2
6168593|NCT01802632|21260016|P4|Overall Study|Death|0
6168594|NCT01802632|21260017|P3|Overall Study|Death|38
6168595|NCT01802632|21260018|P2|Overall Study|Death|1
6168596|NCT01802632|21260019|P1|Overall Study|Death|28
6168722|NCT01609296|21260230|P1|Overall Study|missed visit but known to be alive|28
6168723|NCT01609296|21260230|P1|Overall Study|Exit reason other than withdrawal, death or lost to follow up|35
6168724|NCT01609296|21260230|P1|Overall Study|Lost to Follow-up|21
6168725|NCT01609296|21260230|P1|Overall Study|Withdrawal by Subject|151
6168726|NCT01609296|21260230|P1|Overall Study|Death|253
6168727|NCT01597908|21260386|P3|Crossover Phase|Sponsor Decision|20
6168728|NCT01597908|21260387|P2|Crossover Phase|Sponsor Decision|0
6168729|NCT01597908|21260388|P1|Crossover Phase|Sponsor Decision|0
6168730|NCT01597908|21260386|P3|Crossover Phase|Withdrawal by Subject|3
6168731|NCT01597908|21260387|P2|Crossover Phase|Withdrawal by Subject|0
6168732|NCT01597908|21260388|P1|Crossover Phase|Withdrawal by Subject|0
6168733|NCT01597908|21260386|P3|Crossover Phase|Death|11
6168734|NCT01597908|21260387|P2|Crossover Phase|Death|0
6168735|NCT01597908|21260388|P1|Crossover Phase|Death|0
6168736|NCT01597908|21260386|P3|Randomized Phase|Crossover to Dabrafenib&Trametinib|0
6168737|NCT01597908|21260387|P2|Randomized Phase|Crossover to Dabrafenib&Trametinib|34
6168738|NCT01597908|21260388|P1|Randomized Phase|Crossover to Dabrafenib&Trametinib|0
6168739|NCT01597908|21260386|P3|Randomized Phase|Withdrawal by Subject|0
6168740|NCT01597908|21260387|P2|Randomized Phase|Withdrawal by Subject|22
6168741|NCT01597908|21260388|P1|Randomized Phase|Withdrawal by Subject|26
6168742|NCT01597908|21260386|P3|Randomized Phase|Physician Decision|0
6168743|NCT01597908|21260387|P2|Randomized Phase|Physician Decision|3
6168744|NCT01597908|21260388|P1|Randomized Phase|Physician Decision|6
6168745|NCT01597908|21260386|P3|Randomized Phase|Lost to Follow-up|0
6168746|NCT01597908|21260387|P2|Randomized Phase|Lost to Follow-up|16
6168747|NCT01597908|21260388|P1|Randomized Phase|Lost to Follow-up|9
6168748|NCT01597908|21260386|P3|Randomized Phase|Sponsor Decision|0
6168749|NCT01597908|21260387|P2|Randomized Phase|Sponsor Decision|39
6168750|NCT01597908|21260388|P1|Randomized Phase|Sponsor Decision|93
6168751|NCT01597908|21260386|P3|Randomized Phase|Death|0
6168752|NCT01597908|21260387|P2|Randomized Phase|Death|238
6168753|NCT01597908|21260388|P1|Randomized Phase|Death|217
6168756|NCT01258075|21260471|P2|Overall Study|Other|5
6168757|NCT01258075|21260472|P1|Overall Study|Other|12
6168758|NCT01258075|21260471|P2|Overall Study|Hyperglycemia meeting protocol-specified discontinuation criteria|2
6168759|NCT01258075|21260472|P1|Overall Study|Hyperglycemia meeting protocol-specified discontinuation criteria|1
6168760|NCT01258075|21260471|P2|Overall Study|Withdrawal by Subject|7
6168761|NCT01258075|21260472|P1|Overall Study|Withdrawal by Subject|10
6168762|NCT01258075|21260471|P2|Overall Study|Lost to Follow-up|6
6168763|NCT01258075|21260472|P1|Overall Study|Lost to Follow-up|11
6168764|NCT01258075|21260471|P2|Overall Study|Adverse Event|3
6168765|NCT01258075|21260472|P1|Overall Study|Adverse Event|8
6168781|NCT01087203|21260629|P2|Overall Study|Study terminated by sponsor|27
6168782|NCT01087203|21260630|P1|Overall Study|Study terminated by sponsor|27
6168783|NCT01087203|21260629|P2|Overall Study|Lack of Efficacy|2
6168784|NCT01087203|21260630|P1|Overall Study|Lack of Efficacy|1
6168785|NCT01087203|21260629|P2|Overall Study|Withdrawal by Subject|6
6168786|NCT01087203|21260630|P1|Overall Study|Withdrawal by Subject|2
6168787|NCT01087203|21260629|P2|Overall Study|Lost to Follow-up|0
6168788|NCT01087203|21260630|P1|Overall Study|Lost to Follow-up|2
6168837|NCT01054443|21260719|P4|Overall Study|Withdrawal by Subject|1
6168838|NCT01054443|21260720|P3|Overall Study|Withdrawal by Subject|0
6168839|NCT01054443|21260721|P2|Overall Study|Withdrawal by Subject|0
6168840|NCT01054443|21260722|P1|Overall Study|Withdrawal by Subject|0
6168907|NCT01038778|21260958|P3|Overall Study|Withdrawal by Subject|3
6168908|NCT01038778|21260959|P2|Overall Study|Withdrawal by Subject|2
6168909|NCT01038778|21260960|P1|Overall Study|Withdrawal by Subject|0
6168917|NCT00871858|21261153|P2|Overall Study|Lost to Follow-up|1
6168918|NCT00871858|21261154|P1|Overall Study|Lost to Follow-up|0
6168919|NCT00871858|21261153|P2|Overall Study|Withdrawal by Subject|1
6168920|NCT00871858|21261154|P1|Overall Study|Withdrawal by Subject|1
6168921|NCT00871858|21261153|P2|Overall Study|Adverse Event|1
6168922|NCT00871858|21261154|P1|Overall Study|Adverse Event|1
6168923|NCT00871858|21261153|P2|Overall Study|Protocol Violation|4
6168924|NCT00871858|21261154|P1|Overall Study|Protocol Violation|3
6168963|NCT00827359|21261288|P1|Overall Study|Ineligible|1
6168964|NCT00827359|21261288|P1|Overall Study|Unacceptable Toxicity|5
6168965|NCT00827359|21261288|P1|Overall Study|Progressive Diseas|19
6169002|NCT00711880|21261430|P2|Overall Study|Lack of Efficacy|5
6169003|NCT00711880|21261431|P1|Overall Study|Lack of Efficacy|1
6169004|NCT00711880|21261430|P2|Overall Study|Patient non-compliance|0
6169005|NCT00711880|21261431|P1|Overall Study|Patient non-compliance|1
6169006|NCT00711880|21261430|P2|Overall Study|Adverse Event|2
6169007|NCT00711880|21261431|P1|Overall Study|Adverse Event|11
6169149|NCT00073528|21262181|P2|Overall Study|Protocol Violation|5
6169150|NCT00073528|21262182|P1|Overall Study|Protocol Violation|3
6169151|NCT00073528|21262181|P2|Overall Study|Other|12
6169152|NCT00073528|21262182|P1|Overall Study|Other|9
6169153|NCT00073528|21262181|P2|Overall Study|Other|19
6169154|NCT00073528|21262182|P1|Overall Study|Other|18
6169155|NCT00073528|21262181|P2|Overall Study|Study terminated by Sponsor|29
6169156|NCT00073528|21262182|P1|Overall Study|Study terminated by Sponsor|10
6169157|NCT00073528|21262181|P2|Overall Study|Withdrawal by Subject|45
6169158|NCT00073528|21262182|P1|Overall Study|Withdrawal by Subject|50
6169159|NCT00073528|21262181|P2|Overall Study|Lost to Follow-up|45
6169160|NCT00073528|21262182|P1|Overall Study|Lost to Follow-up|52
6169161|NCT00073528|21262181|P2|Overall Study|Death|473
6169162|NCT00073528|21262182|P1|Overall Study|Death|488
6169163|NCT04089761|21262292|P1|"Treatment Phase"|Lost to Follow-up|1
6169164|NCT04089761|21262292|P1|"Treatment Phase"|No evaluable data|5
6169165|NCT04089761|21262292|P1|"Run In Phase"|Lost to Follow-up|1
6169166|NCT04089761|21262292|P1|"Run In Phase"|Not eligible to proceed to the treatment phase|14
6169167|NCT04043728|21262310|P3|Overall Study|Lost to Follow-up|0
6169168|NCT04043728|21262311|P2|Overall Study|Lost to Follow-up|2
6169169|NCT04043728|21262312|P1|Overall Study|Lost to Follow-up|1
6169170|NCT03967444|21262325|P2|Overall Study|Lost to Follow-up|2
6169171|NCT03967444|21262326|P1|Overall Study|Lost to Follow-up|1
6169172|NCT03859323|21262345|P13|Overall Study|Pregnancy|0
6169173|NCT03859323|21262346|P12|Overall Study|Pregnancy|0
6169174|NCT03859323|21262347|P11|Overall Study|Pregnancy|0
6169175|NCT03859323|21262348|P10|Overall Study|Pregnancy|1
6169176|NCT03859323|21262349|P9|Overall Study|Pregnancy|0
6169177|NCT03859323|21262350|P8|Overall Study|Pregnancy|0
6169178|NCT03859323|21262351|P7|Overall Study|Pregnancy|0
6169179|NCT03859323|21262352|P6|Overall Study|Pregnancy|0
6169180|NCT03859323|21262353|P5|Overall Study|Pregnancy|0
6169181|NCT03859323|21262354|P4|Overall Study|Pregnancy|0
6169182|NCT03859323|21262355|P3|Overall Study|Pregnancy|0
6169183|NCT03859323|21262356|P2|Overall Study|Pregnancy|0
6169184|NCT03859323|21262357|P1|Overall Study|Pregnancy|0
6169185|NCT03859323|21262345|P13|Overall Study|Withdrawal by Subject|1
6169186|NCT03859323|21262346|P12|Overall Study|Withdrawal by Subject|2
6169187|NCT03859323|21262347|P11|Overall Study|Withdrawal by Subject|1
6169188|NCT03859323|21262348|P10|Overall Study|Withdrawal by Subject|1
6169189|NCT03859323|21262349|P9|Overall Study|Withdrawal by Subject|0
6169190|NCT03859323|21262350|P8|Overall Study|Withdrawal by Subject|0
6169191|NCT03859323|21262351|P7|Overall Study|Withdrawal by Subject|0
6169192|NCT03859323|21262352|P6|Overall Study|Withdrawal by Subject|1
6169193|NCT03859323|21262353|P5|Overall Study|Withdrawal by Subject|0
6169194|NCT03859323|21262354|P4|Overall Study|Withdrawal by Subject|0
6169195|NCT03859323|21262355|P3|Overall Study|Withdrawal by Subject|1
6169196|NCT03859323|21262356|P2|Overall Study|Withdrawal by Subject|0
6169197|NCT03859323|21262357|P1|Overall Study|Withdrawal by Subject|0
6169198|NCT03859323|21262345|P13|Overall Study|Lost to Follow-up|0
6169199|NCT03859323|21262346|P12|Overall Study|Lost to Follow-up|0
6169200|NCT03859323|21262347|P11|Overall Study|Lost to Follow-up|0
6169201|NCT03859323|21262348|P10|Overall Study|Lost to Follow-up|0
6169202|NCT03859323|21262349|P9|Overall Study|Lost to Follow-up|0
6169203|NCT03859323|21262350|P8|Overall Study|Lost to Follow-up|0
6169204|NCT03859323|21262351|P7|Overall Study|Lost to Follow-up|1
6169205|NCT03859323|21262352|P6|Overall Study|Lost to Follow-up|0
6169206|NCT03859323|21262353|P5|Overall Study|Lost to Follow-up|0
6169207|NCT03859323|21262354|P4|Overall Study|Lost to Follow-up|0
6169208|NCT03859323|21262355|P3|Overall Study|Lost to Follow-up|0
6169209|NCT03859323|21262356|P2|Overall Study|Lost to Follow-up|0
6169210|NCT03859323|21262357|P1|Overall Study|Lost to Follow-up|0
6169211|NCT03730961|21262556|P2|Overall Study|Adverse Event|1
6169212|NCT03730961|21262557|P1|Overall Study|Adverse Event|0
6169213|NCT03635775|21262645|P4|Overall Study|Did not meet final inclusion criteria based on initial evaluation|1
6169214|NCT03635775|21262646|P3|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0
6169215|NCT03635775|21262647|P2|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0
6169216|NCT03635775|21262648|P1|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0
6169217|NCT03600428|21262664|P2|Overall Study|Lost to Follow-up|4
6169218|NCT03600428|21262665|P1|Overall Study|Lost to Follow-up|5
6169219|NCT03599193|21262681|P2|Overall Study|Lost to Follow-up|1
6169220|NCT03599193|21262682|P1|Overall Study|Lost to Follow-up|0
6169221|NCT03599193|21262681|P2|Overall Study|Protocol Violation|0
6169222|NCT03599193|21262682|P1|Overall Study|Protocol Violation|1
6169223|NCT03599193|21262681|P2|Overall Study|Withdrawal by Subject|0
6169224|NCT03599193|21262682|P1|Overall Study|Withdrawal by Subject|1
6169225|NCT03599193|21262681|P2|Overall Study|Adverse Event|2
6169226|NCT03599193|21262682|P1|Overall Study|Adverse Event|0
6169227|NCT03579290|21262694|P1|Overall Study|Lost to Follow-up|9
6169228|NCT03553823|21262702|P2|Overall Study|Physician Decision|1
6169229|NCT03553823|21262703|P1|Overall Study|Physician Decision|0
6169230|NCT03494725|21262711|P2|Overall Study|Antibiotic use|0
6169231|NCT03494725|21262712|P1|Overall Study|Antibiotic use|1
6169232|NCT03494725|21262711|P2|Overall Study|Withdrawal by Subject|2
6169233|NCT03494725|21262712|P1|Overall Study|Withdrawal by Subject|0
6169234|NCT03432819|21262784|P2|Overall Study|Withdrawal by Subject|3
6169235|NCT03432819|21262785|P1|Overall Study|Withdrawal by Subject|5
6169236|NCT03432819|21262784|P2|Overall Study|Lost to Follow-up|2
6169237|NCT03432819|21262785|P1|Overall Study|Lost to Follow-up|2
6169238|NCT03361137|21262880|P5|Overall Study|Reason not specified|0
6169239|NCT03361137|21262881|P4|Overall Study|Reason not specified|0
6169240|NCT03361137|21262882|P3|Overall Study|Reason not specified|0
6169241|NCT03361137|21262883|P2|Overall Study|Reason not specified|0
6169242|NCT03361137|21262884|P1|Overall Study|Reason not specified|1
6169243|NCT03340961|21262936|P4|Overall Study|Lack of Efficacy|1
6169244|NCT03340961|21262937|P3|Overall Study|Lack of Efficacy|0
6169245|NCT03340961|21262938|P2|Overall Study|Lack of Efficacy|0
6169246|NCT03340961|21262939|P1|Overall Study|Lack of Efficacy|0
6169247|NCT03340961|21262936|P4|Overall Study|Adverse Event|0
6169248|NCT03340961|21262937|P3|Overall Study|Adverse Event|0
6169249|NCT03340961|21262938|P2|Overall Study|Adverse Event|1
6169250|NCT03340961|21262939|P1|Overall Study|Adverse Event|1
6169251|NCT03340961|21262936|P4|Overall Study|Protocol Violation|0
6169252|NCT03340961|21262937|P3|Overall Study|Protocol Violation|1
6169253|NCT03340961|21262938|P2|Overall Study|Protocol Violation|0
6169254|NCT03340961|21262939|P1|Overall Study|Protocol Violation|1
6169255|NCT03340961|21262936|P4|Overall Study|Subject developed an exclusion criterion|0
6169256|NCT03340961|21262937|P3|Overall Study|Subject developed an exclusion criterion|0
6169257|NCT03340961|21262938|P2|Overall Study|Subject developed an exclusion criterion|1
6169258|NCT03340961|21262939|P1|Overall Study|Subject developed an exclusion criterion|0
6169259|NCT03340961|21262936|P4|Overall Study|Wrongful enrollment (I/E criteria not me|1
6169260|NCT03340961|21262937|P3|Overall Study|Wrongful enrollment (I/E criteria not me|0
6169261|NCT03340961|21262938|P2|Overall Study|Wrongful enrollment (I/E criteria not me|1
6169262|NCT03340961|21262939|P1|Overall Study|Wrongful enrollment (I/E criteria not me|0
6169263|NCT03340961|21262936|P4|Overall Study|Use of prohibited treatment|4
6169264|NCT03340961|21262937|P3|Overall Study|Use of prohibited treatment|2
6169265|NCT03340961|21262938|P2|Overall Study|Use of prohibited treatment|3
6169266|NCT03340961|21262939|P1|Overall Study|Use of prohibited treatment|0
6169267|NCT03340961|21262936|P4|Overall Study|Withdrawal by Subject|7
6169268|NCT03340961|21262937|P3|Overall Study|Withdrawal by Subject|4
6169269|NCT03340961|21262938|P2|Overall Study|Withdrawal by Subject|2
6169270|NCT03340961|21262939|P1|Overall Study|Withdrawal by Subject|3
6169271|NCT03340961|21262936|P4|Overall Study|Lost to Follow-up|1
6169272|NCT03340961|21262937|P3|Overall Study|Lost to Follow-up|0
6169273|NCT03340961|21262938|P2|Overall Study|Lost to Follow-up|1
6169274|NCT03340961|21262939|P1|Overall Study|Lost to Follow-up|0
6169275|NCT03340961|21262936|P4|Overall Study|Adverse Event|4
6169276|NCT03340961|21262937|P3|Overall Study|Adverse Event|2
6169277|NCT03340961|21262938|P2|Overall Study|Adverse Event|3
6169278|NCT03340961|21262939|P1|Overall Study|Adverse Event|1
6169279|NCT03338062|21262959|P2|Overall Study|Alternative Therapy|0
6169280|NCT03338062|21262960|P1|Overall Study|Alternative Therapy|1
6169281|NCT03292640|21262985|P2|Overall Study|Lost to Follow-up|24
6169282|NCT03292640|21262986|P1|Overall Study|Lost to Follow-up|24
6169283|NCT03292640|21262985|P2|Overall Study|Adverse Event|2
6169284|NCT03292640|21262986|P1|Overall Study|Adverse Event|20
6169285|NCT03292640|21262985|P2|Overall Study|Withdrawal by Subject|16
6169286|NCT03292640|21262986|P1|Overall Study|Withdrawal by Subject|17
6169287|NCT03264066|21263255|P6|Overall Study|Withdrawal by Subject|0
6169288|NCT03264066|21263256|P5|Overall Study|Withdrawal by Subject|0
6169289|NCT03264066|21263257|P4|Overall Study|Withdrawal by Subject|5
6169290|NCT03264066|21263258|P3|Overall Study|Withdrawal by Subject|0
6169291|NCT03264066|21263259|P2|Overall Study|Withdrawal by Subject|0
6169292|NCT03264066|21263260|P1|Overall Study|Withdrawal by Subject|1
6169293|NCT03264066|21263255|P6|Overall Study|Study Terminated by Sponsor|2
6169294|NCT03264066|21263256|P5|Overall Study|Study Terminated by Sponsor|1
6169295|NCT03264066|21263257|P4|Overall Study|Study Terminated by Sponsor|5
6169296|NCT03264066|21263258|P3|Overall Study|Study Terminated by Sponsor|8
6169297|NCT03264066|21263259|P2|Overall Study|Study Terminated by Sponsor|5
6169298|NCT03264066|21263260|P1|Overall Study|Study Terminated by Sponsor|5
6169299|NCT03264066|21263255|P6|Overall Study|Progressive Disease|0
6169300|NCT03264066|21263256|P5|Overall Study|Progressive Disease|0
6169301|NCT03264066|21263257|P4|Overall Study|Progressive Disease|0
6169302|NCT03264066|21263258|P3|Overall Study|Progressive Disease|1
6169303|NCT03264066|21263259|P2|Overall Study|Progressive Disease|2
6169304|NCT03264066|21263260|P1|Overall Study|Progressive Disease|0
6169305|NCT03264066|21263255|P6|Overall Study|Lost to Follow-up|0
6169306|NCT03264066|21263256|P5|Overall Study|Lost to Follow-up|0
6169307|NCT03264066|21263257|P4|Overall Study|Lost to Follow-up|0
6169308|NCT03264066|21263258|P3|Overall Study|Lost to Follow-up|0
6169309|NCT03264066|21263259|P2|Overall Study|Lost to Follow-up|0
6169310|NCT03264066|21263260|P1|Overall Study|Lost to Follow-up|1
6169311|NCT03264066|21263255|P6|Overall Study|Death|1
6169312|NCT03264066|21263256|P5|Overall Study|Death|6
6169313|NCT03264066|21263257|P4|Overall Study|Death|10
6169314|NCT03264066|21263258|P3|Overall Study|Death|8
6169315|NCT03264066|21263259|P2|Overall Study|Death|12
6169316|NCT03264066|21263260|P1|Overall Study|Death|12
6169317|NCT03264066|21263255|P6|Overall Study|Adverse Event|0
6169318|NCT03264066|21263256|P5|Overall Study|Adverse Event|0
6169319|NCT03264066|21263257|P4|Overall Study|Adverse Event|0
6169320|NCT03264066|21263258|P3|Overall Study|Adverse Event|0
6169321|NCT03264066|21263259|P2|Overall Study|Adverse Event|1
6169322|NCT03264066|21263260|P1|Overall Study|Adverse Event|1
6169323|NCT03072043|21263392|P3|Overall Study|Withdrawal by Subject|4
6169324|NCT03072043|21263393|P2|Overall Study|Withdrawal by Subject|0
6169325|NCT03072043|21263394|P1|Overall Study|Withdrawal by Subject|0
6169326|NCT03072043|21263392|P3|Overall Study|Adverse Event|2
6169327|NCT03072043|21263393|P2|Overall Study|Adverse Event|0
6169328|NCT03072043|21263394|P1|Overall Study|Adverse Event|0
6169329|NCT03072043|21263392|P3|Overall Study|Death|3
6169330|NCT03072043|21263393|P2|Overall Study|Death|0
6169331|NCT03072043|21263394|P1|Overall Study|Death|0
6169332|NCT03067441|21263408|P2|Overall Study|Other|1
6169333|NCT03067441|21263409|P1|Overall Study|Other|1
6169334|NCT03067441|21263408|P2|Overall Study|Physician Decision|3
6169335|NCT03067441|21263409|P1|Overall Study|Physician Decision|1
6169336|NCT03067441|21263408|P2|Overall Study|Study Terminated by Sponsor or Investigator|0
6169337|NCT03067441|21263409|P1|Overall Study|Study Terminated by Sponsor or Investigator|1
6169338|NCT03067441|21263408|P2|Overall Study|Adverse Event|14
6169339|NCT03067441|21263409|P1|Overall Study|Adverse Event|7
6169340|NCT03067441|21263408|P2|Overall Study|Lost to Follow-up|5
6169341|NCT03067441|21263409|P1|Overall Study|Lost to Follow-up|7
6169342|NCT03067441|21263408|P2|Overall Study|Withdrawal by Subject|34
6169343|NCT03067441|21263409|P1|Overall Study|Withdrawal by Subject|16
6169344|NCT02997176|21263469|P4|Overall Study|Withdrawal by Subject|1
6169345|NCT02997176|21263470|P3|Overall Study|Withdrawal by Subject|0
6169346|NCT02997176|21263471|P2|Overall Study|Withdrawal by Subject|2
6169347|NCT02997176|21263472|P1|Overall Study|Withdrawal by Subject|0
6169348|NCT02997176|21263469|P4|Overall Study|Death|1
6169349|NCT02997176|21263470|P3|Overall Study|Death|1
6169350|NCT02997176|21263471|P2|Overall Study|Death|0
6169351|NCT02997176|21263472|P1|Overall Study|Death|0
6169352|NCT02997176|21263469|P4|Overall Study|Progressive Disease|1
6169353|NCT02997176|21263470|P3|Overall Study|Progressive Disease|1
6169354|NCT02997176|21263471|P2|Overall Study|Progressive Disease|0
6169355|NCT02997176|21263472|P1|Overall Study|Progressive Disease|1
6169356|NCT02997176|21263469|P4|Overall Study|Adverse Event|8
6169357|NCT02997176|21263470|P3|Overall Study|Adverse Event|0
6169358|NCT02997176|21263471|P2|Overall Study|Adverse Event|0
6169359|NCT02997176|21263472|P1|Overall Study|Adverse Event|0
6169360|NCT02987543|21263610|P4|Overall Study|Disease progression|1
6169361|NCT02987543|21263611|P3|Overall Study|Disease progression|0
6169362|NCT02987543|21263612|P2|Overall Study|Disease progression|0
6169363|NCT02987543|21263613|P1|Overall Study|Disease progression|0
6169364|NCT02987543|21263610|P4|Overall Study|Investigator decision|0
6169365|NCT02987543|21263611|P3|Overall Study|Investigator decision|0
6169366|NCT02987543|21263612|P2|Overall Study|Investigator decision|1
6169367|NCT02987543|21263613|P1|Overall Study|Investigator decision|0
6169368|NCT02987543|21263610|P4|Overall Study|Study terminated by sponsor|0
6169369|NCT02987543|21263611|P3|Overall Study|Study terminated by sponsor|0
6169370|NCT02987543|21263612|P2|Overall Study|Study terminated by sponsor|0
6169371|NCT02987543|21263613|P1|Overall Study|Study terminated by sponsor|1
6169372|NCT02987543|21263610|P4|Overall Study|Withdrawal by Subject|6
6169373|NCT02987543|21263611|P3|Overall Study|Withdrawal by Subject|7
6169374|NCT02987543|21263612|P2|Overall Study|Withdrawal by Subject|7
6169375|NCT02987543|21263613|P1|Overall Study|Withdrawal by Subject|21
6169376|NCT02987543|21263610|P4|Overall Study|Screen failure|1
6169377|NCT02987543|21263611|P3|Overall Study|Screen failure|0
6169378|NCT02987543|21263612|P2|Overall Study|Screen failure|0
6169379|NCT02987543|21263613|P1|Overall Study|Screen failure|0
6169380|NCT02987543|21263610|P4|Overall Study|Lost to Follow-up|0
6169381|NCT02987543|21263611|P3|Overall Study|Lost to Follow-up|1
6169382|NCT02987543|21263612|P2|Overall Study|Lost to Follow-up|0
6169383|NCT02987543|21263613|P1|Overall Study|Lost to Follow-up|3
6169384|NCT02987543|21263610|P4|Overall Study|Death|28
6169385|NCT02987543|21263611|P3|Overall Study|Death|67
6169386|NCT02987543|21263612|P2|Overall Study|Death|54
6169387|NCT02987543|21263613|P1|Overall Study|Death|88
6169388|NCT02987543|21263610|P4|Overall Study|Ongoing study at data cut off|12
6169389|NCT02987543|21263611|P3|Overall Study|Ongoing study at data cut off|19
6169390|NCT02987543|21263612|P2|Overall Study|Ongoing study at data cut off|21
6169391|NCT02987543|21263613|P1|Overall Study|Ongoing study at data cut off|49
6169392|NCT02953782|21263654|P8|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0
6169393|NCT02953782|21263655|P7|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|1
6169394|NCT02953782|21263656|P6|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0
6169395|NCT02953782|21263657|P5|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0
6169396|NCT02953782|21263658|P4|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0
6169397|NCT02953782|21263659|P3|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0
6169398|NCT02953782|21263660|P2|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0
6169399|NCT02953782|21263661|P1|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0
6169400|NCT02953782|21263654|P8|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|4
6169401|NCT02953782|21263655|P7|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|1
6169402|NCT02953782|21263656|P6|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|1
6169403|NCT02953782|21263657|P5|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0
6169404|NCT02953782|21263658|P4|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0
6169405|NCT02953782|21263659|P3|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0
6169406|NCT02953782|21263660|P2|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0
6169407|NCT02953782|21263661|P1|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0
6169408|NCT02953782|21263654|P8|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|3
6169409|NCT02953782|21263655|P7|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|2
6169410|NCT02953782|21263656|P6|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|1
6169411|NCT02953782|21263657|P5|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0
6169412|NCT02953782|21263658|P4|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0
6169413|NCT02953782|21263659|P3|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0
6169414|NCT02953782|21263660|P2|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0
6169415|NCT02953782|21263661|P1|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0
6169416|NCT02953782|21263654|P8|Phase 2 (Maximum Duration: 11.1 Months)|Death|8
6169417|NCT02953782|21263655|P7|Phase 2 (Maximum Duration: 11.1 Months)|Death|11
6169418|NCT02953782|21263656|P6|Phase 2 (Maximum Duration: 11.1 Months)|Death|14
6169419|NCT02953782|21263657|P5|Phase 2 (Maximum Duration: 11.1 Months)|Death|0
6169420|NCT02953782|21263658|P4|Phase 2 (Maximum Duration: 11.1 Months)|Death|0
6169421|NCT02953782|21263659|P3|Phase 2 (Maximum Duration: 11.1 Months)|Death|0
6169422|NCT02953782|21263660|P2|Phase 2 (Maximum Duration: 11.1 Months)|Death|0
6169423|NCT02953782|21263661|P1|Phase 2 (Maximum Duration: 11.1 Months)|Death|0
6169424|NCT02953782|21263654|P8|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0
6169425|NCT02953782|21263655|P7|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0
6169426|NCT02953782|21263656|P6|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0
6169427|NCT02953782|21263657|P5|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0
6169428|NCT02953782|21263658|P4|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|1
6169429|NCT02953782|21263659|P3|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|1
6169430|NCT02953782|21263660|P2|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0
6169431|NCT02953782|21263661|P1|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0
6169432|NCT02953782|21263654|P8|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0
6169433|NCT02953782|21263655|P7|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0
6169434|NCT02953782|21263656|P6|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0
6169435|NCT02953782|21263657|P5|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1
6169436|NCT02953782|21263658|P4|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1
6169437|NCT02953782|21263659|P3|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0
6169438|NCT02953782|21263660|P2|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1
6169439|NCT02953782|21263661|P1|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0
6169440|NCT02953782|21263654|P8|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0
6169441|NCT02953782|21263655|P7|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0
6169442|NCT02953782|21263656|P6|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0
6169443|NCT02953782|21263657|P5|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|1
6169444|NCT02953782|21263658|P4|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0
6169445|NCT02953782|21263659|P3|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|2
6169446|NCT02953782|21263660|P2|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0
6169447|NCT02953782|21263661|P1|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|1
6169448|NCT02953782|21263654|P8|Phase 1b (Maximum Duration: 14.3 Months)|Death|0
6169449|NCT02953782|21263655|P7|Phase 1b (Maximum Duration: 14.3 Months)|Death|0
6169450|NCT02953782|21263656|P6|Phase 1b (Maximum Duration: 14.3 Months)|Death|0
6169451|NCT02953782|21263657|P5|Phase 1b (Maximum Duration: 14.3 Months)|Death|4
6169452|NCT02953782|21263658|P4|Phase 1b (Maximum Duration: 14.3 Months)|Death|6
6169453|NCT02953782|21263659|P3|Phase 1b (Maximum Duration: 14.3 Months)|Death|6
6169454|NCT02953782|21263660|P2|Phase 1b (Maximum Duration: 14.3 Months)|Death|2
6169455|NCT02953782|21263661|P1|Phase 1b (Maximum Duration: 14.3 Months)|Death|5
6169456|NCT02891850|21263751|P2|Overall Study|Withdrawal by Subject|3
6169457|NCT02891850|21263752|P1|Overall Study|Withdrawal by Subject|2
6169458|NCT02891850|21263751|P2|Overall Study|Pregnancy|0
6169459|NCT02891850|21263752|P1|Overall Study|Pregnancy|1
6169460|NCT02891850|21263751|P2|Overall Study|Physician Decision|0
6169461|NCT02891850|21263752|P1|Overall Study|Physician Decision|1
6169462|NCT02891850|21263751|P2|Overall Study|Death|4
6169463|NCT02891850|21263752|P1|Overall Study|Death|0
6169464|NCT02891850|21263751|P2|Overall Study|Adverse Event|0
6169465|NCT02891850|21263752|P1|Overall Study|Adverse Event|3
6169466|NCT02888106|21263793|P6|Overall Study|Pregnancy|0
6169467|NCT02888106|21263794|P5|Overall Study|Pregnancy|0
6169468|NCT02888106|21263795|P4|Overall Study|Pregnancy|0
6169469|NCT02888106|21263796|P3|Overall Study|Pregnancy|0
6169470|NCT02888106|21263797|P2|Overall Study|Pregnancy|0
6169471|NCT02888106|21263798|P1|Overall Study|Pregnancy|1
6169472|NCT02888106|21263793|P6|Overall Study|Withdrawal of consent|0
6169473|NCT02888106|21263794|P5|Overall Study|Withdrawal of consent|1
6169474|NCT02888106|21263795|P4|Overall Study|Withdrawal of consent|0
6169475|NCT02888106|21263796|P3|Overall Study|Withdrawal of consent|0
6169476|NCT02888106|21263797|P2|Overall Study|Withdrawal of consent|0
6169477|NCT02888106|21263798|P1|Overall Study|Withdrawal of consent|0
6169478|NCT02888106|21263793|P6|Overall Study|Adverse Event|0
6169479|NCT02888106|21263794|P5|Overall Study|Adverse Event|0
6169480|NCT02888106|21263795|P4|Overall Study|Adverse Event|0
6169481|NCT02888106|21263796|P3|Overall Study|Adverse Event|0
6169482|NCT02888106|21263797|P2|Overall Study|Adverse Event|0
6169483|NCT02888106|21263798|P1|Overall Study|Adverse Event|2
6169484|NCT02888106|21263793|P6|Overall Study|Lost to Follow-up|1
6169485|NCT02888106|21263794|P5|Overall Study|Lost to Follow-up|0
6169486|NCT02888106|21263795|P4|Overall Study|Lost to Follow-up|1
6169487|NCT02888106|21263796|P3|Overall Study|Lost to Follow-up|0
6169488|NCT02888106|21263797|P2|Overall Study|Lost to Follow-up|0
6169489|NCT02888106|21263798|P1|Overall Study|Lost to Follow-up|1
6169490|NCT02888106|21263793|P6|Overall Study|Withdrawal by Subject|0
6169491|NCT02888106|21263794|P5|Overall Study|Withdrawal by Subject|0
6169492|NCT02888106|21263795|P4|Overall Study|Withdrawal by Subject|1
6169493|NCT02888106|21263796|P3|Overall Study|Withdrawal by Subject|0
6169494|NCT02888106|21263797|P2|Overall Study|Withdrawal by Subject|2
6169495|NCT02888106|21263798|P1|Overall Study|Withdrawal by Subject|1
6169496|NCT02808429|21263857|P3|Overall Study|Relocation|1
6169497|NCT02808429|21263858|P2|Overall Study|Relocation|0
6169498|NCT02808429|21263859|P1|Overall Study|Relocation|0
6169499|NCT02808429|21263857|P3|Overall Study|Premature study termination by sponsor|1
6169500|NCT02808429|21263858|P2|Overall Study|Premature study termination by sponsor|0
6169501|NCT02808429|21263859|P1|Overall Study|Premature study termination by sponsor|2
6169502|NCT02808429|21263857|P3|Overall Study|Protocol Violation|0
6169503|NCT02808429|21263858|P2|Overall Study|Protocol Violation|1
6169504|NCT02808429|21263859|P1|Overall Study|Protocol Violation|0
6169505|NCT02808429|21263857|P3|Overall Study|Lost to Follow-up|0
6169506|NCT02808429|21263858|P2|Overall Study|Lost to Follow-up|0
6169507|NCT02808429|21263859|P1|Overall Study|Lost to Follow-up|1
6169508|NCT02787850|21263905|P2|Overall Study|Withdrawal by Subject|1
6169509|NCT02787850|21263906|P1|Overall Study|Withdrawal by Subject|0
6169510|NCT02748694|21263947|P15|Overall Study|Voluntary Withdrawal|2
6169511|NCT02748694|21263948|P14|Overall Study|Voluntary Withdrawal|0
6169512|NCT02748694|21263949|P13|Overall Study|Voluntary Withdrawal|0
6169513|NCT02748694|21263950|P12|Overall Study|Voluntary Withdrawal|0
6169514|NCT02748694|21263951|P11|Overall Study|Voluntary Withdrawal|0
6169515|NCT02748694|21263952|P10|Overall Study|Voluntary Withdrawal|0
6169516|NCT02748694|21263953|P9|Overall Study|Voluntary Withdrawal|0
6169517|NCT02748694|21263954|P8|Overall Study|Voluntary Withdrawal|0
6169518|NCT02748694|21263955|P7|Overall Study|Voluntary Withdrawal|0
6169519|NCT02748694|21263956|P6|Overall Study|Voluntary Withdrawal|0
6169520|NCT02748694|21263957|P5|Overall Study|Voluntary Withdrawal|0
6169521|NCT02748694|21263958|P4|Overall Study|Voluntary Withdrawal|0
6169522|NCT02748694|21263959|P3|Overall Study|Voluntary Withdrawal|0
6169523|NCT02748694|21263960|P2|Overall Study|Voluntary Withdrawal|0
6169524|NCT02748694|21263961|P1|Overall Study|Voluntary Withdrawal|0
6169525|NCT02729740|21264169|P1|Overall Study|Other|1
6169526|NCT02729740|21264169|P1|Overall Study|Early Termination|130
6169527|NCT02711553|21264180|P4|Overall Study|On Study Treatment at Study Conclusion|3
6169528|NCT02711553|21264181|P3|Overall Study|On Study Treatment at Study Conclusion|16
6169529|NCT02711553|21264182|P2|Overall Study|On Study Treatment at Study Conclusion|8
6169530|NCT02711553|21264183|P1|Overall Study|On Study Treatment at Study Conclusion|12
6169531|NCT02711553|21264180|P4|Overall Study|Lost to Follow-up|4
6169532|NCT02711553|21264181|P3|Overall Study|Lost to Follow-up|10
6169533|NCT02711553|21264182|P2|Overall Study|Lost to Follow-up|5
6169534|NCT02711553|21264183|P1|Overall Study|Lost to Follow-up|4
6169535|NCT02711553|21264180|P4|Overall Study|Withdrawal by Subject|0
6169536|NCT02711553|21264181|P3|Overall Study|Withdrawal by Subject|1
6169537|NCT02711553|21264182|P2|Overall Study|Withdrawal by Subject|2
6169538|NCT02711553|21264183|P1|Overall Study|Withdrawal by Subject|2
6169539|NCT02697591|21264213|P10|Overall Study|Reason not Specified|3
6169540|NCT02697591|21264214|P9|Overall Study|Reason not Specified|1
6169541|NCT02697591|21264215|P8|Overall Study|Reason not Specified|1
6169542|NCT02697591|21264216|P7|Overall Study|Reason not Specified|3
6169543|NCT02697591|21264217|P6|Overall Study|Reason not Specified|2
6169544|NCT02697591|21264218|P5|Overall Study|Reason not Specified|1
6169545|NCT02697591|21264219|P4|Overall Study|Reason not Specified|1
6169546|NCT02697591|21264220|P3|Overall Study|Reason not Specified|0
6169547|NCT02697591|21264221|P2|Overall Study|Reason not Specified|0
6169548|NCT02697591|21264222|P1|Overall Study|Reason not Specified|0
6169549|NCT02697591|21264213|P10|Overall Study|Death|5
6169550|NCT02697591|21264214|P9|Overall Study|Death|1
6169551|NCT02697591|21264215|P8|Overall Study|Death|1
6169552|NCT02697591|21264216|P7|Overall Study|Death|3
6169553|NCT02697591|21264217|P6|Overall Study|Death|5
6169554|NCT02697591|21264218|P5|Overall Study|Death|4
6169555|NCT02697591|21264219|P4|Overall Study|Death|1
6169556|NCT02697591|21264220|P3|Overall Study|Death|1
6169557|NCT02697591|21264221|P2|Overall Study|Death|3
6169558|NCT02697591|21264222|P1|Overall Study|Death|2
6169559|NCT02697591|21264213|P10|Overall Study|Physician Decision|1
6169560|NCT02697591|21264214|P9|Overall Study|Physician Decision|1
6169561|NCT02697591|21264215|P8|Overall Study|Physician Decision|0
6169562|NCT02697591|21264216|P7|Overall Study|Physician Decision|0
6169563|NCT02697591|21264217|P6|Overall Study|Physician Decision|2
6169564|NCT02697591|21264218|P5|Overall Study|Physician Decision|1
6169565|NCT02697591|21264219|P4|Overall Study|Physician Decision|0
6169566|NCT02697591|21264220|P3|Overall Study|Physician Decision|0
6169567|NCT02697591|21264221|P2|Overall Study|Physician Decision|0
6169568|NCT02697591|21264222|P1|Overall Study|Physician Decision|1
6169569|NCT02697591|21264213|P10|Overall Study|Withdrawal by Subject|10
6169570|NCT02697591|21264214|P9|Overall Study|Withdrawal by Subject|6
6169571|NCT02697591|21264215|P8|Overall Study|Withdrawal by Subject|1
6169572|NCT02697591|21264216|P7|Overall Study|Withdrawal by Subject|9
6169573|NCT02697591|21264217|P6|Overall Study|Withdrawal by Subject|6
6169574|NCT02697591|21264218|P5|Overall Study|Withdrawal by Subject|7
6169575|NCT02697591|21264219|P4|Overall Study|Withdrawal by Subject|1
6169576|NCT02697591|21264220|P3|Overall Study|Withdrawal by Subject|2
6169577|NCT02697591|21264221|P2|Overall Study|Withdrawal by Subject|1
6169578|NCT02697591|21264222|P1|Overall Study|Withdrawal by Subject|1
6169579|NCT02697591|21264213|P10|Overall Study|Lost to Follow-up|1
6169580|NCT02697591|21264214|P9|Overall Study|Lost to Follow-up|0
6169581|NCT02697591|21264215|P8|Overall Study|Lost to Follow-up|0
6169582|NCT02697591|21264216|P7|Overall Study|Lost to Follow-up|1
6169583|NCT02697591|21264217|P6|Overall Study|Lost to Follow-up|1
6169584|NCT02697591|21264218|P5|Overall Study|Lost to Follow-up|0
6169585|NCT02697591|21264219|P4|Overall Study|Lost to Follow-up|0
6169586|NCT02697591|21264220|P3|Overall Study|Lost to Follow-up|0
6169587|NCT02697591|21264221|P2|Overall Study|Lost to Follow-up|0
6169588|NCT02697591|21264222|P1|Overall Study|Lost to Follow-up|0
6169589|NCT02684617|21264341|P3|Overall Study|Study Terminated by Sponsor|5
6169590|NCT02684617|21264342|P2|Overall Study|Study Terminated by Sponsor|1
6169591|NCT02684617|21264343|P1|Overall Study|Study Terminated by Sponsor|6
6169592|NCT02684617|21264341|P3|Overall Study|Screen Failure|2
6169593|NCT02684617|21264342|P2|Overall Study|Screen Failure|0
6169594|NCT02684617|21264343|P1|Overall Study|Screen Failure|1
6169595|NCT02684617|21264341|P3|Overall Study|Withdrawal by Subject|4
6169596|NCT02684617|21264342|P2|Overall Study|Withdrawal by Subject|0
6169597|NCT02684617|21264343|P1|Overall Study|Withdrawal by Subject|2
6169598|NCT02684617|21264341|P3|Overall Study|Death|28
6169599|NCT02684617|21264342|P2|Overall Study|Death|16
6169600|NCT02684617|21264343|P1|Overall Study|Death|8
6169601|NCT02684617|21264341|P3|Overall Study|Adverse Event|1
6169602|NCT02684617|21264342|P2|Overall Study|Adverse Event|0
6169603|NCT02684617|21264343|P1|Overall Study|Adverse Event|1
6169604|NCT02660489|21264382|P2|Overall Study|no rhinovirus infection|4
6169605|NCT02660489|21264383|P1|Overall Study|no rhinovirus infection|4
6169606|NCT02660489|21264382|P2|Overall Study|Adverse Event|3
6169607|NCT02660489|21264383|P1|Overall Study|Adverse Event|1
6169608|NCT02660489|21264382|P2|Overall Study|Lost to Follow-up|1
6169609|NCT02660489|21264383|P1|Overall Study|Lost to Follow-up|1
6169610|NCT02576509|21264439|P2|Follow-up Period|Other reason|2
6169611|NCT02576509|21264440|P1|Follow-up Period|Other reason|1
6169612|NCT02576509|21264439|P2|Follow-up Period|Lost to Follow-up|1
6169613|NCT02576509|21264440|P1|Follow-up Period|Lost to Follow-up|0
6169614|NCT02576509|21264439|P2|Follow-up Period|Participant withdrew consent|14
6169615|NCT02576509|21264440|P1|Follow-up Period|Participant withdrew consent|7
6169616|NCT02576509|21264439|P2|Follow-up Period|Death|35
6169617|NCT02576509|21264440|P1|Follow-up Period|Death|41
6169618|NCT02576509|21264439|P2|Treatment Period|Other reason|7
6169619|NCT02576509|21264440|P1|Treatment Period|Other reason|2
6169620|NCT02576509|21264439|P2|Treatment Period|Participant no longer meets criteria|0
6169621|NCT02576509|21264440|P1|Treatment Period|Participant no longer meets criteria|1
6169622|NCT02576509|21264439|P2|Treatment Period|Poor/non-compliance|1
6169623|NCT02576509|21264440|P1|Treatment Period|Poor/non-compliance|0
6169624|NCT02576509|21264439|P2|Treatment Period|Maximum clinical benefit|0
6169625|NCT02576509|21264440|P1|Treatment Period|Maximum clinical benefit|1
6169626|NCT02576509|21264439|P2|Treatment Period|Lost to Follow-up|1
6169627|NCT02576509|21264440|P1|Treatment Period|Lost to Follow-up|0
6169628|NCT02576509|21264439|P2|Treatment Period|Participant withdrew consent|7
6169629|NCT02576509|21264440|P1|Treatment Period|Participant withdrew consent|2
6169630|NCT02576509|21264439|P2|Treatment Period|Participant request to stop treatment|17
6169631|NCT02576509|21264440|P1|Treatment Period|Participant request to stop treatment|8
6169632|NCT02576509|21264439|P2|Treatment Period|Adverse event unrelated to study drug|40
6169633|NCT02576509|21264440|P1|Treatment Period|Adverse event unrelated to study drug|37
6169634|NCT02576509|21264439|P2|Treatment Period|Death|1
6169635|NCT02576509|21264440|P1|Treatment Period|Death|1
6169636|NCT02576509|21264439|P2|Treatment Period|Study drug toxicity|41
6169637|NCT02576509|21264440|P1|Treatment Period|Study drug toxicity|32
6169638|NCT02576509|21264439|P2|Treatment Period|Disease progression|240
6169639|NCT02576509|21264440|P1|Treatment Period|Disease progression|245
6169640|NCT02576509|21264439|P2|Pre-Treatment Period|Participant no longer meets criteria|2
6169641|NCT02576509|21264440|P1|Pre-Treatment Period|Participant no longer meets criteria|3
6169642|NCT02576509|21264439|P2|Pre-Treatment Period|Participant withdrew consent|5
6169643|NCT02576509|21264440|P1|Pre-Treatment Period|Participant withdrew consent|1
6169644|NCT02576509|21264439|P2|Pre-Treatment Period|Participant request to stop therapy|2
6169645|NCT02576509|21264440|P1|Pre-Treatment Period|Participant request to stop therapy|0
6169646|NCT02536508|21264457|P3|Overall Study|Administrative Reasons|0
6169647|NCT02536508|21264458|P2|Overall Study|Administrative Reasons|1
6169648|NCT02536508|21264459|P1|Overall Study|Administrative Reasons|0
6169649|NCT02536508|21264457|P3|Overall Study|Major Protocol Deviation|2
6169650|NCT02536508|21264458|P2|Overall Study|Major Protocol Deviation|2
6169651|NCT02536508|21264459|P1|Overall Study|Major Protocol Deviation|2
6169652|NCT02536508|21264457|P3|Overall Study|Physician Decision|2
6169653|NCT02536508|21264458|P2|Overall Study|Physician Decision|4
6169654|NCT02536508|21264459|P1|Overall Study|Physician Decision|0
6169655|NCT02536508|21264457|P3|Overall Study|Protocol Discontinuation Criteria|2
6169656|NCT02536508|21264458|P2|Overall Study|Protocol Discontinuation Criteria|2
6169657|NCT02536508|21264459|P1|Overall Study|Protocol Discontinuation Criteria|3
6169658|NCT02536508|21264457|P3|Overall Study|Lack of Efficacy|4
6169659|NCT02536508|21264458|P2|Overall Study|Lack of Efficacy|5
6169660|NCT02536508|21264459|P1|Overall Study|Lack of Efficacy|3
6169661|NCT02536508|21264457|P3|Overall Study|Lost to Follow-up|0
6169662|NCT02536508|21264458|P2|Overall Study|Lost to Follow-up|4
6169663|NCT02536508|21264459|P1|Overall Study|Lost to Follow-up|12
6169664|NCT02536508|21264457|P3|Overall Study|Adverse Event|6
6169665|NCT02536508|21264458|P2|Overall Study|Adverse Event|13
6169666|NCT02536508|21264459|P1|Overall Study|Adverse Event|14
6169667|NCT02536508|21264457|P3|Overall Study|Withdrawal by Subject|7
6169668|NCT02536508|21264458|P2|Overall Study|Withdrawal by Subject|13
6169669|NCT02536508|21264459|P1|Overall Study|Withdrawal by Subject|18
6169670|NCT02443155|21264474|P4|Overall Study|Death|0
6169671|NCT02443155|21264475|P3|Overall Study|Death|1
6169672|NCT02443155|21264476|P2|Overall Study|Death|0
6169673|NCT02443155|21264477|P1|Overall Study|Death|0
6169674|NCT02443155|21264474|P4|Overall Study|Protocol Violation|1
6169675|NCT02443155|21264475|P3|Overall Study|Protocol Violation|1
6169676|NCT02443155|21264476|P2|Overall Study|Protocol Violation|0
6169677|NCT02443155|21264477|P1|Overall Study|Protocol Violation|1
6169678|NCT02443155|21264474|P4|Overall Study|Lost to Follow-up|1
6169679|NCT02443155|21264475|P3|Overall Study|Lost to Follow-up|0
6169680|NCT02443155|21264476|P2|Overall Study|Lost to Follow-up|2
6169681|NCT02443155|21264477|P1|Overall Study|Lost to Follow-up|1
6169682|NCT02443155|21264474|P4|Overall Study|Pregnancy|2
6169683|NCT02443155|21264475|P3|Overall Study|Pregnancy|1
6169684|NCT02443155|21264476|P2|Overall Study|Pregnancy|1
6169685|NCT02443155|21264477|P1|Overall Study|Pregnancy|3
6169686|NCT02443155|21264474|P4|Overall Study|Withdrawal by Subject|9
6169687|NCT02443155|21264475|P3|Overall Study|Withdrawal by Subject|3
6169688|NCT02443155|21264476|P2|Overall Study|Withdrawal by Subject|7
6169689|NCT02443155|21264477|P1|Overall Study|Withdrawal by Subject|4
6169690|NCT02443155|21264474|P4|Overall Study|Unclassified|1
6169691|NCT02443155|21264475|P3|Overall Study|Unclassified|2
6169692|NCT02443155|21264476|P2|Overall Study|Unclassified|0
6169693|NCT02443155|21264477|P1|Overall Study|Unclassified|0
6169694|NCT02443155|21264474|P4|Overall Study|Adverse Event|2
6169695|NCT02443155|21264475|P3|Overall Study|Adverse Event|1
6169696|NCT02443155|21264476|P2|Overall Study|Adverse Event|4
6169697|NCT02443155|21264477|P1|Overall Study|Adverse Event|3
6169698|NCT02432274|21264986|P8|Overall Study|Ongoing|7
6169699|NCT02432274|21264987|P7|Overall Study|Ongoing|0
6169700|NCT02432274|21264988|P6|Overall Study|Ongoing|0
6169701|NCT02432274|21264989|P5|Overall Study|Ongoing|3
6169702|NCT02432274|21264990|P4|Overall Study|Ongoing|1
6169703|NCT02432274|21264991|P3|Overall Study|Ongoing|1
6169704|NCT02432274|21264992|P2|Overall Study|Ongoing|0
6169705|NCT02432274|21264993|P1|Overall Study|Ongoing|0
6169706|NCT02432274|21264986|P8|Overall Study|Other than specified|1
6169707|NCT02432274|21264987|P7|Overall Study|Other than specified|0
6169708|NCT02432274|21264988|P6|Overall Study|Other than specified|1
6169709|NCT02432274|21264989|P5|Overall Study|Other than specified|0
6169710|NCT02432274|21264990|P4|Overall Study|Other than specified|0
6169711|NCT02432274|21264991|P3|Overall Study|Other than specified|0
6169712|NCT02432274|21264992|P2|Overall Study|Other than specified|1
6169713|NCT02432274|21264993|P1|Overall Study|Other than specified|0
6169714|NCT02432274|21264986|P8|Overall Study|Participant Choice|0
6169715|NCT02432274|21264987|P7|Overall Study|Participant Choice|1
6169716|NCT02432274|21264988|P6|Overall Study|Participant Choice|0
6169717|NCT02432274|21264989|P5|Overall Study|Participant Choice|0
6169718|NCT02432274|21264990|P4|Overall Study|Participant Choice|0
6169719|NCT02432274|21264991|P3|Overall Study|Participant Choice|1
6169720|NCT02432274|21264992|P2|Overall Study|Participant Choice|0
6169721|NCT02432274|21264993|P1|Overall Study|Participant Choice|0
6169722|NCT02432274|21264986|P8|Overall Study|Withdrawal by Subject|2
6169723|NCT02432274|21264987|P7|Overall Study|Withdrawal by Subject|1
6169724|NCT02432274|21264988|P6|Overall Study|Withdrawal by Subject|0
6169725|NCT02432274|21264989|P5|Overall Study|Withdrawal by Subject|2
6169726|NCT02432274|21264990|P4|Overall Study|Withdrawal by Subject|0
6169727|NCT02432274|21264991|P3|Overall Study|Withdrawal by Subject|0
6169728|NCT02432274|21264992|P2|Overall Study|Withdrawal by Subject|0
6169729|NCT02432274|21264993|P1|Overall Study|Withdrawal by Subject|0
6169730|NCT02432274|21264986|P8|Overall Study|Adverse Event|0
6169731|NCT02432274|21264987|P7|Overall Study|Adverse Event|2
6169732|NCT02432274|21264988|P6|Overall Study|Adverse Event|0
6169733|NCT02432274|21264989|P5|Overall Study|Adverse Event|1
6169734|NCT02432274|21264990|P4|Overall Study|Adverse Event|0
6169735|NCT02432274|21264991|P3|Overall Study|Adverse Event|1
6169736|NCT02432274|21264992|P2|Overall Study|Adverse Event|0
6169737|NCT02432274|21264993|P1|Overall Study|Adverse Event|0
6169738|NCT02432274|21264986|P8|Overall Study|Clinical Disease Progression|1
6169739|NCT02432274|21264987|P7|Overall Study|Clinical Disease Progression|0
6169740|NCT02432274|21264988|P6|Overall Study|Clinical Disease Progression|0
6169741|NCT02432274|21264989|P5|Overall Study|Clinical Disease Progression|1
6169742|NCT02432274|21264990|P4|Overall Study|Clinical Disease Progression|0
6169743|NCT02432274|21264991|P3|Overall Study|Clinical Disease Progression|1
6169744|NCT02432274|21264992|P2|Overall Study|Clinical Disease Progression|4
6169745|NCT02432274|21264993|P1|Overall Study|Clinical Disease Progression|0
6169746|NCT02432274|21264986|P8|Overall Study|Radiological Disease Progression|9
6169747|NCT02432274|21264987|P7|Overall Study|Radiological Disease Progression|11
6169748|NCT02432274|21264988|P6|Overall Study|Radiological Disease Progression|6
6169749|NCT02432274|21264989|P5|Overall Study|Radiological Disease Progression|24
6169750|NCT02432274|21264990|P4|Overall Study|Radiological Disease Progression|0
6169751|NCT02432274|21264991|P3|Overall Study|Radiological Disease Progression|7
6169752|NCT02432274|21264992|P2|Overall Study|Radiological Disease Progression|4
6169753|NCT02432274|21264993|P1|Overall Study|Radiological Disease Progression|3
6169754|NCT02413372|21265109|P3|Follow-up|Subject unable to return for visit|1
6169755|NCT02413372|21265110|P2|Follow-up|Subject unable to return for visit|0
6169756|NCT02413372|21265111|P1|Follow-up|Subject unable to return for visit|0
6169757|NCT02413372|21265109|P3|Follow-up|Subject Withdrew Consent|1
6169758|NCT02413372|21265110|P2|Follow-up|Subject Withdrew Consent|0
6169759|NCT02413372|21265111|P1|Follow-up|Subject Withdrew Consent|1
6169760|NCT02413372|21265109|P3|Follow-up|Lost to Follow-up|0
6169761|NCT02413372|21265110|P2|Follow-up|Lost to Follow-up|1
6169762|NCT02413372|21265111|P1|Follow-up|Lost to Follow-up|1
6169763|NCT02413372|21265109|P3|Treatment|Withdrawal by Subject|0
6169764|NCT02413372|21265110|P2|Treatment|Withdrawal by Subject|0
6169765|NCT02413372|21265111|P1|Treatment|Withdrawal by Subject|1
6169766|NCT02413372|21265109|P3|Treatment|Lost to Follow-up|1
6169767|NCT02413372|21265110|P2|Treatment|Lost to Follow-up|2
6169768|NCT02413372|21265111|P1|Treatment|Lost to Follow-up|0
6169769|NCT02264990|21265201|P2|Overall Study|Other|1
6169770|NCT02264990|21265202|P1|Overall Study|Other|0
6169771|NCT02264990|21265201|P2|Overall Study|Lost to Follow-up|3
6169772|NCT02264990|21265202|P1|Overall Study|Lost to Follow-up|1
6169773|NCT02264990|21265201|P2|Overall Study|Withdrawal by Subject|5
6169774|NCT02264990|21265202|P1|Overall Study|Withdrawal by Subject|4
6169775|NCT02264990|21265201|P2|Overall Study|Death|250
6169776|NCT02264990|21265202|P1|Overall Study|Death|255
6169777|NCT02239263|21265218|P1|Overall Study|Protocol Violation|6
6169778|NCT02202434|21265228|P4|Overall Study|Other|1
6169779|NCT02202434|21265229|P3|Overall Study|Other|0
6169780|NCT02202434|21265230|P2|Overall Study|Other|0
6169781|NCT02202434|21265231|P1|Overall Study|Other|1
6169782|NCT02202434|21265228|P4|Overall Study|Visit Missed|5
6169783|NCT02202434|21265229|P3|Overall Study|Visit Missed|0
6169784|NCT02202434|21265230|P2|Overall Study|Visit Missed|12
6169785|NCT02202434|21265231|P1|Overall Study|Visit Missed|21
6169786|NCT02202434|21265228|P4|Overall Study|Completed Study|0
6169787|NCT02202434|21265229|P3|Overall Study|Completed Study|0
6169788|NCT02202434|21265230|P2|Overall Study|Completed Study|0
6169789|NCT02202434|21265231|P1|Overall Study|Completed Study|1
6169790|NCT02202434|21265228|P4|Overall Study|Withdrawal by Subject|4
6169791|NCT02202434|21265229|P3|Overall Study|Withdrawal by Subject|1
6169792|NCT02202434|21265230|P2|Overall Study|Withdrawal by Subject|14
6169793|NCT02202434|21265231|P1|Overall Study|Withdrawal by Subject|13
6169794|NCT02202434|21265228|P4|Overall Study|Physician Decision|0
6169795|NCT02202434|21265229|P3|Overall Study|Physician Decision|0
6169796|NCT02202434|21265230|P2|Overall Study|Physician Decision|3
6169797|NCT02202434|21265231|P1|Overall Study|Physician Decision|2
6169798|NCT02202434|21265228|P4|Overall Study|Lost to Follow-up|0
6169799|NCT02202434|21265229|P3|Overall Study|Lost to Follow-up|1
6169800|NCT02202434|21265230|P2|Overall Study|Lost to Follow-up|1
6169801|NCT02202434|21265231|P1|Overall Study|Lost to Follow-up|1
6169802|NCT02202434|21265228|P4|Overall Study|Death|27
6169803|NCT02202434|21265229|P3|Overall Study|Death|13
6169804|NCT02202434|21265230|P2|Overall Study|Death|39
6169805|NCT02202434|21265231|P1|Overall Study|Death|70
6169806|NCT02198794|21265366|P3|Part B: Randomized (13 Weeks)|Lost to Follow-up|2
6169807|NCT02198794|21265367|P2|Part B: Randomized (13 Weeks)|Lost to Follow-up|2
6169808|NCT02198794|21265368|P1|Part B: Randomized (13 Weeks)|Lost to Follow-up|0
6169809|NCT02198794|21265366|P3|Part B: Randomized (13 Weeks)|Withdrawal by Subject|1
6169810|NCT02198794|21265367|P2|Part B: Randomized (13 Weeks)|Withdrawal by Subject|3
6169811|NCT02198794|21265368|P1|Part B: Randomized (13 Weeks)|Withdrawal by Subject|0
6169812|NCT02198794|21265366|P3|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0
6169813|NCT02198794|21265367|P2|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0
6169814|NCT02198794|21265368|P1|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|142
6169815|NCT02198794|21265366|P3|Part A: Open-Label (158 Weeks)|Protocol deviation|0
6169816|NCT02198794|21265367|P2|Part A: Open-Label (158 Weeks)|Protocol deviation|0
6169817|NCT02198794|21265368|P1|Part A: Open-Label (158 Weeks)|Protocol deviation|1
6169818|NCT02198794|21265366|P3|Part A: Open-Label (158 Weeks)|Study terminated|0
6169819|NCT02198794|21265367|P2|Part A: Open-Label (158 Weeks)|Study terminated|0
6169820|NCT02198794|21265368|P1|Part A: Open-Label (158 Weeks)|Study terminated|1
6169821|NCT02198794|21265366|P3|Part A: Open-Label (158 Weeks)|Other than specified|0
6169822|NCT02198794|21265367|P2|Part A: Open-Label (158 Weeks)|Other than specified|0
6169823|NCT02198794|21265368|P1|Part A: Open-Label (158 Weeks)|Other than specified|5
6169824|NCT02198794|21265366|P3|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0
6169825|NCT02198794|21265367|P2|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0
6169826|NCT02198794|21265368|P1|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|3
6169827|NCT02198794|21265366|P3|Part A: Open-Label (158 Weeks)|Death|0
6169828|NCT02198794|21265367|P2|Part A: Open-Label (158 Weeks)|Death|0
6169829|NCT02198794|21265368|P1|Part A: Open-Label (158 Weeks)|Death|8
6169830|NCT02198794|21265366|P3|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0
6169831|NCT02198794|21265367|P2|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0
6169832|NCT02198794|21265368|P1|Part A: Open-Label (158 Weeks)|Lack of Efficacy|9
6169833|NCT02198794|21265366|P3|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0
6169834|NCT02198794|21265367|P2|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0
6169835|NCT02198794|21265368|P1|Part A: Open-Label (158 Weeks)|Lost to Follow-up|24
6169836|NCT02198794|21265366|P3|Part A: Open-Label (158 Weeks)|Adverse Event|0
6169837|NCT02198794|21265367|P2|Part A: Open-Label (158 Weeks)|Adverse Event|0
6169838|NCT02198794|21265368|P1|Part A: Open-Label (158 Weeks)|Adverse Event|33
6169839|NCT02198794|21265366|P3|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0
6169840|NCT02198794|21265367|P2|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0
6169841|NCT02198794|21265368|P1|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|79
6169842|NCT02112877|21265394|P2|Overall Study|Visit Missed|6
6169843|NCT02112877|21265395|P1|Overall Study|Visit Missed|1
6169844|NCT02112877|21265394|P2|Overall Study|Withdrawal by Subject|7
6169845|NCT02112877|21265395|P1|Overall Study|Withdrawal by Subject|1
6169846|NCT02087046|21265417|P1|Overall Study|Physician Decision|1
6169847|NCT02087046|21265417|P1|Overall Study|Withdrawal by Subject|2
6169848|NCT02087046|21265417|P1|Overall Study|Lost to Follow-up|3
6169849|NCT02087046|21265417|P1|Overall Study|Death|1
6169850|NCT02087046|21265417|P1|Overall Study|Adverse Event|4
6169851|NCT02081196|21265493|P1|Overall Study|Lost to Follow-up|1
6169852|NCT02043678|21265551|P2|Overall Study|Ongoing with treatment|38
6169853|NCT02043678|21265552|P1|Overall Study|Ongoing with treatment|34
6169854|NCT02043678|21265551|P2|Overall Study|Withdrawal by Subject|15
6169855|NCT02043678|21265552|P1|Overall Study|Withdrawal by Subject|12
6169856|NCT02043678|21265551|P2|Overall Study|Protocol-driven decision point|56
6169857|NCT02043678|21265552|P1|Overall Study|Protocol-driven decision point|56
6169858|NCT02043678|21265551|P2|Overall Study|Radiological PD|80
6169859|NCT02043678|21265552|P1|Overall Study|Radiological PD|91
6169860|NCT02043678|21265551|P2|Overall Study|Clinical PD|138
6169861|NCT02043678|21265552|P1|Overall Study|Clinical PD|108
6169862|NCT02043678|21265551|P2|Overall Study|Other|16
6169863|NCT02043678|21265552|P1|Overall Study|Other|19
6169864|NCT02043678|21265551|P2|Overall Study|Lost to Follow-up|1
6169865|NCT02043678|21265552|P1|Overall Study|Lost to Follow-up|1
6169866|NCT02043678|21265551|P2|Overall Study|AE without clinical PD|34
6169867|NCT02043678|21265552|P1|Overall Study|AE without clinical PD|51
6169868|NCT02043678|21265551|P2|Overall Study|AE with clinical progressive disease(PD)|18
6169869|NCT02043678|21265552|P1|Overall Study|AE with clinical progressive disease(PD)|18
6169870|NCT02043678|21265551|P2|Overall Study|Never treated|9
6169871|NCT02043678|21265552|P1|Overall Study|Never treated|11
6169872|NCT01859403|21265595|P2|Overall Study|Physician Decision|1
6169873|NCT01859403|21265596|P1|Overall Study|Physician Decision|0
6169874|NCT01859403|21265595|P2|Overall Study|Withdrawal by Subject|1
6169875|NCT01859403|21265596|P1|Overall Study|Withdrawal by Subject|1
6169876|NCT01859403|21265595|P2|Overall Study|Lost to Follow-up|2
6169877|NCT01859403|21265596|P1|Overall Study|Lost to Follow-up|0
6169878|NCT01835470|21265640|P1|Long Term Treatment Period|Lack of Efficacy|3
6169879|NCT01835470|21265640|P1|Long Term Treatment Period|Subject Request to Discontinue|1
6169880|NCT01817959|21265660|P2|Overall Study|Patient didn't proceed to 1st Islet Inf|1
6169881|NCT01817959|21265661|P1|Overall Study|Patient didn't proceed to 1st Islet Inf|1
6169882|NCT01817959|21265660|P2|Overall Study|Adverse Event|0
6169883|NCT01817959|21265661|P1|Overall Study|Adverse Event|1
6169884|NCT01817959|21265660|P2|Overall Study|forbidden medication|1
6169885|NCT01817959|21265661|P1|Overall Study|forbidden medication|1
6169886|NCT01817959|21265660|P2|Overall Study|Graft loss|1
6169887|NCT01817959|21265661|P1|Overall Study|Graft loss|1
6169888|NCT01801930|21265709|P4|Overall Study|DLT occurs|0
6169889|NCT01801930|21265710|P3|Overall Study|DLT occurs|0
6169890|NCT01801930|21265711|P2|Overall Study|DLT occurs|1
6169891|NCT01801930|21265712|P1|Overall Study|DLT occurs|0
6169892|NCT01801930|21265709|P4|Overall Study|Clear progression of the primary disease is observed|6
6169893|NCT01801930|21265710|P3|Overall Study|Clear progression of the primary disease is observed|6
6169894|NCT01801930|21265711|P2|Overall Study|Clear progression of the primary disease is observed|5
6169895|NCT01801930|21265712|P1|Overall Study|Clear progression of the primary disease is observed|6
6169896|NCT01783444|21265733|P3|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|52
6169897|NCT01783444|21265734|P2|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|53
6169898|NCT01783444|21265735|P1|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|69
6169899|NCT01783444|21265733|P3|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|15
6169900|NCT01783444|21265734|P2|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|16
6169901|NCT01783444|21265735|P1|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|7
6169902|NCT01783444|21265733|P3|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|0
6169903|NCT01783444|21265734|P2|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|1
6169904|NCT01783444|21265735|P1|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|0
6169905|NCT01783444|21265733|P3|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|8
6169906|NCT01783444|21265734|P2|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|8
6169907|NCT01783444|21265735|P1|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|4
6169908|NCT01783444|21265733|P3|Post-Treatment Efficacy Follow-Up Phase|Death|5
6169909|NCT01783444|21265734|P2|Post-Treatment Efficacy Follow-Up Phase|Death|7
6169910|NCT01783444|21265735|P1|Post-Treatment Efficacy Follow-Up Phase|Death|9
6169911|NCT01783444|21265733|P3|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|11
6169912|NCT01783444|21265734|P2|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|8
6169913|NCT01783444|21265735|P1|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|7
6169914|NCT01783444|21265733|P3|Treatment Phase|Physician Decision|5
6169915|NCT01783444|21265734|P2|Treatment Phase|Physician Decision|6
6169916|NCT01783444|21265735|P1|Treatment Phase|Physician Decision|8
6169917|NCT01783444|21265733|P3|Treatment Phase|Administrative problems|1
6169918|NCT01783444|21265734|P2|Treatment Phase|Administrative problems|0
6169919|NCT01783444|21265735|P1|Treatment Phase|Administrative problems|2
6169920|NCT01783444|21265733|P3|Treatment Phase|Withdrawal by Subject|9
6169921|NCT01783444|21265734|P2|Treatment Phase|Withdrawal by Subject|8
6169922|NCT01783444|21265735|P1|Treatment Phase|Withdrawal by Subject|6
6169923|NCT01783444|21265733|P3|Treatment Phase|Protocol Violation|2
6169924|NCT01783444|21265734|P2|Treatment Phase|Protocol Violation|1
6169925|NCT01783444|21265735|P1|Treatment Phase|Protocol Violation|1
6169926|NCT01783444|21265733|P3|Treatment Phase|Death|2
6169927|NCT01783444|21265734|P2|Treatment Phase|Death|2
6169928|NCT01783444|21265735|P1|Treatment Phase|Death|2
6169929|NCT01783444|21265733|P3|Treatment Phase|Disease Progression|64
6169930|NCT01783444|21265734|P2|Treatment Phase|Disease Progression|66
6169931|NCT01783444|21265735|P1|Treatment Phase|Disease Progression|76
6169932|NCT01783444|21265733|P3|Treatment Phase|Adverse Event|19
6169933|NCT01783444|21265734|P2|Treatment Phase|Adverse Event|20
6169934|NCT01783444|21265735|P1|Treatment Phase|Adverse Event|9
6169935|NCT01714817|21265773|P2|Long-Term Extension (LTE) Period|Study was terminated|1
6169936|NCT01714817|21265774|P1|Long-Term Extension (LTE) Period|Study was terminated|0
6169937|NCT01714817|21265773|P2|Long-Term Extension (LTE) Period|Investigator decision, study termination|1
6169938|NCT01714817|21265774|P1|Long-Term Extension (LTE) Period|Investigator decision, study termination|0
6169939|NCT01714817|21265773|P2|Long-Term Extension (LTE) Period|Absence of renal response|1
6169940|NCT01714817|21265774|P1|Long-Term Extension (LTE) Period|Absence of renal response|0
6169941|NCT01714817|21265773|P2|Long-Term Extension (LTE) Period|Completed Year 2, did not enter LTE|38
6169942|NCT01714817|21265774|P1|Long-Term Extension (LTE) Period|Completed Year 2, did not enter LTE|33
6169943|NCT01714817|21265773|P2|Long-Term Extension (LTE) Period|Participant no longer meets criteria|0
6169944|NCT01714817|21265774|P1|Long-Term Extension (LTE) Period|Participant no longer meets criteria|1
6169945|NCT01714817|21265773|P2|Long-Term Extension (LTE) Period|Study drug toxicity|0
6169946|NCT01714817|21265774|P1|Long-Term Extension (LTE) Period|Study drug toxicity|1
6169947|NCT01714817|21265773|P2|Long-Term Extension (LTE) Period|Pregnancy|0
6169948|NCT01714817|21265774|P1|Long-Term Extension (LTE) Period|Pregnancy|1
6169949|NCT01714817|21265773|P2|Long-Term Extension (LTE) Period|Lost to Follow-up|1
6169950|NCT01714817|21265774|P1|Long-Term Extension (LTE) Period|Lost to Follow-up|0
6169951|NCT01714817|21265773|P2|Long-Term Extension (LTE) Period|Adverse Event unrelated to study drug|0
6169952|NCT01714817|21265774|P1|Long-Term Extension (LTE) Period|Adverse Event unrelated to study drug|1
6169953|NCT01714817|21265773|P2|Long-Term Extension (LTE) Period|Participant withdrew consent|1
6169954|NCT01714817|21265774|P1|Long-Term Extension (LTE) Period|Participant withdrew consent|1
6169955|NCT01714817|21265773|P2|Long-Term Extension (LTE) Period|Participant request to stop treatment|1
6169956|NCT01714817|21265774|P1|Long-Term Extension (LTE) Period|Participant request to stop treatment|1
6169957|NCT01714817|21265773|P2|Long-Term Extension (LTE) Period|Not effective|1
6169958|NCT01714817|21265774|P1|Long-Term Extension (LTE) Period|Not effective|0
6169959|NCT01714817|21265773|P2|Long-Term Extension (LTE) Period|Disease progression|4
6169960|NCT01714817|21265774|P1|Long-Term Extension (LTE) Period|Disease progression|1
6169961|NCT01714817|21265773|P2|Long-Term Extension (LTE) Period|Administrative reason by Sponsor|21
6169962|NCT01714817|21265774|P1|Long-Term Extension (LTE) Period|Administrative reason by Sponsor|27
6169963|NCT01714817|21265773|P2|Year 2 Period|Given cyclophosphamide, corticosteroids|1
6169964|NCT01714817|21265774|P1|Year 2 Period|Given cyclophosphamide, corticosteroids|0
6169965|NCT01714817|21265773|P2|Year 2 Period|Completed Year 1, did not enter Year 2|1
6169966|NCT01714817|21265774|P1|Year 2 Period|Completed Year 1, did not enter Year 2|2
6169967|NCT01714817|21265773|P2|Year 2 Period|Pregnancy|1
6169968|NCT01714817|21265774|P1|Year 2 Period|Pregnancy|1
6169969|NCT01714817|21265773|P2|Year 2 Period|Participant went to US stopped treatment|1
6169970|NCT01714817|21265774|P1|Year 2 Period|Participant went to US stopped treatment|0
6169971|NCT01714817|21265773|P2|Year 2 Period|Lost to Follow-up|0
6169972|NCT01714817|21265774|P1|Year 2 Period|Lost to Follow-up|2
6169973|NCT01714817|21265773|P2|Year 2 Period|Participant no longer meets criteria|4
6169974|NCT01714817|21265774|P1|Year 2 Period|Participant no longer meets criteria|1
6169975|NCT01714817|21265773|P2|Year 2 Period|Participant withdrew consent|5
6169976|NCT01714817|21265774|P1|Year 2 Period|Participant withdrew consent|1
6169977|NCT01714817|21265773|P2|Year 2 Period|Administrative reason by Sponsor|3
6169978|NCT01714817|21265774|P1|Year 2 Period|Administrative reason by Sponsor|4
6169979|NCT01714817|21265773|P2|Year 2 Period|Participant request to stop treatment|4
6169980|NCT01714817|21265774|P1|Year 2 Period|Participant request to stop treatment|4
6169981|NCT01714817|21265773|P2|Year 2 Period|Adverse Event|6
6169982|NCT01714817|21265774|P1|Year 2 Period|Adverse Event|7
6169983|NCT01714817|21265773|P2|Year 2 Period|Lack of Efficacy|12
6169984|NCT01714817|21265774|P1|Year 2 Period|Lack of Efficacy|4
6169985|NCT01714817|21265773|P2|Year 1 Period|Hypersensitivity to the medication|1
6169986|NCT01714817|21265774|P1|Year 1 Period|Hypersensitivity to the medication|0
6169987|NCT01714817|21265773|P2|Year 1 Period|Antiproteinuric changed/dose increased|1
6169988|NCT01714817|21265774|P1|Year 1 Period|Antiproteinuric changed/dose increased|0
6169989|NCT01714817|21265773|P2|Year 1 Period|Need of use of Prohibited Medications|0
6169990|NCT01714817|21265774|P1|Year 1 Period|Need of use of Prohibited Medications|1
6169991|NCT01714817|21265773|P2|Year 1 Period|Change in Concomitant Medication|1
6169992|NCT01714817|21265774|P1|Year 1 Period|Change in Concomitant Medication|0
6169993|NCT01714817|21265773|P2|Year 1 Period|Not treated- received ACE inhibition|0
6169994|NCT01714817|21265774|P1|Year 1 Period|Not treated- received ACE inhibition|1
6169995|NCT01714817|21265773|P2|Year 1 Period|Participant no longer meets criteria|2
6169996|NCT01714817|21265774|P1|Year 1 Period|Participant no longer meets criteria|6
6169997|NCT01714817|21265773|P2|Year 1 Period|Pregnancy|0
6169998|NCT01714817|21265774|P1|Year 1 Period|Pregnancy|2
6169999|NCT01714817|21265773|P2|Year 1 Period|Poor / non-compliance|1
6170000|NCT01714817|21265774|P1|Year 1 Period|Poor / non-compliance|0
6170001|NCT01714817|21265773|P2|Year 1 Period|Lost to Follow-up|2
6170002|NCT01714817|21265774|P1|Year 1 Period|Lost to Follow-up|0
6170003|NCT01714817|21265773|P2|Year 1 Period|Death|1
6170004|NCT01714817|21265774|P1|Year 1 Period|Death|1
6170005|NCT01714817|21265773|P2|Year 1 Period|Withdrawal by Subject|7
6170006|NCT01714817|21265774|P1|Year 1 Period|Withdrawal by Subject|6
6170007|NCT01714817|21265773|P2|Year 1 Period|Adverse Event|17
6170008|NCT01714817|21265774|P1|Year 1 Period|Adverse Event|20
6170009|NCT01714817|21265773|P2|Year 1 Period|Lack of Efficacy|9
6170010|NCT01714817|21265774|P1|Year 1 Period|Lack of Efficacy|11
6170011|NCT01610206|21265870|P2|Overall Study|Adverse Event|30
6170012|NCT01610206|21265871|P1|Overall Study|Adverse Event|10
6170013|NCT01605071|21265881|P2|Overall Study|Withdrawal by Subject|2
6170014|NCT01605071|21265882|P1|Overall Study|Withdrawal by Subject|3
6170015|NCT01379573|21265926|P1|Overall Study|Screen Failure|10
6170016|NCT01379573|21265926|P1|Overall Study|Lost to Follow-up|1
6170017|NCT01311024|21265940|P2|Overall Study|Protocol Violation|22
6170018|NCT01311024|21265941|P1|Overall Study|Protocol Violation|35
6170019|NCT01254409|21265951|P4|Overall Study|Adverse Event|0
6170020|NCT01254409|21265952|P3|Overall Study|Adverse Event|0
6170021|NCT01254409|21265953|P2|Overall Study|Adverse Event|1
6170022|NCT01254409|21265954|P1|Overall Study|Adverse Event|0
6170023|NCT01209624|21266006|P1|Overall Study|Other|4
6170024|NCT01209624|21266006|P1|Overall Study|Lost to Follow-up|290
6170025|NCT01209624|21266006|P1|Overall Study|Lack of Efficacy|17
6170026|NCT01209624|21266006|P1|Overall Study|Adverse Event|13
6170027|NCT01209624|21266006|P1|Overall Study|Death|2
6170028|NCT01136811|21266068|P1|Overall Study|Physician Decision|11
6170029|NCT01129024|21266075|P1|Overall Study|Needed a Platelet Transfusion|1
6170030|NCT01129024|21266075|P1|Overall Study|Lack of Efficacy|3
6170031|NCT01129024|21266075|P1|Overall Study|Withdrawal by Subject|2
6170032|NCT01129024|21266075|P1|Overall Study|Study Terminated by Sponsor|8
6170033|NCT01129024|21266075|P1|Overall Study|Physician Decision|5
6170034|NCT01064648|21266087|P4|Phase II|Under Review|0
6170035|NCT01064648|21266088|P3|Phase II|Under Review|2
6170036|NCT01064648|21266089|P2|Phase II|Under Review|0
6170037|NCT01064648|21266090|P1|Phase II|Under Review|0
6170038|NCT01064648|21266087|P4|Phase II|Non-protocol specified|3
6170039|NCT01064648|21266088|P3|Phase II|Non-protocol specified|5
6170040|NCT01064648|21266089|P2|Phase II|Non-protocol specified|0
6170041|NCT01064648|21266090|P1|Phase II|Non-protocol specified|0
6170042|NCT01064648|21266087|P4|Phase II|Progression|27
6170043|NCT01064648|21266088|P3|Phase II|Progression|21
6170044|NCT01064648|21266089|P2|Phase II|Progression|0
6170045|NCT01064648|21266090|P1|Phase II|Progression|0
6170046|NCT01064648|21266087|P4|Phase II|Withdrawal by Subject|5
6170047|NCT01064648|21266088|P3|Phase II|Withdrawal by Subject|2
6170048|NCT01064648|21266089|P2|Phase II|Withdrawal by Subject|0
6170049|NCT01064648|21266090|P1|Phase II|Withdrawal by Subject|0
6170050|NCT01064648|21266087|P4|Phase II|Death|5
6170051|NCT01064648|21266088|P3|Phase II|Death|4
6170052|NCT01064648|21266089|P2|Phase II|Death|0
6170053|NCT01064648|21266090|P1|Phase II|Death|0
6170054|NCT01064648|21266087|P4|Phase II|Adverse Event|8
6170055|NCT01064648|21266088|P3|Phase II|Adverse Event|15
6170056|NCT01064648|21266089|P2|Phase II|Adverse Event|0
6170057|NCT01064648|21266090|P1|Phase II|Adverse Event|0
6170058|NCT01064648|21266087|P4|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0
6170059|NCT01064648|21266088|P3|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0
6170060|NCT01064648|21266089|P2|Phase I Cohort 2: Dose Level 2|Non-protocol specified|4
6170061|NCT01064648|21266090|P1|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0
6170062|NCT01064648|21266087|P4|Phase I Cohort 2: Dose Level 2|Progression|0
6170063|NCT01064648|21266088|P3|Phase I Cohort 2: Dose Level 2|Progression|0
6170064|NCT01064648|21266089|P2|Phase I Cohort 2: Dose Level 2|Progression|5
6170065|NCT01064648|21266090|P1|Phase I Cohort 2: Dose Level 2|Progression|0
6170066|NCT01064648|21266087|P4|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0
6170067|NCT01064648|21266088|P3|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0
6170068|NCT01064648|21266089|P2|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|1
6170069|NCT01064648|21266090|P1|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0
6170070|NCT01064648|21266087|P4|Phase I Cohort 2: Dose Level 2|Adverse Event|0
6170071|NCT01064648|21266088|P3|Phase I Cohort 2: Dose Level 2|Adverse Event|0
6170072|NCT01064648|21266089|P2|Phase I Cohort 2: Dose Level 2|Adverse Event|3
6170073|NCT01064648|21266090|P1|Phase I Cohort 2: Dose Level 2|Adverse Event|0
6170074|NCT01064648|21266087|P4|Phase I Cohort1: Dose Level 1|Non-protocol specified|0
6170075|NCT01064648|21266088|P3|Phase I Cohort1: Dose Level 1|Non-protocol specified|0
6170076|NCT01064648|21266089|P2|Phase I Cohort1: Dose Level 1|Non-protocol specified|0
6170077|NCT01064648|21266090|P1|Phase I Cohort1: Dose Level 1|Non-protocol specified|2
6170078|NCT01064648|21266087|P4|Phase I Cohort1: Dose Level 1|Progression|0
6170079|NCT01064648|21266088|P3|Phase I Cohort1: Dose Level 1|Progression|0
6170080|NCT01064648|21266089|P2|Phase I Cohort1: Dose Level 1|Progression|0
6170081|NCT01064648|21266090|P1|Phase I Cohort1: Dose Level 1|Progression|5
6170082|NCT01051661|21266119|P6|Overall Study|Withdrawal by Subject|34
6170083|NCT01051661|21266120|P5|Overall Study|Withdrawal by Subject|12
6170084|NCT01051661|21266121|P4|Overall Study|Withdrawal by Subject|28
6170085|NCT01051661|21266122|P3|Overall Study|Withdrawal by Subject|13
6170086|NCT01051661|21266123|P2|Overall Study|Withdrawal by Subject|30
6170087|NCT01051661|21266124|P1|Overall Study|Withdrawal by Subject|16
6170088|NCT01051661|21266119|P6|Overall Study|Protocol Violation|1
6170089|NCT01051661|21266120|P5|Overall Study|Protocol Violation|2
6170090|NCT01051661|21266121|P4|Overall Study|Protocol Violation|1
6170091|NCT01051661|21266122|P3|Overall Study|Protocol Violation|0
6170092|NCT01051661|21266123|P2|Overall Study|Protocol Violation|0
6170093|NCT01051661|21266124|P1|Overall Study|Protocol Violation|0
6170094|NCT01051661|21266119|P6|Overall Study|Subject lost legal representation|0
6170095|NCT01051661|21266120|P5|Overall Study|Subject lost legal representation|1
6170096|NCT01051661|21266121|P4|Overall Study|Subject lost legal representation|0
6170097|NCT01051661|21266122|P3|Overall Study|Subject lost legal representation|0
6170098|NCT01051661|21266123|P2|Overall Study|Subject lost legal representation|0
6170099|NCT01051661|21266124|P1|Overall Study|Subject lost legal representation|0
6170100|NCT01051661|21266119|P6|Overall Study|Failure to comply with protocol|0
6170101|NCT01051661|21266120|P5|Overall Study|Failure to comply with protocol|0
6170102|NCT01051661|21266121|P4|Overall Study|Failure to comply with protocol|0
6170103|NCT01051661|21266122|P3|Overall Study|Failure to comply with protocol|2
6170104|NCT01051661|21266123|P2|Overall Study|Failure to comply with protocol|0
6170105|NCT01051661|21266124|P1|Overall Study|Failure to comply with protocol|0
6170106|NCT01051661|21266119|P6|Overall Study|Consent not received from both parents|1
6170107|NCT01051661|21266120|P5|Overall Study|Consent not received from both parents|0
6170108|NCT01051661|21266121|P4|Overall Study|Consent not received from both parents|0
6170109|NCT01051661|21266122|P3|Overall Study|Consent not received from both parents|0
6170110|NCT01051661|21266123|P2|Overall Study|Consent not received from both parents|0
6170111|NCT01051661|21266124|P1|Overall Study|Consent not received from both parents|0
6170112|NCT01051661|21266119|P6|Overall Study|Unable to attend visit(s)|2
6170113|NCT01051661|21266120|P5|Overall Study|Unable to attend visit(s)|3
6170114|NCT01051661|21266121|P4|Overall Study|Unable to attend visit(s)|1
6170115|NCT01051661|21266122|P3|Overall Study|Unable to attend visit(s)|2
6170116|NCT01051661|21266123|P2|Overall Study|Unable to attend visit(s)|4
6170117|NCT01051661|21266124|P1|Overall Study|Unable to attend visit(s)|2
6170118|NCT01051661|21266119|P6|Overall Study|Data not reliable|1
6170119|NCT01051661|21266120|P5|Overall Study|Data not reliable|0
6170120|NCT01051661|21266121|P4|Overall Study|Data not reliable|0
6170121|NCT01051661|21266122|P3|Overall Study|Data not reliable|0
6170122|NCT01051661|21266123|P2|Overall Study|Data not reliable|0
6170123|NCT01051661|21266124|P1|Overall Study|Data not reliable|1
6170124|NCT01051661|21266119|P6|Overall Study|Refused blood sampling|1
6170125|NCT01051661|21266120|P5|Overall Study|Refused blood sampling|0
6170126|NCT01051661|21266121|P4|Overall Study|Refused blood sampling|0
6170127|NCT01051661|21266122|P3|Overall Study|Refused blood sampling|0
6170128|NCT01051661|21266123|P2|Overall Study|Refused blood sampling|0
6170129|NCT01051661|21266124|P1|Overall Study|Refused blood sampling|0
6170130|NCT01051661|21266119|P6|Overall Study|Migrated/moved from study area|3
6170131|NCT01051661|21266120|P5|Overall Study|Migrated/moved from study area|7
6170132|NCT01051661|21266121|P4|Overall Study|Migrated/moved from study area|8
6170133|NCT01051661|21266122|P3|Overall Study|Migrated/moved from study area|6
6170134|NCT01051661|21266123|P2|Overall Study|Migrated/moved from study area|6
6170135|NCT01051661|21266124|P1|Overall Study|Migrated/moved from study area|1
6170136|NCT01051661|21266119|P6|Overall Study|Lost to Follow-up|24
6170137|NCT01051661|21266120|P5|Overall Study|Lost to Follow-up|10
6170138|NCT01051661|21266121|P4|Overall Study|Lost to Follow-up|17
6170139|NCT01051661|21266122|P3|Overall Study|Lost to Follow-up|15
6170140|NCT01051661|21266123|P2|Overall Study|Lost to Follow-up|22
6170141|NCT01051661|21266124|P1|Overall Study|Lost to Follow-up|13
6170142|NCT01051661|21266119|P6|Overall Study|Adverse Event|0
6170143|NCT01051661|21266120|P5|Overall Study|Adverse Event|0
6170144|NCT01051661|21266121|P4|Overall Study|Adverse Event|1
6170145|NCT01051661|21266122|P3|Overall Study|Adverse Event|1
6170146|NCT01051661|21266123|P2|Overall Study|Adverse Event|1
6170147|NCT01051661|21266124|P1|Overall Study|Adverse Event|1
6170148|NCT00955682|21266346|P2|Booster Period (Month 48- 49)|Lost to Follow-up|1
6170149|NCT00955682|21266347|P1|Booster Period (Month 48- 49)|Lost to Follow-up|1
6170150|NCT00950690|21266453|P1|Overall Study|Other|163
6170151|NCT00950690|21266453|P1|Overall Study|Lost to Follow-up|40
6170152|NCT00950690|21266453|P1|Overall Study|Lack of Efficacy|22
6170153|NCT00950690|21266453|P1|Overall Study|Adverse Event|15
6170154|NCT00950690|21266453|P1|Overall Study|Death|4
6170155|NCT00864097|21266471|P4|Overall Study|Other|1
6170156|NCT00864097|21266472|P3|Overall Study|Other|0
6170157|NCT00864097|21266473|P2|Overall Study|Other|0
6170158|NCT00864097|21266474|P1|Overall Study|Other|0
6170159|NCT00864097|21266471|P4|Overall Study|Randomized but not treated|0
6170160|NCT00864097|21266472|P3|Overall Study|Randomized but not treated|1
6170161|NCT00864097|21266473|P2|Overall Study|Randomized but not treated|0
6170162|NCT00864097|21266474|P1|Overall Study|Randomized but not treated|2
6170163|NCT00864097|21266471|P4|Overall Study|Terminated by sponsor|99
6170164|NCT00864097|21266472|P3|Overall Study|Terminated by sponsor|102
6170165|NCT00864097|21266473|P2|Overall Study|Terminated by sponsor|112
6170166|NCT00864097|21266474|P1|Overall Study|Terminated by sponsor|105
6170167|NCT00864097|21266471|P4|Overall Study|Protocol Violation|1
6170168|NCT00864097|21266472|P3|Overall Study|Protocol Violation|0
6170169|NCT00864097|21266473|P2|Overall Study|Protocol Violation|1
6170170|NCT00864097|21266474|P1|Overall Study|Protocol Violation|2
6170171|NCT00864097|21266471|P4|Overall Study|Withdrawal by Subject|12
6170172|NCT00864097|21266472|P3|Overall Study|Withdrawal by Subject|11
6170173|NCT00864097|21266473|P2|Overall Study|Withdrawal by Subject|11
6170174|NCT00864097|21266474|P1|Overall Study|Withdrawal by Subject|15
6170175|NCT00864097|21266471|P4|Overall Study|Lost to Follow-up|1
6170176|NCT00864097|21266472|P3|Overall Study|Lost to Follow-up|0
6170177|NCT00864097|21266473|P2|Overall Study|Lost to Follow-up|1
6170178|NCT00864097|21266474|P1|Overall Study|Lost to Follow-up|0
6170179|NCT00864097|21266471|P4|Overall Study|Lack of Efficacy|2
6170180|NCT00864097|21266472|P3|Overall Study|Lack of Efficacy|7
6170181|NCT00864097|21266473|P2|Overall Study|Lack of Efficacy|3
6170182|NCT00864097|21266474|P1|Overall Study|Lack of Efficacy|9
6170183|NCT00864097|21266471|P4|Overall Study|Adverse Event|9
6170184|NCT00864097|21266472|P3|Overall Study|Adverse Event|11
6170185|NCT00864097|21266473|P2|Overall Study|Adverse Event|8
6170186|NCT00864097|21266474|P1|Overall Study|Adverse Event|6
6170187|NCT00864097|21266471|P4|Overall Study|Death|0
6170188|NCT00864097|21266472|P3|Overall Study|Death|0
6170189|NCT00864097|21266473|P2|Overall Study|Death|1
6170190|NCT00864097|21266474|P1|Overall Study|Death|0
6170191|NCT00860574|21266576|P1|Overall Study|Relapse|1
6170192|NCT00860574|21266576|P1|Overall Study|Death|2
6170193|NCT00744471|21266591|P4|Overall Study|Lost to Follow-up|0
6170194|NCT00744471|21266592|P3|Overall Study|Lost to Follow-up|2
6170195|NCT00744471|21266593|P2|Overall Study|Lost to Follow-up|0
6170196|NCT00744471|21266594|P1|Overall Study|Lost to Follow-up|0
6170197|NCT00744471|21266591|P4|Overall Study|Lack of Efficacy|31
6170198|NCT00744471|21266592|P3|Overall Study|Lack of Efficacy|19
6170199|NCT00744471|21266593|P2|Overall Study|Lack of Efficacy|37
6170200|NCT00744471|21266594|P1|Overall Study|Lack of Efficacy|83
6170201|NCT00744471|21266591|P4|Overall Study|Other|2
6170202|NCT00744471|21266592|P3|Overall Study|Other|6
6170203|NCT00744471|21266593|P2|Overall Study|Other|3
6170204|NCT00744471|21266594|P1|Overall Study|Other|2
6170205|NCT00744471|21266591|P4|Overall Study|Entered extension study|91
6170206|NCT00744471|21266592|P3|Overall Study|Entered extension study|100
6170207|NCT00744471|21266593|P2|Overall Study|Entered extension study|84
6170208|NCT00744471|21266594|P1|Overall Study|Entered extension study|41
6170209|NCT00744471|21266591|P4|Overall Study|Protocol Violation|2
6170210|NCT00744471|21266592|P3|Overall Study|Protocol Violation|1
6170211|NCT00744471|21266593|P2|Overall Study|Protocol Violation|4
6170212|NCT00744471|21266594|P1|Overall Study|Protocol Violation|1
6170213|NCT00744471|21266591|P4|Overall Study|Withdrawal by Subject|12
6170214|NCT00744471|21266592|P3|Overall Study|Withdrawal by Subject|15
6170215|NCT00744471|21266593|P2|Overall Study|Withdrawal by Subject|9
6170216|NCT00744471|21266594|P1|Overall Study|Withdrawal by Subject|9
6170217|NCT00744471|21266591|P4|Overall Study|Adverse Event|9
6170218|NCT00744471|21266592|P3|Overall Study|Adverse Event|5
6170219|NCT00744471|21266593|P2|Overall Study|Adverse Event|7
6170220|NCT00744471|21266594|P1|Overall Study|Adverse Event|6
6170221|NCT00744471|21266591|P4|Overall Study|Death|1
6170222|NCT00744471|21266592|P3|Overall Study|Death|0
6170223|NCT00744471|21266593|P2|Overall Study|Death|0
6170224|NCT00744471|21266594|P1|Overall Study|Death|0
6170225|NCT00744471|21266591|P4|Overall Study|Randomized but not treated|0
6170226|NCT00744471|21266592|P3|Overall Study|Randomized but not treated|4
6170227|NCT00744471|21266593|P2|Overall Study|Randomized but not treated|1
6170228|NCT00744471|21266594|P1|Overall Study|Randomized but not treated|1
6170229|NCT00688181|21266720|P1|Overall Study|Non-clinical Reason|2
6170230|NCT00688181|21266720|P1|Overall Study|Unknown Reason|4
6170231|NCT00688181|21266720|P1|Overall Study|Lost to Follow-up|17
6170232|NCT00590681|21266727|P1|Overall Study|disease progression|1
6170233|NCT00590681|21266727|P1|Overall Study|Lost to Follow-up|1
6170234|NCT00590681|21266727|P1|Overall Study|Death|3
6170235|NCT00590681|21266727|P1|Overall Study|Adverse Event|8
6170236|NCT00590681|21266727|P1|Overall Study|Withdrawal by Subject|7
6170237|NCT00588770|21266738|P2|Overall Study|Patient non-compliance|2
6170238|NCT00588770|21266739|P1|Overall Study|Patient non-compliance|2
6170239|NCT00588770|21266738|P2|Overall Study|Physician discretion|0
6170240|NCT00588770|21266739|P1|Overall Study|Physician discretion|2
6170241|NCT00588770|21266738|P2|Overall Study|Lack of Efficacy|10
6170242|NCT00588770|21266739|P1|Overall Study|Lack of Efficacy|8
6170243|NCT00588770|21266738|P2|Overall Study|Not start protocol therapy|9
6170244|NCT00588770|21266739|P1|Overall Study|Not start protocol therapy|0
6170245|NCT00588770|21266738|P2|Overall Study|Other complicating disease|2
6170246|NCT00588770|21266739|P1|Overall Study|Other complicating disease|3
6170247|NCT00588770|21266738|P2|Overall Study|Alternative therapy|4
6170248|NCT00588770|21266739|P1|Overall Study|Alternative therapy|2
6170249|NCT00588770|21266738|P2|Overall Study|Withdrawal by Subject|25
6170250|NCT00588770|21266739|P1|Overall Study|Withdrawal by Subject|15
6170251|NCT00588770|21266738|P2|Overall Study|Death|22
6170252|NCT00588770|21266739|P1|Overall Study|Death|13
6170253|NCT00588770|21266738|P2|Overall Study|Adverse Event|58
6170254|NCT00588770|21266739|P1|Overall Study|Adverse Event|29
6170255|NCT00588770|21266738|P2|Overall Study|Disease progression|68
6170256|NCT00588770|21266739|P1|Overall Study|Disease progression|85
6170257|NCT00571519|21266756|P7|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0
6170258|NCT00571519|21266757|P6|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0
6170259|NCT00571519|21266758|P5|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0
6170260|NCT00571519|21266759|P4|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0
6170261|NCT00571519|21266760|P3|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|1
6170262|NCT00571519|21266761|P2|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0
6170263|NCT00571519|21266762|P1|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0
6170264|NCT00571519|21266756|P7|Overall Study|Termination of study by Sponsor|22
6170265|NCT00571519|21266757|P6|Overall Study|Termination of study by Sponsor|9
6170266|NCT00571519|21266758|P5|Overall Study|Termination of study by Sponsor|8
6170267|NCT00571519|21266759|P4|Overall Study|Termination of study by Sponsor|24
6170268|NCT00571519|21266760|P3|Overall Study|Termination of study by Sponsor|10
6170269|NCT00571519|21266761|P2|Overall Study|Termination of study by Sponsor|7
6170270|NCT00571519|21266762|P1|Overall Study|Termination of study by Sponsor|2
6170271|NCT00571519|21266756|P7|Overall Study|Therapeutic failure/lack of efficacy|0
6170272|NCT00571519|21266757|P6|Overall Study|Therapeutic failure/lack of efficacy|0
6170273|NCT00571519|21266758|P5|Overall Study|Therapeutic failure/lack of efficacy|0
6170274|NCT00571519|21266759|P4|Overall Study|Therapeutic failure/lack of efficacy|0
6170275|NCT00571519|21266760|P3|Overall Study|Therapeutic failure/lack of efficacy|0
6170276|NCT00571519|21266761|P2|Overall Study|Therapeutic failure/lack of efficacy|1
6170277|NCT00571519|21266762|P1|Overall Study|Therapeutic failure/lack of efficacy|0
6170278|NCT00571519|21266756|P7|Overall Study|Hyperglycemia meeting discontinuation criteria|0
6170279|NCT00571519|21266757|P6|Overall Study|Hyperglycemia meeting discontinuation criteria|0
6170280|NCT00571519|21266758|P5|Overall Study|Hyperglycemia meeting discontinuation criteria|0
6170281|NCT00571519|21266759|P4|Overall Study|Hyperglycemia meeting discontinuation criteria|1
6170282|NCT00571519|21266760|P3|Overall Study|Hyperglycemia meeting discontinuation criteria|1
6170283|NCT00571519|21266761|P2|Overall Study|Hyperglycemia meeting discontinuation criteria|0
6170284|NCT00571519|21266762|P1|Overall Study|Hyperglycemia meeting discontinuation criteria|1
6170285|NCT00571519|21266756|P7|Overall Study|Subject withdrew consent|2
6170286|NCT00571519|21266757|P6|Overall Study|Subject withdrew consent|1
6170287|NCT00571519|21266758|P5|Overall Study|Subject withdrew consent|1
6170288|NCT00571519|21266759|P4|Overall Study|Subject withdrew consent|2
6170289|NCT00571519|21266760|P3|Overall Study|Subject withdrew consent|0
6170290|NCT00571519|21266761|P2|Overall Study|Subject withdrew consent|1
6170291|NCT00571519|21266762|P1|Overall Study|Subject withdrew consent|0
6170292|NCT00565851|21266884|P8|Chemotherapy Assignment|Still On Chemotherapy|1
6170293|NCT00565851|21266885|P7|Chemotherapy Assignment|Still On Chemotherapy|0
6170294|NCT00565851|21266886|P6|Chemotherapy Assignment|Still On Chemotherapy|1
6170295|NCT00565851|21266887|P5|Chemotherapy Assignment|Still On Chemotherapy|0
6170296|NCT00565851|21266888|P4|Chemotherapy Assignment|Still On Chemotherapy|18
6170297|NCT00565851|21266889|P3|Chemotherapy Assignment|Still On Chemotherapy|0
6170298|NCT00565851|21266890|P2|Chemotherapy Assignment|Still On Chemotherapy|14
6170299|NCT00565851|21266891|P1|Chemotherapy Assignment|Still On Chemotherapy|0
6170300|NCT00565851|21266884|P8|Chemotherapy Assignment|Never Initiated Chemotherapy|2
6170301|NCT00565851|21266885|P7|Chemotherapy Assignment|Never Initiated Chemotherapy|0
6170302|NCT00565851|21266886|P6|Chemotherapy Assignment|Never Initiated Chemotherapy|2
6170303|NCT00565851|21266887|P5|Chemotherapy Assignment|Never Initiated Chemotherapy|0
6170304|NCT00565851|21266888|P4|Chemotherapy Assignment|Never Initiated Chemotherapy|18
6170305|NCT00565851|21266889|P3|Chemotherapy Assignment|Never Initiated Chemotherapy|3
6170306|NCT00565851|21266890|P2|Chemotherapy Assignment|Never Initiated Chemotherapy|9
6170307|NCT00565851|21266891|P1|Chemotherapy Assignment|Never Initiated Chemotherapy|9
6170308|NCT00486252|21266925|P1|Overall Study|Other|18
6170309|NCT00486252|21266925|P1|Overall Study|Lost to Follow-up|24
6170310|NCT00486252|21266925|P1|Overall Study|Lack of Efficacy|9
6170311|NCT00486252|21266925|P1|Overall Study|Adverse Event|7
6170312|NCT00445978|21266940|P1|Week 12 - Week 16 (20 mg/kg/Day)|Lost to Follow-up|1
6170313|NCT00445978|21266940|P1|Week 8 - Week 12 (10 mg/kg/Day)|Pregnancy|1
6170314|NCT00445978|21266940|P1|Week 4 - Week 8 (5 mg/kg/Day)|Withdrew Consent|1
6170315|NCT00445978|21266940|P1|Week 4 - Week 8 (5 mg/kg/Day)|Lost to Follow-up|1
6170316|NCT00445978|21266940|P1|Week 4 - Week 8 (5 mg/kg/Day)|Physician Decision|1
6170317|NCT00445978|21266940|P1|Week 4 - Week 8 (5 mg/kg/Day)|Adverse Event|1
6170318|NCT00445978|21266940|P1|Week 0 - Week 4 (2.5 mg/kg/Day)|Study Compliance|1
6170319|NCT00445978|21266940|P1|Week 0 - Week 4 (2.5 mg/kg/Day)|Physician Decision|1
6170320|NCT00445978|21266940|P1|Week 0 - Week 4 (2.5 mg/kg/Day)|Adverse Event|1
6170321|NCT00352027|21266986|P1|Overall Study|Progressive disease|3
6170322|NCT00085735|21267445|P6|Overall Study|Pt transferred to inst w/out study open|0
6170323|NCT00085735|21267446|P5|Overall Study|Pt transferred to inst w/out study open|0
6170324|NCT00085735|21267447|P4|Overall Study|Pt transferred to inst w/out study open|0
6170325|NCT00085735|21267448|P3|Overall Study|Pt transferred to inst w/out study open|0
6170326|NCT00085735|21267449|P2|Overall Study|Pt transferred to inst w/out study open|0
6170327|NCT00085735|21267450|P1|Overall Study|Pt transferred to inst w/out study open|1
6170328|NCT00085735|21267445|P6|Overall Study|Reason not documented|0
6170329|NCT00085735|21267446|P5|Overall Study|Reason not documented|1
6170330|NCT00085735|21267447|P4|Overall Study|Reason not documented|0
6170331|NCT00085735|21267448|P3|Overall Study|Reason not documented|1
6170332|NCT00085735|21267449|P2|Overall Study|Reason not documented|0
6170333|NCT00085735|21267450|P1|Overall Study|Reason not documented|1
6170334|NCT00085735|21267445|P6|Overall Study|Excess residual disease|4
6170335|NCT00085735|21267446|P5|Overall Study|Excess residual disease|1
6170336|NCT00085735|21267447|P4|Overall Study|Excess residual disease|1
6170337|NCT00085735|21267448|P3|Overall Study|Excess residual disease|1
6170338|NCT00085735|21267449|P2|Overall Study|Excess residual disease|2
6170339|NCT00085735|21267450|P1|Overall Study|Excess residual disease|2
6170340|NCT00085735|21267445|P6|Overall Study|Patient ineligible|8
6170341|NCT00085735|21267446|P5|Overall Study|Patient ineligible|17
6170342|NCT00085735|21267447|P4|Overall Study|Patient ineligible|7
6170343|NCT00085735|21267448|P3|Overall Study|Patient ineligible|3
6170344|NCT00085735|21267449|P2|Overall Study|Patient ineligible|0
6170345|NCT00085735|21267450|P1|Overall Study|Patient ineligible|1
6170346|NCT00085735|21267445|P6|Overall Study|Withdrawal by Subject|8
6170347|NCT00085735|21267446|P5|Overall Study|Withdrawal by Subject|7
6170348|NCT00085735|21267447|P4|Overall Study|Withdrawal by Subject|5
6170349|NCT00085735|21267448|P3|Overall Study|Withdrawal by Subject|4
6170350|NCT00085735|21267449|P2|Overall Study|Withdrawal by Subject|0
6170351|NCT00085735|21267450|P1|Overall Study|Withdrawal by Subject|1
6170352|NCT00085735|21267445|P6|Overall Study|Protocol Violation|0
6170353|NCT00085735|21267446|P5|Overall Study|Protocol Violation|0
6170354|NCT00085735|21267447|P4|Overall Study|Protocol Violation|0
6170355|NCT00085735|21267448|P3|Overall Study|Protocol Violation|0
6170356|NCT00085735|21267449|P2|Overall Study|Protocol Violation|0
6170357|NCT00085735|21267450|P1|Overall Study|Protocol Violation|1
6170358|NCT00085735|21267445|P6|Overall Study|Physician Decision|8
6170359|NCT00085735|21267446|P5|Overall Study|Physician Decision|11
6170360|NCT00085735|21267447|P4|Overall Study|Physician Decision|3
6170361|NCT00085735|21267448|P3|Overall Study|Physician Decision|2
6170362|NCT00085735|21267449|P2|Overall Study|Physician Decision|3
6170363|NCT00085735|21267450|P1|Overall Study|Physician Decision|2
6170364|NCT00085735|21267445|P6|Overall Study|Lost to Follow-up|0
6170365|NCT00085735|21267446|P5|Overall Study|Lost to Follow-up|1
6170366|NCT00085735|21267447|P4|Overall Study|Lost to Follow-up|0
6170367|NCT00085735|21267448|P3|Overall Study|Lost to Follow-up|0
6170368|NCT00085735|21267449|P2|Overall Study|Lost to Follow-up|1
6170369|NCT00085735|21267450|P1|Overall Study|Lost to Follow-up|0
6170370|NCT00085735|21267445|P6|Overall Study|Lack of Efficacy|3
6170371|NCT00085735|21267446|P5|Overall Study|Lack of Efficacy|4
6170372|NCT00085735|21267447|P4|Overall Study|Lack of Efficacy|3
6170373|NCT00085735|21267448|P3|Overall Study|Lack of Efficacy|6
6170374|NCT00085735|21267449|P2|Overall Study|Lack of Efficacy|4
6170375|NCT00085735|21267450|P1|Overall Study|Lack of Efficacy|2
6170376|NCT00085735|21267445|P6|Overall Study|Adverse Event|0
6170377|NCT00085735|21267446|P5|Overall Study|Adverse Event|0
6170378|NCT00085735|21267447|P4|Overall Study|Adverse Event|0
6170379|NCT00085735|21267448|P3|Overall Study|Adverse Event|0
6170380|NCT00085735|21267449|P2|Overall Study|Adverse Event|0
6170381|NCT00085735|21267450|P1|Overall Study|Adverse Event|1
